Number	of	Number	NN	B-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	lymphocytes	in	IN	B-PP	Olymphocytes	and	lymphocyte	NNS	B-NP	B-cell_typeand	their	and	CC	O	Otheir	sensitivity	their	PRP$	B-NP	Osensitivity	to	sensitivity	NN	I-NP	Oto	hormone	to	TO	B-PP	Ohormone	action	hormone	NN	B-NP	Oaction	.	action	NN	I-NP	O.	The	.	.	O	OThe	study	The	DT	B-NP	Ostudy	demonstrated	study	NN	I-NP	Odemonstrated	a	demonstrate	VBD	B-VP	Oa	decreased	a	DT	B-NP	Odecreased	level	decrease	VBN	I-NP	Olevel	of	level	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	(	receptor	NNS	I-NP	I-protein(	GR	(	(	O	OGR	)	GR	NN	B-NP	B-protein)	in	)	)	O	Oin	peripheral	in	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	lymphocytes	blood	NN	I-NP	I-cell_typelymphocytes	from	lymphocyte	NNS	I-NP	I-cell_typefrom	hypercholesterolemic	from	IN	B-PP	Ohypercholesterolemic	subjects	hypercholesterolemic	JJ	B-NP	Osubjects	","	subject	NNS	I-NP	O","	and	","	","	O	Oand	an	and	CC	O	Oan	elevated	an	DT	B-NP	Oelevated	level	elevate	VBN	I-NP	Olevel	in	level	NN	I-NP	Oin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	acute	with	IN	B-PP	Oacute	myocardial	acute	JJ	B-NP	Omyocardial	infarction	myocardial	JJ	I-NP	Oinfarction	.	infarction	NN	I-NP	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	lymphocytes	the	DT	B-NP	Olymphocytes	with	lymphocyte	NNS	I-NP	B-cell_typewith	a	with	IN	B-PP	Oa	high	a	DT	B-NP	Ohigh	GR	high	JJ	I-NP	OGR	number	GR	NN	I-NP	B-proteinnumber	","	number	NN	I-NP	O","	dexamethasone	","	","	O	Odexamethasone	inhibited	dexamethasone	NN	B-NP	Oinhibited	[	inhibit	VBD	B-VP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	#NAME?	]	)	I-NP	O#NAME?	and	#NAME?	NN	I-NP	Oand	[	and	CC	O	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	#NAME?	]	)	I-NP	O#NAME?	incorporation	#NAME?	NN	I-NP	Oincorporation	into	incorporation	NN	I-NP	Ointo	DNA	into	IN	B-PP	ODNA	and	DNA	NN	B-NP	Oand	cholesterol	and	CC	I-NP	Ocholesterol	","	cholesterol	NN	I-NP	O","	respectively	","	","	O	Orespectively	","	respectively	RB	B-ADVP	O","	in	","	","	O	Oin	the	in	IN	B-PP	Othe	same	the	DT	B-NP	Osame	manner	same	JJ	I-NP	Omanner	as	manner	NN	I-NP	Oas	in	as	IN	B-PP	Oin	the	in	IN	B-PP	Othe	control	the	DT	B-NP	Ocontrol	cells	control	NN	I-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	On	.	.	O	OOn	the	On	IN	B-PP	Othe	other	the	DT	B-NP	Oother	hand	other	JJ	I-NP	Ohand	","	hand	NN	I-NP	O","	a	","	","	O	Oa	decreased	a	DT	B-NP	Odecreased	GR	decrease	VBN	I-NP	OGR	number	GR	NN	I-NP	B-proteinnumber	resulted	number	NN	I-NP	Oresulted	in	result	VBD	B-VP	Oin	a	in	IN	B-PP	Oa	less	a	DT	B-NP	Oless	efficient	less	RBR	I-NP	Oefficient	dexamethasone	efficient	JJ	I-NP	Odexamethasone	inhibition	dexamethasone	NN	I-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	the	of	IN	B-PP	Othe	incorporation	the	DT	B-NP	Oincorporation	of	incorporation	NN	I-NP	Oof	labeled	of	IN	B-PP	Olabeled	compounds	label	VBN	B-NP	Ocompounds	.	compound	NNS	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	showed	datum	NNS	I-NP	Oshowed	that	show	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	sensitivity	the	DT	B-NP	Osensitivity	of	sensitivity	NN	I-NP	Oof	lymphocytes	of	IN	B-PP	Olymphocytes	to	lymphocyte	NNS	B-NP	B-cell_typeto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	changed	glucocorticoid	NNS	B-NP	Ochanged	only	change	VBD	B-VP	Oonly	with	only	RB	B-ADVP	Owith	a	with	IN	B-PP	Oa	decrease	a	DT	B-NP	Odecrease	of	decrease	NN	I-NP	Oof	GR	of	IN	B-PP	OGR	level	GR	NN	B-NP	B-proteinlevel	.	level	NN	I-NP	O.	[	.	.	O	O[	1	[	(	O	O1	","	1	CD	B-NP	B-protein","	25-Dihydroxyvitamin	","	","	O	I-protein25-Dihydroxyvitamin	D3	25-Dihydroxyvitamin	NN	B-NP	I-proteinD3	receptors	D3	NN	I-NP	I-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	lymphocytes	in	IN	B-PP	Olymphocytes	and	lymphocyte	NNS	B-NP	B-cell_typeand	T-	and	CC	O	OT-	and	T-	NN	B-NP	B-cell_typeand	B-lymphocyte	and	CC	I-NP	I-cell_typeB-lymphocyte	count	B-lymphocyte	NN	I-NP	I-cell_typecount	in	count	NN	I-NP	Oin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	glomerulonephritis	with	IN	B-PP	Oglomerulonephritis	]	glomerulonephritis	NN	B-NP	O]	Content	]	)	O	OContent	of	Content	NN	B-NP	Oof	receptors	of	IN	B-PP	Oreceptors	to	receptor	NNS	B-NP	Oto	hormonal	to	TO	B-PP	Ohormonal	form	hormonal	JJ	B-NP	Oform	of	form	NN	I-NP	Oof	vitamin	of	IN	B-PP	Ovitamin	D3	vitamin	NN	B-NP	OD3	","	D3	NN	I-NP	O","	1.25	","	","	O	O1.25	(	1.25	CD	B-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	","	2D3	NN	B-NP	O","	constituted	","	","	O	Oconstituted	27.3	constitute	VBD	B-VP	O27.3	fmole/mg	27.3	CD	B-NP	Ofmole/mg	of	fmole/mg	NN	I-NP	Oof	protein	of	IN	B-PP	Oprotein	in	protein	NN	B-NP	Oin	lymphocytes	in	IN	B-PP	Olymphocytes	of	lymphocyte	NNS	B-NP	B-cell_typeof	peripheric	of	IN	B-PP	Operipheric	blood	peripheric	JJ	B-NP	Oblood	of	blood	NN	I-NP	Oof	children	of	IN	B-PP	Ochildren	with	child	NNS	B-NP	Owith	glomerulonephritis	with	IN	B-PP	Oglomerulonephritis	.	glomerulonephritis	NN	B-NP	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	patients	the	DT	B-NP	Opatients	concentration	patient	NNS	I-NP	Oconcentration	of	concentration	NN	I-NP	Oof	total	of	IN	B-PP	Ototal	and	total	JJ	B-NP	Oand	ionized	and	CC	I-NP	Oionized	form	ionize	VBN	I-NP	Oform	of	form	NN	I-NP	Oof	Ca2+	of	IN	B-PP	OCa2+	was	Ca2+	NN	B-NP	Owas	decreased	be	VBD	B-VP	Odecreased	down	decrease	VBN	I-VP	Odown	to	down	RB	B-ADVP	Oto	2.04	to	TO	B-PP	O2.04	mmole/L	2.04	CD	B-NP	Ommole/L	and	mmole/L	NN	I-NP	Oand	1.09	and	CC	O	O1.09	mmole/L	1.09	CD	B-NP	Ommole/L	","	mmole/L	NN	I-NP	O","	respectively	","	","	O	Orespectively	","	respectively	RB	B-ADVP	O","	while	","	","	O	Owhile	an	while	IN	B-SBAR	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	parathormone	in	IN	B-PP	Oparathormone	(	parathormone	NN	B-NP	O(	PTH	(	(	O	OPTH	)	PTH	NN	B-NP	O)	by	)	)	O	Oby	36	by	IN	B-PP	O36	%	36	CD	B-NP	O%	and	%	NN	I-NP	Oand	a	and	CC	O	Oa	distinct	a	DT	B-NP	Odistinct	decrease	distinct	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	25	in	IN	B-PP	O25	(	25	CD	B-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	D	)	)	O	OD	concentration	D	NN	B-NP	Oconcentration	(	concentration	NN	I-NP	O(	lower	(	(	O	Olower	than	low	JJR	B-NP	Othan	1.25	than	IN	I-NP	O1.25	ng/ml	1.25	CD	I-NP	Ong/ml	)	ng/ml	NN	I-NP	O)	was	)	)	O	Owas	found	be	VBD	B-VP	Ofound	in	find	VBN	I-VP	Oin	blood	in	IN	B-PP	Oblood	;	blood	NN	B-NP	O;	content	;	:	O	Ocontent	of	content	NN	B-NP	Oof	cAMP	of	IN	B-PP	OcAMP	was	cAMP	NN	B-NP	Owas	also	be	VBD	B-VP	Oalso	decreased	also	RB	I-VP	Odecreased	in	decrease	VBN	I-VP	Oin	lymphocytes	in	IN	B-PP	Olymphocytes	by	lymphocyte	NNS	B-NP	B-cell_typeby	33	by	IN	B-PP	O33	%	33	CD	B-NP	O%	.	%	NN	I-NP	O.	At	.	.	O	OAt	the	At	IN	B-PP	Othe	same	the	DT	B-NP	Osame	time	same	JJ	I-NP	Otime	","	time	NN	I-NP	O","	total	","	","	O	Ototal	content	total	JJ	B-NP	Ocontent	of	content	NN	I-NP	Oof	T	of	IN	B-PP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	was	lymphocyte	NNS	I-NP	I-cell_typewas	decreased	be	VBD	B-VP	Odecreased	1.5-fold	decrease	VBN	I-VP	O1.5-fold	in	1.5-fold	RB	B-ADVP	Oin	peripheric	in	IN	B-PP	Operipheric	blood	peripheric	JJ	B-NP	Oblood	.	blood	NN	I-NP	O.	Treatment	.	.	O	OTreatment	with	Treatment	NN	B-NP	Owith	I-hydroxyvitamin	with	IN	B-PP	OI-hydroxyvitamin	D3	I-hydroxyvitamin	NN	B-NP	OD3	(	D3	NN	I-NP	O(	1-1.5	(	(	O	O1-1.5	mg	1-1.5	CD	B-NP	Omg	daily	mg	NN	I-NP	Odaily	","	daily	RB	B-ADVP	O","	within	","	","	O	Owithin	4	within	IN	B-PP	O4	weeks	4	CD	B-NP	Oweeks	)	week	NNS	I-NP	O)	led	)	)	O	Oled	to	lead	VBD	B-VP	Oto	normalization	to	TO	B-PP	Onormalization	of	normalization	NN	B-NP	Oof	total	of	IN	B-PP	Ototal	and	total	JJ	B-NP	Oand	ionized	and	CC	I-NP	Oionized	form	ionize	VBN	I-NP	Oform	of	form	NN	I-NP	Oof	Ca2+	of	IN	B-PP	OCa2+	and	Ca2+	NN	B-NP	Oand	of	and	CC	B-PP	Oof	25	of	IN	B-PP	O25	(	25	CD	B-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	D	)	)	O	OD	","	D	NN	B-NP	O","	but	","	","	O	Obut	did	but	CC	O	Odid	not	do	VBD	B-VP	Onot	affect	not	RB	I-VP	Oaffect	the	affect	VB	I-VP	Othe	PTH	the	DT	B-NP	OPTH	content	PTH	NN	I-NP	Ocontent	in	content	NN	I-NP	Oin	blood	in	IN	B-PP	Oblood	.	blood	NN	B-NP	O.	Concentration	.	.	O	OConcentration	of	Concentration	NN	B-NP	Oof	the	of	IN	B-PP	Othe	receptors	the	DT	B-NP	Oreceptors	to	receptor	NNS	I-NP	Oto	1.25	to	TO	B-PP	O1.25	(	1.25	CD	B-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	was	2D3	NN	B-NP	Owas	elevated	be	VBD	B-VP	Oelevated	up	elevate	VBN	I-VP	Oup	to	up	RB	B-NP	Oto	39.7	to	TO	I-NP	O39.7	fmole/mg	39.7	CD	I-NP	Ofmole/mg	after	fmole/mg	NN	I-NP	Oafter	I	after	IN	B-PP	OI	week	I	NN	B-NP	Oweek	of	week	NN	I-NP	Oof	the	of	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	","	treatment	NN	I-NP	O","	whereas	","	","	O	Owhereas	it	whereas	IN	O	Oit	was	it	PRP	B-NP	Owas	decreased	be	VBD	B-VP	Odecreased	to	decrease	VBN	I-VP	Oto	the	to	TO	B-PP	Othe	initial	the	DT	B-NP	Oinitial	level	initial	JJ	I-NP	Olevel	24.8	level	NN	I-NP	O24.8	fmole/mg	24.8	CD	I-NP	Ofmole/mg	within	fmole/mg	NN	I-NP	Owithin	4	within	IN	B-PP	O4	weeks	4	CD	B-NP	Oweeks	;	week	NNS	I-NP	O;	simultaneous	;	:	O	Osimultaneous	alteration	simultaneous	JJ	B-NP	Oalteration	in	alteration	NN	I-NP	Oin	the	in	IN	B-PP	Othe	cAMP	the	DT	B-NP	OcAMP	content	cAMP	NN	I-NP	Ocontent	was	content	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	lymphocytes	in	IN	B-PP	Olymphocytes	.	lymphocyte	NNS	B-NP	B-cell_type.	Treatment	.	.	O	OTreatment	with	Treatment	NN	B-NP	Owith	1-	with	IN	B-PP	O1-	(	1-	NN	B-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	D3	)	)	O	OD3	normalized	D3	NN	B-NP	Onormalized	also	normalize	VBD	B-VP	Oalso	the	also	RB	B-ADVP	Othe	T	the	DT	B-NP	OT	lymphocytes	T	NN	I-NP	B-cell_typelymphocytes	content	lymphocyte	NNS	I-NP	I-cell_typecontent	in	content	NN	I-NP	Oin	peripheric	in	IN	B-PP	Operipheric	blood	peripheric	JJ	B-NP	Oblood	.	blood	NN	I-NP	O.	The	.	.	O	OThe	data	The	DT	B-NP	Odata	obtained	datum	NNS	I-NP	Oobtained	suggest	obtain	VBN	B-VP	Osuggest	that	suggest	VBP	B-VP	Othat	under	that	IN	B-SBAR	Ounder	conditions	under	IN	B-PP	Oconditions	of	condition	NNS	B-NP	Oof	glomerulonephritis	of	IN	B-PP	Oglomerulonephritis	only	glomerulonephritis	NN	B-NP	Oonly	high	only	RB	B-NP	Ohigh	content	high	JJ	I-NP	Ocontent	of	content	NN	I-NP	Oof	receptors	of	IN	B-PP	Oreceptors	to	receptor	NNS	B-NP	Oto	1.25	to	TO	B-PP	O1.25	(	1.25	CD	B-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	in	2D3	NN	B-NP	Oin	lymphocytes	in	IN	B-PP	Olymphocytes	enabled	lymphocyte	NNS	B-NP	B-cell_typeenabled	to	enable	VBD	B-VP	Oto	perform	to	TO	I-VP	Operform	the	perform	VB	I-VP	Othe	cell	the	DT	B-NP	Ocell	response	cell	NN	I-NP	Oresponse	to	response	NN	I-NP	Oto	the	to	TO	B-PP	Othe	hormone	the	DT	B-NP	Ohormone	effect	hormone	NN	I-NP	Oeffect	.	effect	NN	I-NP	O.	Tumor	.	.	O	OTumor	and	Tumor	NN	B-NP	Oand	serum	and	CC	I-NP	Oserum	beta-2-microglobulin	serum	NN	I-NP	B-proteinbeta-2-microglobulin	expression	beta-2-microglobulin	NN	I-NP	I-proteinexpression	in	expression	NN	I-NP	Oin	women	in	IN	B-PP	Owomen	with	woman	NNS	B-NP	Owith	breast	with	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	.	cancer	NN	I-NP	O.	To	.	.	O	OTo	investigate	To	TO	B-VP	Oinvestigate	whether	investigate	VB	I-VP	Owhether	the	whether	IN	B-SBAR	Othe	tumor	the	DT	B-NP	Otumor	expression	tumor	NN	I-NP	Oexpression	of	expression	NN	I-NP	Oof	beta-2-microglobulin	of	IN	B-PP	Obeta-2-microglobulin	(	beta-2-microglobulin	NN	B-NP	B-protein(	beta	(	(	O	Obeta	2-M	beta	SYM	B-NP	B-protein2-M	)	2-M	NN	I-NP	I-protein)	could	)	)	O	Ocould	serve	could	MD	B-VP	Oserve	as	serve	VB	I-VP	Oas	a	as	IN	B-PP	Oa	marker	a	DT	B-NP	Omarker	of	marker	NN	I-NP	Oof	tumor	of	IN	B-PP	Otumor	biologic	tumor	NN	B-NP	Obiologic	behavior	biologic	JJ	I-NP	Obehavior	","	behavior	NN	I-NP	O","	the	","	","	O	Othe	authors	the	DT	B-NP	Oauthors	studied	author	NNS	I-NP	Ostudied	specimens	study	VBD	B-VP	Ospecimens	of	specimen	NNS	B-NP	Oof	breast	of	IN	B-PP	Obreast	carcinomas	breast	NN	B-NP	Ocarcinomas	from	carcinoma	NNS	I-NP	Ofrom	60	from	IN	B-PP	O60	consecutive	60	CD	B-NP	Oconsecutive	female	consecutive	JJ	I-NP	Ofemale	patients	female	JJ	I-NP	Opatients	.	patient	NNS	I-NP	O.	Presence	.	.	O	OPresence	of	Presence	NN	B-NP	Oof	beta	of	IN	B-PP	Obeta	2-M	beta	SYM	B-NP	B-protein2-M	was	2-M	NN	I-NP	I-proteinwas	analyzed	be	VBD	B-VP	Oanalyzed	by	analyze	VBN	I-VP	Oby	immunohistochemistry	by	IN	B-PP	Oimmunohistochemistry	.	immunohistochemistry	NN	B-NP	O.	No	.	.	O	ONo	significant	No	DT	B-NP	Osignificant	correlations	significant	JJ	I-NP	Ocorrelations	were	correlation	NNS	I-NP	Owere	found	be	VBD	B-VP	Ofound	between	find	VBN	I-VP	Obetween	tumor	between	IN	B-PP	Otumor	beta	tumor	NN	B-NP	B-proteinbeta	2-M	beta	NN	I-NP	I-protein2-M	expression	2-M	NN	I-NP	I-proteinexpression	and	expression	NN	I-NP	Oand	several	and	CC	O	Oseveral	histologic	several	JJ	B-NP	Ohistologic	attributes	histologic	JJ	I-NP	Oattributes	such	attribute	NNS	I-NP	Osuch	as	such	JJ	B-PP	Oas	type	as	IN	I-PP	Otype	","	type	NN	B-NP	O","	histologic	","	","	O	Ohistologic	and	histologic	JJ	B-NP	Oand	nuclear	and	CC	I-NP	Onuclear	grades	nuclear	JJ	I-NP	Ogrades	","	grade	NNS	I-NP	O","	mitotic	","	","	O	Omitotic	index	mitotic	JJ	B-NP	Oindex	","	index	NN	I-NP	O","	necrosis	","	","	O	Onecrosis	","	necrosis	NN	B-NP	O","	vascular	","	","	O	Ovascular	invasion	vascular	JJ	B-NP	Oinvasion	","	invasion	NN	I-NP	O","	and	","	","	O	Oand	lymphocytic	and	CC	O	Olymphocytic	infiltration	lymphocytic	JJ	B-NP	Oinfiltration	.	infiltration	NN	I-NP	O.	Likewise	.	.	O	OLikewise	","	Likewise	RB	B-ADVP	O","	beta	","	","	O	Obeta	2-M	beta	NN	B-NP	B-protein2-M	was	2-M	NN	I-NP	I-proteinwas	not	be	VBD	B-VP	Onot	associated	not	RB	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	markers	with	IN	B-PP	Omarkers	of	marker	NNS	B-NP	Oof	disease	of	IN	B-PP	Odisease	extension	disease	NN	B-NP	Oextension	such	extension	NN	I-NP	Osuch	as	such	JJ	B-PP	Oas	TNM	as	IN	I-PP	OTNM	","	TNM	NN	B-NP	B-protein","	(	","	","	O	O(	UICC	(	(	O	OUICC	","	UICC	NN	B-NP	O","	classification	","	","	O	Oclassification	of	classification	NN	B-NP	Oof	malignant	of	IN	B-PP	Omalignant	tumors	malignant	JJ	B-NP	Otumors	)	tumor	NNS	I-NP	O)	staging	)	)	O	Ostaging	and	stag	VBG	B-VP	Oand	axillary	and	CC	O	Oaxillary	lymph	axillary	JJ	B-NP	Olymph	node	lymph	NN	I-NP	Onode	involvement	node	NN	I-NP	Oinvolvement	or	involvement	NN	I-NP	Oor	with	or	CC	B-PP	Owith	estrogen	with	IN	B-PP	Oestrogen	","	estrogen	NN	B-NP	O","	progesterone	","	","	O	Oprogesterone	","	progesterone	NN	B-NP	O","	and	","	","	O	Oand	glucocorticoid	and	CC	O	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	levels	receptor	NN	I-NP	I-proteinlevels	.	level	NNS	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	there	","	","	O	Othere	was	there	EX	B-NP	Owas	a	be	VBD	B-VP	Oa	significantly	a	DT	B-NP	Osignificantly	positive	significantly	RB	I-NP	Opositive	association	positive	JJ	I-NP	Oassociation	between	association	NN	I-NP	Obetween	tumor	between	IN	B-PP	Otumor	beta	tumor	NN	B-NP	B-proteinbeta	2-M	beta	NN	I-NP	I-protein2-M	expression	2-M	NN	I-NP	I-proteinexpression	and	expression	NN	I-NP	Oand	the	and	CC	O	Othe	degree	the	DT	B-NP	Odegree	of	degree	NN	I-NP	Oof	lymphocytic	of	IN	B-PP	Olymphocytic	infiltration	lymphocytic	JJ	B-NP	Oinfiltration	in	infiltration	NN	I-NP	Oin	the	in	IN	B-PP	Othe	tumor	the	DT	B-NP	Otumor	tissue	tumor	NN	I-NP	Otissue	.	tissue	NN	I-NP	O.	Beta	.	.	O	OBeta	2-M	Beta	SYM	O	O2-M	serum	2-M	NN	B-NP	Oserum	levels	serum	NN	I-NP	Olevels	were	level	NNS	I-NP	Owere	determined	be	VBD	B-VP	Odetermined	by	determine	VBN	I-VP	Oby	an	by	IN	B-PP	Oan	enzyme-linked	an	DT	B-NP	Oenzyme-linked	immunosorbent	enzyme-linked	JJ	I-NP	Oimmunosorbent	assay	immunosorbent	JJ	I-NP	Oassay	in	assay	NN	I-NP	Oin	samples	in	IN	B-PP	Osamples	from	sample	NNS	B-NP	Ofrom	22	from	IN	B-PP	O22	of	22	CD	B-NP	Oof	the	of	IN	B-PP	Othe	above	the	DT	B-NP	Oabove	women	above	JJ	I-NP	Owomen	.	woman	NNS	I-NP	O.	Although	.	.	O	OAlthough	some	Although	IN	B-SBAR	Osome	of	some	DT	B-NP	Oof	the	of	IN	B-PP	Othe	highest	the	DT	B-NP	Ohighest	values	high	JJS	I-NP	Ovalues	had	value	NNS	I-NP	Ohad	been	have	VBD	B-VP	Obeen	obtained	be	VBN	I-VP	Oobtained	in	obtain	VBN	I-VP	Oin	women	in	IN	B-PP	Owomen	with	woman	NNS	B-NP	Owith	larger	with	IN	B-PP	Olarger	(	large	JJR	B-NP	O(	T4	(	(	I-NP	OT4	)	T4	NN	I-NP	O)	primary	)	)	I-NP	Oprimary	tumors	primary	JJ	I-NP	Otumors	","	tumor	NNS	I-NP	O","	the	","	","	O	Othe	authors	the	DT	B-NP	Oauthors	failed	author	NNS	I-NP	Ofailed	to	fail	VBD	B-VP	Oto	detect	to	TO	I-VP	Odetect	any	detect	VB	I-VP	Oany	statistical	any	DT	B-NP	Ostatistical	relationship	statistical	JJ	I-NP	Orelationship	between	relationship	NN	I-NP	Obetween	beta	between	IN	B-PP	Obeta	2-M	beta	SYM	B-NP	B-protein2-M	expression	2-M	NN	I-NP	I-proteinexpression	in	expression	NN	I-NP	Oin	the	in	IN	B-PP	Othe	tumor	the	DT	B-NP	Otumor	with	tumor	NN	I-NP	Owith	serum	with	IN	B-PP	Oserum	levels	serum	NN	B-NP	Olevels	or	level	NNS	I-NP	Oor	between	or	CC	B-PP	Obetween	serum	between	IN	B-PP	Oserum	beta	serum	NN	B-NP	B-proteinbeta	2-M	beta	NN	I-NP	I-protein2-M	and	2-M	NN	I-NP	I-proteinand	the	and	CC	O	Othe	above	the	DT	B-NP	Oabove	histologic	above	JJ	I-NP	Ohistologic	","	histologic	NN	I-NP	O","	laboratory	","	","	O	Olaboratory	","	laboratory	NN	B-NP	O","	and	","	","	O	Oand	clinical	and	CC	O	Oclinical	factors	clinical	JJ	B-NP	Ofactors	.	factor	NNS	I-NP	O.	[	.	.	O	O[	Preliminary	[	(	O	OPreliminary	observation	Preliminary	JJ	B-NP	Oobservation	of	observation	NN	I-NP	Oof	level	of	IN	B-PP	Olevel	free-form	level	NN	B-NP	Ofree-form	E	free-form	JJ	I-NP	OE	receptor	E	NN	I-NP	Oreceptor	levels	receptor	NN	I-NP	Olevels	in	level	NNS	I-NP	Oin	serum	in	IN	B-PP	Oserum	of	serum	NN	B-NP	Oof	normal	of	IN	B-PP	Onormal	childbearing-aged	normal	JJ	B-NP	Ochildbearing-aged	and	childbearing-aged	JJ	I-NP	Oand	pregnant	and	CC	I-NP	Opregnant	women	pregnant	JJ	I-NP	Owomen	]	woman	NNS	I-NP	O]	In	]	)	O	OIn	137	In	IN	B-PP	O137	cases	137	CD	B-NP	Ocases	of	case	NNS	I-NP	Oof	childbearing-aged	of	IN	B-PP	Ochildbearing-aged	and	childbearing-aged	JJ	B-NP	Oand	pregnant	and	CC	I-NP	Opregnant	women	pregnant	JJ	I-NP	Owomen	","	woman	NNS	I-NP	O","	free	","	","	O	Ofree	form	free	JJ	B-NP	Oform	E	form	NN	I-NP	OE	receptor	E	NN	I-NP	Oreceptor	levels	receptor	NN	I-NP	Olevels	(	level	NNS	I-NP	O(	sE	(	(	O	OsE	)	sE	NN	B-NP	B-protein)	in	)	)	O	Oin	serum	in	IN	B-PP	Oserum	were	serum	NN	B-NP	Owere	measured	be	VBD	B-VP	Omeasured	by	measure	VBN	I-VP	Oby	ELISA	by	IN	B-PP	OELISA	.	ELISA	NN	B-NP	O.	The	.	.	O	OThe	level	The	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	sE	of	IN	B-PP	OsE	was	sE	NN	B-NP	B-proteinwas	significantly	be	VBD	B-VP	Osignificantly	decreased	significantly	RB	I-VP	Odecreased	during	decrease	VBN	I-VP	Oduring	the	during	IN	B-PP	Othe	first	the	DT	B-NP	Ofirst	trimester	first	JJ	I-NP	Otrimester	","	trimester	NN	I-NP	O","	slightly	","	","	O	Oslightly	higher	slightly	RB	B-ADJP	Ohigher	in	high	JJR	I-ADJP	Oin	the	in	IN	B-PP	Othe	second	the	DT	B-NP	Osecond	trimester	second	JJ	I-NP	Otrimester	","	trimester	NN	I-NP	O","	and	","	","	O	Oand	recovered	and	CC	O	Orecovered	to	recover	VBD	B-VP	Oto	normal	to	TO	B-PP	Onormal	in	normal	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	third	the	DT	B-NP	Othird	trimester	third	JJ	I-NP	Otrimester	.	trimester	NN	I-NP	O.	The	.	.	O	OThe	level	The	DT	B-NP	Olevel	remained	level	NN	I-NP	Oremained	lower	remain	VBD	B-VP	Olower	in	low	JJR	B-ADJP	Oin	29	in	IN	B-PP	O29	PIH	29	CD	B-NP	OPIH	women	PIH	NN	I-NP	Owomen	but	woman	NNS	I-NP	Obut	appeared	but	CC	O	Oappeared	higher	appear	VBD	B-VP	Ohigher	in	high	JJR	B-ADVP	Oin	overdue	in	IN	B-PP	Ooverdue	pregnancies	overdue	JJ	B-NP	Opregnancies	as	pregnancy	NNS	I-NP	Oas	compared	as	IN	B-PP	Ocompared	with	compare	VBN	B-PP	Owith	the	with	IN	B-PP	Othe	normal	the	DT	B-NP	Onormal	3rd	normal	JJ	I-NP	O3rd	trimester	3rd	NN	I-NP	Otrimester	range	trimester	NN	I-NP	Orange	.	range	NN	I-NP	O.	The	.	.	O	OThe	results	The	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	there	that	IN	B-SBAR	Othere	is	there	EX	B-NP	Ois	a	be	VBZ	B-VP	Oa	relationship	a	DT	B-NP	Orelationship	between	relationship	NN	I-NP	Obetween	a	between	IN	B-PP	Oa	change	a	DT	B-NP	Ochange	in	change	NN	I-NP	Oin	T	in	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	function	cell	NN	I-NP	Ofunction	and	function	NN	I-NP	Oand	pregnancy	and	CC	I-NP	Opregnancy	.	pregnancy	NN	I-NP	O.	Kappa	.	.	O	OKappa	B-specific	Kappa	NN	B-NP	B-proteinB-specific	DNA	B-specific	JJ	I-NP	I-proteinDNA	binding	DNA	NN	I-NP	I-proteinbinding	proteins	binding	NN	I-NP	I-proteinproteins	:	protein	NNS	I-NP	I-protein:	role	:	:	O	Orole	in	role	NN	B-NP	Oin	the	in	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	interleukin-2	human	JJ	B-NP	B-DNAinterleukin-2	gene	interleukin-2	NN	I-NP	I-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	.	expression	NN	I-NP	O.	Transcriptional	.	.	O	OTranscriptional	activation	Transcriptional	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	interleukin-2	human	JJ	I-NP	B-DNAinterleukin-2	(	interleukin-2	NN	I-NP	I-DNA(	IL-2	(	(	O	I-DNAIL-2	)	IL-2	NN	B-NP	I-DNA)	gene	)	)	O	I-DNAgene	","	gene	NN	B-NP	I-DNA","	like	","	","	O	Olike	induction	like	IN	B-PP	Oinduction	of	induction	NN	B-NP	Oof	the	of	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	receptor	IL-2	NN	I-NP	B-DNAreceptor	alpha	receptor	NN	I-NP	I-DNAalpha	(	alpha	NN	I-NP	I-DNA(	IL-2R	(	(	O	I-DNAIL-2R	alpha	IL-2R	NN	B-NP	I-DNAalpha	)	alpha	NN	I-NP	I-DNA)	gene	)	)	O	I-DNAgene	and	gene	NN	B-NP	I-DNAand	the	and	CC	O	Othe	type	the	DT	B-NP	Otype	1	type	NN	I-NP	O1	human	1	CD	I-NP	Ohuman	immunodeficiency	human	JJ	I-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	(	virus	NN	I-NP	O(	HIV-1	(	(	O	OHIV-1	)	HIV-1	NN	B-NP	O)	","	)	)	O	O","	is	","	","	O	Ois	shown	be	VBZ	B-VP	Oshown	to	show	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	modulated	be	VB	I-VP	Omodulated	by	modulate	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	kappa	a	DT	B-NP	Okappa	B-like	kappa	NN	I-NP	B-DNAB-like	enhancer	B-like	JJ	I-NP	I-DNAenhancer	element	enhancer	NN	I-NP	I-DNAelement	.	element	NN	I-NP	I-DNA.	Mutation	.	.	O	OMutation	of	Mutation	NN	B-NP	Oof	a	of	IN	B-PP	Oa	kappa	a	DT	B-NP	Okappa	B	kappa	NN	I-NP	B-DNAB	core	B	NN	I-NP	I-DNAcore	sequence	core	NN	I-NP	I-DNAsequence	identified	sequence	NN	I-NP	I-DNAidentified	in	identify	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	(	promoter	NN	I-NP	I-DNA(	-206	(	(	O	O-206	to	-206	CD	B-NP	B-DNAto	-195	to	TO	O	I-DNA-195	)	-195	CD	B-NP	I-DNA)	partially	)	)	O	Opartially	inhibits	partially	RB	B-ADVP	Oinhibits	both	inhibit	VBZ	B-VP	Oboth	mitogen-	both	CC	O	Omitogen-	and	mitogen-	NN	B-NP	B-proteinand	HTLV-I	and	CC	O	OHTLV-I	Tax-mediated	HTLV-I	NN	B-NP	OTax-mediated	activation	Tax-mediated	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	this	of	IN	B-PP	Othis	transcription	this	DT	B-NP	Otranscription	unit	transcription	NN	I-NP	B-DNAunit	and	unit	NN	I-NP	I-DNAand	blocks	and	CC	O	Oblocks	the	block	VBZ	B-VP	Othe	specific	the	DT	B-NP	Ospecific	binding	specific	JJ	I-NP	Obinding	of	binding	NN	I-NP	Oof	two	of	IN	B-PP	Otwo	inducible	two	CD	B-NP	Oinducible	cellular	inducible	JJ	I-NP	Ocellular	factors	cellular	JJ	I-NP	B-proteinfactors	.	factor	NNS	I-NP	I-protein.	These	.	.	O	OThese	kappa	These	DT	B-NP	Okappa	B-specific	kappa	NN	I-NP	B-proteinB-specific	proteins	B-specific	JJ	I-NP	I-proteinproteins	(	protein	NNS	I-NP	I-protein(	80	(	(	O	O80	to	80	CD	B-NP	Oto	90	to	TO	I-NP	O90	and	90	CD	I-NP	Oand	50	and	CC	I-NP	O50	to	50	CD	I-NP	Oto	55	to	TO	I-NP	O55	kilodaltons	55	CD	I-NP	Okilodaltons	)	kilodalton	NNS	I-NP	O)	similarly	)	)	O	Osimilarly	interact	similarly	RB	B-ADVP	Ointeract	with	interact	VBP	B-VP	Owith	the	with	IN	B-PP	Othe	functional	the	DT	B-NP	Ofunctional	kappa	functional	JJ	I-NP	B-DNAkappa	B	kappa	NN	I-NP	I-DNAB	enhancer	B	NN	I-NP	I-DNAenhancer	present	enhancer	NN	I-NP	I-DNApresent	in	present	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	IL-2R	the	DT	B-NP	OIL-2R	alpha	IL-2R	NN	I-NP	B-DNAalpha	promoter	alpha	NN	I-NP	I-DNApromoter	.	promoter	NN	I-NP	I-DNA.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	these	that	IN	B-SBAR	Othese	kappa	these	DT	B-NP	Okappa	B-specific	kappa	NN	I-NP	B-proteinB-specific	proteins	B-specific	JJ	I-NP	I-proteinproteins	have	protein	NNS	I-NP	I-proteinhave	a	have	VBP	B-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	coordinate	the	DT	B-NP	Ocoordinate	regulation	coordinate	JJ	I-NP	Oregulation	of	regulation	NN	I-NP	Oof	this	of	IN	B-PP	Othis	growth	this	DT	B-NP	Ogrowth	factor-growth	growth	NN	I-NP	B-DNAfactor-growth	factor	factor-growth	NN	I-NP	I-DNAfactor	receptor	factor	NN	I-NP	I-DNAreceptor	gene	receptor	NN	I-NP	I-DNAgene	system	gene	NN	I-NP	I-DNAsystem	that	system	NN	I-NP	Othat	controls	that	WDT	B-NP	Ocontrols	T	control	VBZ	B-VP	OT	cell	T	NN	B-NP	B-cell_typecell	proliferation	cell	NN	I-NP	I-cell_typeproliferation	.	proliferation	NN	I-NP	O.	Novel	.	.	O	ONovel	region	Novel	JJ	B-NP	Oregion	within	region	NN	I-NP	Owithin	the	within	IN	B-PP	Othe	V	the	DT	B-NP	OV	kappa	V	NN	I-NP	B-DNAkappa	gene	kappa	NN	I-NP	I-DNAgene	promoter	gene	NN	I-NP	I-DNApromoter	is	promoter	NN	I-NP	I-DNAis	responsible	be	VBZ	B-VP	Oresponsible	for	responsible	JJ	B-ADJP	Ofor	tissue	for	IN	B-PP	Otissue	and	tissue	NN	B-NP	Oand	stage-specific	and	CC	O	Ostage-specific	expression	stage-specific	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	immunoglobulin	of	IN	B-PP	Oimmunoglobulin	genes	immunoglobulin	NN	B-NP	B-DNAgenes	in	gene	NNS	I-NP	I-DNAin	human	in	IN	B-PP	Ohuman	lymphoid	human	JJ	B-NP	B-cell_typelymphoid	neoplasms	lymphoid	JJ	I-NP	I-cell_typeneoplasms	.	neoplasm	NNS	I-NP	I-cell_type.	Immunoglobulin	.	.	O	OImmunoglobulin	gene-specific	Immunoglobulin	NN	B-NP	B-proteingene-specific	transacting	gene-specific	JJ	I-NP	I-proteintransacting	factors	transact	VBG	I-NP	I-proteinfactors	have	factor	NNS	I-NP	I-proteinhave	been	have	VBP	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	play	to	TO	I-VP	Oplay	a	play	VB	I-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	lymphoid	in	IN	B-PP	Olymphoid	tissue-specific	lymphoid	JJ	B-NP	Otissue-specific	expression	tissue-specific	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	immunoglobulin	of	IN	B-PP	Oimmunoglobulin	genes	immunoglobulin	NN	B-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	The	.	.	O	OThe	role	The	DT	B-NP	Orole	of	role	NN	I-NP	Oof	these	of	IN	B-PP	Othese	factors	these	DT	B-NP	Ofactors	in	factor	NNS	I-NP	Oin	B-cell	in	IN	B-PP	OB-cell	differentiation	B-cell	NN	B-NP	B-cell_typedifferentiation	and	differentiation	NN	I-NP	Oand	stage-specific	and	CC	O	Ostage-specific	expression	stage-specific	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	these	of	IN	B-PP	Othese	genes	these	DT	B-NP	Ogenes	is	gene	NNS	I-NP	Ois	","	be	VBZ	B-VP	O","	however	","	","	O	Ohowever	","	however	RB	B-ADVP	O","	not	","	","	O	Onot	fully	not	RB	O	Ofully	understood	fully	RB	B-VP	Ounderstood	.	understand	VBN	I-VP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	used	have	VBP	B-VP	Oused	a	use	VBN	I-VP	Oa	model	a	DT	B-NP	Omodel	of	model	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	lymphoid	human	JJ	B-NP	Olymphoid	neoplasia	lymphoid	JJ	I-NP	Oneoplasia	to	neoplasia	NN	I-NP	Oto	address	to	TO	B-VP	Oaddress	this	address	VB	I-VP	Othis	question	this	DT	B-NP	Oquestion	.	question	NN	I-NP	O.	Different	.	.	O	ODifferent	fragments	Different	JJ	B-NP	Ofragments	of	fragment	NNS	I-NP	Oof	unrearranged	of	IN	B-PP	Ounrearranged	human	unrearranged	JJ	B-NP	Ohuman	variable	human	JJ	I-NP	Ovariable	region	variable	JJ	I-NP	Oregion	of	region	NN	I-NP	Oof	immunoglobulin	of	IN	B-PP	Oimmunoglobulin	kappa	immunoglobulin	NN	B-NP	B-DNAkappa	gene	kappa	NN	I-NP	I-DNAgene	(	gene	NN	I-NP	I-DNA(	V	(	(	O	OV	kappa	V	NN	B-NP	Okappa	)	kappa	NN	I-NP	O)	were	)	)	O	Owere	used	be	VBD	B-VP	Oused	for	use	VBN	I-VP	Ofor	cell-free	for	IN	B-PP	Ocell-free	in	cell-free	JJ	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	transcription	vitro	FW	I-NP	Otranscription	and	transcription	NN	I-NP	Oand	DNA	and	CC	I-NP	ODNA	mobility	DNA	NN	I-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assays	shift	NN	I-NP	Oassays	.	assay	NNS	I-NP	O.	Previously	.	.	O	OPreviously	described	Previously	RB	B-NP	Odescribed	enhancement	describe	VBN	I-NP	Oenhancement	of	enhancement	NN	I-NP	Oof	in	of	IN	B-PP	Oin	vitro	in	FW	B-NP	Ovitro	transcription	vitro	FW	I-NP	Otranscription	that	transcription	NN	I-NP	Othat	was	that	WDT	B-NP	Owas	only	be	VBD	B-VP	Oonly	seen	only	RB	I-VP	Oseen	with	see	VBN	I-VP	Owith	nuclear	with	IN	B-PP	Onuclear	extracts	nuclear	JJ	B-NP	Oextracts	derived	extract	NNS	I-NP	Oderived	from	derive	VBN	B-VP	Ofrom	B-cell	from	IN	B-PP	OB-cell	neoplasms	B-cell	NN	B-NP	B-cell_typeneoplasms	corresponding	neoplasm	NNS	I-NP	I-cell_typecorresponding	to	correspond	VBG	B-VP	Oto	the	to	TO	B-PP	Othe	late	the	DT	B-NP	Olate	stages	late	JJ	I-NP	Ostages	of	stage	NNS	I-NP	Oof	B-cell	of	IN	B-PP	OB-cell	differentiation	B-cell	NN	B-NP	Odifferentiation	was	differentiation	NN	I-NP	Owas	shown	be	VBD	B-VP	Oshown	to	show	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	dependent	be	VB	I-VP	Odependent	on	dependent	JJ	B-ADJP	Oon	the	on	IN	B-PP	Othe	actions	the	DT	B-NP	Oactions	of	action	NNS	I-NP	Oof	these	of	IN	B-PP	Othese	factor	these	DT	B-NP	Ofactor	(	factor	NN	I-NP	O(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	on	)	)	O	Oon	the	on	IN	B-PP	Othe	DNA	the	DT	B-NP	ODNA	region	DNA	NN	I-NP	B-DNAregion	within	region	NN	I-NP	I-DNAwithin	the	within	IN	B-PP	Othe	V	the	DT	B-NP	OV	kappa	V	NN	I-NP	B-DNAkappa	gene	kappa	NN	I-NP	I-DNAgene	promoter	gene	NN	I-NP	I-DNApromoter	.	promoter	NN	I-NP	I-DNA.	This	.	.	O	OThis	region	This	DT	B-NP	Oregion	is	region	NN	I-NP	Ois	located	be	VBZ	B-VP	Olocated	within	located	JJ	B-ADJP	Owithin	the	within	IN	B-PP	Othe	920	the	DT	B-NP	O920	bp	920	CD	I-NP	B-DNAbp	fragment	bp	NN	I-NP	I-DNAfragment	located	fragment	NN	I-NP	I-DNAlocated	210	located	JJ	I-NP	I-DNA210	bp	210	CD	I-NP	I-DNAbp	upstream	bp	NN	I-NP	I-DNAupstream	from	upstream	RB	B-ADVP	I-DNAfrom	the	from	IN	B-PP	Othe	coding	the	DT	B-NP	Ocoding	region	cod	VBG	I-NP	Oregion	and	region	NN	I-NP	Oand	this	and	CC	O	Othis	fragment	this	DT	B-NP	Ofragment	represents	fragment	NN	I-NP	Orepresents	a	represent	VBZ	B-VP	Oa	possible	a	DT	B-NP	Opossible	novel	possible	JJ	I-NP	Onovel	DNA	novel	JJ	I-NP	ODNA	region	DNA	NN	I-NP	B-DNAregion	","	region	NN	I-NP	I-DNA","	which	","	","	O	Owhich	plays	which	WDT	B-NP	Oplays	a	play	VBZ	B-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	stage-	the	DT	B-NP	Ostage-	and	stage-	NN	I-NP	Oand	tissue-specific	and	CC	O	Otissue-specific	expression	tissue-specific	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	immunoglobulin	of	IN	B-PP	Oimmunoglobulin	genes	immunoglobulin	NN	B-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	[	.	.	O	O[	Determination	[	(	O	ODetermination	of	Determination	NN	B-NP	Oof	the	of	IN	B-PP	Othe	sensitivity	the	DT	B-NP	Osensitivity	to	sensitivity	NN	I-NP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	in	glucocorticoid	NNS	B-NP	Oin	vitro	in	FW	B-ADVP	Ovitro	]	vitro	FW	I-ADVP	O]	A	]	)	O	OA	modified	A	DT	B-NP	Omodified	method	modify	VBN	I-NP	Omethod	for	method	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	determination	the	DT	B-NP	Odetermination	of	determination	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	lymphocytes	human	JJ	B-NP	B-cell_typelymphocytes	is	lymphocyte	NNS	I-NP	I-cell_typeis	suggested	be	VBZ	B-VP	Osuggested	.	suggest	VBN	I-VP	O.	The	.	.	O	OThe	principal	The	DT	B-NP	Oprincipal	distinction	principal	JJ	I-NP	Odistinction	of	distinction	NN	I-NP	Oof	the	of	IN	B-PP	Othe	method	the	DT	B-NP	Omethod	is	method	NN	I-NP	Ois	standardization	be	VBZ	B-VP	Ostandardization	by	standardization	NN	B-NP	Oby	the	by	IN	B-PP	Othe	lymphocyte	the	DT	B-NP	Olymphocyte	count	lymphocyte	NN	I-NP	Ocount	in	count	NN	I-NP	Oin	a	in	IN	B-PP	Oa	sample	a	DT	B-NP	Osample	(	sample	NN	I-NP	O(	1	(	(	O	O1	mln	1	CD	B-NP	Omln	)	mln	NN	I-NP	O)	and	)	)	O	Oand	the	and	CC	O	Othe	labeled	the	DT	B-NP	Olabeled	hormone	label	VBN	I-NP	Ohormone	concentration	hormone	NN	I-NP	Oconcentration	.	concentration	NN	I-NP	O.	The	.	.	O	OThe	modification	The	DT	B-NP	Omodification	saves	modification	NN	I-NP	Osaves	time	save	VBZ	B-VP	Otime	and	time	NN	B-NP	Oand	money	and	CC	I-NP	Omoney	","	money	NN	I-NP	O","	limits	","	","	O	Olimits	the	limit	VBZ	B-VP	Othe	range	the	DT	B-NP	Orange	of	range	NN	I-NP	Oof	the	of	IN	B-PP	Othe	data	the	DT	B-NP	Odata	variations	datum	NNS	I-NP	Ovariations	","	variation	NNS	I-NP	O","	and	","	","	O	Oand	makes	and	CC	O	Omakes	use	make	VBZ	B-VP	Ouse	of	use	NN	B-NP	Oof	a	of	IN	B-PP	Oa	lesser	a	DT	B-NP	Olesser	volume	less	JJR	I-NP	Ovolume	of	volume	NN	I-NP	Oof	blood	of	IN	B-PP	Oblood	.	blood	NN	B-NP	O.	Examinations	.	.	O	OExaminations	of	Examination	NNS	B-NP	Oof	70	of	IN	B-PP	O70	children	70	CD	B-NP	Ochildren	aged	child	NNS	I-NP	Oaged	4	age	VBN	B-ADJP	O4	to	4	CD	B-NP	Oto	15	to	TO	B-PP	O15	suffering	15	CD	B-NP	Osuffering	from	suffer	VBG	B-VP	Ofrom	the	from	IN	B-PP	Othe	nephrotic	the	DT	B-NP	Onephrotic	form	nephrotic	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	glomerulonephritis	of	IN	B-PP	Oglomerulonephritis	have	glomerulonephritis	NN	B-NP	Ohave	made	have	VBP	B-VP	Omade	it	make	VBN	I-VP	Oit	possible	it	PRP	B-NP	Opossible	to	possible	JJ	B-ADJP	Oto	distinguish	to	TO	B-VP	Odistinguish	two	distinguish	VB	I-VP	Otwo	groups	two	CD	B-NP	Ogroups	of	group	NNS	I-NP	Oof	patients	of	IN	B-PP	Opatients	:	patient	NNS	B-NP	O:	with	:	:	O	Owith	relatively	with	IN	B-PP	Orelatively	high	relatively	RB	B-NP	Ohigh	values	high	JJ	I-NP	Ovalues	of	value	NNS	I-NP	Oof	specific	of	IN	B-PP	Ospecific	binding	specific	JJ	B-NP	Obinding	X	binding	NN	I-NP	OX	=	X	NN	I-NP	O=	6820.1	=	SYM	B-VP	O6820.1	+/-	6820.1	CD	B-NP	O+/-	530	+/-	SYM	B-NP	O530	(	530	CD	I-NP	O(	n	(	(	O	On	=	n	NN	B-NP	O=	30	=	SYM	B-VP	O30	","	30	CD	B-NP	O","	p	","	","	O	Op	=	p	NN	B-NP	O=	0.95	=	SYM	B-VP	O0.95	","	0.95	CD	B-NP	O","	t	","	","	O	Ot	=	t	NN	B-NP	O=	2.04	=	JJ	B-VP	O2.04	)	2.04	CD	B-NP	O)	","	)	)	O	O","	this	","	","	O	Othis	corresponding	this	DT	B-NP	Ocorresponding	to	correspond	VBG	B-VP	Oto	a	to	TO	B-PP	Oa	clinical	a	DT	B-NP	Oclinical	form	clinical	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	hormone	of	IN	B-PP	Ohormone	#NAME?	hormone	NN	B-NP	O#NAME?	glomerulonephritis	#NAME?	JJ	I-NP	Oglomerulonephritis	","	glomerulonephritis	NN	I-NP	O","	and	","	","	O	Oand	with	and	CC	O	Owith	relatively	with	IN	B-PP	Orelatively	low	relatively	RB	B-NP	Olow	values	low	JJ	I-NP	Ovalues	of	value	NNS	I-NP	Oof	specific	of	IN	B-PP	Ospecific	binding	specific	JJ	B-NP	Obinding	X	binding	NN	I-NP	OX	=	X	NN	I-NP	O=	1815.2	=	SYM	B-VP	O1815.2	+/-	1815.2	CD	B-NP	O+/-	302.8	+/-	SYM	B-NP	O302.8	(	302.8	CD	I-NP	O(	n	(	(	O	On	=	n	NN	B-NP	O=	40	=	SYM	B-VP	O40	","	40	CD	B-NP	O","	p	","	","	O	Op	=	p	NN	B-NP	O=	0.95	=	SYM	B-VP	O0.95	","	0.95	CD	B-NP	O","	t	","	","	O	Ot	=	t	NN	B-NP	O=	1.96	=	JJ	B-VP	O1.96	)	1.96	CD	B-NP	O)	","	)	)	O	O","	that	","	","	O	Othat	corresponds	that	WDT	B-NP	Ocorresponds	to	correspond	VBZ	B-VP	Oto	hormone	to	TO	B-PP	Ohormone	#NAME?	hormone	NN	B-NP	O#NAME?	glomerulonephritis	#NAME?	JJ	I-NP	Oglomerulonephritis	.	glomerulonephritis	NN	I-NP	O.	Dynamic	.	.	O	ODynamic	studies	Dynamic	JJ	B-NP	Ostudies	have	study	NNS	I-NP	Ohave	not	have	VBP	B-VP	Onot	shown	not	RB	I-VP	Oshown	any	show	VBN	I-VP	Oany	statistically	any	DT	B-NP	Ostatistically	significant	statistically	RB	I-NP	Osignificant	changes	significant	JJ	I-NP	Ochanges	in	change	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	specific	the	DT	B-NP	Ospecific	binding	specific	JJ	I-NP	Obinding	values	binding	NN	I-NP	Ovalues	.	value	NNS	I-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	permit	result	NNS	I-NP	Opermit	regarding	permit	VBP	B-VP	Oregarding	the	regard	VBG	I-VP	Othe	specific	the	DT	B-NP	Ospecific	binding	specific	JJ	I-NP	Obinding	value	binding	NN	I-NP	Ovalue	as	value	NN	I-NP	Oas	a	as	IN	B-PP	Oa	prognostic	a	DT	B-NP	Oprognostic	criterion	prognostic	JJ	I-NP	Ocriterion	in	criterion	NN	I-NP	Oin	the	in	IN	B-PP	Othe	assessment	the	DT	B-NP	Oassessment	of	assessment	NN	I-NP	Oof	corticosteroid	of	IN	B-PP	Ocorticosteroid	therapy	corticosteroid	NN	B-NP	Otherapy	;	therapy	NN	I-NP	O;	this	;	:	O	Othis	allows	this	DT	B-NP	Oallows	a	allow	VBZ	B-VP	Oa	wide	a	DT	B-NP	Owide	employment	wide	JJ	I-NP	Oemployment	of	employment	NN	I-NP	Oof	the	of	IN	B-PP	Othe	described	the	DT	B-NP	Odescribed	method	describe	VBN	I-NP	Omethod	in	method	NN	I-NP	Oin	practical	in	IN	B-PP	Opractical	nephrology	practical	JJ	B-NP	Onephrology	.	nephrology	NN	I-NP	O.	Octamer-binding	.	.	O	OOctamer-binding	proteins	Octamer-binding	JJ	B-NP	B-proteinproteins	from	protein	NNS	I-NP	I-proteinfrom	B	from	IN	B-PP	OB	or	B	NN	B-NP	Oor	HeLa	or	CC	O	OHeLa	cells	HeLa	NN	B-NP	B-cell_linecells	stimulate	cell	NNS	I-NP	I-cell_linestimulate	transcription	stimulate	VBP	B-VP	Otranscription	of	transcription	NN	B-NP	Oof	the	of	IN	B-PP	Othe	immunoglobulin	the	DT	B-NP	Oimmunoglobulin	heavy-chain	immunoglobulin	NN	I-NP	B-DNAheavy-chain	promoter	heavy-chain	JJ	I-NP	I-DNApromoter	in	promoter	NN	I-NP	I-DNAin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	The	.	.	O	OThe	B-cell	The	DT	B-NP	OB-cell	#NAME?	B-cell	NN	I-NP	O#NAME?	specificity	#NAME?	JJ	I-NP	Ospecificity	of	specificity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	immunoglobulin	the	DT	B-NP	Oimmunoglobulin	(	immunoglobulin	NN	I-NP	B-DNA(	Ig	(	(	I-NP	I-DNAIg	)	Ig	NN	I-NP	I-DNA)	heavy-chain	)	)	I-NP	I-DNAheavy-chain	and	heavy-chain	JJ	I-NP	I-DNAand	light-chain	and	CC	I-NP	I-DNAlight-chain	promoters	light-chain	JJ	I-NP	I-DNApromoters	is	promoter	NNS	I-NP	I-DNAis	mediated	be	VBZ	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	an	by	IN	B-PP	Oan	octanucleotide	an	DT	B-NP	Ooctanucleotide	(	octanucleotide	NN	I-NP	B-DNA(	OCTA	(	(	O	I-DNAOCTA	)	OCTA	NN	B-NP	I-DNA)	element	)	)	O	I-DNAelement	","	element	NN	B-NP	I-DNA","	ATGCAAAT	","	","	O	OATGCAAAT	","	ATGCAAAT	NN	B-NP	O","	that	","	","	O	Othat	is	that	WDT	B-NP	Ois	also	be	VBZ	B-VP	Oalso	a	also	RB	B-ADVP	Oa	functional	a	DT	B-NP	Ofunctional	component	functional	JJ	I-NP	Ocomponent	of	component	NN	I-NP	Oof	other	of	IN	B-PP	Oother	RNA	other	JJ	B-NP	ORNA	polymerase	RNA	NN	I-NP	B-DNApolymerase	II	polymerase	NN	I-NP	I-DNAII	promoters	II	CD	B-NP	I-DNApromoters	","	promoter	NNS	I-NP	I-DNA","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	snRNA	as	IN	I-PP	OsnRNA	and	snRNA	NN	B-NP	B-DNAand	histone	and	CC	I-NP	I-DNAhistone	H2B	histone	NN	I-NP	I-DNAH2B	promoters	H2B	NN	I-NP	I-DNApromoters	.	promoter	NNS	I-NP	I-DNA.	Two	.	.	O	OTwo	nuclear	Two	CD	B-NP	Onuclear	proteins	nuclear	JJ	I-NP	B-proteinproteins	that	protein	NNS	I-NP	I-proteinthat	bind	that	WDT	B-NP	Obind	specifically	bind	VBP	B-VP	Ospecifically	and	specifically	RB	B-ADVP	Oand	with	and	CC	O	Owith	high	with	IN	B-PP	Ohigh	affinity	high	JJ	B-NP	Oaffinity	to	affinity	NN	I-NP	Oto	the	to	TO	B-PP	Othe	OCTA	the	DT	B-NP	OOCTA	element	OCTA	NN	I-NP	B-DNAelement	have	element	NN	I-NP	I-DNAhave	been	have	VBP	B-VP	Obeen	identified	be	VBN	I-VP	Oidentified	.	identify	VBN	I-VP	O.	NF-A1	.	.	O	ONF-A1	is	NF-A1	NN	B-NP	B-proteinis	present	be	VBZ	B-VP	Opresent	in	present	JJ	B-ADJP	Oin	a	in	IN	B-PP	Oa	variety	a	DT	B-NP	Ovariety	of	variety	NN	I-NP	Oof	cell	of	IN	B-PP	Ocell	types	cell	NN	B-NP	Otypes	","	type	NNS	I-NP	O","	whereas	","	","	O	Owhereas	the	whereas	IN	O	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	NF-A2	of	IN	B-PP	ONF-A2	is	NF-A2	NN	B-NP	B-proteinis	essentially	be	VBZ	B-VP	Oessentially	confined	essentially	RB	I-VP	Oconfined	to	confine	VBN	I-VP	Oto	B	to	TO	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	leading	","	","	O	Oleading	to	lead	VBG	B-VP	Oto	the	to	TO	B-PP	Othe	hypothesis	the	DT	B-NP	Ohypothesis	that	hypothesis	NN	I-NP	Othat	NF-A2	that	IN	B-SBAR	ONF-A2	activates	NF-A2	NN	B-NP	B-proteinactivates	cell-type-specific	activate	VBZ	B-VP	Ocell-type-specific	transcription	cell-type-specific	JJ	B-NP	Otranscription	of	transcription	NN	I-NP	Oof	the	of	IN	B-PP	Othe	Ig	the	DT	B-NP	OIg	promoter	Ig	NN	I-NP	B-DNApromoter	and	promoter	NN	I-NP	I-DNAand	NF-A1	and	CC	I-NP	ONF-A1	mediates	NF-A1	NN	I-NP	B-proteinmediates	the	mediate	VBZ	B-VP	Othe	other	the	DT	B-NP	Oother	responses	other	JJ	I-NP	Oresponses	of	response	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	OCTA	the	DT	B-NP	OOCTA	element	OCTA	NN	I-NP	B-DNAelement	.	element	NN	I-NP	I-DNA.	Extracts	.	.	O	OExtracts	of	Extract	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	B-cell	the	DT	B-NP	OB-cell	line	B-cell	NN	I-NP	B-cell_lineline	","	line	NN	I-NP	I-cell_line","	BJA-B	","	","	O	OBJA-B	","	BJA-B	NN	B-NP	B-cell_line","	contain	","	","	O	Ocontain	high	contain	VBP	B-VP	Ohigh	levels	high	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	NF-A2	of	IN	B-PP	ONF-A2	and	NF-A2	NN	B-NP	B-proteinand	specifically	and	CC	O	Ospecifically	transcribe	specifically	RB	B-VP	Otranscribe	Ig	transcribe	VBP	I-VP	OIg	promoters	Ig	NN	B-NP	B-DNApromoters	.	promoter	NNS	I-NP	I-DNA.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	extracts	","	","	O	Oextracts	from	extract	NNS	B-NP	Ofrom	HeLa	from	IN	B-PP	OHeLa	cells	HeLa	NN	B-NP	B-cell_linecells	transcribed	cell	NNS	I-NP	I-cell_linetranscribed	the	transcribe	VBD	B-VP	Othe	Ig	the	DT	B-NP	OIg	promoter	Ig	NN	I-NP	B-DNApromoter	poorly	promoter	NN	I-NP	I-DNApoorly	.	poorly	RB	B-ADVP	O.	Surprisingly	.	.	O	OSurprisingly	","	Surprisingly	RB	B-ADVP	O","	addition	","	","	O	Oaddition	of	addition	NN	B-NP	Oof	either	of	IN	B-PP	Oeither	affinity-enriched	either	CC	B-NP	Oaffinity-enriched	NF-A2	affinity-enriched	JJ	I-NP	ONF-A2	or	NF-A2	NN	I-NP	B-proteinor	NF-A1	or	CC	I-NP	ONF-A1	to	NF-A1	NN	I-NP	B-proteinto	either	to	TO	B-PP	Oeither	a	either	CC	O	Oa	HeLa	a	DT	B-NP	OHeLa	extract	HeLa	NN	I-NP	Oextract	or	extract	NN	I-NP	Oor	a	or	CC	O	Oa	partially	a	DT	B-NP	Opartially	purified	partially	RB	I-NP	Opurified	reaction	purify	VBN	I-NP	Oreaction	system	reaction	NN	I-NP	Osystem	specifically	system	NN	I-NP	Ospecifically	stimulates	specifically	RB	B-ADVP	Ostimulates	the	stimulate	VBZ	B-VP	Othe	Ig	the	DT	B-NP	OIg	promoter	Ig	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	This	.	.	O	OThis	suggests	This	DT	B-NP	Osuggests	that	suggest	VBZ	B-VP	Othat	the	that	IN	B-SBAR	Othe	constitutive	the	DT	B-NP	Oconstitutive	OCTA-binding	constitutive	JJ	I-NP	B-proteinOCTA-binding	factor	OCTA-binding	JJ	I-NP	I-proteinfactor	NF-A1	factor	NN	I-NP	I-proteinNF-A1	can	NF-A1	NN	I-NP	B-proteincan	activate	can	MD	B-VP	Oactivate	transcription	activate	VB	I-VP	Otranscription	of	transcription	NN	B-NP	Oof	the	of	IN	B-PP	Othe	Ig	the	DT	B-NP	OIg	promoter	Ig	NN	I-NP	B-DNApromoter	and	promoter	NN	I-NP	I-DNAand	that	and	CC	O	Othat	B-cell	that	IN	B-SBAR	OB-cell	#NAME?	B-cell	NN	B-NP	B-cell_type#NAME?	transcription	#NAME?	JJ	I-NP	Otranscription	of	transcription	NN	I-NP	Oof	this	of	IN	B-PP	Othis	promoter	this	DT	B-NP	Opromoter	","	promoter	NN	I-NP	B-DNA","	at	","	","	O	Oat	least	at	IN	B-ADVP	Oleast	in	least	JJS	I-ADVP	Oin	vitro	in	FW	B-ADVP	Ovitro	","	vitro	FW	I-ADVP	O","	is	","	","	O	Ois	partially	be	VBZ	B-VP	Opartially	due	partially	RB	B-ADJP	Odue	to	due	JJ	I-ADJP	Oto	a	to	TO	B-PP	Oa	quantitative	a	DT	B-NP	Oquantitative	difference	quantitative	JJ	I-NP	Odifference	in	difference	NN	I-NP	Oin	the	in	IN	B-PP	Othe	amount	the	DT	B-NP	Oamount	of	amount	NN	I-NP	Oof	OCTA-binding	of	IN	B-PP	OOCTA-binding	protein	OCTA-binding	JJ	B-NP	B-proteinprotein	.	protein	NN	I-NP	I-protein.	Because	.	.	O	OBecause	NF-A1	Because	IN	B-SBAR	ONF-A1	can	NF-A1	NN	B-NP	B-proteincan	stimulate	can	MD	B-VP	Ostimulate	Ig	stimulate	VB	I-VP	OIg	transcription	Ig	NN	B-NP	B-proteintranscription	","	transcription	NN	I-NP	O","	the	","	","	O	Othe	inability	the	DT	B-NP	Oinability	of	inability	NN	I-NP	Oof	this	of	IN	B-PP	Othis	factor	this	DT	B-NP	Ofactor	to	factor	NN	I-NP	Oto	activate	to	TO	B-VP	Oactivate	in	activate	VB	I-VP	Oin	vivo	in	FW	B-ADVP	Ovivo	the	vivo	FW	I-ADVP	Othe	Ig	the	DT	B-NP	OIg	promoter	Ig	NN	I-NP	B-DNApromoter	to	promoter	NN	I-NP	I-DNAto	the	to	TO	B-PP	Othe	same	the	DT	B-NP	Osame	degree	same	JJ	I-NP	Odegree	as	degree	NN	I-NP	Oas	the	as	IN	B-PP	Othe	snRNA	the	DT	B-NP	OsnRNA	promoters	snRNA	NN	I-NP	B-DNApromoters	probably	promoter	NNS	I-NP	I-DNAprobably	reflects	probably	RB	B-ADVP	Oreflects	a	reflect	VBZ	B-VP	Oa	difference	a	DT	B-NP	Odifference	in	difference	NN	I-NP	Oin	the	in	IN	B-PP	Othe	context	the	DT	B-NP	Ocontext	of	context	NN	I-NP	Oof	the	of	IN	B-PP	Othe	OCTA	the	DT	B-NP	OOCTA	element	OCTA	NN	I-NP	B-DNAelement	in	element	NN	I-NP	I-DNAin	these	in	IN	B-PP	Othese	two	these	DT	B-NP	Otwo	types	two	CD	I-NP	Otypes	of	type	NNS	I-NP	Oof	promoters	of	IN	B-PP	Opromoters	.	promoter	NNS	B-NP	B-DNA.	Identification	.	.	O	OIdentification	of	Identification	NN	B-NP	Oof	a	of	IN	B-PP	Oa	putative	a	DT	B-NP	Oputative	regulator	putative	JJ	I-NP	B-proteinregulator	of	regulator	NN	I-NP	I-proteinof	early	of	IN	B-PP	Oearly	T	early	JJ	B-NP	B-DNAT	cell	T	NN	I-NP	I-DNAcell	activation	cell	NN	I-NP	I-DNAactivation	genes	activation	NN	I-NP	I-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Molecules	.	.	O	OMolecules	involved	Molecule	NNS	B-NP	Oinvolved	in	involve	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	antigen	the	DT	B-NP	Oantigen	receptor-dependent	antigen	NN	I-NP	Oreceptor-dependent	regulation	receptor-dependent	JJ	I-NP	Oregulation	of	regulation	NN	I-NP	Oof	early	of	IN	B-PP	Oearly	T	early	JJ	B-NP	B-DNAT	cell	T	NN	I-NP	I-DNAcell	activation	cell	NN	I-NP	I-DNAactivation	genes	activation	NN	I-NP	I-DNAgenes	were	gene	NNS	I-NP	I-DNAwere	investigated	be	VBD	B-VP	Oinvestigated	with	investigate	VBN	I-VP	Owith	the	with	IN	B-PP	Othe	use	the	DT	B-NP	Ouse	of	use	NN	I-NP	Oof	functional	of	IN	B-PP	Ofunctional	sequences	functional	JJ	B-NP	Osequences	of	sequence	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	T	the	DT	B-NP	OT	cell	T	NN	I-NP	B-DNAcell	activation-specific	cell	NN	I-NP	I-DNAactivation-specific	enhancer	activation-specific	JJ	I-NP	I-DNAenhancer	of	enhancer	NN	I-NP	I-DNAof	interleukin-2	of	IN	B-PP	Ointerleukin-2	(	interleukin-2	NN	B-NP	B-protein(	IL-2	(	(	O	OIL-2	)	IL-2	NN	B-NP	B-protein)	.	)	)	O	O.	One	.	.	O	OOne	of	One	CD	B-NP	Oof	these	of	IN	B-PP	Othese	sequences	these	DT	B-NP	Osequences	forms	sequence	NNS	I-NP	Oforms	a	form	VBZ	B-VP	Oa	protein	a	DT	B-NP	Oprotein	complex	protein	NN	I-NP	B-proteincomplex	","	complex	NN	I-NP	I-protein","	NFAT-1	","	","	O	ONFAT-1	","	NFAT-1	NN	B-NP	B-protein","	specifically	","	","	O	Ospecifically	with	specifically	RB	B-ADVP	Owith	nuclear	with	IN	B-PP	Onuclear	extracts	nuclear	JJ	B-NP	Oextracts	of	extract	NNS	I-NP	Oof	activated	of	IN	B-PP	Oactivated	T	activate	VBN	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	This	.	.	O	OThis	complex	This	DT	B-NP	Ocomplex	appeared	complex	NN	I-NP	Oappeared	10	appear	VBD	B-VP	O10	to	10	CD	B-NP	Oto	25	to	TO	I-NP	O25	minutes	25	CD	I-NP	Ominutes	before	minute	NNS	I-NP	Obefore	the	before	IN	B-SBAR	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	gene	IL-2	NN	I-NP	B-DNAgene	.	gene	NN	I-NP	I-DNA.	Studies	.	.	O	OStudies	with	Study	NNS	B-NP	Owith	inhibitors	with	IN	B-PP	Oinhibitors	of	inhibitor	NNS	B-NP	Oof	protein	of	IN	B-PP	Oprotein	synthesis	protein	NN	B-NP	Osynthesis	indicated	synthesis	NN	I-NP	Oindicated	that	indicate	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	time	the	DT	B-NP	Otime	of	time	NN	I-NP	Oof	synthesis	of	IN	B-PP	Osynthesis	of	synthesis	NN	B-NP	Oof	the	of	IN	B-PP	Othe	activator	the	DT	B-NP	Oactivator	of	activator	NN	I-NP	Oof	the	of	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	gene	IL-2	NN	I-NP	B-DNAgene	in	gene	NN	I-NP	I-DNAin	Jurkat	in	IN	B-PP	OJurkat	T	Jurkat	NN	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	corresponds	cell	NNS	I-NP	I-cell_linecorresponds	to	correspond	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	time	the	DT	B-NP	Otime	of	time	NN	I-NP	Oof	appearance	of	IN	B-PP	Oappearance	of	appearance	NN	B-NP	Oof	NFAT-1	of	IN	B-PP	ONFAT-1	.	NFAT-1	NN	B-NP	B-protein.	NFAT-1	.	.	O	ONFAT-1	","	NFAT-1	NN	B-NP	B-protein","	or	","	","	O	Oor	a	or	CC	O	Oa	very	a	DT	B-NP	Overy	similar	very	RB	I-NP	Osimilar	protein	similar	JJ	I-NP	Oprotein	","	protein	NN	I-NP	O","	bound	","	","	O	Obound	functional	bind	VBD	B-VP	Ofunctional	sequences	functional	JJ	B-NP	Osequences	of	sequence	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	long	the	DT	B-NP	Olong	terminal	long	JJ	I-NP	B-DNAterminal	repeat	terminal	JJ	I-NP	I-DNArepeat	(	repeat	NN	I-NP	I-DNA(	LTR	(	(	O	OLTR	)	LTR	NN	B-NP	B-DNA)	of	)	)	O	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	immunodeficiency	human	JJ	I-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	;	1	CD	I-NP	O;	the	;	:	O	Othe	LTR	the	DT	B-NP	OLTR	of	LTR	NN	I-NP	B-DNAof	this	of	IN	B-PP	Othis	virus	this	DT	B-NP	Ovirus	is	virus	NN	I-NP	Ois	known	be	VBZ	B-VP	Oknown	to	know	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	stimulated	be	VB	I-VP	Ostimulated	during	stimulate	VBN	I-VP	Oduring	early	during	IN	B-PP	Oearly	T	early	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	activation	cell	NN	I-NP	Oactivation	.	activation	NN	I-NP	O.	The	.	.	O	OThe	binding	The	DT	B-NP	Obinding	site	bind	VBG	I-NP	B-DNAsite	for	site	NN	I-NP	I-DNAfor	this	for	IN	B-PP	Othis	complex	this	DT	B-NP	Ocomplex	activated	complex	NN	I-NP	Oactivated	a	activate	VBD	B-VP	Oa	linked	a	DT	B-NP	Olinked	promoter	link	VBN	I-NP	Opromoter	after	promoter	NN	I-NP	Oafter	transfection	after	IN	B-PP	Otransfection	into	transfection	NN	B-NP	Ointo	antigen	into	IN	B-PP	Oantigen	receptor-activated	antigen	NN	B-NP	B-cell_typereceptor-activated	T	receptor-activated	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	but	cell	NNS	I-NP	I-cell_typebut	not	but	CC	B-CONJP	Onot	other	not	RB	I-CONJP	Oother	cell	other	JJ	B-NP	Ocell	types	cell	NN	I-NP	Otypes	.	type	NNS	I-NP	O.	These	.	.	O	OThese	characteristics	These	DT	B-NP	Ocharacteristics	suggest	characteristic	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	NFAT-1	that	IN	B-SBAR	ONFAT-1	transmits	NFAT-1	NN	B-NP	B-proteintransmits	signals	transmit	VBZ	B-VP	Osignals	initiated	signal	NNS	B-NP	Oinitiated	at	initiate	VBN	B-VP	Oat	the	at	IN	B-PP	Othe	T	the	DT	B-NP	OT	cell	T	NN	I-NP	B-proteincell	antigen	cell	NN	I-NP	I-proteinantigen	receptor	antigen	NN	I-NP	I-proteinreceptor	.	receptor	NN	I-NP	I-protein.	Characterization	.	.	O	OCharacterization	of	Characterization	NN	B-NP	Oof	thyroid	of	IN	B-PP	Othyroid	hormone	thyroid	NN	B-NP	B-proteinhormone	receptors	hormone	NN	I-NP	I-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	IM-9	human	JJ	B-NP	B-cell_typeIM-9	lymphocytes	IM-9	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Although	.	.	O	OAlthough	putatively	Although	IN	B-SBAR	Oputatively	identified	putatively	RB	B-ADVP	Oidentified	more	identify	VBN	B-VP	Omore	than	more	JJR	B-NP	Othan	10	than	IN	I-NP	O10	years	10	CD	I-NP	Oyears	ago	year	NNS	I-NP	Oago	","	ago	IN	B-ADVP	O","	thyroid	","	","	O	Othyroid	hormone	thyroid	NN	B-NP	B-proteinhormone	receptors	hormone	NN	I-NP	I-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	tissues	human	JJ	B-NP	Otissues	remain	tissue	NNS	I-NP	Oremain	poorly	remain	VBP	B-VP	Opoorly	characterized	poorly	RB	B-ADJP	Ocharacterized	.	characterize	VBN	I-ADJP	O.	As	.	.	O	OAs	a	As	IN	B-PP	Oa	first	a	DT	B-NP	Ofirst	step	first	JJ	I-NP	Ostep	towards	step	NN	I-NP	Otowards	understanding	towards	IN	B-PP	Ounderstanding	the	understand	VBG	B-VP	Othe	mechanism	the	DT	B-NP	Omechanism	of	mechanism	NN	I-NP	Oof	thyroid	of	IN	B-PP	Othyroid	hormone	thyroid	NN	B-NP	Ohormone	action	hormone	NN	I-NP	Oaction	in	action	NN	I-NP	Oin	man	in	IN	B-PP	Oman	we	man	NN	B-NP	Owe	have	we	PRP	B-NP	Ohave	characterized	have	VBP	B-VP	Ocharacterized	T3	characterize	VBN	I-VP	OT3	binding	T3	NN	B-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	in	site	NNS	I-NP	I-DNAin	nuclei	in	IN	B-PP	Onuclei	of	nucleus	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	lymphoblastoid	human	JJ	I-NP	B-cell_linelymphoblastoid	line	lymphoblastoid	JJ	I-NP	I-cell_lineline	","	line	NN	I-NP	I-cell_line","	IM-9	","	","	O	OIM-9	cells	IM-9	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	In	.	.	O	OIn	whole	In	IN	B-PP	Owhole	cell	whole	JJ	B-NP	Ocell	experiments	cell	NN	I-NP	Oexperiments	at	experiment	NNS	I-NP	Oat	37	at	IN	B-PP	O37	degrees	37	CD	B-NP	Odegrees	C	degree	NNS	I-NP	OC	","	C	JJ	B-NP	O","	nuclear	","	","	I-NP	Onuclear	binding	nuclear	JJ	I-NP	Obinding	of	binding	NN	I-NP	Oof	[	of	IN	B-PP	O[	125I	[	(	O	O125I	]	125I	NN	B-NP	O]	T3	]	)	I-NP	OT3	was	T3	NN	I-NP	Owas	saturable	be	VBD	B-VP	Osaturable	(	saturable	JJ	B-ADJP	O(	Kd	(	(	O	OKd	34	Kd	NN	B-NP	O34	+/-	34	CD	I-NP	O+/-	6	+/-	SYM	I-NP	O6	pmol/l	6	CD	I-NP	Opmol/l	)	pmol/l	NN	I-NP	O)	and	)	)	O	Oand	of	and	CC	O	Oof	finite	of	IN	B-PP	Ofinite	capacity	finite	JJ	B-NP	Ocapacity	(	capacity	NN	I-NP	O(	approximately	(	(	O	Oapproximately	equal	approximately	RB	B-ADJP	Oequal	to	equal	JJ	I-ADJP	Oto	350	to	TO	B-PP	O350	sites/cell	350	CD	B-NP	Osites/cell	)	sites/cell	NNS	I-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	binding	The	DT	B-NP	Obinding	sites	bind	VBG	I-NP	B-DNAsites	were	site	NNS	I-NP	I-DNAwere	extracted	be	VBD	B-VP	Oextracted	from	extract	VBN	I-VP	Ofrom	a	from	IN	B-PP	Oa	nuclear	a	DT	B-NP	Onuclear	pellet	nuclear	JJ	I-NP	Opellet	by	pellet	NN	I-NP	Oby	treatment	by	IN	B-PP	Otreatment	with	treatment	NN	B-NP	Owith	0.4	with	IN	B-PP	O0.4	mol/l	0.4	CD	B-NP	Omol/l	KCl	mol/l	NN	I-NP	OKCl	and	KCl	NN	I-NP	Oand	sonication	and	CC	I-NP	Osonication	.	sonication	NN	I-NP	O.	Separation	.	.	O	OSeparation	of	Separation	NN	B-NP	Oof	bound	of	IN	B-PP	Obound	from	bind	VBN	B-VP	Ofrom	free	from	IN	B-PP	Ofree	[	free	JJ	B-NP	O[	125I	[	(	I-NP	O125I	]	125I	NN	I-NP	O]	T3	]	)	I-NP	OT3	in	T3	NN	I-NP	Oin	the	in	IN	B-PP	Othe	extracts	the	DT	B-NP	Oextracts	was	extract	NNS	I-NP	Owas	achieved	be	VBD	B-VP	Oachieved	using	achieve	VBN	I-VP	Ousing	the	use	VBG	I-VP	Othe	calcium	the	DT	B-NP	Ocalcium	phosphate	calcium	NN	I-NP	Ophosphate	matrix	phosphate	NN	I-NP	Omatrix	","	matrix	NN	I-NP	O","	hydroxyapatite	","	","	O	Ohydroxyapatite	at	hydroxyapatite	NN	B-NP	Oat	a	at	IN	B-PP	Oa	concentration	a	DT	B-NP	Oconcentration	of	concentration	NN	I-NP	Oof	0.3	of	IN	B-PP	O0.3	ml	0.3	CD	B-NP	Oml	of	ml	NN	I-NP	Oof	a	of	IN	B-PP	Oa	150	a	DT	B-NP	O150	g/l	150	CD	I-NP	Og/l	slurry	g/l	NN	I-NP	Oslurry	.	slurry	NN	I-NP	O.	Rectilinear	.	.	O	ORectilinear	Scatchard	Rectilinear	NNP	B-NP	OScatchard	plots	Scatchard	NNP	I-NP	Oplots	were	plot	NNS	I-NP	Owere	obtained	be	VBD	B-VP	Oobtained	only	obtain	VBN	I-VP	Oonly	when	only	RB	B-ADVP	Owhen	the	when	WRB	I-ADVP	Othe	hydroxyapatite	the	DT	B-NP	Ohydroxyapatite	was	hydroxyapatite	NN	I-NP	Owas	washed	be	VBD	B-VP	Owashed	with	wash	VBN	I-VP	Owith	a	with	IN	B-PP	Oa	buffer	a	DT	B-NP	Obuffer	containing	buffer	NN	I-NP	Ocontaining	0.5	contain	VBG	B-VP	O0.5	%	0.5	CD	B-NP	O%	Triton	%	NN	I-NP	OTriton	X-100	Triton	NN	I-NP	OX-100	.	X-100	NN	I-NP	O.	Under	.	.	O	OUnder	these	Under	IN	B-PP	Othese	conditions	these	DT	B-NP	Oconditions	T3	condition	NNS	I-NP	OT3	binding	T3	NN	I-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	in	site	NNS	I-NP	I-DNAin	the	in	IN	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	extracts	nuclear	JJ	I-NP	Oextracts	were	extract	NNS	I-NP	Owere	present	be	VBD	B-VP	Opresent	at	present	JJ	B-ADJP	Oat	a	at	IN	B-PP	Oa	concentration	a	DT	B-NP	Oconcentration	of	concentration	NN	I-NP	Oof	22.4	of	IN	B-PP	O22.4	+/-	22.4	CD	B-NP	O+/-	8.6	+/-	SYM	I-NP	O8.6	fmol/mg	8.6	CD	I-NP	Ofmol/mg	protein	fmol/mg	NN	I-NP	Oprotein	and	protein	NN	I-NP	Oand	showed	and	CC	O	Oshowed	an	show	VBD	B-VP	Oan	affinity	an	DT	B-NP	Oaffinity	of	affinity	NN	I-NP	Oof	(	of	IN	B-PP	O(	Kd	(	(	O	OKd	","	Kd	NN	B-NP	O","	room	","	","	O	Oroom	temperature	room	NN	B-NP	Otemperature	)	temperature	NN	I-NP	O)	140	)	)	O	O140	+/-	140	CD	B-NP	O+/-	10	+/-	SYM	I-NP	O10	pmol/l	10	CD	I-NP	Opmol/l	.	pmol/l	NN	I-NP	O.	The	.	.	O	OThe	same	The	DT	B-NP	Osame	assay	same	JJ	I-NP	Oassay	system	assay	NN	I-NP	Osystem	was	system	NN	I-NP	Owas	used	be	VBD	B-VP	Oused	to	use	VBN	I-VP	Oto	determine	to	TO	B-VP	Odetermine	the	determine	VB	I-VP	Othe	hierarchy	the	DT	B-NP	Ohierarchy	of	hierarchy	NN	I-NP	Oof	affinities	of	IN	B-PP	Oaffinities	for	affinity	NNS	B-NP	Ofor	a	for	IN	B-PP	Oa	range	a	DT	B-NP	Orange	of	range	NN	I-NP	Oof	natural	of	IN	B-PP	Onatural	and	natural	JJ	B-NP	Oand	synthetic	and	CC	I-NP	Osynthetic	analogues	synthetic	JJ	I-NP	Oanalogues	.	analogue	NNS	I-NP	O.	Calling	.	.	O	OCalling	T3	Call	VBG	B-VP	OT3	100	T3	NN	B-NP	O100	","	100	CD	I-NP	O","	the	","	","	O	Othe	order	the	DT	B-NP	Oorder	of	order	NN	I-NP	Oof	potencies	of	IN	B-PP	Opotencies	observed	potency	NNS	B-NP	Oobserved	was	observe	VBN	B-VP	Owas	:	be	VBD	B-VP	O:	Triac	:	:	O	OTriac	","	Triac	NN	B-NP	O","	500	","	","	O	O500	;	500	CD	B-NP	O;	3	;	:	O	O3	","	3	CD	B-NP	O","	5-diiodo-3'-isopropylthyronine	","	","	I-NP	O5-diiodo-3'-isopropylthyronine	","	5-diiodo-3'-isopropylthyronine	CD	I-NP	O","	89	","	","	I-NP	O89	;	89	CD	I-NP	O;	T4	;	:	O	OT4	","	T4	NN	B-NP	O","	32	","	","	O	O32	;	32	CD	B-NP	O;	3	;	:	O	O3	","	3	CD	B-NP	O","	5-dimethyl-3'isopropylthyronine	","	","	O	O5-dimethyl-3'isopropylthyronine	2	5-dimethyl-3'isopropylthyronine	CD	B-NP	O2	;	2	CD	I-NP	O;	3	;	:	O	O3	","	3	CD	B-NP	O","	5-T2	","	","	O	O5-T2	","	5-T2	NN	B-NP	O","	0.7	","	","	O	O0.7	","	0.7	CD	B-NP	O","	rT3	","	","	O	OrT3	","	rT3	NN	B-NP	O","	0.4	","	","	O	O0.4	;	0.4	CD	B-NP	O;	3'5'-T2	;	:	O	O3'5'-T2	","	3'5'-T2	NN	B-NP	O","	less	","	","	O	Oless	than	less	JJR	B-NP	Othan	0.01	than	IN	I-NP	O0.01	.	0.01	CD	I-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	T3	the	DT	B-NP	OT3	binding	T3	NN	I-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	present	site	NNS	I-NP	I-DNApresent	in	present	JJ	B-ADJP	Oin	human	in	IN	B-PP	Ohuman	IM-9	human	JJ	B-NP	OIM-9	lymphocyte	IM-9	NN	I-NP	Olymphocyte	nuclei	lymphocyte	NN	I-NP	Onuclei	and	nucleus	NNS	I-NP	Oand	extracts	and	CC	I-NP	Oextracts	thereof	extract	NNS	I-NP	Othereof	are	thereof	RB	B-ADVP	Oare	thyroid	be	VBP	B-VP	Othyroid	hormone	thyroid	JJ	B-NP	B-proteinhormone	receptors	hormone	NN	I-NP	I-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	These	.	.	O	OThese	cells	These	DT	B-NP	Ocells	may	cell	NNS	I-NP	Omay	be	may	MD	B-VP	Obe	a	be	VB	I-VP	Oa	useful	a	DT	B-NP	Ouseful	tool	useful	JJ	I-NP	Otool	to	tool	NN	I-NP	Oto	increase	to	TO	B-VP	Oincrease	our	increase	VB	I-VP	Oour	understanding	our	PRP$	B-NP	Ounderstanding	of	understanding	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	T3	human	JJ	B-NP	B-proteinT3	receptors	T3	NN	I-NP	I-proteinreceptors	Definition	receptor	NNS	I-NP	I-proteinDefinition	of	Definition	NN	B-NP	Oof	T-cell	of	IN	B-PP	OT-cell	specific	T-cell	NN	B-NP	Ospecific	DNA-binding	specific	JJ	I-NP	ODNA-binding	factors	DNA-binding	JJ	I-NP	B-proteinfactors	that	factor	NNS	I-NP	I-proteinthat	interact	that	WDT	B-NP	Ointeract	with	interact	VBP	B-VP	Owith	a	with	IN	B-PP	Oa	3'-silencer	a	DT	B-NP	O3'-silencer	in	3'-silencer	NN	I-NP	B-DNAin	the	in	IN	B-PP	Othe	CD4+	the	DT	B-NP	OCD4+	T-cell	CD4+	JJ	I-NP	B-DNAT-cell	gene	T-cell	NN	I-NP	I-DNAgene	Rpt-1	gene	NN	I-NP	I-DNARpt-1	.	Rpt-1	NN	I-NP	B-protein.	Analysis	.	.	O	OAnalysis	of	Analysis	NN	B-NP	Oof	the	of	IN	B-PP	Othe	region	the	DT	B-NP	Oregion	3	region	NN	I-NP	O3	'	3	CD	I-NP	O'	to	'	SYM	B-NP	Oto	the	to	TO	B-PP	Othe	CD4+	the	DT	B-NP	OCD4+	T-cell	CD4+	JJ	I-NP	B-DNAT-cell	gene	T-cell	NN	I-NP	I-DNAgene	Rpt-1	gene	NN	I-NP	I-DNARpt-1	(	Rpt-1	NN	I-NP	B-protein(	encoding	(	(	O	Oencoding	regulatory	encode	VBG	B-VP	Oregulatory	protein	regulatory	JJ	B-NP	B-proteinprotein	T-lymphocyte	protein	NN	I-NP	I-proteinT-lymphocyte	1	T-lymphocyte	NN	I-NP	O1	)	1	CD	I-NP	O)	led	)	)	O	Oled	to	lead	VBD	B-VP	Oto	the	to	TO	B-PP	Othe	definition	the	DT	B-NP	Odefinition	of	definition	NN	I-NP	Oof	a	of	IN	B-PP	Oa	silencer	a	DT	B-NP	Osilencer	element	silencer	NN	I-NP	B-DNAelement	that	element	NN	I-NP	I-DNAthat	inhibits	that	WDT	B-NP	Oinhibits	heterologous	inhibit	VBZ	B-VP	Oheterologous	gene	heterologous	JJ	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	in	expression	NN	I-NP	Oin	certain	in	IN	B-PP	Ocertain	CD4+	certain	JJ	B-NP	OCD4+	T-cell	CD4+	JJ	I-NP	B-cell_lineT-cell	lines	T-cell	NN	I-NP	I-cell_linelines	but	line	NNS	I-NP	I-cell_linebut	not	but	CC	B-PP	Onot	in	not	RB	B-PP	Oin	B-cell	in	IN	I-PP	OB-cell	or	B-cell	NN	B-NP	B-cell_lineor	non-lymphoid	or	CC	O	I-cell_linenon-lymphoid	cell	non-lymphoid	JJ	B-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	.	line	NNS	I-NP	I-cell_line.	Functional	.	.	O	OFunctional	silencer	Functional	JJ	B-NP	Osilencer	activity	silencer	NN	I-NP	Oactivity	in	activity	NN	I-NP	Oin	vivo	in	FW	B-ADVP	Ovivo	was	vivo	FW	I-ADVP	Owas	associated	be	VBD	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	the	with	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	a	of	IN	B-PP	Oa	specific	a	DT	B-NP	Ospecific	silencer-DNA-protein	specific	JJ	I-NP	Osilencer-DNA-protein	complex	silencer-DNA-protein	JJ	I-NP	B-proteincomplex	in	complex	NN	I-NP	I-proteinin	electrophoretic	in	IN	B-PP	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assays	shift	NN	I-NP	Oassays	with	assay	NNS	I-NP	Owith	T-cell	with	IN	B-PP	OT-cell	extracts	T-cell	NN	B-NP	Oextracts	.	extract	NNS	I-NP	O.	Formation	.	.	O	OFormation	of	Formation	NN	B-NP	Oof	this	of	IN	B-PP	Othis	complex	this	DT	B-NP	Ocomplex	was	complex	NN	I-NP	Owas	selectively	be	VBD	B-VP	Oselectively	inhibited	selectively	RB	I-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	region	the	DT	B-NP	Oregion	in	region	NN	I-NP	Oin	HIV-1	in	IN	B-PP	OHIV-1	containing	HIV-1	NN	B-NP	Ocontaining	a	contain	VBG	B-VP	Oa	silencer	a	DT	B-NP	Osilencer	element	silencer	NN	I-NP	B-DNAelement	.	element	NN	I-NP	I-DNA.	We	.	.	O	OWe	discuss	We	PRP	B-NP	Odiscuss	the	discuss	VBP	B-VP	Othe	possibility	the	DT	B-NP	Opossibility	that	possibility	NN	I-NP	Othat	DNA-binding	that	IN	B-SBAR	ODNA-binding	factors	DNA-binding	JJ	B-NP	B-proteinfactors	may	factor	NNS	I-NP	I-proteinmay	coregulate	may	MD	B-VP	Ocoregulate	HIV-1	coregulate	VB	I-VP	OHIV-1	and	HIV-1	NN	B-NP	Oand	Rpt-1	and	CC	I-NP	ORpt-1	gene	Rpt-1	NN	I-NP	Ogene	expression	gene	NN	I-NP	Oexpression	through	expression	NN	I-NP	Othrough	a	through	IN	B-PP	Oa	common	a	DT	B-NP	Ocommon	transcriptional	common	JJ	I-NP	Otranscriptional	silencer	transcriptional	JJ	I-NP	B-DNAsilencer	element	silencer	NN	I-NP	I-DNAelement	.	element	NN	I-NP	I-DNA.	Congenital	.	.	O	OCongenital	immunodeficiencies	Congenital	JJ	B-NP	Oimmunodeficiencies	associated	immunodeficiency	NNS	I-NP	Oassociated	with	associate	VBN	B-VP	Owith	absence	with	IN	B-PP	Oabsence	of	absence	NN	B-NP	Oof	HLA	of	IN	B-PP	OHLA	class	HLA	NN	B-NP	B-proteinclass	II	class	NN	I-NP	I-proteinII	antigens	II	CD	B-NP	I-proteinantigens	on	antigen	NNS	I-NP	I-proteinon	lymphocytes	on	IN	B-PP	Olymphocytes	result	lymphocyte	NNS	B-NP	B-cell_typeresult	from	result	VBP	B-VP	Ofrom	distinct	from	IN	B-PP	Odistinct	mutations	distinct	JJ	B-NP	Omutations	in	mutation	NNS	I-NP	Oin	trans-acting	in	IN	B-PP	Otrans-acting	factors	trans-acting	JJ	B-NP	B-proteinfactors	.	factor	NNS	I-NP	I-protein.	Coordinate	.	.	O	OCoordinate	regulation	Coordinate	JJ	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	HLA	of	IN	B-PP	OHLA	class	HLA	NN	B-NP	B-DNAclass	II	class	NN	I-NP	I-DNAII	gene	II	CD	I-NP	I-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	during	expression	NN	I-NP	Oduring	development	during	IN	B-PP	Odevelopment	and	development	NN	B-NP	Oand	coinduction	and	CC	I-NP	Ocoinduction	of	coinduction	NN	I-NP	Oof	class	of	IN	B-PP	Oclass	II	class	NN	B-NP	B-DNAII	genes	II	CD	I-NP	I-DNAgenes	by	gene	NNS	I-NP	I-DNAby	soluble	by	IN	B-PP	Osoluble	factors	soluble	JJ	B-NP	B-proteinfactors	suggests	factor	NNS	I-NP	I-proteinsuggests	that	suggest	VBZ	B-VP	Othat	common	that	IN	B-SBAR	Ocommon	trans-acting	common	JJ	B-NP	B-proteintrans-acting	factor	trans-acting	JJ	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	control	)	)	O	Ocontrol	expression	control	NN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	these	of	IN	B-PP	Othese	genes	these	DT	B-NP	Ogenes	.	gene	NNS	I-NP	O.	In	.	.	O	OIn	B-lymphoblastoid	In	IN	B-PP	OB-lymphoblastoid	cell	B-lymphoblastoid	JJ	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	derived	line	NNS	I-NP	I-cell_linederived	from	derive	VBN	B-VP	Ofrom	two	from	IN	B-PP	Otwo	independent	two	CD	B-NP	Oindependent	class	independent	JJ	I-NP	Oclass	II-deficient	class	NN	I-NP	OII-deficient	bare	II-deficient	JJ	I-NP	Obare	lymphocyte	bare	JJ	I-NP	Olymphocyte	syndrome	lymphocyte	NN	I-NP	Osyndrome	patients	syndrome	NN	I-NP	Opatients	","	patient	NNS	I-NP	O","	we	","	","	O	Owe	observed	we	PRP	B-NP	Oobserved	a	observe	VBD	B-VP	Oa	drastic	a	DT	B-NP	Odrastic	decrease	drastic	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	transcription	in	IN	B-PP	Otranscription	rates	transcription	NN	B-NP	Orates	of	rate	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	class	the	DT	B-NP	Oclass	II	class	NN	I-NP	B-DNAII	genes	II	CD	B-NP	I-DNAgenes	.	gene	NNS	I-NP	I-DNA.	When	.	.	O	OWhen	these	When	WRB	B-ADVP	Othese	cell	these	DT	B-NP	Ocell	lines	cell	NN	I-NP	B-cell_linelines	are	line	NNS	I-NP	I-cell_lineare	fused	be	VBP	B-VP	Ofused	","	fuse	VBN	I-VP	O","	class	","	","	O	Oclass	II	class	NN	B-NP	B-DNAII	genes	II	CD	I-NP	I-DNAgenes	are	gene	NNS	I-NP	I-DNAare	reexpressed	be	VBP	B-VP	Oreexpressed	","	reexpresse	VBN	I-VP	O","	indicating	","	","	O	Oindicating	that	indicate	VBG	B-VP	Othat	immunodeficiencies	that	IN	B-SBAR	Oimmunodeficiencies	in	immunodeficiency	NNS	B-NP	Oin	bare	in	IN	B-PP	Obare	lymphocyte	bare	JJ	B-NP	Olymphocyte	syndrome	lymphocyte	NN	I-NP	Osyndrome	patients	syndrome	NN	I-NP	Opatients	are	patient	NNS	I-NP	Oare	the	be	VBP	B-VP	Othe	result	the	DT	B-NP	Oresult	of	result	NN	I-NP	Oof	two	of	IN	B-PP	Otwo	distinct	two	CD	B-NP	Odistinct	mutations	distinct	JJ	I-NP	Omutations	.	mutation	NNS	I-NP	O.	Further	.	.	O	OFurther	studies	Further	JJ	B-NP	Ostudies	show	study	NNS	I-NP	Oshow	that	show	VBP	B-VP	Othat	genes	that	IN	B-SBAR	Ogenes	governing	gene	NNS	B-NP	Ogoverning	the	govern	VBG	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	class	of	IN	B-PP	Oclass	II	class	NN	B-NP	B-proteinII	antigens	II	CD	I-NP	I-proteinantigens	fall	antigen	NNS	I-NP	I-proteinfall	into	fall	VBP	B-VP	Ointo	at	into	IN	B-PP	Oat	least	at	IN	B-NP	Oleast	three	least	JJS	I-NP	Othree	complementation	three	CD	I-NP	Ocomplementation	groups	complementation	NN	I-NP	Ogroups	;	group	NNS	I-NP	O;	two	;	:	O	Otwo	of	two	CD	B-NP	Oof	these	of	IN	B-PP	Othese	were	these	DT	B-NP	Owere	previously	be	VBD	B-VP	Opreviously	unidentified	previously	RB	B-ADJP	Ounidentified	in	unidentified	JJ	I-ADJP	Oin	mutant	in	IN	B-PP	Omutant	cell	mutant	JJ	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	generated	line	NNS	I-NP	I-cell_linegenerated	in	generate	VBN	B-VP	Oin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	we	","	","	O	Owe	report	we	PRP	B-NP	Oreport	the	report	VBP	B-VP	Othe	identification	the	DT	B-NP	Oidentification	of	identification	NN	I-NP	Oof	two	of	IN	B-PP	Otwo	discrete	two	CD	B-NP	Odiscrete	complexes	discrete	JJ	I-NP	Ocomplexes	","	complex	NNS	I-NP	O","	NFX1.1	","	","	O	ONFX1.1	and	NFX1.1	NN	B-NP	B-proteinand	NFX1.2	and	CC	I-NP	ONFX1.2	","	NFX1.2	NN	I-NP	B-protein","	that	","	","	O	Othat	bind	that	WDT	B-NP	Obind	to	bind	VBP	B-VP	Oto	the	to	TO	B-PP	Othe	DRA	the	DT	B-NP	ODRA	X	DRA	NN	I-NP	B-DNAX	consensus	X	NN	I-NP	I-DNAconsensus	element	consensus	NN	I-NP	I-DNAelement	.	element	NN	I-NP	I-DNA.	Though	.	.	O	OThough	the	Though	IN	B-SBAR	Othe	mutation	the	DT	B-NP	Omutation	in	mutation	NN	I-NP	Oin	at	in	IN	B-PP	Oat	least	at	IN	B-NP	Oleast	one	least	JJS	I-NP	Oone	mutant	one	CD	I-NP	Omutant	line	mutant	JJ	I-NP	B-cell_lineline	generated	line	NN	I-NP	I-cell_linegenerated	in	generate	VBN	B-VP	Oin	vitro	in	FW	B-ADVP	Ovitro	(	vitro	FW	I-ADVP	O(	RJ2.2.5	(	(	O	ORJ2.2.5	)	RJ2.2.5	NN	B-NP	B-cell_line)	affects	)	)	O	Oaffects	products	affect	VBZ	B-VP	Oproducts	functioning	product	NNS	B-NP	Ofunctioning	via	function	VBG	B-VP	Ovia	interaction	via	IN	B-PP	Ointeraction	with	interaction	NN	B-NP	Owith	the	with	IN	B-PP	Othe	X	the	DT	B-NP	OX	box	X	NN	I-NP	B-DNAbox	","	box	NN	I-NP	I-DNA","	clear	","	","	O	Oclear	alterations	clear	JJ	B-NP	Oalterations	in	alteration	NNS	I-NP	Oin	either	in	IN	B-PP	Oeither	NFX1.1	either	CC	O	ONFX1.1	or	NFX1.1	NN	B-NP	B-proteinor	NFX1.2	or	CC	I-NP	ONFX1.2	are	NFX1.2	NN	I-NP	B-proteinare	not	be	VBP	B-VP	Onot	found	not	RB	I-VP	Ofound	in	find	VBN	I-VP	Oin	any	in	IN	B-PP	Oany	of	any	DT	B-NP	Oof	the	of	IN	B-PP	Othe	mutant	the	DT	B-NP	Omutant	cell	mutant	JJ	I-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	.	line	NNS	I-NP	I-cell_line.	In	.	.	O	OIn	vivo	In	FW	B-NP	Ovivo	responsiveness	vivo	FW	I-NP	Oresponsiveness	to	responsiveness	NN	I-NP	Oto	glucocorticoid	to	TO	B-PP	Oglucocorticoid	correlated	glucocorticoid	NN	B-NP	Ocorrelated	with	correlate	VBD	B-VP	Owith	glucocorticoid	with	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	content	receptor	NN	I-NP	I-proteincontent	in	content	NN	I-NP	Oin	peripheral	in	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	leukocytes	blood	NN	I-NP	I-cell_typeleukocytes	in	leukocyte	NNS	I-NP	I-cell_typein	normal	in	IN	B-PP	Onormal	humans	normal	JJ	B-NP	Ohumans	.	human	NNS	I-NP	O.	Dexamethasone	.	.	O	ODexamethasone	loading	Dexamethasone	NN	B-NP	Oloading	tests	loading	NN	I-NP	Otests	(	test	NNS	I-NP	O(	0.1	(	(	O	O0.1	mg	0.1	CD	B-NP	Omg	dexamethasone/kg	mg	NN	I-NP	Odexamethasone/kg	","	dexamethasone/kg	NN	I-NP	O","	iv	","	","	O	Oiv	)	iv	NN	B-NP	O)	were	)	)	O	Owere	performed	be	VBD	B-VP	Operformed	in	perform	VBN	I-VP	Oin	18	in	IN	B-PP	O18	normal	18	CD	B-NP	Onormal	males	normal	JJ	I-NP	Omales	to	male	NNS	I-NP	Oto	evaluate	to	TO	B-VP	Oevaluate	the	evaluate	VB	I-VP	Othe	individual	the	DT	B-NP	Oindividual	responsiveness	individual	JJ	I-NP	Oresponsiveness	to	responsiveness	NN	I-NP	Oto	glucocorticoid	to	TO	B-PP	Oglucocorticoid	.	glucocorticoid	NN	B-NP	O.	There	.	.	O	OThere	were	There	EX	B-NP	Owere	inter-individual	be	VBD	B-VP	Ointer-individual	differences	inter-individual	JJ	B-NP	Odifferences	in	difference	NNS	I-NP	Oin	increase	in	IN	B-PP	Oincrease	in	increase	NN	B-NP	Oin	peripheral	in	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	polymorphonuclear	blood	NN	I-NP	I-cell_typepolymorphonuclear	leukocyte	polymorphonuclear	JJ	I-NP	I-cell_typeleukocyte	count	leukocyte	NN	I-NP	I-cell_typecount	","	count	NN	I-NP	O","	decrease	","	","	O	Odecrease	in	decrease	NN	B-NP	Oin	peripheral	in	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	lymphocyte	blood	NN	I-NP	I-cell_typelymphocyte	count	lymphocyte	NN	I-NP	I-cell_typecount	","	count	NN	I-NP	O","	and	","	","	O	Oand	increase	and	CC	O	Oincrease	in	increase	NN	B-NP	Oin	plasma	in	IN	B-PP	Oplasma	free	plasma	NN	B-NP	Ofree	fatty	free	JJ	I-NP	Ofatty	acids	fatty	JJ	I-NP	Oacids	levels	acid	NNS	I-NP	Olevels	after	level	NNS	I-NP	Oafter	dexamethasone	after	IN	B-PP	Odexamethasone	injection	dexamethasone	NN	B-NP	Oinjection	.	injection	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	there	","	","	O	Othere	was	there	EX	B-NP	Owas	a	be	VBD	B-VP	Oa	significant	a	DT	B-NP	Osignificant	correlation	significant	JJ	I-NP	Ocorrelation	between	correlation	NN	I-NP	Obetween	the	between	IN	B-PP	Othe	maximum	the	DT	B-NP	Omaximum	increase	maximum	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	polymorphonuclear	in	IN	B-PP	Opolymorphonuclear	leukocytes	polymorphonuclear	JJ	B-NP	B-cell_typeleukocytes	and	leukocyte	NNS	I-NP	I-cell_typeand	the	and	CC	O	Othe	maximum	the	DT	B-NP	Omaximum	decrease	maximum	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	lymphocytes	in	IN	B-PP	Olymphocytes	(	lymphocyte	NNS	B-NP	B-cell_type(	r	(	(	O	Or	=	r	NN	B-NP	O=	0.7514	=	SYM	B-VP	O0.7514	","	0.7514	CD	B-NP	O","	p	","	","	O	Op	less	p	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.0003	than	IN	B-PP	O0.0003	)	0.0003	CD	B-NP	O)	.	)	)	O	O.	Simultaneous	.	.	O	OSimultaneous	measurements	Simultaneous	JJ	B-NP	Omeasurements	of	measurement	NNS	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	content	receptor	NN	I-NP	I-proteincontent	by	content	NN	I-NP	Oby	whole-cell	by	IN	B-PP	Owhole-cell	assay	whole-cell	JJ	B-NP	Oassay	revealed	assay	NN	I-NP	Orevealed	that	reveal	VBD	B-VP	Othat	glucocorticoid	that	IN	B-SBAR	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	content	receptor	NN	I-NP	I-proteincontent	in	content	NN	I-NP	Oin	polymorphonuclear	in	IN	B-PP	Opolymorphonuclear	leukocytes	polymorphonuclear	JJ	B-NP	B-cell_typeleukocytes	linearly	leukocyte	NNS	I-NP	I-cell_typelinearly	correlated	linearly	RB	B-ADVP	Ocorrelated	with	correlate	VBD	B-VP	Owith	that	with	IN	B-PP	Othat	in	that	DT	B-NP	Oin	the	in	IN	B-PP	Othe	corresponding	the	DT	B-NP	Ocorresponding	lymphocytes	corresponding	JJ	I-NP	Olymphocytes	(	lymphocyte	NNS	I-NP	O(	r	(	(	O	Or	=	r	NN	B-NP	O=	0.9482	=	SYM	B-VP	O0.9482	","	0.9482	CD	B-NP	O","	p	","	","	O	Op	less	p	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.0001	than	IN	B-PP	O0.0001	)	0.0001	CD	B-NP	O)	.	)	)	O	O.	There	.	.	O	OThere	were	There	EX	B-NP	Owere	also	be	VBD	B-VP	Oalso	significant	also	RB	B-ADVP	Osignificant	correlations	significant	JJ	B-NP	Ocorrelations	between	correlation	NNS	I-NP	Obetween	the	between	IN	B-PP	Othe	maximum	the	DT	B-NP	Omaximum	increase	maximum	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	polymorphonuclear	in	IN	B-PP	Opolymorphonuclear	leukocytes	polymorphonuclear	JJ	B-NP	B-cell_typeleukocytes	and	leukocyte	NNS	I-NP	I-cell_typeand	glucocorticoid	and	CC	O	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	content	receptor	NN	I-NP	I-proteincontent	in	content	NN	I-NP	Oin	polymorphonuclear	in	IN	B-PP	Opolymorphonuclear	leukocytes	polymorphonuclear	JJ	B-NP	B-cell_typeleukocytes	(	leukocyte	NNS	I-NP	I-cell_type(	r	(	(	O	Or	=	r	NN	B-NP	O=	0.7239	=	SYM	B-VP	O0.7239	","	0.7239	CD	B-NP	O","	p	","	","	O	Op	less	p	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.0007	than	IN	B-PP	O0.0007	)	0.0007	CD	B-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	between	and	CC	O	Obetween	the	between	IN	B-PP	Othe	maximum	the	DT	B-NP	Omaximum	decrease	maximum	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	lymphocytes	in	IN	B-PP	Olymphocytes	and	lymphocyte	NNS	B-NP	B-cell_typeand	glucocorticoid	and	CC	O	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	content	receptor	NN	I-NP	I-proteincontent	in	content	NN	I-NP	Oin	lymphocytes	in	IN	B-PP	Olymphocytes	(	lymphocyte	NNS	B-NP	B-cell_type(	r	(	(	O	Or	=	r	NN	B-NP	O=	0.7703	=	SYM	B-VP	O0.7703	","	0.7703	CD	B-NP	O","	p	","	","	O	Op	less	p	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.0002	than	IN	B-PP	O0.0002	)	0.0002	CD	B-NP	O)	.	)	)	O	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	individual	that	IN	B-SBAR	Oindividual	differences	individual	JJ	B-NP	Odifferences	are	difference	NNS	I-NP	Oare	preserved	be	VBP	B-VP	Opreserved	both	preserve	VBN	I-VP	Oboth	in	both	CC	B-PP	Oin	glucocorticoid	in	IN	I-PP	Oglucocorticoid	responsiveness	glucocorticoid	NN	B-NP	Oresponsiveness	and	responsiveness	NN	I-NP	Oand	in	and	CC	B-PP	Oin	glucocorticoid	in	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	content	receptor	NN	I-NP	I-proteincontent	in	content	NN	I-NP	Oin	peripheral	in	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	leukocytes	blood	NN	I-NP	I-cell_typeleukocytes	in	leukocyte	NNS	I-NP	I-cell_typein	normal	in	IN	B-PP	Onormal	humans	normal	JJ	B-NP	Ohumans	.	human	NNS	I-NP	O.	Estradiol	.	.	O	OEstradiol	receptors	Estradiol	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	the	in	IN	B-PP	Othe	cytosol	the	DT	B-NP	Ocytosol	of	cytosol	NN	I-NP	Oof	peripheral	of	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	hepatitis	in	IN	B-PP	Ohepatitis	B	hepatitis	NN	B-NP	OB	virus	B	NN	I-NP	Ovirus	carriers	virus	NN	I-NP	Ocarriers	treated	carrier	NNS	I-NP	Otreated	with	treat	VBN	B-VP	Owith	interferon-alpha	with	IN	B-PP	Ointerferon-alpha	.	interferon-alpha	NN	B-NP	B-protein.	Estradiol	.	.	O	OEstradiol	receptors	Estradiol	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	the	in	IN	B-PP	Othe	cytosol	the	DT	B-NP	Ocytosol	of	cytosol	NN	I-NP	Oof	peripheral	of	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	the	and	CC	O	Othe	effects	the	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	interferon-alpha	of	IN	B-PP	Ointerferon-alpha	(	interferon-alpha	NN	B-NP	B-protein(	IFN-alpha	(	(	O	OIFN-alpha	)	IFN-alpha	NN	B-NP	B-protein)	on	)	)	O	Oon	estradiol	on	IN	B-PP	Oestradiol	receptors	estradiol	NN	B-NP	B-proteinreceptors	were	receptor	NNS	I-NP	I-proteinwere	studied	be	VBD	B-VP	Ostudied	in	study	VBN	I-VP	Oin	asymptomatic	in	IN	B-PP	Oasymptomatic	hepatitis	asymptomatic	JJ	B-NP	Ohepatitis	B	hepatitis	NN	I-NP	OB	virus	B	NN	I-NP	Ovirus	(	virus	NN	I-NP	O(	HBV	(	(	O	OHBV	)	HBV	NN	B-NP	O)	carriers	)	)	O	Ocarriers	","	carrier	NNS	B-NP	O","	patients	","	","	O	Opatients	with	patient	NNS	B-NP	Owith	chronic	with	IN	B-PP	Ochronic	hepatitis	chronic	JJ	B-NP	Ohepatitis	B	hepatitis	NN	I-NP	OB	and	B	NN	I-NP	Oand	normal	and	CC	O	Onormal	controls	normal	JJ	B-NP	Ocontrols	.	control	NNS	I-NP	O.	The	.	.	O	OThe	level	The	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	estradiol	of	IN	B-PP	Oestradiol	receptors	estradiol	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	the	in	IN	B-PP	Othe	cytosol	the	DT	B-NP	Ocytosol	of	cytosol	NN	I-NP	Oof	mononuclear	of	IN	B-PP	Omononuclear	cells	mononuclear	JJ	B-NP	B-cell_typecells	was	cell	NNS	I-NP	I-cell_typewas	significantly	be	VBD	B-VP	Osignificantly	lower	significantly	RB	B-ADJP	Olower	in	low	JJR	I-ADJP	Oin	asymptomatic	in	IN	B-PP	Oasymptomatic	HBV	asymptomatic	JJ	B-NP	OHBV	carriers	HBV	NN	I-NP	Ocarriers	and	carrier	NNS	I-NP	Oand	patients	and	CC	O	Opatients	with	patient	NNS	B-NP	Owith	chronic	with	IN	B-PP	Ochronic	hepatitis	chronic	JJ	B-NP	Ohepatitis	B	hepatitis	NN	I-NP	OB	","	B	NN	I-NP	O","	compared	","	","	O	Ocompared	to	compare	VBN	B-PP	Oto	normal	to	TO	B-PP	Onormal	controls	normal	JJ	B-NP	Ocontrols	.	control	NNS	I-NP	O.	This	.	.	O	OThis	low	This	DT	B-NP	Olow	level	low	JJ	I-NP	Olevel	of	level	NN	I-NP	Oof	cytosol	of	IN	B-PP	Ocytosol	estradiol	cytosol	NN	B-NP	B-proteinestradiol	receptors	estradiol	NN	I-NP	I-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	chronic	with	IN	B-PP	Ochronic	hepatitis	chronic	JJ	B-NP	Ohepatitis	B	hepatitis	NN	I-NP	OB	was	B	NN	I-NP	Owas	increased	be	VBD	B-VP	Oincreased	by	increase	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	administration	the	DT	B-NP	Oadministration	of	administration	NN	I-NP	Oof	IFN-alpha	of	IN	B-PP	OIFN-alpha	.	IFN-alpha	NN	B-NP	B-protein.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	when	","	","	O	Owhen	peripheral	when	WRB	B-ADVP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	chronic	with	IN	B-PP	Ochronic	hepatitis	chronic	JJ	B-NP	Ohepatitis	B	hepatitis	NN	I-NP	OB	were	B	NN	I-NP	Owere	incubated	be	VBD	B-VP	Oincubated	with	incubate	VBN	I-VP	Owith	IFN-alpha	with	IN	B-PP	OIFN-alpha	in	IFN-alpha	NN	B-NP	B-proteinin	vitro	in	FW	B-ADVP	Ovitro	","	vitro	FW	I-ADVP	O","	the	","	","	O	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	cytosol	of	IN	B-PP	Ocytosol	estradiol	cytosol	NN	B-NP	B-proteinestradiol	receptors	estradiol	NN	I-NP	I-proteinreceptors	also	receptor	NNS	I-NP	I-proteinalso	increased	also	RB	B-ADVP	Oincreased	by	increase	VBD	B-VP	Oby	increasing	by	IN	B-PP	Oincreasing	the	increase	VBG	B-VP	Othe	concentration	the	DT	B-NP	Oconcentration	of	concentration	NN	I-NP	Oof	IFN-alpha	of	IN	B-PP	OIFN-alpha	.	IFN-alpha	NN	B-NP	B-protein.	We	.	.	O	OWe	previously	We	PRP	B-NP	Opreviously	reported	previously	RB	B-ADVP	Oreported	that	report	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	response	the	DT	B-NP	Oresponse	of	response	NN	I-NP	Oof	mononuclear	of	IN	B-PP	Omononuclear	cells	mononuclear	JJ	B-NP	B-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	estrogen	to	TO	B-PP	Oestrogen	is	estrogen	NN	B-NP	Ois	impaired	be	VBZ	B-VP	Oimpaired	in	impaired	JJ	B-ADJP	Oin	HBV	in	IN	B-PP	OHBV	carriers	HBV	NN	B-NP	Ocarriers	","	carrier	NNS	I-NP	O","	and	","	","	O	Oand	our	and	CC	O	Oour	present	our	PRP$	B-NP	Opresent	results	present	JJ	I-NP	Oresults	suggested	result	NNS	I-NP	Osuggested	that	suggest	VBD	B-VP	Othat	this	that	IN	B-SBAR	Othis	may	this	DT	B-NP	Omay	be	may	MD	B-VP	Obe	due	be	VB	I-VP	Odue	to	due	JJ	B-ADVP	Oto	the	to	TO	B-PP	Othe	low	the	DT	B-NP	Olow	level	low	JJ	I-NP	Olevel	of	level	NN	I-NP	Oof	estradiol	of	IN	B-PP	Oestradiol	receptors	estradiol	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	the	in	IN	B-PP	Othe	cytosol	the	DT	B-NP	Ocytosol	of	cytosol	NN	I-NP	Oof	mononuclear	of	IN	B-PP	Omononuclear	cells	mononuclear	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Association	.	.	O	OAssociation	of	Association	NN	B-NP	Oof	increased	of	IN	B-PP	Oincreased	lytic	increase	VBN	B-NP	Olytic	effector	lytic	JJ	I-NP	Oeffector	cell	effector	NN	I-NP	Ocell	function	cell	NN	I-NP	Ofunction	with	function	NN	I-NP	Owith	high	with	IN	B-PP	Ohigh	estrogen	high	JJ	B-NP	Oestrogen	receptor	estrogen	NN	I-NP	B-proteinreceptor	levels	receptor	NN	I-NP	I-proteinlevels	in	level	NNS	I-NP	Oin	tumor-bearing	in	IN	B-PP	Otumor-bearing	patients	tumor-bearing	JJ	B-NP	Opatients	with	patient	NNS	I-NP	Owith	breast	with	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	.	cancer	NN	I-NP	O.	Tumor-bearing	.	.	O	OTumor-bearing	patients	Tumor-bearing	JJ	B-NP	Opatients	with	patient	NNS	I-NP	Owith	breast	with	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	were	cancer	NN	I-NP	Owere	assayed	be	VBD	B-VP	Oassayed	for	assay	VBN	I-VP	Ofor	their	for	IN	B-PP	Otheir	natural	their	PRP$	B-NP	Onatural	killer	natural	JJ	I-NP	B-cell_typekiller	(	killer	NN	I-NP	I-cell_type(	NK	(	(	O	I-cell_typeNK	)	NK	NN	B-NP	I-cell_type)	cell	)	)	O	I-cell_typecell	activity	cell	NN	B-NP	I-cell_typeactivity	and	activity	NN	I-NP	Oand	for	and	CC	B-PP	Ofor	the	for	IN	B-PP	Othe	function	the	DT	B-NP	Ofunction	of	function	NN	I-NP	Oof	activated	of	IN	B-PP	Oactivated	cytotoxic	activate	VBN	B-NP	B-cell_typecytotoxic	T-cells	cytotoxic	JJ	I-NP	I-cell_typeT-cells	","	T-cell	NNS	I-NP	I-cell_type","	as	","	","	O	Oas	assessed	as	IN	B-SBAR	Oassessed	by	assess	VBN	B-VP	Oby	lectin-dependent	by	IN	B-PP	Olectin-dependent	cellular	lectin-dependent	JJ	B-NP	Ocellular	cytotoxicity	cellular	JJ	I-NP	Ocytotoxicity	(	cytotoxicity	NN	I-NP	O(	LDCC	(	(	O	OLDCC	)	LDCC	NN	B-NP	B-protein)	.	)	)	O	O.	Tumor-bearing	.	.	O	OTumor-bearing	patients	Tumor-bearing	JJ	B-NP	Opatients	with	patient	NNS	I-NP	Owith	breast	with	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	had	cancer	NN	I-NP	Ohad	a	have	VBD	B-VP	Oa	significant	a	DT	B-NP	Osignificant	increase	significant	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	NK	in	IN	B-PP	ONK	activity	NK	NN	B-NP	Oactivity	and	activity	NN	I-NP	Oand	in	and	CC	B-PP	Oin	LDCC	in	IN	B-PP	OLDCC	","	LDCC	NN	B-NP	B-cell_line","	as	","	","	O	Oas	compared	as	IN	B-SBAR	Ocompared	with	compare	VBN	B-PP	Owith	healthy	with	IN	B-PP	Ohealthy	control	healthy	JJ	B-NP	Ocontrol	individuals	control	NN	I-NP	Oindividuals	.	individual	NNS	I-NP	O.	Although	.	.	O	OAlthough	the	Although	IN	B-SBAR	Othe	enhanced	the	DT	B-NP	Oenhanced	NK	enhance	VBN	I-NP	ONK	cell	NK	NN	I-NP	B-cell_typecell	activity	cell	NN	I-NP	I-cell_typeactivity	and	activity	NN	I-NP	Oand	LDCC	and	CC	I-NP	OLDCC	were	LDCC	NN	I-NP	B-proteinwere	closely	be	VBD	B-VP	Oclosely	associated	closely	RB	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	high	with	IN	B-PP	Ohigh	levels	high	JJ	B-NP	Olevels	(	level	NNS	I-NP	O(	greater	(	(	O	Ogreater	than	great	JJR	B-NP	Othan	31	than	IN	I-NP	O31	fmol/mg	31	CD	I-NP	Ofmol/mg	)	fmol/mg	NN	I-NP	O)	of	)	)	O	Oof	estrogen	of	IN	B-PP	Oestrogen	receptor	estrogen	NN	B-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	ER	(	(	O	OER	)	ER	NN	B-NP	B-protein)	content	)	)	O	Ocontent	in	content	NN	B-NP	Oin	the	in	IN	B-PP	Othe	primary	the	DT	B-NP	Oprimary	tumor	primary	JJ	I-NP	Otumor	","	tumor	NN	I-NP	O","	no	","	","	O	Ono	other	no	DT	B-NP	Oother	clinical	other	JJ	I-NP	Oclinical	or	clinical	JJ	I-NP	Oor	histologic	or	CC	I-NP	Ohistologic	correlation	histologic	JJ	I-NP	Ocorrelation	between	correlation	NN	I-NP	Obetween	the	between	IN	B-PP	Othe	increase	the	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	either	in	IN	B-PP	Oeither	parameter	either	CC	O	Oparameter	of	parameter	NN	B-NP	Oof	cytotoxic	of	IN	B-PP	Ocytotoxic	effector	cytotoxic	JJ	B-NP	B-cell_typeeffector	cell	effector	NN	I-NP	I-cell_typecell	function	cell	NN	I-NP	I-cell_typefunction	could	function	NN	I-NP	Ocould	be	could	MD	B-VP	Obe	found	be	VB	I-VP	Ofound	.	find	VBN	I-VP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	ER	","	","	O	OER	levels	ER	NN	B-NP	B-proteinlevels	greater	level	NNS	I-NP	Ogreater	than	great	JJR	B-ADJP	Othan	31	than	IN	B-PP	O31	fmol/mg	31	CD	B-NP	Ofmol/mg	might	fmol/mg	NN	I-NP	Omight	be	might	MD	B-VP	Obe	associated	be	VB	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	increased	with	IN	B-PP	Oincreased	cytotoxic	increase	VBN	B-NP	Ocytotoxic	effector	cytotoxic	JJ	I-NP	B-cell_typeeffector	cell	effector	NN	I-NP	I-cell_typecell	function	cell	NN	I-NP	I-cell_typefunction	in	function	NN	I-NP	Oin	tumor-bearing	in	IN	B-PP	Otumor-bearing	patients	tumor-bearing	JJ	B-NP	Opatients	with	patient	NNS	I-NP	Owith	breast	with	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	.	cancer	NN	I-NP	O.	Properties	.	.	O	OProperties	of	Property	NNS	B-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	Epstein-Barr	in	IN	B-PP	OEpstein-Barr	virus-transformed	Epstein-Barr	JJ	B-NP	B-cell_typevirus-transformed	lymphocytes	virus-transformed	JJ	I-NP	I-cell_typelymphocytes	from	lymphocyte	NNS	I-NP	I-cell_typefrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	familial	with	IN	B-PP	Ofamilial	cortisol	familial	JJ	B-NP	Ocortisol	resistance	cortisol	NN	I-NP	Oresistance	.	resistance	NN	I-NP	O.	In	.	.	O	OIn	a	In	IN	B-PP	Oa	previous	a	DT	B-NP	Oprevious	report	previous	JJ	I-NP	Oreport	of	report	NN	I-NP	Oof	two	of	IN	B-PP	Otwo	patients	two	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	familial	with	IN	B-PP	Ofamilial	glucocorticoid	familial	JJ	B-NP	Oglucocorticoid	resistance	glucocorticoid	NN	I-NP	Oresistance	due	resistance	NN	I-NP	Odue	to	due	JJ	B-ADJP	Oto	reduced	to	TO	B-PP	Oreduced	numbers	reduce	VBN	B-NP	Onumbers	of	number	NNS	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	(	receptor	NNS	I-NP	I-protein(	GR	(	(	O	OGR	)	GR	NN	B-NP	B-protein)	","	)	)	O	O","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	shown	have	VBP	B-VP	Oshown	decreased	show	VBN	I-VP	Odecreased	numbers	decrease	VBN	B-NP	Onumbers	of	number	NNS	I-NP	Oof	GR	of	IN	B-PP	OGR	in	GR	NN	B-NP	B-proteinin	peripheral	in	IN	B-PP	Operipheral	mononuclear	peripheral	JJ	B-NP	B-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	cultured	and	CC	O	Ocultured	fibroblasts	culture	VBN	B-NP	B-cell_typefibroblasts	but	fibroblast	NNS	I-NP	I-cell_typebut	normal	but	CC	O	Onormal	affinity	normal	JJ	B-NP	Oaffinity	of	affinity	NN	I-NP	Oof	GR	of	IN	B-PP	OGR	in	GR	NN	B-NP	B-proteinin	both	in	IN	B-PP	Oboth	patients	both	DT	B-NP	Opatients	.	patient	NNS	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	peripheral	","	","	O	Operipheral	lymphocytes	peripheral	JJ	B-NP	B-cell_typelymphocytes	from	lymphocyte	NNS	I-NP	I-cell_typefrom	these	from	IN	B-PP	Othese	patients	these	DT	B-NP	Opatients	","	patient	NNS	I-NP	O","	one	","	","	O	Oone	patient	one	CD	B-NP	Opatient	's	patient	NN	I-NP	O's	son	's	POS	B-NP	Oson	and	son	NN	I-NP	Oand	daughter	and	CC	I-NP	Odaughter	","	daughter	NN	I-NP	O","	and	","	","	O	Oand	normal	and	CC	O	Onormal	subjects	normal	JJ	B-NP	Osubjects	were	subject	NNS	I-NP	Owere	transformed	be	VBD	B-VP	Otransformed	with	transform	VBN	I-VP	Owith	Epstein-Barr	with	IN	B-PP	OEpstein-Barr	virus	Epstein-Barr	JJ	B-NP	Ovirus	.	virus	NN	I-NP	O.	Reduced	.	.	O	OReduced	numbers	Reduce	VBN	B-NP	Onumbers	and	number	NNS	I-NP	Oand	normal	and	CC	O	Onormal	affinity	normal	JJ	B-NP	Oaffinity	of	affinity	NN	I-NP	Oof	GR	of	IN	B-PP	OGR	were	GR	NN	B-NP	B-proteinwere	found	be	VBD	B-VP	Ofound	in	find	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	Epstein-Barr	the	DT	B-NP	OEpstein-Barr	virus-transformed	Epstein-Barr	JJ	I-NP	B-cell_typevirus-transformed	lymphocytes	virus-transformed	JJ	I-NP	I-cell_typelymphocytes	from	lymphocyte	NNS	I-NP	I-cell_typefrom	both	from	IN	B-PP	Oboth	patients	both	DT	B-NP	Opatients	while	patient	NNS	I-NP	Owhile	the	while	IN	B-SBAR	Othe	son	the	DT	B-NP	Oson	and	son	NN	I-NP	Oand	daughter	and	CC	I-NP	Odaughter	had	daughter	NN	I-NP	Ohad	normal	have	VBD	B-VP	Onormal	numbers	normal	JJ	B-ADJP	Onumbers	and	number	NNS	B-NP	Oand	affinity	and	CC	O	Oaffinity	of	affinity	NN	B-NP	Oof	GR	of	IN	B-PP	OGR	.	GR	NN	B-NP	B-protein.	The	.	.	O	OThe	thermal	The	DT	B-NP	Othermal	stability	thermal	JJ	I-NP	Ostability	of	stability	NN	I-NP	Oof	GR	of	IN	B-PP	OGR	and	GR	NN	B-NP	B-proteinand	thermal	and	CC	O	Othermal	activation	thermal	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	cytosolic	of	IN	B-PP	Ocytosolic	receptors	cytosolic	JJ	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	both	in	IN	B-PP	Oboth	patients	both	DT	B-NP	Opatients	were	patient	NNS	I-NP	Owere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	normal	be	VB	I-VP	Onormal	.	normal	JJ	B-ADJP	O.	Although	.	.	O	OAlthough	the	Although	IN	B-SBAR	Othe	percentages	the	DT	B-NP	Opercentages	of	percentage	NNS	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	bound	nuclear	JJ	B-NP	Obound	GR	bind	VBN	I-NP	OGR	were	GR	NN	I-NP	B-proteinwere	similar	be	VBD	B-VP	Osimilar	in	similar	JJ	B-ADJP	Oin	both	in	IN	B-PP	Oboth	patients	both	CC	O	Opatients	and	patient	NNS	B-NP	Oand	normal	and	CC	O	Onormal	controls	normal	JJ	B-NP	Ocontrols	","	control	NNS	I-NP	O","	the	","	","	O	Othe	absolute	the	DT	B-NP	Oabsolute	amounts	absolute	JJ	I-NP	Oamounts	of	amount	NNS	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	bound	nuclear	JJ	B-NP	Obound	GR	bind	VBN	I-NP	OGR	of	GR	NN	I-NP	B-proteinof	the	of	IN	B-PP	Othe	patients	the	DT	B-NP	Opatients	were	patient	NNS	I-NP	Owere	about	be	VBD	B-VP	Oabout	one-half	about	RB	B-NP	Oone-half	that	one-half	JJ	I-NP	Othat	of	that	DT	I-NP	Oof	normal	of	IN	B-PP	Onormal	controls	normal	JJ	B-NP	Ocontrols	.	control	NNS	I-NP	O.	These	.	.	O	OThese	abnormal	These	DT	B-NP	Oabnormal	properties	abnormal	JJ	I-NP	Oproperties	of	property	NNS	I-NP	Oof	GR	of	IN	B-PP	OGR	(	GR	NN	B-NP	B-protein(	reduced	(	(	O	Oreduced	numbers	reduce	VBN	B-VP	Onumbers	of	number	NNS	B-NP	Oof	GR	of	IN	B-PP	OGR	)	GR	NN	B-NP	B-protein)	were	)	)	O	Owere	preserved	be	VBD	B-VP	Opreserved	in	preserve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	transformed	the	DT	B-NP	Otransformed	cells	transform	VBN	I-NP	B-cell_linecells	from	cell	NNS	I-NP	I-cell_linefrom	the	from	IN	B-PP	Othe	patients	the	DT	B-NP	Opatients	.	patient	NNS	I-NP	O.	Octamer	.	.	O	OOctamer	transcription	Octamer	NN	B-NP	B-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	1	factor	NNS	I-NP	I-protein1	and	1	CD	B-NP	I-proteinand	2	and	CC	I-NP	I-protein2	each	2	CD	I-NP	I-proteineach	bind	each	DT	B-NP	Obind	to	bind	VBP	B-VP	Oto	two	to	TO	B-PP	Otwo	different	two	CD	B-NP	Odifferent	functional	different	JJ	I-NP	Ofunctional	elements	functional	JJ	I-NP	Oelements	in	element	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	immunoglobulin	the	DT	B-NP	Oimmunoglobulin	heavy-chain	immunoglobulin	NN	I-NP	B-DNAheavy-chain	promoter	heavy-chain	NN	I-NP	I-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Immunoglobulin	.	.	O	OImmunoglobulin	heavy-chain	Immunoglobulin	NN	B-NP	B-DNAheavy-chain	genes	heavy-chain	JJ	I-NP	I-DNAgenes	contain	gene	NNS	I-NP	I-DNAcontain	two	contain	VBP	B-VP	Otwo	conserved	two	CD	B-NP	Oconserved	sequence	conserve	VBN	I-NP	Osequence	elements	sequence	NN	I-NP	Oelements	5	element	NNS	I-NP	O5	'	5	CD	B-NP	O'	to	'	SYM	B-NP	Oto	the	to	TO	B-PP	Othe	site	the	DT	B-NP	Osite	of	site	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	initiation	transcription	NN	B-NP	Oinitiation	:	initiation	NN	I-NP	O:	the	:	:	O	Othe	octamer	the	DT	B-NP	Ooctamer	ATGCAAAT	octamer	NN	I-NP	OATGCAAAT	and	ATGCAAAT	NN	I-NP	Oand	the	and	CC	O	Othe	heptamer	the	DT	B-NP	Oheptamer	CTCATGA	heptamer	NN	I-NP	B-DNACTCATGA	.	CTCATGA	NN	I-NP	I-DNA.	Both	.	.	O	OBoth	of	Both	DT	B-NP	Oof	these	of	IN	B-PP	Othese	elements	these	DT	B-NP	Oelements	are	element	NNS	I-NP	B-DNAare	required	be	VBP	B-VP	Orequired	for	require	VBN	I-VP	Ofor	normal	for	IN	B-PP	Onormal	cell-specific	normal	JJ	B-NP	Ocell-specific	promoter	cell-specific	JJ	I-NP	Opromoter	function	promoter	NN	I-NP	Ofunction	.	function	NN	I-NP	O.	The	.	.	O	OThe	present	The	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	demonstrates	study	NN	I-NP	Odemonstrates	that	demonstrate	VBZ	B-VP	Othat	both	that	IN	B-SBAR	Oboth	the	both	CC	O	Othe	ubiquitous	the	DT	B-NP	Oubiquitous	and	ubiquitous	JJ	I-NP	Oand	lymphoid-cell-specific	and	CC	I-NP	Olymphoid-cell-specific	octamer	lymphoid-cell-specific	JJ	I-NP	B-proteinoctamer	transcription	octamer	NN	I-NP	I-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	(	factor	NNS	I-NP	I-protein(	OTF-1	(	(	O	OOTF-1	and	OTF-1	NN	B-NP	B-proteinand	OTF-2	and	CC	O	OOTF-2	","	OTF-2	NN	B-NP	B-protein","	respectively	","	","	O	Orespectively	)	respectively	RB	B-ADVP	O)	interact	)	)	O	Ointeract	specifically	interact	VBP	B-VP	Ospecifically	with	specifically	RB	B-ADVP	Owith	each	with	IN	B-PP	Oeach	of	each	DT	B-NP	Oof	the	of	IN	B-PP	Othe	two	the	DT	B-NP	Otwo	conserved	two	CD	I-NP	Oconserved	sequence	conserve	VBN	I-NP	B-DNAsequence	elements	sequence	NN	I-NP	I-DNAelements	","	element	NNS	I-NP	I-DNA","	forming	","	","	O	Oforming	either	form	VBG	B-VP	Oeither	homo-	either	CC	O	Ohomo-	or	homo-	JJ	B-NP	Oor	heterodimeric	or	CC	I-NP	Oheterodimeric	complexes	heterodimeric	JJ	I-NP	B-proteincomplexes	.	complex	NNS	I-NP	I-protein.	This	.	.	O	OThis	was	This	DT	B-NP	Owas	surprising	be	VBD	B-VP	Osurprising	","	surprising	JJ	B-ADJP	O","	since	","	","	O	Osince	the	since	IN	B-SBAR	Othe	heptamer	the	DT	B-NP	Oheptamer	and	heptamer	NN	I-NP	Oand	octamer	and	CC	I-NP	Ooctamer	sequence	octamer	NN	I-NP	B-DNAsequence	motifs	sequence	NN	I-NP	I-DNAmotifs	bear	motif	NNS	I-NP	I-DNAbear	no	bear	VBP	B-VP	Ono	obvious	no	DT	B-NP	Oobvious	similarity	obvious	JJ	I-NP	Osimilarity	to	similarity	NN	I-NP	Oto	each	to	TO	B-PP	Oeach	other	each	DT	B-NP	Oother	.	other	JJ	I-NP	O.	Binding	.	.	O	OBinding	of	Binding	NN	B-NP	Oof	either	of	IN	B-PP	Oeither	factor	either	DT	B-NP	Ofactor	to	factor	NN	I-NP	Oto	the	to	TO	B-PP	Othe	octamer	the	DT	B-NP	Ooctamer	element	octamer	NN	I-NP	B-DNAelement	occurred	element	NN	I-NP	I-DNAoccurred	independently	occur	VBD	B-VP	Oindependently	.	independently	RB	B-ADVP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	OTF	","	","	O	OOTF	interaction	OTF	NN	B-NP	B-proteininteraction	with	interaction	NN	I-NP	Owith	the	with	IN	B-PP	Othe	heptamer	the	DT	B-NP	Oheptamer	sequence	heptamer	NN	I-NP	B-DNAsequence	appeared	sequence	NN	I-NP	I-DNAappeared	to	appear	VBD	B-VP	Oto	require	to	TO	I-VP	Orequire	the	require	VB	I-VP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	an	of	IN	B-PP	Oan	intact	an	DT	B-NP	Ointact	octamer	intact	JJ	I-NP	Ooctamer	motif	octamer	NN	I-NP	B-DNAmotif	and	motif	NN	I-NP	I-DNAand	occurred	and	CC	O	Ooccurred	with	occur	VBD	B-VP	Owith	a	with	IN	B-PP	Oa	spacing	a	DT	B-NP	Ospacing	of	spacing	NN	I-NP	Oof	either	of	IN	B-PP	Oeither	2	either	CC	B-NP	O2	or	2	CD	I-NP	Oor	14	or	CC	I-NP	O14	base	14	CD	I-NP	Obase	pairs	base	NN	I-NP	Opairs	between	pair	NNS	I-NP	Obetween	the	between	IN	B-PP	Othe	two	the	DT	B-NP	Otwo	elements	two	CD	I-NP	Oelements	","	element	NNS	I-NP	O","	suggesting	","	","	O	Osuggesting	coordinate	suggest	VBG	B-VP	Ocoordinate	binding	coordinate	JJ	B-NP	Obinding	resulting	binding	NN	I-NP	Oresulting	from	result	VBG	B-VP	Ofrom	protein-protein	from	IN	B-PP	Oprotein-protein	interactions	protein-protein	JJ	B-NP	Ointeractions	.	interaction	NNS	I-NP	O.	The	.	.	O	OThe	degeneracy	The	DT	B-NP	Odegeneracy	in	degeneracy	NN	I-NP	Oin	sequences	in	IN	B-PP	Osequences	recognized	sequence	NNS	B-NP	Orecognized	by	recognize	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	OTFs	the	DT	B-NP	OOTFs	may	OTF	NNS	I-NP	B-proteinmay	be	may	MD	B-VP	Obe	important	be	VB	I-VP	Oimportant	in	important	JJ	B-ADJP	Oin	widening	in	IN	B-PP	Owidening	the	widen	VBG	B-VP	Othe	range	the	DT	B-NP	Orange	over	range	NN	I-NP	Oover	which	over	IN	B-PP	Owhich	gene	which	WDT	B-NP	Ogene	expression	gene	NN	B-NP	Oexpression	can	expression	NN	I-NP	Ocan	be	can	MD	B-VP	Obe	modulated	be	VB	I-VP	Omodulated	and	modulate	VBN	I-VP	Oand	in	and	CC	O	Oin	establishing	in	IN	B-PP	Oestablishing	cell	establish	VBG	B-VP	Ocell	type	cell	NN	B-NP	Otype	specificity	type	NN	I-NP	Ospecificity	.	specificity	NN	I-NP	O.	Identification	.	.	O	OIdentification	of	Identification	NN	B-NP	Oof	a	of	IN	B-PP	Oa	novel	a	DT	B-NP	Onovel	lymphoid	novel	JJ	I-NP	Olymphoid	specific	lymphoid	JJ	I-NP	Ospecific	octamer	specific	JJ	I-NP	Ooctamer	binding	octamer	NN	I-NP	B-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	OTF-2B	(	(	O	OOTF-2B	)	OTF-2B	NN	B-NP	B-protein)	by	)	)	O	Oby	proteolytic	by	IN	B-PP	Oproteolytic	clipping	proteolytic	JJ	B-NP	Oclipping	bandshift	clipping	NN	I-NP	Obandshift	assay	bandshift	NN	I-NP	Oassay	(	assay	NN	I-NP	O(	PCBA	(	(	O	OPCBA	)	PCBA	NN	B-NP	B-protein)	.	)	)	O	O.	The	.	.	O	OThe	octamer	The	DT	B-NP	Ooctamer	sequence	octamer	NN	I-NP	B-DNAsequence	ATGCAAAT	sequence	NN	I-NP	I-DNAATGCAAAT	is	ATGCAAAT	NN	I-NP	Ois	found	be	VBZ	B-VP	Ofound	in	find	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	promoters	the	DT	B-NP	Opromoters	of	promoter	NNS	I-NP	B-DNAof	immunoglobulin	of	IN	B-PP	Oimmunoglobulin	(	immunoglobulin	NN	B-NP	B-DNA(	Ig	(	(	I-NP	I-DNAIg	)	Ig	NN	I-NP	I-DNA)	heavy	)	)	I-NP	I-DNAheavy	and	heavy	JJ	I-NP	I-DNAand	light	and	CC	I-NP	I-DNAlight	chain	light	JJ	I-NP	I-DNAchain	genes	chain	NN	I-NP	I-DNAgenes	and	gene	NNS	I-NP	I-DNAand	in	and	CC	B-PP	Oin	the	in	IN	B-PP	Othe	heavy	the	DT	B-NP	Oheavy	chain	heavy	JJ	I-NP	B-DNAchain	enhancer	chain	NN	I-NP	I-DNAenhancer	and	enhancer	NN	I-NP	I-DNAand	is	and	CC	O	Ois	a	be	VBZ	B-VP	Oa	major	a	DT	B-NP	Omajor	determinant	major	JJ	I-NP	Odeterminant	of	determinant	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	type	cell	NN	I-NP	Otype	specific	type	NN	I-NP	Ospecific	expression	specific	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	Ig	of	IN	B-PP	OIg	genes	Ig	NN	B-NP	B-DNAgenes	in	gene	NNS	I-NP	I-DNAin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	An	.	.	O	OAn	apparent	An	DT	B-NP	Oapparent	paradox	apparent	JJ	I-NP	Oparadox	is	paradox	NN	I-NP	Ois	that	be	VBZ	B-VP	Othat	the	that	IN	B-SBAR	Othe	same	the	DT	B-NP	Osame	sequence	same	JJ	I-NP	Osequence	serves	sequence	NN	I-NP	Oserves	as	serve	VBZ	B-VP	Oas	an	as	IN	B-PP	Oan	upstream	an	DT	B-NP	Oupstream	promoter	upstream	JJ	I-NP	B-DNApromoter	or	promoter	NN	I-NP	I-DNAor	enhancer	or	CC	I-NP	Oenhancer	element	enhancer	NN	I-NP	B-DNAelement	in	element	NN	I-NP	I-DNAin	a	in	IN	B-PP	Oa	variety	a	DT	B-NP	Ovariety	of	variety	NN	I-NP	Oof	housekeeping	of	IN	B-PP	Ohousekeeping	genes	housekeeping	NN	B-NP	B-DNAgenes	such	gene	NNS	I-NP	I-DNAsuch	as	such	JJ	B-PP	Oas	the	as	IN	I-PP	Othe	histone	the	DT	B-NP	Ohistone	H2B	histone	NN	I-NP	B-DNAH2B	and	H2B	NN	I-NP	I-DNAand	U	and	CC	O	I-DNAU	snRNA	U	NN	B-NP	I-DNAsnRNA	genes	snRNA	NN	I-NP	I-DNAgenes	.	gene	NNS	I-NP	I-DNA.	The	.	.	O	OThe	differential	The	DT	B-NP	Odifferential	usage	differential	JJ	I-NP	Ousage	of	usage	NN	I-NP	Oof	this	of	IN	B-PP	Othis	regulatory	this	DT	B-NP	Oregulatory	sequence	regulatory	JJ	I-NP	B-DNAsequence	motif	sequence	NN	I-NP	I-DNAmotif	is	motif	NN	I-NP	I-DNAis	thought	be	VBZ	B-VP	Othought	to	think	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	mediated	be	VB	I-VP	Omediated	by	mediate	VBN	I-VP	Oby	different	by	IN	B-PP	Odifferent	species	different	JJ	B-NP	Ospecies	of	specie	NNS	I-NP	Oof	octamer	of	IN	B-PP	Ooctamer	binding	octamer	NN	B-NP	B-proteinbinding	proteins	binding	NN	I-NP	I-proteinproteins	.	protein	NNS	I-NP	I-protein.	One	.	.	O	OOne	species	One	CD	B-NP	Ospecies	of	specie	NNS	I-NP	Oof	100	of	IN	B-PP	O100	kd	100	CD	B-NP	Okd	","	kd	NN	I-NP	O","	designated	","	","	O	Odesignated	OTF-1	designate	VBN	B-VP	OOTF-1	","	OTF-1	NN	B-NP	B-protein","	is	","	","	O	Ois	present	be	VBZ	B-VP	Opresent	in	present	JJ	B-ADJP	Oin	all	in	IN	B-PP	Oall	cell	all	DT	B-NP	Ocell	types	cell	NN	I-NP	Otypes	and	type	NNS	I-NP	Oand	may	and	CC	O	Omay	exert	may	MD	B-VP	Oexert	its	exert	VB	I-VP	Oits	activating	its	PRP$	B-NP	Oactivating	function	activate	VBG	I-NP	Ofunction	only	function	NN	I-NP	Oonly	when	only	RB	O	Owhen	it	when	WRB	B-ADVP	Oit	can	it	PRP	B-NP	Ocan	interact	can	MD	B-VP	Ointeract	with	interact	VB	I-VP	Owith	additional	with	IN	B-PP	Oadditional	adjacent	additional	JJ	B-NP	Oadjacent	transcription	adjacent	JJ	I-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	.	factor	NNS	I-NP	I-protein.	The	.	.	O	OThe	lymphoid	The	DT	B-NP	Olymphoid	cell	lymphoid	JJ	I-NP	Ocell	specific	cell	NN	I-NP	Ospecific	octamer	specific	JJ	I-NP	Ooctamer	binding	octamer	NN	I-NP	B-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	of	protein	NN	I-NP	I-proteinof	60	of	IN	B-PP	O60	kd	60	CD	B-NP	B-proteinkd	(	kd	NN	I-NP	I-protein(	OTF-2A	(	(	O	OOTF-2A	)	OTF-2A	NN	B-NP	B-protein)	specifically	)	)	O	Ospecifically	stimulates	specifically	RB	B-ADVP	Ostimulates	Ig	stimulate	VBZ	B-VP	OIg	promoters	Ig	NN	B-NP	B-DNApromoters	which	promoter	NNS	I-NP	I-DNAwhich	consist	which	WDT	B-NP	Oconsist	essentially	consist	VBP	B-VP	Oessentially	of	essentially	RB	B-ADVP	Oof	a	of	IN	B-PP	Oa	TATA-box	a	DT	B-NP	OTATA-box	and	TATA-box	NN	I-NP	B-DNAand	an	and	CC	O	Oan	octamer	an	DT	B-NP	Ooctamer	sequence	octamer	NN	I-NP	B-DNAsequence	upstream	sequence	NN	I-NP	I-DNAupstream	of	upstream	RB	B-ADVP	Oof	it	of	IN	B-PP	Oit	.	it	PRP	B-NP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	present	we	PRP	B-NP	Opresent	evidence	present	VBP	B-VP	Oevidence	for	evidence	NN	B-NP	Ofor	yet	for	IN	B-PP	Oyet	another	yet	RB	B-NP	Oanother	B	another	DT	I-NP	OB	cell	B	NN	I-NP	Ocell	specific	cell	NN	I-NP	Ospecific	octamer	specific	JJ	I-NP	Ooctamer	binding	octamer	NN	I-NP	B-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	of	protein	NN	I-NP	I-proteinof	75	of	IN	B-PP	O75	kd	75	CD	B-NP	B-proteinkd	(	kd	NN	I-NP	I-protein(	OTF-2B	(	(	O	OOTF-2B	)	OTF-2B	NN	B-NP	B-protein)	.	)	)	O	O.	From	.	.	O	OFrom	several	From	IN	B-PP	Oseveral	findings	several	JJ	B-NP	Ofindings	","	finding	NNS	I-NP	O","	including	","	","	O	Oincluding	the	include	VBG	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	OTF-2B	of	IN	B-PP	OOTF-2B	(	OTF-2B	NN	B-NP	B-protein(	but	(	(	O	Obut	not	but	CC	O	Onot	OTF-2A	not	RB	O	OOTF-2A	)	OTF-2A	NN	B-NP	B-protein)	from	)	)	O	Ofrom	a	from	IN	B-PP	Oa	lymphocyte	a	DT	B-NP	Olymphocyte	line	lymphocyte	NN	I-NP	B-cell_lineline	that	line	NN	I-NP	I-cell_linethat	can	that	WDT	B-NP	Ocan	not	can	MD	B-VP	Onot	respond	not	RB	I-VP	Orespond	to	respond	VB	I-VP	Oto	the	to	TO	B-PP	Othe	IgH	the	DT	B-NP	OIgH	enhancer	IgH	NN	I-NP	B-DNAenhancer	","	enhancer	NN	I-NP	I-DNA","	we	","	","	O	Owe	propose	we	PRP	B-NP	Opropose	a	propose	VBP	B-VP	Oa	role	a	DT	B-NP	Orole	of	role	NN	I-NP	Oof	the	of	IN	B-PP	Othe	novel	the	DT	B-NP	Onovel	octamer	novel	JJ	I-NP	Ooctamer	factor	octamer	NN	I-NP	B-proteinfactor	in	factor	NN	I-NP	I-proteinin	the	in	IN	B-PP	Othe	long	the	DT	B-NP	Olong	range	long	JJ	I-NP	Orange	activation	range	NN	I-NP	Oactivation	by	activation	NN	I-NP	Oby	the	by	IN	B-PP	Othe	IgH	the	DT	B-NP	OIgH	enhancer	IgH	NN	I-NP	B-DNAenhancer	.	enhancer	NN	I-NP	I-DNA.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	used	have	VBP	B-VP	Oused	the	use	VBN	I-VP	Othe	proteolytic	the	DT	B-NP	Oproteolytic	clipping	proteolytic	JJ	I-NP	Oclipping	bandshift	clipping	NN	I-NP	Obandshift	assay	bandshift	NN	I-NP	Oassay	(	assay	NN	I-NP	O(	PCBA	(	(	O	OPCBA	)	PCBA	NN	B-NP	O)	technique	)	)	O	Otechnique	to	technique	NN	B-NP	Oto	distinguish	to	TO	B-VP	Odistinguish	the	distinguish	VB	I-VP	Othe	three	the	DT	B-NP	Othree	different	three	CD	I-NP	Odifferent	forms	different	JJ	I-NP	Oforms	found	form	NNS	I-NP	Ofound	in	find	VBN	B-VP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	This	.	.	O	OThis	analysis	This	DT	B-NP	Oanalysis	indicates	analysis	NN	I-NP	Oindicates	that	indicate	VBZ	B-VP	Othat	the	that	IN	B-SBAR	Othe	75	the	DT	B-NP	O75	kd-species	75	CD	I-NP	Okd-species	OTF-2B	kd-specy	NNS	I-NP	OOTF-2B	is	OTF-2B	NN	I-NP	B-proteinis	closely	be	VBZ	B-VP	Oclosely	related	closely	RB	B-ADJP	Orelated	to	related	JJ	I-ADJP	Oto	the	to	TO	B-PP	Othe	60	the	DT	B-NP	O60	kd	60	CD	I-NP	Okd	species	kd	NN	I-NP	Ospecies	OTF-2A	specie	NNS	I-NP	OOTF-2A	.	OTF-2A	NN	I-NP	B-protein.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	interleukin	of	IN	B-PP	Ointerleukin	2	interleukin	NN	B-NP	B-protein2	#NAME?	2	CD	I-NP	I-protein#NAME?	proliferation	#NAME?	JJ	I-NP	Oproliferation	of	proliferation	NN	I-NP	Oof	cloned	of	IN	B-PP	Ocloned	murine	clone	VBN	B-NP	B-cell_typemurine	T	murine	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	glucocorticoids	by	IN	B-PP	Oglucocorticoids	.	glucocorticoid	NNS	B-NP	O.	Possible	.	.	O	OPossible	involvement	Possible	JJ	B-NP	Oinvolvement	of	involvement	NN	I-NP	Oof	an	of	IN	B-PP	Oan	inhibitory	an	DT	B-NP	Oinhibitory	protein	inhibitory	JJ	I-NP	B-proteinprotein	.	protein	NN	I-NP	I-protein.	The	.	.	O	OThe	ability	The	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	glucocorticoids	of	IN	B-PP	Oglucocorticoids	to	glucocorticoid	NNS	B-NP	Oto	inhibit	to	TO	B-VP	Oinhibit	interleukin	inhibit	VB	I-VP	Ointerleukin	2	interleukin	NN	B-NP	B-protein2	(	2	CD	I-NP	I-protein(	IL	(	(	O	OIL	2	IL	NN	B-NP	B-protein2	)	2	CD	I-NP	I-protein)	#NAME?	)	)	I-NP	O#NAME?	T	#NAME?	JJ	I-NP	OT	cell	T	NN	I-NP	Ocell	proliferation	cell	NN	I-NP	Oproliferation	in	proliferation	NN	I-NP	Oin	two	in	IN	B-PP	Otwo	cytotoxic	two	CD	B-NP	Ocytotoxic	T	cytotoxic	JJ	I-NP	B-cell_typeT	cell	T	NN	I-NP	I-cell_typecell	(	cell	NN	I-NP	I-cell_type(	CTL	(	(	O	OCTL	)	CTL	NN	B-NP	B-cell_type)	clones	)	)	O	Oclones	has	clone	NNS	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	studied	be	VBN	I-VP	Ostudied	.	study	VBN	I-VP	O.	A	.	.	O	OA	complete	A	DT	B-NP	Ocomplete	inhibition	complete	JJ	I-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	DNA	of	IN	B-PP	ODNA	synthesis	DNA	NN	B-NP	Osynthesis	by	synthesis	NN	I-NP	Oby	dexamethasone	by	IN	B-PP	Odexamethasone	(	dexamethasone	NN	B-NP	O(	Dx	(	(	O	ODx	)	Dx	NN	B-NP	O)	could	)	)	O	Ocould	be	could	MD	B-VP	Obe	observed	be	VB	I-VP	Oobserved	when	observe	VBN	I-VP	Owhen	IL	when	WRB	B-ADVP	OIL	2-depleted	IL	NN	B-NP	B-cell_line2-depleted	cultures	2-depleted	JJ	I-NP	I-cell_linecultures	of	culture	NNS	I-NP	I-cell_lineof	CTL	of	IN	B-PP	OCTL	were	CTL	NN	B-NP	B-cell_typewere	either	be	VBD	B-VP	Oeither	incubated	either	RB	I-VP	Oincubated	for	incubate	VBN	I-VP	Ofor	6	for	IN	B-PP	O6	h	6	CD	B-NP	Oh	with	h	NN	I-NP	Owith	the	with	IN	B-PP	Othe	hormone	the	DT	B-NP	Ohormone	prior	hormone	NN	I-NP	Oprior	to	prior	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	addition	the	DT	B-NP	Oaddition	of	addition	NN	I-NP	Oof	IL	of	IN	B-PP	OIL	2	IL	NN	B-NP	B-protein2	or	2	CD	I-NP	I-proteinor	treated	or	CC	O	Otreated	simultaneously	treat	VBN	B-VP	Osimultaneously	with	simultaneously	RB	B-ADVP	Owith	Dx	with	IN	B-PP	ODx	and	Dx	NN	B-NP	B-proteinand	a	and	CC	O	Oa	low	a	DT	B-NP	Olow	concentration	low	JJ	I-NP	Oconcentration	of	concentration	NN	I-NP	Oof	IL	of	IN	B-PP	OIL	2	IL	NN	B-NP	B-protein2	.	2	CD	I-NP	I-protein.	No	.	.	O	ONo	significant	No	DT	B-NP	Osignificant	reduction	significant	JJ	I-NP	Oreduction	in	reduction	NN	I-NP	Oin	the	in	IN	B-PP	Othe	number	the	DT	B-NP	Onumber	and	number	NN	I-NP	Oand	affinity	and	CC	O	Oaffinity	of	affinity	NN	B-NP	Oof	IL	of	IN	B-PP	OIL	2	IL	NN	B-NP	B-protein2	receptors	2	CD	I-NP	I-proteinreceptors	was	receptor	NNS	I-NP	I-proteinwas	seen	be	VBD	B-VP	Oseen	after	see	VBN	I-VP	Oafter	6	after	IN	B-PP	O6	h	6	CD	B-NP	Oh	incubation	h	NN	I-NP	Oincubation	with	incubation	NN	I-NP	Owith	Dx	with	IN	B-PP	ODx	.	Dx	NN	B-NP	O.	The	.	.	O	OThe	order	The	DT	B-NP	Oorder	of	order	NN	I-NP	Oof	potency	of	IN	B-PP	Opotency	observed	potency	NN	B-NP	Oobserved	with	observe	VBN	B-VP	Owith	the	with	IN	B-PP	Othe	different	the	DT	B-NP	Odifferent	steroids	different	JJ	I-NP	Osteroids	indicated	steroid	NNS	I-NP	Oindicated	that	indicate	VBD	B-VP	Othat	this	that	IN	B-SBAR	Othis	inhibitory	this	DT	B-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	was	effect	NN	I-NP	Owas	mediated	be	VBD	B-VP	Omediated	through	mediate	VBN	I-VP	Othrough	binding	through	IN	B-PP	Obinding	to	bind	VBG	B-VP	Oto	a	to	TO	B-PP	Oa	specific	a	DT	B-NP	Ospecific	glucocorticoid	specific	JJ	I-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	.	receptor	NN	I-NP	I-protein.	The	.	.	O	OThe	action	The	DT	B-NP	Oaction	of	action	NN	I-NP	Oof	these	of	IN	B-PP	Othese	hormones	these	DT	B-NP	Ohormones	possibly	hormone	NNS	I-NP	Opossibly	involves	possibly	RB	B-ADVP	Oinvolves	the	involve	VBZ	B-VP	Othe	synthesis	the	DT	B-NP	Osynthesis	of	synthesis	NN	I-NP	Oof	an	of	IN	B-PP	Oan	inhibitory	an	DT	B-NP	Oinhibitory	protein	inhibitory	JJ	I-NP	B-proteinprotein	(	protein	NN	I-NP	I-protein(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	","	)	)	O	O","	since	","	","	O	Osince	the	since	IN	B-SBAR	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	cycloheximide	of	IN	B-PP	Ocycloheximide	during	cycloheximide	NN	B-NP	Oduring	the	during	IN	B-PP	Othe	incubation	the	DT	B-NP	Oincubation	with	incubation	NN	I-NP	Owith	Dx	with	IN	B-PP	ODx	prevented	Dx	NN	B-NP	Oprevented	the	prevent	VBD	B-VP	Othe	inhibition	the	DT	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	DNA	of	IN	B-PP	ODNA	synthesis	DNA	NN	B-NP	Osynthesis	.	synthesis	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	supernatant	","	","	O	Osupernatant	from	supernatant	JJ	B-ADJP	Ofrom	Dx-treated	from	IN	B-PP	ODx-treated	CTL	Dx-treated	JJ	B-NP	B-cell_typeCTL	contained	CTL	NN	I-NP	I-cell_typecontained	a	contain	VBD	B-VP	Oa	nondialyzable	a	DT	B-NP	Onondialyzable	factor	nondialyzable	JJ	I-NP	B-proteinfactor	which	factor	NN	I-NP	I-proteinwhich	inhibited	which	WDT	B-NP	Oinhibited	DNA	inhibit	VBD	B-VP	ODNA	synthesis	DNA	NN	B-NP	Osynthesis	and	synthesis	NN	I-NP	Oand	cell	and	CC	O	Ocell	growth	cell	NN	B-NP	Ogrowth	of	growth	NN	I-NP	Oof	CTL	of	IN	B-PP	OCTL	clones	CTL	NN	B-NP	B-cell_lineclones	induced	clone	NNS	I-NP	I-cell_lineinduced	by	induce	VBN	B-VP	Oby	IL	by	IN	B-PP	OIL	2	IL	NN	B-NP	B-protein2	.	2	CD	I-NP	I-protein.	Blocking	.	.	O	OBlocking	of	Blocking	NN	B-NP	Oof	IL	of	IN	B-PP	OIL	2	IL	NN	B-NP	B-protein2	synthesis	2	CD	I-NP	I-proteinsynthesis	and	synthesis	NN	I-NP	Oand	IL	and	CC	O	OIL	2	IL	NN	B-NP	B-protein2	receptor	2	CD	I-NP	I-proteinreceptor	formation	receptor	NN	I-NP	I-proteinformation	have	formation	NN	I-NP	Ohave	been	have	VBP	B-VP	Obeen	proposed	be	VBN	I-VP	Oproposed	as	propose	VBN	I-VP	Oas	one	as	IN	B-PP	Oone	of	one	CD	B-NP	Oof	the	of	IN	B-PP	Othe	major	the	DT	B-NP	Omajor	mechanisms	major	JJ	I-NP	Omechanisms	of	mechanism	NNS	I-NP	Oof	glucocorticoid-induced	of	IN	B-PP	Oglucocorticoid-induced	immunosuppression	glucocorticoid-induced	JJ	B-NP	Oimmunosuppression	.	immunosuppression	NN	I-NP	O.	Our	.	.	O	OOur	results	Our	PRP$	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	these	that	IN	B-SBAR	Othese	hormones	these	DT	B-NP	Ohormones	may	hormone	NNS	I-NP	Omay	also	may	MD	B-VP	Oalso	affect	also	RB	I-VP	Oaffect	T	affect	VB	I-VP	OT	cell	T	NN	B-NP	Ocell	proliferation	cell	NN	I-NP	Oproliferation	by	proliferation	NN	I-NP	Oby	inhibiting	by	IN	B-PP	Oinhibiting	IL	inhibit	VBG	B-VP	OIL	2	IL	NN	B-NP	B-protein2	activity	2	CD	I-NP	I-proteinactivity	.	activity	NN	I-NP	O.	Identification	.	.	O	OIdentification	and	Identification	NN	B-NP	Oand	purification	and	CC	I-NP	Opurification	of	purification	NN	I-NP	Oof	a	of	IN	B-PP	Oa	human	a	DT	B-NP	Ohuman	immunoglobulin-enhancer-binding	human	JJ	I-NP	B-proteinimmunoglobulin-enhancer-binding	protein	immunoglobulin-enhancer-binding	JJ	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	NF-kappa	(	(	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	)	B	NN	I-NP	I-protein)	that	)	)	O	Othat	activates	that	WDT	B-NP	Oactivates	transcription	activate	VBZ	B-VP	Otranscription	from	transcription	NN	B-NP	Ofrom	a	from	IN	B-PP	Oa	human	a	DT	B-NP	Ohuman	immunodeficiency	human	JJ	I-NP	B-DNAimmunodeficiency	virus	immunodeficiency	NN	I-NP	I-DNAvirus	type	virus	NN	I-NP	I-DNAtype	1	type	NN	I-NP	I-DNA1	promoter	1	CD	I-NP	I-DNApromoter	in	promoter	NN	I-NP	I-DNAin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	The	.	.	O	OThe	enhancer-binding	The	DT	B-NP	Oenhancer-binding	factor	enhancer-binding	JJ	I-NP	Ofactor	NF-kappa	factor	NN	I-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	","	B	NN	I-NP	I-protein","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	found	be	VBZ	B-VP	Ofound	only	find	VBN	I-VP	Oonly	in	only	RB	B-ADVP	Oin	cells	in	IN	B-PP	Ocells	that	cell	NNS	B-NP	Othat	transcribe	that	WDT	B-NP	Otranscribe	immunoglobulin	transcribe	VBP	B-VP	Oimmunoglobulin	light	immunoglobulin	NN	B-NP	B-DNAlight	chain	light	JJ	I-NP	I-DNAchain	genes	chain	NN	I-NP	I-DNAgenes	","	gene	NNS	I-NP	I-DNA","	has	","	","	O	Ohas	been	have	VBZ	B-VP	Obeen	purified	be	VBN	I-VP	Opurified	from	purify	VBN	I-VP	Ofrom	nuclear	from	IN	B-PP	Onuclear	extracts	nuclear	JJ	B-NP	Oextracts	of	extract	NNS	I-NP	Oof	Namalwa	of	IN	B-PP	ONamalwa	cells	Namalwa	NN	B-NP	B-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	human	(	(	O	Ohuman	Burkitt	human	JJ	B-NP	B-cell_lineBurkitt	lymphoma	Burkitt	NN	I-NP	I-cell_linelymphoma	cells	lymphoma	NN	I-NP	I-cell_linecells	)	cell	NNS	I-NP	I-cell_line)	by	)	)	O	Oby	sequence-specific	by	IN	B-PP	Osequence-specific	DNA	sequence-specific	JJ	B-NP	ODNA	affinity	DNA	NN	I-NP	Oaffinity	chromatography	affinity	NN	I-NP	Ochromatography	.	chromatography	NN	I-NP	O.	The	.	.	O	OThe	purified	The	DT	B-NP	Opurified	NF-kappa	purify	VBN	I-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	has	B	NN	I-NP	I-proteinhas	been	have	VBZ	B-VP	Obeen	identified	be	VBN	I-VP	Oidentified	as	identify	VBN	I-VP	Oas	a	as	IN	B-PP	Oa	51-kDa	a	DT	B-NP	O51-kDa	polypeptide	51-kDa	JJ	I-NP	B-proteinpolypeptide	by	polypeptide	NN	I-NP	I-proteinby	UV-crosslinking	by	IN	B-PP	OUV-crosslinking	analysis	UV-crosslinking	NN	B-NP	Oanalysis	.	analysis	NN	I-NP	O.	``	.	.	O	O``	Footprint	``	``	O	OFootprint	''	Footprint	NNP	B-NP	O''	and	''	''	O	Oand	methylation-interference	and	CC	O	Omethylation-interference	analyses	methylation-interference	NN	B-NP	Oanalyses	have	analysis	NNS	I-NP	Ohave	shown	have	VBP	B-VP	Oshown	that	show	VBN	I-VP	Othat	purified	that	IN	B-SBAR	Opurified	NF-kappa	purify	VBN	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	has	B	NN	I-NP	I-proteinhas	a	have	VBZ	B-VP	Oa	binding	a	DT	B-NP	Obinding	activity	binding	NN	I-NP	Oactivity	specific	activity	NN	I-NP	Ospecific	for	specific	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	kappa	the	DT	B-NP	Okappa	light	kappa	NN	I-NP	B-DNAlight	chain	light	JJ	I-NP	I-DNAchain	enhancer	chain	NN	I-NP	I-DNAenhancer	sequence	enhancer	NN	I-NP	I-DNAsequence	.	sequence	NN	I-NP	I-DNA.	The	.	.	O	OThe	purified	The	DT	B-NP	Opurified	factor	purify	VBN	I-NP	B-proteinfactor	activated	factor	NN	I-NP	I-proteinactivated	in	activate	VBN	B-VP	Oin	vitro	in	FW	B-NP	Ovitro	transcription	vitro	FW	I-NP	Otranscription	of	transcription	NN	I-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	immunodeficiency	human	JJ	I-NP	B-DNAimmunodeficiency	virus	immunodeficiency	NN	I-NP	I-DNAvirus	type	virus	NN	I-NP	I-DNAtype	I	type	NN	I-NP	I-DNAI	promoter	I	CD	I-NP	I-DNApromoter	by	promoter	NN	I-NP	I-DNAby	binding	by	IN	B-PP	Obinding	to	bind	VBG	B-VP	Oto	an	to	TO	B-PP	Oan	upstream	an	DT	B-NP	Oupstream	NF-kappa	upstream	JJ	I-NP	B-DNANF-kappa	B-binding	NF-kappa	NN	I-NP	I-DNAB-binding	site	B-binding	JJ	I-NP	I-DNAsite	Lymphocyte	site	NN	I-NP	I-DNALymphocyte	glucocorticoid	Lymphocyte	NN	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	binding	receptor	NN	I-NP	I-proteinbinding	in	binding	NN	I-NP	Oin	depression	in	IN	B-PP	Odepression	:	depression	NN	B-NP	O:	normal	:	:	O	Onormal	values	normal	JJ	B-NP	Ovalues	following	value	NNS	I-NP	Ofollowing	recovery	follow	VBG	B-PP	Orecovery	.	recovery	NN	B-NP	O.	The	.	.	O	OThe	number	The	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	sites	receptor	NN	I-NP	I-proteinsites	in	site	NNS	I-NP	Oin	lymphocytes	in	IN	B-PP	Olymphocytes	and	lymphocyte	NNS	B-NP	B-cell_typeand	plasma	and	CC	O	Oplasma	cortisol	plasma	NN	B-NP	Ocortisol	concentrations	cortisol	NN	I-NP	Oconcentrations	were	concentration	NNS	I-NP	Owere	measured	be	VBD	B-VP	Omeasured	in	measure	VBN	I-VP	Oin	20	in	IN	B-PP	O20	patients	20	CD	B-NP	Opatients	who	patient	NNS	I-NP	Owho	had	who	WP	B-NP	Ohad	recovered	have	VBD	B-VP	Orecovered	from	recover	VBN	I-VP	Ofrom	major	from	IN	B-PP	Omajor	depressive	major	JJ	B-NP	Odepressive	disorder	depressive	JJ	I-NP	Odisorder	and	disorder	NN	I-NP	Oand	20	and	CC	O	O20	healthy	20	CD	B-NP	Ohealthy	control	healthy	JJ	I-NP	Ocontrol	subjects	control	NN	I-NP	Osubjects	.	subject	NNS	I-NP	O.	The	.	.	O	OThe	number	The	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	sites	receptor	NN	I-NP	I-proteinsites	in	site	NNS	I-NP	Oin	lymphocytes	in	IN	B-PP	Olymphocytes	from	lymphocyte	NNS	B-NP	B-cell_typefrom	the	from	IN	B-PP	Othe	recovered	the	DT	B-NP	Orecovered	depressed	recover	VBN	I-NP	Odepressed	group	depressed	JJ	I-NP	Ogroup	was	group	NN	I-NP	Owas	not	be	VBD	B-VP	Onot	significantly	not	RB	O	Osignificantly	different	significantly	RB	B-ADJP	Odifferent	from	different	JJ	I-ADJP	Ofrom	that	from	IN	B-PP	Othat	of	that	DT	B-NP	Oof	the	of	IN	B-PP	Othe	control	the	DT	B-NP	Ocontrol	group	control	NN	I-NP	Ogroup	.	group	NN	I-NP	O.	Although	.	.	O	OAlthough	the	Although	IN	B-SBAR	Othe	mean	the	DT	B-NP	Omean	plasma	mean	JJ	I-NP	Oplasma	cortisol	plasma	NN	I-NP	Ocortisol	concentration	cortisol	NN	I-NP	Oconcentration	in	concentration	NN	I-NP	Oin	recovered	in	IN	B-PP	Orecovered	depressives	recover	VBN	B-NP	Odepressives	was	depressive	NNS	I-NP	Owas	higher	be	VBD	B-VP	Ohigher	than	high	JJR	B-ADJP	Othan	in	than	IN	B-PP	Oin	control	in	IN	B-PP	Ocontrol	subjects	control	NN	B-NP	Osubjects	","	subject	NNS	I-NP	O","	the	","	","	O	Othe	difference	the	DT	B-NP	Odifference	only	difference	NN	I-NP	Oonly	just	only	RB	B-VP	Ojust	reached	just	RB	I-VP	Oreached	significance	reach	VBD	I-VP	Osignificance	.	significance	NN	B-NP	O.	This	.	.	O	OThis	study	This	DT	B-NP	Ostudy	shows	study	NN	I-NP	Oshows	that	show	VBZ	B-VP	Othat	the	that	IN	B-SBAR	Othe	reduction	the	DT	B-NP	Oreduction	in	reduction	NN	I-NP	Oin	glucocorticoid	in	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	numbers	receptor	NN	I-NP	I-proteinnumbers	which	number	NNS	I-NP	Owhich	occurs	which	WDT	B-NP	Ooccurs	during	occur	VBZ	B-VP	Oduring	acute	during	IN	B-PP	Oacute	depressive	acute	JJ	B-NP	Odepressive	illness	depressive	JJ	I-NP	Oillness	does	illness	NN	I-NP	Odoes	not	do	VBZ	B-VP	Onot	persist	not	RB	I-VP	Opersist	on	persist	VB	I-VP	Oon	recovery	on	IN	B-PP	Orecovery	and	recovery	NN	B-NP	Oand	is	and	CC	O	Ois	","	be	VBZ	B-VP	O","	therefore	","	","	O	Otherefore	","	therefore	RB	B-ADVP	O","	state-dependent	","	","	O	Ostate-dependent	.	state-dependent	JJ	B-ADJP	O.	Identification	.	.	O	OIdentification	and	Identification	NN	B-NP	Oand	purification	and	CC	I-NP	Opurification	of	purification	NN	I-NP	Oof	a	of	IN	B-PP	Oa	human	a	DT	B-NP	Ohuman	lymphoid-specific	human	JJ	I-NP	B-proteinlymphoid-specific	octamer-binding	lymphoid-specific	JJ	I-NP	I-proteinoctamer-binding	protein	octamer-binding	JJ	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	OTF-2	(	(	O	OOTF-2	)	OTF-2	NN	B-NP	B-protein)	that	)	)	O	Othat	activates	that	WDT	B-NP	Oactivates	transcription	activate	VBZ	B-VP	Otranscription	of	transcription	NN	B-NP	Oof	an	of	IN	B-PP	Oan	immunoglobulin	an	DT	B-NP	Oimmunoglobulin	promoter	immunoglobulin	NN	I-NP	B-DNApromoter	in	promoter	NN	I-NP	I-DNAin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	The	.	.	O	OThe	octamer	The	DT	B-NP	Ooctamer	sequence	octamer	NN	I-NP	B-DNAsequence	5'-ATGCAAAT	sequence	NN	I-NP	I-DNA5'-ATGCAAAT	","	5'-ATGCAAAT	NN	I-NP	O","	in	","	","	O	Oin	either	in	IN	B-PP	Oeither	orientation	either	CC	O	Oorientation	","	orientation	NN	B-NP	O","	serves	","	","	O	Oserves	as	serve	VBZ	B-VP	Oas	an	as	IN	B-PP	Oan	upstream	an	DT	B-NP	Oupstream	element	upstream	JJ	I-NP	B-DNAelement	in	element	NN	I-NP	I-DNAin	a	in	IN	B-PP	Oa	variety	a	DT	B-NP	Ovariety	of	variety	NN	I-NP	Oof	promoters	of	IN	B-PP	Opromoters	and	promoter	NNS	B-NP	B-DNAand	also	and	CC	O	Oalso	occurs	also	RB	B-VP	Ooccurs	as	occur	VBZ	I-VP	Oas	a	as	IN	B-PP	Oa	modular	a	DT	B-NP	Omodular	enhancer	modular	JJ	I-NP	B-DNAenhancer	element	enhancer	NN	I-NP	I-DNAelement	.	element	NN	I-NP	I-DNA.	It	.	.	O	OIt	is	It	PRP	B-NP	Ois	of	be	VBZ	B-VP	Oof	particular	of	IN	B-PP	Oparticular	interest	particular	JJ	B-NP	Ointerest	in	interest	NN	I-NP	Oin	immunoglobulin	in	IN	B-PP	Oimmunoglobulin	genes	immunoglobulin	NN	B-NP	B-DNAgenes	since	gene	NNS	I-NP	I-DNAsince	it	since	IN	B-SBAR	Oit	is	it	PRP	B-NP	Ois	found	be	VBZ	B-VP	Ofound	in	find	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	upstream	the	DT	B-NP	Oupstream	regions	upstream	JJ	I-NP	B-DNAregions	of	region	NNS	I-NP	I-DNAof	all	of	IN	B-PP	Oall	heavy	all	DT	B-NP	Oheavy	and	heavy	JJ	I-NP	B-DNAand	light	and	CC	I-NP	I-DNAlight	chain	light	JJ	I-NP	I-DNAchain	promoters	chain	NN	I-NP	I-DNApromoters	and	promoter	NNS	I-NP	I-DNAand	in	and	CC	B-PP	Oin	the	in	IN	B-PP	Othe	heavy	the	DT	B-NP	Oheavy	chain	heavy	JJ	I-NP	B-DNAchain	enhancer	chain	NN	I-NP	I-DNAenhancer	","	enhancer	NN	I-NP	I-DNA","	both	","	","	O	Oboth	of	both	DT	B-NP	Oof	which	of	IN	B-PP	Owhich	are	which	WDT	B-NP	Oare	known	be	VBP	B-VP	Oknown	to	know	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	necessary	be	VB	I-VP	Onecessary	for	necessary	JJ	B-ADJP	Ofor	cell-specific	for	IN	B-PP	Ocell-specific	expression	cell-specific	JJ	B-NP	Oexpression	.	expression	NN	I-NP	O.	We	.	.	O	OWe	report	We	PRP	B-NP	Oreport	here	report	VBP	B-VP	Ohere	the	here	RB	B-ADVP	Othe	chromatographic	the	DT	B-NP	Ochromatographic	separation	chromatographic	JJ	I-NP	Oseparation	of	separation	NN	I-NP	Oof	ubiquitous	of	IN	B-PP	Oubiquitous	and	ubiquitous	JJ	B-NP	Oand	B	and	CC	I-NP	OB	cell-specific	B	NN	I-NP	B-proteincell-specific	octamer-binding	cell-specific	JJ	I-NP	I-proteinoctamer-binding	proteins	octamer-binding	JJ	I-NP	I-proteinproteins	.	protein	NNS	I-NP	I-protein.	The	.	.	O	OThe	B	The	DT	B-NP	OB	cell	B	NN	I-NP	B-proteincell	factor	cell	NN	I-NP	I-proteinfactor	was	factor	NN	I-NP	I-proteinwas	purified	be	VBD	B-VP	Opurified	to	purify	VBN	I-VP	Oto	homogeneity	to	TO	B-PP	Ohomogeneity	using	homogeneity	NN	B-NP	Ousing	affinity	use	VBG	B-VP	Oaffinity	chromatography	affinity	NN	B-NP	Ochromatography	and	chromatography	NN	I-NP	Oand	consists	and	CC	O	Oconsists	of	consist	VBZ	B-VP	Oof	three	of	IN	B-PP	Othree	peptides	three	CD	B-NP	Opeptides	of	peptide	NNS	I-NP	Oof	62	of	IN	B-PP	O62	","	62	CD	B-NP	O","	61	","	","	I-NP	O61	","	61	CD	I-NP	O","	and	","	","	O	Oand	58.5	and	CC	O	O58.5	+/-	58.5	CD	B-NP	O+/-	1.5	+/-	SYM	I-NP	O1.5	kd	1.5	CD	I-NP	Okd	.	kd	NN	I-NP	O.	Each	.	.	O	OEach	of	Each	DT	B-NP	Oof	the	of	IN	B-PP	Othe	polypeptides	the	DT	B-NP	Opolypeptides	was	polypeptide	NNS	I-NP	Owas	renatured	be	VBD	B-VP	Orenatured	after	renature	VBN	I-VP	Oafter	SDS-PAGE	after	IN	B-PP	OSDS-PAGE	and	SDS-PAGE	NN	B-NP	Oand	shown	and	CC	O	Oshown	to	show	VBN	B-VP	Oto	bind	to	TO	I-VP	Obind	to	bind	VB	I-VP	Oto	the	to	TO	B-PP	Othe	octamer	the	DT	B-NP	Ooctamer	sequence	octamer	NN	I-NP	B-DNAsequence	.	sequence	NN	I-NP	I-DNA.	The	.	.	O	OThe	specific	The	DT	B-NP	Ospecific	DNA	specific	JJ	I-NP	ODNA	binding	DNA	NN	I-NP	Obinding	activity	binding	NN	I-NP	Oactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	pure	the	DT	B-NP	Opure	B	pure	JJ	I-NP	B-proteinB	cell-specific	B	NN	I-NP	I-proteincell-specific	factor	cell-specific	JJ	I-NP	I-proteinfactor	was	factor	NN	I-NP	I-proteinwas	indistinguishable	be	VBD	B-VP	Oindistinguishable	from	indistinguishable	JJ	B-ADJP	Ofrom	that	from	IN	B-PP	Othat	of	that	DT	B-NP	Oof	the	of	IN	B-PP	Othe	affinity-purified	the	DT	B-NP	Oaffinity-purified	ubiquitous	affinity-purified	JJ	I-NP	B-proteinubiquitous	factor	ubiquitous	JJ	I-NP	I-proteinfactor	.	factor	NN	I-NP	I-protein.	This	.	.	O	OThis	B	This	DT	B-NP	OB	cell-specific	B	NN	I-NP	B-proteincell-specific	octamer-binding	cell-specific	JJ	I-NP	I-proteinoctamer-binding	factor	octamer-binding	JJ	I-NP	I-proteinfactor	","	factor	NN	I-NP	I-protein","	in	","	","	O	Oin	pure	in	IN	B-PP	Opure	form	pure	JJ	B-NP	Oform	","	form	NN	I-NP	O","	activated	","	","	O	Oactivated	transcription	activate	VBD	B-VP	Otranscription	from	transcription	NN	B-NP	Ofrom	a	from	IN	B-PP	Oa	kappa	a	DT	B-NP	Okappa	light	kappa	NN	I-NP	B-DNAlight	chain	light	JJ	I-NP	I-DNAchain	promoter	chain	NN	I-NP	I-DNApromoter	in	promoter	NN	I-NP	I-DNAin	vitro	in	FW	B-ADVP	Ovitro	","	vitro	FW	I-ADVP	O","	thus	","	","	O	Othus	demonstrating	thus	RB	B-ADVP	Odemonstrating	that	demonstrate	VBG	B-VP	Othat	it	that	IN	B-SBAR	Oit	is	it	PRP	B-NP	Ois	indeed	be	VBZ	B-VP	Oindeed	a	indeed	RB	B-ADVP	Oa	B	a	DT	B-NP	OB	cell-specific	B	NN	I-NP	B-proteincell-specific	transcription	cell-specific	JJ	I-NP	I-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	for	factor	NN	I-NP	I-proteinfor	this	for	IN	B-PP	Othis	gene	this	DT	B-NP	Ogene	.	gene	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	to	addition	NN	B-NP	Oto	the	to	TO	B-PP	Othe	ubiquitous	the	DT	B-NP	Oubiquitous	and	ubiquitous	JJ	I-NP	Oand	B	and	CC	I-NP	OB	cell-specific	B	NN	I-NP	B-proteincell-specific	octamer-binding	cell-specific	JJ	I-NP	I-proteinoctamer-binding	factors	octamer-binding	JJ	I-NP	I-proteinfactors	","	factor	NNS	I-NP	I-protein","	we	","	","	O	Owe	identified	we	PRP	B-NP	Oidentified	several	identify	VBD	B-VP	Oseveral	additional	several	JJ	B-NP	Oadditional	proteins	additional	JJ	I-NP	Oproteins	","	protein	NNS	I-NP	O","	one	","	","	O	Oone	of	one	CD	B-NP	Oof	which	of	IN	B-PP	Owhich	is	which	WDT	B-NP	Ois	B	be	VBZ	B-VP	OB	cell	B	NN	B-NP	Ocell	#NAME?	cell	NN	I-NP	O#NAME?	","	#NAME?	JJ	B-ADJP	O","	that	","	","	O	Othat	interact	that	WDT	B-NP	Ointeract	with	interact	VBP	B-VP	Owith	the	with	IN	B-PP	Othe	kappa	the	DT	B-NP	Okappa	promoter	kappa	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Decreased	.	.	O	ODecreased	deoxyribonucleic	Decrease	VBN	B-NP	Odeoxyribonucleic	acid	deoxyribonucleic	JJ	I-NP	Oacid	binding	acid	NN	I-NP	Obinding	of	binding	NN	I-NP	Oof	glucocorticoid-receptor	of	IN	B-PP	Oglucocorticoid-receptor	complex	glucocorticoid-receptor	NN	B-NP	B-proteincomplex	in	complex	NN	I-NP	I-proteinin	cultured	in	IN	B-PP	Ocultured	skin	culture	VBN	B-NP	B-cell_lineskin	fibroblasts	skin	NN	I-NP	I-cell_linefibroblasts	from	fibroblast	NNS	I-NP	I-cell_linefrom	a	from	IN	B-PP	Oa	patient	a	DT	B-NP	Opatient	with	patient	NN	I-NP	Owith	the	with	IN	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	resistance	glucocorticoid	NN	I-NP	Oresistance	syndrome	resistance	NN	I-NP	Osyndrome	.	syndrome	NN	I-NP	O.	A	.	.	O	OA	patient	A	DT	B-NP	Opatient	with	patient	NN	I-NP	Owith	the	with	IN	B-PP	Othe	syndrome	the	DT	B-NP	Osyndrome	of	syndrome	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	resistance	glucocorticoid	NN	B-NP	Oresistance	was	resistance	NN	I-NP	Owas	studied	be	VBD	B-VP	Ostudied	.	study	VBN	I-VP	O.	A	.	.	O	OA	27-yr-old	A	DT	B-NP	O27-yr-old	woman	27-yr-old	JJ	I-NP	Owoman	initially	woman	NN	I-NP	Oinitially	was	initially	RB	B-ADVP	Owas	diagnosed	be	VBD	B-VP	Odiagnosed	as	diagnose	VBN	I-VP	Oas	having	as	IN	B-PP	Ohaving	Cushing	have	VBG	B-VP	OCushing	's	Cushing	NN	B-NP	O's	disease	's	POS	B-NP	Odisease	","	disease	NN	I-NP	O","	based	","	","	O	Obased	on	base	VBN	B-PP	Oon	the	on	IN	B-PP	Othe	findings	the	DT	B-NP	Ofindings	of	finding	NNS	I-NP	Oof	high	of	IN	B-PP	Ohigh	plasma	high	JJ	B-NP	Oplasma	ACTH	plasma	NN	I-NP	OACTH	and	ACTH	NN	I-NP	Oand	serum	and	CC	I-NP	Oserum	cortisol	serum	NN	I-NP	Ocortisol	levels	cortisol	NN	I-NP	Olevels	","	level	NNS	I-NP	O","	increased	","	","	O	Oincreased	urinary	increase	VBN	B-NP	Ourinary	cortisol	urinary	JJ	I-NP	Ocortisol	secretion	cortisol	NN	I-NP	Osecretion	","	secretion	NN	I-NP	O","	resistance	","	","	O	Oresistance	to	resistance	NN	B-NP	Oto	adrenal	to	TO	B-PP	Oadrenal	suppression	adrenal	JJ	B-NP	Osuppression	with	suppression	NN	I-NP	Owith	dexamethasone	with	IN	B-PP	Odexamethasone	","	dexamethasone	NN	B-NP	O","	and	","	","	O	Oand	bilateral	and	CC	O	Obilateral	adrenal	bilateral	JJ	B-NP	Oadrenal	hyperplasia	adrenal	JJ	I-NP	Ohyperplasia	by	hyperplasia	NN	I-NP	Oby	computed	by	IN	B-PP	Ocomputed	tomography	compute	VBN	B-NP	Otomography	and	tomography	NN	I-NP	Oand	scintigraphy	and	CC	I-NP	Oscintigraphy	of	scintigraphy	NN	I-NP	Oof	the	of	IN	B-PP	Othe	adrenal	the	DT	B-NP	Oadrenal	glands	adrenal	JJ	I-NP	Oglands	.	gland	NNS	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	she	","	","	O	Oshe	had	she	PRP	B-NP	Ohad	no	have	VBD	B-VP	Ono	signs	no	DT	B-NP	Osigns	or	sign	NNS	I-NP	Oor	symptoms	or	CC	I-NP	Osymptoms	of	symptom	NNS	I-NP	Oof	Cushing	of	IN	B-PP	OCushing	's	Cushing	NNP	B-NP	O's	syndrome	's	POS	B-NP	Osyndrome	.	syndrome	NN	I-NP	O.	During	.	.	O	ODuring	a	During	IN	B-PP	Oa	5-yr	a	DT	B-NP	O5-yr	follow-up	5-yr	JJ	I-NP	Ofollow-up	","	follow-up	NN	I-NP	O","	no	","	","	O	Ono	clinical	no	DT	B-NP	Oclinical	abnormalities	clinical	JJ	I-NP	Oabnormalities	developed	abnormality	NNS	I-NP	Odeveloped	","	develop	VBD	B-VP	O","	although	","	","	O	Oalthough	hypercortisolism	although	IN	B-SBAR	Ohypercortisolism	persisted	hypercortisolism	NN	B-NP	Opersisted	.	persist	VBD	B-VP	O.	End-organ	.	.	O	OEnd-organ	resistance	End-organ	JJ	B-NP	Oresistance	to	resistance	NN	I-NP	Oto	cortisol	to	TO	B-PP	Ocortisol	was	cortisol	NN	B-NP	Owas	suspected	be	VBD	B-VP	Osuspected	.	suspect	VBN	I-VP	O.	To	.	.	O	OTo	explain	To	TO	B-VP	Oexplain	the	explain	VB	I-VP	Othe	end-organ	the	DT	B-NP	Oend-organ	resistance	end-organ	JJ	I-NP	Oresistance	to	resistance	NN	I-NP	Oto	cortisol	to	TO	B-PP	Ocortisol	","	cortisol	NN	B-NP	O","	the	","	","	O	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	(	receptor	NNS	I-NP	I-protein(	GR	(	(	O	OGR	)	GR	NN	B-NP	B-protein)	in	)	)	O	Oin	peripheral	in	IN	B-PP	Operipheral	mononuclear	peripheral	JJ	B-NP	B-cell_typemononuclear	leukocytes	mononuclear	JJ	I-NP	I-cell_typeleukocytes	and	leukocyte	NNS	I-NP	I-cell_typeand	cultured	and	CC	O	Ocultured	skin	culture	VBN	B-NP	B-cell_lineskin	fibroblasts	skin	NN	I-NP	I-cell_linefibroblasts	from	fibroblast	NNS	I-NP	I-cell_linefrom	a	from	IN	B-PP	Oa	forearm	a	DT	B-NP	Oforearm	skin	forearm	NN	I-NP	Oskin	biopsy	skin	NN	I-NP	Obiopsy	were	biopsy	NN	I-NP	Owere	characterized	be	VBD	B-VP	Ocharacterized	and	characterize	VBN	I-VP	Oand	compared	and	CC	O	Ocompared	with	compare	VBN	B-VP	Owith	the	with	IN	B-PP	Othe	results	the	DT	B-NP	Oresults	of	result	NNS	I-NP	Oof	similar	of	IN	B-PP	Osimilar	studies	similar	JJ	B-NP	Ostudies	in	study	NNS	I-NP	Oin	normal	in	IN	B-PP	Onormal	subjects	normal	JJ	B-NP	Osubjects	.	subject	NNS	I-NP	O.	The	.	.	O	OThe	patient	The	DT	B-NP	Opatient	's	patient	NN	I-NP	O's	GR	's	POS	B-NP	OGR	in	GR	NN	I-NP	B-proteinin	whole	in	IN	B-PP	Owhole	cell	whole	JJ	B-NP	Ocell	assays	cell	NN	I-NP	Oassays	had	assay	NNS	I-NP	Ohad	an	have	VBD	B-VP	Oan	increased	an	DT	B-NP	Oincreased	dissociation	increase	VBN	I-NP	Odissociation	constant	dissociation	NN	I-NP	Oconstant	(	constant	NN	I-NP	O(	Kd	(	(	O	OKd	)	Kd	NN	B-NP	O)	.	)	)	O	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	cytosol	the	DT	B-NP	Ocytosol	of	cytosol	NN	I-NP	Oof	cultured	of	IN	B-PP	Ocultured	skin	culture	VBN	B-NP	B-cell_lineskin	fibroblasts	skin	NN	I-NP	I-cell_linefibroblasts	from	fibroblast	NNS	I-NP	I-cell_linefrom	the	from	IN	B-PP	Othe	patient	the	DT	B-NP	Opatient	","	patient	NN	I-NP	O","	there	","	","	O	Othere	was	there	EX	B-NP	Owas	also	be	VBD	B-VP	Oalso	decreased	also	RB	I-VP	Odecreased	binding	decrease	VBN	I-VP	Obinding	capacity	binding	NN	B-NP	Ocapacity	.	capacity	NN	I-NP	O.	The	.	.	O	OThe	thermal	The	DT	B-NP	Othermal	stability	thermal	JJ	I-NP	Ostability	and	stability	NN	I-NP	Oand	the	and	CC	O	Othe	sedimentation	the	DT	B-NP	Osedimentation	coefficient	sedimentation	NN	I-NP	Ocoefficient	in	coefficient	NN	I-NP	Oin	a	in	IN	B-PP	Oa	sucrose	a	DT	B-NP	Osucrose	density	sucrose	NN	I-NP	Odensity	gradient	density	NN	I-NP	Ogradient	of	gradient	NN	I-NP	Oof	the	of	IN	B-PP	Othe	receptors	the	DT	B-NP	Oreceptors	in	receptor	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	cytosol	the	DT	B-NP	Ocytosol	of	cytosol	NN	I-NP	Oof	cultured	of	IN	B-PP	Ocultured	skin	culture	VBN	B-NP	B-cell_lineskin	fibroblasts	skin	NN	I-NP	I-cell_linefibroblasts	from	fibroblast	NNS	I-NP	I-cell_linefrom	the	from	IN	B-PP	Othe	patient	the	DT	B-NP	Opatient	and	patient	NN	I-NP	Oand	normal	and	CC	O	Onormal	subjects	normal	JJ	B-NP	Osubjects	were	subject	NNS	I-NP	Owere	similar	be	VBD	B-VP	Osimilar	.	similar	JJ	B-ADJP	O.	GR	.	.	O	OGR	complex	GR	NN	B-NP	B-proteincomplex	activation	complex	NN	I-NP	I-proteinactivation	","	activation	NN	I-NP	O","	analyzed	","	","	O	Oanalyzed	by	analyze	VBN	B-VP	Oby	DEAE-cellulose	by	IN	B-PP	ODEAE-cellulose	chromatography	DEAE-cellulose	NN	B-NP	Ochromatography	","	chromatography	NN	I-NP	O","	was	","	","	O	Owas	decreased	be	VBD	B-VP	Odecreased	in	decrease	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	patient	the	DT	B-NP	Opatient	.	patient	NN	I-NP	O.	DNA	.	.	O	ODNA	binding	DNA	NN	B-NP	Obinding	of	binding	NN	I-NP	Oof	the	of	IN	B-PP	Othe	GR	the	DT	B-NP	OGR	complex	GR	NN	I-NP	B-proteincomplex	after	complex	NN	I-NP	I-proteinafter	temperature-induced	after	IN	B-PP	Otemperature-induced	activation	temperature-induced	JJ	B-NP	Oactivation	was	activation	NN	I-NP	Owas	lower	be	VBD	B-VP	Olower	in	low	JJR	B-ADJP	Oin	the	in	IN	B-PP	Othe	patient	the	DT	B-NP	Opatient	than	patient	NN	I-NP	Othan	in	than	IN	B-PP	Oin	normal	in	IN	B-PP	Onormal	subjects	normal	JJ	B-NP	Osubjects	.	subject	NNS	I-NP	O.	Nuclear	.	.	O	ONuclear	translocation	Nuclear	JJ	B-NP	Otranslocation	of	translocation	NN	I-NP	Oof	GR	of	IN	B-PP	OGR	complexes	GR	NN	B-NP	B-proteincomplexes	from	complex	NNS	I-NP	I-proteinfrom	the	from	IN	B-PP	Othe	patient	the	DT	B-NP	Opatient	was	patient	NN	I-NP	Owas	also	be	VBD	B-VP	Oalso	slightly	also	RB	B-ADVP	Oslightly	decreased	slightly	RB	B-ADJP	Odecreased	.	decrease	VBN	I-ADJP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	patient	the	DT	B-NP	Opatient	's	patient	NN	I-NP	O's	glucocorticoid	's	POS	B-NP	Oglucocorticoid	resistance	glucocorticoid	NN	I-NP	Oresistance	was	resistance	NN	I-NP	Owas	due	be	VBD	B-VP	Odue	to	due	JJ	B-ADJP	Oto	a	to	TO	B-PP	Oa	decrease	a	DT	B-NP	Odecrease	in	decrease	NN	I-NP	Oin	the	in	IN	B-PP	Othe	affinity	the	DT	B-NP	Oaffinity	of	affinity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	receptor	the	DT	B-NP	Oreceptor	for	receptor	NN	I-NP	Ofor	glucocorticoids	for	IN	B-PP	Oglucocorticoids	and	glucocorticoid	NNS	B-NP	Oand	a	and	CC	O	Oa	decrease	a	DT	B-NP	Odecrease	in	decrease	NN	I-NP	Oin	the	in	IN	B-PP	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	the	of	IN	B-PP	Othe	GR	the	DT	B-NP	OGR	complex	GR	NN	I-NP	B-proteincomplex	to	complex	NN	I-NP	I-proteinto	DNA	to	TO	B-PP	ODNA	.	DNA	NN	B-NP	O.	Granulocyte-macrophage	.	.	O	OGranulocyte-macrophage	colony-stimulating	Granulocyte-macrophage	JJ	B-NP	B-proteincolony-stimulating	factor	colony-stimulating	JJ	I-NP	I-proteinfactor	.	factor	NN	I-NP	I-protein.	Sensitive	.	.	O	OSensitive	and	Sensitive	JJ	B-NP	Oand	receptor-mediated	and	CC	I-NP	Oreceptor-mediated	regulation	receptor-mediated	JJ	I-NP	Oregulation	by	regulation	NN	I-NP	Oby	1	by	IN	B-PP	O1	","	1	CD	B-NP	O","	25-dihydroxyvitamin	","	","	O	O25-dihydroxyvitamin	D3	25-dihydroxyvitamin	NN	B-NP	OD3	in	D3	NN	I-NP	Oin	normal	in	IN	B-PP	Onormal	human	normal	JJ	B-NP	B-cell_typehuman	peripheral	human	JJ	I-NP	I-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	lymphocytes	blood	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	1	that	IN	B-SBAR	O1	","	1	CD	B-NP	O","	25-dihydroxyvitamin	","	","	O	O25-dihydroxyvitamin	D3	25-dihydroxyvitamin	NN	B-NP	OD3	(	D3	NN	I-NP	O(	1	(	(	O	O1	","	1	CD	B-NP	O","	25	","	","	I-NP	O25	[	25	CD	I-NP	O[	OH	[	(	O	OOH	]	OH	NN	B-NP	O]	2D3	]	)	O	O2D3	)	2D3	NN	B-NP	O)	","	)	)	O	O","	the	","	","	O	Othe	most	the	DT	B-NP	Omost	hormonally	most	RBS	I-NP	Ohormonally	active	hormonally	RB	I-NP	Oactive	metabolite	active	JJ	I-NP	Ometabolite	of	metabolite	NN	I-NP	Oof	vitamin	of	IN	B-PP	Ovitamin	D3	vitamin	NN	B-NP	OD3	","	D3	NN	I-NP	O","	modulates	","	","	O	Omodulates	sensitively	modulate	VBZ	B-VP	Osensitively	and	sensitively	RB	B-ADVP	Oand	specifically	and	CC	I-ADVP	Ospecifically	both	specifically	RB	I-ADVP	Oboth	the	both	CC	O	Othe	protein	the	DT	B-NP	Oprotein	and	protein	NN	I-NP	Oand	messenger	and	CC	I-NP	Omessenger	RNA	messenger	NN	I-NP	ORNA	accumulation	RNA	NN	I-NP	Oaccumulation	of	accumulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	multilineage	the	DT	B-NP	Omultilineage	growth	multilineage	JJ	I-NP	B-proteingrowth	factor	growth	NN	I-NP	I-proteinfactor	granulocyte-macrophage	factor	NN	I-NP	I-proteingranulocyte-macrophage	colony-stimulating	granulocyte-macrophage	JJ	B-NP	I-proteincolony-stimulating	factor	colony-stimulating	JJ	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	GM-CSF	(	(	O	OGM-CSF	)	GM-CSF	NN	B-NP	B-protein)	.	)	)	O	O.	The	.	.	O	OThe	regulation	The	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	GM-CSF	of	IN	B-PP	OGM-CSF	expression	GM-CSF	NN	B-NP	B-proteinexpression	is	expression	NN	I-NP	Ois	seen	be	VBZ	B-VP	Oseen	in	see	VBN	I-VP	Oin	both	in	IN	B-PP	Oboth	normal	both	CC	B-NP	Onormal	human	normal	JJ	I-NP	B-cell_typehuman	mitogen-activated	human	JJ	I-NP	I-cell_typemitogen-activated	T	mitogen-activated	JJ	I-NP	I-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	T	and	CC	O	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	from	lymphocyte	NNS	I-NP	I-cell_typefrom	a	from	IN	B-PP	Oa	line	a	DT	B-NP	Oline	(	line	NN	I-NP	O(	S-LB1	(	(	O	OS-LB1	)	S-LB1	NN	B-NP	B-cell_line)	transformed	)	)	O	Otransformed	with	transform	VBN	B-VP	Owith	human	with	IN	B-PP	Ohuman	T	human	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	lymphotropic	cell	NN	I-NP	Olymphotropic	virus	lymphotropic	JJ	I-NP	Ovirus	1	virus	NN	I-NP	O1	(	1	CD	I-NP	O(	HTLV-1	(	(	O	OHTLV-1	)	HTLV-1	NN	B-NP	O)	.	)	)	O	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	cells	","	","	O	Ocells	from	cell	NNS	B-NP	Ofrom	a	from	IN	B-PP	Oa	HTLV-1	a	DT	B-NP	OHTLV-1	transformed	HTLV-1	NN	I-NP	B-cell_linetransformed	T	transform	VBD	B-VP	I-cell_lineT	lymphocyte	T	NN	B-NP	I-cell_linelymphocyte	line	lymphocyte	NN	I-NP	I-cell_lineline	(	line	NN	I-NP	I-cell_line(	Ab-VDR	(	(	O	OAb-VDR	)	Ab-VDR	NN	B-NP	O)	established	)	)	O	Oestablished	from	establish	VBN	B-VP	Ofrom	a	from	IN	B-PP	Oa	patient	a	DT	B-NP	Opatient	with	patient	NN	I-NP	Owith	vitamin	with	IN	B-PP	Ovitamin	D-resistant	vitamin	NN	B-NP	OD-resistant	rickets	D-resistant	JJ	I-NP	Orickets	type	ricket	NNS	I-NP	Otype	II	type	NN	I-NP	OII	with	II	CD	I-NP	Owith	undetectable	with	IN	B-PP	Oundetectable	1	undetectable	JJ	B-NP	O1	","	1	CD	I-NP	O","	25	","	","	I-NP	O25	(	25	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	cellular	2D3	NN	B-NP	Ocellular	receptors	cellular	JJ	I-NP	Oreceptors	are	receptor	NNS	I-NP	Oare	resistant	be	VBP	B-VP	Oresistant	to	resistant	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	action	the	DT	B-NP	Oaction	of	action	NN	I-NP	Oof	1	of	IN	B-PP	O1	","	1	CD	B-NP	O","	25	","	","	I-NP	O25	(	25	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	.	2D3	NN	B-NP	O.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	GM-CSF	of	IN	B-PP	OGM-CSF	expression	GM-CSF	NN	B-NP	B-proteinexpression	by	expression	NN	I-NP	Oby	1	by	IN	B-PP	O1	","	1	CD	B-NP	O","	25	","	","	I-NP	O25	(	25	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	can	2D3	NN	B-NP	Ocan	occur	can	MD	B-VP	Ooccur	independently	occur	VB	I-VP	Oindependently	of	independently	RB	B-ADVP	Oof	interleukin	of	IN	B-PP	Ointerleukin	2	interleukin	NN	B-NP	B-protein2	regulation	2	CD	I-NP	I-proteinregulation	and	regulation	NN	I-NP	Oand	is	and	CC	O	Ois	probably	be	VBZ	B-VP	Oprobably	mediated	probably	RB	I-VP	Omediated	through	mediate	VBN	I-VP	Othrough	cellular	through	IN	B-PP	Ocellular	1	cellular	JJ	B-NP	B-protein1	","	1	CD	I-NP	I-protein","	25	","	","	I-NP	I-protein25	(	25	CD	I-NP	I-protein(	OH	(	(	O	I-proteinOH	)	OH	NN	B-NP	I-protein)	2D3	)	)	O	I-protein2D3	receptors	2D3	NN	B-NP	I-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	1	that	IN	B-SBAR	O1	","	1	CD	B-NP	O","	25	","	","	I-NP	O25	(	25	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	may	2D3	NN	B-NP	Omay	be	may	MD	B-VP	Obe	important	be	VB	I-VP	Oimportant	in	important	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	physiology	the	DT	B-NP	Ophysiology	of	physiology	NN	I-NP	Oof	hematopoiesis	of	IN	B-PP	Ohematopoiesis	.	hematopoiesis	NN	B-NP	O.	Altered	.	.	O	OAltered	interaction	Altered	JJ	B-NP	Ointeraction	between	interaction	NN	I-NP	Obetween	triiodothyronine	between	IN	B-PP	Otriiodothyronine	and	triiodothyronine	NN	B-NP	Oand	its	and	CC	O	Oits	nuclear	its	PRP$	B-NP	Onuclear	receptors	nuclear	JJ	I-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	absence	in	IN	B-PP	Oabsence	of	absence	NN	B-NP	Oof	cortisol	of	IN	B-PP	Ocortisol	:	cortisol	NN	B-NP	O:	a	:	:	O	Oa	proposed	a	DT	B-NP	Oproposed	mechanism	propose	VBN	I-NP	Omechanism	for	mechanism	NN	I-NP	Ofor	increased	for	IN	B-PP	Oincreased	thyrotropin	increase	VBN	B-NP	Othyrotropin	secretion	thyrotropin	NN	I-NP	Osecretion	in	secretion	NN	I-NP	Oin	corticosteroid	in	IN	B-PP	Ocorticosteroid	deficiency	corticosteroid	NN	B-NP	Odeficiency	states	deficiency	NN	I-NP	Ostates	.	state	NNS	I-NP	O.	Thyroid	.	.	O	OThyroid	hormones	Thyroid	JJ	B-NP	Ohormones	occasionally	hormone	NNS	I-NP	Ooccasionally	appear	occasionally	RB	B-ADVP	Oappear	less	appear	VBP	B-VP	Oless	effective	less	RBR	B-ADJP	Oeffective	when	effective	JJ	I-ADJP	Owhen	administered	when	WRB	B-ADVP	Oadministered	alone	administer	VBN	B-VP	Oalone	to	alone	RB	B-ADVP	Oto	patients	to	TO	B-PP	Opatients	with	patient	NNS	B-NP	Owith	panhypopituitarism	with	IN	B-PP	Opanhypopituitarism	","	panhypopituitarism	NN	B-NP	O","	and	","	","	O	Oand	manifestations	and	CC	O	Omanifestations	suggestive	manifestation	NNS	B-NP	Osuggestive	of	suggestive	JJ	B-ADJP	Oof	hypothyroidism	of	IN	B-PP	Ohypothyroidism	have	hypothyroidism	NN	B-NP	Ohave	been	have	VBP	B-VP	Obeen	reported	be	VBN	I-VP	Oreported	in	report	VBN	I-VP	Oin	patients	in	IN	B-PP	Opatients	suffering	patient	NNS	B-NP	Osuffering	from	suffer	VBG	B-VP	Ofrom	untreated	from	IN	B-PP	Ountreated	Addison	untreated	JJ	B-NP	OAddison	's	Addison	NN	I-NP	O's	disease	's	POS	B-NP	Odisease	.	disease	NN	I-NP	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	latter	the	DT	B-NP	Olatter	condition	latter	JJ	I-NP	Ocondition	","	condition	NN	I-NP	O","	thyrotropin	","	","	O	Othyrotropin	secretion	thyrotropin	NN	B-NP	Osecretion	is	secretion	NN	I-NP	Ois	increased	be	VBZ	B-VP	Oincreased	:	increase	VBN	I-VP	O:	this	:	:	O	Othis	occurs	this	DT	B-NP	Ooccurs	already	occur	VBZ	B-VP	Oalready	after	already	RB	B-ADVP	Oafter	as	after	IN	B-PP	Oas	little	as	RB	B-NP	Olittle	as	little	JJ	I-NP	Oas	2	as	IN	I-NP	O2	days	2	CD	I-NP	Odays	of	day	NNS	I-NP	Oof	temporary	of	IN	B-PP	Otemporary	withdrawal	temporary	JJ	B-NP	Owithdrawal	of	withdrawal	NN	I-NP	Oof	therapy	of	IN	B-PP	Otherapy	with	therapy	NN	B-NP	Owith	substitution	with	IN	B-PP	Osubstitution	doses	substitution	NN	B-NP	Odoses	of	dose	NNS	I-NP	Oof	corticosteroids	of	IN	B-PP	Ocorticosteroids	while	corticosteroid	NNS	B-NP	Owhile	circulating	while	IN	B-SBAR	Ocirculating	levels	circulate	VBG	B-VP	Olevels	of	level	NNS	B-NP	Oof	thyroid	of	IN	B-PP	Othyroid	hormones	thyroid	JJ	B-NP	Ohormones	remain	hormone	NNS	I-NP	Oremain	within	remain	VBP	B-VP	Owithin	normal	within	IN	B-PP	Onormal	limits	normal	JJ	B-NP	Olimits	.	limit	NNS	I-NP	O.	Therefore	.	.	O	OTherefore	","	Therefore	RB	B-ADVP	O","	a	","	","	O	Oa	possible	a	DT	B-NP	Opossible	role	possible	JJ	I-NP	Orole	of	role	NN	I-NP	Oof	cortisol	of	IN	B-PP	Ocortisol	in	cortisol	NN	B-NP	Oin	interaction	in	IN	B-PP	Ointeraction	between	interaction	NN	B-NP	Obetween	triiodothyronine	between	IN	B-PP	Otriiodothyronine	and	triiodothyronine	NN	B-NP	Oand	its	and	CC	O	Oits	nuclear	its	PRP$	B-NP	Onuclear	receptors	nuclear	JJ	I-NP	B-proteinreceptors	was	receptor	NNS	I-NP	I-proteinwas	examined	be	VBD	B-VP	Oexamined	at	examine	VBN	I-VP	Oat	the	at	IN	B-PP	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	circulating	of	IN	B-PP	Ocirculating	lymphocytes	circulate	VBG	B-VP	B-cell_typelymphocytes	obtained	lymphocyte	NNS	B-NP	I-cell_typeobtained	from	obtain	VBN	B-VP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	primary	with	IN	B-PP	Oprimary	or	primary	JJ	B-NP	Oor	secondary	or	CC	I-NP	Osecondary	adrenocortical	secondary	JJ	I-NP	Oadrenocortical	failure	adrenocortical	JJ	I-NP	Ofailure	.	failure	NN	I-NP	O.	The	.	.	O	OThe	affinity	The	DT	B-NP	Oaffinity	of	affinity	NN	I-NP	Oof	these	of	IN	B-PP	Othese	receptors	these	DT	B-NP	Oreceptors	was	receptor	NNS	I-NP	Owas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	decreased	be	VB	I-VP	Odecreased	","	decrease	VBN	I-VP	O","	by	","	","	O	Oby	more	by	IN	B-PP	Omore	than	more	JJR	B-NP	Othan	50	than	IN	I-NP	O50	%	50	CD	I-NP	O%	on	%	NN	I-NP	Oon	average	on	IN	B-PP	Oaverage	","	average	NN	B-NP	O","	in	","	","	O	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	cortisol	of	IN	B-PP	Ocortisol	treatments	cortisol	NN	B-NP	Otreatments	.	treatment	NNS	I-NP	O.	This	.	.	O	OThis	change	This	DT	B-NP	Ochange	was	change	NN	I-NP	Owas	promptly	be	VBD	B-VP	Opromptly	corrected	promptly	RB	I-VP	Ocorrected	upon	correct	VBN	I-VP	Oupon	resumption	upon	IN	B-PP	Oresumption	of	resumption	NN	B-NP	Oof	therapy	of	IN	B-PP	Otherapy	.	therapy	NN	B-NP	O.	The	.	.	O	OThe	number	The	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	binding	of	IN	B-PP	Obinding	sites	bind	VBG	B-NP	B-proteinsites	was	site	NNS	I-NP	I-proteinwas	not	be	VBD	B-VP	Onot	significantly	not	RB	O	Osignificantly	modified	significantly	RB	B-ADJP	Omodified	.	modify	VBN	I-ADJP	O.	The	.	.	O	OThe	influence	The	DT	B-NP	Oinfluence	of	influence	NN	I-NP	Oof	cortisol	of	IN	B-PP	Ocortisol	on	cortisol	NN	B-NP	Oon	thyroid	on	IN	B-PP	Othyroid	hormone	thyroid	NN	B-NP	B-proteinhormone	receptors	hormone	NN	I-NP	I-proteinreceptors	discussed	receptor	NNS	I-NP	I-proteindiscussed	here	discuss	VBN	B-VP	Ohere	might	here	RB	B-ADVP	Omight	account	might	MD	B-VP	Oaccount	for	account	VB	I-VP	Ofor	the	for	IN	B-PP	Othe	clinical	the	DT	B-NP	Oclinical	observations	clinical	JJ	I-NP	Oobservations	mentioned	observation	NNS	I-NP	Omentioned	above	mention	VBN	B-VP	Oabove	.	above	RB	B-ADVP	O.	Inhibition	.	.	O	OInhibition	by	Inhibition	NN	B-NP	Oby	cortisol	by	IN	B-PP	Ocortisol	of	cortisol	NN	B-NP	Oof	human	of	IN	B-PP	Ohuman	natural	human	JJ	B-NP	B-cell_typenatural	killer	natural	JJ	I-NP	I-cell_typekiller	(	killer	NN	I-NP	I-cell_type(	NK	(	(	O	I-cell_typeNK	)	NK	NN	B-NP	I-cell_type)	cell	)	)	O	I-cell_typecell	activity	cell	NN	B-NP	I-cell_typeactivity	.	activity	NN	I-NP	O.	The	.	.	O	OThe	effects	The	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	cortisol	of	IN	B-PP	Ocortisol	on	cortisol	NN	B-NP	Oon	the	on	IN	B-PP	Othe	natural	the	DT	B-NP	Onatural	killer	natural	JJ	I-NP	Okiller	(	killer	NN	I-NP	O(	NK	(	(	O	ONK	)	NK	NN	B-NP	O)	activity	)	)	O	Oactivity	of	activity	NN	B-NP	Oof	human	of	IN	B-PP	Ohuman	peripheral	human	JJ	B-NP	B-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	(	mononuclear	JJ	B-ADJP	I-cell_type(	PBM	(	(	O	I-cell_typePBM	)	PBM	NN	B-NP	I-cell_type)	cells	)	)	I-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	studied	be	VBD	B-VP	Ostudied	in	study	VBN	I-VP	Oin	vitro	in	FW	B-ADVP	Ovitro	using	vitro	FW	I-ADVP	Ousing	a	use	VBG	B-VP	Oa	direct	a	DT	B-NP	Odirect	4-h	direct	JJ	I-NP	O4-h	51Cr-release	4-h	JJ	I-NP	O51Cr-release	assay	51Cr-release	NN	I-NP	Oassay	and	assay	NN	I-NP	Oand	K	and	CC	O	OK	562	K	NN	B-NP	B-cell_line562	cell	562	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	as	line	NN	I-NP	I-cell_lineas	a	as	IN	B-PP	Oa	target	a	DT	B-NP	Otarget	.	target	NN	I-NP	O.	Preincubation	.	.	O	OPreincubation	for	Preincubation	NN	B-NP	Ofor	20	for	IN	B-PP	O20	h	20	CD	B-NP	Oh	of	h	NN	I-NP	Oof	PBM	of	IN	B-PP	OPBM	cells	PBM	NN	B-NP	B-cell_typecells	drawn	cell	NNS	I-NP	I-cell_typedrawn	from	draw	VBN	B-VP	Ofrom	healthy	from	IN	B-PP	Ohealthy	donors	healthy	JJ	B-NP	Odonors	with	donor	NNS	I-NP	Owith	1	with	IN	B-PP	O1	X	1	CD	B-NP	OX	10	X	SYM	I-NP	O10	(	10	CD	I-NP	O(	-8	(	(	O	O-8	)	-8	CD	B-NP	O)	to	)	)	O	Oto	1	to	TO	B-PP	O1	X	1	CD	B-NP	OX	10	X	SYM	O	O10	(	10	CD	O	O(	-5	(	(	O	O-5	)	-5	CD	B-NP	O)	M	)	)	O	OM	cortisol	M	NN	B-NP	Ocortisol	resulted	cortisol	NN	I-NP	Oresulted	in	result	VBD	B-VP	Oin	a	in	IN	B-PP	Oa	significant	a	DT	B-NP	Osignificant	decrease	significant	JJ	I-NP	Odecrease	of	decrease	NN	I-NP	Oof	NK	of	IN	B-PP	ONK	cell	NK	NN	B-NP	B-cell_typecell	activity	cell	NN	I-NP	I-cell_typeactivity	.	activity	NN	I-NP	O.	The	.	.	O	OThe	magnitude	The	DT	B-NP	Omagnitude	of	magnitude	NN	I-NP	Oof	the	of	IN	B-PP	Othe	suppression	the	DT	B-NP	Osuppression	was	suppression	NN	I-NP	Owas	directly	be	VBD	B-VP	Odirectly	related	directly	RB	B-ADJP	Orelated	to	relate	VBN	I-ADJP	Oto	the	to	TO	B-PP	Othe	steroid	the	DT	B-NP	Osteroid	concentration	steroid	NN	I-NP	Oconcentration	and	concentration	NN	I-NP	Oand	inversely	and	CC	O	Oinversely	related	inversely	RB	B-ADJP	Orelated	to	related	JJ	I-ADJP	Oto	the	to	TO	B-PP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	effector	of	IN	B-PP	Oeffector	cells	effector	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Cortisol	.	.	O	OCortisol	was	Cortisol	NN	B-NP	Owas	able	be	VBD	B-VP	Oable	to	able	JJ	B-ADJP	Oto	minimize	to	TO	B-VP	Ominimize	the	minimize	VB	I-VP	Othe	enhancement	the	DT	B-NP	Oenhancement	of	enhancement	NN	I-NP	Oof	NK	of	IN	B-PP	ONK	cytotoxicity	NK	NN	B-NP	Ocytotoxicity	obtainable	cytotoxicity	NN	I-NP	Oobtainable	in	obtainable	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	immune	of	IN	B-PP	Oimmune	interferon	immune	JJ	B-NP	B-proteininterferon	(	interferon	NN	I-NP	I-protein(	IFN-gamma	(	(	O	OIFN-gamma	)	IFN-gamma	NN	B-NP	B-protein)	.	)	)	O	O.	A	.	.	O	OA	significantly	A	DT	B-NP	Osignificantly	higher	significantly	RB	I-NP	Ohigher	suppression	high	JJR	I-NP	Osuppression	was	suppression	NN	I-NP	Owas	achieved	be	VBD	B-VP	Oachieved	after	achieve	VBN	I-VP	Oafter	sequential	after	IN	B-PP	Osequential	exposure	sequential	JJ	B-NP	Oexposure	of	exposure	NN	I-NP	Oof	PBM	of	IN	B-PP	OPBM	cells	PBM	NN	B-NP	B-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	cortisol	to	TO	B-PP	Ocortisol	and	cortisol	NN	B-NP	Oand	equimolar	and	CC	O	Oequimolar	levels	equimolar	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	prostaglandin	of	IN	B-PP	Oprostaglandin	E2	prostaglandin	NN	B-NP	B-proteinE2	(	E2	NN	I-NP	I-protein(	PgE2	(	(	O	OPgE2	)	PgE2	NN	B-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	concomitant	The	DT	B-NP	Oconcomitant	incubation	concomitant	JJ	I-NP	Oincubation	with	incubation	NN	I-NP	Owith	theophylline	with	IN	B-PP	Otheophylline	and	theophylline	NN	B-NP	Oand	isobutyl-methylxanthine	and	CC	I-NP	Oisobutyl-methylxanthine	failed	isobutyl-methylxanthine	NN	I-NP	Ofailed	to	fail	VBD	B-VP	Oto	enhance	to	TO	I-VP	Oenhance	the	enhance	VB	I-VP	Othe	cortisol-induced	the	DT	B-NP	Ocortisol-induced	suppression	cortisol-induced	JJ	I-NP	Osuppression	","	suppression	NN	I-NP	O","	whereas	","	","	O	Owhereas	PgE2-dependent	whereas	IN	O	OPgE2-dependent	inhibition	PgE2-dependent	JJ	B-NP	Oinhibition	significantly	inhibition	NN	I-NP	Osignificantly	increased	significantly	RB	B-VP	Oincreased	after	increase	VBD	I-VP	Oafter	exposure	after	IN	B-PP	Oexposure	of	exposure	NN	B-NP	Oof	PBM	of	IN	B-PP	OPBM	cells	PBM	NN	B-NP	B-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	methyl-xanthines	to	TO	B-PP	Omethyl-xanthines	.	methyl-xanthine	NNS	B-NP	O.	The	.	.	O	OThe	inhibitory	The	DT	B-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	cortisol	of	IN	B-PP	Ocortisol	was	cortisol	NN	B-NP	Owas	partially	be	VBD	B-VP	Opartially	or	partially	RB	B-VP	Oor	totally	or	CC	I-VP	Ototally	prevented	totally	RB	I-VP	Oprevented	by	prevent	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	concomitant	the	DT	B-NP	Oconcomitant	incubation	concomitant	JJ	I-NP	Oincubation	with	incubation	NN	I-NP	Owith	equimolar	with	IN	B-PP	Oequimolar	amounts	equimolar	JJ	B-NP	Oamounts	of	amount	NNS	I-NP	Oof	11-deoxycortisol	of	IN	B-PP	O11-deoxycortisol	and	11-deoxycortisol	NN	B-NP	Oand	RU	and	CC	I-NP	ORU	486	RU	NN	I-NP	O486	but	486	CD	I-NP	Obut	not	but	CC	B-PP	Onot	of	not	RB	B-PP	Oof	progesterone	of	IN	I-PP	Oprogesterone	.	progesterone	NN	B-NP	O.	Treatment	.	.	O	OTreatment	of	Treatment	NN	B-NP	Oof	NK	of	IN	B-PP	ONK	effectors	NK	NN	B-NP	B-proteineffectors	with	effector	NNS	I-NP	I-proteinwith	a	with	IN	B-PP	Oa	monoclonal	a	DT	B-NP	Omonoclonal	anti-human	monoclonal	JJ	I-NP	B-proteinanti-human	corticosteroid-binding	anti-human	JJ	I-NP	I-proteincorticosteroid-binding	globulin	corticosteroid-binding	JJ	I-NP	I-proteinglobulin	(	globulin	NN	I-NP	I-protein(	CBG	(	(	O	I-proteinCBG	)	CBG	NN	B-NP	I-protein)	antibody	)	)	O	I-proteinantibody	produced	antibody	NN	B-NP	I-proteinproduced	an	produce	VBD	B-VP	Oan	enhancement	an	DT	B-NP	Oenhancement	of	enhancement	NN	I-NP	Oof	the	of	IN	B-PP	Othe	spontaneous	the	DT	B-NP	Ospontaneous	NK	spontaneous	JJ	I-NP	ONK	activity	NK	NN	I-NP	Oactivity	and	activity	NN	I-NP	Oand	a	and	CC	O	Oa	partial	a	DT	B-NP	Opartial	suppression	partial	JJ	I-NP	Osuppression	of	suppression	NN	I-NP	Oof	cortisol-mediated	of	IN	B-PP	Ocortisol-mediated	effects	cortisol-mediated	JJ	B-NP	Oeffects	.	effect	NNS	I-NP	O.	Our	.	.	O	OOur	results	Our	PRP$	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	endogenous	that	IN	B-SBAR	Oendogenous	glucocorticoids	endogenous	JJ	B-NP	Oglucocorticoids	play	glucocorticoid	NNS	I-NP	Oplay	a	play	VBP	B-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	NK	of	IN	B-PP	ONK	cell-mediated	NK	NN	B-NP	Ocell-mediated	cytotoxicity	cell-mediated	JJ	I-NP	Ocytotoxicity	.	cytotoxicity	NN	I-NP	O.	Since	.	.	O	OSince	the	Since	IN	B-SBAR	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	cortisol	of	IN	B-PP	Ocortisol	was	cortisol	NN	B-NP	Owas	additive	be	VBD	B-VP	Oadditive	to	additive	JJ	B-ADJP	Oto	that	to	TO	B-PP	Othat	of	that	DT	B-NP	Oof	PgE2	of	IN	B-PP	OPgE2	and	PgE2	NN	B-NP	Oand	was	and	CC	O	Owas	not	be	VBD	B-VP	Onot	changed	not	RB	I-VP	Ochanged	by	change	VBN	I-VP	Oby	phosphodiesterase	by	IN	B-PP	Ophosphodiesterase	inhibitors	phosphodiesterase	NN	B-NP	B-proteininhibitors	","	inhibitor	NNS	I-NP	O","	it	","	","	O	Oit	is	it	PRP	B-NP	Ois	conceivable	be	VBZ	B-VP	Oconceivable	that	conceivable	JJ	B-ADJP	Othat	the	that	IN	B-SBAR	Othe	hormone	the	DT	B-NP	Ohormone	acts	hormone	NN	I-NP	Oacts	at	act	VBZ	B-VP	Oat	a	at	IN	B-PP	Oa	level	a	DT	B-NP	Olevel	different	level	NN	I-NP	Odifferent	from	different	JJ	B-ADJP	Ofrom	the	from	IN	B-PP	Othe	adenylate	the	DT	B-NP	Oadenylate	cyclase	adenylate	NN	I-NP	B-proteincyclase	-	cyclase	NN	I-NP	I-protein-	phosphodiesterase	-	HYPH	B-NP	Ophosphodiesterase	system	phosphodiesterase	NN	I-NP	B-proteinsystem	.	system	NN	I-NP	O.	Data	.	.	O	OData	obtained	Datum	NNS	B-NP	Oobtained	with	obtain	VBN	B-VP	Owith	the	with	IN	B-PP	Othe	use	the	DT	B-NP	Ouse	of	use	NN	I-NP	Oof	antiglucocorticoids	of	IN	B-PP	Oantiglucocorticoids	and	antiglucocorticoid	NNS	B-NP	Oand	the	and	CC	O	Othe	anti-CBG	the	DT	B-NP	Oanti-CBG	antibody	anti-CBG	JJ	I-NP	B-proteinantibody	are	antibody	NN	I-NP	I-proteinare	compatible	be	VBP	B-VP	Ocompatible	with	compatible	JJ	B-ADJP	Owith	a	with	IN	B-PP	Oa	role	a	DT	B-NP	Orole	both	role	NN	I-NP	Oboth	of	both	DT	B-NP	Oof	high-affinity	of	IN	B-PP	Ohigh-affinity	glucocorticoid	high-affinity	JJ	B-NP	B-proteinglucocorticoid	receptors	glucocorticoid	NN	I-NP	I-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	of	and	CC	B-PP	Oof	CBG	of	IN	B-PP	OCBG	in	CBG	NN	B-NP	B-proteinin	mediating	in	IN	B-PP	Omediating	cortisol	mediate	VBG	B-VP	Ocortisol	action	cortisol	NN	B-NP	Oaction	on	action	NN	I-NP	Oon	the	on	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	NK	human	JJ	I-NP	ONK	cell	NK	NN	I-NP	Ocell	activity	cell	NN	I-NP	Oactivity	.	activity	NN	I-NP	O.	Interaction	.	.	O	OInteraction	of	Interaction	NN	B-NP	Oof	cell-type-specific	of	IN	B-PP	Ocell-type-specific	nuclear	cell-type-specific	JJ	B-NP	B-proteinnuclear	proteins	nuclear	JJ	I-NP	I-proteinproteins	with	protein	NNS	I-NP	I-proteinwith	immunoglobulin	with	IN	B-PP	Oimmunoglobulin	VH	immunoglobulin	NN	B-NP	B-DNAVH	promoter	VH	NN	I-NP	I-DNApromoter	region	promoter	NN	I-NP	I-DNAregion	sequences	region	NN	I-NP	I-DNAsequences	.	sequence	NNS	I-NP	I-DNA.	All	.	.	O	OAll	human	All	DT	B-NP	Ohuman	and	human	JJ	I-NP	B-DNAand	murine	and	CC	I-NP	I-DNAmurine	immunoglobulin	murine	JJ	I-NP	I-DNAimmunoglobulin	heavy	immunoglobulin	NN	I-NP	I-DNAheavy	chain	heavy	JJ	I-NP	I-DNAchain	variable	chain	NN	I-NP	I-DNAvariable	region	variable	JJ	I-NP	I-DNAregion	(	region	NN	I-NP	I-DNA(	VH	(	(	O	I-DNAVH	)	VH	NN	B-NP	I-DNA)	genes	)	)	O	I-DNAgenes	contain	gene	NNS	B-NP	I-DNAcontain	the	contain	VBP	B-VP	Othe	sequence	the	DT	B-NP	Osequence	ATGCAAAT	sequence	NN	I-NP	OATGCAAAT	approximately	ATGCAAAT	NN	I-NP	Oapproximately	70	approximately	RB	B-NP	O70	nucleotides	70	CD	I-NP	B-DNAnucleotides	5	nucleotide	NNS	I-NP	I-DNA5	'	5	CD	I-NP	I-DNA'	from	'	SYM	B-NP	I-DNAfrom	the	from	IN	B-PP	Othe	site	the	DT	B-NP	Osite	of	site	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	initiation	transcription	NN	B-NP	Oinitiation	.	initiation	NN	I-NP	O.	This	.	.	O	OThis	octanucleotide	This	DT	B-NP	Ooctanucleotide	","	octanucleotide	NN	I-NP	O","	in	","	","	O	Oin	reverse	in	IN	B-PP	Oreverse	orientation	reverse	JJ	B-NP	Oorientation	","	orientation	NN	I-NP	O","	is	","	","	O	Ois	also	be	VBZ	B-VP	Oalso	found	also	RB	I-VP	Ofound	in	find	VBN	I-VP	Oin	all	in	IN	B-PP	Oall	light	all	DT	B-NP	Olight	chain	light	JJ	I-NP	B-DNAchain	variable	chain	NN	I-NP	I-DNAvariable	region	variable	JJ	I-NP	I-DNAregion	(	region	NN	I-NP	I-DNA(	VL	(	(	O	I-DNAVL	)	VL	NN	B-NP	I-DNA)	genes	)	)	O	I-DNAgenes	","	gene	NNS	B-NP	I-DNA","	and	","	","	O	Oand	in	and	CC	O	Oin	the	in	IN	B-PP	Othe	immunoglobulin	the	DT	B-NP	Oimmunoglobulin	heavy	immunoglobulin	NN	I-NP	B-DNAheavy	chain	heavy	JJ	I-NP	I-DNAchain	transcriptional	chain	NN	I-NP	I-DNAtranscriptional	enhancer	transcriptional	JJ	I-NP	I-DNAenhancer	.	enhancer	NN	I-NP	I-DNA.	Transfection	.	.	O	OTransfection	studies	Transfection	NN	B-NP	Ostudies	have	study	NNS	I-NP	Ohave	established	have	VBP	B-VP	Oestablished	that	establish	VBN	I-VP	Othat	this	that	IN	B-SBAR	Othis	octamer	this	DT	B-NP	Ooctamer	is	octamer	NN	I-NP	B-DNAis	involved	be	VBZ	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	lymphoid-specific	the	DT	B-NP	Olymphoid-specific	transcription	lymphoid-specific	JJ	I-NP	Otranscription	of	transcription	NN	I-NP	Oof	immunoglobulin	of	IN	B-PP	Oimmunoglobulin	genes	immunoglobulin	NN	B-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Octamer-containing	.	.	O	OOctamer-containing	fragments	Octamer-containing	JJ	B-NP	B-DNAfragments	have	fragment	NNS	I-NP	I-DNAhave	been	have	VBP	B-VP	Obeen	reported	be	VBN	I-VP	Oreported	to	report	VBN	I-VP	Oto	bind	to	TO	I-VP	Obind	a	bind	VB	I-VP	Oa	factor	a	DT	B-NP	Ofactor	present	factor	NN	I-NP	Opresent	in	present	JJ	B-ADJP	Oin	nuclear	in	IN	B-PP	Onuclear	extracts	nuclear	JJ	B-NP	Oextracts	of	extract	NNS	I-NP	Oof	human	of	IN	B-PP	Ohuman	cell	human	JJ	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	;	line	NNS	I-NP	I-cell_line;	however	;	:	O	Ohowever	","	however	RB	B-ADVP	O","	identical	","	","	O	Oidentical	binding	identical	JJ	B-NP	Obinding	activity	binding	NN	I-NP	Oactivity	was	activity	NN	I-NP	Owas	detected	be	VBD	B-VP	Odetected	in	detect	VBN	I-VP	Oin	both	in	IN	B-PP	Oboth	B	both	CC	O	OB	lymphoid	B	NN	B-NP	Olymphoid	and	lymphoid	JJ	I-NP	Oand	non-lymphoid	and	CC	I-NP	Onon-lymphoid	cells	non-lymphoid	JJ	I-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	establish	we	PRP	B-NP	Oestablish	that	establish	VBP	B-VP	Othat	nuclear	that	IN	B-SBAR	Onuclear	extracts	nuclear	JJ	B-NP	Oextracts	from	extract	NNS	I-NP	Ofrom	distinct	from	IN	B-PP	Odistinct	cell	distinct	JJ	B-NP	Ocell	types	cell	NN	I-NP	Otypes	differ	type	NNS	I-NP	Odiffer	in	differ	VBP	B-VP	Oin	their	in	IN	B-PP	Otheir	ability	their	PRP$	B-NP	Oability	to	ability	NN	I-NP	Oto	interact	to	TO	B-VP	Ointeract	with	interact	VB	I-VP	Owith	octamer-containing	with	IN	B-PP	Ooctamer-containing	fragments	octamer-containing	JJ	B-NP	B-DNAfragments	.	fragment	NNS	I-NP	I-DNA.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	also	have	VBP	B-VP	Oalso	detected	also	RB	I-VP	Odetected	a	detect	VBN	I-VP	Oa	DNA-protein	a	DT	B-NP	ODNA-protein	interaction	DNA-protein	JJ	I-NP	Ointeraction	that	interaction	NN	I-NP	Othat	may	that	WDT	B-NP	Omay	be	may	MD	B-VP	Obe	involved	be	VB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	cell-type	the	DT	B-NP	Ocell-type	specificity	cell-type	JJ	I-NP	Ospecificity	of	specificity	NN	I-NP	Oof	immunoglobulin	of	IN	B-PP	Oimmunoglobulin	expression	immunoglobulin	NN	B-NP	B-proteinexpression	","	expression	NN	I-NP	O","	and	","	","	O	Oand	we	and	CC	O	Owe	have	we	PRP	B-NP	Ohave	determined	have	VBP	B-VP	Odetermined	that	determine	VBN	I-VP	Othat	a	that	IN	B-SBAR	Oa	sequence	a	DT	B-NP	Osequence	upstream	sequence	NN	I-NP	Oupstream	of	upstream	RB	B-ADVP	Oof	the	of	IN	B-PP	Othe	octamer	the	DT	B-NP	Ooctamer	participates	octamer	NN	I-NP	B-DNAparticipates	in	participate	VBZ	B-VP	Oin	an	in	IN	B-PP	Oan	interaction	an	DT	B-NP	Ointeraction	with	interaction	NN	I-NP	Owith	a	with	IN	B-PP	Oa	nuclear	a	DT	B-NP	Onuclear	protein	nuclear	JJ	I-NP	B-proteinprotein	(	protein	NN	I-NP	I-protein(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	.	)	)	O	O.	Preferential	.	.	O	OPreferential	transcription	Preferential	JJ	B-NP	Otranscription	of	transcription	NN	I-NP	Oof	HTLV-I	of	IN	B-PP	OHTLV-I	LTR	HTLV-I	NN	B-NP	B-DNALTR	in	LTR	NN	I-NP	I-DNAin	cell-free	in	IN	B-PP	Ocell-free	extracts	cell-free	JJ	B-NP	Oextracts	of	extract	NNS	I-NP	Oof	human	of	IN	B-PP	Ohuman	T	human	JJ	B-NP	B-proteinT	cells	T	NN	I-NP	I-proteincells	producing	cell	NNS	I-NP	I-proteinproducing	HTLV-I	produce	VBG	B-VP	I-proteinHTLV-I	viral	HTLV-I	NN	B-NP	I-proteinviral	proteins	viral	JJ	I-NP	I-proteinproteins	.	protein	NNS	I-NP	I-protein.	The	.	.	O	OThe	promoters	The	DT	B-NP	Opromoters	of	promoter	NNS	I-NP	B-DNAof	the	of	IN	B-PP	Othe	adenovirus	the	DT	B-NP	Oadenovirus	2	adenovirus	NN	I-NP	B-DNA2	major	2	CD	I-NP	I-DNAmajor	late	major	JJ	I-NP	I-DNAlate	gene	late	JJ	I-NP	I-DNAgene	","	gene	NN	I-NP	I-DNA","	the	","	","	O	Othe	mouse	the	DT	B-NP	Omouse	beta-globin	mouse	NN	I-NP	B-DNAbeta-globin	gene	beta-globin	NN	I-NP	I-DNAgene	","	gene	NN	I-NP	I-DNA","	the	","	","	O	Othe	mouse	the	DT	B-NP	Omouse	immunoglobulin	mouse	NN	I-NP	B-DNAimmunoglobulin	VH	immunoglobulin	NN	I-NP	I-DNAVH	gene	VH	NN	I-NP	I-DNAgene	and	gene	NN	I-NP	I-DNAand	the	and	CC	O	Othe	LTR	the	DT	B-NP	OLTR	of	LTR	NN	I-NP	B-DNAof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	T-lymphotropic	human	JJ	I-NP	OT-lymphotropic	retrovirus	T-lymphotropic	JJ	I-NP	Oretrovirus	type	retrovirus	NN	I-NP	Otype	I	type	NN	I-NP	OI	were	I	CD	I-NP	Owere	tested	be	VBD	B-VP	Otested	for	test	VBN	I-VP	Ofor	their	for	IN	B-PP	Otheir	transcription	their	PRP$	B-NP	Otranscription	activities	transcription	NN	I-NP	Oactivities	in	activity	NNS	I-NP	Oin	cell-free	in	IN	B-PP	Ocell-free	extracts	cell-free	JJ	B-NP	Oextracts	of	extract	NNS	I-NP	Oof	four	of	IN	B-PP	Ofour	cell	four	CD	B-NP	Ocell	lines	cell	NN	I-NP	B-cell_linelines	;	line	NNS	I-NP	I-cell_line;	HeLa	;	:	O	OHeLa	","	HeLa	NN	B-NP	O","	CESS	","	","	O	OCESS	(	CESS	NN	B-NP	O(	Epstein-Barr	(	(	O	OEpstein-Barr	virus-transformed	Epstein-Barr	JJ	B-NP	B-cell_linevirus-transformed	human	virus-transformed	JJ	I-NP	I-cell_linehuman	B	human	JJ	I-NP	I-cell_lineB	cell	B	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	)	line	NN	I-NP	I-cell_line)	","	)	)	O	O","	MT-1	","	","	O	OMT-1	(	MT-1	NN	B-NP	B-cell_line(	HTLV-I-infected	(	(	O	OHTLV-I-infected	human	HTLV-I-infected	JJ	B-NP	B-cell_linehuman	T	human	JJ	I-NP	I-cell_lineT	cell	T	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	without	line	NN	I-NP	I-cell_linewithout	viral	without	IN	B-PP	Oviral	protein	viral	JJ	B-NP	B-proteinprotein	synthesis	protein	NN	I-NP	I-proteinsynthesis	)	synthesis	NN	I-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	MT-2	and	CC	O	OMT-2	(	MT-2	NN	B-NP	B-cell_line(	HTLV-I-infected	(	(	O	OHTLV-I-infected	human	HTLV-I-infected	JJ	B-NP	B-cell_linehuman	T	human	JJ	I-NP	I-cell_lineT	cell	T	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	producing	line	NN	I-NP	I-cell_lineproducing	viral	produce	VBG	B-VP	Oviral	proteins	viral	JJ	B-NP	B-proteinproteins	)	protein	NNS	I-NP	I-protein)	.	)	)	O	O.	LTR	.	.	O	OLTR	was	LTR	NN	B-NP	B-DNAwas	preferentially	be	VBD	B-VP	Opreferentially	transcribed	preferentially	RB	I-VP	Otranscribed	in	transcribe	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	extracts	the	DT	B-NP	Oextracts	of	extract	NNS	I-NP	Oof	MT-2	of	IN	B-PP	OMT-2	although	MT-2	NN	B-NP	B-proteinalthough	the	although	IN	B-SBAR	Othe	other	the	DT	B-NP	Oother	three	other	JJ	I-NP	Othree	genes	three	CD	I-NP	Ogenes	were	gene	NNS	I-NP	Owere	transcribed	be	VBD	B-VP	Otranscribed	with	transcribe	VBN	I-VP	Owith	relatively	with	IN	B-PP	Orelatively	constant	relatively	RB	B-NP	Oconstant	efficiencies	constant	JJ	I-NP	Oefficiencies	in	efficiency	NNS	I-NP	Oin	different	in	IN	B-PP	Odifferent	extracts	different	JJ	B-NP	Oextracts	.	extract	NNS	I-NP	O.	The	.	.	O	OThe	results	The	DT	B-NP	Oresults	agree	result	NNS	I-NP	Oagree	well	agree	VBP	B-VP	Owell	with	well	RB	B-ADVP	Owith	the	with	IN	B-PP	Othe	previous	the	DT	B-NP	Oprevious	in	previous	JJ	I-NP	Oin	vivo	in	FW	I-NP	Ovivo	studies	vivo	FW	I-NP	Ostudies	on	study	NNS	I-NP	Oon	the	on	IN	B-PP	Othe	promoter	the	DT	B-NP	Opromoter	activity	promoter	NN	I-NP	Oactivity	of	activity	NN	I-NP	Oof	HTLV-I	of	IN	B-PP	OHTLV-I	LTR	HTLV-I	NN	B-NP	B-DNALTR	.	LTR	NN	I-NP	I-DNA.	Mixing	.	.	O	OMixing	of	Mixing	NN	B-NP	Oof	HeLa	of	IN	B-PP	OHeLa	and	HeLa	NN	B-NP	B-cell_lineand	MT-2	and	CC	I-NP	OMT-2	extracts	MT-2	NN	I-NP	Oextracts	revealed	extract	NNS	I-NP	Orevealed	the	reveal	VBD	B-VP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	a	of	IN	B-PP	Oa	LTR-specific	a	DT	B-NP	OLTR-specific	stimulating	LTR-specific	JJ	I-NP	Ostimulating	activity	stimulating	NN	I-NP	Oactivity	in	activity	NN	I-NP	Oin	MT-2	in	IN	B-PP	OMT-2	extracts	MT-2	NN	B-NP	Oextracts	.	extract	NNS	I-NP	O.	A	.	.	O	OA	nuclear	A	DT	B-NP	Onuclear	factor	nuclear	JJ	I-NP	B-proteinfactor	that	factor	NN	I-NP	I-proteinthat	binds	that	WDT	B-NP	Obinds	to	bind	VBZ	B-VP	Oto	a	to	TO	B-PP	Oa	conserved	a	DT	B-NP	Oconserved	sequence	conserve	VBN	I-NP	B-DNAsequence	motif	sequence	NN	I-NP	I-DNAmotif	in	motif	NN	I-NP	I-DNAin	transcriptional	in	IN	B-PP	Otranscriptional	control	transcriptional	JJ	B-NP	B-DNAcontrol	elements	control	NN	I-NP	I-DNAelements	of	element	NNS	I-NP	I-DNAof	immunoglobulin	of	IN	B-PP	Oimmunoglobulin	genes	immunoglobulin	NN	B-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Trans-acting	.	.	O	OTrans-acting	factors	Trans-acting	JJ	B-NP	B-proteinfactors	that	factor	NNS	I-NP	I-proteinthat	mediate	that	WDT	B-NP	Omediate	B-cell	mediate	VBP	B-VP	OB-cell	specific	B-cell	NN	B-NP	Ospecific	transcription	specific	JJ	I-NP	Otranscription	of	transcription	NN	I-NP	Oof	immunoglobulin	of	IN	B-PP	Oimmunoglobulin	genes	immunoglobulin	NN	B-NP	B-DNAgenes	have	gene	NNS	I-NP	I-DNAhave	been	have	VBP	B-VP	Obeen	postulated	be	VBN	I-VP	Opostulated	based	postulate	VBN	I-VP	Obased	on	base	VBN	B-PP	Oon	an	on	IN	B-PP	Oan	analysis	an	DT	B-NP	Oanalysis	of	analysis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	exogenously	of	IN	B-PP	Oexogenously	introduced	exogenously	RB	B-NP	Ointroduced	immunoglobulin	introduce	VBN	I-NP	Oimmunoglobulin	gene	immunoglobulin	NN	I-NP	Ogene	recombinants	gene	NN	I-NP	Orecombinants	in	recombinant	NNS	I-NP	Oin	lymphoid	in	IN	B-PP	Olymphoid	and	lymphoid	JJ	B-NP	B-cell_typeand	non-lymphoid	and	CC	I-NP	I-cell_typenon-lymphoid	cells	non-lymphoid	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Two	.	.	O	OTwo	B-cell-specific	Two	CD	B-NP	OB-cell-specific	","	B-cell-specific	JJ	I-NP	O","	cis-acting	","	","	I-NP	Ocis-acting	transcriptional	cis-acting	JJ	I-NP	B-DNAtranscriptional	regulatory	transcriptional	JJ	I-NP	I-DNAregulatory	elements	regulatory	JJ	I-NP	I-DNAelements	have	element	NNS	I-NP	I-DNAhave	been	have	VBP	B-VP	Obeen	identified	be	VBN	I-VP	Oidentified	.	identify	VBN	I-VP	O.	One	.	.	O	OOne	element	One	CD	B-NP	Oelement	is	element	NN	I-NP	Ois	located	be	VBZ	B-VP	Olocated	in	locate	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	intron	the	DT	B-NP	Ointron	between	intron	NN	I-NP	B-DNAbetween	the	between	IN	B-PP	Othe	variable	the	DT	B-NP	Ovariable	(	variable	JJ	I-NP	B-DNA(	V	(	(	O	I-DNAV	)	V	NN	B-NP	I-DNA)	and	)	)	O	I-DNAand	constant	and	CC	O	I-DNAconstant	(	constant	JJ	B-NP	I-DNA(	C	(	(	O	I-DNAC	)	C	NN	B-NP	I-DNA)	regions	)	)	O	I-DNAregions	of	region	NNS	B-NP	I-DNAof	both	of	IN	B-PP	Oboth	heavy	both	CC	B-NP	Oheavy	and	heavy	JJ	I-NP	B-DNAand	kappa	and	CC	O	I-DNAkappa	light-chain	kappa	NN	B-NP	I-DNAlight-chain	genes	light-chain	JJ	I-NP	I-DNAgenes	and	gene	NNS	I-NP	I-DNAand	acts	and	CC	O	Oacts	as	act	VBZ	B-VP	Oas	a	as	IN	B-PP	Oa	transcriptional	a	DT	B-NP	Otranscriptional	enhancer	transcriptional	JJ	I-NP	B-DNAenhancer	.	enhancer	NN	I-NP	I-DNA.	The	.	.	O	OThe	second	The	DT	B-NP	Osecond	element	second	JJ	I-NP	B-DNAelement	is	element	NN	I-NP	I-DNAis	found	be	VBZ	B-VP	Ofound	upstream	find	VBN	I-VP	Oupstream	of	upstream	RB	B-ADVP	Oof	both	of	IN	B-PP	Oboth	heavy	both	CC	B-NP	Oheavy	and	heavy	JJ	I-NP	B-DNAand	kappa	and	CC	I-NP	I-DNAkappa	light-chain	kappa	NN	I-NP	I-DNAlight-chain	gene	light-chain	NN	I-NP	I-DNAgene	promoters	gene	NN	I-NP	I-DNApromoters	.	promoter	NNS	I-NP	I-DNA.	This	.	.	O	OThis	element	This	DT	B-NP	Oelement	directs	element	NN	I-NP	Odirects	lymphoid-specific	direct	VBZ	B-VP	Olymphoid-specific	transcription	lymphoid-specific	JJ	B-NP	Otranscription	even	transcription	NN	I-NP	Oeven	in	even	RB	B-ADVP	Oin	the	in	IN	B-PP	Othe	presence	the	DT	I-PP	Opresence	of	presence	NN	I-PP	Oof	viral	of	IN	I-PP	Oviral	enhancers	viral	JJ	B-NP	B-DNAenhancers	.	enhancer	NNS	I-NP	I-DNA.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	sought	have	VBP	B-VP	Osought	nuclear	seek	VBN	I-VP	Onuclear	factors	nuclear	JJ	B-NP	B-proteinfactors	that	factor	NNS	I-NP	I-proteinthat	might	that	WDT	B-NP	Omight	bind	might	MD	B-VP	Obind	specifically	bind	VB	I-VP	Ospecifically	to	specifically	RB	B-ADVP	Oto	these	to	TO	B-PP	Othese	two	these	DT	B-NP	Otwo	regulatory	two	CD	I-NP	Oregulatory	elements	regulatory	JJ	I-NP	B-DNAelements	by	element	NNS	I-NP	I-DNAby	application	by	IN	B-PP	Oapplication	of	application	NN	B-NP	Oof	a	of	IN	B-PP	Oa	modified	a	DT	B-NP	Omodified	gel	modify	VBN	I-NP	Ogel	electrophoresis	gel	NN	I-NP	Oelectrophoresis	DNA	electrophoresis	NN	I-NP	ODNA	binding	DNA	NN	I-NP	Obinding	assay	binding	NN	I-NP	Oassay	.	assay	NN	I-NP	O.	We	.	.	O	OWe	report	We	PRP	B-NP	Oreport	here	report	VBP	B-VP	Ohere	the	here	RB	B-ADVP	Othe	identification	the	DT	B-NP	Oidentification	of	identification	NN	I-NP	Oof	a	of	IN	B-PP	Oa	human	a	DT	B-NP	Ohuman	B-cell	human	JJ	I-NP	B-proteinB-cell	nuclear	B-cell	NN	I-NP	I-proteinnuclear	factor	nuclear	JJ	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	IgNF-A	(	(	O	OIgNF-A	)	IgNF-A	NN	B-NP	B-protein)	that	)	)	O	Othat	binds	that	WDT	B-NP	Obinds	to	bind	VBZ	B-VP	Oto	DNA	to	TO	B-PP	ODNA	sequences	DNA	NN	B-NP	B-DNAsequences	in	sequence	NNS	I-NP	I-DNAin	the	in	IN	B-PP	Othe	upstream	the	DT	B-NP	Oupstream	regions	upstream	JJ	I-NP	B-DNAregions	of	region	NNS	I-NP	I-DNAof	both	of	IN	B-PP	Oboth	the	both	CC	O	Othe	mouse	the	DT	B-NP	Omouse	heavy	mouse	NN	I-NP	B-DNAheavy	and	heavy	NN	I-NP	I-DNAand	kappa	and	CC	O	I-DNAkappa	light-chain	kappa	NN	B-NP	I-DNAlight-chain	gene	light-chain	NN	I-NP	I-DNAgene	promoters	gene	NN	I-NP	I-DNApromoters	and	promoter	NNS	I-NP	I-DNAand	also	and	CC	O	Oalso	to	also	RB	B-ADVP	Oto	the	to	TO	B-PP	Othe	mouse	the	DT	B-NP	Omouse	heavy-chain	mouse	NN	I-NP	B-DNAheavy-chain	gene	heavy-chain	JJ	I-NP	I-DNAgene	enhancer	gene	NN	I-NP	I-DNAenhancer	.	enhancer	NN	I-NP	I-DNA.	This	.	.	O	OThis	sequence-specific	This	DT	B-NP	Osequence-specific	binding	sequence-specific	JJ	I-NP	Obinding	is	binding	NN	I-NP	Ois	probably	be	VBZ	B-VP	Oprobably	mediated	probably	RB	I-VP	Omediated	by	mediate	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	highly	a	DT	B-NP	Ohighly	conserved	highly	RB	I-NP	Oconserved	sequence	conserve	VBN	I-NP	Osequence	motif	sequence	NN	I-NP	Omotif	","	motif	NN	I-NP	O","	ATTTGCAT	","	","	O	OATTTGCAT	","	ATTTGCAT	NN	B-NP	O","	present	","	","	O	Opresent	in	present	JJ	B-ADJP	Oin	all	in	IN	B-PP	Oall	three	all	DT	B-NP	Othree	transcriptional	three	CD	I-NP	Otranscriptional	elements	transcriptional	JJ	I-NP	B-DNAelements	.	element	NNS	I-NP	I-DNA.	Interestingly	.	.	O	OInterestingly	","	Interestingly	RB	B-ADVP	O","	a	","	","	O	Oa	factor	a	DT	B-NP	Ofactor	showing	factor	NN	I-NP	Oshowing	similar	show	VBG	B-VP	Osimilar	binding	similar	JJ	B-NP	Obinding	specificity	binding	NN	I-NP	Ospecificity	to	specificity	NN	I-NP	Oto	IgNF-A	to	TO	B-PP	OIgNF-A	is	IgNF-A	NN	B-NP	B-proteinis	also	be	VBZ	B-VP	Oalso	present	also	RB	B-ADVP	Opresent	in	present	JJ	B-ADJP	Oin	human	in	IN	B-PP	Ohuman	HeLa	human	JJ	B-NP	B-cell_lineHeLa	cells	HeLa	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	The	.	.	O	OThe	new	The	DT	B-NP	Onew	world	new	JJ	I-NP	Oworld	primates	world	NN	I-NP	Oprimates	as	primate	NNS	I-NP	Oas	animal	as	IN	B-PP	Oanimal	models	animal	NN	B-NP	Omodels	of	model	NNS	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	resistance	glucocorticoid	NN	B-NP	Oresistance	.	resistance	NN	I-NP	O.	Many	.	.	O	OMany	New	Many	JJ	B-NP	ONew	World	New	JJ	I-NP	OWorld	primate	World	NN	I-NP	Oprimate	species	primate	JJ	I-NP	Ospecies	have	specie	NNS	I-NP	Ohave	greatly	have	VBP	B-VP	Ogreatly	increased	greatly	RB	I-VP	Oincreased	plasma	increase	VBN	I-VP	Oplasma	cortisol	plasma	NN	B-NP	Ocortisol	concentrations	cortisol	NN	I-NP	Oconcentrations	","	concentration	NNS	I-NP	O","	decreased	","	","	O	Odecreased	plasma	decrease	VBN	B-NP	Oplasma	cortisol	plasma	NN	I-NP	Ocortisol	binding	cortisol	NN	I-NP	Obinding	globulin	binding	NN	I-NP	Oglobulin	capacity	globulin	NN	I-NP	Ocapacity	and	capacity	NN	I-NP	Oand	affinity	and	CC	O	Oaffinity	","	affinity	NN	B-NP	O","	marked	","	","	O	Omarked	resistance	marked	JJ	B-NP	Oresistance	of	resistance	NN	I-NP	Oof	the	of	IN	B-PP	Othe	hypothalamic-pituitary-adrenal	the	DT	B-NP	Ohypothalamic-pituitary-adrenal	axis	hypothalamic-pituitary-adrenal	JJ	I-NP	Oaxis	to	axis	NN	I-NP	Oto	suppression	to	TO	B-PP	Osuppression	by	suppression	NN	B-NP	Oby	dexamethasone	by	IN	B-PP	Odexamethasone	","	dexamethasone	NN	B-NP	O","	and	","	","	O	Oand	no	and	CC	O	Ono	biological	no	DT	B-NP	Obiological	evidence	biological	JJ	I-NP	Oevidence	of	evidence	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	excess	glucocorticoid	NN	B-NP	Oexcess	.	excess	NN	I-NP	O.	These	.	.	O	OThese	primates	These	DT	B-NP	Oprimates	also	primate	NNS	I-NP	Oalso	have	also	RB	B-ADVP	Ohave	high	have	VBP	B-VP	Ohigh	levels	high	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	circulating	of	IN	B-PP	Ocirculating	progesterone	circulate	VBG	B-VP	Oprogesterone	","	progesterone	NN	B-NP	O","	estrogen	","	","	O	Oestrogen	","	estrogen	NN	B-NP	O","	mineralocorticoid	","	","	O	Omineralocorticoid	","	mineralocorticoid	NN	B-NP	O","	androgen	","	","	O	Oandrogen	and	androgen	NN	B-NP	Oand	vitamin	and	CC	O	Ovitamin	D	vitamin	NN	B-NP	OD	.	D	NN	I-NP	O.	The	.	.	O	OThe	glucocorticoid	The	DT	B-NP	Oglucocorticoid	target	glucocorticoid	NN	I-NP	Otarget	tissues	target	NN	I-NP	Otissues	that	tissue	NNS	I-NP	Othat	have	that	WDT	B-NP	Ohave	been	have	VBP	B-VP	Obeen	examined	be	VBN	I-VP	Oexamined	(	examine	VBN	I-VP	O(	circulating	(	(	O	Ocirculating	mononuclear	circulate	VBG	B-VP	B-cell_typemononuclear	lymphocytes	mononuclear	JJ	B-NP	I-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	cultured	and	CC	O	Ocultured	skin	culture	VBN	B-NP	B-cell_lineskin	fibroblasts	skin	NN	I-NP	I-cell_linefibroblasts	)	fibroblast	NNS	I-NP	I-cell_line)	have	)	)	O	Ohave	normal	have	VBP	B-VP	Onormal	concentrations	normal	JJ	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	with	receptor	NNS	I-NP	I-proteinwith	decreased	with	IN	B-PP	Odecreased	affinity	decrease	VBN	B-NP	Oaffinity	for	affinity	NN	I-NP	Ofor	dexamethasone	for	IN	B-PP	Odexamethasone	.	dexamethasone	NN	B-NP	O.	Transformation	.	.	O	OTransformation	of	Transformation	NN	B-NP	Oof	B-lymphocytes	of	IN	B-PP	OB-lymphocytes	with	B-lymphocyte	NNS	B-NP	B-cell_typewith	the	with	IN	B-PP	Othe	Epstein-Barr	the	DT	B-NP	OEpstein-Barr	virus	Epstein-Barr	JJ	I-NP	Ovirus	leads	virus	NN	I-NP	Oleads	to	lead	VBZ	B-VP	Oto	glucocorticoid	to	TO	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	induction	receptor	NN	I-NP	I-proteininduction	that	induction	NN	I-NP	Othat	is	that	WDT	B-NP	Ois	less	be	VBZ	B-VP	Oless	than	less	JJR	B-ADJP	Othan	that	than	IN	B-PP	Othat	observed	that	DT	B-NP	Oobserved	with	observe	VBN	B-VP	Owith	cells	with	IN	B-PP	Ocells	from	cell	NNS	B-NP	Ofrom	Old	from	IN	B-PP	OOld	World	Old	NNP	B-NP	OWorld	primates	World	NNP	I-NP	Oprimates	.	primate	NNS	I-NP	O.	The	.	.	O	OThe	receptor	The	DT	B-NP	Oreceptor	in	receptor	NN	I-NP	Oin	these	in	IN	B-PP	Othese	cells	these	DT	B-NP	Ocells	has	cell	NNS	I-NP	Ohas	a	have	VBZ	B-VP	Oa	low	a	DT	B-NP	Olow	affinity	low	JJ	I-NP	Oaffinity	for	affinity	NN	I-NP	Ofor	dexamethasone	for	IN	B-PP	Odexamethasone	.	dexamethasone	NN	B-NP	O.	The	.	.	O	OThe	low	The	DT	B-NP	Olow	affinity	low	JJ	I-NP	Oaffinity	leads	affinity	NN	I-NP	Oleads	to	lead	VBZ	B-VP	Oto	an	to	TO	B-PP	Oan	increased	an	DT	B-NP	Oincreased	loss	increase	VBN	I-NP	Oloss	of	loss	NN	I-NP	Oof	specific	of	IN	B-PP	Ospecific	bound	specific	JJ	B-NP	Obound	ligand	bind	VBN	I-NP	Oligand	during	ligand	NN	I-NP	Oduring	thermal	during	IN	B-PP	Othermal	activation	thermal	JJ	B-NP	Oactivation	.	activation	NN	I-NP	O.	Meroreceptor	.	.	O	OMeroreceptor	generation	Meroreceptor	NN	B-NP	Ogeneration	is	generation	NN	I-NP	Ois	normal	be	VBZ	B-VP	Onormal	.	normal	JJ	B-ADJP	O.	The	.	.	O	OThe	molecular	The	DT	B-NP	Omolecular	weight	molecular	JJ	I-NP	Oweight	of	weight	NN	I-NP	Oof	the	of	IN	B-PP	Othe	receptor	the	DT	B-NP	Oreceptor	","	receptor	NN	I-NP	O","	determined	","	","	O	Odetermined	by	determine	VBN	B-VP	Oby	SDS-PAGE	by	IN	B-PP	OSDS-PAGE	","	SDS-PAGE	NN	B-NP	O","	is	","	","	O	Ois	similar	be	VBZ	B-VP	Osimilar	to	similar	JJ	B-ADJP	Oto	that	to	TO	B-PP	Othat	of	that	DT	B-NP	Oof	Old	of	IN	B-PP	OOld	World	Old	NNP	B-NP	OWorld	primates	World	NNP	I-NP	Oprimates	(	primate	NNS	I-NP	O(	approximately	(	(	O	Oapproximately	92	approximately	RB	B-NP	O92	","	92	CD	I-NP	O","	0	","	","	I-NP	O0	)	0	CD	I-NP	O)	and	)	)	O	Oand	the	and	CC	O	Othe	activation	the	DT	B-NP	Oactivation	pattern	activation	NN	I-NP	Opattern	per	pattern	NN	I-NP	Oper	se	per	FW	B-ADVP	Ose	","	se	FW	I-ADVP	O","	examined	","	","	O	Oexamined	in	examine	VBN	B-VP	Oin	vitro	in	FW	B-ADVP	Ovitro	by	vitro	FW	I-ADVP	Oby	heating	by	IN	B-PP	Oheating	cytosol	heat	VBG	B-VP	Ocytosol	and	cytosol	NN	B-NP	Oand	performing	and	CC	O	Operforming	phosphocellulose	perform	VBG	B-VP	Ophosphocellulose	chromatography	phosphocellulose	NN	B-NP	Ochromatography	","	chromatography	NN	I-NP	O","	appears	","	","	O	Oappears	similar	appear	VBZ	B-VP	Osimilar	to	similar	JJ	B-ADJP	Oto	that	to	TO	B-PP	Othat	of	that	DT	B-NP	Oof	human	of	IN	B-PP	Ohuman	controls	human	JJ	B-NP	Ocontrols	.	control	NNS	I-NP	O.	The	.	.	O	OThe	ratios	The	DT	B-NP	Oratios	of	ratio	NNS	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	to	nuclear	JJ	B-NP	Oto	cytosolic	to	TO	B-PP	Ocytosolic	hormone-receptor-complexes	cytosolic	JJ	B-NP	B-proteinhormone-receptor-complexes	and	hormone-receptor-complex	NNS	I-NP	I-proteinand	of	and	CC	B-PP	Oof	cytosolic	of	IN	B-PP	Ocytosolic	activated	cytosolic	JJ	B-NP	B-proteinactivated	to	activate	VBN	B-VP	I-proteinto	unactivated	to	TO	B-PP	I-proteinunactivated	receptor	unactivated	JJ	B-NP	I-proteinreceptor	complexes	receptor	NN	I-NP	I-proteincomplexes	in	complex	NNS	I-NP	I-proteinin	intact	in	IN	B-PP	Ointact	cells	intact	JJ	B-NP	B-cell_typecells	are	cell	NNS	I-NP	I-cell_typeare	similar	be	VBP	B-VP	Osimilar	to	similar	JJ	B-ADJP	Oto	Old	to	TO	B-PP	OOld	World	Old	NNP	B-NP	OWorld	primates	World	NNP	I-NP	Oprimates	.	primate	NNS	I-NP	O.	Results	.	.	O	OResults	from	Result	NNS	B-NP	Ofrom	mixing	from	IN	B-PP	Omixing	studies	mix	VBG	B-NP	Ostudies	do	study	NNS	I-NP	Odo	not	do	VBP	B-VP	Onot	support	not	RB	I-VP	Osupport	the	support	VB	I-VP	Othe	hypothesis	the	DT	B-NP	Ohypothesis	that	hypothesis	NN	I-NP	Othat	a	that	IN	B-SBAR	Oa	binding	a	DT	B-NP	Obinding	inhibitor	binding	NN	I-NP	Oinhibitor	(	inhibitor	NN	I-NP	O(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	or	)	)	O	Oor	a	or	CC	O	Oa	deficient	a	DT	B-NP	Odeficient	cytosolic	deficient	JJ	I-NP	Ocytosolic	positive	cytosolic	JJ	I-NP	Opositive	modifier	positive	JJ	I-NP	Omodifier	(	modifier	NN	I-NP	O(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	of	)	)	O	Oof	binding	of	IN	B-PP	Obinding	underlies	binding	NN	B-NP	Ounderlies	the	underlie	VBZ	B-VP	Othe	findings	the	DT	B-NP	Ofindings	in	finding	NNS	I-NP	Oin	these	in	IN	B-PP	Othese	primates	these	DT	B-NP	Oprimates	.	primate	NNS	I-NP	O.	The	.	.	O	OThe	New	The	DT	B-NP	ONew	World	New	NNP	I-NP	OWorld	primates	World	NN	I-NP	Oprimates	","	primate	NNS	I-NP	O","	unlike	","	","	O	Ounlike	men	unlike	IN	B-PP	Omen	with	man	NNS	B-NP	Owith	the	with	IN	B-PP	Othe	syndrome	the	DT	B-NP	Osyndrome	of	syndrome	NN	I-NP	Oof	primary	of	IN	B-PP	Oprimary	cortisol	primary	JJ	B-NP	Ocortisol	resistance	cortisol	NN	I-NP	Oresistance	","	resistance	NN	I-NP	O","	have	","	","	O	Ohave	compensated	have	VBP	B-VP	Ocompensated	for	compensate	VBN	I-VP	Ofor	their	for	IN	B-PP	Otheir	condition	their	PRP$	B-NP	Ocondition	with	condition	NN	I-NP	Owith	intra-adrenal	with	IN	B-PP	Ointra-adrenal	and	intra-adrenal	JJ	B-NP	Oand	mineralocorticoid	and	CC	I-NP	Omineralocorticoid	receptor	mineralocorticoid	NN	I-NP	Oreceptor	adaptations	receptor	NN	I-NP	Oadaptations	.	adaptation	NNS	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	unlike	","	","	O	Ounlike	Old	unlike	IN	B-PP	OOld	World	Old	NNP	B-NP	OWorld	primates	World	NNP	I-NP	Oprimates	","	primate	NNS	I-NP	O","	cortisol	","	","	O	Ocortisol	in	cortisol	NN	B-NP	Oin	New	in	IN	B-PP	ONew	World	New	JJ	B-NP	OWorld	primates	World	NN	I-NP	Oprimates	has	primate	NNS	I-NP	Ohas	only	have	VBZ	B-VP	Oonly	weak	only	RB	B-NP	Oweak	sodium-retaining	weak	JJ	I-NP	Osodium-retaining	potency	sodium-retaining	JJ	I-NP	Opotency	because	potency	NN	I-NP	Obecause	the	because	IN	B-SBAR	Othe	aldosterone	the	DT	B-NP	Oaldosterone	receptor	aldosterone	NN	I-NP	B-proteinreceptor	has	receptor	NN	I-NP	I-proteinhas	a	have	VBZ	B-VP	Oa	low	a	DT	B-NP	Olow	affinity	low	JJ	I-NP	Oaffinity	for	affinity	NN	I-NP	Ofor	cortisol	for	IN	B-PP	Ocortisol	.	cortisol	NN	B-NP	O.	The	.	.	O	OThe	common	The	DT	B-NP	Ocommon	element	common	JJ	I-NP	Oelement	that	element	NN	I-NP	Othat	would	that	WDT	B-NP	Owould	explain	would	MD	B-VP	Oexplain	the	explain	VB	I-VP	Othe	apparent	the	DT	B-NP	Oapparent	resistance	apparent	JJ	I-NP	Oresistance	to	resistance	NN	I-NP	Oto	six	to	TO	B-PP	Osix	steroid	six	CD	B-NP	Osteroid	hormones	steroid	NN	I-NP	Ohormones	in	hormone	NNS	I-NP	Oin	New	in	IN	B-PP	ONew	World	New	JJ	B-NP	OWorld	primates	World	NN	I-NP	Oprimates	Acetylation	primate	NNS	I-NP	OAcetylation	and	Acetylation	NN	B-NP	Oand	modulation	and	CC	I-NP	Omodulation	of	modulation	NN	I-NP	Oof	erythroid	of	IN	B-PP	Oerythroid	Kruppel-like	erythroid	JJ	B-NP	B-proteinKruppel-like	factor	Kruppel-like	JJ	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	EKLF	(	(	O	OEKLF	)	EKLF	NN	B-NP	B-protein)	activity	)	)	O	Oactivity	by	activity	NN	B-NP	Oby	interaction	by	IN	B-PP	Ointeraction	with	interaction	NN	B-NP	Owith	histone	with	IN	B-PP	Ohistone	acetyltransferases	histone	NN	B-NP	B-proteinacetyltransferases	.	acetyltransferas	NNS	I-NP	I-protein.	Erythroid	.	.	O	OErythroid	Kruppel-like	Erythroid	JJ	B-NP	B-proteinKruppel-like	factor	Kruppel-like	JJ	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	EKLF	(	(	O	OEKLF	)	EKLF	NN	B-NP	B-protein)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	red	a	DT	B-NP	Ored	cell-specific	red	JJ	I-NP	B-proteincell-specific	transcriptional	cell-specific	JJ	I-NP	I-proteintranscriptional	activator	transcriptional	JJ	I-NP	I-proteinactivator	that	activator	NN	I-NP	I-proteinthat	is	that	WDT	B-NP	Ois	crucial	be	VBZ	B-VP	Ocrucial	for	crucial	JJ	B-ADJP	Ofor	consolidating	for	IN	B-PP	Oconsolidating	the	consolidate	VBG	B-VP	Othe	switch	the	DT	B-NP	Oswitch	to	switch	NN	I-NP	Oto	high	to	TO	B-PP	Ohigh	levels	high	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	adult	of	IN	B-PP	Oadult	beta-globin	adult	JJ	B-NP	Obeta-globin	expression	beta-globin	NN	I-NP	B-proteinexpression	during	expression	NN	I-NP	Oduring	erythroid	during	IN	B-PP	Oerythroid	ontogeny	erythroid	JJ	B-NP	Oontogeny	.	ontogeny	NN	I-NP	O.	EKLF	.	.	O	OEKLF	is	EKLF	NN	B-NP	B-proteinis	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	integrity	for	IN	B-PP	Ointegrity	of	integrity	NN	B-NP	Oof	the	of	IN	B-PP	Othe	chromatin	the	DT	B-NP	Ochromatin	structure	chromatin	NN	I-NP	B-DNAstructure	at	structure	NN	I-NP	Oat	the	at	IN	B-PP	Othe	beta-like	the	DT	B-NP	Obeta-like	globin	beta-like	JJ	I-NP	B-DNAglobin	locus	globin	NN	I-NP	I-DNAlocus	","	locus	NN	I-NP	I-DNA","	and	","	","	O	Oand	it	and	CC	O	Oit	interacts	it	PRP	B-NP	Ointeracts	with	interact	VBZ	B-VP	Owith	a	with	IN	B-PP	Oa	positive-acting	a	DT	B-NP	Opositive-acting	factor	positive-acting	JJ	I-NP	B-proteinfactor	in	factor	NN	I-NP	I-proteinin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	We	.	.	O	OWe	find	We	PRP	B-NP	Ofind	that	find	VBP	B-VP	Othat	EKLF	that	IN	B-SBAR	OEKLF	is	EKLF	NN	B-NP	B-proteinis	an	be	VBZ	B-VP	Oan	acetylated	an	DT	B-NP	Oacetylated	transcription	acetylate	VBN	I-NP	B-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	","	factor	NN	I-NP	I-protein","	and	","	","	O	Oand	that	and	CC	O	Othat	it	that	IN	B-SBAR	Oit	interacts	it	PRP	B-NP	Ointeracts	in	interact	VBZ	B-VP	Oin	vivo	in	FW	B-ADVP	Ovivo	with	vivo	FW	I-ADVP	Owith	CBP	with	IN	B-PP	OCBP	","	CBP	NN	B-NP	B-protein","	p300	","	","	O	Op300	","	p300	NN	B-NP	B-protein","	and	","	","	O	Oand	P/CAF	and	CC	O	OP/CAF	.	P/CAF	NN	B-NP	B-protein.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	its	","	","	O	Oits	interactions	its	PRP$	B-NP	Ointeractions	with	interaction	NNS	I-NP	Owith	these	with	IN	B-PP	Othese	histone	these	DT	B-NP	Ohistone	acetyltransferases	histone	NN	I-NP	B-proteinacetyltransferases	are	acetyltransferas	NNS	I-NP	I-proteinare	not	be	VBP	B-VP	Onot	equivalent	not	RB	O	Oequivalent	","	equivalent	JJ	B-ADJP	O","	as	","	","	O	Oas	CBP	as	IN	B-SBAR	OCBP	and	CBP	NN	B-NP	B-proteinand	p300	and	CC	I-NP	Op300	","	p300	NN	I-NP	B-protein","	but	","	","	B-NP	Obut	not	but	CC	I-NP	Onot	P/CAF	not	RB	I-NP	OP/CAF	","	P/CAF	NN	B-NP	B-protein","	utilize	","	","	O	Outilize	EKLF	utilize	VBP	B-VP	OEKLF	as	EKLF	NN	B-NP	B-proteinas	a	as	IN	B-PP	Oa	substrate	a	DT	B-NP	Osubstrate	for	substrate	NN	I-NP	Ofor	in	for	IN	B-PP	Oin	vitro	in	FW	B-NP	Ovitro	acetylation	vitro	FW	I-NP	Oacetylation	within	acetylation	NN	I-NP	Owithin	its	within	IN	B-PP	Oits	trans-activation	its	PRP$	B-NP	Otrans-activation	region	trans-activation	NN	I-NP	B-proteinregion	.	region	NN	I-NP	I-protein.	The	.	.	O	OThe	functional	The	DT	B-NP	Ofunctional	effects	functional	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	these	of	IN	B-PP	Othese	interactions	these	DT	B-NP	Ointeractions	are	interaction	NNS	I-NP	Oare	that	be	VBP	B-VP	Othat	CBP	that	IN	B-SBAR	OCBP	and	CBP	NN	B-NP	B-proteinand	p300	and	CC	I-NP	Op300	","	p300	NN	I-NP	B-protein","	but	","	","	B-NP	Obut	not	but	CC	I-NP	Onot	P/CAF	not	RB	I-NP	OP/CAF	","	P/CAF	NN	B-NP	B-protein","	enhance	","	","	O	Oenhance	EKLF	enhance	VBP	B-VP	OEKLF	's	EKLF	NN	B-NP	B-protein's	transcriptional	's	POS	B-NP	Otranscriptional	activation	transcriptional	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	beta-globin	the	DT	B-NP	Obeta-globin	promoter	beta-globin	NN	I-NP	B-DNApromoter	in	promoter	NN	I-NP	I-DNAin	erythroid	in	IN	B-PP	Oerythroid	cells	erythroid	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	establish	result	NNS	I-NP	Oestablish	EKLF	establish	VBP	B-VP	OEKLF	as	EKLF	NN	B-NP	B-proteinas	a	as	IN	B-PP	Oa	tissue-specific	a	DT	B-NP	Otissue-specific	transcription	tissue-specific	JJ	I-NP	B-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	that	factor	NN	I-NP	I-proteinthat	undergoes	that	WDT	B-NP	Oundergoes	post-translational	undergo	VBZ	B-VP	Opost-translational	acetylation	post-translational	JJ	B-NP	Oacetylation	and	acetylation	NN	I-NP	Oand	suggest	and	CC	O	Osuggest	a	suggest	VBP	B-VP	Oa	mechanism	a	DT	B-NP	Omechanism	by	mechanism	NN	I-NP	Oby	which	by	IN	B-PP	Owhich	EKLF	which	WDT	B-NP	OEKLF	is	EKLF	NN	B-NP	B-proteinis	able	be	VBZ	B-VP	Oable	to	able	JJ	B-ADJP	Oto	alter	to	TO	B-VP	Oalter	chromatin	alter	VB	I-VP	Ochromatin	structure	chromatin	NN	B-NP	B-DNAstructure	and	structure	NN	I-NP	Oand	induce	and	CC	O	Oinduce	beta-globin	induce	VB	B-VP	Obeta-globin	expression	beta-globin	NN	B-NP	B-proteinexpression	within	expression	NN	I-NP	Owithin	the	within	IN	B-PP	Othe	beta-like	the	DT	B-NP	Obeta-like	globin	beta-like	JJ	I-NP	B-DNAglobin	cluster	globin	NN	I-NP	I-DNAcluster	.	cluster	NN	I-NP	I-DNA.	Recognition	.	.	O	ORecognition	of	Recognition	NN	B-NP	Oof	herpes	of	IN	B-PP	Oherpes	simplex	herpes	NN	B-NP	B-proteinsimplex	virus	simplex	NN	I-NP	I-proteinvirus	type	virus	NN	I-NP	I-proteintype	2	type	NN	I-NP	I-protein2	tegument	2	CD	I-NP	I-proteintegument	proteins	tegument	NN	I-NP	I-proteinproteins	by	protein	NNS	I-NP	I-proteinby	CD4	by	IN	B-PP	OCD4	T	CD4	NN	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	infiltrating	cell	NNS	I-NP	I-cell_typeinfiltrating	human	infiltrate	VBG	B-VP	Ohuman	genital	human	JJ	B-NP	Ogenital	herpes	genital	JJ	I-NP	Oherpes	lesions	herpes	NN	I-NP	Olesions	.	lesion	NNS	I-NP	O.	The	.	.	O	OThe	local	The	DT	B-NP	Olocal	cellular	local	JJ	I-NP	Ocellular	immune	cellular	JJ	I-NP	Oimmune	response	immune	JJ	I-NP	Oresponse	to	response	NN	I-NP	Oto	herpes	to	TO	B-PP	Oherpes	simplex	herpes	NN	B-NP	Osimplex	virus	simplex	NN	I-NP	Ovirus	(	virus	NN	I-NP	O(	HSV	(	(	O	OHSV	)	HSV	NN	B-NP	O)	is	)	)	O	Ois	important	be	VBZ	B-VP	Oimportant	in	important	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	control	the	DT	B-NP	Ocontrol	of	control	NN	I-NP	Oof	recurrent	of	IN	B-PP	Orecurrent	HSV	recurrent	JJ	B-NP	OHSV	infection	HSV	NN	I-NP	Oinfection	.	infection	NN	I-NP	O.	The	.	.	O	OThe	antiviral	The	DT	B-NP	Oantiviral	functions	antiviral	JJ	I-NP	Ofunctions	of	function	NNS	I-NP	Oof	infiltrating	of	IN	B-PP	Oinfiltrating	CD4-bearing	infiltrate	VBG	B-VP	B-cell_typeCD4-bearing	T	CD4-bearing	JJ	B-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	may	cell	NNS	I-NP	I-cell_typemay	include	may	MD	B-VP	Oinclude	cytotoxicity	include	VB	I-VP	Ocytotoxicity	","	cytotoxicity	NN	B-NP	O","	inhibition	","	","	O	Oinhibition	of	inhibition	NN	B-NP	Oof	viral	of	IN	B-PP	Oviral	growth	viral	JJ	B-NP	Ogrowth	","	growth	NN	I-NP	O","	lymphokine	","	","	O	Olymphokine	secretion	lymphokine	NN	B-NP	B-proteinsecretion	","	secretion	NN	I-NP	O","	and	","	","	O	Oand	support	and	CC	O	Osupport	of	support	NN	B-NP	Oof	humoral	of	IN	B-PP	Ohumoral	and	humoral	JJ	B-NP	Oand	CD8	and	CC	I-NP	OCD8	responses	CD8	NN	I-NP	B-proteinresponses	.	response	NNS	I-NP	O.	The	.	.	O	OThe	antigens	The	DT	B-NP	Oantigens	recognized	antigen	NNS	I-NP	Orecognized	by	recognize	VBN	B-VP	Oby	many	by	IN	B-PP	Omany	HSV-specific	many	JJ	B-NP	OHSV-specific	CD4	HSV-specific	JJ	I-NP	B-cell_typeCD4	T	CD4	NN	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	localizing	cell	NNS	I-NP	I-cell_typelocalizing	to	localize	VBG	B-VP	Oto	genital	to	TO	B-PP	Ogenital	HSV-2	genital	JJ	B-NP	OHSV-2	lesions	HSV-2	NN	I-NP	Olesions	are	lesion	NNS	I-NP	Oare	unknown	be	VBP	B-VP	Ounknown	.	unknown	JJ	B-ADJP	O.	T	.	.	O	OT	cells	T	NN	B-NP	B-cell_typecells	recognizing	cell	NNS	I-NP	I-cell_typerecognizing	antigens	recognize	VBG	B-VP	Oantigens	encoded	antigen	NNS	B-NP	Oencoded	within	encode	VBN	B-VP	Owithin	map	within	IN	B-PP	Omap	units	map	NN	B-NP	Ounits	0.67	unit	NNS	I-NP	O0.67	to	0.67	CD	B-NP	Oto	0.73	to	TO	B-PP	O0.73	of	0.73	CD	B-NP	Oof	HSV	of	IN	B-PP	OHSV	DNA	HSV	NN	B-NP	B-DNADNA	are	DNA	NN	I-NP	I-DNAare	frequently	be	VBP	B-VP	Ofrequently	recovered	frequently	RB	I-VP	Orecovered	from	recover	VBN	I-VP	Ofrom	herpetic	from	IN	B-PP	Oherpetic	lesions	herpetic	JJ	B-NP	Olesions	.	lesion	NNS	I-NP	O.	Expression	.	.	O	OExpression	cloning	Expression	NN	B-NP	Ocloning	with	cloning	NN	I-NP	Owith	this	with	IN	B-PP	Othis	region	this	DT	B-NP	Oregion	of	region	NN	I-NP	Oof	DNA	of	IN	B-PP	ODNA	now	DNA	NN	B-NP	Onow	shows	now	RB	B-ADVP	Oshows	that	show	VBZ	B-VP	Othat	tegument	that	IN	B-SBAR	Otegument	protein	tegument	NN	B-NP	B-proteinprotein	VP22	protein	NN	I-NP	I-proteinVP22	and	VP22	NN	I-NP	B-proteinand	the	and	CC	O	Othe	viral	the	DT	B-NP	Oviral	dUTPase	viral	JJ	I-NP	B-proteindUTPase	","	dUTPase	NN	I-NP	I-protein","	encoded	","	","	O	Oencoded	by	encode	VBN	B-VP	Oby	genes	by	IN	B-PP	Ogenes	UL49	gene	NNS	B-NP	OUL49	and	UL49	NN	I-NP	B-DNAand	UL50	and	CC	I-NP	OUL50	","	UL50	NN	I-NP	B-protein","	respectively	","	","	O	Orespectively	","	respectively	RB	B-ADVP	O","	are	","	","	O	Oare	T-cell	be	VBP	B-VP	OT-cell	antigens	T-cell	NN	B-NP	B-proteinantigens	.	antigen	NNS	I-NP	I-protein.	Separate	.	.	O	OSeparate	epitopes	Separate	JJ	B-NP	Oepitopes	in	epitope	NNS	I-NP	B-proteinin	VP22	in	IN	B-PP	OVP22	were	VP22	NN	B-NP	B-proteinwere	defined	be	VBD	B-VP	Odefined	for	define	VBN	I-VP	Ofor	T-cell	for	IN	B-PP	OT-cell	clones	T-cell	NN	B-NP	B-cell_lineclones	from	clone	NNS	I-NP	I-cell_linefrom	each	from	IN	B-PP	Oeach	of	each	DT	B-NP	Oof	three	of	IN	B-PP	Othree	patients	three	CD	B-NP	Opatients	.	patient	NNS	I-NP	O.	Reactivity	.	.	O	OReactivity	with	Reactivity	NN	B-NP	Owith	the	with	IN	B-PP	Othe	tegument	the	DT	B-NP	Otegument	protein	tegument	NN	I-NP	B-proteinprotein	encoded	protein	NN	I-NP	I-proteinencoded	by	encode	VBN	B-VP	Oby	UL21	by	IN	B-PP	OUL21	was	UL21	NN	B-NP	B-proteinwas	identified	be	VBD	B-VP	Oidentified	for	identify	VBN	I-VP	Ofor	an	for	IN	B-PP	Oan	additional	an	DT	B-NP	Oadditional	patient	additional	JJ	I-NP	Opatient	.	patient	NN	I-NP	O.	Three	.	.	O	OThree	new	Three	CD	B-NP	Onew	epitopes	new	JJ	I-NP	Oepitopes	were	epitope	NNS	I-NP	B-proteinwere	identified	be	VBD	B-VP	Oidentified	in	identify	VBN	I-VP	Oin	VP16	in	IN	B-PP	OVP16	","	VP16	NN	B-NP	B-protein","	a	","	","	O	Oa	tegument	a	DT	B-NP	Otegument	protein	tegument	JJ	I-NP	B-proteinprotein	associated	protein	NN	I-NP	I-proteinassociated	with	associate	VBN	B-VP	Owith	VP22	with	IN	B-PP	OVP22	.	VP22	NN	B-NP	B-protein.	Some	.	.	O	OSome	tegument-specific	Some	DT	B-NP	Otegument-specific	CD4	tegument-specific	JJ	I-NP	B-cell_lineCD4	T-cell	CD4	NN	I-NP	I-cell_lineT-cell	clones	T-cell	NN	I-NP	I-cell_lineclones	exhibited	clone	NNS	I-NP	I-cell_lineexhibited	cytotoxic	exhibit	VBD	B-VP	Ocytotoxic	activity	cytotoxic	JJ	B-NP	Oactivity	against	activity	NN	I-NP	Oagainst	HSV-infected	against	IN	B-PP	OHSV-infected	cells	HSV-infected	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	herpes	that	IN	B-SBAR	Oherpes	simplex	herpes	NN	B-NP	B-proteinsimplex	tegument	simplex	NN	I-NP	I-proteintegument	proteins	tegument	NN	I-NP	I-proteinproteins	are	protein	NNS	I-NP	I-proteinare	processed	be	VBP	B-VP	Oprocessed	for	process	VBN	I-VP	Ofor	antigen	for	IN	B-PP	Oantigen	presentation	antigen	NN	B-NP	Opresentation	in	presentation	NN	I-NP	Oin	vivo	in	FW	B-ADVP	Ovivo	and	vivo	FW	I-ADVP	Oand	are	and	CC	O	Oare	possible	be	VBP	B-VP	Opossible	candidate	possible	JJ	B-NP	Ocandidate	compounds	candidate	NN	I-NP	Ocompounds	for	compound	NNS	I-NP	Ofor	herpes	for	IN	B-PP	Oherpes	simplex	herpes	NN	B-NP	Osimplex	vaccines	simplex	NN	I-NP	Ovaccines	.	vaccine	NNS	I-NP	O.	Fibrinogen	.	.	O	OFibrinogen	activates	Fibrinogen	NN	B-NP	B-proteinactivates	NF-kappa	activate	VBZ	B-VP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	transcription	B	NN	I-NP	I-proteintranscription	factors	transcription	NN	I-NP	B-proteinfactors	in	factor	NNS	I-NP	I-proteinin	mononuclear	in	IN	B-PP	Omononuclear	phagocytes	mononuclear	JJ	B-NP	B-cell_typephagocytes	.	phagocyte	NNS	I-NP	I-cell_type.	Adhesion	.	.	O	OAdhesion	to	Adhesion	NN	B-NP	Oto	extracellular	to	TO	B-PP	Oextracellular	matrices	extracellular	JJ	B-NP	Omatrices	is	matrix	NNS	I-NP	Ois	known	be	VBZ	B-VP	Oknown	to	know	VBN	I-VP	Oto	modulate	to	TO	I-VP	Omodulate	leukocyte	modulate	VB	I-VP	Oleukocyte	activation	leukocyte	NN	B-NP	Oactivation	","	activation	NN	I-NP	O","	although	","	","	O	Oalthough	the	although	IN	B-SBAR	Othe	mechanisms	the	DT	B-NP	Omechanisms	are	mechanism	NNS	I-NP	Oare	not	be	VBP	B-VP	Onot	fully	not	RB	I-VP	Ofully	understood	fully	RB	I-VP	Ounderstood	.	understand	VBN	I-VP	O.	Mononuclear	.	.	O	OMononuclear	phagocytes	Mononuclear	JJ	B-NP	B-cell_typephagocytes	are	phagocyte	NNS	I-NP	I-cell_typeare	exposed	be	VBP	B-VP	Oexposed	to	expose	VBN	I-VP	Oto	fibrinous	to	TO	B-PP	Ofibrinous	provisional	fibrinous	JJ	B-NP	Oprovisional	matrix	provisional	JJ	I-NP	Omatrix	throughout	matrix	NN	I-NP	Othroughout	migration	throughout	IN	B-PP	Omigration	into	migration	NN	B-NP	Ointo	inflammatory	into	IN	B-PP	Oinflammatory	foci	inflammatory	JJ	B-NP	Ofoci	","	focus	NNS	I-NP	O","	so	","	","	O	Oso	this	so	RB	O	Othis	study	this	DT	B-NP	Ostudy	was	study	NN	I-NP	Owas	undertaken	be	VBD	B-VP	Oundertaken	to	undertake	VBN	I-VP	Oto	determine	to	TO	B-VP	Odetermine	whether	determine	VB	I-VP	Owhether	fibrinogen	whether	IN	B-SBAR	Ofibrinogen	triggers	fibrinogen	NN	B-NP	B-proteintriggers	activation	trigger	VBZ	B-VP	Oactivation	of	activation	NN	B-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	transcription	B	NN	I-NP	I-proteintranscription	factors	transcription	NN	I-NP	B-proteinfactors	.	factor	NNS	I-NP	I-protein.	U937	.	.	O	OU937	cells	U937	NN	B-NP	B-cell_linecells	differentiated	cell	NNS	I-NP	I-cell_linedifferentiated	with	differentiate	VBN	B-VP	Owith	PMA	with	IN	B-PP	OPMA	in	PMA	NN	B-NP	Oin	nonadherent	in	IN	B-PP	Ononadherent	culture	nonadherent	JJ	B-NP	B-cell_lineculture	were	culture	NN	I-NP	I-cell_linewere	shown	be	VBD	B-VP	Oshown	to	show	VBN	I-VP	Oto	express	to	TO	I-VP	Oexpress	two	express	VB	I-VP	Otwo	fibrinogen-binding	two	CD	B-NP	Ofibrinogen-binding	integrins	fibrinogen-binding	JJ	I-NP	B-proteinintegrins	","	integrin	NNS	I-NP	I-protein","	predominately	","	","	O	Opredominately	CD11b/CD18	predominately	RB	B-NP	OCD11b/CD18	","	CD11b/CD18	NN	I-NP	B-protein","	and	","	","	O	Oand	to	and	CC	O	Oto	a	to	TO	B-PP	Oa	lesser	a	DT	B-NP	Olesser	extent	less	JJR	I-NP	Oextent	","	extent	NN	I-NP	O","	CD11c/CD18	","	","	I-NP	OCD11c/CD18	.	CD11c/CD18	NN	I-NP	B-protein.	Cells	.	.	O	OCells	stimulated	Cell	NNS	B-NP	Ostimulated	with	stimulate	VBN	B-VP	Owith	fibrinogen	with	IN	B-PP	Ofibrinogen	(	fibrinogen	NN	B-NP	B-protein(	10-100	(	(	O	O10-100	microg/ml	10-100	CD	B-NP	Omicrog/ml	)	microg/ml	NN	I-NP	O)	/Mn2+	)	)	O	O/Mn2+	(	/Mn2+	NN	B-NP	O(	50	(	(	O	O50	microM	50	CD	B-NP	OmicroM	)	microM	NN	I-NP	O)	for	)	)	O	Ofor	2	for	IN	B-PP	O2	h	2	CD	B-NP	Oh	were	h	NN	I-NP	Owere	examined	be	VBD	B-VP	Oexamined	by	examine	VBN	I-VP	Oby	electrophoretic	by	IN	B-PP	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assay	shift	NN	I-NP	Oassay	.	assay	NN	I-NP	O.	NF-kappa	.	.	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	","	activation	NN	I-NP	O","	minimal	","	","	O	Ominimal	in	minimal	JJ	B-ADJP	Oin	unstimulated	in	IN	B-PP	Ounstimulated	cells	unstimulated	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	was	","	","	O	Owas	substantially	be	VBD	B-VP	Osubstantially	up-regulated	substantially	RB	I-VP	Oup-regulated	by	up-regulate	VBN	I-VP	Oby	fibrinogen	by	IN	B-PP	Ofibrinogen	.	fibrinogen	NN	B-NP	B-protein.	Fibrinogen	.	.	O	OFibrinogen	also	Fibrinogen	NN	B-NP	B-proteinalso	caused	also	RB	B-ADVP	Ocaused	activation	cause	VBD	B-VP	Oactivation	of	activation	NN	B-NP	Oof	AP-1	of	IN	B-PP	OAP-1	","	AP-1	NN	B-NP	B-protein","	but	","	","	O	Obut	not	but	CC	O	Onot	SP1	not	RB	O	OSP1	or	SP1	NN	B-NP	B-proteinor	cAMP	or	CC	O	OcAMP	response	cAMP	NN	B-NP	B-proteinresponse	element-binding	response	NN	I-NP	I-proteinelement-binding	protein	element-binding	JJ	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	CREB	(	(	O	I-proteinCREB	)	CREB	NN	B-NP	I-protein)	factors	)	)	O	I-proteinfactors	.	factor	NNS	B-NP	I-protein.	Blocking	.	.	O	OBlocking	mAbs	Block	VBG	B-VP	OmAbs	against	mAb	NNS	B-NP	B-proteinagainst	CD18	against	IN	B-PP	OCD18	and	CD18	NN	B-NP	B-proteinand	CD11b	and	CC	I-NP	OCD11b	abrogated	CD11b	NN	I-NP	B-proteinabrogated	fibrinogen	abrogate	VBD	B-VP	Ofibrinogen	#NAME?	fibrinogen	NN	B-NP	B-protein#NAME?	NF-kappa	#NAME?	JJ	I-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	.	activation	NN	I-NP	O.	To	.	.	O	OTo	determine	To	TO	B-VP	Odetermine	the	determine	VB	I-VP	Othe	effects	the	DT	B-NP	Oeffects	on	effect	NNS	I-NP	Oon	transcriptional	on	IN	B-PP	Otranscriptional	regulation	transcriptional	JJ	B-NP	Oregulation	","	regulation	NN	I-NP	O","	U937	","	","	O	OU937	cells	U937	NN	B-NP	B-cell_linecells	were	cell	NNS	I-NP	I-cell_linewere	transfected	be	VBD	B-VP	Otransfected	with	transfecte	VBN	I-VP	Owith	a	with	IN	B-PP	Oa	plasmid	a	DT	B-NP	Oplasmid	containing	plasmid	NN	I-NP	B-DNAcontaining	the	contain	VBG	B-VP	Othe	HIV-1	the	DT	B-NP	OHIV-1	enhancer	HIV-1	NN	I-NP	B-DNAenhancer	(	enhancer	NN	I-NP	I-DNA(	bearing	(	(	O	Obearing	two	bear	VBG	B-VP	Otwo	NF-kappa	two	CD	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-DNAB	sites	B	NN	I-NP	I-DNAsites	)	site	NNS	I-NP	I-DNA)	coupled	)	)	O	Ocoupled	to	couple	VBN	B-VP	Oto	a	to	TO	B-PP	Oa	chloramphenicol	a	DT	B-NP	Ochloramphenicol	acetyltransferase	chloramphenicol	NN	I-NP	B-DNAacetyltransferase	(	acetyltransferase	NN	I-NP	I-DNA(	CAT	(	(	O	I-DNACAT	)	CAT	NN	B-NP	I-DNA)	reporter	)	)	O	I-DNAreporter	.	reporter	NN	B-NP	I-DNA.	Cells	.	.	O	OCells	were	Cell	NNS	B-NP	Owere	subsequently	be	VBD	B-VP	Osubsequently	stimulated	subsequently	RB	I-VP	Ostimulated	with	stimulate	VBN	I-VP	Owith	1	with	IN	B-PP	O1	)	1	LS	O	O)	PMA	)	)	O	OPMA	for	PMA	NN	B-NP	Ofor	24	for	IN	B-PP	O24	h	24	CD	B-NP	Oh	","	h	NN	I-NP	O","	inducing	","	","	O	Oinducing	CAT	induce	VBG	B-VP	OCAT	activity	CAT	NN	B-NP	B-proteinactivity	by	activity	NN	I-NP	Oby	2.6-fold	by	IN	B-PP	O2.6-fold	","	2.6-fold	JJ	B-ADJP	O","	2	","	","	O	O2	)	2	LS	B-LST	O)	fibrinogen	)	)	O	Ofibrinogen	/Mn2+	fibrinogen	NN	B-NP	B-protein/Mn2+	for	/Mn2+	NN	I-NP	Ofor	2	for	IN	B-PP	O2	h	2	CD	B-NP	Oh	","	h	NN	I-NP	O","	inducing	","	","	O	Oinducing	CAT	induce	VBG	B-VP	OCAT	activity	CAT	NN	B-NP	B-proteinactivity	by	activity	NN	I-NP	Oby	3.2-fold	by	IN	B-PP	O3.2-fold	","	3.2-fold	JJ	B-ADJP	O","	or	","	","	O	Oor	3	or	CC	O	O3	)	3	LS	B-LST	O)	costimulation	)	)	O	Ocostimulation	with	costimulation	NN	B-NP	Owith	fibrinogen	with	IN	B-PP	Ofibrinogen	and	fibrinogen	NN	B-NP	B-proteinand	PMA	and	CC	I-NP	OPMA	","	PMA	NN	I-NP	O","	inducing	","	","	O	Oinducing	5.7-fold	induce	VBG	B-VP	O5.7-fold	the	5.7-fold	JJ	B-ADJP	Othe	CAT	the	DT	B-NP	OCAT	activity	CAT	NN	I-NP	B-proteinactivity	induced	activity	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	PMA	by	IN	B-PP	OPMA	alone	PMA	NN	B-NP	Oalone	.	alone	RB	B-ADVP	O.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	contact	that	IN	B-SBAR	Ocontact	with	contact	NN	B-NP	Owith	fibrinogen-derived	with	IN	B-PP	Ofibrinogen-derived	proteins	fibrinogen-derived	JJ	B-NP	B-proteinproteins	may	protein	NNS	I-NP	I-proteinmay	contribute	may	MD	B-VP	Ocontribute	to	contribute	VB	I-VP	Oto	mononuclear	to	TO	B-PP	Omononuclear	phagocyte	mononuclear	JJ	B-NP	B-cell_typephagocyte	activation	phagocyte	NN	I-NP	I-cell_typeactivation	by	activation	NN	I-NP	Oby	signaling	by	IN	B-PP	Osignaling	through	signaling	NN	B-NP	Othrough	CD11b/CD18	through	IN	B-PP	OCD11b/CD18	","	CD11b/CD18	NN	B-NP	B-protein","	resulting	","	","	O	Oresulting	in	result	VBG	B-VP	Oin	selective	in	IN	B-PP	Oselective	activation	selective	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	transcriptional	of	IN	B-PP	Otranscriptional	regulatory	transcriptional	JJ	B-NP	B-proteinregulatory	factors	regulatory	JJ	I-NP	I-proteinfactors	","	factor	NNS	I-NP	I-protein","	including	","	","	O	Oincluding	NF-kappa	include	VBG	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	.	B	NN	I-NP	I-protein.	Peripheral	.	.	O	OPeripheral	blood	Peripheral	JJ	B-NP	B-cell_typeblood	T	blood	NN	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	monocytes	and	CC	O	Omonocytes	and	monocyte	NNS	B-NP	B-cell_typeand	B	and	CC	O	OB	cell	B	NN	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	derived	line	NNS	I-NP	I-cell_linederived	from	derive	VBN	B-VP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	lupus	with	IN	B-PP	Olupus	express	lupus	NN	B-NP	Oexpress	estrogen	express	VBP	B-VP	Oestrogen	receptor	estrogen	NN	B-NP	B-RNAreceptor	transcripts	receptor	NN	I-NP	I-RNAtranscripts	similar	transcript	NNS	I-NP	I-RNAsimilar	to	similar	JJ	B-ADJP	Oto	those	to	TO	B-PP	Othose	of	those	DT	B-NP	Oof	normal	of	IN	B-PP	Onormal	cells	normal	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	OBJECTIVE	.	.	O	OOBJECTIVE	:	OBJECTIVE	NN	B-NP	O:	To	:	:	O	OTo	identify	To	TO	B-VP	Oidentify	and	identify	VB	I-VP	Oand	characterize	and	CC	I-VP	Ocharacterize	estrogen	characterize	VB	I-VP	Oestrogen	receptor	estrogen	NN	B-NP	B-RNAreceptor	(	receptor	NN	I-NP	I-RNA(	ER	(	(	O	I-RNAER	)	ER	NN	B-NP	I-RNA)	transcripts	)	)	O	I-RNAtranscripts	expressed	transcript	NNS	B-NP	I-RNAexpressed	in	express	VBN	B-VP	Oin	immune	in	IN	B-PP	Oimmune	cells	immune	JJ	B-NP	B-cell_typecells	of	cell	NNS	I-NP	I-cell_typeof	patients	of	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	systemic	with	IN	B-PP	Osystemic	lupus	systemic	JJ	B-NP	Olupus	erythematosus	lupus	NN	I-NP	Oerythematosus	(	erythematosus	NN	I-NP	O(	SLE	(	(	O	OSLE	)	SLE	NN	B-NP	O)	and	)	)	O	Oand	healthy	and	CC	O	Ohealthy	donors	healthy	JJ	B-NP	Odonors	.	donor	NNS	I-NP	O.	METHODS	.	.	O	OMETHODS	:	METHODS	NNS	B-NP	O:	Peripheral	:	:	O	OPeripheral	blood	Peripheral	JJ	B-NP	B-cell_typeblood	monocytes	blood	NN	I-NP	I-cell_typemonocytes	and	monocyte	NNS	I-NP	I-cell_typeand	T	and	CC	O	OT	cells	T	NN	B-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	prepared	be	VBD	B-VP	Oprepared	from	prepare	VBN	I-VP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	SLE	with	IN	B-PP	OSLE	(	SLE	NN	B-NP	O(	n	(	(	O	On	=	n	NN	B-NP	O=	6	=	SYM	B-VP	O6	)	6	CD	B-NP	O)	and	)	)	O	Oand	healthy	and	CC	O	Ohealthy	donors	healthy	JJ	B-NP	Odonors	(	donor	NNS	I-NP	O(	n	(	(	O	On	=	n	NN	B-NP	O=	8	=	SYM	B-VP	O8	)	8	CD	B-NP	O)	.	)	)	O	O.	T	.	.	O	OT	cells	T	NN	B-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	separated	be	VBD	B-VP	Oseparated	into	separate	VBN	I-VP	Ointo	CD4	into	IN	B-PP	OCD4	and	CD4	NN	B-NP	B-proteinand	CD8	and	CC	I-NP	OCD8	.	CD8	NN	I-NP	B-protein.	Some	.	.	O	OSome	monocytes	Some	DT	B-NP	Omonocytes	and	monocyte	NNS	B-NP	B-cell_typeand	T	and	CC	O	OT	cells	T	NN	B-NP	B-cell_typecells	were	cell	NNS	B-NP	I-cell_typewere	stimulated	be	VBD	B-VP	Ostimulated	with	stimulate	VBN	I-VP	Owith	estradiol	with	IN	B-PP	Oestradiol	","	estradiol	NN	B-NP	O","	PMA	","	","	O	OPMA	","	PMA	NN	B-NP	O","	and	","	","	O	Oand	ionomycin	and	CC	O	Oionomycin	.	ionomycin	NN	B-NP	O.	Epstein-Barr	.	.	O	OEpstein-Barr	virus-transformed	Epstein-Barr	JJ	B-NP	B-cell_linevirus-transformed	B	virus-transformed	JJ	I-NP	I-cell_lineB	cell	B	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	(	line	NNS	I-NP	I-cell_line(	n	(	(	O	On	=	n	NN	B-NP	O=	7	=	SYM	B-VP	O7	)	7	CD	B-NP	O)	and	)	)	O	Oand	B	and	CC	O	OB	cell	B	NN	B-NP	B-cell_linecell	hybridomas	cell	NN	I-NP	I-cell_linehybridomas	(	hybridoma	NNS	I-NP	I-cell_line(	n	(	(	O	On	=	n	NN	B-NP	O=	2	=	SYM	B-VP	O2	)	2	CD	B-NP	O)	established	)	)	O	Oestablished	from	establish	VBN	B-VP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	SLE	with	IN	B-PP	OSLE	and	SLE	NN	B-NP	Oand	a	and	CC	O	Oa	healthy	a	DT	B-NP	Ohealthy	individual	healthy	JJ	I-NP	Oindividual	were	individual	NN	I-NP	Owere	used	be	VBD	B-VP	Oused	as	use	VBN	I-VP	Oas	a	as	IN	B-PP	Oa	B	a	DT	B-NP	OB	cell	B	NN	I-NP	Ocell	source	cell	NN	I-NP	Osource	.	source	NN	I-NP	O.	These	.	.	O	OThese	cells	These	DT	B-NP	Ocells	were	cell	NNS	I-NP	Owere	examined	be	VBD	B-VP	Oexamined	for	examine	VBN	I-VP	Ofor	ER	for	IN	B-PP	OER	mRNA	ER	NN	B-NP	B-RNAmRNA	by	mRNA	NN	I-NP	I-RNAby	reverse	by	IN	B-PP	Oreverse	transcription	reverse	JJ	B-NP	Otranscription	nested	transcription	NN	I-NP	Onested	polymerase	nest	VBD	B-VP	Opolymerase	chain	polymerase	NN	B-NP	Ochain	reaction	chain	NN	I-NP	Oreaction	.	reaction	NN	I-NP	O.	Amplified	.	.	O	OAmplified	cDNA	Amplify	VBN	B-NP	OcDNA	were	cDNA	NN	I-NP	B-DNAwere	sequenced	be	VBD	B-VP	Osequenced	by	sequence	VBN	I-VP	Oby	standard	by	IN	B-PP	Ostandard	methods	standard	JJ	B-NP	Omethods	.	method	NNS	I-NP	O.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	In	:	:	O	OIn	all	In	IN	B-PP	Oall	cells	all	DT	B-NP	Ocells	tested	cell	NNS	I-NP	Otested	","	test	VBN	B-VP	O","	ER	","	","	O	OER	mRNA	ER	NN	B-NP	B-RNAmRNA	was	mRNA	NN	I-NP	I-RNAwas	expressed	be	VBD	B-VP	Oexpressed	without	express	VBN	I-VP	Owithout	prior	without	IN	B-PP	Oprior	in	prior	JJ	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	stimulation	vitro	FW	I-NP	Ostimulation	.	stimulation	NN	I-NP	O.	Partial	.	.	O	OPartial	sequences	Partial	JJ	B-NP	Osequences	from	sequence	NNS	I-NP	Ofrom	exons	from	IN	B-PP	Oexons	8-Jan	exon	NNS	B-NP	B-DNA8-Jan	were	8-Jan	CD	B-NP	I-DNAwere	nearly	be	VBD	B-VP	Onearly	identical	nearly	RB	B-ADJP	Oidentical	to	identical	JJ	I-ADJP	Oto	the	to	TO	B-PP	Othe	published	the	DT	B-NP	Opublished	sequence	publish	VBN	I-NP	Osequence	of	sequence	NN	I-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	ER	human	JJ	I-NP	B-RNAER	mRNA	ER	NN	I-NP	I-RNAmRNA	.	mRNA	NN	I-NP	I-RNA.	There	.	.	O	OThere	were	There	EX	B-NP	Owere	no	be	VBD	B-VP	Ono	notable	no	DT	B-NP	Onotable	differences	notable	JJ	I-NP	Odifferences	in	difference	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	ER	the	DT	B-NP	OER	transcripts	ER	NN	I-NP	B-RNAtranscripts	between	transcript	NNS	I-NP	I-RNAbetween	patients	between	IN	B-PP	Opatients	and	patient	NNS	B-NP	Oand	healthy	and	CC	O	Ohealthy	controls	healthy	JJ	B-NP	Ocontrols	.	control	NNS	I-NP	O.	Variant	.	.	O	OVariant	receptor	Variant	JJ	B-NP	Oreceptor	transcripts	receptor	NN	I-NP	Otranscripts	lacking	transcript	NNS	I-NP	Olacking	exon	lack	VBG	B-VP	Oexon	5	exon	NN	B-NP	B-DNA5	or	5	CD	I-NP	I-DNAor	exon	or	CC	O	Oexon	7	exon	NN	B-NP	B-DNA7	","	7	CD	I-NP	I-DNA","	which	","	","	O	Owhich	encodes	which	WDT	B-NP	Oencodes	the	encode	VBZ	B-VP	Othe	hormone	the	DT	B-NP	Ohormone	binding	hormone	NN	I-NP	B-proteinbinding	domain	binding	NN	I-NP	I-proteindomain	","	domain	NN	I-NP	I-protein","	were	","	","	O	Owere	identified	be	VBD	B-VP	Oidentified	in	identify	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	majority	the	DT	B-NP	Omajority	of	majority	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cells	the	DT	B-NP	Ocells	.	cell	NNS	I-NP	O.	Precise	.	.	O	OPrecise	deletion	Precise	JJ	B-NP	Odeletion	of	deletion	NN	I-NP	Oof	the	of	IN	B-PP	Othe	exons	the	DT	B-NP	Oexons	suggests	exon	NNS	I-NP	B-DNAsuggests	that	suggest	VBZ	B-VP	Othat	they	that	IN	B-SBAR	Othey	are	they	PRP	B-NP	Oare	alternatively	be	VBP	B-VP	Oalternatively	spliced	alternatively	RB	I-VP	B-RNAspliced	transcripts	splice	VBN	I-VP	I-RNAtranscripts	.	transcript	NNS	B-NP	I-RNA.	Whether	.	.	O	OWhether	the	Whether	IN	B-SBAR	Othe	detected	the	DT	B-NP	Odetected	transcripts	detect	VBN	I-NP	Otranscripts	are	transcript	NNS	I-NP	Oare	translated	be	VBP	B-VP	Otranslated	into	translate	VBN	I-VP	Ointo	functional	into	IN	B-PP	Ofunctional	receptor	functional	JJ	B-NP	Oreceptor	proteins	receptor	NN	I-NP	B-proteinproteins	remains	protein	NNS	I-NP	I-proteinremains	to	remain	VBZ	B-VP	Oto	be	to	TO	I-VP	Obe	determined	be	VB	I-VP	Odetermined	.	determine	VBN	I-VP	O.	In	.	.	O	OIn	vitro	In	FW	B-NP	Ovitro	stimulation	vitro	FW	I-NP	Ostimulation	did	stimulation	NN	I-NP	Odid	not	do	VBD	B-VP	Onot	affect	not	RB	I-VP	Oaffect	ER	affect	VB	I-VP	OER	mRNA	ER	NN	B-NP	B-RNAmRNA	expression	mRNA	NN	I-NP	I-RNAexpression	.	expression	NN	I-NP	O.	The	.	.	O	OThe	presence	The	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	variants	of	IN	B-PP	Ovariants	did	variant	NNS	B-NP	Odid	not	do	VBD	B-VP	Onot	correlate	not	RB	I-VP	Ocorrelate	with	correlate	VB	I-VP	Owith	disease	with	IN	B-PP	Odisease	activity	disease	NN	B-NP	Oactivity	or	activity	NN	I-NP	Oor	medication	or	CC	I-NP	Omedication	.	medication	NN	I-NP	O.	CONCLUSION	.	.	O	OCONCLUSION	:	CONCLUSION	NN	B-NP	O:	Monocytes	:	:	O	OMonocytes	","	Monocyte	NNS	B-NP	B-cell_type","	T	","	","	O	OT	cells	T	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	B	and	CC	O	OB	cells	B	NN	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	patients	in	IN	B-PP	Opatients	express	patient	NNS	B-NP	Oexpress	transcripts	express	VBP	B-VP	Otranscripts	of	transcript	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	normal	the	DT	B-NP	Onormal	wild	normal	JJ	I-NP	Owild	type	wild	JJ	I-NP	B-proteintype	ER	type	NN	I-NP	I-proteinER	and	ER	NN	I-NP	I-proteinand	the	and	CC	O	Othe	hormone	the	DT	B-NP	Ohormone	binding	hormone	NN	I-NP	B-proteinbinding	domain	binding	NN	I-NP	I-proteindomain	variants	domain	NN	I-NP	I-proteinvariants	in	variant	NNS	I-NP	I-proteinin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	DNA	.	.	O	ODNA	damaging	DNA	NN	B-NP	Odamaging	agents	damaging	NN	I-NP	Oagents	induce	agent	NNS	I-NP	Oinduce	expression	induce	VBP	B-VP	Oexpression	of	expression	NN	B-NP	Oof	Fas	of	IN	B-PP	OFas	ligand	Fas	NN	B-NP	B-proteinligand	and	ligand	NN	I-NP	I-proteinand	subsequent	and	CC	O	Osubsequent	apoptosis	subsequent	JJ	B-NP	Oapoptosis	in	apoptosis	NN	I-NP	Oin	T	in	IN	B-PP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	via	lymphocyte	NNS	I-NP	I-cell_typevia	the	via	IN	B-PP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	and	B	NN	I-NP	I-proteinand	AP-1	and	CC	O	OAP-1	.	AP-1	NN	B-NP	B-protein.	Apoptosis	.	.	O	OApoptosis	induced	Apoptosis	NN	B-NP	Oinduced	by	induce	VBN	B-VP	Oby	DNA	by	IN	B-PP	ODNA	damage	DNA	NN	B-NP	Odamage	and	damage	NN	I-NP	Oand	other	and	CC	O	Oother	stresses	other	JJ	B-NP	Ostresses	can	stress	NNS	I-NP	Ocan	proceed	can	MD	B-VP	Oproceed	via	proceed	VB	I-VP	Ovia	expression	via	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	Fas	of	IN	B-PP	OFas	ligand	Fas	NN	B-NP	B-proteinligand	(	ligand	NN	I-NP	I-protein(	FasL	(	(	O	OFasL	)	FasL	NN	B-NP	B-protein)	and	)	)	O	Oand	ligation	and	CC	O	Oligation	of	ligation	NN	B-NP	Oof	its	of	IN	B-PP	Oits	receptor	its	PRP$	B-NP	Oreceptor	","	receptor	NN	I-NP	O","	Fas	","	","	O	OFas	(	Fas	NN	B-NP	B-protein(	CD95	(	(	O	OCD95	)	CD95	NN	B-NP	B-protein)	.	)	)	O	O.	We	.	.	O	OWe	report	We	PRP	B-NP	Oreport	that	report	VBP	B-VP	Othat	activation	that	IN	B-SBAR	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	two	the	DT	B-NP	Otwo	transcription	two	CD	I-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	NF-kappa	factor	NNS	I-NP	I-proteinNF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	and	B	NN	I-NP	I-proteinand	AP-1	and	CC	O	OAP-1	is	AP-1	NN	B-NP	B-proteinis	crucially	be	VBZ	B-VP	Ocrucially	involved	crucially	RB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	FasL	in	IN	B-PP	OFasL	expression	FasL	NN	B-NP	B-proteinexpression	induced	expression	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	etoposide	by	IN	B-PP	Oetoposide	","	etoposide	NN	B-NP	O","	teniposide	","	","	O	Oteniposide	","	teniposide	NN	B-NP	O","	and	","	","	O	Oand	UV	and	CC	O	OUV	irradiation	UV	NN	B-NP	Oirradiation	.	irradiation	NN	I-NP	O.	A	.	.	O	OA	nondegradable	A	DT	B-NP	Onondegradable	mutant	nondegradable	JJ	I-NP	Omutant	of	mutant	NN	I-NP	Oof	I	of	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	blocked	B	NN	I-NP	I-proteinblocked	both	block	VBD	B-VP	Oboth	FasL	both	CC	O	OFasL	expression	FasL	NN	B-NP	B-proteinexpression	and	expression	NN	B-NP	Oand	apoptosis	and	CC	O	Oapoptosis	induced	apoptosis	NN	B-NP	Oinduced	by	induce	VBN	B-VP	Oby	DNA	by	IN	B-PP	ODNA	damage	DNA	NN	B-NP	Odamage	but	damage	NN	I-NP	Obut	not	but	CC	B-NP	Onot	Fas	not	RB	I-NP	OFas	ligation	Fas	NN	B-NP	B-proteinligation	.	ligation	NN	I-NP	O.	These	.	.	O	OThese	stimuli	These	DT	B-NP	Ostimuli	also	stimulus	NNS	I-NP	Oalso	induced	also	RB	B-ADVP	Oinduced	the	induce	VBD	B-VP	Othe	stress-activated	the	DT	B-NP	Ostress-activated	kinase	stress-activated	JJ	I-NP	B-proteinkinase	pathway	kinase	NN	I-NP	I-proteinpathway	(	pathway	NN	I-NP	O(	SAPK/JNK	(	(	O	OSAPK/JNK	)	SAPK/JNK	NN	B-NP	B-protein)	","	)	)	O	O","	which	","	","	O	Owhich	was	which	WDT	B-NP	Owas	required	be	VBD	B-VP	Orequired	for	require	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	maximal	the	DT	B-NP	Omaximal	induction	maximal	JJ	I-NP	Oinduction	of	induction	NN	I-NP	Oof	apoptosis	of	IN	B-PP	Oapoptosis	.	apoptosis	NN	B-NP	O.	A	.	.	O	OA	1.2	A	DT	B-NP	O1.2	kb	1.2	CD	I-NP	Okb	FasL	kb	NN	I-NP	OFasL	promoter	FasL	NN	I-NP	B-DNApromoter	responded	promoter	NN	I-NP	I-DNAresponded	to	respond	VBD	B-VP	Oto	DNA	to	TO	B-PP	ODNA	damage	DNA	NN	B-NP	Odamage	","	damage	NN	I-NP	O","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	coexpression	as	IN	I-CONJP	Ocoexpression	with	coexpression	NN	B-NP	Owith	p65	with	IN	B-PP	Op65	Rel	p65	NN	B-NP	B-proteinRel	or	Rel	NN	I-NP	I-proteinor	Fos/Jun	or	CC	I-NP	OFos/Jun	.	Fos/Jun	NN	I-NP	B-protein.	Mutations	.	.	O	OMutations	in	Mutation	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	relevant	the	DT	B-NP	Orelevant	NF-kappa	relevant	JJ	I-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	and	B	NN	I-NP	I-proteinand	AP-1	and	CC	O	OAP-1	binding	AP-1	NN	B-NP	B-DNAbinding	sites	binding	NN	B-NP	I-DNAsites	eliminated	site	NNS	I-NP	I-DNAeliminated	these	eliminate	VBD	B-VP	Othese	responses	these	DT	B-NP	Oresponses	.	response	NNS	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	activation	","	","	O	Oactivation	of	activation	NN	B-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	and	B	NN	I-NP	I-proteinand	AP-1	and	CC	O	OAP-1	contributes	AP-1	NN	B-NP	B-proteincontributes	to	contribute	VBZ	B-VP	Oto	stress-induced	to	TO	B-PP	Ostress-induced	apoptosis	stress-induced	JJ	B-NP	Oapoptosis	via	apoptosis	NN	I-NP	Ovia	the	via	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	FasL	of	IN	B-PP	OFasL	.	FasL	NN	B-NP	B-protein.	A	.	.	O	OA	small	A	DT	B-NP	Osmall	","	small	JJ	I-NP	O","	nonpeptidyl	","	","	I-NP	Ononpeptidyl	mimic	nonpeptidyl	JJ	I-NP	Omimic	of	mimic	NN	I-NP	Oof	granulocyte-colony-stimulating	of	IN	B-PP	Ogranulocyte-colony-stimulating	factor	granulocyte-colony-stimulating	JJ	B-NP	B-proteinfactor	[	factor	NN	I-NP	I-protein[	see	[	(	O	Osee	commetns	see	VB	B-VP	Ocommetns	]	commetn	NNS	B-NP	O]	A	]	)	O	OA	nonpeptidyl	A	DT	B-NP	Ononpeptidyl	small	nonpeptidyl	JJ	I-NP	Osmall	molecule	small	JJ	I-NP	Omolecule	SB	molecule	NN	I-NP	OSB	247464	SB	NN	I-NP	O247464	","	247464	CD	I-NP	O","	capable	","	","	O	Ocapable	of	capable	JJ	B-ADJP	Oof	activating	of	IN	B-PP	Oactivating	granulocyte-colony-stimulating	activate	VBG	B-VP	Ogranulocyte-colony-stimulating	factor	granulocyte-colony-stimulating	JJ	B-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	G-CSF	(	(	O	OG-CSF	)	G-CSF	NN	B-NP	B-protein)	signal	)	)	O	Osignal	transduction	signal	NN	B-NP	Otransduction	pathways	transduction	NN	I-NP	Opathways	","	pathway	NNS	I-NP	O","	was	","	","	O	Owas	identified	be	VBD	B-VP	Oidentified	in	identify	VBN	I-VP	Oin	a	in	IN	B-PP	Oa	high-throughput	a	DT	B-NP	Ohigh-throughput	assay	high-throughput	JJ	I-NP	Oassay	in	assay	NN	I-NP	Oin	cultured	in	IN	B-PP	Ocultured	cells	culture	VBN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Like	.	.	O	OLike	G-CSF	Like	IN	B-PP	OG-CSF	","	G-CSF	NN	B-NP	B-protein","	SB	","	","	O	OSB	247464	SB	NN	B-NP	O247464	induced	247464	CD	I-NP	Oinduced	tyrosine	induce	VBD	B-VP	Otyrosine	phosphorylation	tyrosine	NN	B-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	multiple	of	IN	B-PP	Omultiple	signaling	multiple	JJ	B-NP	B-proteinsignaling	proteins	signaling	NN	I-NP	I-proteinproteins	and	protein	NNS	I-NP	I-proteinand	stimulated	and	CC	O	Ostimulated	primary	stimulate	VBN	B-VP	Oprimary	murine	primary	JJ	B-NP	B-cell_typemurine	bone	murine	JJ	I-NP	I-cell_typebone	marrow	bone	NN	I-NP	I-cell_typemarrow	cells	marrow	NN	I-NP	I-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	form	to	TO	B-VP	Oform	granulocytic	form	VB	I-VP	Ogranulocytic	colonies	granulocytic	JJ	B-NP	B-cell_typecolonies	in	colony	NNS	I-NP	I-cell_typein	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	It	.	.	O	OIt	also	It	PRP	B-NP	Oalso	elevated	also	RB	B-ADVP	Oelevated	peripheral	elevate	VBD	B-VP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	neutrophil	blood	NN	I-NP	I-cell_typeneutrophil	counts	neutrophil	NN	I-NP	I-cell_typecounts	in	count	NNS	I-NP	Oin	mice	in	IN	B-PP	Omice	.	mouse	NNS	B-NP	O.	The	.	.	O	OThe	extracellular	The	DT	B-NP	Oextracellular	domain	extracellular	JJ	I-NP	B-proteindomain	of	domain	NN	I-NP	I-proteinof	the	of	IN	B-PP	Othe	murine	the	DT	B-NP	Omurine	G-CSF	murine	JJ	I-NP	B-proteinG-CSF	receptor	G-CSF	NN	I-NP	I-proteinreceptor	was	receptor	NN	I-NP	I-proteinwas	required	be	VBD	B-VP	Orequired	for	require	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	SB	of	IN	B-PP	OSB	247464	SB	NN	B-NP	O247464	","	247464	CD	I-NP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	the	that	IN	B-SBAR	Othe	compound	the	DT	B-NP	Ocompound	acts	compound	NN	I-NP	Oacts	by	act	VBZ	B-VP	Oby	oligomerizing	by	IN	B-PP	Ooligomerizing	receptor	oligomerize	VBG	B-VP	B-proteinreceptor	chains	receptor	NN	B-NP	I-proteinchains	.	chain	NNS	I-NP	I-protein.	The	.	.	O	OThe	results	The	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	a	that	IN	B-SBAR	Oa	small	a	DT	B-NP	Osmall	molecule	small	JJ	I-NP	Omolecule	can	molecule	NN	I-NP	Ocan	activate	can	MD	B-VP	Oactivate	a	activate	VB	I-VP	Oa	receptor	a	DT	B-NP	Oreceptor	that	receptor	NN	I-NP	Othat	normally	that	WDT	B-NP	Onormally	binds	normally	RB	B-ADVP	Obinds	a	bind	VBZ	B-VP	Oa	relatively	a	DT	B-NP	Orelatively	large	relatively	RB	I-NP	Olarge	protein	large	JJ	I-NP	Oprotein	ligand	protein	NN	I-NP	Oligand	.	ligand	NN	I-NP	O.	Minimal	.	.	O	OMinimal	residual	Minimal	JJ	B-NP	Oresidual	disease	residual	JJ	I-NP	Odisease	in	disease	NN	I-NP	Oin	acute	in	IN	B-PP	Oacute	myelogenous	acute	JJ	B-NP	Omyelogenous	leukemia	myelogenous	JJ	I-NP	Oleukemia	with	leukemia	NN	I-NP	Owith	PML/RAR	with	IN	B-PP	OPML/RAR	alpha	PML/RAR	NN	B-NP	B-proteinalpha	or	alpha	NN	I-NP	I-proteinor	AML1/ETO	or	CC	O	OAML1/ETO	mRNA	AML1/ETO	NN	B-NP	B-RNAmRNA	and	mRNA	NN	I-NP	I-RNAand	phenotypic	and	CC	O	Ophenotypic	analysis	phenotypic	JJ	B-NP	Oanalysis	of	analysis	NN	I-NP	Oof	possible	of	IN	B-PP	Opossible	T	possible	JJ	B-NP	OT	and	T	NN	I-NP	Oand	natural	and	CC	I-NP	Onatural	killer	natural	JJ	I-NP	B-cell_typekiller	cells	killer	NN	I-NP	I-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	bone	in	IN	B-PP	Obone	marrow	bone	NN	B-NP	Omarrow	.	marrow	NN	I-NP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	studied	we	PRP	B-NP	Ostudied	minimal	study	VBD	B-VP	Ominimal	residual	minimal	JJ	B-NP	Oresidual	disease	residual	JJ	I-NP	Odisease	(	disease	NN	I-NP	O(	MRD	(	(	O	OMRD	)	MRD	NN	B-NP	O)	of	)	)	O	Oof	patients	of	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	acute	with	IN	B-PP	Oacute	myeloid	acute	JJ	B-NP	Omyeloid	leukemia	myeloid	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	AML	(	(	O	OAML	)	AML	NN	B-NP	O)	who	)	)	O	Owho	have	who	WP	B-NP	Ohave	PML/RAR	have	VBP	B-VP	OPML/RAR	alpha	PML/RAR	NN	B-NP	B-proteinalpha	or	alpha	NN	I-NP	I-proteinor	AML1/ETO	or	CC	I-NP	OAML1/ETO	as	AML1/ETO	NN	I-NP	B-proteinas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	the	as	IN	I-CONJP	Othe	phenotypic	the	DT	B-NP	Ophenotypic	analysis	phenotypic	JJ	I-NP	Oanalysis	of	analysis	NN	I-NP	Oof	lymphocyte	of	IN	B-PP	Olymphocyte	subsets	lymphocyte	NN	B-NP	B-cell_typesubsets	involved	subset	NNS	I-NP	I-cell_typeinvolved	in	involve	VBN	B-VP	Oin	antitumor	in	IN	B-PP	Oantitumor	immunity	antitumor	NN	B-NP	Oimmunity	.	immunity	NN	I-NP	O.	Eight	.	.	O	OEight	patients	Eight	CD	B-NP	Opatients	in	patient	NNS	I-NP	Oin	long-term	in	IN	B-PP	Olong-term	(	long-term	JJ	O	O(	LT	(	(	O	OLT	;	LT	JJ	B-ADJP	O;	3	;	:	O	O3	to	3	CD	B-NP	Oto	15	to	TO	I-NP	O15	years	15	CD	I-NP	Oyears	)	year	NNS	I-NP	O)	and	)	)	O	Oand	15	and	CC	O	O15	patients	15	CD	B-NP	Opatients	in	patient	NNS	I-NP	Oin	short-term	in	IN	B-PP	Oshort-term	(	short-term	JJ	O	O(	ST	(	(	O	OST	;	ST	JJ	B-ADJP	O;	up	;	:	O	Oup	to	up	RB	B-NP	Oto	3	to	TO	I-NP	O3	years	3	CD	I-NP	Oyears	)	year	NNS	I-NP	O)	remission	)	)	O	Oremission	were	remission	NN	B-NP	Owere	studied	be	VBD	B-VP	Ostudied	.	study	VBN	I-VP	O.	Using	.	.	O	OUsing	the	Use	VBG	B-VP	Othe	reverse	the	DT	B-NP	Oreverse	transcription-polymerase	reverse	JJ	I-NP	Otranscription-polymerase	chain	transcription-polymerase	NN	I-NP	Ochain	reaction	chain	NN	I-NP	Oreaction	(	reaction	NN	I-NP	O(	RT	(	(	O	ORT	)	RT	NN	B-NP	O)	assay	)	)	O	Oassay	","	assay	NN	B-NP	O","	the	","	","	O	Othe	limit	the	DT	B-NP	Olimit	of	limit	NN	I-NP	Oof	detection	of	IN	B-PP	Odetection	was	detection	NN	B-NP	Owas	10	be	VBD	B-VP	O10	(	10	CD	B-NP	O(	-5	(	(	O	O-5	)	-5	CD	B-NP	O)	to	)	)	O	Oto	10	to	TO	B-PP	O10	(	10	CD	B-NP	O(	-6	(	(	O	O-6	)	-6	CD	B-NP	O)	for	)	)	O	Ofor	PML/RAR	for	IN	B-PP	OPML/RAR	alpha	PML/RAR	NN	B-NP	B-RNAalpha	transcript	alpha	NN	I-NP	I-RNAtranscript	and	transcript	NN	I-NP	I-RNAand	10	and	CC	O	O10	(	10	CD	B-NP	O(	-4	(	(	O	O-4	)	-4	CD	B-NP	O)	to	)	)	O	Oto	10	to	TO	B-PP	O10	(	10	CD	B-NP	O(	-5	(	(	O	O-5	)	-5	CD	B-NP	O)	for	)	)	O	Ofor	the	for	IN	B-PP	Othe	AML1/ETO	the	DT	B-NP	OAML1/ETO	transcript	AML1/ETO	NN	I-NP	B-RNAtranscript	.	transcript	NN	I-NP	I-RNA.	Simultaneously	.	.	O	OSimultaneously	","	Simultaneously	RB	B-ADVP	O","	T	","	","	O	OT	lymphocyte	T	NN	B-NP	B-cell_typelymphocyte	subsets	lymphocyte	NN	I-NP	I-cell_typesubsets	and	subset	NNS	I-NP	I-cell_typeand	NK	and	CC	O	ONK	cells	NK	NN	B-NP	B-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	the	from	IN	B-PP	Othe	peripheral	the	DT	B-NP	Operipheral	blood	peripheral	JJ	I-NP	Oblood	(	blood	NN	I-NP	O(	PB	(	(	O	OPB	)	PB	NN	B-NP	O)	and	)	)	O	Oand	bone	and	CC	O	Obone	marrow	bone	NN	B-NP	Omarrow	(	marrow	NN	I-NP	O(	BM	(	(	O	OBM	)	BM	NN	B-NP	O)	were	)	)	O	Owere	investigated	be	VBD	B-VP	Oinvestigated	by	investigate	VBN	I-VP	Oby	flow	by	IN	B-PP	Oflow	cytometric	flow	NN	B-NP	Ocytometric	analysis	cytometric	JJ	I-NP	Oanalysis	.	analysis	NN	I-NP	O.	Four	.	.	O	OFour	of	Four	CD	B-NP	Oof	the	of	IN	B-PP	Othe	eight	the	DT	B-NP	Oeight	patients	eight	CD	I-NP	Opatients	in	patient	NNS	I-NP	Oin	LT	in	IN	B-PP	OLT	and	LT	NN	B-NP	B-proteinand	7	and	CC	O	I-protein7	of	7	CD	B-NP	I-proteinof	the	of	IN	B-PP	Othe	15	the	DT	B-NP	O15	patients	15	CD	I-NP	Opatients	in	patient	NNS	I-NP	Oin	ST	in	IN	B-PP	OST	remission	ST	JJ	B-NP	Oremission	were	remission	NN	I-NP	Owere	MRD-positive	be	VBD	B-VP	OMRD-positive	.	MRD-positive	JJ	B-ADJP	O.	Although	.	.	O	OAlthough	all	Although	IN	B-SBAR	Oall	MRD-positive	all	DT	B-NP	OMRD-positive	patients	MRD-positive	JJ	I-NP	Opatients	in	patient	NNS	I-NP	Oin	LT	in	IN	B-PP	OLT	remission	LT	NN	B-NP	Oremission	are	remission	NN	I-NP	Oare	still	be	VBP	B-VP	Ostill	until	still	RB	B-ADVP	Ountil	now	until	IN	B-PP	Onow	event-free	now	RB	B-NP	Oevent-free	","	event-free	JJ	B-ADJP	O","	3	","	","	O	O3	of	3	CD	B-NP	Oof	the	of	IN	B-PP	Othe	7	the	DT	B-NP	O7	MRD-positive	7	CD	I-NP	OMRD-positive	(	MRD-positive	JJ	I-NP	O(	MRD+	(	(	O	OMRD+	)	MRD+	JJ	B-ADJP	O)	patients	)	)	O	Opatients	in	patient	NNS	B-NP	Oin	ST	in	IN	B-PP	OST	remission	ST	JJ	B-NP	Oremission	soon	remission	NN	I-NP	Osoon	relapsed	soon	RB	B-ADVP	Orelapsed	.	relapse	VBD	B-VP	O.	The	.	.	O	OThe	total	The	DT	B-NP	Ototal	populations	total	JJ	I-NP	Opopulations	of	population	NNS	I-NP	Oof	CD4	of	IN	B-PP	OCD4	+	CD4	NN	B-NP	B-protein+	","	+	SYM	B-NP	O","	CD8	","	","	O	OCD8	+	CD8	NN	B-NP	B-protein+	and	+	SYM	B-NP	Oand	CD56	and	CC	O	OCD56	+	CD56	NN	B-NP	B-protein+	[	+	SYM	O	O[	possible	[	(	O	Opossible	T-cell	possible	JJ	B-NP	OT-cell	and	T-cell	NN	I-NP	Oand	natural	and	CC	O	Onatural	killer	natural	JJ	B-NP	B-cell_typekiller	(	killer	NN	I-NP	I-cell_type(	T/NK	(	(	O	I-cell_typeT/NK	)	T/NK	NN	B-NP	I-cell_type)	populations	)	)	O	I-cell_typepopulations	]	population	NNS	B-NP	I-cell_type]	in	]	)	O	Oin	the	in	IN	B-PP	Othe	BM	the	DT	B-NP	OBM	of	BM	NN	I-NP	Oof	ST	of	IN	B-PP	OST	patients	ST	JJ	B-NP	Opatients	and	patient	NNS	I-NP	Oand	MRD+/LT	and	CC	O	OMRD+/LT	patients	MRD+/LT	NN	B-NP	Opatients	were	patient	NNS	I-NP	Owere	significantly	be	VBD	B-VP	Osignificantly	(	significantly	RB	B-ADVP	O(	p	(	(	O	Op	<	p	NN	B-NP	O<	0.01	<	JJR	B-NP	O0.01	)	0.01	CD	I-NP	O)	low	)	)	O	Olow	.	low	JJ	B-ADJP	O.	The	.	.	O	OThe	CD8+	The	DT	B-NP	OCD8+	CD28+	CD8+	JJ	I-NP	B-cell_typeCD28+	population	CD28+	JJ	I-NP	I-cell_typepopulation	showed	population	NN	I-NP	I-cell_typeshowed	the	show	VBD	B-VP	Othe	same	the	DT	B-NP	Osame	tendency	same	JJ	I-NP	Otendency	(	tendency	NN	I-NP	O(	p	(	(	O	Op	<	p	NN	B-NP	O<	.01-.02	<	JJR	B-NP	O.01-.02	)	.01-.02	CD	I-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	T/NK	The	DT	B-NP	OT/NK	subsets	T/NK	NN	I-NP	B-cell_typesubsets	in	subset	NNS	I-NP	I-cell_typein	the	in	IN	B-PP	Othe	BM	the	DT	B-NP	OBM	of	BM	NN	I-NP	Oof	MRD-negative	of	IN	B-PP	OMRD-negative	(	MRD-negative	JJ	O	O(	MRD-	(	(	O	OMRD-	)	MRD-	JJ	B-ADJP	O)	LT	)	)	O	OLT	(	LT	NN	B-NP	O(	MRD-/LT	(	(	O	OMRD-/LT	)	MRD-/LT	JJ	O	O)	patients	)	)	O	Opatients	showed	patient	NNS	B-NP	Oshowed	similar	show	VBD	B-VP	Osimilar	numbers	similar	JJ	B-NP	Onumbers	of	number	NNS	I-NP	Oof	cells	of	IN	B-PP	Ocells	as	cell	NNS	B-NP	Oas	normal	as	IN	B-PP	Onormal	volunteers	normal	JJ	B-NP	Ovolunteers	.	volunteer	NNS	I-NP	O.	Basically	.	.	O	OBasically	","	Basically	RB	B-ADVP	O","	the	","	","	O	Othe	total	the	DT	B-NP	Ototal	percentage	total	JJ	I-NP	Opercentage	of	percentage	NN	I-NP	Oof	the	of	IN	B-PP	Othe	CD4+	the	DT	B-NP	OCD4+	","	CD4+	JJ	I-NP	B-cell_type","	CD8+	","	","	I-NP	I-cell_typeCD8+	and	CD8+	JJ	I-NP	I-cell_typeand	CD56+	and	CC	I-NP	I-cell_typeCD56+	cell	CD56+	JJ	I-NP	I-cell_typecell	populations	cell	NN	I-NP	I-cell_typepopulations	in	population	NNS	I-NP	I-cell_typein	the	in	IN	B-PP	Othe	BM	the	DT	B-NP	OBM	was	BM	NN	I-NP	Owas	increased	be	VBD	B-VP	Oincreased	and	increase	VBN	I-VP	Oand	in	and	CC	O	Oin	the	in	IN	B-PP	Othe	following	the	DT	B-NP	Ofollowing	order	follow	VBG	I-NP	Oorder	:	order	NN	I-NP	O:	MRD-/LT	:	:	O	OMRD-/LT	patients	MRD-/LT	JJ	B-NP	Opatients	","	patient	NNS	I-NP	O","	normal	","	","	O	Onormal	volunteers	normal	JJ	B-NP	Ovolunteers	","	volunteer	NNS	I-NP	O","	MRD+/LT	","	","	O	OMRD+/LT	patients	MRD+/LT	JJ	B-NP	Opatients	and	patient	NNS	I-NP	Oand	MRD+	and	CC	O	OMRD+	or	MRD+	JJ	B-NP	Oor	-/ST	or	CC	I-NP	O-/ST	patients	-/ST	JJ	I-NP	Opatients	.	patient	NNS	I-NP	O.	The	.	.	O	OThe	percentages	The	DT	B-NP	Opercentages	of	percentage	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	T/NK-cell	the	DT	B-NP	OT/NK-cell	subsets	T/NK-cell	NN	I-NP	B-cell_typesubsets	in	subset	NNS	I-NP	I-cell_typein	the	in	IN	B-PP	Othe	PB	the	DT	B-NP	OPB	were	PB	NN	I-NP	Owere	not	be	VBD	B-VP	Onot	significantly	not	RB	B-ADJP	Osignificantly	different	significantly	RB	I-ADJP	Odifferent	among	different	JJ	I-ADJP	Oamong	these	among	IN	B-PP	Othese	groups	these	DT	B-NP	Ogroups	.	group	NNS	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	the	","	","	O	Othe	difference	the	DT	B-NP	Odifference	of	difference	NN	I-NP	Oof	the	of	IN	B-PP	Othe	possible	the	DT	B-NP	Opossible	T/NK-cell	possible	JJ	I-NP	OT/NK-cell	phenotype	T/NK-cell	NN	I-NP	Ophenotype	in	phenotype	NN	I-NP	Oin	the	in	IN	B-PP	Othe	BM	the	DT	B-NP	OBM	may	BM	NN	I-NP	Omay	strongly	may	MD	B-VP	Ostrongly	influence	strongly	RB	I-VP	Oinfluence	clinical	influence	VB	I-VP	Oclinical	and	clinical	JJ	B-NP	Oand	molecular	and	CC	I-NP	Omolecular	remission	molecular	JJ	I-NP	Oremission	.	remission	NN	I-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	still	result	NNS	I-NP	Ostill	remain	still	RB	B-ADVP	Oremain	to	remain	VBP	B-VP	Oto	be	to	TO	I-VP	Obe	confirmed	be	VB	I-VP	Oconfirmed	by	confirm	VBN	I-VP	Oby	further	by	IN	B-PP	Ofurther	studies	further	JJ	B-NP	Ostudies	of	study	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	functional	the	DT	B-NP	Ofunctional	anti-tumor	functional	JJ	I-NP	Oanti-tumor	immunity	anti-tumor	JJ	I-NP	Oimmunity	of	immunity	NN	I-NP	Oof	T/NK	of	IN	B-PP	OT/NK	cells	T/NK	NN	B-NP	B-cell_typecells	of	cell	NNS	I-NP	I-cell_typeof	AML	of	IN	B-PP	OAML	in	AML	NN	B-NP	Oin	remission	in	IN	B-PP	Oremission	.	remission	NN	B-NP	O.	Mycobacterium	.	.	O	OMycobacterium	tuberculosis	Mycobacterium	NN	B-NP	Otuberculosis	mannose-capped	tuberculosis	NN	I-NP	Omannose-capped	lipoarabinomannan	mannose-capped	JJ	I-NP	Olipoarabinomannan	can	lipoarabinomannan	NN	I-NP	Ocan	induce	can	MD	B-VP	Oinduce	NF-kappaB	induce	VB	I-VP	ONF-kappaB	#NAME?	NF-kappaB	NN	B-NP	B-protein#NAME?	activation	#NAME?	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	immunodeficiency	human	JJ	B-NP	B-DNAimmunodeficiency	virus	immunodeficiency	NN	I-NP	I-DNAvirus	type	virus	NN	I-NP	I-DNAtype	1	type	NN	I-NP	I-DNA1	long	1	CD	I-NP	I-DNAlong	terminal	long	JJ	I-NP	I-DNAterminal	repeat	terminal	JJ	I-NP	I-DNArepeat	in	repeat	NN	I-NP	I-DNAin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Tuberculosis	.	.	O	OTuberculosis	has	Tuberculosis	NN	B-NP	Ohas	emerged	have	VBZ	B-VP	Oemerged	as	emerge	VBN	I-VP	Oas	an	as	IN	B-PP	Oan	epidemic	an	DT	B-NP	Oepidemic	","	epidemic	JJ	I-NP	O","	extended	","	","	O	Oextended	by	extend	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	large	the	DT	B-NP	Olarge	number	large	JJ	I-NP	Onumber	of	number	NN	I-NP	Oof	individuals	of	IN	B-PP	Oindividuals	infected	individual	NNS	B-NP	Oinfected	with	infect	VBN	B-VP	Owith	human	with	IN	B-PP	Ohuman	immunodeficiency	human	JJ	B-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	(	1	CD	I-NP	O(	HIV-1	(	(	O	OHIV-1	)	HIV-1	NN	B-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	major	The	DT	B-NP	Omajor	goal	major	JJ	I-NP	Ogoal	of	goal	NN	I-NP	Oof	this	of	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	was	study	NN	I-NP	Owas	to	be	VBD	B-VP	Oto	determine	to	TO	B-VP	Odetermine	whether	determine	VB	I-VP	Owhether	the	whether	IN	B-SBAR	Othe	mycobacterial	the	DT	B-NP	Omycobacterial	cell	mycobacterial	JJ	I-NP	B-cell_typecell	wall	cell	NN	I-NP	I-cell_typewall	component	wall	NN	I-NP	Ocomponent	mannose-capped	component	NN	I-NP	Omannose-capped	lipoarabinomannan	mannose-capped	JJ	I-NP	Olipoarabinomannan	(	lipoarabinomannan	NN	I-NP	O(	ManLAM	(	(	O	OManLAM	)	ManLAM	NN	B-NP	O)	of	)	)	O	Oof	Mycobacterium	of	IN	B-PP	OMycobacterium	tuberculosis	Mycobacterium	NN	B-NP	Otuberculosis	(	tuberculosis	NN	I-NP	O(	M.	(	(	O	OM.	tuberculosis	M.	NN	B-NP	Otuberculosis	)	tuberculosis	NN	I-NP	O)	could	)	)	O	Ocould	activate	could	MD	B-VP	Oactivate	transcription	activate	VB	I-VP	Otranscription	of	transcription	NN	B-NP	Oof	HIV-1	of	IN	B-PP	OHIV-1	in	HIV-1	NN	B-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	with	cell	NNS	I-NP	I-cell_typewith	the	with	IN	B-PP	Othe	use	the	DT	B-NP	Ouse	of	use	NN	I-NP	Oof	an	of	IN	B-PP	Oan	in	an	DT	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	cell	vitro	FW	I-NP	Ocell	culture	cell	NN	I-NP	Oculture	system	culture	NN	I-NP	Osystem	.	system	NN	I-NP	O.	These	.	.	O	OThese	experiments	These	DT	B-NP	Oexperiments	are	experiment	NNS	I-NP	Oare	of	be	VBP	B-VP	Oof	prime	of	IN	B-PP	Oprime	importance	prime	JJ	B-NP	Oimportance	considering	importance	NN	I-NP	Oconsidering	that	consider	VBG	B-VP	Othat	CD4	that	IN	B-SBAR	OCD4	#NAME?	CD4	NN	B-NP	B-protein#NAME?	T	#NAME?	JJ	I-NP	OT	lymphocytes	T	NN	I-NP	Olymphocytes	represent	lymphocyte	NNS	I-NP	Orepresent	the	represent	VBP	B-VP	Othe	major	the	DT	B-NP	Omajor	virus	major	JJ	I-NP	Ovirus	reservoir	virus	NN	I-NP	Oreservoir	in	reservoir	NN	I-NP	Oin	the	in	IN	B-PP	Othe	peripheral	the	DT	B-NP	Operipheral	blood	peripheral	JJ	I-NP	Oblood	of	blood	NN	I-NP	Oof	infected	of	IN	B-PP	Oinfected	individuals	infected	JJ	B-NP	Oindividuals	.	individual	NNS	I-NP	O.	Using	.	.	O	OUsing	the	Use	VBG	B-VP	Othe	1G5	the	DT	B-NP	O1G5	cell	1G5	NN	I-NP	B-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	harbouring	line	NN	I-NP	I-cell_lineharbouring	the	harbour	VBG	B-VP	Othe	luciferase	the	DT	B-NP	Oluciferase	reporter	luciferase	NN	I-NP	B-DNAreporter	gene	reporter	NN	I-NP	I-DNAgene	under	gene	NN	I-NP	I-DNAunder	the	under	IN	B-PP	Othe	control	the	DT	B-NP	Ocontrol	of	control	NN	I-NP	Oof	the	of	IN	B-PP	Othe	HIV-1	the	DT	B-NP	OHIV-1	LTR	HIV-1	NN	I-NP	B-DNALTR	","	LTR	NN	I-NP	I-DNA","	it	","	","	O	Oit	was	it	PRP	B-NP	Owas	first	be	VBD	B-VP	Ofirst	found	first	RB	I-VP	Ofound	that	find	VBN	I-VP	Othat	culture	that	IN	B-SBAR	Oculture	protein	culture	NN	B-NP	Oprotein	filtrates	protein	NN	I-NP	Ofiltrates	(	filtrate	NNS	I-NP	O(	CFP	(	(	O	OCFP	)	CFP	NN	B-NP	O)	from	)	)	O	Ofrom	M.	from	IN	B-PP	OM.	tuberculosis	M.	FW	B-NP	Otuberculosis	or	tuberculosis	FW	I-NP	Oor	purified	or	CC	O	Opurified	ManLAM	purify	VBN	B-NP	OManLAM	could	ManLAM	NN	I-NP	Ocould	activate	could	MD	B-VP	Oactivate	HIV-1	activate	VB	I-VP	OHIV-1	LTR-dependent	HIV-1	NN	B-NP	B-DNALTR-dependent	gene	LTR-dependent	JJ	I-NP	I-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	unlike	expression	NN	I-NP	Ounlike	similarly	unlike	IN	B-PP	Osimilarly	prepared	similarly	RB	B-NP	Oprepared	CFP	prepare	VBN	I-NP	OCFP	extracts	CFP	NN	I-NP	Oextracts	devoid	extract	NNS	I-NP	Odevoid	of	devoid	JJ	B-ADJP	Oof	ManLAM	of	IN	B-PP	OManLAM	.	ManLAM	NN	B-NP	O.	The	.	.	O	OThe	implication	The	DT	B-NP	Oimplication	of	implication	NN	I-NP	Oof	protein	of	IN	B-PP	Oprotein	tyrosine	protein	NN	B-NP	B-proteintyrosine	kinase	tyrosine	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	","	)	)	O	O","	protein	","	","	O	Oprotein	kinase	protein	NN	B-NP	B-proteinkinase	A	kinase	NN	I-NP	I-proteinA	and/or	A	NN	I-NP	I-proteinand/or	protein	and/or	CC	O	Oprotein	kinase	protein	NN	B-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	was	C	NN	I-NP	I-proteinwas	highlighted	be	VBD	B-VP	Ohighlighted	by	highlight	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	abrogation	the	DT	B-NP	Oabrogation	of	abrogation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	ManLAM-mediated	the	DT	B-NP	OManLAM-mediated	activation	ManLAM-mediated	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	HIV-1	of	IN	B-PP	OHIV-1	LTR-driven	HIV-1	NN	B-NP	B-DNALTR-driven	gene	LTR-driven	JJ	I-NP	I-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	using	expression	NN	I-NP	Ousing	herbimycin	use	VBG	B-VP	Oherbimycin	A	herbimycin	NN	B-NP	OA	and	A	NN	I-NP	Oand	H7	and	CC	I-NP	OH7	.	H7	NN	I-NP	B-protein.	It	.	.	O	OIt	was	It	PRP	B-NP	Owas	also	be	VBD	B-VP	Oalso	determined	also	RB	I-VP	Odetermined	","	determine	VBN	I-VP	O","	using	","	","	O	Ousing	electrophoresis	use	VBG	B-VP	Oelectrophoresis	mobility	electrophoresis	NN	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assays	shift	NN	I-NP	Oassays	","	assay	NNS	I-NP	O","	that	","	","	O	Othat	M.	that	IN	B-SBAR	OM.	tuberculosis	M.	FW	B-NP	Otuberculosis	ManLAM	tuberculosis	FW	I-NP	OManLAM	led	ManLAM	NN	I-NP	Oled	to	lead	VBD	B-VP	Oto	the	to	TO	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	translocation	nuclear	JJ	I-NP	Otranslocation	of	translocation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	NF-kappaB	factor	NN	I-NP	I-proteinNF-kappaB	.	NF-kappaB	NN	I-NP	B-protein.	M.	.	.	O	OM.	tuberculosis	M.	FW	B-NP	Otuberculosis	ManLAM	tuberculosis	FW	I-NP	OManLAM	resulted	ManLAM	NN	I-NP	Oresulted	in	result	VBD	B-VP	Oin	clear	in	IN	B-PP	Oclear	induction	clear	JJ	B-NP	Oinduction	of	induction	NN	I-NP	Oof	the	of	IN	B-PP	Othe	luciferase	the	DT	B-NP	Oluciferase	gene	luciferase	NN	I-NP	B-DNAgene	placed	gene	NN	I-NP	I-DNAplaced	under	place	VBN	B-VP	Ounder	the	under	IN	B-PP	Othe	control	the	DT	B-NP	Ocontrol	of	control	NN	I-NP	Oof	the	of	IN	B-PP	Othe	wild-type	the	DT	B-NP	Owild-type	","	wild-type	JJ	I-NP	O","	but	","	","	O	Obut	not	but	CC	O	Onot	the	not	RB	O	Othe	kappaB-mutated	the	DT	B-NP	OkappaB-mutated	","	kappaB-mutated	JJ	I-NP	O","	HIV-1	","	","	I-NP	OHIV-1	LTR	HIV-1	NN	I-NP	B-DNALTR	region	LTR	NN	I-NP	I-DNAregion	.	region	NN	I-NP	O.	Finally	.	.	O	OFinally	","	Finally	RB	B-ADVP	O","	the	","	","	O	Othe	ManLAM-mediated	the	DT	B-NP	OManLAM-mediated	activation	ManLAM-mediated	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	HIV-1	of	IN	B-PP	OHIV-1	LTR	HIV-1	NN	B-NP	B-DNALTR	transcription	LTR	NN	I-NP	I-DNAtranscription	was	transcription	NN	I-NP	Owas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	independent	be	VB	I-VP	Oindependent	of	independent	JJ	B-ADJP	Oof	the	of	IN	B-PP	Othe	autocrine	the	DT	B-NP	Oautocrine	or	autocrine	JJ	I-NP	Oor	paracrine	or	CC	I-NP	Oparacrine	action	paracrine	JJ	I-NP	Oaction	of	action	NN	I-NP	Oof	endogenous	of	IN	B-PP	Oendogenous	TNF-alpha	endogenous	JJ	B-NP	B-proteinTNF-alpha	.	TNF-alpha	NN	I-NP	I-protein.	The	.	.	O	OThe	results	The	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	M.	that	IN	B-SBAR	OM.	tuberculosis	M.	NN	B-NP	Otuberculosis	can	tuberculosis	NN	I-NP	Ocan	upregulate	can	MD	B-VP	Oupregulate	HIV-1	upregulate	VB	I-VP	OHIV-1	expression	HIV-1	NN	B-NP	Oexpression	in	expression	NN	I-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	could	and	CC	O	Ocould	thus	could	MD	B-VP	Othus	have	thus	RB	I-VP	Ohave	the	have	VB	I-VP	Othe	potential	the	DT	B-NP	Opotential	to	potential	NN	I-NP	Oto	influence	to	TO	B-VP	Oinfluence	the	influence	VB	I-VP	Othe	pathogenesis	the	DT	B-NP	Opathogenesis	of	pathogenesis	NN	I-NP	Oof	HIV-1	of	IN	B-PP	OHIV-1	infection	HIV-1	NN	B-NP	Oinfection	.	infection	NN	I-NP	O.	Human	.	.	O	OHuman	immunodeficiency	Human	JJ	B-NP	B-DNAimmunodeficiency	virus	immunodeficiency	NN	I-NP	I-DNAvirus	type	virus	NN	I-NP	I-DNAtype	1	type	NN	I-NP	I-DNA1	long	1	CD	I-NP	I-DNAlong	terminal	long	JJ	I-NP	I-DNAterminal	repeat	terminal	JJ	I-NP	I-DNArepeat	quasispecies	repeat	NN	I-NP	I-DNAquasispecies	differ	quasispecy	NNS	I-NP	I-DNAdiffer	in	differ	VBP	B-VP	Oin	basal	in	IN	B-PP	Obasal	transcription	basal	JJ	B-NP	Otranscription	and	transcription	NN	I-NP	Oand	nuclear	and	CC	O	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	recruitment	factor	NN	I-NP	I-proteinrecruitment	in	recruitment	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	glial	human	JJ	B-NP	B-cell_typeglial	cells	glial	JJ	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	lymphocytes	and	CC	O	Olymphocytes	.	lymphocyte	NNS	B-NP	B-cell_type.	The	.	.	O	OThe	generation	The	DT	B-NP	Ogeneration	of	generation	NN	I-NP	Oof	genomic	of	IN	B-PP	Ogenomic	diversity	genomic	JJ	B-NP	Odiversity	during	diversity	NN	I-NP	Oduring	the	during	IN	B-PP	Othe	course	the	DT	B-NP	Ocourse	of	course	NN	I-NP	Oof	infection	of	IN	B-PP	Oinfection	has	infection	NN	B-NP	Ohas	the	have	VBZ	B-VP	Othe	potential	the	DT	B-NP	Opotential	to	potential	NN	I-NP	Oto	affect	to	TO	B-VP	Oaffect	all	affect	VB	I-VP	Oall	aspects	all	DT	B-NP	Oaspects	of	aspect	NNS	I-NP	Oof	HIV-1	of	IN	B-PP	OHIV-1	replication	HIV-1	NN	B-NP	Oreplication	","	replication	NN	I-NP	O","	including	","	","	O	Oincluding	expression	include	VBG	B-PP	Oexpression	of	expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	proviral	the	DT	B-NP	Oproviral	genome	proviral	JJ	I-NP	B-DNAgenome	.	genome	NN	I-NP	I-DNA.	To	.	.	O	OTo	gain	To	TO	B-VP	Ogain	a	gain	VB	I-VP	Oa	better	a	DT	B-NP	Obetter	understanding	good	JJR	I-NP	Ounderstanding	of	understanding	NN	I-NP	Oof	the	of	IN	B-PP	Othe	impact	the	DT	B-NP	Oimpact	of	impact	NN	I-NP	Oof	long	of	IN	B-PP	Olong	terminal	long	JJ	B-NP	B-DNAterminal	repeat	terminal	JJ	I-NP	I-DNArepeat	(	repeat	NN	I-NP	I-DNA(	LTR	(	(	O	OLTR	)	LTR	NN	B-NP	B-DNA)	sequence	)	)	O	Osequence	diversity	sequence	NN	B-NP	Odiversity	on	diversity	NN	I-NP	Oon	LTR-directed	on	IN	B-PP	OLTR-directed	gene	LTR-directed	JJ	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	in	expression	NN	I-NP	Oin	cells	in	IN	B-PP	Ocells	of	cell	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	central	the	DT	B-NP	Ocentral	nervous	central	JJ	I-NP	Onervous	system	nervous	JJ	I-NP	Osystem	(	system	NN	I-NP	O(	CNS	(	(	O	OCNS	)	CNS	NN	B-NP	B-protein)	and	)	)	O	Oand	immune	and	CC	O	Oimmune	system	immune	JJ	B-NP	Osystem	","	system	NN	I-NP	O","	we	","	","	O	Owe	amplified	we	PRP	B-NP	Oamplified	and	amplify	VBD	B-VP	Oand	cloned	and	CC	O	Ocloned	LTRs	clone	VBN	B-NP	OLTRs	from	LTR	NNS	I-NP	B-DNAfrom	proviral	from	IN	B-PP	Oproviral	DNA	proviral	JJ	B-NP	B-DNADNA	in	DNA	NN	I-NP	I-DNAin	HIV-1-infected	in	IN	B-PP	OHIV-1-infected	peripheral	HIV-1-infected	JJ	B-NP	Operipheral	blood	peripheral	JJ	I-NP	Oblood	.	blood	NN	I-NP	O.	Sequence	.	.	O	OSequence	analysis	Sequence	NN	B-NP	Oanalysis	of	analysis	NN	I-NP	Oof	nineteen	of	IN	B-PP	Onineteen	LTRs	nineteen	CD	B-NP	OLTRs	cloned	LTR	NNS	I-NP	B-DNAcloned	from	clone	VBN	B-VP	Ofrom	2	from	IN	B-PP	O2	adult	2	CD	B-NP	Oadult	and	adult	JJ	I-NP	Oand	3	and	CC	O	O3	pediatric	3	CD	B-NP	Opediatric	patients	pediatric	JJ	I-NP	Opatients	revealed	patient	NNS	I-NP	Orevealed	an	reveal	VBD	B-VP	Oan	average	an	DT	B-NP	Oaverage	of	average	NN	I-NP	Oof	33	of	IN	B-PP	O33	nucleotide	33	CD	B-NP	Onucleotide	changes	nucleotide	NN	I-NP	Ochanges	(	change	NNS	I-NP	O(	with	(	(	O	Owith	respect	with	IN	B-PP	Orespect	to	respect	NN	B-NP	Oto	the	to	TO	B-PP	Othe	sequence	the	DT	B-NP	Osequence	of	sequence	NN	I-NP	Oof	the	of	IN	B-PP	Othe	LAI	the	DT	B-NP	OLAI	LTR	LAI	NN	I-NP	B-DNALTR	)	LTR	NN	I-NP	I-DNA)	within	)	)	O	Owithin	the	within	IN	B-PP	Othe	455-bp	the	DT	B-NP	O455-bp	U3	455-bp	JJ	I-NP	B-DNAU3	region	U3	NN	I-NP	I-DNAregion	.	region	NN	I-NP	I-DNA.	Transient	.	.	O	OTransient	expression	Transient	JJ	B-NP	Oexpression	analyses	expression	NN	I-NP	Oanalyses	in	analysis	NNS	I-NP	Oin	cells	in	IN	B-PP	Ocells	of	cell	NNS	B-NP	Oof	neuroglial	of	IN	B-PP	Oneuroglial	and	neuroglial	JJ	B-NP	Oand	lymphocytic	and	CC	I-NP	Olymphocytic	origin	lymphocytic	JJ	I-NP	Oorigin	demonstrated	origin	NN	I-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	some	that	IN	B-SBAR	Osome	of	some	DT	B-NP	Oof	these	of	IN	B-PP	Othese	LTRs	these	DT	B-NP	OLTRs	had	LTR	NNS	I-NP	B-DNAhad	activities	have	VBD	B-VP	Oactivities	which	activity	NNS	B-NP	Owhich	varied	which	WDT	B-NP	Ovaried	significantly	vary	VBD	B-VP	Osignificantly	from	significantly	RB	B-ADVP	Ofrom	the	from	IN	B-PP	Othe	LAI	the	DT	B-NP	OLAI	LTR	LAI	NN	I-NP	B-DNALTR	in	LTR	NN	I-NP	I-DNAin	U-373	in	IN	B-PP	OU-373	MG	U-373	NN	B-NP	B-cell_lineMG	cells	MG	NN	I-NP	I-cell_linecells	(	cell	NNS	I-NP	I-cell_line(	an	(	(	O	Oan	astrocytoma	an	DT	B-NP	Oastrocytoma	cell	astrocytoma	NN	I-NP	B-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	)	line	NN	I-NP	I-cell_line)	as	)	)	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	in	as	IN	I-CONJP	Oin	Jurkat	in	IN	B-PP	OJurkat	cells	Jurkat	NN	B-NP	B-cell_linecells	(	cell	NNS	I-NP	I-cell_line(	a	(	(	O	Oa	CD4-positive	a	DT	B-NP	OCD4-positive	lymphocyte	CD4-positive	JJ	I-NP	B-cell_linelymphocyte	cell	lymphocyte	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	)	line	NN	I-NP	I-cell_line)	.	)	)	O	O.	While	.	.	O	OWhile	LTRs	While	IN	B-SBAR	OLTRs	which	LTR	NNS	B-NP	B-DNAwhich	demonstrated	which	WDT	B-NP	Odemonstrated	the	demonstrate	VBD	B-VP	Othe	highest	the	DT	B-NP	Ohighest	activities	high	JJS	I-NP	Oactivities	in	activity	NNS	I-NP	Oin	U-373	in	IN	B-PP	OU-373	MG	U-373	NN	B-NP	B-cell_lineMG	cells	MG	NN	I-NP	I-cell_linecells	also	cell	NNS	I-NP	I-cell_linealso	yielded	also	RB	B-ADVP	Oyielded	high	yield	VBD	B-VP	Ohigh	activities	high	JJ	B-NP	Oactivities	in	activity	NNS	I-NP	Oin	Jurkat	in	IN	B-PP	OJurkat	cells	Jurkat	NN	B-NP	B-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	the	","	","	O	Othe	LTRs	the	DT	B-NP	OLTRs	were	LTR	NNS	I-NP	B-DNAwere	generally	be	VBD	B-VP	Ogenerally	more	generally	RB	B-ADJP	Omore	active	more	RBR	I-ADJP	Oactive	in	active	JJ	I-ADJP	Oin	Jurkat	in	IN	B-PP	OJurkat	cells	Jurkat	NN	B-NP	B-cell_linecells	when	cell	NNS	I-NP	I-cell_linewhen	compared	when	WRB	B-ADVP	Ocompared	to	compare	VBN	B-PP	Oto	the	to	TO	B-PP	Othe	LAI	the	DT	B-NP	OLAI	LTR	LAI	NN	I-NP	B-DNALTR	.	LTR	NN	I-NP	I-DNA.	Differences	.	.	O	ODifferences	in	Difference	NNS	B-NP	Oin	LTR	in	IN	B-PP	OLTR	sequence	LTR	NN	B-NP	B-DNAsequence	also	sequence	NN	I-NP	I-DNAalso	resulted	also	RB	B-ADVP	Oresulted	in	result	VBD	B-VP	Oin	differences	in	IN	B-PP	Odifferences	in	difference	NNS	B-NP	Oin	transcription	in	IN	B-PP	Otranscription	factor	transcription	NN	B-NP	B-proteinfactor	recruitment	factor	NN	I-NP	I-proteinrecruitment	to	recruitment	NN	I-NP	Oto	cis-acting	to	TO	B-PP	Ocis-acting	sites	cis-acting	JJ	B-NP	B-DNAsites	within	site	NNS	I-NP	I-DNAwithin	the	within	IN	B-PP	Othe	U3	the	DT	B-NP	OU3	region	U3	NN	I-NP	B-DNAregion	of	region	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	LTR	the	DT	B-NP	OLTR	","	LTR	NN	I-NP	B-DNA","	as	","	","	O	Oas	demonstrated	as	IN	B-SBAR	Odemonstrated	by	demonstrate	VBN	B-VP	Oby	electrophoretic	by	IN	B-PP	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assays	shift	NN	I-NP	Oassays	.	assay	NNS	I-NP	O.	In	.	.	O	OIn	particular	In	IN	B-PP	Oparticular	","	particular	JJ	B-NP	O","	naturally	","	","	O	Onaturally	occurring	naturally	RB	B-VP	Ooccurring	sequence	occur	VBG	I-VP	Osequence	variation	sequence	NN	B-NP	Ovariation	impacted	variation	NN	I-NP	Oimpacted	transcription	impact	VBD	B-VP	Otranscription	factor	transcription	NN	B-NP	B-proteinfactor	binding	factor	NN	I-NP	I-proteinbinding	to	bind	VBG	B-VP	Oto	an	to	TO	B-PP	Oan	activating	an	DT	B-NP	Oactivating	transcription	activate	VBG	I-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	/	factor	NN	I-NP	I-protein/	cAMP	/	SYM	B-NP	OcAMP	response	cAMP	NN	I-NP	Oresponse	element	response	NN	I-NP	Oelement	binding	element	NN	I-NP	Obinding	(	binding	NN	I-NP	O(	ATF	(	(	O	OATF	/	ATF	NN	B-NP	B-protein/	CREB	/	SYM	B-NP	OCREB	)	CREB	NN	I-NP	B-protein)	binding	)	)	O	Obinding	site	binding	NN	B-NP	Osite	(	site	NN	I-NP	O(	located	(	(	O	Olocated	between	located	JJ	B-ADJP	Obetween	the	between	IN	B-PP	Othe	LEF-1	the	DT	B-NP	OLEF-1	and	LEF-1	NN	I-NP	B-proteinand	distal	and	CC	O	Odistal	NF-kappaB	distal	JJ	B-NP	ONF-kappaB	transcription	NF-kappaB	NN	I-NP	B-proteintranscription	factor	transcription	NN	I-NP	Ofactor	binding	factor	NN	I-NP	Obinding	sites	binding	NN	I-NP	Osites	)	site	NNS	I-NP	O)	that	)	)	O	Othat	we	that	WDT	B-NP	Owe	identified	we	PRP	B-NP	Oidentified	in	identify	VBD	B-VP	Oin	previous	in	IN	B-PP	Oprevious	studies	previous	JJ	B-NP	Ostudies	of	study	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	HIV-1	the	DT	B-NP	OHIV-1	LTR	HIV-1	NN	I-NP	B-DNALTR	.	LTR	NN	I-NP	I-DNA.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	suggest	finding	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	LTR	that	IN	B-SBAR	OLTR	sequence	LTR	NN	B-NP	B-DNAsequence	changes	sequence	NN	I-NP	I-DNAchanges	can	change	NNS	I-NP	Ocan	significantly	can	MD	B-VP	Osignificantly	affect	significantly	RB	I-VP	Oaffect	basal	affect	VB	I-VP	Obasal	LTR	basal	JJ	B-NP	OLTR	function	LTR	NN	I-NP	B-DNAfunction	and	function	NN	I-NP	Oand	transcription	and	CC	O	Otranscription	factor	transcription	NN	B-NP	B-proteinfactor	recruitment	factor	NN	I-NP	I-proteinrecruitment	","	recruitment	NN	I-NP	O","	which	","	","	O	Owhich	may	which	WDT	B-NP	Omay	","	may	MD	B-VP	O","	in	","	","	O	Oin	turn	in	IN	B-PP	Oturn	","	turn	NN	B-NP	O","	alter	","	","	O	Oalter	the	alter	VBP	B-VP	Othe	course	the	DT	B-NP	Ocourse	of	course	NN	I-NP	Oof	viral	of	IN	B-PP	Oviral	replication	viral	JJ	B-NP	Oreplication	in	replication	NN	I-NP	Oin	cells	in	IN	B-PP	Ocells	of	cell	NNS	B-NP	Oof	CNS	of	IN	B-PP	OCNS	and	CNS	NN	B-NP	B-proteinand	immune	and	CC	O	Oimmune	system	immune	JJ	B-NP	Osystem	origin	system	NN	I-NP	Oorigin	.	origin	NN	I-NP	O.	HMG	.	.	O	OHMG	box	HMG	NN	B-NP	B-proteinbox	containing	box	NN	I-NP	I-proteincontaining	transcription	contain	VBG	B-VP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	in	factor	NNS	I-NP	I-proteinin	lymphocyte	in	IN	B-PP	Olymphocyte	differentiation	lymphocyte	NN	B-NP	B-cell_typedifferentiation	.	differentiation	NN	I-NP	O.	The	.	.	O	OThe	identification	The	DT	B-NP	Oidentification	of	identification	NN	I-NP	Oof	the	of	IN	B-PP	Othe	mammalian	the	DT	B-NP	Omammalian	sex-determining	mammalian	JJ	I-NP	B-DNAsex-determining	gene	sex-determining	JJ	I-NP	I-DNAgene	Sry	gene	NN	I-NP	I-DNASry	has	Sry	NN	I-NP	I-DNAhas	led	have	VBZ	B-VP	Oled	to	lead	VBN	I-VP	Oto	the	to	TO	B-PP	Othe	discovery	the	DT	B-NP	Odiscovery	of	discovery	NN	I-NP	Oof	a	of	IN	B-PP	Oa	large	a	DT	B-NP	Olarge	family	large	JJ	I-NP	Ofamily	of	family	NN	I-NP	Oof	related	of	IN	B-PP	Orelated	(	related	JJ	B-NP	O(	'	(	(	O	O'	HMG	'	``	O	OHMG	box	HMG	NN	B-NP	B-proteinbox	'	box	NN	I-NP	I-protein'	)	'	''	O	O)	transcription	)	)	O	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	that	factor	NNS	I-NP	I-proteinthat	control	that	WDT	B-NP	Ocontrol	developmental	control	VBP	B-VP	Odevelopmental	events	developmental	JJ	B-NP	Oevents	in	event	NNS	I-NP	Oin	yeast	in	IN	B-PP	Oyeast	","	yeast	NN	B-NP	O","	C.	","	","	O	OC.	elegans	C.	NNP	B-NP	Oelegans	","	elegans	NNP	I-NP	O","	Drosophila	","	","	O	ODrosophila	and	Drosophila	NNP	B-NP	Oand	vertebrates	and	CC	O	Overtebrates	.	vertebrate	NNS	B-NP	O.	In	.	.	O	OIn	lymphocyte	In	IN	B-PP	Olymphocyte	differentiation	lymphocyte	NN	B-NP	B-cell_typedifferentiation	","	differentiation	NN	I-NP	O","	several	","	","	O	Oseveral	HMG	several	JJ	B-NP	OHMG	box	HMG	NN	I-NP	B-proteinbox	proteins	box	NN	I-NP	I-proteinproteins	play	protein	NNS	I-NP	I-proteinplay	a	play	VBP	B-VP	Oa	decisive	a	DT	B-NP	Odecisive	role	decisive	JJ	I-NP	Orole	.	role	NN	I-NP	O.	Sox-4	.	.	O	OSox-4	is	Sox-4	NN	B-NP	B-proteinis	important	be	VBZ	B-VP	Oimportant	for	important	JJ	B-ADJP	Ofor	very	for	IN	B-PP	Overy	early	very	RB	B-NP	Oearly	B-cell	early	JJ	I-NP	OB-cell	differentiation	B-cell	NN	I-NP	Odifferentiation	","	differentiation	NN	I-NP	O","	while	","	","	O	Owhile	TCF-1	while	IN	B-SBAR	OTCF-1	/	TCF-1	NN	B-NP	B-protein/	LEF-1	/	SYM	B-NP	OLEF-1	play	LEF-1	NN	I-NP	B-proteinplay	a	play	VBP	B-VP	Oa	crucial	a	DT	B-NP	Ocrucial	role	crucial	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	early	in	IN	B-PP	Oearly	thymocyte	early	JJ	B-NP	Othymocyte	development	thymocyte	NN	I-NP	Odevelopment	.	development	NN	I-NP	O.	TCF/LEF	.	.	O	OTCF/LEF	proteins	TCF/LEF	NN	B-NP	B-proteinproteins	have	protein	NNS	I-NP	I-proteinhave	recently	have	VBP	B-VP	Orecently	been	recently	RB	I-VP	Obeen	found	be	VBN	I-VP	Ofound	to	find	VBN	I-VP	Oto	constitute	to	TO	I-VP	Oconstitute	a	constitute	VB	I-VP	Oa	downstream	a	DT	B-NP	Odownstream	component	downstream	JJ	I-NP	Ocomponent	of	component	NN	I-NP	Oof	the	of	IN	B-PP	Othe	Wingless/Wnt	the	DT	B-NP	OWingless/Wnt	signal	Wingless/Wnt	NN	I-NP	Osignal	transduction	signal	NN	I-NP	Otransduction	pathway	transduction	NN	I-NP	Opathway	.	pathway	NN	I-NP	O.	In	.	.	O	OIn	flies	In	IN	B-PP	Oflies	","	fly	NNS	B-NP	O","	this	","	","	O	Othis	pathway	this	DT	B-NP	Opathway	controls	pathway	NN	I-NP	Ocontrols	segment	control	VBZ	B-VP	Osegment	polarity	segment	NN	B-NP	Opolarity	;	polarity	NN	I-NP	O;	in	;	:	O	Oin	Xenopus	in	IN	B-PP	OXenopus	it	Xenopus	NN	B-NP	Oit	controls	it	PRP	B-NP	Ocontrols	the	control	VBZ	B-VP	Othe	definition	the	DT	B-NP	Odefinition	of	definition	NN	I-NP	Oof	the	of	IN	B-PP	Othe	body	the	DT	B-NP	Obody	axis	body	NN	I-NP	Oaxis	.	axis	NN	I-NP	O.	Deregulation	.	.	O	ODeregulation	of	Deregulation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	pathway	the	DT	B-NP	Opathway	occurs	pathway	NN	I-NP	Ooccurs	in	occur	VBZ	B-VP	Oin	several	in	IN	B-PP	Oseveral	human	several	JJ	B-NP	Ohuman	tumors	human	JJ	I-NP	Otumors	.	tumor	NNS	I-NP	O.	These	.	.	O	OThese	insights	These	DT	B-NP	Oinsights	in	insight	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	molecular	the	DT	B-NP	Omolecular	events	molecular	JJ	I-NP	Oevents	that	event	NNS	I-NP	Othat	are	that	WDT	B-NP	Oare	involved	be	VBP	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	TCF/LEF	in	IN	B-PP	OTCF/LEF	function	TCF/LEF	NN	B-NP	B-proteinfunction	in	function	NN	I-NP	Oin	these	in	IN	B-PP	Othese	organisms	these	DT	B-NP	Oorganisms	may	organism	NNS	I-NP	Omay	eventually	may	MD	B-VP	Oeventually	lead	eventually	RB	I-VP	Olead	to	lead	VB	I-VP	Oto	the	to	TO	B-PP	Othe	understanding	the	DT	B-NP	Ounderstanding	of	understanding	NN	I-NP	Oof	the	of	IN	B-PP	Othe	function	the	DT	B-NP	Ofunction	of	function	NN	I-NP	Oof	these	of	IN	B-PP	Othese	HMG	these	DT	B-NP	OHMG	box	HMG	NN	I-NP	B-proteinbox	proteins	box	NN	I-NP	I-proteinproteins	in	protein	NNS	I-NP	I-proteinin	lymphoid	in	IN	B-PP	Olymphoid	development	lymphoid	JJ	B-NP	Odevelopment	Transcriptional	development	NN	I-NP	OTranscriptional	regulation	Transcriptional	JJ	B-NP	Oregulation	by	regulation	NN	I-NP	Oby	C/EBP	by	IN	B-PP	OC/EBP	alpha	C/EBP	NN	B-NP	B-proteinalpha	and	alpha	NN	I-NP	I-proteinand	#NAME?	and	CC	O	I-protein#NAME?	in	#NAME?	NN	B-NP	I-proteinin	the	in	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	gene	the	DT	B-NP	Ogene	for	gene	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	MRP14	the	DT	B-NP	OMRP14	myeloid	MRP14	NN	I-NP	B-proteinmyeloid	calcium	myeloid	JJ	I-NP	I-proteincalcium	binding	calcium	NN	I-NP	I-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	.	protein	NN	I-NP	I-protein.	Transcriptional	.	.	O	OTranscriptional	regulation	Transcriptional	JJ	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	gene	the	DT	B-NP	Ogene	for	gene	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	myeloid	the	DT	B-NP	Omyeloid	calcium	myeloid	JJ	I-NP	B-proteincalcium	binding	calcium	NN	I-NP	I-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	","	protein	NN	I-NP	I-protein","	MRP14	","	","	O	OMRP14	","	MRP14	NN	B-NP	B-protein","	was	","	","	O	Owas	investigated	be	VBD	B-VP	Oinvestigated	in	investigate	VBN	I-VP	Oin	human	in	IN	B-PP	Ohuman	monocytic	human	JJ	B-NP	B-cell_linemonocytic	leukemia	monocytic	JJ	I-NP	I-cell_lineleukemia	cell	leukemia	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	.	line	NNS	I-NP	I-cell_line.	The	.	.	O	OThe	MRP14	The	DT	B-NP	OMRP14	gene	MRP14	NN	I-NP	B-DNAgene	was	gene	NN	I-NP	I-DNAwas	not	be	VBD	B-VP	Onot	expressed	not	RB	I-VP	Oexpressed	in	express	VBN	I-VP	Oin	monoblastic	in	IN	B-PP	Omonoblastic	ML-1	monoblastic	JJ	B-NP	B-cell_lineML-1	cells	ML-1	NN	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	promonocytic	","	","	O	Opromonocytic	U-937	promonocytic	JJ	B-NP	B-cell_lineU-937	cells	U-937	NN	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	or	","	","	O	Oor	promyelocytic	or	CC	O	Opromyelocytic	HL-60	promyelocytic	JJ	B-NP	B-cell_lineHL-60	cells	HL-60	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	On	.	.	O	OOn	the	On	IN	B-PP	Othe	other	the	DT	B-NP	Oother	hand	other	JJ	I-NP	Ohand	","	hand	NN	I-NP	O","	the	","	","	O	Othe	gene	the	DT	B-NP	Ogene	was	gene	NN	I-NP	Owas	expressed	be	VBD	B-VP	Oexpressed	in	express	VBN	I-VP	Oin	monocytic	in	IN	B-PP	Omonocytic	THP-1	monocytic	JJ	B-NP	B-cell_lineTHP-1	cells	THP-1	NN	I-NP	I-cell_linecells	and	cell	NNS	I-NP	I-cell_lineand	in	and	CC	B-PP	Oin	the	in	IN	B-PP	Othe	HL-60	the	DT	B-NP	OHL-60	cells	HL-60	NN	I-NP	B-cell_linecells	treated	cell	NNS	I-NP	I-cell_linetreated	with	treat	VBN	B-VP	Owith	1	with	IN	B-PP	O1	","	1	CD	B-NP	O","	25-dihydroxyvitamin	","	","	O	O25-dihydroxyvitamin	D3	25-dihydroxyvitamin	NN	B-NP	OD3	(	D3	NN	I-NP	O(	VD3	(	(	O	OVD3	)	VD3	NN	B-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	level	The	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	MRP14	of	IN	B-PP	OMRP14	in	MRP14	NN	B-NP	B-proteinin	VD3-treated	in	IN	B-PP	OVD3-treated	HL-60	VD3-treated	JJ	B-NP	B-cell_lineHL-60	cells	HL-60	NN	I-NP	I-cell_linecells	was	cell	NNS	I-NP	I-cell_linewas	two-fold	be	VBD	B-VP	Otwo-fold	higher	two-fold	RB	B-ADJP	Ohigher	than	high	JJR	I-ADJP	Othan	that	than	IN	B-PP	Othat	in	that	DT	B-NP	Oin	THP-1	in	IN	B-PP	OTHP-1	cells	THP-1	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Among	.	.	O	OAmong	several	Among	IN	B-PP	Oseveral	known	several	JJ	B-NP	Oknown	transcription	known	JJ	I-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	binding	factor	NN	I-NP	I-proteinbinding	motifs	binding	NN	I-NP	Omotifs	","	motif	NNS	I-NP	O","	nuclear	","	","	O	Onuclear	protein	nuclear	JJ	B-NP	B-proteinprotein	(	protein	NN	I-NP	I-protein(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	of	)	)	O	Oof	VD3-treated	of	IN	B-PP	OVD3-treated	HL-60	VD3-treated	JJ	B-NP	B-cell_lineHL-60	cells	HL-60	NN	I-NP	I-cell_linecells	and	cell	NNS	I-NP	I-cell_lineand	THP-1	and	CC	O	OTHP-1	cells	THP-1	NN	B-NP	B-cell_linecells	bound	cell	NNS	I-NP	I-cell_linebound	to	bind	VBD	B-VP	Oto	the	to	TO	B-PP	Othe	CCAAT/enhancer	the	DT	B-NP	OCCAAT/enhancer	binding	CCAAT/enhancer	NN	I-NP	B-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	C/EBP	(	(	O	OC/EBP	)	C/EBP	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	motif	#NAME?	JJ	B-NP	Omotif	that	motif	NN	I-NP	Othat	was	that	WDT	B-NP	Owas	located	be	VBD	B-VP	Olocated	in	located	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	upstream	the	DT	B-NP	Oupstream	region	upstream	JJ	I-NP	B-DNAregion	of	region	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	MRP14	the	DT	B-NP	OMRP14	gene	MRP14	NN	I-NP	B-DNAgene	(	gene	NN	I-NP	I-DNA(	-81	(	(	O	O-81	)	-81	CD	B-NP	B-DNA)	","	)	)	O	O","	as	","	","	O	Oas	evidenced	as	IN	B-SBAR	Oevidenced	by	evidence	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	competitive	the	DT	B-NP	Ocompetitive	gel	competitive	JJ	I-NP	Ogel	mobility-shift	gel	NN	I-NP	Omobility-shift	assay	mobility-shift	NN	I-NP	Oassay	.	assay	NN	I-NP	O.	An	.	.	O	OAn	antibody	An	DT	B-NP	Oantibody	for	antibody	NN	I-NP	Ofor	C/EBP	for	IN	B-PP	OC/EBP	alpha	C/EBP	NN	B-NP	B-proteinalpha	super-shifted	alpha	NN	I-NP	I-proteinsuper-shifted	the	super-shifte	VBD	B-VP	Othe	nucleoprotein	the	DT	B-NP	Onucleoprotein	complex	nucleoprotein	NN	I-NP	B-proteincomplex	in	complex	NN	I-NP	I-proteinin	THP-1	in	IN	B-PP	OTHP-1	cells	THP-1	NN	B-NP	B-cell_linecells	but	cell	NNS	I-NP	I-cell_linebut	not	but	CC	B-PP	Onot	in	not	RB	B-PP	Oin	the	in	IN	I-PP	Othe	VD3-treated	the	DT	B-NP	OVD3-treated	HL-60	VD3-treated	JJ	I-NP	B-cell_lineHL-60	cells	HL-60	NN	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	whereas	","	","	O	Owhereas	an	whereas	IN	O	Oan	antibody	an	DT	B-NP	Oantibody	for	antibody	NN	I-NP	Ofor	C/EBP	for	IN	B-PP	OC/EBP	beta	C/EBP	NN	B-NP	B-proteinbeta	blocked	beta	NN	I-NP	I-proteinblocked	the	block	VBD	B-VP	Othe	formation	the	DT	B-NP	Oformation	of	formation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	complex	the	DT	B-NP	Ocomplex	with	complex	NN	I-NP	Owith	the	with	IN	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	factor	nuclear	JJ	I-NP	B-proteinfactor	of	factor	NN	I-NP	I-proteinof	the	of	IN	B-PP	Othe	HL-60	the	DT	B-NP	OHL-60	cells	HL-60	NN	I-NP	B-cell_linecells	but	cell	NNS	I-NP	I-cell_linebut	not	but	CC	B-PP	Onot	with	not	RB	B-PP	Owith	that	with	IN	I-PP	Othat	of	that	DT	B-NP	Oof	THP-1	of	IN	B-PP	OTHP-1	cells	THP-1	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	An	.	.	O	OAn	anti-C/EBP	An	DT	B-NP	Oanti-C/EBP	delta	anti-C/EBP	JJ	I-NP	B-proteindelta	antibody	delta	NN	I-NP	I-proteinantibody	had	antibody	NN	I-NP	I-proteinhad	no	have	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	on	effect	NN	I-NP	Oon	the	on	IN	B-PP	Othe	complex	the	DT	B-NP	Ocomplex	in	complex	NN	I-NP	Oin	either	in	IN	B-PP	Oeither	cell	either	DT	B-NP	Ocell	.	cell	NN	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	it	","	","	O	Oit	was	it	PRP	B-NP	Owas	concluded	be	VBD	B-VP	Oconcluded	that	conclude	VBN	I-VP	Othat	C/EBP	that	IN	B-SBAR	OC/EBP	alpha	C/EBP	NN	B-NP	B-proteinalpha	and	alpha	NN	I-NP	I-proteinand	#NAME?	and	CC	O	I-protein#NAME?	were	#NAME?	NN	B-NP	I-proteinwere	able	be	VBD	B-VP	Oable	to	able	JJ	B-ADJP	Oto	bind	to	TO	B-VP	Obind	to	bind	VB	I-VP	Oto	the	to	TO	B-PP	Othe	C/EBP	the	DT	B-NP	OC/EBP	motif	C/EBP	NN	I-NP	B-DNAmotif	","	motif	NN	I-NP	I-DNA","	and	","	","	O	Oand	that	and	CC	O	Othat	C/EBP	that	IN	B-SBAR	OC/EBP	alpha	C/EBP	NN	B-NP	B-proteinalpha	bound	alpha	NN	I-NP	I-proteinbound	to	bind	VBD	B-VP	Oto	the	to	TO	B-PP	Othe	motif	the	DT	B-NP	Omotif	in	motif	NN	I-NP	Oin	THP-1	in	IN	B-PP	OTHP-1	cells	THP-1	NN	B-NP	B-cell_linecells	and	cell	NNS	I-NP	I-cell_lineand	C/EBP	and	CC	O	OC/EBP	beta	C/EBP	NN	B-NP	B-proteinbeta	bound	beta	NN	I-NP	I-proteinbound	to	bind	VBD	B-VP	Oto	that	to	TO	B-PP	Othat	in	that	DT	B-NP	Oin	the	in	IN	B-PP	Othe	VD3-treated	the	DT	B-NP	OVD3-treated	HL-60	VD3-treated	JJ	I-NP	B-cell_lineHL-60	cells	HL-60	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	to	","	","	O	Oto	examine	to	TO	B-VP	Oexamine	the	examine	VB	I-VP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	activity	transcriptional	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	C/EBP	the	DT	B-NP	OC/EBP	motif	C/EBP	NN	I-NP	B-DNAmotif	","	motif	NN	I-NP	I-DNA","	we	","	","	O	Owe	transfected	we	PRP	B-NP	Otransfected	several	transfecte	VBD	B-VP	Oseveral	constructed	several	JJ	B-NP	Oconstructed	luciferase	construct	VBN	I-NP	Oluciferase	reporter	luciferase	NN	I-NP	B-DNAreporter	DNAs	reporter	NN	I-NP	I-DNADNAs	into	DNA	NNS	I-NP	I-DNAinto	HL-60	into	IN	B-PP	OHL-60	cells	HL-60	NN	B-NP	B-cell_linecells	and	cell	NNS	I-NP	I-cell_lineand	THP-1	and	CC	O	OTHP-1	cells	THP-1	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	The	.	.	O	OThe	luciferase	The	DT	B-NP	Oluciferase	activity	luciferase	NN	I-NP	B-proteinactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	C/EBP	the	DT	B-NP	OC/EBP	motif	C/EBP	NN	I-NP	B-DNAmotif	in	motif	NN	I-NP	I-DNAin	HL-60	in	IN	B-PP	OHL-60	cells	HL-60	NN	B-NP	B-cell_linecells	was	cell	NNS	I-NP	I-cell_linewas	increased	be	VBD	B-VP	Oincreased	by	increase	VBN	I-VP	Oby	VD3	by	IN	B-PP	OVD3	treatment	VD3	NN	B-NP	Otreatment	.	treatment	NN	I-NP	O.	The	.	.	O	OThe	C/EBP	The	DT	B-NP	OC/EBP	motif	C/EBP	NN	I-NP	B-DNAmotif	in	motif	NN	I-NP	I-DNAin	the	in	IN	B-PP	Othe	MRP14	the	DT	B-NP	OMRP14	gene	MRP14	NN	I-NP	B-DNAgene	was	gene	NN	I-NP	I-DNAwas	confirmed	be	VBD	B-VP	Oconfirmed	to	confirm	VBN	I-VP	Oto	function	to	TO	I-VP	Ofunction	as	function	VB	I-VP	Oas	a	as	IN	B-PP	Oa	regulatory	a	DT	B-NP	Oregulatory	region	regulatory	JJ	I-NP	B-DNAregion	in	region	NN	I-NP	I-DNAin	VD3-treated	in	IN	B-PP	OVD3-treated	HL-60	VD3-treated	JJ	B-NP	B-cell_lineHL-60	cells	HL-60	NN	I-NP	I-cell_linecells	and	cell	NNS	I-NP	I-cell_lineand	THP-1	and	CC	O	OTHP-1	cells	THP-1	NN	B-NP	B-cell_linecells	by	cell	NNS	I-NP	I-cell_lineby	the	by	IN	B-PP	Othe	assay	the	DT	B-NP	Oassay	.	assay	NN	I-NP	O.	Since	.	.	O	OSince	C/EBP	Since	IN	B-SBAR	OC/EBP	beta	C/EBP	NN	B-NP	B-proteinbeta	was	beta	NN	I-NP	I-proteinwas	also	be	VBD	B-VP	Oalso	detected	also	RB	I-VP	Odetected	in	detect	VBN	I-VP	Oin	VD3-untreated	in	IN	B-PP	OVD3-untreated	HL-60	VD3-untreated	JJ	B-NP	B-cell_lineHL-60	cells	HL-60	NN	I-NP	I-cell_linecells	by	cell	NNS	I-NP	I-cell_lineby	immunoblotting	by	IN	B-PP	Oimmunoblotting	","	immunoblotting	NN	B-NP	O","	VD3	","	","	O	OVD3	activated	VD3	NN	B-NP	Oactivated	C/EBP	activate	VBD	B-VP	OC/EBP	beta	C/EBP	NN	B-NP	B-proteinbeta	to	beta	NN	I-NP	I-proteinto	bind	to	TO	B-VP	Obind	to	bind	VB	I-VP	Oto	the	to	TO	B-PP	Othe	motif	the	DT	B-NP	Omotif	","	motif	NN	I-NP	O","	probably	","	","	O	Oprobably	through	probably	RB	B-ADVP	Othrough	post-translational	through	IN	B-PP	Opost-translational	modification	post-translational	JJ	B-NP	Omodification	.	modification	NN	I-NP	O.	Patients	.	.	O	OPatients	with	Patient	NNS	B-NP	Owith	high-risk	with	IN	B-PP	Ohigh-risk	myelodysplastic	high-risk	JJ	B-NP	Omyelodysplastic	syndrome	myelodysplastic	JJ	I-NP	Osyndrome	can	syndrome	NN	I-NP	Ocan	have	can	MD	B-VP	Ohave	polyclonal	have	VB	I-VP	Opolyclonal	or	polyclonal	JJ	B-NP	Oor	clonal	or	CC	I-NP	Oclonal	haemopoiesis	clonal	JJ	I-NP	Ohaemopoiesis	in	haemopoiesis	NN	I-NP	Oin	complete	in	IN	B-PP	Ocomplete	haematological	complete	JJ	B-NP	Ohaematological	remission	haematological	JJ	I-NP	Oremission	.	remission	NN	I-NP	O.	The	.	.	O	OThe	clonality	The	DT	B-NP	Oclonality	of	clonality	NN	I-NP	Oof	mature	of	IN	B-PP	Omature	peripheral	mature	JJ	B-NP	Operipheral	blood-derived	peripheral	JJ	I-NP	Oblood-derived	myeloid	blood-derived	JJ	I-NP	Omyeloid	and	myeloid	JJ	I-NP	Oand	lymphoid	and	CC	I-NP	Olymphoid	cells	lymphoid	JJ	I-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	bone	and	CC	O	Obone	marrow	bone	NN	B-NP	B-cell_typemarrow	haemopoietic	marrow	NN	I-NP	I-cell_typehaemopoietic	progenitors	haemopoietic	JJ	I-NP	I-cell_typeprogenitors	from	progenitor	NNS	I-NP	I-cell_typefrom	18	from	IN	B-PP	O18	females	18	CD	B-NP	Ofemales	with	female	NNS	I-NP	Owith	myelodysplasia	with	IN	B-PP	Omyelodysplasia	(	myelodysplasia	NN	B-NP	O(	MDS	(	(	O	OMDS	)	MDS	NN	B-NP	O)	(	)	)	O	O(	five	(	(	O	Ofive	refractory	five	CD	B-NP	Orefractory	anaemia	refractory	JJ	I-NP	Oanaemia	","	anaemia	NN	I-NP	O","	RA	","	","	O	ORA	;	RA	NN	B-NP	O;	one	;	:	O	Oone	RA	one	CD	B-NP	ORA	with	RA	NN	I-NP	Owith	ringed	with	IN	B-PP	Oringed	sideroblasts	ringed	JJ	B-NP	B-cell_typesideroblasts	","	sideroblast	NNS	I-NP	I-cell_type","	RARS	","	","	O	ORARS	;	RARS	NN	B-NP	B-protein;	three	;	:	O	Othree	chronic	three	CD	B-NP	Ochronic	myelomonocytic	chronic	JJ	I-NP	Omyelomonocytic	leukaemia	myelomonocytic	JJ	I-NP	Oleukaemia	","	leukaemia	NN	I-NP	O","	CMML	","	","	O	OCMML	;	CMML	NN	B-NP	O;	four	;	:	O	Ofour	RA	four	CD	B-NP	ORA	with	RA	NN	I-NP	Owith	excess	with	IN	B-PP	Oexcess	of	excess	NN	B-NP	Oof	blasts	of	IN	B-PP	Oblasts	","	blast	NNS	B-NP	B-cell_type","	RAEB	","	","	O	ORAEB	;	RAEB	NN	B-NP	B-protein;	five	;	:	O	Ofive	RAEB	five	CD	B-NP	ORAEB	in	RAEB	NN	I-NP	B-proteinin	transformation	in	IN	B-PP	Otransformation	","	transformation	NN	B-NP	O","	RAEB-t	","	","	O	ORAEB-t	)	RAEB-t	NN	B-NP	O)	was	)	)	O	Owas	studied	be	VBD	B-VP	Ostudied	by	study	VBN	I-VP	Oby	X-chromosome	by	IN	B-PP	OX-chromosome	inactivation	X-chromosome	NN	B-NP	B-DNAinactivation	analysis	inactivation	NN	I-NP	Oanalysis	.	analysis	NN	I-NP	O.	Using	.	.	O	OUsing	the	Use	VBG	B-VP	Othe	human	the	DT	B-NP	Ohuman	androgen-receptor	human	JJ	I-NP	B-proteinandrogen-receptor	(	androgen-receptor	NN	I-NP	I-protein(	HUMARA	(	(	O	OHUMARA	)	HUMARA	NN	B-NP	B-DNA)	assay	)	)	O	Oassay	","	assay	NN	B-NP	O","	we	","	","	O	Owe	analysed	we	PRP	B-NP	Oanalysed	the	analyse	VBD	B-VP	Othe	clonal	the	DT	B-NP	Oclonal	patterns	clonal	JJ	I-NP	Opatterns	of	pattern	NNS	I-NP	Oof	highly	of	IN	B-PP	Ohighly	purified	highly	RB	B-NP	B-cell_typepurified	immature	purify	VBN	I-NP	I-cell_typeimmature	CD34+	immature	JJ	I-NP	I-cell_typeCD34+	38-	CD34+	JJ	I-NP	I-cell_type38-	and	38-	CD	I-NP	I-cell_typeand	committed	and	CC	O	I-cell_typecommitted	CD34+	commit	VBN	B-VP	I-cell_typeCD34+	38+	CD34+	JJ	B-NP	I-cell_type38+	marrow-derived	38+	JJ	I-NP	I-cell_typemarrow-derived	progenitors	marrow-derived	JJ	I-NP	I-cell_typeprogenitors	","	progenitor	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	CD16+	and	CC	O	OCD16+	14-	CD16+	JJ	B-NP	B-cell_type14-	granulocytes	14-	JJ	I-NP	I-cell_typegranulocytes	","	granulocyte	NNS	I-NP	I-cell_type","	CD14+	","	","	O	OCD14+	monocytes	CD14+	JJ	B-NP	B-cell_typemonocytes	","	monocyte	NNS	I-NP	I-cell_type","	CD3+	","	","	O	OCD3+	T	CD3+	JJ	B-NP	B-cell_typeT	and	T	NN	I-NP	I-cell_typeand	CD19+	and	CC	I-NP	I-cell_typeCD19+	B	CD19+	JJ	I-NP	I-cell_typeB	lymphocytes	B	NN	I-NP	I-cell_typelymphocytes	from	lymphocyte	NNS	I-NP	I-cell_typefrom	peripheral	from	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	Oblood	.	blood	NN	I-NP	O.	In	.	.	O	OIn	high-risk	In	IN	B-PP	Ohigh-risk	patients	high-risk	JJ	B-NP	Opatients	(	patient	NNS	I-NP	O(	RAEB	(	(	O	ORAEB	","	RAEB	NN	B-NP	B-protein","	RAEB-t	","	","	I-NP	ORAEB-t	)	RAEB-t	NN	I-NP	O)	","	)	)	O	O","	clonality	","	","	O	Oclonality	analysis	clonality	NN	B-NP	Oanalysis	was	analysis	NN	I-NP	Owas	performed	be	VBD	B-VP	Operformed	before	perform	VBN	I-VP	Obefore	and	before	IN	B-PP	Oand	after	and	CC	I-PP	Oafter	intensive	after	IN	I-PP	Ointensive	remission-induction	intensive	JJ	B-NP	Oremission-induction	treatment	remission-induction	NN	I-NP	Otreatment	.	treatment	NN	I-NP	O.	All	.	.	O	OAll	patients	All	DT	B-NP	Opatients	","	patient	NNS	I-NP	O","	except	","	","	O	Oexcept	one	except	IN	B-PP	Oone	with	one	CD	B-NP	Owith	RA	with	IN	B-PP	ORA	","	RA	NN	B-NP	O","	had	","	","	O	Ohad	predominance	have	VBD	B-VP	Opredominance	of	predominance	NN	B-NP	Oof	a	of	IN	B-PP	Oa	single	a	DT	B-NP	Osingle	clone	single	JJ	I-NP	Oclone	in	clone	NN	I-NP	Oin	their	in	IN	B-PP	Otheir	granulocytes	their	PRP$	B-NP	Ogranulocytes	and	granulocyte	NNS	I-NP	B-cell_typeand	monocytes	and	CC	I-NP	Omonocytes	.	monocyte	NNS	I-NP	B-cell_type.	The	.	.	O	OThe	same	The	DT	B-NP	Osame	clonal	same	JJ	I-NP	Oclonal	pattern	clonal	JJ	I-NP	Opattern	was	pattern	NN	I-NP	Owas	found	be	VBD	B-VP	Ofound	in	find	VBN	I-VP	Oin	CD34+	in	IN	B-PP	OCD34+	progenitor	CD34+	JJ	B-NP	B-cell_typeprogenitor	cells	progenitor	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	CD3+	","	","	O	OCD3+	T	CD3+	JJ	B-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	were	lymphocyte	NNS	I-NP	I-cell_typewere	polyclonal	be	VBD	B-VP	Opolyclonal	or	polyclonal	JJ	B-ADJP	Oor	oligoclonal	or	CC	I-ADJP	Ooligoclonal	in	oligoclonal	JJ	I-ADJP	Oin	14/18	in	IN	B-PP	O14/18	patients	14/18	CD	B-NP	Opatients	.	patient	NNS	I-NP	O.	X-chromosome	.	.	O	OX-chromosome	inactivation	X-chromosome	NN	B-NP	B-DNAinactivation	patterns	inactivation	NN	I-NP	Opatterns	of	pattern	NNS	I-NP	Oof	CD19+	of	IN	B-PP	OCD19+	B	CD19+	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	highly	be	VBD	B-VP	Ohighly	concordant	highly	RB	B-ADJP	Oconcordant	with	concordant	JJ	I-ADJP	Owith	CD3+	with	IN	B-PP	OCD3+	T	CD3+	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	except	cell	NNS	I-NP	I-cell_typeexcept	for	except	IN	B-PP	Ofor	two	for	IN	B-PP	Otwo	patients	two	CD	B-NP	Opatients	(	patient	NNS	I-NP	O(	one	(	(	O	Oone	RA	one	CD	B-NP	ORA	","	RA	NN	I-NP	O","	one	","	","	O	Oone	CMML	one	CD	B-NP	OCMML	)	CMML	NN	I-NP	O)	with	)	)	O	Owith	monoclonal	with	IN	B-PP	Omonoclonal	B	monoclonal	JJ	B-NP	B-proteinB	and	B	NN	I-NP	I-proteinand	polyclonal	and	CC	O	Opolyclonal	T	polyclonal	JJ	B-NP	OT	lymphocytes	T	NN	I-NP	B-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	therefore	","	","	O	Otherefore	suggesting	therefore	RB	B-ADVP	Osuggesting	a	suggest	VBG	B-VP	Oa	clonal	a	DT	B-NP	Oclonal	mutation	clonal	JJ	I-NP	Omutation	in	mutation	NN	I-NP	Oin	a	in	IN	B-PP	Oa	progenitor	a	DT	B-NP	Oprogenitor	common	progenitor	NN	I-NP	Ocommon	to	common	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	myeloid	the	DT	B-NP	Omyeloid	and	myeloid	JJ	I-NP	B-cell_typeand	B-lymphoid	and	CC	I-NP	I-cell_typeB-lymphoid	lineages	B-lymphoid	JJ	I-NP	I-cell_typelineages	or	lineage	NNS	I-NP	I-cell_typeor	the	or	CC	O	Othe	coexistence	the	DT	B-NP	Ocoexistence	of	coexistence	NN	I-NP	Oof	MDS	of	IN	B-PP	OMDS	and	MDS	NN	B-NP	Oand	a	and	CC	O	Oa	B-cell	a	DT	B-NP	OB-cell	disorder	B-cell	NN	I-NP	Odisorder	in	disorder	NN	I-NP	Oin	these	in	IN	B-PP	Othese	particular	these	DT	B-NP	Oparticular	patients	particular	JJ	I-NP	Opatients	.	patient	NNS	I-NP	O.	After	.	.	O	OAfter	high-dose	After	IN	B-PP	Ohigh-dose	non-myeloablative	high-dose	JJ	B-NP	Onon-myeloablative	chemotherapy	non-myeloablative	JJ	I-NP	Ochemotherapy	","	chemotherapy	NN	I-NP	O","	polyclonal	","	","	O	Opolyclonal	haemopoiesis	polyclonal	JJ	B-NP	Ohaemopoiesis	was	haemopoiesis	NN	I-NP	Owas	reinstalled	be	VBD	B-VP	Oreinstalled	in	reinstall	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	mature	the	DT	B-NP	Omature	myeloid	mature	JJ	I-NP	B-cell_typemyeloid	cells	myeloid	JJ	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	immature	and	CC	O	Oimmature	and	immature	JJ	B-NP	B-cell_typeand	committed	and	CC	I-NP	I-cell_typecommitted	marrow	commit	VBN	I-NP	I-cell_typemarrow	progenitors	marrow	NN	I-NP	I-cell_typeprogenitors	in	progenitor	NNS	I-NP	I-cell_typein	three	in	IN	B-PP	Othree	of	three	CD	B-NP	Oof	four	of	IN	I-NP	Ofour	patients	four	CD	I-NP	Opatients	achieving	patient	NNS	I-NP	Oachieving	complete	achieve	VBG	B-VP	Ocomplete	haematological	complete	JJ	B-NP	Ohaematological	remission	haematological	JJ	I-NP	Oremission	.	remission	NN	I-NP	O.	Therefore	.	.	O	OTherefore	we	Therefore	RB	B-ADVP	Owe	conclude	we	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	most	that	IN	B-SBAR	Omost	haematological	most	JJS	B-NP	Ohaematological	remissions	haematological	JJ	I-NP	Oremissions	in	remission	NNS	I-NP	Oin	MDS	in	IN	B-PP	OMDS	are	MDS	NN	B-NP	Oare	associated	be	VBP	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	restoration	with	IN	B-PP	Orestoration	of	restoration	NN	B-NP	Oof	polyclonal	of	IN	B-PP	Opolyclonal	haemopoiesis	polyclonal	JJ	B-NP	Ohaemopoiesis	.	haemopoiesis	NN	I-NP	O.	Prominent	.	.	O	OProminent	sex	Prominent	JJ	B-NP	Osex	steroid	sex	NN	I-NP	Osteroid	metabolism	steroid	NN	I-NP	Ometabolism	in	metabolism	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	lymphocytes	human	JJ	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Steroid	.	.	O	OSteroid	metabolism	Steroid	NN	B-NP	Ometabolism	was	metabolism	NN	I-NP	Owas	investigated	be	VBD	B-VP	Oinvestigated	in	investigate	VBN	I-VP	Oin	cultured	in	IN	B-PP	Ocultured	human	culture	VBN	B-NP	B-cell_linehuman	B-lymphoblastoid	human	JJ	I-NP	I-cell_lineB-lymphoblastoid	cells	B-lymphoblastoid	JJ	I-NP	I-cell_linecells	(	cell	NNS	I-NP	I-cell_line(	B-LCL	(	(	O	OB-LCL	)	B-LCL	NN	B-NP	B-cell_line)	","	)	)	O	O","	and	","	","	O	Oand	peripheral	and	CC	O	Operipheral	blood	peripheral	JJ	B-NP	Oblood	T	blood	NN	I-NP	OT	and	T	NN	I-NP	Oand	B	and	CC	I-NP	OB	cells	B	NN	I-NP	Ocells	.	cell	NNS	I-NP	O.	Gene	.	.	O	OGene	expression	Gene	NN	B-NP	Oexpression	was	expression	NN	I-NP	Owas	examined	be	VBD	B-VP	Oexamined	by	examine	VBN	I-VP	Oby	reverse-transcription	by	IN	B-PP	Oreverse-transcription	polymerase	reverse-transcription	NN	B-NP	Opolymerase	chain	polymerase	NN	I-NP	Ochain	reaction	chain	NN	I-NP	Oreaction	amplification	reaction	NN	I-NP	Oamplification	(	amplification	NN	I-NP	O(	RT-PCR	(	(	O	ORT-PCR	)	RT-PCR	NN	B-NP	O)	.	)	)	O	O.	Appropriate	.	.	O	OAppropriate	sized	Appropriate	JJ	B-NP	Osized	transcripts	sized	JJ	I-NP	Otranscripts	were	transcript	NNS	I-NP	Owere	detected	be	VBD	B-VP	Odetected	in	detect	VBN	I-VP	Oin	both	in	IN	B-PP	Oboth	cultured	both	CC	B-NP	Ocultured	and	culture	VBN	I-NP	Oand	fresh	and	CC	I-NP	Ofresh	peripheral	fresh	JJ	I-NP	Operipheral	lymphocytes	peripheral	JJ	I-NP	B-cell_typelymphocytes	for	lymphocyte	NNS	I-NP	I-cell_typefor	CYP11A	for	IN	B-PP	OCYP11A	","	CYP11A	NN	B-NP	B-protein","	CYP17	","	","	O	OCYP17	","	CYP17	NN	B-NP	B-protein","	HSD11L	","	","	O	OHSD11L	(	HSD11L	NN	B-NP	B-protein(	11beta-hydroxysteroid	(	(	O	O11beta-hydroxysteroid	dehydrogenase	11beta-hydroxysteroid	JJ	B-NP	B-proteindehydrogenase	I	dehydrogenase	NN	I-NP	I-proteinI	)	I	CD	I-NP	I-protein)	","	)	)	O	O","	HSD17B1	","	","	O	OHSD17B1	(	HSD17B1	NN	B-NP	B-protein(	17beta-hydroxysteroid	(	(	O	O17beta-hydroxysteroid	dehydrogenase	17beta-hydroxysteroid	NN	B-NP	B-proteindehydrogenase	type	dehydrogenase	NN	I-NP	I-proteintype	I	type	NN	I-NP	I-proteinI	)	I	CD	I-NP	I-protein)	and	)	)	O	Oand	SRD5A1	and	CC	O	OSRD5A1	(	SRD5A1	NN	B-NP	B-protein(	5alpha-reductase	(	(	O	O5alpha-reductase	I	5alpha-reductase	NN	B-NP	OI	)	I	CD	I-NP	O)	.	)	)	O	O.	B-LCL	.	.	O	OB-LCL	","	B-LCL	NN	B-NP	B-cell_line","	but	","	","	O	Obut	not	but	CC	O	Onot	T	not	RB	O	OT	and	T	NN	B-NP	B-cell_typeand	B	and	CC	I-NP	I-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	expressed	","	","	O	Oexpressed	CYP11B	express	VBD	B-VP	OCYP11B	.	CYP11B	NN	B-NP	B-protein.	There	.	.	O	OThere	was	There	EX	B-NP	Owas	minimal	be	VBD	B-VP	Ominimal	expression	minimal	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	HSD3B1	of	IN	B-PP	OHSD3B1	and	HSD3B1	NN	B-NP	B-proteinand	HSD3B2	and	CC	O	OHSD3B2	(	HSD3B2	NN	B-NP	B-protein(	3beta-hydroxysteroid	(	(	O	O3beta-hydroxysteroid	dehydrogenase	3beta-hydroxysteroid	NN	B-NP	Odehydrogenase	I	dehydrogenase	NN	I-NP	OI	and	I	CD	B-NP	Oand	II	and	CC	I-NP	OII	)	II	CD	I-NP	O)	in	)	)	O	Oin	B-LCL	in	IN	B-PP	OB-LCL	and	B-LCL	NN	B-NP	B-cell_lineand	T	and	CC	O	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	B-NP	I-cell_type.	Transcripts	.	.	O	OTranscripts	for	Transcript	NNS	B-NP	Ofor	CYP19	for	IN	B-PP	OCYP19	and	CYP19	NN	B-NP	B-proteinand	HSD11K	and	CC	I-NP	OHSD11K	were	HSD11K	NN	I-NP	B-proteinwere	not	be	VBD	B-VP	Onot	detected	not	RB	I-VP	Odetected	.	detect	VBN	I-VP	O.	Corresponding	.	.	O	OCorresponding	enzymatic	Correspond	VBG	B-VP	Oenzymatic	activity	enzymatic	JJ	B-NP	Oactivity	was	activity	NN	I-NP	Owas	detectable	be	VBD	B-VP	Odetectable	only	detectable	JJ	B-ADJP	Oonly	for	only	RB	B-ADVP	Ofor	17-hydroxysteroid	for	IN	B-PP	O17-hydroxysteroid	dehydrogenase	17-hydroxysteroid	JJ	B-NP	B-proteindehydrogenase	and	dehydrogenase	NN	I-NP	I-proteinand	5alpha-reductase	and	CC	I-NP	O5alpha-reductase	","	5alpha-reductase	NN	I-NP	B-protein","	respectively	","	","	O	Orespectively	producing	respectively	RB	B-VP	Oproducing	testosterone	produce	VBG	I-VP	Otestosterone	and	testosterone	NN	B-NP	Oand	5alpha-dihydrotestosterone	and	CC	I-NP	O5alpha-dihydrotestosterone	.	5alpha-dihydrotestosterone	NN	I-NP	O.	Steroid	.	.	O	OSteroid	identities	Steroid	NN	B-NP	Oidentities	were	identity	NNS	I-NP	Owere	confirmed	be	VBD	B-VP	Oconfirmed	by	confirm	VBN	I-VP	Oby	gas	by	IN	B-PP	Ogas	chromatography/mass	gas	NN	B-NP	Ochromatography/mass	spectrometry	chromatography/mass	NN	I-NP	Ospectrometry	(	spectrometry	NN	I-NP	O(	GC/MS	(	(	O	OGC/MS	)	GC/MS	NN	B-NP	B-protein)	.	)	)	O	O.	One	.	.	O	OOne	metabolite	One	CD	B-NP	Ometabolite	thought	metabolite	NN	I-NP	Othought	to	think	VBN	B-VP	Oto	be	to	TO	I-VP	Obe	deoxycorticosterone	be	VB	I-VP	Odeoxycorticosterone	was	deoxycorticosterone	NN	B-NP	Owas	identified	be	VBD	B-VP	Oidentified	by	identify	VBN	I-VP	Oby	GC/MS	by	IN	B-PP	OGC/MS	as	GC/MS	NN	B-NP	B-proteinas	6alpha-hydroxypregnanolone	as	IN	B-PP	O6alpha-hydroxypregnanolone	.	6alpha-hydroxypregnanolone	NN	B-NP	O.	It	.	.	O	OIt	was	It	PRP	B-NP	Owas	concluded	be	VBD	B-VP	Oconcluded	that	conclude	VBN	I-VP	Othat	sex	that	IN	B-SBAR	Osex	hormone	sex	NN	B-NP	Ohormone	metabolism	hormone	NN	I-NP	Ometabolism	","	metabolism	NN	I-NP	O","	including	","	","	O	Oincluding	androgen	include	VBG	B-PP	Oandrogen	synthesis	androgen	NN	B-NP	Osynthesis	","	synthesis	NN	I-NP	O","	occurs	","	","	O	Ooccurs	in	occur	VBZ	B-VP	Oin	lymphocytes	in	IN	B-PP	Olymphocytes	","	lymphocyte	NNS	B-NP	B-cell_type","	and	","	","	O	Oand	may	and	CC	O	Omay	modulate	may	MD	B-VP	Omodulate	immune	modulate	VB	I-VP	Oimmune	response	immune	JJ	B-NP	Oresponse	.	response	NN	I-NP	O.	Human	.	.	O	OHuman	white	Human	JJ	B-NP	B-cell_typewhite	blood	white	JJ	I-NP	I-cell_typeblood	cells	blood	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	hair	and	CC	O	Ohair	follicles	hair	NN	B-NP	Ofollicles	are	follicle	NNS	I-NP	Oare	good	be	VBP	B-VP	Ogood	sources	good	JJ	B-NP	Osources	of	source	NNS	I-NP	Oof	mRNA	of	IN	B-PP	OmRNA	for	mRNA	NN	B-NP	B-RNAfor	the	for	IN	B-PP	Othe	pterin	the	DT	B-NP	Opterin	carbinolamine	pterin	NN	I-NP	B-proteincarbinolamine	dehydratase/dimerization	carbinolamine	NN	I-NP	I-proteindehydratase/dimerization	cofactor	dehydratase/dimerization	NN	I-NP	I-proteincofactor	of	cofactor	NN	I-NP	I-proteinof	HNF1	of	IN	B-PP	OHNF1	for	HNF1	NN	B-NP	B-proteinfor	mutation	for	IN	B-PP	Omutation	detection	mutation	NN	B-NP	Odetection	.	detection	NN	I-NP	O.	Pterin	.	.	O	OPterin	carbinolamine	Pterin	NN	B-NP	B-proteincarbinolamine	dehydratase/dimerization	carbinolamine	NN	I-NP	I-proteindehydratase/dimerization	cofactor	dehydratase/dimerization	NN	I-NP	I-proteincofactor	of	cofactor	NN	I-NP	I-proteinof	HNF1	of	IN	B-PP	OHNF1	(	HNF1	NN	B-NP	B-protein(	PCD/DCoH	(	(	O	OPCD/DCoH	)	PCD/DCoH	NN	B-NP	B-protein)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	protein	a	DT	B-NP	Oprotein	that	protein	NN	I-NP	Othat	has	that	WDT	B-NP	Ohas	a	have	VBZ	B-VP	Oa	dual	a	DT	B-NP	Odual	function	dual	JJ	I-NP	Ofunction	.	function	NN	I-NP	O.	It	.	.	O	OIt	is	It	PRP	B-NP	Ois	a	be	VBZ	B-VP	Oa	pterin	a	DT	B-NP	Opterin	4alpha-carbinolamine	pterin	NN	I-NP	B-protein4alpha-carbinolamine	dehydratase	4alpha-carbinolamine	NN	I-NP	I-proteindehydratase	that	dehydratase	NN	I-NP	I-proteinthat	is	that	WDT	B-NP	Ois	involved	be	VBZ	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	regeneration	the	DT	B-NP	Oregeneration	of	regeneration	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cofactor	the	DT	B-NP	Ocofactor	tetrahydrobiopterin	cofactor	NN	I-NP	B-proteintetrahydrobiopterin	during	tetrahydrobiopterin	NN	I-NP	I-proteinduring	the	during	IN	B-PP	Othe	phenylalanine	the	DT	B-NP	Ophenylalanine	hydroxylase-	phenylalanine	NN	I-NP	Ohydroxylase-	catalyzed	hydroxylase-	NN	I-NP	Ocatalyzed	hydroxylation	catalyze	VBD	B-VP	Ohydroxylation	of	hydroxylation	NN	B-NP	Oof	phenylalanine	of	IN	B-PP	Ophenylalanine	.	phenylalanine	NN	B-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	it	","	","	O	Oit	is	it	PRP	B-NP	Ois	the	be	VBZ	B-VP	Othe	dimerization	the	DT	B-NP	Odimerization	cofactor	dimerization	NN	I-NP	B-proteincofactor	of	cofactor	NN	I-NP	I-proteinof	HNF1	of	IN	B-PP	OHNF1	that	HNF1	NN	B-NP	B-proteinthat	is	that	WDT	B-NP	Ois	able	be	VBZ	B-VP	Oable	to	able	JJ	B-ADJP	Oto	activate	to	TO	B-VP	Oactivate	the	activate	VB	I-VP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	activity	transcriptional	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	HNF1	of	IN	B-PP	OHNF1	.	HNF1	NN	B-NP	B-protein.	Deficiencies	.	.	O	ODeficiencies	in	Deficiency	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	gene	the	DT	B-NP	Ogene	for	gene	NN	I-NP	Ofor	this	for	IN	B-PP	Othis	dual	this	DT	B-NP	Odual	functional	dual	JJ	I-NP	B-proteinfunctional	protein	functional	JJ	I-NP	I-proteinprotein	result	protein	NN	I-NP	I-proteinresult	in	result	VBP	B-VP	Oin	hyperphenylalaninemia	in	IN	B-PP	Ohyperphenylalaninemia	.	hyperphenylalaninemia	NN	B-NP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	report	we	PRP	B-NP	Oreport	for	report	VBP	B-VP	Ofor	the	for	IN	B-PP	Othe	first	the	DT	B-NP	Ofirst	time	first	JJ	I-NP	Otime	that	time	NN	I-NP	Othat	the	that	IN	B-ADVP	Othe	PCD/DCoH	the	DT	B-NP	OPCD/DCoH	mRNA	PCD/DCoH	NN	I-NP	B-RNAmRNA	is	mRNA	NN	I-NP	I-RNAis	present	be	VBZ	B-VP	Opresent	in	present	JJ	B-ADJP	Oin	human	in	IN	B-PP	Ohuman	white	human	JJ	B-NP	B-cell_typewhite	blood	white	JJ	I-NP	I-cell_typeblood	cells	blood	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	hair	and	CC	O	Ohair	follicles	hair	NN	B-NP	Ofollicles	.	follicle	NNS	I-NP	O.	Taking	.	.	O	OTaking	advantage	Take	VBG	B-VP	Oadvantage	of	advantage	NN	B-NP	Oof	this	of	IN	B-PP	Othis	finding	this	DT	B-NP	Ofinding	","	finding	NN	I-NP	O","	a	","	","	O	Oa	sensitive	a	DT	B-NP	Osensitive	","	sensitive	JJ	I-NP	O","	rapid	","	","	I-NP	Orapid	and	rapid	JJ	I-NP	Oand	convenient	and	CC	I-NP	Oconvenient	method	convenient	JJ	I-NP	Omethod	for	method	NN	I-NP	Ofor	screening	for	IN	B-PP	Oscreening	mutations	screening	NN	B-NP	Omutations	occurring	mutation	NNS	I-NP	Ooccurring	in	occur	VBG	B-VP	Oin	the	in	IN	B-PP	Othe	coding	the	DT	B-NP	Ocoding	region	cod	VBG	I-NP	Oregion	of	region	NN	I-NP	Oof	this	of	IN	B-PP	Othis	gene	this	DT	B-NP	Ogene	has	gene	NN	I-NP	Ohas	been	have	VBZ	B-VP	Obeen	described	be	VBN	I-VP	Odescribed	.	describe	VBN	I-VP	O.	Copyright	.	.	O	OCopyright	1998	Copyright	NN	B-NP	O1998	Academic	1998	CD	I-NP	OAcademic	Press	Academic	NNP	I-NP	OPress	.	Press	NNP	I-NP	O.	Biochemical	.	.	O	OBiochemical	characterization	Biochemical	JJ	B-NP	Ocharacterization	of	characterization	NN	I-NP	Oof	the	of	IN	B-PP	Othe	NF-Y	the	DT	B-NP	ONF-Y	transcription	NF-Y	NN	I-NP	B-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	complex	factor	NN	I-NP	I-proteincomplex	during	complex	NN	I-NP	I-proteinduring	B	during	IN	B-PP	OB	lymphocyte	B	NN	B-NP	Olymphocyte	development	lymphocyte	NN	I-NP	Odevelopment	.	development	NN	I-NP	O.	The	.	.	O	OThe	transcription	The	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	","	factor	NN	I-NP	I-protein","	NF-Y	","	","	O	ONF-Y	","	NF-Y	NN	B-NP	B-protein","	plays	","	","	O	Oplays	a	play	VBZ	B-VP	Oa	critical	a	DT	B-NP	Ocritical	role	critical	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	tissue-specific	in	IN	B-PP	Otissue-specific	major	tissue-specific	JJ	B-NP	B-DNAmajor	histocompatibility	major	JJ	I-NP	I-DNAhistocompatibility	complex	histocompatibility	NN	I-NP	I-DNAcomplex	class	complex	NN	I-NP	I-DNAclass	II	class	NN	I-NP	I-DNAII	gene	II	CD	I-NP	I-DNAgene	transcription	gene	NN	I-NP	I-DNAtranscription	.	transcription	NN	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	report	this	DT	B-NP	Oreport	the	report	NN	I-NP	Othe	biochemical	the	DT	B-NP	Obiochemical	properties	biochemical	JJ	I-NP	Oproperties	of	property	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	heterotrimeric	the	DT	B-NP	Oheterotrimeric	NF-Y	heterotrimeric	JJ	I-NP	B-proteinNF-Y	complex	NF-Y	NN	I-NP	I-proteincomplex	have	complex	NN	I-NP	I-proteinhave	been	have	VBP	B-VP	Obeen	characterized	be	VBN	I-VP	Ocharacterized	during	characterize	VBN	I-VP	Oduring	stage-specific	during	IN	B-PP	Ostage-specific	B-cell	stage-specific	JJ	B-NP	OB-cell	development	B-cell	NN	I-NP	Odevelopment	","	development	NN	I-NP	O","	and	","	","	O	Oand	in	and	CC	O	Oin	several	in	IN	B-PP	Oseveral	class	several	JJ	B-NP	Oclass	II-	class	NN	I-NP	B-cell_lineII-	mutant	II-	NN	I-NP	I-cell_linemutant	B-cell	mutant	JJ	I-NP	I-cell_lineB-cell	lines	B-cell	NN	I-NP	I-cell_linelines	","	line	NNS	I-NP	I-cell_line","	which	","	","	O	Owhich	represent	which	WDT	B-NP	Orepresent	distinct	represent	VBP	B-VP	Odistinct	bare	distinct	JJ	B-NP	Obare	lymphocyte	bare	JJ	I-NP	Olymphocyte	syndrome	lymphocyte	NN	I-NP	Osyndrome	class	syndrome	NN	I-NP	Oclass	II	class	NN	I-NP	OII	genetic	II	CD	I-NP	Ogenetic	complementation	genetic	JJ	I-NP	Ocomplementation	groups	complementation	NN	I-NP	Ogroups	.	group	NNS	I-NP	O.	The	.	.	O	OThe	NF-Y	The	DT	B-NP	ONF-Y	complex	NF-Y	NN	I-NP	B-proteincomplex	derived	complex	NN	I-NP	I-proteinderived	from	derive	VBN	B-VP	Ofrom	class	from	IN	B-PP	Oclass	II+	class	NN	B-NP	B-cell_lineII+	mature	II+	JJ	I-NP	I-cell_linemature	B-cells	mature	JJ	I-NP	I-cell_lineB-cells	bound	B-cell	NNS	I-NP	I-cell_linebound	with	bind	VBD	B-VP	Owith	high	with	IN	B-PP	Ohigh	affinity	high	JJ	B-NP	Oaffinity	to	affinity	NN	I-NP	Oto	anion	to	TO	B-PP	Oanion	exchangers	anion	NN	B-NP	B-proteinexchangers	","	exchanger	NNS	I-NP	I-protein","	and	","	","	O	Oand	eluted	and	CC	O	Oeluted	as	elute	VBD	B-VP	Oas	an	as	IN	B-PP	Oan	intact	an	DT	B-NP	Ointact	trimeric	intact	JJ	I-NP	B-proteintrimeric	complex	trimeric	JJ	I-NP	I-proteincomplex	","	complex	NN	I-NP	I-protein","	whereas	","	","	O	Owhereas	","	whereas	IN	O	O","	NF-Y	","	","	O	ONF-Y	derived	NF-Y	NN	B-NP	B-proteinderived	from	derive	VBN	B-VP	Ofrom	class	from	IN	B-PP	Oclass	II-	class	NN	B-NP	B-cell_lineII-	plasma	II-	NN	I-NP	I-cell_lineplasma	B-cells	plasma	NN	I-NP	I-cell_lineB-cells	","	B-cell	NNS	I-NP	I-cell_line","	and	","	","	B-PP	Oand	from	and	CC	I-PP	Ofrom	bare	from	IN	B-PP	Obare	lymphocyte	bare	JJ	B-NP	B-cell_linelymphocyte	syndrome	lymphocyte	NN	I-NP	I-cell_linesyndrome	group	syndrome	NN	I-NP	I-cell_linegroup	II	group	NN	I-NP	I-cell_lineII	cell	II	CD	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	","	line	NNS	I-NP	I-cell_line","	RJ2.2.5	","	","	O	ORJ2.2.5	and	RJ2.2.5	NN	B-NP	B-cell_lineand	RM3	and	CC	I-NP	ORM3	","	RM3	NN	I-NP	B-protein","	dissociated	","	","	O	Odissociated	into	dissociate	VBN	B-VP	Ointo	discrete	into	IN	B-PP	Odiscrete	NF-YA	discrete	JJ	B-NP	ONF-YA	and	NF-YA	NN	I-NP	Oand	NF-YB	and	CC	I-NP	ONF-YB	:	NF-YB	NN	I-NP	B-protein:	C	:	SYM	I-NP	OC	subunit	C	NN	I-NP	Osubunit	fractions	subunit	NN	I-NP	Ofractions	.	fraction	NNS	I-NP	O.	Recombination	.	.	O	ORecombination	of	Recombination	NN	B-NP	Oof	the	of	IN	B-PP	Othe	MPC11	the	DT	B-NP	OMPC11	plasma	MPC11	NN	I-NP	Oplasma	B-cell	plasma	NN	I-NP	OB-cell	derived	B-cell	NN	I-NP	Oderived	NF-Y	derive	VBN	I-NP	ONF-Y	A	NF-Y	NN	I-NP	B-proteinA	:	A	NN	I-NP	O:	B	:	:	O	OB	:	B	NN	B-NP	O:	C	:	:	O	OC	complex	C	NN	B-NP	Ocomplex	with	complex	NN	I-NP	Owith	the	with	IN	B-PP	Othe	low	the	DT	B-NP	Olow	molecular	low	JJ	I-NP	B-proteinmolecular	mass	molecular	JJ	I-NP	I-proteinmass	protein	mass	NN	I-NP	I-proteinprotein	fraction	protein	NN	I-NP	I-proteinfraction	","	fraction	NN	I-NP	O","	NF-Y-associated	","	","	O	ONF-Y-associated	factors	NF-Y-associated	JJ	B-NP	B-proteinfactors	(	factor	NNS	I-NP	I-protein(	YAFs	(	(	O	OYAFs	)	YAF	NNS	B-NP	B-protein)	","	)	)	O	O","	derived	","	","	O	Oderived	from	derive	VBN	B-VP	Ofrom	mature	from	IN	B-PP	Omature	A20	mature	JJ	B-NP	OA20	B-cell	A20	NN	I-NP	OB-cell	nuclei	B-cell	NN	I-NP	Onuclei	","	nucleus	NNS	I-NP	O","	conferred	","	","	O	Oconferred	high	confer	VBD	B-VP	Ohigh	affinity	high	JJ	B-NP	Oaffinity	anion	affinity	NN	I-NP	Oanion	exchange	anion	NN	I-NP	Oexchange	binding	exchange	NN	I-NP	Obinding	to	bind	VBG	B-VP	Oto	NF-Y	to	TO	B-PP	ONF-Y	as	NF-Y	NN	B-NP	B-proteinas	an	as	IN	B-PP	Oan	intact	an	DT	B-NP	Ointact	trimeric	intact	JJ	I-NP	B-proteintrimeric	complex	trimeric	JJ	I-NP	I-proteincomplex	.	complex	NN	I-NP	I-protein.	Recombination	.	.	O	ORecombination	of	Recombination	NN	B-NP	Oof	the	of	IN	B-PP	Othe	native	the	DT	B-NP	Onative	NF-YA	native	JJ	I-NP	ONF-YA	:	NF-YA	NN	I-NP	O:	B	:	:	O	OB	:	B	NN	B-NP	O:	C	:	:	O	OC	complex	C	NN	B-NP	Ocomplex	with	complex	NN	I-NP	Owith	the	with	IN	B-PP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	cofactor	transcriptional	JJ	I-NP	B-proteincofactor	","	cofactor	NN	I-NP	I-protein","	PC4	","	","	O	OPC4	","	PC4	NN	B-NP	B-protein","	likewise	","	","	O	Olikewise	conferred	likewise	RB	B-ADVP	Oconferred	high	confer	VBD	B-VP	Ohigh	affinity	high	JJ	B-NP	Oaffinity	NF-Y	affinity	NN	I-NP	ONF-Y	binding	NF-Y	NN	I-NP	B-proteinbinding	to	bind	VBG	B-VP	Oto	anion	to	TO	B-PP	Oanion	exchangers	anion	NN	B-NP	B-proteinexchangers	","	exchanger	NNS	I-NP	I-protein","	and	","	","	O	Oand	stabilized	and	CC	O	Ostabilized	NF-Y	stabilize	VBD	B-VP	ONF-Y	interaction	NF-Y	NN	B-NP	B-proteininteraction	with	interaction	NN	I-NP	Owith	CCAAT-box	with	IN	B-PP	OCCAAT-box	DNA	CCAAT-box	NN	B-NP	B-DNADNA	motifs	DNA	NN	I-NP	I-DNAmotifs	in	motif	NNS	I-NP	I-DNAin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	Interaction	.	.	O	OInteraction	between	Interaction	NN	B-NP	Obetween	PC4	between	IN	B-PP	OPC4	and	PC4	NN	B-NP	B-proteinand	NF-Y	and	CC	I-NP	ONF-Y	was	NF-Y	NN	I-NP	B-proteinwas	mapped	be	VBD	B-VP	Omapped	to	map	VBN	I-VP	Oto	the	to	TO	B-PP	Othe	C-terminal	the	DT	B-NP	OC-terminal	region	C-terminal	JJ	I-NP	B-proteinregion	of	region	NN	I-NP	I-proteinof	PC4	of	IN	B-PP	OPC4	","	PC4	NN	B-NP	B-protein","	and	","	","	O	Oand	the	and	CC	O	Othe	subunit	the	DT	B-NP	Osubunit	interaction	subunit	NN	I-NP	Ointeraction	subdomain	interaction	NN	I-NP	Osubdomain	of	subdomain	NN	I-NP	Oof	the	of	IN	B-PP	Othe	highly	the	DT	B-NP	Ohighly	conserved	highly	RB	I-NP	Oconserved	DNA	conserve	VBN	I-NP	ODNA	binding-subunit	DNA	NN	I-NP	B-proteinbinding-subunit	interaction	binding-subunit	NN	I-NP	I-proteininteraction	domain	interaction	NN	I-NP	I-proteindomain	(	domain	NN	I-NP	I-protein(	DBD	(	(	O	ODBD	)	DBD	NN	B-NP	B-protein)	of	)	)	O	Oof	NF-YA	of	IN	B-PP	ONF-YA	.	NF-YA	NN	B-NP	B-protein.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	in	that	IN	B-SBAR	Oin	class	in	IN	B-PP	Oclass	II+	class	NN	B-NP	OII+	mature	II+	JJ	I-NP	Omature	B-cells	mature	JJ	I-NP	OB-cells	NF-Y	B-cell	NNS	I-NP	ONF-Y	is	NF-Y	NN	I-NP	B-proteinis	associated	be	VBZ	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	the	with	IN	B-PP	Othe	protein	the	DT	B-NP	Oprotein	cofactor	protein	NN	I-NP	B-proteincofactor	","	cofactor	NN	I-NP	I-protein","	PC4	","	","	O	OPC4	","	PC4	NN	B-NP	B-protein","	which	","	","	O	Owhich	may	which	WDT	B-NP	Omay	play	may	MD	B-VP	Oplay	an	play	VB	I-VP	Oan	important	an	DT	B-NP	Oimportant	role	important	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	NF-Y-mediated	in	IN	B-PP	ONF-Y-mediated	transcriptional	NF-Y-mediated	JJ	B-NP	Otranscriptional	control	transcriptional	JJ	I-NP	Ocontrol	of	control	NN	I-NP	Oof	class	of	IN	B-PP	Oclass	II	class	NN	B-NP	B-DNAII	genes	II	CD	I-NP	I-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Arrest	.	.	O	OArrest	of	Arrest	NN	B-NP	Oof	B	of	IN	B-PP	OB	lymphocyte	B	NN	B-NP	B-cell_typelymphocyte	terminal	lymphocyte	NN	I-NP	I-cell_typeterminal	differentiation	terminal	JJ	I-NP	Odifferentiation	by	differentiation	NN	I-NP	Oby	CD40	by	IN	B-PP	OCD40	signaling	CD40	NN	B-NP	B-proteinsignaling	:	signaling	NN	I-NP	O:	mechanism	:	:	O	Omechanism	for	mechanism	NN	B-NP	Ofor	lack	for	IN	B-PP	Olack	of	lack	NN	B-NP	Oof	antibody-secreting	of	IN	B-PP	Oantibody-secreting	cells	antibody-secreting	JJ	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	germinal	in	IN	B-PP	Ogerminal	centers	germinal	JJ	B-NP	Ocenters	.	center	NNS	I-NP	O.	Despite	.	.	O	ODespite	extensive	Despite	IN	B-PP	Oextensive	research	extensive	JJ	B-NP	Oresearch	","	research	NN	I-NP	O","	the	","	","	O	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	CD40	of	IN	B-PP	OCD40	signaling	CD40	NN	B-NP	B-proteinsignaling	in	signaling	NN	I-NP	Oin	B	in	IN	B-PP	OB	cell	B	NN	B-NP	B-cell_typecell	terminal	cell	NN	I-NP	I-cell_typeterminal	differentiation	terminal	JJ	I-NP	Odifferentiation	remains	differentiation	NN	I-NP	Oremains	controversial	remain	VBZ	B-VP	Ocontroversial	.	controversial	JJ	B-ADJP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	CD40	that	IN	B-SBAR	OCD40	engagement	CD40	NN	B-NP	B-proteinengagement	arrests	engagement	NN	I-NP	Oarrests	B	arrest	VBZ	B-VP	OB	cell	B	NN	B-NP	Ocell	differentiation	cell	NN	I-NP	Odifferentiation	prior	differentiation	NN	I-NP	Oprior	to	prior	JJ	B-ADJP	Oto	plasma	to	TO	B-PP	Oplasma	cell	plasma	NN	B-NP	Ocell	formation	cell	NN	I-NP	Oformation	.	formation	NN	I-NP	O.	This	.	.	O	OThis	arrest	This	DT	B-NP	Oarrest	is	arrest	NN	I-NP	Ois	manifested	be	VBZ	B-VP	Omanifested	at	manifest	VBN	I-VP	Oat	a	at	IN	B-PP	Oa	molecular	a	DT	B-NP	Omolecular	level	molecular	JJ	I-NP	Olevel	as	level	NN	I-NP	Oas	a	as	IN	B-PP	Oa	reduction	a	DT	B-NP	Oreduction	in	reduction	NN	I-NP	Oin	mRNA	in	IN	B-PP	OmRNA	levels	mRNA	NN	B-NP	B-RNAlevels	of	level	NNS	I-NP	Oof	secretory	of	IN	B-PP	Osecretory	immunoglobulin	secretory	JJ	B-NP	Oimmunoglobulin	gene	immunoglobulin	NN	I-NP	B-proteingene	products	gene	NN	I-NP	I-proteinproducts	such	product	NNS	I-NP	I-proteinsuch	as	such	JJ	B-PP	Oas	mu	as	IN	I-PP	Omu	(	mu	NN	B-NP	O(	s	(	(	O	Os	)	s	NNS	B-NP	O)	and	)	)	O	Oand	J	and	CC	O	OJ	chain	J	NN	B-NP	B-proteinchain	as	chain	NN	I-NP	I-proteinas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	the	as	IN	I-CONJP	Othe	loss	the	DT	B-NP	Oloss	of	loss	NN	I-NP	Oof	the	of	IN	B-PP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	regulator	transcriptional	JJ	I-NP	B-proteinregulator	BLIMP-1	regulator	NN	I-NP	I-proteinBLIMP-1	.	BLIMP-1	NN	I-NP	I-protein.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	the	","	","	O	Othe	inhibition	the	DT	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	B	of	IN	B-PP	OB	cell	B	NN	B-NP	B-cell_typecell	differentiation	cell	NN	I-NP	I-cell_typedifferentiation	by	differentiation	NN	I-NP	Oby	CD40	by	IN	B-PP	OCD40	engagement	CD40	NN	B-NP	B-proteinengagement	could	engagement	NN	I-NP	Ocould	not	could	MD	B-VP	Onot	be	not	RB	I-VP	Obe	overcome	be	VB	I-VP	Oovercome	by	overcome	VBN	I-VP	Oby	either	by	IN	B-PP	Oeither	mitogens	either	CC	B-NP	Omitogens	or	mitogen	NNS	I-NP	B-proteinor	cytokines	or	CC	I-NP	Ocytokines	","	cytokine	NNS	I-NP	B-protein","	but	","	","	O	Obut	could	but	CC	O	Ocould	be	could	MD	B-VP	Obe	reversed	be	VB	I-VP	Oreversed	by	reverse	VBN	I-VP	Oby	antibodies	by	IN	B-PP	Oantibodies	that	antibody	NNS	B-NP	B-proteinthat	interfere	that	WDT	B-NP	Ointerfere	with	interfere	VBP	B-VP	Owith	the	with	IN	B-PP	Othe	CD40	the	DT	B-NP	OCD40	/	CD40	NN	I-NP	B-protein/	gp39	/	SYM	B-NP	Ogp39	interaction	gp39	NN	I-NP	B-proteininteraction	.	interaction	NN	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	secretory	that	IN	B-SBAR	Osecretory	immunoglobulin	secretory	JJ	B-NP	B-proteinimmunoglobulin	is	immunoglobulin	NN	I-NP	I-proteinis	not	be	VBZ	B-VP	Onot	produced	not	RB	I-VP	Oproduced	by	produce	VBN	I-VP	Oby	B	by	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	that	cell	NNS	I-NP	I-cell_typethat	are	that	WDT	B-NP	Oare	actively	be	VBP	B-VP	Oactively	engaged	actively	RB	I-VP	Oengaged	by	engage	VBN	I-VP	Oby	gp39-expressing	by	IN	B-PP	Ogp39-expressing	T	gp39-expressing	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	A	.	.	O	OA	positively	A	DT	B-NP	Opositively	charged	positively	RB	I-NP	Ocharged	alpha-lipoic	charge	VBN	I-NP	Oalpha-lipoic	acid	alpha-lipoic	JJ	I-NP	Oacid	analogue	acid	NN	I-NP	Oanalogue	with	analogue	NN	I-NP	Owith	increased	with	IN	B-PP	Oincreased	cellular	increase	VBN	B-NP	Ocellular	uptake	cellular	JJ	I-NP	Ouptake	and	uptake	NN	I-NP	Oand	more	and	CC	O	Omore	potent	more	RBR	B-NP	Opotent	immunomodulatory	potent	JJ	I-NP	Oimmunomodulatory	activity	immunomodulatory	JJ	I-NP	Oactivity	.	activity	NN	I-NP	O.	alpha-Lipoic	.	.	O	Oalpha-Lipoic	acid	alpha-Lipoic	JJ	B-NP	Oacid	(	acid	NN	I-NP	O(	LA	(	(	O	OLA	)	LA	NN	B-NP	O)	is	)	)	O	Ois	taken	be	VBZ	B-VP	Otaken	up	take	VBN	I-VP	Oup	by	up	RP	B-PRT	Oby	cells	by	IN	B-PP	Ocells	and	cell	NNS	B-NP	Oand	reduced	and	CC	O	Oreduced	to	reduce	VBN	B-VP	Oto	its	to	TO	B-PP	Oits	potent	its	PRP$	B-NP	Opotent	dithiol	potent	JJ	I-NP	Odithiol	form	dithiol	NN	I-NP	Oform	","	form	NN	I-NP	O","	dihydrolipoate	","	","	O	Odihydrolipoate	(	dihydrolipoate	NN	B-NP	O(	DHLA	(	(	O	ODHLA	)	DHLA	NN	B-NP	O)	","	)	)	O	O","	much	","	","	O	Omuch	of	much	JJ	B-NP	Oof	which	of	IN	B-PP	Owhich	is	which	WDT	B-NP	Ois	rapidly	be	VBZ	B-VP	Orapidly	effluxed	rapidly	RB	I-VP	Oeffluxed	out	effluxe	VBN	I-VP	Oout	from	out	RP	B-PRT	Ofrom	cells	from	IN	B-PP	Ocells	.	cell	NNS	B-NP	O.	To	.	.	O	OTo	improve	To	TO	B-VP	Oimprove	retention	improve	VB	I-VP	Oretention	in	retention	NN	B-NP	Oin	cells	in	IN	B-PP	Ocells	","	cell	NNS	B-NP	O","	the	","	","	O	Othe	LA	the	DT	B-NP	OLA	molecule	LA	NN	I-NP	B-proteinmolecule	was	molecule	NN	I-NP	I-proteinwas	modified	be	VBD	B-VP	Omodified	to	modify	VBN	I-VP	Oto	confer	to	TO	I-VP	Oconfer	a	confer	VB	I-VP	Oa	positive	a	DT	B-NP	Opositive	charge	positive	JJ	I-NP	Ocharge	at	charge	NN	I-NP	Oat	physiological	at	IN	B-PP	Ophysiological	pH	physiological	JJ	B-NP	OpH	.	pH	NN	I-NP	O.	N	.	.	O	ON	","	N	NN	B-NP	O","	N-dimethyl	","	","	O	ON-dimethyl	","	N-dimethyl	NN	B-NP	O","	N'-2-amidoethyl-lipoate	","	","	O	ON'-2-amidoethyl-lipoate	was	N'-2-amidoethyl-lipoate	NN	B-NP	Owas	synthesized	be	VBD	B-VP	Osynthesized	.	synthesize	VBN	I-VP	O.	The	.	.	O	OThe	protonated	The	DT	B-NP	Oprotonated	form	protonated	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	the	of	IN	B-PP	Othe	new	the	DT	B-NP	Onew	molecule	new	JJ	I-NP	Omolecule	is	molecule	NN	I-NP	Ois	referred	be	VBZ	B-VP	Oreferred	to	refer	VBN	I-VP	Oto	as	to	TO	B-PP	Oas	LA-Plus	as	IN	B-PP	OLA-Plus	.	LA-Plus	NN	B-NP	O.	The	.	.	O	OThe	uptake	The	DT	B-NP	Ouptake	of	uptake	NN	I-NP	Oof	LA-Plus	of	IN	B-PP	OLA-Plus	by	LA-Plus	NN	B-NP	Oby	human	by	IN	B-PP	Ohuman	Wurzburg	human	JJ	B-NP	B-cell_lineWurzburg	T	Wurzburg	NN	I-NP	I-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	was	cell	NNS	I-NP	I-cell_linewas	higher	be	VBD	B-VP	Ohigher	compared	high	JJR	B-ADJP	Ocompared	to	compare	VBN	B-PP	Oto	that	to	TO	B-PP	Othat	of	that	DT	B-NP	Oof	LA	of	IN	B-PP	OLA	.	LA	NN	B-NP	O.	Several-fold	.	.	O	OSeveral-fold	higher	Several-fold	RB	B-NP	Ohigher	amounts	high	JJR	I-NP	Oamounts	of	amount	NNS	I-NP	Oof	DHLA-Plus	of	IN	B-PP	ODHLA-Plus	","	DHLA-Plus	NN	B-NP	O","	the	","	","	O	Othe	corresponding	the	DT	B-NP	Ocorresponding	reduced	correspond	VBG	I-NP	Oreduced	form	reduce	VBN	I-NP	Oform	of	form	NN	I-NP	Oof	LA-Plus	of	IN	B-PP	OLA-Plus	","	LA-Plus	NN	B-NP	O","	were	","	","	O	Owere	detected	be	VBD	B-VP	Odetected	in	detect	VBN	I-VP	Oin	LA-Plus	in	IN	B-PP	OLA-Plus	treated	LA-Plus	JJ	B-NP	B-cell_linetreated	cells	treat	VBN	I-NP	I-cell_linecells	compared	cell	NNS	I-NP	I-cell_linecompared	to	compare	VBN	B-VP	Oto	the	to	TO	B-PP	Othe	amount	the	DT	B-NP	Oamount	of	amount	NN	I-NP	Oof	DHLA	of	IN	B-PP	ODHLA	found	DHLA	NN	B-NP	Ofound	in	find	VBN	B-VP	Oin	cells	in	IN	B-PP	Ocells	treated	cell	NNS	B-NP	Otreated	with	treat	VBN	B-VP	Owith	LA	with	IN	B-PP	OLA	.	LA	NN	B-NP	O.	At	.	.	O	OAt	100	At	IN	B-PP	O100	microM	100	CD	B-NP	OmicroM	","	microM	NN	I-NP	O","	LA	","	","	O	OLA	did	LA	NN	B-NP	Odid	not	do	VBD	B-VP	Onot	but	not	RB	O	Obut	LA-Plus	but	CC	O	OLA-Plus	inhibited	LA-Plus	NN	B-NP	Oinhibited	H2O2	inhibit	VBD	B-VP	OH2O2	induced	H2O2	NN	B-NP	Oinduced	NF-kappaB	induced	JJ	I-NP	ONF-kappaB	activation	NF-kappaB	NN	I-NP	B-proteinactivation	and	activation	NN	I-NP	Oand	NF-kappaB	and	CC	O	ONF-kappaB	directed	NF-kappaB	NN	B-NP	B-proteindirected	IL-2	direct	VBD	B-VP	OIL-2	receptor	IL-2	NN	B-NP	B-proteinreceptor	expression	receptor	NN	I-NP	I-proteinexpression	.	expression	NN	I-NP	O.	Both	.	.	O	OBoth	LA	Both	CC	O	OLA	and	LA	NN	B-NP	Oand	LA-Plus	and	CC	I-NP	OLA-Plus	synergised	LA-Plus	NN	I-NP	Osynergised	with	synergise	VBN	B-VP	Owith	selenium	with	IN	B-PP	Oselenium	in	selenium	NN	B-NP	Oin	inhibiting	in	IN	B-PP	Oinhibiting	H2O2	inhibit	VBG	B-VP	OH2O2	induced	H2O2	NN	B-NP	Oinduced	NF-kappaB	induce	VBD	B-VP	ONF-kappaB	activation	NF-kappaB	NN	B-NP	B-proteinactivation	.	activation	NN	I-NP	O.	At	.	.	O	OAt	150	At	IN	B-PP	O150	microM	150	CD	B-NP	OmicroM	LA-Plus	microM	NN	I-NP	OLA-Plus	","	LA-Plus	NN	I-NP	O","	but	","	","	O	Obut	not	but	CC	O	Onot	LA	not	RB	O	OLA	","	LA	NN	B-NP	O","	inhibited	","	","	O	Oinhibited	TNFalpha	inhibit	VBD	B-VP	OTNFalpha	induced	TNFalpha	NN	B-NP	B-proteininduced	NF-kappaB	induced	JJ	I-NP	ONF-kappaB	activation	NF-kappaB	NN	I-NP	B-proteinactivation	.	activation	NN	I-NP	O.	At	.	.	O	OAt	5	At	IN	B-PP	O5	microM	5	CD	B-NP	OmicroM	LA-Plus	microM	NN	I-NP	OLA-Plus	","	LA-Plus	NN	I-NP	O","	but	","	","	O	Obut	not	but	CC	O	Onot	LA	not	RB	O	OLA	","	LA	NN	B-NP	O","	protected	","	","	O	Oprotected	against	protect	VBD	B-VP	Oagainst	both	against	IN	B-PP	Oboth	spontaneous	both	CC	B-NP	Ospontaneous	and	spontaneous	JJ	I-NP	Oand	etoposide	and	CC	I-NP	Oetoposide	induced	etoposide	NN	I-NP	Oinduced	apoptosis	induce	VBD	B-VP	Oapoptosis	in	apoptosis	NN	B-NP	Oin	rat	in	IN	B-PP	Orat	thymocytes	rat	NN	B-NP	B-cell_typethymocytes	.	thymocyte	NNS	I-NP	I-cell_type.	LA-Plus	.	.	O	OLA-Plus	is	LA-Plus	NN	B-NP	Ois	thus	be	VBZ	B-VP	Othus	an	thus	RB	B-ADVP	Oan	improved	an	DT	B-NP	Oimproved	form	improved	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	LA	of	IN	B-PP	OLA	with	LA	NN	B-NP	Owith	increased	with	IN	B-PP	Oincreased	therapeutic	increase	VBN	B-NP	Otherapeutic	potential	therapeutic	JJ	I-NP	Opotential	.	potential	NN	I-NP	O.	Copyright	.	.	O	OCopyright	1998	Copyright	NN	B-NP	O1998	Academic	1998	CD	I-NP	OAcademic	Press	Academic	NNP	I-NP	OPress	.	Press	NNP	I-NP	O.	Carrier	.	.	O	OCarrier	identification	Carri	JJR	B-NP	Oidentification	in	identification	NN	I-NP	Oin	X-linked	in	IN	B-PP	OX-linked	immunodeficiency	X-linked	JJ	B-NP	Oimmunodeficiency	diseases	immunodeficiency	NN	I-NP	Odiseases	.	disease	NNS	I-NP	O.	OBJECTIVE	.	.	O	OOBJECTIVE	:	OBJECTIVE	NN	B-NP	O:	Carrier	:	:	O	OCarrier	identification	Carri	JJR	B-NP	Oidentification	in	identification	NN	I-NP	Oin	X-linked	in	IN	B-PP	OX-linked	immunodeficiency	X-linked	JJ	B-NP	Oimmunodeficiency	disorders	immunodeficiency	NN	I-NP	Odisorders	can	disorder	NNS	I-NP	Ocan	be	can	MD	B-VP	Obe	based	be	VB	I-VP	Obased	on	base	VBN	I-VP	Oon	the	on	IN	B-PP	Othe	demonstration	the	DT	B-NP	Odemonstration	of	demonstration	NN	I-NP	Oof	non-random	of	IN	B-PP	Onon-random	X	non-random	JJ	B-NP	OX	inactivation	X	NN	I-NP	Oinactivation	(	inactivation	NN	I-NP	O(	NRXI	(	(	O	ONRXI	)	NRXI	NN	B-NP	B-DNA)	in	)	)	O	Oin	affected	in	IN	B-PP	Oaffected	blood	affect	VBN	B-NP	Oblood	cell	blood	NN	I-NP	B-cell_typecell	lineages	cell	NN	I-NP	I-cell_typelineages	when	lineage	NNS	I-NP	I-cell_typewhen	growth	when	WRB	B-ADVP	Ogrowth	is	growth	NN	B-NP	Ois	impaired	be	VBZ	B-VP	Oimpaired	in	impair	VBN	I-VP	Oin	cells	in	IN	B-PP	Ocells	expressing	cell	NNS	B-NP	Oexpressing	the	express	VBG	B-VP	Othe	abnormal	the	DT	B-NP	Oabnormal	gene	abnormal	JJ	I-NP	B-DNAgene	.	gene	NN	I-NP	I-DNA.	We	.	.	O	OWe	examined	We	PRP	B-NP	Oexamined	the	examine	VBD	B-VP	Othe	utility	the	DT	B-NP	Outility	of	utility	NN	I-NP	Oof	seeking	of	IN	B-PP	Oseeking	evidence	seek	VBG	B-VP	Oevidence	of	evidence	NN	B-NP	Oof	NRXI	of	IN	B-PP	ONRXI	to	NRXI	NN	B-NP	B-proteinto	test	to	TO	B-VP	Otest	the	test	VB	I-VP	Othe	carrier	the	DT	B-NP	Ocarrier	status	carrier	NN	I-NP	Ostatus	of	status	NN	I-NP	Oof	women	of	IN	B-PP	Owomen	in	woman	NNS	B-NP	Oin	families	in	IN	B-PP	Ofamilies	affected	family	NNS	B-NP	Oaffected	by	affect	VBN	B-VP	Oby	X-linked	by	IN	B-PP	OX-linked	severe	X-linked	JJ	B-NP	Osevere	combined	severe	JJ	I-NP	Ocombined	immunodeficiency	combined	JJ	I-NP	Oimmunodeficiency	(	immunodeficiency	NN	I-NP	O(	XSCID	(	(	O	OXSCID	)	XSCID	NN	B-NP	O)	and	)	)	O	Oand	X-linked	and	CC	O	OX-linked	hypogammaglobulinaemia	X-linked	JJ	B-NP	Ohypogammaglobulinaemia	(	hypogammaglobulinaemia	NN	I-NP	O(	XLH	(	(	O	OXLH	)	XLH	NN	B-NP	O)	","	)	)	O	O","	to	","	","	O	Oto	identify	to	TO	B-VP	Oidentify	as	identify	VB	I-VP	Oas	carriers	as	IN	B-PP	Ocarriers	the	carrier	NNS	B-NP	Othe	mothers	the	DT	B-NP	Omothers	of	mother	NNS	I-NP	Oof	boys	of	IN	B-PP	Oboys	with	boy	NNS	B-NP	Owith	SCID	with	IN	B-PP	OSCID	or	SCID	NN	B-NP	Oor	hypogammaglobulinaemia	or	CC	I-NP	Ohypogammaglobulinaemia	whose	hypogammaglobulinaemia	NN	I-NP	Owhose	phenotype	whose	WP$	B-NP	Ophenotype	suggested	phenotype	NN	I-NP	Osuggested	X-linkage	suggest	VBD	B-VP	OX-linkage	and	X-linkage	NN	B-NP	Oand	to	and	CC	O	Oto	infer	to	TO	B-VP	Oinfer	X-linkage	infer	VB	I-VP	OX-linkage	in	X-linkage	NN	B-NP	Oin	boys	in	IN	B-PP	Oboys	with	boy	NNS	B-NP	Owith	SCID	with	IN	B-PP	OSCID	or	SCID	NN	B-NP	Oor	hypogammaglobulinaemia	or	CC	I-NP	Ohypogammaglobulinaemia	whose	hypogammaglobulinaemia	NN	I-NP	Owhose	disease	whose	WP$	B-NP	Odisease	was	disease	NN	I-NP	Owas	not	be	VBD	B-VP	Onot	clearly	not	RB	O	Oclearly	X-linked	clearly	RB	B-ADJP	OX-linked	on	X-linked	JJ	I-ADJP	Oon	the	on	IN	B-PP	Othe	basis	the	DT	B-NP	Obasis	either	basis	NN	I-NP	Oeither	of	either	CC	B-PP	Oof	family	of	IN	B-PP	Ofamily	history	family	NN	B-NP	Ohistory	or	history	NN	I-NP	Oor	clinical	or	CC	O	Oclinical	and	clinical	JJ	B-NP	Oand	immunological	and	CC	I-NP	Oimmunological	characteristics	immunological	JJ	I-NP	Ocharacteristics	.	characteristic	NNS	I-NP	O.	METHODOLOGY	.	.	O	OMETHODOLOGY	:	METHODOLOGY	NN	B-NP	O:	A	:	:	O	OA	polymerase	A	DT	B-NP	Opolymerase	chain	polymerase	NN	I-NP	Ochain	reaction-based	chain	NN	I-NP	Oreaction-based	method	reaction-based	JJ	I-NP	Omethod	was	method	NN	I-NP	Owas	used	be	VBD	B-VP	Oused	to	use	VBN	I-VP	Oto	amplify	to	TO	B-VP	Oamplify	a	amplify	VB	I-VP	Oa	polymorphic	a	DT	B-NP	Opolymorphic	CAG	polymorphic	JJ	I-NP	B-DNACAG	repeat	CAG	NN	I-NP	I-DNArepeat	in	repeat	NN	I-NP	I-DNAin	the	in	IN	B-PP	Othe	first	the	DT	B-NP	Ofirst	exon	first	JJ	I-NP	B-DNAexon	of	exon	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	androgen	the	DT	B-NP	Oandrogen	receptor	androgen	NN	I-NP	B-DNAreceptor	gene	receptor	NN	I-NP	I-DNAgene	after	gene	NN	I-NP	I-DNAafter	selective	after	IN	B-PP	Oselective	digestion	selective	JJ	B-NP	Odigestion	of	digestion	NN	I-NP	Oof	the	of	IN	B-PP	Othe	active	the	DT	B-NP	Oactive	X	active	JJ	I-NP	OX	chromosome	X	NN	I-NP	B-DNAchromosome	with	chromosome	NN	I-NP	I-DNAwith	a	with	IN	B-PP	Oa	methylation-sensitive	a	DT	B-NP	Omethylation-sensitive	enzyme	methylation-sensitive	JJ	I-NP	B-proteinenzyme	","	enzyme	NN	I-NP	I-protein","	HpaII	","	","	O	OHpaII	to	HpaII	NN	B-NP	Oto	distinguish	to	TO	B-VP	Odistinguish	between	distinguish	VB	I-VP	Obetween	the	between	IN	B-PP	Othe	paternal	the	DT	B-NP	Opaternal	and	paternal	JJ	I-NP	B-DNAand	maternal	and	CC	I-NP	I-DNAmaternal	alleles	maternal	JJ	I-NP	I-DNAalleles	and	allele	NNS	I-NP	I-DNAand	to	and	CC	O	Oto	identify	to	TO	B-VP	Oidentify	their	identify	VB	I-VP	Otheir	methylation	their	PRP$	B-NP	Omethylation	status	methylation	NN	I-NP	Ostatus	.	status	NN	I-NP	O.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	Heterozygosity	:	:	O	OHeterozygosity	was	Heterozygosity	NN	B-NP	Owas	found	be	VBD	B-VP	Ofound	in	find	VBN	I-VP	Oin	24	in	IN	B-PP	O24	of	24	CD	B-NP	Oof	31	of	IN	B-PP	O31	female	31	CD	B-NP	Ofemale	subjects	female	JJ	I-NP	Osubjects	(	subject	NNS	I-NP	O(	77	(	(	O	O77	%	77	CD	B-NP	O%	)	%	NN	I-NP	O)	.	)	)	O	O.	As	.	.	O	OAs	anticipated	As	IN	B-SBAR	Oanticipated	","	anticipate	VBN	B-VP	O","	NRXI	","	","	O	ONRXI	could	NRXI	NNP	B-NP	Ocould	be	could	MD	B-VP	Obe	demonstrated	be	VB	I-VP	Odemonstrated	in	demonstrate	VBN	I-VP	Oin	all	in	IN	B-PP	Oall	lymphoid	all	DT	B-NP	Olymphoid	cells	lymphoid	JJ	I-NP	B-cell_typecells	studied	cell	NNS	I-NP	I-cell_typestudied	from	study	VBN	B-VP	Ofrom	obligate	from	IN	B-PP	Oobligate	carriers	obligate	JJ	B-NP	Ocarriers	of	carrier	NNS	I-NP	Oof	XSCID	of	IN	B-PP	OXSCID	and	XSCID	NN	B-NP	Oand	an	and	CC	O	Oan	obligate	an	DT	B-NP	Oobligate	carrier	obligate	JJ	I-NP	Ocarrier	of	carrier	NN	I-NP	Oof	XLH	of	IN	B-PP	OXLH	but	XLH	NN	B-NP	B-proteinbut	not	but	CC	B-PP	Onot	on	not	RB	B-PP	Oon	a	on	IN	I-PP	Oa	carrier	a	DT	B-NP	Ocarrier	of	carrier	NN	I-NP	Oof	X-linked	of	IN	B-PP	OX-linked	immunodeficiency	X-linked	JJ	B-NP	Oimmunodeficiency	with	immunodeficiency	NN	I-NP	Owith	hyper-IgM	with	IN	B-PP	Ohyper-IgM	.	hyper-IgM	NN	B-NP	O.	The	.	.	O	OThe	finding	The	DT	B-NP	Ofinding	of	finding	NN	I-NP	Oof	NRXI	of	IN	B-PP	ONRXI	in	NRXI	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	mother	the	DT	B-NP	Omother	of	mother	NN	I-NP	Oof	a	of	IN	B-PP	Oa	boy	a	DT	B-NP	Oboy	with	boy	NN	I-NP	Owith	a	with	IN	B-PP	Oa	SCID	a	DT	B-NP	OSCID	variant	SCID	NN	I-NP	B-cell_linevariant	showed	variant	NN	I-NP	I-cell_lineshowed	her	show	VBD	B-VP	Oher	to	her	PRP	B-NP	Oto	be	to	TO	B-VP	Obe	a	be	VB	I-VP	Oa	carrier	a	DT	B-NP	Ocarrier	of	carrier	NN	I-NP	Oof	XSCID	of	IN	B-PP	OXSCID	and	XSCID	NN	B-NP	Oand	establishes	and	CC	O	Oestablishes	that	establish	VBZ	B-VP	Othat	her	that	IN	B-SBAR	Oher	son	her	PRP$	B-NP	Oson	has	son	NN	I-NP	Ohas	XSCID	have	VBZ	B-VP	OXSCID	","	XSCID	NN	B-NP	O","	not	","	","	O	Onot	otherwise	not	RB	O	Ootherwise	evident	otherwise	RB	B-ADJP	Oevident	from	evident	JJ	I-ADJP	Ofrom	available	from	IN	B-PP	Oavailable	data	available	JJ	B-NP	Odata	.	datum	NNS	I-NP	O.	CONCLUSIONS	.	.	O	OCONCLUSIONS	:	CONCLUSIONS	NNS	B-NP	O:	This	:	:	O	OThis	PCR	This	DT	B-NP	OPCR	assay	PCR	NN	I-NP	Oassay	provides	assay	NN	I-NP	Oprovides	a	provide	VBZ	B-VP	Oa	rapid	a	DT	B-NP	Orapid	method	rapid	JJ	I-NP	Omethod	for	method	NN	I-NP	Ofor	carrier	for	IN	B-PP	Ocarrier	detection	carrier	NN	B-NP	Odetection	of	detection	NN	I-NP	Oof	X-linked	of	IN	B-PP	OX-linked	immunodeficiencies	X-linked	JJ	B-NP	Oimmunodeficiencies	","	immunodeficiency	NNS	I-NP	O","	and	","	","	O	Oand	has	and	CC	O	Ohas	allowed	have	VBZ	B-VP	Oallowed	us	allow	VBN	I-VP	Ous	to	us	PRP	B-NP	Oto	expand	to	TO	B-VP	Oexpand	the	expand	VB	I-VP	Othe	phenotype	the	DT	B-NP	Ophenotype	of	phenotype	NN	I-NP	Oof	XSCID	of	IN	B-PP	OXSCID	Leukocyte-endothelial	XSCID	NN	B-NP	OLeukocyte-endothelial	interaction	Leukocyte-endothelial	JJ	B-NP	Ointeraction	is	interaction	NN	I-NP	Ois	augmented	be	VBZ	B-VP	Oaugmented	by	augment	VBN	I-VP	Oby	high	by	IN	B-PP	Ohigh	glucose	high	JJ	B-NP	Oglucose	concentrations	glucose	NN	I-NP	Oconcentrations	and	concentration	NNS	I-NP	Oand	hyperglycemia	and	CC	O	Ohyperglycemia	in	hyperglycemia	NN	B-NP	Oin	a	in	IN	B-PP	Oa	NF-kB-dependent	a	DT	B-NP	ONF-kB-dependent	fashion	NF-kB-dependent	JJ	I-NP	Ofashion	.	fashion	NN	I-NP	O.	We	.	.	O	OWe	addressed	We	PRP	B-NP	Oaddressed	the	address	VBD	B-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	hyperglycemia	of	IN	B-PP	Ohyperglycemia	in	hyperglycemia	NN	B-NP	Oin	leukocyte-endothelium	in	IN	B-PP	Oleukocyte-endothelium	interaction	leukocyte-endothelium	JJ	B-NP	Ointeraction	under	interaction	NN	I-NP	Ounder	flow	under	IN	B-PP	Oflow	conditions	flow	NN	B-NP	Oconditions	by	condition	NNS	I-NP	Oby	exposing	by	IN	B-PP	Oexposing	human	expose	VBG	B-VP	Ohuman	umbilical	human	JJ	B-NP	B-cell_typeumbilical	vein	umbilical	JJ	I-NP	I-cell_typevein	endothelial	vein	NN	I-NP	I-cell_typeendothelial	cells	endothelial	JJ	I-NP	I-cell_typecells	for	cell	NNS	I-NP	I-cell_typefor	24	for	IN	B-PP	O24	h	24	CD	B-NP	Oh	to	h	NN	I-NP	Oto	normal	to	TO	B-PP	Onormal	(	normal	JJ	B-ADJP	O(	5	(	(	O	O5	mM	5	CD	B-NP	OmM	)	mM	NN	I-NP	O)	","	)	)	O	O","	high	","	","	O	Ohigh	concentration	high	JJ	B-NP	Oconcentration	of	concentration	NN	I-NP	Oof	glucose	of	IN	B-PP	Oglucose	(	glucose	NN	B-NP	O(	30	(	(	O	O30	mM	30	CD	B-NP	OmM	)	mM	NN	I-NP	O)	","	)	)	O	O","	advanced	","	","	O	Oadvanced	glycosylation	advance	VBD	B-VP	Oglycosylation	end	glycosylation	NN	B-NP	B-proteinend	product-albumin	end	NN	I-NP	I-proteinproduct-albumin	(	product-albumin	NN	I-NP	I-protein(	100	(	(	O	O100	microg/ml	100	CD	B-NP	Omicrog/ml	)	microg/ml	NN	I-NP	O)	","	)	)	O	O","	or	","	","	O	Oor	hyperglycemic	or	CC	O	Ohyperglycemic	(	hyperglycemic	JJ	B-ADJP	O(	174-316	(	(	O	O174-316	mg/dl	174-316	CD	B-NP	Omg/dl	)	mg/dl	NN	I-NP	O)	sera	)	)	O	Osera	from	serum	NNS	B-NP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	diabetes	with	IN	B-PP	Odiabetes	and	diabetes	NN	B-NP	Oand	abnormal	and	CC	O	Oabnormal	hemoglobin	abnormal	JJ	B-NP	Ohemoglobin	A1c	hemoglobin	NN	I-NP	OA1c	(	A1c	NN	I-NP	O(	8.1+/-1.4	(	(	O	O8.1+/-1.4	%	8.1+/-1.4	CD	B-NP	O%	)	%	NN	I-NP	O)	.	)	)	O	O.	At	.	.	O	OAt	the	At	IN	B-PP	Othe	end	the	DT	B-NP	Oend	of	end	NN	I-NP	Oof	incubation	of	IN	B-PP	Oincubation	endothelial	incubation	NN	B-NP	Oendothelial	cells	endothelial	JJ	I-NP	Ocells	were	cell	NNS	I-NP	Owere	perfused	be	VBD	B-VP	Operfused	with	perfuse	VBN	I-VP	Owith	total	with	IN	B-PP	Ototal	leukocyte	total	JJ	B-NP	Oleukocyte	suspension	leukocyte	NN	I-NP	Osuspension	in	suspension	NN	I-NP	Oin	a	in	IN	B-PP	Oa	parallel	a	DT	B-NP	Oparallel	plate	parallel	JJ	I-NP	Oplate	flow	plate	NN	I-NP	Oflow	chamber	flow	NN	I-NP	Ochamber	under	chamber	NN	I-NP	Ounder	laminar	under	IN	B-PP	Olaminar	flow	laminar	JJ	B-NP	Oflow	(	flow	NN	I-NP	O(	1.5	(	(	O	O1.5	dyn/cm2	1.5	CD	B-NP	Odyn/cm2	)	dyn/cm2	NN	I-NP	O)	.	)	)	O	O.	Rolling	.	.	O	ORolling	and	Rolling	NN	B-NP	Oand	adherent	and	CC	O	Oadherent	cells	adherent	JJ	B-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	evaluated	be	VBD	B-VP	Oevaluated	by	evaluate	VBN	I-VP	Oby	digital	by	IN	B-PP	Odigital	image	digital	JJ	B-NP	Oimage	processing	image	NN	I-NP	Oprocessing	.	processing	NN	I-NP	O.	Results	.	.	O	OResults	showed	Result	NNS	B-NP	Oshowed	that	show	VBD	B-VP	Othat	30	that	IN	B-SBAR	O30	mM	30	CD	B-NP	OmM	glucose	mM	NN	I-NP	Oglucose	significantly	glucose	NN	I-NP	Osignificantly	(	significantly	RB	B-ADVP	O(	P	(	(	O	OP	<	P	NN	B-NP	O<	0.01	<	SYM	O	O0.01	)	0.01	CD	B-NP	O)	increased	)	)	O	Oincreased	the	increase	VBD	B-VP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	adherent	of	IN	B-PP	Oadherent	leukocytes	adherent	JJ	B-NP	B-cell_typeleukocytes	to	leukocyte	NNS	I-NP	I-cell_typeto	endothelial	to	TO	B-PP	Oendothelial	cells	endothelial	JJ	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	respect	in	IN	B-PP	Orespect	to	respect	NN	B-NP	Oto	control	to	TO	B-PP	Ocontrol	(	control	NN	B-NP	O(	5	(	(	O	O5	mM	5	CD	B-NP	OmM	glucose	mM	NN	I-NP	Oglucose	;	glucose	NN	I-NP	O;	151+/-19	;	:	O	O151+/-19	versus	151+/-19	CD	B-NP	Oversus	33+/-8	versus	IN	I-NP	O33+/-8	cells/mm2	33+/-8	CD	I-NP	Ocells/mm2	)	cells/mm2	NNS	I-NP	O)	.	)	)	O	O.	A	.	.	O	OA	similar	A	DT	B-NP	Osimilar	response	similar	JJ	I-NP	Oresponse	was	response	NN	I-NP	Owas	induced	be	VBD	B-VP	Oinduced	by	induce	VBN	I-VP	Oby	endothelial	by	IN	B-PP	Oendothelial	stimulation	endothelial	JJ	B-NP	Ostimulation	with	stimulation	NN	I-NP	Owith	IL-1beta	with	IN	B-PP	OIL-1beta	","	IL-1beta	NN	B-NP	B-protein","	here	","	","	O	Ohere	used	here	RB	B-ADVP	Oused	as	use	VBN	B-VP	Oas	positive	as	IN	B-PP	Opositive	control	positive	JJ	B-NP	Ocontrol	(	control	NN	I-NP	O(	195+/-20	(	(	O	O195+/-20	cells/mm2	195+/-20	CD	B-NP	Ocells/mm2	)	cells/mm2	NNS	I-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	number	The	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	rolling	of	IN	B-PP	Orolling	cells	roll	VBG	B-VP	B-cell_typecells	on	cell	NNS	B-NP	I-cell_typeon	endothelial	on	IN	B-PP	Oendothelial	surface	endothelial	JJ	B-NP	Osurface	was	surface	NN	I-NP	Owas	not	be	VBD	B-VP	Onot	affected	not	RB	I-VP	Oaffected	by	affect	VBN	I-VP	Oby	high	by	IN	B-PP	Ohigh	glucose	high	JJ	B-NP	Oglucose	level	glucose	NN	I-NP	Olevel	.	level	NN	I-NP	O.	Stable	.	.	O	OStable	adhesion	Stable	JJ	B-NP	Oadhesion	of	adhesion	NN	I-NP	Oof	leukocytes	of	IN	B-PP	Oleukocytes	to	leukocyte	NNS	B-NP	B-cell_typeto	glucose-treated	to	TO	B-PP	Oglucose-treated	as	glucose-treated	JJ	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	to	as	IN	I-CONJP	Oto	IL-1beta-stimulated	to	TO	B-PP	OIL-1beta-stimulated	endothelial	IL-1beta-stimulated	JJ	B-NP	B-cell_lineendothelial	cells	endothelial	JJ	I-NP	I-cell_linecells	was	cell	NNS	I-NP	I-cell_linewas	preceded	be	VBD	B-VP	Opreceded	by	precede	VBN	I-VP	Oby	short	by	IN	B-PP	Oshort	interaction	short	JJ	B-NP	Ointeraction	of	interaction	NN	I-NP	Oof	leukocytes	of	IN	B-PP	Oleukocytes	with	leukocyte	NNS	B-NP	B-cell_typewith	the	with	IN	B-PP	Othe	endothelial	the	DT	B-NP	Oendothelial	surface	endothelial	JJ	I-NP	Osurface	.	surface	NN	I-NP	O.	The	.	.	O	OThe	distance	The	DT	B-NP	Odistance	travelled	distance	NN	I-NP	Otravelled	by	travel	VBN	B-VP	Oby	leukocytes	by	IN	B-PP	Oleukocytes	before	leukocyte	NNS	B-NP	B-cell_typebefore	arrest	before	IN	B-PP	Oarrest	on	arrest	NN	B-NP	Oon	30	on	IN	B-PP	O30	mM	30	CD	B-NP	OmM	glucose	mM	NN	I-NP	Oglucose	","	glucose	NN	I-NP	O","	or	","	","	O	Oor	on	or	CC	O	Oon	IL-1beta-treated	on	IN	B-PP	OIL-1beta-treated	endothelial	IL-1beta-treated	JJ	B-NP	B-cell_lineendothelial	cells	endothelial	JJ	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	was	","	","	O	Owas	significantly	be	VBD	B-VP	Osignificantly	(	significantly	RB	B-ADVP	O(	P	(	(	O	OP	<	P	NN	B-NP	O<	0.01	<	SYM	B-NP	O0.01	)	0.01	CD	I-NP	O)	higher	)	)	O	Ohigher	than	high	JJR	B-ADJP	Othan	that	than	IN	B-PP	Othat	observed	that	DT	B-NP	Oobserved	for	observe	VBN	B-VP	Ofor	leukocytes	for	IN	B-PP	Oleukocytes	adhering	leukocyte	NNS	B-NP	B-cell_typeadhering	on	adhere	VBG	B-VP	Oon	control	on	IN	B-PP	Ocontrol	endothelium	control	NN	B-NP	Oendothelium	(	endothelium	NN	I-NP	O(	30	(	(	O	O30	mM	30	CD	B-NP	OmM	glucose	mM	NN	I-NP	Oglucose	:	glucose	NN	I-NP	O:	76.7+/-3.5	:	:	O	O76.7+/-3.5	;	76.7+/-3.5	CD	B-NP	O;	IL1beta	;	:	O	OIL1beta	:	IL1beta	NN	B-NP	B-protein:	69.7+/-4	:	:	O	O69.7+/-4	versus	69.7+/-4	CD	B-NP	Oversus	5	versus	IN	I-NP	O5	mM	5	CD	I-NP	OmM	glucose	mM	NN	I-NP	Oglucose	:	glucose	NN	I-NP	O:	21.5+/-5	:	:	O	O21.5+/-5	microm	21.5+/-5	CD	B-NP	Omicrom	)	microm	NN	I-NP	O)	.	)	)	O	O.	Functional	.	.	O	OFunctional	blocking	Functional	JJ	B-NP	Oblocking	of	blocking	NN	I-NP	Oof	E-selectin	of	IN	B-PP	OE-selectin	","	E-selectin	NN	B-NP	B-protein","	intercellular	","	","	O	Ointercellular	cell	intercellular	JJ	B-NP	B-proteincell	adhesion	cell	NN	I-NP	I-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	","	molecule-1	NN	I-NP	I-protein","	and	","	","	O	Oand	vascular	and	CC	O	Ovascular	cell	vascular	JJ	B-NP	B-proteincell	adhesion	cell	NN	I-NP	I-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	on	molecule-1	NN	I-NP	I-proteinon	endothelial	on	IN	B-PP	Oendothelial	cells	endothelial	JJ	B-NP	B-cell_typecells	with	cell	NNS	I-NP	I-cell_typewith	the	with	IN	B-PP	Othe	corresponding	the	DT	B-NP	Ocorresponding	mouse	correspond	VBG	I-NP	Omouse	mAb	mouse	NN	I-NP	B-proteinmAb	significantly	mAb	NN	I-NP	I-proteinsignificantly	inhibited	significantly	RB	B-ADVP	Oinhibited	glucose-induced	inhibit	VBD	B-VP	Oglucose-induced	increase	glucose-induced	JJ	B-NP	Oincrease	in	increase	NN	I-NP	Oin	leukocyte	in	IN	B-PP	Oleukocyte	adhesion	leukocyte	NN	B-NP	Oadhesion	(	adhesion	NN	I-NP	O(	67+/-16	(	(	O	O67+/-16	","	67+/-16	CD	B-NP	O","	83+/-12	","	","	I-NP	O83+/-12	","	83+/-12	CD	I-NP	O","	62+/-8	","	","	I-NP	O62+/-8	versus	62+/-8	CD	I-NP	Oversus	144+/-21	versus	IN	I-NP	O144+/-21	cells/	144+/-21	CD	I-NP	Ocells/	mm2	cells/	NNS	I-NP	Omm2	)	mm2	NN	I-NP	O)	.	)	)	O	O.	Confocal	.	.	O	OConfocal	fluorescence	Confocal	JJ	B-NP	Ofluorescence	microscopy	fluorescence	NN	I-NP	Omicroscopy	studies	microscopy	NN	I-NP	Ostudies	showed	study	NNS	I-NP	Oshowed	that	show	VBD	B-VP	Othat	30	that	IN	B-SBAR	O30	mM	30	CD	B-NP	OmM	glucose	mM	NN	I-NP	Oglucose	induced	glucose	NN	I-NP	Oinduced	an	induce	VBD	B-VP	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	endothelial	in	IN	B-PP	Oendothelial	surface	endothelial	JJ	B-NP	Osurface	expression	surface	NN	I-NP	Oexpression	of	expression	NN	I-NP	Oof	E-selectin	of	IN	B-PP	OE-selectin	","	E-selectin	NN	B-NP	B-protein","	intercellular	","	","	O	Ointercellular	cell	intercellular	JJ	B-NP	B-proteincell	adhesion	cell	NN	I-NP	I-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	","	molecule-1	NN	I-NP	I-protein","	and	","	","	O	Oand	vascular	and	CC	O	Ovascular	cell	vascular	JJ	B-NP	B-proteincell	adhesion	cell	NN	I-NP	I-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	.	molecule-1	NN	I-NP	I-protein.	Electrophoretic	.	.	O	OElectrophoretic	mobility	Electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assay	shift	NN	I-NP	Oassay	of	assay	NN	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	extracts	nuclear	JJ	B-NP	Oextracts	of	extract	NNS	I-NP	Oof	human	of	IN	B-PP	Ohuman	umbilical	human	JJ	B-NP	B-cell_typeumbilical	vein	umbilical	JJ	I-NP	I-cell_typevein	endothelial	vein	NN	I-NP	I-cell_typeendothelial	cells	endothelial	JJ	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	HUVEC	(	(	O	OHUVEC	)	HUVEC	NNS	B-NP	B-cell_line)	exposed	)	)	O	Oexposed	for	expose	VBN	B-VP	Ofor	1	for	IN	B-PP	O1	h	1	CD	B-NP	Oh	to	h	NN	I-NP	Oto	30	to	TO	B-PP	O30	mM	30	CD	B-NP	OmM	glucose	mM	NN	I-NP	Oglucose	revealed	glucose	NN	I-NP	Orevealed	an	reveal	VBD	B-VP	Oan	intense	an	DT	B-NP	Ointense	NF-kB	intense	JJ	I-NP	ONF-kB	activation	NF-kB	NN	I-NP	B-proteinactivation	.	activation	NN	I-NP	O.	Treatment	.	.	O	OTreatment	of	Treatment	NN	B-NP	Oof	HUVEC	of	IN	B-PP	OHUVEC	exposed	HUVEC	NNS	B-NP	B-cell_lineexposed	to	expose	VBN	B-VP	Oto	high	to	TO	B-PP	Ohigh	glucose	high	JJ	B-NP	Oglucose	with	glucose	NN	I-NP	Owith	the	with	IN	B-PP	Othe	NF-kB	the	DT	B-NP	ONF-kB	inhibitors	NF-kB	NN	I-NP	B-proteininhibitors	pyrrolidinedithiocarbamate	inhibitor	NNS	I-NP	Opyrrolidinedithiocarbamate	(	pyrrolidinedithiocarbamate	NN	I-NP	O(	100	(	(	O	O100	microM	100	CD	B-NP	OmicroM	)	microM	NN	I-NP	O)	and	)	)	O	Oand	tosyl-phe-chloromethylketone	and	CC	O	Otosyl-phe-chloromethylketone	(	tosyl-phe-chloromethylketone	NN	B-NP	O(	25	(	(	O	O25	microM	25	CD	B-NP	OmicroM	)	microM	NN	I-NP	O)	significantly	)	)	O	Osignificantly	reduced	significantly	RB	B-VP	Oreduced	(	reduce	VBD	I-VP	O(	P	(	(	O	OP	<	P	NN	O	O<	0.05	<	SYM	O	O0.05	)	0.05	CD	O	O)	leukocyte	)	)	O	Oleukocyte	adhesion	leukocyte	NN	B-NP	Oadhesion	in	adhesion	NN	I-NP	Oin	respect	in	IN	B-PP	Orespect	to	respect	NN	B-NP	Oto	HUVEC	to	TO	B-PP	OHUVEC	treated	HUVEC	NN	B-NP	B-cell_linetreated	with	treat	VBN	B-VP	Owith	glucose	with	IN	B-PP	Oglucose	alone	glucose	NN	B-NP	Oalone	.	alone	RB	B-ADVP	O.	A	.	.	O	OA	significant	A	DT	O	Osignificant	(	significant	JJ	O	O(	P	(	(	O	OP	<	P	NN	B-NP	O<	0.01	<	SYM	O	O0.01	)	0.01	CD	O	O)	inhibitory	)	)	O	Oinhibitory	effect	inhibitory	JJ	B-NP	Oeffect	on	effect	NN	I-NP	Oon	glucose-induced	on	IN	B-PP	Oglucose-induced	leukocyte	glucose-induced	JJ	B-NP	Oleukocyte	adhesion	leukocyte	NN	I-NP	Oadhesion	was	adhesion	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	after	observe	VBN	I-VP	Oafter	blocking	after	IN	B-PP	Oblocking	protein	block	VBG	B-VP	Oprotein	kinase	protein	NN	B-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	activity	C	NN	I-NP	I-proteinactivity	with	activity	NN	I-NP	Owith	staurosporine	with	IN	B-PP	Ostaurosporine	(	staurosporine	NN	B-NP	O(	5	(	(	O	O5	nM	5	CD	B-NP	OnM	)	nM	NN	I-NP	O)	.	)	)	O	O.	When	.	.	O	OWhen	HUVEC	When	WRB	B-ADVP	OHUVEC	were	HUVEC	NNS	B-NP	B-cell_typewere	treated	be	VBD	B-VP	Otreated	with	treat	VBN	I-VP	Owith	specific	with	IN	B-PP	Ospecific	antisense	specific	JJ	B-NP	Oantisense	oligodesoxynucleotides	antisense	JJ	I-NP	Ooligodesoxynucleotides	against	oligodesoxynucleotide	NNS	I-NP	Oagainst	PKCalpha	against	IN	B-PP	OPKCalpha	and	PKCalpha	NN	B-NP	B-proteinand	PKCepsilon	and	CC	I-NP	OPKCepsilon	isoforms	PKCepsilon	NN	I-NP	B-proteinisoforms	before	isoform	NNS	I-NP	I-proteinbefore	the	before	IN	B-PP	Othe	addition	the	DT	B-NP	Oaddition	of	addition	NN	I-NP	Oof	30	of	IN	B-PP	O30	mM	30	CD	B-NP	OmM	glucose	mM	NN	I-NP	Oglucose	","	glucose	NN	I-NP	O","	a	","	","	O	Oa	significant	a	DT	O	Osignificant	(	significant	JJ	O	O(	P	(	(	O	OP	<	P	NN	O	O<	0.05	<	SYM	O	O0.05	)	0.05	CD	O	O)	reduction	)	)	O	Oreduction	in	reduction	NN	B-NP	Oin	the	in	IN	B-PP	Othe	adhesion	the	DT	B-NP	Oadhesion	was	adhesion	NN	I-NP	Owas	also	be	VBD	B-VP	Oalso	seen	also	RB	I-VP	Oseen	.	see	VBN	I-VP	O.	Advanced	.	.	O	OAdvanced	glycosylation	Advance	VBN	B-NP	Oglycosylation	end	glycosylation	NN	I-NP	B-proteinend	product-albumin	end	NN	I-NP	I-proteinproduct-albumin	significantly	product-albumin	NN	I-NP	I-proteinsignificantly	increased	significantly	RB	B-ADVP	Oincreased	the	increase	VBD	B-VP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	adhering	of	IN	B-PP	Oadhering	leukocytes	adhering	JJ	B-NP	B-cell_typeleukocytes	in	leukocyte	NNS	I-NP	I-cell_typein	respect	in	IN	B-PP	Orespect	to	respect	NN	B-NP	Oto	native	to	TO	B-PP	Onative	albumin	native	JJ	B-NP	Oalbumin	used	albumin	NN	I-NP	Oused	as	use	VBN	B-VP	Oas	control	as	IN	B-PP	Ocontrol	(	control	NN	B-NP	O(	110+/-16	(	(	O	O110+/-16	versus	110+/-16	CD	B-NP	Oversus	66+/-7	versus	IN	B-PP	O66+/-7	","	66+/-7	CD	B-NP	O","	P	","	","	O	OP	<	P	NN	B-NP	O<	0.01	<	SYM	B-NP	O0.01	)	0.01	CD	I-NP	O)	.	)	)	O	O.	Sera	.	.	O	OSera	from	Sera	NN	B-NP	Ofrom	diabetic	from	IN	B-PP	Odiabetic	patients	diabetic	JJ	B-NP	Opatients	significantly	patient	NNS	I-NP	Osignificantly	(	significantly	RB	B-ADVP	O(	P	(	(	O	OP	<	P	NN	B-NP	O<	0.01	<	SYM	O	O0.01	)	0.01	CD	B-NP	O)	enhanced	)	)	O	Oenhanced	leukocyte	enhance	VBD	B-VP	Oleukocyte	adhesion	leukocyte	NN	B-NP	Oadhesion	as	adhesion	NN	I-NP	Oas	compared	as	IN	B-PP	Ocompared	with	compare	VBN	B-PP	Owith	controls	with	IN	B-PP	Ocontrols	","	control	NNS	B-NP	O","	despite	","	","	O	Odespite	normal	despite	IN	B-PP	Onormal	levels	normal	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	IL-1beta	of	IN	B-PP	OIL-1beta	and	IL-1beta	NN	B-NP	B-proteinand	TNFalpha	and	CC	I-NP	OTNFalpha	in	TNFalpha	NN	I-NP	B-proteinin	these	in	IN	B-PP	Othese	sera	these	DT	B-NP	Osera	.	serum	NNS	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	indicate	datum	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	high	that	IN	B-SBAR	Ohigh	glucose	high	JJ	B-NP	Oglucose	concentration	glucose	NN	I-NP	Oconcentration	and	concentration	NN	I-NP	Oand	hyperglycemia	and	CC	I-NP	Ohyperglycemia	promote	hyperglycemia	NN	I-NP	Opromote	leukocyte	promote	VBP	B-VP	Oleukocyte	adhesion	leukocyte	NN	B-NP	Oadhesion	to	adhesion	NN	I-NP	Oto	the	to	TO	B-PP	Othe	endothelium	the	DT	B-NP	Oendothelium	through	endothelium	NN	I-NP	Othrough	upregulation	through	IN	B-PP	Oupregulation	of	upregulation	NN	B-NP	Oof	cell	of	IN	B-PP	Ocell	surface	cell	NN	B-NP	Osurface	expression	surface	NN	I-NP	Oexpression	of	expression	NN	I-NP	Oof	adhesive	of	IN	B-PP	Oadhesive	proteins	adhesive	JJ	B-NP	B-proteinproteins	","	protein	NNS	I-NP	I-protein","	possibly	","	","	O	Opossibly	depending	possibly	RB	B-ADVP	Odepending	on	depend	VBG	B-PP	Oon	NF-kB	on	IN	B-PP	ONF-kB	activation	NF-kB	NN	B-NP	B-proteinactivation	.	activation	NN	I-NP	O.	Ikaros	.	.	O	OIkaros	in	Ikaros	NN	B-NP	B-proteinin	hemopoietic	in	IN	B-PP	Ohemopoietic	lineage	hemopoietic	JJ	B-NP	Olineage	determination	lineage	NN	I-NP	Odetermination	and	determination	NN	I-NP	Oand	homeostasis	and	CC	I-NP	Ohomeostasis	.	homeostasis	NN	I-NP	O.	Studies	.	.	O	OStudies	on	Study	NNS	B-NP	Oon	the	on	IN	B-PP	Othe	molecular	the	DT	B-NP	Omolecular	mechanisms	molecular	JJ	I-NP	Omechanisms	that	mechanism	NNS	I-NP	Othat	control	that	WDT	B-NP	Ocontrol	hemopoietic	control	VBP	B-VP	Ohemopoietic	differentiation	hemopoietic	JJ	B-NP	Odifferentiation	have	differentiation	NN	I-NP	Ohave	focused	have	VBP	B-VP	Ofocused	on	focus	VBN	I-VP	Oon	signaling	on	IN	B-PP	Osignaling	cascades	signaling	NN	B-NP	Ocascades	and	cascade	NNS	I-NP	Oand	nuclear	and	CC	O	Onuclear	effectors	nuclear	JJ	B-NP	Oeffectors	that	effector	NNS	I-NP	Othat	drive	that	WDT	B-NP	Odrive	this	drive	VBP	B-VP	Othis	complex	this	DT	B-NP	Ocomplex	developmental	complex	JJ	I-NP	Odevelopmental	system	developmental	JJ	I-NP	Osystem	in	system	NN	I-NP	Oin	a	in	IN	B-PP	Oa	regulated	a	DT	B-NP	Oregulated	fashion	regulated	JJ	I-NP	Ofashion	.	fashion	NN	I-NP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	review	we	PRP	B-NP	Oreview	the	review	VBP	B-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	Ikaros	of	IN	B-PP	OIkaros	","	Ikaros	NN	B-NP	B-protein","	the	","	","	O	Othe	founding	the	DT	B-NP	Ofounding	member	founding	JJ	I-NP	Omember	of	member	NN	I-NP	Oof	a	of	IN	B-PP	Oa	unique	a	DT	B-NP	Ounique	family	unique	JJ	I-NP	Ofamily	of	family	NN	I-NP	Oof	zinc	of	IN	B-PP	Ozinc	finger	zinc	NN	B-NP	B-proteinfinger	transcription	finger	NN	I-NP	I-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	in	factor	NNS	I-NP	I-proteinin	this	in	IN	B-PP	Othis	developmental	this	DT	B-NP	Odevelopmental	process	developmental	JJ	I-NP	Oprocess	.	process	NN	I-NP	O.	Studies	.	.	O	OStudies	on	Study	NNS	B-NP	Oon	an	on	IN	B-PP	Oan	Ikaros	an	DT	B-NP	OIkaros	null	Ikaros	NN	I-NP	B-proteinnull	mutation	null	JJ	I-NP	Omutation	have	mutation	NN	I-NP	Ohave	revealed	have	VBP	B-VP	Orevealed	an	reveal	VBN	I-VP	Oan	essential	an	DT	B-NP	Oessential	role	essential	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	this	for	IN	B-PP	Othis	factor	this	DT	B-NP	Ofactor	in	factor	NN	I-NP	Oin	lymphoid	in	IN	B-PP	Olymphoid	cell	lymphoid	JJ	B-NP	B-cell_typecell	fate	cell	NN	I-NP	I-cell_typefate	determination	fate	NN	I-NP	Odetermination	and	determination	NN	I-NP	Oand	at	and	CC	B-PP	Oat	subsequent	at	IN	B-PP	Osubsequent	branch	subsequent	JJ	B-NP	Obranch	points	branch	NN	I-NP	Opoints	of	point	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	T	the	DT	B-NP	OT	cell	T	NN	I-NP	Ocell	differentiation	cell	NN	I-NP	Odifferentiation	pathway	differentiation	NN	I-NP	Opathway	.	pathway	NN	I-NP	O.	Differences	.	.	O	ODifferences	in	Difference	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	phenotypes	the	DT	B-NP	Ophenotypes	of	phenotype	NNS	I-NP	Oof	a	of	IN	B-PP	Oa	null	a	DT	B-NP	Onull	and	null	NN	I-NP	Oand	a	and	CC	O	Oa	dominant	a	DT	B-NP	Odominant	negative	dominant	JJ	I-NP	Onegative	(	negative	JJ	I-NP	O(	DN	(	(	O	ODN	)	DN	JJ	B-ADJP	O)	Ikaros	)	)	O	OIkaros	mutation	Ikaros	NN	B-NP	Omutation	provide	mutation	NN	I-NP	Oprovide	insight	provide	VBP	B-VP	Oinsight	into	insight	NN	B-NP	Ointo	a	into	IN	B-PP	Oa	regulatory	a	DT	B-NP	Oregulatory	network	regulatory	JJ	I-NP	Onetwork	through	network	NN	I-NP	Othrough	which	through	IN	B-PP	Owhich	Ikaros	which	WDT	B-NP	OIkaros	proteins	Ikaros	NN	B-NP	B-proteinproteins	exert	protein	NNS	I-NP	I-proteinexert	their	exert	VBP	B-VP	Otheir	effects	their	PRP$	B-NP	Oeffects	in	effect	NNS	I-NP	Oin	development	in	IN	B-PP	Odevelopment	.	development	NN	B-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	a	addition	NN	B-NP	Oa	comparative	a	DT	B-NP	Ocomparative	analysis	comparative	JJ	I-NP	Oanalysis	of	analysis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	hemopoietic	the	DT	B-NP	Ohemopoietic	stem	hemopoietic	JJ	I-NP	B-cell_typestem	cell	stem	NN	I-NP	I-cell_typecell	and	cell	NN	I-NP	I-cell_typeand	precursor	and	CC	I-NP	Oprecursor	compartment	precursor	NN	I-NP	Ocompartment	resulting	compartment	NN	I-NP	Oresulting	from	result	VBG	B-VP	Ofrom	the	from	IN	B-PP	Othe	two	the	DT	B-NP	Otwo	Ikaros	two	CD	I-NP	OIkaros	mutations	Ikaros	NN	I-NP	Omutations	reveals	mutation	NNS	I-NP	Oreveals	a	reveal	VBZ	B-VP	Oa	profound	a	DT	B-NP	Oprofound	yet	profound	JJ	I-NP	Oyet	not	yet	CC	O	Onot	absolute	not	RB	O	Oabsolute	requirement	absolute	JJ	B-NP	Orequirement	for	requirement	NN	I-NP	Ofor	Ikaros	for	IN	B-PP	OIkaros	Induction	Ikaros	NN	B-NP	B-proteinInduction	of	Induction	NN	B-NP	Oof	early	of	IN	B-PP	Oearly	B	early	JJ	B-NP	B-proteinB	cell	B	NN	I-NP	I-proteincell	factor	cell	NN	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	EBF	(	(	O	OEBF	)	EBF	NN	B-NP	B-protein)	and	)	)	O	Oand	multiple	and	CC	O	Omultiple	B	multiple	JJ	B-NP	OB	lineage	B	NN	I-NP	B-DNAlineage	genes	lineage	NN	I-NP	I-DNAgenes	by	gene	NNS	I-NP	I-DNAby	the	by	IN	B-PP	Othe	basic	the	DT	B-NP	Obasic	helix-loop-helix	basic	JJ	I-NP	B-proteinhelix-loop-helix	transcription	helix-loop-helix	JJ	I-NP	I-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	E12	factor	NN	I-NP	I-proteinE12	.	E12	NN	I-NP	B-protein.	The	.	.	O	OThe	transcription	The	DT	B-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	encoded	factor	NNS	I-NP	I-proteinencoded	by	encode	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	E2A	the	DT	B-NP	OE2A	and	E2A	NN	I-NP	B-DNAand	early	and	CC	O	I-DNAearly	B	early	JJ	B-NP	I-DNAB	cell	B	NN	I-NP	I-DNAcell	factor	cell	NN	I-NP	I-DNAfactor	(	factor	NN	I-NP	I-DNA(	EBF	(	(	O	I-DNAEBF	)	EBF	NN	B-NP	I-DNA)	genes	)	)	O	I-DNAgenes	are	gene	NNS	B-NP	I-DNAare	required	be	VBP	B-VP	Orequired	for	require	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	proper	the	DT	B-NP	Oproper	development	proper	JJ	I-NP	Odevelopment	of	development	NN	I-NP	Oof	B	of	IN	B-PP	OB	lymphocytes	B	NN	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	the	","	","	O	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	B	of	IN	B-PP	OB	lineage	B	NN	B-NP	B-cell_typelineage	cells	lineage	NN	I-NP	I-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	E2A-	in	IN	B-PP	OE2A-	and	E2A-	NN	B-NP	Oand	EBF-deficient	and	CC	O	OEBF-deficient	mice	EBF-deficient	JJ	B-NP	Omice	has	mouse	NNS	I-NP	Ohas	made	have	VBZ	B-VP	Omade	it	make	VBN	I-VP	Oit	difficult	it	PRP	B-NP	Odifficult	to	difficult	JJ	B-ADJP	Oto	determine	to	TO	B-VP	Odetermine	the	determine	VB	I-VP	Othe	function	the	DT	B-NP	Ofunction	or	function	NN	I-NP	Oor	relationship	or	CC	I-NP	Orelationship	between	relationship	NN	I-NP	Obetween	these	between	IN	B-PP	Othese	proteins	these	DT	B-NP	Oproteins	.	protein	NNS	I-NP	O.	We	.	.	O	OWe	report	We	PRP	B-NP	Oreport	the	report	VBP	B-VP	Othe	identification	the	DT	B-NP	Oidentification	of	identification	NN	I-NP	Oof	a	of	IN	B-PP	Oa	novel	a	DT	B-NP	Onovel	model	novel	JJ	I-NP	Omodel	system	model	NN	I-NP	Osystem	in	system	NN	I-NP	Oin	which	in	IN	B-PP	Owhich	the	which	WDT	B-NP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	E2A	of	IN	B-PP	OE2A	and	E2A	NN	B-NP	B-proteinand	EBF	and	CC	I-NP	OEBF	in	EBF	NN	I-NP	B-proteinin	the	in	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	multiple	of	IN	B-PP	Omultiple	B	multiple	JJ	B-NP	OB	lineage	B	NN	I-NP	Olineage	traits	lineage	NN	I-NP	Otraits	can	trait	NNS	I-NP	Ocan	be	can	MD	B-VP	Obe	studied	be	VB	I-VP	Ostudied	.	study	VBN	I-VP	O.	We	.	.	O	OWe	found	We	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	conversion	the	DT	B-NP	Oconversion	of	conversion	NN	I-NP	Oof	70Z/3	of	IN	B-PP	O70Z/3	pre-B	70Z/3	NN	B-NP	B-proteinpre-B	lymphocytes	pre-B	JJ	I-NP	Olymphocytes	to	lymphocyte	NNS	I-NP	Oto	cells	to	TO	B-PP	Ocells	with	cell	NNS	B-NP	Owith	a	with	IN	B-PP	Oa	macrophage-like	a	DT	B-NP	Omacrophage-like	phenotype	macrophage-like	JJ	I-NP	Ophenotype	is	phenotype	NN	I-NP	Ois	associated	be	VBZ	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	the	with	IN	B-PP	Othe	loss	the	DT	B-NP	Oloss	of	loss	NN	I-NP	Oof	E2A	of	IN	B-PP	OE2A	and	E2A	NN	B-NP	B-proteinand	EBF	and	CC	I-NP	OEBF	.	EBF	NN	I-NP	B-protein.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	we	","	","	O	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	ectopic	that	IN	B-SBAR	Oectopic	expression	ectopic	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	E2A	the	DT	B-NP	OE2A	protein	E2A	NN	I-NP	B-proteinprotein	E12	protein	NN	I-NP	I-proteinE12	in	E12	NN	I-NP	B-proteinin	this	in	IN	B-PP	Othis	macrophage	this	DT	B-NP	Omacrophage	line	macrophage	NN	I-NP	Oline	results	line	NN	I-NP	Oresults	in	result	VBZ	B-VP	Oin	the	in	IN	B-PP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	many	of	IN	B-PP	Omany	B	many	JJ	B-NP	OB	lineage	B	NN	I-NP	B-DNAlineage	genes	lineage	NN	I-NP	I-DNAgenes	","	gene	NNS	I-NP	I-DNA","	including	","	","	O	Oincluding	EBF	include	VBG	B-PP	OEBF	","	EBF	NN	B-NP	B-protein","	IL7Ralpha	","	","	O	OIL7Ralpha	","	IL7Ralpha	NN	B-NP	B-protein","	lambda5	","	","	O	Olambda5	","	lambda5	NN	B-NP	B-protein","	and	","	","	O	Oand	Rag-1	and	CC	O	ORag-1	","	Rag-1	NN	B-NP	B-protein","	and	","	","	O	Oand	the	and	CC	O	Othe	ability	the	DT	B-NP	Oability	to	ability	NN	I-NP	Oto	induce	to	TO	B-VP	Oinduce	kappa	induce	VB	I-VP	Okappa	light	kappa	NN	B-NP	B-proteinlight	chain	light	JJ	I-NP	I-proteinchain	in	chain	NN	I-NP	I-proteinin	response	in	IN	B-PP	Oresponse	to	response	NN	I-PP	Oto	mitogen	to	TO	I-PP	Omitogen	.	mitogen	NN	B-NP	B-protein.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	EBF	of	IN	B-PP	OEBF	may	EBF	NN	B-NP	B-proteinmay	be	may	MD	B-VP	Obe	one	be	VB	I-VP	Oone	of	one	CD	B-NP	Oof	the	of	IN	B-PP	Othe	critical	the	DT	B-NP	Ocritical	functions	critical	JJ	I-NP	Ofunctions	of	function	NNS	I-NP	Oof	E12	of	IN	B-PP	OE12	in	E12	NN	B-NP	B-proteinin	regulating	in	IN	B-PP	Oregulating	the	regulate	VBG	B-VP	Othe	B	the	DT	B-NP	OB	lineage	B	NN	I-NP	Olineage	phenotype	lineage	NN	I-NP	Ophenotype	since	phenotype	NN	I-NP	Osince	expression	since	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	EBF	of	IN	B-PP	OEBF	alone	EBF	NN	B-NP	B-proteinalone	leads	alone	RB	B-ADVP	Oleads	to	lead	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	a	of	IN	B-PP	Oa	subset	a	DT	B-NP	Osubset	of	subset	NN	I-NP	Oof	E12	of	IN	B-PP	OE12	#NAME?	E12	NN	B-NP	B-protein#NAME?	traits	#NAME?	JJ	I-NP	Otraits	.	trait	NNS	I-NP	O.	Our	.	.	O	OOur	data	Our	PRP$	B-NP	Odata	demonstrate	datum	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	","	that	IN	B-SBAR	O","	in	","	","	O	Oin	the	in	IN	B-PP	Othe	context	the	DT	B-NP	Ocontext	of	context	NN	I-NP	Oof	this	of	IN	B-PP	Othis	macrophage	this	DT	B-NP	Omacrophage	line	macrophage	NN	I-NP	Oline	","	line	NN	I-NP	O","	E12	","	","	O	OE12	induces	E12	NN	B-NP	B-proteininduces	expression	induce	VBZ	B-VP	Oexpression	of	expression	NN	B-NP	Oof	EBF	of	IN	B-PP	OEBF	and	EBF	NN	B-NP	B-proteinand	together	and	CC	O	Otogether	these	together	RB	B-ADVP	Othese	transcription	these	DT	B-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	coordinately	factor	NNS	I-NP	I-proteincoordinately	regulate	coordinately	RB	B-ADVP	Oregulate	numerous	regulate	VBP	B-VP	Onumerous	B	numerous	JJ	B-NP	OB	lineage-associated	B	NN	I-NP	B-DNAlineage-associated	genes	lineage-associated	JJ	I-NP	I-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Activation-induced	.	.	O	OActivation-induced	down-regulation	Activation-induced	JJ	B-NP	Odown-regulation	of	down-regulation	NN	I-NP	Oof	retinoid	of	IN	B-PP	Oretinoid	receptor	retinoid	NN	B-NP	B-proteinreceptor	RXRalpha	receptor	NN	I-NP	I-proteinRXRalpha	expression	RXRalpha	NN	I-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	T	human	JJ	B-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Role	.	.	O	ORole	of	Role	NN	B-NP	Oof	cell	of	IN	B-PP	Ocell	cycle	cell	NN	B-NP	Ocycle	regulation	cycle	NN	I-NP	Oregulation	.	regulation	NN	I-NP	O.	A	.	.	O	OA	5.4-kilobase	A	DT	B-NP	O5.4-kilobase	mRNA	5.4-kilobase	NN	I-NP	B-RNAmRNA	","	mRNA	NN	I-NP	I-RNA","	the	","	","	O	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	which	of	IN	B-PP	Owhich	is	which	WDT	B-NP	Ois	down-regulated	be	VBZ	B-VP	Odown-regulated	after	down-regulate	VBN	I-VP	Oafter	treatment	after	IN	B-PP	Otreatment	of	treatment	NN	B-NP	Oof	human	of	IN	B-PP	Ohuman	peripheral	human	JJ	B-NP	B-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	PBMCs	(	(	O	OPBMCs	)	PBMC	NNS	B-NP	B-cell_type)	with	)	)	O	Owith	various	with	IN	B-PP	Ovarious	T	various	JJ	B-NP	OT	cell-activating	T	NN	I-NP	Ocell-activating	agents	cell-activating	JJ	I-NP	Oagents	","	agent	NNS	I-NP	O","	was	","	","	O	Owas	isolated	be	VBD	B-VP	Oisolated	using	isolate	VBN	I-VP	Ousing	an	use	VBG	I-VP	Oan	mRNA	an	DT	B-NP	OmRNA	differential	mRNA	NN	I-NP	B-RNAdifferential	display	differential	JJ	I-NP	Odisplay	method	display	NN	I-NP	Omethod	.	method	NN	I-NP	O.	Nucleotide	.	.	O	ONucleotide	sequence	Nucleotide	NN	B-NP	Osequence	analysis	sequence	NN	I-NP	Oanalysis	identified	analysis	NN	I-NP	Oidentified	the	identify	VBD	B-VP	Othe	5	the	DT	B-NP	O5	'	5	CD	I-NP	B-DNA'	end	'	SYM	I-NP	I-DNAend	of	end	NN	I-NP	I-DNAof	this	of	IN	B-PP	Othis	RNA	this	DT	B-NP	ORNA	as	RNA	NN	I-NP	Oas	human	as	IN	B-SBAR	Ohuman	retinoid	human	JJ	B-NP	B-RNAretinoid	receptor	retinoid	NN	I-NP	I-RNAreceptor	RXRalpha	receptor	NN	I-NP	I-RNARXRalpha	mRNA	RXRalpha	NN	I-NP	I-RNAmRNA	.	mRNA	NN	I-NP	I-RNA.	Here	.	.	O	OHere	","	Here	RB	B-ADVP	O","	we	","	","	O	Owe	report	we	PRP	B-NP	Oreport	the	report	VBP	B-VP	Othe	nucleotide	the	DT	B-NP	Onucleotide	sequence	nucleotide	NN	I-NP	B-DNAsequence	of	sequence	NN	I-NP	I-DNAof	3.6	of	IN	B-PP	O3.6	kilobases	3.6	CD	B-NP	Okilobases	of	kilobas	NNS	I-NP	Oof	this	of	IN	B-PP	Othis	RNA	this	DT	B-NP	ORNA	","	RNA	NN	I-NP	O","	which	","	","	O	Owhich	represents	which	WDT	B-NP	Orepresents	the	represent	VBZ	B-VP	Othe	3	the	DT	B-NP	O3	'	3	CD	I-NP	B-DNA'	end	'	SYM	I-NP	I-DNAend	of	end	NN	I-NP	I-DNAof	RXRalpha	of	IN	B-PP	ORXRalpha	mRNA	RXRalpha	NN	B-NP	B-RNAmRNA	","	mRNA	NN	I-NP	I-RNA","	the	","	","	O	Othe	sequence	the	DT	B-NP	Osequence	of	sequence	NN	I-NP	Oof	which	of	IN	B-PP	Owhich	has	which	WDT	B-NP	Ohas	not	have	VBZ	B-VP	Onot	been	not	RB	I-VP	Obeen	previously	be	VBN	I-VP	Opreviously	described	previously	RB	I-VP	Odescribed	.	describe	VBN	I-VP	O.	Activated	.	.	O	OActivated	PBMCs	Activate	VBN	B-NP	OPBMCs	also	PBMC	NNS	I-NP	B-cell_typealso	expressed	also	RB	B-ADVP	Oexpressed	lower	express	VBD	B-VP	Olower	levels	low	JJR	B-NP	Olevels	of	level	NNS	I-NP	Oof	RXRalpha	of	IN	B-PP	ORXRalpha	protein	RXRalpha	NN	B-NP	B-proteinprotein	","	protein	NN	I-NP	I-protein","	and	","	","	O	Oand	a	and	CC	O	Oa	DNA	a	DT	B-NP	ODNA	binding	DNA	NN	I-NP	Obinding	assay	binding	NN	I-NP	Oassay	showed	assay	NN	I-NP	Oshowed	that	show	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	activation-induced	the	DT	B-NP	Oactivation-induced	loss	activation-induced	JJ	I-NP	Oloss	of	loss	NN	I-NP	Oof	RXRalpha	of	IN	B-PP	ORXRalpha	mRNA	RXRalpha	NN	B-NP	B-RNAmRNA	and	mRNA	NN	I-NP	I-RNAand	protein	and	CC	O	Oprotein	expression	protein	NN	B-NP	Oexpression	correlated	expression	NN	I-NP	Ocorrelated	with	correlate	VBD	B-VP	Owith	the	with	IN	B-PP	Othe	loss	the	DT	B-NP	Oloss	of	loss	NN	I-NP	Oof	DNA	of	IN	B-PP	ODNA	binding	DNA	NN	B-NP	Obinding	activity	binding	NN	I-NP	Oactivity	of	activity	NN	I-NP	Oof	this	of	IN	B-PP	Othis	protein	this	DT	B-NP	Oprotein	.	protein	NN	I-NP	O.	We	.	.	O	OWe	present	We	PRP	B-NP	Opresent	evidence	present	VBP	B-VP	Oevidence	that	evidence	NN	B-NP	Othat	the	that	IN	B-SBAR	Othe	transition	the	DT	B-NP	Otransition	from	transition	NN	I-NP	Ofrom	G0/G1	from	IN	B-PP	OG0/G1	to	G0/G1	NN	B-NP	Oto	S	to	TO	B-PP	OS	phase	S	NN	B-NP	Ophase	of	phase	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	cycle	cell	NN	I-NP	Ocycle	results	cycle	NN	I-NP	Oresults	in	result	VBZ	B-VP	Oin	the	in	IN	B-PP	Othe	down-regulation	the	DT	B-NP	Odown-regulation	of	down-regulation	NN	I-NP	Oof	RXRalpha	of	IN	B-PP	ORXRalpha	expression	RXRalpha	NN	B-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	that	and	CC	O	Othat	cell	that	IN	B-SBAR	Ocell	cycle	cell	NN	B-NP	Ocycle	inhibitors	cycle	NN	I-NP	Oinhibitors	","	inhibitor	NNS	I-NP	O","	which	","	","	O	Owhich	block	which	WDT	B-NP	Oblock	the	block	VBP	B-VP	Othe	cells	the	DT	B-NP	Ocells	in	cell	NNS	I-NP	Oin	G1	in	IN	B-PP	OG1	phase	G1	NN	B-NP	Ophase	","	phase	NN	I-NP	O","	prevent	","	","	O	Oprevent	this	prevent	VBP	B-VP	Othis	down-regulation	this	DT	B-NP	Odown-regulation	.	down-regulation	NN	I-NP	O.	The	.	.	O	OThe	decrease	The	DT	B-NP	Odecrease	in	decrease	NN	I-NP	Oin	the	in	IN	B-PP	Othe	levels	the	DT	B-NP	Olevels	of	level	NNS	I-NP	Oof	RXRalpha	of	IN	B-PP	ORXRalpha	mRNA	RXRalpha	NN	B-NP	B-RNAmRNA	was	mRNA	NN	I-NP	I-RNAwas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	regulated	be	VB	I-VP	Oregulated	at	regulate	VBN	I-VP	Oat	the	at	IN	B-PP	Othe	post-transcriptional	the	DT	B-NP	Opost-transcriptional	level	post-transcriptional	JJ	I-NP	Olevel	and	level	NN	I-NP	Oand	involved	and	CC	O	Oinvolved	new	involve	VBD	B-VP	Onew	protein	new	JJ	B-NP	Oprotein	synthesis	protein	NN	I-NP	Osynthesis	.	synthesis	NN	I-NP	O.	These	.	.	O	OThese	observations	These	DT	B-NP	Oobservations	indicate	observation	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	levels	the	DT	B-NP	Olevels	of	level	NNS	I-NP	Oof	RXRalpha	of	IN	B-PP	ORXRalpha	expression	RXRalpha	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	T	in	IN	B-PP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	are	lymphocyte	NNS	I-NP	I-cell_typeare	coupled	be	VBP	B-VP	Ocoupled	to	couple	VBN	I-VP	Oto	cell	to	TO	B-PP	Ocell	cycle	cell	NN	B-NP	Ocycle	progression	cycle	NN	I-NP	Oprogression	","	progression	NN	I-NP	O","	and	","	","	O	Oand	there	and	CC	O	Othere	is	there	EX	B-NP	Ois	tight	be	VBZ	B-VP	Otight	regulatory	tight	JJ	B-NP	Oregulatory	control	regulatory	JJ	I-NP	Ocontrol	of	control	NN	I-NP	Oof	RXRalpha	of	IN	B-PP	ORXRalpha	expression	RXRalpha	NN	B-NP	B-proteinexpression	during	expression	NN	I-NP	Oduring	the	during	IN	B-PP	Othe	transition	the	DT	B-NP	Otransition	from	transition	NN	I-NP	Ofrom	G0/G1	from	IN	B-PP	OG0/G1	to	G0/G1	NN	B-NP	Oto	S	to	TO	B-PP	OS	phase	S	NN	B-NP	Ophase	of	phase	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	cycle	cell	NN	I-NP	Ocycle	.	cycle	NN	I-NP	O.	Epidemiology	.	.	O	OEpidemiology	and	Epidemiology	NN	B-NP	Oand	pathogenesis	and	CC	I-NP	Opathogenesis	of	pathogenesis	NN	I-NP	Oof	AIDS-related	of	IN	B-PP	OAIDS-related	lymphomas	AIDS-related	JJ	B-NP	Olymphomas	.	lymphoma	NNS	I-NP	O.	Among	.	.	O	OAmong	patients	Among	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	congenital	with	IN	B-PP	Ocongenital	and	congenital	JJ	B-NP	Oand	acquired	and	CC	I-NP	Oacquired	immunodeficiencies	acquire	VBN	I-NP	Oimmunodeficiencies	","	immunodeficiency	NNS	I-NP	O","	non-Hodgkin	","	","	O	Onon-Hodgkin	's	non-Hodgkin	JJ	B-NP	O's	lymphoma	's	POS	B-NP	Olymphoma	(	lymphoma	NN	I-NP	O(	NHLs	(	(	O	ONHLs	)	NHL	NNS	B-NP	O)	are	)	)	O	Oare	the	be	VBP	B-VP	Othe	most	the	DT	B-NP	Omost	common	most	RBS	I-NP	Ocommon	tumors	common	JJ	I-NP	Otumors	of	tumor	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	immune	the	DT	B-NP	Oimmune	system	immune	JJ	I-NP	Osystem	.	system	NN	I-NP	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	setting	the	DT	B-NP	Osetting	of	setting	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	immunodeficiency	human	JJ	B-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	(	virus	NN	I-NP	O(	HIV	(	(	O	OHIV	)	HIV	NN	B-NP	O)	infection	)	)	O	Oinfection	","	infection	NN	B-NP	O","	as	","	","	O	Oas	many	as	RB	B-NP	Omany	as	many	JJ	I-NP	Oas	10	as	IN	I-NP	O10	%	10	CD	I-NP	O%	to	%	NN	I-NP	Oto	20	to	TO	I-NP	O20	%	20	CD	I-NP	O%	of	%	NN	I-NP	Oof	people	of	IN	B-PP	Opeople	ultimately	people	NNS	B-NP	Oultimately	developed	ultimately	RB	B-ADVP	Odeveloped	NHLs	develop	VBD	B-VP	ONHLs	.	NHL	NNS	B-NP	O.	These	.	.	O	OThese	tumors	These	DT	B-NP	Otumors	are	tumor	NNS	I-NP	Oare	clinically	be	VBP	B-VP	Oclinically	aggressive	clinically	RB	B-ADJP	Oaggressive	","	aggressive	JJ	I-ADJP	O","	frequently	","	","	O	Ofrequently	involve	frequently	RB	B-ADVP	Oinvolve	extranodal	involve	VBP	B-VP	Oextranodal	sites	extranodal	JJ	B-NP	Osites	","	site	NNS	I-NP	O","	and	","	","	O	Oand	often	and	CC	O	Ooften	exhibit	often	RB	B-VP	Oexhibit	unique	exhibit	VBP	I-VP	Ounique	features	unique	JJ	B-NP	Ofeatures	that	feature	NNS	I-NP	Othat	distinguish	that	WDT	B-NP	Odistinguish	them	distinguish	VBP	B-VP	Othem	from	them	PRP	B-NP	Ofrom	NHL	from	IN	B-PP	ONHL	arising	NHL	NN	B-NP	Oarising	in	arise	VBG	B-VP	Oin	individuals	in	IN	B-PP	Oindividuals	with	individual	NNS	B-NP	Owith	other	with	IN	B-PP	Oother	forms	other	JJ	B-NP	Oforms	of	form	NNS	I-NP	Oof	immunosuppression	of	IN	B-PP	Oimmunosuppression	.	immunosuppression	NN	B-NP	O.	Important	.	.	O	OImportant	in	Important	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	HIV-associated	of	IN	B-PP	OHIV-associated	NHL	HIV-associated	JJ	B-NP	ONHL	are	NHL	NN	I-NP	Oare	cytokines	be	VBP	B-VP	Ocytokines	and	cytokine	NNS	B-NP	B-proteinand	other	and	CC	O	Oother	factors	other	JJ	B-NP	Ofactors	that	factor	NNS	I-NP	Othat	induce	that	WDT	B-NP	Oinduce	B-cell	induce	VBP	B-VP	OB-cell	proliferation	B-cell	NN	B-NP	B-cell_typeproliferation	and	proliferation	NN	I-NP	Oand	increase	and	CC	O	Oincrease	the	increase	VB	B-VP	Othe	likelihood	the	DT	B-NP	Olikelihood	of	likelihood	NN	I-NP	Oof	mutations	of	IN	B-PP	Omutations	of	mutation	NNS	B-NP	Oof	c-myc	of	IN	B-PP	Oc-myc	","	c-myc	NN	B-NP	B-DNA","	bcl-6	","	","	O	Obcl-6	","	bcl-6	NN	B-NP	B-protein","	and	","	","	O	Oand	other	and	CC	O	Oother	tumor-suppressor	other	JJ	B-NP	Otumor-suppressor	genes	tumor-suppressor	JJ	I-NP	B-DNAgenes	with	gene	NNS	I-NP	I-DNAwith	carcinogenic	with	IN	B-PP	Ocarcinogenic	potential	carcinogenic	JJ	B-NP	Opotential	.	potential	NN	I-NP	O.	Specific	.	.	O	OSpecific	forms	Specific	JJ	B-NP	Oforms	of	form	NNS	I-NP	Oof	HIV-associated	of	IN	B-PP	OHIV-associated	NHL	HIV-associated	JJ	B-NP	ONHL	are	NHL	NN	I-NP	Oare	linked	be	VBP	B-VP	Olinked	to	link	VBN	I-VP	Oto	expression	to	TO	B-PP	Oexpression	of	expression	NN	B-NP	Oof	Epstein-Barr	of	IN	B-PP	OEpstein-Barr	virus	Epstein-Barr	JJ	B-NP	B-proteinvirus	(	virus	NN	I-NP	I-protein(	EBV	(	(	O	I-proteinEBV	)	EBV	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	proteins	#NAME?	JJ	B-NP	I-proteinproteins	;	protein	NNS	I-NP	I-protein;	the	;	:	O	Othe	newly	the	DT	B-NP	Onewly	described	newly	RB	I-NP	Odescribed	DNA	describe	VBN	I-NP	ODNA	virus	DNA	NN	I-NP	Ovirus	","	virus	NN	I-NP	O","	Karposi	","	","	O	OKarposi	's	Karposi	NNP	B-NP	O's	sarcoma-associated	's	POS	B-NP	Osarcoma-associated	herpesvirus/human	sarcoma-associated	JJ	I-NP	Oherpesvirus/human	herpesvirus-8	herpesvirus/human	JJ	I-NP	Oherpesvirus-8	(	herpesvirus-8	NN	I-NP	O(	KSHV/HHV-8	(	(	O	OKSHV/HHV-8	)	KSHV/HHV-8	NN	B-NP	O)	;	)	)	O	O;	and	;	:	O	Oand	perhaps	and	CC	O	Operhaps	HIV	perhaps	RB	B-ADVP	OHIV	.	HIV	NN	B-NP	O.	Elucidation	.	.	O	OElucidation	of	Elucidation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	factors	the	DT	B-NP	Ofactors	that	factor	NNS	I-NP	Othat	contribute	that	WDT	B-NP	Ocontribute	to	contribute	VBP	B-VP	Oto	the	to	TO	B-PP	Othe	high	the	DT	B-NP	Ohigh	incidence	high	JJ	I-NP	Oincidence	of	incidence	NN	I-NP	Oof	NHL	of	IN	B-PP	ONHL	among	NHL	NN	B-NP	Oamong	patients	among	IN	B-PP	Opatients	infected	patient	NNS	B-NP	Oinfected	with	infect	VBN	B-VP	Owith	HIV	with	IN	B-PP	OHIV	provides	HIV	NN	B-NP	Oprovides	insights	provide	VBZ	B-VP	Oinsights	into	insight	NNS	B-NP	Ointo	important	into	IN	B-PP	Oimportant	elements	important	JJ	B-NP	Oelements	of	element	NNS	I-NP	Oof	lymphomagenesis	of	IN	B-PP	Olymphomagenesis	.	lymphomagenesis	NN	B-NP	O.	Matrix	.	.	O	OMatrix	metalloproteinase	Matrix	NN	B-NP	B-proteinmetalloproteinase	expression	metalloproteinase	NN	I-NP	I-proteinexpression	in	expression	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	breast	human	JJ	B-NP	Obreast	cancer	breast	NN	I-NP	Ocancer	:	cancer	NN	I-NP	O:	an	:	:	O	Oan	immunohistochemical	an	DT	B-NP	Oimmunohistochemical	study	immunohistochemical	JJ	I-NP	Ostudy	including	study	NN	I-NP	Oincluding	correlation	include	VBG	B-PP	Ocorrelation	with	correlation	NN	B-NP	Owith	cathepsin	with	IN	B-PP	Ocathepsin	D	cathepsin	NN	B-NP	B-proteinD	","	D	NN	I-NP	I-protein","	type	","	","	O	Otype	IV	type	NN	B-NP	B-proteinIV	collagen	IV	CD	I-NP	I-proteincollagen	","	collagen	NN	I-NP	I-protein","	laminin	","	","	O	Olaminin	","	laminin	NN	B-NP	B-protein","	fibronectin	","	","	O	Ofibronectin	","	fibronectin	NN	B-NP	B-protein","	EGFR	","	","	O	OEGFR	","	EGFR	NN	B-NP	B-protein","	c-erbB-2	","	","	O	Oc-erbB-2	oncoprotein	c-erbB-2	NN	B-NP	B-proteinoncoprotein	","	oncoprotein	NN	I-NP	I-protein","	p53	","	","	O	Op53	","	p53	NN	B-NP	B-protein","	steroid	","	","	O	Osteroid	receptors	steroid	NN	B-NP	B-proteinreceptors	status	receptor	NNS	I-NP	I-proteinstatus	and	status	NN	I-NP	Oand	proliferative	and	CC	O	Oproliferative	indices	proliferative	JJ	B-NP	Oindices	.	index	NNS	I-NP	O.	Matrix	.	.	O	OMatrix	metalloproteinase	Matrix	NN	B-NP	B-proteinmetalloproteinase	s	metalloproteinase	NN	I-NP	I-proteins	(	s	NNS	I-NP	I-protein(	MMPs	(	(	O	OMMPs	)	MMP	NNS	B-NP	B-protein)	are	)	)	O	Oare	a	be	VBP	B-VP	Oa	group	a	DT	B-NP	Ogroup	of	group	NN	I-NP	Oof	enzymes	of	IN	B-PP	Oenzymes	thought	enzyme	NNS	B-NP	B-proteinthought	to	think	VBN	B-VP	Oto	be	to	TO	I-VP	Obe	responsible	be	VB	I-VP	Oresponsible	for	responsible	JJ	B-ADJP	Ofor	both	for	IN	B-PP	Oboth	normal	both	CC	B-NP	Onormal	connective	normal	JJ	I-NP	Oconnective	tissue	connective	JJ	I-NP	Otissue	matrix	tissue	NN	I-NP	Omatrix	remodelling	matrix	NN	I-NP	Oremodelling	and	remodelling	NN	I-NP	Oand	accelerated	and	CC	O	Oaccelerated	breakdown	accelerate	VBD	B-VP	Obreakdown	associated	breakdown	NN	B-NP	Oassociated	with	associate	VBN	B-VP	Owith	tumour	with	IN	B-PP	Otumour	development	tumour	NN	B-NP	Odevelopment	.	development	NN	I-NP	O.	The	.	.	O	OThe	current	The	DT	B-NP	Ocurrent	study	current	JJ	I-NP	Ostudy	aimed	study	NN	I-NP	Oaimed	to	aim	VBD	B-VP	Oto	investigate	to	TO	I-VP	Oinvestigate	the	investigate	VB	I-VP	Othe	immunohistochemical	the	DT	B-NP	Oimmunohistochemical	expression	immunohistochemical	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	matrix	of	IN	B-PP	Omatrix	metalloproteinase	matrix	NN	B-NP	B-proteinmetalloproteinase	3	metalloproteinase	NN	I-NP	I-protein3	(	3	CD	I-NP	I-protein(	MMP-3	(	(	O	OMMP-3	","	MMP-3	NN	B-NP	B-protein","	stromelysin-1	","	","	O	Ostromelysin-1	)	stromelysin-1	NN	B-NP	B-protein)	in	)	)	O	Oin	correlation	in	IN	B-PP	Ocorrelation	with	correlation	NN	B-NP	Owith	the	with	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	Basement	of	IN	B-PP	OBasement	Membrane	Basement	NN	B-NP	B-proteinMembrane	(	Membrane	NN	I-NP	I-protein(	BM	(	(	O	I-proteinBM	)	BM	NN	B-NP	I-protein)	antigen	)	)	O	I-proteinantigen	(	antigen	NN	B-NP	I-protein(	type	(	(	O	Otype	IV	type	NN	B-NP	B-proteinIV	collagen	IV	CD	I-NP	I-proteincollagen	","	collagen	NN	I-NP	I-protein","	laminin	","	","	O	Olaminin	)	laminin	NN	B-NP	B-protein)	","	)	)	O	O","	fibronectin	","	","	O	Ofibronectin	","	fibronectin	NN	B-NP	B-protein","	cathepsin	","	","	O	Ocathepsin	D	cathepsin	NN	B-NP	B-proteinD	","	D	NN	I-NP	I-protein","	p53	","	","	O	Op53	","	p53	NN	B-NP	B-protein","	c-erbB-2	","	","	O	Oc-erbB-2	","	c-erbB-2	NN	B-NP	B-protein","	proliferative	","	","	O	Oproliferative	activity	proliferative	JJ	B-NP	Oactivity	(	activity	NN	I-NP	O(	Ki-67	(	(	O	OKi-67	","	Ki-67	NN	B-NP	B-protein","	PCNA	","	","	O	OPCNA	)	PCNA	NN	B-NP	B-protein)	","	)	)	O	O","	steroid	","	","	O	Osteroid	receptor	steroid	NN	B-NP	B-proteinreceptor	content	receptor	NN	I-NP	I-proteincontent	as	content	NN	I-NP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	to	as	IN	I-CONJP	Oto	the	to	TO	B-PP	Othe	other	the	DT	B-NP	Oother	conventional	other	JJ	I-NP	Oconventional	clinicopathological	conventional	JJ	I-NP	Oclinicopathological	parameters	clinicopathological	JJ	I-NP	Oparameters	in	parameter	NNS	I-NP	Oin	breast	in	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	.	cancer	NN	I-NP	O.	This	.	.	O	OThis	study	This	DT	B-NP	Ostudy	was	study	NN	I-NP	Owas	performed	be	VBD	B-VP	Operformed	on	perform	VBN	I-VP	Oon	a	on	IN	B-PP	Oa	series	a	DT	B-NP	Oseries	of	series	NN	I-NP	Oof	frozen	of	IN	B-PP	Ofrozen	and	frozen	NN	B-NP	Oand	paraffin	and	CC	I-NP	Oparaffin	sections	paraffin	NN	I-NP	Osections	from	section	NNS	I-NP	Ofrom	84	from	IN	B-PP	O84	breast	84	CD	B-NP	Obreast	cancer	breast	NN	I-NP	Ocancer	specimens	cancer	NN	I-NP	Ospecimens	by	specimen	NNS	I-NP	Oby	immunohistochemistry	by	IN	B-PP	Oimmunohistochemistry	using	immunohistochemistry	NN	B-NP	Ousing	the	use	VBG	B-VP	Othe	monoclonal	the	DT	B-NP	Omonoclonal	antibody	monoclonal	JJ	I-NP	B-proteinantibody	MMP-3	antibody	NN	I-NP	I-proteinMMP-3	(	MMP-3	NN	I-NP	B-protein(	Ab-1	(	(	O	OAb-1	)	Ab-1	NN	B-NP	B-protein)	.	)	)	O	O.	Stromelysin-1	.	.	O	OStromelysin-1	(	Stromelysin-1	NN	B-NP	B-protein(	ST1	(	(	O	OST1	)	ST1	NN	B-NP	B-protein)	was	)	)	O	Owas	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	about	in	IN	B-PP	Oabout	10	about	RB	B-NP	O10	%	10	CD	I-NP	O%	of	%	NN	I-NP	Oof	epithelial	of	IN	B-PP	Oepithelial	cells	epithelial	JJ	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	the	in	IN	B-PP	Othe	control	the	DT	B-NP	Ocontrol	groups	control	NN	I-NP	Ogroups	(	group	NNS	I-NP	O(	cases	(	(	O	Ocases	of	case	NNS	B-NP	Oof	fibrocystic	of	IN	B-PP	Ofibrocystic	and	fibrocystic	JJ	B-NP	Oand	benign	and	CC	I-NP	Obenign	proliferative	benign	JJ	I-NP	Oproliferative	breast	proliferative	JJ	I-NP	Obreast	disease	breast	NN	I-NP	Odisease	)	disease	NN	I-NP	O)	","	)	)	O	O","	while	","	","	O	Owhile	expression	while	IN	B-SBAR	Oexpression	(	expression	NN	B-NP	O(	>	(	(	O	O>	10	>	JJR	B-NP	O10	%	10	CD	I-NP	O%	of	%	NN	I-NP	Oof	expression	of	IN	B-PP	Oexpression	)	expression	NN	B-NP	O)	was	)	)	O	Owas	detected	be	VBD	B-VP	Odetected	in	detect	VBN	I-VP	Oin	89.7	in	IN	B-PP	O89.7	%	89.7	CD	B-NP	O%	of	%	NN	I-NP	Oof	tumours	of	IN	B-PP	Otumours	.	tumour	NNS	B-NP	O.	The	.	.	O	OThe	expression	The	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	ST1	of	IN	B-PP	OST1	in	ST1	NN	B-NP	B-proteinin	carcinoma	in	IN	B-PP	Ocarcinoma	cells	carcinoma	NN	B-NP	B-cell_typecells	was	cell	NNS	I-NP	I-cell_typewas	strongly	be	VBD	B-VP	Ostrongly	associated	strongly	RB	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	its	with	IN	B-PP	Oits	presence	its	PRP$	B-NP	Opresence	in	presence	NN	I-NP	Oin	the	in	IN	B-PP	Othe	stroma	the	DT	B-NP	Ostroma	(	stroma	NN	I-NP	O(	p	(	(	O	Op	<	p	NN	B-NP	O<	0.001	<	SYM	O	O0.001	)	0.001	CD	B-NP	O)	.	)	)	O	O.	A	.	.	O	OA	significantly	A	DT	B-NP	Osignificantly	positive	significantly	RB	I-NP	Opositive	correlation	positive	JJ	I-NP	Ocorrelation	was	correlation	NN	I-NP	Owas	found	be	VBD	B-VP	Ofound	between	find	VBN	I-VP	Obetween	ST1	between	IN	B-PP	OST1	expression	ST1	NN	B-NP	B-proteinexpression	","	expression	NN	I-NP	O","	and	","	","	O	Oand	p53	and	CC	O	Op53	tumour	p53	NN	B-NP	B-proteintumour	suppressor	tumour	NN	I-NP	I-proteinsuppressor	gene	suppressor	NN	I-NP	I-proteingene	product	gene	NN	I-NP	I-proteinproduct	(	product	NN	I-NP	I-protein(	p	(	(	O	Op	=	p	NN	B-NP	O=	0.004	=	SYM	B-VP	O0.004	)	0.004	CD	B-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	a	and	CC	O	Oa	relationship	a	DT	B-NP	Orelationship	with	relationship	NN	I-NP	Owith	c-erbB-2	with	IN	B-PP	Oc-erbB-2	protein	c-erbB-2	NN	B-NP	B-proteinprotein	and	protein	NN	I-NP	I-proteinand	progesterone	and	CC	O	Oprogesterone	receptor	progesterone	NN	B-NP	B-proteinreceptor	status	receptor	NN	I-NP	I-proteinstatus	was	status	NN	I-NP	Owas	also	be	VBD	B-VP	Oalso	indicated	also	RB	I-VP	Oindicated	.	indicate	VBN	I-VP	O.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	suggest	finding	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	ST1	that	IN	B-SBAR	OST1	expression	ST1	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	breast	in	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	tissue	cancer	NN	I-NP	Otissue	is	tissue	NN	I-NP	Ois	irrespective	be	VBZ	B-VP	Oirrespective	of	irrespective	JJ	B-ADJP	Oof	the	of	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	extracellular	the	DT	B-NP	Oextracellular	matrix	extracellular	JJ	I-NP	B-proteinmatrix	component	matrix	NN	I-NP	I-proteincomponent	","	component	NN	I-NP	I-protein","	the	","	","	O	Othe	proteolytic	the	DT	B-NP	Oproteolytic	enzyme	proteolytic	JJ	I-NP	Oenzyme	cathepsin	enzyme	NN	I-NP	Ocathepsin	D	cathepsin	NN	I-NP	OD	and	D	NN	I-NP	Oand	the	and	CC	O	Othe	growth	the	DT	B-NP	Ogrowth	fraction	growth	NN	I-NP	Ofraction	of	fraction	NN	I-NP	Oof	the	of	IN	B-PP	Othe	tumour	the	DT	B-NP	Otumour	","	tumour	NN	I-NP	O","	and	","	","	O	Oand	that	and	CC	O	Othat	it	that	IN	B-SBAR	Oit	could	it	PRP	B-NP	Ocould	be	could	MD	B-VP	Obe	a	be	VB	I-VP	Oa	potential	a	DT	B-NP	Opotential	new	potential	JJ	I-NP	Onew	prognostic	new	JJ	I-NP	Oprognostic	marker	prognostic	JJ	I-NP	Omarker	in	marker	NN	I-NP	Oin	breast	in	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	.	cancer	NN	I-NP	O.	Use	.	.	O	OUse	of	Use	NN	B-NP	Oof	transfected	of	IN	B-PP	Otransfected	liver	transfecte	VBN	B-NP	B-cell_lineliver	cells	liver	NN	I-NP	I-cell_linecells	to	cell	NNS	I-NP	I-cell_lineto	evaluate	to	TO	B-VP	Oevaluate	potential	evaluate	VB	I-VP	Opotential	mechanisms	potential	JJ	B-NP	Omechanisms	of	mechanism	NNS	I-NP	Oof	alcohol-induced	of	IN	B-PP	Oalcohol-induced	liver	alcohol-induced	JJ	B-NP	Oliver	injury	liver	NN	I-NP	Oinjury	[	injury	NN	I-NP	O[	see	[	(	O	Osee	comments	see	VB	B-VP	Ocomments	]	comment	NNS	B-NP	O]	There	]	)	O	OThere	is	There	EX	B-NP	Ois	increased	be	VBZ	B-VP	Oincreased	activity	increase	VBN	B-NP	Oactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	proinflammatory	the	DT	B-NP	Oproinflammatory	cytokine	proinflammatory	JJ	I-NP	B-proteincytokine	","	cytokine	NN	I-NP	I-protein","	tumor	","	","	O	Otumor	necrosis	tumor	NN	B-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	TNF	(	(	O	OTNF	)	TNF	NN	B-NP	B-protein)	in	)	)	O	Oin	alcoholic	in	IN	B-PP	Oalcoholic	liver	alcoholic	JJ	B-NP	Oliver	disease	liver	NN	I-NP	Odisease	(	disease	NN	I-NP	O(	ALD	(	(	O	OALD	)	ALD	NN	B-NP	O)	.	)	)	O	O.	Hepatic	.	.	O	OHepatic	neutrophil	Hepatic	JJ	B-NP	Oneutrophil	infiltration	neutrophil	NN	I-NP	Oinfiltration	is	infiltration	NN	I-NP	Ois	a	be	VBZ	B-VP	Oa	principal	a	DT	B-NP	Oprincipal	injurious	principal	JJ	I-NP	Oinjurious	manifestation	injurious	JJ	I-NP	Omanifestation	of	manifestation	NN	I-NP	Oof	ALD	of	IN	B-PP	OALD	.	ALD	NN	B-NP	O.	TNF	.	.	O	OTNF	can	TNF	NN	B-NP	B-proteincan	induce	can	MD	B-VP	Oinduce	cellular	induce	VB	I-VP	Ocellular	oxidative	cellular	JJ	B-NP	Ooxidative	injury	oxidative	JJ	I-NP	Oinjury	directly	injury	NN	I-NP	Odirectly	","	directly	RB	B-ADVP	O","	and	","	","	O	Oand	indirectly	and	CC	O	Oindirectly	by	indirectly	RB	B-ADVP	Oby	inducing	by	IN	B-PP	Oinducing	neutrophil	induce	VBG	B-VP	Oneutrophil	chemotactic	neutrophil	NN	B-NP	Ochemotactic	factor	chemotactic	JJ	I-NP	Ofactor	(	factor	NN	I-NP	O(	IL-8	(	(	O	OIL-8	)	IL-8	NN	B-NP	B-protein)	production	)	)	O	Oproduction	by	production	NN	B-NP	Oby	hepatocytes	by	IN	B-PP	Ohepatocytes	.	hepatocyte	NNS	B-NP	B-cell_type.	IL-8	.	.	O	OIL-8	activates	IL-8	NN	B-NP	B-proteinactivates	and	activate	VBZ	B-VP	Oand	chemotactically	and	CC	O	Ochemotactically	attracts	chemotactically	RB	B-VP	Oattracts	neutrophils	attract	VBZ	I-VP	Oneutrophils	to	neutrophil	NNS	B-NP	B-cell_typeto	the	to	TO	B-PP	Othe	liver	the	DT	B-NP	Oliver	where	liver	NN	I-NP	Owhere	they	where	WRB	B-ADVP	Othey	release	they	PRP	B-NP	Orelease	oxidizing	release	VBP	B-VP	Ooxidizing	substances	oxidize	VBG	I-VP	Osubstances	.	substance	NNS	B-NP	O.	Patients	.	.	O	OPatients	with	Patient	NNS	B-NP	Owith	ALD	with	IN	B-PP	OALD	also	ALD	NN	B-NP	Oalso	have	also	RB	B-ADVP	Ohave	decreased	have	VBP	B-VP	Odecreased	protective	decrease	VBN	I-VP	Oprotective	factors	protective	JJ	B-NP	B-proteinfactors	for	factor	NNS	I-NP	I-proteinfor	cellular	for	IN	B-PP	Ocellular	oxidative	cellular	JJ	B-NP	Ooxidative	injury	oxidative	JJ	I-NP	Oinjury	.	injury	NN	I-NP	O.	Manganous	.	.	O	OManganous	superoxide	Manganous	JJ	B-NP	B-proteinsuperoxide	dismutase	superoxide	NN	I-NP	I-proteindismutase	(	dismutase	NN	I-NP	I-protein(	MnSOD	(	(	O	OMnSOD	)	MnSOD	NN	B-NP	B-protein)	is	)	)	O	Ois	an	be	VBZ	B-VP	Oan	antioxidant	an	DT	B-NP	Oantioxidant	protective	antioxidant	JJ	I-NP	B-proteinprotective	factor	protective	JJ	I-NP	I-proteinfactor	.	factor	NN	I-NP	I-protein.	The	.	.	O	OThe	objectives	The	DT	B-NP	Oobjectives	of	objective	NNS	I-NP	Oof	these	of	IN	B-PP	Othese	studies	these	DT	B-NP	Ostudies	were	study	NNS	I-NP	Owere	to	be	VBD	B-VP	Oto	investigate	to	TO	I-VP	Oinvestigate	mechanisms	investigate	VB	I-VP	Omechanisms	for	mechanism	NNS	B-NP	Ofor	induction	for	IN	B-PP	Oinduction	of	induction	NN	B-NP	Oof	an	of	IN	B-PP	Oan	injurious	an	DT	B-NP	Oinjurious	factor	injurious	JJ	I-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	IL-8	(	(	O	OIL-8	)	IL-8	NN	B-NP	B-protein)	and	)	)	O	Oand	a	and	CC	O	Oa	protective	a	DT	B-NP	Oprotective	factor	protective	JJ	I-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	MnSOD	(	(	O	OMnSOD	)	MnSOD	NN	B-NP	B-protein)	in	)	)	O	Oin	the	in	IN	B-PP	Othe	HepG2	the	DT	B-NP	OHepG2	human	HepG2	NN	I-NP	B-cell_linehuman	hepatoma	human	JJ	I-NP	I-cell_linehepatoma	cell	hepatoma	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	.	line	NN	I-NP	I-cell_line.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	first	the	DT	B-NP	Ofirst	set	first	JJ	I-NP	Oset	of	set	NN	I-NP	Oof	experiments	of	IN	B-PP	Oexperiments	","	experiment	NNS	B-NP	O","	IL-8	","	","	O	OIL-8	gene	IL-8	NN	B-NP	B-DNAgene	reporter	gene	NN	I-NP	I-DNAreporter	constructs	reporter	NN	I-NP	I-DNAconstructs	were	construct	NNS	I-NP	I-DNAwere	used	be	VBD	B-VP	Oused	to	use	VBN	I-VP	Oto	transiently	to	TO	B-VP	Otransiently	transfect	transiently	RB	I-VP	Otransfect	a	transfect	VB	I-VP	Oa	derivative	a	DT	B-NP	Oderivative	(	derivative	JJ	I-NP	O(	MVh2E1-9	(	(	O	OMVh2E1-9	)	MVh2E1-9	NN	B-NP	O)	of	)	)	O	Oof	the	of	IN	B-PP	Othe	HepG2	the	DT	B-NP	OHepG2	cell	HepG2	NN	I-NP	B-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	which	line	NN	I-NP	I-cell_linewhich	expresses	which	WDT	B-NP	Oexpresses	P-4502E1	express	VBZ	B-VP	OP-4502E1	and	P-4502E1	NN	B-NP	B-proteinand	metabolizes	and	CC	O	Ometabolizes	ethanol	metabolize	VBZ	B-VP	Oethanol	.	ethanol	NN	B-NP	O.	Inactivation	.	.	O	OInactivation	of	Inactivation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	NF-kappaB	the	DT	B-NP	ONF-kappaB	and	NF-kappaB	NN	I-NP	B-proteinand	3'NF-IL-6	and	CC	I-NP	O3'NF-IL-6	DNA	3'NF-IL-6	NN	I-NP	B-DNADNA	binding	DNA	NN	I-NP	I-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	decreased	site	NNS	I-NP	I-DNAdecreased	IL-8	decrease	VBD	B-VP	OIL-8	gene	IL-8	NN	B-NP	B-DNAgene	transcriptional	gene	NN	I-NP	I-DNAtranscriptional	activation	transcriptional	JJ	I-NP	Oactivation	in	activation	NN	I-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	I-PP	Oto	TNF	to	TO	I-PP	OTNF	while	TNF	NN	B-NP	B-proteinwhile	inactivation	while	IN	B-SBAR	Oinactivation	of	inactivation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	5'NF-IL-6	the	DT	B-NP	O5'NF-IL-6	binding	5'NF-IL-6	NN	I-NP	B-DNAbinding	site	binding	NN	I-NP	I-DNAsite	increased	site	NN	I-NP	I-DNAincreased	IL-8	increase	VBD	B-VP	OIL-8	gene	IL-8	NN	B-NP	B-DNAgene	transcriptional	gene	NN	I-NP	I-DNAtranscriptional	activity	transcriptional	JJ	I-NP	Oactivity	in	activity	NN	I-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	I-PP	Oto	TNF	to	TO	I-PP	OTNF	.	TNF	NN	B-NP	B-protein.	This	.	.	O	OThis	system	This	DT	B-NP	Osystem	may	system	NN	I-NP	Omay	be	may	MD	B-VP	Obe	useful	be	VB	I-VP	Ouseful	to	useful	JJ	B-ADJP	Oto	assess	to	TO	B-VP	Oassess	the	assess	VB	I-VP	Othe	effects	the	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	ethanol	of	IN	B-PP	Oethanol	on	ethanol	NN	B-NP	Oon	TNF	on	IN	B-PP	OTNF	#NAME?	TNF	NN	B-NP	B-protein#NAME?	hepatocyte	#NAME?	JJ	I-NP	Ohepatocyte	IL-8	hepatocyte	NN	I-NP	OIL-8	production	IL-8	NN	I-NP	B-proteinproduction	.	production	NN	I-NP	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	second	the	DT	B-NP	Osecond	set	second	JJ	I-NP	Oset	of	set	NN	I-NP	Oof	experiments	of	IN	B-PP	Oexperiments	","	experiment	NNS	B-NP	O","	HepG2	","	","	O	OHepG2	cells	HepG2	NN	B-NP	B-cell_linecells	were	cell	NNS	I-NP	I-cell_linewere	cultured	be	VBD	B-VP	Ocultured	in	culture	VBN	I-VP	Oin	25	in	IN	B-PP	O25	to	25	CD	B-NP	Oto	100	to	TO	I-NP	O100	mmol	100	CD	I-NP	Ommol	concentrations	mmol	NN	I-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	ethanol	of	IN	B-PP	Oethanol	.	ethanol	NN	B-NP	O.	Both	.	.	O	OBoth	TNF	Both	CC	O	OTNF	and	TNF	NN	B-NP	B-proteinand	ethanol	and	CC	I-NP	Oethanol	increased	ethanol	NN	I-NP	Oincreased	HepG2	increase	VBD	B-VP	OHepG2	cell	HepG2	NN	B-NP	Ocell	MnSOD	cell	NN	I-NP	OMnSOD	activity	MnSOD	NN	I-NP	B-proteinactivity	in	activity	NN	I-NP	Oin	short-term	in	IN	B-PP	Oshort-term	(	short-term	JJ	B-NP	B-cell_line(	72	(	(	O	I-cell_line72	hr	72	CD	B-NP	I-cell_linehr	)	hr	NN	I-NP	I-cell_line)	cultures	)	)	O	I-cell_linecultures	with	culture	NNS	B-NP	I-cell_linewith	ethanol	with	IN	B-PP	Oethanol	.	ethanol	NN	B-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	after	","	","	O	Oafter	long-term	after	IN	B-PP	Olong-term	(	long-term	JJ	B-ADJP	B-cell_line(	10	(	(	O	I-cell_line10	weeks	10	CD	B-NP	I-cell_lineweeks	)	week	NNS	I-NP	I-cell_line)	culture	)	)	O	I-cell_lineculture	with	culture	NN	B-NP	I-cell_linewith	ethanol	with	IN	B-PP	Oethanol	","	ethanol	NN	B-NP	O","	there	","	","	O	Othere	was	there	EX	B-NP	Owas	no	be	VBD	B-VP	Ono	induction	no	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	MnSOD	of	IN	B-PP	OMnSOD	by	MnSOD	NN	B-NP	B-proteinby	ethanol	by	IN	B-PP	Oethanol	and	ethanol	NN	B-NP	Oand	there	and	CC	O	Othere	was	there	EX	B-NP	Owas	a	be	VBD	B-VP	Oa	diminished	a	DT	B-NP	Odiminished	induction	diminish	VBN	I-NP	Oinduction	of	induction	NN	I-NP	Oof	MnSOD	of	IN	B-PP	OMnSOD	in	MnSOD	NN	B-NP	B-proteinin	response	in	IN	B-PP	Oresponse	to	response	NN	I-PP	Oto	TNF	to	TO	I-PP	OTNF	.	TNF	NN	B-NP	B-protein.	Further	.	.	O	OFurther	studies	Further	JJ	B-NP	Ostudies	are	study	NNS	I-NP	Oare	needed	be	VBP	B-VP	Oneeded	to	need	VBN	I-VP	Oto	assess	to	TO	B-VP	Oassess	the	assess	VB	I-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	this	of	IN	B-PP	Othis	diminished	this	DT	B-NP	Odiminished	induction	diminish	VBN	I-NP	Oinduction	of	induction	NN	I-NP	Oof	MnSOD	of	IN	B-PP	OMnSOD	with	MnSOD	NN	B-NP	B-proteinwith	chronic	with	IN	B-PP	Ochronic	ethanol	chronic	JJ	B-NP	Oethanol	culture	ethanol	NN	I-NP	Oculture	on	culture	NN	I-NP	Oon	HepG2	on	IN	B-PP	OHepG2	cell	HepG2	NN	B-NP	Ocell	susceptibility	cell	NN	I-NP	Osusceptibility	to	susceptibility	NN	I-NP	Oto	TNF	to	TO	B-PP	OTNF	cytotoxicity	TNF	NN	B-NP	B-proteincytotoxicity	.	cytotoxicity	NN	I-NP	O.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	transfected	that	IN	B-SBAR	Otransfected	liver	transfecte	VBN	B-NP	B-cell_lineliver	cell	liver	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	can	line	NNS	I-NP	I-cell_linecan	be	can	MD	B-VP	Obe	used	be	VB	I-VP	Oused	to	use	VBN	I-VP	Oto	evaluate	to	TO	B-VP	Oevaluate	mechanisms	evaluate	VB	I-VP	Omechanisms	for	mechanism	NNS	B-NP	Ofor	increased	for	IN	B-PP	Oincreased	injurious	increase	VBN	B-NP	Oinjurious	factors	injurious	JJ	I-NP	B-proteinfactors	and	factor	NNS	I-NP	I-proteinand	decreased	and	CC	O	Odecreased	protective	decrease	VBD	B-VP	Oprotective	factors	protective	JJ	B-NP	B-proteinfactors	in	factor	NNS	I-NP	I-proteinin	alcoholic	in	IN	B-PP	Oalcoholic	liver	alcoholic	JJ	B-NP	Oliver	injury	liver	NN	I-NP	Oinjury	.	injury	NN	I-NP	O.	Tissue	.	.	O	OTissue	factor	Tissue	NN	B-NP	B-proteinfactor	transcription	factor	NN	I-NP	I-proteintranscription	driven	transcription	NN	I-NP	Odriven	by	drive	VBN	B-VP	Oby	Egr-1	by	IN	B-PP	OEgr-1	is	Egr-1	NN	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	critical	a	DT	B-NP	Ocritical	mechanism	critical	JJ	I-NP	Omechanism	of	mechanism	NN	I-NP	Oof	murine	of	IN	B-PP	Omurine	pulmonary	murine	JJ	B-NP	B-proteinpulmonary	fibrin	pulmonary	JJ	I-NP	I-proteinfibrin	deposition	fibrin	NN	I-NP	I-proteindeposition	in	deposition	NN	I-NP	Oin	hypoxia	in	IN	B-PP	Ohypoxia	.	hypoxia	NN	B-NP	O.	Local	.	.	O	OLocal	hypoxemia	Local	JJ	B-NP	Ohypoxemia	and	hypoxemia	NN	I-NP	Oand	stasis	and	CC	I-NP	Ostasis	trigger	stasis	NN	I-NP	Otrigger	thrombosis	trigger	NN	I-NP	Othrombosis	.	thrombosis	NN	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	demonstrated	have	VBP	B-VP	Odemonstrated	previously	demonstrate	VBN	I-VP	Opreviously	that	previously	RB	B-ADVP	Othat	in	that	IN	B-SBAR	Oin	a	in	IN	B-PP	Oa	murine	a	DT	B-NP	Omurine	model	murine	JJ	I-NP	Omodel	of	model	NN	I-NP	Oof	normobaric	of	IN	B-PP	Onormobaric	hypoxia	normobaric	JJ	B-NP	Ohypoxia	pulmonary	hypoxia	NN	I-NP	Opulmonary	fibrin	pulmonary	JJ	I-NP	Ofibrin	deposition	fibrin	NN	I-NP	Odeposition	is	deposition	NN	I-NP	Ois	a	be	VBZ	B-VP	Oa	result	a	DT	B-NP	Oresult	of	result	NN	I-NP	Oof	expression	of	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	tissue	of	IN	B-PP	Otissue	factor	tissue	NN	B-NP	B-proteinfactor	","	factor	NN	I-NP	I-protein","	especially	","	","	O	Oespecially	in	especially	RB	B-ADVP	Oin	oxygen-deprived	in	IN	B-PP	Ooxygen-deprived	mononuclear	oxygen-deprived	JJ	B-NP	B-cell_typemononuclear	phagocytes	mononuclear	JJ	I-NP	I-cell_typephagocytes	(	phagocyte	NNS	I-NP	I-cell_type(	MPs	(	(	O	OMPs	)	MP	NNS	B-NP	B-protein)	.	)	)	O	O.	We	.	.	O	OWe	now	We	PRP	B-NP	Onow	show	now	RB	B-ADVP	Oshow	that	show	VBP	B-VP	Othat	transcription	that	IN	B-SBAR	Otranscription	factor	transcription	NN	B-NP	B-proteinfactor	early-growth-response	factor	NN	I-NP	I-proteinearly-growth-response	gene	early-growth-response	JJ	I-NP	I-proteingene	product	gene	NN	I-NP	I-proteinproduct	(	product	NN	I-NP	I-protein(	Egr-1	(	(	O	OEgr-1	)	Egr-1	NN	B-NP	B-protein)	is	)	)	O	Ois	rapidly	be	VBZ	B-VP	Orapidly	activated	rapidly	RB	I-VP	Oactivated	in	activate	VBN	I-VP	Oin	hypoxia	in	IN	B-PP	Ohypoxia	","	hypoxia	NN	B-NP	O","	both	","	","	O	Oboth	in	both	CC	O	Oin	vitro	in	FW	B-ADVP	Ovitro	and	vitro	FW	I-ADVP	Oand	in	and	CC	O	Oin	vivo	in	FW	B-ADVP	Ovivo	","	vivo	FW	I-ADVP	O","	and	","	","	O	Oand	is	and	CC	O	Ois	responsible	be	VBZ	B-VP	Oresponsible	for	responsible	JJ	B-ADJP	Ofor	transcription	for	IN	B-PP	Otranscription	and	transcription	NN	B-NP	Oand	expression	and	CC	O	Oexpression	of	expression	NN	B-NP	Oof	tissue	of	IN	B-PP	Otissue	factor	tissue	NN	B-NP	B-proteinfactor	in	factor	NN	I-NP	I-proteinin	hypoxic	in	IN	B-PP	Ohypoxic	lung	hypoxic	JJ	B-NP	Olung	.	lung	NN	I-NP	O.	MPs	.	.	O	OMPs	and	MP	NNS	B-NP	Oand	HeLa	and	CC	O	OHeLa	cells	HeLa	NN	B-NP	B-cell_linecells	subjected	cell	NNS	I-NP	I-cell_linesubjected	to	subject	VBN	B-VP	Oto	hypoxia	to	TO	B-PP	Ohypoxia	(	hypoxia	NN	B-NP	O(	pO2	(	(	O	OpO2	approximately	pO2	NN	B-NP	Oapproximately	13	approximately	RB	B-NP	O13	torr	13	CD	I-NP	Otorr	)	torr	NN	I-NP	O)	had	)	)	O	Ohad	increased	have	VBD	B-VP	Oincreased	levels	increase	VBN	I-VP	Olevels	of	level	NNS	B-NP	Oof	tissue	of	IN	B-PP	Otissue	factor	tissue	NN	B-NP	B-RNAfactor	transcripts	factor	NN	I-NP	I-RNAtranscripts	(	transcript	NNS	I-NP	I-RNA(	approximately	(	(	O	Oapproximately	18-fold	approximately	RB	B-NP	O18-fold	)	18-fold	JJ	I-NP	O)	and	)	)	O	Oand	an	and	CC	O	Oan	increased	an	DT	B-NP	Oincreased	rate	increase	VBN	I-NP	Orate	of	rate	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	(	transcription	NN	B-NP	O(	approximately	(	(	O	Oapproximately	15-fold	approximately	RB	B-ADVP	O15-fold	)	15-fold	RB	B-ADVP	O)	","	)	)	O	O","	based	","	","	O	Obased	on	base	VBN	B-PP	Oon	nuclear	on	IN	B-PP	Onuclear	run-on	nuclear	JJ	B-NP	Orun-on	analysis	run-on	JJ	I-NP	Oanalysis	.	analysis	NN	I-NP	O.	Gel-shift	.	.	O	OGel-shift	analysis	Gel-shift	JJ	B-NP	Oanalysis	of	analysis	NN	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	extracts	nuclear	JJ	B-NP	Oextracts	from	extract	NNS	I-NP	Ofrom	hypoxic	from	IN	B-PP	Ohypoxic	MPs	hypoxic	JJ	B-NP	OMPs	and	MP	NNS	I-NP	Oand	HeLa	and	CC	O	OHeLa	cells	HeLa	NN	B-NP	B-cell_linecells	demonstrated	cell	NNS	I-NP	I-cell_linedemonstrated	increased	demonstrate	VBD	B-VP	Oincreased	DNA-binding	increase	VBN	B-NP	ODNA-binding	activity	DNA-binding	JJ	I-NP	Oactivity	at	activity	NN	I-NP	Oat	the	at	IN	B-PP	Othe	serum	the	DT	B-NP	Oserum	response	serum	NN	I-NP	B-DNAresponse	region	response	NN	I-NP	I-DNAregion	(	region	NN	I-NP	I-DNA(	SRR	(	(	O	OSRR	;	SRR	NN	B-NP	B-DNA;	-7.928571429	;	:	O	I-DNA-7.928571429	bp	-7.928571429	CD	B-NP	I-DNAbp	)	bp	NN	I-NP	I-DNA)	of	)	)	O	Oof	the	of	IN	B-PP	Othe	tissue	the	DT	B-NP	Otissue	factor	tissue	NN	I-NP	B-DNAfactor	promoter	factor	NN	I-NP	I-DNApromoter	at	promoter	NN	I-NP	I-DNAat	Egr-1	at	IN	B-PP	OEgr-1	motifs	Egr-1	NN	B-NP	B-DNAmotifs	.	motif	NNS	I-NP	I-DNA.	Using	.	.	O	OUsing	32P-labeled	Use	VBG	B-VP	O32P-labeled	Egr	32P-labeled	JJ	B-NP	OEgr	consensus	Egr	NN	I-NP	Oconsensus	oligonucleotide	consensus	NN	I-NP	Ooligonucleotide	","	oligonucleotide	NN	I-NP	O","	we	","	","	O	Owe	observed	we	PRP	B-NP	Oobserved	induction	observe	VBD	B-VP	Oinduction	of	induction	NN	B-NP	Oof	DNA-binding	of	IN	B-PP	ODNA-binding	activity	DNA-binding	JJ	B-NP	Oactivity	in	activity	NN	I-NP	Oin	nuclear	in	IN	B-PP	Onuclear	extracts	nuclear	JJ	B-NP	Oextracts	from	extract	NNS	I-NP	Ofrom	hypoxic	from	IN	B-PP	Ohypoxic	lung	hypoxic	JJ	B-NP	Olung	and	lung	NN	I-NP	Oand	HeLa	and	CC	I-NP	OHeLa	cells	HeLa	NN	I-NP	B-cell_linecells	because	cell	NNS	I-NP	I-cell_linebecause	of	because	IN	B-PP	Oof	activation	of	IN	I-PP	Oactivation	of	activation	NN	B-NP	Oof	Egr-1	of	IN	B-PP	OEgr-1	","	Egr-1	NN	B-NP	B-protein","	by	","	","	O	Oby	means	by	IN	B-PP	Omeans	of	mean	NNS	B-NP	Oof	supershift	of	IN	B-PP	Osupershift	analysis	supershift	NN	B-NP	Oanalysis	.	analysis	NN	I-NP	O.	Transient	.	.	O	OTransient	transfection	Transient	JJ	B-NP	Otransfection	of	transfection	NN	I-NP	Oof	HeLa	of	IN	B-PP	OHeLa	cells	HeLa	NN	B-NP	B-cell_linecells	with	cell	NNS	I-NP	I-cell_linewith	chimeric	with	IN	B-PP	Ochimeric	plasmids	chimeric	JJ	B-NP	B-DNAplasmids	containing	plasmid	NNS	I-NP	I-DNAcontaining	wild-type	contain	VBG	B-VP	Owild-type	or	wild-type	JJ	B-NP	Oor	mutant	or	CC	I-NP	Omutant	SRR	mutant	JJ	I-NP	OSRR	from	SRR	NN	I-NP	Ofrom	the	from	IN	B-PP	Othe	tissue	the	DT	B-NP	Otissue	factor	tissue	NN	I-NP	B-DNAfactor	promoter	factor	NN	I-NP	I-DNApromoter	showed	promoter	NN	I-NP	I-DNAshowed	that	show	VBD	B-VP	Othat	intact	that	IN	B-SBAR	Ointact	Sp1	intact	JJ	B-NP	OSp1	sites	Sp1	NN	I-NP	B-DNAsites	are	site	NNS	I-NP	I-DNAare	necessary	be	VBP	B-VP	Onecessary	for	necessary	JJ	B-ADJP	Ofor	basal	for	IN	B-PP	Obasal	promoter	basal	JJ	B-NP	B-DNApromoter	activity	promoter	NN	I-NP	I-DNAactivity	","	activity	NN	I-NP	O","	whereas	","	","	O	Owhereas	the	whereas	IN	O	Othe	integrity	the	DT	B-NP	Ointegrity	of	integrity	NN	I-NP	Oof	Egr-1	of	IN	B-PP	OEgr-1	sites	Egr-1	NN	B-NP	B-DNAsites	was	site	NNS	I-NP	I-DNAwas	required	be	VBD	B-VP	Orequired	for	require	VBN	I-VP	Ofor	hypoxia-enhanced	for	IN	B-PP	Ohypoxia-enhanced	expression	hypoxia-enhanced	JJ	B-NP	Oexpression	.	expression	NN	I-NP	O.	A	.	.	O	OA	central	A	DT	B-NP	Ocentral	role	central	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	Egr-1	for	IN	B-PP	OEgr-1	in	Egr-1	NN	B-NP	B-proteinin	hypoxia-mediated	in	IN	B-PP	Ohypoxia-mediated	tissue	hypoxia-mediated	JJ	B-NP	Otissue	factor	tissue	NN	I-NP	B-proteinfactor	expression	factor	NN	I-NP	I-proteinexpression	was	expression	NN	I-NP	Owas	confirmed	be	VBD	B-VP	Oconfirmed	by	confirm	VBN	I-VP	Oby	experiments	by	IN	B-PP	Oexperiments	with	experiment	NNS	B-NP	Owith	homozygous	with	IN	B-PP	Ohomozygous	Egr-1	homozygous	JJ	B-NP	OEgr-1	null	Egr-1	NN	I-NP	B-proteinnull	mice	null	JJ	I-NP	Omice	;	mouse	NNS	I-NP	O;	wild-type	;	:	O	Owild-type	mice	wild-type	JJ	B-NP	Omice	subjected	mouse	NNS	I-NP	Osubjected	to	subject	VBN	B-VP	Oto	oxygen	to	TO	B-PP	Ooxygen	deprivation	oxygen	NN	B-NP	Odeprivation	expressed	deprivation	NN	I-NP	Oexpressed	tissue	express	VBD	B-VP	Otissue	factor	tissue	NN	B-NP	B-proteinfactor	and	factor	NN	I-NP	I-proteinand	showed	and	CC	O	Oshowed	fibrin	show	VBD	B-VP	Ofibrin	deposition	fibrin	NN	B-NP	Odeposition	","	deposition	NN	I-NP	O","	but	","	","	O	Obut	hypoxic	but	CC	O	Ohypoxic	homozygous	hypoxic	JJ	B-NP	Ohomozygous	Egr-1	homozygous	JJ	I-NP	OEgr-1	null	Egr-1	NN	I-NP	B-proteinnull	mice	null	JJ	I-NP	Omice	displayed	mouse	NNS	I-NP	Odisplayed	neither	display	VBD	B-VP	Oneither	tissue	neither	CC	O	Otissue	factor	tissue	NN	B-NP	B-proteinfactor	nor	factor	NN	I-NP	I-proteinnor	fibrin	nor	CC	O	Ofibrin	.	fibrin	NN	B-NP	B-protein.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	delineate	datum	NNS	I-NP	Odelineate	a	delineate	VBP	B-VP	Oa	novel	a	DT	B-NP	Onovel	biology	novel	JJ	I-NP	Obiology	for	biology	NN	I-NP	Ofor	hypoxia-induced	for	IN	B-PP	Ohypoxia-induced	fibrin	hypoxia-induced	JJ	B-NP	Ofibrin	deposition	fibrin	NN	I-NP	Odeposition	","	deposition	NN	I-NP	O","	in	","	","	O	Oin	which	in	IN	B-PP	Owhich	oxygen	which	WDT	B-NP	Ooxygen	deprivation-induced	oxygen	NN	B-NP	Odeprivation-induced	activation	deprivation-induced	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	Egr-1	of	IN	B-PP	OEgr-1	","	Egr-1	NN	B-NP	B-protein","	resulting	","	","	O	Oresulting	in	result	VBG	B-VP	Oin	expression	in	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	tissue	of	IN	B-PP	Otissue	factor	tissue	NN	B-NP	B-proteinfactor	","	factor	NN	I-NP	I-protein","	has	","	","	O	Ohas	an	have	VBZ	B-VP	Oan	unexpected	an	DT	B-NP	Ounexpected	and	unexpected	JJ	I-NP	Oand	central	and	CC	I-NP	Ocentral	role	central	JJ	I-NP	Orole	.	role	NN	I-NP	O.	Kinetics	.	.	O	OKinetics	of	Kinetic	NNS	B-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	and	cytokine	NN	B-NP	B-proteinand	NFAT	and	CC	I-NP	ONFAT	gene	NFAT	NN	I-NP	B-proteingene	expression	gene	NN	I-NP	Oexpression	in	expression	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	interleukin-2-dependent	human	JJ	B-NP	B-cell_typeinterleukin-2-dependent	T	interleukin-2-dependent	JJ	I-NP	I-cell_typeT	lymphoblasts	T	NN	I-NP	I-cell_typelymphoblasts	stimulated	lymphoblast	NNS	I-NP	I-cell_typestimulated	via	stimulate	VBN	B-VP	Ovia	T-cell	via	IN	B-PP	OT-cell	receptor	T-cell	NN	B-NP	B-proteinreceptor	.	receptor	NN	I-NP	I-protein.	T	.	.	O	OT	cells	T	NN	B-NP	B-cell_typecells	respond	cell	NNS	I-NP	I-cell_typerespond	to	respond	VBP	B-VP	Oto	mitogenic	to	TO	B-PP	Omitogenic	or	mitogenic	JJ	B-NP	Oor	antigenic	or	CC	I-NP	Oantigenic	stimulation	antigenic	JJ	I-NP	Ostimulation	by	stimulation	NN	I-NP	Oby	proliferation	by	IN	B-PP	Oproliferation	and	proliferation	NN	B-NP	Oand	by	and	CC	B-PP	Oby	turning	by	IN	B-PP	Oturning	on	turn	VBG	B-VP	Oon	cytokine	on	IN	B-PP	Ocytokine	gene	cytokine	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	.	expression	NN	I-NP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	have	we	PRP	B-NP	Ohave	analysed	have	VBP	B-VP	Oanalysed	the	analyse	VBN	I-VP	Othe	kinetics	the	DT	B-NP	Okinetics	and	kinetic	NNS	I-NP	Oand	nature	and	CC	I-NP	Onature	of	nature	NN	I-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	production	cytokine	NN	B-NP	B-proteinproduction	in	production	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	peripheral	human	JJ	B-NP	B-cell_typeperipheral	blood-derived	peripheral	JJ	I-NP	I-cell_typeblood-derived	T	blood-derived	JJ	I-NP	I-cell_typeT	lymphoblasts	T	NN	I-NP	I-cell_typelymphoblasts	stimulated	lymphoblast	NNS	I-NP	I-cell_typestimulated	with	stimulate	VBN	B-VP	Owith	anti-CD3	with	IN	B-PP	Oanti-CD3	antibodies	anti-CD3	JJ	B-NP	B-proteinantibodies	or	antibody	NNS	I-NP	I-proteinor	Lens	or	CC	O	OLens	culinaris	Lens	NNP	B-NP	Oculinaris	lectin	culinaris	NN	I-NP	Olectin	(	lectin	NN	I-NP	O(	LCL	(	(	O	OLCL	)	LCL	NN	B-NP	B-cell_line)	.	)	)	O	O.	T	.	.	O	OT	cells	T	NN	B-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	purified	be	VBD	B-VP	Opurified	from	purify	VBN	I-VP	Ofrom	peripheral	from	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	PBMC	(	(	O	OPBMC	)	PBMC	NN	B-NP	B-cell_type)	and	)	)	O	Oand	primarily	and	CC	O	Oprimarily	activated	primarily	RB	B-VP	Oactivated	with	activate	VBN	I-VP	Owith	anti-CD3	with	IN	B-PP	Oanti-CD3	antibodies	anti-CD3	JJ	B-NP	B-proteinantibodies	and	antibody	NNS	I-NP	I-proteinand	cultured	and	CC	O	Ocultured	in	culture	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	interleukin-2	of	IN	B-PP	Ointerleukin-2	(	interleukin-2	NN	B-NP	B-protein(	IL-2	(	(	O	OIL-2	)	IL-2	NN	B-NP	B-protein)	.	)	)	O	O.	Anti-CD3-restimulated	.	.	O	OAnti-CD3-restimulated	T	Anti-CD3-restimulated	JJ	B-NP	B-proteinT	cells	T	NN	I-NP	I-proteincells	(	cell	NNS	I-NP	I-protein(	mainly	(	(	O	Omainly	CD8+	mainly	RB	B-ADJP	OCD8+	)	CD8+	JJ	I-ADJP	O)	produced	)	)	O	Oproduced	IL-2	produce	VBD	B-VP	OIL-2	","	IL-2	NN	B-NP	B-protein","	interferon-gamma	","	","	O	Ointerferon-gamma	(	interferon-gamma	NN	B-NP	B-protein(	IFN-gamma	(	(	O	OIFN-gamma	)	IFN-gamma	NN	B-NP	B-protein)	and	)	)	O	Oand	tumour	and	CC	O	Otumour	necrosis	tumour	NN	B-NP	B-proteinnecrosis	factor-alpha	necrosis	NN	I-NP	I-proteinfactor-alpha	(	factor-alpha	NN	I-NP	I-protein(	TNF-alpha	(	(	O	OTNF-alpha	)	TNF-alpha	NN	B-NP	B-protein)	and	)	)	O	Oand	low	and	CC	O	Olow	levels	low	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	IL-4	of	IN	B-PP	OIL-4	and	IL-4	NN	B-NP	B-proteinand	IL-10	and	CC	I-NP	OIL-10	transcripts	IL-10	NN	I-NP	B-proteintranscripts	and	transcript	NNS	I-NP	Oand	proteins	and	CC	I-NP	Oproteins	.	protein	NNS	I-NP	O.	No	.	.	O	ONo	IL-6	No	DT	B-NP	OIL-6	gene	IL-6	NN	I-NP	B-proteingene	expression	gene	NN	I-NP	Oexpression	was	expression	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	.	observe	VBN	I-VP	O.	In	.	.	O	OIn	LCL-stimulated	In	IN	B-PP	OLCL-stimulated	cells	LCL-stimulated	JJ	B-NP	B-cell_linecells	the	cell	NNS	I-NP	I-cell_linethe	cytokine	the	DT	B-NP	Ocytokine	production	cytokine	NN	I-NP	B-proteinproduction	pattern	production	NN	I-NP	Opattern	was	pattern	NN	I-NP	Owas	very	be	VBD	B-VP	Overy	similar	very	RB	B-ADJP	Osimilar	.	similar	JJ	I-ADJP	O.	Steady-state	.	.	O	OSteady-state	mRNA	Steady-state	JJ	B-NP	OmRNA	levels	mRNA	NN	I-NP	Olevels	of	level	NNS	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	","	IL-2	NN	B-NP	B-protein","	IL-10	","	","	O	OIL-10	and	IL-10	NN	B-NP	B-proteinand	IFN-gamma	and	CC	I-NP	OIFN-gamma	peaked	IFN-gamma	NN	I-NP	B-proteinpeaked	at	peak	VBD	B-VP	Oat	3	at	IN	B-PP	O3	hr	3	CD	B-NP	Ohr	after	hr	NN	I-NP	Oafter	anti-CD3	after	IN	B-PP	Oanti-CD3	stimulation	anti-CD3	JJ	B-NP	B-proteinstimulation	and	stimulation	NN	I-NP	Oand	declined	and	CC	O	Odeclined	rapidly	decline	VBD	B-VP	Orapidly	thereafter	rapidly	RB	B-ADVP	Othereafter	.	thereafter	RB	I-ADVP	O.	The	.	.	O	OThe	kinetics	The	DT	B-NP	Okinetics	of	kinetic	NNS	I-NP	Oof	TNF-alpha	of	IN	B-PP	OTNF-alpha	mRNA	TNF-alpha	NN	B-NP	B-RNAmRNA	expression	mRNA	NN	I-NP	I-RNAexpression	was	expression	NN	I-NP	Owas	faster	be	VBD	B-VP	Ofaster	","	fast	JJR	B-ADJP	O","	being	","	","	O	Obeing	at	be	VBG	B-VP	Oat	its	at	IN	B-PP	Oits	peak	its	PRP$	B-NP	Opeak	level	peak	JJ	I-NP	Olevel	1	level	NN	I-NP	O1	hr	1	CD	I-NP	Ohr	after	hr	NN	I-NP	Oafter	stimulation	after	IN	B-PP	Ostimulation	.	stimulation	NN	B-NP	O.	Anti-CD3-stimulated	.	.	O	OAnti-CD3-stimulated	IL-2	Anti-CD3-stimulated	JJ	B-NP	OIL-2	gene	IL-2	NN	I-NP	B-proteingene	expression	gene	NN	I-NP	Oexpression	was	expression	NN	I-NP	Owas	down-regulated	be	VBD	B-VP	Odown-regulated	by	down-regulate	VBN	I-VP	Oby	protein	by	IN	B-PP	Oprotein	synthesis	protein	NN	B-NP	Osynthesis	inhibitor	synthesis	NN	I-NP	Oinhibitor	","	inhibitor	NN	I-NP	O","	whereas	","	","	O	Owhereas	IL-10	whereas	IN	O	OIL-10	","	IL-10	NN	B-NP	B-protein","	IFN-gamma	","	","	I-NP	OIFN-gamma	and	IFN-gamma	NN	I-NP	B-proteinand	TNF-alpha	and	CC	I-NP	OTNF-alpha	genes	TNF-alpha	NN	I-NP	B-DNAgenes	were	gene	NNS	I-NP	I-DNAwere	readily	be	VBD	B-VP	Oreadily	induced	readily	RB	I-VP	Oinduced	independent	induce	VBN	I-VP	Oindependent	of	independent	JJ	B-ADJP	Oof	ongoing	of	IN	B-PP	Oongoing	protein	ongoing	JJ	B-NP	B-proteinprotein	synthesis	protein	NN	I-NP	I-proteinsynthesis	.	synthesis	NN	I-NP	O.	T-cell	.	.	O	OT-cell	receptor	T-cell	NN	B-NP	B-proteinreceptor	stimulation	receptor	NN	I-NP	I-proteinstimulation	also	stimulation	NN	I-NP	Oalso	induced	also	RB	B-ADVP	Oinduced	a	induce	VBD	B-VP	Oa	very	a	DT	B-NP	Overy	rapid	very	RB	I-NP	Orapid	expression	rapid	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	c-jun	of	IN	B-PP	Oc-jun	","	c-jun	NN	B-NP	B-DNA","	c-fos	","	","	O	Oc-fos	and	c-fos	NN	B-NP	B-DNAand	NFATc1	and	CC	O	ONFATc1	(	NFATc1	NN	B-NP	B-DNA(	NFATc	(	(	O	I-DNANFATc	)	NFATc	NN	B-NP	I-DNA)	genes	)	)	O	I-DNAgenes	","	gene	NNS	B-NP	I-DNA","	the	","	","	O	Othe	gene	the	DT	B-NP	Ogene	products	gene	NN	I-NP	B-proteinproducts	of	product	NNS	I-NP	I-proteinof	which	of	IN	B-PP	Owhich	are	which	WDT	B-NP	Oare	involved	be	VBP	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	cytokine	in	IN	B-PP	Ocytokine	gene	cytokine	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	.	expression	NN	I-NP	O.	In	.	.	O	OIn	conclusion	In	IN	B-PP	Oconclusion	","	conclusion	NN	B-NP	O","	the	","	","	O	Othe	cytokines	the	DT	B-NP	Ocytokines	synthesized	cytokine	NNS	I-NP	B-proteinsynthesized	by	synthesize	VBN	B-VP	Oby	IL-2-dependent	by	IN	B-PP	OIL-2-dependent	T	IL-2-dependent	JJ	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	were	cell	NNS	I-NP	I-cell_linewere	predominantly	be	VBD	B-VP	Opredominantly	IL-2	predominantly	RB	B-ADVP	OIL-2	","	IL-2	NN	B-NP	B-protein","	IFN-gamma	","	","	I-NP	OIFN-gamma	and	IFN-gamma	NN	I-NP	B-proteinand	TNF-alpha	and	CC	I-NP	OTNF-alpha	.	TNF-alpha	NN	I-NP	B-protein.	An	.	.	O	OAn	animal	An	DT	B-NP	Oanimal	model	animal	NN	I-NP	Omodel	to	model	NN	I-NP	Oto	study	to	TO	B-VP	Ostudy	local	study	VB	I-VP	Olocal	oxidation	local	JJ	B-NP	Ooxidation	of	oxidation	NN	I-NP	Oof	LDL	of	IN	B-PP	OLDL	and	LDL	NN	B-NP	B-proteinand	its	and	CC	O	Oits	biological	its	PRP$	B-NP	Obiological	effects	biological	JJ	I-NP	Oeffects	in	effect	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	arterial	the	DT	B-NP	Oarterial	wall	arterial	JJ	I-NP	Owall	.	wall	NN	I-NP	O.	Oxidized	.	.	O	OOxidized	LDL	Oxidize	VBN	B-NP	B-proteinLDL	(	LDL	NN	I-NP	I-protein(	oxLDL	(	(	O	OoxLDL	)	oxLDL	NN	B-NP	B-protein)	is	)	)	O	Ois	present	be	VBZ	B-VP	Opresent	in	present	JJ	B-ADJP	Oin	atherosclerotic	in	IN	B-PP	Oatherosclerotic	lesions	atherosclerotic	JJ	B-NP	Olesions	and	lesion	NNS	I-NP	Oand	is	and	CC	O	Ois	believed	be	VBZ	B-VP	Obelieved	to	believe	VBN	I-VP	Oto	play	to	TO	I-VP	Oplay	a	play	VB	I-VP	Oa	key	a	DT	B-NP	Okey	role	key	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	atherogenesis	in	IN	B-PP	Oatherogenesis	.	atherogenesis	NN	B-NP	O.	Mainly	.	.	O	OMainly	on	Mainly	RB	B-ADVP	Oon	the	on	IN	B-PP	Othe	basis	the	DT	B-NP	Obasis	of	basis	NN	I-NP	Oof	cell	of	IN	B-PP	Ocell	culture	cell	NN	B-NP	Oculture	studies	culture	NN	I-NP	Ostudies	","	study	NNS	I-NP	O","	oxLDL	","	","	O	OoxLDL	has	oxLDL	NN	B-NP	B-proteinhas	been	have	VBZ	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	produce	to	TO	I-VP	Oproduce	many	produce	VB	I-VP	Omany	biological	many	JJ	B-NP	Obiological	effects	biological	JJ	I-NP	Oeffects	that	effect	NNS	I-NP	Othat	influence	that	WDT	B-NP	Oinfluence	the	influence	VBP	B-VP	Othe	atherosclerotic	the	DT	B-NP	Oatherosclerotic	process	atherosclerotic	JJ	I-NP	Oprocess	.	process	NN	I-NP	O.	To	.	.	O	OTo	study	To	TO	B-VP	Ostudy	LDL	study	VB	I-VP	OLDL	oxidation	LDL	NN	B-NP	B-proteinoxidation	in	oxidation	NN	I-NP	Oin	vivo	in	FW	B-ADVP	Ovivo	","	vivo	FW	I-ADVP	O","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	established	have	VBP	B-VP	Oestablished	a	establish	VBN	I-VP	Oa	model	a	DT	B-NP	Omodel	in	model	NN	I-NP	Oin	which	in	IN	B-PP	Owhich	Sprague-Dawley	which	WDT	B-NP	OSprague-Dawley	rats	Sprague-Dawley	JJ	B-NP	Orats	are	rat	NNS	I-NP	Oare	given	be	VBP	B-VP	Ogiven	a	give	VBN	I-VP	Oa	single	a	DT	B-NP	Osingle	injection	single	JJ	I-NP	Oinjection	of	injection	NN	I-NP	Oof	unmodified	of	IN	B-PP	Ounmodified	human	unmodified	JJ	B-NP	Ohuman	LDL	human	JJ	I-NP	OLDL	(	LDL	NN	I-NP	O(	>	(	(	O	O>	or	>	SYM	B-NP	Oor	=	or	CC	O	O=	4	=	SYM	B-VP	O4	mg/kg	4	CD	B-NP	Omg/kg	body	mg/kg	NN	I-NP	Obody	weight	body	NN	I-NP	Oweight	)	weight	NN	I-NP	O)	.	)	)	O	O.	Within	.	.	O	OWithin	6	Within	IN	B-PP	O6	hours	6	CD	B-NP	Ohours	","	hour	NNS	I-NP	O","	an	","	","	O	Oan	accumulation	an	DT	B-NP	Oaccumulation	of	accumulation	NN	I-NP	Oof	apolipoprotein	of	IN	B-PP	Oapolipoprotein	B	apolipoprotein	NN	B-NP	OB	and	B	NN	I-NP	Oand	epitopes	and	CC	O	Oepitopes	present	epitope	NNS	B-NP	Opresent	on	present	JJ	B-ADJP	Oon	oxLDL	on	IN	B-PP	OoxLDL	are	oxLDL	NN	B-NP	B-proteinare	detected	be	VBP	B-VP	Odetected	in	detect	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	arterial	the	DT	B-NP	Oarterial	endothelium	arterial	JJ	I-NP	Oendothelium	and	endothelium	NN	I-NP	Oand	media	and	CC	I-NP	Omedia	.	medium	NNS	I-NP	O.	The	.	.	O	OThe	presence	The	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	oxLDL	of	IN	B-PP	OoxLDL	is	oxLDL	NN	B-NP	B-proteinis	associated	be	VBZ	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	activation	with	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	nuclear	factor	NN	I-NP	I-proteinnuclear	factor-kappaB	nuclear	JJ	I-NP	B-proteinfactor-kappaB	in	factor-kappaB	NN	I-NP	I-proteinin	the	in	IN	B-PP	Othe	endothelium	the	DT	B-NP	Oendothelium	as	endothelium	NN	I-NP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	endothelial	as	IN	I-CONJP	Oendothelial	expression	endothelial	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	intercellular	of	IN	B-PP	Ointercellular	adhesion	intercellular	JJ	B-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	.	molecule-1	NN	I-NP	I-protein.	Injection	.	.	O	OInjection	of	Injection	NN	B-NP	Oof	LDL	of	IN	B-PP	OLDL	enriched	LDL	NN	B-NP	B-proteinenriched	with	enrich	VBN	B-VP	Owith	the	with	IN	B-PP	Othe	antioxidant	the	DT	B-NP	Oantioxidant	probucol	antioxidant	JJ	I-NP	Oprobucol	resulted	probucol	NN	I-NP	Oresulted	in	result	VBD	B-VP	Oin	arterial	in	IN	B-PP	Oarterial	accumulation	arterial	JJ	B-NP	Oaccumulation	of	accumulation	NN	I-NP	Oof	apolipoprotein	of	IN	B-PP	Oapolipoprotein	B	apolipoprotein	NN	B-NP	OB	","	B	NN	I-NP	O","	but	","	","	O	Obut	the	but	CC	O	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	oxLDL-specific	of	IN	B-PP	OoxLDL-specific	epitopes	oxLDL-specific	JJ	B-NP	B-proteinepitopes	was	epitope	NNS	I-NP	I-proteinwas	reduced	be	VBD	B-VP	Oreduced	at	reduce	VBN	I-VP	Oat	24	at	IN	B-PP	O24	hours	24	CD	B-NP	Ohours	.	hour	NNS	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	this	","	","	O	Othis	simple	this	DT	B-NP	Osimple	model	simple	JJ	I-NP	Omodel	has	model	NN	I-NP	Ohas	the	have	VBZ	B-VP	Othe	potential	the	DT	B-NP	Opotential	to	potential	NN	I-NP	Oto	analyze	to	TO	B-VP	Oanalyze	the	analyze	VB	I-VP	Othe	mechanisms	the	DT	B-NP	Omechanisms	behind	mechanism	NNS	I-NP	Obehind	and	behind	IN	B-ADVP	Oand	biological	and	CC	O	Obiological	effects	biological	JJ	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	LDL	of	IN	B-PP	OLDL	oxidation	LDL	NN	B-NP	B-proteinoxidation	in	oxidation	NN	I-NP	Oin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	Molecular	.	.	O	OMolecular	mechanisms	Molecular	JJ	B-NP	Omechanisms	of	mechanism	NNS	I-NP	Oof	promoter	of	IN	B-PP	Opromoter	regulation	promoter	NN	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	gp34	the	DT	B-NP	Ogp34	gene	gp34	NN	I-NP	B-DNAgene	that	gene	NN	I-NP	I-DNAthat	is	that	WDT	B-NP	Ois	trans-activated	be	VBZ	B-VP	Otrans-activated	by	trans-activate	VBN	I-VP	Oby	an	by	IN	B-PP	Oan	oncoprotein	an	DT	B-NP	Ooncoprotein	Tax	oncoprotein	NN	I-NP	B-proteinTax	of	Tax	NN	I-NP	B-proteinof	human	of	IN	B-PP	Ohuman	T	human	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	leukemia	cell	NN	I-NP	Oleukemia	virus	leukemia	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	I	type	NN	I-NP	OI	.	I	CD	I-NP	O.	We	.	.	O	OWe	investigated	We	PRP	B-NP	Oinvestigated	the	investigate	VBD	B-VP	Othe	molecular	the	DT	B-NP	Omolecular	mechanism	molecular	JJ	I-NP	Omechanism	of	mechanism	NN	I-NP	Oof	transcriptional	of	IN	B-PP	Otranscriptional	activation	transcriptional	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	gp34	the	DT	B-NP	Ogp34	gene	gp34	NN	I-NP	B-DNAgene	by	gene	NN	I-NP	I-DNAby	the	by	IN	B-PP	Othe	Tax	the	DT	B-NP	OTax	oncoprotein	Tax	NN	I-NP	B-proteinoncoprotein	of	oncoprotein	NN	I-NP	I-proteinof	human	of	IN	B-PP	Ohuman	T	human	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	leukemia	cell	NN	I-NP	Oleukemia	virus	leukemia	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	I	type	NN	I-NP	OI	(	I	CD	I-NP	O(	HTLV-I	(	(	O	OHTLV-I	)	HTLV-I	NN	B-NP	O)	.	)	)	O	O.	gp34	.	.	O	Ogp34	is	gp34	NN	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	type	a	DT	B-NP	Otype	II	type	NN	I-NP	B-proteinII	transmembrane	II	CD	I-NP	I-proteintransmembrane	molecule	transmembrane	JJ	I-NP	I-proteinmolecule	belonging	molecule	NN	I-NP	I-proteinbelonging	to	belong	VBG	B-VP	Oto	the	to	TO	B-PP	Othe	tumor	the	DT	B-NP	Otumor	necrosis	tumor	NN	I-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	family	factor	NN	I-NP	I-proteinfamily	and	family	NN	I-NP	I-proteinand	is	and	CC	O	Ois	constitutively	be	VBZ	B-VP	Oconstitutively	expressed	constitutively	RB	I-VP	Oexpressed	on	express	VBN	I-VP	Oon	HTLV-I-producing	on	IN	B-PP	OHTLV-I-producing	cells	HTLV-I-producing	JJ	B-NP	B-cell_typecells	but	cell	NNS	I-NP	I-cell_typebut	not	but	CC	B-NP	Onot	normal	not	RB	I-NP	Onormal	resting	normal	JJ	I-NP	B-cell_typeresting	T	rest	VBG	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	transcriptional	The	DT	B-NP	Otranscriptional	regulatory	transcriptional	JJ	I-NP	B-DNAregulatory	region	regulatory	JJ	I-NP	I-DNAregion	of	region	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	gp34	the	DT	B-NP	Ogp34	gene	gp34	NN	I-NP	B-DNAgene	was	gene	NN	I-NP	I-DNAwas	activated	be	VBD	B-VP	Oactivated	by	activate	VBN	I-VP	Oby	HTLV-I	by	IN	B-PP	OHTLV-I	Tax	HTLV-I	NN	B-NP	B-proteinTax	in	Tax	NN	I-NP	I-proteinin	the	in	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	T	human	JJ	I-NP	B-cell_lineT	cell	T	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	Jurkat	line	NN	I-NP	I-cell_lineJurkat	","	Jurkat	NN	I-NP	I-cell_line","	in	","	","	O	Oin	which	in	IN	B-PP	Owhich	endogenous	which	WDT	B-NP	Oendogenous	gp34	endogenous	JJ	B-NP	Ogp34	is	gp34	NN	I-NP	B-proteinis	induced	be	VBZ	B-VP	Oinduced	by	induce	VBN	I-VP	Oby	Tax	by	IN	B-PP	OTax	.	Tax	NN	B-NP	B-protein.	Sequence	.	.	O	OSequence	analysis	Sequence	NN	B-NP	Oanalysis	demonstrated	analysis	NN	I-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	two	that	IN	B-SBAR	Otwo	NF-kappaB-like	two	CD	B-NP	ONF-kappaB-like	elements	NF-kappaB-like	JJ	I-NP	B-DNAelements	(	element	NNS	I-NP	I-DNA(	1	(	(	O	O1	and	1	CD	B-NP	Oand	2	and	CC	I-NP	O2	)	2	CD	I-NP	O)	were	)	)	O	Owere	present	be	VBD	B-VP	Opresent	in	present	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	regulatory	the	DT	B-NP	Oregulatory	region	regulatory	JJ	I-NP	B-DNAregion	.	region	NN	I-NP	I-DNA.	Both	.	.	O	OBoth	NF-kappaB-like	Both	DT	B-NP	ONF-kappaB-like	elements	NF-kappaB-like	JJ	I-NP	B-DNAelements	were	element	NNS	I-NP	I-DNAwere	able	be	VBD	B-VP	Oable	to	able	JJ	B-ADJP	Oto	bind	to	TO	B-VP	Obind	to	bind	VB	I-VP	Oto	NF-kappaB	to	TO	B-PP	ONF-kappaB	or	NF-kappaB	NN	B-NP	B-proteinor	its	or	CC	O	Oits	related	its	PRP$	B-NP	Orelated	factor	related	JJ	I-NP	Ofactor	(	factor	NN	I-NP	O(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	in	)	)	O	Oin	a	in	IN	B-PP	Oa	Tax	a	DT	B-NP	OTax	#NAME?	Tax	NN	I-NP	B-protein#NAME?	manner	#NAME?	JJ	I-NP	Omanner	.	manner	NN	I-NP	O.	Chloramphenicol	.	.	O	OChloramphenicol	acetyltransferase	Chloramphenicol	NN	B-NP	B-proteinacetyltransferase	assays	acetyltransferase	NN	I-NP	I-proteinassays	indicated	assay	NNS	I-NP	Oindicated	that	indicate	VBD	B-VP	Othat	NF-kappaB-like	that	IN	B-SBAR	ONF-kappaB-like	element	NF-kappaB-like	JJ	B-NP	B-DNAelement	1	element	NN	I-NP	I-DNA1	was	1	CD	I-NP	I-DNAwas	Tax	be	VBD	B-VP	OTax	#NAME?	Tax	NN	B-NP	B-protein#NAME?	","	#NAME?	JJ	B-ADJP	O","	although	","	","	O	Oalthough	the	although	IN	B-SBAR	Othe	activity	the	DT	B-NP	Oactivity	was	activity	NN	I-NP	Owas	lower	be	VBD	B-VP	Olower	than	low	JJR	B-ADJP	Othan	that	than	IN	B-PP	Othat	the	that	IN	B-SBAR	Othe	native	the	DT	B-NP	Onative	promoter	native	JJ	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	NF-kappaB	.	.	O	ONF-kappaB	#NAME?	NF-kappaB	NN	B-NP	B-protein#NAME?	element	#NAME?	JJ	I-NP	Oelement	2	element	NN	I-NP	O2	elevated	2	CD	I-NP	Oelevated	promoter	elevated	JJ	I-NP	Opromoter	activity	promoter	NN	I-NP	Oactivity	when	activity	NN	I-NP	Owhen	combined	when	WRB	B-ADVP	Ocombined	with	combine	VBN	B-VP	Owith	NF-kappaB-like	with	IN	B-PP	ONF-kappaB-like	element	NF-kappaB-like	JJ	B-NP	B-DNAelement	1	element	NN	I-NP	I-DNA1	","	1	CD	I-NP	I-DNA","	indicating	","	","	O	Oindicating	cooperative	indicate	VBG	B-VP	Ocooperative	function	cooperative	JJ	B-NP	Ofunction	of	function	NN	I-NP	Oof	the	of	IN	B-PP	Othe	elements	the	DT	B-NP	Oelements	for	element	NNS	I-NP	Ofor	maximum	for	IN	B-PP	Omaximum	promoter	maximum	NN	B-NP	Opromoter	function	promoter	NN	I-NP	Ofunction	.	function	NN	I-NP	O.	Unlike	.	.	O	OUnlike	typical	Unlike	IN	B-PP	Otypical	NF-kappaB	typical	JJ	B-NP	ONF-kappaB	elements	NF-kappaB	NN	I-NP	B-DNAelements	","	element	NNS	I-NP	I-DNA","	the	","	","	O	Othe	NF-kappaB-like	the	DT	B-NP	ONF-kappaB-like	elements	NF-kappaB-like	JJ	I-NP	B-DNAelements	in	element	NNS	I-NP	I-DNAin	gp34	in	IN	B-PP	Ogp34	were	gp34	NN	B-NP	B-proteinwere	not	be	VBD	B-VP	Onot	activated	not	RB	I-VP	Oactivated	by	activate	VBN	I-VP	Oby	treatment	by	IN	B-PP	Otreatment	of	treatment	NN	B-NP	Oof	Jurkat	of	IN	B-PP	OJurkat	cells	Jurkat	NN	B-NP	B-cell_linecells	with	cell	NNS	I-NP	I-cell_linewith	phorbol	with	IN	B-PP	Ophorbol	ester	phorbol	NN	B-NP	Oester	despite	ester	NN	I-NP	Odespite	induction	despite	IN	B-PP	Oinduction	of	induction	NN	B-NP	Oof	the	of	IN	B-PP	Othe	NF-kappaB	the	DT	B-NP	ONF-kappaB	#NAME?	NF-kappaB	NN	I-NP	B-protein#NAME?	binding	#NAME?	JJ	I-NP	Obinding	activity	binding	NN	I-NP	Oactivity	.	activity	NN	I-NP	O.	Chloramphenicol	.	.	O	OChloramphenicol	acetyltransferase	Chloramphenicol	NN	B-NP	B-proteinacetyltransferase	reporter	acetyltransferase	NN	I-NP	I-proteinreporter	assays	reporter	NN	I-NP	Oassays	using	assay	NNS	I-NP	Ousing	the	use	VBG	B-VP	Othe	region	the	DT	B-NP	Oregion	upstream	region	NN	I-NP	Oupstream	of	upstream	JJ	B-ADJP	Oof	the	of	IN	B-PP	Othe	NF-kappaB-like	the	DT	B-NP	ONF-kappaB-like	elements	NF-kappaB-like	JJ	I-NP	B-DNAelements	identified	element	NNS	I-NP	I-DNAidentified	an	identify	VBD	B-VP	Oan	upstream	an	DT	B-NP	Oupstream	region	upstream	JJ	I-NP	B-DNAregion	that	region	NN	I-NP	I-DNAthat	reduced	that	WDT	B-NP	Oreduced	transcription	reduce	VBD	B-VP	Otranscription	from	transcription	NN	B-NP	Ofrom	cognate	from	IN	B-PP	Ocognate	and	cognate	JJ	B-NP	Oand	noncognate	and	CC	I-NP	Ononcognate	core	noncognate	JJ	I-NP	B-DNAcore	promoters	core	NN	I-NP	I-DNApromoters	in	promoter	NNS	I-NP	I-DNAin	a	in	IN	B-PP	Oa	Tax-independent	a	DT	B-NP	OTax-independent	manner	Tax-independent	JJ	I-NP	Omanner	.	manner	NN	I-NP	O.	Our	.	.	O	OOur	results	Our	PRP$	B-NP	Oresults	imply	result	NNS	I-NP	Oimply	complex	imply	VBP	B-VP	Ocomplex	regulation	complex	JJ	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	expression	of	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	gp34	the	DT	B-NP	Ogp34	gene	gp34	NN	I-NP	B-DNAgene	and	gene	NN	I-NP	I-DNAand	suggest	and	CC	O	Osuggest	implication	suggest	VBP	B-VP	Oimplication	of	implication	NN	B-NP	Oof	gp34	of	IN	B-PP	Ogp34	in	gp34	NN	B-NP	B-proteinin	proliferation	in	IN	B-PP	Oproliferation	of	proliferation	NN	B-NP	Oof	HTLV-I	of	IN	B-PP	OHTLV-I	infected	HTLV-I	NN	B-NP	B-cell_typeinfected	T	infected	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	beta-Amyloid	.	.	O	Obeta-Amyloid	fibrils	beta-Amyloid	JJ	B-NP	B-proteinfibrils	activate	fibril	NNS	I-NP	I-proteinactivate	parallel	activate	VBP	B-VP	Oparallel	mitogen-activated	parallel	JJ	B-NP	Omitogen-activated	protein	mitogen-activated	JJ	I-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	pathways	kinase	NN	I-NP	I-proteinpathways	in	pathway	NNS	I-NP	Oin	microglia	in	IN	B-PP	Omicroglia	and	microglia	NN	B-NP	B-cell_typeand	THP1	and	CC	I-NP	OTHP1	monocytes	THP1	NN	I-NP	B-cell_linemonocytes	.	monocyte	NNS	I-NP	I-cell_line.	The	.	.	O	OThe	senile	The	DT	B-NP	Osenile	plaques	senile	JJ	I-NP	Oplaques	of	plaque	NNS	I-NP	Oof	Alzheimer	of	IN	B-PP	OAlzheimer	's	Alzheimer	NNP	B-NP	O's	disease	's	POS	B-NP	Odisease	are	disease	NN	I-NP	Oare	foci	be	VBP	B-VP	Ofoci	of	focus	NNS	B-NP	Oof	local	of	IN	B-PP	Olocal	inflammatory	local	JJ	B-NP	Oinflammatory	responses	inflammatory	JJ	I-NP	Oresponses	","	response	NNS	I-NP	O","	as	","	","	O	Oas	evidenced	as	IN	B-SBAR	Oevidenced	by	evidence	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	acute	of	IN	B-PP	Oacute	phase	acute	JJ	B-NP	B-proteinphase	proteins	phase	NN	I-NP	I-proteinproteins	and	protein	NNS	I-NP	I-proteinand	oxidative	and	CC	O	Ooxidative	damage	oxidative	JJ	B-NP	Odamage	.	damage	NN	I-NP	O.	Fibrillar	.	.	O	OFibrillar	forms	Fibrillar	JJ	B-NP	Oforms	of	form	NNS	I-NP	Oof	beta-amyloid	of	IN	B-PP	Obeta-amyloid	(	beta-amyloid	NN	B-NP	O(	Abeta	(	(	O	OAbeta	)	Abeta	NN	B-NP	O)	","	)	)	O	O","	which	","	","	O	Owhich	are	which	WDT	B-NP	Oare	the	be	VBP	B-VP	Othe	primary	the	DT	B-NP	Oprimary	constituents	primary	JJ	I-NP	Oconstituents	of	constituent	NNS	I-NP	Oof	senile	of	IN	B-PP	Osenile	plaques	senile	JJ	B-NP	Oplaques	","	plaque	NNS	I-NP	O","	have	","	","	O	Ohave	been	have	VBP	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	activate	to	TO	I-VP	Oactivate	tyrosine	activate	VB	I-VP	Otyrosine	kinase-dependent	tyrosine	NN	B-NP	Okinase-dependent	signal	kinase-dependent	JJ	I-NP	Osignal	transduction	signal	NN	I-NP	Otransduction	cascades	transduction	NN	I-NP	Ocascades	","	cascade	NNS	I-NP	O","	resulting	","	","	O	Oresulting	in	result	VBG	B-VP	Oin	inflammatory	in	IN	B-PP	Oinflammatory	responses	inflammatory	JJ	B-NP	Oresponses	in	response	NNS	I-NP	Oin	microglia	in	IN	B-PP	Omicroglia	.	microglia	NNS	B-NP	B-cell_type.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	the	","	","	O	Othe	downstream	the	DT	B-NP	Odownstream	signaling	downstream	JJ	I-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	mediating	pathway	NNS	I-NP	Omediating	Abeta	mediate	VBG	B-VP	OAbeta	#NAME?	Abeta	NN	B-NP	O#NAME?	inflammatory	#NAME?	JJ	I-NP	Oinflammatory	events	inflammatory	JJ	I-NP	Oevents	are	event	NNS	I-NP	Oare	not	be	VBP	B-VP	Onot	well	not	RB	I-VP	Owell	characterized	well	RB	I-VP	Ocharacterized	.	characterize	VBN	I-VP	O.	We	.	.	O	OWe	report	We	PRP	B-NP	Oreport	that	report	VBP	B-VP	Othat	exposure	that	IN	B-SBAR	Oexposure	of	exposure	NN	B-NP	Oof	primary	of	IN	B-PP	Oprimary	rat	primary	JJ	B-NP	B-cell_typerat	microglia	rat	NN	I-NP	I-cell_typemicroglia	and	microglia	NNS	I-NP	I-cell_typeand	human	and	CC	O	Ohuman	THP1	human	JJ	B-NP	B-cell_typeTHP1	monocytes	THP1	NN	I-NP	I-cell_typemonocytes	to	monocyte	NNS	I-NP	I-cell_typeto	fibrillar	to	TO	B-PP	Ofibrillar	Abeta	fibrillar	JJ	B-NP	B-proteinAbeta	results	Abeta	NN	I-NP	I-proteinresults	in	result	VBZ	B-VP	Oin	the	in	IN	B-PP	Othe	tyrosine	the	DT	B-NP	Otyrosine	kinase	tyrosine	NN	I-NP	B-proteinkinase	#NAME?	kinase	NN	I-NP	I-protein#NAME?	activation	#NAME?	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	two	of	IN	B-PP	Otwo	parallel	two	CD	B-NP	Oparallel	signal	parallel	JJ	I-NP	Osignal	transduction	signal	NN	I-NP	Otransduction	cascades	transduction	NN	I-NP	Ocascades	involving	cascade	NNS	I-NP	Oinvolving	members	involve	VBG	B-VP	Omembers	of	member	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	mitogen-activated	the	DT	B-NP	Omitogen-activated	protein	mitogen-activated	JJ	I-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	MAPK	(	(	O	I-proteinMAPK	)	MAPK	NN	B-NP	I-protein)	superfamily	)	)	O	I-proteinsuperfamily	.	superfamily	NN	B-NP	I-protein.	Abeta	.	.	O	OAbeta	stimulated	Abeta	NN	B-NP	Ostimulated	the	stimulate	VBD	B-VP	Othe	rapid	the	DT	B-NP	Orapid	","	rapid	JJ	I-NP	O","	transient	","	","	I-NP	Otransient	activation	transient	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	extracellular	of	IN	B-PP	Oextracellular	signal-regulated	extracellular	JJ	B-NP	B-proteinsignal-regulated	kinase	signal-regulated	JJ	I-NP	I-proteinkinase	1	kinase	NN	I-NP	I-protein1	(	1	CD	I-NP	I-protein(	ERK1	(	(	O	OERK1	)	ERK1	NN	B-NP	B-protein)	and	)	)	O	Oand	ERK2	and	CC	O	OERK2	in	ERK2	NN	B-NP	B-proteinin	microglia	in	IN	B-PP	Omicroglia	and	microglia	NN	B-NP	B-cell_typeand	ERK2	and	CC	I-NP	OERK2	in	ERK2	NN	I-NP	B-proteinin	THP1	in	IN	B-PP	OTHP1	monocytes	THP1	NN	B-NP	B-cell_linemonocytes	.	monocyte	NNS	I-NP	I-cell_line.	A	.	.	O	OA	second	A	DT	B-NP	Osecond	superfamily	second	JJ	I-NP	Osuperfamily	member	superfamily	NN	I-NP	Omember	","	member	NN	I-NP	O","	p38	","	","	O	Op38	MAPK	p38	NN	B-NP	B-proteinMAPK	","	MAPK	NN	I-NP	I-protein","	was	","	","	O	Owas	also	be	VBD	B-VP	Oalso	activated	also	RB	I-VP	Oactivated	with	activate	VBN	I-VP	Owith	similar	with	IN	B-PP	Osimilar	kinetics	similar	JJ	B-NP	Okinetics	.	kinetic	NNS	I-NP	O.	Scavenger	.	.	O	OScavenger	receptor	Scavenger	NN	B-NP	B-proteinreceptor	and	receptor	NN	I-NP	I-proteinand	receptor	and	CC	O	Oreceptor	for	receptor	NN	B-NP	Ofor	advanced	for	IN	B-PP	Oadvanced	glycated	advance	VBN	B-NP	Oglycated	end	glycate	VBN	I-NP	Oend	products	end	NN	I-NP	Oproducts	(	product	NNS	I-NP	O(	RAGE	(	(	O	ORAGE	)	RAGE	NN	B-NP	O)	ligands	)	)	O	Oligands	failed	ligand	NNS	B-NP	Ofailed	to	fail	VBD	B-VP	Oto	activate	to	TO	I-VP	Oactivate	ERK	activate	VB	I-VP	OERK	and	ERK	NN	B-NP	B-proteinand	p38	and	CC	I-NP	Op38	MAPK	p38	NN	I-NP	B-proteinMAPK	in	MAPK	NN	I-NP	I-proteinin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	significant	of	IN	B-PP	Osignificant	increases	significant	JJ	B-NP	Oincreases	in	increase	NNS	I-NP	Oin	protein	in	IN	B-PP	Oprotein	tyrosine	protein	NN	B-NP	Otyrosine	phosphorylation	tyrosine	NN	I-NP	Ophosphorylation	","	phosphorylation	NN	I-NP	O","	demonstrating	","	","	O	Odemonstrating	that	demonstrate	VBG	B-VP	Othat	scavenger	that	IN	B-SBAR	Oscavenger	receptors	scavenger	NN	B-NP	B-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	RAGE	and	CC	O	ORAGE	are	RAGE	NN	B-NP	B-proteinare	not	be	VBP	B-VP	Onot	linked	not	RB	I-VP	Olinked	to	link	VBN	I-VP	Oto	these	to	TO	B-PP	Othese	pathways	these	DT	B-NP	Opathways	.	pathway	NNS	I-NP	O.	Importantly	.	.	O	OImportantly	","	Importantly	RB	B-ADVP	O","	the	","	","	O	Othe	stress-activated	the	DT	B-NP	Ostress-activated	protein	stress-activated	JJ	I-NP	B-proteinprotein	kinases	protein	NN	I-NP	I-proteinkinases	(	kinase	NNS	I-NP	I-protein(	SAPKs	(	(	O	OSAPKs	)	SAPK	NNS	B-NP	B-protein)	were	)	)	O	Owere	not	be	VBD	B-VP	Onot	significantly	not	RB	I-VP	Osignificantly	activated	significantly	RB	I-VP	Oactivated	in	activate	VBN	I-VP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	I-PP	Oto	Abeta	to	TO	I-PP	OAbeta	.	Abeta	NN	B-NP	B-protein.	Downstream	.	.	O	ODownstream	effectors	Downstream	JJ	B-NP	Oeffectors	of	effector	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	MAPK	the	DT	B-NP	OMAPK	signal	MAPK	NN	I-NP	B-proteinsignal	transduction	signal	NN	I-NP	Otransduction	cascades	transduction	NN	I-NP	Ocascades	include	cascade	NNS	I-NP	Oinclude	MAPKAP	include	VBP	B-VP	OMAPKAP	kinases	MAPKAP	NN	B-NP	B-proteinkinases	","	kinase	NNS	I-NP	I-protein","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	RSK1	as	IN	I-PP	ORSK1	and	RSK1	NN	B-NP	B-proteinand	RSK2	and	CC	I-NP	ORSK2	","	RSK2	NN	I-NP	B-protein","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	transcription	as	IN	I-CONJP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	.	factor	NNS	I-NP	I-protein.	Exposure	.	.	O	OExposure	of	Exposure	NN	B-NP	Oof	microglia	of	IN	B-PP	Omicroglia	and	microglia	NN	B-NP	B-cell_typeand	THP1	and	CC	I-NP	OTHP1	monocytes	THP1	NN	I-NP	B-cell_linemonocytes	to	monocyte	NNS	I-NP	I-cell_lineto	Abeta	to	TO	B-PP	OAbeta	resulted	Abeta	NN	B-NP	Oresulted	in	result	VBD	B-VP	Oin	the	in	IN	B-PP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	RSK1	of	IN	B-PP	ORSK1	and	RSK1	NN	B-NP	B-proteinand	RSK2	and	CC	O	ORSK2	and	RSK2	NN	B-NP	B-proteinand	phosphorylation	and	CC	I-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	cAMP	of	IN	B-PP	OcAMP	response	cAMP	NN	B-NP	B-proteinresponse	element-binding	response	NN	I-NP	I-proteinelement-binding	protein	element-binding	JJ	I-NP	I-proteinprotein	at	protein	NN	I-NP	I-proteinat	Ser133	at	IN	B-PP	OSer133	","	Ser133	NN	B-NP	O","	providing	","	","	O	Oproviding	a	provide	VBG	B-VP	Oa	mechanism	a	DT	B-NP	Omechanism	for	mechanism	NN	I-NP	Ofor	Abeta	for	IN	B-PP	OAbeta	#NAME?	Abeta	NN	B-NP	B-protein#NAME?	changes	#NAME?	JJ	I-NP	Ochanges	in	change	NNS	I-NP	Oin	gene	in	IN	B-PP	Ogene	expression	gene	NN	B-NP	Oexpression	Regulation	expression	NN	I-NP	ORegulation	of	Regulation	NN	B-NP	Oof	cellular	of	IN	B-PP	Ocellular	retinoic	cellular	JJ	B-NP	B-proteinretinoic	acid	retinoic	JJ	I-NP	I-proteinacid	binding	acid	NN	I-NP	I-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	CRABP	(	(	O	OCRABP	II	CRABP	NN	B-NP	B-proteinII	)	II	CD	I-NP	I-protein)	during	)	)	O	Oduring	human	during	IN	B-PP	Ohuman	monocyte	human	JJ	B-NP	Omonocyte	differentiation	monocyte	NN	I-NP	Odifferentiation	in	differentiation	NN	I-NP	Oin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	Cellular	.	.	O	OCellular	retinoic	Cellular	JJ	B-NP	B-proteinretinoic	acid	retinoic	JJ	I-NP	I-proteinacid	binding	acid	NN	I-NP	I-proteinbinding	proteins	binding	NN	I-NP	I-proteinproteins	(	protein	NNS	I-NP	I-protein(	CRABP	(	(	O	OCRABP	)	CRABP	NN	B-NP	B-protein)	are	)	)	O	Oare	low	be	VBP	B-VP	Olow	molecular	low	JJ	B-NP	B-proteinmolecular	weight	molecular	JJ	I-NP	I-proteinweight	proteins	weight	NN	I-NP	I-proteinproteins	whose	protein	NNS	I-NP	I-proteinwhose	precise	whose	WP$	B-NP	Oprecise	function	precise	JJ	I-NP	Ofunction	remains	function	NN	I-NP	Oremains	unknown	remain	VBZ	B-VP	Ounknown	.	unknown	JJ	B-ADJP	O.	They	.	.	O	OThey	bind	They	PRP	B-NP	Obind	retinoids	bind	VBP	B-VP	Oretinoids	and	retinoid	NNS	B-NP	Oand	may	and	CC	O	Omay	thereby	may	MD	B-VP	Othereby	modulate	thereby	RB	I-VP	Omodulate	the	modulate	VB	I-VP	Othe	intracellular	the	DT	B-NP	Ointracellular	steady-state	intracellular	JJ	I-NP	Osteady-state	concentration	steady-state	JJ	I-NP	Oconcentration	of	concentration	NN	I-NP	Oof	retinoids	of	IN	B-PP	Oretinoids	.	retinoid	NNS	B-NP	O.	Whereas	.	.	O	OWhereas	CRABP	Whereas	IN	B-SBAR	OCRABP	I	CRABP	NN	B-NP	B-proteinI	is	I	CD	I-NP	I-proteinis	ubiquitously	be	VBZ	B-VP	Oubiquitously	expressed	ubiquitously	RB	I-VP	Oexpressed	","	express	VBN	I-VP	O","	CRABP	","	","	O	OCRABP	II	CRABP	NN	B-NP	B-proteinII	is	II	CD	I-NP	I-proteinis	mainly	be	VBZ	B-VP	Omainly	detected	mainly	RB	I-VP	Odetected	in	detect	VBN	I-VP	Oin	various	in	IN	B-PP	Ovarious	cell	various	JJ	B-NP	Ocell	types	cell	NN	I-NP	Otypes	of	type	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	skin	the	DT	B-NP	Oskin	.	skin	NN	I-NP	O.	By	.	.	O	OBy	representative	By	IN	B-PP	Orepresentative	difference	representative	JJ	B-NP	Odifference	analysis	difference	NN	I-NP	Oanalysis	we	analysis	NN	I-NP	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	CRABP	that	IN	B-SBAR	OCRABP	II	CRABP	NN	B-NP	B-proteinII	is	II	CD	I-NP	I-proteinis	also	be	VBZ	B-VP	Oalso	strongly	also	RB	I-VP	Ostrongly	expressed	strongly	RB	I-VP	Oexpressed	in	express	VBN	I-VP	Oin	human	in	IN	B-PP	Ohuman	monocyte-derived	human	JJ	B-NP	B-cell_typemonocyte-derived	macrophages	monocyte-derived	JJ	I-NP	I-cell_typemacrophages	(	macrophage	NNS	I-NP	I-cell_type(	MAC	(	(	O	OMAC	)	MAC	NN	B-NP	O)	but	)	)	O	Obut	not	but	CC	B-PP	Onot	in	not	RB	B-PP	Oin	freshly	in	IN	I-PP	Ofreshly	isolated	freshly	RB	B-NP	B-cell_typeisolated	monocytes	isolate	VBN	I-NP	I-cell_typemonocytes	(	monocyte	NNS	I-NP	I-cell_type(	MO	(	(	O	OMO	)	MO	NN	B-NP	B-cell_type)	.	)	)	O	O.	The	.	.	O	OThe	CRABP	The	DT	B-NP	OCRABP	II	CRABP	NN	I-NP	B-RNAII	mRNA	II	CD	I-NP	I-RNAmRNA	was	mRNA	NN	I-NP	I-RNAwas	gradually	be	VBD	B-VP	Ogradually	upregulated	gradually	RB	I-VP	Oupregulated	during	upregulate	VBN	I-VP	Oduring	differentiation	during	IN	B-PP	Odifferentiation	from	differentiation	NN	B-NP	Ofrom	MO	from	IN	B-PP	OMO	to	MO	NN	B-NP	B-cell_typeto	MAC	to	TO	B-PP	OMAC	in	MAC	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	2	of	IN	B-PP	O2	%	2	CD	B-NP	O%	serum	%	NN	I-NP	Oserum	.	serum	NN	I-NP	O.	Adherence	.	.	O	OAdherence	","	Adherence	NN	B-NP	O","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	important	be	VBZ	B-VP	Oimportant	for	important	JJ	B-ADJP	Ofor	MO	for	IN	B-PP	OMO	differentiation	MO	NN	B-NP	Odifferentiation	","	differentiation	NN	I-NP	O","	induced	","	","	O	Oinduced	CRABP	induce	VBD	B-VP	OCRABP	II	CRABP	NN	B-NP	B-proteinII	expression	II	CD	I-NP	I-proteinexpression	","	expression	NN	I-NP	O","	but	","	","	O	Obut	the	but	CC	O	Othe	addition	the	DT	B-NP	Oaddition	of	addition	NN	I-NP	Oof	10	of	IN	B-PP	O10	(	10	CD	B-NP	O(	-7	(	(	O	O-7	)	-7	CD	B-NP	O)	M	)	)	O	OM	retinoic	M	NN	B-NP	Oretinoic	acid	retinoic	JJ	I-NP	Oacid	inhibited	acid	NN	I-NP	Oinhibited	the	inhibit	VBD	B-VP	Othe	upregulation	the	DT	B-NP	Oupregulation	of	upregulation	NN	I-NP	Oof	CRABP	of	IN	B-PP	OCRABP	II	CRABP	NN	B-NP	B-proteinII	expression	II	CD	I-NP	I-proteinexpression	during	expression	NN	I-NP	Oduring	MO/MAC	during	IN	B-PP	OMO/MAC	differentiation	MO/MAC	NN	B-NP	Odifferentiation	.	differentiation	NN	I-NP	O.	As	.	.	O	OAs	MO	As	IN	B-SBAR	OMO	can	MO	NN	B-NP	B-cell_typecan	differentiate	can	MD	B-VP	Odifferentiate	along	differentiate	VB	I-VP	Oalong	the	along	IN	B-PP	Othe	classical	the	DT	B-NP	Oclassical	pathway	classical	JJ	I-NP	Opathway	not	pathway	NN	I-NP	Onot	only	not	RB	B-CONJP	Oonly	to	only	RB	I-CONJP	Oto	MAC	to	TO	B-PP	OMAC	but	MAC	NN	B-NP	B-proteinbut	also	but	CC	B-CONJP	Oalso	to	also	RB	I-CONJP	Oto	dendritic	to	TO	B-PP	Odendritic	cells	dendritic	JJ	B-NP	B-cell_typecells	we	cell	NNS	I-NP	I-cell_typewe	analyzed	we	PRP	B-NP	Oanalyzed	the	analyze	VBD	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	CRABP	of	IN	B-PP	OCRABP	II	CRABP	NN	B-NP	B-proteinII	in	II	CD	I-NP	I-proteinin	MO-derived	in	IN	B-PP	OMO-derived	dendritic	MO-derived	JJ	B-NP	B-cell_typedendritic	cells	dendritic	JJ	I-NP	I-cell_typecells	cultured	cell	NNS	I-NP	I-cell_typecultured	with	culture	VBN	B-VP	Owith	10	with	IN	B-PP	O10	%	10	CD	B-NP	O%	FCS	%	NN	I-NP	OFCS	","	FCS	NN	I-NP	O","	IL-4	","	","	O	OIL-4	","	IL-4	NN	B-NP	B-protein","	and	","	","	O	Oand	GM-CSF	and	CC	O	OGM-CSF	.	GM-CSF	NN	B-NP	B-protein.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	to	contrast	NN	B-NP	Oto	MAC	to	TO	B-PP	OMAC	","	MAC	NN	B-NP	B-protein","	MO-derived	","	","	O	OMO-derived	dendritic	MO-derived	JJ	B-NP	B-cell_typedendritic	cells	dendritic	JJ	I-NP	I-cell_typecells	showed	cell	NNS	I-NP	I-cell_typeshowed	an	show	VBD	B-VP	Oan	extremely	an	DT	B-NP	Oextremely	low	extremely	RB	I-NP	Olow	expression	low	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	CRABP	of	IN	B-PP	OCRABP	II	CRABP	NN	B-NP	B-proteinII	.	II	CD	I-NP	I-protein.	From	.	.	O	OFrom	these	From	IN	B-PP	Othese	results	these	DT	B-NP	Oresults	we	result	NNS	I-NP	Owe	conclude	we	PRP	B-NP	Oconclude	(	conclude	VBP	B-VP	O(	1	(	(	O	O1	)	1	CD	B-NP	O)	that	)	)	O	Othat	the	that	IN	B-SBAR	Othe	availability	the	DT	B-NP	Oavailability	and	availability	NN	I-NP	Oand	the	and	CC	O	Othe	metabolism	the	DT	B-NP	Ometabolism	of	metabolism	NN	I-NP	Oof	retinoids	of	IN	B-PP	Oretinoids	may	retinoid	NNS	B-NP	Omay	be	may	MD	B-VP	Obe	different	be	VB	I-VP	Odifferent	in	different	JJ	B-ADJP	Oin	MAC	in	IN	B-PP	OMAC	compared	MAC	NN	B-NP	B-proteincompared	to	compare	VBN	B-VP	Oto	MO	to	TO	B-PP	OMO	and	MO	NN	B-NP	B-cell_typeand	dendritic	and	CC	O	Odendritic	cells	dendritic	JJ	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	(	and	CC	O	O(	2	(	(	B-LST	O2	)	2	LS	I-LST	O)	that	)	)	O	Othat	this	that	IN	B-SBAR	Othis	may	this	DT	B-NP	Omay	influence	may	MD	B-VP	Oinfluence	differentiation	influence	VB	I-VP	Odifferentiation	and	differentiation	NN	B-NP	Oand	activation	and	CC	I-NP	Oactivation	of	activation	NN	I-NP	Oof	those	of	IN	B-PP	Othose	cells	those	DT	B-NP	Ocells	.	cell	NNS	I-NP	O.	Transcription	.	.	O	OTranscription	factor	Transcription	NN	B-NP	B-proteinfactor	B-cell-specific	factor	NN	I-NP	I-proteinB-cell-specific	activator	B-cell-specific	JJ	I-NP	I-proteinactivator	protein	activator	NN	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	BSAP	(	(	O	OBSAP	)	BSAP	NN	B-NP	B-protein)	is	)	)	O	Ois	differentially	be	VBZ	B-VP	Odifferentially	expressed	differentially	RB	I-VP	Oexpressed	in	express	VBN	I-VP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	in	and	CC	B-PP	Oin	subsets	in	IN	B-PP	Osubsets	of	subset	NNS	B-NP	Oof	B-cell	of	IN	B-PP	OB-cell	lymphomas	B-cell	NN	B-NP	B-cell_typelymphomas	.	lymphoma	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	paired	The	DT	B-NP	Opaired	box	paired	JJ	I-NP	B-DNAbox	containing	box	NN	I-NP	I-DNAcontaining	gene	contain	VBG	B-VP	Ogene	PAX-5	gene	NN	B-NP	OPAX-5	encodes	PAX-5	NN	I-NP	B-DNAencodes	the	encode	VBZ	B-VP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	BSAP	factor	NN	I-NP	I-proteinBSAP	(	BSAP	NN	I-NP	B-protein(	B-cell-specific	(	(	O	OB-cell-specific	activator	B-cell-specific	JJ	B-NP	B-proteinactivator	protein	activator	NN	I-NP	I-proteinprotein	)	protein	NN	I-NP	I-protein)	","	)	)	O	O","	which	","	","	O	Owhich	plays	which	WDT	B-NP	Oplays	a	play	VBZ	B-VP	Oa	key	a	DT	B-NP	Okey	role	key	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	B-lymphocyte	in	IN	B-PP	OB-lymphocyte	development	B-lymphocyte	NN	B-NP	B-cell_typedevelopment	.	development	NN	I-NP	O.	Despite	.	.	O	ODespite	its	Despite	IN	B-PP	Oits	known	its	PRP$	B-NP	Oknown	involvement	known	JJ	I-NP	Oinvolvement	in	involvement	NN	I-NP	Oin	a	in	IN	B-PP	Oa	rare	a	DT	B-NP	Orare	subtype	rare	JJ	I-NP	Osubtype	of	subtype	NN	I-NP	Oof	non-Hodgkin	of	IN	B-PP	Onon-Hodgkin	's	non-Hodgkin	JJ	B-NP	O's	lymphoma	's	POS	B-NP	Olymphoma	(	lymphoma	NN	I-NP	O(	NHL	(	(	O	ONHL	)	NHL	NN	B-NP	O)	","	)	)	O	O","	a	","	","	O	Oa	detailed	a	DT	B-NP	Odetailed	examination	detailed	JJ	I-NP	Oexamination	of	examination	NN	I-NP	Oof	BSAP	of	IN	B-PP	OBSAP	expression	BSAP	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	NHL	in	IN	B-PP	ONHL	has	NHL	NN	B-NP	Ohas	not	have	VBZ	B-VP	Onot	been	not	RB	I-VP	Obeen	previously	be	VBN	I-VP	Opreviously	reported	previously	RB	I-VP	Oreported	.	report	VBN	I-VP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	analyzed	we	PRP	B-NP	Oanalyzed	normal	analyze	VBD	B-VP	Onormal	and	normal	JJ	B-NP	Oand	malignant	and	CC	I-NP	Omalignant	lymphoid	malignant	JJ	I-NP	Olymphoid	tissues	lymphoid	JJ	I-NP	Otissues	and	tissue	NNS	I-NP	Oand	cell	and	CC	O	Ocell	lines	cell	NN	B-NP	Olines	","	line	NNS	I-NP	O","	including	","	","	O	Oincluding	102	include	VBG	B-PP	O102	cases	102	CD	B-NP	Ocases	of	case	NNS	I-NP	Oof	B-cell	of	IN	B-PP	OB-cell	NHL	B-cell	NN	B-NP	ONHL	","	NHL	NN	I-NP	O","	23	","	","	O	O23	cases	23	CD	B-NP	Ocases	of	case	NNS	I-NP	Oof	T-	of	IN	B-PP	OT-	and	T-	NN	B-NP	Oand	null-cell	and	CC	I-NP	Onull-cell	NHL	null-cell	NN	I-NP	ONHL	","	NHL	NN	I-NP	O","	and	","	","	O	Oand	18	and	CC	O	O18	cases	18	CD	B-NP	Ocases	of	case	NNS	I-NP	Oof	Hodgkin	of	IN	B-PP	OHodgkin	's	Hodgkin	NN	B-NP	O's	disease	's	POS	B-NP	Odisease	.	disease	NN	I-NP	O.	Normal	.	.	O	ONormal	lymphoid	Normal	JJ	B-NP	Olymphoid	tissues	lymphoid	JJ	I-NP	Otissues	showed	tissue	NNS	I-NP	Oshowed	strong	show	VBD	B-VP	Ostrong	nuclear	strong	JJ	B-NP	Onuclear	BSAP	nuclear	JJ	I-NP	OBSAP	expression	BSAP	NN	I-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	mantle	in	IN	B-PP	Omantle	zone	mantle	NN	B-NP	B-cell_typezone	B	zone	NN	I-NP	I-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	less	","	","	O	Oless	intense	less	RBR	B-NP	Ointense	reactivity	intense	JJ	I-NP	Oreactivity	in	reactivity	NN	I-NP	Oin	follicular	in	IN	B-PP	Ofollicular	center	follicular	JJ	B-NP	B-cell_typecenter	B	center	NN	I-NP	I-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	no	and	CC	O	Ono	expression	no	DT	B-NP	Oexpression	in	expression	NN	I-NP	Oin	cells	in	IN	B-PP	Ocells	of	cell	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	T-cell-rich	the	DT	B-NP	OT-cell-rich	zones	T-cell-rich	JJ	I-NP	Ozones	.	zone	NNS	I-NP	O.	Monocytoid	.	.	O	OMonocytoid	B	Monocytoid	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	showed	cell	NNS	I-NP	I-cell_typeshowed	weak	show	VBD	B-VP	Oweak	expression	weak	JJ	B-NP	Oexpression	","	expression	NN	I-NP	O","	whereas	","	","	O	Owhereas	plasma	whereas	IN	O	Oplasma	cells	plasma	NN	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	extrafollicular	and	CC	O	Oextrafollicular	large	extrafollicular	JJ	B-NP	B-cell_typelarge	transformed	large	JJ	I-NP	I-cell_typetransformed	B	transform	VBN	I-NP	I-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	negative	be	VBD	B-VP	Onegative	.	negative	JJ	B-ADJP	O.	Of	.	.	O	OOf	the	Of	IN	B-PP	Othe	102	the	DT	B-NP	O102	B-cell	102	CD	I-NP	OB-cell	NHLs	B-cell	NN	I-NP	ONHLs	","	NHL	NNS	I-NP	O","	83	","	","	O	O83	(	83	CD	B-NP	O(	81	(	(	O	O81	%	81	CD	B-NP	O%	)	%	NN	I-NP	O)	demonstrated	)	)	O	Odemonstrated	BSAP	demonstrate	VBD	B-VP	OBSAP	expression	BSAP	NN	B-NP	B-proteinexpression	.	expression	NN	I-NP	O.	All	.	.	O	OAll	of	All	DT	B-NP	Oof	the	of	IN	B-PP	Othe	13	the	DT	B-NP	O13	(	13	CD	I-NP	O(	100	(	(	O	O100	%	100	CD	B-NP	O%	)	%	NN	I-NP	O)	B-cell	)	)	O	OB-cell	chronic	B-cell	NN	B-NP	Ochronic	lymphocytic	chronic	JJ	I-NP	Olymphocytic	leukemias	lymphocytic	JJ	I-NP	Oleukemias	(	leukemia	NNS	I-NP	O(	B-CLLs	(	(	O	OB-CLLs	)	B-CLL	NNS	B-NP	B-cell_line)	","	)	)	O	O","	21	","	","	O	O21	of	21	CD	B-NP	Oof	(	of	IN	B-PP	O(	100	(	(	O	O100	%	100	CD	B-NP	O%	)	%	NN	I-NP	O)	mantle	)	)	O	Omantle	cells	mantle	NN	B-NP	Ocells	(	cell	NNS	I-NP	O(	MCLs	(	(	O	OMCLs	)	MCL	NNS	B-NP	B-cell_line)	","	)	)	O	O","	and	","	","	O	Oand	20	and	CC	O	O20	of	20	CD	B-NP	Oof	21	of	IN	B-PP	O21	(	21	CD	B-NP	O(	95	(	(	O	O95	%	95	CD	B-NP	O%	)	%	NN	I-NP	O)	follicular	)	)	O	Ofollicular	lymphomas	follicular	JJ	B-NP	Olymphomas	(	lymphoma	NNS	I-NP	O(	FLs	(	(	O	OFLs	)	FL	NNS	B-NP	B-protein)	were	)	)	O	Owere	positive	be	VBD	B-VP	Opositive	.	positive	JJ	B-ADJP	O.	Moderate	.	.	O	OModerate	staining	Moderate	JJ	B-NP	Ostaining	intensities	staining	NN	I-NP	Ointensities	were	intensity	NNS	I-NP	Owere	found	be	VBD	B-VP	Ofound	in	find	VBN	I-VP	Oin	most	in	IN	B-PP	Omost	B-CLL	most	JJS	B-NP	OB-CLL	and	B-CLL	NN	I-NP	B-cell_lineand	FL	and	CC	I-NP	OFL	cases	FL	NN	I-NP	Ocases	","	case	NNS	I-NP	O","	whereas	","	","	O	Owhereas	most	whereas	IN	O	Omost	MCLs	most	JJS	B-NP	OMCLs	showed	MCL	NNS	I-NP	B-cell_typeshowed	strong	show	VBD	B-VP	Ostrong	reactions	strong	JJ	B-NP	Oreactions	","	reaction	NNS	I-NP	O","	paralleling	","	","	O	Oparalleling	the	parallel	VBG	B-VP	Othe	strong	the	DT	B-NP	Ostrong	reactivity	strong	JJ	I-NP	Oreactivity	of	reactivity	NN	I-NP	Oof	nonmalignant	of	IN	B-PP	Ononmalignant	mantle	nonmalignant	JJ	B-NP	B-cell_typemantle	cells	mantle	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Eight	.	.	O	OEight	of	Eight	CD	B-NP	Oof	12	of	IN	B-PP	O12	(	12	CD	B-NP	O(	67	(	(	O	O67	%	67	CD	B-NP	O%	)	%	NN	I-NP	O)	marginal	)	)	O	Omarginal	zone	marginal	JJ	B-NP	Ozone	lymphoma	zone	NN	I-NP	Olymphoma	cases	lymphoma	NN	I-NP	Ocases	showed	case	NNS	I-NP	Oshowed	negative	show	VBD	B-VP	Onegative	or	negative	JJ	B-NP	Oor	low	or	CC	I-NP	Olow	BSAP	low	JJ	I-NP	OBSAP	levels	BSAP	NN	I-NP	B-proteinlevels	","	level	NNS	I-NP	O","	and	","	","	O	Oand	17	and	CC	O	O17	of	17	CD	B-NP	Oof	24	of	IN	B-PP	O24	(	24	CD	B-NP	O(	71	(	(	O	O71	%	71	CD	B-NP	O%	)	%	NN	I-NP	O)	large	)	)	O	Olarge	B-cell	large	JJ	B-NP	OB-cell	lymphomas	B-cell	NN	I-NP	B-cell_typelymphomas	displayed	lymphoma	NNS	I-NP	I-cell_typedisplayed	moderate	display	VBD	B-VP	Omoderate	to	moderate	JJ	B-ADJP	Oto	strong	to	TO	B-PP	Ostrong	expression	strong	JJ	B-NP	Oexpression	.	expression	NN	I-NP	O.	None	.	.	O	ONone	of	None	NN	B-NP	Oof	the	of	IN	B-PP	Othe	23	the	DT	B-NP	O23	T-	23	CD	I-NP	OT-	and	T-	NN	I-NP	Oand	null-cell	and	CC	I-NP	Onull-cell	lymphomas	null-cell	NN	I-NP	Olymphomas	reacted	lymphoma	NNS	I-NP	Oreacted	with	react	VBD	B-VP	Owith	the	with	IN	B-PP	Othe	BSAP	the	DT	B-NP	OBSAP	antisera	BSAP	NN	I-NP	B-proteinantisera	","	antiserum	NNS	I-NP	O","	whereas	","	","	O	Owhereas	in	whereas	IN	O	Oin	Hodgkin	in	IN	B-PP	OHodgkin	's	Hodgkin	NNP	B-NP	O's	disease	's	POS	B-NP	Odisease	","	disease	NN	I-NP	O","	2	","	","	O	O2	of	2	CD	B-NP	Oof	4	of	IN	B-PP	O4	(	4	CD	B-NP	O(	50	(	(	O	O50	%	50	CD	B-NP	O%	)	%	NN	I-NP	O)	nodular	)	)	O	Onodular	lymphocytic	nodular	JJ	B-NP	Olymphocytic	predominance	lymphocytic	JJ	I-NP	Opredominance	and	predominance	NN	I-NP	Oand	5	and	CC	O	O5	of	5	CD	B-NP	Oof	14	of	IN	B-PP	O14	(	14	CD	B-NP	O(	36	(	(	O	O36	%	36	CD	B-NP	O%	)	%	NN	I-NP	O)	classical	)	)	O	Oclassical	cases	classical	JJ	B-NP	Ocases	showed	case	NNS	I-NP	Oshowed	weak	show	VBD	B-VP	Oweak	nuclear	weak	JJ	B-NP	Onuclear	or	nuclear	JJ	I-NP	Oor	nucleolar	or	CC	I-NP	Onucleolar	BSAP	nucleolar	JJ	I-NP	OBSAP	reactions	BSAP	NN	I-NP	Oreactions	in	reaction	NNS	I-NP	Oin	a	in	IN	B-PP	Oa	fraction	a	DT	B-NP	Ofraction	of	fraction	NN	I-NP	Oof	the	of	IN	B-PP	Othe	tumor	the	DT	B-NP	Otumor	cells	tumor	NN	I-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Western	.	.	O	OWestern	blot	Western	NN	B-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	showed	analysis	NN	I-NP	Oshowed	a	show	VBD	B-VP	Oa	52-kD	a	DT	B-NP	O52-kD	BSAP	52-kD	JJ	I-NP	B-proteinBSAP	band	BSAP	NN	I-NP	I-proteinband	in	band	NN	I-NP	I-proteinin	B-cell	in	IN	B-PP	OB-cell	lines	B-cell	NN	B-NP	B-cell_linelines	","	line	NNS	I-NP	I-cell_line","	but	","	","	B-PP	Obut	not	but	CC	I-PP	Onot	in	not	RB	B-PP	Oin	non-B-cell	in	IN	I-PP	Onon-B-cell	or	non-B-cell	JJ	B-NP	B-cell_lineor	plasma	or	CC	I-NP	I-cell_lineplasma	cell	plasma	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	.	line	NNS	I-NP	I-cell_line.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	BSAP	that	IN	B-SBAR	OBSAP	expression	BSAP	NN	B-NP	B-proteinexpression	is	expression	NN	I-NP	Ois	largely	be	VBZ	B-VP	Olargely	restricted	largely	RB	B-ADJP	Orestricted	to	restricted	JJ	I-ADJP	Oto	lymphomas	to	TO	B-PP	Olymphomas	of	lymphoma	NNS	B-NP	Oof	B-cell	of	IN	B-PP	OB-cell	lineage	B-cell	NN	B-NP	B-cell_typelineage	and	lineage	NN	I-NP	I-cell_typeand	that	and	CC	O	Othat	BSAP	that	IN	B-SBAR	OBSAP	expression	BSAP	NN	B-NP	B-proteinexpression	varies	expression	NN	I-NP	Ovaries	in	vary	VBZ	B-VP	Oin	B-cell	in	IN	B-PP	OB-cell	subsets	B-cell	NN	B-NP	B-cell_typesubsets	and	subset	NNS	I-NP	I-cell_typeand	subtypes	and	CC	I-NP	Osubtypes	of	subtype	NNS	I-NP	Oof	B-cell	of	IN	B-PP	OB-cell	NHL	B-cell	NN	B-NP	ONHL	.	NHL	NN	I-NP	O.	The	.	.	O	OThe	high	The	DT	B-NP	Ohigh	levels	high	JJ	I-NP	Olevels	of	level	NNS	I-NP	Oof	BSAP	of	IN	B-PP	OBSAP	","	BSAP	NN	B-NP	B-protein","	especially	","	","	O	Oespecially	those	especially	RB	B-ADVP	Othose	found	those	DT	B-NP	Ofound	in	find	VBN	B-VP	Oin	large-cell	in	IN	B-PP	Olarge-cell	lymphomas	large-cell	JJ	B-NP	Olymphomas	and	lymphoma	NNS	I-NP	Oand	in	and	CC	B-PP	Oin	some	in	IN	B-PP	Osome	follicular	some	DT	B-NP	Ofollicular	lymphomas	follicular	JJ	I-NP	B-cell_typelymphomas	","	lymphoma	NNS	I-NP	I-cell_type","	may	","	","	O	Omay	be	may	MD	B-VP	Obe	a	be	VB	I-VP	Oa	consequence	a	DT	B-NP	Oconsequence	of	consequence	NN	I-NP	Oof	deregulated	of	IN	B-PP	Oderegulated	gene	deregulate	VBN	B-NP	Ogene	expression	gene	NN	I-NP	Oexpression	and	expression	NN	I-NP	Oand	suggest	and	CC	O	Osuggest	a	suggest	VBP	B-VP	Oa	possible	a	DT	B-NP	Opossible	involvement	possible	JJ	I-NP	Oinvolvement	of	involvement	NN	I-NP	Oof	PAX-5	of	IN	B-PP	OPAX-5	in	PAX-5	NN	B-NP	B-proteinin	certain	in	IN	B-PP	Ocertain	B-cell	certain	JJ	B-NP	OB-cell	malignancies	B-cell	NN	I-NP	Omalignancies	.	malignancy	NNS	I-NP	O.	This	.	.	O	OThis	is	This	DT	B-NP	Ois	a	be	VBZ	B-VP	Oa	US	a	DT	B-NP	OUS	government	US	NNP	I-NP	Ogovernment	work	government	NN	I-NP	Owork	.	work	NN	I-NP	O.	There	.	.	O	OThere	are	There	EX	B-NP	Oare	no	be	VBP	B-VP	Ono	restrictions	no	DT	B-NP	Orestrictions	on	restriction	NNS	I-NP	Oon	its	on	IN	B-PP	Oits	use	its	PRP$	B-NP	Ouse	.	use	NN	I-NP	O.	Mitogen	.	.	O	OMitogen	and	Mitogen	NN	B-NP	B-proteinand	growth	and	CC	I-NP	Ogrowth	factor-induced	growth	NN	I-NP	Ofactor-induced	activation	factor-induced	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	a	of	IN	B-PP	Oa	STAT-like	a	DT	B-NP	OSTAT-like	molecule	STAT-like	JJ	I-NP	B-proteinmolecule	in	molecule	NN	I-NP	I-proteinin	channel	in	IN	B-PP	Ochannel	catfish	channel	NN	B-NP	B-cell_typecatfish	lymphoid	catfish	NN	I-NP	I-cell_typelymphoid	cells	lymphoid	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	This	.	.	O	OThis	article	This	DT	B-NP	Oarticle	describes	article	NN	I-NP	Odescribes	the	describe	VBZ	B-VP	Othe	identification	the	DT	B-NP	Oidentification	of	identification	NN	I-NP	Oof	a	of	IN	B-PP	Oa	putative	a	DT	B-NP	Oputative	STAT	putative	JJ	I-NP	OSTAT	molecule	STAT	NN	I-NP	B-proteinmolecule	in	molecule	NN	I-NP	I-proteinin	the	in	IN	B-PP	Othe	channel	the	DT	B-NP	Ochannel	catfish	channel	NN	I-NP	Ocatfish	(	catfish	NN	I-NP	O(	Ictalurus	(	(	O	OIctalurus	punctatus	Ictalurus	NN	B-NP	Opunctatus	)	punctatus	NN	I-NP	O)	","	)	)	O	O","	the	","	","	O	Othe	first	the	DT	B-NP	Ofirst	report	first	JJ	I-NP	Oreport	of	report	NN	I-NP	Oof	such	of	IN	B-PP	Osuch	a	such	JJ	B-NP	Oa	molecule	a	DT	I-NP	Omolecule	in	molecule	NN	I-NP	Oin	a	in	IN	B-PP	Oa	'lower	a	DT	B-NP	O'lower	'	'low	JJR	I-NP	O'	vertebrate	'	POS	B-NP	Overtebrate	.	vertebrate	NN	I-NP	O.	A	.	.	O	OA	monoclonal	A	DT	B-NP	Omonoclonal	antibody	monoclonal	JJ	I-NP	B-proteinantibody	against	antibody	NN	I-NP	I-proteinagainst	human	against	IN	B-PP	Ohuman	STAT6	human	JJ	B-NP	OSTAT6	recognizes	STAT6	NN	I-NP	B-proteinrecognizes	an	recognize	VBZ	B-VP	Oan	approximately	an	DT	B-NP	Oapproximately	100	approximately	RB	I-NP	O100	kDa	100	CD	I-NP	B-proteinkDa	molecule	kDa	NN	I-NP	I-proteinmolecule	that	molecule	NN	I-NP	I-proteinthat	becomes	that	WDT	B-NP	Obecomes	activated	become	VBZ	B-VP	Oactivated	and	activate	VBN	I-VP	Oand	translocates	and	CC	O	Otranslocates	to	translocate	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	nucleus	the	DT	B-NP	Onucleus	upon	nucleus	NN	I-NP	Oupon	both	upon	IN	B-PP	Oboth	growth	both	CC	O	Ogrowth	factor	growth	NN	B-NP	B-proteinfactor	and	factor	NN	I-NP	I-proteinand	mitogen	and	CC	O	Omitogen	stimulation	mitogen	NN	B-NP	B-proteinstimulation	of	stimulation	NN	I-NP	Oof	catfish	of	IN	B-PP	Ocatfish	leukocytes	catfish	NN	B-NP	B-cell_typeleukocytes	.	leukocyte	NNS	I-NP	I-cell_type.	This	.	.	O	OThis	presumed	This	DT	B-NP	Opresumed	catfish	presumed	JJ	I-NP	Ocatfish	STAT	catfish	NN	I-NP	OSTAT	binds	STAT	NN	I-NP	B-proteinbinds	the	bind	VBZ	B-VP	Othe	mammalian	the	DT	B-NP	Omammalian	interferon-gamma	mammalian	JJ	I-NP	B-DNAinterferon-gamma	activation	interferon-gamma	NN	I-NP	I-DNAactivation	site	activation	NN	I-NP	I-DNAsite	","	site	NN	I-NP	I-DNA","	a	","	","	O	Oa	known	a	DT	B-NP	Oknown	motif	known	JJ	I-NP	Omotif	of	motif	NN	I-NP	Oof	mammalian	of	IN	B-PP	Omammalian	STAT	mammalian	JJ	B-NP	OSTAT	binding	STAT	NN	I-NP	Obinding	","	binding	NN	I-NP	O","	as	","	","	O	Oas	shown	as	IN	B-SBAR	Oshown	by	show	VBN	B-VP	Oby	electromobility	by	IN	B-PP	Oelectromobility	shift	electromobility	NN	B-NP	Oshift	assays	shift	NN	I-NP	Oassays	.	assay	NNS	I-NP	O.	Purification	.	.	O	OPurification	of	Purification	NN	B-NP	Oof	the	of	IN	B-PP	Othe	proteins	the	DT	B-NP	Oproteins	present	protein	NNS	I-NP	Opresent	in	present	JJ	B-ADJP	Oin	these	in	IN	B-PP	Othese	DNA	these	DT	B-NP	ODNA	complexes	DNA	NN	I-NP	B-proteincomplexes	confirms	complex	NNS	I-NP	I-proteinconfirms	that	confirm	VBZ	B-VP	Othat	the	that	IN	B-SBAR	Othe	catfish	the	DT	B-NP	Ocatfish	reactive	catfish	NN	I-NP	B-proteinreactive	molecule	reactive	JJ	I-NP	I-proteinmolecule	binds	molecule	NN	I-NP	I-proteinbinds	to	bind	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	interferon-gamma	the	DT	B-NP	Ointerferon-gamma	activation	interferon-gamma	NN	I-NP	B-DNAactivation	site	activation	NN	I-NP	I-DNAsite	sequence	site	NN	I-NP	I-DNAsequence	.	sequence	NN	I-NP	I-DNA.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	STAT	that	IN	B-SBAR	OSTAT	molecules	STAT	NN	B-NP	B-proteinmolecules	have	molecule	NNS	I-NP	I-proteinhave	been	have	VBP	B-VP	Obeen	highly	be	VBN	I-VP	Ohighly	conserved	highly	RB	I-VP	Oconserved	in	conserve	VBN	I-VP	Oin	vertebrate	in	IN	B-PP	Overtebrate	evolution	vertebrate	NN	B-NP	Oevolution	.	evolution	NN	I-NP	O.	Isolation	.	.	O	OIsolation	and	Isolation	NN	B-NP	Oand	analysis	and	CC	I-NP	Oanalysis	of	analysis	NN	I-NP	Oof	a	of	IN	B-PP	Oa	T	a	DT	B-NP	OT	cell	T	NN	I-NP	B-proteincell	clone	cell	NN	I-NP	I-proteinclone	variant	clone	NN	I-NP	I-proteinvariant	exhibiting	variant	NN	I-NP	I-proteinexhibiting	constitutively	exhibit	VBG	B-VP	I-proteinconstitutively	phosphorylated	constitutively	RB	B-NP	I-proteinphosphorylated	Ser133	phosphorylate	VBN	I-NP	I-proteinSer133	cAMP	Ser133	NN	I-NP	I-proteincAMP	response	cAMP	NN	I-NP	I-proteinresponse	element-binding	response	NN	I-NP	I-proteinelement-binding	protein	element-binding	JJ	I-NP	I-proteinprotein	.	protein	NN	I-NP	I-protein.	In	.	.	O	OIn	driving	In	IN	B-PP	Odriving	T	drive	VBG	B-VP	OT	cell	T	NN	B-NP	Ocell	proliferation	cell	NN	I-NP	Oproliferation	","	proliferation	NN	I-NP	O","	IL-2	","	","	O	OIL-2	stimulates	IL-2	NN	B-NP	B-proteinstimulates	a	stimulate	VBZ	B-VP	Oa	new	a	DT	B-NP	Onew	program	new	JJ	I-NP	Oprogram	of	program	NN	I-NP	Oof	gene	of	IN	B-PP	Ogene	expression	gene	NN	B-NP	Oexpression	that	expression	NN	I-NP	Othat	includes	that	WDT	B-NP	Oincludes	proliferating	include	VBZ	B-VP	Oproliferating	cell	proliferate	VBG	B-NP	Ocell	nuclear	cell	NN	I-NP	Onuclear	antigen	nuclear	JJ	I-NP	Oantigen	(	antigen	NN	I-NP	O(	PCNA	(	(	O	OPCNA	)	PCNA	NN	B-NP	B-protein)	","	)	)	O	O","	a	","	","	O	Oa	requisite	a	DT	B-NP	Orequisite	processivity	requisite	JJ	I-NP	B-proteinprocessivity	factor	processivity	NN	I-NP	I-proteinfactor	for	factor	NN	I-NP	I-proteinfor	DNA	for	IN	B-PP	ODNA	polymerase	DNA	NN	B-NP	B-proteinpolymerase	delta	polymerase	NN	I-NP	I-proteindelta	.	delta	NN	I-NP	I-protein.	PCNA	.	.	O	OPCNA	transcription	PCNA	NN	B-NP	Otranscription	is	transcription	NN	I-NP	Ois	regulated	be	VBZ	B-VP	Oregulated	in	regulate	VBN	I-VP	Oin	part	in	IN	B-PP	Opart	through	part	NN	B-NP	Othrough	tandem	through	IN	B-PP	Otandem	CRE	tandem	JJ	B-NP	B-DNACRE	sequences	CRE	NN	I-NP	I-DNAsequences	in	sequence	NNS	I-NP	I-DNAin	the	in	IN	B-PP	Othe	promoter	the	DT	B-NP	Opromoter	and	promoter	NN	I-NP	B-DNAand	CRE	and	CC	I-NP	OCRE	binding	CRE	NN	I-NP	B-proteinbinding	proteins	binding	NN	I-NP	I-proteinproteins	;	protein	NNS	I-NP	I-protein;	IL-2	;	:	O	OIL-2	stimulates	IL-2	NN	B-NP	B-proteinstimulates	CREB	stimulate	VBZ	B-VP	OCREB	phosphorylation	CREB	NN	B-NP	B-proteinphosphorylation	in	phosphorylation	NN	I-NP	Oin	the	in	IN	B-PP	Othe	resting	the	DT	B-NP	Oresting	cloned	rest	VBG	I-NP	B-cell_typecloned	T	clone	VBN	I-NP	I-cell_typeT	lymphocyte	T	NN	I-NP	I-cell_typelymphocyte	","	lymphocyte	NN	I-NP	I-cell_type","	L2	","	","	O	OL2	.	L2	NN	B-NP	B-DNA.	After	.	.	O	OAfter	culturing	After	IN	B-PP	Oculturing	L2	culture	VBG	B-VP	OL2	cells	L2	NN	B-NP	B-cell_linecells	for	cell	NNS	I-NP	I-cell_linefor	greater	for	IN	B-PP	Ogreater	than	great	JJR	B-NP	Othan	91	than	IN	I-NP	O91	days	91	CD	I-NP	Odays	","	day	NNS	I-NP	O","	we	","	","	O	Owe	consistently	we	PRP	B-NP	Oconsistently	isolate	consistently	RB	B-ADVP	Oisolate	a	isolate	VBP	B-VP	Oa	stable	a	DT	B-NP	Ostable	variant	stable	JJ	I-NP	Ovariant	that	variant	NN	I-NP	Othat	exhibits	that	WDT	B-NP	Oexhibits	constitutive	exhibit	VBZ	B-VP	Oconstitutive	CREB	constitutive	JJ	B-NP	OCREB	phosphorylation	CREB	NN	I-NP	B-proteinphosphorylation	.	phosphorylation	NN	I-NP	O.	L2	.	.	O	OL2	and	L2	NN	B-NP	B-DNAand	L2	and	CC	I-NP	OL2	variant	L2	NN	I-NP	B-cell_linevariant	cells	variant	NN	I-NP	I-cell_linecells	were	cell	NNS	I-NP	I-cell_linewere	tested	be	VBD	B-VP	Otested	for	test	VBN	I-VP	Ofor	IL-2	for	IN	B-PP	OIL-2	responsiveness	IL-2	NN	B-NP	B-proteinresponsiveness	and	responsiveness	NN	I-NP	Oand	rapamycin	and	CC	O	Orapamycin	sensitivity	rapamycin	NN	B-NP	Osensitivity	with	sensitivity	NN	I-NP	Owith	respect	with	IN	B-PP	Orespect	to	respect	NN	B-NP	Oto	specific	to	TO	B-PP	Ospecific	kinase	specific	JJ	B-NP	Okinase	activity	kinase	NN	I-NP	Oactivity	","	activity	NN	I-NP	O","	PCNA	","	","	O	OPCNA	expression	PCNA	NN	B-NP	B-proteinexpression	and	expression	NN	B-NP	Oand	proliferation	and	CC	O	Oproliferation	.	proliferation	NN	B-NP	O.	In	.	.	O	OIn	L2	In	IN	B-PP	OL2	cells	L2	NN	B-NP	B-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	IL-2	","	","	O	OIL-2	stimulated	IL-2	NN	B-NP	B-proteinstimulated	and	stimulate	VBN	B-VP	Oand	rapamycin	and	CC	O	Orapamycin	inhibited	rapamycin	NN	B-NP	Oinhibited	the	inhibit	VBD	B-VP	Othe	following	the	DT	B-NP	Ofollowing	:	following	NN	I-NP	O:	cAMP-independent	:	:	O	OcAMP-independent	CREB	cAMP-independent	JJ	B-NP	OCREB	kinase	CREB	NN	I-NP	B-proteinkinase	activity	kinase	NN	I-NP	I-proteinactivity	","	activity	NN	I-NP	O","	PCNA	","	","	O	OPCNA	expression	PCNA	NN	B-NP	B-proteinexpression	and	expression	NN	B-NP	Oand	proliferation	and	CC	O	Oproliferation	.	proliferation	NN	B-NP	O.	In	.	.	O	OIn	L2	In	IN	B-PP	OL2	variant	L2	NN	B-NP	B-cell_linevariant	cells	variant	NN	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	CREB	","	","	O	OCREB	kinase	CREB	NN	B-NP	B-proteinkinase	activity	kinase	NN	I-NP	I-proteinactivity	was	activity	NN	I-NP	Owas	constitutively	be	VBD	B-VP	Oconstitutively	high	constitutively	RB	B-ADJP	Ohigh	;	high	JJ	I-ADJP	O;	IL-2	;	:	O	OIL-2	stimulated	IL-2	NN	B-NP	B-proteinstimulated	and	stimulate	VBN	B-VP	Oand	rapamycin	and	CC	O	Orapamycin	blocked	rapamycin	NN	B-NP	Oblocked	PCNA	block	VBD	B-VP	OPCNA	expression	PCNA	NN	B-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	proliferation	and	CC	O	Oproliferation	.	proliferation	NN	B-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	IL-2	that	IN	B-SBAR	OIL-2	induces	IL-2	NN	B-NP	B-proteininduces	a	induce	VBZ	B-VP	Oa	rapamycin-sensitive	a	DT	B-NP	Orapamycin-sensitive	","	rapamycin-sensitive	JJ	I-NP	O","	cAMP-independent	","	","	I-NP	OcAMP-independent	CREB	cAMP-independent	JJ	I-NP	OCREB	kinase	CREB	NN	I-NP	B-proteinkinase	activity	kinase	NN	I-NP	I-proteinactivity	in	activity	NN	I-NP	Oin	L2	in	IN	B-PP	OL2	cells	L2	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	phosphorylation	","	","	O	Ophosphorylation	of	phosphorylation	NN	B-NP	Oof	CREB	of	IN	B-PP	OCREB	alone	CREB	NN	B-NP	B-proteinalone	is	alone	RB	B-ADVP	Ois	not	be	VBZ	B-VP	Onot	sufficient	not	RB	O	Osufficient	to	sufficient	JJ	B-ADJP	Oto	drive	to	TO	B-VP	Odrive	PCNA	drive	VB	I-VP	OPCNA	expression	PCNA	NN	B-NP	B-proteinexpression	and	expression	NN	B-NP	Oand	L2	and	CC	O	OL2	cell	L2	NN	B-NP	Ocell	proliferation	cell	NN	I-NP	Oproliferation	in	proliferation	NN	I-NP	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	.	IL-2	NN	B-NP	B-protein.	Serotonin	.	.	O	OSerotonin	derivative	Serotonin	NN	B-NP	Oderivative	","	derivative	NN	I-NP	O","	N-	","	","	O	ON-	(	N-	NN	B-NP	B-protein(	p-coumaroyl	(	(	O	I-proteinp-coumaroyl	)	p-coumaroyl	NN	B-NP	I-protein)	serotonin	)	)	O	I-proteinserotonin	","	serotonin	NN	B-NP	I-protein","	inhibits	","	","	O	Oinhibits	the	inhibit	VBZ	B-VP	Othe	production	the	DT	B-NP	Oproduction	of	production	NN	I-NP	Oof	TNF-alpha	of	IN	B-PP	OTNF-alpha	","	TNF-alpha	NN	B-NP	B-protein","	IL-1alpha	","	","	O	OIL-1alpha	","	IL-1alpha	NN	B-NP	B-protein","	IL-1beta	","	","	O	OIL-1beta	","	IL-1beta	NN	B-NP	B-protein","	and	","	","	O	Oand	IL-6	and	CC	O	OIL-6	by	IL-6	NN	B-NP	B-proteinby	endotoxin-stimulated	by	IN	B-PP	Oendotoxin-stimulated	human	endotoxin-stimulated	JJ	B-NP	B-cell_typehuman	blood	human	JJ	I-NP	I-cell_typeblood	monocytes	blood	NN	I-NP	I-cell_typemonocytes	.	monocyte	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	reported	have	VBP	B-VP	Oreported	that	report	VBN	I-VP	Othat	N-	that	IN	B-SBAR	ON-	(	N-	NN	B-NP	B-protein(	p-coumaroyl	(	(	O	I-proteinp-coumaroyl	)	p-coumaroyl	NN	B-NP	I-protein)	serotonin	)	)	O	I-proteinserotonin	(	serotonin	NN	B-NP	I-protein(	CS	(	(	O	OCS	)	CS	NN	B-NP	O)	and	)	)	O	Oand	its	and	CC	O	Oits	derivatives	its	PRP$	B-NP	Oderivatives	with	derivative	NNS	I-NP	Owith	antioxidative	with	IN	B-PP	Oantioxidative	activity	antioxidative	JJ	B-NP	Oactivity	are	activity	NN	I-NP	Oare	present	be	VBP	B-VP	Opresent	in	present	JJ	B-ADJP	Oin	safflower	in	IN	B-PP	Osafflower	seeds	safflow	JJR	B-NP	Oseeds	.	seed	NNS	I-NP	O.	As	.	.	O	OAs	reactive	As	IN	B-SBAR	Oreactive	oxygen	reactive	JJ	B-NP	Ooxygen	species	oxygen	NN	I-NP	Ospecies	(	specie	NNS	I-NP	O(	ROS	(	(	O	OROS	)	ROS	NNS	B-NP	O)	are	)	)	O	Oare	implicated	be	VBP	B-VP	Oimplicated	in	implicate	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	signaling	the	DT	B-NP	Osignaling	of	signaling	NN	I-NP	Oof	lipopolysaccharide	of	IN	B-PP	Olipopolysaccharide	(	lipopolysaccharide	NN	B-NP	O(	LPS	(	(	O	OLPS	)	LPS	NN	B-NP	O)	","	)	)	O	O","	we	","	","	O	Owe	examined	we	PRP	B-NP	Oexamined	whether	examine	VBD	B-VP	Owhether	CS	whether	IN	B-SBAR	OCS	has	CS	NN	B-NP	Ohas	a	have	VBZ	B-VP	Oa	suppressive	a	DT	B-NP	Osuppressive	effect	suppressive	JJ	I-NP	Oeffect	on	effect	NN	I-NP	Oon	inflammatory	on	IN	B-PP	Oinflammatory	cytokine	inflammatory	JJ	B-NP	B-proteincytokine	generation	cytokine	NN	I-NP	I-proteingeneration	from	generation	NN	I-NP	Ofrom	human	from	IN	B-PP	Ohuman	monocyte	human	JJ	B-NP	B-cell_typemonocyte	s	monocyte	NN	I-NP	I-cell_types	in	s	NNS	I-NP	I-cell_typein	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	CS	.	.	O	OCS	at	CS	NNS	B-NP	Oat	50-200	at	IN	B-PP	O50-200	microM	50-200	CD	B-NP	OmicroM	reduced	microM	NN	I-NP	Oreduced	tumor	reduce	VBD	B-VP	Otumor	necrosis	tumor	NN	B-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	TNF	(	(	O	OTNF	)	TNF	NN	B-NP	B-protein)	","	)	)	O	O","	interleukin-1	","	","	O	Ointerleukin-1	(	interleukin-1	NN	B-NP	B-protein(	IL-1	(	(	O	OIL-1	)	IL-1	NN	B-NP	B-protein)	","	)	)	O	O","	and	","	","	O	Oand	IL-6	and	CC	O	OIL-6	activities	IL-6	NN	B-NP	B-proteinactivities	in	activity	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	culture	the	DT	B-NP	Oculture	supernatants	culture	NN	I-NP	Osupernatants	from	supernatant	NNS	I-NP	Ofrom	LPS-stimulated	from	IN	B-PP	OLPS-stimulated	human	LPS-stimulated	JJ	B-NP	B-cell_typehuman	blood	human	JJ	I-NP	I-cell_typeblood	monocytes	blood	NN	I-NP	I-cell_typemonocytes	without	monocyte	NNS	I-NP	I-cell_typewithout	cytotoxicity	without	IN	B-PP	Ocytotoxicity	.	cytotoxicity	NN	B-NP	O.	ELISA	.	.	O	OELISA	assay	ELISA	NN	B-NP	Oassay	revealed	assay	NN	I-NP	Orevealed	that	reveal	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	production	the	DT	B-NP	Oproduction	of	production	NN	I-NP	Oof	TNF-alpha	of	IN	B-PP	OTNF-alpha	","	TNF-alpha	NN	B-NP	B-protein","	IL-1alpha	","	","	O	OIL-1alpha	","	IL-1alpha	NN	B-NP	B-protein","	IL-1beta	","	","	O	OIL-1beta	","	IL-1beta	NN	B-NP	B-protein","	and	","	","	O	Oand	IL-6	and	CC	O	OIL-6	was	IL-6	NN	B-NP	B-proteinwas	inhibited	be	VBD	B-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	CS	by	IN	B-PP	OCS	.	CS	NN	B-NP	O.	Northern	.	.	O	ONorthern	blot	Northern	NN	B-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	showed	analysis	NN	I-NP	Oshowed	that	show	VBD	B-VP	Othat	LPS-induced	that	IN	B-SBAR	OLPS-induced	expression	LPS-induced	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	these	of	IN	B-PP	Othese	cytokine	these	DT	B-NP	Ocytokine	mRNA	cytokine	NN	I-NP	B-RNAmRNA	in	mRNA	NN	I-NP	I-RNAin	monocytes	in	IN	B-PP	Omonocytes	was	monocyte	NNS	B-NP	B-cell_typewas	suppressed	be	VBD	B-VP	Osuppressed	by	suppress	VBN	I-VP	Oby	CS	by	IN	B-PP	OCS	.	CS	NN	B-NP	O.	NF-kappaB	.	.	O	ONF-kappaB	activation	NF-kappaB	NN	B-NP	B-proteinactivation	was	activation	NN	I-NP	Owas	also	be	VBD	B-VP	Oalso	inhibited	also	RB	I-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	CS	by	IN	B-PP	OCS	.	CS	NN	B-NP	O.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	indicate	finding	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	CS	that	IN	B-SBAR	OCS	has	CS	NN	B-NP	Ohas	a	have	VBZ	B-VP	Oa	suppressive	a	DT	B-NP	Osuppressive	effect	suppressive	JJ	I-NP	Oeffect	on	effect	NN	I-NP	Oon	proinflammatory	on	IN	B-PP	Oproinflammatory	cytokine	proinflammatory	JJ	B-NP	B-proteincytokine	production	cytokine	NN	I-NP	I-proteinproduction	from	production	NN	I-NP	Ofrom	monocytes	from	IN	B-PP	Omonocytes	","	monocyte	NNS	B-NP	B-cell_type","	and	","	","	O	Oand	this	and	CC	O	Othis	effect	this	DT	B-NP	Oeffect	is	effect	NN	I-NP	Ois	based	be	VBZ	B-VP	Obased	in	base	VBN	I-VP	Oin	part	in	IN	B-PP	Opart	on	part	NN	B-NP	Oon	the	on	IN	B-PP	Othe	suppression	the	DT	B-NP	Osuppression	of	suppression	NN	I-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	mRNA	cytokine	NN	B-NP	B-RNAmRNA	expression	mRNA	NN	I-NP	I-RNAexpression	through	expression	NN	I-NP	Othrough	inhibition	through	IN	B-PP	Oinhibition	of	inhibition	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	activation	NF-kappaB	NN	B-NP	B-proteinactivation	.	activation	NN	I-NP	O.	Elevated	.	.	O	OElevated	expression	Elevated	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	differentiation	of	IN	B-PP	Odifferentiation	inhibitory	differentiation	NN	B-NP	Oinhibitory	factor	inhibitory	JJ	I-NP	Ofactor	nm23	factor	NN	I-NP	Onm23	mRNA	nm23	NN	I-NP	OmRNA	in	mRNA	NN	I-NP	Oin	monoblastic	in	IN	B-PP	Omonoblastic	crisis	monoblastic	JJ	B-NP	Ocrisis	of	crisis	NN	I-NP	Oof	a	of	IN	B-PP	Oa	patient	a	DT	B-NP	Opatient	with	patient	NN	I-NP	Owith	chronic	with	IN	B-PP	Ochronic	myelogenous	chronic	JJ	B-NP	Omyelogenous	leukemia	myelogenous	JJ	I-NP	Oleukemia	.	leukemia	NN	I-NP	O.	Differentiation	.	.	O	ODifferentiation	inhibitory	Differentiation	NN	B-NP	B-DNAinhibitory	factor	inhibitory	JJ	I-NP	I-DNAfactor	nm23	factor	NN	I-NP	I-DNAnm23	gene	nm23	NN	I-NP	I-DNAgene	has	gene	NN	I-NP	I-DNAhas	been	have	VBZ	B-VP	Obeen	found	be	VBN	I-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	expressed	be	VB	I-VP	Oexpressed	in	express	VBN	I-VP	Oin	high	in	IN	B-PP	Ohigh	quantities	high	JJ	B-NP	Oquantities	in	quantity	NNS	I-NP	Oin	acute	in	IN	B-PP	Oacute	myelogenous	acute	JJ	B-NP	Omyelogenous	leukemia	myelogenous	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	AML	(	(	O	OAML	)	AML	NN	B-NP	O)	","	)	)	O	O","	especially	","	","	O	Oespecially	in	especially	RB	B-ADVP	Oin	acute	in	IN	B-PP	Oacute	monocytic	acute	JJ	B-NP	Omonocytic	leukemia	monocytic	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	AML-M5	(	(	O	OAML-M5	)	AML-M5	NN	B-NP	O)	and	)	)	O	Oand	is	and	CC	O	Ois	suggested	be	VBZ	B-VP	Osuggested	as	suggest	VBN	I-VP	Oas	a	as	IN	B-PP	Oa	new	a	DT	B-NP	Onew	prognostic	new	JJ	I-NP	Oprognostic	factor	prognostic	JJ	I-NP	Ofactor	in	factor	NN	I-NP	Oin	AML-M5	in	IN	B-PP	OAML-M5	.	AML-M5	NN	B-NP	O.	We	.	.	O	OWe	report	We	PRP	B-NP	Oreport	an	report	VBP	B-VP	Oan	example	an	DT	B-NP	Oexample	of	example	NN	I-NP	Oof	elevated	of	IN	B-PP	Oelevated	expression	elevate	VBN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	nm23	of	IN	B-PP	Onm23	mRNA	nm23	NN	B-NP	B-RNAmRNA	in	mRNA	NN	I-NP	I-RNAin	a	in	IN	B-PP	Oa	patient	a	DT	B-NP	Opatient	with	patient	NN	I-NP	Owith	chronic	with	IN	B-PP	Ochronic	myelogenous	chronic	JJ	B-NP	Omyelogenous	leukemia	myelogenous	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	CML	(	(	O	OCML	)	CML	NN	B-NP	O)	who	)	)	O	Owho	developed	who	WP	B-NP	Odeveloped	monoblastic	develop	VBD	B-VP	Omonoblastic	crisis	monoblastic	JJ	B-NP	Ocrisis	.	crisis	NN	I-NP	O.	Relative	.	.	O	ORelative	levels	Relative	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	nm23-H1	of	IN	B-PP	Onm23-H1	and	nm23-H1	NN	B-NP	B-RNAand	0	and	CC	O	I-RNA0	mRNA	0	NN	B-NP	I-RNAmRNA	extracted	mRNA	NN	I-NP	I-RNAextracted	from	extract	VBN	B-VP	Ofrom	the	from	IN	B-PP	Othe	patient	the	DT	B-NP	Opatient	's	patient	NN	I-NP	O's	peripheral	's	POS	B-NP	Operipheral	blood	peripheral	JJ	I-NP	B-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	bone	and	CC	O	Obone	marrow	bone	NN	B-NP	B-cell_typemarrow	mononuclear	marrow	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	measured	be	VBD	B-VP	Omeasured	by	measure	VBN	I-VP	Oby	quantitative	by	IN	B-PP	Oquantitative	reverse	quantitative	JJ	B-NP	Oreverse	transcriptase	reverse	JJ	I-NP	B-proteintranscriptase	polymerase	transcriptase	NN	I-NP	I-proteinpolymerase	chain	polymerase	NN	I-NP	Ochain	reaction	chain	NN	I-NP	Oreaction	.	reaction	NN	I-NP	O.	The	.	.	O	OThe	level	The	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	nm23-H1	of	IN	B-PP	Onm23-H1	mRNA	nm23-H1	NN	B-NP	B-RNAmRNA	in	mRNA	NN	I-NP	I-RNAin	CML	in	IN	B-PP	OCML	cells	CML	NN	B-NP	B-cell_typecells	at	cell	NNS	I-NP	I-cell_typeat	the	at	IN	B-PP	Othe	chronic	the	DT	B-NP	Ochronic	phase	chronic	JJ	I-NP	Ophase	was	phase	NN	I-NP	Owas	as	be	VBD	B-VP	Oas	high	as	RB	B-ADJP	Ohigh	as	high	JJ	I-ADJP	Oas	that	as	IN	B-PP	Othat	in	that	DT	B-NP	Oin	bone	in	IN	B-PP	Obone	marrow	bone	NN	B-NP	B-cell_typemarrow	cells	marrow	NN	I-NP	I-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	healthy	from	IN	B-PP	Ohealthy	volunteers	healthy	JJ	B-NP	Ovolunteers	.	volunteer	NNS	I-NP	O.	The	.	.	O	OThe	mRNA	The	DT	B-NP	OmRNA	level	mRNA	NN	I-NP	B-RNAlevel	of	level	NN	I-NP	Oof	nm23-H2	of	IN	B-PP	Onm23-H2	was	nm23-H2	NN	B-NP	B-proteinwas	slightly	be	VBD	B-VP	Oslightly	below	slightly	RB	B-ADVP	Obelow	the	below	IN	B-PP	Othe	normal	the	DT	B-NP	Onormal	level	normal	JJ	I-NP	Olevel	.	level	NN	I-NP	O.	At	.	.	O	OAt	blastic	At	IN	B-PP	Oblastic	crisis	blastic	JJ	B-NP	Ocrisis	","	crisis	NN	I-NP	O","	however	","	","	O	Ohowever	","	however	RB	B-ADVP	O","	expression	","	","	O	Oexpression	of	expression	NN	B-NP	Oof	both	of	IN	B-PP	Oboth	nm23-H1	both	CC	O	Onm23-H1	and	nm23-H1	NN	B-NP	B-proteinand	0	and	CC	O	O0	mRNA	0	NN	B-NP	B-RNAmRNA	was	mRNA	NN	I-NP	I-RNAwas	elevated	be	VBD	B-VP	Oelevated	to	elevate	VBN	I-VP	Oto	about	to	TO	B-PP	Oabout	three	about	RB	B-NP	Othree	to	three	CD	I-NP	Oto	nine	to	TO	I-NP	Onine	times	nine	CD	I-NP	Otimes	of	time	NNS	I-NP	Oof	that	of	IN	B-PP	Othat	at	that	DT	B-NP	Oat	the	at	IN	B-PP	Othe	chronic	the	DT	B-NP	Ochronic	phase	chronic	JJ	I-NP	Ophase	.	phase	NN	I-NP	O.	Proliferated	.	.	O	OProliferated	blastic	Proliferate	VBN	B-NP	Oblastic	cells	blastic	JJ	I-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	positive	be	VBD	B-VP	Opositive	for	positive	JJ	B-ADJP	Ofor	non-specific	for	IN	B-PP	Onon-specific	esterase	non-specific	JJ	B-NP	Oesterase	","	esterase	NN	I-NP	B-protein","	and	","	","	O	Oand	the	and	CC	O	Othe	serum	the	DT	B-NP	Oserum	lysozyme	serum	NN	I-NP	B-proteinlysozyme	level	lysozyme	NN	I-NP	I-proteinlevel	was	level	NN	I-NP	Owas	elevated	be	VBD	B-VP	Oelevated	and	elevate	VBN	I-VP	Oand	diagnosed	and	CC	O	Odiagnosed	as	diagnose	VBN	B-VP	Oas	monoblastic	as	IN	B-PP	Omonoblastic	crisis	monoblastic	JJ	B-NP	Ocrisis	.	crisis	NN	I-NP	O.	The	.	.	O	OThe	patient	The	DT	B-NP	Opatient	received	patient	NN	I-NP	Oreceived	combined	receive	VBD	B-VP	Ocombined	chemotherapy	combine	VBN	I-VP	Ochemotherapy	but	chemotherapy	NN	B-NP	Obut	response	but	CC	O	Oresponse	was	response	NN	B-NP	Owas	partial	be	VBD	B-VP	Opartial	.	partial	JJ	B-ADJP	O.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	are	finding	NNS	I-NP	Oare	compatible	be	VBP	B-VP	Ocompatible	with	compatible	JJ	B-ADJP	Owith	our	with	IN	B-PP	Oour	previous	our	PRP$	B-NP	Oprevious	report	previous	JJ	I-NP	Oreport	that	report	NN	I-NP	Othat	nm23	that	IN	B-SBAR	Onm23	gene	nm23	NN	B-NP	B-DNAgene	is	gene	NN	I-NP	I-DNAis	overexpressed	be	VBZ	B-VP	Ooverexpressed	in	overexpresse	VBN	I-VP	Oin	monocytic	in	IN	B-PP	Omonocytic	leukemia	monocytic	JJ	B-NP	Oleukemia	.	leukemia	NN	I-NP	O.	Increased	.	.	O	OIncreased	transcription	Increase	VBN	B-NP	Otranscription	decreases	transcription	NN	I-NP	Odecreases	the	decrease	VBZ	B-VP	Othe	spontaneous	the	DT	B-NP	Ospontaneous	mutation	spontaneous	JJ	I-NP	Omutation	rate	mutation	NN	I-NP	Orate	at	rate	NN	I-NP	Oat	the	at	IN	B-PP	Othe	thymidine	the	DT	B-NP	Othymidine	kinase	thymidine	NN	I-NP	B-DNAkinase	locus	kinase	NN	I-NP	I-DNAlocus	in	locus	NN	I-NP	I-DNAin	human	in	IN	B-PP	Ohuman	cells	human	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Transcription	.	.	O	OTranscription	increases	Transcription	NN	B-NP	Oincreases	DNA	increase	VBZ	B-VP	ODNA	repair	DNA	NN	B-NP	Orepair	efficiency	repair	NN	I-NP	Oefficiency	and	efficiency	NN	I-NP	Oand	modulates	and	CC	O	Omodulates	the	modulate	VBZ	B-VP	Othe	distribution	the	DT	B-NP	Odistribution	of	distribution	NN	I-NP	Oof	certain	of	IN	B-PP	Ocertain	types	certain	JJ	B-NP	Otypes	of	type	NNS	I-NP	Oof	DNA	of	IN	B-PP	ODNA	damage	DNA	NN	B-NP	Odamage	.	damage	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	increased	","	","	O	Oincreased	transcription	increase	VBN	B-NP	Otranscription	level	transcription	NN	I-NP	Olevel	stimulates	level	NN	I-NP	Ostimulates	spontaneous	stimulate	VBZ	B-VP	Ospontaneous	mutation	spontaneous	JJ	B-NP	Omutation	rate	mutation	NN	I-NP	Orate	in	rate	NN	I-NP	Oin	yeast	in	IN	B-PP	Oyeast	.	yeast	NN	B-NP	O.	We	.	.	O	OWe	explored	We	PRP	B-NP	Oexplored	whether	explore	VBD	B-VP	Owhether	transcription	whether	IN	B-SBAR	Otranscription	level	transcription	NN	B-NP	Olevel	affects	level	NN	I-NP	Oaffects	spontaneous	affect	VBZ	B-VP	Ospontaneous	mutation	spontaneous	JJ	B-NP	Omutation	rate	mutation	NN	I-NP	Orate	in	rate	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	cells	human	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	first	We	PRP	B-NP	Ofirst	developed	first	RB	B-ADVP	Odeveloped	two	develop	VBD	B-VP	Otwo	thymidine	two	CD	B-NP	Othymidine	kinase	thymidine	NN	I-NP	B-proteinkinase	(	kinase	NN	I-NP	I-protein(	tk	(	(	O	Otk	)	tk	NN	B-NP	O)	inducible	)	)	O	Oinducible	human	inducible	JJ	B-NP	Ohuman	cell	human	JJ	I-NP	Ocell	lines	cell	NN	I-NP	Olines	using	line	NNS	I-NP	Ousing	the	use	VBG	B-VP	Othe	Gal4-Estrogen	the	DT	B-NP	OGal4-Estrogen	receptor	Gal4-Estrogen	NN	I-NP	B-proteinreceptor	system	receptor	NN	I-NP	I-proteinsystem	.	system	NN	I-NP	O.	In	.	.	O	OIn	our	In	IN	B-PP	Oour	TK6i-G3	our	PRP$	B-NP	OTK6i-G3	and	TK6i-G3	NN	I-NP	Oand	G9	and	CC	I-NP	OG9	tk	G9	NN	I-NP	B-cell_linetk	heterozygous	tk	NN	I-NP	I-cell_lineheterozygous	cell	heterozygous	JJ	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	","	line	NNS	I-NP	I-cell_line","	the	","	","	O	Othe	active	the	DT	B-NP	Oactive	tk	active	JJ	I-NP	B-DNAtk	allele	tk	NN	I-NP	I-DNAallele	is	allele	NN	I-NP	I-DNAis	linked	be	VBZ	B-VP	Olinked	to	link	VBN	I-VP	Oto	an	to	TO	B-PP	Oan	inducible	an	DT	B-NP	Oinducible	promoter	inducible	JJ	I-NP	B-DNApromoter	element	promoter	NN	I-NP	I-DNAelement	.	element	NN	I-NP	I-DNA.	Tk	.	.	O	OTk	mRNA	Tk	NN	B-NP	B-RNAmRNA	is	mRNA	NN	I-NP	I-RNAis	induced	be	VBZ	B-VP	Oinduced	following	induce	VBN	I-VP	Ofollowing	treatment	follow	VBG	B-PP	Otreatment	with	treatment	NN	B-NP	Owith	estrogen	with	IN	B-PP	Oestrogen	.	estrogen	NN	B-NP	O.	Spontaneous	.	.	O	OSpontaneous	mutation	Spontaneous	JJ	B-NP	Omutation	rate	mutation	NN	I-NP	Orate	was	rate	NN	I-NP	Owas	significantly	be	VBD	B-VP	Osignificantly	decreased	significantly	RB	I-VP	Odecreased	in	decrease	VBN	I-VP	Oin	human	in	IN	B-PP	Ohuman	cell	human	JJ	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	after	line	NNS	I-NP	I-cell_lineafter	induction	after	IN	B-PP	Oinduction	in	induction	NN	B-NP	Oin	contrast	in	IN	B-PP	Ocontrast	to	contrast	NN	B-NP	Oto	the	to	TO	B-PP	Othe	report	the	DT	B-NP	Oreport	in	report	NN	I-NP	Oin	yeast	in	IN	B-PP	Oyeast	.	yeast	NN	B-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	humans	","	","	O	Ohumans	may	human	NNS	B-NP	Omay	have	may	MD	B-VP	Ohave	evolved	have	VB	I-VP	Oevolved	different	evolve	VBN	I-VP	Odifferent	or	different	JJ	B-NP	Oor	additional	or	CC	I-NP	Oadditional	mechanisms	additional	JJ	I-NP	Omechanisms	to	mechanism	NNS	I-NP	Oto	deal	to	TO	B-VP	Odeal	with	deal	VB	I-VP	Owith	transcription	with	IN	B-PP	Otranscription	related	transcription	NN	B-NP	Orelated	spontaneous	related	JJ	I-NP	Ospontaneous	mutagenesis	spontaneous	JJ	I-NP	Omutagenesis	.	mutagenesis	NN	I-NP	O.	Copyright	.	.	O	OCopyright	1998	Copyright	NN	B-NP	O1998	Elsevier	1998	CD	I-NP	OElsevier	Science	Elsevier	NNP	I-NP	OScience	B.V	Science	NNP	I-NP	OB.V	.	B.V	NNP	I-NP	O.	All	.	.	O	OAll	rights	All	DT	B-NP	Orights	reserved	right	NNS	I-NP	Oreserved	.	reserve	VBN	B-VP	O.	Mutation	.	.	O	OMutation	of	Mutation	NN	B-NP	Oof	BCL-6	of	IN	B-PP	OBCL-6	gene	BCL-6	NN	B-NP	B-DNAgene	in	gene	NN	I-NP	I-DNAin	normal	in	IN	B-PP	Onormal	B	normal	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	the	by	IN	B-PP	Othe	process	the	DT	B-NP	Oprocess	of	process	NN	I-NP	Oof	somatic	of	IN	B-PP	Osomatic	hypermutation	somatic	JJ	B-NP	Ohypermutation	of	hypermutation	NN	I-NP	Oof	Ig	of	IN	B-PP	OIg	genes	Ig	NN	B-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Immunoglobulin	.	.	O	OImmunoglobulin	(	Immunoglobulin	NN	B-NP	B-DNA(	Ig	(	(	O	I-DNAIg	)	Ig	NN	B-NP	I-DNA)	genes	)	)	O	I-DNAgenes	are	gene	NNS	B-NP	I-DNAare	hypermutated	be	VBP	B-VP	Ohypermutated	in	hypermutate	VBN	I-VP	Oin	B	in	IN	B-PP	OB	lymphocytes	B	NN	B-NP	B-cell_typelymphocytes	that	lymphocyte	NNS	I-NP	I-cell_typethat	are	that	WDT	B-NP	Oare	the	be	VBP	B-VP	Othe	precursors	the	DT	B-NP	Oprecursors	to	precursor	NNS	I-NP	Oto	memory	to	TO	B-PP	Omemory	B	memory	NN	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	mutations	The	DT	B-NP	Omutations	are	mutation	NNS	I-NP	Oare	linked	be	VBP	B-VP	Olinked	to	link	VBN	I-VP	Oto	transcription	to	TO	B-PP	Otranscription	initiation	transcription	NN	B-NP	Oinitiation	","	initiation	NN	I-NP	O","	but	","	","	O	Obut	non-Ig	but	CC	O	Onon-Ig	promoters	non-Ig	JJ	B-NP	B-DNApromoters	are	promoter	NNS	I-NP	I-DNAare	permissible	be	VBP	B-VP	Opermissible	for	permissible	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	mutation	the	DT	B-NP	Omutation	process	mutation	NN	I-NP	Oprocess	;	process	NN	I-NP	O;	thus	;	:	O	Othus	","	thus	RB	B-ADVP	O","	other	","	","	O	Oother	genes	other	JJ	B-NP	Ogenes	expressed	gene	NNS	I-NP	Oexpressed	in	express	VBN	B-VP	Oin	mutating	in	IN	B-PP	Omutating	B	mutate	VBG	B-VP	OB	cells	B	NN	B-NP	B-cell_typecells	may	cell	NNS	I-NP	I-cell_typemay	also	may	MD	B-VP	Oalso	be	also	RB	I-VP	Obe	subject	be	VB	I-VP	Osubject	to	subject	JJ	B-ADJP	Oto	somatic	to	TO	B-PP	Osomatic	hypermutation	somatic	JJ	B-NP	Ohypermutation	.	hypermutation	NN	I-NP	O.	Significant	.	.	O	OSignificant	mutations	Significant	JJ	B-NP	Omutations	were	mutation	NNS	I-NP	Owere	not	be	VBD	B-VP	Onot	observed	not	RB	I-VP	Oobserved	in	observe	VBN	I-VP	Oin	c-MYC	in	IN	B-PP	Oc-MYC	","	c-MYC	NN	B-NP	B-protein","	S14	","	","	O	OS14	","	S14	NN	B-NP	B-protein","	or	","	","	O	Oor	alpha-fetoprotein	or	CC	O	Oalpha-fetoprotein	(	alpha-fetoprotein	NN	B-NP	B-DNA(	AFP	(	(	O	I-DNAAFP	)	AFP	NN	B-NP	I-DNA)	genes	)	)	O	I-DNAgenes	","	gene	NNS	B-NP	I-DNA","	but	","	","	O	Obut	BCL-6	but	CC	O	OBCL-6	was	BCL-6	NN	B-NP	B-proteinwas	highly	be	VBD	B-VP	Ohighly	mutated	highly	RB	B-ADJP	Omutated	in	mutated	JJ	I-ADJP	Oin	a	in	IN	B-PP	Oa	large	a	DT	B-NP	Olarge	proportion	large	JJ	I-NP	Oproportion	of	proportion	NN	I-NP	Oof	memory	of	IN	B-PP	Omemory	B	memory	NN	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	of	cell	NNS	I-NP	I-cell_typeof	normal	of	IN	B-PP	Onormal	individuals	normal	JJ	B-NP	Oindividuals	.	individual	NNS	I-NP	O.	The	.	.	O	OThe	mutation	The	DT	B-NP	Omutation	pattern	mutation	NN	I-NP	Opattern	was	pattern	NN	I-NP	Owas	similar	be	VBD	B-VP	Osimilar	to	similar	JJ	B-ADJP	Oto	that	to	TO	B-PP	Othat	of	that	DT	B-NP	Oof	Ig	of	IN	B-PP	OIg	genes	Ig	NN	B-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	CD28-mediated	.	.	O	OCD28-mediated	activation	CD28-mediated	JJ	B-NP	Oactivation	in	activation	NN	I-NP	Oin	CD45RA+	in	IN	B-PP	OCD45RA+	and	CD45RA+	JJ	B-NP	Oand	CD45RO+	and	CC	I-NP	OCD45RO+	T	CD45RO+	JJ	I-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	:	cell	NNS	I-NP	I-cell_type:	enhanced	:	:	O	Oenhanced	levels	enhance	VBN	B-VP	Olevels	of	level	NNS	B-NP	Oof	reactive	of	IN	B-PP	Oreactive	oxygen	reactive	JJ	B-NP	Ooxygen	intermediates	oxygen	NN	I-NP	Ointermediates	and	intermediate	NNS	I-NP	Oand	c-Rel	and	CC	O	Oc-Rel	nuclear	c-Rel	NN	B-NP	B-proteinnuclear	translocation	nuclear	JJ	I-NP	Otranslocation	in	translocation	NN	I-NP	Oin	CD45RA+	in	IN	B-PP	OCD45RA+	cells	CD45RA+	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	analyzed	have	VBP	B-VP	Oanalyzed	the	analyze	VBN	I-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	complete	of	IN	B-PP	Ocomplete	T	complete	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	activation	cell	NN	I-NP	Oactivation	(	activation	NN	I-NP	O(	anti-CD3	(	(	O	Oanti-CD3	plus	anti-CD3	NN	B-NP	B-proteinplus	anti-CD28	plus	CC	O	Oanti-CD28	)	anti-CD28	NN	B-NP	B-protein)	on	)	)	O	Oon	the	on	IN	B-PP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	in	NF-kappaB	NN	B-NP	B-proteinin	CD45RA+	in	IN	B-PP	OCD45RA+	(	CD45RA+	JJ	O	O(	naive	(	(	O	Onaive	)	naive	JJ	B-ADJP	O)	and	)	)	O	Oand	CD45RO+	and	CC	O	OCD45RO+	(	CD45RO+	JJ	B-NP	B-cell_type(	memory/effector	(	(	O	I-cell_typememory/effector	)	memory/effector	NN	B-NP	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Long	.	.	O	OLong	exposure	Long	JJ	B-NP	Oexposure	(	exposure	NN	I-NP	O(	24	(	(	O	O24	h	24	CD	B-NP	Oh	)	h	NN	I-NP	O)	induced	)	)	O	Oinduced	stronger	induce	VBD	B-VP	Ostronger	NF-kappaB	strong	JJR	B-NP	ONF-kappaB	DNA	NF-kappaB	NN	I-NP	B-proteinDNA	binding	DNA	NN	I-NP	Obinding	in	binding	NN	I-NP	Oin	CD45RA+	in	IN	B-PP	OCD45RA+	cells	CD45RA+	JJ	B-NP	B-cell_typecells	than	cell	NNS	I-NP	I-cell_typethan	in	than	IN	B-PP	Oin	CD45RO+	in	IN	B-PP	OCD45RO+	cells	CD45RO+	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Analysis	.	.	O	OAnalysis	of	Analysis	NN	B-NP	Oof	the	of	IN	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	c-Rel	nuclear	JJ	I-NP	B-proteinc-Rel	protein	c-Rel	NN	I-NP	I-proteinprotein	indicated	protein	NN	I-NP	I-proteinindicated	that	indicate	VBD	B-VP	Othat	after	that	IN	B-SBAR	Oafter	anti-CD3+anti-CD28	after	IN	B-SBAR	Oanti-CD3+anti-CD28	stimulation	anti-CD3+anti-CD28	JJ	B-NP	Ostimulation	the	stimulation	NN	I-NP	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	c-Rel	of	IN	B-PP	Oc-Rel	was	c-Rel	NN	B-NP	B-proteinwas	higher	be	VBD	B-VP	Ohigher	in	high	JJR	B-ADJP	Oin	CD45RA+	in	IN	B-PP	OCD45RA+	cells	CD45RA+	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Analysis	.	.	O	OAnalysis	of	Analysis	NN	B-NP	Oof	the	of	IN	B-PP	Othe	cytoplasmic	the	DT	B-NP	Ocytoplasmic	inhibitor	cytoplasmic	JJ	I-NP	B-proteininhibitor	IkappaBalpha	inhibitor	NN	I-NP	I-proteinIkappaBalpha	indicated	IkappaBalpha	NN	I-NP	B-proteinindicated	that	indicate	VBD	B-VP	Othat	anti-CD3+anti-CD28	that	IN	B-SBAR	Oanti-CD3+anti-CD28	stimulation	anti-CD3+anti-CD28	JJ	B-NP	Ostimulation	induced	stimulation	NN	I-NP	Oinduced	a	induce	VBD	B-VP	Oa	long-lasting	a	DT	B-NP	Olong-lasting	degradation	long-lasting	JJ	I-NP	Odegradation	in	degradation	NN	I-NP	Oin	CD45RA+	in	IN	B-PP	OCD45RA+	cells	CD45RA+	JJ	B-NP	B-cell_linecells	but	cell	NNS	I-NP	I-cell_linebut	in	but	CC	B-PP	Oin	CD45RO+	in	IN	B-PP	OCD45RO+	cells	CD45RO+	JJ	B-NP	B-cell_typecells	the	cell	NNS	I-NP	I-cell_typethe	degradation	the	DT	B-NP	Odegradation	process	degradation	NN	I-NP	Oprocess	was	process	NN	I-NP	Owas	more	be	VBD	B-VP	Omore	rapid	more	RBR	B-ADJP	Orapid	.	rapid	JJ	I-ADJP	O.	Because	.	.	O	OBecause	the	Because	IN	B-SBAR	Othe	CD28	the	DT	B-NP	OCD28	costimulus	CD28	NN	I-NP	B-proteincostimulus	is	costimulus	NN	I-NP	Ois	known	be	VBZ	B-VP	Oknown	to	know	VBN	I-VP	Oto	induce	to	TO	I-VP	Oinduce	the	induce	VB	I-VP	Othe	production	the	DT	B-NP	Oproduction	of	production	NN	I-NP	Oof	reactive	of	IN	B-PP	Oreactive	oxygen	reactive	JJ	B-NP	Ooxygen	intermediates	oxygen	NN	I-NP	Ointermediates	(	intermediate	NNS	I-NP	O(	ROIs	(	(	O	OROIs	)	ROI	NNS	B-NP	O)	","	)	)	O	O","	the	","	","	O	Othe	intracellular	the	DT	B-NP	Ointracellular	ROI	intracellular	JJ	I-NP	OROI	levels	ROI	NN	I-NP	Olevels	in	level	NNS	I-NP	Oin	CD45RA+	in	IN	B-PP	OCD45RA+	and	CD45RA+	JJ	B-NP	Oand	CD45RO+	and	CC	I-NP	OCD45RO+	cells	CD45RO+	JJ	I-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	compared	be	VBD	B-VP	Ocompared	by	compare	VBN	I-VP	Oby	flow	by	IN	B-PP	Oflow	cytometry	flow	NN	B-NP	Ocytometry	.	cytometry	NN	I-NP	O.	ROIs	.	.	O	OROIs	were	ROI	NNS	B-NP	Owere	produced	be	VBD	B-VP	Oproduced	in	produce	VBN	I-VP	Oin	both	in	IN	B-PP	Oboth	cell	both	DT	B-NP	Ocell	types	cell	NN	I-NP	Otypes	","	type	NNS	I-NP	O","	but	","	","	O	Obut	more	but	CC	O	Omore	strongly	more	RBR	B-ADVP	Ostrongly	in	strongly	RB	I-ADVP	Oin	CD45RA+	in	IN	B-PP	OCD45RA+	cells	CD45RA+	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	data	The	DT	B-NP	Odata	presented	datum	NNS	I-NP	Opresented	in	present	VBN	B-VP	Oin	this	in	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	further	study	NN	I-NP	Ofurther	emphasize	further	RB	B-ADVP	Oemphasize	the	emphasize	VBP	B-VP	Othe	differences	the	DT	B-NP	Odifferences	between	difference	NNS	I-NP	Obetween	CD45RA+	between	IN	B-PP	OCD45RA+	and	CD45RA+	JJ	B-NP	Oand	CD45RO+	and	CC	I-NP	OCD45RO+	T	CD45RO+	JJ	I-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	in	lymphocyte	NNS	I-NP	I-cell_typein	ROI-dependent	in	IN	B-PP	OROI-dependent	signaling	ROI-dependent	JJ	B-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	.	pathway	NNS	I-NP	O.	Non-Hodgkin	.	.	O	ONon-Hodgkin	's	Non-Hodgkin	JJ	B-NP	O's	lymphoma	's	POS	B-NP	Olymphoma	involving	lymphoma	NN	I-NP	Oinvolving	bilateral	involve	VBG	B-VP	Obilateral	breasts	bilateral	JJ	B-NP	Obreasts	[	breast	NNS	I-NP	O[	see	[	(	O	Osee	comments	see	VB	B-VP	Ocomments	]	comment	NNS	B-NP	O]	We	]	)	O	OWe	describe	We	PRP	B-NP	Odescribe	here	describe	VBP	B-VP	Ohere	two	here	RB	B-ADVP	Otwo	cases	two	CD	B-NP	Ocases	of	case	NNS	I-NP	Oof	diffuse	of	IN	B-PP	Odiffuse	large	diffuse	JJ	B-NP	Olarge	cell	large	JJ	I-NP	Ocell	type	cell	NN	I-NP	Otype	non-Hodgkin	type	NN	I-NP	Onon-Hodgkin	's	non-Hodgkin	JJ	B-NP	O's	lymphoma	's	POS	B-NP	Olymphoma	affecting	lymphoma	NN	I-NP	Oaffecting	the	affect	VBG	B-VP	Othe	bilateral	the	DT	B-NP	Obilateral	breasts	bilateral	JJ	I-NP	Obreasts	.	breast	NNS	I-NP	O.	The	.	.	O	OThe	contralateral	The	DT	B-NP	Ocontralateral	tumor	contralateral	JJ	I-NP	Otumor	in	tumor	NN	I-NP	Oin	one	in	IN	B-PP	Oone	case	one	CD	B-NP	Ocase	appeared	case	NN	I-NP	Oappeared	17	appear	VBD	B-VP	O17	months	17	CD	B-NP	Omonths	after	month	NNS	I-NP	Oafter	the	after	IN	B-PP	Othe	first	the	DT	B-NP	Ofirst	mastectomy	first	JJ	I-NP	Omastectomy	","	mastectomy	NN	I-NP	O","	whereas	","	","	O	Owhereas	the	whereas	IN	O	Othe	bilateral	the	DT	B-NP	Obilateral	tumors	bilateral	JJ	I-NP	Otumors	occurred	tumor	NNS	I-NP	Ooccurred	concurrently	occur	VBD	B-VP	Oconcurrently	in	concurrently	RB	B-ADVP	Oin	the	in	IN	B-PP	Othe	other	the	DT	B-NP	Oother	patient	other	JJ	I-NP	Opatient	who	patient	NN	I-NP	Owho	was	who	WP	B-NP	Owas	pregnant	be	VBD	B-VP	Opregnant	and	pregnant	JJ	B-ADJP	Oand	showed	and	CC	O	Oshowed	widespread	show	VBD	B-VP	Owidespread	dissemination	widespread	JJ	B-NP	Odissemination	at	dissemination	NN	I-NP	Oat	initial	at	IN	B-PP	Oinitial	presentation	initial	JJ	B-NP	Opresentation	.	presentation	NN	I-NP	O.	Lymphoma	.	.	O	OLymphoma	cells	Lymphoma	NN	B-NP	B-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	both	from	IN	B-PP	Oboth	cases	both	DT	B-NP	Ocases	showed	case	NNS	I-NP	Oshowed	the	show	VBD	B-VP	Othe	mature	the	DT	B-NP	Omature	B-cell	mature	JJ	I-NP	OB-cell	immunophenotype	B-cell	NN	I-NP	Oimmunophenotype	and	immunophenotype	NN	I-NP	Oand	had	and	CC	O	Ohad	rearrangements	have	VBD	B-VP	Orearrangements	of	rearrangement	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	BCL6	the	DT	B-NP	OBCL6	gene	BCL6	NN	I-NP	B-DNAgene	.	gene	NN	I-NP	I-DNA.	Both	.	.	O	OBoth	patients	Both	DT	B-NP	Opatients	developed	patient	NNS	I-NP	Odeveloped	progressive	develop	VBD	B-VP	Oprogressive	disease	progressive	JJ	B-NP	Odisease	despite	disease	NN	I-NP	Odespite	chemo-radiotherapy	despite	IN	B-PP	Ochemo-radiotherapy	and	chemo-radiotherapy	NN	B-NP	Oand	died	and	CC	O	Odied	of	die	VBD	B-VP	Oof	leukemic	of	IN	B-PP	Oleukemic	manifestations	leukemic	JJ	B-NP	Omanifestations	.	manifestation	NNS	I-NP	O.	There	.	.	O	OThere	were	There	EX	B-NP	Owere	no	be	VBD	B-VP	Ono	apparent	no	DT	B-NP	Oapparent	pathological	apparent	JJ	I-NP	Opathological	features	pathological	JJ	I-NP	Ofeatures	of	feature	NNS	I-NP	Oof	lymphomas	of	IN	B-PP	Olymphomas	of	lymphoma	NNS	B-NP	Oof	mucosa-associated	of	IN	B-PP	Omucosa-associated	lymphoid	mucosa-associated	JJ	B-NP	Olymphoid	tissue	lymphoid	JJ	I-NP	Otissue	origin	tissue	NN	I-NP	Oorigin	Biochemical	origin	NN	I-NP	OBiochemical	characterization	Biochemical	JJ	B-NP	Ocharacterization	of	characterization	NN	I-NP	Oof	MIP-1	of	IN	B-PP	OMIP-1	alpha	MIP-1	NN	B-NP	B-proteinalpha	nuclear	alpha	NN	I-NP	I-proteinnuclear	protein	nuclear	JJ	I-NP	I-proteinprotein	.	protein	NN	I-NP	I-protein.	A	.	.	O	OA	family	A	DT	B-NP	Ofamily	of	family	NN	I-NP	Oof	hematopoietic	of	IN	B-PP	Ohematopoietic	specific	hematopoietic	JJ	B-NP	B-proteinspecific	transcription	specific	JJ	I-NP	I-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	","	factor	NNS	I-NP	I-protein","	MIP-1	","	","	O	OMIP-1	alpha	MIP-1	NN	B-NP	B-proteinalpha	nuclear	alpha	NN	I-NP	I-proteinnuclear	protein	nuclear	JJ	I-NP	Oprotein	(	protein	NN	I-NP	O(	MNP	(	(	O	OMNP	)	MNP	NN	B-NP	B-protein)	family	)	)	O	Ofamily	","	family	NN	B-NP	O","	has	","	","	O	Ohas	recently	have	VBZ	B-VP	Orecently	been	recently	RB	I-VP	Obeen	identified	be	VBN	I-VP	Oidentified	.	identify	VBN	I-VP	O.	They	.	.	O	OThey	are	They	PRP	B-NP	Oare	intimately	be	VBP	B-VP	Ointimately	involved	intimately	RB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	regulating	in	IN	B-PP	Oregulating	the	regulate	VBG	B-VP	Othe	transcription	the	DT	B-NP	Otranscription	of	transcription	NN	I-NP	Oof	the	of	IN	B-PP	Othe	huMIP-1	the	DT	B-NP	OhuMIP-1	alpha	huMIP-1	NN	I-NP	B-DNAalpha	gene	alpha	NN	I-NP	I-DNAgene	in	gene	NN	I-NP	I-DNAin	monocytes	in	IN	B-PP	Omonocytes	","	monocyte	NNS	B-NP	B-cell_type","	T-cells	","	","	O	OT-cells	","	T-cell	NNS	B-NP	B-cell_type","	and	","	","	O	Oand	transformed	and	CC	O	Otransformed	B-cells	transform	VBN	B-NP	B-cell_lineB-cells	.	B-cell	NNS	I-NP	I-cell_line.	One	.	.	O	OOne	member	One	CD	B-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	family	the	DT	B-NP	Ofamily	(	family	NN	I-NP	O(	MNP-1	(	(	O	OMNP-1	)	MNP-1	NN	B-NP	B-protein)	is	)	)	O	Ois	essential	be	VBZ	B-VP	Oessential	for	essential	JJ	B-ADJP	Ofor	promoter	for	IN	B-PP	Opromoter	activity	promoter	NN	B-NP	Oactivity	in	activity	NN	I-NP	Oin	monocytes	in	IN	B-PP	Omonocytes	and	monocyte	NNS	B-NP	B-cell_typeand	B-cells	and	CC	I-NP	OB-cells	","	B-cell	NNS	I-NP	B-cell_type","	while	","	","	O	Owhile	another	while	IN	B-SBAR	Oanother	(	another	DT	B-NP	O(	MNP-2	(	(	O	OMNP-2	)	MNP-2	NN	B-NP	B-protein)	is	)	)	O	Ois	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	full	for	IN	B-PP	Ofull	promotor	full	JJ	B-NP	Opromotor	activity	promotor	NN	I-NP	Oactivity	in	activity	NN	I-NP	Oin	T-cells	in	IN	B-PP	OT-cells	.	T-cell	NNS	B-NP	B-cell_type.	A	.	.	O	OA	third	A	DT	B-NP	Othird	member	third	JJ	I-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	family	the	DT	B-NP	Ofamily	(	family	NN	I-NP	O(	MNP-3	(	(	O	OMNP-3	)	MNP-3	NN	B-NP	B-protein)	is	)	)	O	Ois	expressed	be	VBZ	B-VP	Oexpressed	in	express	VBN	I-VP	Oin	PMA	in	IN	B-PP	OPMA	induced	PMA	NN	B-NP	B-cell_lineinduced	HL60	induced	JJ	I-NP	I-cell_lineHL60	cells	HL60	NN	I-NP	I-cell_linecells	and	cell	NNS	I-NP	I-cell_lineand	probably	and	CC	O	Oprobably	has	probably	RB	B-VP	Ohas	a	have	VBZ	I-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	monocyte	in	IN	B-PP	Omonocyte	differentiation	monocyte	NN	B-NP	Odifferentiation	.	differentiation	NN	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	communication	this	DT	B-NP	Ocommunication	we	communication	NN	I-NP	Owe	demonstrate	we	PRP	B-NP	Odemonstrate	by	demonstrate	VBP	B-VP	Oby	two	by	IN	B-PP	Otwo	techniques	two	CD	B-NP	Otechniques	that	technique	NNS	I-NP	Othat	MNP-1	that	IN	B-NP	OMNP-1	and	MNP-1	NN	B-NP	B-proteinand	MNP-2	and	CC	I-NP	OMNP-2	are	MNP-2	NN	I-NP	B-proteinare	distinct	be	VBP	B-VP	Odistinct	but	distinct	JJ	B-NP	Obut	related	but	CC	I-NP	Orelated	factors	related	JJ	I-NP	Ofactors	","	factor	NNS	I-NP	O","	and	","	","	O	Oand	we	and	CC	O	Owe	present	we	PRP	B-NP	Opresent	further	present	VBP	B-VP	Ofurther	evidence	further	JJ	B-NP	Oevidence	to	evidence	NN	I-NP	Oto	show	to	TO	B-VP	Oshow	that	show	VB	I-VP	Othat	MNP-1	that	IN	B-SBAR	OMNP-1	acts	MNP-1	NN	B-NP	B-proteinacts	as	act	VBZ	B-VP	Oas	a	as	IN	B-PP	Oa	heterodimer	a	DT	B-NP	Oheterodimer	.	heterodimer	NN	I-NP	B-protein.	Bcl-3	.	.	O	OBcl-3	expression	Bcl-3	NN	B-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	nuclear	and	CC	O	Onuclear	translocation	nuclear	JJ	B-NP	Otranslocation	are	translocation	NN	I-NP	Oare	induced	be	VBP	B-VP	Oinduced	by	induce	VBN	I-VP	Oby	granulocyte-macrophage	by	IN	B-PP	Ogranulocyte-macrophage	colony-stimulating	granulocyte-macrophage	JJ	B-NP	B-proteincolony-stimulating	factor	colony-stimulating	JJ	I-NP	I-proteinfactor	and	factor	NN	I-NP	I-proteinand	erythropoietin	and	CC	I-NP	Oerythropoietin	in	erythropoietin	NN	I-NP	B-proteinin	proliferating	in	IN	B-PP	Oproliferating	human	proliferate	VBG	B-VP	B-cell_typehuman	erythroid	human	JJ	B-NP	I-cell_typeerythroid	precursors	erythroid	JJ	I-NP	I-cell_typeprecursors	.	precursor	NNS	I-NP	I-cell_type.	Bcl-3	.	.	O	OBcl-3	is	Bcl-3	NN	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	proto-oncogene	a	DT	B-NP	Oproto-oncogene	involved	proto-oncogene	NN	I-NP	B-DNAinvolved	in	involve	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	chromosomal	the	DT	B-NP	Ochromosomal	translocation	chromosomal	JJ	I-NP	Otranslocation	t	translocation	NN	I-NP	Ot	(	t	NN	I-NP	O(	14	(	(	O	O14	;	14	CD	B-NP	O;	19	;	:	O	O19	)	19	CD	B-NP	O)	found	)	)	O	Ofound	in	find	VBN	B-VP	Oin	some	in	IN	B-PP	Osome	patients	some	DT	B-NP	Opatients	with	patient	NNS	I-NP	Owith	chronic	with	IN	B-PP	Ochronic	lymphocytic	chronic	JJ	B-NP	Olymphocytic	leukemia	lymphocytic	JJ	I-NP	Oleukemia	.	leukemia	NN	I-NP	O.	It	.	.	O	OIt	shares	It	PRP	B-NP	Oshares	structural	share	VBZ	B-VP	Ostructural	similarities	structural	JJ	B-NP	Osimilarities	with	similarity	NNS	I-NP	Owith	and	with	IN	B-PP	Oand	is	and	CC	O	Ois	a	be	VBZ	B-VP	Oa	member	a	DT	B-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	IkappaB	the	DT	B-NP	OIkappaB	family	IkappaB	NN	I-NP	B-proteinfamily	of	family	NN	I-NP	I-proteinof	proteins	of	IN	B-PP	Oproteins	.	protein	NNS	B-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	report	this	DT	B-NP	Oreport	","	report	NN	I-NP	O","	involvement	","	","	O	Oinvolvement	of	involvement	NN	B-NP	Oof	Bcl-3	of	IN	B-PP	OBcl-3	in	Bcl-3	NN	B-NP	B-proteinin	hematopoietic	in	IN	B-PP	Ohematopoietic	growth	hematopoietic	JJ	B-NP	Ogrowth	factor-stimulated	growth	NN	I-NP	Ofactor-stimulated	erythroid	factor-stimulated	JJ	I-NP	Oerythroid	proliferation	erythroid	JJ	I-NP	Oproliferation	and	proliferation	NN	I-NP	Oand	differentiation	and	CC	O	Odifferentiation	was	differentiation	NN	B-NP	Owas	examined	be	VBD	B-VP	Oexamined	.	examine	VBN	I-VP	O.	In	.	.	O	OIn	TF-1	In	IN	B-PP	OTF-1	cells	TF-1	NN	B-NP	B-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	an	","	","	O	Oan	erythroleukemia	an	DT	B-NP	Oerythroleukemia	cell	erythroleukemia	NN	I-NP	B-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	","	line	NN	I-NP	I-cell_line","	granulocyte-macrophage	","	","	O	Ogranulocyte-macrophage	colony-stimulating	granulocyte-macrophage	JJ	B-NP	B-proteincolony-stimulating	factor	colony-stimulating	JJ	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	GM-CSF	(	(	O	OGM-CSF	)	GM-CSF	NN	B-NP	B-protein)	and	)	)	O	Oand	erythropoietin	and	CC	O	Oerythropoietin	(	erythropoietin	NN	B-NP	B-protein(	Epo	(	(	O	OEpo	)	Epo	NN	B-NP	B-protein)	greatly	)	)	O	Ogreatly	enhanced	greatly	RB	B-VP	Oenhanced	Bcl-3	enhance	VBD	I-VP	OBcl-3	expression	Bcl-3	NN	B-NP	B-proteinexpression	at	expression	NN	I-NP	Oat	both	at	IN	B-PP	Oboth	the	both	CC	O	Othe	protein	the	DT	B-NP	Oprotein	and	protein	NN	I-NP	Oand	mRNA	and	CC	I-NP	OmRNA	levels	mRNA	NN	I-NP	Olevels	in	level	NNS	I-NP	Oin	association	in	IN	B-PP	Oassociation	with	association	NN	B-NP	Owith	stimulation	with	IN	B-PP	Ostimulation	of	stimulation	NN	B-NP	Oof	proliferation	of	IN	B-PP	Oproliferation	.	proliferation	NN	B-NP	O.	Bcl-3	.	.	O	OBcl-3	protein	Bcl-3	NN	B-NP	B-proteinprotein	was	protein	NN	I-NP	I-proteinwas	also	be	VBD	B-VP	Oalso	highly	also	RB	B-ADVP	Ohighly	expressed	highly	RB	B-VP	Oexpressed	in	express	VBN	I-VP	Oin	early	in	IN	B-PP	Oearly	burst-forming	early	JJ	B-NP	B-cell_lineburst-forming	unit-erythroid	burst-forming	JJ	I-NP	I-cell_lineunit-erythroid	(	unit-erythroid	JJ	I-NP	I-cell_line(	BFU-E	(	(	O	I-cell_lineBFU-E	)	BFU-E	NN	B-NP	I-cell_line)	#NAME?	)	)	O	I-cell_line#NAME?	erythroid	#NAME?	JJ	B-NP	I-cell_lineerythroid	precursors	erythroid	JJ	I-NP	I-cell_lineprecursors	(	precursor	NNS	I-NP	I-cell_line(	day	(	(	O	Oday	7	day	NN	B-NP	O7	)	7	CD	I-NP	O)	and	)	)	O	Oand	decreased	and	CC	O	Odecreased	during	decrease	VBN	B-VP	Oduring	maturation	during	IN	B-PP	Omaturation	(	maturation	NN	B-NP	O(	days	(	(	O	Odays	10	day	NNS	B-NP	O10	and	10	CD	B-NP	Oand	14	and	CC	I-NP	O14	)	14	CD	I-NP	O)	","	)	)	O	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	Bcl-3	that	IN	B-SBAR	OBcl-3	is	Bcl-3	NN	B-NP	B-proteinis	involved	be	VBZ	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	normal	in	IN	B-PP	Onormal	erythroid	normal	JJ	B-NP	Oerythroid	proliferation	erythroid	JJ	I-NP	Oproliferation	.	proliferation	NN	I-NP	O.	In	.	.	O	OIn	these	In	IN	B-PP	Othese	hematopoietic	these	DT	B-NP	Ohematopoietic	cells	hematopoietic	JJ	I-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	Bcl-3	","	","	O	OBcl-3	was	Bcl-3	NN	B-NP	B-proteinwas	hyperphosphorylated	be	VBD	B-VP	Ohyperphosphorylated	.	hyperphosphorylate	VBN	I-VP	O.	GM-CSF	.	.	O	OGM-CSF	and	GM-CSF	NN	B-NP	B-proteinand	Epo	and	CC	I-NP	OEpo	modulated	Epo	NN	I-NP	B-proteinmodulated	the	modulate	VBD	B-VP	Othe	subcellular	the	DT	B-NP	Osubcellular	localization	subcellular	JJ	I-NP	Olocalization	of	localization	NN	I-NP	Oof	Bcl-3	of	IN	B-PP	OBcl-3	.	Bcl-3	NN	B-NP	B-protein.	Upon	.	.	O	OUpon	stimulation	Upon	IN	B-PP	Ostimulation	of	stimulation	NN	B-NP	Oof	TF-1	of	IN	B-PP	OTF-1	cells	TF-1	NN	B-NP	B-cell_linecells	with	cell	NNS	I-NP	I-cell_linewith	GM-CSF	with	IN	B-PP	OGM-CSF	or	GM-CSF	NN	B-NP	B-proteinor	Epo	or	CC	I-NP	OEpo	","	Epo	NN	I-NP	B-protein","	the	","	","	O	Othe	nuclear	the	DT	B-NP	Onuclear	translocation	nuclear	JJ	I-NP	Otranslocation	of	translocation	NN	I-NP	Oof	Bcl-3	of	IN	B-PP	OBcl-3	was	Bcl-3	NN	B-NP	B-proteinwas	dramatically	be	VBD	B-VP	Odramatically	enhanced	dramatically	RB	I-VP	Oenhanced	.	enhance	VBN	I-VP	O.	Overexpression	.	.	O	OOverexpression	of	Overexpression	NN	B-NP	Oof	Bcl-3	of	IN	B-PP	OBcl-3	in	Bcl-3	NN	B-NP	B-proteinin	TF-1	in	IN	B-PP	OTF-1	cells	TF-1	NN	B-NP	B-cell_linecells	by	cell	NNS	I-NP	I-cell_lineby	transient	by	IN	B-PP	Otransient	transfection	transient	JJ	B-NP	Otransfection	along	transfection	NN	I-NP	Oalong	with	along	IN	B-PP	Owith	the	with	IN	B-PP	Othe	NF-kappaB	the	DT	B-NP	ONF-kappaB	factors	NF-kappaB	NN	I-NP	B-proteinfactors	p50	factor	NNS	I-NP	I-proteinp50	or	p50	NN	B-NP	B-proteinor	p52	or	CC	O	Op52	resulted	p52	NN	B-NP	B-proteinresulted	in	result	VBD	B-VP	Oin	significant	in	IN	B-PP	Osignificant	induction	significant	JJ	B-NP	Oinduction	of	induction	NN	I-NP	Oof	an	of	IN	B-PP	Oan	human	an	DT	B-NP	Ohuman	immunodeficiency	human	JJ	I-NP	B-DNAimmunodeficiency	virus-type	immunodeficiency	NN	I-NP	I-DNAvirus-type	1	virus-type	NN	I-NP	I-DNA1	(	1	CD	I-NP	I-DNA(	HIV-1	(	(	O	I-DNAHIV-1	)	HIV-1	NN	B-NP	I-DNA)	kappaB-TATA-luceriferase	)	)	O	I-DNAkappaB-TATA-luceriferase	reporter	kappaB-TATA-luceriferase	NN	B-NP	I-DNAreporter	plasmid	reporter	NN	I-NP	I-DNAplasmid	","	plasmid	NN	I-NP	I-DNA","	demonstrating	","	","	O	Odemonstrating	that	demonstrate	VBG	B-VP	Othat	Bcl-3	that	IN	B-SBAR	OBcl-3	has	Bcl-3	NN	B-NP	B-proteinhas	a	have	VBZ	B-VP	Oa	positive	a	DT	B-NP	Opositive	role	positive	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	transactivation	in	IN	B-PP	Otransactivation	of	transactivation	NN	B-NP	Oof	kappaB-containing	of	IN	B-PP	OkappaB-containing	genes	kappaB-containing	JJ	B-NP	B-DNAgenes	in	gene	NNS	I-NP	I-DNAin	erythroid	in	IN	B-PP	Oerythroid	cells	erythroid	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Stimulation	.	.	O	OStimulation	with	Stimulation	NN	B-NP	Owith	GM-CSF	with	IN	B-PP	OGM-CSF	enhanced	GM-CSF	NN	B-NP	B-proteinenhanced	c-myb	enhance	VBD	B-VP	Oc-myb	mRNA	c-myb	NN	B-NP	B-RNAmRNA	expression	mRNA	NN	I-NP	I-RNAexpression	in	expression	NN	I-NP	Oin	these	in	IN	B-PP	Othese	cells	these	DT	B-NP	Ocells	.	cell	NNS	I-NP	O.	Bcl-3	.	.	O	OBcl-3	in	Bcl-3	NN	B-NP	B-proteinin	nuclear	in	IN	B-PP	Onuclear	extracts	nuclear	JJ	B-NP	Oextracts	of	extract	NNS	I-NP	Oof	TF-1	of	IN	B-PP	OTF-1	cells	TF-1	NN	B-NP	B-cell_linecells	bound	cell	NNS	I-NP	I-cell_linebound	to	bind	VBD	B-VP	Oto	a	to	TO	B-PP	Oa	kappaB	a	DT	B-NP	OkappaB	enhancer	kappaB	NN	I-NP	B-DNAenhancer	in	enhancer	NN	I-NP	I-DNAin	the	in	IN	B-PP	Othe	c-myb	the	DT	B-NP	Oc-myb	promoter	c-myb	NN	I-NP	B-DNApromoter	together	promoter	NN	I-NP	I-DNAtogether	with	together	RB	B-ADVP	Owith	NF-kappaB2/p52	with	IN	B-PP	ONF-kappaB2/p52	and	NF-kappaB2/p52	NN	B-NP	B-proteinand	this	and	CC	O	Othis	binding	this	DT	B-NP	Obinding	activity	binding	NN	I-NP	Oactivity	was	activity	NN	I-NP	Owas	enhanced	be	VBD	B-VP	Oenhanced	by	enhance	VBN	I-VP	Oby	GM-CSF	by	IN	B-PP	OGM-CSF	stimulation	GM-CSF	NN	B-NP	B-proteinstimulation	.	stimulation	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	cotransfection	","	","	O	Ocotransfection	of	cotransfection	NN	B-NP	Oof	Bcl-3	of	IN	B-PP	OBcl-3	with	Bcl-3	NN	B-NP	B-proteinwith	p52	with	IN	B-PP	Op52	or	p52	NN	B-NP	B-proteinor	p50	or	CC	I-NP	Op50	in	p50	NN	I-NP	B-proteinin	TF-1	in	IN	B-PP	OTF-1	cells	TF-1	NN	B-NP	B-cell_linecells	resulted	cell	NNS	I-NP	I-cell_lineresulted	in	result	VBD	B-VP	Oin	significant	in	IN	B-PP	Osignificant	activation	significant	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	a	of	IN	B-PP	Oa	c-myb	a	DT	B-NP	Oc-myb	kappaB-TATA-luceriferase	c-myb	NN	I-NP	B-DNAkappaB-TATA-luceriferase	reporter	kappaB-TATA-luceriferase	NN	I-NP	I-DNAreporter	plasmid	reporter	NN	I-NP	I-DNAplasmid	.	plasmid	NN	I-NP	I-DNA.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	suggest	finding	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	Bcl-3	that	IN	B-SBAR	OBcl-3	may	Bcl-3	NN	B-NP	B-proteinmay	participate	may	MD	B-VP	Oparticipate	in	participate	VB	I-VP	Oin	the	in	IN	B-PP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	regulation	transcriptional	JJ	I-NP	Oregulation	of	regulation	NN	I-NP	Oof	certain	of	IN	B-PP	Ocertain	kappaB-containing	certain	JJ	B-NP	OkappaB-containing	genes	kappaB-containing	JJ	I-NP	B-DNAgenes	involved	gene	NNS	I-NP	I-DNAinvolved	in	involve	VBN	B-VP	Oin	hematopoiesis	in	IN	B-PP	Ohematopoiesis	","	hematopoiesis	NN	B-NP	O","	including	","	","	O	Oincluding	c-myb	include	VBG	B-PP	Oc-myb	.	c-myb	NN	B-NP	B-DNA.	Copyright	.	.	O	OCopyright	1998	Copyright	NN	B-NP	O1998	by	1998	CD	I-NP	Oby	The	by	IN	B-PP	OThe	American	The	NNP	B-NP	OAmerican	Society	American	NNP	I-NP	OSociety	of	Society	NNP	I-NP	Oof	Hematology	of	IN	B-PP	OHematology	.	Hematology	NNP	B-NP	O.	5-Lipoxygenase	.	.	O	O5-Lipoxygenase	compartmentalization	5-Lipoxygenase	NN	B-NP	B-proteincompartmentalization	in	compartmentalization	NN	I-NP	Oin	granulocytic	in	IN	B-PP	Ogranulocytic	cells	granulocytic	JJ	B-NP	B-cell_typecells	is	cell	NNS	I-NP	I-cell_typeis	modulated	be	VBZ	B-VP	Omodulated	by	modulate	VBN	I-VP	Oby	an	by	IN	B-PP	Oan	internal	an	DT	B-NP	Ointernal	bipartite	internal	JJ	I-NP	B-DNAbipartite	nuclear	bipartite	JJ	I-NP	I-DNAnuclear	localizing	nuclear	JJ	I-NP	I-DNAlocalizing	sequence	localize	VBG	I-NP	I-DNAsequence	and	sequence	NN	I-NP	I-DNAand	nuclear	and	CC	O	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	kappa	factor	NN	I-NP	I-proteinkappa	B	kappa	NN	I-NP	I-proteinB	complex	B	NN	I-NP	I-proteincomplex	formation	complex	NN	I-NP	I-proteinformation	.	formation	NN	I-NP	O.	A	.	.	O	OA	region	A	DT	B-NP	Oregion	of	region	NN	I-NP	Oof	basic	of	IN	B-PP	Obasic	amino	basic	JJ	B-NP	B-proteinamino	acids	amino	NN	I-NP	I-proteinacids	spanning	acid	NNS	I-NP	I-proteinspanning	residues	span	VBG	B-VP	I-proteinresidues	639-656	residue	NNS	B-NP	I-protein639-656	in	639-656	CD	B-NP	I-proteinin	the	in	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	5-lipoxygenase	human	JJ	I-NP	B-DNA5-lipoxygenase	sequence	5-lipoxygenase	NN	I-NP	I-DNAsequence	resembles	sequence	NN	I-NP	I-DNAresembles	a	resemble	VBZ	B-VP	Oa	consensus	a	DT	B-NP	Oconsensus	bipartite	consensus	NN	I-NP	B-DNAbipartite	nuclear	bipartite	JJ	I-NP	I-DNAnuclear	localizing	nuclear	JJ	I-NP	I-DNAlocalizing	sequence	localize	VBG	I-NP	I-DNAsequence	.	sequence	NN	I-NP	I-DNA.	A	.	.	O	OA	synthetic	A	DT	B-NP	Osynthetic	peptide	synthetic	JJ	I-NP	Opeptide	consisting	peptide	NN	I-NP	Oconsisting	of	consist	VBG	B-VP	Oof	the	of	IN	B-PP	Othe	Kaposi	the	DT	B-NP	OKaposi	fibroblast	Kaposi	NNP	I-NP	B-DNAfibroblast	growth	fibroblast	NN	I-NP	I-DNAgrowth	factor	growth	NN	I-NP	I-DNAfactor	signal	factor	NN	I-NP	I-DNAsignal	sequence	signal	NN	I-NP	I-DNAsequence	fused	sequence	NN	I-NP	I-DNAfused	to	fuse	VBN	B-VP	Oto	the	to	TO	B-PP	Othe	5-lipoxygenase639-656	the	DT	B-NP	O5-lipoxygenase639-656	bipartite	5-lipoxygenase639-656	CD	I-NP	B-DNAbipartite	nuclear	bipartite	JJ	I-NP	I-DNAnuclear	localizing	nuclear	JJ	I-NP	I-DNAlocalizing	sequence	localizing	JJ	I-NP	I-DNAsequence	has	sequence	NN	I-NP	I-DNAhas	a	have	VBZ	B-VP	Oa	prominent	a	DT	B-NP	Oprominent	inhibitory	prominent	JJ	I-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	on	effect	NN	I-NP	Oon	5-lipoxygenase	on	IN	B-PP	O5-lipoxygenase	catalysis	5-lipoxygenase	NN	B-NP	B-proteincatalysis	in	catalysis	NN	I-NP	Oin	granulocytic	in	IN	B-PP	Ogranulocytic	HL-60	granulocytic	JJ	B-NP	B-cell_lineHL-60	cells	HL-60	NN	I-NP	I-cell_linecells	activated	cell	NNS	I-NP	I-cell_lineactivated	by	activate	VBN	B-VP	Oby	calcium	by	IN	B-PP	Ocalcium	ionophor	calcium	NN	B-NP	Oionophor	A23187	ionophor	NN	I-NP	OA23187	.	A23187	NN	I-NP	O.	Recombinant	.	.	O	ORecombinant	5-lipoxygenase	Recombinant	JJ	B-NP	B-protein5-lipoxygenase	was	5-lipoxygenase	NN	I-NP	I-proteinwas	not	be	VBD	B-VP	Onot	affected	not	RB	I-VP	Oaffected	by	affect	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	peptide	the	DT	B-NP	Opeptide	.	peptide	NN	I-NP	O.	The	.	.	O	OThe	peptide	The	DT	B-NP	Opeptide	also	peptide	NN	I-NP	Oalso	inhibited	also	RB	B-ADVP	Oinhibited	redistribution	inhibit	VBD	B-VP	Oredistribution	of	redistribution	NN	B-NP	Oof	5-lipoxygenase	of	IN	B-PP	O5-lipoxygenase	from	5-lipoxygenase	NN	B-NP	B-proteinfrom	the	from	IN	B-PP	Othe	cytosol	the	DT	B-NP	Ocytosol	to	cytosol	NN	I-NP	Oto	the	to	TO	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	membrane	nuclear	JJ	I-NP	Omembrane	of	membrane	NN	I-NP	Oof	HL-60	of	IN	B-PP	OHL-60	cells	HL-60	NN	B-NP	B-cell_linecells	stimulated	cell	NNS	I-NP	I-cell_linestimulated	by	stimulate	VBN	B-VP	Oby	A23187	by	IN	B-PP	OA23187	.	A23187	NN	B-NP	O.	5-Lipoxygenase	.	.	O	O5-Lipoxygenase	protein	5-Lipoxygenase	NN	B-NP	B-proteinprotein	was	protein	NN	I-NP	I-proteinwas	detected	be	VBD	B-VP	Odetected	in	detect	VBN	I-VP	Oin	nuclear	in	IN	B-PP	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	kappaB	factor	NN	I-NP	I-proteinkappaB	(	kappaB	NN	I-NP	I-protein(	NF-kappaB	(	(	O	ONF-kappaB	)	NF-kappaB	NN	B-NP	B-protein)	p65	)	)	O	Op65	subunit	p65	NN	B-NP	Osubunit	immunoprecipitate	subunit	NN	I-NP	Oimmunoprecipitate	fractions	immunoprecipitate	NN	I-NP	Ofractions	prepared	fraction	NNS	I-NP	Oprepared	from	prepare	VBN	B-VP	Ofrom	HL-60	from	IN	B-PP	OHL-60	cell	HL-60	NN	B-NP	Ocell	lysates	cell	NN	I-NP	Olysates	.	lysate	NNS	I-NP	O.	The	.	.	O	OThe	amount	The	DT	B-NP	Oamount	of	amount	NN	I-NP	Oof	5-lipoxygenase	of	IN	B-PP	O5-lipoxygenase	protein	5-lipoxygenase	NN	B-NP	B-proteinprotein	coimmunoprecipitated	protein	NN	I-NP	I-proteincoimmunoprecipitated	by	coimmunoprecipitate	VBN	B-VP	Oby	NF-kappaB	by	IN	B-PP	ONF-kappaB	antiserum	NF-kappaB	NN	B-NP	B-proteinantiserum	was	antiserum	NN	I-NP	Owas	increased	be	VBD	B-VP	Oincreased	following	increase	VBN	I-VP	Ofollowing	A23187	follow	VBG	B-PP	OA23187	stimulation	A23187	NN	B-NP	Ostimulation	.	stimulation	NN	I-NP	O.	In	.	.	O	OIn	cells	In	IN	B-PP	Ocells	treated	cell	NNS	B-NP	Otreated	with	treat	VBN	B-VP	Owith	agents	with	IN	B-PP	Oagents	that	agent	NNS	B-NP	Othat	block	that	WDT	B-NP	Oblock	5-lipoxygenase	block	VBP	B-VP	O5-lipoxygenase	translocation	5-lipoxygenase	NN	B-NP	B-proteintranslocation	to	translocation	NN	I-NP	Oto	the	to	TO	B-PP	Othe	nucleus	the	DT	B-NP	Onucleus	","	nucleus	NN	I-NP	O","	5-lipoxygenase	","	","	O	O5-lipoxygenase	protein	5-lipoxygenase	NN	B-NP	B-proteinprotein	appearing	protein	NN	I-NP	I-proteinappearing	in	appear	VBG	B-VP	Oin	the	in	IN	B-PP	Othe	NF-kappaB	the	DT	B-NP	ONF-kappaB	immunoprecipitate	NF-kappaB	NN	I-NP	B-proteinimmunoprecipitate	was	immunoprecipitate	NN	I-NP	Owas	diminished	be	VBD	B-VP	Odiminished	.	diminish	VBN	I-VP	O.	Our	.	.	O	OOur	results	Our	PRP$	B-NP	Oresults	implicate	result	NNS	I-NP	Oimplicate	an	implicate	VBP	B-VP	Oan	internal	an	DT	B-NP	Ointernal	bipartite	internal	JJ	I-NP	B-DNAbipartite	nuclear	bipartite	JJ	I-NP	I-DNAnuclear	localizing	nuclear	JJ	I-NP	I-DNAlocalizing	sequence	localize	VBG	I-NP	I-DNAsequence	as	sequence	NN	I-NP	I-DNAas	a	as	IN	B-PP	Oa	regulatory	a	DT	B-NP	Oregulatory	domain	regulatory	JJ	I-NP	B-proteindomain	that	domain	NN	I-NP	I-proteinthat	modulates	that	WDT	B-NP	Omodulates	5-lipoxygenase	modulate	VBZ	B-VP	O5-lipoxygenase	redistribution	5-lipoxygenase	NN	B-NP	B-proteinredistribution	and	redistribution	NN	I-NP	Oand	catalysis	and	CC	I-NP	Ocatalysis	in	catalysis	NN	I-NP	Oin	granulocytic	in	IN	B-PP	Ogranulocytic	cells	granulocytic	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Additionally	.	.	O	OAdditionally	","	Additionally	RB	B-ADVP	O","	our	","	","	O	Oour	results	our	PRP$	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	molecular	that	IN	B-SBAR	Omolecular	determinants	molecular	JJ	B-NP	Odeterminants	which	determinant	NNS	I-NP	Owhich	govern	which	WDT	B-NP	Ogovern	5-lipoxygenase	govern	VBP	B-VP	O5-lipoxygenase	and	5-lipoxygenase	NN	B-NP	B-proteinand	NF-kappaB	and	CC	I-NP	ONF-kappaB	redistribution	NF-kappaB	NN	I-NP	B-proteinredistribution	to	redistribution	NN	I-NP	Oto	the	to	TO	B-PP	Othe	nucleus	the	DT	B-NP	Onucleus	may	nucleus	NN	I-NP	Omay	be	may	MD	B-VP	Obe	coordinately	be	VB	I-VP	Ocoordinately	controlled	coordinately	RB	I-VP	Ocontrolled	in	control	VBN	I-VP	Oin	granulocytic	in	IN	B-PP	Ogranulocytic	cells	granulocytic	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Copyright	.	.	O	OCopyright	1998	Copyright	NN	B-NP	O1998	Academic	1998	CD	I-NP	OAcademic	Press	Academic	NNP	I-NP	OPress	.	Press	NNP	I-NP	O.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	CD28/CD3-mediated	of	IN	B-PP	OCD28/CD3-mediated	costimulation	CD28/CD3-mediated	JJ	B-NP	Ocostimulation	of	costimulation	NN	I-NP	Oof	naive	of	IN	B-PP	Onaive	and	naive	JJ	B-NP	B-cell_typeand	memory	and	CC	I-NP	I-cell_typememory	human	memory	NN	I-NP	I-cell_typehuman	T	human	JJ	I-NP	I-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	by	lymphocyte	NNS	I-NP	I-cell_typeby	intracellular	by	IN	B-PP	Ointracellular	incorporation	intracellular	JJ	B-NP	Oincorporation	of	incorporation	NN	I-NP	Oof	polyclonal	of	IN	B-PP	Opolyclonal	antibodies	polyclonal	JJ	B-NP	B-proteinantibodies	specific	antibody	NNS	I-NP	I-proteinspecific	for	specific	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	activator	the	DT	B-NP	Oactivator	protein-1	activator	NN	I-NP	B-proteinprotein-1	transcriptional	protein-1	NN	I-NP	I-proteintranscriptional	complex	transcriptional	JJ	I-NP	I-proteincomplex	.	complex	NN	I-NP	I-protein.	A	.	.	O	OA	number	A	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	indirect	of	IN	B-PP	Oindirect	methods	indirect	JJ	B-NP	Omethods	have	method	NNS	I-NP	Ohave	been	have	VBP	B-VP	Obeen	utilized	be	VBN	I-VP	Outilized	in	utilize	VBN	I-VP	Oin	demonstrating	in	IN	B-PP	Odemonstrating	activator	demonstrate	VBG	B-VP	Oactivator	protein-1	activator	NN	B-NP	B-proteinprotein-1	transcription	protein-1	NN	I-NP	I-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	function	factor	NN	I-NP	I-proteinfunction	in	function	NN	I-NP	Oin	IL-2	in	IN	B-PP	OIL-2	promoter	IL-2	NN	B-NP	B-DNApromoter	activity	promoter	NN	I-NP	I-DNAactivity	.	activity	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	there	","	","	O	Othere	has	there	EX	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	no	be	VBN	I-VP	Ono	direct	no	DT	B-NP	Odirect	demonstration	direct	JJ	I-NP	Odemonstration	that	demonstration	NN	I-NP	Othat	activator	that	IN	B-NP	Oactivator	protein-1	activator	NN	B-NP	B-proteinprotein-1	is	protein-1	NN	I-NP	I-proteinis	involved	be	VBZ	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	CD28-dependent	in	IN	B-PP	OCD28-dependent	costimulation	CD28-dependent	JJ	B-NP	Ocostimulation	of	costimulation	NN	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	gene	IL-2	NN	B-NP	B-DNAgene	transcription	gene	NN	I-NP	I-DNAtranscription	in	transcription	NN	I-NP	Oin	freshly	in	IN	B-PP	Ofreshly	isolated	freshly	RB	B-NP	Oisolated	naive	isolate	VBN	I-NP	Onaive	and	naive	JJ	I-NP	Oand	memory	and	CC	I-NP	Omemory	human	memory	NN	I-NP	B-cell_typehuman	T	human	JJ	I-NP	I-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	To	.	.	O	OTo	address	To	TO	B-VP	Oaddress	this	address	VB	I-VP	Othis	issue	this	DT	B-NP	Oissue	","	issue	NN	I-NP	O","	the	","	","	O	Othe	method	the	DT	B-NP	Omethod	of	method	NN	I-NP	Oof	scrape	of	IN	B-PP	Oscrape	loading	scrape	NN	B-NP	Oloading	was	loading	NN	I-NP	Owas	applied	be	VBD	B-VP	Oapplied	to	apply	VBN	I-VP	Oto	purified	to	TO	B-PP	Opurified	peripheral	purify	VBN	B-NP	B-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	T	blood	NN	I-NP	I-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Since	.	.	O	OSince	scrape	Since	IN	B-SBAR	Oscrape	loading	scrape	NN	B-NP	Oloading	relies	loading	NN	I-NP	Orelies	on	rely	VBZ	B-VP	Oon	adherent	on	IN	B-PP	Oadherent	cells	adherent	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	peripheral	","	","	O	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	human	blood	NN	I-NP	I-cell_typehuman	T	human	JJ	I-NP	I-cell_typeT	(	T	NN	I-NP	I-cell_type(	PB-T	(	(	I-NP	I-cell_typePB-T	)	PB-T	NN	I-NP	I-cell_type)	cells	)	)	I-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	immobilized	be	VBD	B-VP	Oimmobilized	on	immobilize	VBN	I-VP	Oon	the	on	IN	B-PP	Othe	nonspecific	the	DT	B-NP	Ononspecific	cell	nonspecific	JJ	I-NP	Ocell	attachment	cell	NN	I-NP	Oattachment	factor	attachment	NN	I-NP	Ofactor	poly-L-lysine	factor	NN	I-NP	Opoly-L-lysine	.	poly-L-lysine	NN	I-NP	O.	Cells	.	.	O	OCells	scraped	Cell	NNS	B-NP	Oscraped	off	scrap	VBD	B-VP	Ooff	poly-L-lysine	off	RP	B-PRT	Opoly-L-lysine	in	poly-L-lysine	NN	B-NP	Oin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	Ig	of	IN	B-PP	OIg	FITC	Ig	NN	B-NP	B-proteinFITC	efficiently	FITC	NN	I-NP	I-proteinefficiently	incorporated	efficiently	RB	B-ADVP	Oincorporated	Ig	incorporate	VBD	B-VP	OIg	","	Ig	NN	B-NP	B-protein","	with	","	","	O	Owith	relatively	with	IN	B-PP	Orelatively	uniform	relatively	RB	B-NP	Ouniform	fluorescence	uniform	JJ	I-NP	Ofluorescence	.	fluorescence	NN	I-NP	O.	T	.	.	O	OT	cells	T	NN	B-NP	B-cell_typecells	retained	cell	NNS	I-NP	I-cell_typeretained	their	retain	VBD	B-VP	Otheir	physical	their	PRP$	B-NP	Ophysical	parameters	physical	JJ	I-NP	Oparameters	as	parameter	NNS	I-NP	Oas	measured	as	IN	B-SBAR	Omeasured	by	measure	VBN	B-VP	Oby	forward	by	IN	B-PP	Oforward	and	forward	JJ	B-NP	Oand	side	and	CC	I-NP	Oside	light	side	NN	I-NP	Olight	scatter	light	NN	I-NP	Oscatter	","	scatter	NN	I-NP	O","	and	","	","	O	Oand	functional	and	CC	O	Ofunctional	activity	functional	JJ	B-NP	Oactivity	as	activity	NN	I-NP	Oas	measured	as	IN	B-SBAR	Omeasured	by	measure	VBN	B-VP	Oby	costimulation	by	IN	B-PP	Ocostimulation	of	costimulation	NN	B-NP	Oof	proliferation	of	IN	B-PP	Oproliferation	and	proliferation	NN	B-NP	Oand	IL-2	and	CC	O	OIL-2	production	IL-2	NN	B-NP	B-proteinproduction	after	production	NN	I-NP	Oafter	being	after	IN	B-PP	Obeing	scraped	be	VBG	B-VP	Oscraped	off	scrap	VBN	I-VP	Ooff	this	off	RP	B-PRT	Othis	substrate	this	DT	B-NP	Osubstrate	.	substrate	NN	I-NP	O.	CD28/CD3-costimulated	.	.	O	OCD28/CD3-costimulated	T	CD28/CD3-costimulated	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	produced	cell	NNS	I-NP	I-cell_typeproduced	intracellular	produce	VBD	B-VP	Ointracellular	IL-2	intracellular	JJ	B-NP	OIL-2	from	IL-2	NN	I-NP	B-proteinfrom	all	from	IN	B-PP	Oall	subsets	all	DT	B-NP	Osubsets	measured	subset	NNS	I-NP	Omeasured	(	measure	VBN	B-VP	O(	CD4+	(	(	O	OCD4+	","	CD4+	JJ	B-NP	B-protein","	CD4-	","	","	I-NP	OCD4-	","	CD4-	JJ	I-NP	O","	CD45RO+	","	","	I-NP	OCD45RO+	","	CD45RO+	JJ	I-NP	O","	and	","	","	O	Oand	CD45RO-	and	CC	O	OCD45RO-	)	CD45RO-	NN	B-NP	B-protein)	.	)	)	O	O.	IL-2	.	.	O	OIL-2	production	IL-2	NN	B-NP	B-proteinproduction	and	production	NN	I-NP	Oand	intracellular	and	CC	O	Ointracellular	accumulation	intracellular	JJ	B-NP	Oaccumulation	in	accumulation	NN	I-NP	Oin	nonscraped	in	IN	B-PP	Ononscraped	PB-T	nonscraped	JJ	B-NP	B-cell_typePB-T	cells	PB-T	NN	I-NP	I-cell_typecells	activated	cell	NNS	I-NP	I-cell_typeactivated	with	activate	VBN	B-VP	Owith	CD28/CD3	with	IN	B-PP	OCD28/CD3	coligation	CD28/CD3	NN	B-NP	Ocoligation	were	coligation	NN	I-NP	Owere	skewed	be	VBD	B-VP	Oskewed	favoring	skew	VBN	I-VP	Ofavoring	CD45RO+	favor	VBG	B-VP	OCD45RO+	and	CD45RO+	JJ	B-NP	Oand	CD4+	and	CC	I-NP	OCD4+	subsets	CD4+	JJ	I-NP	B-cell_typesubsets	","	subset	NNS	I-NP	I-cell_type","	as	","	","	O	Oas	was	as	IN	B-SBAR	Owas	IL-2	be	VBD	B-VP	OIL-2	production	IL-2	NN	B-NP	B-proteinproduction	in	production	NN	I-NP	Oin	scraped	in	IN	B-PP	Oscraped	PB-T	scrap	VBN	B-NP	B-cell_linePB-T	cells	PB-T	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	The	.	.	O	OThe	intracellular	The	DT	B-NP	Ointracellular	incorporation	intracellular	JJ	I-NP	Oincorporation	of	incorporation	NN	I-NP	Oof	Abs	of	IN	B-PP	OAbs	specific	Ab	NNS	B-NP	B-proteinspecific	for	specific	JJ	B-ADJP	Ofor	c-Fos	for	IN	B-PP	Oc-Fos	and	c-Fos	NN	B-NP	B-proteinand	c-Jun	and	CC	I-NP	Oc-Jun	family	c-Jun	NN	I-NP	B-proteinfamily	members	family	NN	I-NP	I-proteinmembers	by	member	NNS	I-NP	I-proteinby	scrape	by	IN	B-PP	Oscrape	loading	scrape	NN	B-NP	Oloading	inhibited	loading	NN	I-NP	Oinhibited	the	inhibit	VBD	B-VP	Othe	production	the	DT	B-NP	Oproduction	and	production	NN	I-NP	Oand	intracellular	and	CC	I-NP	Ointracellular	accumulation	intracellular	JJ	I-NP	Oaccumulation	of	accumulation	NN	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	within	IL-2	NN	B-NP	B-proteinwithin	6	within	IN	B-PP	O6	h	6	CD	B-NP	Oh	of	h	NN	I-NP	Oof	costimulation	of	IN	B-PP	Ocostimulation	with	costimulation	NN	B-NP	Owith	PMA/ionomycin	with	IN	B-PP	OPMA/ionomycin	","	PMA/ionomycin	NN	B-NP	O","	or	","	","	O	Oor	costimulation	or	CC	O	Ocostimulation	by	costimulation	NN	B-NP	Oby	CD28	by	IN	B-PP	OCD28	and	CD28	NN	B-NP	B-proteinand	CD3	and	CC	I-NP	OCD3	ligation	CD3	NN	I-NP	B-proteinligation	.	ligation	NN	I-NP	O.	Scrape	.	.	O	OScrape	loading	Scrape	NN	B-NP	Oloading	thus	loading	NN	I-NP	Othus	provides	thus	RB	B-ADVP	Oprovides	an	provide	VBZ	B-VP	Oan	efficient	an	DT	B-NP	Oefficient	mechanism	efficient	JJ	I-NP	Omechanism	for	mechanism	NN	I-NP	Ofor	intracellular	for	IN	B-PP	Ointracellular	incorporation	intracellular	JJ	B-NP	Oincorporation	of	incorporation	NN	I-NP	Oof	macromolecules	of	IN	B-PP	Omacromolecules	","	macromolecule	NNS	B-NP	B-protein","	and	","	","	O	Oand	the	and	CC	O	Othe	first	the	DT	B-NP	Ofirst	direct	first	JJ	I-NP	Odirect	evidence	direct	JJ	I-NP	Oevidence	that	evidence	NN	I-NP	Othat	c-Fos	that	IN	B-SBAR	Oc-Fos	and	c-Fos	NN	B-NP	B-proteinand	c-Jun	and	CC	I-NP	Oc-Jun	are	c-Jun	NN	I-NP	B-proteinare	involved	be	VBP	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	transcription	in	IN	B-PP	Otranscription	of	transcription	NN	B-NP	Oof	the	of	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	gene	IL-2	NN	I-NP	B-DNAgene	within	gene	NN	I-NP	I-DNAwithin	its	within	IN	B-PP	Oits	correct	its	PRP$	B-NP	Ocorrect	chromosomal	correct	JJ	I-NP	Ochromosomal	context	chromosomal	JJ	I-NP	Ocontext	","	context	NN	I-NP	O","	in	","	","	O	Oin	resting	in	IN	B-PP	Oresting	human	rest	VBG	B-NP	B-cell_typehuman	T	human	JJ	I-NP	I-cell_typeT	lymphocyte	T	NN	I-NP	I-cell_typelymphocyte	subpopulations	lymphocyte	NN	I-NP	I-cell_typesubpopulations	.	subpopulation	NNS	I-NP	I-cell_type.	Differential	.	.	O	ODifferential	expression	Differential	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	Nur77	of	IN	B-PP	ONur77	family	Nur77	NN	B-NP	B-proteinfamily	members	family	NN	I-NP	I-proteinmembers	in	member	NNS	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	T-lymphotropic	human	JJ	B-NP	B-cell_typeT-lymphotropic	virus	T-lymphotropic	JJ	I-NP	I-cell_typevirus	type	virus	NN	I-NP	I-cell_typetype	1-infected	type	NN	I-NP	I-cell_type1-infected	cells	1-infected	JJ	I-NP	I-cell_typecells	:	cell	NNS	I-NP	I-cell_type:	transactivation	:	:	O	Otransactivation	of	transactivation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	TR3/nur77	the	DT	B-NP	OTR3/nur77	gene	TR3/nur77	NN	I-NP	B-DNAgene	by	gene	NN	I-NP	I-DNAby	Tax	by	IN	B-PP	OTax	protein	Tax	NN	B-NP	B-proteinprotein	.	protein	NN	I-NP	I-protein.	We	.	.	O	OWe	analyzed	We	PRP	B-NP	Oanalyzed	the	analyze	VBD	B-VP	Othe	differential	the	DT	B-NP	Odifferential	expression	differential	JJ	I-NP	Oexpression	and	expression	NN	I-NP	Oand	regulation	and	CC	O	Oregulation	of	regulation	NN	B-NP	Oof	three	of	IN	B-PP	Othree	members	three	CD	B-NP	Omembers	of	member	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	Nur77	the	DT	B-NP	ONur77	transcription	Nur77	NN	I-NP	B-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	family	factor	NN	I-NP	I-proteinfamily	by	family	NN	I-NP	I-proteinby	the	by	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	T-lymphotropic	human	JJ	I-NP	B-proteinT-lymphotropic	virus	T-lymphotropic	JJ	I-NP	I-proteinvirus	type	virus	NN	I-NP	I-proteintype	1	type	NN	I-NP	I-protein1	(	1	CD	I-NP	I-protein(	HTLV-1	(	(	O	I-proteinHTLV-1	)	HTLV-1	NN	B-NP	I-protein)	Tax	)	)	O	I-proteinTax	protein	Tax	NN	B-NP	I-proteinprotein	.	protein	NN	I-NP	I-protein.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	demonstrated	have	VBP	B-VP	Odemonstrated	that	demonstrate	VBN	I-VP	Othat	in	that	IN	B-SBAR	Oin	both	in	IN	B-PP	Oboth	HTLV-1-infected	both	CC	B-NP	OHTLV-1-infected	cells	HTLV-1-infected	JJ	I-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	Tax-expressing	and	CC	O	OTax-expressing	JPX-9	Tax-expressing	JJ	B-NP	B-cell_lineJPX-9	cells	JPX-9	NN	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	TR3/nur77	","	","	O	OTR3/nur77	is	TR3/nur77	NN	B-NP	B-proteinis	highly	be	VBZ	B-VP	Ohighly	expressed	highly	RB	I-VP	Oexpressed	","	express	VBN	I-VP	O","	whereas	","	","	O	Owhereas	neither	whereas	IN	O	Oneither	NOR-1	neither	CC	O	ONOR-1	nor	NOR-1	NN	B-NP	B-proteinnor	NOT	nor	CC	O	ONOT	expression	NOT	NN	B-NP	B-proteinexpression	is	expression	NN	I-NP	Ois	detectable	be	VBZ	B-VP	Odetectable	.	detectable	JJ	B-ADJP	O.	Transient	.	.	O	OTransient	transfection	Transient	JJ	B-NP	Otransfection	analysis	transfection	NN	I-NP	Oanalysis	further	analysis	NN	I-NP	Ofurther	confirmed	further	RBR	B-ADVP	Oconfirmed	the	confirm	VBD	B-VP	Othe	Tax	the	DT	B-NP	OTax	transactivation	Tax	NN	I-NP	B-proteintransactivation	of	transactivation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	TR3/nur77	the	DT	B-NP	OTR3/nur77	promoter	TR3/nur77	NN	I-NP	B-DNApromoter	but	promoter	NN	I-NP	I-DNAbut	not	but	CC	B-NP	Onot	the	not	RB	I-NP	Othe	NOR-1	the	DT	B-NP	ONOR-1	promoter	NOR-1	NN	I-NP	B-DNApromoter	in	promoter	NN	I-NP	I-DNAin	different	in	IN	B-PP	Odifferent	cell	different	JJ	B-NP	Ocell	types	cell	NN	I-NP	Otypes	.	type	NNS	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	expression	","	","	O	Oexpression	of	expression	NN	B-NP	Oof	a	of	IN	B-PP	Oa	luciferase	a	DT	B-NP	Oluciferase	reporter	luciferase	NN	I-NP	B-DNAreporter	gene	reporter	NN	I-NP	I-DNAgene	driven	gene	NN	I-NP	I-DNAdriven	by	drive	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	NGFI-B	the	DT	B-NP	ONGFI-B	(	NGFI-B	NN	I-NP	B-protein(	rat	(	(	O	Orat	homolog	rat	NN	B-NP	Ohomolog	of	homolog	NN	I-NP	Oof	TR3/Nur77	of	IN	B-PP	OTR3/Nur77	)	TR3/Nur77	NN	B-NP	O)	response	)	)	O	Oresponse	element	response	NN	B-NP	Oelement	(	element	NN	I-NP	O(	NBRE	(	(	O	ONBRE	)	NBRE	NN	B-NP	B-DNA)	provided	)	)	O	Oprovided	evidence	provide	VBD	B-VP	Oevidence	that	evidence	NN	B-NP	Othat	Tax	that	IN	B-SBAR	OTax	#NAME?	Tax	NN	B-NP	B-protein#NAME?	transactivation	#NAME?	JJ	I-NP	Otransactivation	resulted	transactivation	NN	I-NP	Oresulted	in	result	VBD	B-VP	Oin	the	in	IN	B-PP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	a	of	IN	B-PP	Oa	functional	a	DT	B-NP	Ofunctional	protein	functional	JJ	I-NP	B-proteinprotein	.	protein	NN	I-NP	I-protein.	Cotransfection	.	.	O	OCotransfection	assays	Cotransfection	NN	B-NP	Oassays	with	assay	NNS	I-NP	Owith	the	with	IN	B-PP	Othe	TR3/nur77	the	DT	B-NP	OTR3/nur77	promoter	TR3/nur77	NN	I-NP	B-DNApromoter	sequence	promoter	NN	I-NP	I-DNAsequence	or	sequence	NN	I-NP	I-DNAor	the	or	CC	O	Othe	NBRE	the	DT	B-NP	ONBRE	binding	NBRE	NN	I-NP	B-DNAbinding	motif	binding	NN	I-NP	I-DNAmotif	together	motif	NN	I-NP	I-DNAtogether	with	together	RB	B-ADVP	Owith	a	with	IN	B-PP	Oa	series	a	DT	B-NP	Oseries	of	series	NN	I-NP	Oof	Tax	of	IN	B-PP	OTax	mutants	Tax	NN	B-NP	B-proteinmutants	have	mutant	NNS	I-NP	I-proteinhave	shown	have	VBP	B-VP	Oshown	that	show	VBN	I-VP	Othat	Tax	that	IN	B-SBAR	OTax	#NAME?	Tax	NN	B-NP	B-protein#NAME?	TR3/nur77	#NAME?	JJ	I-NP	OTR3/nur77	expression	TR3/nur77	NN	I-NP	B-proteinexpression	is	expression	NN	I-NP	Ois	mediated	be	VBZ	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	CREB/ATF-related	by	IN	B-PP	OCREB/ATF-related	transcription	CREB/ATF-related	JJ	B-NP	B-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	.	factor	NNS	I-NP	I-protein.	Negative	.	.	O	ONegative	regulation	Negative	JJ	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	heat	the	DT	B-NP	Oheat	shock	heat	NN	I-NP	Oshock	transcriptional	shock	NN	I-NP	Otranscriptional	response	transcriptional	JJ	I-NP	Oresponse	by	response	NN	I-NP	Oby	HSBP1	by	IN	B-PP	OHSBP1	.	HSBP1	NN	B-NP	B-protein.	In	.	.	O	OIn	response	In	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	stress	to	TO	B-PP	Ostress	","	stress	NN	B-NP	O","	heat	","	","	O	Oheat	shock	heat	NN	B-NP	B-proteinshock	factor	shock	NN	I-NP	I-proteinfactor	1	factor	NN	I-NP	I-protein1	(	1	CD	I-NP	I-protein(	HSF1	(	(	O	OHSF1	)	HSF1	NN	B-NP	B-protein)	acquires	)	)	O	Oacquires	rapid	acquire	VBZ	B-VP	Orapid	DNA	rapid	JJ	B-NP	ODNA	binding	DNA	NN	I-NP	Obinding	and	binding	NN	I-NP	Oand	transient	and	CC	O	Otransient	transcriptional	transient	JJ	B-NP	Otranscriptional	activity	transcriptional	JJ	I-NP	Oactivity	while	activity	NN	I-NP	Owhile	undergoing	while	IN	B-SBAR	Oundergoing	conformational	undergo	VBG	B-VP	Oconformational	transition	conformational	JJ	B-NP	Otransition	from	transition	NN	I-NP	Ofrom	an	from	IN	B-PP	Oan	inert	an	DT	B-NP	Oinert	non-DNA-binding	inert	JJ	I-NP	B-proteinnon-DNA-binding	monomer	non-DNA-binding	JJ	I-NP	I-proteinmonomer	to	monomer	NN	I-NP	I-proteinto	active	to	TO	B-PP	Oactive	functional	active	JJ	B-NP	Ofunctional	trimers	functional	JJ	I-NP	Otrimers	.	trimer	NNS	I-NP	O.	Attenuation	.	.	O	OAttenuation	of	Attenuation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	inducible	the	DT	B-NP	Oinducible	transcriptional	inducible	JJ	I-NP	Otranscriptional	response	transcriptional	JJ	I-NP	Oresponse	occurs	response	NN	I-NP	Ooccurs	during	occur	VBZ	B-VP	Oduring	heat	during	IN	B-PP	Oheat	shock	heat	NN	B-NP	Oshock	or	shock	NN	I-NP	Oor	upon	or	CC	B-PP	Oupon	recovery	upon	IN	B-PP	Orecovery	at	recovery	NN	B-NP	Oat	non-stress	at	IN	B-PP	Onon-stress	conditions	non-stress	JJ	B-NP	Oconditions	and	condition	NNS	I-NP	Oand	involves	and	CC	O	Oinvolves	dissociation	involve	VBZ	B-VP	Odissociation	of	dissociation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	HSF1	the	DT	B-NP	OHSF1	trimer	HSF1	NN	I-NP	B-proteintrimer	and	trimer	NN	I-NP	Oand	loss	and	CC	I-NP	Oloss	of	loss	NN	I-NP	Oof	activity	of	IN	B-PP	Oactivity	.	activity	NN	B-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	used	have	VBP	B-VP	Oused	the	use	VBN	I-VP	Othe	hydrophobic	the	DT	B-NP	Ohydrophobic	repeats	hydrophobic	JJ	I-NP	B-DNArepeats	of	repeat	NNS	I-NP	I-DNAof	the	of	IN	B-PP	Othe	HSF1	the	DT	B-NP	OHSF1	trimerization	HSF1	NN	I-NP	B-proteintrimerization	domain	trimerization	NN	I-NP	I-proteindomain	in	domain	NN	I-NP	I-proteinin	the	in	IN	B-PP	Othe	yeast	the	DT	B-NP	Oyeast	two-hybrid	yeast	NN	I-NP	Otwo-hybrid	protein	two-hybrid	JJ	I-NP	Oprotein	interaction	protein	NN	I-NP	Ointeraction	assay	interaction	NN	I-NP	Oassay	to	assay	NN	I-NP	Oto	identify	to	TO	B-VP	Oidentify	heat	identify	VB	I-VP	Oheat	shock	heat	NN	B-NP	B-proteinshock	factor	shock	NN	I-NP	I-proteinfactor	binding	factor	NN	I-NP	I-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	1	protein	NN	I-NP	I-protein1	(	1	CD	I-NP	I-protein(	HSBP1	(	(	O	OHSBP1	)	HSBP1	NN	B-NP	B-protein)	","	)	)	O	O","	a	","	","	O	Oa	novel	a	DT	B-NP	Onovel	","	novel	JJ	I-NP	O","	conserved	","	","	I-NP	Oconserved	","	conserve	VBN	I-NP	O","	76-amino-acid	","	","	I-NP	O76-amino-acid	protein	76-amino-acid	JJ	I-NP	B-proteinprotein	that	protein	NN	I-NP	I-proteinthat	contains	that	WDT	B-NP	Ocontains	two	contain	VBZ	B-VP	Otwo	extended	two	CD	B-NP	Oextended	arrays	extend	VBN	I-NP	Oarrays	of	array	NNS	I-NP	Oof	hydrophobic	of	IN	B-PP	Ohydrophobic	repeats	hydrophobic	JJ	B-NP	B-proteinrepeats	that	repeat	NNS	I-NP	I-proteinthat	interact	that	WDT	B-NP	Ointeract	with	interact	VBP	B-VP	Owith	the	with	IN	B-PP	Othe	HSF1	the	DT	B-NP	OHSF1	heptad	HSF1	NN	I-NP	B-proteinheptad	repeats	heptad	NN	I-NP	Orepeats	.	repeat	NNS	I-NP	O.	HSBP1	.	.	O	OHSBP1	is	HSBP1	NN	B-NP	B-proteinis	nuclear-localized	be	VBZ	B-VP	Onuclear-localized	and	nuclear-localized	JJ	B-ADJP	Oand	interacts	and	CC	O	Ointeracts	in	interact	VBZ	B-VP	Oin	vivo	in	FW	B-ADVP	Ovivo	with	vivo	FW	I-ADVP	Owith	the	with	IN	B-PP	Othe	active	the	DT	B-NP	Oactive	trimeric	active	JJ	I-NP	Otrimeric	state	trimeric	JJ	I-NP	Ostate	of	state	NN	I-NP	Oof	HSF1	of	IN	B-PP	OHSF1	that	HSF1	NN	B-NP	B-proteinthat	appears	that	WDT	B-NP	Oappears	during	appear	VBZ	B-VP	Oduring	heat	during	IN	B-PP	Oheat	shock	heat	NN	B-NP	Oshock	.	shock	NN	I-NP	O.	During	.	.	O	ODuring	attenuation	During	IN	B-PP	Oattenuation	of	attenuation	NN	B-NP	Oof	HSF1	of	IN	B-PP	OHSF1	to	HSF1	NN	B-NP	B-proteinto	the	to	TO	B-PP	Othe	inert	the	DT	B-NP	Oinert	monomer	inert	JJ	I-NP	B-proteinmonomer	","	monomer	NN	I-NP	I-protein","	HSBP1	","	","	O	OHSBP1	associates	HSBP1	NN	B-NP	B-proteinassociates	with	associate	VBZ	B-VP	Owith	Hsp70	with	IN	B-PP	OHsp70	.	Hsp70	NN	B-NP	B-protein.	HSBP1	.	.	O	OHSBP1	negatively	HSBP1	NN	B-NP	B-proteinnegatively	affects	negatively	RB	B-ADVP	Oaffects	HSF1	affect	VBZ	B-VP	OHSF1	DNA-binding	HSF1	NN	B-NP	B-proteinDNA-binding	activity	DNA-binding	JJ	I-NP	Oactivity	","	activity	NN	I-NP	O","	and	","	","	O	Oand	overexpression	and	CC	O	Ooverexpression	of	overexpression	NN	B-NP	Oof	HSBP1	of	IN	B-PP	OHSBP1	in	HSBP1	NN	B-NP	B-proteinin	mammalian	in	IN	B-PP	Omammalian	cells	mammalian	JJ	B-NP	B-cell_typecells	represses	cell	NNS	I-NP	I-cell_typerepresses	the	repress	VBZ	B-VP	Othe	transactivation	the	DT	B-NP	Otransactivation	activity	transactivation	NN	I-NP	Oactivity	of	activity	NN	I-NP	Oof	HSF1	of	IN	B-PP	OHSF1	.	HSF1	NN	B-NP	B-protein.	To	.	.	O	OTo	establish	To	TO	B-VP	Oestablish	a	establish	VB	I-VP	Oa	biological	a	DT	B-NP	Obiological	role	biological	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	HSBP1	for	IN	B-PP	OHSBP1	","	HSBP1	NN	B-NP	B-protein","	the	","	","	O	Othe	homologous	the	DT	B-NP	Ohomologous	Caenorhabditis	homologous	JJ	I-NP	B-proteinCaenorhabditis	elegans	Caenorhabditis	NN	I-NP	I-proteinelegans	protein	elegan	NNS	I-NP	I-proteinprotein	was	protein	NN	I-NP	I-proteinwas	overexpressed	be	VBD	B-VP	Ooverexpressed	in	overexpresse	VBN	I-VP	Oin	body	in	IN	B-PP	Obody	wall	body	NN	B-NP	B-cell_typewall	muscle	wall	NN	I-NP	I-cell_typemuscle	cells	muscle	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	was	and	CC	O	Owas	shown	be	VBD	B-VP	Oshown	to	show	VBN	I-VP	Oto	block	to	TO	I-VP	Oblock	activation	block	VB	I-VP	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	heat	the	DT	B-NP	Oheat	shock	heat	NN	I-NP	Oshock	response	shock	NN	I-NP	Oresponse	from	response	NN	I-NP	Ofrom	a	from	IN	B-PP	Oa	heat	a	DT	B-NP	Oheat	shock	heat	NN	I-NP	B-DNAshock	promoter-reporter	shock	NN	I-NP	I-DNApromoter-reporter	construct	promoter-reporter	NN	I-NP	I-DNAconstruct	.	construct	NN	I-NP	I-DNA.	Alteration	.	.	O	OAlteration	in	Alteration	NN	B-NP	Oin	the	in	IN	B-PP	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	HSBP1	of	IN	B-PP	OHSBP1	expression	HSBP1	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	C.	in	IN	B-PP	OC.	elegans	C.	NNP	B-NP	Oelegans	has	elegans	NNP	I-NP	Ohas	severe	have	VBZ	B-VP	Osevere	effects	severe	JJ	B-NP	Oeffects	on	effect	NNS	I-NP	Oon	survival	on	IN	B-PP	Osurvival	of	survival	NN	B-NP	Oof	the	of	IN	B-PP	Othe	animals	the	DT	B-NP	Oanimals	after	animal	NNS	I-NP	Oafter	thermal	after	IN	B-PP	Othermal	and	thermal	JJ	B-NP	Oand	chemical	and	CC	I-NP	Ochemical	stress	chemical	JJ	I-NP	Ostress	","	stress	NN	I-NP	O","	consistent	","	","	O	Oconsistent	with	consistent	JJ	B-ADJP	Owith	a	with	IN	B-PP	Oa	role	a	DT	B-NP	Orole	for	role	NN	I-NP	Ofor	HSBP1	for	IN	B-PP	OHSBP1	as	HSBP1	NN	B-NP	B-proteinas	a	as	IN	B-PP	Oa	negative	a	DT	B-NP	Onegative	regulator	negative	JJ	I-NP	Oregulator	of	regulator	NN	I-NP	Oof	the	of	IN	B-PP	Othe	heat	the	DT	B-NP	Oheat	shock	heat	NN	I-NP	Oshock	response	shock	NN	I-NP	Oresponse	.	response	NN	I-NP	O.	Long-range	.	.	O	OLong-range	transcriptional	Long-range	JJ	B-NP	Otranscriptional	regulation	transcriptional	JJ	I-NP	Oregulation	of	regulation	NN	I-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	gene	cytokine	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	.	expression	NN	I-NP	O.	Most	.	.	O	OMost	studies	Most	JJS	B-NP	Ostudies	on	study	NNS	I-NP	Oon	the	on	IN	B-PP	Othe	control	the	DT	B-NP	Ocontrol	of	control	NN	I-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	gene	cytokine	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	have	expression	NN	I-NP	Ohave	involved	have	VBP	B-VP	Oinvolved	the	involve	VBN	I-VP	Othe	functional	the	DT	B-NP	Ofunctional	analysis	functional	JJ	I-NP	Oanalysis	of	analysis	NN	I-NP	Oof	proximal	of	IN	B-PP	Oproximal	promoters	proximal	JJ	B-NP	B-DNApromoters	.	promoter	NNS	I-NP	I-DNA.	Recent	.	.	O	ORecent	work	Recent	JJ	B-NP	Owork	has	work	NN	I-NP	Ohas	identified	have	VBZ	B-VP	Oidentified	distal	identify	VBN	I-VP	Odistal	elements	distal	JJ	B-NP	B-DNAelements	that	element	NNS	I-NP	I-DNAthat	mediate	that	WDT	B-NP	Omediate	long-range	mediate	VBP	B-VP	Olong-range	cytokine	long-range	JJ	B-NP	B-DNAcytokine	gene	cytokine	NN	I-NP	I-DNAgene	regulation	gene	NN	I-NP	I-DNAregulation	and	regulation	NN	I-NP	Oand	has	and	CC	O	Ohas	implicated	have	VBZ	B-VP	Oimplicated	chromatin	implicate	VBN	I-VP	Ochromatin	reorganization	chromatin	NN	B-NP	B-DNAreorganization	in	reorganization	NN	I-NP	Oin	regulation	in	IN	B-PP	Oregulation	of	regulation	NN	B-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	gene	cytokine	NN	B-NP	B-DNAgene	loci	gene	NN	I-NP	I-DNAloci	.	locus	NNS	I-NP	I-DNA.	These	.	.	O	OThese	studies	These	DT	B-NP	Ostudies	have	study	NNS	I-NP	Ohave	begun	have	VBP	B-VP	Obegun	to	begin	VBN	I-VP	Oto	elucidate	to	TO	I-VP	Oelucidate	the	elucidate	VB	I-VP	Othe	basis	the	DT	B-NP	Obasis	for	basis	NN	I-NP	Ofor	cell-specificity	for	IN	B-PP	Ocell-specificity	and	cell-specificity	NN	B-NP	Oand	high-level	and	CC	O	Ohigh-level	expression	high-level	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	genes	cytokine	NN	B-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	A	.	.	O	OA	signaling	A	DT	B-NP	Osignaling	complex	signaling	NN	I-NP	B-proteincomplex	of	complex	NN	I-NP	I-proteinof	Ca2+-calmodulin-dependent	of	IN	B-PP	OCa2+-calmodulin-dependent	protein	Ca2+-calmodulin-dependent	JJ	B-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	IV	kinase	NN	I-NP	I-proteinIV	and	IV	CD	B-NP	I-proteinand	protein	and	CC	O	Oprotein	phosphatase	protein	NN	B-NP	B-proteinphosphatase	2A	phosphatase	NN	I-NP	I-protein2A	[	2A	NN	I-NP	I-protein[	see	[	(	O	Osee	comments	see	VB	B-VP	Ocomments	]	comment	NNS	B-NP	O]	Stimulation	]	)	O	OStimulation	of	Stimulation	NN	B-NP	Oof	T	of	IN	B-PP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	results	lymphocyte	NNS	I-NP	I-cell_typeresults	in	result	VBZ	B-VP	Oin	a	in	IN	B-PP	Oa	rapid	a	DT	B-NP	Orapid	increase	rapid	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	intracellular	in	IN	B-PP	Ointracellular	calcium	intracellular	JJ	B-NP	Ocalcium	concentration	calcium	NN	I-NP	Oconcentration	(	concentration	NN	I-NP	O(	[	(	(	O	O[	Ca2+	[	(	O	OCa2+	]	Ca2+	NN	B-NP	O]	i	]	)	I-NP	Oi	)	i	NN	I-NP	O)	that	)	)	O	Othat	parallels	that	WDT	B-NP	Oparallels	the	parallel	VBZ	B-VP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	Ca2+-calmodulin-dependent	of	IN	B-PP	OCa2+-calmodulin-dependent	protein	Ca2+-calmodulin-dependent	JJ	B-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	IV	kinase	NN	I-NP	I-proteinIV	(	IV	CD	I-NP	I-protein(	CaMKIV	(	(	O	OCaMKIV	)	CaMKIV	NN	B-NP	B-protein)	","	)	)	O	O","	a	","	","	O	Oa	nuclear	a	DT	B-NP	Onuclear	enzyme	nuclear	JJ	I-NP	B-proteinenzyme	that	enzyme	NN	I-NP	I-proteinthat	can	that	WDT	B-NP	Ocan	phosphorylate	can	MD	B-VP	Ophosphorylate	and	phosphorylate	VB	I-VP	Oand	activate	and	CC	I-VP	Oactivate	the	activate	VB	I-VP	Othe	cyclic	the	DT	B-NP	Ocyclic	adenosine	cyclic	JJ	I-NP	B-proteinadenosine	monophosphate	adenosine	NN	I-NP	I-proteinmonophosphate	(	monophosphate	NN	I-NP	I-protein(	cAMP	(	(	O	I-proteincAMP	)	cAMP	NN	B-NP	I-protein)	response	)	)	O	I-proteinresponse	element-binding	response	NN	B-NP	I-proteinelement-binding	protein	element-binding	JJ	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	CREB	(	(	O	OCREB	)	CREB	NN	B-NP	B-protein)	.	)	)	O	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	inactivation	","	","	O	Oinactivation	of	inactivation	NN	B-NP	Oof	CaMKIV	of	IN	B-PP	OCaMKIV	occurs	CaMKIV	NN	B-NP	B-proteinoccurs	despite	occur	VBZ	B-VP	Odespite	the	despite	IN	B-PP	Othe	sustained	the	DT	B-NP	Osustained	increase	sustained	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	[	in	IN	B-PP	O[	Ca2+	[	(	B-NP	OCa2+	]	Ca2+	NN	I-NP	O]	i	]	)	I-NP	Oi	that	i	NN	I-NP	Othat	is	that	WDT	B-NP	Ois	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	T	for	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	.	activation	NN	I-NP	O.	A	.	.	O	OA	stable	A	DT	B-NP	Ostable	and	stable	JJ	I-NP	Oand	stoichiometric	and	CC	I-NP	Ostoichiometric	complex	stoichiometric	JJ	I-NP	Ocomplex	of	complex	NN	I-NP	Oof	CaMKIV	of	IN	B-PP	OCaMKIV	with	CaMKIV	NN	B-NP	B-proteinwith	protein	with	IN	B-PP	Oprotein	serine-threonine	protein	NN	B-NP	B-proteinserine-threonine	phosphatase	serine-threonine	NN	I-NP	I-proteinphosphatase	2A	phosphatase	NN	I-NP	I-protein2A	(	2A	NN	I-NP	I-protein(	PP2A	(	(	O	OPP2A	)	PP2A	NN	B-NP	B-protein)	was	)	)	O	Owas	identified	be	VBD	B-VP	Oidentified	in	identify	VBN	I-VP	Oin	which	in	IN	B-PP	Owhich	PP2A	which	WDT	B-NP	OPP2A	dephosphorylates	PP2A	NN	B-NP	B-proteindephosphorylates	CaMKIV	dephosphorylate	VBZ	B-VP	OCaMKIV	and	CaMKIV	NN	B-NP	B-proteinand	functions	and	CC	O	Ofunctions	as	function	VBZ	B-VP	Oas	a	as	IN	B-PP	Oa	negative	a	DT	B-NP	Onegative	regulator	negative	JJ	I-NP	Oregulator	of	regulator	NN	I-NP	Oof	CaMKIV	of	IN	B-PP	OCaMKIV	signaling	CaMKIV	NN	B-NP	B-proteinsignaling	.	signaling	NN	I-NP	O.	In	.	.	O	OIn	Jurkat	In	IN	B-PP	OJurkat	T	Jurkat	NN	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	inhibition	","	","	O	Oinhibition	of	inhibition	NN	B-NP	Oof	PP2A	of	IN	B-PP	OPP2A	activity	PP2A	NN	B-NP	B-proteinactivity	by	activity	NN	I-NP	Oby	small	by	IN	B-PP	Osmall	t	small	JJ	B-NP	B-proteint	antigen	t	NN	I-NP	I-proteinantigen	enhanced	antigen	NN	I-NP	I-proteinenhanced	activation	enhance	VBD	B-VP	Oactivation	of	activation	NN	B-NP	Oof	CREB	of	IN	B-PP	OCREB	#NAME?	CREB	NN	B-NP	B-protein#NAME?	transcription	#NAME?	JJ	I-NP	Otranscription	by	transcription	NN	I-NP	Oby	CaMKIV	by	IN	B-PP	OCaMKIV	.	CaMKIV	NN	B-NP	B-protein.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	reveal	finding	NNS	I-NP	Oreveal	an	reveal	VBP	B-VP	Oan	intracellular	an	DT	B-NP	Ointracellular	signaling	intracellular	JJ	I-NP	Osignaling	mechanism	signaling	NN	I-NP	Omechanism	whereby	mechanism	NN	I-NP	Owhereby	a	whereby	WRB	B-ADVP	Oa	protein	a	DT	B-NP	Oprotein	serine-threonine	protein	NN	I-NP	B-proteinserine-threonine	kinase	serine-threonine	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	CaMKIV	(	(	O	OCaMKIV	)	CaMKIV	NN	B-NP	B-protein)	is	)	)	O	Ois	regulated	be	VBZ	B-VP	Oregulated	by	regulate	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	tightly	a	DT	B-NP	Otightly	associated	tightly	RB	I-NP	Oassociated	protein	associate	VBN	I-NP	Oprotein	serine-threonine	protein	NN	I-NP	B-proteinserine-threonine	phosphatase	serine-threonine	NN	I-NP	I-proteinphosphatase	(	phosphatase	NN	I-NP	I-protein(	PP2A	(	(	O	OPP2A	)	PP2A	NN	B-NP	B-protein)	.	)	)	O	O.	Hypoxia	.	.	O	OHypoxia	down-regulates	Hypoxia	NN	B-NP	Odown-regulates	MCP-1	down-regulate	VBZ	B-VP	OMCP-1	expression	MCP-1	NN	B-NP	B-proteinexpression	:	expression	NN	I-NP	O:	implications	:	:	O	Oimplications	for	implication	NNS	B-NP	Ofor	macrophage	for	IN	B-PP	Omacrophage	distribution	macrophage	NN	B-NP	Odistribution	in	distribution	NN	I-NP	Oin	tumors	in	IN	B-PP	Otumors	.	tumor	NNS	B-NP	O.	Monocyte	.	.	O	OMonocyte	chemoattractant	Monocyte	NN	B-NP	B-proteinchemoattractant	protein	chemoattractant	NN	I-NP	I-proteinprotein	1	protein	NN	I-NP	I-protein1	(	1	CD	I-NP	I-protein(	MCP-1	(	(	O	OMCP-1	)	MCP-1	NN	B-NP	B-protein)	is	)	)	O	Ois	likely	be	VBZ	B-VP	Olikely	to	likely	JJ	B-ADJP	Oto	contribute	to	TO	B-VP	Ocontribute	to	contribute	VB	I-VP	Oto	the	to	TO	B-PP	Othe	macrophage	the	DT	B-NP	Omacrophage	infiltrate	macrophage	NN	I-NP	Oinfiltrate	in	infiltrate	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	ovarian	human	JJ	B-NP	Oovarian	carcinomas	ovarian	JJ	I-NP	Ocarcinomas	.	carcinoma	NNS	I-NP	O.	Although	.	.	O	OAlthough	MCP-1	Although	IN	B-SBAR	OMCP-1	is	MCP-1	NN	B-NP	B-proteinis	predominantly	be	VBZ	B-VP	Opredominantly	expressed	predominantly	RB	I-VP	Oexpressed	by	express	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	tumor	the	DT	B-NP	Otumor	parenchyma	tumor	NN	I-NP	Oparenchyma	","	parenchyma	NN	I-NP	O","	macrophages	","	","	O	Omacrophages	accumulate	macrophage	NNS	B-NP	B-cell_typeaccumulate	at	accumulate	VBP	B-VP	Oat	highest	at	IN	B-PP	Ohighest	density	high	JJS	B-NP	Odensity	in	density	NN	I-NP	Oin	necrotic	in	IN	B-PP	Onecrotic	regions	necrotic	JJ	B-NP	B-proteinregions	","	region	NNS	I-NP	I-protein","	which	","	","	O	Owhich	are	which	WDT	B-NP	Oare	associated	be	VBP	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	low	with	IN	B-PP	Olow	oxygen	low	JJ	B-NP	Ooxygen	tensions	oxygen	NN	I-NP	Otensions	.	tension	NNS	I-NP	O.	Tumor	.	.	O	OTumor	necrosis	Tumor	NN	B-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	alpha	factor	NN	I-NP	I-proteinalpha	(	alpha	NN	I-NP	I-protein(	TNF-alpha	(	(	O	OTNF-alpha	)	TNF-alpha	NN	B-NP	B-protein)	can	)	)	O	Ocan	stimulate	can	MD	B-VP	Ostimulate	MCP-1	stimulate	VB	I-VP	OMCP-1	production	MCP-1	NN	B-NP	B-proteinproduction	and	production	NN	I-NP	Oand	is	and	CC	O	Ois	also	be	VBZ	B-VP	Oalso	present	also	RB	B-ADVP	Opresent	within	present	JJ	B-ADJP	Owithin	ovarian	within	IN	B-PP	Oovarian	carcinomas	ovarian	JJ	B-NP	Ocarcinomas	.	carcinoma	NNS	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	investigated	have	VBP	B-VP	Oinvestigated	the	investigate	VBN	I-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	hypoxia	of	IN	B-PP	Ohypoxia	both	hypoxia	NN	B-NP	Oboth	on	both	CC	B-PP	Oon	MCP-1	on	IN	B-PP	OMCP-1	expression	MCP-1	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	ovarian	in	IN	B-PP	Oovarian	cancer	ovarian	JJ	B-NP	B-cell_linecancer	cell	cancer	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	and	line	NNS	I-NP	I-cell_lineand	monocyte	and	CC	O	Omonocyte	migration	monocyte	NN	B-NP	Omigration	.	migration	NN	I-NP	O.	Hypoxia	.	.	O	OHypoxia	down-regulated	Hypoxia	NN	B-NP	Odown-regulated	TNF-alpha-induced	down-regulate	VBD	B-VP	OTNF-alpha-induced	MCP-1	TNF-alpha-induced	JJ	B-NP	OMCP-1	mRNA	MCP-1	NN	I-NP	B-RNAmRNA	and	mRNA	NN	I-NP	I-RNAand	protein	and	CC	O	Oprotein	production	protein	NN	B-NP	Oproduction	by	production	NN	I-NP	Oby	ovarian	by	IN	B-PP	Oovarian	cancer	ovarian	JJ	B-NP	B-cell_typecancer	cells	cancer	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	effect	The	DT	B-NP	Oeffect	was	effect	NN	I-NP	Owas	mimicked	be	VBD	B-VP	Omimicked	by	mimic	VBN	I-VP	Oby	cobalt	by	IN	B-PP	Ocobalt	chloride	cobalt	NN	B-NP	Ochloride	and	chloride	NN	I-NP	Oand	desferrioxamine	and	CC	I-NP	Odesferrioxamine	","	desferrioxamine	NN	I-NP	O","	consistent	","	","	O	Oconsistent	with	consistent	JJ	B-ADJP	Owith	a	with	IN	B-PP	Oa	specific	a	DT	B-NP	Ospecific	oxygen-sensing	specific	JJ	I-NP	Ooxygen-sensing	mechanism	oxygen-sensing	JJ	I-NP	Omechanism	.	mechanism	NN	I-NP	O.	Unlike	.	.	O	OUnlike	antioxidants	Unlike	IN	B-PP	Oantioxidants	","	antioxidant	NNS	B-NP	O","	hypoxia	","	","	O	Ohypoxia	did	hypoxia	NN	B-NP	Odid	not	do	VBD	B-VP	Onot	inhibit	not	RB	I-VP	Oinhibit	nuclear	inhibit	VB	I-VP	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	KB	factor	NN	I-NP	I-proteinKB	mobilization	KB	NN	I-NP	I-proteinmobilization	.	mobilization	NN	I-NP	O.	Monocyte	.	.	O	OMonocyte	migration	Monocyte	NN	B-NP	Omigration	in	migration	NN	I-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	I-PP	Oto	MCP-1	to	TO	I-PP	OMCP-1	was	MCP-1	NN	B-NP	B-proteinwas	also	be	VBD	B-VP	Oalso	diminished	also	RB	I-VP	Odiminished	under	diminish	VBN	I-VP	Ounder	hypoxic	under	IN	B-PP	Ohypoxic	conditions	hypoxic	JJ	B-NP	Oconditions	.	condition	NNS	I-NP	O.	Down-regulation	.	.	O	ODown-regulation	of	Down-regulation	NN	B-NP	Oof	MCP-1	of	IN	B-PP	OMCP-1	expression	MCP-1	NN	B-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	the	and	CC	O	Othe	inhibition	the	DT	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	monocyte	of	IN	B-PP	Omonocyte	migration	monocyte	NN	B-NP	Omigration	are	migration	NN	I-NP	Oare	independent	be	VBP	B-VP	Oindependent	effects	independent	JJ	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	hypoxia	of	IN	B-PP	Ohypoxia	that	hypoxia	NN	B-NP	Othat	may	that	WDT	B-NP	Omay	contribute	may	MD	B-VP	Ocontribute	to	contribute	VB	I-VP	Oto	the	to	TO	B-PP	Othe	distribution	the	DT	B-NP	Odistribution	of	distribution	NN	I-NP	Oof	macrophages	of	IN	B-PP	Omacrophages	within	macrophage	NNS	B-NP	B-cell_typewithin	ovarian	within	IN	B-PP	Oovarian	tumors	ovarian	JJ	B-NP	Otumors	.	tumor	NNS	I-NP	O.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	kappa	factor	NN	I-NP	I-proteinkappa	B	kappa	NN	I-NP	I-proteinB	inflammatory	B	NN	I-NP	I-proteininflammatory	bowel	inflammatory	JJ	I-NP	Obowel	disease	bowel	NN	I-NP	Odisease	[	disease	NN	I-NP	O[	see	[	(	O	Osee	comments	see	VB	B-VP	Ocomments	]	comment	NNS	B-NP	O]	BACKGROUND	]	)	O	OBACKGROUND	:	BACKGROUND	NN	B-NP	O:	Expression	:	:	O	OExpression	of	Expression	NN	B-NP	Oof	pro-inflammatory	of	IN	B-PP	Opro-inflammatory	cytokines	pro-inflammatory	JJ	B-NP	B-proteincytokines	is	cytokine	NNS	I-NP	I-proteinis	increased	be	VBZ	B-VP	Oincreased	in	increase	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	intestinal	the	DT	B-NP	Ointestinal	lamina	intestinal	JJ	I-NP	Olamina	propria	lamina	NN	I-NP	Opropria	of	propria	NN	I-NP	Oof	patients	of	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	inflammatory	with	IN	B-PP	Oinflammatory	bowel	inflammatory	JJ	B-NP	Obowel	disease	bowel	NN	I-NP	Odisease	(	disease	NN	I-NP	O(	IBD	(	(	O	OIBD	)	IBD	NN	B-NP	O)	.	)	)	O	O.	Nuclear	.	.	O	ONuclear	factor	Nuclear	JJ	B-NP	B-proteinfactor	kappa	factor	NN	I-NP	I-proteinkappa	B	kappa	NN	I-NP	I-proteinB	(	B	NN	I-NP	I-protein(	NF	(	(	O	ONF	kappa	NF	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	)	B	NN	I-NP	I-protein)	controls	)	)	O	Ocontrols	transcription	control	VBZ	B-VP	Otranscription	of	transcription	NN	B-NP	Oof	inflammation	of	IN	B-PP	Oinflammation	genes	inflammation	NN	B-NP	Ogenes	.	gene	NNS	I-NP	O.	On	.	.	O	OOn	activation	On	IN	B-PP	Oactivation	","	activation	NN	B-NP	O","	NF	","	","	O	ONF	kappa	NF	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	is	B	NN	I-NP	I-proteinis	rapidly	be	VBZ	B-VP	Orapidly	released	rapidly	RB	I-VP	Oreleased	from	release	VBN	I-VP	Ofrom	its	from	IN	B-PP	Oits	cytoplasmic	its	PRP$	B-NP	Ocytoplasmic	inhibitor	cytoplasmic	JJ	I-NP	B-proteininhibitor	(	inhibitor	NN	I-NP	I-protein(	I	(	(	O	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	)	B	NN	I-NP	I-protein)	","	)	)	O	O","	transmigrates	","	","	O	Otransmigrates	into	transmigrate	VBZ	B-VP	Ointo	the	into	IN	B-PP	Othe	nucleus	the	DT	B-NP	Onucleus	","	nucleus	NN	I-NP	O","	and	","	","	O	Oand	binds	and	CC	O	Obinds	to	bind	VBZ	B-VP	Oto	DNA	to	TO	B-PP	ODNA	response	DNA	NN	B-NP	B-DNAresponse	elements	response	NN	I-NP	I-DNAelements	in	element	NNS	I-NP	I-DNAin	gene	in	IN	B-PP	Ogene	promoter	gene	NN	B-NP	B-DNApromoter	regions	promoter	NN	I-NP	I-DNAregions	.	region	NNS	I-NP	I-DNA.	AIMS	.	.	O	OAIMS	:	AIMS	NNS	B-NP	O:	To	:	:	O	OTo	investigate	To	TO	B-VP	Oinvestigate	whether	investigate	VB	I-VP	Owhether	increased	whether	IN	B-SBAR	Oincreased	activation	increase	VBN	B-NP	Oactivation	of	activation	NN	I-NP	Oof	NF	of	IN	B-PP	ONF	kappa	NF	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	is	B	NN	I-NP	I-proteinis	important	be	VBZ	B-VP	Oimportant	in	important	JJ	B-ADJP	Oin	IBD	in	IN	B-PP	OIBD	and	IBD	NN	B-NP	Oand	may	and	CC	O	Omay	be	may	MD	B-VP	Obe	down-regulated	be	VB	I-VP	Odown-regulated	by	down-regulate	VBN	I-VP	Oby	anti-inflammatory	by	IN	B-PP	Oanti-inflammatory	treatment	anti-inflammatory	JJ	B-NP	Otreatment	.	treatment	NN	I-NP	O.	METHODS	.	.	O	OMETHODS	:	METHODS	NNS	B-NP	O:	Activation	:	:	O	OActivation	of	Activation	NN	B-NP	Oof	NF	of	IN	B-PP	ONF	kappa	NF	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	was	B	NN	I-NP	I-proteinwas	determined	be	VBD	B-VP	Odetermined	by	determine	VBN	I-VP	Oby	western	by	IN	B-PP	Owestern	blot	western	JJ	B-NP	Oblot	assessment	blot	NN	I-NP	Oassessment	and	assessment	NN	I-NP	Oand	electrophoretic	and	CC	O	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assay	shift	NN	I-NP	Oassay	in	assay	NN	I-NP	Oin	nuclear	in	IN	B-PP	Onuclear	extracts	nuclear	JJ	B-NP	Oextracts	of	extract	NNS	I-NP	Oof	colonic	of	IN	B-PP	Ocolonic	biopsy	colonic	JJ	B-NP	Obiopsy	samples	biopsy	NN	I-NP	Osamples	as	sample	NNS	I-NP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	lamina	as	IN	I-CONJP	Olamina	propria	lamina	NN	B-NP	B-cell_typepropria	mononuclear	propria	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	Nuclear	:	:	O	ONuclear	levels	Nuclear	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	NF	of	IN	B-PP	ONF	kappa	NF	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	p65	B	NN	I-NP	I-proteinp65	are	p65	NN	I-NP	I-proteinare	increased	be	VBP	B-VP	Oincreased	in	increase	VBN	I-VP	Oin	lamina	in	IN	B-PP	Olamina	propria	lamina	NN	B-NP	Opropria	biopsy	propria	NN	I-NP	Obiopsy	specimens	biopsy	NN	I-NP	Ospecimens	from	specimen	NNS	I-NP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	Crohn	with	IN	B-PP	OCrohn	's	Crohn	NN	B-NP	O's	disease	's	POS	B-NP	Odisease	in	disease	NN	I-NP	Oin	comparison	in	IN	B-PP	Ocomparison	with	comparison	NN	B-NP	Owith	patients	with	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	ulcerative	with	IN	B-PP	Oulcerative	colitis	ulcerative	JJ	B-NP	Ocolitis	and	colitis	NN	I-NP	Oand	controls	and	CC	I-NP	Ocontrols	.	control	NNS	I-NP	O.	Increased	.	.	O	OIncreased	activation	Increase	VBN	B-NP	Oactivation	of	activation	NN	I-NP	Oof	NF	of	IN	B-PP	ONF	kappa	NF	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	was	B	NN	I-NP	I-proteinwas	detected	be	VBD	B-VP	Odetected	in	detect	VBN	I-VP	Oin	lamina	in	IN	B-PP	Olamina	propria	lamina	NN	B-NP	B-cell_typepropria	mononuclear	propria	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	active	with	IN	B-PP	Oactive	IBD	active	JJ	B-NP	OIBD	.	IBD	NN	I-NP	O.	Corticosteroids	.	.	O	OCorticosteroids	strongly	Corticosteroid	NNS	B-NP	Ostrongly	inhibit	strongly	RB	B-VP	Oinhibit	intestinal	inhibit	VBP	I-VP	Ointestinal	NF	intestinal	JJ	B-NP	ONF	kappa	NF	NN	I-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	activation	B	NN	I-NP	I-proteinactivation	in	activation	NN	I-NP	Oin	IBD	in	IN	B-PP	OIBD	in	IBD	NN	B-NP	Oin	vivo	in	FW	B-ADVP	Ovivo	and	vivo	FW	I-ADVP	Oand	in	and	CC	O	Oin	vitro	in	FW	B-ADVP	Ovitro	by	vitro	FW	I-ADVP	Oby	stabilising	by	IN	B-PP	Ostabilising	the	stabilise	VBG	B-VP	Othe	cytosolic	the	DT	B-NP	Ocytosolic	inhibitor	cytosolic	JJ	I-NP	B-proteininhibitor	I	inhibitor	NN	I-NP	I-proteinI	kappa	I	NN	I-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	against	alpha	NN	I-NP	I-proteinagainst	activation	against	IN	B-PP	Oactivation	induced	activation	NN	B-NP	Oinduced	degradation	induce	VBN	I-NP	Odegradation	.	degradation	NN	I-NP	O.	CONCLUSIONS	.	.	O	OCONCLUSIONS	:	CONCLUSIONS	NNS	B-NP	O:	In	:	:	O	OIn	both	In	IN	B-PP	Oboth	IBDs	both	DT	B-NP	OIBDs	","	IBD	NNS	I-NP	B-protein","	but	","	","	O	Obut	particularly	but	CC	O	Oparticularly	Crohn	particularly	RB	B-ADVP	OCrohn	's	Crohn	NNP	B-NP	O's	disease	's	POS	B-NP	Odisease	","	disease	NN	I-NP	O","	increased	","	","	O	Oincreased	activation	increase	VBD	B-VP	Oactivation	of	activation	NN	B-NP	Oof	NF	of	IN	B-PP	ONF	kappa	NF	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	may	B	NN	I-NP	I-proteinmay	be	may	MD	B-VP	Obe	involved	be	VB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	inflammatory	the	DT	B-NP	Oinflammatory	response	inflammatory	JJ	I-NP	Oresponse	.	response	NN	I-NP	O.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	NF	of	IN	B-PP	ONF	kappa	NF	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	activation	B	NN	I-NP	I-proteinactivation	may	activation	NN	I-NP	Omay	represent	may	MD	B-VP	Orepresent	a	represent	VB	I-VP	Oa	mechanism	a	DT	B-NP	Omechanism	by	mechanism	NN	I-NP	Oby	which	by	IN	B-PP	Owhich	steroids	which	WDT	B-NP	Osteroids	exert	steroid	NNS	B-NP	Oexert	an	exert	VBP	B-VP	Oan	anti-inflammatory	an	DT	B-NP	Oanti-inflammatory	effect	anti-inflammatory	JJ	I-NP	Oeffect	in	effect	NN	I-NP	Oin	IBD	in	IN	B-PP	OIBD	Insufficient	IBD	NN	B-NP	OInsufficient	glycemic	Insufficient	JJ	B-NP	Oglycemic	control	glycemic	JJ	I-NP	Ocontrol	increases	control	NN	I-NP	Oincreases	nuclear	increase	VBZ	B-VP	Onuclear	factor-kappa	nuclear	JJ	B-NP	B-proteinfactor-kappa	B	factor-kappa	NN	I-NP	I-proteinB	binding	B	NN	I-NP	I-proteinbinding	activity	binding	NN	I-NP	Oactivity	in	activity	NN	I-NP	Oin	peripheral	in	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	isolated	cell	NNS	I-NP	I-cell_typeisolated	from	isolate	VBN	B-VP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	type	with	IN	B-PP	Otype	1	type	NN	B-NP	O1	diabetes	1	CD	I-NP	Odiabetes	.	diabetes	NN	I-NP	O.	OBJECTIVE	.	.	O	OOBJECTIVE	:	OBJECTIVE	NN	B-NP	O:	The	:	:	O	OThe	redox-sensitive	The	DT	B-NP	Oredox-sensitive	transcription	redox-sensitive	JJ	I-NP	B-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	nuclear	factor	NN	I-NP	I-proteinnuclear	factor-kappa	nuclear	JJ	I-NP	B-proteinfactor-kappa	B	factor-kappa	NN	I-NP	I-proteinB	(	B	NN	I-NP	I-protein(	NF-kappa	(	(	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	)	B	NN	I-NP	I-protein)	is	)	)	O	Ois	believed	be	VBZ	B-VP	Obelieved	to	believe	VBN	I-VP	Oto	contribute	to	TO	I-VP	Ocontribute	to	contribute	VB	I-VP	Oto	late	to	TO	B-PP	Olate	diabetic	late	JJ	B-NP	Odiabetic	complications	diabetic	JJ	I-NP	Ocomplications	.	complication	NNS	I-NP	O.	It	.	.	O	OIt	is	It	PRP	B-NP	Ois	unknown	be	VBZ	B-VP	Ounknown	whether	unknown	JJ	B-ADJP	Owhether	NF-kappa	whether	IN	B-SBAR	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	is	B	NN	I-NP	I-proteinis	influenced	be	VBZ	B-VP	Oinfluenced	by	influence	VBN	I-VP	Oby	glycemic	by	IN	B-PP	Oglycemic	control	glycemic	JJ	B-NP	Ocontrol	.	control	NN	I-NP	O.	RESEARCH	.	.	O	ORESEARCH	DESIGN	RESEARCH	NN	B-NP	ODESIGN	AND	DESIGN	NN	I-NP	OAND	METHODS	AND	CC	B-NP	OMETHODS	:	METHODS	NNS	I-NP	O:	To	:	:	O	OTo	determine	To	TO	B-VP	Odetermine	whether	determine	VB	I-VP	Owhether	NF-kappa	whether	IN	B-SBAR	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	is	B	NN	I-NP	I-proteinis	activated	be	VBZ	B-VP	Oactivated	in	activate	VBN	I-VP	Oin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	insufficient	with	IN	B-PP	Oinsufficient	glycemic	insufficient	JJ	B-NP	Oglycemic	control	glycemic	JJ	I-NP	Ocontrol	(	control	NN	I-NP	O(	HbA1c	(	(	O	OHbA1c	>	HbA1c	NN	B-NP	O>	10	>	SYM	O	O10	%	10	CD	B-NP	O%	)	%	NN	I-NP	O)	","	)	)	O	O","	we	","	","	O	Owe	developed	we	PRP	B-NP	Odeveloped	a	develop	VBD	B-VP	Oa	tissue	a	DT	B-NP	Otissue	culture-independent	tissue	NN	I-NP	Oculture-independent	electrophoretic	culture-independent	JJ	I-NP	Oelectrophoretic	mobility	electrophoretic	JJ	I-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assay	shift	NN	I-NP	Oassay	(	assay	NN	I-NP	O(	EMSA	(	(	O	OEMSA	)	EMSA	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	semiquantitative	#NAME?	JJ	B-NP	Osemiquantitative	detection	semiquantitative	JJ	I-NP	Odetection	system	detection	NN	I-NP	Osystem	that	system	NN	I-NP	Othat	allowed	that	WDT	B-NP	Oallowed	us	allow	VBD	B-VP	Ous	to	us	PRP	B-NP	Oto	determine	to	TO	B-VP	Odetermine	NF-kappa	determine	VB	I-VP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	in	activation	NN	I-NP	Oin	ex	in	IN	B-PP	Oex	vivo-isolated	ex	NN	B-NP	Ovivo-isolated	peripheral	vivo-isolated	JJ	I-NP	Operipheral	blood	peripheral	JJ	I-NP	B-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	PBMCs	(	(	O	OPBMCs	)	PBMC	NNS	B-NP	B-cell_type)	.	)	)	O	O.	We	.	.	O	OWe	included	We	PRP	B-NP	Oincluded	43	include	VBD	B-VP	O43	patients	43	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	type	with	IN	B-PP	Otype	1	type	NN	B-NP	O1	diabetes	1	CD	I-NP	Odiabetes	in	diabetes	NN	I-NP	Oin	this	in	IN	B-PP	Othis	cross-sectional	this	DT	B-NP	Ocross-sectional	study	cross-sectional	JJ	I-NP	Ostudy	.	study	NN	I-NP	O.	10	.	.	O	O10	of	10	CD	B-NP	Oof	those	of	IN	B-PP	Othose	received	those	DT	B-NP	Oreceived	the	receive	VBD	B-VP	Othe	antioxidant	the	DT	B-NP	Oantioxidant	thioctic	antioxidant	JJ	I-NP	Othioctic	acid	thioctic	JJ	I-NP	Oacid	(	acid	NN	I-NP	O(	600	(	(	O	O600	mg/day	600	CD	B-NP	Omg/day	p.o.	mg/day	NN	I-NP	Op.o.	)	p.o.	NN	I-NP	O)	for	)	)	O	Ofor	2	for	IN	B-PP	O2	weeks	2	CD	B-NP	Oweeks	.	week	NNS	I-NP	O.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	Monocytes	:	:	O	OMonocytes	of	Monocyte	NNS	B-NP	B-cell_typeof	patients	of	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	HbA1c	with	IN	B-PP	OHbA1c	levels	HbA1c	NN	B-NP	Olevels	>	level	NNS	I-NP	O>	10	>	SYM	B-NP	O10	%	10	CD	B-NP	O%	demonstrated	%	NN	I-NP	Odemonstrated	significantly	demonstrate	VBD	B-VP	Osignificantly	higher	significantly	RB	B-NP	Ohigher	NF-kappa	high	JJR	I-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	binding	B	NN	I-NP	I-proteinbinding	activity	binding	NN	I-NP	Oactivity	in	activity	NN	I-NP	Oin	an	in	IN	B-PP	Oan	EMSA	an	DT	B-NP	OEMSA	and	EMSA	NN	I-NP	Oand	a	and	CC	O	Oa	stronger	a	DT	B-NP	Ostronger	NF-kappa	strong	JJR	I-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	staining	B	NN	I-NP	I-proteinstaining	in	staining	NN	I-NP	Oin	immunohistochemistry	in	IN	B-PP	Oimmunohistochemistry	than	immunohistochemistry	NN	B-NP	Othan	monocytes	than	IN	B-PP	Omonocytes	of	monocyte	NNS	B-NP	B-cell_typeof	patients	of	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	HbA1c	with	IN	B-PP	OHbA1c	levels	HbA1c	NN	B-NP	Olevels	of	level	NNS	I-NP	Oof	8-Jun	of	IN	B-PP	O8-Jun	%	8-Jun	CD	B-NP	O%	.	%	NN	I-NP	O.	The	.	.	O	OThe	increase	The	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	NF-kappa	in	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	correlated	activation	NN	I-NP	Ocorrelated	with	correlate	VBD	B-VP	Owith	an	with	IN	B-PP	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	plasmatic	in	IN	B-PP	Oplasmatic	markers	plasmatic	JJ	B-NP	Omarkers	of	marker	NNS	I-NP	Oof	lipid	of	IN	B-PP	Olipid	peroxidation	lipid	NN	B-NP	Operoxidation	.	peroxidation	NN	I-NP	O.	Treatment	.	.	O	OTreatment	with	Treatment	NN	B-NP	Owith	the	with	IN	B-PP	Othe	antioxidant	the	DT	B-NP	Oantioxidant	thioctic	antioxidant	JJ	I-NP	Othioctic	acid	thioctic	JJ	I-NP	Oacid	decreased	acid	NN	I-NP	Odecreased	NF-kappa	decrease	VBD	B-VP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	binding	B	NN	I-NP	I-proteinbinding	activity	binding	NN	I-NP	Oactivity	.	activity	NN	I-NP	O.	CONCLUSIONS	.	.	O	OCONCLUSIONS	:	CONCLUSIONS	NNS	B-NP	O:	Hyperglycemia	:	:	O	OHyperglycemia	induces	Hyperglycemia	NN	B-NP	Oinduces	activation	induce	VBZ	B-VP	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	NF-kappa	factor	NN	I-NP	I-proteinNF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	in	B	NN	I-NP	I-proteinin	ex	in	IN	B-PP	Oex	vivo-isolated	ex	NN	B-NP	Ovivo-isolated	PBMCs	vivo-isolated	JJ	I-NP	OPBMCs	of	PBMC	NNS	I-NP	B-cell_typeof	patients	of	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	type	with	IN	B-PP	Otype	1	type	NN	B-NP	O1	diabetes	1	CD	I-NP	Odiabetes	.	diabetes	NN	I-NP	O.	NF-kappa	.	.	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	is	activation	NN	I-NP	Ois	at	be	VBZ	B-VP	Oat	least	at	IN	B-ADVP	Oleast	partially	least	JJS	I-ADVP	Opartially	dependent	partially	RB	B-ADJP	Odependent	on	dependent	JJ	I-ADJP	Oon	oxidative	on	IN	B-PP	Ooxidative	stress	oxidative	JJ	B-NP	Ostress	","	stress	NN	I-NP	O","	since	","	","	O	Osince	the	since	IN	B-SBAR	Othe	antioxidant	the	DT	B-NP	Oantioxidant	thioctic	antioxidant	JJ	I-NP	Othioctic	acid	thioctic	JJ	I-NP	Oacid	significantly	acid	NN	I-NP	Osignificantly	lowered	significantly	RB	B-ADVP	Olowered	the	lower	VBD	B-VP	Othe	extent	the	DT	B-NP	Oextent	of	extent	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	binding	B	NN	I-NP	I-proteinbinding	activity	binding	NN	I-NP	Oactivity	.	activity	NN	I-NP	O.	Synergistic	.	.	O	OSynergistic	activation	Synergistic	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	MAP	of	IN	B-PP	OMAP	kinase	MAP	NN	B-NP	B-proteinkinase	(	kinase	NN	I-NP	I-protein(	ERK1/2	(	(	O	OERK1/2	)	ERK1/2	NN	B-NP	B-protein)	by	)	)	O	Oby	erythropoietin	by	IN	B-PP	Oerythropoietin	and	erythropoietin	NN	B-NP	B-proteinand	stem	and	CC	I-NP	Ostem	cell	stem	NN	I-NP	B-proteincell	factor	cell	NN	I-NP	I-proteinfactor	is	factor	NN	I-NP	I-proteinis	essential	be	VBZ	B-VP	Oessential	for	essential	JJ	B-ADJP	Ofor	expanded	for	IN	B-PP	Oexpanded	erythropoiesis	expand	VBN	B-NP	Oerythropoiesis	.	erythropoiesis	NN	I-NP	O.	Stem	.	.	O	OStem	cell	Stem	NN	B-NP	B-proteincell	factor	cell	NN	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	SCF	(	(	O	OSCF	)	SCF	NN	B-NP	B-protein)	and	)	)	O	Oand	erythropoietin	and	CC	O	Oerythropoietin	(	erythropoietin	NN	B-NP	B-protein(	EPO	(	(	O	OEPO	)	EPO	NN	B-NP	B-protein)	work	)	)	O	Owork	synergistically	work	NN	B-NP	Osynergistically	to	synergistically	RB	B-ADVP	Oto	support	to	TO	B-VP	Osupport	erythropoiesis	support	VB	I-VP	Oerythropoiesis	","	erythropoiesis	NN	B-NP	O","	but	","	","	O	Obut	the	but	CC	O	Othe	mechanism	the	DT	B-NP	Omechanism	for	mechanism	NN	I-NP	Ofor	this	for	IN	B-PP	Othis	synergism	this	DT	B-NP	Osynergism	is	synergism	NN	I-NP	Ois	unknown	be	VBZ	B-VP	Ounknown	.	unknown	JJ	B-ADJP	O.	By	.	.	O	OBy	using	By	IN	B-PP	Ousing	purified	use	VBG	B-VP	Opurified	human	purify	VBN	B-NP	B-cell_linehuman	erythroid	human	JJ	I-NP	I-cell_lineerythroid	colony-forming	erythroid	JJ	I-NP	I-cell_linecolony-forming	cells	colony-forming	JJ	I-NP	I-cell_linecells	(	cell	NNS	I-NP	I-cell_line(	ECFC	(	(	O	OECFC	)	ECFC	NN	B-NP	B-cell_type)	","	)	)	O	O","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	found	have	VBP	B-VP	Ofound	that	find	VBN	I-VP	Othat	SCF	that	IN	B-SBAR	OSCF	and	SCF	NN	B-NP	B-proteinand	EPO	and	CC	I-NP	OEPO	synergistically	EPO	NN	I-NP	B-proteinsynergistically	activate	synergistically	RB	B-ADVP	Oactivate	MAP	activate	VBP	B-VP	OMAP	kinase	MAP	NN	B-NP	B-proteinkinase	(	kinase	NN	I-NP	I-protein(	MAPK	(	(	O	OMAPK	","	MAPK	NN	B-NP	B-protein","	ERK1/2	","	","	O	OERK1/2	)	ERK1/2	NN	B-NP	B-protein)	","	)	)	O	O","	which	","	","	O	Owhich	correlates	which	WDT	B-NP	Ocorrelates	with	correlate	VBZ	B-VP	Owith	the	with	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	growth	cell	NN	I-NP	Ogrowth	and	growth	NN	I-NP	Oand	thus	and	CC	O	Othus	may	thus	RB	B-VP	Omay	be	may	MD	I-VP	Obe	responsible	be	VB	I-VP	Oresponsible	for	responsible	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	synergistic	the	DT	B-NP	Osynergistic	effects	synergistic	JJ	I-NP	Oeffects	.	effect	NNS	I-NP	O.	Treatment	.	.	O	OTreatment	of	Treatment	NN	B-NP	Oof	the	of	IN	B-PP	Othe	cells	the	DT	B-NP	Ocells	with	cell	NNS	I-NP	Owith	PD98059	with	IN	B-PP	OPD98059	and	PD98059	NN	B-NP	Oand	wortmannin	and	CC	I-NP	Owortmannin	","	wortmannin	NN	I-NP	O","	inhibitors	","	","	O	Oinhibitors	of	inhibitor	NNS	B-NP	Oof	MEK	of	IN	B-PP	OMEK	and	MEK	NN	B-NP	B-proteinand	PI-3	and	CC	I-NP	OPI-3	kinase	PI-3	NN	I-NP	B-proteinkinase	","	kinase	NN	I-NP	I-protein","	respectively	","	","	O	Orespectively	","	respectively	RB	B-ADVP	O","	inhibited	","	","	O	Oinhibited	the	inhibit	VBD	B-VP	Othe	synergistic	the	DT	B-NP	Osynergistic	activation	synergistic	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	MAPK	of	IN	B-PP	OMAPK	and	MAPK	NN	B-NP	B-proteinand	also	and	CC	O	Oalso	the	also	RB	B-ADVP	Othe	cell	the	DT	B-NP	Ocell	growth	cell	NN	I-NP	Ogrowth	","	growth	NN	I-NP	O","	further	","	","	O	Ofurther	supporting	further	RB	B-VP	Osupporting	this	support	VBG	I-VP	Othis	conclusion	this	DT	B-NP	Oconclusion	.	conclusion	NN	I-NP	O.	Wortmannin	.	.	O	OWortmannin	only	Wortmannin	NN	B-NP	Oonly	inhibits	only	RB	B-ADVP	Oinhibits	MAPK	inhibit	VBZ	B-VP	OMAPK	activation	MAPK	NN	B-NP	B-proteinactivation	induced	activation	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	EPO	by	IN	B-PP	OEPO	but	EPO	NN	B-NP	B-proteinbut	not	but	CC	B-CONJP	Onot	that	not	RB	I-CONJP	Othat	by	that	DT	B-NP	Oby	SCF	by	IN	B-PP	OSCF	","	SCF	NN	B-NP	B-protein","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	SCF	that	IN	B-SBAR	OSCF	and	SCF	NN	B-NP	B-proteinand	EPO	and	CC	I-NP	OEPO	may	EPO	NN	I-NP	B-proteinmay	activate	may	MD	B-VP	Oactivate	MAPK	activate	VB	I-VP	OMAPK	through	MAPK	NN	B-NP	B-proteinthrough	different	through	IN	B-PP	Odifferent	pathways	different	JJ	B-NP	Opathways	","	pathway	NNS	I-NP	O","	which	","	","	O	Owhich	would	which	WDT	B-NP	Owould	facilitate	would	MD	B-VP	Ofacilitate	synergy	facilitate	VB	I-VP	Osynergy	.	synergy	NN	B-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	EPO	","	","	O	OEPO	","	EPO	NN	B-NP	B-protein","	but	","	","	O	Obut	not	but	CC	O	Onot	SCF	not	RB	O	OSCF	","	SCF	NN	B-NP	B-protein","	led	","	","	O	Oled	to	lead	VBD	B-VP	Oto	activation	to	TO	B-PP	Oactivation	of	activation	NN	B-NP	Oof	STAT5	of	IN	B-PP	OSTAT5	","	STAT5	NN	B-NP	B-protein","	whereas	","	","	O	Owhereas	SCF	whereas	IN	O	OSCF	and	SCF	NN	B-NP	B-proteinand	wortmannin	and	CC	I-NP	Owortmannin	had	wortmannin	NN	I-NP	Ohad	no	have	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	on	effect	NN	I-NP	Oon	the	on	IN	B-PP	Othe	EPO	the	DT	B-NP	OEPO	#NAME?	EPO	NN	I-NP	B-protein#NAME?	STAT5	#NAME?	JJ	I-NP	OSTAT5	activation	STAT5	NN	I-NP	B-proteinactivation	","	activation	NN	I-NP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	STAT5	that	IN	B-SBAR	OSTAT5	is	STAT5	NN	B-NP	B-proteinis	not	be	VBZ	B-VP	Onot	involved	not	RB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	synergistic	the	DT	B-NP	Osynergistic	action	synergistic	JJ	I-NP	Oaction	of	action	NN	I-NP	Oof	SCF	of	IN	B-PP	OSCF	and	SCF	NN	B-NP	B-proteinand	EPO	and	CC	I-NP	OEPO	.	EPO	NN	I-NP	B-protein.	Together	.	.	O	OTogether	","	Together	RB	B-ADVP	O","	the	","	","	O	Othe	data	the	DT	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	synergistic	that	IN	B-SBAR	Osynergistic	activation	synergistic	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	MAPK	of	IN	B-PP	OMAPK	by	MAPK	NN	B-NP	B-proteinby	SCF	by	IN	B-PP	OSCF	and	SCF	NN	B-NP	B-proteinand	EPO	and	CC	I-NP	OEPO	is	EPO	NN	I-NP	B-proteinis	essential	be	VBZ	B-VP	Oessential	for	essential	JJ	B-ADJP	Ofor	expanded	for	IN	B-PP	Oexpanded	erythropoiesis	expand	VBN	B-NP	Oerythropoiesis	.	erythropoiesis	NN	I-NP	O.	Copyright	.	.	O	OCopyright	1998	Copyright	NN	B-NP	O1998	by	1998	CD	I-NP	Oby	The	by	IN	B-PP	OThe	American	The	NNP	B-NP	OAmerican	Society	American	NNP	I-NP	OSociety	of	Society	NNP	I-NP	Oof	Hematology	of	IN	B-PP	OHematology	.	Hematology	NNP	B-NP	O.	The	.	.	O	OThe	molecular	The	DT	B-NP	Omolecular	and	molecular	JJ	I-NP	Oand	phenotypic	and	CC	I-NP	Ophenotypic	profile	phenotypic	JJ	I-NP	Oprofile	of	profile	NN	I-NP	Oof	primary	of	IN	B-PP	Oprimary	central	primary	JJ	B-NP	Ocentral	nervous	central	JJ	I-NP	Onervous	system	nervous	JJ	I-NP	Osystem	lymphoma	system	NN	I-NP	Olymphoma	identifies	lymphoma	NN	I-NP	Oidentifies	distinct	identify	VBZ	B-VP	Odistinct	categories	distinct	JJ	B-NP	Ocategories	of	category	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	disease	the	DT	B-NP	Odisease	and	disease	NN	I-NP	Oand	is	and	CC	O	Ois	consistent	be	VBZ	B-VP	Oconsistent	with	consistent	JJ	B-ADJP	Owith	histogenetic	with	IN	B-PP	Ohistogenetic	derivation	histogenetic	JJ	B-NP	Oderivation	from	derivation	NN	I-NP	Ofrom	germinal	from	IN	B-PP	Ogerminal	center-related	germinal	JJ	B-NP	B-cell_typecenter-related	B	center-related	JJ	I-NP	I-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Primary	.	.	O	OPrimary	central	Primary	JJ	B-NP	Ocentral	nervous	central	JJ	I-NP	Onervous	system	nervous	JJ	I-NP	Osystem	lymphoma	system	NN	I-NP	Olymphoma	(	lymphoma	NN	I-NP	O(	PCNSL	(	(	O	OPCNSL	)	PCNSL	NN	B-NP	B-protein)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	major	a	DT	B-NP	Omajor	cause	major	JJ	I-NP	Ocause	of	cause	NN	I-NP	Oof	morbidity	of	IN	B-PP	Omorbidity	and	morbidity	NN	B-NP	Oand	mortality	and	CC	I-NP	Omortality	among	mortality	NN	I-NP	Oamong	human	among	IN	B-PP	Ohuman	immunodeficiency	human	JJ	B-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	(	virus	NN	I-NP	O(	HIV	(	(	O	OHIV	)	HIV	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	individuals	#NAME?	JJ	B-NP	Oindividuals	.	individual	NNS	I-NP	O.	The	.	.	O	OThe	precise	The	DT	B-NP	Oprecise	histogenetic	precise	JJ	I-NP	Ohistogenetic	derivation	histogenetic	JJ	I-NP	Oderivation	and	derivation	NN	I-NP	Oand	the	and	CC	O	Othe	molecular	the	DT	B-NP	Omolecular	pathogenesis	molecular	JJ	I-NP	Opathogenesis	of	pathogenesis	NN	I-NP	Oof	PCNSL	of	IN	B-PP	OPCNSL	is	PCNSL	NN	B-NP	B-proteinis	poorly	be	VBZ	B-VP	Opoorly	understood	poorly	RB	I-VP	Ounderstood	.	understand	VBN	I-VP	O.	In	.	.	O	OIn	an	In	IN	B-PP	Oan	attempt	an	DT	B-NP	Oattempt	to	attempt	NN	I-NP	Oto	clarify	to	TO	B-VP	Oclarify	the	clarify	VB	I-VP	Othe	histogenesis	the	DT	B-NP	Ohistogenesis	and	histogenesis	NN	I-NP	Oand	pathogenesis	and	CC	I-NP	Opathogenesis	of	pathogenesis	NN	I-NP	Oof	these	of	IN	B-PP	Othese	lymphomas	these	DT	B-NP	Olymphomas	","	lymphoma	NNS	I-NP	O","	49	","	","	O	O49	PCNSL	49	CD	B-NP	OPCNSL	(	PCNSL	NN	I-NP	O(	26	(	(	O	O26	acquired	26	CD	B-NP	Oacquired	immunodeficiency	acquire	VBN	I-NP	Oimmunodeficiency	syndrome	immunodeficiency	NN	I-NP	Osyndrome	[	syndrome	NN	I-NP	O[	AIDS	[	(	I-NP	OAIDS	]	AIDS	NN	I-NP	O]	#NAME?	]	)	I-NP	O#NAME?	and	#NAME?	JJ	I-NP	Oand	23	and	CC	O	O23	AIDS-unrelated	23	CD	B-NP	OAIDS-unrelated	)	AIDS-unrelated	JJ	I-NP	O)	were	)	)	O	Owere	analyzed	be	VBD	B-VP	Oanalyzed	for	analyze	VBN	I-VP	Ofor	multiple	for	IN	B-PP	Omultiple	biologic	multiple	JJ	B-NP	Obiologic	markers	biologic	JJ	I-NP	Omarkers	","	marker	NNS	I-NP	O","	which	","	","	O	Owhich	are	which	WDT	B-NP	Oare	known	be	VBP	B-VP	Oknown	to	know	VBN	I-VP	Oto	bear	to	TO	I-VP	Obear	histogenetic	bear	VB	I-VP	Ohistogenetic	and	histogenetic	JJ	B-NP	Oand	pathogenetic	and	CC	I-NP	Opathogenetic	significance	pathogenetic	JJ	I-NP	Osignificance	for	significance	NN	I-NP	Ofor	mature	for	IN	B-PP	Omature	B-cell	mature	JJ	B-NP	B-cell_typeB-cell	neoplasms	B-cell	NN	I-NP	I-cell_typeneoplasms	.	neoplasm	NNS	I-NP	I-cell_type.	PCNSL	.	.	O	OPCNSL	associated	PCNSL	NN	B-NP	B-proteinassociated	frequently	associate	VBN	B-VP	Ofrequently	(	frequently	RB	B-ADVP	O(	50	(	(	O	O50	%	50	CD	B-NP	O%	)	%	NN	I-NP	O)	with	)	)	O	Owith	mutations	with	IN	B-PP	Omutations	of	mutation	NNS	B-NP	Oof	BCL-6	of	IN	B-PP	OBCL-6	5	BCL-6	NN	B-NP	B-DNA5	'	5	CD	I-NP	I-DNA'	noncoding	'	SYM	I-NP	I-DNAnoncoding	regions	noncoding	JJ	I-NP	I-DNAregions	","	region	NNS	I-NP	I-DNA","	which	","	","	O	Owhich	are	which	WDT	B-NP	Oare	regarded	be	VBP	B-VP	Oregarded	as	regard	VBN	I-VP	Oas	a	as	IN	B-PP	Oa	marker	a	DT	B-NP	Omarker	of	marker	NN	I-NP	Oof	B-cell	of	IN	B-PP	OB-cell	transition	B-cell	NN	B-NP	Otransition	through	transition	NN	I-NP	Othrough	the	through	IN	B-PP	Othe	germinal	the	DT	B-NP	Ogerminal	center	germinal	JJ	I-NP	Ocenter	(	center	NN	I-NP	O(	GC	(	(	O	OGC	)	GC	NN	B-NP	O)	.	)	)	O	O.	Expression	.	.	O	OExpression	of	Expression	NN	B-NP	Oof	BCL-6	of	IN	B-PP	OBCL-6	protein	BCL-6	NN	B-NP	B-proteinprotein	","	protein	NN	I-NP	I-protein","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	restricted	be	VBZ	B-VP	Orestricted	to	restricted	JJ	B-ADJP	Oto	GC	to	TO	B-PP	OGC	B	GC	NN	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	throughout	cell	NNS	I-NP	I-cell_typethroughout	physiologic	throughout	IN	B-PP	Ophysiologic	B-cell	physiologic	JJ	B-NP	OB-cell	maturation	B-cell	NN	I-NP	Omaturation	","	maturation	NN	I-NP	O","	was	","	","	O	Owas	detected	be	VBD	B-VP	Odetected	in	detect	VBN	I-VP	Oin	100	in	IN	B-PP	O100	%	100	CD	B-NP	O%	AIDS-unrelated	%	NN	I-NP	OAIDS-unrelated	PCNSL	AIDS-unrelated	JJ	I-NP	OPCNSL	and	PCNSL	NN	I-NP	Oand	in	and	CC	O	Oin	56.2	in	IN	B-PP	O56.2	%	56.2	CD	B-NP	O%	AIDS-related	%	NN	I-NP	OAIDS-related	cases	AIDS-related	JJ	I-NP	Ocases	.	case	NNS	I-NP	O.	Notably	.	.	O	ONotably	","	Notably	RB	B-ADVP	O","	among	","	","	O	Oamong	AIDS-related	among	IN	B-PP	OAIDS-related	PCNSL	AIDS-related	JJ	B-NP	OPCNSL	","	PCNSL	NN	I-NP	O","	expression	","	","	O	Oexpression	of	expression	NN	B-NP	Oof	BCL-6	of	IN	B-PP	OBCL-6	was	BCL-6	NN	B-NP	B-proteinwas	mutually	be	VBD	B-VP	Omutually	exclusive	mutually	RB	B-ADJP	Oexclusive	with	exclusive	JJ	I-ADJP	Owith	expression	with	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	Epstein-Barr	of	IN	B-PP	OEpstein-Barr	virus	Epstein-Barr	JJ	B-NP	B-proteinvirus	(	virus	NN	I-NP	I-protein(	EBV	(	(	O	I-proteinEBV	)	EBV	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	latent	#NAME?	JJ	B-NP	I-proteinlatent	membrane	latent	JJ	I-NP	I-proteinmembrane	protein	membrane	NN	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	LMP	(	(	O	OLMP	)	LMP	NN	B-NP	O)	-1	)	)	O	O-1	and	-1	CD	B-NP	Oand	","	and	CC	O	O","	with	","	","	O	Owith	few	with	IN	B-PP	Ofew	exceptions	few	JJ	B-NP	Oexceptions	","	exception	NNS	I-NP	O","	also	","	","	O	Oalso	of	also	RB	B-ADVP	Oof	BCL-2	of	IN	B-PP	OBCL-2	.	BCL-2	NN	B-NP	B-protein.	All	.	.	O	OAll	but	All	DT	B-NP	Obut	one	but	IN	I-NP	Oone	PCNSL	one	CD	I-NP	OPCNSL	expressed	PCNSL	NN	I-NP	B-proteinexpressed	hMSH2	express	VBD	B-VP	OhMSH2	","	hMSH2	NN	B-NP	B-protein","	which	","	","	O	Owhich	among	which	WDT	B-NP	Oamong	mature	among	IN	B-PP	Omature	B	mature	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	selectively	cell	NNS	I-NP	I-cell_typeselectively	stains	selectively	RB	B-ADVP	Ostains	GC	stain	VBZ	B-VP	OGC	B	GC	NN	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	PCNSL	that	IN	B-SBAR	OPCNSL	may	PCNSL	NN	B-NP	B-proteinmay	be	may	MD	B-VP	Obe	frequently	be	VB	I-VP	Ofrequently	related	frequently	RB	I-VP	Orelated	to	relate	VBN	I-VP	Oto	GC	to	TO	B-PP	OGC	B	GC	NN	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	may	and	CC	O	Omay	be	may	MD	B-VP	Obe	segregated	be	VB	I-VP	Osegregated	into	segregate	VBN	I-VP	Ointo	two	into	IN	B-PP	Otwo	major	two	CD	B-NP	Omajor	biologic	major	JJ	I-NP	Obiologic	categories	biologic	JJ	I-NP	Ocategories	based	category	NNS	I-NP	Obased	on	base	VBN	B-PP	Oon	the	on	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	pattern	expression	NN	I-NP	Opattern	of	pattern	NN	I-NP	Oof	BCL-6	of	IN	B-PP	OBCL-6	","	BCL-6	NN	B-NP	B-protein","	LMP-1	","	","	O	OLMP-1	","	LMP-1	NN	B-NP	B-protein","	and	","	","	O	Oand	BCL-2	and	CC	O	OBCL-2	.	BCL-2	NN	B-NP	B-protein.	BCL-6	.	.	O	OBCL-6	(	BCL-6	NN	B-NP	B-protein(	+	(	(	O	O+	)	+	SYM	B-NP	O)	/	)	)	O	O/	LMP-1	/	SYM	B-NP	OLMP-1	(	LMP-1	NN	I-NP	B-protein(	-	(	(	O	O-	)	-	SYM	B-NP	O)	/	)	)	O	O/	BCL-2	/	SYM	B-NP	OBCL-2	(	BCL-2	NN	I-NP	B-protein(	-	(	(	O	O-	)	-	SYM	O	O)	PCNSL	)	)	O	OPCNSL	occur	PCNSL	NN	B-NP	Ooccur	both	occur	VBP	B-VP	Oboth	in	both	CC	O	Oin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	and	presence	NN	I-NP	Oand	in	and	CC	B-PP	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	HIV	of	IN	B-PP	OHIV	infection	HIV	NN	B-NP	Oinfection	and	infection	NN	I-NP	Oand	consistently	and	CC	O	Oconsistently	display	consistently	RB	B-VP	Odisplay	a	display	VBP	I-VP	Oa	large	a	DT	B-NP	Olarge	noncleaved	large	JJ	I-NP	Ononcleaved	cell	noncleaved	JJ	I-NP	Ocell	morphology	cell	NN	I-NP	Omorphology	.	morphology	NN	I-NP	O.	Conversely	.	.	O	OConversely	","	Conversely	RB	B-ADVP	O","	BCL-6	","	","	O	OBCL-6	(	BCL-6	NN	B-NP	B-protein(	-	(	(	O	O-	)	-	SYM	B-NP	O)	/	)	)	O	O/	LMP-1	/	SYM	B-NP	OLMP-1	(	LMP-1	NN	I-NP	B-protein(	+	(	(	O	O+	)	+	SYM	B-NP	O)	/	)	)	O	O/	BCL-2	/	SYM	B-NP	OBCL-2	(	BCL-2	NN	I-NP	B-protein(	+	(	(	O	O+	)	+	SYM	O	O)	PCNSL	)	)	O	OPCNSL	are	PCNSL	NN	B-NP	Oare	restricted	be	VBP	B-VP	Orestricted	to	restricted	JJ	B-ADJP	Oto	HIV-infected	to	TO	B-PP	OHIV-infected	hosts	HIV-infected	JJ	B-NP	Ohosts	and	host	NNS	I-NP	Oand	are	and	CC	O	Oare	represented	be	VBP	B-VP	Orepresented	by	represent	VBN	I-VP	Oby	lymphomas	by	IN	B-PP	Olymphomas	with	lymphoma	NNS	B-NP	Owith	immunoblastic	with	IN	B-PP	Oimmunoblastic	features	immunoblastic	JJ	B-NP	Ofeatures	.	feature	NNS	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	are	datum	NNS	I-NP	Oare	relevant	be	VBP	B-VP	Orelevant	for	relevant	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	pathogenesis	the	DT	B-NP	Opathogenesis	and	pathogenesis	NN	I-NP	Oand	histogenesis	and	CC	I-NP	Ohistogenesis	of	histogenesis	NN	I-NP	Oof	PCNSL	of	IN	B-PP	OPCNSL	and	PCNSL	NN	B-NP	B-proteinand	may	and	CC	O	Omay	be	may	MD	B-VP	Obe	helpful	be	VB	I-VP	Ohelpful	to	helpful	JJ	B-ADJP	Oto	segregate	to	TO	B-VP	Osegregate	distinct	segregate	VB	I-VP	Odistinct	biologic	distinct	JJ	B-NP	Obiologic	and	biologic	JJ	I-NP	Oand	prognostic	and	CC	I-NP	Oprognostic	categories	prognostic	JJ	I-NP	Ocategories	of	category	NNS	I-NP	Oof	these	of	IN	B-PP	Othese	lymphomas	these	DT	B-NP	Olymphomas	.	lymphoma	NNS	I-NP	O.	Copyright	.	.	O	OCopyright	1998	Copyright	NN	B-NP	O1998	by	1998	CD	I-NP	Oby	The	by	IN	B-PP	OThe	American	The	NNP	B-NP	OAmerican	Society	American	NNP	I-NP	OSociety	of	Society	NNP	I-NP	Oof	Hematology	of	IN	B-PP	OHematology	.	Hematology	NNP	B-NP	O.	Antioxidant	.	.	O	OAntioxidant	regulation	Antioxidant	JJ	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	phorbol	of	IN	B-PP	Ophorbol	ester-induced	phorbol	NN	B-NP	Oester-induced	adhesion	ester-induced	JJ	I-NP	Oadhesion	of	adhesion	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	Jurkat	human	JJ	B-NP	B-cell_lineJurkat	T-cells	Jurkat	NN	I-NP	I-cell_lineT-cells	to	T-cell	NNS	I-NP	I-cell_lineto	endothelial	to	TO	B-PP	Oendothelial	cells	endothelial	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Regulation	.	.	O	ORegulation	of	Regulation	NN	B-NP	Oof	adhesion	of	IN	B-PP	Oadhesion	molecule	adhesion	NN	B-NP	B-proteinmolecule	expression	molecule	NN	I-NP	I-proteinexpression	and	expression	NN	I-NP	Oand	function	and	CC	O	Ofunction	by	function	NN	B-NP	Oby	reactive	by	IN	B-PP	Oreactive	oxygen	reactive	JJ	B-NP	Ooxygen	species	oxygen	NN	I-NP	Ospecies	via	specie	NNS	I-NP	Ovia	specific	via	IN	B-PP	Ospecific	redox	specific	JJ	B-NP	Oredox	sensitive	redox	NN	I-NP	Osensitive	mechanisms	sensitive	JJ	I-NP	Omechanisms	have	mechanism	NNS	I-NP	Ohave	been	have	VBP	B-VP	Obeen	reported	be	VBN	I-VP	Oreported	.	report	VBN	I-VP	O.	The	.	.	O	OThe	effects	The	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	clinically	of	IN	B-PP	Oclinically	safe	clinically	RB	B-NP	Osafe	antioxidants	safe	JJ	I-NP	Oantioxidants	in	antioxidant	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	adhesion	of	IN	B-PP	Oadhesion	molecule	adhesion	NN	B-NP	B-proteinmolecule	expression	molecule	NN	I-NP	I-proteinexpression	in	expression	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	endothelial	human	JJ	B-NP	B-cell_typeendothelial	cells	endothelial	JJ	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	ECV	(	(	O	OECV	)	ECV	NN	B-NP	B-protein)	","	)	)	O	O","	and	","	","	O	Oand	adherence	and	CC	O	Oadherence	of	adherence	NN	B-NP	Oof	human	of	IN	B-PP	Ohuman	Jurkat	human	JJ	B-NP	B-cell_lineJurkat	T	Jurkat	NN	I-NP	I-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	to	cell	NNS	I-NP	I-cell_lineto	ECV	to	TO	B-PP	OECV	cells	ECV	NN	B-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	investigated	be	VBD	B-VP	Oinvestigated	.	investigate	VBN	I-VP	O.	The	.	.	O	OThe	thiol	The	DT	B-NP	Othiol	antioxidant	thiol	NN	I-NP	Oantioxidant	","	antioxidant	NN	I-NP	O","	alpha-lipoate	","	","	O	Oalpha-lipoate	","	alpha-lipoate	NN	B-NP	O","	at	","	","	O	Oat	clinically	at	IN	B-PP	Oclinically	relevant	clinically	RB	B-NP	Orelevant	doses	relevant	JJ	I-NP	Odoses	down-regulated	dose	NNS	I-NP	Odown-regulated	phorbol	down-regulate	VBD	B-VP	Ophorbol	12-myristate	phorbol	NN	B-NP	O12-myristate	13-acetate	12-myristate	NN	I-NP	O13-acetate	(	13-acetate	NN	I-NP	O(	PMA	(	(	O	OPMA	)	PMA	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	adhesion	#NAME?	JJ	B-NP	Oadhesion	molecule	adhesion	NN	I-NP	B-proteinmolecule	expression	molecule	NN	I-NP	I-proteinexpression	and	expression	NN	I-NP	Oand	cell-cell	and	CC	O	Ocell-cell	adhesion	cell-cell	JJ	B-NP	Oadhesion	.	adhesion	NN	I-NP	O.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	PMA-induced	of	IN	B-PP	OPMA-induced	ICAM-1	PMA-induced	JJ	B-NP	OICAM-1	and	ICAM-1	NN	I-NP	B-proteinand	VCAM-1	and	CC	I-NP	OVCAM-1	expression	VCAM-1	NN	I-NP	B-proteinexpression	as	expression	NN	I-NP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	PMA-induced	as	IN	I-CONJP	OPMA-induced	adhesion	PMA-induced	JJ	B-NP	Oadhesion	of	adhesion	NN	I-NP	Oof	Jurkat	of	IN	B-PP	OJurkat	T-cells	Jurkat	NN	B-NP	B-cell_lineT-cells	to	T-cell	NNS	I-NP	I-cell_lineto	ECV	to	TO	B-PP	OECV	cells	ECV	NN	B-NP	B-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	alpha-lipoate	by	IN	B-PP	Oalpha-lipoate	was	alpha-lipoate	NN	B-NP	Owas	dose	be	VBD	B-VP	Odose	dependent	dose	NN	B-NP	Odependent	(	dependent	JJ	B-ADJP	O(	50-250	(	(	O	O50-250	microM	50-250	CD	B-NP	OmicroM	)	microM	NN	I-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	effect	The	DT	B-NP	Oeffect	was	effect	NN	I-NP	Owas	significant	be	VBD	B-VP	Osignificant	for	significant	JJ	B-ADJP	Ofor	ICAM-1	for	IN	B-PP	OICAM-1	(	ICAM-1	NN	B-NP	B-protein(	p	(	(	O	Op	<	p	NN	B-NP	O<	0.01	<	JJR	B-NP	O0.01	)	0.01	CD	I-NP	O)	and	)	)	O	Oand	VCAM-1	and	CC	O	OVCAM-1	(	VCAM-1	NN	B-NP	B-protein(	p	(	(	O	Op	<	p	NN	B-NP	O<	0.01	<	JJR	B-NP	O0.01	)	0.01	CD	I-NP	O)	expression	)	)	O	Oexpression	in	expression	NN	B-NP	Oin	cells	in	IN	B-PP	Ocells	pretreated	cell	NNS	B-NP	Opretreated	with	pretreate	VBN	B-VP	Owith	100	with	IN	B-PP	O100	microM	100	CD	B-NP	OmicroM	alpha-lipoate	microM	NN	I-NP	Oalpha-lipoate	compared	alpha-lipoate	NN	I-NP	Ocompared	to	compare	VBN	B-VP	Oto	PMA-activated	to	TO	B-PP	OPMA-activated	untreated	PMA-activated	JJ	B-NP	B-cell_typeuntreated	cells	untreated	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	PMA-induced	of	IN	B-PP	OPMA-induced	adhesion	PMA-induced	JJ	B-NP	B-proteinadhesion	molecule	adhesion	NN	I-NP	I-proteinmolecule	expression	molecule	NN	I-NP	I-proteinexpression	and	expression	NN	I-NP	Oand	cell-cell	and	CC	O	Ocell-cell	adhesion	cell-cell	JJ	B-NP	Oadhesion	was	adhesion	NN	I-NP	Owas	more	be	VBD	B-VP	Omore	pronounced	more	RBR	B-ADJP	Opronounced	when	pronounced	JJ	I-ADJP	Owhen	a	when	WRB	B-ADVP	Oa	combination	a	DT	B-NP	Ocombination	of	combination	NN	I-NP	Oof	antioxidants	of	IN	B-PP	Oantioxidants	","	antioxidant	NNS	B-NP	O","	alpha-lipoate	","	","	I-NP	Oalpha-lipoate	and	alpha-lipoate	NN	I-NP	Oand	alpha-tocopherol	and	CC	I-NP	Oalpha-tocopherol	","	alpha-tocopherol	NN	I-NP	O","	were	","	","	O	Owere	used	be	VBD	B-VP	Oused	compared	use	VBN	I-VP	Ocompared	to	compare	VBN	B-PP	Oto	the	to	TO	B-PP	Othe	use	the	DT	B-NP	Ouse	of	use	NN	I-NP	Oof	either	of	IN	B-PP	Oeither	of	either	DT	B-NP	Oof	these	of	IN	B-PP	Othese	antioxidant	these	DT	B-NP	Oantioxidant	alone	antioxidant	NN	I-NP	Oalone	.	alone	RB	B-ADVP	O.	The	.	.	O	OThe	regulation	The	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	adhesion	of	IN	B-PP	Oadhesion	molecule	adhesion	NN	B-NP	B-proteinmolecule	expression	molecule	NN	I-NP	I-proteinexpression	and	expression	NN	I-NP	Oand	function	and	CC	O	Ofunction	by	function	NN	B-NP	Oby	low	by	IN	B-PP	Olow	concentration	low	JJ	B-NP	Oconcentration	of	concentration	NN	I-NP	Oof	antioxidants	of	IN	B-PP	Oantioxidants	investigated	antioxidant	NNS	B-NP	Oinvestigated	does	investigate	VBN	B-VP	Odoes	not	do	VBZ	B-VP	Onot	appear	not	RB	I-VP	Oappear	to	appear	VB	I-VP	Oto	be	to	TO	I-VP	Obe	NF-kappaB	be	VB	I-VP	ONF-kappaB	regulated	NF-kappaB	NN	B-NP	B-proteinregulated	or	regulated	JJ	B-ADJP	Oor	transcription	or	CC	O	Otranscription	dependent	transcription	NN	B-ADJP	Odependent	because	dependent	JJ	I-ADJP	Obecause	no	because	IN	B-SBAR	Ono	change	no	DT	B-NP	Ochange	in	change	NN	I-NP	Oin	the	in	IN	B-PP	Othe	mRNA	the	DT	B-NP	OmRNA	response	mRNA	NN	I-NP	B-RNAresponse	was	response	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	.	observe	VBN	I-VP	O.	Protein	.	.	O	OProtein	kinase	Protein	NN	B-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	(	C	NN	I-NP	I-protein(	PKC	(	(	O	OPKC	)	PKC	NN	B-NP	B-protein)	has	)	)	O	Ohas	been	have	VBZ	B-VP	Obeen	suggested	be	VBN	I-VP	Osuggested	to	suggest	VBN	I-VP	Oto	regulate	to	TO	I-VP	Oregulate	PMA-induced	regulate	VB	I-VP	OPMA-induced	adhesion	PMA-induced	JJ	B-NP	B-proteinadhesion	molecule	adhesion	NN	I-NP	I-proteinmolecule	expression	molecule	NN	I-NP	I-proteinexpression	by	expression	NN	I-NP	Oby	post-transcriptional	by	IN	B-PP	Opost-transcriptional	stabilization	post-transcriptional	JJ	B-NP	Ostabilization	of	stabilization	NN	I-NP	Oof	adhesion	of	IN	B-PP	Oadhesion	molecule	adhesion	NN	B-NP	B-RNAmolecule	mRNA	molecule	NN	I-NP	I-RNAmRNA	.	mRNA	NN	I-NP	I-RNA.	Alpha-lipoate	.	.	O	OAlpha-lipoate	pretreatment	Alpha-lipoate	JJ	B-NP	Opretreatment	did	pretreatment	NN	I-NP	Odid	not	do	VBD	B-VP	Onot	influence	not	RB	I-VP	Oinfluence	the	influence	VB	I-VP	Othe	response	the	DT	B-NP	Oresponse	of	response	NN	I-NP	Oof	PKC	of	IN	B-PP	OPKC	activity	PKC	NN	B-NP	B-proteinactivity	to	activity	NN	I-NP	Oto	PMA	to	TO	B-PP	OPMA	.	PMA	NN	B-NP	O.	Oxidants	.	.	O	OOxidants	are	Oxidant	NNS	B-NP	Oare	known	be	VBP	B-VP	Oknown	to	know	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	involved	be	VB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	cell	of	IN	B-PP	Ocell	adhesion	cell	NN	B-NP	Oadhesion	processes	adhesion	NN	I-NP	Oprocesses	.	process	NNS	I-NP	O.	Treatment	.	.	O	OTreatment	of	Treatment	NN	B-NP	Oof	ECV	of	IN	B-PP	OECV	cells	ECV	NN	B-NP	B-cell_linecells	with	cell	NNS	I-NP	I-cell_linewith	PMA	with	IN	B-PP	OPMA	induced	PMA	NN	B-NP	Oinduced	generation	induce	VBD	B-VP	Ogeneration	of	generation	NN	B-NP	Oof	intracellular	of	IN	B-PP	Ointracellular	oxidants	intracellular	JJ	B-NP	Ooxidants	.	oxidant	NNS	I-NP	O.	Alpha-lipoate	.	.	O	OAlpha-lipoate	(	Alpha-lipoate	NN	B-NP	O(	100	(	(	O	O100	or	100	CD	B-NP	Oor	250	or	CC	I-NP	O250	microM	250	CD	I-NP	OmicroM	)	microM	NN	I-NP	O)	treatment	)	)	O	Otreatment	decreased	treatment	NN	B-NP	Odecreased	PMA-induced	decrease	VBD	B-VP	OPMA-induced	generation	PMA-induced	JJ	B-NP	Ogeneration	of	generation	NN	I-NP	Oof	intracellular	of	IN	B-PP	Ointracellular	oxidants	intracellular	JJ	B-NP	Ooxidants	.	oxidant	NNS	I-NP	O.	The	.	.	O	OThe	inhibitory	The	DT	B-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	low	of	IN	B-PP	Olow	concentration	low	JJ	B-NP	Oconcentration	of	concentration	NN	I-NP	Oof	alpha-lipaote	of	IN	B-PP	Oalpha-lipaote	alone	alpha-lipaote	NN	B-NP	Oalone	or	alone	RB	B-ADVP	Oor	in	or	CC	O	Oin	combination	in	IN	B-PP	Ocombination	with	combination	NN	B-NP	Owith	alpha-tocopherol	with	IN	B-PP	Oalpha-tocopherol	on	alpha-tocopherol	NN	B-NP	Oon	agonist-induced	on	IN	B-PP	Oagonist-induced	adhesion	agonist-induced	JJ	B-NP	Oadhesion	processes	adhesion	NN	I-NP	Oprocesses	observed	process	NNS	I-NP	Oobserved	in	observe	VBN	B-VP	Oin	this	in	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	may	study	NN	I-NP	Omay	be	may	MD	B-VP	Obe	of	be	VB	I-VP	Oof	potential	of	IN	B-PP	Opotential	therapeutic	potential	JJ	B-NP	Otherapeutic	value	therapeutic	JJ	I-NP	Ovalue	.	value	NN	I-NP	O.	Binding	.	.	O	OBinding	of	Binding	NN	B-NP	Oof	human	of	IN	B-PP	Ohuman	immunodeficiency	human	JJ	B-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	to	1	CD	I-NP	Oto	CD4	to	TO	B-PP	OCD4	and	CD4	NN	B-NP	B-proteinand	CXCR4	and	CC	I-NP	OCXCR4	receptors	CXCR4	NN	I-NP	B-proteinreceptors	differentially	receptor	NNS	I-NP	I-proteindifferentially	regulates	differentially	RB	B-ADVP	Oregulates	expression	regulate	VBZ	B-VP	Oexpression	of	expression	NN	B-NP	Oof	inflammatory	of	IN	B-PP	Oinflammatory	genes	inflammatory	JJ	B-NP	B-DNAgenes	and	gene	NNS	I-NP	I-DNAand	activates	and	CC	O	Oactivates	the	activate	VBZ	B-VP	Othe	MEK	the	DT	B-NP	OMEK	/ERK	MEK	NN	I-NP	B-protein/ERK	signaling	/ERK	NN	I-NP	B-proteinsignaling	pathway	signaling	NN	I-NP	Opathway	.	pathway	NN	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	previously	have	VBP	B-VP	Opreviously	shown	previously	RB	I-VP	Oshown	that	show	VBN	I-VP	Othat	binding	that	IN	B-SBAR	Obinding	of	binding	NN	B-NP	Oof	human	of	IN	B-PP	Ohuman	immunodeficiency	human	JJ	B-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	(	1	CD	I-NP	O(	HIV-1	(	(	O	OHIV-1	)	HIV-1	NN	B-NP	O)	virions	)	)	O	Ovirions	to	virion	NNS	B-NP	Oto	CD4	to	TO	B-PP	OCD4	receptors	CD4	NN	B-NP	B-proteinreceptors	stimulates	receptor	NNS	I-NP	I-proteinstimulates	association	stimulate	VBZ	B-VP	Oassociation	of	association	NN	B-NP	Oof	Lck	of	IN	B-PP	OLck	with	Lck	NN	B-NP	B-proteinwith	Raf-1	with	IN	B-PP	ORaf-1	and	Raf-1	NN	B-NP	B-proteinand	results	and	CC	O	Oresults	in	result	VBZ	B-VP	Oin	the	in	IN	B-PP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	Raf-1	of	IN	B-PP	ORaf-1	kinase	Raf-1	NN	B-NP	B-proteinkinase	in	kinase	NN	I-NP	I-proteinin	a	in	IN	B-PP	Oa	Ras-independent	a	DT	B-NP	ORas-independent	manner	Ras-independent	JJ	I-NP	Omanner	.	manner	NN	I-NP	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	present	the	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	demonstrate	we	PRP	B-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	HIV-1	that	IN	B-SBAR	OHIV-1	envelope	HIV-1	NN	B-NP	B-proteinenvelope	glycoproteins	envelope	NN	I-NP	I-proteinglycoproteins	of	glycoprotein	NNS	I-NP	I-proteinof	both	of	IN	B-PP	Oboth	T-cell-tropic	both	CC	B-NP	OT-cell-tropic	and	T-cell-tropic	JJ	I-NP	Oand	macrophagetropic	and	CC	I-NP	Omacrophagetropic	strains	macrophagetropic	JJ	I-NP	Ostrains	rapidly	strain	NNS	I-NP	Orapidly	activate	rapidly	RB	B-ADVP	Oactivate	the	activate	VBP	B-VP	Othe	ERK/mitogen-activated	the	DT	B-NP	OERK/mitogen-activated	protein	ERK/mitogen-activated	JJ	I-NP	B-proteinprotein	(	protein	NN	I-NP	I-protein(	MAP	(	(	O	I-proteinMAP	)	MAP	NN	B-NP	I-protein)	kinase	)	)	O	I-proteinkinase	pathway	kinase	NN	B-NP	I-proteinpathway	and	pathway	NN	I-NP	Oand	the	and	CC	O	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	transcription	nuclear	JJ	B-NP	B-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	(	factor	NNS	I-NP	I-protein(	AP-1	(	(	O	OAP-1	","	AP-1	NN	B-NP	B-protein","	NF-kappaB	","	","	O	ONF-kappaB	","	NF-kappaB	NN	B-NP	B-protein","	and	","	","	O	Oand	C/EBP	and	CC	O	OC/EBP	)	C/EBP	NN	B-NP	B-protein)	and	)	)	O	Oand	stimulate	and	CC	O	Ostimulate	expression	stimulate	VBP	B-VP	Oexpression	of	expression	NN	B-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	and	cytokine	NN	B-NP	B-proteinand	chemokine	and	CC	I-NP	Ochemokine	genes	chemokine	NN	I-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	The	.	.	O	OThe	activation	The	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	this	of	IN	B-PP	Othis	signaling	this	DT	B-NP	Osignaling	pathway	signaling	NN	I-NP	Opathway	requires	pathway	NN	I-NP	Orequires	functional	require	VBZ	B-VP	Ofunctional	CD4	functional	JJ	B-NP	OCD4	receptors	CD4	NN	I-NP	B-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	is	and	CC	O	Ois	independent	be	VBZ	B-VP	Oindependent	of	independent	JJ	B-ADJP	Oof	binding	of	IN	B-PP	Obinding	to	bind	VBG	B-VP	Oto	CXCR4	to	TO	B-PP	OCXCR4	.	CXCR4	NN	B-NP	B-protein.	Binding	.	.	O	OBinding	of	Binding	NN	B-NP	Oof	the	of	IN	B-PP	Othe	natural	the	DT	B-NP	Onatural	ligand	natural	JJ	I-NP	B-proteinligand	stromal	ligand	NN	I-NP	I-proteinstromal	cell-derived	stromal	JJ	I-NP	I-proteincell-derived	factor	cell-derived	JJ	I-NP	I-proteinfactor	1	factor	NN	I-NP	I-protein1	(	1	CD	I-NP	I-protein(	SDF-1	(	(	O	OSDF-1	)	SDF-1	NN	B-NP	B-protein)	to	)	)	O	Oto	CXCR4	to	TO	B-PP	OCXCR4	","	CXCR4	NN	B-NP	B-protein","	which	","	","	O	Owhich	inhibits	which	WDT	B-NP	Oinhibits	entry	inhibit	VBZ	B-VP	Oentry	of	entry	NN	B-NP	Oof	T-cell-tropic	of	IN	B-PP	OT-cell-tropic	HIV-1	T-cell-tropic	JJ	B-NP	OHIV-1	","	HIV-1	NN	I-NP	O","	activates	","	","	O	Oactivates	also	activate	VBZ	B-VP	Oalso	the	also	RB	B-ADVP	Othe	ERK/	the	DT	B-NP	OERK/	MAP	ERK/	NN	I-NP	B-proteinMAP	kinase	MAP	NN	I-NP	I-proteinkinase	pathway	kinase	NN	I-NP	I-proteinpathway	.	pathway	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	SDF-1	","	","	O	OSDF-1	did	SDF-1	NN	B-NP	B-proteindid	not	do	VBD	B-VP	Onot	affect	not	RB	I-VP	Oaffect	the	affect	VB	I-VP	Othe	CD4-mediated	the	DT	B-NP	OCD4-mediated	expression	CD4-mediated	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	and	cytokine	NN	B-NP	B-proteinand	chemokine	and	CC	I-NP	Ochemokine	genes	chemokine	NN	I-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	provide	result	NNS	I-NP	Oprovide	firm	provide	VBP	B-VP	Ofirm	molecular	firm	JJ	B-NP	Omolecular	evidence	molecular	JJ	I-NP	Oevidence	that	evidence	NN	I-NP	Othat	binding	that	IN	B-SBAR	Obinding	of	binding	NN	B-NP	Oof	HIV-1	of	IN	B-PP	OHIV-1	envelope	HIV-1	NN	B-NP	B-proteinenvelope	glycoproteins	envelope	NN	I-NP	I-proteinglycoproteins	to	glycoprotein	NNS	I-NP	I-proteinto	CD4	to	TO	B-PP	OCD4	receptor	CD4	NN	B-NP	B-proteinreceptor	initiates	receptor	NN	I-NP	I-proteininitiates	a	initiate	VBZ	B-VP	Oa	signaling	a	DT	B-NP	Osignaling	pathway	signaling	NN	I-NP	Opathway	(	pathway	NN	I-NP	O(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	independent	)	)	O	Oindependent	of	independent	JJ	B-ADJP	Oof	the	of	IN	B-PP	Othe	binding	the	DT	B-NP	Obinding	to	binding	NN	I-NP	Oto	the	to	TO	B-PP	Othe	chemokine	the	DT	B-NP	Ochemokine	receptor	chemokine	NN	I-NP	B-proteinreceptor	that	receptor	NN	I-NP	I-proteinthat	leads	that	WDT	B-NP	Oleads	to	lead	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	aberrant	the	DT	B-NP	Oaberrant	expression	aberrant	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	inflammatory	of	IN	B-PP	Oinflammatory	genes	inflammatory	JJ	B-NP	B-DNAgenes	and	gene	NNS	I-NP	I-DNAand	may	and	CC	O	Omay	contribute	may	MD	B-VP	Ocontribute	significantly	contribute	VB	I-VP	Osignificantly	to	significantly	RB	B-ADVP	Oto	HIV-1	to	TO	B-PP	OHIV-1	replication	HIV-1	NN	B-NP	Oreplication	as	replication	NN	I-NP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	to	as	IN	I-CONJP	Oto	deregulation	to	TO	B-PP	Oderegulation	of	deregulation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	immune	the	DT	B-NP	Oimmune	system	immune	JJ	I-NP	Osystem	.	system	NN	I-NP	O.	Antigen	.	.	O	OAntigen	receptor	Antigen	NN	B-NP	B-proteinreceptor	signaling	receptor	NN	I-NP	I-proteinsignaling	induces	signaling	NN	I-NP	Oinduces	MAP	induce	VBZ	B-VP	OMAP	kinase-mediated	MAP	NN	B-NP	Okinase-mediated	phosphorylation	kinase-mediated	JJ	I-NP	Ophosphorylation	and	phosphorylation	NN	I-NP	Oand	degradation	and	CC	I-NP	Odegradation	of	degradation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	BCL-6	the	DT	B-NP	OBCL-6	transcription	BCL-6	NN	I-NP	B-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	.	factor	NN	I-NP	I-protein.	The	.	.	O	OThe	bcl-6	The	DT	B-NP	Obcl-6	proto-oncogene	bcl-6	NN	I-NP	B-DNAproto-oncogene	encodes	proto-oncogene	NN	I-NP	I-DNAencodes	a	encode	VBZ	B-VP	Oa	POZ/zinc	a	DT	B-NP	OPOZ/zinc	finger	POZ/zinc	NN	I-NP	B-proteinfinger	transcriptional	finger	NN	I-NP	I-proteintranscriptional	repressor	transcriptional	JJ	I-NP	I-proteinrepressor	expressed	repressor	NN	I-NP	I-proteinexpressed	in	express	VBN	B-VP	Oin	germinal	in	IN	B-PP	Ogerminal	center	germinal	JJ	B-NP	B-cell_typecenter	(	center	NN	I-NP	I-cell_type(	GC	(	(	O	I-cell_typeGC	)	GC	NN	B-NP	I-cell_type)	B	)	)	O	I-cell_typeB	and	B	NN	B-NP	I-cell_typeand	T	and	CC	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	and	cell	NNS	B-NP	I-cell_typeand	required	and	CC	O	Orequired	for	require	VBN	B-VP	Ofor	GC	for	IN	B-PP	OGC	formation	GC	NN	B-NP	Oformation	and	formation	NN	I-NP	Oand	antibody	and	CC	O	Oantibody	affinity	antibody	NN	B-NP	Oaffinity	maturation	affinity	NN	I-NP	Omaturation	.	maturation	NN	I-NP	O.	Deregulation	.	.	O	ODeregulation	of	Deregulation	NN	B-NP	Oof	bcl-6	of	IN	B-PP	Obcl-6	expression	bcl-6	NN	B-NP	B-proteinexpression	by	expression	NN	I-NP	Oby	chromosomal	by	IN	B-PP	Ochromosomal	rearrangements	chromosomal	JJ	B-NP	Orearrangements	and	rearrangement	NNS	I-NP	Oand	point	and	CC	O	Opoint	mutations	point	NN	B-NP	Omutations	of	mutation	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	bcl-6	the	DT	B-NP	Obcl-6	promoter	bcl-6	NN	I-NP	B-DNApromoter	region	promoter	NN	I-NP	I-DNAregion	are	region	NN	I-NP	I-DNAare	implicated	be	VBP	B-VP	Oimplicated	in	implicate	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	pathogenesis	the	DT	B-NP	Opathogenesis	of	pathogenesis	NN	I-NP	Oof	B-cell	of	IN	B-PP	OB-cell	lymphoma	B-cell	NN	B-NP	B-cell_typelymphoma	.	lymphoma	NN	I-NP	I-cell_type.	The	.	.	O	OThe	signals	The	DT	B-NP	Osignals	regulating	signal	NNS	I-NP	Oregulating	bcl-6	regulate	VBG	B-VP	Obcl-6	expression	bcl-6	NN	B-NP	B-proteinexpression	are	expression	NN	I-NP	Oare	not	be	VBP	B-VP	Onot	known	not	RB	I-VP	Oknown	.	know	VBN	I-VP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	antigen	that	IN	B-SBAR	Oantigen	receptor	antigen	NN	B-NP	B-proteinreceptor	activation	receptor	NN	I-NP	I-proteinactivation	leads	activation	NN	I-NP	Oleads	to	lead	VBZ	B-VP	Oto	BCL-6	to	TO	B-PP	OBCL-6	phosphorylation	BCL-6	NN	B-NP	B-proteinphosphorylation	by	phosphorylation	NN	I-NP	Oby	mitogen-activated	by	IN	B-PP	Omitogen-activated	protein	mitogen-activated	JJ	B-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	MAPK	(	(	O	OMAPK	)	MAPK	NN	B-NP	B-protein)	.	)	)	O	O.	Phosphorylation	.	.	O	OPhosphorylation	","	Phosphorylation	NN	B-NP	O","	in	","	","	O	Oin	turn	in	IN	B-PP	Oturn	","	turn	NN	B-NP	O","	targets	","	","	O	Otargets	BCL-6	target	VBZ	B-VP	OBCL-6	for	BCL-6	NN	B-NP	B-proteinfor	rapid	for	IN	B-PP	Orapid	degradation	rapid	JJ	B-NP	Odegradation	by	degradation	NN	I-NP	Oby	the	by	IN	B-PP	Othe	ubiquitin	the	DT	B-NP	Oubiquitin	/	ubiquitin	NN	I-NP	B-protein/	proteasome	/	SYM	B-NP	Oproteasome	pathway	proteasome	NN	I-NP	B-proteinpathway	.	pathway	NN	I-NP	O.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	indicate	finding	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	BCL-6	that	IN	B-SBAR	OBCL-6	expression	BCL-6	NN	B-NP	B-proteinexpression	is	expression	NN	I-NP	Ois	directly	be	VBZ	B-VP	Odirectly	controlled	directly	RB	I-VP	Ocontrolled	by	control	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	antigen	the	DT	B-NP	Oantigen	receptor	antigen	NN	I-NP	B-proteinreceptor	via	receptor	NN	I-NP	I-proteinvia	MAPK	via	IN	B-PP	OMAPK	activation	MAPK	NN	B-NP	B-proteinactivation	.	activation	NN	I-NP	O.	This	.	.	O	OThis	signaling	This	DT	B-NP	Osignaling	pathway	signaling	NN	I-NP	Opathway	may	pathway	NN	I-NP	Omay	be	may	MD	B-VP	Obe	crucial	be	VB	I-VP	Ocrucial	for	crucial	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	control	the	DT	B-NP	Ocontrol	of	control	NN	I-NP	Oof	B-cell	of	IN	B-PP	OB-cell	differentiation	B-cell	NN	B-NP	B-cell_typedifferentiation	and	differentiation	NN	I-NP	Oand	antibody	and	CC	O	Oantibody	response	antibody	NN	B-NP	Oresponse	and	response	NN	I-NP	Oand	has	and	CC	O	Ohas	implications	have	VBZ	B-VP	Oimplications	for	implication	NNS	B-NP	Ofor	the	for	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	other	of	IN	B-PP	Oother	POZ/zinc	other	JJ	B-NP	OPOZ/zinc	finger	POZ/zinc	NN	I-NP	B-proteinfinger	transcription	finger	NN	I-NP	I-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	in	factor	NNS	I-NP	I-proteinin	other	in	IN	B-PP	Oother	tissues	other	JJ	B-NP	Otissues	.	tissue	NNS	I-NP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	receptors	Glucocorticoid	NN	B-NP	B-proteinreceptors	are	receptor	NNS	I-NP	I-proteinare	differentially	be	VBP	B-VP	Odifferentially	expressed	differentially	RB	I-VP	Oexpressed	in	express	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	cells	the	DT	B-NP	Ocells	and	cell	NNS	I-NP	Oand	tissues	and	CC	I-NP	Otissues	of	tissue	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	immune	the	DT	B-NP	Oimmune	system	immune	JJ	I-NP	Osystem	.	system	NN	I-NP	O.	Cytosolic	.	.	O	OCytosolic	glucocorticoid	Cytosolic	JJ	B-NP	B-proteinglucocorticoid	receptor	glucocorticoid	NN	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	GR	(	(	O	OGR	)	GR	NN	B-NP	B-protein)	binding	)	)	O	Obinding	studies	binding	NN	B-NP	Ostudies	on	study	NNS	I-NP	Oon	immune	on	IN	B-PP	Oimmune	tissues	immune	JJ	B-NP	Otissues	demonstrate	tissue	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	thymus	the	DT	B-NP	Othymus	exhibits	thymus	NN	I-NP	Oexhibits	three	exhibit	VBZ	B-VP	Othree	to	three	CD	B-NP	Oto	four	to	TO	I-NP	Ofour	times	four	CD	I-NP	Otimes	higher	time	NNS	I-NP	Ohigher	levels	high	JJR	I-NP	Olevels	of	level	NNS	I-NP	Oof	GR	of	IN	B-PP	OGR	protein	GR	NN	B-NP	B-proteinprotein	than	protein	NN	I-NP	I-proteinthan	the	than	IN	B-PP	Othe	spleen	the	DT	B-NP	Ospleen	.	spleen	NN	I-NP	O.	High	.	.	O	OHigh	levels	High	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	GR	of	IN	B-PP	OGR	are	GR	NN	B-NP	B-proteinare	consistent	be	VBP	B-VP	Oconsistent	with	consistent	JJ	B-ADJP	Owith	the	with	IN	B-PP	Othe	exquisite	the	DT	B-NP	Oexquisite	sensitivity	exquisite	JJ	I-NP	Osensitivity	of	sensitivity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	thymus	the	DT	B-NP	Othymus	to	thymus	NN	I-NP	Oto	glucocorticoid	to	TO	B-PP	Oglucocorticoid	exposure	glucocorticoid	NN	B-NP	Oexposure	.	exposure	NN	I-NP	O.	Nevertheless	.	.	O	ONevertheless	","	Nevertheless	RB	B-ADVP	O","	whole	","	","	O	Owhole	cell	whole	JJ	B-NP	Ocell	binding	cell	NN	I-NP	Obinding	studies	binding	NN	I-NP	Ostudies	reveal	study	NNS	I-NP	Oreveal	similar	reveal	VBP	B-VP	Osimilar	levels	similar	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	GR	of	IN	B-PP	OGR	in	GR	NN	B-NP	B-proteinin	immature	in	IN	B-PP	Oimmature	thymic	immature	JJ	B-NP	B-cell_typethymic	T	thymic	JJ	I-NP	I-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	more	and	CC	O	Omore	mature	more	RBR	B-NP	Omature	","	mature	JJ	I-NP	O","	splenic	","	","	I-NP	Osplenic	T	splenic	JJ	I-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	whole	","	","	O	Owhole	cell	whole	JJ	B-NP	Ocell	binding	cell	NN	I-NP	Obinding	techniques	binding	NN	I-NP	Otechniques	indicate	technique	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	neutrophils	that	IN	B-SBAR	Oneutrophils	(	neutrophil	NNS	B-NP	B-cell_type(	which	(	(	O	Owhich	represent	which	WDT	B-NP	Orepresent	roughly	represent	VBP	B-VP	Oroughly	30	roughly	RB	B-NP	O30	%	30	CD	I-NP	O%	of	%	NN	I-NP	Oof	splenic	of	IN	B-PP	Osplenic	leukocytes	splenic	JJ	B-NP	B-cell_typeleukocytes	)	leukocyte	NNS	I-NP	I-cell_type)	exhibit	)	)	O	Oexhibit	higher	exhibit	VBP	B-VP	Ohigher	GR	high	JJR	B-NP	OGR	than	GR	NN	I-NP	B-proteinthan	both	than	IN	B-SBAR	Oboth	T	both	CC	O	OT	and	T	NN	B-NP	B-cell_typeand	B	and	CC	I-NP	I-cell_typeB	lymphocytes	B	NN	I-NP	I-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	further	","	","	O	Ofurther	contradicting	further	RB	B-ADVP	Ocontradicting	results	contradict	VBG	B-VP	Oresults	from	result	NNS	B-NP	Ofrom	cytosolic	from	IN	B-PP	Ocytosolic	binding	cytosolic	JJ	B-NP	Obinding	studies	binding	NN	I-NP	Ostudies	.	study	NNS	I-NP	O.	To	.	.	O	OTo	address	To	TO	B-VP	Oaddress	these	address	VB	I-VP	Othese	inconsistencies	these	DT	B-NP	Oinconsistencies	","	inconsistency	NNS	I-NP	O","	GR	","	","	O	OGR	protein	GR	NN	B-NP	B-proteinprotein	was	protein	NN	I-NP	I-proteinwas	assessed	be	VBD	B-VP	Oassessed	in	assess	VBN	I-VP	Oin	immune	in	IN	B-PP	Oimmune	cells	immune	JJ	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	tissues	and	CC	O	Otissues	using	tissue	NNS	B-NP	Ousing	cytosolic	use	VBG	B-VP	Ocytosolic	radioligand	cytosolic	JJ	B-NP	Oradioligand	binding	radioligand	NN	I-NP	Obinding	.	binding	NN	I-NP	O.	Western	.	.	O	OWestern	blot	Western	NN	B-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	","	analysis	NN	I-NP	O","	and	","	","	O	Oand	immunocytochemistry	and	CC	O	Oimmunocytochemistry	.	immunocytochemistry	NN	B-NP	O.	Consistent	.	.	O	OConsistent	with	Consistent	JJ	B-ADJP	Owith	previous	with	IN	B-PP	Oprevious	cytosolic	previous	JJ	B-NP	Ocytosolic	receptor	cytosolic	JJ	I-NP	Oreceptor	binding	receptor	NN	I-NP	Obinding	studies	binding	NN	I-NP	Ostudies	on	study	NNS	I-NP	Oon	immune	on	IN	B-PP	Oimmune	tissue	immune	JJ	B-NP	Otissue	homogenates	tissue	NN	I-NP	Ohomogenates	","	homogenate	NNS	I-NP	O","	thymic	","	","	O	Othymic	T	thymic	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	have	to	TO	I-VP	Ohave	higher	have	VB	I-VP	Ohigher	levels	high	JJR	B-NP	Olevels	of	level	NNS	I-NP	Oof	GR	of	IN	B-PP	OGR	than	GR	NN	B-NP	B-proteinthan	T	than	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	isolated	cell	NNS	I-NP	I-cell_typeisolated	from	isolate	VBN	B-VP	Ofrom	the	from	IN	B-PP	Othe	spleen	the	DT	B-NP	Ospleen	.	spleen	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	neutrophils	","	","	O	Oneutrophils	were	neutrophil	NNS	B-NP	B-cell_typewere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	have	to	TO	I-VP	Ohave	fewer	have	VB	I-VP	Ofewer	GR	few	JJR	B-NP	OGR	than	GR	NN	I-NP	B-proteinthan	lymphocytes	than	IN	B-SBAR	Olymphocytes	and	lymphocyte	NNS	B-NP	B-cell_typeand	monocytes	and	CC	I-NP	Omonocytes	.	monocyte	NNS	I-NP	B-cell_type.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	a	indicate	VBP	B-VP	Oa	meaningful	a	DT	B-NP	Omeaningful	relationship	meaningful	JJ	I-NP	Orelationship	between	relationship	NN	I-NP	Obetween	receptor	between	IN	B-PP	Oreceptor	expression	receptor	NN	B-NP	Oexpression	and	expression	NN	I-NP	Oand	known	and	CC	O	Oknown	sensitivity	know	VBN	B-VP	Osensitivity	to	sensitivity	NN	B-NP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	.	glucocorticoid	NNS	B-NP	O.	Functional	.	.	O	OFunctional	replacement	Functional	JJ	B-NP	Oreplacement	of	replacement	NN	I-NP	Oof	the	of	IN	B-PP	Othe	mouse	the	DT	B-NP	Omouse	E2A	mouse	NN	I-NP	B-DNAE2A	gene	E2A	NN	I-NP	I-DNAgene	with	gene	NN	I-NP	I-DNAwith	a	with	IN	B-PP	Oa	human	a	DT	B-NP	Ohuman	HEB	human	JJ	I-NP	B-DNAHEB	cDNA	HEB	NN	I-NP	I-DNAcDNA	.	cDNA	NN	I-NP	I-DNA.	The	.	.	O	OThe	mammalian	The	DT	B-NP	Omammalian	E2A	mammalian	JJ	I-NP	OE2A	","	E2A	NN	I-NP	B-protein","	HEB	","	","	O	OHEB	","	HEB	NN	B-NP	B-protein","	and	","	","	O	Oand	E2-2	and	CC	O	OE2-2	genes	E2-2	NN	B-NP	B-DNAgenes	encode	gene	NNS	I-NP	I-DNAencode	a	encode	VBP	B-VP	Oa	unique	a	DT	B-NP	Ounique	class	unique	JJ	I-NP	Oclass	of	class	NN	I-NP	Oof	basic	of	IN	B-PP	Obasic	helix-loop-helix	basic	JJ	B-NP	B-proteinhelix-loop-helix	(	helix-loop-helix	JJ	I-NP	I-protein(	bHLH	(	(	O	I-proteinbHLH	)	bHLH	JJ	B-ADJP	I-protein)	transcription	)	)	O	I-proteintranscription	factors	transcription	NN	B-NP	I-proteinfactors	that	factor	NNS	I-NP	I-proteinthat	are	that	WDT	B-NP	Oare	evolutionarily	be	VBP	B-VP	Oevolutionarily	conserved	evolutionarily	RB	I-VP	Oconserved	and	conserve	VBN	I-VP	Oand	essential	and	CC	O	Oessential	for	essential	JJ	B-ADJP	Ofor	embryonic	for	IN	B-PP	Oembryonic	and	embryonic	JJ	B-NP	Oand	postnatal	and	CC	I-NP	Opostnatal	development	postnatal	JJ	I-NP	Odevelopment	.	development	NN	I-NP	O.	While	.	.	O	OWhile	the	While	IN	B-SBAR	Othe	structural	the	DT	B-NP	Ostructural	and	structural	JJ	I-NP	Oand	functional	and	CC	I-NP	Ofunctional	similarities	functional	JJ	I-NP	Osimilarities	among	similarity	NNS	I-NP	Oamong	the	among	IN	B-PP	Othe	gene	the	DT	B-NP	Ogene	products	gene	NN	I-NP	B-proteinproducts	are	product	NNS	I-NP	I-proteinare	well	be	VBP	B-VP	Owell	demonstrated	well	RB	I-VP	Odemonstrated	","	demonstrate	VBN	I-VP	O","	it	","	","	O	Oit	is	it	PRP	B-NP	Ois	not	be	VBZ	B-VP	Onot	clear	not	RB	O	Oclear	why	clear	JJ	B-ADJP	Owhy	deletion	why	WRB	B-ADVP	Odeletion	of	deletion	NN	B-NP	Oof	E2A	of	IN	B-PP	OE2A	","	E2A	NN	B-NP	B-protein","	but	","	","	O	Obut	not	but	CC	O	Onot	HEB	not	RB	O	OHEB	or	HEB	NN	B-NP	B-proteinor	E2-2	or	CC	I-NP	OE2-2	","	E2-2	NN	I-NP	B-protein","	leads	","	","	O	Oleads	to	lead	VBZ	B-VP	Oto	a	to	TO	B-PP	Oa	complete	a	DT	B-NP	Ocomplete	arrest	complete	JJ	I-NP	Oarrest	in	arrest	NN	I-NP	Oin	B-lymphocyte	in	IN	B-PP	OB-lymphocyte	development	B-lymphocyte	NN	B-NP	B-cell_typedevelopment	.	development	NN	I-NP	O.	To	.	.	O	OTo	understand	To	TO	B-VP	Ounderstand	the	understand	VB	I-VP	Othe	molecular	the	DT	B-NP	Omolecular	basis	molecular	JJ	I-NP	Obasis	of	basis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	functional	the	DT	B-NP	Ofunctional	specificity	functional	JJ	I-NP	Ospecificity	between	specificity	NN	I-NP	Obetween	E2A	between	IN	B-PP	OE2A	and	E2A	NN	B-NP	B-proteinand	HEB	and	CC	I-NP	OHEB	/	HEB	NN	I-NP	B-protein/	E2-2	/	SYM	B-NP	OE2-2	in	E2-2	NN	I-NP	B-proteinin	mammalian	in	IN	B-PP	Omammalian	development	mammalian	JJ	B-NP	Odevelopment	","	development	NN	I-NP	O","	we	","	","	O	Owe	generated	we	PRP	B-NP	Ogenerated	and	generate	VBD	B-VP	Oand	tested	and	CC	I-VP	Otested	a	test	VBD	I-VP	Oa	panel	a	DT	B-NP	Opanel	of	panel	NN	I-NP	Oof	E2A	of	IN	B-PP	OE2A	knockin	E2A	NN	B-NP	B-proteinknockin	mutations	knockin	NN	I-NP	Omutations	including	mutation	NNS	I-NP	Oincluding	subtle	include	VBG	B-PP	Osubtle	mutations	subtle	JJ	B-NP	Omutations	in	mutation	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	E12	the	DT	B-NP	OE12	and	E12	NN	I-NP	B-proteinand	E47	and	CC	I-NP	OE47	exons	E47	NN	I-NP	B-DNAexons	and	exon	NNS	I-NP	I-DNAand	substitution	and	CC	O	Osubstitution	of	substitution	NN	B-NP	Oof	both	of	IN	B-PP	Oboth	E12	both	CC	O	OE12	and	E12	NN	B-NP	B-proteinand	E47	and	CC	O	OE47	exons	E47	NN	B-NP	B-proteinexons	with	exon	NNS	I-NP	I-proteinwith	a	with	IN	B-PP	Oa	human	a	DT	B-NP	Ohuman	HEB	human	JJ	I-NP	B-DNAHEB	cDNA	HEB	NN	I-NP	I-DNAcDNA	.	cDNA	NN	I-NP	I-DNA.	We	.	.	O	OWe	find	We	PRP	B-NP	Ofind	that	find	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	alternatively	the	DT	B-NP	Oalternatively	spliced	alternatively	RB	I-NP	Ospliced	E12	splice	VBN	I-NP	OE12	and	E12	NN	I-NP	B-proteinand	E47	and	CC	I-NP	OE47	bHLH	E47	NN	I-NP	B-proteinbHLH	proteins	bHLH	JJ	I-NP	I-proteinproteins	of	protein	NNS	I-NP	I-proteinof	the	of	IN	B-PP	Othe	E2A	the	DT	B-NP	OE2A	gene	E2A	NN	I-NP	B-DNAgene	play	gene	NN	I-NP	I-DNAplay	similar	play	VBP	B-VP	Osimilar	and	similar	JJ	B-NP	Oand	additive	and	CC	I-NP	Oadditive	roles	additive	JJ	I-NP	Oroles	in	role	NNS	I-NP	Oin	supporting	in	IN	B-PP	Osupporting	B	support	VBG	B-VP	OB	lymphopoiesis	B	NN	B-NP	Olymphopoiesis	.	lymphopoiesis	NN	I-NP	O.	Further	.	.	O	OFurther	","	Further	RB	B-ADVP	O","	we	","	","	O	Owe	find	we	PRP	B-NP	Ofind	that	find	VBP	B-VP	Othat	HEB	that	IN	B-SBAR	OHEB	driven	HEB	NN	B-NP	B-proteindriven	by	drive	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	endogenous	the	DT	B-NP	Oendogenous	E2A	endogenous	JJ	I-NP	B-DNAE2A	promoter	E2A	NN	I-NP	I-DNApromoter	can	promoter	NN	I-NP	I-DNAcan	functionally	can	MD	B-VP	Ofunctionally	replace	functionally	RB	I-VP	Oreplace	E2A	replace	VB	I-VP	OE2A	in	E2A	NN	B-NP	B-proteinin	supporting	in	IN	B-PP	Osupporting	B-cell	support	VBG	B-VP	OB-cell	commitment	B-cell	NN	B-NP	Ocommitment	and	commitment	NN	I-NP	Oand	differentiation	and	CC	O	Odifferentiation	toward	differentiation	NN	B-NP	Otoward	completion	toward	IN	B-PP	Ocompletion	.	completion	NN	B-NP	O.	Finally	.	.	O	OFinally	","	Finally	RB	B-ADVP	O","	the	","	","	O	Othe	postnatal	the	DT	B-NP	Opostnatal	lethality	postnatal	JJ	I-NP	Olethality	associated	lethality	NN	I-NP	Oassociated	with	associate	VBN	B-VP	Owith	E2A	with	IN	B-PP	OE2A	disruption	E2A	NN	B-NP	B-proteindisruption	is	disruption	NN	I-NP	Ois	fully	be	VBZ	B-VP	Ofully	rescued	fully	RB	I-VP	Orescued	by	rescue	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	addition	the	DT	B-NP	Oaddition	of	addition	NN	I-NP	Oof	HEB	of	IN	B-PP	OHEB	.	HEB	NN	B-NP	B-protein.	This	.	.	O	OThis	study	This	DT	B-NP	Ostudy	suggests	study	NN	I-NP	Osuggests	that	suggest	VBZ	B-VP	Othat	the	that	IN	B-SBAR	Othe	functional	the	DT	B-NP	Ofunctional	divergence	functional	JJ	I-NP	Odivergence	among	divergence	NN	I-NP	Oamong	E12	among	IN	B-PP	OE12	","	E12	NN	B-NP	B-protein","	E47	","	","	O	OE47	","	E47	NN	B-NP	B-protein","	and	","	","	O	Oand	HEB	and	CC	O	OHEB	in	HEB	NN	B-NP	B-proteinin	different	in	IN	B-PP	Odifferent	cell	different	JJ	B-NP	Ocell	types	cell	NN	I-NP	Otypes	is	type	NNS	I-NP	Ois	partially	be	VBZ	B-VP	Opartially	defined	partially	RB	I-VP	Odefined	by	define	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	context	the	DT	B-NP	Ocontext	of	context	NN	I-NP	Oof	gene	of	IN	B-PP	Ogene	expression	gene	NN	B-NP	Oexpression	.	expression	NN	I-NP	O.	Biased	.	.	O	OBiased	dependency	Bias	VBN	B-NP	Odependency	of	dependency	NN	I-NP	Oof	CD80	of	IN	B-PP	OCD80	versus	CD80	NN	B-NP	B-proteinversus	CD86	versus	CC	I-NP	OCD86	in	CD86	NN	I-NP	B-proteinin	the	in	IN	B-PP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	regulating	factor	NNS	I-NP	I-proteinregulating	the	regulate	VBG	B-VP	Othe	human	the	DT	B-NP	Ohuman	IL-2	human	JJ	I-NP	B-DNAIL-2	promoter	IL-2	NN	I-NP	I-DNApromoter	.	promoter	NN	I-NP	I-DNA.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	to	addition	NN	B-NP	Oto	the	to	TO	B-PP	Othe	signals	the	DT	B-NP	Osignals	obtained	signal	NNS	I-NP	Oobtained	by	obtain	VBN	B-VP	Oby	ligation	by	IN	B-PP	Oligation	of	ligation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	TCR	the	DT	B-NP	OTCR	","	TCR	NN	I-NP	B-protein","	T	","	","	O	OT	cells	T	NN	B-NP	B-cell_typecells	need	cell	NNS	I-NP	I-cell_typeneed	additional	need	VBP	B-VP	Oadditional	","	additional	JJ	B-NP	O","	co-stimulatory	","	","	I-NP	Oco-stimulatory	signals	co-stimulatory	JJ	I-NP	Osignals	to	signal	NNS	I-NP	Oto	be	to	TO	B-VP	Obe	activated	be	VB	I-VP	Oactivated	.	activate	VBN	I-VP	O.	One	.	.	O	OOne	such	One	CD	B-NP	Osuch	co-stimulatory	such	JJ	I-NP	Oco-stimulatory	signal	co-stimulatory	JJ	I-NP	Osignal	is	signal	NN	I-NP	Ois	delivered	be	VBZ	B-VP	Odelivered	when	deliver	VBN	I-VP	Owhen	CD28	when	WRB	B-ADVP	OCD28	on	CD28	NN	B-NP	B-proteinon	T	on	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	binds	cell	NNS	I-NP	I-cell_typebinds	to	bind	VBZ	B-VP	Oto	CD80	to	TO	B-PP	OCD80	or	CD80	NN	B-NP	B-proteinor	CD86	or	CC	I-NP	OCD86	on	CD86	NN	I-NP	B-proteinon	antigen-presenting	on	IN	B-PP	Oantigen-presenting	cells	antigen-presenting	JJ	B-NP	B-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	APC	(	(	O	OAPC	)	APC	NN	B-NP	B-cell_type)	.	)	)	O	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	present	the	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	analyzed	we	PRP	B-NP	Oanalyzed	the	analyze	VBD	B-VP	Othe	ability	the	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	CD80	of	IN	B-PP	OCD80	and	CD80	NN	B-NP	B-proteinand	CD86	and	CC	I-NP	OCD86	to	CD86	NN	I-NP	B-proteinto	co-stimulate	to	TO	B-VP	Oco-stimulate	human	co-stimulate	VB	I-VP	Ohuman	T	human	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	activated	cell	NNS	I-NP	I-cell_typeactivated	by	activate	VBN	B-VP	Oby	superantigen	by	IN	B-PP	Osuperantigen	.	superantigen	NN	B-NP	B-protein.	Using	.	.	O	OUsing	the	Use	VBG	B-VP	Othe	Raji	the	DT	B-NP	ORaji	B	Raji	NN	I-NP	OB	cell	B	NN	I-NP	Ocell	lymphoma	cell	NN	I-NP	Olymphoma	","	lymphoma	NN	I-NP	O","	which	","	","	O	Owhich	express	which	WDT	B-NP	Oexpress	similar	express	VBP	B-VP	Osimilar	levels	similar	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	CD80	of	IN	B-PP	OCD80	and	CD80	NN	B-NP	B-proteinand	CD86	and	CC	I-NP	OCD86	","	CD86	NN	I-NP	B-protein","	it	","	","	O	Oit	was	it	PRP	B-NP	Owas	found	be	VBD	B-VP	Ofound	that	find	VBN	I-VP	Othat	T	that	IN	B-SBAR	OT	cell	T	NN	B-NP	B-cell_typecell	proliferation	cell	NN	I-NP	I-cell_typeproliferation	was	proliferation	NN	I-NP	Owas	mainly	be	VBD	B-VP	Omainly	co-stimulated	mainly	RB	I-VP	Oco-stimulated	by	co-stimulate	VBN	I-VP	Oby	CD80	by	IN	B-PP	OCD80	.	CD80	NN	B-NP	B-protein.	To	.	.	O	OTo	further	To	TO	B-VP	Ofurther	characterize	further	RB	I-VP	Ocharacterize	the	characterize	VB	I-VP	Othe	consequences	the	DT	B-NP	Oconsequences	of	consequence	NNS	I-NP	Oof	this	of	IN	B-PP	Othis	biased	this	DT	B-NP	Obiased	co-stimulatory	biased	JJ	I-NP	Oco-stimulatory	dependency	co-stimulatory	JJ	I-NP	Odependency	","	dependency	NN	I-NP	O","	we	","	","	O	Owe	employed	we	PRP	B-NP	Oemployed	a	employ	VBD	B-VP	Oa	well-defined	a	DT	B-NP	Owell-defined	system	well-defined	JJ	I-NP	Osystem	of	system	NN	I-NP	Oof	transfected	of	IN	B-PP	Otransfected	CHO	transfecte	VBN	B-NP	B-cell_lineCHO	cells	CHO	NN	I-NP	I-cell_linecells	expressing	cell	NNS	I-NP	I-cell_lineexpressing	human	express	VBG	B-VP	Ohuman	MHC	human	JJ	B-NP	B-proteinMHC	class	MHC	NN	I-NP	I-proteinclass	II	class	NN	I-NP	I-proteinII	together	II	CD	I-NP	I-proteintogether	with	together	RB	B-ADVP	Owith	CD80	with	IN	B-PP	OCD80	","	CD80	NN	B-NP	B-protein","	CD86	","	","	I-NP	OCD86	or	CD86	NN	I-NP	B-proteinor	CD80	or	CC	I-NP	OCD80	and	CD80	NN	I-NP	B-proteinand	CD86	and	CC	I-NP	OCD86	.	CD86	NN	I-NP	B-protein.	Proliferation	.	.	O	OProliferation	of	Proliferation	NN	B-NP	Oof	freshly	of	IN	B-PP	Ofreshly	prepared	freshly	RB	B-NP	Oprepared	CD4+	prepare	VBN	I-NP	OCD4+	T	CD4+	JJ	I-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	required	cell	NNS	I-NP	I-cell_typerequired	the	require	VBD	B-VP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	either	of	IN	B-PP	Oeither	CD80	either	CC	O	OCD80	or	CD80	NN	B-NP	B-proteinor	CD86	or	CC	I-NP	OCD86	.	CD86	NN	I-NP	B-protein.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	IL-2	","	","	O	OIL-2	production	IL-2	NN	B-NP	B-proteinproduction	reached	production	NN	I-NP	Oreached	only	reach	VBD	B-VP	Oonly	suboptimal	only	RB	B-NP	Osuboptimal	levels	suboptimal	JJ	I-NP	Olevels	in	level	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	presence	the	DT	I-PP	Opresence	of	presence	NN	I-PP	Oof	CD86	of	IN	I-PP	OCD86	but	CD86	NN	B-NP	B-proteinbut	optimal	but	CC	O	Ooptimal	levels	optimal	JJ	B-NP	Olevels	with	level	NNS	I-NP	Owith	CD80	with	IN	B-PP	OCD80	.	CD80	NN	B-NP	B-protein.	To	.	.	O	OTo	analyze	To	TO	B-VP	Oanalyze	IL-2	analyze	VB	I-VP	OIL-2	transcriptional	IL-2	NN	B-NP	B-proteintranscriptional	activity	transcriptional	JJ	I-NP	Oactivity	in	activity	NN	I-NP	Oin	CD80	in	IN	B-PP	OCD80	and	CD80	NN	B-NP	B-proteinand	CD86	and	CC	O	OCD86	co-stimulated	CD86	NN	B-NP	B-proteinco-stimulated	T	co-stimulated	JJ	I-NP	OT	cells	T	NN	I-NP	B-cell_typecells	we	cell	NNS	I-NP	I-cell_typewe	used	we	PRP	B-NP	Oused	Jurkat	use	VBD	B-VP	OJurkat	T	Jurkat	NN	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	transfected	cell	NNS	I-NP	I-cell_linetransfected	with	transfecte	VBN	B-VP	Owith	luciferase	with	IN	B-PP	Oluciferase	reporter	luciferase	NN	B-NP	B-DNAreporter	gene	reporter	NN	I-NP	I-DNAgene	constructs	gene	NN	I-NP	I-DNAconstructs	.	construct	NNS	I-NP	I-DNA.	CD80	.	.	O	OCD80	induced	CD80	NN	B-NP	B-proteininduced	higher	induce	VBD	B-VP	Ohigher	levels	high	JJR	B-NP	Olevels	of	level	NNS	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	promoter	IL-2	NN	B-NP	B-DNApromoter	#NAME?	promoter	NN	I-NP	I-DNA#NAME?	activity	#NAME?	NN	I-NP	I-DNAactivity	compared	activity	NN	I-NP	Ocompared	to	compare	VBN	B-VP	Oto	CD86	to	TO	B-PP	OCD86	.	CD86	NN	B-NP	B-protein.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	the	","	","	O	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	regulating	factor	NNS	I-NP	I-proteinregulating	the	regulate	VBG	B-VP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter-enhancer	IL-2	NN	I-NP	B-DNApromoter-enhancer	region	promoter-enhancer	JJ	I-NP	I-DNAregion	including	region	NN	I-NP	I-DNAincluding	activation	include	VBG	B-PP	Oactivation	protein-1	activation	NN	B-NP	Oprotein-1	","	protein-1	NN	I-NP	O","	CD28	","	","	O	OCD28	response	CD28	NN	B-NP	B-DNAresponse	element	response	NN	I-NP	I-DNAelement	and	element	NN	I-NP	I-DNAand	nuclear	and	CC	O	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	kappaB	factor	NN	I-NP	I-proteinkappaB	were	kappaB	NN	I-NP	I-proteinwere	8-Apr	be	VBD	B-VP	O8-Apr	times	8-Apr	CD	B-ADJP	Otimes	higher	time	NNS	I-ADJP	Ohigher	after	high	JJR	I-ADJP	Oafter	CD80	after	IN	B-PP	OCD80	compared	CD80	NN	B-NP	B-proteincompared	to	compare	VBN	B-VP	Oto	CD86	to	TO	B-PP	OCD86	ligation	CD86	NN	B-NP	B-proteinligation	.	ligation	NN	I-NP	O.	Our	.	.	O	OOur	results	Our	PRP$	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	eventual	the	DT	B-NP	Oeventual	appearance	eventual	JJ	I-NP	Oappearance	of	appearance	NN	I-NP	Oof	CD80	of	IN	B-PP	OCD80	on	CD80	NN	B-NP	B-proteinon	recently	on	IN	B-PP	Orecently	activated	recently	RB	B-NP	Oactivated	CD86+	activate	VBN	I-NP	OCD86+	APC	CD86+	JJ	I-NP	OAPC	is	APC	NN	I-NP	Ois	important	be	VBZ	B-VP	Oimportant	for	important	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	superinduction	the	DT	B-NP	Osuperinduction	of	superinduction	NN	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	production	IL-2	NN	B-NP	B-proteinproduction	and	production	NN	I-NP	Oand	to	and	CC	O	Oto	support	to	TO	B-VP	Osupport	vigorous	support	VB	I-VP	Ovigorous	T	vigorous	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	proliferation	cell	NN	I-NP	Oproliferation	.	proliferation	NN	I-NP	O.	Duplication	.	.	O	ODuplication	of	Duplication	NN	B-NP	Oof	the	of	IN	B-PP	Othe	DR3	the	DT	B-NP	ODR3	gene	DR3	NN	I-NP	B-DNAgene	on	gene	NN	I-NP	I-DNAon	human	on	IN	B-PP	Ohuman	chromosome	human	JJ	B-NP	B-DNAchromosome	1p36	chromosome	NN	I-NP	I-DNA1p36	and	1p36	NN	I-NP	I-DNAand	its	and	CC	O	Oits	deletion	its	PRP$	B-NP	Odeletion	in	deletion	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	neuroblastoma	human	JJ	B-NP	B-cell_typeneuroblastoma	.	neuroblastoma	NN	I-NP	I-cell_type.	The	.	.	O	OThe	human	The	DT	B-NP	Ohuman	DR3	human	JJ	I-NP	B-DNADR3	gene	DR3	NN	I-NP	I-DNAgene	","	gene	NN	I-NP	I-DNA","	whose	","	","	O	Owhose	product	whose	WP$	B-NP	Oproduct	is	product	NN	I-NP	Ois	also	be	VBZ	B-VP	Oalso	known	also	RB	I-VP	Oknown	as	know	VBN	I-VP	Oas	Wsl-1/APO-3/TRAMP/LARD	as	IN	B-PP	OWsl-1/APO-3/TRAMP/LARD	","	Wsl-1/APO-3/TRAMP/LARD	NN	B-NP	O","	encodes	","	","	O	Oencodes	a	encode	VBZ	B-VP	Oa	tumor	a	DT	B-NP	Otumor	necrosis	tumor	NN	I-NP	B-proteinnecrosis	factor-related	necrosis	NN	I-NP	I-proteinfactor-related	receptor	factor-related	JJ	I-NP	I-proteinreceptor	that	receptor	NN	I-NP	I-proteinthat	is	that	WDT	B-NP	Ois	expressed	be	VBZ	B-VP	Oexpressed	primarily	express	VBN	I-VP	Oprimarily	on	primarily	RB	B-ADVP	Oon	the	on	IN	B-PP	Othe	surface	the	DT	B-NP	Osurface	of	surface	NN	I-NP	Oof	thymocytes	of	IN	B-PP	Othymocytes	and	thymocyte	NNS	B-NP	B-cell_typeand	lymphocytes	and	CC	I-NP	Olymphocytes	.	lymphocyte	NNS	I-NP	B-cell_type.	DR3	.	.	O	ODR3	is	DR3	NN	B-NP	B-proteinis	capable	be	VBZ	B-VP	Ocapable	of	capable	JJ	B-ADJP	Oof	inducing	of	IN	B-PP	Oinducing	both	induce	VBG	B-VP	Oboth	NF-kappa	both	CC	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	and	activation	NN	B-NP	Oand	apoptosis	and	CC	O	Oapoptosis	when	apoptosis	NN	B-NP	Owhen	overexpressed	when	WRB	B-ADVP	Ooverexpressed	in	overexpresse	VBN	B-VP	Oin	mammalian	in	IN	B-PP	Omammalian	cells	mammalian	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	although	","	","	O	Oalthough	its	although	IN	B-SBAR	Oits	ligand	its	PRP$	B-NP	Oligand	has	ligand	NN	I-NP	Ohas	not	have	VBZ	B-VP	Onot	yet	not	RB	I-VP	Oyet	been	yet	RB	I-VP	Obeen	identified	be	VBN	I-VP	Oidentified	.	identify	VBN	I-VP	O.	We	.	.	O	OWe	report	We	PRP	B-NP	Oreport	here	report	VBP	B-VP	Ohere	that	here	RB	B-ADVP	Othat	the	that	IN	B-SBAR	Othe	DR3	the	DT	B-NP	ODR3	gene	DR3	NN	I-NP	B-DNAgene	locus	gene	NN	I-NP	I-DNAlocus	is	locus	NN	I-NP	I-DNAis	tandemly	be	VBZ	B-VP	Otandemly	duplicated	tandemly	RB	I-VP	Oduplicated	on	duplicate	VBN	I-VP	Oon	human	on	IN	B-PP	Ohuman	chromosome	human	JJ	B-NP	Ochromosome	band	chromosome	NN	I-NP	Oband	1p36.2-p36.3	band	NN	I-NP	O1p36.2-p36.3	and	1p36.2-p36.3	NN	I-NP	Oand	that	and	CC	O	Othat	these	that	IN	B-SBAR	Othese	genes	these	DT	B-NP	Ogenes	are	gene	NNS	I-NP	Oare	hemizygously	be	VBP	B-VP	Ohemizygously	deleted	hemizygously	RB	I-VP	Odeleted	and/or	delete	VBN	I-VP	Oand/or	translocated	and/or	CC	O	Otranslocated	to	translocate	VBN	B-VP	Oto	another	to	TO	B-PP	Oanother	chromosome	another	DT	B-NP	Ochromosome	in	chromosome	NN	I-NP	B-DNAin	neuroblastoma	in	IN	B-PP	Oneuroblastoma	(	neuroblastoma	NN	B-NP	B-cell_line(	NB	(	(	O	I-cell_lineNB	)	NB	NN	B-NP	I-cell_line)	cell	)	)	O	I-cell_linecell	lines	cell	NN	B-NP	I-cell_linelines	with	line	NNS	I-NP	I-cell_linewith	amplified	with	IN	B-PP	Oamplified	MYCN	amplify	VBN	B-NP	OMYCN	.	MYCN	NN	I-NP	B-protein.	Duplication	.	.	O	ODuplication	of	Duplication	NN	B-NP	Oof	at	of	IN	B-PP	Oat	least	at	IN	B-ADVP	Oleast	a	least	JJS	I-ADVP	Oa	portion	a	DT	B-NP	Oportion	of	portion	NN	I-NP	Oof	the	of	IN	B-PP	Othe	DR3	the	DT	B-NP	ODR3	gene	DR3	NN	I-NP	B-DNAgene	","	gene	NN	I-NP	I-DNA","	including	","	","	O	Oincluding	the	include	VBG	B-PP	Othe	extracellular	the	DT	B-NP	Oextracellular	and	extracellular	JJ	I-NP	Oand	transmembrane	and	CC	I-NP	Otransmembrane	regions	transmembrane	NN	I-NP	B-proteinregions	but	region	NNS	I-NP	I-proteinbut	not	but	CC	B-NP	Onot	the	not	RB	I-NP	Othe	cytoplasmic	the	DT	B-NP	Ocytoplasmic	domain	cytoplasmic	JJ	I-NP	B-proteindomain	","	domain	NN	I-NP	I-protein","	was	","	","	O	Owas	demonstrated	be	VBD	B-VP	Odemonstrated	by	demonstrate	VBN	I-VP	Oby	both	by	IN	B-PP	Oboth	fluorescence	both	CC	O	Ofluorescence	in	fluorescence	NN	B-NP	Oin	situ	in	FW	B-NP	Ositu	hybridization	situ	FW	I-NP	Ohybridization	and	hybridization	NN	I-NP	Oand	genomic	and	CC	O	Ogenomic	Southern	genomic	JJ	B-NP	OSouthern	blotting	Southern	JJ	I-NP	Oblotting	.	blotting	NN	I-NP	O.	In	.	.	O	OIn	most	In	IN	B-PP	Omost	NB	most	JJS	B-NP	ONB	cell	NB	NN	I-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	","	line	NNS	I-NP	I-cell_line","	both	","	","	O	Oboth	the	both	CC	O	Othe	DR3	the	DT	B-NP	ODR3	and	DR3	NN	I-NP	B-proteinand	the	and	CC	O	Othe	DR3L	the	DT	B-NP	ODR3L	sequences	DR3L	NN	I-NP	B-DNAsequences	are	sequence	NNS	I-NP	I-DNAare	simultaneously	be	VBP	B-VP	Osimultaneously	deleted	simultaneously	RB	I-VP	Odeleted	and/or	delete	VBN	I-VP	Oand/or	translocated	and/or	CC	O	Otranslocated	to	translocate	VBN	B-VP	Oto	another	to	TO	B-PP	Oanother	chromosome	another	DT	B-NP	Ochromosome	.	chromosome	NN	I-NP	B-DNA.	Finally	.	.	O	OFinally	","	Finally	RB	B-ADVP	O","	DR3/	","	","	O	ODR3/	Wsl-1	DR3/	NN	B-NP	OWsl-1	protein	Wsl-1	NN	I-NP	Oprotein	expression	protein	NN	I-NP	Oexpression	is	expression	NN	I-NP	Ois	quite	be	VBZ	B-VP	Oquite	variable	quite	RB	B-ADJP	Ovariable	among	variable	JJ	I-ADJP	Oamong	these	among	IN	B-PP	Othese	NB	these	DT	B-NP	ONB	cell	NB	NN	I-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	","	line	NNS	I-NP	I-cell_line","	with	","	","	O	Owith	very	with	IN	B-PP	Overy	low	very	RB	B-NP	Olow	or	low	JJ	I-NP	Oor	undetectable	or	CC	I-NP	Oundetectable	levels	undetectable	JJ	I-NP	Olevels	in	level	NNS	I-NP	Oin	7	in	IN	B-PP	O7	of	7	CD	B-NP	Oof	17	of	IN	B-PP	O17	NB	17	CD	B-NP	ONB	cell	NB	NN	I-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	Differential	line	NNS	I-NP	I-cell_lineDifferential	protection	Differential	JJ	B-NP	Oprotection	of	protection	NN	I-NP	Oof	normal	of	IN	B-PP	Onormal	and	normal	JJ	B-NP	Oand	malignant	and	CC	I-NP	Omalignant	human	malignant	JJ	I-NP	B-cell_typehuman	myeloid	human	JJ	I-NP	I-cell_typemyeloid	progenitors	myeloid	JJ	I-NP	I-cell_typeprogenitors	(	progenitor	NNS	I-NP	I-cell_type(	CFU-GM	(	(	O	OCFU-GM	)	CFU-GM	NN	B-NP	B-protein)	from	)	)	O	Ofrom	Ara-C	from	IN	B-PP	OAra-C	toxicity	Ara-C	NN	B-NP	Otoxicity	using	toxicity	NN	I-NP	Ousing	cycloheximide	use	VBG	B-VP	Ocycloheximide	.	cycloheximide	NN	B-NP	O.	Cycloheximide	.	.	O	OCycloheximide	","	Cycloheximide	NN	B-NP	O","	a	","	","	O	Oa	reversible	a	DT	B-NP	Oreversible	protein	reversible	JJ	I-NP	Oprotein	synthesis	protein	NN	I-NP	Osynthesis	inhibitor	synthesis	NN	I-NP	Oinhibitor	","	inhibitor	NN	I-NP	O","	is	","	","	O	Ois	thought	be	VBZ	B-VP	Othought	to	think	VBN	I-VP	Oto	block	to	TO	I-VP	Oblock	DNA	block	VB	I-VP	ODNA	replication	DNA	NN	B-NP	Oreplication	in	replication	NN	I-NP	Oin	normal	in	IN	B-PP	Onormal	cells	normal	JJ	B-NP	B-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	preventing	by	IN	B-PP	Opreventing	synthesis	prevent	VBG	B-VP	Osynthesis	of	synthesis	NN	B-NP	Oof	a	of	IN	B-PP	Oa	labile	a	DT	B-NP	Olabile	protein	labile	JJ	I-NP	B-proteinprotein	.	protein	NN	I-NP	I-protein.	In	.	.	O	OIn	animal	In	IN	B-PP	Oanimal	systems	animal	NN	B-NP	Osystems	","	system	NNS	I-NP	O","	cycloheximide	","	","	O	Ocycloheximide	protects	cycloheximide	NN	B-NP	Oprotects	normal	protect	VBZ	B-VP	Onormal	cells	normal	JJ	B-NP	B-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	cytotoxic	from	IN	B-PP	Ocytotoxic	S-phase	cytotoxic	JJ	B-NP	OS-phase	specific	S-phase	NN	I-NP	Ospecific	agents	specific	JJ	I-NP	Oagents	","	agent	NNS	I-NP	O","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	cytosine	as	IN	I-PP	Ocytosine	arabinoside	cytosine	NN	B-NP	Oarabinoside	(	arabinoside	NN	I-NP	O(	Ara-C	(	(	O	OAra-C	)	Ara-C	NN	B-NP	O)	.	)	)	O	O.	Malignant	.	.	O	OMalignant	cells	Malignant	JJ	B-NP	B-cell_typecells	appear	cell	NNS	I-NP	I-cell_typeappear	not	appear	VBP	B-VP	Onot	to	not	RB	O	Oto	be	to	TO	B-VP	Obe	susceptible	be	VB	I-VP	Osusceptible	to	susceptible	JJ	B-ADJP	Oto	cycloheximide-induced	to	TO	B-PP	Ocycloheximide-induced	cycle	cycloheximide-induced	JJ	B-NP	Ocycle	arrest	cycle	NN	I-NP	Oarrest	and	arrest	NN	I-NP	Oand	","	and	CC	O	O","	subsequently	","	","	O	Osubsequently	","	subsequently	RB	B-ADVP	O","	may	","	","	O	Omay	not	may	MD	B-VP	Onot	be	not	RB	I-VP	Obe	protected	be	VB	I-VP	Oprotected	from	protect	VBN	I-VP	Ofrom	Ara-C	from	IN	B-PP	OAra-C	cytotoxicity	Ara-C	NN	B-NP	Ocytotoxicity	.	cytotoxicity	NN	I-NP	O.	The	.	.	O	OThe	effect	The	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	cycloheximide	of	IN	B-PP	Ocycloheximide	on	cycloheximide	NN	B-NP	Oon	granulocyte/macrophage	on	IN	B-PP	Ogranulocyte/macrophage	progenitors	granulocyte/macrophage	JJ	B-NP	B-cell_typeprogenitors	(	progenitor	NNS	I-NP	I-cell_type(	CFU-GM	(	(	O	OCFU-GM	)	CFU-GM	NN	B-NP	B-protein)	after	)	)	O	Oafter	in	after	IN	B-PP	Oin	vitro	in	FW	B-NP	Ovitro	Ara-C	vitro	FW	I-NP	OAra-C	exposure	Ara-C	NN	I-NP	Oexposure	was	exposure	NN	I-NP	Owas	examined	be	VBD	B-VP	Oexamined	using	examine	VBN	I-VP	Ousing	normal	use	VBG	B-VP	Onormal	human	normal	JJ	B-NP	Ohuman	bone	human	JJ	I-NP	Obone	marrow	bone	NN	I-NP	Omarrow	","	marrow	NN	I-NP	O","	malignant	","	","	O	Omalignant	progenitors	malignant	JJ	B-NP	B-cell_typeprogenitors	from	progenitor	NNS	I-NP	I-cell_typefrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	chronic	with	IN	B-PP	Ochronic	myelogenous	chronic	JJ	B-NP	Omyelogenous	leukemia	myelogenous	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	CML	(	(	O	OCML	)	CML	NN	B-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	clonogenic	and	CC	O	Oclonogenic	cells	clonogenic	JJ	B-NP	B-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	the	from	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	acute	human	JJ	I-NP	B-cell_lineacute	nonlymphocytic	acute	JJ	I-NP	I-cell_linenonlymphocytic	leukemia	nonlymphocytic	JJ	I-NP	I-cell_lineleukemia	cell	leukemia	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	HL-60	line	NNS	I-NP	I-cell_lineHL-60	and	HL-60	NN	B-NP	B-cell_lineand	KG-1	and	CC	O	OKG-1	.	KG-1	NN	B-NP	B-cell_line.	Mononuclear	.	.	O	OMononuclear	or	Mononuclear	JJ	B-NP	B-cell_typeor	clonogenic	or	CC	I-NP	I-cell_typeclonogenic	cells	clonogenic	JJ	I-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	incubated	be	VBD	B-VP	Oincubated	for	incubate	VBN	I-VP	Ofor	one	for	IN	B-PP	Oone	hour	one	CD	B-NP	Ohour	with	hour	NN	I-NP	Owith	cycloheximide	with	IN	B-PP	Ocycloheximide	","	cycloheximide	NN	B-NP	O","	followed	","	","	O	Ofollowed	by	follow	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	addition	the	DT	B-NP	Oaddition	","	addition	NN	I-NP	O","	for	","	","	O	Ofor	three	for	IN	B-PP	Othree	or	three	CD	B-NP	Oor	17	or	CC	I-NP	O17	hours	17	CD	I-NP	Ohours	","	hour	NNS	I-NP	O","	of	","	","	O	Oof	Ara-C	of	IN	B-PP	OAra-C	before	Ara-C	NN	B-NP	Obefore	being	before	IN	B-PP	Obeing	plated	be	VBG	B-VP	Oplated	in	plat	VBN	I-VP	Oin	a	in	IN	B-PP	Oa	methylcellulose	a	DT	B-NP	Omethylcellulose	culture	methylcellulose	NN	I-NP	Oculture	system	culture	NN	I-NP	Osystem	.	system	NN	I-NP	O.	CFU-GM	.	.	O	OCFU-GM	survival	CFU-GM	NN	B-NP	Osurvival	was	survival	NN	I-NP	Owas	significantly	be	VBD	B-VP	Osignificantly	increase	significantly	RB	I-VP	Oincrease	if	increase	VB	I-VP	Oif	normal	if	IN	B-SBAR	Onormal	cells	normal	JJ	B-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	treated	be	VBD	B-VP	Otreated	with	treat	VBN	I-VP	Owith	cycloheximide	with	IN	B-PP	Ocycloheximide	before	cycloheximide	NN	B-NP	Obefore	Ara-C	before	IN	B-PP	OAra-C	exposure	Ara-C	NN	B-NP	Oexposure	.	exposure	NN	I-NP	O.	Similar	.	.	O	OSimilar	cycloheximide	Similar	JJ	B-NP	Ocycloheximide	pretreatment	cycloheximide	NN	I-NP	Opretreatment	of	pretreatment	NN	I-NP	Oof	CML	of	IN	B-PP	OCML	progenitors	CML	NN	B-NP	B-cell_typeprogenitors	and	progenitor	NNS	I-NP	I-cell_typeand	clonogenic	and	CC	O	Oclonogenic	HL-60	clonogenic	JJ	B-NP	OHL-60	and	HL-60	NN	I-NP	Oand	KG-1	and	CC	I-NP	OKG-1	cells	KG-1	NN	I-NP	B-cell_linecells	failed	cell	NNS	I-NP	I-cell_linefailed	to	fail	VBD	B-VP	Oto	protect	to	TO	I-VP	Oprotect	CFU-GM	protect	VB	I-VP	OCFU-GM	from	CFU-GM	NN	B-NP	B-proteinfrom	Ara-C-induced	from	IN	B-PP	OAra-C-induced	cytotoxicity	Ara-C-induced	JJ	B-NP	Ocytotoxicity	.	cytotoxicity	NN	I-NP	O.	Primary	.	.	O	OPrimary	cortisol	Primary	JJ	B-NP	Ocortisol	resistance	cortisol	NN	I-NP	Oresistance	accompanied	resistance	NN	I-NP	Oaccompanied	by	accompany	VBN	B-VP	Oby	a	by	IN	B-PP	Oa	reduction	a	DT	B-NP	Oreduction	in	reduction	NN	I-NP	Oin	glucocorticoid	in	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	two	in	IN	B-PP	Otwo	members	two	CD	B-NP	Omembers	of	member	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	same	the	DT	B-NP	Osame	family	same	JJ	I-NP	Ofamily	.	family	NN	I-NP	O.	This	.	.	O	OThis	report	This	DT	B-NP	Oreport	describes	report	NN	I-NP	Odescribes	studies	describe	VBZ	B-VP	Ostudies	of	study	NNS	B-NP	Oof	a	of	IN	B-PP	Oa	man	a	DT	B-NP	Oman	suspected	man	NN	I-NP	Osuspected	of	suspect	VBN	B-VP	Oof	having	of	IN	B-PP	Ohaving	primary	have	VBG	B-VP	Oprimary	cortisol	primary	JJ	B-NP	Ocortisol	resistance	cortisol	NN	I-NP	Oresistance	.	resistance	NN	I-NP	O.	This	.	.	O	OThis	conclusion	This	DT	B-NP	Oconclusion	is	conclusion	NN	I-NP	Ois	based	be	VBZ	B-VP	Obased	on	base	VBN	I-VP	Oon	his	on	IN	B-PP	Ohis	high	his	PRP$	B-NP	Ohigh	plasma	high	JJ	I-NP	Oplasma	cortisol	plasma	NN	I-NP	Ocortisol	levels	cortisol	NN	I-NP	Olevels	and	level	NNS	I-NP	Oand	high	and	CC	O	Ohigh	24-h	high	JJ	B-NP	O24-h	urinary	24-h	JJ	I-NP	Ourinary	17-hydroxycorticosteroid	urinary	JJ	I-NP	O17-hydroxycorticosteroid	and	17-hydroxycorticosteroid	NN	I-NP	Oand	cortisol	and	CC	O	Ocortisol	excretion	cortisol	NN	B-NP	Oexcretion	","	excretion	NN	I-NP	O","	plus	","	","	O	Oplus	the	plus	CC	O	Othe	fact	the	DT	B-NP	Ofact	that	fact	NN	I-NP	Othat	he	that	IN	B-SBAR	Ohe	had	he	PRP	B-NP	Ohad	no	have	VBD	B-VP	Ono	manifestations	no	DT	B-NP	Omanifestations	of	manifestation	NNS	I-NP	Oof	Cushing	of	IN	B-PP	OCushing	's	Cushing	NNP	B-NP	O's	syndrome	's	POS	B-NP	Osyndrome	.	syndrome	NN	I-NP	O.	Among	.	.	O	OAmong	family	Among	IN	B-PP	Ofamily	members	family	NN	B-NP	Omembers	tested	member	NNS	I-NP	Otested	","	test	VBN	B-VP	O","	his	","	","	O	Ohis	mother	his	PRP$	B-NP	Omother	also	mother	NN	I-NP	Oalso	had	also	RB	B-ADVP	Ohad	hypercortisolemia	have	VBD	B-VP	Ohypercortisolemia	.	hypercortisolemia	NN	B-NP	O.	Both	.	.	O	OBoth	mother	Both	CC	O	Omother	and	mother	NN	B-NP	Oand	son	and	CC	I-NP	Oson	had	son	NN	I-NP	Ohad	high	have	VBD	B-VP	Ohigh	levels	high	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	unbound	of	IN	B-PP	Ounbound	plasma	unbound	JJ	B-NP	Oplasma	cortisol	plasma	NN	I-NP	Ocortisol	","	cortisol	NN	I-NP	O","	but	","	","	O	Obut	their	but	CC	O	Otheir	plasma	their	PRP$	B-NP	Oplasma	ACTH	plasma	NN	I-NP	OACTH	concentrations	ACTH	NN	I-NP	Oconcentrations	were	concentration	NNS	I-NP	Owere	within	be	VBD	B-VP	Owithin	the	within	IN	B-PP	Othe	normal	the	DT	B-NP	Onormal	range	normal	JJ	I-NP	Orange	.	range	NN	I-NP	O.	Both	.	.	O	OBoth	were	Both	DT	B-NP	Owere	partially	be	VBD	B-VP	Opartially	resistant	partially	RB	B-ADJP	Oresistant	to	resistant	JJ	I-ADJP	Oto	dexamethasone	to	TO	B-PP	Odexamethasone	adrenal	dexamethasone	NN	B-NP	Oadrenal	suppression	adrenal	JJ	I-NP	Osuppression	","	suppression	NN	I-NP	O","	and	","	","	O	Oand	both	and	CC	O	Oboth	had	both	DT	B-NP	Ohad	mild	have	VBD	B-VP	Omild	hypertension	mild	JJ	B-NP	Ohypertension	without	hypertension	NN	I-NP	Owithout	hypokalemia	without	IN	B-PP	Ohypokalemia	.	hypokalemia	NN	B-NP	O.	To	.	.	O	OTo	study	To	TO	B-VP	Ostudy	this	study	VB	I-VP	Othis	apparent	this	DT	B-NP	Oapparent	end-organ	apparent	JJ	I-NP	Oend-organ	resistance	end-organ	JJ	I-NP	Oresistance	to	resistance	NN	I-NP	Oto	cortisol	to	TO	B-PP	Ocortisol	","	cortisol	NN	B-NP	O","	we	","	","	O	Owe	examined	we	PRP	B-NP	Oexamined	the	examine	VBD	B-VP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	peripheral	in	IN	B-PP	Operipheral	mononuclear	peripheral	JJ	B-NP	B-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Using	.	.	O	OUsing	whole	Use	VBG	B-VP	Owhole	cell	whole	JJ	B-NP	Ocell	assays	cell	NN	I-NP	Oassays	","	assay	NNS	I-NP	O","	glucocorticoid	","	","	O	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	both	in	IN	B-PP	Oboth	patients	both	DT	B-NP	Opatients	were	patient	NNS	I-NP	Owere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	have	to	TO	I-VP	Ohave	reduced	have	VB	I-VP	Oreduced	total	reduce	VBN	I-VP	Ototal	binding	total	JJ	B-NP	Obinding	capacity	binding	NN	I-NP	Ocapacity	.	capacity	NN	I-NP	O.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	these	that	IN	B-SBAR	Othese	two	these	DT	B-NP	Otwo	patients	two	CD	I-NP	Opatients	","	patient	NNS	I-NP	O","	members	","	","	O	Omembers	of	member	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	same	the	DT	B-NP	Osame	family	same	JJ	I-NP	Ofamily	","	family	NN	I-NP	O","	have	","	","	O	Ohave	primary	have	VBP	B-VP	Oprimary	cortisol	primary	JJ	B-NP	Ocortisol	resistance	cortisol	NN	I-NP	Oresistance	accompanied	resistance	NN	I-NP	Oaccompanied	by	accompany	VBN	B-VP	Oby	a	by	IN	B-PP	Oa	reduced	a	DT	B-NP	Oreduced	number	reduce	VBN	I-NP	Onumber	of	number	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	[	.	.	O	O[	Glucocorticoid	[	(	O	OGlucocorticoid	receptors	Glucocorticoid	NN	B-NP	B-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	response	and	CC	O	Oresponse	to	response	NN	B-NP	Oto	polychemotherapy	to	TO	B-PP	Opolychemotherapy	in	polychemotherapy	NN	B-NP	Oin	acute	in	IN	B-PP	Oacute	lymphatic	acute	JJ	B-NP	Olymphatic	leukemia	lymphatic	JJ	I-NP	Oleukemia	]	leukemia	NN	I-NP	O]	Glucocorticoid	]	)	O	OGlucocorticoid	receptor	Glucocorticoid	NN	B-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	GR	(	(	O	OGR	)	GR	NN	B-NP	B-protein)	levels	)	)	O	Olevels	were	level	NNS	B-NP	Owere	quantified	be	VBD	B-VP	Oquantified	in	quantify	VBN	I-VP	Oin	leukemic	in	IN	B-PP	Oleukemic	blasts	leukemic	JJ	B-NP	B-cell_typeblasts	from	blast	NNS	I-NP	I-cell_typefrom	peripheral	from	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	Oblood	of	blood	NN	I-NP	Oof	86	of	IN	B-PP	O86	patients	86	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	acute	with	IN	B-PP	Oacute	lymphoblastic	acute	JJ	B-NP	Olymphoblastic	leukemia	lymphoblastic	JJ	I-NP	Oleukemia	.	leukemia	NN	I-NP	O.	The	.	.	O	OThe	subsequent	The	DT	B-NP	Osubsequent	achievement	subsequent	JJ	I-NP	Oachievement	of	achievement	NN	I-NP	Oof	complete	of	IN	B-PP	Ocomplete	remission	complete	JJ	B-NP	Oremission	after	remission	NN	I-NP	Oafter	combination	after	IN	B-PP	Ocombination	chemotherapy	combination	NN	B-NP	Ochemotherapy	was	chemotherapy	NN	I-NP	Owas	correlated	be	VBD	B-VP	Ocorrelated	with	correlate	VBN	I-VP	Owith	high	with	IN	B-PP	Ohigh	receptor	high	JJ	B-NP	Oreceptor	levels	receptor	NN	I-NP	Olevels	.	level	NNS	I-NP	O.	Forty-seven	.	.	O	OForty-seven	of	Forty-seven	CD	B-NP	Oof	50	of	IN	B-PP	O50	patients	50	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	leukemic	with	IN	B-PP	Oleukemic	cells	leukemic	JJ	B-NP	B-cell_typecells	containing	cell	NNS	I-NP	I-cell_typecontaining	more	contain	VBG	B-VP	Omore	than	more	JJR	B-NP	Othan	6	than	IN	I-NP	O6	","	6	CD	I-NP	O","	0	","	","	I-NP	O0	receptor	0	CD	I-NP	Oreceptor	sites	receptor	NN	I-NP	Osites	and	site	NNS	I-NP	Oand	22	and	CC	O	O22	of	22	CD	B-NP	Oof	36	of	IN	B-PP	O36	patients	36	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	cells	with	IN	B-PP	Ocells	containing	cell	NNS	B-NP	Ocontaining	less	contain	VBG	B-VP	Oless	than	less	JJR	B-NP	Othan	6	than	IN	I-NP	O6	","	6	CD	I-NP	O","	0	","	","	I-NP	O0	receptor	0	CD	I-NP	Oreceptor	sites	receptor	NN	I-NP	Osites	achieved	site	NNS	I-NP	Oachieved	remission	achieve	VBD	B-VP	Oremission	.	remission	NN	B-NP	O.	The	.	.	O	OThe	study	The	DT	B-NP	Ostudy	of	study	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	leukemic	in	IN	B-PP	Oleukemic	cells	leukemic	JJ	B-NP	B-cell_typecells	may	cell	NNS	I-NP	I-cell_typemay	predict	may	MD	B-VP	Opredict	response	predict	VB	I-VP	Oresponse	to	response	NN	B-NP	Oto	combination	to	TO	B-PP	Ocombination	chemotherapy	combination	NN	B-NP	Ochemotherapy	in	chemotherapy	NN	I-NP	Oin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	acute	with	IN	B-PP	Oacute	lymphoblastic	acute	JJ	B-NP	Olymphoblastic	leukemia	lymphoblastic	JJ	I-NP	Oleukemia	.	leukemia	NN	I-NP	O.	Specific	.	.	O	OSpecific	uptake	Specific	JJ	B-NP	Ouptake	of	uptake	NN	I-NP	Oof	1	of	IN	B-PP	O1	","	1	CD	B-NP	O","	25-dihydroxycholecalciferol	","	","	O	O25-dihydroxycholecalciferol	by	25-dihydroxycholecalciferol	NN	B-NP	Oby	human	by	IN	B-PP	Ohuman	chronic	human	JJ	B-NP	B-cell_typechronic	myeloid	chronic	JJ	I-NP	I-cell_typemyeloid	leukemia	myeloid	JJ	I-NP	I-cell_typeleukemia	cells	leukemia	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	examined	have	VBP	B-VP	Oexamined	mononuclear	examine	VBN	I-VP	Omononuclear	cell	mononuclear	JJ	B-NP	Ocell	preparations	cell	NN	I-NP	Opreparations	from	preparation	NNS	I-NP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	chronic	with	IN	B-PP	Ochronic	myeloid	chronic	JJ	B-NP	Omyeloid	leukemia	myeloid	JJ	I-NP	Oleukemia	[	leukemia	NN	I-NP	O[	CML	[	(	O	OCML	]	CML	NN	B-NP	O]	for	]	)	O	Ofor	binding	for	IN	B-PP	Obinding	of	binding	NN	B-NP	Oof	and	of	IN	B-PP	Oand	response	and	CC	O	Oresponse	to	response	NN	B-NP	Oto	1	to	TO	B-PP	O1	","	1	CD	B-NP	O","	25-dihydroxycholecalciferol	","	","	O	O25-dihydroxycholecalciferol	[	25-dihydroxycholecalciferol	NN	B-NP	O[	1	[	(	I-NP	O1	","	1	CD	I-NP	O","	25-	","	","	I-NP	O25-	(	25-	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	]	2D3	NN	B-NP	O]	.	]	)	O	O.	Whole	.	.	O	OWhole	cells	Whole	JJ	B-NP	B-cell_typecells	specifically	cell	NNS	I-NP	I-cell_typespecifically	took	specifically	RB	B-ADVP	Otook	up	take	VBD	B-VP	Oup	[	up	RP	B-PRT	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	-1	]	)	O	O-1	","	-1	CD	B-NP	O","	25-	","	","	O	O25-	(	25-	CD	B-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	with	2D3	NN	B-NP	Owith	high	with	IN	B-PP	Ohigh	affinity	high	JJ	B-NP	Oaffinity	(	affinity	NN	I-NP	O(	Kd	(	(	O	OKd	3.6	Kd	NN	B-NP	O3.6	X	3.6	CD	I-NP	OX	10	X	SYM	B-NP	O10	(	10	CD	I-NP	O(	-11	(	(	O	O-11	)	-11	CD	B-NP	O)	M	)	)	O	OM	)	M	NN	B-NP	O)	and	)	)	O	Oand	low	and	CC	O	Olow	capacity	low	JJ	B-NP	Ocapacity	.	capacity	NN	I-NP	O.	Subcellular	.	.	O	OSubcellular	fractionation	Subcellular	JJ	B-NP	Ofractionation	of	fractionation	NN	I-NP	Oof	labeled	of	IN	B-PP	Olabeled	cells	label	VBN	B-NP	B-cell_typecells	showed	cell	NNS	I-NP	I-cell_typeshowed	that	show	VBD	B-VP	Othat	binding	that	IN	B-SBAR	Obinding	was	binding	NN	B-NP	Owas	restricted	be	VBD	B-VP	Orestricted	to	restricted	JJ	B-ADJP	Oto	cytosols	to	TO	B-PP	Ocytosols	and	cytosol	NNS	B-NP	Oand	nuclei	and	CC	I-NP	Onuclei	.	nucleus	NNS	I-NP	O.	Sucrose	.	.	O	OSucrose	gradient	Sucrose	NN	B-NP	Ogradient	centrifugation	gradient	NN	I-NP	Ocentrifugation	of	centrifugation	NN	I-NP	Oof	cells	of	IN	B-PP	Ocells	preincubated	cell	NNS	B-NP	Opreincubated	with	preincubate	VBN	B-VP	Owith	[	with	IN	B-PP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	-1	]	)	O	O-1	","	-1	CD	B-NP	O","	25-	","	","	O	O25-	(	25-	CD	B-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	revealed	2D3	NN	B-NP	Orevealed	a	reveal	VBD	B-VP	Oa	single	a	DT	B-NP	Osingle	3.6S	single	JJ	I-NP	O3.6S	peak	3.6S	NN	I-NP	Opeak	which	peak	NN	I-NP	Owhich	was	which	WDT	B-NP	Owas	totally	be	VBD	B-VP	Ototally	displaced	totally	RB	I-VP	Odisplaced	with	displace	VBN	I-VP	Owith	100-fold	with	IN	B-PP	O100-fold	excess	100-fold	JJ	B-NP	Oexcess	nonradioactive	excess	JJ	I-NP	Ononradioactive	hormone	nonradioactive	JJ	I-NP	Ohormone	.	hormone	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	we	","	","	O	Owe	were	we	PRP	B-NP	Owere	unable	be	VBD	B-VP	Ounable	to	unable	JJ	B-ADJP	Oto	demonstrate	to	TO	B-VP	Odemonstrate	specific	demonstrate	VB	I-VP	Ospecific	binding	specific	JJ	B-NP	Obinding	of	binding	NN	I-NP	Oof	1	of	IN	B-PP	O1	","	1	CD	B-NP	O","	25-	","	","	I-NP	O25-	(	25-	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	by	2D3	NN	B-NP	Oby	postlabeling	by	IN	B-PP	Opostlabeling	standard	postlabele	VBG	B-VP	Ostandard	cytosol	standard	JJ	B-NP	Ocytosol	preparations	cytosol	NN	I-NP	Opreparations	.	preparation	NNS	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	cytosols	","	","	O	Ocytosols	prepared	cytosol	NNS	B-NP	Oprepared	from	prepare	VBN	B-VP	Ofrom	a	from	IN	B-PP	Oa	mixture	a	DT	B-NP	Omixture	of	mixture	NN	I-NP	Oof	CML	of	IN	B-PP	OCML	cells	CML	NN	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	1	and	CC	O	O1	","	1	CD	B-NP	O","	25-	","	","	I-NP	O25-	(	25-	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	receptor-positive	2D3	NN	B-NP	Oreceptor-positive	T47D	receptor-positive	JJ	I-NP	OT47D	(	T47D	NN	I-NP	O(	human	(	(	O	Ohuman	breast	human	JJ	B-NP	Obreast	cancer	breast	NN	I-NP	Ocancer	)	cancer	NN	I-NP	O)	cells	)	)	I-NP	Ocells	had	cell	NNS	I-NP	Ohad	less	have	VBD	B-VP	Oless	than	less	JJR	B-NP	Othan	10	than	IN	I-NP	O10	%	10	CD	I-NP	O%	of	%	NN	I-NP	Oof	the	of	IN	B-PP	Othe	binding	the	DT	B-NP	Obinding	measured	binding	NN	I-NP	Omeasured	in	measure	VBN	B-VP	Oin	T47D	in	IN	B-PP	OT47D	cytosol	T47D	NN	B-NP	Ocytosol	alone	cytosol	NN	I-NP	Oalone	.	alone	RB	B-ADVP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	the	","	","	O	Othe	levels	the	DT	B-NP	Olevels	of	level	NNS	I-NP	Oof	binding	of	IN	B-PP	Obinding	in	binding	NN	B-NP	Oin	T47D	in	IN	B-PP	OT47D	cytosols	T47D	NN	B-NP	Ocytosols	were	cytosol	NNS	I-NP	Owere	not	be	VBD	B-VP	Onot	reduced	not	RB	I-VP	Oreduced	if	reduce	VBN	I-VP	Oif	the	if	IN	B-SBAR	Othe	receptors	the	DT	B-NP	Oreceptors	were	receptor	NNS	I-NP	Owere	occupied	be	VBD	B-VP	Ooccupied	with	occupy	VBN	I-VP	Owith	[	with	IN	B-PP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	-1	]	)	O	O-1	","	-1	CD	B-NP	O","	25-	","	","	O	O25-	(	25-	CD	B-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	prior	2D3	NN	B-NP	Oprior	to	prior	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	addition	the	DT	B-NP	Oaddition	of	addition	NN	I-NP	Oof	the	of	IN	B-PP	Othe	CML	the	DT	B-NP	OCML	cytosols	CML	NN	I-NP	Ocytosols	.	cytosol	NNS	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	CML	","	","	O	OCML	cells	CML	NN	B-NP	B-cell_typecells	appear	cell	NNS	I-NP	I-cell_typeappear	to	appear	VBP	B-VP	Oto	contain	to	TO	I-VP	Ocontain	both	contain	VB	I-VP	Oboth	the	both	CC	O	Othe	receptor	the	DT	B-NP	Oreceptor	for	receptor	NN	I-NP	Ofor	1	for	IN	B-PP	O1	","	1	CD	B-NP	O","	25-	","	","	I-NP	O25-	(	25-	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	and	2D3	NN	B-NP	Oand	an	and	CC	O	Oan	unknown	an	DT	B-NP	Ounknown	substance	unknown	JJ	I-NP	Osubstance	which	substance	NN	I-NP	Owhich	prevents	which	WDT	B-NP	Oprevents	its	prevent	VBZ	B-VP	Oits	detection	its	PRP$	B-NP	Odetection	following	detection	NN	I-NP	Ofollowing	the	follow	VBG	B-PP	Othe	preparation	the	DT	B-NP	Opreparation	of	preparation	NN	I-NP	Oof	cytosol	of	IN	B-PP	Ocytosol	.	cytosol	NN	B-NP	O.	Cells	.	.	O	OCells	from	Cell	NNS	B-NP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	CML	with	IN	B-PP	OCML	in	CML	NN	B-NP	Oin	the	in	IN	B-PP	Othe	chronic	the	DT	B-NP	Ochronic	phase	chronic	JJ	I-NP	Ophase	specifically	phase	NN	I-NP	Ospecifically	bound	specifically	RB	B-ADVP	Obound	more	bind	VBD	B-VP	Omore	1	more	RBR	B-NP	O1	","	1	CD	I-NP	O","	25-	","	","	I-NP	O25-	(	25-	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	[	2D3	NN	B-NP	O[	18	[	(	O	O18	+/-	18	CD	B-NP	O+/-	3.2	+/-	CC	I-NP	O3.2	(	3.2	CD	I-NP	O(	S.E.	(	(	O	OS.E.	)	S.E.	NN	B-NP	O)	fmol/10	)	)	O	Ofmol/10	(	fmol/10	NN	B-NP	O(	7	(	(	O	O7	)	7	CD	B-NP	O)	cells	)	)	O	Ocells	]	cell	NNS	B-NP	O]	than	]	)	O	Othan	did	than	IN	B-SBAR	Odid	those	do	VBD	O	Othose	in	those	DT	B-NP	Oin	acute	in	IN	B-PP	Oacute	myeloid	acute	JJ	B-NP	Omyeloid	transformation	myeloid	JJ	I-NP	Otransformation	[	transformation	NN	I-NP	O[	7.2	[	(	O	O7.2	+/-	7.2	CD	B-NP	O+/-	1.5	+/-	CC	I-NP	O1.5	]	1.5	CD	I-NP	O]	or	]	)	O	Oor	than	or	CC	O	Othan	did	than	IN	B-SBAR	Odid	cells	do	VBD	O	Ocells	from	cell	NNS	B-NP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	acute	with	IN	B-PP	Oacute	myeloid	acute	JJ	B-NP	Omyeloid	leukemia	myeloid	JJ	I-NP	Oleukemia	[	leukemia	NN	I-NP	O[	2.6	[	(	O	O2.6	+/-	2.6	CD	B-NP	O+/-	0.8	+/-	CC	I-NP	O0.8	]	0.8	CD	I-NP	O]	.	]	)	O	O.	Only	.	.	O	OOnly	cells	Only	RB	B-NP	Ocells	from	cell	NNS	I-NP	Ofrom	the	from	IN	B-PP	Othe	first	the	DT	B-NP	Ofirst	group	first	JJ	I-NP	Ogroup	of	group	NN	I-NP	Oof	patients	of	IN	B-PP	Opatients	responded	patient	NNS	B-NP	Oresponded	to	respond	VBD	B-VP	Oto	the	to	TO	B-PP	Othe	addition	the	DT	B-NP	Oaddition	of	addition	NN	I-NP	Oof	1	of	IN	B-PP	O1	","	1	CD	B-NP	O","	25-	","	","	I-NP	O25-	(	25-	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	by	2D3	NN	B-NP	Oby	differentiating	by	IN	B-PP	Odifferentiating	along	differentiate	VBG	B-VP	Oalong	the	along	IN	B-PP	Othe	monocyte-macrophage	the	DT	B-NP	Omonocyte-macrophage	pathway	monocyte-macrophage	JJ	I-NP	Opathway	.	pathway	NN	I-NP	O.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	differentiation-induction	the	DT	B-NP	Odifferentiation-induction	effect	differentiation-induction	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	1	of	IN	B-PP	O1	","	1	CD	B-NP	O","	25-	","	","	I-NP	O25-	(	25-	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	is	2D3	NN	B-NP	Ois	likely	be	VBZ	B-VP	Olikely	to	likely	JJ	B-ADJP	Oto	depend	to	TO	B-VP	Odepend	on	depend	VB	I-VP	Oon	adequate	on	IN	B-PP	Oadequate	levels	adequate	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	receptor	of	IN	B-PP	Oreceptor	and	receptor	NN	B-NP	B-proteinand	that	and	CC	O	Othat	intact	that	IN	B-SBAR	Ointact	cells	intact	JJ	B-NP	B-cell_typecells	rather	cell	NNS	I-NP	I-cell_typerather	than	rather	RB	B-PP	Othan	cytosol	than	IN	I-PP	Ocytosol	preparations	cytosol	NN	B-NP	Opreparations	should	preparation	NNS	I-NP	Oshould	be	should	MD	B-VP	Obe	studied	be	VB	I-VP	Ostudied	before	study	VBN	I-VP	Obefore	cells	before	IN	B-PP	Ocells	of	cell	NNS	B-NP	Oof	a	of	IN	B-PP	Oa	particular	a	DT	B-NP	Oparticular	tissue	particular	JJ	I-NP	Otissue	are	tissue	NN	I-NP	Oare	designated	be	VBP	B-VP	Odesignated	as	designate	VBN	I-VP	Oas	receptor	as	IN	B-PP	Oreceptor	negative	receptor	NN	B-NP	Onegative	.	negative	JJ	B-ADJP	O.	Effect	.	.	O	OEffect	of	Effect	NN	B-NP	Oof	cell	of	IN	B-PP	Ocell	cycle	cell	NN	B-NP	Ocycle	position	cycle	NN	I-NP	Oposition	on	position	NN	I-NP	Oon	dexamethasone	on	IN	B-PP	Odexamethasone	binding	dexamethasone	NN	B-NP	Obinding	by	binding	NN	I-NP	Oby	mouse	by	IN	B-PP	Omouse	and	mouse	NN	B-NP	B-cell_lineand	human	and	CC	O	I-cell_linehuman	lymphoid	human	JJ	B-NP	I-cell_linelymphoid	cell	lymphoid	JJ	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	:	line	NNS	I-NP	I-cell_line:	correlation	:	:	O	Ocorrelation	between	correlation	NN	B-NP	Obetween	an	between	IN	B-PP	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	dexamethasone	in	IN	B-PP	Odexamethasone	binding	dexamethasone	NN	B-NP	Obinding	during	binding	NN	I-NP	Oduring	S	during	IN	B-PP	OS	phase	S	NN	B-NP	Ophase	and	phase	NN	I-NP	Oand	dexamethasone	and	CC	O	Odexamethasone	sensitivity	dexamethasone	NN	B-NP	Osensitivity	.	sensitivity	NN	I-NP	O.	We	.	.	O	OWe	determined	We	PRP	B-NP	Odetermined	the	determine	VBD	B-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	cell	of	IN	B-PP	Ocell	cycle	cell	NN	B-NP	Ocycle	position	cycle	NN	I-NP	Oposition	on	position	NN	I-NP	Oon	the	on	IN	B-PP	Othe	amount	the	DT	B-NP	Oamount	of	amount	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	that	dexamethasone	NN	B-NP	Othat	was	that	WDT	B-NP	Owas	specifically	be	VBD	B-VP	Ospecifically	bound	specifically	RB	I-VP	Obound	by	bind	VBN	I-VP	Oby	mouse	by	IN	B-PP	Omouse	and	mouse	NN	B-NP	Oand	human	and	CC	O	Ohuman	lymphoid	human	JJ	B-NP	B-cell_linelymphoid	cell	lymphoid	JJ	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	.	line	NNS	I-NP	I-cell_line.	Cell	.	.	O	OCell	lines	Cell	NN	B-NP	B-cell_linelines	that	line	NNS	I-NP	I-cell_linethat	were	that	WDT	B-NP	Owere	either	be	VBD	B-VP	Oeither	sensitive	either	CC	O	Osensitive	or	sensitive	JJ	B-ADJP	Oor	resistant	or	CC	I-ADJP	Oresistant	to	resistant	JJ	I-ADJP	Oto	growth	to	TO	B-PP	Ogrowth	inhibition	growth	NN	B-NP	Oinhibition	by	inhibition	NN	I-NP	Oby	dexamethasone	by	IN	B-PP	Odexamethasone	were	dexamethasone	NN	B-NP	Owere	compared	be	VBD	B-VP	Ocompared	.	compare	VBN	I-VP	O.	Exponentially	.	.	O	OExponentially	growing	Exponentially	RB	B-NP	Ogrowing	cells	grow	VBG	I-NP	Ocells	were	cell	NNS	I-NP	Owere	separated	be	VBD	B-VP	Oseparated	by	separate	VBN	I-VP	Oby	centrifugal	by	IN	B-PP	Ocentrifugal	elutriation	centrifugal	JJ	B-NP	Oelutriation	into	elutriation	NN	I-NP	Ointo	fractions	into	IN	B-PP	Ofractions	that	fraction	NNS	B-NP	Othat	corresponded	that	WDT	B-NP	Ocorresponded	to	correspond	VBD	B-VP	Oto	different	to	TO	B-PP	Odifferent	positions	different	JJ	B-NP	Opositions	in	position	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	cycle	cell	NN	I-NP	Ocycle	.	cycle	NN	I-NP	O.	The	.	.	O	OThe	cell	The	DT	B-NP	Ocell	cycle	cell	NN	I-NP	Ocycle	phase	cycle	NN	I-NP	Ophase	distribution	phase	NN	I-NP	Odistribution	of	distribution	NN	I-NP	Oof	each	of	IN	B-PP	Oeach	fraction	each	DT	B-NP	Ofraction	was	fraction	NN	I-NP	Owas	estimated	be	VBD	B-VP	Oestimated	by	estimate	VBN	I-VP	Oby	flow	by	IN	B-PP	Oflow	cytometry	flow	NN	B-NP	Ocytometry	and	cytometry	NN	I-NP	Oand	autoradiography	and	CC	I-NP	Oautoradiography	.	autoradiography	NN	I-NP	O.	The	.	.	O	OThe	amount	The	DT	B-NP	Oamount	of	amount	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	bound	dexamethasone	NN	B-NP	Obound	per	bind	VBN	B-VP	Oper	cell	per	IN	B-PP	Ocell	in	cell	NN	B-NP	Oin	each	in	IN	B-PP	Oeach	fraction	each	DT	B-NP	Ofraction	was	fraction	NN	I-NP	Owas	measured	be	VBD	B-VP	Omeasured	by	measure	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	whole	a	DT	B-NP	Owhole	cell	whole	JJ	I-NP	Ocell	binding	cell	NN	I-NP	Obinding	assay	binding	NN	I-NP	Oassay	.	assay	NN	I-NP	O.	In	.	.	O	OIn	three	In	IN	B-PP	Othree	dexamethasone-sensitive	three	CD	B-NP	Odexamethasone-sensitive	cell	dexamethasone-sensitive	JJ	I-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	(	line	NNS	I-NP	I-cell_line(	two	(	(	O	Otwo	mouse	two	CD	B-NP	Omouse	and	mouse	NN	I-NP	Oand	one	and	CC	O	Oone	human	one	CD	B-NP	Ohuman	)	human	JJ	I-NP	O)	","	)	)	O	O","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	amount	the	DT	B-NP	Oamount	of	amount	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	bound	dexamethasone	NN	B-NP	Obound	per	bind	VBN	B-VP	Oper	cell	per	IN	B-PP	Ocell	increased	cell	NN	B-NP	Oincreased	2-4-fold	increase	VBD	B-VP	O2-4-fold	between	2-4-fold	RB	B-ADVP	Obetween	G1	between	IN	B-PP	OG1	phase	G1	NN	B-NP	Ophase	and	phase	NN	I-NP	Oand	S	and	CC	O	OS	phase	S	NN	B-NP	Ophase	","	phase	NN	I-NP	O","	and	","	","	O	Oand	then	and	CC	O	Othen	decreased	then	RB	B-VP	Odecreased	during	decrease	VBD	I-VP	Oduring	G2/M	during	IN	B-PP	OG2/M	phase	G2/M	NN	B-NP	Ophase	.	phase	NN	I-NP	O.	Results	.	.	O	OResults	were	Result	NNS	B-NP	Owere	the	be	VBD	B-VP	Othe	same	the	DT	B-NP	Osame	when	same	JJ	I-NP	Owhen	the	when	WRB	B-ADVP	Othe	amount	the	DT	B-NP	Oamount	of	amount	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	bound	dexamethasone	NN	B-NP	Obound	per	bind	VBN	B-VP	Oper	milligram	per	IN	B-PP	Omilligram	of	milligram	NN	B-NP	Oof	cell	of	IN	B-PP	Ocell	protein	cell	NN	B-NP	B-proteinprotein	was	protein	NN	I-NP	I-proteinwas	measured	be	VBD	B-VP	Omeasured	.	measure	VBN	I-VP	O.	Binding	.	.	O	OBinding	affinity	Binding	NN	B-NP	Oaffinity	was	affinity	NN	I-NP	Owas	the	be	VBD	B-VP	Othe	same	the	DT	B-NP	Osame	during	same	JJ	I-NP	Oduring	G1	during	IN	B-PP	OG1	phase	G1	NN	B-NP	Ophase	and	phase	NN	I-NP	Oand	S	and	CC	O	OS	phase	S	NN	B-NP	Ophase	","	phase	NN	I-NP	O","	but	","	","	O	Obut	the	but	CC	O	Othe	proportion	the	DT	B-NP	Oproportion	of	proportion	NN	I-NP	Oof	bound	of	IN	B-PP	Obound	dexamethasone	bind	VBN	B-NP	Odexamethasone	that	dexamethasone	NN	I-NP	Othat	translocated	that	WDT	B-NP	Otranslocated	to	translocate	VBD	B-VP	Oto	the	to	TO	B-PP	Othe	nucleus	the	DT	B-NP	Onucleus	was	nucleus	NN	I-NP	Owas	greater	be	VBD	B-VP	Ogreater	during	great	JJR	B-ADJP	Oduring	S	during	IN	B-PP	OS	phase	S	NN	B-NP	Ophase	.	phase	NN	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	amount	the	DT	B-NP	Oamount	of	amount	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	bound	dexamethasone	NN	B-NP	Obound	per	bind	VBN	B-VP	Oper	cell	per	IN	B-PP	Ocell	by	cell	NN	B-NP	Oby	three	by	IN	B-PP	Othree	dexamethasone-resistant	three	CD	B-NP	Odexamethasone-resistant	cell	dexamethasone-resistant	JJ	I-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	(	line	NNS	I-NP	I-cell_line(	two	(	(	O	Otwo	mouse	two	CD	B-NP	Omouse	and	mouse	NN	I-NP	Oand	one	and	CC	O	Oone	human	one	CD	B-NP	Ohuman	)	human	JJ	I-NP	O)	did	)	)	O	Odid	not	do	VBD	B-VP	Onot	increase	not	RB	I-VP	Oincrease	during	increase	VB	I-VP	Oduring	S	during	IN	B-PP	OS	phase	S	NN	B-NP	Ophase	.	phase	NN	I-NP	O.	Our	.	.	O	OOur	results	Our	PRP$	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	cell	that	IN	B-SBAR	Ocell	cycle	cell	NN	B-NP	Ocycle	changes	cycle	NN	I-NP	Ochanges	in	change	NNS	I-NP	Oin	dexamethasone	in	IN	B-PP	Odexamethasone	binding	dexamethasone	NN	B-NP	Obinding	are	binding	NN	I-NP	Oare	not	be	VBP	B-VP	Onot	simply	not	RB	I-VP	Osimply	related	simply	RB	I-VP	Orelated	to	relate	VBN	I-VP	Oto	changes	to	TO	B-PP	Ochanges	in	change	NNS	B-NP	Oin	cell	in	IN	B-PP	Ocell	protein	cell	NN	B-NP	Oprotein	or	protein	NN	I-NP	Oor	cell	or	CC	O	Ocell	volume	cell	NN	B-NP	Ovolume	during	volume	NN	I-NP	Oduring	the	during	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	cycle	cell	NN	I-NP	Ocycle	.	cycle	NN	I-NP	O.	An	.	.	O	OAn	increase	An	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	dexamethasone	in	IN	B-PP	Odexamethasone	binding	dexamethasone	NN	B-NP	Obinding	during	binding	NN	I-NP	Oduring	S	during	IN	B-PP	OS	phase	S	NN	B-NP	Ophase	may	phase	NN	I-NP	Omay	be	may	MD	B-VP	Obe	required	be	VB	I-VP	Orequired	for	require	VBN	I-VP	Ofor	dexamethasone	for	IN	B-PP	Odexamethasone	to	dexamethasone	NN	B-NP	Oto	inhibit	to	TO	B-VP	Oinhibit	cell	inhibit	VB	I-VP	Ocell	growth	cell	NN	B-NP	Ogrowth	","	growth	NN	I-NP	O","	and	","	","	O	Oand	a	and	CC	O	Oa	failure	a	DT	B-NP	Ofailure	of	failure	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	binding	dexamethasone	NN	B-NP	Obinding	to	binding	NN	I-NP	Oto	increase	to	TO	B-VP	Oincrease	during	increase	VB	I-VP	Oduring	S	during	IN	B-PP	OS	phase	S	NN	B-NP	Ophase	might	phase	NN	I-NP	Omight	represent	might	MD	B-VP	Orepresent	a	represent	VB	I-VP	Oa	new	a	DT	B-NP	Onew	mechanism	new	JJ	I-NP	Omechanism	of	mechanism	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	resistance	dexamethasone	NN	B-NP	Oresistance	in	resistance	NN	I-NP	Oin	lymphoid	in	IN	B-PP	Olymphoid	cells	lymphoid	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Presence	.	.	O	OPresence	and	Presence	NN	B-NP	Oand	steroid	and	CC	I-NP	Osteroid	inducibility	steroid	NN	I-NP	Oinducibility	of	inducibility	NN	I-NP	Oof	glutamine	of	IN	B-PP	Oglutamine	synthetase	glutamine	NN	B-NP	B-proteinsynthetase	in	synthetase	NN	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	leukemic	human	JJ	B-NP	B-cell_typeleukemic	cells	leukemic	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Glutamine	.	.	O	OGlutamine	synthetase	Glutamine	NN	B-NP	B-proteinsynthetase	(	synthetase	NN	I-NP	I-protein(	EC	(	(	O	OEC	6.3.1.2	EC	NN	B-NP	O6.3.1.2	;	6.3.1.2	NN	I-NP	O;	GS	;	:	O	OGS	)	GS	NN	B-NP	O)	is	)	)	O	Ois	present	be	VBZ	B-VP	Opresent	in	present	JJ	B-ADJP	Oin	lymphoblasts	in	IN	B-PP	Olymphoblasts	from	lymphoblast	NNS	B-NP	B-cell_typefrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	acute	with	IN	B-PP	Oacute	lymphoblastic	acute	JJ	B-NP	Olymphoblastic	leukemia	lymphoblastic	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	ALL	(	(	O	OALL	)	ALL	NN	B-NP	O)	as	)	)	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	in	as	IN	I-CONJP	Oin	normal	in	IN	B-PP	Onormal	peripheral	normal	JJ	B-NP	B-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	lymphocytes	blood	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	16	In	IN	B-PP	O16	out	16	CD	B-NP	Oout	of	out	IN	I-NP	Oof	20	of	IN	I-NP	O20	ALL	20	CD	I-NP	OALL	patients	ALL	NN	I-NP	Opatients	studied	patient	NNS	I-NP	Ostudied	exposure	study	VBD	B-VP	Oexposure	of	exposure	NN	B-NP	Oof	the	of	IN	B-PP	Othe	cells	the	DT	B-NP	Ocells	to	cell	NNS	I-NP	Oto	physiological	to	TO	B-PP	Ophysiological	concentrations	physiological	JJ	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	in	dexamethasone	NN	B-NP	Oin	vitro	in	FW	B-ADVP	Ovitro	increased	vitro	FW	I-ADVP	Oincreased	enzyme	increase	VBN	B-NP	Oenzyme	activity	enzyme	NN	I-NP	Oactivity	above	activity	NN	I-NP	Oabove	the	above	IN	B-PP	Othe	control	the	DT	B-NP	Ocontrol	levels	control	NN	I-NP	Olevels	.	level	NNS	I-NP	O.	The	.	.	O	OThe	increase	The	DT	B-NP	Oincrease	was	increase	NN	I-NP	Owas	specific	be	VBD	B-VP	Ospecific	for	specific	JJ	B-ADJP	Ofor	glucocorticoid	for	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	ligands	receptor	NN	I-NP	I-proteinligands	.	ligand	NNS	I-NP	O.	A	.	.	O	OA	direct	A	DT	B-NP	Odirect	correlation	direct	JJ	I-NP	Ocorrelation	was	correlation	NN	I-NP	Owas	found	be	VBD	B-VP	Ofound	between	find	VBN	I-VP	Obetween	the	between	IN	B-PP	Othe	magnitude	the	DT	B-NP	Omagnitude	of	magnitude	NN	I-NP	Oof	glucocorticoid-mediated	of	IN	B-PP	Oglucocorticoid-mediated	increase	glucocorticoid-mediated	JJ	B-NP	Oincrease	of	increase	NN	I-NP	Oof	GS	of	IN	B-PP	OGS	activity	GS	NN	B-NP	Oactivity	and	activity	NN	I-NP	Oand	the	and	CC	O	Othe	cellular	the	DT	B-NP	Ocellular	levels	cellular	JJ	I-NP	Olevels	of	level	NNS	I-NP	Oof	specific	of	IN	B-PP	Ospecific	glucocorticoid	specific	JJ	B-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	assayed	receptor	NNS	I-NP	I-proteinassayed	in	assay	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	same	the	DT	B-NP	Osame	cell	same	JJ	I-NP	Ocell	specimen	cell	NN	I-NP	Ospecimen	.	specimen	NN	I-NP	O.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	the	","	","	O	Othe	basal	the	DT	B-NP	Obasal	levels	basal	JJ	I-NP	Olevels	of	level	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	enzyme	the	DT	B-NP	Oenzyme	measured	enzyme	NN	I-NP	B-proteinmeasured	in	measure	VBN	B-VP	Oin	cells	in	IN	B-PP	Ocells	prior	cell	NNS	B-NP	Oprior	to	prior	RB	B-ADVP	Oto	exposure	to	TO	B-PP	Oexposure	to	exposure	NN	B-NP	Oto	dexamethasone	to	TO	B-PP	Odexamethasone	correlated	dexamethasone	NN	B-NP	Ocorrelated	negatively	correlate	VBD	B-VP	Onegatively	with	negatively	RB	B-ADVP	Owith	receptor	with	IN	B-PP	Oreceptor	density	receptor	NN	B-NP	Odensity	.	density	NN	I-NP	O.	It	.	.	O	OIt	is	It	PRP	B-NP	Ois	suggested	be	VBZ	B-VP	Osuggested	that	suggest	VBN	I-VP	Othat	the	that	IN	B-SBAR	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	steroid-inducible	of	IN	B-PP	Osteroid-inducible	GS	steroid-inducible	JJ	B-NP	B-proteinGS	in	GS	NN	I-NP	I-proteinin	ALL	in	IN	B-PP	OALL	cells	ALL	NN	B-NP	B-cell_linecells	may	cell	NNS	I-NP	I-cell_linemay	prove	may	MD	B-VP	Oprove	to	prove	VB	I-VP	Oto	be	to	TO	I-VP	Obe	a	be	VB	I-VP	Oa	marker	a	DT	B-NP	Omarker	for	marker	NN	I-NP	Ofor	functional	for	IN	B-PP	Ofunctional	receptor	functional	JJ	B-NP	Oreceptor	sites	receptor	NN	I-NP	Osites	.	site	NNS	I-NP	O.	Binding	.	.	O	OBinding	of	Binding	NN	B-NP	Oof	progestins	of	IN	B-PP	Oprogestins	to	progestin	NNS	B-NP	Oto	the	to	TO	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	.	receptor	NN	I-NP	I-protein.	Correlation	.	.	O	OCorrelation	to	Correlation	NN	B-NP	Oto	their	to	TO	B-PP	Otheir	glucocorticoid-like	their	PRP$	B-NP	Oglucocorticoid-like	effects	glucocorticoid-like	JJ	I-NP	Oeffects	on	effect	NNS	I-NP	Oon	in	on	IN	B-PP	Oin	vitro	in	FW	B-NP	Ovitro	functions	vitro	FW	I-NP	Ofunctions	of	function	NNS	I-NP	Oof	human	of	IN	B-PP	Ohuman	mononuclear	human	JJ	B-NP	B-cell_typemononuclear	leukocytes	mononuclear	JJ	I-NP	I-cell_typeleukocytes	.	leukocyte	NNS	I-NP	I-cell_type.	A	.	.	O	OA	number	A	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	physiological	of	IN	B-PP	Ophysiological	and	physiological	JJ	B-NP	Oand	synthetic	and	CC	I-NP	Osynthetic	progestins	synthetic	JJ	I-NP	Oprogestins	were	progestin	NNS	I-NP	Owere	tested	be	VBD	B-VP	Otested	for	test	VBN	I-VP	Ofor	their	for	IN	B-PP	Otheir	ability	their	PRP$	B-NP	Oability	to	ability	NN	I-NP	Oto	compete	to	TO	B-VP	Ocompete	with	compete	VB	I-VP	Owith	[	with	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	dexamethasone	]	)	I-NP	Odexamethasone	for	dexamethasone	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	binding	the	DT	B-NP	Obinding	to	binding	NN	I-NP	Oto	the	to	TO	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	of	receptor	NN	I-NP	I-proteinof	human	of	IN	B-PP	Ohuman	mononuclear	human	JJ	B-NP	B-cell_typemononuclear	leukocytes	mononuclear	JJ	I-NP	I-cell_typeleukocytes	and	leukocyte	NNS	I-NP	I-cell_typeand	their	and	CC	O	Otheir	ability	their	PRP$	B-NP	Oability	to	ability	NN	I-NP	Oto	elicit	to	TO	B-VP	Oelicit	glucocorticoid-like	elicit	VB	I-VP	Oglucocorticoid-like	effects	glucocorticoid-like	JJ	B-NP	Oeffects	on	effect	NNS	I-NP	Oon	the	on	IN	B-PP	Othe	same	the	DT	B-NP	Osame	cells	same	JJ	I-NP	Ocells	.	cell	NNS	I-NP	O.	As	.	.	O	OAs	compared	As	IN	B-SBAR	Ocompared	to	compare	VBN	B-PP	Oto	the	to	TO	B-PP	Othe	reference	the	DT	B-NP	Oreference	compound	reference	NN	I-NP	Ocompound	dexamethasone	compound	NN	I-NP	Odexamethasone	(	dexamethasone	NN	I-NP	O(	relative	(	(	O	Orelative	receptor	relative	JJ	B-NP	Oreceptor	binding	receptor	NN	I-NP	Obinding	affinity	binding	NN	I-NP	Oaffinity	defined	affinity	NN	I-NP	Odefined	as	define	VBN	B-VP	Oas	100	as	IN	B-PP	O100	%	100	CD	B-NP	O%	)	%	NN	I-NP	O)	","	)	)	O	O","	two	","	","	O	Otwo	potent	two	CD	B-NP	Opotent	synthetic	potent	JJ	I-NP	Osynthetic	progestins	synthetic	JJ	I-NP	Oprogestins	with	progestin	NNS	I-NP	Owith	a	with	IN	B-PP	Oa	pregnane-type	a	DT	B-NP	Opregnane-type	structure	pregnane-type	JJ	I-NP	Ostructure	","	structure	NN	I-NP	O","	megestrol	","	","	O	Omegestrol	acetate	megestrol	NN	B-NP	Oacetate	and	acetate	NN	I-NP	Oand	medroxyprogesterone	and	CC	O	Omedroxyprogesterone	acetate	medroxyprogesterone	NN	B-NP	Oacetate	","	acetate	NN	I-NP	O","	were	","	","	O	Owere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	display	to	TO	I-VP	Odisplay	a	display	VB	I-VP	Oa	considerable	a	DT	B-NP	Oconsiderable	binding	considerable	JJ	I-NP	Obinding	affinity	binding	NN	I-NP	Oaffinity	towards	affinity	NN	I-NP	Otowards	the	towards	IN	B-PP	Othe	receptor	the	DT	B-NP	Oreceptor	(	receptor	NN	I-NP	O(	46	(	(	O	O46	and	46	CD	B-NP	Oand	42	and	CC	I-NP	O42	%	42	CD	I-NP	O%	","	%	NN	I-NP	O","	respectively	","	","	O	Orespectively	)	respectively	RB	B-ADVP	O)	.	)	)	O	O.	The	.	.	O	OThe	relative	The	DT	B-NP	Orelative	binding	relative	JJ	I-NP	Obinding	affinity	binding	NN	I-NP	Oaffinity	of	affinity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	naturally	the	DT	B-NP	Onaturally	occurring	naturally	RB	I-NP	Ooccurring	ligand	occur	VBG	I-NP	Oligand	","	ligand	NN	I-NP	O","	cortisol	","	","	O	Ocortisol	","	cortisol	NN	B-NP	O","	to	","	","	O	Oto	the	to	TO	B-PP	Othe	receptor	the	DT	B-NP	Oreceptor	was	receptor	NN	I-NP	Owas	clearly	be	VBD	B-VP	Oclearly	lower	clearly	RB	B-ADJP	Olower	(	low	JJR	I-ADJP	O(	25	(	(	O	O25	%	25	CD	B-NP	O%	)	%	NN	I-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	effective	The	DT	B-NP	Oeffective	binding	effective	JJ	I-NP	Obinding	of	binding	NN	I-NP	Oof	medroxyprogesterone	of	IN	B-PP	Omedroxyprogesterone	acetate	medroxyprogesterone	NN	B-NP	Oacetate	to	acetate	NN	I-NP	Oto	the	to	TO	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	was	receptor	NN	I-NP	I-proteinwas	confirmed	be	VBD	B-VP	Oconfirmed	by	confirm	VBN	I-VP	Oby	direct	by	IN	B-PP	Odirect	binding	direct	JJ	B-NP	Obinding	studies	binding	NN	I-NP	Ostudies	utilizing	study	NNS	I-NP	Outilizing	a	utilize	VBG	B-VP	Oa	tritiated	a	DT	B-NP	Otritiated	derivative	tritiate	VBN	I-NP	Oderivative	of	derivative	NN	I-NP	Oof	this	of	IN	B-PP	Othis	steroid	this	DT	B-NP	Osteroid	.	steroid	NN	I-NP	O.	No	.	.	O	ONo	evidence	No	DT	B-NP	Oevidence	for	evidence	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	existence	the	DT	B-NP	Oexistence	of	existence	NN	I-NP	Oof	a	of	IN	B-PP	Oa	specific	a	DT	B-NP	Ospecific	progesterone	specific	JJ	I-NP	Oprogesterone	receptor	progesterone	NN	I-NP	B-proteinreceptor	in	receptor	NN	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	mononuclear	human	JJ	B-NP	B-cell_typemononuclear	leukocytes	mononuclear	JJ	I-NP	I-cell_typeleukocytes	was	leukocyte	NNS	I-NP	I-cell_typewas	obtained	be	VBD	B-VP	Oobtained	as	obtain	VBN	I-VP	Oas	judged	as	IN	B-SBAR	Ojudged	by	judge	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	results	the	DT	B-NP	Oresults	of	result	NNS	I-NP	Oof	competition	of	IN	B-PP	Ocompetition	experiments	competition	NN	B-NP	Oexperiments	where	experiment	NNS	I-NP	Owhere	a	where	WRB	B-ADVP	Oa	progesterone	a	DT	B-NP	Oprogesterone	receptor-specific	progesterone	NN	I-NP	Oreceptor-specific	ligand	receptor-specific	JJ	I-NP	Oligand	[	ligand	NN	I-NP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	Org	]	)	O	OOrg	2058	Org	NNP	B-NP	O2058	was	2058	CD	I-NP	Owas	used	be	VBD	B-VP	Oused	.	use	VBN	I-VP	O.	Medroxyprogesterone	.	.	O	OMedroxyprogesterone	acetate	Medroxyprogesterone	NN	B-NP	Oacetate	and	acetate	NN	I-NP	Oand	megestrol	and	CC	I-NP	Omegestrol	acetate	megestrol	NN	I-NP	Oacetate	also	acetate	NN	I-NP	Oalso	induced	also	RB	B-ADVP	Oinduced	glucocorticoid-like	induce	VBD	B-VP	Oglucocorticoid-like	effects	glucocorticoid-like	JJ	B-NP	Oeffects	on	effect	NNS	I-NP	Oon	the	on	IN	B-PP	Othe	lymphocyte	the	DT	B-NP	Olymphocyte	functions	lymphocyte	NN	I-NP	Ofunctions	.	function	NNS	I-NP	O.	These	.	.	O	OThese	included	These	DT	B-NP	Oincluded	inhibition	include	VBD	B-VP	Oinhibition	of	inhibition	NN	B-NP	Oof	the	of	IN	B-PP	Othe	proliferative	the	DT	B-NP	Oproliferative	responses	proliferative	JJ	I-NP	Oresponses	to	response	NNS	I-NP	Oto	the	to	TO	B-PP	Othe	T-cell	the	DT	B-NP	OT-cell	mitogens	T-cell	NN	I-NP	B-proteinmitogens	concanavalin	mitogen	NNS	I-NP	I-proteinconcanavalin	A	concanavalin	NN	I-NP	OA	and	A	NN	I-NP	Oand	phytohaemagglutinin	and	CC	O	Ophytohaemagglutinin	and	phytohaemagglutinin	NN	B-NP	B-proteinand	an	and	CC	O	Oan	enhanced	an	DT	B-NP	Oenhanced	accumulation	enhance	VBN	I-NP	Oaccumulation	of	accumulation	NN	I-NP	Oof	immunoglobulin	of	IN	B-PP	Oimmunoglobulin	secreting	immunoglobulin	NN	B-NP	B-cell_typesecreting	cells	secreting	NN	I-NP	I-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	pokeweed	in	IN	B-PP	Opokeweed	mitogen-stimulated	pokeweed	NN	B-NP	B-cell_linemitogen-stimulated	cultures	mitogen-stimulated	JJ	I-NP	I-cell_linecultures	.	culture	NNS	I-NP	I-cell_line.	The	.	.	O	OThe	progestin	The	DT	B-NP	Oprogestin	effect	progestin	NN	I-NP	Oeffect	appears	effect	NN	I-NP	Oappears	to	appear	VBZ	B-VP	Oto	be	to	TO	I-VP	Obe	mediated	be	VB	I-VP	Omediated	through	mediate	VBN	I-VP	Othrough	a	through	IN	B-PP	Oa	radiosensitive	a	DT	B-NP	Oradiosensitive	(	radiosensitive	JJ	I-NP	O(	suppressor	(	(	O	Osuppressor	)	suppressor	NN	B-NP	O)	subpopulation	)	)	O	Osubpopulation	of	subpopulation	NN	B-NP	Oof	T	of	IN	B-PP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	the	","	","	O	Othe	synthetic	the	DT	B-NP	Osynthetic	progestins	synthetic	JJ	I-NP	Oprogestins	related	progestin	NNS	I-NP	Orelated	structurally	relate	VBN	B-VP	Ostructurally	to	structurally	RB	B-ADVP	Oto	19-nortestosterone	to	TO	B-PP	O19-nortestosterone	","	19-nortestosterone	NN	B-NP	O","	norethisterone	","	","	I-NP	Onorethisterone	and	norethisterone	NN	I-NP	Oand	d-norgestrel	and	CC	I-NP	Od-norgestrel	","	d-norgestrel	NN	I-NP	O","	were	","	","	O	Owere	virtually	be	VBD	B-VP	Ovirtually	devoid	virtually	RB	B-ADJP	Odevoid	of	devoid	JJ	I-ADJP	Oof	binding	of	IN	B-PP	Obinding	affinity	binding	NN	B-NP	Oaffinity	towards	affinity	NN	I-NP	Otowards	the	towards	IN	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	nor	receptor	NN	I-NP	I-proteinnor	did	nor	CC	O	Odid	they	do	VBD	O	Othey	measurably	they	PRP	B-NP	Omeasurably	influence	measurably	RB	B-ADVP	Oinfluence	the	influence	VB	B-VP	Othe	in	the	DT	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	lymphocyte	vitro	FW	I-NP	Olymphocyte	functions	lymphocyte	NN	I-NP	Ofunctions	.	function	NNS	I-NP	O.	These	.	.	O	OThese	studies	These	DT	B-NP	Ostudies	demonstrate	study	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	certain	that	IN	B-SBAR	Ocertain	progestins	certain	JJ	B-NP	Oprogestins	in	progestin	NNS	I-NP	Oin	common	in	IN	B-PP	Ocommon	clinical	common	JJ	B-NP	Oclinical	use	clinical	JJ	I-NP	Ouse	probably	use	NN	I-NP	Oprobably	possess	probably	RB	B-ADVP	Opossess	inherent	possess	VBP	B-VP	Oinherent	glucocorticoid	inherent	JJ	B-NP	Oglucocorticoid	activity	glucocorticoid	NN	I-NP	Oactivity	and	activity	NN	I-NP	Oand	suggest	and	CC	O	Osuggest	that	suggest	VBP	B-VP	Othat	side	that	IN	B-SBAR	Oside	effects	side	JJ	B-NP	Oeffects	attributable	effect	NNS	I-NP	Oattributable	to	attributable	JJ	B-ADJP	Oto	this	to	TO	B-PP	Othis	character	this	DT	B-NP	Ocharacter	(	character	NN	I-NP	O(	e.g.	(	(	O	Oe.g.	suppression	e.g.	FW	B-NP	Osuppression	of	suppression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	pituitary-adrenal	the	DT	B-NP	Opituitary-adrenal	axis	pituitary-adrenal	JJ	I-NP	Oaxis	)	axis	NN	I-NP	O)	might	)	)	O	Omight	be	might	MD	B-VP	Obe	expected	be	VB	I-VP	Oexpected	when	expect	VBN	I-VP	Owhen	these	when	WRB	B-ADVP	Othese	compounds	these	DT	B-NP	Ocompounds	are	compound	NNS	I-NP	Oare	used	be	VBP	B-VP	Oused	in	use	VBN	I-VP	Oin	pharmacological	in	IN	B-PP	Opharmacological	doses	pharmacological	JJ	B-NP	Odoses	.	dose	NNS	I-NP	O.	Metabolic	.	.	O	OMetabolic	and	Metabolic	JJ	B-NP	Oand	ultrastructural	and	CC	I-NP	Oultrastructural	aspects	ultrastructural	JJ	I-NP	Oaspects	of	aspect	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	in	the	DT	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	lysis	vitro	FW	I-NP	Olysis	of	lysis	NN	I-NP	Oof	chronic	of	IN	B-PP	Ochronic	lymphocytic	chronic	JJ	B-NP	B-cell_typelymphocytic	leukemia	lymphocytic	JJ	I-NP	I-cell_typeleukemia	cells	leukemia	NN	I-NP	I-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	glucocorticoids	by	IN	B-PP	Oglucocorticoids	.	glucocorticoid	NNS	B-NP	O.	Human	.	.	O	OHuman	chronic	Human	JJ	B-NP	B-cell_linechronic	lymphocytic	chronic	JJ	I-NP	I-cell_linelymphocytic	leukemia	lymphocytic	JJ	I-NP	I-cell_lineleukemia	(	leukemia	NN	I-NP	I-cell_line(	CLL	(	(	O	I-cell_lineCLL	)	CLL	NN	B-NP	I-cell_line)	cells	)	)	O	I-cell_linecells	like	cell	NNS	B-NP	I-cell_linelike	prothymocytes	like	IN	B-PP	Oprothymocytes	and	prothymocyte	NNS	B-NP	B-cell_typeand	immunoactivated	and	CC	O	Oimmunoactivated	T-lymphocytes	immunoactivated	JJ	B-NP	B-cell_typeT-lymphocytes	are	T-lymphocyte	NNS	I-NP	I-cell_typeare	readily	be	VBP	B-VP	Oreadily	lysed	readily	RB	I-VP	Olysed	in	lyse	VBN	I-VP	Oin	vitro	in	FW	B-ADVP	Ovitro	by	vitro	FW	I-ADVP	Oby	pharmacological	by	IN	B-PP	Opharmacological	concentrations	pharmacological	JJ	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	glucocorticoids	of	IN	B-PP	Oglucocorticoids	such	glucocorticoid	NNS	B-NP	Osuch	as	such	JJ	B-PP	Oas	cortisol	as	IN	I-PP	Ocortisol	","	cortisol	NN	B-NP	O","	whereas	","	","	O	Owhereas	peripheral	whereas	IN	O	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	lymphocytes	blood	NN	I-NP	I-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	thymocytes	and	CC	I-NP	Othymocytes	are	thymocyte	NNS	I-NP	B-cell_typeare	unaffected	be	VBP	B-VP	Ounaffected	by	unaffected	JJ	B-ADJP	Oby	the	by	IN	B-PP	Othe	hormone	the	DT	B-NP	Ohormone	.	hormone	NN	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	metabolic	","	","	O	Ometabolic	and	metabolic	JJ	B-NP	Oand	ultrastructural	and	CC	I-NP	Oultrastructural	aspects	ultrastructural	JJ	I-NP	Oaspects	of	aspect	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	cortisol-induced	the	DT	B-NP	Ocortisol-induced	killing	cortisol-induced	JJ	I-NP	Okilling	process	killing	NN	I-NP	Oprocess	of	process	NN	I-NP	Oof	CLL	of	IN	B-PP	OCLL	cells	CLL	NN	B-NP	B-cell_linecells	are	cell	NNS	I-NP	I-cell_lineare	recorded	be	VBP	B-VP	Orecorded	.	record	VBN	I-VP	O.	In	.	.	O	OIn	vitro	In	FW	B-NP	Ovitro	lysis	vitro	FW	I-NP	Olysis	was	lysis	NN	I-NP	Owas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	temperature	be	VB	I-VP	Otemperature	dependent	temperature	NN	B-NP	Odependent	and	dependent	JJ	I-NP	Oand	was	and	CC	O	Owas	detected	be	VBD	B-VP	Odetected	only	detect	VBN	I-VP	Oonly	after	only	RB	B-ADVP	Oafter	6	after	IN	B-PP	O6	to	6	CD	B-NP	Oto	8	to	TO	I-NP	O8	hr	8	CD	I-NP	Ohr	incubation	hr	NN	I-NP	Oincubation	with	incubation	NN	I-NP	Owith	cortisol	with	IN	B-PP	Ocortisol	by	cortisol	NN	B-NP	Oby	means	by	IN	B-PP	Omeans	of	mean	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	trypan	the	DT	B-NP	Otrypan	blue	trypan	NN	I-NP	Oblue	exclusion	blue	JJ	I-NP	Oexclusion	test	exclusion	NN	I-NP	Otest	.	test	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	30	","	","	O	O30	min	30	CD	B-NP	Omin	of	min	NN	I-NP	Oof	incubation	of	IN	B-PP	Oincubation	with	incubation	NN	B-NP	Owith	cortisol	with	IN	B-PP	Ocortisol	at	cortisol	NN	B-NP	Oat	either	at	IN	B-PP	Oeither	37	either	CC	B-NP	O37	degrees	37	CD	I-NP	Odegrees	or	degree	NNS	I-NP	Oor	4	or	CC	O	O4	degrees	4	CD	B-NP	Odegrees	followed	degree	NNS	I-NP	Ofollowed	by	follow	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	removal	the	DT	B-NP	Oremoval	of	removal	NN	I-NP	Oof	the	of	IN	B-PP	Othe	hormone	the	DT	B-NP	Ohormone	was	hormone	NN	I-NP	Owas	still	be	VBD	B-VP	Ostill	sufficient	still	RB	B-ADVP	Osufficient	to	sufficient	JJ	B-ADJP	Oto	induce	to	TO	B-VP	Oinduce	the	induce	VB	I-VP	Othe	lytic	the	DT	B-NP	Olytic	process	lytic	JJ	I-NP	Oprocess	.	process	NN	I-NP	O.	Ultrastructural	.	.	O	OUltrastructural	studies	Ultrastructural	JJ	B-NP	Ostudies	demonstrated	study	NNS	I-NP	Odemonstrated	sequential	demonstrate	VBD	B-VP	Osequential	changes	sequential	JJ	B-NP	Ochanges	in	change	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	cytoplasm	the	DT	B-NP	Ocytoplasm	","	cytoplasm	NN	I-NP	O","	including	","	","	O	Oincluding	swelling	include	VBG	B-PP	Oswelling	of	swelling	NN	B-NP	Oof	mitochondria	of	IN	B-PP	Omitochondria	and	mitochondrion	NNS	B-NP	Oand	cytoplasmic	and	CC	O	Ocytoplasmic	decompartmentalization	cytoplasmic	JJ	B-NP	Odecompartmentalization	","	decompartmentalization	NN	I-NP	O","	followed	","	","	O	Ofollowed	by	follow	VBN	B-VP	Oby	loss	by	IN	B-PP	Oloss	of	loss	NN	B-NP	Oof	surface	of	IN	B-PP	Osurface	microvilli	surface	NN	B-NP	Omicrovilli	with	microvilli	NNS	I-NP	Owith	the	with	IN	B-PP	Othe	appearance	the	DT	B-NP	Oappearance	of	appearance	NN	I-NP	Oof	``	of	IN	B-PP	O``	holes	``	``	O	Oholes	''	hole	NNS	B-NP	O''	in	''	''	O	Oin	the	in	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	membrane	cell	NN	I-NP	Omembrane	","	membrane	NN	I-NP	O","	and	","	","	O	Oand	subsequent	and	CC	O	Osubsequent	condensation	subsequent	JJ	B-NP	Ocondensation	of	condensation	NN	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	chromatin	nuclear	JJ	B-NP	B-proteinchromatin	.	chromatin	NN	I-NP	I-protein.	The	.	.	O	OThe	large	The	DT	B-NP	Olarge	holes	large	JJ	I-NP	Oholes	in	hole	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	membrane	the	DT	B-NP	Omembrane	appearing	membrane	NN	I-NP	Oappearing	after	appear	VBG	B-VP	Oafter	6	after	IN	B-SBAR	O6	hr	6	CD	B-NP	Ohr	of	hr	NN	I-NP	Oof	incubation	of	IN	B-PP	Oincubation	with	incubation	NN	B-NP	Owith	the	with	IN	B-PP	Othe	hormone	the	DT	B-NP	Ohormone	may	hormone	NN	I-NP	Omay	be	may	MD	B-VP	Obe	the	be	VB	I-VP	Othe	cause	the	DT	B-NP	Ocause	for	cause	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	penetration	the	DT	B-NP	Openetration	of	penetration	NN	I-NP	Oof	the	of	IN	B-PP	Othe	viable	the	DT	B-NP	Oviable	stain	viable	JJ	I-NP	Ostain	into	stain	NN	I-NP	Ointo	the	into	IN	B-PP	Othe	dead	the	DT	B-NP	Odead	cells	dead	JJ	I-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	as	","	","	O	Oas	seen	as	IN	B-SBAR	Oseen	by	see	VBN	B-VP	Oby	light	by	IN	B-PP	Olight	microscopy	light	JJ	B-NP	Omicroscopy	.	microscopy	NN	I-NP	O.	Addition	.	.	O	OAddition	of	Addition	NN	B-NP	Oof	metabolic	of	IN	B-PP	Ometabolic	inhibitors	metabolic	JJ	B-NP	Oinhibitors	including	inhibitor	NNS	I-NP	Oincluding	actinomycin	include	VBG	B-PP	Oactinomycin	D	actinomycin	NN	B-NP	OD	","	D	NN	I-NP	O","	puromycin	","	","	O	Opuromycin	","	puromycin	NN	B-NP	O","	and	","	","	O	Oand	cycloheximide	and	CC	O	Ocycloheximide	following	cycloheximide	NN	B-NP	Ofollowing	administration	follow	VBG	B-PP	Oadministration	of	administration	NN	B-NP	Oof	cortisol	of	IN	B-PP	Ocortisol	resulted	cortisol	NN	B-NP	Oresulted	in	result	VBD	B-VP	Oin	inhibition	in	IN	B-PP	Oinhibition	of	inhibition	NN	B-NP	Oof	the	of	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	lysis	cell	NN	I-NP	Olysis	.	lysis	NN	I-NP	O.	An	.	.	O	OAn	excess	An	DT	B-NP	Oexcess	of	excess	NN	I-NP	Oof	an	of	IN	B-PP	Oan	antagonist	an	DT	B-NP	Oantagonist	such	antagonist	NN	I-NP	Osuch	as	such	JJ	B-PP	Oas	cortexolone	as	IN	I-PP	Ocortexolone	was	cortexolone	NN	B-NP	Owas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	inhibit	to	TO	I-VP	Oinhibit	the	inhibit	VB	I-VP	Othe	cortisol-induced	the	DT	B-NP	Ocortisol-induced	cytolysis	cortisol-induced	JJ	I-NP	Ocytolysis	of	cytolysis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	CLL	the	DT	B-NP	OCLL	cells	CLL	NN	I-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	It	.	.	O	OIt	is	It	PRP	B-NP	Ois	suggested	be	VBZ	B-VP	Osuggested	that	suggest	VBN	I-VP	Othat	the	that	IN	B-SBAR	Othe	glucocorticoid-induced	the	DT	B-NP	Oglucocorticoid-induced	lysis	glucocorticoid-induced	JJ	I-NP	Olysis	of	lysis	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	CLL	human	JJ	B-NP	B-cell_lineCLL	cells	CLL	NN	I-NP	I-cell_linecells	is	cell	NNS	I-NP	I-cell_lineis	similar	be	VBZ	B-VP	Osimilar	to	similar	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	phenomenon	the	DT	B-NP	Ophenomenon	observed	phenomenon	NN	I-NP	Oobserved	in	observe	VBN	B-VP	Oin	rat	in	IN	B-PP	Orat	or	rat	NN	B-NP	Oor	murine	or	CC	O	Omurine	lymphocytes	murine	JJ	B-NP	B-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	is	and	CC	O	Ois	mediated	be	VBZ	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	interaction	by	IN	B-PP	Ointeraction	of	interaction	NN	B-NP	Oof	the	of	IN	B-PP	Othe	steroid	the	DT	B-NP	Osteroid	molecule	steroid	NN	I-NP	B-proteinmolecule	with	molecule	NN	I-NP	I-proteinwith	the	with	IN	B-PP	Othe	cytoplasmic	the	DT	B-NP	Ocytoplasmic	receptor	cytoplasmic	JJ	I-NP	B-proteinreceptor	.	receptor	NN	I-NP	I-protein.	The	.	.	O	OThe	resulting	The	DT	B-NP	Oresulting	complex	result	VBG	I-NP	Ocomplex	appears	complex	NN	I-NP	Oappears	to	appear	VBZ	B-VP	Oto	activate	to	TO	I-VP	Oactivate	specific	activate	VB	I-VP	Ospecific	gene	specific	JJ	B-NP	Ogene	(	gene	NN	I-NP	O(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	the	)	)	O	Othe	products	the	DT	B-NP	Oproducts	of	product	NNS	I-NP	Oof	which	of	IN	B-PP	Owhich	eventually	which	WDT	B-NP	Oeventually	cause	eventually	RB	B-ADVP	Ocause	cytolysis	cause	VBP	B-VP	Ocytolysis	.	cytolysis	NN	B-NP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	receptors	Glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	lymphoid	in	IN	B-PP	Olymphoid	tumors	lymphoid	JJ	B-NP	Otumors	.	tumor	NNS	I-NP	O.	There	.	.	O	OThere	is	There	EX	B-NP	Ois	a	be	VBZ	B-VP	Oa	range	a	DT	B-NP	Orange	of	range	NN	I-NP	Oof	levels	of	IN	B-PP	Olevels	of	level	NNS	B-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	numbers	receptor	NN	I-NP	I-proteinnumbers	seen	number	NNS	I-NP	Oseen	in	see	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	various	the	DT	B-NP	Ovarious	subclasses	various	JJ	I-NP	Osubclasses	of	subclass	NNS	I-NP	Oof	acute	of	IN	B-PP	Oacute	lymphatic	acute	JJ	B-NP	Olymphatic	leukemia	lymphatic	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	ALL	(	(	O	OALL	)	ALL	NN	B-NP	O)	.	)	)	O	O.	This	.	.	O	OThis	variability	This	DT	B-NP	Ovariability	can	variability	NN	I-NP	Ocan	not	can	MD	B-VP	Onot	be	not	RB	I-VP	Obe	explained	be	VB	I-VP	Oexplained	by	explain	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	known	the	DT	B-NP	Oknown	correlation	known	JJ	I-NP	Ocorrelation	between	correlation	NN	I-NP	Obetween	active	between	IN	B-PP	Oactive	cell	active	JJ	B-NP	Ocell	proliferation	cell	NN	I-NP	Oproliferation	and	proliferation	NN	I-NP	Oand	an	and	CC	O	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	the	in	IN	B-PP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	receptors	of	IN	B-PP	Oreceptors	","	receptor	NNS	B-NP	B-protein","	since	","	","	O	Osince	the	since	IN	B-SBAR	Othe	tumors	the	DT	B-NP	Otumors	with	tumor	NNS	I-NP	Owith	the	with	IN	B-PP	Othe	highest	the	DT	B-NP	Ohighest	growth	high	JJS	I-NP	Ogrowth	fraction	growth	NN	I-NP	Ofraction	(	fraction	NN	I-NP	O(	i.e.	(	(	O	Oi.e.	","	i.e.	FW	B-NP	O","	Burkitt	","	","	O	OBurkitt	's	Burkitt	NN	B-NP	O's	lymphoma	's	POS	B-NP	Olymphoma	and	lymphoma	NN	I-NP	Oand	T-cell	and	CC	I-NP	OT-cell	leukemia	T-cell	NN	I-NP	Oleukemia	)	leukemia	NN	I-NP	O)	tend	)	)	O	Otend	to	tend	VBP	B-VP	Oto	have	to	TO	I-VP	Ohave	lower	have	VB	I-VP	Olower	average	low	JJR	B-NP	Oaverage	receptor	average	JJ	I-NP	Oreceptor	numbers	receptor	NN	I-NP	Onumbers	than	number	NNS	I-NP	Othan	do	than	IN	B-SBAR	Odo	tumors	do	VBP	O	Otumors	with	tumor	NNS	B-NP	Owith	lower	with	IN	B-PP	Olower	growth	low	JJR	B-NP	Ogrowth	fractions	growth	NN	I-NP	Ofractions	such	fraction	NNS	I-NP	Osuch	as	such	JJ	B-PP	Oas	common	as	IN	I-PP	Ocommon	ALL	common	JJ	B-NP	OALL	.	ALL	NN	I-NP	O.	All	.	.	O	OAll	clinical	All	DT	B-NP	Oclinical	specimens	clinical	JJ	I-NP	Ospecimens	from	specimen	NNS	I-NP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	lymphatic	with	IN	B-PP	Olymphatic	leukemia	lymphatic	JJ	B-NP	Oleukemia	have	leukemia	NN	I-NP	Ohave	some	have	VBP	B-VP	Osome	measurable	some	DT	B-NP	Omeasurable	level	measurable	JJ	I-NP	Olevel	of	level	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	;	receptor	NNS	I-NP	I-protein;	therefore	;	:	O	Otherefore	","	therefore	RB	B-ADVP	O","	the	","	","	O	Othe	resistance	the	DT	B-NP	Oresistance	seen	resistance	NN	I-NP	Oseen	in	see	VBN	B-VP	Oin	vivo	in	FW	B-ADVP	Ovivo	can	vivo	FW	I-ADVP	Ocan	not	can	MD	B-VP	Onot	be	not	RB	I-VP	Obe	explained	be	VB	I-VP	Oexplained	by	explain	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	lack	the	DT	B-NP	Olack	of	lack	NN	I-NP	Oof	receptors	of	IN	B-PP	Oreceptors	.	receptor	NNS	B-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	there	","	","	O	Othere	has	there	EX	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	a	be	VBN	I-VP	Oa	positive	a	DT	B-NP	Opositive	correlation	positive	JJ	I-NP	Ocorrelation	","	correlation	NN	I-NP	O","	in	","	","	O	Oin	our	in	IN	B-PP	Oour	hands	our	PRP$	B-NP	Ohands	","	hand	NNS	I-NP	O","	with	","	","	O	Owith	receptor	with	IN	B-PP	Oreceptor	level	receptor	NN	B-NP	Olevel	and	level	NN	I-NP	Oand	prognosis	and	CC	I-NP	Oprognosis	.	prognosis	NN	I-NP	O.	On	.	.	O	OOn	the	On	IN	B-PP	Othe	basis	the	DT	B-NP	Obasis	of	basis	NN	I-NP	Oof	in	of	IN	B-PP	Oin	vitro	in	FW	B-NP	Ovitro	models	vitro	FW	I-NP	Omodels	","	model	NNS	I-NP	O","	it	","	","	O	Oit	is	it	PRP	B-NP	Ois	proposed	be	VBZ	B-VP	Oproposed	that	propose	VBN	I-VP	Othat	perhaps	that	IN	B-SBAR	Operhaps	the	perhaps	RB	B-ADVP	Othe	high	the	DT	B-NP	Ohigh	receptor	high	JJ	I-NP	B-cell_linereceptor	cell	receptor	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	(	line	NNS	I-NP	I-cell_line(	i.e.	(	(	O	Oi.e.	","	i.e.	FW	B-NP	O","	common	","	","	O	Ocommon	ALL	common	JJ	B-NP	OALL	of	ALL	NN	I-NP	Oof	childhood	of	IN	B-PP	Ochildhood	)	childhood	NN	B-NP	O)	have	)	)	O	Ohave	relative	have	VBP	B-VP	Orelative	stability	relative	JJ	B-NP	Ostability	of	stability	NN	I-NP	Oof	their	of	IN	B-PP	Otheir	genetic	their	PRP$	B-NP	Ogenetic	material	genetic	JJ	I-NP	Omaterial	making	material	NN	I-NP	Omaking	glucocorticoid-resistant	make	VBG	B-VP	Oglucocorticoid-resistant	mutations	glucocorticoid-resistant	JJ	B-NP	Omutations	less	mutation	NNS	I-NP	Oless	likely	less	RBR	B-ADJP	Olikely	to	likely	JJ	I-ADJP	Oto	occur	to	TO	B-VP	Ooccur	in	occur	VB	I-VP	Oin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	these	with	IN	B-PP	Othese	cells	these	DT	B-NP	Ocells	than	cell	NNS	I-NP	Othan	in	than	IN	B-PP	Oin	low-receptor	in	IN	B-PP	Olow-receptor	cell	low-receptor	JJ	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	(	line	NNS	I-NP	I-cell_line(	i.e.	(	(	O	Oi.e.	","	i.e.	FW	B-NP	O","	T-cell	","	","	O	OT-cell	leukemia	T-cell	NN	B-NP	Oleukemia	)	leukemia	NN	I-NP	O)	.	)	)	O	O.	This	.	.	O	OThis	greater	This	DT	B-NP	Ogreater	genetic	great	JJR	I-NP	Ogenetic	variability	genetic	JJ	I-NP	Ovariability	in	variability	NN	I-NP	Oin	the	in	IN	B-PP	Othe	low-receptor	the	DT	B-NP	Olow-receptor	lines	low-receptor	JJ	I-NP	B-cell_linelines	could	line	NNS	I-NP	I-cell_linecould	account	could	MD	B-VP	Oaccount	for	account	VB	I-VP	Ofor	the	for	IN	B-PP	Othe	earlier	the	DT	B-NP	Oearlier	emergence	early	JJR	I-NP	Oemergence	of	emergence	NN	I-NP	Oof	clinical	of	IN	B-PP	Oclinical	glucocorticoid	clinical	JJ	B-NP	Oglucocorticoid	resistance	glucocorticoid	NN	I-NP	Oresistance	in	resistance	NN	I-NP	Oin	these	in	IN	B-PP	Othese	patients	these	DT	B-NP	Opatients	.	patient	NNS	I-NP	O.	[	.	.	O	O[	Tumor	[	(	O	OTumor	histology	Tumor	NN	B-NP	Ohistology	and	histology	NN	I-NP	Oand	steroid	and	CC	O	Osteroid	receptors	steroid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	breast	in	IN	B-PP	Obreast	carcinoma	breast	NN	B-NP	Ocarcinoma	]	carcinoma	NN	I-NP	O]	In	]	)	O	OIn	Specimens	In	IN	B-PP	OSpecimens	of	Specimens	NNP	B-NP	Oof	115	of	IN	B-PP	O115	patients	115	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	breast	with	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	4	cancer	NN	I-NP	O4	tumorparameters	4	CD	B-NP	Otumorparameters	(	tumorparameter	NNS	I-NP	O(	tumorsize	(	(	O	Otumorsize	","	tumorsize	NN	B-NP	O","	tumorboder	","	","	O	Otumorboder	","	tumorboder	NN	B-NP	O","	nucleargrade	","	","	O	Onucleargrade	","	nucleargrade	NN	B-NP	O","	lymphocytic	","	","	O	Olymphocytic	stromal	lymphocytic	JJ	B-NP	Ostromal	reaction	stromal	JJ	I-NP	Oreaction	)	reaction	NN	I-NP	O)	3	)	)	O	O3	features	3	CD	B-NP	Ofeatures	of	feature	NNS	I-NP	Oof	regional	of	IN	B-PP	Oregional	lymphnodes	regional	JJ	B-NP	Olymphnodes	(	lymphnode	NNS	I-NP	O(	sinushistiocytosis	(	(	O	Osinushistiocytosis	","	sinushistiocytosis	NN	B-NP	O","	T-cellreaction	","	","	O	OT-cellreaction	","	T-cellreaction	NN	B-NP	O","	lymphnode	","	","	O	Olymphnode	metastases	lymphnode	NN	B-NP	B-proteinmetastases	)	metastasis	NNS	I-NP	I-protein)	and	)	)	O	Oand	estrogen	and	CC	O	Oestrogen	and	estrogen	NN	B-NP	Oand	progesteron	and	CC	I-NP	Oprogesteron	receptors	progesteron	NN	I-NP	B-proteinreceptors	were	receptor	NNS	I-NP	I-proteinwere	determined	be	VBD	B-VP	Odetermined	.	determine	VBN	I-VP	O.	A	.	.	O	OA	strong	A	DT	B-NP	Ostrong	sinushistiocytosis	strong	JJ	I-NP	Osinushistiocytosis	and	sinushistiocytosis	NN	I-NP	Oand	T-cellreaction	and	CC	I-NP	OT-cellreaction	could	T-cellreaction	NN	I-NP	Ocould	be	could	MD	B-VP	Obe	verified	be	VB	I-VP	Overified	mainly	verify	VBN	I-VP	Omainly	in	mainly	RB	B-ADVP	Oin	metastases	in	IN	B-PP	Ometastases	in	metastasis	NNS	B-NP	Oin	free	in	IN	B-PP	Ofree	lymphnodes	free	JJ	B-NP	Olymphnodes	.	lymphnode	NNS	I-NP	O.	The	.	.	O	OThe	steroid	The	DT	B-NP	Osteroid	receptor	steroid	NN	I-NP	B-proteinreceptor	content	receptor	NN	I-NP	I-proteincontent	does	content	NN	I-NP	Odoes	not	do	VBZ	B-VP	Onot	correlate	not	RB	I-VP	Ocorrelate	with	correlate	VB	I-VP	Owith	histological	with	IN	B-PP	Ohistological	parameters	histological	JJ	B-NP	Oparameters	Aldosterone-receptor	parameter	NNS	I-NP	OAldosterone-receptor	deficiency	Aldosterone-receptor	JJ	B-NP	Odeficiency	in	deficiency	NN	I-NP	Oin	pseudohypoaldosteronism	in	IN	B-PP	Opseudohypoaldosteronism	.	pseudohypoaldosteronism	NN	B-NP	O.	Pseudohypoaldosteronism	.	.	O	OPseudohypoaldosteronism	","	Pseudohypoaldosteronism	NN	B-NP	O","	a	","	","	O	Oa	syndrome	a	DT	B-NP	Osyndrome	characterized	syndrome	NN	I-NP	Ocharacterized	by	characterize	VBN	B-VP	Oby	salt	by	IN	B-PP	Osalt	wasting	salt	NN	B-NP	Owasting	and	wasting	NN	I-NP	Oand	failure	and	CC	O	Ofailure	to	failure	NN	B-NP	Oto	thrive	to	TO	B-VP	Othrive	","	thrive	VB	I-VP	O","	usually	","	","	O	Ousually	presents	usually	RB	B-ADVP	Opresents	in	present	VBZ	B-VP	Oin	infancy	in	IN	B-PP	Oinfancy	as	infancy	NN	B-NP	Oas	high	as	IN	B-PP	Ohigh	urinary	high	JJ	B-NP	Ourinary	levels	urinary	JJ	I-NP	Olevels	of	level	NNS	I-NP	Oof	sodium	of	IN	B-PP	Osodium	despite	sodium	NN	B-NP	Odespite	hyponatremia	despite	IN	B-PP	Ohyponatremia	","	hyponatremia	NN	B-NP	O","	hyperkalemia	","	","	O	Ohyperkalemia	","	hyperkalemia	NN	B-NP	O","	hyperreninemia	","	","	O	Ohyperreninemia	","	hyperreninemia	NN	B-NP	O","	and	","	","	O	Oand	elevated	and	CC	O	Oelevated	aldosterone	elevated	JJ	B-NP	Oaldosterone	levels	aldosterone	NN	I-NP	Olevels	.	level	NNS	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	investigated	have	VBP	B-VP	Oinvestigated	this	investigate	VBN	I-VP	Othis	syndrome	this	DT	B-NP	Osyndrome	for	syndrome	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	possibility	the	DT	B-NP	Opossibility	of	possibility	NN	I-NP	Oof	abnormal	of	IN	B-PP	Oabnormal	Type	abnormal	JJ	B-NP	OType	I	Type	NN	I-NP	OI	or	I	CD	I-NP	Oor	``	or	CC	O	O``	mineralocorticoid-like	``	``	B-NP	B-proteinmineralocorticoid-like	''	mineralocorticoid-like	JJ	I-NP	I-protein''	receptors	''	''	I-NP	I-proteinreceptors	","	receptor	NNS	I-NP	I-protein","	which	","	","	O	Owhich	have	which	WDT	B-NP	Ohave	intrinsic	have	VBP	B-VP	Ointrinsic	steroid	intrinsic	JJ	B-NP	Osteroid	specificity	steroid	NN	I-NP	Ospecificity	indistinguishable	specificity	NN	I-NP	Oindistinguishable	from	indistinguishable	JJ	B-ADJP	Ofrom	that	from	IN	B-PP	Othat	of	that	DT	B-NP	Oof	renal	of	IN	B-PP	Orenal	mineralocorticoid	renal	JJ	B-NP	B-proteinmineralocorticoid	receptors	mineralocorticoid	NN	I-NP	I-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	are	and	CC	O	Oare	found	be	VBP	B-VP	Ofound	in	find	VBN	I-VP	Oin	many	in	IN	B-PP	Omany	tissues	many	JJ	B-NP	Otissues	and	tissue	NNS	I-NP	Oand	cells	and	CC	I-NP	Ocells	","	cell	NNS	I-NP	O","	including	","	","	O	Oincluding	mononuclear	include	VBG	B-PP	Omononuclear	leukocytes	mononuclear	JJ	B-NP	B-cell_typeleukocytes	.	leukocyte	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	studied	have	VBP	B-VP	Ostudied	three	study	VBN	I-VP	Othree	patients	three	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	pseudohypoaldosteronism	with	IN	B-PP	Opseudohypoaldosteronism	:	pseudohypoaldosteronism	NN	B-NP	O:	the	:	:	O	Othe	28-year-old	the	DT	B-NP	O28-year-old	index	28-year-old	JJ	I-NP	Oindex	case	index	NN	I-NP	Ocase	in	case	NN	I-NP	Oin	Melbourne	in	IN	B-PP	OMelbourne	(	Melbourne	NN	B-NP	O(	Patient	(	(	O	OPatient	1	Patient	NN	B-NP	B-protein1	)	1	CD	I-NP	I-protein)	and	)	)	O	Oand	two	and	CC	O	Otwo	siblings	two	CD	B-NP	Osiblings	in	sibling	NNS	I-NP	Oin	Munich	in	IN	B-PP	OMunich	","	Munich	NNP	B-NP	O","	eight	","	","	O	Oeight	and	eight	CD	B-NP	Oand	two	and	CC	I-NP	Otwo	years	two	CD	I-NP	Oyears	of	year	NNS	I-NP	Oof	age	of	IN	B-PP	Oage	(	age	NN	B-NP	O(	Patients	(	(	O	OPatients	2	Patient	NNS	B-NP	O2	and	2	CD	B-NP	Oand	3	and	CC	I-NP	O3	)	3	CD	I-NP	O)	;	)	)	O	O;	clinically	;	:	O	Oclinically	","	clinically	RB	B-ADVP	O","	Patient	","	","	O	OPatient	3	Patient	NN	B-NP	B-protein3	had	3	CD	I-NP	I-proteinhad	a	have	VBD	B-VP	Oa	less	a	DT	B-NP	Oless	severe	less	RBR	I-NP	Osevere	case	severe	JJ	I-NP	Ocase	than	case	NN	I-NP	Othan	his	than	IN	B-PP	Ohis	sister	his	PRP$	B-NP	Osister	.	sister	NN	I-NP	O.	Percoll-separated	.	.	O	OPercoll-separated	control	Percoll-separated	JJ	B-NP	B-cell_typecontrol	monocytes	control	NN	I-NP	I-cell_typemonocytes	bound	monocyte	NNS	I-NP	I-cell_typebound	[	bind	VBN	B-VP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	aldosterone	]	)	I-NP	Oaldosterone	with	aldosterone	NN	I-NP	Owith	high	with	IN	B-PP	Ohigh	affinity	high	JJ	B-NP	Oaffinity	(	affinity	NN	I-NP	O(	Kd	(	(	O	OKd	approximately	Kd	NN	B-NP	Oapproximately	3	approximately	RB	B-NP	O3	nM	3	CD	I-NP	OnM	)	nM	NN	I-NP	O)	and	)	)	O	Oand	limited	and	CC	O	Olimited	capacity	limit	VBN	B-NP	Ocapacity	(	capacity	NN	I-NP	O(	150	(	(	O	O150	to	150	CD	B-NP	B-DNAto	600	to	TO	I-NP	I-DNA600	sites	600	CD	I-NP	I-DNAsites	per	site	NNS	I-NP	I-DNAper	cell	per	IN	B-PP	Ocell	)	cell	NN	B-NP	O)	.	)	)	O	O.	On	.	.	O	OOn	repeated	On	IN	B-PP	Orepeated	examination	repeat	VBN	B-NP	Oexamination	","	examination	NN	I-NP	O","	no	","	","	O	Ono	[	no	DT	B-NP	O[	3H	[	(	I-NP	O3H	]	3H	NN	I-NP	O]	aldosterone	]	)	I-NP	Oaldosterone	binding	aldosterone	NN	I-NP	Obinding	was	binding	NN	I-NP	Owas	found	be	VBD	B-VP	Ofound	in	find	VBN	I-VP	Oin	monocytes	in	IN	B-PP	Omonocytes	from	monocyte	NNS	B-NP	B-cell_typefrom	Patients	from	IN	B-PP	OPatients	1	Patient	NNS	B-NP	B-protein1	and	1	CD	I-NP	I-proteinand	2	and	CC	I-NP	I-protein2	;	2	CD	I-NP	I-protein;	in	;	:	O	Oin	Patient	in	IN	B-PP	OPatient	3	Patient	NN	B-NP	O3	","	3	CD	I-NP	O","	the	","	","	O	Othe	levels	the	DT	B-NP	Olevels	were	level	NNS	I-NP	Owere	62	be	VBD	B-VP	O62	sites	62	CD	B-NP	B-DNAsites	per	site	NNS	I-NP	I-DNAper	cell	per	IN	B-PP	Ocell	","	cell	NN	B-NP	O","	more	","	","	O	Omore	than	more	JJR	B-NP	Othan	2	than	IN	I-NP	O2	S.D.	2	CD	I-NP	OS.D.	below	S.D.	NNP	I-NP	Obelow	those	below	IN	B-PP	Othose	of	those	DT	B-NP	Oof	the	of	IN	B-PP	Othe	control	the	DT	B-NP	Ocontrol	.	control	NN	I-NP	O.	Levels	.	.	O	OLevels	in	Level	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	parents	the	DT	B-NP	Oparents	of	parent	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	Munich	the	DT	B-NP	OMunich	patients	Munich	JJ	I-NP	Opatients	(	patient	NNS	I-NP	O(	first	(	(	O	Ofirst	cousins	first	JJ	B-NP	Ocousins	)	cousin	NNS	I-NP	O)	were	)	)	O	Owere	normal	be	VBD	B-VP	Onormal	.	normal	JJ	B-ADJP	O.	It	.	.	O	OIt	appears	It	PRP	B-NP	Oappears	that	appear	VBZ	B-VP	Othat	pseudohypoaldosteronism	that	IN	B-SBAR	Opseudohypoaldosteronism	is	pseudohypoaldosteronism	NN	B-NP	Ois	caused	be	VBZ	B-VP	Ocaused	by	cause	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	Type	a	DT	B-NP	OType	I	Type	NN	I-NP	B-proteinI	receptor	I	CD	I-NP	I-proteinreceptor	defect	receptor	NN	I-NP	I-proteindefect	","	defect	NN	I-NP	O","	that	","	","	O	Othat	the	that	IN	B-SBAR	Othe	defect	the	DT	B-NP	Odefect	may	defect	NN	I-NP	Omay	be	may	MD	B-VP	Obe	complete	be	VB	I-VP	Ocomplete	or	complete	JJ	B-ADJP	Oor	partial	or	CC	I-ADJP	Opartial	","	partial	JJ	I-ADJP	O","	that	","	","	O	Othat	transmission	that	DT	B-NP	Otransmission	may	transmission	NN	I-NP	Omay	be	may	MD	B-VP	Obe	autosomal	be	VB	I-VP	Oautosomal	recessive	autosomal	JJ	B-ADJP	Orecessive	","	recessive	JJ	B-ADJP	O","	and	","	","	O	Oand	that	and	CC	O	Othat	the	that	IN	B-SBAR	Othe	study	the	DT	B-NP	Ostudy	of	study	NN	I-NP	Oof	patients	of	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	pseudohypoaldosteronism	with	IN	B-PP	Opseudohypoaldosteronism	may	pseudohypoaldosteronism	NN	B-NP	Omay	indicate	may	MD	B-VP	Oindicate	physiologic	indicate	VB	I-VP	Ophysiologic	roles	physiologic	JJ	B-NP	Oroles	for	role	NNS	I-NP	Ofor	Type	for	IN	B-PP	OType	I	Type	NN	B-NP	B-proteinI	receptors	I	CD	I-NP	I-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	nonepithelial	in	IN	B-PP	Ononepithelial	tissues	nonepithelial	JJ	B-NP	Otissues	.	tissue	NNS	I-NP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	inhibition	Glucocorticoid	NN	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	urokinase-like	of	IN	B-PP	Ourokinase-like	plasminogen	urokinase-like	JJ	B-NP	B-proteinplasminogen	activators	plasminogen	NN	I-NP	I-proteinactivators	in	activator	NNS	I-NP	I-proteinin	cultured	in	IN	B-PP	Ocultured	human	culture	VBN	B-NP	B-cell_linehuman	lymphoblasts	human	JJ	I-NP	I-cell_linelymphoblasts	.	lymphoblast	NNS	I-NP	I-cell_line.	Two	.	.	O	OTwo	human	Two	CD	B-NP	Ohuman	lymphoblast	human	JJ	I-NP	B-cell_linelymphoblast	cell	lymphoblast	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	","	line	NNS	I-NP	I-cell_line","	LICR-LON-HMy2	","	","	O	OLICR-LON-HMy2	(	LICR-LON-HMy2	NN	B-NP	O(	HMy2	(	(	O	OHMy2	cells	HMy2	NN	B-NP	B-cell_linecells	)	cell	NNS	I-NP	I-cell_line)	and	)	)	O	Oand	GM4672A	and	CC	O	OGM4672A	cells	GM4672A	NN	B-NP	B-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	are	","	","	O	Oare	moderately	be	VBP	B-VP	Omoderately	growth	moderately	RB	B-ADVP	Ogrowth	inhibited	growth	NN	B-NP	Oinhibited	by	inhibit	VBN	B-VP	Oby	dexamethasone	by	IN	B-PP	Odexamethasone	(	dexamethasone	NN	B-NP	O(	1	(	(	O	O1	","	1	CD	B-NP	O","	4-pregnadien-9-fluoro-16	","	","	O	O4-pregnadien-9-fluoro-16	alpha-methyl-11	4-pregnadien-9-fluoro-16	CD	B-NP	Oalpha-methyl-11	beta	alpha-methyl-11	NN	I-NP	Obeta	","	beta	SYM	B-NP	O","	17	","	","	O	O17	alpha	17	CD	B-NP	Oalpha	","	alpha	SYM	B-NP	O","	21-triol-3	","	","	O	O21-triol-3	","	21-triol-3	CD	B-NP	O","	20-dione	","	","	O	O20-dione	)	20-dione	NN	B-NP	O)	(	)	)	O	O(	Dex	(	(	O	ODex	)	Dex	NN	B-NP	O)	.	)	)	O	O.	Both	.	.	O	OBoth	cell	Both	DT	B-NP	Ocell	types	cell	NN	I-NP	Otypes	secrete	type	NNS	I-NP	Osecrete	a	secrete	VBP	B-VP	Oa	urokinase	a	DT	B-NP	Ourokinase	(	urokinase	NN	I-NP	O(	UK	(	(	O	OUK	)	UK	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	plasminogen	#NAME?	JJ	B-NP	Oplasminogen	activator	plasminogen	NN	I-NP	Oactivator	(	activator	NN	I-NP	O(	PA	(	(	O	OPA	)	PA	NN	B-NP	O)	.	)	)	O	O.	Treatment	.	.	O	OTreatment	of	Treatment	NN	B-NP	Oof	both	of	IN	B-PP	Oboth	HMy2	both	CC	O	OHMy2	and	HMy2	NN	B-NP	B-proteinand	GM4672A	and	CC	O	OGM4672A	cells	GM4672A	NN	B-NP	Ocells	with	cell	NNS	I-NP	Owith	Dex	with	IN	B-PP	ODex	for	Dex	NN	B-NP	Ofor	4-Jan	for	IN	B-PP	O4-Jan	days	4-Jan	CD	B-NP	Odays	inhibits	day	NNS	I-NP	Oinhibits	extracellular	inhibit	VBZ	B-VP	Oextracellular	PA	extracellular	JJ	B-NP	OPA	activity	PA	NN	I-NP	Oactivity	in	activity	NN	I-NP	Oin	a	in	IN	B-PP	Oa	concentration-dependent	a	DT	B-NP	Oconcentration-dependent	manner	concentration-dependent	JJ	I-NP	Omanner	","	manner	NN	I-NP	O","	being	","	","	O	Obeing	half-maximal	be	VBG	B-VP	Ohalf-maximal	at	half-maximal	JJ	B-ADJP	Oat	approximately	at	IN	B-PP	Oapproximately	1	approximately	RB	B-NP	O1	X	1	CD	I-NP	OX	10	X	SYM	I-NP	O10	(	10	CD	I-NP	O(	-9	(	(	O	O-9	)	-9	CD	B-NP	O)	M	)	)	O	OM	.	M	NN	B-NP	O.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	PA	of	IN	B-PP	OPA	in	PA	NN	B-NP	Oin	both	in	IN	B-PP	Oboth	cell	both	DT	B-NP	Ocell	types	cell	NN	I-NP	Otypes	is	type	NNS	I-NP	Ois	specific	be	VBZ	B-VP	Ospecific	for	specific	JJ	B-ADJP	Ofor	active	for	IN	B-PP	Oactive	glucocorticoids	active	JJ	B-NP	Oglucocorticoids	","	glucocorticoid	NNS	I-NP	O","	and	","	","	O	Oand	this	and	CC	O	Othis	specificity	this	DT	B-NP	Ospecificity	parallels	specificity	NN	I-NP	Oparallels	the	parallel	VBZ	B-VP	Othe	ability	the	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	various	of	IN	B-PP	Ovarious	steroids	various	JJ	B-NP	Osteroids	to	steroid	NNS	I-NP	Oto	bind	to	TO	B-VP	Obind	to	bind	VB	I-VP	Oto	glucocorticoid	to	TO	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	HMy2	.	.	O	OHMy2	cell	HMy2	NN	B-NP	Ocell	PA	cell	NN	I-NP	OPA	is	PA	NN	I-NP	Ois	fully	be	VBZ	B-VP	Ofully	suppressible	fully	RB	B-ADJP	Osuppressible	by	suppressible	JJ	I-ADJP	Oby	Dex	by	IN	B-PP	ODex	","	Dex	NN	B-NP	O","	whereas	","	","	O	Owhereas	up	whereas	IN	O	Oup	to	up	IN	B-NP	Oto	one	to	TO	I-NP	Oone	third	one	CD	I-NP	Othird	of	third	NN	I-NP	Oof	the	of	IN	B-PP	Othe	activator	the	DT	B-NP	Oactivator	expressed	activator	NN	I-NP	Oexpressed	by	express	VBN	B-VP	Oby	GM4672A	by	IN	B-PP	OGM4672A	cells	GM4672A	NN	B-NP	B-cell_linecells	is	cell	NNS	I-NP	I-cell_lineis	resistant	be	VBZ	B-VP	Oresistant	to	resistant	JJ	B-ADJP	Oto	glucocorticoid	to	TO	B-PP	Oglucocorticoid	inhibition	glucocorticoid	NN	B-NP	Oinhibition	.	inhibition	NN	I-NP	O.	Mixing	.	.	O	OMixing	experiments	Mix	VBG	B-VP	Oexperiments	using	experiment	NNS	B-NP	Ousing	a	use	VBG	B-VP	Oa	UK	a	DT	B-NP	OUK	standard	UK	NNP	I-NP	Ostandard	and	standard	NN	I-NP	Oand	conditioned	and	CC	O	Oconditioned	media	condition	VBN	B-NP	Omedia	from	medium	NNS	I-NP	Ofrom	Dex-treated	from	IN	B-PP	ODex-treated	cells	Dex-treated	JJ	B-NP	B-cell_linecells	suggest	cell	NNS	I-NP	I-cell_linesuggest	an	suggest	VBP	B-VP	Oan	absence	an	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	glucocorticoid-inducible	of	IN	B-PP	Oglucocorticoid-inducible	inhibitors	glucocorticoid-inducible	JJ	B-NP	B-proteininhibitors	to	inhibitor	NNS	I-NP	I-proteinto	UK	to	TO	B-PP	OUK	or	UK	NN	B-NP	B-proteinor	plasmin	or	CC	I-NP	Oplasmin	in	plasmin	NN	I-NP	Oin	both	in	IN	B-PP	Oboth	cell	both	DT	B-NP	Ocell	types	cell	NN	I-NP	Otypes	.	type	NNS	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	conditioned	","	","	O	Oconditioned	media	condition	VBN	B-NP	Omedia	from	medium	NNS	I-NP	Ofrom	Dex-treated	from	IN	B-PP	ODex-treated	GM4672A	Dex-treated	JJ	B-NP	B-cell_lineGM4672A	cells	GM4672A	NN	I-NP	I-cell_linecells	inhibits	cell	NNS	I-NP	I-cell_lineinhibits	a	inhibit	VBZ	B-VP	Oa	portion	a	DT	B-NP	Oportion	of	portion	NN	I-NP	Oof	the	of	IN	B-PP	Othe	homologous	the	DT	B-NP	Ohomologous	cellular	homologous	JJ	I-NP	Ocellular	activator	cellular	JJ	I-NP	Oactivator	in	activator	NN	I-NP	Oin	conditioned	in	IN	B-PP	Oconditioned	media	condition	VBN	B-NP	Omedia	from	medium	NNS	I-NP	Ofrom	control	from	IN	B-PP	Ocontrol	GM4672A	control	NN	B-NP	B-cell_lineGM4672A	cells	GM4672A	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	low	","	","	O	Olow	levels	low	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	glucocorticoid-inducible	of	IN	B-PP	Oglucocorticoid-inducible	inhibitors	glucocorticoid-inducible	JJ	B-NP	B-proteininhibitors	may	inhibitor	NNS	I-NP	I-proteinmay	contribute	may	MD	B-VP	Ocontribute	to	contribute	VB	I-VP	Oto	","	to	TO	B-PP	O","	but	","	","	O	Obut	can	but	CC	O	Ocan	not	can	MD	B-VP	Onot	fully	not	RB	I-VP	Ofully	account	fully	RB	I-VP	Oaccount	for	account	VB	I-VP	Ofor	","	for	IN	B-PP	O","	Dex	","	","	O	ODex	inhibition	Dex	NN	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	GM4672A	of	IN	B-PP	OGM4672A	PA	GM4672A	NN	B-NP	B-proteinPA	activity	PA	NN	I-NP	I-proteinactivity	.	activity	NN	I-NP	O.	Glucocorticoid-inducible	.	.	O	OGlucocorticoid-inducible	inhibitors	Glucocorticoid-inducible	JJ	B-NP	Oinhibitors	in	inhibitor	NNS	I-NP	Oin	HMy2	in	IN	B-PP	OHMy2	cells	HMy2	NN	B-NP	B-cell_linecells	are	cell	NNS	I-NP	I-cell_lineare	either	be	VBP	B-VP	Oeither	totally	either	RB	B-ADVP	Ototally	absent	totally	RB	B-ADJP	Oabsent	or	absent	JJ	I-ADJP	Oor	are	or	CC	O	Oare	present	be	VBP	B-VP	Opresent	at	present	JJ	B-ADJP	Oat	undetectable	at	IN	B-PP	Oundetectable	levels	undetectable	JJ	B-NP	Olevels	.	level	NNS	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	regulation	","	","	O	Oregulation	of	regulation	NN	B-NP	Oof	UK-like	of	IN	B-PP	OUK-like	PAs	UK-like	JJ	B-NP	OPAs	in	PA	NNS	I-NP	Oin	HMy2	in	IN	B-PP	OHMy2	and	HMy2	NN	B-NP	B-cell_lineand	GM4672A	and	CC	I-NP	I-cell_lineGM4672A	cells	GM4672A	NN	I-NP	I-cell_linecells	differs	cell	NNS	I-NP	I-cell_linediffers	with	differ	VBZ	B-VP	Owith	respect	with	IN	B-PP	Orespect	to	respect	NN	B-NP	Oto	the	to	TO	B-PP	Othe	extent	the	DT	B-NP	Oextent	to	extent	NN	I-NP	Oto	which	to	TO	B-PP	Owhich	glucocorticoids	which	WDT	B-NP	Oglucocorticoids	inhibit	glucocorticoid	NNS	B-NP	Oinhibit	constitutively	inhibit	VBP	B-VP	Oconstitutively	expressed	constitutively	RB	B-NP	Oexpressed	activator	express	VBN	I-NP	Oactivator	levels	activator	NN	I-NP	Olevels	","	level	NNS	I-NP	O","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	the	as	IN	I-CONJP	Othe	possible	the	DT	B-NP	Opossible	contribution	possible	JJ	I-NP	Ocontribution	of	contribution	NN	I-NP	Oof	glucocorticoid-inducible	of	IN	B-PP	Oglucocorticoid-inducible	inhibitors	glucocorticoid-inducible	JJ	B-NP	B-proteininhibitors	to	inhibitor	NNS	I-NP	I-proteinto	the	to	TO	B-PP	Othe	regulatory	the	DT	B-NP	Oregulatory	process	regulatory	JJ	I-NP	Oprocess	in	process	NN	I-NP	Oin	GM4672A	in	IN	B-PP	OGM4672A	cells	GM4672A	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Characterization	.	.	O	OCharacterization	of	Characterization	NN	B-NP	Oof	aldosterone	of	IN	B-PP	Oaldosterone	binding	aldosterone	NN	B-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	in	site	NNS	I-NP	I-DNAin	circulating	in	IN	B-PP	Ocirculating	human	circulate	VBG	B-VP	B-cell_typehuman	mononuclear	human	JJ	B-NP	I-cell_typemononuclear	leukocytes	mononuclear	JJ	I-NP	I-cell_typeleukocytes	.	leukocyte	NNS	I-NP	I-cell_type.	Aldosterone	.	.	O	OAldosterone	binding	Aldosterone	NN	B-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	in	site	NNS	I-NP	I-DNAin	human	in	IN	B-PP	Ohuman	mononuclear	human	JJ	B-NP	B-cell_typemononuclear	leukocytes	mononuclear	JJ	I-NP	I-cell_typeleukocytes	were	leukocyte	NNS	I-NP	I-cell_typewere	characterized	be	VBD	B-VP	Ocharacterized	after	characterize	VBN	I-VP	Oafter	separation	after	IN	B-PP	Oseparation	of	separation	NN	B-NP	Oof	cells	of	IN	B-PP	Ocells	from	cell	NNS	B-NP	Ofrom	blood	from	IN	B-PP	Oblood	by	blood	NN	B-NP	Oby	a	by	IN	B-PP	Oa	Percoll	a	DT	B-NP	OPercoll	gradient	Percoll	NNP	I-NP	Ogradient	.	gradient	NN	I-NP	O.	After	.	.	O	OAfter	washing	After	IN	B-PP	Owashing	and	washing	NN	B-NP	Oand	resuspension	and	CC	I-NP	Oresuspension	in	resuspension	NN	I-NP	Oin	RPMI-1640	in	IN	B-PP	ORPMI-1640	medium	RPMI-1640	NN	B-NP	B-cell_linemedium	","	medium	NN	I-NP	I-cell_line","	cells	","	","	O	I-cell_linecells	were	cell	NNS	B-NP	I-cell_linewere	incubated	be	VBD	B-VP	Oincubated	at	incubate	VBN	I-VP	Oat	37	at	IN	B-PP	O37	degrees	37	CD	B-NP	Odegrees	C	degree	NNS	I-NP	OC	for	C	JJ	B-ADJP	Ofor	1	for	IN	B-PP	O1	h	1	CD	B-NP	Oh	with	h	NN	I-NP	Owith	different	with	IN	B-PP	Odifferent	concentrations	different	JJ	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	aldosterone	]	)	I-NP	Oaldosterone	plus	aldosterone	NN	I-NP	Oplus	a	plus	CC	O	Oa	100-fold	a	DT	B-NP	O100-fold	concentration	100-fold	JJ	I-NP	Oconcentration	of	concentration	NN	I-NP	Oof	RU-26988	of	IN	B-PP	ORU-26988	(	RU-26988	NN	B-NP	O(	11	(	(	O	O11	alpha	11	CD	B-NP	Oalpha	","	alpha	SYM	O	O","	17	","	","	O	O17	alpha-dihydroxy-17	17	CD	B-NP	Oalpha-dihydroxy-17	beta-propynylandrost-1	alpha-dihydroxy-17	NN	I-NP	Obeta-propynylandrost-1	","	beta-propynylandrost-1	NN	I-NP	O","	4	","	","	O	O4	","	4	CD	B-NP	O","	6-trien-3-one	","	","	O	O6-trien-3-one	)	6-trien-3-one	NN	B-NP	O)	","	)	)	O	O","	with	","	","	O	Owith	or	with	IN	B-PP	Oor	without	or	CC	B-PP	Owithout	an	without	IN	B-PP	Oan	excess	an	DT	B-NP	Oexcess	of	excess	NN	I-NP	Oof	unlabeled	of	IN	B-PP	Ounlabeled	aldosterone	unlabeled	JJ	B-NP	Oaldosterone	.	aldosterone	NN	I-NP	O.	Aldosterone	.	.	O	OAldosterone	binds	Aldosterone	NN	B-NP	Obinds	to	bind	VBZ	B-VP	Oto	a	to	TO	B-PP	Oa	single	a	DT	B-NP	Osingle	class	single	JJ	I-NP	Oclass	of	class	NN	I-NP	Oof	receptors	of	IN	B-PP	Oreceptors	with	receptor	NNS	B-NP	B-proteinwith	an	with	IN	B-PP	Oan	affinity	an	DT	B-NP	Oaffinity	of	affinity	NN	I-NP	Oof	2.7	of	IN	B-PP	O2.7	+/-	2.7	CD	B-NP	O+/-	0.5	+/-	SYM	I-NP	O0.5	nM	0.5	CD	I-NP	OnM	(	nM	NN	I-NP	O(	means	(	(	O	Omeans	+/-	mean	VBZ	B-VP	O+/-	SD	+/-	SYM	B-NP	OSD	","	SD	NN	I-NP	O","	n	","	","	O	On	=	n	NN	B-NP	O=	14	=	SYM	B-VP	O14	)	14	CD	B-NP	O)	and	)	)	O	Oand	a	and	CC	O	Oa	capacity	a	DT	B-NP	Ocapacity	of	capacity	NN	I-NP	Oof	290	of	IN	B-PP	O290	+/-	290	CD	B-NP	O+/-	108	+/-	SYM	I-NP	O108	sites/cell	108	CD	I-NP	Osites/cell	(	sites/cell	NNS	I-NP	O(	n	(	(	O	On	=	n	NN	B-NP	O=	14	=	SYM	B-VP	O14	)	14	CD	B-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	specificity	The	DT	B-NP	Ospecificity	data	specificity	NN	I-NP	Odata	show	datum	NNS	I-NP	Oshow	a	show	VBP	B-VP	Oa	hierarchy	a	DT	B-NP	Ohierarchy	of	hierarchy	NN	I-NP	Oof	affinity	of	IN	B-PP	Oaffinity	of	affinity	NN	B-NP	Oof	desoxycorticosterone	of	IN	B-PP	Odesoxycorticosterone	=	desoxycorticosterone	NN	B-NP	O=	corticosterone	=	SYM	B-VP	Ocorticosterone	=	corticosterone	NN	B-NP	O=	aldosterone	=	SYM	B-VP	Oaldosterone	greater	aldosterone	NN	B-NP	Ogreater	than	great	JJR	B-ADJP	Othan	hydrocortisone	than	IN	B-PP	Ohydrocortisone	greater	hydrocortisone	NN	B-NP	Ogreater	than	great	JJR	B-ADJP	Othan	dexamethasone	than	IN	B-PP	Odexamethasone	.	dexamethasone	NN	B-NP	O.	The	.	.	O	OThe	results	The	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	mononuclear	that	IN	B-SBAR	Omononuclear	leukocytes	mononuclear	JJ	B-NP	B-cell_typeleukocytes	could	leukocyte	NNS	I-NP	I-cell_typecould	be	could	MD	B-VP	Obe	useful	be	VB	I-VP	Ouseful	for	useful	JJ	B-ADJP	Ofor	studying	for	IN	B-PP	Ostudying	the	study	VBG	B-VP	Othe	physiological	the	DT	B-NP	Ophysiological	significance	physiological	JJ	I-NP	Osignificance	of	significance	NN	I-NP	Oof	these	of	IN	B-PP	Othese	mineralocorticoid	these	DT	B-NP	Omineralocorticoid	receptors	mineralocorticoid	NN	I-NP	B-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	their	and	CC	O	Otheir	regulation	their	PRP$	B-NP	Oregulation	in	regulation	NN	I-NP	Oin	humans	in	IN	B-PP	Ohumans	.	human	NNS	B-NP	O.	Mineralocorticoid	.	.	O	OMineralocorticoid	and	Mineralocorticoid	NN	B-NP	Oand	glucocorticoid	and	CC	I-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	circulating	in	IN	B-PP	Ocirculating	mononuclear	circulate	VBG	B-VP	B-cell_typemononuclear	leukocytes	mononuclear	JJ	B-NP	I-cell_typeleukocytes	of	leukocyte	NNS	I-NP	I-cell_typeof	patients	of	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	primary	with	IN	B-PP	Oprimary	hyperaldosteronism	primary	JJ	B-NP	Ohyperaldosteronism	.	hyperaldosteronism	NN	I-NP	O.	Mineralocorticoid	.	.	O	OMineralocorticoid	and	Mineralocorticoid	NN	B-NP	Oand	glucocorticoid	and	CC	I-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	were	receptor	NNS	I-NP	I-proteinwere	measured	be	VBD	B-VP	Omeasured	in	measure	VBN	I-VP	Oin	circulating	in	IN	B-PP	Ocirculating	mononuclear	circulate	VBG	B-VP	B-cell_typemononuclear	leukocytes	mononuclear	JJ	B-NP	I-cell_typeleukocytes	in	leukocyte	NNS	I-NP	I-cell_typein	5	in	IN	B-PP	O5	patients	5	CD	B-NP	Opatients	affected	patient	NNS	I-NP	Oaffected	by	affect	VBN	B-VP	Oby	Conn	by	IN	B-PP	OConn	's	Conn	NNP	B-NP	O's	syndrome	's	POS	B-NP	Osyndrome	(	syndrome	NN	I-NP	O(	3	(	(	O	O3	cases	3	CD	B-NP	Ocases	of	case	NNS	I-NP	Oof	bilateral	of	IN	B-PP	Obilateral	adrenal	bilateral	JJ	B-NP	Oadrenal	hyperplasia	adrenal	JJ	I-NP	Ohyperplasia	and	hyperplasia	NN	I-NP	Oand	2	and	CC	O	O2	cases	2	CD	B-NP	Ocases	of	case	NNS	I-NP	Oof	adenoma	of	IN	B-PP	Oadenoma	plus	adenoma	NN	B-NP	Oplus	unilateral	plus	CC	O	Ounilateral	hyperplasia	unilateral	JJ	B-NP	Ohyperplasia	)	hyperplasia	NN	I-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	number	The	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	the	of	IN	B-PP	Othe	binding	the	DT	B-NP	Obinding	sites	bind	VBG	I-NP	B-DNAsites	per	site	NNS	I-NP	I-DNAper	cell	per	IN	B-PP	Ocell	resulted	cell	NN	B-NP	Oresulted	significantly	result	VBD	B-VP	Osignificantly	lower	significantly	RB	B-ADJP	Olower	(	low	JJR	I-ADJP	O(	189	(	(	O	O189	+/-	189	CD	B-NP	O+/-	114	+/-	CC	I-NP	O114	","	114	CD	I-NP	O","	mean	","	","	O	Omean	+/-	mean	NN	B-NP	O+/-	SD	+/-	SYM	I-NP	OSD	)	SD	NN	I-NP	O)	","	)	)	O	O","	as	","	","	O	Oas	compared	as	IN	B-SBAR	Ocompared	with	compare	VBN	B-PP	Owith	the	with	IN	B-PP	Othe	normal	the	DT	B-NP	Onormal	controls	normal	JJ	I-NP	Ocontrols	(	control	NNS	I-NP	O(	298	(	(	O	O298	+/-	298	CD	B-NP	O+/-	105	+/-	CC	I-NP	O105	)	105	CD	I-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	affinity	The	DT	B-NP	Oaffinity	of	affinity	NN	I-NP	Oof	aldosterone	of	IN	B-PP	Oaldosterone	for	aldosterone	NN	B-NP	Ofor	the	for	IN	B-PP	Othe	receptor	the	DT	B-NP	Oreceptor	was	receptor	NN	I-NP	Owas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	not	be	VB	I-VP	Onot	different	not	RB	B-ADJP	Odifferent	than	different	JJ	I-ADJP	Othan	that	than	IN	B-PP	Othat	of	that	DT	B-NP	Oof	healthy	of	IN	B-PP	Ohealthy	control	healthy	JJ	B-NP	Ocontrol	subjects	control	NN	I-NP	Osubjects	.	subject	NNS	I-NP	O.	The	.	.	O	OThe	capacity	The	DT	B-NP	Ocapacity	and	capacity	NN	I-NP	Oand	the	and	CC	O	Othe	affinity	the	DT	B-NP	Oaffinity	of	affinity	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	for	dexamethasone	NN	B-NP	Ofor	glucocorticoid	for	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	ranged	receptor	NNS	I-NP	I-proteinranged	in	range	VBD	B-VP	Oin	the	in	IN	B-PP	Othe	normal	the	DT	B-NP	Onormal	values	normal	JJ	I-NP	Ovalues	.	value	NNS	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	a	suggest	VBP	B-VP	Oa	possible	a	DT	B-NP	Opossible	down-regulation	possible	JJ	I-NP	Odown-regulation	of	down-regulation	NN	I-NP	Oof	mineralocorticoid	of	IN	B-PP	Omineralocorticoid	receptors	mineralocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	humans	in	IN	B-PP	Ohumans	.	human	NNS	B-NP	O.	Short-term	.	.	O	OShort-term	and	Short-term	JJ	B-NP	Oand	long-term	and	CC	I-NP	Olong-term	effects	long-term	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	estrogen	of	IN	B-PP	Oestrogen	on	estrogen	NN	B-NP	Oon	lymphoid	on	IN	B-PP	Olymphoid	tissues	lymphoid	JJ	B-NP	Otissues	and	tissue	NNS	I-NP	Oand	lymphoid	and	CC	O	Olymphoid	cells	lymphoid	JJ	B-NP	B-cell_typecells	with	cell	NNS	I-NP	I-cell_typewith	some	with	IN	B-PP	Osome	remarks	some	DT	B-NP	Oremarks	on	remark	NNS	I-NP	Oon	the	on	IN	B-PP	Othe	significance	the	DT	B-NP	Osignificance	for	significance	NN	I-NP	Ofor	carcinogenesis	for	IN	B-PP	Ocarcinogenesis	.	carcinogenesis	NN	B-NP	O.	Estrogens	.	.	O	OEstrogens	have	Estrogen	NNS	B-NP	Ohave	long	have	VBP	B-VP	Olong	been	long	RB	I-VP	Obeen	thought	be	VBN	I-VP	Othought	to	think	VBN	I-VP	Oto	play	to	TO	I-VP	Oplay	a	play	VB	I-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	regulating	in	IN	B-PP	Oregulating	the	regulate	VBG	B-VP	Othe	immune	the	DT	B-NP	Oimmune	system	immune	JJ	I-NP	Osystem	.	system	NN	I-NP	O.	The	.	.	O	OThe	difference	The	DT	B-NP	Odifference	in	difference	NN	I-NP	Oin	some	in	IN	B-PP	Osome	types	some	DT	B-NP	Otypes	of	type	NNS	I-NP	Oof	immune	of	IN	B-PP	Oimmune	responses	immune	JJ	B-NP	Oresponses	between	response	NNS	I-NP	Obetween	males	between	IN	B-PP	Omales	and	male	NNS	B-NP	Oand	females	and	CC	I-NP	Ofemales	is	female	NNS	I-NP	Ois	well-known	be	VBZ	B-VP	Owell-known	","	well-known	JJ	B-ADJP	O","	as	","	","	O	Oas	is	as	IN	B-SBAR	Ois	the	be	VBZ	B-VP	Othe	pronounced	the	DT	B-NP	Opronounced	thymic	pronounced	JJ	I-NP	Othymic	involution	thymic	JJ	I-NP	Oinvolution	induced	involution	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	exogenous	by	IN	B-PP	Oexogenous	estrogens	exogenous	JJ	B-NP	Oestrogens	.	estrogen	NNS	I-NP	O.	Estrogens	.	.	O	OEstrogens	stimulate	Estrogen	NNS	B-NP	Ostimulate	some	stimulate	VBP	B-VP	Osome	aspects	some	DT	B-NP	Oaspects	of	aspect	NNS	I-NP	Oof	macrophage	of	IN	B-PP	Omacrophage	activity	macrophage	NN	B-NP	B-cell_typeactivity	and	activity	NN	I-NP	Oand	","	and	CC	O	O","	depending	","	","	O	Odepending	on	depend	VBG	B-PP	Oon	dose	on	IN	B-PP	Odose	and	dose	NN	B-NP	Oand	mitogen	and	CC	I-NP	Omitogen	","	mitogen	NN	I-NP	O","	inhibit	","	","	O	Oinhibit	or	inhibit	VBP	B-VP	Oor	stimulate	or	CC	I-VP	Ostimulate	lymphocyte	stimulate	VBP	I-VP	Olymphocyte	proliferative	lymphocyte	NN	B-NP	Oproliferative	response	proliferative	JJ	I-NP	Oresponse	in	response	NN	I-NP	Oin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	Another	.	.	O	OAnother	example	Another	DT	B-NP	Oexample	is	example	NN	I-NP	Ois	the	be	VBZ	B-VP	Othe	estrogen	the	DT	B-NP	Oestrogen	effect	estrogen	NN	I-NP	Oeffect	on	effect	NN	I-NP	Oon	the	on	IN	B-PP	Othe	delayed	the	DT	B-NP	Odelayed	type	delay	VBN	I-NP	Otype	hypersensitivity	type	NN	I-NP	Ohypersensitivity	response	hypersensitivity	NN	I-NP	Oresponse	.	response	NN	I-NP	O.	A	.	.	O	OA	broad	A	DT	B-NP	Obroad	review	broad	JJ	I-NP	Oreview	is	review	NN	I-NP	Ois	given	be	VBZ	B-VP	Ogiven	of	give	VBN	I-VP	Oof	such	of	IN	B-PP	Osuch	estrogen	such	JJ	B-NP	Oestrogen	effects	estrogen	NN	I-NP	Oeffects	on	effect	NNS	I-NP	Oon	lymphoid	on	IN	B-PP	Olymphoid	tissue	lymphoid	JJ	B-NP	Otissue	and	tissue	NN	I-NP	Oand	immune	and	CC	O	Oimmune	response	immune	JJ	B-NP	Oresponse	.	response	NN	I-NP	O.	Most	.	.	O	OMost	of	Most	JJS	B-NP	Oof	the	of	IN	B-PP	Othe	studies	the	DT	B-NP	Ostudies	published	study	NNS	I-NP	Opublished	so	publish	VBN	B-VP	Oso	far	so	RB	B-ADVP	Ofar	are	far	RB	I-ADVP	Oare	phenomenological	be	VBP	B-VP	Ophenomenological	.	phenomenological	JJ	B-ADJP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	the	","	","	O	Othe	recent	the	DT	B-NP	Orecent	description	recent	JJ	I-NP	Odescription	of	description	NN	I-NP	Oof	estrogen	of	IN	B-PP	Oestrogen	receptors	estrogen	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	the	in	IN	B-PP	Othe	thymus	the	DT	B-NP	Othymus	and	thymus	NN	I-NP	Oand	in	and	CC	B-PP	Oin	some	in	IN	B-PP	Osome	lymphocyte	some	DT	B-NP	Olymphocyte	subpopulations	lymphocyte	NN	I-NP	B-cell_typesubpopulations	","	subpopulation	NNS	I-NP	I-cell_type","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	a	as	IN	I-CONJP	Oa	deeper	a	DT	B-NP	Odeeper	understanding	deep	JJR	I-NP	Ounderstanding	of	understanding	NN	I-NP	Oof	regulating	of	IN	B-PP	Oregulating	factors	regulate	VBG	B-VP	B-proteinfactors	in	factor	NNS	B-NP	I-proteinin	the	in	IN	B-PP	Othe	immune	the	DT	B-NP	Oimmune	system	immune	JJ	I-NP	Osystem	","	system	NN	I-NP	O","	open	","	","	O	Oopen	the	open	VB	B-VP	Othe	possibility	the	DT	B-NP	Opossibility	of	possibility	NN	I-NP	Oof	a	of	IN	B-PP	Oa	more	a	DT	B-NP	Omore	detailed	more	RBR	I-NP	Odetailed	understanding	detailed	JJ	I-NP	Ounderstanding	of	understanding	NN	I-NP	Oof	the	of	IN	B-PP	Othe	estrogen	the	DT	B-NP	Oestrogen	mechanism	estrogen	NN	I-NP	Omechanism	of	mechanism	NN	I-NP	Oof	interference	of	IN	B-PP	Ointerference	.	interference	NN	B-NP	O.	Estrogen	.	.	O	OEstrogen	effects	Estrogen	NN	B-NP	Oeffects	in	effect	NNS	I-NP	Oin	adults	in	IN	B-PP	Oadults	are	adult	NNS	B-NP	Oare	reversible	be	VBP	B-VP	Oreversible	.	reversible	JJ	B-ADJP	O.	After	.	.	O	OAfter	treating	After	IN	B-PP	Otreating	neonatal	treat	VBG	B-VP	Oneonatal	mice	neonatal	JJ	B-NP	Omice	with	mouse	NNS	I-NP	Owith	the	with	IN	B-PP	Othe	synthetic	the	DT	B-NP	Osynthetic	estrogen	synthetic	JJ	I-NP	Oestrogen	diethylstilbestrol	estrogen	NN	I-NP	Odiethylstilbestrol	(	diethylstilbestrol	NN	I-NP	O(	DES	(	(	O	ODES	)	DES	NN	B-NP	O)	","	)	)	O	O","	disturbances	","	","	O	Odisturbances	are	disturbance	NNS	B-NP	Oare	induced	be	VBP	B-VP	Oinduced	in	induce	VBN	I-VP	Oin	lymphocyte	in	IN	B-PP	Olymphocyte	populations	lymphocyte	NN	B-NP	B-cell_typepopulations	and	population	NNS	I-NP	I-cell_typeand	lymphocyte	and	CC	O	Olymphocyte	functions	lymphocyte	NN	B-NP	Ofunctions	which	function	NNS	I-NP	Owhich	are	which	WDT	B-NP	Oare	permanent	be	VBP	B-VP	Opermanent	and	permanent	JJ	B-ADJP	Oand	irreversible	and	CC	I-ADJP	Oirreversible	.	irreversible	JJ	I-ADJP	O.	Lymphocytes	.	.	O	OLymphocytes	from	Lymphocyte	NNS	B-NP	B-cell_typefrom	adult	from	IN	B-PP	Oadult	","	adult	JJ	B-NP	O","	neonatally	","	","	I-NP	Oneonatally	DES-treated	neonatally	RB	I-NP	ODES-treated	female	DES-treated	JJ	I-NP	Ofemale	mice	female	JJ	I-NP	Omice	have	mouse	NNS	I-NP	Ohave	a	have	VBP	B-VP	Oa	reduced	a	DT	B-NP	Oreduced	mitogen	reduce	VBN	I-NP	Omitogen	response	mitogen	NN	I-NP	Oresponse	to	response	NN	I-NP	Oto	ConA	to	TO	B-PP	OConA	and	ConA	NN	B-NP	Oand	LPS	and	CC	O	OLPS	(	LPS	NN	B-NP	O(	T	(	(	O	OT	and	T	NN	B-NP	Oand	B	and	CC	I-NP	OB	cell	B	NN	I-NP	B-proteincell	mitogen	cell	NN	I-NP	I-proteinmitogen	)	mitogen	NN	I-NP	I-protein)	and	)	)	O	Oand	the	and	CC	O	Othe	delayed	the	DT	B-NP	Odelayed	type	delay	VBN	I-NP	Otype	hypersensitivity	type	NN	I-NP	Ohypersensitivity	response	hypersensitivity	NN	I-NP	Oresponse	is	response	NN	I-NP	Ois	depressed	be	VBZ	B-VP	Odepressed	.	depress	VBN	I-VP	O.	A	.	.	O	OA	detailed	A	DT	B-NP	Odetailed	analysis	detailed	JJ	I-NP	Oanalysis	demonstrated	analysis	NN	I-NP	Odemonstrated	a	demonstrate	VBD	B-VP	Oa	decreased	a	DT	B-NP	Odecreased	T	decrease	VBN	I-NP	OT	helper	T	NN	I-NP	Ohelper	cell	helper	NN	I-NP	Ocell	population	cell	NN	I-NP	Opopulation	.	population	NN	I-NP	O.	The	.	.	O	OThe	activity	The	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	Natural	of	IN	B-PP	ONatural	Killer	Natural	JJ	B-NP	B-cell_typeKiller	cells	Killer	NN	I-NP	I-cell_typecells	is	cell	NNS	I-NP	I-cell_typeis	permanently	be	VBZ	B-VP	Opermanently	reduced	permanently	RB	I-VP	Oreduced	and	reduce	VBN	I-VP	Oand	this	and	CC	O	Othis	functional	this	DT	B-NP	Ofunctional	impairment	functional	JJ	I-NP	Oimpairment	is	impairment	NN	I-NP	Ois	related	be	VBZ	B-VP	Orelated	to	related	JJ	B-ADJP	Oto	a	to	TO	B-PP	Oa	decreased	a	DT	B-NP	Odecreased	number	decrease	VBN	I-NP	Onumber	of	number	NN	I-NP	Oof	these	of	IN	B-PP	Othese	cells	these	DT	B-NP	Ocells	","	cell	NNS	I-NP	O","	in	","	","	O	Oin	turn	in	IN	B-PP	Oturn	determined	turn	NN	B-NP	Odetermined	at	determine	VBN	B-VP	Oat	the	at	IN	B-PP	Othe	bone	the	DT	B-NP	Obone	marrow	bone	NN	I-NP	Omarrow	level	marrow	NN	I-NP	Olevel	.	level	NN	I-NP	O.	The	.	.	O	OThe	same	The	DT	B-NP	Osame	animals	same	JJ	I-NP	Oanimals	have	animal	NNS	I-NP	Ohave	an	have	VBP	B-VP	Oan	increased	an	DT	B-NP	Oincreased	sensitivity	increase	VBN	I-NP	Osensitivity	to	sensitivity	NN	I-NP	Oto	chemical	to	TO	B-PP	Ochemical	carcinogens	chemical	JJ	B-NP	Ocarcinogens	(	carcinogen	NNS	I-NP	O(	methylcholanthrene	(	(	O	Omethylcholanthrene	)	methylcholanthrene	NN	B-NP	O)	and	)	)	O	Oand	they	and	CC	O	Othey	spontaneously	they	PRP	B-NP	Ospontaneously	develop	spontaneously	RB	B-VP	Odevelop	epithelial	develop	VBP	I-VP	Oepithelial	changes	epithelial	JJ	B-NP	Ochanges	in	change	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	uterine	the	DT	B-NP	Outerine	cervix	uterine	JJ	I-NP	Ocervix	which	cervix	NN	I-NP	Owhich	morphologically	which	WDT	B-NP	Omorphologically	are	morphologically	RB	B-ADVP	Oare	similar	be	VBP	B-VP	Osimilar	to	similar	JJ	B-ADJP	Oto	adenocarcinoma	to	TO	B-PP	Oadenocarcinoma	.	adenocarcinoma	NN	B-NP	O.	The	.	.	O	OThe	association	The	DT	B-NP	Oassociation	between	association	NN	I-NP	Obetween	estrogen-associated	between	IN	B-PP	Oestrogen-associated	malignancy	estrogen-associated	JJ	B-NP	Omalignancy	and	malignancy	NN	I-NP	Oand	estrogen	and	CC	I-NP	Oestrogen	effects	estrogen	NN	I-NP	Oeffects	in	effect	NNS	I-NP	Oin	lymphocyte	in	IN	B-PP	Olymphocyte	functions	lymphocyte	NN	B-NP	Ofunctions	deserves	function	NNS	I-NP	Odeserves	further	deserve	VBZ	B-VP	Ofurther	study	further	JJ	B-NP	Ostudy	.	study	NN	I-NP	O.	Drugs	.	.	O	ODrugs	affecting	Drug	NNS	B-NP	Oaffecting	the	affect	VBG	B-VP	Othe	hormonal	the	DT	B-NP	Ohormonal	receptors	hormonal	JJ	I-NP	B-proteinreceptors	of	receptor	NNS	I-NP	I-proteinof	normal	of	IN	B-PP	Onormal	and	normal	JJ	B-NP	B-cell_typeand	leukaemic	and	CC	I-NP	I-cell_typeleukaemic	peripheral	leukaemic	JJ	I-NP	I-cell_typeperipheral	leucocytes	peripheral	JJ	I-NP	I-cell_typeleucocytes	.	leucocyte	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	authors	The	DT	B-NP	Oauthors	investigated	author	NNS	I-NP	Oinvestigated	the	investigate	VBD	B-VP	Othe	behaviour	the	DT	B-NP	Obehaviour	of	behaviour	NN	I-NP	Oof	steroid	of	IN	B-PP	Osteroid	hormone	steroid	NN	B-NP	Ohormone	uptake	hormone	NN	I-NP	Ouptake	in	uptake	NN	I-NP	Oin	leukaemic	in	IN	B-PP	Oleukaemic	cells	leukaemic	JJ	B-NP	B-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	CML	(	(	O	OCML	","	CML	NN	B-NP	O","	CLL	","	","	O	OCLL	","	CLL	NN	B-NP	O","	AML	","	","	O	OAML	","	AML	NN	B-NP	O","	ALL	","	","	O	OALL	)	ALL	NN	B-NP	O)	","	)	)	O	O","	in	","	","	O	Oin	basal	in	IN	B-PP	Obasal	conditions	basal	JJ	B-NP	Oconditions	and	condition	NNS	I-NP	Oand	after	and	CC	B-PP	Oafter	incubation	after	IN	B-PP	Oincubation	with	incubation	NN	B-NP	Owith	drugs	with	IN	B-PP	Odrugs	which	drug	NNS	B-NP	Owhich	modify	which	WDT	B-NP	Omodify	the	modify	VBP	B-VP	Othe	cellular	the	DT	B-NP	Ocellular	concentration	cellular	JJ	I-NP	Oconcentration	of	concentration	NN	I-NP	Oof	cAMP	of	IN	B-PP	OcAMP	","	cAMP	NN	B-NP	O","	PGE	","	","	I-NP	OPGE	and	PGE	NN	I-NP	Oand	PGF	and	CC	I-NP	OPGF	.	PGF	NN	I-NP	B-protein.	The	.	.	O	OThe	results	The	DT	B-NP	Oresults	demonstrated	result	NNS	I-NP	Odemonstrated	the	demonstrate	VBD	B-VP	Othe	presence	the	DT	B-NP	Opresence	in	presence	NN	I-NP	Oin	leukaemic	in	IN	B-PP	Oleukaemic	cells	leukaemic	JJ	B-NP	B-cell_typecells	of	cell	NNS	I-NP	I-cell_typeof	an	of	IN	B-PP	Oan	alteration	an	DT	B-NP	Oalteration	in	alteration	NN	I-NP	Oin	the	in	IN	B-PP	Othe	incorporation	the	DT	B-NP	Oincorporation	of	incorporation	NN	I-NP	Oof	steroid	of	IN	B-PP	Osteroid	hormones	steroid	NN	B-NP	Ohormones	.	hormone	NNS	I-NP	O.	This	.	.	O	OThis	alteration	This	DT	B-NP	Oalteration	was	alteration	NN	I-NP	Owas	scarcely	be	VBD	B-VP	Oscarcely	modified	scarcely	RB	I-VP	Omodified	by	modify	VBN	I-VP	Oby	incubation	by	IN	B-PP	Oincubation	with	incubation	NN	B-NP	Owith	theophylline	with	IN	B-PP	Otheophylline	","	theophylline	NN	B-NP	O","	which	","	","	O	Owhich	increases	which	WDT	B-NP	Oincreases	cellular	increase	VBZ	B-VP	Ocellular	concentration	cellular	JJ	B-NP	Oconcentration	of	concentration	NN	I-NP	Oof	cAMP	of	IN	B-PP	OcAMP	.	cAMP	NN	B-NP	O.	On	.	.	O	OOn	the	On	IN	B-PP	Othe	other	the	DT	B-NP	Oother	hand	other	JJ	I-NP	Ohand	","	hand	NN	I-NP	O","	it	","	","	O	Oit	was	it	PRP	B-NP	Owas	moderately	be	VBD	B-VP	Omoderately	counteracted	moderately	RB	I-VP	Ocounteracted	by	counteract	VBN	I-VP	Oby	thioproline	by	IN	B-PP	Othioproline	and	thioproline	NN	B-NP	Oand	was	and	CC	O	Owas	evidently	be	VBD	B-VP	Oevidently	inhibited	evidently	RB	I-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	flurbiprofen	by	IN	B-PP	Oflurbiprofen	","	flurbiprofen	NN	B-NP	O","	which	","	","	O	Owhich	also	which	WDT	B-NP	Oalso	reduced	also	RB	B-ADVP	Oreduced	cellular	reduce	VBD	B-VP	Ocellular	concentrations	cellular	JJ	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	prostaglandins	of	IN	B-PP	Oprostaglandins	","	prostaglandin	NNS	B-NP	O","	particularly	","	","	O	Oparticularly	PGE2	particularly	RB	B-NP	OPGE2	","	PGE2	NN	I-NP	B-protein","	with	","	","	O	Owith	the	with	IN	B-PP	Othe	exception	the	DT	B-NP	Oexception	of	exception	NN	I-NP	Oof	PGF2	of	IN	B-PP	OPGF2	which	PGF2	NN	B-NP	B-proteinwhich	showed	which	WDT	B-NP	Oshowed	a	show	VBD	B-VP	Oa	poor	a	DT	B-NP	Opoor	response	poor	JJ	I-NP	Oresponse	.	response	NN	I-NP	O.	Differences	.	.	O	ODifferences	were	Difference	NNS	B-NP	Owere	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	behavior	the	DT	B-NP	Obehavior	of	behavior	NN	I-NP	Oof	hormonal	of	IN	B-PP	Ohormonal	uptake	hormonal	JJ	B-NP	Ouptake	of	uptake	NN	I-NP	Oof	CML	of	IN	B-PP	OCML	","	CML	NN	B-NP	O","	in	","	","	O	Oin	contrast	in	IN	B-PP	Ocontrast	to	contrast	NN	B-NP	Oto	that	to	TO	B-PP	Othat	of	that	DT	B-NP	Oof	AML	of	IN	B-PP	OAML	","	AML	NN	B-NP	O","	CLL	","	","	O	OCLL	and	CLL	NN	B-NP	Oand	ALL	and	CC	O	OALL	peripheral	ALL	NN	B-NP	Operipheral	leucocytes	peripheral	JJ	I-NP	Oleucocytes	.	leucocyte	NNS	I-NP	O.	Human	.	.	O	OHuman	breast	Human	JJ	B-NP	Obreast	cancer	breast	NN	I-NP	Ocancer	and	cancer	NN	I-NP	Oand	impaired	and	CC	O	Oimpaired	NK	impaired	JJ	B-NP	ONK	cell	NK	NN	I-NP	Ocell	function	cell	NN	I-NP	Ofunction	.	function	NN	I-NP	O.	Recent	.	.	O	ORecent	advances	Recent	JJ	B-NP	Oadvances	in	advance	NNS	I-NP	Oin	tumor	in	IN	B-PP	Otumor	immunology	tumor	NN	B-NP	Oimmunology	have	immunology	NN	I-NP	Ohave	led	have	VBP	B-VP	Oled	to	lead	VBN	I-VP	Oto	the	to	TO	B-PP	Othe	discovery	the	DT	B-NP	Odiscovery	of	discovery	NN	I-NP	Oof	a	of	IN	B-PP	Oa	new	a	DT	B-NP	Onew	lymphoid	new	JJ	I-NP	Olymphoid	cell	lymphoid	JJ	I-NP	Ocell	with	cell	NN	I-NP	Owith	unique	with	IN	B-PP	Ounique	antitumor	unique	JJ	B-NP	Oantitumor	activity	antitumor	JJ	I-NP	Oactivity	.	activity	NN	I-NP	O.	Natural	.	.	O	ONatural	killer	Natural	JJ	B-NP	B-cell_typekiller	(	killer	NN	I-NP	I-cell_type(	NK	(	(	O	I-cell_typeNK	)	NK	NN	B-NP	I-cell_type)	cells	)	)	O	I-cell_typecells	form	cell	NNS	B-NP	I-cell_typeform	an	form	VBP	B-VP	Oan	antitumor	an	DT	B-NP	Oantitumor	surveillance	antitumor	JJ	I-NP	Osurveillance	system	surveillance	NN	I-NP	Osystem	and	system	NN	I-NP	Oand	appear	and	CC	O	Oappear	to	appear	VBP	B-VP	Oto	be	to	TO	I-VP	Obe	vital	be	VB	I-VP	Ovital	in	vital	JJ	B-ADJP	Oin	preventing	in	IN	B-PP	Opreventing	tumor	prevent	VBG	B-VP	Otumor	growth	tumor	NN	B-NP	Ogrowth	and	growth	NN	I-NP	Oand	metastasis	and	CC	O	Ometastasis	in	metastasis	NN	B-NP	Oin	animal	in	IN	B-PP	Oanimal	models	animal	NN	B-NP	Omodels	.	model	NNS	I-NP	O.	We	.	.	O	OWe	studied	We	PRP	B-NP	Ostudied	NK	study	VBD	B-VP	ONK	activity	NK	NN	B-NP	Oactivity	in	activity	NN	I-NP	Oin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	benign	with	IN	B-PP	Obenign	and	benign	JJ	B-NP	Oand	malignant	and	CC	I-NP	Omalignant	breast	malignant	JJ	I-NP	Obreast	disease	breast	NN	I-NP	Odisease	","	disease	NN	I-NP	O","	using	","	","	O	Ousing	a	use	VBG	B-VP	Oa	chromium-51	a	DT	B-NP	Ochromium-51	release	chromium-51	NN	I-NP	Orelease	microtiter	release	NN	I-NP	Omicrotiter	cytotoxicity	microtiter	NN	I-NP	Ocytotoxicity	assay	cytotoxicity	NN	I-NP	Oassay	with	assay	NN	I-NP	Owith	K562	with	IN	B-PP	OK562	cells	K562	NN	B-NP	B-cell_linecells	as	cell	NNS	I-NP	I-cell_lineas	targets	as	IN	B-PP	Otargets	.	target	NNS	B-NP	O.	Compared	.	.	O	OCompared	with	Compare	VBN	B-PP	Owith	benign	with	IN	B-PP	Obenign	controls	benign	JJ	B-NP	Ocontrols	","	control	NNS	I-NP	O","	patients	","	","	O	Opatients	with	patient	NNS	B-NP	Owith	malignancies	with	IN	B-PP	Omalignancies	had	malignancy	NNS	B-NP	Ohad	significantly	have	VBD	B-VP	Osignificantly	depressed	significantly	RB	B-NP	Odepressed	NK	depressed	JJ	I-NP	ONK	#NAME?	NK	NN	I-NP	O#NAME?	lysis	#NAME?	JJ	I-NP	Olysis	(	lysis	NN	I-NP	O(	P	(	(	O	OP	less	P	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.01	than	IN	B-PP	O0.01	)	0.01	CD	B-NP	O)	.	)	)	O	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	lysis	","	","	O	Olysis	in	lysis	NN	B-NP	Oin	those	in	IN	B-PP	Othose	with	those	DT	B-NP	Owith	advanced	with	IN	B-PP	Oadvanced	disease	advance	VBN	B-NP	Odisease	(	disease	NN	I-NP	O(	stages	(	(	O	Ostages	II	stage	NNS	B-NP	OII	","	II	CD	I-NP	O","	III	","	","	I-NP	OIII	","	III	CD	I-NP	O","	and	","	","	O	Oand	IV	and	CC	O	OIV	)	IV	CD	B-NP	O)	was	)	)	O	Owas	significantly	be	VBD	B-VP	Osignificantly	less	significantly	RB	B-ADJP	Oless	than	less	JJR	I-ADJP	Othan	in	than	IN	B-PP	Oin	those	in	IN	B-PP	Othose	with	those	DT	B-NP	Owith	limited	with	IN	B-PP	Olimited	disease	limited	JJ	B-NP	Odisease	(	disease	NN	I-NP	O(	stage	(	(	O	Ostage	I	stage	NN	B-NP	OI	)	I	CD	I-NP	O)	(	)	)	O	O(	P	(	(	O	OP	less	P	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.01	than	IN	B-PP	O0.01	)	0.01	CD	B-NP	O)	.	)	)	O	O.	NK	.	.	O	ONK	activity	NK	NN	B-NP	Oactivity	was	activity	NN	I-NP	Owas	not	be	VBD	B-VP	Onot	correlated	not	RB	I-VP	Ocorrelated	to	correlate	VBN	I-VP	Oto	estrogen	to	TO	B-PP	Oestrogen	or	estrogen	NN	B-NP	Oor	progesterone	or	CC	I-NP	Oprogesterone	receptor	progesterone	NN	I-NP	B-proteinreceptor	states	receptor	NN	I-NP	I-proteinstates	.	state	NNS	I-NP	O.	Positive	.	.	O	OPositive	correlation	Positive	JJ	B-NP	Ocorrelation	of	correlation	NN	I-NP	Oof	a	of	IN	B-PP	Oa	depressed	a	DT	B-NP	Odepressed	natural	depressed	JJ	I-NP	Onatural	killer	natural	JJ	I-NP	Okiller	activity	killer	NN	I-NP	Oactivity	with	activity	NN	I-NP	Owith	the	with	IN	B-PP	Othe	extent	the	DT	B-NP	Oextent	of	extent	NN	I-NP	Oof	tumor	of	IN	B-PP	Otumor	spread	tumor	NN	B-NP	Ospread	supports	spread	NN	I-NP	Osupports	the	support	VBZ	B-VP	Othe	concept	the	DT	B-NP	Oconcept	of	concept	NN	I-NP	Oof	an	of	IN	B-PP	Oan	NK	an	DT	B-NP	ONK	cell	NK	NN	I-NP	Ocell	immune	cell	NN	I-NP	Oimmune	surveillance	immune	JJ	I-NP	Osurveillance	system	surveillance	NN	I-NP	Osystem	in	system	NN	I-NP	Oin	breast	in	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	and	cancer	NN	I-NP	Oand	emphasizes	and	CC	O	Oemphasizes	its	emphasize	VBZ	B-VP	Oits	importance	its	PRP$	B-NP	Oimportance	in	importance	NN	I-NP	Oin	this	in	IN	B-PP	Othis	malignancy	this	DT	B-NP	Omalignancy	.	malignancy	NN	I-NP	O.	Immunosuppressive	.	.	O	OImmunosuppressive	effect	Immunosuppressive	JJ	B-NP	Oeffect	of	effect	NN	I-NP	Oof	serum	of	IN	B-PP	Oserum	progesterone	serum	NN	B-NP	Oprogesterone	during	progesterone	NN	I-NP	Oduring	pregnancy	during	IN	B-PP	Opregnancy	depends	pregnancy	NN	B-NP	Odepends	on	depend	VBZ	B-VP	Oon	the	on	IN	B-PP	Othe	progesterone	the	DT	B-NP	Oprogesterone	binding	progesterone	NN	I-NP	Obinding	capacity	binding	NN	I-NP	Ocapacity	of	capacity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	lymphocytes	the	DT	B-NP	Olymphocytes	.	lymphocyte	NNS	I-NP	B-cell_type.	Cytotoxic	.	.	O	OCytotoxic	activity	Cytotoxic	JJ	B-NP	Oactivity	and	activity	NN	I-NP	Oand	progesterone	and	CC	O	Oprogesterone	binding	progesterone	NN	B-NP	Obinding	capacity	binding	NN	I-NP	Ocapacity	of	capacity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	lymphocytes	the	DT	B-NP	Olymphocytes	","	lymphocyte	NNS	I-NP	B-cell_type","	together	","	","	O	Otogether	with	together	RB	B-ADVP	Owith	serum	with	IN	B-PP	Oserum	progesterone	serum	NN	B-NP	Oprogesterone	concentrations	progesterone	NN	I-NP	Oconcentrations	","	concentration	NNS	I-NP	O","	were	","	","	O	Owere	determined	be	VBD	B-VP	Odetermined	in	determine	VBN	I-VP	Oin	women	in	IN	B-PP	Owomen	with	woman	NNS	B-NP	Owith	normal	with	IN	B-PP	Onormal	pregnancy	normal	JJ	B-NP	Opregnancy	or	pregnancy	NN	I-NP	Oor	with	or	CC	B-PP	Owith	a	with	IN	B-PP	Oa	clinical	a	DT	B-NP	Oclinical	diagnosis	clinical	JJ	I-NP	Odiagnosis	of	diagnosis	NN	I-NP	Oof	threatened	of	IN	B-PP	Othreatened	abortion	threaten	VBN	B-NP	Oabortion	or	abortion	NN	I-NP	Oor	threatened	or	CC	O	Othreatened	premature	threaten	VBD	B-VP	Opremature	labour	premature	JJ	B-NP	Olabour	.	labour	NN	I-NP	O.	The	.	.	O	OThe	lymphocytes	The	DT	B-NP	Olymphocytes	of	lymphocyte	NNS	I-NP	B-cell_typeof	women	of	IN	B-PP	Owomen	with	woman	NNS	B-NP	Owith	threatened	with	IN	B-PP	Othreatened	abortion	threaten	VBN	B-NP	Oabortion	or	abortion	NN	I-NP	Oor	threatened	or	CC	O	Othreatened	premature	threaten	VBD	B-VP	Opremature	labour	premature	JJ	B-NP	Olabour	showed	labour	NN	I-NP	Oshowed	significantly	show	VBD	B-VP	Osignificantly	higher	significantly	RB	B-NP	Ohigher	cytotoxic	high	JJR	I-NP	Ocytotoxic	activity	cytotoxic	JJ	I-NP	Oactivity	(	activity	NN	I-NP	O(	P	(	(	O	OP	less	P	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.001	than	IN	B-PP	O0.001	)	0.001	CD	B-NP	O)	and	)	)	O	Oand	significantly	and	CC	O	Osignificantly	lower	significantly	RB	B-NP	Olower	progesterone	low	JJR	I-NP	Oprogesterone	binding	progesterone	NN	I-NP	Obinding	capacity	binding	NN	I-NP	Ocapacity	(	capacity	NN	I-NP	O(	P	(	(	O	OP	less	P	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.001	than	IN	B-PP	O0.001	)	0.001	CD	B-NP	O)	than	)	)	O	Othan	did	than	IN	B-SBAR	Odid	lymphocytes	do	VBD	O	Olymphocytes	obtained	lymphocyte	NNS	B-NP	B-cell_typeobtained	from	obtain	VBN	B-VP	Ofrom	the	from	IN	B-PP	Othe	healthy	the	DT	B-NP	Ohealthy	pregnant	healthy	JJ	I-NP	Opregnant	women	pregnant	JJ	I-NP	Owomen	.	woman	NNS	I-NP	O.	Significant	.	.	O	OSignificant	inverse	Significant	JJ	B-NP	Oinverse	correlation	inverse	JJ	I-NP	Ocorrelation	was	correlation	NN	I-NP	Owas	found	be	VBD	B-VP	Ofound	between	find	VBN	I-VP	Obetween	progesterone	between	IN	B-PP	Oprogesterone	binding	progesterone	NN	B-NP	Obinding	capacity	binding	NN	I-NP	Ocapacity	and	capacity	NN	I-NP	Oand	cytotoxic	and	CC	O	Ocytotoxic	activity	cytotoxic	JJ	B-NP	Oactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	lymphocytes	the	DT	B-NP	Olymphocytes	(	lymphocyte	NNS	I-NP	B-cell_type(	P	(	(	O	OP	less	P	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.001	than	IN	B-PP	O0.001	)	0.001	CD	B-NP	O)	","	)	)	O	O","	but	","	","	O	Obut	the	but	CC	O	Othe	progesterone	the	DT	B-NP	Oprogesterone	concentration	progesterone	NN	I-NP	Oconcentration	of	concentration	NN	I-NP	Oof	the	of	IN	B-PP	Othe	pregnancy	the	DT	B-NP	Opregnancy	serum	pregnancy	NN	I-NP	Oserum	appeared	serum	NN	I-NP	Oappeared	to	appear	VBD	B-VP	Oto	have	to	TO	I-VP	Ohave	no	have	VB	I-VP	Ono	influence	no	DT	B-NP	Oinfluence	on	influence	NN	I-NP	Oon	the	on	IN	B-PP	Othe	other	the	DT	B-NP	Oother	two	other	JJ	I-NP	Otwo	parameters	two	CD	I-NP	Oparameters	.	parameter	NNS	I-NP	O.	The	.	.	O	OThe	findings	The	DT	B-NP	Ofindings	indicate	finding	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	intact	that	IN	B-SBAR	Ointact	progesterone	intact	JJ	B-NP	Oprogesterone	binding	progesterone	NN	I-NP	Obinding	capacity	binding	NN	I-NP	Ocapacity	of	capacity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	lymphocytes	the	DT	B-NP	Olymphocytes	is	lymphocyte	NNS	I-NP	B-cell_typeis	an	be	VBZ	B-VP	Oan	essential	an	DT	B-NP	Oessential	factor	essential	JJ	I-NP	Ofactor	for	factor	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	manifestation	the	DT	B-NP	Omanifestation	of	manifestation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	blocking	the	DT	B-NP	Oblocking	effect	block	VBG	I-NP	Oeffect	exerted	effect	NN	I-NP	Oexerted	by	exert	VBN	B-VP	Oby	pregnancy	by	IN	B-PP	Opregnancy	serum	pregnancy	NN	B-NP	Oserum	on	serum	NN	I-NP	Oon	lymphocyte	on	IN	B-PP	Olymphocyte	cytotoxicity	lymphocyte	NN	B-NP	Ocytotoxicity	in	cytotoxicity	NN	I-NP	Oin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	Serum	.	.	O	OSerum	sex	Serum	NN	B-NP	Osex	steroid	sex	NN	I-NP	Osteroid	and	steroid	NN	I-NP	Oand	peptide	and	CC	O	Opeptide	hormone	peptide	NN	B-NP	Ohormone	concentrations	hormone	NN	I-NP	Oconcentrations	","	concentration	NNS	I-NP	O","	and	","	","	O	Oand	endometrial	and	CC	O	Oendometrial	estrogen	endometrial	JJ	B-NP	Oestrogen	and	estrogen	NN	I-NP	Oand	progestin	and	CC	I-NP	Oprogestin	receptor	progestin	NN	I-NP	B-proteinreceptor	levels	receptor	NN	I-NP	I-proteinlevels	during	level	NNS	I-NP	Oduring	administration	during	IN	B-PP	Oadministration	of	administration	NN	B-NP	Oof	human	of	IN	B-PP	Ohuman	leukocyte	human	JJ	B-NP	B-proteinleukocyte	interferon	leukocyte	NN	I-NP	I-proteininterferon	.	interferon	NN	I-NP	I-protein.	Five	.	.	O	OFive	normally	Five	CD	B-NP	Onormally	cycling	normally	RB	I-NP	Ocycling	healthy	cycle	VBG	I-NP	Ohealthy	women	healthy	JJ	B-NP	Owomen	were	woman	NNS	I-NP	Owere	given	be	VBD	B-VP	Ogiven	daily	give	VBN	I-VP	Odaily	subcutaneous	daily	JJ	B-NP	Osubcutaneous	injections	subcutaneous	JJ	I-NP	Oinjections	of	injection	NNS	I-NP	Oof	human	of	IN	B-PP	Ohuman	leukocyte	human	JJ	B-NP	B-cell_typeleukocyte	interferon	leukocyte	NN	I-NP	I-cell_typeinterferon	(	interferon	NN	I-NP	O(	3	(	(	O	O3	X	3	CD	B-NP	OX	10	X	SYM	O	O10	(	10	CD	B-NP	O(	6	(	(	O	O6	)	6	CD	B-NP	O)	units/day	)	)	O	Ounits/day	)	units/day	NN	B-NP	O)	from	)	)	O	Ofrom	the	from	IN	B-PP	Othe	3rd	the	DT	B-NP	O3rd	through	3rd	NN	I-NP	Othrough	23rd	through	IN	B-PP	O23rd	day	23rd	JJ	B-NP	Oday	of	day	NN	I-NP	Oof	the	of	IN	B-PP	Othe	menstrual	the	DT	B-NP	Omenstrual	cycle	menstrual	JJ	I-NP	Ocycle	","	cycle	NN	I-NP	O","	and	","	","	O	Oand	serum	and	CC	O	Oserum	steroid	serum	NN	B-NP	Osteroid	and	steroid	NN	I-NP	Oand	peptide	and	CC	O	Opeptide	hormone	peptide	NN	B-NP	Ohormone	concentrations	hormone	NN	I-NP	Oconcentrations	monitored	concentration	NNS	I-NP	Omonitored	at	monitor	VBN	B-VP	Oat	3-day	at	IN	B-PP	O3-day	intervals	3-day	JJ	B-NP	Ointervals	during	interval	NNS	I-NP	Oduring	the	during	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	and	treatment	NN	I-NP	Oand	the	and	CC	O	Othe	preceding	the	DT	B-NP	Opreceding	control	precede	VBG	I-NP	Ocontrol	cycle	control	NN	I-NP	Ocycle	.	cycle	NN	I-NP	O.	Concentrations	.	.	O	OConcentrations	of	Concentration	NNS	B-NP	Oof	cytosol	of	IN	B-PP	Ocytosol	and	cytosol	NN	B-NP	Oand	nuclear	and	CC	O	Onuclear	estrogen	nuclear	JJ	B-NP	B-proteinestrogen	receptors	estrogen	NN	I-NP	I-proteinreceptors	(	receptor	NNS	I-NP	I-protein(	ERC	(	(	O	OERC	and	ERC	NN	B-NP	B-proteinand	ERN	and	CC	I-NP	OERN	","	ERN	NN	I-NP	B-protein","	respectively	","	","	O	Orespectively	)	respectively	RB	B-ADVP	O)	and	)	)	O	Oand	progestin	and	CC	O	Oprogestin	receptors	progestin	NN	B-NP	B-proteinreceptors	(	receptor	NNS	I-NP	I-protein(	PRC	(	(	O	OPRC	and	PRC	NN	B-NP	B-proteinand	PRN	and	CC	O	OPRN	)	PRN	NN	B-NP	B-protein)	were	)	)	O	Owere	also	be	VBD	B-VP	Oalso	measured	also	RB	I-VP	Omeasured	from	measure	VBN	I-VP	Ofrom	endometrial	from	IN	B-PP	Oendometrial	biopsies	endometrial	JJ	B-NP	Obiopsies	taken	biopsy	NNS	I-NP	Otaken	on	take	VBN	B-VP	Oon	the	on	IN	B-PP	Othe	24th	the	DT	B-NP	O24th	day	24th	JJ	I-NP	Oday	of	day	NN	I-NP	Oof	the	of	IN	B-PP	Othe	control	the	DT	B-NP	Ocontrol	and	control	NN	I-NP	Oand	treatment	and	CC	I-NP	Otreatment	cycle	treatment	NN	I-NP	Ocycle	.	cycle	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	an	","	","	O	Oan	extensive	an	DT	B-NP	Oextensive	monitoring	extensive	JJ	I-NP	Omonitoring	of	monitoring	NN	I-NP	Oof	clinical	of	IN	B-PP	Oclinical	chemical	clinical	JJ	B-NP	Ochemical	and	chemical	NN	I-NP	Oand	hematological	and	CC	O	Ohematological	tests	hematological	JJ	B-NP	Otests	from	test	NNS	I-NP	Ofrom	the	from	IN	B-PP	Othe	blood	the	DT	B-NP	Oblood	samples	blood	NN	I-NP	B-cell_typesamples	were	sample	NNS	I-NP	I-cell_typewere	performed	be	VBD	B-VP	Operformed	.	perform	VBN	I-VP	O.	Serum	.	.	O	OSerum	estradiol	Serum	NN	B-NP	Oestradiol	and	estradiol	NN	I-NP	Oand	progesterone	and	CC	O	Oprogesterone	concentrations	progesterone	NN	B-NP	Oconcentrations	were	concentration	NNS	I-NP	Owere	significantly	be	VBD	B-VP	Osignificantly	decreased	significantly	RB	I-VP	Odecreased	during	decrease	VBN	I-VP	Oduring	the	during	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	cycle	treatment	NN	I-NP	Ocycle	","	cycle	NN	I-NP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	interferon	that	IN	B-SBAR	Ointerferon	interacts	interferon	NN	B-NP	B-proteininteracts	in	interact	VBZ	B-VP	Oin	vivo	in	FW	B-ADVP	Ovivo	with	vivo	FW	I-ADVP	Owith	the	with	IN	B-PP	Othe	function	the	DT	B-NP	Ofunction	of	function	NN	I-NP	Oof	both	of	IN	B-PP	Oboth	FSH	both	CC	O	OFSH	and	FSH	NN	B-NP	Oand	LH	and	CC	I-NP	OLH	.	LH	NN	I-NP	O.	No	.	.	O	ONo	significant	No	DT	B-NP	Osignificant	changes	significant	JJ	I-NP	Ochanges	were	change	NNS	I-NP	Owere	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	serum	the	DT	B-NP	Oserum	peptide	serum	NN	I-NP	Opeptide	hormone	peptide	NN	I-NP	Ohormone	concentrations	hormone	NN	I-NP	Oconcentrations	measured	concentration	NNS	I-NP	Omeasured	(	measure	VBN	B-VP	O(	FSH	(	(	O	OFSH	","	FSH	NN	B-NP	O","	LH	","	","	O	OLH	","	LH	NN	B-NP	O","	prolactin	","	","	O	Oprolactin	","	prolactin	NN	B-NP	O","	insulin	","	","	O	Oinsulin	","	insulin	NN	B-NP	B-protein","	growth	","	","	O	Ogrowth	hormone	growth	NN	B-NP	Ohormone	and	hormone	NN	I-NP	Oand	TSH	and	CC	O	OTSH	)	TSH	NN	B-NP	O)	;	)	)	O	O;	neither	;	:	O	Oneither	were	neither	CC	O	Owere	the	be	VBD	B-VP	Othe	levels	the	DT	B-NP	Olevels	of	level	NNS	I-NP	Oof	endometrial	of	IN	B-PP	Oendometrial	ERC	endometrial	JJ	B-NP	OERC	","	ERC	NN	I-NP	O","	ERN	","	","	I-NP	OERN	","	ERN	NN	I-NP	B-protein","	PRC	","	","	I-NP	OPRC	and	PRC	NN	I-NP	B-proteinand	PRN	and	CC	I-NP	OPRN	affected	PRN	NN	I-NP	Oaffected	by	affect	VBN	B-VP	Oby	interferon	by	IN	B-PP	Ointerferon	administration	interferon	NN	B-NP	B-proteinadministration	.	administration	NN	I-NP	O.	As	.	.	O	OAs	expected	As	IN	B-SBAR	Oexpected	","	expect	VBN	B-VP	O","	interferon	","	","	O	Ointerferon	administration	interferon	NN	B-NP	Oadministration	resulted	administration	NN	I-NP	Oresulted	in	result	VBD	B-VP	Oin	decreased	in	IN	B-PP	Odecreased	leukocyte	decrease	VBN	B-NP	Oleukocyte	counts	leukocyte	NN	I-NP	Ocounts	.	count	NNS	I-NP	O.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	an	","	","	O	Oan	increasing	an	DT	B-NP	Oincreasing	tendency	increase	VBG	I-NP	Otendency	in	tendency	NN	I-NP	Oin	the	in	IN	B-PP	Othe	activities	the	DT	B-NP	Oactivities	of	activity	NNS	I-NP	Oof	serum	of	IN	B-PP	Oserum	alkaline	serum	NN	B-NP	B-proteinalkaline	phosphatase	alkaline	NN	I-NP	I-proteinphosphatase	and	phosphatase	NN	I-NP	I-proteinand	gamma-glutamyltransferase	and	CC	I-NP	Ogamma-glutamyltransferase	during	gamma-glutamyltransferase	NN	I-NP	B-proteinduring	the	during	IN	B-PP	Othe	interferon	the	DT	B-NP	Ointerferon	therapy	interferon	NN	I-NP	Otherapy	shows	therapy	NN	I-NP	Oshows	that	show	VBZ	B-VP	Othat	interferon	that	IN	B-SBAR	Ointerferon	may	interferon	NN	B-NP	B-proteinmay	slightly	may	MD	B-VP	Oslightly	interfere	slightly	RB	I-VP	Ointerfere	with	interfere	VB	I-VP	Owith	the	with	IN	B-PP	Othe	liver	the	DT	B-NP	Oliver	function	liver	NN	I-NP	Ofunction	.	function	NN	I-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	one	that	IN	B-SBAR	Oone	of	one	CD	B-NP	Oof	the	of	IN	B-PP	Othe	mechanisms	the	DT	B-NP	Omechanisms	by	mechanism	NNS	I-NP	Oby	which	by	IN	B-PP	Owhich	interferon	which	WDT	B-NP	Ointerferon	treatment	interferon	NN	B-NP	B-proteintreatment	may	treatment	NN	I-NP	Omay	affect	may	MD	B-VP	Oaffect	the	affect	VB	I-VP	Othe	growth	the	DT	B-NP	Ogrowth	of	growth	NN	I-NP	Oof	hormone-dependent	of	IN	B-PP	Ohormone-dependent	neoplasms	hormone-dependent	JJ	B-NP	Oneoplasms	could	neoplasm	NNS	I-NP	Ocould	be	could	MD	B-VP	Obe	the	be	VB	I-VP	Othe	interaction	the	DT	B-NP	Ointeraction	with	interaction	NN	I-NP	Owith	production	with	IN	B-PP	Oproduction	and/or	production	NN	B-NP	Oand/or	function	and/or	CC	I-NP	Ofunction	of	function	NN	I-NP	Oof	circulating	of	IN	B-PP	Ocirculating	hormonal	circulate	VBG	B-VP	Ohormonal	compounds	hormonal	JJ	B-NP	Ocompounds	.	compound	NNS	I-NP	O.	[	.	.	O	O[	Glucocorticoid	[	(	B-NP	OGlucocorticoid	receptor	Glucocorticoid	NN	I-NP	B-proteinreceptor	level	receptor	NN	I-NP	I-proteinlevel	in	level	NN	I-NP	Oin	the	in	IN	B-PP	Othe	blood	the	DT	B-NP	Oblood	leukocytes	blood	NN	I-NP	B-cell_typeleukocytes	in	leukocyte	NNS	I-NP	I-cell_typein	different	in	IN	B-PP	Odifferent	acute	different	JJ	B-NP	Oacute	diseases	acute	JJ	I-NP	Odiseases	]	disease	NNS	I-NP	O]	Content	]	)	O	OContent	of	Content	NN	B-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	cytosol	in	IN	B-PP	Ocytosol	of	cytosol	NN	B-NP	Oof	blood	of	IN	B-PP	Oblood	leukocytes	blood	NN	B-NP	B-cell_typeleukocytes	","	leukocyte	NNS	I-NP	I-cell_type","	concentration	","	","	O	Oconcentration	of	concentration	NN	B-NP	Oof	cortisol	of	IN	B-PP	Ocortisol	and	cortisol	NN	B-NP	Oand	amount	and	CC	I-NP	Oamount	of	amount	NN	I-NP	Oof	leukocytes	of	IN	B-PP	Oleukocytes	in	leukocyte	NNS	B-NP	B-cell_typein	blood	in	IN	B-PP	Oblood	were	blood	NN	B-NP	Owere	studied	be	VBD	B-VP	Ostudied	in	study	VBN	I-VP	Oin	20	in	IN	B-PP	O20	patients	20	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	acute	with	IN	B-PP	Oacute	impairments	acute	JJ	B-NP	Oimpairments	within	impairment	NNS	I-NP	Owithin	the	within	IN	B-PP	Othe	second	the	DT	B-NP	Osecond	day	second	JJ	I-NP	Oday	of	day	NN	I-NP	Oof	the	of	IN	B-PP	Othe	disease	the	DT	B-NP	Odisease	.	disease	NN	I-NP	O.	Content	.	.	O	OContent	of	Content	NN	B-NP	Oof	receptors	of	IN	B-PP	Oreceptors	in	receptor	NNS	B-NP	B-proteinin	cytosol	in	IN	B-PP	Ocytosol	of	cytosol	NN	B-NP	Oof	blood	of	IN	B-PP	Oblood	leukocytes	blood	NN	B-NP	B-cell_typeleukocytes	was	leukocyte	NNS	I-NP	I-cell_typewas	studied	be	VBD	B-VP	Ostudied	using	study	VBN	I-VP	Ousing	3H-triamcinolone	use	VBG	B-VP	O3H-triamcinolone	acetonide	3H-triamcinolone	JJ	B-NP	Oacetonide	.	acetonide	NN	I-NP	O.	Distinct	.	.	O	ODistinct	increase	Distinct	JJ	B-NP	Oincrease	in	increase	NN	I-NP	Oin	amount	in	IN	B-PP	Oamount	of	amount	NN	B-NP	Oof	the	of	IN	B-PP	Othe	leukocyte	the	DT	B-NP	Oleukocyte	glucocorticoid	leukocyte	NN	I-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	was	receptor	NNS	I-NP	I-proteinwas	found	be	VBD	B-VP	Ofound	in	find	VBN	I-VP	Oin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	poisoning	with	IN	B-PP	Opoisoning	by	poisoning	NN	B-NP	Oby	dichlorethane	by	IN	B-PP	Odichlorethane	and	dichlorethane	NN	B-NP	Oand	hypnotic	and	CC	O	Ohypnotic	drugs	hypnotic	JJ	B-NP	Odrugs	under	drug	NNS	I-NP	Ounder	conditions	under	IN	B-PP	Oconditions	of	condition	NNS	B-NP	Oof	acute	of	IN	B-PP	Oacute	myocardial	acute	JJ	B-NP	Omyocardial	infarction	myocardial	JJ	I-NP	Oinfarction	.	infarction	NN	I-NP	O.	In	.	.	O	OIn	acute	In	IN	B-PP	Oacute	pancreatitis	acute	JJ	B-NP	Opancreatitis	content	pancreatitis	NN	I-NP	Ocontent	of	content	NN	I-NP	Oof	the	of	IN	B-PP	Othe	leukocyte	the	DT	B-NP	Oleukocyte	receptors	leukocyte	NN	I-NP	B-proteinreceptors	was	receptor	NNS	I-NP	I-proteinwas	not	be	VBD	B-VP	Onot	altered	not	RB	I-VP	Oaltered	as	alter	VBN	I-VP	Oas	compared	as	IN	B-SBAR	Ocompared	with	compare	VBN	B-PP	Owith	controls	with	IN	B-PP	Ocontrols	.	control	NNS	B-NP	O.	Concentration	.	.	O	OConcentration	of	Concentration	NN	B-NP	Oof	endogenous	of	IN	B-PP	Oendogenous	cortisol	endogenous	JJ	B-NP	Ocortisol	was	cortisol	NN	I-NP	Owas	increased	be	VBD	B-VP	Oincreased	in	increase	VBN	I-VP	Oin	blood	in	IN	B-PP	Oblood	of	blood	NN	B-NP	Oof	all	of	IN	B-PP	Oall	the	all	PDT	B-NP	Othe	patients	the	DT	I-NP	Opatients	","	patient	NNS	I-NP	O","	except	","	","	O	Oexcept	of	except	IN	B-PP	Oof	the	of	IN	B-PP	Othe	cases	the	DT	B-NP	Ocases	of	case	NNS	I-NP	Oof	acetate	of	IN	B-PP	Oacetate	intoxication	acetate	NN	B-NP	Ointoxication	.	intoxication	NN	I-NP	O.	Reverse	.	.	O	OReverse	correlation	Reverse	JJ	B-NP	Ocorrelation	was	correlation	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	between	observe	VBN	I-VP	Obetween	concentration	between	IN	B-PP	Oconcentration	of	concentration	NN	B-NP	Oof	cortisol	of	IN	B-PP	Ocortisol	in	cortisol	NN	B-NP	Oin	blood	in	IN	B-PP	Oblood	and	blood	NN	B-NP	Oand	content	and	CC	I-NP	Ocontent	of	content	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	leukocytes	in	IN	B-PP	Oleukocytes	.	leukocyte	NNS	B-NP	B-cell_type.	But	.	.	O	OBut	in	But	CC	O	Oin	the	in	IN	B-PP	Othe	patients	the	DT	B-NP	Opatients	with	patient	NNS	I-NP	Owith	acute	with	IN	B-PP	Oacute	pancreatitis	acute	JJ	B-NP	Opancreatitis	the	pancreatitis	NN	I-NP	Othe	decrease	the	DT	B-NP	Odecrease	in	decrease	NN	I-NP	Oin	content	in	IN	B-PP	Ocontent	of	content	NN	B-NP	Oof	leukocyte	of	IN	B-PP	Oleukocyte	glucocorticoid	leukocyte	NN	B-NP	B-proteinglucocorticoid	receptors	glucocorticoid	NN	I-NP	I-proteinreceptors	was	receptor	NNS	I-NP	I-proteinwas	not	be	VBD	B-VP	Onot	observed	not	RB	I-VP	Oobserved	although	observe	VBN	I-VP	Oalthough	there	although	IN	B-SBAR	Othere	was	there	EX	B-NP	Owas	an	be	VBD	B-VP	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	cortisol	in	IN	B-PP	Ocortisol	concentration	cortisol	NN	B-NP	Oconcentration	in	concentration	NN	I-NP	Oin	blood	in	IN	B-PP	Oblood	.	blood	NN	B-NP	O.	The	.	.	O	OThe	role	The	DT	B-NP	Orole	of	role	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	immunological	in	IN	B-PP	Oimmunological	processes	immunological	JJ	B-NP	Oprocesses	under	process	NNS	I-NP	Ounder	conditions	under	IN	B-PP	Oconditions	of	condition	NNS	B-NP	Oof	purulent	of	IN	B-PP	Opurulent	complications	purulent	JJ	B-NP	Ocomplications	and	complication	NNS	I-NP	Oand	possibility	and	CC	O	Opossibility	to	possibility	NN	B-NP	Oto	regulate	to	TO	B-VP	Oregulate	the	regulate	VB	I-VP	Othe	metabolism	the	DT	B-NP	Ometabolism	in	metabolism	NN	I-NP	Oin	leukocytes	in	IN	B-PP	Oleukocytes	Therapeutic	leukocyte	NNS	B-NP	B-cell_typeTherapeutic	concentrations	Therapeutic	JJ	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	glucocorticoids	of	IN	B-PP	Oglucocorticoids	suppress	glucocorticoid	NNS	B-NP	Osuppress	the	suppress	VBP	B-VP	Othe	antimicrobial	the	DT	B-NP	Oantimicrobial	activity	antimicrobial	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	macrophages	human	JJ	B-NP	B-cell_typemacrophages	without	macrophage	NNS	I-NP	I-cell_typewithout	impairing	without	IN	B-PP	Oimpairing	their	impair	VBG	B-VP	Otheir	responsiveness	their	PRP$	B-NP	Oresponsiveness	to	responsiveness	NN	I-NP	Oto	gamma	to	TO	B-PP	Ogamma	interferon	gamma	NN	B-NP	B-proteininterferon	.	interferon	NN	I-NP	I-protein.	By	.	.	O	OBy	exposing	By	IN	B-PP	Oexposing	human	expose	VBG	B-VP	Ohuman	blood-derived	human	JJ	B-NP	B-cell_typeblood-derived	macrophages	blood-derived	JJ	I-NP	I-cell_typemacrophages	and	macrophage	NNS	I-NP	I-cell_typeand	alveolar	and	CC	O	Oalveolar	macrophages	alveolar	JJ	B-NP	B-cell_typemacrophages	in	macrophage	NNS	I-NP	I-cell_typein	vitro	in	FW	B-ADVP	Ovitro	to	vitro	FW	I-ADVP	Oto	dexamethasone	to	TO	B-PP	Odexamethasone	","	dexamethasone	NN	B-NP	O","	we	","	","	O	Owe	showed	we	PRP	B-NP	Oshowed	in	show	VBD	B-VP	Oin	these	in	IN	B-PP	Othese	studies	these	DT	B-NP	Ostudies	that	study	NNS	I-NP	Othat	glucocorticoids	that	IN	B-NP	Oglucocorticoids	markedly	glucocorticoid	NNS	B-NP	Omarkedly	suppress	markedly	RB	B-ADVP	Osuppress	the	suppress	VBP	B-VP	Othe	antimicrobial	the	DT	B-NP	Oantimicrobial	activity	antimicrobial	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	macrophages	of	IN	B-PP	Omacrophages	but	macrophage	NNS	B-NP	B-cell_typebut	not	but	CC	B-NP	Onot	macrophage	not	RB	I-NP	Omacrophage	activation	macrophage	NN	B-NP	Oactivation	by	activation	NN	I-NP	Oby	lymphokines	by	IN	B-PP	Olymphokines	.	lymphokine	NNS	B-NP	B-protein.	As	.	.	O	OAs	little	As	RB	B-NP	Olittle	as	little	JJ	I-NP	Oas	2.5	as	IN	I-NP	O2.5	X	2.5	CD	I-NP	OX	10	X	SYM	I-NP	O10	(	10	CD	I-NP	O(	-8	(	(	O	O-8	)	-8	CD	B-NP	O)	mol/liter	)	)	O	Omol/liter	of	mol/liter	NN	B-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	prevented	dexamethasone	NN	B-NP	Oprevented	macrophages	prevent	VBD	B-VP	Omacrophages	from	macrophage	NNS	B-NP	B-cell_typefrom	inhibiting	from	IN	B-PP	Oinhibiting	germination	inhibit	VBG	B-VP	Ogermination	of	germination	NN	B-NP	Oof	Aspergillus	of	IN	B-PP	OAspergillus	spores	Aspergillus	NN	B-NP	Ospores	or	spore	NNS	I-NP	Oor	from	or	CC	B-PP	Ofrom	eliminating	from	IN	B-PP	Oeliminating	ingested	eliminate	VBG	B-VP	Oingested	bacteria	ingest	VBN	B-NP	Obacteria	such	bacteria	NNS	I-NP	Osuch	as	such	JJ	B-PP	Oas	Listeria	as	IN	I-PP	OListeria	","	Listeria	NNP	B-NP	O","	Nocardia	","	","	O	ONocardia	","	Nocardia	NNP	B-NP	O","	or	","	","	O	Oor	Salmonella	or	CC	O	OSalmonella	.	Salmonella	NNP	B-NP	O.	Damage	.	.	O	ODamage	to	Damage	NN	B-NP	Oto	macrophage	to	TO	B-PP	Omacrophage	function	macrophage	NN	B-NP	Ofunction	was	function	NN	I-NP	Owas	inhibited	be	VBD	B-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	progesterone	by	IN	B-PP	Oprogesterone	and	progesterone	NN	B-NP	Oand	appeared	and	CC	O	Oappeared	to	appear	VBD	B-VP	Oto	be	to	TO	I-VP	Obe	receptor-mediated	be	VB	I-VP	Oreceptor-mediated	.	receptor-mediated	JJ	B-ADJP	O.	In	.	.	O	OIn	accordance	In	IN	B-PP	Oaccordance	with	accordance	NN	B-NP	Owith	in	with	IN	B-PP	Oin	vivo	in	FW	B-NP	Ovivo	observations	vivo	FW	I-NP	Oobservations	","	observation	NNS	I-NP	O","	dexamethasone	","	","	O	Odexamethasone	required	dexamethasone	NN	B-NP	Orequired	24-36	require	VBD	B-VP	O24-36	h	24-36	CD	B-NP	Oh	to	h	NN	I-NP	Oto	suppress	to	TO	B-VP	Osuppress	antimicrobial	suppress	VB	I-VP	Oantimicrobial	activity	antimicrobial	JJ	B-NP	Oactivity	.	activity	NN	I-NP	O.	While	.	.	O	OWhile	glucocorticoids	While	IN	B-SBAR	Oglucocorticoids	interfered	glucocorticoid	NNS	B-NP	Ointerfered	with	interfere	VBD	B-VP	Owith	base-line	with	IN	B-PP	Obase-line	activity	base-line	NN	B-NP	Oactivity	of	activity	NN	I-NP	Oof	macrophages	of	IN	B-PP	Omacrophages	","	macrophage	NNS	B-NP	B-cell_type","	dexamethasone	","	","	O	Odexamethasone	concentrations	dexamethasone	NN	B-NP	Oconcentrations	comparable	concentration	NNS	I-NP	Ocomparable	to	comparable	JJ	B-ADJP	Oto	drug	to	TO	B-PP	Odrug	levels	drug	NN	B-NP	Olevels	in	level	NNS	I-NP	Oin	patients	in	IN	B-PP	Opatients	had	patient	NNS	B-NP	Ohad	no	have	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	on	effect	NN	I-NP	Oon	macrophage	on	IN	B-PP	Omacrophage	activation	macrophage	NN	B-NP	B-cell_typeactivation	.	activation	NN	I-NP	O.	Proliferating	.	.	O	OProliferating	lymphocytes	Proliferate	VBG	B-NP	B-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	gamma-interferon	and	CC	O	Ogamma-interferon	thus	gamma-interferon	NN	B-NP	B-proteinthus	increased	thus	RB	B-ADVP	Oincreased	the	increase	VBD	B-VP	Othe	antimicrobial	the	DT	B-NP	Oantimicrobial	activity	antimicrobial	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	phagocytes	of	IN	B-PP	Ophagocytes	exposed	phagocyte	NNS	B-NP	B-cell_typeexposed	to	expose	VBN	B-VP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	over	glucocorticoid	NNS	B-NP	Oover	that	over	IN	B-PP	Othat	of	that	DT	B-NP	Oof	control	of	IN	B-PP	Ocontrol	cells	control	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Macrophage	.	.	O	OMacrophage	activation	Macrophage	NN	B-NP	Oactivation	and	activation	NN	I-NP	Oand	correction	and	CC	O	Ocorrection	of	correction	NN	B-NP	Oof	the	of	IN	B-PP	Othe	dexamethasone	the	DT	B-NP	Odexamethasone	effect	dexamethasone	NN	I-NP	Oeffect	by	effect	NN	I-NP	Oby	gamma-interferon	by	IN	B-PP	Ogamma-interferon	","	gamma-interferon	NN	B-NP	B-protein","	however	","	","	O	Ohowever	","	however	RB	B-ADVP	O","	was	","	","	O	Owas	dependent	be	VBD	B-VP	Odependent	on	dependent	JJ	B-ADJP	Oon	the	on	IN	B-PP	Othe	pathogen	the	DT	B-NP	Opathogen	.	pathogen	NN	I-NP	O.	The	.	.	O	OThe	lymphokine	The	DT	B-NP	Olymphokine	enhanced	lymphokine	NN	I-NP	B-proteinenhanced	the	enhance	VBD	B-VP	Othe	antimicrobial	the	DT	B-NP	Oantimicrobial	activity	antimicrobial	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	dexamethasone-treated	of	IN	B-PP	Odexamethasone-treated	macrophages	dexamethasone-treated	JJ	B-NP	B-cell_typemacrophages	against	macrophage	NNS	I-NP	I-cell_typeagainst	Listeria	against	IN	B-PP	OListeria	and	Listeria	NNP	B-NP	Oand	Salmonella	and	CC	I-NP	OSalmonella	but	Salmonella	NNP	I-NP	Obut	not	but	CC	B-PP	Onot	against	not	RB	B-NP	Oagainst	Aspergillus	against	IN	B-PP	OAspergillus	or	Aspergillus	NNP	B-NP	Oor	Nocardia	or	CC	I-NP	ONocardia	.	Nocardia	NNP	I-NP	O.	Dexamethasone-induced	.	.	O	ODexamethasone-induced	damage	Dexamethasone-induced	JJ	B-NP	Odamage	to	damage	NN	I-NP	Oto	the	to	TO	B-PP	Othe	antimicrobial	the	DT	B-NP	Oantimicrobial	activity	antimicrobial	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	macrophages	human	JJ	B-NP	B-cell_typemacrophages	in	macrophage	NNS	I-NP	I-cell_typein	vitro	in	FW	B-NP	Ovitro	parallels	vitro	FW	I-NP	Oparallels	observations	parallel	NNS	I-NP	Oobservations	that	observation	NNS	I-NP	Othat	glucocorticoids	that	IN	B-NP	Oglucocorticoids	render	glucocorticoid	NNS	B-NP	Orender	laboratory	render	VBP	B-VP	Olaboratory	animals	laboratory	NN	B-NP	Oanimals	susceptible	animal	NNS	I-NP	Osusceptible	to	susceptible	JJ	B-ADJP	Oto	listeriosis	to	TO	B-PP	Olisteriosis	and	listeriosis	NN	B-NP	Oand	aspergillosis	and	CC	I-NP	Oaspergillosis	by	aspergillosis	NN	I-NP	Oby	damaging	by	IN	B-PP	Odamaging	resident	damage	VBG	B-VP	B-cell_typeresident	macrophages	resident	JJ	B-NP	I-cell_typemacrophages	.	macrophage	NNS	I-NP	I-cell_type.	Suppression	.	.	O	OSuppression	of	Suppression	NN	B-NP	Oof	macrophage	of	IN	B-PP	Omacrophage	antimicrobial	macrophage	NN	B-NP	Oantimicrobial	activity	antimicrobial	JJ	I-NP	Oactivity	should	activity	NN	I-NP	Oshould	thus	should	MD	B-VP	Othus	be	thus	RB	I-VP	Obe	considered	be	VB	I-VP	Oconsidered	when	consider	VBN	I-VP	Owhen	treating	when	WRB	B-ADVP	Otreating	patients	treat	VBG	B-VP	Opatients	with	patient	NNS	B-NP	Owith	glucocorticoids	with	IN	B-PP	Oglucocorticoids	;	glucocorticoid	NNS	B-NP	O;	its	;	:	O	Oits	prevention	its	PRP$	B-NP	Oprevention	by	prevention	NN	I-NP	Oby	gamma-interferon	by	IN	B-PP	Ogamma-interferon	might	gamma-interferon	NN	B-NP	B-proteinmight	be	might	MD	B-VP	Obe	beneficial	be	VB	I-VP	Obeneficial	for	beneficial	JJ	B-ADJP	Ofor	some	for	IN	B-PP	Osome	but	some	DT	B-NP	Obut	not	but	CC	I-NP	Onot	all	not	RB	I-NP	Oall	pathogens	all	DT	B-NP	Opathogens	.	pathogen	NNS	I-NP	O.	Interleukin	.	.	O	OInterleukin	2	Interleukin	NN	B-NP	B-protein2	receptor	2	CD	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	Tac	(	(	O	OTac	antigen	Tac	NN	B-NP	B-proteinantigen	)	antigen	NN	I-NP	I-protein)	expression	)	)	O	Oexpression	in	expression	NN	B-NP	Oin	HTLV-I-associated	in	IN	B-PP	OHTLV-I-associated	adult	HTLV-I-associated	JJ	B-NP	Oadult	T-cell	adult	JJ	I-NP	OT-cell	leukemia	T-cell	NN	I-NP	Oleukemia	.	leukemia	NN	I-NP	O.	Interleukin-2	.	.	O	OInterleukin-2	(	Interleukin-2	NN	B-NP	B-protein(	IL-2	(	(	O	OIL-2	)	IL-2	NN	B-NP	B-protein)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	lymphokine	a	DT	B-NP	Olymphokine	synthesized	lymphokine	NN	I-NP	B-proteinsynthesized	by	synthesize	VBN	B-VP	Oby	some	by	IN	B-PP	Osome	T-cells	some	DT	B-NP	OT-cells	following	T-cell	NNS	I-NP	B-cell_typefollowing	activation	follow	VBG	B-PP	Oactivation	.	activation	NN	B-NP	O.	Resting	.	.	O	OResting	T-cells	Rest	VBG	B-NP	B-cell_typeT-cells	do	T-cell	NNS	I-NP	I-cell_typedo	not	do	VBP	B-VP	Onot	express	not	RB	I-VP	Oexpress	IL-2	express	VB	I-VP	OIL-2	receptors	IL-2	NN	B-NP	B-proteinreceptors	","	receptor	NNS	I-NP	I-protein","	but	","	","	O	Obut	receptors	but	CC	O	Oreceptors	are	receptor	NNS	B-NP	Oare	rapidly	be	VBP	B-VP	Orapidly	expressed	rapidly	RB	I-VP	Oexpressed	on	express	VBN	I-VP	Oon	T-cells	on	IN	B-PP	OT-cells	following	T-cell	NNS	B-NP	B-cell_typefollowing	interaction	follow	VBG	B-PP	Ointeraction	of	interaction	NN	B-NP	Oof	antigens	of	IN	B-PP	Oantigens	","	antigen	NNS	B-NP	B-protein","	mitogens	","	","	O	Omitogens	","	mitogen	NNS	B-NP	B-protein","	or	","	","	O	Oor	monoclonal	or	CC	O	Omonoclonal	antibodies	monoclonal	JJ	B-NP	B-proteinantibodies	with	antibody	NNS	I-NP	I-proteinwith	the	with	IN	B-PP	Othe	antigen-specific	the	DT	B-NP	Oantigen-specific	T-cell	antigen-specific	JJ	I-NP	B-proteinT-cell	receptor	T-cell	NN	I-NP	I-proteinreceptor	complex	receptor	NN	I-NP	I-proteincomplex	.	complex	NN	I-NP	I-protein.	Using	.	.	O	OUsing	anti-Tac	Use	VBG	B-VP	Oanti-Tac	","	anti-Tac	JJ	B-ADJP	O","	a	","	","	O	Oa	monoclonal	a	DT	B-NP	Omonoclonal	antibody	monoclonal	JJ	I-NP	B-proteinantibody	that	antibody	NN	I-NP	I-proteinthat	recognizes	that	WDT	B-NP	Orecognizes	the	recognize	VBZ	B-VP	Othe	IL-2	the	DT	B-NP	OIL-2	receptor	IL-2	NN	I-NP	B-proteinreceptor	","	receptor	NN	I-NP	I-protein","	the	","	","	O	Othe	receptor	the	DT	B-NP	Oreceptor	has	receptor	NN	I-NP	Ohas	been	have	VBZ	B-VP	Obeen	purified	be	VBN	I-VP	Opurified	and	purify	VBN	I-VP	Oand	shown	and	CC	O	Oshown	to	show	VBN	B-VP	Oto	be	to	TO	I-VP	Obe	a	be	VB	I-VP	Oa	Mr	a	DT	B-NP	OMr	33	Mr	NN	I-NP	O33	","	33	CD	I-NP	O","	0	","	","	I-NP	O0	peptide	0	CD	I-NP	Opeptide	that	peptide	NN	I-NP	Othat	is	that	WDT	B-NP	Ois	posttranslationally	be	VBZ	B-VP	Oposttranslationally	glycosylated	posttranslationally	RB	I-VP	Oglycosylated	to	glycosylate	VBN	I-VP	Oto	a	to	TO	B-PP	Oa	Mr	a	DT	B-NP	OMr	55	Mr	NN	I-NP	B-protein55	","	55	CD	I-NP	I-protein","	0	","	","	I-NP	I-protein0	mature	0	CD	I-NP	I-proteinmature	form	mature	JJ	I-NP	I-proteinform	.	form	NN	I-NP	I-protein.	Normal	.	.	O	ONormal	resting	Normal	JJ	B-NP	B-cell_typeresting	T-cells	rest	VBG	I-NP	I-cell_typeT-cells	and	T-cell	NNS	I-NP	I-cell_typeand	most	and	CC	O	Omost	leukemic	most	RBS	B-NP	Oleukemic	T-cell	leukemic	JJ	I-NP	B-cell_typeT-cell	populations	T-cell	NN	I-NP	I-cell_typepopulations	do	population	NNS	I-NP	I-cell_typedo	not	do	VBP	B-VP	Onot	express	not	RB	I-VP	Oexpress	IL-2	express	VB	I-VP	OIL-2	receptors	IL-2	NN	B-NP	B-proteinreceptors	;	receptor	NNS	I-NP	I-protein;	however	;	:	O	Ohowever	","	however	RB	B-ADVP	O","	the	","	","	O	Othe	leukemic	the	DT	B-NP	Oleukemic	cells	leukemic	JJ	I-NP	B-cell_typecells	of	cell	NNS	I-NP	I-cell_typeof	the	of	IN	B-PP	Othe	11	the	DT	B-NP	O11	patients	11	CD	I-NP	Opatients	examined	patient	NNS	I-NP	Oexamined	who	examine	VBN	B-VP	Owho	had	who	WP	B-NP	Ohad	human	have	VBD	B-VP	Ohuman	T-cell	human	JJ	B-NP	OT-cell	lymphotropic	T-cell	NN	I-NP	Olymphotropic	virus-associated	lymphotropic	JJ	I-NP	Ovirus-associated	adult	virus-associated	JJ	I-NP	Oadult	T-cell	adult	JJ	I-NP	OT-cell	leukemia	T-cell	NN	I-NP	Oleukemia	expressed	leukemia	NN	I-NP	Oexpressed	the	express	VBD	B-VP	Othe	Tac	the	DT	B-NP	OTac	antigen	Tac	NNP	I-NP	B-proteinantigen	.	antigen	NN	I-NP	I-protein.	In	.	.	O	OIn	human	In	IN	B-PP	Ohuman	T-cell	human	JJ	B-NP	B-cell_typeT-cell	lymphotropic	T-cell	NN	I-NP	I-cell_typelymphotropic	virus-I	lymphotropic	JJ	I-NP	I-cell_typevirus-I	infected	virus-I	NN	I-NP	I-cell_typeinfected	cells	infected	JJ	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	the	","	","	O	Othe	Mr	the	DT	B-NP	OMr	42	Mr	NN	I-NP	B-protein42	","	42	CD	I-NP	I-protein","	0	","	","	I-NP	I-protein0	long	0	CD	I-NP	I-proteinlong	open	long	JJ	I-NP	I-proteinopen	reading	open	JJ	I-NP	I-proteinreading	frame	reading	NN	I-NP	I-proteinframe	protein	frame	NN	I-NP	I-proteinprotein	encoded	protein	NN	I-NP	I-proteinencoded	in	encode	VBN	B-VP	Oin	part	in	IN	B-PP	Opart	by	part	NN	B-NP	Oby	the	by	IN	B-PP	Othe	pX	the	DT	B-NP	OpX	region	pX	NN	I-NP	B-DNAregion	of	region	NN	I-NP	I-DNAof	this	of	IN	B-PP	Othis	virus	this	DT	B-NP	Ovirus	may	virus	NN	I-NP	Omay	act	may	MD	B-VP	Oact	as	act	VB	I-VP	Oas	a	as	IN	B-PP	Oa	transacting	a	DT	B-NP	Otransacting	transcriptional	transact	VBG	I-NP	Otranscriptional	activator	transcriptional	JJ	I-NP	B-proteinactivator	that	activator	NN	I-NP	I-proteinthat	induces	that	WDT	B-NP	Oinduces	IL-2	induce	VBZ	B-VP	OIL-2	receptor	IL-2	NN	B-NP	B-DNAreceptor	gene	receptor	NN	I-NP	I-DNAgene	transcription	gene	NN	I-NP	I-DNAtranscription	","	transcription	NN	I-NP	O","	thus	","	","	O	Othus	providing	thus	RB	B-ADVP	Oproviding	an	provide	VBG	B-VP	Oan	explanation	an	DT	B-NP	Oexplanation	for	explanation	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	constant	the	DT	B-NP	Oconstant	association	constant	JJ	I-NP	Oassociation	of	association	NN	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	receptor	IL-2	NN	B-NP	B-proteinreceptor	expression	receptor	NN	I-NP	I-proteinexpression	with	expression	NN	I-NP	Owith	adult	with	IN	B-PP	Oadult	T-cell	adult	JJ	B-NP	OT-cell	lymphotropic	T-cell	NN	I-NP	Olymphotropic	virus-I	lymphotropic	JJ	I-NP	Ovirus-I	infection	virus-I	NN	I-NP	Oinfection	of	infection	NN	I-NP	Oof	lymphoid	of	IN	B-PP	Olymphoid	cells	lymphoid	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	constant	The	DT	B-NP	Oconstant	expression	constant	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	large	of	IN	B-PP	Olarge	numbers	large	JJ	B-NP	Onumbers	of	number	NNS	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	receptors	IL-2	NN	B-NP	B-proteinreceptors	which	receptor	NNS	I-NP	I-proteinwhich	may	which	WDT	B-NP	Omay	be	may	MD	B-VP	Obe	aberrant	be	VB	I-VP	Oaberrant	may	aberrant	JJ	B-ADJP	Omay	play	may	MD	B-VP	Oplay	a	play	VB	I-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	uncontrolled	the	DT	B-NP	Ouncontrolled	growth	uncontrolled	JJ	I-NP	Ogrowth	of	growth	NN	I-NP	Oof	adult	of	IN	B-PP	Oadult	T-cell	adult	JJ	B-NP	B-cell_typeT-cell	leukemia	T-cell	NN	I-NP	I-cell_typeleukemia	cells	leukemia	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Two	.	.	O	OTwo	patients	Two	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	Tac-positive	with	IN	B-PP	OTac-positive	adult	Tac-positive	JJ	B-NP	Oadult	T-cell	adult	JJ	I-NP	OT-cell	leukemia	T-cell	NN	I-NP	Oleukemia	have	leukemia	NN	I-NP	Ohave	been	have	VBP	B-VP	Obeen	treated	be	VBN	I-VP	Otreated	with	treat	VBN	I-VP	Owith	the	with	IN	B-PP	Othe	anti-Tac	the	DT	B-NP	Oanti-Tac	.	anti-Tac	NN	I-NP	B-protein.	One	.	.	O	OOne	of	One	CD	B-NP	Oof	the	of	IN	B-PP	Othe	patients	the	DT	B-NP	Opatients	had	patient	NNS	I-NP	Ohad	6-	have	VBD	B-VP	O6-	and	6-	CD	B-NP	Oand	3-mo	and	CC	O	O3-mo	remissions	3-mo	JJ	B-NP	Oremissions	of	remission	NNS	I-NP	Oof	his	of	IN	B-PP	Ohis	leukemia	his	PRP$	B-NP	Oleukemia	following	leukemia	NN	I-NP	Ofollowing	two	follow	VBG	B-PP	Otwo	courses	two	CD	B-NP	Ocourses	of	course	NNS	I-NP	Oof	therapy	of	IN	B-PP	Otherapy	with	therapy	NN	B-NP	Owith	this	with	IN	B-PP	Othis	monoclonal	this	DT	B-NP	Omonoclonal	antibody	monoclonal	JJ	I-NP	B-proteinantibody	directed	antibody	NN	I-NP	I-proteindirected	toward	direct	VBN	B-VP	Otoward	this	toward	IN	B-PP	Othis	growth	this	DT	B-NP	Ogrowth	factor	growth	NN	I-NP	B-proteinfactor	receptor	factor	NN	I-NP	I-proteinreceptor	.	receptor	NN	I-NP	I-protein.	Lymphocyte	.	.	O	OLymphocyte	glucocorticoid	Lymphocyte	NN	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	binding	receptor	NN	I-NP	I-proteinbinding	in	binding	NN	I-NP	Oin	depressed	in	IN	B-PP	Odepressed	patients	depressed	JJ	B-NP	Opatients	with	patient	NNS	I-NP	Owith	hypercortisolemia	with	IN	B-PP	Ohypercortisolemia	.	hypercortisolemia	NN	B-NP	O.	Despite	.	.	O	ODespite	elevated	Despite	IN	B-PP	Oelevated	levels	elevate	VBN	B-NP	Olevels	of	level	NNS	I-NP	Oof	serum	of	IN	B-PP	Oserum	and	serum	NN	B-NP	Oand	urinary	and	CC	O	Ourinary	cortisol	urinary	JJ	B-NP	Ocortisol	","	cortisol	NN	I-NP	O","	patients	","	","	O	Opatients	with	patient	NNS	B-NP	Owith	depressive	with	IN	B-PP	Odepressive	illness	depressive	JJ	B-NP	Oillness	manifest	illness	NN	I-NP	Omanifest	none	manifest	NN	I-NP	Onone	of	none	NN	I-NP	Oof	the	of	IN	B-PP	Othe	clinical	the	DT	B-NP	Oclinical	stigmata	clinical	JJ	I-NP	Ostigmata	of	stigmata	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	excess	glucocorticoid	NN	B-NP	Oexcess	.	excess	NN	I-NP	O.	This	.	.	O	OThis	hypercortisolemia	This	DT	B-NP	Ohypercortisolemia	in	hypercortisolemia	NN	I-NP	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	clinical	of	IN	B-PP	Oclinical	effects	clinical	JJ	B-NP	Oeffects	suggests	effect	NNS	I-NP	Osuggests	a	suggest	VBZ	B-VP	Oa	state	a	DT	B-NP	Ostate	of	state	NN	I-NP	Oof	hormone	of	IN	B-PP	Ohormone	resistance	hormone	NN	B-NP	Oresistance	and	resistance	NN	I-NP	Oand	could	and	CC	O	Ocould	be	could	MD	B-VP	Obe	mediated	be	VB	I-VP	Omediated	by	mediate	VBN	I-VP	Oby	alterations	by	IN	B-PP	Oalterations	in	alteration	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	.	receptor	NN	I-NP	I-protein.	Earlier	.	.	O	OEarlier	studies	Early	JJR	B-NP	Ostudies	have	study	NNS	I-NP	Ohave	shown	have	VBP	B-VP	Oshown	that	show	VBN	I-VP	Othat	small	that	IN	B-SBAR	Osmall	doses	small	JJ	B-NP	Odoses	of	dose	NNS	I-NP	Oof	glucocorticoids	of	IN	B-PP	Oglucocorticoids	cause	glucocorticoid	NNS	B-NP	Ocause	a	cause	VBP	B-VP	Oa	decrease	a	DT	B-NP	Odecrease	in	decrease	NN	I-NP	Oin	glucocorticoid	in	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	binding	receptor	NN	I-NP	I-proteinbinding	in	binding	NN	I-NP	Oin	normal	in	IN	B-PP	Onormal	human	normal	JJ	B-NP	B-cell_typehuman	lymphocytes	human	JJ	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	White	.	.	O	OWhite	cells	White	JJ	B-NP	B-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	depressed	from	IN	B-PP	Odepressed	patients	depressed	JJ	B-NP	Opatients	with	patient	NNS	I-NP	Owith	significant	with	IN	B-PP	Osignificant	hypercortisolemia	significant	JJ	B-NP	Ohypercortisolemia	would	hypercortisolemia	NN	I-NP	Owould	be	would	MD	B-VP	Obe	expected	be	VB	I-VP	Oexpected	to	expect	VBN	I-VP	Oto	show	to	TO	I-VP	Oshow	a	show	VB	I-VP	Oa	similar	a	DT	B-NP	Osimilar	change	similar	JJ	I-NP	Ochange	in	change	NN	I-NP	Oin	receptor	in	IN	B-PP	Oreceptor	concentration	receptor	NN	B-NP	Oconcentration	if	concentration	NN	I-NP	Oif	peripheral	if	IN	B-SBAR	Operipheral	tissues	peripheral	JJ	B-NP	Otissues	are	tissue	NNS	I-NP	Oare	adequately	be	VBP	B-VP	Oadequately	exposed	adequately	RB	I-VP	Oexposed	to	expose	VBN	I-VP	Oto	and	to	TO	B-PP	Oand	sensitive	and	CC	O	Osensitive	to	sensitive	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	hormone	the	DT	B-NP	Ohormone	.	hormone	NN	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	we	study	NN	I-NP	Owe	compared	we	PRP	B-NP	Ocompared	the	compare	VBD	B-VP	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	dexamethasone	]	)	I-NP	Odexamethasone	to	dexamethasone	NN	I-NP	Oto	lymphocytes	to	TO	B-PP	Olymphocytes	from	lymphocyte	NNS	B-NP	B-cell_typefrom	normal	from	IN	B-PP	Onormal	subjects	normal	JJ	B-NP	Osubjects	and	subject	NNS	I-NP	Oand	depressed	and	CC	O	Odepressed	patients	depressed	JJ	B-NP	Opatients	with	patient	NNS	I-NP	Owith	hypercortisolemia	with	IN	B-PP	Ohypercortisolemia	.	hypercortisolemia	NN	B-NP	O.	Lymphocytes	.	.	O	OLymphocytes	from	Lymphocyte	NNS	B-NP	B-cell_typefrom	normal	from	IN	B-PP	Onormal	subjects	normal	JJ	B-NP	Osubjects	had	subject	NNS	I-NP	Ohad	a	have	VBD	B-VP	Oa	mean	a	DT	B-NP	Omean	receptor	mean	JJ	I-NP	Oreceptor	concentration	receptor	NN	I-NP	Oconcentration	of	concentration	NN	I-NP	Oof	10.2	of	IN	B-PP	O10.2	+/-	10.2	CD	B-NP	O+/-	0.66	+/-	SYM	I-NP	O0.66	fm/10	0.66	CD	I-NP	Ofm/10	(	fm/10	NN	I-NP	O(	6	(	(	O	O6	)	6	CD	B-NP	O)	cells	)	)	O	Ocells	(	cell	NNS	B-NP	O(	S.E.M.	(	(	O	OS.E.M.	)	S.E.M.	NN	B-NP	B-protein)	and	)	)	O	Oand	a	and	CC	O	Oa	dissociation	a	DT	B-NP	Odissociation	constant	dissociation	NN	I-NP	Oconstant	of	constant	NN	I-NP	Oof	4.8	of	IN	B-PP	O4.8	+/-	4.8	CD	B-NP	O+/-	0.47	+/-	SYM	I-NP	O0.47	nM	0.47	CD	I-NP	OnM	.	nM	NN	I-NP	O.	Lymphocytes	.	.	O	OLymphocytes	from	Lymphocyte	NNS	B-NP	B-cell_typefrom	depressed	from	IN	B-PP	Odepressed	patients	depressed	JJ	B-NP	Opatients	with	patient	NNS	I-NP	Owith	abnormal	with	IN	B-PP	Oabnormal	800	abnormal	JJ	B-NP	O800	h	800	CD	I-NP	Oh	serum	h	NN	I-NP	Oserum	cortisol	serum	NN	I-NP	Ocortisol	after	cortisol	NN	I-NP	Oafter	dexamethasone	after	IN	B-SBAR	Odexamethasone	had	dexamethasone	NN	B-NP	Ohad	a	have	VBD	B-VP	Oa	mean	a	DT	B-NP	Omean	receptor	mean	JJ	I-NP	Oreceptor	concentration	receptor	NN	I-NP	Oconcentration	of	concentration	NN	I-NP	Oof	8.8	of	IN	B-PP	O8.8	+/-	8.8	CD	B-NP	O+/-	0.75	+/-	SYM	I-NP	O0.75	fm/10	0.75	CD	I-NP	Ofm/10	(	fm/10	NN	I-NP	O(	6	(	(	O	O6	)	6	CD	B-NP	O)	cells	)	)	O	Ocells	","	cell	NNS	B-NP	O","	which	","	","	O	Owhich	was	which	WDT	B-NP	Owas	not	be	VBD	B-VP	Onot	significantly	not	RB	O	Osignificantly	different	significantly	RB	B-ADJP	Odifferent	from	different	JJ	I-ADJP	Ofrom	that	from	IN	B-PP	Othat	in	that	DT	B-NP	Oin	lymphocytes	in	IN	B-PP	Olymphocytes	from	lymphocyte	NNS	B-NP	B-cell_typefrom	normal	from	IN	B-PP	Onormal	subjects	normal	JJ	B-NP	Osubjects	or	subject	NNS	I-NP	Oor	from	or	CC	B-PP	Ofrom	depressed	from	IN	B-PP	Odepressed	subjects	depressed	JJ	B-NP	Osubjects	with	subject	NNS	I-NP	Owith	normal	with	IN	B-PP	Onormal	post-dexamethasone	normal	JJ	B-NP	Opost-dexamethasone	cortisol	post-dexamethasone	JJ	I-NP	Ocortisol	levels	cortisol	NN	I-NP	Olevels	(	level	NNS	I-NP	O(	9.4	(	(	O	O9.4	+/-	9.4	CD	B-NP	O+/-	0.95	+/-	SYM	I-NP	O0.95	fm/10	0.95	CD	I-NP	Ofm/10	(	fm/10	NN	I-NP	O(	6	(	(	O	O6	)	6	CD	B-NP	O)	cells	)	)	I-NP	Ocells	)	cell	NNS	I-NP	O)	.	)	)	O	O.	Lymphocytes	.	.	O	OLymphocytes	from	Lymphocyte	NNS	B-NP	B-cell_typefrom	depressed	from	IN	B-PP	Odepressed	patients	depressed	JJ	B-NP	Opatients	with	patient	NNS	I-NP	Owith	elevated	with	IN	B-PP	Oelevated	urinary	elevated	JJ	B-NP	Ourinary	free	urinary	JJ	I-NP	Ofree	cortisol	free	JJ	I-NP	Ocortisol	excretion	cortisol	NN	I-NP	Oexcretion	(	excretion	NN	I-NP	O(	UFC	(	(	O	OUFC	)	UFC	NN	B-NP	O)	also	)	)	O	Oalso	had	also	RB	B-ADVP	Ohad	normal	have	VBD	B-VP	Onormal	receptor	normal	JJ	B-NP	Oreceptor	concentration	receptor	NN	I-NP	Oconcentration	and	concentration	NN	I-NP	Oand	binding	and	CC	O	Obinding	affinity	binding	NN	B-NP	Oaffinity	for	affinity	NN	I-NP	Ofor	dexamethasone	for	IN	B-PP	Odexamethasone	.	dexamethasone	NN	B-NP	O.	The	.	.	O	OThe	lack	The	DT	B-NP	Olack	of	lack	NN	I-NP	Oof	a	of	IN	B-PP	Oa	change	a	DT	B-NP	Ochange	in	change	NN	I-NP	Oin	lymphocyte	in	IN	B-PP	Olymphocyte	glucocorticoid	lymphocyte	NN	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	concentration	receptor	NN	I-NP	I-proteinconcentration	in	concentration	NN	I-NP	Oin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	cortisol	of	IN	B-PP	Ocortisol	excess	cortisol	NN	B-NP	Oexcess	suggests	excess	NN	I-NP	Osuggests	the	suggest	VBZ	B-VP	Othe	possibility	the	DT	B-NP	Opossibility	that	possibility	NN	I-NP	Othat	hypercortisolemia	that	IN	B-SBAR	Ohypercortisolemia	in	hypercortisolemia	NN	B-NP	Oin	depressive	in	IN	B-PP	Odepressive	illness	depressive	JJ	B-NP	Oillness	represents	illness	NN	I-NP	Orepresents	a	represent	VBZ	B-VP	Oa	state	a	DT	B-NP	Ostate	of	state	NN	I-NP	Oof	peripheral	of	IN	B-PP	Operipheral	glucocorticoid	peripheral	JJ	B-NP	Oglucocorticoid	resistance	glucocorticoid	NN	I-NP	Oresistance	.	resistance	NN	I-NP	O.	Structure	.	.	O	OStructure	and	Structure	NN	B-NP	Oand	regulation	and	CC	I-NP	Oregulation	of	regulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	hormone	glucocorticoid	NN	I-NP	B-proteinhormone	receptor	hormone	NN	I-NP	I-proteinreceptor	.	receptor	NN	I-NP	I-protein.	The	.	.	O	OThe	glucocorticoid	The	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	is	receptor	NN	I-NP	I-proteinis	an	be	VBZ	B-VP	Oan	intracellular	an	DT	B-NP	Ointracellular	protein	intracellular	JJ	I-NP	B-proteinprotein	which	protein	NN	I-NP	I-proteinwhich	possesses	which	WDT	B-NP	Opossesses	three	possess	VBZ	B-VP	Othree	distinct	three	CD	B-NP	Odistinct	domains	distinct	JJ	I-NP	Odomains	","	domain	NNS	I-NP	O","	one	","	","	O	Oone	that	one	CD	B-NP	Othat	binds	that	WDT	B-NP	Obinds	agonist	bind	VBZ	B-VP	Oagonist	and	agonist	NN	B-NP	Oand	antagonist	and	CC	I-NP	Oantagonist	steroids	antagonist	NN	I-NP	Osteroids	","	steroid	NNS	I-NP	O","	one	","	","	O	Oone	that	one	CD	B-NP	Othat	binds	that	WDT	B-NP	Obinds	DNA	bind	VBZ	B-VP	ODNA	","	DNA	NN	B-NP	O","	and	","	","	O	Oand	one	and	CC	O	Oone	that	one	CD	B-NP	Othat	binds	that	WDT	B-NP	Obinds	anti-receptor	bind	VBZ	B-VP	Oanti-receptor	antibodies	anti-receptor	JJ	B-NP	B-proteinantibodies	and	antibody	NNS	I-NP	I-proteinand	is	and	CC	O	Ois	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	glucocorticoid	for	IN	B-PP	Oglucocorticoid	modulation	glucocorticoid	NN	B-NP	Omodulation	of	modulation	NN	I-NP	Oof	gene	of	IN	B-PP	Ogene	expression	gene	NN	B-NP	Oexpression	.	expression	NN	I-NP	O.	In	.	.	O	OIn	intact	In	IN	B-PP	Ointact	cells	intact	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	receptor	","	","	O	Oreceptor	number	receptor	NN	B-NP	Onumber	","	number	NN	I-NP	O","	affinity	","	","	O	Oaffinity	and	affinity	NN	B-NP	Oand	activity	and	CC	I-NP	Oactivity	can	activity	NN	I-NP	Ocan	change	can	MD	B-VP	Ochange	in	change	VB	I-VP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	factors	to	TO	B-PP	Ofactors	that	factor	NNS	B-NP	Othat	bind	that	WDT	B-NP	Obind	to	bind	VBP	B-VP	Oto	the	to	TO	B-PP	Othe	receptor	the	DT	B-NP	Oreceptor	","	receptor	NN	I-NP	O","	or	","	","	O	Oor	that	or	CC	O	Othat	act	that	WDT	B-NP	Oact	indirectly	act	VBP	B-VP	Oindirectly	through	indirectly	RB	B-ADVP	Othrough	ill-defined	through	IN	B-PP	Oill-defined	mechanisms	ill-defined	JJ	B-NP	Omechanisms	which	mechanism	NNS	I-NP	Owhich	may	which	WDT	B-NP	Omay	include	may	MD	B-VP	Oinclude	resumption	include	VB	I-VP	Oresumption	or	resumption	NN	B-NP	Oor	arrest	or	CC	I-NP	Oarrest	of	arrest	NN	I-NP	Oof	cell	of	IN	B-PP	Ocell	cycling	cell	NN	B-NP	Ocycling	and	cycling	NN	I-NP	Oand	variations	and	CC	O	Ovariations	in	variation	NNS	B-NP	Oin	intracellular	in	IN	B-PP	Ointracellular	calcium	intracellular	JJ	B-NP	Ocalcium	ion	calcium	NN	I-NP	Oion	concentrations	ion	NN	I-NP	Oconcentrations	.	concentration	NNS	I-NP	O.	Some	.	.	O	OSome	of	Some	DT	B-NP	Oof	these	of	IN	B-PP	Othese	factors	these	DT	B-NP	Ofactors	appear	factor	NNS	I-NP	Oappear	to	appear	VBP	B-VP	Oto	exert	to	TO	I-VP	Oexert	their	exert	VB	I-VP	Otheir	effect	their	PRP$	B-NP	Oeffect	by	effect	NN	I-NP	Oby	controlling	by	IN	B-PP	Ocontrolling	critical	control	VBG	B-VP	Ocritical	receptor	critical	JJ	B-NP	Oreceptor	properties	receptor	NN	I-NP	Oproperties	such	property	NNS	I-NP	Osuch	as	such	JJ	B-PP	Oas	ATP-dependent	as	IN	I-PP	OATP-dependent	phosphorylation	ATP-dependent	JJ	B-NP	Ophosphorylation	","	phosphorylation	NN	I-NP	O","	integrity	","	","	O	Ointegrity	of	integrity	NN	B-NP	Oof	thiol	of	IN	B-PP	Othiol	groups	thiol	NN	B-NP	Ogroups	","	group	NNS	I-NP	O","	and	","	","	O	Oand	exposure	and	CC	O	Oexposure	of	exposure	NN	B-NP	Oof	key	of	IN	B-PP	Okey	amino	key	JJ	B-NP	Oamino	acid	amino	JJ	I-NP	Oacid	residues	acid	NN	I-NP	Oresidues	.	residue	NNS	I-NP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	agonists	Glucocorticoid	NN	B-NP	Oagonists	promote	agonist	NNS	I-NP	Opromote	the	promote	VBP	B-VP	Othe	'transformation	the	DT	B-NP	O'transformation	'	'transformation	NN	I-NP	O'	of	'	''	O	Oof	the	of	IN	B-PP	Othe	receptor	the	DT	B-NP	Oreceptor	into	receptor	NN	I-NP	Ointo	the	into	IN	B-PP	Othe	DNA-binding	the	DT	B-NP	ODNA-binding	state	DNA-binding	JJ	I-NP	B-proteinstate	","	state	NN	I-NP	I-protein","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	competent	be	VBZ	B-VP	Ocompetent	for	competent	JJ	B-ADJP	Ofor	modulating	for	IN	B-PP	Omodulating	gene	modulate	VBG	B-VP	Ogene	expression	gene	NN	B-NP	Oexpression	.	expression	NN	I-NP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	antagonists	Glucocorticoid	NN	B-NP	Oantagonists	are	antagonist	NNS	I-NP	Oare	steroids	be	VBP	B-VP	Osteroids	that	steroid	NNS	B-NP	Othat	interact	that	WDT	B-NP	Ointeract	with	interact	VBP	B-VP	Owith	the	with	IN	B-PP	Othe	receptor	the	DT	B-NP	Oreceptor	but	receptor	NN	I-NP	Obut	either	but	CC	O	Oeither	fail	either	CC	O	Ofail	to	fail	VBP	B-VP	Oto	produce	to	TO	I-VP	Oproduce	a	produce	VB	I-VP	Oa	stable	a	DT	B-NP	Ostable	complex	stable	JJ	I-NP	Ocomplex	or	complex	NN	I-NP	Oor	produce	or	CC	O	Oproduce	a	produce	VB	B-VP	Oa	stable	a	DT	B-NP	Ostable	but	stable	JJ	I-NP	B-proteinbut	inefficient	but	CC	I-NP	I-proteininefficient	complex	inefficient	JJ	I-NP	I-proteincomplex	.	complex	NN	I-NP	I-protein.	Although	.	.	O	OAlthough	substituent	Although	IN	B-SBAR	Osubstituent	groups	substituent	JJ	B-NP	Ogroups	that	group	NNS	I-NP	Othat	confer	that	WDT	B-NP	Oconfer	agonist	confer	VBP	B-VP	Oagonist	or	agonist	NN	B-NP	Oor	antagonist	or	CC	I-NP	Oantagonist	activity	antagonist	NN	I-NP	Oactivity	to	activity	NN	I-NP	Oto	the	to	TO	B-PP	Othe	steroid	the	DT	B-NP	Osteroid	have	steroid	NN	I-NP	Ohave	been	have	VBP	B-VP	Obeen	identified	be	VBN	I-VP	Oidentified	","	identify	VBN	I-VP	O","	the	","	","	O	Othe	molecular	the	DT	B-NP	Omolecular	determinants	molecular	JJ	I-NP	Odeterminants	of	determinant	NNS	I-NP	Oof	this	of	IN	B-PP	Othis	difference	this	DT	B-NP	Odifference	at	difference	NN	I-NP	Oat	the	at	IN	B-PP	Othe	receptor	the	DT	B-NP	Oreceptor	level	receptor	NN	I-NP	Olevel	remain	level	NN	I-NP	Oremain	unknown	remain	VBP	B-VP	Ounknown	.	unknown	JJ	B-ADJP	O.	Most	.	.	O	OMost	in	Most	JJS	B-ADVP	Oin	vitro	in	FW	B-ADVP	Ovitro	and	vitro	FW	I-ADVP	Oand	in	and	CC	O	Oin	vivo	in	FW	B-NP	Ovivo	data	vivo	FW	I-NP	Odata	on	datum	NNS	I-NP	Oon	receptor	on	IN	B-PP	Oreceptor	regulation	receptor	NN	B-NP	Oregulation	can	regulation	NN	I-NP	Ocan	be	can	MD	B-VP	Obe	accommodated	be	VB	I-VP	Oaccommodated	by	accommodate	VBN	I-VP	Oby	postulating	by	IN	B-PP	Opostulating	the	postulate	VBG	B-VP	Othe	existence	the	DT	B-NP	Oexistence	of	existence	NN	I-NP	Oof	an	of	IN	B-PP	Oan	intracellular	an	DT	B-NP	Ointracellular	cycle	intracellular	JJ	I-NP	Ocycle	that	cycle	NN	I-NP	Othat	involves	that	WDT	B-NP	Oinvolves	five	involve	VBZ	B-VP	Ofive	states	five	CD	B-NP	Ostates	of	state	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	receptor	the	DT	B-NP	Oreceptor	.	receptor	NN	I-NP	O.	The	.	.	O	OThe	active	The	DT	B-NP	Oactive	free	active	JJ	I-NP	B-proteinfree	receptor	free	JJ	I-NP	I-proteinreceptor	is	receptor	NN	I-NP	I-proteinis	phosphorylated	be	VBZ	B-VP	Ophosphorylated	","	phosphorylate	VBN	I-VP	O","	reduced	","	","	O	Oreduced	","	reduce	VBN	B-VP	O","	and	","	","	O	Oand	presumably	and	CC	O	Opresumably	oligomeric	presumably	RB	B-ADJP	Ooligomeric	(	oligomeric	JJ	I-ADJP	O(	state	(	(	O	Ostate	A	state	NN	B-NP	B-proteinA	)	A	NN	I-NP	I-protein)	.	)	)	O	O.	Following	.	.	O	OFollowing	binding	Follow	VBG	B-PP	Obinding	of	binding	NN	B-NP	Oof	an	of	IN	B-PP	Oan	agonist	an	DT	B-NP	Oagonist	(	agonist	NN	I-NP	O(	state	(	(	O	Ostate	B	state	NN	B-NP	B-proteinB	)	B	NN	I-NP	I-protein)	","	)	)	O	O","	it	","	","	O	Oit	can	it	PRP	B-NP	Ocan	become	can	MD	B-VP	Obecome	transformed	become	VB	I-VP	Otransformed	by	transform	VBN	I-VP	Oby	dissociation	by	IN	B-PP	Odissociation	into	dissociation	NN	B-NP	Ointo	its	into	IN	B-PP	Oits	subunits	its	PRP$	B-NP	Osubunits	and	subunit	NNS	I-NP	Oand	dephosphorylation	and	CC	I-NP	Odephosphorylation	(	dephosphorylation	NN	I-NP	O(	state	(	(	O	Ostate	C	state	NN	B-NP	OC	)	C	NN	I-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	transformed	The	DT	B-NP	Otransformed	receptor	transform	VBN	I-NP	B-proteinreceptor	then	receptor	NN	I-NP	I-proteinthen	interacts	then	RB	B-ADVP	Ointeracts	with	interact	VBZ	B-VP	Owith	chromatin	with	IN	B-PP	Ochromatin	(	chromatin	NN	B-NP	B-DNA(	state	(	(	O	Ostate	D	state	NN	B-NP	OD	)	D	NN	I-NP	O)	.	)	)	O	O.	Dissociation	.	.	O	ODissociation	of	Dissociation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	steroid	the	DT	B-NP	Osteroid	and	steroid	NN	I-NP	Oand	oxidation	and	CC	I-NP	Ooxidation	of	oxidation	NN	I-NP	Oof	receptor	of	IN	B-PP	Oreceptor	thiol	receptor	NN	B-NP	Othiol	group	thiol	NN	I-NP	Ogroup	(	group	NN	I-NP	O(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	lead	)	)	O	Olead	to	lead	VBP	B-VP	Oto	the	to	TO	B-PP	Othe	inactive	the	DT	B-NP	Oinactive	receptor	inactive	JJ	I-NP	B-proteinreceptor	form	receptor	NN	I-NP	I-proteinform	(	form	NN	I-NP	O(	state	(	(	O	Ostate	E	state	NN	B-NP	OE	)	E	NN	I-NP	O)	.	)	)	O	O.	Reduction	.	.	O	OReduction	and	Reduction	NN	B-NP	Oand	rephosphorylation	and	CC	I-NP	Orephosphorylation	of	rephosphorylation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	receptor	the	DT	B-NP	Oreceptor	enable	receptor	NN	I-NP	Oenable	it	enable	NN	I-NP	Oit	to	it	PRP	B-NP	Oto	bind	to	TO	B-VP	Obind	steroids	bind	VB	I-VP	Osteroids	again	steroid	NNS	B-NP	Oagain	so	again	RB	B-ADVP	Oso	that	so	IN	B-SBAR	Othat	the	that	IN	I-SBAR	Othe	cycle	the	DT	B-NP	Ocycle	is	cycle	NN	I-NP	Ois	closed	be	VBZ	B-VP	Oclosed	.	close	VBN	I-VP	O.	Thermodynamics	.	.	O	OThermodynamics	of	Thermodynamic	NNS	B-NP	Oof	steroid	of	IN	B-PP	Osteroid	binding	steroid	NN	B-NP	Obinding	to	binding	NN	I-NP	Oto	the	to	TO	B-PP	Othe	human	the	DT	B-NP	Ohuman	glucocorticoid	human	JJ	I-NP	B-proteinglucocorticoid	receptor	glucocorticoid	NN	I-NP	I-proteinreceptor	.	receptor	NN	I-NP	I-protein.	The	.	.	O	OThe	thermodynamics	The	DT	B-NP	Othermodynamics	of	thermodynamic	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	interaction	the	DT	B-NP	Ointeraction	of	interaction	NN	I-NP	Oof	glucocorticoids	of	IN	B-PP	Oglucocorticoids	with	glucocorticoid	NNS	B-NP	Owith	their	with	IN	B-PP	Otheir	receptor	their	PRP$	B-NP	Oreceptor	were	receptor	NN	I-NP	Owere	studied	be	VBD	B-VP	Ostudied	in	study	VBN	I-VP	Oin	cytosol	in	IN	B-PP	Ocytosol	from	cytosol	NN	B-NP	Ofrom	human	from	IN	B-PP	Ohuman	lymphoblastoid	human	JJ	B-NP	B-cell_typelymphoblastoid	cells	lymphoblastoid	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	rate	The	DT	B-NP	Orate	and	rate	NN	I-NP	Oand	affinity	and	CC	I-NP	Oaffinity	constants	affinity	NN	I-NP	Oconstants	of	constant	NNS	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	and	dexamethasone	NN	B-NP	Oand	cortisol	and	CC	O	Ocortisol	between	cortisol	NN	B-NP	Obetween	0	between	IN	B-PP	O0	degree	0	CD	B-NP	Odegree	and	degree	NN	I-NP	Oand	25	and	CC	O	O25	degrees	25	CD	B-NP	Odegrees	C	degree	NNS	I-NP	OC	were	C	NN	I-NP	Owere	calculated	be	VBD	B-VP	Ocalculated	by	calculate	VBN	I-VP	Oby	curve-fitting	by	IN	B-PP	Ocurve-fitting	from	curve-fitting	JJ	B-NP	Ofrom	time-course	from	IN	B-PP	Otime-course	and	time-course	NN	B-NP	Oand	equilibrium	and	CC	I-NP	Oequilibrium	kinetics	equilibrium	NN	I-NP	Okinetics	.	kinetic	NNS	I-NP	O.	The	.	.	O	OThe	data	The	DT	B-NP	Odata	were	datum	NNS	I-NP	Owere	consistent	be	VBD	B-VP	Oconsistent	with	consistent	JJ	B-ADJP	Owith	a	with	IN	B-PP	Oa	simple	a	DT	B-NP	Osimple	reversible	simple	JJ	I-NP	Oreversible	bimolecular	reversible	JJ	I-NP	Obimolecular	interaction	bimolecular	JJ	I-NP	Ointeraction	.	interaction	NN	I-NP	O.	Arrhenius	.	.	O	OArrhenius	and	Arrhenius	NNP	B-NP	Oand	Va	and	CC	I-NP	OVa	n't	Va	NNP	I-NP	On't	Hoff	n't	RB	O	OHoff	plots	Hoff	NNP	B-NP	Oplots	were	plot	NNS	I-NP	Owere	curvilinear	be	VBD	B-VP	Ocurvilinear	for	curvilinear	JJ	B-ADJP	Ofor	both	for	IN	B-PP	Oboth	steroids	both	DT	B-NP	Osteroids	.	steroid	NNS	I-NP	O.	At	.	.	O	OAt	equilibrium	At	IN	B-PP	Oequilibrium	","	equilibrium	NN	B-NP	O","	the	","	","	O	Othe	solution	the	DT	B-NP	Osolution	for	solution	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	equation	the	DT	B-NP	Oequation	delta	equation	NN	I-NP	B-proteindelta	G	delta	SYM	B-NP	I-proteinG	=	G	NN	I-NP	I-protein=	delta	=	SYM	B-VP	Odelta	H	delta	SYM	B-NP	OH	-	H	NN	I-NP	O-	T	-	HYPH	I-NP	OT	X	T	NN	I-NP	B-proteinX	delta	X	NN	I-NP	I-proteindelta	S	delta	NN	I-NP	I-proteinS	(	S	NN	I-NP	I-protein(	eqn.	(	(	O	Oeqn.	1	eqn.	NN	B-NP	B-protein1	)	1	CD	I-NP	I-protein)	was	)	)	O	Owas	(	be	VBD	B-VP	O(	in	(	(	O	Oin	kJ	in	IN	B-PP	OkJ	X	kJ	NN	B-NP	OX	mol-1	X	SYM	B-NP	Omol-1	)	mol-1	NN	I-NP	O)	-47	)	)	O	O-47	=	-47	CD	B-NP	O=	36	=	SYM	B-VP	O36	-	36	CD	B-NP	O-	83	-	HYPH	I-NP	O83	(	83	CD	I-NP	O(	dexamethasone	(	(	O	Odexamethasone	)	dexamethasone	NN	B-NP	O)	and	)	)	O	Oand	-42	and	CC	O	O-42	=	-42	CD	B-NP	O=	-9	=	SYM	B-VP	O-9	-	-9	CD	B-NP	O-	33	-	HYPH	I-NP	O33	(	33	CD	I-NP	O(	cortisol	(	(	O	Ocortisol	)	cortisol	NN	B-NP	O)	at	)	)	O	Oat	0	at	IN	B-PP	O0	degree	0	CD	B-NP	Odegree	C	degree	NN	I-NP	OC	.	C	NN	I-NP	O.	Enthalpy	.	.	O	OEnthalpy	and	Enthalpy	NN	B-NP	Oand	entropy	and	CC	I-NP	Oentropy	changes	entropy	NN	I-NP	Ochanges	decreased	change	NNS	I-NP	Odecreased	quasi-linearly	decrease	VBD	B-VP	Oquasi-linearly	with	quasi-linearly	RB	B-ADVP	Owith	temperature	with	IN	B-PP	Otemperature	such	temperature	NN	B-NP	Osuch	that	such	JJ	B-NP	Othat	","	that	IN	I-NP	O","	at	","	","	O	Oat	25	at	IN	B-PP	O25	degrees	25	CD	B-NP	Odegrees	C	degree	NNS	I-NP	OC	","	C	JJ	B-ADJP	O","	the	","	","	O	Othe	respective	the	DT	B-NP	Orespective	values	respective	JJ	I-NP	Ovalues	were	value	NNS	I-NP	Owere	-50	be	VBD	B-VP	O-50	=	-50	CD	B-NP	O=	-75	=	SYM	B-VP	O-75	+	-75	CD	B-NP	O+	25	+	SYM	I-NP	O25	and	25	CD	I-NP	Oand	-43	and	CC	I-NP	O-43	=	-43	CD	I-NP	O=	-48	=	SYM	B-VP	O-48	+	-48	CD	B-NP	O+	5	+	SYM	B-NP	O5	.	5	CD	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	for	","	","	O	Ofor	both	for	IN	B-PP	Oboth	steroids	both	DT	B-NP	Osteroids	","	steroid	NNS	I-NP	O","	the	","	","	O	Othe	interaction	the	DT	B-NP	Ointeraction	was	interaction	NN	I-NP	Owas	entropy-driven	be	VBD	B-VP	Oentropy-driven	at	entropy-driven	JJ	B-ADJP	Oat	low	at	IN	B-PP	Olow	temperature	low	JJ	B-NP	Otemperature	and	temperature	NN	I-NP	Oand	became	and	CC	O	Obecame	entirely	become	VBD	B-VP	Oentirely	enthalpy-driven	entirely	RB	B-ADJP	Oenthalpy-driven	at	enthalpy-driven	JJ	I-ADJP	Oat	20	at	IN	B-PP	O20	degrees	20	CD	B-NP	Odegrees	C	degree	NNS	I-NP	OC	.	C	JJ	B-ADJP	O.	Thermodynamic	.	.	O	OThermodynamic	values	Thermodynamic	JJ	B-NP	Ovalues	for	value	NNS	I-NP	Ofor	the	for	IN	B-PP	Othe	transition	the	DT	B-NP	Otransition	state	transition	NN	I-NP	Ostate	were	state	NN	I-NP	Owere	calculated	be	VBD	B-VP	Ocalculated	from	calculate	VBN	I-VP	Ofrom	the	from	IN	B-PP	Othe	rate	the	DT	B-NP	Orate	constants	rate	NN	I-NP	Oconstants	.	constant	NNS	I-NP	O.	For	.	.	O	OFor	the	For	IN	B-PP	Othe	forward	the	DT	B-NP	Oforward	reaction	forward	JJ	I-NP	Oreaction	","	reaction	NN	I-NP	O","	eqn.	","	","	O	Oeqn.	(	eqn.	FW	B-NP	O(	1	(	(	O	O1	)	1	CD	B-NP	O)	gave	)	)	O	Ogave	45	give	VBD	B-VP	O45	=	45	CD	B-NP	O=	84	=	SYM	B-VP	O84	-	84	CD	B-NP	O-	39	-	HYPH	I-NP	O39	(	39	CD	I-NP	O(	dexamethasone	(	(	O	Odexamethasone	)	dexamethasone	NN	B-NP	O)	and	)	)	O	Oand	46	and	CC	O	O46	=	46	CD	B-NP	O=	60	=	SYM	B-VP	O60	-	60	CD	B-NP	O-	14	-	HYPH	I-NP	O14	(	14	CD	I-NP	O(	cortisol	(	(	O	Ocortisol	)	cortisol	NN	B-NP	O)	at	)	)	O	Oat	0	at	IN	B-PP	O0	degree	0	CD	B-NP	Odegree	C	degree	NN	I-NP	OC	","	C	NN	I-NP	O","	and	","	","	O	Oand	44	and	CC	O	O44	=	44	CD	B-NP	O=	24	=	SYM	B-VP	O24	+	24	CD	B-NP	O+	20	+	SYM	I-NP	O20	(	20	CD	I-NP	O(	dexamethasone	(	(	O	Odexamethasone	)	dexamethasone	NN	B-NP	O)	and	)	)	O	Oand	46	and	CC	O	O46	=	46	CD	B-NP	O=	28	=	SYM	B-VP	O28	+	28	CD	B-NP	O+	18	+	SYM	B-NP	O18	(	18	CD	I-NP	O(	cortisol	(	(	O	Ocortisol	)	cortisol	NN	B-NP	O)	at	)	)	O	Oat	25	at	IN	B-PP	O25	degrees	25	CD	B-NP	Odegrees	C	degree	NNS	I-NP	OC	.	C	JJ	B-ADJP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	fit	datum	NNS	I-NP	Ofit	quite	fit	VBP	B-VP	Oquite	well	quite	RB	B-ADVP	Owell	with	well	RB	I-ADVP	Owith	a	with	IN	B-PP	Oa	two-step	a	DT	B-NP	Otwo-step	model	two-step	JJ	I-NP	Omodel	[	model	NN	I-NP	O[	Ross	[	(	O	ORoss	&	Ross	NNP	B-NP	O&	Subramanian	&	CC	I-NP	OSubramanian	(	Subramanian	NNP	I-NP	O(	1981	(	(	O	O1981	)	1981	CD	B-NP	O)	Biochemistry	)	)	O	OBiochemistry	20	Biochemistry	NNP	B-NP	O20	","	20	CD	I-NP	O","	3096-3102	","	","	I-NP	O3096-3102	]	3096-3102	CD	I-NP	O]	proposed	]	)	O	Oproposed	for	propose	VBN	B-VP	Ofor	ligand-protein	for	IN	B-PP	Oligand-protein	interactions	ligand-protein	JJ	B-NP	Ointeractions	","	interaction	NNS	I-NP	O","	which	","	","	O	Owhich	involves	which	WDT	B-NP	Oinvolves	a	involve	VBZ	B-VP	Oa	partial	a	DT	B-NP	Opartial	immobilization	partial	JJ	I-NP	Oimmobilization	of	immobilization	NN	I-NP	Oof	the	of	IN	B-PP	Othe	reacting	the	DT	B-NP	Oreacting	species	react	VBG	I-NP	Ospecies	governed	specie	NNS	I-NP	Ogoverned	by	govern	VBN	B-VP	Oby	hydrophobic	by	IN	B-PP	Ohydrophobic	forces	hydrophobic	JJ	B-NP	Oforces	","	force	NNS	I-NP	O","	followed	","	","	O	Ofollowed	by	follow	VBN	B-VP	Oby	stabilization	by	IN	B-PP	Ostabilization	of	stabilization	NN	B-NP	Oof	the	of	IN	B-PP	Othe	complex	the	DT	B-NP	Ocomplex	by	complex	NN	I-NP	Oby	short-range	by	IN	B-PP	Oshort-range	interactions	short-range	JJ	B-NP	Ointeractions	.	interaction	NNS	I-NP	O.	On	.	.	O	OOn	the	On	IN	B-PP	Othe	basis	the	DT	B-NP	Obasis	of	basis	NN	I-NP	Oof	this	of	IN	B-PP	Othis	model	this	DT	B-NP	Omodel	","	model	NN	I-NP	O","	an	","	","	O	Oan	analysis	an	DT	B-NP	Oanalysis	of	analysis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	transition-state	the	DT	B-NP	Otransition-state	thermodynamics	transition-state	JJ	I-NP	Othermodynamics	led	thermodynamic	NNS	I-NP	Oled	to	lead	VBD	B-VP	Oto	the	to	TO	B-PP	Othe	conclusion	the	DT	B-NP	Oconclusion	that	conclusion	NN	I-NP	Othat	no	that	IN	B-SBAR	Ono	more	no	DT	B-NP	Omore	than	more	JJR	I-NP	Othan	half	than	IN	I-NP	Ohalf	of	half	NN	I-NP	Oof	the	of	IN	B-PP	Othe	steroid	the	DT	B-NP	Osteroid	molecular	steroid	NN	I-NP	Omolecular	area	molecular	JJ	I-NP	Oarea	is	area	NN	I-NP	Ois	engaged	be	VBZ	B-VP	Oengaged	in	engage	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	binding	the	DT	B-NP	Obinding	process	binding	NN	I-NP	Oprocess	.	process	NN	I-NP	O.	Cell	.	.	O	OCell	cycle-related	Cell	NN	B-NP	Ocycle-related	changes	cycle-related	JJ	I-NP	Ochanges	in	change	NNS	I-NP	Oin	number	in	IN	B-PP	Onumber	of	number	NN	B-NP	Oof	T-lymphocyte	of	IN	B-PP	OT-lymphocyte	receptors	T-lymphocyte	NN	B-NP	B-proteinreceptors	for	receptor	NNS	I-NP	I-proteinfor	glucocorticoids	for	IN	B-PP	Oglucocorticoids	and	glucocorticoid	NNS	B-NP	Oand	insulin	and	CC	I-NP	Oinsulin	.	insulin	NN	I-NP	B-protein.	Enriched	.	.	O	OEnriched	human	Enrich	VBN	B-NP	Ohuman	peripheral	human	JJ	I-NP	B-cell_typeperipheral	T-lymphocytes	peripheral	JJ	I-NP	I-cell_typeT-lymphocytes	were	T-lymphocyte	NNS	I-NP	I-cell_typewere	stimulated	be	VBD	B-VP	Ostimulated	with	stimulate	VBN	I-VP	Owith	PHA	with	IN	B-PP	OPHA	and	PHA	NN	B-NP	B-proteinand	examined	and	CC	O	Oexamined	for	examine	VBN	B-VP	Ofor	variations	for	IN	B-PP	Ovariations	in	variation	NNS	B-NP	Oin	insulin	in	IN	B-PP	Oinsulin	and	insulin	NN	B-NP	B-proteinand	glucocorticoid	and	CC	O	Oglucocorticoid	(	glucocorticoid	NN	B-NP	B-protein(	dexamethasone	(	(	O	I-proteindexamethasone	)	dexamethasone	NN	B-NP	I-protein)	receptor	)	)	O	I-proteinreceptor	numbers	receptor	NN	B-NP	I-proteinnumbers	during	number	NNS	I-NP	Oduring	the	during	IN	B-PP	Othe	early	the	DT	B-NP	Oearly	phases	early	JJ	I-NP	Ophases	of	phase	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	cycle	cell	NN	I-NP	Ocycle	.	cycle	NN	I-NP	O.	Cells	.	.	O	OCells	in	Cell	NNS	B-NP	Oin	G0	in	IN	B-PP	OG0	","	G0	NN	B-NP	O","	G1a	","	","	I-NP	OG1a	and	G1a	NN	I-NP	B-proteinand	G1b	and	CC	I-NP	OG1b	phases	G1b	NN	I-NP	Ophases	","	phase	NNS	I-NP	O","	where	","	","	O	Owhere	the	where	WRB	B-ADVP	Othe	G1a	the	DT	B-NP	OG1a	-	G1a	NN	I-NP	B-protein-	G1b	-	HYPH	I-NP	OG1b	transition	G1b	NN	I-NP	Otransition	is	transition	NN	I-NP	Ois	an	be	VBZ	B-VP	Oan	Interleukin	an	DT	B-NP	OInterleukin	2	Interleukin	NN	I-NP	B-protein2	dependent	2	CD	I-NP	I-proteindependent	event	dependent	JJ	I-NP	Oevent	","	event	NN	I-NP	O","	were	","	","	O	Owere	quantitated	be	VBD	B-VP	Oquantitated	by	quantitate	VBN	I-VP	Oby	flow	by	IN	B-PP	Oflow	cytometry	flow	NN	B-NP	Ocytometry	.	cytometry	NN	I-NP	O.	Few	.	.	O	OFew	but	Few	JJ	B-NP	Obut	significant	but	CC	I-NP	Osignificant	numbers	significant	JJ	I-NP	Onumbers	of	number	NNS	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	(	receptor	NNS	I-NP	I-protein(	2700/cell	(	(	O	O2700/cell	)	2700/cell	NN	B-NP	O)	and	)	)	O	Oand	no	and	CC	O	Ono	insulin	no	DT	B-NP	Oinsulin	receptors	insulin	NN	I-NP	B-proteinreceptors	(	receptor	NNS	I-NP	I-protein(	#NAME?	(	(	O	O#NAME?	)	#NAME?	NN	B-NP	O)	were	)	)	O	Owere	found	be	VBD	B-VP	Ofound	in	find	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	resting	the	DT	B-NP	Oresting	(	resting	NN	I-NP	O(	G0	(	(	O	OG0	)	G0	NN	B-NP	O)	phase	)	)	O	Ophase	.	phase	NN	B-NP	O.	As	.	.	O	OAs	cells	As	IN	B-SBAR	Ocells	entered	cell	NNS	B-NP	Oentered	the	enter	VBD	B-VP	Othe	G1a	the	DT	B-NP	OG1a	phase	G1a	NN	I-NP	Ophase	the	phase	NN	I-NP	Othe	specific	the	DT	B-NP	Ospecific	binding	specific	JJ	I-NP	Obinding	of	binding	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	increased	dexamethasone	NN	B-NP	Oincreased	and	increase	VBD	B-VP	Oand	of	and	CC	O	Oof	insulin	of	IN	B-PP	Oinsulin	took	insulin	NN	B-NP	B-proteintook	place	take	VBD	B-VP	Oplace	.	place	NN	B-NP	O.	Although	.	.	O	OAlthough	the	Although	IN	B-SBAR	Othe	specific	the	DT	B-NP	Ospecific	binding	specific	JJ	I-NP	Obinding	further	binding	NN	I-NP	Ofurther	increased	further	RBR	B-ADVP	Oincreased	as	increase	VBD	B-VP	Oas	T-cells	as	IN	B-SBAR	OT-cells	entered	T-cell	NNS	B-NP	B-cell_typeentered	the	enter	VBD	B-VP	Othe	G1b	the	DT	B-NP	OG1b	phase	G1b	NN	I-NP	Ophase	(	phase	NN	I-NP	O(	as	(	(	O	Oas	measured	as	IN	B-SBAR	Omeasured	at	measure	VBN	B-VP	Oat	44	at	IN	B-PP	O44	h	44	CD	B-NP	Oh	of	h	NN	I-NP	Oof	incubation	of	IN	B-PP	Oincubation	and	incubation	NN	B-NP	Oand	using	and	CC	O	Ousing	hydroxyurea-treated	use	VBG	B-VP	Ohydroxyurea-treated	cells	hydroxyurea-treated	JJ	B-NP	B-cell_linecells	)	cell	NNS	I-NP	I-cell_line)	","	)	)	O	O","	the	","	","	O	Othe	major	the	DT	B-NP	Omajor	changes	major	JJ	I-NP	Ochanges	in	change	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	specific	the	DT	B-NP	Ospecific	binding	specific	JJ	I-NP	Obinding	of	binding	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	took	dexamethasone	NN	B-NP	Otook	place	take	VBD	B-VP	Oplace	during	place	NN	B-NP	Oduring	the	during	IN	B-PP	Othe	period	the	DT	B-NP	Operiod	16	period	NN	I-NP	O16	-	16	CD	I-NP	O-	20	-	HYPH	I-NP	O20	h	20	CD	I-NP	Oh	after	h	NN	I-NP	Oafter	stimulation	after	IN	B-PP	Ostimulation	.	stimulation	NN	B-NP	O.	Based	.	.	O	OBased	on	Base	VBN	B-PP	Oon	these	on	IN	B-PP	Othese	findings	these	DT	B-NP	Ofindings	","	finding	NNS	I-NP	O","	it	","	","	O	Oit	is	it	PRP	B-NP	Ois	concluded	be	VBZ	B-VP	Oconcluded	that	conclude	VBN	I-VP	Othat	both	that	IN	B-SBAR	Oboth	receptor	both	CC	O	Oreceptor	types	receptor	NN	B-NP	Otypes	(	type	NNS	I-NP	O(	cell	(	(	O	Ocell	membrane	cell	NN	B-NP	Omembrane	and	membrane	NN	I-NP	Oand	cytoplasmic	and	CC	O	Ocytoplasmic	receptors	cytoplasmic	JJ	B-NP	B-proteinreceptors	)	receptor	NNS	I-NP	I-protein)	are	)	)	O	Oare	being	be	VBP	B-VP	Obeing	formed	be	VBG	I-VP	Oformed	and	form	VBN	I-VP	Oand	increased	and	CC	O	Oincreased	at	increase	VBN	B-VP	Oat	G1	at	IN	B-PP	OG1	phase	G1	NN	B-NP	Ophase	prior	phase	NN	I-NP	Oprior	to	prior	JJ	B-ADJP	Oto	cell	to	TO	B-PP	Ocell	proliferation	cell	NN	B-NP	Oproliferation	","	proliferation	NN	I-NP	O","	indicating	","	","	O	Oindicating	the	indicate	VBG	B-VP	Othe	importance	the	DT	B-NP	Oimportance	of	importance	NN	I-NP	Oof	G1	of	IN	B-PP	OG1	phase	G1	NN	B-NP	Ophase	in	phase	NN	I-NP	Oin	immunoregulation	in	IN	B-PP	Oimmunoregulation	.	immunoregulation	NN	B-NP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	receptors	Glucocorticoid	NN	B-NP	B-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	cortico-sensitivity	and	CC	O	Ocortico-sensitivity	in	cortico-sensitivity	NN	B-NP	Oin	a	in	IN	B-PP	Oa	human	a	DT	B-NP	Ohuman	clonal	human	JJ	I-NP	B-cell_lineclonal	monocytic	clonal	JJ	I-NP	I-cell_linemonocytic	cell	monocytic	JJ	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	","	line	NN	I-NP	I-cell_line","	CM-SM	","	","	O	OCM-SM	.	CM-SM	NN	B-NP	B-cell_line.	CM-SM	.	.	O	OCM-SM	is	CM-SM	NN	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	clonal	a	DT	B-NP	Oclonal	line	clonal	JJ	I-NP	B-cell_lineline	of	line	NN	I-NP	I-cell_lineof	human	of	IN	B-PP	Ohuman	precursor	human	JJ	B-NP	B-cell_typeprecursor	mononuclear	precursor	NN	I-NP	I-cell_typemononuclear	phagocytes	mononuclear	JJ	I-NP	I-cell_typephagocytes	inducible	phagocyte	NNS	I-NP	I-cell_typeinducible	to	inducible	JJ	B-ADJP	Oto	macrophage	to	TO	B-PP	Omacrophage	differentiation	macrophage	NN	B-NP	Odifferentiation	in	differentiation	NN	I-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	the	to	TO	B-PP	Othe	tumor	the	DT	B-NP	Otumor	promoter	tumor	NN	I-NP	Opromoter	phorbol	promoter	NN	I-NP	Ophorbol	ester	phorbol	NN	I-NP	Oester	12-O-tetradecanoyl-phorbol-13-acetate	ester	NN	I-NP	O12-O-tetradecanoyl-phorbol-13-acetate	(	12-O-tetradecanoyl-phorbol-13-acetate	NN	I-NP	O(	TPA	(	(	O	OTPA	)	TPA	NN	B-NP	O)	.	)	)	O	O.	Untreated	.	.	O	OUntreated	CM-SM	Untreated	JJ	B-NP	B-cell_lineCM-SM	cells	CM-SM	NN	I-NP	I-cell_linecells	contain	cell	NNS	I-NP	I-cell_linecontain	single	contain	VBP	B-VP	Osingle	class	single	JJ	B-NP	Oclass	","	class	NN	I-NP	O","	high-affinity	","	","	O	Ohigh-affinity	(	high-affinity	NN	B-NP	O(	KD	(	(	O	OKD	=	KD	NN	B-NP	O=	4	=	SYM	B-VP	O4	X	4	CD	B-NP	OX	10	X	SYM	O	O10	(	10	CD	B-NP	O(	-9	(	(	O	O-9	)	-9	CD	B-NP	O)	M	)	)	O	OM	)	M	NN	B-NP	O)	glucocorticoid-specific	)	)	O	Oglucocorticoid-specific	receptor	glucocorticoid-specific	JJ	B-NP	Oreceptor	sites	receptor	NN	I-NP	Osites	(	site	NNS	I-NP	O(	approximately	(	(	O	Oapproximately	60	approximately	RB	B-NP	O60	","	60	CD	I-NP	O","	0	","	","	I-NP	O0	per	0	CD	I-NP	Oper	cell	per	IN	B-PP	Ocell	)	cell	NN	B-NP	O)	","	)	)	O	O","	as	","	","	O	Oas	measured	as	IN	B-SBAR	Omeasured	by	measure	VBN	B-VP	Oby	a	by	IN	B-PP	Oa	whole	a	DT	B-NP	Owhole	cell	whole	JJ	I-NP	Ocell	assay	cell	NN	I-NP	Oassay	","	assay	NN	I-NP	O","	at	","	","	O	Oat	37	at	IN	B-PP	O37	degrees	37	CD	B-NP	Odegrees	C	degree	NNS	I-NP	OC	","	C	NN	I-NP	O","	using	","	","	O	Ousing	[	use	VBG	B-VP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	triamcinolone	]	)	O	Otriamcinolone	acetonide	triamcinolone	NN	B-NP	Oacetonide	(	acetonide	NN	I-NP	O(	TA	(	(	O	OTA	)	TA	NN	B-NP	B-protein)	.	)	)	O	O.	Exposure	.	.	O	OExposure	of	Exposure	NN	B-NP	Oof	CM-SM	of	IN	B-PP	OCM-SM	to	CM-SM	NN	B-NP	B-proteinto	dexamethasone	to	TO	B-PP	Odexamethasone	(	dexamethasone	NN	B-NP	O(	DEX	(	(	O	ODEX	)	DEX	NN	B-NP	O)	produced	)	)	O	Oproduced	a	produce	VBD	B-VP	Oa	progressive	a	DT	B-NP	Oprogressive	","	progressive	JJ	I-NP	O","	dose-	","	","	I-NP	Odose-	and	dose-	NN	I-NP	Oand	time-related	and	CC	I-NP	Otime-related	series	time-related	JJ	I-NP	Oseries	of	series	NN	I-NP	Oof	changes	of	IN	B-PP	Ochanges	in	change	NNS	B-NP	Oin	CM-SM	in	IN	B-PP	OCM-SM	cell	CM-SM	NN	B-NP	Ocell	growth	cell	NN	I-NP	Ogrowth	","	growth	NN	I-NP	O","	saturation	","	","	O	Osaturation	density	saturation	NN	B-NP	Odensity	","	density	NN	I-NP	O","	morphology	","	","	O	Omorphology	","	morphology	NN	B-NP	O","	and	","	","	O	Oand	functional	and	CC	O	Ofunctional	properties	functional	JJ	B-NP	Oproperties	","	property	NNS	I-NP	O","	with	","	","	O	Owith	half-maximal	with	IN	B-PP	Ohalf-maximal	effects	half-maximal	JJ	B-NP	Oeffects	at	effect	NNS	I-NP	Oat	about	at	IN	B-PP	Oabout	10	about	RB	B-NP	O10	(	10	CD	I-NP	O(	-9	(	(	O	O-9	)	-9	CD	B-NP	O)	M	)	)	O	OM	for	M	NN	B-NP	Ofor	DEX	for	IN	B-PP	ODEX	.	DEX	NN	B-NP	O.	TA-receptor	.	.	O	OTA-receptor	sites	TA-receptor	NN	B-NP	B-DNAsites	rapidly	site	NNS	I-NP	I-DNArapidly	decreased	rapidly	RB	B-ADVP	Odecreased	(	decrease	VBD	B-VP	O(	about	(	(	O	Oabout	70	about	RB	B-NP	O70	%	70	CD	I-NP	O%	)	%	NN	I-NP	O)	after	)	)	O	Oafter	DEX	after	IN	B-PP	ODEX	treatment	DEX	NN	B-NP	Otreatment	","	treatment	NN	I-NP	O","	without	","	","	O	Owithout	any	without	IN	B-PP	Oany	apparent	any	DT	B-NP	Oapparent	change	apparent	JJ	I-NP	Ochange	in	change	NN	I-NP	Oin	steroid	in	IN	B-PP	Osteroid	specificity	steroid	NN	B-NP	Ospecificity	and	specificity	NN	I-NP	Oand	affinity	and	CC	O	Oaffinity	.	affinity	NN	B-NP	O.	After	.	.	O	OAfter	5	After	IN	B-PP	O5	days	5	CD	B-NP	Odays	in	day	NNS	I-NP	Oin	culture	in	IN	B-PP	Oculture	with	culture	NN	B-NP	Owith	a	with	IN	B-PP	Oa	saturating	a	DT	B-NP	Osaturating	concentration	saturating	JJ	I-NP	Oconcentration	(	concentration	NN	I-NP	O(	3.6	(	(	O	O3.6	X	3.6	CD	B-NP	OX	10	X	SYM	O	O10	(	10	CD	B-NP	O(	-8	(	(	O	O-8	)	-8	CD	B-NP	O)	M	)	)	O	OM	)	M	NN	B-NP	O)	of	)	)	O	Oof	hormone	of	IN	B-PP	Ohormone	","	hormone	NN	B-NP	O","	the	","	","	O	Othe	cells	the	DT	B-NP	Ocells	reached	cell	NNS	I-NP	Oreached	a	reach	VBD	B-VP	Oa	saturation	a	DT	B-NP	Osaturation	density	saturation	NN	I-NP	Odensity	of	density	NN	I-NP	Oof	about	of	IN	B-PP	Oabout	9	about	IN	B-NP	O9	X	9	CD	I-NP	OX	10	X	SYM	I-NP	O10	(	10	CD	I-NP	O(	6	(	(	O	O6	)	6	CD	B-NP	O)	viable	)	)	O	Oviable	cells/ml	viable	JJ	B-NP	Ocells/ml	(	cells/ml	NNS	I-NP	O(	about	(	(	O	Oabout	4	about	RB	B-NP	O4	X	4	CD	I-NP	OX	10	X	SYM	I-NP	O10	(	10	CD	I-NP	O(	6	(	(	O	O6	)	6	CD	B-NP	O)	viable	)	)	O	Oviable	cells/ml	viable	JJ	B-NP	Ocells/ml	in	cells/ml	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	controls	the	DT	B-NP	Ocontrols	)	control	NNS	I-NP	O)	","	)	)	O	O","	while	","	","	O	Owhile	the	while	IN	B-SBAR	Othe	modal	the	DT	B-NP	Omodal	volume	modal	JJ	I-NP	Ovolume	of	volume	NN	I-NP	Oof	the	of	IN	B-PP	Othe	resulting	the	DT	B-NP	Oresulting	cell	result	VBG	I-NP	Ocell	population	cell	NN	I-NP	Opopulation	was	population	NN	I-NP	Owas	approximately	be	VBD	B-VP	Oapproximately	60	approximately	RB	B-NP	O60	%	60	CD	I-NP	O%	","	%	NN	I-NP	O","	as	","	","	O	Oas	compared	as	IN	B-SBAR	Ocompared	to	compare	VBN	B-VP	Oto	the	to	TO	B-PP	Othe	volume	the	DT	B-NP	Ovolume	of	volume	NN	I-NP	Oof	untreated	of	IN	B-PP	Ountreated	cells	untreated	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	DEX-treated	.	.	O	ODEX-treated	cells	DEX-treated	JJ	B-NP	B-cell_linecells	appeared	cell	NNS	I-NP	I-cell_lineappeared	less	appear	VBD	B-VP	Oless	differentiated	less	RBR	B-ADJP	Odifferentiated	than	differentiate	VBN	I-ADJP	Othan	controls	than	IN	B-PP	Ocontrols	","	control	NNS	B-NP	O","	as	","	","	O	Oas	assessed	as	IN	B-SBAR	Oassessed	by	assess	VBN	B-VP	Oby	combined	by	IN	B-PP	Ocombined	morphologic	combine	VBN	B-NP	Omorphologic	","	morphologic	JJ	I-NP	O","	antigenic	","	","	I-NP	Oantigenic	","	antigenic	JJ	I-NP	O","	and	","	","	O	Oand	cytoenzymatic	and	CC	O	Ocytoenzymatic	analyses	cytoenzymatic	JJ	B-NP	Oanalyses	.	analysis	NNS	I-NP	O.	DEX	.	.	O	ODEX	almost	DEX	NN	B-NP	Oalmost	completely	almost	RB	B-ADVP	Ocompletely	inhibited	completely	RB	I-ADVP	Oinhibited	TPA	inhibit	VBD	B-VP	OTPA	activation	TPA	NN	B-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	following	the	DT	B-NP	Ofollowing	macrophage	follow	VBG	I-NP	Omacrophage	functions	macrophage	NN	I-NP	Ofunctions	:	function	NNS	I-NP	O:	adherency	:	:	O	Oadherency	to	adherency	NN	B-NP	Oto	the	to	TO	B-PP	Othe	culture	the	DT	B-NP	Oculture	plate	culture	NN	I-NP	Oplate	","	plate	NN	I-NP	O","	expression	","	","	O	Oexpression	of	expression	NN	B-NP	Oof	lysosomal	of	IN	B-PP	Olysosomal	enzymes	lysosomal	JJ	B-NP	B-proteinenzymes	","	enzyme	NNS	I-NP	I-protein","	Fc	","	","	O	OFc	and	Fc	NN	B-NP	B-proteinand	C3	and	CC	I-NP	OC3	receptors	C3	NN	I-NP	B-proteinreceptors	","	receptor	NNS	I-NP	I-protein","	and	","	","	O	Oand	stimulation	and	CC	O	Ostimulation	of	stimulation	NN	B-NP	Oof	phagocytosis	of	IN	B-PP	Ophagocytosis	.	phagocytosis	NN	B-NP	O.	After	.	.	O	OAfter	removal	After	IN	B-PP	Oremoval	of	removal	NN	B-NP	Oof	DEX	of	IN	B-PP	ODEX	","	DEX	NN	B-NP	O","	the	","	","	O	Othe	cells	the	DT	B-NP	Ocells	","	cell	NNS	I-NP	O","	within	","	","	O	Owithin	a	within	IN	B-PP	Oa	few	a	DT	B-NP	Ofew	passages	few	JJ	I-NP	Opassages	","	passage	NNS	I-NP	O","	returned	","	","	O	Oreturned	to	return	VBD	B-VP	Oto	a	to	TO	B-PP	Oa	state	a	DT	B-NP	Ostate	apparently	state	NN	I-NP	Oapparently	identical	apparently	RB	B-ADJP	Oidentical	to	identical	JJ	I-ADJP	Oto	the	to	TO	B-PP	Othe	untreated	the	DT	B-NP	Ountreated	controls	untreated	JJ	I-NP	Ocontrols	and	control	NNS	I-NP	Oand	could	and	CC	O	Ocould	be	could	MD	B-VP	Obe	induced	be	VB	I-VP	Oinduced	to	induce	VBN	I-VP	Oto	macrophage	to	TO	B-PP	Omacrophage	differentiation	macrophage	NN	B-NP	Odifferentiation	in	differentiation	NN	I-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	I-PP	Oto	TPA	to	TO	I-PP	OTPA	.	TPA	NN	B-NP	O.	Acute	.	.	O	OAcute	lymphoblastic	Acute	JJ	B-NP	Olymphoblastic	leukemia	lymphoblastic	JJ	I-NP	Oleukemia	in	leukemia	NN	I-NP	Oin	children	in	IN	B-PP	Ochildren	:	child	NNS	B-NP	O:	current	:	:	O	Ocurrent	status	current	JJ	B-NP	Ostatus	","	status	NN	I-NP	O","	controversies	","	","	O	Ocontroversies	","	controversy	NNS	B-NP	O","	and	","	","	O	Oand	future	and	CC	O	Ofuture	perspective	future	JJ	B-NP	Operspective	.	perspective	NN	I-NP	O.	Disease-free	.	.	O	ODisease-free	survival	Disease-free	JJ	B-NP	Osurvival	(	survival	NN	I-NP	O(	DFS	(	(	O	ODFS	)	DFS	NN	B-NP	O)	in	)	)	O	Oin	childhood	in	IN	B-PP	Ochildhood	ALL	childhood	NN	B-NP	OALL	is	ALL	NN	I-NP	Ois	60	be	VBZ	B-VP	O60	%	60	CD	B-NP	O%	","	%	NN	I-NP	O","	and	","	","	O	Oand	survival	and	CC	O	Osurvival	in	survival	NN	B-NP	Oin	good	in	IN	B-PP	Ogood	","	good	JJ	B-NP	O","	average	","	","	I-NP	Oaverage	","	average	JJ	I-NP	O","	and	","	","	O	Oand	poor	and	CC	O	Opoor	prognostic	poor	JJ	B-NP	Oprognostic	groups	prognostic	JJ	I-NP	Ogroups	defined	group	NNS	I-NP	Odefined	by	define	VBN	B-VP	Oby	initial	by	IN	B-PP	Oinitial	WBC	initial	JJ	B-NP	OWBC	and	WBC	NN	I-NP	Oand	age	and	CC	I-NP	Oage	is	age	NN	I-NP	Ois	90	be	VBZ	B-VP	O90	","	90	CD	B-NP	O","	60	","	","	I-NP	O60	","	60	CD	I-NP	O","	and	","	","	O	Oand	45	and	CC	O	O45	%	45	CD	B-NP	O%	","	%	NN	I-NP	O","	respectively	","	","	O	Orespectively	.	respectively	RB	B-ADVP	O.	Additional	.	.	O	OAdditional	immunological	Additional	JJ	B-NP	Oimmunological	","	immunological	JJ	I-NP	O","	morphological	","	","	I-NP	Omorphological	","	morphological	JJ	I-NP	O","	biochemical	","	","	I-NP	Obiochemical	","	biochemical	JJ	I-NP	O","	cytokinetic	","	","	I-NP	Ocytokinetic	","	cytokinetic	JJ	I-NP	O","	and	","	","	O	Oand	cytogenetic	and	CC	O	Ocytogenetic	factors	cytogenetic	JJ	B-NP	B-proteinfactors	have	factor	NNS	I-NP	I-proteinhave	been	have	VBP	B-VP	Obeen	identified	be	VBN	I-VP	Oidentified	","	identify	VBN	I-VP	O","	illustrating	","	","	O	Oillustrating	the	illustrate	VBG	B-VP	Othe	heterogeneity	the	DT	B-NP	Oheterogeneity	of	heterogeneity	NN	I-NP	Oof	ALL	of	IN	B-PP	OALL	and	ALL	NN	B-NP	Oand	its	and	CC	O	Oits	derivation	its	PRP$	B-NP	Oderivation	from	derivation	NN	I-NP	Ofrom	malignant	from	IN	B-PP	Omalignant	clones	malignant	JJ	B-NP	B-cell_lineclones	at	clone	NNS	I-NP	I-cell_lineat	various	at	IN	B-PP	Ovarious	stages	various	JJ	B-NP	Ostages	of	stage	NNS	I-NP	Oof	differentiation	of	IN	B-PP	Odifferentiation	and	differentiation	NN	B-NP	Oand	with	and	CC	B-PP	Owith	varying	with	IN	B-PP	Ovarying	rates	vary	VBG	B-NP	Orates	of	rate	NNS	I-NP	Oof	proliferation	of	IN	B-PP	Oproliferation	.	proliferation	NN	B-NP	O.	Of	.	.	O	OOf	biologic	Of	IN	B-PP	Obiologic	importance	biologic	JJ	B-NP	Oimportance	","	importance	NN	I-NP	O","	these	","	","	O	Othese	factors	these	DT	B-NP	Ofactors	may	factor	NNS	I-NP	Omay	refine	may	MD	B-VP	Orefine	further	refine	VB	I-VP	Ofurther	the	further	RBR	B-ADVP	Othe	characteristic	the	DT	B-NP	Ocharacteristic	features	characteristic	JJ	I-NP	Ofeatures	of	feature	NNS	I-NP	Oof	clinically-determined	of	IN	B-PP	Oclinically-determined	prognostic	clinically-determined	JJ	B-NP	Oprognostic	groups	prognostic	JJ	I-NP	Ogroups	.	group	NNS	I-NP	O.	Multivariate	.	.	O	OMultivariate	analysis	Multivariate	JJ	B-NP	Oanalysis	of	analysis	NN	I-NP	Oof	large	of	IN	B-PP	Olarge	prospective	large	JJ	B-NP	Oprospective	trials	prospective	JJ	I-NP	Otrials	with	trial	NNS	I-NP	Owith	homogeneous	with	IN	B-PP	Ohomogeneous	therapy	homogeneous	JJ	B-NP	Otherapy	will	therapy	NN	I-NP	Owill	be	will	MD	B-VP	Obe	required	be	VB	I-VP	Orequired	to	require	VBN	I-VP	Oto	determine	to	TO	B-VP	Odetermine	the	determine	VB	I-VP	Othe	independent	the	DT	B-NP	Oindependent	prognostic	independent	JJ	I-NP	Oprognostic	importance	prognostic	JJ	I-NP	Oimportance	of	importance	NN	I-NP	Oof	these	of	IN	B-PP	Othese	factors	these	DT	B-NP	Ofactors	.	factor	NNS	I-NP	O.	Current	.	.	O	OCurrent	treatment	Current	JJ	B-NP	Otreatment	strategies	treatment	NN	I-NP	Ostrategies	in	strategy	NNS	I-NP	Oin	ALL	in	IN	B-PP	OALL	include	ALL	NN	B-NP	Oinclude	(	include	VBP	B-VP	O(	1	(	(	O	O1	)	1	CD	B-NP	O)	tailoring	)	)	O	Otailoring	therapy	tailor	VBG	B-VP	Otherapy	and	therapy	NN	B-NP	Oand	its	and	CC	O	Oits	intensity	its	PRP$	B-NP	Ointensity	to	intensity	NN	I-NP	Oto	prognostic	to	TO	B-PP	Oprognostic	groups	prognostic	JJ	B-NP	Ogroups	;	group	NNS	I-NP	O;	(	;	:	O	O(	2	(	(	B-LST	O2	)	2	LS	I-LST	O)	multiple-drug	)	)	O	Omultiple-drug	combinations	multiple-drug	JJ	B-NP	Ocombinations	in	combination	NNS	I-NP	Oin	induction	in	IN	B-PP	Oinduction	;	induction	NN	B-NP	O;	(	;	:	O	O(	3	(	(	B-LST	O3	)	3	LS	I-LST	O)	early	)	)	O	Oearly	use	early	JJ	B-NP	Ouse	of	use	NN	I-NP	Oof	intrathecal	of	IN	B-PP	Ointrathecal	(	intrathecal	JJ	O	O(	IT	(	(	O	OIT	)	IT	JJ	B-ADJP	O)	methotrexate	)	)	O	Omethotrexate	(	methotrexate	NN	B-NP	O(	MTX	(	(	O	OMTX	)	MTX	NN	B-NP	B-protein)	;	)	)	O	O;	(	;	:	O	O(	4	(	(	B-LST	O4	)	4	LS	I-LST	O)	CNS	)	)	O	OCNS	prophylaxis	CNS	NN	B-NP	Oprophylaxis	with	prophylaxis	NN	I-NP	Owith	IT	with	IN	B-PP	OIT	MTX	IT	NN	B-NP	B-proteinMTX	alone	MTX	NN	I-NP	I-proteinalone	in	alone	RB	B-ADVP	Oin	good	in	IN	B-PP	Ogood	prognosis	good	JJ	B-NP	Oprognosis	patients	prognosis	NN	I-NP	Opatients	and	patient	NNS	I-NP	Oand	combined	and	CC	O	Ocombined	cranial	combined	JJ	B-NP	Ocranial	radiation	cranial	JJ	I-NP	Oradiation	(	radiation	NN	I-NP	O(	CXRT	(	(	O	OCXRT	)	CXRT	NN	B-NP	B-protein)	","	)	)	O	O","	1800	","	","	O	O1800	rads	1800	CD	B-NP	Orads	plus	rad	NNS	I-NP	Oplus	IT	plus	CC	O	OIT	MTX	IT	NN	B-NP	B-proteinMTX	","	MTX	NN	I-NP	I-protein","	in	","	","	O	Oin	average	in	IN	B-PP	Oaverage	and	average	JJ	B-NP	Oand	poor	and	CC	I-NP	Opoor	prognosis	poor	JJ	I-NP	Oprognosis	patients	prognosis	NN	I-NP	Opatients	.	patient	NNS	I-NP	O.	Current	.	.	O	OCurrent	studies	Current	JJ	B-NP	Ostudies	show	study	NNS	I-NP	Oshow	a	show	VBP	B-VP	Oa	CNS	a	DT	B-NP	OCNS	relapse	CNS	NN	I-NP	B-proteinrelapse	rate	relapse	NN	I-NP	Orate	of	rate	NN	I-NP	Oof	5	of	IN	B-PP	O5	%	5	CD	B-NP	O%	in	%	NN	I-NP	Oin	all	in	IN	B-PP	Oall	prognostic	all	DT	B-NP	Oprognostic	groups	prognostic	JJ	I-NP	Ogroups	.	group	NNS	I-NP	O.	Late	.	.	O	OLate	neuropsychological	Late	JJ	B-NP	Oneuropsychological	defects	neuropsychological	JJ	I-NP	Odefects	caused	defect	NNS	I-NP	Ocaused	by	cause	VBN	B-VP	Oby	cranial	by	IN	B-PP	Ocranial	XRT	cranial	JJ	B-NP	OXRT	and	XRT	NN	I-NP	Oand	IT	and	CC	I-NP	OIT	MTX	IT	NN	I-NP	B-proteinMTX	have	MTX	NN	I-NP	I-proteinhave	prompted	have	VBP	B-VP	Oprompted	programs	prompt	VBN	I-VP	Oprograms	designed	program	NNS	B-NP	Odesigned	to	design	VBN	B-VP	Oto	reduce	to	TO	I-VP	Oreduce	the	reduce	VB	I-VP	Othe	potential	the	DT	B-NP	Opotential	late	potential	JJ	I-NP	Olate	toxicity	late	JJ	I-NP	Otoxicity	of	toxicity	NN	I-NP	Oof	CNS	of	IN	B-PP	OCNS	prophylaxis	CNS	NN	B-NP	B-proteinprophylaxis	.	prophylaxis	NN	I-NP	O.	More	.	.	O	OMore	pronounced	More	RBR	B-ADJP	Opronounced	in	pronounced	JJ	I-ADJP	Oin	younger	in	IN	B-PP	Oyounger	children	young	JJR	B-NP	Ochildren	","	child	NNS	I-NP	O","	these	","	","	O	Othese	abnormalities	these	DT	B-NP	Oabnormalities	include	abnormality	NNS	I-NP	Oinclude	decreased	include	VBP	B-VP	Odecreased	IQ	decrease	VBN	B-NP	OIQ	","	IQ	NN	I-NP	O","	visual-motor	","	","	O	Ovisual-motor	incoordination	visual-motor	JJ	B-NP	Oincoordination	","	incoordination	NN	I-NP	O","	poor	","	","	O	Opoor	performance	poor	JJ	B-NP	Operformance	in	performance	NN	I-NP	Oin	mathematics	in	IN	B-PP	Omathematics	","	mathematic	NNS	B-NP	O","	and	","	","	O	Oand	memory	and	CC	O	Omemory	dysfunction	memory	NN	B-NP	Odysfunction	.	dysfunction	NN	I-NP	O.	Until	.	.	O	OUntil	1980	Until	IN	B-PP	O1980	","	1980	CD	B-NP	O","	more	","	","	O	Omore	intensive	more	RBR	B-NP	Ointensive	induction	intensive	JJ	I-NP	Oinduction	","	induction	NN	I-NP	O","	consolidation	","	","	O	Oconsolidation	","	consolidation	NN	B-NP	O","	and	","	","	O	Oand	maintenance	and	CC	O	Omaintenance	therapy	maintenance	NN	B-NP	Otherapy	had	therapy	NN	I-NP	Ohad	failed	have	VBD	B-VP	Ofailed	to	fail	VBN	I-VP	Oto	prolong	to	TO	I-VP	Oprolong	DFS	prolong	VB	I-VP	ODFS	in	DFS	NN	B-NP	B-proteinin	children	in	IN	B-PP	Ochildren	with	child	NNS	B-NP	Owith	a	with	IN	B-PP	Oa	poor	a	DT	B-NP	Opoor	prognosis	poor	JJ	I-NP	Oprognosis	.	prognosis	NN	I-NP	O.	In	.	.	O	OIn	West	In	IN	B-PP	OWest	Germany	West	NNP	B-NP	OGermany	(	Germany	NNP	I-NP	O(	Berlin-Frankfurt-Muenster	(	(	O	OBerlin-Frankfurt-Muenster	protocol	Berlin-Frankfurt-Muenster	NNP	B-NP	Oprotocol	)	protocol	NN	I-NP	O)	a	)	)	O	Oa	70	a	DT	B-NP	O70	to	70	CD	I-NP	Oto	75	to	TO	I-NP	O75	%	75	CD	I-NP	O%	DFS	%	NN	I-NP	ODFS	is	DFS	NN	I-NP	Ois	seen	be	VBZ	B-VP	Oseen	in	see	VBN	I-VP	Oin	all	in	IN	B-PP	Oall	patients	all	DT	B-NP	Opatients	regardless	patient	NNS	I-NP	Oregardless	of	regardless	RB	B-ADVP	Oof	initial	of	IN	B-PP	Oinitial	WBC	initial	JJ	B-NP	OWBC	","	WBC	NN	I-NP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	effective	that	IN	B-SBAR	Oeffective	therapy	effective	JJ	B-NP	Otherapy	will	therapy	NN	I-NP	Owill	override	will	MD	B-VP	Ooverride	prognostic	override	VB	I-VP	Oprognostic	factors	prognostic	JJ	B-NP	Ofactors	.	factor	NNS	I-NP	O.	Ultra-high-dose	.	.	O	OUltra-high-dose	MTX	Ultra-high-dose	JJ	B-NP	OMTX	","	MTX	NN	I-NP	O","	without	","	","	O	Owithout	cranial	without	IN	B-PP	Ocranial	radiation	cranial	JJ	B-NP	Oradiation	","	radiation	NN	I-NP	O","	is	","	","	O	Ois	also	be	VBZ	B-VP	Oalso	showing	also	RB	I-VP	Oshowing	promise	show	VBG	I-VP	Opromise	in	promise	NN	B-NP	Oin	poor	in	IN	B-PP	Opoor	prognosis	poor	JJ	B-NP	Oprognosis	patients	prognosis	NN	I-NP	Opatients	.	patient	NNS	I-NP	O.	Other	.	.	O	OOther	issues	Other	JJ	B-NP	Oissues	include	issue	NNS	I-NP	Oinclude	the	include	VBP	B-VP	Othe	optimal	the	DT	B-NP	Ooptimal	duration	optimal	JJ	I-NP	Oduration	of	duration	NN	I-NP	Oof	therapy	of	IN	B-PP	Otherapy	","	therapy	NN	B-NP	O","	the	","	","	O	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	testicular	of	IN	B-PP	Otesticular	biopsies	testicular	JJ	B-NP	Obiopsies	","	biopsy	NNS	I-NP	O","	and	","	","	O	Oand	prophylactic	and	CC	O	Oprophylactic	testicular	prophylactic	JJ	B-NP	Otesticular	radiation	testicular	JJ	I-NP	Oradiation	.	radiation	NN	I-NP	O.	Recent	.	.	O	ORecent	studies	Recent	JJ	B-NP	Ostudies	suggest	study	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	prognostic	that	IN	B-SBAR	Oprognostic	factors	prognostic	JJ	B-NP	Ofactors	lose	factor	NNS	I-NP	Olose	their	lose	VBP	B-VP	Otheir	significance	their	PRP$	B-NP	Osignificance	after	significance	NN	I-NP	Oafter	2	after	IN	B-PP	O2	years	2	CD	B-NP	Oyears	of	year	NNS	I-NP	Oof	continuous	of	IN	B-PP	Ocontinuous	complete	continuous	JJ	B-NP	Ocomplete	remission	complete	JJ	I-NP	Oremission	and	remission	NN	I-NP	Oand	that	and	CC	O	Othat	2	that	IN	B-SBAR	O2	years	2	CD	B-NP	Oyears	of	year	NNS	I-NP	Oof	maintenance	of	IN	B-PP	Omaintenance	therapy	maintenance	NN	B-NP	Otherapy	is	therapy	NN	I-NP	Ois	adequate	be	VBZ	B-VP	Oadequate	.	adequate	JJ	B-ADJP	O.	Bilateral	.	.	O	OBilateral	open-wedge	Bilateral	JJ	B-NP	Oopen-wedge	testicular	open-wedge	JJ	I-NP	Otesticular	biopsies	testicular	JJ	I-NP	Obiopsies	have	biopsy	NNS	I-NP	Ohave	identified	have	VBP	B-VP	Oidentified	occult	identify	VBN	I-VP	Ooccult	testicular	occult	JJ	B-NP	Otesticular	disease	testicular	JJ	I-NP	Odisease	in	disease	NN	I-NP	Oin	8	in	IN	B-PP	O8	to	8	CD	B-NP	Oto	10	to	TO	I-NP	O10	%	10	CD	I-NP	O%	of	%	NN	I-NP	Oof	males	of	IN	B-PP	Omales	.	male	NNS	B-NP	O.	A	.	.	O	OA	unified	A	DT	B-NP	Ounified	approach	unified	JJ	I-NP	Oapproach	to	approach	NN	I-NP	Oto	children	to	TO	B-PP	Ochildren	with	child	NNS	B-NP	Owith	leukemia/lymphoma	with	IN	B-PP	Oleukemia/lymphoma	","	leukemia/lymphoma	NN	B-NP	O","	a	","	","	O	Oa	group	a	DT	B-NP	Ogroup	with	group	NN	I-NP	Owith	a	with	IN	B-PP	Oa	particularly	a	DT	B-NP	Oparticularly	poor	particularly	RB	I-NP	Opoor	prognosis	poor	JJ	I-NP	Oprognosis	","	prognosis	NN	I-NP	O","	utilizing	","	","	O	Outilizing	NHL-type	utilize	VBG	B-VP	ONHL-type	therapy	NHL-type	JJ	B-NP	Otherapy	may	therapy	NN	I-NP	Omay	be	may	MD	B-VP	Obe	more	be	VB	I-VP	Omore	effective	more	RBR	B-ADJP	Oeffective	than	effective	JJ	I-ADJP	Othan	conventional	than	IN	B-PP	Oconventional	ALL	conventional	JJ	B-NP	OALL	therapy	ALL	NN	I-NP	Otherapy	.	therapy	NN	I-NP	O.	(	.	.	O	O(	ABSTRACT	(	(	O	OABSTRACT	TRUNCATED	ABSTRACT	NN	B-NP	OTRUNCATED	AT	TRUNCATED	VBN	B-VP	OAT	400	AT	IN	B-PP	O400	WORDS	400	CD	B-NP	OWORDS	)	WORDS	NNS	I-NP	O)	Glucocorticoid	)	)	O	OGlucocorticoid	receptor	Glucocorticoid	NN	B-NP	B-proteinreceptor	and	receptor	NN	I-NP	I-proteinand	in	and	CC	O	Oin	vitro	in	FW	B-NP	Ovitro	sensitivity	vitro	FW	I-NP	Osensitivity	to	sensitivity	NN	I-NP	Oto	steroid	to	TO	B-PP	Osteroid	hormones	steroid	NN	B-NP	Ohormones	in	hormone	NNS	I-NP	Oin	human	in	IN	B-PP	Ohuman	lymphoproliferative	human	JJ	B-NP	Olymphoproliferative	diseases	lymphoproliferative	JJ	I-NP	Odiseases	and	disease	NNS	I-NP	Oand	myeloid	and	CC	O	Omyeloid	leukemia	myeloid	JJ	B-NP	Oleukemia	.	leukemia	NN	I-NP	O.	The	.	.	O	OThe	glucocorticoid	The	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	GR	(	(	O	OGR	)	GR	NN	B-NP	B-protein)	quantitation	)	)	O	Oquantitation	by	quantitation	NN	B-NP	Oby	a	by	IN	B-PP	Oa	whole-cell	a	DT	B-NP	Owhole-cell	assay	whole-cell	JJ	I-NP	Oassay	and/or	assay	NN	I-NP	Oand/or	cytosol	and/or	CC	I-NP	Ocytosol	technique	cytosol	NN	I-NP	Otechnique	and	technique	NN	I-NP	Oand	the	and	CC	O	Othe	in	the	DT	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	sensitivity	vitro	FW	I-NP	Osensitivity	to	sensitivity	NN	I-NP	Oto	steroids	to	TO	B-PP	Osteroids	have	steroid	NNS	B-NP	Ohave	been	have	VBP	B-VP	Obeen	assessed	be	VBN	I-VP	Oassessed	in	assess	VBN	I-VP	Oin	peripheral	in	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	cells	blood	NN	I-NP	I-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	normal	from	IN	B-PP	Onormal	donors	normal	JJ	B-NP	Odonors	and	donor	NNS	I-NP	Oand	patients	and	CC	O	Opatients	with	patient	NNS	B-NP	Owith	chronic	with	IN	B-PP	Ochronic	lymphatic	chronic	JJ	B-NP	Olymphatic	leukemia	lymphatic	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	CLL	(	(	O	OCLL	)	CLL	NN	B-NP	O)	","	)	)	O	O","	acute	","	","	O	Oacute	lymphoblastic	acute	JJ	B-NP	Olymphoblastic	leukemia	lymphoblastic	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	ALL	(	(	O	OALL	)	ALL	NN	B-NP	O)	","	)	)	O	O","	lymphosarcoma	","	","	O	Olymphosarcoma	cell	lymphosarcoma	NN	B-NP	Ocell	leukemia	cell	NN	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	LSCL	(	(	O	OLSCL	)	LSCL	NN	B-NP	B-protein)	","	)	)	O	O","	acute	","	","	O	Oacute	nonlymphatic	acute	JJ	B-NP	Ononlymphatic	leukemia	nonlymphatic	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	ANLL	(	(	O	OANLL	)	ANLL	NN	B-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	chronic	and	CC	O	Ochronic	myeloid	chronic	JJ	B-NP	Omyeloid	leukemia	myeloid	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	CML	(	(	O	OCML	)	CML	NN	B-NP	O)	.	)	)	O	O.	Within	.	.	O	OWithin	the	Within	IN	B-PP	Othe	lymphoproliferative	the	DT	B-NP	Olymphoproliferative	diseases	lymphoproliferative	JJ	I-NP	Odiseases	","	disease	NNS	I-NP	O","	ALL	","	","	O	OALL	cells	ALL	NN	B-NP	B-cell_linecells	exhibited	cell	NNS	I-NP	I-cell_lineexhibited	the	exhibit	VBD	B-VP	Othe	highest	the	DT	B-NP	Ohighest	GR	high	JJS	I-NP	OGR	concentration	GR	NN	I-NP	B-proteinconcentration	(	concentration	NN	I-NP	O(	regardless	(	(	O	Oregardless	of	regardless	RB	B-ADVP	Oof	the	of	IN	B-PP	Othe	method	the	DT	B-NP	Omethod	used	method	NN	I-NP	Oused	)	use	VBN	B-VP	O)	and	)	)	O	Oand	the	and	CC	O	Othe	highest	the	DT	B-NP	Ohighest	in	high	JJS	I-NP	Oin	vitro	in	FW	I-NP	Ovitro	inhibition	vitro	FW	I-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	spontaneous	of	IN	B-PP	Ospontaneous	[	spontaneous	JJ	B-NP	O[	3H	[	(	I-NP	O3H	]	3H	NN	I-NP	O]	thymidine	]	)	O	Othymidine	(	thymidine	NN	B-NP	O(	[	(	(	O	O[	3H	[	(	O	O3H	]	3H	NN	O	O]	TdR	]	)	O	OTdR	)	TdR	NN	B-NP	O)	uptake	)	)	O	Ouptake	by	uptake	NN	B-NP	Oby	glucocorticoids	by	IN	B-PP	Oglucocorticoids	.	glucocorticoid	NNS	B-NP	O.	A	.	.	O	OA	significant	A	DT	B-NP	Osignificant	relationship	significant	JJ	I-NP	Orelationship	between	relationship	NN	I-NP	Obetween	GR	between	IN	B-PP	OGR	concentration	GR	NN	B-NP	B-proteinconcentration	(	concentration	NN	I-NP	O(	whole-cell	(	(	O	Owhole-cell	assay	whole-cell	JJ	B-NP	Oassay	)	assay	NN	I-NP	O)	and	)	)	O	Oand	in	and	CC	O	Oin	vitro	in	FW	B-NP	Ovitro	sensitivity	vitro	FW	I-NP	Osensitivity	to	sensitivity	NN	I-NP	Oto	dexamethasone	to	TO	B-PP	Odexamethasone	was	dexamethasone	NN	B-NP	Owas	also	be	VBD	B-VP	Oalso	found	also	RB	I-VP	Ofound	.	find	VBN	I-VP	O.	On	.	.	O	OOn	the	On	IN	B-PP	Othe	contrary	the	DT	B-NP	Ocontrary	","	contrary	NN	I-NP	O","	CLL	","	","	O	OCLL	cells	CLL	NN	B-NP	B-cell_linecells	presented	cell	NNS	I-NP	I-cell_linepresented	the	present	VBD	B-VP	Othe	highest	the	DT	B-NP	Ohighest	sensitivity	high	JJS	I-NP	Osensitivity	to	sensitivity	NN	I-NP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	in	glucocorticoid	NNS	B-NP	Oin	PHA-stimulated	in	IN	B-PP	OPHA-stimulated	cell	PHA-stimulated	JJ	B-NP	B-cell_linecell	cultures	cell	NN	I-NP	I-cell_linecultures	.	culture	NNS	I-NP	I-cell_line.	Cells	.	.	O	OCells	from	Cell	NNS	B-NP	Ofrom	the	from	IN	B-PP	Othe	only	the	DT	B-NP	Oonly	two	only	JJ	I-NP	Otwo	ALL	two	CD	I-NP	OALL	patients	ALL	NN	I-NP	Opatients	who	patient	NNS	I-NP	Owho	did	who	WP	B-NP	Odid	not	do	VBD	B-VP	Onot	undergo	not	RB	I-VP	Oundergo	a	undergo	VB	I-VP	Oa	remission	a	DT	B-NP	Oremission	after	remission	NN	I-NP	Oafter	glucocorticoid-inclusive	after	IN	B-PP	Oglucocorticoid-inclusive	chemotherapy	glucocorticoid-inclusive	JJ	B-NP	Ochemotherapy	had	chemotherapy	NN	I-NP	Ohad	both	have	VBD	B-VP	Oboth	the	both	CC	O	Othe	lowest	the	DT	B-NP	Olowest	in	low	JJS	I-NP	Oin	vitro	in	FW	I-NP	Ovitro	sensitivity	vitro	FW	I-NP	Osensitivity	to	sensitivity	NN	I-NP	Oto	dexamethasone	to	TO	B-PP	Odexamethasone	and	dexamethasone	NN	B-NP	Oand	the	and	CC	O	Othe	lowest	the	DT	B-NP	Olowest	GR	low	JJS	I-NP	OGR	concentration	GR	NN	I-NP	B-proteinconcentration	with	concentration	NN	I-NP	Owith	whole-cell	with	IN	B-PP	Owhole-cell	assay	whole-cell	JJ	B-NP	Oassay	.	assay	NN	I-NP	O.	Concerning	.	.	O	OConcerning	myeloid	Concern	VBG	B-VP	Omyeloid	leukemia	myeloid	JJ	B-NP	Oleukemia	","	leukemia	NN	I-NP	O","	ANLL	","	","	O	OANLL	patients	ANLL	NN	B-NP	Opatients	had	patient	NNS	I-NP	Ohad	GR	have	VBD	B-VP	OGR	concentrations	GR	NN	B-NP	B-proteinconcentrations	slightly	concentration	NNS	I-NP	Oslightly	higher	slightly	RB	B-ADJP	Ohigher	than	high	JJR	I-ADJP	Othan	those	than	IN	B-PP	Othose	found	those	DT	B-NP	Ofound	in	find	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	ALL	the	DT	B-NP	OALL	group	ALL	NN	I-NP	Ogroup	but	group	NN	I-NP	Obut	exhibited	but	CC	O	Oexhibited	the	exhibit	VBD	B-VP	Othe	lowest	the	DT	B-NP	Olowest	degree	low	JJS	I-NP	Odegree	of	degree	NN	I-NP	Oof	inhibition	of	IN	B-PP	Oinhibition	of	inhibition	NN	B-NP	Oof	spontaneous	of	IN	B-PP	Ospontaneous	[	spontaneous	JJ	B-NP	O[	3H	[	(	I-NP	O3H	]	3H	NN	I-NP	O]	TdR	]	)	I-NP	OTdR	uptake	TdR	NN	I-NP	Ouptake	by	uptake	NN	I-NP	Oby	dexamethasone	by	IN	B-PP	Odexamethasone	(	dexamethasone	NN	B-NP	O(	stimulatory	(	(	O	Ostimulatory	effects	stimulatory	JJ	B-NP	Oeffects	occurred	effect	NNS	I-NP	Ooccurred	in	occur	VBD	B-VP	Oin	some	in	IN	B-PP	Osome	cases	some	DT	B-NP	Ocases	)	case	NNS	I-NP	O)	.	)	)	O	O.	CML	.	.	O	OCML	cells	CML	NN	B-NP	B-cell_typecells	exhibited	cell	NNS	I-NP	I-cell_typeexhibited	an	exhibit	VBD	B-VP	Oan	inhibition	an	DT	B-NP	Oinhibition	degree	inhibition	NN	I-NP	Odegree	by	degree	NN	I-NP	Oby	in	by	IN	B-PP	Oin	vitro	in	FW	B-NP	Ovitro	glucocorticoids	vitro	FW	I-NP	Oglucocorticoids	significantly	glucocorticoid	NNS	I-NP	Osignificantly	higher	significantly	RB	B-ADJP	Ohigher	than	high	JJR	I-ADJP	Othan	that	than	IN	B-PP	Othat	of	that	DT	B-NP	Oof	ANLL	of	IN	B-PP	OANLL	cells	ANLL	NN	B-NP	B-cell_linecells	but	cell	NNS	I-NP	I-cell_linebut	not	but	CC	O	Onot	different	not	RB	B-ADJP	Odifferent	from	different	JJ	I-ADJP	Ofrom	that	from	IN	B-PP	Othat	of	that	DT	B-NP	Oof	lymphoproliferative	of	IN	B-PP	Olymphoproliferative	diseases	lymphoproliferative	JJ	B-NP	Odiseases	.	disease	NNS	I-NP	O.	No	.	.	O	ONo	clear	No	DT	B-NP	Oclear	relationship	clear	JJ	I-NP	Orelationship	among	relationship	NN	I-NP	Oamong	GR	among	IN	B-PP	OGR	pattern	GR	NN	B-NP	B-proteinpattern	","	pattern	NN	I-NP	O","	in	","	","	O	Oin	vitro	in	FW	B-NP	Ovitro	cell	vitro	FW	I-NP	Ocell	sensitivity	cell	NN	I-NP	Osensitivity	to	sensitivity	NN	I-NP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	","	glucocorticoid	NNS	B-NP	O","	and	","	","	O	Oand	clinicohematologic	and	CC	O	Oclinicohematologic	parameters	clinicohematologic	JJ	B-NP	Oparameters	was	parameter	NNS	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	myeloid	in	IN	B-PP	Omyeloid	leukemia-bearing	myeloid	JJ	B-NP	Oleukemia-bearing	patients	leukemia-bearing	JJ	I-NP	Opatients	.	patient	NNS	I-NP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	receptors	Glucocorticoid	NN	B-NP	B-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	in	and	CC	O	Oin	vitro	in	FW	B-NP	Ovitro	corticosensitivity	vitro	FW	I-NP	Ocorticosensitivity	of	corticosensitivity	NN	I-NP	Oof	peanut-positive	of	IN	B-PP	Opeanut-positive	and	peanut-positive	JJ	B-NP	Oand	peanut-negative	and	CC	I-NP	Opeanut-negative	human	peanut-negative	JJ	I-NP	Ohuman	thymocyte	human	JJ	I-NP	Othymocyte	subpopulations	thymocyte	NN	I-NP	Osubpopulations	.	subpopulation	NNS	I-NP	O.	In	.	.	O	OIn	6	In	IN	B-PP	O6	human	6	CD	B-NP	Ohuman	thymus	human	JJ	I-NP	Othymus	glands	thymus	NN	I-NP	Oglands	","	gland	NNS	I-NP	O","	the	","	","	O	Othe	immature	the	DT	B-NP	Oimmature	subset	immature	JJ	I-NP	B-cell_typesubset	of	subset	NN	I-NP	I-cell_typeof	thymocytes	of	IN	B-PP	Othymocytes	was	thymocyte	NNS	B-NP	B-cell_typewas	separated	be	VBD	B-VP	Oseparated	from	separate	VBN	I-VP	Ofrom	the	from	IN	B-PP	Othe	more	the	DT	B-NP	Omore	mature	more	RBR	I-NP	Omature	one	mature	JJ	I-NP	Oone	","	one	CD	I-NP	O","	by	","	","	O	Oby	differential	by	IN	B-PP	Odifferential	peanut	differential	JJ	B-NP	Opeanut	lectin	peanut	NN	I-NP	Olectin	agglutination	lectin	NN	I-NP	Oagglutination	.	agglutination	NN	I-NP	O.	These	.	.	O	OThese	2	These	DT	B-NP	O2	cell	2	CD	I-NP	Ocell	subpopulations	cell	NN	I-NP	Osubpopulations	were	subpopulation	NNS	I-NP	Owere	analyzed	be	VBD	B-VP	Oanalyzed	for	analyze	VBN	I-VP	Ofor	glucocorticoid	for	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	content	receptor	NN	I-NP	I-proteincontent	by	content	NN	I-NP	Oby	using	by	IN	B-PP	Ousing	a	use	VBG	B-VP	Oa	whole	a	DT	B-NP	Owhole	cell	whole	JJ	I-NP	Ocell	assay	cell	NN	I-NP	Oassay	","	assay	NN	I-NP	O","	with	","	","	O	Owith	(	with	IN	B-PP	O(	3H	(	(	O	O3H	)	3H	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	acetonide	#NAME?	JJ	B-NP	Oacetonide	as	acetonide	NN	I-NP	Oas	tracer	as	IN	B-PP	Otracer	.	tracer	NN	B-NP	O.	The	.	.	O	OThe	unagglutinated	The	DT	B-NP	Ounagglutinated	thymocytes	unagglutinated	JJ	I-NP	B-cell_typethymocytes	(	thymocyte	NNS	I-NP	I-cell_type(	peanut	(	(	O	Opeanut	negative	peanut	NN	B-NP	Onegative	)	negative	JJ	I-NP	O)	contained	)	)	O	Ocontained	about	contain	VBD	B-VP	Oabout	2	about	RB	B-NP	O2	times	2	CD	I-NP	Otimes	more	time	NNS	I-NP	Omore	receptor	more	JJR	I-NP	Oreceptor	sites	receptor	NN	I-NP	Osites	per	site	NNS	I-NP	Oper	cell	per	IN	B-PP	Ocell	than	cell	NN	B-NP	Othan	agglutinated	than	IN	B-SBAR	Oagglutinated	(	agglutinate	VBN	B-VP	O(	peanut	(	(	O	Opeanut	positive	peanut	NN	B-NP	Opositive	)	positive	JJ	B-ADJP	O)	ones	)	)	O	Oones	(	one	NNS	B-NP	O(	7650	(	(	O	O7650	+/-	7650	CD	B-NP	O+/-	1550	+/-	CC	I-NP	O1550	S.D.	1550	CD	I-NP	OS.D.	verus	S.D.	NNP	I-NP	Overus	3195	verus	CC	O	O3195	+/-	3195	CD	B-NP	O+/-	896	+/-	CC	I-NP	O896	S.D.	896	CD	I-NP	OS.D.	)	S.D.	NNP	I-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	affinity	The	DT	B-NP	Oaffinity	for	affinity	NN	I-NP	Ofor	steroid	for	IN	B-PP	Osteroid	was	steroid	NN	B-NP	Owas	similar	be	VBD	B-VP	Osimilar	in	similar	JJ	B-ADJP	Oin	both	in	IN	B-PP	Oboth	cell	both	DT	B-NP	Ocell	subsets	cell	NN	I-NP	B-cell_typesubsets	","	subset	NNS	I-NP	I-cell_type","	as	","	","	O	Oas	was	as	IN	B-SBAR	Owas	the	be	VBD	B-VP	Othe	stereospecificity	the	DT	B-NP	Ostereospecificity	for	stereospecificity	NN	I-NP	Ofor	glucocorticoids	for	IN	B-PP	Oglucocorticoids	","	glucocorticoid	NNS	B-NP	O","	the	","	","	O	Othe	time-course	the	DT	B-NP	Otime-course	of	time-course	NN	I-NP	Oof	steroid-receptor	of	IN	B-PP	Osteroid-receptor	association	steroid-receptor	JJ	B-NP	Oassociation	","	association	NN	I-NP	O","	and	","	","	O	Oand	cytoplasmic	and	CC	O	Ocytoplasmic	to	cytoplasmic	JJ	B-ADJP	Oto	nuclear	to	TO	B-PP	Onuclear	translocation	nuclear	JJ	B-NP	Otranslocation	.	translocation	NN	I-NP	O.	Despite	.	.	O	ODespite	the	Despite	IN	B-PP	Othe	greater	the	DT	B-NP	Ogreater	number	great	JJR	I-NP	Onumber	of	number	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	sites	receptor	NN	I-NP	I-proteinsites	","	site	NNS	I-NP	O","	the	","	","	O	Othe	peanut-negative	the	DT	B-NP	Opeanut-negative	thymocyte	peanut-negative	JJ	I-NP	Othymocyte	subpopulation	thymocyte	NN	I-NP	Osubpopulation	did	subpopulation	NN	I-NP	Odid	not	do	VBD	B-VP	Onot	differ	not	RB	I-VP	Odiffer	from	differ	VB	I-VP	Ofrom	the	from	IN	B-PP	Othe	peanut-positive	the	DT	B-NP	Opeanut-positive	one	peanut-positive	JJ	I-NP	Oone	in	one	CD	I-NP	Oin	its	in	IN	B-PP	Oits	sensitivity	its	PRP$	B-NP	Osensitivity	to	sensitivity	NN	I-NP	Oto	the	to	TO	B-PP	Othe	inhibitory	the	DT	B-NP	Oinhibitory	effects	inhibitory	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	triamcinolone	of	IN	B-PP	Otriamcinolone	acetonide	triamcinolone	NN	B-NP	Oacetonide	","	acetonide	NN	I-NP	O","	as	","	","	O	Oas	determined	as	IN	B-SBAR	Odetermined	by	determine	VBN	B-VP	Oby	measurements	by	IN	B-PP	Omeasurements	of	measurement	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	incorporation	the	DT	B-NP	Oincorporation	of	incorporation	NN	I-NP	Oof	radiolabeled	of	IN	B-PP	Oradiolabeled	precursors	radiolabele	VBN	B-NP	Oprecursors	of	precursor	NNS	I-NP	Oof	protein	of	IN	B-PP	Oprotein	and	protein	NN	B-NP	Oand	DNA	and	CC	I-NP	ODNA	.	DNA	NN	I-NP	O.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	the	","	","	O	Othe	peanut-negative	the	DT	B-NP	Opeanut-negative	subset	peanut-negative	JJ	I-NP	Osubset	appeared	subset	NN	I-NP	Oappeared	more	appear	VBD	B-VP	Omore	resistant	more	RBR	B-ADJP	Oresistant	in	resistant	JJ	I-ADJP	Oin	vitro	in	FW	B-ADVP	Ovitro	to	vitro	FW	I-ADVP	Oto	the	to	TO	B-PP	Othe	steroid-induced	the	DT	B-NP	Osteroid-induced	cell	steroid-induced	JJ	I-NP	Ocell	lysis	cell	NN	I-NP	Olysis	as	lysis	NN	I-NP	Oas	compared	as	IN	B-SBAR	Ocompared	to	compare	VBN	B-PP	Oto	the	to	TO	B-PP	Othe	peanut-positive	the	DT	B-NP	Opeanut-positive	one	peanut-positive	JJ	I-NP	Oone	.	one	CD	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	our	","	","	O	Oour	data	our	PRP$	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	glucocorticoid	that	IN	B-SBAR	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	density	receptor	NN	I-NP	I-proteindensity	and	density	NN	I-NP	Oand	corticosensitivity	and	CC	I-NP	Ocorticosensitivity	are	corticosensitivity	NN	I-NP	Oare	not	be	VBP	B-VP	Onot	directly	not	RB	I-VP	Odirectly	correlated	directly	RB	I-VP	Ocorrelated	and	correlate	VBN	I-VP	Oand	that	and	CC	O	Othat	the	that	IN	B-SBAR	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	sites	receptor	NN	I-NP	I-proteinsites	may	site	NNS	I-NP	Omay	be	may	MD	B-VP	Obe	dependent	be	VB	I-VP	Odependent	on	dependent	JJ	B-ADJP	Oon	the	on	IN	B-PP	Othe	degree	the	DT	B-NP	Odegree	of	degree	NN	I-NP	Oof	immunologic	of	IN	B-PP	Oimmunologic	maturation	immunologic	JJ	B-NP	Omaturation	Defective	maturation	NN	I-NP	ODefective	binding	Defective	JJ	B-NP	Obinding	and	binding	NN	I-NP	Oand	function	and	CC	I-NP	Ofunction	of	function	NN	I-NP	Oof	1	of	IN	B-PP	O1	","	1	CD	B-NP	B-protein","	25-dihydroxyvitamin	","	","	O	I-protein25-dihydroxyvitamin	D3	25-dihydroxyvitamin	NN	B-NP	I-proteinD3	receptors	D3	NN	I-NP	I-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	peripheral	in	IN	B-PP	Operipheral	mononuclear	peripheral	JJ	B-NP	B-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	of	cell	NNS	I-NP	I-cell_typeof	patients	of	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	end-organ	with	IN	B-PP	Oend-organ	resistance	end-organ	JJ	B-NP	Oresistance	to	resistance	NN	I-NP	Oto	1	to	TO	B-PP	O1	","	1	CD	B-NP	O","	25-dihydroxyvitamin	","	","	O	O25-dihydroxyvitamin	D	25-dihydroxyvitamin	NN	B-NP	OD	.	D	NN	I-NP	O.	Lectin-induced	.	.	O	OLectin-induced	DNA	Lectin-induced	JJ	B-NP	ODNA	synthesis	DNA	NN	I-NP	Osynthesis	by	synthesis	NN	I-NP	Oby	peripheral	by	IN	B-PP	Operipheral	mononuclear	peripheral	JJ	B-NP	B-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	17	from	IN	B-PP	O17	normal	17	CD	B-NP	Onormal	donors	normal	JJ	I-NP	Odonors	was	donor	NNS	I-NP	Owas	inhibited	be	VBD	B-VP	Oinhibited	(	inhibit	VBN	I-VP	O(	40-60	(	(	O	O40-60	%	40-60	CD	B-NP	O%	)	%	NN	I-NP	O)	by	)	)	O	Oby	1	by	IN	B-PP	O1	","	1	CD	B-NP	O","	25-dihydroxyvitamin	","	","	O	O25-dihydroxyvitamin	D3	25-dihydroxyvitamin	NN	B-NP	OD3	(	D3	NN	I-NP	O(	1	(	(	O	O1	","	1	CD	B-NP	O","	25	","	","	I-NP	O25	[	25	CD	I-NP	O[	OH	[	(	O	OOH	]	OH	NN	B-NP	O]	2D3	]	)	O	O2D3	)	2D3	NN	B-NP	O)	at	)	)	O	Oat	physiological	at	IN	B-PP	Ophysiological	concentrations	physiological	JJ	B-NP	Oconcentrations	(	concentration	NNS	I-NP	O(	10	(	(	O	O10	(	10	CD	B-NP	O(	-10	(	(	O	O-10	)	-10	CD	B-NP	O)	-10	)	)	O	O-10	(	-10	CD	B-NP	O(	-9	(	(	O	O-9	)	-9	CD	B-NP	O)	M	)	)	O	OM	)	M	NN	B-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	lymphocytes	The	DT	B-NP	Olymphocytes	acquire	lymphocyte	NNS	I-NP	B-cell_typeacquire	specific	acquire	VBP	B-VP	Ospecific	receptors	specific	JJ	B-NP	Oreceptors	for	receptor	NNS	I-NP	Ofor	1	for	IN	B-PP	O1	","	1	CD	B-NP	O","	25	","	","	I-NP	O25	(	25	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	upon	2D3	NN	B-NP	Oupon	activation	upon	IN	B-PP	Oactivation	by	activation	NN	B-NP	Oby	the	by	IN	B-PP	Othe	lectins	the	DT	B-NP	Olectins	.	lectin	NNS	I-NP	B-protein.	This	.	.	O	OThis	process	This	DT	B-NP	Oprocess	precedes	process	NN	I-NP	Oprecedes	the	precede	VBZ	B-VP	Othe	inhibitory	the	DT	B-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	1	of	IN	B-PP	O1	","	1	CD	B-NP	O","	25	","	","	I-NP	O25	(	25	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	.	2D3	NN	B-NP	O.	We	.	.	O	OWe	studied	We	PRP	B-NP	Ostudied	lymphocytes	study	VBD	B-VP	Olymphocytes	from	lymphocyte	NNS	B-NP	B-cell_typefrom	six	from	IN	B-PP	Osix	patients	six	CD	B-NP	Opatients	from	patient	NNS	I-NP	Ofrom	four	from	IN	B-PP	Ofour	different	four	CD	B-NP	Odifferent	kindreds	different	JJ	I-NP	Okindreds	with	kindred	NNS	I-NP	Owith	the	with	IN	B-PP	Othe	syndrome	the	DT	B-NP	Osyndrome	of	syndrome	NN	I-NP	Oof	hereditary	of	IN	B-PP	Ohereditary	end-organ	hereditary	JJ	B-NP	Oend-organ	resistance	end-organ	JJ	I-NP	Oresistance	to	resistance	NN	I-NP	Oto	1	to	TO	B-PP	O1	","	1	CD	B-NP	O","	25	","	","	I-NP	O25	(	25	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D	)	)	O	O2D	(	2D	NN	B-NP	O(	the	(	(	O	Othe	so-called	the	DT	B-NP	Oso-called	vitamin	so-called	JJ	I-NP	Ovitamin	D-dependent	vitamin	NN	I-NP	OD-dependent	rickets	D-dependent	JJ	I-NP	Orickets	type	ricket	NNS	I-NP	Otype	II	type	NN	I-NP	OII	)	II	CD	I-NP	O)	.	)	)	O	O.	In	.	.	O	OIn	five	In	IN	B-PP	Ofive	patients	five	CD	B-NP	Opatients	(	patient	NNS	I-NP	O(	three	(	(	O	Othree	kindreds	three	CD	B-NP	Okindreds	)	kindred	NNS	I-NP	O)	peripheral	)	)	O	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	did	cell	NNS	I-NP	I-cell_typedid	not	do	VBD	B-VP	Onot	acquire	not	RB	I-VP	Oacquire	receptors	acquire	VB	I-VP	Oreceptors	for	receptor	NNS	B-NP	Ofor	1	for	IN	B-PP	O1	","	1	CD	B-NP	O","	25	","	","	I-NP	O25	(	25	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	upon	2D3	NN	B-NP	Oupon	phytohemagglutinin-induced	upon	IN	B-PP	Ophytohemagglutinin-induced	activation	phytohemagglutinin-induced	JJ	B-NP	Oactivation	.	activation	NN	I-NP	O.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	in	","	","	O	Oin	contrast	in	IN	B-PP	Ocontrast	to	contrast	NN	B-NP	Oto	normal	to	TO	B-PP	Onormal	lymphocytes	normal	JJ	B-NP	B-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	the	","	","	O	Othe	mitogenic	the	DT	B-NP	Omitogenic	stimulation	mitogenic	JJ	I-NP	Ostimulation	of	stimulation	NN	I-NP	Oof	these	of	IN	B-PP	Othese	patients	these	DT	B-NP	Opatients	'	patient	NNS	I-NP	O'	lymphocytes	'	POS	B-NP	Olymphocytes	by	lymphocyte	NNS	I-NP	B-cell_typeby	phytohemagglutinin	by	IN	B-PP	Ophytohemagglutinin	and	phytohemagglutinin	NN	B-NP	B-proteinand	concanavalin	and	CC	I-NP	Oconcanavalin	A	concanavalin	NN	I-NP	OA	was	A	NN	I-NP	Owas	not	be	VBD	B-VP	Onot	inhibited	not	RB	I-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	1	by	IN	B-PP	O1	","	1	CD	B-NP	O","	25	","	","	I-NP	O25	(	25	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	.	2D3	NN	B-NP	O.	Activated	.	.	O	OActivated	lymphocytes	Activate	VBN	B-NP	B-cell_typelymphocytes	of	lymphocyte	NNS	I-NP	I-cell_typeof	the	of	IN	B-PP	Othe	sixth	the	DT	B-NP	Osixth	patient	sixth	JJ	I-NP	Opatient	from	patient	NN	I-NP	Ofrom	a	from	IN	B-PP	Oa	fourth	a	DT	B-NP	Ofourth	kindred	fourth	JJ	I-NP	Okindred	exhibited	kindred	NN	I-NP	Oexhibited	normal	exhibit	VBD	B-VP	Onormal	binding	normal	JJ	B-NP	Obinding	of	binding	NN	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	1	]	)	I-NP	O1	","	1	CD	I-NP	O","	25	","	","	I-NP	O25	(	25	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	but	2D3	NN	B-NP	Obut	the	but	CC	O	Othe	hormone	the	DT	B-NP	Ohormone	failed	hormone	NN	I-NP	Ofailed	to	fail	VBD	B-VP	Oto	inhibit	to	TO	I-VP	Oinhibit	the	inhibit	VB	I-VP	Othe	mitogenic	the	DT	B-NP	Omitogenic	stimulation	mitogenic	JJ	I-NP	Ostimulation	.	stimulation	NN	I-NP	O.	A	.	.	O	OA	similar	A	DT	B-NP	Osimilar	pattern	similar	JJ	I-NP	Opattern	of	pattern	NN	I-NP	Oof	the	of	IN	B-PP	Othe	vitamin	the	DT	B-NP	Ovitamin	D	vitamin	NN	I-NP	OD	effector	D	NN	I-NP	Oeffector	system	effector	NN	I-NP	Osystem	was	system	NN	I-NP	Owas	previously	be	VBD	B-VP	Opreviously	observed	previously	RB	I-VP	Oobserved	in	observe	VBN	I-VP	Oin	fibroblasts	in	IN	B-PP	Ofibroblasts	cultured	fibroblast	NNS	B-NP	B-cell_typecultured	from	culture	VBN	B-VP	Ofrom	skin	from	IN	B-PP	Oskin	biopsies	skin	NN	B-NP	Obiopsies	of	biopsy	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	same	the	DT	B-NP	Osame	group	same	JJ	I-NP	Ogroup	of	group	NN	I-NP	Oof	patients	of	IN	B-PP	Opatients	.	patient	NNS	B-NP	O.	The	.	.	O	OThe	conclusions	The	DT	B-NP	Oconclusions	from	conclusion	NNS	I-NP	Ofrom	these	from	IN	B-PP	Othese	findings	these	DT	B-NP	Ofindings	are	finding	NNS	I-NP	Oare	:	be	VBP	B-VP	O:	(	:	:	O	O(	a	(	(	B-LST	Oa	)	a	LS	I-LST	O)	the	)	)	O	Othe	inhibition	the	DT	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	mitogenic	of	IN	B-PP	Omitogenic	stimulation	mitogenic	JJ	B-NP	Ostimulation	by	stimulation	NN	I-NP	Oby	1	by	IN	B-PP	O1	","	1	CD	B-NP	O","	25	","	","	I-NP	O25	(	25	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	is	2D3	NN	B-NP	Ois	mediated	be	VBZ	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	specific	by	IN	B-PP	Ospecific	functional	specific	JJ	B-NP	Ofunctional	receptors	functional	JJ	I-NP	Oreceptors	to	receptor	NNS	I-NP	Oto	the	to	TO	B-PP	Othe	hormone	the	DT	B-NP	Ohormone	;	hormone	NN	I-NP	O;	and	;	:	O	Oand	(	and	CC	O	O(	b	(	(	B-LST	Ob	)	b	LS	I-LST	O)	the	)	)	O	Othe	receptors	the	DT	B-NP	Oreceptors	for	receptor	NNS	I-NP	Ofor	1	for	IN	B-PP	O1	","	1	CD	B-NP	O","	25	","	","	I-NP	O25	(	25	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	in	2D3	NN	B-NP	Oin	mononuclear	in	IN	B-PP	Omononuclear	cells	mononuclear	JJ	B-NP	B-cell_typecells	are	cell	NNS	I-NP	I-cell_typeare	probably	be	VBP	B-VP	Oprobably	controlled	probably	RB	I-VP	Ocontrolled	genetically	control	VBN	I-VP	Ogenetically	by	genetically	RB	B-ADVP	Oby	the	by	IN	B-PP	Othe	same	the	DT	B-NP	Osame	mechanisms	same	JJ	I-NP	Omechanisms	as	mechanism	NNS	I-NP	Oas	the	as	IN	B-PP	Othe	effector	the	DT	B-NP	Oeffector	system	effector	NN	I-NP	Osystem	in	system	NN	I-NP	Oin	well-characterized	in	IN	B-PP	Owell-characterized	target	well-characterized	JJ	B-NP	Otarget	organs	target	NN	I-NP	Oorgans	of	organ	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	hormone	the	DT	B-NP	Ohormone	","	hormone	NN	I-NP	O","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	intestine	as	IN	I-PP	Ointestine	and	intestine	NN	B-NP	Oand	kidney	and	CC	I-NP	Okidney	.	kidney	NN	I-NP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	receptors	Glucocorticoid	NN	B-NP	B-proteinreceptors	of	receptor	NNS	I-NP	I-proteinof	mononuclear	of	IN	B-PP	Omononuclear	leukocytes	mononuclear	JJ	B-NP	B-cell_typeleukocytes	from	leukocyte	NNS	I-NP	I-cell_typefrom	myasthenia	from	IN	B-PP	Omyasthenia	gravis	myasthenia	NN	B-NP	Ogravis	patients	gravis	NN	I-NP	Opatients	.	patient	NNS	I-NP	O.	The	.	.	O	OThe	present	The	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	was	study	NN	I-NP	Owas	performed	be	VBD	B-VP	Operformed	to	perform	VBN	I-VP	Oto	analyse	to	TO	I-VP	Oanalyse	glucocorticoid	analyse	VB	I-VP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	GR	(	(	O	OGR	)	GR	NN	B-NP	B-protein)	binding	)	)	O	Obinding	in	binding	NN	B-NP	Oin	peripheral	in	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	leukocytes	mononuclear	JJ	I-NP	I-cell_typeleukocytes	(	leukocyte	NNS	I-NP	I-cell_type(	MNL	(	(	O	OMNL	)	MNL	NNS	B-NP	B-cell_type)	from	)	)	O	Ofrom	39	from	IN	B-PP	O39	myasthenia	39	CD	B-NP	Omyasthenia	gravis	myasthenia	NN	I-NP	Ogravis	(	gravis	NN	I-NP	O(	MG	(	(	O	OMG	)	MG	NN	B-NP	O)	patients	)	)	O	Opatients	(	patient	NNS	B-NP	O(	unoperated	(	(	O	Ounoperated	patients	unoperated	JJ	B-NP	Opatients	(	patient	NNS	I-NP	O(	n	(	(	O	On	=	n	NN	B-NP	O=	13	=	SYM	B-VP	O13	)	13	CD	B-NP	O)	","	)	)	O	O","	thymectomized	","	","	O	Othymectomized	patients	thymectomize	VBN	B-NP	Opatients	(	patient	NNS	I-NP	O(	n	(	(	O	On	=	n	NN	B-NP	O=	14	=	SYM	B-VP	O14	)	14	CD	B-NP	O)	and	)	)	O	Oand	patients	and	CC	O	Opatients	receiving	patient	NNS	B-NP	Oreceiving	glucocorticoids	receive	VBG	B-VP	Oglucocorticoids	:	glucocorticoid	NNS	B-NP	O:	thymectomized	:	:	O	Othymectomized	(	thymectomize	VBN	B-VP	O(	n	(	(	O	On	=	n	NN	B-NP	O=	11	=	SYM	B-VP	O11	)	11	CD	B-NP	O)	and	)	)	O	Oand	unoperated	and	CC	O	Ounoperated	(	unoperated	JJ	B-NP	O(	n	(	(	O	On	=	n	NN	B-NP	O=	6	=	SYM	B-VP	O6	]	6	CD	B-NP	O]	.	]	)	O	O.	A	.	.	O	OA	whole	A	DT	B-NP	Owhole	cell	whole	JJ	I-NP	Ocell	binding	cell	NN	I-NP	Obinding	assay	binding	NN	I-NP	Oassay	with	assay	NN	I-NP	Owith	3	with	IN	B-PP	O3	(	3	CD	B-NP	O(	H	(	(	O	OH	)	H	NN	B-NP	O)	dexamethasone	)	)	O	Odexamethasone	was	dexamethasone	NN	B-NP	Owas	used	be	VBD	B-VP	Oused	.	use	VBN	I-VP	O.	GR	.	.	O	OGR	mean	GR	NN	B-NP	B-proteinmean	values	mean	NN	I-NP	Ovalues	were	value	NNS	I-NP	Owere	significantly	be	VBD	B-VP	Osignificantly	higher	significantly	RB	B-ADJP	Ohigher	in	high	JJR	I-ADJP	Oin	the	in	IN	B-PP	Othe	MNL	the	DT	B-NP	OMNL	of	MNL	NN	I-NP	B-cell_typeof	MG	of	IN	B-PP	OMG	patients	MG	NN	B-NP	Opatients	(	patient	NNS	I-NP	O(	thymectomized	(	(	O	Othymectomized	or	thymectomize	VBN	B-VP	Oor	not	or	CC	O	Onot	)	not	RB	O	O)	not	)	)	O	Onot	receiving	not	RB	O	Oreceiving	glucocorticoid	receive	VBG	B-VP	Oglucocorticoid	than	glucocorticoid	NN	B-NP	Othan	in	than	IN	B-PP	Oin	the	in	IN	B-PP	Othe	MNL	the	DT	B-NP	OMNL	of	MNL	NN	I-NP	B-cell_typeof	healthy	of	IN	B-PP	Ohealthy	donors	healthy	JJ	B-NP	Odonors	.	donor	NNS	I-NP	O.	Affinity	.	.	O	OAffinity	was	Affinity	NN	B-NP	Owas	within	be	VBD	B-VP	Owithin	the	within	IN	B-PP	Othe	normal	the	DT	B-NP	Onormal	range	normal	JJ	I-NP	Orange	.	range	NN	I-NP	O.	Sex	.	.	O	OSex	","	Sex	NN	B-NP	B-protein","	age	","	","	O	Oage	or	age	NN	B-NP	Oor	clinical	or	CC	O	Oclinical	forms	clinical	JJ	B-NP	Oforms	of	form	NNS	I-NP	Oof	illness	of	IN	B-PP	Oillness	did	illness	NN	B-NP	Odid	not	do	VBD	B-VP	Onot	influence	not	RB	I-VP	Oinfluence	the	influence	VB	I-VP	Othe	results	the	DT	B-NP	Oresults	.	result	NNS	I-NP	O.	In	.	.	O	OIn	patients	In	IN	B-PP	Opatients	receiving	patient	NNS	B-NP	Oreceiving	prednisone	receive	VBG	B-VP	Oprednisone	(	prednisone	NN	B-NP	O(	Pd	(	(	O	OPd	)	Pd	NN	B-NP	O)	the	)	)	O	Othe	GR	the	DT	B-NP	OGR	values	GR	NN	I-NP	B-proteinvalues	were	value	NNS	I-NP	Owere	significantly	be	VBD	B-VP	Osignificantly	lower	significantly	RB	B-ADJP	Olower	than	low	JJR	I-ADJP	Othan	in	than	IN	B-PP	Oin	MG	in	IN	B-PP	OMG	patients	MG	NN	B-NP	Opatients	without	patient	NNS	I-NP	Owithout	Pd	without	IN	B-PP	OPd	therapy	Pd	NN	B-NP	Otherapy	","	therapy	NN	I-NP	O","	independent	","	","	O	Oindependent	of	independent	JJ	B-ADJP	Oof	Pd	of	IN	B-PP	OPd	dose	Pd	NN	B-NP	Odose	or	dose	NN	I-NP	Oor	time	or	CC	O	Otime	of	time	NN	B-NP	Oof	administration	of	IN	B-PP	Oadministration	.	administration	NN	B-NP	O.	No	.	.	O	ONo	differences	No	DT	B-NP	Odifferences	in	difference	NNS	I-NP	Oin	receptor	in	IN	B-PP	Oreceptor	binding	receptor	NN	B-NP	Obinding	between	binding	NN	I-NP	Obetween	normal	between	IN	B-PP	Onormal	subjects	normal	JJ	B-NP	Osubjects	and	subject	NNS	I-NP	Oand	MG	and	CC	O	OMG	patients	MG	NN	B-NP	Opatients	receiving	patient	NNS	I-NP	Oreceiving	Pd	receive	VBG	B-VP	OPd	have	Pd	NN	B-NP	Ohave	been	have	VBP	B-VP	Obeen	found	be	VBN	I-VP	Ofound	.	find	VBN	I-VP	O.	Immunological	.	.	O	OImmunological	interference	Immunological	JJ	B-NP	Ointerference	of	interference	NN	I-NP	Oof	high	of	IN	B-PP	Ohigh	dose	high	JJ	B-NP	Odose	corticosteroids	dose	NN	I-NP	Ocorticosteroids	.	corticosteroid	NNS	I-NP	O.	High-dose	.	.	O	OHigh-dose	corticosteroids	High-dose	JJ	B-NP	Ocorticosteroids	(	corticosteroid	NNS	I-NP	O(	HDC	(	(	O	OHDC	)	HDC	NN	B-NP	B-cell_type)	will	)	)	O	Owill	influence	will	MD	B-VP	Oinfluence	cellular	influence	VB	I-VP	Ocellular	as	cellular	JJ	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	humoral	as	IN	I-CONJP	Ohumoral	participants	humoral	JJ	B-NP	Oparticipants	of	participant	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	immune	the	DT	B-NP	Oimmune	response	immune	JJ	I-NP	Oresponse	.	response	NN	I-NP	O.	The	.	.	O	OThe	lymphoid	The	DT	B-NP	Olymphoid	tissue	lymphoid	JJ	I-NP	Otissue	will	tissue	NN	I-NP	Owill	decrease	will	MD	B-VP	Odecrease	in	decrease	VB	I-VP	Oin	size	in	IN	B-PP	Osize	and	size	NN	B-NP	Oand	weight	and	CC	I-NP	Oweight	after	weight	NN	I-NP	Oafter	prolonged	after	IN	B-PP	Oprolonged	treatment	prolonged	JJ	B-NP	Otreatment	with	treatment	NN	I-NP	Owith	HDC	with	IN	B-PP	OHDC	.	HDC	NN	B-NP	B-cell_type.	Lymphocyte	.	.	O	OLymphocyte	functions	Lymphocyte	NN	B-NP	Ofunctions	will	function	NNS	I-NP	Owill	be	will	MD	B-VP	Obe	impaired	be	VB	I-VP	Oimpaired	.	impair	VBN	I-VP	O.	Reduced	.	.	O	OReduced	synthesis	Reduce	VBN	B-NP	Osynthesis	of	synthesis	NN	I-NP	Oof	B-	of	IN	B-PP	OB-	as	B-	NN	B-NP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	T-lymphocytes	as	IN	I-CONJP	OT-lymphocytes	will	T-lymphocyte	NNS	B-NP	B-cell_typewill	be	will	MD	B-VP	Obe	seen	be	VB	I-VP	Oseen	.	see	VBN	I-VP	O.	The	.	.	O	OThe	inhibitory	The	DT	B-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	on	effect	NN	I-NP	Oon	B-cell	on	IN	B-PP	OB-cell	function	B-cell	NN	B-NP	B-cell_typefunction	can	function	NN	I-NP	Ocan	be	can	MD	B-VP	Obe	observed	be	VB	I-VP	Oobserved	both	observe	VBN	I-VP	Oboth	as	both	CC	O	Oas	decreased	as	IN	B-SBAR	Odecreased	serum	decrease	VBN	B-NP	Oserum	levels	serum	NN	I-NP	Olevels	of	level	NNS	I-NP	Oof	immunoglobulins	of	IN	B-PP	Oimmunoglobulins	and	immunoglobulin	NNS	B-NP	B-proteinand	as	and	CC	B-PP	Oas	impaired	as	IN	B-PP	Oimpaired	binding	impaired	JJ	B-NP	Obinding	of	binding	NN	I-NP	Oof	antibodies	of	IN	B-PP	Oantibodies	and	antibody	NNS	B-NP	B-proteinand	complement	and	CC	O	Ocomplement	to	complement	NN	B-NP	Oto	the	to	TO	B-PP	Othe	cellular	the	DT	B-NP	Ocellular	surface	cellular	JJ	I-NP	Osurface	.	surface	NN	I-NP	O.	Reduced	.	.	O	OReduced	T-cell	Reduce	VBN	B-NP	OT-cell	function	T-cell	NN	I-NP	Ofunction	indicated	function	NN	I-NP	Oindicated	by	indicate	VBN	B-VP	Oby	impaired	by	IN	B-PP	Oimpaired	stimulation	impaired	JJ	B-NP	Ostimulation	by	stimulation	NN	I-NP	Oby	PHA	by	IN	B-PP	OPHA	and	PHA	NN	B-NP	B-proteinand	porkweed	and	CC	I-NP	Oporkweed	as	porkweed	NN	I-NP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	by	as	IN	I-CONJP	Oby	impaired	by	IN	B-PP	Oimpaired	lymphokinin	impaired	JJ	B-NP	Olymphokinin	effects	lymphokinin	NN	I-NP	Oeffects	on	effect	NNS	I-NP	Oon	leukocyte	on	IN	B-PP	Oleukocyte	migration	leukocyte	NN	B-NP	Omigration	inhibition	migration	NN	I-NP	Oinhibition	has	inhibition	NN	I-NP	Ohas	been	have	VBZ	B-VP	Obeen	reported	be	VBN	I-VP	Oreported	.	report	VBN	I-VP	O.	Reduced	.	.	O	OReduced	lymphocyte	Reduce	VBN	B-NP	Olymphocyte	adherence	lymphocyte	NN	I-NP	Oadherence	to	adherence	NN	I-NP	Oto	antigen	to	TO	B-PP	Oantigen	and	antigen	NN	B-NP	Oand	suppressed	and	CC	O	Osuppressed	lymphocyte	suppress	VBD	B-VP	Olymphocyte	reaction	lymphocyte	NN	B-NP	Oreaction	have	reaction	NN	I-NP	Ohave	also	have	VBP	B-VP	Oalso	been	also	RB	I-VP	Obeen	observed	be	VBN	I-VP	Oobserved	.	observe	VBN	I-VP	O.	Humoral	.	.	O	OHumoral	factors	Humoral	JJ	B-NP	B-proteinfactors	involved	factor	NNS	I-NP	I-proteininvolved	in	involve	VBN	B-VP	Oin	chemotaxis	in	IN	B-PP	Ochemotaxis	","	chemotaxis	NN	B-NP	O","	opsonisation	","	","	O	Oopsonisation	","	opsonisation	NN	B-NP	O","	phagocytosis	","	","	O	Ophagocytosis	","	phagocytosis	NN	B-NP	O","	vascular	","	","	O	Ovascular	permeability	vascular	JJ	B-NP	Opermeability	leading	permeability	NN	I-NP	Oleading	to	lead	VBG	B-VP	Oto	leakage	to	TO	B-PP	Oleakage	of	leakage	NN	B-NP	Oof	fluid	of	IN	B-PP	Ofluid	and	fluid	NN	B-NP	Oand	cells	and	CC	I-NP	Ocells	and	cell	NNS	I-NP	Oand	factors	and	CC	O	Ofactors	involved	factor	NNS	B-NP	Oinvolved	in	involve	VBN	B-VP	Oin	lysis	in	IN	B-PP	Olysis	of	lysis	NN	B-NP	Oof	antigens	of	IN	B-PP	Oantigens	are	antigen	NNS	B-NP	B-proteinare	impaired	be	VBP	B-VP	Oimpaired	.	impaired	JJ	B-ADJP	O.	This	.	.	O	OThis	can	This	DT	B-NP	Ocan	be	can	MD	B-VP	Obe	explained	be	VB	I-VP	Oexplained	partly	explain	VBN	I-VP	Opartly	by	partly	RB	B-ADVP	Oby	the	by	IN	B-PP	Othe	observed	the	DT	B-NP	Oobserved	reduced	observe	VBN	I-NP	Oreduced	complement	reduce	VBN	I-NP	Ocomplement	activation	complement	NN	I-NP	Oactivation	via	activation	NN	I-NP	Ovia	the	via	IN	B-PP	Othe	alternative	the	DT	B-NP	Oalternative	as	alternative	NN	I-NP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	the	as	IN	I-CONJP	Othe	classical	the	DT	B-NP	Oclassical	pathway	classical	JJ	I-NP	Opathway	in	pathway	NN	I-NP	Oin	association	in	IN	B-PP	Oassociation	with	association	NN	B-NP	Owith	HDC	with	IN	B-PP	OHDC	therapy	HDC	NN	B-NP	Otherapy	.	therapy	NN	I-NP	O.	Acute	.	.	O	OAcute	processes	Acute	JJ	B-NP	Oprocesses	with	process	NNS	I-NP	Owith	increased	with	IN	B-PP	Oincreased	vascular	increase	VBN	B-NP	Ovascular	permeability	vascular	JJ	I-NP	Opermeability	and	permeability	NN	I-NP	Oand	accumulation	and	CC	I-NP	Oaccumulation	of	accumulation	NN	I-NP	Oof	leukocytes	of	IN	B-PP	Oleukocytes	as	leukocyte	NNS	B-NP	B-cell_typeas	impairing	as	IN	B-PP	Oimpairing	factors	impair	VBG	B-VP	B-proteinfactors	could	factor	NNS	B-NP	I-proteincould	be	could	MD	B-VP	Obe	influenced	be	VB	I-VP	Oinfluenced	beneficially	influence	VBN	I-VP	Obeneficially	by	beneficially	RB	B-ADVP	Oby	HDC	by	IN	B-PP	OHDC	therapy	HDC	NN	B-NP	Otherapy	.	therapy	NN	I-NP	O.	This	.	.	O	OThis	positive	This	DT	B-NP	Opositive	effect	positive	JJ	I-NP	Oeffect	can	effect	NN	I-NP	Ocan	be	can	MD	B-VP	Obe	seen	be	VB	I-VP	Oseen	in	see	VBN	I-VP	Oin	treatment	in	IN	B-PP	Otreatment	of	treatment	NN	B-NP	Oof	septic	of	IN	B-PP	Oseptic	shock	septic	JJ	B-NP	Oshock	or	shock	NN	I-NP	Oor	rejection	or	CC	I-NP	Orejection	of	rejection	NN	I-NP	Oof	a	of	IN	B-PP	Oa	transplant	a	DT	B-NP	Otransplant	.	transplant	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	if	","	","	O	Oif	sepsis	if	IN	B-SBAR	Osepsis	or	sepsis	NN	B-NP	Oor	rejection	or	CC	I-NP	Orejection	is	rejection	NN	I-NP	Ois	not	be	VBZ	B-VP	Onot	rapidly	not	RB	O	Orapidly	reversed	rapidly	RB	B-ADVP	Oreversed	","	reverse	VBD	B-VP	O","	complications	","	","	O	Ocomplications	such	complication	NNS	B-NP	Osuch	as	such	JJ	B-PP	Oas	multisystem	as	IN	I-PP	Omultisystem	organ	multisystem	JJ	B-NP	Oorgan	failure	organ	NN	I-NP	Ofailure	and	failure	NN	I-NP	Oand	bacteremia	and	CC	O	Obacteremia	are	bacteremia	NN	B-NP	Oare	prone	be	VBP	B-VP	Oprone	to	prone	JJ	B-ADJP	Oto	appear	to	TO	B-VP	Oappear	.	appear	VB	I-VP	O.	Identification	.	.	O	OIdentification	of	Identification	NN	B-NP	Oof	human	of	IN	B-PP	Ohuman	leukemic	human	JJ	B-NP	B-proteinleukemic	glucocorticoid	leukemic	JJ	I-NP	I-proteinglucocorticoid	receptors	glucocorticoid	NN	I-NP	I-proteinreceptors	using	receptor	NNS	I-NP	I-proteinusing	affinity	use	VBG	B-VP	Oaffinity	labeling	affinity	NN	B-NP	Olabeling	and	labeling	NN	I-NP	Oand	anti-human	and	CC	O	Oanti-human	glucocorticoid	anti-human	JJ	B-NP	B-proteinglucocorticoid	receptor	glucocorticoid	NN	I-NP	I-proteinreceptor	antibodies	receptor	NN	I-NP	I-proteinantibodies	.	antibody	NNS	I-NP	I-protein.	Antisera	.	.	O	OAntisera	raised	Antiserum	NNS	B-NP	Oraised	against	raise	VBN	B-VP	Oagainst	human	against	IN	B-PP	Ohuman	lymphoid	human	JJ	B-NP	B-proteinlymphoid	glucocorticoid	lymphoid	JJ	I-NP	I-proteinglucocorticoid	receptors	glucocorticoid	NN	I-NP	I-proteinreceptors	were	receptor	NNS	I-NP	I-proteinwere	used	be	VBD	B-VP	Oused	in	use	VBN	I-VP	Oin	combination	in	IN	B-PP	Ocombination	with	combination	NN	B-NP	Owith	the	with	IN	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	affinity	receptor	NN	I-NP	I-proteinaffinity	label	affinity	NN	I-NP	Olabel	[	label	NN	I-NP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	dexamethasone	]	)	O	Odexamethasone	21-mesylate	dexamethasone	NN	B-NP	O21-mesylate	[	21-mesylate	NN	I-NP	O[	(	[	(	O	O(	3H	(	(	O	O3H	]	3H	NN	B-NP	O]	DM	]	)	O	ODM	)	DM	NN	B-NP	O)	to	)	)	O	Oto	identify	to	TO	B-VP	Oidentify	the	identify	VB	I-VP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	of	receptor	NNS	I-NP	I-proteinof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	B-lymphoblastoid	human	JJ	I-NP	B-cell_lineB-lymphoblastoid	cell	B-lymphoblastoid	JJ	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	IM-9	line	NN	I-NP	I-cell_lineIM-9	and	IM-9	NN	I-NP	B-cell_lineand	the	and	CC	O	Othe	human	the	DT	B-NP	Ohuman	T-cell	human	JJ	I-NP	B-cell_lineT-cell	leukemic	T-cell	NN	I-NP	I-cell_lineleukemic	cell	leukemic	JJ	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	CEM-C7	line	NN	I-NP	I-cell_lineCEM-C7	.	CEM-C7	NN	I-NP	B-cell_line.	Antisera	.	.	O	OAntisera	were	Antiserum	NNS	B-NP	Owere	obtained	be	VBD	B-VP	Oobtained	following	obtain	VBN	I-VP	Ofollowing	immunization	follow	VBG	B-PP	Oimmunization	of	immunization	NN	B-NP	Oof	New	of	IN	B-PP	ONew	Zealand	New	NNP	B-NP	OZealand	White	Zealand	NNP	I-NP	OWhite	rabbits	White	NNP	I-NP	Orabbits	with	rabbit	NNS	I-NP	Owith	[	with	IN	B-PP	O[	3H	[	(	O	O3H	]	3H	NN	O	O]	triamcinolone	]	)	O	Otriamcinolone	acetonide	triamcinolone	NN	B-NP	Oacetonide	[	acetonide	NN	I-NP	O[	(	[	(	O	O(	3H	(	(	O	O3H	]	3H	NN	B-NP	O]	TA	]	)	O	OTA	)	TA	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	receptor	#NAME?	NN	B-NP	B-proteinreceptor	complexes	receptor	NN	I-NP	I-proteincomplexes	partially	complex	NNS	I-NP	I-proteinpartially	purified	partially	RB	B-VP	Opurified	by	purify	VBN	I-VP	Oby	two-stage	by	IN	B-PP	Otwo-stage	DNA-cellulose	two-stage	JJ	B-NP	ODNA-cellulose	chromatography	DNA-cellulose	JJ	I-NP	Ochromatography	.	chromatography	NN	I-NP	O.	The	.	.	O	OThe	presence	The	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	anti-human	of	IN	B-PP	Oanti-human	glucocorticoid	anti-human	JJ	B-NP	B-proteinglucocorticoid	receptor	glucocorticoid	NN	I-NP	I-proteinreceptor	antibodies	receptor	NN	I-NP	I-proteinantibodies	was	antibody	NNS	I-NP	I-proteinwas	verified	be	VBD	B-VP	Overified	by	verify	VBN	I-VP	Oby	:	by	IN	B-PP	O:	(	:	:	O	O(	a	(	(	B-LST	Oa	)	a	LS	I-LST	O)	adsorption	)	)	O	Oadsorption	of	adsorption	NN	B-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	O	B-protein3H	]	3H	NN	B-NP	I-protein]	TA-receptor-antibody	]	)	I-NP	I-proteinTA-receptor-antibody	complexes	TA-receptor-antibody	NN	I-NP	I-proteincomplexes	to	complex	NNS	I-NP	I-proteinto	Protein	to	TO	B-PP	OProtein	A	Protein	NN	B-NP	B-proteinA	;	A	NN	I-NP	I-protein;	(	;	:	O	O(	b	(	(	B-LST	Ob	)	b	LS	I-LST	O)	a	)	)	O	Oa	shift	a	DT	B-NP	Oshift	to	shift	NN	I-NP	Oto	higher	to	TO	B-PP	Ohigher	apparent	high	JJR	B-NP	Oapparent	molecular	apparent	JJ	I-NP	Omolecular	weight	molecular	JJ	I-NP	Oweight	in	weight	NN	I-NP	Oin	the	in	IN	B-PP	Othe	elution	the	DT	B-NP	Oelution	position	elution	NN	I-NP	Oposition	from	position	NN	I-NP	Ofrom	Sephacryl	from	IN	B-PP	OSephacryl	S300	Sephacryl	NN	B-NP	OS300	of	S300	NN	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	O	B-protein3H	]	3H	NN	B-NP	I-protein]	TA-receptor	]	)	I-NP	I-proteinTA-receptor	complexes	TA-receptor	NN	I-NP	I-proteincomplexes	incubated	complex	NNS	I-NP	I-proteinincubated	with	incubate	VBN	B-VP	Owith	immune	with	IN	B-PP	Oimmune	serum	immune	JJ	B-NP	Oserum	;	serum	NN	I-NP	O;	and	;	:	O	Oand	(	and	CC	O	O(	c	(	(	B-LST	Oc	)	c	LS	I-LST	O)	the	)	)	O	Othe	ability	the	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	immune	of	IN	B-PP	Oimmune	serum	immune	JJ	B-NP	Oserum	to	serum	NN	I-NP	Oto	displace	to	TO	B-VP	Odisplace	[	displace	VB	I-VP	O[	3H	[	(	O	B-protein3H	]	3H	NN	B-NP	I-protein]	TA-receptor	]	)	O	I-proteinTA-receptor	complexes	TA-receptor	NN	B-NP	I-proteincomplexes	on	complex	NNS	I-NP	I-proteinon	sucrose	on	IN	B-PP	Osucrose	gradients	sucrose	NN	B-NP	Ogradients	.	gradient	NNS	I-NP	O.	These	.	.	O	OThese	antibodies	These	DT	B-NP	Oantibodies	also	antibody	NNS	I-NP	B-proteinalso	recognized	also	RB	B-ADVP	Orecognized	rat	recognize	VBD	B-VP	Orat	liver	rat	NN	B-NP	Oliver	and	liver	NN	I-NP	Oand	murine	and	CC	O	Omurine	S49	murine	JJ	B-NP	OS49	cell	S49	NN	I-NP	Ocell	glucocorticoid	cell	NN	I-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	Sodium	.	.	O	OSodium	dodecyl	Sodium	NN	B-NP	Ododecyl	sulfate-polyacrylamide	dodecyl	NN	I-NP	Osulfate-polyacrylamide	gel	sulfate-polyacrylamide	NN	I-NP	Ogel	electrophoresis	gel	NN	I-NP	Oelectrophoresis	of	electrophoresis	NN	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	DM-labeled	]	)	I-NP	ODM-labeled	IM-9	DM-labeled	JJ	I-NP	OIM-9	cytosol	IM-9	NN	I-NP	Ocytosol	identified	cytosol	NN	I-NP	Oidentified	a	identify	VBD	B-VP	Oa	major	a	DT	B-NP	Omajor	competable	major	JJ	I-NP	Ocompetable	band	competable	JJ	I-NP	Oband	with	band	NN	I-NP	Owith	a	with	IN	B-PP	Oa	molecular	a	DT	B-NP	Omolecular	weight	molecular	JJ	I-NP	Oweight	of	weight	NN	I-NP	Oof	approximately	of	IN	B-PP	Oapproximately	90	approximately	RB	B-NP	O90	","	90	CD	I-NP	O","	0	","	","	I-NP	O0	","	0	CD	I-NP	O","	three	","	","	I-NP	Othree	minor	three	CD	I-NP	Ominor	competable	minor	JJ	I-NP	B-proteincompetable	components	competable	JJ	I-NP	I-proteincomponents	with	component	NNS	I-NP	I-proteinwith	molecular	with	IN	B-PP	Omolecular	weights	molecular	JJ	B-NP	Oweights	of	weight	NNS	I-NP	Oof	approximately	of	IN	B-PP	Oapproximately	78	approximately	RB	B-NP	O78	","	78	CD	I-NP	O","	0	","	","	I-NP	O0	","	0	CD	I-NP	O","	approximately	","	","	O	Oapproximately	51	approximately	RB	B-NP	O51	","	51	CD	I-NP	O","	0	","	","	I-NP	O0	","	0	CD	I-NP	O","	and	","	","	O	Oand	approximately	and	CC	O	Oapproximately	38	approximately	RB	B-NP	O38	","	38	CD	I-NP	O","	500	","	","	I-NP	O500	","	500	CD	I-NP	O","	and	","	","	O	Oand	at	and	CC	O	Oat	least	at	IN	B-NP	Oleast	21	least	JJS	I-NP	O21	other	21	CD	I-NP	Oother	noncompetable	other	JJ	I-NP	Ononcompetable	components	noncompetable	JJ	I-NP	B-proteincomponents	.	component	NNS	I-NP	I-protein.	Following	.	.	O	OFollowing	immunoprecipitation	Follow	VBG	B-NP	Oimmunoprecipitation	of	immunoprecipitation	NN	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	DM-labeled	]	)	I-NP	ODM-labeled	cytosol	DM-labeled	JJ	I-NP	Ocytosol	with	cytosol	NN	I-NP	Owith	immune	with	IN	B-PP	Oimmune	serum	immune	JJ	B-NP	Oserum	","	serum	NN	I-NP	O","	only	","	","	O	Oonly	the	only	RB	B-NP	Othe	Mr	the	DT	I-NP	OMr	90	Mr	NN	I-NP	O90	","	90	CD	I-NP	O","	0	","	","	I-NP	O0	and	0	CD	I-NP	Oand	78	and	CC	I-NP	O78	","	78	CD	I-NP	O","	0	","	","	I-NP	O0	components	0	CD	I-NP	Ocomponents	were	component	NNS	I-NP	Owere	seen	be	VBD	B-VP	Oseen	.	see	VBN	I-VP	O.	Sodium	.	.	O	OSodium	dodecyl	Sodium	NN	B-NP	Ododecyl	sulfate-polyacrylamide	dodecyl	NN	I-NP	Osulfate-polyacrylamide	gel	sulfate-polyacrylamide	NN	I-NP	Ogel	electrophoresis	gel	NN	I-NP	Oelectrophoresis	of	electrophoresis	NN	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	DM-labeled	]	)	I-NP	ODM-labeled	CEM-C7	DM-labeled	JJ	I-NP	OCEM-C7	cytosol	CEM-C7	NN	I-NP	Ocytosol	revealed	cytosol	NN	I-NP	Orevealed	a	reveal	VBD	B-VP	Oa	larger	a	DT	B-NP	Olarger	number	large	JJR	I-NP	Onumber	of	number	NN	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	B-NP	B-protein3H	]	3H	NN	I-NP	I-protein]	DM-labeled	]	)	I-NP	I-proteinDM-labeled	components	DM-labeled	JJ	I-NP	I-proteincomponents	.	component	NNS	I-NP	I-protein.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	after	","	","	O	Oafter	immunoprecipitation	after	IN	B-PP	Oimmunoprecipitation	of	immunoprecipitation	NN	B-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	DM-labeled	]	)	I-NP	ODM-labeled	CEM-C7	DM-labeled	JJ	I-NP	OCEM-C7	cytosol	CEM-C7	NN	I-NP	Ocytosol	","	cytosol	NN	I-NP	O","	a	","	","	O	Oa	predominant	a	DT	B-NP	Opredominant	competable	predominant	JJ	I-NP	Ocompetable	component	competable	JJ	I-NP	Ocomponent	with	component	NN	I-NP	Owith	a	with	IN	B-PP	Oa	molecular	a	DT	B-NP	Omolecular	weight	molecular	JJ	I-NP	Oweight	of	weight	NN	I-NP	Oof	90	of	IN	B-PP	O90	","	90	CD	B-NP	O","	0	","	","	I-NP	O0	was	0	CD	I-NP	Owas	easily	be	VBD	B-VP	Oeasily	identified	easily	RB	I-VP	Oidentified	.	identify	VBN	I-VP	O.	This	.	.	O	OThis	component	This	DT	B-NP	Ocomponent	was	component	NN	I-NP	Owas	markedly	be	VBD	B-VP	Omarkedly	diminished	markedly	RB	I-VP	Odiminished	when	diminish	VBN	I-VP	Owhen	cytosols	when	WRB	B-ADVP	Ocytosols	from	cytosol	NNS	B-NP	Ofrom	the	from	IN	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor-deficient	glucocorticoid	NN	I-NP	B-cell_linereceptor-deficient	cell	receptor-deficient	JJ	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	ICR-27	line	NN	I-NP	I-cell_lineICR-27	were	ICR-27	NN	I-NP	B-cell_linewere	used	be	VBD	B-VP	Oused	.	use	VBN	I-VP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	the	","	","	O	Othe	combination	the	DT	B-NP	Ocombination	of	combination	NN	I-NP	Oof	affinity	of	IN	B-PP	Oaffinity	labeling	affinity	NN	B-NP	Olabeling	and	labeling	NN	I-NP	Oand	anti-human	and	CC	O	Oanti-human	glucocorticoid	anti-human	JJ	B-NP	B-proteinglucocorticoid	receptor	glucocorticoid	NN	I-NP	I-proteinreceptor	antibodies	receptor	NN	I-NP	I-proteinantibodies	is	antibody	NNS	I-NP	I-proteinis	capable	be	VBZ	B-VP	Ocapable	of	capable	JJ	B-ADJP	Oof	providing	of	IN	B-PP	Oproviding	direct	provide	VBG	B-VP	Odirect	physical	direct	JJ	B-NP	Ophysical	identification	physical	JJ	I-NP	Oidentification	of	identification	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	lymphoid	human	JJ	B-NP	B-proteinlymphoid	glucocorticoid	lymphoid	JJ	I-NP	I-proteinglucocorticoid	receptors	glucocorticoid	NN	I-NP	I-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	Effect	.	.	O	OEffect	of	Effect	NN	B-NP	Oof	thymosin	of	IN	B-PP	Othymosin	on	thymosin	NN	B-NP	Oon	glucocorticoid	on	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	activity	receptor	NN	I-NP	I-proteinactivity	and	activity	NN	I-NP	Oand	glucocorticoid	and	CC	O	Oglucocorticoid	sensitivity	glucocorticoid	NN	B-NP	Osensitivity	of	sensitivity	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	thymocytes	human	JJ	B-NP	B-cell_typethymocytes	.	thymocyte	NNS	I-NP	I-cell_type.	Incubation	.	.	O	OIncubation	with	Incubation	NN	B-NP	Owith	thymosin	with	IN	B-PP	Othymosin	fraction	thymosin	NN	B-NP	B-proteinfraction	5	fraction	NN	I-NP	I-protein5	","	5	CD	I-NP	I-protein","	(	","	","	O	O(	TMS	(	(	O	OTMS	F5	TMS	NNP	B-NP	OF5	at	F5	NNP	I-NP	Oat	300	at	IN	B-PP	O300	micrograms/ml	300	CD	B-NP	Omicrograms/ml	)	micrograms/ml	NN	I-NP	O)	a	)	)	O	Oa	partially	a	DT	B-NP	Opartially	purified	partially	RB	I-NP	Opurified	thymic	purify	VBN	I-NP	B-proteinthymic	factor	thymic	JJ	I-NP	I-proteinfactor	","	factor	NN	I-NP	I-protein","	reduced	","	","	O	Oreduced	the	reduce	VBD	B-VP	Othe	steroid	the	DT	B-NP	Osteroid	binding	steroid	NN	I-NP	Obinding	activity	binding	NN	I-NP	Oactivity	of	activity	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	infant	human	JJ	B-NP	B-cell_typeinfant	thymocytes	infant	NN	I-NP	I-cell_typethymocytes	from	thymocyte	NNS	I-NP	I-cell_typefrom	9.6	from	IN	B-PP	O9.6	+/-	9.6	CD	B-NP	O+/-	2.1	+/-	SYM	I-NP	O2.1	fmole/ml	2.1	CD	I-NP	Ofmole/ml	to	fmole/ml	NN	I-NP	Oto	5	to	TO	B-PP	O5	+/-	5	CD	B-NP	O+/-	2	+/-	SYM	I-NP	O2	fmole/ml	2	CD	I-NP	Ofmole/ml	.	fmole/ml	NN	I-NP	O.	The	.	.	O	OThe	glucocorticoid	The	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	activity	receptor	NN	I-NP	I-proteinactivity	in	activity	NN	I-NP	Oin	normal	in	IN	B-PP	Onormal	infant	normal	JJ	B-NP	B-cell_typeinfant	thymocytes	infant	NN	I-NP	I-cell_typethymocytes	was	thymocyte	NNS	I-NP	I-cell_typewas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	2	be	VB	I-VP	O2	","	2	CD	B-NP	O","	146	","	","	I-NP	O146	+/-	146	CD	I-NP	O+/-	726	+/-	CC	I-NP	O726	(	726	CD	I-NP	O(	s.d.	(	(	O	Os.d.	)	s.d.	NN	B-NP	O)	sites	)	)	O	Osites	per	site	NNS	B-NP	Oper	cell	per	IN	B-PP	Ocell	with	cell	NN	B-NP	Owith	dissociation	with	IN	B-PP	Odissociation	constant	dissociation	NN	B-NP	Oconstant	of	constant	NN	I-NP	Oof	1.4	of	IN	B-PP	O1.4	+/-	1.4	CD	B-NP	O+/-	0.6	+/-	SYM	I-NP	O0.6	X	0.6	CD	I-NP	OX	10	X	SYM	I-NP	O10	(	10	CD	I-NP	O(	-8	(	(	O	O-8	)	-8	CD	B-NP	O)	M	)	)	O	OM	.	M	NN	B-NP	O.	TMS	.	.	O	OTMS	F5	TMS	NN	B-NP	B-proteinF5	also	F5	NN	I-NP	I-proteinalso	increased	also	RB	B-ADVP	Oincreased	the	increase	VBD	B-VP	Othe	resistance	the	DT	B-NP	Oresistance	of	resistance	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	thymocytes	human	JJ	B-NP	B-cell_typethymocytes	to	thymocyte	NNS	I-NP	I-cell_typeto	the	to	TO	B-PP	Othe	cytolytic	the	DT	B-NP	Ocytolytic	effect	cytolytic	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	(	dexamethasone	NN	B-NP	O(	2.5	(	(	O	O2.5	X	2.5	CD	B-NP	OX	10	X	SYM	O	O10	(	10	CD	B-NP	O(	-8	(	(	O	O-8	)	-8	CD	B-NP	O)	M	)	)	O	OM	)	M	NN	B-NP	O)	to	)	)	O	Oto	168.6	to	TO	B-PP	O168.6	+/-	168.6	CD	B-NP	O+/-	30.2	+/-	SYM	I-NP	O30.2	%	30.2	CD	I-NP	O%	of	%	NN	I-NP	Oof	control	of	IN	B-PP	Ocontrol	(	control	NN	B-NP	O(	P	(	(	O	OP	less	P	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.01	than	IN	B-PP	O0.01	)	0.01	CD	B-NP	O)	.	)	)	O	O.	In	.	.	O	OIn	animals	In	IN	B-PP	Oanimals	","	animal	NNS	B-NP	O","	medullary	","	","	O	Omedullary	and	medullary	JJ	B-NP	Oand	peripheral	and	CC	I-NP	Operipheral	blood	peripheral	JJ	I-NP	B-cell_typeblood	T	blood	NN	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	are	cell	NNS	I-NP	I-cell_typeare	more	be	VBP	B-VP	Omore	resistant	more	RBR	B-ADJP	Oresistant	to	resistant	JJ	I-ADJP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	than	glucocorticoid	NNS	B-NP	Othan	immature	than	IN	B-PP	Oimmature	thymic	immature	JJ	B-NP	B-cell_typethymic	T	thymic	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	results	The	DT	B-NP	Oresults	show	result	NNS	I-NP	Oshow	that	show	VBP	B-VP	Othat	thymosin	that	IN	B-SBAR	Othymosin	can	thymosin	NN	B-NP	Ocan	induce	can	MD	B-VP	Oinduce	changes	induce	VB	I-VP	Ochanges	consistent	change	NNS	B-NP	Oconsistent	with	consistent	JJ	B-ADJP	Owith	differentiation	with	IN	B-PP	Odifferentiation	in	differentiation	NN	B-NP	Oin	human	in	IN	B-PP	Ohuman	thymocytes	human	JJ	B-NP	B-cell_typethymocytes	.	thymocyte	NNS	I-NP	I-cell_type.	These	.	.	O	OThese	in	These	DT	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	results	vitro	FW	I-NP	Oresults	are	result	NNS	I-NP	Oare	consistent	be	VBP	B-VP	Oconsistent	with	consistent	JJ	B-ADJP	Owith	a	with	IN	B-PP	Oa	physiological	a	DT	B-NP	Ophysiological	role	physiological	JJ	I-NP	Orole	of	role	NN	I-NP	Oof	thymosin	of	IN	B-PP	Othymosin	in	thymosin	NN	B-NP	B-proteinin	intrathymic	in	IN	B-PP	Ointrathymic	T	intrathymic	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	maturation	cell	NN	I-NP	Omaturation	in	maturation	NN	I-NP	Oin	man	in	IN	B-PP	Oman	.	man	NN	B-NP	O.	Incubation	.	.	O	OIncubation	of	Incubation	NN	B-NP	Oof	a	of	IN	B-PP	Oa	human	a	DT	B-NP	Ohuman	malignant	human	JJ	I-NP	B-cell_linemalignant	thymus	malignant	JJ	I-NP	I-cell_linethymus	derived	thymus	NN	I-NP	I-cell_linederived	T	derive	VBN	I-NP	I-cell_lineT	cell	T	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	(	line	NN	I-NP	I-cell_line(	MOLT	(	(	O	OMOLT	3	MOLT	NN	B-NP	B-cell_line3	)	3	CD	I-NP	I-cell_line)	with	)	)	O	Owith	TMS	with	IN	B-PP	OTMS	F5	TMS	NN	B-NP	B-proteinF5	also	F5	NN	I-NP	I-proteinalso	resulted	also	RB	B-ADVP	Oresulted	in	result	VBD	B-VP	Oin	a	in	IN	B-PP	Oa	significant	a	DT	B-NP	Osignificant	reduction	significant	JJ	I-NP	Oreduction	of	reduction	NN	I-NP	Oof	the	of	IN	B-PP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	steroid	of	IN	B-PP	Osteroid	binding	steroid	NN	B-NP	B-proteinbinding	sites	binding	NN	I-NP	I-proteinsites	to	site	NNS	I-NP	I-proteinto	44.2	to	TO	B-PP	O44.2	+/-	44.2	CD	B-NP	O+/-	15.3	+/-	SYM	I-NP	O15.3	%	15.3	CD	I-NP	O%	of	%	NN	I-NP	Oof	control	of	IN	B-PP	Ocontrol	(	control	NN	B-NP	O(	P	(	(	O	OP	less	P	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.05	than	IN	B-PP	O0.05	)	0.05	CD	B-NP	O)	","	)	)	O	O","	but	","	","	O	Obut	TMS	but	CC	O	OTMS	F5	TMS	NN	B-NP	B-proteinF5	did	F5	NN	I-NP	I-proteindid	not	do	VBD	B-VP	Onot	significantly	not	RB	I-VP	Osignificantly	reduce	significantly	RB	I-VP	Oreduce	the	reduce	VB	I-VP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	sensitivity	glucocorticoid	NN	I-NP	Osensitivity	of	sensitivity	NN	I-NP	Oof	MOLT	of	IN	B-PP	OMOLT	3	MOLT	NN	B-NP	B-cell_line3	cells	3	CD	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Specific	.	.	O	OSpecific	high-affinity	Specific	JJ	B-NP	Ohigh-affinity	receptors	high-affinity	JJ	I-NP	B-proteinreceptors	for	receptor	NNS	I-NP	I-proteinfor	1	for	IN	B-PP	O1	","	1	CD	B-NP	O","	25-dihydroxyvitamin	","	","	O	O25-dihydroxyvitamin	D3	25-dihydroxyvitamin	NN	B-NP	OD3	in	D3	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	peripheral	human	JJ	B-NP	B-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	:	cell	NNS	I-NP	I-cell_type:	presence	:	:	O	Opresence	in	presence	NN	B-NP	Oin	monocytes	in	IN	B-PP	Omonocytes	and	monocyte	NNS	B-NP	B-cell_typeand	induction	and	CC	O	Oinduction	in	induction	NN	B-NP	Oin	T	in	IN	B-PP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	following	lymphocyte	NNS	I-NP	I-cell_typefollowing	activation	follow	VBG	B-PP	Oactivation	.	activation	NN	B-NP	O.	Human	.	.	O	OHuman	peripheral	Human	JJ	B-NP	B-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	monocytes	blood	NN	I-NP	I-cell_typemonocytes	have	monocyte	NNS	I-NP	I-cell_typehave	high	have	VBP	B-VP	Ohigh	affinity	high	JJ	B-NP	B-DNAaffinity	binding	affinity	NN	I-NP	I-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	for	site	NNS	I-NP	I-DNAfor	1	for	IN	B-PP	O1	","	1	CD	B-NP	O","	25-	","	","	I-NP	O25-	(	25-	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	(	2D3	NN	B-NP	O(	Kd	(	(	O	OKd	0.14	Kd	NN	B-NP	O0.14	nM	0.14	CD	I-NP	OnM	","	nM	NN	I-NP	O","	sedimentation	","	","	O	Osedimentation	coefficient	sedimentation	NN	B-NP	Ocoefficient	3.7S	coefficient	JJ	I-NP	O3.7S	)	3.7S	NN	I-NP	O)	.	)	)	O	O.	Resting	.	.	O	OResting	human	Rest	VBG	B-VP	B-cell_typehuman	peripheral	human	JJ	B-NP	I-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	T	blood	NN	I-NP	I-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	however	","	","	O	Ohowever	","	however	RB	B-ADVP	O","	do	","	","	O	Odo	not	do	VBP	B-VP	Onot	have	not	RB	I-VP	Ohave	a	have	VB	I-VP	Oa	demonstrable	a	DT	B-NP	Odemonstrable	1	demonstrable	JJ	I-NP	B-protein1	","	1	CD	I-NP	I-protein","	25-	","	","	I-NP	I-protein25-	(	25-	CD	I-NP	I-protein(	OH	(	(	O	I-proteinOH	)	OH	NN	B-NP	I-protein)	2D3	)	)	O	I-protein2D3	receptor	2D3	NN	B-NP	I-proteinreceptor	.	receptor	NN	I-NP	I-protein.	After	.	.	O	OAfter	activation	After	IN	B-PP	Oactivation	with	activation	NN	B-NP	Owith	phytohemagglutinin	with	IN	B-PP	Ophytohemagglutinin	the	phytohemagglutinin	NN	B-NP	B-proteinthe	T	the	DT	B-NP	OT	cells	T	NN	I-NP	B-cell_typecells	exhibit	cell	NNS	I-NP	I-cell_typeexhibit	the	exhibit	VBP	B-VP	Othe	receptor	the	DT	B-NP	Oreceptor	within	receptor	NN	I-NP	Owithin	24	within	IN	B-PP	O24	h	24	CD	B-NP	Oh	","	h	NN	I-NP	O","	and	","	","	O	Oand	this	and	CC	O	Othis	expression	this	DT	B-NP	Oexpression	is	expression	NN	I-NP	Ois	blocked	be	VBZ	B-VP	Oblocked	by	block	VBN	I-VP	Oby	cycloheximide	by	IN	B-PP	Ocycloheximide	.	cycloheximide	NN	B-NP	O.	The	.	.	O	OThe	receptor	The	DT	B-NP	Oreceptor	in	receptor	NN	I-NP	Oin	activated	in	IN	B-PP	Oactivated	T	activate	VBN	B-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	has	lymphocyte	NNS	I-NP	I-cell_typehas	a	have	VBZ	B-VP	Oa	sedimentation	a	DT	B-NP	Osedimentation	coefficient	sedimentation	NN	I-NP	Ocoefficient	of	coefficient	NN	I-NP	Oof	3.7S	of	IN	B-PP	O3.7S	and	3.7S	NN	B-NP	Oand	a	and	CC	O	Oa	high	a	DT	B-NP	Ohigh	affinity	high	JJ	I-NP	Oaffinity	(	affinity	NN	I-NP	O(	Kd	(	(	O	OKd	0.1	Kd	NN	B-NP	O0.1	nM	0.1	CD	I-NP	OnM	)	nM	NN	I-NP	O)	for	)	)	O	Ofor	the	for	IN	B-PP	Othe	ligand	the	DT	B-NP	Oligand	.	ligand	NN	I-NP	O.	Effects	.	.	O	OEffects	of	Effect	NNS	B-NP	Oof	chronic	of	IN	B-PP	Ochronic	glucocorticoid	chronic	JJ	B-NP	Oglucocorticoid	excess	glucocorticoid	NN	I-NP	Oexcess	in	excess	NN	I-NP	Oin	man	in	IN	B-PP	Oman	on	man	NN	B-NP	Oon	insulin	on	IN	B-PP	Oinsulin	binding	insulin	NN	B-NP	Obinding	to	binding	NN	I-NP	Oto	circulating	to	TO	B-PP	Ocirculating	cells	circulate	VBG	B-VP	B-cell_typecells	:	cell	NNS	B-NP	I-cell_type:	differences	:	:	O	Odifferences	between	difference	NNS	B-NP	Obetween	endogenous	between	IN	B-PP	Oendogenous	and	endogenous	JJ	B-NP	Oand	exogenous	and	CC	I-NP	Oexogenous	hypercorticism	exogenous	JJ	I-NP	Ohypercorticism	.	hypercorticism	NN	I-NP	O.	We	.	.	O	OWe	measured	We	PRP	B-NP	Omeasured	[	measure	VBD	B-VP	O[	125I	[	(	O	O125I	]	125I	NN	B-NP	O]	insulin	]	)	I-NP	Oinsulin	binding	insulin	NN	I-NP	Obinding	to	binding	NN	I-NP	Oto	circulating	to	TO	B-PP	Ocirculating	monocytes	circulate	VBG	B-VP	B-cell_typemonocytes	or	monocyte	NNS	B-NP	I-cell_typeor	erythrocytes	or	CC	I-NP	Oerythrocytes	from	erythrocyte	NNS	I-NP	B-cell_typefrom	16	from	IN	B-PP	O16	patients	16	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	chronic	with	IN	B-PP	Ochronic	glucocorticoid	chronic	JJ	B-NP	Oglucocorticoid	excess	glucocorticoid	NN	I-NP	Oexcess	","	excess	NN	I-NP	O","	9	","	","	O	O9	chronically	9	CD	B-NP	Ochronically	treated	chronically	RB	B-VP	Otreated	with	treat	VBN	I-VP	Owith	prednisone	with	IN	B-PP	Oprednisone	and	prednisone	NN	B-NP	Oand	7	and	CC	O	O7	with	7	CD	B-NP	Owith	adrenocortical	with	IN	B-PP	Oadrenocortical	hyperfunction	adrenocortical	JJ	B-NP	Ohyperfunction	.	hyperfunction	NN	I-NP	O.	With	.	.	O	OWith	monocytes	With	IN	B-PP	Omonocytes	","	monocyte	NNS	B-NP	B-cell_type","	[	","	","	O	O[	125I	[	(	B-LST	O125I	]	125I	LS	I-LST	O]	insulin	]	)	O	Oinsulin	binding	insulin	NN	B-NP	Obinding	was	binding	NN	I-NP	Owas	iincreased	be	VBD	B-VP	Oiincreased	in	iincrease	VBN	I-VP	Oin	all	in	IN	B-PP	Oall	patients	all	DT	B-NP	Opatients	.	patient	NNS	I-NP	O.	Analysis	.	.	O	OAnalysis	of	Analysis	NN	B-NP	Oof	binding	of	IN	B-PP	Obinding	data	binding	NN	B-NP	Odata	indicated	datum	NNS	I-NP	Oindicated	that	indicate	VBD	B-VP	Othat	increased	that	IN	B-SBAR	Oincreased	binding	increase	VBN	B-NP	Obinding	in	binding	NN	I-NP	Oin	patients	in	IN	B-PP	Opatients	treated	patient	NNS	B-NP	Otreated	with	treat	VBN	B-VP	Owith	prednisone	with	IN	B-PP	Oprednisone	was	prednisone	NN	B-NP	Owas	due	be	VBD	B-VP	Odue	to	due	JJ	B-ADJP	Oto	an	to	TO	B-PP	Oan	ncrease	an	DT	B-NP	Oncrease	in	ncrease	NN	I-NP	Oin	receptor	in	IN	B-PP	Oreceptor	concentration	receptor	NN	B-NP	Oconcentration	","	concentration	NN	I-NP	O","	whereas	","	","	O	Owhereas	in	whereas	IN	O	Oin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	adrenocortical	with	IN	B-PP	Oadrenocortical	hyperfunction	adrenocortical	JJ	B-NP	Ohyperfunction	","	hyperfunction	NN	I-NP	O","	it	","	","	O	Oit	was	it	PRP	B-NP	Owas	due	be	VBD	B-VP	Odue	to	due	JJ	B-ADJP	Oto	an	to	TO	B-PP	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	receptor	in	IN	B-PP	Oreceptor	affinity	receptor	NN	B-NP	Oaffinity	.	affinity	NN	I-NP	O.	With	.	.	O	OWith	erythrocytes	With	IN	B-PP	Oerythrocytes	from	erythrocyte	NNS	B-NP	B-cell_typefrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	adrenocortical	with	IN	B-PP	Oadrenocortical	hyperfunction	adrenocortical	JJ	B-NP	Ohyperfunction	there	hyperfunction	NN	I-NP	Othere	was	there	EX	B-NP	Owas	an	be	VBD	B-VP	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	receptor	in	IN	B-PP	Oreceptor	affinity	receptor	NN	B-NP	Oaffinity	and	affinity	NN	I-NP	Oand	a	and	CC	O	Oa	decrease	a	DT	B-NP	Odecrease	in	decrease	NN	I-NP	Oin	receptor	in	IN	B-PP	Oreceptor	concentration	receptor	NN	B-NP	Oconcentration	","	concentration	NN	I-NP	O","	so	","	","	O	Oso	that	so	IN	B-SBAR	Othat	the	that	IN	I-SBAR	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	[	of	IN	B-PP	O[	125I	[	(	O	B-protein125I	]	125I	NN	B-NP	I-protein]	insulin	]	)	I-NP	I-proteininsulin	was	insulin	NN	I-NP	I-proteinwas	normal	be	VBD	B-VP	Onormal	.	normal	JJ	B-ADJP	O.	The	.	.	O	OThe	disparity	The	DT	B-NP	Odisparity	of	disparity	NN	I-NP	Oof	results	of	IN	B-PP	Oresults	between	result	NNS	B-NP	Obetween	endogenous	between	IN	B-PP	Oendogenous	and	endogenous	JJ	B-NP	Oand	exogenous	and	CC	I-NP	Oexogenous	hypercorticism	exogenous	JJ	I-NP	Ohypercorticism	","	hypercorticism	NN	I-NP	O","	between	","	","	O	Obetween	the	between	IN	B-PP	Othe	two	the	DT	B-NP	Otwo	cell	two	CD	I-NP	Ocell	types	cell	NN	I-NP	Otypes	","	type	NNS	I-NP	O","	and	","	","	O	Oand	between	and	CC	O	Obetween	the	between	IN	B-PP	Othe	present	the	DT	B-NP	Opresent	studies	present	JJ	I-NP	Ostudies	and	study	NNS	I-NP	Oand	previous	and	CC	O	Oprevious	studies	previous	JJ	B-NP	Ostudies	suggest	study	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	effects	the	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	excess	glucocorticoid	NN	B-NP	Oexcess	on	excess	NN	I-NP	Oon	the	on	IN	B-PP	Othe	insulin	the	DT	B-NP	Oinsulin	receptor	insulin	NN	I-NP	B-proteinreceptor	are	receptor	NN	I-NP	I-proteinare	extremely	be	VBP	B-VP	Oextremely	complex	extremely	RB	B-ADJP	Ocomplex	and	complex	JJ	I-ADJP	Oand	wide-ranging	and	CC	I-ADJP	Owide-ranging	and	wide-ranging	JJ	I-ADJP	Oand	that	and	CC	O	Othat	in	that	IN	B-SBAR	Oin	this	in	IN	B-PP	Othis	condition	this	DT	B-NP	Ocondition	","	condition	NN	I-NP	O","	extrapolations	","	","	O	Oextrapolations	in	extrapolation	NNS	B-NP	Oin	humans	in	IN	B-PP	Ohumans	from	human	NNS	B-NP	Ofrom	data	from	IN	B-PP	Odata	with	datum	NNS	B-NP	Owith	circulating	with	IN	B-PP	Ocirculating	cells	circulate	VBG	B-VP	B-cell_typecells	to	cell	NNS	B-NP	I-cell_typeto	liver	to	TO	B-PP	Oliver	and	liver	NN	B-NP	Oand	muscle	and	CC	I-NP	Omuscle	may	muscle	NN	I-NP	Omay	not	may	MD	B-VP	Onot	be	not	RB	I-VP	Obe	appropriate	be	VB	I-VP	Oappropriate	.	appropriate	JJ	B-ADJP	O.	Reduced	.	.	O	OReduced	level	Reduce	VBN	B-NP	Olevel	of	level	NN	I-NP	Oof	cellular	of	IN	B-PP	Ocellular	glucocorticoid	cellular	JJ	B-NP	B-proteinglucocorticoid	receptors	glucocorticoid	NN	I-NP	I-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	anorexia	with	IN	B-PP	Oanorexia	nervosa	anorexia	NN	B-NP	Onervosa	.	nervosa	NN	I-NP	O.	Specific	.	.	O	OSpecific	glucocorticoid	Specific	JJ	B-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	were	receptor	NNS	I-NP	I-proteinwere	measured	be	VBD	B-VP	Omeasured	in	measure	VBN	I-VP	Oin	circulating	in	IN	B-PP	Ocirculating	mononuclear	circulate	VBG	B-VP	B-cell_typemononuclear	leukocytes	mononuclear	JJ	B-NP	I-cell_typeleukocytes	from	leukocyte	NNS	I-NP	I-cell_typefrom	12	from	IN	B-PP	O12	patients	12	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	anorexia	with	IN	B-PP	Oanorexia	nervosa	anorexia	NN	B-NP	Onervosa	and	nervosa	NN	I-NP	Oand	21	and	CC	O	O21	healthy	21	CD	B-NP	Ohealthy	control	healthy	JJ	I-NP	Ocontrol	subjects	control	NN	I-NP	Osubjects	.	subject	NNS	I-NP	O.	Cells	.	.	O	OCells	from	Cell	NNS	B-NP	Ofrom	patients	from	IN	B-PP	Opatients	were	patient	NNS	B-NP	Owere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	contain	to	TO	I-VP	Ocontain	a	contain	VB	I-VP	Oa	significantly	a	DT	O	Osignificantly	(	significantly	RB	O	O(	p	(	(	O	Op	less	p	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.01	than	IN	B-PP	O0.01	)	0.01	CD	B-NP	O)	lower	)	)	O	Olower	level	low	JJR	B-NP	Olevel	of	level	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	3830	(	(	O	O3830	+/-	3830	CD	B-NP	O+/-	210	+/-	CC	I-NP	O210	sites/cell	210	CD	I-NP	Osites/cell	","	sites/cell	NNS	I-NP	O","	mean	","	","	O	Omean	+/-	mean	NN	B-NP	O+/-	SE	+/-	SYM	I-NP	OSE	)	SE	NN	I-NP	O)	than	)	)	O	Othan	those	than	IN	B-PP	Othose	from	those	DT	B-NP	Ofrom	controls	from	IN	B-PP	Ocontrols	(	control	NNS	B-NP	O(	4930	(	(	O	O4930	+/-	4930	CD	B-NP	O+/-	250	+/-	CC	I-NP	O250	sites/cell	250	CD	I-NP	Osites/cell	)	sites/cell	NNS	I-NP	O)	.	)	)	O	O.	A	.	.	O	OA	partial	A	DT	B-NP	Opartial	glucocorticoid	partial	JJ	I-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	defect	receptor	NN	I-NP	I-proteindefect	may	defect	NN	I-NP	Omay	well	may	MD	B-VP	Owell	explain	well	RB	I-VP	Oexplain	the	explain	VB	I-VP	Othe	abnormal	the	DT	B-NP	Oabnormal	cortisol	abnormal	JJ	I-NP	Ocortisol	metabolism	cortisol	NN	I-NP	Ometabolism	and	metabolism	NN	I-NP	Oand	glucocorticoid	and	CC	I-NP	Oglucocorticoid	resistance	glucocorticoid	NN	I-NP	Oresistance	commonly	resistance	NN	I-NP	Ocommonly	found	commonly	RB	B-VP	Ofound	in	find	VBN	I-VP	Oin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	anorexia	with	IN	B-PP	Oanorexia	nervosa	anorexia	NN	B-NP	Onervosa	.	nervosa	NN	I-NP	O.	Regulation	.	.	O	ORegulation	of	Regulation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	in	receptor	NN	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	lymphocytes	human	JJ	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	presence	The	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	a	of	IN	B-PP	Oa	glucocorticoid	a	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	in	receptor	NN	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	lymphocytes	human	JJ	B-NP	B-cell_typelymphocytes	is	lymphocyte	NNS	I-NP	I-cell_typeis	well	be	VBZ	B-VP	Owell	established	well	RB	I-VP	Oestablished	","	establish	VBN	I-VP	O","	but	","	","	O	Obut	factors	but	CC	O	Ofactors	affecting	factor	NNS	B-NP	Oaffecting	its	affect	VBG	B-VP	Oits	regulation	its	PRP$	B-NP	Oregulation	have	regulation	NN	I-NP	Ohave	not	have	VBP	B-VP	Onot	been	not	RB	I-VP	Obeen	described	be	VBN	I-VP	Odescribed	.	describe	VBN	I-VP	O.	Using	.	.	O	OUsing	a	Use	VBG	B-VP	Oa	competitive	a	DT	B-NP	Ocompetitive	binding	competitive	JJ	I-NP	Obinding	whole	binding	NN	I-NP	Owhole	cell	whole	JJ	I-NP	Ocell	assay	cell	NN	I-NP	Oassay	","	assay	NN	I-NP	O","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	examined	have	VBP	B-VP	Oexamined	the	examine	VBN	I-VP	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	#NAME?	]	)	I-NP	O#NAME?	at	#NAME?	NN	I-NP	Oat	24	at	IN	B-PP	O24	and	24	CD	B-NP	Oand	37	and	CC	I-NP	O37	degrees	37	CD	I-NP	Odegrees	C	degree	NNS	I-NP	OC	in	C	JJ	B-ADJP	Oin	untreated	in	IN	B-PP	Ountreated	normal	untreated	JJ	B-NP	Onormal	subjects	normal	JJ	I-NP	Osubjects	and	subject	NNS	I-NP	Oand	in	and	CC	B-PP	Oin	healthy	in	IN	B-PP	Ohealthy	subjects	healthy	JJ	B-NP	Osubjects	taking	subject	NNS	I-NP	Otaking	various	take	VBG	B-VP	Ovarious	glucocorticoid	various	JJ	B-NP	Oglucocorticoid	preparations	glucocorticoid	NN	I-NP	Opreparations	.	preparation	NNS	I-NP	O.	At	.	.	O	OAt	24	At	IN	B-PP	O24	degrees	24	CD	B-NP	Odegrees	C	degree	NNS	I-NP	OC	normal	C	JJ	B-NP	Onormal	human	normal	JJ	I-NP	Ohuman	lymphocytes	human	JJ	I-NP	Olymphocytes	had	lymphocyte	NNS	I-NP	Ohad	6000	have	VBD	B-VP	O6000	binding	6000	CD	B-NP	Obinding	sites/cell	bind	VBG	I-NP	Osites/cell	and	sites/cell	NNS	I-NP	Oand	a	and	CC	O	Oa	dissociation	a	DT	B-NP	Odissociation	constant	dissociation	NN	I-NP	Oconstant	of	constant	NN	I-NP	Oof	4	of	IN	B-PP	O4	x	4	CD	B-NP	Ox	10	x	NN	I-NP	O10	(	10	CD	I-NP	O(	-9	(	(	O	O-9	)	-9	CD	B-NP	O)	M	)	)	O	OM	.	M	NN	B-NP	O.	The	.	.	O	OThe	administration	The	DT	B-NP	Oadministration	of	administration	NN	I-NP	Oof	1	of	IN	B-PP	O1	mg	1	CD	B-NP	Omg	of	mg	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	","	dexamethasone	NN	B-NP	O","	5	","	","	O	O5	mg	5	CD	B-NP	Omg	of	mg	NN	I-NP	Oof	prednisone	of	IN	B-PP	Oprednisone	","	prednisone	NN	B-NP	O","	and	","	","	O	Oand	37.5	and	CC	O	O37.5	mg	37.5	CD	B-NP	Omg	of	mg	NN	I-NP	Oof	cortisone	of	IN	B-PP	Ocortisone	acetate	cortisone	NN	B-NP	Oacetate	resulted	acetate	NN	I-NP	Oresulted	in	result	VBD	B-VP	Oin	a	in	IN	B-PP	Oa	30	a	DT	B-NP	O30	%	30	CD	I-NP	O%	decrease	%	NN	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	binding	in	IN	B-PP	Obinding	sites	bind	VBG	B-NP	Osites	after	site	NNS	I-NP	Oafter	1	after	IN	B-PP	O1	week	1	CD	B-NP	Oweek	with	week	NN	I-NP	Owith	no	with	IN	B-PP	Ono	change	no	DT	B-NP	Ochange	in	change	NN	I-NP	Oin	binding	in	IN	B-PP	Obinding	affinity	binding	NN	B-NP	Oaffinity	.	affinity	NN	I-NP	O.	No	.	.	O	ONo	changes	No	DT	B-NP	Ochanges	in	change	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	binding	of	IN	B-PP	Obinding	sites	bind	VBG	B-NP	B-proteinsites	was	site	NNS	I-NP	I-proteinwas	noted	be	VBD	B-VP	Onoted	before	note	VBN	I-VP	Obefore	1	before	IN	B-PP	O1	week	1	CD	B-NP	Oweek	and	week	NN	I-NP	Oand	the	and	CC	O	Othe	diminished	the	DT	B-NP	Odiminished	number	diminish	VBN	I-NP	Onumber	persisted	number	NN	I-NP	Opersisted	for	persist	VBD	B-VP	Ofor	1	for	IN	B-PP	O1	week	1	CD	B-NP	Oweek	after	week	NN	I-NP	Oafter	discontinuation	after	IN	B-PP	Odiscontinuation	of	discontinuation	NN	B-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	treatment	glucocorticoid	NN	B-NP	Otreatment	.	treatment	NN	I-NP	O.	Lymphocytes	.	.	O	OLymphocytes	from	Lymphocyte	NNS	B-NP	B-cell_typefrom	hospitalized	from	IN	B-PP	Ohospitalized	patients	hospitalize	VBN	B-NP	Opatients	taking	patient	NNS	I-NP	Otaking	40-60	take	VBG	B-VP	O40-60	mg	40-60	CD	B-NP	Omg	of	mg	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	daily	dexamethasone	NN	B-NP	Odaily	demonstrated	daily	RB	B-ADVP	Odemonstrated	the	demonstrate	VBD	B-VP	Othe	same	the	DT	B-NP	Osame	change	same	JJ	I-NP	Ochange	in	change	NN	I-NP	Oin	number	in	IN	B-PP	Onumber	of	number	NN	B-NP	Oof	binding	of	IN	B-PP	Obinding	sites	bind	VBG	B-NP	B-proteinsites	that	site	NNS	I-NP	I-proteinthat	was	that	WDT	B-NP	Owas	seen	be	VBD	B-VP	Oseen	in	see	VBN	I-VP	Oin	normal	in	IN	B-PP	Onormal	subjects	normal	JJ	B-NP	Osubjects	taking	subject	NNS	I-NP	Otaking	1	take	VBG	B-VP	O1	mg	1	CD	B-NP	Omg	of	mg	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	.	dexamethasone	NN	B-NP	O.	When	.	.	O	OWhen	binding	When	WRB	B-ADVP	Obinding	assays	binding	NN	B-NP	Oassays	were	assay	NNS	I-NP	Owere	carried	be	VBD	B-VP	Ocarried	out	carry	VBN	I-VP	Oout	at	out	RP	B-PRT	Oat	physiologic	at	IN	B-PP	Ophysiologic	temperature	physiologic	JJ	B-NP	Otemperature	there	temperature	NN	I-NP	Othere	was	there	EX	B-NP	Owas	the	be	VBD	B-VP	Othe	same	the	DT	B-NP	Osame	decrease	same	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	number	in	IN	B-PP	Onumber	of	number	NN	B-NP	Oof	binding	of	IN	B-PP	Obinding	sites	bind	VBG	B-NP	Osites	after	site	NNS	I-NP	Oafter	dexamethasone	after	IN	B-PP	Odexamethasone	administration	dexamethasone	NN	B-NP	Oadministration	","	administration	NN	I-NP	O","	and	","	","	O	Oand	in	and	CC	O	Oin	addition	in	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	there	","	","	O	Othere	was	there	EX	B-NP	Owas	a	be	VBD	B-VP	Oa	two-fold	a	DT	B-NP	Otwo-fold	increase	two-fold	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	binding	in	IN	B-PP	Obinding	affinity	binding	NN	B-NP	Oaffinity	.	affinity	NN	I-NP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	administration	Glucocorticoid	NN	B-NP	Oadministration	results	administration	NN	I-NP	Oresults	in	result	VBZ	B-VP	Oin	a	in	IN	B-PP	Oa	time-dependent	a	DT	B-NP	Otime-dependent	decrease	time-dependent	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	the	in	IN	B-PP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	lymphocyte	of	IN	B-PP	Olymphocyte	glucocorticoid	lymphocyte	NN	B-NP	B-proteinglucocorticoid	binding	glucocorticoid	NN	I-NP	I-proteinbinding	sites	binding	NN	I-NP	I-proteinsites	that	site	NNS	I-NP	I-proteinthat	is	that	WDT	B-NP	Ois	independent	be	VBZ	B-VP	Oindependent	of	independent	JJ	B-ADJP	Oof	the	of	IN	B-PP	Othe	type	the	DT	B-NP	Otype	of	type	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	administered	glucocorticoid	NN	B-NP	Oadministered	.	administer	VBN	B-VP	O.	This	.	.	O	OThis	is	This	DT	B-NP	Ois	the	be	VBZ	B-VP	Othe	first	the	DT	B-NP	Ofirst	in	first	JJ	I-NP	Oin	vivo	in	FW	I-NP	Ovivo	demonstration	vivo	FW	I-NP	Odemonstration	that	demonstration	NN	I-NP	Othat	glucocorticoids	that	IN	B-NP	Oglucocorticoids	modulate	glucocorticoid	NNS	B-NP	Omodulate	their	modulate	VBP	B-VP	Otheir	own	their	PRP$	B-NP	Oown	receptors	own	JJ	I-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	man	in	IN	B-PP	Oman	.	man	NN	B-NP	O.	Immunoglobulin	.	.	O	OImmunoglobulin	localization	Immunoglobulin	NN	B-NP	Olocalization	in	localization	NN	I-NP	Oin	benign	in	IN	B-PP	Obenign	and	benign	JJ	B-NP	Oand	malignant	and	CC	I-NP	Omalignant	lesions	malignant	JJ	I-NP	Olesions	of	lesion	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	mammary	human	JJ	I-NP	Omammary	gland	mammary	JJ	I-NP	Ogland	.	gland	NN	I-NP	O.	Using	.	.	O	OUsing	direct	Use	VBG	B-VP	Odirect	imunofluorescence	direct	JJ	B-NP	Oimunofluorescence	","	imunofluorescence	NN	I-NP	O","	lesions	","	","	O	Olesions	from	lesion	NNS	B-NP	Ofrom	266	from	IN	B-PP	O266	human	266	CD	B-NP	Ohuman	breast	human	JJ	I-NP	Obreast	specimens	breast	NN	I-NP	Ospecimens	were	specimen	NNS	I-NP	Owere	studied	be	VBD	B-VP	Ostudied	for	study	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	IgA	of	IN	B-PP	OIgA	","	IgA	NN	B-NP	B-protein","	IgM	","	","	O	OIgM	","	IgM	NN	B-NP	B-protein","	or	","	","	O	Oor	IgG	or	CC	O	OIgG	localization	IgG	NN	B-NP	B-proteinlocalization	.	localization	NN	I-NP	O.	The	.	.	O	OThe	lesions	The	DT	B-NP	Olesions	included	lesion	NNS	I-NP	B-DNAincluded	benign	include	VBD	B-VP	I-DNAbenign	elements	benign	JJ	B-NP	I-DNAelements	from	element	NNS	I-NP	I-DNAfrom	66	from	IN	B-PP	O66	subcutaneous	66	CD	B-NP	Osubcutaneous	mastectomy	subcutaneous	JJ	I-NP	Omastectomy	specimens	mastectomy	NN	I-NP	Ospecimens	in	specimen	NNS	I-NP	Oin	which	in	IN	B-PP	Owhich	the	which	WDT	B-NP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	simultaneous	of	IN	B-PP	Osimultaneous	breast	simultaneous	JJ	B-NP	Obreast	malignancy	breast	NN	I-NP	Omalignancy	was	malignancy	NN	I-NP	Owas	documented	be	VBD	B-VP	Odocumented	","	document	VBN	I-VP	O","	primary	","	","	O	Oprimary	breast	primary	JJ	B-NP	Obreast	carcinomas	breast	NN	I-NP	Ocarcinomas	from	carcinoma	NNS	I-NP	Ofrom	153	from	IN	B-PP	O153	mastectomy	153	CD	B-NP	Omastectomy	specimens	mastectomy	NN	I-NP	Ospecimens	","	specimen	NNS	I-NP	O","	and	","	","	O	Oand	47	and	CC	O	O47	biopsies	47	CD	B-NP	Obiopsies	containing	biopsy	NNS	I-NP	Ocontaining	metastatic	contain	VBG	B-VP	Ometastatic	breast	metastatic	JJ	B-NP	Obreast	cancer	breast	NN	I-NP	Ocancer	.	cancer	NN	I-NP	O.	A	.	.	O	OA	statistically	A	DT	B-NP	Ostatistically	significant	statistically	RB	I-NP	Osignificant	association	significant	JJ	I-NP	Oassociation	of	association	NN	I-NP	Oof	IgA	of	IN	B-PP	OIgA	and	IgA	NN	B-NP	B-proteinand	IgM	and	CC	I-NP	OIgM	with	IgM	NN	I-NP	B-proteinwith	benign	with	IN	B-PP	Obenign	lesions	benign	JJ	B-NP	Olesions	was	lesion	NNS	I-NP	Owas	contrasted	be	VBD	B-VP	Ocontrasted	to	contrast	VBN	I-VP	Oto	the	to	TO	B-PP	Othe	association	the	DT	B-NP	Oassociation	of	association	NN	I-NP	Oof	IgG	of	IN	B-PP	OIgG	with	IgG	NN	B-NP	B-proteinwith	malignant	with	IN	B-PP	Omalignant	lesions	malignant	JJ	B-NP	Olesions	.	lesion	NNS	I-NP	O.	In	.	.	O	OIn	both	In	IN	B-PP	Oboth	primary	both	CC	O	Oprimary	and	primary	JJ	B-NP	Oand	metastatic	and	CC	I-NP	Ometastatic	lesions	metastatic	JJ	I-NP	Olesions	","	lesion	NNS	I-NP	O","	IgG	","	","	O	OIgG	localization	IgG	NN	B-NP	B-proteinlocalization	was	localization	NN	I-NP	Owas	associated	be	VBD	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	estrogen-receptor-poor	with	IN	B-PP	Oestrogen-receptor-poor	primary	estrogen-receptor-poor	JJ	B-NP	Oprimary	cancers	primary	JJ	I-NP	Ocancers	as	cancer	NNS	I-NP	Oas	compared	as	IN	B-PP	Ocompared	with	compare	VBN	B-PP	Owith	estrogen-receptor-rich	with	IN	B-PP	Oestrogen-receptor-rich	primary	estrogen-receptor-rich	JJ	B-NP	Oprimary	cancers	primary	JJ	I-NP	Ocancers	.	cancer	NNS	I-NP	O.	Among	.	.	O	OAmong	primary	Among	IN	B-PP	Oprimary	breast	primary	JJ	B-NP	Obreast	cancer	breast	NN	I-NP	Ocancer	patients	cancer	NN	I-NP	Opatients	","	patient	NNS	I-NP	O","	IgG	","	","	O	OIgG	localization	IgG	NN	B-NP	B-proteinlocalization	in	localization	NN	I-NP	Oin	the	in	IN	B-PP	Othe	tumor	the	DT	B-NP	Otumor	correlated	tumor	NN	I-NP	Ocorrelated	with	correlate	VBD	B-VP	Owith	relative	with	IN	B-PP	Orelative	lymphopenia	relative	JJ	B-NP	Olymphopenia	.	lymphopenia	NN	I-NP	O.	A	.	.	O	OA	shorter	A	DT	B-NP	Oshorter	disease-free	short	JJR	I-NP	Odisease-free	interval	disease-free	JJ	I-NP	Ointerval	was	interval	NN	I-NP	Owas	noted	be	VBD	B-VP	Onoted	in	note	VBN	I-VP	Oin	association	in	IN	B-PP	Oassociation	with	association	NN	B-NP	Owith	IgG	with	IN	B-PP	OIgG	localization	IgG	NN	B-NP	B-proteinlocalization	among	localization	NN	I-NP	Oamong	the	among	IN	B-PP	Othe	metastatic	the	DT	B-NP	Ometastatic	breast	metastatic	JJ	I-NP	Obreast	lesions	breast	NN	I-NP	Olesions	.	lesion	NNS	I-NP	O.	No	.	.	O	ONo	statistically	No	DT	B-NP	Ostatistically	significant	statistically	RB	I-NP	Osignificant	association	significant	JJ	I-NP	Oassociation	between	association	NN	I-NP	Obetween	stage	between	IN	B-PP	Ostage	of	stage	NN	B-NP	Oof	disease	of	IN	B-PP	Odisease	and	disease	NN	B-NP	Oand	immunoglobulin	and	CC	O	Oimmunoglobulin	presence	immunoglobulin	NN	B-NP	B-proteinpresence	was	presence	NN	I-NP	Owas	demonstrable	be	VBD	B-VP	Odemonstrable	.	demonstrable	JJ	B-ADJP	O.	Moderate-to-severe	.	.	O	OModerate-to-severe	intraductal	Moderate-to-severe	JJ	B-NP	Ointraductal	epithelial	intraductal	JJ	I-NP	Oepithelial	hyperplasias	epithelial	JJ	I-NP	Ohyperplasias	were	hyperplasia	NNS	I-NP	Owere	more	be	VBD	B-VP	Omore	often	more	RBR	I-VP	Ooften	associated	often	RB	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	immunoglobulin	with	IN	B-PP	Oimmunoglobulin	G	immunoglobulin	NN	B-NP	OG	localization	G	NN	I-NP	Olocalization	that	localization	NN	I-NP	Othat	were	that	WDT	B-NP	Owere	other	be	VBD	B-VP	Oother	benign	other	JJ	B-NP	Obenign	lesions	benign	JJ	I-NP	Olesions	Correlation	lesion	NNS	I-NP	OCorrelation	of	Correlation	NN	B-NP	Oof	steroid	of	IN	B-PP	Osteroid	receptors	steroid	NN	B-NP	B-proteinreceptors	with	receptor	NNS	I-NP	I-proteinwith	histologic	with	IN	B-PP	Ohistologic	differentiation	histologic	JJ	B-NP	Odifferentiation	in	differentiation	NN	I-NP	Oin	mammary	in	IN	B-PP	Omammary	carcinoma	mammary	JJ	B-NP	Ocarcinoma	.	carcinoma	NN	I-NP	O.	A	.	.	O	OA	Singapore	A	DT	B-NP	OSingapore	experience	Singapore	NNP	I-NP	Oexperience	.	experience	NN	I-NP	O.	Cancer	.	.	O	OCancer	of	Cancer	NN	B-NP	Oof	the	of	IN	B-PP	Othe	breast	the	DT	B-NP	Obreast	is	breast	NN	I-NP	Ois	the	be	VBZ	B-VP	Othe	most	the	DT	B-NP	Omost	common	most	RBS	I-NP	Ocommon	tumor	common	JJ	I-NP	Otumor	in	tumor	NN	I-NP	Oin	females	in	IN	B-PP	Ofemales	in	female	NNS	B-NP	Oin	Singapore	in	IN	B-PP	OSingapore	","	Singapore	NNP	B-NP	O","	with	","	","	O	Owith	the	with	IN	B-PP	Othe	rate	the	DT	B-NP	Orate	of	rate	NN	I-NP	Oof	20.7	of	IN	B-PP	O20.7	per	20.7	CD	B-NP	Oper	100	per	IN	B-PP	O100	","	100	CD	B-NP	O","	0	","	","	O	O0	per	0	CD	B-NP	Oper	year	per	IN	B-PP	Oyear	(	year	NN	B-NP	O(	1977	(	(	O	O1977	estimate	1977	CD	B-NP	Oestimate	)	estimate	NN	I-NP	O)	","	)	)	O	O","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	predicted	be	VBZ	B-VP	Opredicted	to	predict	VBN	I-VP	Oto	increase	to	TO	I-VP	Oincrease	to	increase	VB	I-VP	Oto	29.8	to	TO	B-PP	O29.8	per	29.8	CD	B-NP	Oper	100	per	IN	B-PP	O100	","	100	CD	B-NP	O","	0	","	","	O	O0	women	0	CD	B-NP	Owomen	per	woman	NNS	I-NP	Oper	year	per	IN	B-PP	Oyear	by	year	NN	B-NP	Oby	1995	by	IN	B-PP	O1995	.	1995	CD	B-NP	O.	A	.	.	O	OA	detailed	A	DT	B-NP	Odetailed	histopathologic	detailed	JJ	I-NP	Ohistopathologic	review	histopathologic	JJ	I-NP	Oreview	of	review	NN	I-NP	Oof	50	of	IN	B-PP	O50	primary	50	CD	B-NP	Oprimary	breast	primary	JJ	I-NP	Obreast	cancer	breast	NN	I-NP	Ocancer	tumors	cancer	NN	I-NP	Otumors	analyzed	tumor	NNS	I-NP	Oanalyzed	for	analyze	VBN	B-VP	Ofor	estrogen	for	IN	B-PP	Oestrogen	receptor	estrogen	NN	B-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	ER	(	(	I-NP	OER	)	ER	NN	I-NP	B-protein)	level	)	)	I-NP	Olevel	was	level	NN	I-NP	Owas	carried	be	VBD	B-VP	Ocarried	out	carry	VBN	I-VP	Oout	and	out	RP	B-PRT	Oand	a	and	CC	O	Oa	variety	a	DT	B-NP	Ovariety	of	variety	NN	I-NP	Oof	morphologic	of	IN	B-PP	Omorphologic	features	morphologic	JJ	B-NP	Ofeatures	correlated	feature	NNS	I-NP	Ocorrelated	with	correlate	VBD	B-VP	Owith	ER	with	IN	B-PP	OER	results	ER	NN	B-NP	B-proteinresults	to	result	NNS	I-NP	Oto	identify	to	TO	B-VP	Oidentify	any	identify	VB	I-VP	Oany	factors	any	DT	B-NP	Ofactors	that	factor	NNS	I-NP	Othat	will	that	WDT	B-NP	Owill	improve	will	MD	B-VP	Oimprove	the	improve	VB	I-VP	Othe	management	the	DT	B-NP	Omanagement	and	management	NN	I-NP	Oand	prognosis	and	CC	I-NP	Oprognosis	for	prognosis	NN	I-NP	Ofor	breast	for	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	.	cancer	NN	I-NP	O.	Cytosol	.	.	O	OCytosol	was	Cytosol	NN	B-NP	Owas	incubated	be	VBD	B-VP	Oincubated	with	incubate	VBN	I-VP	Owith	3H-estradiol	with	IN	B-PP	O3H-estradiol	in	3H-estradiol	NN	B-NP	Oin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	and	presence	NN	I-NP	Oand	absence	and	CC	I-NP	Oabsence	of	absence	NN	I-NP	Oof	cold	of	IN	B-PP	Ocold	diethylstilbestrol	cold	JJ	B-NP	Odiethylstilbestrol	","	diethylstilbestrol	NN	I-NP	O","	and	","	","	O	Oand	bound	and	CC	O	Obound	and	bind	VBD	B-VP	Oand	free	and	CC	O	Ofree	hormone	free	JJ	B-NP	Ohormone	were	hormone	NN	I-NP	Owere	separated	be	VBD	B-VP	Oseparated	by	separate	VBN	I-VP	Oby	Dextran-coated	by	IN	B-PP	ODextran-coated	charcoal	Dextran-coated	JJ	B-NP	Ocharcoal	method	charcoal	NN	I-NP	Omethod	.	method	NN	I-NP	O.	Tumors	.	.	O	OTumors	binding	Tumor	NNS	B-NP	Obinding	more	bind	VBG	B-VP	Omore	than	more	JJR	B-NP	Othan	5	than	IN	I-NP	O5	fmol/mg	5	CD	I-NP	Ofmol/mg	cytosol	fmol/mg	NN	I-NP	Ocytosol	protein	cytosol	NN	I-NP	B-proteinprotein	were	protein	NN	I-NP	I-proteinwere	classified	be	VBD	B-VP	Oclassified	as	classify	VBN	I-VP	Oas	ER	as	IN	B-PP	OER	#NAME?	ER	NN	B-NP	B-protein#NAME?	.	#NAME?	JJ	B-ADJP	O.	Progesterone	.	.	O	OProgesterone	receptor	Progesterone	NN	B-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	PR	(	(	O	OPR	)	PR	NN	B-NP	B-protein)	level	)	)	O	Olevel	was	level	NN	B-NP	Owas	analyzed	be	VBD	B-VP	Oanalyzed	in	analyze	VBN	I-VP	Oin	some	in	IN	B-PP	Osome	specimens	some	DT	B-NP	Ospecimens	with	specimen	NNS	I-NP	Owith	the	with	IN	B-PP	Othe	use	the	DT	B-NP	Ouse	of	use	NN	I-NP	Oof	a	of	IN	B-PP	Oa	similar	a	DT	B-NP	Osimilar	method	similar	JJ	I-NP	Omethod	.	method	NN	I-NP	O.	Most	.	.	O	OMost	of	Most	JJS	B-NP	Oof	the	of	IN	B-PP	Othe	patients	the	DT	B-NP	Opatients	were	patient	NNS	I-NP	Owere	Chinese	be	VBD	B-VP	OChinese	(	Chinese	JJ	B-ADJP	O(	90	(	(	O	O90	%	90	CD	B-NP	O%	)	%	NN	I-NP	O)	.	)	)	O	O.	Three	.	.	O	OThree	patients	Three	CD	B-NP	Opatients	were	patient	NNS	I-NP	Owere	Malays	be	VBD	B-VP	OMalays	","	Malay	NNS	B-NP	O","	one	","	","	O	Oone	was	one	CD	B-NP	Owas	Indian	be	VBD	B-VP	OIndian	","	Indian	JJ	B-ADJP	O","	and	","	","	O	Oand	one	and	CC	O	Oone	was	one	CD	B-NP	Owas	European	be	VBD	B-VP	OEuropean	in	European	JJ	B-ADJP	Oin	this	in	IN	B-PP	Othis	series	this	DT	B-NP	Oseries	.	series	NN	I-NP	O.	Results	.	.	O	OResults	indicated	Result	NNS	B-NP	Oindicated	that	indicate	VBD	B-VP	Othat	there	that	IN	B-SBAR	Othere	was	there	EX	B-NP	Owas	strong	be	VBD	B-VP	Ostrong	correlation	strong	JJ	B-NP	Ocorrelation	between	correlation	NN	I-NP	Obetween	ER	between	IN	B-PP	OER	level	ER	NN	B-NP	B-proteinlevel	","	level	NN	I-NP	O","	age	","	","	O	Oage	","	age	NN	B-NP	O","	and	","	","	O	Oand	histologic	and	CC	O	Ohistologic	grade	histologic	JJ	B-NP	Ograde	of	grade	NN	I-NP	Oof	the	of	IN	B-PP	Othe	tumors	the	DT	B-NP	Otumors	.	tumor	NNS	I-NP	O.	No	.	.	O	ONo	correlation	No	DT	B-NP	Ocorrelation	existed	correlation	NN	I-NP	Oexisted	between	exist	VBD	B-VP	Obetween	absence	between	IN	B-PP	Oabsence	or	absence	NN	B-NP	Oor	presence	or	CC	I-NP	Opresence	of	presence	NN	I-NP	Oof	lymph	of	IN	B-PP	Olymph	node	lymph	NN	B-NP	B-proteinnode	metastases	node	NN	I-NP	I-proteinmetastases	and	metastasis	NNS	I-NP	I-proteinand	ER	and	CC	O	OER	.	ER	NN	B-NP	B-protein.	Although	.	.	O	OAlthough	there	Although	IN	B-SBAR	Othere	was	there	EX	B-NP	Owas	a	be	VBD	B-VP	Oa	trend	a	DT	B-NP	Otrend	for	trend	NN	I-NP	Ofor	ER	for	IN	B-PP	OER	#NAME?	ER	NN	B-NP	B-protein#NAME?	tumors	#NAME?	JJ	I-NP	Otumors	to	tumor	NNS	I-NP	Oto	have	to	TO	B-VP	Ohave	a	have	VB	I-VP	Oa	low-grade	a	DT	B-NP	Olow-grade	lymphocytic	low-grade	JJ	I-NP	Olymphocytic	infiltration	lymphocytic	JJ	I-NP	Oinfiltration	","	infiltration	NN	I-NP	O","	the	","	","	O	Othe	difference	the	DT	B-NP	Odifference	was	difference	NN	I-NP	Owas	not	be	VBD	B-VP	Onot	statistically	not	RB	O	Ostatistically	significant	statistically	RB	B-ADJP	Osignificant	.	significant	JJ	I-ADJP	O.	Mononuclear	.	.	O	OMononuclear	cells	Mononuclear	JJ	B-NP	B-cell_typecells	infiltrating	cell	NNS	I-NP	I-cell_typeinfiltrating	human	infiltrate	VBG	B-VP	Ohuman	mammary	human	JJ	B-NP	Omammary	carcinomas	mammary	JJ	I-NP	Ocarcinomas	:	carcinoma	NNS	I-NP	O:	immunohistochemical	:	:	O	Oimmunohistochemical	analysis	immunohistochemical	JJ	B-NP	Oanalysis	with	analysis	NN	I-NP	Owith	monoclonal	with	IN	B-PP	Omonoclonal	antibodies	monoclonal	JJ	B-NP	B-proteinantibodies	.	antibody	NNS	I-NP	I-protein.	Breast	.	.	O	OBreast	carcinomas	Breast	NN	B-NP	Ocarcinomas	were	carcinoma	NNS	I-NP	Owere	examined	be	VBD	B-VP	Oexamined	by	examine	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	immunoperoxidase	the	DT	B-NP	Oimmunoperoxidase	technique	immunoperoxidase	NN	I-NP	Otechnique	using	technique	NN	I-NP	Ousing	antisera	use	VBG	B-VP	Oantisera	specific	antiserum	NNS	B-NP	Ospecific	for	specific	JJ	B-ADJP	Ofor	lymphocyte	for	IN	B-PP	Olymphocyte	subsets	lymphocyte	NN	B-NP	B-cell_typesubsets	","	subset	NNS	I-NP	I-cell_type","	monocytes	","	","	O	Omonocytes	","	monocyte	NNS	B-NP	B-cell_type","	NK	","	","	O	ONK	cells	NK	NN	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	major	and	CC	O	Omajor	histocompatibility	major	JJ	B-NP	B-proteinhistocompatibility	antigens	histocompatibility	NN	I-NP	I-proteinantigens	(	antigen	NNS	I-NP	I-protein(	HLA-A	(	(	O	OHLA-A	","	HLA-A	NN	B-NP	B-protein","	#NAME?	","	","	O	O#NAME?	","	#NAME?	NN	B-NP	B-protein","	-C	","	","	O	O-C	;	-C	NN	B-NP	B-protein;	Ia-like	;	:	O	OIa-like	)	Ia-like	JJ	B-ADJP	O)	.	)	)	O	O.	Sixty-four	.	.	O	OSixty-four	per	Sixty-four	CD	B-NP	Oper	cent	per	IN	B-PP	Ocent	of	cent	NN	B-NP	Oof	the	of	IN	B-PP	Othe	patients	the	DT	B-NP	Opatients	had	patient	NNS	I-NP	Ohad	a	have	VBD	B-VP	Oa	moderate	a	DT	B-NP	Omoderate	or	moderate	JJ	I-NP	Oor	strong	or	CC	I-NP	Ostrong	mononuclear	strong	JJ	I-NP	Omononuclear	cell	mononuclear	JJ	I-NP	Ocell	infiltration	cell	NN	I-NP	Oinfiltration	","	infiltration	NN	I-NP	O","	77	","	","	O	O77	%	77	CD	B-NP	O%	of	%	NN	I-NP	Oof	the	of	IN	B-PP	Othe	patients	the	DT	B-NP	Opatients	without	patient	NNS	I-NP	Owithout	mononuclear	without	IN	B-PP	Omononuclear	cell	mononuclear	JJ	B-NP	Ocell	infiltration	cell	NN	I-NP	Oinfiltration	had	infiltration	NN	I-NP	Ohad	receptors	have	VBD	B-VP	Oreceptors	for	receptor	NNS	B-NP	Ofor	estrogens	for	IN	B-PP	Oestrogens	as	estrogen	NNS	B-NP	Oas	compared	as	IN	B-SBAR	Ocompared	to	compare	VBN	B-VP	Oto	51	to	TO	B-PP	O51	%	51	CD	B-NP	O%	of	%	NN	I-NP	Oof	the	of	IN	B-PP	Othe	patients	the	DT	B-NP	Opatients	with	patient	NNS	I-NP	Owith	infiltration	with	IN	B-PP	Oinfiltration	.	infiltration	NN	B-NP	O.	The	.	.	O	OThe	majority	The	DT	B-NP	Omajority	of	majority	NN	I-NP	Oof	the	of	IN	B-PP	Othe	infiltrating	the	DT	B-NP	Oinfiltrating	mononuclear	infiltrate	VBG	I-NP	Omononuclear	cells	mononuclear	JJ	I-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	T	be	VBD	B-VP	OT	cells	T	NN	B-NP	B-cell_typecells	;	cell	NNS	I-NP	I-cell_type;	generally	;	:	O	Ogenerally	the	generally	RB	B-ADVP	Othe	OKT8	the	DT	B-NP	OOKT8	cells	OKT8	NN	I-NP	B-cell_linecells	were	cell	NNS	I-NP	I-cell_linewere	predominant	be	VBD	B-VP	Opredominant	.	predominant	JJ	B-ADJP	O.	The	.	.	O	OThe	Leu	The	DT	B-NP	OLeu	3A/OKT8	Leu	NN	I-NP	O3A/OKT8	cell	3A/OKT8	NN	I-NP	Ocell	ratio	cell	NN	I-NP	Oratio	was	ratio	NN	I-NP	Owas	not	be	VBD	B-VP	Onot	related	not	RB	O	Orelated	to	related	JJ	B-ADJP	Oto	histological	to	TO	B-PP	Ohistological	type	histological	JJ	B-NP	Otype	","	type	NN	I-NP	O","	tumor	","	","	O	Otumor	size	tumor	NN	B-NP	Osize	","	size	NN	I-NP	O","	age	","	","	O	Oage	of	age	NN	B-NP	Oof	the	of	IN	B-PP	Othe	patient	the	DT	B-NP	Opatient	or	patient	NN	I-NP	Oor	presence	or	CC	I-NP	Opresence	of	presence	NN	I-NP	Oof	metastases	of	IN	B-PP	Ometastases	.	metastasis	NNS	B-NP	O.	Some	.	.	O	OSome	of	Some	DT	B-NP	Oof	the	of	IN	B-PP	Othe	T	the	DT	B-NP	OT	cells	T	NN	I-NP	B-cell_typecells	had	cell	NNS	I-NP	I-cell_typehad	the	have	VBD	B-VP	Othe	Ia	the	DT	B-NP	OIa	antigen	Ia	NN	I-NP	B-proteinantigen	and	antigen	NN	I-NP	I-proteinand	were	and	CC	O	Owere	thus	be	VBD	B-VP	Othus	probably	thus	RB	I-VP	Oprobably	activated	probably	RB	I-VP	Oactivated	.	activate	VBN	I-VP	O.	The	.	.	O	OThe	B	The	DT	B-NP	OB	cells	B	NN	I-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	either	be	VBD	B-VP	Oeither	absent	either	CC	O	Oabsent	or	absent	JJ	B-ADJP	Oor	less	or	CC	O	Oless	numerous	less	RBR	B-ADJP	Onumerous	than	numerous	JJ	I-ADJP	Othan	the	than	IN	B-PP	Othe	T	the	DT	B-NP	OT	cells	T	NN	I-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	There	.	.	O	OThere	was	There	EX	B-NP	Owas	no	be	VBD	B-VP	Ono	relation	no	DT	B-NP	Orelation	between	relation	NN	I-NP	Obetween	their	between	IN	B-PP	Otheir	distribution	their	PRP$	B-NP	Odistribution	and	distribution	NN	I-NP	Oand	the	and	CC	O	Othe	various	the	DT	B-NP	Ovarious	parameters	various	JJ	I-NP	Oparameters	studied	parameter	NNS	I-NP	Ostudied	.	study	VBN	B-VP	O.	A	.	.	O	OA	few	A	DT	B-NP	Ofew	monocytes	few	JJ	I-NP	Omonocytes	were	monocyte	NNS	I-NP	B-cell_typewere	heterogeneous	be	VBD	B-VP	Oheterogeneous	according	heterogeneous	JJ	B-ADJP	Oaccording	to	accord	VBG	B-PP	Oto	their	to	TO	B-PP	Otheir	markers	their	PRP$	B-NP	Omarkers	(	marker	NNS	I-NP	O(	OKM	(	(	O	OOKM	I	OKM	NN	B-NP	OI	and	I	CD	I-NP	Oand	acid	and	CC	O	Oacid	phosphatase	acid	NN	B-NP	B-proteinphosphatase	)	phosphatase	NN	I-NP	I-protein)	.	)	)	O	O.	In	.	.	O	OIn	6	In	IN	B-PP	O6	cases	6	CD	B-NP	Ocases	only	case	NNS	I-NP	Oonly	there	only	RB	B-ADVP	Othere	was	there	EX	B-NP	Owas	a	be	VBD	B-VP	Oa	strong	a	DT	B-NP	Ostrong	infiltration	strong	JJ	I-NP	Oinfiltration	of	infiltration	NN	I-NP	Oof	mononuclear	of	IN	B-PP	Omononuclear	cells	mononuclear	JJ	B-NP	B-cell_typecells	positive	cell	NNS	I-NP	I-cell_typepositive	for	positive	JJ	B-ADJP	Ofor	acid	for	IN	B-PP	Oacid	phosphatase	acid	NN	B-NP	B-proteinphosphatase	.	phosphatase	NN	I-NP	I-protein.	The	.	.	O	OThe	number	The	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	the	of	IN	B-PP	Othe	natural	the	DT	B-NP	Onatural	killer	natural	JJ	I-NP	B-cell_typekiller	cells	killer	NN	I-NP	I-cell_typecells	was	cell	NNS	I-NP	I-cell_typewas	also	be	VBD	B-VP	Oalso	low	also	RB	B-ADVP	Olow	.	low	JJ	B-ADJP	O.	Only	.	.	O	OOnly	a	Only	RB	B-NP	Oa	few	a	DT	I-NP	Ofew	mononuclear	few	JJ	I-NP	Omononuclear	infiltrating	mononuclear	JJ	I-NP	B-cell_typeinfiltrating	cells	infiltrating	NN	I-NP	I-cell_typecells	had	cell	NNS	I-NP	I-cell_typehad	receptors	have	VBD	B-VP	Oreceptors	for	receptor	NNS	B-NP	Ofor	transferrin	for	IN	B-PP	Otransferrin	.	transferrin	NN	B-NP	B-protein.	There	.	.	O	OThere	was	There	EX	B-NP	Owas	a	be	VBD	B-VP	Oa	positive	a	DT	B-NP	Opositive	correlation	positive	JJ	I-NP	Ocorrelation	between	correlation	NN	I-NP	Obetween	the	between	IN	B-PP	Othe	inflammatory	the	DT	B-NP	Oinflammatory	infiltration	inflammatory	JJ	I-NP	Oinfiltration	and	infiltration	NN	I-NP	Oand	the	and	CC	O	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	HLA	of	IN	B-PP	OHLA	class-I	HLA	NN	B-NP	B-proteinclass-I	antigens	class-I	NN	I-NP	I-proteinantigens	on	antigen	NNS	I-NP	I-proteinon	tumor	on	IN	B-PP	Otumor	cell	tumor	NN	B-NP	B-cell_typecell	s	cell	NN	I-NP	I-cell_types	.	s	NNS	I-NP	I-cell_type.	Some	.	.	O	OSome	of	Some	DT	B-NP	Oof	the	of	IN	B-PP	Othe	antisera	the	DT	B-NP	Oantisera	specific	antiserum	NNS	I-NP	Ospecific	for	specific	JJ	B-ADJP	Ofor	lymphocyte	for	IN	B-PP	Olymphocyte	subsets	lymphocyte	NN	B-NP	B-cell_typesubsets	also	subset	NNS	I-NP	I-cell_typealso	stained	also	RB	B-ADVP	Ostained	the	stain	VBD	B-VP	Othe	breast	the	DT	B-NP	Obreast	carcinoma	breast	NN	I-NP	B-cell_typecarcinoma	cells	carcinoma	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	great	The	DT	B-NP	Ogreat	variations	great	JJ	I-NP	Ovariations	in	variation	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	subsets	the	DT	B-NP	Osubsets	of	subset	NNS	I-NP	Oof	mononuclear	of	IN	B-PP	Omononuclear	cells	mononuclear	JJ	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	breast	in	IN	B-PP	Obreast	carcinomas	breast	NN	B-NP	Ocarcinomas	may	carcinoma	NNS	I-NP	Omay	correspond	may	MD	B-VP	Ocorrespond	to	correspond	VB	I-VP	Oto	various	to	TO	B-PP	Ovarious	systems	various	JJ	B-NP	Osystems	of	system	NNS	I-NP	Oof	defense	of	IN	B-PP	Odefense	against	defense	NN	B-NP	Oagainst	neoplasm	against	IN	B-PP	Oneoplasm	.	neoplasm	NN	B-NP	O.	A	.	.	O	OA	case	A	DT	B-NP	Ocase	of	case	NN	I-NP	Oof	male	of	IN	B-PP	Omale	pseudohermaphroditism	male	JJ	B-NP	Opseudohermaphroditism	with	pseudohermaphroditism	NN	I-NP	Owith	normal	with	IN	B-PP	Onormal	androgen	normal	JJ	B-NP	Oandrogen	receptor	androgen	NN	I-NP	Oreceptor	binding	receptor	NN	I-NP	Obinding	and	binding	NN	I-NP	Oand	47	and	CC	O	O47	","	47	CD	B-NP	O","	XYY	","	","	O	OXYY	karyotype	XYY	NN	B-NP	Okaryotype	.	karyotype	NN	I-NP	O.	A	.	.	O	OA	case	A	DT	B-NP	Ocase	of	case	NN	I-NP	Oof	male	of	IN	B-PP	Omale	pseudohermaphroditism	male	JJ	B-NP	Opseudohermaphroditism	with	pseudohermaphroditism	NN	I-NP	Owith	47	with	IN	B-PP	O47	","	47	CD	B-NP	O","	XYY	","	","	O	OXYY	karyotype	XYY	NN	B-NP	Okaryotype	in	karyotype	NN	I-NP	Oin	blood	in	IN	B-PP	Oblood	and	blood	NN	B-NP	Oand	cutaneous	and	CC	O	Ocutaneous	fibroblasts	cutaneous	JJ	B-NP	B-cell_typefibroblasts	is	fibroblast	NNS	I-NP	I-cell_typeis	described	be	VBZ	B-VP	Odescribed	.	describe	VBN	I-VP	O.	The	.	.	O	OThe	plasma	The	DT	B-NP	Oplasma	testosterone	plasma	NN	I-NP	Otestosterone	response	testosterone	NN	I-NP	Oresponse	to	response	NN	I-NP	Oto	HCG	to	TO	B-PP	OHCG	stimulation	HCG	NN	B-NP	Ostimulation	was	stimulation	NN	I-NP	Owas	slightly	be	VBD	B-VP	Oslightly	below	slightly	RB	B-ADVP	Obelow	the	below	IN	B-PP	Othe	normal	the	DT	B-NP	Onormal	range	normal	JJ	I-NP	Orange	on	range	NN	I-NP	Oon	two	on	IN	B-PP	Otwo	occasions	two	CD	B-NP	Ooccasions	suggesting	occasion	NNS	I-NP	Osuggesting	a	suggest	VBG	B-VP	Oa	deficit	a	DT	B-NP	Odeficit	of	deficit	NN	I-NP	Oof	gonadal	of	IN	B-PP	Ogonadal	function	gonadal	JJ	B-NP	Ofunction	.	function	NN	I-NP	O.	A	.	.	O	OA	study	A	DT	B-NP	Ostudy	of	study	NN	I-NP	Oof	the	of	IN	B-PP	Othe	receptors	the	DT	B-NP	Oreceptors	for	receptor	NNS	I-NP	Ofor	dihydrotestosterone	for	IN	B-PP	Odihydrotestosterone	in	dihydrotestosterone	NN	B-NP	Oin	fibroblasts	in	IN	B-PP	Ofibroblasts	of	fibroblast	NNS	B-NP	B-cell_typeof	genital	of	IN	B-PP	Ogenital	and	genital	JJ	B-NP	Oand	nongenital	and	CC	I-NP	Onongenital	skin	nongenital	JJ	I-NP	Oskin	showed	skin	NN	I-NP	Oshowed	a	show	VBD	B-VP	Oa	normal	a	DT	B-NP	Onormal	concentration	normal	JJ	I-NP	Oconcentration	of	concentration	NN	I-NP	Oof	receptors	of	IN	B-PP	Oreceptors	in	receptor	NNS	B-NP	Oin	genital	in	IN	B-PP	Ogenital	skin	genital	JJ	B-NP	Oskin	;	skin	NN	I-NP	O;	5-alpha-reductase	;	:	O	O5-alpha-reductase	activity	5-alpha-reductase	NN	B-NP	B-proteinactivity	in	activity	NN	I-NP	Oin	fibroblasts	in	IN	B-PP	Ofibroblasts	of	fibroblast	NNS	B-NP	B-cell_typeof	the	of	IN	B-PP	Othe	genital	the	DT	B-NP	Ogenital	skin	genital	JJ	I-NP	Oskin	was	skin	NN	I-NP	Owas	low	be	VBD	B-VP	Olow	","	low	JJ	B-ADJP	O","	but	","	","	O	Obut	the	but	CC	O	Othe	plasma	the	DT	B-NP	Oplasma	relationship	plasma	NN	I-NP	Orelationship	testosterone/dihydrotestosterone	relationship	NN	I-NP	Otestosterone/dihydrotestosterone	under	testosterone/dihydrotestosterone	NN	I-NP	Ounder	HCG	under	IN	B-PP	OHCG	stimulation	HCG	NN	B-NP	Ostimulation	was	stimulation	NN	I-NP	Owas	normal	be	VBD	B-VP	Onormal	.	normal	JJ	B-ADJP	O.	The	.	.	O	OThe	diagnostic	The	DT	B-NP	Odiagnostic	possibility	diagnostic	JJ	I-NP	Opossibility	of	possibility	NN	I-NP	Oof	a	of	IN	B-PP	Oa	complete	a	DT	B-NP	Ocomplete	testicular	complete	JJ	I-NP	Otesticular	feminization	testicular	JJ	I-NP	Ofeminization	syndrome	feminization	NN	I-NP	Osyndrome	with	syndrome	NN	I-NP	Owith	normal	with	IN	B-PP	Onormal	receptors	normal	JJ	B-NP	B-proteinreceptors	for	receptor	NNS	I-NP	I-proteinfor	dihydrotestosterone	for	IN	B-PP	Odihydrotestosterone	is	dihydrotestosterone	NN	B-NP	Ois	commented	be	VBZ	B-VP	Ocommented	on	comment	VBN	I-VP	Oon	.	on	IN	B-PP	O.	1	.	.	O	O1	","	1	CD	B-NP	O","	25-Dihydroxyvitamin	","	","	O	O25-Dihydroxyvitamin	D3	25-Dihydroxyvitamin	NN	B-NP	OD3	inhibits	D3	NN	I-NP	Oinhibits	antigen-induced	inhibit	VBZ	B-VP	Oantigen-induced	T	antigen-induced	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	activation	cell	NN	I-NP	Oactivation	.	activation	NN	I-NP	O.	The	.	.	O	OThe	proliferative	The	DT	B-NP	Oproliferative	response	proliferative	JJ	I-NP	Oresponse	of	response	NN	I-NP	Oof	murine	of	IN	B-PP	Omurine	spleen	murine	JJ	B-NP	B-cell_typespleen	and	spleen	NN	I-NP	I-cell_typeand	thymus	and	CC	I-NP	I-cell_typethymus	cells	thymus	NN	I-NP	I-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	antigen	to	TO	B-PP	Oantigen	but	antigen	NN	B-NP	Obut	not	but	CC	B-PP	Onot	to	not	RB	B-PP	Oto	lectin	to	TO	I-PP	Olectin	was	lectin	NN	B-NP	B-proteinwas	inhibited	be	VBD	B-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	active	the	DT	B-NP	Oactive	metabolite	active	JJ	I-NP	Ometabolite	of	metabolite	NN	I-NP	Oof	vitamin	of	IN	B-PP	Ovitamin	D3	vitamin	NN	B-NP	OD3	","	D3	NN	I-NP	O","	1	","	","	O	O1	","	1	CD	B-NP	O","	25-	","	","	I-NP	O25-	(	25-	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	.	2D3	NN	B-NP	O.	To	.	.	O	OTo	directly	To	TO	B-VP	Odirectly	examine	directly	RB	I-VP	Oexamine	the	examine	VB	I-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	1	of	IN	B-PP	O1	","	1	CD	B-NP	O","	25-	","	","	I-NP	O25-	(	25-	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	on	2D3	NN	B-NP	Oon	T	on	IN	B-PP	OT	cell	T	NN	B-NP	B-cell_typecell	activation	cell	NN	I-NP	I-cell_typeactivation	in	activation	NN	I-NP	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	other	of	IN	B-PP	Oother	complicating	other	JJ	B-NP	Ocomplicating	interactions	complicate	VBG	I-NP	Ointeractions	","	interaction	NNS	I-NP	O","	we	","	","	O	Owe	utilized	we	PRP	B-NP	Outilized	a	utilize	VBD	B-VP	Oa	panel	a	DT	B-NP	Opanel	of	panel	NN	I-NP	Oof	cloned	of	IN	B-PP	Ocloned	Ia-restricted	clone	VBN	B-NP	B-cell_lineIa-restricted	T	Ia-restricted	JJ	I-NP	I-cell_lineT	cell	T	NN	I-NP	I-cell_linecell	hybridomas	cell	NN	I-NP	I-cell_linehybridomas	that	hybridoma	NNS	I-NP	I-cell_linethat	secrete	that	WDT	B-NP	Osecrete	IL	secrete	VBP	B-VP	OIL	2	IL	NN	B-NP	B-protein2	on	2	CD	I-NP	I-proteinon	activation	on	IN	B-PP	Oactivation	by	activation	NN	B-NP	Oby	cloned	by	IN	B-PP	Ocloned	Ia-bearing	clone	VBN	B-NP	B-cell_lineIa-bearing	stimulator	Ia-bearing	JJ	I-NP	I-cell_linestimulator	cells	stimulator	NN	I-NP	I-cell_linecells	(	cell	NNS	I-NP	I-cell_line(	TA3	(	(	O	OTA3	)	TA3	NN	B-NP	B-protein)	or	)	)	O	Oor	when	or	CC	O	Owhen	stimulated	when	WRB	B-ADVP	Ostimulated	by	stimulate	VBN	B-VP	Oby	mitogen	by	IN	B-PP	Omitogen	.	mitogen	NN	B-NP	B-protein.	Physiologic	.	.	O	OPhysiologic	concentrations	Physiologic	JJ	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	1	of	IN	B-PP	O1	","	1	CD	B-NP	O","	25-	","	","	I-NP	O25-	(	25-	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	(	2D3	NN	B-NP	O(	0.01	(	(	O	O0.01	to	0.01	CD	B-NP	Oto	0.1	to	TO	O	O0.1	nm	0.1	CD	B-NP	Onm	)	nm	NN	I-NP	O)	inhibited	)	)	O	Oinhibited	the	inhibit	VBD	B-VP	Othe	antigen-induced	the	DT	B-NP	Oantigen-induced	secretion	antigen-induced	JJ	I-NP	Osecretion	of	secretion	NN	I-NP	Oof	IL	of	IN	B-PP	OIL	2	IL	NN	B-NP	B-protein2	by	2	CD	I-NP	I-proteinby	several	by	IN	B-PP	Oseveral	of	several	JJ	B-NP	Oof	these	of	IN	B-PP	Othese	T	these	DT	B-NP	OT	cell	T	NN	I-NP	B-cell_linecell	hybridomas	cell	NN	I-NP	I-cell_linehybridomas	.	hybridoma	NNS	I-NP	I-cell_line.	This	.	.	O	OThis	inhibition	This	DT	B-NP	Oinhibition	was	inhibition	NN	I-NP	Owas	dependent	be	VBD	B-VP	Odependent	on	dependent	JJ	B-ADJP	Oon	the	on	IN	B-PP	Othe	concentration	the	DT	B-NP	Oconcentration	of	concentration	NN	I-NP	Oof	the	of	IN	B-PP	Othe	free	the	DT	B-NP	Ofree	hormone	free	JJ	I-NP	Ohormone	and	hormone	NN	I-NP	Oand	could	and	CC	O	Ocould	be	could	MD	B-VP	Obe	overcome	be	VB	I-VP	Oovercome	by	overcome	VBN	I-VP	Oby	increasing	by	IN	B-PP	Oincreasing	the	increase	VBG	B-VP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	Ia-bearing	of	IN	B-PP	OIa-bearing	stimulator	Ia-bearing	JJ	B-NP	B-cell_linestimulator	cells	stimulator	NN	I-NP	I-cell_linecells	used	cell	NNS	I-NP	I-cell_lineused	.	use	VBN	B-VP	O.	Pretreatment	.	.	O	OPretreatment	of	Pretreatment	NN	B-NP	Oof	the	of	IN	B-PP	Othe	T	the	DT	B-NP	OT	hybridoma	T	NN	I-NP	B-cell_linehybridoma	but	hybridoma	NN	I-NP	I-cell_linebut	not	but	CC	B-CONJP	Onot	the	not	RB	I-CONJP	Othe	TA3	the	DT	B-NP	OTA3	stimulator	TA3	NN	I-NP	B-cell_linestimulator	cell	stimulator	NN	I-NP	I-cell_linecell	with	cell	NN	I-NP	I-cell_linewith	1	with	IN	B-PP	O1	","	1	CD	B-NP	O","	25-	","	","	I-NP	O25-	(	25-	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	resulted	2D3	NN	B-NP	Oresulted	in	result	VBD	B-VP	Oin	inhibition	in	IN	B-PP	Oinhibition	of	inhibition	NN	B-NP	Oof	activation	of	IN	B-PP	Oactivation	.	activation	NN	B-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	are	result	NNS	I-NP	Oare	consistent	be	VBP	B-VP	Oconsistent	with	consistent	JJ	B-ADJP	Owith	the	with	IN	B-PP	Othe	finding	the	DT	B-NP	Ofinding	that	finding	NN	I-NP	Othat	specific	that	IN	B-SBAR	Ospecific	1	specific	JJ	B-NP	O1	","	1	CD	I-NP	B-protein","	25-	","	","	I-NP	I-protein25-	(	25-	CD	I-NP	I-protein(	OH	(	(	O	I-proteinOH	)	OH	NN	B-NP	I-protein)	2D3	)	)	O	I-protein2D3	receptors	2D3	NN	B-NP	I-proteinreceptors	are	receptor	NNS	I-NP	I-proteinare	present	be	VBP	B-VP	Opresent	on	present	JJ	B-ADJP	Oon	the	on	IN	B-PP	Othe	T	the	DT	B-NP	OT	cell	T	NN	I-NP	B-cell_linecell	hybridomas	cell	NN	I-NP	I-cell_linehybridomas	but	hybridoma	NNS	I-NP	I-cell_linebut	are	but	CC	O	Oare	lacking	be	VBP	B-VP	Olacking	in	lack	VBG	I-VP	Oin	TA3	in	IN	B-PP	OTA3	cells	TA3	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	1	.	.	O	O1	","	1	CD	B-NP	O","	25-	","	","	I-NP	O25-	(	25-	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	failed	2D3	NN	B-NP	Ofailed	","	fail	VBD	B-VP	O","	however	","	","	O	Ohowever	","	however	RB	B-ADVP	O","	to	","	","	O	Oto	inhibit	to	TO	B-VP	Oinhibit	the	inhibit	VB	I-VP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	T	the	DT	B-NP	OT	cell	T	NN	I-NP	B-cell_linecell	hybridomas	cell	NN	I-NP	I-cell_linehybridomas	by	hybridoma	NNS	I-NP	I-cell_lineby	lectin	by	IN	B-PP	Olectin	or	lectin	NN	B-NP	B-proteinor	by	or	CC	B-PP	Oby	an	by	IN	B-PP	Oan	anti-Thy-1	an	DT	B-NP	Oanti-Thy-1	antibody	anti-Thy-1	JJ	I-NP	B-proteinantibody	.	antibody	NN	I-NP	I-protein.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	suggest	finding	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	1	that	IN	B-NP	O1	","	1	CD	I-NP	O","	25-	","	","	I-NP	O25-	(	25-	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	may	2D3	NN	B-NP	Omay	be	may	MD	B-VP	Obe	interfering	be	VB	I-VP	Ointerfering	with	interfere	VBG	I-VP	Owith	early	with	IN	B-PP	Oearly	events	early	JJ	B-NP	Oevents	of	event	NNS	I-NP	Oof	antigen-induced	of	IN	B-PP	Oantigen-induced	T	antigen-induced	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	activation	cell	NN	I-NP	Oactivation	","	activation	NN	I-NP	O","	perhaps	","	","	O	Operhaps	by	perhaps	RB	B-ADVP	Oby	hindering	by	IN	B-PP	Ohindering	T	hinder	VBG	B-VP	OT	cell	T	NN	B-NP	Ocell	recognition	cell	NN	I-NP	Orecognition	of	recognition	NN	I-NP	Oof	the	of	IN	B-PP	Othe	relevant	the	DT	B-NP	Orelevant	antigen	relevant	JJ	I-NP	B-proteinantigen	on	antigen	NN	I-NP	I-proteinon	stimulator	on	IN	B-PP	Ostimulator	cell	stimulator	NN	B-NP	Ocell	surfaces	cell	NN	I-NP	Osurfaces	.	surface	NNS	I-NP	O.	This	.	.	O	OThis	system	This	DT	B-NP	Osystem	should	system	NN	I-NP	Oshould	prove	should	MD	B-VP	Oprove	useful	prove	VB	I-VP	Ouseful	in	useful	JJ	B-ADJP	Oin	studying	in	IN	B-PP	Ostudying	the	study	VBG	B-VP	Othe	molecular	the	DT	B-NP	Omolecular	mechanisms	molecular	JJ	I-NP	Omechanisms	by	mechanism	NNS	I-NP	Oby	which	by	IN	B-PP	Owhich	1	which	WDT	B-NP	O1	","	1	CD	I-NP	O","	25-	","	","	I-NP	O25-	(	25-	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	acts	2D3	NN	B-NP	Oacts	to	act	VBZ	B-VP	Oto	inhibit	to	TO	I-VP	Oinhibit	T	inhibit	VB	I-VP	OT	cell	T	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	and	activation	NN	I-NP	Oand	subsequent	and	CC	O	Osubsequent	IL	subsequent	JJ	B-NP	OIL	2	IL	NN	I-NP	B-protein2	production	2	CD	I-NP	I-proteinproduction	.	production	NN	I-NP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	receptors	Glucocorticoid	NN	B-NP	B-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	steroid	and	CC	O	Osteroid	sensitivity	steroid	JJ	B-NP	Osensitivity	in	sensitivity	NN	I-NP	Oin	normal	in	IN	B-PP	Onormal	and	normal	JJ	B-NP	Oand	neoplastic	and	CC	I-NP	Oneoplastic	human	neoplastic	JJ	I-NP	Ohuman	lymphoid	human	JJ	I-NP	Olymphoid	tissues	lymphoid	JJ	I-NP	Otissues	:	tissue	NNS	I-NP	O:	a	:	:	O	Oa	review	a	DT	B-NP	Oreview	.	review	NN	I-NP	O.	The	.	.	O	OThe	determination	The	DT	B-NP	Odetermination	of	determination	NN	I-NP	Oof	estrogen	of	IN	B-PP	Oestrogen	and	estrogen	NN	B-NP	Oand	progesterone	and	CC	O	Oprogesterone	receptors	progesterone	NN	B-NP	B-proteinreceptors	in	receptor	NNS	B-NP	I-proteinin	breast	in	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	has	cancer	NN	I-NP	Ohas	been	have	VBZ	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	useful	be	VB	I-VP	Ouseful	in	useful	JJ	B-ADJP	Oin	predicting	in	IN	B-PP	Opredicting	the	predict	VBG	B-VP	Othe	response	the	DT	B-NP	Oresponse	to	response	NN	I-NP	Oto	endocrine	to	TO	B-PP	Oendocrine	therapy	endocrine	JJ	B-NP	Otherapy	.	therapy	NN	I-NP	O.	Given	.	.	O	OGiven	their	Give	VBN	B-VP	Otheir	well-known	their	PRP$	B-NP	Owell-known	inhibitory	well-known	JJ	I-NP	Oinhibitory	effects	inhibitory	JJ	I-NP	Oeffects	on	effect	NNS	I-NP	Oon	lymphoid	on	IN	B-PP	Olymphoid	tissue	lymphoid	JJ	B-NP	Otissue	","	tissue	NN	I-NP	O","	glucocorticoids	","	","	O	Oglucocorticoids	have	glucocorticoid	NNS	B-NP	Ohave	been	have	VBP	B-VP	Obeen	used	be	VBN	I-VP	Oused	widely	use	VBN	I-VP	Owidely	in	widely	RB	B-ADVP	Oin	the	in	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	of	treatment	NN	I-NP	Oof	leukemia	of	IN	B-PP	Oleukemia	.	leukemia	NN	B-NP	O.	Given	.	.	O	OGiven	these	Give	VBN	B-PP	Othese	facts	these	DT	B-NP	Ofacts	","	fact	NNS	I-NP	O","	over	","	","	O	Oover	the	over	IN	B-PP	Othe	last	the	DT	B-NP	Olast	10	last	JJ	I-NP	O10	years	10	CD	I-NP	Oyears	","	year	NNS	I-NP	O","	several	","	","	O	Oseveral	investigators	several	JJ	B-NP	Oinvestigators	have	investigator	NNS	I-NP	Ohave	measured	have	VBP	B-VP	Omeasured	the	measure	VBN	I-VP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	normal	in	IN	B-PP	Onormal	and	normal	JJ	B-NP	Oand	neoplastic	and	CC	I-NP	Oneoplastic	lymphoid	neoplastic	JJ	I-NP	Olymphoid	tissue	lymphoid	JJ	I-NP	Otissue	to	tissue	NN	I-NP	Oto	see	to	TO	B-VP	Osee	whether	see	VB	I-VP	Owhether	their	whether	IN	B-SBAR	Otheir	number	their	PRP$	B-NP	Onumber	correlated	number	NN	I-NP	Ocorrelated	with	correlate	VBD	B-VP	Owith	glucocorticoid	with	IN	B-PP	Oglucocorticoid	responsiveness	glucocorticoid	NN	B-NP	Oresponsiveness	in	responsiveness	NN	I-NP	Oin	vitro	in	FW	B-ADVP	Ovitro	or	vitro	FW	I-ADVP	Oor	in	or	CC	O	Oin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	No	.	.	O	ONo	clear	No	DT	B-NP	Oclear	correlation	clear	JJ	I-NP	Ocorrelation	could	correlation	NN	I-NP	Ocould	be	could	MD	B-VP	Obe	established	be	VB	I-VP	Oestablished	between	establish	VBN	I-VP	Obetween	the	between	IN	B-PP	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	and	receptor	NN	I-NP	I-proteinand	the	and	CC	O	Othe	in	the	DT	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	action	vitro	FW	I-NP	Oaction	of	action	NN	I-NP	Oof	steroids	of	IN	B-PP	Osteroids	in	steroid	NNS	B-NP	Oin	normal	in	IN	B-PP	Onormal	and	normal	JJ	B-NP	Oand	neoplastic	and	CC	I-NP	Oneoplastic	lymphoid	neoplastic	JJ	I-NP	Olymphoid	tissue	lymphoid	JJ	I-NP	Otissue	.	tissue	NN	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	attempts	","	","	O	Oattempts	to	attempt	VBZ	B-VP	Oto	correlate	to	TO	I-VP	Ocorrelate	glucocorticoid	correlate	VB	I-VP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	levels	receptor	NN	I-NP	I-proteinlevels	in	level	NNS	I-NP	Oin	acute	in	IN	B-PP	Oacute	lymphocytic	acute	JJ	B-NP	Olymphocytic	leukemia	lymphocytic	JJ	I-NP	Oleukemia	to	leukemia	NN	I-NP	Oto	in	to	TO	B-PP	Oin	vivo	in	FW	B-NP	Ovivo	steroid	vivo	FW	I-NP	Osteroid	responsiveness	steroid	NN	I-NP	Oresponsiveness	and	responsiveness	NN	I-NP	Oand	immunological	and	CC	O	Oimmunological	type	immunological	JJ	B-NP	Otype	using	type	NN	I-NP	Ousing	the	use	VBG	B-VP	Othe	whole-cell-binding	the	DT	B-NP	Owhole-cell-binding	assay	whole-cell-binding	JJ	I-NP	Oassay	for	assay	NN	I-NP	Ofor	receptor	for	IN	B-PP	Oreceptor	determination	receptor	NN	B-NP	Odetermination	and	determination	NN	I-NP	Oand	selecting	and	CC	O	Oselecting	the	select	VBG	B-VP	Othe	patients	the	DT	B-NP	Opatients	according	patient	NNS	I-NP	Oaccording	to	accord	VBG	B-PP	Oto	age	to	TO	B-PP	Oage	and	age	NN	B-NP	Oand	immunological	and	CC	I-NP	Oimmunological	criteria	immunological	JJ	I-NP	Ocriteria	have	criterion	NNS	I-NP	Ohave	been	have	VBP	B-VP	Obeen	more	be	VBN	I-VP	Omore	successful	more	RBR	B-ADJP	Osuccessful	.	successful	JJ	I-ADJP	O.	[	.	.	O	O[	Glucocorticoid	[	(	O	OGlucocorticoid	receptors	Glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	normal	in	IN	B-PP	Onormal	human	normal	JJ	B-NP	B-cell_typehuman	lymphocytes	human	JJ	I-NP	I-cell_typelymphocytes	]	lymphocyte	NNS	I-NP	I-cell_type]	Glucocorticoid	]	)	O	OGlucocorticoid	(	Glucocorticoid	NN	B-NP	B-protein(	GC	(	(	O	I-proteinGC	)	GC	NN	B-NP	I-protein)	receptors	)	)	O	I-proteinreceptors	were	receptor	NNS	B-NP	I-proteinwere	studied	be	VBD	B-VP	Ostudied	in	study	VBN	I-VP	Oin	intact	in	IN	B-PP	Ointact	lymphocytes	intact	JJ	B-NP	B-cell_typelymphocytes	from	lymphocyte	NNS	I-NP	I-cell_typefrom	11	from	IN	B-PP	O11	donors	11	CD	B-NP	Odonors	.	donor	NNS	I-NP	O.	GC	.	.	O	OGC	binding	GC	NN	B-NP	Obinding	parameters	binding	NN	I-NP	Oparameters	were	parameter	NNS	I-NP	Owere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	highly	be	VB	I-VP	Ohighly	reproducible	highly	RB	B-ADJP	Oreproducible	in	reproducible	JJ	I-ADJP	Oin	repeated	in	IN	B-PP	Orepeated	experiments	repeat	VBN	B-NP	Oexperiments	with	experiment	NNS	I-NP	Owith	lymphocytes	with	IN	B-PP	Olymphocytes	.	lymphocyte	NNS	B-NP	B-cell_type.	It	.	.	O	OIt	was	It	PRP	B-NP	Owas	shown	be	VBD	B-VP	Oshown	that	show	VBN	I-VP	Othat	GC	that	IN	B-SBAR	OGC	receptors	GC	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	donors	in	IN	B-PP	Odonors	'	donor	NNS	B-NP	B-cell_type'	lymphocytes	'	POS	B-NP	I-cell_typelymphocytes	could	lymphocyte	NNS	I-NP	I-cell_typecould	be	could	MD	B-VP	Obe	distributed	be	VB	I-VP	Odistributed	into	distribute	VBN	I-VP	Ointo	two	into	IN	B-PP	Otwo	different	two	CD	B-NP	Odifferent	classes	different	JJ	I-NP	Oclasses	similarly	class	NNS	I-NP	Osimilarly	to	similarly	RB	B-ADVP	Oto	the	to	TO	B-PP	Othe	pattern	the	DT	B-NP	Opattern	seen	pattern	NN	I-NP	Oseen	in	see	VBN	B-VP	Oin	skin	in	IN	B-PP	Oskin	fibroblasts	skin	NN	B-NP	B-cell_typefibroblasts	.	fibroblast	NNS	I-NP	I-cell_type.	Human	.	.	O	OHuman	lymphocytes	Human	JJ	B-NP	B-cell_typelymphocytes	are	lymphocyte	NNS	I-NP	I-cell_typeare	an	be	VBP	B-VP	Oan	adequate	an	DT	B-NP	Oadequate	object	adequate	JJ	I-NP	Oobject	for	object	NN	I-NP	Ofor	studying	for	IN	B-PP	Ostudying	genetically	study	VBG	B-VP	Ogenetically	determined	genetically	RB	B-NP	Odetermined	variability	determine	VBN	I-NP	Ovariability	of	variability	NN	I-NP	Oof	GC	of	IN	B-PP	OGC	receptors	GC	NN	B-NP	B-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	its	and	CC	O	Oits	clinical	its	PRP$	B-NP	Oclinical	importance	clinical	JJ	I-NP	Oimportance	.	importance	NN	I-NP	O.	Specific	.	.	O	OSpecific	estrogen	Specific	JJ	B-NP	Oestrogen	binding	estrogen	NN	I-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	in	site	NNS	I-NP	I-DNAin	human	in	IN	B-PP	Ohuman	lymphoid	human	JJ	B-NP	B-cell_typelymphoid	cells	lymphoid	JJ	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	thymic	and	CC	O	Othymic	cells	thymic	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	binding	The	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	estrogen	of	IN	B-PP	Oestrogen	in	estrogen	NN	B-NP	Oin	preparations	in	IN	B-PP	Opreparations	of	preparation	NNS	B-NP	Oof	human	of	IN	B-PP	Ohuman	peripheral	human	JJ	B-NP	B-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	by	as	IN	I-CONJP	Oby	splenic	by	IN	B-PP	Osplenic	and	splenic	JJ	B-NP	Oand	thymic	and	CC	I-NP	Othymic	cells	thymic	JJ	I-NP	B-cell_typecells	is	cell	NNS	I-NP	I-cell_typeis	demonstrated	be	VBZ	B-VP	Odemonstrated	by	demonstrate	VBN	I-VP	Oby	three	by	IN	B-PP	Othree	different	three	CD	B-NP	Odifferent	approaches	different	JJ	I-NP	Oapproaches	(	approach	NNS	I-NP	O(	Dextran-coated	(	(	O	ODextran-coated	charcoal	Dextran-coated	JJ	B-NP	Ocharcoal	method	charcoal	NN	I-NP	Omethod	","	method	NN	I-NP	O","	whole	","	","	O	Owhole	cell	whole	JJ	B-NP	Ocell	assay	cell	NN	I-NP	Oassay	","	assay	NN	I-NP	O","	and	","	","	O	Oand	gel	and	CC	O	Ogel	filtration	gel	NN	B-NP	Ofiltration	on	filtration	NN	I-NP	Oon	a	on	IN	B-PP	Oa	sepharose	a	DT	B-NP	Osepharose	4B	sepharose	NN	I-NP	O4B	column	4B	NN	I-NP	Ocolumn	)	column	NN	I-NP	O)	.	)	)	O	O.	Scatchard	.	.	O	OScatchard	's	Scatchard	NNP	B-NP	O's	analysis	's	POS	B-NP	Oanalysis	of	analysis	NN	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	#NAME?	]	)	O	O#NAME?	(	#NAME?	NN	B-NP	O(	R2858	(	(	O	OR2858	)	R2858	NN	B-NP	O)	and	)	)	O	Oand	[	and	CC	O	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	#NAME?	]	)	I-NP	O#NAME?	binding	#NAME?	NN	I-NP	Obinding	proves	binding	NN	I-NP	Oproves	the	prove	VBZ	B-VP	Othe	existence	the	DT	B-NP	Oexistence	of	existence	NN	I-NP	Oof	a	of	IN	B-PP	Oa	single	a	DT	B-NP	Osingle	class	single	JJ	I-NP	Oclass	of	class	NN	I-NP	Oof	receptor	of	IN	B-PP	Oreceptor	sites	receptor	NN	B-NP	Osites	having	site	NNS	I-NP	Ohaving	a	have	VBG	B-VP	Oa	dissociation	a	DT	B-NP	Odissociation	constant	dissociation	NN	I-NP	Oconstant	of	constant	NN	I-NP	Oof	0.18-2.4	of	IN	B-PP	O0.18-2.4	X	0.18-2.4	CD	B-NP	OX	10	X	SYM	I-NP	O10	(	10	CD	I-NP	O(	-9	(	(	O	O-9	)	-9	CD	B-NP	O)	M	)	)	O	OM	.	M	NN	B-NP	O.	Physicochemical	.	.	O	OPhysicochemical	properties	Physicochemical	JJ	B-NP	Oproperties	of	property	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	binder	the	DT	B-NP	Obinder	","	binder	NN	I-NP	O","	including	","	","	O	Oincluding	binding	include	VBG	B-PP	Obinding	capacity	binding	NN	B-NP	Ocapacity	and	capacity	NN	I-NP	Oand	steroid	and	CC	O	Osteroid	specificity	steroid	NN	B-NP	Ospecificity	","	specificity	NN	I-NP	O","	are	","	","	O	Oare	quite	be	VBP	B-VP	Oquite	similar	quite	RB	B-ADJP	Osimilar	to	similar	JJ	I-ADJP	Oto	those	to	TO	B-PP	Othose	reported	those	DT	B-NP	Oreported	for	report	VBN	B-VP	Ofor	the	for	IN	B-PP	Othe	thymus	the	DT	B-NP	Othymus	of	thymus	NN	I-NP	Oof	small	of	IN	B-PP	Osmall	mammalian	small	JJ	B-NP	Omammalian	species	mammalian	JJ	I-NP	Ospecies	or	specie	NNS	I-NP	Oor	human	or	CC	O	Ohuman	thymoma	human	JJ	B-NP	Othymoma	.	thymoma	NN	I-NP	O.	Administration	.	.	O	OAdministration	of	Administration	NN	B-NP	Oof	fibroblast	of	IN	B-PP	Ofibroblast	interferon	fibroblast	NN	B-NP	B-proteininterferon	to	interferon	NN	I-NP	I-proteinto	patients	to	TO	B-PP	Opatients	with	patient	NNS	B-NP	Owith	advanced	with	IN	B-PP	Oadvanced	breast	advance	VBN	B-NP	Obreast	cancer	breast	NN	I-NP	Ocancer	:	cancer	NN	I-NP	O:	possible	:	:	O	Opossible	effects	possible	JJ	B-NP	Oeffects	on	effect	NNS	I-NP	Oon	skin	on	IN	B-PP	Oskin	metastasis	skin	NN	B-NP	Ometastasis	and	metastasis	NN	I-NP	Oand	on	and	CC	B-PP	Oon	hormone	on	IN	B-PP	Ohormone	receptors	hormone	NN	B-NP	B-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	Eleven	.	.	O	OEleven	patients	Eleven	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	metastasized	with	IN	B-PP	Ometastasized	breast	metastasize	VBN	B-NP	Obreast	cancer	breast	NN	I-NP	Ocancer	received	cancer	NN	I-NP	Oreceived	8	receive	VBD	B-VP	O8	intramuscular	8	CD	B-NP	Ointramuscular	injections	intramuscular	JJ	I-NP	Oinjections	of	injection	NNS	I-NP	Oof	6	of	IN	B-PP	O6	x	6	CD	B-NP	Ox	10	x	SYM	I-NP	O10	(	10	CD	I-NP	O(	6	(	(	O	O6	)	6	CD	B-NP	O)	units	)	)	O	Ounits	of	unit	NNS	B-NP	Oof	human	of	IN	B-PP	Ohuman	fibroblast	human	JJ	B-NP	B-proteinfibroblast	interferon	fibroblast	NN	I-NP	I-proteininterferon	over	interferon	NN	I-NP	I-proteinover	a	over	IN	B-PP	Oa	period	a	DT	B-NP	Operiod	of	period	NN	I-NP	Oof	40	of	IN	B-PP	O40	days	40	CD	B-NP	Odays	.	day	NNS	I-NP	O.	The	.	.	O	OThe	injections	The	DT	B-NP	Oinjections	did	injection	NNS	I-NP	Odid	not	do	VBD	B-VP	Onot	cause	not	RB	I-VP	Ocause	local	cause	VB	I-VP	Olocal	irritation	local	JJ	B-NP	Oirritation	or	irritation	NN	I-NP	Oor	inflammation	or	CC	I-NP	Oinflammation	.	inflammation	NN	I-NP	O.	Fever	.	.	O	OFever	occurred	Fever	NNP	B-NP	Ooccurred	in	occur	VBD	B-VP	Oin	only	in	IN	B-PP	Oonly	1	only	RB	B-NP	O1	of	1	CD	I-NP	Oof	the	of	IN	B-PP	Othe	11	the	DT	B-NP	O11	patients	11	CD	I-NP	Opatients	.	patient	NNS	I-NP	O.	Although	.	.	O	OAlthough	several	Although	IN	B-SBAR	Oseveral	types	several	JJ	B-NP	Otypes	of	type	NNS	I-NP	Oof	metastases	of	IN	B-PP	Ometastases	were	metastasis	NNS	B-NP	Owere	monitored	be	VBD	B-VP	Omonitored	","	monitor	VBN	I-VP	O","	only	","	","	O	Oonly	skin	only	RB	B-NP	Oskin	nodules	skin	NN	I-NP	Onodules	consistently	nodule	NNS	I-NP	Oconsistently	(	consistently	RB	B-ADVP	O(	10	(	(	O	O10	out	10	CD	B-NP	Oout	of	out	IN	B-PP	Oof	11	of	IN	B-PP	O11	patients	11	CD	B-NP	Opatients	)	patient	NNS	I-NP	O)	exhibited	)	)	O	Oexhibited	changes	exhibit	VBD	B-VP	Ochanges	that	change	NNS	B-NP	Othat	were	that	WDT	B-NP	Owere	suggestive	be	VBD	B-VP	Osuggestive	of	suggestive	JJ	B-ADJP	Oof	a	of	IN	B-PP	Oa	therapeutic	a	DT	B-NP	Otherapeutic	effect	therapeutic	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	the	of	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	regimen	treatment	NN	I-NP	Oregimen	:	regimen	NN	I-NP	O:	either	:	:	O	Oeither	a	either	CC	O	Oa	simple	a	DT	B-NP	Osimple	decrease	simple	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	size	in	IN	B-PP	Osize	of	size	NN	B-NP	Oof	some	of	IN	B-PP	Osome	nodules	some	DT	B-NP	Onodules	or	nodule	NNS	I-NP	Oor	central	or	CC	O	Ocentral	necrosis	central	JJ	B-NP	Onecrosis	accompanied	necrosis	NN	I-NP	Oaccompanied	by	accompany	VBN	B-VP	Oby	an	by	IN	B-PP	Oan	inflammatory	an	DT	B-NP	Oinflammatory	reaction	inflammatory	JJ	I-NP	Oreaction	.	reaction	NN	I-NP	O.	NK-activity	.	.	O	ONK-activity	of	NK-activity	NN	B-NP	Oof	peripheral	of	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	leukocytes	blood	NN	I-NP	I-cell_typeleukocytes	was	leukocyte	NNS	I-NP	I-cell_typewas	significantly	be	VBD	B-VP	Osignificantly	increased	significantly	RB	I-VP	Oincreased	after	increase	VBN	I-VP	Oafter	administration	after	IN	B-PP	Oadministration	of	administration	NN	B-NP	Oof	the	of	IN	B-PP	Othe	first	the	DT	B-NP	Ofirst	dose	first	JJ	I-NP	Odose	;	dose	NN	I-NP	O;	the	;	:	O	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	subsequent	of	IN	B-PP	Osubsequent	injections	subsequent	JJ	B-NP	Oinjections	was	injection	NNS	I-NP	Owas	less	be	VBD	B-VP	Oless	clear	less	RBR	B-ADJP	Oclear	.	clear	JJ	I-ADJP	O.	Receptors	.	.	O	OReceptors	for	Receptor	NNS	B-NP	Ofor	estrogens	for	IN	B-PP	Oestrogens	and	estrogen	NNS	B-NP	Oand	progestogens	and	CC	I-NP	Oprogestogens	were	progestogen	NNS	I-NP	Owere	increased	be	VBD	B-VP	Oincreased	in	increase	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	tumor	the	DT	B-NP	Otumor	biopsies	tumor	NN	I-NP	Obiopsies	of	biopsy	NNS	I-NP	Oof	2	of	IN	B-PP	O2	out	2	CD	B-NP	Oout	of	out	IN	I-NP	Oof	2	of	IN	I-NP	O2	and	2	CD	I-NP	Oand	5	and	CC	I-NP	O5	out	5	CD	I-NP	Oout	of	out	IN	B-PP	Oof	6	of	IN	B-PP	O6	patients	6	CD	B-NP	Opatients	tested	patient	NNS	I-NP	Otested	respectively	test	VBN	B-VP	Orespectively	.	respectively	RB	B-ADVP	O.	Decreased	.	.	O	ODecreased	glucocorticoid	Decrease	VBN	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	binding	receptor	NN	I-NP	I-proteinbinding	in	binding	NN	I-NP	Oin	adrenal	in	IN	B-PP	Oadrenal	insufficiency	adrenal	JJ	B-NP	Oinsufficiency	.	insufficiency	NN	I-NP	O.	To	.	.	O	OTo	examine	To	TO	B-VP	Oexamine	the	examine	VB	I-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	deficiency	glucocorticoid	NN	B-NP	Odeficiency	on	deficiency	NN	I-NP	Oon	the	on	IN	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	","	receptor	NN	I-NP	I-protein","	we	","	","	O	Owe	examine	we	PRP	B-NP	Oexamine	the	examine	VBP	B-VP	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	dexamethasone	]	)	I-NP	Odexamethasone	to	dexamethasone	NN	I-NP	Oto	lymphocytes	to	TO	B-PP	Olymphocytes	in	lymphocyte	NNS	B-NP	B-cell_typein	normal	in	IN	B-PP	Onormal	subjects	normal	JJ	B-NP	Osubjects	and	subject	NNS	I-NP	Oand	patients	and	CC	O	Opatients	with	patient	NNS	B-NP	Owith	adrenal	with	IN	B-PP	Oadrenal	insufficiency	adrenal	JJ	B-NP	Oinsufficiency	before	insufficiency	NN	I-NP	Obefore	and	before	IN	B-PP	Oand	after	and	CC	I-PP	Oafter	glucocorticoid	after	IN	I-PP	Oglucocorticoid	replacement	glucocorticoid	NN	B-NP	Oreplacement	therapy	replacement	NN	I-NP	Otherapy	.	therapy	NN	I-NP	O.	Using	.	.	O	OUsing	a	Use	VBG	B-VP	Oa	whole	a	DT	B-NP	Owhole	cell	whole	JJ	I-NP	Ocell	competitive	cell	NN	I-NP	Ocompetitive	binding	competitive	JJ	I-NP	Obinding	assay	binding	NN	I-NP	Oassay	","	assay	NN	I-NP	O","	normal	","	","	O	Onormal	human	normal	JJ	B-NP	Ohuman	lymphocytes	human	JJ	I-NP	Olymphocytes	had	lymphocyte	NNS	I-NP	Ohad	5977	have	VBD	B-VP	O5977	+/-	5977	CD	B-NP	O+/-	1487	+/-	SYM	I-NP	O1487	(	1487	CD	I-NP	O(	mean	(	(	O	Omean	+/-	mean	NN	B-NP	O+/-	SD	+/-	SYM	O	OSD	)	SD	NN	B-NP	O)	binding	)	)	O	Obinding	sites/cell	binding	NN	B-NP	Osites/cell	and	sites/cell	NNS	I-NP	Oand	a	and	CC	O	Oa	dissociation	a	DT	B-NP	Odissociation	constant	dissociation	NN	I-NP	Oconstant	of	constant	NN	I-NP	Oof	10	of	IN	B-PP	O10	+/-	10	CD	B-NP	O+/-	2	+/-	SYM	I-NP	O2	nM	2	CD	I-NP	OnM	.	nM	NN	I-NP	O.	Lymphocytes	.	.	O	OLymphocytes	from	Lymphocyte	NNS	B-NP	B-cell_typefrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	untreated	with	IN	B-PP	Ountreated	adrenal	untreated	JJ	B-NP	Oadrenal	insufficiency	adrenal	JJ	I-NP	Oinsufficiency	had	insufficiency	NN	I-NP	Ohad	fewer	have	VBD	B-VP	Ofewer	binding	few	JJR	B-NP	Obinding	sites	bind	VBG	I-NP	Osites	(	site	NNS	I-NP	O(	3364	(	(	O	O3364	+/-322	3364	CD	B-NP	O+/-322	)	+/-322	CC	O	O)	and	)	)	O	Oand	a	and	CC	O	Oa	2-fold	a	DT	B-NP	O2-fold	increase	2-fold	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	binding	in	IN	B-PP	Obinding	affinity	binding	NN	B-NP	Oaffinity	(	affinity	NN	I-NP	O(	5.4	(	(	O	O5.4	+/-	5.4	CD	B-NP	O+/-	0.9	+/-	SYM	I-NP	O0.9	mM	0.9	CD	I-NP	OmM	)	mM	NN	I-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	administration	The	DT	B-NP	Oadministration	of	administration	NN	I-NP	Oof	conventional	of	IN	B-PP	Oconventional	replacement	conventional	JJ	B-NP	Oreplacement	doses	replacement	NN	I-NP	Odoses	of	dose	NNS	I-NP	Oof	cortisone	of	IN	B-PP	Ocortisone	acetate	cortisone	NN	B-NP	Oacetate	for	acetate	NN	I-NP	Ofor	6	for	IN	B-PP	O6	months	6	CD	B-NP	Omonths	caused	month	NNS	I-NP	Ocaused	no	cause	VBD	B-VP	Ono	change	no	DT	B-NP	Ochange	in	change	NN	I-NP	Oin	receptor	in	IN	B-PP	Oreceptor	number	receptor	NN	B-NP	Onumber	","	number	NN	I-NP	O","	but	","	","	O	Obut	was	but	CC	O	Owas	associated	be	VBD	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	a	with	IN	B-PP	Oa	decrease	a	DT	B-NP	Odecrease	in	decrease	NN	I-NP	Oin	binding	in	IN	B-PP	Obinding	affinity	binding	NN	B-NP	Oaffinity	toward	affinity	NN	I-NP	Otoward	normal	toward	IN	B-PP	Onormal	.	normal	JJ	B-ADJP	O.	After	.	.	O	OAfter	long	After	IN	B-PP	Olong	term	long	JJ	B-NP	Oterm	glucocorticoid	term	NN	I-NP	Oglucocorticoid	replacement	glucocorticoid	NN	I-NP	Oreplacement	therapy	replacement	NN	I-NP	Otherapy	","	therapy	NN	I-NP	O","	binding	","	","	O	Obinding	parameters	bind	VBG	B-NP	Oparameters	were	parameter	NNS	I-NP	Owere	similar	be	VBD	B-VP	Osimilar	to	similar	JJ	B-ADJP	Oto	those	to	TO	B-PP	Othose	in	those	DT	B-NP	Oin	patients	in	IN	B-PP	Opatients	before	patient	NNS	B-NP	Obefore	treatment	before	IN	B-PP	Otreatment	.	treatment	NN	B-NP	O.	The	.	.	O	OThe	physiological	The	DT	B-NP	Ophysiological	implications	physiological	JJ	I-NP	Oimplications	of	implication	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	decreased	the	DT	B-NP	Odecreased	receptor	decrease	VBN	I-NP	Oreceptor	number	receptor	NN	I-NP	Onumber	and	number	NN	I-NP	Oand	increased	and	CC	O	Oincreased	binding	increase	VBD	B-VP	Obinding	affinity	binding	NN	B-NP	Oaffinity	in	affinity	NN	I-NP	Oin	adrenal	in	IN	B-PP	Oadrenal	insufficiency	adrenal	JJ	B-NP	Oinsufficiency	remain	insufficiency	NN	I-NP	Oremain	to	remain	VBP	B-VP	Oto	be	to	TO	I-VP	Obe	elucidated	be	VB	I-VP	Oelucidated	.	elucidate	VBN	I-VP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	receptor	Glucocorticoid	NN	B-NP	B-proteinreceptor	concentrations	receptor	NN	I-NP	I-proteinconcentrations	and	concentration	NNS	I-NP	Oand	terminal	and	CC	O	Oterminal	transferase	terminal	JJ	B-NP	B-proteintransferase	activity	transferase	NN	I-NP	I-proteinactivity	as	activity	NN	I-NP	Oas	indicators	as	IN	B-PP	Oindicators	of	indicator	NNS	B-NP	Oof	prognosis	of	IN	B-PP	Oprognosis	in	prognosis	NN	B-NP	Oin	acute	in	IN	B-PP	Oacute	non-lymphocytic	acute	JJ	B-NP	Onon-lymphocytic	leukaemia	non-lymphocytic	JJ	I-NP	Oleukaemia	.	leukaemia	NN	I-NP	O.	Activity	.	.	O	OActivity	of	Activity	NN	B-NP	Oof	terminal	of	IN	B-PP	Oterminal	deoxynucleotidyl	terminal	JJ	B-NP	B-proteindeoxynucleotidyl	transferase	deoxynucleotidyl	NN	I-NP	I-proteintransferase	(	transferase	NN	I-NP	I-protein(	TdT	(	(	O	OTdT	)	TdT	NN	B-NP	B-protein)	","	)	)	O	O","	adenosine	","	","	O	Oadenosine	deaminase	adenosine	NN	B-NP	B-proteindeaminase	","	deaminase	NN	I-NP	I-protein","	and	","	","	O	Oand	5'nucleotidase	and	CC	O	O5'nucleotidase	and	5'nucleotidase	NN	B-NP	B-proteinand	the	and	CC	O	Othe	cellular	the	DT	B-NP	Ocellular	concentration	cellular	JJ	I-NP	Oconcentration	of	concentration	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	(	glucocorticoid	NN	B-NP	B-protein(	dexamethasone	(	(	O	I-proteindexamethasone	)	dexamethasone	NN	B-NP	I-protein)	receptor	)	)	O	I-proteinreceptor	were	receptor	NN	B-NP	I-proteinwere	determined	be	VBD	B-VP	Odetermined	in	determine	VBN	I-VP	Oin	25	in	IN	B-PP	O25	patients	25	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	acute	with	IN	B-PP	Oacute	non-lymphocytic	acute	JJ	B-NP	Onon-lymphocytic	leukaemia	non-lymphocytic	JJ	I-NP	Oleukaemia	.	leukaemia	NN	I-NP	O.	All	.	.	O	OAll	patients	All	DT	B-NP	Opatients	were	patient	NNS	I-NP	Owere	treated	be	VBD	B-VP	Otreated	according	treat	VBN	I-VP	Oaccording	to	accord	VBG	B-PP	Oto	a	to	TO	B-PP	Oa	common	a	DT	B-NP	Ocommon	protocol	common	JJ	I-NP	Oprotocol	.	protocol	NN	I-NP	O.	Increased	.	.	O	OIncreased	activity	Increase	VBN	B-NP	Oactivity	of	activity	NN	I-NP	Oof	TdT	of	IN	B-PP	OTdT	(	TdT	NN	B-NP	O(	greater	(	(	O	Ogreater	than	great	JJR	B-NP	Othan	0.1	than	IN	I-NP	O0.1	unit/microgram	0.1	CD	I-NP	Ounit/microgram	DNA	unit/microgram	NN	I-NP	ODNA	)	DNA	NN	I-NP	O)	was	)	)	O	Owas	found	be	VBD	B-VP	Ofound	in	find	VBN	I-VP	Oin	11	in	IN	B-PP	O11	patients	11	CD	B-NP	Opatients	.	patient	NNS	I-NP	O.	This	.	.	O	OThis	group	This	DT	B-NP	Ogroup	of	group	NN	I-NP	Oof	patients	of	IN	B-PP	Opatients	was	patient	NNS	B-NP	Owas	shown	be	VBD	B-VP	Oshown	to	show	VBN	I-VP	Oto	have	to	TO	I-VP	Ohave	higher	have	VB	I-VP	Ohigher	remission	high	JJR	B-NP	Oremission	and	remission	NN	I-NP	Oand	survival	and	CC	I-NP	Osurvival	rates	survival	NN	I-NP	Orates	(	rate	NNS	I-NP	O(	p	(	(	O	Op	=	p	NN	B-NP	O=	0.06	=	SYM	B-VP	O0.06	)	0.06	CD	B-NP	O)	compared	)	)	O	Ocompared	with	compare	VBN	B-PP	Owith	patients	with	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	low	with	IN	B-PP	Olow	activity	low	JJ	B-NP	Oactivity	of	activity	NN	I-NP	Oof	TdT	of	IN	B-PP	OTdT	.	TdT	NN	B-NP	B-protein.	The	.	.	O	OThe	glucocorticoid	The	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	concentration	receptor	NN	I-NP	I-proteinconcentration	of	concentration	NN	I-NP	Oof	the	of	IN	B-PP	Othe	leukaemic	the	DT	B-NP	Oleukaemic	blast	leukaemic	JJ	I-NP	B-cell_typeblast	cells	blast	NN	I-NP	I-cell_typecells	ranged	cell	NNS	I-NP	I-cell_typeranged	from	range	VBD	B-VP	Ofrom	0	from	IN	B-PP	O0	to	0	CD	B-NP	Oto	0.94	to	TO	I-NP	O0.94	fmol/microgram	0.94	CD	I-NP	Ofmol/microgram	DNA	fmol/microgram	NN	I-NP	ODNA	.	DNA	NN	I-NP	O.	Thirteen	.	.	O	OThirteen	patients	Thirteen	CD	B-NP	Opatients	had	patient	NNS	I-NP	Ohad	blast	have	VBD	B-VP	Oblast	cells	blast	NN	B-NP	B-cell_typecells	with	cell	NNS	I-NP	I-cell_typewith	a	with	IN	B-PP	Oa	glucocorticoid	a	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	concentration	receptor	NN	I-NP	I-proteinconcentration	over	concentration	NN	I-NP	Oover	0.22	over	IN	B-PP	O0.22	fmol/microgram	0.22	CD	B-NP	Ofmol/microgram	DNA	fmol/microgram	NN	I-NP	ODNA	.	DNA	NN	I-NP	O.	These	.	.	O	OThese	patients	These	DT	B-NP	Opatients	had	patient	NNS	I-NP	Ohad	significantly	have	VBD	B-VP	Osignificantly	increased	significantly	RB	I-VP	Oincreased	remission	increase	VBN	I-VP	Oremission	and	remission	NN	B-NP	Oand	survival	and	CC	I-NP	Osurvival	rates	survival	NN	I-NP	Orates	(	rate	NNS	I-NP	O(	p	(	(	O	Op	=	p	NN	B-NP	O=	0.006	=	SYM	B-VP	O0.006	)	0.006	CD	B-NP	O)	compared	)	)	O	Ocompared	with	compare	VBN	B-PP	Owith	those	with	IN	B-PP	Othose	with	those	DT	B-NP	Owith	a	with	IN	B-PP	Oa	low	a	DT	B-NP	Olow	receptor	low	JJ	I-NP	Oreceptor	concentration	receptor	NN	I-NP	Oconcentration	.	concentration	NN	I-NP	O.	This	.	.	O	OThis	finding	This	DT	B-NP	Ofinding	can	finding	NN	I-NP	Ocan	not	can	MD	B-VP	Onot	be	not	RB	I-VP	Obe	explained	be	VB	I-VP	Oexplained	by	explain	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	difference	a	DT	B-NP	Odifference	in	difference	NN	I-NP	Oin	sensitivity	in	IN	B-PP	Osensitivity	to	sensitivity	NN	B-NP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	since	glucocorticoid	NNS	B-NP	Osince	these	since	IN	B-PP	Othese	were	these	DT	B-NP	Owere	not	be	VBD	B-VP	Onot	used	not	RB	I-VP	Oused	as	use	VBN	I-VP	Oas	therapeutic	as	IN	B-PP	Otherapeutic	agents	therapeutic	JJ	B-NP	Oagents	.	agent	NNS	I-NP	O.	Adenosine	.	.	O	OAdenosine	deaminase	Adenosine	NN	B-NP	B-proteindeaminase	and	deaminase	NN	I-NP	I-proteinand	5'nucleotidase	and	CC	I-NP	O5'nucleotidase	activities	5'nucleotidase	NN	I-NP	Oactivities	both	activity	NNS	I-NP	Oboth	varied	both	DT	O	Ovaried	within	vary	VBD	B-VP	Owithin	two	within	IN	B-PP	Otwo	orders	two	CD	B-NP	Oorders	of	order	NNS	I-NP	Oof	magnitude	of	IN	B-PP	Omagnitude	.	magnitude	NN	B-NP	O.	No	.	.	O	ONo	correlation	No	DT	B-NP	Ocorrelation	could	correlation	NN	I-NP	Ocould	be	could	MD	B-VP	Obe	found	be	VB	I-VP	Ofound	between	find	VBN	I-VP	Obetween	activities	between	IN	B-PP	Oactivities	of	activity	NNS	B-NP	Oof	these	of	IN	B-PP	Othese	enzymes	these	DT	B-NP	Oenzymes	and	enzyme	NNS	I-NP	B-proteinand	remission	and	CC	O	Oremission	or	remission	NN	B-NP	Oor	survival	or	CC	I-NP	Osurvival	rate	survival	NN	I-NP	Orate	.	rate	NN	I-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	show	result	NNS	I-NP	Oshow	that	show	VBP	B-VP	Othat	measurements	that	IN	B-SBAR	Omeasurements	of	measurement	NNS	B-NP	Oof	TdT	of	IN	B-PP	OTdT	activity	TdT	NN	B-NP	B-proteinactivity	and	activity	NN	I-NP	Oand	the	and	CC	O	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	concentration	receptor	NN	I-NP	I-proteinconcentration	yield	concentration	NN	I-NP	Oyield	valuable	yield	NN	I-NP	Ovaluable	prognostic	valuable	JJ	I-NP	Oprognostic	information	prognostic	JJ	I-NP	Oinformation	in	information	NN	I-NP	Oin	acute	in	IN	B-PP	Oacute	non-lymphocytic	acute	JJ	B-NP	Onon-lymphocytic	leukaemia	non-lymphocytic	JJ	I-NP	Oleukaemia	[	leukaemia	NN	I-NP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	cortivazol	]	)	O	Ocortivazol	:	cortivazol	NN	B-NP	O:	a	:	:	O	Oa	unique	a	DT	B-NP	Ounique	high	unique	JJ	I-NP	Ohigh	affinity	high	JJ	I-NP	Oaffinity	ligand	affinity	NN	I-NP	Oligand	for	ligand	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	.	receptor	NN	I-NP	I-protein.	Cortivazol	.	.	O	OCortivazol	(	Cortivazol	NN	B-NP	O(	CVZ	(	(	O	OCVZ	)	CVZ	NN	B-NP	O)	and	)	)	O	Oand	deacylcortivazol	and	CC	O	Odeacylcortivazol	(	deacylcortivazol	NN	B-NP	O(	DAC	(	(	O	ODAC	)	DAC	NN	B-NP	O)	are	)	)	O	Oare	pyrazolosteroids	be	VBP	B-VP	Opyrazolosteroids	with	pyrazolosteroid	NNS	B-NP	Owith	potent	with	IN	B-PP	Opotent	glucocorticoid	potent	JJ	B-NP	Oglucocorticoid	activity	glucocorticoid	NN	I-NP	Oactivity	.	activity	NN	I-NP	O.	In	.	.	O	OIn	previous	In	IN	B-PP	Oprevious	work	previous	JJ	B-NP	Owork	we	work	NN	I-NP	Owe	showed	we	PRP	B-NP	Oshowed	that	show	VBD	B-VP	Othat	DAC	that	IN	B-SBAR	ODAC	is	DAC	NN	B-NP	B-proteinis	40-fold	be	VBZ	B-VP	O40-fold	more	40-fold	RB	B-ADJP	Omore	potent	more	RBR	I-ADJP	Opotent	than	potent	JJ	I-ADJP	Othan	dexamethasone	than	IN	B-PP	Odexamethasone	(	dexamethasone	NN	B-NP	O(	DEX	(	(	O	ODEX	)	DEX	NN	B-NP	O)	in	)	)	O	Oin	lysing	in	IN	B-PP	Olysing	leukemic	lyse	VBG	B-VP	B-cell_typeleukemic	lymphoblasts	leukemic	JJ	B-NP	I-cell_typelymphoblasts	.	lymphoblast	NNS	I-NP	I-cell_type.	To	.	.	O	OTo	assess	To	TO	B-VP	Oassess	the	assess	VB	I-VP	Othe	interaction	the	DT	B-NP	Ointeraction	between	interaction	NN	I-NP	Obetween	these	between	IN	B-PP	Othese	atypical	these	DT	B-NP	Oatypical	steroids	atypical	JJ	I-NP	Osteroids	and	steroid	NNS	I-NP	Oand	the	and	CC	O	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	","	receptor	NN	I-NP	I-protein","	we	","	","	O	Owe	examined	we	PRP	B-NP	Oexamined	the	examine	VBD	B-VP	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	CVZ	]	)	I-NP	OCVZ	to	CVZ	NN	I-NP	Oto	cytosol	to	TO	B-PP	Ocytosol	from	cytosol	NN	B-NP	Ofrom	glucocorticoid-sensitive	from	IN	B-PP	Oglucocorticoid-sensitive	and	glucocorticoid-sensitive	JJ	B-NP	Oand	#NAME?	and	CC	I-NP	O#NAME?	variants	#NAME?	JJ	I-NP	B-cell_linevariants	of	variant	NNS	I-NP	I-cell_lineof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	leukemic	human	JJ	I-NP	B-cell_lineleukemic	cell	leukemic	JJ	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	CEM	line	NN	I-NP	I-cell_lineCEM	C7	CEM	NN	I-NP	I-cell_lineC7	.	C7	NN	I-NP	I-cell_line.	In	.	.	O	OIn	glucocorticoid-sensitive	In	IN	B-PP	Oglucocorticoid-sensitive	cells	glucocorticoid-sensitive	JJ	B-NP	B-cell_linecells	[	cell	NNS	I-NP	I-cell_line[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	CVZ	]	)	I-NP	OCVZ	causes	CVZ	NN	I-NP	Ocauses	a	cause	VBZ	B-VP	Oa	2-fold	a	DT	B-NP	O2-fold	induction	2-fold	JJ	I-NP	Oinduction	of	induction	NN	I-NP	Oof	glutamine	of	IN	B-PP	Oglutamine	synthetase	glutamine	NN	B-NP	B-proteinsynthetase	and	synthetase	NN	I-NP	I-proteinand	binds	and	CC	O	Obinds	to	bind	VBZ	B-VP	Oto	a	to	TO	B-PP	Oa	protein	a	DT	B-NP	Oprotein	in	protein	NN	I-NP	Oin	the	in	IN	B-PP	Othe	4.6	the	DT	B-NP	O4.6	S	4.6	CD	I-NP	OS	region	S	NN	I-NP	Oregion	of	region	NN	I-NP	Oof	high	of	IN	B-PP	Ohigh	salt	high	JJ	B-NP	Osalt	sucrose	salt	NN	I-NP	Osucrose	gradients	sucrose	NN	I-NP	Ogradients	.	gradient	NNS	I-NP	O.	On	.	.	O	OOn	DEAE-cellulose	On	IN	B-PP	ODEAE-cellulose	chromatography	DEAE-cellulose	NN	B-NP	Ochromatography	","	chromatography	NN	I-NP	O","	[	","	","	O	O[	3H	[	(	O	B-protein3H	]	3H	NN	B-NP	I-protein]	CVZ-receptor	]	)	O	I-proteinCVZ-receptor	complexes	CVZ-receptor	NN	B-NP	I-proteincomplexes	show	complex	NNS	I-NP	I-proteinshow	a	show	VBP	B-VP	Oa	shift	a	DT	B-NP	Oshift	from	shift	NN	I-NP	Ofrom	high	from	IN	B-PP	Ohigh	(	high	JJ	B-NP	O(	0.25	(	(	O	O0.25	M	0.25	CD	B-NP	OM	KP	M	NN	I-NP	OKP	)	KP	NN	I-NP	O)	to	)	)	O	Oto	low	to	TO	B-PP	Olow	salt	low	JJ	B-NP	Osalt	(	salt	NN	I-NP	O(	0.09	(	(	O	O0.09	M	0.09	CD	B-NP	OM	KP	M	NN	I-NP	OKP	)	KP	NN	I-NP	O)	eluting	)	)	O	Oeluting	forms	elute	VBG	B-VP	Oforms	upon	form	NNS	B-NP	Oupon	activation	upon	IN	B-PP	Oactivation	.	activation	NN	B-NP	O.	CVZ	.	.	O	OCVZ	competes	CVZ	NN	B-NP	Ocompetes	for	compete	NNS	I-NP	Ofor	a	for	IN	B-PP	Oa	97	a	DT	B-NP	O97	","	97	CD	I-NP	B-protein","	000-dalton	","	","	O	I-protein000-dalton	protein	000-dalton	JJ	B-NP	I-proteinprotein	labeled	protein	NN	I-NP	I-proteinlabeled	by	label	VBN	B-VP	Oby	[	by	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	dexamethasone	]	)	I-NP	Odexamethasone	mesylate	dexamethasone	NN	I-NP	Omesylate	.	mesylate	NN	I-NP	O.	Scatchard	.	.	O	OScatchard	analysis	Scatchard	NN	B-NP	Oanalysis	of	analysis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	CVZ	]	)	I-NP	OCVZ	in	CVZ	NN	I-NP	Oin	glucocorticoid-sensitive	in	IN	B-PP	Oglucocorticoid-sensitive	cells	glucocorticoid-sensitive	JJ	B-NP	B-cell_linecells	revealed	cell	NNS	I-NP	I-cell_linerevealed	a	reveal	VBD	B-VP	Oa	curvilinear	a	DT	B-NP	Ocurvilinear	plot	curvilinear	JJ	I-NP	Oplot	which	plot	NN	I-NP	Owhich	resolved	which	WDT	B-NP	Oresolved	into	resolve	VBD	B-VP	Ointo	high	into	IN	B-PP	Ohigh	(	high	JJ	B-NP	O(	0.4	(	(	O	O0.4	nM	0.4	CD	B-NP	OnM	)	nM	NN	I-NP	O)	and	)	)	O	Oand	low	and	CC	O	Olow	(	low	JJ	B-ADJP	O(	11	(	(	O	O11	nM	11	CD	B-NP	OnM	)	nM	NN	I-NP	O)	affinity	)	)	O	Oaffinity	components	affinity	NN	B-NP	Ocomponents	.	component	NNS	I-NP	O.	The	.	.	O	OThe	receptor	The	DT	B-NP	Oreceptor	concentration	receptor	NN	I-NP	Oconcentration	of	concentration	NN	I-NP	Oof	the	of	IN	B-PP	Othe	low	the	DT	B-NP	Olow	affinity	low	JJ	I-NP	B-DNAaffinity	site	affinity	NN	I-NP	I-DNAsite	(	site	NN	I-NP	I-DNA(	0.3	(	(	O	O0.3	pmol/mg	0.3	CD	B-NP	Opmol/mg	protein	pmol/mg	NN	I-NP	Oprotein	)	protein	NN	I-NP	O)	was	)	)	O	Owas	approximately	be	VBD	B-VP	Oapproximately	twice	approximately	RB	B-NP	Otwice	that	twice	RB	I-NP	Othat	of	that	DT	I-NP	Oof	the	of	IN	B-PP	Othe	high	the	DT	B-NP	Ohigh	affinity	high	JJ	I-NP	B-DNAaffinity	site	affinity	NN	I-NP	I-DNAsite	(	site	NN	I-NP	I-DNA(	0.14	(	(	O	O0.14	pmol/mg	0.14	CD	B-NP	Opmol/mg	protein	pmol/mg	NN	I-NP	Oprotein	)	protein	NN	I-NP	O)	.	)	)	O	O.	Dissociation	.	.	O	ODissociation	experiments	Dissociation	NN	B-NP	Oexperiments	with	experiment	NNS	I-NP	Owith	dilution	with	IN	B-PP	Odilution	and/or	dilution	NN	B-NP	Oand/or	excess	and/or	CC	O	Oexcess	unlabeled	excess	JJ	B-NP	Ounlabeled	CVZ	unlabeled	JJ	I-NP	OCVZ	supported	CVZ	NN	I-NP	Osupported	the	support	VBD	B-VP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	independent	of	IN	B-PP	Oindependent	sites	independent	JJ	B-NP	Osites	.	site	NNS	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	the	","	","	O	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	DEX	]	)	I-NP	ODEX	to	DEX	NN	I-NP	Oto	C7	to	TO	B-PP	OC7	cytosol	C7	NN	B-NP	Ocytosol	revealed	cytosol	NN	I-NP	Orevealed	a	reveal	VBD	B-VP	Oa	single	a	DT	B-NP	Osingle	class	single	JJ	I-NP	Oclass	of	class	NN	I-NP	Oof	binding	of	IN	B-PP	Obinding	sites	bind	VBG	B-NP	B-DNAsites	(	site	NNS	I-NP	I-DNA(	Kd	(	(	O	OKd	=	Kd	NN	B-NP	O=	1.9	=	SYM	B-VP	O1.9	nM	1.9	CD	B-NP	OnM	;	nM	NN	I-NP	O;	receptor	;	:	O	Oreceptor	concentration	receptor	NN	B-NP	Oconcentration	","	concentration	NN	I-NP	O","	0.46	","	","	O	O0.46	pmol/mg	0.46	CD	B-NP	Opmol/mg	protein	pmol/mg	NN	I-NP	Oprotein	)	protein	NN	I-NP	O)	.	)	)	O	O.	Examination	.	.	O	OExamination	of	Examination	NN	B-NP	Oof	the	of	IN	B-PP	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	CVZ	]	)	I-NP	OCVZ	using	CVZ	NN	I-NP	Ousing	10	use	VBG	B-VP	O10	(	10	CD	B-NP	O(	-5	(	(	O	O-5	)	-5	CD	B-NP	O)	M	)	)	O	OM	DEX	M	NN	B-NP	ODEX	as	DEX	NN	I-NP	Oas	the	as	IN	B-PP	Othe	competing	the	DT	B-NP	Ocompeting	ligand	compete	VBG	I-NP	Oligand	showed	ligand	NN	I-NP	Oshowed	that	show	VBD	B-VP	Othat	DEX	that	IN	B-SBAR	ODEX	binds	DEX	NN	B-NP	Obinds	only	bind	VBZ	B-VP	Oonly	to	only	RB	B-ADVP	Oto	the	to	TO	B-PP	Othe	low	the	DT	B-NP	Olow	affinity	low	JJ	I-NP	B-DNAaffinity	site	affinity	NN	I-NP	I-DNAsite	detected	site	NN	I-NP	I-DNAdetected	by	detect	VBN	B-VP	Oby	[	by	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	CVZ	]	)	I-NP	OCVZ	.	CVZ	NN	I-NP	O.	In	.	.	O	OIn	cytosol	In	IN	B-PP	Ocytosol	from	cytosol	NN	B-NP	Ofrom	a	from	IN	B-PP	Oa	glucocorticoid-resistant	a	DT	B-NP	Oglucocorticoid-resistant	cell	glucocorticoid-resistant	JJ	I-NP	B-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	with	line	NN	I-NP	I-cell_linewith	virtually	with	IN	B-PP	Ovirtually	no	virtually	RB	B-NP	Ono	[	no	DT	I-NP	O[	3H	[	(	I-NP	O3H	]	3H	NN	I-NP	O]	DEX	]	)	I-NP	ODEX	binding	DEX	NN	I-NP	Obinding	","	binding	NN	I-NP	O","	[	","	","	O	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	CVZ	]	)	I-NP	OCVZ	detected	CVZ	NN	I-NP	Odetected	a	detect	VBD	B-VP	Oa	single	a	DT	B-NP	Osingle	high	single	JJ	I-NP	Ohigh	affinity	high	JJ	I-NP	Oaffinity	binding	affinity	NN	I-NP	Obinding	site	binding	NN	I-NP	Osite	that	site	NN	I-NP	Othat	was	that	WDT	B-NP	Owas	similar	be	VBD	B-VP	Osimilar	in	similar	JJ	B-ADJP	Oin	dissociation	in	IN	B-PP	Odissociation	constant	dissociation	NN	B-NP	Oconstant	(	constant	NN	I-NP	O(	0.8	(	(	O	O0.8	nM	0.8	CD	B-NP	OnM	)	nM	NN	I-NP	O)	and	)	)	O	Oand	receptor	and	CC	O	Oreceptor	concentration	receptor	NN	B-NP	Oconcentration	(	concentration	NN	I-NP	O(	0.13	(	(	O	O0.13	pmol/mg	0.13	CD	B-NP	Opmol/mg	protein	pmol/mg	NN	I-NP	Oprotein	)	protein	NN	I-NP	O)	to	)	)	O	Oto	the	to	TO	B-PP	Othe	high	the	DT	B-NP	Ohigh	affinity	high	JJ	I-NP	B-DNAaffinity	site	affinity	NN	I-NP	I-DNAsite	detected	site	NN	I-NP	I-DNAdetected	in	detect	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	glucocorticoid-sensitive	the	DT	B-NP	Oglucocorticoid-sensitive	cell	glucocorticoid-sensitive	JJ	I-NP	B-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	C7	line	NN	I-NP	I-cell_lineC7	.	C7	NN	I-NP	O.	A	.	.	O	OA	controlled	A	DT	B-NP	Ocontrolled	pore	control	VBN	I-NP	Opore	glass	pore	NN	I-NP	Oglass	bead	glass	NN	I-NP	Obead	assay	bead	NN	I-NP	Oassay	for	assay	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	measurement	the	DT	B-NP	Omeasurement	of	measurement	NN	I-NP	Oof	cytoplasmic	of	IN	B-PP	Ocytoplasmic	and	cytoplasmic	JJ	B-NP	Oand	nuclear	and	CC	I-NP	Onuclear	glucocorticoid	nuclear	JJ	I-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	An	.	.	O	OAn	assay	An	DT	B-NP	Oassay	for	assay	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	quantitation	the	DT	B-NP	Oquantitation	of	quantitation	NN	I-NP	Oof	cytoplasmic	of	IN	B-PP	Ocytoplasmic	and	cytoplasmic	JJ	B-NP	Oand	nuclear	and	CC	I-NP	Onuclear	glucocorticoid	nuclear	JJ	I-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	lymphoid	in	IN	B-PP	Olymphoid	tissue	lymphoid	JJ	B-NP	Otissue	has	tissue	NN	I-NP	Ohas	been	have	VBZ	B-VP	Obeen	developed	be	VBN	I-VP	Odeveloped	using	develop	VBN	I-VP	Ousing	controlled	use	VBG	B-VP	Ocontrolled	pore	control	VBN	B-NP	Opore	glass	pore	NN	I-NP	Oglass	(	glass	NN	I-NP	O(	CPG	(	(	O	OCPG	)	CPG	NN	B-NP	O)	beads	)	)	O	Obeads	.	bead	VBZ	B-VP	O.	Soluble	.	.	O	OSoluble	receptor	Soluble	JJ	B-NP	B-proteinreceptor	--	receptor	NN	I-NP	I-protein--	3H-steroid	--	:	O	I-protein3H-steroid	complex	3H-steroid	JJ	B-NP	I-proteincomplex	(	complex	NN	I-NP	I-protein(	cytosol	(	(	O	Ocytosol	or	cytosol	NN	B-NP	Oor	nuclear	or	CC	O	Onuclear	extract	nuclear	JJ	B-NP	Oextract	)	extract	NN	I-NP	O)	is	)	)	O	Ois	adsorbed	be	VBZ	B-VP	Oadsorbed	quantitatively	adsorb	VBN	I-VP	Oquantitatively	within	quantitatively	RB	B-ADVP	Owithin	the	within	IN	B-PP	Othe	crevasses	the	DT	B-NP	Ocrevasses	of	crevasse	NNS	I-NP	Oof	porous	of	IN	B-PP	Oporous	glass	porous	JJ	B-NP	Oglass	beads	glass	NN	I-NP	Obeads	.	bead	NNS	I-NP	O.	Excess	.	.	O	OExcess	labeled	Excess	JJ	B-NP	Olabeled	steroid	label	VBN	I-NP	Osteroid	as	steroid	NN	I-NP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	most	as	IN	I-CONJP	Omost	non-specifically	most	JJS	B-NP	Onon-specifically	bound	non-specifically	RB	I-NP	Obound	steroid	bind	VBN	I-NP	Osteroid	is	steroid	NN	I-NP	Ois	easily	be	VBZ	B-VP	Oeasily	washed	easily	RB	I-VP	Owashed	away	wash	VBN	I-VP	Oaway	","	away	RB	B-ADVP	O","	leaving	","	","	O	Oleaving	the	leave	VBG	B-VP	Othe	hormone-receptor	the	DT	B-NP	Ohormone-receptor	complex	hormone-receptor	NN	I-NP	B-proteincomplex	retained	complex	NN	I-NP	I-proteinretained	by	retain	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	beads	the	DT	B-NP	Obeads	.	bead	NNS	I-NP	O.	Bound	.	.	O	OBound	3H-steroid	Bound	NN	B-NP	O3H-steroid	is	3H-steroid	NN	I-NP	Ois	eluted	be	VBZ	B-VP	Oeluted	with	elute	VBN	I-VP	Owith	ethanol	with	IN	B-PP	Oethanol	and	ethanol	NN	B-NP	Oand	measured	and	CC	O	Omeasured	for	measure	VBN	B-VP	Ofor	radioactivity	for	IN	B-PP	Oradioactivity	.	radioactivity	NN	B-NP	O.	This	.	.	O	OThis	procedure	This	DT	B-NP	Oprocedure	which	procedure	NN	I-NP	Owhich	is	which	WDT	B-NP	Ois	simple	be	VBZ	B-VP	Osimple	","	simple	JJ	B-ADJP	O","	rapid	","	","	O	Orapid	","	rapid	JJ	B-ADJP	O","	and	","	","	O	Oand	highly	and	CC	O	Ohighly	reproducible	highly	RB	B-ADJP	Oreproducible	is	reproducible	JJ	I-ADJP	Ois	carried	be	VBZ	B-VP	Ocarried	out	carry	VBN	I-VP	Oout	using	out	RP	B-PRT	Ousing	frozen	use	VBG	B-VP	Ofrozen	samples	freeze	VBN	B-NP	Osamples	(	sample	NNS	I-NP	O(	stable	(	(	O	Ostable	for	stable	JJ	B-ADJP	Ofor	many	for	IN	B-PP	Omany	months	many	JJ	B-NP	Omonths	)	month	NNS	I-NP	O)	containing	)	)	O	Ocontaining	as	contain	VBG	B-VP	Oas	few	as	RB	B-ADJP	Ofew	as	few	JJ	I-ADJP	Oas	1	as	IN	B-PP	O1	X	1	CD	B-NP	OX	10	X	SYM	I-NP	O10	(	10	CD	I-NP	O(	7	(	(	O	O7	)	7	CD	B-NP	O)	cells	)	)	O	Ocells	.	cell	NNS	B-NP	O.	A	.	.	O	OA	comparison	A	DT	B-NP	Ocomparison	of	comparison	NN	I-NP	Oof	the	of	IN	B-PP	Othe	CPG	the	DT	B-NP	OCPG	assay	CPG	NN	I-NP	Oassay	to	assay	NN	I-NP	Oto	dextran	to	TO	B-VP	Odextran	coated	dextran	VB	I-VP	Ocoated	charcoal	coated	JJ	B-NP	Ocharcoal	and	charcoal	NN	I-NP	Oand	a	and	CC	O	Oa	whole	a	DT	B-NP	Owhole	cell	whole	JJ	I-NP	Ocell	assay	cell	NN	I-NP	Oassay	demonstrates	assay	NN	I-NP	Odemonstrates	that	demonstrate	VBZ	B-VP	Othat	CPG	that	IN	B-SBAR	OCPG	and	CPG	NN	B-NP	B-proteinand	dextran	and	CC	O	Odextran	coated	dextran	NN	B-NP	Ocoated	charcoal	coated	JJ	I-NP	Ocharcoal	give	charcoal	NN	I-NP	Ogive	equivalent	give	VBP	B-VP	Oequivalent	measurements	equivalent	JJ	B-NP	Omeasurements	of	measurement	NNS	I-NP	Oof	cytosolic	of	IN	B-PP	Ocytosolic	receptor	cytosolic	JJ	B-NP	B-proteinreceptor	concentration	receptor	NN	I-NP	I-proteinconcentration	","	concentration	NN	I-NP	O","	while	","	","	O	Owhile	the	while	IN	B-SBAR	Othe	CPG	the	DT	B-NP	OCPG	and	CPG	NN	I-NP	B-DNAand	whole	and	CC	I-NP	Owhole	cell	whole	JJ	I-NP	Ocell	assays	cell	NN	I-NP	Oassays	provide	assay	NNS	I-NP	Oprovide	equivalent	provide	VBP	B-VP	Oequivalent	values	equivalent	JJ	B-NP	Ovalues	for	value	NNS	I-NP	Ofor	total	for	IN	B-PP	Ototal	receptor	total	JJ	B-NP	Oreceptor	content	receptor	NN	I-NP	Ocontent	.	content	NN	I-NP	O.	Plasmacytoid	.	.	O	OPlasmacytoid	blast	Plasmacytoid	JJ	B-NP	Oblast	crisis	blast	NN	I-NP	Ocrisis	in	crisis	NN	I-NP	Oin	B-cell	in	IN	B-PP	OB-cell	chronic	B-cell	NN	B-NP	Ochronic	lymphocytic	chronic	JJ	I-NP	Olymphocytic	leukemia	lymphocytic	JJ	I-NP	Oleukemia	:	leukemia	NN	I-NP	O:	effect	:	:	O	Oeffect	of	effect	NN	B-NP	Oof	estradiol	of	IN	B-PP	Oestradiol	on	estradiol	NN	B-NP	Oon	growth	on	IN	B-PP	Ogrowth	and	growth	NN	B-NP	Oand	differentiation	and	CC	O	Odifferentiation	in	differentiation	NN	B-NP	Oin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	Evolution	.	.	O	OEvolution	of	Evolution	NN	B-NP	Oof	a	of	IN	B-PP	Oa	case	a	DT	B-NP	Ocase	of	case	NN	I-NP	Oof	chronic	of	IN	B-PP	Ochronic	lymphocytic	chronic	JJ	B-NP	Olymphocytic	leukemia	lymphocytic	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	CLL	(	(	O	OCLL	)	CLL	NN	B-NP	O)	into	)	)	O	Ointo	blast	into	IN	B-PP	Oblast	crisis	blast	NN	B-NP	Ocrisis	was	crisis	NN	I-NP	Owas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	characterized	be	VB	I-VP	Ocharacterized	by	characterize	VBN	I-VP	Oby	three	by	IN	B-PP	Othree	unusual	three	CD	B-NP	Ounusual	features	unusual	JJ	I-NP	Ofeatures	(	feature	NNS	I-NP	O(	1	(	(	B-LST	O1	)	1	LS	I-LST	O)	the	)	)	O	Othe	phenotype	the	DT	B-NP	Ophenotype	of	phenotype	NN	I-NP	Oof	the	of	IN	B-PP	Othe	emerging	the	DT	B-NP	Oemerging	blast	emerge	VBG	I-NP	Oblast	cells	blast	NN	I-NP	B-cell_typecells	was	cell	NNS	I-NP	I-cell_typewas	that	be	VBD	B-VP	Othat	of	that	IN	B-SBAR	Oof	pre-plasmacytoid	of	IN	B-PP	Opre-plasmacytoid	cells	pre-plasmacytoid	JJ	B-NP	B-cell_typecells	as	cell	NNS	I-NP	I-cell_typeas	shown	as	IN	B-SBAR	Oshown	by	show	VBN	B-VP	Oby	plasma	by	IN	B-PP	Oplasma	cell	plasma	NN	B-NP	Ocell	morphology	cell	NN	I-NP	Omorphology	and	morphology	NN	I-NP	Oand	an	and	CC	O	Oan	immunological	an	DT	B-NP	Oimmunological	phenotype	immunological	JJ	I-NP	Ophenotype	corresponding	phenotype	NN	I-NP	Ocorresponding	partially	correspond	VBG	B-VP	Opartially	with	partially	RB	B-ADVP	Owith	CLL-	with	IN	B-PP	OCLL-	or	CLL-	NN	B-NP	Oor	intermediate	or	CC	O	Ointermediate	B-cells	intermediate	JJ	B-NP	B-cell_typeB-cells	","	B-cell	NNS	I-NP	I-cell_type","	partially	","	","	O	Opartially	with	partially	RB	B-ADVP	Owith	plasma	with	IN	B-PP	Oplasma	cells	plasma	NN	B-NP	B-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	terminal	(	(	O	Oterminal	transferase	terminal	JJ	B-NP	B-proteintransferase	-	transferase	NN	I-NP	I-protein-	","	-	HYPH	B-ADJP	O","	common	","	","	O	Ocommon	acute	common	JJ	B-NP	Oacute	lymphocytic	acute	JJ	I-NP	B-proteinlymphocytic	leukemia	lymphocytic	JJ	I-NP	I-proteinleukemia	antigen	leukemia	NN	I-NP	I-proteinantigen	-	antigen	NN	I-NP	I-protein-	","	-	HYPH	B-ADJP	O","	Ia+	","	","	O	OIa+	","	Ia+	NN	B-NP	B-protein","	surface	","	","	O	Osurface	immunoglobulin	surface	NN	B-NP	B-proteinimmunoglobulin	heavy	immunoglobulin	NN	I-NP	I-proteinheavy	chains	heavy	JJ	I-NP	I-proteinchains	-	chain	NNS	I-NP	I-protein-	","	-	HYPH	B-ADJP	O","	surface	","	","	O	Osurface	kappa	surface	NN	B-NP	B-proteinkappa	light	kappa	NN	I-NP	I-proteinlight	chains	light	JJ	I-NP	I-proteinchains	+	chain	NNS	I-NP	I-protein+	","	+	SYM	B-NP	O","	intracytoplasmic	","	","	O	Ointracytoplasmic	immunoglobulin	intracytoplasmic	JJ	B-NP	Oimmunoglobulin	A+	immunoglobulin	NN	I-NP	OA+	and	A+	JJ	I-NP	Oand	G+	and	CC	I-NP	OG+	","	G+	JJ	I-NP	O","	BA-1+	","	","	I-NP	OBA-1+	","	BA-1+	JJ	I-NP	O","	polyclonal	","	","	I-NP	Opolyclonal	gammaglobulin	polyclonal	JJ	I-NP	Ogammaglobulin	production	gammaglobulin	NN	I-NP	Oproduction	)	production	NN	I-NP	O)	;	)	)	O	O;	(	;	:	O	O(	2	(	(	B-LST	O2	)	2	LS	I-LST	O)	cytogenetic	)	)	O	Ocytogenetic	analysis	cytogenetic	JJ	B-NP	Oanalysis	of	analysis	NN	I-NP	Oof	spontaneous	of	IN	B-PP	Ospontaneous	metaphases	spontaneous	JJ	B-NP	Ometaphases	revealed	metaphase	NNS	I-NP	Orevealed	that	reveal	VBD	B-VP	Othat	in	that	IN	B-SBAR	Oin	addition	in	IN	B-PP	Oaddition	to	addition	NN	B-NP	Oto	the	to	TO	B-PP	Othe	typical	the	DT	B-NP	Otypical	CLL	typical	JJ	I-NP	OCLL	abnormality	CLL	NN	I-NP	Oabnormality	","	abnormality	NN	I-NP	O","	trisomy	","	","	O	Otrisomy	12	trisomy	NN	B-NP	O12	","	12	CD	I-NP	O","	in	","	","	O	Oin	all	in	IN	B-PP	Oall	of	all	DT	B-NP	Oof	the	of	IN	B-PP	Othe	cells	the	DT	B-NP	Ocells	","	cell	NNS	I-NP	O","	an	","	","	O	Oan	additional	an	DT	B-NP	Oadditional	translocation	additional	JJ	I-NP	Otranslocation	between	translocation	NN	I-NP	Obetween	chromosomes	between	IN	B-PP	Ochromosomes	14	chromosome	NNS	B-NP	B-DNA14	and	14	CD	B-NP	I-DNAand	17	and	CC	I-NP	O17	was	17	CD	I-NP	Owas	present	be	VBD	B-VP	Opresent	in	present	JJ	B-ADJP	Oin	40	in	IN	B-PP	O40	%	40	CD	B-NP	O%	with	%	NN	I-NP	Owith	a	with	IN	B-PP	Oa	presumptive	a	DT	B-NP	Opresumptive	breakpoint	presumptive	JJ	I-NP	Obreakpoint	on	breakpoint	NN	I-NP	Oon	chromosome	on	IN	B-PP	Ochromosome	14	chromosome	NN	B-NP	B-DNA14	(	14	CD	I-NP	I-DNA(	q12-3	(	(	O	Oq12-3	)	q12-3	NN	B-NP	O)	never	)	)	O	Onever	described	never	RB	B-VP	Odescribed	before	describe	VBN	I-VP	Obefore	(	before	IN	B-PP	O(	commonly	(	(	O	Ocommonly	q32	commonly	RB	B-NP	Oq32	)	q32	NN	I-NP	O)	and	)	)	O	Oand	(	and	CC	O	O(	3	(	(	B-LST	O3	)	3	LS	I-LST	O)	the	)	)	O	Othe	progression	the	DT	B-NP	Oprogression	of	progression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	disease	the	DT	B-NP	Odisease	was	disease	NN	I-NP	Owas	associated	be	VBD	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	a	with	IN	B-PP	Oa	striking	a	DT	B-NP	Ostriking	increase	striking	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	the	in	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	by	expression	NN	I-NP	Oby	the	by	IN	B-PP	Othe	transformed	the	DT	B-NP	Otransformed	cells	transform	VBN	I-NP	B-cell_linecells	of	cell	NNS	I-NP	I-cell_lineof	specific	of	IN	B-PP	Ospecific	binding	specific	JJ	B-NP	Obinding	sites	bind	VBG	I-NP	B-DNAsites	for	site	NNS	I-NP	I-DNAfor	estradiol	for	IN	B-PP	Oestradiol	(	estradiol	NN	B-NP	O(	E2	(	(	O	OE2	)	E2	NN	B-NP	O)	due	)	)	O	Odue	to	due	IN	B-PP	Oto	an	to	TO	B-PP	Oan	actual	an	DT	B-NP	Oactual	increase	actual	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	total	in	IN	B-PP	Ototal	cellular	total	JJ	B-NP	Ocellular	receptor	cellular	JJ	I-NP	Oreceptor	proteins	receptor	NN	I-NP	Oproteins	and	protein	NNS	I-NP	Oand	not	and	CC	O	Onot	to	not	RB	B-PP	Oto	a	to	TO	I-PP	Oa	change	a	DT	B-NP	Ochange	in	change	NN	I-NP	Oin	receptor	in	IN	B-PP	Oreceptor	affinity	receptor	NN	B-NP	Oaffinity	for	affinity	NN	I-NP	Ofor	E2	for	IN	B-PP	OE2	.	E2	NN	B-NP	B-protein.	The	.	.	O	OThe	functional	The	DT	B-NP	Ofunctional	status	functional	JJ	I-NP	Ostatus	of	status	NN	I-NP	Oof	the	of	IN	B-PP	Othe	steroid	the	DT	B-NP	Osteroid	receptors	steroid	NN	I-NP	B-proteinreceptors	was	receptor	NNS	I-NP	I-proteinwas	confirmed	be	VBD	B-VP	Oconfirmed	by	confirm	VBN	I-VP	Oby	nuclear	by	IN	B-PP	Onuclear	transfer	nuclear	JJ	B-NP	Otransfer	of	transfer	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cytoplasmic	the	DT	B-NP	Ocytoplasmic	hormone-receptor	cytoplasmic	JJ	I-NP	B-proteinhormone-receptor	complex	hormone-receptor	NN	I-NP	I-proteincomplex	upon	complex	NN	I-NP	I-proteinupon	temperature	upon	IN	B-PP	Otemperature	activation	temperature	NN	B-NP	Oactivation	.	activation	NN	I-NP	O.	Since	.	.	O	OSince	the	Since	IN	B-SBAR	Othe	rise	the	DT	B-NP	Orise	in	rise	NN	I-NP	Oin	E2-receptor	in	IN	B-PP	OE2-receptor	display	E2-receptor	NN	B-NP	Odisplay	paralleled	display	NN	I-NP	Oparalleled	a	parallel	VBD	B-VP	Oa	large	a	DT	B-NP	Olarge	increase	large	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	the	in	IN	B-PP	Othe	proliferative	the	DT	B-NP	Oproliferative	activity	proliferative	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cells	the	DT	B-NP	Ocells	as	cell	NNS	I-NP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	a	as	IN	I-CONJP	Oa	change	a	DT	B-NP	Ochange	in	change	NN	I-NP	Oin	their	in	IN	B-PP	Otheir	maturation	their	PRP$	B-NP	Omaturation	status	maturation	NN	I-NP	Ostatus	the	status	NN	I-NP	Othe	question	the	DT	B-NP	Oquestion	was	question	NN	I-NP	Owas	raised	be	VBD	B-VP	Oraised	as	raise	VBN	I-VP	Oas	to	as	IN	B-PP	Oto	whether	to	TO	B-PP	Owhether	the	whether	IN	B-SBAR	Othe	E2-receptor	the	DT	B-NP	OE2-receptor	should	E2-receptor	NN	I-NP	B-proteinshould	be	should	MD	B-VP	Obe	considered	be	VB	I-VP	Oconsidered	as	consider	VBN	I-VP	Oas	a	as	IN	B-PP	Oa	physiological	a	DT	B-NP	Ophysiological	marker	physiological	JJ	I-NP	Omarker	of	marker	NN	I-NP	Oof	growth	of	IN	B-PP	Ogrowth	rate	growth	NN	B-NP	Orate	or	rate	NN	I-NP	Oor	of	or	CC	B-PP	Oof	cellular	of	IN	B-PP	Ocellular	differentiation	cellular	JJ	B-NP	Odifferentiation	.	differentiation	NN	I-NP	O.	Exposure	.	.	O	OExposure	of	Exposure	NN	B-NP	Oof	the	of	IN	B-PP	Othe	patient	the	DT	B-NP	Opatient	's	patient	NN	I-NP	O's	blast	's	POS	B-NP	Oblast	cells	blast	NN	I-NP	B-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	E2	to	TO	B-PP	OE2	in	E2	NN	B-NP	B-proteinin	vitro	in	FW	B-ADVP	Ovitro	resulted	vitro	FW	I-ADVP	Oresulted	in	result	VBD	B-VP	Oin	cessation	in	IN	B-PP	Ocessation	of	cessation	NN	B-NP	Oof	cell	of	IN	B-PP	Ocell	growth	cell	NN	B-NP	Ogrowth	following	growth	NN	I-NP	Ofollowing	at	follow	VBG	B-PP	Oat	least	at	IN	B-NP	Oleast	one	least	JJS	I-NP	Oone	mitosis	one	CD	I-NP	Omitosis	after	mitosis	NN	I-NP	Oafter	addition	after	IN	B-PP	Oaddition	of	addition	NN	B-NP	Oof	the	of	IN	B-PP	Othe	inducer	the	DT	B-NP	Oinducer	as	inducer	NN	I-NP	Oas	seen	as	IN	B-SBAR	Oseen	from	see	VBN	B-VP	Ofrom	the	from	IN	B-PP	Othe	replacement	the	DT	B-NP	Oreplacement	of	replacement	NN	I-NP	Oof	the	of	IN	B-PP	Othe	large	the	DT	B-NP	Olarge	blasts	large	JJ	I-NP	B-cell_typeblasts	by	blast	NNS	I-NP	I-cell_typeby	small	by	IN	B-PP	Osmall	CLL-like	small	JJ	B-NP	B-cell_typeCLL-like	cells	CLL-like	JJ	I-NP	I-cell_typecells	without	cell	NNS	I-NP	I-cell_typewithout	definite	without	IN	B-PP	Odefinite	signs	definite	JJ	B-NP	Osigns	of	sign	NNS	I-NP	Oof	alteration	of	IN	B-PP	Oalteration	of	alteration	NN	B-NP	Oof	the	of	IN	B-PP	Othe	differentiation	the	DT	B-NP	Odifferentiation	status	differentiation	NN	I-NP	Ostatus	.	status	NN	I-NP	O.	This	.	.	O	OThis	suggests	This	DT	B-NP	Osuggests	the	suggest	VBZ	B-VP	Othe	association	the	DT	B-NP	Oassociation	of	association	NN	I-NP	Oof	E2-receptor	of	IN	B-PP	OE2-receptor	expression	E2-receptor	NN	B-NP	B-proteinexpression	with	expression	NN	I-NP	Owith	control	with	IN	B-PP	Ocontrol	of	control	NN	B-NP	Oof	growth	of	IN	B-PP	Ogrowth	rather	growth	NN	B-NP	Orather	than	rather	RB	B-CONJP	Othan	cell	than	IN	I-CONJP	Ocell	maturation	cell	NN	B-NP	Omaturation	.	maturation	NN	I-NP	O.	Multiple	.	.	O	OMultiple	forms	Multiple	JJ	B-NP	Oforms	and	form	NNS	I-NP	Oand	fragments	and	CC	I-NP	Ofragments	of	fragment	NNS	I-NP	Oof	cytosolic	of	IN	B-PP	Ocytosolic	glucocorticoid	cytosolic	JJ	B-NP	B-proteinglucocorticoid	receptors	glucocorticoid	NN	I-NP	I-proteinreceptors	from	receptor	NNS	I-NP	I-proteinfrom	human	from	IN	B-PP	Ohuman	leukemic	human	JJ	B-NP	B-cell_typeleukemic	cells	leukemic	JJ	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	normal	and	CC	O	Onormal	lymphocytes	normal	JJ	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Therapy	.	.	O	OTherapy	with	Therapy	NN	B-NP	Owith	glucocorticoids	with	IN	B-PP	Oglucocorticoids	is	glucocorticoid	NNS	B-NP	Ois	generally	be	VBZ	B-VP	Ogenerally	more	generally	RB	B-ADJP	Omore	effective	more	RBR	I-ADJP	Oeffective	in	effective	JJ	I-ADJP	Oin	acute	in	IN	B-PP	Oacute	lymphoblastic	acute	JJ	B-NP	Olymphoblastic	leukemia	lymphoblastic	JJ	I-NP	Oleukemia	than	leukemia	NN	I-NP	Othan	in	than	IN	B-PP	Oin	other	in	IN	B-PP	Oother	types	other	JJ	B-NP	Otypes	of	type	NNS	I-NP	Oof	human	of	IN	B-PP	Ohuman	leukemia	human	JJ	B-NP	Oleukemia	.	leukemia	NN	I-NP	O.	Previous	.	.	O	OPrevious	studies	Previous	JJ	B-NP	Ostudies	","	study	NNS	I-NP	O","	however	","	","	O	Ohowever	","	however	RB	B-ADVP	O","	have	","	","	O	Ohave	not	have	VBP	B-VP	Onot	revealed	not	RB	I-VP	Orevealed	any	reveal	VBN	I-VP	Oany	consistent	any	DT	B-NP	Oconsistent	relationship	consistent	JJ	I-NP	Orelationship	between	relationship	NN	I-NP	Obetween	clinical	between	IN	B-PP	Oclinical	responsiveness	clinical	JJ	B-NP	Oresponsiveness	and	responsiveness	NN	I-NP	Oand	the	and	CC	O	Othe	cellular	the	DT	B-NP	Ocellular	or	cellular	JJ	I-NP	Oor	cytosolic	or	CC	I-NP	Ocytosolic	concentration	cytosolic	JJ	I-NP	Oconcentration	of	concentration	NN	I-NP	Oof	glucocorticoid-binding	of	IN	B-PP	Oglucocorticoid-binding	sites	glucocorticoid-binding	JJ	B-NP	B-DNAsites	.	site	NNS	I-NP	I-DNA.	The	.	.	O	OThe	objectives	The	DT	B-NP	Oobjectives	of	objective	NNS	I-NP	Oof	this	of	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	were	study	NN	I-NP	Owere	to	be	VBD	B-VP	Oto	determine	to	TO	I-VP	Odetermine	whether	determine	VB	I-VP	Owhether	there	whether	IN	B-SBAR	Othere	are	there	EX	B-NP	Oare	intrinsic	be	VBP	B-VP	Ointrinsic	structural	intrinsic	JJ	B-NP	Ostructural	differences	structural	JJ	I-NP	Odifferences	among	difference	NNS	I-NP	Oamong	the	among	IN	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	various	in	IN	B-PP	Ovarious	types	various	JJ	B-NP	Otypes	of	type	NNS	I-NP	Oof	leukemic	of	IN	B-PP	Oleukemic	cells	leukemic	JJ	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	normal	and	CC	O	Onormal	lymphocytes	normal	JJ	B-NP	B-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	to	and	CC	O	Oto	investigate	to	TO	B-VP	Oinvestigate	the	investigate	VB	I-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	endogenous	of	IN	B-PP	Oendogenous	peptidases	endogenous	JJ	B-NP	B-proteinpeptidases	in	peptidase	NNS	I-NP	I-proteinin	receptor	in	IN	B-PP	Oreceptor	degradation	receptor	NN	B-NP	Odegradation	.	degradation	NN	I-NP	O.	Cytosols	.	.	O	OCytosols	were	Cytosol	NNS	B-NP	Owere	prepared	be	VBD	B-VP	Oprepared	from	prepare	VBN	I-VP	Ofrom	fresh	from	IN	B-PP	Ofresh	or	fresh	JJ	B-NP	Oor	rapidly	or	CC	I-NP	Orapidly	frozen	rapidly	RB	I-NP	Ofrozen	leukocytes	freeze	VBN	I-NP	Oleukocytes	from	leukocyte	NNS	I-NP	B-cell_typefrom	6	from	IN	B-PP	O6	healthy	6	CD	B-NP	Ohealthy	adults	healthy	JJ	I-NP	Oadults	and	adult	NNS	I-NP	Oand	35	and	CC	O	O35	high-risk	35	CD	B-NP	Ohigh-risk	leukemia	high-risk	JJ	I-NP	Oleukemia	patients	leukemia	NN	I-NP	Opatients	(	patient	NNS	I-NP	O(	median	(	(	O	Omedian	white	median	JJ	B-NP	Owhite	blood	white	JJ	I-NP	Oblood	cell	blood	NN	I-NP	Ocell	count	cell	NN	I-NP	Ocount	","	count	NN	I-NP	O","	150	","	","	O	O150	","	150	CD	B-NP	O","	0	","	","	O	O0	cells/microliter	0	CD	B-NP	Ocells/microliter	;	cells/microliter	NNS	I-NP	O;	median	;	:	O	Omedian	age	median	JJ	B-NP	Oage	","	age	NN	I-NP	O","	13	","	","	O	O13	years	13	CD	B-NP	Oyears	)	year	NNS	I-NP	O)	.	)	)	O	O.	Receptors	.	.	O	OReceptors	were	Receptor	NNS	B-NP	Owere	labeled	be	VBD	B-VP	Olabeled	with	label	VBN	I-VP	Owith	[	with	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	triamcinolone	]	)	I-NP	Otriamcinolone	acetonide	triamcinolone	NN	I-NP	Oacetonide	and	acetonide	NN	I-NP	Oand	quantitated	and	CC	O	Oquantitated	by	quantitate	VBN	B-VP	Oby	charcoal-dextran	by	IN	B-PP	Ocharcoal-dextran	treatment	charcoal-dextran	JJ	B-NP	Otreatment	or	treatment	NN	I-NP	Oor	Sephadex	or	CC	I-NP	OSephadex	LH-20	Sephadex	NN	I-NP	OLH-20	chromatography	LH-20	NN	I-NP	Ochromatography	.	chromatography	NN	I-NP	O.	Mean	.	.	O	OMean	and	Mean	JJ	B-NP	Oand	median	and	CC	I-NP	Omedian	cytosolic	median	JJ	I-NP	Ocytosolic	receptor	cytosolic	JJ	I-NP	Oreceptor	concentrations	receptor	NN	I-NP	Oconcentrations	in	concentration	NNS	I-NP	Oin	12	in	IN	B-PP	O12	acute	12	CD	B-NP	Oacute	lymphoblastic	acute	JJ	I-NP	Olymphoblastic	leukemia	lymphoblastic	JJ	I-NP	Oleukemia	specimens	leukemia	NN	I-NP	Ospecimens	lacking	specimen	NNS	I-NP	Olacking	the	lack	VBG	B-VP	Othe	standard	the	DT	B-NP	Ostandard	B-cell	standard	JJ	I-NP	OB-cell	or	B-cell	NN	I-NP	Oor	T-cell	or	CC	I-NP	OT-cell	markers	T-cell	NN	I-NP	B-proteinmarkers	(	marker	NNS	I-NP	I-protein(	``	(	(	O	O``	null	``	``	O	B-cell_typenull	cells	null	NN	B-NP	I-cell_typecells	''	cell	NNS	I-NP	I-cell_type''	)	''	''	O	O)	were	)	)	O	Owere	approximately	be	VBD	B-VP	Oapproximately	4-fold	approximately	RB	B-ADVP	O4-fold	higher	4-fold	RB	B-ADJP	Ohigher	than	high	JJR	I-ADJP	Othan	in	than	IN	B-PP	Oin	23	in	IN	B-PP	O23	other	23	CD	B-NP	Oother	leukemic	other	JJ	I-NP	Oleukemic	cell	leukemic	JJ	I-NP	Ocell	specimens	cell	NN	I-NP	Ospecimens	.	specimen	NNS	I-NP	O.	No	.	.	O	ONo	other	No	DT	B-NP	Oother	consistent	other	JJ	I-NP	Oconsistent	differences	consistent	JJ	I-NP	Odifferences	in	difference	NNS	I-NP	Oin	receptor	in	IN	B-PP	Oreceptor	content	receptor	NN	B-NP	Ocontent	were	content	NN	I-NP	Owere	observed	be	VBD	B-VP	Oobserved	.	observe	VBN	I-VP	O.	Agarose	.	.	O	OAgarose	filtration	Agarose	NN	B-NP	Ofiltration	and	filtration	NN	I-NP	Oand	ultracentrifugation	and	CC	I-NP	Oultracentrifugation	in	ultracentrifugation	NN	I-NP	Oin	hypotonic	in	IN	B-PP	Ohypotonic	buffers	hypotonic	JJ	B-NP	Obuffers	containing	buffer	NNS	I-NP	Ocontaining	20	contain	VBG	B-VP	O20	mM	20	CD	B-NP	OmM	Na2MoO4	mM	NN	I-NP	ONa2MoO4	revealed	Na2MoO4	NN	I-NP	Orevealed	complexes	reveal	VBD	B-VP	Ocomplexes	of	complex	NNS	B-NP	Oof	similar	of	IN	B-PP	Osimilar	size	similar	JJ	B-NP	Osize	and	size	NN	I-NP	Oand	shape	and	CC	I-NP	Oshape	in	shape	NN	I-NP	Oin	all	in	IN	B-PP	Oall	clinical	all	DT	B-NP	Oclinical	specimens	clinical	JJ	I-NP	Ospecimens	tested	specimen	NNS	I-NP	Otested	and	test	VBN	B-VP	Oand	two	and	CC	O	Otwo	established	two	CD	B-NP	Oestablished	leukemic	establish	VBN	I-NP	Oleukemic	cell	leukemic	JJ	I-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	.	line	NNS	I-NP	I-cell_line.	They	.	.	O	OThey	had	They	PRP	B-NP	Ohad	Stokes	have	VBD	B-VP	OStokes	radii	Stokes	NNP	B-NP	Oradii	(	radius	NNS	I-NP	O(	Rs	(	(	O	ORs	)	R	NNS	B-NP	B-protein)	of	)	)	O	Oof	8.1	of	IN	B-PP	O8.1	+/-	8.1	CD	B-NP	O+/-	0.5	+/-	CC	I-NP	O0.5	(	0.5	CD	I-NP	O(	S.D.	(	(	O	OS.D.	)	S.D.	NN	B-NP	O)	nm	)	)	O	Onm	(	nm	NN	B-NP	O(	n	(	(	O	On	=	n	NN	B-NP	O=	50	=	SYM	B-VP	O50	)	50	CD	B-NP	O)	","	)	)	O	O","	sedimentation	","	","	O	Osedimentation	coefficients	sedimentation	NN	B-NP	Ocoefficients	of	coefficient	NNS	I-NP	Oof	9.5	of	IN	B-PP	O9.5	+/-	9.5	CD	B-NP	O+/-	0.3S	+/-	SYM	I-NP	O0.3S	(	0.3S	NN	I-NP	O(	n	(	(	O	On	=	n	NN	B-NP	O=	40	=	SYM	B-VP	O40	)	40	CD	B-NP	O)	","	)	)	O	O","	molecular	","	","	O	Omolecular	weights	molecular	JJ	B-NP	Oweights	of	weight	NNS	I-NP	Oof	approximately	of	IN	B-PP	Oapproximately	330	approximately	RB	B-NP	O330	","	330	CD	I-NP	O","	0	","	","	I-NP	O0	","	0	CD	I-NP	O","	and	","	","	O	Oand	axial	and	CC	O	Oaxial	ratios	axial	JJ	B-NP	Oratios	(	ratio	NNS	I-NP	O(	a/b	(	(	O	Oa/b	)	a/b	NN	B-NP	O)	of	)	)	O	Oof	approximately	of	IN	B-PP	Oapproximately	12	approximately	RB	B-NP	O12	.	12	CD	I-NP	O.	In	.	.	O	OIn	hypertonic	In	IN	B-PP	Ohypertonic	","	hypertonic	JJ	B-NP	O","	molybdate-free	","	","	I-NP	Omolybdate-free	buffer	molybdate-free	JJ	I-NP	Obuffer	","	buffer	NN	I-NP	O","	these	","	","	O	Othese	oligomeric	these	DT	B-NP	Ooligomeric	complexes	oligomeric	JJ	I-NP	B-proteincomplexes	were	complex	NNS	I-NP	I-proteinwere	dissociated	be	VBD	B-VP	Odissociated	into	dissociate	VBN	I-VP	Ointo	subunits	into	IN	B-PP	Osubunits	with	subunit	NNS	B-NP	Owith	Rs	with	IN	B-PP	ORs	of	R	NNS	B-NP	B-proteinof	5.9	of	IN	B-PP	O5.9	+/-	5.9	CD	B-NP	O+/-	0.3	+/-	SYM	I-NP	O0.3	nm	0.3	CD	I-NP	Onm	(	nm	NN	I-NP	O(	n	(	(	O	On	=	n	NN	B-NP	O=	12	=	SYM	B-VP	O12	)	12	CD	B-NP	O)	and	)	)	O	Oand	a/b	and	CC	O	Oa/b	of	a/b	NN	B-NP	Oof	11	of	IN	B-PP	O11	to	11	CD	B-NP	Oto	12	to	TO	B-PP	O12	","	12	CD	B-NP	O","	as	","	","	O	Oas	observed	as	IN	B-SBAR	Oobserved	previously	observe	VBN	B-VP	Opreviously	for	previously	RB	B-ADVP	Ofor	other	for	IN	B-PP	Oother	receptors	other	JJ	B-NP	Oreceptors	.	receptor	NNS	I-NP	O.	Fragmentation	.	.	O	OFragmentation	of	Fragmentation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	oligomer	the	DT	B-NP	Ooligomer	and	oligomer	NN	I-NP	Oand	the	and	CC	O	Othe	subunit	the	DT	B-NP	Osubunit	was	subunit	NN	I-NP	Owas	evident	be	VBD	B-VP	Oevident	in	evident	JJ	B-ADJP	Oin	some	in	IN	B-PP	Osome	cytosols	some	DT	B-NP	Ocytosols	.	cytosol	NNS	I-NP	O.	High	.	.	O	OHigh	activities	High	JJ	B-NP	Oactivities	of	activity	NNS	I-NP	Oof	peptidases	of	IN	B-PP	Opeptidases	of	peptidase	NNS	B-NP	Oof	various	of	IN	B-PP	Ovarious	specificities	various	JJ	B-NP	Ospecificities	were	specificity	NNS	I-NP	Owere	detected	be	VBD	B-VP	Odetected	in	detect	VBN	I-VP	Oin	leukemic	in	IN	B-PP	Oleukemic	cell	leukemic	JJ	B-NP	B-cell_typecell	cytosols	cell	NN	I-NP	I-cell_typecytosols	","	cytosol	NNS	I-NP	O","	as	","	","	O	Oas	in	as	IN	B-PP	Oin	other	in	IN	B-PP	Oother	cytosols	other	JJ	B-NP	Ocytosols	","	cytosol	NNS	I-NP	O","	by	","	","	O	Oby	fluorometric	by	IN	B-PP	Ofluorometric	assays	fluorometric	JJ	B-NP	Oassays	with	assay	NNS	I-NP	Owith	derivatives	with	IN	B-PP	Oderivatives	of	derivative	NNS	B-NP	Oof	7-amino-4-methylcoumarin	of	IN	B-PP	O7-amino-4-methylcoumarin	.	7-amino-4-methylcoumarin	NN	B-NP	B-protein.	Receptor	.	.	O	OReceptor	cleavage	Receptor	NN	B-NP	Ocleavage	by	cleavage	NN	I-NP	Oby	these	by	IN	B-PP	Othese	and	these	DT	B-NP	Oand	other	and	CC	I-NP	Oother	endogenous	other	JJ	I-NP	Oendogenous	enzymes	endogenous	JJ	I-NP	B-proteinenzymes	may	enzyme	NNS	I-NP	I-proteinmay	account	may	MD	B-VP	Oaccount	for	account	VB	I-VP	Ofor	previous	for	IN	B-PP	Oprevious	observations	previous	JJ	B-NP	Oobservations	of	observation	NNS	I-NP	Oof	``	of	IN	B-PP	O``	abnormal	``	``	B-NP	B-proteinabnormal	''	abnormal	JJ	I-NP	I-protein''	receptors	''	''	I-NP	I-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	cytosols	in	IN	B-PP	Ocytosols	from	cytosol	NNS	B-NP	Ofrom	some	from	IN	B-PP	Osome	leukemic	some	DT	B-NP	Oleukemic	specimens	leukemic	JJ	I-NP	Ospecimens	.	specimen	NNS	I-NP	O.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	intrinsic	that	IN	B-SBAR	Ointrinsic	structural	intrinsic	JJ	B-NP	Ostructural	defects	structural	JJ	I-NP	Odefects	in	defect	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	receptors	the	DT	B-NP	Oreceptors	are	receptor	NNS	I-NP	Oare	unlikely	be	VBP	B-VP	Ounlikely	explanations	unlikely	JJ	B-NP	Oexplanations	for	explanation	NNS	I-NP	Ofor	the	for	IN	B-PP	Othe	unresponsiveness	the	DT	B-NP	Ounresponsiveness	of	unresponsiveness	NN	I-NP	Oof	some	of	IN	B-PP	Osome	types	some	DT	B-NP	Otypes	of	type	NNS	I-NP	Oof	leukemia	of	IN	B-PP	Oleukemia	to	leukemia	NN	B-NP	Oto	steroid	to	TO	B-PP	Osteroid	therapy	steroid	NN	B-NP	Otherapy	.	therapy	NN	I-NP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	receptor	Glucocorticoid	NN	B-NP	B-proteinreceptor	number	receptor	NN	I-NP	I-proteinnumber	and	number	NN	I-NP	Oand	intracellular	and	CC	O	Ointracellular	water	intracellular	JJ	B-NP	Owater	space	water	NN	I-NP	Ospace	.	space	NN	I-NP	O.	In	.	.	O	OIn	order	In	IN	B-SBAR	Oorder	to	order	NN	O	Oto	elucidate	to	TO	B-VP	Oelucidate	the	elucidate	VB	I-VP	Othe	relationship	the	DT	B-NP	Orelationship	between	relationship	NN	I-NP	Obetween	cell	between	IN	B-PP	Ocell	water	cell	NN	B-NP	Owater	content	water	NN	I-NP	Ocontent	and	content	NN	I-NP	Oand	number	and	CC	I-NP	Onumber	of	number	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	","	receptor	NNS	I-NP	I-protein","	eleven	","	","	O	Oeleven	normal	eleven	CD	B-NP	Onormal	and	normal	JJ	I-NP	Oand	malignant	and	CC	I-NP	Omalignant	lymphoid	malignant	JJ	I-NP	Olymphoid	or	lymphoid	JJ	I-NP	Oor	myelomonocytic	or	CC	I-NP	Omyelomonocytic	cell	myelomonocytic	JJ	I-NP	B-cell_typecell	types	cell	NN	I-NP	I-cell_typetypes	originating	type	NNS	I-NP	I-cell_typeoriginating	from	originate	VBG	B-VP	Ofrom	mouse	from	IN	B-PP	Omouse	","	mouse	NN	B-NP	O","	rat	","	","	O	Orat	and	rat	NN	B-NP	Oand	man	and	CC	O	Oman	were	man	NN	B-NP	Owere	investigated	be	VBD	B-VP	Oinvestigated	.	investigate	VBN	I-VP	O.	The	.	.	O	OThe	cellular	The	DT	B-NP	Ocellular	water	cellular	JJ	I-NP	Owater	space	water	NN	I-NP	Ospace	was	space	NN	I-NP	Owas	measured	be	VBD	B-VP	Omeasured	with	measure	VBN	I-VP	Owith	3H2O	with	IN	B-PP	O3H2O	","	3H2O	NN	B-NP	O","	and	","	","	O	Oand	glucocorticoid	and	CC	O	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	number	receptor	NN	I-NP	I-proteinnumber	was	number	NN	I-NP	Owas	measured	be	VBD	B-VP	Omeasured	in	measure	VBN	I-VP	Oin	a	in	IN	B-PP	Oa	whole-cell	a	DT	B-NP	Owhole-cell	binding	whole-cell	JJ	I-NP	Obinding	assay	binding	NN	I-NP	Oassay	with	assay	NN	I-NP	Owith	[	with	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	dexamethasone	]	)	I-NP	Odexamethasone	at	dexamethasone	NN	I-NP	Oat	30	at	IN	B-PP	O30	and	30	CD	B-NP	Oand	37	and	CC	I-NP	O37	degrees	37	CD	I-NP	Odegrees	C	degree	NNS	I-NP	OC	.	C	JJ	B-ADJP	O.	The	.	.	O	OThe	intracellular	The	DT	B-NP	Ointracellular	water	intracellular	JJ	I-NP	Owater	phase	water	NN	I-NP	Ophase	concentration	phase	NN	I-NP	Oconcentration	of	concentration	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	(	receptor	NNS	I-NP	I-protein(	around	(	(	O	Oaround	40	around	IN	B-NP	O40	nmol/l	40	CD	I-NP	Onmol/l	cell	nmol/l	NN	I-NP	Ocell	water	cell	NN	I-NP	Owater	)	water	NN	I-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	the	and	CC	O	Othe	dependence	the	DT	B-NP	Odependence	of	dependence	NN	I-NP	Oof	receptor	of	IN	B-PP	Oreceptor	affinity	receptor	NN	B-NP	Oaffinity	on	affinity	NN	I-NP	Oon	temperature	on	IN	B-PP	Otemperature	were	temperature	NN	B-NP	Owere	similar	be	VBD	B-VP	Osimilar	in	similar	JJ	B-ADJP	Oin	normal	in	IN	B-PP	Onormal	and	normal	JJ	B-NP	Oand	malignant	and	CC	I-NP	Omalignant	rodent	malignant	JJ	I-NP	Orodent	and	rodent	NN	I-NP	Oand	human	and	CC	O	Ohuman	cells	human	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	It	.	.	O	OIt	is	It	PRP	B-NP	Ois	concluded	be	VBZ	B-VP	Oconcluded	that	conclude	VBN	I-VP	Othat	comparisons	that	IN	B-SBAR	Ocomparisons	of	comparison	NNS	B-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	levels	receptor	NN	I-NP	I-proteinlevels	are	level	NNS	I-NP	Oare	best	be	VBP	B-VP	Obest	made	best	RB	I-VP	Omade	on	make	VBN	I-VP	Oon	the	on	IN	B-PP	Othe	basis	the	DT	B-NP	Obasis	of	basis	NN	I-NP	Oof	intracellular	of	IN	B-PP	Ointracellular	receptor	intracellular	JJ	B-NP	B-proteinreceptor	concentrations	receptor	NN	I-NP	I-proteinconcentrations	.	concentration	NNS	I-NP	O.	Covalent	.	.	O	OCovalent	labeling	Covalent	JJ	B-NP	Olabeling	of	labeling	NN	I-NP	Oof	rat	of	IN	B-PP	Orat	thymocyte	rat	NN	B-NP	B-cell_typethymocyte	and	thymocyte	NN	I-NP	I-cell_typeand	human	and	CC	O	Ohuman	lymphoid	human	JJ	B-NP	Olymphoid	glucocorticoid	lymphoid	JJ	I-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	.	receptor	NN	I-NP	I-protein.	Lymphoid	.	.	O	OLymphoid	cells	Lymphoid	JJ	B-NP	B-cell_typecells	contain	cell	NNS	I-NP	I-cell_typecontain	specific	contain	VBP	B-VP	Ospecific	receptors	specific	JJ	B-NP	Oreceptors	for	receptor	NNS	I-NP	Ofor	glucocorticoids	for	IN	B-PP	Oglucocorticoids	.	glucocorticoid	NNS	B-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	used	have	VBP	B-VP	Oused	[	use	VBN	I-VP	O[	3H	[	(	O	O3H	]	3H	NN	O	O]	dexamethasone-21-mesylate	]	)	O	Odexamethasone-21-mesylate	to	dexamethasone-21-mesylate	NN	B-NP	Oto	label	to	TO	B-VP	Olabel	covalently	label	VB	I-VP	Ocovalently	glucocorticoid	covalently	RB	B-ADVP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	rat	in	IN	B-PP	Orat	thymic	rat	NN	B-NP	B-cell_typethymic	lymphocytes	thymic	JJ	I-NP	I-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	in	and	CC	B-PP	Oin	neoplastic	in	IN	B-PP	Oneoplastic	cells	neoplastic	JJ	B-NP	B-cell_typecells	obtained	cell	NNS	I-NP	I-cell_typeobtained	from	obtain	VBN	B-VP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	acute	with	IN	B-PP	Oacute	lymphoblastic	acute	JJ	B-NP	Olymphoblastic	leukemia	lymphoblastic	JJ	I-NP	Oleukemia	and	leukemia	NN	I-NP	Oand	malignant	and	CC	O	Omalignant	lymphoma	malignant	JJ	B-NP	Olymphoma	.	lymphoma	NN	I-NP	O.	The	.	.	O	OThe	covalently	The	DT	B-NP	Ocovalently	labeled	covalently	RB	I-NP	Olabeled	glucocorticoid	label	VBN	I-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	were	receptor	NNS	I-NP	I-proteinwere	identified	be	VBD	B-VP	Oidentified	by	identify	VBN	I-VP	Oby	polyacrylamide	by	IN	B-PP	Opolyacrylamide	gel	polyacrylamide	NN	B-NP	Ogel	electrophoresis	gel	NN	I-NP	Oelectrophoresis	(	electrophoresis	NN	I-NP	O(	in	(	(	O	Oin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	0.1	of	IN	B-PP	O0.1	%	0.1	CD	B-NP	O%	sodium	%	NN	I-NP	Osodium	dodecyl	sodium	NN	I-NP	Ododecyl	sulfate	dodecyl	NN	I-NP	Osulfate	)	sulfate	NN	I-NP	O)	.	)	)	O	O.	In	.	.	O	OIn	cytosolic	In	IN	B-PP	Ocytosolic	fractions	cytosolic	JJ	B-NP	Ofractions	prepared	fraction	NNS	I-NP	Oprepared	from	prepare	VBN	B-VP	Ofrom	rat	from	IN	B-PP	Orat	thymic	rat	NN	B-NP	B-cell_typethymic	lymphocytes	thymic	JJ	I-NP	I-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	[	","	","	O	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	#NAME?	]	)	I-NP	O#NAME?	labels	#NAME?	NN	I-NP	Olabels	a	label	VBZ	B-VP	Oa	protein	a	DT	B-NP	Oprotein	(	protein	NN	I-NP	O(	Mr	(	(	O	OMr	approximately	Mr	NN	B-NP	B-proteinapproximately	equal	approximately	RB	B-ADJP	Oequal	to	equal	JJ	I-ADJP	Oto	95	to	TO	B-PP	O95	","	95	CD	B-NP	O","	0	","	","	I-NP	O0	)	0	CD	I-NP	O)	which	)	)	O	Owhich	was	which	WDT	B-NP	Owas	identified	be	VBD	B-VP	Oidentified	as	identify	VBN	I-VP	Oas	the	as	IN	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	by	receptor	NN	I-NP	I-proteinby	the	by	IN	B-PP	Othe	following	the	DT	B-NP	Ofollowing	criteria	follow	VBG	I-NP	Ocriteria	:	criterion	NNS	I-NP	O:	(	:	:	O	O(	a	(	(	B-LST	Oa	)	a	LS	I-LST	O)	labeling	)	)	O	Olabeling	of	labeling	NN	B-NP	Oof	this	of	IN	B-PP	Othis	moiety	this	DT	B-NP	Omoiety	is	moiety	NN	I-NP	Ois	inhibited	be	VBZ	B-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	treatment	by	IN	B-PP	Otreatment	with	treatment	NN	B-NP	Owith	a	with	IN	B-PP	Oa	100-fold	a	DT	B-NP	O100-fold	molar	100-fold	JJ	I-NP	Omolar	excess	molar	JJ	I-NP	Oexcess	of	excess	NN	I-NP	Oof	glucocorticoids	of	IN	B-PP	Oglucocorticoids	","	glucocorticoid	NNS	B-NP	O","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	dexamethasone	as	IN	I-PP	Odexamethasone	and	dexamethasone	NN	B-NP	Oand	triamcinolone	and	CC	I-NP	Otriamcinolone	acetonide	triamcinolone	NN	I-NP	Oacetonide	;	acetonide	NN	I-NP	O;	and	;	:	O	Oand	(	and	CC	O	O(	b	(	(	B-LST	Ob	)	b	LS	I-LST	O)	the	)	)	O	Othe	covalently	the	DT	B-NP	Ocovalently	labeled	covalently	RB	I-NP	Olabeled	Mr	label	VBN	I-NP	OMr	approximately	Mr	NN	I-NP	B-proteinapproximately	equal	approximately	RB	B-ADJP	Oequal	to	equal	JJ	I-ADJP	Oto	95	to	TO	B-PP	O95	","	95	CD	B-NP	O","	0	","	","	O	O0	protein	0	CD	B-NP	Oprotein	is	protein	NN	I-NP	Ois	activated	be	VBZ	B-VP	Oactivated	(	activate	VBN	I-VP	O(	by	(	(	O	Oby	heating	by	IN	B-PP	Oheating	at	heat	VBG	B-VP	Oat	20	at	IN	B-PP	O20	degrees	20	CD	B-NP	Odegrees	for	degree	NNS	I-NP	Ofor	30	for	IN	B-PP	O30	min	30	CD	B-NP	Omin	)	min	NN	I-NP	O)	to	)	)	O	Oto	a	to	TO	B-PP	Oa	form	a	DT	B-NP	Oform	that	form	NN	I-NP	Othat	binds	that	WDT	B-NP	Obinds	to	bind	VBZ	B-VP	Oto	DNA-cellulose	to	TO	B-PP	ODNA-cellulose	.	DNA-cellulose	NN	B-NP	O.	When	.	.	O	OWhen	intact	When	WRB	B-ADVP	Ointact	thymocytes	intact	JJ	B-NP	B-cell_typethymocytes	are	thymocyte	NNS	I-NP	I-cell_typeare	treated	be	VBP	B-VP	Otreated	with	treat	VBN	I-VP	Owith	[	with	IN	B-PP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	dexamethasone-21-mesylate	]	)	I-NP	Odexamethasone-21-mesylate	","	dexamethasone-21-mesylate	NN	I-NP	O","	an	","	","	O	Oan	Mr	an	DT	B-NP	OMr	approximately	Mr	NN	I-NP	B-proteinapproximately	equal	approximately	RB	B-ADJP	Oequal	to	equal	JJ	I-ADJP	Oto	95	to	TO	B-PP	O95	","	95	CD	B-NP	O","	0	","	","	O	O0	moiety	0	CD	B-NP	Omoiety	is	moiety	NN	I-NP	Ois	also	be	VBZ	B-VP	Oalso	labeled	also	RB	I-VP	Olabeled	covalently	label	VBN	I-VP	Ocovalently	.	covalently	RB	B-ADVP	O.	Approximately	.	.	O	OApproximately	35	Approximately	RB	B-NP	O35	%	35	CD	I-NP	O%	of	%	NN	I-NP	Oof	the	of	IN	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	can	receptor	NNS	I-NP	I-proteincan	be	can	MD	B-VP	Obe	labeled	be	VB	I-VP	Olabeled	covalently	label	VBN	I-VP	Ocovalently	when	covalently	RB	B-ADVP	Owhen	intact	when	WRB	B-ADVP	Ointact	thymocytes	intact	JJ	B-NP	B-cell_typethymocytes	are	thymocyte	NNS	I-NP	I-cell_typeare	treated	be	VBP	B-VP	Otreated	with	treat	VBN	I-VP	Owith	100	with	IN	B-PP	O100	nM	100	CD	B-NP	OnM	[	nM	NN	I-NP	O[	3H	[	(	I-NP	O3H	]	3H	NN	I-NP	O]	dexamethasone-21-mesylate	]	)	I-NP	Odexamethasone-21-mesylate	for	dexamethasone-21-mesylate	NN	I-NP	Ofor	30	for	IN	B-PP	O30	min	30	CD	B-NP	Omin	at	min	NN	I-NP	Oat	4	at	IN	B-PP	O4	degrees	4	CD	B-NP	Odegrees	.	degree	NNS	I-NP	O.	Neoplastic	.	.	O	ONeoplastic	cells	Neoplastic	JJ	B-NP	B-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	acute	from	IN	B-PP	Oacute	lymphoblastic	acute	JJ	B-NP	Olymphoblastic	leukemia	lymphoblastic	JJ	I-NP	Oleukemia	and	leukemia	NN	I-NP	Oand	malignant	and	CC	O	Omalignant	lymphoma	malignant	JJ	B-NP	Olymphoma	were	lymphoma	NN	I-NP	Owere	treated	be	VBD	B-VP	Otreated	with	treat	VBN	I-VP	Owith	[	with	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	dexamethasone-21-mesylate	]	)	I-NP	Odexamethasone-21-mesylate	.	dexamethasone-21-mesylate	NN	I-NP	O.	In	.	.	O	OIn	all	In	IN	B-PP	Oall	samples	all	DT	B-NP	Osamples	","	sample	NNS	I-NP	O","	an	","	","	O	Oan	Mr	an	DT	B-NP	OMr	approximately	Mr	NN	I-NP	B-proteinapproximately	equal	approximately	RB	B-ADJP	Oequal	to	equal	JJ	I-ADJP	Oto	95	to	TO	B-PP	O95	","	95	CD	B-NP	O","	0	","	","	O	O0	moiety	0	CD	B-NP	Omoiety	was	moiety	NN	I-NP	Owas	labeled	be	VBD	B-VP	Olabeled	covalently	label	VBN	I-VP	Ocovalently	;	covalently	RB	B-ADVP	O;	labeling	;	:	O	Olabeling	was	labeling	NN	B-NP	Owas	inhibited	be	VBD	B-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	excess	by	IN	B-PP	Oexcess	glucocorticoid	excess	JJ	B-NP	Oglucocorticoid	.	glucocorticoid	NN	I-NP	O.	Smaller	.	.	O	OSmaller	moieties	Small	JJR	B-NP	Omoieties	were	moiety	NNS	I-NP	Owere	also	be	VBD	B-VP	Oalso	identified	also	RB	I-VP	Oidentified	by	identify	VBN	I-VP	Oby	competition	by	IN	B-PP	Ocompetition	experiments	competition	NN	B-NP	Oexperiments	;	experiment	NNS	I-NP	O;	these	;	:	O	Othese	may	these	DT	B-NP	Omay	represent	may	MD	B-VP	Orepresent	proteolytic	represent	VB	I-VP	Oproteolytic	fragments	proteolytic	JJ	B-NP	B-proteinfragments	of	fragment	NNS	I-NP	I-proteinof	the	of	IN	B-PP	Othe	Mr	the	DT	B-NP	OMr	approximately	Mr	NN	I-NP	B-proteinapproximately	equal	approximately	RB	B-ADJP	Oequal	to	equal	JJ	I-ADJP	Oto	95	to	TO	B-PP	O95	","	95	CD	B-NP	O","	0	","	","	O	O0	receptor	0	CD	B-NP	Oreceptor	.	receptor	NN	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	in	","	","	O	Oin	rat	in	IN	B-PP	Orat	and	rat	NN	B-NP	Oand	human	and	CC	O	Ohuman	lymphoid	human	JJ	B-NP	B-cell_typelymphoid	cells	lymphoid	JJ	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	[	","	","	O	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	dexamethasone-21-mesylate	]	)	I-NP	Odexamethasone-21-mesylate	can	dexamethasone-21-mesylate	NN	I-NP	Ocan	be	can	MD	B-VP	Obe	used	be	VB	I-VP	Oused	to	use	VBN	I-VP	Oto	label	to	TO	B-VP	Olabel	covalently	label	VB	I-VP	Ocovalently	the	covalently	RB	B-ADVP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	.	receptor	NN	I-NP	I-protein.	The	.	.	O	OThe	association	The	DT	B-NP	Oassociation	of	association	NN	I-NP	Oof	cytosol	of	IN	B-PP	Ocytosol	oestrogen	cytosol	NN	B-NP	Ooestrogen	and	oestrogen	NN	I-NP	Oand	progesterone	and	CC	O	Oprogesterone	receptors	progesterone	NN	B-NP	B-proteinreceptors	with	receptor	NNS	B-NP	I-proteinwith	histological	with	IN	B-PP	Ohistological	features	histological	JJ	B-NP	Ofeatures	of	feature	NNS	I-NP	Oof	breast	of	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	and	cancer	NN	I-NP	Oand	early	and	CC	O	Oearly	recurrence	early	JJ	B-NP	Orecurrence	of	recurrence	NN	I-NP	Oof	disease	of	IN	B-PP	Odisease	.	disease	NN	B-NP	O.	Two	.	.	O	OTwo	hundred	Two	CD	B-NP	Ohundred	and	hundred	CD	I-NP	Oand	eighty-eight	and	CC	I-NP	Oeighty-eight	primary	eighty-eight	CD	I-NP	Oprimary	breast	primary	JJ	I-NP	Obreast	tumours	breast	NN	I-NP	Otumours	were	tumour	NNS	I-NP	Owere	examined	be	VBD	B-VP	Oexamined	for	examine	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	or	presence	NN	I-NP	Oor	absence	or	CC	I-NP	Oabsence	of	absence	NN	I-NP	Oof	oestrogen	of	IN	B-PP	Ooestrogen	(	oestrogen	NN	B-NP	O(	REc	(	(	O	OREc	)	REc	NN	B-NP	B-protein)	and	)	)	O	Oand	progesterone	and	CC	O	Oprogesterone	(	progesterone	NN	B-NP	B-protein(	RPc	(	(	O	I-proteinRPc	)	RPc	NN	B-NP	I-protein)	receptors	)	)	O	I-proteinreceptors	.	receptor	NNS	B-NP	I-protein.	Analysis	.	.	O	OAnalysis	has	Analysis	NN	B-NP	Ohas	shown	have	VBZ	B-VP	Oshown	a	show	VBN	I-VP	Oa	relative	a	DT	B-NP	Orelative	interdependence	relative	JJ	I-NP	Ointerdependence	between	interdependence	NN	I-NP	Obetween	the	between	IN	B-PP	Othe	steroid	the	DT	B-NP	Osteroid	receptor	steroid	NN	I-NP	B-proteinreceptor	status	receptor	NN	I-NP	I-proteinstatus	of	status	NN	I-NP	Oof	primary	of	IN	B-PP	Oprimary	breast	primary	JJ	B-NP	Obreast	cancer	breast	NN	I-NP	Ocancer	and	cancer	NN	I-NP	Oand	other	and	CC	O	Oother	prognostic	other	JJ	B-NP	Oprognostic	variables	prognostic	JJ	I-NP	Ovariables	such	variable	NNS	I-NP	Osuch	as	such	JJ	B-PP	Oas	histological	as	IN	I-PP	Ohistological	grade	histological	JJ	B-NP	Ograde	","	grade	NN	I-NP	O","	lymphocytic	","	","	O	Olymphocytic	infiltration	lymphocytic	JJ	B-NP	Oinfiltration	and	infiltration	NN	I-NP	Oand	tumour	and	CC	I-NP	Otumour	elastosis	tumour	NN	I-NP	Oelastosis	.	elastosis	NN	I-NP	O.	There	.	.	O	OThere	were	There	EX	B-NP	Owere	significant	be	VBD	B-VP	Osignificant	associations	significant	JJ	B-NP	Oassociations	between	association	NNS	I-NP	Obetween	epithelial	between	IN	B-PP	Oepithelial	cellularity	epithelial	JJ	B-NP	Ocellularity	","	cellularity	NN	I-NP	O","	stromal	","	","	O	Ostromal	fibrosis	stromal	JJ	B-NP	Ofibrosis	and	fibrosis	NN	I-NP	Oand	the	and	CC	O	Othe	value	the	DT	B-NP	Ovalue	of	value	NN	I-NP	Oof	REc	of	IN	B-PP	OREc	in	REc	NN	B-NP	B-proteinin	those	in	IN	B-PP	Othose	tumours	those	DT	B-NP	Otumours	in	tumour	NNS	I-NP	Oin	which	in	IN	B-PP	Owhich	the	which	WDT	B-NP	Othe	receptor	the	DT	B-NP	Oreceptor	was	receptor	NN	I-NP	Owas	present	be	VBD	B-VP	Opresent	.	present	JJ	B-ADJP	O.	Cellularity	.	.	O	OCellularity	and	Cellularity	NN	B-NP	Oand	fibrosis	and	CC	I-NP	Ofibrosis	were	fibrosis	NN	I-NP	Owere	unrelated	be	VBD	B-VP	Ounrelated	to	unrelated	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	presence	the	DT	B-NP	Opresence	or	presence	NN	I-NP	Oor	absence	or	CC	I-NP	Oabsence	of	absence	NN	I-NP	Oof	oestrogen	of	IN	B-PP	Ooestrogen	receptor	oestrogen	NN	B-NP	B-proteinreceptor	.	receptor	NN	I-NP	I-protein.	By	.	.	O	OBy	contrast	By	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	neither	","	","	O	Oneither	the	neither	CC	O	Othe	presence	the	DT	B-NP	Opresence	or	presence	NN	I-NP	Oor	absence	or	CC	I-NP	Oabsence	nor	absence	NN	I-NP	Onor	the	nor	CC	O	Othe	value	the	DT	B-NP	Ovalue	of	value	NN	I-NP	Oof	RPc	of	IN	B-PP	ORPc	could	RPc	NN	B-NP	B-proteincould	be	could	MD	B-VP	Obe	related	be	VB	I-VP	Orelated	to	relate	VBN	I-VP	Oto	cellularity	to	TO	B-PP	Ocellularity	or	cellularity	NN	B-NP	Oor	fibrosis	or	CC	I-NP	Ofibrosis	.	fibrosis	NN	I-NP	O.	The	.	.	O	OThe	value	The	DT	B-NP	Ovalue	of	value	NN	I-NP	Oof	REc	of	IN	B-PP	OREc	and	REc	NN	B-NP	B-proteinand	RPc	and	CC	I-NP	ORPc	analysis	RPc	NN	I-NP	Oanalysis	as	analysis	NN	I-NP	Oas	an	as	IN	B-PP	Oan	indicator	an	DT	B-NP	Oindicator	of	indicator	NN	I-NP	Oof	prognosis	of	IN	B-PP	Oprognosis	was	prognosis	NN	B-NP	Owas	examined	be	VBD	B-VP	Oexamined	in	examine	VBN	I-VP	Oin	a	in	IN	B-PP	Oa	sub-group	a	DT	B-NP	Osub-group	of	sub-group	NN	I-NP	Oof	175	of	IN	B-PP	O175	patients	175	CD	B-NP	Opatients	receiving	patient	NNS	I-NP	Oreceiving	no	receive	VBG	B-VP	Ono	additional	no	DT	B-NP	Oadditional	treatment	additional	JJ	I-NP	Otreatment	following	treatment	NN	I-NP	Ofollowing	mastectomy	follow	VBG	I-NP	Omastectomy	.	mastectomy	NN	I-NP	O.	Overall	.	.	O	OOverall	relapse-free	Overall	JJ	B-NP	Orelapse-free	survival	relapse-free	JJ	I-NP	Osurvival	(	survival	NN	I-NP	O(	RFS	(	(	O	ORFS	)	RFS	NN	B-NP	B-protein)	was	)	)	O	Owas	no	be	VBD	B-VP	Ono	different	no	RB	B-ADJP	Odifferent	for	different	JJ	I-ADJP	Ofor	those	for	IN	B-PP	Othose	patients	those	DT	B-NP	Opatients	with	patient	NNS	I-NP	Owith	receptors	with	IN	B-PP	Oreceptors	compared	receptor	NNS	B-NP	Ocompared	to	compare	VBN	B-VP	Oto	those	to	TO	B-PP	Othose	without	those	DT	B-NP	Owithout	them	without	IN	B-PP	Othem	(	them	PRP	B-NP	O(	REc	(	(	O	OREc	P	REc	NN	B-NP	OP	=	P	NN	I-NP	O=	0.11	=	SYM	B-VP	O0.11	","	0.11	CD	B-NP	O","	RPc	","	","	O	ORPc	P	RPc	NN	B-NP	OP	=	P	NN	I-NP	O=	0.7	=	SYM	B-VP	O0.7	)	0.7	CD	B-NP	O)	.	)	)	O	O.	There	.	.	O	OThere	was	There	EX	B-NP	Owas	no	be	VBD	B-VP	Ono	difference	no	DT	B-NP	Odifference	in	difference	NN	I-NP	Oin	RFS	in	IN	B-PP	ORFS	of	RFS	NN	B-NP	B-proteinof	receptor	of	IN	B-PP	Oreceptor	positive	receptor	NN	B-NP	Opositive	and	positive	JJ	I-NP	Oand	negative	and	CC	I-NP	Onegative	tumours	negative	JJ	I-NP	Otumours	when	tumour	NNS	I-NP	Owhen	the	when	WRB	B-ADVP	Othe	axillary	the	DT	B-NP	Oaxillary	node	axillary	JJ	I-NP	Onode	status	node	NN	I-NP	Ostatus	was	status	NN	I-NP	Owas	taken	be	VBD	B-VP	Otaken	into	take	VBN	I-VP	Ointo	account	into	IN	B-PP	Oaccount	.	account	NN	B-NP	O.	Clinical	.	.	O	OClinical	implications	Clinical	JJ	B-NP	Oimplications	of	implication	NNS	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	leukemia	human	JJ	B-NP	Oleukemia	.	leukemia	NN	I-NP	O.	Normal	.	.	O	ONormal	lymphoid	Normal	JJ	B-NP	B-cell_typelymphoid	cells	lymphoid	JJ	I-NP	I-cell_typecells	contain	cell	NNS	I-NP	I-cell_typecontain	glucocorticoid	contain	VBP	B-VP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	.	receptor	NN	I-NP	I-protein.	A	.	.	O	OA	variety	A	DT	B-NP	Ovariety	of	variety	NN	I-NP	Oof	stimuli	of	IN	B-PP	Ostimuli	that	stimulus	NNS	B-NP	Othat	activate	that	WDT	B-NP	Oactivate	these	activate	VBP	B-VP	Othese	cells	these	DT	B-NP	Ocells	also	cell	NNS	I-NP	Oalso	induce	also	RB	B-ADVP	Oinduce	increases	induce	VBP	B-VP	Oincreases	in	increase	NNS	B-NP	Oin	receptor	in	IN	B-PP	Oreceptor	concentration	receptor	NN	B-NP	Oconcentration	.	concentration	NN	I-NP	O.	Similar	.	.	O	OSimilar	glucocorticoid	Similar	JJ	B-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	can	receptor	NNS	I-NP	I-proteincan	be	can	MD	B-VP	Obe	detected	be	VB	I-VP	Odetected	in	detect	VBN	I-VP	Oin	lymphoid	in	IN	B-PP	Olymphoid	cells	lymphoid	JJ	B-NP	B-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	acute	with	IN	B-PP	Oacute	lymphoblastic	acute	JJ	B-NP	Olymphoblastic	leukemia	lymphoblastic	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	ALL	(	(	O	OALL	)	ALL	NN	B-NP	O)	.	)	)	O	O.	Absence	.	.	O	OAbsence	of	Absence	NN	B-NP	Oof	the	of	IN	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	usually	(	(	O	Ousually	found	usually	RB	B-VP	Ofound	in	find	VBN	I-VP	Oin	treated	in	IN	B-PP	Otreated	patients	treat	VBN	B-NP	Opatients	)	patient	NNS	I-NP	O)	predicts	)	)	O	Opredicts	lack	predict	VBZ	B-VP	Olack	of	lack	NN	B-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	responsiveness	glucocorticoid	NN	B-NP	Oresponsiveness	.	responsiveness	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	in	","	","	O	Oin	our	in	IN	B-PP	Oour	hands	our	PRP$	B-NP	Ohands	","	hand	NNS	I-NP	O","	glucocorticoid	","	","	O	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	levels	receptor	NN	I-NP	I-proteinlevels	correlate	level	NNS	I-NP	Ocorrelate	with	correlate	VBP	B-VP	Owith	the	with	IN	B-PP	Othe	duration	the	DT	B-NP	Oduration	of	duration	NN	I-NP	Oof	complete	of	IN	B-PP	Ocomplete	remission	complete	JJ	B-NP	Oremission	in	remission	NN	I-NP	Oin	ALL	in	IN	B-PP	OALL	(	ALL	NN	B-NP	O(	though	(	(	O	Othough	not	though	IN	B-SBAR	Onot	in	not	RB	O	Oin	other	in	IN	B-PP	Oother	forms	other	JJ	B-NP	Oforms	of	form	NNS	I-NP	Oof	leukemia	of	IN	B-PP	Oleukemia	)	leukemia	NN	B-NP	O)	.	)	)	O	O.	This	.	.	O	OThis	association	This	DT	B-NP	Oassociation	is	association	NN	I-NP	Ois	independent	be	VBZ	B-VP	Oindependent	of	independent	JJ	B-ADJP	Oof	cell	of	IN	B-PP	Ocell	type	cell	NN	B-NP	Otype	","	type	NN	I-NP	O","	age	","	","	O	Oage	","	age	NN	B-NP	O","	sex	","	","	O	Osex	","	sex	NN	B-NP	O","	or	","	","	O	Oor	initial	or	CC	O	Oinitial	leukocyte	initial	JJ	B-NP	Oleukocyte	count	leukocyte	NN	I-NP	Ocount	.	count	NN	I-NP	O.	The	.	.	O	OThe	level	The	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	receptor	of	IN	B-PP	Oreceptor	shows	receptor	NN	B-NP	B-proteinshows	a	show	VBZ	B-VP	Oa	negative	a	DT	B-NP	Onegative	correlation	negative	JJ	I-NP	Ocorrelation	with	correlation	NN	I-NP	Owith	increasing	with	IN	B-PP	Oincreasing	aggressiveness	increase	VBG	B-NP	Oaggressiveness	of	aggressiveness	NN	I-NP	Oof	the	of	IN	B-PP	Othe	tumor	the	DT	B-NP	Otumor	(	tumor	NN	I-NP	O(	null-cell	(	(	O	Onull-cell	leukemia	null-cell	JJ	B-NP	Oleukemia	greater	leukemia	NN	I-NP	Ogreater	than	great	JJR	B-ADJP	Othan	T-cell	than	IN	B-PP	OT-cell	leukemia	T-cell	NN	B-NP	Oleukemia	greater	leukemia	NN	I-NP	Ogreater	than	great	JJR	B-ADJP	Othan	Burkitt	than	IN	B-PP	OBurkitt	's	Burkitt	NN	B-NP	O's	lymphoma	's	POS	B-NP	Olymphoma	)	lymphoma	NN	I-NP	O)	.	)	)	O	O.	Corticosteroid-mediated	.	.	O	OCorticosteroid-mediated	immunoregulation	Corticosteroid-mediated	JJ	B-NP	Oimmunoregulation	in	immunoregulation	NN	I-NP	Oin	man	in	IN	B-PP	Oman	.	man	NN	B-NP	O.	Glucocorticoids	.	.	O	OGlucocorticoids	have	Glucocorticoid	NNS	B-NP	Ohave	profound	have	VBP	B-VP	Oprofound	and	profound	JJ	B-NP	Oand	complex	and	CC	I-NP	Ocomplex	effects	complex	JJ	I-NP	Oeffects	on	effect	NNS	I-NP	Oon	the	on	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	immune	human	JJ	I-NP	Oimmune	response	immune	JJ	I-NP	Oresponse	.	response	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	the	","	","	O	Othe	precise	the	DT	B-NP	Oprecise	mechanisms	precise	JJ	I-NP	Omechanisms	of	mechanism	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	corticosteroid-induced	the	DT	B-NP	Ocorticosteroid-induced	immunoregulation	corticosteroid-induced	JJ	I-NP	Oimmunoregulation	in	immunoregulation	NN	I-NP	Oin	man	in	IN	B-PP	Oman	have	man	NN	B-NP	Ohave	not	have	VBP	B-VP	Onot	been	not	RB	I-VP	Obeen	precisely	be	VBN	I-VP	Oprecisely	defined	precisely	RB	B-ADJP	Odefined	.	define	VBN	I-ADJP	O.	Intracytoplasmic	.	.	O	OIntracytoplasmic	corticosteroid-specific	Intracytoplasmic	JJ	B-NP	B-proteincorticosteroid-specific	receptors	corticosteroid-specific	JJ	I-NP	I-proteinreceptors	appear	receptor	NNS	I-NP	I-proteinappear	to	appear	VBP	B-VP	Oto	be	to	TO	I-VP	Obe	an	be	VB	I-VP	Oan	important	an	DT	B-NP	Oimportant	common	important	JJ	I-NP	Ocommon	pathway	common	JJ	I-NP	Opathway	for	pathway	NN	I-NP	Ofor	steroid-induced	for	IN	B-PP	Osteroid-induced	changes	steroid-induced	JJ	B-NP	Ochanges	","	change	NNS	I-NP	O","	but	","	","	O	Obut	variations	but	CC	O	Ovariations	of	variation	NNS	B-NP	Oof	receptor	of	IN	B-PP	Oreceptor	parameters	receptor	NN	B-NP	Oparameters	do	parameter	NNS	I-NP	Odo	not	do	VBP	B-VP	Onot	account	not	RB	I-VP	Oaccount	for	account	VB	I-VP	Ofor	the	for	IN	B-PP	Othe	multifaceted	the	DT	B-NP	Omultifaceted	effects	multifaceted	JJ	I-NP	Oeffects	on	effect	NNS	I-NP	Oon	the	on	IN	B-PP	Othe	immune	the	DT	B-NP	Oimmune	system	immune	JJ	I-NP	Osystem	.	system	NN	I-NP	O.	Human	.	.	O	OHuman	circulating	Human	JJ	B-ADJP	B-cell_typecirculating	mononuclear	circulate	VBG	B-VP	I-cell_typemononuclear	cells	mononuclear	JJ	B-NP	I-cell_typecells	redistribute	cell	NNS	I-NP	I-cell_typeredistribute	out	redistribute	VBP	B-VP	Oout	of	out	IN	B-PP	Oof	the	of	IN	B-PP	Othe	intravascular	the	DT	B-NP	Ointravascular	compartment	intravascular	JJ	I-NP	Ocompartment	following	compartment	NN	I-NP	Ofollowing	treatment	follow	VBG	B-PP	Otreatment	with	treatment	NN	B-NP	Owith	corticosteroids	with	IN	B-PP	Ocorticosteroids	.	corticosteroid	NNS	B-NP	O.	Although	.	.	O	OAlthough	certain	Although	IN	B-SBAR	Ocertain	components	certain	JJ	B-NP	Ocomponents	at	component	NNS	I-NP	Oat	this	at	IN	B-PP	Othis	redistribution	this	DT	B-NP	Oredistribution	phenomenon	redistribution	NN	I-NP	Ophenomenon	have	phenomenon	NN	I-NP	Ohave	been	have	VBP	B-VP	Obeen	well-characterized	be	VBN	I-VP	Owell-characterized	","	well-characterized	JJ	B-ADJP	O","	the	","	","	O	Othe	importance	the	DT	B-NP	Oimportance	of	importance	NN	I-NP	Oof	this	of	IN	B-PP	Othis	compartmental	this	DT	B-NP	Ocompartmental	cellular	compartmental	JJ	I-NP	Ocellular	shift	cellular	JJ	I-NP	Oshift	with	shift	NN	I-NP	Owith	respect	with	IN	B-PP	Orespect	to	respect	NN	B-NP	Oto	the	to	TO	B-PP	Othe	mechanisms	the	DT	B-NP	Omechanisms	of	mechanism	NNS	I-NP	Oof	corticosteroid-induced	of	IN	B-PP	Ocorticosteroid-induced	immunoregulation	corticosteroid-induced	JJ	B-NP	Oimmunoregulation	are	immunoregulation	NN	I-NP	Oare	less	be	VBP	B-VP	Oless	well-defined	less	RBR	B-ADJP	Owell-defined	.	well-defined	JJ	I-ADJP	O.	Recent	.	.	O	ORecent	observations	Recent	JJ	B-NP	Oobservations	that	observation	NNS	I-NP	Othat	activated	that	IN	B-NP	Oactivated	lymphocytes	activate	VBN	B-NP	B-cell_typelymphocytes	may	lymphocyte	NNS	I-NP	I-cell_typemay	be	may	MD	B-VP	Obe	sensitive	be	VB	I-VP	Osensitive	to	sensitive	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	lytic	the	DT	B-NP	Olytic	effects	lytic	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	glucocorticoids	of	IN	B-PP	Oglucocorticoids	suggest	glucocorticoid	NNS	B-NP	Osuggest	that	suggest	VBP	B-VP	Othat	under	that	IN	B-SBAR	Ounder	certain	under	IN	B-PP	Ocertain	situations	certain	JJ	B-NP	Osituations	the	situation	NNS	I-NP	Othe	elimination	the	DT	B-NP	Oelimination	of	elimination	NN	I-NP	Oof	selected	of	IN	B-PP	Oselected	subsets	select	VBN	B-NP	Osubsets	of	subset	NNS	I-NP	Oof	cells	of	IN	B-PP	Ocells	may	cell	NNS	B-NP	Omay	be	may	MD	B-VP	Obe	a	be	VB	I-VP	Oa	relevant	a	DT	B-NP	Orelevant	mechanism	relevant	JJ	I-NP	Omechanism	of	mechanism	NN	I-NP	Oof	corticosteroid-mediated	of	IN	B-PP	Ocorticosteroid-mediated	immunoregulation	corticosteroid-mediated	JJ	B-NP	Oimmunoregulation	in	immunoregulation	NN	I-NP	Oin	man	in	IN	B-PP	Oman	.	man	NN	B-NP	O.	Corticosteroid-mediated	.	.	O	OCorticosteroid-mediated	effects	Corticosteroid-mediated	JJ	B-NP	Oeffects	on	effect	NNS	I-NP	Oon	monocyte	on	IN	B-PP	Omonocyte	function	monocyte	NN	B-NP	Ofunction	may	function	NN	I-NP	Omay	be	may	MD	B-VP	Obe	an	be	VB	I-VP	Oan	important	an	DT	B-NP	Oimportant	mechanism	important	JJ	I-NP	Omechanism	of	mechanism	NN	I-NP	Oof	drug-induced	of	IN	B-PP	Odrug-induced	immunoregulation	drug-induced	JJ	B-NP	Oimmunoregulation	in	immunoregulation	NN	I-NP	Oin	monocyte-dependent	in	IN	B-PP	Omonocyte-dependent	responses	monocyte-dependent	JJ	B-NP	Oresponses	.	response	NNS	I-NP	O.	In	.	.	O	OIn	some	In	IN	B-PP	Osome	experimental	some	DT	B-NP	Oexperimental	conditions	experimental	JJ	I-NP	Oconditions	","	condition	NNS	I-NP	O","	corticosteroids	","	","	O	Ocorticosteroids	inhibit	corticosteroid	NNS	B-NP	Oinhibit	Interleukin	inhibit	VBP	B-VP	OInterleukin	1	Interleukin	NN	B-NP	B-protein1	production	1	CD	I-NP	I-proteinproduction	by	production	NN	I-NP	Oby	monocytes	by	IN	B-PP	Omonocytes	.	monocyte	NNS	B-NP	B-cell_type.	The	.	.	O	OThe	immunoregulatory	The	DT	B-NP	Oimmunoregulatory	effects	immunoregulatory	JJ	I-NP	B-proteineffects	of	effect	NNS	I-NP	Oof	corticosteroids	of	IN	B-PP	Ocorticosteroids	on	corticosteroid	NNS	B-NP	Oon	lymphocyte	on	IN	B-PP	Olymphocyte	immune	lymphocyte	NN	B-NP	Oimmune	responses	immune	JJ	I-NP	Oresponses	are	response	NNS	I-NP	Oare	complex	be	VBP	B-VP	Ocomplex	.	complex	JJ	B-ADJP	O.	In	.	.	O	OIn	vitro	In	FW	B-NP	Ovitro	corticosteroids	vitro	FW	I-NP	Ocorticosteroids	appear	corticosteroid	NNS	I-NP	Oappear	to	appear	VBP	B-VP	Oto	selectively	to	TO	I-VP	Oselectively	affect	selectively	RB	I-VP	Oaffect	early	affect	VB	I-VP	Oearly	immunoregulatory	early	JJ	B-NP	Oimmunoregulatory	events	immunoregulatory	JJ	I-NP	Oevents	as	event	NNS	I-NP	Oas	opposed	as	IN	B-SBAR	Oopposed	to	oppose	VBN	B-VP	Oto	altering	to	TO	B-PP	Oaltering	an	alter	VBG	B-VP	Oan	established	an	DT	B-NP	Oestablished	response	established	JJ	I-NP	Oresponse	.	response	NN	I-NP	O.	Multiple	.	.	O	OMultiple	sites	Multiple	JJ	B-NP	Osites	of	site	NNS	I-NP	Oof	steroid-induced	of	IN	B-PP	Osteroid-induced	modulations	steroid-induced	JJ	B-NP	Omodulations	of	modulation	NNS	I-NP	Oof	human	of	IN	B-PP	Ohuman	B	human	JJ	B-NP	OB	cell	B	NN	I-NP	Ocell	responses	cell	NN	I-NP	Oresponses	have	response	NNS	I-NP	Ohave	been	have	VBP	B-VP	Obeen	defined	be	VBN	I-VP	Odefined	.	define	VBN	I-VP	O.	Human	.	.	O	OHuman	lymphoid	Human	JJ	B-NP	B-cell_linelymphoid	cell	lymphoid	JJ	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	and	line	NNS	I-NP	I-cell_lineand	glucocorticoids	and	CC	I-NP	Oglucocorticoids	:	glucocorticoid	NNS	I-NP	O:	II	:	:	O	OII	.	II	CD	B-NP	O.	Whole	.	.	O	OWhole	cell	Whole	JJ	B-NP	Ocell	and	cell	NN	I-NP	Oand	cytoplasmic	and	CC	O	Ocytoplasmic	binding	cytoplasmic	JJ	B-NP	Obinding	properties	binding	NN	I-NP	Oproperties	of	property	NNS	I-NP	Oof	lymphoblastoid	of	IN	B-PP	Olymphoblastoid	","	lymphoblastoid	JJ	B-NP	O","	leukaemia	","	","	I-NP	Oleukaemia	and	leukaemia	NN	I-NP	Oand	lymphoma	and	CC	I-NP	Olymphoma	lines	lymphoma	NN	I-NP	Olines	.	line	NNS	I-NP	O.	The	.	.	O	OThe	glucocorticoid	The	DT	B-NP	Oglucocorticoid	binding	glucocorticoid	NN	I-NP	Obinding	properties	binding	NN	I-NP	Oproperties	of	property	NNS	I-NP	Oof	18	of	IN	B-PP	O18	human	18	CD	B-NP	Ohuman	lymphoid	human	JJ	I-NP	B-cell_linelymphoid	cell	lymphoid	JJ	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	(	line	NNS	I-NP	I-cell_line(	HLCL	(	(	O	OHLCL	)	HLCL	NN	B-NP	B-cell_line)	have	)	)	O	Ohave	been	have	VBP	B-VP	Obeen	investigated	be	VBN	I-VP	Oinvestigated	.	investigate	VBN	I-VP	O.	The	.	.	O	OThe	specificity	The	DT	B-NP	Ospecificity	of	specificity	NN	I-NP	Oof	steroid	of	IN	B-PP	Osteroid	binding	steroid	NN	B-NP	Obinding	was	binding	NN	I-NP	Owas	confirmed	be	VBD	B-VP	Oconfirmed	with	confirm	VBN	I-VP	Owith	various	with	IN	B-PP	Ovarious	glucocorticoid	various	JJ	B-NP	Oglucocorticoid	agonists	glucocorticoid	NN	I-NP	Oagonists	and	agonist	NNS	I-NP	Oand	antagonists	and	CC	I-NP	Oantagonists	.	antagonist	NNS	I-NP	O.	A	.	.	O	OA	gradation	A	DT	B-NP	Ogradation	in	gradation	NN	I-NP	Oin	whole	in	IN	B-PP	Owhole	cell	whole	JJ	B-NP	B-cell_typecell	and	cell	NN	I-NP	I-cell_typeand	cytoplasmic	and	CC	I-NP	Ocytoplasmic	glucocorticoid	cytoplasmic	JJ	I-NP	Oglucocorticoid	binding	glucocorticoid	NN	I-NP	Obinding	capacity	binding	NN	I-NP	Ocapacity	was	capacity	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	different	the	DT	B-NP	Odifferent	cell	different	JJ	I-NP	Ocell	line	cell	NN	I-NP	Oline	types	line	NN	I-NP	Otypes	:	type	NNS	I-NP	O:	lymphoblastoid	:	:	O	Olymphoblastoid	greater	lymphoblastoid	JJ	B-ADJP	Ogreater	than	great	JJR	B-ADJP	Othan	lymphoma	than	IN	B-PP	Olymphoma	greater	lymphoma	NN	B-NP	Ogreater	than	great	JJR	B-ADJP	Othan	leukaemia	than	IN	B-PP	Oleukaemia	.	leukaemia	NN	B-NP	O.	The	.	.	O	OThe	cytoplasmic	The	DT	B-NP	Ocytoplasmic	receptors	cytoplasmic	JJ	I-NP	B-proteinreceptors	of	receptor	NNS	I-NP	I-proteinof	leukaemia	of	IN	B-PP	Oleukaemia	and	leukaemia	NN	B-NP	Oand	lymphoblastoid	and	CC	O	Olymphoblastoid	lines	lymphoblastoid	JJ	B-NP	B-cell_linelines	appeared	line	NNS	I-NP	I-cell_lineappeared	to	appear	VBD	B-VP	Oto	contain	to	TO	I-VP	Ocontain	both	contain	VB	I-VP	Oboth	proteinaceous	both	CC	O	Oproteinaceous	and	proteinaceous	JJ	B-NP	Oand	phospholipid	and	CC	I-NP	Ophospholipid	components	phospholipid	NN	I-NP	B-proteincomponents	.	component	NNS	I-NP	I-protein.	Cytoplasmic	.	.	O	OCytoplasmic	steroid-receptor	Cytoplasmic	JJ	B-NP	B-proteinsteroid-receptor	complexes	steroid-receptor	NN	I-NP	I-proteincomplexes	exhibited	complex	NNS	I-NP	I-proteinexhibited	a	exhibit	VBD	B-VP	Oa	wide	a	DT	B-NP	Owide	range	wide	JJ	I-NP	Orange	of	range	NN	I-NP	Oof	sedimentation	of	IN	B-PP	Osedimentation	coefficients	sedimentation	NN	B-NP	Ocoefficients	(	coefficient	NNS	I-NP	O(	8.5-11.3S	(	(	O	O8.5-11.3S	)	8.5-11.3S	NN	B-NP	O)	in	)	)	O	Oin	low	in	IN	B-PP	Olow	ionic	low	JJ	B-NP	Oionic	strength	ionic	JJ	I-NP	Ostrength	buffer	strength	NN	I-NP	Obuffer	but	buffer	NN	I-NP	Obut	there	but	CC	O	Othere	was	there	EX	B-NP	Owas	no	be	VBD	B-VP	Ono	correlation	no	DT	B-NP	Ocorrelation	with	correlation	NN	I-NP	Owith	cell	with	IN	B-PP	Ocell	line	cell	NN	B-NP	Oline	type	line	NN	I-NP	Otype	or	type	NN	I-NP	Oor	glucocorticoid	or	CC	I-NP	Oglucocorticoid	sensitivity	glucocorticoid	NN	I-NP	Osensitivity	.	sensitivity	NN	I-NP	O.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	these	of	IN	B-PP	Othese	complexes	these	DT	B-NP	Ocomplexes	by	complex	NNS	I-NP	Oby	heat	by	IN	B-PP	Oheat	(	heat	NN	B-NP	O(	37	(	(	O	O37	degrees	37	CD	B-NP	Odegrees	C	degree	NNS	I-NP	OC	)	C	NN	I-NP	O)	or	)	)	O	Oor	exposure	or	CC	O	Oexposure	to	exposure	NN	B-NP	Oto	high	to	TO	B-PP	Ohigh	ionic	high	JJ	B-NP	Oionic	strength	ionic	JJ	I-NP	Ostrength	buffer	strength	NN	I-NP	Obuffer	(	buffer	NN	I-NP	O(	0.3	(	(	O	O0.3	M	0.3	CD	B-NP	OM	NaCl	M	NN	I-NP	ONaCl	)	NaCl	NN	I-NP	O)	induced	)	)	O	Oinduced	nuclear	induce	VBD	B-VP	Onuclear	binding	nuclear	JJ	B-NP	Obinding	of	binding	NN	I-NP	Oof	steroid	of	IN	B-PP	Osteroid	but	steroid	NN	B-NP	Obut	only	but	CC	O	Oonly	complexes	only	JJ	B-NP	Ocomplexes	in	complex	NNS	I-NP	Oin	high	in	IN	B-PP	Ohigh	ionic	high	JJ	B-NP	Oionic	strength	ionic	JJ	I-NP	Ostrength	buffer	strength	NN	I-NP	Obuffer	manifested	buffer	NN	I-NP	Omanifested	changes	manifest	VBD	B-VP	Ochanges	in	change	NNS	B-NP	Oin	sedimentation	in	IN	B-PP	Osedimentation	coefficient	sedimentation	NN	B-NP	Ocoefficient	.	coefficient	NN	I-NP	O.	No	.	.	O	ONo	correlation	No	DT	B-NP	Ocorrelation	was	correlation	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	between	observe	VBN	I-VP	Obetween	the	between	IN	B-PP	Othe	level	the	DT	B-NP	Olevel	or	level	NN	I-NP	Oor	nature	or	CC	I-NP	Onature	of	nature	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	binding	glucocorticoid	NN	B-NP	Obinding	and	binding	NN	I-NP	Oand	the	and	CC	O	Othe	cytolethal	the	DT	B-NP	Ocytolethal	or	cytolethal	JJ	I-NP	Oor	cytostatic	or	CC	I-NP	Ocytostatic	responsiveness	cytostatic	JJ	I-NP	Oresponsiveness	of	responsiveness	NN	I-NP	Oof	HLCL	of	IN	B-PP	OHLCL	to	HLCL	NN	B-NP	B-cell_lineto	glucocorticoid	to	TO	B-PP	Oglucocorticoid	treatment	glucocorticoid	NN	B-NP	Otreatment	in	treatment	NN	I-NP	Oin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	The	.	.	O	OThe	resistance	The	DT	B-NP	Oresistance	to	resistance	NN	I-NP	Oto	cytolethal	to	TO	B-PP	Ocytolethal	effects	cytolethal	JJ	B-NP	Oeffects	can	effect	NNS	I-NP	Ocan	not	can	MD	B-VP	Onot	be	not	RB	I-VP	Obe	ascribed	be	VB	I-VP	Oascribed	to	ascribe	VBN	I-VP	Oto	a	to	TO	B-PP	Oa	failure	a	DT	B-NP	Ofailure	of	failure	NN	I-NP	Oof	cells	of	IN	B-PP	Ocells	to	cell	NNS	B-NP	Oto	take	to	TO	B-VP	Otake	up	take	VB	I-VP	Oup	and	up	RP	B-PRT	Oand	bind	and	CC	O	Obind	steroid	bind	VBP	B-VP	Osteroid	or	steroid	NN	B-NP	Oor	to	or	CC	B-PP	Oto	significant	to	TO	B-PP	Osignificant	differences	significant	JJ	B-NP	Odifferences	in	difference	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	molecular	the	DT	B-NP	Omolecular	species	molecular	JJ	I-NP	Ospecies	of	specie	NNS	I-NP	Oof	cytoplasmic	of	IN	B-PP	Ocytoplasmic	receptors	cytoplasmic	JJ	B-NP	B-proteinreceptors	present	receptor	NNS	I-NP	I-proteinpresent	.	present	JJ	B-ADJP	O.	The	.	.	O	OThe	molecular	The	DT	B-NP	Omolecular	mechanisms	molecular	JJ	I-NP	Omechanisms	by	mechanism	NNS	I-NP	Oby	which	by	IN	B-PP	Owhich	glucocorticoids	which	WDT	B-NP	Oglucocorticoids	achieve	glucocorticoid	NNS	B-NP	Oachieve	cytolethal	achieve	VBP	B-VP	Ocytolethal	responses	cytolethal	JJ	B-NP	Oresponses	in	response	NNS	I-NP	Oin	human	in	IN	B-PP	Ohuman	lymphoid	human	JJ	B-NP	B-cell_typelymphoid	cells	lymphoid	JJ	I-NP	I-cell_typecells	CD28	cell	NNS	I-NP	I-cell_typeCD28	#NAME?	CD28	NN	B-NP	B-protein#NAME?	activation	#NAME?	JJ	I-NP	Oactivation	in	activation	NN	I-NP	Oin	CD45RA+	in	IN	B-PP	OCD45RA+	and	CD45RA+	JJ	B-NP	Oand	CD45RO+	and	CC	I-NP	OCD45RO+	T	CD45RO+	JJ	I-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	:	cell	NNS	I-NP	I-cell_type:	enhanced	:	:	O	Oenhanced	levels	enhance	VBN	B-VP	Olevels	of	level	NNS	B-NP	Oof	reactive	of	IN	B-PP	Oreactive	oxygen	reactive	JJ	B-NP	Ooxygen	intermediates	oxygen	NN	I-NP	Ointermediates	and	intermediate	NNS	I-NP	Oand	c-Rel	and	CC	O	Oc-Rel	nuclear	c-Rel	NN	B-NP	B-proteinnuclear	translocation	nuclear	JJ	I-NP	Otranslocation	in	translocation	NN	I-NP	Oin	CD45RA+	in	IN	B-PP	OCD45RA+	cells	CD45RA+	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	analyzed	have	VBP	B-VP	Oanalyzed	the	analyze	VBN	I-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	complete	of	IN	B-PP	Ocomplete	T	complete	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	activation	cell	NN	I-NP	Oactivation	(	activation	NN	I-NP	O(	anti-CD3	(	(	O	Oanti-CD3	plus	anti-CD3	NN	B-NP	B-proteinplus	anti-CD28	plus	CC	O	Oanti-CD28	)	anti-CD28	NN	B-NP	B-protein)	on	)	)	O	Oon	the	on	IN	B-PP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	in	NF-kappaB	NN	B-NP	B-proteinin	CD45RA+	in	IN	B-PP	OCD45RA+	(	CD45RA+	JJ	O	O(	naive	(	(	O	Onaive	)	naive	JJ	B-ADJP	O)	and	)	)	O	Oand	CD45RO+	and	CC	O	OCD45RO+	(	CD45RO+	JJ	B-NP	B-cell_type(	memory/effector	(	(	O	I-cell_typememory/effector	)	memory/effector	NN	B-NP	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Long	.	.	O	OLong	exposure	Long	JJ	B-NP	Oexposure	(	exposure	NN	I-NP	O(	24	(	(	O	O24	h	24	CD	B-NP	Oh	)	h	NN	I-NP	O)	induced	)	)	O	Oinduced	stronger	induce	VBD	B-VP	Ostronger	NF-kappaB	strong	JJR	B-NP	ONF-kappaB	DNA	NF-kappaB	NN	I-NP	B-proteinDNA	binding	DNA	NN	I-NP	Obinding	in	binding	NN	I-NP	Oin	CD45RA+	in	IN	B-PP	OCD45RA+	cells	CD45RA+	JJ	B-NP	B-cell_typecells	than	cell	NNS	I-NP	I-cell_typethan	in	than	IN	B-PP	Oin	CD45RO+	in	IN	B-PP	OCD45RO+	cells	CD45RO+	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Analysis	.	.	O	OAnalysis	of	Analysis	NN	B-NP	Oof	the	of	IN	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	c-Rel	nuclear	JJ	I-NP	B-proteinc-Rel	protein	c-Rel	NN	I-NP	I-proteinprotein	indicated	protein	NN	I-NP	I-proteinindicated	that	indicate	VBD	B-VP	Othat	after	that	IN	B-SBAR	Oafter	anti-CD3+anti-CD28	after	IN	B-SBAR	Oanti-CD3+anti-CD28	stimulation	anti-CD3+anti-CD28	JJ	B-NP	Ostimulation	the	stimulation	NN	I-NP	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	c-Rel	of	IN	B-PP	Oc-Rel	was	c-Rel	NN	B-NP	B-proteinwas	higher	be	VBD	B-VP	Ohigher	in	high	JJR	B-ADJP	Oin	CD45RA+	in	IN	B-PP	OCD45RA+	cells	CD45RA+	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Analysis	.	.	O	OAnalysis	of	Analysis	NN	B-NP	Oof	the	of	IN	B-PP	Othe	cytoplasmic	the	DT	B-NP	Ocytoplasmic	inhibitor	cytoplasmic	JJ	I-NP	B-proteininhibitor	IkappaBalpha	inhibitor	NN	I-NP	I-proteinIkappaBalpha	indicated	IkappaBalpha	NN	I-NP	B-proteinindicated	that	indicate	VBD	B-VP	Othat	anti-CD3+anti-CD28	that	IN	B-SBAR	Oanti-CD3+anti-CD28	stimulation	anti-CD3+anti-CD28	JJ	B-NP	Ostimulation	induced	stimulation	NN	I-NP	Oinduced	a	induce	VBD	B-VP	Oa	long-lasting	a	DT	B-NP	Olong-lasting	degradation	long-lasting	JJ	I-NP	Odegradation	in	degradation	NN	I-NP	Oin	CD45RA+	in	IN	B-PP	OCD45RA+	cells	CD45RA+	JJ	B-NP	B-cell_linecells	but	cell	NNS	I-NP	I-cell_linebut	in	but	CC	B-PP	Oin	CD45RO+	in	IN	B-PP	OCD45RO+	cells	CD45RO+	JJ	B-NP	B-cell_typecells	the	cell	NNS	I-NP	I-cell_typethe	degradation	the	DT	B-NP	Odegradation	process	degradation	NN	I-NP	Oprocess	was	process	NN	I-NP	Owas	more	be	VBD	B-VP	Omore	rapid	more	RBR	B-ADJP	Orapid	.	rapid	JJ	I-ADJP	O.	Because	.	.	O	OBecause	the	Because	IN	B-SBAR	Othe	CD28	the	DT	B-NP	OCD28	costimulus	CD28	NN	I-NP	B-proteincostimulus	is	costimulus	NN	I-NP	Ois	known	be	VBZ	B-VP	Oknown	to	know	VBN	I-VP	Oto	induce	to	TO	I-VP	Oinduce	the	induce	VB	I-VP	Othe	production	the	DT	B-NP	Oproduction	of	production	NN	I-NP	Oof	reactive	of	IN	B-PP	Oreactive	oxygen	reactive	JJ	B-NP	Ooxygen	intermediates	oxygen	NN	I-NP	Ointermediates	(	intermediate	NNS	I-NP	O(	ROIs	(	(	O	OROIs	)	ROI	NNS	B-NP	O)	","	)	)	O	O","	the	","	","	O	Othe	intracellular	the	DT	B-NP	Ointracellular	ROI	intracellular	JJ	I-NP	OROI	levels	ROI	NN	I-NP	Olevels	in	level	NNS	I-NP	Oin	CD45RA+	in	IN	B-PP	OCD45RA+	and	CD45RA+	JJ	B-NP	Oand	CD45RO+	and	CC	I-NP	OCD45RO+	cells	CD45RO+	JJ	I-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	compared	be	VBD	B-VP	Ocompared	by	compare	VBN	I-VP	Oby	flow	by	IN	B-PP	Oflow	cytometry	flow	NN	B-NP	Ocytometry	.	cytometry	NN	I-NP	O.	ROIs	.	.	O	OROIs	were	ROI	NNS	B-NP	Owere	produced	be	VBD	B-VP	Oproduced	in	produce	VBN	I-VP	Oin	both	in	IN	B-PP	Oboth	cell	both	DT	B-NP	Ocell	types	cell	NN	I-NP	Otypes	","	type	NNS	I-NP	O","	but	","	","	O	Obut	more	but	CC	O	Omore	strongly	more	RBR	B-ADVP	Ostrongly	in	strongly	RB	I-ADVP	Oin	CD45RA+	in	IN	B-PP	OCD45RA+	cells	CD45RA+	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	data	The	DT	B-NP	Odata	presented	datum	NNS	I-NP	Opresented	in	present	VBN	B-VP	Oin	this	in	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	further	study	NN	I-NP	Ofurther	emphasize	further	RB	B-ADVP	Oemphasize	the	emphasize	VBP	B-VP	Othe	differences	the	DT	B-NP	Odifferences	between	difference	NNS	I-NP	Obetween	CD45RA+	between	IN	B-PP	OCD45RA+	and	CD45RA+	JJ	B-NP	Oand	CD45RO+	and	CC	I-NP	OCD45RO+	T	CD45RO+	JJ	I-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	in	lymphocyte	NNS	I-NP	I-cell_typein	ROI-dependent	in	IN	B-PP	OROI-dependent	signaling	ROI-dependent	JJ	B-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	.	pathway	NNS	I-NP	O.	Ikaros	.	.	O	OIkaros	in	Ikaros	NN	B-NP	B-proteinin	hemopoietic	in	IN	B-PP	Ohemopoietic	lineage	hemopoietic	JJ	B-NP	Olineage	determination	lineage	NN	I-NP	Odetermination	and	determination	NN	I-NP	Oand	homeostasis	and	CC	I-NP	Ohomeostasis	.	homeostasis	NN	I-NP	O.	Studies	.	.	O	OStudies	on	Study	NNS	B-NP	Oon	the	on	IN	B-PP	Othe	molecular	the	DT	B-NP	Omolecular	mechanisms	molecular	JJ	I-NP	Omechanisms	that	mechanism	NNS	I-NP	Othat	control	that	WDT	B-NP	Ocontrol	hemopoietic	control	VBP	B-VP	Ohemopoietic	differentiation	hemopoietic	JJ	B-NP	Odifferentiation	have	differentiation	NN	I-NP	Ohave	focused	have	VBP	B-VP	Ofocused	on	focus	VBN	I-VP	Oon	signaling	on	IN	B-PP	Osignaling	cascades	signaling	NN	B-NP	Ocascades	and	cascade	NNS	I-NP	Oand	nuclear	and	CC	O	Onuclear	effectors	nuclear	JJ	B-NP	Oeffectors	that	effector	NNS	I-NP	Othat	drive	that	WDT	B-NP	Odrive	this	drive	VBP	B-VP	Othis	complex	this	DT	B-NP	Ocomplex	developmental	complex	JJ	I-NP	Odevelopmental	system	developmental	JJ	I-NP	Osystem	in	system	NN	I-NP	Oin	a	in	IN	B-PP	Oa	regulated	a	DT	B-NP	Oregulated	fashion	regulated	JJ	I-NP	Ofashion	.	fashion	NN	I-NP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	review	we	PRP	B-NP	Oreview	the	review	VBP	B-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	Ikaros	of	IN	B-PP	OIkaros	","	Ikaros	NN	B-NP	B-protein","	the	","	","	O	Othe	founding	the	DT	B-NP	Ofounding	member	founding	JJ	I-NP	Omember	of	member	NN	I-NP	Oof	a	of	IN	B-PP	Oa	unique	a	DT	B-NP	Ounique	family	unique	JJ	I-NP	Ofamily	of	family	NN	I-NP	Oof	zinc	of	IN	B-PP	Ozinc	finger	zinc	NN	B-NP	B-proteinfinger	transcription	finger	NN	I-NP	I-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	in	factor	NNS	I-NP	I-proteinin	this	in	IN	B-PP	Othis	developmental	this	DT	B-NP	Odevelopmental	process	developmental	JJ	I-NP	Oprocess	.	process	NN	I-NP	O.	Studies	.	.	O	OStudies	on	Study	NNS	B-NP	Oon	an	on	IN	B-PP	Oan	Ikaros	an	DT	B-NP	OIkaros	null	Ikaros	NN	I-NP	B-proteinnull	mutation	null	JJ	I-NP	Omutation	have	mutation	NN	I-NP	Ohave	revealed	have	VBP	B-VP	Orevealed	an	reveal	VBN	I-VP	Oan	essential	an	DT	B-NP	Oessential	role	essential	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	this	for	IN	B-PP	Othis	factor	this	DT	B-NP	Ofactor	in	factor	NN	I-NP	Oin	lymphoid	in	IN	B-PP	Olymphoid	cell	lymphoid	JJ	B-NP	B-cell_typecell	fate	cell	NN	I-NP	I-cell_typefate	determination	fate	NN	I-NP	Odetermination	and	determination	NN	I-NP	Oand	at	and	CC	B-PP	Oat	subsequent	at	IN	B-PP	Osubsequent	branch	subsequent	JJ	B-NP	Obranch	points	branch	NN	I-NP	Opoints	of	point	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	T	the	DT	B-NP	OT	cell	T	NN	I-NP	Ocell	differentiation	cell	NN	I-NP	Odifferentiation	pathway	differentiation	NN	I-NP	Opathway	.	pathway	NN	I-NP	O.	Differences	.	.	O	ODifferences	in	Difference	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	phenotypes	the	DT	B-NP	Ophenotypes	of	phenotype	NNS	I-NP	Oof	a	of	IN	B-PP	Oa	null	a	DT	B-NP	Onull	and	null	NN	I-NP	Oand	a	and	CC	O	Oa	dominant	a	DT	B-NP	Odominant	negative	dominant	JJ	I-NP	Onegative	(	negative	JJ	I-NP	O(	DN	(	(	O	ODN	)	DN	JJ	B-ADJP	O)	Ikaros	)	)	O	OIkaros	mutation	Ikaros	NN	B-NP	Omutation	provide	mutation	NN	I-NP	Oprovide	insight	provide	VBP	B-VP	Oinsight	into	insight	NN	B-NP	Ointo	a	into	IN	B-PP	Oa	regulatory	a	DT	B-NP	Oregulatory	network	regulatory	JJ	I-NP	Onetwork	through	network	NN	I-NP	Othrough	which	through	IN	B-PP	Owhich	Ikaros	which	WDT	B-NP	OIkaros	proteins	Ikaros	NN	B-NP	B-proteinproteins	exert	protein	NNS	I-NP	I-proteinexert	their	exert	VBP	B-VP	Otheir	effects	their	PRP$	B-NP	Oeffects	in	effect	NNS	I-NP	Oin	development	in	IN	B-PP	Odevelopment	.	development	NN	B-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	a	addition	NN	B-NP	Oa	comparative	a	DT	B-NP	Ocomparative	analysis	comparative	JJ	I-NP	Oanalysis	of	analysis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	hemopoietic	the	DT	B-NP	Ohemopoietic	stem	hemopoietic	JJ	I-NP	B-cell_typestem	cell	stem	NN	I-NP	I-cell_typecell	and	cell	NN	I-NP	I-cell_typeand	precursor	and	CC	I-NP	Oprecursor	compartment	precursor	NN	I-NP	Ocompartment	resulting	compartment	NN	I-NP	Oresulting	from	result	VBG	B-VP	Ofrom	the	from	IN	B-PP	Othe	two	the	DT	B-NP	Otwo	Ikaros	two	CD	I-NP	OIkaros	mutations	Ikaros	NN	I-NP	Omutations	reveals	mutation	NNS	I-NP	Oreveals	a	reveal	VBZ	B-VP	Oa	profound	a	DT	B-NP	Oprofound	yet	profound	JJ	I-NP	Oyet	not	yet	CC	O	Onot	absolute	not	RB	O	Oabsolute	requirement	absolute	JJ	B-NP	Orequirement	for	requirement	NN	I-NP	Ofor	Ikaros	for	IN	B-PP	OIkaros	in	Ikaros	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	production	the	DT	B-NP	Oproduction	and	production	NN	I-NP	Oand	differentiation	and	CC	I-NP	Odifferentiation	of	differentiation	NN	I-NP	Oof	these	of	IN	B-PP	Othese	populations	these	DT	B-NP	Opopulations	.	population	NNS	I-NP	O.	Overexpression	.	.	O	OOverexpression	of	Overexpression	NN	B-NP	Oof	p65	of	IN	B-PP	Op65	and	p65	NN	B-NP	B-proteinand	c-Jun	and	CC	I-NP	Oc-Jun	substitutes	c-Jun	NN	I-NP	B-proteinsubstitutes	for	substitute	NNS	I-NP	Ofor	B7-1	for	IN	B-PP	OB7-1	costimulation	B7-1	NN	B-NP	B-proteincostimulation	by	costimulation	NN	I-NP	Oby	targeting	by	IN	B-PP	Otargeting	the	target	VBG	B-VP	Othe	CD28RE	the	DT	B-NP	OCD28RE	within	CD28RE	NN	I-NP	B-DNAwithin	the	within	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	The	.	.	O	OThe	role	The	DT	B-NP	Orole	of	role	NN	I-NP	Oof	Rel	of	IN	B-PP	ORel	and	Rel	NN	B-NP	B-proteinand	activation	and	CC	O	Oactivation	protein-1	activation	NN	B-NP	Oprotein-1	(	protein-1	NN	I-NP	O(	AP-1	(	(	O	OAP-1	)	AP-1	NN	B-NP	B-protein)	in	)	)	O	Oin	IL-2	in	IN	B-PP	OIL-2	promoter	IL-2	NN	B-NP	B-DNApromoter	activity	promoter	NN	I-NP	I-DNAactivity	in	activity	NN	I-NP	Oin	B7-1-	in	IN	B-PP	OB7-1-	and	B7-1-	NN	B-NP	B-proteinand	leukocyte	and	CC	O	Oleukocyte	function-associated	leukocyte	NN	B-NP	B-proteinfunction-associated	Ag-3	function-associated	JJ	I-NP	I-proteinAg-3	(	Ag-3	NN	I-NP	I-protein(	LFA.	(	(	O	OLFA.	3	LFA.	NN	B-NP	B-protein3	)	3	CD	I-NP	I-protein)	#NAME?	)	)	O	O#NAME?	T	#NAME?	JJ	B-NP	OT	cells	T	NN	I-NP	B-cell_typecells	has	cell	NNS	I-NP	I-cell_typehas	been	have	VBZ	B-VP	Obeen	evaluated	be	VBN	I-VP	Oevaluated	.	evaluate	VBN	I-VP	O.	We	.	.	O	OWe	demonstrate	We	PRP	B-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	overexpression	that	IN	B-SBAR	Ooverexpression	of	overexpression	NN	B-NP	Oof	c-Jun	of	IN	B-PP	Oc-Jun	but	c-Jun	NN	B-NP	B-proteinbut	not	but	CC	B-NP	Onot	c-Fos	not	RB	I-NP	Oc-Fos	increases	c-Fos	NN	B-NP	B-proteinincreases	IL-2	increase	VBZ	B-VP	OIL-2	promoter	IL-2	NN	B-NP	B-DNApromoter	activity	promoter	NN	I-NP	I-DNAactivity	in	activity	NN	I-NP	Oin	both	in	IN	B-PP	Oboth	B7-1-	both	CC	O	OB7-1-	and	B7-1-	NN	B-NP	B-proteinand	LFA-3-costimulated	and	CC	O	OLFA-3-costimulated	Jurkat	LFA-3-costimulated	JJ	B-NP	B-cell_lineJurkat	T	Jurkat	NN	I-NP	I-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Cotransfection	.	.	O	OCotransfection	of	Cotransfection	NN	B-NP	Oof	both	of	IN	B-PP	Oboth	c-Jun	both	CC	O	Oc-Jun	and	c-Jun	NN	B-NP	B-proteinand	c-Fos	and	CC	O	Oc-Fos	substitutes	c-Fos	NN	B-NP	B-proteinsubstitutes	for	substitute	NNS	I-NP	Ofor	B7-1	for	IN	B-PP	OB7-1	costimulation	B7-1	NN	B-NP	B-proteincostimulation	in	costimulation	NN	I-NP	Oin	driving	in	IN	B-PP	Odriving	an	drive	VBG	B-VP	Oan	activation	an	DT	B-NP	Oactivation	protein-1	activation	NN	I-NP	Oprotein-1	response	protein-1	NN	I-NP	Oresponse	element	response	NN	I-NP	Oelement	but	element	NN	I-NP	Obut	not	but	CC	B-PP	Onot	for	not	RB	B-PP	Ofor	the	for	IN	I-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Overexpression	.	.	O	OOverexpression	of	Overexpression	NN	B-NP	Oof	Rel	of	IN	B-PP	ORel	proteins	Rel	NN	B-NP	B-proteinproteins	demonstrated	protein	NNS	I-NP	I-proteindemonstrated	that	demonstrate	VBD	B-VP	Othat	p65-expressing	that	IN	B-SBAR	Op65-expressing	Jurkat	p65-expressing	JJ	B-NP	B-cell_lineJurkat	cells	Jurkat	NN	I-NP	I-cell_linecells	transcribed	cell	NNS	I-NP	I-cell_linetranscribed	equally	transcribe	VBN	B-VP	Oequally	well	equally	RB	B-ADVP	Owell	a	well	RB	I-ADVP	Oa	nuclear	a	DT	B-NP	Onuclear	factor	nuclear	JJ	I-NP	B-DNAfactor	kappabeta	factor	NN	I-NP	I-DNAkappabeta	reporter	kappabeta	NN	I-NP	I-DNAreporter	construct	reporter	NN	I-NP	I-DNAconstruct	when	construct	NN	I-NP	I-DNAwhen	costimulated	when	WRB	B-ADVP	Ocostimulated	with	costimulate	VBN	B-VP	Owith	B7-1	with	IN	B-PP	OB7-1	or	B7-1	NN	B-NP	B-proteinor	LFA-3	or	CC	I-NP	OLFA-3	","	LFA-3	NN	I-NP	B-protein","	but	","	","	O	Obut	transcription	but	CC	O	Otranscription	of	transcription	NN	B-NP	Oof	IL-2	of	IN	B-PP	OIL-2	promoter	IL-2	NN	B-NP	B-DNApromoter	or	promoter	NN	I-NP	I-DNAor	CD28	or	CC	O	OCD28	response	CD28	NN	B-NP	B-DNAresponse	element	response	NN	I-NP	I-DNAelement	(	element	NN	I-NP	I-DNA(	CD28RE	(	(	O	OCD28RE	)	CD28RE	NN	B-NP	B-DNA)	#NAME?	)	)	O	O#NAME?	reporters	#NAME?	JJ	B-NP	Oreporters	was	reporter	NNS	I-NP	Owas	superior	be	VBD	B-VP	Osuperior	in	superior	JJ	B-ADJP	Oin	B7-1-costimulated	in	IN	B-PP	OB7-1-costimulated	cells	B7-1-costimulated	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Combined	.	.	O	OCombined	expression	Combine	VBN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	c-Jun	of	IN	B-PP	Oc-Jun	and	c-Jun	NN	B-NP	B-proteinand	p65	and	CC	I-NP	Op65	induced	p65	NN	I-NP	B-proteininduced	vigorous	induce	VBD	B-VP	Ovigorous	transcription	vigorous	JJ	B-NP	Otranscription	of	transcription	NN	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	promoter-	IL-2	NN	B-NP	B-DNApromoter-	and	promoter-	NN	I-NP	I-DNAand	CD28RE-driven	and	CC	O	OCD28RE-driven	reporter	CD28RE-driven	JJ	B-NP	B-DNAreporter	constructs	reporter	NN	I-NP	I-DNAconstructs	in	construct	NNS	I-NP	I-DNAin	both	in	IN	B-PP	Oboth	LFA-3-	both	CC	O	OLFA-3-	and	LFA-3-	NN	B-NP	B-proteinand	B7-1-costimulated	and	CC	O	OB7-1-costimulated	Jurkat	B7-1-costimulated	JJ	B-NP	B-cell_lineJurkat	cells	Jurkat	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Mutating	.	.	O	OMutating	the	Mutate	VBG	B-VP	Othe	CD28RE	the	DT	B-NP	OCD28RE	but	CD28RE	NN	I-NP	B-DNAbut	not	but	CC	B-NP	Onot	the	not	RB	I-NP	Othe	upstream	the	DT	B-NP	Oupstream	nuclear	upstream	JJ	I-NP	B-DNAnuclear	factor	nuclear	JJ	I-NP	I-DNAfactor	kappabeta-binding	factor	NN	I-NP	I-DNAkappabeta-binding	site	kappabeta-binding	JJ	I-NP	I-DNAsite	in	site	NN	I-NP	I-DNAin	the	in	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	reduced	promoter	NN	I-NP	I-DNAreduced	B7-1	reduce	VBD	B-VP	OB7-1	#NAME?	B7-1	NN	B-NP	B-protein#NAME?	transcription	#NAME?	JJ	I-NP	Otranscription	>	transcription	NN	I-NP	O>	90	>	SYM	B-NP	O90	%	90	CD	B-NP	O%	.	%	NN	I-NP	O.	The	.	.	O	OThe	results	The	DT	B-NP	Oresults	implicates	result	NNS	I-NP	Oimplicates	a	implicate	VBZ	B-VP	Oa	major	a	DT	B-NP	Omajor	role	major	JJ	I-NP	Orole	of	role	NN	I-NP	Oof	the	of	IN	B-PP	Othe	CD28RE	the	DT	B-NP	OCD28RE	in	CD28RE	NN	I-NP	B-DNAin	the	in	IN	B-PP	Othe	integration	the	DT	B-NP	Ointegration	of	integration	NN	I-NP	Oof	p65	of	IN	B-PP	Op65	/	p65	NN	B-NP	B-protein/	c-Jun	/	SYM	B-VP	Oc-Jun	#NAME?	c-Jun	NN	B-NP	B-protein#NAME?	transcription	#NAME?	JJ	I-NP	Otranscription	within	transcription	NN	I-NP	Owithin	the	within	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	We	.	.	O	OWe	suggest	We	PRP	B-NP	Osuggest	that	suggest	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	transition	the	DT	B-NP	Otransition	from	transition	NN	I-NP	Ofrom	an	from	IN	B-PP	Oan	autocrine	an	DT	B-NP	Oautocrine	LFA-3	autocrine	JJ	I-NP	OLFA-3	#NAME?	LFA-3	NN	I-NP	B-protein#NAME?	immune	#NAME?	JJ	I-NP	Oimmune	response	immune	JJ	I-NP	Oresponse	to	response	NN	I-NP	Oto	a	to	TO	B-PP	Oa	B7	a	DT	B-NP	OB7	--	B7	NN	I-NP	B-protein--	induced	--	:	O	Oinduced	paracrine	induce	VBD	B-VP	Oparacrine	immune	paracrine	JJ	B-NP	Oimmune	response	immune	JJ	I-NP	Oresponse	involves	response	NN	I-NP	Oinvolves	the	involve	VBZ	B-VP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	c-Jun	of	IN	B-PP	Oc-Jun	and	c-Jun	NN	B-NP	B-proteinand	p65	and	CC	I-NP	Op65	","	p65	NN	I-NP	B-protein","	which	","	","	O	Owhich	target	which	WDT	B-NP	Otarget	the	target	VBP	B-VP	Othe	CD28RE	the	DT	B-NP	OCD28RE	region	CD28RE	NN	I-NP	B-DNAregion	of	region	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Defects	.	.	O	ODefects	in	Defect	NNS	B-NP	Oin	actin-cap	in	IN	B-PP	Oactin-cap	formation	actin-cap	NN	B-NP	Oformation	in	formation	NN	I-NP	Oin	Vav-deficient	in	IN	B-PP	OVav-deficient	mice	Vav-deficient	JJ	B-NP	Omice	implicate	mouse	NNS	I-NP	Oimplicate	an	implicate	VBP	B-VP	Oan	actin	an	DT	B-NP	Oactin	requirement	actin	NN	I-NP	B-proteinrequirement	for	requirement	NN	I-NP	Ofor	lymphocyte	for	IN	B-PP	Olymphocyte	signal	lymphocyte	NN	B-NP	B-cell_typesignal	transduction	signal	NN	I-NP	Otransduction	.	transduction	NN	I-NP	O.	BACKGROUND	.	.	O	OBACKGROUND	:	BACKGROUND	NN	B-NP	O:	Antigen-receptor	:	:	O	OAntigen-receptor	interactions	Antigen-receptor	JJ	B-NP	Ointeractions	on	interaction	NNS	I-NP	Oon	lymphocytes	on	IN	B-PP	Olymphocytes	result	lymphocyte	NNS	B-NP	B-cell_typeresult	in	result	VBP	B-VP	Oin	local	in	IN	B-PP	Olocal	clustering	local	JJ	B-NP	Oclustering	of	clustering	NN	I-NP	Oof	actin	of	IN	B-PP	Oactin	","	actin	NN	B-NP	B-protein","	receptors	","	","	O	Oreceptors	and	receptor	NNS	B-NP	Oand	signaling	and	CC	O	Osignaling	molecules	signal	VBG	B-VP	B-proteinmolecules	into	molecule	NNS	B-NP	I-proteininto	an	into	IN	B-PP	Oan	asymmetric	an	DT	B-NP	Oasymmetric	membrane	asymmetric	JJ	I-NP	Omembrane	structure	membrane	NN	I-NP	Ostructure	termed	structure	NN	I-NP	Otermed	a	term	VBN	B-VP	Oa	cap	a	DT	B-NP	Ocap	.	cap	NN	I-NP	B-protein.	Although	.	.	O	OAlthough	actin	Although	IN	B-SBAR	Oactin	polymerization	actin	NN	B-NP	B-proteinpolymerization	is	polymerization	NN	I-NP	Ois	known	be	VBZ	B-VP	Oknown	to	know	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	required	be	VB	I-VP	Orequired	","	require	VBN	I-VP	O","	the	","	","	O	Othe	mechanisms	the	DT	B-NP	Omechanisms	underlying	mechanism	NNS	I-NP	Ounderlying	cap	underlie	VBG	B-VP	Ocap	formation	cap	NN	B-NP	Oformation	are	formation	NN	I-NP	Oare	unclear	be	VBP	B-VP	Ounclear	.	unclear	JJ	B-ADJP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	studied	have	VBP	B-VP	Ostudied	the	study	VBN	I-VP	Othe	events	the	DT	B-NP	Oevents	underlying	event	NNS	I-NP	Ounderlying	cap	underlie	VBG	B-VP	Ocap	formation	cap	NN	B-NP	Oformation	using	formation	NN	I-NP	Ousing	mice	use	VBG	B-VP	Omice	bearing	mouse	NNS	B-NP	Obearing	a	bear	VBG	B-VP	Oa	null	a	DT	B-NP	Onull	mutation	null	JJ	I-NP	Omutation	in	mutation	NN	I-NP	Oin	vav	in	IN	B-PP	Ovav	(	vav	NN	B-NP	B-protein(	vav	(	(	O	Ovav	-/-	vav	NN	B-NP	B-protein-/-	)	-/-	SYM	B-ADJP	O)	","	)	)	O	O","	a	","	","	O	Oa	gene	a	DT	B-NP	Ogene	that	gene	NN	I-NP	Othat	encodes	that	WDT	B-NP	Oencodes	a	encode	VBZ	B-VP	Oa	guanine-nucleotide	a	DT	B-NP	Oguanine-nucleotide	exchange	guanine-nucleotide	JJ	I-NP	B-proteinexchange	factor	exchange	NN	I-NP	I-proteinfactor	for	factor	NN	I-NP	I-proteinfor	the	for	IN	B-PP	Othe	GTPase	the	DT	B-NP	OGTPase	Rac	GTPase	NN	I-NP	B-proteinRac	.	Rac	NN	I-NP	I-protein.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	Lymphocytes	:	:	O	OLymphocytes	from	Lymphocyte	NNS	B-NP	B-cell_typefrom	vav	from	IN	B-PP	Ovav	-/-	vav	NN	B-NP	B-protein-/-	mice	-/-	JJ	I-NP	Omice	failed	mouse	NNS	I-NP	Ofailed	to	fail	VBD	B-VP	Oto	form	to	TO	I-VP	Oform	T-cell	form	VB	I-VP	OT-cell	receptor	T-cell	NN	B-NP	B-proteinreceptor	caps	receptor	NN	I-NP	I-proteincaps	following	cap	NNS	I-NP	I-proteinfollowing	activation	follow	VBG	B-PP	Oactivation	and	activation	NN	B-NP	Oand	had	and	CC	O	Ohad	a	have	VBD	B-VP	Oa	defective	a	DT	B-NP	Odefective	actin	defective	JJ	I-NP	Oactin	cytoskeleton	actin	NN	I-NP	Ocytoskeleton	.	cytoskeleton	NN	I-NP	O.	The	.	.	O	OThe	vav-/-	The	DT	B-NP	Ovav-/-	T	vav-/-	JJ	I-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	deficient	be	VBD	B-VP	Odeficient	in	deficient	JJ	B-ADJP	Oin	interleukin-2	in	IN	B-PP	Ointerleukin-2	(	interleukin-2	NN	B-NP	B-protein(	IL-2	(	(	O	OIL-2	)	IL-2	NN	B-NP	B-protein)	production	)	)	O	Oproduction	and	production	NN	B-NP	Oand	proliferation	and	CC	I-NP	Oproliferation	","	proliferation	NN	I-NP	O","	and	","	","	O	Oand	the	and	CC	O	Othe	peak	the	DT	B-NP	Opeak	of	peak	NN	I-NP	Oof	Ca2+	of	IN	B-PP	OCa2+	mobilization	Ca2+	NN	B-NP	Omobilization	was	mobilization	NN	I-NP	Owas	reduced	be	VBD	B-VP	Oreduced	although	reduce	VBN	I-VP	Oalthough	of	although	IN	B-SBAR	Oof	normal	of	IN	B-PP	Onormal	duration	normal	JJ	B-NP	Oduration	.	duration	NN	I-NP	O.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	Jun	of	IN	B-PP	OJun	N-terminal	Jun	NN	B-NP	B-proteinN-terminal	kinase	N-terminal	JJ	I-NP	I-proteinkinase	or	kinase	NN	I-NP	I-proteinor	stress-activated	or	CC	O	Ostress-activated	kinase	stress-activated	JJ	B-NP	B-proteinkinase	(	kinase	NN	I-NP	I-protein(	JNK	(	(	O	OJNK	or	JNK	NN	B-NP	B-proteinor	SAPK	or	CC	O	OSAPK	)	SAPK	NN	B-NP	B-protein)	and	)	)	O	Oand	mitogen-activated	and	CC	O	Omitogen-activated	protein	mitogen-activated	JJ	B-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	MAPK	(	(	O	OMAPK	)	MAPK	NN	B-NP	B-protein)	and	)	)	O	Oand	the	and	CC	O	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	NF-ATc1	factor	NN	I-NP	I-proteinNF-ATc1	and	NF-ATc1	NN	I-NP	B-proteinand	egr-1	and	CC	I-NP	Oegr-1	genes	egr-1	NN	I-NP	Ogenes	was	gene	NNS	I-NP	Owas	normal	be	VBD	B-VP	Onormal	.	normal	JJ	B-ADJP	O.	Despite	.	.	O	ODespite	the	Despite	IN	B-PP	Othe	reduced	the	DT	B-NP	Oreduced	Ca2+	reduce	VBN	I-NP	OCa2+	mobilization	Ca2+	NN	I-NP	Omobilization	","	mobilization	NN	I-NP	O","	translocation	","	","	O	Otranslocation	of	translocation	NN	B-NP	Oof	cytoplasmic	of	IN	B-PP	Ocytoplasmic	NF-ATc	cytoplasmic	JJ	B-NP	B-proteinNF-ATc	to	NF-ATc	NN	I-NP	I-proteinto	the	to	TO	B-PP	Othe	nucleus	the	DT	B-NP	Onucleus	was	nucleus	NN	I-NP	Owas	normal	be	VBD	B-VP	Onormal	","	normal	JJ	B-ADJP	O","	reflecting	","	","	O	Oreflecting	that	reflect	VBG	B-VP	Othat	the	that	IN	B-SBAR	Othe	lower	the	DT	B-NP	Olower	levels	low	JJR	I-NP	Olevels	of	level	NNS	I-NP	Oof	Ca2+	of	IN	B-PP	OCa2+	in	Ca2+	NN	B-NP	Oin	vav-/-	in	IN	B-PP	Ovav-/-	cells	vav-/-	JJ	B-NP	B-cell_linecells	were	cell	NNS	I-NP	I-cell_linewere	still	be	VBD	B-VP	Ostill	sufficient	still	RB	B-ADVP	Osufficient	to	sufficient	JJ	B-ADJP	Oto	activate	to	TO	B-VP	Oactivate	calcineurin	activate	VB	I-VP	Ocalcineurin	.	calcineurin	NN	B-NP	B-protein.	Treatment	.	.	O	OTreatment	of	Treatment	NN	B-NP	Oof	lymphocytes	of	IN	B-PP	Olymphocytes	with	lymphocyte	NNS	B-NP	B-cell_typewith	cytochalasin	with	IN	B-PP	Ocytochalasin	D	cytochalasin	NN	B-NP	OD	","	D	NN	I-NP	O","	which	","	","	O	Owhich	blocks	which	WDT	B-NP	Oblocks	actin	block	VBZ	B-VP	Oactin	polymerization	actin	NN	B-NP	B-proteinpolymerization	","	polymerization	NN	I-NP	O","	inhibited	","	","	O	Oinhibited	cap	inhibit	VBD	B-VP	Ocap	formation	cap	NN	B-NP	Oformation	and	formation	NN	I-NP	Oand	produced	and	CC	O	Oproduced	defects	produce	VBD	B-VP	Odefects	in	defect	NNS	B-NP	Oin	signaling	in	IN	B-PP	Osignaling	and	signaling	NN	B-NP	Oand	IL-2	and	CC	O	OIL-2	transcriptional	IL-2	NN	B-NP	B-proteintranscriptional	induction	transcriptional	JJ	I-NP	Oinduction	in	induction	NN	I-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	antigen-receptor	to	TO	B-PP	Oantigen-receptor	signaling	antigen-receptor	JJ	B-NP	Osignaling	that	signaling	NN	I-NP	Othat	were	that	WDT	B-NP	Owere	nearly	be	VBD	B-VP	Onearly	identical	nearly	RB	B-ADJP	Oidentical	to	identical	JJ	I-ADJP	Oto	those	to	TO	B-PP	Othose	seen	those	DT	B-NP	Oseen	in	see	VBN	B-VP	Oin	vav-/-	in	IN	B-PP	Ovav-/-	cells	vav-/-	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	transfection	In	IN	B-PP	Otransfection	studies	transfection	NN	B-NP	Ostudies	","	study	NNS	I-NP	O","	either	","	","	O	Oeither	constitutively	either	CC	B-NP	Oconstitutively	active	constitutively	RB	I-NP	Oactive	Vav	active	JJ	I-NP	OVav	or	Vav	NN	I-NP	B-proteinor	Rac	or	CC	I-NP	ORac	could	Rac	NN	I-NP	B-proteincould	complement	could	MD	B-VP	Ocomplement	constitutively	complement	VB	I-VP	Oconstitutively	active	constitutively	RB	B-NP	Oactive	calcineurin	active	JJ	I-NP	Ocalcineurin	to	calcineurin	NN	I-NP	B-proteinto	activate	to	TO	B-VP	Oactivate	NF-AT-dependent	activate	VB	I-VP	ONF-AT-dependent	transcription	NF-AT-dependent	JJ	B-NP	Otranscription	.	transcription	NN	I-NP	O.	CONCLUSIONS	.	.	O	OCONCLUSIONS	:	CONCLUSIONS	NNS	B-NP	O:	These	:	:	O	OThese	results	These	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	Vav	that	IN	B-SBAR	OVav	is	Vav	NN	B-NP	B-proteinis	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	cap	for	IN	B-PP	Ocap	formation	cap	NN	B-NP	Oformation	in	formation	NN	I-NP	Oin	lymphocytes	in	IN	B-PP	Olymphocytes	.	lymphocyte	NNS	B-NP	B-cell_type.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	the	","	","	O	Othe	correlation	the	DT	B-NP	Ocorrelation	between	correlation	NN	I-NP	Obetween	cap	between	IN	B-PP	Ocap	formation	cap	NN	B-NP	Oformation	","	formation	NN	I-NP	O","	IL-2	","	","	O	OIL-2	production	IL-2	NN	B-NP	B-proteinproduction	and	production	NN	I-NP	Oand	proliferation	and	CC	I-NP	Oproliferation	supports	proliferation	NN	I-NP	Osupports	the	support	VBZ	B-VP	Othe	hypothesis	the	DT	B-NP	Ohypothesis	that	hypothesis	NN	I-NP	Othat	an	that	IN	B-SBAR	Oan	actin-dependent	an	DT	B-NP	Oactin-dependent	pathway	actin-dependent	JJ	I-NP	Opathway	is	pathway	NN	I-NP	Ois	a	be	VBZ	B-VP	Oa	source	a	DT	B-NP	Osource	of	source	NN	I-NP	Oof	specialized	of	IN	B-PP	Ospecialized	growth	specialize	VBN	B-NP	Ogrowth	regulatory	growth	NN	I-NP	Oregulatory	signals	regulatory	JJ	I-NP	Osignals	.	signal	NNS	I-NP	O.	CD14	.	.	O	OCD14	#NAME?	CD14	NN	B-NP	B-protein#NAME?	activation	#NAME?	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	endothelial	human	JJ	B-NP	B-cell_typeendothelial	cells	endothelial	JJ	I-NP	I-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	Bacteroides	by	IN	B-PP	OBacteroides	fragilis	Bacteroide	NNS	B-NP	Ofragilis	outer	fragili	VBZ	B-VP	Oouter	membrane	outer	JJ	B-NP	Omembrane	.	membrane	NN	I-NP	O.	We	.	.	O	OWe	studied	We	PRP	B-NP	Ostudied	the	study	VBD	B-VP	Othe	capacity	the	DT	B-NP	Ocapacity	of	capacity	NN	I-NP	Oof	isolated	of	IN	B-PP	Oisolated	Bacteriodes	isolate	VBN	B-NP	OBacteriodes	fragilis	Bacteriode	NNS	I-NP	Ofragilis	outer	fragili	VBZ	B-VP	Oouter	membrane	outer	JJ	B-NP	Omembrane	","	membrane	NN	I-NP	O","	B.	","	","	O	OB.	fragilis	B.	NNP	B-NP	Ofragilis	NCTC9343	fragilis	NN	I-NP	ONCTC9343	lipopolysaccharide	NCTC9343	NN	I-NP	Olipopolysaccharide	(	lipopolysaccharide	NN	I-NP	O(	LPS	(	(	O	OLPS	;	LPS	NN	B-NP	O;	endotoxin	;	:	O	Oendotoxin	)	endotoxin	NN	B-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	B.	and	CC	O	OB.	fragilis	B.	NNP	B-NP	Ofragilis	NCTC9343	fragilis	NN	I-NP	ONCTC9343	capsular	NCTC9343	NN	I-NP	Ocapsular	polysaccharides	capsular	JJ	I-NP	Opolysaccharides	to	polysaccharide	NNS	I-NP	Oto	activate	to	TO	B-VP	Oactivate	human	activate	VB	I-VP	Ohuman	umbilical	human	JJ	B-NP	B-cell_typeumbilical	vein	umbilical	JJ	I-NP	I-cell_typevein	endothelial	vein	NN	I-NP	I-cell_typeendothelial	cell	endothelial	JJ	I-NP	I-cell_typecell	(	cell	NN	I-NP	I-cell_type(	HUVEC	(	(	O	OHUVEC	)	HUVEC	NN	B-NP	B-cell_line)	monolayers	)	)	O	Omonolayers	.	monolayer	NNS	B-NP	O.	To	.	.	O	OTo	assess	To	TO	B-VP	Oassess	HUVEC	assess	VB	I-VP	OHUVEC	activation	HUVEC	NN	B-NP	B-proteinactivation	","	activation	NN	I-NP	O","	E-selectin	","	","	O	OE-selectin	expression	E-selectin	NN	B-NP	B-proteinexpression	was	expression	NN	I-NP	Owas	measured	be	VBD	B-VP	Omeasured	by	measure	VBN	I-VP	Oby	enzyme-linked	by	IN	B-PP	Oenzyme-linked	immunosorbent	enzyme-linked	JJ	B-NP	Oimmunosorbent	assay	immunosorbent	JJ	I-NP	Oassay	(	assay	NN	I-NP	O(	ELISA	(	(	O	OELISA	)	ELISA	NN	B-NP	O)	","	)	)	O	O","	Northern	","	","	O	ONorthern	blot	Northern	NN	B-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	for	analysis	NN	I-NP	Ofor	E-selectin-specific	for	IN	B-PP	OE-selectin-specific	mRNA	E-selectin-specific	JJ	B-NP	B-RNAmRNA	","	mRNA	NN	I-NP	I-RNA","	and	","	","	O	Oand	electrophoretic	and	CC	O	Oelectrophoretic	gel	electrophoretic	JJ	B-NP	Ogel	mobility	gel	NN	I-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assay	shift	NN	I-NP	Oassay	(	assay	NN	I-NP	O(	EMSA	(	(	O	OEMSA	)	EMSA	NN	B-NP	O)	for	)	)	O	Ofor	NF-kappa	for	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	","	B	NN	I-NP	I-protein","	a	","	","	O	Oa	transcription	a	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	necessary	factor	NN	I-NP	I-proteinnecessary	for	necessary	JJ	B-ADJP	Ofor	E-selectin	for	IN	B-PP	OE-selectin	gene	E-selectin	NN	B-NP	B-DNAgene	activation	gene	NN	I-NP	I-DNAactivation	.	activation	NN	I-NP	O.	Exposure	.	.	O	OExposure	of	Exposure	NN	B-NP	Oof	HUVECs	of	IN	B-PP	OHUVECs	to	HUVEC	NNS	B-NP	B-cell_lineto	B.	to	TO	B-PP	OB.	fragilis	B.	NNP	B-NP	Ofragilis	outer	fragilis	NN	I-NP	Oouter	membrane	outer	JJ	I-NP	Omembrane	fractions	membrane	NN	I-NP	Ofractions	","	fraction	NNS	I-NP	O","	separated	","	","	O	Oseparated	from	separate	VBN	B-VP	Ofrom	other	from	IN	B-PP	Oother	components	other	JJ	B-NP	Ocomponents	of	component	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	B.	the	DT	B-NP	OB.	fragilis	B.	NNP	I-NP	Ofragilis	cell	fragilis	NN	I-NP	Ocell	wall	cell	NN	I-NP	Owall	by	wall	NN	I-NP	Oby	isopycnic	by	IN	B-PP	Oisopycnic	","	isopycnic	JJ	B-NP	O","	sucrose	","	","	I-NP	Osucrose	gradient	sucrose	NN	I-NP	Ogradient	centrifugation	gradient	NN	I-NP	Ocentrifugation	","	centrifugation	NN	I-NP	O","	significantly	","	","	O	Osignificantly	increased	significantly	RB	B-VP	Oincreased	surface	increase	VBD	I-VP	Osurface	expression	surface	NN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	E-selectin	of	IN	B-PP	OE-selectin	and	E-selectin	NN	B-NP	B-proteinand	induced	and	CC	O	Oinduced	functional	induce	VBD	B-VP	Ofunctional	endothelial	functional	JJ	B-NP	Oendothelial	cell	endothelial	JJ	I-NP	Ocell	#NAME?	cell	NN	I-NP	O#NAME?	leukocyte	#NAME?	JJ	I-NP	Oleukocyte	adhesion	leukocyte	NN	I-NP	Oadhesion	.	adhesion	NN	I-NP	O.	B.	.	.	O	OB.	fragilis	B.	NNP	B-NP	Ofragilis	outer	fragili	VBZ	B-VP	Oouter	membranes	outer	JJ	B-NP	Omembranes	induced	membrane	NNS	I-NP	Oinduced	translocation	induce	VBD	B-VP	Otranslocation	of	translocation	NN	B-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	to	B	NN	I-NP	I-proteinto	HUVEC	to	TO	B-PP	OHUVEC	nuclei	HUVEC	NN	B-NP	B-cell_linenuclei	and	nucleus	NNS	I-NP	Oand	accumulation	and	CC	O	Oaccumulation	of	accumulation	NN	B-NP	Oof	E-selectin	of	IN	B-PP	OE-selectin	mRNA	E-selectin	NN	B-NP	B-RNAmRNA	in	mRNA	NN	I-NP	I-RNAin	HUVEC	in	IN	B-PP	OHUVEC	cytoplasm	HUVEC	NN	B-NP	B-cell_typecytoplasm	.	cytoplasm	NN	I-NP	O.	E-selectin	.	.	O	OE-selectin	expression	E-selectin	NN	B-NP	B-proteinexpression	induced	expression	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	B.	by	IN	B-PP	OB.	fragilis	B.	NNP	B-NP	Ofragilis	outer	fragili	VBZ	B-VP	Oouter	membranes	outer	JJ	B-NP	Omembranes	was	membrane	NNS	I-NP	Owas	not	be	VBD	B-VP	Onot	blocked	not	RB	I-VP	Oblocked	by	block	VBN	I-VP	Oby	polymixin	by	IN	B-PP	Opolymixin	B	polymixin	NN	B-NP	OB	.	B	NN	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	E-selectin	","	","	O	OE-selectin	expression	E-selectin	NN	B-NP	B-proteinexpression	induced	expression	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	outer	by	IN	B-PP	Oouter	membrane	outer	JJ	B-NP	Omembrane	fractions	membrane	NN	I-NP	Ofractions	purified	fraction	NNS	I-NP	Opurified	from	purify	VBN	B-VP	Ofrom	E.	from	IN	B-PP	OE.	coli	E.	FW	B-NP	Ocoli	was	coli	FW	I-NP	Owas	competitively	be	VBD	B-VP	Ocompetitively	inhibited	competitively	RB	I-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	polymixin	by	IN	B-PP	Opolymixin	B	polymixin	NN	B-NP	OB	.	B	NN	I-NP	O.	Neither	.	.	O	ONeither	purified	Neither	CC	O	Opurified	B.	purify	VBN	B-NP	OB.	fragilis	B.	NNP	I-NP	Ofragilis	LPS	fragilis	NN	I-NP	OLPS	","	LPS	NN	I-NP	O","	a	","	","	O	Oa	prominent	a	DT	B-NP	Oprominent	constituent	prominent	JJ	I-NP	Oconstituent	of	constituent	NN	I-NP	Oof	the	of	IN	B-PP	Othe	outer	the	DT	B-NP	Oouter	membrane	outer	JJ	I-NP	Omembrane	","	membrane	NN	I-NP	O","	nor	","	","	O	Onor	purified	nor	CC	O	Opurified	B.	purify	VBN	O	OB.	fragilis	B.	NNP	B-NP	Ofragilis	capsular	fragili	VBZ	B-VP	Ocapsular	polysaccharides	capsular	JJ	B-NP	Opolysaccharides	induced	polysaccharide	NNS	I-NP	Oinduced	HUVEC	induce	VBD	B-VP	OHUVEC	activation	HUVEC	NN	B-NP	B-cell_typeactivation	.	activation	NN	I-NP	O.	Two	.	.	O	OTwo	different	Two	CD	B-NP	Odifferent	monoclonal	different	JJ	I-NP	Omonoclonal	antibodies	monoclonal	JJ	I-NP	B-proteinantibodies	directed	antibody	NNS	I-NP	I-proteindirected	against	direct	VBN	B-VP	Oagainst	human	against	IN	B-PP	Ohuman	CD14	human	JJ	B-NP	B-proteinCD14	completely	CD14	NN	I-NP	I-proteincompletely	inhibited	completely	RB	B-ADVP	Oinhibited	B.	inhibit	VBD	B-VP	OB.	fragilis	B.	NNP	B-NP	Ofragilis	outer	fragilis	NN	I-NP	Oouter	membrane-induced	outer	JJ	I-NP	Omembrane-induced	NF-kappa	membrane-induced	JJ	I-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	","	activation	NN	I-NP	O","	E-selectin	","	","	O	OE-selectin	transcription	E-selectin	NN	B-NP	B-proteintranscription	","	transcription	NN	I-NP	O","	and	","	","	O	Oand	E-selectin	and	CC	O	OE-selectin	surface	E-selectin	NN	B-NP	B-proteinsurface	expression	surface	NN	I-NP	Oexpression	.	expression	NN	I-NP	O.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	outer	the	DT	B-NP	Oouter	membrane	outer	JJ	I-NP	Omembrane	component	membrane	NN	I-NP	Ocomponent	of	component	NN	I-NP	Oof	the	of	IN	B-PP	Othe	B.	the	DT	B-NP	OB.	fragilis	B.	NNP	I-NP	Ofragilis	cell	fragilis	NN	I-NP	Ocell	wall	cell	NN	I-NP	Owall	contains	wall	NN	I-NP	Ocontains	a	contain	VBZ	B-VP	Oa	proinflammatory	a	DT	B-NP	Oproinflammatory	factor	proinflammatory	JJ	I-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	","	)	)	O	O","	that	","	","	O	Othat	is	that	WDT	B-NP	Ois	not	be	VBZ	B-VP	Onot	LPS	not	RB	O	OLPS	","	LPS	NN	B-NP	O","	which	","	","	O	Owhich	induces	which	WDT	B-NP	Oinduces	human	induce	VBZ	B-VP	Ohuman	endothelial	human	JJ	B-NP	B-cell_typeendothelial	cell	endothelial	JJ	I-NP	I-cell_typecell	activation	cell	NN	I-NP	I-cell_typeactivation	by	activation	NN	I-NP	Oby	a	by	IN	B-PP	Oa	soluble	a	DT	B-NP	Osoluble	CD14	soluble	JJ	I-NP	OCD14	#NAME?	CD14	NN	I-NP	B-protein#NAME?	mechanism	#NAME?	JJ	I-NP	Omechanism	.	mechanism	NN	I-NP	O.	NF-kappaB	.	.	O	ONF-kappaB	protects	NF-kappaB	NN	B-NP	B-proteinprotects	HIV-1-infected	protect	VBZ	B-VP	OHIV-1-infected	myeloid	HIV-1-infected	JJ	B-NP	B-cell_typemyeloid	cells	myeloid	JJ	I-NP	I-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	apoptosis	from	IN	B-PP	Oapoptosis	.	apoptosis	NN	B-NP	O.	HIV-1	.	.	O	OHIV-1	infection	HIV-1	NN	B-NP	Oinfection	of	infection	NN	I-NP	Oof	primary	of	IN	B-PP	Oprimary	monocytic	primary	JJ	B-NP	B-cell_typemonocytic	cells	monocytic	JJ	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	myeloid	and	CC	O	Omyeloid	cell	myeloid	JJ	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	results	line	NNS	I-NP	I-cell_lineresults	in	result	VBZ	B-VP	Oin	sustained	in	IN	B-PP	Osustained	NF-kappaB	sustained	JJ	B-NP	ONF-kappaB	activation	NF-kappaB	NN	I-NP	B-proteinactivation	.	activation	NN	I-NP	O.	Recently	.	.	O	ORecently	","	Recently	RB	B-ADVP	O","	NF-kappaB	","	","	O	ONF-kappaB	induction	NF-kappaB	NN	B-NP	B-proteininduction	has	induction	NN	I-NP	Ohas	been	have	VBZ	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	play	to	TO	I-VP	Oplay	a	play	VB	I-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	protecting	in	IN	B-PP	Oprotecting	cells	protect	VBG	B-VP	Ocells	from	cell	NNS	B-NP	Ofrom	programmed	from	IN	B-PP	Oprogrammed	cell	program	VBN	B-NP	Ocell	death	cell	NN	I-NP	Odeath	.	death	NN	I-NP	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	present	the	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	sought	we	PRP	B-NP	Osought	to	seek	VBD	B-VP	Oto	investigate	to	TO	I-VP	Oinvestigate	whether	investigate	VB	I-VP	Owhether	constitutive	whether	IN	B-SBAR	Oconstitutive	NF-kappaB	constitutive	JJ	B-NP	ONF-kappaB	activity	NF-kappaB	NN	I-NP	B-proteinactivity	in	activity	NN	I-NP	Oin	chronically	in	IN	B-PP	Ochronically	HIV-1-infected	chronically	RB	B-NP	OHIV-1-infected	promonocytic	HIV-1-infected	JJ	I-NP	Opromonocytic	U937	promonocytic	JJ	I-NP	OU937	(	U937	NN	I-NP	O(	U9-IIIB	(	(	O	OU9-IIIB	)	U9-IIIB	NN	B-NP	B-protein)	and	)	)	O	Oand	myeloblastic	and	CC	O	Omyeloblastic	PLB-985	myeloblastic	JJ	B-NP	B-cell_linePLB-985	(	PLB-985	NN	I-NP	I-cell_line(	PLB-IIIB	(	(	O	I-cell_linePLB-IIIB	)	PLB-IIIB	NN	B-NP	I-cell_line)	cells	)	)	I-NP	I-cell_linecells	affects	cell	NNS	I-NP	I-cell_lineaffects	apoptotic	affect	VBZ	B-VP	Oapoptotic	signaling	apoptotic	JJ	B-NP	Osignaling	.	signaling	NN	I-NP	O.	TNFalpha	.	.	O	OTNFalpha	and	TNFalpha	NN	B-NP	B-proteinand	cycloheximide	and	CC	I-NP	Ocycloheximide	caused	cycloheximide	NN	I-NP	Ocaused	infected	cause	VBD	B-VP	Oinfected	cells	infected	JJ	B-NP	B-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	undergo	to	TO	B-VP	Oundergo	apoptosis	undergo	VB	I-VP	Oapoptosis	more	apoptosis	NN	B-NP	Omore	rapidly	more	RBR	B-ADVP	Orapidly	than	rapidly	RB	I-ADVP	Othan	parental	than	IN	B-PP	Oparental	U937	parental	JJ	B-NP	OU937	and	U937	NN	I-NP	Oand	PLB-985	and	CC	I-NP	OPLB-985	cells	PLB-985	NN	I-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	TNFalpha	of	IN	B-PP	OTNFalpha	#NAME?	TNFalpha	NN	B-NP	B-protein#NAME?	NF-kappaB	#NAME?	JJ	I-NP	ONF-kappaB	activation	NF-kappaB	NN	I-NP	B-proteinactivation	using	activation	NN	I-NP	Ousing	the	use	VBG	B-VP	Othe	antioxidant	the	DT	B-NP	Oantioxidant	N-acetylcysteine	antioxidant	JJ	I-NP	ON-acetylcysteine	(	N-acetylcysteine	NN	I-NP	O(	NAC	(	(	O	ONAC	)	NAC	NN	B-NP	O)	resulted	)	)	O	Oresulted	in	result	VBD	B-VP	Oin	increased	in	IN	B-PP	Oincreased	apoptosis	increase	VBN	B-NP	Oapoptosis	in	apoptosis	NN	I-NP	Oin	both	in	IN	B-PP	Oboth	U937	both	CC	O	OU937	and	U937	NN	B-NP	B-cell_lineand	U9-IIIB	and	CC	I-NP	OU9-IIIB	cells	U9-IIIB	NN	I-NP	B-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	while	","	","	O	Owhile	preactivation	while	IN	B-SBAR	Opreactivation	of	preactivation	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	with	NF-kappaB	NN	B-NP	B-proteinwith	the	with	IN	B-PP	Othe	non-apoptotic	the	DT	B-NP	Onon-apoptotic	inducer	non-apoptotic	JJ	I-NP	Oinducer	IL-1beta	inducer	NN	I-NP	OIL-1beta	caused	IL-1beta	NN	I-NP	B-proteincaused	a	cause	VBD	B-VP	Oa	relative	a	DT	B-NP	Orelative	decrease	relative	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	apoptosis	in	IN	B-PP	Oapoptosis	.	apoptosis	NN	B-NP	O.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	constitutive	of	IN	B-PP	Oconstitutive	NF-kappaB	constitutive	JJ	B-NP	ONF-kappaB	activity	NF-kappaB	NN	I-NP	B-proteinactivity	in	activity	NN	I-NP	Oin	U9-IIIB	in	IN	B-PP	OU9-IIIB	and	U9-IIIB	NN	B-NP	B-cell_lineand	PLB-IIIB	and	CC	I-NP	OPLB-IIIB	cells	PLB-IIIB	NN	I-NP	B-cell_linecells	also	cell	NNS	I-NP	I-cell_linealso	induced	also	RB	B-ADVP	Oinduced	apoptosis	induce	VBD	B-VP	Oapoptosis	","	apoptosis	NN	B-NP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	NF-kappaB	that	IN	B-SBAR	ONF-kappaB	protects	NF-kappaB	NN	B-NP	B-proteinprotects	cells	protect	VBZ	B-VP	Ocells	from	cell	NNS	B-NP	Ofrom	a	from	IN	B-PP	Oa	persistent	a	DT	B-NP	Opersistent	apoptotic	persistent	JJ	I-NP	Oapoptotic	signal	apoptotic	JJ	I-NP	Osignal	.	signal	NN	I-NP	O.	TNFalpha	.	.	O	OTNFalpha	plus	TNFalpha	NN	B-NP	B-proteinplus	NAC	plus	CC	I-NP	ONAC	treatment	NAC	NN	I-NP	Otreatment	resulted	treatment	NN	I-NP	Oresulted	in	result	VBD	B-VP	Oin	a	in	IN	B-PP	Oa	marked	a	DT	B-NP	Omarked	decrease	marked	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	Bcl-2	in	IN	B-PP	OBcl-2	protein	Bcl-2	NN	B-NP	B-proteinprotein	levels	protein	NN	I-NP	Olevels	in	level	NNS	I-NP	Oin	HIV-1-infected	in	IN	B-PP	OHIV-1-infected	cells	HIV-1-infected	JJ	B-NP	B-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	coupled	","	","	O	Ocoupled	with	couple	VBN	B-VP	Owith	an	with	IN	B-PP	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	Bax	in	IN	B-PP	OBax	protein	Bax	NN	B-NP	B-proteinprotein	compared	protein	NN	I-NP	I-proteincompared	to	compare	VBN	B-VP	Oto	uninfected	to	TO	B-PP	Ouninfected	cells	uninfected	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	the	that	IN	B-SBAR	Othe	difference	the	DT	B-NP	Odifference	in	difference	NN	I-NP	Oin	susceptibility	in	IN	B-PP	Osusceptibility	to	susceptibility	NN	B-NP	Oto	TNFalpha	to	TO	B-PP	OTNFalpha	#NAME?	TNFalpha	NN	B-NP	B-protein#NAME?	apoptosis	#NAME?	JJ	I-NP	Oapoptosis	may	apoptosis	NN	I-NP	Omay	relate	may	MD	B-VP	Orelate	to	relate	VB	I-VP	Oto	the	to	TO	B-PP	Othe	differences	the	DT	B-NP	Odifferences	in	difference	NNS	I-NP	Oin	relative	in	IN	B-PP	Orelative	levels	relative	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	Bcl-2	of	IN	B-PP	OBcl-2	and	Bcl-2	NN	B-NP	B-proteinand	Bax	and	CC	I-NP	OBax	.	Bax	NN	I-NP	B-protein.	The	.	.	O	OThe	protective	The	DT	B-NP	Oprotective	role	protective	JJ	I-NP	Orole	of	role	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	in	NF-kappaB	NN	B-NP	B-proteinin	blocking	in	IN	B-PP	Oblocking	TNFalpha-	block	VBG	B-VP	OTNFalpha-	and	TNFalpha-	NN	B-NP	B-proteinand	HIV-1-induced	and	CC	O	OHIV-1-induced	apoptosis	HIV-1-induced	JJ	B-NP	Oapoptosis	was	apoptosis	NN	I-NP	Owas	supported	be	VBD	B-VP	Osupported	by	support	VBN	I-VP	Oby	studies	by	IN	B-PP	Ostudies	in	study	NNS	B-NP	Oin	Jurkat	in	IN	B-PP	OJurkat	T	Jurkat	NN	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	engineered	cell	NNS	I-NP	I-cell_lineengineered	to	engineer	VBN	B-VP	Oto	express	to	TO	B-VP	Oexpress	IkappaB	express	VB	I-VP	OIkappaB	alpha	IkappaB	NN	B-NP	B-proteinalpha	repressor	alpha	NN	I-NP	I-proteinrepressor	mutants	repressor	NN	I-NP	I-proteinmutants	(	mutant	NNS	I-NP	I-protein(	TD-IkappaB	(	(	O	OTD-IkappaB	)	TD-IkappaB	NN	B-NP	O)	under	)	)	O	Ounder	the	under	IN	B-PP	Othe	control	the	DT	B-NP	Ocontrol	of	control	NN	I-NP	Oof	a	of	IN	B-PP	Oa	tetracycline-responsive	a	DT	B-NP	Otetracycline-responsive	promoter	tetracycline-responsive	JJ	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Cells	.	.	O	OCells	underwent	Cell	NNS	B-NP	Ounderwent	apoptosis	undergo	VBD	B-VP	Oapoptosis	in	apoptosis	NN	B-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	TNFalpha	to	TO	B-PP	OTNFalpha	only	TNFalpha	NN	B-NP	B-proteinonly	when	only	RB	B-ADVP	Owhen	NF-kappaB	when	WRB	I-ADVP	ONF-kappaB	activation	NF-kappaB	NN	B-NP	B-proteinactivation	was	activation	NN	I-NP	Owas	inhibited	be	VBD	B-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	TD-IkappaB	by	IN	B-PP	OTD-IkappaB	expression	TD-IkappaB	NN	B-NP	B-proteinexpression	.	expression	NN	I-NP	O.	As	.	.	O	OAs	was	As	IN	B-SBAR	Owas	observed	be	VBD	B-VP	Oobserved	for	observe	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	U9-IIIB	the	DT	B-NP	OU9-IIIB	cells	U9-IIIB	NN	I-NP	B-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	TNFalpha	","	","	O	OTNFalpha	treatment	TNFalpha	NN	B-NP	B-proteintreatment	also	treatment	NN	I-NP	Oalso	induced	also	RB	B-ADVP	Oinduced	a	induce	VBD	B-VP	Oa	marked	a	DT	B-NP	Omarked	decrease	marked	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	Bcl-2	in	IN	B-PP	OBcl-2	protein	Bcl-2	NN	B-NP	B-proteinprotein	levels	protein	NN	I-NP	Olevels	in	level	NNS	I-NP	Oin	TD-IkappaB	in	IN	B-PP	OTD-IkappaB	expressing	TD-IkappaB	NN	B-NP	B-cell_lineexpressing	cells	express	VBG	B-VP	I-cell_linecells	.	cell	NNS	B-NP	I-cell_line.	These	.	.	O	OThese	experiments	These	DT	B-NP	Oexperiments	demonstrate	experiment	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	apoptotic	that	IN	B-SBAR	Oapoptotic	signaling	apoptotic	JJ	B-NP	Osignaling	is	signaling	NN	I-NP	Ois	perturbed	be	VBZ	B-VP	Operturbed	in	perturb	VBN	I-VP	Oin	HIV-1-infected	in	IN	B-PP	OHIV-1-infected	U9-IIIB	HIV-1-infected	JJ	B-NP	B-cell_typeU9-IIIB	cells	U9-IIIB	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	indicate	and	CC	O	Oindicate	that	indicate	VBP	B-VP	Othat	NF-kappaB	that	IN	B-SBAR	ONF-kappaB	activation	NF-kappaB	NN	B-NP	B-proteinactivation	may	activation	NN	I-NP	Omay	play	may	MD	B-VP	Oplay	an	play	VB	I-VP	Oan	additional	an	DT	B-NP	Oadditional	protective	additional	JJ	I-NP	Oprotective	role	protective	JJ	I-NP	Orole	against	role	NN	I-NP	Oagainst	HIV-1-induced	against	IN	B-PP	OHIV-1-induced	apoptosis	HIV-1-induced	JJ	B-NP	Oapoptosis	in	apoptosis	NN	I-NP	Oin	myeloid	in	IN	B-PP	Omyeloid	cells	myeloid	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Human	.	.	O	OHuman	normal	Human	JJ	B-NP	B-cell_typenormal	peripheral	normal	JJ	I-NP	I-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	B-lymphocytes	blood	NN	I-NP	I-cell_typeB-lymphocytes	are	B-lymphocyte	NNS	I-NP	I-cell_typeare	deficient	be	VBP	B-VP	Odeficient	in	deficient	JJ	B-ADJP	Oin	DNA-dependent	in	IN	B-PP	ODNA-dependent	protein	DNA-dependent	JJ	B-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	activity	kinase	NN	I-NP	I-proteinactivity	due	activity	NN	I-NP	Odue	to	due	IN	B-PP	Oto	the	to	TO	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	a	of	IN	B-PP	Oa	variant	a	DT	B-NP	Ovariant	form	variant	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	the	of	IN	B-PP	Othe	Ku86	the	DT	B-NP	OKu86	protein	Ku86	NN	I-NP	B-proteinprotein	.	protein	NN	I-NP	I-protein.	The	.	.	O	OThe	heterodimeric	The	DT	B-NP	Oheterodimeric	Ku	heterodimeric	JJ	I-NP	B-proteinKu	protein	Ku	NN	I-NP	I-proteinprotein	","	protein	NN	I-NP	I-protein","	which	","	","	O	Owhich	comprises	which	WDT	B-NP	Ocomprises	a	comprise	VBZ	B-VP	Oa	86	a	DT	B-NP	O86	kDa	86	CD	I-NP	OkDa	(	kDa	NN	I-NP	O(	Ku86	(	(	O	OKu86	)	Ku86	NN	B-NP	O)	amd	)	)	O	Oamd	a	amd	VBD	B-VP	Oa	70	a	DT	B-NP	O70	kDa	70	CD	I-NP	B-proteinkDa	(	kDa	NN	I-NP	I-protein(	Ku70	(	(	O	I-proteinKu70	)	Ku70	NN	B-NP	I-protein)	subunits	)	)	O	I-proteinsubunits	","	subunit	NNS	B-NP	I-protein","	is	","	","	O	Ois	an	be	VBZ	B-VP	Oan	abundant	an	DT	B-NP	Oabundant	nuclear	abundant	JJ	I-NP	B-proteinnuclear	DNA-binding	nuclear	JJ	I-NP	I-proteinDNA-binding	protein	DNA-binding	JJ	I-NP	I-proteinprotein	which	protein	NN	I-NP	I-proteinwhich	binds	which	WDT	B-NP	Obinds	in	bind	VBZ	B-VP	Oin	vitro	in	FW	B-ADVP	Ovitro	to	vitro	FW	I-ADVP	Oto	DNA	to	TO	B-PP	ODNA	termini	DNA	NN	B-NP	B-proteintermini	without	terminus	NNS	I-NP	I-proteinwithout	sequence	without	IN	B-PP	Osequence	specificity	sequence	NN	B-NP	Ospecificity	.	specificity	NN	I-NP	O.	Ku	.	.	O	OKu	is	Ku	NN	B-NP	B-proteinis	the	be	VBZ	B-VP	Othe	DNA-targeting	the	DT	B-NP	ODNA-targeting	component	DNA-targeting	JJ	I-NP	B-proteincomponent	of	component	NN	I-NP	I-proteinof	the	of	IN	B-PP	Othe	large	the	DT	B-NP	Olarge	catalytic	large	JJ	I-NP	B-proteincatalytic	sub-unit	catalytic	JJ	I-NP	I-proteinsub-unit	of	sub-unit	NN	I-NP	I-proteinof	the	of	IN	B-PP	Othe	DNA-dependent	the	DT	B-NP	ODNA-dependent	protein	DNA-dependent	JJ	I-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	complex	kinase	NN	I-NP	I-proteincomplex	(	complex	NN	I-NP	I-protein(	DNA-PK	(	(	O	ODNA-PK	[	DNA-PK	NN	B-NP	B-protein[	CS	[	(	O	OCS	]	CS	NN	B-NP	O]	)	]	)	O	O)	","	)	)	O	O","	that	","	","	O	Othat	plays	that	WDT	B-NP	Oplays	a	play	VBZ	B-VP	Oa	critical	a	DT	B-NP	Ocritical	role	critical	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	mammalian	in	IN	B-PP	Omammalian	double-strand	mammalian	JJ	B-NP	Odouble-strand	break	double-strand	JJ	I-NP	Obreak	repair	break	NN	I-NP	Orepair	and	repair	NN	I-NP	Oand	lymphoid	and	CC	O	Olymphoid	V	lymphoid	JJ	B-NP	OV	(	V	NN	I-NP	O(	D	(	(	O	OD	)	D	NN	B-NP	O)	J	)	)	O	OJ	recombination	J	NN	B-NP	Orecombination	.	recombination	NN	I-NP	O.	By	.	.	O	OBy	using	By	IN	B-PP	Ousing	electrophoretic	use	VBG	B-VP	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assays	shift	NN	I-NP	Oassays	","	assay	NNS	I-NP	O","	we	","	","	O	Owe	demonstrated	we	PRP	B-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	in	that	IN	B-SBAR	Oin	addition	in	IN	B-PP	Oaddition	to	addition	NN	B-NP	Oto	the	to	TO	B-PP	Othe	major	the	DT	B-NP	Omajor	Ku	major	JJ	I-NP	OKu	x	Ku	NN	I-NP	B-proteinx	DNA	x	SYM	B-NP	I-proteinDNA	complex	DNA	NN	I-NP	I-proteincomplex	usually	complex	NN	I-NP	I-proteinusually	detected	usually	RB	B-VP	Odetected	in	detect	VBN	I-VP	Oin	cell	in	IN	B-PP	Ocell	line	cell	NN	B-NP	Oline	extracts	line	NN	I-NP	Oextracts	","	extract	NNS	I-NP	O","	a	","	","	O	Oa	second	a	DT	B-NP	Osecond	complex	second	JJ	I-NP	Ocomplex	with	complex	NN	I-NP	Owith	faster	with	IN	B-PP	Ofaster	electrophoretic	fast	JJR	B-NP	Oelectrophoretic	mobility	electrophoretic	JJ	I-NP	Omobility	was	mobility	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	normal	in	IN	B-PP	Onormal	peripheral	normal	JJ	B-NP	B-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	lymphocytes	blood	NN	I-NP	I-cell_typelymphocytes	(	lymphocyte	NNS	I-NP	I-cell_type(	PBL	(	(	O	OPBL	)	PBL	NNS	B-NP	B-cell_type)	extracts	)	)	O	Oextracts	.	extract	NNS	B-NP	O.	The	.	.	O	OThe	presence	The	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	this	of	IN	B-PP	Othis	faster	this	DT	B-NP	Ofaster	migrating	fast	JJR	I-NP	B-proteinmigrating	complex	migrate	VBG	I-NP	I-proteincomplex	was	complex	NN	I-NP	I-proteinwas	restricted	be	VBD	B-VP	Orestricted	to	restricted	JJ	B-ADJP	Oto	B	to	TO	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	among	cell	NNS	I-NP	I-cell_typeamong	the	among	IN	B-PP	Othe	circulating	the	DT	B-NP	Ocirculating	lymphocyte	circulate	VBG	I-NP	Olymphocyte	population	lymphocyte	NN	I-NP	Opopulation	.	population	NN	I-NP	O.	Western	.	.	O	OWestern	blot	Western	NN	B-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	revealed	analysis	NN	I-NP	Orevealed	that	reveal	VBD	B-VP	Othat	B	that	IN	B-SBAR	OB	cells	B	NN	B-NP	B-cell_typecells	express	cell	NNS	I-NP	I-cell_typeexpress	a	express	VBP	B-VP	Oa	variant	a	DT	B-NP	Ovariant	form	variant	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	the	of	IN	B-PP	Othe	Ku86	the	DT	B-NP	OKu86	protein	Ku86	NN	I-NP	B-proteinprotein	with	protein	NN	I-NP	I-proteinwith	an	with	IN	B-PP	Oan	apparent	an	DT	B-NP	Oapparent	molecular	apparent	JJ	I-NP	Omolecular	weight	molecular	JJ	I-NP	Oweight	of	weight	NN	I-NP	Oof	69	of	IN	B-PP	O69	kDa	69	CD	B-NP	B-proteinkDa	","	kDa	NN	I-NP	I-protein","	and	","	","	B-NP	Oand	not	and	CC	I-NP	Onot	the	not	RB	I-NP	Othe	86	the	DT	B-NP	O86	kDa-	86	CD	I-NP	B-proteinkDa-	full-length	kDa-	NN	I-NP	I-proteinfull-length	protein	full-length	JJ	I-NP	I-proteinprotein	.	protein	NN	I-NP	I-protein.	Although	.	.	O	OAlthough	the	Although	IN	B-SBAR	Othe	heterodimer	the	DT	B-NP	Oheterodimer	Ku70/variant-Ku86	heterodimer	NN	I-NP	B-proteinKu70/variant-Ku86	binds	Ku70/variant-Ku86	NN	I-NP	I-proteinbinds	to	bind	VBZ	B-VP	Oto	DNA-ends	to	TO	B-PP	ODNA-ends	","	DNA-end	NNS	B-NP	O","	this	","	","	O	Othis	altered	this	DT	B-NP	Oaltered	form	altered	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	the	of	IN	B-PP	Othe	Ku	the	DT	B-NP	OKu	heterodimer	Ku	NN	I-NP	B-proteinheterodimer	has	heterodimer	NN	I-NP	I-proteinhas	a	have	VBZ	B-VP	Oa	decreased	a	DT	B-NP	Odecreased	ability	decrease	VBN	I-NP	Oability	to	ability	NN	I-NP	Oto	recruit	to	TO	B-VP	Orecruit	the	recruit	VB	I-VP	Othe	catalytic	the	DT	B-NP	Ocatalytic	component	catalytic	JJ	I-NP	B-proteincomponent	of	component	NN	I-NP	I-proteinof	the	of	IN	B-PP	Othe	complex	the	DT	B-NP	Ocomplex	","	complex	NN	I-NP	O","	DNA-PK	","	","	O	ODNA-PK	(	DNA-PK	NN	B-NP	B-protein(	CS	(	(	O	I-proteinCS	)	CS	NN	B-NP	I-protein)	","	)	)	O	I-protein","	which	","	","	O	Owhich	contributes	which	WDT	B-NP	Ocontributes	to	contribute	VBZ	B-VP	Oto	an	to	TO	B-PP	Oan	absence	an	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	detectable	of	IN	B-PP	Odetectable	DNA-PK	detectable	JJ	B-NP	ODNA-PK	activity	DNA-PK	NN	I-NP	B-proteinactivity	in	activity	NN	I-NP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	provide	datum	NNS	I-NP	Oprovide	a	provide	VBP	B-VP	Oa	molecular	a	DT	B-NP	Omolecular	basis	molecular	JJ	I-NP	Obasis	for	basis	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	increased	the	DT	B-NP	Oincreased	sensitivity	increase	VBN	I-NP	Osensitivity	of	sensitivity	NN	I-NP	Oof	B	of	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	ionizing	to	TO	B-PP	Oionizing	radiation	ionize	VBG	B-VP	Oradiation	and	radiation	NN	B-NP	Oand	identify	and	CC	O	Oidentify	a	identify	VBP	B-VP	Oa	new	a	DT	B-NP	Onew	mechanism	new	JJ	I-NP	Omechanism	of	mechanism	NN	I-NP	Oof	regulation	of	IN	B-PP	Oregulation	of	regulation	NN	B-NP	Oof	DNA-PK	of	IN	B-PP	ODNA-PK	activity	DNA-PK	NN	B-NP	B-proteinactivity	that	activity	NN	I-NP	Othat	operates	that	WDT	B-NP	Ooperates	in	operate	VBZ	B-VP	Oin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	Co-stimulation	.	.	O	OCo-stimulation	of	Co-stimulation	NN	B-NP	Oof	human	of	IN	B-PP	Ohuman	peripheral	human	JJ	B-NP	B-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	with	cell	NNS	I-NP	I-cell_typewith	IL-2	with	IN	B-PP	OIL-2	and	IL-2	NN	B-NP	B-proteinand	anti-CD3	and	CC	O	Oanti-CD3	monoclonal	anti-CD3	JJ	B-NP	B-proteinmonoclonal	antibodies	monoclonal	JJ	I-NP	I-proteinantibodies	induces	antibody	NNS	I-NP	I-proteininduces	phosphorylation	induce	VBZ	B-VP	Ophosphorylation	of	phosphorylation	NN	B-NP	Oof	CREB	of	IN	B-PP	OCREB	.	CREB	NN	B-NP	B-protein.	Phosphorylation	.	.	O	OPhosphorylation	of	Phosphorylation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	cAMP-response	the	DT	B-NP	OcAMP-response	element	cAMP-response	JJ	I-NP	B-proteinelement	binding	element	NN	I-NP	I-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	CREB	protein	NN	I-NP	I-proteinCREB	within	CREB	NN	I-NP	B-proteinwithin	1	within	IN	B-PP	O1	h	1	CD	B-NP	Oh	of	h	NN	I-NP	Oof	CD2	of	IN	B-PP	OCD2	but	CD2	NN	B-NP	B-proteinbut	not	but	CC	B-NP	Onot	CD3	not	RB	I-NP	OCD3	cross-linking	CD3	NN	B-NP	B-proteincross-linking	of	cross-linking	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	PBMC	human	JJ	B-NP	OPBMC	was	PBMC	NN	I-NP	B-cell_typewas	recently	be	VBD	B-VP	Orecently	demonstrated	recently	RB	I-VP	Odemonstrated	.	demonstrate	VBN	I-VP	O.	The	.	.	O	OThe	absence	The	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	P-CREB	of	IN	B-PP	OP-CREB	following	P-CREB	NN	B-NP	B-proteinfollowing	CD3	follow	VBG	B-PP	OCD3	cross-linking	CD3	NN	B-NP	B-proteincross-linking	was	cross-linking	NN	I-NP	Owas	unexpected	be	VBD	B-VP	Ounexpected	","	unexpected	JJ	B-ADJP	O","	as	","	","	O	Oas	other	as	IN	B-SBAR	Oother	laboratories	other	JJ	B-NP	Olaboratories	reported	laboratory	NNS	I-NP	Oreported	increased	report	VBD	B-VP	Oincreased	phosphorylation	increase	VBN	B-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	CREB	of	IN	B-PP	OCREB	following	CREB	NN	B-NP	B-proteinfollowing	CD3	follow	VBG	B-PP	OCD3	cross-linking	CD3	NN	B-NP	B-proteincross-linking	of	cross-linking	NN	I-NP	Oof	the	of	IN	B-PP	Othe	Jurkat	the	DT	B-NP	OJurkat	lymphocyte	Jurkat	NN	I-NP	B-cell_linelymphocyte	cell	lymphocyte	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	.	line	NN	I-NP	I-cell_line.	Due	.	.	O	ODue	to	Due	JJ	B-PP	Oto	Jurkat	to	TO	I-PP	OJurkat	T-cells	Jurkat	NN	B-NP	B-cell_lineT-cells	being	T-cell	NNS	I-NP	I-cell_linebeing	IL-2-independent	be	VBG	B-VP	OIL-2-independent	","	IL-2-independent	JJ	B-ADJP	O","	it	","	","	O	Oit	was	it	PRP	B-NP	Owas	postulated	be	VBD	B-VP	Opostulated	that	postulate	VBN	I-VP	Othat	IL-2	that	IN	B-SBAR	OIL-2	might	IL-2	NN	B-NP	B-proteinmight	provide	might	MD	B-VP	Oprovide	a	provide	VB	I-VP	Oa	necessary	a	DT	B-NP	Onecessary	co-stimulus	necessary	JJ	I-NP	Oco-stimulus	for	co-stimulus	NN	I-NP	Ofor	phosphorylation	for	IN	B-PP	Ophosphorylation	of	phosphorylation	NN	B-NP	Oof	CREB	of	IN	B-PP	OCREB	in	CREB	NN	B-NP	B-proteinin	primary	in	IN	B-PP	Oprimary	lymphocytes	primary	JJ	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Therefore	.	.	O	OTherefore	","	Therefore	RB	B-ADVP	O","	P-CREB	","	","	O	OP-CREB	was	P-CREB	NN	B-NP	B-proteinwas	evaluated	be	VBD	B-VP	Oevaluated	following	evaluate	VBN	I-VP	Ofollowing	co-stimulation	follow	VBG	B-PP	Oco-stimulation	of	co-stimulation	NN	B-NP	Oof	human	of	IN	B-PP	Ohuman	PBMC	human	JJ	B-NP	OPBMC	through	PBMC	NN	I-NP	B-cell_typethrough	the	through	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	and	IL-2	NN	I-NP	B-proteinand	CD2	and	CC	I-NP	OCD2	or	CD2	NN	I-NP	B-proteinor	CD3	or	CC	I-NP	OCD3	receptors	CD3	NN	I-NP	B-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	IL-2	.	.	O	OIL-2	did	IL-2	NN	B-NP	B-proteindid	not	do	VBD	B-VP	Onot	further	not	RB	I-VP	Ofurther	augment	further	RBR	I-VP	Oaugment	phosphorylation	augment	VB	I-VP	Ophosphorylation	of	phosphorylation	NN	B-NP	Oof	CREB	of	IN	B-PP	OCREB	following	CREB	NN	B-NP	B-proteinfollowing	CD2	follow	VBG	B-PP	OCD2	cross-linking	CD2	NN	B-NP	B-proteincross-linking	.	cross-linking	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	while	","	","	O	Owhile	neither	while	IN	B-SBAR	Oneither	IL-2	neither	CC	O	OIL-2	nor	IL-2	NN	B-NP	B-proteinnor	CD3	nor	CC	I-NP	OCD3	cross-linking	CD3	NN	I-NP	B-proteincross-linking	alone	cross-linking	NN	I-NP	Oalone	induced	alone	RB	B-ADVP	Oinduced	P-CREB	induce	VBD	B-VP	OP-CREB	","	P-CREB	NN	B-NP	B-protein","	a	","	","	O	Oa	4.5-fold	a	DT	B-NP	O4.5-fold	increase	4.5-fold	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	phosphorylation	in	IN	B-PP	Ophosphorylation	of	phosphorylation	NN	B-NP	Oof	CREB	of	IN	B-PP	OCREB	within	CREB	NN	B-NP	B-proteinwithin	1	within	IN	B-PP	O1	h	1	CD	B-NP	Oh	of	h	NN	I-NP	Oof	IL-2/CD3	of	IN	B-PP	OIL-2/CD3	co-stimulation	IL-2/CD3	NN	B-NP	Oco-stimulation	was	co-stimulation	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	.	observe	VBN	I-VP	O.	Phosphorylation	.	.	O	OPhosphorylation	was	Phosphorylation	NN	B-NP	Owas	not	be	VBD	B-VP	Onot	associated	not	RB	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	the	with	IN	B-PP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	cAMP	of	IN	B-PP	OcAMP	","	cAMP	NN	B-NP	O","	and	","	","	O	Oand	inhibition	and	CC	O	Oinhibition	of	inhibition	NN	B-NP	Oof	PKA	of	IN	B-PP	OPKA	signaling	PKA	NN	B-NP	B-proteinsignaling	had	signaling	NN	I-NP	Ohad	no	have	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	on	effect	NN	I-NP	Oon	P-CREB	on	IN	B-PP	OP-CREB	.	P-CREB	NN	B-NP	B-protein.	Consistent	.	.	O	OConsistent	with	Consistent	JJ	B-ADJP	Owith	signal	with	IN	B-PP	Osignal	transduction	signal	NN	B-NP	Otransduction	through	transduction	NN	I-NP	Othrough	p56lck	through	IN	B-PP	Op56lck	or	p56lck	NN	B-NP	B-proteinor	p59fyn	or	CC	I-NP	Op59fyn	","	p59fyn	NN	I-NP	B-protein","	inhibition	","	","	O	Oinhibition	of	inhibition	NN	B-NP	Oof	PTK	of	IN	B-PP	OPTK	signaling	PTK	NN	B-NP	B-proteinsignaling	reduced	signaling	NN	I-NP	Oreduced	phosphorylation	reduce	VBD	B-VP	Ophosphorylation	50	phosphorylation	NN	B-NP	O50	%	50	CD	B-NP	O%	.	%	NN	I-NP	O.	Interestingly	.	.	O	OInterestingly	","	Interestingly	RB	B-ADVP	O","	inhibiting	","	","	O	Oinhibiting	PKC	inhibit	VBG	B-VP	OPKC	signaling	PKC	NN	B-NP	B-proteinsignaling	with	signaling	NN	I-NP	Owith	calphostin	with	IN	B-PP	Ocalphostin	C	calphostin	NN	B-NP	OC	further	C	NN	I-NP	Ofurther	increased	further	RBR	B-ADVP	Oincreased	P-CREB	increase	VBD	B-VP	OP-CREB	levels	P-CREB	NN	B-NP	B-proteinlevels	3-fold	level	NNS	I-NP	O3-fold	over	3-fold	RB	B-ADVP	Oover	that	over	IN	B-PP	Othat	observed	that	DT	B-NP	Oobserved	in	observe	VBN	B-VP	Oin	IL-2/CD3	in	IN	B-PP	OIL-2/CD3	co-stimulated	IL-2/CD3	NN	B-NP	B-cell_lineco-stimulated	cells	co-stimulated	JJ	I-NP	I-cell_linecells	not	cell	NNS	I-NP	I-cell_linenot	pretreated	not	RB	B-VP	Opretreated	with	pretreate	VBN	I-VP	Owith	a	with	IN	B-PP	Oa	PKC	a	DT	B-NP	OPKC	inhibitor	PKC	NN	I-NP	B-proteininhibitor	.	inhibitor	NN	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	to	contrast	NN	B-NP	Oto	previous	to	TO	B-PP	Oprevious	studies	previous	JJ	B-NP	Ostudies	performed	study	NNS	I-NP	Operformed	in	perform	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	exogenous	of	IN	B-PP	Oexogenous	IL-2	exogenous	JJ	B-NP	OIL-2	","	IL-2	NN	I-NP	B-protein","	no	","	","	O	Ono	increase	no	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	binding	in	IN	B-PP	Obinding	of	binding	NN	B-NP	Oof	CREB	of	IN	B-PP	OCREB	to	CREB	NN	B-NP	B-proteinto	a	to	TO	B-PP	Oa	32P-labeled	a	DT	B-NP	O32P-labeled	oligonucleotide	32P-labeled	JJ	I-NP	B-DNAoligonucleotide	probe	oligonucleotide	NN	I-NP	I-DNAprobe	was	probe	NN	I-NP	I-DNAwas	observed	be	VBD	B-VP	Oobserved	by	observe	VBN	I-VP	Oby	electrophoretic	by	IN	B-PP	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assay	shift	NN	I-NP	Oassay	.	assay	NN	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	IL-2	the	DT	B-NP	OIL-2	and	IL-2	NN	I-NP	B-proteinand	CD3	and	CC	I-NP	OCD3	signaling	CD3	NN	I-NP	B-proteinsignaling	pathways	signaling	NN	I-NP	Opathways	provide	pathway	NNS	I-NP	Oprovide	a	provide	VBP	B-VP	Oa	necessary	a	DT	B-NP	Onecessary	and	necessary	JJ	I-NP	Oand	co-operative	and	CC	I-NP	Oco-operative	stimulus	co-operative	JJ	I-NP	Ostimulus	promoting	stimulus	NN	I-NP	Opromoting	phosphorylation	promote	VBG	B-VP	Ophosphorylation	of	phosphorylation	NN	B-NP	Oof	CREB	of	IN	B-PP	OCREB	following	CREB	NN	B-NP	B-proteinfollowing	receptor	follow	VBG	B-PP	Oreceptor	cross-linking	receptor	NN	B-NP	Ocross-linking	.	cross-linking	NN	I-NP	O.	HIV-1	.	.	O	OHIV-1	infection	HIV-1	NN	B-NP	Oinfection	induces	infection	NN	I-NP	Oinduces	a	induce	VBZ	B-VP	Oa	selective	a	DT	B-NP	Oselective	reduction	selective	JJ	I-NP	Oreduction	in	reduction	NN	I-NP	Oin	STAT5	in	IN	B-PP	OSTAT5	protein	STAT5	NN	B-NP	B-proteinprotein	expression	protein	NN	I-NP	Oexpression	.	expression	NN	I-NP	O.	HIV-1	.	.	O	OHIV-1	infection	HIV-1	NN	B-NP	Oinfection	is	infection	NN	I-NP	Ois	accompanied	be	VBZ	B-VP	Oaccompanied	by	accompany	VBN	I-VP	Oby	qualitative	by	IN	B-PP	Oqualitative	and	qualitative	JJ	B-NP	Oand	quantitative	and	CC	I-NP	Oquantitative	defects	quantitative	JJ	I-NP	Odefects	in	defect	NNS	I-NP	Oin	CD4+	in	IN	B-PP	OCD4+	T	CD4+	JJ	B-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Loss	.	.	O	OLoss	of	Loss	NN	B-NP	Oof	immune	of	IN	B-PP	Oimmune	function	immune	JJ	B-NP	Ofunction	in	function	NN	I-NP	Oin	HIV	in	IN	B-PP	OHIV	patients	HIV	NN	B-NP	Opatients	is	patient	NNS	I-NP	Ois	usually	be	VBZ	B-VP	Ousually	associated	usually	RB	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	a	with	IN	B-PP	Oa	profound	a	DT	B-NP	Oprofound	dysregulation	profound	JJ	I-NP	Odysregulation	of	dysregulation	NN	I-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	production	cytokine	NN	B-NP	B-proteinproduction	.	production	NN	I-NP	O.	To	.	.	O	OTo	investigate	To	TO	B-VP	Oinvestigate	whether	investigate	VB	I-VP	Owhether	cytokine	whether	IN	B-SBAR	Ocytokine	signaling	cytokine	NN	B-NP	B-proteinsignaling	defects	signaling	NN	I-NP	Odefects	occur	defect	NNS	I-NP	Ooccur	during	occur	VBP	B-VP	Oduring	HIV	during	IN	B-PP	OHIV	infection	HIV	NN	B-NP	Oinfection	","	infection	NN	I-NP	O","	PHA	","	","	O	OPHA	blasts	PHA	NN	B-NP	B-cell_lineblasts	from	blast	NNS	I-NP	I-cell_linefrom	healthy	from	IN	B-PP	Ohealthy	human	healthy	JJ	B-NP	Ohuman	donors	human	JJ	I-NP	Odonors	were	donor	NNS	I-NP	Owere	infected	be	VBD	B-VP	Oinfected	with	infect	VBN	I-VP	Owith	two	with	IN	B-PP	Otwo	strains	two	CD	B-NP	Ostrains	of	strain	NNS	I-NP	Oof	HIV-1	of	IN	B-PP	OHIV-1	and	HIV-1	NN	B-NP	Oand	screened	and	CC	O	Oscreened	for	screen	VBD	B-VP	Ofor	the	for	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	STAT	of	IN	B-PP	OSTAT	proteins	STAT	NN	B-NP	B-proteinproteins	used	protein	NNS	I-NP	I-proteinused	in	use	VBN	B-VP	Oin	cytokine	in	IN	B-PP	Ocytokine	signaling	cytokine	NN	B-NP	B-proteinsignaling	.	signaling	NN	I-NP	O.	A	.	.	O	OA	selective	A	DT	B-NP	Oselective	decrease	selective	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	STAT5B	in	IN	B-PP	OSTAT5B	was	STAT5B	NN	B-NP	B-proteinwas	seen	be	VBD	B-VP	Oseen	8	see	VBN	I-VP	O8	days	8	CD	B-NP	Odays	after	day	NNS	I-NP	Oafter	infection	after	IN	B-PP	Oinfection	with	infection	NN	B-NP	Owith	the	with	IN	B-PP	Othe	BZ167	the	DT	B-NP	OBZ167	dual-tropic	BZ167	NN	I-NP	Odual-tropic	HIV	dual-tropic	JJ	I-NP	OHIV	isolate	HIV	NN	I-NP	Oisolate	","	isolate	NN	I-NP	O","	but	","	","	O	Obut	not	but	CC	O	Onot	with	not	RB	O	Owith	the	with	IN	B-PP	Othe	Ba-L	the	DT	B-NP	OBa-L	","	Ba-L	NN	I-NP	O","	M-tropic	","	","	O	OM-tropic	strain	M-tropic	JJ	B-NP	Ostrain	.	strain	NN	I-NP	O.	Based	.	.	O	OBased	on	Base	VBN	B-PP	Oon	these	on	IN	B-PP	Othese	findings	these	DT	B-NP	Ofindings	","	finding	NNS	I-NP	O","	purified	","	","	O	Opurified	T	purify	VBN	B-NP	OT	cells	T	NN	I-NP	B-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	HIV-infected	from	IN	B-PP	OHIV-infected	patients	HIV-infected	JJ	B-NP	Opatients	in	patient	NNS	I-NP	Oin	different	in	IN	B-PP	Odifferent	stages	different	JJ	B-NP	Ostages	of	stage	NNS	I-NP	Oof	disease	of	IN	B-PP	Odisease	were	disease	NN	B-NP	Owere	also	be	VBD	B-VP	Oalso	tested	also	RB	I-VP	Otested	for	test	VBN	I-VP	Ofor	STAT	for	IN	B-PP	OSTAT	expression	STAT	NN	B-NP	B-proteinexpression	;	expression	NN	I-NP	O;	decreases	;	:	O	Odecreases	in	decrease	VBZ	B-VP	Oin	STAT5A	in	IN	B-PP	OSTAT5A	","	STAT5A	NN	B-NP	B-protein","	STAT5B	","	","	O	OSTAT5B	","	STAT5B	NN	B-NP	B-protein","	and	","	","	O	Oand	STAT1alpha	and	CC	O	OSTAT1alpha	were	STAT1alpha	NN	B-NP	B-proteinwere	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	all	in	IN	B-PP	Oall	patients	all	DT	B-NP	Opatients	.	patient	NNS	I-NP	O.	The	.	.	O	OThe	reduction	The	DT	B-NP	Oreduction	in	reduction	NN	I-NP	Oin	STATs	in	IN	B-PP	OSTATs	seen	STAT	NNS	B-NP	B-proteinseen	in	see	VBN	B-VP	Oin	vivo	in	FW	B-ADVP	Ovivo	and	vivo	FW	I-ADVP	Oand	in	and	CC	O	Oin	vitro	in	FW	B-ADVP	Ovitro	after	vitro	FW	I-ADVP	Oafter	HIV	after	IN	B-PP	OHIV	infection	HIV	NN	B-NP	Oinfection	may	infection	NN	I-NP	Omay	contribute	may	MD	B-VP	Ocontribute	to	contribute	VB	I-VP	Oto	the	to	TO	B-PP	Othe	loss	the	DT	B-NP	Oloss	of	loss	NN	I-NP	Oof	T	of	IN	B-PP	OT	cell	T	NN	B-NP	B-cell_typecell	function	cell	NN	I-NP	I-cell_typefunction	in	function	NN	I-NP	Oin	HIV	in	IN	B-PP	OHIV	disease	HIV	NN	B-NP	Odisease	.	disease	NN	I-NP	O.	Transcription	.	.	O	OTranscription	factors	Transcription	NN	B-NP	B-proteinfactors	that	factor	NNS	I-NP	I-proteinthat	regulate	that	WDT	B-NP	Oregulate	monocyte	regulate	VBP	B-VP	Omonocyte	/	monocyte	NN	B-NP	B-cell_type/	macrophage	/	SYM	B-VP	Omacrophage	differentiation	macrophage	NN	B-NP	Odifferentiation	.	differentiation	NN	I-NP	O.	Although	.	.	O	OAlthough	all	Although	IN	B-SBAR	Oall	the	all	PDT	B-NP	Othe	cells	the	DT	I-NP	Ocells	in	cell	NNS	I-NP	Oin	an	in	IN	B-PP	Oan	organism	an	DT	B-NP	Oorganism	contain	organism	NN	I-NP	Ocontain	the	contain	VBP	B-VP	Othe	same	the	DT	B-NP	Osame	genetic	same	JJ	I-NP	Ogenetic	information	genetic	JJ	I-NP	Oinformation	","	information	NN	I-NP	O","	differences	","	","	O	Odifferences	in	difference	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	phenotype	cell	NN	I-NP	Ophenotype	arise	phenotype	NN	I-NP	Oarise	from	arise	VBP	B-VP	Ofrom	the	from	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	lineage-specific	of	IN	B-PP	Olineage-specific	genes	lineage-specific	JJ	B-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	During	.	.	O	ODuring	myelopoiesis	During	IN	B-PP	Omyelopoiesis	","	myelopoiesis	NN	B-NP	O","	external	","	","	O	Oexternal	differentiating	external	JJ	B-NP	Odifferentiating	signals	differentiate	VBG	I-NP	Osignals	regulate	signal	NNS	I-NP	Oregulate	the	regulate	VBP	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	a	of	IN	B-PP	Oa	set	a	DT	B-NP	Oset	of	set	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	.	factor	NNS	I-NP	I-protein.	The	.	.	O	OThe	combined	The	DT	B-NP	Ocombined	action	combined	JJ	I-NP	Oaction	of	action	NN	I-NP	Oof	these	of	IN	B-PP	Othese	transcription	these	DT	B-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	subsequently	factor	NNS	I-NP	I-proteinsubsequently	determines	subsequently	RB	B-ADVP	Odetermines	the	determine	VBZ	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	myeloid-specific	of	IN	B-PP	Omyeloid-specific	genes	myeloid-specific	JJ	B-NP	B-DNAgenes	and	gene	NNS	I-NP	I-DNAand	the	and	CC	O	Othe	generation	the	DT	B-NP	Ogeneration	of	generation	NN	I-NP	Oof	monocytes	of	IN	B-PP	Omonocytes	and	monocyte	NNS	B-NP	B-cell_typeand	macrophages	and	CC	O	Omacrophages	.	macrophage	NNS	B-NP	B-cell_type.	In	.	.	O	OIn	particular	In	IN	B-PP	Oparticular	","	particular	JJ	B-NP	O","	the	","	","	O	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	PU.1	factor	NN	I-NP	I-proteinPU.1	has	PU.1	NN	I-NP	B-proteinhas	a	have	VBZ	B-VP	Oa	critical	a	DT	B-NP	Ocritical	role	critical	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	this	in	IN	B-PP	Othis	process	this	DT	B-NP	Oprocess	.	process	NN	I-NP	O.	We	.	.	O	OWe	review	We	PRP	B-NP	Oreview	the	review	VBP	B-VP	Othe	contribution	the	DT	B-NP	Ocontribution	of	contribution	NN	I-NP	Oof	several	of	IN	B-PP	Oseveral	transcription	several	JJ	B-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	to	factor	NNS	I-NP	I-proteinto	the	to	TO	B-PP	Othe	control	the	DT	B-NP	Ocontrol	of	control	NN	I-NP	Oof	macrophage	of	IN	B-PP	Omacrophage	development	macrophage	NN	B-NP	Odevelopment	Transcription	development	NN	I-NP	OTranscription	factor	Transcription	NN	B-NP	B-proteinfactor	LKLF	factor	NN	I-NP	I-proteinLKLF	is	LKLF	NN	I-NP	I-proteinis	sufficient	be	VBZ	B-VP	Osufficient	to	sufficient	JJ	B-ADJP	Oto	program	to	TO	B-PP	Oprogram	T	program	NN	B-NP	OT	cell	T	NN	I-NP	Ocell	quiescence	cell	NN	I-NP	Oquiescence	via	quiescence	NN	I-NP	Ovia	a	via	IN	B-PP	Oa	c-Myc	a	DT	B-NP	Oc-Myc	--	c-Myc	NN	I-NP	B-protein--	dependent	--	:	O	Odependent	pathway	dependent	JJ	B-NP	Opathway	.	pathway	NN	I-NP	O.	T	.	.	O	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	circulate	lymphocyte	NNS	I-NP	I-cell_typecirculate	in	circulate	VBP	B-VP	Oin	a	in	IN	B-PP	Oa	quiescent	a	DT	B-NP	Oquiescent	state	quiescent	JJ	I-NP	Ostate	until	state	NN	I-NP	Ountil	they	until	IN	B-SBAR	Othey	encounter	they	PRP	B-NP	Oencounter	cognate	encounter	VBP	B-VP	Ocognate	antigen	cognate	JJ	B-NP	B-proteinantigen	bound	antigen	NN	I-NP	I-proteinbound	to	bind	VBD	B-VP	Oto	the	to	TO	B-PP	Othe	surface	the	DT	B-NP	Osurface	of	surface	NN	I-NP	Oof	an	of	IN	B-PP	Oan	antigen-presenting	an	DT	B-NP	Oantigen-presenting	cell	antigen-presenting	JJ	I-NP	B-cell_typecell	.	cell	NN	I-NP	I-cell_type.	The	.	.	O	OThe	molecular	The	DT	B-NP	Omolecular	pathways	molecular	JJ	I-NP	Opathways	that	pathway	NNS	I-NP	Othat	regulate	that	WDT	B-NP	Oregulate	T	regulate	VBP	B-VP	OT	cell	T	NN	B-NP	Ocell	quiescence	cell	NN	I-NP	Oquiescence	remain	quiescence	NN	I-NP	Oremain	largely	remain	VBP	B-VP	Olargely	unknown	largely	RB	B-ADJP	Ounknown	.	unknown	JJ	I-ADJP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	forced	that	IN	B-SBAR	Oforced	expression	force	VBN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	lung	the	DT	B-NP	Olung	Kruppel-like	lung	NN	I-NP	B-proteinKruppel-like	transcription	Kruppel-like	JJ	I-NP	I-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	LKLF	(	(	O	OLKLF	)	LKLF	NN	B-NP	B-protein)	in	)	)	O	Oin	Jurkat	in	IN	B-PP	OJurkat	T	Jurkat	NN	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	is	cell	NNS	I-NP	I-cell_lineis	sufficient	be	VBZ	B-VP	Osufficient	to	sufficient	JJ	B-ADJP	Oto	program	to	TO	B-VP	Oprogram	a	program	VB	I-VP	Oa	quiescent	a	DT	B-NP	Oquiescent	phenotype	quiescent	JJ	I-NP	Ophenotype	characterized	phenotype	NN	I-NP	Ocharacterized	by	characterize	VBN	B-VP	Oby	decreased	by	IN	B-PP	Odecreased	proliferation	decrease	VBN	B-NP	Oproliferation	","	proliferation	NN	I-NP	O","	reduced	","	","	O	Oreduced	cell	reduce	VBD	B-VP	Ocell	size	cell	NN	B-NP	Osize	and	size	NN	I-NP	Oand	protein	and	CC	O	Oprotein	synthesis	protein	NN	B-NP	Osynthesis	and	synthesis	NN	I-NP	Oand	decreased	and	CC	O	Odecreased	surface	decrease	VBD	B-VP	Osurface	expression	surface	NN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	activation	of	IN	B-PP	Oactivation	markers	activation	NN	B-NP	Omarkers	.	marker	NNS	I-NP	O.	Conversely	.	.	O	OConversely	","	Conversely	RB	B-ADVP	O","	LKLF-deficient	","	","	O	OLKLF-deficient	peripheral	LKLF-deficient	JJ	B-NP	B-cell_typeperipheral	T	peripheral	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	produced	cell	NNS	I-NP	I-cell_typeproduced	by	produce	VBN	B-VP	Oby	gene	by	IN	B-PP	Ogene	targeting	gene	NN	B-NP	Otargeting	showed	targeting	NN	I-NP	Oshowed	increased	show	VBD	B-VP	Oincreased	proliferation	increase	VBN	B-NP	Oproliferation	","	proliferation	NN	I-NP	O","	increased	","	","	O	Oincreased	cell	increase	VBD	B-VP	Ocell	size	cell	NN	B-NP	Osize	and	size	NN	I-NP	Oand	enhanced	and	CC	O	Oenhanced	expression	enhance	VBN	B-VP	Oexpression	of	expression	NN	B-NP	Oof	surface	of	IN	B-PP	Osurface	activation	surface	NN	B-NP	B-proteinactivation	markers	activation	NN	I-NP	I-proteinmarkers	in	marker	NNS	I-NP	I-proteinin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	LKLF	.	.	O	OLKLF	appeared	LKLF	NN	B-NP	B-proteinappeared	to	appear	VBD	B-VP	Oto	function	to	TO	I-VP	Ofunction	","	function	VB	I-VP	O","	at	","	","	O	Oat	least	at	IN	B-ADVP	Oleast	in	least	JJS	I-ADVP	Oin	part	in	IN	B-PP	Opart	","	part	NN	B-NP	O","	by	","	","	O	Oby	decreasing	by	IN	B-PP	Odecreasing	expression	decrease	VBG	B-VP	Oexpression	of	expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	proto-oncogene	the	DT	B-NP	Oproto-oncogene	encoding	proto-oncogene	NN	I-NP	B-DNAencoding	c-Myc	encode	VBG	B-VP	Oc-Myc	.	c-Myc	NN	B-NP	B-protein.	Forced	.	.	O	OForced	expression	Force	VBN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	LKLF	of	IN	B-PP	OLKLF	was	LKLF	NN	B-NP	B-proteinwas	associated	be	VBD	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	markedly	with	IN	B-PP	Omarkedly	decreased	markedly	RB	B-NP	Odecreased	c-Myc	decrease	VBN	I-NP	Oc-Myc	expression	c-Myc	NN	I-NP	B-proteinexpression	.	expression	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	many	","	","	O	Omany	effects	many	JJ	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	LKLF	of	IN	B-PP	OLKLF	expression	LKLF	NN	B-NP	B-proteinexpression	were	expression	NN	I-NP	Owere	mimicked	be	VBD	B-VP	Omimicked	by	mimic	VBN	I-VP	Oby	expression	by	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	dominant-negative	the	DT	B-NP	Odominant-negative	MadMyc	dominant-negative	JJ	I-NP	B-proteinMadMyc	protein	MadMyc	NN	I-NP	I-proteinprotein	and	protein	NN	I-NP	I-proteinand	rescued	and	CC	O	Orescued	by	rescue	VBN	B-VP	Oby	overexpression	by	IN	B-PP	Ooverexpression	of	overexpression	NN	B-NP	Oof	c-Myc	of	IN	B-PP	Oc-Myc	.	c-Myc	NN	B-NP	B-protein.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	LKLF	","	","	O	OLKLF	is	LKLF	NN	B-NP	B-proteinis	both	be	VBZ	B-VP	Oboth	necessary	both	CC	O	Onecessary	and	necessary	JJ	B-NP	Oand	sufficient	and	CC	I-NP	Osufficient	to	sufficient	JJ	I-NP	Oto	program	to	TO	B-PP	Oprogram	quiescence	program	NN	B-NP	Oquiescence	in	quiescence	NN	I-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	functions	and	CC	O	Ofunctions	","	function	NNS	B-NP	O","	in	","	","	O	Oin	part	in	IN	B-PP	Opart	","	part	NN	B-NP	O","	by	","	","	O	Oby	negatively	by	IN	B-PP	Onegatively	regulating	negatively	RB	B-ADVP	Oregulating	a	regulate	VBG	B-VP	Oa	c-Myc	a	DT	B-NP	Oc-Myc	--	c-Myc	NN	I-NP	B-protein--	dependent	--	:	O	Odependent	pathway	dependent	JJ	B-NP	Opathway	.	pathway	NN	I-NP	O.	HTLV-1	.	.	O	OHTLV-1	p12	HTLV-1	NN	B-NP	B-proteinp12	(	p12	NN	I-NP	I-protein(	I	(	(	O	I-proteinI	)	I	NN	B-NP	I-protein)	protein	)	)	O	I-proteinprotein	enhances	protein	NN	B-NP	I-proteinenhances	STAT5	enhance	VBZ	B-VP	OSTAT5	activation	STAT5	NN	B-NP	B-proteinactivation	and	activation	NN	I-NP	Oand	decreases	and	CC	O	Odecreases	the	decrease	VBZ	B-VP	Othe	interleukin-2	the	DT	B-NP	Ointerleukin-2	requirement	interleukin-2	NN	I-NP	B-proteinrequirement	for	requirement	NN	I-NP	Ofor	proliferation	for	IN	B-PP	Oproliferation	of	proliferation	NN	B-NP	Oof	primary	of	IN	B-PP	Oprimary	human	primary	JJ	B-NP	B-cell_typehuman	peripheral	human	JJ	I-NP	I-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	p12	The	DT	B-NP	Op12	(	p12	NN	I-NP	B-protein(	I	(	(	O	I-proteinI	)	I	NN	B-NP	I-protein)	protein	)	)	O	I-proteinprotein	","	protein	NN	B-NP	I-protein","	encoded	","	","	O	Oencoded	by	encode	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	pX	the	DT	B-NP	OpX	open	pX	NN	I-NP	B-proteinopen	reading	open	JJ	I-NP	I-proteinreading	frame	reading	NN	I-NP	I-proteinframe	I	frame	NN	I-NP	I-proteinI	of	I	CD	I-NP	I-proteinof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	T-lymphotropic	human	JJ	I-NP	OT-lymphotropic	virus	T-lymphotropic	JJ	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	(	1	CD	I-NP	O(	HTLV-1	(	(	O	OHTLV-1	)	HTLV-1	NN	B-NP	O)	","	)	)	O	O","	is	","	","	O	Ois	a	be	VBZ	B-VP	Oa	hydrophobic	a	DT	B-NP	Ohydrophobic	protein	hydrophobic	JJ	I-NP	B-proteinprotein	that	protein	NN	I-NP	I-proteinthat	localizes	that	WDT	B-NP	Olocalizes	to	localize	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	endoplasmic	the	DT	B-NP	Oendoplasmic	reticulum	endoplasmic	JJ	I-NP	Oreticulum	and	reticulum	NN	I-NP	Oand	the	and	CC	O	Othe	Golgi	the	DT	B-NP	OGolgi	.	Golgi	NNP	I-NP	O.	Although	.	.	O	OAlthough	p12	Although	IN	B-SBAR	Op12	(	p12	NN	B-NP	B-protein(	I	(	(	O	I-proteinI	)	I	NN	B-NP	I-protein)	contains	)	)	O	I-proteincontains	4	contain	VBZ	B-VP	O4	minimal	4	CD	B-NP	Ominimal	proline-rich	minimal	JJ	I-NP	Oproline-rich	","	proline-rich	JJ	I-NP	O","	src	","	","	I-NP	Osrc	homology	src	NN	I-NP	B-DNAhomology	3-binding	homology	NN	I-NP	I-DNA3-binding	motifs	3-binding	JJ	I-NP	I-DNAmotifs	(	motif	NNS	I-NP	I-DNA(	PXXP	(	(	O	OPXXP	)	PXXP	NN	B-NP	B-protein)	","	)	)	O	O","	a	","	","	O	Oa	characteristic	a	DT	B-NP	Ocharacteristic	commonly	characteristic	JJ	I-NP	Ocommonly	found	commonly	RB	I-NP	Ofound	in	find	VBN	I-VP	Oin	proteins	in	IN	B-PP	Oproteins	involved	protein	NNS	B-NP	Oinvolved	in	involve	VBN	B-VP	Oin	signaling	in	IN	B-PP	Osignaling	pathways	signaling	NN	B-NP	Opathways	","	pathway	NNS	I-NP	O","	it	","	","	O	Oit	has	it	PRP	B-NP	Ohas	not	have	VBZ	B-VP	Onot	been	not	RB	I-VP	Obeen	known	be	VBN	I-VP	Oknown	whether	know	VBN	I-VP	Owhether	p12	whether	IN	B-SBAR	Op12	(	p12	NN	B-NP	B-protein(	I	(	(	O	I-proteinI	)	I	NN	B-NP	I-protein)	has	)	)	O	I-proteinhas	a	have	VBZ	B-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	modulating	in	IN	B-PP	Omodulating	intracellular	modulate	VBG	B-VP	Ointracellular	signaling	intracellular	JJ	B-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	.	pathway	NNS	I-NP	O.	This	.	.	O	OThis	study	This	DT	B-NP	Ostudy	demonstrated	study	NN	I-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	p12	that	IN	B-SBAR	Op12	(	p12	NN	B-NP	B-protein(	I	(	(	O	I-proteinI	)	I	NN	B-NP	I-protein)	binds	)	)	O	I-proteinbinds	to	bind	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	cytoplasmic	the	DT	B-NP	Ocytoplasmic	domain	cytoplasmic	JJ	I-NP	B-proteindomain	of	domain	NN	I-NP	I-proteinof	the	of	IN	B-PP	Othe	interleukin-2	the	DT	B-NP	Ointerleukin-2	receptor	interleukin-2	NN	I-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	IL-2R	(	(	O	I-proteinIL-2R	)	IL-2R	NN	B-NP	I-protein)	beta	)	)	O	I-proteinbeta	chain	beta	NN	B-NP	I-proteinchain	that	chain	NN	I-NP	I-proteinthat	is	that	WDT	B-NP	Ois	involved	be	VBZ	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	recruitment	the	DT	B-NP	Orecruitment	of	recruitment	NN	I-NP	Oof	the	of	IN	B-PP	Othe	Jak1	the	DT	B-NP	OJak1	and	Jak1	NN	I-NP	B-proteinand	Jak3	and	CC	I-NP	OJak3	kinases	Jak3	NN	I-NP	B-proteinkinases	.	kinase	NNS	I-NP	I-protein.	As	.	.	O	OAs	a	As	IN	B-PP	Oa	result	a	DT	B-NP	Oresult	of	result	NN	I-NP	Oof	this	of	IN	B-PP	Othis	interaction	this	DT	B-NP	Ointeraction	","	interaction	NN	I-NP	O","	p12	","	","	O	Op12	(	p12	NN	B-NP	B-protein(	I	(	(	O	I-proteinI	)	I	NN	B-NP	I-protein)	increases	)	)	O	I-proteinincreases	signal	increase	VBZ	B-VP	Osignal	transducers	signal	NN	B-NP	B-proteintransducers	and	transducer	NNS	I-NP	I-proteinand	activators	and	CC	I-NP	I-proteinactivators	of	activator	NNS	I-NP	I-proteinof	transcription	of	IN	B-PP	I-proteintranscription	5	transcription	NN	B-NP	I-protein5	(	5	CD	I-NP	I-protein(	STAT5	(	(	O	OSTAT5	)	STAT5	NN	B-NP	B-protein)	DNA	)	)	O	ODNA	binding	DNA	NN	B-NP	Obinding	and	binding	NN	I-NP	Oand	transcriptional	and	CC	O	Otranscriptional	activity	transcriptional	JJ	B-NP	Oactivity	and	activity	NN	I-NP	Oand	this	and	CC	O	Othis	effect	this	DT	B-NP	Oeffect	depends	effect	NN	I-NP	Odepends	on	depend	VBZ	B-VP	Oon	the	on	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	both	of	IN	B-PP	Oboth	IL-2R	both	CC	O	OIL-2R	beta	IL-2R	NN	B-NP	B-proteinbeta	and	beta	NN	I-NP	I-proteinand	gamma	and	CC	O	Ogamma	(	gamma	NN	B-NP	B-protein(	c	(	(	O	I-proteinc	)	c	NN	B-NP	I-protein)	chains	)	)	O	I-proteinchains	and	chain	NNS	B-NP	I-proteinand	Jak3	and	CC	I-NP	OJak3	.	Jak3	NN	I-NP	B-protein.	Transduction	.	.	O	OTransduction	of	Transduction	NN	B-NP	Oof	primary	of	IN	B-PP	Oprimary	human	primary	JJ	B-NP	B-cell_typehuman	peripheral	human	JJ	I-NP	I-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	PBMCs	(	(	O	OPBMCs	)	PBMC	NNS	B-NP	B-cell_type)	with	)	)	O	Owith	a	with	IN	B-PP	Oa	human	a	DT	B-NP	Ohuman	immunodeficiency	human	JJ	I-NP	B-DNAimmunodeficiency	virus	immunodeficiency	NN	I-NP	I-DNAvirus	type	virus	NN	I-NP	I-DNAtype	1-based	type	NN	I-NP	I-DNA1-based	retroviral	1-based	JJ	I-NP	I-DNAretroviral	vector	retroviral	JJ	I-NP	I-DNAvector	expressing	vector	NN	I-NP	I-DNAexpressing	p12	express	VBG	B-VP	Op12	(	p12	NN	B-NP	B-protein(	I	(	(	O	I-proteinI	)	I	NN	B-NP	I-protein)	also	)	)	O	I-proteinalso	resulted	also	RB	B-ADVP	Oresulted	in	result	VBD	B-VP	Oin	increased	in	IN	B-PP	Oincreased	STAT5	increase	VBN	B-NP	OSTAT5	phosphorylation	STAT5	NN	I-NP	B-proteinphosphorylation	and	phosphorylation	NN	I-NP	Oand	DNA	and	CC	O	ODNA	binding	DNA	NN	B-NP	Obinding	.	binding	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	p12	","	","	O	Op12	(	p12	NN	B-NP	B-protein(	I	(	(	O	I-proteinI	)	I	NN	B-NP	I-protein)	could	)	)	O	I-proteincould	increase	could	MD	B-VP	Oincrease	proliferation	increase	VB	I-VP	Oproliferation	of	proliferation	NN	B-NP	Oof	human	of	IN	B-PP	Ohuman	PBMCs	human	JJ	B-NP	OPBMCs	only	PBMC	NNS	I-NP	B-cell_typeonly	after	only	RB	B-ADVP	Oafter	stimulation	after	IN	B-PP	Ostimulation	of	stimulation	NN	B-NP	Oof	T-cell	of	IN	B-PP	OT-cell	receptors	T-cell	NN	B-NP	B-proteinreceptors	by	receptor	NNS	I-NP	I-proteinby	treatment	by	IN	B-PP	Otreatment	of	treatment	NN	B-NP	Oof	cells	of	IN	B-PP	Ocells	with	cell	NNS	B-NP	Owith	low	with	IN	B-PP	Olow	concentrations	low	JJ	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	alphaCD3	of	IN	B-PP	OalphaCD3	and	alphaCD3	NN	B-NP	B-proteinand	alphaCD28	and	CC	I-NP	OalphaCD28	antibodies	alphaCD28	NN	I-NP	B-proteinantibodies	.	antibody	NNS	I-NP	I-protein.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	the	","	","	O	Othe	proliferative	the	DT	B-NP	Oproliferative	advantage	proliferative	JJ	I-NP	Oadvantage	of	advantage	NN	I-NP	Oof	p12	of	IN	B-PP	Op12	(	p12	NN	B-NP	O(	I	(	(	I-NP	OI	)	I	NN	I-NP	O)	#NAME?	)	)	I-NP	O#NAME?	PBMCs	#NAME?	JJ	I-NP	OPBMCs	was	PBMC	NNS	I-NP	B-cell_typewas	evident	be	VBD	B-VP	Oevident	mainly	evident	JJ	B-ADJP	Omainly	at	mainly	RB	B-ADVP	Oat	low	at	IN	B-PP	Olow	concentrations	low	JJ	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	.	IL-2	NN	B-NP	B-protein.	Together	.	.	O	OTogether	","	Together	RB	B-ADVP	O","	these	","	","	O	Othese	data	these	DT	B-NP	Odata	indicate	datum	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	p12	that	IN	B-SBAR	Op12	(	p12	NN	B-NP	B-protein(	I	(	(	O	I-proteinI	)	I	NN	B-NP	I-protein)	may	)	)	O	I-proteinmay	confer	may	MD	B-VP	Oconfer	a	confer	VB	I-VP	Oa	proliferative	a	DT	B-NP	Oproliferative	advantage	proliferative	JJ	I-NP	Oadvantage	on	advantage	NN	I-NP	Oon	HTLV-1-infected	on	IN	B-PP	OHTLV-1-infected	cells	HTLV-1-infected	JJ	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	the	in	IN	B-PP	Othe	presence	the	DT	I-PP	Opresence	of	presence	NN	I-PP	Oof	suboptimal	of	IN	I-PP	Osuboptimal	antigen	suboptimal	JJ	B-NP	Oantigen	stimulation	antigen	NN	I-NP	Ostimulation	and	stimulation	NN	I-NP	Oand	that	and	CC	O	Othat	this	that	IN	B-SBAR	Othis	event	this	DT	B-NP	Oevent	may	event	NN	I-NP	Omay	account	may	MD	B-VP	Oaccount	for	account	VB	I-VP	Ofor	the	for	IN	B-PP	Othe	clonal	the	DT	B-NP	Oclonal	proliferation	clonal	JJ	I-NP	Oproliferation	of	proliferation	NN	I-NP	Oof	infected	of	IN	B-PP	Oinfected	T	infected	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	(	.	.	O	O(	Blood.	(	(	O	OBlood.	2001	Blood.	NNP	B-NP	O2001	;	2001	CD	I-NP	O;	98	;	:	O	O98	:	98	CD	B-NP	O:	823-829	:	:	O	O823-829	)	823-829	CD	B-NP	O)	Single	)	)	O	OSingle	dose	Single	JJ	B-NP	Odose	intranasal	dose	NN	I-NP	Ointranasal	administration	intranasal	JJ	I-NP	Oadministration	of	administration	NN	I-NP	Oof	retinal	of	IN	B-PP	Oretinal	autoantigen	retinal	JJ	B-NP	B-proteinautoantigen	generates	autoantigen	NN	I-NP	I-proteingenerates	a	generate	VBZ	B-VP	Oa	rapid	a	DT	B-NP	Orapid	accumulation	rapid	JJ	I-NP	Oaccumulation	and	accumulation	NN	I-NP	Oand	cell	and	CC	O	Ocell	activation	cell	NN	B-NP	Oactivation	in	activation	NN	I-NP	Oin	draining	in	IN	B-PP	Odraining	lymph	drain	VBG	B-VP	Olymph	node	lymph	NN	B-NP	Onode	and	node	NN	I-NP	Oand	spleen	and	CC	I-NP	Ospleen	:	spleen	NN	I-NP	O:	implications	:	:	O	Oimplications	for	implication	NNS	B-NP	Ofor	tolerance	for	IN	B-PP	Otolerance	therapy	tolerance	NN	B-NP	Otherapy	.	therapy	NN	I-NP	O.	BACKGROUND/AIMS	.	.	O	OBACKGROUND/AIMS	:	BACKGROUND/AIMS	NN	B-NP	O:	A	:	:	O	OA	single	A	DT	B-NP	Osingle	intranasal	single	JJ	I-NP	Ointranasal	delivery	intranasal	JJ	I-NP	Odelivery	of	delivery	NN	I-NP	Oof	retinal	of	IN	B-PP	Oretinal	autoantigen	retinal	JJ	B-NP	B-proteinautoantigen	suppresses	autoantigen	NN	I-NP	I-proteinsuppresses	effectively	suppress	VBZ	B-VP	Oeffectively	experimental	effectively	RB	B-NP	Oexperimental	autoimmune	experimental	JJ	I-NP	Oautoimmune	uveoretinitis	autoimmune	JJ	I-NP	Ouveoretinitis	(	uveoretinitis	NN	I-NP	O(	EAU	(	(	O	OEAU	)	EAU	NN	B-NP	B-protein)	.	)	)	O	O.	To	.	.	O	OTo	further	To	TO	B-PP	Ofurther	unravel	further	RB	B-NP	Ounravel	underlying	unravel	JJ	I-NP	Ounderlying	mechanisms	underlie	VBG	I-NP	Omechanisms	the	mechanism	NNS	I-NP	Othe	authors	the	DT	B-NP	Oauthors	wished	author	NNS	I-NP	Owished	to	wish	VBD	B-VP	Oto	determine	to	TO	I-VP	Odetermine	","	determine	VB	I-VP	O","	firstly	","	","	O	Ofirstly	","	firstly	RB	B-ADVP	O","	the	","	","	O	Othe	kinetics	the	DT	B-NP	Okinetics	of	kinetic	NNS	I-NP	Oof	antigen	of	IN	B-PP	Oantigen	delivery	antigen	NN	B-NP	Odelivery	and	delivery	NN	I-NP	Oand	","	and	CC	O	O","	secondly	","	","	O	Osecondly	","	secondly	RB	B-ADVP	O","	the	","	","	O	Othe	early	the	DT	B-NP	Oearly	cellular	early	JJ	I-NP	Ocellular	responses	cellular	JJ	I-NP	Oresponses	involved	response	NNS	I-NP	Oinvolved	in	involve	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	initial	the	DT	B-NP	Oinitial	stages	initial	JJ	I-NP	Ostages	of	stage	NNS	I-NP	Oof	nasal	of	IN	B-PP	Onasal	mucosal	nasal	JJ	B-NP	Omucosal	tolerance	mucosal	JJ	I-NP	Otolerance	induction	tolerance	NN	I-NP	Oinduction	.	induction	NN	I-NP	O.	METHODS	.	.	O	OMETHODS	:	METHODS	NNS	B-NP	O:	Flow	:	:	O	OFlow	cytometry	Flow	NN	B-NP	Ocytometry	","	cytometry	NN	I-NP	O","	cell	","	","	O	Ocell	proliferation	cell	NN	B-NP	Oproliferation	assays	proliferation	NN	I-NP	Oassays	","	assay	NNS	I-NP	O","	and	","	","	O	Oand	microscopy	and	CC	O	Omicroscopy	were	microscopy	NN	B-NP	Owere	used	be	VBD	B-VP	Oused	to	use	VBN	I-VP	Oto	track	to	TO	B-VP	Otrack	antigen	track	VB	I-VP	Oantigen	following	antigen	NN	B-NP	Ofollowing	a	follow	VBG	B-PP	Oa	single	a	DT	B-NP	Osingle	","	single	JJ	I-NP	O","	intranasal	","	","	I-NP	Ointranasal	dose	intranasal	JJ	I-NP	Odose	of	dose	NN	I-NP	Oof	Alexa-488	of	IN	B-PP	OAlexa-488	labelled	Alexa-488	NN	B-NP	B-proteinlabelled	retinal	labelled	JJ	I-NP	I-proteinretinal	antigen	retinal	JJ	I-NP	I-proteinantigen	.	antigen	NN	I-NP	I-protein.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	A	:	:	O	OA	rapid	A	DT	B-NP	Orapid	accumulation	rapid	JJ	I-NP	Oaccumulation	of	accumulation	NN	I-NP	Oof	antigen	of	IN	B-PP	Oantigen	within	antigen	NN	B-NP	Owithin	both	within	IN	B-PP	Oboth	superficial	both	CC	O	Osuperficial	cervical	superficial	JJ	B-NP	Ocervical	lymph	cervical	JJ	I-NP	Olymph	nodes	lymph	NN	I-NP	Onodes	(	node	NNS	I-NP	O(	SCLN	(	(	O	OSCLN	)	SCLN	NN	B-NP	B-protein)	and	)	)	O	Oand	spleen	and	CC	O	Ospleen	was	spleen	NN	B-NP	Owas	observed	be	VBD	B-VP	Oobserved	after	observe	VBN	I-VP	Oafter	30	after	IN	B-PP	O30	minutes	30	CD	B-NP	Ominutes	.	minute	NNS	I-NP	O.	Significant	.	.	O	OSignificant	proliferative	Significant	JJ	B-NP	Oproliferative	responses	proliferative	JJ	I-NP	Oresponses	to	response	NNS	I-NP	Oto	IRBP	to	TO	B-PP	OIRBP	were	IRBP	NN	B-NP	B-proteinwere	elicited	be	VBD	B-VP	Oelicited	by	elicit	VBN	I-VP	Oby	48	by	IN	B-PP	O48	hours	48	CD	B-NP	Ohours	indicating	hour	NNS	I-NP	Oindicating	that	indicate	VBG	B-VP	Othat	systemic	that	IN	B-SBAR	Osystemic	priming	systemic	JJ	B-NP	Opriming	of	priming	NN	I-NP	Oof	naive	of	IN	B-PP	Onaive	T	naive	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	retinal	to	TO	B-PP	Oretinal	antigen	retinal	JJ	B-NP	B-proteinantigen	had	antigen	NN	I-NP	I-proteinhad	occurred	have	VBD	B-VP	Ooccurred	.	occur	VBN	I-VP	O.	Cell	.	.	O	OCell	activation	Cell	NN	B-NP	Oactivation	was	activation	NN	I-NP	Owas	further	be	VBD	B-VP	Ofurther	confirmed	further	RBR	I-VP	Oconfirmed	by	confirm	VBN	I-VP	Oby	immunoprecipitation	by	IN	B-PP	Oimmunoprecipitation	studies	immunoprecipitation	NN	B-NP	Ostudies	","	study	NNS	I-NP	O","	which	","	","	O	Owhich	demonstrated	which	WDT	B-NP	Odemonstrated	phosphorylation	demonstrate	VBD	B-VP	Ophosphorylation	of	phosphorylation	NN	B-NP	Oof	STAT4	of	IN	B-PP	OSTAT4	but	STAT4	NN	B-NP	B-proteinbut	not	but	CC	B-NP	Onot	STAT6	not	RB	I-NP	OSTAT6	in	STAT6	NN	B-NP	B-proteinin	both	in	IN	B-PP	Oboth	lymph	both	DT	B-NP	Olymph	nodes	lymph	NN	I-NP	Onodes	and	node	NNS	I-NP	Oand	spleen	and	CC	I-NP	Ospleen	.	spleen	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	at	","	","	O	Oat	24	at	IN	B-PP	O24	hours	24	CD	B-NP	Ohours	","	hour	NNS	I-NP	O","	STAT4	","	","	O	OSTAT4	heterodimerisation	STAT4	NN	B-NP	B-proteinheterodimerisation	with	heterodimerisation	NN	I-NP	Owith	STAT	with	IN	B-PP	OSTAT	3	STAT	NN	B-NP	B-protein3	was	3	CD	I-NP	I-proteinwas	only	be	VBD	B-VP	Oonly	observed	only	RB	I-VP	Oobserved	in	observe	VBN	I-VP	Oin	spleen	in	IN	B-PP	Ospleen	.	spleen	NN	B-NP	O.	CONCLUSIONS	.	.	O	OCONCLUSIONS	:	CONCLUSIONS	NNS	B-NP	O:	The	:	:	O	OThe	results	The	DT	B-NP	Oresults	provide	result	NNS	I-NP	Oprovide	novel	provide	VBP	B-VP	Onovel	evidence	novel	JJ	B-NP	Oevidence	that	evidence	NN	I-NP	Othat	following	that	IN	B-SBAR	Ofollowing	a	follow	VBG	B-VP	Oa	single	a	DT	B-NP	Osingle	intranasal	single	JJ	I-NP	Ointranasal	application	intranasal	JJ	I-NP	Oapplication	rapid	application	NN	I-NP	Orapid	transfer	rapid	JJ	I-NP	Otransfer	of	transfer	NN	I-NP	Oof	antigen	of	IN	B-PP	Oantigen	occurs	antigen	NN	B-NP	Ooccurs	.	occur	VBZ	B-VP	O.	Resulting	.	.	O	OResulting	T	Result	VBG	B-VP	OT	cell	T	NN	B-NP	Ocell	proliferation	cell	NN	I-NP	Oproliferation	develops	proliferation	NN	I-NP	Odevelops	consequent	develop	VBZ	B-VP	Oconsequent	to	consequent	JJ	B-ADJP	Oto	differential	to	TO	B-PP	Odifferential	cell	differential	JJ	B-NP	Ocell	signalling	cell	NN	I-NP	Osignalling	in	signalling	NN	I-NP	Oin	SCLN	in	IN	B-PP	OSCLN	and	SCLN	NN	B-NP	B-proteinand	spleen	and	CC	I-NP	Ospleen	.	spleen	NN	I-NP	O.	Further	.	.	O	OFurther	understanding	Further	JJ	B-NP	Ounderstanding	of	understanding	NN	I-NP	Oof	these	of	IN	B-PP	Othese	underlying	these	DT	B-NP	Ounderlying	cellular	underlie	VBG	I-NP	Ocellular	mechanisms	cellular	JJ	I-NP	Omechanisms	","	mechanism	NNS	I-NP	O","	in	","	","	O	Oin	particular	in	IN	B-PP	Oparticular	as	particular	JJ	B-ADJP	Oas	is	as	IN	B-SBAR	Ois	inferred	be	VBZ	B-VP	Oinferred	by	infer	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	results	the	DT	B-NP	Oresults	the	result	NNS	I-NP	Othe	contribution	the	DT	B-NP	Ocontribution	of	contribution	NN	I-NP	Oof	local	of	IN	B-PP	Olocal	versus	local	JJ	B-NP	Oversus	systemic	versus	IN	B-PP	Osystemic	tolerance	systemic	JJ	B-NP	Otolerance	induction	tolerance	NN	I-NP	Oinduction	","	induction	NN	I-NP	O","	may	","	","	O	Omay	assist	may	MD	B-VP	Oassist	in	assist	VB	I-VP	Oin	strategies	in	IN	B-PP	Ostrategies	to	strategy	NNS	B-NP	Oto	clinically	to	TO	B-VP	Oclinically	apply	clinically	RB	I-VP	Oapply	mucosal	apply	VB	I-VP	Omucosal	tolerance	mucosal	JJ	B-NP	Otolerance	therapy	tolerance	NN	I-NP	Otherapy	successfully	therapy	NN	I-NP	Osuccessfully	.	successfully	RB	B-ADVP	O.	Regulation	.	.	O	ORegulation	of	Regulation	NN	B-NP	Oof	interleukin	of	IN	B-PP	Ointerleukin	(	interleukin	NN	B-NP	B-protein(	IL	(	(	O	I-proteinIL	)	IL	NN	B-NP	I-protein)	-18	)	)	O	I-protein-18	receptor	-18	CD	B-NP	I-proteinreceptor	alpha	receptor	NN	I-NP	I-proteinalpha	chain	alpha	NN	I-NP	I-proteinchain	expression	chain	NN	I-NP	I-proteinexpression	on	expression	NN	I-NP	Oon	CD4	on	IN	B-PP	OCD4	(	CD4	NN	B-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	during	cell	NNS	I-NP	I-cell_typeduring	T	during	IN	B-PP	OT	helper	T	NN	B-NP	Ohelper	(	helper	NN	I-NP	O(	Th	(	(	O	OTh	)	Th	NN	B-NP	O)	1/Th2	)	)	O	O1/Th2	differentiation	1/Th2	NN	B-NP	Odifferentiation	.	differentiation	NN	I-NP	O.	Critical	.	.	O	OCritical	downregulatory	Critical	JJ	B-NP	Odownregulatory	role	downregulatory	JJ	I-NP	Orole	of	role	NN	I-NP	Oof	IL-4	of	IN	B-PP	OIL-4	.	IL-4	NN	B-NP	B-protein.	Interleukin	.	.	O	OInterleukin	(	Interleukin	NN	B-NP	B-protein(	IL	(	(	O	I-proteinIL	)	IL	NN	B-NP	I-protein)	-18	)	)	O	I-protein-18	has	-18	CD	B-NP	I-proteinhas	been	have	VBZ	B-VP	Obeen	well	be	VBN	I-VP	Owell	characterized	well	RB	I-VP	Ocharacterized	as	characterize	VBN	I-VP	Oas	a	as	IN	B-PP	Oa	costimulatory	a	DT	B-NP	Ocostimulatory	factor	costimulatory	JJ	I-NP	B-proteinfactor	for	factor	NN	I-NP	I-proteinfor	the	for	IN	B-PP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	IL-12-mediated	of	IN	B-PP	OIL-12-mediated	interferon	IL-12-mediated	JJ	B-NP	B-proteininterferon	(	interferon	NN	I-NP	I-protein(	IFN	(	(	O	I-proteinIFN	)	IFN	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	production	#NAME?	NN	B-NP	I-proteinproduction	by	production	NN	I-NP	Oby	T	by	IN	B-PP	OT	helper	T	NN	B-NP	B-cell_typehelper	(	helper	NN	I-NP	I-cell_type(	Th	(	(	O	I-cell_typeTh	)	Th	NN	B-NP	I-cell_type)	1	)	)	O	I-cell_type1	cells	1	CD	B-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	but	","	","	O	Obut	also	but	CC	O	Oalso	can	also	RB	B-ADVP	Ocan	induce	can	MD	B-VP	Oinduce	IL-4	induce	VB	I-VP	OIL-4	production	IL-4	NN	B-NP	B-proteinproduction	and	production	NN	I-NP	Oand	thus	and	CC	O	Othus	facilitate	thus	RB	B-VP	Ofacilitate	the	facilitate	VB	I-VP	Othe	differentiation	the	DT	B-NP	Odifferentiation	of	differentiation	NN	I-NP	Oof	Th2	of	IN	B-PP	OTh2	cells	Th2	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	To	.	.	O	OTo	determine	To	TO	B-VP	Odetermine	the	determine	VB	I-VP	Othe	mechanisms	the	DT	B-NP	Omechanisms	by	mechanism	NNS	I-NP	Oby	which	by	IN	B-PP	Owhich	IL-18	which	WDT	B-NP	OIL-18	might	IL-18	NN	B-NP	B-proteinmight	regulate	might	MD	B-VP	Oregulate	these	regulate	VB	I-VP	Othese	diametrically	these	DT	B-NP	Odiametrically	distinct	diametrically	RB	I-NP	Odistinct	immune	distinct	JJ	I-NP	Oimmune	responses	immune	JJ	I-NP	Oresponses	","	response	NNS	I-NP	O","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	analyzed	have	VBP	B-VP	Oanalyzed	the	analyze	VBN	I-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	cytokines	of	IN	B-PP	Ocytokines	in	cytokine	NNS	B-NP	B-proteinin	the	in	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	IL-18	of	IN	B-PP	OIL-18	receptor	IL-18	NN	B-NP	B-proteinreceptor	alpha	receptor	NN	I-NP	I-proteinalpha	chain	alpha	NN	I-NP	I-proteinchain	(	chain	NN	I-NP	I-protein(	IL-18Ralpha	(	(	O	OIL-18Ralpha	)	IL-18Ralpha	NN	B-NP	B-protein)	expression	)	)	O	Oexpression	.	expression	NN	B-NP	O.	The	.	.	O	OThe	majority	The	DT	B-NP	Omajority	of	majority	NN	I-NP	Oof	peripheral	of	IN	B-PP	Operipheral	CD4	peripheral	JJ	B-NP	B-cell_typeCD4	(	CD4	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	constitutively	cell	NNS	I-NP	I-cell_typeconstitutively	expressed	constitutively	RB	B-ADVP	Oexpressed	the	express	VBD	B-VP	Othe	IL-18Ralpha	the	DT	B-NP	OIL-18Ralpha	.	IL-18Ralpha	NN	I-NP	B-protein.	Upon	.	.	O	OUpon	antigen	Upon	IN	B-PP	Oantigen	stimulation	antigen	NN	B-NP	Ostimulation	in	stimulation	NN	I-NP	Oin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	IL-12	of	IN	B-PP	OIL-12	","	IL-12	NN	B-NP	B-protein","	marked	","	","	O	Omarked	enhancement	marked	JJ	B-NP	Oenhancement	of	enhancement	NN	I-NP	Oof	IL-18Ralpha	of	IN	B-PP	OIL-18Ralpha	expression	IL-18Ralpha	NN	B-NP	B-proteinexpression	was	expression	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	.	observe	VBN	I-VP	O.	IL-12	.	.	O	OIL-12	#NAME?	IL-12	NN	B-NP	B-protein#NAME?	upregulation	#NAME?	JJ	I-NP	Oupregulation	of	upregulation	NN	I-NP	Oof	IL-18Ralpha	of	IN	B-PP	OIL-18Ralpha	required	IL-18Ralpha	NN	B-NP	B-proteinrequired	IFN-gamma	require	VBD	B-VP	OIFN-gamma	.	IFN-gamma	NN	B-NP	B-protein.	Activated	.	.	O	OActivated	CD4	Activate	VBN	B-NP	B-cell_typeCD4	(	CD4	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	that	cell	NNS	I-NP	I-cell_typethat	expressed	that	WDT	B-NP	Oexpressed	low	express	VBD	B-VP	Olow	levels	low	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	IL-18Ralpha	of	IN	B-PP	OIL-18Ralpha	could	IL-18Ralpha	NN	B-NP	B-proteincould	produce	could	MD	B-VP	Oproduce	IFN-gamma	produce	VB	I-VP	OIFN-gamma	when	IFN-gamma	NN	B-NP	B-proteinwhen	stimulated	when	WRB	B-ADVP	Ostimulated	with	stimulate	VBN	B-VP	Owith	the	with	IN	B-PP	Othe	combination	the	DT	B-NP	Ocombination	of	combination	NN	I-NP	Oof	IL-12	of	IN	B-PP	OIL-12	and	IL-12	NN	B-NP	B-proteinand	IL-18	and	CC	I-NP	OIL-18	","	IL-18	NN	I-NP	B-protein","	while	","	","	O	Owhile	CD4	while	IN	B-SBAR	OCD4	(	CD4	NN	B-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	cells	)	)	O	I-cell_typecells	which	cell	NNS	B-NP	I-cell_typewhich	expressed	which	WDT	B-NP	Oexpressed	high	express	VBD	B-VP	Ohigh	levels	high	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	IL-18Ralpha	of	IN	B-PP	OIL-18Ralpha	could	IL-18Ralpha	NN	B-NP	B-proteincould	respond	could	MD	B-VP	Orespond	to	respond	VB	I-VP	Oto	IL-18	to	TO	B-PP	OIL-18	alone	IL-18	NN	B-NP	B-proteinalone	.	alone	RB	B-ADVP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	T	","	","	O	OT	cell	T	NN	B-NP	Ocell	stimulation	cell	NN	I-NP	Ostimulation	in	stimulation	NN	I-NP	Oin	the	in	IN	B-PP	Othe	presence	the	DT	I-PP	Opresence	of	presence	NN	I-PP	Oof	IL-4	of	IN	I-PP	OIL-4	resulted	IL-4	NN	B-NP	B-proteinresulted	in	result	VBD	B-VP	Oin	a	in	IN	B-PP	Oa	downregulation	a	DT	B-NP	Odownregulation	of	downregulation	NN	I-NP	Oof	IL-18Ralpha	of	IN	B-PP	OIL-18Ralpha	expression	IL-18Ralpha	NN	B-NP	B-proteinexpression	.	expression	NN	I-NP	O.	Both	.	.	O	OBoth	IL-4	Both	CC	O	OIL-4	(	IL-4	NN	B-NP	B-protein(	-/	(	(	O	O-/	)	-/	SYM	B-NP	O)	-	)	)	O	O-	and	-	HYPH	O	Oand	signal	and	CC	O	Osignal	transducer	signal	NN	B-NP	B-proteintransducer	and	transducer	NN	I-NP	I-proteinand	activator	and	CC	O	I-proteinactivator	of	activator	NN	B-NP	I-proteinof	transcription	of	IN	B-PP	I-proteintranscription	(	transcription	NN	B-NP	I-protein(	Stat	(	(	O	I-proteinStat	)	Stat	NN	B-NP	I-protein)	6	)	)	O	I-protein6	(	6	CD	B-NP	I-protein(	-/	(	(	O	O-/	)	-/	SYM	B-NP	O)	-	)	)	O	O-	T	-	HYPH	B-NP	OT	cells	T	NN	I-NP	B-cell_typecells	expressed	cell	NNS	I-NP	I-cell_typeexpressed	higher	express	VBD	B-VP	Ohigher	levels	high	JJR	B-NP	Olevels	of	level	NNS	I-NP	Oof	IL-18Ralpha	of	IN	B-PP	OIL-18Ralpha	after	IL-18Ralpha	NN	B-NP	B-proteinafter	TCR	after	IN	B-PP	OTCR	stimulation	TCR	NN	B-NP	B-proteinstimulation	.	stimulation	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	activated	","	","	O	Oactivated	T	activate	VBN	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	Stat6	from	IN	B-PP	OStat6	(	Stat6	NN	B-NP	B-protein(	-/	(	(	O	O-/	)	-/	SYM	B-NP	O)	-	)	)	O	O-	mice	-	HYPH	B-NP	Omice	produced	mouse	NNS	I-NP	Oproduced	more	produce	VBD	B-VP	Omore	IFN-gamma	more	JJR	B-NP	OIFN-gamma	in	IFN-gamma	NN	I-NP	B-proteinin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	IL-18	to	TO	B-PP	OIL-18	than	IL-18	NN	B-NP	B-proteinthan	wild-type	than	IN	B-PP	Owild-type	controls	wild-type	JJ	B-NP	Ocontrols	.	control	NNS	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	positive/negative	","	","	O	Opositive/negative	regulation	positive/negative	JJ	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	IL-18Ralpha	the	DT	B-NP	OIL-18Ralpha	by	IL-18Ralpha	NN	I-NP	B-proteinby	the	by	IN	B-PP	Othe	major	the	DT	B-NP	Omajor	inductive	major	JJ	I-NP	Oinductive	cytokines	inductive	JJ	I-NP	Ocytokines	(	cytokine	NNS	I-NP	B-protein(	IL-12	(	(	O	OIL-12	and	IL-12	NN	B-NP	B-proteinand	IL-4	and	CC	O	OIL-4	)	IL-4	NN	B-NP	B-protein)	determines	)	)	O	Odetermines	the	determine	VBZ	B-VP	Othe	capacity	the	DT	B-NP	Ocapacity	of	capacity	NN	I-NP	Oof	IL-18	of	IN	B-PP	OIL-18	to	IL-18	NN	B-NP	B-proteinto	polarize	to	TO	B-VP	Opolarize	an	polarize	VB	I-VP	Oan	immune	an	DT	B-NP	Oimmune	response	immune	JJ	I-NP	Oresponse	.	response	NN	I-NP	O.	Glucocorticoid-regulated	.	.	O	OGlucocorticoid-regulated	transcription	Glucocorticoid-regulated	JJ	B-NP	B-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	.	factor	NNS	I-NP	I-protein.	Glucocorticoids	.	.	O	OGlucocorticoids	are	Glucocorticoid	NNS	B-NP	Oare	the	be	VBP	B-VP	Othe	most	the	DT	B-NP	Omost	effective	most	RBS	I-NP	Oeffective	antiinflammatory	effective	JJ	I-NP	Oantiinflammatory	drugs	antiinflammatory	JJ	I-NP	Odrugs	used	drug	NNS	I-NP	Oused	in	use	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	of	treatment	NN	I-NP	Oof	asthma	of	IN	B-PP	Oasthma	.	asthma	NN	B-NP	O.	They	.	.	O	OThey	act	They	PRP	B-NP	Oact	by	act	VBP	B-VP	Oby	binding	by	IN	B-PP	Obinding	to	bind	VBG	B-VP	Oto	a	to	TO	B-PP	Oa	specific	a	DT	B-NP	Ospecific	receptor	specific	JJ	I-NP	Oreceptor	(	receptor	NN	I-NP	O(	GR	(	(	O	OGR	)	GR	NN	B-NP	B-protein)	that	)	)	O	Othat	","	that	WDT	B-NP	O","	upon	","	","	O	Oupon	activation	upon	IN	B-PP	Oactivation	","	activation	NN	B-NP	O","	translocates	","	","	O	Otranslocates	to	translocate	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	nucleus	the	DT	B-NP	Onucleus	and	nucleus	NN	I-NP	Oand	either	and	CC	O	Oeither	increases	either	CC	O	Oincreases	(	increase	NNS	B-NP	O(	transactivates	(	(	O	Otransactivates	)	transactivate	NNS	B-NP	O)	or	)	)	O	Oor	decreases	or	CC	O	Odecreases	(	decrease	VBZ	B-NP	O(	transrepresses	(	(	O	Otransrepresses	)	transrepresse	VBZ	O	O)	gene	)	)	O	Ogene	expression	gene	NN	B-NP	Oexpression	.	expression	NN	I-NP	O.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	pro-inflammatory	of	IN	B-PP	Opro-inflammatory	transcription	pro-inflammatory	JJ	B-NP	B-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	such	factor	NNS	I-NP	I-proteinsuch	as	such	JJ	B-PP	Oas	activator	as	IN	I-PP	Oactivator	protein	activator	NN	B-NP	B-proteinprotein	(	protein	NN	I-NP	I-protein(	AP	(	(	O	I-proteinAP	)	AP	NN	B-NP	I-protein)	-1	)	)	O	I-protein-1	","	-1	CD	B-NP	I-protein","	signal	","	","	O	Osignal	transducers	signal	NN	B-NP	Otransducers	and	transducer	NNS	I-NP	Oand	activators	and	CC	O	Oactivators	of	activator	NNS	B-NP	Oof	transcription	of	IN	B-PP	Otranscription	(	transcription	NN	B-NP	O(	STATs	(	(	O	OSTATs	)	STAT	NNS	B-NP	B-protein)	","	)	)	O	O","	nuclear	","	","	O	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	of	factor	NN	I-NP	I-proteinof	activated	of	IN	B-PP	I-proteinactivated	T	activate	VBN	B-NP	I-proteinT	cells	T	NN	I-NP	I-proteincells	(	cell	NNS	I-NP	I-protein(	NFAT	(	(	O	ONFAT	)	NFAT	NN	B-NP	B-protein)	and	)	)	O	Oand	nuclear	and	CC	O	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	NF	(	(	O	I-proteinNF	)	NF	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	B	#NAME?	NN	B-NP	I-proteinB	is	B	NN	I-NP	I-proteinis	thought	be	VBZ	B-VP	Othought	to	think	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	a	be	VB	I-VP	Oa	major	a	DT	B-NP	Omajor	action	major	JJ	I-NP	Oaction	of	action	NN	I-NP	Oof	glucocorticoids	of	IN	B-PP	Oglucocorticoids	.	glucocorticoid	NNS	B-NP	O.	Acetylation	.	.	O	OAcetylation	of	Acetylation	NN	B-NP	Oof	histones	of	IN	B-PP	Ohistones	allows	histone	NNS	B-NP	B-proteinallows	unwinding	allow	VBZ	B-VP	Ounwinding	of	unwinding	NN	B-NP	Oof	the	of	IN	B-PP	Othe	local	the	DT	B-NP	Olocal	DNA	local	JJ	I-NP	ODNA	structure	DNA	NN	I-NP	Ostructure	and	structure	NN	I-NP	Oand	enables	and	CC	O	Oenables	RNA	enable	VBZ	B-VP	ORNA	polymerase	RNA	NN	B-NP	B-proteinpolymerase	II	polymerase	NN	I-NP	I-proteinII	to	II	CD	I-NP	I-proteinto	enhance	to	TO	B-VP	Oenhance	gene	enhance	VB	I-VP	Ogene	transcription	gene	NN	B-NP	Otranscription	.	transcription	NN	I-NP	O.	Histone	.	.	O	OHistone	acetylation	Histone	NN	B-NP	Oacetylation	is	acetylation	NN	I-NP	Ois	regulated	be	VBZ	B-VP	Oregulated	by	regulate	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	balance	a	DT	B-NP	Obalance	between	balance	NN	I-NP	Obetween	the	between	IN	B-PP	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	histone	of	IN	B-PP	Ohistone	acetyltransferases	histone	NN	B-NP	B-proteinacetyltransferases	(	acetyltransferas	NNS	I-NP	I-protein(	HATs	(	(	O	OHATs	)	HAT	NNS	B-NP	B-protein)	and	)	)	O	Oand	histone	and	CC	O	Ohistone	deacetylases	histone	NN	B-NP	B-proteindeacetylases	(	deacetylas	NNS	I-NP	I-protein(	HDACs	(	(	O	OHDACs	)	HDAC	NNS	B-NP	B-cell_type)	.	)	)	O	O.	GR	.	.	O	OGR	acts	GR	NN	B-NP	B-proteinacts	as	act	VBZ	B-VP	Oas	a	as	IN	B-PP	Oa	direct	a	DT	B-NP	Odirect	inhibitor	direct	JJ	I-NP	Oinhibitor	of	inhibitor	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B-induced	NF-kappa	NN	B-NP	OB-induced	HAT	B-induced	JJ	I-NP	OHAT	activity	HAT	NN	I-NP	Oactivity	and	activity	NN	I-NP	Oand	also	and	CC	O	Oalso	by	also	RB	B-ADVP	Oby	recruiting	by	IN	B-PP	Orecruiting	HDAC2	recruit	VBG	B-VP	OHDAC2	to	HDAC2	NN	B-NP	B-proteinto	the	to	TO	B-PP	Othe	NF-kappa	the	DT	B-NP	ONF-kappa	B/HAT	NF-kappa	NN	I-NP	B-proteinB/HAT	complex	B/HAT	NN	I-NP	I-proteincomplex	.	complex	NN	I-NP	I-protein.	A	.	.	O	OA	sub-group	A	DT	B-NP	Osub-group	of	sub-group	NN	I-NP	Oof	patients	of	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	glucocorticoid-insensitive	with	IN	B-PP	Oglucocorticoid-insensitive	asthma	glucocorticoid-insensitive	JJ	B-NP	Oasthma	have	asthma	NN	I-NP	Ohave	an	have	VBP	B-VP	Oan	inability	an	DT	B-NP	Oinability	to	inability	NN	I-NP	Oto	induce	to	TO	B-VP	Oinduce	histone	induce	VB	I-VP	Ohistone	acetylation	histone	NN	B-NP	Oacetylation	in	acetylation	NN	I-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	I-PP	Oto	dexamethasone	to	TO	I-PP	Odexamethasone	suggesting	dexamethasone	NN	B-NP	Osuggesting	reduced	suggest	VBG	B-VP	Oreduced	expression	reduce	VBN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	a	of	IN	B-PP	Oa	GR-specific	a	DT	B-NP	OGR-specific	HAT	GR-specific	JJ	I-NP	B-proteinHAT	.	HAT	NN	I-NP	I-protein.	This	.	.	O	OThis	suggests	This	DT	B-NP	Osuggests	that	suggest	VBZ	B-VP	Othat	pharmacological	that	IN	B-SBAR	Opharmacological	manipulation	pharmacological	JJ	B-NP	Omanipulation	of	manipulation	NN	I-NP	Oof	specific	of	IN	B-PP	Ospecific	histone	specific	JJ	B-NP	Ohistone	acetylation	histone	NN	I-NP	Oacetylation	status	acetylation	NN	I-NP	Ostatus	is	status	NN	I-NP	Ois	a	be	VBZ	B-VP	Oa	potentially	a	DT	B-NP	Opotentially	useful	potentially	RB	I-NP	Ouseful	approach	useful	JJ	I-NP	Oapproach	for	approach	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	of	treatment	NN	I-NP	Oof	inflammatory	of	IN	B-PP	Oinflammatory	diseases	inflammatory	JJ	B-NP	Odiseases	.	disease	NNS	I-NP	O.	Identification	.	.	O	OIdentification	of	Identification	NN	B-NP	Oof	the	of	IN	B-PP	Othe	precise	the	DT	B-NP	Oprecise	mechanism	precise	JJ	I-NP	Omechanism	by	mechanism	NN	I-NP	Oby	which	by	IN	B-PP	Owhich	activated	which	WDT	B-NP	Oactivated	GR	activate	VBN	B-NP	OGR	recruits	GR	NN	I-NP	B-proteinrecruits	HDAC2	recruit	VBZ	B-VP	OHDAC2	may	HDAC2	NN	B-NP	B-proteinmay	reveal	may	MD	B-VP	Oreveal	new	reveal	VB	I-VP	Onew	targets	new	JJ	B-NP	Otargets	for	target	NNS	I-NP	Ofor	the	for	IN	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	drugs	of	IN	B-PP	Odrugs	that	drug	NNS	B-NP	Othat	may	that	WDT	B-NP	Omay	dissociate	may	MD	B-VP	Odissociate	the	dissociate	VB	I-VP	Othe	antiinflammatory	the	DT	B-NP	Oantiinflammatory	actions	antiinflammatory	JJ	I-NP	Oactions	of	action	NNS	I-NP	Oof	glucocorticoids	of	IN	B-PP	Oglucocorticoids	from	glucocorticoid	NNS	B-NP	Ofrom	their	from	IN	B-PP	Otheir	side	their	PRP$	B-NP	Oside	effects	side	NN	I-NP	Oeffects	that	effect	NNS	I-NP	Othat	are	that	WDT	B-NP	Oare	largely	be	VBP	B-VP	Olargely	due	largely	RB	B-ADVP	Odue	to	due	JJ	B-ADJP	Oto	gene	to	TO	B-PP	Ogene	induction	gene	NN	B-NP	Oinduction	.	induction	NN	I-NP	O.	Copyright	.	.	O	OCopyright	Academic	Copyright	NN	B-NP	OAcademic	Press	Academic	NNP	I-NP	OPress	.	Press	NNP	I-NP	O.	Differential	.	.	O	ODifferential	ultraviolet-B-induced	Differential	JJ	B-NP	Oultraviolet-B-induced	immunomodulation	ultraviolet-B-induced	JJ	I-NP	Oimmunomodulation	in	immunomodulation	NN	I-NP	Oin	XPA	in	IN	B-PP	OXPA	","	XPA	NN	B-NP	O","	XPC	","	","	O	OXPC	","	XPC	NN	B-NP	B-protein","	and	","	","	O	Oand	CSB	and	CC	O	OCSB	DNA	CSB	NN	B-NP	B-proteinDNA	repair-deficient	DNA	NN	I-NP	Orepair-deficient	mice	repair-deficient	JJ	I-NP	Omice	.	mouse	NNS	I-NP	O.	Ultraviolet	.	.	O	OUltraviolet	B	Ultraviolet	NN	B-NP	OB	irradiation	B	NN	I-NP	Oirradiation	has	irradiation	NN	I-NP	Ohas	serious	have	VBZ	B-VP	Oserious	consequences	serious	JJ	B-NP	Oconsequences	for	consequence	NNS	I-NP	Ofor	cellular	for	IN	B-PP	Ocellular	immunity	cellular	JJ	B-NP	Oimmunity	and	immunity	NN	I-NP	Oand	can	and	CC	O	Ocan	suppress	can	MD	B-VP	Osuppress	the	suppress	VB	I-VP	Othe	rejection	the	DT	B-NP	Orejection	of	rejection	NN	I-NP	Oof	skin	of	IN	B-PP	Oskin	tumors	skin	NN	B-NP	Otumors	and	tumor	NNS	I-NP	Oand	the	and	CC	O	Othe	resistance	the	DT	B-NP	Oresistance	to	resistance	NN	I-NP	Oto	infectious	to	TO	B-PP	Oinfectious	diseases	infectious	JJ	B-NP	Odiseases	.	disease	NNS	I-NP	O.	DNA	.	.	O	ODNA	damage	DNA	NN	B-NP	Odamage	plays	damage	NN	I-NP	Oplays	a	play	VBZ	B-VP	Oa	crucial	a	DT	B-NP	Ocrucial	role	crucial	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	these	in	IN	B-PP	Othese	immunomodulatory	these	DT	B-NP	Oimmunomodulatory	effects	immunomodulatory	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	ultraviolet	of	IN	B-PP	Oultraviolet	B	ultraviolet	NN	B-NP	B-proteinB	","	B	NN	I-NP	I-protein","	as	","	","	O	Oas	impaired	as	IN	B-SBAR	Oimpaired	repair	impaired	JJ	B-NP	Orepair	of	repair	NN	I-NP	Oof	ultraviolet-B-induced	of	IN	B-PP	Oultraviolet-B-induced	DNA	ultraviolet-B-induced	JJ	B-NP	ODNA	damage	DNA	NN	I-NP	Odamage	has	damage	NN	I-NP	Ohas	been	have	VBZ	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	cause	to	TO	I-VP	Ocause	suppression	cause	VB	I-VP	Osuppression	of	suppression	NN	B-NP	Oof	cellular	of	IN	B-PP	Ocellular	immunity	cellular	JJ	B-NP	Oimmunity	.	immunity	NN	I-NP	O.	Ultraviolet-B-induced	.	.	O	OUltraviolet-B-induced	DNA	Ultraviolet-B-induced	JJ	B-NP	ODNA	damage	DNA	NN	I-NP	Odamage	is	damage	NN	I-NP	Ois	repaired	be	VBZ	B-VP	Orepaired	by	repair	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	nucleotide	the	DT	B-NP	Onucleotide	excision	nucleotide	NN	I-NP	Oexcision	repair	excision	NN	I-NP	Orepair	mechanism	repair	NN	I-NP	Omechanism	very	mechanism	NN	I-NP	Overy	efficiently	very	RB	B-ADVP	Oefficiently	.	efficiently	RB	I-ADVP	O.	Nucleotide	.	.	O	ONucleotide	excision	Nucleotide	NN	B-NP	Oexcision	repair	excision	NN	I-NP	Orepair	comprises	repair	NN	I-NP	Ocomprises	two	comprise	VBZ	B-VP	Otwo	subpathways	two	CD	B-NP	Osubpathways	:	subpathway	NNS	I-NP	O:	transcription-coupled	:	:	O	Otranscription-coupled	and	transcription-coupled	JJ	B-NP	Oand	global	and	CC	I-NP	Oglobal	genome	global	JJ	I-NP	Ogenome	repair	genome	NN	I-NP	Orepair	.	repair	NN	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	the	study	NN	I-NP	Othe	immunologic	the	DT	B-NP	Oimmunologic	consequences	immunologic	JJ	I-NP	Oconsequences	of	consequence	NNS	I-NP	Oof	specific	of	IN	B-PP	Ospecific	nucleotide	specific	JJ	B-NP	Onucleotide	excision	nucleotide	NN	I-NP	Oexcision	repair	excision	NN	I-NP	Orepair	defects	repair	NN	I-NP	Odefects	in	defect	NNS	I-NP	Oin	three	in	IN	B-PP	Othree	mouse	three	CD	B-NP	Omouse	models	mouse	NN	I-NP	Omodels	","	model	NNS	I-NP	O","	XPA	","	","	O	OXPA	","	XPA	NN	B-NP	B-protein","	XPC	","	","	O	OXPC	","	XPC	NN	B-NP	B-protein","	and	","	","	O	Oand	CSB	and	CC	O	OCSB	mutant	CSB	NN	B-NP	B-proteinmutant	mice	mutant	JJ	I-NP	Omice	","	mouse	NNS	I-NP	O","	were	","	","	O	Owere	investigated	be	VBD	B-VP	Oinvestigated	.	investigate	VBN	I-VP	O.	XPA	.	.	O	OXPA	mice	XPA	NN	B-NP	Omice	carry	mouse	NNS	I-NP	Ocarry	a	carry	VBP	B-VP	Oa	total	a	DT	B-NP	Ototal	nucleotide	total	JJ	I-NP	Onucleotide	excision	nucleotide	NN	I-NP	Oexcision	repair	excision	NN	I-NP	Orepair	defect	repair	NN	I-NP	Odefect	","	defect	NN	I-NP	O","	whereas	","	","	O	Owhereas	XPC	whereas	IN	O	OXPC	and	XPC	NN	B-NP	B-cell_typeand	CSB	and	CC	I-NP	OCSB	mice	CSB	NN	I-NP	Omice	only	mouse	NNS	I-NP	Oonly	lack	only	RB	B-ADVP	Olack	global	lack	VBP	B-VP	Oglobal	genome	global	JJ	B-NP	B-DNAgenome	and	genome	NN	I-NP	I-DNAand	transcription-coupled	and	CC	O	Otranscription-coupled	nucleotide	transcription-coupled	JJ	B-NP	Onucleotide	excision	nucleotide	NN	I-NP	Oexcision	repair	excision	NN	I-NP	Orepair	","	repair	NN	I-NP	O","	respectively	","	","	O	Orespectively	.	respectively	RB	B-ADVP	O.	Our	.	.	O	OOur	data	Our	PRP$	B-NP	Odata	demonstrate	datum	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	cellular	that	IN	B-SBAR	Ocellular	immune	cellular	JJ	B-NP	Oimmune	parameters	immune	JJ	I-NP	Oparameters	in	parameter	NNS	I-NP	Oin	XPA	in	IN	B-PP	OXPA	","	XPA	NN	B-NP	O","	XPC	","	","	O	OXPC	","	XPC	NN	B-NP	B-protein","	and	","	","	O	Oand	CSB	and	CC	O	OCSB	mice	CSB	NN	B-NP	B-proteinmice	are	mouse	NNS	I-NP	Oare	normal	be	VBP	B-VP	Onormal	compared	normal	JJ	B-ADJP	Ocompared	with	compare	VBN	B-PP	Owith	their	with	IN	B-PP	Otheir	wild-type	their	PRP$	B-NP	Owild-type	(	wild-type	JJ	I-NP	O(	control	(	(	O	Ocontrol	)	control	NN	B-NP	O)	littermates	)	)	O	Olittermates	.	littermate	NNS	B-NP	O.	This	.	.	O	OThis	may	This	DT	B-NP	Omay	indicate	may	MD	B-VP	Oindicate	that	indicate	VB	I-VP	Othat	the	that	IN	B-SBAR	Othe	reported	the	DT	B-NP	Oreported	altered	report	VBN	I-NP	Oaltered	cellular	altered	JJ	I-NP	Ocellular	responses	cellular	JJ	I-NP	Oresponses	in	response	NNS	I-NP	Oin	xeroderma	in	IN	B-PP	Oxeroderma	pigmentosum	xeroderma	NN	B-NP	Opigmentosum	patients	pigmentosum	NN	I-NP	Opatients	are	patient	NNS	I-NP	Oare	not	be	VBP	B-VP	Onot	constitutive	not	RB	O	Oconstitutive	but	constitutive	JJ	B-ADJP	Obut	could	but	CC	O	Ocould	be	could	MD	B-VP	Obe	due	be	VB	I-VP	Odue	to	due	JJ	B-ADVP	Oto	external	to	TO	B-PP	Oexternal	factors	external	JJ	B-NP	B-proteinfactors	","	factor	NNS	I-NP	I-protein","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	ultraviolet	as	IN	I-PP	Oultraviolet	B	ultraviolet	JJ	B-NP	OB	.	B	NN	I-NP	O.	Upon	.	.	O	OUpon	exposure	Upon	IN	B-PP	Oexposure	to	exposure	NN	B-NP	Oto	ultraviolet	to	TO	B-VP	Oultraviolet	B	ultraviolet	VB	I-VP	OB	","	B	NN	B-NP	O","	only	","	","	O	Oonly	XPA	only	RB	B-NP	OXPA	mice	XPA	NN	I-NP	Omice	are	mouse	NNS	I-NP	Oare	very	be	VBP	B-VP	Overy	sensitive	very	RB	B-ADJP	Osensitive	to	sensitive	JJ	I-ADJP	Oto	ultraviolet-B-induced	to	TO	B-PP	Oultraviolet-B-induced	inhibition	ultraviolet-B-induced	JJ	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	Th1-mediated	of	IN	B-PP	OTh1-mediated	contact	Th1-mediated	JJ	B-NP	Ocontact	hypersensitivity	contact	NN	I-NP	Ohypersensitivity	responses	hypersensitivity	NN	I-NP	Oresponses	and	response	NNS	I-NP	Oand	interferon-gamma	and	CC	O	Ointerferon-gamma	production	interferon-gamma	NN	B-NP	B-proteinproduction	in	production	NN	I-NP	Oin	skin	in	IN	B-PP	Oskin	draining	skin	NN	B-NP	Odraining	lymph	drain	VBG	B-VP	Olymph	nodes	lymph	NN	B-NP	Onodes	.	node	NNS	I-NP	O.	Lipopolysaccharide-stimulated	.	.	O	OLipopolysaccharide-stimulated	tumor	Lipopolysaccharide-stimulated	JJ	B-NP	Otumor	necrosis	tumor	NN	I-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	alpha	factor	NN	I-NP	I-proteinalpha	and	alpha	NN	I-NP	I-proteinand	interleukin-10	and	CC	O	Ointerleukin-10	production	interleukin-10	NN	B-NP	B-proteinproduction	are	production	NN	I-NP	Oare	significantly	be	VBP	B-VP	Osignificantly	augmented	significantly	RB	I-VP	Oaugmented	in	augment	VBN	I-VP	Oin	both	in	IN	B-PP	Oboth	XPA	both	CC	O	OXPA	and	XPA	NN	B-NP	B-DNAand	CSB	and	CC	I-NP	OCSB	mice	CSB	NN	I-NP	Omice	after	mouse	NNS	I-NP	Oafter	ultraviolet	after	IN	B-PP	Oultraviolet	B	ultraviolet	NN	B-NP	OB	exposure	B	NN	I-NP	Oexposure	.	exposure	NN	I-NP	O.	Lymph	.	.	O	OLymph	node	Lymph	NN	B-NP	Onode	cell	node	NN	I-NP	Ocell	numbers	cell	NN	I-NP	Onumbers	were	number	NNS	I-NP	Owere	increased	be	VBD	B-VP	Oincreased	very	increase	VBN	I-VP	Overy	significantly	very	RB	B-ADVP	Osignificantly	in	significantly	RB	I-ADVP	Oin	XPA	in	IN	B-PP	OXPA	","	XPA	NN	B-NP	B-DNA","	mildly	","	","	O	Omildly	increased	mildly	RB	B-VP	Oincreased	in	increase	VBD	I-VP	Oin	CSB	in	IN	B-PP	OCSB	","	CSB	NNP	B-NP	O","	and	","	","	B-PP	Oand	not	and	CC	I-PP	Onot	in	not	RB	B-PP	Oin	XPC	in	IN	I-PP	OXPC	mice	XPC	NN	B-NP	Omice	.	mouse	NNS	I-NP	O.	In	.	.	O	OIn	general	In	IN	B-PP	Ogeneral	XPC	general	JJ	B-NP	OXPC	mice	XPC	NN	I-NP	Omice	do	mouse	NNS	I-NP	Odo	not	do	VBP	B-VP	Onot	exhibit	not	RB	I-VP	Oexhibit	any	exhibit	VB	I-VP	Oany	indication	any	DT	B-NP	Oindication	of	indication	NN	I-NP	Oof	enhanced	of	IN	B-PP	Oenhanced	ultraviolet	enhance	VBN	B-NP	Oultraviolet	B	ultraviolet	NN	I-NP	OB	susceptibility	B	NN	I-NP	Osusceptibility	with	susceptibility	NN	I-NP	Owith	regard	with	IN	B-PP	Oregard	to	regard	NN	B-NP	Oto	the	to	TO	B-PP	Othe	immune	the	DT	B-NP	Oimmune	parameters	immune	JJ	I-NP	Oparameters	analyzed	parameter	NNS	I-NP	Oanalyzed	.	analyze	VBN	B-VP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	both	that	IN	B-SBAR	Oboth	global	both	CC	O	Oglobal	genome	global	JJ	B-NP	Ogenome	repair	genome	NN	I-NP	Orepair	and	repair	NN	I-NP	Oand	transcription-coupled	and	CC	O	Otranscription-coupled	repair	transcription-coupled	JJ	B-NP	Orepair	are	repair	NN	I-NP	Oare	needed	be	VBP	B-VP	Oneeded	to	need	VBN	I-VP	Oto	prevent	to	TO	B-VP	Oprevent	immunomodulation	prevent	VB	I-VP	Oimmunomodulation	by	immunomodulation	NN	B-NP	Oby	ultraviolet	by	IN	B-PP	Oultraviolet	B	ultraviolet	NN	B-NP	OB	","	B	NN	I-NP	O","	whereas	","	","	O	Owhereas	transcription-coupled	whereas	IN	O	Otranscription-coupled	repair	transcription-coupled	JJ	B-NP	Orepair	is	repair	NN	I-NP	Ois	the	be	VBZ	B-VP	Othe	major	the	DT	B-NP	Omajor	DNA	major	JJ	I-NP	ODNA	repair	DNA	NN	I-NP	Orepair	subpathway	repair	NN	I-NP	Osubpathway	of	subpathway	NN	I-NP	Oof	nucleotide	of	IN	B-PP	Onucleotide	excision	nucleotide	NN	B-NP	Oexcision	repair	excision	NN	I-NP	Orepair	that	repair	NN	I-NP	Othat	prevents	that	WDT	B-NP	Oprevents	the	prevent	VBZ	B-VP	Othe	acute	the	DT	B-NP	Oacute	ultraviolet-B-induced	acute	JJ	I-NP	Oultraviolet-B-induced	effects	ultraviolet-B-induced	JJ	I-NP	Oeffects	such	effect	NNS	I-NP	Osuch	as	such	JJ	B-PP	Oas	erythema	as	IN	I-PP	Oerythema	.	erythema	NN	B-NP	O.	Biomechanical	.	.	O	OBiomechanical	strain	Biomechanical	JJ	B-NP	Ostrain	induces	strain	NN	I-NP	Oinduces	class	induce	VBZ	B-VP	Oclass	a	class	NN	B-NP	Oa	scavenger	a	DT	B-NP	Oscavenger	receptor	scavenger	NN	I-NP	B-proteinreceptor	expression	receptor	NN	I-NP	I-proteinexpression	in	expression	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	monocyte/macrophages	human	JJ	B-NP	B-cell_typemonocyte/macrophages	and	monocyte/macrophage	NNS	I-NP	I-cell_typeand	THP-1	and	CC	O	OTHP-1	cells	THP-1	NN	B-NP	B-cell_linecells	:	cell	NNS	I-NP	I-cell_line:	a	:	:	O	Oa	potential	a	DT	B-NP	Opotential	mechanism	potential	JJ	I-NP	Omechanism	of	mechanism	NN	I-NP	Oof	increased	of	IN	B-PP	Oincreased	atherosclerosis	increase	VBN	B-NP	Oatherosclerosis	in	atherosclerosis	NN	I-NP	Oin	hypertension	in	IN	B-PP	Ohypertension	.	hypertension	NN	B-NP	O.	BACKGROUND	.	.	O	OBACKGROUND	:	BACKGROUND	NN	B-NP	O:	Although	:	:	O	OAlthough	hypertension	Although	IN	B-SBAR	Ohypertension	is	hypertension	NN	B-NP	Ois	an	be	VBZ	B-VP	Oan	important	an	DT	B-NP	Oimportant	risk	important	JJ	I-NP	Orisk	factor	risk	NN	I-NP	Ofactor	for	factor	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	atherosclerosis	of	IN	B-PP	Oatherosclerosis	","	atherosclerosis	NN	B-NP	O","	the	","	","	O	Othe	mechanisms	the	DT	B-NP	Omechanisms	for	mechanism	NNS	I-NP	Ofor	this	for	IN	B-PP	Othis	interaction	this	DT	B-NP	Ointeraction	are	interaction	NN	I-NP	Oare	incompletely	be	VBP	B-VP	Oincompletely	described	incompletely	RB	I-VP	Odescribed	.	describe	VBN	I-VP	O.	Previous	.	.	O	OPrevious	studies	Previous	JJ	B-NP	Ostudies	have	study	NNS	I-NP	Ohave	suggested	have	VBP	B-VP	Osuggested	that	suggest	VBN	I-VP	Othat	biomechanical	that	IN	B-SBAR	Obiomechanical	strain	biomechanical	JJ	B-NP	Ostrain	regulates	strain	NN	I-NP	Oregulates	macrophage	regulate	VBZ	B-VP	Omacrophage	phenotype	macrophage	NN	B-NP	Ophenotype	.	phenotype	NN	I-NP	O.	We	.	.	O	OWe	tested	We	PRP	B-NP	Otested	the	test	VBD	B-VP	Othe	hypothesis	the	DT	B-NP	Ohypothesis	that	hypothesis	NN	I-NP	Othat	biomechanical	that	IN	B-SBAR	Obiomechanical	strain	biomechanical	JJ	B-NP	Ostrain	can	strain	NN	I-NP	Ocan	induce	can	MD	B-VP	Oinduce	expression	induce	VB	I-VP	Oexpression	of	expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	class	the	DT	B-NP	Oclass	A	class	NN	I-NP	B-proteinA	scavenger	A	NN	I-NP	I-proteinscavenger	receptor	scavenger	NN	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	SRA	(	(	O	OSRA	)	SRA	NN	B-NP	B-protein)	","	)	)	O	O","	an	","	","	O	Oan	important	an	DT	B-NP	Oimportant	lipoprotein	important	JJ	I-NP	Olipoprotein	receptor	lipoprotein	NN	I-NP	B-proteinreceptor	in	receptor	NN	I-NP	I-proteinin	atherogenesis	in	IN	B-PP	Oatherogenesis	.	atherogenesis	NN	B-NP	O.	METHODS	.	.	O	OMETHODS	AND	METHODS	NNS	B-NP	OAND	RESULTS	AND	CC	I-NP	ORESULTS	:	RESULTS	NNS	I-NP	O:	Human	:	:	O	OHuman	monocyte/macrophages	Human	JJ	B-NP	B-cell_typemonocyte/macrophages	or	monocyte/macrophage	NNS	I-NP	I-cell_typeor	THP-1	or	CC	O	OTHP-1	cells	THP-1	NN	B-NP	B-cell_linecells	were	cell	NNS	I-NP	I-cell_linewere	cultured	be	VBD	B-VP	Ocultured	in	culture	VBN	I-VP	Oin	a	in	IN	B-PP	Oa	device	a	DT	B-NP	Odevice	that	device	NN	I-NP	Othat	imposes	that	WDT	B-NP	Oimposes	uniform	impose	VBZ	B-VP	Ouniform	biaxial	uniform	JJ	B-NP	Obiaxial	cyclic	biaxial	JJ	I-NP	Ocyclic	1-Hz	cyclic	JJ	I-NP	O1-Hz	strains	1-Hz	NN	I-NP	Ostrains	of	strain	NNS	I-NP	Oof	0	of	IN	B-PP	O0	%	0	CD	B-NP	O%	","	%	NN	I-NP	O","	1	","	","	O	O1	%	1	CD	B-NP	O%	","	%	NN	I-NP	O","	2	","	","	O	O2	%	2	CD	B-NP	O%	","	%	NN	I-NP	O","	or	","	","	O	Oor	3	or	CC	O	O3	%	3	CD	B-NP	O%	","	%	NN	I-NP	O","	and	","	","	O	Oand	SRA	and	CC	O	OSRA	expression	SRA	NN	B-NP	B-proteinexpression	was	expression	NN	I-NP	Owas	analyzed	be	VBD	B-VP	Oanalyzed	.	analyze	VBN	I-VP	O.	Mechanical	.	.	O	OMechanical	strains	Mechanical	JJ	B-NP	Ostrains	induced	strain	NNS	I-NP	Oinduced	SRA	induce	VBD	B-VP	OSRA	mRNA	SRA	NN	B-NP	B-RNAmRNA	(	mRNA	NN	I-NP	I-RNA(	3.5+/-0.6-fold	(	(	O	O3.5+/-0.6-fold	at	3.5+/-0.6-fold	RB	B-ADVP	Oat	3	at	IN	B-PP	O3	%	3	CD	B-NP	O%	strain	%	NN	I-NP	Ostrain	for	strain	NN	I-NP	Ofor	48	for	IN	B-PP	O48	hours	48	CD	B-NP	Ohours	","	hour	NNS	I-NP	O","	P	","	","	O	OP	<	P	NN	B-NP	O<	0.01	<	SYM	B-NP	O0.01	)	0.01	CD	I-NP	O)	and	)	)	O	Oand	SRA	and	CC	O	OSRA	protein	SRA	NN	B-NP	B-proteinprotein	in	protein	NN	I-NP	I-proteinin	THP-1	in	IN	B-PP	OTHP-1	cells	THP-1	NN	B-NP	B-cell_linecells	in	cell	NNS	I-NP	I-cell_linein	an	in	IN	B-PP	Oan	amplitude-dependent	an	DT	B-NP	Oamplitude-dependent	manner	amplitude-dependent	JJ	I-NP	Omanner	.	manner	NN	I-NP	O.	This	.	.	O	OThis	induction	This	DT	B-NP	Oinduction	was	induction	NN	I-NP	Owas	accompanied	be	VBD	B-VP	Oaccompanied	by	accompany	VBN	I-VP	Oby	augmented	by	IN	B-PP	Oaugmented	expression	augmented	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	class	the	DT	B-NP	Oclass	B	class	NN	I-NP	B-proteinB	scavenger	B	NN	I-NP	I-proteinscavenger	receptor	scavenger	NN	I-NP	I-proteinreceptor	CD36	receptor	NN	I-NP	I-proteinCD36	(	CD36	NN	I-NP	O(	2.8+/-0.3-fold	(	(	O	O2.8+/-0.3-fold	","	2.8+/-0.3-fold	JJ	B-ADJP	O","	P	","	","	O	OP	<	P	NN	B-NP	O<	0.001	<	SYM	B-NP	O0.001	)	0.001	CD	I-NP	O)	but	)	)	O	Obut	not	but	CC	B-PP	Onot	by	not	RB	B-PP	Oby	increased	by	IN	I-PP	Oincreased	peroxisome	increase	VBN	B-NP	Operoxisome	proliferator-activated	peroxisome	NN	I-NP	B-proteinproliferator-activated	receptor-gamma	proliferator-activated	JJ	I-NP	I-proteinreceptor-gamma	expression	receptor-gamma	NN	I-NP	I-proteinexpression	.	expression	NN	I-NP	O.	To	.	.	O	OTo	evaluate	To	TO	B-VP	Oevaluate	this	evaluate	VB	I-VP	Othis	effect	this	DT	B-NP	Oeffect	in	effect	NN	I-NP	Oin	vivo	in	FW	B-ADVP	Ovivo	","	vivo	FW	I-ADVP	O","	apolipoprotein	","	","	O	Oapolipoprotein	E	apolipoprotein	NN	B-NP	OE	(	E	NN	I-NP	O(	-/-	(	(	O	O-/-	)	-/-	JJ	O	O)	mice	)	)	O	Omice	were	mouse	NNS	B-NP	Owere	randomly	be	VBD	B-VP	Orandomly	assigned	randomly	RB	I-VP	Oassigned	to	assign	VBN	I-VP	Oto	receive	to	TO	I-VP	Oreceive	standard	receive	VB	I-VP	Ostandard	chow	standard	JJ	B-NP	Ochow	","	chow	NN	I-NP	O","	a	","	","	O	Oa	high-cholesterol	a	DT	B-NP	Ohigh-cholesterol	diet	high-cholesterol	JJ	I-NP	Odiet	","	diet	NN	I-NP	O","	or	","	","	O	Oor	a	or	CC	O	Oa	high-cholesterol	a	DT	B-NP	Ohigh-cholesterol	diet	high-cholesterol	JJ	I-NP	Odiet	with	diet	NN	I-NP	Owith	hypertension	with	IN	B-PP	Ohypertension	induced	hypertension	NN	B-NP	Oinduced	by	induce	VBN	B-VP	Oby	angiotensin	by	IN	B-PP	Oangiotensin	II	angiotensin	NN	B-NP	OII	infusion	II	CD	I-NP	Oinfusion	for	infusion	NN	I-NP	Ofor	8	for	IN	B-PP	O8	weeks	8	CD	B-NP	Oweeks	.	week	NNS	I-NP	O.	Immunohistochemistry	.	.	O	OImmunohistochemistry	revealed	Immunohistochemistry	NN	B-NP	Orevealed	that	reveal	VBD	B-VP	Othat	among	that	IN	B-SBAR	Oamong	macrophages	among	IN	B-PP	Omacrophages	in	macrophage	NNS	B-NP	B-cell_typein	atherosclerotic	in	IN	B-PP	Oatherosclerotic	lesions	atherosclerotic	JJ	B-NP	Olesions	of	lesion	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	aorta	the	DT	B-NP	Oaorta	","	aorta	NN	I-NP	O","	the	","	","	O	Othe	proportion	the	DT	B-NP	Oproportion	of	proportion	NN	I-NP	Oof	macrophages	of	IN	B-PP	Omacrophages	with	macrophage	NNS	B-NP	B-cell_typewith	SRA	with	IN	B-PP	OSRA	expression	SRA	NN	B-NP	B-proteinexpression	was	expression	NN	I-NP	Owas	highest	be	VBD	B-VP	Ohighest	in	high	JJS	B-ADJP	Oin	hypertensive	in	IN	B-PP	Ohypertensive	animals	hypertensive	JJ	B-NP	Oanimals	on	animal	NNS	I-NP	Oon	a	on	IN	B-PP	Oa	high-cholesterol	a	DT	B-NP	Ohigh-cholesterol	diet	high-cholesterol	NN	I-NP	Odiet	(	diet	NN	I-NP	O(	43.9+/-0.7	(	(	O	O43.9+/-0.7	%	43.9+/-0.7	CD	B-NP	O%	","	%	NN	I-NP	O","	versus	","	","	O	Oversus	12.0+/-2.0	versus	IN	B-ADVP	O12.0+/-2.0	%	12.0+/-2.0	CD	B-NP	O%	for	%	NN	I-NP	Ofor	normotensive	for	IN	B-PP	Onormotensive	animals	normotensive	JJ	B-NP	Oanimals	on	animal	NNS	I-NP	Oon	a	on	IN	B-PP	Oa	high-cholesterol	a	DT	B-NP	Ohigh-cholesterol	diet	high-cholesterol	JJ	I-NP	Odiet	and	diet	NN	I-NP	Oand	4.7+/-4.7	and	CC	O	O4.7+/-4.7	%	4.7+/-4.7	CD	B-NP	O%	for	%	NN	I-NP	Ofor	animals	for	IN	B-PP	Oanimals	on	animal	NNS	B-NP	Oon	standard	on	IN	B-PP	Ostandard	chow	standard	JJ	B-NP	Ochow	;	chow	NN	I-NP	O;	P	;	:	O	OP	<	P	NN	B-NP	O<	0.001	<	SYM	B-NP	O0.001	)	0.001	CD	I-NP	O)	.	)	)	O	O.	CONCLUSIONS	.	.	O	OCONCLUSIONS	:	CONCLUSIONS	NNS	B-NP	O:	Biomechanical	:	:	O	OBiomechanical	strain	Biomechanical	JJ	B-NP	Ostrain	induces	strain	NN	I-NP	Oinduces	SRA	induce	VBZ	B-VP	OSRA	expression	SRA	NN	B-NP	B-proteinexpression	by	expression	NN	I-NP	Oby	monocyte/macrophages	by	IN	B-PP	Omonocyte/macrophages	","	monocyte/macrophage	NNS	B-NP	B-cell_type","	suggesting	","	","	O	Osuggesting	a	suggest	VBG	B-VP	Oa	novel	a	DT	B-NP	Onovel	mechanism	novel	JJ	I-NP	Omechanism	for	mechanism	NN	I-NP	Ofor	promotion	for	IN	B-PP	Opromotion	of	promotion	NN	B-NP	Oof	atherosclerosis	of	IN	B-PP	Oatherosclerosis	in	atherosclerosis	NN	B-NP	Oin	hypertensive	in	IN	B-PP	Ohypertensive	patients	hypertensive	JJ	B-NP	Opatients	.	patient	NNS	I-NP	O.	High	.	.	O	OHigh	glucose	High	JJ	B-NP	Oglucose	induces	glucose	NN	I-NP	Oinduces	MCP-1	induce	VBZ	B-VP	OMCP-1	expression	MCP-1	NN	B-NP	B-proteinexpression	partly	expression	NN	I-NP	Opartly	via	partly	RB	B-ADVP	Ovia	tyrosine	via	IN	B-PP	Otyrosine	kinase-AP-1	tyrosine	NN	B-NP	B-proteinkinase-AP-1	pathway	kinase-AP-1	NN	I-NP	I-proteinpathway	in	pathway	NN	I-NP	Oin	peritoneal	in	IN	B-PP	Operitoneal	mesothelial	peritoneal	JJ	B-NP	B-cell_typemesothelial	cells	mesothelial	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	BACKGROUND	.	.	O	OBACKGROUND	:	BACKGROUND	NN	B-NP	O:	High	:	:	O	OHigh	glucose	High	JJ	B-NP	Oglucose	in	glucose	NN	I-NP	Oin	peritoneal	in	IN	B-PP	Operitoneal	dialysis	peritoneal	JJ	B-NP	Odialysis	solutions	dialysis	NN	I-NP	Osolutions	has	solution	NNS	I-NP	Ohas	been	have	VBZ	B-VP	Obeen	implicated	be	VBN	I-VP	Oimplicated	in	implicate	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	pathogenesis	the	DT	B-NP	Opathogenesis	of	pathogenesis	NN	I-NP	Oof	peritoneal	of	IN	B-PP	Operitoneal	fibrosis	peritoneal	JJ	B-NP	Ofibrosis	in	fibrosis	NN	I-NP	Oin	chronic	in	IN	B-PP	Ochronic	ambulatory	chronic	JJ	B-NP	Oambulatory	peritoneal	ambulatory	JJ	I-NP	Operitoneal	dialysis	peritoneal	JJ	I-NP	Odialysis	(	dialysis	NN	I-NP	O(	CAPD	(	(	O	OCAPD	)	CAPD	NN	B-NP	O)	patients	)	)	O	Opatients	.	patient	NNS	B-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	the	","	","	O	Othe	mechanisms	the	DT	B-NP	Omechanisms	are	mechanism	NNS	I-NP	Oare	not	be	VBP	B-VP	Onot	very	not	RB	O	Overy	clear	very	RB	B-ADJP	Oclear	.	clear	JJ	I-ADJP	O.	Peritoneal	.	.	O	OPeritoneal	macrophages	Peritoneal	JJ	B-NP	B-cell_typemacrophages	seem	macrophage	NNS	I-NP	I-cell_typeseem	to	seem	VBP	B-VP	Oto	participate	to	TO	I-VP	Oparticipate	in	participate	VB	I-VP	Oin	the	in	IN	B-PP	Othe	process	the	DT	B-NP	Oprocess	of	process	NN	I-NP	Oof	peritoneal	of	IN	B-PP	Operitoneal	fibrosis	peritoneal	JJ	B-NP	Ofibrosis	and	fibrosis	NN	I-NP	Oand	monocyte	and	CC	I-NP	Omonocyte	chemoattractant	monocyte	NN	I-NP	B-proteinchemoattractant	protein-1	chemoattractant	NN	I-NP	I-proteinprotein-1	(	protein-1	NN	I-NP	I-protein(	MCP-1	(	(	O	OMCP-1	)	MCP-1	NN	B-NP	B-protein)	plays	)	)	O	Oplays	a	play	VBZ	B-VP	Oa	key	a	DT	B-NP	Okey	role	key	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	recruitment	the	DT	B-NP	Orecruitment	of	recruitment	NN	I-NP	Oof	monocytes	of	IN	B-PP	Omonocytes	toward	monocyte	NNS	B-NP	B-cell_typetoward	the	toward	IN	B-PP	Othe	peritoneal	the	DT	B-NP	Operitoneal	cavity	peritoneal	JJ	I-NP	Ocavity	.	cavity	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	little	","	","	O	Olittle	is	little	JJ	B-NP	Ois	known	be	VBZ	B-VP	Oknown	about	know	VBN	I-VP	Oabout	the	about	IN	B-PP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	high	of	IN	B-PP	Ohigh	glucose	high	JJ	B-NP	Oglucose	on	glucose	NN	I-NP	Oon	MCP-1	on	IN	B-PP	OMCP-1	expression	MCP-1	NN	B-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	its	and	CC	O	Oits	signal	its	PRP$	B-NP	Osignal	transduction	signal	NN	I-NP	Otransduction	pathway	transduction	NN	I-NP	Opathway	in	pathway	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	peritoneal	human	JJ	B-NP	B-cell_typeperitoneal	mesothelial	peritoneal	JJ	I-NP	I-cell_typemesothelial	cells	mesothelial	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	METHODS	.	.	O	OMETHODS	:	METHODS	NNS	B-NP	O:	Mesothelial	:	:	O	OMesothelial	cells	Mesothelial	JJ	B-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	cultured	be	VBD	B-VP	Ocultured	with	culture	VBN	I-VP	Owith	glucose	with	IN	B-PP	Oglucose	(	glucose	NN	B-NP	O(	5	(	(	O	O5	to	5	CD	B-NP	Oto	100	to	TO	O	O100	mmol/L	100	CD	B-NP	Ommol/L	)	mmol/L	NN	I-NP	O)	or	)	)	O	Oor	mannitol	or	CC	O	Omannitol	chronically	mannitol	NN	B-NP	Ochronically	for	chronically	RB	B-ADVP	Ofor	up	for	IN	B-PP	Oup	to	up	RB	B-NP	Oto	seven	to	TO	I-NP	Oseven	days	seven	CD	I-NP	Odays	.	day	NNS	I-NP	O.	MCP-1	.	.	O	OMCP-1	expression	MCP-1	NN	B-NP	B-proteinexpression	of	expression	NN	I-NP	Oof	mRNA	of	IN	B-PP	OmRNA	and	mRNA	NN	B-NP	B-RNAand	protein	and	CC	I-NP	Oprotein	was	protein	NN	I-NP	Owas	measured	be	VBD	B-VP	Omeasured	by	measure	VBN	I-VP	Oby	Northern	by	IN	B-PP	ONorthern	blot	Northern	NN	B-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	and	analysis	NN	I-NP	Oand	enzyme-linked	and	CC	O	Oenzyme-linked	immunosorbent	enzyme-linked	JJ	B-NP	Oimmunosorbent	assay	immunosorbent	JJ	I-NP	Oassay	(	assay	NN	I-NP	O(	ELISA	(	(	O	OELISA	)	ELISA	NN	B-NP	O)	.	)	)	O	O.	Chemotactic	.	.	O	OChemotactic	activity	Chemotactic	JJ	B-NP	Oactivity	of	activity	NN	I-NP	Oof	high-glucose-conditioned	of	IN	B-PP	Ohigh-glucose-conditioned	culture	high-glucose-conditioned	JJ	B-NP	Oculture	supernatant	culture	NN	I-NP	Osupernatant	was	supernatant	NN	I-NP	Owas	measured	be	VBD	B-VP	Omeasured	by	measure	VBN	I-VP	Oby	chemotactic	by	IN	B-PP	Ochemotactic	assay	chemotactic	JJ	B-NP	Oassay	.	assay	NN	I-NP	O.	To	.	.	O	OTo	examine	To	TO	B-VP	Oexamine	the	examine	VB	I-VP	Othe	roles	the	DT	B-NP	Oroles	of	role	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	activator	factor	NNS	I-NP	I-proteinactivator	protein-1	activator	NN	B-NP	B-proteinprotein-1	(	protein-1	NN	I-NP	I-protein(	AP-1	(	(	O	OAP-1	)	AP-1	NN	B-NP	B-protein)	and	)	)	O	Oand	nuclear	and	CC	O	Onuclear	factor-kappaB	nuclear	JJ	B-NP	B-proteinfactor-kappaB	(	factor-kappaB	NN	I-NP	I-protein(	NF-kappaB	(	(	O	ONF-kappaB	)	NF-kappaB	NN	B-NP	B-protein)	","	)	)	O	O","	electrophoretic	","	","	O	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assay	shift	NN	I-NP	Oassay	(	assay	NN	I-NP	O(	EMSA	(	(	O	OEMSA	)	EMSA	NN	B-NP	O)	was	)	)	O	Owas	performed	be	VBD	B-VP	Operformed	.	perform	VBN	I-VP	O.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	Glucose	:	:	O	OGlucose	induced	Glucose	NN	B-NP	Oinduced	MCP-1	induce	VBD	B-VP	OMCP-1	mRNA	MCP-1	NN	B-NP	B-RNAmRNA	expression	mRNA	NN	I-NP	I-RNAexpression	in	expression	NN	I-NP	Oin	a	in	IN	B-PP	Oa	time-	a	DT	B-NP	Otime-	and	time-	NN	I-NP	Oand	dose-dependent	and	CC	I-NP	Odose-dependent	manner	dose-dependent	JJ	I-NP	Omanner	.	manner	NN	I-NP	O.	MCP-1	.	.	O	OMCP-1	protein	MCP-1	NN	B-NP	B-proteinprotein	in	protein	NN	I-NP	I-proteinin	cell	in	IN	B-PP	Ocell	culture	cell	NN	B-NP	Oculture	supernant	culture	NN	I-NP	Osupernant	was	supernant	NN	I-NP	Owas	also	be	VBD	B-VP	Oalso	increased	also	RB	I-VP	Oincreased	.	increase	VBN	I-VP	O.	Equivalent	.	.	O	OEquivalent	concentrations	Equivalent	JJ	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	mannitol	of	IN	B-PP	Omannitol	had	mannitol	NN	B-NP	Ohad	no	have	VBD	B-VP	Ono	significant	no	DT	B-NP	Osignificant	effect	significant	JJ	I-NP	Oeffect	.	effect	NN	I-NP	O.	High-glucose-conditioned	.	.	O	OHigh-glucose-conditioned	supernatant	High-glucose-conditioned	JJ	B-NP	Osupernatant	possessed	supernatant	NN	I-NP	Opossessed	an	possess	VBD	B-VP	Oan	increased	an	DT	B-NP	Oincreased	chemotactic	increase	VBN	I-NP	Ochemotactic	activity	chemotactic	JJ	I-NP	Oactivity	for	activity	NN	I-NP	Ofor	monocytes	for	IN	B-PP	Omonocytes	","	monocyte	NNS	B-NP	B-cell_type","	which	","	","	O	Owhich	was	which	WDT	B-NP	Owas	neutralized	be	VBD	B-VP	Oneutralized	by	neutralize	VBN	I-VP	Oby	anti-MCP-1	by	IN	B-PP	Oanti-MCP-1	antibody	anti-MCP-1	JJ	B-NP	B-proteinantibody	.	antibody	NN	I-NP	I-protein.	EMSA	.	.	O	OEMSA	revealed	EMSA	NN	B-NP	Orevealed	that	reveal	VBD	B-VP	Othat	glucose	that	IN	B-SBAR	Oglucose	increased	glucose	NN	B-NP	Oincreased	the	increase	VBD	B-VP	Othe	AP-1	the	DT	B-NP	OAP-1	binding	AP-1	NN	I-NP	B-proteinbinding	activity	binding	NN	I-NP	Oactivity	in	activity	NN	I-NP	Oin	a	in	IN	B-PP	Oa	time-	a	DT	B-NP	Otime-	and	time-	NN	I-NP	Oand	dose-dependent	and	CC	I-NP	Odose-dependent	manner	dose-dependent	JJ	I-NP	Omanner	","	manner	NN	I-NP	O","	but	","	","	B-NP	Obut	not	but	CC	I-NP	Onot	NF-kappaB	not	RB	I-NP	ONF-kappaB	.	NF-kappaB	NN	B-NP	B-protein.	Curcumin	.	.	O	OCurcumin	","	Curcumin	NN	B-NP	O","	an	","	","	O	Oan	inhibitor	an	DT	B-NP	Oinhibitor	of	inhibitor	NN	I-NP	Oof	AP-1	of	IN	B-PP	OAP-1	","	AP-1	NN	B-NP	B-protein","	dose-dependently	","	","	O	Odose-dependently	suppressed	dose-dependently	RB	B-ADVP	Osuppressed	the	suppress	VBD	B-VP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	MCP-1	of	IN	B-PP	OMCP-1	mRNA	MCP-1	NN	B-NP	B-RNAmRNA	by	mRNA	NN	I-NP	I-RNAby	high	by	IN	B-PP	Ohigh	glucose	high	JJ	B-NP	Oglucose	.	glucose	NN	I-NP	O.	Tyrosine	.	.	O	OTyrosine	kinase	Tyrosine	NN	B-NP	B-proteinkinase	inhibitors	kinase	NN	I-NP	I-proteininhibitors	such	inhibitor	NNS	I-NP	Osuch	as	such	JJ	B-PP	Oas	genistein	as	IN	I-PP	Ogenistein	(	genistein	NN	B-NP	O(	12.5	(	(	O	O12.5	to	12.5	CD	B-NP	Oto	50	to	TO	I-NP	O50	micromol/L	50	CD	I-NP	Omicromol/L	)	micromol/L	NN	I-NP	O)	and	)	)	O	Oand	herbimycin	and	CC	O	Oherbimycin	A	herbimycin	NN	B-NP	OA	(	A	NN	I-NP	O(	0.1	(	(	O	O0.1	to	0.1	CD	B-NP	Oto	1	to	TO	I-NP	O1	micromol/L	1	CD	I-NP	Omicromol/L	)	micromol/L	NN	I-NP	O)	inhibited	)	)	O	Oinhibited	the	inhibit	VBD	B-VP	Othe	high-glucose-induced	the	DT	B-NP	Ohigh-glucose-induced	MCP-1	high-glucose-induced	JJ	I-NP	OMCP-1	mRNA	MCP-1	NN	I-NP	B-RNAmRNA	expression	mRNA	NN	I-NP	I-RNAexpression	in	expression	NN	I-NP	Oin	a	in	IN	B-PP	Oa	dose-dependent	a	DT	B-NP	Odose-dependent	manner	dose-dependent	JJ	I-NP	Omanner	","	manner	NN	I-NP	O","	and	","	","	O	Oand	also	and	CC	O	Oalso	suppressed	also	RB	B-VP	Osuppressed	the	suppress	VBD	I-VP	Othe	high-glucose-induced	the	DT	B-NP	Ohigh-glucose-induced	AP-1	high-glucose-induced	JJ	I-NP	OAP-1	binding	AP-1	NN	I-NP	B-proteinbinding	activity	binding	NN	I-NP	Oactivity	.	activity	NN	I-NP	O.	CONCLUSIONS	.	.	O	OCONCLUSIONS	:	CONCLUSIONS	NNS	B-NP	O:	:	:	:	O	O:	High	:	:	O	OHigh	glucose	High	JJ	B-NP	Oglucose	induced	glucose	NN	I-NP	Oinduced	mesothelial	induce	VBD	B-VP	Omesothelial	MCP-1	mesothelial	JJ	B-NP	OMCP-1	expression	MCP-1	NN	I-NP	B-proteinexpression	partly	expression	NN	I-NP	Opartly	via	partly	RB	B-ADVP	Ovia	the	via	IN	B-PP	Othe	tyrosine	the	DT	B-NP	Otyrosine	kinase-	tyrosine	NN	I-NP	B-proteinkinase-	AP-1	kinase-	NN	I-NP	I-proteinAP-1	pathway	AP-1	NN	I-NP	B-proteinpathway	.	pathway	NN	I-NP	O.	Signal	.	.	O	OSignal	thresholds	Signal	NN	B-NP	Othresholds	and	threshold	NNS	I-NP	Oand	modular	and	CC	O	Omodular	synergy	modular	JJ	B-NP	Osynergy	during	synergy	NN	I-NP	Oduring	expression	during	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	costimulatory	of	IN	B-PP	Ocostimulatory	molecules	costimulatory	JJ	B-NP	B-proteinmolecules	in	molecule	NNS	I-NP	I-proteinin	B	in	IN	B-PP	OB	lymphocytes	B	NN	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	analyzed	We	PRP	B-NP	Oanalyzed	intracellular	analyze	VBD	B-VP	Ointracellular	pathways	intracellular	JJ	B-NP	Opathways	modulating	pathway	NNS	I-NP	Omodulating	surface	modulate	VBG	B-VP	Osurface	densities	surface	NN	B-NP	Odensities	of	density	NNS	I-NP	Oof	CD80	of	IN	B-PP	OCD80	and	CD80	NN	B-NP	B-proteinand	CD86	and	CC	I-NP	OCD86	in	CD86	NN	I-NP	B-proteinin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	activated	cell	NNS	I-NP	I-cell_typeactivated	through	activate	VBN	B-VP	Othrough	ligation	through	IN	B-PP	Oligation	of	ligation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	Ag	the	DT	B-NP	OAg	receptor	Ag	NN	I-NP	B-proteinreceptor	","	receptor	NN	I-NP	I-protein","	and	","	","	O	Oand	the	and	CC	O	Othe	adhesion	the	DT	B-NP	Oadhesion	molecule	adhesion	NN	I-NP	B-proteinmolecule	CD54	molecule	NN	I-NP	I-proteinCD54	.	CD54	NN	I-NP	B-protein.	Whereas	.	.	O	OWhereas	B	Whereas	IN	B-SBAR	OB	cell	B	NN	B-NP	B-proteincell	Ag	cell	NN	I-NP	I-proteinAg	receptor	Ag	NN	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	BCR	(	(	O	OBCR	)	BCR	NN	B-NP	B-protein)	cross-linking	)	)	O	Ocross-linking	alone	cross-linking	NN	B-NP	Oalone	stimulated	alone	RB	B-ADVP	Ostimulated	increased	stimulate	VBD	B-VP	Oincreased	expression	increase	VBN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	CD86	of	IN	B-PP	OCD86	","	CD86	NN	B-NP	B-protein","	up-regulation	","	","	O	Oup-regulation	of	up-regulation	NN	B-NP	Oof	CD80	of	IN	B-PP	OCD80	required	CD80	NN	B-NP	B-proteinrequired	dual	require	VBD	B-VP	Odual	stimulation	dual	JJ	B-NP	Ostimulation	with	stimulation	NN	I-NP	Owith	anti-IgM	with	IN	B-PP	Oanti-IgM	and	anti-IgM	JJ	B-NP	B-proteinand	anti-CD54	and	CC	I-NP	Oanti-CD54	.	anti-CD54	JJ	I-NP	B-protein.	The	.	.	O	OThe	principal	The	DT	B-NP	Oprincipal	downstream	principal	JJ	I-NP	Odownstream	component	downstream	JJ	I-NP	Ocomponent	contributed	component	NN	I-NP	Ocontributed	by	contribute	VBN	B-VP	Oby	BCR	by	IN	B-PP	OBCR	signaling	BCR	NN	B-NP	B-proteinsignaling	","	signaling	NN	I-NP	O","	toward	","	","	O	Otoward	both	toward	IN	B-PP	Oboth	CD80	both	CC	O	OCD80	and	CD80	NN	B-NP	B-proteinand	CD86	and	CC	O	OCD86	induction	CD86	NN	B-NP	B-proteininduction	","	induction	NN	I-NP	O","	was	","	","	O	Owas	the	be	VBD	B-VP	Othe	elevated	the	DT	B-NP	Oelevated	concentration	elevated	JJ	I-NP	Oconcentration	of	concentration	NN	I-NP	Oof	free	of	IN	B-PP	Ofree	cytoplasmic	free	JJ	B-NP	Ocytoplasmic	Ca	cytoplasmic	JJ	I-NP	OCa	(	Ca	NN	I-NP	O(	2+	(	(	O	O2+	)	2+	JJ	B-ADVP	O)	","	)	)	O	O","	recruited	","	","	O	Orecruited	by	recruit	VBN	B-VP	Oby	way	by	IN	B-PP	Oway	of	way	NN	B-NP	Oof	capacitative	of	IN	B-PP	Ocapacitative	influx	capacitative	JJ	B-NP	Oinflux	.	influx	NN	I-NP	O.	This	.	.	O	OThis	alone	This	DT	B-NP	Oalone	was	alone	RB	B-ADVP	Owas	sufficient	be	VBD	B-VP	Osufficient	to	sufficient	JJ	B-ADJP	Oto	generate	to	TO	B-VP	Ogenerate	an	generate	VB	I-VP	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	CD86	in	IN	B-PP	OCD86	levels	CD86	NN	B-NP	B-proteinlevels	.	level	NNS	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	CD80	","	","	O	OCD80	enhancement	CD80	NN	B-NP	B-proteinenhancement	required	enhancement	NN	I-NP	Orequired	the	require	VBD	B-VP	Othe	concerted	the	DT	B-NP	Oconcerted	action	concerted	JJ	I-NP	Oaction	of	action	NN	I-NP	Oof	both	of	IN	B-PP	Oboth	intracellular	both	CC	O	Ointracellular	Ca	intracellular	JJ	B-NP	OCa	(	Ca	NN	I-NP	O(	2+	(	(	O	O2+	)	2+	JJ	O	O)	concentration	)	)	O	Oconcentration	and	concentration	NN	B-NP	Oand	CD54-initiated	and	CC	O	OCD54-initiated	pathways	CD54-initiated	JJ	B-NP	Opathways	.	pathway	NNS	I-NP	O.	The	.	.	O	OThe	nexus	The	DT	B-NP	Onexus	between	nexus	NN	I-NP	Obetween	anti-IgM	between	IN	B-PP	Oanti-IgM	and	anti-IgM	JJ	B-NP	B-proteinand	anti-CD54	and	CC	I-NP	Oanti-CD54	stimulation	anti-CD54	JJ	I-NP	B-proteinstimulation	","	stimulation	NN	I-NP	O","	in	","	","	O	Oin	the	in	IN	B-PP	Othe	context	the	DT	B-NP	Ocontext	of	context	NN	I-NP	Oof	CD80	of	IN	B-PP	OCD80	regulation	CD80	NN	B-NP	B-proteinregulation	","	regulation	NN	I-NP	O","	was	","	","	O	Owas	identified	be	VBD	B-VP	Oidentified	to	identify	VBN	I-VP	Oto	involve	to	TO	I-VP	Oinvolve	a	involve	VB	I-VP	Oa	self-propagating	a	DT	B-NP	Oself-propagating	process	self-propagating	JJ	I-NP	Oprocess	of	process	NN	I-NP	Oof	sequential	of	IN	B-PP	Osequential	synergy	sequential	JJ	B-NP	Osynergy	.	synergy	NN	I-NP	O.	The	.	.	O	OThe	first	The	DT	B-NP	Ofirst	step	first	JJ	I-NP	Ostep	involved	step	NN	I-NP	Oinvolved	amplified	involve	VBD	B-VP	Oamplified	accumulation	amplify	VBN	B-NP	Oaccumulation	of	accumulation	NN	I-NP	Oof	intracellular	of	IN	B-PP	Ointracellular	cAMP	intracellular	JJ	B-NP	OcAMP	","	cAMP	NN	I-NP	O","	as	","	","	O	Oas	a	as	IN	B-PP	Oa	result	a	DT	B-NP	Oresult	of	result	NN	I-NP	Oof	cross-talk	of	IN	B-PP	Ocross-talk	between	cross-talk	NN	B-NP	Obetween	BCR	between	IN	B-PP	OBCR	#NAME?	BCR	NN	B-NP	B-protein#NAME?	Ca	#NAME?	JJ	I-NP	OCa	(	Ca	NN	I-NP	O(	2+	(	(	O	O2+	)	2+	JJ	B-ADJP	O)	and	)	)	O	Oand	CD54-derived	and	CC	O	OCD54-derived	signals	CD54-derived	JJ	B-NP	Osignals	.	signal	NNS	I-NP	O.	This	.	.	O	OThis	then	This	DT	B-NP	Othen	facilitated	then	RB	B-ADVP	Ofacilitated	a	facilitate	VBD	B-VP	Oa	second	a	DT	B-NP	Osecond	synergistic	second	JJ	I-NP	Osynergistic	interaction	synergistic	JJ	I-NP	Ointeraction	between	interaction	NN	I-NP	Obetween	Ca	between	IN	B-PP	OCa	(	Ca	NN	B-NP	O(	2+	(	(	O	O2+	)	2+	JJ	B-ADJP	O)	and	)	)	O	Oand	cAMP	and	CC	O	OcAMP	","	cAMP	NN	B-NP	O","	culminating	","	","	O	Oculminating	in	culminate	VBG	B-VP	Oin	CD80	in	IN	B-PP	OCD80	expression	CD80	NN	B-NP	B-proteinexpression	.	expression	NN	I-NP	O.	Our	.	.	O	OOur	findings	Our	PRP$	B-NP	Ofindings	of	finding	NNS	I-NP	Oof	distinct	of	IN	B-PP	Odistinct	signal	distinct	JJ	B-NP	Osignal	transducer	signal	NN	I-NP	B-proteintransducer	requirements	transducer	NN	I-NP	I-proteinrequirements	","	requirement	NNS	I-NP	I-protein","	with	","	","	O	Owith	the	with	IN	B-PP	Othe	added	the	DT	B-NP	Oadded	consequences	add	VBN	I-NP	Oconsequences	of	consequence	NNS	I-NP	Oof	cross-talk	of	IN	B-PP	Ocross-talk	","	cross-talk	NN	B-NP	O","	offers	","	","	O	Ooffers	an	offer	VBZ	B-VP	Oan	explanation	an	DT	B-NP	Oexplanation	for	explanation	NN	I-NP	Ofor	variable	for	IN	B-PP	Ovariable	modulation	variable	JJ	B-NP	Omodulation	of	modulation	NN	I-NP	Oof	costimulatory	of	IN	B-PP	Ocostimulatory	molecule	costimulatory	JJ	B-NP	B-proteinmolecule	expression	molecule	NN	I-NP	I-proteinexpression	in	expression	NN	I-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	diverse	to	TO	B-PP	Odiverse	physiological	diverse	JJ	B-NP	Ophysiological	stimuli	physiological	JJ	I-NP	Ostimuli	.	stimulus	NNS	I-NP	O.	Importantly	.	.	O	OImportantly	","	Importantly	RB	B-ADVP	O","	these	","	","	O	Othese	results	these	DT	B-NP	Oresults	also	result	NNS	I-NP	Oalso	reveal	also	RB	B-ADVP	Oreveal	how	reveal	VBP	B-VP	Ohow	concentration	how	WRB	B-ADVP	Oconcentration	threshold	concentration	NN	B-NP	Othreshold	barriers	threshold	NN	I-NP	Obarriers	for	barrier	NNS	I-NP	Ofor	recruitment	for	IN	B-PP	Orecruitment	of	recruitment	NN	B-NP	Oof	individual	of	IN	B-PP	Oindividual	second	individual	JJ	B-NP	Osecond	messengers	second	JJ	I-NP	Omessengers	can	messenger	NNS	I-NP	Ocan	be	can	MD	B-VP	Obe	overcome	be	VB	I-VP	Oovercome	by	overcome	VBN	I-VP	Oby	constructive	by	IN	B-PP	Oconstructive	convergence	constructive	JJ	B-NP	Oconvergence	of	convergence	NN	I-NP	Oof	signaling	of	IN	B-PP	Osignaling	modules	signaling	NN	B-NP	Omodules	.	module	NNS	I-NP	O.	The	.	.	O	OThe	role	The	DT	B-NP	Orole	of	role	NN	I-NP	Oof	Epstein-Barr	of	IN	B-PP	OEpstein-Barr	virus	Epstein-Barr	JJ	B-NP	Ovirus	in	virus	NN	I-NP	Oin	neoplastic	in	IN	B-PP	Oneoplastic	transformation	neoplastic	JJ	B-NP	Otransformation	.	transformation	NN	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	review	this	DT	B-NP	Oreview	","	review	NN	I-NP	O","	we	","	","	O	Owe	focus	we	PRP	B-NP	Ofocus	on	focus	VBP	B-VP	Oon	new	on	IN	B-PP	Onew	data	new	JJ	B-NP	Odata	from	datum	NNS	I-NP	Ofrom	basic	from	IN	B-PP	Obasic	","	basic	JJ	B-NP	O","	translational	","	","	I-NP	Otranslational	and	translational	JJ	I-NP	Oand	clinical	and	CC	I-NP	Oclinical	research	clinical	JJ	I-NP	Oresearch	relating	research	NN	I-NP	Orelating	to	relate	VBG	B-VP	Oto	the	to	TO	B-PP	Othe	Epstein-Barr	the	DT	B-NP	OEpstein-Barr	virus	Epstein-Barr	JJ	I-NP	Ovirus	(	virus	NN	I-NP	O(	EBV	(	(	O	OEBV	)	EBV	NN	B-NP	O)	.	)	)	O	O.	Beside	.	.	O	OBeside	its	Beside	IN	B-PP	Oits	well-known	its	PRP$	B-NP	Owell-known	tropism	well-known	JJ	I-NP	Otropism	for	tropism	NN	I-NP	Ofor	B	for	IN	B-PP	OB	lymphocytes	B	NN	B-NP	B-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	epithelial	and	CC	O	Oepithelial	cells	epithelial	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	EBV	","	","	O	OEBV	also	EBV	NN	B-NP	Oalso	infects	also	RB	B-ADVP	Oinfects	T	infect	VBZ	B-VP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	monocytes	","	","	O	Omonocytes	and	monocyte	NNS	B-NP	B-cell_typeand	granulocytes	and	CC	O	Ogranulocytes	.	granulocyte	NNS	B-NP	B-cell_type.	After	.	.	O	OAfter	primary	After	IN	B-PP	Oprimary	infection	primary	JJ	B-NP	Oinfection	","	infection	NN	I-NP	O","	EBV	","	","	O	OEBV	persists	EBV	NN	B-NP	Opersists	throughout	persist	VBZ	B-VP	Othroughout	the	throughout	IN	B-PP	Othe	life	the	DT	B-NP	Olife	span	life	NN	I-NP	Ospan	in	span	NN	I-NP	Oin	resting	in	IN	B-PP	Oresting	memory	rest	VBG	B-NP	B-cell_typememory	B	memory	NN	I-NP	I-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	from	","	","	O	Ofrom	where	from	IN	B-PP	Owhere	it	where	WRB	B-ADVP	Oit	is	it	PRP	B-NP	Ois	reactivated	be	VBZ	B-VP	Oreactivated	upon	reactivate	VBN	I-VP	Oupon	breakdown	upon	IN	B-PP	Obreakdown	of	breakdown	NN	B-NP	Oof	cellular	of	IN	B-PP	Ocellular	immunity	cellular	JJ	B-NP	Oimmunity	.	immunity	NN	I-NP	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	process	the	DT	B-NP	Oprocess	of	process	NN	I-NP	Oof	neoplastic	of	IN	B-PP	Oneoplastic	transformation	neoplastic	JJ	B-NP	Otransformation	","	transformation	NN	I-NP	O","	the	","	","	O	Othe	EBV-encoded	the	DT	B-NP	OEBV-encoded	latent	EBV-encoded	JJ	I-NP	B-DNAlatent	membrane	latent	JJ	I-NP	I-DNAmembrane	protein	membrane	NN	I-NP	I-DNAprotein	1	protein	NN	I-NP	I-DNA1	(	1	CD	I-NP	I-DNA(	LMP1	(	(	O	I-DNALMP1	)	LMP1	NN	B-NP	I-DNA)	oncogene	)	)	O	I-DNAoncogene	represents	oncogene	NN	B-NP	I-DNArepresents	the	represent	VBZ	B-VP	Othe	major	the	DT	B-NP	Omajor	driving	major	JJ	I-NP	Odriving	force	drive	VBG	I-NP	Oforce	.	force	NN	I-NP	O.	LMP1	.	.	O	OLMP1	acts	LMP1	NN	B-NP	B-proteinacts	like	act	VBZ	B-VP	Olike	a	like	IN	B-PP	Oa	constitutively	a	DT	B-NP	Oconstitutively	activated	constitutively	RB	I-NP	B-proteinactivated	receptor	activate	VBN	I-NP	I-proteinreceptor	of	receptor	NN	I-NP	I-proteinof	the	of	IN	B-PP	Othe	tumor	the	DT	B-NP	Otumor	necrosis	tumor	NN	I-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	receptor	factor	NN	I-NP	I-proteinreceptor	family	receptor	NN	I-NP	I-proteinfamily	and	family	NN	I-NP	I-proteinand	allows	and	CC	O	Oallows	the	allow	VBZ	B-VP	Othe	amplification	the	DT	B-NP	Oamplification	or	amplification	NN	I-NP	Oor	bypassing	or	CC	I-NP	Obypassing	of	bypassing	NN	I-NP	Oof	physiological	of	IN	B-PP	Ophysiological	regulatory	physiological	JJ	B-NP	Oregulatory	signals	regulatory	JJ	I-NP	Osignals	through	signal	NNS	I-NP	Othrough	direct	through	IN	B-PP	Odirect	and	direct	JJ	B-NP	Oand	indirect	and	CC	I-NP	Oindirect	interactions	indirect	JJ	I-NP	Ointeractions	with	interaction	NNS	I-NP	Owith	proteins	with	IN	B-PP	Oproteins	of	protein	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	tumor	the	DT	B-NP	Otumor	necrosis	tumor	NN	I-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	receptor-associated	factor	NN	I-NP	I-proteinreceptor-associated	factor	receptor-associated	JJ	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	TRAF	(	(	O	I-proteinTRAF	)	TRAF	NN	B-NP	I-protein)	family	)	)	O	I-proteinfamily	.	family	NN	B-NP	I-protein.	TRAF2	.	.	O	OTRAF2	#NAME?	TRAF2	NN	B-NP	B-protein#NAME?	NF-kappaB	#NAME?	JJ	I-NP	ONF-kappaB	activation	NF-kappaB	NN	I-NP	B-proteinactivation	","	activation	NN	I-NP	O","	AP-1	","	","	O	OAP-1	induction	AP-1	NN	B-NP	B-proteininduction	and	induction	NN	I-NP	Oand	JAK3	and	CC	I-NP	OJAK3	/	JAK3	NN	I-NP	B-protein/	STAT	/	SYM	B-NP	OSTAT	activation	STAT	NN	B-NP	B-proteinactivation	may	activation	NN	I-NP	Omay	result	may	MD	B-VP	Oresult	in	result	VB	I-VP	Oin	sustained	in	IN	B-PP	Osustained	proliferation	sustained	JJ	B-NP	Oproliferation	leading	proliferation	NN	I-NP	Oleading	to	lead	VBG	B-VP	Oto	lymphoma	to	TO	B-PP	Olymphoma	.	lymphoma	NN	B-NP	O.	The	.	.	O	OThe	ability	The	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	LMP1	of	IN	B-PP	OLMP1	to	LMP1	NN	B-NP	B-proteinto	suppress	to	TO	B-VP	Osuppress	germinal	suppress	VB	I-VP	Ogerminal	center	germinal	JJ	B-NP	Ocenter	formation	center	NN	I-NP	Oformation	and	formation	NN	I-NP	Oand	its	and	CC	O	Oits	capacity	its	PRP$	B-NP	Ocapacity	to	capacity	NN	I-NP	Oto	mediate	to	TO	B-VP	Omediate	its	mediate	VB	I-VP	Oits	own	its	PRP$	B-NP	Oown	transcriptional	own	JJ	I-NP	Otranscriptional	activation	transcriptional	JJ	I-NP	Oactivation	shed	activation	NN	I-NP	Oshed	new	shed	VBD	B-VP	Onew	light	new	JJ	B-NP	Olight	on	light	NN	I-NP	Oon	the	on	IN	B-PP	Othe	pathogenesis	the	DT	B-NP	Opathogenesis	of	pathogenesis	NN	I-NP	Oof	EBV-associated	of	IN	B-PP	OEBV-associated	latency	EBV-associated	JJ	B-NP	Olatency	type	latency	NN	I-NP	Otype	II	type	NN	I-NP	OII	lymphoproliferations	II	CD	I-NP	Olymphoproliferations	like	lymphoproliferation	NNS	I-NP	Olike	Hodgkin	like	IN	B-PP	OHodgkin	's	Hodgkin	NNP	B-NP	O's	disease	's	POS	B-NP	Odisease	and	disease	NN	I-NP	Oand	angioimmunoblastic	and	CC	O	Oangioimmunoblastic	lymphadenopathy	angioimmunoblastic	JJ	B-NP	Olymphadenopathy	.	lymphadenopathy	NN	I-NP	O.	The	.	.	O	OThe	carboxy	The	DT	B-NP	Ocarboxy	terminus	carboxy	NN	I-NP	B-proteinterminus	of	terminus	NN	I-NP	I-proteinof	LMP1	of	IN	B-PP	OLMP1	is	LMP1	NN	B-NP	B-proteinis	also	be	VBZ	B-VP	Oalso	a	also	RB	B-ADVP	Oa	reliable	a	DT	B-NP	Oreliable	marker	reliable	JJ	I-NP	Omarker	for	marker	NN	I-NP	Ofor	individual	for	IN	B-PP	Oindividual	EBV	individual	JJ	B-NP	OEBV	strain	EBV	NN	I-NP	Ostrain	identification	strain	NN	I-NP	Oidentification	and	identification	NN	I-NP	Oand	thus	and	CC	O	Othus	offers	thus	RB	B-VP	Ooffers	new	offer	VBZ	I-VP	Onew	possibilities	new	JJ	B-NP	Opossibilities	in	possibility	NNS	I-NP	Oin	tracing	in	IN	B-PP	Otracing	the	trace	VBG	B-VP	Othe	molecular	the	DT	B-NP	Omolecular	events	molecular	JJ	I-NP	Oevents	leading	event	NNS	I-NP	Oleading	to	lead	VBG	B-VP	Oto	posttransplant	to	TO	I-VP	Oposttransplant	lymphoproliferative	posttransplant	VB	I-VP	Olymphoproliferative	disorders	lymphoproliferative	JJ	B-NP	Odisorders	(	disorder	NNS	I-NP	O(	PTLDs	(	(	O	OPTLDs	)	PTLD	NNS	B-NP	B-protein)	.	)	)	O	O.	Cytotoxic	.	.	O	OCytotoxic	T	Cytotoxic	JJ	B-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	directed	lymphocyte	NNS	I-NP	I-cell_typedirected	against	direct	VBN	B-VP	Oagainst	well-characterized	against	IN	B-PP	Owell-characterized	epitopes	well-characterized	JJ	B-NP	Oepitopes	of	epitope	NNS	I-NP	Oof	EBV	of	IN	B-PP	OEBV	latency	EBV	NN	B-NP	B-DNAlatency	genes	latency	NN	I-NP	I-DNAgenes	represent	gene	NNS	I-NP	I-DNArepresent	an	represent	VBP	B-VP	Oan	already	an	DT	B-NP	Oalready	successful	already	RB	I-NP	Osuccessful	and	successful	JJ	I-NP	Oand	promising	and	CC	I-NP	Opromising	therapeutic	promising	JJ	I-NP	Otherapeutic	approach	therapeutic	JJ	I-NP	Oapproach	to	approach	NN	I-NP	Oto	EBV-associated	to	TO	B-PP	OEBV-associated	lymphomas	EBV-associated	JJ	B-NP	Olymphomas	","	lymphoma	NNS	I-NP	O","	in	","	","	O	Oin	particular	in	IN	B-PP	Oparticular	PTLDs	particular	JJ	B-NP	OPTLDs	Interferon-alpha	PTLD	NNS	I-NP	OInterferon-alpha	drives	Interferon-alpha	NN	B-NP	B-proteindrives	T	drive	VBZ	B-VP	OT	cell-mediated	T	NN	B-NP	Ocell-mediated	immunopathology	cell-mediated	JJ	I-NP	Oimmunopathology	in	immunopathology	NN	I-NP	Oin	the	in	IN	B-PP	Othe	intestine	the	DT	B-NP	Ointestine	.	intestine	NN	I-NP	O.	The	.	.	O	OThe	ability	The	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	interferon	of	IN	B-PP	Ointerferon	(	interferon	NN	B-NP	B-protein(	IFN	(	(	O	I-proteinIFN	)	IFN	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	to	#NAME?	NN	B-NP	I-proteinto	induce	to	TO	B-VP	Oinduce	autoimmunity	induce	VB	I-VP	Oautoimmunity	and	autoimmunity	NN	B-NP	Oand	exacerbate	and	CC	I-NP	Oexacerbate	Th1	exacerbate	NN	I-NP	OTh1	diseases	Th1	NN	I-NP	Odiseases	is	disease	NNS	I-NP	Ois	well	be	VBZ	B-VP	Owell	known	well	RB	B-ADJP	Oknown	.	know	VBN	I-ADJP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	recently	have	VBP	B-VP	Orecently	described	recently	RB	I-VP	Odescribed	enhanced	describe	VBN	I-VP	Oenhanced	expression	enhance	VBN	I-VP	Oexpression	of	expression	NN	B-NP	Oof	IFN-alpha	of	IN	B-PP	OIFN-alpha	in	IFN-alpha	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	mucosa	the	DT	B-NP	Omucosa	of	mucosa	NN	I-NP	Oof	patients	of	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	celiac	with	IN	B-PP	Oceliac	disease	celiac	JJ	B-NP	Odisease	(	disease	NN	I-NP	O(	CD	(	(	O	OCD	)	CD	NN	B-NP	O)	","	)	)	O	O","	a	","	","	O	Oa	gluten-sensitive	a	DT	B-NP	Ogluten-sensitive	Th1-mediated	gluten-sensitive	JJ	I-NP	OTh1-mediated	enteropathy	Th1-mediated	JJ	I-NP	Oenteropathy	","	enteropathy	NN	I-NP	O","	characterized	","	","	O	Ocharacterized	by	characterize	VBN	B-VP	Oby	villous	by	IN	B-PP	Ovillous	atrophy	villous	JJ	B-NP	Oatrophy	and	atrophy	NN	I-NP	Oand	crypt	and	CC	I-NP	Ocrypt	cell	crypt	NN	I-NP	Ocell	hyperplasia	cell	NN	I-NP	Ohyperplasia	.	hyperplasia	NN	I-NP	O.	Previous	.	.	O	OPrevious	studies	Previous	JJ	B-NP	Ostudies	from	study	NNS	I-NP	Ofrom	this	from	IN	B-PP	Othis	laboratory	this	DT	B-NP	Olaboratory	have	laboratory	NN	I-NP	Ohave	shown	have	VBP	B-VP	Oshown	that	show	VBN	I-VP	Othat	T	that	IN	B-SBAR	OT	cell	T	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	in	activation	NN	I-NP	Oin	explant	in	IN	B-PP	Oexplant	cultures	explant	NN	B-NP	Ocultures	of	culture	NNS	I-NP	Oof	human	of	IN	B-PP	Ohuman	fetal	human	JJ	B-NP	Ofetal	gut	fetal	JJ	I-NP	Ogut	can	gut	NN	I-NP	Ocan	also	can	MD	B-VP	Oalso	result	also	RB	I-VP	Oresult	in	result	VB	I-VP	Oin	villous	in	IN	B-PP	Ovillous	atrophy	villous	JJ	B-NP	Oatrophy	and	atrophy	NN	I-NP	Oand	crypt	and	CC	I-NP	Ocrypt	cell	crypt	NN	I-NP	Ocell	hyperplasia	cell	NN	I-NP	Ohyperplasia	.	hyperplasia	NN	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	","	have	VBP	B-VP	O","	therefore	","	","	O	Otherefore	","	therefore	RB	B-ADVP	O","	examined	","	","	O	Oexamined	changes	examine	VBN	B-NP	Ochanges	that	change	NNS	I-NP	Othat	take	that	WDT	B-NP	Otake	place	take	VBP	B-VP	Oplace	in	place	NN	B-NP	Oin	explant	in	IN	B-PP	Oexplant	cultures	explant	NN	B-NP	Ocultures	of	culture	NNS	I-NP	Oof	human	of	IN	B-PP	Ohuman	fetal	human	JJ	B-NP	Ofetal	gut	fetal	JJ	I-NP	Ogut	after	gut	NN	I-NP	Oafter	activation	after	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	T	of	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	with	cell	NNS	I-NP	I-cell_typewith	anti-CD3	with	IN	B-PP	Oanti-CD3	and/or	anti-CD3	NN	B-NP	B-proteinand/or	IFN-alpha	and/or	CC	I-NP	OIFN-alpha	.	IFN-alpha	NN	I-NP	B-protein.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	activation	that	IN	B-SBAR	Oactivation	of	activation	NN	B-NP	Oof	T	of	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	with	cell	NNS	I-NP	I-cell_typewith	anti-CD3	with	IN	B-PP	Oanti-CD3	alone	anti-CD3	NN	B-NP	B-proteinalone	elicits	alone	RB	B-ADVP	Oelicits	a	elicit	VBZ	B-VP	Oa	small	a	DT	B-NP	Osmall	IFN-gamma	small	JJ	I-NP	OIFN-gamma	and	IFN-gamma	NN	I-NP	B-proteinand	TNF-alpha	and	CC	I-NP	OTNF-alpha	response	TNF-alpha	NN	I-NP	B-proteinresponse	with	response	NN	I-NP	Owith	no	with	IN	B-PP	Ono	tissue	no	DT	B-NP	Otissue	injury	tissue	NN	I-NP	Oinjury	.	injury	NN	I-NP	O.	Similarly	.	.	O	OSimilarly	","	Similarly	RB	B-ADVP	O","	no	","	","	O	Ono	changes	no	DT	B-NP	Ochanges	are	change	NNS	I-NP	Oare	seen	be	VBP	B-VP	Oseen	in	see	VBN	I-VP	Oin	explants	in	IN	B-PP	Oexplants	cultured	explant	NNS	B-NP	Ocultured	with	culture	VBN	B-VP	Owith	IFN-alpha	with	IN	B-PP	OIFN-alpha	alone	IFN-alpha	NN	B-NP	B-proteinalone	.	alone	RB	B-ADVP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	addition	","	","	O	Oaddition	of	addition	NN	B-NP	Oof	IFN-alpha	of	IN	B-PP	OIFN-alpha	with	IFN-alpha	NN	B-NP	B-proteinwith	anti-CD3	with	IN	B-PP	Oanti-CD3	results	anti-CD3	NN	B-NP	B-proteinresults	in	result	VBZ	B-VP	Oin	enhanced	in	IN	B-PP	Oenhanced	Th1	enhance	VBN	B-NP	OTh1	response	Th1	NN	I-NP	Oresponse	and	response	NN	I-NP	Oand	crypt	and	CC	I-NP	Ocrypt	cell	crypt	NN	I-NP	Ocell	hyperplasia	cell	NN	I-NP	Ohyperplasia	.	hyperplasia	NN	I-NP	O.	This	.	.	O	OThis	is	This	DT	B-NP	Ois	associated	be	VBZ	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	enhanced	with	IN	B-PP	Oenhanced	phosphorylation	enhance	VBN	B-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	STAT1	of	IN	B-PP	OSTAT1	","	STAT1	NN	B-NP	B-protein","	STAT3	","	","	O	OSTAT3	","	STAT3	NN	B-NP	B-protein","	and	","	","	O	Oand	Fyn	and	CC	O	OFyn	","	Fyn	NN	B-NP	B-protein","	a	","	","	O	Oa	Src	a	DT	B-NP	OSrc	homology	Src	NN	I-NP	B-proteinhomology	tyrosine	homology	NN	I-NP	I-proteintyrosine	kinase	tyrosine	NN	I-NP	I-proteinkinase	","	kinase	NN	I-NP	I-protein","	which	","	","	O	Owhich	interacts	which	WDT	B-NP	Ointeracts	with	interact	VBZ	B-VP	Owith	both	with	IN	B-PP	Oboth	TCR	both	CC	O	OTCR	and	TCR	NN	B-NP	B-proteinand	IFN-alpha	and	CC	O	OIFN-alpha	signal	IFN-alpha	NN	B-NP	B-proteinsignal	components	signal	NN	I-NP	Ocomponents	.	component	NNS	I-NP	O.	Together	.	.	O	OTogether	these	Together	RB	B-ADVP	Othese	data	these	DT	B-NP	Odata	indicate	datum	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	IFN-alpha	that	IN	B-SBAR	OIFN-alpha	can	IFN-alpha	NN	B-NP	B-proteincan	facilitate	can	MD	B-VP	Ofacilitate	activation	facilitate	VB	I-VP	Oactivation	of	activation	NN	B-NP	Oof	Th1-reactive	of	IN	B-PP	OTh1-reactive	cells	Th1-reactive	JJ	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	the	in	IN	B-PP	Othe	gut	the	DT	B-NP	Ogut	and	gut	NN	I-NP	Oand	drive	and	CC	I-NP	Odrive	immunopathology	drive	NN	I-NP	Oimmunopathology	.	immunopathology	NN	I-NP	O.	Suppression	.	.	O	OSuppression	of	Suppression	NN	B-NP	Oof	tumor	of	IN	B-PP	Otumor	necrosis	tumor	NN	B-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	alpha	factor	NN	I-NP	I-proteinalpha	production	alpha	NN	I-NP	I-proteinproduction	by	production	NN	I-NP	Oby	cAMP	by	IN	B-PP	OcAMP	in	cAMP	NN	B-NP	Oin	human	in	IN	B-PP	Ohuman	monocytes	human	JJ	B-NP	B-cell_typemonocytes	:	monocyte	NNS	I-NP	I-cell_type:	dissociation	:	:	O	Odissociation	with	dissociation	NN	B-NP	Owith	mRNA	with	IN	B-PP	OmRNA	level	mRNA	NN	B-NP	Olevel	and	level	NN	I-NP	Oand	independent	and	CC	O	Oindependent	of	independent	JJ	B-ADJP	Oof	interleukin-10	of	IN	B-PP	Ointerleukin-10	.	interleukin-10	NN	B-NP	B-protein.	BACKGROUND	.	.	O	OBACKGROUND	:	BACKGROUND	NN	B-NP	O:	Elevation	:	:	O	OElevation	of	Elevation	NN	B-NP	Oof	cellular	of	IN	B-PP	Ocellular	cAMP	cellular	JJ	B-NP	OcAMP	inhibits	cAMP	NN	I-NP	Oinhibits	lipopolysaccharide	inhibit	VBZ	B-VP	Olipopolysaccharide	(	lipopolysaccharide	NN	B-NP	O(	LPS	(	(	O	OLPS	)	LPS	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	tumor	#NAME?	JJ	B-NP	Otumor	necrosis	tumor	NN	I-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	alpha	factor	NN	I-NP	I-proteinalpha	(	alpha	NN	I-NP	I-protein(	TNF-alpha	(	(	O	OTNF-alpha	)	TNF-alpha	NN	B-NP	B-protein)	production	)	)	O	Oproduction	and	production	NN	B-NP	Oand	increases	and	CC	O	Oincreases	the	increase	VBZ	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	interleukin	of	IN	B-PP	Ointerleukin	(	interleukin	NN	B-NP	B-protein(	IL	(	(	O	I-proteinIL	)	IL	NN	B-NP	I-protein)	-10	)	)	O	I-protein-10	in	-10	CD	B-NP	I-proteinin	mononuclear	in	IN	B-PP	Omononuclear	cells	mononuclear	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	TNF-alpha	.	.	O	OTNF-alpha	gene	TNF-alpha	NN	B-NP	B-proteingene	expression	gene	NN	I-NP	Oexpression	obligates	expression	NN	I-NP	Oobligates	activation	obligate	VBZ	B-VP	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	nuclear	factor	NN	I-NP	I-proteinnuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	kappaB	factor	NN	I-NP	I-proteinkappaB	(	kappaB	NN	I-NP	I-protein(	NF-kappaB	(	(	O	ONF-kappaB	)	NF-kappaB	NN	B-NP	B-protein)	.	)	)	O	O.	Exogenous	.	.	O	OExogenous	IL-10	Exogenous	JJ	B-NP	OIL-10	inhibits	IL-10	NN	I-NP	B-proteininhibits	NF-kappaB	inhibit	VBZ	B-VP	ONF-kappaB	in	NF-kappaB	NN	B-NP	B-proteinin	monocytes	in	IN	B-PP	Omonocytes	and	monocyte	NNS	B-NP	B-cell_typeand	thus	and	CC	O	Othus	attenuates	thus	RB	B-VP	Oattenuates	TNF-alpha	attenuate	VBZ	I-VP	OTNF-alpha	production	TNF-alpha	NN	B-NP	B-proteinproduction	.	production	NN	I-NP	O.	We	.	.	O	OWe	examined	We	PRP	B-NP	Oexamined	the	examine	VBD	B-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	endogenous	of	IN	B-PP	Oendogenous	IL-10	endogenous	JJ	B-NP	OIL-10	in	IL-10	NN	I-NP	B-proteinin	the	in	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	activation	NF-kappaB	NN	B-NP	B-proteinactivation	and	activation	NN	I-NP	Oand	TNF-alpha	and	CC	O	OTNF-alpha	production	TNF-alpha	NN	B-NP	B-proteinproduction	in	production	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	monocytes	human	JJ	B-NP	B-cell_typemonocytes	by	monocyte	NNS	I-NP	I-cell_typeby	cAMP	by	IN	B-PP	OcAMP	.	cAMP	NN	B-NP	O.	METHODS	.	.	O	OMETHODS	:	METHODS	NNS	B-NP	O:	Human	:	:	O	OHuman	monocytes	Human	JJ	B-NP	B-cell_typemonocytes	were	monocyte	NNS	I-NP	I-cell_typewere	stimulated	be	VBD	B-VP	Ostimulated	with	stimulate	VBN	I-VP	Owith	Escherichia	with	IN	B-PP	OEscherichia	coli	Escherichia	FW	B-NP	Ocoli	LPS	coli	FW	I-NP	OLPS	(	LPS	NN	I-NP	O(	100	(	(	O	O100	ng/ml	100	CD	B-NP	Ong/ml	)	ng/ml	NN	I-NP	O)	with	)	)	O	Owith	and	with	IN	B-PP	Oand	without	and	CC	I-PP	Owithout	forskolin	without	IN	I-PP	Oforskolin	(	forskolin	NN	B-NP	O(	FSK	(	(	O	OFSK	","	FSK	NN	B-NP	B-protein","	50	","	","	O	O50	microM	50	CD	B-NP	OmicroM	)	microM	NN	I-NP	O)	or	)	)	O	Oor	dibutyryl	or	CC	O	Odibutyryl	cyclic	dibutyryl	NN	B-NP	Ocyclic	AMP	cyclic	JJ	I-NP	OAMP	(	AMP	NN	I-NP	O(	dbcAMP	(	(	O	OdbcAMP	","	dbcAMP	NN	B-NP	O","	100	","	","	O	O100	microM	100	CD	B-NP	OmicroM	)	microM	NN	I-NP	O)	.	)	)	O	O.	Cytokine	.	.	O	OCytokine	(	Cytokine	NN	B-NP	B-protein(	TNF-alpha	(	(	O	OTNF-alpha	and	TNF-alpha	NN	B-NP	B-proteinand	IL-10	and	CC	O	OIL-10	)	IL-10	NN	B-NP	B-protein)	release	)	)	O	Orelease	was	release	NN	B-NP	Owas	measured	be	VBD	B-VP	Omeasured	by	measure	VBN	I-VP	Oby	immunoassay	by	IN	B-PP	Oimmunoassay	.	immunoassay	NN	B-NP	O.	TNF-alpha	.	.	O	OTNF-alpha	mRNA	TNF-alpha	NN	B-NP	B-RNAmRNA	was	mRNA	NN	I-NP	I-RNAwas	measured	be	VBD	B-VP	Omeasured	by	measure	VBN	I-VP	Oby	reverse	by	IN	B-PP	Oreverse	transcription	reverse	JJ	B-NP	Otranscription	polymerase	transcription	NN	I-NP	Opolymerase	chain	polymerase	NN	I-NP	Ochain	reaction	chain	NN	I-NP	Oreaction	","	reaction	NN	I-NP	O","	and	","	","	O	Oand	NF-kappaB	and	CC	O	ONF-kappaB	DNA	NF-kappaB	NN	B-NP	B-proteinDNA	binding	DNA	NN	I-NP	Obinding	activity	binding	NN	I-NP	Oactivity	was	activity	NN	I-NP	Owas	assessed	be	VBD	B-VP	Oassessed	by	assess	VBN	I-VP	Oby	gel	by	IN	B-PP	Ogel	mobility	gel	NN	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assay	shift	NN	I-NP	Oassay	.	assay	NN	I-NP	O.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	cAMP-elevating	:	:	O	OcAMP-elevating	agents	cAMP-elevating	JJ	B-NP	Oagents	inhibited	agent	NNS	I-NP	Oinhibited	LPS-stimulated	inhibit	VBD	B-VP	OLPS-stimulated	TNF-alpha	LPS-stimulated	JJ	B-NP	OTNF-alpha	release	TNF-alpha	NN	I-NP	B-proteinrelease	(	release	NN	I-NP	O(	0.77	(	(	O	O0.77	+/-	0.77	CD	B-NP	O+/-	0.13	+/-	CC	I-NP	O0.13	ng/10	0.13	CD	I-NP	Ong/10	(	ng/10	CD	I-NP	O(	6	(	(	O	O6	)	6	CD	B-NP	O)	cells	)	)	O	Ocells	in	cell	NNS	B-NP	Oin	LPS	in	IN	B-PP	OLPS	+	LPS	NN	B-NP	O+	dbcAMP	+	CC	I-NP	OdbcAMP	and	dbcAMP	NN	I-NP	Oand	0.68	and	CC	O	O0.68	+/-	0.68	CD	B-NP	O+/-	0.19	+/-	CC	I-NP	O0.19	ng/10	0.19	CD	I-NP	Ong/10	(	ng/10	CD	I-NP	O(	6	(	(	O	O6	)	6	CD	B-NP	O)	cells	)	)	O	Ocells	in	cell	NNS	B-NP	Oin	LPS	in	IN	B-PP	OLPS	+	LPS	NN	B-NP	O+	FSK	+	SYM	B-NP	OFSK	","	FSK	NN	I-NP	B-protein","	both	","	","	O	Oboth	P	both	DT	B-NP	OP	<	P	NN	I-NP	O<	0.05	<	JJR	B-NP	O0.05	vs	0.05	CD	I-NP	Ovs	1.61	vs	IN	B-PP	O1.61	+/-	1.61	CD	B-NP	O+/-	0.34	+/-	SYM	I-NP	O0.34	ng/10	0.34	CD	I-NP	Ong/10	(	ng/10	CD	I-NP	O(	6	(	(	O	O6	)	6	CD	B-NP	O)	cells	)	)	O	Ocells	in	cell	NNS	B-NP	Oin	LPS	in	IN	B-PP	OLPS	alone	LPS	NN	B-NP	Oalone	)	alone	RB	B-ADVP	O)	.	)	)	O	O.	Conversely	.	.	O	OConversely	","	Conversely	RB	B-ADVP	O","	cAMP	","	","	O	OcAMP	enhanced	cAMP	NN	B-NP	Oenhanced	LPS-stimulated	enhance	VBD	B-VP	OLPS-stimulated	IL-10	LPS-stimulated	JJ	B-NP	OIL-10	release	IL-10	NN	I-NP	B-proteinrelease	(	release	NN	I-NP	O(	100	(	(	O	O100	+/-	100	CD	B-NP	O+/-	21.5	+/-	SYM	I-NP	O21.5	pg/10	21.5	CD	I-NP	Opg/10	(	pg/10	NN	I-NP	O(	6	(	(	O	O6	)	6	CD	B-NP	O)	cells	)	)	O	Ocells	in	cell	NNS	B-NP	Oin	LPS	in	IN	B-PP	OLPS	+	LPS	NN	B-NP	O+	dbcAMP	+	CC	I-NP	OdbcAMP	and	dbcAMP	NN	I-NP	Oand	110	and	CC	O	O110	+/-	110	CD	B-NP	O+/-	25.2	+/-	SYM	I-NP	O25.2	pg/10	25.2	CD	I-NP	Opg/10	(	pg/10	NN	I-NP	O(	6	(	(	O	O6	)	6	CD	B-NP	O)	cells	)	)	O	Ocells	in	cell	NNS	B-NP	Oin	LPS	in	IN	B-PP	OLPS	+	LPS	NN	B-NP	O+	FSK	+	SYM	B-NP	OFSK	","	FSK	NN	I-NP	B-protein","	both	","	","	O	Oboth	P	both	DT	B-NP	OP	<	P	NN	I-NP	O<	0.05	<	JJR	B-NP	O0.05	vs	0.05	CD	I-NP	Ovs	53.3	vs	IN	B-PP	O53.3	+/-	53.3	CD	B-NP	O+/-	12.8	+/-	SYM	I-NP	O12.8	pg/10	12.8	CD	I-NP	Opg/10	(	pg/10	NN	I-NP	O(	6	(	(	O	O6	)	6	CD	B-NP	O)	cells	)	)	O	Ocells	in	cell	NNS	B-NP	Oin	LPS	in	IN	B-PP	OLPS	alone	LPS	NN	B-NP	Oalone	)	alone	RB	B-ADVP	O)	.	)	)	O	O.	Neither	.	.	O	ONeither	TNF-alpha	Neither	CC	O	OTNF-alpha	mRNA	TNF-alpha	NN	B-NP	B-RNAmRNA	expression	mRNA	NN	I-NP	I-RNAexpression	nor	expression	NN	I-NP	Onor	NF-kappaB	nor	CC	O	ONF-kappaB	activation	NF-kappaB	NN	B-NP	B-proteinactivation	stimulated	activation	NN	I-NP	Ostimulated	by	stimulate	VBN	B-VP	Oby	LPS	by	IN	B-PP	OLPS	was	LPS	NN	B-NP	Owas	inhibited	be	VBD	B-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	cAMP-elevating	the	DT	B-NP	OcAMP-elevating	agents	cAMP-elevating	JJ	I-NP	Oagents	.	agent	NNS	I-NP	O.	Neutralization	.	.	O	ONeutralization	of	Neutralization	NN	B-NP	Oof	IL-10	of	IN	B-PP	OIL-10	with	IL-10	NN	B-NP	B-proteinwith	a	with	IN	B-PP	Oa	specific	a	DT	B-NP	Ospecific	antibody	specific	JJ	I-NP	Oantibody	did	antibody	NN	I-NP	Odid	not	do	VBD	B-VP	Onot	attenuate	not	RB	I-VP	Oattenuate	the	attenuate	VB	I-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	cAMP-elevating	of	IN	B-PP	OcAMP-elevating	agents	cAMP-elevating	JJ	B-NP	Oagents	on	agent	NNS	I-NP	Oon	TNF-alpha	on	IN	B-PP	OTNF-alpha	production	TNF-alpha	NN	B-NP	B-proteinproduction	.	production	NN	I-NP	O.	CONCLUSION	.	.	O	OCONCLUSION	:	CONCLUSION	NN	B-NP	O:	The	:	:	O	OThe	results	The	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	cAMP	that	IN	B-SBAR	OcAMP	inhibits	cAMP	NN	B-NP	Oinhibits	LPS-stimulated	inhibit	VBZ	B-VP	OLPS-stimulated	TNF-alpha	LPS-stimulated	JJ	B-NP	OTNF-alpha	production	TNF-alpha	NN	I-NP	B-proteinproduction	through	production	NN	I-NP	Othrough	a	through	IN	B-PP	Oa	posttranscriptional	a	DT	B-NP	Oposttranscriptional	mechanism	posttranscriptional	JJ	I-NP	Omechanism	that	mechanism	NN	I-NP	Othat	is	that	WDT	B-NP	Ois	independent	be	VBZ	B-VP	Oindependent	of	independent	JJ	B-ADJP	Oof	endogenous	of	IN	B-PP	Oendogenous	IL-10	endogenous	JJ	B-NP	OIL-10	.	IL-10	NN	I-NP	B-protein.	Copyright	.	.	O	OCopyright	2001	Copyright	NN	B-NP	O2001	Academic	2001	CD	I-NP	OAcademic	Press	Academic	NNP	I-NP	OPress	.	Press	NNP	I-NP	O.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	p21	the	DT	B-NP	Op21	(	p21	NN	I-NP	B-DNA(	CIP1/WAF1	(	(	O	I-DNACIP1/WAF1	)	CIP1/WAF1	NN	B-NP	I-DNA)	promoter	)	)	O	I-DNApromoter	by	promoter	NN	B-NP	I-DNAby	bone	by	IN	B-PP	Obone	morphogenetic	bone	NN	B-NP	B-proteinmorphogenetic	protein-2	morphogenetic	JJ	I-NP	I-proteinprotein-2	in	protein-2	NN	I-NP	I-proteinin	mouse	in	IN	B-PP	Omouse	B	mouse	NN	B-NP	B-cell_typeB	lineage	B	NN	I-NP	I-cell_typelineage	cells	lineage	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	BMPs	.	.	O	OBMPs	exert	BMP	NNS	B-NP	Oexert	a	exert	VBP	B-VP	Oa	negative	a	DT	B-NP	Onegative	growth	negative	JJ	I-NP	Ogrowth	effect	growth	NN	I-NP	Oeffect	on	effect	NN	I-NP	Oon	various	on	IN	B-PP	Ovarious	types	various	JJ	B-NP	Otypes	of	type	NNS	I-NP	Oof	cells	of	IN	B-PP	Ocells	.	cell	NNS	B-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	previously	have	VBP	B-VP	Opreviously	reported	previously	RB	I-VP	Oreported	that	report	VBN	I-VP	Othat	BMP-2	that	IN	B-SBAR	OBMP-2	inhibited	BMP-2	NN	B-NP	B-proteininhibited	the	inhibit	VBD	B-VP	Othe	growth	the	DT	B-NP	Ogrowth	of	growth	NN	I-NP	Oof	HS-72	of	IN	B-PP	OHS-72	mouse	HS-72	NN	B-NP	B-cell_linemouse	hybridoma	mouse	NN	I-NP	I-cell_linehybridoma	cells	hybridoma	NN	I-NP	I-cell_linecells	by	cell	NNS	I-NP	I-cell_lineby	inducing	by	IN	B-PP	Oinducing	p21	induce	VBG	B-VP	Op21	(	p21	NN	B-NP	B-protein(	CIP1/WAF1	(	(	O	I-proteinCIP1/WAF1	)	CIP1/WAF1	NN	B-NP	I-protein)	expression	)	)	O	I-proteinexpression	.	expression	NN	B-NP	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	present	the	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	demonstrated	we	PRP	B-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	BMP-2	that	IN	B-SBAR	OBMP-2	activated	BMP-2	NN	B-NP	B-proteinactivated	the	activate	VBD	B-VP	Othe	mouse	the	DT	B-NP	Omouse	p21	mouse	NN	I-NP	B-DNAp21	(	p21	NN	I-NP	I-DNA(	CIP1/WAF1	(	(	O	I-DNACIP1/WAF1	)	CIP1/WAF1	NN	B-NP	I-DNA)	promoter	)	)	O	I-DNApromoter	in	promoter	NN	B-NP	I-DNAin	HS-72	in	IN	B-PP	OHS-72	cells	HS-72	NN	B-NP	B-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	and	","	","	O	Oand	that	and	CC	O	Othat	a	that	IN	B-SBAR	Oa	29-base	a	DT	B-NP	O29-base	pair	29-base	JJ	I-NP	B-DNApair	(	pair	NN	I-NP	I-DNA(	b	(	(	O	I-DNAb	)	b	NN	B-NP	I-DNA)	region	)	)	O	I-DNAregion	of	region	NN	B-NP	I-DNAof	the	of	IN	B-PP	Othe	promoter	the	DT	B-NP	Opromoter	(	promoter	NN	I-NP	B-DNA(	1.014736842	(	(	O	O1.014736842	relative	1.014736842	CD	B-NP	Orelative	to	relative	JJ	B-ADVP	Oto	the	to	TO	B-PP	Othe	TATA	the	DT	B-NP	OTATA	box	TATA	NN	I-NP	B-DNAbox	)	box	NN	I-NP	I-DNA)	","	)	)	O	O","	conserved	","	","	O	Oconserved	between	conserve	VBN	B-VP	Obetween	mice	between	IN	B-PP	Omice	and	mouse	NNS	B-NP	Oand	humans	and	CC	I-NP	Ohumans	","	human	NNS	I-NP	O","	was	","	","	O	Owas	responsive	be	VBD	B-VP	Oresponsive	to	responsive	JJ	B-ADJP	Oto	BMP-2	to	TO	B-PP	OBMP-2	as	BMP-2	NN	B-NP	B-proteinas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	expression	as	IN	I-CONJP	Oexpression	of	expression	NN	B-NP	Oof	Smad1	of	IN	B-PP	OSmad1	","	Smad1	NN	B-NP	B-protein","	Smad4	","	","	O	OSmad4	","	Smad4	NN	B-NP	B-protein","	and	","	","	O	Oand	constitutively	and	CC	O	Oconstitutively	active	constitutively	RB	B-NP	Oactive	mutants	active	JJ	I-NP	Omutants	of	mutant	NNS	I-NP	Oof	BMP	of	IN	B-PP	OBMP	type	BMP	NN	B-NP	B-proteintype	I	type	NN	I-NP	I-proteinI	receptors	I	CD	I-NP	I-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	an	","	","	O	Oan	oligonucleotide	an	DT	B-NP	Ooligonucleotide	containing	oligonucleotide	NN	I-NP	Ocontaining	the	contain	VBG	B-VP	Othe	29-b	the	DT	B-NP	O29-b	region	29-b	JJ	I-NP	B-DNAregion	was	region	NN	I-NP	I-DNAwas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	associated	be	VB	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	Smad4	with	IN	B-PP	OSmad4	and	Smad4	NN	B-NP	B-proteinand	phosphorylated	and	CC	O	Ophosphorylated	Smad1	phosphorylate	VBN	B-NP	OSmad1	in	Smad1	NN	I-NP	B-proteinin	the	in	IN	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	extract	nuclear	JJ	I-NP	Oextract	of	extract	NN	I-NP	Oof	BMP-2	of	IN	B-PP	OBMP-2	#NAME?	BMP-2	NN	B-NP	B-cell_line#NAME?	HS-72	#NAME?	JJ	I-NP	I-cell_lineHS-72	cells	HS-72	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggested	result	NNS	I-NP	Osuggested	that	suggest	VBD	B-VP	Othat	BMP-2	that	IN	B-SBAR	OBMP-2	might	BMP-2	NN	B-NP	B-proteinmight	activate	might	MD	B-VP	Oactivate	p21	activate	VB	I-VP	Op21	(	p21	NN	B-NP	O(	CIP1/WAF1	(	(	O	OCIP1/WAF1	)	CIP1/WAF1	NN	B-NP	O)	transcription	)	)	O	Otranscription	by	transcription	NN	B-NP	Oby	inducing	by	IN	B-PP	Oinducing	a	induce	VBG	B-VP	Oa	binding	a	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	Smad4	of	IN	B-PP	OSmad4	and	Smad4	NN	B-NP	B-proteinand	Smad1	and	CC	I-NP	OSmad1	to	Smad1	NN	I-NP	B-proteinto	the	to	TO	B-PP	Othe	29-b	the	DT	B-NP	O29-b	region	29-b	JJ	I-NP	B-DNAregion	in	region	NN	I-NP	I-DNAin	HS-72	in	IN	B-PP	OHS-72	cells	HS-72	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Dendritic	.	.	O	ODendritic	cell	Dendritic	JJ	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	from	development	NN	I-NP	Ofrom	common	from	IN	B-PP	Ocommon	myeloid	common	JJ	B-NP	B-cell_typemyeloid	progenitors	myeloid	JJ	I-NP	I-cell_typeprogenitors	.	progenitor	NNS	I-NP	I-cell_type.	Dendritic	.	.	O	ODendritic	cells	Dendritic	JJ	B-NP	B-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	DCs	(	(	O	ODCs	)	DC	NNS	B-NP	B-cell_type)	are	)	)	O	Oare	professional	be	VBP	B-VP	Oprofessional	antigen-presenting	professional	JJ	B-NP	B-cell_typeantigen-presenting	cells	antigen-presenting	JJ	I-NP	I-cell_typecells	which	cell	NNS	I-NP	I-cell_typewhich	both	which	WDT	B-NP	Oboth	initiate	both	DT	B-NP	Oinitiate	adaptive	initiate	VBP	B-VP	Oadaptive	immune	adaptive	JJ	B-NP	Oimmune	responses	immune	JJ	I-NP	Oresponses	and	response	NNS	I-NP	Oand	control	and	CC	O	Ocontrol	tolerance	control	NN	B-NP	Otolerance	to	tolerance	NN	I-NP	Oto	self-antigens	to	TO	B-PP	Oself-antigens	.	self-antigen	NNS	B-NP	B-protein.	It	.	.	O	OIt	has	It	PRP	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	suggested	be	VBN	I-VP	Osuggested	that	suggest	VBN	I-VP	Othat	these	that	IN	B-SBAR	Othese	different	these	DT	B-NP	Odifferent	effects	different	JJ	I-NP	Oeffects	on	effect	NNS	I-NP	Oon	responder	on	IN	B-PP	Oresponder	cells	responder	NN	B-NP	B-cell_typecells	depend	cell	NNS	I-NP	I-cell_typedepend	on	depend	VBP	B-VP	Oon	subsets	on	IN	B-PP	Osubsets	of	subset	NNS	B-NP	Oof	DCs	of	IN	B-PP	ODCs	arising	DC	NNS	B-NP	B-cell_typearising	from	arise	VBG	B-VP	Ofrom	either	from	IN	B-PP	Oeither	myeloid	either	CC	B-NP	Omyeloid	or	myeloid	JJ	I-NP	Oor	lymphoid	or	CC	I-NP	Olymphoid	hematopoietic	lymphoid	JJ	I-NP	Ohematopoietic	origins	hematopoietic	JJ	I-NP	Oorigins	.	origin	NNS	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	model	this	DT	B-NP	Omodel	","	model	NN	I-NP	O","	CD8	","	","	O	OCD8	alpha+	CD8	NN	B-NP	B-proteinalpha+	Mac-1-	alpha+	SYM	B-VP	OMac-1-	DCs	Mac-1-	NN	B-NP	ODCs	are	DC	NNS	I-NP	B-cell_typeare	supposed	be	VBP	B-VP	Osupposed	to	suppose	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	of	be	VB	I-VP	Oof	lymphoid	of	IN	B-PP	Olymphoid	while	lymphoid	JJ	B-NP	B-cell_typewhile	CD8	while	IN	B-SBAR	I-cell_typeCD8	alpha-	CD8	NN	B-NP	I-cell_typealpha-	Mac-1+	alpha-	NN	I-NP	I-cell_typeMac-1+	DCs	Mac-1+	JJ	I-NP	I-cell_typeDCs	are	DC	NNS	I-NP	I-cell_typeare	supposed	be	VBP	B-VP	Osupposed	to	suppose	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	of	be	VB	I-VP	Oof	myeloid	of	IN	B-PP	Omyeloid	origin	myeloid	JJ	B-NP	B-proteinorigin	.	origin	NN	I-NP	I-protein.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	summarize	we	PRP	B-NP	Osummarize	our	summarize	VBP	B-VP	Oour	findings	our	PRP$	B-NP	Ofindings	that	finding	NNS	I-NP	Othat	both	that	IN	B-SBAR	Oboth	CD8	both	CC	O	OCD8	alpha+	CD8	NN	B-NP	B-proteinalpha+	and	alpha+	SYM	B-NP	Oand	CD8	and	CC	O	OCD8	alpha-	CD8	NN	B-NP	B-cell_typealpha-	DCs	alpha-	NN	I-NP	I-cell_typeDCs	can	DC	NNS	I-NP	I-cell_typecan	arise	can	MD	B-VP	Oarise	from	arise	VB	I-VP	Ofrom	clonogenic	from	IN	B-PP	Oclonogenic	common	clonogenic	JJ	B-NP	B-cell_typecommon	myeloid	common	JJ	I-NP	I-cell_typemyeloid	progenitors	myeloid	JJ	I-NP	I-cell_typeprogenitors	(	progenitor	NNS	I-NP	I-cell_type(	CMPs	(	(	O	OCMPs	)	CMP	NNS	B-NP	B-protein)	in	)	)	O	Oin	both	in	IN	B-PP	Oboth	thymus	both	CC	O	Othymus	and	thymus	NN	B-NP	Oand	spleen	and	CC	I-NP	Ospleen	.	spleen	NN	I-NP	O.	Therefore	.	.	O	OTherefore	CD8	Therefore	RB	B-NP	OCD8	alpha	CD8	NN	I-NP	B-proteinalpha	expression	alpha	NN	I-NP	I-proteinexpression	DCs	expression	NN	I-NP	ODCs	does	DC	NNS	I-NP	B-cell_typedoes	not	do	VBZ	B-VP	Onot	indicate	not	RB	I-VP	Oindicate	a	indicate	VB	I-VP	Oa	lymphoid	a	DT	B-NP	Olymphoid	origin	lymphoid	JJ	I-NP	Oorigin	and	origin	NN	I-NP	Oand	differences	and	CC	I-NP	Odifferences	among	difference	NNS	I-NP	Oamong	CD8	among	IN	B-PP	OCD8	alpha+	CD8	NN	B-NP	B-proteinalpha+	and	alpha+	SYM	B-NP	Oand	CD8	and	CC	O	OCD8	alpha-	CD8	NN	B-NP	B-cell_typealpha-	DCs	alpha-	NN	I-NP	I-cell_typeDCs	might	DC	NNS	I-NP	I-cell_typemight	rather	might	MD	B-VP	Orather	reflect	rather	RB	I-VP	Oreflect	maturation	reflect	VB	I-VP	Omaturation	status	maturation	NN	B-NP	Ostatus	than	status	NN	I-NP	Othan	ontogeny	than	IN	B-PP	Oontogeny	.	ontogeny	NN	B-NP	O.	On	.	.	O	OOn	the	On	IN	B-PP	Othe	basis	the	DT	B-NP	Obasis	of	basis	NN	I-NP	Oof	transplantation	of	IN	B-PP	Otransplantation	studies	transplantation	NN	B-NP	Ostudies	","	study	NNS	I-NP	O","	it	","	","	O	Oit	seems	it	PRP	B-NP	Oseems	likely	seem	VBZ	B-VP	Olikely	that	likely	JJ	B-ADJP	Othat	most	that	IN	B-SBAR	Omost	of	most	JJS	B-NP	Oof	the	of	IN	B-PP	Othe	DCs	the	DT	B-NP	ODCs	in	DC	NNS	I-NP	B-cell_typein	secondary	in	IN	B-PP	Osecondary	lymphoid	secondary	JJ	B-NP	Olymphoid	organs	lymphoid	JJ	I-NP	Oorgans	and	organ	NNS	I-NP	Oand	a	and	CC	O	Oa	substantial	a	DT	B-NP	Osubstantial	fraction	substantial	JJ	I-NP	Ofraction	of	fraction	NN	I-NP	Oof	thymic	of	IN	B-PP	Othymic	DCs	thymic	JJ	B-NP	B-cell_typeDCs	are	DC	NNS	I-NP	I-cell_typeare	myeloid-derived	be	VBP	B-VP	Omyeloid-derived	.	myeloid-derived	JJ	B-ADJP	O.	Macrophage	.	.	O	OMacrophage	stimulation	Macrophage	NN	B-NP	Ostimulation	with	stimulation	NN	I-NP	Owith	Murabutide	with	IN	B-PP	OMurabutide	","	Murabutide	NNP	B-NP	O","	an	","	","	O	Oan	HIV-suppressive	an	DT	B-NP	OHIV-suppressive	muramyl	HIV-suppressive	JJ	I-NP	Omuramyl	peptide	muramyl	NN	I-NP	Opeptide	derivative	peptide	NN	I-NP	Oderivative	","	derivative	NN	I-NP	O","	selectively	","	","	O	Oselectively	activates	selectively	RB	B-VP	Oactivates	extracellular	activate	VBZ	I-VP	Oextracellular	signal-regulated	extracellular	JJ	B-NP	B-proteinsignal-regulated	kinases	signal-regulated	JJ	I-NP	I-proteinkinases	1	kinase	NNS	I-NP	I-protein1	and	1	CD	I-NP	I-proteinand	2	and	CC	I-NP	I-protein2	","	2	CD	I-NP	I-protein","	C/EBPbeta	","	","	I-NP	OC/EBPbeta	and	C/EBPbeta	NN	I-NP	B-proteinand	STAT1	and	CC	I-NP	OSTAT1	:	STAT1	NN	I-NP	B-protein:	role	:	:	O	Orole	of	role	NN	B-NP	Oof	CD14	of	IN	B-PP	OCD14	and	CD14	NN	B-NP	B-proteinand	Toll-like	and	CC	O	OToll-like	receptors	Toll-like	JJ	B-NP	B-proteinreceptors	2	receptor	NNS	I-NP	I-protein2	and	2	CD	B-NP	I-proteinand	4	and	CC	I-NP	I-protein4	.	4	CD	I-NP	I-protein.	The	.	.	O	OThe	smallest	The	DT	B-NP	Osmallest	unit	small	JJS	I-NP	Ounit	of	unit	NN	I-NP	Oof	bacterial	of	IN	B-PP	Obacterial	peptidoglycans	bacterial	JJ	B-NP	Opeptidoglycans	known	peptidoglycan	NNS	I-NP	Oknown	to	know	VBN	B-VP	Oto	be	to	TO	I-VP	Obe	endowed	be	VB	I-VP	Oendowed	with	endow	VBN	I-VP	Owith	biological	with	IN	B-PP	Obiological	activities	biological	JJ	B-NP	Oactivities	is	activity	NNS	I-NP	Ois	muramyl	be	VBZ	B-VP	Omuramyl	dipeptide	muramyl	NN	B-NP	Odipeptide	(	dipeptide	NN	I-NP	O(	MDP	(	(	O	OMDP	)	MDP	NN	B-NP	O)	.	)	)	O	O.	A	.	.	O	OA	clinically	A	DT	B-NP	Oclinically	acceptable	clinically	RB	I-NP	Oacceptable	synthetic	acceptable	JJ	I-NP	Osynthetic	derivative	synthetic	JJ	I-NP	Oderivative	of	derivative	NN	I-NP	Oof	MDP	of	IN	B-PP	OMDP	","	MDP	NN	B-NP	O","	namely	","	","	O	Onamely	murabutide	namely	RB	B-ADVP	Omurabutide	(	murabutide	NN	B-NP	O(	MB	(	(	O	OMB	)	MB	NN	B-NP	B-protein)	","	)	)	O	O","	has	","	","	O	Ohas	been	have	VBZ	B-VP	Obeen	found	be	VBN	I-VP	Ofound	to	find	VBN	I-VP	Oto	present	to	TO	I-VP	Opresent	interesting	present	VB	I-VP	Ointeresting	pharmacological	interesting	JJ	B-NP	Opharmacological	properties	pharmacological	JJ	I-NP	Oproperties	and	property	NNS	I-NP	Oand	to	and	CC	O	Oto	suppress	to	TO	B-VP	Osuppress	HIV-1	suppress	VB	I-VP	OHIV-1	replication	HIV-1	NN	B-NP	Oreplication	in	replication	NN	I-NP	Oin	monocyte-derived	in	IN	B-PP	Omonocyte-derived	macrophages	monocyte-derived	JJ	B-NP	B-cell_typemacrophages	(	macrophage	NNS	I-NP	I-cell_type(	MDM	(	(	O	OMDM	)	MDM	NN	B-NP	B-cell_type)	.	)	)	O	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	addressed	have	VBP	B-VP	Oaddressed	the	address	VBN	I-VP	Othe	signaling	the	DT	B-NP	Osignaling	events	signaling	NN	I-NP	Oevents	activated	event	NNS	I-NP	Oactivated	in	activate	VBN	B-VP	Oin	MDM	in	IN	B-PP	OMDM	following	MDM	NN	B-NP	B-cell_typefollowing	stimulation	follow	VBG	B-PP	Ostimulation	with	stimulation	NN	B-NP	Owith	either	with	IN	B-PP	Oeither	MB	either	CC	O	OMB	or	MB	NN	B-NP	B-proteinor	the	or	CC	O	Othe	potent	the	DT	B-NP	Opotent	immunostimulant	potent	JJ	I-NP	Oimmunostimulant	LPS	immunostimulant	JJ	I-NP	OLPS	.	LPS	NN	I-NP	O.	We	.	.	O	OWe	also	We	PRP	B-NP	Oalso	examined	also	RB	B-ADVP	Oexamined	whether	examine	VBD	B-VP	Owhether	signaling	whether	IN	B-SBAR	Osignaling	by	signaling	NN	B-NP	Oby	muramyl	by	IN	B-PP	Omuramyl	peptides	muramyl	NN	B-NP	Opeptides	involves	peptide	NNS	I-NP	Oinvolves	the	involve	VBZ	B-VP	Othe	use	the	DT	B-NP	Ouse	of	use	NN	I-NP	Oof	cell	of	IN	B-PP	Ocell	surface	cell	NN	B-NP	B-proteinsurface	receptors	surface	NN	I-NP	I-proteinreceptors	","	receptor	NNS	I-NP	I-protein","	including	","	","	O	Oincluding	CD14	include	VBG	B-PP	OCD14	and	CD14	NN	B-NP	B-proteinand	Toll-like	and	CC	O	OToll-like	receptor	Toll-like	JJ	B-NP	B-proteinreceptor	2	receptor	NN	I-NP	I-protein2	(	2	CD	I-NP	I-protein(	TLR2	(	(	O	OTLR2	)	TLR2	NN	B-NP	B-protein)	or	)	)	O	Oor	TLR4	or	CC	O	OTLR4	that	TLR4	NN	B-NP	B-proteinthat	are	that	WDT	B-NP	Oare	known	be	VBP	B-VP	Oknown	to	know	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	signal-transducing	be	VB	I-VP	Osignal-transducing	receptors	signal-transducing	JJ	B-NP	B-proteinreceptors	for	receptor	NNS	I-NP	I-proteinfor	other	for	IN	B-PP	Oother	bacterial	other	JJ	B-NP	Obacterial	cell	bacterial	JJ	I-NP	Ocell	wall	cell	NN	I-NP	Owall	components	wall	NN	I-NP	Ocomponents	.	component	NNS	I-NP	O.	We	.	.	O	OWe	demonstrate	We	PRP	B-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	","	that	IN	B-SBAR	O","	unlike	","	","	O	Ounlike	LPS	unlike	IN	B-PP	OLPS	","	LPS	NN	B-NP	O","	the	","	","	O	Othe	safe	the	DT	B-NP	Osafe	immunomodulator	safe	JJ	I-NP	Oimmunomodulator	MB	immunomodulator	NN	I-NP	OMB	selectively	MB	NN	I-NP	Oselectively	activates	selectively	RB	B-ADVP	Oactivates	extracellular	activate	VBZ	B-VP	Oextracellular	signal-regulated	extracellular	JJ	B-NP	B-proteinsignal-regulated	kinases	signal-regulated	JJ	I-NP	I-proteinkinases	(	kinase	NNS	I-NP	I-protein(	Erk	(	(	O	OErk	)	Erk	NN	B-NP	B-protein)	2-Jan	)	)	O	O2-Jan	","	2-Jan	CD	B-NP	O","	in	","	","	O	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	detectable	of	IN	B-PP	Odetectable	Jun	detectable	JJ	B-NP	OJun	N-terminal	Jun	NN	I-NP	B-proteinN-terminal	kinase	N-terminal	JJ	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	JNK	(	(	O	OJNK	)	JNK	NN	B-NP	B-protein)	or	)	)	O	Oor	p38	or	CC	O	Op38	mitogen-activated	p38	NN	B-NP	B-proteinmitogen-activated	kinase	mitogen-activated	JJ	I-NP	I-proteinkinase	activation	kinase	NN	I-NP	I-proteinactivation	.	activation	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	STAT1	","	","	O	OSTAT1	activation	STAT1	NN	B-NP	B-proteinactivation	but	activation	NN	I-NP	Obut	weak	but	CC	O	Oweak	or	weak	JJ	B-ADJP	Oor	no	or	CC	O	Ono	activation	no	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	STAT3	of	IN	B-PP	OSTAT3	or	STAT3	NN	B-NP	B-proteinor	STAT5	or	CC	I-NP	OSTAT5	respectively	STAT5	NN	I-NP	B-proteinrespectively	","	respectively	RB	B-ADVP	O","	could	","	","	O	Ocould	be	could	MD	B-VP	Obe	detected	be	VB	I-VP	Odetected	in	detect	VBN	I-VP	Oin	MB-stimulated	in	IN	B-PP	OMB-stimulated	MDM	MB-stimulated	JJ	B-NP	B-cell_lineMDM	.	MDM	NN	I-NP	I-cell_line.	Using	.	.	O	OUsing	MonoMac6	Use	VBG	B-VP	OMonoMac6	cells	MonoMac6	NN	B-NP	B-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	we	","	","	O	Owe	observed	we	PRP	B-NP	Oobserved	high	observe	VBD	B-VP	Ohigh	C/EBPbeta	high	JJ	B-NP	OC/EBPbeta	and	C/EBPbeta	NN	I-NP	B-proteinand	AP-1	and	CC	O	OAP-1	but	AP-1	NN	B-NP	B-proteinbut	weaker	but	CC	O	Oweaker	and	weak	JJR	B-NP	Oand	transient	and	CC	I-NP	Otransient	NF-kappaB	transient	JJ	I-NP	ONF-kappaB	activation	NF-kappaB	NN	I-NP	B-proteinactivation	by	activation	NN	I-NP	Oby	MB	by	IN	B-PP	OMB	.	MB	NN	B-NP	B-protein.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	the	","	","	O	Othe	truncated	the	DT	B-NP	Otruncated	form	truncate	VBN	I-NP	Oform	of	form	NN	I-NP	Oof	C/EBPbeta	of	IN	B-PP	OC/EBPbeta	","	C/EBPbeta	NN	B-NP	B-protein","	known	","	","	O	Oknown	to	know	VBN	B-VP	Oto	repress	to	TO	I-VP	Orepress	HIV-1	repress	VB	I-VP	OHIV-1	transcription	HIV-1	NN	B-NP	Otranscription	","	transcription	NN	I-NP	O","	was	","	","	O	Owas	detected	be	VBD	B-VP	Odetected	in	detect	VBN	I-VP	Oin	extracts	in	IN	B-PP	Oextracts	from	extract	NNS	B-NP	Ofrom	MB-treated	from	IN	B-PP	OMB-treated	THP-1	MB-treated	JJ	B-NP	B-cell_lineTHP-1	cells	THP-1	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Surprisingly	.	.	O	OSurprisingly	","	Surprisingly	RB	B-ADVP	O","	neither	","	","	O	Oneither	MB	neither	CC	O	OMB	nor	MB	NN	B-NP	B-proteinnor	MDP	nor	CC	I-NP	OMDP	were	MDP	NN	I-NP	Owere	able	be	VBD	B-VP	Oable	to	able	JJ	B-ADJP	Oto	transduce	to	TO	B-VP	Otransduce	signals	transduce	VB	I-VP	Osignals	via	signal	NNS	B-NP	Ovia	CD14	via	IN	B-PP	OCD14	and	CD14	NN	B-NP	B-proteinand	TLR2	and	CC	I-NP	OTLR2	or	TLR2	NN	I-NP	B-proteinor	4	or	CC	O	O4	.	4	CD	B-NP	O.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	present	finding	NNS	I-NP	Opresent	major	present	VBP	B-VP	Omajor	differences	major	JJ	B-NP	Odifferences	in	difference	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	early	the	DT	B-NP	Oearly	cell	early	JJ	I-NP	Ocell	activation	cell	NN	I-NP	Oactivation	process	activation	NN	I-NP	Oprocess	between	process	NN	I-NP	Obetween	LPS	between	IN	B-PP	OLPS	and	LPS	NN	B-NP	Oand	muramyl	and	CC	I-NP	Omuramyl	peptides	muramyl	NN	I-NP	Opeptides	","	peptide	NNS	I-NP	O","	and	","	","	O	Oand	strongly	and	CC	O	Ostrongly	argue	strongly	RB	B-VP	Oargue	for	argue	VBP	I-VP	Ofor	the	for	IN	B-PP	Othe	implication	the	DT	B-NP	Oimplication	of	implication	NN	I-NP	Oof	co-receptors	of	IN	B-PP	Oco-receptors	other	co-receptor	NNS	B-NP	B-proteinother	than	other	JJ	B-ADJP	Othan	TLR2	than	IN	B-PP	OTLR2	and	TLR2	NN	B-NP	B-proteinand	TLR4	and	CC	I-NP	OTLR4	in	TLR4	NN	I-NP	B-proteinin	mediating	in	IN	B-PP	Omediating	the	mediate	VBG	B-VP	Othe	signaling	the	DT	B-NP	Osignaling	events	signaling	NN	I-NP	Oevents	induced	event	NNS	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	defined	by	IN	B-PP	Odefined	subunits	define	VBN	B-NP	Osubunits	of	subunit	NNS	I-NP	Oof	bacterial	of	IN	B-PP	Obacterial	peptidoglycans	bacterial	JJ	B-NP	Opeptidoglycans	.	peptidoglycan	NNS	I-NP	O.	Nuclear	.	.	O	ONuclear	peroxisome	Nuclear	JJ	B-NP	B-proteinperoxisome	proliferator-activated	peroxisome	NN	I-NP	I-proteinproliferator-activated	receptors	proliferator-activated	JJ	I-NP	I-proteinreceptors	alpha	receptor	NNS	I-NP	I-proteinalpha	and	alpha	NN	I-NP	I-proteinand	gamma	and	CC	I-NP	Ogamma	have	gamma	NN	I-NP	Ohave	opposing	have	VBP	B-VP	Oopposing	effects	oppose	VBG	I-VP	Oeffects	on	effect	NNS	B-NP	Oon	monocyte	on	IN	B-PP	Omonocyte	chemotaxis	monocyte	NN	B-NP	Ochemotaxis	in	chemotaxis	NN	I-NP	Oin	endometriosis	in	IN	B-PP	Oendometriosis	.	endometriosis	NN	B-NP	O.	The	.	.	O	OThe	peroxisome	The	DT	B-NP	Operoxisome	proliferator-activated	peroxisome	NN	I-NP	B-proteinproliferator-activated	receptors	proliferator-activated	JJ	I-NP	I-proteinreceptors	(	receptor	NNS	I-NP	I-protein(	PPARs	(	(	O	OPPARs	)	PPAR	NNS	B-NP	B-protein)	alpha	)	)	O	Oalpha	and	alpha	NN	B-NP	Oand	gamma	and	CC	O	Ogamma	are	gamma	NN	B-NP	Oare	nuclear	be	VBP	B-VP	Onuclear	receptors	nuclear	JJ	B-NP	B-proteinreceptors	that	receptor	NNS	I-NP	I-proteinthat	play	that	WDT	B-NP	Oplay	important	play	VBP	B-VP	Oimportant	roles	important	JJ	B-NP	Oroles	in	role	NNS	I-NP	Oin	inflammatory	in	IN	B-PP	Oinflammatory	diseases	inflammatory	JJ	B-NP	Odiseases	like	disease	NNS	I-NP	Olike	ulcerative	like	IN	B-PP	Oulcerative	colitis	ulcerative	JJ	B-NP	Ocolitis	and	colitis	NN	I-NP	Oand	arthritis	and	CC	I-NP	Oarthritis	.	arthritis	NN	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	examined	we	PRP	B-NP	Oexamined	the	examine	VBD	B-VP	Othe	possible	the	DT	B-NP	Opossible	role	possible	JJ	I-NP	Orole	of	role	NN	I-NP	Oof	PPARs	of	IN	B-PP	OPPARs	in	PPAR	NNS	B-NP	B-proteinin	macrophage	in	IN	B-PP	Omacrophage	attraction	macrophage	NN	B-NP	Oattraction	into	attraction	NN	I-NP	Ointo	the	into	IN	B-PP	Othe	peritoneal	the	DT	B-NP	Operitoneal	cavity	peritoneal	JJ	I-NP	Ocavity	of	cavity	NN	I-NP	Oof	patients	of	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	endometriosis	with	IN	B-PP	Oendometriosis	.	endometriosis	NN	B-NP	O.	We	.	.	O	OWe	identified	We	PRP	B-NP	Oidentified	PPAR-alpha	identify	VBD	B-VP	OPPAR-alpha	and	PPAR-alpha	NN	B-NP	B-proteinand	#NAME?	and	CC	I-NP	O#NAME?	messenger	#NAME?	NN	I-NP	B-RNAmessenger	RNA	messenger	NN	I-NP	I-RNARNA	by	RNA	NN	I-NP	I-RNAby	RT-PCR	by	IN	B-PP	ORT-PCR	and	RT-PCR	NN	B-NP	Oand	protein	and	CC	I-NP	Oprotein	by	protein	NN	I-NP	Oby	immunoblotting	by	IN	B-PP	Oimmunoblotting	of	immunoblotting	NN	B-NP	Oof	lysates	of	IN	B-PP	Olysates	of	lysate	NNS	B-NP	Oof	peritoneal	of	IN	B-PP	Operitoneal	macrophages	peritoneal	JJ	B-NP	B-cell_typemacrophages	and	macrophage	NNS	I-NP	I-cell_typeand	monocytic	and	CC	O	Omonocytic	U937	monocytic	JJ	B-NP	B-cell_lineU937	cells	U937	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Using	.	.	O	OUsing	immunocytochemistry	Use	VBG	B-VP	Oimmunocytochemistry	","	immunocytochemistry	NN	B-NP	O","	we	","	","	O	Owe	localized	we	PRP	B-NP	Olocalized	PPAR-alpha	localize	VBD	B-VP	OPPAR-alpha	and	PPAR-alpha	NN	B-NP	B-proteinand	#NAME?	and	CC	I-NP	O#NAME?	within	#NAME?	NN	I-NP	B-proteinwithin	the	within	IN	B-PP	Othe	nuclei	the	DT	B-NP	Onuclei	of	nucleus	NNS	I-NP	Oof	both	of	IN	B-PP	Oboth	cell	both	DT	B-NP	Ocell	types	cell	NN	I-NP	Otypes	.	type	NNS	I-NP	O.	Monocyte	.	.	O	OMonocyte	chemotactic	Monocyte	NN	B-NP	Ochemotactic	activity	chemotactic	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	peritoneal	of	IN	B-PP	Operitoneal	fluid	peritoneal	JJ	B-NP	Ofluid	from	fluid	NN	I-NP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	endometriosis	with	IN	B-PP	Oendometriosis	was	endometriosis	NN	B-NP	Owas	quantified	be	VBD	B-VP	Oquantified	in	quantify	VBN	I-VP	Oin	Boyden	in	IN	B-PP	OBoyden	chambers	Boyden	NNP	B-NP	Ochambers	.	chamber	NNS	I-NP	O.	Migration	.	.	O	OMigration	of	Migration	NN	B-NP	Oof	U937	of	IN	B-PP	OU937	cells	U937	NN	B-NP	B-cell_linecells	was	cell	NNS	I-NP	I-cell_linewas	increased	be	VBD	B-VP	Oincreased	by	increase	VBN	I-VP	Oby	WY	by	IN	B-PP	OWY	14643	WY	NN	B-NP	O14643	and	14643	CD	I-NP	Oand	reduced	and	CC	O	Oreduced	by	reduce	VBN	B-VP	Oby	rosiglitazone	by	IN	B-PP	Orosiglitazone	.	rosiglitazone	NN	B-NP	O.	Peritoneal	.	.	O	OPeritoneal	fluid	Peritoneal	JJ	B-NP	Ofluid	from	fluid	NN	I-NP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	endometriosis	with	IN	B-PP	Oendometriosis	activated	endometriosis	NN	B-NP	Oactivated	U937	activated	JJ	I-NP	OU937	cells	U937	NN	I-NP	Ocells	transiently	cell	NNS	I-NP	Otransiently	transfected	transiently	RB	B-VP	Otransfected	with	transfecte	VBN	I-VP	Owith	a	with	IN	B-PP	Oa	PPAR-alpha/GAL4	a	DT	B-NP	OPPAR-alpha/GAL4	luciferase	PPAR-alpha/GAL4	NN	I-NP	B-DNAluciferase	reporter	luciferase	NN	I-NP	I-DNAreporter	.	reporter	NN	I-NP	I-DNA.	By	.	.	O	OBy	contrast	By	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	peritoneal	","	","	O	Operitoneal	fluid	peritoneal	JJ	B-NP	Ofluid	did	fluid	NN	I-NP	Odid	not	do	VBD	B-VP	Onot	cause	not	RB	I-VP	Ocause	significant	cause	VB	I-VP	Osignificant	activation	significant	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	PPAR-gamma/GAL4	of	IN	B-PP	OPPAR-gamma/GAL4	constructs	PPAR-gamma/GAL4	NN	B-NP	B-DNAconstructs	.	construct	NNS	I-NP	I-DNA.	The	.	.	O	OThe	U937	The	DT	B-NP	OU937	cells	U937	NN	I-NP	B-cell_linecells	transiently	cell	NNS	I-NP	I-cell_linetransiently	transfected	transiently	RB	B-VP	Otransfected	with	transfecte	VBN	I-VP	Owith	a	with	IN	B-PP	Oa	PPAR	a	DT	B-NP	OPPAR	response	PPAR	NN	I-NP	B-DNAresponse	element	response	NN	I-NP	I-DNAelement	luciferase	element	NN	I-NP	I-DNAluciferase	reporter	luciferase	NN	I-NP	I-DNAreporter	showed	reporter	NN	I-NP	I-DNAshowed	disease	show	VBD	B-VP	Odisease	stage-dependent	disease	NN	B-NP	Ostage-dependent	up-regulation	stage-dependent	JJ	I-NP	Oup-regulation	when	up-regulation	NN	I-NP	Owhen	treated	when	WRB	B-ADVP	Otreated	with	treat	VBN	B-VP	Owith	peritoneal	with	IN	B-PP	Operitoneal	fluid	peritoneal	JJ	B-NP	Ofluid	from	fluid	NN	I-NP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	endometriosis	with	IN	B-PP	Oendometriosis	.	endometriosis	NN	B-NP	O.	Treatment	.	.	O	OTreatment	with	Treatment	NN	B-NP	Owith	peritoneal	with	IN	B-PP	Operitoneal	fluid	peritoneal	JJ	B-NP	Ofluid	from	fluid	NN	I-NP	Ofrom	healthy	from	IN	B-PP	Ohealthy	controls	healthy	JJ	B-NP	Ocontrols	down-regulated	control	NNS	I-NP	Odown-regulated	PPAR	down-regulate	VBD	B-VP	OPPAR	response	PPAR	NN	B-NP	B-DNAresponse	element	response	NN	I-NP	I-DNAelement	transactivation	element	NN	I-NP	I-DNAtransactivation	.	transactivation	NN	I-NP	O.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	peritoneal	that	IN	B-SBAR	Operitoneal	fluid	peritoneal	JJ	B-NP	Ofluid	of	fluid	NN	I-NP	Oof	endometriosis	of	IN	B-PP	Oendometriosis	patients	endometriosis	NN	B-NP	Opatients	contains	patient	NNS	I-NP	Ocontains	activators	contain	VBZ	B-VP	Oactivators	of	activator	NNS	B-NP	Oof	PPAR-alpha	of	IN	B-PP	OPPAR-alpha	that	PPAR-alpha	NN	B-NP	B-proteinthat	stimulate	that	WDT	B-NP	Ostimulate	macrophage	stimulate	VBP	B-VP	Omacrophage	chemotaxis	macrophage	NN	B-NP	Ochemotaxis	.	chemotaxis	NN	I-NP	O.	Inhibitors	.	.	O	OInhibitors	of	Inhibitor	NNS	B-NP	Oof	PPAR-alpha	of	IN	B-PP	OPPAR-alpha	or	PPAR-alpha	NN	B-NP	B-proteinor	activators	or	CC	I-NP	Oactivators	of	activator	NNS	I-NP	Oof	PPAR-gamma	of	IN	B-PP	OPPAR-gamma	could	PPAR-gamma	NN	B-NP	B-proteincould	be	could	MD	B-VP	Obe	developed	be	VB	I-VP	Odeveloped	for	develop	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	of	treatment	NN	I-NP	Oof	inflammation	of	IN	B-PP	Oinflammation	associated	inflammation	NN	B-NP	Oassociated	with	associate	VBN	B-VP	Owith	endometriosis	with	IN	B-PP	Oendometriosis	.	endometriosis	NN	B-NP	O.	Long-term-impaired	.	.	O	OLong-term-impaired	expression	Long-term-impaired	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor-kappa	nuclear	JJ	B-NP	B-proteinfactor-kappa	B	factor-kappa	NN	I-NP	I-proteinB	and	B	NN	I-NP	I-proteinand	I	and	CC	O	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	in	alpha	NN	I-NP	I-proteinin	peripheral	in	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	of	cell	NNS	I-NP	I-cell_typeof	trauma	of	IN	B-PP	Otrauma	patients	trauma	NN	B-NP	Opatients	.	patient	NNS	I-NP	O.	Nuclear	.	.	O	ONuclear	factor	Nuclear	JJ	B-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	NF	(	(	O	I-proteinNF	)	NF	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	B	#NAME?	NN	B-NP	I-proteinB	expression	B	NN	I-NP	I-proteinexpression	and	expression	NN	I-NP	Oand	dimer	and	CC	O	Odimer	characteristics	dimer	NN	B-NP	Ocharacteristics	were	characteristic	NNS	I-NP	Owere	studied	be	VBD	B-VP	Ostudied	in	study	VBN	I-VP	Oin	peripheral	in	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	PBMCs	(	(	O	OPBMCs	)	PBMC	NNS	B-NP	B-cell_type)	of	)	)	O	Oof	major-trauma	of	IN	B-PP	Omajor-trauma	patients	major-trauma	NN	B-NP	Opatients	and	patient	NNS	I-NP	Oand	healthy	and	CC	O	Ohealthy	controls	healthy	JJ	B-NP	Ocontrols	.	control	NNS	I-NP	O.	Analysis	.	.	O	OAnalysis	of	Analysis	NN	B-NP	Oof	PBMCs	of	IN	B-PP	OPBMCs	on	PBMC	NNS	B-NP	B-cell_typeon	days	on	IN	B-PP	Odays	1	day	NNS	B-NP	O1	","	1	CD	I-NP	O","	3	","	","	I-NP	O3	","	3	CD	I-NP	O","	5	","	","	I-NP	O5	","	5	CD	I-NP	O","	and	","	","	O	Oand	10	and	CC	O	O10	after	10	CD	B-NP	Oafter	trauma	after	IN	B-SBAR	Otrauma	revealed	trauma	NN	B-NP	Orevealed	that	reveal	VBD	B-VP	Othat	expression	that	IN	B-SBAR	Oexpression	of	expression	NN	B-NP	Oof	both	of	IN	B-PP	Oboth	p65p50	both	DT	B-NP	Op65p50	heterodimers	p65p50	NN	I-NP	B-proteinheterodimers	and	heterodimer	NNS	I-NP	I-proteinand	p50p50	and	CC	O	Op50p50	homodimers	p50p50	NN	B-NP	B-proteinhomodimers	was	homodimer	NNS	I-NP	I-proteinwas	significantly	be	VBD	B-VP	Osignificantly	reduced	significantly	RB	I-VP	Oreduced	compared	reduce	VBN	I-VP	Ocompared	with	compare	VBN	B-PP	Owith	that	with	IN	B-PP	Othat	in	that	DT	B-NP	Oin	controls	in	IN	B-PP	Ocontrols	.	control	NNS	B-NP	O.	In	.	.	O	OIn	vitro	In	FW	B-NP	Ovitro	lipopolysaccharide	vitro	FW	I-NP	Olipopolysaccharide	(	lipopolysaccharide	NN	I-NP	O(	LPS	(	(	O	OLPS	)	LPS	NN	B-NP	O)	stimulation	)	)	O	Ostimulation	of	stimulation	NN	B-NP	Oof	PBMCs	of	IN	B-PP	OPBMCs	induced	PBMC	NNS	B-NP	B-cell_typeinduced	NF-kappa	induce	VBD	B-VP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	translocation	B	NN	I-NP	I-proteintranslocation	.	translocation	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	throughout	","	","	O	Othroughout	the	throughout	IN	B-PP	Othe	survey	the	DT	B-NP	Osurvey	","	survey	NN	I-NP	O","	p65p50	","	","	O	Op65p50	activation	p65p50	NN	B-NP	B-proteinactivation	remained	activation	NN	I-NP	Oremained	significantly	remain	VBD	B-VP	Osignificantly	lower	significantly	RB	B-ADJP	Olower	in	low	JJR	I-ADJP	Oin	trauma	in	IN	B-PP	Otrauma	patients	trauma	NN	B-NP	Opatients	than	patient	NNS	I-NP	Othan	in	than	IN	B-PP	Oin	controls	in	IN	B-PP	Ocontrols	.	control	NNS	B-NP	O.	After	.	.	O	OAfter	LPS	After	IN	B-PP	OLPS	stimulation	LPS	NN	B-NP	Ostimulation	in	stimulation	NN	I-NP	Oin	vitro	in	FW	B-ADVP	Ovitro	","	vitro	FW	I-ADVP	O","	the	","	","	O	Othe	p65p50/p50p50	the	DT	B-NP	Op65p50/p50p50	ratio	p65p50/p50p50	NN	I-NP	B-proteinratio	was	ratio	NN	I-NP	Owas	significantly	be	VBD	B-VP	Osignificantly	lower	significantly	RB	B-ADJP	Olower	in	low	JJR	I-ADJP	Oin	PBMCs	in	IN	B-PP	OPBMCs	from	PBMC	NNS	B-NP	B-cell_typefrom	trauma	from	IN	B-PP	Otrauma	patients	trauma	NN	B-NP	Opatients	than	patient	NNS	I-NP	Othan	from	than	IN	B-PP	Ofrom	healthy	from	IN	B-PP	Ohealthy	controls	healthy	JJ	B-NP	Ocontrols	.	control	NNS	I-NP	O.	The	.	.	O	OThe	ex	The	DT	B-NP	Oex	vivo	ex	FW	I-NP	Ovivo	expression	vivo	FW	I-NP	Oexpression	of	expression	NN	I-NP	Oof	I	of	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	was	alpha	NN	I-NP	I-proteinwas	higher	be	VBD	B-VP	Ohigher	in	high	JJR	B-ADJP	Oin	PBMCs	in	IN	B-PP	OPBMCs	of	PBMC	NNS	B-NP	B-cell_typeof	controls	of	IN	B-PP	Ocontrols	than	control	NNS	B-NP	Othan	of	than	IN	B-PP	Oof	trauma	of	IN	B-PP	Otrauma	patients	trauma	NN	B-NP	Opatients	.	patient	NNS	I-NP	O.	LPS	.	.	O	OLPS	did	LPS	NN	B-NP	Odid	not	do	VBD	B-VP	Onot	induce	not	RB	I-VP	Oinduce	I	induce	VB	I-VP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	expression	B	NN	I-NP	I-proteinexpression	in	expression	NN	I-NP	Oin	PBMCs	in	IN	B-PP	OPBMCs	from	PBMC	NNS	B-NP	B-cell_typefrom	trauma	from	IN	B-PP	Otrauma	patients	trauma	NN	B-NP	Opatients	","	patient	NNS	I-NP	O","	but	","	","	O	Obut	strong	but	CC	O	Ostrong	induction	strong	JJ	B-NP	Oinduction	was	induction	NN	I-NP	Owas	obtained	be	VBD	B-VP	Oobtained	with	obtain	VBN	I-VP	Owith	staphylococci	with	IN	B-PP	Ostaphylococci	","	staphylococci	NNS	B-NP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	this	that	IN	B-SBAR	Othis	defect	this	DT	B-NP	Odefect	is	defect	NN	I-NP	Ois	not	be	VBZ	B-VP	Onot	universal	not	RB	O	Ouniversal	and	universal	JJ	B-ADJP	Oand	depends	and	CC	O	Odepends	on	depend	VBZ	B-VP	Oon	the	on	IN	B-PP	Othe	nature	the	DT	B-NP	Onature	of	nature	NN	I-NP	Oof	the	of	IN	B-PP	Othe	activating	the	DT	B-NP	Oactivating	signal	activate	VBG	I-NP	Osignal	.	signal	NN	I-NP	O.	Although	.	.	O	OAlthough	no	Although	IN	B-SBAR	Ono	direct	no	DT	B-NP	Odirect	correlation	direct	JJ	I-NP	Ocorrelation	was	correlation	NN	I-NP	Owas	found	be	VBD	B-VP	Ofound	between	find	VBN	I-VP	Obetween	levels	between	IN	B-PP	Olevels	of	level	NNS	B-NP	Oof	interleukin-10	of	IN	B-PP	Ointerleukin-10	or	interleukin-10	NN	B-NP	B-proteinor	transforming	or	CC	O	Otransforming	growth	transform	VBG	B-NP	B-proteingrowth	factor-beta	growth	NN	I-NP	I-proteinfactor-beta	and	factor-beta	NN	I-NP	I-proteinand	NF-kappa	and	CC	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	","	B	NN	I-NP	I-protein","	these	","	","	O	Othese	immunosuppressive	these	DT	B-NP	Oimmunosuppressive	cytokines	immunosuppressive	JJ	I-NP	B-proteincytokines	were	cytokine	NNS	I-NP	I-proteinwere	significantly	be	VBD	B-VP	Osignificantly	elevated	significantly	RB	I-VP	Oelevated	in	elevate	VBN	I-VP	Oin	trauma	in	IN	B-PP	Otrauma	patients	trauma	NN	B-NP	Opatients	by	patient	NNS	I-NP	Oby	10	by	IN	B-PP	O10	days	10	CD	B-NP	Odays	after	day	NNS	I-NP	Oafter	admission	after	IN	B-PP	Oadmission	.	admission	NN	B-NP	O.	The	.	.	O	OThe	long-term	The	DT	B-NP	Olong-term	low-basal	long-term	JJ	I-NP	Olow-basal	and	low-basal	JJ	I-NP	Oand	LPS-induced	and	CC	I-NP	OLPS-induced	nuclear	LPS-induced	JJ	I-NP	Onuclear	translocation	nuclear	JJ	I-NP	Otranslocation	of	translocation	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	recalled	B	NN	I-NP	I-proteinrecalled	long-term	recall	VBD	B-VP	Olong-term	immunoparalysis	long-term	JJ	B-NP	Oimmunoparalysis	observed	immunoparalysis	NN	I-NP	Oobserved	in	observe	VBN	B-VP	Oin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	severe	with	IN	B-PP	Osevere	inflammatory	severe	JJ	B-NP	Oinflammatory	stress	inflammatory	JJ	I-NP	Ostress	such	stress	NN	I-NP	Osuch	as	such	JJ	B-PP	Oas	trauma	as	IN	I-PP	Otrauma	.	trauma	NN	B-NP	O.	Hepatic	.	.	O	OHepatic	ischemia-reperfusion	Hepatic	JJ	B-NP	Oischemia-reperfusion	injury	ischemia-reperfusion	NN	I-NP	Oinjury	.	injury	NN	I-NP	O.	BACKGROUND	.	.	O	OBACKGROUND	:	BACKGROUND	NN	B-NP	O:	The	:	:	O	OThe	morbidity	The	DT	B-NP	Omorbidity	associated	morbidity	NN	I-NP	Oassociated	with	associate	VBN	B-VP	Owith	liver	with	IN	B-PP	Oliver	transplantation	liver	NN	B-NP	Otransplantation	and	transplantation	NN	I-NP	Oand	major	and	CC	O	Omajor	hepatic	major	JJ	B-NP	Ohepatic	resections	hepatic	JJ	I-NP	Oresections	is	resection	NNS	I-NP	Ois	partly	be	VBZ	B-VP	Opartly	a	partly	RB	B-ADVP	Oa	result	a	DT	B-NP	Oresult	of	result	NN	I-NP	Oof	ischemia-reperfusion	of	IN	B-PP	Oischemia-reperfusion	injury	ischemia-reperfusion	NN	B-NP	Oinjury	.	injury	NN	I-NP	O.	DATA	.	.	O	ODATA	SOURCES	DATA	NN	B-NP	OSOURCES	:	SOURCES	NNS	I-NP	O:	The	:	:	O	OThe	entire	The	DT	B-NP	Oentire	world	entire	JJ	I-NP	Oworld	literature	world	NN	I-NP	Oliterature	on	literature	NN	I-NP	Oon	the	on	IN	B-PP	Othe	subject	the	DT	B-NP	Osubject	was	subject	NN	I-NP	Owas	searched	be	VBD	B-VP	Osearched	via	search	VBN	I-VP	Ovia	Medline	via	IN	B-PP	OMedline	.	Medline	NN	B-NP	O.	Keywords	.	.	O	OKeywords	included	Keyword	NNS	B-NP	Oincluded	reperfusion	include	VBD	B-VP	Oreperfusion	injury	reperfusion	NN	B-NP	Oinjury	","	injury	NN	I-NP	O","	transplantation	","	","	O	Otransplantation	","	transplantation	NN	B-NP	O","	liver	","	","	O	Oliver	resection	liver	NN	B-NP	Oresection	","	resection	NN	I-NP	O","	nitric	","	","	O	Onitric	oxide	nitric	JJ	B-NP	Ooxide	","	oxide	NN	I-NP	O","	endothelin	","	","	O	Oendothelin	","	endothelin	NN	B-NP	B-protein","	cytokines	","	","	O	Ocytokines	","	cytokine	NNS	B-NP	B-protein","	Kupffer	","	","	O	OKupffer	cells	Kupffer	NNP	B-NP	B-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	ischemic/ischaemic	","	","	O	Oischemic/ischaemic	preconditioning	ischemic/ischaemic	JJ	B-NP	Opreconditioning	","	preconditioning	NN	I-NP	O","	and	","	","	O	Oand	nuclear	and	CC	O	Onuclear	factor-kappa	nuclear	JJ	B-NP	B-proteinfactor-kappa	B	factor-kappa	NN	I-NP	I-proteinB	.	B	NN	I-NP	I-protein.	CONCLUSIONS	.	.	O	OCONCLUSIONS	:	CONCLUSIONS	NNS	B-NP	O:	An	:	:	O	OAn	imbalance	An	DT	B-NP	Oimbalance	between	imbalance	NN	I-NP	Obetween	endothelin	between	IN	B-PP	Oendothelin	and	endothelin	NN	B-NP	B-proteinand	nitric	and	CC	O	Onitric	oxide	nitric	JJ	B-NP	Ooxide	levels	oxide	NN	I-NP	Olevels	results	level	NNS	I-NP	Oresults	in	result	VBZ	B-VP	Oin	failure	in	IN	B-PP	Ofailure	of	failure	NN	B-NP	Oof	the	of	IN	B-PP	Othe	hepatic	the	DT	B-NP	Ohepatic	microcirculation	hepatic	JJ	I-NP	Omicrocirculation	at	microcirculation	NN	I-NP	Oat	the	at	IN	B-PP	Othe	onset	the	DT	B-NP	Oonset	of	onset	NN	I-NP	Oof	reperfusion	of	IN	B-PP	Oreperfusion	.	reperfusion	NN	B-NP	O.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor-kappa	nuclear	JJ	B-NP	B-proteinfactor-kappa	B	factor-kappa	NN	I-NP	I-proteinB	in	B	NN	I-NP	I-proteinin	the	in	IN	B-PP	Othe	liver	the	DT	B-NP	Oliver	promotes	liver	NN	I-NP	Opromotes	proinflammatory	promote	VBZ	B-VP	Oproinflammatory	cytokine	proinflammatory	JJ	B-NP	B-proteincytokine	and	cytokine	NN	I-NP	I-proteinand	adhesion	and	CC	I-NP	Oadhesion	molecule	adhesion	NN	I-NP	B-proteinmolecule	synthesis	molecule	NN	I-NP	I-proteinsynthesis	.	synthesis	NN	I-NP	O.	These	.	.	O	OThese	result	These	DT	B-NP	Oresult	in	result	VBP	B-VP	Oin	oxygen-derived	in	IN	B-PP	Ooxygen-derived	free	oxygen-derived	JJ	B-NP	Ofree	radical	free	JJ	I-NP	Oradical	production	radical	NN	I-NP	Oproduction	and	production	NN	I-NP	Oand	neutrophil	and	CC	I-NP	Oneutrophil	recruitment	neutrophil	NN	I-NP	B-cell_typerecruitment	","	recruitment	NN	I-NP	O","	further	","	","	O	Ofurther	contributing	further	RB	B-VP	Ocontributing	to	contribute	VBG	I-VP	Oto	cellular	to	TO	B-PP	Ocellular	injury	cellular	JJ	B-NP	Oinjury	.	injury	NN	I-NP	O.	Various	.	.	O	OVarious	therapeutic	Various	JJ	B-NP	Otherapeutic	modalities	therapeutic	JJ	I-NP	Omodalities	acting	modality	NNS	I-NP	Oacting	on	act	VBG	B-VP	Oon	the	on	IN	B-PP	Othe	above	the	DT	B-NP	Oabove	mediators	above	JJ	I-NP	Omediators	have	mediator	NNS	I-NP	Ohave	been	have	VBP	B-VP	Obeen	successfully	be	VBN	I-VP	Osuccessfully	used	successfully	RB	I-VP	Oused	to	use	VBN	I-VP	Oto	attenuate	to	TO	B-VP	Oattenuate	reperfusion	attenuate	VB	I-VP	Oreperfusion	injury	reperfusion	NN	B-NP	Oinjury	in	injury	NN	I-NP	Oin	animal	in	IN	B-PP	Oanimal	models	animal	NN	B-NP	Omodels	of	model	NNS	I-NP	Oof	hepatic	of	IN	B-PP	Ohepatic	transplantation	hepatic	JJ	B-NP	Otransplantation	and	transplantation	NN	I-NP	Oand	resection	and	CC	I-NP	Oresection	.	resection	NN	I-NP	O.	Application	.	.	O	OApplication	of	Application	NN	B-NP	Oof	the	of	IN	B-PP	Othe	knowledge	the	DT	B-NP	Oknowledge	gained	knowledge	NN	I-NP	Ogained	from	gain	VBN	B-VP	Ofrom	animal	from	IN	B-PP	Oanimal	models	animal	NN	B-NP	Omodels	of	model	NNS	I-NP	Oof	hepatic	of	IN	B-PP	Ohepatic	ischemia-reperfusion	hepatic	JJ	B-NP	Oischemia-reperfusion	to	ischemia-reperfusion	NN	I-NP	Oto	the	to	TO	B-PP	Othe	clinical	the	DT	B-NP	Oclinical	setting	clinical	JJ	I-NP	Osetting	will	setting	NN	I-NP	Owill	improve	will	MD	B-VP	Oimprove	the	improve	VB	I-VP	Othe	outcome	the	DT	B-NP	Ooutcome	of	outcome	NN	I-NP	Oof	hepatic	of	IN	B-PP	Ohepatic	surgery	hepatic	JJ	B-NP	Osurgery	.	surgery	NN	I-NP	O.	Down-regulation	.	.	O	ODown-regulation	of	Down-regulation	NN	B-NP	Oof	IL-12	of	IN	B-PP	OIL-12	p40	IL-12	NN	B-NP	B-DNAp40	gene	p40	NN	I-NP	I-DNAgene	in	gene	NN	I-NP	I-DNAin	Plasmodium	in	IN	B-PP	OPlasmodium	berghei-infected	Plasmodium	NN	B-NP	Oberghei-infected	mice	berghei-infected	JJ	I-NP	Omice	.	mouse	NNS	I-NP	O.	We	.	.	O	OWe	analyzed	We	PRP	B-NP	Oanalyzed	the	analyze	VBD	B-VP	Othe	mechanism	the	DT	B-NP	Omechanism	that	mechanism	NN	I-NP	Othat	causes	that	WDT	B-NP	Ocauses	suppression	cause	VBZ	B-VP	Osuppression	of	suppression	NN	B-NP	Oof	IL-12	of	IN	B-PP	OIL-12	p40	IL-12	NN	B-NP	B-proteinp40	gene	p40	NN	I-NP	Ogene	induction	gene	NN	I-NP	Oinduction	during	induction	NN	I-NP	Oduring	Plasmodium	during	IN	B-PP	OPlasmodium	berghei	Plasmodium	NNP	B-NP	Oberghei	infection	berghei	NNP	I-NP	Oinfection	.	infection	NN	I-NP	O.	Although	.	.	O	OAlthough	IL-12	Although	IN	B-SBAR	OIL-12	together	IL-12	NN	B-NP	B-proteintogether	with	together	RB	B-ADVP	Owith	IFN-gamma	with	IN	B-PP	OIFN-gamma	plays	IFN-gamma	NN	B-NP	B-proteinplays	an	play	VBZ	B-VP	Oan	important	an	DT	B-NP	Oimportant	role	important	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	protection	in	IN	B-PP	Oprotection	against	protection	NN	B-NP	Oagainst	pathogenic	against	IN	B-PP	Opathogenic	infection	pathogenic	JJ	B-NP	Oinfection	","	infection	NN	I-NP	O","	the	","	","	O	Othe	IL-12	the	DT	B-NP	OIL-12	p70	IL-12	NN	I-NP	B-proteinp70	protein	p70	NN	I-NP	I-proteinprotein	production	protein	NN	I-NP	I-proteinproduction	of	production	NN	I-NP	Oof	infected	of	IN	B-PP	Oinfected	macrophages	infected	JJ	B-NP	B-cell_typemacrophages	is	macrophage	NNS	I-NP	I-cell_typeis	lower	be	VBZ	B-VP	Olower	than	low	JJR	B-ADJP	Othan	that	than	IN	B-PP	Othat	by	that	DT	B-NP	Oby	the	by	IN	B-PP	Othe	uninfected	the	DT	B-NP	Ouninfected	macrophages	uninfected	JJ	I-NP	B-cell_typemacrophages	.	macrophage	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	showed	We	PRP	B-NP	Oshowed	in	show	VBD	B-VP	Oin	the	in	IN	B-PP	Othe	present	the	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	that	study	NN	I-NP	Othat	the	that	IN	B-SBAR	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	IL-12	of	IN	B-PP	OIL-12	p40	IL-12	NN	B-NP	B-proteinp40	gene	p40	NN	I-NP	Ogene	but	gene	NN	I-NP	Obut	not	but	CC	B-NP	Onot	IL-12	not	RB	I-NP	OIL-12	p35	IL-12	NN	B-NP	B-proteinp35	gene	p35	NN	I-NP	Ogene	in	gene	NN	I-NP	Oin	macrophages	in	IN	B-PP	Omacrophages	of	macrophage	NNS	B-NP	B-cell_typeof	P.	of	IN	B-PP	OP.	berghei-infected	P.	NNP	B-NP	Oberghei-infected	mice	berghei-infected	JJ	I-NP	Omice	was	mouse	NNS	I-NP	Owas	profoundly	be	VBD	B-VP	Oprofoundly	inhibited	profoundly	RB	I-VP	Oinhibited	.	inhibit	VBN	I-VP	O.	The	.	.	O	OThe	inhibition	The	DT	B-NP	Oinhibition	was	inhibition	NN	I-NP	Owas	induced	be	VBD	B-VP	Oinduced	by	induce	VBN	I-VP	Oby	interaction	by	IN	B-PP	Ointeraction	with	interaction	NN	B-NP	Owith	macrophages	with	IN	B-PP	Omacrophages	that	macrophage	NNS	B-NP	B-cell_typethat	had	that	WDT	B-NP	Ohad	contacted	have	VBD	B-VP	Ocontacted	with	contact	VBN	I-VP	Owith	P.	with	IN	B-PP	OP.	berghei-infected	P.	NN	B-NP	B-cell_typeberghei-infected	erythrocytes	berghei-infected	JJ	I-NP	I-cell_typeerythrocytes	and	erythrocyte	NNS	I-NP	I-cell_typeand	was	and	CC	O	Owas	mediated	be	VBD	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	soluble	a	DT	B-NP	Osoluble	factor	soluble	JJ	I-NP	B-proteinfactor	","	factor	NN	I-NP	I-protein","	IL-10	","	","	O	OIL-10	.	IL-10	NN	B-NP	B-protein.	There	.	.	O	OThere	was	There	EX	B-NP	Owas	comparable	be	VBD	B-VP	Ocomparable	activation	comparable	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	in	NF-kappaB	NN	B-NP	B-proteinin	uninfected	in	IN	B-PP	Ouninfected	and	uninfected	JJ	B-NP	B-cell_typeand	infected	and	CC	I-NP	I-cell_typeinfected	cells	infected	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	induction	The	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	IFN-regulatory	of	IN	B-PP	OIFN-regulatory	factor-1	IFN-regulatory	JJ	B-NP	B-DNAfactor-1	gene	factor-1	NN	I-NP	I-DNAgene	was	gene	NN	I-NP	I-DNAwas	comparable	be	VBD	B-VP	Ocomparable	in	comparable	JJ	B-ADJP	Oin	transcription	in	IN	B-PP	Otranscription	level	transcription	NN	B-NP	Olevel	in	level	NN	I-NP	Oin	uninfected	in	IN	B-PP	Ouninfected	and	uninfected	JJ	B-NP	B-cell_typeand	infected	and	CC	I-NP	I-cell_typeinfected	cells	infected	JJ	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	while	","	","	O	Owhile	the	while	IN	B-SBAR	Othe	unidentified	the	DT	B-NP	Ounidentified	complex	unidentified	JJ	I-NP	Ocomplex	formation	complex	NN	I-NP	Oformation	of	formation	NN	I-NP	Oof	IFN-regulatory	of	IN	B-PP	OIFN-regulatory	factor-1	IFN-regulatory	JJ	B-NP	B-proteinfactor-1	was	factor-1	NN	I-NP	I-proteinwas	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	infected	in	IN	B-PP	Oinfected	cells	infected	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Therefore	.	.	O	OTherefore	","	Therefore	RB	B-ADVP	O","	the	","	","	O	Othe	inhibition	the	DT	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	the	of	IN	B-PP	Othe	IL-12	the	DT	B-NP	OIL-12	p40	IL-12	NN	I-NP	B-proteinp40	gene	p40	NN	I-NP	Ogene	induction	gene	NN	I-NP	Oinduction	appeared	induction	NN	I-NP	Oappeared	to	appear	VBD	B-VP	Oto	be	to	TO	I-VP	Obe	regulated	be	VB	I-VP	Oregulated	at	regulate	VBN	I-VP	Oat	transcriptional	at	IN	B-PP	Otranscriptional	regulation	transcriptional	JJ	B-NP	Oregulation	level	regulation	NN	I-NP	Olevel	of	level	NN	I-NP	Oof	the	of	IN	B-PP	Othe	gene	the	DT	B-NP	Ogene	.	gene	NN	I-NP	O.	The	.	.	O	OThe	Friend	The	DT	B-NP	OFriend	of	Friend	NN	I-NP	Oof	GATA	of	IN	B-PP	OGATA	proteins	GATA	NN	B-NP	B-proteinproteins	U-shaped	protein	NNS	I-NP	I-proteinU-shaped	","	U-shaped	JJ	B-ADJP	O","	FOG-1	","	","	O	OFOG-1	","	FOG-1	NN	B-NP	B-protein","	and	","	","	O	Oand	FOG-2	and	CC	O	OFOG-2	function	FOG-2	NN	B-NP	B-proteinfunction	as	function	NN	I-NP	Oas	negative	as	IN	B-PP	Onegative	regulators	negative	JJ	B-NP	Oregulators	of	regulator	NNS	I-NP	Oof	blood	of	IN	B-PP	Oblood	","	blood	NN	B-NP	O","	heart	","	","	O	Oheart	","	heart	NN	B-NP	O","	and	","	","	O	Oand	eye	and	CC	O	Oeye	development	eye	NN	B-NP	Odevelopment	in	development	NN	I-NP	Oin	Drosophila	in	IN	B-PP	ODrosophila	.	Drosophila	NNP	B-NP	O.	Friend	.	.	O	OFriend	of	Friend	NN	B-NP	Oof	GATA	of	IN	B-PP	OGATA	(	GATA	NN	B-NP	B-protein(	FOG	(	(	O	I-proteinFOG	)	FOG	NN	B-NP	I-protein)	proteins	)	)	O	I-proteinproteins	regulate	protein	NNS	B-NP	I-proteinregulate	GATA	regulate	VBP	B-VP	OGATA	factor-activated	GATA	NN	B-NP	B-DNAfactor-activated	gene	factor-activated	JJ	I-NP	I-DNAgene	transcription	gene	NN	I-NP	I-DNAtranscription	.	transcription	NN	I-NP	O.	During	.	.	O	ODuring	vertebrate	During	IN	B-PP	Overtebrate	hematopoiesis	vertebrate	NN	B-NP	Ohematopoiesis	","	hematopoiesis	NN	I-NP	O","	FOG	","	","	O	OFOG	and	FOG	NN	B-NP	B-proteinand	GATA	and	CC	I-NP	OGATA	proteins	GATA	NN	I-NP	B-proteinproteins	cooperate	protein	NNS	I-NP	I-proteincooperate	to	cooperate	VBP	B-VP	Oto	promote	to	TO	I-VP	Opromote	erythrocyte	promote	VB	I-VP	Oerythrocyte	and	erythrocyte	NN	B-NP	B-cell_typeand	megakaryocyte	and	CC	I-NP	Omegakaryocyte	differentiation	megakaryocyte	NN	I-NP	Odifferentiation	.	differentiation	NN	I-NP	O.	The	.	.	O	OThe	Drosophila	The	DT	B-NP	ODrosophila	FOG	Drosophila	NNP	I-NP	OFOG	homologue	FOG	NN	I-NP	Ohomologue	U-shaped	homologue	NN	I-NP	OU-shaped	(	U-shaped	JJ	B-ADJP	O(	Ush	(	(	O	OUsh	)	Ush	NN	B-NP	B-protein)	is	)	)	O	Ois	expressed	be	VBZ	B-VP	Oexpressed	similarly	express	VBN	I-VP	Osimilarly	in	similarly	RB	B-ADVP	Oin	the	in	IN	B-PP	Othe	blood	the	DT	B-NP	Oblood	cell	blood	NN	I-NP	Ocell	anlage	cell	NN	I-NP	Oanlage	during	anlage	NN	I-NP	Oduring	embryogenesis	during	IN	B-PP	Oembryogenesis	.	embryogenesis	NN	B-NP	O.	During	.	.	O	ODuring	hematopoiesis	During	IN	B-PP	Ohematopoiesis	","	hematopoiesis	NN	B-NP	O","	the	","	","	O	Othe	acute	the	DT	B-NP	Oacute	myeloid	acute	JJ	I-NP	Omyeloid	leukemia	myeloid	JJ	I-NP	Oleukemia	1	leukemia	NN	I-NP	O1	homologue	1	CD	I-NP	Ohomologue	Lozenge	homologue	NN	I-NP	OLozenge	and	Lozenge	NN	I-NP	Oand	Glial	and	CC	O	OGlial	cells	Glial	JJ	B-NP	B-cell_typecells	missing	cell	NNS	I-NP	I-cell_typemissing	are	miss	VBG	B-VP	Oare	required	be	VBP	B-VP	Orequired	for	require	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	production	the	DT	B-NP	Oproduction	of	production	NN	I-NP	Oof	crystal	of	IN	B-PP	Ocrystal	cells	crystal	JJ	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	plasmatocytes	and	CC	O	Oplasmatocytes	","	plasmatocyte	NNS	B-NP	B-cell_type","	respectively	","	","	O	Orespectively	.	respectively	RB	B-ADVP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	additional	","	","	O	Oadditional	factors	additional	JJ	B-NP	Ofactors	have	factor	NNS	I-NP	Ohave	been	have	VBP	B-VP	Obeen	predicted	be	VBN	I-VP	Opredicted	to	predict	VBN	I-VP	Oto	control	to	TO	I-VP	Ocontrol	crystal	control	VB	I-VP	Ocrystal	cell	crystal	JJ	B-NP	Ocell	proliferation	cell	NN	I-NP	Oproliferation	.	proliferation	NN	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	report	this	DT	B-NP	Oreport	","	report	NN	I-NP	O","	we	","	","	O	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	Ush	that	IN	B-SBAR	OUsh	is	Ush	NN	B-NP	B-proteinis	expressed	be	VBZ	B-VP	Oexpressed	in	express	VBN	I-VP	Oin	hemocyte	in	IN	B-PP	Ohemocyte	precursors	hemocyte	NN	B-NP	B-cell_typeprecursors	and	precursor	NNS	I-NP	I-cell_typeand	plasmatocytes	and	CC	I-NP	Oplasmatocytes	throughout	plasmatocyte	NNS	I-NP	B-cell_typethroughout	embryogenesis	throughout	IN	B-PP	Oembryogenesis	and	embryogenesis	NN	B-NP	Oand	larval	and	CC	O	Olarval	development	larval	JJ	B-NP	Odevelopment	","	development	NN	I-NP	O","	and	","	","	O	Oand	the	and	CC	O	Othe	GATA	the	DT	B-NP	OGATA	factor	GATA	NN	I-NP	B-proteinfactor	Serpent	factor	NN	I-NP	I-proteinSerpent	is	Serpent	NN	I-NP	Ois	essential	be	VBZ	B-VP	Oessential	for	essential	JJ	B-ADJP	Ofor	Ush	for	IN	B-PP	OUsh	embryonic	Ush	NNP	B-NP	Oembryonic	expression	embryonic	JJ	I-NP	Oexpression	.	expression	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	loss	","	","	O	Oloss	of	loss	NN	B-NP	Oof	ush	of	IN	B-PP	Oush	function	ush	JJ	B-NP	Ofunction	results	function	NN	I-NP	Oresults	in	result	VBZ	B-VP	Oin	an	in	IN	B-PP	Oan	overproduction	an	DT	B-NP	Ooverproduction	of	overproduction	NN	I-NP	Oof	crystal	of	IN	B-PP	Ocrystal	cells	crystal	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	whereas	","	","	O	Owhereas	forced	whereas	IN	O	Oforced	expression	force	VBN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	Ush	of	IN	B-PP	OUsh	reduces	Ush	NNP	B-NP	Oreduces	this	reduce	VBZ	B-VP	Othis	cell	this	DT	B-NP	Ocell	population	cell	NN	I-NP	Opopulation	.	population	NN	I-NP	O.	Murine	.	.	O	OMurine	FOG-1	Murine	JJ	B-NP	B-proteinFOG-1	and	FOG-1	NN	I-NP	I-proteinand	FOG-2	and	CC	I-NP	OFOG-2	also	FOG-2	NN	I-NP	B-proteinalso	can	also	RB	B-ADVP	Ocan	repress	can	MD	B-VP	Orepress	crystal	repress	VB	I-VP	Ocrystal	cell	crystal	JJ	B-NP	Ocell	production	cell	NN	I-NP	Oproduction	","	production	NN	I-NP	O","	but	","	","	O	Obut	a	but	CC	O	Oa	mutant	a	DT	B-NP	Omutant	version	mutant	JJ	I-NP	Oversion	of	version	NN	I-NP	Oof	FOG-2	of	IN	B-PP	OFOG-2	lacking	FOG-2	NN	B-NP	B-proteinlacking	a	lack	VBG	B-VP	Oa	conserved	a	DT	B-NP	Oconserved	motif	conserve	VBN	I-NP	B-DNAmotif	that	motif	NN	I-NP	I-DNAthat	binds	that	WDT	B-NP	Obinds	the	bind	VBZ	B-VP	Othe	corepressor	the	DT	B-NP	Ocorepressor	C-terminal	corepressor	NN	I-NP	B-proteinC-terminal	binding	C-terminal	JJ	I-NP	I-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	fails	protein	NN	I-NP	I-proteinfails	to	fail	VBZ	B-VP	Oto	affect	to	TO	I-VP	Oaffect	the	affect	VB	I-VP	Othe	cell	the	DT	B-NP	Ocell	lineage	cell	NN	I-NP	B-cell_typelineage	.	lineage	NN	I-NP	I-cell_type.	The	.	.	O	OThe	GATA	The	DT	B-NP	OGATA	factor	GATA	NN	I-NP	B-proteinfactor	Pannier	factor	NN	I-NP	I-proteinPannier	(	Pannier	NN	I-NP	O(	Pnr	(	(	O	OPnr	)	Pnr	NN	B-NP	B-protein)	is	)	)	O	Ois	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	eye	for	IN	B-PP	Oeye	and	eye	NN	B-NP	Oand	heart	and	CC	I-NP	Oheart	development	heart	NN	I-NP	Odevelopment	in	development	NN	I-NP	Oin	Drosophila	in	IN	B-PP	ODrosophila	.	Drosophila	NNP	B-NP	O.	When	.	.	O	OWhen	Ush	When	WRB	B-ADVP	OUsh	","	Ush	NN	B-NP	B-protein","	FOG-1	","	","	O	OFOG-1	","	FOG-1	NN	B-NP	B-protein","	FOG-2	","	","	O	OFOG-2	","	FOG-2	NN	B-NP	B-protein","	or	","	","	O	Oor	mutant	or	CC	O	Omutant	FOG-2	mutant	JJ	B-NP	OFOG-2	is	FOG-2	NN	I-NP	Ois	coexpressed	be	VBZ	B-VP	Ocoexpressed	with	coexpresse	VBN	I-VP	Owith	Pnr	with	IN	B-PP	OPnr	during	Pnr	NN	B-NP	B-proteinduring	these	during	IN	B-PP	Othese	developmental	these	DT	B-NP	Odevelopmental	processes	developmental	JJ	I-NP	Oprocesses	","	process	NNS	I-NP	O","	severe	","	","	O	Osevere	eye	severe	JJ	B-NP	Oeye	and	eye	NN	I-NP	Oand	heart	and	CC	I-NP	Oheart	phenotypes	heart	NN	I-NP	Ophenotypes	result	phenotype	NNS	I-NP	Oresult	","	result	VBP	B-VP	O","	consistent	","	","	O	Oconsistent	with	consistent	JJ	B-ADJP	Owith	a	with	IN	B-PP	Oa	conserved	a	DT	B-NP	Oconserved	negative	conserve	VBN	I-NP	Onegative	regulation	negative	JJ	I-NP	Oregulation	of	regulation	NN	I-NP	Oof	Pnr	of	IN	B-PP	OPnr	function	Pnr	NN	B-NP	B-proteinfunction	.	function	NN	I-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	fly	the	DT	B-NP	Ofly	and	fly	NN	I-NP	B-proteinand	mouse	and	CC	I-NP	I-proteinmouse	FOG	mouse	NN	I-NP	I-proteinFOG	proteins	FOG	NN	I-NP	I-proteinproteins	function	protein	NNS	I-NP	I-proteinfunction	similarly	function	VBP	B-VP	Osimilarly	in	similarly	RB	B-ADVP	Oin	three	in	IN	B-PP	Othree	distinct	three	CD	B-NP	Odistinct	cellular	distinct	JJ	I-NP	Ocellular	contexts	cellular	JJ	I-NP	Ocontexts	in	context	NNS	I-NP	Oin	Drosophila	in	IN	B-PP	ODrosophila	","	Drosophila	NNP	B-NP	O","	but	","	","	O	Obut	may	but	CC	O	Omay	use	may	MD	B-VP	Ouse	different	use	VB	I-VP	Odifferent	mechanisms	different	JJ	B-NP	Omechanisms	to	mechanism	NNS	I-NP	Oto	regulate	to	TO	B-VP	Oregulate	genetic	regulate	VB	I-VP	Ogenetic	events	genetic	JJ	B-NP	Oevents	in	event	NNS	I-NP	Oin	blood	in	IN	B-PP	Oblood	vs	blood	NN	B-NP	Ovs	.	v	NNS	I-NP	O.	cardial	.	.	O	Ocardial	or	cardial	JJ	B-NP	B-cell_typeor	eye	or	CC	I-NP	I-cell_typeeye	cell	eye	NN	I-NP	I-cell_typecell	lineages	cell	NN	I-NP	I-cell_typelineages	The	lineage	NNS	I-NP	I-cell_typeThe	RING	The	DT	B-NP	ORING	finger	RING	NN	I-NP	B-proteinfinger	protein	finger	NN	I-NP	I-proteinprotein	Siah-1	protein	NN	I-NP	I-proteinSiah-1	regulates	Siah-1	NN	I-NP	Oregulates	the	regulate	VBZ	B-VP	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	the	of	IN	B-PP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	coactivator	transcriptional	JJ	I-NP	Ocoactivator	OBF-1	coactivator	NN	I-NP	OOBF-1	.	OBF-1	NN	I-NP	B-protein.	The	.	.	O	OThe	transcriptional	The	DT	B-NP	Otranscriptional	coactivator	transcriptional	JJ	I-NP	Ocoactivator	OBF-1	coactivator	NN	I-NP	OOBF-1	","	OBF-1	NN	I-NP	B-protein","	which	","	","	O	Owhich	interacts	which	WDT	B-NP	Ointeracts	with	interact	VBZ	B-VP	Owith	1-Oct	with	IN	B-PP	O1-Oct	and	1-Oct	NN	B-NP	B-proteinand	2-Oct	and	CC	I-NP	O2-Oct	and	2-Oct	NN	I-NP	B-proteinand	the	and	CC	O	Othe	octamer	the	DT	B-NP	Ooctamer	site	octamer	NN	I-NP	B-DNAsite	DNA	site	NN	I-NP	I-DNADNA	","	DNA	NN	I-NP	I-DNA","	has	","	","	O	Ohas	been	have	VBZ	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	critical	be	VB	I-VP	Ocritical	for	critical	JJ	B-ADJP	Ofor	development	for	IN	B-PP	Odevelopment	of	development	NN	B-NP	Oof	a	of	IN	B-PP	Oa	normal	a	DT	B-NP	Onormal	immune	normal	JJ	I-NP	Oimmune	response	immune	JJ	I-NP	Oresponse	and	response	NN	I-NP	Oand	the	and	CC	O	Othe	formation	the	DT	B-NP	Oformation	of	formation	NN	I-NP	Oof	germinal	of	IN	B-PP	Ogerminal	centers	germinal	JJ	B-NP	Ocenters	in	center	NNS	I-NP	Oin	secondary	in	IN	B-PP	Osecondary	lymphoid	secondary	JJ	B-NP	Olymphoid	organs	lymphoid	JJ	I-NP	Oorgans	.	organ	NNS	I-NP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	have	we	PRP	B-NP	Ohave	identified	have	VBP	B-VP	Oidentified	the	identify	VBN	I-VP	Othe	RING	the	DT	B-NP	ORING	finger	RING	NN	I-NP	B-proteinfinger	protein	finger	NN	I-NP	I-proteinprotein	Siah-1	protein	NN	I-NP	I-proteinSiah-1	as	Siah-1	NN	I-NP	Oas	a	as	IN	B-PP	Oa	protein	a	DT	B-NP	Oprotein	interacting	protein	NN	I-NP	Ointeracting	specifically	interact	VBG	B-VP	Ospecifically	with	specifically	RB	B-ADVP	Owith	OBF-1	with	IN	B-PP	OOBF-1	.	OBF-1	NN	B-NP	B-protein.	This	.	.	O	OThis	interaction	This	DT	B-NP	Ointeraction	is	interaction	NN	I-NP	Ois	mediated	be	VBZ	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	C-terminal	the	DT	B-NP	OC-terminal	part	C-terminal	JJ	I-NP	B-proteinpart	of	part	NN	I-NP	I-proteinof	Siah-1	of	IN	B-PP	OSiah-1	and	Siah-1	NN	B-NP	B-proteinand	by	and	CC	B-PP	Oby	residues	by	IN	B-PP	Oresidues	in	residue	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	N-terminus	the	DT	B-NP	ON-terminus	of	N-terminus	NN	I-NP	B-proteinof	OBF-1	of	IN	B-PP	OOBF-1	","	OBF-1	NN	B-NP	B-protein","	partly	","	","	O	Opartly	distinct	partly	RB	B-ADJP	Odistinct	from	distinct	JJ	I-ADJP	Ofrom	the	from	IN	B-PP	Othe	residues	the	DT	B-NP	Oresidues	required	residue	NNS	I-NP	Orequired	for	require	VBN	B-VP	Ofor	formation	for	IN	B-PP	Oformation	of	formation	NN	B-NP	Oof	a	of	IN	B-PP	Oa	complex	a	DT	B-NP	Ocomplex	with	complex	NN	I-NP	Owith	the	with	IN	B-PP	Othe	Oct	the	DT	B-NP	OOct	POU	Oct	NN	I-NP	B-proteinPOU	domains	POU	NN	I-NP	I-proteindomains	and	domain	NNS	I-NP	I-proteinand	the	and	CC	O	Othe	DNA	the	DT	B-NP	ODNA	.	DNA	NN	I-NP	O.	Interaction	.	.	O	OInteraction	between	Interaction	NN	B-NP	Obetween	Siah-1	between	IN	B-PP	OSiah-1	and	Siah-1	NN	B-NP	B-proteinand	OBF-1	and	CC	I-NP	OOBF-1	leads	OBF-1	NN	I-NP	B-proteinleads	to	lead	VBZ	B-VP	Oto	downregulation	to	TO	B-PP	Odownregulation	of	downregulation	NN	B-NP	Oof	OBF-1	of	IN	B-PP	OOBF-1	protein	OBF-1	NN	B-NP	B-proteinprotein	level	protein	NN	I-NP	I-proteinlevel	but	level	NN	I-NP	Obut	not	but	CC	B-NP	Onot	mRNA	not	RB	I-NP	OmRNA	","	mRNA	NN	B-NP	B-RNA","	and	","	","	O	Oand	to	and	CC	O	Oto	a	to	TO	B-PP	Oa	corresponding	a	DT	B-NP	Ocorresponding	reduction	corresponding	JJ	I-NP	Oreduction	in	reduction	NN	I-NP	Oin	octamer	in	IN	B-PP	Ooctamer	site-dependent	octamer	NN	B-NP	Osite-dependent	transcription	site-dependent	JJ	I-NP	Otranscription	activation	transcription	NN	I-NP	Oactivation	.	activation	NN	I-NP	O.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	the	of	IN	B-PP	Othe	ubiquitin-proteasome	the	DT	B-NP	Oubiquitin-proteasome	pathway	ubiquitin-proteasome	JJ	I-NP	Opathway	in	pathway	NN	I-NP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	leads	cell	NNS	I-NP	I-cell_typeleads	to	lead	VBZ	B-VP	Oto	elevated	to	TO	B-PP	Oelevated	levels	elevate	VBN	B-NP	Olevels	of	level	NNS	I-NP	Oof	OBF-1	of	IN	B-PP	OOBF-1	protein	OBF-1	NN	B-NP	B-proteinprotein	.	protein	NN	I-NP	I-protein.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	in	","	","	O	Oin	immunized	in	IN	B-PP	Oimmunized	mice	immunize	VBN	B-NP	Omice	","	mouse	NNS	I-NP	O","	OBF-1	","	","	O	OOBF-1	protein	OBF-1	NN	B-NP	B-proteinprotein	amounts	protein	NN	I-NP	Oamounts	are	amount	NNS	I-NP	Oare	dramatically	be	VBP	B-VP	Odramatically	increased	dramatically	RB	I-VP	Oincreased	in	increase	VBN	I-VP	Oin	primary	in	IN	B-PP	Oprimary	activated	primary	JJ	B-NP	B-cell_typeactivated	B	activate	VBN	I-NP	I-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	without	","	","	O	Owithout	concomitant	without	IN	B-PP	Oconcomitant	increase	concomitant	JJ	B-NP	Oincrease	in	increase	NN	I-NP	Oin	OBF-1	in	IN	B-PP	OOBF-1	mRNA	OBF-1	NN	B-NP	B-RNAmRNA	.	mRNA	NN	I-NP	I-RNA.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	Siah-1	that	IN	B-SBAR	OSiah-1	is	Siah-1	NN	B-NP	B-proteinis	part	be	VBZ	B-VP	Opart	of	part	NN	B-NP	Oof	a	of	IN	B-PP	Oa	novel	a	DT	B-NP	Onovel	regulatory	novel	JJ	I-NP	Oregulatory	loop	regulatory	JJ	I-NP	Oloop	controlling	loop	NN	I-NP	Ocontrolling	the	control	VBG	B-VP	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	OBF-1	of	IN	B-PP	OOBF-1	protein	OBF-1	NN	B-NP	B-proteinprotein	in	protein	NN	I-NP	I-proteinin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	beta-catenin	The	DT	B-NP	Obeta-catenin	--	beta-catenin	NN	I-NP	B-protein--	TCF-1	--	:	O	OTCF-1	pathway	TCF-1	NN	B-NP	B-proteinpathway	ensures	pathway	NN	I-NP	Oensures	CD4	ensure	NNS	I-NP	OCD4	(	CD4	NN	I-NP	O(	+	(	(	O	O+	)	+	SYM	O	O)	CD8	)	)	O	OCD8	(	CD8	NN	B-NP	O(	+	(	(	O	O+	)	+	SYM	O	O)	thymocyte	)	)	O	Othymocyte	survival	thymocyte	NN	B-NP	Osurvival	.	survival	NN	I-NP	O.	The	.	.	O	OThe	association	The	DT	B-NP	Oassociation	of	association	NN	I-NP	Oof	trans-acting	of	IN	B-PP	Otrans-acting	T	trans-acting	JJ	B-NP	B-proteinT	cell	T	NN	I-NP	I-proteincell	factors	cell	NN	I-NP	I-proteinfactors	(	factor	NNS	I-NP	I-protein(	TCFs	(	(	O	OTCFs	)	TCF	NNS	B-NP	B-protein)	or	)	)	O	Oor	lymphoid	or	CC	O	Olymphoid	enhancer	lymphoid	JJ	B-NP	B-proteinenhancer	factor	enhancer	NN	I-NP	I-proteinfactor	1	factor	NN	I-NP	I-protein1	(	1	CD	I-NP	I-protein(	LEF-1	(	(	O	OLEF-1	)	LEF-1	NN	B-NP	B-protein)	with	)	)	O	Owith	their	with	IN	B-PP	Otheir	coactivator	their	PRP$	B-NP	Ocoactivator	beta-catenin	coactivator	NN	I-NP	B-proteinbeta-catenin	mediates	beta-catenin	NN	I-NP	I-proteinmediates	transient	mediate	VBZ	B-VP	Otransient	transcriptional	transient	JJ	B-NP	Otranscriptional	responses	transcriptional	JJ	I-NP	Oresponses	to	response	NNS	I-NP	Oto	extracellular	to	TO	B-PP	Oextracellular	Wnt	extracellular	JJ	B-NP	OWnt	signals	Wnt	NN	I-NP	Osignals	.	signal	NNS	I-NP	O.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	here	show	VBP	B-VP	Ohere	that	here	RB	B-ADVP	Othat	T	that	IN	B-SBAR	OT	cell	T	NN	B-NP	Ocell	maturation	cell	NN	I-NP	Omaturation	depends	maturation	NN	I-NP	Odepends	on	depend	VBZ	B-VP	Oon	the	on	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	the	of	IN	B-PP	Othe	beta-catenin	the	DT	B-NP	Obeta-catenin	--	beta-catenin	NN	I-NP	B-protein--	binding	--	:	O	I-proteinbinding	domain	binding	NN	B-NP	I-proteindomain	in	domain	NN	I-NP	I-proteinin	TCF-1	in	IN	B-PP	OTCF-1	.	TCF-1	NN	B-NP	B-protein.	This	.	.	O	OThis	domain	This	DT	B-NP	Odomain	is	domain	NN	I-NP	Ois	necessary	be	VBZ	B-VP	Onecessary	to	necessary	JJ	B-ADJP	Oto	mediate	to	TO	B-VP	Omediate	the	mediate	VB	I-VP	Othe	survival	the	DT	B-NP	Osurvival	of	survival	NN	I-NP	Oof	immature	of	IN	B-PP	Oimmature	CD4	immature	JJ	B-NP	B-cell_typeCD4	(	CD4	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	CD8	)	)	O	I-cell_typeCD8	(	CD8	NN	B-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	double-positive	)	)	O	I-cell_typedouble-positive	(	double-positive	JJ	O	I-cell_type(	DP	(	(	O	I-cell_typeDP	)	DP	NN	B-NP	I-cell_type)	thymocytes	)	)	O	I-cell_typethymocytes	.	thymocyte	NNS	B-NP	I-cell_type.	Accelerated	.	.	O	OAccelerated	spontaneous	Accelerate	VBN	B-NP	Ospontaneous	thymocyte	spontaneous	JJ	I-NP	Othymocyte	death	thymocyte	NN	I-NP	Odeath	in	death	NN	I-NP	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	TCF-1	of	IN	B-PP	OTCF-1	correlates	TCF-1	NN	B-NP	B-proteincorrelates	with	correlate	VBZ	B-VP	Owith	aberrantly	with	IN	B-PP	Oaberrantly	low	aberrantly	RB	B-NP	Olow	expression	low	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	anti-apoptotic	the	DT	B-NP	Oanti-apoptotic	protein	anti-apoptotic	JJ	I-NP	B-proteinprotein	Bcl-x	protein	NN	I-NP	I-proteinBcl-x	(	Bcl-x	NN	I-NP	B-protein(	L	(	(	O	I-proteinL	)	L	NN	B-NP	I-protein)	.	)	)	O	I-protein.	Increasing	.	.	O	OIncreasing	anti-apoptotic	Increase	VBG	B-VP	Oanti-apoptotic	effectors	anti-apoptotic	JJ	B-NP	B-proteineffectors	in	effector	NNS	I-NP	I-proteinin	thymocytes	in	IN	B-PP	Othymocytes	by	thymocyte	NNS	B-NP	B-cell_typeby	the	by	IN	B-PP	Othe	use	the	DT	B-NP	Ouse	of	use	NN	I-NP	Oof	a	of	IN	B-PP	Oa	Bcl-2	a	DT	B-NP	OBcl-2	transgene	Bcl-2	NN	I-NP	B-proteintransgene	rescued	transgene	NN	I-NP	Orescued	TCF-1-deficient	rescue	VBD	B-VP	OTCF-1-deficient	DP	TCF-1-deficient	JJ	B-NP	B-cell_typeDP	thymocytes	DP	NN	I-NP	I-cell_typethymocytes	from	thymocyte	NNS	I-NP	I-cell_typefrom	apoptosis	from	IN	B-PP	Oapoptosis	.	apoptosis	NN	B-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	TCF-1	","	","	O	OTCF-1	","	TCF-1	NN	B-NP	B-protein","	upon	","	","	O	Oupon	association	upon	IN	B-PP	Oassociation	with	association	NN	B-NP	Owith	beta-catenin	with	IN	B-PP	Obeta-catenin	","	beta-catenin	NN	B-NP	B-protein","	transiently	","	","	O	Otransiently	ensures	transiently	RB	B-ADVP	Oensures	the	ensure	VBZ	B-VP	Othe	survival	the	DT	B-NP	Osurvival	of	survival	NN	I-NP	Oof	immature	of	IN	B-PP	Oimmature	T	immature	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	which	","	","	O	Owhich	enables	which	WDT	B-NP	Oenables	them	enable	VBZ	B-VP	Othem	to	them	PRP	B-NP	Oto	generate	to	TO	B-VP	Ogenerate	and	generate	VB	I-VP	Oand	edit	and	CC	I-VP	Oedit	T	edit	VB	I-VP	OT	cell	T	NN	B-NP	B-proteincell	receptor	cell	NN	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	TCR	(	(	O	I-proteinTCR	)	TCR	NN	B-NP	I-protein)	alpha	)	)	O	I-proteinalpha	chains	alpha	NN	B-NP	I-proteinchains	and	chain	NNS	I-NP	I-proteinand	attempt	and	CC	O	Oattempt	TCR	attempt	NN	B-NP	OTCR	#NAME?	TCR	NN	I-NP	B-protein#NAME?	positive	#NAME?	JJ	I-NP	Opositive	selection	positive	JJ	I-NP	Oselection	.	selection	NN	I-NP	O.	TRAIL/Apo2L	.	.	O	OTRAIL/Apo2L	ligand	TRAIL/Apo2L	NN	B-NP	B-proteinligand	selectively	ligand	NN	I-NP	I-proteinselectively	induces	selectively	RB	B-ADVP	Oinduces	apoptosis	induce	VBZ	B-VP	Oapoptosis	and	apoptosis	NN	B-NP	Oand	overcomes	and	CC	O	Oovercomes	drug	overcome	VBZ	B-VP	Odrug	resistance	drug	NN	B-NP	Oresistance	in	resistance	NN	I-NP	Oin	multiple	in	IN	B-PP	Omultiple	myeloma	multiple	JJ	B-NP	Omyeloma	:	myeloma	NN	I-NP	O:	therapeutic	:	:	O	Otherapeutic	applications	therapeutic	JJ	B-NP	Oapplications	.	application	NNS	I-NP	O.	Multiple	.	.	O	OMultiple	myeloma	Multiple	JJ	B-NP	Omyeloma	(	myeloma	NN	I-NP	O(	MM	(	(	O	OMM	)	MM	NN	B-NP	O)	remains	)	)	O	Oremains	incurable	remain	VBZ	B-VP	Oincurable	and	incurable	JJ	B-NP	Oand	novel	and	CC	I-NP	Onovel	treatments	novel	JJ	I-NP	Otreatments	are	treatment	NNS	I-NP	Oare	urgently	be	VBP	B-VP	Ourgently	needed	urgently	RB	I-VP	Oneeded	.	need	VBN	I-VP	O.	Preclinical	.	.	O	OPreclinical	in	Preclinical	JJ	B-ADJP	Oin	vitro	in	FW	B-ADVP	Ovitro	and	vitro	FW	I-ADVP	Oand	in	and	CC	O	Oin	vivo	in	FW	B-NP	Ovivo	evaluations	vivo	FW	I-NP	Oevaluations	were	evaluation	NNS	I-NP	Owere	performed	be	VBD	B-VP	Operformed	to	perform	VBN	I-VP	Oto	assess	to	TO	B-VP	Oassess	the	assess	VB	I-VP	Othe	potential	the	DT	B-NP	Opotential	therapeutic	potential	JJ	I-NP	Otherapeutic	applications	therapeutic	JJ	I-NP	Oapplications	of	application	NNS	I-NP	Oof	human	of	IN	B-PP	Ohuman	recombinant	human	JJ	B-NP	B-proteinrecombinant	tumor	recombinant	JJ	I-NP	I-proteintumor	necrosis	tumor	NN	I-NP	I-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	TNF	(	(	O	OTNF	)	TNF	NN	B-NP	B-protein)	#NAME?	)	)	O	O#NAME?	apoptosis-inducing	#NAME?	JJ	B-NP	Oapoptosis-inducing	ligand/Apo2	apoptosis-inducing	JJ	I-NP	B-proteinligand/Apo2	ligand	ligand/Apo2	NN	I-NP	I-proteinligand	(	ligand	NN	I-NP	I-protein(	TRAIL/Apo2L	(	(	O	OTRAIL/Apo2L	)	TRAIL/Apo2L	NN	B-NP	B-protein)	in	)	)	O	Oin	MM	in	IN	B-PP	OMM	.	MM	NN	B-NP	O.	TRAIL/Apo2L	.	.	O	OTRAIL/Apo2L	potently	TRAIL/Apo2L	NN	B-NP	Opotently	induced	potently	RB	B-ADVP	Oinduced	apoptosis	induce	VBD	B-VP	Oapoptosis	of	apoptosis	NN	B-NP	Oof	MM	of	IN	B-PP	OMM	cells	MM	NN	B-NP	B-cell_linecells	from	cell	NNS	I-NP	I-cell_linefrom	patients	from	IN	B-PP	Opatients	and	patient	NNS	B-NP	Oand	the	and	CC	O	Othe	majority	the	DT	B-NP	Omajority	of	majority	NN	I-NP	Oof	MM	of	IN	B-PP	OMM	cell	MM	NN	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	","	line	NNS	I-NP	I-cell_line","	including	","	","	O	Oincluding	cells	include	VBG	B-PP	Ocells	sensitive	cell	NNS	B-NP	Osensitive	or	sensitive	JJ	B-ADJP	Oor	resistant	or	CC	O	Oresistant	to	resistant	JJ	B-ADJP	Oto	dexamethasone	to	TO	B-PP	Odexamethasone	(	dexamethasone	NN	B-NP	O(	Dex	(	(	O	ODex	)	Dex	NN	B-NP	O)	","	)	)	O	O","	doxorubicin	","	","	O	Odoxorubicin	(	doxorubicin	NN	B-NP	O(	Dox	(	(	O	ODox	)	Dox	NN	B-NP	B-protein)	","	)	)	O	O","	melphalan	","	","	O	Omelphalan	","	melphalan	NN	B-NP	O","	and	","	","	O	Oand	mitoxantrone	and	CC	O	Omitoxantrone	.	mitoxantrone	NN	B-NP	O.	TRAIL/Apo2L	.	.	O	OTRAIL/Apo2L	also	TRAIL/Apo2L	NN	B-NP	B-proteinalso	overcame	also	RB	B-ADVP	Oovercame	the	overcome	VBD	B-VP	Othe	survival	the	DT	B-NP	Osurvival	effect	survival	NN	I-NP	Oeffect	of	effect	NN	I-NP	Oof	interleukin	of	IN	B-PP	Ointerleukin	6	interleukin	NN	B-NP	B-protein6	on	6	CD	I-NP	I-proteinon	MM	on	IN	B-PP	OMM	cells	MM	NN	B-NP	B-cell_linecells	and	cell	NNS	I-NP	I-cell_lineand	did	and	CC	O	Odid	not	do	VBD	B-VP	Onot	affect	not	RB	I-VP	Oaffect	the	affect	VB	I-VP	Othe	survival	the	DT	B-NP	Osurvival	of	survival	NN	I-NP	Oof	peripheral	of	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	and	blood	NN	I-NP	I-cell_typeand	bone	and	CC	I-NP	I-cell_typebone	marrow	bone	NN	I-NP	I-cell_typemarrow	mononuclear	marrow	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	purified	and	CC	O	Opurified	B	purify	VBN	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	healthy	from	IN	B-PP	Ohealthy	donors	healthy	JJ	B-NP	Odonors	.	donor	NNS	I-NP	O.	The	.	.	O	OThe	status	The	DT	B-NP	Ostatus	of	status	NN	I-NP	Oof	the	of	IN	B-PP	Othe	TRAIL	the	DT	B-NP	OTRAIL	receptors	TRAIL	NN	I-NP	B-proteinreceptors	(	receptor	NNS	I-NP	I-protein(	assessed	(	(	O	Oassessed	by	assess	VBN	B-VP	Oby	immunoblotting	by	IN	B-PP	Oimmunoblotting	and	immunoblotting	NN	B-NP	Oand	flow	and	CC	I-NP	Oflow	cytometry	flow	NN	I-NP	Ocytometry	)	cytometry	NN	I-NP	O)	could	)	)	O	Ocould	not	could	MD	B-VP	Onot	predict	not	RB	I-VP	Opredict	TRAIL	predict	VB	I-VP	OTRAIL	sensitivity	TRAIL	NN	B-NP	B-proteinsensitivity	of	sensitivity	NN	I-NP	Oof	MM	of	IN	B-PP	OMM	cells	MM	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	The	.	.	O	OThe	anti-MM	The	DT	B-NP	Oanti-MM	activity	anti-MM	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	TRAIL/Apo2L	of	IN	B-PP	OTRAIL/Apo2L	was	TRAIL/Apo2L	NN	B-NP	B-proteinwas	confirmed	be	VBD	B-VP	Oconfirmed	in	confirm	VBN	I-VP	Oin	nu/xid/bg	in	IN	B-PP	Onu/xid/bg	mice	nu/xid/bg	NN	B-NP	Omice	xenografted	mouse	NNS	I-NP	Oxenografted	with	xenografte	VBN	B-VP	Owith	human	with	IN	B-PP	Ohuman	MM	human	JJ	B-NP	B-cell_typeMM	cells	MM	NN	I-NP	I-cell_typecells	;	cell	NNS	I-NP	I-cell_type;	TRAIL	;	:	O	OTRAIL	(	TRAIL	NN	B-NP	B-protein(	500	(	(	O	O500	microg	500	CD	B-NP	Omicrog	intraperitoneally	microg	NN	I-NP	Ointraperitoneally	daily	intraperitoneally	RB	B-ADVP	Odaily	for	daily	RB	I-ADVP	Ofor	14	for	IN	B-PP	O14	days	14	CD	B-NP	Odays	)	day	NNS	I-NP	O)	was	)	)	O	Owas	well	be	VBD	B-VP	Owell	tolerated	well	RB	I-VP	Otolerated	and	tolerate	VBN	I-VP	Oand	significantly	and	CC	O	Osignificantly	suppressed	significantly	RB	B-VP	Osuppressed	the	suppress	VBD	I-VP	Othe	growth	the	DT	B-NP	Ogrowth	of	growth	NN	I-NP	Oof	plasmacytomas	of	IN	B-PP	Oplasmacytomas	.	plasmacytoma	NNS	B-NP	B-cell_type.	Dox	.	.	O	ODox	up-regulated	Dox	NNP	B-NP	Oup-regulated	the	up-regulate	VBD	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	TRAIL	the	DT	B-NP	OTRAIL	receptor	TRAIL	NN	I-NP	B-proteinreceptor	death	receptor	NN	I-NP	I-proteindeath	receptor	death	NN	I-NP	Oreceptor	5	receptor	NN	I-NP	O5	(	5	CD	I-NP	O(	DR5	(	(	O	ODR5	)	DR5	NN	B-NP	B-protein)	and	)	)	O	Oand	synergistically	and	CC	O	Osynergistically	enhanced	synergistically	RB	B-VP	Oenhanced	the	enhance	VBD	I-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	TRAIL	of	IN	B-PP	OTRAIL	not	TRAIL	NN	B-NP	B-proteinnot	only	not	RB	B-CONJP	Oonly	against	only	RB	I-CONJP	Oagainst	MM	against	IN	B-PP	OMM	cells	MM	NN	B-NP	B-cell_linecells	sensitive	cell	NNS	I-NP	I-cell_linesensitive	to	sensitive	JJ	B-ADJP	Oto	","	to	TO	B-PP	O","	but	","	","	O	Obut	also	but	CC	B-CONJP	Oalso	against	also	RB	I-CONJP	Oagainst	those	against	IN	B-PP	Othose	resistant	those	DT	B-NP	Oresistant	to	resistant	JJ	B-ADJP	Oto	","	to	TO	B-PP	O","	Dex-	","	","	O	ODex-	or	Dex-	NN	B-NP	Oor	Dox-induced	or	CC	O	ODox-induced	apoptosis	Dox-induced	JJ	B-NP	Oapoptosis	.	apoptosis	NN	I-NP	O.	Nuclear	.	.	O	ONuclear	factor	Nuclear	JJ	B-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	NF	(	(	O	I-proteinNF	)	NF	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	inhibitors	#NAME?	NN	B-NP	I-proteininhibitors	","	inhibitor	NNS	I-NP	O","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	SN50	as	IN	I-PP	OSN50	(	SN50	NN	B-NP	B-protein(	a	(	(	O	Oa	cell-permeable	a	DT	B-NP	Ocell-permeable	inhibitor	cell-permeable	JJ	I-NP	Oinhibitor	of	inhibitor	NN	I-NP	Oof	the	of	IN	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	translocation	nuclear	JJ	I-NP	Otranslocation	and	translocation	NN	I-NP	Oand	transcriptional	and	CC	O	Otranscriptional	activity	transcriptional	JJ	B-NP	Oactivity	of	activity	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	)	NF-kappaB	NN	B-NP	B-protein)	or	)	)	O	Oor	the	or	CC	O	Othe	proteasome	the	DT	B-NP	Oproteasome	inhibitor	proteasome	NN	I-NP	B-proteininhibitor	PS-341	inhibitor	NN	I-NP	OPS-341	","	PS-341	NN	I-NP	O","	enhanced	","	","	O	Oenhanced	the	enhance	VBD	B-VP	Othe	proapoptotic	the	DT	B-NP	Oproapoptotic	activity	proapoptotic	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	TRAIL/Apo2L	of	IN	B-PP	OTRAIL/Apo2L	against	TRAIL/Apo2L	NN	B-NP	B-proteinagainst	TRAIL-sensitive	against	IN	B-PP	OTRAIL-sensitive	MM	TRAIL-sensitive	JJ	B-NP	B-cell_lineMM	cells	MM	NN	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	whereas	","	","	O	Owhereas	SN50	whereas	IN	O	OSN50	reversed	SN50	NN	B-NP	B-proteinreversed	the	reverse	VBD	B-VP	Othe	TRAIL	the	DT	B-NP	OTRAIL	resistance	TRAIL	NN	I-NP	B-proteinresistance	of	resistance	NN	I-NP	Oof	ARH-77	of	IN	B-PP	OARH-77	and	ARH-77	NN	B-NP	B-proteinand	IM-9	and	CC	I-NP	OIM-9	MM	IM-9	NN	I-NP	B-cell_lineMM	cells	MM	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Importantly	.	.	O	OImportantly	","	Importantly	RB	B-ADVP	O","	normal	","	","	O	Onormal	B	normal	JJ	B-NP	B-cell_typeB	lymphocytes	B	NN	I-NP	I-cell_typelymphocytes	were	lymphocyte	NNS	I-NP	I-cell_typewere	not	be	VBD	B-VP	Onot	sensitized	not	RB	I-VP	Osensitized	to	sensitize	VBN	I-VP	Oto	TRAIL	to	TO	B-PP	OTRAIL	by	TRAIL	NN	B-NP	B-proteinby	either	by	IN	B-PP	Oeither	Dox	either	CC	O	ODox	","	Dox	NNP	B-NP	O","	SN50	","	","	O	OSN50	","	SN50	NN	B-NP	B-protein","	or	","	","	O	Oor	PS-341	or	CC	O	OPS-341	.	PS-341	NN	B-NP	B-protein.	These	.	.	O	OThese	preclinical	These	DT	B-NP	Opreclinical	studies	preclinical	JJ	I-NP	Ostudies	suggest	study	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	TRAIL/Apo2L	that	IN	B-SBAR	OTRAIL/Apo2L	can	TRAIL/Apo2L	NN	B-NP	B-proteincan	overcome	can	MD	B-VP	Oovercome	conventional	overcome	VB	I-VP	Oconventional	drug	conventional	JJ	B-NP	Odrug	resistance	drug	NN	I-NP	Oresistance	and	resistance	NN	I-NP	Oand	provide	and	CC	O	Oprovide	the	provide	VBP	B-VP	Othe	basis	the	DT	B-NP	Obasis	for	basis	NN	I-NP	Ofor	clinical	for	IN	B-PP	Oclinical	trials	clinical	JJ	B-NP	Otrials	of	trial	NNS	I-NP	Oof	TRAIL	of	IN	B-PP	OTRAIL	#NAME?	TRAIL	NN	B-NP	B-protein#NAME?	treatment	#NAME?	JJ	I-NP	Otreatment	regimens	treatment	NN	I-NP	Oregimens	to	regimen	VBZ	B-VP	Oto	improve	to	TO	I-VP	Oimprove	outcome	improve	VB	I-VP	Ooutcome	in	outcome	NN	B-NP	Oin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	MM	with	IN	B-PP	OMM	.	MM	NN	B-NP	O.	(	.	.	O	O(	Blood.	(	(	O	OBlood.	2001	Blood.	NNP	B-NP	O2001	;	2001	CD	I-NP	O;	98	;	:	O	O98	:	98	CD	B-NP	O:	795-804	:	:	O	O795-804	)	795-804	CD	B-NP	O)	CD28	)	)	O	OCD28	costimulation	CD28	NN	B-NP	B-proteincostimulation	is	costimulation	NN	I-NP	Ois	required	be	VBZ	B-VP	Orequired	not	require	VBN	I-VP	Onot	only	not	RB	B-CONJP	Oonly	to	only	RB	I-CONJP	Oto	induce	to	TO	B-VP	Oinduce	IL-12	induce	VB	I-VP	OIL-12	receptor	IL-12	NN	B-NP	B-proteinreceptor	but	receptor	NN	I-NP	I-proteinbut	also	but	CC	B-CONJP	Oalso	to	also	RB	I-CONJP	Oto	render	to	TO	B-VP	Orender	janus	render	VB	I-VP	Ojanus	kinases/STAT4	janus	NN	B-NP	Okinases/STAT4	responsive	kinases/STAT4	NN	I-NP	Oresponsive	to	responsive	JJ	B-ADJP	Oto	IL-12	to	TO	B-PP	OIL-12	stimulation	IL-12	NN	B-NP	B-proteinstimulation	in	stimulation	NN	I-NP	Oin	TCR-triggered	in	IN	B-PP	OTCR-triggered	T	TCR-triggered	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	activation	The	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	resting	of	IN	B-PP	Oresting	T	rest	VBG	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	for	cell	NNS	I-NP	I-cell_typefor	the	for	IN	B-PP	Othe	acquisition	the	DT	B-NP	Oacquisition	of	acquisition	NN	I-NP	Oof	various	of	IN	B-PP	Ovarious	functions	various	JJ	B-NP	Ofunctions	depends	function	NNS	I-NP	Odepends	on	depend	VBZ	B-VP	Oon	whether	on	IN	B-PP	Owhether	CD28	whether	IN	B-SBAR	OCD28	costimulatory	CD28	NN	B-NP	B-proteincostimulatory	signals	costimulatory	JJ	I-NP	Osignals	are	signal	NNS	I-NP	Oare	provided	be	VBP	B-VP	Oprovided	upon	provide	VBN	I-VP	Oupon	T	upon	IN	B-PP	OT	cell	T	NN	B-NP	B-proteincell	receptor	cell	NN	I-NP	I-proteinreceptor	stimulation	receptor	NN	I-NP	I-proteinstimulation	.	stimulation	NN	I-NP	O.	Here	.	.	O	OHere	","	Here	RB	B-ADVP	O","	we	","	","	O	Owe	investigated	we	PRP	B-NP	Oinvestigated	how	investigate	VBD	B-VP	Ohow	CD28	how	WRB	B-ADVP	OCD28	costimulation	CD28	NN	B-NP	B-proteincostimulation	functions	costimulation	NN	I-NP	Ofunctions	to	function	VBZ	B-VP	Oto	allow	to	TO	I-VP	Oallow	TCR	allow	VB	I-VP	OTCR	#NAME?	TCR	NN	B-NP	B-protein#NAME?	resting	#NAME?	JJ	I-NP	Oresting	T	rest	VBG	I-NP	OT	cells	T	NN	I-NP	B-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	acquire	to	TO	B-VP	Oacquire	IL-12	acquire	VB	I-VP	OIL-12	responsiveness	IL-12	NN	B-NP	B-proteinresponsiveness	.	responsiveness	NN	I-NP	O.	When	.	.	O	OWhen	T	When	WRB	B-ADVP	OT	cells	T	NN	B-NP	B-cell_typecells	are	cell	NNS	I-NP	I-cell_typeare	stimulated	be	VBP	B-VP	Ostimulated	with	stimulate	VBN	I-VP	Owith	low	with	IN	B-PP	Olow	doses	low	JJ	B-NP	Odoses	of	dose	NNS	I-NP	Oof	anti-CD3	of	IN	B-PP	Oanti-CD3	mAb	anti-CD3	JJ	B-NP	B-proteinmAb	","	mAb	NN	I-NP	I-protein","	CD28	","	","	O	OCD28	costimulation	CD28	NN	B-NP	B-proteincostimulation	was	costimulation	NN	I-NP	Owas	required	be	VBD	B-VP	Orequired	for	require	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	optimal	the	DT	B-NP	Ooptimal	levels	optimal	JJ	I-NP	Olevels	of	level	NNS	I-NP	Oof	IL-12	of	IN	B-PP	OIL-12	receptor	IL-12	NN	B-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	IL-12R	(	(	O	OIL-12R	)	IL-12R	NN	B-NP	B-protein)	expression	)	)	O	Oexpression	.	expression	NN	B-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	stimulation	","	","	O	Ostimulation	of	stimulation	NN	B-NP	Oof	T	of	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	with	cell	NNS	I-NP	I-cell_typewith	high	with	IN	B-PP	Ohigh	doses	high	JJ	B-NP	Odoses	of	dose	NNS	I-NP	Oof	anti-CD3	of	IN	B-PP	Oanti-CD3	alone	anti-CD3	NN	B-NP	B-proteinalone	induced	alone	RB	B-ADVP	Oinduced	comparable	induce	VBD	B-VP	Ocomparable	levels	comparable	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	IL-12R	of	IN	B-PP	OIL-12R	expression	IL-12R	NN	B-NP	B-proteinexpression	to	expression	NN	I-NP	Oto	those	to	TO	B-PP	Othose	induced	those	DT	B-NP	Oinduced	upon	induce	VBN	B-VP	Oupon	CD28	upon	IN	B-PP	OCD28	costimulation	CD28	NN	B-NP	B-proteincostimulation	.	costimulation	NN	I-NP	O.	Nevertheless	.	.	O	ONevertheless	","	Nevertheless	RB	B-ADVP	O","	there	","	","	O	Othere	was	there	EX	B-NP	Owas	a	be	VBD	B-VP	Oa	substantial	a	DT	B-NP	Osubstantial	difference	substantial	JJ	I-NP	Odifference	in	difference	NN	I-NP	Oin	IL-12	in	IN	B-PP	OIL-12	responsiveness	IL-12	NN	B-NP	B-proteinresponsiveness	between	responsiveness	NN	I-NP	Obetween	these	between	IN	B-PP	Othese	two	these	DT	B-NP	Otwo	groups	two	CD	I-NP	Ogroups	of	group	NNS	I-NP	Oof	T	of	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	:	cell	NNS	I-NP	I-cell_type:	compared	:	:	O	Ocompared	to	compare	VBN	B-VP	Oto	anti-CD28-costimulated	to	TO	B-PP	Oanti-CD28-costimulated	T	anti-CD28-costimulated	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	T	","	","	O	OT	cells	T	NN	B-NP	B-cell_typecells	that	cell	NNS	I-NP	I-cell_typethat	were	that	WDT	B-NP	Owere	not	be	VBD	B-VP	Onot	costimulated	not	RB	I-VP	Ocostimulated	with	costimulate	VBN	I-VP	Owith	anti-CD28	with	IN	B-PP	Oanti-CD28	exhibited	anti-CD28	NN	B-NP	B-proteinexhibited	decreased	exhibit	VBD	B-VP	Odecreased	levels	decrease	VBN	B-NP	Olevels	of	level	NNS	I-NP	Oof	Janus	of	IN	B-PP	OJanus	kinases	Janus	NN	B-NP	B-proteinkinases	(	kinase	NNS	I-NP	I-protein(	JAK	(	(	O	OJAK	)	JAK	NN	B-NP	B-protein)	JAK2/TYK2	)	)	O	OJAK2/TYK2	and	JAK2/TYK2	NN	B-NP	Oand	STAT4	and	CC	I-NP	OSTAT4	phosphorylation	STAT4	NN	I-NP	B-proteinphosphorylation	and	phosphorylation	NN	I-NP	Oand	IFN-y	and	CC	O	OIFN-y	production	IFN-y	NN	B-NP	Oproduction	following	production	NN	I-NP	Ofollowing	IL-12	follow	VBG	B-PP	OIL-12	stimulation	IL-12	NN	B-NP	B-proteinstimulation	.	stimulation	NN	I-NP	O.	Importantly	.	.	O	OImportantly	","	Importantly	RB	B-ADVP	O","	STAT6	","	","	O	OSTAT6	phosphorylation	STAT6	NN	B-NP	B-proteinphosphorylation	following	phosphorylation	NN	I-NP	Ofollowing	IL-4	follow	VBG	B-PP	OIL-4	stimulation	IL-4	NN	B-NP	B-proteinstimulation	was	stimulation	NN	I-NP	Owas	not	be	VBD	B-VP	Onot	decreased	not	RB	I-VP	Odecreased	in	decrease	VBN	I-VP	Oin	anti-CD28-uncostimulated	in	IN	B-PP	Oanti-CD28-uncostimulated	T	anti-CD28-uncostimulated	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	These	.	.	O	OThese	resutls	These	DT	B-NP	Oresutls	indicate	resutl	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	CD28	that	IN	B-SBAR	OCD28	costimulation	CD28	NN	B-NP	B-proteincostimulation	not	costimulation	NN	I-NP	Onot	only	not	RB	B-CONJP	Oonly	contributes	only	RB	I-CONJP	Ocontributes	to	contribute	VBZ	B-VP	Oto	up-regulating	to	TO	B-PP	Oup-regulating	IL-12R	up-regulate	VBG	B-VP	OIL-12R	expression	IL-12R	NN	B-NP	B-proteinexpression	but	expression	NN	I-NP	Obut	is	but	CC	O	Ois	also	be	VBZ	B-VP	Oalso	required	also	RB	I-VP	Orequired	to	require	VBN	I-VP	Oto	render	to	TO	I-VP	Orender	JAKs/STAT4	render	VB	I-VP	OJAKs/STAT4	responsive	JAKs/STAT4	NN	B-NP	Oresponsive	to	responsive	JJ	B-ADJP	Oto	IL-12	to	TO	B-PP	OIL-12	stimulation	IL-12	NN	B-NP	B-proteinstimulation	.	stimulation	NN	I-NP	O.	Constitutively	.	.	O	OConstitutively	activated	Constitutively	RB	B-NP	Oactivated	Akt-1	activate	VBN	I-NP	OAkt-1	is	Akt-1	NN	I-NP	B-proteinis	vital	be	VBZ	B-VP	Ovital	for	vital	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	survival	the	DT	B-NP	Osurvival	of	survival	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	monocyte-differentiated	human	JJ	B-NP	B-cell_typemonocyte-differentiated	macrophages	monocyte-differentiated	JJ	I-NP	I-cell_typemacrophages	.	macrophage	NNS	I-NP	I-cell_type.	Role	.	.	O	ORole	of	Role	NN	B-NP	Oof	Mcl-1	of	IN	B-PP	OMcl-1	","	Mcl-1	NN	B-NP	B-protein","	independent	","	","	O	Oindependent	of	independent	JJ	B-ADJP	Oof	nuclear	of	IN	B-PP	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	NF	(	(	O	I-proteinNF	)	NF	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	","	#NAME?	NN	B-NP	I-protein","	Bad	","	","	O	OBad	","	Bad	NN	B-NP	B-protein","	or	","	","	O	Oor	caspase	or	CC	O	Ocaspase	activation	caspase	NN	B-NP	B-proteinactivation	.	activation	NN	I-NP	O.	Recent	.	.	O	ORecent	data	Recent	JJ	B-NP	Odata	from	datum	NNS	I-NP	Ofrom	mice	from	IN	B-PP	Omice	deficient	mouse	NNS	B-NP	Odeficient	for	deficient	JJ	B-ADJP	Ofor	phosphatase	for	IN	B-PP	Ophosphatase	and	phosphatase	NN	B-NP	B-proteinand	tensin	and	CC	I-NP	Otensin	homologue	tensin	NN	I-NP	Ohomologue	deleted	homologue	NN	I-NP	Odeleted	from	delete	VBN	B-VP	Ofrom	chromosome	from	IN	B-PP	Ochromosome	10	chromosome	NN	B-NP	B-DNA10	or	10	CD	I-NP	I-DNAor	src	or	CC	I-NP	Osrc	homology	src	NN	I-NP	B-proteinhomology	2	homology	NN	I-NP	I-protein2	domain-containing	2	CD	I-NP	I-proteindomain-containing	5	domain-containing	JJ	I-NP	I-protein5	'	5	CD	I-NP	I-protein'	inositol	'	SYM	I-NP	I-proteininositol	phosphatase	inositol	NN	I-NP	I-proteinphosphatase	","	phosphatase	NN	I-NP	I-protein","	phosphatases	","	","	O	Ophosphatases	that	phosphatas	NNS	B-NP	B-proteinthat	negatively	that	WDT	B-NP	Onegatively	regulate	negatively	RB	B-ADVP	Oregulate	the	regulate	VBP	B-VP	Othe	phosphatidylinositol	the	DT	B-NP	Ophosphatidylinositol	3-kinase	phosphatidylinositol	NN	I-NP	B-protein3-kinase	(	3-kinase	NN	I-NP	I-protein(	PI3K	(	(	O	OPI3K	)	PI3K	NN	B-NP	B-protein)	pathway	)	)	O	Opathway	","	pathway	NN	B-NP	O","	revealed	","	","	O	Orevealed	an	reveal	VBD	B-VP	Oan	increased	an	DT	B-NP	Oincreased	number	increase	VBN	I-NP	Onumber	of	number	NN	I-NP	Oof	macrophages	of	IN	B-PP	Omacrophages	in	macrophage	NNS	B-NP	B-cell_typein	these	in	IN	B-PP	Othese	animals	these	DT	B-NP	Oanimals	","	animal	NNS	I-NP	O","	suggesting	","	","	O	Osuggesting	an	suggest	VBG	B-VP	Oan	essential	an	DT	B-NP	Oessential	role	essential	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	PI3K	the	DT	B-NP	OPI3K	pathway	PI3K	NN	I-NP	B-proteinpathway	for	pathway	NN	I-NP	Ofor	macro-phage	for	IN	B-PP	Omacro-phage	survival	macro-phage	NN	B-NP	Osurvival	.	survival	NN	I-NP	O.	Here	.	.	O	OHere	","	Here	RB	B-ADVP	O","	we	","	","	O	Owe	focused	we	PRP	B-NP	Ofocused	on	focus	VBD	B-VP	Oon	the	on	IN	B-PP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	the	of	IN	B-PP	Othe	PI3K-regulated	the	DT	B-NP	OPI3K-regulated	serine/threonine	PI3K-regulated	JJ	I-NP	B-proteinserine/threonine	kinase	serine/threonine	NN	I-NP	I-proteinkinase	Akt-1	kinase	NN	I-NP	I-proteinAkt-1	in	Akt-1	NN	I-NP	B-proteinin	modulating	in	IN	B-PP	Omodulating	macrophage	modulate	VBG	B-VP	Omacrophage	survival	macrophage	NN	B-NP	Osurvival	.	survival	NN	I-NP	O.	Akt-1	.	.	O	OAkt-1	was	Akt-1	NN	B-NP	B-proteinwas	constitutively	be	VBD	B-VP	Oconstitutively	activated	constitutively	RB	I-VP	Oactivated	in	activate	VBN	I-VP	Oin	human	in	IN	B-PP	Ohuman	macrophages	human	JJ	B-NP	B-cell_typemacrophages	and	macrophage	NNS	I-NP	I-cell_typeand	addition	and	CC	O	Oaddition	of	addition	NN	B-NP	Oof	the	of	IN	B-PP	Othe	PI3K	the	DT	B-NP	OPI3K	inhibitor	PI3K	NN	I-NP	B-proteininhibitor	","	inhibitor	NN	I-NP	O","	LY294002	","	","	O	OLY294002	","	LY294002	NN	B-NP	O","	suppressed	","	","	O	Osuppressed	the	suppress	VBD	B-VP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	Akt-1	of	IN	B-PP	OAkt-1	and	Akt-1	NN	B-NP	B-proteinand	induced	and	CC	O	Oinduced	cell	induce	VBD	B-VP	Ocell	death	cell	NN	B-NP	Odeath	.	death	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	suppression	","	","	O	Osuppression	of	suppression	NN	B-NP	Oof	Akt-1	of	IN	B-PP	OAkt-1	by	Akt-1	NN	B-NP	B-proteinby	inhibition	by	IN	B-PP	Oinhibition	of	inhibition	NN	B-NP	Oof	PI3K	of	IN	B-PP	OPI3K	or	PI3K	NN	B-NP	B-proteinor	a	or	CC	O	Oa	dominant	a	DT	B-NP	Odominant	negative	dominant	JJ	I-NP	Onegative	(	negative	JJ	I-NP	O(	DN	(	(	O	ODN	)	DN	JJ	B-ADJP	O)	Akt-1	)	)	O	OAkt-1	resulted	Akt-1	NN	B-NP	Oresulted	in	result	VBD	B-VP	Oin	loss	in	IN	B-PP	Oloss	of	loss	NN	B-NP	Oof	mitochondrial	of	IN	B-PP	Omitochondrial	transmembrane	mitochondrial	JJ	B-NP	Otransmembrane	potential	transmembrane	JJ	I-NP	Opotential	","	potential	NN	I-NP	O","	activation	","	","	O	Oactivation	of	activation	NN	B-NP	Oof	caspases-9	of	IN	B-PP	Ocaspases-9	and	caspases-9	NN	B-NP	B-proteinand	-3	and	CC	O	I-protein-3	","	-3	CD	B-NP	I-protein","	and	","	","	O	Oand	DNA	and	CC	O	ODNA	fragmentation	DNA	NN	B-NP	Ofragmentation	.	fragmentation	NN	I-NP	O.	The	.	.	O	OThe	effects	The	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	PI3K	of	IN	B-PP	OPI3K	inhibition	PI3K	NN	B-NP	B-proteininhibition	were	inhibition	NN	I-NP	Owere	reversed	be	VBD	B-VP	Oreversed	by	reverse	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	ectopic	the	DT	B-NP	Oectopic	expression	ectopic	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	constitutively	of	IN	B-PP	Oconstitutively	activated	constitutively	RB	B-NP	Oactivated	Akt-1	activate	VBN	I-NP	OAkt-1	or	Akt-1	NN	I-NP	B-proteinor	Bcl-x	or	CC	I-NP	OBcl-x	(	Bcl-x	NN	I-NP	B-protein(	L	(	(	O	I-proteinL	)	L	NN	B-NP	I-protein)	.	)	)	O	I-protein.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	PI3K	of	IN	B-PP	OPI3K	/Akt-1	PI3K	NN	B-NP	B-protein/Akt-1	pathway	/Akt-1	NN	I-NP	B-proteinpathway	either	pathway	NN	I-NP	Oeither	by	either	CC	B-PP	Oby	LY294002	by	IN	B-PP	OLY294002	or	LY294002	NN	B-NP	Oor	DN	or	CC	I-NP	ODN	Akt-1	DN	NN	I-NP	OAkt-1	had	Akt-1	NN	I-NP	Ohad	no	have	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	on	effect	NN	I-NP	Oon	the	on	IN	B-PP	Othe	constitutive	the	DT	B-NP	Oconstitutive	or	constitutive	JJ	I-NP	Oor	inducible	or	CC	I-NP	Oinducible	activation	inducible	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	NF	(	(	O	I-proteinNF	)	NF	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	in	#NAME?	NN	B-NP	I-proteinin	human	in	IN	B-PP	Ohuman	macrophages	human	JJ	B-NP	B-cell_typemacrophages	.	macrophage	NNS	I-NP	I-cell_type.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	after	","	","	O	Oafter	inhibition	after	IN	B-PP	Oinhibition	of	inhibition	NN	B-NP	Oof	the	of	IN	B-PP	Othe	PI3K	the	DT	B-NP	OPI3K	/	PI3K	NN	I-NP	B-protein/	Akt-1	/	SYM	B-NP	OAkt-1	pathway	Akt-1	NN	I-NP	B-proteinpathway	","	pathway	NN	I-NP	O","	a	","	","	O	Oa	marked	a	DT	B-NP	Omarked	decrease	marked	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	the	in	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	antiapoptotic	the	DT	B-NP	Oantiapoptotic	molecule	antiapoptotic	JJ	I-NP	B-proteinmolecule	Mcl-1	molecule	NN	I-NP	I-proteinMcl-1	","	Mcl-1	NN	I-NP	B-protein","	but	","	","	O	Obut	not	but	CC	O	Onot	other	not	RB	O	Oother	Bcl-2	other	JJ	B-NP	OBcl-2	family	Bcl-2	NN	I-NP	B-proteinfamily	members	family	NN	I-NP	I-proteinmembers	was	member	NNS	I-NP	I-proteinwas	observed	be	VBD	B-VP	Oobserved	","	observe	VBN	I-VP	O","	and	","	","	O	Oand	Mcl-1	and	CC	O	OMcl-1	rescued	Mcl-1	NN	B-NP	B-proteinrescued	macrophages	rescue	VBD	B-VP	Omacrophages	from	macrophage	NNS	B-NP	B-cell_typefrom	LY294002-induced	from	IN	B-PP	OLY294002-induced	cell	LY294002-induced	JJ	B-NP	B-cell_linecell	death	cell	NN	I-NP	I-cell_linedeath	.	death	NN	I-NP	O.	Further	.	.	O	OFurther	","	Further	RB	B-ADVP	O","	inhibition	","	","	O	Oinhibition	of	inhibition	NN	B-NP	Oof	Mcl-1	of	IN	B-PP	OMcl-1	by	Mcl-1	NN	B-NP	B-proteinby	antisense	by	IN	B-PP	Oantisense	oligonucleotides	antisense	JJ	B-NP	Ooligonucleotides	","	oligonucleotide	NNS	I-NP	O","	also	","	","	O	Oalso	resulted	also	RB	B-ADVP	Oresulted	in	result	VBD	B-VP	Oin	macrophage	in	IN	B-PP	Omacrophage	apoptosis	macrophage	NN	B-NP	B-cell_typeapoptosis	.	apoptosis	NN	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	our	","	","	O	Oour	findings	our	PRP$	B-NP	Ofindings	demonstrate	finding	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	constitutive	the	DT	B-NP	Oconstitutive	activation	constitutive	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	Akt-1	of	IN	B-PP	OAkt-1	regulates	Akt-1	NN	B-NP	B-proteinregulates	macrophage	regulate	VBZ	B-VP	Omacrophage	survival	macrophage	NN	B-NP	Osurvival	through	survival	NN	I-NP	Othrough	Mcl-1	through	IN	B-PP	OMcl-1	","	Mcl-1	NN	B-NP	B-protein","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	independent	be	VBZ	B-VP	Oindependent	of	independent	JJ	B-ADJP	Oof	caspases	of	IN	B-PP	Ocaspases	","	caspas	NNS	B-NP	B-protein","	NF-kappaB	","	","	O	ONF-kappaB	","	NF-kappaB	NN	B-NP	B-protein","	or	","	","	O	Oor	Bad	or	CC	O	OBad	.	Bad	NNP	B-NP	B-protein.	GRbeta	.	.	O	OGRbeta	expression	GRbeta	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	nasal	in	IN	B-PP	Onasal	polyp	nasal	JJ	B-NP	B-cell_typepolyp	inflammatory	polyp	NN	I-NP	I-cell_typeinflammatory	cells	inflammatory	JJ	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	its	and	CC	O	Oits	relationship	its	PRP$	B-NP	Orelationship	to	relationship	NN	I-NP	Oto	the	to	TO	B-PP	Othe	anti-inflammatory	the	DT	B-NP	Oanti-inflammatory	effects	anti-inflammatory	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	intranasal	of	IN	B-PP	Ointranasal	fluticasone	intranasal	JJ	B-NP	Ofluticasone	.	fluticasone	NN	I-NP	O.	BACKGROUND	.	.	O	OBACKGROUND	:	BACKGROUND	NN	B-NP	O:	Nasal	:	:	O	ONasal	polyposis	Nasal	JJ	B-NP	Opolyposis	disease	polyposis	NN	I-NP	Odisease	is	disease	NN	I-NP	Ois	an	be	VBZ	B-VP	Oan	inflammatory	an	DT	B-NP	Oinflammatory	disorder	inflammatory	JJ	I-NP	Odisorder	with	disorder	NN	I-NP	Owith	intense	with	IN	B-PP	Ointense	eosinophilic	intense	JJ	B-NP	Oeosinophilic	infiltration	eosinophilic	JJ	I-NP	Oinfiltration	of	infiltration	NN	I-NP	Oof	respiratory	of	IN	B-PP	Orespiratory	mucosa	respiratory	JJ	B-NP	Omucosa	that	mucosa	NN	I-NP	Othat	is	that	WDT	B-NP	Ois	often	be	VBZ	B-VP	Ooften	difficult	often	RB	B-ADVP	Odifficult	to	difficult	JJ	B-ADJP	Oto	control	to	TO	B-VP	Ocontrol	with	control	VB	I-VP	Owith	topical	with	IN	B-PP	Otopical	steroids	topical	JJ	B-NP	Osteroids	.	steroid	NNS	I-NP	O.	Recent	.	.	O	ORecent	evidence	Recent	JJ	B-NP	Oevidence	suggests	evidence	NN	I-NP	Osuggests	that	suggest	VBZ	B-VP	Othat	overexpression	that	IN	B-SBAR	Ooverexpression	of	overexpression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	splice	receptor	NN	I-NP	I-proteinsplice	variant	splice	NN	I-NP	Ovariant	GRbeta	variant	JJ	I-NP	OGRbeta	in	GRbeta	NN	I-NP	B-proteinin	inflammatory	in	IN	B-PP	Oinflammatory	cells	inflammatory	JJ	B-NP	B-cell_typecells	might	cell	NNS	I-NP	I-cell_typemight	contribute	might	MD	B-VP	Ocontribute	to	contribute	VB	I-VP	Oto	steroid	to	TO	B-PP	Osteroid	insensitivity	steroid	NN	B-NP	Oinsensitivity	in	insensitivity	NN	I-NP	Oin	diseases	in	IN	B-PP	Odiseases	such	disease	NNS	B-NP	Osuch	as	such	JJ	B-PP	Oas	asthma	as	IN	I-PP	Oasthma	.	asthma	NN	B-NP	O.	OBJECTIVE	.	.	O	OOBJECTIVE	:	OBJECTIVE	NN	B-NP	O:	The	:	:	O	OThe	purposes	The	DT	B-NP	Opurposes	of	purpose	NNS	I-NP	Oof	this	of	IN	B-PP	Othis	investigation	this	DT	B-NP	Oinvestigation	were	investigation	NN	I-NP	Owere	to	be	VBD	B-VP	Oto	determine	to	TO	I-VP	Odetermine	whether	determine	VB	I-VP	Owhether	nasal	whether	IN	B-SBAR	Onasal	polyp	nasal	JJ	B-NP	B-cell_typepolyp	(	polyp	NN	I-NP	I-cell_type(	NP	(	(	O	I-cell_typeNP	)	NP	NN	B-NP	I-cell_type)	inflammatory	)	)	O	I-cell_typeinflammatory	cells	inflammatory	JJ	B-NP	I-cell_typecells	overexpress	cell	NNS	I-NP	I-cell_typeoverexpress	GRbeta	overexpres	VBP	B-VP	OGRbeta	and	GRbeta	NN	B-NP	B-proteinand	to	and	CC	O	Oto	examine	to	TO	B-VP	Oexamine	whether	examine	VB	I-VP	Owhether	GRbeta	whether	IN	B-SBAR	OGRbeta	overexpression	GRbeta	NN	B-NP	B-proteinoverexpression	is	overexpression	NN	I-NP	Ois	associated	be	VBZ	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	insensitivity	with	IN	B-PP	Oinsensitivity	to	insensitivity	NN	B-NP	Oto	the	to	TO	B-PP	Othe	potent	the	DT	B-NP	Opotent	topical	potent	JJ	I-NP	Otopical	steroid	topical	JJ	I-NP	Osteroid	fluticasone	steroid	NN	I-NP	Ofluticasone	propionate	fluticasone	NN	I-NP	Opropionate	(	propionate	NN	I-NP	O(	FP	(	(	O	OFP	)	FP	NN	B-NP	O)	.	)	)	O	O.	METHODS	.	.	O	OMETHODS	:	METHODS	NNS	B-NP	O:	Biopsies	:	:	O	OBiopsies	were	Biopsy	NNS	B-NP	Owere	obtained	be	VBD	B-VP	Oobtained	from	obtain	VBN	I-VP	Ofrom	10	from	IN	B-PP	O10	subjects	10	CD	B-NP	Osubjects	with	subject	NNS	I-NP	Owith	NPs	with	IN	B-PP	ONPs	before	NP	NNS	B-NP	B-proteinbefore	and	before	IN	B-PP	Oand	4	and	CC	B-NP	O4	weeks	4	CD	I-NP	Oweeks	after	week	NNS	I-NP	Oafter	treatment	after	IN	B-PP	Otreatment	with	treatment	NN	B-NP	Owith	intranasal	with	IN	B-PP	Ointranasal	FP	intranasal	JJ	B-NP	OFP	.	FP	NN	I-NP	O.	Middle	.	.	O	OMiddle	turbinates	Middle	NNP	B-NP	Oturbinates	biopsies	turbinate	VBZ	B-VP	Obiopsies	from	biopsy	NNS	B-NP	Ofrom	6	from	IN	B-PP	O6	healthy	6	CD	B-NP	Ohealthy	","	healthy	JJ	I-NP	O","	nonallergic	","	","	I-NP	Ononallergic	subjects	nonallergic	JJ	I-NP	Osubjects	served	subject	NNS	I-NP	Oserved	as	serve	VBD	B-VP	Oas	normal	as	IN	B-PP	Onormal	controls	normal	JJ	B-NP	Ocontrols	.	control	NNS	I-NP	O.	Biopsies	.	.	O	OBiopsies	were	Biopsy	NNS	B-NP	Owere	immunostained	be	VBD	B-VP	Oimmunostained	for	immunostaine	VBN	I-VP	Ofor	inflammatory	for	IN	B-PP	Oinflammatory	cell	inflammatory	JJ	B-NP	B-proteincell	markers	cell	NN	I-NP	I-proteinmarkers	as	marker	NNS	I-NP	I-proteinas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	GRbeta	as	IN	I-CONJP	OGRbeta	and	GRbeta	NN	B-NP	B-proteinand	probed	and	CC	O	Oprobed	for	probe	VBD	B-VP	Ofor	various	for	IN	B-PP	Ovarious	cytokine	various	JJ	B-NP	Ocytokine	mRNA	cytokine	NN	I-NP	B-RNAmRNA	.	mRNA	NN	I-NP	I-RNA.	The	.	.	O	OThe	anti-inflammatory	The	DT	B-NP	Oanti-inflammatory	response	anti-inflammatory	JJ	I-NP	Oresponse	to	response	NN	I-NP	Oto	FP	to	TO	B-PP	OFP	was	FP	NN	B-NP	Owas	examined	be	VBD	B-VP	Oexamined	in	examine	VBN	I-VP	Oin	relation	in	IN	B-PP	Orelation	to	relation	NN	B-NP	Oto	pretreatment	to	TO	B-PP	Opretreatment	levels	pretreatment	NN	B-NP	Olevels	of	level	NNS	I-NP	Oof	GRbeta	of	IN	B-PP	OGRbeta	expression	GRbeta	NN	B-NP	B-proteinexpression	.	expression	NN	I-NP	O.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	The	:	:	O	OThe	total	The	DT	B-NP	Ototal	numbers	total	JJ	I-NP	Onumbers	of	number	NNS	I-NP	Oof	inflammatory	of	IN	B-PP	Oinflammatory	cells	inflammatory	JJ	B-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	increased	be	VBD	B-VP	Oincreased	in	increase	VBN	I-VP	Oin	NPs	in	IN	B-PP	ONPs	.	NP	NNS	B-NP	B-protein.	The	.	.	O	OThe	percentage	The	DT	B-NP	Opercentage	of	percentage	NN	I-NP	Oof	inflammatory	of	IN	B-PP	Oinflammatory	cells	inflammatory	JJ	B-NP	B-cell_typecells	expressing	cell	NNS	I-NP	I-cell_typeexpressing	GRbeta	express	VBG	B-VP	OGRbeta	was	GRbeta	NN	B-NP	B-proteinwas	also	be	VBD	B-VP	Oalso	increased	also	RB	I-VP	Oincreased	(	increase	VBN	I-VP	O(	40.5	(	(	O	O40.5	%	40.5	CD	B-NP	O%	+/-	%	NN	I-NP	O+/-	19.2	+/-	SYM	B-NP	O19.2	%	19.2	CD	B-NP	O%	vs	%	NN	I-NP	Ovs	16.1	vs	IN	B-PP	O16.1	%	16.1	CD	B-NP	O%	+/-	%	NN	I-NP	O+/-	4	+/-	SYM	B-NP	O4	%	4	CD	B-NP	O%	","	%	NN	I-NP	O","	P	","	","	O	OP	0.009	P	NN	B-NP	O0.009	)	0.009	NN	I-NP	O)	.	)	)	O	O.	GRbeta	.	.	O	OGRbeta	expression	GRbeta	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	NPs	in	IN	B-PP	ONPs	was	NP	NNS	B-NP	B-proteinwas	almost	be	VBD	B-VP	Oalmost	exclusive	almost	RB	B-ADJP	Oexclusive	to	exclusive	JJ	I-ADJP	Oto	T	to	TO	B-PP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	eosinophils	","	","	O	Oeosinophils	","	eosinophil	NNS	B-NP	B-cell_type","	and	","	","	O	Oand	macrophages	and	CC	O	Omacrophages	.	macrophage	NNS	B-NP	B-cell_type.	An	.	.	O	OAn	inverse	An	DT	B-NP	Oinverse	correlation	inverse	JJ	I-NP	Ocorrelation	was	correlation	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	between	observe	VBN	I-VP	Obetween	the	between	IN	B-PP	Othe	baseline	the	DT	B-NP	Obaseline	inflammatory	baseline	NN	I-NP	Oinflammatory	cell	inflammatory	JJ	I-NP	Ocell	GRbeta	cell	NN	I-NP	OGRbeta	expression	GRbeta	NN	I-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	the	and	CC	O	Othe	reduction	the	DT	B-NP	Oreduction	after	reduction	NN	I-NP	Oafter	FP	after	IN	B-PP	OFP	treatment	FP	NN	B-NP	Otreatment	in	treatment	NN	I-NP	Oin	EG2-positive	in	IN	B-PP	OEG2-positive	eosinophils	EG2-positive	JJ	B-NP	B-cell_typeeosinophils	","	eosinophil	NNS	I-NP	I-cell_type","	CD4-positive	","	","	O	OCD4-positive	T	CD4-positive	JJ	B-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	endothelial	","	","	O	Oendothelial	VCAM-1	endothelial	JJ	B-NP	OVCAM-1	expression	VCAM-1	NN	I-NP	B-proteinexpression	","	expression	NN	I-NP	O","	and	","	","	O	Oand	IL-4	and	CC	O	OIL-4	mRNA-positive	IL-4	NN	B-NP	B-proteinmRNA-positive	cells	mRNA-positive	JJ	I-NP	Ocells	.	cell	NNS	I-NP	O.	NPs	.	.	O	ONPs	that	NP	NNS	B-NP	B-proteinthat	were	that	WDT	B-NP	Owere	``	be	VBD	B-VP	O``	FP-insensitive	``	``	B-ADJP	OFP-insensitive	''	FP-insensitive	JJ	I-ADJP	O''	in	''	''	O	Oin	terms	in	IN	B-PP	Oterms	of	term	NNS	B-NP	Oof	suppression	of	IN	B-PP	Osuppression	of	suppression	NN	B-NP	Oof	eosinophil	of	IN	B-PP	Oeosinophil	numbers	eosinophil	NN	B-NP	Onumbers	(	number	NNS	I-NP	O(	major	(	(	O	Omajor	basic	major	JJ	B-NP	Obasic	protein	basic	JJ	I-NP	Oprotein	#NAME?	protein	NN	I-NP	O#NAME?	)	#NAME?	JJ	B-ADJP	O)	had	)	)	O	Ohad	a	have	VBD	B-VP	Oa	significantly	a	DT	B-NP	Osignificantly	greater	significantly	RB	I-NP	Ogreater	percentage	great	JJR	I-NP	Opercentage	of	percentage	NN	I-NP	Oof	GRbeta-positive	of	IN	B-PP	OGRbeta-positive	inflammatory	GRbeta-positive	JJ	B-NP	B-cell_typeinflammatory	cells	inflammatory	JJ	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	a	","	","	O	Oa	higher	a	DT	B-NP	Ohigher	ratio	high	JJR	I-NP	Oratio	of	ratio	NN	I-NP	Oof	GRbeta-positive/GRalpha-positive	of	IN	B-PP	OGRbeta-positive/GRalpha-positive	cells	GRbeta-positive/GRalpha-positive	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	increased	and	CC	O	Oincreased	numbers	increase	VBN	B-NP	Onumbers	of	number	NNS	I-NP	Oof	GRbeta-positive	of	IN	B-PP	OGRbeta-positive	eosinophils	GRbeta-positive	JJ	B-NP	B-cell_typeeosinophils	and	eosinophil	NNS	I-NP	I-cell_typeand	macrophages	and	CC	O	Omacrophages	in	macrophage	NNS	B-NP	B-cell_typein	comparison	in	IN	B-PP	Ocomparison	with	comparison	NN	B-NP	Owith	those	with	IN	B-PP	Othose	that	those	DT	B-NP	Othat	were	that	WDT	B-NP	Owere	``	be	VBD	B-VP	O``	FP-sensitive.	``	``	O	OFP-sensitive.	''	FP-sensitive.	NNP	B-NP	O''	``	''	''	O	O``	FP-insensitive	``	``	B-NP	OFP-insensitive	''	FP-insensitive	JJ	I-NP	O''	NPs	''	''	I-NP	ONPs	also	NP	NNS	I-NP	B-proteinalso	demonstrated	also	RB	B-ADVP	Odemonstrated	a	demonstrate	VBD	B-VP	Oa	higher	a	DT	B-NP	Ohigher	percentage	high	JJR	I-NP	Opercentage	of	percentage	NN	I-NP	Oof	IL-5-positive	of	IN	B-PP	OIL-5-positive	inflammatory	IL-5-positive	JJ	B-NP	B-cell_lineinflammatory	cells	inflammatory	JJ	I-NP	I-cell_linecells	expressing	cell	NNS	I-NP	I-cell_lineexpressing	GRbeta	express	VBG	B-VP	OGRbeta	before	GRbeta	NN	B-NP	B-proteinbefore	and	before	IN	B-PP	Oand	after	and	CC	I-PP	Oafter	FP	after	IN	I-PP	OFP	treatment	FP	NN	B-NP	Otreatment	.	treatment	NN	I-NP	O.	CONCLUSION	.	.	O	OCONCLUSION	:	CONCLUSION	NN	B-NP	O:	GRbeta	:	:	O	OGRbeta	expression	GRbeta	NN	B-NP	B-proteinexpression	appears	expression	NN	I-NP	Oappears	to	appear	VBZ	B-VP	Oto	be	to	TO	I-VP	Obe	a	be	VB	I-VP	Oa	marker	a	DT	B-NP	Omarker	of	marker	NN	I-NP	Oof	steroid	of	IN	B-PP	Osteroid	insensitivity	steroid	NN	B-NP	Oinsensitivity	in	insensitivity	NN	I-NP	Oin	NPs	in	IN	B-PP	ONPs	.	NP	NNS	B-NP	B-protein.	Expression	.	.	O	OExpression	of	Expression	NN	B-NP	Oof	GRbeta	of	IN	B-PP	OGRbeta	by	GRbeta	NN	B-NP	B-proteinby	NP	by	IN	B-PP	ONP	inflammatory	NP	NN	B-NP	B-cell_typeinflammatory	cells	inflammatory	JJ	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	particularly	","	","	O	Oparticularly	T	particularly	RB	B-NP	OT	cells	T	NN	I-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	eosinophils	and	CC	I-NP	Oeosinophils	","	eosinophil	NNS	I-NP	B-cell_type","	might	","	","	O	Omight	render	might	MD	B-VP	Orender	them	render	VB	I-VP	Othem	resistant	them	PRP	B-NP	Oresistant	to	resistant	JJ	B-ADJP	Oto	suppression	to	TO	B-PP	Osuppression	by	suppression	NN	B-NP	Oby	topical	by	IN	B-PP	Otopical	steroids	topical	JJ	B-NP	Osteroids	and	steroid	NNS	I-NP	Oand	thereby	and	CC	O	Othereby	contribute	thereby	RB	B-VP	Ocontribute	to	contribute	VBP	I-VP	Oto	persistent	to	TO	B-PP	Opersistent	NP	persistent	JJ	B-NP	ONP	inflammation	NP	NN	I-NP	Oinflammation	.	inflammation	NN	I-NP	O.	Transcriptional	.	.	O	OTranscriptional	regulation	Transcriptional	JJ	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	galectin-10	of	IN	B-PP	Ogalectin-10	(	galectin-10	NN	B-NP	B-protein(	eosinophil	(	(	O	Oeosinophil	Charcot-Leyden	eosinophil	NN	B-NP	B-proteinCharcot-Leyden	crystal	Charcot-Leyden	NN	I-NP	I-proteincrystal	protein	crystal	NN	I-NP	I-proteinprotein	)	protein	NN	I-NP	I-protein)	:	)	)	O	O:	a	:	:	O	Oa	GC	a	DT	B-NP	OGC	box	GC	NN	I-NP	B-DNAbox	(	box	NN	I-NP	I-DNA(	-44	(	(	O	O-44	to	-44	CD	B-NP	B-DNAto	-50	to	TO	O	I-DNA-50	)	-50	CD	B-NP	I-DNA)	controls	)	)	O	Ocontrols	butyric	control	VBZ	B-VP	Obutyric	acid	butyric	JJ	B-NP	Oacid	induction	acid	NN	I-NP	Oinduction	of	induction	NN	I-NP	Oof	gene	of	IN	B-PP	Ogene	expression	gene	NN	B-NP	Oexpression	.	expression	NN	I-NP	O.	Galectin-10	.	.	O	OGalectin-10	(	Galectin-10	NN	B-NP	B-protein(	gal-10	(	(	O	Ogal-10	","	gal-10	NN	B-NP	B-protein","	also	","	","	O	Oalso	known	also	RB	B-VP	Oknown	as	know	VBN	I-VP	Oas	Charcot-Leyden	as	IN	B-PP	OCharcot-Leyden	crystal	Charcot-Leyden	JJ	B-NP	B-proteincrystal	protein	crystal	JJ	I-NP	I-proteinprotein	)	protein	NN	I-NP	I-protein)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	member	a	DT	B-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	galectin	the	DT	B-NP	Ogalectin	family	galectin	NN	I-NP	B-proteinfamily	of	family	NN	I-NP	I-proteinof	beta-galactoside	of	IN	B-PP	Obeta-galactoside	binding	beta-galactoside	NN	B-NP	B-proteinbinding	proteins	binding	NN	I-NP	I-proteinproteins	that	protein	NNS	I-NP	I-proteinthat	is	that	WDT	B-NP	Ois	expressed	be	VBZ	B-VP	Oexpressed	uniquely	express	VBN	I-VP	Ouniquely	in	uniquely	RB	B-ADVP	Oin	eosinophilic	in	IN	B-PP	Oeosinophilic	and	eosinophilic	JJ	B-NP	Oand	basophilic	and	CC	I-NP	Obasophilic	leukocytes	basophilic	JJ	I-NP	B-cell_typeleukocytes	.	leukocyte	NNS	I-NP	I-cell_type.	To	.	.	O	OTo	gain	To	TO	B-VP	Ogain	a	gain	VB	I-VP	Oa	better	a	DT	B-NP	Obetter	understanding	good	JJR	I-NP	Ounderstanding	of	understanding	NN	I-NP	Oof	galectin	of	IN	B-PP	Ogalectin	gene	galectin	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	","	expression	NN	I-NP	O","	we	","	","	O	Owe	present	we	PRP	B-NP	Opresent	an	present	VBP	B-VP	Oan	analysis	an	DT	B-NP	Oanalysis	of	analysis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	regulation	transcriptional	JJ	I-NP	Oregulation	of	regulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	gene	the	DT	B-NP	Ogene	encoding	gene	NN	I-NP	Oencoding	gal-10	encode	VBG	B-VP	Ogal-10	.	gal-10	NN	B-NP	B-protein.	Analysis	.	.	O	OAnalysis	of	Analysis	NN	B-NP	Oof	the	of	IN	B-PP	Othe	minimal	the	DT	B-NP	Ominimal	promoter	minimal	JJ	I-NP	B-DNApromoter	revealed	promoter	NN	I-NP	I-DNArevealed	nine	reveal	VBD	B-VP	Onine	consensus-binding	nine	CD	B-NP	Oconsensus-binding	sites	consensus-binding	JJ	I-NP	B-DNAsites	for	site	NNS	I-NP	I-DNAfor	transcription	for	IN	B-PP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	","	factor	NNS	I-NP	I-protein","	including	","	","	O	Oincluding	several	include	VBG	B-PP	Oseveral	that	several	JJ	B-NP	Othat	are	that	WDT	B-NP	Oare	also	be	VBP	B-VP	Oalso	found	also	RB	I-VP	Ofound	in	find	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	minimal	the	DT	B-NP	Ominimal	promoters	minimal	JJ	I-NP	B-DNApromoters	of	promoter	NNS	I-NP	I-DNAof	galectins	of	IN	B-PP	Ogalectins	-1	galectin	NNS	B-NP	B-protein-1	","	-1	CD	I-NP	I-protein","	-2	","	","	I-NP	O-2	","	-2	CD	I-NP	O","	and	","	","	O	Oand	-3	and	CC	O	O-3	.	-3	CD	B-NP	O.	The	.	.	O	OThe	decrease	The	DT	B-NP	Odecrease	in	decrease	NN	I-NP	Oin	gal-10	in	IN	B-PP	Ogal-10	promoter	gal-10	NN	B-NP	B-DNApromoter	activity	promoter	NN	I-NP	I-DNAactivity	after	activity	NN	I-NP	Oafter	disruption	after	IN	B-PP	Odisruption	of	disruption	NN	B-NP	Oof	either	of	IN	B-PP	Oeither	the	either	CC	O	Othe	GC	the	DT	B-NP	OGC	box	GC	NN	I-NP	B-DNAbox	(	box	NN	I-NP	I-DNA(	-44	(	(	O	O-44	to	-44	CD	B-NP	B-DNAto	-50	to	TO	O	I-DNA-50	)	-50	CD	B-NP	I-DNA)	or	)	)	O	Oor	the	or	CC	O	Othe	Oct	the	DT	B-NP	OOct	site	Oct	NN	I-NP	B-DNAsite	(	site	NN	I-NP	I-DNA(	-255	(	(	O	O-255	to	-255	CD	B-NP	B-DNAto	-261	to	TO	O	I-DNA-261	)	-261	CD	B-NP	I-DNA)	suggests	)	)	O	Osuggests	that	suggest	VBZ	B-VP	Othat	these	that	IN	B-SBAR	Othese	sites	these	DT	B-NP	Osites	","	site	NNS	I-NP	O","	along	","	","	O	Oalong	with	along	IN	B-PP	Owith	the	with	IN	B-PP	Othe	previously	the	DT	B-NP	Opreviously	characterized	previously	RB	I-NP	Ocharacterized	GATA	characterize	VBN	I-NP	OGATA	and	GATA	NN	I-NP	B-DNAand	EoTF	and	CC	I-NP	I-DNAEoTF	sites	EoTF	NN	I-NP	I-DNAsites	","	site	NNS	I-NP	I-DNA","	are	","	","	O	Oare	necessary	be	VBP	B-VP	Onecessary	for	necessary	JJ	B-ADJP	Ofor	full	for	IN	B-PP	Ofull	promoter	full	JJ	B-NP	Opromoter	activity	promoter	NN	I-NP	Oactivity	.	activity	NN	I-NP	O.	By	.	.	O	OBy	supershift	By	IN	B-PP	Osupershift	analysis	supershift	NN	B-NP	Oanalysis	","	analysis	NN	I-NP	O","	we	","	","	O	Owe	demonstrate	we	PRP	B-NP	Odemonstrate	binding	demonstrate	VBP	B-VP	Obinding	of	binding	NN	B-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	Sp1	factor	NNS	I-NP	I-proteinSp1	and	Sp1	NN	B-NP	B-proteinand	1-Oct	and	CC	O	O1-Oct	to	1-Oct	NN	B-NP	B-proteinto	the	to	TO	B-PP	Othe	consensus	the	DT	B-NP	Oconsensus	GC	consensus	NN	I-NP	B-DNAGC	box	GC	NN	I-NP	I-DNAbox	and	box	NN	I-NP	I-DNAand	the	and	CC	O	Othe	Oct	the	DT	B-NP	OOct	site	Oct	NN	I-NP	B-DNAsite	","	site	NN	I-NP	I-DNA","	respectively	","	","	O	Orespectively	.	respectively	RB	B-ADVP	O.	Similar	.	.	O	OSimilar	to	Similar	JJ	B-ADJP	Oto	gal-1	to	TO	B-PP	Ogal-1	","	gal-1	NN	B-NP	B-protein","	gal-10	","	","	O	Ogal-10	expression	gal-10	NN	B-NP	B-proteinexpression	is	expression	NN	I-NP	Ois	induced	be	VBZ	B-VP	Oinduced	by	induce	VBN	I-VP	Oby	butyric	by	IN	B-PP	Obutyric	acid	butyric	JJ	B-NP	Oacid	","	acid	NN	I-NP	O","	an	","	","	O	Oan	effect	an	DT	B-NP	Oeffect	that	effect	NN	I-NP	Othat	is	that	WDT	B-NP	Ois	lost	be	VBZ	B-VP	Olost	upon	lose	VBN	I-VP	Oupon	ablation	upon	IN	B-PP	Oablation	of	ablation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	GC	the	DT	B-NP	OGC	box	GC	NN	I-NP	B-DNAbox	.	box	NN	I-NP	I-DNA.	Additionally	.	.	O	OAdditionally	","	Additionally	RB	B-ADVP	O","	we	","	","	O	Owe	demonstrate	we	PRP	B-NP	Odemonstrate	AML3	demonstrate	VBP	B-VP	OAML3	binding	AML3	NN	B-NP	B-proteinbinding	to	bind	VBG	B-VP	Oto	the	to	TO	B-PP	Othe	consensus	the	DT	B-NP	Oconsensus	AML	consensus	NN	I-NP	B-DNAAML	site	AML	NN	I-NP	I-DNAsite	and	site	NN	I-NP	I-DNAand	YY1	and	CC	O	OYY1	binding	YY1	NN	B-NP	B-proteinbinding	to	binding	NN	I-NP	Oto	the	to	TO	B-PP	Othe	Inr	the	DT	B-NP	OInr	sequence	Inr	NN	I-NP	B-DNAsequence	","	sequence	NN	I-NP	I-DNA","	both	","	","	O	Oboth	elements	both	DT	B-NP	Oelements	functioning	element	NNS	I-NP	Ofunctioning	as	function	VBG	B-VP	Oas	silencers	as	IN	B-PP	Osilencers	in	silencer	NNS	B-NP	B-DNAin	the	in	IN	B-PP	Othe	gal-10	the	DT	B-NP	Ogal-10	promoter	gal-10	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Tumour-stromal	.	.	O	OTumour-stromal	interactions	Tumour-stromal	JJ	B-NP	Ointeractions	.	interaction	NNS	I-NP	O.	Role	.	.	O	ORole	of	Role	NN	B-NP	Oof	the	of	IN	B-PP	Othe	stroma	the	DT	B-NP	Ostroma	in	stroma	NN	I-NP	Oin	mammary	in	IN	B-PP	Omammary	development	mammary	JJ	B-NP	Odevelopment	.	development	NN	I-NP	O.	Mammary	.	.	O	OMammary	development	Mammary	JJ	B-NP	Odevelopment	depends	development	NN	I-NP	Odepends	on	depend	VBZ	B-VP	Oon	branching	on	IN	B-PP	Obranching	morphogenesis	branch	VBG	B-VP	Omorphogenesis	","	morphogenesis	NN	B-NP	O","	namely	","	","	O	Onamely	the	namely	RB	B-ADVP	Othe	bifurcation	the	DT	B-NP	Obifurcation	and	bifurcation	NN	I-NP	Oand	extension	and	CC	I-NP	Oextension	of	extension	NN	I-NP	Oof	ductal	of	IN	B-PP	Oductal	growth	ductal	JJ	B-NP	Ogrowth	points	growth	NN	I-NP	Opoints	(	point	NNS	I-NP	O(	end	(	(	O	Oend	buds	end	NN	B-NP	Obuds	)	bud	NNS	I-NP	O)	and	)	)	O	Oand	secretory	and	CC	O	Osecretory	lobules	secretory	JJ	B-NP	Olobules	into	lobule	NNS	I-NP	Ointo	a	into	IN	B-PP	Oa	more	a	DT	O	Omore	or	more	RBR	B-ADVP	Oor	less	or	CC	I-ADVP	Oless	fatty	less	RBR	B-NP	Ofatty	stroma	fatty	JJ	I-NP	Ostroma	.	stroma	NN	I-NP	O.	Because	.	.	O	OBecause	breast	Because	IN	B-SBAR	Obreast	carcinomas	breast	NN	B-NP	Ocarcinomas	are	carcinoma	NNS	I-NP	Oare	overwhelmingly	be	VBP	B-VP	Ooverwhelmingly	ductal	overwhelmingly	RB	B-ADJP	Oductal	in	ductal	JJ	I-ADJP	Oin	origin	in	IN	B-PP	Oorigin	","	origin	NN	B-NP	O","	this	","	","	O	Othis	review	this	DT	B-NP	Oreview	focuses	review	NN	I-NP	Ofocuses	on	focus	VBZ	B-VP	Oon	stromal	on	IN	B-PP	Ostromal	influences	stromal	JJ	B-NP	Oinfluences	guiding	influence	NNS	I-NP	Oguiding	postnatal	guide	VBG	B-VP	Opostnatal	ductal	postnatal	JJ	B-NP	Oductal	development	ductal	JJ	I-NP	Odevelopment	and	development	NN	I-NP	Oand	there	and	CC	O	Othere	is	there	EX	B-NP	Ois	only	be	VBZ	B-VP	Oonly	the	only	RB	B-NP	Othe	briefest	the	DT	I-NP	Obriefest	account	brief	JJS	I-NP	Oaccount	of	account	NN	I-NP	Oof	the	of	IN	B-PP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	embryonic	of	IN	B-PP	Oembryonic	stroma	embryonic	JJ	B-NP	Ostroma	(	stroma	NN	I-NP	O(	mesenchyme	(	(	O	Omesenchyme	)	mesenchyme	NN	B-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	stroma	The	DT	B-NP	Ostroma	as	stroma	NN	I-NP	Oas	the	as	IN	B-PP	Othe	necessary	the	DT	B-NP	Onecessary	target	necessary	JJ	I-NP	Otarget	for	target	NN	I-NP	Ofor	endocrine	for	IN	B-PP	Oendocrine	mammogens	endocrine	JJ	B-NP	B-proteinmammogens	and	mammogen	NNS	I-NP	I-proteinand	the	and	CC	O	Othe	source	the	DT	B-NP	Osource	of	source	NN	I-NP	Oof	stimulatory	of	IN	B-PP	Ostimulatory	growth	stimulatory	JJ	B-NP	B-proteingrowth	factors	growth	NN	I-NP	I-proteinfactors	is	factor	NNS	I-NP	I-proteinis	described	be	VBZ	B-VP	Odescribed	and	describe	VBN	I-VP	Oand	the	and	CC	O	Othe	importance	the	DT	B-NP	Oimportance	of	importance	NN	I-NP	Oof	mammary	of	IN	B-PP	Omammary	epithelium-induced	mammary	JJ	B-NP	Oepithelium-induced	modifications	epithelium-induced	JJ	I-NP	Omodifications	of	modification	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	periductal	the	DT	B-NP	Operiductal	stroma	periductal	JJ	I-NP	Ostroma	is	stroma	NN	I-NP	Ois	emphasized	be	VBZ	B-VP	Oemphasized	.	emphasize	VBN	I-VP	O.	Evidence	.	.	O	OEvidence	is	Evidence	NN	B-NP	Ois	presented	be	VBZ	B-VP	Opresented	that	present	VBN	I-VP	Othat	if	that	IN	B-SBAR	Oif	they	if	IN	B-SBAR	Othey	are	they	PRP	B-NP	Oare	to	be	VBP	B-VP	Oto	grow	to	TO	I-VP	Ogrow	","	grow	VB	I-VP	O","	end	","	","	O	Oend	buds	end	NN	B-NP	Obuds	must	bud	NNS	I-NP	Omust	condition	must	MD	B-VP	Ocondition	proximal	condition	VB	I-VP	Oproximal	fatty	proximal	JJ	B-NP	Ofatty	stroma	fatty	JJ	I-NP	Ostroma	by	stroma	NN	I-NP	Oby	recruiting	by	IN	B-PP	Orecruiting	white	recruit	VBG	B-VP	Owhite	blood	white	JJ	B-NP	B-cell_typeblood	cells	blood	NN	I-NP	I-cell_typecells	as	cell	NNS	I-NP	I-cell_typeas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	inducing	as	IN	I-CONJP	Oinducing	stromal	induce	VBG	B-VP	Ostromal	cell	stromal	JJ	B-NP	Ocell	division	cell	NN	I-NP	Odivision	and	division	NN	I-NP	Oand	","	and	CC	O	O","	possibly	","	","	O	Opossibly	","	possibly	RB	B-ADVP	O","	estrogen	","	","	O	Oestrogen	receptors	estrogen	NN	B-NP	B-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	The	.	.	O	OThe	induction	The	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	a	of	IN	B-PP	Oa	fibrous	a	DT	B-NP	Ofibrous	stromal	fibrous	JJ	I-NP	Ostromal	tunic	stromal	JJ	I-NP	Otunic	around	tunic	NN	I-NP	Oaround	the	around	IN	B-PP	Othe	end	the	DT	B-NP	Oend	bud	end	NN	I-NP	Obud	is	bud	NN	I-NP	Ois	described	be	VBZ	B-VP	Odescribed	and	describe	VBN	I-VP	Oand	its	and	CC	O	Oits	likely	its	PRP$	B-NP	Olikely	role	likely	JJ	I-NP	Orole	as	role	NN	I-NP	Oas	a	as	IN	B-PP	Oa	complex	a	DT	B-NP	Ocomplex	ductal	complex	JJ	I-NP	Oductal	morphogen	ductal	JJ	I-NP	Omorphogen	is	morphogen	NN	I-NP	Ois	discussed	be	VBZ	B-VP	Odiscussed	;	discuss	VBN	I-VP	O;	a	;	:	O	Oa	possible	a	DT	B-NP	Opossible	role	possible	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	growth	in	IN	B-PP	Ogrowth	inhibition	growth	NN	B-NP	Oinhibition	is	inhibition	NN	I-NP	Ois	also	be	VBZ	B-VP	Oalso	considered	also	RB	I-VP	Oconsidered	.	consider	VBN	I-VP	O.	Although	.	.	O	OAlthough	the	Although	IN	B-SBAR	Othe	signals	the	DT	B-NP	Osignals	governing	signal	NNS	I-NP	Ogoverning	fibrotic	govern	VBG	B-VP	Ofibrotic	induction	fibrotic	JJ	B-NP	Oinduction	","	induction	NN	I-NP	O","	ductal	","	","	O	Oductal	morphogenesis	ductal	JJ	B-NP	Omorphogenesis	","	morphogenesis	NN	I-NP	O","	and	","	","	O	Oand	growth	and	CC	O	Ogrowth	inhibition	growth	NN	B-NP	Oinhibition	are	inhibition	NN	I-NP	Oare	unknown	be	VBP	B-VP	Ounknown	","	unknown	JJ	B-ADJP	O","	a	","	","	O	Oa	role	a	DT	B-NP	Orole	for	role	NN	I-NP	Ofor	transforming	for	IN	B-PP	Otransforming	growth	transform	VBG	B-VP	B-proteingrowth	factor-beta	growth	NN	B-NP	I-proteinfactor-beta	is	factor-beta	NN	I-NP	I-proteinis	highly	be	VBZ	B-VP	Ohighly	likely	highly	RB	B-ADJP	Olikely	and	likely	JJ	I-ADJP	Oand	is	and	CC	O	Ois	discussed	be	VBZ	B-VP	Odiscussed	.	discuss	VBN	I-VP	O.	Finally	.	.	O	OFinally	","	Finally	RB	B-ADVP	O","	a	","	","	O	Oa	need	a	DT	B-NP	Oneed	for	need	NN	I-NP	Ofor	new	for	IN	B-PP	Onew	conceptual	new	JJ	B-NP	Oconceptual	and	conceptual	JJ	I-NP	Oand	experimental	and	CC	I-NP	Oexperimental	approaches	experimental	JJ	I-NP	Oapproaches	to	approach	NNS	I-NP	Oto	understanding	to	TO	B-PP	Ounderstanding	stromal-epithelial	understand	VBG	B-VP	Ostromal-epithelial	signaling	stromal-epithelial	JJ	B-NP	Osignaling	is	signaling	NN	I-NP	Ois	discussed	be	VBZ	B-VP	Odiscussed	.	discuss	VBN	I-VP	O.	Adipophilin	.	.	O	OAdipophilin	is	Adipophilin	NN	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	sensitive	a	DT	B-NP	Osensitive	marker	sensitive	JJ	I-NP	Omarker	for	marker	NN	I-NP	Ofor	lipid	for	IN	B-PP	Olipid	loading	lipid	NN	B-NP	Oloading	in	loading	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	blood	human	JJ	B-NP	B-cell_typeblood	monocytes	blood	NN	I-NP	I-cell_typemonocytes	.	monocyte	NNS	I-NP	I-cell_type.	Adipophilin	.	.	O	OAdipophilin	","	Adipophilin	NN	B-NP	B-protein","	a	","	","	O	Oa	marker	a	DT	B-NP	Omarker	of	marker	NN	I-NP	Oof	lipid	of	IN	B-PP	Olipid	accumulation	lipid	NN	B-NP	Oaccumulation	initially	accumulation	NN	I-NP	Oinitially	described	initially	RB	B-VP	Odescribed	in	describe	VBN	I-VP	Oin	adipocytes	in	IN	B-PP	Oadipocytes	","	adipocyte	NNS	B-NP	B-cell_type","	was	","	","	O	Owas	recently	be	VBD	B-VP	Orecently	shown	recently	RB	I-VP	Oshown	to	show	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	induced	be	VB	I-VP	Oinduced	in	induce	VBN	I-VP	Oin	macrophage	in	IN	B-PP	Omacrophage	foam	macrophage	NN	B-NP	B-cell_typefoam	cells	foam	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	found	We	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	even	that	IN	B-SBAR	Oeven	freshly	even	RB	B-NP	Ofreshly	isolated	freshly	RB	I-NP	Oisolated	blood	isolate	VBN	I-NP	Oblood	monocytes	blood	NN	I-NP	B-cell_typemonocytes	express	monocyte	NNS	I-NP	I-cell_typeexpress	adipophilin	express	VBP	B-VP	Oadipophilin	and	adipophilin	NN	B-NP	B-proteinand	that	and	CC	O	Othat	the	that	IN	B-SBAR	Othe	amount	the	DT	B-NP	Oamount	of	amount	NN	I-NP	Oof	adipophilin	of	IN	B-PP	Oadipophilin	protein	adipophilin	NN	B-NP	B-proteinprotein	is	protein	NN	I-NP	I-proteinis	variable	be	VBZ	B-VP	Ovariable	in	variable	JJ	B-ADJP	Oin	monocytes	in	IN	B-PP	Omonocytes	from	monocyte	NNS	B-NP	B-cell_typefrom	different	from	IN	B-PP	Odifferent	healthy	different	JJ	B-NP	Ohealthy	individuals	healthy	JJ	I-NP	Oindividuals	.	individual	NNS	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	the	","	","	O	Othe	physiological	the	DT	B-NP	Ophysiological	expression	physiological	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	adipophilin	of	IN	B-PP	Oadipophilin	does	adipophilin	NN	B-NP	B-proteindoes	not	do	VBZ	B-VP	Onot	correlate	not	RB	I-VP	Ocorrelate	with	correlate	VB	I-VP	Owith	the	with	IN	B-PP	Othe	levels	the	DT	B-NP	Olevels	of	level	NNS	I-NP	Oof	free	of	IN	B-PP	Ofree	fatty	free	JJ	B-NP	Ofatty	acids	fatty	JJ	I-NP	Oacids	","	acid	NNS	I-NP	O","	cholesterylesters	","	","	O	Ocholesterylesters	or	cholesterylester	NNS	B-NP	Oor	free	or	CC	O	Ofree	cholesterol	free	JJ	B-NP	Ocholesterol	.	cholesterol	NN	I-NP	O.	Enzymatically	.	.	O	OEnzymatically	modified	Enzymatically	RB	B-NP	Omodified	low-density	modify	VBN	I-NP	Olow-density	lipoprotein	low-density	JJ	I-NP	B-proteinlipoprotein	(	lipoprotein	NN	I-NP	I-protein(	E-LDL	(	(	O	OE-LDL	)	E-LDL	NN	B-NP	B-protein)	induces	)	)	O	Oinduces	rapid	induce	VBZ	B-VP	Orapid	foam	rapid	JJ	B-NP	Ofoam	cell	foam	NN	I-NP	Ocell	formation	cell	NN	I-NP	Oformation	in	formation	NN	I-NP	Oin	monocytes	in	IN	B-PP	Omonocytes	and	monocyte	NNS	B-NP	B-cell_typeand	upregulates	and	CC	O	Oupregulates	adipophilin	upregulate	VBZ	B-VP	Oadipophilin	mRNA	adipophilin	NN	B-NP	B-RNAmRNA	and	mRNA	NN	I-NP	I-RNAand	protein	and	CC	I-NP	Oprotein	within	protein	NN	I-NP	Owithin	2	within	IN	B-PP	O2	h	2	CD	B-NP	Oh	of	h	NN	I-NP	Oof	incubation	of	IN	B-PP	Oincubation	.	incubation	NN	B-NP	O.	This	.	.	O	OThis	rapid	This	DT	B-NP	Orapid	induction	rapid	JJ	I-NP	Oinduction	of	induction	NN	I-NP	Oof	adipophilin	of	IN	B-PP	Oadipophilin	is	adipophilin	NN	B-NP	B-proteinis	accompanied	be	VBZ	B-VP	Oaccompanied	by	accompany	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	significant	a	DT	B-NP	Osignificant	increase	significant	JJ	I-NP	Oincrease	of	increase	NN	I-NP	Oof	free	of	IN	B-PP	Ofree	fatty	free	JJ	B-NP	Ofatty	acids	fatty	JJ	I-NP	Oacids	in	acid	NNS	I-NP	Oin	monocytes	in	IN	B-PP	Omonocytes	incubated	monocyte	NNS	B-NP	B-cell_typeincubated	with	incubate	VBN	B-VP	Owith	E-LDL	with	IN	B-PP	OE-LDL	.	E-LDL	NN	B-NP	B-protein.	Adipophilin	.	.	O	OAdipophilin	facilitates	Adipophilin	NN	B-NP	B-proteinfacilitates	the	facilitate	VBZ	B-VP	Othe	uptake	the	DT	B-NP	Ouptake	of	uptake	NN	I-NP	Oof	free	of	IN	B-PP	Ofree	fatty	free	JJ	B-NP	Ofatty	acids	fatty	JJ	I-NP	Oacids	","	acid	NNS	I-NP	O","	and	","	","	O	Oand	here	and	CC	O	Ohere	we	here	RB	B-ADVP	Owe	demonstrate	we	PRP	B-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	free	that	IN	B-SBAR	Ofree	fatty	free	JJ	B-NP	Ofatty	acids	fatty	JJ	I-NP	Oacids	increase	acid	NNS	I-NP	Oincrease	is	increase	VBP	B-VP	Ois	related	be	VBZ	B-VP	Orelated	to	related	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	early	the	DT	B-NP	Oearly	upregulation	early	JJ	I-NP	Oupregulation	of	upregulation	NN	I-NP	Oof	adipophilin	of	IN	B-PP	Oadipophilin	expression	adipophilin	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	blood	in	IN	B-PP	Oblood	monocytes	blood	NN	B-NP	B-cell_typemonocytes	.	monocyte	NNS	I-NP	I-cell_type.	Fatty	.	.	O	OFatty	acids	Fatty	JJ	B-NP	Oacids	are	acid	NNS	I-NP	Oare	ligands	be	VBP	B-VP	Oligands	for	ligand	NNS	B-NP	Ofor	peroxisome	for	IN	B-PP	Operoxisome	proliferator-activated	peroxisome	NN	B-NP	B-proteinproliferator-activated	receptor-gamma	proliferator-activated	JJ	I-NP	I-proteinreceptor-gamma	(	receptor-gamma	NN	I-NP	I-protein(	PPARgamma	(	(	O	OPPARgamma	)	PPARgamma	NN	B-NP	B-protein)	","	)	)	O	O","	and	","	","	O	Oand	the	and	CC	O	Othe	upregulation	the	DT	B-NP	Oupregulation	of	upregulation	NN	I-NP	Oof	adipophilin	of	IN	B-PP	Oadipophilin	mRNA	adipophilin	NN	B-NP	B-RNAmRNA	by	mRNA	NN	I-NP	I-RNAby	PPARgamma	by	IN	B-PP	OPPARgamma	agonists	PPARgamma	NN	B-NP	B-proteinagonists	like	agonist	NNS	I-NP	Olike	15d-PGJ	like	IN	B-PP	O15d-PGJ	(	15d-PGJ	NN	B-NP	O(	2	(	(	O	O2	)	2	CD	B-NP	O)	and	)	)	O	Oand	ciglitazone	and	CC	O	Ociglitazone	indicates	ciglitazone	NN	B-NP	Oindicates	that	indicate	VBZ	B-VP	Othat	PPARgamma	that	IN	B-SBAR	OPPARgamma	may	PPARgamma	NN	B-NP	B-proteinmay	mediate	may	MD	B-VP	Omediate	the	mediate	VB	I-VP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	adipophilin	of	IN	B-PP	Oadipophilin	expression	adipophilin	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	blood	human	JJ	B-NP	B-cell_typeblood	monocytes	blood	NN	I-NP	I-cell_typemonocytes	.	monocyte	NNS	I-NP	I-cell_type.	Constitutive	.	.	O	OConstitutive	expression	Constitutive	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	MHC	of	IN	B-PP	OMHC	class	MHC	NN	B-NP	B-DNAclass	II	class	NN	I-NP	I-DNAII	genes	II	CD	B-NP	I-DNAgenes	in	gene	NNS	I-NP	I-DNAin	melanoma	in	IN	B-PP	Omelanoma	cell	melanoma	NN	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	results	line	NNS	I-NP	I-cell_lineresults	from	result	VBZ	B-VP	Ofrom	the	from	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	of	transcription	NN	I-NP	Oof	class	of	IN	B-PP	Oclass	II	class	NN	B-NP	B-proteinII	transactivator	II	CD	I-NP	I-proteintransactivator	abnormally	transactivator	NN	I-NP	I-proteinabnormally	initiated	abnormally	RB	B-VP	Oinitiated	from	initiate	VBN	I-VP	Ofrom	its	from	IN	B-PP	Oits	B	its	PRP$	B-NP	OB	cell-specific	B	NN	I-NP	B-DNAcell-specific	promoter	cell-specific	JJ	I-NP	I-DNApromoter	.	promoter	NN	I-NP	I-DNA.	In	.	.	O	OIn	melanoma	In	IN	B-PP	Omelanoma	cell	melanoma	NN	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	","	line	NNS	I-NP	I-cell_line","	two	","	","	O	Otwo	different	two	CD	B-NP	Odifferent	patterns	different	JJ	I-NP	Opatterns	of	pattern	NNS	I-NP	Oof	MHC	of	IN	B-PP	OMHC	class	MHC	NN	B-NP	B-proteinclass	II	class	NN	I-NP	I-proteinII	expression	II	CD	I-NP	I-proteinexpression	have	expression	NN	I-NP	Ohave	been	have	VBP	B-VP	Obeen	described	be	VBN	I-VP	Odescribed	","	describe	VBN	I-VP	O","	either	","	","	O	Oeither	an	either	CC	O	Oan	IFN	an	DT	B-NP	OIFN	gamma-inducible	IFN	NN	I-NP	B-proteingamma-inducible	expression	gamma-inducible	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	HLA-DR	of	IN	B-PP	OHLA-DR	and	HLA-DR	NN	B-NP	B-proteinand	HLA-DP	and	CC	I-NP	OHLA-DP	","	HLA-DP	NN	I-NP	B-DNA","	with	","	","	O	Owith	a	with	IN	B-PP	Oa	faint	a	DT	B-NP	Ofaint	or	faint	JJ	I-NP	Oor	null	or	CC	I-NP	Onull	expression	null	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	HLA-DQ	of	IN	B-PP	OHLA-DQ	","	HLA-DQ	NN	B-NP	B-DNA","	resembling	","	","	O	Oresembling	that	resemble	VBG	B-VP	Othat	described	that	IN	B-SBAR	Odescribed	for	describe	VBN	B-VP	Ofor	melanocytes	for	IN	B-PP	Omelanocytes	","	melanocyte	NNS	B-NP	B-cell_type","	or	","	","	O	Oor	a	or	CC	O	Oa	constitutive	a	DT	B-NP	Oconstitutive	expression	constitutive	JJ	I-NP	Oexpression	","	expression	NN	I-NP	O","	i.e.	","	","	O	Oi.e.	","	i.e.	FW	B-NP	O","	IFN-gamma	","	","	O	OIFN-gamma	independent	IFN-gamma	NN	B-NP	B-proteinindependent	","	independent	JJ	I-NP	O","	of	","	","	O	Oof	all	of	IN	B-PP	Oall	three	all	DT	B-NP	Othree	HLA-D	three	CD	I-NP	OHLA-D	isotypes	HLA-D	NN	I-NP	B-proteinisotypes	.	isotype	NNS	I-NP	I-protein.	As	.	.	O	OAs	this	As	IN	B-SBAR	Othis	latter	this	DT	B-NP	Olatter	phenotype	latter	JJ	I-NP	Ophenotype	has	phenotype	NN	I-NP	Ohas	been	have	VBZ	B-VP	Obeen	associated	be	VBN	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	a	with	IN	B-PP	Oa	more	a	DT	B-NP	Omore	rapid	more	RBR	I-NP	Orapid	progression	rapid	JJ	I-NP	Oprogression	of	progression	NN	I-NP	Oof	melanoma	of	IN	B-PP	Omelanoma	tumors	melanoma	NN	B-NP	Otumors	","	tumor	NNS	I-NP	O","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	analyzed	have	VBP	B-VP	Oanalyzed	in	analyze	VBN	I-VP	Oin	different	in	IN	B-PP	Odifferent	melanoma	different	JJ	B-NP	Omelanoma	cell	melanoma	NN	I-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	the	line	NNS	I-NP	I-cell_linethe	molecular	the	DT	B-NP	Omolecular	mechanisms	molecular	JJ	I-NP	Omechanisms	leading	mechanism	NNS	I-NP	Oleading	to	lead	VBG	B-VP	Oto	this	to	TO	B-PP	Othis	abnormal	this	DT	B-NP	Oabnormal	pattern	abnormal	JJ	I-NP	Opattern	of	pattern	NN	I-NP	Oof	MHC	of	IN	B-PP	OMHC	class	MHC	NN	B-NP	B-proteinclass	II	class	NN	I-NP	I-proteinII	expression	II	CD	I-NP	I-proteinexpression	.	expression	NN	I-NP	O.	In	.	.	O	OIn	agreement	In	IN	B-PP	Oagreement	with	agreement	NN	I-PP	Owith	the	with	IN	I-PP	Othe	evidence	the	DT	B-NP	Oevidence	of	evidence	NN	I-NP	Oof	a	of	IN	B-PP	Oa	coordinate	a	DT	B-NP	Ocoordinate	transcription	coordinate	JJ	I-NP	Otranscription	of	transcription	NN	I-NP	Oof	the	of	IN	B-PP	Othe	HLA-D	the	DT	B-NP	OHLA-D	genes	HLA-D	NN	I-NP	B-DNAgenes	in	gene	NNS	I-NP	I-DNAin	these	in	IN	B-PP	Othese	cell	these	DT	B-NP	Ocell	lines	cell	NN	I-NP	B-cell_linelines	","	line	NNS	I-NP	I-cell_line","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	shown	have	VBP	B-VP	Oshown	the	show	VBN	I-VP	Othe	constitutive	the	DT	B-NP	Oconstitutive	expression	constitutive	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	CIITA	of	IN	B-PP	OCIITA	(	CIITA	NN	B-NP	B-protein(	class	(	(	O	Oclass	II	class	NN	B-NP	B-proteinII	transactivator	II	CD	I-NP	I-proteintransactivator	)	transactivator	NN	I-NP	I-protein)	transcripts	)	)	O	Otranscripts	","	transcript	NNS	B-NP	O","	CIITA	","	","	O	OCIITA	being	CIITA	NN	B-NP	B-proteinbeing	known	be	VBG	B-VP	Oknown	as	know	VBN	I-VP	Oas	the	as	IN	B-PP	Othe	master	the	DT	B-NP	Omaster	switch	master	NN	I-NP	Oswitch	of	switch	NN	I-NP	Oof	MHC	of	IN	B-PP	OMHC	class	MHC	NN	B-NP	B-proteinclass	II	class	NN	I-NP	I-proteinII	expression	II	CD	I-NP	I-proteinexpression	.	expression	NN	I-NP	O.	Unexpectedly	.	.	O	OUnexpectedly	","	Unexpectedly	RB	B-ADVP	O","	these	","	","	O	Othese	transcripts	these	DT	B-NP	Otranscripts	initiate	transcript	NNS	I-NP	Oinitiate	from	initiate	VBP	B-VP	Ofrom	promoter	from	IN	B-PP	Opromoter	III	promoter	NN	B-NP	B-DNAIII	of	III	CD	I-NP	I-DNAof	the	of	IN	B-PP	Othe	CIITA	the	DT	B-NP	OCIITA	gene	CIITA	NN	I-NP	B-DNAgene	","	gene	NN	I-NP	I-DNA","	a	","	","	O	Oa	promoter	a	DT	B-NP	Opromoter	that	promoter	NN	I-NP	B-DNAthat	is	that	WDT	B-NP	Ois	mainly	be	VBZ	B-VP	Omainly	used	mainly	RB	I-VP	Oused	constitutively	use	VBN	I-VP	Oconstitutively	in	constitutively	RB	B-ADVP	Oin	B	in	IN	B-PP	OB	lymphocytes	B	NN	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	This	.	.	O	OThis	expression	This	DT	B-NP	Oexpression	was	expression	NN	I-NP	Owas	further	be	VBD	B-VP	Ofurther	shown	further	RB	I-VP	Oshown	to	show	VBN	I-VP	Oto	occur	to	TO	I-VP	Ooccur	through	occur	VB	I-VP	Othrough	factor	through	IN	B-PP	Ofactor	(	factor	NN	B-NP	O(	s	(	(	O	Os	)	s	NNS	B-NP	O)	acting	)	)	O	Oacting	on	act	VBG	B-VP	Oon	the	on	IN	B-PP	Othe	enhancer	the	DT	B-NP	Oenhancer	located	enhancer	NN	I-NP	B-DNAlocated	upstream	located	JJ	B-ADJP	Oupstream	of	upstream	RB	B-ADVP	Oof	CIITA	of	IN	B-PP	OCIITA	promoter	CIITA	NN	B-NP	B-DNApromoter	III	promoter	NN	I-NP	I-DNAIII	","	III	CD	I-NP	O","	which	","	","	O	Owhich	was	which	WDT	B-NP	Owas	previously	be	VBD	B-VP	Opreviously	described	previously	RB	I-VP	Odescribed	in	describe	VBN	I-VP	Oin	epithelioid	in	IN	B-PP	Oepithelioid	cells	epithelioid	JJ	B-NP	B-cell_typecells	as	cell	NNS	I-NP	I-cell_typeas	an	as	IN	B-PP	Oan	IFN-gamma-response	an	DT	B-NP	OIFN-gamma-response	sequence	IFN-gamma-response	JJ	I-NP	B-DNAsequence	.	sequence	NN	I-NP	I-DNA.	The	.	.	O	OThe	hypothesis	The	DT	B-NP	Ohypothesis	of	hypothesis	NN	I-NP	Oof	a	of	IN	B-PP	Oa	general	a	DT	B-NP	Ogeneral	abnormality	general	JJ	I-NP	Oabnormality	of	abnormality	NN	I-NP	Oof	the	of	IN	B-PP	Othe	IFN-gamma	the	DT	B-NP	OIFN-gamma	transduction	IFN-gamma	NN	I-NP	B-proteintransduction	pathway	transduction	NN	I-NP	Opathway	was	pathway	NN	I-NP	Owas	dismissed	be	VBD	B-VP	Odismissed	.	dismiss	VBN	I-VP	O.	Constitutive	.	.	O	OConstitutive	transcription	Constitutive	JJ	B-NP	Otranscription	of	transcription	NN	I-NP	Oof	CIITA	of	IN	B-PP	OCIITA	from	CIITA	NN	B-NP	B-proteinfrom	promoter	from	IN	B-PP	Opromoter	III	promoter	NN	B-NP	B-DNAIII	having	III	CD	I-NP	I-DNAhaving	been	have	VBG	B-VP	Obeen	observed	be	VBN	I-VP	Oobserved	in	observe	VBN	I-VP	Oin	unrelated	in	IN	B-PP	Ounrelated	melanoma	unrelated	JJ	B-NP	B-cell_linemelanoma	cell	melanoma	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	","	line	NNS	I-NP	I-cell_line","	we	","	","	O	Owe	propose	we	PRP	B-NP	Opropose	the	propose	VBP	B-VP	Othe	hypothesis	the	DT	B-NP	Ohypothesis	that	hypothesis	NN	I-NP	Othat	this	that	IN	B-SBAR	Othis	phenomenon	this	DT	B-NP	Ophenomenon	might	phenomenon	NN	I-NP	Omight	not	might	MD	B-VP	Onot	be	not	RB	I-VP	Obe	a	be	VB	I-VP	Oa	random	a	DT	B-NP	Orandom	event	random	JJ	I-NP	Oevent	","	event	NN	I-NP	O","	but	","	","	O	Obut	could	but	CC	O	Ocould	be	could	MD	B-VP	Obe	linked	be	VB	I-VP	Olinked	to	link	VBN	I-VP	Oto	the	to	TO	B-PP	Othe	neoplasic	the	DT	B-NP	Oneoplasic	state	neoplasic	JJ	I-NP	Ostate	of	state	NN	I-NP	Oof	the	of	IN	B-PP	Othe	melanoma	the	DT	B-NP	Omelanoma	cells	melanoma	NN	I-NP	B-cell_typecells	Caspase	cell	NNS	I-NP	I-cell_typeCaspase	#NAME?	Caspase	NN	B-NP	B-protein#NAME?	calcineurin	#NAME?	JJ	I-NP	Ocalcineurin	activation	calcineurin	NN	I-NP	B-proteinactivation	contributes	activation	NN	I-NP	Ocontributes	to	contribute	VBZ	B-VP	Oto	IL-2	to	TO	B-PP	OIL-2	release	IL-2	NN	B-NP	B-proteinrelease	during	release	NN	I-NP	Oduring	T	during	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	.	activation	NN	I-NP	O.	Calcineurin	.	.	O	OCalcineurin	","	Calcineurin	NN	B-NP	B-protein","	a	","	","	O	Oa	Ca	a	DT	B-NP	OCa	(	Ca	NN	I-NP	O(	2+	(	(	O	O2+	)	2+	JJ	B-ADJP	O)	/calmodulin-dependent	)	)	O	O/calmodulin-dependent	Ser/Thr	/calmodulin-dependent	JJ	B-NP	B-proteinSer/Thr	phosphatase	Ser/Thr	NN	I-NP	I-proteinphosphatase	(	phosphatase	NN	I-NP	I-protein(	protein	(	(	O	Oprotein	phosphatase	protein	NN	B-NP	B-proteinphosphatase	2B	phosphatase	NN	I-NP	I-protein2B	)	2B	NN	I-NP	I-protein)	","	)	)	O	O","	plays	","	","	O	Oplays	a	play	VBZ	B-VP	Oa	critical	a	DT	B-NP	Ocritical	role	critical	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	IL-2	in	IN	B-PP	OIL-2	production	IL-2	NN	B-NP	B-proteinproduction	during	production	NN	I-NP	Oduring	T	during	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	.	activation	NN	I-NP	O.	It	.	.	O	OIt	has	It	PRP	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	previously	be	VBN	I-VP	Opreviously	reported	previously	RB	I-VP	Oreported	that	report	VBN	I-VP	Othat	IL-2	that	IN	B-SBAR	OIL-2	release	IL-2	NN	B-NP	B-proteinrelease	in	release	NN	I-NP	Oin	activated	in	IN	B-PP	Oactivated	Jurkat	activate	VBN	B-NP	OJurkat	T	Jurkat	NN	I-NP	OT	requires	T	NN	I-NP	Orequires	caspase-like	require	VBZ	B-VP	Ocaspase-like	activity	caspase-like	JJ	B-NP	Oactivity	(	activity	NN	I-NP	O(	Posmantur	(	(	O	OPosmantur	et	Posmantur	NNP	B-NP	Oet	al.	et	FW	I-NP	Oal.	(	al.	FW	I-NP	O(	1998	(	(	O	O1998	)	1998	CD	B-NP	O)	Exp.	)	)	O	OExp.	Cell.	Exp.	NNP	B-NP	OCell.	Res.	Cell.	NNP	I-NP	ORes.	244	Res.	NNP	I-NP	O244	","	244	CD	I-NP	O","	302-309	","	","	I-NP	O302-309	)	302-309	CD	I-NP	O)	.	)	)	O	O.	We	.	.	O	OWe	report	We	PRP	B-NP	Oreport	here	report	VBP	B-VP	Ohere	that	here	RB	B-ADVP	Othat	the	that	IN	B-SBAR	Othe	60-kDa	the	DT	B-NP	O60-kDa	catalytic	60-kDa	JJ	I-NP	B-proteincatalytic	subunit	catalytic	JJ	I-NP	I-proteinsubunit	of	subunit	NN	I-NP	I-proteinof	calcineurin	of	IN	B-PP	Ocalcineurin	A	calcineurin	NN	B-NP	B-proteinA	(	A	NN	I-NP	O(	Cn	(	(	O	OCn	A	Cn	NN	B-NP	B-proteinA	)	A	NN	I-NP	I-protein)	was	)	)	O	Owas	partially	be	VBD	B-VP	Opartially	cleaved	partially	RB	I-VP	Ocleaved	to	cleave	VBN	I-VP	Oto	a	to	TO	B-PP	Oa	45-kDa	a	DT	B-NP	O45-kDa	form	45-kDa	JJ	I-NP	B-proteinform	in	form	NN	I-NP	I-proteinin	phytohemagglutinin	in	IN	B-PP	Ophytohemagglutinin	A	phytohemagglutinin	NN	B-NP	B-proteinA	(	A	NN	I-NP	O(	PHA	(	(	O	OPHA	)	PHA	NN	B-NP	B-protein)	or	)	)	O	Oor	phorbol	or	CC	O	Ophorbol	ester	phorbol	NN	B-NP	Oester	+	ester	NN	I-NP	O+	ionomycin	+	SYM	O	Oionomycin	(	ionomycin	NN	B-NP	O(	P	(	(	O	OP	+	P	NN	B-NP	O+	I	+	SYM	I-NP	OI	)	I	NN	I-NP	O)	#NAME?	)	)	I-NP	O#NAME?	Jurkat	#NAME?	JJ	I-NP	OJurkat	cells	Jurkat	NN	I-NP	Ocells	.	cell	NNS	I-NP	O.	In	.	.	O	OIn	parallel	In	IN	B-PP	Oparallel	","	parallel	JJ	B-NP	O","	proteolytic	","	","	I-NP	Oproteolytic	activation	proteolytic	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	upstream	of	IN	B-PP	Oupstream	caspases	upstream	JJ	B-NP	B-proteincaspases	(	caspas	NNS	I-NP	I-protein(	caspase-8	(	(	O	Ocaspase-8	and	caspase-8	NN	B-NP	B-proteinand	-9	and	CC	O	I-protein-9	)	-9	CD	B-NP	I-protein)	as	)	)	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	effector	as	IN	I-CONJP	Oeffector	caspase-3	effector	NN	B-NP	B-proteincaspase-3	was	caspase-3	NN	I-NP	I-proteinwas	also	be	VBD	B-VP	Oalso	observed	also	RB	I-VP	Oobserved	.	observe	VBN	I-VP	O.	Cn	.	.	O	OCn	A	Cn	NN	B-NP	OA	cleavage	A	NN	I-NP	Ocleavage	was	cleavage	NN	I-NP	Owas	caspase	be	VBD	B-VP	Ocaspase	mediated	caspase	NN	I-VP	B-proteinmediated	","	mediate	VBN	I-VP	O","	since	","	","	O	Osince	it	since	IN	B-SBAR	Oit	was	it	PRP	B-NP	Owas	inhibitable	be	VBD	B-VP	Oinhibitable	by	inhibitable	JJ	B-ADJP	Oby	pan-caspase	by	IN	B-PP	Opan-caspase	inhibitor	pan-caspase	NN	B-NP	B-proteininhibitor	Cbz-Asp-CH	inhibitor	NN	I-NP	OCbz-Asp-CH	(	Cbz-Asp-CH	NN	I-NP	O(	2	(	(	O	O2	)	2	CD	B-NP	O)	OC	)	)	O	OOC	(	OC	NN	B-NP	B-protein(	O	(	(	O	I-proteinO	)	O	NN	B-NP	I-protein)	-2	)	)	O	I-protein-2	","	-2	CD	B-NP	I-protein","	6-dichlorobenzene	","	","	O	O6-dichlorobenzene	(	6-dichlorobenzene	NN	B-NP	O(	Z-D-DCB	(	(	O	OZ-D-DCB	)	Z-D-DCB	NN	B-NP	B-protein)	.	)	)	O	O.	Cn	.	.	O	OCn	A	Cn	NN	B-NP	OA	cleavage	A	NN	I-NP	Ocleavage	was	cleavage	NN	I-NP	Owas	also	be	VBD	B-VP	Oalso	observed	also	RB	I-VP	Oobserved	when	observe	VBN	I-VP	Owhen	purified	when	WRB	B-ADVP	Opurified	calcineurin	purify	VBN	B-NP	Ocalcineurin	was	calcineurin	NN	I-NP	B-proteinwas	digested	be	VBD	B-VP	Odigested	in	digest	VBN	I-VP	Oin	vitro	in	FW	B-ADVP	Ovitro	with	vitro	FW	I-ADVP	Owith	caspase-3	with	IN	B-PP	Ocaspase-3	.	caspase-3	NN	B-NP	B-protein.	Truncated	.	.	O	OTruncated	Cn	Truncate	VBN	B-NP	OCn	A	Cn	NN	I-NP	OA	was	A	NN	I-NP	Owas	associated	be	VBD	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	enhanced	with	IN	B-PP	Oenhanced	phosphatase	enhance	VBN	B-NP	Ophosphatase	activity	phosphatase	NN	I-NP	B-proteinactivity	and	activity	NN	I-NP	Oand	reduced	and	CC	O	Oreduced	calmodulin	reduce	VBD	B-VP	Ocalmodulin	sensitivity	calmodulin	NN	B-NP	B-proteinsensitivity	.	sensitivity	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	in	","	","	O	Oin	PHA	in	IN	B-PP	OPHA	or	PHA	NN	B-NP	B-proteinor	P	or	CC	O	OP	+	P	NN	B-NP	B-cell_line+	I-activated	+	CC	I-NP	I-cell_lineI-activated	Jurkat	I-activated	JJ	I-NP	I-cell_lineJurkat	cells	Jurkat	NN	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	dephosphorylation	","	","	O	Odephosphorylation	of	dephosphorylation	NN	B-NP	Oof	calcineurin	of	IN	B-PP	Ocalcineurin	substrate	calcineurin	NN	B-NP	B-proteinsubstrate	NFATc	substrate	NN	I-NP	I-proteinNFATc	(	NFATc	NN	I-NP	I-protein(	a	(	(	O	Oa	transcription	a	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	known	factor	NN	I-NP	I-proteinknown	to	know	VBN	B-VP	Oto	be	to	TO	I-VP	Obe	involved	be	VB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	transactivation	in	IN	B-PP	Otransactivation	of	transactivation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	gene	IL-2	NN	I-NP	B-DNAgene	)	gene	NN	I-NP	I-DNA)	","	)	)	O	O","	was	","	","	O	Owas	also	be	VBD	B-VP	Oalso	suppressed	also	RB	I-VP	Osuppressed	by	suppress	VBN	I-VP	Oby	Z-D-DCB	by	IN	B-PP	OZ-D-DCB	.	Z-D-DCB	NN	B-NP	B-protein.	Taken	.	.	O	OTaken	together	Take	VBN	B-VP	Otogether	","	together	RB	B-ADVP	O","	our	","	","	O	Oour	results	our	PRP$	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	caspase-mediated	that	IN	B-SBAR	Ocaspase-mediated	cleavage	caspase-mediated	JJ	B-NP	Ocleavage	of	cleavage	NN	I-NP	Oof	Cn	of	IN	B-PP	OCn	A	Cn	NN	B-NP	B-proteinA	contributes	A	NN	I-NP	I-proteincontributes	to	contribute	VBZ	B-VP	Oto	IL-2	to	TO	B-PP	OIL-2	production	IL-2	NN	B-NP	B-proteinproduction	during	production	NN	I-NP	Oduring	T	during	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	.	activation	NN	I-NP	O.	Copyright	.	.	O	OCopyright	2001	Copyright	NN	B-NP	O2001	Academic	2001	CD	I-NP	OAcademic	Press	Academic	NNP	I-NP	OPress	.	Press	NNP	I-NP	O.	Maturation	.	.	O	OMaturation	of	Maturation	NN	B-NP	Oof	human	of	IN	B-PP	Ohuman	dendritic	human	JJ	B-NP	B-cell_typedendritic	cells	dendritic	JJ	I-NP	I-cell_typecells	as	cell	NNS	I-NP	I-cell_typeas	sulfasalazine	as	IN	B-PP	Osulfasalazine	target	sulfasalazine	NN	B-NP	Otarget	.	target	NN	I-NP	O.	AIM	.	.	O	OAIM	:	AIM	NN	B-NP	O:	Sulfasalazine	:	:	O	OSulfasalazine	","	Sulfasalazine	NN	B-NP	O","	a	","	","	O	Oa	nonsteroidal	a	DT	B-NP	Ononsteroidal	anti-inflammatory	nonsteroidal	JJ	I-NP	Oanti-inflammatory	drug	anti-inflammatory	JJ	I-NP	Odrug	","	drug	NN	I-NP	O","	is	","	","	O	Ois	effective	be	VBZ	B-VP	Oeffective	in	effective	JJ	B-ADJP	Oin	treating	in	IN	B-PP	Otreating	some	treat	VBG	B-VP	Osome	autoimmune	some	DT	B-NP	Oautoimmune	diseases	autoimmune	JJ	I-NP	Odiseases	","	disease	NNS	I-NP	O","	but	","	","	O	Obut	its	but	CC	O	Oits	mechanism	its	PRP$	B-NP	Omechanism	of	mechanism	NN	I-NP	Oof	action	of	IN	B-PP	Oaction	is	action	NN	B-NP	Ois	unclear	be	VBZ	B-VP	Ounclear	.	unclear	JJ	B-ADJP	O.	To	.	.	O	OTo	determine	To	TO	B-VP	Odetermine	whether	determine	VB	I-VP	Owhether	dendritic	whether	IN	B-SBAR	Odendritic	cells	dendritic	JJ	B-NP	B-cell_typecells	could	cell	NNS	I-NP	I-cell_typecould	be	could	MD	B-VP	Obe	a	be	VB	I-VP	Oa	possible	a	DT	B-NP	Opossible	target	possible	JJ	I-NP	Otarget	of	target	NN	I-NP	Oof	the	of	IN	B-PP	Othe	drug	the	DT	B-NP	Odrug	","	drug	NN	I-NP	O","	we	","	","	O	Owe	studied	we	PRP	B-NP	Ostudied	the	study	VBD	B-VP	Othe	effects	the	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	sulfasalazine	of	IN	B-PP	Osulfasalazine	and	sulfasalazine	NN	B-NP	Oand	its	and	CC	O	Oits	metabolites	its	PRP$	B-NP	Ometabolites	","	metabolite	NNS	I-NP	O","	aminosalicylate	","	","	I-NP	Oaminosalicylate	and	aminosalicylate	NN	I-NP	Oand	sulfapyridine	and	CC	I-NP	Osulfapyridine	","	sulfapyridine	NN	I-NP	O","	on	","	","	O	Oon	in	on	IN	B-PP	Oin	vitro	in	FW	B-NP	Ovitro	maturation	vitro	FW	I-NP	Omaturation	(	maturation	NN	I-NP	O(	terminal	(	(	O	Oterminal	differentiation	terminal	JJ	B-NP	Odifferentiation	)	differentiation	NN	I-NP	O)	of	)	)	O	Oof	human	of	IN	B-PP	Ohuman	myeloid	human	JJ	B-NP	B-cell_typemyeloid	dendritic	myeloid	JJ	I-NP	I-cell_typedendritic	cells	dendritic	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	METHODS	.	.	O	OMETHODS	:	METHODS	NNS	B-NP	O:	We	:	:	O	OWe	prepared	We	PRP	B-NP	Oprepared	immature	prepare	VBD	B-VP	Oimmature	dendritic	immature	JJ	B-NP	B-cell_typedendritic	cells	dendritic	JJ	I-NP	I-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	incubating	by	IN	B-PP	Oincubating	CD14-positive	incubate	VBG	B-VP	OCD14-positive	cells	CD14-positive	JJ	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	the	in	IN	B-PP	Othe	presence	the	DT	I-PP	Opresence	of	presence	NN	I-PP	Oof	granulocyte-	of	IN	I-PP	Ogranulocyte-	macrophage	granulocyte-	NN	B-NP	B-proteinmacrophage	colony-stimulating	macrophage	NN	B-NP	I-proteincolony-stimulating	factor	colony-stimulating	JJ	I-NP	I-proteinfactor	and	factor	NN	I-NP	I-proteinand	interleukin	and	CC	O	Ointerleukin	(	interleukin	NN	B-NP	B-protein(	IL	(	(	O	I-proteinIL	)	IL	NN	B-NP	I-protein)	-4	)	)	O	I-protein-4	.	-4	CD	B-NP	I-protein.	The	.	.	O	OThe	cells	The	DT	B-NP	Ocells	were	cell	NNS	I-NP	Owere	matured	be	VBD	B-VP	Omatured	by	mature	VBN	I-VP	Oby	addition	by	IN	B-PP	Oaddition	of	addition	NN	B-NP	Oof	tumor	of	IN	B-PP	Otumor	necrosis	tumor	NN	B-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	TNF	(	(	O	OTNF	)	TNF	NN	B-NP	B-protein)	#NAME?	)	)	O	O#NAME?	","	#NAME?	NN	B-NP	O","	IL-1	","	","	O	OIL-1	beta	IL-1	NN	B-NP	B-proteinbeta	","	beta	NN	I-NP	I-protein","	and	","	","	O	Oand	prostaglandin	and	CC	O	Oprostaglandin	E2	prostaglandin	NN	B-NP	B-proteinE2	in	E2	NN	I-NP	I-proteinin	the	in	IN	B-PP	Othe	presence	the	DT	I-PP	Opresence	of	presence	NN	I-PP	Oof	sulfasalazine	of	IN	I-PP	Osulfasalazine	or	sulfasalazine	NN	B-NP	Oor	its	or	CC	O	Oits	metabolites	its	PRP$	B-NP	Ometabolites	--	metabolite	NNS	I-NP	O--	aminosalicylate	--	:	O	Oaminosalicylate	and	aminosalicylate	NN	B-NP	Oand	sulfapyridine	and	CC	I-NP	Osulfapyridine	","	sulfapyridine	NN	I-NP	O","	or	","	","	O	Oor	their	or	CC	O	Otheir	combinations	their	PRP$	B-NP	Ocombinations	.	combination	NNS	I-NP	O.	We	.	.	O	OWe	quantified	We	PRP	B-NP	Oquantified	the	quantify	VBD	B-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	drugs	of	IN	B-PP	Odrugs	on	drug	NNS	B-NP	Oon	the	on	IN	B-PP	Othe	dendritic	the	DT	B-NP	Odendritic	cell	dendritic	JJ	I-NP	Ocell	characteristics	cell	NN	I-NP	Ocharacteristics	","	characteristic	NNS	I-NP	O","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	stimulation	as	IN	I-PP	Ostimulation	of	stimulation	NN	B-NP	Oof	autologous	of	IN	B-PP	Oautologous	and	autologous	JJ	B-NP	Oand	allogeneic	and	CC	I-NP	Oallogeneic	pan-T	allogeneic	JJ	I-NP	Opan-T	cell	pan-T	NN	I-NP	Ocell	proliferation	cell	NN	I-NP	Oproliferation	","	proliferation	NN	I-NP	O","	surface	","	","	O	Osurface	marker	surface	NN	B-NP	Omarker	phenotype	marker	NN	I-NP	Ophenotype	","	phenotype	NN	I-NP	O","	IL-12	","	","	O	OIL-12	p40	IL-12	NN	B-NP	B-proteinp40	subunit	p40	NN	I-NP	Osubunit	secretion	subunit	NN	I-NP	Osecretion	","	secretion	NN	I-NP	O","	and	","	","	O	Oand	activation	and	CC	O	Oactivation	of	activation	NN	B-NP	Oof	nuclear	of	IN	B-PP	Onuclear	transcription	nuclear	JJ	B-NP	B-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	NF	(	(	O	I-proteinNF	)	NF	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	B	#NAME?	NN	B-NP	I-proteinB	.	B	NN	I-NP	I-protein.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	Dendritic	:	:	O	ODendritic	cells	Dendritic	JJ	B-NP	B-cell_typecells	treated	cell	NNS	I-NP	I-cell_typetreated	with	treat	VBN	B-VP	Owith	sulfasalazine	with	IN	B-PP	Osulfasalazine	(	sulfasalazine	NN	B-NP	O(	1.25	(	(	O	O1.25	micromol/L	1.25	CD	B-NP	Omicromol/L	or	micromol/L	NN	I-NP	Oor	2.5	or	CC	O	O2.5	micromol/L	2.5	CD	B-NP	Omicromol/L	)	micromol/L	NN	I-NP	O)	could	)	)	O	Ocould	not	could	MD	B-VP	Onot	stimulate	not	RB	I-VP	Ostimulate	T	stimulate	VB	I-VP	OT	cells	T	NN	B-NP	B-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	p	(	(	O	Op	<	p	NN	B-NP	O<	0.028	<	JJR	B-NP	O0.028	","	0.028	CD	I-NP	O","	two-sided	","	","	O	Otwo-sided	paired	two-sided	JJ	B-NP	Opaired	t-test	paired	JJ	I-NP	Ot-test	)	t-test	NN	I-NP	O)	.	)	)	O	O.	In	.	.	O	OIn	distinction	In	IN	B-PP	Odistinction	to	distinction	NN	B-NP	Oto	drug-free	to	TO	B-PP	Odrug-free	maturing	drug-free	JJ	B-NP	B-cell_typematuring	dendritic	mature	VBG	I-NP	I-cell_typedendritic	cells	dendritic	JJ	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	2.5	","	","	O	O2.5	micromol/L	2.5	CD	B-NP	Omicromol/L	sulfasalazine	micromol/L	NN	I-NP	Osulfasalazine	upregulated	sulfasalazine	NN	I-NP	Oupregulated	the	upregulate	VBD	B-VP	Othe	levels	the	DT	B-NP	Olevels	of	level	NNS	I-NP	Oof	CD14	of	IN	B-PP	OCD14	and	CD14	NN	B-NP	B-proteinand	CD68	and	CC	I-NP	OCD68	and	CD68	NN	I-NP	B-proteinand	downregulated	and	CC	O	Odownregulated	the	downregulate	VBD	B-VP	Othe	levels	the	DT	B-NP	Olevels	of	level	NNS	I-NP	Oof	CD40	of	IN	B-PP	OCD40	","	CD40	NN	B-NP	B-protein","	CD80	","	","	O	OCD80	","	CD80	NN	B-NP	B-protein","	and	","	","	O	Oand	CD83	and	CC	O	OCD83	(	CD83	NN	B-NP	B-protein(	for	(	(	O	Ofor	all	for	IN	B-PP	Oall	CD	all	DT	B-NP	OCD	markers	CD	NNP	I-NP	B-proteinmarkers	","	marker	NNS	I-NP	I-protein","	p	","	","	O	Op	<	p	NN	B-NP	O<	0.03	<	SYM	B-VP	O0.03	for	0.03	CD	B-NP	Ofor	difference	for	IN	B-PP	Odifference	between	difference	NN	B-NP	Obetween	measurements	between	IN	B-PP	Omeasurements	in	measurement	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	and	absence	NN	I-NP	Oand	the	and	CC	O	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	sulfasalazine	of	IN	B-PP	Osulfasalazine	)	sulfasalazine	NN	B-NP	O)	.	)	)	O	O.	From	.	.	O	OFrom	concentration-dependent	From	IN	B-PP	Oconcentration-dependent	changes	concentration-dependent	JJ	B-NP	Ochanges	in	change	NNS	I-NP	Oin	CD83	in	IN	B-PP	OCD83	expression	CD83	NN	B-NP	B-proteinexpression	","	expression	NN	I-NP	O","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	an	find	VBD	B-VP	Oan	apparent	an	DT	B-NP	Oapparent	ID50	apparent	JJ	I-NP	OID50	>	ID50	NN	I-NP	B-protein>	>	>	SYM	O	O>	1.5	>	SYM	O	O1.5	micromol/L	1.5	CD	B-NP	Omicromol/L	sulfasalazine	micromol/L	NN	I-NP	Osulfasalazine	.	sulfasalazine	NN	I-NP	O.	The	.	.	O	OThe	apparent	The	DT	B-NP	Oapparent	ID50	apparent	JJ	I-NP	OID50	value	ID50	NN	I-NP	Ovalue	for	value	NN	I-NP	Ofor	aminosalicylate-inhibited	for	IN	B-PP	Oaminosalicylate-inhibited	maturation	aminosalicylate-inhibited	JJ	B-NP	Omaturation	was	maturation	NN	I-NP	Owas	4	be	VBD	B-VP	O4	micromol/L	4	CD	B-NP	Omicromol/L	.	micromol/L	NN	I-NP	O.	Sulfapyridine	.	.	O	OSulfapyridine	had	Sulfapyridine	NN	B-NP	Ohad	no	have	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	.	effect	NN	I-NP	O.	At	.	.	O	OAt	1.25	At	IN	B-PP	O1.25	micromol/L	1.25	CD	B-NP	Omicromol/L	","	micromol/L	NN	I-NP	O","	sulfasalazine	","	","	O	Osulfasalazine	largely	sulfasalazine	NN	B-NP	Olargely	inhibited	largely	RB	B-VP	Oinhibited	NF-kB	inhibit	VBD	I-VP	ONF-kB	activation	NF-kB	NN	B-NP	B-proteinactivation	in	activation	NN	I-NP	Oin	dendritic	in	IN	B-PP	Odendritic	cells	dendritic	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	CONCLUSION	.	.	O	OCONCLUSION	:	CONCLUSION	NN	B-NP	O:	Maturing	:	:	O	OMaturing	human	Mature	VBG	B-VP	Ohuman	dendritic	human	JJ	B-NP	B-cell_typedendritic	cells	dendritic	JJ	I-NP	I-cell_typecells	are	cell	NNS	I-NP	I-cell_typeare	hundred-fold	be	VBP	B-VP	Ohundred-fold	more	hundred-fold	RB	B-ADJP	Omore	sensitive	more	RBR	I-ADJP	Osensitive	to	sensitive	JJ	I-ADJP	Oto	sulfasalazine	to	TO	B-PP	Osulfasalazine	than	sulfasalazine	NN	B-NP	Othan	T	than	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	NK	and	CC	O	ONK	cells	NK	NN	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	the	and	CC	O	Othe	most	the	DT	B-NP	Omost	sensitive	most	RBS	I-NP	Osensitive	human	sensitive	JJ	I-NP	Ohuman	cells	human	JJ	I-NP	Ocells	described	cell	NNS	I-NP	Odescribed	so	describe	VBN	B-VP	Oso	far	so	RB	B-ADVP	Ofar	.	far	RB	I-ADVP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	dendritic	","	","	O	Odendritic	cell	dendritic	JJ	B-NP	Ocell	maturation	cell	NN	I-NP	Omaturation	is	maturation	NN	I-NP	Ois	an	be	VBZ	B-VP	Oan	important	an	DT	B-NP	Oimportant	target	important	JJ	I-NP	Otarget	of	target	NN	I-NP	Oof	sulfasalazine	of	IN	B-PP	Osulfasalazine	.	sulfasalazine	NN	B-NP	O.	Because	.	.	O	OBecause	of	Because	IN	B-PP	Oof	the	of	IN	I-PP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	dendritic	of	IN	B-PP	Odendritic	cells	dendritic	JJ	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	(	in	IN	B-PP	O(	auto	(	(	O	Oauto	)	auto	NN	B-NP	O)	immunity	)	)	O	Oimmunity	","	immunity	NN	B-NP	O","	inhibition	","	","	O	Oinhibition	of	inhibition	NN	B-NP	Oof	their	of	IN	B-PP	Otheir	maturation	their	PRP$	B-NP	Omaturation	might	maturation	NN	I-NP	Omight	provide	might	MD	B-VP	Oprovide	a	provide	VB	I-VP	Oa	target	a	DT	B-NP	Otarget	for	target	NN	I-NP	Ofor	further	for	IN	B-PP	Ofurther	optimization	further	JJ	B-NP	Ooptimization	of	optimization	NN	I-NP	Oof	sulfasalazine	of	IN	B-PP	Osulfasalazine	therapy	sulfasalazine	NN	B-NP	Otherapy	.	therapy	NN	I-NP	O.	Defective	.	.	O	ODefective	function	Defective	JJ	B-NP	Ofunction	of	function	NN	I-NP	Oof	the	of	IN	B-PP	Othe	proteasome	the	DT	B-NP	Oproteasome	in	proteasome	NN	I-NP	B-proteinin	autoimmunity	in	IN	B-PP	Oautoimmunity	:	autoimmunity	NN	B-NP	O:	involvement	:	:	O	Oinvolvement	of	involvement	NN	B-NP	Oof	impaired	of	IN	B-PP	Oimpaired	NF-kappaB	impaired	JJ	B-NP	ONF-kappaB	activation	NF-kappaB	NN	I-NP	B-proteinactivation	.	activation	NN	I-NP	O.	Type	.	.	O	OType	1	Type	NN	B-NP	O1	diabetes	1	CD	I-NP	Odiabetes	(	diabetes	NN	I-NP	O(	also	(	(	O	Oalso	known	also	RB	B-VP	Oknown	as	know	VBN	I-VP	Oas	insulin-dependent	as	IN	B-PP	Oinsulin-dependent	diabetes	insulin-dependent	JJ	B-NP	Odiabetes	mellitus	diabetes	NN	I-NP	Omellitus	or	mellitus	NN	I-NP	Oor	juvenile-onset	or	CC	O	Ojuvenile-onset	diabetes	juvenile-onset	NN	B-NP	Odiabetes	)	diabetes	NN	I-NP	O)	is	)	)	O	Ois	usually	be	VBZ	B-VP	Ousually	caused	usually	RB	I-VP	Ocaused	by	cause	VBN	I-VP	Oby	T	by	IN	B-PP	OT	cell-mediated	T	NN	B-NP	Ocell-mediated	autoimmunity	cell-mediated	JJ	I-NP	Oautoimmunity	","	autoimmunity	NN	I-NP	O","	with	","	","	O	Owith	a	with	IN	B-PP	Oa	prediabetic	a	DT	B-NP	Oprediabetic	state	prediabetic	JJ	I-NP	Ostate	characterized	state	NN	I-NP	Ocharacterized	by	characterize	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	production	the	DT	B-NP	Oproduction	of	production	NN	I-NP	Oof	autoantibodies	of	IN	B-PP	Oautoantibodies	specific	autoantibody	NNS	B-NP	B-proteinspecific	for	specific	JJ	B-ADJP	Ofor	proteins	for	IN	B-PP	Oproteins	expressed	protein	NNS	B-NP	Oexpressed	by	express	VBN	B-VP	Oby	pancreatic	by	IN	B-PP	Opancreatic	beta	pancreatic	JJ	B-NP	B-cell_typebeta	cells	beta	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	nonobese	The	DT	B-NP	Ononobese	patient	nonobese	JJ	I-NP	Opatient	with	patient	NN	I-NP	Owith	diabetes	with	IN	B-PP	Odiabetes	(	diabetes	NN	B-NP	O(	NOD	(	(	O	ONOD	)	NOD	NN	B-NP	O)	mouse	)	)	O	Omouse	is	mouse	NN	B-NP	Ois	a	be	VBZ	B-VP	Oa	spontaneous	a	DT	B-NP	Ospontaneous	model	spontaneous	JJ	I-NP	Omodel	of	model	NN	I-NP	Oof	type	of	IN	B-PP	Otype	1	type	NN	B-NP	O1	diabetes	1	CD	I-NP	Odiabetes	with	diabetes	NN	I-NP	Owith	a	with	IN	B-PP	Oa	strong	a	DT	B-NP	Ostrong	genetic	strong	JJ	I-NP	Ogenetic	component	genetic	JJ	I-NP	Ocomponent	that	component	NN	I-NP	Othat	maps	that	WDT	B-NP	Omaps	to	map	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	major	the	DT	B-NP	Omajor	histocompatibility	major	JJ	I-NP	B-DNAhistocompatibility	complex	histocompatibility	NN	I-NP	I-DNAcomplex	(	complex	NN	I-NP	I-DNA(	MHC	(	(	O	I-DNAMHC	)	MHC	NN	B-NP	I-DNA)	region	)	)	O	I-DNAregion	of	region	NN	B-NP	I-DNAof	the	of	IN	B-PP	Othe	genome	the	DT	B-NP	Ogenome	.	genome	NN	I-NP	O.	A	.	.	O	OA	specific	A	DT	B-NP	Ospecific	proteasome	specific	JJ	I-NP	Oproteasome	defect	proteasome	NN	I-NP	B-proteindefect	has	defect	NN	I-NP	Ohas	been	have	VBZ	B-VP	Obeen	identified	be	VBN	I-VP	Oidentified	in	identify	VBN	I-VP	Oin	NOD	in	IN	B-PP	ONOD	mouse	NOD	NN	B-NP	Omouse	in	mouse	NN	I-NP	Oin	select	in	IN	B-PP	Oselect	lymphocytic	select	JJ	B-NP	Olymphocytic	and	lymphocytic	JJ	I-NP	Oand	monocytic	and	CC	I-NP	Omonocytic	lineages	monocytic	JJ	I-NP	B-cell_typelineages	that	lineage	NNS	I-NP	I-cell_typethat	results	that	WDT	B-NP	Oresults	from	result	VBZ	B-VP	Ofrom	down-regulation	from	IN	B-PP	Odown-regulation	of	down-regulation	NN	B-NP	Oof	expression	of	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	proteasome	the	DT	B-NP	Oproteasome	subunit	proteasome	NN	I-NP	B-proteinsubunit	LMP2	subunit	NN	I-NP	I-proteinLMP2	","	LMP2	NN	I-NP	B-protein","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	encoded	be	VBZ	B-VP	Oencoded	by	encode	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	gene	a	DT	B-NP	Ogene	in	gene	NN	I-NP	Oin	the	in	IN	B-PP	Othe	MHC	the	DT	B-NP	OMHC	genomic	MHC	NN	I-NP	B-DNAgenomic	region	genomic	JJ	I-NP	I-DNAregion	.	region	NN	I-NP	I-DNA.	This	.	.	O	OThis	defect	This	DT	B-NP	Odefect	prevents	defect	NN	I-NP	Oprevents	the	prevent	VBZ	B-VP	Othe	proteolytic	the	DT	B-NP	Oproteolytic	processing	proteolytic	JJ	I-NP	Oprocessing	required	processing	NN	I-NP	Orequired	for	require	VBN	B-VP	Ofor	the	for	IN	B-PP	Othe	production	the	DT	B-NP	Oproduction	and	production	NN	I-NP	Oand	activation	and	CC	I-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	nuclear	factor	NN	I-NP	I-proteinnuclear	factor-kappaB	nuclear	JJ	I-NP	B-proteinfactor-kappaB	(	factor-kappaB	NN	I-NP	I-protein(	NF-kappaB	(	(	O	ONF-kappaB	)	NF-kappaB	NN	B-NP	B-protein)	","	)	)	O	O","	which	","	","	O	Owhich	plays	which	WDT	B-NP	Oplays	important	play	VBZ	B-VP	Oimportant	roles	important	JJ	B-NP	Oroles	in	role	NNS	I-NP	Oin	immune	in	IN	B-PP	Oimmune	and	immune	JJ	B-NP	Oand	inflammatory	and	CC	I-NP	Oinflammatory	responses	inflammatory	JJ	I-NP	Oresponses	","	response	NNS	I-NP	O","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	increases	as	IN	I-CONJP	Oincreases	the	increase	VBZ	B-VP	Othe	susceptibility	the	DT	B-NP	Osusceptibility	of	susceptibility	NN	I-NP	Oof	the	of	IN	B-PP	Othe	affected	the	DT	B-NP	Oaffected	cells	affect	VBN	I-NP	B-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	apoptosis	to	TO	B-PP	Oapoptosis	induced	apoptosis	NN	B-NP	Oinduced	by	induce	VBN	B-VP	Oby	tumor	by	IN	B-PP	Otumor	necrosis	tumor	NN	B-NP	B-proteinnecrosis	factor-alpha	necrosis	NN	I-NP	I-proteinfactor-alpha	(	factor-alpha	NN	I-NP	I-protein(	TNF-alpha	(	(	O	OTNF-alpha	)	TNF-alpha	NN	B-NP	B-protein)	.	)	)	O	O.	The	.	.	O	OThe	novel	The	DT	B-NP	Onovel	role	novel	JJ	I-NP	Orole	of	role	NN	I-NP	Oof	the	of	IN	B-PP	Othe	proteasome	the	DT	B-NP	Oproteasome	in	proteasome	NN	I-NP	B-proteinin	dysfunction	in	IN	B-PP	Odysfunction	in	dysfunction	NN	B-NP	Oin	autoimmunity	in	IN	B-PP	Oautoimmunity	is	autoimmunity	NN	B-NP	Ois	presented	be	VBZ	B-VP	Opresented	and	present	VBN	I-VP	Oand	documented	and	CC	O	Odocumented	to	document	VBN	B-VP	Oto	be	to	TO	I-VP	Obe	both	be	VB	I-VP	Oboth	tissue	both	CC	O	Otissue	and	tissue	NN	B-NP	Oand	developmental	and	CC	O	Odevelopmental	stage	developmental	JJ	B-NP	Ostage	specific	stage	NN	I-NP	Ospecific	.	specific	JJ	B-ADJP	O.	We	.	.	O	OWe	propose	We	PRP	B-NP	Opropose	a	propose	VBP	B-VP	Oa	role	a	DT	B-NP	Orole	of	role	NN	I-NP	Oof	the	of	IN	B-PP	Othe	proteasome	the	DT	B-NP	Oproteasome	as	proteasome	NN	I-NP	B-proteinas	a	as	IN	B-PP	Oa	step	a	DT	B-NP	Ostep	in	step	NN	I-NP	Oin	disease	in	IN	B-PP	Odisease	pathogenesis	disease	NN	B-NP	Opathogenesis	and	pathogenesis	NN	I-NP	Oand	tissue	and	CC	O	Otissue	targeting	tissue	NN	B-NP	Otargeting	.	targeting	NN	I-NP	O.	Down-regulation	.	.	O	ODown-regulation	of	Down-regulation	NN	B-NP	Oof	TDT	of	IN	B-PP	OTDT	transcription	TDT	NN	B-NP	Otranscription	in	transcription	NN	I-NP	Oin	CD4	in	IN	B-PP	OCD4	(	CD4	NN	B-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	CD8	)	)	O	I-cell_typeCD8	(	CD8	NN	B-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	thymocytes	)	)	O	I-cell_typethymocytes	by	thymocyte	NNS	B-NP	I-cell_typeby	Ikaros	by	IN	B-PP	OIkaros	proteins	Ikaros	NN	B-NP	B-proteinproteins	in	protein	NNS	I-NP	I-proteinin	direct	in	IN	B-PP	Odirect	competition	direct	JJ	B-NP	Ocompetition	with	competition	NN	I-NP	Owith	an	with	IN	B-PP	Oan	Ets	an	DT	B-NP	OEts	activator	Ets	NN	I-NP	B-DNAactivator	.	activator	NN	I-NP	I-DNA.	Ikaros	.	.	O	OIkaros	is	Ikaros	NN	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	unique	a	DT	B-NP	Ounique	regulator	unique	JJ	I-NP	Oregulator	of	regulator	NN	I-NP	Oof	lymphopoiesis	of	IN	B-PP	Olymphopoiesis	that	lymphopoiesis	NN	B-NP	Othat	associates	that	WDT	B-NP	Oassociates	with	associate	VBZ	B-VP	Owith	pericentromeric	with	IN	B-PP	Opericentromeric	heterochromatin	pericentromeric	JJ	B-NP	B-proteinheterochromatin	and	heterochromatin	NN	I-NP	I-proteinand	has	and	CC	O	Ohas	been	have	VBZ	B-VP	Obeen	implicated	be	VBN	I-VP	Oimplicated	in	implicate	VBN	I-VP	Oin	heritable	in	IN	B-PP	Oheritable	gene	heritable	JJ	B-NP	Ogene	inactivation	gene	NN	I-NP	Oinactivation	.	inactivation	NN	I-NP	O.	Binding	.	.	O	OBinding	and	Binding	NN	B-NP	Oand	competition	and	CC	I-NP	Ocompetition	experiments	competition	NN	I-NP	Oexperiments	demonstrate	experiment	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	Ikaros	that	IN	B-SBAR	OIkaros	dimers	Ikaros	NN	B-NP	B-proteindimers	compete	dimer	NNS	I-NP	I-proteincompete	with	compete	VBP	B-VP	Owith	an	with	IN	B-PP	Oan	Ets	an	DT	B-NP	OEts	activator	Ets	NN	I-NP	Oactivator	for	activator	NN	I-NP	Ofor	occupancy	for	IN	B-PP	Ooccupancy	of	occupancy	NN	B-NP	Oof	the	of	IN	B-PP	Othe	lymphocyte-specific	the	DT	B-NP	Olymphocyte-specific	TdT	lymphocyte-specific	JJ	I-NP	B-DNATdT	promoter	TdT	NN	I-NP	I-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Mutations	.	.	O	OMutations	that	Mutation	NNS	B-NP	Othat	selectively	that	WDT	B-NP	Oselectively	disrupt	selectively	RB	B-ADVP	Odisrupt	Ikaros	disrupt	VBP	B-VP	OIkaros	binding	Ikaros	NN	B-NP	B-proteinbinding	to	bind	VBG	B-VP	Oto	an	to	TO	B-PP	Oan	integrated	an	DT	B-NP	Ointegrated	TdT	integrate	VBN	I-NP	OTdT	promoter	TdT	NN	I-NP	B-DNApromoter	had	promoter	NN	I-NP	I-DNAhad	no	have	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	on	effect	NN	I-NP	Oon	promoter	on	IN	B-PP	Opromoter	function	promoter	NN	B-NP	Ofunction	in	function	NN	I-NP	Oin	a	in	IN	B-PP	Oa	CD4	a	DT	B-NP	OCD4	(	CD4	NN	I-NP	B-cell_line(	+	(	(	O	I-cell_line+	)	+	SYM	O	I-cell_line)	CD8	)	)	O	I-cell_lineCD8	(	CD8	NN	B-NP	I-cell_line(	+	(	(	O	I-cell_line+	)	+	SYM	O	I-cell_line)	thymocyte	)	)	O	I-cell_linethymocyte	line	thymocyte	NN	B-NP	I-cell_lineline	.	line	NN	I-NP	I-cell_line.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	these	","	","	O	Othese	mutations	these	DT	B-NP	Omutations	abolished	mutation	NNS	I-NP	Oabolished	down-regulation	abolish	VBD	B-VP	Odown-regulation	on	down-regulation	NN	B-NP	Oon	differentiation	on	IN	B-PP	Odifferentiation	","	differentiation	NN	B-NP	O","	providing	","	","	O	Oproviding	evidence	provide	VBG	B-VP	Oevidence	that	evidence	NN	B-NP	Othat	Ikaros	that	IN	B-SBAR	OIkaros	plays	Ikaros	NN	B-NP	B-proteinplays	a	play	VBZ	B-VP	Oa	direct	a	DT	B-NP	Odirect	role	direct	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	repression	in	IN	B-PP	Orepression	.	repression	NN	B-NP	O.	Reduced	.	.	O	OReduced	access	Reduce	VBN	B-NP	Oaccess	to	access	NN	I-NP	Oto	restriction	to	TO	B-PP	Orestriction	enzyme	restriction	NN	B-NP	B-proteinenzyme	cleavage	enzyme	NN	I-NP	I-proteincleavage	suggested	cleavage	NN	I-NP	Osuggested	that	suggest	VBD	B-VP	Othat	chromatin	that	IN	B-SBAR	Ochromatin	alterations	chromatin	NN	B-NP	B-DNAalterations	accompany	alteration	NNS	I-NP	Oaccompany	down-regulation	accompany	NN	I-NP	Odown-regulation	.	down-regulation	NN	I-NP	O.	The	.	.	O	OThe	Ikaros-dependent	The	DT	B-NP	OIkaros-dependent	down-regulation	Ikaros-dependent	JJ	I-NP	Odown-regulation	event	down-regulation	NN	I-NP	Oevent	and	event	NN	I-NP	Oand	the	and	CC	O	Othe	observed	the	DT	B-NP	Oobserved	chromatin	observe	VBN	I-NP	Ochromatin	alterations	chromatin	NN	I-NP	B-DNAalterations	appear	alteration	NNS	I-NP	Oappear	to	appear	VBP	B-VP	Oto	precede	to	TO	I-VP	Oprecede	pericentromeric	precede	VB	I-VP	Opericentromeric	repositioning	pericentromeric	JJ	B-NP	Orepositioning	.	repositioning	NN	I-NP	O.	Current	.	.	O	OCurrent	models	Current	JJ	B-NP	Omodels	propose	model	NNS	I-NP	Opropose	that	propose	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	functions	the	DT	B-NP	Ofunctions	of	function	NNS	I-NP	Oof	Ikaros	of	IN	B-PP	OIkaros	should	Ikaros	NN	B-NP	B-proteinshould	be	should	MD	B-VP	Obe	disrupted	be	VB	I-VP	Odisrupted	by	disrupt	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	small	a	DT	B-NP	Osmall	isoform	small	JJ	I-NP	Oisoform	that	isoform	NN	I-NP	Othat	retains	that	WDT	B-NP	Oretains	the	retain	VBZ	B-VP	Othe	dimerization	the	DT	B-NP	Odimerization	domain	dimerization	NN	I-NP	B-proteindomain	and	domain	NN	I-NP	I-proteinand	lacks	and	CC	O	Olacks	the	lack	VBZ	B-VP	Othe	DNA-binding	the	DT	B-NP	ODNA-binding	domain	DNA-binding	JJ	I-NP	B-proteindomain	.	domain	NN	I-NP	I-protein.	Surprisingly	.	.	O	OSurprisingly	","	Surprisingly	RB	B-ADVP	O","	in	","	","	O	Oin	the	in	IN	B-PP	Othe	CD4	the	DT	B-NP	OCD4	(	CD4	NN	I-NP	B-cell_line(	+	(	(	O	I-cell_line+	)	+	SYM	O	I-cell_line)	CD8	)	)	O	I-cell_lineCD8	(	CD8	NN	B-NP	I-cell_line(	+	(	(	O	I-cell_line+	)	+	SYM	O	I-cell_line)	thymocyte	)	)	O	I-cell_linethymocyte	line	thymocyte	NN	B-NP	I-cell_lineline	","	line	NN	I-NP	I-cell_line","	overexpression	","	","	O	Ooverexpression	of	overexpression	NN	B-NP	Oof	a	of	IN	B-PP	Oa	small	a	DT	B-NP	Osmall	Ikaros	small	JJ	I-NP	OIkaros	isoform	Ikaros	NN	I-NP	B-proteinisoform	had	isoform	NN	I-NP	I-proteinhad	no	have	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	on	effect	NN	I-NP	Oon	differentiation	on	IN	B-PP	Odifferentiation	or	differentiation	NN	B-NP	Oor	on	or	CC	B-PP	Oon	the	on	IN	B-PP	Othe	pericentromeric	the	DT	B-NP	Opericentromeric	targeting	pericentromeric	JJ	I-NP	Otargeting	and	targeting	NN	I-NP	Oand	DNA-binding	and	CC	O	ODNA-binding	properties	DNA-binding	JJ	B-NP	Oproperties	of	property	NNS	I-NP	Oof	Ikaros	of	IN	B-PP	OIkaros	.	Ikaros	NN	B-NP	B-protein.	Rather	.	.	O	ORather	","	Rather	RB	B-ADVP	O","	the	","	","	O	Othe	small	the	DT	B-NP	Osmall	isoform	small	JJ	I-NP	Oisoform	assembled	isoform	NN	I-NP	Oassembled	into	assemble	VBN	B-VP	Ointo	multimeric	into	IN	B-PP	Omultimeric	complexes	multimeric	JJ	B-NP	B-proteincomplexes	with	complex	NNS	I-NP	I-proteinwith	DNA-bound	with	IN	B-PP	ODNA-bound	Ikaros	DNA-bound	JJ	B-NP	B-proteinIkaros	at	Ikaros	NN	I-NP	I-proteinat	the	at	IN	B-PP	Othe	pericentromeric	the	DT	B-NP	Opericentromeric	foci	pericentromeric	JJ	I-NP	B-cell_typefoci	.	focus	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	capacity	The	DT	B-NP	Ocapacity	for	capacity	NN	I-NP	Ofor	in	for	IN	B-PP	Oin	vivo	in	FW	B-NP	Ovivo	multimer	vivo	FW	I-NP	Omultimer	formation	multimer	NN	I-NP	Oformation	suggests	formation	NN	I-NP	Osuggests	that	suggest	VBZ	B-VP	Othat	interactions	that	IN	B-SBAR	Ointeractions	between	interaction	NNS	B-NP	Obetween	Ikaros	between	IN	B-PP	OIkaros	dimers	Ikaros	NN	B-NP	B-proteindimers	bound	dimer	NNS	I-NP	I-proteinbound	to	bind	VBD	B-VP	Oto	the	to	TO	B-PP	Othe	TdT	the	DT	B-NP	OTdT	promoter	TdT	NN	I-NP	B-DNApromoter	and	promoter	NN	I-NP	I-DNAand	those	and	CC	O	Othose	bound	those	DT	B-NP	Obound	to	bind	VBN	B-VP	Oto	pericentromeric	to	TO	B-PP	Opericentromeric	repeat	pericentromeric	JJ	B-NP	B-DNArepeat	sequences	repeat	NN	I-NP	I-DNAsequences	may	sequence	NNS	I-NP	I-DNAmay	contribute	may	MD	B-VP	Ocontribute	to	contribute	VB	I-VP	Oto	the	to	TO	B-PP	Othe	pericentromeric	the	DT	B-NP	Opericentromeric	repositioning	pericentromeric	JJ	I-NP	Orepositioning	of	repositioning	NN	I-NP	Oof	the	of	IN	B-PP	Othe	inactive	the	DT	B-NP	Oinactive	gene	inactive	JJ	I-NP	B-DNAgene	.	gene	NN	I-NP	I-DNA.	Type	.	.	O	OType	I	Type	NN	B-NP	B-proteinI	interferons	I	CD	I-NP	I-proteininterferons	and	interferon	NNS	I-NP	I-proteinand	IL-12	and	CC	O	OIL-12	:	IL-12	NN	B-NP	B-protein:	convergence	:	:	O	Oconvergence	and	convergence	NN	B-NP	Oand	cross-regulation	and	CC	I-NP	Ocross-regulation	among	cross-regulation	NN	I-NP	Oamong	mediators	among	IN	B-PP	Omediators	of	mediator	NNS	B-NP	Oof	cellular	of	IN	B-PP	Ocellular	immunity	cellular	JJ	B-NP	Oimmunity	.	immunity	NN	I-NP	O.	Therapeutic	.	.	O	OTherapeutic	use	Therapeutic	JJ	B-NP	Ouse	of	use	NN	I-NP	Oof	type	of	IN	B-PP	Otype	I	type	NN	B-NP	B-proteinI	IFN	I	CD	I-NP	I-proteinIFN	(	IFN	NN	I-NP	I-protein(	IFN-alpha/beta	(	(	O	OIFN-alpha/beta	)	IFN-alpha/beta	NN	B-NP	B-protein)	has	)	)	O	Ohas	become	have	VBZ	B-VP	Obecome	common	become	VBN	I-VP	Ocommon	.	common	JJ	B-ADJP	O.	Many	.	.	O	OMany	of	Many	JJ	B-NP	Oof	the	of	IN	B-PP	Othe	diverse	the	DT	B-NP	Odiverse	diseases	diverse	JJ	I-NP	Odiseases	targeted	disease	NNS	I-NP	Otargeted	are	target	VBN	B-VP	Oare	marked	be	VBP	B-VP	Omarked	by	mark	VBN	I-VP	Oby	pathogenetic	by	IN	B-PP	Opathogenetic	abnormalities	pathogenetic	JJ	B-NP	Oabnormalities	in	abnormality	NNS	I-NP	Oin	cell-mediated	in	IN	B-PP	Ocell-mediated	immunity	cell-mediated	JJ	B-NP	Oimmunity	(	immunity	NN	I-NP	O(	CMI	(	(	O	OCMI	)	CMI	NN	B-NP	B-protein)	","	)	)	O	O","	these	","	","	O	Othese	cellular	these	DT	B-NP	Ocellular	immune	cellular	JJ	I-NP	Oimmune	responses	immune	JJ	I-NP	Oresponses	either	response	NNS	I-NP	Oeither	causing	either	CC	O	Ocausing	injury	cause	VBG	B-VP	Oinjury	to	injury	NN	B-NP	Oto	the	to	TO	B-PP	Othe	host	the	DT	B-NP	Ohost	","	host	NN	I-NP	O","	lacking	","	","	O	Olacking	sufficient	lack	VBG	B-VP	Osufficient	vigor	sufficient	JJ	B-NP	Ovigor	for	vigor	NN	I-NP	Ofor	virus	for	IN	B-PP	Ovirus	or	virus	NN	B-NP	Oor	tumor	or	CC	O	Otumor	clearance	tumor	NN	B-NP	Oclearance	","	clearance	NN	I-NP	O","	or	","	","	O	Oor	both	or	CC	O	Oboth	.	both	DT	B-NP	O.	In	.	.	O	OIn	general	In	IN	B-PP	Ogeneral	","	general	JJ	B-NP	O","	therapeutic	","	","	I-NP	Otherapeutic	efficacy	therapeutic	JJ	I-NP	Oefficacy	is	efficacy	NN	I-NP	Ois	limited	be	VBZ	B-VP	Olimited	.	limit	VBN	B-ADJP	O.	It	.	.	O	OIt	is	It	PRP	B-NP	Ois	thus	be	VBZ	B-VP	Othus	notable	thus	RB	B-ADJP	Onotable	that	notable	JJ	I-ADJP	Othat	the	that	IN	B-SBAR	Othe	pleiotropic	the	DT	B-NP	Opleiotropic	effects	pleiotropic	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	type	of	IN	B-PP	Otype	I	type	NN	B-NP	B-proteinI	IFN	I	CD	I-NP	I-proteinIFN	on	IFN	NN	I-NP	I-proteinon	CMI	on	IN	B-PP	OCMI	remain	CMI	NN	B-NP	B-proteinremain	poorly	remain	VBP	B-VP	Opoorly	understood	poorly	RB	B-ADJP	Ounderstood	.	understand	VBN	I-ADJP	O.	We	.	.	O	OWe	characterized	We	PRP	B-NP	Ocharacterized	the	characterize	VBD	B-VP	Othe	effects	the	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	type	of	IN	B-PP	Otype	I	type	NN	B-NP	B-proteinI	IFN	I	CD	I-NP	I-proteinIFN	on	IFN	NN	I-NP	I-proteinon	the	on	IN	B-PP	Othe	production	the	DT	B-NP	Oproduction	of	production	NN	I-NP	Oof	IL-12	of	IN	B-PP	OIL-12	","	IL-12	NN	B-NP	B-protein","	the	","	","	O	Othe	central	the	DT	B-NP	Ocentral	immunoregulatory	central	JJ	I-NP	B-proteinimmunoregulatory	cytokine	immunoregulatory	JJ	I-NP	I-proteincytokine	of	cytokine	NN	I-NP	I-proteinof	the	of	IN	B-PP	Othe	CD4	the	DT	B-NP	OCD4	(	CD4	NN	I-NP	O(	+	(	(	O	O+	)	+	SYM	O	O)	T	)	)	O	OT	cell	T	NN	B-NP	Ocell	arm	cell	NN	I-NP	Oarm	of	arm	NN	I-NP	Oof	CMI	of	IN	B-PP	OCMI	.	CMI	NN	B-NP	B-protein.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	type	that	IN	B-SBAR	Otype	I	type	NN	B-NP	B-proteinI	IFN	I	CD	I-NP	I-proteinIFN	are	IFN	NN	I-NP	I-proteinare	potent	be	VBP	B-VP	Opotent	inhibitors	potent	JJ	B-NP	Oinhibitors	of	inhibitor	NNS	I-NP	Oof	IL-12	of	IN	B-PP	OIL-12	production	IL-12	NN	B-NP	B-proteinproduction	by	production	NN	I-NP	Oby	human	by	IN	B-PP	Ohuman	monocytes/macrophages	human	JJ	B-NP	B-cell_typemonocytes/macrophages	.	monocytes/macrophage	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	underlying	The	DT	B-NP	Ounderlying	mechanism	underlying	JJ	I-NP	Omechanism	involves	mechanism	NN	I-NP	Oinvolves	transcriptional	involve	VBZ	B-VP	Otranscriptional	inhibition	transcriptional	JJ	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	the	of	IN	B-PP	Othe	IL-12p40	the	DT	B-NP	OIL-12p40	gene	IL-12p40	NN	I-NP	B-DNAgene	","	gene	NN	I-NP	I-DNA","	marked	","	","	O	Omarked	by	mark	VBN	B-VP	Oby	down-regulation	by	IN	B-PP	Odown-regulation	of	down-regulation	NN	B-NP	Oof	PU.1	of	IN	B-PP	OPU.1	binding	PU.1	NN	B-NP	B-proteinbinding	activity	binding	NN	I-NP	Oactivity	at	activity	NN	I-NP	Oat	the	at	IN	B-PP	Othe	upstream	the	DT	B-NP	Oupstream	Ets	upstream	JJ	I-NP	B-DNAEts	site	Ets	NN	I-NP	I-DNAsite	of	site	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	IL-12p40	the	DT	B-NP	OIL-12p40	promoter	IL-12p40	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Type	.	.	O	OType	I	Type	NN	B-NP	B-proteinI	IFN	I	CD	I-NP	I-proteinIFN	have	IFN	NN	I-NP	I-proteinhave	previously	have	VBP	B-VP	Opreviously	been	previously	RB	I-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	able	be	VB	I-VP	Oable	to	able	JJ	B-ADJP	Oto	substitute	to	TO	B-VP	Osubstitute	for	substitute	VB	I-VP	Ofor	IL-12	for	IN	B-PP	OIL-12	in	IL-12	NN	B-NP	B-proteinin	driving	in	IN	B-PP	Odriving	IFN-gamma	drive	VBG	B-VP	OIFN-gamma	production	IFN-gamma	NN	B-NP	B-proteinproduction	from	production	NN	I-NP	Ofrom	T	from	IN	B-PP	OT	and	T	NN	B-NP	B-cell_typeand	NK	and	CC	I-NP	I-cell_typeNK	cells	NK	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	ability	The	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	IFN-alpha/beta	of	IN	B-PP	OIFN-alpha/beta	to	IFN-alpha/beta	NN	B-NP	B-proteinto	suppress	to	TO	B-VP	Osuppress	IL-12	suppress	VB	I-VP	OIL-12	production	IL-12	NN	B-NP	B-proteinproduction	while	production	NN	I-NP	Owhile	up-regulating	while	IN	B-SBAR	Oup-regulating	IFN-gamma	up-regulate	VBG	B-VP	OIFN-gamma	production	IFN-gamma	NN	B-NP	B-proteinproduction	suggests	production	NN	I-NP	Osuggests	a	suggest	VBZ	B-VP	Oa	possible	a	DT	B-NP	Opossible	mechanistic	possible	JJ	I-NP	Omechanistic	basis	mechanistic	JJ	I-NP	Obasis	for	basis	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	difficulties	the	DT	B-NP	Odifficulties	of	difficulty	NNS	I-NP	Oof	employing	of	IN	B-PP	Oemploying	these	employ	VBG	B-VP	Othese	cytokines	these	DT	B-NP	Ocytokines	in	cytokine	NNS	I-NP	B-proteinin	diseases	in	IN	B-PP	Odiseases	involving	disease	NNS	B-NP	Oinvolving	abnormalities	involve	VBG	B-VP	Oabnormalities	of	abnormality	NNS	B-NP	Oof	CMI	of	IN	B-PP	OCMI	.	CMI	NN	B-NP	B-protein.	Nuclear	.	.	O	ONuclear	factor-kappaB	Nuclear	JJ	B-NP	B-proteinfactor-kappaB	suppressive	factor-kappaB	NN	I-NP	I-proteinsuppressive	and	suppressive	JJ	I-NP	Oand	inhibitor-kappaB	and	CC	I-NP	Oinhibitor-kappaB	stimulatory	inhibitor-kappaB	NN	I-NP	Ostimulatory	effects	stimulatory	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	troglitazone	of	IN	B-PP	Otroglitazone	in	troglitazone	NN	B-NP	Oin	obese	in	IN	B-PP	Oobese	patients	obese	JJ	B-NP	Opatients	with	patient	NNS	I-NP	Owith	type	with	IN	B-PP	Otype	2	type	NN	B-NP	O2	diabetes	2	CD	I-NP	Odiabetes	:	diabete	NNS	I-NP	O:	evidence	:	:	O	Oevidence	of	evidence	NN	B-NP	Oof	an	of	IN	B-PP	Oan	antiinflammatory	an	DT	B-NP	Oantiinflammatory	action	antiinflammatory	JJ	I-NP	Oaction	?	action	NN	I-NP	O?	It	?	.	O	OIt	has	It	PRP	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	recently	show	VBN	I-VP	Orecently	that	recently	RB	B-ADVP	Othat	troglitazone	that	IN	B-SBAR	Otroglitazone	exerts	troglitazone	NN	B-NP	Oexerts	an	exert	VBZ	B-VP	Oan	anti-inflammatory	an	DT	B-NP	Oanti-inflammatory	effect	anti-inflammatory	JJ	I-NP	Oeffect	","	effect	NN	I-NP	O","	in	","	","	O	Oin	vitro	in	FW	B-ADVP	Ovitro	","	vitro	FW	I-ADVP	O","	and	","	","	O	Oand	in	and	CC	O	Oin	experimental	in	IN	B-PP	Oexperimental	animals	experimental	JJ	B-NP	Oanimals	.	animal	NNS	I-NP	O.	To	.	.	O	OTo	test	To	TO	B-VP	Otest	these	test	VB	I-VP	Othese	properties	these	DT	B-NP	Oproperties	in	property	NNS	I-NP	Oin	humans	in	IN	B-PP	Ohumans	","	human	NNS	B-NP	O","	we	","	","	O	Owe	investigated	we	PRP	B-NP	Oinvestigated	the	investigate	VBD	B-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	troglitazone	of	IN	B-PP	Otroglitazone	on	troglitazone	NN	B-NP	Oon	the	on	IN	B-PP	Othe	proinflammatory	the	DT	B-NP	Oproinflammatory	transcription	proinflammatory	JJ	I-NP	B-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	nuclear	factor	NN	I-NP	I-proteinnuclear	factor-kappaB	nuclear	JJ	I-NP	B-proteinfactor-kappaB	and	factor-kappaB	NN	I-NP	I-proteinand	its	and	CC	O	Oits	inhibitory	its	PRP$	B-NP	Oinhibitory	protein	inhibitory	JJ	I-NP	B-proteinprotein	IkappaB	protein	NN	I-NP	I-proteinIkappaB	in	IkappaB	NN	I-NP	B-proteinin	mononuclear	in	IN	B-PP	Omononuclear	cells	mononuclear	JJ	B-NP	B-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	MNC	(	(	O	OMNC	)	MNC	NN	B-NP	B-cell_type)	and	)	)	O	Oand	plasma	and	CC	O	Oplasma	soluble	plasma	NN	B-NP	B-proteinsoluble	intracellular	soluble	JJ	I-NP	I-proteinintracellular	adhesion	intracellular	JJ	I-NP	I-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	","	molecule-1	NN	I-NP	I-protein","	monocyte	","	","	O	Omonocyte	chemoattractant	monocyte	NN	B-NP	B-proteinchemoattractant	protein-1	chemoattractant	NN	I-NP	I-proteinprotein-1	","	protein-1	NN	I-NP	I-protein","	plasminogen	","	","	O	Oplasminogen	activator	plasminogen	NN	B-NP	B-proteinactivator	inhibitor-1	activator	NN	I-NP	I-proteininhibitor-1	","	inhibitor-1	NN	I-NP	I-protein","	and	","	","	O	Oand	C-reactive	and	CC	O	OC-reactive	protein	C-reactive	JJ	B-NP	B-proteinprotein	.	protein	NN	I-NP	I-protein.	We	.	.	O	OWe	also	We	PRP	B-NP	Oalso	examined	also	RB	B-ADVP	Oexamined	the	examine	VBD	B-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	troglitazone	of	IN	B-PP	Otroglitazone	on	troglitazone	NN	B-NP	Oon	reactive	on	IN	B-PP	Oreactive	oxygen	reactive	JJ	B-NP	Ooxygen	species	oxygen	NN	I-NP	Ospecies	generation	specie	NNS	I-NP	Ogeneration	","	generation	NN	I-NP	O","	p47	","	","	O	Op47	(	p47	NN	B-NP	B-protein(	phox	(	(	O	I-proteinphox	)	phox	NN	B-NP	I-protein)	subunit	)	)	O	I-proteinsubunit	expression	subunit	NN	B-NP	I-proteinexpression	","	expression	NN	I-NP	O","	9-hydroxyoctadecadienoic	","	","	O	O9-hydroxyoctadecadienoic	acid	9-hydroxyoctadecadienoic	JJ	B-NP	Oacid	(	acid	NN	I-NP	O(	9-HODE	(	(	O	O9-HODE	)	9-HODE	NN	B-NP	O)	","	)	)	O	O","	13-HODE	","	","	O	O13-HODE	","	13-HODE	NN	B-NP	O","	o-tyrosine	","	","	O	Oo-tyrosine	","	o-tyrosine	NN	B-NP	O","	and	","	","	O	Oand	m-tyrosine	and	CC	O	Om-tyrosine	in	m-tyrosine	NN	B-NP	Oin	obese	in	IN	B-PP	Oobese	patients	obese	JJ	B-NP	Opatients	with	patient	NNS	I-NP	Owith	type	with	IN	B-PP	Otype	2	type	NN	B-NP	O2	diabetes	2	CD	I-NP	Odiabetes	.	diabete	NNS	I-NP	O.	Seven	.	.	O	OSeven	obese	Seven	CD	B-NP	Oobese	patients	obese	JJ	I-NP	Opatients	with	patient	NNS	I-NP	Owith	type	with	IN	B-PP	Otype	2	type	NN	B-NP	O2	diabetes	2	CD	I-NP	Odiabetes	were	diabete	NNS	I-NP	Owere	treated	be	VBD	B-VP	Otreated	with	treat	VBN	I-VP	Owith	troglitazone	with	IN	B-PP	Otroglitazone	(	troglitazone	NN	B-NP	O(	400	(	(	O	O400	mg/day	400	CD	B-NP	Omg/day	)	mg/day	NN	I-NP	O)	for	)	)	O	Ofor	4	for	IN	B-PP	O4	weeks	4	CD	B-NP	Oweeks	.	week	NNS	I-NP	O.	Blood	.	.	O	OBlood	samples	Blood	NN	B-NP	Osamples	were	sample	NNS	I-NP	Owere	obtained	be	VBD	B-VP	Oobtained	at	obtain	VBN	I-VP	Oat	weekly	at	IN	B-PP	Oweekly	intervals	weekly	JJ	B-NP	Ointervals	.	interval	NNS	I-NP	O.	Nuclear	.	.	O	ONuclear	factor-kappaB	Nuclear	JJ	B-NP	B-proteinfactor-kappaB	binding	factor-kappaB	NN	I-NP	I-proteinbinding	activity	binding	NN	I-NP	Oactivity	in	activity	NN	I-NP	Oin	MNC	in	IN	B-PP	OMNC	nuclear	MNC	NN	B-NP	B-cell_typenuclear	extracts	nuclear	JJ	I-NP	Oextracts	was	extract	NNS	I-NP	Owas	significantly	be	VBD	B-VP	Osignificantly	inhibited	significantly	RB	I-VP	Oinhibited	after	inhibit	VBN	I-VP	Oafter	troglitazone	after	IN	B-PP	Otroglitazone	treatment	troglitazone	NN	B-NP	Otreatment	at	treatment	NN	I-NP	Oat	week	at	IN	B-PP	Oweek	1	week	NN	B-NP	O1	and	1	CD	I-NP	Oand	continued	and	CC	O	Ocontinued	to	continue	VBD	B-VP	Oto	be	to	TO	I-VP	Obe	inhibited	be	VB	I-VP	Oinhibited	up	inhibit	VBN	I-VP	Oup	to	up	IN	B-PP	Oto	week	to	TO	B-PP	Oweek	4	week	NN	B-NP	B-protein4	.	4	CD	I-NP	I-protein.	On	.	.	O	OOn	the	On	IN	B-PP	Othe	other	the	DT	B-NP	Oother	hand	other	JJ	I-NP	Ohand	","	hand	NN	I-NP	O","	IkappaB	","	","	O	OIkappaB	protein	IkappaB	NN	B-NP	B-proteinprotein	levels	protein	NN	I-NP	Olevels	increased	level	NNS	I-NP	Oincreased	significantly	increase	VBD	B-VP	Osignificantly	after	significantly	RB	B-ADVP	Oafter	troglitazone	after	IN	B-PP	Otroglitazone	treatment	troglitazone	NN	B-NP	Otreatment	at	treatment	NN	I-NP	Oat	week	at	IN	B-PP	Oweek	1	week	NN	B-NP	O1	","	1	CD	I-NP	O","	and	","	","	O	Oand	this	and	CC	O	Othis	increase	this	DT	B-NP	Oincrease	persisted	increase	NN	I-NP	Opersisted	throughout	persist	VBD	B-VP	Othroughout	the	throughout	IN	B-PP	Othe	study	the	DT	B-NP	Ostudy	.	study	NN	I-NP	O.	Plasma	.	.	O	OPlasma	monocyte	Plasma	NN	B-NP	B-proteinmonocyte	chemoattractant	monocyte	NN	I-NP	I-proteinchemoattractant	protein-1	chemoattractant	NN	I-NP	I-proteinprotein-1	and	protein-1	NN	I-NP	I-proteinand	soluble	and	CC	O	Osoluble	intracellular	soluble	JJ	B-NP	Ointracellular	adhesion	intracellular	JJ	I-NP	Oadhesion	molecule-1	adhesion	NN	I-NP	Omolecule-1	concentrations	molecule-1	NN	I-NP	Oconcentrations	did	concentration	NNS	I-NP	Odid	not	do	VBD	B-VP	Onot	decrease	not	RB	I-VP	Odecrease	significantly	decrease	VB	I-VP	Osignificantly	after	significantly	RB	B-ADVP	Oafter	troglitazone	after	IN	B-PP	Otroglitazone	treatment	troglitazone	NN	B-NP	Otreatment	","	treatment	NN	I-NP	O","	although	","	","	O	Oalthough	there	although	IN	B-SBAR	Othere	was	there	EX	B-NP	Owas	a	be	VBD	B-VP	Oa	trend	a	DT	B-NP	Otrend	toward	trend	NN	I-NP	Otoward	inhibition	toward	IN	B-PP	Oinhibition	.	inhibition	NN	B-NP	O.	Reactive	.	.	O	OReactive	oxygen	Reactive	JJ	B-NP	Ooxygen	species	oxygen	NN	I-NP	Ospecies	generation	species	NN	I-NP	Ogeneration	by	generation	NN	I-NP	Oby	polymorphonuclear	by	IN	B-PP	Opolymorphonuclear	cells	polymorphonuclear	JJ	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	MNC	and	CC	O	OMNC	","	MNC	NN	B-NP	B-cell_type","	p47	","	","	O	Op47	(	p47	NN	B-NP	B-protein(	phox	(	(	O	I-proteinphox	)	phox	NN	B-NP	I-protein)	subunit	)	)	O	I-proteinsubunit	protein	subunit	NN	B-NP	I-proteinprotein	quantities	protein	NN	I-NP	Oquantities	","	quantity	NNS	I-NP	O","	plasminogen	","	","	O	Oplasminogen	activator	plasminogen	NN	B-NP	B-proteinactivator	inhibitor-1	activator	NN	I-NP	I-proteininhibitor-1	","	inhibitor-1	NN	I-NP	I-protein","	and	","	","	O	Oand	C-reactive	and	CC	O	OC-reactive	protein	C-reactive	JJ	B-NP	B-proteinprotein	levels	protein	NN	I-NP	I-proteinlevels	decreased	level	NNS	I-NP	Odecreased	significantly	decrease	VBD	B-VP	Osignificantly	after	significantly	RB	B-ADVP	Oafter	troglitazone	after	IN	B-PP	Otroglitazone	intake	troglitazone	NN	B-NP	Ointake	.	intake	NN	I-NP	O.	13-HODE/linoleic	.	.	O	O13-HODE/linoleic	acid	13-HODE/linoleic	JJ	B-NP	Oacid	and	acid	NN	I-NP	Oand	9-HODE/linoleic	and	CC	O	O9-HODE/linoleic	acid	9-HODE/linoleic	JJ	B-NP	Oacid	ratios	acid	NN	I-NP	Oratios	also	ratio	NNS	I-NP	Oalso	decreased	also	RB	B-ADVP	Odecreased	after	decrease	VBD	B-VP	Oafter	troglitazone	after	IN	B-PP	Otroglitazone	intake	troglitazone	NN	B-NP	Ointake	.	intake	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	o-tyrosine/phenylalanine	","	","	O	Oo-tyrosine/phenylalanine	and	o-tyrosine/phenylalanine	JJ	B-NP	Oand	m-tyrosine/phenylalanine	and	CC	I-NP	Om-tyrosine/phenylalanine	ratios	m-tyrosine/phenylalanine	JJ	I-NP	Oratios	did	ratio	NNS	I-NP	Odid	not	do	VBD	B-VP	Onot	change	not	RB	I-VP	Ochange	significantly	change	VB	I-VP	Osignificantly	.	significantly	RB	B-ADVP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	show	datum	NNS	I-NP	Oshow	that	show	VBP	B-VP	Othat	troglitazone	that	IN	B-SBAR	Otroglitazone	has	troglitazone	NN	B-NP	Ohas	profound	have	VBZ	B-VP	Oprofound	antiinflammatory	profound	VBN	I-VP	Oantiinflammatory	effects	antiinflammatory	JJ	B-NP	Oeffects	in	effect	NNS	I-NP	Oin	addition	in	IN	B-PP	Oaddition	to	addition	NN	B-NP	Oto	antioxidant	to	TO	B-PP	Oantioxidant	effects	antioxidant	JJ	B-NP	Oeffects	in	effect	NNS	I-NP	Oin	obese	in	IN	B-PP	Oobese	type	obese	JJ	B-NP	Otype	2	type	NN	I-NP	O2	diabetics	2	CD	B-NP	Odiabetics	;	diabetic	NNS	I-NP	O;	these	;	:	O	Othese	effects	these	DT	B-NP	Oeffects	may	effect	NNS	I-NP	Omay	be	may	MD	B-VP	Obe	relevant	be	VB	I-VP	Orelevant	to	relevant	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	recently	the	DT	B-NP	Orecently	described	recently	RB	I-NP	Odescribed	beneficial	describe	VBN	I-NP	Obeneficial	antiatherosclerotic	beneficial	JJ	I-NP	Oantiatherosclerotic	effects	antiatherosclerotic	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	troglitazone	of	IN	B-PP	Otroglitazone	at	troglitazone	NN	B-NP	Oat	the	at	IN	B-PP	Othe	vascular	the	DT	B-NP	Ovascular	level	vascular	JJ	I-NP	Olevel	.	level	NN	I-NP	O.	OX40	.	.	O	OOX40	stimulation	OX40	NN	B-NP	B-proteinstimulation	by	stimulation	NN	I-NP	Oby	gp34/OX40	by	IN	B-PP	Ogp34/OX40	ligand	gp34/OX40	NN	B-NP	B-proteinligand	enhances	ligand	NN	I-NP	I-proteinenhances	productive	enhance	VBZ	B-VP	Oproductive	human	productive	JJ	B-NP	Ohuman	immunodeficiency	human	JJ	I-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	infection	1	CD	I-NP	Oinfection	.	infection	NN	I-NP	O.	OX40	.	.	O	OOX40	is	OX40	NN	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	member	a	DT	B-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	tumor	the	DT	B-NP	Otumor	necrosis	tumor	NN	I-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	TNF	(	(	O	I-proteinTNF	)	TNF	NN	B-NP	I-protein)	receptor	)	)	O	I-proteinreceptor	superfamily	receptor	NN	B-NP	I-proteinsuperfamily	and	superfamily	NN	I-NP	I-proteinand	known	and	CC	O	Oknown	to	know	VBN	B-VP	Oto	be	to	TO	I-VP	Obe	an	be	VB	I-VP	Oan	important	an	DT	B-NP	Oimportant	costimulatory	important	JJ	I-NP	Ocostimulatory	molecule	costimulatory	JJ	I-NP	B-proteinmolecule	expressed	molecule	NN	I-NP	I-proteinexpressed	on	express	VBN	B-VP	Oon	activated	on	IN	B-PP	Oactivated	T	activate	VBN	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	To	.	.	O	OTo	investigate	To	TO	B-VP	Oinvestigate	the	investigate	VB	I-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	costimulation	of	IN	B-PP	Ocostimulation	of	costimulation	NN	B-NP	Oof	OX40	of	IN	B-PP	OOX40	in	OX40	NN	B-NP	B-proteinin	human	in	IN	B-PP	Ohuman	immunodeficiency	human	JJ	B-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	(	1	CD	I-NP	O(	HIV-1	(	(	O	OHIV-1	)	HIV-1	NN	B-NP	O)	infection	)	)	O	Oinfection	by	infection	NN	B-NP	Oby	its	by	IN	B-PP	Oits	natural	its	PRP$	B-NP	Onatural	ligand	natural	JJ	I-NP	Oligand	","	ligand	NN	I-NP	O","	gp34	","	","	O	Ogp34	","	gp34	NN	B-NP	B-protein","	the	","	","	O	Othe	OX40-transfected	the	DT	B-NP	OOX40-transfected	ACH-2	OX40-transfected	JJ	I-NP	B-cell_lineACH-2	cell	ACH-2	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	","	line	NN	I-NP	I-cell_line","	ACH-2/OX40	","	","	O	OACH-2/OX40	","	ACH-2/OX40	NN	B-NP	B-cell_line","	chronically	","	","	O	Ochronically	infected	chronically	RB	B-VP	Oinfected	with	infect	VBN	I-VP	Owith	HIV-1	with	IN	B-PP	OHIV-1	","	HIV-1	NN	B-NP	O","	was	","	","	O	Owas	cocultured	be	VBD	B-VP	Ococultured	with	coculture	VBN	I-VP	Owith	paraformaldehyde	with	IN	B-PP	Oparaformaldehyde	(	paraformaldehyde	NN	B-NP	B-cell_line(	PFA	(	(	O	I-cell_linePFA	)	PFA	NN	B-NP	I-cell_line)	#NAME?	)	)	O	I-cell_line#NAME?	gp34-transfected	#NAME?	JJ	B-NP	I-cell_linegp34-transfected	mouse	gp34-transfected	JJ	I-NP	I-cell_linemouse	cell	mouse	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	","	line	NN	I-NP	I-cell_line","	SV-T2/gp34	","	","	O	OSV-T2/gp34	.	SV-T2/gp34	NN	B-NP	O.	The	.	.	O	OThe	results	The	DT	B-NP	Oresults	showed	result	NNS	I-NP	Oshowed	that	show	VBD	B-VP	Othat	HIV-1	that	IN	B-SBAR	OHIV-1	production	HIV-1	NN	B-NP	Oproduction	was	production	NN	I-NP	Owas	strongly	be	VBD	B-VP	Ostrongly	induced	strongly	RB	I-VP	Oinduced	.	induce	VBN	I-VP	O.	This	.	.	O	OThis	was	This	DT	B-NP	Owas	followed	be	VBD	B-VP	Ofollowed	by	follow	VBN	I-VP	Oby	apparent	by	IN	B-PP	Oapparent	apoptosis	apparent	JJ	B-NP	Oapoptosis	","	apoptosis	NN	I-NP	O","	and	","	","	O	Oand	both	and	CC	O	Oboth	processes	both	DT	B-NP	Oprocesses	were	process	NNS	I-NP	Owere	specifically	be	VBD	B-VP	Ospecifically	inhibited	specifically	RB	I-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	gp34	the	DT	B-NP	Ogp34	#NAME?	gp34	NN	I-NP	B-protein#NAME?	neutralizing	#NAME?	JJ	I-NP	Oneutralizing	monoclonal	neutralize	VBG	B-VP	Omonoclonal	antibody	monoclonal	JJ	B-NP	B-proteinantibody	5A8	antibody	NN	I-NP	I-protein5A8	.	5A8	NN	I-NP	I-protein.	Endogenous	.	.	O	OEndogenous	TNF	Endogenous	JJ	B-NP	OTNF	alpha	TNF	NN	I-NP	B-proteinalpha	(	alpha	NN	I-NP	I-protein(	TNF-alpha	(	(	O	OTNF-alpha	)	TNF-alpha	NN	B-NP	B-protein)	and	)	)	O	Oand	TNF-beta	and	CC	O	OTNF-beta	production	TNF-beta	NN	B-NP	B-proteinproduction	were	production	NN	I-NP	Owere	not	be	VBD	B-VP	Onot	involved	not	RB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	enhanced	the	DT	B-NP	Oenhanced	HIV-1	enhance	VBN	I-NP	OHIV-1	production	HIV-1	NN	I-NP	Oproduction	.	production	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	enhanced	","	","	O	Oenhanced	HIV-1	enhance	VBN	B-NP	OHIV-1	transcription	HIV-1	NN	I-NP	Otranscription	in	transcription	NN	I-NP	Oin	gp34	in	IN	B-PP	Ogp34	#NAME?	gp34	NN	B-NP	B-cell_line#NAME?	ACH-2/OX40	#NAME?	JJ	I-NP	I-cell_lineACH-2/OX40	cells	ACH-2/OX40	NN	I-NP	I-cell_linecells	was	cell	NNS	I-NP	I-cell_linewas	dependent	be	VBD	B-VP	Odependent	on	dependent	JJ	B-ADJP	Oon	the	on	IN	B-PP	Othe	kappa	the	DT	B-NP	Okappa	B	kappa	NN	I-NP	B-DNAB	site	B	NN	I-NP	I-DNAsite	of	site	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	HIV-1	the	DT	B-NP	OHIV-1	long	HIV-1	NN	I-NP	B-DNAlong	terminal	long	JJ	I-NP	I-DNAterminal	repeat	terminal	JJ	I-NP	I-DNArepeat	","	repeat	NN	I-NP	I-DNA","	and	","	","	O	Oand	the	and	CC	O	Othe	OX40-gp34	the	DT	B-NP	OOX40-gp34	interaction	OX40-gp34	NN	I-NP	Ointeraction	activated	interaction	NN	I-NP	Oactivated	NF-kappa	activate	VBD	B-VP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	consisting	B	NN	I-NP	I-proteinconsisting	of	consist	VBG	B-VP	Oof	p50	of	IN	B-PP	Op50	and	p50	NN	B-NP	B-proteinand	p65	and	CC	I-NP	Op65	subunits	p65	NN	I-NP	B-proteinsubunits	.	subunit	NNS	I-NP	I-protein.	When	.	.	O	OWhen	primary	When	WRB	B-ADVP	Oprimary	activated	primary	JJ	B-NP	B-cell_typeactivated	CD4	activate	VBN	I-NP	I-cell_typeCD4	(	CD4	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	acutely	cell	NNS	I-NP	I-cell_typeacutely	infected	acutely	RB	B-VP	Oinfected	with	infect	VBN	I-VP	Owith	HIV-1	with	IN	B-PP	OHIV-1	(	HIV-1	NN	B-NP	O(	NL4-3	(	(	O	ONL4-3	)	NL4-3	NN	B-NP	O)	(	)	)	O	O(	CXCR4-using	(	(	O	OCXCR4-using	T-cell-line-tropic	CXCR4-using	JJ	B-NP	OT-cell-line-tropic	)	T-cell-line-tropic	JJ	I-NP	O)	were	)	)	O	Owere	cocultured	be	VBD	B-VP	Ococultured	with	coculture	VBN	I-VP	Owith	PFA-fixed	with	IN	B-PP	OPFA-fixed	gp34	PFA-fixed	JJ	B-NP	B-cell_linegp34	(	gp34	NN	I-NP	I-cell_line(	+	(	(	O	I-cell_line+	)	+	SYM	O	I-cell_line)	human	)	)	O	I-cell_linehuman	T-cell	human	JJ	B-NP	I-cell_lineT-cell	leukemia	T-cell	NN	I-NP	I-cell_lineleukemia	virus	leukemia	NN	I-NP	I-cell_linevirus	type	virus	NN	I-NP	I-cell_linetype	1-bearing	type	NN	I-NP	I-cell_line1-bearing	MT-2	1-bearing	JJ	I-NP	I-cell_lineMT-2	cells	MT-2	NN	I-NP	I-cell_linecells	or	cell	NNS	I-NP	I-cell_lineor	SV-T2/gp34	or	CC	O	OSV-T2/gp34	cells	SV-T2/gp34	NN	B-NP	B-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	HIV-1	","	","	O	OHIV-1	production	HIV-1	NN	B-NP	Oproduction	was	production	NN	I-NP	Owas	also	be	VBD	B-VP	Oalso	markedly	also	RB	I-VP	Omarkedly	enhanced	markedly	RB	I-VP	Oenhanced	.	enhance	VBN	I-VP	O.	The	.	.	O	OThe	enhancement	The	DT	B-NP	Oenhancement	was	enhancement	NN	I-NP	Owas	again	be	VBD	B-VP	Oagain	significantly	again	RB	I-VP	Osignificantly	inhibited	significantly	RB	I-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	5A8	by	IN	B-PP	O5A8	.	5A8	NN	B-NP	B-protein.	The	.	.	O	OThe	present	The	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	first	study	NN	I-NP	Ofirst	shows	first	RB	B-ADVP	Oshows	that	show	VBZ	B-VP	Othat	OX40-gp34	that	IN	B-SBAR	OOX40-gp34	interaction	OX40-gp34	NN	B-NP	Ointeraction	stimulates	interaction	NN	I-NP	Ostimulates	HIV-1	stimulate	VBZ	B-VP	OHIV-1	expression	HIV-1	NN	B-NP	Oexpression	and	expression	NN	I-NP	Oand	suggests	and	CC	O	Osuggests	that	suggest	VBZ	B-VP	Othat	OX40	that	IN	B-SBAR	OOX40	triggering	OX40	NN	B-NP	B-proteintriggering	by	triggering	NN	I-NP	Oby	gp34	by	IN	B-PP	Ogp34	may	gp34	NN	B-NP	B-proteinmay	play	may	MD	B-VP	Oplay	an	play	VB	I-VP	Oan	important	an	DT	B-NP	Oimportant	role	important	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	enhancing	in	IN	B-PP	Oenhancing	HIV-1	enhance	VBG	B-VP	OHIV-1	production	HIV-1	NN	B-NP	Oproduction	in	production	NN	I-NP	Oin	both	in	IN	B-PP	Oboth	acutely	both	CC	I-PP	Oacutely	and	acutely	RB	I-PP	Oand	latently	and	CC	O	Olatently	infected	latently	RB	B-NP	Oinfected	CD4	infected	JJ	I-NP	OCD4	(	CD4	NN	I-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	Troglitazone	.	.	O	OTroglitazone	","	Troglitazone	NN	B-NP	O","	a	","	","	O	Oa	PPARgamma	a	DT	B-NP	OPPARgamma	ligand	PPARgamma	NN	I-NP	B-proteinligand	","	ligand	NN	I-NP	O","	inhibits	","	","	O	Oinhibits	osteopontin	inhibit	VBZ	B-VP	Oosteopontin	gene	osteopontin	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	in	expression	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	monocytes/macrophage	human	JJ	B-NP	B-cell_linemonocytes/macrophage	THP-1	monocytes/macrophage	NN	I-NP	I-cell_lineTHP-1	cells	THP-1	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Peroxizome	.	.	O	OPeroxizome	proliferator-activated	Peroxizome	NN	B-NP	B-proteinproliferator-activated	receptor-gamma	proliferator-activated	JJ	I-NP	I-proteinreceptor-gamma	(	receptor-gamma	NN	I-NP	I-protein(	PPARgamma	(	(	O	OPPARgamma	)	PPARgamma	NN	B-NP	B-protein)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	member	a	DT	B-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	receptor	nuclear	JJ	I-NP	B-proteinreceptor	family	receptor	NN	I-NP	I-proteinfamily	of	family	NN	I-NP	I-proteinof	transcription	of	IN	B-PP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	that	factor	NNS	I-NP	I-proteinthat	regulate	that	WDT	B-NP	Oregulate	adipocyte	regulate	VBP	B-VP	Oadipocyte	differentiation	adipocyte	NN	B-NP	B-cell_typedifferentiation	.	differentiation	NN	I-NP	O.	Recent	.	.	O	ORecent	studies	Recent	JJ	B-NP	Ostudies	indicate	study	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	liganded	that	IN	B-SBAR	Oliganded	PPARgamma	liganded	JJ	B-NP	OPPARgamma	not	PPARgamma	NN	I-NP	B-proteinnot	only	not	RB	B-CONJP	Oonly	promotes	only	RB	I-CONJP	Opromotes	differentiation	promote	VBZ	B-VP	Odifferentiation	but	differentiation	NN	B-NP	Obut	also	but	CC	O	Oalso	inhibits	also	RB	B-VP	Oinhibits	the	inhibit	VBZ	I-VP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	macrophages	of	IN	B-PP	Omacrophages	.	macrophage	NNS	B-NP	B-cell_type.	Osteopontin	.	.	O	OOsteopontin	","	Osteopontin	NN	B-NP	B-protein","	a	","	","	O	Oa	component	a	DT	B-NP	Ocomponent	of	component	NN	I-NP	Oof	extracellular	of	IN	B-PP	Oextracellular	matrix	extracellular	JJ	B-NP	Omatrix	","	matrix	NN	I-NP	O","	is	","	","	O	Ois	synthesized	be	VBZ	B-VP	Osynthesized	by	synthesize	VBN	I-VP	Oby	macrophages	by	IN	B-PP	Omacrophages	in	macrophage	NNS	B-NP	B-cell_typein	atherosclerotic	in	IN	B-PP	Oatherosclerotic	plaques	atherosclerotic	JJ	B-NP	Oplaques	.	plaque	NNS	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	examined	we	PRP	B-NP	Oexamined	whether	examine	VBD	B-VP	Owhether	PPARgamma	whether	IN	B-SBAR	OPPARgamma	ligand	PPARgamma	NN	B-NP	B-proteinligand	regulates	ligand	NN	I-NP	Oregulates	osteopontin	regulate	VBZ	B-VP	Oosteopontin	gene	osteopontin	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	in	expression	NN	I-NP	Oin	THP-1	in	IN	B-PP	OTHP-1	cells	THP-1	NN	B-NP	B-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	a	","	","	O	Oa	cell	a	DT	B-NP	Ocell	line	cell	NN	I-NP	B-cell_lineline	derived	line	NN	I-NP	I-cell_linederived	from	derive	VBN	B-VP	Ofrom	human	from	IN	B-PP	Ohuman	monocytic	human	JJ	B-NP	B-cell_typemonocytic	leukemia	monocytic	JJ	I-NP	I-cell_typeleukemia	cells	leukemia	NN	I-NP	I-cell_typecells	which	cell	NNS	I-NP	I-cell_typewhich	can	which	WDT	B-NP	Ocan	differentiate	can	MD	B-VP	Odifferentiate	to	differentiate	VB	I-VP	Oto	macrophage	to	TO	B-PP	Omacrophage	upon	macrophage	NN	B-NP	B-cell_typeupon	stimulation	upon	IN	B-PP	Ostimulation	with	stimulation	NN	B-NP	Owith	phorbol	with	IN	B-PP	Ophorbol	ester	phorbol	NN	B-NP	Oester	PMA	ester	NN	I-NP	OPMA	.	PMA	NN	I-NP	O.	Northern	.	.	O	ONorthern	blot	Northern	NN	B-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	showed	analysis	NN	I-NP	Oshowed	that	show	VBD	B-VP	Othat	osteopontin	that	IN	B-SBAR	Oosteopontin	expression	osteopontin	NN	B-NP	B-proteinexpression	is	expression	NN	I-NP	Ois	markedly	be	VBZ	B-VP	Omarkedly	induced	markedly	RB	I-VP	Oinduced	in	induce	VBN	I-VP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	PMA	to	TO	B-PP	OPMA	.	PMA	NN	B-NP	O.	Troglitazone	.	.	O	OTroglitazone	","	Troglitazone	NN	B-NP	O","	a	","	","	O	Oa	PPARgamma	a	DT	B-NP	OPPARgamma	ligand	PPARgamma	NN	I-NP	B-proteinligand	","	ligand	NN	I-NP	O","	dramatically	","	","	O	Odramatically	attenuated	dramatically	RB	B-ADVP	Oattenuated	the	attenuate	VBD	B-VP	Othe	PMA-induced	the	DT	B-NP	OPMA-induced	osteopontin	PMA-induced	JJ	I-NP	Oosteopontin	expression	osteopontin	NN	I-NP	Oexpression	.	expression	NN	I-NP	O.	Transient	.	.	O	OTransient	transfection	Transient	JJ	B-NP	Otransfection	assays	transfection	NN	I-NP	Oassays	of	assay	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	osteopontin	human	JJ	I-NP	B-DNAosteopontin	promoter/luciferase	osteopontin	NN	I-NP	I-DNApromoter/luciferase	construct	promoter/luciferase	NN	I-NP	I-DNAconstruct	which	construct	NN	I-NP	I-DNAwhich	contains	which	WDT	B-NP	Ocontains	a	contain	VBZ	B-VP	Oa	5'-flanking	a	DT	B-NP	O5'-flanking	region	5'-flanking	JJ	I-NP	B-DNAregion	between	region	NN	I-NP	I-DNAbetween	-1500	between	IN	B-PP	O-1500	and	-1500	CD	B-NP	Oand	87	and	CC	I-NP	O87	relative	87	CD	I-NP	Orelative	to	relative	JJ	B-ADVP	Oto	the	to	TO	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	start	transcription	NN	I-NP	B-DNAstart	site	start	NN	I-NP	I-DNAsite	demonstrate	site	NN	I-NP	I-DNAdemonstrate	that	demonstrate	VBP	B-VP	Othat	either	that	IN	B-SBAR	Oeither	treatment	either	CC	O	Otreatment	with	treatment	NN	B-NP	Owith	troglitazone	with	IN	B-PP	Otroglitazone	or	troglitazone	NN	B-NP	Oor	cotransfection	or	CC	I-NP	Ocotransfection	of	cotransfection	NN	I-NP	Oof	PPARgamma	of	IN	B-PP	OPPARgamma	expression	PPARgamma	NN	B-NP	B-proteinexpression	vector	expression	NN	I-NP	Ovector	inhibits	vector	NN	I-NP	Oinhibits	osteopontin	inhibit	VBZ	B-VP	Oosteopontin	promoter	osteopontin	NN	B-NP	B-DNApromoter	activity	promoter	NN	I-NP	I-DNAactivity	.	activity	NN	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	indicate	datum	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	troglitazone	that	IN	B-SBAR	Otroglitazone	reduces	troglitazone	NN	B-NP	Oreduces	osteopontin	reduce	VBZ	B-VP	Oosteopontin	gene	osteopontin	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	at	expression	NN	I-NP	Oat	transcriptional	at	IN	B-PP	Otranscriptional	level	transcriptional	JJ	B-NP	Olevel	through	level	NN	I-NP	Othrough	PPARgamma	through	IN	B-PP	OPPARgamma	activation	PPARgamma	NN	B-NP	B-proteinactivation	","	activation	NN	I-NP	O","	and	","	","	O	Oand	suggest	and	CC	O	Osuggest	the	suggest	VBP	B-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	troglitazone	of	IN	B-PP	Otroglitazone	in	troglitazone	NN	B-NP	Oin	inhibiting	in	IN	B-PP	Oinhibiting	the	inhibit	VBG	B-VP	Othe	ability	the	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	macrophages	of	IN	B-PP	Omacrophages	to	macrophage	NNS	B-NP	B-cell_typeto	produce	to	TO	B-VP	Oproduce	extracellular	produce	VB	I-VP	Oextracellular	matrix	extracellular	JJ	B-NP	Omatrix	","	matrix	NN	I-NP	O","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	particularly	be	VBZ	B-VP	Oparticularly	relevant	particularly	RB	B-ADJP	Orelevant	to	relevant	JJ	I-ADJP	Oto	atherosclerotic	to	TO	B-PP	Oatherosclerotic	plaque	atherosclerotic	JJ	B-NP	Oplaque	formation	plaque	NN	I-NP	Oformation	.	formation	NN	I-NP	O.	Transcription	.	.	O	OTranscription	factor	Transcription	NN	B-NP	B-proteinfactor	NF-kappa	factor	NN	I-NP	I-proteinNF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	regulates	B	NN	I-NP	I-proteinregulates	Ig	regulate	VBZ	B-VP	OIg	lambda	Ig	NN	B-NP	B-DNAlambda	light	lambda	NN	I-NP	I-DNAlight	chain	light	JJ	I-NP	I-DNAchain	gene	chain	NN	I-NP	I-DNAgene	rearrangement	gene	NN	I-NP	I-DNArearrangement	.	rearrangement	NN	I-NP	O.	The	.	.	O	OThe	tissue-	The	DT	B-NP	Otissue-	and	tissue-	NN	I-NP	Oand	stage-specific	and	CC	I-NP	Ostage-specific	assembly	stage-specific	JJ	I-NP	Oassembly	of	assembly	NN	I-NP	Oof	Ig	of	IN	B-PP	OIg	and	Ig	NN	B-NP	B-DNAand	TCR	and	CC	I-NP	I-DNATCR	genes	TCR	NN	I-NP	I-DNAgenes	is	gene	NNS	I-NP	I-DNAis	mediated	be	VBZ	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	common	a	DT	B-NP	Ocommon	V	common	JJ	I-NP	B-proteinV	(	V	NN	I-NP	I-protein(	D	(	(	O	I-proteinD	)	D	NN	B-NP	I-protein)	J	)	)	O	I-proteinJ	recombinase	J	NN	B-NP	I-proteinrecombinase	complex	recombinase	NN	I-NP	I-proteincomplex	in	complex	NN	I-NP	I-proteinin	precursor	in	IN	B-PP	Oprecursor	lymphocytes	precursor	NN	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Directed	.	.	O	ODirected	alterations	Direct	VBN	B-NP	Oalterations	in	alteration	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	accessibility	the	DT	B-NP	Oaccessibility	of	accessibility	NN	I-NP	Oof	V	of	IN	B-PP	OV	","	V	NNP	B-NP	O","	D	","	","	O	OD	","	D	NNP	B-NP	O","	and	","	","	O	Oand	J	and	CC	O	OJ	gene	J	NN	B-NP	B-DNAgene	segments	gene	NN	I-NP	I-DNAsegments	target	segment	NNS	I-NP	I-DNAtarget	the	target	VBP	B-VP	Othe	recombinase	the	DT	B-NP	Orecombinase	to	recombinase	NN	I-NP	Oto	specific	to	TO	B-PP	Ospecific	Ag	specific	JJ	B-NP	OAg	receptor	Ag	NN	I-NP	Oreceptor	loci	receptor	NN	I-NP	Oloci	.	locus	NNS	I-NP	O.	Accessibility	.	.	O	OAccessibility	within	Accessibility	NN	B-NP	Owithin	a	within	IN	B-PP	Oa	given	a	DT	B-NP	Ogiven	locus	give	VBN	I-NP	Olocus	is	locus	NN	I-NP	Ois	regulated	be	VBZ	B-VP	Oregulated	by	regulate	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	functional	the	DT	B-NP	Ofunctional	interaction	functional	JJ	I-NP	Ointeraction	of	interaction	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	with	factor	NNS	I-NP	I-proteinwith	cognate	with	IN	B-PP	Ocognate	enhancer	cognate	JJ	B-NP	B-DNAenhancer	elements	enhancer	NN	I-NP	I-DNAelements	and	element	NNS	I-NP	I-DNAand	correlates	and	CC	O	Ocorrelates	with	correlate	VBZ	B-VP	Owith	the	with	IN	B-PP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	activity	transcriptional	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	unrearranged	of	IN	B-PP	Ounrearranged	gene	unrearranged	JJ	B-NP	Ogene	segments	gene	NN	I-NP	Osegments	.	segment	NNS	I-NP	O.	As	.	.	O	OAs	demonstrated	As	IN	B-SBAR	Odemonstrated	in	demonstrate	VBN	B-VP	Oin	our	in	IN	B-PP	Oour	prior	our	PRP$	B-NP	Oprior	studies	prior	JJ	I-NP	Ostudies	","	study	NNS	I-NP	O","	rearrangement	","	","	O	Orearrangement	of	rearrangement	NN	B-NP	Oof	the	of	IN	B-PP	Othe	Igkappa	the	DT	B-NP	OIgkappa	locus	Igkappa	NN	I-NP	B-DNAlocus	is	locus	NN	I-NP	I-DNAis	regulated	be	VBZ	B-VP	Oregulated	by	regulate	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	inducible	the	DT	B-NP	Oinducible	transcription	inducible	JJ	I-NP	B-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	NF-kappaB	factor	NN	I-NP	I-proteinNF-kappaB	.	NF-kappaB	NN	I-NP	B-protein.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	to	contrast	NN	B-NP	Oto	the	to	TO	B-PP	Othe	Igkappa	the	DT	B-NP	OIgkappa	locus	Igkappa	NN	I-NP	B-DNAlocus	","	locus	NN	I-NP	I-DNA","	known	","	","	O	Oknown	transcriptional	know	VBN	B-VP	Otranscriptional	control	transcriptional	JJ	B-NP	B-DNAcontrol	elements	control	NN	I-NP	I-DNAelements	in	element	NNS	I-NP	I-DNAin	the	in	IN	B-PP	Othe	Iglambda	the	DT	B-NP	OIglambda	locus	Iglambda	NNP	I-NP	B-DNAlocus	lack	locus	NN	I-NP	I-DNAlack	functional	lack	VBP	B-VP	Ofunctional	NF-kappaB	functional	JJ	B-NP	ONF-kappaB	binding	NF-kappaB	NN	I-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	.	site	NNS	I-NP	I-DNA.	Consistent	.	.	O	OConsistent	with	Consistent	JJ	B-ADJP	Owith	this	with	IN	B-PP	Othis	observation	this	DT	B-NP	Oobservation	","	observation	NN	I-NP	O","	the	","	","	O	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	assembled	of	IN	B-PP	Oassembled	Iglambda	assemble	VBN	B-NP	OIglambda	genes	Iglambda	NN	I-NP	B-DNAgenes	in	gene	NNS	I-NP	I-DNAin	mature	in	IN	B-PP	Omature	B	mature	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	has	cell	NNS	I-NP	I-cell_typehas	been	have	VBZ	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	NF-kappaB	be	VB	I-VP	ONF-kappaB	independent	NF-kappaB	NN	B-NP	B-proteinindependent	.	independent	JJ	B-ADJP	O.	Nonetheless	.	.	O	ONonetheless	","	Nonetheless	RB	B-ADVP	O","	we	","	","	O	Owe	now	we	PRP	B-NP	Onow	show	now	RB	B-ADVP	Oshow	that	show	VBP	B-VP	Othat	specific	that	IN	B-SBAR	Ospecific	repression	specific	JJ	B-NP	Orepression	of	repression	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	inhibits	NF-kappaB	NN	B-NP	B-proteininhibits	germline	inhibit	VBZ	B-VP	Ogermline	transcription	germline	NN	B-NP	B-DNAtranscription	and	transcription	NN	I-NP	Oand	recombination	and	CC	O	Orecombination	of	recombination	NN	B-NP	Oof	Iglambda	of	IN	B-PP	OIglambda	gene	Iglambda	NN	B-NP	B-DNAgene	segments	gene	NN	I-NP	I-DNAsegments	in	segment	NNS	I-NP	I-DNAin	precursor	in	IN	B-PP	Oprecursor	B	precursor	NN	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Molecular	.	.	O	OMolecular	analyses	Molecular	JJ	B-NP	Oanalyses	indicate	analysis	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	block	the	DT	B-NP	Oblock	in	block	NN	I-NP	Oin	NF-kappaB	in	IN	B-PP	ONF-kappaB	impairs	NF-kappaB	NN	B-NP	B-proteinimpairs	Iglambda	impair	VBZ	B-VP	OIglambda	rearrangement	Iglambda	NNP	B-NP	Orearrangement	at	rearrangement	NN	I-NP	Oat	the	at	IN	B-PP	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	recombinase	of	IN	B-PP	Orecombinase	accessibility	recombinase	NN	B-NP	Oaccessibility	.	accessibility	NN	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	the	","	","	O	Othe	activities	the	DT	B-NP	Oactivities	of	activity	NNS	I-NP	Oof	known	of	IN	B-PP	Oknown	Iglambda	know	VBN	B-NP	OIglambda	promoter	Iglambda	NN	I-NP	B-DNApromoter	and	promoter	NN	I-NP	I-DNAand	enhancer	and	CC	I-NP	Oenhancer	elements	enhancer	NN	I-NP	B-DNAelements	are	element	NNS	I-NP	I-DNAare	unaffected	be	VBP	B-VP	Ounaffected	in	unaffected	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	same	the	DT	B-NP	Osame	cellular	same	JJ	I-NP	Ocellular	background	cellular	JJ	I-NP	Obackground	.	background	NN	I-NP	O.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	expand	finding	NNS	I-NP	Oexpand	the	expand	VBP	B-VP	Othe	range	the	DT	B-NP	Orange	of	range	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	action	NF-kappaB	NN	B-NP	B-proteinaction	in	action	NN	I-NP	Oin	precursor	in	IN	B-PP	Oprecursor	B	precursor	NN	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	beyond	cell	NNS	I-NP	I-cell_typebeyond	Igkappa	beyond	IN	B-PP	OIgkappa	to	Igkappa	NN	B-NP	B-proteinto	include	to	TO	B-VP	Oinclude	the	include	VB	I-VP	Othe	control	the	DT	B-NP	Ocontrol	of	control	NN	I-NP	Oof	recombinational	of	IN	B-PP	Orecombinational	accessibility	recombinational	JJ	B-NP	Oaccessibility	at	accessibility	NN	I-NP	Oat	both	at	IN	B-PP	Oboth	L	both	CC	O	OL	chain	L	NN	B-NP	B-DNAchain	loci	chain	NN	I-NP	I-DNAloci	.	locus	NNS	I-NP	I-DNA.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	our	","	","	O	Oour	results	our	PRP$	B-NP	Oresults	strongly	result	NNS	I-NP	Ostrongly	suggest	strongly	RB	B-ADVP	Osuggest	the	suggest	VBP	B-VP	Othe	existence	the	DT	B-NP	Oexistence	of	existence	NN	I-NP	Oof	a	of	IN	B-PP	Oa	novel	a	DT	B-NP	Onovel	Iglambda	novel	JJ	I-NP	OIglambda	regulatory	Iglambda	NN	I-NP	B-DNAregulatory	element	regulatory	JJ	I-NP	I-DNAelement	that	element	NN	I-NP	I-DNAthat	is	that	WDT	B-NP	Ois	either	be	VBZ	B-VP	Oeither	directly	either	CC	O	Odirectly	or	directly	RB	B-VP	Oor	indirectly	or	CC	I-VP	Oindirectly	activated	indirectly	RB	I-VP	Oactivated	by	activate	VBN	I-VP	Oby	NF-kappaB	by	IN	B-PP	ONF-kappaB	during	NF-kappaB	NN	B-NP	B-proteinduring	the	during	IN	B-PP	Othe	early	the	DT	B-NP	Oearly	stages	early	JJ	I-NP	Ostages	of	stage	NNS	I-NP	Oof	B	of	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	.	development	NN	I-NP	O.	Transcription	.	.	O	OTranscription	factor	Transcription	NN	B-NP	B-proteinfactor	STAT5A	factor	NN	I-NP	I-proteinSTAT5A	is	STAT5A	NN	I-NP	B-proteinis	a	be	VBZ	B-VP	Oa	substrate	a	DT	B-NP	Osubstrate	of	substrate	NN	I-NP	Oof	Bruton	of	IN	B-PP	OBruton	's	Bruton	NNP	B-NP	B-protein's	tyrosine	's	POS	B-NP	I-proteintyrosine	kinase	tyrosine	NN	I-NP	I-proteinkinase	in	kinase	NN	I-NP	I-proteinin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	STAT5A	.	.	O	OSTAT5A	is	STAT5A	NN	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	molecular	a	DT	B-NP	Omolecular	regulator	molecular	JJ	I-NP	Oregulator	of	regulator	NN	I-NP	Oof	proliferation	of	IN	B-PP	Oproliferation	","	proliferation	NN	B-NP	O","	differentiation	","	","	O	Odifferentiation	","	differentiation	NN	B-NP	O","	and	","	","	O	Oand	apoptosis	and	CC	O	Oapoptosis	in	apoptosis	NN	B-NP	Oin	lymphohematopoietic	in	IN	B-PP	Olymphohematopoietic	cells	lymphohematopoietic	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	STAT5A	that	IN	B-SBAR	OSTAT5A	can	STAT5A	NN	B-NP	B-proteincan	serve	can	MD	B-VP	Oserve	as	serve	VB	I-VP	Oas	a	as	IN	B-PP	Oa	functional	a	DT	B-NP	Ofunctional	substrate	functional	JJ	I-NP	Osubstrate	of	substrate	NN	I-NP	Oof	Bruton	of	IN	B-PP	OBruton	's	Bruton	NNP	B-NP	B-protein's	tyrosine	's	POS	B-NP	I-proteintyrosine	kinase	tyrosine	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	BTK	(	(	O	OBTK	)	BTK	NN	B-NP	B-protein)	.	)	)	O	O.	Purified	.	.	O	OPurified	recombinant	Purify	VBN	B-NP	B-proteinrecombinant	BTK	recombinant	JJ	I-NP	I-proteinBTK	was	BTK	NN	I-NP	I-proteinwas	capable	be	VBD	B-VP	Ocapable	of	capable	JJ	B-ADJP	Oof	directly	of	IN	B-PP	Odirectly	binding	directly	RB	B-VP	Obinding	purified	bind	VBG	I-VP	Opurified	recombinant	purify	VBN	I-VP	Orecombinant	STAT5A	recombinant	JJ	B-NP	OSTAT5A	with	STAT5A	NN	I-NP	B-proteinwith	high	with	IN	B-PP	Ohigh	affinity	high	JJ	B-NP	Oaffinity	(	affinity	NN	I-NP	O(	K	(	(	O	OK	(	K	NN	B-NP	O(	d	(	(	O	Od	)	d	NN	B-NP	O)	=	)	)	O	O=	44	=	SYM	B-VP	O44	nm	44	CD	B-NP	Onm	)	nm	NN	I-NP	O)	","	)	)	O	O","	as	","	","	O	Oas	determined	as	IN	B-SBAR	Odetermined	by	determine	VBN	B-VP	Oby	surface	by	IN	B-PP	Osurface	plasmon	surface	NN	B-NP	Oplasmon	resonance	plasmon	NN	I-NP	Oresonance	using	resonance	NN	I-NP	Ousing	a	use	VBG	B-VP	Oa	BIAcore	a	DT	B-NP	OBIAcore	biosensor	BIAcore	NN	I-NP	Obiosensor	system	biosensor	NN	I-NP	Osystem	.	system	NN	I-NP	O.	BTK	.	.	O	OBTK	was	BTK	NN	B-NP	B-proteinwas	also	be	VBD	B-VP	Oalso	capable	also	RB	B-ADVP	Ocapable	of	capable	JJ	B-ADJP	Oof	tyrosine-phosphorylating	of	IN	B-PP	Otyrosine-phosphorylating	ectopically	tyrosine-phosphorylate	VBG	B-VP	Oectopically	expressed	ectopically	RB	B-NP	Oexpressed	recombinant	express	VBN	I-NP	Orecombinant	STAT5A	recombinant	JJ	I-NP	OSTAT5A	on	STAT5A	NN	I-NP	B-proteinon	Tyr	on	IN	B-PP	OTyr	(	Tyr	NN	B-NP	B-protein(	694	(	(	O	O694	)	694	CD	B-NP	O)	both	)	)	O	Oboth	in	both	CC	O	Oin	vitro	in	FW	B-ADVP	Ovitro	and	vitro	FW	I-ADVP	Oand	in	and	CC	O	Oin	vivo	in	FW	B-ADVP	Ovivo	in	vivo	FW	I-ADVP	Oin	a	in	IN	B-PP	Oa	Janus	a	DT	B-NP	OJanus	kinase	Janus	NN	I-NP	B-proteinkinase	3	kinase	NN	I-NP	I-protein3	#NAME?	3	CD	I-NP	I-protein#NAME?	fashion	#NAME?	JJ	I-NP	Ofashion	.	fashion	NN	I-NP	O.	BTK	.	.	O	OBTK	phosphorylated	BTK	NN	B-NP	B-proteinphosphorylated	the	phosphorylate	VBD	B-VP	Othe	Y665F	the	DT	B-NP	OY665F	","	Y665F	NN	I-NP	B-protein","	Y668F	","	","	O	OY668F	","	Y668F	NN	B-NP	B-protein","	and	","	","	O	Oand	Y682F	and	CC	O	OY682F	","	Y682F	NN	B-NP	B-protein","	Y683F	","	","	O	OY683F	mutants	Y683F	NN	B-NP	B-proteinmutants	but	mutant	NNS	I-NP	I-proteinbut	not	but	CC	B-NP	Onot	the	not	RB	I-NP	Othe	Y694F	the	DT	B-NP	OY694F	mutant	Y694F	NN	I-NP	B-proteinmutant	of	mutant	NN	I-NP	I-proteinof	STAT5A	of	IN	B-PP	OSTAT5A	.	STAT5A	NN	B-NP	B-protein.	STAT5A	.	.	O	OSTAT5A	mutations	STAT5A	NN	B-NP	B-proteinmutations	in	mutation	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	Src	the	DT	B-NP	OSrc	homology	Src	NN	I-NP	B-proteinhomology	2	homology	NN	I-NP	I-protein2	(	2	CD	I-NP	I-protein(	SH2	(	(	O	I-proteinSH2	)	SH2	NN	B-NP	I-protein)	and	)	)	O	I-proteinand	SH3	and	CC	O	I-proteinSH3	domains	SH3	NN	B-NP	I-proteindomains	did	domain	NNS	I-NP	I-proteindid	not	do	VBD	B-VP	Onot	alter	not	RB	I-VP	Oalter	the	alter	VB	I-VP	Othe	BTK	the	DT	B-NP	OBTK	#NAME?	BTK	NN	I-NP	B-protein#NAME?	tyrosine	#NAME?	JJ	I-NP	Otyrosine	phosphorylation	tyrosine	NN	I-NP	Ophosphorylation	.	phosphorylation	NN	I-NP	O.	Recombinant	.	.	O	ORecombinant	BTK	Recombinant	JJ	B-NP	B-proteinBTK	proteins	BTK	NN	I-NP	I-proteinproteins	with	protein	NNS	I-NP	I-proteinwith	mutant	with	IN	B-PP	Omutant	pleckstrin	mutant	JJ	B-NP	Opleckstrin	homology	pleckstrin	NN	I-NP	Ohomology	","	homology	NN	I-NP	O","	SH2	","	","	O	OSH2	","	SH2	NN	B-NP	B-protein","	or	","	","	O	Oor	SH3	or	CC	O	OSH3	domains	SH3	NN	B-NP	B-proteindomains	were	domain	NNS	I-NP	I-proteinwere	capable	be	VBD	B-VP	Ocapable	of	capable	JJ	B-ADJP	Oof	phosphorylating	of	IN	B-PP	Ophosphorylating	STAT5A	phosphorylate	VBG	B-VP	OSTAT5A	","	STAT5A	NN	B-NP	B-protein","	whereas	","	","	O	Owhereas	recombinant	whereas	IN	O	Orecombinant	BTK	recombinant	JJ	B-NP	B-proteinBTK	proteins	BTK	NN	I-NP	I-proteinproteins	with	protein	NNS	I-NP	I-proteinwith	SH1/kinase	with	IN	B-PP	OSH1/kinase	domain	SH1/kinase	NN	B-NP	B-proteindomain	mutations	domain	NN	I-NP	I-proteinmutations	were	mutation	NNS	I-NP	Owere	not	be	VBD	B-VP	Onot	.	not	RB	O	O.	In	.	.	O	OIn	pull-down	In	IN	B-PP	Opull-down	experiments	pull-down	JJ	B-NP	Oexperiments	","	experiment	NNS	I-NP	O","	only	","	","	O	Oonly	full-length	only	RB	B-NP	Ofull-length	BTK	full-length	JJ	I-NP	OBTK	and	BTK	NN	I-NP	B-proteinand	its	and	CC	O	Oits	SH1/kinase	its	PRP$	B-NP	OSH1/kinase	domain	SH1/kinase	NN	I-NP	B-proteindomain	(	domain	NN	I-NP	I-protein(	but	(	(	O	Obut	not	but	CC	B-CONJP	Onot	the	not	RB	I-CONJP	Othe	pleckstrin	the	DT	B-NP	Opleckstrin	homology	pleckstrin	NN	I-NP	Ohomology	","	homology	NN	I-NP	O","	SH2	","	","	O	OSH2	","	SH2	NN	B-NP	B-protein","	or	","	","	O	Oor	SH3	or	CC	O	OSH3	domains	SH3	NN	B-NP	B-proteindomains	)	domain	NNS	I-NP	I-protein)	were	)	)	O	Owere	capable	be	VBD	B-VP	Ocapable	of	capable	JJ	B-ADJP	Oof	binding	of	IN	B-PP	Obinding	STAT5A	bind	VBG	B-VP	OSTAT5A	.	STAT5A	NN	B-NP	B-protein.	Ectopically	.	.	O	OEctopically	expressed	Ectopically	RB	B-NP	Oexpressed	BTK	express	VBN	I-NP	OBTK	kinase	BTK	NN	I-NP	B-proteinkinase	domain	kinase	NN	I-NP	I-proteindomain	was	domain	NN	I-NP	I-proteinwas	capable	be	VBD	B-VP	Ocapable	of	capable	JJ	B-ADJP	Oof	tyrosine-phosphorylating	of	IN	B-PP	Otyrosine-phosphorylating	STAT5A	tyrosine-phosphorylating	JJ	B-NP	OSTAT5A	both	STAT5A	NN	I-NP	B-proteinboth	in	both	CC	O	Oin	vitro	in	FW	B-ADVP	Ovitro	and	vitro	FW	I-ADVP	Oand	in	and	CC	O	Oin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	BTK	.	.	O	OBTK	#NAME?	BTK	NN	B-NP	B-protein#NAME?	tyrosine	#NAME?	JJ	I-NP	Otyrosine	phosphorylation	tyrosine	NN	I-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	ectopically	of	IN	B-PP	Oectopically	expressed	ectopically	RB	B-NP	Oexpressed	wild	express	VBN	I-NP	Owild	type	wild	JJ	I-NP	Otype	(	type	NN	I-NP	O(	but	(	(	O	Obut	not	but	CC	O	Onot	Tyr	not	RB	O	OTyr	(	Tyr	NN	B-NP	B-protein(	694	(	(	O	O694	)	694	CD	B-NP	O)	mutant	)	)	O	Omutant	)	mutant	NN	B-NP	O)	STAT5A	)	)	O	OSTAT5A	enhanced	STAT5A	NN	B-NP	B-proteinenhanced	its	enhance	VBD	B-VP	Oits	DNA	its	PRP$	B-NP	ODNA	binding	DNA	NN	I-NP	Obinding	activity	binding	NN	I-NP	Oactivity	.	activity	NN	I-NP	O.	In	.	.	O	OIn	BTK	In	IN	B-PP	OBTK	#NAME?	BTK	NN	B-NP	B-cell_line#NAME?	chicken	#NAME?	JJ	I-NP	I-cell_linechicken	B	chicken	NN	I-NP	I-cell_lineB	cells	B	NN	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	anti-IgM-stimulated	","	","	O	Oanti-IgM-stimulated	tyrosine	anti-IgM-stimulated	JJ	B-NP	Otyrosine	phosphorylation	tyrosine	NN	I-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	STAT5	of	IN	B-PP	OSTAT5	protein	STAT5	NN	B-NP	B-proteinprotein	was	protein	NN	I-NP	I-proteinwas	prevented	be	VBD	B-VP	Oprevented	by	prevent	VBN	I-VP	Oby	pretreatment	by	IN	B-PP	Opretreatment	with	pretreatment	NN	B-NP	Owith	the	with	IN	B-PP	Othe	BTK	the	DT	B-NP	OBTK	inhibitor	BTK	NN	I-NP	B-proteininhibitor	LFM-A13	inhibitor	NN	I-NP	OLFM-A13	but	LFM-A13	NN	I-NP	Obut	not	but	CC	B-PP	Onot	by	not	RB	B-PP	Oby	pretreatment	by	IN	I-PP	Opretreatment	with	pretreatment	NN	B-NP	Owith	the	with	IN	B-PP	Othe	JAK3	the	DT	B-NP	OJAK3	inhibitor	JAK3	NN	I-NP	B-proteininhibitor	HI-P131	inhibitor	NN	I-NP	OHI-P131	.	HI-P131	NN	I-NP	O.	B	.	.	O	OB	cell	B	NN	B-NP	B-proteincell	antigen	cell	NN	I-NP	I-proteinantigen	receptor	antigen	NN	I-NP	I-proteinreceptor	ligation	receptor	NN	I-NP	I-proteinligation	resulted	ligation	NN	I-NP	Oresulted	in	result	VBD	B-VP	Oin	enhanced	in	IN	B-PP	Oenhanced	tyrosine	enhance	VBN	B-NP	Otyrosine	phosphorylation	tyrosine	NN	I-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	STAT5	of	IN	B-PP	OSTAT5	in	STAT5	NN	B-NP	B-proteinin	BTK	in	IN	B-PP	OBTK	#NAME?	BTK	NN	B-NP	B-protein#NAME?	chicken	#NAME?	JJ	I-NP	Ochicken	B	chicken	NN	I-NP	OB	cells	B	NN	I-NP	Ocells	reconstituted	cell	NNS	I-NP	Oreconstituted	with	reconstitute	VBN	B-VP	Owith	wild	with	IN	B-PP	Owild	type	wild	JJ	B-NP	B-proteintype	human	type	NN	I-NP	I-proteinhuman	BTK	human	JJ	I-NP	I-proteinBTK	but	BTK	NN	I-NP	I-proteinbut	not	but	CC	B-PP	Onot	in	not	RB	B-PP	Oin	BTK	in	IN	I-PP	OBTK	#NAME?	BTK	NN	B-NP	B-cell_line#NAME?	chicken	#NAME?	JJ	I-NP	I-cell_linechicken	B	chicken	NN	I-NP	I-cell_lineB	cells	B	NN	I-NP	I-cell_linecells	reconstituted	cell	NNS	I-NP	I-cell_linereconstituted	with	reconstitute	VBN	B-VP	Owith	kinase-inactive	with	IN	B-PP	Okinase-inactive	mutant	kinase-inactive	JJ	B-NP	B-proteinmutant	BTK	mutant	JJ	I-NP	I-proteinBTK	.	BTK	NN	I-NP	I-protein.	Similarly	.	.	O	OSimilarly	","	Similarly	RB	B-ADVP	O","	anti-IgM	","	","	O	Oanti-IgM	stimulation	anti-IgM	JJ	B-NP	B-proteinstimulation	resulted	stimulation	NN	I-NP	Oresulted	in	result	VBD	B-VP	Oin	enhanced	in	IN	B-PP	Oenhanced	tyrosine	enhance	VBN	B-NP	Otyrosine	phosphorylation	tyrosine	NN	I-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	STAT5A	of	IN	B-PP	OSTAT5A	in	STAT5A	NN	B-NP	B-proteinin	BTK	in	IN	B-PP	OBTK	#NAME?	BTK	NN	B-NP	B-cell_type#NAME?	B	#NAME?	JJ	I-NP	I-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	wild	from	IN	B-PP	Owild	type	wild	JJ	B-NP	Otype	mice	type	NN	I-NP	Omice	but	mouse	NNS	I-NP	Obut	not	but	CC	B-PP	Onot	in	not	RB	B-PP	Oin	BTK	in	IN	I-PP	OBTK	#NAME?	BTK	NN	B-NP	B-cell_line#NAME?	B	#NAME?	JJ	I-NP	I-cell_lineB	cells	B	NN	I-NP	I-cell_linecells	from	cell	NNS	I-NP	I-cell_linefrom	XID	from	IN	B-PP	OXID	mice	XID	NN	B-NP	Omice	.	mouse	NNS	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	to	contrast	NN	B-NP	Oto	B	to	TO	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	XID	from	IN	B-PP	OXID	mice	XID	NN	B-NP	Omice	","	mouse	NNS	I-NP	O","	B	","	","	O	OB	cells	B	NN	B-NP	B-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	JAK3	from	IN	B-PP	OJAK3	knockout	JAK3	NN	B-NP	B-proteinknockout	mice	knockout	NN	I-NP	Omice	showed	mouse	NNS	I-NP	Oshowed	a	show	VBD	B-VP	Oa	normal	a	DT	B-NP	Onormal	STAT5A	normal	JJ	I-NP	OSTAT5A	phosphorylation	STAT5A	NN	I-NP	B-proteinphosphorylation	response	phosphorylation	NN	I-NP	Oresponse	to	response	NN	I-NP	Oto	anti-IgM	to	TO	B-PP	Oanti-IgM	stimulation	anti-IgM	JJ	B-NP	B-proteinstimulation	.	stimulation	NN	I-NP	O.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	provide	finding	NNS	I-NP	Oprovide	unprecedented	provide	VBP	B-VP	Ounprecedented	experimental	unprecedented	JJ	B-NP	Oexperimental	evidence	experimental	JJ	I-NP	Oevidence	that	evidence	NN	I-NP	Othat	BTK	that	IN	B-SBAR	OBTK	plays	BTK	NN	B-NP	B-proteinplays	a	play	VBZ	B-VP	Oa	nonredundant	a	DT	B-NP	Ononredundant	and	nonredundant	JJ	I-NP	Oand	pivotal	and	CC	I-NP	Opivotal	role	pivotal	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	B	in	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	antigen	cell	NN	I-NP	Oantigen	receptor-mediated	antigen	NN	I-NP	Oreceptor-mediated	STAT5A	receptor-mediated	JJ	I-NP	OSTAT5A	activation	STAT5A	NN	I-NP	B-proteinactivation	in	activation	NN	I-NP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	Role	cell	NNS	I-NP	I-cell_typeRole	of	Role	NN	B-NP	Oof	T-bet	of	IN	B-PP	OT-bet	in	T-bet	NN	B-NP	B-proteinin	commitment	in	IN	B-PP	Ocommitment	of	commitment	NN	B-NP	Oof	TH1	of	IN	B-PP	OTH1	cells	TH1	NN	B-NP	B-cell_linecells	before	cell	NNS	I-NP	I-cell_linebefore	IL-12	before	IN	B-PP	OIL-12	#NAME?	IL-12	NN	B-NP	B-protein#NAME?	selection	#NAME?	JJ	I-NP	Oselection	.	selection	NN	I-NP	O.	How	.	.	O	OHow	cytokines	How	WRB	B-ADVP	Ocytokines	control	cytokine	NNS	B-NP	B-proteincontrol	differentiation	control	VBP	B-VP	Odifferentiation	of	differentiation	NN	B-NP	Oof	helper	of	IN	B-PP	Ohelper	T	helper	NN	B-NP	B-cell_typeT	(	T	NN	I-NP	I-cell_type(	TH	(	(	I-NP	I-cell_typeTH	)	TH	NN	I-NP	I-cell_type)	cells	)	)	I-NP	I-cell_typecells	is	cell	NNS	I-NP	I-cell_typeis	controversial	be	VBZ	B-VP	Ocontroversial	.	controversial	JJ	B-ADJP	O.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	T-bet	that	IN	B-SBAR	OT-bet	","	T-bet	NN	B-NP	O","	without	","	","	O	Owithout	apparent	without	IN	B-PP	Oapparent	assistance	apparent	JJ	B-NP	Oassistance	from	assistance	NN	I-NP	Ofrom	interleukin	from	IN	B-PP	Ointerleukin	12	interleukin	NN	B-NP	B-protein12	(	12	CD	I-NP	I-protein(	IL-12	(	(	O	OIL-12	)	IL-12	NN	B-NP	B-protein)	/	)	)	O	O/	STAT4	/	SYM	B-NP	OSTAT4	","	STAT4	NN	I-NP	B-protein","	specifies	","	","	O	Ospecifies	TH1	specify	VBZ	B-VP	OTH1	effector	TH1	NN	B-NP	Oeffector	fate	effector	NN	I-NP	Ofate	by	fate	NN	I-NP	Oby	targeting	by	IN	B-PP	Otargeting	chromatin	target	VBG	B-VP	Ochromatin	remodeling	chromatin	NN	B-NP	B-DNAremodeling	to	remodeling	NN	I-NP	Oto	individual	to	TO	B-PP	Oindividual	interferon-gamma	individual	JJ	B-NP	Ointerferon-gamma	(	interferon-gamma	NN	I-NP	B-protein(	IFN-gamma	(	(	O	OIFN-gamma	)	IFN-gamma	NN	B-NP	B-protein)	alleles	)	)	O	Oalleles	and	allele	NNS	B-NP	Oand	by	and	CC	B-PP	Oby	inducing	by	IN	B-PP	Oinducing	IL-12	induce	VBG	B-VP	OIL-12	receptor	IL-12	NN	B-NP	B-proteinreceptor	beta2	receptor	NN	I-NP	I-proteinbeta2	expression	beta2	NN	I-NP	I-proteinexpression	.	expression	NN	I-NP	O.	Subsequently	.	.	O	OSubsequently	","	Subsequently	RB	B-ADVP	O","	it	","	","	O	Oit	appears	it	PRP	B-NP	Oappears	that	appear	VBZ	B-VP	Othat	IL-12	that	IN	B-SBAR	OIL-12	/	IL-12	NN	B-NP	B-protein/	STAT4	/	SYM	B-NP	OSTAT4	serves	STAT4	NN	I-NP	B-proteinserves	two	serve	VBZ	B-VP	Otwo	essential	two	CD	B-NP	Oessential	functions	essential	JJ	I-NP	Ofunctions	in	function	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	TH1	of	IN	B-PP	OTH1	cells	TH1	NN	B-NP	B-cell_typecells	:	cell	NNS	I-NP	I-cell_type:	as	:	:	O	Oas	growth	as	IN	B-SBAR	Ogrowth	signal	growth	NN	B-NP	Osignal	","	signal	NN	I-NP	O","	inducing	","	","	O	Oinducing	survival	induce	VBG	B-VP	Osurvival	and	survival	NN	B-NP	Oand	cell	and	CC	I-NP	Ocell	division	cell	NN	I-NP	Odivision	;	division	NN	I-NP	O;	and	;	:	O	Oand	as	and	CC	O	Oas	trans-activator	as	IN	B-PP	Otrans-activator	","	trans-activator	NN	B-NP	B-protein","	prolonging	","	","	O	Oprolonging	IFN-gamma	prolong	VBG	B-VP	OIFN-gamma	synthesis	IFN-gamma	NN	B-NP	B-proteinsynthesis	through	synthesis	NN	I-NP	Othrough	a	through	IN	B-PP	Oa	genetic	a	DT	B-NP	Ogenetic	interaction	genetic	JJ	I-NP	Ointeraction	with	interaction	NN	I-NP	Owith	the	with	IN	B-PP	Othe	coactivator	the	DT	B-NP	Ocoactivator	","	coactivator	NN	I-NP	B-protein","	CREB-binding	","	","	O	OCREB-binding	protein	CREB-binding	JJ	B-NP	B-proteinprotein	.	protein	NN	I-NP	I-protein.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	a	that	IN	B-SBAR	Oa	cytokine	a	DT	B-NP	Ocytokine	does	cytokine	NN	I-NP	B-proteindoes	not	do	VBZ	B-VP	Onot	simply	not	RB	I-VP	Osimply	induce	simply	RB	I-VP	Oinduce	TH	induce	VB	I-VP	OTH	fate	TH	NN	B-NP	Ofate	choice	fate	NN	I-NP	Ochoice	but	choice	NN	I-NP	Obut	instead	but	CC	O	Oinstead	may	instead	RB	B-VP	Omay	act	may	MD	I-VP	Oact	as	act	VB	I-VP	Oas	an	as	IN	B-PP	Oan	essential	an	DT	B-NP	Oessential	secondary	essential	JJ	I-NP	Osecondary	stimulus	secondary	JJ	I-NP	Ostimulus	that	stimulus	NN	I-NP	Othat	mediates	that	WDT	B-NP	Omediates	selective	mediate	VBZ	B-VP	Oselective	survival	selective	JJ	B-NP	Osurvival	of	survival	NN	I-NP	Oof	a	of	IN	B-PP	Oa	lineage	a	DT	B-NP	Olineage	.	lineage	NN	I-NP	O.	Stat6	.	.	O	OStat6	is	Stat6	NN	B-NP	B-proteinis	necessary	be	VBZ	B-VP	Onecessary	and	necessary	JJ	B-ADJP	Oand	sufficient	and	CC	I-ADJP	Osufficient	for	sufficient	JJ	I-ADJP	Ofor	IL-4	for	IN	B-PP	OIL-4	's	IL-4	NN	B-NP	B-protein's	role	's	POS	B-NP	Orole	in	role	NN	I-NP	Oin	Th2	in	IN	B-PP	OTh2	differentiation	Th2	NN	B-NP	Odifferentiation	and	differentiation	NN	I-NP	Oand	cell	and	CC	O	Ocell	expansion	cell	NN	B-NP	Oexpansion	.	expansion	NN	I-NP	O.	IL-4	.	.	O	OIL-4	plays	IL-4	NN	B-NP	B-proteinplays	a	play	VBZ	B-VP	Oa	critical	a	DT	B-NP	Ocritical	role	critical	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	differentiation	the	DT	B-NP	Odifferentiation	of	differentiation	NN	I-NP	Oof	T	of	IN	B-PP	OT	CR-stimulated	T	NN	B-NP	B-cell_typeCR-stimulated	naive	CR-stimulated	JJ	I-NP	I-cell_typenaive	CD4	naive	JJ	I-NP	I-cell_typeCD4	T	CD4	NN	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	the	to	TO	B-PP	Othe	Th2	the	DT	B-NP	OTh2	phenotype	Th2	NN	I-NP	B-cell_typephenotype	.	phenotype	NN	I-NP	I-cell_type.	In	.	.	O	OIn	response	In	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	IL-4	to	TO	B-PP	OIL-4	","	IL-4	NN	B-NP	B-protein","	the	","	","	O	Othe	IL-4R	the	DT	B-NP	OIL-4R	activates	IL-4R	NN	I-NP	B-proteinactivates	a	activate	VBZ	B-VP	Oa	set	a	DT	B-NP	Oset	of	set	NN	I-NP	Oof	phosphotyrosine	of	IN	B-PP	Ophosphotyrosine	binding	phosphotyrosine	NN	B-NP	B-proteinbinding	domain-containing	binding	NN	I-NP	I-proteindomain-containing	proteins	domain-containing	JJ	I-NP	I-proteinproteins	","	protein	NNS	I-NP	I-protein","	including	","	","	O	Oincluding	insulin	include	VBG	B-PP	Oinsulin	receptor	insulin	NN	B-NP	B-proteinreceptor	substrate	receptor	NN	I-NP	I-proteinsubstrate	2-Jan	substrate	NN	I-NP	I-protein2-Jan	","	2-Jan	CD	I-NP	I-protein","	Shc	","	","	O	OShc	","	Shc	NNP	B-NP	B-protein","	and	","	","	O	Oand	IL-4R	and	CC	O	OIL-4R	interacting	IL-4R	NN	B-NP	B-proteininteracting	protein	interact	VBG	B-VP	I-proteinprotein	","	protein	NN	B-NP	I-protein","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	Stat6	as	IN	I-CONJP	OStat6	.	Stat6	NN	B-NP	B-protein.	Stat6	.	.	O	OStat6	has	Stat6	NN	B-NP	B-proteinhas	been	have	VBZ	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	required	be	VB	I-VP	Orequired	for	require	VBN	I-VP	Ofor	Th2	for	IN	B-PP	OTh2	differentiation	Th2	NN	B-NP	Odifferentiation	.	differentiation	NN	I-NP	O.	To	.	.	O	OTo	determine	To	TO	B-VP	Odetermine	the	determine	VB	I-VP	Othe	roles	the	DT	B-NP	Oroles	of	role	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	phosphotyrosine	the	DT	B-NP	Ophosphotyrosine	binding	phosphotyrosine	NN	I-NP	B-proteinbinding	adaptors	binding	NN	I-NP	I-proteinadaptors	in	adaptor	NNS	I-NP	I-proteinin	Th2	in	IN	B-PP	OTh2	differentiation	Th2	NN	B-NP	Odifferentiation	","	differentiation	NN	I-NP	O","	we	","	","	O	Owe	prepared	we	PRP	B-NP	Oprepared	a	prepare	VBD	B-VP	Oa	retrovirus	a	DT	B-NP	Oretrovirus	containing	retrovirus	NN	I-NP	Ocontaining	a	contain	VBG	B-VP	Oa	mutant	a	DT	B-NP	Omutant	of	mutant	NN	I-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	(	human	JJ	I-NP	B-protein(	h	(	(	O	I-proteinh	)	h	NN	B-NP	I-protein)	IL-4R	)	)	O	I-proteinIL-4R	alpha-chain	IL-4R	NN	B-NP	I-proteinalpha-chain	","	alpha-chain	NN	I-NP	I-protein","	Y497F	","	","	O	OY497F	","	Y497F	NN	B-NP	B-protein","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	unable	be	VBZ	B-VP	Ounable	to	unable	JJ	B-ADJP	Oto	recruit	to	TO	B-VP	Orecruit	these	recruit	VB	I-VP	Othese	adaptors	these	DT	B-NP	Oadaptors	.	adaptor	NNS	I-NP	O.	The	.	.	O	OThe	mutant	The	DT	B-NP	Omutant	hIL-4Ralpha	mutant	JJ	I-NP	B-proteinhIL-4Ralpha	","	hIL-4Ralpha	NN	I-NP	I-protein","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	the	as	IN	I-CONJP	Othe	wild-type	the	DT	B-NP	Owild-type	(	wild-type	JJ	I-NP	B-protein(	WT	(	(	O	I-proteinWT	)	WT	JJ	O	I-protein)	hIL-4Ralpha	)	)	O	I-proteinhIL-4Ralpha	","	hIL-4Ralpha	NN	B-NP	I-protein","	was	","	","	O	Owas	introduced	be	VBD	B-VP	Ointroduced	into	introduce	VBN	I-VP	Ointo	naive	into	IN	B-PP	Onaive	CD4	naive	JJ	B-NP	B-cell_typeCD4	T	CD4	NN	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Upon	.	.	O	OUpon	hIL-4	Upon	IN	B-PP	OhIL-4	stimulation	hIL-4	NN	B-NP	B-proteinstimulation	","	stimulation	NN	I-NP	O","	Y497F	","	","	O	OY497F	worked	Y497F	NN	B-NP	B-proteinworked	as	work	VBD	B-VP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	the	as	IN	I-CONJP	Othe	WT	the	DT	B-NP	OWT	hIL-4Ralpha	WT	JJ	I-NP	B-proteinhIL-4Ralpha	in	hIL-4Ralpha	NN	I-NP	I-proteinin	driving	in	IN	B-PP	Odriving	Th2	drive	VBG	B-VP	OTh2	differentiation	Th2	NN	B-NP	Odifferentiation	","	differentiation	NN	I-NP	O","	as	","	","	O	Oas	measured	as	IN	B-SBAR	Omeasured	by	measure	VBN	B-VP	Oby	Gata3	by	IN	B-PP	OGata3	up-regulation	Gata3	NN	B-NP	B-proteinup-regulation	and	up-regulation	NN	I-NP	Oand	IL-4	and	CC	O	OIL-4	production	IL-4	NN	B-NP	B-proteinproduction	.	production	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	IL-4-driven	","	","	O	OIL-4-driven	cell	IL-4-driven	JJ	B-NP	Ocell	expansion	cell	NN	I-NP	Oexpansion	was	expansion	NN	I-NP	Owas	also	be	VBD	B-VP	Oalso	normal	also	RB	B-ADVP	Onormal	in	normal	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	cells	the	DT	B-NP	Ocells	infected	cell	NNS	I-NP	Oinfected	with	infect	VBN	B-VP	Owith	Y497F	with	IN	B-PP	OY497F	","	Y497F	NN	B-NP	B-protein","	although	","	","	O	Oalthough	cells	although	IN	B-SBAR	Ocells	infected	cell	NNS	B-NP	Oinfected	with	infect	VBN	B-VP	Owith	Y497F	with	IN	B-PP	OY497F	were	Y497F	NN	B-NP	B-proteinwere	not	be	VBD	B-VP	Onot	capable	not	RB	B-ADJP	Ocapable	of	capable	JJ	I-ADJP	Oof	phosphorylating	of	IN	B-PP	Ophosphorylating	insulin	phosphorylate	VBG	B-VP	Oinsulin	receptor	insulin	NN	B-NP	B-proteinreceptor	substrate	receptor	NN	I-NP	I-proteinsubstrate	2	substrate	NN	I-NP	I-protein2	.	2	CD	I-NP	I-protein.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	signal	the	DT	B-NP	Osignal	pathway	signal	NN	I-NP	Opathway	mediated	pathway	NN	I-NP	Omediated	by	mediate	VBN	B-VP	Oby	Y497	by	IN	B-PP	OY497	is	Y497	NN	B-NP	B-proteinis	dispensable	be	VBZ	B-VP	Odispensable	for	dispensable	JJ	B-ADJP	Ofor	both	for	IN	B-PP	Oboth	IL-4	both	CC	O	OIL-4	#NAME?	IL-4	NN	B-NP	B-protein#NAME?	Th2	#NAME?	JJ	I-NP	OTh2	differentiation	Th2	NN	I-NP	Odifferentiation	and	differentiation	NN	I-NP	Oand	cell	and	CC	O	Ocell	expansion	cell	NN	B-NP	Oexpansion	.	expansion	NN	I-NP	O.	Both	.	.	O	OBoth	WT	Both	CC	O	OWT	and	WT	NN	B-NP	Oand	Y497F	and	CC	I-NP	OY497F	hIL-4Ralpha	Y497F	NN	I-NP	B-proteinhIL-4Ralpha	lose	hIL-4Ralpha	NN	I-NP	I-proteinlose	the	lose	VBP	B-VP	Othe	ability	the	DT	B-NP	Oability	to	ability	NN	I-NP	Oto	drive	to	TO	B-VP	Odrive	Th2	drive	VB	I-VP	OTh2	differentiation	Th2	NN	B-NP	Odifferentiation	and	differentiation	NN	I-NP	Oand	cell	and	CC	O	Ocell	expansion	cell	NN	B-NP	Oexpansion	in	expansion	NN	I-NP	Oin	Stat6-knockout	in	IN	B-PP	OStat6-knockout	CD4	Stat6-knockout	JJ	B-NP	B-cell_typeCD4	T	CD4	NN	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	A	.	.	O	OA	constitutively	A	DT	B-NP	Oconstitutively	activated	constitutively	RB	I-NP	Oactivated	form	activated	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	Stat6	of	IN	B-PP	OStat6	introduced	Stat6	NN	B-NP	B-proteinintroduced	into	introduce	VBN	B-VP	Ointo	CD4	into	IN	B-PP	OCD4	T	CD4	NN	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	resulted	cell	NNS	I-NP	I-cell_typeresulted	in	result	VBD	B-VP	Oin	both	in	IN	B-PP	Oboth	Th2	both	CC	O	OTh2	differentiation	Th2	NN	B-NP	Odifferentiation	and	differentiation	NN	I-NP	Oand	enhanced	and	CC	O	Oenhanced	cell	enhance	VBN	B-NP	Ocell	expansion	cell	NN	I-NP	Oexpansion	.	expansion	NN	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	activated	","	","	O	Oactivated	Stat6	activate	VBN	B-NP	OStat6	is	Stat6	NN	I-NP	B-proteinis	necessary	be	VBZ	B-VP	Onecessary	and	necessary	JJ	B-ADJP	Oand	sufficient	and	CC	I-ADJP	Osufficient	to	sufficient	JJ	I-ADJP	Oto	mediate	to	TO	B-VP	Omediate	both	mediate	VB	I-VP	Oboth	IL-4	both	CC	O	OIL-4	#NAME?	IL-4	NN	B-NP	B-protein#NAME?	Th2	#NAME?	JJ	I-NP	OTh2	differentiation	Th2	NN	I-NP	Odifferentiation	and	differentiation	NN	I-NP	Oand	cell	and	CC	O	Ocell	expansion	cell	NN	B-NP	Oexpansion	in	expansion	NN	I-NP	Oin	CD4	in	IN	B-PP	OCD4	T	CD4	NN	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	effect	The	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	HIV-1	of	IN	B-PP	OHIV-1	regulatory	HIV-1	NN	B-NP	B-proteinregulatory	proteins	regulatory	JJ	I-NP	I-proteinproteins	on	protein	NNS	I-NP	I-proteinon	cellular	on	IN	B-PP	Ocellular	genes	cellular	JJ	B-NP	B-DNAgenes	:	gene	NNS	I-NP	I-DNA:	derepression	:	:	O	Oderepression	of	derepression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	by	promoter	NN	I-NP	I-DNAby	Tat	by	IN	B-PP	OTat	.	Tat	NN	B-NP	B-protein.	In	.	.	O	OIn	HIV-infected	In	IN	B-PP	OHIV-infected	individuals	HIV-infected	JJ	B-NP	Oindividuals	dysregulation	individual	NNS	I-NP	Odysregulation	of	dysregulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	immune	the	DT	B-NP	Oimmune	system	immune	JJ	I-NP	Osystem	is	system	NN	I-NP	Ois	characterized	be	VBZ	B-VP	Ocharacterized	by	characterize	VBN	I-VP	Oby	severe	by	IN	B-PP	Osevere	disorders	severe	JJ	B-NP	Odisorders	of	disorder	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	cytokine	the	DT	B-NP	Ocytokine	network	cytokine	NN	I-NP	B-proteinnetwork	.	network	NN	I-NP	I-protein.	Increase	.	.	O	OIncrease	secretion	Increase	NN	B-NP	Osecretion	of	secretion	NN	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	","	IL-2	NN	B-NP	B-protein","	the	","	","	O	Othe	major	the	DT	B-NP	Omajor	T	major	JJ	I-NP	OT	cell	T	NN	I-NP	Ocell	growth	cell	NN	I-NP	Ogrowth	and	growth	NN	I-NP	Oand	differentiation	and	CC	O	Odifferentiation	cytokine	differentiation	NN	B-NP	Ocytokine	","	cytokine	NN	I-NP	B-protein","	may	","	","	O	Omay	play	may	MD	B-VP	Oplay	a	play	VB	I-VP	Oa	decisive	a	DT	B-NP	Odecisive	role	decisive	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	sensitization	in	IN	B-PP	Osensitization	of	sensitization	NN	B-NP	Oof	T	of	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	for	cell	NNS	I-NP	I-cell_typefor	activation	for	IN	B-PP	Oactivation	induced	activation	NN	B-NP	Oinduced	apoptosis	induce	VBD	B-VP	Oapoptosis	and	apoptosis	NN	B-NP	Oand	indirect	and	CC	O	Oindirect	death	indirect	JJ	B-NP	Odeath	of	death	NN	I-NP	Oof	activated	of	IN	B-PP	Oactivated	T	activate	VBN	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	through	cell	NNS	I-NP	I-cell_typethrough	augmented	through	IN	B-PP	Oaugmented	virus	augmented	JJ	B-NP	Ovirus	replication	virus	NN	I-NP	Oreplication	.	replication	NN	I-NP	O.	We	.	.	O	OWe	investigated	We	PRP	B-NP	Oinvestigated	the	investigate	VBD	B-VP	Othe	cause	the	DT	B-NP	Ocause	of	cause	NN	I-NP	Oof	enhanced	of	IN	B-PP	Oenhanced	IL-2	enhance	VBN	B-NP	OIL-2	secretion	IL-2	NN	I-NP	B-proteinsecretion	and	secretion	NN	I-NP	Oand	found	and	CC	O	Ofound	that	find	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	HIV	the	DT	B-NP	OHIV	Tat	HIV	NN	I-NP	B-proteinTat	induces	Tat	NN	I-NP	I-proteininduces	this	induce	VBZ	B-VP	Othis	effect	this	DT	B-NP	Oeffect	.	effect	NN	I-NP	O.	We	.	.	O	OWe	demonstrate	We	PRP	B-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	increased	that	IN	B-SBAR	Oincreased	IL-2	increase	VBN	B-NP	OIL-2	secretion	IL-2	NN	I-NP	B-proteinsecretion	is	secretion	NN	I-NP	Ois	due	be	VBZ	B-VP	Odue	to	due	IN	B-PP	Oto	Tat	to	TO	B-PP	OTat	#NAME?	Tat	NN	B-NP	B-protein#NAME?	IL-2	#NAME?	JJ	I-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	activation	promoter	NN	I-NP	I-DNAactivation	.	activation	NN	I-NP	O.	Tat	.	.	O	OTat	derepresses	Tat	NN	B-NP	B-proteinderepresses	and	derepresse	VBZ	B-VP	Oand	activates	and	CC	I-VP	Oactivates	the	activate	VBZ	I-VP	Othe	distal	the	DT	B-NP	Odistal	AP-1	distal	JJ	I-NP	B-DNAAP-1	site	AP-1	NN	I-NP	I-DNAsite	(	site	NN	I-NP	I-DNA(	position	(	(	O	Oposition	-185	position	NN	B-NP	B-DNA-185	to	-185	CD	I-NP	I-DNAto	-177	to	TO	I-NP	I-DNA-177	)	-177	CD	I-NP	I-DNA)	in	)	)	O	Oin	the	in	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	In	.	.	O	OIn	nonstimulated	In	IN	B-PP	Ononstimulated	T	nonstimulated	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	a	cell	NNS	I-NP	I-cell_typea	repressor	a	DT	B-NP	Orepressor	complex	repressor	NN	I-NP	B-proteincomplex	containing	complex	NN	I-NP	I-proteincontaining	NF-IL6	contain	VBG	B-VP	ONF-IL6	","	NF-IL6	NN	B-NP	B-protein","	JunB	","	","	O	OJunB	","	JunB	NN	B-NP	B-protein","	c-Fos	","	","	O	Oc-Fos	and	c-Fos	NN	B-NP	B-proteinand	Fra-1	and	CC	I-NP	OFra-1	is	Fra-1	NN	I-NP	B-proteinis	formed	be	VBZ	B-VP	Oformed	on	form	VBN	I-VP	Oon	the	on	IN	B-PP	Othe	AP-1	the	DT	B-NP	OAP-1	(	AP-1	NN	I-NP	B-DNA(	IL-2/d	(	(	O	I-DNAIL-2/d	)	IL-2/d	NN	B-NP	I-DNA)	site	)	)	O	I-DNAsite	and	site	NN	B-NP	I-DNAand	represses	and	CC	O	Orepresses	IL-2	repress	VBZ	B-VP	OIL-2	promoter	IL-2	NN	B-NP	B-DNApromoter	activity	promoter	NN	I-NP	I-DNAactivity	.	activity	NN	I-NP	O.	After	.	.	O	OAfter	T	After	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	","	activation	NN	I-NP	O","	a	","	","	O	Oa	heterodimeric	a	DT	B-NP	Oheterodimeric	activator	heterodimeric	JJ	I-NP	B-proteinactivator	containing	activator	NN	I-NP	I-proteincontaining	p65	contain	VBG	B-VP	Op65	and	p65	NN	B-NP	B-proteinand	c-Jun	and	CC	I-NP	Oc-Jun	binds	c-Jun	NN	I-NP	B-proteinbinds	to	bind	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	AP-1	the	DT	B-NP	OAP-1	(	AP-1	NN	B-NP	B-DNA(	IL-2/d	(	(	O	I-DNAIL-2/d	)	IL-2/d	NN	B-NP	I-DNA)	site	)	)	O	I-DNAsite	.	site	NN	B-NP	I-DNA.	HIV	.	.	O	OHIV	Tat	HIV	NN	B-NP	B-proteinTat	enhances	Tat	NN	I-NP	I-proteinenhances	activation	enhance	VBZ	B-VP	Oactivation	of	activation	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	and	NF-kappaB	NN	B-NP	B-proteinand	consequently	and	CC	O	Oconsequently	","	consequently	RB	B-ADVP	O","	activates	","	","	O	Oactivates	the	activate	VBZ	B-VP	Othe	AP-1	the	DT	B-NP	OAP-1	(	AP-1	NN	B-NP	B-DNA(	IL-2/d	(	(	O	I-DNAIL-2/d	)	IL-2/d	NN	B-NP	I-DNA)	site	)	)	O	I-DNAsite	.	site	NN	B-NP	I-DNA.	Our	.	.	O	OOur	data	Our	PRP$	B-NP	Odata	provide	datum	NNS	I-NP	Oprovide	evidence	provide	VBP	B-VP	Oevidence	for	evidence	NN	B-NP	Ofor	a	for	IN	B-PP	Oa	novel	a	DT	B-NP	Onovel	mechanism	novel	JJ	I-NP	Omechanism	by	mechanism	NN	I-NP	Oby	which	by	IN	B-PP	Owhich	HIV	which	WDT	B-NP	OHIV	Tat	HIV	NN	B-NP	B-proteinTat	dysregulates	Tat	NN	I-NP	I-proteindysregulates	IL-2	dysregulate	VBZ	B-VP	OIL-2	production	IL-2	NN	B-NP	B-proteinproduction	and	production	NN	I-NP	Oand	therefore	and	CC	O	Otherefore	may	therefore	RB	B-VP	Omay	contribute	may	MD	I-VP	Ocontribute	to	contribute	VB	I-VP	Oto	the	to	TO	B-PP	Othe	HIV-1	the	DT	B-NP	OHIV-1	infection	HIV-1	NN	I-NP	Oinfection	in	infection	NN	I-NP	Oin	a	in	IN	B-PP	Oa	way	a	DT	B-NP	Oway	yet	way	NN	I-NP	Oyet	to	yet	RB	B-ADVP	Oto	be	to	TO	B-VP	Obe	clarified	be	VB	I-VP	Oclarified	.	clarify	VBN	I-VP	O.	Transforming	.	.	O	OTransforming	growth	Transform	VBG	B-NP	B-proteingrowth	factor-beta1	growth	NN	I-NP	I-proteinfactor-beta1	interferes	factor-beta1	NN	I-NP	I-proteininterferes	with	interfere	VBZ	B-VP	Owith	thrombopoietin-induced	with	IN	B-PP	Othrombopoietin-induced	signal	thrombopoietin-induced	JJ	B-NP	Osignal	transduction	signal	NN	I-NP	Otransduction	in	transduction	NN	I-NP	Oin	megakaryoblastic	in	IN	B-PP	Omegakaryoblastic	and	megakaryoblastic	JJ	B-NP	Oand	erythroleukemic	and	CC	I-NP	Oerythroleukemic	cells	erythroleukemic	JJ	I-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	OBJECTIVE	.	.	O	OOBJECTIVE	:	OBJECTIVE	NN	B-NP	O:	Thrombopoietin	:	:	O	OThrombopoietin	(	Thrombopoietin	NN	B-NP	B-protein(	TPO	(	(	O	OTPO	)	TPO	NN	B-NP	B-protein)	and	)	)	O	Oand	transforming	and	CC	O	Otransforming	growth	transform	VBG	B-VP	B-proteingrowth	factor-beta	growth	NN	B-NP	I-proteinfactor-beta	(	factor-beta	NN	I-NP	I-protein(	1	(	(	O	O1	)	1	CD	B-NP	O)	(	)	)	O	O(	TGF-beta	(	(	O	OTGF-beta	(	TGF-beta	NN	B-NP	B-protein(	1	(	(	O	O1	)	1	CD	B-NP	O)	)	)	)	O	O)	have	)	)	O	Ohave	been	have	VBP	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	exert	to	TO	I-VP	Oexert	opposite	exert	VB	I-VP	Oopposite	effects	opposite	JJ	B-NP	Oeffects	on	effect	NNS	I-NP	Oon	proliferation	on	IN	B-PP	Oproliferation	and	proliferation	NN	B-NP	Oand	megakaryocytic	and	CC	O	Omegakaryocytic	differentiation	megakaryocytic	JJ	B-NP	Odifferentiation	of	differentiation	NN	I-NP	Oof	hematopoietic	of	IN	B-PP	Ohematopoietic	cells	hematopoietic	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	To	.	.	O	OTo	determine	To	TO	B-VP	Odetermine	whether	determine	VB	I-VP	Owhether	TGF-beta	whether	IN	B-SBAR	OTGF-beta	(	TGF-beta	NN	B-NP	B-protein(	1	(	(	O	O1	)	1	CD	B-NP	O)	interferes	)	)	O	Ointerferes	directly	interfere	VBZ	B-VP	Odirectly	with	directly	RB	B-ADVP	Owith	TPO	with	IN	B-PP	OTPO	#NAME?	TPO	NN	B-NP	B-protein#NAME?	signal	#NAME?	JJ	I-NP	Osignal	transduction	signal	NN	I-NP	Otransduction	in	transduction	NN	I-NP	Oin	hematopoietic	in	IN	B-PP	Ohematopoietic	cells	hematopoietic	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	we	","	","	O	Owe	compared	we	PRP	B-NP	Ocompared	the	compare	VBD	B-VP	Othe	regulatory	the	DT	B-NP	Oregulatory	effects	regulatory	JJ	I-NP	Oeffects	in	effect	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	TPO	the	DT	B-NP	OTPO	#NAME?	TPO	NN	I-NP	B-cell_line#NAME?	cell	#NAME?	JJ	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	Mo-7e	line	NNS	I-NP	I-cell_lineMo-7e	and	Mo-7e	NN	I-NP	Oand	HEL	and	CC	I-NP	OHEL	.	HEL	NN	I-NP	B-protein.	MATERIALS	.	.	O	OMATERIALS	AND	MATERIALS	NNS	B-NP	OAND	METHODS	AND	CC	I-NP	OMETHODS	:	METHODS	NNS	I-NP	O:	The	:	:	O	OThe	cells	The	DT	B-NP	Ocells	were	cell	NNS	I-NP	Owere	stimulated	be	VBD	B-VP	Ostimulated	by	stimulate	VBN	I-VP	Oby	100	by	IN	B-PP	O100	ng/mL	100	CD	B-NP	Ong/mL	TPO	ng/mL	NN	I-NP	OTPO	and/or	TPO	NN	I-NP	B-proteinand/or	100	and/or	CC	O	O100	ng/mL	100	CD	B-NP	Ong/mL	TGF-beta1	ng/mL	NN	I-NP	OTGF-beta1	and	TGF-beta1	NN	I-NP	B-proteinand	analyzed	and	CC	O	Oanalyzed	for	analyze	VBN	B-VP	Ofor	proliferation	for	IN	B-PP	Oproliferation	(	proliferation	NN	B-NP	O(	3H	(	(	O	O3H	thymidine	3H	NN	B-NP	Othymidine	incorporation	thymidine	NN	I-NP	Oincorporation	)	incorporation	NN	I-NP	O)	","	)	)	O	O","	viability	","	","	O	Oviability	(	viability	NN	B-NP	O(	trypan	(	(	O	Otrypan	blue	trypan	NN	B-NP	Oblue	exclusion	blue	JJ	I-NP	Oexclusion	)	exclusion	NN	I-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	protein	and	CC	O	Oprotein	expression	protein	NN	B-NP	Oexpression	and	expression	NN	B-NP	Oand	phosphorylation	and	CC	O	Ophosphorylation	(	phosphorylation	NN	B-NP	O(	Western	(	(	O	OWestern	blot	Western	NN	B-NP	Oblot	)	blot	NN	I-NP	O)	.	)	)	O	O.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	TPO	:	:	O	OTPO	enhanced	TPO	NN	B-NP	B-proteinenhanced	the	enhance	VBD	B-VP	Othe	proliferation	the	DT	B-NP	Oproliferation	of	proliferation	NN	I-NP	Oof	Mo-7e	of	IN	B-PP	OMo-7e	cells	Mo-7e	NN	B-NP	B-cell_typecells	as	cell	NNS	I-NP	I-cell_typeas	determined	as	IN	B-SBAR	Odetermined	by	determine	VBN	B-VP	Oby	3H-thymidine	by	IN	B-PP	O3H-thymidine	incorporation	3H-thymidine	NN	B-NP	Oincorporation	","	incorporation	NN	I-NP	O","	whereas	","	","	O	Owhereas	TGF-beta1	whereas	IN	O	OTGF-beta1	suppressed	TGF-beta1	NN	B-NP	B-proteinsuppressed	baseline	suppress	VBD	B-VP	Obaseline	cell	baseline	NN	B-NP	Ocell	growth	cell	NN	I-NP	Ogrowth	and	growth	NN	I-NP	Oand	antagonized	and	CC	O	Oantagonized	the	antagonize	VBD	B-VP	Othe	proliferative	the	DT	B-NP	Oproliferative	effect	proliferative	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	TPO	of	IN	B-PP	OTPO	.	TPO	NN	B-NP	B-protein.	TPO	.	.	O	OTPO	#NAME?	TPO	NN	B-NP	B-protein#NAME?	proliferation	#NAME?	JJ	I-NP	Oproliferation	also	proliferation	NN	I-NP	Oalso	was	also	RB	B-ADVP	Owas	reduced	be	VBD	B-VP	Oreduced	by	reduce	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	specific	a	DT	B-NP	Ospecific	inhibitor	specific	JJ	I-NP	Oinhibitor	of	inhibitor	NN	I-NP	Oof	the	of	IN	B-PP	Othe	mitogen-activated	the	DT	B-NP	Omitogen-activated	protein	mitogen-activated	JJ	I-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	MAPK	(	(	O	OMAPK	)	MAPK	NN	B-NP	B-protein)	pathway	)	)	O	Opathway	(	pathway	NN	B-NP	O(	PD098059	(	(	O	OPD098059	)	PD098059	NN	B-NP	O)	","	)	)	O	O","	which	","	","	O	Owhich	inhibits	which	WDT	B-NP	Oinhibits	activation	inhibit	VBZ	B-VP	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	MAPK	the	DT	B-NP	OMAPK	extracellular	MAPK	NN	I-NP	B-proteinextracellular	signal-regulated	extracellular	JJ	I-NP	Osignal-regulated	kinases	signal-regulated	JJ	I-NP	Okinases	(	kinase	NNS	I-NP	O(	ERK	(	(	O	OERK	)	ERK	NN	B-NP	B-protein)	ERK1	)	)	O	OERK1	and	ERK1	NN	B-NP	B-proteinand	ERK2	and	CC	I-NP	OERK2	","	ERK2	NN	I-NP	B-protein","	and	","	","	O	Oand	AG490	and	CC	O	OAG490	","	AG490	NN	B-NP	O","	an	","	","	O	Oan	inhibitor	an	DT	B-NP	Oinhibitor	of	inhibitor	NN	I-NP	Oof	Janus	of	IN	B-PP	OJanus	kinase-2	Janus	NN	B-NP	B-proteinkinase-2	","	kinase-2	NN	I-NP	I-protein","	which	","	","	O	Owhich	completely	which	WDT	B-NP	Ocompletely	blocked	completely	RB	B-ADVP	Oblocked	TPO	block	VBD	B-VP	OTPO	#NAME?	TPO	NN	B-NP	B-protein#NAME?	proliferation	#NAME?	JJ	I-NP	Oproliferation	.	proliferation	NN	I-NP	O.	As	.	.	O	OAs	demonstrated	As	IN	B-SBAR	Odemonstrated	by	demonstrate	VBN	B-VP	Oby	Western	by	IN	B-PP	OWestern	blotting	Western	JJ	B-NP	Oblotting	","	blotting	NN	I-NP	O","	TGF-beta1	","	","	O	OTGF-beta1	reduced	TGF-beta1	NN	B-NP	B-proteinreduced	the	reduce	VBD	B-VP	Othe	TPO	the	DT	B-NP	OTPO	#NAME?	TPO	NN	I-NP	B-protein#NAME?	ERK1	#NAME?	JJ	I-NP	OERK1	/	ERK1	NN	I-NP	B-protein/	ERK2	/	SYM	B-NP	OERK2	and	ERK2	NN	B-NP	B-proteinand	STAT5	and	CC	I-NP	OSTAT5	phosphorylation	STAT5	NN	I-NP	B-proteinphosphorylation	in	phosphorylation	NN	I-NP	Oin	Mo-7e	in	IN	B-PP	OMo-7e	and	Mo-7e	NN	B-NP	Oand	HEL	and	CC	I-NP	OHEL	cells	HEL	NN	I-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	This	.	.	O	OThis	effect	This	DT	B-NP	Oeffect	was	effect	NN	I-NP	Owas	completely	be	VBD	B-VP	Ocompletely	reversed	completely	RB	I-VP	Oreversed	by	reverse	VBN	I-VP	Oby	preincubation	by	IN	B-PP	Opreincubation	with	preincubation	NN	B-NP	Owith	a	with	IN	B-PP	Oa	tyrosine	a	DT	B-NP	Otyrosine	phosphatase	tyrosine	NN	I-NP	B-proteinphosphatase	inhibitor	phosphatase	NN	I-NP	I-proteininhibitor	(	inhibitor	NN	I-NP	O(	Na3VO4	(	(	O	ONa3VO4	)	Na3VO4	NN	B-NP	O)	","	)	)	O	O","	which	","	","	O	Owhich	suggests	which	WDT	B-NP	Osuggests	that	suggest	VBZ	B-VP	Othat	TGF-beta1	that	IN	B-SBAR	OTGF-beta1	activated	TGF-beta1	NN	B-NP	B-proteinactivated	a	activate	VBD	B-VP	Oa	phosphatase	a	DT	B-NP	Ophosphatase	.	phosphatase	NN	I-NP	B-protein.	Although	.	.	O	OAlthough	STAT3	Although	IN	B-SBAR	OSTAT3	also	STAT3	NN	B-NP	B-proteinalso	was	also	RB	B-ADVP	Owas	activated	be	VBD	B-VP	Oactivated	by	activate	VBN	I-VP	Oby	TPO	by	IN	B-PP	OTPO	","	TPO	NN	B-NP	B-protein","	STAT3	","	","	O	OSTAT3	activation	STAT3	NN	B-NP	B-proteinactivation	remained	activation	NN	I-NP	Oremained	unaltered	remain	VBD	B-VP	Ounaltered	by	unaltered	JJ	B-ADJP	Oby	TGF-beta1	by	IN	B-PP	OTGF-beta1	.	TGF-beta1	NN	B-NP	B-protein.	CONCLUSION	.	.	O	OCONCLUSION	:	CONCLUSION	NN	B-NP	O:	Taken	:	:	O	OTaken	together	Take	VBN	B-VP	Otogether	","	together	RB	B-ADVP	O","	these	","	","	O	Othese	data	these	DT	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	TGF-beta1	that	IN	B-SBAR	OTGF-beta1	modulates	TGF-beta1	NN	B-NP	B-proteinmodulates	TPO	modulate	VBZ	B-VP	OTPO	#NAME?	TPO	NN	B-NP	B-protein#NAME?	effects	#NAME?	JJ	I-NP	Oeffects	on	effect	NNS	I-NP	Oon	megakaryocytic	on	IN	B-PP	Omegakaryocytic	proliferation	megakaryocytic	JJ	B-NP	Oproliferation	by	proliferation	NN	I-NP	Oby	interfering	by	IN	B-PP	Ointerfering	with	interfere	VBG	B-VP	Owith	TPO	with	IN	B-PP	OTPO	#NAME?	TPO	NN	B-NP	B-protein#NAME?	signal	#NAME?	JJ	I-NP	Osignal	transduction	signal	NN	I-NP	Otransduction	","	transduction	NN	I-NP	O","	particularly	","	","	O	Oparticularly	by	particularly	RB	B-ADVP	Oby	reducing	by	IN	B-PP	Oreducing	the	reduce	VBG	B-VP	Othe	activities	the	DT	B-NP	Oactivities	of	activity	NNS	I-NP	Oof	MAPK	of	IN	B-PP	OMAPK	ERK1/ERK2	MAPK	NN	B-NP	B-proteinERK1/ERK2	and	ERK1/ERK2	NN	I-NP	Oand	STAT5	and	CC	I-NP	OSTAT5	.	STAT5	NN	I-NP	B-protein.	Invariant	.	.	O	OInvariant	chain	Invariant	JJ	B-NP	B-proteinchain	induces	chain	NN	I-NP	I-proteininduces	B	induce	VBZ	B-VP	OB	cell	B	NN	B-NP	Ocell	maturation	cell	NN	I-NP	Omaturation	by	maturation	NN	I-NP	Oby	activating	by	IN	B-PP	Oactivating	a	activate	VBG	B-VP	Oa	TAF	a	DT	B-NP	OTAF	(	TAF	NN	I-NP	B-protein(	II	(	(	O	OII	)	II	CD	B-NP	O)	105-NF-kappaB	)	)	O	O105-NF-kappaB	#NAME?	105-NF-kappaB	NN	B-NP	O#NAME?	transcription	#NAME?	JJ	I-NP	Otranscription	program	transcription	NN	I-NP	Oprogram	.	program	NN	I-NP	O.	Early	.	.	O	OEarly	stages	Early	JJ	B-NP	Ostages	of	stage	NNS	I-NP	Oof	B	of	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	occur	development	NN	I-NP	Ooccur	in	occur	VBP	B-VP	Oin	the	in	IN	B-PP	Othe	bone	the	DT	B-NP	Obone	marrow	bone	NN	I-NP	Omarrow	","	marrow	NN	I-NP	O","	resulting	","	","	O	Oresulting	in	result	VBG	B-VP	Oin	formation	in	IN	B-PP	Oformation	of	formation	NN	B-NP	Oof	immature	of	IN	B-PP	Oimmature	B	immature	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	From	.	.	O	OFrom	there	From	IN	B-PP	Othere	these	there	EX	B-NP	Othese	immature	these	DT	B-NP	Oimmature	cells	immature	JJ	I-NP	B-cell_typecells	migrate	cell	NNS	I-NP	I-cell_typemigrate	to	migrate	VBP	B-VP	Oto	the	to	TO	B-PP	Othe	spleen	the	DT	B-NP	Ospleen	where	spleen	NN	I-NP	Owhere	they	where	WRB	B-ADVP	Othey	differentiate	they	PRP	B-NP	Odifferentiate	to	differentiate	VBP	B-VP	Oto	mature	to	TO	B-PP	Omature	cells	mature	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	This	.	.	O	OThis	final	This	DT	B-NP	Ofinal	maturation	final	JJ	I-NP	Omaturation	step	maturation	NN	I-NP	Ostep	is	step	NN	I-NP	Ois	crucial	be	VBZ	B-VP	Ocrucial	for	crucial	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	B	the	DT	B-NP	OB	cells	B	NN	I-NP	B-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	become	to	TO	B-VP	Obecome	responsive	become	VB	I-VP	Oresponsive	to	responsive	JJ	B-ADJP	Oto	antigens	to	TO	B-PP	Oantigens	and	antigen	NNS	B-NP	Oand	to	and	CC	O	Oto	participate	to	TO	B-VP	Oparticipate	in	participate	VB	I-VP	Oin	the	in	IN	B-PP	Othe	immune	the	DT	B-NP	Oimmune	response	immune	JJ	I-NP	Oresponse	.	response	NN	I-NP	O.	Recently	.	.	O	ORecently	","	Recently	RB	B-ADVP	O","	invariant	","	","	O	Oinvariant	chain	invariant	JJ	B-NP	B-proteinchain	(	chain	NN	I-NP	I-protein(	Ii	(	(	O	OIi	)	Ii	NN	B-NP	B-protein)	","	)	)	O	O","	a	","	","	O	Oa	major	a	DT	B-NP	Omajor	histocompatibility	major	JJ	I-NP	Ohistocompatibility	complex	histocompatibility	NN	I-NP	Ocomplex	class	complex	NN	I-NP	Oclass	II	class	NN	I-NP	OII	chaperone	II	CD	I-NP	Ochaperone	","	chaperone	NN	I-NP	O","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	the	as	IN	I-CONJP	Othe	transcription	the	DT	B-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	c-Rel	factor	NNS	I-NP	I-proteinc-Rel	and	c-Rel	NN	B-NP	B-proteinand	p65/RelA	and	CC	I-NP	Op65/RelA	","	p65/RelA	NN	I-NP	B-protein","	were	","	","	O	Owere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	play	to	TO	I-VP	Oplay	a	play	VB	I-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	final	the	DT	B-NP	Ofinal	antigen-independent	final	JJ	I-NP	Oantigen-independent	differentiation	antigen-independent	JJ	I-NP	Odifferentiation	stage	differentiation	NN	I-NP	Ostage	of	stage	NN	I-NP	Oof	B	of	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	the	in	IN	B-PP	Othe	spleen	the	DT	B-NP	Ospleen	.	spleen	NN	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	investigated	we	PRP	B-NP	Oinvestigated	a	investigate	VBD	B-VP	Oa	possible	a	DT	B-NP	Opossible	link	possible	JJ	I-NP	Olink	between	link	NN	I-NP	Obetween	Ii	between	IN	B-PP	OIi	#NAME?	Ii	NN	B-NP	B-protein#NAME?	B	#NAME?	JJ	I-NP	OB	cell	B	NN	I-NP	Ocell	maturation	cell	NN	I-NP	Omaturation	and	maturation	NN	I-NP	Oand	the	and	CC	O	Othe	NF-kappaB	the	DT	B-NP	ONF-kappaB	pathway	NF-kappaB	NN	I-NP	B-proteinpathway	.	pathway	NN	I-NP	O.	Our	.	.	O	OOur	studies	Our	PRP$	B-NP	Ostudies	indicate	study	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	Ii	that	IN	B-SBAR	OIi	#NAME?	Ii	NN	B-NP	B-protein#NAME?	B	#NAME?	JJ	I-NP	OB	cell	B	NN	I-NP	Ocell	maturation	cell	NN	I-NP	Omaturation	involves	maturation	NN	I-NP	Oinvolves	activation	involve	VBZ	B-VP	Oactivation	of	activation	NN	B-NP	Oof	transcription	of	IN	B-PP	Otranscription	mediated	transcription	NN	B-NP	Omediated	by	mediate	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	NF-kappaB	the	DT	B-NP	ONF-kappaB	p65/RelA	NF-kappaB	NN	I-NP	B-proteinp65/RelA	homodimer	p65/RelA	NN	I-NP	B-proteinhomodimer	and	homodimer	NN	I-NP	I-proteinand	requires	and	CC	O	Orequires	the	require	VBZ	B-VP	Othe	B	the	DT	B-NP	OB	cell-enriched	B	NN	I-NP	B-proteincell-enriched	coactivator	cell-enriched	JJ	I-NP	I-proteincoactivator	TBP-associated	coactivator	NN	I-NP	I-proteinTBP-associated	factor	TBP-associated	JJ	I-NP	Ofactor	(	factor	NN	I-NP	O(	II	(	(	O	OII	)	II	CD	B-NP	O)	105	)	)	O	O105	.	105	CD	B-NP	O.	Androgens	.	.	O	OAndrogens	indirectly	Androgen	NNS	B-NP	Oindirectly	accelerate	indirectly	RB	B-ADVP	Oaccelerate	thymocyte	accelerate	VBP	B-VP	Othymocyte	apoptosis	thymocyte	NN	B-NP	B-cell_typeapoptosis	.	apoptosis	NN	I-NP	O.	Apoptotic	.	.	O	OApoptotic	processes	Apoptotic	JJ	B-NP	Oprocesses	","	process	NNS	I-NP	O","	or	","	","	O	Oor	the	or	CC	O	Othe	disturbance	the	DT	B-NP	Odisturbance	of	disturbance	NN	I-NP	Oof	the	of	IN	B-PP	Othe	natural	the	DT	B-NP	Onatural	regulation	natural	JJ	I-NP	Oregulation	of	regulation	NN	I-NP	Oof	these	of	IN	B-PP	Othese	processes	these	DT	B-NP	Oprocesses	","	process	NNS	I-NP	O","	may	","	","	O	Omay	be	may	MD	B-VP	Obe	involved	be	VB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	pathogenesis	the	DT	B-NP	Opathogenesis	of	pathogenesis	NN	I-NP	Oof	autoimmune	of	IN	B-PP	Oautoimmune	diseases	autoimmune	JJ	B-NP	Odiseases	(	disease	NNS	I-NP	O(	AID	(	(	O	OAID	)	AID	NN	B-NP	O)	.	)	)	O	O.	Women	.	.	O	OWomen	are	Woman	NNS	B-NP	Oare	","	be	VBP	B-VP	O","	in	","	","	O	Oin	general	in	IN	B-PP	Ogeneral	","	general	JJ	B-ADJP	O","	more	","	","	O	Omore	susceptible	more	RBR	B-ADJP	Osusceptible	than	susceptible	JJ	I-ADJP	Othan	men	than	IN	B-SBAR	Omen	to	man	NNS	B-NP	Oto	develop	to	TO	B-VP	Odevelop	AID	develop	VB	I-VP	OAID	like	AID	NN	B-NP	Olike	rheumatoid	like	IN	B-PP	Orheumatoid	arthritis	rheumatoid	JJ	B-NP	Oarthritis	.	arthritis	NN	I-NP	O.	Androgens	.	.	O	OAndrogens	and	Androgen	NNS	B-NP	Oand	glucocorticoids	and	CC	I-NP	Oglucocorticoids	","	glucocorticoid	NNS	I-NP	O","	in	","	","	O	Oin	contrast	in	IN	B-PP	Ocontrast	to	contrast	NN	B-NP	Oto	oestrogens	to	TO	B-PP	Ooestrogens	","	oestrogen	NNS	B-NP	O","	have	","	","	O	Ohave	favourable	have	VBP	B-VP	Ofavourable	effects	favourable	JJ	B-NP	Oeffects	in	effect	NNS	I-NP	Oin	AID	in	IN	B-PP	OAID	models	AID	NN	B-NP	B-cell_linemodels	as	model	NNS	I-NP	I-cell_lineas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	in	as	IN	I-CONJP	Oin	human	in	IN	B-PP	Ohuman	AID	human	JJ	B-NP	OAID	.	AID	NN	I-NP	O.	It	.	.	O	OIt	is	It	PRP	B-NP	Ois	known	be	VBZ	B-VP	Oknown	that	know	VBN	I-VP	Othat	glucocorticoids	that	IN	B-SBAR	Oglucocorticoids	(	glucocorticoid	NNS	B-NP	O(	GC	(	(	O	OGC	)	GC	NN	B-NP	O)	","	)	)	O	O","	used	","	","	O	Oused	for	use	VBN	B-VP	Ofor	treatment	for	IN	B-PP	Otreatment	of	treatment	NN	B-NP	Oof	AID	of	IN	B-PP	OAID	","	AID	NN	B-NP	O","	increase	","	","	O	Oincrease	apoptosis	increase	VBP	B-VP	Oapoptosis	in	apoptosis	NN	B-NP	Oin	the	in	IN	B-PP	Othe	thymus	the	DT	B-NP	Othymus	resulting	thymus	NN	I-NP	Oresulting	in	result	VBG	B-VP	Oin	decreased	in	IN	B-PP	Odecreased	numbers	decrease	VBN	B-NP	Onumbers	of	number	NNS	I-NP	Oof	CD4+	of	IN	B-PP	OCD4+	CD8+	CD4+	JJ	B-NP	B-cell_typeCD8+	thymocytes	CD8+	JJ	I-NP	I-cell_typethymocytes	.	thymocyte	NNS	I-NP	I-cell_type.	It	.	.	O	OIt	was	It	PRP	B-NP	Owas	asked	be	VBD	B-VP	Oasked	whether	ask	VBN	I-VP	Owhether	androgens	whether	IN	B-SBAR	Oandrogens	","	androgen	NNS	B-NP	O","	in	","	","	O	Oin	contrast	in	IN	B-PP	Ocontrast	to	contrast	NN	B-NP	Oto	oestrogens	to	TO	B-PP	Ooestrogens	","	oestrogen	NNS	B-NP	O","	exert	","	","	O	Oexert	their	exert	VBP	B-VP	Otheir	favourable	their	PRP$	B-NP	Ofavourable	effects	favourable	JJ	I-NP	Oeffects	in	effect	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	of	treatment	NN	I-NP	Oof	AID	of	IN	B-PP	OAID	by	AID	NN	B-NP	Oby	a	by	IN	B-PP	Oa	mechanism	a	DT	B-NP	Omechanism	comparable	mechanism	NN	I-NP	Ocomparable	to	comparable	JJ	B-ADJP	Oto	that	to	TO	B-PP	Othat	described	that	DT	B-NP	Odescribed	for	describe	VBN	B-VP	Ofor	GC	for	IN	B-PP	OGC	by	GC	NN	B-NP	Oby	eliminating	by	IN	B-PP	Oeliminating	the	eliminate	VBG	B-VP	Othe	apoptosis	the	DT	B-NP	Oapoptosis	prone	apoptosis	NN	I-NP	Oprone	CD4+	prone	JJ	I-NP	OCD4+	CD8+	CD4+	JJ	I-NP	OCD8+	population	CD8+	JJ	I-NP	Opopulation	in	population	NN	I-NP	Oin	the	in	IN	B-PP	Othe	thymus	the	DT	B-NP	Othymus	.	thymus	NN	I-NP	O.	Although	.	.	O	OAlthough	both	Although	IN	B-SBAR	Oboth	androgens	both	DT	B-NP	Oandrogens	and	androgen	NNS	I-NP	Oand	oestrogens	and	CC	I-NP	Ooestrogens	proved	oestrogen	NNS	I-NP	Oproved	thymolytic	prove	VBD	B-VP	Othymolytic	","	thymolytic	JJ	B-ADJP	O","	a	","	","	O	Oa	significantly	a	DT	B-NP	Osignificantly	decreased	significantly	RB	I-NP	Odecreased	percentage	decrease	VBN	I-NP	Opercentage	of	percentage	NN	I-NP	Oof	CD4+	of	IN	B-PP	OCD4+	CD8+	CD4+	JJ	B-NP	B-cell_typeCD8+	thymocytes	CD8+	JJ	I-NP	I-cell_typethymocytes	was	thymocyte	NNS	I-NP	I-cell_typewas	observed	be	VBD	B-VP	Oobserved	by	observe	VBN	I-VP	Oby	flow	by	IN	B-PP	Oflow	cytometry	flow	NN	B-NP	Ocytometry	after	cytometry	NN	I-NP	Oafter	treatment	after	IN	B-PP	Otreatment	of	treatment	NN	B-NP	Oof	mice	of	IN	B-PP	Omice	with	mouse	NNS	B-NP	Owith	the	with	IN	B-PP	Othe	androgen	the	DT	B-NP	Oandrogen	methyltestosterone	androgen	NN	I-NP	Omethyltestosterone	","	methyltestosterone	NN	I-NP	O","	but	","	","	O	Obut	not	but	CC	O	Onot	with	not	RB	O	Owith	the	with	IN	B-PP	Othe	oestrogen	the	DT	B-NP	Ooestrogen	ethinylestradiol	oestrogen	NN	I-NP	Oethinylestradiol	.	ethinylestradiol	NN	I-NP	O.	To	.	.	O	OTo	investigate	To	TO	B-VP	Oinvestigate	whether	investigate	VB	I-VP	Owhether	the	whether	IN	B-SBAR	Othe	observed	the	DT	B-NP	Oobserved	thymolytic	observe	VBN	I-NP	Othymolytic	effects	thymolytic	JJ	I-NP	Oeffects	were	effect	NNS	I-NP	Owere	due	be	VBD	B-VP	Odue	to	due	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	hormone	of	IN	B-PP	Ohormone	receptors	hormone	NN	B-NP	B-proteinreceptors	on	receptor	NNS	I-NP	I-proteinon	thymocytes	on	IN	B-PP	Othymocytes	","	thymocyte	NNS	B-NP	B-cell_type","	cells	","	","	O	Ocells	were	cell	NNS	B-NP	Owere	isolated	be	VBD	B-VP	Oisolated	from	isolate	VBN	I-VP	Ofrom	the	from	IN	B-PP	Othe	thymus	the	DT	B-NP	Othymus	and	thymus	NN	I-NP	Oand	incubated	and	CC	O	Oincubated	with	incubate	VBN	B-VP	Owith	androgens	with	IN	B-PP	Oandrogens	or	androgen	NNS	B-NP	Oor	oestrogens	or	CC	I-NP	Ooestrogens	to	oestrogen	NNS	I-NP	Oto	measure	to	TO	B-VP	Omeasure	apoptosis	measure	VB	I-VP	Oapoptosis	.	apoptosis	NN	B-NP	O.	Several	.	.	O	OSeveral	techniques	Several	JJ	B-NP	Otechniques	were	technique	NNS	I-NP	Owere	used	be	VBD	B-VP	Oused	to	use	VBN	I-VP	Oto	determine	to	TO	B-VP	Odetermine	thymocyte	determine	VB	I-VP	Othymocyte	apoptosis	thymocyte	NN	B-NP	B-cell_typeapoptosis	in	apoptosis	NN	I-NP	Oin	vitro	in	FW	B-ADVP	Ovitro	","	vitro	FW	I-ADVP	O","	but	","	","	O	Obut	no	but	CC	O	Ono	enhanced	no	DT	B-NP	Oenhanced	apoptotic	enhance	VBN	I-NP	Oapoptotic	signal	apoptotic	JJ	I-NP	Osignal	was	signal	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	.	observe	VBN	I-VP	O.	Using	.	.	O	OUsing	the	Use	VBG	B-VP	Othe	very	the	DT	B-NP	Overy	sensitive	very	RB	I-NP	Osensitive	TUNEL	sensitive	JJ	I-NP	OTUNEL	assay	TUNEL	NN	I-NP	Oassay	","	assay	NN	I-NP	O","	no	","	","	O	Ono	direct	no	DT	B-NP	Odirect	effect	direct	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	androgens	of	IN	B-PP	Oandrogens	on	androgen	NNS	B-NP	Oon	thymocytes	on	IN	B-PP	Othymocytes	in	thymocyte	NNS	B-NP	B-cell_typein	vitro	in	FW	B-PP	Ovitro	could	vitro	FW	B-NP	Ocould	be	could	MD	B-VP	Obe	observed	be	VB	I-VP	Oobserved	.	observe	VBN	I-VP	O.	This	.	.	O	OThis	is	This	DT	B-NP	Ois	in	be	VBZ	B-VP	Oin	sharp	in	IN	B-PP	Osharp	contrast	sharp	JJ	B-NP	Ocontrast	to	contrast	NN	I-NP	Oto	the	to	TO	B-PP	Othe	high	the	DT	B-NP	Ohigh	signal	high	JJ	I-NP	Osignal	observed	signal	NN	I-NP	Oobserved	with	observe	VBN	B-VP	Owith	GC	with	IN	B-PP	OGC	.	GC	NN	B-NP	O.	Therefore	.	.	O	OTherefore	","	Therefore	RB	B-ADVP	O","	upon	","	","	O	Oupon	in	upon	IN	B-PP	Oin	vivo	in	FW	B-NP	Ovivo	androgen	vivo	FW	I-NP	Oandrogen	treatment	androgen	NN	I-NP	Otreatment	","	treatment	NN	I-NP	O","	other	","	","	O	Oother	cells	other	JJ	B-NP	Ocells	containing	cell	NNS	I-NP	Ocontaining	androgen	contain	VBG	B-VP	Oandrogen	receptors	androgen	NN	B-NP	B-proteinreceptors	than	receptor	NNS	I-NP	I-proteinthan	thymocytes	than	IN	B-SBAR	Othymocytes	are	thymocyte	NNS	B-NP	B-cell_typeare	probably	be	VBP	B-VP	Oprobably	involved	probably	RB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	inducing	in	IN	B-PP	Oinducing	the	induce	VBG	B-VP	Othe	increase	the	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	thymic	in	IN	B-PP	Othymic	apoptosis	thymic	JJ	B-NP	Oapoptosis	.	apoptosis	NN	I-NP	O.	To	.	.	O	OTo	study	To	TO	B-VP	Ostudy	the	study	VB	I-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	the	of	IN	B-PP	Othe	androgen	the	DT	B-NP	Oandrogen	receptor	androgen	NN	I-NP	B-proteinreceptor	on	receptor	NN	I-NP	I-proteinon	thymocyte	on	IN	B-PP	Othymocyte	apoptosis	thymocyte	NN	B-NP	B-cell_typeapoptosis	","	apoptosis	NN	I-NP	O","	androgen	","	","	O	Oandrogen	receptor	androgen	NN	B-NP	B-proteinreceptor	mutant	receptor	NN	I-NP	I-proteinmutant	(	mutant	NN	I-NP	I-protein(	Tfm/Y	(	(	O	OTfm/Y	)	Tfm/Y	NN	B-NP	B-protein)	mice	)	)	O	Omice	were	mouse	NNS	B-NP	Owere	treated	be	VBD	B-VP	Otreated	with	treat	VBN	I-VP	Owith	androgens	with	IN	B-PP	Oandrogens	.	androgen	NNS	B-NP	O.	No	.	.	O	ONo	alterations	No	DT	B-NP	Oalterations	of	alteration	NNS	I-NP	Oof	thymocyte	of	IN	B-PP	Othymocyte	subpopulations	thymocyte	NN	B-NP	B-cell_typesubpopulations	were	subpopulation	NNS	I-NP	I-cell_typewere	seen	be	VBD	B-VP	Oseen	","	see	VBN	I-VP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	changes	that	IN	B-SBAR	Ochanges	in	change	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	percentage	the	DT	B-NP	Opercentage	of	percentage	NN	I-NP	Oof	CD4+	of	IN	B-PP	OCD4+	CD8+	CD4+	JJ	B-NP	B-cell_typeCD8+	thymocytes	CD8+	JJ	I-NP	I-cell_typethymocytes	after	thymocyte	NNS	I-NP	I-cell_typeafter	administration	after	IN	B-PP	Oadministration	of	administration	NN	B-NP	Oof	androgens	of	IN	B-PP	Oandrogens	depend	androgen	NNS	B-NP	Odepend	on	depend	VBP	B-VP	Oon	the	on	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	functional	of	IN	B-PP	Ofunctional	androgen	functional	JJ	B-NP	Oandrogen	receptors	androgen	NN	I-NP	B-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	it	","	","	O	Oit	is	it	PRP	B-NP	Ois	concluded	be	VBZ	B-VP	Oconcluded	that	conclude	VBN	I-VP	Othat	androgens	that	IN	B-SBAR	Oandrogens	indirectly	androgen	NNS	B-NP	Oindirectly	accelerate	indirectly	RB	B-ADVP	Oaccelerate	thymocyte	accelerate	VBP	B-VP	Othymocyte	apoptosis	thymocyte	NN	B-NP	B-cell_typeapoptosis	in	apoptosis	NN	I-NP	Oin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	AP-1	factor	NNS	I-NP	I-proteinAP-1	and	AP-1	NN	B-NP	B-proteinand	NF-kappaB	and	CC	O	ONF-kappaB	in	NF-kappaB	NN	B-NP	B-proteinin	CD4	in	IN	B-PP	OCD4	T	CD4	NN	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	peroxisome	by	IN	B-PP	Operoxisome	proliferator-activated	peroxisome	NN	B-NP	B-proteinproliferator-activated	receptor	proliferator-activated	JJ	I-NP	I-proteinreceptor	gamma	receptor	NN	I-NP	I-proteingamma	ligands	gamma	NN	I-NP	I-proteinligands	.	ligand	NNS	I-NP	I-protein.	The	.	.	O	OThe	peroxisome	The	DT	B-NP	Operoxisome	proliferator-activated	peroxisome	NN	I-NP	B-proteinproliferator-activated	receptor	proliferator-activated	JJ	I-NP	I-proteinreceptor	gamma	receptor	NN	I-NP	I-proteingamma	(	gamma	NN	I-NP	I-protein(	PPARgamma	(	(	O	OPPARgamma	)	PPARgamma	NN	B-NP	B-protein)	","	)	)	O	O","	a	","	","	O	Oa	member	a	DT	B-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	hormone	nuclear	JJ	I-NP	B-proteinhormone	receptor	hormone	NN	I-NP	I-proteinreceptor	superfamily	receptor	NN	I-NP	I-proteinsuperfamily	","	superfamily	NN	I-NP	I-protein","	is	","	","	O	Ois	essential	be	VBZ	B-VP	Oessential	for	essential	JJ	B-ADJP	Ofor	adipocyte	for	IN	B-PP	Oadipocyte	differentiation	adipocyte	NN	B-NP	B-cell_typedifferentiation	and	differentiation	NN	I-NP	Oand	glucose	and	CC	O	Oglucose	homeostasis	glucose	NN	B-NP	Ohomeostasis	.	homeostasis	NN	I-NP	O.	PPARgamma	.	.	O	OPPARgamma	has	PPARgamma	NN	B-NP	B-proteinhas	been	have	VBZ	B-VP	Obeen	found	be	VBN	I-VP	Ofound	recently	find	VBN	I-VP	Orecently	to	recently	RB	B-ADVP	Oto	regulate	to	TO	B-VP	Oregulate	macrophage	regulate	VB	I-VP	Omacrophage	activation	macrophage	NN	B-NP	Oactivation	in	activation	NN	I-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	mitogens	to	TO	B-PP	Omitogens	and	mitogen	NNS	B-NP	B-proteinand	inflammation	and	CC	I-NP	Oinflammation	.	inflammation	NN	I-NP	O.	Our	.	.	O	OOur	study	Our	PRP$	B-NP	Ostudy	shows	study	NN	I-NP	Oshows	PPARgamma	show	VBZ	B-VP	OPPARgamma	to	PPARgamma	NN	B-NP	B-proteinto	be	to	TO	B-VP	Obe	preferentially	be	VB	I-VP	Opreferentially	expressed	preferentially	RB	I-VP	Oexpressed	in	express	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	nuclei	the	DT	B-NP	Onuclei	of	nucleus	NNS	I-NP	Oof	resting	of	IN	B-PP	Oresting	T	rest	VBG	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	to	and	CC	O	Oto	increase	to	TO	B-VP	Oincrease	upon	increase	VB	I-VP	Oupon	activation	upon	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	T	of	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	either	by	IN	B-PP	Oeither	anti-CD3	either	CC	B-NP	Oanti-CD3	and	anti-CD3	JJ	I-NP	B-proteinand	anti-CD28	and	CC	I-NP	Oanti-CD28	or	anti-CD28	JJ	I-NP	B-proteinor	phorbol	or	CC	I-NP	Ophorbol	myristyl	phorbol	NN	I-NP	Omyristyl	acetate	myristyl	NN	I-NP	Oacetate	(	acetate	NN	I-NP	O(	PMA	(	(	O	OPMA	)	PMA	NN	B-NP	O)	.	)	)	O	O.	We	.	.	O	OWe	also	We	PRP	B-NP	Oalso	found	also	RB	B-ADVP	Ofound	the	find	VBD	B-VP	Othe	PPARgamma	the	DT	B-NP	OPPARgamma	ligand	PPARgamma	NN	I-NP	B-proteinligand	ciglitizone	ligand	NN	I-NP	Ociglitizone	to	ciglitizone	NN	I-NP	Oto	attenuate	to	TO	B-VP	Oattenuate	the	attenuate	VB	I-VP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	T	of	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	inhibiting	by	IN	B-PP	Oinhibiting	cytokine	inhibit	VBG	B-VP	Ocytokine	gene	cytokine	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	and	expression	NN	I-NP	Oand	anti-CD3	and	CC	O	Oanti-CD3	and	anti-CD3	JJ	B-NP	B-proteinand	anti-CD28	and	CC	I-NP	Oanti-CD28	or	anti-CD28	JJ	I-NP	B-proteinor	PMA-induced	or	CC	I-NP	OPMA-induced	proliferative	PMA-induced	JJ	I-NP	Oproliferative	responses	proliferative	JJ	I-NP	Oresponses	.	response	NNS	I-NP	O.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	both	of	IN	B-PP	Oboth	the	both	CC	O	Othe	proliferative	the	DT	B-NP	Oproliferative	response	proliferative	JJ	I-NP	Oresponse	and	response	NN	I-NP	Oand	inflammatory	and	CC	O	Oinflammatory	cytokine	inflammatory	JJ	B-NP	B-proteincytokine	expression	cytokine	NN	I-NP	I-proteinexpression	in	expression	NN	I-NP	Oin	CD4	in	IN	B-PP	OCD4	T	CD4	NN	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	was	cell	NNS	I-NP	I-cell_typewas	correlated	be	VBD	B-VP	Ocorrelated	with	correlate	VBN	I-VP	Owith	suppression	with	IN	B-PP	Osuppression	of	suppression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	activated	the	DT	B-NP	Oactivated	transcription	activate	VBN	I-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	AP1	factor	NNS	I-NP	I-proteinAP1	and	AP1	NN	B-NP	B-proteinand	NF-kappaB	and	CC	I-NP	ONF-kappaB	.	NF-kappaB	NN	I-NP	B-protein.	PPARgamma	.	.	O	OPPARgamma	ligands	PPARgamma	NN	B-NP	B-proteinligands	also	ligand	NNS	I-NP	I-proteinalso	strongly	also	RB	B-ADVP	Ostrongly	inhibited	strongly	RB	B-VP	Oinhibited	SEA-induced	inhibit	VBD	I-VP	OSEA-induced	Vbeta3	SEA-induced	JJ	B-NP	OVbeta3	T	Vbeta3	NN	I-NP	OT	cell	T	NN	I-NP	Ocell	activation	cell	NN	I-NP	Oactivation	in	activation	NN	I-NP	Oin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	","	result	NNS	I-NP	O","	together	","	","	O	Otogether	with	together	RB	B-ADVP	Owith	previous	with	IN	B-PP	Oprevious	findings	previous	JJ	B-NP	Ofindings	of	finding	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	inhibitory	the	DT	B-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	PPARgamma	of	IN	B-PP	OPPARgamma	ligands	PPARgamma	NN	B-NP	B-proteinligands	on	ligand	NNS	I-NP	I-proteinon	activated	on	IN	B-PP	Oactivated	macrophages	activate	VBN	B-NP	B-cell_typemacrophages	","	macrophage	NNS	I-NP	I-cell_type","	provide	","	","	O	Oprovide	clear	provide	VBP	B-VP	Oclear	evidence	clear	JJ	B-NP	Oevidence	for	evidence	NN	I-NP	Ofor	PPARgamma	for	IN	B-PP	OPPARgamma	as	PPARgamma	NN	B-NP	B-proteinas	a	as	IN	B-PP	Oa	negative	a	DT	B-NP	Onegative	regulator	negative	JJ	I-NP	Oregulator	of	regulator	NN	I-NP	Oof	the	of	IN	B-PP	Othe	inflammatory	the	DT	B-NP	Oinflammatory	activation	inflammatory	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	both	of	IN	B-PP	Oboth	macrophage	both	CC	O	Omacrophage	and	macrophage	NN	B-NP	B-cell_typeand	T	and	CC	O	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	B-NP	I-cell_type.	PPARgamma	.	.	O	OPPARgamma	may	PPARgamma	NN	B-NP	B-proteinmay	thus	may	MD	B-VP	Othus	be	thus	RB	I-VP	Obe	a	be	VB	I-VP	Oa	potential	a	DT	B-NP	Opotential	therapeutic	potential	JJ	I-NP	Otherapeutic	target	therapeutic	JJ	I-NP	Otarget	for	target	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	of	treatment	NN	I-NP	Oof	autoimmunity	of	IN	B-PP	Oautoimmunity	.	autoimmunity	NN	B-NP	O.	A	.	.	O	OA	prominent	A	DT	B-NP	Oprominent	role	prominent	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	activator	for	IN	B-PP	Oactivator	protein-1	activator	NN	B-NP	B-proteinprotein-1	in	protein-1	NN	I-NP	I-proteinin	the	in	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	of	transcription	NN	I-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	2B4	human	JJ	I-NP	B-DNA2B4	(	2B4	NN	I-NP	I-DNA(	CD244	(	(	O	I-DNACD244	)	CD244	NN	B-NP	I-DNA)	gene	)	)	O	I-DNAgene	in	gene	NN	B-NP	I-DNAin	NK	in	IN	B-PP	ONK	cells	NK	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	cell	The	DT	B-NP	Ocell	surface	cell	NN	I-NP	B-proteinsurface	glycoprotein	surface	NN	I-NP	I-proteinglycoprotein	2B4	glycoprotein	NN	I-NP	I-protein2B4	(	2B4	NN	I-NP	I-protein(	CD244	(	(	O	OCD244	)	CD244	NN	B-NP	B-protein)	of	)	)	O	Oof	the	of	IN	B-PP	Othe	Ig	the	DT	B-NP	OIg	superfamily	Ig	NN	I-NP	B-proteinsuperfamily	is	superfamily	NN	I-NP	I-proteinis	involved	be	VBZ	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	NK	of	IN	B-PP	ONK	and	NK	NN	B-NP	Oand	T	and	CC	I-NP	OT	lymphocyte	T	NN	I-NP	Olymphocyte	functions	lymphocyte	NN	I-NP	Ofunctions	.	function	NNS	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	recently	have	VBP	B-VP	Orecently	identified	recently	RB	I-VP	Oidentified	CD48	identify	VBN	I-VP	OCD48	as	CD48	NN	B-NP	B-proteinas	the	as	IN	B-PP	Othe	high	the	DT	B-NP	Ohigh	affinity	high	JJ	I-NP	B-proteinaffinity	counterreceptor	affinity	NN	I-NP	I-proteincounterreceptor	for	counterreceptor	NN	I-NP	I-proteinfor	2B4	for	IN	B-PP	O2B4	in	2B4	NN	B-NP	B-proteinin	both	in	IN	B-PP	Oboth	mice	both	CC	B-NP	Omice	and	mouse	NNS	I-NP	Oand	humans	and	CC	I-NP	Ohumans	.	human	NNS	I-NP	O.	The	.	.	O	OThe	cytoplasmic	The	DT	B-NP	Ocytoplasmic	domain	cytoplasmic	JJ	I-NP	B-proteindomain	of	domain	NN	I-NP	I-proteinof	2B4	of	IN	B-PP	O2B4	associates	2B4	NN	B-NP	B-proteinassociates	with	associate	VBZ	B-VP	Owith	src	with	IN	B-PP	Osrc	homology	src	NN	B-NP	B-proteinhomology	2	homology	NN	I-NP	I-protein2	domain-containing	2	CD	I-NP	I-proteindomain-containing	protein	domain-containing	JJ	I-NP	I-proteinprotein	or	protein	NN	I-NP	I-proteinor	signaling	or	CC	I-NP	Osignaling	lymphocyte	signaling	NN	I-NP	B-proteinlymphocyte	activation	lymphocyte	NN	I-NP	I-proteinactivation	molecule-associated	activation	NN	I-NP	I-proteinmolecule-associated	protein	molecule-associated	JJ	I-NP	I-proteinprotein	","	protein	NN	I-NP	I-protein","	whose	","	","	O	Owhose	mutation	whose	WP$	B-NP	Omutation	is	mutation	NN	I-NP	Ois	the	be	VBZ	B-VP	Othe	underlying	the	DT	B-NP	Ounderlying	genetic	underlie	VBG	I-NP	Ogenetic	defect	genetic	JJ	I-NP	Odefect	in	defect	NN	I-NP	Oin	the	in	IN	B-PP	Othe	X-linked	the	DT	B-NP	OX-linked	lymphoproliferative	X-linked	JJ	I-NP	Olymphoproliferative	syndrome	lymphoproliferative	JJ	I-NP	Osyndrome	.	syndrome	NN	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	report	we	PRP	B-NP	Oreport	the	report	VBP	B-VP	Othe	molecular	the	DT	B-NP	Omolecular	cloning	molecular	JJ	I-NP	Ocloning	and	cloning	NN	I-NP	Oand	characterization	and	CC	I-NP	Ocharacterization	of	characterization	NN	I-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	2B4	human	JJ	I-NP	B-DNA2B4	(	2B4	NN	I-NP	I-DNA(	h2B4	(	(	O	I-DNAh2B4	)	h2B4	NN	B-NP	I-DNA)	promoter	)	)	O	I-DNApromoter	.	promoter	NN	B-NP	I-DNA.	Through	.	.	O	OThrough	primer	Through	IN	B-PP	Oprimer	extension	primer	NN	B-NP	Oextension	analysis	extension	NN	I-NP	Oanalysis	","	analysis	NN	I-NP	O","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	transcription	the	DT	B-NP	Otranscription	of	transcription	NN	I-NP	Oof	the	of	IN	B-PP	Othe	h2B4	the	DT	B-NP	Oh2B4	gene	h2B4	NN	I-NP	B-DNAgene	initiates	gene	NN	I-NP	I-DNAinitiates	at	initiate	VBZ	B-VP	Oat	multiple	at	IN	B-PP	Omultiple	start	multiple	JJ	B-NP	B-DNAstart	sites	start	NN	I-NP	I-DNAsites	.	site	NNS	I-NP	I-DNA.	We	.	.	O	OWe	isolated	We	PRP	B-NP	Oisolated	h2B4	isolate	VBD	B-VP	Oh2B4	genomic	h2B4	NN	B-NP	B-cell_linegenomic	clones	genomic	JJ	I-NP	I-cell_lineclones	and	clone	NNS	I-NP	I-cell_lineand	PCR	and	CC	I-NP	OPCR	amplified	PCR	NN	I-NP	Oamplified	the	amplify	VBD	B-VP	Othe	5	the	DT	B-NP	O5	'	5	CD	I-NP	B-DNA'	untranslated	'	SYM	I-NP	I-DNAuntranslated	region	untranslated	JJ	I-NP	I-DNAregion	containing	region	NN	I-NP	I-DNAcontaining	the	contain	VBG	B-VP	Othe	promoter	the	DT	B-NP	Opromoter	elements	promoter	NN	I-NP	B-DNAelements	.	element	NNS	I-NP	I-DNA.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	identified	have	VBP	B-VP	Oidentified	a	identify	VBN	I-VP	Oa	functional	a	DT	B-NP	Ofunctional	AP-1	functional	JJ	I-NP	OAP-1	site	AP-1	NN	I-NP	B-DNAsite	that	site	NN	I-NP	I-DNAthat	lies	that	WDT	B-NP	Olies	between	lie	VBZ	B-VP	Obetween	(	between	IN	B-PP	O(	-106	(	(	O	O-106	to	-106	CD	O	B-DNAto	-100	to	TO	O	I-DNA-100	)	-100	CD	B-NP	I-DNA)	through	)	)	O	Othrough	transient	through	IN	B-PP	Otransient	transfection	transient	JJ	B-NP	Otransfection	analysis	transfection	NN	I-NP	Oanalysis	in	analysis	NN	I-NP	Oin	YT	in	IN	B-PP	OYT	cells	YT	NN	B-NP	B-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	a	","	","	O	Oa	human	a	DT	B-NP	Ohuman	NK	human	JJ	I-NP	B-cell_lineNK	cell	NK	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	.	line	NN	I-NP	I-cell_line.	EMSAs	.	.	O	OEMSAs	with	EMSA	NNS	B-NP	Owith	Abs	with	IN	B-PP	OAbs	specific	Ab	NNS	B-NP	B-proteinspecific	for	specific	JJ	B-ADJP	Ofor	various	for	IN	B-PP	Ovarious	protein	various	JJ	B-NP	Oprotein	factors	protein	NN	I-NP	B-proteinfactors	of	factor	NNS	I-NP	I-proteinof	the	of	IN	B-PP	Othe	AP-1	the	DT	B-NP	OAP-1	family	AP-1	NN	I-NP	B-proteinfamily	revealed	family	NN	I-NP	I-proteinrevealed	that	reveal	VBD	B-VP	Othat	multiple	that	IN	B-SBAR	Omultiple	members	multiple	JJ	B-NP	Omembers	of	member	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	Jun	the	DT	B-NP	OJun	family	Jun	NN	I-NP	B-proteinfamily	are	family	NN	I-NP	I-proteinare	involved	be	VBP	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	h2B4	the	DT	B-NP	Oh2B4	gene	h2B4	NN	I-NP	B-DNAgene	.	gene	NN	I-NP	I-DNA.	Mutation	.	.	O	OMutation	of	Mutation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	AP-1	the	DT	B-NP	OAP-1	site	AP-1	NN	I-NP	B-DNAsite	not	site	NN	I-NP	I-DNAnot	only	not	RB	B-CONJP	Oonly	abolishes	only	RB	I-CONJP	Oabolishes	protein/DNA	abolish	VBZ	B-VP	Oprotein/DNA	interactions	protein/DNA	NN	B-NP	Ointeractions	but	interaction	NNS	I-NP	Obut	also	but	CC	B-NP	Oalso	promoter	also	RB	I-NP	Opromoter	activity	promoter	NN	B-NP	Oactivity	.	activity	NN	I-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	demonstrate	result	NNS	I-NP	Odemonstrate	a	demonstrate	VBP	B-VP	Oa	significant	a	DT	B-NP	Osignificant	role	significant	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	AP-1	for	IN	B-PP	OAP-1	in	AP-1	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	regulation	transcriptional	JJ	I-NP	Oregulation	of	regulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	h2B4	the	DT	B-NP	Oh2B4	gene	h2B4	NN	I-NP	B-DNAgene	.	gene	NN	I-NP	I-DNA.	Functional	.	.	O	OFunctional	correction	Functional	JJ	B-NP	Ocorrection	of	correction	NN	I-NP	Oof	FA-C	of	IN	B-PP	OFA-C	cells	FA-C	NN	B-NP	B-cell_linecells	with	cell	NNS	I-NP	I-cell_linewith	FANCC	with	IN	B-PP	OFANCC	suppresses	FANCC	NN	B-NP	B-proteinsuppresses	the	suppress	VBZ	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	interferon	of	IN	B-PP	Ointerferon	gamma-inducible	interferon	NN	B-NP	B-DNAgamma-inducible	genes	gamma-inducible	JJ	I-NP	I-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Because	.	.	O	OBecause	hematopoietic	Because	IN	B-SBAR	Ohematopoietic	cells	hematopoietic	JJ	B-NP	B-cell_typecells	derived	cell	NNS	I-NP	I-cell_typederived	from	derive	VBN	B-VP	Ofrom	Fanconi	from	IN	B-PP	OFanconi	anemia	Fanconi	NNP	B-NP	Oanemia	(	anemia	NN	I-NP	O(	FA	(	(	O	OFA	)	FA	NN	B-NP	O)	patients	)	)	O	Opatients	of	patient	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	C-complementation	the	DT	B-NP	OC-complementation	group	C-complementation	NN	I-NP	Ogroup	(	group	NN	I-NP	O(	FA-C	(	(	O	OFA-C	)	FA-C	NN	B-NP	B-protein)	are	)	)	O	Oare	hypersensitive	be	VBP	B-VP	Ohypersensitive	to	hypersensitive	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	inhibitory	the	DT	B-NP	Oinhibitory	effects	inhibitory	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	interferon	of	IN	B-PP	Ointerferon	gamma	interferon	NN	B-NP	B-proteingamma	(	gamma	NN	I-NP	I-protein(	IFNgamma	(	(	O	OIFNgamma	)	IFNgamma	NN	B-NP	B-protein)	","	)	)	O	O","	the	","	","	O	Othe	products	the	DT	B-NP	Oproducts	of	product	NNS	I-NP	Oof	certain	of	IN	B-PP	Ocertain	IFNgamma-inducible	certain	JJ	B-NP	OIFNgamma-inducible	genes	IFNgamma-inducible	JJ	I-NP	B-DNAgenes	known	gene	NNS	I-NP	I-DNAknown	to	know	VBN	B-VP	Oto	influence	to	TO	I-VP	Oinfluence	hematopoietic	influence	VB	I-VP	Ohematopoietic	cell	hematopoietic	JJ	B-NP	B-cell_typecell	survival	cell	NN	I-NP	I-cell_typesurvival	were	survival	NN	I-NP	Owere	quantified	be	VBD	B-VP	Oquantified	.	quantify	VBN	I-VP	O.	High	.	.	O	OHigh	constitutive	High	JJ	B-NP	Oconstitutive	expression	constitutive	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	IFNgamma-inducible	the	DT	B-NP	OIFNgamma-inducible	genes	IFNgamma-inducible	JJ	I-NP	B-DNAgenes	","	gene	NNS	I-NP	I-DNA","	IFN-stimulated	","	","	O	OIFN-stimulated	gene	IFN-stimulated	JJ	B-NP	B-proteingene	factor	gene	NN	I-NP	I-proteinfactor	3	factor	NN	I-NP	I-protein3	gamma	3	CD	B-NP	I-proteingamma	subunit	gamma	NN	I-NP	I-proteinsubunit	(	subunit	NN	I-NP	I-protein(	ISGF3gamma	(	(	O	OISGF3gamma	)	ISGF3gamma	NN	B-NP	B-protein)	","	)	)	O	O","	IFN	","	","	O	OIFN	regulatory	IFN	NN	B-NP	B-proteinregulatory	factor-1	regulatory	JJ	I-NP	I-proteinfactor-1	(	factor-1	NN	I-NP	I-protein(	IRF-1	(	(	O	OIRF-1	)	IRF-1	NN	B-NP	B-protein)	","	)	)	O	O","	and	","	","	O	Oand	the	and	CC	O	Othe	cyclin-dependent	the	DT	B-NP	Ocyclin-dependent	kinase	cyclin-dependent	JJ	I-NP	B-proteinkinase	inhibitor	kinase	NN	I-NP	I-proteininhibitor	p21	inhibitor	NN	I-NP	Op21	(	p21	NN	I-NP	O(	WAF1	(	(	O	OWAF1	)	WAF1	NN	B-NP	B-protein)	was	)	)	O	Owas	found	be	VBD	B-VP	Ofound	in	find	VBN	I-VP	Oin	FANCC	in	IN	B-PP	OFANCC	mutant	FANCC	NN	B-NP	B-cell_linemutant	B	mutant	JJ	I-NP	I-cell_lineB	lymphoblasts	B	NN	I-NP	I-cell_linelymphoblasts	","	lymphoblast	NNS	I-NP	I-cell_line","	low-density	","	","	O	Olow-density	bone	low-density	JJ	B-NP	B-cell_typebone	marrow	bone	NN	I-NP	I-cell_typemarrow	cells	marrow	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	murine	and	CC	O	Omurine	embryonic	murine	JJ	B-NP	B-cell_typeembryonic	fibroblasts	embryonic	JJ	I-NP	I-cell_typefibroblasts	.	fibroblast	NNS	I-NP	I-cell_type.	Paradoxically	.	.	O	OParadoxically	","	Paradoxically	RB	B-ADVP	O","	these	","	","	O	Othese	cells	these	DT	B-NP	Ocells	do	cell	NNS	I-NP	Odo	not	do	VBP	B-VP	Onot	activate	not	RB	I-VP	Oactivate	signal	activate	VB	I-VP	Osignal	transducer	signal	NN	B-NP	B-proteintransducer	and	transducer	NN	I-NP	I-proteinand	activator	and	CC	I-NP	I-proteinactivator	of	activator	NN	I-NP	I-proteinof	transcription	of	IN	B-PP	I-proteintranscription	(	transcription	NN	B-NP	I-protein(	STAT	(	(	O	I-proteinSTAT	)	STAT	NN	B-NP	I-protein)	1	)	)	O	I-protein1	properly	1	CD	B-NP	I-proteinproperly	.	properly	RB	I-NP	O.	In	.	.	O	OIn	an	In	IN	B-PP	Oan	attempt	an	DT	B-NP	Oattempt	to	attempt	NN	I-NP	Oto	clarify	to	TO	B-VP	Oclarify	mechanisms	clarify	VB	I-VP	Omechanisms	by	mechanism	NNS	B-NP	Oby	which	by	IN	B-PP	Owhich	FA-C	which	WDT	B-NP	OFA-C	cells	FA-C	NN	B-NP	B-cell_linecells	overexpress	cell	NNS	I-NP	I-cell_lineoverexpress	IFNgamma-inducible	overexpres	VBP	B-VP	OIFNgamma-inducible	genes	IFNgamma-inducible	JJ	B-NP	B-DNAgenes	in	gene	NNS	I-NP	I-DNAin	the	in	IN	B-PP	Othe	face	the	DT	B-NP	Oface	of	face	NN	I-NP	Oof	defective	of	IN	B-PP	Odefective	STAT1	defective	JJ	B-NP	OSTAT1	phosphorylation	STAT1	NN	I-NP	B-proteinphosphorylation	","	phosphorylation	NN	I-NP	O","	it	","	","	O	Oit	was	it	PRP	B-NP	Owas	reasoned	be	VBD	B-VP	Oreasoned	that	reason	VBN	I-VP	Othat	decreased	that	IN	B-SBAR	Odecreased	levels	decrease	VBN	B-NP	Olevels	of	level	NNS	I-NP	Oof	activated	of	IN	B-PP	Oactivated	STAT1	activate	VBN	B-NP	OSTAT1	might	STAT1	NN	I-NP	B-proteinmight	result	might	MD	B-VP	Oresult	in	result	VB	I-VP	Oin	reduced	in	IN	B-PP	Oreduced	expression	reduce	VBN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	a	of	IN	B-PP	Oa	hematopoietic	a	DT	B-NP	Ohematopoietic	IFNgamma-responsive	hematopoietic	JJ	I-NP	B-proteinIFNgamma-responsive	protein	IFNgamma-responsive	JJ	I-NP	I-proteinprotein	that	protein	NN	I-NP	I-proteinthat	normally	that	WDT	B-NP	Onormally	modulates	normally	RB	B-ADVP	Omodulates	expression	modulate	VBZ	B-VP	Oexpression	of	expression	NN	B-NP	Oof	other	of	IN	B-PP	Oother	IFNgamma-responsive	other	JJ	B-NP	OIFNgamma-responsive	genes	IFNgamma-responsive	JJ	I-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Levels	.	.	O	OLevels	of	Level	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	IFNgamma	the	DT	B-NP	OIFNgamma	#NAME?	IFNgamma	NN	I-NP	B-protein#NAME?	factor	#NAME?	JJ	I-NP	Ofactor	IFN	factor	NN	I-NP	OIFN	consensus	IFN	NN	I-NP	Oconsensus	sequence	consensus	NN	I-NP	Osequence	binding	sequence	NN	I-NP	Obinding	protein	binding	NN	I-NP	Oprotein	(	protein	NN	I-NP	O(	ICSBP	(	(	O	OICSBP	)	ICSBP	NN	B-NP	B-protein)	","	)	)	O	O","	a	","	","	O	Oa	negative	a	DT	B-NP	Onegative	trans-acting	negative	JJ	I-NP	Otrans-acting	regulator	trans-acting	JJ	I-NP	Oregulator	of	regulator	NN	I-NP	Oof	some	of	IN	B-PP	Osome	IFNgamma-inducible	some	DT	B-NP	OIFNgamma-inducible	genes	IFNgamma-inducible	JJ	I-NP	B-DNAgenes	","	gene	NNS	I-NP	I-DNA","	were	","	","	O	Owere	quantified	be	VBD	B-VP	Oquantified	.	quantify	VBN	I-VP	O.	ICSBP	.	.	O	OICSBP	levels	ICSBP	NN	B-NP	B-proteinlevels	were	level	NNS	I-NP	Owere	reduced	be	VBD	B-VP	Oreduced	in	reduce	VBN	I-VP	Oin	FA-C	in	IN	B-PP	OFA-C	B	FA-C	NN	B-NP	B-cell_lineB	lymphoblasts	B	NN	I-NP	I-cell_linelymphoblasts	and	lymphoblast	NNS	I-NP	I-cell_lineand	MEFs	and	CC	I-NP	OMEFs	.	MEF	NNS	I-NP	B-protein.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	enforced	","	","	O	Oenforced	expression	enforce	VBN	B-VP	Oexpression	of	expression	NN	B-NP	Oof	ICSBP	of	IN	B-PP	OICSBP	failed	ICSBP	NN	B-NP	B-proteinfailed	to	fail	VBD	B-VP	Oto	down-regulate	to	TO	I-VP	Odown-regulate	IRF-1	down-regulate	VB	I-VP	OIRF-1	","	IRF-1	NN	B-NP	B-protein","	ISGF3gamma	","	","	O	OISGF3gamma	","	ISGF3gamma	NN	B-NP	B-protein","	and	","	","	O	Oand	p21	and	CC	O	Op21	(	p21	NN	B-NP	B-protein(	WAF1	(	(	O	I-proteinWAF1	)	WAF1	NN	B-NP	I-protein)	.	)	)	O	I-protein.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	the	","	","	O	Othe	FANCC	the	DT	B-NP	OFANCC	protein	FANCC	NN	I-NP	B-proteinprotein	functions	protein	NN	I-NP	I-proteinfunctions	to	function	VBZ	B-VP	Oto	modulate	to	TO	I-VP	Omodulate	expression	modulate	VB	I-VP	Oexpression	of	expression	NN	B-NP	Oof	a	of	IN	B-PP	Oa	family	a	DT	B-NP	Ofamily	of	family	NN	I-NP	Oof	genes	of	IN	B-PP	Ogenes	that	gene	NNS	B-NP	Othat	in	that	IN	B-NP	Oin	normal	in	IN	B-PP	Onormal	cells	normal	JJ	B-NP	B-cell_typecells	are	cell	NNS	I-NP	I-cell_typeare	inducible	be	VBP	B-VP	Oinducible	only	inducible	JJ	B-ADJP	Oonly	by	only	RB	B-ADVP	Oby	specific	by	IN	B-PP	Ospecific	environmental	specific	JJ	B-NP	Oenvironmental	cues	environmental	JJ	I-NP	Ocues	for	cue	NNS	I-NP	Ofor	apoptosis	for	IN	B-PP	Oapoptosis	or	apoptosis	NN	B-NP	Oor	mitogenic	or	CC	O	Omitogenic	inhibition	mitogenic	JJ	B-NP	Oinhibition	","	inhibition	NN	I-NP	O","	but	","	","	O	Obut	it	but	CC	O	Oit	does	it	PRP	B-NP	Odoes	so	do	VBZ	B-VP	Oso	independently	so	RB	B-ADVP	Oindependently	of	independently	RB	I-ADVP	Oof	the	of	IN	B-PP	Othe	classic	the	DT	B-NP	Oclassic	IFN-STAT1	classic	JJ	I-NP	OIFN-STAT1	pathway	IFN-STAT1	NN	I-NP	B-proteinpathway	and	pathway	NN	I-NP	Oand	is	and	CC	O	Ois	not	be	VBZ	B-VP	Onot	the	not	RB	O	Othe	direct	the	DT	B-NP	Odirect	result	direct	JJ	I-NP	Oresult	of	result	NN	I-NP	Oof	reduced	of	IN	B-PP	Oreduced	ICSBP	reduce	VBN	B-NP	OICSBP	expression	ICSBP	NN	I-NP	B-proteinexpression	.	expression	NN	I-NP	O.	A	.	.	O	OA	genetic	A	DT	B-NP	Ogenetic	investigation	genetic	JJ	I-NP	Oinvestigation	of	investigation	NN	I-NP	Oof	E2A	of	IN	B-PP	OE2A	function	E2A	NN	B-NP	B-proteinfunction	in	function	NN	I-NP	Oin	lymphocyte	in	IN	B-PP	Olymphocyte	development	lymphocyte	NN	B-NP	Odevelopment	.	development	NN	I-NP	O.	Lymphocytes	.	.	O	OLymphocytes	are	Lymphocyte	NNS	B-NP	B-cell_typeare	derived	be	VBP	B-VP	Oderived	from	derive	VBN	I-VP	Ofrom	hematopoietic	from	IN	B-PP	Ohematopoietic	stem	hematopoietic	JJ	B-NP	B-cell_typestem	cells	stem	NN	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	HSC	(	(	O	OHSC	)	HSC	NN	B-NP	B-cell_type)	following	)	)	O	Ofollowing	a	follow	VBG	B-PP	Oa	series	a	DT	B-NP	Oseries	of	series	NN	I-NP	Oof	regulated	of	IN	B-PP	Oregulated	differentiation	regulate	VBN	B-NP	Odifferentiation	events	differentiation	NN	I-NP	Oevents	.	event	NNS	I-NP	O.	Multipotent	.	.	O	OMultipotent	HSCs	Multipotent	JJ	B-NP	OHSCs	become	HSC	NNS	I-NP	B-cell_typebecome	committed	become	VBP	B-VP	Ocommitted	to	commit	VBN	B-ADJP	Oto	the	to	TO	B-PP	Othe	B	the	DT	B-NP	OB	cell	B	NN	I-NP	B-cell_typecell	lineage	cell	NN	I-NP	I-cell_typelineage	in	lineage	NN	I-NP	I-cell_typein	bone	in	IN	B-PP	Obone	marrow	bone	NN	B-NP	Omarrow	and	marrow	NN	I-NP	Oand	the	and	CC	O	Othe	T	the	DT	B-NP	OT	cell	T	NN	I-NP	B-cell_typecell	lineage	cell	NN	I-NP	I-cell_typelineage	in	lineage	NN	I-NP	I-cell_typein	the	in	IN	B-PP	Othe	thymus	the	DT	B-NP	Othymus	after	thymus	NN	I-NP	Oafter	receiving	after	IN	B-PP	Oreceiving	appropriate	receive	VBG	B-VP	Oappropriate	signals	appropriate	JJ	B-NP	Osignals	from	signal	NNS	I-NP	Ofrom	the	from	IN	B-PP	Othe	corresponding	the	DT	B-NP	Ocorresponding	microenvironment	corresponding	JJ	I-NP	Omicroenvironment	.	microenvironment	NN	I-NP	O.	These	.	.	O	OThese	committed	These	DT	B-NP	Ocommitted	lymphoid	commit	VBN	I-NP	B-cell_typelymphoid	cells	lymphoid	JJ	I-NP	I-cell_typecells	must	cell	NNS	I-NP	I-cell_typemust	then	must	MD	B-VP	Othen	undergo	then	RB	I-VP	Oundergo	V	undergo	VB	I-VP	OV	(	V	NN	B-NP	O(	D	(	(	O	OD	)	D	NN	B-NP	O)	J	)	)	O	OJ	recombination	J	NN	B-NP	Orecombination	at	recombination	NN	I-NP	Oat	the	at	IN	B-PP	Othe	immunoglobulin	the	DT	B-NP	Oimmunoglobulin	gene	immunoglobulin	NN	I-NP	B-DNAgene	or	gene	NN	I-NP	I-DNAor	T	or	CC	O	OT	cell	T	NN	B-NP	Ocell	receptor	cell	NN	I-NP	Oreceptor	gene	receptor	NN	I-NP	Ogene	locus	gene	NN	I-NP	Olocus	resulting	locus	NN	I-NP	Oresulting	in	result	VBG	B-VP	Oin	clonal	in	IN	B-PP	Oclonal	production	clonal	JJ	B-NP	Oproduction	of	production	NN	I-NP	Oof	functional	of	IN	B-PP	Ofunctional	B	functional	JJ	B-NP	OB	or	B	NN	I-NP	Oor	T	or	CC	I-NP	OT	lymphocytes	T	NN	I-NP	B-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	respectively	","	","	O	Orespectively	.	respectively	RB	B-ADVP	O.	Lymphocyte	.	.	O	OLymphocyte	commitment	Lymphocyte	NN	B-NP	Ocommitment	and	commitment	NN	I-NP	Oand	differentiation	and	CC	O	Odifferentiation	are	differentiation	NN	B-NP	Oare	accompanied	be	VBP	B-VP	Oaccompanied	by	accompany	VBN	I-VP	Oby	programmed	by	IN	B-PP	Oprogrammed	gene	program	VBN	B-NP	Ogene	expression	gene	NN	I-NP	Oexpression	or	expression	NN	I-NP	Oor	repression	or	CC	O	Orepression	events	repression	NN	B-NP	Oevents	which	event	NNS	I-NP	Owhich	are	which	WDT	B-NP	Oare	driven	be	VBP	B-VP	Odriven	by	drive	VBN	I-VP	Oby	lineage	by	IN	B-PP	Olineage	and	lineage	NN	B-NP	Oand	stage	and	CC	O	Ostage	specific	stage	NN	B-NP	Ospecific	transcription	specific	JJ	I-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	.	factor	NNS	I-NP	I-protein.	The	.	.	O	OThe	basic-helix-loop-helix	The	DT	B-NP	Obasic-helix-loop-helix	(	basic-helix-loop-helix	JJ	I-NP	B-protein(	bHLH	(	(	O	I-proteinbHLH	)	bHLH	JJ	B-ADJP	I-protein)	transcription	)	)	O	I-proteintranscription	factors	transcription	NN	B-NP	I-proteinfactors	encoded	factor	NNS	I-NP	I-proteinencoded	by	encode	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	E2A	the	DT	B-NP	OE2A	gene	E2A	NN	I-NP	B-DNAgene	are	gene	NN	I-NP	I-DNAare	involved	be	VBP	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	several	in	IN	B-PP	Oseveral	differentiation	several	JJ	B-NP	Odifferentiation	events	differentiation	NN	I-NP	Oevents	during	event	NNS	I-NP	Oduring	B	during	IN	B-PP	OB	and	B	NN	B-NP	Oand	T	and	CC	I-NP	OT	cell	T	NN	I-NP	Ocell	development	cell	NN	I-NP	Odevelopment	","	development	NN	I-NP	O","	including	","	","	O	Oincluding	lineage	include	VBG	B-PP	Olineage	commitment	lineage	NN	B-NP	Ocommitment	","	commitment	NN	I-NP	O","	initiation	","	","	O	Oinitiation	of	initiation	NN	B-NP	Oof	V	of	IN	B-PP	OV	(	V	NN	B-NP	O(	D	(	(	O	OD	)	D	NN	B-NP	O)	J	)	)	O	OJ	recombination	J	NN	B-NP	Orecombination	","	recombination	NN	I-NP	O","	and	","	","	O	Oand	antigen	and	CC	O	Oantigen	receptor	antigen	NN	B-NP	B-proteinreceptor	mediated	receptor	NN	I-NP	I-proteinmediated	proliferation	mediate	VBD	B-VP	Oproliferation	and	proliferation	NN	B-NP	Oand	differentiation	and	CC	O	Odifferentiation	.	differentiation	NN	B-NP	O.	Several	.	.	O	OSeveral	recent	Several	JJ	B-NP	Orecent	reviews	recent	JJ	I-NP	Oreviews	have	review	NNS	I-NP	Ohave	provided	have	VBP	B-VP	Oprovided	a	provide	VBN	I-VP	Oa	comprehensive	a	DT	B-NP	Ocomprehensive	discussion	comprehensive	JJ	I-NP	Odiscussion	of	discussion	NN	I-NP	Oof	biochemical	of	IN	B-PP	Obiochemical	","	biochemical	JJ	B-NP	O","	cellular	","	","	I-NP	Ocellular	","	cellular	JJ	I-NP	O","	and	","	","	O	Oand	genetic	and	CC	O	Ogenetic	research	genetic	JJ	B-NP	Oresearch	on	research	NN	I-NP	Oon	E2A	on	IN	B-PP	OE2A	function	E2A	NN	B-NP	B-proteinfunction	in	function	NN	I-NP	Oin	lymphocyte	in	IN	B-PP	Olymphocyte	development	lymphocyte	NN	B-NP	Odevelopment	(	development	NN	I-NP	O(	1	(	(	O	O1	","	1	CD	B-NP	O","	2	","	","	I-NP	O2	)	2	CD	I-NP	O)	.	)	)	O	O.	Here	.	.	O	OHere	","	Here	RB	B-ADVP	O","	we	","	","	O	Owe	only	we	PRP	B-NP	Oonly	discuss	only	RB	B-ADVP	Odiscuss	some	discuss	VBZ	B-VP	Osome	of	some	DT	B-NP	Oof	the	of	IN	B-PP	Othe	genetic	the	DT	B-NP	Ogenetic	approaches	genetic	JJ	I-NP	Oapproaches	our	approach	VBZ	B-VP	Oour	laboratory	our	PRP$	B-NP	Olaboratory	(	laboratory	NN	I-NP	O(	except	(	(	O	Oexcept	where	except	IN	B-PP	Owhere	it	where	WRB	B-ADVP	Oit	is	it	PRP	B-NP	Ois	noted	be	VBZ	B-VP	Onoted	)	note	VBN	I-VP	O)	has	)	)	O	Ohas	undertaken	have	VBZ	B-VP	Oundertaken	to	undertake	VBN	I-VP	Oto	investigate	to	TO	I-VP	Oinvestigate	the	investigate	VB	I-VP	Othe	molecular	the	DT	B-NP	Omolecular	pathways	molecular	JJ	I-NP	Opathways	mediated	pathway	NNS	I-NP	Omediated	by	mediate	VBN	B-VP	Oby	E2A	by	IN	B-PP	OE2A	transcription	E2A	NN	B-NP	B-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	in	factor	NNS	I-NP	I-proteinin	lymphocyte	in	IN	B-PP	Olymphocyte	development	lymphocyte	NN	B-NP	Odevelopment	D609	development	NN	I-NP	OD609	inhibits	D609	NN	B-NP	Oinhibits	ionizing	inhibit	VBZ	B-VP	Oionizing	radiation-induced	ionize	VBG	I-VP	Oradiation-induced	oxidative	radiation-induced	JJ	B-NP	Ooxidative	damage	oxidative	JJ	I-NP	Odamage	by	damage	NN	I-NP	Oby	acting	by	IN	B-PP	Oacting	as	act	VBG	B-VP	Oas	a	as	IN	B-PP	Oa	potent	a	DT	B-NP	Opotent	antioxidant	potent	JJ	I-NP	Oantioxidant	.	antioxidant	NN	I-NP	O.	Tricyclodecan-9-yl-xanthogenate	.	.	O	OTricyclodecan-9-yl-xanthogenate	(	Tricyclodecan-9-yl-xanthogenate	NN	B-NP	O(	D609	(	(	O	OD609	)	D609	NN	B-NP	O)	has	)	)	O	Ohas	been	have	VBZ	B-VP	Obeen	extensively	be	VBN	I-VP	Oextensively	studied	extensively	RB	I-VP	Ostudied	in	study	VBN	I-VP	Oin	biological	in	IN	B-PP	Obiological	systems	biological	JJ	B-NP	Osystems	and	system	NNS	I-NP	Oand	exhibits	and	CC	O	Oexhibits	a	exhibit	VBZ	B-VP	Oa	variety	a	DT	B-NP	Ovariety	of	variety	NN	I-NP	Oof	biological	of	IN	B-PP	Obiological	functions	biological	JJ	B-NP	Ofunctions	","	function	NNS	I-NP	O","	including	","	","	O	Oincluding	antiviral	include	VBG	B-PP	Oantiviral	","	antiviral	JJ	B-NP	O","	antitumor	","	","	I-NP	Oantitumor	","	antitumor	JJ	I-NP	O","	and	","	","	O	Oand	anti-inflammatory	and	CC	O	Oanti-inflammatory	activities	anti-inflammatory	JJ	B-NP	Oactivities	.	activity	NNS	I-NP	O.	Most	.	.	O	OMost	of	Most	JJS	B-NP	Oof	these	of	IN	B-PP	Othese	activities	these	DT	B-NP	Oactivities	have	activity	NNS	I-NP	Ohave	been	have	VBP	B-VP	Obeen	largely	be	VBN	I-VP	Olargely	attributed	largely	RB	I-VP	Oattributed	to	attribute	VBN	I-VP	Oto	the	to	TO	B-PP	Othe	inhibitory	the	DT	B-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	D609	of	IN	B-PP	OD609	on	D609	NN	B-NP	Oon	phosphatidylcholine-specific	on	IN	B-PP	Ophosphatidylcholine-specific	phospholipase	phosphatidylcholine-specific	JJ	B-NP	B-proteinphospholipase	C	phospholipase	NN	I-NP	I-proteinC	.	C	NN	I-NP	I-protein.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	as	","	","	O	Oas	a	as	IN	B-PP	Oa	xanthate	a	DT	B-NP	Oxanthate	derivative	xanthate	NN	I-NP	Oderivative	","	derivative	NN	I-NP	O","	D609	","	","	O	OD609	is	D609	NN	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	strong	a	DT	B-NP	Ostrong	electrolyte	strong	JJ	I-NP	Oelectrolyte	and	electrolyte	NN	I-NP	Oand	readily	and	CC	O	Oreadily	dissociates	readily	RB	B-VP	Odissociates	to	dissociate	VBZ	I-VP	Oto	xanthate	to	TO	I-VP	Oxanthate	anions	xanthate	VB	I-VP	Oanions	and	anion	NNS	B-NP	Oand	cations	and	CC	I-NP	Ocations	of	cation	NNS	I-NP	Oof	alkali	of	IN	B-PP	Oalkali	metals	alkali	JJ	B-NP	Ometals	in	metal	NNS	I-NP	Oin	solution	in	IN	B-PP	Osolution	.	solution	NN	B-NP	O.	Xanthate	.	.	O	OXanthate	anions	Xanthate	NN	B-NP	Oanions	and	anion	NNS	I-NP	Oand	protonated	and	CC	O	Oprotonated	xanthic	protonate	VBN	B-VP	Oxanthic	acid	xanthic	JJ	B-NP	Oacid	contain	acid	NN	I-NP	Ocontain	a	contain	VBP	B-VP	Oa	free	a	DT	B-NP	Ofree	thiol	free	JJ	I-NP	Othiol	moiety	thiol	NN	I-NP	Omoiety	and	moiety	NN	I-NP	Oand	are	and	CC	O	Oare	highly	be	VBP	B-VP	Ohighly	reductive	highly	RB	B-ADJP	Oreductive	.	reductive	JJ	I-ADJP	O.	This	.	.	O	OThis	implies	This	DT	B-NP	Oimplies	that	imply	VBZ	B-VP	Othat	D609	that	IN	B-SBAR	OD609	and	D609	NN	B-NP	Oand	other	and	CC	O	Oother	xanthate	other	JJ	B-NP	Oxanthate	derivatives	xanthate	NN	I-NP	Oderivatives	may	derivative	NNS	I-NP	Omay	function	may	MD	B-VP	Ofunction	as	function	VB	I-VP	Oas	potent	as	IN	B-PP	Opotent	antioxidants	potent	JJ	B-NP	Oantioxidants	.	antioxidant	NNS	I-NP	O.	Indeed	.	.	O	OIndeed	","	Indeed	RB	B-ADVP	O","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	D609	that	IN	B-SBAR	OD609	inhibited	D609	NN	B-NP	Oinhibited	the	inhibit	VBD	B-VP	Othe	Fenton	the	DT	B-NP	OFenton	reaction-induced	Fenton	NNP	I-NP	Oreaction-induced	oxidation	reaction-induced	JJ	I-NP	Ooxidation	of	oxidation	NN	I-NP	Oof	dihydrorhodamine	of	IN	B-PP	Odihydrorhodamine	123	dihydrorhodamine	NN	B-NP	O123	in	123	CD	I-NP	Oin	a	in	IN	B-PP	Oa	dose-dependent	a	DT	B-NP	Odose-dependent	manner	dose-dependent	JJ	I-NP	Omanner	similar	manner	NN	I-NP	Osimilar	to	similar	JJ	B-ADJP	Oto	that	to	TO	B-PP	Othat	of	that	DT	B-NP	Oof	pyrrolidinedithiocarbamate	of	IN	B-PP	Opyrrolidinedithiocarbamate	","	pyrrolidinedithiocarbamate	NN	B-NP	O","	a	","	","	O	Oa	well	a	DT	B-NP	Owell	known	well	RB	I-NP	Oknown	antioxidant	know	VBN	I-NP	Oantioxidant	.	antioxidant	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	D609	","	","	O	OD609	inhibited	D609	NN	B-NP	B-proteininhibited	the	inhibit	VBD	B-VP	Othe	formation	the	DT	B-NP	Oformation	of	formation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	alpha-phenyl-tert-butylnitrone-free	the	DT	B-NP	Oalpha-phenyl-tert-butylnitrone-free	radical	alpha-phenyl-tert-butylnitrone-free	JJ	I-NP	Oradical	spin	radical	NN	I-NP	Ospin	adducts	spin	NN	I-NP	Oadducts	and	adduct	NNS	I-NP	Oand	lipid	and	CC	O	Olipid	peroxidation	lipid	NN	B-NP	Operoxidation	of	peroxidation	NN	I-NP	Oof	synaptosomal	of	IN	B-PP	Osynaptosomal	membranes	synaptosomal	JJ	B-NP	Omembranes	by	membrane	NNS	I-NP	Oby	the	by	IN	B-PP	Othe	Fenton	the	DT	B-NP	OFenton	reagents	Fenton	NNP	I-NP	Oreagents	.	reagent	NNS	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	preincubation	","	","	O	Opreincubation	of	preincubation	NN	B-NP	Oof	lymphocytes	of	IN	B-PP	Olymphocytes	with	lymphocyte	NNS	B-NP	B-cell_typewith	D609	with	IN	B-PP	OD609	resulted	D609	NN	B-NP	Oresulted	in	result	VBD	B-VP	Oin	a	in	IN	B-PP	Oa	significant	a	DT	B-NP	Osignificant	diminution	significant	JJ	I-NP	Odiminution	of	diminution	NN	I-NP	Oof	ionizing	of	IN	B-PP	Oionizing	radiation	ionize	VBG	B-VP	Oradiation	(	radiation	NN	B-NP	O(	IR	(	(	O	OIR	)	IR	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	1	#NAME?	JJ	B-NP	O1	)	1	CD	I-NP	O)	production	)	)	O	Oproduction	of	production	NN	B-NP	Oof	reactive	of	IN	B-PP	Oreactive	oxygen	reactive	JJ	B-NP	Ooxygen	species	oxygen	NN	I-NP	Ospecies	;	specie	NNS	I-NP	O;	2	;	:	O	O2	)	2	LS	B-LST	O)	decrease	)	)	O	Odecrease	in	decrease	VB	B-VP	Oin	intracellular	in	IN	B-PP	Ointracellular	reduced	intracellular	JJ	B-NP	Oreduced	glutathione	reduce	VBN	I-NP	Oglutathione	;	glutathione	NN	I-NP	O;	3	;	:	O	O3	)	3	LS	B-LST	O)	oxidative	)	)	O	Ooxidative	damage	oxidative	JJ	B-NP	Odamage	to	damage	NN	I-NP	Oto	proteins	to	TO	B-PP	Oproteins	and	protein	NNS	B-NP	Oand	lipids	and	CC	I-NP	Olipids	;	lipid	NNS	I-NP	O;	and	;	:	O	Oand	4	and	CC	O	O4	)	4	LS	B-LST	O)	activation	)	)	O	Oactivation	of	activation	NN	B-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor-kappaB	nuclear	JJ	B-NP	B-proteinfactor-kappaB	.	factor-kappaB	NN	I-NP	I-protein.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	when	","	","	O	Owhen	D609	when	WRB	B-ADVP	OD609	(	D609	NN	B-NP	O(	50	(	(	O	O50	mg/kg	50	CD	B-NP	Omg/kg	i.v.	mg/kg	NN	I-NP	Oi.v.	)	i.v.	NN	I-NP	O)	was	)	)	O	Owas	administered	be	VBD	B-VP	Oadministered	to	administer	VBN	I-VP	Oto	mice	to	TO	B-PP	Omice	10	mouse	NNS	B-NP	O10	min	10	CD	B-NP	Omin	prior	min	NN	I-NP	Oprior	to	prior	JJ	B-ADVP	Oto	total	to	TO	B-PP	Ototal	body	total	JJ	B-NP	Obody	IR	body	NN	I-NP	OIR	(	IR	NN	I-NP	O(	6.5	(	(	O	O6.5	and	6.5	CD	B-NP	Oand	8.5	and	CC	I-NP	O8.5	Gy	8.5	CD	I-NP	OGy	)	Gy	NN	I-NP	O)	","	)	)	O	O","	it	","	","	O	Oit	protected	it	PRP	B-NP	Oprotected	the	protect	VBD	B-VP	Othe	mice	the	DT	B-NP	Omice	from	mouse	NNS	I-NP	Ofrom	IR-induced	from	IN	B-PP	OIR-induced	lethality	IR-induced	JJ	B-NP	Olethality	.	lethality	NN	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	these	","	","	O	Othese	results	these	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	D609	that	IN	B-SBAR	OD609	is	D609	NN	B-NP	B-DNAis	a	be	VBZ	B-VP	Oa	potent	a	DT	B-NP	Opotent	antioxidant	potent	JJ	I-NP	Oantioxidant	and	antioxidant	NN	I-NP	Oand	has	and	CC	O	Ohas	the	have	VBZ	B-VP	Othe	ability	the	DT	B-NP	Oability	to	ability	NN	I-NP	Oto	inhibit	to	TO	B-VP	Oinhibit	IR-induced	inhibit	VB	I-VP	OIR-induced	cellular	IR-induced	JJ	B-NP	Ocellular	oxidative	cellular	JJ	I-NP	Ooxidative	stress	oxidative	JJ	I-NP	Ostress	.	stress	NN	I-NP	O.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	AP-1	of	IN	B-PP	OAP-1	by	AP-1	NN	B-NP	B-proteinby	the	by	IN	B-PP	Othe	glucocorticoid-inducible	the	DT	B-NP	Oglucocorticoid-inducible	protein	glucocorticoid-inducible	JJ	I-NP	B-proteinprotein	GILZ	protein	NN	I-NP	I-proteinGILZ	.	GILZ	NN	I-NP	O.	The	.	.	O	OThe	immunosuppressive	The	DT	B-NP	Oimmunosuppressive	effects	immunosuppressive	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	glucocorticoids	of	IN	B-PP	Oglucocorticoids	arise	glucocorticoid	NNS	B-NP	Oarise	largely	arise	VBP	B-VP	Olargely	by	largely	RB	B-ADVP	Oby	inhibition	by	IN	B-PP	Oinhibition	of	inhibition	NN	B-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	gene	cytokine	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	","	expression	NN	I-NP	O","	which	","	","	O	Owhich	has	which	WDT	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	ascribed	be	VBN	I-VP	Oascribed	to	ascribe	VBN	I-VP	Oto	interference	to	TO	B-PP	Ointerference	between	interference	NN	B-NP	Obetween	the	between	IN	B-PP	Othe	glucocorticoid	the	DT	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	and	receptor	NN	I-NP	I-proteinand	transcription	and	CC	O	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	such	factor	NNS	I-NP	I-proteinsuch	as	such	JJ	B-PP	Oas	AP-1	as	IN	I-PP	OAP-1	and	AP-1	NN	B-NP	B-proteinand	NF-kappa	and	CC	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	as	B	NN	I-NP	I-proteinas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	by	as	IN	I-CONJP	Oby	competition	by	IN	B-PP	Ocompetition	for	competition	NN	B-NP	Ofor	common	for	IN	B-PP	Ocommon	coactivators	common	JJ	B-NP	B-proteincoactivators	.	coactivator	NNS	I-NP	I-protein.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	glucocorticoid-induced	that	IN	B-SBAR	Oglucocorticoid-induced	inhibition	glucocorticoid-induced	JJ	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	interleukin-2	of	IN	B-PP	Ointerleukin-2	mRNA	interleukin-2	NN	B-NP	B-RNAmRNA	expression	mRNA	NN	I-NP	I-RNAexpression	in	expression	NN	I-NP	Oin	activated	in	IN	B-PP	Oactivated	normal	activate	VBN	B-NP	Onormal	T	normal	JJ	I-NP	OT	cells	T	NN	I-NP	B-cell_typecells	required	cell	NNS	I-NP	I-cell_typerequired	new	require	VBD	B-VP	Onew	protein	new	JJ	B-NP	Oprotein	synthesis	protein	NN	I-NP	Osynthesis	","	synthesis	NN	I-NP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	this	that	IN	B-SBAR	Othis	phenomenon	this	DT	B-NP	Ophenomenon	is	phenomenon	NN	I-NP	Ois	secondary	be	VBZ	B-VP	Osecondary	to	secondary	JJ	B-ADJP	Oto	expression	to	TO	B-PP	Oexpression	of	expression	NN	B-NP	Oof	glucocorticoid-regulated	of	IN	B-PP	Oglucocorticoid-regulated	genes	glucocorticoid-regulated	JJ	B-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	One	.	.	O	OOne	of	One	CD	B-NP	Oof	the	of	IN	B-PP	Othe	most	the	DT	B-NP	Omost	prominent	most	RBS	I-NP	B-DNAprominent	glucocorticoid-induced	prominent	JJ	I-NP	I-DNAglucocorticoid-induced	genes	glucocorticoid-induced	JJ	I-NP	I-DNAgenes	is	gene	NNS	I-NP	I-DNAis	glucocorticoid-induced	be	VBZ	B-VP	Oglucocorticoid-induced	leucine	glucocorticoid-induced	JJ	B-NP	Oleucine	zipper	leucine	NN	I-NP	Ozipper	(	zipper	NN	I-NP	O(	GILZ	(	(	O	OGILZ	)	GILZ	NN	B-NP	B-protein)	","	)	)	O	O","	which	","	","	O	Owhich	has	which	WDT	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	reported	be	VBN	I-VP	Oreported	to	report	VBN	I-VP	Oto	inhibit	to	TO	I-VP	Oinhibit	activation-induced	inhibit	VB	I-VP	Oactivation-induced	up-regulation	activation-induced	JJ	B-NP	Oup-regulation	of	up-regulation	NN	I-NP	Oof	Fas	of	IN	B-PP	OFas	ligand	Fas	NN	B-NP	B-RNAligand	(	ligand	NN	I-NP	I-RNA(	FasL	(	(	O	I-RNAFasL	)	FasL	NN	B-NP	I-RNA)	mRNA	)	)	O	I-RNAmRNA	.	mRNA	NN	B-NP	I-RNA.	Indeed	.	.	O	OIndeed	","	Indeed	RB	B-ADVP	O","	transient	","	","	O	Otransient	expression	transient	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	GILZ	of	IN	B-PP	OGILZ	in	GILZ	NN	B-NP	B-proteinin	Jurkat	in	IN	B-PP	OJurkat	T	Jurkat	NN	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	blocked	cell	NNS	I-NP	I-cell_lineblocked	induction	block	VBD	B-VP	Oinduction	of	induction	NN	B-NP	Oof	a	of	IN	B-PP	Oa	reporter	a	DT	B-NP	Oreporter	construct	reporter	NN	I-NP	B-DNAconstruct	driven	construct	NN	I-NP	I-DNAdriven	by	drive	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	FasL	the	DT	B-NP	OFasL	promoter	FasL	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	This	.	.	O	OThis	could	This	DT	B-NP	Ocould	be	could	MD	B-VP	Obe	accounted	be	VB	I-VP	Oaccounted	for	account	VBN	I-VP	Ofor	by	for	IN	B-PP	Oby	GILZ	by	IN	B-PP	OGILZ	#NAME?	GILZ	NN	B-NP	B-protein#NAME?	inhibition	#NAME?	JJ	I-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	Egr-2	of	IN	B-PP	OEgr-2	and	Egr-2	NN	B-NP	B-proteinand	Egr-3	and	CC	I-NP	OEgr-3	","	Egr-3	NN	I-NP	B-protein","	NFAT/AP-1	","	","	O	ONFAT/AP-1	#NAME?	NFAT/AP-1	NN	B-NP	B-protein#NAME?	transcription	#NAME?	JJ	I-NP	I-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	that	factor	NNS	I-NP	I-proteinthat	bind	that	WDT	B-NP	Obind	a	bind	VBP	B-VP	Oa	regulatory	a	DT	B-NP	Oregulatory	element	regulatory	JJ	I-NP	B-DNAelement	in	element	NN	I-NP	I-DNAin	the	in	IN	B-PP	Othe	FasL	the	DT	B-NP	OFasL	promoter	FasL	NN	I-NP	B-DNApromoter	and	promoter	NN	I-NP	I-DNAand	up-regulate	and	CC	O	Oup-regulate	FasL	up-regulate	VBP	B-VP	OFasL	expression	FasL	NN	B-NP	B-proteinexpression	.	expression	NN	I-NP	O.	GILZ	.	.	O	OGILZ	also	GILZ	NN	B-NP	B-proteinalso	potently	also	RB	B-ADVP	Opotently	inhibited	potently	RB	B-ADVP	Oinhibited	AP-1-driven	inhibit	VBD	B-VP	OAP-1-driven	and	AP-1-driven	JJ	B-ADJP	Oand	IL-2	and	CC	O	OIL-2	promoter-driven	IL-2	NN	B-NP	B-DNApromoter-driven	reporter	promoter-driven	JJ	I-NP	I-DNAreporter	constructs	reporter	NN	I-NP	I-DNAconstructs	","	construct	NNS	I-NP	I-DNA","	and	","	","	O	Oand	recombinant	and	CC	O	Orecombinant	GILZ	recombinant	JJ	B-NP	B-proteinGILZ	specifically	GILZ	NN	I-NP	I-proteinspecifically	interacted	specifically	RB	B-ADVP	Ointeracted	with	interact	VBD	B-VP	Owith	c-Fos	with	IN	B-PP	Oc-Fos	and	c-Fos	NN	B-NP	B-proteinand	c-Jun	and	CC	I-NP	Oc-Jun	in	c-Jun	NN	I-NP	B-proteinin	vitro	in	FW	B-ADVP	Ovitro	and	vitro	FW	I-ADVP	Oand	inhibited	and	CC	O	Oinhibited	the	inhibit	VBD	B-VP	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	active	of	IN	B-PP	Oactive	AP-1	active	JJ	B-NP	OAP-1	to	AP-1	NN	I-NP	B-proteinto	its	to	TO	B-PP	Oits	target	its	PRP$	B-NP	Otarget	DNA	target	NN	I-NP	ODNA	.	DNA	NN	I-NP	O.	Whereas	.	.	O	OWhereas	homodimerization	Whereas	IN	B-PP	Ohomodimerization	of	homodimerization	NN	B-NP	Oof	GILZ	of	IN	B-PP	OGILZ	required	GILZ	NN	B-NP	B-proteinrequired	the	require	VBD	B-VP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	its	of	IN	B-PP	Oits	leucine	its	PRP$	B-NP	Oleucine	zipper	leucine	NN	I-NP	B-proteinzipper	","	zipper	NN	I-NP	I-protein","	the	","	","	O	Othe	interaction	the	DT	B-NP	Ointeraction	with	interaction	NN	I-NP	Owith	c-Fos	with	IN	B-PP	Oc-Fos	and	c-Fos	NN	B-NP	B-proteinand	c-Jun	and	CC	I-NP	Oc-Jun	occurred	c-Jun	NN	I-NP	B-proteinoccurred	through	occur	VBD	B-VP	Othrough	the	through	IN	B-PP	Othe	N-terminal	the	DT	B-NP	ON-terminal	60-amino	N-terminal	JJ	I-NP	B-protein60-amino	acid	60-amino	JJ	I-NP	I-proteinacid	region	acid	NN	I-NP	I-proteinregion	of	region	NN	I-NP	I-proteinof	GILZ	of	IN	B-PP	OGILZ	.	GILZ	NN	B-NP	B-protein.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	GILZ	","	","	O	OGILZ	represents	GILZ	NN	B-NP	B-proteinrepresents	a	represent	VBZ	B-VP	Oa	glucocorticoid-induced	a	DT	B-NP	Oglucocorticoid-induced	gene	glucocorticoid-induced	JJ	I-NP	B-proteingene	product	gene	NN	I-NP	I-proteinproduct	that	product	NN	I-NP	I-proteinthat	can	that	WDT	B-NP	Ocan	inhibit	can	MD	B-VP	Oinhibit	a	inhibit	VB	I-VP	Oa	variety	a	DT	B-NP	Ovariety	of	variety	NN	I-NP	Oof	activation-induced	of	IN	B-PP	Oactivation-induced	events	activation-induced	JJ	B-NP	Oevents	","	event	NNS	I-NP	O","	at	","	","	O	Oat	least	at	IN	B-ADVP	Oleast	in	least	JJS	I-ADVP	Oin	part	in	IN	B-PP	Opart	by	part	NN	B-NP	Oby	direct	by	IN	B-PP	Odirect	interference	direct	JJ	B-NP	Ointerference	with	interference	NN	I-NP	Owith	AP-1	with	IN	B-PP	OAP-1	","	AP-1	NN	B-NP	B-protein","	and	","	","	O	Oand	is	and	CC	O	Ois	therefore	be	VBZ	B-VP	Otherefore	a	therefore	RB	B-ADVP	Oa	candidate	a	DT	B-NP	Ocandidate	for	candidate	NN	I-NP	Ofor	a	for	IN	B-PP	Oa	mediator	a	DT	B-NP	Omediator	of	mediator	NN	I-NP	Oof	glucocorticoid-induced	of	IN	B-PP	Oglucocorticoid-induced	immunosuppression	glucocorticoid-induced	JJ	B-NP	Oimmunosuppression	.	immunosuppression	NN	I-NP	O.	Pharmacokinetic	.	.	O	OPharmacokinetic	differences	Pharmacokinetic	JJ	B-NP	Odifferences	between	difference	NNS	I-NP	Obetween	a	between	IN	B-PP	Oa	T	a	DT	B-NP	OT	cell-tolerizing	T	NN	I-NP	Ocell-tolerizing	and	cell-tolerizing	NN	I-NP	Oand	a	and	CC	O	Oa	T	a	DT	B-NP	OT	cell-activating	T	NN	I-NP	Ocell-activating	peptide	cell-activating	JJ	I-NP	Opeptide	.	peptide	NN	I-NP	O.	Vaccination	.	.	O	OVaccination	with	Vaccination	NN	B-NP	Owith	a	with	IN	B-PP	Oa	peptide	a	DT	B-NP	Opeptide	representing	peptide	NN	I-NP	Orepresenting	a	represent	VBG	B-VP	Oa	CTL	a	DT	B-NP	OCTL	epitope	CTL	NN	I-NP	B-proteinepitope	from	epitope	NN	I-NP	I-proteinfrom	the	from	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	papillomavirus	human	JJ	I-NP	B-proteinpapillomavirus	(	papillomavirus	NN	I-NP	I-protein(	HPV	(	(	O	I-proteinHPV	)	HPV	NN	B-NP	I-protein)	16	)	)	O	I-protein16	E7	16	CD	B-NP	I-proteinE7	protein	E7	NN	I-NP	I-proteinprotein	induces	protein	NN	I-NP	I-proteininduces	a	induce	VBZ	B-VP	Oa	specific	a	DT	B-NP	Ospecific	CTL	specific	JJ	I-NP	OCTL	response	CTL	NN	I-NP	Oresponse	that	response	NN	I-NP	Othat	prevents	that	WDT	B-NP	Oprevents	the	prevent	VBZ	B-VP	Othe	outgrowth	the	DT	B-NP	Ooutgrowth	of	outgrowth	NN	I-NP	Oof	HPV16	of	IN	B-PP	OHPV16	E7-expressing	HPV16	NN	B-NP	OE7-expressing	tumors	E7-expressing	JJ	I-NP	Otumors	.	tumor	NNS	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	vaccination	","	","	O	Ovaccination	with	vaccination	NN	B-NP	Owith	a	with	IN	B-PP	Oa	peptide	a	DT	B-NP	Opeptide	encoding	peptide	NN	I-NP	Oencoding	an	encode	VBG	B-VP	Oan	adenovirus	an	DT	B-NP	Oadenovirus	type	adenovirus	NN	I-NP	B-proteintype	5	type	NN	I-NP	I-protein5	(	5	CD	I-NP	I-protein(	Ad5	(	(	O	I-proteinAd5	)	Ad5	NN	B-NP	I-protein)	E1A	)	)	O	I-proteinE1A	CTL	E1A	NN	B-NP	I-proteinCTL	epitope	CTL	NN	I-NP	I-proteinepitope	results	epitope	NN	I-NP	I-proteinresults	in	result	VBZ	B-VP	Oin	CTL	in	IN	B-PP	OCTL	tolerance	CTL	NN	B-NP	Otolerance	and	tolerance	NN	I-NP	Oand	enhanced	and	CC	O	Oenhanced	growth	enhance	VBN	B-VP	Ogrowth	of	growth	NN	B-NP	Oof	an	of	IN	B-PP	Oan	Ad5	an	DT	B-NP	OAd5	E1A-expressing	Ad5	NN	I-NP	OE1A-expressing	tumor	E1A-expressing	JJ	I-NP	Otumor	.	tumor	NN	I-NP	O.	It	.	.	O	OIt	is	It	PRP	B-NP	Ois	unclear	be	VBZ	B-VP	Ounclear	why	unclear	JJ	B-ADJP	Owhy	these	why	WRB	B-ADVP	Othese	peptides	these	DT	B-NP	Opeptides	induce	peptide	NNS	I-NP	Oinduce	such	induce	VBP	B-VP	Osuch	opposite	such	JJ	B-NP	Oopposite	effects	opposite	JJ	I-NP	Oeffects	.	effect	NNS	I-NP	O.	To	.	.	O	OTo	determine	To	TO	B-VP	Odetermine	whether	determine	VB	I-VP	Owhether	a	whether	IN	B-SBAR	Oa	difference	a	DT	B-NP	Odifference	in	difference	NN	I-NP	Oin	pharmacokinetics	in	IN	B-PP	Opharmacokinetics	can	pharmacokinetic	NNS	B-NP	Ocan	explain	can	MD	B-VP	Oexplain	the	explain	VB	I-VP	Othe	functional	the	DT	B-NP	Ofunctional	contrasts	functional	JJ	I-NP	Ocontrasts	","	contrast	NNS	I-NP	O","	tritiated	","	","	O	Otritiated	Ad5	tritiate	VBD	B-VP	OAd5	E1A	Ad5	NN	B-NP	B-proteinE1A	and	E1A	NN	I-NP	I-proteinand	HPV16	and	CC	O	OHPV16	E7	HPV16	NN	B-NP	OE7	peptides	E7	NN	I-NP	Opeptides	were	peptide	NNS	I-NP	Owere	injected	be	VBD	B-VP	Oinjected	into	inject	VBN	I-VP	Ointo	mice	into	IN	B-PP	Omice	.	mouse	NNS	B-NP	O.	Results	.	.	O	OResults	show	Result	NNS	B-NP	Oshow	that	show	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	tolerizing	the	DT	B-NP	Otolerizing	peptide	tolerize	VBG	I-NP	Opeptide	spread	peptide	NN	I-NP	Ospread	through	spread	NN	I-NP	Othrough	the	through	IN	B-PP	Othe	body	the	DT	B-NP	Obody	16	body	NN	I-NP	O16	times	16	CD	B-NP	Otimes	faster	time	NNS	I-NP	Ofaster	than	faster	RBR	B-ADVP	Othan	the	than	IN	B-PP	Othe	activating	the	DT	B-NP	Oactivating	peptide	activate	VBG	I-NP	Opeptide	and	peptide	NN	I-NP	Oand	was	and	CC	O	Owas	cleared	be	VBD	B-VP	Ocleared	at	clear	VBN	I-VP	Oat	least	at	IN	B-NP	Oleast	2	least	JJS	I-NP	O2	times	2	CD	I-NP	Otimes	faster	time	NNS	I-NP	Ofaster	.	faster	RBR	B-ADVP	O.	The	.	.	O	OThe	HPV16	The	DT	B-NP	OHPV16	E7	HPV16	NN	I-NP	OE7	peptide	E7	NN	I-NP	Opeptide	kinetics	peptide	NN	I-NP	Okinetics	correlated	kinetic	NNS	I-NP	Ocorrelated	with	correlate	VBD	B-VP	Owith	the	with	IN	B-PP	Othe	kinetics	the	DT	B-NP	Okinetics	of	kinetic	NNS	I-NP	Oof	HPV16	of	IN	B-PP	OHPV16	E7	HPV16	NN	B-NP	OE7	#NAME?	E7	NN	I-NP	O#NAME?	CTL	#NAME?	JJ	I-NP	OCTL	induction	CTL	NN	I-NP	Oinduction	.	induction	NN	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	Ad5	","	","	O	OAd5	E1A	Ad5	NN	B-NP	OE1A	peptide	E1A	NN	I-NP	Opeptide	injection	peptide	NN	I-NP	Oinjection	resulted	injection	NN	I-NP	Oresulted	in	result	VBD	B-VP	Oin	physical	in	IN	B-PP	Ophysical	deletion	physical	JJ	B-NP	Odeletion	of	deletion	NN	I-NP	Oof	preexisting	of	IN	B-PP	Opreexisting	Ad5	preexist	VBG	B-VP	OAd5	E1A	Ad5	NN	B-NP	B-proteinE1A	#NAME?	E1A	NN	I-NP	I-protein#NAME?	CTLs	#NAME?	JJ	I-NP	OCTLs	within	CTL	NNS	I-NP	B-cell_typewithin	24	within	IN	B-PP	O24	h	24	CD	B-NP	Oh	after	h	NN	I-NP	Oafter	injection	after	IN	B-PP	Oinjection	.	injection	NN	B-NP	O.	This	.	.	O	OThis	tolerization	This	DT	B-NP	Otolerization	occurred	tolerization	NN	I-NP	Ooccurred	at	occur	VBD	B-VP	Oat	the	at	IN	B-PP	Othe	time	the	DT	B-NP	Otime	when	time	NN	I-NP	Owhen	the	when	WRB	B-ADVP	Othe	peptide	the	DT	B-NP	Opeptide	reached	peptide	NN	I-NP	Oreached	its	reach	VBD	B-VP	Oits	maximum	its	PRP$	B-NP	Omaximum	peptide	maximum	JJ	I-NP	Opeptide	concentration	peptide	NN	I-NP	Oconcentration	in	concentration	NN	I-NP	Oin	the	in	IN	B-PP	Othe	organs	the	DT	B-NP	Oorgans	.	organ	NNS	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	ubiquitous	that	IN	B-SBAR	Oubiquitous	expression	ubiquitous	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	tolerizing	the	DT	B-NP	Otolerizing	Ad5	tolerize	VBG	I-NP	OAd5	E1A	Ad5	NN	I-NP	OE1A	peptide	E1A	NN	I-NP	Opeptide	within	peptide	NN	I-NP	Owithin	a	within	IN	B-PP	Oa	short	a	DT	B-NP	Oshort	period	short	JJ	I-NP	Operiod	of	period	NN	I-NP	Oof	time	of	IN	B-PP	Otime	causes	time	NN	B-NP	Ocauses	activation-induced	cause	VBZ	B-VP	Oactivation-induced	cell	activation-induced	JJ	B-NP	Ocell	death	cell	NN	I-NP	Odeath	of	death	NN	I-NP	Oof	Ad5	of	IN	B-PP	OAd5	E1A	Ad5	NN	B-NP	B-proteinE1A	#NAME?	E1A	NN	I-NP	I-protein#NAME?	CTLs	#NAME?	JJ	I-NP	OCTLs	.	CTL	NNS	I-NP	B-cell_type.	Therefore	.	.	O	OTherefore	","	Therefore	RB	B-ADVP	O","	information	","	","	O	Oinformation	on	information	NN	B-NP	Oon	the	on	IN	B-PP	Othe	pharmacokinetics	the	DT	B-NP	Opharmacokinetics	of	pharmacokinetic	NNS	I-NP	Oof	peptides	of	IN	B-PP	Opeptides	is	peptide	NNS	B-NP	Ois	vital	be	VBZ	B-VP	Ovital	for	vital	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	safety	the	DT	B-NP	Osafety	and	safety	NN	I-NP	Oand	efficacy	and	CC	I-NP	Oefficacy	of	efficacy	NN	I-NP	Oof	peptide-based	of	IN	B-PP	Opeptide-based	vaccines	peptide-based	JJ	B-NP	Ovaccines	.	vaccine	NNS	I-NP	O.	Smad3	.	.	O	OSmad3	and	Smad3	NN	B-NP	B-proteinand	Smad4	and	CC	I-NP	OSmad4	mediate	Smad4	NN	I-NP	B-proteinmediate	transforming	mediate	VBP	B-VP	Otransforming	growth	transform	VBG	I-VP	B-proteingrowth	factor-beta1	growth	NN	B-NP	I-proteinfactor-beta1	#NAME?	factor-beta1	NN	I-NP	I-protein#NAME?	IgA	#NAME?	JJ	I-NP	OIgA	expression	IgA	NN	I-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	murine	in	IN	B-PP	Omurine	B	murine	JJ	B-NP	B-cell_typeB	lymphocytes	B	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Transforming	.	.	O	OTransforming	growth	Transform	VBG	B-NP	B-proteingrowth	factor	growth	NN	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	TGF	(	(	O	I-proteinTGF	)	TGF	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	is	#NAME?	NN	B-NP	I-proteinis	well	be	VBZ	B-VP	Owell	established	well	RB	I-VP	Oestablished	as	establish	VBN	I-VP	Oas	a	as	IN	B-PP	Oa	critical	a	DT	B-NP	Ocritical	IgA	critical	JJ	I-NP	OIgA	isotype	IgA	NN	I-NP	B-proteinisotype	switching	isotype	NN	I-NP	I-proteinswitching	factor	switching	NN	I-NP	I-proteinfactor	and	factor	NN	I-NP	I-proteinand	Smad	and	CC	O	OSmad	molecules	Smad	NN	B-NP	B-proteinmolecules	have	molecule	NNS	I-NP	I-proteinhave	been	have	VBP	B-VP	Obeen	reported	be	VBN	I-VP	Oreported	to	report	VBN	I-VP	Oto	act	to	TO	I-VP	Oact	as	act	VB	I-VP	Oas	transducers	as	IN	B-PP	Otransducers	and	transducer	NNS	B-NP	Oand	transcriptional	and	CC	O	Otranscriptional	factors	transcriptional	JJ	B-NP	B-proteinfactors	in	factor	NNS	I-NP	I-proteinin	the	in	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	TGF-beta1	of	IN	B-PP	OTGF-beta1	#NAME?	TGF-beta1	NN	B-NP	B-DNA#NAME?	genes	#NAME?	JJ	I-NP	I-DNAgenes	.	gene	NNS	I-NP	I-DNA.	We	.	.	O	OWe	examined	We	PRP	B-NP	Oexamined	the	examine	VBD	B-VP	Othe	involvement	the	DT	B-NP	Oinvolvement	of	involvement	NN	I-NP	Oof	Smad	of	IN	B-PP	OSmad	proteins	Smad	NN	B-NP	B-proteinproteins	in	protein	NNS	I-NP	I-proteinin	TGF-beta1	in	IN	B-PP	OTGF-beta1	#NAME?	TGF-beta1	NN	B-NP	B-protein#NAME?	IgA	#NAME?	JJ	I-NP	OIgA	expression	IgA	NN	I-NP	B-proteinexpression	.	expression	NN	I-NP	O.	First	.	.	O	OFirst	","	First	RB	B-ADVP	O","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	TGF-beta1	that	IN	B-SBAR	OTGF-beta1	significantly	TGF-beta1	NN	B-NP	B-proteinsignificantly	increases	significantly	RB	B-VP	Oincreases	endogenous	increase	VBZ	I-VP	Oendogenous	germ-line	endogenous	JJ	B-NP	Ogerm-line	(	germ-line	NN	I-NP	B-DNA(	GL	(	(	O	OGL	)	GL	NN	B-NP	O)	alpha	)	)	O	Oalpha	transcripts	alpha	NN	B-NP	Otranscripts	by	transcript	NNS	I-NP	Oby	LPS-stimulated	by	IN	B-PP	OLPS-stimulated	CH12.LX.4933	LPS-stimulated	JJ	B-NP	OCH12.LX.4933	(	CH12.LX.4933	NN	I-NP	O(	mu	(	(	O	Omu	(	mu	SYM	O	O(	+	(	(	O	O+	)	+	SYM	O	O)	)	)	)	O	O)	B	)	)	O	OB	lymphoma	B	NN	B-NP	Olymphoma	cells	lymphoma	NN	I-NP	Ocells	.	cell	NNS	I-NP	O.	To	.	.	O	OTo	investigate	To	TO	B-VP	Oinvestigate	its	investigate	VB	I-VP	Oits	signaling	its	PRP$	B-NP	Osignaling	mechanisms	signaling	NN	I-NP	Omechanisms	","	mechanism	NNS	I-NP	O","	the	","	","	O	Othe	lymphoma	the	DT	B-NP	Olymphoma	cell	lymphoma	NN	I-NP	B-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	was	line	NN	I-NP	I-cell_linewas	transfected	be	VBD	B-VP	Otransfected	with	transfecte	VBN	I-VP	Owith	pFL3	with	IN	B-PP	OpFL3	that	pFL3	NN	B-NP	B-proteinthat	contains	that	WDT	B-NP	Ocontains	the	contain	VBZ	B-VP	Othe	TGF-beta-responsive	the	DT	B-NP	OTGF-beta-responsive	element	TGF-beta-responsive	JJ	I-NP	B-DNAelement	of	element	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	GLalpha	the	DT	B-NP	OGLalpha	promoter	GLalpha	NN	I-NP	B-DNApromoter	","	promoter	NN	I-NP	I-DNA","	and	","	","	O	Oand	stimulated	and	CC	O	Ostimulated	with	stimulate	VBN	B-VP	Owith	TGF-beta1	with	IN	B-PP	OTGF-beta1	.	TGF-beta1	NN	B-NP	B-protein.	Similar	.	.	O	OSimilar	to	Similar	JJ	B-ADJP	Oto	endogenous	to	TO	B-PP	Oendogenous	GLalpha	endogenous	JJ	B-NP	OGLalpha	transcripts	GLalpha	NN	I-NP	B-RNAtranscripts	","	transcript	NNS	I-NP	I-RNA","	TGF-beta1	","	","	O	OTGF-beta1	induces	TGF-beta1	NN	B-NP	B-proteininduces	GLalpha	induce	VBZ	B-VP	OGLalpha	promoter	GLalpha	NN	B-NP	B-DNApromoter	activity	promoter	NN	I-NP	I-DNAactivity	and	activity	NN	I-NP	Oand	overexpression	and	CC	O	Ooverexpression	of	overexpression	NN	B-NP	Oof	Smad3	of	IN	B-PP	OSmad3	markedly	Smad3	NN	B-NP	B-proteinmarkedly	enhances	markedly	RB	B-ADVP	Oenhances	the	enhance	VBZ	B-VP	Othe	promoter	the	DT	B-NP	Opromoter	activity	promoter	NN	I-NP	Oactivity	.	activity	NN	I-NP	O.	This	.	.	O	OThis	activity	This	DT	B-NP	Oactivity	is	activity	NN	I-NP	Ois	further	be	VBZ	B-VP	Ofurther	augmented	further	RBR	I-VP	Oaugmented	by	augment	VBN	I-VP	Oby	cotransfected	by	IN	B-PP	Ocotransfected	Smad4	cotransfecte	VBN	B-NP	OSmad4	.	Smad4	NN	I-NP	B-protein.	On	.	.	O	OOn	the	On	IN	B-PP	Othe	other	the	DT	B-NP	Oother	hand	other	JJ	I-NP	Ohand	","	hand	NN	I-NP	O","	Smad7	","	","	O	OSmad7	substantially	Smad7	NN	B-NP	B-proteinsubstantially	abrogates	substantially	RB	B-VP	Oabrogates	the	abrogate	VBZ	I-VP	Othe	synergistic	the	DT	B-NP	Osynergistic	effect	synergistic	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	Smad3/4	of	IN	B-PP	OSmad3/4	on	Smad3/4	NN	B-NP	B-proteinon	GLalpha	on	IN	B-PP	OGLalpha	promoter	GLalpha	NN	B-NP	B-DNApromoter	activity	promoter	NN	I-NP	I-DNAactivity	.	activity	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	overexpression	","	","	O	Ooverexpression	of	overexpression	NN	B-NP	Oof	Smad3/4	of	IN	B-PP	OSmad3/4	enhances	Smad3/4	NN	B-NP	B-proteinenhances	TGF-beta1	enhance	VBZ	B-VP	OTGF-beta1	#NAME?	TGF-beta1	NN	B-NP	B-protein#NAME?	endogenous	#NAME?	JJ	I-NP	Oendogenous	GLalpha	endogenous	JJ	I-NP	OGLalpha	transcripts	GLalpha	NN	I-NP	B-RNAtranscripts	in	transcript	NNS	I-NP	I-RNAin	normal	in	IN	B-PP	Onormal	spleen	normal	JJ	B-NP	Ospleen	B	spleen	NN	I-NP	OB	cell	B	NN	I-NP	Ocell	s	cell	NN	I-NP	Os	.	s	NNS	I-NP	O.	Finally	.	.	O	OFinally	","	Finally	RB	B-ADVP	O","	in	","	","	O	Oin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	TGF-beta1	of	IN	B-PP	OTGF-beta1	","	TGF-beta1	NN	B-NP	B-protein","	overexpression	","	","	O	Ooverexpression	of	overexpression	NN	B-NP	Oof	Smad3/4	of	IN	B-PP	OSmad3/4	selectively	Smad3/4	NN	B-NP	B-proteinselectively	increases	selectively	RB	B-ADVP	Oincreases	both	increase	VBZ	B-VP	Oboth	surface	both	CC	O	Osurface	IgA	surface	NN	B-NP	OIgA	expression	IgA	NN	I-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	IgA	and	CC	O	OIgA	production	IgA	NN	B-NP	B-proteinproduction	.	production	NN	I-NP	O.	The	.	.	O	OThe	results	The	DT	B-NP	Oresults	from	result	NNS	I-NP	Ofrom	the	from	IN	B-PP	Othe	present	the	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	indicate	study	NN	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	Smad3	that	IN	B-SBAR	OSmad3	","	Smad3	NN	B-NP	B-protein","	Smad4	","	","	O	OSmad4	","	Smad4	NN	B-NP	B-protein","	and	","	","	O	Oand	Smad7	and	CC	O	OSmad7	","	Smad7	NN	B-NP	B-protein","	at	","	","	O	Oat	least	at	IN	B-ADVP	Oleast	in	least	JJS	I-ADVP	Oin	part	in	IN	B-PP	Opart	","	part	NN	B-NP	O","	serve	","	","	O	Oserve	as	serve	VBP	B-VP	Oas	mediators	as	IN	B-PP	Omediators	linking	mediator	NNS	B-NP	Olinking	TGF-beta1	link	VBG	B-VP	OTGF-beta1	to	TGF-beta1	NN	B-NP	B-proteinto	transcriptional	to	TO	B-PP	Otranscriptional	regulation	transcriptional	JJ	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	IgA	of	IN	B-PP	OIgA	switching	IgA	NN	B-NP	B-DNAswitching	related	switching	NN	I-NP	I-DNArelated	gene	related	JJ	I-NP	I-DNAgene	and	gene	NN	I-NP	I-DNAand	regulation	and	CC	O	Oregulation	of	regulation	NN	B-NP	Oof	IgA	of	IN	B-PP	OIgA	class	IgA	NN	B-NP	B-proteinclass	switching	class	NN	I-NP	Oswitching	.	switching	NN	I-NP	O.	The	.	.	O	OThe	translesion	The	DT	B-NP	Otranslesion	DNA	translesion	NN	I-NP	B-proteinDNA	polymerase	DNA	NN	I-NP	I-proteinpolymerase	zeta	polymerase	NN	I-NP	I-proteinzeta	plays	zeta	NN	I-NP	I-proteinplays	a	play	VBZ	B-VP	Oa	major	a	DT	B-NP	Omajor	role	major	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	Ig	in	IN	B-PP	OIg	and	Ig	NN	B-NP	B-proteinand	bcl-6	and	CC	O	Obcl-6	somatic	bcl-6	NN	B-NP	B-proteinsomatic	hypermutation	somatic	JJ	I-NP	Ohypermutation	.	hypermutation	NN	I-NP	O.	Ig	.	.	O	OIg	somatic	Ig	NN	B-NP	Osomatic	mutations	somatic	JJ	I-NP	Omutations	would	mutation	NNS	I-NP	Owould	be	would	MD	B-VP	Obe	introduced	be	VB	I-VP	Ointroduced	by	introduce	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	polymerase	a	DT	B-NP	Opolymerase	(	polymerase	NN	I-NP	O(	pol	(	(	O	Opol	)	pol	NN	B-NP	O)	while	)	)	O	Owhile	repairing	while	IN	B-SBAR	Orepairing	DNA	repair	VBG	B-VP	ODNA	outside	DNA	NN	B-NP	Ooutside	main	outside	IN	B-PP	Omain	DNA	main	JJ	B-NP	ODNA	replication	DNA	NN	I-NP	Oreplication	.	replication	NN	I-NP	O.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	human	that	IN	B-SBAR	Ohuman	B	human	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	constitutively	cell	NNS	I-NP	I-cell_typeconstitutively	express	constitutively	RB	B-ADVP	Oexpress	the	express	VBP	B-VP	Othe	translesion	the	DT	B-NP	Otranslesion	pol	translesion	NN	I-NP	B-proteinpol	zeta	pol	NN	I-NP	I-proteinzeta	","	zeta	NN	I-NP	I-protein","	which	","	","	O	Owhich	effectively	which	WDT	B-NP	Oeffectively	extends	effectively	RB	B-ADVP	Oextends	DNA	extend	VBZ	B-VP	ODNA	past	DNA	NN	B-NP	Opast	mismatched	past	IN	B-PP	Omismatched	bases	mismatch	VBN	B-NP	Obases	(	base	NNS	I-NP	O(	mispair	(	(	O	Omispair	extender	mispair	NN	B-NP	Oextender	)	extender	NN	I-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	pol	and	CC	O	Opol	eta	pol	NN	B-NP	Oeta	","	eta	NN	I-NP	O","	which	","	","	O	Owhich	bypasses	which	WDT	B-NP	Obypasses	DNA	bypass	VBZ	B-VP	ODNA	lesions	DNA	NN	B-NP	Olesions	in	lesion	NNS	I-NP	Oin	an	in	IN	B-PP	Oan	error-free	an	DT	B-NP	Oerror-free	fashion	error-free	JJ	I-NP	Ofashion	.	fashion	NN	I-NP	O.	Upon	.	.	O	OUpon	B	Upon	IN	B-PP	OB	cell	B	NN	B-NP	B-proteincell	receptor	cell	NN	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	BCR	(	(	O	OBCR	)	BCR	NN	B-NP	B-protein)	engagement	)	)	O	Oengagement	and	engagement	NN	B-NP	Oand	coculture	and	CC	I-NP	Ococulture	with	coculture	NN	I-NP	Owith	activated	with	IN	B-PP	Oactivated	CD4+	activate	VBN	B-NP	B-cell_typeCD4+	T	CD4+	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	these	","	","	O	Othese	lymphocytes	these	DT	B-NP	Olymphocytes	upregulated	lymphocyte	NNS	I-NP	B-cell_typeupregulated	pol	upregulate	VBD	B-VP	Opol	zeta	pol	NN	B-NP	Ozeta	","	zeta	NN	I-NP	O","	downregulated	","	","	O	Odownregulated	pol	downregulate	VBD	B-VP	Opol	eta	pol	NN	B-NP	Oeta	","	eta	NN	I-NP	O","	and	","	","	O	Oand	mutated	and	CC	O	Omutated	the	mutate	VBD	B-VP	Othe	Ig	the	DT	B-NP	OIg	and	Ig	NN	I-NP	B-DNAand	bcl-6	and	CC	I-NP	I-DNAbcl-6	genes	bcl-6	NN	I-NP	I-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	the	of	IN	B-PP	Othe	pol	the	DT	B-NP	Opol	zeta	pol	NN	I-NP	B-proteinzeta	REV3	zeta	NN	I-NP	I-proteinREV3	catalytic	REV3	NN	I-NP	I-proteincatalytic	subunit	catalytic	JJ	I-NP	I-proteinsubunit	by	subunit	NN	I-NP	I-proteinby	specific	by	IN	B-PP	Ospecific	phosphorothioate-modified	specific	JJ	B-NP	Ophosphorothioate-modified	oligonucleotides	phosphorothioate-modified	JJ	I-NP	Ooligonucleotides	impaired	oligonucleotide	NNS	I-NP	Oimpaired	Ig	impair	VBD	B-VP	OIg	and	Ig	NN	B-NP	B-proteinand	bcl-6	and	CC	I-NP	Obcl-6	hypermutation	bcl-6	NN	I-NP	B-proteinhypermutation	and	hypermutation	NN	I-NP	Oand	UV	and	CC	O	OUV	damage-induced	UV	NN	B-NP	Odamage-induced	DNA	damage-induced	JJ	I-NP	ODNA	mutagenesis	DNA	NN	I-NP	Omutagenesis	","	mutagenesis	NN	I-NP	O","	without	","	","	O	Owithout	affecting	without	IN	B-PP	Oaffecting	cell	affect	VBG	B-VP	Ocell	cycle	cell	NN	B-NP	Ocycle	or	cycle	NN	I-NP	Oor	viability	or	CC	O	Oviability	.	viability	NN	B-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	pol	","	","	O	Opol	zeta	pol	NN	B-NP	B-proteinzeta	plays	zeta	NN	I-NP	I-proteinplays	a	play	VBZ	B-VP	Oa	critical	a	DT	B-NP	Ocritical	role	critical	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	Ig	in	IN	B-PP	OIg	and	Ig	NN	B-NP	B-proteinand	bcl-6	and	CC	I-NP	Obcl-6	hypermutation	bcl-6	NN	I-NP	B-proteinhypermutation	","	hypermutation	NN	I-NP	O","	perhaps	","	","	O	Operhaps	facilitated	perhaps	RB	B-VP	Ofacilitated	by	facilitate	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	downregulation	the	DT	B-NP	Odownregulation	of	downregulation	NN	I-NP	Oof	pol	of	IN	B-PP	Opol	eta	pol	NN	B-NP	Oeta	.	eta	NN	I-NP	O.	Molecular	.	.	O	OMolecular	mechanism	Molecular	JJ	B-NP	Omechanism	of	mechanism	NN	I-NP	Oof	cell	of	IN	B-PP	Ocell	cycle	cell	NN	B-NP	Ocycle	progression	cycle	NN	I-NP	Oprogression	induced	progression	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	oncogene	the	DT	B-NP	Ooncogene	product	oncogene	NN	I-NP	B-proteinproduct	Tax	product	NN	I-NP	I-proteinTax	of	Tax	NN	I-NP	B-proteinof	human	of	IN	B-PP	Ohuman	T-cell	human	JJ	B-NP	OT-cell	leukemia	T-cell	NN	I-NP	Oleukemia	virus	leukemia	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	I	type	NN	I-NP	OI	.	I	CD	I-NP	O.	The	.	.	O	OThe	trans-activator	The	DT	B-NP	Otrans-activator	protein	trans-activator	JJ	I-NP	B-proteinprotein	Tax	protein	NN	I-NP	I-proteinTax	of	Tax	NN	I-NP	B-proteinof	human	of	IN	B-PP	Ohuman	T-cell	human	JJ	B-NP	OT-cell	leukemia	T-cell	NN	I-NP	Oleukemia	virus	leukemia	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	I	type	NN	I-NP	OI	(	I	CD	I-NP	O(	HTLV-I	(	(	O	OHTLV-I	)	HTLV-I	NN	B-NP	O)	plays	)	)	O	Oplays	an	play	VBZ	B-VP	Oan	important	an	DT	B-NP	Oimportant	role	important	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	adult	of	IN	B-PP	Oadult	T-cell	adult	JJ	B-NP	OT-cell	leukemia	T-cell	NN	I-NP	Oleukemia	through	leukemia	NN	I-NP	Othrough	","	through	IN	B-PP	O","	at	","	","	O	Oat	least	at	IN	B-ADVP	Oleast	in	least	JJS	I-ADVP	Oin	part	in	IN	B-PP	Opart	","	part	NN	B-NP	O","	its	","	","	O	Oits	ability	its	PRP$	B-NP	Oability	to	ability	NN	I-NP	Oto	stimulate	to	TO	B-VP	Ostimulate	cell	stimulate	VB	I-VP	Ocell	growth	cell	NN	B-NP	Ogrowth	.	growth	NN	I-NP	O.	We	.	.	O	OWe	previously	We	PRP	B-NP	Opreviously	reported	previously	RB	B-ADVP	Oreported	that	report	VBD	B-VP	Othat	Tax	that	IN	B-SBAR	OTax	induced	Tax	NN	B-NP	B-proteininduced	cell	induce	VBD	B-VP	Ocell	cycle	cell	NN	B-NP	Ocycle	progression	cycle	NN	I-NP	Oprogression	from	progression	NN	I-NP	Ofrom	G0/G1	from	IN	B-PP	OG0/G1	phase	G0/G1	NN	B-NP	Ophase	to	phase	NN	I-NP	Oto	S	to	TO	B-PP	OS	and	S	NN	B-NP	Oand	G2/M	and	CC	I-NP	OG2/M	phases	G2/M	NN	I-NP	Ophases	in	phase	NNS	I-NP	Oin	human	in	IN	B-PP	Ohuman	T-cell	human	JJ	B-NP	B-cell_lineT-cell	line	T-cell	NN	I-NP	I-cell_lineline	Kit	line	NN	I-NP	I-cell_lineKit	225	Kit	NN	I-NP	I-cell_line225	cells	225	CD	B-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	To	.	.	O	OTo	elucidate	To	TO	B-VP	Oelucidate	molecular	elucidate	VB	I-VP	Omolecular	mechanism	molecular	JJ	B-NP	Omechanism	of	mechanism	NN	I-NP	Oof	Tax	of	IN	B-PP	OTax	#NAME?	Tax	NN	B-NP	B-protein#NAME?	cell	#NAME?	JJ	I-NP	Ocell	cycle	cell	NN	I-NP	Ocycle	progression	cycle	NN	I-NP	Oprogression	","	progression	NN	I-NP	O","	we	","	","	O	Owe	systematically	we	PRP	B-NP	Osystematically	examined	systematically	RB	B-ADVP	Oexamined	the	examine	VBD	B-VP	Othe	effects	the	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	Tax	of	IN	B-PP	OTax	on	Tax	NN	B-NP	B-proteinon	biochemical	on	IN	B-PP	Obiochemical	events	biochemical	JJ	B-NP	Oevents	associated	event	NNS	I-NP	Oassociated	with	associate	VBN	B-VP	Owith	cell	with	IN	B-PP	Ocell	cycle	cell	NN	B-NP	Ocycle	progression	cycle	NN	I-NP	Oprogression	.	progression	NN	I-NP	O.	Introduction	.	.	O	OIntroduction	of	Introduction	NN	B-NP	Oof	Tax	of	IN	B-PP	OTax	into	Tax	NN	B-NP	B-proteininto	resting	into	IN	B-PP	Oresting	Kit	rest	VBG	B-NP	B-cell_lineKit	225	Kit	NN	I-NP	I-cell_line225	cells	225	CD	I-NP	I-cell_linecells	induced	cell	NNS	I-NP	I-cell_lineinduced	activation	induce	VBD	B-VP	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	G1/S	the	DT	B-NP	OG1/S	transition	G1/S	NN	I-NP	Otransition	regulation	transition	NN	I-NP	Oregulation	cascade	regulation	NN	I-NP	Ocascade	consisting	cascade	NN	I-NP	Oconsisting	of	consist	VBG	B-VP	Oof	activation	of	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	cyclin	of	IN	B-PP	Ocyclin	dependent	cyclin	NN	B-NP	B-proteindependent	kinase	dependent	JJ	I-NP	I-proteinkinase	2	kinase	NN	I-NP	I-protein2	(	2	CD	I-NP	I-protein(	CDK2	(	(	O	OCDK2	)	CDK2	NN	B-NP	B-protein)	and	)	)	O	Oand	CDK4	and	CC	O	OCDK4	","	CDK4	NN	B-NP	B-protein","	phosphorylation	","	","	O	Ophosphorylation	of	phosphorylation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	Rb	the	DT	B-NP	ORb	family	Rb	NN	I-NP	B-proteinfamily	proteins	family	NN	I-NP	I-proteinproteins	and	protein	NNS	I-NP	I-proteinand	an	and	CC	O	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	free	in	IN	B-PP	Ofree	E2F	free	JJ	B-NP	OE2F	.	E2F	NN	I-NP	B-protein.	The	.	.	O	OThe	kinase	The	DT	B-NP	Okinase	activation	kinase	NN	I-NP	Oactivation	was	activation	NN	I-NP	Owas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	result	to	TO	I-VP	Oresult	from	result	VB	I-VP	Ofrom	Tax	from	IN	B-PP	OTax	#NAME?	Tax	NN	B-NP	B-protein#NAME?	expression	#NAME?	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	genes	of	IN	B-PP	Ogenes	for	gene	NNS	B-NP	Ofor	cell	for	IN	B-PP	Ocell	cycle	cell	NN	B-NP	B-proteincycle	regulatory	cycle	NN	I-NP	I-proteinregulatory	molecules	regulatory	JJ	I-NP	I-proteinmolecules	including	molecule	NNS	I-NP	I-proteinincluding	cyclin	include	VBG	B-PP	Ocyclin	D2	cyclin	NN	B-NP	B-proteinD2	","	D2	NN	I-NP	I-protein","	cyclin	","	","	O	Ocyclin	E	cyclin	NN	B-NP	B-DNAE	","	E	NN	I-NP	I-DNA","	E2F1	","	","	O	OE2F1	","	E2F1	NN	B-NP	B-protein","	CDK2	","	","	O	OCDK2	","	CDK2	NN	B-NP	B-protein","	CDK4	","	","	O	OCDK4	and	CDK4	NN	B-NP	B-proteinand	CDK6	and	CC	I-NP	OCDK6	","	CDK6	NN	I-NP	B-protein","	and	","	","	O	Oand	Tax	and	CC	O	OTax	#NAME?	Tax	NN	B-NP	B-protein#NAME?	reduction	#NAME?	JJ	I-NP	Oreduction	of	reduction	NN	I-NP	Oof	CDK	of	IN	B-PP	OCDK	inhibitors	CDK	NN	B-NP	B-proteininhibitors	p19	inhibitor	NNS	I-NP	Op19	(	p19	NN	I-NP	B-protein(	INK4d	(	(	O	I-proteinINK4d	)	INK4d	NN	B-NP	I-protein)	and	)	)	O	I-proteinand	p27	and	CC	O	Op27	(	p27	NN	B-NP	B-protein(	Kip1	(	(	O	I-proteinKip1	)	Kip1	NN	B-NP	I-protein)	.	)	)	O	I-protein.	These	.	.	O	OThese	modulations	These	DT	B-NP	Omodulations	by	modulation	NNS	I-NP	Oby	Tax	by	IN	B-PP	OTax	always	Tax	NN	B-NP	B-proteinalways	paralleled	always	RB	B-ADVP	Oparalleled	the	parallel	VBD	B-VP	Othe	ability	the	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	Tax	of	IN	B-PP	OTax	to	Tax	NN	B-NP	B-proteinto	activate	to	TO	B-VP	Oactivate	the	activate	VB	I-VP	Othe	NF-kappaB	the	DT	B-NP	ONF-kappaB	transcription	NF-kappaB	NN	I-NP	B-proteintranscription	pathway	transcription	NN	I-NP	Opathway	.	pathway	NN	I-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	the	indicate	VBP	B-VP	Othe	important	the	DT	B-NP	Oimportant	role	important	JJ	I-NP	Orole	of	role	NN	I-NP	Oof	Tax	of	IN	B-PP	OTax	#NAME?	Tax	NN	B-NP	B-protein#NAME?	trans-activation	#NAME?	JJ	I-NP	Otrans-activation	of	trans-activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	genes	the	DT	B-NP	Ogenes	for	gene	NNS	I-NP	Ofor	cell	for	IN	B-PP	Ocell	cycle	cell	NN	B-NP	B-proteincycle	regulatory	cycle	NN	I-NP	I-proteinregulatory	molecules	regulatory	JJ	I-NP	I-proteinmolecules	in	molecule	NNS	I-NP	I-proteinin	Tax	in	IN	B-PP	OTax	#NAME?	Tax	NN	B-NP	B-protein#NAME?	cell	#NAME?	JJ	I-NP	Ocell	cycle	cell	NN	I-NP	Ocycle	progression	cycle	NN	I-NP	Oprogression	.	progression	NN	I-NP	O.	Cot	.	.	O	OCot	kinase	Cot	NN	B-NP	B-proteinkinase	induces	kinase	NN	I-NP	I-proteininduces	cyclooxygenase-2	induce	VBZ	B-VP	Ocyclooxygenase-2	expression	cyclooxygenase-2	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	through	cell	NNS	I-NP	I-cell_typethrough	activation	through	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	factor	nuclear	JJ	I-NP	B-proteinfactor	of	factor	NN	I-NP	I-proteinof	activated	of	IN	B-PP	I-proteinactivated	T	activate	VBN	B-NP	I-proteinT	cells	T	NN	I-NP	I-proteincells	.	cell	NNS	I-NP	I-protein.	Cyclooxygenase-2	.	.	O	OCyclooxygenase-2	(	Cyclooxygenase-2	NN	B-NP	B-protein(	COX-2	(	(	O	OCOX-2	)	COX-2	NN	B-NP	B-protein)	is	)	)	O	Ois	induced	be	VBZ	B-VP	Oinduced	in	induce	VBN	I-VP	Oin	human	in	IN	B-PP	Ohuman	T	human	JJ	B-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	upon	lymphocyte	NNS	I-NP	I-cell_typeupon	T	upon	IN	B-PP	OT	cell	T	NN	B-NP	B-proteincell	receptor	cell	NN	I-NP	I-proteinreceptor	triggering	receptor	NN	I-NP	I-proteintriggering	.	triggering	NN	I-NP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	report	we	PRP	B-NP	Oreport	that	report	VBP	B-VP	Othat	Cot	that	IN	B-SBAR	OCot	kinase	Cot	NN	B-NP	B-proteinkinase	","	kinase	NN	I-NP	I-protein","	a	","	","	O	Oa	mitogen-activated	a	DT	B-NP	Omitogen-activated	protein	mitogen-activated	JJ	I-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	kinase	kinase	NN	I-NP	I-proteinkinase	kinase	kinase	NN	I-NP	I-proteinkinase	involved	kinase	NN	I-NP	I-proteininvolved	in	involve	VBN	B-VP	Oin	T	in	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	","	activation	NN	I-NP	O","	up-regulates	","	","	O	Oup-regulates	COX-2	up-regulate	VBZ	B-VP	OCOX-2	gene	COX-2	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	in	expression	NN	I-NP	Oin	Jurkat	in	IN	B-PP	OJurkat	T	Jurkat	NN	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Induction	.	.	O	OInduction	of	Induction	NN	B-NP	Oof	COX-2	of	IN	B-PP	OCOX-2	promoter	COX-2	NN	B-NP	B-DNApromoter	activity	promoter	NN	I-NP	I-DNAactivity	by	activity	NN	I-NP	Oby	Cot	by	IN	B-PP	OCot	kinase	Cot	NN	B-NP	B-proteinkinase	occurred	kinase	NN	I-NP	I-proteinoccurred	mainly	occur	VBD	B-VP	Omainly	through	mainly	RB	B-ADVP	Othrough	activation	through	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	factor	nuclear	JJ	I-NP	B-proteinfactor	of	factor	NN	I-NP	I-proteinof	activated	of	IN	B-PP	I-proteinactivated	T	activate	VBN	B-NP	I-proteinT	cells	T	NN	I-NP	I-proteincells	(	cell	NNS	I-NP	I-protein(	NFAT	(	(	O	ONFAT	)	NFAT	NN	B-NP	B-protein)	.	)	)	O	O.	Mutation	.	.	O	OMutation	of	Mutation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	distal	the	DT	B-NP	Odistal	(	distal	JJ	I-NP	B-DNA(	1.082474227	(	(	O	I-DNA1.082474227	)	1.082474227	CD	B-NP	I-DNA)	and	)	)	O	I-DNAand	proximal	and	CC	O	I-DNAproximal	(	proximal	JJ	B-ADJP	I-DNA(	1.245901639	(	(	O	I-DNA1.245901639	)	1.245901639	CD	O	I-DNA)	NFAT	)	)	O	I-DNANFAT	response	NFAT	NN	B-NP	I-DNAresponse	elements	response	NN	I-NP	I-DNAelements	in	element	NNS	I-NP	I-DNAin	the	in	IN	B-PP	Othe	COX-2	the	DT	B-NP	OCOX-2	promoter	COX-2	NN	I-NP	B-DNApromoter	abolished	promoter	NN	I-NP	I-DNAabolished	the	abolish	VBD	B-VP	Othe	activation	the	DT	B-NP	Oactivation	induced	activation	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	Cot	by	IN	B-PP	OCot	kinase	Cot	NN	B-NP	B-proteinkinase	.	kinase	NN	I-NP	I-protein.	Even	.	.	O	OEven	more	Even	RB	B-ADVP	Omore	","	more	RBR	I-ADVP	O","	coexpression	","	","	O	Ocoexpression	of	coexpression	NN	B-NP	Oof	a	of	IN	B-PP	Oa	dominant	a	DT	B-NP	Odominant	negative	dominant	JJ	I-NP	Onegative	version	negative	JJ	I-NP	Oversion	of	version	NN	I-NP	Oof	NFAT	of	IN	B-PP	ONFAT	inhibited	NFAT	NN	B-NP	B-proteininhibited	Cot	inhibit	VBD	B-VP	OCot	kinase	Cot	NN	B-NP	B-proteinkinase	#NAME?	kinase	NN	I-NP	I-protein#NAME?	COX-2	#NAME?	JJ	I-NP	OCOX-2	promoter	COX-2	NN	I-NP	B-DNApromoter	activation	promoter	NN	I-NP	I-DNAactivation	","	activation	NN	I-NP	O","	whereas	","	","	O	Owhereas	cotransfection	whereas	IN	O	Ocotransfection	of	cotransfection	NN	B-NP	Oof	a	of	IN	B-PP	Oa	constitutively	a	DT	B-NP	Oconstitutively	active	constitutively	RB	I-NP	Oactive	version	active	JJ	I-NP	Oversion	of	version	NN	I-NP	Oof	the	of	IN	B-PP	Othe	calcium-dependent	the	DT	B-NP	Ocalcium-dependent	phosphatase	calcium-dependent	JJ	I-NP	B-proteinphosphatase	calcineurin	phosphatase	NN	I-NP	I-proteincalcineurin	synergizes	calcineurin	NN	I-NP	B-proteinsynergizes	with	synergize	VBZ	B-VP	Owith	Cot	with	IN	B-PP	OCot	kinase	Cot	NN	B-NP	B-proteinkinase	in	kinase	NN	I-NP	I-proteinin	the	in	IN	B-PP	Othe	up-regulation	the	DT	B-NP	Oup-regulation	of	up-regulation	NN	I-NP	Oof	COX-2	of	IN	B-PP	OCOX-2	promoter	COX-2	NN	B-NP	B-DNApromoter	#NAME?	promoter	NN	I-NP	I-DNA#NAME?	transcription	#NAME?	JJ	I-NP	Otranscription	.	transcription	NN	I-NP	O.	Strikingly	.	.	O	OStrikingly	","	Strikingly	RB	B-ADVP	O","	Cot	","	","	O	OCot	kinase	Cot	NN	B-NP	B-proteinkinase	increased	kinase	NN	I-NP	I-proteinincreased	transactivation	increase	VBD	B-VP	Otransactivation	mediated	transactivation	NN	B-NP	Omediated	by	mediate	VBN	B-VP	Oby	a	by	IN	B-PP	Oa	GAL4-NFAT	a	DT	B-NP	OGAL4-NFAT	fusion	GAL4-NFAT	NN	I-NP	B-proteinfusion	protein	fusion	NN	I-NP	I-proteinprotein	containing	protein	NN	I-NP	I-proteincontaining	the	contain	VBG	B-VP	Othe	N-terminal	the	DT	B-NP	ON-terminal	transactivation	N-terminal	JJ	I-NP	B-proteintransactivation	domain	transactivation	NN	I-NP	I-proteindomain	of	domain	NN	I-NP	I-proteinof	NFATp	of	IN	B-PP	ONFATp	.	NFATp	NN	B-NP	B-protein.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	to	contrast	NN	B-NP	Oto	phorbol	to	TO	B-PP	Ophorbol	ester	phorbol	NN	B-NP	Oester	plus	ester	NN	I-NP	Oplus	calcium	plus	CC	O	Ocalcium	ionophore	calcium	NN	B-NP	Oionophore	A23187	ionophore	NN	I-NP	OA23187	","	A23187	NN	I-NP	O","	Cot	","	","	O	OCot	kinase	Cot	NN	B-NP	B-proteinkinase	increases	kinase	NN	I-NP	I-proteinincreases	both	increase	VBZ	B-VP	Oboth	COX-2	both	CC	O	OCOX-2	promoter	COX-2	NN	B-NP	B-DNApromoter	activity	promoter	NN	I-NP	I-DNAactivity	and	activity	NN	I-NP	Oand	NFAT	and	CC	O	ONFAT	#NAME?	NFAT	NN	B-NP	B-protein#NAME?	transactivation	#NAME?	JJ	I-NP	Otransactivation	in	transactivation	NN	I-NP	Oin	a	in	IN	B-PP	Oa	cyclosporin	a	DT	B-NP	Ocyclosporin	A-independent	cyclosporin	NN	I-NP	OA-independent	manner	A-independent	JJ	I-NP	Omanner	.	manner	NN	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	indicate	datum	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	Cot	that	IN	B-SBAR	OCot	kinase	Cot	NN	B-NP	B-proteinkinase	up-regulates	kinase	NN	I-NP	I-proteinup-regulates	COX-2	up-regulate	VBZ	B-VP	OCOX-2	promoter	COX-2	NN	B-NP	B-DNApromoter	#NAME?	promoter	NN	I-NP	I-DNA#NAME?	transcription	#NAME?	JJ	I-NP	Otranscription	through	transcription	NN	I-NP	Othrough	the	through	IN	B-PP	Othe	NFAT	the	DT	B-NP	ONFAT	response	NFAT	NN	I-NP	B-DNAresponse	elements	response	NN	I-NP	I-DNAelements	","	element	NNS	I-NP	I-DNA","	being	","	","	O	Obeing	the	be	VBG	B-VP	Othe	Cot	the	DT	B-NP	OCot	kinase	Cot	NN	I-NP	B-proteinkinase	#NAME?	kinase	NN	I-NP	I-protein#NAME?	NFAT	#NAME?	JJ	I-NP	ONFAT	#NAME?	NFAT	NN	I-NP	B-protein#NAME?	transactivation	#NAME?	JJ	I-NP	Otransactivation	presumably	transactivation	NN	I-NP	Opresumably	implicated	presumably	RB	B-VP	Oimplicated	in	implicate	VBN	I-VP	Oin	this	in	IN	B-PP	Othis	up-regulation	this	DT	B-NP	Oup-regulation	.	up-regulation	NN	I-NP	O.	Positive	.	.	O	OPositive	and	Positive	JJ	B-NP	Oand	negative	and	CC	I-NP	Onegative	roles	negative	JJ	I-NP	Oroles	of	role	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	trans-acting	the	DT	B-NP	Otrans-acting	T	trans-acting	JJ	I-NP	B-proteinT	cell	T	NN	I-NP	I-proteincell	factor-1	cell	NN	I-NP	I-proteinfactor-1	for	factor-1	NN	I-NP	I-proteinfor	the	for	IN	B-PP	Othe	acquisition	the	DT	B-NP	Oacquisition	of	acquisition	NN	I-NP	Oof	distinct	of	IN	B-PP	Odistinct	Ly-49	distinct	JJ	B-NP	OLy-49	MHC	Ly-49	NN	I-NP	B-proteinMHC	class	MHC	NN	I-NP	I-proteinclass	I	class	NN	I-NP	I-proteinI	receptors	I	CD	B-NP	I-proteinreceptors	by	receptor	NNS	I-NP	I-proteinby	NK	by	IN	B-PP	ONK	cells	NK	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Members	.	.	O	OMembers	of	Member	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	Ly-49	the	DT	B-NP	OLy-49	gene	Ly-49	NN	I-NP	B-proteingene	family	gene	NN	I-NP	I-proteinfamily	code	family	NN	I-NP	I-proteincode	for	code	NN	I-NP	Ofor	class	for	IN	B-PP	Oclass	I	class	NN	B-NP	B-proteinI	MHC-specific	I	CD	I-NP	I-proteinMHC-specific	receptors	MHC-specific	JJ	I-NP	I-proteinreceptors	that	receptor	NNS	I-NP	I-proteinthat	regulate	that	WDT	B-NP	Oregulate	NK	regulate	VBP	B-VP	ONK	cell	NK	NN	B-NP	B-cell_typecell	function	cell	NN	I-NP	I-cell_typefunction	.	function	NN	I-NP	O.	Due	.	.	O	ODue	to	Due	JJ	B-PP	Oto	a	to	TO	I-PP	Oa	combinatorial	a	DT	B-NP	Ocombinatorial	distribution	combinatorial	JJ	I-NP	Odistribution	of	distribution	NN	I-NP	Oof	Ly-49	of	IN	B-PP	OLy-49	receptors	Ly-49	NN	B-NP	B-proteinreceptors	","	receptor	NNS	I-NP	I-protein","	NK	","	","	O	ONK	cells	NK	NN	B-NP	B-cell_typecells	display	cell	NNS	I-NP	I-cell_typedisplay	considerable	display	VBP	B-VP	Oconsiderable	clonal	considerable	JJ	B-NP	Oclonal	heterogeneity	clonal	JJ	I-NP	Oheterogeneity	.	heterogeneity	NN	I-NP	O.	The	.	.	O	OThe	acquisition	The	DT	B-NP	Oacquisition	of	acquisition	NN	I-NP	Oof	one	of	IN	B-PP	Oone	Ly-49	one	CD	B-NP	OLy-49	receptor	Ly-49	NN	I-NP	B-proteinreceptor	","	receptor	NN	I-NP	I-protein","	Ly-49A	","	","	O	OLy-49A	is	Ly-49A	NN	B-NP	B-proteinis	strictly	be	VBZ	B-VP	Ostrictly	dependent	strictly	RB	B-ADJP	Odependent	on	dependent	JJ	I-ADJP	Oon	the	on	IN	B-PP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	trans-acting	transcriptional	JJ	I-NP	B-proteintrans-acting	factor	trans-acting	JJ	I-NP	I-proteinfactor	T	factor	NN	I-NP	I-proteinT	cell-specific	T	NN	I-NP	I-proteincell-specific	factor-1	cell-specific	JJ	I-NP	I-proteinfactor-1	(	factor-1	NN	I-NP	I-protein(	TCF-1	(	(	O	OTCF-1	)	TCF-1	NN	B-NP	B-protein)	.	)	)	O	O.	Indeed	.	.	O	OIndeed	","	Indeed	RB	B-ADVP	O","	TCF-1	","	","	O	OTCF-1	binds	TCF-1	NN	B-NP	B-proteinbinds	to	bind	VBZ	B-VP	Oto	two	to	TO	B-PP	Otwo	sites	two	CD	B-NP	Osites	in	site	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	Ly-49a	the	DT	B-NP	OLy-49a	promoter	Ly-49a	NN	I-NP	B-DNApromoter	and	promoter	NN	I-NP	I-DNAand	regulates	and	CC	O	Oregulates	its	regulate	VBZ	B-VP	Oits	activity	its	PRP$	B-NP	Oactivity	","	activity	NN	I-NP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	the	that	IN	B-SBAR	Othe	Ly-49a	the	DT	B-NP	OLy-49a	gene	Ly-49a	NN	I-NP	B-DNAgene	is	gene	NN	I-NP	I-DNAis	a	be	VBZ	B-VP	Oa	direct	a	DT	B-NP	Odirect	TCF-1	direct	JJ	I-NP	OTCF-1	target	TCF-1	NN	I-NP	B-proteintarget	.	target	NN	I-NP	O.	TCF-1	.	.	O	OTCF-1	deficiency	TCF-1	NN	B-NP	B-proteindeficiency	resulted	deficiency	NN	I-NP	Oresulted	in	result	VBD	B-VP	Oin	the	in	IN	B-PP	Othe	altered	the	DT	B-NP	Oaltered	usage	altered	JJ	I-NP	Ousage	of	usage	NN	I-NP	Oof	additional	of	IN	B-PP	Oadditional	Ly-49	additional	JJ	B-NP	OLy-49	receptors	Ly-49	NN	I-NP	B-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	in	show	VBP	B-VP	Oin	this	in	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	using	","	","	O	Ousing	TCF-1	use	VBG	B-VP	OTCF-1	beta	TCF-1	NN	B-NP	B-proteinbeta	(	beta	NN	I-NP	I-protein(	2	(	(	O	O2	)	2	CD	B-NP	O)	#NAME?	)	)	O	O#NAME?	double-deficient	#NAME?	JJ	B-NP	Odouble-deficient	mice	double-deficient	JJ	I-NP	Omice	","	mouse	NNS	I-NP	O","	that	","	","	O	Othat	these	that	IN	B-SBAR	Othese	repertoire	these	DT	B-NP	Orepertoire	alterations	repertoire	NN	I-NP	Oalterations	are	alteration	NNS	I-NP	Oare	not	be	VBP	B-VP	Onot	due	not	RB	O	Odue	to	due	JJ	B-ADJP	Oto	Ly-49/MHC	to	TO	B-PP	OLy-49/MHC	class	Ly-49/MHC	NN	B-NP	Oclass	I	class	NN	I-NP	OI	interactions	I	CD	B-NP	Ointeractions	.	interaction	NNS	I-NP	O.	Our	.	.	O	OOur	findings	Our	PRP$	B-NP	Ofindings	rather	finding	NNS	I-NP	Orather	suggest	rather	RB	B-ADVP	Osuggest	a	suggest	VBP	B-VP	Oa	TCF-1	a	DT	B-NP	OTCF-1	#NAME?	TCF-1	NN	I-NP	B-protein#NAME?	","	#NAME?	JJ	B-ADJP	O","	cell	","	","	O	Ocell	autonomous	cell	NN	B-NP	Oautonomous	effect	autonomous	JJ	I-NP	Oeffect	on	effect	NN	I-NP	Oon	the	on	IN	B-PP	Othe	acquisition	the	DT	B-NP	Oacquisition	of	acquisition	NN	I-NP	Oof	multiple	of	IN	B-PP	Omultiple	Ly-49	multiple	JJ	B-NP	OLy-49	receptors	Ly-49	NN	I-NP	B-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	Besides	.	.	O	OBesides	reduced	Besides	IN	B-PP	Oreduced	receptor	reduce	VBN	B-NP	Oreceptor	usage	receptor	NN	I-NP	Ousage	(	usage	NN	I-NP	O(	Ly-49A	(	(	O	OLy-49A	and	Ly-49A	NN	B-NP	Oand	D	and	CC	O	OD	)	D	NN	B-NP	O)	","	)	)	O	O","	we	","	","	O	Owe	also	we	PRP	B-NP	Oalso	observed	also	RB	B-ADVP	Oobserved	no	observe	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	(	effect	NN	I-NP	O(	Ly-49C	(	(	O	OLy-49C	)	Ly-49C	NN	B-NP	O)	and	)	)	O	Oand	significantly	and	CC	O	Osignificantly	expanded	significantly	RB	B-VP	Oexpanded	(	expand	VBN	I-VP	O(	Ly-49G	(	(	O	OLy-49G	and	Ly-49G	NN	B-NP	Oand	I	and	CC	O	OI	)	I	NN	B-NP	O)	receptor	)	)	O	Oreceptor	usage	receptor	NN	B-NP	Ousage	in	usage	NN	I-NP	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	TCF-1	of	IN	B-PP	OTCF-1	.	TCF-1	NN	B-NP	B-protein.	These	.	.	O	OThese	effects	These	DT	B-NP	Oeffects	did	effect	NNS	I-NP	Odid	not	do	VBD	B-VP	Onot	in	not	RB	O	Oin	all	in	IN	B-PP	Oall	cases	all	DT	B-NP	Ocases	correlate	case	NNS	I-NP	Ocorrelate	with	correlate	VBP	B-VP	Owith	the	with	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	TCF	of	IN	B-PP	OTCF	binding	TCF	NN	B-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	in	site	NNS	I-NP	I-DNAin	the	in	IN	B-PP	Othe	respective	the	DT	B-NP	Orespective	proximal	respective	JJ	I-NP	Oproximal	promoter	proximal	JJ	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Therefore	.	.	O	OTherefore	","	Therefore	RB	B-ADVP	O","	besides	","	","	O	Obesides	TCF-1	besides	IN	B-PP	OTCF-1	binding	TCF-1	NN	B-NP	B-proteinbinding	to	binding	NN	I-NP	Oto	the	to	TO	B-PP	Othe	proximal	the	DT	B-NP	Oproximal	promoter	proximal	JJ	I-NP	B-DNApromoter	","	promoter	NN	I-NP	I-DNA","	Ly-49	","	","	O	OLy-49	acquisition	Ly-49	NN	B-NP	Oacquisition	may	acquisition	NN	I-NP	Omay	also	may	MD	B-VP	Oalso	be	also	RB	I-VP	Obe	regulated	be	VB	I-VP	Oregulated	by	regulate	VBN	I-VP	Oby	TCF-1	by	IN	B-PP	OTCF-1	binding	TCF-1	NN	B-NP	B-proteinbinding	to	bind	VBG	B-VP	Oto	more	to	TO	B-PP	Omore	distant	more	RBR	B-NP	Odistant	cis-acting	distant	JJ	I-NP	B-DNAcis-acting	elements	cis-acting	JJ	I-NP	I-DNAelements	and/or	element	NNS	I-NP	I-DNAand/or	by	and/or	CC	B-PP	Oby	regulating	by	IN	B-PP	Oregulating	the	regulate	VBG	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	additional	of	IN	B-PP	Oadditional	trans-acting	additional	JJ	B-NP	Otrans-acting	factors	trans-acting	JJ	I-NP	B-proteinfactors	.	factor	NNS	I-NP	I-protein.	Consistent	.	.	O	OConsistent	with	Consistent	JJ	B-ADJP	Owith	the	with	IN	B-PP	Othe	observed	the	DT	B-NP	Oobserved	differential	observe	VBN	I-NP	Odifferential	","	differential	JJ	I-NP	O","	positive	","	","	I-NP	Opositive	or	positive	JJ	I-NP	Oor	negative	or	CC	I-NP	Onegative	role	negative	JJ	I-NP	Orole	of	role	NN	I-NP	Oof	TCF-1	of	IN	B-PP	OTCF-1	for	TCF-1	NN	B-NP	B-proteinfor	Ly-49	for	IN	B-PP	OLy-49	receptor	Ly-49	NN	B-NP	B-proteinreceptor	acquisition	receptor	NN	I-NP	I-proteinacquisition	","	acquisition	NN	I-NP	O","	reporter	","	","	O	Oreporter	gene	reporter	NN	B-NP	Ogene	assays	gene	NN	I-NP	Oassays	revealed	assay	NNS	I-NP	Orevealed	the	reveal	VBD	B-VP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	an	of	IN	B-PP	Oan	inducing	an	DT	B-NP	Oinducing	as	induce	VBG	I-NP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	a	as	IN	I-CONJP	Oa	repressing	a	DT	B-NP	Orepressing	TCF	repress	VBG	I-NP	OTCF	site	TCF	NN	I-NP	B-DNAsite	in	site	NN	I-NP	I-DNAin	certain	in	IN	B-PP	Ocertain	proximal	certain	JJ	B-NP	Oproximal	Ly-49	proximal	JJ	I-NP	B-DNALy-49	promoters	Ly-49	NN	I-NP	I-DNApromoters	.	promoter	NNS	I-NP	I-DNA.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	reveal	finding	NNS	I-NP	Oreveal	an	reveal	VBP	B-VP	Oan	important	an	DT	B-NP	Oimportant	role	important	JJ	I-NP	Orole	of	role	NN	I-NP	Oof	TCF-1	of	IN	B-PP	OTCF-1	for	TCF-1	NN	B-NP	B-proteinfor	the	for	IN	B-PP	Othe	formation	the	DT	B-NP	Oformation	of	formation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	NK	the	DT	B-NP	ONK	cell	NK	NN	I-NP	Ocell	receptor	cell	NN	I-NP	Oreceptor	repertoire	receptor	NN	I-NP	Orepertoire	.	repertoire	NN	I-NP	O.	Ligation	.	.	O	OLigation	of	Ligation	NN	B-NP	Oof	CD11b	of	IN	B-PP	OCD11b	and	CD11b	NN	B-NP	B-proteinand	CD11c	and	CC	O	OCD11c	beta	CD11c	NN	B-NP	B-proteinbeta	(	beta	NN	I-NP	I-protein(	2	(	(	O	I-protein2	)	2	CD	B-NP	I-protein)	integrins	)	)	O	I-proteinintegrins	by	integrin	NNS	B-NP	I-proteinby	antibodies	by	IN	B-PP	Oantibodies	or	antibody	NNS	B-NP	B-proteinor	soluble	or	CC	O	Osoluble	CD23	soluble	JJ	B-NP	OCD23	induces	CD23	NN	I-NP	B-proteininduces	macrophage	induce	VBZ	B-VP	Omacrophage	inflammatory	macrophage	NN	B-NP	B-proteininflammatory	protein	inflammatory	JJ	I-NP	I-proteinprotein	1alpha	protein	NN	I-NP	I-protein1alpha	(	1alpha	NN	I-NP	I-protein(	MIP-1alpha	(	(	O	OMIP-1alpha	)	MIP-1alpha	NN	B-NP	B-protein)	and	)	)	O	Oand	MIP-1beta	and	CC	O	OMIP-1beta	production	MIP-1beta	NN	B-NP	B-proteinproduction	in	production	NN	I-NP	Oin	primary	in	IN	B-PP	Oprimary	human	primary	JJ	B-NP	B-cell_typehuman	monocytes	human	JJ	I-NP	I-cell_typemonocytes	through	monocyte	NNS	I-NP	I-cell_typethrough	a	through	IN	B-PP	Oa	pathway	a	DT	B-NP	Opathway	dependent	pathway	NN	I-NP	Odependent	on	dependent	JJ	B-ADJP	Oon	nuclear	on	IN	B-PP	Onuclear	factor-kappaB	nuclear	JJ	B-NP	B-proteinfactor-kappaB	.	factor-kappaB	NN	I-NP	I-protein.	Chemokines	.	.	O	OChemokines	and	Chemokine	NNS	B-NP	B-proteinand	adhesion	and	CC	O	Oadhesion	molecules	adhesion	NN	B-NP	B-proteinmolecules	such	molecule	NNS	I-NP	I-proteinsuch	as	such	JJ	B-PP	Oas	integrins	as	IN	I-PP	Ointegrins	play	integrin	NNS	B-NP	B-proteinplay	a	play	VBP	B-VP	Oa	major	a	DT	B-NP	Omajor	part	major	JJ	I-NP	Opart	in	part	NN	I-NP	Oin	the	in	IN	B-PP	Othe	trafficking	the	DT	B-NP	Otrafficking	","	trafficking	NN	I-NP	O","	extravasation	","	","	O	Oextravasation	","	extravasation	NN	B-NP	O","	and	","	","	O	Oand	recruitment	and	CC	O	Orecruitment	of	recruitment	NN	B-NP	Oof	leukocytes	of	IN	B-PP	Oleukocytes	to	leukocyte	NNS	B-NP	B-cell_typeto	inflammatory	to	TO	B-PP	Oinflammatory	sites	inflammatory	JJ	B-NP	Osites	.	site	NNS	I-NP	O.	This	.	.	O	OThis	study	This	DT	B-NP	Ostudy	investigated	study	NN	I-NP	Oinvestigated	the	investigate	VBD	B-VP	Othe	effects	the	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	beta	of	IN	B-PP	Obeta	(	beta	NN	B-NP	B-protein(	2	(	(	O	I-protein2	)	2	CD	B-NP	I-protein)	integrin	)	)	O	I-proteinintegrin	engagement	integrin	NN	B-NP	I-proteinengagement	on	engagement	NN	I-NP	Oon	chemokine	on	IN	B-PP	Ochemokine	production	chemokine	NN	B-NP	B-proteinproduction	by	production	NN	I-NP	Oby	freshly	by	IN	B-PP	Ofreshly	isolated	freshly	RB	B-NP	B-cell_typeisolated	human	isolate	VBN	I-NP	I-cell_typehuman	monocytes	human	JJ	I-NP	I-cell_typemonocytes	.	monocyte	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	found	We	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	ligation	that	IN	B-SBAR	Oligation	of	ligation	NN	B-NP	Oof	CD11b	of	IN	B-PP	OCD11b	or	CD11b	NN	B-NP	B-proteinor	CD11c	or	CC	I-NP	OCD11c	but	CD11c	NN	I-NP	B-proteinbut	not	but	CC	B-NP	Onot	CD11a	not	RB	I-NP	OCD11a	alpha	CD11a	NN	B-NP	B-proteinalpha	chains	alpha	NN	I-NP	I-proteinchains	of	chain	NNS	I-NP	I-proteinof	beta	of	IN	B-PP	Obeta	(	beta	NN	B-NP	B-protein(	2	(	(	O	I-protein2	)	2	CD	B-NP	I-protein)	integrins	)	)	O	I-proteinintegrins	by	integrin	NNS	B-NP	I-proteinby	antibodies	by	IN	B-PP	Oantibodies	or	antibody	NNS	B-NP	B-proteinor	soluble	or	CC	O	Osoluble	CD23	soluble	JJ	B-NP	OCD23	(	CD23	NN	I-NP	B-protein(	sCD23	(	(	O	OsCD23	)	sCD23	NN	B-NP	B-protein)	fusion	)	)	O	Ofusion	proteins	fusion	NN	B-NP	Oproteins	rapidly	protein	NNS	I-NP	Orapidly	induced	rapidly	RB	B-ADVP	Oinduced	transcription	induce	VBD	B-VP	Otranscription	and	transcription	NN	B-NP	Oand	secretion	and	CC	O	Osecretion	of	secretion	NN	B-NP	Oof	interleukin	of	IN	B-PP	Ointerleukin	8	interleukin	NN	B-NP	B-protein8	","	8	CD	I-NP	I-protein","	macrophage	","	","	O	Omacrophage	inflammatory	macrophage	NN	B-NP	B-proteininflammatory	protein	inflammatory	JJ	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	MIP	(	(	O	I-proteinMIP	)	MIP	NN	B-NP	I-protein)	1alpha	)	)	O	I-protein1alpha	","	1alpha	NN	B-NP	I-protein","	and	","	","	O	Oand	MIP-1beta	and	CC	O	OMIP-1beta	.	MIP-1beta	NN	B-NP	B-protein.	Because	.	.	O	OBecause	the	Because	IN	B-SBAR	Othe	promoters	the	DT	B-NP	Opromoters	of	promoter	NNS	I-NP	B-DNAof	these	of	IN	B-PP	Othese	chemokine	these	DT	B-NP	Ochemokine	genes	chemokine	NN	I-NP	B-DNAgenes	contain	gene	NNS	I-NP	I-DNAcontain	kappaB	contain	VBP	B-VP	OkappaB	binding	kappaB	NN	B-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	","	site	NNS	I-NP	I-DNA","	we	","	","	O	Owe	assessed	we	PRP	B-NP	Oassessed	the	assess	VBD	B-VP	Othe	possible	the	DT	B-NP	Opossible	role	possible	JJ	I-NP	Orole	of	role	NN	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor-kappaB	nuclear	JJ	B-NP	B-proteinfactor-kappaB	(	factor-kappaB	NN	I-NP	I-protein(	NF-kappaB	(	(	O	ONF-kappaB	)	NF-kappaB	NN	B-NP	B-protein)	in	)	)	O	Oin	controlling	in	IN	B-PP	Ocontrolling	induction	control	VBG	B-VP	Oinduction	of	induction	NN	B-NP	Oof	the	of	IN	B-PP	Othe	genes	the	DT	B-NP	Ogenes	through	gene	NNS	I-NP	Othrough	beta	through	IN	B-PP	Obeta	(	beta	NN	B-NP	B-protein(	2	(	(	O	I-protein2	)	2	CD	B-NP	I-protein)	integrin	)	)	O	I-proteinintegrin	engagement	integrin	NN	B-NP	I-proteinengagement	.	engagement	NN	I-NP	O.	Electrophoretic	.	.	O	OElectrophoretic	mobility	Electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assays	shift	NN	I-NP	Oassays	showed	assay	NNS	I-NP	Oshowed	that	show	VBD	B-VP	Othat	sCD23	that	IN	B-SBAR	OsCD23	or	sCD23	NN	B-NP	B-proteinor	antibodies	or	CC	I-NP	Oantibodies	to	antibody	NNS	I-NP	B-proteinto	CD11b	to	TO	B-PP	OCD11b	or	CD11b	NN	B-NP	B-proteinor	to	or	CC	B-PP	Oto	CD11c	to	TO	B-PP	OCD11c	up-regulated	CD11c	NN	B-NP	B-proteinup-regulated	DNA-binding	up-regulated	JJ	I-NP	ODNA-binding	activity	DNA-binding	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	.	NF-kappaB	NN	B-NP	B-protein.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	was	NF-kappaB	NN	B-NP	B-proteinwas	accompanied	be	VBD	B-VP	Oaccompanied	by	accompany	VBN	I-VP	Oby	degradation	by	IN	B-PP	Odegradation	of	degradation	NN	B-NP	Oof	its	of	IN	B-PP	Oits	cytosolic	its	PRP$	B-NP	Ocytosolic	inhibitor	cytosolic	JJ	I-NP	B-proteininhibitor	IkappaB-alpha	inhibitor	NN	I-NP	I-proteinIkappaB-alpha	.	IkappaB-alpha	NN	I-NP	B-protein.	Blockade	.	.	O	OBlockade	of	Blockade	NN	B-NP	Oof	depletion	of	IN	B-PP	Odepletion	of	depletion	NN	B-NP	Oof	IkappaB-alpha	of	IN	B-PP	OIkappaB-alpha	by	IkappaB-alpha	NN	B-NP	B-proteinby	proteasome	by	IN	B-PP	Oproteasome	inhibitors	proteasome	NN	B-NP	B-proteininhibitors	(	inhibitor	NNS	I-NP	O(	proteasome	(	(	O	Oproteasome	inhibitor	proteasome	NN	B-NP	B-proteininhibitor	I	inhibitor	NN	I-NP	OI	or	I	CD	I-NP	Oor	acetyl-leucinyl-leucinyl-norleucinal	or	CC	O	Oacetyl-leucinyl-leucinyl-norleucinal	)	acetyl-leucinyl-leucinyl-norleucinal	JJ	B-ADJP	O)	led	)	)	O	Oled	to	lead	VBD	B-VP	Oto	concomitant	to	TO	B-PP	Oconcomitant	inhibition	concomitant	JJ	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	DNA-binding	NF-kappaB	NN	B-NP	B-proteinDNA-binding	activity	DNA-binding	JJ	I-NP	Oactivity	and	activity	NN	I-NP	Oand	expression	and	CC	O	Oexpression	of	expression	NN	B-NP	Oof	MIP-1alpha	of	IN	B-PP	OMIP-1alpha	and	MIP-1alpha	NN	B-NP	B-proteinand	MIP-1beta	and	CC	I-NP	OMIP-1beta	messenger	MIP-1beta	NN	I-NP	B-RNAmessenger	RNA	messenger	NN	I-NP	I-RNARNA	induced	RNA	NN	I-NP	I-RNAinduced	by	induce	VBN	B-VP	Oby	beta	by	IN	B-PP	Obeta	(	beta	NN	B-NP	B-protein(	2	(	(	O	I-protein2	)	2	CD	B-NP	I-protein)	integrin	)	)	O	I-proteinintegrin	ligation	integrin	NN	B-NP	I-proteinligation	.	ligation	NN	I-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	triggering	that	IN	B-SBAR	Otriggering	of	triggering	NN	B-NP	Oof	CD11b	of	IN	B-PP	OCD11b	or	CD11b	NN	B-NP	B-proteinor	CD11c	or	CC	I-NP	OCD11c	beta	CD11c	NN	I-NP	B-proteinbeta	(	beta	SYM	B-NP	I-protein(	2	(	(	B-LST	I-protein2	)	2	LS	I-LST	I-protein)	integrin	)	)	O	I-proteinintegrin	on	integrin	NN	B-NP	I-proteinon	primary	on	IN	B-PP	Oprimary	human	primary	JJ	B-NP	B-cell_typehuman	monocytes	human	JJ	I-NP	I-cell_typemonocytes	provides	monocyte	NNS	I-NP	I-cell_typeprovides	activation	provide	VBZ	B-VP	Oactivation	signals	activation	NN	B-NP	Osignals	leading	signal	NNS	I-NP	Oleading	to	lead	VBG	B-VP	Oto	nuclear	to	TO	B-PP	Onuclear	translocation	nuclear	JJ	B-NP	Otranslocation	of	translocation	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	and	NF-kappaB	NN	B-NP	B-proteinand	subsequent	and	CC	O	Osubsequent	secretion	subsequent	JJ	B-NP	Osecretion	of	secretion	NN	I-NP	Oof	MIP-1alpha	of	IN	B-PP	OMIP-1alpha	and	MIP-1alpha	NN	B-NP	B-proteinand	MIP-1beta	and	CC	I-NP	OMIP-1beta	that	MIP-1beta	NN	I-NP	B-proteinthat	may	that	WDT	B-NP	Omay	have	may	MD	B-VP	Ohave	an	have	VB	I-VP	Oan	important	an	DT	B-NP	Oimportant	role	important	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	recruitment	in	IN	B-PP	Orecruitment	of	recruitment	NN	B-NP	Oof	other	of	IN	B-PP	Oother	inflammatory	other	JJ	B-NP	Oinflammatory	cells	inflammatory	JJ	I-NP	B-cell_typecells	during	cell	NNS	I-NP	I-cell_typeduring	initiation	during	IN	B-PP	Oinitiation	of	initiation	NN	B-NP	Oof	an	of	IN	B-PP	Oan	inflammatory	an	DT	B-NP	Oinflammatory	response	inflammatory	JJ	I-NP	Oresponse	Synergistic	response	NN	I-NP	OSynergistic	transcriptional	Synergistic	JJ	B-NP	Otranscriptional	activation	transcriptional	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	Acyl-coenzyme	human	JJ	B-NP	B-proteinAcyl-coenzyme	A	Acyl-coenzyme	NN	I-NP	I-proteinA	:	A	NN	I-NP	I-protein:	cholesterol	:	:	O	Ocholesterol	acyltransterase-1	cholesterol	NN	B-NP	B-DNAacyltransterase-1	gene	acyltransterase-1	NN	I-NP	I-DNAgene	by	gene	NN	I-NP	I-DNAby	interferon-gamma	by	IN	B-PP	Ointerferon-gamma	and	interferon-gamma	NN	B-NP	B-proteinand	all-trans-retinoic	and	CC	O	Oall-trans-retinoic	acid	all-trans-retinoic	JJ	B-NP	Oacid	THP-1	acid	NN	I-NP	OTHP-1	cells	THP-1	NN	I-NP	Ocells	.	cell	NNS	I-NP	O.	Acyl-coenzyme	.	.	O	OAcyl-coenzyme	A	Acyl-coenzyme	NN	B-NP	OA	:	A	NN	I-NP	O:	cholesterol	:	:	O	Ocholesterol	acyltransferase	cholesterol	NN	B-NP	Oacyltransferase	(	acyltransferase	NN	I-NP	O(	ACAT	(	(	O	OACAT	)	ACAT	NN	B-NP	B-protein)	is	)	)	O	Ois	an	be	VBZ	B-VP	Oan	intracellular	an	DT	B-NP	Ointracellular	enzyme	intracellular	JJ	I-NP	B-proteinenzyme	involved	enzyme	NN	I-NP	I-proteininvolved	in	involve	VBN	B-VP	Oin	cellular	in	IN	B-PP	Ocellular	cholesterol	cellular	JJ	B-NP	Ocholesterol	homeostasis	cholesterol	NN	I-NP	Ohomeostasis	and	homeostasis	NN	I-NP	Oand	in	and	CC	B-PP	Oin	atherosclerotic	in	IN	B-PP	Oatherosclerotic	foam	atherosclerotic	JJ	B-NP	Ofoam	cell	foam	NN	I-NP	Ocell	formation	cell	NN	I-NP	Oformation	.	formation	NN	I-NP	O.	Human	.	.	O	OHuman	ACAT-1	Human	JJ	B-NP	B-DNAACAT-1	gene	ACAT-1	NN	I-NP	I-DNAgene	contains	gene	NN	I-NP	I-DNAcontains	two	contain	VBZ	B-VP	Otwo	promoters	two	CD	B-NP	Opromoters	(	promoter	NNS	I-NP	B-DNA(	P1	(	(	O	OP1	and	P1	NN	B-NP	B-DNAand	P7	and	CC	O	OP7	)	P7	NN	B-NP	B-DNA)	","	)	)	O	O","	each	","	","	O	Oeach	located	each	DT	B-NP	Olocated	in	located	JJ	B-ADJP	Oin	a	in	IN	B-PP	Oa	different	a	DT	B-NP	Odifferent	chromosome	different	JJ	I-NP	Ochromosome	(	chromosome	NN	I-NP	O(	1	(	(	O	O1	and	1	CD	B-NP	Oand	7	and	CC	I-NP	O7	)	7	CD	I-NP	O)	(	)	)	O	O(	Li	(	(	O	OLi	","	Li	NNP	B-NP	O","	B.	","	","	O	OB.	L.	B.	NNP	B-NP	OL.	","	L.	NNP	I-NP	O","	Li	","	","	O	OLi	","	Li	NNP	B-NP	O","	X.	","	","	O	OX.	L.	X.	NNP	B-NP	OL.	","	L.	NNP	I-NP	O","	Duan	","	","	O	ODuan	","	Duan	NNP	B-NP	O","	Z.	","	","	O	OZ.	J.	Z.	NNP	B-NP	OJ.	","	J.	NNP	I-NP	O","	Lee	","	","	O	OLee	","	Lee	NNP	B-NP	O","	O.	","	","	O	OO.	","	O.	NNP	B-NP	O","	Lin	","	","	O	OLin	","	Lin	NNP	B-NP	B-protein","	S.	","	","	O	OS.	","	S.	NNP	B-NP	O","	Ma	","	","	O	OMa	","	Ma	NNP	B-NP	O","	Z.	","	","	O	OZ.	M.	Z.	NNP	B-NP	OM.	","	M.	NNP	I-NP	O","	Chang	","	","	O	OChang	","	Chang	NNP	B-NP	O","	C.	","	","	O	OC.	C.	C.	NNP	B-NP	OC.	","	C.	NNP	I-NP	O","	Yang	","	","	O	OYang	","	Yang	NNP	B-NP	O","	X.	","	","	O	OX.	Y.	X.	NNP	B-NP	OY.	","	Y.	NNP	I-NP	O","	Park	","	","	O	OPark	","	Park	NNP	B-NP	O","	J.	","	","	O	OJ.	P.	J.	NNP	B-NP	OP.	","	P.	NNP	I-NP	O","	Mohandas	","	","	O	OMohandas	","	Mohandas	NNP	B-NP	O","	T.	","	","	O	OT.	K.	T.	NNP	B-NP	OK.	","	K.	NNP	I-NP	O","	Noll	","	","	O	ONoll	","	Noll	NNP	B-NP	O","	W.	","	","	O	OW.	","	W.	NNP	B-NP	O","	Chan	","	","	O	OChan	","	Chan	NNP	B-NP	O","	L.	","	","	O	OL.	","	L.	NNP	B-NP	O","	and	","	","	O	Oand	Chang	and	CC	O	OChang	","	Chang	NNP	B-NP	O","	T.	","	","	O	OT.	Y.	T.	NNP	B-NP	OY.	(	Y.	NNP	I-NP	O(	1999	(	(	O	O1999	)	1999	CD	B-NP	O)	J.	)	)	O	OJ.	Biol	J.	NNP	B-NP	OBiol	Chem.	Biol	NNP	I-NP	OChem.	274	Chem.	NNP	I-NP	O274	","	274	CD	I-NP	O","	11060-11071	","	","	I-NP	O11060-11071	)	11060-11071	CD	I-NP	O)	.	)	)	O	O.	Interferon-gamma	.	.	O	OInterferon-gamma	(	Interferon-gamma	NN	B-NP	B-protein(	IFN-gamma	(	(	O	OIFN-gamma	)	IFN-gamma	NN	B-NP	B-protein)	","	)	)	O	O","	a	","	","	O	Oa	cytokine	a	DT	B-NP	Ocytokine	that	cytokine	NN	I-NP	B-proteinthat	exerts	that	WDT	B-NP	Oexerts	many	exert	VBZ	B-VP	Omany	pro-atherosclerotic	many	JJ	B-NP	Opro-atherosclerotic	effects	pro-atherosclerotic	JJ	I-NP	Oeffects	in	effect	NNS	I-NP	Oin	vivo	in	FW	B-ADVP	Ovivo	","	vivo	FW	I-ADVP	O","	causes	","	","	O	Ocauses	up-regulation	cause	VBZ	B-VP	Oup-regulation	of	up-regulation	NN	B-NP	Oof	ACAT-1	of	IN	B-PP	OACAT-1	mRNA	ACAT-1	NN	B-NP	B-RNAmRNA	in	mRNA	NN	I-NP	I-RNAin	human	in	IN	B-PP	Ohuman	blood	human	JJ	B-NP	B-cell_typeblood	monocyte-derived	blood	NN	I-NP	I-cell_typemonocyte-derived	macrophages	monocyte-derived	JJ	I-NP	I-cell_typemacrophages	and	macrophage	NNS	I-NP	I-cell_typeand	macrophage-like	and	CC	O	Omacrophage-like	cells	macrophage-like	JJ	B-NP	B-cell_typecells	but	cell	NNS	I-NP	I-cell_typebut	not	but	CC	B-PP	Onot	in	not	RB	B-PP	Oin	other	in	IN	I-PP	Oother	cell	other	JJ	B-NP	Ocell	types	cell	NN	I-NP	Otypes	.	type	NNS	I-NP	O.	To	.	.	O	OTo	examine	To	TO	B-VP	Oexamine	the	examine	VB	I-VP	Othe	molecular	the	DT	B-NP	Omolecular	nature	molecular	JJ	I-NP	Onature	of	nature	NN	I-NP	Oof	this	of	IN	B-PP	Othis	observation	this	DT	B-NP	Oobservation	","	observation	NN	I-NP	O","	we	","	","	O	Owe	identified	we	PRP	B-NP	Oidentified	within	identify	VBD	B-VP	Owithin	the	within	IN	B-PP	Othe	ACAT-1	the	DT	B-NP	OACAT-1	P1	ACAT-1	NN	I-NP	B-DNAP1	promoter	P1	NN	I-NP	I-DNApromoter	a	promoter	NN	I-NP	I-DNAa	159-base	a	DT	B-NP	O159-base	pair	159-base	JJ	I-NP	B-DNApair	core	pair	NN	I-NP	I-DNAcore	region	core	NN	I-NP	I-DNAregion	.	region	NN	I-NP	I-DNA.	This	.	.	O	OThis	region	This	DT	B-NP	Oregion	contains	region	NN	I-NP	Ocontains	4	contain	VBZ	B-VP	O4	Sp1	4	CD	B-NP	B-DNASp1	elements	Sp1	NN	I-NP	I-DNAelements	and	element	NNS	I-NP	I-DNAand	an	and	CC	O	Oan	IFN-gamma	an	DT	B-NP	OIFN-gamma	activated	IFN-gamma	NN	I-NP	B-proteinactivated	sequence	activate	VBN	B-VP	Osequence	(	sequence	NN	B-NP	O(	GAS	(	(	O	OGAS	)	GAS	NN	B-NP	B-DNA)	that	)	)	O	Othat	overlaps	that	WDT	B-NP	Ooverlaps	with	overlap	VBZ	B-VP	Owith	the	with	IN	B-PP	Othe	second	the	DT	B-NP	Osecond	Sp1	second	JJ	I-NP	B-DNASp1	element	Sp1	NN	I-NP	I-DNAelement	.	element	NN	I-NP	I-DNA.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	monocytic	the	DT	B-NP	Omonocytic	cell	monocytic	JJ	I-NP	B-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	THP-1	line	NN	I-NP	I-cell_lineTHP-1	cell	THP-1	NN	I-NP	I-cell_linecell	","	cell	NN	I-NP	I-cell_line","	the	","	","	O	Othe	combination	the	DT	B-NP	Ocombination	of	combination	NN	I-NP	Oof	IFN-gamma	of	IN	B-PP	OIFN-gamma	and	IFN-gamma	NN	B-NP	B-proteinand	all-trans-retinoic	and	CC	O	Oall-trans-retinoic	acid	all-trans-retinoic	JJ	B-NP	Oacid	(	acid	NN	I-NP	O(	a	(	(	O	Oa	known	a	DT	B-NP	Oknown	differentiation	know	VBN	I-NP	Odifferentiation	agent	differentiation	NN	I-NP	Oagent	)	agent	NN	I-NP	O)	enhances	)	)	O	Oenhances	the	enhance	VBZ	B-VP	Othe	ACAT-1	the	DT	B-NP	OACAT-1	P1	ACAT-1	NN	I-NP	B-DNAP1	promoter	P1	NN	I-NP	I-DNApromoter	but	promoter	NN	I-NP	I-DNAbut	not	but	CC	B-NP	Onot	the	not	RB	I-NP	Othe	P7	the	DT	B-NP	OP7	promoter	P7	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Additional	.	.	O	OAdditional	experiments	Additional	JJ	B-NP	Oexperiments	showed	experiment	NNS	I-NP	Oshowed	that	show	VBD	B-VP	Othat	all-trans-retinoic	that	IN	B-SBAR	Oall-trans-retinoic	acid	all-trans-retinoic	JJ	B-NP	Oacid	causes	acid	NN	I-NP	Ocauses	large	cause	VBZ	B-VP	Olarge	induction	large	JJ	B-NP	Oinduction	of	induction	NN	I-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	STAT1	factor	NN	I-NP	I-proteinSTAT1	","	STAT1	NN	I-NP	B-protein","	while	","	","	O	Owhile	IFN-gamma	while	IN	B-SBAR	OIFN-gamma	causes	IFN-gamma	NN	B-NP	B-proteincauses	activation	cause	VBZ	B-VP	Oactivation	of	activation	NN	B-NP	Oof	STAT1	of	IN	B-PP	OSTAT1	such	STAT1	NN	B-NP	B-proteinsuch	that	such	JJ	B-NP	Othat	it	that	IN	B-NP	Oit	binds	it	PRP	B-NP	Obinds	to	bind	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	GAS/Sp1	the	DT	B-NP	OGAS/Sp1	site	GAS/Sp1	NN	I-NP	B-DNAsite	in	site	NN	I-NP	I-DNAin	the	in	IN	B-PP	Othe	ACAT-1	the	DT	B-NP	OACAT-1	P1	ACAT-1	NN	I-NP	B-DNAP1	promoter	P1	NN	I-NP	I-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Our	.	.	O	OOur	work	Our	PRP$	B-NP	Owork	provides	work	NN	I-NP	Oprovides	a	provide	VBZ	B-VP	Oa	molecular	a	DT	B-NP	Omolecular	mechanism	molecular	JJ	I-NP	Omechanism	to	mechanism	NN	I-NP	Oto	account	to	TO	B-VP	Oaccount	for	account	VB	I-VP	Ofor	the	for	IN	B-PP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	IFN-gamma	of	IN	B-PP	OIFN-gamma	in	IFN-gamma	NN	B-NP	B-proteinin	causing	in	IN	B-PP	Ocausing	transcriptional	cause	VBG	B-VP	Otranscriptional	activation	transcriptional	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	ACAT-1	of	IN	B-PP	OACAT-1	in	ACAT-1	NN	B-NP	B-proteinin	macrophage-like	in	IN	B-PP	Omacrophage-like	cells	macrophage-like	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Inhaled	.	.	O	OInhaled	nitric	Inhale	VBN	B-NP	Onitric	oxide	nitric	JJ	I-NP	Ooxide	down-regulates	oxide	NN	I-NP	Odown-regulates	intrapulmonary	down-regulate	VBZ	B-VP	Ointrapulmonary	nitric	intrapulmonary	JJ	B-NP	Onitric	oxide	nitric	JJ	I-NP	Ooxide	production	oxide	NN	I-NP	Oproduction	in	production	NN	I-NP	Oin	lipopolysaccharide-induced	in	IN	B-PP	Olipopolysaccharide-induced	acute	lipopolysaccharide-induced	JJ	B-NP	Oacute	lung	acute	JJ	I-NP	Olung	injury	lung	NN	I-NP	Oinjury	.	injury	NN	I-NP	O.	OBJECTIVE	.	.	O	OOBJECTIVE	:	OBJECTIVE	NN	B-NP	O:	To	:	:	O	OTo	examine	To	TO	B-VP	Oexamine	whether	examine	VB	I-VP	Owhether	inhaled	whether	IN	B-SBAR	Oinhaled	nitric	inhale	VBN	B-NP	Onitric	oxide	nitric	JJ	I-NP	Ooxide	(	oxide	NN	I-NP	O(	NO	(	(	O	ONO	)	NO	NN	B-NP	O)	affected	)	)	O	Oaffected	the	affect	VBD	B-VP	Othe	intrapulmonary	the	DT	B-NP	Ointrapulmonary	production	intrapulmonary	JJ	I-NP	Oproduction	of	production	NN	I-NP	Oof	NO	of	IN	B-PP	ONO	","	NO	NN	B-NP	O","	reactive	","	","	O	Oreactive	oxygen	reactive	JJ	B-NP	Ooxygen	species	oxygen	NN	I-NP	Ospecies	","	specie	NNS	I-NP	O","	and	","	","	O	Oand	nuclear	and	CC	O	Onuclear	factor-kappaB	nuclear	JJ	B-NP	B-proteinfactor-kappaB	in	factor-kappaB	NN	I-NP	I-proteinin	a	in	IN	B-PP	Oa	lipopolysaccharide	a	DT	B-NP	Olipopolysaccharide	(	lipopolysaccharide	NN	I-NP	O(	LPS	(	(	O	OLPS	)	LPS	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	model	#NAME?	JJ	B-NP	Omodel	of	model	NN	I-NP	Oof	acute	of	IN	B-PP	Oacute	lung	acute	JJ	B-NP	Olung	injury	lung	NN	I-NP	Oinjury	.	injury	NN	I-NP	O.	DESIGN	.	.	O	ODESIGN	:	DESIGN	NN	B-NP	O:	Prospective	:	:	O	OProspective	","	Prospective	JJ	B-ADJP	O","	randomized	","	","	O	Orandomized	","	randomize	VBN	B-VP	O","	laboratory	","	","	O	Olaboratory	study	laboratory	NN	B-NP	Ostudy	.	study	NN	I-NP	O.	SETTING	.	.	O	OSETTING	:	SETTING	NN	B-NP	O:	Experimental	:	:	O	OExperimental	laboratory	Experimental	JJ	B-NP	Olaboratory	at	laboratory	NN	I-NP	Oat	a	at	IN	B-PP	Oa	biomedical	a	DT	B-NP	Obiomedical	institute	biomedical	JJ	I-NP	Oinstitute	.	institute	NN	I-NP	O.	SUBJECTS	.	.	O	OSUBJECTS	:	SUBJECTS	NNS	B-NP	O:	Twenty	:	:	O	OTwenty	male	Twenty	CD	B-NP	Omale	rabbits	male	JJ	I-NP	Orabbits	weighing	rabbit	NNS	I-NP	Oweighing	2.5-3.5	weigh	VBG	B-VP	O2.5-3.5	kg	2.5-3.5	CD	B-NP	Okg	.	kg	NN	I-NP	O.	INTERVENTIONS	.	.	O	OINTERVENTIONS	:	INTERVENTIONS	NNS	B-NP	O:	Saline	:	:	O	OSaline	or	Saline	NN	B-NP	Oor	LPS	or	CC	O	OLPS	(	LPS	NN	B-NP	O(	5	(	(	O	O5	mg/kg	5	CD	B-NP	Omg/kg	of	mg/kg	NN	I-NP	Oof	body	of	IN	B-PP	Obody	weight	body	NN	B-NP	Oweight	)	weight	NN	I-NP	O)	was	)	)	O	Owas	administered	be	VBD	B-VP	Oadministered	intravenously	administer	VBN	I-VP	Ointravenously	with	intravenously	RB	B-ADVP	Owith	or	with	IN	B-PP	Oor	without	or	CC	B-PP	Owithout	NO	without	IN	B-PP	ONO	inhalation	NO	NN	B-NP	Oinhalation	(	inhalation	NN	I-NP	O(	10	(	(	O	O10	ppm	10	CD	B-NP	Oppm	)	ppm	NN	I-NP	O)	in	)	)	O	Oin	each	in	IN	B-PP	Oeach	group	each	DT	B-NP	Ogroup	of	group	NN	I-NP	Oof	five	of	IN	B-PP	Ofive	rabbits	five	CD	B-NP	Orabbits	.	rabbit	NNS	I-NP	O.	MEASUREMENTS	.	.	O	OMEASUREMENTS	AND	MEASUREMENTS	NNS	B-NP	OAND	MAIN	AND	CC	I-NP	OMAIN	RESULTS	MAIN	NN	I-NP	ORESULTS	:	RESULTS	NNS	I-NP	O:	LPS	:	:	O	OLPS	increased	LPS	NN	B-NP	Oincreased	the	increase	VBD	B-VP	Othe	lung	the	DT	B-NP	Olung	leak	lung	NN	I-NP	Oleak	index	leak	NN	I-NP	Oindex	","	index	NN	I-NP	O","	the	","	","	O	Othe	neutrophils	the	DT	B-NP	Oneutrophils	and	neutrophil	NNS	I-NP	B-cell_typeand	NO	and	CC	I-NP	ONO	levels	NO	NN	I-NP	Olevels	in	level	NNS	I-NP	Oin	bronchoalveolar	in	IN	B-PP	Obronchoalveolar	lavage	bronchoalveolar	JJ	B-NP	Olavage	fluid	lavage	NN	I-NP	Ofluid	","	fluid	NN	I-NP	O","	and	","	","	O	Oand	NO	and	CC	O	ONO	levels	NO	NN	B-NP	Olevels	produced	level	NNS	I-NP	Oproduced	by	produce	VBN	B-VP	Oby	resting	by	IN	B-PP	Oresting	and	rest	VBG	B-NP	Oand	stimulated	and	CC	I-NP	Ostimulated	alveolar	stimulate	VBN	I-NP	Oalveolar	macrophages	alveolar	JJ	I-NP	B-cell_typemacrophages	.	macrophage	NNS	I-NP	I-cell_type.	Inhaled	.	.	O	OInhaled	NO	Inhaled	JJ	B-NP	ONO	decreased	NO	NN	I-NP	Odecreased	the	decrease	VBD	B-VP	Othe	lung	the	DT	B-NP	Olung	leak	lung	NN	I-NP	Oleak	index	leak	NN	I-NP	Oindex	","	index	NN	I-NP	O","	the	","	","	O	Othe	neutrophils	the	DT	B-NP	Oneutrophils	and	neutrophil	NNS	I-NP	B-cell_typeand	NO	and	CC	I-NP	ONO	levels	NO	NN	I-NP	Olevels	as	level	NNS	I-NP	Oas	measured	as	IN	B-SBAR	Omeasured	by	measure	VBN	B-VP	Oby	nitrite	by	IN	B-PP	Onitrite	levels	nitrite	NN	B-NP	Olevels	in	level	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	lavage	the	DT	B-NP	Olavage	fluid	lavage	NN	I-NP	Ofluid	","	fluid	NN	I-NP	O","	and	","	","	O	Oand	NO	and	CC	O	ONO	produced	NO	NN	B-NP	Oproduced	by	produce	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	resting	the	DT	B-NP	Oresting	and	resting	NN	I-NP	B-cell_typeand	stimulated	and	CC	O	I-cell_typestimulated	alveolar	stimulate	VBN	B-VP	I-cell_typealveolar	macrophages	alveolar	JJ	B-NP	I-cell_typemacrophages	.	macrophage	NNS	I-NP	I-cell_type.	Inhaled	.	.	O	OInhaled	NO	Inhaled	JJ	B-NP	ONO	also	NO	NN	I-NP	Oalso	blocked	also	RB	B-ADVP	Oblocked	the	block	VBD	B-VP	Othe	activities	the	DT	B-NP	Oactivities	of	activity	NNS	I-NP	Oof	reactive	of	IN	B-PP	Oreactive	oxygen	reactive	JJ	B-NP	Ooxygen	species	oxygen	NN	I-NP	Ospecies	and	specie	NNS	I-NP	Oand	nuclear	and	CC	O	Onuclear	factor-kappaB	nuclear	JJ	B-NP	B-proteinfactor-kappaB	binding	factor-kappaB	NN	I-NP	I-proteinbinding	to	bind	VBG	B-VP	Oto	DNA	to	TO	B-PP	ODNA	in	DNA	NN	B-NP	Oin	lavage	in	IN	B-PP	Olavage	cells	lavage	NN	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	in	and	CC	B-PP	Oin	alveolar	in	IN	B-PP	Oalveolar	macrophages	alveolar	JJ	B-NP	B-cell_typemacrophages	.	macrophage	NNS	I-NP	I-cell_type.	CONCLUSION	.	.	O	OCONCLUSION	:	CONCLUSION	NN	B-NP	O:	Inhaled	:	:	O	OInhaled	NO	Inhaled	JJ	B-NP	ONO	attenuates	NO	NN	I-NP	Oattenuates	LPS-induced	attenuate	VBZ	B-VP	OLPS-induced	acute	LPS-induced	JJ	B-NP	Oacute	lung	acute	JJ	I-NP	Olung	injury	lung	NN	I-NP	Oinjury	","	injury	NN	I-NP	O","	possibly	","	","	O	Opossibly	by	possibly	RB	B-ADVP	Oby	decreasing	by	IN	B-PP	Odecreasing	NO	decrease	VBG	B-VP	ONO	production	NO	NN	B-NP	Oproduction	in	production	NN	I-NP	Oin	the	in	IN	B-PP	Othe	lungs	the	DT	B-NP	Olungs	.	lung	NNS	I-NP	O.	The	.	.	O	OThe	mechanism	The	DT	B-NP	Omechanism	of	mechanism	NN	I-NP	Oof	reducing	of	IN	B-PP	Oreducing	NO	reduce	VBG	B-VP	ONO	production	NO	NN	B-NP	Oproduction	resulting	production	NN	I-NP	Oresulting	from	result	VBG	B-VP	Ofrom	inhaled	from	IN	B-PP	Oinhaled	NO	inhale	VBN	B-NP	ONO	may	NO	NN	I-NP	Omay	involve	may	MD	B-VP	Oinvolve	","	involve	VB	I-VP	O","	in	","	","	O	Oin	part	in	IN	B-PP	Opart	","	part	NN	B-NP	O","	the	","	","	O	Othe	activities	the	DT	B-NP	Oactivities	of	activity	NNS	I-NP	Oof	reactive	of	IN	B-PP	Oreactive	oxygen	reactive	JJ	B-NP	Ooxygen	species	oxygen	NN	I-NP	Ospecies	and/or	specie	NNS	I-NP	Oand/or	nuclear	and/or	CC	O	Onuclear	factor-kappaB	nuclear	JJ	B-NP	B-proteinfactor-kappaB	.	factor-kappaB	NN	I-NP	I-protein.	Treatment	.	.	O	OTreatment	of	Treatment	NN	B-NP	Oof	allergic	of	IN	B-PP	Oallergic	airway	allergic	JJ	B-NP	Oairway	inflammation	airway	NN	I-NP	Oinflammation	and	inflammation	NN	I-NP	Oand	hyperresponsiveness	and	CC	I-NP	Ohyperresponsiveness	by	hyperresponsiveness	NN	I-NP	Oby	antisense-induced	by	IN	B-PP	Oantisense-induced	local	antisense-induced	JJ	B-NP	Olocal	blockade	local	JJ	I-NP	Oblockade	of	blockade	NN	I-NP	Oof	GATA-3	of	IN	B-PP	OGATA-3	expression	GATA-3	NN	B-NP	B-proteinexpression	.	expression	NN	I-NP	O.	Recent	.	.	O	ORecent	studies	Recent	JJ	B-NP	Ostudies	in	study	NNS	I-NP	Oin	transgenic	in	IN	B-PP	Otransgenic	mice	transgenic	JJ	B-NP	Omice	have	mouse	NNS	I-NP	Ohave	revealed	have	VBP	B-VP	Orevealed	that	reveal	VBN	I-VP	Othat	expression	that	IN	B-SBAR	Oexpression	of	expression	NN	B-NP	Oof	a	of	IN	B-PP	Oa	dominant	a	DT	B-NP	Odominant	negative	dominant	JJ	I-NP	Onegative	form	negative	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	GATA-3	factor	NN	I-NP	I-proteinGATA-3	in	GATA-3	NN	I-NP	B-proteinin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	can	cell	NNS	I-NP	I-cell_typecan	prevent	can	MD	B-VP	Oprevent	T	prevent	VB	I-VP	OT	helper	T	NN	B-NP	Ohelper	cell	helper	NN	I-NP	Ocell	type	cell	NN	I-NP	Otype	2	type	NN	I-NP	O2	(	2	CD	I-NP	O(	Th2	(	(	O	OTh2	)	Th2	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	allergic	#NAME?	JJ	B-NP	Oallergic	airway	allergic	JJ	I-NP	Oairway	inflammation	airway	NN	I-NP	Oinflammation	in	inflammation	NN	I-NP	Oin	mice	in	IN	B-PP	Omice	.	mouse	NNS	B-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	it	","	","	O	Oit	remains	it	PRP	B-NP	Oremains	unclear	remain	VBZ	B-VP	Ounclear	whether	unclear	JJ	B-ADJP	Owhether	GATA-3	whether	IN	B-SBAR	OGATA-3	plays	GATA-3	NN	B-NP	B-proteinplays	a	play	VBZ	B-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	effector	the	DT	B-NP	Oeffector	phase	effector	NN	I-NP	Ophase	of	phase	NN	I-NP	Oof	allergic	of	IN	B-PP	Oallergic	airway	allergic	JJ	B-NP	Oairway	inflammation	airway	NN	I-NP	Oinflammation	and	inflammation	NN	I-NP	Oand	whether	and	CC	B-PP	Owhether	antagonizing	whether	IN	B-SBAR	Oantagonizing	the	antagonize	VBG	B-VP	Othe	expression	the	DT	B-NP	Oexpression	and/or	expression	NN	I-NP	Oand/or	function	and/or	CC	I-NP	Ofunction	of	function	NN	I-NP	Oof	GATA-3	of	IN	B-PP	OGATA-3	can	GATA-3	NN	B-NP	B-proteincan	be	can	MD	B-VP	Obe	used	be	VB	I-VP	Oused	for	use	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	therapy	the	DT	B-NP	Otherapy	of	therapy	NN	I-NP	Oof	allergic	of	IN	B-PP	Oallergic	airway	allergic	JJ	B-NP	Oairway	inflammation	airway	NN	I-NP	Oinflammation	and	inflammation	NN	I-NP	Oand	hyperresponsiveness	and	CC	I-NP	Ohyperresponsiveness	.	hyperresponsiveness	NN	I-NP	O.	Here	.	.	O	OHere	","	Here	RB	B-ADVP	O","	we	","	","	O	Owe	analyzed	we	PRP	B-NP	Oanalyzed	the	analyze	VBD	B-VP	Othe	effects	the	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	locally	of	IN	B-PP	Olocally	antagonizing	locally	RB	B-VP	Oantagonizing	GATA-3	antagonize	VBG	I-VP	OGATA-3	function	GATA-3	NN	B-NP	B-proteinfunction	in	function	NN	I-NP	Oin	a	in	IN	B-PP	Oa	murine	a	DT	B-NP	Omurine	model	murine	JJ	I-NP	Omodel	of	model	NN	I-NP	Oof	asthma	of	IN	B-PP	Oasthma	.	asthma	NN	B-NP	O.	We	.	.	O	OWe	could	We	PRP	B-NP	Ocould	suppress	could	MD	B-VP	Osuppress	GATA-3	suppress	VB	I-VP	OGATA-3	expression	GATA-3	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	interleukin	in	IN	B-PP	Ointerleukin	(	interleukin	NN	B-NP	B-cell_type(	IL	(	(	O	I-cell_typeIL	)	IL	NN	B-NP	I-cell_type)	-4	)	)	O	I-cell_type-4	#NAME?	-4	CD	B-NP	I-cell_type#NAME?	T	#NAME?	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	vitro	in	FW	B-ADVP	Ovitro	and	vitro	FW	I-ADVP	Oand	in	and	CC	O	Oin	vivo	in	FW	B-ADVP	Ovivo	by	vivo	FW	I-ADVP	Oby	an	by	IN	B-PP	Oan	antisense	an	DT	B-NP	Oantisense	phosphorothioate	antisense	JJ	I-NP	Ophosphorothioate	oligonucleotide	phosphorothioate	NN	I-NP	Ooligonucleotide	overlapping	oligonucleotide	NN	I-NP	Ooverlapping	the	overlap	VBG	B-VP	Othe	translation	the	DT	B-NP	Otranslation	start	translation	NN	I-NP	B-DNAstart	site	start	NN	I-NP	I-DNAsite	of	site	NN	I-NP	I-DNAof	GATA-3	of	IN	B-PP	OGATA-3	","	GATA-3	NN	B-NP	B-protein","	whereas	","	","	O	Owhereas	nonsense	whereas	IN	O	Ononsense	control	nonsense	NN	B-NP	Ocontrol	oligonucleotides	control	NN	I-NP	Ooligonucleotides	were	oligonucleotide	NNS	I-NP	Owere	virtually	be	VBD	B-VP	Ovirtually	inactive	virtually	RB	B-ADJP	Oinactive	.	inactive	JJ	I-ADJP	O.	In	.	.	O	OIn	a	In	IN	B-PP	Oa	murine	a	DT	B-NP	Omurine	model	murine	JJ	I-NP	Omodel	of	model	NN	I-NP	Oof	asthma	of	IN	B-PP	Oasthma	associated	asthma	NN	B-NP	Oassociated	with	associate	VBN	B-VP	Owith	allergic	with	IN	B-PP	Oallergic	pulmonary	allergic	JJ	B-NP	Opulmonary	inflammation	pulmonary	JJ	I-NP	Oinflammation	and	inflammation	NN	I-NP	Oand	hyperresponsiveness	and	CC	I-NP	Ohyperresponsiveness	in	hyperresponsiveness	NN	I-NP	Oin	ovalbumin	in	IN	B-PP	Oovalbumin	(	ovalbumin	NN	B-NP	O(	OVA	(	(	O	OOVA	)	OVA	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	mice	#NAME?	JJ	B-NP	Omice	","	mouse	NNS	I-NP	O","	local	","	","	O	Olocal	intranasal	local	JJ	B-NP	Ointranasal	administration	intranasal	JJ	I-NP	Oadministration	of	administration	NN	I-NP	Oof	fluorescein	of	IN	B-PP	Ofluorescein	isothiocyanate-labeled	fluorescein	NN	B-NP	Oisothiocyanate-labeled	GATA-3	isothiocyanate-labeled	JJ	I-NP	OGATA-3	antisense	GATA-3	NN	I-NP	B-proteinantisense	oligonucleotides	antisense	JJ	I-NP	Ooligonucleotides	led	oligonucleotide	NNS	I-NP	Oled	to	lead	VBD	B-VP	Oto	DNA	to	TO	B-PP	ODNA	uptake	DNA	NN	B-NP	Ouptake	in	uptake	NN	I-NP	Oin	lung	in	IN	B-PP	Olung	cells	lung	NN	B-NP	B-cell_typecells	associated	cell	NNS	I-NP	I-cell_typeassociated	with	associate	VBN	B-VP	Owith	a	with	IN	B-PP	Oa	reduction	a	DT	B-NP	Oreduction	of	reduction	NN	I-NP	Oof	intracellular	of	IN	B-PP	Ointracellular	GATA-3	intracellular	JJ	B-NP	OGATA-3	expression	GATA-3	NN	I-NP	B-proteinexpression	.	expression	NN	I-NP	O.	Such	.	.	O	OSuch	intrapulmonary	Such	JJ	B-NP	Ointrapulmonary	blockade	intrapulmonary	JJ	I-NP	Oblockade	of	blockade	NN	I-NP	Oof	GATA-3	of	IN	B-PP	OGATA-3	expression	GATA-3	NN	B-NP	B-proteinexpression	caused	expression	NN	I-NP	Ocaused	an	cause	VBD	B-VP	Oan	abrogation	an	DT	B-NP	Oabrogation	of	abrogation	NN	I-NP	Oof	signs	of	IN	B-PP	Osigns	of	sign	NNS	B-NP	Oof	lung	of	IN	B-PP	Olung	inflammation	lung	NN	B-NP	Oinflammation	including	inflammation	NN	I-NP	Oincluding	infiltration	include	VBG	B-PP	Oinfiltration	of	infiltration	NN	B-NP	Oof	eosinophils	of	IN	B-PP	Oeosinophils	and	eosinophil	NNS	B-NP	B-cell_typeand	Th2	and	CC	O	OTh2	cytokine	Th2	NN	B-NP	B-proteincytokine	production	cytokine	NN	I-NP	I-proteinproduction	.	production	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	treatment	","	","	O	Otreatment	with	treatment	NN	B-NP	Owith	antisense	with	IN	B-PP	Oantisense	but	antisense	JJ	B-NP	Obut	not	but	CC	I-NP	Onot	nonsense	not	RB	I-ADJP	Ononsense	oligonucleotides	nonsense	JJ	B-NP	Ooligonucleotides	induced	oligonucleotide	NNS	I-NP	Oinduced	a	induce	VBD	B-VP	Oa	significant	a	DT	B-NP	Osignificant	reduction	significant	JJ	I-NP	Oreduction	of	reduction	NN	I-NP	Oof	airway	of	IN	B-PP	Oairway	hyperresponsiveness	airway	NN	B-NP	Ohyperresponsiveness	in	hyperresponsiveness	NN	I-NP	Oin	OVA-sensitized	in	IN	B-PP	OOVA-sensitized	mice	OVA-sensitized	JJ	B-NP	Omice	to	mouse	NNS	I-NP	Oto	levels	to	TO	B-PP	Olevels	comparable	level	NNS	B-NP	Ocomparable	to	comparable	JJ	B-ADJP	Oto	saline-treated	to	TO	B-PP	Osaline-treated	control	saline-treated	JJ	B-NP	Ocontrol	mice	control	NN	I-NP	Omice	","	mouse	NNS	I-NP	O","	as	","	","	O	Oas	assessed	as	IN	B-SBAR	Oassessed	by	assess	VBN	B-VP	Oby	both	by	IN	B-PP	Oboth	enhanced	both	CC	O	Oenhanced	pause	enhance	VBN	B-VP	Opause	(	pause	NN	B-NP	O(	PenH	(	(	O	OPenH	)	PenH	NN	B-NP	O)	responses	)	)	O	Oresponses	and	response	NNS	B-NP	Oand	pulmonary	and	CC	O	Opulmonary	resistance	pulmonary	JJ	B-NP	Oresistance	determined	resistance	NN	I-NP	Odetermined	by	determine	VBN	B-VP	Oby	body	by	IN	B-PP	Obody	plethysmography	body	NN	B-NP	Oplethysmography	.	plethysmography	NN	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	indicate	datum	NNS	I-NP	Oindicate	a	indicate	VBP	B-VP	Oa	critical	a	DT	B-NP	Ocritical	role	critical	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	GATA-3	for	IN	B-PP	OGATA-3	in	GATA-3	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	effector	the	DT	B-NP	Oeffector	phase	effector	NN	I-NP	Ophase	of	phase	NN	I-NP	Oof	a	of	IN	B-PP	Oa	murine	a	DT	B-NP	Omurine	asthma	murine	JJ	I-NP	B-cell_lineasthma	model	asthma	NN	I-NP	I-cell_linemodel	and	model	NN	I-NP	I-cell_lineand	suggest	and	CC	O	Osuggest	that	suggest	VBP	B-VP	Othat	local	that	IN	B-SBAR	Olocal	delivery	local	JJ	B-NP	Odelivery	of	delivery	NN	I-NP	Oof	GATA-3	of	IN	B-PP	OGATA-3	antisense	GATA-3	NN	B-NP	B-proteinantisense	oligonucleotides	antisense	JJ	I-NP	Ooligonucleotides	may	oligonucleotide	NNS	I-NP	Omay	be	may	MD	B-VP	Obe	a	be	VB	I-VP	Oa	novel	a	DT	B-NP	Onovel	approach	novel	JJ	I-NP	Oapproach	for	approach	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	of	treatment	NN	I-NP	Oof	airway	of	IN	B-PP	Oairway	hyperresponsiveness	airway	NN	B-NP	Ohyperresponsiveness	such	hyperresponsiveness	NN	I-NP	Osuch	as	such	JJ	B-PP	Oas	in	as	IN	I-PP	Oin	asthma	in	IN	B-PP	Oasthma	.	asthma	NN	B-NP	O.	This	.	.	O	OThis	approach	This	DT	B-NP	Oapproach	has	approach	NN	I-NP	Ohas	the	have	VBZ	B-VP	Othe	potential	the	DT	B-NP	Opotential	advantage	potential	JJ	I-NP	Oadvantage	of	advantage	NN	I-NP	Oof	suppressing	of	IN	B-PP	Osuppressing	the	suppress	VBG	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	various	of	IN	B-PP	Ovarious	proinflammatory	various	JJ	B-NP	Oproinflammatory	Th2	proinflammatory	JJ	I-NP	B-proteinTh2	cytokines	Th2	NN	I-NP	I-proteincytokines	simultaneously	cytokine	NNS	I-NP	I-proteinsimultaneously	rather	simultaneously	RB	B-ADVP	Orather	than	rather	RB	B-CONJP	Othan	suppressing	than	IN	I-CONJP	Osuppressing	the	suppress	VBG	B-VP	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	a	of	IN	B-PP	Oa	single	a	DT	B-NP	Osingle	cytokine	single	JJ	I-NP	Ocytokine	.	cytokine	NN	I-NP	B-protein.	T	.	.	O	OT	helper-cell	T	NN	B-NP	Ohelper-cell	phenotype	helper-cell	JJ	I-NP	Ophenotype	regulates	phenotype	NN	I-NP	Oregulates	atherosclerosis	regulate	VBZ	B-VP	Oatherosclerosis	in	atherosclerosis	NN	B-NP	Oin	mice	in	IN	B-PP	Omice	under	mouse	NNS	B-NP	Ounder	conditions	under	IN	B-PP	Oconditions	of	condition	NNS	B-NP	Oof	mild	of	IN	B-PP	Omild	hypercholesterolemia	mild	JJ	B-NP	Ohypercholesterolemia	.	hypercholesterolemia	NN	I-NP	O.	BACKGROUND	.	.	O	OBACKGROUND	:	BACKGROUND	NN	B-NP	O:	T	:	:	O	OT	cells	T	NN	B-NP	B-cell_typecells	are	cell	NNS	I-NP	I-cell_typeare	implicated	be	VBP	B-VP	Oimplicated	in	implicate	VBN	I-VP	Oin	atherosclerosis	in	IN	B-PP	Oatherosclerosis	","	atherosclerosis	NN	B-NP	O","	but	","	","	O	Obut	little	but	CC	O	Olittle	is	little	JJ	B-NP	Ois	known	be	VBZ	B-VP	Oknown	about	know	VBN	I-VP	Oabout	the	about	IN	B-PP	Othe	genetic	the	DT	B-NP	Ogenetic	control	genetic	JJ	I-NP	Ocontrol	or	control	NN	I-NP	Oor	molecular	or	CC	O	Omolecular	pathways	molecular	JJ	B-NP	Opathways	","	pathway	NNS	I-NP	O","	especially	","	","	O	Oespecially	under	especially	RB	B-ADVP	Ounder	conditions	under	IN	B-PP	Oconditions	of	condition	NNS	B-NP	Oof	mild	of	IN	B-PP	Omild	hypercholesterolemia	mild	JJ	B-NP	Ohypercholesterolemia	.	hypercholesterolemia	NN	I-NP	O.	METHODS	.	.	O	OMETHODS	AND	METHODS	NNS	B-NP	OAND	RESULTS	AND	CC	I-NP	ORESULTS	:	RESULTS	NNS	I-NP	O:	BALB/c	:	:	O	OBALB/c	mice	BALB/c	NN	B-NP	Omice	","	mouse	NNS	I-NP	O","	making	","	","	O	Omaking	a	make	VBG	B-VP	Oa	CD4+	a	DT	B-NP	OCD4+	Th2	CD4+	JJ	I-NP	B-cell_typeTh2	(	Th2	NN	I-NP	I-cell_type(	IL-4+	(	(	O	I-cell_typeIL-4+	)	IL-4+	JJ	O	I-cell_type)	cell	)	)	O	I-cell_typecell	response	cell	NN	B-NP	I-cell_typeresponse	","	response	NN	I-NP	O","	express	","	","	O	Oexpress	both	express	VBP	B-VP	Oboth	MHC	both	CC	O	OMHC	class	MHC	NN	B-NP	B-proteinclass	II	class	NN	I-NP	I-proteinII	antigens	II	CD	B-NP	I-proteinantigens	(	antigen	NNS	I-NP	I-protein(	IA	(	(	O	OIA	(	IA	NN	B-NP	O(	d	(	(	O	Od	)	d	NN	B-NP	O)	","	)	)	O	O","	IE	","	","	O	OIE	(	IE	NN	B-NP	B-protein(	d	(	(	O	I-proteind	)	d	NN	B-NP	I-protein)	)	)	)	O	I-protein)	and	)	)	O	Oand	are	and	CC	O	Oare	atherosclerosis-resistant	be	VBP	B-VP	Oatherosclerosis-resistant	.	atherosclerosis-resistant	JJ	B-ADJP	O.	C57Bl/6	.	.	O	OC57Bl/6	mice	C57Bl/6	NN	B-NP	Omice	produce	mouse	NNS	I-NP	Oproduce	a	produce	VBP	B-VP	Oa	CD4+	a	DT	B-NP	OCD4+	Th1	CD4+	JJ	I-NP	OTh1	(	Th1	NN	I-NP	O(	interferon	(	(	O	Ointerferon	[	interferon	NN	B-NP	B-protein[	IFN	[	(	O	OIFN	]	IFN	NN	B-NP	B-protein]	gamma+	]	)	O	Ogamma+	)	gamma+	NN	B-NP	O)	response	)	)	O	Oresponse	","	response	NN	B-NP	O","	express	","	","	O	Oexpress	IA	express	VBP	B-VP	OIA	(	IA	NN	B-NP	O(	b	(	(	O	Ob	)	b	NN	B-NP	O)	but	)	)	O	Obut	no	but	CC	O	Ono	IE	no	DT	B-NP	OIE	","	IE	NN	I-NP	O","	and	","	","	O	Oand	are	and	CC	O	Oare	atherosclerosis-prone	be	VBP	B-VP	Oatherosclerosis-prone	.	atherosclerosis-prone	JJ	B-ADJP	O.	To	.	.	O	OTo	evaluate	To	TO	B-VP	Oevaluate	T	evaluate	VB	I-VP	OT	helper-cell	T	NN	B-NP	Ohelper-cell	phenotype	helper-cell	JJ	I-NP	Ophenotype	in	phenotype	NN	I-NP	Oin	fatty	in	IN	B-PP	Ofatty	streak	fatty	JJ	B-NP	Ostreak	formation	streak	NN	I-NP	Oformation	","	formation	NN	I-NP	O","	wild-type	","	","	O	Owild-type	C57Bl/6	wild-type	JJ	B-NP	OC57Bl/6	mice	C57Bl/6	NN	I-NP	Omice	(	mouse	NNS	I-NP	O(	IA	(	(	O	OIA	(	IA	NN	B-NP	O(	b	(	(	O	Ob	)	b	NN	B-NP	O)	+IE-	)	)	O	O+IE-	)	+IE-	NN	B-NP	O)	and	)	)	O	Oand	transgenic	and	CC	O	Otransgenic	mice	transgenic	JJ	B-NP	Omice	","	mouse	NNS	I-NP	O","	either	","	","	O	Oeither	AB	either	CC	O	OAB	(	AB	NN	B-NP	O(	o	(	(	O	Oo	)	o	NN	B-NP	O)	","	)	)	O	O","	IA	","	","	O	OIA	(	IA	NN	B-NP	O(	b	(	(	O	Ob	)	b	NN	B-NP	O)	-IE-	)	)	O	O-IE-	;	-IE-	NN	B-NP	O;	ABEalpha	;	:	O	OABEalpha	","	ABEalpha	NN	B-NP	B-protein","	IA-IE	","	","	O	OIA-IE	(	IA-IE	NN	B-NP	B-protein(	k	(	(	O	Ok	)	k	NN	B-NP	O)	+	)	)	O	O+	;	+	SYM	B-NP	O;	or	;	:	O	Oor	BL	or	CC	O	OBL	:	BL	NN	B-NP	O:	TG	:	:	O	OTG	:	TG	NN	B-NP	B-protein:	Ealpha	:	:	O	I-proteinEalpha	","	Ealpha	NN	B-NP	I-protein","	IA	","	","	O	OIA	(	IA	NN	B-NP	O(	b	(	(	O	Ob	)	b	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	(	#NAME?	NN	B-NP	O(	k	(	(	O	Ok	)	k	NN	B-NP	O)	+	)	)	O	O+	","	+	SYM	B-NP	O","	were	","	","	O	Owere	fed	be	VBD	B-VP	Ofed	a	feed	VBN	I-VP	Oa	high-cholesterol	a	DT	B-NP	Ohigh-cholesterol	diet	high-cholesterol	JJ	I-NP	Odiet	for	diet	NN	I-NP	Ofor	16	for	IN	B-PP	O16	weeks	16	CD	B-NP	Oweeks	and	week	NNS	I-NP	Oand	evaluated	and	CC	O	Oevaluated	histomorphometrically	evaluate	VBN	B-VP	Ohistomorphometrically	for	histomorphometrically	RB	B-ADVP	Ofor	aortic	for	IN	B-PP	Oaortic	lesions	aortic	JJ	B-NP	Olesions	.	lesion	NNS	I-NP	O.	Lesion	.	.	O	OLesion	size	Lesion	NN	B-NP	Osize	in	size	NN	I-NP	Oin	AB	in	IN	B-PP	OAB	(	AB	NN	B-NP	O(	o	(	(	O	Oo	)	o	NN	B-NP	O)	","	)	)	O	O","	ABEalpha	","	","	O	OABEalpha	","	ABEalpha	NN	B-NP	B-protein","	and	","	","	O	Oand	BL	and	CC	O	OBL	:	BL	NN	B-NP	O:	TG	:	:	O	OTG	:	TG	NN	B-NP	O:	Ealpha	:	:	O	OEalpha	strains	Ealpha	NN	B-NP	Ostrains	was	strain	NNS	I-NP	Owas	decreased	be	VBD	B-VP	Odecreased	by	decrease	VBN	I-VP	Oby	54	by	IN	B-PP	O54	%	54	CD	B-NP	O%	","	%	NN	I-NP	O","	79	","	","	O	O79	%	79	CD	B-NP	O%	","	%	NN	I-NP	O","	and	","	","	O	Oand	82	and	CC	O	O82	%	82	CD	B-NP	O%	","	%	NN	I-NP	O","	respectively	","	","	O	Orespectively	","	respectively	RB	B-ADVP	O","	compared	","	","	O	Ocompared	with	compare	VBN	B-PP	Owith	wild-type	with	IN	B-PP	Owild-type	","	wild-type	JJ	B-ADJP	O","	correlating	","	","	O	Ocorrelating	with	correlate	VBG	B-VP	Owith	decreased	with	IN	B-PP	Odecreased	Th1	decrease	VBN	B-NP	OTh1	and	Th1	NN	I-NP	Oand	increased	and	CC	O	Oincreased	Th2	increase	VBD	B-VP	OTh2	expression	Th2	NN	B-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	suggesting	and	CC	O	Osuggesting	that	suggest	VBG	B-VP	Othat	T	that	IN	B-SBAR	OT	helper-cell	T	NN	B-NP	Ohelper-cell	phenotype	helper-cell	NN	I-NP	Ophenotype	is	phenotype	NN	I-NP	Ois	important	be	VBZ	B-VP	Oimportant	in	important	JJ	B-ADJP	Oin	fatty	in	IN	B-PP	Ofatty	lesion	fatty	JJ	B-NP	Olesion	development	lesion	NN	I-NP	Odevelopment	.	development	NN	I-NP	O.	Decreasing	.	.	O	ODecreasing	Th1	Decrease	VBG	B-VP	OTh1	cells	Th1	NN	B-NP	B-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	antibodies	by	IN	B-PP	Oantibodies	(	antibody	NNS	B-NP	B-protein(	alpha-CD4	(	(	O	Oalpha-CD4	)	alpha-CD4	NN	B-NP	B-protein)	or	)	)	O	Oor	cytokines	or	CC	O	Ocytokines	(	cytokine	NNS	B-NP	B-protein(	IL-4	(	(	O	OIL-4	)	IL-4	NN	B-NP	B-protein)	also	)	)	O	Oalso	caused	also	RB	B-ADVP	Ocaused	>	cause	VBD	B-VP	O>	/=80	>	SYM	B-NP	O/=80	%	/=80	CD	B-NP	O%	reductions	%	NN	I-NP	Oreductions	in	reduction	NNS	I-NP	Oin	lesion	in	IN	B-PP	Olesion	size	lesion	NN	B-NP	Osize	.	size	NN	I-NP	O.	Immunohistology	.	.	O	OImmunohistology	revealed	Immunohistology	NN	B-NP	Orevealed	IFN-gamma	reveal	VBD	B-VP	OIFN-gamma	","	IFN-gamma	NN	B-NP	B-protein","	but	","	","	O	Obut	not	but	CC	O	Onot	IL-4	not	RB	O	OIL-4	","	IL-4	NN	B-NP	B-protein","	colocalized	","	","	O	Ocolocalized	with	colocalize	VBD	B-VP	Owith	activated	with	IN	B-PP	Oactivated	macrophages	activate	VBN	B-NP	B-cell_typemacrophages	.	macrophage	NNS	I-NP	I-cell_type.	Confirming	.	.	O	OConfirming	these	Confirm	VBG	B-VP	Othese	findings	these	DT	B-NP	Ofindings	in	finding	NNS	I-NP	Oin	a	in	IN	B-PP	Oa	different	a	DT	B-NP	Odifferent	mouse	different	JJ	I-NP	Omouse	strain	mouse	NN	I-NP	Ostrain	","	strain	NN	I-NP	O","	BALB/c	","	","	O	OBALB/c	Stat	BALB/c	NN	B-NP	OStat	6	Stat	NN	I-NP	O6	knockout	6	CD	I-NP	Oknockout	mice	knockout	NN	I-NP	Omice	(	mouse	NNS	I-NP	O(	Th2	(	(	O	OTh2	cell-deficient	Th2	NN	B-NP	Ocell-deficient	)	cell-deficient	JJ	I-NP	O)	developed	)	)	O	Odeveloped	aortic	develop	VBD	B-VP	Oaortic	lesions	aortic	JJ	B-NP	Olesions	comparable	lesion	NNS	I-NP	Ocomparable	to	comparable	JJ	B-ADJP	Oto	C57Bl/6	to	TO	B-PP	OC57Bl/6	mice	C57Bl/6	NN	B-NP	Omice	on	mouse	NNS	I-NP	Oon	the	on	IN	B-PP	Othe	same	the	DT	B-NP	Osame	diet	same	JJ	I-NP	Odiet	.	diet	NN	I-NP	O.	CONCLUSIONS	.	.	O	OCONCLUSIONS	:	CONCLUSIONS	NNS	B-NP	O:	In	:	:	O	OIn	mildly	In	IN	B-PP	Omildly	hypercholesterolemic	mildly	RB	B-NP	Ohypercholesterolemic	C57Bl/6	hypercholesterolemic	JJ	I-NP	OC57Bl/6	mice	C57Bl/6	NN	I-NP	Omice	","	mouse	NNS	I-NP	O","	presence	","	","	O	Opresence	of	presence	NN	B-NP	Oof	IA	of	IN	B-PP	OIA	(	IA	NN	B-NP	O(	b	(	(	O	Ob	)	b	NN	B-NP	O)	and	)	)	O	Oand	absence	and	CC	O	Oabsence	of	absence	NN	B-NP	Oof	IE	of	IN	B-PP	OIE	regulated	IE	JJ	B-NP	Oregulated	CD4+	regulate	VBN	I-NP	OCD4+	T	CD4+	JJ	I-NP	OT	helper-cell	T	NN	I-NP	Ohelper-cell	phenotype	helper-cell	NN	I-NP	Ophenotype	;	phenotype	NN	I-NP	O;	fatty	;	:	O	Ofatty	lesions	fatty	JJ	B-NP	Olesions	were	lesion	NNS	I-NP	Owere	proportional	be	VBD	B-VP	Oproportional	to	proportional	JJ	B-ADJP	Oto	IFNgamma+	to	TO	B-PP	OIFNgamma+	Th1	IFNgamma+	JJ	B-NP	B-cell_lineTh1	cells	Th1	NN	I-NP	I-cell_linecells	in	cell	NNS	I-NP	I-cell_linein	both	in	IN	B-PP	Oboth	C57Bl/6	both	CC	O	OC57Bl/6	and	C57Bl/6	NN	B-NP	Oand	BALB/c	and	CC	I-NP	OBALB/c	strains	BALB/c	NN	I-NP	Ostrains	.	strain	NNS	I-NP	O.	IFN-gamma	.	.	O	OIFN-gamma	may	IFN-gamma	NN	B-NP	B-proteinmay	participate	may	MD	B-VP	Oparticipate	through	participate	VB	I-VP	Othrough	macrophage	through	IN	B-PP	Omacrophage	activation	macrophage	NN	B-NP	Oactivation	","	activation	NN	I-NP	O","	whereas	","	","	O	Owhereas	IL-4	whereas	IN	O	OIL-4	may	IL-4	NN	B-NP	B-proteinmay	act	may	MD	B-VP	Oact	to	act	VB	I-VP	Oto	limit	to	TO	I-VP	Olimit	Th1-cell	limit	VB	I-VP	OTh1-cell	response	Th1-cell	NN	B-NP	Oresponse	.	response	NN	I-NP	O.	Requirement	.	.	O	ORequirement	for	Requirement	NN	B-NP	Ofor	p38	for	IN	B-PP	Op38	and	p38	NN	B-NP	B-proteinand	p44/p42	and	CC	I-NP	Op44/p42	mitogen-activated	p44/p42	NN	I-NP	B-proteinmitogen-activated	protein	mitogen-activated	JJ	I-NP	I-proteinprotein	kinases	protein	NN	I-NP	I-proteinkinases	in	kinase	NNS	I-NP	I-proteinin	RAGE	in	IN	B-PP	ORAGE	#NAME?	RAGE	NN	B-NP	O#NAME?	nuclear	#NAME?	JJ	I-NP	Onuclear	factor-kappaB	nuclear	JJ	I-NP	B-proteinfactor-kappaB	transcriptional	factor-kappaB	NN	I-NP	I-proteintranscriptional	activation	transcriptional	JJ	I-NP	Oactivation	and	activation	NN	I-NP	Oand	cytokine	and	CC	O	Ocytokine	secretion	cytokine	NN	B-NP	B-proteinsecretion	.	secretion	NN	I-NP	O.	Advanced	.	.	O	OAdvanced	glycation	Advance	VBN	B-NP	Oglycation	end	glycation	NN	I-NP	B-proteinend	product	end	NN	I-NP	I-proteinproduct	(	product	NN	I-NP	I-protein(	AGE	(	(	O	OAGE	)	AGE	NN	B-NP	O)	activation	)	)	O	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	signal-transducing	the	DT	B-NP	Osignal-transducing	receptor	signal-transducing	JJ	I-NP	B-proteinreceptor	for	receptor	NN	I-NP	I-proteinfor	AGE	for	IN	B-PP	OAGE	(	AGE	NN	B-NP	O(	RAGE	(	(	O	ORAGE	)	RAGE	NN	B-NP	O)	has	)	)	O	Ohas	been	have	VBZ	B-VP	Obeen	linked	be	VBN	I-VP	Olinked	to	link	VBN	I-VP	Oto	a	to	TO	B-PP	Oa	proinflammatory	a	DT	B-NP	Oproinflammatory	phenotypic	proinflammatory	JJ	I-NP	Ophenotypic	change	phenotypic	JJ	I-NP	Ochange	within	change	NN	I-NP	Owithin	cells	within	IN	B-PP	Ocells	.	cell	NNS	B-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	the	","	","	O	Othe	precise	the	DT	B-NP	Oprecise	intracellular	precise	JJ	I-NP	Ointracellular	signaling	intracellular	JJ	I-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	involved	pathway	NNS	I-NP	Oinvolved	have	involve	VBN	B-VP	Ohave	not	have	VBP	B-VP	Onot	been	not	RB	I-VP	Obeen	elucidated	be	VBN	I-VP	Oelucidated	.	elucidate	VBN	I-VP	O.	We	.	.	O	OWe	demonstrate	We	PRP	B-NP	Odemonstrate	here	demonstrate	VBP	B-VP	Ohere	that	here	RB	B-ADVP	Othat	human	that	IN	B-SBAR	Ohuman	serum	human	JJ	B-NP	B-proteinserum	albumin	serum	NN	I-NP	I-proteinalbumin	modified	albumin	NN	I-NP	I-proteinmodified	with	modify	VBN	B-VP	Owith	N	with	IN	B-PP	ON	(	N	NN	B-NP	O(	varepsilon	(	(	O	Ovarepsilon	)	varepsilon	NN	B-NP	O)	-	)	)	O	O-	(	-	HYPH	O	O(	carboxymethyl	(	(	O	Ocarboxymethyl	)	carboxymethyl	NN	B-NP	O)	lysine	)	)	O	Olysine	(	lysine	NN	B-NP	O(	CML	(	(	O	OCML	)	CML	NN	B-NP	O)	","	)	)	O	O","	a	","	","	O	Oa	major	a	DT	B-NP	Omajor	AGE	major	JJ	I-NP	OAGE	adduct	AGE	NN	I-NP	Oadduct	that	adduct	NN	I-NP	Othat	progressively	that	WDT	B-NP	Oprogressively	accumulates	progressively	RB	B-ADVP	Oaccumulates	with	accumulate	VBZ	B-VP	Owith	aging	with	IN	B-PP	Oaging	","	aging	NN	B-NP	O","	diabetes	","	","	O	Odiabetes	","	diabetes	NN	B-NP	O","	and	","	","	O	Oand	renal	and	CC	O	Orenal	failure	renal	JJ	B-NP	Ofailure	","	failure	NN	I-NP	O","	induced	","	","	O	Oinduced	nuclear	induce	VBD	B-VP	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	NF	(	(	O	I-proteinNF	)	NF	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	#NAME?	#NAME?	NN	B-NP	I-protein#NAME?	reporter	#NAME?	JJ	I-NP	Oreporter	gene	reporter	NN	I-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	in	expression	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	monocytic	human	JJ	B-NP	B-cell_linemonocytic	THP-1	monocytic	JJ	I-NP	I-cell_lineTHP-1	cells	THP-1	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	The	.	.	O	OThe	NF-kappaB	The	DT	B-NP	ONF-kappaB	response	NF-kappaB	NN	I-NP	B-proteinresponse	was	response	NN	I-NP	Owas	blocked	be	VBD	B-VP	Oblocked	with	block	VBN	I-VP	Owith	a	with	IN	B-PP	Oa	synthetic	a	DT	B-NP	Osynthetic	peptide	synthetic	JJ	I-NP	Opeptide	corresponding	peptide	NN	I-NP	Ocorresponding	to	correspond	VBG	B-VP	Oto	the	to	TO	B-PP	Othe	putative	the	DT	B-NP	Oputative	ligand-binding	putative	JJ	I-NP	B-proteinligand-binding	domain	ligand-binding	JJ	I-NP	I-proteindomain	of	domain	NN	I-NP	I-proteinof	RAGE	of	IN	B-PP	ORAGE	","	RAGE	NN	B-NP	B-protein","	with	","	","	O	Owith	anti-	with	IN	B-PP	Oanti-	RAGE	anti-	JJ	B-NP	ORAGE	antiserum	RAGE	NN	I-NP	Oantiserum	","	antiserum	NN	I-NP	O","	and	","	","	O	Oand	by	and	CC	O	Oby	coexpression	by	IN	B-PP	Ocoexpression	of	coexpression	NN	B-NP	Oof	truncated	of	IN	B-PP	Otruncated	receptors	truncate	VBN	B-NP	B-proteinreceptors	lacking	receptor	NNS	I-NP	I-proteinlacking	the	lack	VBG	B-VP	Othe	intracellular	the	DT	B-NP	Ointracellular	domain	intracellular	JJ	I-NP	B-proteindomain	.	domain	NN	I-NP	I-protein.	Signal	.	.	O	OSignal	transduction	Signal	NN	B-NP	Otransduction	from	transduction	NN	I-NP	Ofrom	RAGE	from	IN	B-PP	ORAGE	to	RAGE	NN	B-NP	Oto	NF-kappaB	to	TO	B-PP	ONF-kappaB	involved	NF-kappaB	NN	B-NP	B-proteininvolved	the	involve	VBD	B-VP	Othe	generation	the	DT	B-NP	Ogeneration	of	generation	NN	I-NP	Oof	reactive	of	IN	B-PP	Oreactive	oxygen	reactive	JJ	B-NP	Ooxygen	species	oxygen	NN	I-NP	Ospecies	","	specie	NNS	I-NP	O","	since	","	","	O	Osince	reporter	since	IN	B-SBAR	Oreporter	gene	reporter	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	was	expression	NN	I-NP	Owas	blocked	be	VBD	B-VP	Oblocked	with	block	VBN	I-VP	Owith	the	with	IN	B-PP	Othe	antioxidant	the	DT	B-NP	Oantioxidant	N-acetyl-L-cysteine	antioxidant	JJ	I-NP	ON-acetyl-L-cysteine	.	N-acetyl-L-cysteine	NN	I-NP	O.	CML-modified	.	.	O	OCML-modified	albumin	CML-modified	JJ	B-NP	Oalbumin	produced	albumin	NN	I-NP	Oproduced	rapid	produce	VBD	B-VP	Orapid	transient	rapid	JJ	B-NP	Otransient	activation	transient	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	tyrosine	of	IN	B-PP	Otyrosine	phosphorylation	tyrosine	NN	B-NP	Ophosphorylation	","	phosphorylation	NN	I-NP	O","	extracellular	","	","	O	Oextracellular	signal-regulated	extracellular	JJ	B-NP	B-proteinsignal-regulated	kinase	signal-regulated	JJ	I-NP	I-proteinkinase	1	kinase	NN	I-NP	I-protein1	and	1	CD	I-NP	I-proteinand	2	and	CC	I-NP	I-protein2	","	2	CD	I-NP	I-protein","	and	","	","	O	Oand	p38	and	CC	O	Op38	mitogen-activated	p38	NN	B-NP	B-proteinmitogen-activated	protein	mitogen-activated	JJ	I-NP	I-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	MAPK	(	(	O	OMAPK	)	MAPK	NN	B-NP	B-protein)	","	)	)	O	O","	but	","	","	O	Obut	not	but	CC	O	Onot	c-Jun	not	RB	O	Oc-Jun	NH	c-Jun	NN	B-NP	B-proteinNH	(	NH	NN	I-NP	I-protein(	2	(	(	O	I-protein2	)	2	CD	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	kinase	#NAME?	JJ	B-NP	I-proteinkinase	.	kinase	NN	I-NP	I-protein.	RAGE	.	.	O	ORAGE	#NAME?	RAGE	NN	B-NP	O#NAME?	NF-kappaB	#NAME?	JJ	I-NP	ONF-kappaB	activation	NF-kappaB	NN	I-NP	B-proteinactivation	was	activation	NN	I-NP	Owas	suppressed	be	VBD	B-VP	Osuppressed	by	suppress	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	selective	the	DT	B-NP	Oselective	p38	selective	JJ	I-NP	Op38	MAPK	p38	NN	I-NP	B-proteinMAPK	inhibitor	MAPK	NN	I-NP	I-proteininhibitor	SB203580	inhibitor	NN	I-NP	OSB203580	and	SB203580	NN	I-NP	Oand	by	and	CC	B-PP	Oby	coexpression	by	IN	B-PP	Ocoexpression	of	coexpression	NN	B-NP	Oof	a	of	IN	B-PP	Oa	kinase-dead	a	DT	B-NP	Okinase-dead	p38	kinase-dead	JJ	I-NP	B-proteinp38	dominant-negative	p38	NN	I-NP	I-proteindominant-negative	mutant	dominant-negative	JJ	I-NP	I-proteinmutant	.	mutant	NN	I-NP	I-protein.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	by	NF-kappaB	NN	B-NP	B-proteinby	CML-modified	by	IN	B-PP	OCML-modified	albumin	CML-modified	JJ	B-NP	B-proteinalbumin	increased	albumin	NN	I-NP	I-proteinincreased	secretion	increase	VBD	B-VP	Osecretion	of	secretion	NN	B-NP	Oof	proinflammatory	of	IN	B-PP	Oproinflammatory	cytokines	proinflammatory	JJ	B-NP	B-proteincytokines	(	cytokine	NNS	I-NP	I-protein(	tumor	(	(	O	Otumor	necrosis	tumor	NN	B-NP	B-proteinnecrosis	factor-alpha	necrosis	NN	I-NP	I-proteinfactor-alpha	","	factor-alpha	NN	I-NP	I-protein","	interleukin-1beta	","	","	O	Ointerleukin-1beta	","	interleukin-1beta	NN	B-NP	B-protein","	and	","	","	O	Oand	monocyte	and	CC	O	Omonocyte	chemoattractant	monocyte	NN	B-NP	B-proteinchemoattractant	protein-1	chemoattractant	NN	I-NP	I-proteinprotein-1	)	protein-1	NN	I-NP	I-protein)	severalfold	)	)	O	Oseveralfold	","	severalfold	RB	B-ADVP	O","	and	","	","	O	Oand	inhibition	and	CC	O	Oinhibition	of	inhibition	NN	B-NP	Oof	p38	of	IN	B-PP	Op38	MAPK	p38	NN	B-NP	B-proteinMAPK	blocked	MAPK	NN	I-NP	I-proteinblocked	these	block	VBD	B-VP	Othese	increases	these	DT	B-NP	Oincreases	.	increase	NNS	I-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	p38	that	IN	B-SBAR	Op38	MAPK	p38	NN	B-NP	B-proteinMAPK	activation	MAPK	NN	I-NP	I-proteinactivation	mediates	activation	NN	I-NP	Omediates	RAGE	mediate	VBZ	B-VP	ORAGE	#NAME?	RAGE	NN	B-NP	O#NAME?	NF-kappaB	#NAME?	JJ	I-NP	ONF-kappaB	#NAME?	NF-kappaB	NN	I-NP	B-protein#NAME?	secretion	#NAME?	JJ	I-NP	Osecretion	of	secretion	NN	I-NP	Oof	proinflammatory	of	IN	B-PP	Oproinflammatory	cytokines	proinflammatory	JJ	B-NP	B-proteincytokines	and	cytokine	NNS	I-NP	I-proteinand	suggest	and	CC	O	Osuggest	that	suggest	VBP	B-VP	Othat	accelerated	that	IN	B-SBAR	Oaccelerated	inflammation	accelerate	VBN	B-NP	Oinflammation	may	inflammation	NN	I-NP	Omay	be	may	MD	B-VP	Obe	a	be	VB	I-VP	Oa	consequence	a	DT	B-NP	Oconsequence	of	consequence	NN	I-NP	Oof	cellular	of	IN	B-PP	Ocellular	activation	cellular	JJ	B-NP	Oactivation	induced	activation	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	this	by	IN	B-PP	Othis	receptor	this	DT	B-NP	Oreceptor	.	receptor	NN	I-NP	O.	Antigen-receptor	.	.	O	OAntigen-receptor	cross-linking	Antigen-receptor	JJ	B-NP	Ocross-linking	and	cross-linking	NN	I-NP	Oand	lipopolysaccharide	and	CC	I-NP	Olipopolysaccharide	trigger	lipopolysaccharide	NN	I-NP	Otrigger	distinct	trigger	NN	I-NP	Odistinct	phosphoinositide	distinct	JJ	I-NP	Ophosphoinositide	3-kinase	phosphoinositide	NN	I-NP	B-protein3-kinase	#NAME?	3-kinase	NN	I-NP	I-protein#NAME?	pathways	#NAME?	JJ	I-NP	Opathways	to	pathway	NNS	I-NP	Oto	NF-kappa	to	TO	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	in	activation	NN	I-NP	Oin	primary	in	IN	B-PP	Oprimary	B	primary	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	NF-kappaB/Rel	The	DT	B-NP	ONF-kappaB/Rel	transcription	NF-kappaB/Rel	NN	I-NP	B-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	play	factor	NNS	I-NP	I-proteinplay	an	play	VBP	B-VP	Oan	important	an	DT	B-NP	Oimportant	role	important	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	genes	of	IN	B-PP	Ogenes	involved	gene	NNS	B-NP	B-DNAinvolved	in	involve	VBN	B-VP	Oin	B	in	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	","	development	NN	I-NP	O","	differentiation	","	","	O	Odifferentiation	and	differentiation	NN	B-NP	Oand	function	and	CC	O	Ofunction	.	function	NN	B-NP	O.	Nuclear	.	.	O	ONuclear	NF-kappaB	Nuclear	JJ	B-NP	B-proteinNF-kappaB	is	NF-kappaB	NN	I-NP	I-proteinis	induced	be	VBZ	B-VP	Oinduced	in	induce	VBN	I-VP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	engagement	by	IN	B-PP	Oengagement	of	engagement	NN	B-NP	Oof	either	of	IN	B-PP	Oeither	the	either	CC	O	Othe	BCR	the	DT	B-NP	OBCR	or	BCR	NN	I-NP	B-proteinor	CD40	or	CC	I-NP	OCD40	or	CD40	NN	I-NP	B-proteinor	by	or	CC	B-PP	Oby	stimulation	by	IN	B-PP	Ostimulation	with	stimulation	NN	B-NP	Owith	lipopolysaccharide	with	IN	B-PP	Olipopolysaccharide	(	lipopolysaccharide	NN	B-NP	O(	LPS	(	(	O	OLPS	)	LPS	NN	B-NP	O)	.	)	)	O	O.	Despite	.	.	O	ODespite	the	Despite	IN	B-PP	Othe	importance	the	DT	B-NP	Oimportance	of	importance	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	to	NF-kappaB	NN	B-NP	B-proteinto	B	to	TO	B-PP	OB	cell	B	NN	B-NP	Ocell	function	cell	NN	I-NP	Ofunction	","	function	NN	I-NP	O","	little	","	","	O	Olittle	is	little	JJ	B-NP	Ois	known	be	VBZ	B-VP	Oknown	about	know	VBN	I-VP	Oabout	the	about	IN	B-PP	Othe	signaling	the	DT	B-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	leading	pathway	NNS	I-NP	Oleading	to	lead	VBG	B-VP	Oto	NF-kappaB	to	TO	B-PP	ONF-kappaB	activation	NF-kappaB	NN	B-NP	B-proteinactivation	.	activation	NN	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	report	this	DT	B-NP	Oreport	we	report	NN	I-NP	Owe	address	we	PRP	B-NP	Oaddress	the	address	VBP	B-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	phosphoinositide	of	IN	B-PP	Ophosphoinositide	3'-kinase	phosphoinositide	NN	B-NP	B-protein3'-kinase	(	3'-kinase	NN	I-NP	I-protein(	PI	(	(	O	OPI	3-kinase	PI	NN	B-NP	B-protein3-kinase	)	3-kinase	NN	I-NP	I-protein)	in	)	)	O	Oin	BCR	in	IN	B-PP	OBCR	-	BCR	NN	B-NP	B-protein-	and	-	HYPH	B-NP	Oand	LPS-induced	and	CC	I-NP	OLPS-induced	NF-kappaB	LPS-induced	JJ	I-NP	ONF-kappaB	activation	NF-kappaB	NN	I-NP	B-proteinactivation	using	activation	NN	I-NP	Ousing	populations	use	VBG	B-VP	Opopulations	of	population	NNS	B-NP	Oof	primary	of	IN	B-PP	Oprimary	murine	primary	JJ	B-NP	B-cell_typemurine	resting	murine	JJ	I-NP	I-cell_typeresting	B	rest	VBG	I-NP	I-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Using	.	.	O	OUsing	the	Use	VBG	B-VP	Othe	specific	the	DT	B-NP	Ospecific	pharmacological	specific	JJ	I-NP	Opharmacological	inhibitors	pharmacological	JJ	I-NP	Oinhibitors	of	inhibitor	NNS	I-NP	Oof	PI	of	IN	B-PP	OPI	3-kinase	PI	NN	B-NP	B-protein3-kinase	","	3-kinase	NN	I-NP	I-protein","	Wortmannin	","	","	O	OWortmannin	and	Wortmannin	NN	B-NP	Oand	LY294002	and	CC	I-NP	OLY294002	","	LY294002	NN	I-NP	O","	we	","	","	O	Owe	demonstrate	we	PRP	B-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	PI	that	IN	B-SBAR	OPI	3-kinase	PI	NN	B-NP	B-protein3-kinase	activity	3-kinase	NN	I-NP	I-proteinactivity	is	activity	NN	I-NP	Ois	vital	be	VBZ	B-VP	Ovital	for	vital	JJ	B-ADJP	Ofor	BCR	for	IN	B-PP	OBCR	#NAME?	BCR	NN	B-NP	B-protein#NAME?	NF-kappaB	#NAME?	JJ	I-NP	ONF-kappaB	DNA-binding	NF-kappaB	NN	I-NP	B-proteinDNA-binding	activity	DNA-binding	JJ	I-NP	Oactivity	.	activity	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	we	","	","	O	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	this	that	IN	B-SBAR	Othis	is	this	DT	B-NP	Ois	achieved	be	VBZ	B-VP	Oachieved	via	achieve	VBN	I-VP	Ovia	protein	via	IN	B-PP	Oprotein	kinase	protein	NN	B-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	#NAME?	C	NN	I-NP	I-protein#NAME?	degradation	#NAME?	JJ	I-NP	Odegradation	of	degradation	NN	I-NP	Oof	IkappaBalpha	of	IN	B-PP	OIkappaBalpha	.	IkappaBalpha	NN	B-NP	B-protein.	Similar	.	.	O	OSimilar	analyses	Similar	JJ	B-NP	Oanalyses	reveal	analysis	NNS	I-NP	Oreveal	that	reveal	VBP	B-VP	Othat	PI	that	IN	B-SBAR	OPI	3-kinase	PI	NN	B-NP	B-protein3-kinase	is	3-kinase	NN	I-NP	I-proteinis	also	be	VBZ	B-VP	Oalso	critical	also	RB	B-ADVP	Ocritical	in	critical	JJ	B-ADJP	Oin	triggering	in	IN	B-PP	Otriggering	NF-kappaB	trigger	VBG	B-VP	ONF-kappaB	DNA-binding	NF-kappaB	NN	B-NP	B-proteinDNA-binding	activity	DNA-binding	JJ	I-NP	Oactivity	and	activity	NN	I-NP	Oand	IkappaBalpha	and	CC	I-NP	OIkappaBalpha	degradation	IkappaBalpha	NN	I-NP	B-proteindegradation	following	degradation	NN	I-NP	Ofollowing	LPS	follow	VBG	B-PP	OLPS	stimulation	LPS	NN	B-NP	Ostimulation	.	stimulation	NN	I-NP	O.	Interestingly	.	.	O	OInterestingly	","	Interestingly	RB	B-ADVP	O","	a	","	","	O	Oa	PKC	a	DT	B-NP	OPKC	inhibitor	PKC	NN	I-NP	B-proteininhibitor	which	inhibitor	NN	I-NP	Owhich	blocked	which	WDT	B-NP	Oblocked	the	block	VBD	B-VP	Othe	BCR	the	DT	B-NP	OBCR	#NAME?	BCR	NN	I-NP	B-protein#NAME?	IkappaBalpha	#NAME?	JJ	I-NP	OIkappaBalpha	degradation	IkappaBalpha	NN	I-NP	B-proteindegradation	had	degradation	NN	I-NP	Ohad	no	have	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	on	effect	NN	I-NP	Oon	the	on	IN	B-PP	Othe	degradation	the	DT	B-NP	Odegradation	of	degradation	NN	I-NP	Oof	IkappaBalpha	of	IN	B-PP	OIkappaBalpha	after	IkappaBalpha	NN	B-NP	B-proteinafter	LPS	after	IN	B-PP	OLPS	stimulation	LPS	NN	B-NP	Ostimulation	.	stimulation	NN	I-NP	O.	Taken	.	.	O	OTaken	together	Take	VBN	B-VP	Otogether	","	together	RB	B-ADVP	O","	our	","	","	O	Oour	results	our	PRP$	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	the	indicate	VBP	B-VP	Othe	involvement	the	DT	B-NP	Oinvolvement	of	involvement	NN	I-NP	Oof	PI	of	IN	B-PP	OPI	3-kinase	PI	NN	B-NP	B-protein3-kinase	in	3-kinase	NN	I-NP	I-proteinin	at	in	IN	B-PP	Oat	least	at	IN	B-NP	Oleast	two	least	JJS	I-NP	Otwo	distinct	two	CD	I-NP	Odistinct	signaling	distinct	JJ	I-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	leading	pathway	NNS	I-NP	Oleading	to	lead	VBG	B-VP	Oto	activation	to	TO	B-PP	Oactivation	of	activation	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	in	NF-kappaB	NN	B-NP	B-proteinin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Tetramer-guided	.	.	O	OTetramer-guided	epitope	Tetramer-guided	JJ	B-NP	Oepitope	mapping	epitope	NN	I-NP	Omapping	:	mapping	NN	I-NP	O:	rapid	:	:	O	Orapid	identification	rapid	JJ	B-NP	Oidentification	and	identification	NN	I-NP	Oand	characterization	and	CC	I-NP	Ocharacterization	of	characterization	NN	I-NP	Oof	immunodominant	of	IN	B-PP	Oimmunodominant	CD4+	immunodominant	JJ	B-NP	B-proteinCD4+	T	CD4+	JJ	I-NP	I-proteinT	cell	T	NN	I-NP	I-proteincell	epitopes	cell	NN	I-NP	I-proteinepitopes	from	epitope	NNS	I-NP	I-proteinfrom	complex	from	IN	B-PP	Ocomplex	antigens	complex	NN	B-NP	B-proteinantigens	.	antigen	NNS	I-NP	I-protein.	T	.	.	O	OT	cell	T	NN	B-NP	Ocell	responses	cell	NN	I-NP	Oresponses	to	response	NNS	I-NP	Oto	Ags	to	TO	B-PP	OAgs	involve	Ag	NNS	B-NP	B-proteininvolve	recognition	involve	VB	B-VP	Orecognition	of	recognition	NN	B-NP	Oof	selected	of	IN	B-PP	Oselected	peptide	select	VBN	B-NP	Opeptide	epitopes	peptide	NN	I-NP	B-proteinepitopes	contained	epitope	NNS	I-NP	I-proteincontained	within	contain	VBD	B-VP	Owithin	the	within	IN	B-PP	Othe	antigenic	the	DT	B-NP	Oantigenic	protein	antigenic	JJ	I-NP	B-proteinprotein	.	protein	NN	I-NP	I-protein.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	report	this	DT	B-NP	Oreport	","	report	NN	I-NP	O","	we	","	","	O	Owe	describe	we	PRP	B-NP	Odescribe	a	describe	VBP	B-VP	Oa	new	a	DT	B-NP	Onew	approach	new	JJ	I-NP	Oapproach	for	approach	NN	I-NP	Ofor	direct	for	IN	B-PP	Odirect	identification	direct	JJ	B-NP	Oidentification	of	identification	NN	I-NP	Oof	CD4+	of	IN	B-PP	OCD4+	T	CD4+	JJ	B-NP	B-proteinT	cell	T	NN	I-NP	I-proteincell	epitopes	cell	NN	I-NP	I-proteinepitopes	of	epitope	NNS	I-NP	I-proteinof	complex	of	IN	B-PP	Ocomplex	Ags	complex	JJ	B-NP	OAgs	that	Ag	NNS	I-NP	B-proteinthat	uses	that	WDT	B-NP	Ouses	human	use	VBZ	B-VP	Ohuman	class	human	JJ	B-NP	B-proteinclass	II	class	NN	I-NP	I-proteinII	tetramers	II	CD	B-NP	I-proteintetramers	to	tetramer	NNS	I-NP	I-proteinto	identify	to	TO	B-VP	Oidentify	reactive	identify	VB	I-VP	Oreactive	cells	reactive	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	With	.	.	O	OWith	a	With	IN	B-PP	Oa	panel	a	DT	B-NP	Opanel	of	panel	NN	I-NP	Oof	60	of	IN	B-PP	O60	overlapping	60	CD	B-NP	Ooverlapping	peptides	overlap	VBG	I-NP	Opeptides	covering	peptide	NNS	I-NP	Ocovering	the	cover	VBG	B-VP	Othe	entire	the	DT	B-NP	Oentire	sequence	entire	JJ	I-NP	Osequence	of	sequence	NN	I-NP	Oof	the	of	IN	B-PP	Othe	VP16	the	DT	B-NP	OVP16	protein	VP16	NN	I-NP	B-proteinprotein	","	protein	NN	I-NP	I-protein","	a	","	","	O	Oa	major	a	DT	B-NP	Omajor	Ag	major	JJ	I-NP	OAg	for	Ag	NN	I-NP	B-proteinfor	HSV-2	for	IN	B-PP	OHSV-2	","	HSV-2	NN	B-NP	O","	we	","	","	O	Owe	generated	we	PRP	B-NP	Ogenerated	a	generate	VBD	B-VP	Oa	panel	a	DT	B-NP	Opanel	of	panel	NN	I-NP	Oof	class	of	IN	B-PP	Oclass	II	class	NN	B-NP	B-proteinII	MHC	II	CD	I-NP	I-proteinMHC	tetramers	MHC	NN	I-NP	I-proteintetramers	loaded	tetramer	NNS	I-NP	I-proteinloaded	with	load	VBN	B-VP	Owith	peptide	with	IN	B-PP	Opeptide	pools	peptide	NN	B-NP	Opools	that	pool	NNS	I-NP	Othat	were	that	WDT	B-NP	Owere	used	be	VBD	B-VP	Oused	to	use	VBN	I-VP	Oto	stain	to	TO	B-VP	Ostain	peripheral	stain	VB	I-VP	Operipheral	lymphocytes	peripheral	JJ	B-NP	B-cell_typelymphocytes	of	lymphocyte	NNS	I-NP	I-cell_typeof	an	of	IN	B-PP	Oan	HSV-2	an	DT	B-NP	OHSV-2	infected	HSV-2	NN	I-NP	Oinfected	individual	infected	JJ	I-NP	Oindividual	.	individual	NN	I-NP	O.	With	.	.	O	OWith	this	With	IN	B-PP	Othis	approach	this	DT	B-NP	Oapproach	","	approach	NN	I-NP	O","	we	","	","	O	Owe	identified	we	PRP	B-NP	Oidentified	four	identify	VBD	B-VP	Ofour	new	four	CD	B-NP	Onew	DRA1*0101/DRB1*0401-	new	JJ	I-NP	ODRA1*0101/DRB1*0401-	and	DRA1*0101/DRB1*0401-	NN	I-NP	Oand	two	and	CC	O	Otwo	DRA1*0101/DRB1*0404-restricted	two	CD	B-NP	ODRA1*0101/DRB1*0404-restricted	","	DRA1*0101/DRB1*0404-restricted	JJ	I-NP	O","	VP16-specific	","	","	I-NP	OVP16-specific	epitopes	VP16-specific	JJ	I-NP	B-proteinepitopes	.	epitope	NNS	I-NP	I-protein.	By	.	.	O	OBy	using	By	IN	B-PP	Ousing	tetramers	use	VBG	B-VP	Otetramers	to	tetramer	NNS	B-NP	Oto	sort	to	TO	B-VP	Osort	individual	sort	VB	I-VP	Oindividual	cells	individual	JJ	B-NP	Ocells	","	cell	NNS	I-NP	O","	we	","	","	O	Owe	easily	we	PRP	B-NP	Oeasily	obtained	easily	RB	B-ADVP	Oobtained	a	obtain	VBD	B-VP	Oa	large	a	DT	B-NP	Olarge	number	large	JJ	I-NP	Onumber	of	number	NN	I-NP	Oof	clones	of	IN	B-PP	Oclones	specific	clone	NNS	B-NP	Ospecific	to	specific	JJ	B-ADJP	Oto	these	to	TO	B-PP	Othese	epitopes	these	DT	B-NP	Oepitopes	.	epitope	NNS	I-NP	B-protein.	Although	.	.	O	OAlthough	DRA1*0101/DRB1*0401	Although	IN	B-SBAR	ODRA1*0101/DRB1*0401	and	DRA1*0101/DRB1*0401	NN	B-NP	Oand	DRA1*0101/DRB1*0404	and	CC	I-NP	ODRA1*0101/DRB1*0404	are	DRA1*0101/DRB1*0404	NN	I-NP	Oare	structurally	be	VBP	B-VP	Ostructurally	very	structurally	RB	B-NP	Overy	similar	very	RB	I-NP	Osimilar	","	similar	JJ	I-NP	O","	nonoverlapping	","	","	I-NP	Ononoverlapping	VP16	nonoverlapping	JJ	I-NP	B-proteinVP16	epitopes	VP16	NN	I-NP	I-proteinepitopes	were	epitope	NNS	I-NP	I-proteinwere	identified	be	VBD	B-VP	Oidentified	","	identify	VBN	I-VP	O","	illustrating	","	","	O	Oillustrating	high	illustrate	VBG	B-VP	Ohigh	selectivity	high	JJ	B-NP	Oselectivity	of	selectivity	NN	I-NP	Oof	individual	of	IN	B-PP	Oindividual	allele	individual	JJ	B-NP	Oallele	polymorphisms	allele	NN	I-NP	B-DNApolymorphisms	within	polymorphism	NNS	I-NP	I-DNAwithin	common	within	IN	B-PP	Ocommon	MHC	common	JJ	B-NP	OMHC	variants	MHC	NN	I-NP	Ovariants	.	variant	NNS	I-NP	O.	This	.	.	O	OThis	rapid	This	DT	B-NP	Orapid	approach	rapid	JJ	I-NP	Oapproach	to	approach	NN	I-NP	Oto	detecting	to	TO	B-PP	Odetecting	CD4+	detect	VBG	B-VP	OCD4+	T	CD4+	JJ	B-NP	B-proteinT	cell	T	NN	I-NP	I-proteincell	epitopes	cell	NN	I-NP	I-proteinepitopes	from	epitope	NNS	I-NP	I-proteinfrom	complex	from	IN	B-PP	Ocomplex	Ags	complex	JJ	B-NP	OAgs	can	Ag	NNS	I-NP	B-proteincan	be	can	MD	B-VP	Obe	applied	be	VB	I-VP	Oapplied	to	apply	VBN	I-VP	Oto	any	to	TO	B-PP	Oany	known	any	DT	B-NP	Oknown	Ag	know	VBN	I-NP	OAg	that	Ag	NN	I-NP	B-proteinthat	gives	that	WDT	B-NP	Ogives	a	give	VBZ	B-VP	Oa	T	a	DT	B-NP	OT	cell	T	NN	I-NP	Ocell	response	cell	NN	I-NP	Oresponse	.	response	NN	I-NP	O.	Localized	.	.	O	OLocalized	pancreatic	Localize	VBN	B-NP	Opancreatic	NF-kappaB	pancreatic	JJ	I-NP	ONF-kappaB	activation	NF-kappaB	NN	I-NP	B-proteinactivation	and	activation	NN	I-NP	Oand	inflammatory	and	CC	O	Oinflammatory	response	inflammatory	JJ	B-NP	Oresponse	in	response	NN	I-NP	Oin	taurocholate-induced	in	IN	B-PP	Otaurocholate-induced	pancreatitis	taurocholate-induced	JJ	B-NP	Opancreatitis	.	pancreatitis	NN	I-NP	O.	Transcription	.	.	O	OTranscription	factor	Transcription	NN	B-NP	B-proteinfactor	nuclear	factor	NN	I-NP	I-proteinnuclear	factor-kappaB	nuclear	JJ	I-NP	B-proteinfactor-kappaB	(	factor-kappaB	NN	I-NP	I-protein(	NF-kappaB	(	(	O	ONF-kappaB	)	NF-kappaB	NN	B-NP	B-protein)	is	)	)	O	Ois	activated	be	VBZ	B-VP	Oactivated	in	activate	VBN	I-VP	Oin	cerulein	in	IN	B-PP	Ocerulein	pancreatitis	cerulein	NN	B-NP	Opancreatitis	and	pancreatitis	NN	I-NP	Oand	mediates	and	CC	O	Omediates	cytokine	mediate	VBZ	B-VP	Ocytokine	expression	cytokine	NN	B-NP	B-proteinexpression	.	expression	NN	I-NP	O.	The	.	.	O	OThe	role	The	DT	B-NP	Orole	of	role	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	factor	transcription	NN	B-NP	B-proteinfactor	activation	factor	NN	I-NP	I-proteinactivation	in	activation	NN	I-NP	Oin	other	in	IN	B-PP	Oother	models	other	JJ	B-NP	Omodels	of	model	NNS	I-NP	Oof	pancreatitis	of	IN	B-PP	Opancreatitis	has	pancreatitis	NN	B-NP	Ohas	not	have	VBZ	B-VP	Onot	been	not	RB	I-VP	Obeen	established	be	VBN	I-VP	Oestablished	.	establish	VBN	I-VP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	report	we	PRP	B-NP	Oreport	upregulation	report	VBP	B-VP	Oupregulation	of	upregulation	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	and	NF-kappaB	NN	B-NP	B-proteinand	inflammatory	and	CC	O	Oinflammatory	molecules	inflammatory	JJ	B-NP	B-proteinmolecules	","	molecule	NNS	I-NP	I-protein","	and	","	","	O	Oand	their	and	CC	O	Otheir	correlation	their	PRP$	B-NP	Ocorrelation	with	correlation	NN	I-NP	Owith	local	with	IN	B-PP	Olocal	pancreatic	local	JJ	B-NP	Opancreatic	injury	pancreatic	JJ	I-NP	Oinjury	","	injury	NN	I-NP	O","	in	","	","	O	Oin	a	in	IN	B-PP	Oa	model	a	DT	B-NP	Omodel	of	model	NN	I-NP	Oof	severe	of	IN	B-PP	Osevere	pancreatitis	severe	JJ	B-NP	Opancreatitis	.	pancreatitis	NN	I-NP	O.	Rats	.	.	O	ORats	received	Rat	NNS	B-NP	Oreceived	intraductal	receive	VBD	B-VP	Ointraductal	infusion	intraductal	JJ	B-NP	Oinfusion	of	infusion	NN	I-NP	Oof	taurocholate	of	IN	B-PP	Otaurocholate	or	taurocholate	NN	B-NP	Oor	saline	or	CC	I-NP	Osaline	","	saline	NN	I-NP	O","	and	","	","	O	Oand	the	and	CC	O	Othe	pancreatic	the	DT	B-NP	Opancreatic	head	pancreatic	JJ	I-NP	Ohead	and	head	NN	I-NP	Oand	tail	and	CC	I-NP	Otail	were	tail	NN	I-NP	Owere	analyzed	be	VBD	B-VP	Oanalyzed	separately	analyze	VBN	I-VP	Oseparately	.	separately	RB	B-ADVP	O.	NF-kappaB	.	.	O	ONF-kappaB	and	NF-kappaB	NN	B-NP	B-proteinand	activator	and	CC	I-NP	Oactivator	protein-1	activator	NN	I-NP	B-proteinprotein-1	(	protein-1	NN	I-NP	I-protein(	AP-1	(	(	O	OAP-1	)	AP-1	NN	B-NP	B-protein)	activation	)	)	O	Oactivation	were	activation	NN	B-NP	Owere	assessed	be	VBD	B-VP	Oassessed	by	assess	VBN	I-VP	Oby	gel	by	IN	B-PP	Ogel	shift	gel	NN	B-NP	Oshift	assay	shift	NN	I-NP	Oassay	","	assay	NN	I-NP	O","	and	","	","	O	Oand	mRNA	and	CC	O	OmRNA	expression	mRNA	NN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	interleukin-6	of	IN	B-PP	Ointerleukin-6	","	interleukin-6	NN	B-NP	B-protein","	tumor	","	","	O	Otumor	necrosis	tumor	NN	B-NP	B-proteinnecrosis	factor-alpha	necrosis	NN	I-NP	I-proteinfactor-alpha	","	factor-alpha	NN	I-NP	I-protein","	KC	","	","	O	OKC	","	KC	NN	B-NP	O","	monocyte	","	","	O	Omonocyte	chemoattractant	monocyte	NN	B-NP	B-proteinchemoattractant	protein-1	chemoattractant	NN	I-NP	I-proteinprotein-1	","	protein-1	NN	I-NP	I-protein","	and	","	","	O	Oand	inducible	and	CC	O	Oinducible	nitric	inducible	JJ	B-NP	Onitric	oxide	nitric	JJ	I-NP	B-proteinoxide	synthase	oxide	NN	I-NP	I-proteinsynthase	was	synthase	NN	I-NP	I-proteinwas	assessed	be	VBD	B-VP	Oassessed	by	assess	VBN	I-VP	Oby	semiquantitative	by	IN	B-PP	Osemiquantitative	RT-PCR	semiquantitative	JJ	B-NP	ORT-PCR	.	RT-PCR	NN	I-NP	O.	Morphological	.	.	O	OMorphological	damage	Morphological	JJ	B-NP	Odamage	and	damage	NN	I-NP	Oand	trypsin	and	CC	I-NP	Otrypsin	activation	trypsin	NN	I-NP	B-proteinactivation	were	activation	NN	I-NP	Owere	much	be	VBD	B-VP	Omuch	greater	much	RB	B-ADJP	Ogreater	in	great	JJR	I-ADJP	Oin	the	in	IN	B-PP	Othe	pancreatic	the	DT	B-NP	Opancreatic	head	pancreatic	JJ	I-NP	Ohead	than	head	NN	I-NP	Othan	tail	than	IN	B-PP	Otail	","	tail	NN	B-NP	O","	in	","	","	O	Oin	parallel	in	IN	B-PP	Oparallel	with	parallel	NN	B-NP	Owith	a	with	IN	B-PP	Oa	stronger	a	DT	B-NP	Ostronger	activation	strong	JJR	I-NP	Oactivation	of	activation	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	and	NF-kappaB	NN	B-NP	B-proteinand	cytokine	and	CC	O	Ocytokine	mRNA	cytokine	NN	B-NP	B-RNAmRNA	.	mRNA	NN	B-NP	I-RNA.	Saline	.	.	O	OSaline	infusion	Saline	NN	B-NP	Oinfusion	mildly	infusion	NN	I-NP	Omildly	affected	mildly	RB	B-VP	Oaffected	these	affect	VBD	I-VP	Othese	parameters	these	DT	B-NP	Oparameters	.	parameter	NNS	I-NP	O.	AP-1	.	.	O	OAP-1	was	AP-1	NN	B-NP	B-proteinwas	strongly	be	VBD	B-VP	Ostrongly	activated	strongly	RB	I-VP	Oactivated	in	activate	VBN	I-VP	Oin	both	in	IN	B-PP	Oboth	pancreatic	both	DT	B-NP	Opancreatic	segments	pancreatic	JJ	I-NP	Osegments	after	segment	NNS	I-NP	Oafter	either	after	IN	B-PP	Oeither	taurocholate	either	CC	O	Otaurocholate	or	taurocholate	NN	B-NP	Oor	saline	or	CC	O	Osaline	infusion	saline	NN	B-NP	Oinfusion	.	infusion	NN	I-NP	O.	NF-kappaB	.	.	O	ONF-kappaB	inhibition	NF-kappaB	NN	B-NP	B-proteininhibition	with	inhibition	NN	I-NP	Owith	N-acetylcysteine	with	IN	B-PP	ON-acetylcysteine	ameliorated	N-acetylcysteine	NN	B-NP	Oameliorated	the	ameliorate	VBD	B-VP	Othe	local	the	DT	B-NP	Olocal	inflammatory	local	JJ	I-NP	Oinflammatory	response	inflammatory	JJ	I-NP	Oresponse	.	response	NN	I-NP	O.	Correlation	.	.	O	OCorrelation	between	Correlation	NN	B-NP	Obetween	localized	between	IN	B-PP	Olocalized	NF-kappaB	localized	JJ	B-NP	ONF-kappaB	activation	NF-kappaB	NN	I-NP	B-proteinactivation	","	activation	NN	I-NP	O","	cytokine	","	","	O	Ocytokine	upregulation	cytokine	NN	B-NP	B-proteinupregulation	","	upregulation	NN	I-NP	O","	and	","	","	O	Oand	tissue	and	CC	O	Otissue	damage	tissue	NN	B-NP	Odamage	suggests	damage	NN	I-NP	Osuggests	a	suggest	VBZ	B-VP	Oa	key	a	DT	B-NP	Okey	role	key	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	NF-kappaB	for	IN	B-PP	ONF-kappaB	in	NF-kappaB	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	the	of	IN	B-PP	Othe	inflammatory	the	DT	B-NP	Oinflammatory	response	inflammatory	JJ	I-NP	Oresponse	of	response	NN	I-NP	Oof	acute	of	IN	B-PP	Oacute	pancreatitis	acute	JJ	B-NP	Opancreatitis	.	pancreatitis	NN	I-NP	O.	CD45	.	.	O	OCD45	tyrosine	CD45	NN	B-NP	B-proteintyrosine	phosphatase	tyrosine	NN	I-NP	I-proteinphosphatase	controls	phosphatase	NN	I-NP	I-proteincontrols	common	control	VBZ	B-VP	Ocommon	gamma-chain	common	JJ	B-NP	B-proteingamma-chain	cytokine	gamma-chain	NN	I-NP	I-proteincytokine	#NAME?	cytokine	NN	I-NP	I-protein#NAME?	STAT	#NAME?	JJ	I-NP	OSTAT	and	STAT	NN	I-NP	B-proteinand	extracellular	and	CC	O	Oextracellular	signal-related	extracellular	JJ	B-NP	Osignal-related	kinase	signal-related	JJ	I-NP	Okinase	phosphorylation	kinase	NN	I-NP	Ophosphorylation	in	phosphorylation	NN	I-NP	Oin	activated	in	IN	B-PP	Oactivated	human	activate	VBN	B-NP	Ohuman	lymphoblasts	human	JJ	I-NP	B-cell_typelymphoblasts	:	lymphoblast	NNS	I-NP	I-cell_type:	inhibition	:	:	O	Oinhibition	of	inhibition	NN	B-NP	Oof	proliferation	of	IN	B-PP	Oproliferation	without	proliferation	NN	B-NP	Owithout	induction	without	IN	B-PP	Oinduction	of	induction	NN	B-NP	Oof	apoptosis	of	IN	B-PP	Oapoptosis	.	apoptosis	NN	B-NP	O.	The	.	.	O	OThe	objective	The	DT	B-NP	Oobjective	of	objective	NN	I-NP	Oof	this	of	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	was	study	NN	I-NP	Owas	to	be	VBD	B-VP	Oto	test	to	TO	B-VP	Otest	whether	test	VB	I-VP	Owhether	CD45	whether	IN	B-SBAR	OCD45	signals	CD45	NN	B-NP	B-proteinsignals	can	signal	NNS	I-NP	Ocan	influence	can	MD	B-VP	Oinfluence	signaling	influence	VB	I-VP	Osignaling	processes	signaling	NN	B-NP	Oprocesses	in	process	NNS	I-NP	Oin	activated	in	IN	B-PP	Oactivated	human	activate	VBN	B-NP	B-cell_typehuman	lymphoblasts	human	JJ	I-NP	I-cell_typelymphoblasts	.	lymphoblast	NNS	I-NP	I-cell_type.	To	.	.	O	OTo	this	To	TO	B-PP	Othis	end	this	DT	B-NP	Oend	","	end	NN	I-NP	O","	we	","	","	O	Owe	generated	we	PRP	B-NP	Ogenerated	lymphoblasts	generate	VBD	B-VP	Olymphoblasts	which	lymphoblast	NNS	B-NP	B-cell_typewhich	proliferate	which	WDT	B-NP	Oproliferate	in	proliferate	VBP	B-VP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	common	to	TO	B-PP	Ocommon	gamma-chain	common	JJ	B-NP	B-proteingamma-chain	cytokines	gamma-chain	NN	I-NP	I-proteincytokines	","	cytokine	NNS	I-NP	I-protein","	but	","	","	O	Obut	readily	but	CC	O	Oreadily	undergo	readily	RB	B-VP	Oundergo	apoptosis	undergo	VBP	I-VP	Oapoptosis	after	apoptosis	NN	B-NP	Oafter	cytokine	after	IN	B-PP	Ocytokine	withdrawal	cytokine	NN	B-NP	B-proteinwithdrawal	.	withdrawal	NN	I-NP	O.	In	.	.	O	OIn	experiments	In	IN	B-PP	Oexperiments	with	experiment	NNS	B-NP	Owith	the	with	IN	B-PP	Othe	CD45R0	the	DT	B-NP	OCD45R0	mAb	CD45R0	NN	I-NP	B-proteinmAb	UCHL-1	mAb	NN	I-NP	I-proteinUCHL-1	","	UCHL-1	NN	I-NP	O","	but	","	","	O	Obut	not	but	CC	O	Onot	control	not	RB	O	Ocontrol	CD45	control	VB	B-VP	OCD45	mAbs	CD45	NN	B-NP	B-proteinmAbs	","	mAb	NNS	I-NP	I-protein","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	significant	find	VBD	B-VP	Osignificant	inhibition	significant	JJ	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	proliferation	of	IN	B-PP	Oproliferation	.	proliferation	NN	B-NP	O.	Interestingly	.	.	O	OInterestingly	","	Interestingly	RB	B-ADVP	O","	the	","	","	O	Othe	pan-CD45	the	DT	B-NP	Opan-CD45	mAb	pan-CD45	NN	I-NP	OmAb	GAP8.3	mAb	NN	I-NP	OGAP8.3	","	GAP8.3	NN	I-NP	O","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	most	be	VBZ	B-VP	Omost	effective	most	RBS	B-ADJP	Oeffective	in	effective	JJ	I-ADJP	Oin	inhibition	in	IN	B-PP	Oinhibition	of	inhibition	NN	B-NP	Oof	OKT-3-mediated	of	IN	B-PP	OOKT-3-mediated	proliferation	OKT-3-mediated	JJ	B-NP	Oproliferation	in	proliferation	NN	I-NP	Oin	quiescent	in	IN	B-PP	Oquiescent	lymphocytes	quiescent	JJ	B-NP	B-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	was	","	","	O	Owas	ineffective	be	VBD	B-VP	Oineffective	in	ineffective	JJ	B-ADJP	Oin	lymphoblasts	in	IN	B-PP	Olymphoblasts	.	lymphoblast	NNS	B-NP	B-cell_type.	Addition	.	.	O	OAddition	of	Addition	NN	B-NP	Oof	CD3	of	IN	B-PP	OCD3	mAb	CD3	NN	B-NP	B-proteinmAb	OKT-3	mAb	NN	I-NP	OOKT-3	had	OKT-3	NN	I-NP	B-proteinhad	no	have	VBD	B-VP	Ono	influence	no	DT	B-NP	Oinfluence	on	influence	NN	I-NP	Oon	IL-2-mediated	on	IN	B-PP	OIL-2-mediated	proliferation	IL-2-mediated	JJ	B-NP	Oproliferation	(	proliferation	NN	I-NP	O(	with	(	(	O	Owith	or	with	IN	B-PP	Oor	without	or	CC	I-PP	Owithout	UCHL-1	without	IN	I-PP	OUCHL-1	)	UCHL-1	NN	B-NP	B-protein)	.	)	)	O	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	after	","	","	O	Oafter	addition	after	IN	B-PP	Oaddition	of	addition	NN	B-NP	Oof	OKT-3	of	IN	B-PP	OOKT-3	to	OKT-3	NN	B-NP	B-proteinto	IL-4	to	TO	B-PP	OIL-4	-	IL-4	NN	B-NP	B-protein-	and	-	HYPH	O	Oand	IL-7	and	CC	O	OIL-7	#NAME?	IL-7	NN	B-NP	B-protein#NAME?	proliferation	#NAME?	JJ	I-NP	Oproliferation	assays	proliferation	NN	I-NP	Oassays	","	assay	NNS	I-NP	O","	UCHL-1	","	","	O	OUCHL-1	signals	UCHL-1	NN	B-NP	B-proteinsignals	could	signal	NNS	I-NP	Ocould	not	could	MD	B-VP	Onot	significantly	not	RB	I-VP	Osignificantly	alter	significantly	RB	I-VP	Oalter	cellular	alter	VB	I-VP	Ocellular	proliferation	cellular	JJ	B-NP	Oproliferation	.	proliferation	NN	I-NP	O.	We	.	.	O	OWe	did	We	PRP	B-NP	Odid	not	do	VBD	B-VP	Onot	find	not	RB	I-VP	Ofind	induction	find	VB	I-VP	Oinduction	of	induction	NN	B-NP	Oof	apoptosis	of	IN	B-PP	Oapoptosis	following	apoptosis	NN	B-NP	Ofollowing	CD45R0	follow	VBG	B-PP	OCD45R0	signaling	CD45R0	NN	B-NP	B-proteinsignaling	.	signaling	NN	I-NP	O.	In	.	.	O	OIn	Western	In	IN	B-PP	OWestern	blots	Western	JJ	B-NP	Oblots	using	blot	NNS	I-NP	Ousing	mAbs	use	VBG	B-VP	OmAbs	detecting	mAb	NNS	B-NP	B-proteindetecting	phosphorylated	detect	VBG	B-VP	Ophosphorylated	STAT-3	phosphorylate	VBN	B-NP	OSTAT-3	","	STAT-3	NN	I-NP	B-protein","	STAT-5	","	","	O	OSTAT-5	","	STAT-5	NN	B-NP	B-protein","	STAT-6	","	","	O	OSTAT-6	","	STAT-6	NN	B-NP	B-protein","	or	","	","	O	Oor	extracellular	or	CC	O	Oextracellular	signal-related	extracellular	JJ	B-NP	B-proteinsignal-related	kinase	signal-related	JJ	I-NP	I-proteinkinase	2-Jan	kinase	NN	I-NP	I-protein2-Jan	","	2-Jan	CD	I-NP	I-protein","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	CD45R0	that	IN	B-SBAR	OCD45R0	signaling	CD45R0	NN	B-NP	B-proteinsignaling	could	signaling	NN	I-NP	Ocould	effectively	could	MD	B-VP	Oeffectively	diminish	effectively	RB	I-VP	Odiminish	phosphorylation	diminish	VB	I-VP	Ophosphorylation	of	phosphorylation	NN	B-NP	Oof	these	of	IN	B-PP	Othese	intracellular	these	DT	B-NP	Ointracellular	signaling	intracellular	JJ	I-NP	Osignaling	components	signaling	NN	I-NP	Ocomponents	.	component	NNS	I-NP	O.	Using	.	.	O	OUsing	RT-PCR	Use	VBG	B-VP	ORT-PCR	","	RT-PCR	NN	B-NP	O","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	CD45R0	that	IN	B-SBAR	OCD45R0	signaling	CD45R0	NN	B-NP	B-proteinsignaling	inhibited	signaling	NN	I-NP	Oinhibited	IL-2	inhibit	VBD	B-VP	OIL-2	mRNA	IL-2	NN	B-NP	B-RNAmRNA	production	mRNA	NN	I-NP	I-RNAproduction	without	production	NN	I-NP	Owithout	major	without	IN	B-PP	Omajor	influence	major	JJ	B-NP	Oinfluence	on	influence	NN	I-NP	Oon	IL-13	on	IN	B-PP	OIL-13	","	IL-13	NN	B-NP	B-protein","	IL-5	","	","	O	OIL-5	","	IL-5	NN	B-NP	B-protein","	or	","	","	O	Oor	IFN-gamma	or	CC	O	OIFN-gamma	mRNA	IFN-gamma	NN	B-NP	B-RNAmRNA	levels	mRNA	NN	I-NP	I-RNAlevels	.	level	NNS	I-NP	O.	Costimulation	.	.	O	OCostimulation	with	Costimulation	NN	B-NP	Owith	OKT-3	with	IN	B-PP	OOKT-3	and	OKT-3	NN	B-NP	B-proteinand	IL-2	and	CC	I-NP	OIL-2	optimally	IL-2	NN	I-NP	B-proteinoptimally	induced	optimally	RB	B-ADVP	Oinduced	secretion	induce	VBD	B-VP	Osecretion	of	secretion	NN	B-NP	Oof	IFN-gamma	of	IN	B-PP	OIFN-gamma	","	IFN-gamma	NN	B-NP	B-protein","	TNF-alpha	","	","	O	OTNF-alpha	","	TNF-alpha	NN	B-NP	B-protein","	and	","	","	O	Oand	IL-5	and	CC	O	OIL-5	","	IL-5	NN	B-NP	B-protein","	which	","	","	O	Owhich	was	which	WDT	B-NP	Owas	not	be	VBD	B-VP	Onot	decreased	not	RB	I-VP	Odecreased	by	decrease	VBN	I-VP	Oby	CD45	by	IN	B-PP	OCD45	signals	CD45	NN	B-NP	B-proteinsignals	.	signal	NNS	I-NP	O.	In	.	.	O	OIn	conclusion	In	IN	B-PP	Oconclusion	","	conclusion	NN	B-NP	O","	we	","	","	O	Owe	illustrate	we	PRP	B-NP	Oillustrate	that	illustrate	VBP	B-VP	Othat	CD45R0	that	IN	B-SBAR	OCD45R0	signals	CD45R0	NN	B-NP	B-proteinsignals	control	signal	NNS	I-NP	Ocontrol	early	control	VBP	B-VP	Oearly	cytokine	early	JJ	B-NP	Ocytokine	receptor-associated	cytokine	NN	I-NP	Oreceptor-associated	signaling	receptor-associated	JJ	I-NP	Osignaling	processes	signaling	NN	I-NP	Oprocesses	and	process	NNS	I-NP	Oand	mRNA	and	CC	O	OmRNA	and	mRNA	NN	B-NP	Oand	DNA	and	CC	I-NP	ODNA	synthesis	DNA	NN	I-NP	Osynthesis	in	synthesis	NN	I-NP	Oin	activated	in	IN	B-PP	Oactivated	human	activate	VBN	B-NP	B-cell_typehuman	lymphoblasts	human	JJ	I-NP	I-cell_typelymphoblasts	.	lymphoblast	NNS	I-NP	I-cell_type.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	we	","	","	O	Owe	show	we	PRP	B-NP	Oshow	the	show	VBP	B-VP	Othe	existence	the	DT	B-NP	Oexistence	of	existence	NN	I-NP	Oof	CD45	of	IN	B-PP	OCD45	epitopes	CD45	NN	B-NP	B-proteinepitopes	(	epitope	NNS	I-NP	I-protein(	GAP8.3	(	(	O	OGAP8.3	)	GAP8.3	NN	B-NP	B-protein)	","	)	)	O	O","	which	","	","	O	Owhich	are	which	WDT	B-NP	Oare	active	be	VBP	B-VP	Oactive	and	active	JJ	B-ADJP	Oand	critical	and	CC	I-ADJP	Ocritical	for	critical	JJ	I-ADJP	Ofor	signaling	for	IN	B-PP	Osignaling	in	signaling	NN	B-NP	Oin	quiescent	in	IN	B-PP	Oquiescent	lymphocytes	quiescent	JJ	B-NP	B-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	but	","	","	O	Obut	are	but	CC	O	Oare	nonfunctional	be	VBP	B-VP	Ononfunctional	in	nonfunctional	JJ	B-ADJP	Oin	activated	in	IN	B-PP	Oactivated	human	activate	VBN	B-NP	B-cell_typehuman	lymphoblasts	human	JJ	I-NP	I-cell_typelymphoblasts	.	lymphoblast	NNS	I-NP	I-cell_type.	Pax5	.	.	O	OPax5	determines	Pax5	NN	B-NP	B-proteindetermines	the	determine	VBZ	B-VP	Othe	identity	the	DT	B-NP	Oidentity	of	identity	NN	I-NP	Oof	B	of	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	the	from	IN	B-PP	Othe	beginning	the	DT	B-NP	Obeginning	to	beginning	NN	I-NP	Oto	the	to	TO	B-PP	Othe	end	the	DT	B-NP	Oend	of	end	NN	I-NP	Oof	B-lymphopoiesis	of	IN	B-PP	OB-lymphopoiesis	.	B-lymphopoiesis	NN	B-NP	O.	Despite	.	.	O	ODespite	being	Despite	IN	B-PP	Obeing	one	be	VBG	B-VP	Oone	of	one	CD	B-NP	Oof	the	of	IN	B-PP	Othe	most	the	DT	B-NP	Omost	intensively	most	RBS	I-NP	Ointensively	studied	intensively	RB	I-NP	Ostudied	cell	study	VBN	I-NP	Ocell	types	cell	NN	I-NP	Otypes	","	type	NNS	I-NP	O","	the	","	","	O	Othe	molecular	the	DT	B-NP	Omolecular	basis	molecular	JJ	I-NP	Obasis	of	basis	NN	I-NP	Oof	B	of	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	specification	cell	NN	I-NP	Ospecification	is	specification	NN	I-NP	Ois	largely	be	VBZ	B-VP	Olargely	unknown	largely	RB	B-ADJP	Ounknown	.	unknown	JJ	I-ADJP	O.	The	.	.	O	OThe	Pax5	The	DT	B-NP	OPax5	gene	Pax5	NN	I-NP	B-DNAgene	encoding	gene	NN	I-NP	I-DNAencoding	the	encode	VBG	B-VP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	BSAP	factor	NN	I-NP	I-proteinBSAP	is	BSAP	NN	I-NP	B-proteinis	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	progression	for	IN	B-PP	Oprogression	of	progression	NN	B-NP	Oof	B-lymphopoiesis	of	IN	B-PP	OB-lymphopoiesis	beyond	B-lymphopoiesis	NN	B-NP	Obeyond	the	beyond	IN	B-PP	Othe	pro-B	the	DT	B-NP	Opro-B	cell	pro-B	JJ	I-NP	Ocell	stage	cell	NN	I-NP	Ostage	.	stage	NN	I-NP	O.	Pax5-deficient	.	.	O	OPax5-deficient	pro-B	Pax5-deficient	JJ	B-NP	B-cell_typepro-B	cells	pro-B	JJ	I-NP	I-cell_typecells	are	cell	NNS	I-NP	I-cell_typeare	","	be	VBP	B-VP	O","	however	","	","	O	Ohowever	","	however	RB	B-ADVP	O","	not	","	","	O	Onot	yet	not	RB	B-VP	Oyet	committed	yet	RB	I-VP	Ocommitted	to	commit	VBN	I-VP	Oto	the	to	TO	B-PP	Othe	B-lymphoid	the	DT	B-NP	OB-lymphoid	lineage	B-lymphoid	JJ	I-NP	B-cell_typelineage	","	lineage	NN	I-NP	I-cell_type","	but	","	","	O	Obut	instead	but	CC	O	Oinstead	have	instead	RB	B-ADVP	Ohave	a	have	VBP	B-VP	Oa	broad	a	DT	B-NP	Obroad	lymphomyeloid	broad	JJ	I-NP	Olymphomyeloid	developmental	lymphomyeloid	JJ	I-NP	Odevelopmental	potential	developmental	JJ	I-NP	Opotential	.	potential	NN	I-NP	O.	Pax5	.	.	O	OPax5	appears	Pax5	NN	B-NP	B-proteinappears	to	appear	VBZ	B-VP	Oto	mediate	to	TO	I-VP	Omediate	B-lineage	mediate	VB	I-VP	OB-lineage	commitment	B-lineage	NN	B-NP	Ocommitment	by	commitment	NN	I-NP	Oby	repressing	by	IN	B-PP	Orepressing	the	repress	VBG	B-VP	Othe	transcription	the	DT	B-NP	Otranscription	of	transcription	NN	I-NP	Oof	non-B-lymphoid	of	IN	B-PP	Onon-B-lymphoid	genes	non-B-lymphoid	JJ	B-NP	B-DNAgenes	and	gene	NNS	I-NP	I-DNAand	by	and	CC	B-PP	Oby	simultaneously	by	IN	B-PP	Osimultaneously	activating	simultaneously	RB	B-VP	Oactivating	the	activate	VBG	I-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	B-lineage-specific	of	IN	B-PP	OB-lineage-specific	genes	B-lineage-specific	JJ	B-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Pax5	.	.	O	OPax5	thus	Pax5	NN	B-NP	B-proteinthus	functions	thus	RB	B-ADVP	Ofunctions	both	function	VBZ	B-VP	Oboth	as	both	DT	B-PP	Oas	a	as	IN	I-PP	Oa	transcriptional	a	DT	B-NP	Otranscriptional	repressor	transcriptional	JJ	I-NP	B-proteinrepressor	and	repressor	NN	I-NP	I-proteinand	activator	and	CC	I-NP	Oactivator	","	activator	NN	I-NP	O","	depending	","	","	O	Odepending	on	depend	VBG	B-PP	Oon	its	on	IN	B-PP	Oits	interactions	its	PRP$	B-NP	Ointeractions	with	interaction	NNS	I-NP	Owith	corepressors	with	IN	B-PP	Ocorepressors	of	corepressor	NNS	B-NP	B-proteinof	the	of	IN	B-PP	Othe	Groucho	the	DT	B-NP	OGroucho	protein	Groucho	NNP	I-NP	B-proteinprotein	family	protein	NN	I-NP	I-proteinfamily	or	family	NN	I-NP	I-proteinor	with	or	CC	B-PP	Owith	positive	with	IN	B-PP	Opositive	regulators	positive	JJ	B-NP	B-proteinregulators	such	regulator	NNS	I-NP	I-proteinsuch	as	such	JJ	B-PP	Oas	the	as	IN	I-PP	Othe	TATA-binding	the	DT	B-NP	OTATA-binding	protein	TATA-binding	JJ	I-NP	B-proteinprotein	.	protein	NN	I-NP	I-protein.	Once	.	.	O	OOnce	committed	Once	RB	O	Ocommitted	to	commit	VBN	B-ADJP	Oto	the	to	TO	B-PP	Othe	B-lineage	the	DT	B-NP	OB-lineage	","	B-lineage	NN	I-NP	O","	B	","	","	O	OB	cells	B	NN	B-NP	B-cell_typecells	require	cell	NNS	I-NP	I-cell_typerequire	Pax5	require	VBP	B-VP	OPax5	function	Pax5	NN	B-NP	B-proteinfunction	to	function	NN	I-NP	Oto	maintain	to	TO	B-VP	Omaintain	their	maintain	VB	I-VP	Otheir	B-lymphoid	their	PRP$	B-NP	OB-lymphoid	identity	B-lymphoid	JJ	I-NP	Oidentity	throughout	identity	NN	I-NP	Othroughout	B	throughout	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	Partners	development	NN	I-NP	OPartners	in	Partner	NNS	B-NP	Oin	transcription	in	IN	B-PP	Otranscription	:	transcription	NN	B-NP	O:	NFAT	:	:	O	ONFAT	and	NFAT	NN	B-NP	B-proteinand	AP-1	and	CC	O	OAP-1	.	AP-1	NN	B-NP	B-protein.	Combinatorial	.	.	O	OCombinatorial	regulation	Combinatorial	JJ	B-NP	Oregulation	is	regulation	NN	I-NP	Ois	a	be	VBZ	B-VP	Oa	powerful	a	DT	B-NP	Opowerful	mechanism	powerful	JJ	I-NP	Omechanism	that	mechanism	NN	I-NP	Othat	enables	that	WDT	B-NP	Oenables	tight	enable	VBZ	B-VP	Otight	control	tight	JJ	B-NP	Ocontrol	of	control	NN	I-NP	Oof	gene	of	IN	B-PP	Ogene	expression	gene	NN	B-NP	Oexpression	","	expression	NN	I-NP	O","	via	","	","	O	Ovia	integration	via	IN	B-PP	Ointegration	of	integration	NN	B-NP	Oof	multiple	of	IN	B-PP	Omultiple	signaling	multiple	JJ	B-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	that	pathway	NNS	I-NP	Othat	induce	that	WDT	B-NP	Oinduce	different	induce	VBP	B-VP	Odifferent	transcription	different	JJ	B-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	required	factor	NNS	I-NP	I-proteinrequired	for	require	VBN	B-VP	Ofor	enhanceosome	for	IN	B-PP	Oenhanceosome	assembly	enhanceosome	NN	B-NP	Oassembly	.	assembly	NN	I-NP	O.	The	.	.	O	OThe	four	The	DT	B-NP	Ofour	calcium-regulated	four	CD	I-NP	Ocalcium-regulated	transcription	calcium-regulated	JJ	I-NP	B-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	of	factor	NNS	I-NP	I-proteinof	the	of	IN	B-PP	Othe	NFAT	the	DT	B-NP	ONFAT	family	NFAT	NN	I-NP	B-proteinfamily	act	family	NN	I-NP	I-proteinact	synergistically	act	VBP	B-VP	Osynergistically	with	synergistically	RB	B-ADVP	Owith	AP-1	with	IN	B-PP	OAP-1	(	AP-1	NN	B-NP	B-protein(	Fos/Jun	(	(	O	I-proteinFos/Jun	)	Fos/Jun	NN	B-NP	I-protein)	proteins	)	)	O	I-proteinproteins	on	protein	NNS	B-NP	I-proteinon	composite	on	IN	B-PP	Ocomposite	DNA	composite	JJ	B-NP	B-DNADNA	elements	DNA	NN	I-NP	I-DNAelements	which	element	NNS	I-NP	I-DNAwhich	contain	which	WDT	B-NP	Ocontain	adjacent	contain	VBP	B-VP	Oadjacent	NFAT	adjacent	JJ	B-NP	ONFAT	and	NFAT	NN	I-NP	B-proteinand	AP-1	and	CC	O	OAP-1	binding	AP-1	NN	B-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	","	site	NNS	I-NP	I-DNA","	where	","	","	O	Owhere	they	where	WRB	B-ADVP	Othey	form	they	PRP	B-NP	Oform	highly	form	VBP	B-VP	Ohighly	stable	highly	RB	B-NP	Ostable	ternary	stable	JJ	I-NP	Oternary	complexes	ternary	JJ	I-NP	Ocomplexes	to	complex	NNS	I-NP	Oto	regulate	to	TO	B-VP	Oregulate	the	regulate	VB	I-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	diverse	of	IN	B-PP	Odiverse	inducible	diverse	JJ	B-NP	B-DNAinducible	genes	inducible	JJ	I-NP	I-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Concomitant	.	.	O	OConcomitant	induction	Concomitant	JJ	B-NP	Oinduction	of	induction	NN	I-NP	Oof	NFAT	of	IN	B-PP	ONFAT	and	NFAT	NN	B-NP	B-proteinand	AP-1	and	CC	O	OAP-1	requires	AP-1	NN	B-NP	B-proteinrequires	concerted	require	VBZ	B-VP	Oconcerted	activation	concerted	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	two	of	IN	B-PP	Otwo	different	two	CD	B-NP	Odifferent	signaling	different	JJ	I-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	:	pathway	NNS	I-NP	O:	calcium/calcineurin	:	:	O	Ocalcium/calcineurin	","	calcium/calcineurin	NN	B-NP	B-protein","	which	","	","	O	Owhich	promotes	which	WDT	B-NP	Opromotes	NFAT	promote	VBZ	B-VP	ONFAT	dephosphorylation	NFAT	NN	B-NP	B-proteindephosphorylation	","	dephosphorylation	NN	I-NP	O","	nuclear	","	","	O	Onuclear	translocation	nuclear	JJ	B-NP	Otranslocation	and	translocation	NN	I-NP	Oand	activation	and	CC	I-NP	Oactivation	;	activation	NN	I-NP	O;	and	;	:	O	Oand	protein	and	CC	O	Oprotein	kinase	protein	NN	B-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	(	C	NN	I-NP	I-protein(	PKC	(	(	O	OPKC	)	PKC	NN	B-NP	B-protein)	/Ras	)	)	O	O/Ras	","	/Ras	NN	B-NP	B-protein","	which	","	","	O	Owhich	promotes	which	WDT	B-NP	Opromotes	the	promote	VBZ	B-VP	Othe	synthesis	the	DT	B-NP	Osynthesis	","	synthesis	NN	I-NP	O","	phosphorylation	","	","	I-NP	Ophosphorylation	and	phosphorylation	NN	I-NP	Oand	activation	and	CC	I-NP	Oactivation	of	activation	NN	I-NP	Oof	members	of	IN	B-PP	Omembers	of	member	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	Fos	the	DT	B-NP	OFos	and	Fos	NN	I-NP	B-proteinand	Jun	and	CC	I-NP	OJun	families	Jun	NN	I-NP	B-proteinfamilies	of	family	NNS	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	.	factor	NNS	I-NP	I-protein.	A	.	.	O	OA	fifth	A	DT	B-NP	Ofifth	member	fifth	JJ	I-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	NFAT	the	DT	B-NP	ONFAT	family	NFAT	NN	I-NP	B-proteinfamily	","	family	NN	I-NP	I-protein","	NFAT5	","	","	O	ONFAT5	","	NFAT5	NN	B-NP	B-protein","	controls	","	","	O	Ocontrols	the	control	VBZ	B-VP	Othe	cellular	the	DT	B-NP	Ocellular	response	cellular	JJ	I-NP	Oresponse	to	response	NN	I-NP	Oto	osmotic	to	TO	B-PP	Oosmotic	stress	osmotic	JJ	B-NP	Ostress	","	stress	NN	I-NP	O","	by	","	","	O	Oby	a	by	IN	B-PP	Oa	mechanism	a	DT	B-NP	Omechanism	that	mechanism	NN	I-NP	Othat	requires	that	WDT	B-NP	Orequires	dimer	require	VBZ	B-VP	Odimer	formation	dimer	NN	B-NP	Oformation	and	formation	NN	I-NP	Oand	is	and	CC	O	Ois	independent	be	VBZ	B-VP	Oindependent	of	independent	JJ	B-ADJP	Oof	calcineurin	of	IN	B-PP	Ocalcineurin	or	calcineurin	NN	B-NP	B-proteinor	of	or	CC	B-PP	Oof	interaction	of	IN	B-PP	Ointeraction	with	interaction	NN	B-NP	Owith	AP-1	with	IN	B-PP	OAP-1	.	AP-1	NN	B-NP	B-protein.	Pharmacological	.	.	O	OPharmacological	interference	Pharmacological	JJ	B-NP	Ointerference	with	interference	NN	I-NP	Owith	theNFAT	with	IN	B-PP	OtheNFAT	:	theNFAT	NN	B-NP	O:	AP-1	:	:	O	OAP-1	interaction	AP-1	NN	B-NP	B-proteininteraction	may	interaction	NN	I-NP	Omay	be	may	MD	B-VP	Obe	useful	be	VB	I-VP	Ouseful	in	useful	JJ	B-ADJP	Oin	selective	in	IN	B-PP	Oselective	manipulation	selective	JJ	B-NP	Omanipulation	of	manipulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	immune	the	DT	B-NP	Oimmune	response	immune	JJ	I-NP	Oresponse	.	response	NN	I-NP	O.	Balanced	.	.	O	OBalanced	activation	Balanced	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	NFAT	of	IN	B-PP	ONFAT	and	NFAT	NN	B-NP	B-proteinand	AP-1	and	CC	O	OAP-1	is	AP-1	NN	B-NP	B-proteinis	known	be	VBZ	B-VP	Oknown	to	know	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	required	be	VB	I-VP	Orequired	for	require	VBN	I-VP	Ofor	productive	for	IN	B-PP	Oproductive	immune	productive	JJ	B-NP	Oimmune	responses	immune	JJ	I-NP	Oresponses	","	response	NNS	I-NP	O","	but	","	","	O	Obut	the	but	CC	O	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	NFAT	of	IN	B-PP	ONFAT	:	NFAT	NN	B-NP	B-protein:	AP-1	:	:	O	OAP-1	interactions	AP-1	NN	B-NP	B-proteininteractions	in	interaction	NNS	I-NP	Oin	other	in	IN	B-PP	Oother	cell	other	JJ	B-NP	Ocell	types	cell	NN	I-NP	Otypes	and	type	NNS	I-NP	Oand	biological	and	CC	O	Obiological	processes	biological	JJ	B-NP	Oprocesses	remains	process	NNS	I-NP	Oremains	to	remain	VBZ	B-VP	Oto	be	to	TO	I-VP	Obe	understood	be	VB	I-VP	Ounderstood	.	understand	VBN	I-VP	O.	Cytokine	.	.	O	OCytokine	production	Cytokine	NN	B-NP	B-proteinproduction	by	production	NN	I-NP	Oby	Vgamma	by	IN	B-PP	OVgamma	(	Vgamma	NN	B-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	#NAME?	)	)	O	I-cell_type#NAME?	subsets	#NAME?	NN	B-NP	I-cell_typesubsets	is	subset	NNS	I-NP	I-cell_typeis	an	be	VBZ	B-VP	Oan	important	an	DT	B-NP	Oimportant	factor	important	JJ	I-NP	Ofactor	determining	factor	NN	I-NP	Odetermining	CD4	determine	VBG	B-VP	OCD4	(	CD4	NN	B-NP	O(	+	(	(	O	O+	)	+	SYM	O	O)	#NAME?	)	)	O	O#NAME?	phenotype	#NAME?	NN	B-NP	Ophenotype	and	phenotype	NN	I-NP	Oand	susceptibility	and	CC	O	Osusceptibility	of	susceptibility	NN	B-NP	Oof	BALB/c	of	IN	B-PP	OBALB/c	mice	BALB/c	NN	B-NP	Omice	to	mouse	NNS	I-NP	Oto	coxsackievirus	to	TO	B-PP	Ocoxsackievirus	B3-induced	coxsackievirus	NN	B-NP	OB3-induced	myocarditis	B3-induced	JJ	I-NP	Omyocarditis	.	myocarditis	NN	I-NP	O.	Two	.	.	O	OTwo	coxsackievirus	Two	CD	B-NP	Ocoxsackievirus	B3	coxsackievirus	NN	I-NP	OB3	(	B3	NN	I-NP	O(	CVB3	(	(	O	OCVB3	)	CVB3	NN	B-NP	B-protein)	variants	)	)	O	Ovariants	(	variant	NNS	B-NP	O(	H3	(	(	O	OH3	and	H3	NN	B-NP	B-cell_lineand	H310A1	and	CC	O	OH310A1	)	H310A1	NN	B-NP	O)	differ	)	)	O	Odiffer	by	differ	VBP	B-VP	Oby	a	by	IN	B-PP	Oa	single	a	DT	B-NP	Osingle	amino	single	JJ	I-NP	Oamino	acid	amino	NN	I-NP	Oacid	mutation	acid	NN	I-NP	Omutation	in	mutation	NN	I-NP	Oin	the	in	IN	B-PP	Othe	VP2	the	DT	B-NP	OVP2	capsid	VP2	NN	I-NP	B-proteincapsid	protein	capsid	NN	I-NP	I-proteinprotein	.	protein	NN	I-NP	I-protein.	H3	.	.	O	OH3	induces	H3	NN	B-NP	Oinduces	severe	induce	VBZ	B-VP	Osevere	myocarditis	severe	JJ	B-NP	Omyocarditis	in	myocarditis	NN	I-NP	Oin	BALB/c	in	IN	B-PP	OBALB/c	mice	BALB/c	NN	B-NP	Omice	","	mouse	NNS	I-NP	O","	but	","	","	O	Obut	H310A1	but	CC	O	OH310A1	is	H310A1	NN	B-NP	B-proteinis	amyocarditic	be	VBZ	B-VP	Oamyocarditic	.	amyocarditic	JJ	B-ADJP	O.	Infection	.	.	O	OInfection	with	Infection	NN	B-NP	Owith	H3	with	IN	B-PP	OH3	","	H3	NN	B-NP	B-protein","	but	","	","	B-NP	Obut	not	but	CC	I-NP	Onot	H310A1	not	RB	I-NP	OH310A1	","	H310A1	NN	B-NP	B-protein","	preferentially	","	","	O	Opreferentially	activates	preferentially	RB	B-VP	Oactivates	Vgamma4	activate	VBZ	I-VP	OVgamma4	Vdelta4	Vgamma4	NN	B-NP	B-cell_lineVdelta4	cells	Vdelta4	NN	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	which	","	","	O	Owhich	are	which	WDT	B-NP	Oare	strongly	be	VBP	B-VP	Ostrongly	positive	strongly	RB	B-ADJP	Opositive	for	positive	JJ	I-ADJP	Ofor	gamma	for	IN	B-PP	Ogamma	interferon	gamma	NN	B-NP	B-proteininterferon	(	interferon	NN	I-NP	I-protein(	IFN-gamma	(	(	O	OIFN-gamma	)	IFN-gamma	NN	B-NP	B-protein)	","	)	)	O	O","	whereas	","	","	O	Owhereas	Vgamma1	whereas	IN	O	OVgamma1	Vdelta4	Vgamma1	NN	B-NP	B-cell_lineVdelta4	cells	Vdelta4	NN	I-NP	I-cell_linecells	are	cell	NNS	I-NP	I-cell_lineare	increased	be	VBP	B-VP	Oincreased	in	increase	VBN	I-VP	Oin	both	in	IN	B-PP	Oboth	H3	both	CC	O	OH3	and	H3	NN	B-NP	B-cell_lineand	H310A1	and	CC	O	OH310A1	virus-infected	H310A1	NN	B-NP	Ovirus-infected	animals	virus-infected	JJ	I-NP	Oanimals	.	animal	NNS	I-NP	O.	Depletion	.	.	O	ODepletion	of	Depletion	NN	B-NP	Oof	Vgamma1	of	IN	B-PP	OVgamma1	(	Vgamma1	NN	B-NP	B-cell_line(	+	(	(	O	I-cell_line+	)	+	SYM	O	I-cell_line)	cells	)	)	O	I-cell_linecells	using	cell	NNS	B-NP	I-cell_lineusing	monoclonal	use	VBG	B-VP	Omonoclonal	anti-Vgamma1	monoclonal	JJ	B-NP	B-proteinanti-Vgamma1	antibody	anti-Vgamma1	NN	I-NP	I-proteinantibody	enhanced	antibody	NN	I-NP	I-proteinenhanced	myocarditis	enhance	VBD	B-VP	Omyocarditis	and	myocarditis	NN	B-NP	Oand	CD4	and	CC	O	OCD4	(	CD4	NN	B-NP	O(	+	(	(	O	O+	)	+	SYM	B-NP	O)	-	)	)	O	O-	","	-	HYPH	O	O","	IFN-gamma	","	","	O	OIFN-gamma	(	IFN-gamma	NN	B-NP	B-protein(	+	(	(	O	O+	)	+	SYM	O	O)	#NAME?	)	)	O	O#NAME?	responses	#NAME?	JJ	B-NP	Oresponses	in	response	NNS	I-NP	Oin	both	in	IN	B-PP	Oboth	H3-	both	CC	O	OH3-	and	H3-	NN	B-NP	Oand	H310A1-infected	and	CC	O	OH310A1-infected	mice	H310A1-infected	JJ	B-NP	Omice	yet	mouse	NNS	I-NP	Oyet	decreased	yet	RB	B-ADVP	Odecreased	the	decrease	VBD	B-VP	Othe	CD4	the	DT	B-NP	OCD4	(	CD4	NN	I-NP	O(	+	(	(	O	O+	)	+	SYM	B-NP	O)	-	)	)	O	O-	","	-	HYPH	O	O","	IL-4	","	","	O	OIL-4	(	IL-4	NN	B-NP	B-protein(	+	(	(	O	O+	)	+	SYM	O	O)	#NAME?	)	)	O	O#NAME?	response	#NAME?	JJ	B-NP	Oresponse	.	response	NN	I-NP	O.	Depleting	.	.	O	ODepleting	Vgamma4	Deplete	VBG	B-VP	OVgamma4	(	Vgamma4	NN	B-NP	B-protein(	+	(	(	O	O+	)	+	SYM	O	O)	cells	)	)	O	Ocells	suppressed	cell	NNS	B-NP	Osuppressed	myocarditis	suppress	VBD	B-VP	Omyocarditis	and	myocarditis	NN	B-NP	Oand	reduced	and	CC	O	Oreduced	CD4	reduce	VBN	B-NP	OCD4	(	CD4	NN	I-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	IFN-gamma	)	)	O	I-cell_typeIFN-gamma	(	IFN-gamma	NN	B-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	cells	)	)	O	I-cell_typecells	but	cell	NNS	B-NP	I-cell_typebut	increased	but	CC	O	Oincreased	CD4	increase	VBD	B-VP	OCD4	(	CD4	NN	B-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	IL-4	)	)	O	I-cell_typeIL-4	(	IL-4	NN	B-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	role	The	DT	B-NP	Orole	of	role	NN	I-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	production	cytokine	NN	B-NP	B-proteinproduction	by	production	NN	I-NP	Oby	Vgamma1	by	IN	B-PP	OVgamma1	(	Vgamma1	NN	B-NP	B-protein(	+	(	(	O	O+	)	+	SYM	B-NP	O)	and	)	)	O	Oand	Vgamma4	and	CC	O	OVgamma4	(	Vgamma4	NN	B-NP	B-protein(	+	(	(	O	O+	)	+	SYM	O	O)	T	)	)	O	OT	cells	T	NN	B-NP	Ocells	was	cell	NNS	I-NP	Owas	investigated	be	VBD	B-VP	Oinvestigated	by	investigate	VBN	I-VP	Oby	adoptively	by	IN	B-PP	Oadoptively	transferring	adoptively	RB	B-VP	Otransferring	these	transfer	VBG	I-VP	Othese	cells	these	DT	B-NP	Ocells	isolated	cell	NNS	I-NP	Oisolated	from	isolate	VBN	B-VP	Ofrom	H3-infected	from	IN	B-PP	OH3-infected	BALB/c	H3-infected	JJ	B-NP	OBALB/c	Stat4	BALB/c	NN	I-NP	OStat4	knockout	Stat4	NN	I-NP	Oknockout	(	knockout	NN	I-NP	O(	Stat4ko	(	(	O	OStat4ko	)	Stat4ko	NN	B-NP	O)	(	)	)	O	O(	defective	(	(	O	Odefective	in	defective	JJ	B-ADJP	Oin	IFN-gamma	in	IN	B-PP	OIFN-gamma	expression	IFN-gamma	NN	B-NP	B-proteinexpression	)	expression	NN	I-NP	O)	or	)	)	O	Oor	BALB/c	or	CC	O	OBALB/c	Stat6ko	BALB/c	NN	B-NP	OStat6ko	(	Stat6ko	NN	I-NP	O(	defective	(	(	O	Odefective	in	defective	JJ	B-ADJP	Oin	IL-4	in	IN	B-PP	OIL-4	expression	IL-4	NN	B-NP	B-proteinexpression	)	expression	NN	I-NP	O)	mice	)	)	O	Omice	into	mouse	NNS	B-NP	Ointo	H3	into	IN	B-PP	OH3	virus-infected	H3	NN	B-NP	Ovirus-infected	wild-type	virus-infected	JJ	I-NP	Owild-type	BALB/c	wild-type	JJ	I-NP	OBALB/c	recipients	BALB/c	NN	I-NP	Orecipients	.	recipient	NNS	I-NP	O.	Vgamma4	.	.	O	OVgamma4	and	Vgamma4	NN	B-NP	B-proteinand	Vgamma1	and	CC	I-NP	OVgamma1	(	Vgamma1	NN	I-NP	B-protein(	+	(	(	O	O+	)	+	SYM	O	O)	T	)	)	O	OT	cells	T	NN	B-NP	Ocells	from	cell	NNS	I-NP	Ofrom	Stat4ko	from	IN	B-PP	OStat4ko	mice	Stat4ko	NN	B-NP	Omice	expressed	mouse	NNS	I-NP	Oexpressed	IL-4	express	VBD	B-VP	OIL-4	but	IL-4	NN	B-NP	B-proteinbut	no	but	CC	O	Ono	or	no	DT	B-NP	Oor	minimal	or	CC	I-NP	Ominimal	IFN-gamma	minimal	JJ	I-NP	OIFN-gamma	","	IFN-gamma	NN	I-NP	B-protein","	whereas	","	","	O	Owhereas	these	whereas	IN	O	Othese	cell	these	DT	B-NP	Ocell	populations	cell	NN	I-NP	B-cell_linepopulations	derived	population	NNS	I-NP	I-cell_linederived	from	derive	VBN	B-VP	Ofrom	Stat6ko	from	IN	B-PP	OStat6ko	mice	Stat6ko	NN	B-NP	Omice	expressed	mouse	NNS	I-NP	Oexpressed	IFN-gamma	express	VBD	B-VP	OIFN-gamma	but	IFN-gamma	NN	B-NP	B-proteinbut	no	but	CC	O	Ono	IL-4	no	DT	B-NP	OIL-4	.	IL-4	NN	I-NP	B-protein.	Stat4ko	.	.	O	OStat4ko	Vgamma1	Stat4ko	NN	B-NP	B-cell_typeVgamma1	(	Vgamma1	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	cells	)	)	O	I-cell_typecells	(	cell	NNS	B-NP	I-cell_type(	IL-4	(	(	O	OIL-4	(	IL-4	NN	B-NP	B-protein(	+	(	(	O	O+	)	+	SYM	B-NP	O)	)	)	)	O	O)	suppress	)	)	O	Osuppress	myocarditis	suppress	VBP	B-VP	Omyocarditis	.	myocarditis	NN	B-NP	O.	Stat6ko	.	.	O	OStat6ko	Vgamma1	Stat6ko	NN	B-NP	B-cell_typeVgamma1	(	Vgamma1	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	cells	)	)	O	I-cell_typecells	(	cell	NNS	B-NP	I-cell_type(	IFN-gamma	(	(	O	OIFN-gamma	(	IFN-gamma	NN	B-NP	B-protein(	+	(	(	O	O+	)	+	SYM	B-NP	O)	)	)	)	O	O)	were	)	)	O	Owere	not	be	VBD	B-VP	Onot	inhibitory	not	RB	O	Oinhibitory	.	inhibitory	JJ	B-ADJP	O.	Stat6ko	.	.	O	OStat6ko	Vgamma4	Stat6ko	NN	B-NP	B-cell_typeVgamma4	(	Vgamma4	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	cells	)	)	O	I-cell_typecells	(	cell	NNS	B-NP	I-cell_type(	IFN-gamma	(	(	O	OIFN-gamma	(	IFN-gamma	NN	B-NP	B-protein(	+	(	(	O	O+	)	+	SYM	B-NP	O)	)	)	)	O	O)	significantly	)	)	O	Osignificantly	enhanced	significantly	RB	B-ADVP	Oenhanced	myocarditis	enhance	VBD	B-VP	Omyocarditis	.	myocarditis	NN	B-NP	O.	Stat4ko	.	.	O	OStat4ko	Vgamma4	Stat4ko	NN	B-NP	B-cell_typeVgamma4	(	Vgamma4	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	cells	)	)	O	I-cell_typecells	(	cell	NNS	B-NP	I-cell_type(	IL-4	(	(	O	OIL-4	(	IL-4	NN	B-NP	B-protein(	+	(	(	O	O+	)	+	SYM	B-NP	O)	)	)	)	O	O)	neither	)	)	O	Oneither	inhibited	neither	CC	B-VP	Oinhibited	nor	inhibit	VBN	I-VP	Onor	enhanced	nor	CC	I-VP	Oenhanced	disease	enhance	VBN	I-VP	Odisease	.	disease	NN	B-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	show	result	NNS	I-NP	Oshow	that	show	VBP	B-VP	Othat	distinct	that	IN	B-SBAR	Odistinct	gammadelta-T-cell	distinct	JJ	B-NP	Ogammadelta-T-cell	subsets	gammadelta-T-cell	NN	I-NP	B-cell_typesubsets	control	subset	NNS	I-NP	I-cell_typecontrol	myocarditis	control	VBP	B-VP	Omyocarditis	susceptibility	myocarditis	PRP$	B-NP	Osusceptibility	and	susceptibility	NN	I-NP	Oand	bias	and	CC	I-NP	Obias	the	bias	NN	I-NP	Othe	CD4	the	DT	B-NP	OCD4	(	CD4	NN	I-NP	O(	+	(	(	O	O+	)	+	SYM	O	O)	#NAME?	)	)	O	O#NAME?	response	#NAME?	NN	B-NP	Oresponse	.	response	NN	I-NP	O.	The	.	.	O	OThe	cytokines	The	DT	B-NP	Ocytokines	produced	cytokine	NNS	I-NP	B-proteinproduced	by	produce	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	Vgamma	the	DT	B-NP	OVgamma	subpopulation	Vgamma	NN	I-NP	Osubpopulation	have	subpopulation	NN	I-NP	Ohave	a	have	VBP	B-VP	Oa	significant	a	DT	B-NP	Osignificant	influence	significant	JJ	I-NP	Oinfluence	on	influence	NN	I-NP	Oon	the	on	IN	B-PP	Othe	CD4	the	DT	B-NP	OCD4	(	CD4	NN	I-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	#NAME?	)	)	O	I-cell_type#NAME?	phenotype	#NAME?	NN	B-NP	I-cell_typephenotype	.	phenotype	NN	I-NP	I-cell_type.	Plasmin	.	.	O	OPlasmin	#NAME?	Plasmin	NN	B-NP	O#NAME?	expression	#NAME?	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	cytokines	of	IN	B-PP	Ocytokines	and	cytokine	NNS	B-NP	B-proteinand	tissue	and	CC	O	Otissue	factor	tissue	NN	B-NP	B-proteinfactor	in	factor	NN	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	monocytes	human	JJ	B-NP	B-cell_typemonocytes	involves	monocyte	NNS	I-NP	I-cell_typeinvolves	AP-1	involve	VBZ	B-VP	OAP-1	and	AP-1	NN	B-NP	B-proteinand	IKKbeta	and	CC	O	OIKKbeta	#NAME?	IKKbeta	NN	B-NP	B-protein#NAME?	NF-kappaB	#NAME?	JJ	I-NP	ONF-kappaB	activation	NF-kappaB	NN	I-NP	B-proteinactivation	.	activation	NN	I-NP	O.	It	.	.	O	OIt	was	It	PRP	B-NP	Owas	previously	be	VBD	B-VP	Opreviously	shown	previously	RB	I-VP	Oshown	that	show	VBN	I-VP	Othat	plasmin	that	IN	B-SBAR	Oplasmin	activates	plasmin	NN	B-NP	Oactivates	human	activate	VBZ	B-VP	Ohuman	peripheral	human	JJ	B-NP	B-cell_typeperipheral	monocytes	peripheral	JJ	I-NP	I-cell_typemonocytes	in	monocyte	NNS	I-NP	I-cell_typein	terms	in	IN	B-PP	Oterms	of	term	NNS	B-NP	Oof	lipid	of	IN	B-PP	Olipid	mediator	lipid	NN	B-NP	Omediator	release	mediator	NN	I-NP	Orelease	and	release	NN	I-NP	Oand	chemotactic	and	CC	O	Ochemotactic	migration	chemotactic	JJ	B-NP	Omigration	.	migration	NN	I-NP	O.	Here	.	.	O	OHere	it	Here	RB	B-ADVP	Oit	is	it	PRP	B-NP	Ois	demonstrated	be	VBZ	B-VP	Odemonstrated	that	demonstrate	VBN	I-VP	Othat	plasmin	that	IN	B-SBAR	Oplasmin	induces	plasmin	NN	B-NP	Oinduces	proinflammatory	induce	VBZ	B-VP	Oproinflammatory	cytokine	proinflammatory	JJ	B-NP	B-proteincytokine	release	cytokine	NN	I-NP	I-proteinrelease	and	release	NN	I-NP	Oand	tissue	and	CC	O	Otissue	factor	tissue	NN	B-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	TF	(	(	O	OTF	)	TF	NN	B-NP	B-protein)	expression	)	)	O	Oexpression	by	expression	NN	B-NP	Oby	monocytes	by	IN	B-PP	Omonocytes	.	monocyte	NNS	B-NP	B-cell_type.	Plasmin	.	.	O	OPlasmin	0.043	Plasmin	NN	B-NP	O0.043	to	0.043	CD	I-NP	Oto	1.43	to	TO	I-NP	O1.43	CTA	1.43	CD	I-NP	OCTA	U/mL	CTA	NN	I-NP	OU/mL	","	U/mL	NN	I-NP	O","	but	","	","	O	Obut	not	but	CC	O	Onot	active	not	RB	O	Oactive	site-blocked	active	JJ	B-NP	Osite-blocked	plasmin	site-blocked	JJ	I-NP	Oplasmin	","	plasmin	NN	I-NP	O","	triggered	","	","	O	Otriggered	concentration-dependent	trigger	VBD	B-VP	Oconcentration-dependent	expression	concentration-dependent	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	mRNA	of	IN	B-PP	OmRNA	for	mRNA	NN	B-NP	B-RNAfor	interleukin-1alpha	for	IN	B-PP	Ointerleukin-1alpha	(	interleukin-1alpha	NN	B-NP	B-protein(	IL-1alpha	(	(	O	OIL-1alpha	)	IL-1alpha	NN	B-NP	B-protein)	","	)	)	O	O","	IL-1beta	","	","	O	OIL-1beta	","	IL-1beta	NN	B-NP	B-protein","	tumor	","	","	O	Otumor	necrosis	tumor	NN	B-NP	B-proteinnecrosis	factor-alpha	necrosis	NN	I-NP	I-proteinfactor-alpha	(	factor-alpha	NN	I-NP	I-protein(	TNF-alpha	(	(	O	OTNF-alpha	)	TNF-alpha	NN	B-NP	B-protein)	","	)	)	O	O","	and	","	","	O	Oand	TF	and	CC	O	OTF	with	TF	NN	B-NP	B-proteinwith	maximum	with	IN	B-PP	Omaximum	responses	maximum	JJ	B-NP	Oresponses	after	response	NNS	I-NP	Oafter	4	after	IN	B-PP	O4	hours	4	CD	B-NP	Ohours	.	hour	NNS	I-NP	O.	Plasmin	.	.	O	OPlasmin	#NAME?	Plasmin	NN	B-NP	O#NAME?	mRNA	#NAME?	JJ	I-NP	OmRNA	expression	mRNA	NN	I-NP	Oexpression	was	expression	NN	I-NP	Owas	inhibited	be	VBD	B-VP	Oinhibited	in	inhibit	VBN	I-VP	Oin	a	in	IN	B-PP	Oa	concentration-dependent	a	DT	B-NP	Oconcentration-dependent	manner	concentration-dependent	JJ	I-NP	Omanner	by	manner	NN	I-NP	Oby	the	by	IN	B-PP	Othe	lysine	the	DT	B-NP	Olysine	analogue	lysine	NN	I-NP	Oanalogue	trans-4-	analogue	NN	I-NP	Otrans-4-	(	trans-4-	NN	I-NP	O(	aminomethyl	(	(	O	Oaminomethyl	)	aminomethyl	NN	B-NP	O)	cyclohexane-1-carboxylic	)	)	O	Ocyclohexane-1-carboxylic	acid	cyclohexane-1-carboxylic	JJ	B-NP	Oacid	(	acid	NN	I-NP	O(	t-AMCA	(	(	O	Ot-AMCA	)	t-AMCA	NN	B-NP	O)	.	)	)	O	O.	Increases	.	.	O	OIncreases	in	Increase	NNS	B-NP	Oin	mRNA	in	IN	B-PP	OmRNA	levels	mRNA	NN	B-NP	B-RNAlevels	were	level	NNS	I-NP	Owere	followed	be	VBD	B-VP	Ofollowed	by	follow	VBN	I-VP	Oby	concentration-	by	IN	B-PP	Oconcentration-	and	concentration-	NN	B-NP	Oand	time-dependent	and	CC	O	Otime-dependent	release	time-dependent	JJ	B-NP	Orelease	of	release	NN	I-NP	Oof	IL-1alpha	of	IN	B-PP	OIL-1alpha	","	IL-1alpha	NN	B-NP	B-protein","	IL-1beta	","	","	I-NP	OIL-1beta	and	IL-1beta	NN	I-NP	B-proteinand	TNF-alpha	and	CC	I-NP	OTNF-alpha	and	TNF-alpha	NN	I-NP	B-proteinand	by	and	CC	B-PP	Oby	TF	by	IN	B-PP	OTF	expression	TF	NN	B-NP	B-proteinexpression	on	expression	NN	I-NP	Oon	monocyte	on	IN	B-PP	Omonocyte	surfaces	monocyte	NN	B-NP	Osurfaces	.	surface	NNS	I-NP	O.	Neither	.	.	O	ONeither	cytokines	Neither	CC	O	Ocytokines	nor	cytokine	NNS	B-NP	B-proteinnor	TF	nor	CC	O	OTF	could	TF	NN	B-NP	B-proteincould	be	could	MD	B-VP	Obe	detected	be	VB	I-VP	Odetected	when	detect	VBN	I-VP	Owhen	monocytes	when	WRB	B-ADVP	Omonocytes	were	monocyte	NNS	B-NP	B-cell_typewere	preincubated	be	VBD	B-VP	Opreincubated	with	preincubate	VBN	I-VP	Owith	actinomycin	with	IN	B-PP	Oactinomycin	D	actinomycin	NN	B-NP	OD	or	D	NN	I-NP	Oor	cycloheximide	or	CC	I-NP	Ocycloheximide	.	cycloheximide	NN	I-NP	O.	Electrophoretic	.	.	O	OElectrophoretic	mobility	Electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assays	shift	NN	I-NP	Oassays	indicated	assay	NNS	I-NP	Oindicated	plasmin	indicate	VBD	B-VP	Oplasmin	#NAME?	plasmin	NN	B-NP	O#NAME?	activation	#NAME?	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	;	NF-kappaB	NN	B-NP	B-protein;	DNA-binding	;	:	O	ODNA-binding	complexes	DNA-binding	JJ	B-NP	B-proteincomplexes	were	complex	NNS	I-NP	I-proteinwere	composed	be	VBD	B-VP	Ocomposed	of	compose	VBN	I-VP	Oof	p50	of	IN	B-PP	Op50	","	p50	NN	B-NP	B-protein","	p65	","	","	O	Op65	","	p65	NN	B-NP	B-protein","	and	","	","	O	Oand	c-Rel	and	CC	O	Oc-Rel	","	c-Rel	NN	B-NP	B-protein","	as	","	","	O	Oas	shown	as	IN	B-SBAR	Oshown	by	show	VBN	B-VP	Oby	supershift	by	IN	B-PP	Osupershift	experiments	supershift	NN	B-NP	Oexperiments	.	experiment	NNS	I-NP	O.	Nuclear	.	.	O	ONuclear	translocation	Nuclear	JJ	B-NP	Otranslocation	of	translocation	NN	I-NP	Oof	NF-kappaB/Rel	of	IN	B-PP	ONF-kappaB/Rel	proteins	NF-kappaB/Rel	NN	B-NP	B-proteinproteins	coincided	protein	NNS	I-NP	I-proteincoincided	with	coincide	VBD	B-VP	Owith	IkappaBalpha	with	IN	B-PP	OIkappaBalpha	degradation	IkappaBalpha	NN	B-NP	B-proteindegradation	.	degradation	NN	I-NP	O.	At	.	.	O	OAt	variance	At	IN	B-PP	Ovariance	with	variance	NN	B-NP	Owith	endotoxic	with	IN	B-PP	Oendotoxic	lipopolysaccharide	endotoxic	JJ	B-NP	Olipopolysaccharide	","	lipopolysaccharide	NN	I-NP	O","	plasmin	","	","	O	Oplasmin	elicited	plasmin	NN	B-NP	Oelicited	the	elicit	VBD	B-VP	Othe	rapid	the	DT	B-NP	Orapid	degradation	rapid	JJ	I-NP	Odegradation	of	degradation	NN	I-NP	Oof	another	of	IN	B-PP	Oanother	cytoplasmic	another	DT	B-NP	Ocytoplasmic	NF-kappaB	cytoplasmic	JJ	I-NP	ONF-kappaB	inhibitor	NF-kappaB	NN	I-NP	B-proteininhibitor	","	inhibitor	NN	I-NP	O","	p105	","	","	O	Op105	.	p105	NN	B-NP	B-protein.	Proteolysis	.	.	O	OProteolysis	of	Proteolysis	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	inhibitors	NF-kappaB	NN	B-NP	B-proteininhibitors	was	inhibitor	NNS	I-NP	Owas	apparently	be	VBD	B-VP	Oapparently	due	apparently	RB	B-ADVP	Odue	to	due	JJ	B-PP	Oto	transient	to	TO	I-PP	Otransient	activation	transient	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	IkappaB	of	IN	B-PP	OIkappaB	kinase	IkappaB	NN	B-NP	B-proteinkinase	(	kinase	NN	I-NP	I-protein(	IKK	(	(	O	OIKK	)	IKK	NN	B-NP	B-protein)	beta	)	)	O	Obeta	that	beta	NN	B-NP	Othat	reached	that	WDT	B-NP	Oreached	maximum	reach	VBD	B-VP	Omaximum	activity	maximum	JJ	B-NP	Oactivity	at	activity	NN	I-NP	Oat	1	at	IN	B-PP	O1	hour	1	CD	B-NP	Ohour	after	hour	NN	I-NP	Oafter	plasmin	after	IN	B-PP	Oplasmin	stimulation	plasmin	NN	B-NP	Ostimulation	.	stimulation	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	AP-1	","	","	O	OAP-1	binding	AP-1	NN	B-NP	B-proteinbinding	was	binding	NN	I-NP	Owas	increased	be	VBD	B-VP	Oincreased	in	increase	VBN	I-VP	Oin	plasmin	in	IN	B-PP	Oplasmin	#NAME?	plasmin	NN	B-NP	O#NAME?	monocytes	#NAME?	JJ	I-NP	Omonocytes	","	monocyte	NNS	I-NP	B-cell_type","	with	","	","	O	Owith	most	with	IN	B-PP	Omost	complexes	most	JJS	B-NP	Ocomplexes	composed	complex	NNS	I-NP	Ocomposed	of	compose	VBN	B-VP	Oof	JunD	of	IN	B-PP	OJunD	","	JunD	NN	B-NP	B-protein","	c-Fos	","	","	O	Oc-Fos	","	c-Fos	NN	B-NP	B-protein","	and	","	","	O	Oand	FosB	and	CC	O	OFosB	.	FosB	NN	B-NP	B-protein.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	further	finding	NNS	I-NP	Ofurther	substantiate	further	RBR	B-VP	Osubstantiate	the	substantiate	VB	I-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	plasmin	of	IN	B-PP	Oplasmin	as	plasmin	NN	B-NP	Oas	a	as	IN	B-PP	Oa	proinflammatory	a	DT	B-NP	Oproinflammatory	activator	proinflammatory	JJ	I-NP	B-proteinactivator	of	activator	NN	I-NP	I-proteinof	human	of	IN	B-PP	Ohuman	monocytes	human	JJ	B-NP	B-cell_typemonocytes	and	monocyte	NNS	I-NP	I-cell_typeand	reveal	and	CC	O	Oreveal	an	reveal	VB	B-VP	Oan	important	an	DT	B-NP	Oimportant	new	important	JJ	I-NP	Onew	link	new	JJ	I-NP	Olink	between	link	NN	I-NP	Obetween	the	between	IN	B-PP	Othe	plasminogen-plasmin	the	DT	B-NP	Oplasminogen-plasmin	system	plasminogen-plasmin	NN	I-NP	Osystem	and	system	NN	I-NP	Oand	inflammation	and	CC	I-NP	Oinflammation	.	inflammation	NN	I-NP	O.	(	.	.	O	O(	Blood.	(	(	O	OBlood.	2001	Blood.	NNP	B-NP	O2001	;	2001	CD	I-NP	O;	97	;	:	O	O97	:	97	CD	B-NP	O:	3941-3950	:	:	O	O3941-3950	)	3941-3950	CD	B-NP	O)	STAT3	)	)	O	OSTAT3	is	STAT3	NN	B-NP	B-proteinis	constitutively	be	VBZ	B-VP	Oconstitutively	active	constitutively	RB	B-ADJP	Oactive	in	active	JJ	I-ADJP	Oin	some	in	IN	B-PP	Osome	patients	some	DT	B-NP	Opatients	with	patient	NNS	I-NP	Owith	Polycythemia	with	IN	B-PP	OPolycythemia	rubra	Polycythemia	NN	B-NP	Orubra	vera	rubra	NN	I-NP	Overa	.	vera	NN	I-NP	O.	OBJECTIVE	.	.	O	OOBJECTIVE	:	OBJECTIVE	NN	B-NP	O:	Polycythemia	:	:	O	OPolycythemia	vera	Polycythemia	NN	B-NP	Overa	is	vera	NN	I-NP	Ois	a	be	VBZ	B-VP	Oa	clonal	a	DT	B-NP	Oclonal	stem	clonal	JJ	I-NP	Ostem	cell	stem	NN	I-NP	Ocell	disorder	cell	NN	I-NP	Odisorder	characterized	disorder	NN	I-NP	Ocharacterized	by	characterize	VBN	B-VP	Oby	hyperproliferation	by	IN	B-PP	Ohyperproliferation	of	hyperproliferation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	erythroid	the	DT	B-NP	Oerythroid	","	erythroid	JJ	I-NP	B-cell_type","	myeloid	","	","	I-NP	I-cell_typemyeloid	","	myeloid	JJ	I-NP	I-cell_type","	and	","	","	O	I-cell_typeand	megakaryocytic	and	CC	O	I-cell_typemegakaryocytic	lineages	megakaryocytic	JJ	B-NP	I-cell_typelineages	.	lineage	NNS	I-NP	I-cell_type.	While	.	.	O	OWhile	it	While	IN	B-SBAR	Oit	has	it	PRP	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	that	show	VBN	I-VP	Othat	progenitor	that	IN	B-SBAR	Oprogenitor	cells	progenitor	NN	B-NP	B-cell_typecells	of	cell	NNS	I-NP	I-cell_typeof	P.	of	IN	B-PP	OP.	vera	P.	NNP	B-NP	Overa	patients	vera	NN	I-NP	Opatients	are	patient	NNS	I-NP	Oare	hypersensitive	be	VBP	B-VP	Ohypersensitive	to	hypersensitive	JJ	B-ADJP	Oto	several	to	TO	B-PP	Oseveral	growth	several	JJ	B-NP	Ogrowth	factors	growth	NN	I-NP	B-proteinfactors	including	factor	NNS	I-NP	I-proteinincluding	erythropoietin	include	VBG	B-PP	Oerythropoietin	","	erythropoietin	NN	B-NP	B-protein","	insulin-like	","	","	O	Oinsulin-like	growth	insulin-like	JJ	B-NP	B-proteingrowth	factor-1	growth	NN	I-NP	I-proteinfactor-1	","	factor-1	NN	I-NP	I-protein","	thrombopoietin	","	","	O	Othrombopoietin	","	thrombopoietin	NN	B-NP	B-protein","	interleukin-3	","	","	O	Ointerleukin-3	","	interleukin-3	NN	B-NP	B-protein","	and	","	","	O	Oand	granulocyte/monocyte	and	CC	O	Ogranulocyte/monocyte	colony-stimulating	granulocyte/monocyte	NN	B-NP	B-proteincolony-stimulating	factor	colony-stimulating	JJ	I-NP	I-proteinfactor	","	factor	NN	I-NP	I-protein","	the	","	","	O	Othe	molecular	the	DT	B-NP	Omolecular	pathogenesis	molecular	JJ	I-NP	Opathogenesis	of	pathogenesis	NN	I-NP	Oof	this	of	IN	B-PP	Othis	disease	this	DT	B-NP	Odisease	remains	disease	NN	I-NP	Oremains	unknown	remain	VBZ	B-VP	Ounknown	.	unknown	JJ	B-ADJP	O.	Growth	.	.	O	OGrowth	factor	Growth	NN	B-NP	B-proteinfactor	hypersensitivity	factor	NN	I-NP	I-proteinhypersensitivity	could	hypersensitivity	NN	I-NP	Ocould	be	could	MD	B-VP	Obe	mediated	be	VB	I-VP	Omediated	by	mediate	VBN	I-VP	Oby	changes	by	IN	B-PP	Ochanges	in	change	NNS	B-NP	Oin	signal	in	IN	B-PP	Osignal	transduction	signal	NN	B-NP	Otransduction	pathways	transduction	NN	I-NP	Opathways	.	pathway	NNS	I-NP	O.	We	.	.	O	OWe	therefore	We	PRP	B-NP	Otherefore	investigated	therefore	RB	B-ADVP	Oinvestigated	a	investigate	VBD	B-VP	Oa	common	a	DT	B-NP	Ocommon	downstream	common	JJ	I-NP	Odownstream	effector	downstream	JJ	I-NP	Oeffector	of	effector	NN	I-NP	Oof	cytokines	of	IN	B-PP	Ocytokines	","	cytokine	NNS	B-NP	B-protein","	the	","	","	O	Othe	signal	the	DT	B-NP	Osignal	transducers	signal	NN	I-NP	Otransducers	and	transducer	NNS	I-NP	Oand	activators	and	CC	I-NP	Oactivators	of	activator	NNS	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	(	transcription	NN	B-NP	O(	STATs	(	(	O	OSTATs	)	STAT	NNS	B-NP	B-protein)	.	)	)	O	O.	A	.	.	O	OA	constitutive	A	DT	B-NP	Oconstitutive	activation	constitutive	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	STAT	of	IN	B-PP	OSTAT	factors	STAT	NN	B-NP	B-proteinfactors	could	factor	NNS	I-NP	I-proteincould	explain	could	MD	B-VP	Oexplain	the	explain	VB	I-VP	Othe	increased	the	DT	B-NP	Oincreased	proliferation	increase	VBN	I-NP	Oproliferation	of	proliferation	NN	I-NP	Oof	P.	of	IN	B-PP	OP.	vera	P.	NNP	B-NP	B-cell_linevera	cells	vera	NN	I-NP	I-cell_linecells	even	cell	NNS	I-NP	I-cell_lineeven	in	even	RB	B-ADVP	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	growth	of	IN	B-PP	Ogrowth	factor	growth	NN	B-NP	B-proteinfactor	stimulation	factor	NN	I-NP	I-proteinstimulation	.	stimulation	NN	I-NP	O.	METHODS	.	.	O	OMETHODS	:	METHODS	NNS	B-NP	O:	Peripheral	:	:	O	OPeripheral	granulocytes	Peripheral	JJ	B-NP	B-cell_typegranulocytes	from	granulocyte	NNS	I-NP	I-cell_typefrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	P.	with	IN	B-PP	OP.	vera	P.	NNP	B-NP	Overa	and	vera	NN	I-NP	Oand	from	and	CC	B-PP	Ofrom	healthy	from	IN	B-PP	Ohealthy	volunteers	healthy	JJ	B-NP	Ovolunteers	were	volunteer	NNS	I-NP	Owere	assayed	be	VBD	B-VP	Oassayed	for	assay	VBN	I-VP	Ofor	STAT1	for	IN	B-PP	OSTAT1	","	STAT1	NN	B-NP	B-protein","	3	","	","	O	O3	","	3	CD	B-NP	O","	and	","	","	O	Oand	5	and	CC	O	O5	DNA	5	CD	B-NP	ODNA	binding	DNA	NN	I-NP	Obinding	by	binding	NN	I-NP	Oby	electrophoretic	by	IN	B-PP	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assay	shift	NN	I-NP	Oassay	.	assay	NN	I-NP	O.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	Four	:	:	O	OFour	of	Four	CD	B-NP	Oof	14	of	IN	B-PP	O14	P.	14	CD	B-NP	OP.	vera	P.	NNP	I-NP	Overa	patients	vera	NN	I-NP	Opatients	analyzed	patient	NNS	I-NP	Oanalyzed	showed	analyze	VBN	B-VP	Oshowed	constitutive	show	VBD	B-VP	Oconstitutive	STAT3	constitutive	JJ	B-NP	OSTAT3	DNA	STAT3	NN	I-NP	B-proteinDNA	binding	DNA	NN	I-NP	Obinding	in	binding	NN	I-NP	Oin	unstimulated	in	IN	B-PP	Ounstimulated	peripheral	unstimulated	JJ	B-NP	B-cell_typeperipheral	granulocytes	peripheral	JJ	I-NP	I-cell_typegranulocytes	","	granulocyte	NNS	I-NP	I-cell_type","	while	","	","	O	Owhile	none	while	IN	B-SBAR	Onone	of	none	NN	B-NP	Oof	the	of	IN	B-PP	Othe	17	the	DT	B-NP	O17	healthy	17	CD	I-NP	Ohealthy	volunteers	healthy	JJ	I-NP	Ovolunteers	tested	volunteer	NNS	I-NP	Otested	did	test	VBN	B-VP	Odid	.	do	VBD	B-VP	O.	None	.	.	O	ONone	of	None	NN	B-NP	Oof	the	of	IN	B-PP	Othe	subjects	the	DT	B-NP	Osubjects	showed	subject	NNS	I-NP	Oshowed	constitutive	show	VBD	B-VP	Oconstitutive	STAT1	constitutive	JJ	B-NP	OSTAT1	or	STAT1	NN	I-NP	B-proteinor	STAT5	or	CC	I-NP	OSTAT5	activity	STAT5	NN	I-NP	B-proteinactivity	.	activity	NN	I-NP	O.	Western	.	.	O	OWestern	blotting	Western	NN	B-NP	Oblotting	demonstrated	blotting	NN	I-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	","	that	IN	B-SBAR	O","	in	","	","	O	Oin	the	in	IN	B-PP	Othe	three	the	DT	B-NP	Othree	patients	three	CD	I-NP	Opatients	","	patient	NNS	I-NP	O","	STAT3	","	","	O	OSTAT3	is	STAT3	NN	B-NP	B-proteinis	constitutively	be	VBZ	B-VP	Oconstitutively	phosphorylated	constitutively	RB	I-VP	Ophosphorylated	on	phosphorylate	VBN	I-VP	Oon	Tyr	on	IN	B-PP	OTyr	705	Tyr	NN	B-NP	O705	","	705	CD	I-NP	O","	whereas	","	","	O	Owhereas	it	whereas	IN	O	Oit	is	it	PRP	B-NP	Ois	unphosphorylated	be	VBZ	B-VP	Ounphosphorylated	in	unphosphorylate	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	other	the	DT	B-NP	Oother	patients	other	JJ	I-NP	Opatients	and	patient	NNS	I-NP	Oand	in	and	CC	B-PP	Oin	controls	in	IN	B-PP	Ocontrols	.	control	NNS	B-NP	O.	Interestingly	.	.	O	OInterestingly	","	Interestingly	RB	B-ADVP	O","	constitutive	","	","	O	Oconstitutive	STAT3	constitutive	JJ	B-NP	OSTAT3	activity	STAT3	NN	I-NP	B-proteinactivity	did	activity	NN	I-NP	Odid	not	do	VBD	B-VP	Onot	correlate	not	RB	I-VP	Ocorrelate	with	correlate	VB	I-VP	Owith	the	with	IN	B-PP	Othe	duration	the	DT	B-NP	Oduration	of	duration	NN	I-NP	Oof	disease	of	IN	B-PP	Odisease	or	disease	NN	B-NP	Oor	the	or	CC	O	Othe	treatment	the	DT	B-NP	Otreatment	regimen	treatment	NN	I-NP	Oregimen	.	regimen	NN	I-NP	O.	It	.	.	O	OIt	was	It	PRP	B-NP	Owas	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	a	in	IN	B-PP	Oa	recently	a	DT	B-NP	Orecently	diagnosed	recently	RB	I-NP	Odiagnosed	patient	diagnose	VBN	I-NP	Opatient	and	patient	NN	I-NP	Oand	in	and	CC	O	Oin	two	in	IN	B-PP	Otwo	patients	two	CD	B-NP	Opatients	treated	patient	NNS	I-NP	Otreated	only	treat	VBN	B-VP	Oonly	with	only	RB	B-ADVP	Owith	phlebotomy	with	IN	B-PP	Ophlebotomy	.	phlebotomy	NN	B-NP	O.	CONCLUSION	.	.	O	OCONCLUSION	:	CONCLUSION	NN	B-NP	O:	Our	:	:	O	OOur	data	Our	PRP$	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	constitutive	that	IN	B-SBAR	Oconstitutive	phosphorylation	constitutive	JJ	B-NP	Ophosphorylation	and	phosphorylation	NN	I-NP	Oand	activation	and	CC	I-NP	Oactivation	of	activation	NN	I-NP	Oof	STAT3	of	IN	B-PP	OSTAT3	is	STAT3	NN	B-NP	B-proteinis	not	be	VBZ	B-VP	Onot	a	not	RB	O	Oa	secondary	a	DT	B-NP	Osecondary	event	secondary	JJ	I-NP	Oevent	induced	event	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	mutagenizing	by	IN	B-PP	Omutagenizing	agents	mutagenize	VBG	B-NP	Oagents	or	agent	NNS	I-NP	Oor	by	or	CC	B-PP	Oby	prolonged	by	IN	B-PP	Oprolonged	hyperproliferation	prolong	VBN	B-NP	Ohyperproliferation	of	hyperproliferation	NN	I-NP	Oof	hematopoietic	of	IN	B-PP	Ohematopoietic	cells	hematopoietic	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	but	","	","	O	Obut	rather	but	CC	O	Orather	represents	rather	RB	B-VP	Orepresents	a	represent	VBZ	I-VP	Oa	primary	a	DT	B-NP	Oprimary	molecular	primary	JJ	I-NP	Omolecular	aberration	molecular	JJ	I-NP	Oaberration	.	aberration	NN	I-NP	O.	Constitutively	.	.	O	OConstitutively	active	Constitutively	RB	B-NP	Oactive	STAT3	active	JJ	I-NP	OSTAT3	may	STAT3	NN	I-NP	B-proteinmay	contribute	may	MD	B-VP	Ocontribute	to	contribute	VB	I-VP	Oto	the	to	TO	B-PP	Othe	growth	the	DT	B-NP	Ogrowth	factor	growth	NN	I-NP	B-proteinfactor	hypersensitivity	factor	NN	I-NP	I-proteinhypersensitivity	of	hypersensitivity	NN	I-NP	Oof	P.	of	IN	B-PP	OP.	vera	P.	NNP	B-NP	B-cell_linevera	cells	vera	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Identification	.	.	O	OIdentification	of	Identification	NN	B-NP	Oof	phosphorylation	of	IN	B-PP	Ophosphorylation	sites	phosphorylation	NN	B-NP	B-proteinsites	for	site	NNS	I-NP	I-proteinfor	Bruton	for	IN	B-PP	OBruton	's	Bruton	NNP	B-NP	B-protein's	tyrosine	's	POS	B-NP	I-proteintyrosine	kinase	tyrosine	NN	I-NP	I-proteinkinase	within	kinase	NN	I-NP	I-proteinwithin	the	within	IN	B-PP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	regulator	transcriptional	JJ	I-NP	B-DNAregulator	BAP/TFII-I	regulator	NN	I-NP	I-DNABAP/TFII-I	.	BAP/TFII-I	NN	I-NP	I-DNA.	Bruton	.	.	O	OBruton	's	Bruton	NNP	B-NP	B-protein's	tyrosine	's	POS	B-NP	I-proteintyrosine	kinase	tyrosine	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	Btk	(	(	O	OBtk	)	Btk	NN	B-NP	B-protein)	","	)	)	O	O","	a	","	","	O	Oa	member	a	DT	B-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	Tec	the	DT	B-NP	OTec	family	Tec	NNP	I-NP	B-proteinfamily	of	family	NN	I-NP	I-proteinof	cytosolic	of	IN	B-PP	Ocytosolic	kinases	cytosolic	JJ	B-NP	B-proteinkinases	","	kinase	NNS	I-NP	I-protein","	is	","	","	O	Ois	essential	be	VBZ	B-VP	Oessential	for	essential	JJ	B-ADJP	Ofor	B	for	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	and	development	NN	I-NP	Oand	function	and	CC	O	Ofunction	.	function	NN	B-NP	O.	BAP/TFII-I	.	.	O	OBAP/TFII-I	","	BAP/TFII-I	NN	B-NP	B-protein","	a	","	","	O	Oa	protein	a	DT	B-NP	Oprotein	implicated	protein	NN	I-NP	Oimplicated	in	implicate	VBN	B-VP	Oin	transcriptional	in	IN	B-PP	Otranscriptional	regulation	transcriptional	JJ	B-NP	Oregulation	","	regulation	NN	I-NP	O","	is	","	","	O	Ois	associated	be	VBZ	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	Btk	with	IN	B-PP	OBtk	in	Btk	NN	B-NP	B-proteinin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	is	and	CC	O	Ois	transiently	be	VBZ	B-VP	Otransiently	phosphorylated	transiently	RB	I-VP	Ophosphorylated	on	phosphorylate	VBN	I-VP	Oon	tyrosine	on	IN	B-PP	Otyrosine	following	tyrosine	NN	B-NP	Ofollowing	B	follow	VBG	B-PP	OB	cell	B	NN	B-NP	Ocell	receptor	cell	NN	I-NP	Oreceptor	engagement	receptor	NN	I-NP	Oengagement	.	engagement	NN	I-NP	O.	BAP/TFII-I	.	.	O	OBAP/TFII-I	is	BAP/TFII-I	NN	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	substrate	a	DT	B-NP	Osubstrate	for	substrate	NN	I-NP	Ofor	Btk	for	IN	B-PP	OBtk	in	Btk	NN	B-NP	B-proteinin	vitro	in	FW	B-ADVP	Ovitro	and	vitro	FW	I-ADVP	Oand	is	and	CC	O	Ois	hyperphosphorylated	be	VBZ	B-VP	Ohyperphosphorylated	on	hyperphosphorylate	VBN	I-VP	Oon	tyrosine	on	IN	B-PP	Otyrosine	upon	tyrosine	NN	B-NP	Oupon	coexpression	upon	IN	B-PP	Ocoexpression	with	coexpression	NN	B-NP	Owith	Btk	with	IN	B-PP	OBtk	in	Btk	NN	B-NP	B-proteinin	mammalian	in	IN	B-PP	Omammalian	cells	mammalian	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	an	In	IN	B-PP	Oan	effort	an	DT	B-NP	Oeffort	to	effort	NN	I-NP	Oto	understand	to	TO	B-VP	Ounderstand	the	understand	VB	I-VP	Othe	physiologic	the	DT	B-NP	Ophysiologic	consequences	physiologic	JJ	I-NP	Oconsequences	of	consequence	NNS	I-NP	Oof	BAP/TFII-I	of	IN	B-PP	OBAP/TFII-I	tyrosine	BAP/TFII-I	NN	B-NP	Otyrosine	phosphorylation	tyrosine	NN	I-NP	Ophosphorylation	following	phosphorylation	NN	I-NP	Ofollowing	B	follow	VBG	B-PP	OB	cell	B	NN	B-NP	B-proteincell	receptor	cell	NN	I-NP	I-proteinreceptor	stimulation	receptor	NN	I-NP	I-proteinstimulation	","	stimulation	NN	I-NP	O","	site-directed	","	","	O	Osite-directed	mutagenesis	site-directed	JJ	B-NP	Omutagenesis	and	mutagenesis	NN	I-NP	Oand	phosphopeptide	and	CC	I-NP	Ophosphopeptide	mapping	phosphopeptide	NN	I-NP	Omapping	were	mapping	NN	I-NP	Owere	used	be	VBD	B-VP	Oused	to	use	VBN	I-VP	Oto	locate	to	TO	B-VP	Olocate	the	locate	VB	I-VP	Othe	predominant	the	DT	B-NP	Opredominant	sites	predominant	JJ	I-NP	Osites	of	site	NNS	I-NP	Oof	BAP/TFII-I	of	IN	B-PP	OBAP/TFII-I	phosphorylation	BAP/TFII-I	NN	B-NP	B-proteinphosphorylation	by	phosphorylation	NN	I-NP	Oby	Btk	by	IN	B-PP	OBtk	in	Btk	NN	B-NP	B-proteinin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	These	.	.	O	OThese	residues	These	DT	B-NP	Oresidues	","	residue	NNS	I-NP	O","	Tyr248	","	","	O	OTyr248	","	Tyr248	NN	B-NP	O","	Tyr357	","	","	O	OTyr357	","	Tyr357	NN	B-NP	O","	and	","	","	O	Oand	Tyr462	and	CC	O	OTyr462	","	Tyr462	NN	B-NP	O","	were	","	","	O	Owere	also	be	VBD	B-VP	Oalso	found	also	RB	I-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	the	be	VB	I-VP	Othe	major	the	DT	B-NP	Omajor	sites	major	JJ	I-NP	Osites	for	site	NNS	I-NP	Ofor	Btk	for	IN	B-PP	OBtk	#NAME?	Btk	NN	B-NP	B-protein#NAME?	phosphorylation	#NAME?	JJ	I-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	BAP/TFII-I	of	IN	B-PP	OBAP/TFII-I	in	BAP/TFII-I	NN	B-NP	B-proteinin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	Residues	.	.	O	OResidues	Tyr357	Residue	NNS	B-NP	OTyr357	and	Tyr357	NN	I-NP	Oand	Tyr462	and	CC	I-NP	OTyr462	are	Tyr462	NN	I-NP	Oare	contained	be	VBP	B-VP	Ocontained	within	contain	VBN	I-VP	Owithin	the	within	IN	B-PP	Othe	loop	the	DT	B-NP	Oloop	regions	loop	NN	I-NP	B-proteinregions	of	region	NNS	I-NP	I-proteinof	adjacent	of	IN	B-PP	Oadjacent	helix-loop-helix-like	adjacent	JJ	B-NP	B-DNAhelix-loop-helix-like	repeats	helix-loop-helix-like	JJ	I-NP	I-DNArepeats	within	repeat	NNS	I-NP	I-DNAwithin	BAP/TFII-I	within	IN	B-PP	OBAP/TFII-I	.	BAP/TFII-I	NN	B-NP	B-protein.	Mutation	.	.	O	OMutation	of	Mutation	NN	B-NP	Oof	either	of	IN	B-PP	Oeither	Tyr248	either	DT	B-NP	OTyr248	","	Tyr248	NN	I-NP	O","	Tyr357	","	","	O	OTyr357	","	Tyr357	NN	B-NP	O","	or	","	","	O	Oor	Tyr462	or	CC	O	OTyr462	to	Tyr462	NN	B-NP	Oto	phenylalanine	to	TO	B-PP	Ophenylalanine	reduced	phenylalanine	NN	B-NP	Oreduced	transcription	reduce	VBD	B-VP	Otranscription	from	transcription	NN	B-NP	Ofrom	a	from	IN	B-PP	Oa	c-fos	a	DT	B-NP	Oc-fos	promoter	c-fos	NN	I-NP	B-DNApromoter	relative	promoter	NN	I-NP	I-DNArelative	to	relative	JJ	B-ADVP	Oto	wild-type	to	TO	B-PP	Owild-type	BAP/TFII-I	wild-type	JJ	B-NP	B-proteinBAP/TFII-I	in	BAP/TFII-I	NN	I-NP	I-proteinin	transfected	in	IN	B-PP	Otransfected	COS-7	transfecte	VBN	B-NP	B-cell_lineCOS-7	cells	COS-7	NN	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	consistent	","	","	O	Oconsistent	with	consistent	JJ	B-ADJP	Owith	the	with	IN	B-PP	Othe	interpretation	the	DT	B-NP	Ointerpretation	that	interpretation	NN	I-NP	Othat	phosphorylation	that	IN	B-SBAR	Ophosphorylation	at	phosphorylation	NN	B-NP	Oat	these	at	IN	B-PP	Othese	sites	these	DT	B-NP	Osites	contributes	site	NNS	I-NP	Ocontributes	to	contribute	VBZ	B-VP	Oto	transcriptional	to	TO	B-PP	Otranscriptional	activation	transcriptional	JJ	B-NP	Oactivation	.	activation	NN	I-NP	O.	Phosphorylation	.	.	O	OPhosphorylation	of	Phosphorylation	NN	B-NP	Oof	BAP/TFII-I	of	IN	B-PP	OBAP/TFII-I	by	BAP/TFII-I	NN	B-NP	B-proteinby	Btk	by	IN	B-PP	OBtk	may	Btk	NN	B-NP	B-proteinmay	link	may	MD	B-VP	Olink	engagement	link	VB	I-VP	Oengagement	of	engagement	NN	B-NP	Oof	receptors	of	IN	B-PP	Oreceptors	such	receptor	NNS	B-NP	Osuch	as	such	JJ	B-PP	Oas	surface	as	IN	I-PP	Osurface	immunoglobulin	surface	NN	B-NP	B-proteinimmunoglobulin	to	immunoglobulin	NN	I-NP	I-proteinto	modulation	to	TO	B-PP	Omodulation	of	modulation	NN	B-NP	Oof	gene	of	IN	B-PP	Ogene	expression	gene	NN	B-NP	Oexpression	.	expression	NN	I-NP	O.	Expression	.	.	O	OExpression	of	Expression	NN	B-NP	Oof	interferon	of	IN	B-PP	Ointerferon	consensus	interferon	NN	B-NP	B-proteinconsensus	sequence	consensus	NN	I-NP	I-proteinsequence	binding	sequence	NN	I-NP	I-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	induces	protein	NN	I-NP	I-proteininduces	potent	induce	VBZ	B-VP	Opotent	immunity	potent	JJ	B-NP	Oimmunity	against	immunity	NN	I-NP	Oagainst	BCR/ABL-induced	against	IN	B-PP	OBCR/ABL-induced	leukemia	BCR/ABL-induced	JJ	B-NP	Oleukemia	.	leukemia	NN	I-NP	O.	Mice	.	.	O	OMice	deficient	Mouse	NNS	B-NP	Odeficient	in	deficient	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	interferon	the	DT	B-NP	Ointerferon	consensus	interferon	NN	I-NP	B-proteinconsensus	sequence	consensus	NN	I-NP	I-proteinsequence	binding	sequence	NN	I-NP	I-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	ICSBP	(	(	O	OICSBP	)	ICSBP	NN	B-NP	B-protein)	develop	)	)	O	Odevelop	a	develop	VBP	B-VP	Oa	disease	a	DT	B-NP	Odisease	resembling	disease	NN	I-NP	Oresembling	chronic	resemble	VBG	B-VP	Ochronic	myeloid	chronic	JJ	B-NP	Omyeloid	leukemia	myeloid	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	CML	(	(	O	OCML	)	CML	NN	B-NP	O)	","	)	)	O	O","	which	","	","	O	Owhich	in	which	WDT	B-NP	Oin	humans	in	IN	B-PP	Ohumans	is	human	NNS	B-NP	Ois	caused	be	VBZ	B-VP	Ocaused	by	cause	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	BCR/ABL	the	DT	B-NP	OBCR/ABL	oncoprotein	BCR/ABL	NN	I-NP	B-proteinoncoprotein	.	oncoprotein	NN	I-NP	I-protein.	Interferon-alpha	.	.	O	OInterferon-alpha	(	Interferon-alpha	NN	B-NP	B-protein(	IFN-alpha	(	(	O	OIFN-alpha	)	IFN-alpha	NN	B-NP	B-protein)	induces	)	)	O	Oinduces	ICSBP	induce	VBZ	B-VP	OICSBP	expression	ICSBP	NN	B-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	is	and	CC	O	Ois	an	be	VBZ	B-VP	Oan	effective	an	DT	B-NP	Oeffective	therapy	effective	JJ	I-NP	Otherapy	for	therapy	NN	I-NP	Ofor	CML	for	IN	B-PP	OCML	.	CML	NN	B-NP	O.	This	.	.	O	OThis	study	This	DT	B-NP	Ostudy	examined	study	NN	I-NP	Oexamined	whether	examine	VBD	B-VP	Owhether	enforced	whether	IN	B-SBAR	Oenforced	expression	enforce	VBN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	ICSBP	of	IN	B-PP	OICSBP	might	ICSBP	NN	B-NP	B-proteinmight	antagonize	might	MD	B-VP	Oantagonize	BCR/ABL-induced	antagonize	VB	I-VP	OBCR/ABL-induced	leukemia	BCR/ABL-induced	JJ	B-NP	Oleukemia	;	leukemia	NN	I-NP	O;	results	;	:	O	Oresults	demonstrated	result	NNS	B-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	ICSBP-modified	that	IN	B-SBAR	OICSBP-modified	cells	ICSBP-modified	JJ	B-NP	B-cell_linecells	generated	cell	NNS	I-NP	I-cell_linegenerated	a	generate	VBD	B-VP	Oa	protective	a	DT	B-NP	Oprotective	CD8	protective	JJ	I-NP	OCD8	(	CD8	NN	I-NP	O(	+	(	(	O	O+	)	+	SYM	O	O)	cytotoxic	)	)	O	Ocytotoxic	T-cell	cytotoxic	JJ	B-NP	OT-cell	response	T-cell	NN	I-NP	Oresponse	against	response	NN	I-NP	Oagainst	BCR/ABL-transformed	against	IN	B-PP	OBCR/ABL-transformed	BaF3	BCR/ABL-transformed	JJ	B-NP	B-cell_lineBaF3	cells	BaF3	NN	I-NP	I-cell_linecells	in	cell	NNS	I-NP	I-cell_linein	a	in	IN	B-PP	Oa	murine	a	DT	B-NP	Omurine	leukemia	murine	JJ	I-NP	Oleukemia	model	leukemia	NN	I-NP	Omodel	.	model	NN	I-NP	O.	ICSBP	.	.	O	OICSBP	expression	ICSBP	NN	B-NP	B-proteinexpression	represents	expression	NN	I-NP	Orepresents	a	represent	VBZ	B-VP	Oa	novel	a	DT	B-NP	Onovel	means	novel	JJ	I-NP	Omeans	of	mean	NNS	I-NP	Oof	stimulating	of	IN	B-PP	Ostimulating	a	stimulate	VBG	B-VP	Oa	host	a	DT	B-NP	Ohost	immune	host	NN	I-NP	Oimmune	response	immune	JJ	I-NP	Oresponse	to	response	NN	I-NP	Oto	BCR/ABL	to	TO	B-PP	OBCR/ABL	(	BCR/ABL	NN	B-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	leukemia	)	)	O	I-cell_typeleukemia	cells	leukemia	NN	B-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	a	and	CC	O	Oa	potential	a	DT	B-NP	Opotential	strategy	potential	JJ	I-NP	Ostrategy	for	strategy	NN	I-NP	Ofor	immunotherapy	for	IN	B-PP	Oimmunotherapy	of	immunotherapy	NN	B-NP	Oof	CML	of	IN	B-PP	OCML	.	CML	NN	B-NP	O.	(	.	.	O	O(	Blood.	(	(	O	OBlood.	2001	Blood.	NNP	B-NP	O2001	;	2001	CD	I-NP	O;	97	;	:	O	O97	:	97	CD	B-NP	O:	3491-3497	:	:	O	O3491-3497	)	3491-3497	CD	B-NP	O)	A	)	)	O	OA	transcriptional	A	DT	B-NP	Otranscriptional	block	transcriptional	JJ	I-NP	Oblock	in	block	NN	I-NP	Oin	the	in	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	at	promoter	NN	I-NP	I-DNAat	the	at	IN	B-PP	Othe	-150	the	DT	B-NP	O-150	AP-1	-150	CD	I-NP	B-DNAAP-1	site	AP-1	NN	I-NP	I-DNAsite	in	site	NN	I-NP	I-DNAin	effector	in	IN	B-PP	Oeffector	CD8+	effector	NN	B-NP	B-cell_typeCD8+	T	CD8+	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Both	.	.	O	OBoth	CD4+	Both	CC	O	OCD4+	and	CD4+	JJ	B-NP	B-cell_typeand	CD8+	and	CC	I-NP	I-cell_typeCD8+	T	CD8+	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	that	cell	NNS	I-NP	I-cell_typethat	produce	that	WDT	B-NP	Oproduce	IL-2	produce	VBP	B-VP	OIL-2	in	IL-2	NN	B-NP	B-proteinin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	Ag	to	TO	B-PP	OAg	recognition	Ag	NN	B-NP	Orecognition	have	recognition	NN	I-NP	Ohave	been	have	VBP	B-VP	Obeen	isolated	be	VBN	I-VP	Oisolated	.	isolate	VBN	I-VP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	most	","	","	O	Omost	effector	most	JJS	B-NP	Oeffector	CD8+	effector	NN	I-NP	OCD8+	T	CD8+	JJ	I-NP	OT	cells	T	NN	I-NP	Ocells	recovered	cell	NNS	I-NP	Orecovered	after	recover	VBN	B-VP	Oafter	exposure	after	IN	B-PP	Oexposure	to	exposure	NN	B-NP	Oto	Ag	to	TO	B-PP	OAg	do	Ag	NN	B-NP	B-proteindo	not	do	VBP	B-VP	Onot	produce	not	RB	I-VP	Oproduce	sufficient	produce	VB	I-VP	Osufficient	IL-2	sufficient	JJ	B-NP	OIL-2	to	IL-2	NN	I-NP	B-proteinto	sustain	to	TO	B-VP	Osustain	growth	sustain	VB	I-VP	Ogrowth	","	growth	NN	B-NP	O","	and	","	","	O	Oand	depend	and	CC	O	Odepend	on	depend	VB	B-VP	Oon	CD4+	on	IN	B-PP	OCD4+	T	CD4+	JJ	B-NP	B-cell_typeT	helper	T	NN	I-NP	I-cell_typehelper	cells	helper	NN	I-NP	I-cell_typecells	for	cell	NNS	I-NP	I-cell_typefor	this	for	IN	B-PP	Othis	obligate	this	DT	B-NP	Oobligate	growth	obligate	JJ	I-NP	B-proteingrowth	factor	growth	NN	I-NP	I-proteinfactor	.	factor	NN	I-NP	I-protein.	IL-2	.	.	O	OIL-2	expression	IL-2	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	CD4+	in	IN	B-PP	OCD4+	T	CD4+	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	is	cell	NNS	I-NP	I-cell_typeis	primarily	be	VBZ	B-VP	Oprimarily	controlled	primarily	RB	I-VP	Ocontrolled	at	control	VBN	I-VP	Oat	the	at	IN	B-PP	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	","	transcription	NN	B-NP	O","	but	","	","	O	Obut	mechanisms	but	CC	O	Omechanisms	restricting	mechanism	NNS	B-NP	Orestricting	IL-2	restrict	VBG	B-VP	OIL-2	production	IL-2	NN	B-NP	B-proteinproduction	in	production	NN	I-NP	Oin	CD8+	in	IN	B-PP	OCD8+	T	CD8+	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	have	cell	NNS	I-NP	I-cell_typehave	not	have	VBP	B-VP	Onot	been	not	RB	I-VP	Obeen	elucidated	be	VBN	I-VP	Oelucidated	.	elucidate	VBN	I-VP	O.	To	.	.	O	OTo	evaluate	To	TO	B-VP	Oevaluate	transcriptional	evaluate	VB	I-VP	Otranscriptional	regulation	transcriptional	JJ	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	gene	IL-2	NN	I-NP	B-DNAgene	in	gene	NN	I-NP	I-DNAin	CD8+	in	IN	B-PP	OCD8+	T	CD8+	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	we	","	","	O	Owe	stably	we	PRP	B-NP	Ostably	transfected	stably	RB	B-VP	Otransfected	reporter	transfecte	VBN	I-VP	Oreporter	genes	reporter	NN	B-NP	B-DNAgenes	into	gene	NNS	I-NP	I-DNAinto	Ag	into	IN	B-PP	OAg	#NAME?	Ag	NN	B-NP	B-cell_line#NAME?	CD8+	#NAME?	JJ	B-NP	I-cell_lineCD8+	T	CD8+	JJ	I-NP	I-cell_lineT	cell	T	NN	I-NP	I-cell_linecell	clones	cell	NN	I-NP	I-cell_lineclones	.	clone	NNS	I-NP	I-cell_line.	CD28+	.	.	O	OCD28+	CD8	CD28+	JJ	B-NP	B-cell_typeCD8	(	CD8	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	unable	cell	NNS	I-NP	I-cell_typeunable	to	unable	JJ	B-ADJP	Oto	transcribe	to	TO	B-VP	Otranscribe	the	transcribe	VB	I-VP	Othe	IL-2	the	DT	B-NP	OIL-2	gene	IL-2	NN	I-NP	B-DNAgene	in	gene	NN	I-NP	I-DNAin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	antigenic	to	TO	B-PP	Oantigenic	stimulation	antigenic	JJ	B-NP	Ostimulation	had	stimulation	NN	I-NP	Ohad	a	have	VBD	B-VP	Oa	block	a	DT	B-NP	Oblock	in	block	NN	I-NP	Oin	transactivation	in	IN	B-PP	Otransactivation	of	transactivation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	-150	the	DT	B-NP	O-150	CD28	-150	CD	I-NP	B-DNACD28	response	CD28	NN	I-NP	I-DNAresponse	element	response	NN	I-NP	I-DNAelement	(	element	NN	I-NP	I-DNA(	CD28RE	(	(	O	OCD28RE	)	CD28RE	NN	B-NP	B-DNA)	/AP-1	)	)	O	O/AP-1	site	/AP-1	NN	B-NP	B-proteinsite	of	site	NN	I-NP	Oof	the	of	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	","	promoter	NN	I-NP	I-DNA","	but	","	","	O	Obut	did	but	CC	O	Odid	transactivate	do	VBD	B-VP	Otransactivate	the	transactivate	VB	I-VP	Othe	composite	the	DT	B-NP	Ocomposite	NFAT/AP-1	composite	JJ	I-NP	B-DNANFAT/AP-1	and	NFAT/AP-1	NN	I-NP	I-DNAand	OCT/AP-1	and	CC	I-NP	I-DNAOCT/AP-1	sites	OCT/AP-1	NN	I-NP	I-DNAsites	","	site	NNS	I-NP	I-DNA","	and	","	","	O	Oand	a	and	CC	O	Oa	consensus	a	DT	B-NP	Oconsensus	AP-1	consensus	NN	I-NP	B-DNAAP-1	motif	AP-1	NN	I-NP	I-DNAmotif	.	motif	NN	I-NP	I-DNA.	Mutation	.	.	O	OMutation	of	Mutation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	nonconsensus	the	DT	B-NP	Ononconsensus	-150	nonconsensus	JJ	I-NP	B-DNA-150	AP-1	-150	CD	I-NP	I-DNAAP-1	site	AP-1	NN	I-NP	I-DNAsite	to	site	NN	I-NP	I-DNAto	a	to	TO	B-PP	Oa	consensus	a	DT	B-NP	Oconsensus	AP-1	consensus	NN	I-NP	B-DNAAP-1	site	AP-1	NN	I-NP	I-DNAsite	","	site	NN	I-NP	I-DNA","	or	","	","	O	Oor	insertion	or	CC	O	Oinsertion	of	insertion	NN	B-NP	Oof	a	of	IN	B-PP	Oa	CD28RE/AP-1	a	DT	B-NP	OCD28RE/AP-1	consensus	CD28RE/AP-1	NN	I-NP	B-DNAconsensus	site	consensus	NN	I-NP	I-DNAsite	upstream	site	NN	I-NP	I-DNAupstream	of	upstream	JJ	B-ADJP	Oof	the	of	IN	B-PP	Othe	native	the	DT	B-NP	Onative	-150	native	JJ	I-NP	B-DNA-150	CD28RE/AP-1	-150	CD	I-NP	I-DNACD28RE/AP-1	site	CD28RE/AP-1	NN	I-NP	I-DNAsite	restored	site	NN	I-NP	I-DNArestored	transactivation	restore	VBD	B-VP	Otransactivation	of	transactivation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	altered	the	DT	B-NP	Oaltered	promoter	altered	JJ	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	defect	the	DT	B-NP	Odefect	at	defect	NN	I-NP	Oat	the	at	IN	B-PP	Othe	-150	the	DT	B-NP	O-150	site	-150	CD	I-NP	B-DNAsite	may	site	NN	I-NP	I-DNAmay	reflect	may	MD	B-VP	Oreflect	the	reflect	VB	I-VP	Othe	absence	the	DT	B-NP	Oabsence	or	absence	NN	I-NP	Oor	inactivity	or	CC	I-NP	Oinactivity	of	inactivity	NN	I-NP	Oof	a	of	IN	B-PP	Oa	required	a	DT	B-NP	Orequired	factor	required	JJ	I-NP	Ofactor	rather	factor	NN	I-NP	Orather	than	rather	RB	B-CONJP	Othan	repression	than	IN	I-CONJP	Orepression	of	repression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Stem	.	.	O	OStem	cell	Stem	NN	B-NP	B-proteincell	factor	cell	NN	I-NP	I-proteinfactor	and	factor	NN	I-NP	I-proteinand	interleukin-3	and	CC	O	Ointerleukin-3	induce	interleukin-3	NN	B-NP	B-proteininduce	stepwise	induce	VBP	B-VP	Ostepwise	generation	stepwise	JJ	B-NP	Ogeneration	of	generation	NN	I-NP	Oof	erythroid	of	IN	B-PP	Oerythroid	precursor	erythroid	JJ	B-NP	B-cell_typeprecursor	cells	precursor	NN	I-NP	I-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	a	from	IN	B-PP	Oa	basic	a	DT	B-NP	Obasic	fibroblast	basic	JJ	I-NP	B-proteinfibroblast	growth	fibroblast	NN	I-NP	I-proteingrowth	factor	growth	NN	I-NP	I-proteinfactor	#NAME?	factor	NN	I-NP	I-protein#NAME?	hematopoietic	#NAME?	JJ	I-NP	Ohematopoietic	stem	hematopoietic	JJ	I-NP	Ostem	cell	stem	NN	I-NP	Ocell	line	cell	NN	I-NP	Oline	","	line	NN	I-NP	O","	A-6	","	","	O	OA-6	.	A-6	NN	B-NP	B-protein.	A	.	.	O	OA	m	A	DT	B-NP	Om	ultipotent	m	NN	I-NP	Oultipotent	immature	ultipotent	JJ	I-NP	Oimmature	myeloid	immature	JJ	I-NP	Omyeloid	cell	myeloid	JJ	I-NP	Ocell	population	cell	NN	I-NP	Opopulation	was	population	NN	I-NP	Owas	produced	be	VBD	B-VP	Oproduced	from	produce	VBN	I-VP	Ofrom	a	from	IN	B-PP	Oa	basic	a	DT	B-NP	Obasic	fibroblast	basic	JJ	I-NP	B-proteinfibroblast	growth	fibroblast	NN	I-NP	I-proteingrowth	factor	growth	NN	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	bFGF	(	(	O	ObFGF	)	bFGF	NN	B-NP	B-protein)	#NAME?	)	)	O	O#NAME?	hematopoietic	#NAME?	JJ	B-NP	Ohematopoietic	stem	hematopoietic	JJ	I-NP	Ostem	cell	stem	NN	I-NP	Ocell	line	cell	NN	I-NP	Oline	","	line	NN	I-NP	O","	A-6	","	","	O	OA-6	","	A-6	NN	B-NP	B-protein","	when	","	","	O	Owhen	cultured	when	WRB	B-ADVP	Ocultured	with	culture	VBN	B-VP	Owith	stem	with	IN	B-PP	Ostem	cell	stem	NN	B-NP	B-proteincell	factor	cell	NN	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	SCF	(	(	O	OSCF	)	SCF	NN	B-NP	B-protein)	replacing	)	)	O	Oreplacing	bFGF	replace	VBG	B-VP	ObFGF	.	bFGF	NN	B-NP	B-protein.	Those	.	.	O	OThose	cells	Those	DT	B-NP	Ocells	were	cell	NNS	I-NP	Owere	positive	be	VBD	B-VP	Opositive	for	positive	JJ	B-ADJP	Ofor	stem	for	IN	B-PP	Ostem	cell	stem	NN	B-NP	B-proteincell	markers	cell	NN	I-NP	I-proteinmarkers	","	marker	NNS	I-NP	I-protein","	c-kit	","	","	O	Oc-kit	and	c-kit	NN	B-NP	B-proteinand	CD34	and	CC	I-NP	OCD34	","	CD34	NN	I-NP	B-protein","	and	","	","	O	Oand	a	and	CC	O	Oa	myeloid	a	DT	B-NP	Omyeloid	cell	myeloid	JJ	I-NP	B-proteincell	marker	cell	NN	I-NP	I-proteinmarker	","	marker	NN	I-NP	I-protein","	F4/80	","	","	O	OF4/80	.	F4/80	NN	B-NP	O.	Some	.	.	O	OSome	cell	Some	DT	B-NP	Ocell	fractions	cell	NN	I-NP	Ofractions	were	fraction	NNS	I-NP	Owere	also	be	VBD	B-VP	Oalso	positive	also	RB	B-ADVP	Opositive	for	positive	JJ	B-ADJP	Ofor	Mac-1	for	IN	B-PP	OMac-1	","	Mac-1	NN	B-NP	B-protein","	a	","	","	O	Oa	macrophage	a	DT	B-NP	Omacrophage	marker	macrophage	NN	I-NP	B-proteinmarker	or	marker	NN	I-NP	I-proteinor	Gr-1	or	CC	I-NP	OGr-1	","	Gr-1	NN	I-NP	B-protein","	a	","	","	O	Oa	granulocytic	a	DT	B-NP	Ogranulocytic	maker	granulocytic	JJ	I-NP	Omaker	","	maker	NN	I-NP	O","	but	","	","	O	Obut	negative	but	CC	O	Onegative	for	negative	JJ	B-ADJP	Ofor	an	for	IN	B-PP	Oan	erythroid	an	DT	B-NP	Oerythroid	marker	erythroid	JJ	I-NP	Omarker	TER119	marker	NN	I-NP	OTER119	.	TER119	NN	I-NP	O.	They	.	.	O	OThey	also	They	PRP	B-NP	Oalso	showed	also	RB	B-ADVP	Oshowed	the	show	VBD	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	mRNA	of	IN	B-PP	OmRNA	for	mRNA	NN	B-NP	B-RNAfor	the	for	IN	B-PP	Othe	myeloid-specific	the	DT	B-NP	Omyeloid-specific	PU.1	myeloid-specific	JJ	I-NP	OPU.1	but	PU.1	NN	I-NP	B-proteinbut	did	but	CC	O	Odid	not	do	VBD	B-VP	Onot	that	not	RB	O	Othat	for	that	DT	B-NP	Ofor	the	for	IN	B-PP	Othe	erythroid-specific	the	DT	B-NP	Oerythroid-specific	GATA-1	erythroid-specific	JJ	I-NP	B-proteinGATA-1	.	GATA-1	NN	I-NP	I-protein.	Among	.	.	O	OAmong	various	Among	IN	B-PP	Ovarious	cytokines	various	JJ	B-NP	Ocytokines	","	cytokine	NNS	I-NP	B-protein","	interleukin-3	","	","	O	Ointerleukin-3	(	interleukin-3	NN	B-NP	B-protein(	IL-3	(	(	O	OIL-3	)	IL-3	NN	B-NP	B-protein)	induced	)	)	O	Oinduced	erythroid	induce	VBD	B-VP	Oerythroid	precursor	erythroid	JJ	B-NP	B-cell_typeprecursor	cells	precursor	NN	I-NP	I-cell_typecells	that	cell	NNS	I-NP	I-cell_typethat	expressed	that	WDT	B-NP	Oexpressed	the	express	VBD	B-VP	Othe	erythroid-specific	the	DT	B-NP	Oerythroid-specific	GATA-1	erythroid-specific	JJ	I-NP	OGATA-1	and	GATA-1	NN	I-NP	B-proteinand	beta-major	and	CC	O	Obeta-major	globin	beta-major	JJ	B-NP	B-proteinglobin	.	globin	NN	I-NP	I-protein.	The	.	.	O	OThe	quantitative	The	DT	B-NP	Oquantitative	analysis	quantitative	JJ	I-NP	Oanalysis	showed	analysis	NN	I-NP	Oshowed	that	show	VBD	B-VP	Othat	erythroid	that	IN	B-SBAR	Oerythroid	precursor	erythroid	JJ	B-NP	B-cell_typeprecursor	cells	precursor	NN	I-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	newly	be	VBD	B-VP	Onewly	produced	newly	RB	I-VP	Oproduced	from	produce	VBN	I-VP	Ofrom	the	from	IN	B-PP	Othe	immature	the	DT	B-NP	Oimmature	myeloid	immature	JJ	I-NP	B-cell_typemyeloid	cells	myeloid	JJ	I-NP	I-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	cultivation	by	IN	B-PP	Ocultivation	with	cultivation	NN	B-NP	Owith	IL-3	with	IN	B-PP	OIL-3	.	IL-3	NN	B-NP	B-protein.	SCF	.	.	O	OSCF	and	SCF	NN	B-NP	B-proteinand	IL-3	and	CC	I-NP	OIL-3	induced	IL-3	NN	I-NP	B-proteininduced	stepwise	induce	VBD	B-VP	Ostepwise	generation	stepwise	JJ	B-NP	Ogeneration	of	generation	NN	I-NP	Oof	erythroid	of	IN	B-PP	Oerythroid	precursor	erythroid	JJ	B-NP	B-cell_typeprecursor	cells	precursor	NN	I-NP	I-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	an	from	IN	B-PP	Oan	A-6	an	DT	B-NP	OA-6	hematopoietic	A-6	NN	I-NP	B-cell_linehematopoietic	stem	hematopoietic	JJ	I-NP	I-cell_linestem	cell	stem	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	.	line	NN	I-NP	I-cell_line.	Copyright	.	.	O	OCopyright	2001	Copyright	NN	B-NP	O2001	Academic	2001	CD	I-NP	OAcademic	Press	Academic	NNP	I-NP	OPress	.	Press	NNP	I-NP	O.	Distinct	.	.	O	ODistinct	BMI-1	Distinct	JJ	B-NP	OBMI-1	and	BMI-1	NN	I-NP	B-proteinand	EZH2	and	CC	I-NP	OEZH2	expression	EZH2	NN	I-NP	B-proteinexpression	patterns	expression	NN	I-NP	Opatterns	in	pattern	NNS	I-NP	Oin	thymocytes	in	IN	B-PP	Othymocytes	and	thymocyte	NNS	B-NP	B-cell_typeand	mature	and	CC	O	Omature	T	mature	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	suggest	cell	NNS	I-NP	I-cell_typesuggest	a	suggest	VBP	B-VP	Oa	role	a	DT	B-NP	Orole	for	role	NN	I-NP	Ofor	Polycomb	for	IN	B-PP	OPolycomb	genes	Polycomb	NN	B-NP	B-DNAgenes	in	gene	NNS	I-NP	I-DNAin	human	in	IN	B-PP	Ohuman	T	human	JJ	B-NP	B-cell_typeT	cell	T	NN	I-NP	I-cell_typecell	differentiation	cell	NN	I-NP	I-cell_typedifferentiation	.	differentiation	NN	I-NP	O.	BMI-1	.	.	O	OBMI-1	and	BMI-1	NN	B-NP	B-proteinand	EZH2	and	CC	I-NP	OEZH2	Polycomb-group	EZH2	NN	I-NP	B-proteinPolycomb-group	(	Polycomb-group	NN	I-NP	I-protein(	PcG	(	(	O	I-proteinPcG	)	PcG	NN	B-NP	I-protein)	proteins	)	)	O	I-proteinproteins	belong	protein	NNS	B-NP	I-proteinbelong	to	belong	VBP	B-VP	Oto	two	to	TO	B-PP	Otwo	distinct	two	CD	B-NP	Odistinct	protein	distinct	JJ	I-NP	Oprotein	complexes	protein	NN	I-NP	B-proteincomplexes	involved	complex	NNS	I-NP	I-proteininvolved	in	involve	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	hematopoiesis	of	IN	B-PP	Ohematopoiesis	.	hematopoiesis	NN	B-NP	O.	Using	.	.	O	OUsing	unique	Use	VBG	B-VP	Ounique	PcG-specific	unique	JJ	B-NP	OPcG-specific	antisera	PcG-specific	JJ	I-NP	Oantisera	and	antiserum	NNS	I-NP	Oand	triple	and	CC	O	Otriple	immunofluorescence	triple	JJ	B-NP	Oimmunofluorescence	","	immunofluorescence	NN	I-NP	O","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	mature	that	IN	B-SBAR	Omature	resting	mature	JJ	B-NP	B-cell_typeresting	peripheral	rest	VBG	I-NP	I-cell_typeperipheral	T	peripheral	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	expressed	cell	NNS	I-NP	I-cell_typeexpressed	BMI-1	express	VBD	B-VP	OBMI-1	","	BMI-1	NN	B-NP	B-protein","	whereas	","	","	O	Owhereas	dividing	whereas	IN	B-PP	Odividing	blasts	divide	VBG	B-NP	B-cell_typeblasts	were	blast	NNS	I-NP	I-cell_typewere	EZH2	be	VBD	B-VP	OEZH2	(	EZH2	NN	B-NP	B-protein(	+	(	(	O	O+	)	+	SYM	B-NP	O)	.	)	)	O	O.	By	.	.	O	OBy	contrast	By	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	subcapsular	","	","	O	Osubcapsular	immature	subcapsular	JJ	B-NP	Oimmature	double-negative	immature	JJ	I-NP	Odouble-negative	(	double-negative	JJ	I-NP	O(	DN	(	(	O	ODN	)	DN	JJ	B-ADJP	O)	(	)	)	O	O(	CD4	(	(	O	OCD4	(	CD4	NN	B-NP	O(	-	(	(	O	O-	)	-	SYM	O	O)	/CD8	)	)	O	O/CD8	(	/CD8	NN	B-NP	B-protein(	-	(	(	O	O-	)	-	SYM	B-NP	O)	)	)	)	O	O)	T	)	)	O	OT	cells	T	NN	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	the	in	IN	B-PP	Othe	thymus	the	DT	B-NP	Othymus	coexpressed	thymus	NN	I-NP	Ocoexpressed	BMI-1	coexpresse	VBD	B-VP	OBMI-1	and	BMI-1	NN	B-NP	B-proteinand	EZH2	and	CC	I-NP	OEZH2	or	EZH2	NN	I-NP	B-proteinor	were	or	CC	O	Owere	BMI-1	be	VBD	B-VP	OBMI-1	single	BMI-1	NN	B-NP	B-proteinsingle	positive	single	JJ	B-ADJP	Opositive	.	positive	JJ	I-ADJP	O.	Their	.	.	O	OTheir	descendants	Their	PRP$	B-NP	Odescendants	","	descendant	NNS	I-NP	O","	double-positive	","	","	O	Odouble-positive	(	double-positive	JJ	B-ADJP	O(	DP	(	(	O	ODP	;	DP	NN	B-NP	O;	CD4	;	:	O	OCD4	(	CD4	NN	B-NP	O(	+	(	(	O	O+	)	+	SYM	O	O)	/CD8	)	)	O	O/CD8	(	/CD8	NN	B-NP	O(	+	(	(	O	O+	)	+	SYM	B-NP	O)	)	)	)	O	O)	cortical	)	)	O	Ocortical	thymocytes	cortical	JJ	B-NP	Othymocytes	","	thymocyte	NNS	I-NP	O","	expressed	","	","	O	Oexpressed	EZH2	express	VBD	B-VP	OEZH2	without	EZH2	NN	B-NP	B-proteinwithout	BMI-1	without	IN	B-PP	OBMI-1	.	BMI-1	NN	B-NP	B-protein.	Most	.	.	O	OMost	EZH2	Most	JJS	B-NP	OEZH2	(	EZH2	NN	I-NP	B-protein(	+	(	(	O	O+	)	+	SYM	O	O)	DN	)	)	O	ODN	and	DN	NN	B-NP	Oand	DP	and	CC	I-NP	ODP	thymocytes	DP	NN	I-NP	B-cell_typethymocytes	were	thymocyte	NNS	I-NP	I-cell_typewere	dividing	be	VBD	B-VP	Odividing	","	divide	VBG	I-VP	O","	while	","	","	O	Owhile	DN	while	IN	B-SBAR	ODN	BMI-1	DN	NN	B-NP	OBMI-1	(	BMI-1	NN	I-NP	O(	+	(	(	O	O+	)	+	SYM	O	O)	/EZH2	)	)	O	O/EZH2	(	/EZH2	NN	B-NP	B-protein(	-	(	(	O	O-	)	-	SYM	O	O)	thymocytes	)	)	O	Othymocytes	were	thymocyte	NNS	B-NP	B-cell_typewere	resting	be	VBD	B-VP	Oresting	and	rest	VBG	I-VP	Oand	proliferation	and	CC	O	Oproliferation	was	proliferation	NN	B-NP	Owas	occasionally	be	VBD	B-VP	Ooccasionally	noted	occasionally	RB	I-VP	Onoted	in	note	VBN	I-VP	Oin	DN	in	IN	B-PP	ODN	BMI-1	DN	NN	B-NP	B-cell_lineBMI-1	(	BMI-1	NN	I-NP	I-cell_line(	+	(	(	O	I-cell_line+	)	+	SYM	O	I-cell_line)	/EZH2	)	)	O	I-cell_line/EZH2	(	/EZH2	NN	B-NP	I-cell_line(	+	(	(	O	I-cell_line+	)	+	SYM	O	I-cell_line)	cells	)	)	O	I-cell_linecells	.	cell	NNS	B-NP	I-cell_line.	Maturation	.	.	O	OMaturation	of	Maturation	NN	B-NP	Oof	DP	of	IN	B-PP	ODP	cortical	DP	NN	B-NP	B-cell_typecortical	thymocytes	cortical	JJ	I-NP	I-cell_typethymocytes	to	thymocyte	NNS	I-NP	I-cell_typeto	single-positive	to	TO	B-PP	Osingle-positive	(	single-positive	JJ	B-NP	O(	CD4	(	(	O	OCD4	(	CD4	NN	B-NP	O(	+	(	(	O	O+	)	+	SYM	O	O)	/CD8	)	)	O	O/CD8	(	/CD8	NN	B-NP	B-protein(	-	(	(	O	O-	)	-	SYM	B-NP	O)	or	)	)	O	Oor	CD8	or	CC	O	OCD8	(	CD8	NN	B-NP	B-protein(	+	(	(	O	O+	)	+	SYM	O	O)	/CD4	)	)	O	O/CD4	(	/CD4	NN	B-NP	B-protein(	-	(	(	O	O-	)	-	SYM	B-NP	O)	)	)	)	O	O)	medullar	)	)	O	Omedullar	thymocytes	medullar	JJ	B-NP	Othymocytes	correlated	thymocyte	NNS	I-NP	Ocorrelated	with	correlate	VBD	B-VP	Owith	decreased	with	IN	B-PP	Odecreased	detectability	decrease	VBN	B-NP	Odetectability	of	detectability	NN	I-NP	Oof	EZH2	of	IN	B-PP	OEZH2	and	EZH2	NN	B-NP	B-proteinand	continued	and	CC	O	Ocontinued	relative	continue	VBD	B-NP	Orelative	absence	relative	JJ	I-NP	Oabsence	of	absence	NN	I-NP	Oof	BMI-1	of	IN	B-PP	OBMI-1	.	BMI-1	NN	B-NP	B-protein.	Our	.	.	O	OOur	data	Our	PRP$	B-NP	Odata	show	datum	NNS	I-NP	Oshow	that	show	VBP	B-VP	Othat	BMI-1	that	IN	B-SBAR	OBMI-1	and	BMI-1	NN	B-NP	B-proteinand	EZH2	and	CC	O	OEZH2	expression	EZH2	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	mature	in	IN	B-PP	Omature	peripheral	mature	JJ	B-NP	B-cell_typeperipheral	T	peripheral	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	is	cell	NNS	I-NP	I-cell_typeis	mutually	be	VBZ	B-VP	Omutually	exclusive	mutually	RB	B-ADJP	Oexclusive	and	exclusive	JJ	I-ADJP	Oand	linked	and	CC	O	Olinked	to	link	VBN	B-VP	Oto	proliferation	to	TO	B-PP	Oproliferation	status	proliferation	NN	B-NP	Ostatus	","	status	NN	I-NP	O","	and	","	","	O	Oand	that	and	CC	O	Othat	this	that	IN	B-SBAR	Othis	pattern	this	DT	B-NP	Opattern	is	pattern	NN	I-NP	Ois	not	be	VBZ	B-VP	Onot	yet	not	RB	I-VP	Oyet	established	yet	RB	I-VP	Oestablished	in	establish	VBN	I-VP	Oin	thymocytes	in	IN	B-PP	Othymocytes	of	thymocyte	NNS	B-NP	B-cell_typeof	the	of	IN	B-PP	Othe	cortex	the	DT	B-NP	Ocortex	and	cortex	NN	I-NP	Oand	medulla	and	CC	I-NP	Omedulla	.	medulla	NN	I-NP	O.	T	.	.	O	OT	cell	T	NN	B-NP	Ocell	stage-specific	cell	NN	I-NP	Ostage-specific	PcG	stage-specific	JJ	I-NP	OPcG	expression	PcG	NN	I-NP	Oexpression	profiles	expression	NN	I-NP	Oprofiles	suggest	profile	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	PcG	that	IN	B-SBAR	OPcG	genes	PcG	NN	B-NP	B-DNAgenes	contribute	gene	NNS	I-NP	I-DNAcontribute	to	contribute	VBP	B-VP	Oto	regulation	to	TO	B-PP	Oregulation	of	regulation	NN	B-NP	Oof	T	of	IN	B-PP	OT	cell	T	NN	B-NP	B-cell_typecell	differentiation	cell	NN	I-NP	I-cell_typedifferentiation	.	differentiation	NN	I-NP	O.	They	.	.	O	OThey	probably	They	PRP	B-NP	Oprobably	reflect	probably	RB	B-ADVP	Oreflect	stabilization	reflect	VBP	B-VP	Ostabilization	of	stabilization	NN	B-NP	Oof	cell	of	IN	B-PP	Ocell	type-specific	cell	NN	B-NP	B-DNAtype-specific	gene	type-specific	JJ	I-NP	I-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	and	expression	NN	I-NP	Oand	irreversibility	and	CC	O	Oirreversibility	of	irreversibility	NN	B-NP	Oof	lineage	of	IN	B-PP	Olineage	choice	lineage	NN	B-NP	Ochoice	.	choice	NN	I-NP	O.	The	.	.	O	OThe	difference	The	DT	B-NP	Odifference	in	difference	NN	I-NP	Oin	PcG	in	IN	B-PP	OPcG	expression	PcG	NN	B-NP	Oexpression	between	expression	NN	I-NP	Obetween	medullar	between	IN	B-PP	Omedullar	thymocytes	medullar	JJ	B-NP	B-cell_typethymocytes	and	thymocyte	NNS	I-NP	I-cell_typeand	mature	and	CC	O	Omature	interfollicular	mature	JJ	B-NP	B-cell_typeinterfollicular	T	interfollicular	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	indicates	cell	NNS	I-NP	I-cell_typeindicates	that	indicate	VBZ	B-VP	Othat	additional	that	IN	B-SBAR	Oadditional	maturation	additional	JJ	B-NP	Omaturation	processes	maturation	NN	I-NP	Oprocesses	occur	process	NNS	I-NP	Ooccur	after	occur	VBP	B-VP	Oafter	thymocyte	after	IN	B-SBAR	Othymocyte	transportation	thymocyte	NN	B-NP	Otransportation	from	transportation	NN	I-NP	Ofrom	the	from	IN	B-PP	Othe	thymus	the	DT	B-NP	Othymus	.	thymus	NN	I-NP	O.	Stepwise	.	.	O	OStepwise	lineage	Stepwise	JJ	B-NP	Olineage	restriction	lineage	NN	I-NP	Orestriction	of	restriction	NN	I-NP	Oof	progenitors	of	IN	B-PP	Oprogenitors	in	progenitor	NNS	B-NP	B-cell_typein	lympho-myelopoiesis	in	IN	B-PP	Olympho-myelopoiesis	.	lympho-myelopoiesis	NN	B-NP	O.	It	.	.	O	OIt	has	It	PRP	B-NP	Ohas	long	have	VBZ	B-VP	Olong	been	long	RB	I-VP	Obeen	controversial	be	VBN	I-VP	Ocontroversial	whether	controversial	JJ	B-ADJP	Owhether	hematopoiesis	whether	IN	B-SBAR	Ohematopoiesis	progresses	hematopoiesis	NN	B-NP	Oprogresses	through	progress	VBZ	B-VP	Othrough	ordered	through	IN	B-PP	Oordered	stages	order	VBN	B-NP	Ostages	of	stage	NNS	I-NP	Oof	determination	of	IN	B-PP	Odetermination	as	determination	NN	B-NP	Oas	in	as	IN	B-PP	Oin	embryonic	in	IN	B-PP	Oembryonic	development	embryonic	JJ	B-NP	Odevelopment	.	development	NN	I-NP	O.	This	.	.	O	OThis	is	This	DT	B-NP	Ois	due	be	VBZ	B-VP	Odue	to	due	IN	B-PP	Oto	the	to	TO	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	a	of	IN	B-PP	Oa	methodology	a	DT	B-NP	Omethodology	capable	methodology	NN	I-NP	Ocapable	of	capable	JJ	B-ADJP	Oof	exactly	of	IN	B-PP	Oexactly	determining	exactly	RB	B-VP	Odetermining	the	determine	VBG	I-VP	Othe	developmental	the	DT	B-NP	Odevelopmental	potential	developmental	JJ	I-NP	Opotential	of	potential	NN	I-NP	Oof	hematopoietic	of	IN	B-PP	Ohematopoietic	stem/progenitor	hematopoietic	JJ	B-NP	B-cell_typestem/progenitor	cells	stem/progenitor	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	multilineage	The	DT	B-NP	Omultilineage	progenitor	multilineage	JJ	I-NP	Oprogenitor	(	progenitor	NN	I-NP	O(	MLP	(	(	O	OMLP	)	MLP	NN	B-NP	O)	assay	)	)	O	Oassay	enabled	assay	NN	B-NP	Oenabled	us	enable	VBD	B-VP	Ous	to	us	PRP	B-NP	Oto	discriminate	to	TO	B-VP	Odiscriminate	among	discriminate	VB	I-VP	Oamong	seven	among	IN	B-PP	Oseven	types	seven	CD	B-NP	Otypes	of	type	NNS	I-NP	Oof	hematopoietic	of	IN	B-PP	Ohematopoietic	progenitors	hematopoietic	JJ	B-NP	B-cell_typeprogenitors	","	progenitor	NNS	I-NP	I-cell_type","	which	","	","	O	Owhich	are	which	WDT	B-NP	Oare	multipotent	be	VBP	B-VP	Omultipotent	progenitor	multipotent	JJ	B-NP	Oprogenitor	p-MTB	progenitor	NN	I-NP	Op-MTB	(	p-MTB	NN	I-NP	O(	capable	(	(	O	Ocapable	of	capable	JJ	B-ADJP	Oof	generating	of	IN	B-PP	Ogenerating	myeloid	generate	VBG	B-VP	Omyeloid	","	myeloid	JJ	B-NP	O","	T	","	","	I-NP	OT	and	T	NN	I-NP	B-cell_typeand	B	and	CC	I-NP	I-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	)	cell	NNS	I-NP	I-cell_type)	","	)	)	O	O","	bipotent	","	","	O	Obipotent	progenitors	bipotent	JJ	B-NP	B-cell_typeprogenitors	p-MT	progenitor	NNS	I-NP	I-cell_typep-MT	","	p-MT	NN	I-NP	O","	p-MB	","	","	I-NP	Op-MB	and	p-MB	NN	I-NP	B-proteinand	p-TB	and	CC	I-NP	Op-TB	","	p-TB	NN	I-NP	B-protein","	and	","	","	O	Oand	unipotent	and	CC	O	Ounipotent	progenitors	unipotent	JJ	B-NP	Oprogenitors	p-M	progenitor	NNS	I-NP	Op-M	","	p-M	NN	I-NP	O","	p-T	","	","	I-NP	Op-T	and	p-T	NN	I-NP	Oand	p-B	and	CC	I-NP	Op-B	.	p-B	NN	I-NP	O.	Among	.	.	O	OAmong	these	Among	IN	B-PP	Othese	seven	these	DT	B-NP	Oseven	types	seven	CD	I-NP	Otypes	","	type	NNS	I-NP	O","	the	","	","	O	Othe	p-TB	the	DT	B-NP	Op-TB	type	p-TB	NN	I-NP	B-proteintype	progenitor	type	NN	I-NP	I-proteinprogenitor	was	progenitor	NN	I-NP	I-proteinwas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	absent	be	VB	I-VP	Oabsent	.	absent	JJ	B-ADJP	O.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	indicate	finding	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	process	the	DT	B-NP	Oprocess	of	process	NN	I-NP	Oof	lineage	of	IN	B-PP	Olineage	commitment	lineage	NN	B-NP	Ocommitment	proceeds	commitment	NN	I-NP	Oproceeds	through	proceed	VBZ	B-VP	Othrough	an	through	IN	B-PP	Oan	ordered	an	DT	B-NP	Oordered	but	order	VBN	I-NP	Obut	not	but	CC	O	Onot	random	not	RB	O	Orandom	process	random	VB	B-VP	Oprocess	.	process	NN	B-NP	O.	By	.	.	O	OBy	extending	By	IN	B-PP	Oextending	the	extend	VBG	B-VP	Othe	area	the	DT	B-NP	Oarea	of	area	NN	I-NP	Oof	investigation	of	IN	B-PP	Oinvestigation	to	investigation	NN	B-NP	Oto	include	to	TO	B-VP	Oinclude	the	include	VB	I-VP	Othe	erythroid	the	DT	B-NP	Oerythroid	lineage	erythroid	JJ	I-NP	B-cell_typelineage	","	lineage	NN	I-NP	I-cell_type","	more	","	","	O	Omore	convincing	more	RBR	B-NP	Oconvincing	evidence	convincing	JJ	I-NP	Oevidence	for	evidence	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	ordered	the	DT	B-NP	Oordered	process	order	VBN	I-NP	Oprocess	was	process	NN	I-NP	Owas	obtained	be	VBD	B-VP	Oobtained	.	obtain	VBN	I-VP	O.	Detailed	.	.	O	ODetailed	and	Detailed	JJ	B-NP	Oand	exact	and	CC	I-NP	Oexact	illustration	exact	JJ	I-NP	Oillustration	of	illustration	NN	I-NP	Oof	the	of	IN	B-PP	Othe	process	the	DT	B-NP	Oprocess	of	process	NN	I-NP	Oof	hematopoiesis	of	IN	B-PP	Ohematopoiesis	will	hematopoiesis	NN	B-NP	Owill	provide	will	MD	B-VP	Oprovide	an	provide	VB	I-VP	Oan	opportunity	an	DT	B-NP	Oopportunity	to	opportunity	NN	I-NP	Oto	revive	to	TO	B-VP	Orevive	hematopoiesis	revive	VB	I-VP	Ohematopoiesis	as	hematopoiesis	NN	B-NP	Oas	one	as	IN	B-PP	Oone	of	one	CD	B-NP	Oof	the	of	IN	B-PP	Othe	most	the	DT	B-NP	Omost	fascinating	most	RBS	I-NP	Ofascinating	targets	fascinating	JJ	I-NP	Otargets	of	target	NNS	I-NP	Oof	research	of	IN	B-PP	Oresearch	in	research	NN	B-NP	Oin	developmental	in	IN	B-PP	Odevelopmental	biology	developmental	JJ	B-NP	Obiology	Epstein-Barr	biology	NN	I-NP	OEpstein-Barr	Virus	Epstein-Barr	JJ	B-NP	OVirus	and	Virus	NN	I-NP	Oand	its	and	CC	O	Oits	glycoprotein-350	its	PRP$	B-NP	Oglycoprotein-350	upregulate	glycoprotein-350	NN	I-NP	B-proteinupregulate	IL-6	upregulate	VBP	B-VP	OIL-6	in	IL-6	NN	B-NP	B-proteinin	human	in	IN	B-PP	Ohuman	B-lymphocytes	human	JJ	B-NP	B-cell_typeB-lymphocytes	via	B-lymphocyte	NNS	I-NP	I-cell_typevia	CD21	via	IN	B-PP	OCD21	","	CD21	NN	B-NP	B-protein","	involving	","	","	O	Oinvolving	activation	involve	VBG	B-VP	Oactivation	of	activation	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	and	NF-kappaB	NN	B-NP	B-proteinand	different	and	CC	O	Odifferent	signaling	different	JJ	B-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	.	pathway	NNS	I-NP	O.	Epstein-Barr	.	.	O	OEpstein-Barr	virus	Epstein-Barr	JJ	B-NP	Ovirus	(	virus	NN	I-NP	O(	EBV	(	(	O	OEBV	)	EBV	NN	B-NP	O)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	ubiquitous	a	DT	B-NP	Oubiquitous	and	ubiquitous	JJ	I-NP	Oand	highly	and	CC	I-NP	Ohighly	immunotropic	highly	RB	I-NP	Oimmunotropic	gamma	immunotropic	JJ	I-NP	Ogamma	herpesvirus	gamma	NN	I-NP	Oherpesvirus	that	herpesvirus	NN	I-NP	Othat	infects	that	WDT	B-NP	Oinfects	more	infect	VBZ	B-VP	Omore	than	more	JJR	B-NP	Othan	90	than	IN	I-NP	O90	%	90	CD	I-NP	O%	of	%	NN	I-NP	Oof	humans	of	IN	B-PP	Ohumans	worldwide	human	NNS	B-NP	Oworldwide	.	worldwide	RB	B-ADVP	O.	Its	.	.	O	OIts	pathogenicity	Its	PRP$	B-NP	Opathogenicity	leads	pathogenicity	NN	I-NP	Oleads	to	lead	VBZ	B-VP	Oto	a	to	TO	B-PP	Oa	number	a	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	diseases	of	IN	B-PP	Odiseases	including	disease	NNS	B-NP	Oincluding	tumors	include	VBG	B-PP	Otumors	that	tumor	NNS	B-NP	Othat	result	that	WDT	B-NP	Oresult	from	result	VBP	B-VP	Ofrom	EBV	from	IN	B-PP	OEBV	's	EBV	NN	B-NP	O's	ability	's	POS	B-NP	Oability	to	ability	NN	I-NP	Oto	readily	to	TO	B-VP	Oreadily	transform	readily	RB	I-VP	Otransform	B-lymphocytes	transform	VB	I-VP	OB-lymphocytes	and	B-lymphocyte	NNS	B-NP	B-cell_typeand	","	and	CC	O	O","	to	","	","	O	Oto	a	to	TO	B-PP	Oa	lesser	a	DT	B-NP	Olesser	extent	less	JJR	I-NP	Oextent	","	extent	NN	I-NP	O","	epithelial	","	","	O	Oepithelial	cells	epithelial	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	EBV	.	.	O	OEBV	utilizes	EBV	NN	B-NP	Outilizes	CD21/CR2	utilize	VBZ	B-VP	OCD21/CR2	as	CD21/CR2	NN	B-NP	B-proteinas	its	as	IN	B-PP	Oits	receptor	its	PRP$	B-NP	Oreceptor	on	receptor	NN	I-NP	Oon	B	on	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	initiate	to	TO	B-VP	Oinitiate	the	initiate	VB	I-VP	Othe	infection	the	DT	B-NP	Oinfection	process	infection	NN	I-NP	Oprocess	.	process	NN	I-NP	O.	EBV	.	.	O	OEBV	binds	EBV	NN	B-NP	Obinds	to	bind	VBZ	B-VP	Oto	CR2	to	TO	B-PP	OCR2	through	CR2	NN	B-NP	B-proteinthrough	its	through	IN	B-PP	Oits	major	its	PRP$	B-NP	Omajor	envelope	major	JJ	I-NP	B-proteinenvelope	glycoprotein-350	envelope	NN	I-NP	I-proteinglycoprotein-350	(	glycoprotein-350	NN	I-NP	I-protein(	gp350	(	(	O	Ogp350	)	gp350	NN	B-NP	B-protein)	and	)	)	O	Oand	is	and	CC	O	Ois	also	be	VBZ	B-VP	Oalso	a	also	RB	B-ADVP	Oa	remarkable	a	DT	B-NP	Oremarkable	immunomodulating	remarkable	JJ	I-NP	Oimmunomodulating	agent	immunomodulating	JJ	I-NP	Oagent	.	agent	NN	I-NP	O.	We	.	.	O	OWe	had	We	PRP	B-NP	Ohad	previously	have	VBD	B-VP	Opreviously	shown	previously	RB	I-VP	Oshown	that	show	VBN	I-VP	Othat	EBV	that	IN	B-SBAR	OEBV	is	EBV	NN	B-NP	Ois	capable	be	VBZ	B-VP	Ocapable	of	capable	JJ	B-ADJP	Oof	modulating	of	IN	B-PP	Omodulating	the	modulate	VBG	B-VP	Othe	synthesis	the	DT	B-NP	Osynthesis	of	synthesis	NN	I-NP	Oof	a	of	IN	B-PP	Oa	number	a	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	cytokines	of	IN	B-PP	Ocytokines	.	cytokine	NNS	B-NP	B-protein.	We	.	.	O	OWe	now	We	PRP	B-NP	Onow	show	now	RB	B-ADVP	Oshow	that	show	VBP	B-VP	Othat	while	that	IN	B-SBAR	Owhile	both	while	IN	B-SBAR	Oboth	purified	both	CC	O	Opurified	recombinant	purify	VBN	B-VP	Orecombinant	gp350	recombinant	JJ	B-NP	Ogp350	(	gp350	NN	I-NP	O(	rgp350	(	(	O	Orgp350	)	rgp350	NN	B-NP	B-protein)	and	)	)	O	Oand	EBV	and	CC	O	OEBV	upregulate	EBV	NN	B-NP	Oupregulate	IL-6	upregulate	VBP	B-VP	OIL-6	mRNA	IL-6	NN	B-NP	B-RNAmRNA	synthesis	mRNA	NN	I-NP	I-RNAsynthesis	in	synthesis	NN	I-NP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	EBV-induced	","	","	O	OEBV-induced	IL-6	EBV-induced	JJ	B-NP	OIL-6	gene	IL-6	NN	I-NP	Ogene	activation	gene	NN	I-NP	Oactivation	occurs	activation	NN	I-NP	Ooccurs	for	occur	VBZ	B-VP	Ofor	a	for	IN	B-PP	Oa	significantly	a	DT	B-NP	Osignificantly	longer	significantly	RB	I-NP	Olonger	period	long	JJR	I-NP	Operiod	of	period	NN	I-NP	Oof	time	of	IN	B-PP	Otime	(	time	NN	B-NP	O(	i.e.	(	(	O	Oi.e.	12	i.e.	FW	B-NP	O12	hours	12	CD	I-NP	Ohours	for	hour	NNS	I-NP	Ofor	EBV	for	IN	B-PP	OEBV	as	EBV	NN	B-NP	Oas	compared	as	IN	B-SBAR	Ocompared	to	compare	VBN	B-PP	Oto	6	to	TO	B-PP	O6	hours	6	CD	B-NP	Ohours	for	hour	NNS	I-NP	Ofor	rgp350	for	IN	B-PP	Orgp350	)	rgp350	NN	B-NP	B-protein)	.	)	)	O	O.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	the	","	","	O	Othe	half-life	the	DT	B-NP	Ohalf-life	of	half-life	NN	I-NP	Oof	EBV-induced	of	IN	B-PP	OEBV-induced	IL-6	EBV-induced	JJ	B-NP	B-RNAIL-6	mRNA	IL-6	NN	I-NP	I-RNAmRNA	was	mRNA	NN	I-NP	I-RNAwas	also	be	VBD	B-VP	Oalso	significantly	also	RB	B-ADVP	Osignificantly	longer	significantly	RB	B-ADJP	Olonger	(	long	JJR	I-ADJP	O(	10	(	(	O	O10	hours	10	CD	B-NP	Ohours	)	hour	NNS	I-NP	O)	than	)	)	O	Othan	that	than	IN	B-PP	Othat	of	that	DT	B-NP	Oof	mRNA	of	IN	B-PP	OmRNA	induced	mRNA	NN	B-NP	B-RNAinduced	by	induce	VBN	B-VP	Oby	rgp350	by	IN	B-PP	Orgp350	(	rgp350	NN	B-NP	B-protein(	about	(	(	O	Oabout	6	about	RB	B-NP	O6	hours	6	CD	I-NP	Ohours	)	hour	NNS	I-NP	O)	.	)	)	O	O.	Both	.	.	O	OBoth	EBV	Both	CC	O	OEBV	and	EBV	NN	B-NP	Oand	gp350	and	CC	I-NP	Ogp350	enhance	gp350	NN	I-NP	B-proteinenhance	the	enhance	VBP	B-VP	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	the	of	IN	B-PP	Othe	NF-kappaB	the	DT	B-NP	ONF-kappaB	transcription	NF-kappaB	NN	I-NP	B-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	","	factor	NN	I-NP	I-protein","	as	","	","	O	Oas	determined	as	IN	B-SBAR	Odetermined	by	determine	VBN	B-VP	Oby	band-shift	by	IN	B-PP	Oband-shift	and	band-shift	NN	B-NP	Oand	augment	and	CC	I-NP	Oaugment	NF-kappaB	augment	NN	I-NP	ONF-kappaB	#NAME?	NF-kappaB	NN	I-NP	B-protein#NAME?	activation	#NAME?	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	a	of	IN	B-PP	Oa	CAT	a	DT	B-NP	OCAT	reporter	CAT	NN	I-NP	B-DNAreporter	plasmid	reporter	NN	I-NP	I-DNAplasmid	.	plasmid	NN	I-NP	I-DNA.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	we	","	","	O	Owe	demonstrate	we	PRP	B-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	while	that	IN	B-SBAR	Owhile	the	while	IN	B-SBAR	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	IL-6	of	IN	B-PP	OIL-6	gene	IL-6	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	by	expression	NN	I-NP	Oby	gp350	by	IN	B-PP	Ogp350	is	gp350	NN	B-NP	B-proteinis	mediated	be	VBZ	B-VP	Omediated	primarily	mediate	VBN	I-VP	Oprimarily	by	primarily	RB	B-ADVP	Oby	the	by	IN	B-PP	Othe	protein	the	DT	B-NP	Oprotein	kinase	protein	NN	I-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	pathway	C	NN	I-NP	I-proteinpathway	","	pathway	NN	I-NP	O","	EBV	","	","	O	OEBV	can	EBV	NN	B-NP	Ocan	mediate	can	MD	B-VP	Omediate	its	mediate	VB	I-VP	Oits	effects	its	PRP$	B-NP	Oeffects	through	effect	NNS	I-NP	Othrough	multiple	through	IN	B-PP	Omultiple	signaling	multiple	JJ	B-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	.	pathway	NNS	I-NP	O.	To	.	.	O	OTo	our	To	TO	B-PP	Oour	knowledge	our	PRP$	B-NP	Oknowledge	this	knowledge	NN	I-NP	Othis	is	this	DT	B-NP	Ois	the	be	VBZ	B-VP	Othe	first	the	DT	B-NP	Ofirst	report	first	JJ	I-NP	Oreport	showing	report	NN	I-NP	Oshowing	that	show	VBG	B-VP	Othat	the	that	IN	B-SBAR	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	a	of	IN	B-PP	Oa	herpesvirus	a	DT	B-NP	Oherpesvirus	envelope	herpesvirus	NN	I-NP	B-proteinenvelope	glycoprotein	envelope	NN	I-NP	I-proteinglycoprotein	to	glycoprotein	NN	I-NP	I-proteinto	CR2	to	TO	B-PP	OCR2	on	CR2	NN	B-NP	B-proteinon	human	on	IN	B-PP	Ohuman	B	human	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	results	cell	NNS	I-NP	I-cell_typeresults	in	result	VBZ	B-VP	Oin	the	in	IN	B-PP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	NF-kappaB	the	DT	B-NP	ONF-kappaB	transcription	NF-kappaB	NN	I-NP	B-proteintranscription	factor	transcription	NN	I-NP	B-proteinfactor	leading	factor	NN	I-NP	I-proteinleading	to	lead	VBG	B-VP	Oto	the	to	TO	B-PP	Othe	upregulation	the	DT	B-NP	Oupregulation	of	upregulation	NN	I-NP	Oof	IL-6	of	IN	B-PP	OIL-6	gene	IL-6	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	in	expression	NN	I-NP	Oin	these	in	IN	B-PP	Othese	lymphocytes	these	DT	B-NP	Olymphocytes	.	lymphocyte	NNS	I-NP	B-cell_type.	Copyright	.	.	O	OCopyright	2001	Copyright	NN	B-NP	O2001	Academic	2001	CD	I-NP	OAcademic	Press	Academic	NNP	I-NP	OPress	.	Press	NNP	I-NP	O.	Gene-	.	.	O	OGene-	and	Gene-	NN	B-NP	Oand	tissue-specificity	and	CC	I-NP	Otissue-specificity	of	tissue-specificity	NN	I-NP	Oof	mutation	of	IN	B-PP	Omutation	in	mutation	NN	B-NP	Oin	Big	in	IN	B-PP	OBig	Blue	Big	JJ	B-NP	OBlue	rats	Blue	JJ	I-NP	Orats	treated	rat	NNS	I-NP	Otreated	with	treat	VBN	B-VP	Owith	the	with	IN	B-PP	Othe	hepatocarcinogen	the	DT	B-NP	Ohepatocarcinogen	N-hydroxy-2-acetylaminofluorene	hepatocarcinogen	NN	I-NP	B-DNAN-hydroxy-2-acetylaminofluorene	.	N-hydroxy-2-acetylaminofluorene	NN	I-NP	I-DNA.	In	.	.	O	OIn	a	In	IN	B-PP	Oa	previous	a	DT	B-NP	Oprevious	study	previous	JJ	I-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	treating	that	IN	B-SBAR	Otreating	transgenic	treat	VBG	B-VP	Otransgenic	Big	transgenic	JJ	B-NP	OBig	Blue	Big	JJ	I-NP	OBlue	rats	Blue	JJ	I-NP	Orats	with	rat	NNS	I-NP	Owith	the	with	IN	B-PP	Othe	hepatocarcinogen	the	DT	B-NP	Ohepatocarcinogen	N-hydroxy-2-acetylaminofluorene	hepatocarcinogen	NN	I-NP	B-DNAN-hydroxy-2-acetylaminofluorene	(	N-hydroxy-2-acetylaminofluorene	NN	I-NP	I-DNA(	N-OH-AAF	(	(	O	ON-OH-AAF	)	N-OH-AAF	NN	B-NP	O)	produced	)	)	O	Oproduced	the	produce	VBD	B-VP	Othe	same	the	DT	B-NP	Osame	major	same	JJ	I-NP	Omajor	DNA	major	JJ	I-NP	ODNA	adduct	DNA	NN	I-NP	Oadduct	in	adduct	NN	I-NP	Oin	the	in	IN	B-PP	Othe	target	the	DT	B-NP	Otarget	liver	target	NN	I-NP	Oliver	and	liver	NN	I-NP	Oand	the	and	CC	O	Othe	nontarget	the	DT	B-NP	Onontarget	spleen	nontarget	JJ	I-NP	B-cell_typespleen	lymphocytes	spleen	NN	I-NP	I-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	bone	and	CC	O	Obone	marrow	bone	NN	B-NP	B-cell_typemarrow	cells	marrow	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	induced	","	","	O	Oinduced	lacI	induce	VBD	B-VP	OlacI	mutants	lacI	NN	B-NP	B-proteinmutants	in	mutant	NNS	I-NP	I-proteinin	the	in	IN	B-PP	Othe	liver	the	DT	B-NP	Oliver	","	liver	NN	I-NP	O","	and	","	","	O	Oand	induced	and	CC	O	Oinduced	much	induce	VBD	B-VP	Omuch	lower	much	RB	B-NP	Olower	frequencies	low	JJR	I-NP	Ofrequencies	of	frequency	NNS	I-NP	Oof	l	of	IN	B-PP	Ol	acI	l	NN	B-NP	B-DNAacI	and	acI	NN	I-NP	I-DNAand	hprt	and	CC	I-NP	Ohprt	mutants	hprt	NN	I-NP	B-proteinmutants	in	mutant	NNS	I-NP	I-proteinin	spleen	in	IN	B-PP	Ospleen	lymphocytes	spleen	NN	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	present	the	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	","	study	NN	I-NP	O","	sequence	","	","	O	Osequence	analysis	sequence	NN	B-NP	Oanalysis	was	analysis	NN	I-NP	Owas	conducted	be	VBD	B-VP	Oconducted	on	conduct	VBN	I-VP	Oon	lacI	on	IN	B-PP	OlacI	DNA	lacI	NN	B-NP	ODNA	and	DNA	NN	I-NP	Oand	hprt	and	CC	O	Ohprt	cDNA	hprt	NN	B-NP	B-DNAcDNA	from	cDNA	NN	I-NP	I-DNAfrom	the	from	IN	B-PP	Othe	mutants	the	DT	B-NP	Omutants	","	mutant	NNS	I-NP	O","	to	","	","	O	Oto	determine	to	TO	B-VP	Odetermine	the	determine	VB	I-VP	Othe	mutational	the	DT	B-NP	Omutational	specificity	mutational	JJ	I-NP	Ospecificity	of	specificity	NN	I-NP	Oof	N-OH-AAF	of	IN	B-PP	ON-OH-AAF	in	N-OH-AAF	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	rat	the	DT	B-NP	Orat	.	rat	NN	I-NP	O.	All	.	.	O	OAll	the	All	PDT	B-NP	Othe	mutation	the	DT	I-NP	Omutation	spectra	mutation	NN	I-NP	Ospectra	from	spectrum	NNS	I-NP	Ofrom	N-OH-AAF-treated	from	IN	B-PP	ON-OH-AAF-treated	rats	N-OH-AAF-treated	JJ	B-NP	Orats	differed	rat	NNS	I-NP	Odiffered	significantly	differ	VBD	B-VP	Osignificantly	from	significantly	RB	B-ADVP	Ofrom	corresponding	from	IN	B-PP	Ocorresponding	mutation	correspond	VBG	B-VP	Omutation	profiles	mutation	NN	B-NP	Oprofiles	from	profile	NNS	I-NP	Ofrom	untreated	from	IN	B-PP	Ountreated	animals	untreated	JJ	B-NP	Oanimals	(	animal	NNS	I-NP	O(	P	(	(	O	OP	=	P	NN	B-NP	O=	0.02	=	SYM	B-VP	O0.02	to	0.02	CD	B-NP	Oto	P	to	TO	B-PP	OP	<	P	NN	B-NP	O<	0.0001	<	SYM	B-NP	O0.0001	)	0.0001	CD	I-NP	O)	.	)	)	O	O.	Although	.	.	O	OAlthough	there	Although	IN	B-SBAR	Othere	were	there	EX	B-NP	Owere	similarities	be	VBD	B-VP	Osimilarities	among	similarity	NNS	B-NP	Oamong	the	among	IN	B-PP	Othe	mutational	the	DT	B-NP	Omutational	patterns	mutational	JJ	I-NP	Opatterns	derived	pattern	NNS	I-NP	Oderived	from	derive	VBN	B-VP	Ofrom	N-OH-AAF-treated	from	IN	B-PP	ON-OH-AAF-treated	rats	N-OH-AAF-treated	JJ	B-NP	Orats	(	rat	NNS	I-NP	O(	e.g.	(	(	O	Oe.g.	","	e.g.	FW	B-NP	O","	G	","	","	O	OG	:	G	NN	B-NP	O:	C	:	SYM	I-NP	OC	--	C	NN	I-NP	O--	>	--	:	O	O>	T	>	JJ	B-NP	OT	:	T	NN	I-NP	O:	A	:	:	O	OA	transversion	A	DT	B-NP	Otransversion	was	transversion	NN	I-NP	Owas	the	be	VBD	B-VP	Othe	most	the	DT	B-NP	Omost	common	most	RBS	I-NP	Ocommon	mutation	common	JJ	I-NP	Omutation	in	mutation	NN	I-NP	Oin	all	in	IN	B-PP	Oall	mutation	all	DT	B-NP	Omutation	sets	mutation	NN	I-NP	Osets	)	set	NNS	I-NP	O)	","	)	)	O	O","	there	","	","	O	Othere	were	there	EX	B-NP	Owere	significant	be	VBD	B-VP	Osignificant	differences	significant	JJ	B-NP	Odifferences	in	difference	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	patterns	the	DT	B-NP	Opatterns	of	pattern	NNS	I-NP	Oof	basepair	of	IN	B-PP	Obasepair	substitution	basepair	NN	B-NP	Osubstitution	and	substitution	NN	I-NP	Oand	frameshift	and	CC	O	Oframeshift	mutation	frameshift	NN	B-NP	Omutation	between	mutation	NN	I-NP	Obetween	the	between	IN	B-PP	Othe	liver	the	DT	B-NP	Oliver	and	liver	NN	I-NP	Oand	spleen	and	CC	I-NP	Ospleen	lymphocyte	spleen	NN	I-NP	B-proteinlymphocyte	lacI	lymphocyte	NN	I-NP	I-proteinlacI	mutants	lacI	NN	I-NP	I-proteinmutants	(	mutant	NNS	I-NP	I-protein(	P	(	(	O	OP	=	P	NN	B-NP	O=	0.02	=	SYM	B-VP	O0.02	)	0.02	CD	B-NP	O)	and	)	)	O	Oand	between	and	CC	O	Obetween	the	between	IN	B-PP	Othe	spleen	the	DT	B-NP	Ospleen	lymphocyte	spleen	NN	I-NP	Olymphocyte	lacI	lymphocyte	NN	I-NP	OlacI	and	lacI	NN	I-NP	Oand	hprt	and	CC	I-NP	Ohprt	mutants	hprt	NN	I-NP	B-proteinmutants	(	mutant	NNS	I-NP	I-protein(	P	(	(	O	OP	=	P	NN	B-NP	O=	0.04	=	SYM	B-VP	O0.04	)	0.04	CD	B-NP	O)	.	)	)	O	O.	Also	.	.	O	OAlso	","	Also	RB	B-ADVP	O","	multiplex	","	","	O	Omultiplex	PCR	multiplex	JJ	B-NP	OPCR	analysis	PCR	NN	I-NP	Oanalysis	of	analysis	NN	I-NP	Oof	genomic	of	IN	B-PP	Ogenomic	DNA	genomic	JJ	B-NP	B-DNADNA	from	DNA	NN	I-NP	I-DNAfrom	the	from	IN	B-PP	Othe	hprt	the	DT	B-NP	Ohprt	mutants	hprt	NN	I-NP	B-proteinmutants	indicated	mutant	NNS	I-NP	I-proteinindicated	that	indicate	VBD	B-VP	Othat	12	that	IN	B-SBAR	O12	%	12	CD	B-NP	O%	of	%	NN	I-NP	Oof	mutants	of	IN	B-PP	Omutants	from	mutant	NNS	B-NP	Ofrom	treated	from	IN	B-PP	Otreated	rats	treat	VBN	B-NP	Orats	had	rat	NNS	I-NP	Ohad	major	have	VBD	B-VP	Omajor	deletions	major	JJ	B-NP	Odeletions	in	deletion	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	hprt	the	DT	B-NP	Ohprt	gene	hprt	NN	I-NP	B-DNAgene	;	gene	NN	I-NP	I-DNA;	no	;	:	O	Ono	corresponding	no	DT	B-NP	Ocorresponding	incidence	corresponding	JJ	I-NP	Oincidence	of	incidence	NN	I-NP	Oof	large	of	IN	B-PP	Olarge	deletions	large	JJ	B-NP	Odeletions	was	deletion	NNS	I-NP	Owas	evident	be	VBD	B-VP	Oevident	among	evident	JJ	B-ADJP	Oamong	lacI	among	IN	B-PP	OlacI	mutations	lacI	NN	B-NP	Omutations	.	mutation	NNS	I-NP	O.	All	.	.	O	OAll	the	All	PDT	B-NP	Othe	mutation	the	DT	I-NP	Omutation	profiles	mutation	NN	I-NP	Oprofiles	reflect	profile	NNS	I-NP	Oreflect	the	reflect	VBP	B-VP	Othe	general	the	DT	B-NP	Ogeneral	mutational	general	JJ	I-NP	Omutational	specificity	mutational	JJ	I-NP	Ospecificity	of	specificity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	major	the	DT	B-NP	Omajor	DNA	major	JJ	I-NP	ODNA	adduct	DNA	NN	I-NP	Oadduct	formed	adduct	NN	I-NP	Oformed	by	form	VBN	B-VP	Oby	N-OH-AAF	by	IN	B-PP	ON-OH-AAF	.	N-OH-AAF	NN	B-NP	B-protein.	The	.	.	O	OThe	differences	The	DT	B-NP	Odifferences	between	difference	NNS	I-NP	Obetween	N-OH-AAF	between	IN	B-PP	ON-OH-AAF	mutation	N-OH-AAF	NN	B-NP	Omutation	in	mutation	NN	I-NP	Oin	the	in	IN	B-PP	Othe	endogenous	the	DT	B-NP	Oendogenous	gene	endogenous	JJ	I-NP	B-DNAgene	and	gene	NN	I-NP	I-DNAand	transgene	and	CC	I-NP	Otransgene	can	transgene	NN	I-NP	Ocan	be	can	MD	B-VP	Obe	partially	be	VB	I-VP	Opartially	explained	partially	RB	I-VP	Oexplained	by	explain	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	structures	the	DT	B-NP	Ostructures	of	structure	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	two	the	DT	B-NP	Otwo	genes	two	CD	I-NP	Ogenes	.	gene	NNS	I-NP	O.	The	.	.	O	OThe	tissue-specificity	The	DT	B-NP	Otissue-specificity	of	tissue-specificity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	mutation	the	DT	B-NP	Omutation	spectra	mutation	NN	I-NP	Ospectra	may	spectrum	NNS	I-NP	Omay	contribute	may	MD	B-VP	Ocontribute	to	contribute	VB	I-VP	Oto	targeting	to	TO	B-PP	Otargeting	tumor	target	VBG	B-VP	Otumor	formation	tumor	NN	B-NP	Oformation	to	formation	NN	I-NP	Oto	the	to	TO	B-PP	Othe	liver	the	DT	B-NP	Oliver	.	liver	NN	I-NP	O.	Environ.	.	.	O	OEnviron.	Mol.	Environ.	NNP	B-NP	OMol.	Mutagen.	Mol.	NNP	I-NP	OMutagen.	37	Mutagen.	NNP	I-NP	O37	:	37	CD	I-NP	O:	203-214	:	:	O	O203-214	","	203-214	CD	B-NP	O","	2001	","	","	I-NP	O2001	.	2001	CD	I-NP	O.	Published	.	.	O	OPublished	2001	Published	NNP	B-NP	O2001	Wiley-Liss	2001	CD	I-NP	OWiley-Liss	","	Wiley-Liss	NNP	I-NP	O","	Inc	","	","	O	OInc	.	Inc	NNP	B-NP	O.	Caspase	.	.	O	OCaspase	#NAME?	Caspase	NN	B-NP	B-protein#NAME?	cleavage	#NAME?	JJ	I-NP	Ocleavage	of	cleavage	NN	I-NP	Oof	the	of	IN	B-PP	Othe	hematopoietic	the	DT	B-NP	Ohematopoietic	specific	hematopoietic	JJ	I-NP	Ospecific	adaptor	specific	JJ	I-NP	Oadaptor	protein	adaptor	NN	I-NP	Oprotein	Gads	protein	NN	I-NP	OGads	alters	Gad	NNS	I-NP	Oalters	signalling	alter	VBZ	B-VP	Osignalling	from	signalling	NN	B-NP	Ofrom	the	from	IN	B-PP	Othe	T	the	DT	B-NP	OT	cell	T	NN	I-NP	B-proteincell	receptor	cell	NN	I-NP	I-proteinreceptor	.	receptor	NN	I-NP	I-protein.	Gads	.	.	O	OGads	is	Gad	NNS	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	SH2	a	DT	B-NP	OSH2	and	SH2	NN	I-NP	B-proteinand	SH3	and	CC	I-NP	OSH3	domain	SH3	NN	I-NP	Odomain	#NAME?	domain	NN	I-NP	O#NAME?	","	#NAME?	JJ	B-NP	O","	hematopoietic-specific	","	","	I-NP	Ohematopoietic-specific	adaptor	hematopoietic-specific	JJ	I-NP	B-proteinadaptor	protein	adaptor	NN	I-NP	I-proteinprotein	that	protein	NN	I-NP	I-proteinthat	functions	that	WDT	B-NP	Ofunctions	in	function	VBZ	B-VP	Oin	signalling	in	IN	B-PP	Osignalling	from	signalling	NN	B-NP	Ofrom	the	from	IN	B-PP	Othe	T	the	DT	B-NP	OT	cell	T	NN	I-NP	B-proteincell	receptor	cell	NN	I-NP	I-proteinreceptor	.	receptor	NN	I-NP	I-protein.	Gads	.	.	O	OGads	acts	Gad	NNS	B-NP	B-proteinacts	by	act	VBZ	B-VP	Oby	linking	by	IN	B-PP	Olinking	SLP-76	link	VBG	B-VP	OSLP-76	","	SLP-76	NN	B-NP	B-protein","	bound	","	","	O	Obound	by	bind	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	carboxy-terminal	the	DT	B-NP	Ocarboxy-terminal	Gads	carboxy-terminal	JJ	I-NP	B-proteinGads	SH3	Gads	NNP	I-NP	I-proteinSH3	domain	SH3	NN	I-NP	I-proteindomain	","	domain	NN	I-NP	I-protein","	to	","	","	O	Oto	tyrosine	to	TO	B-PP	Otyrosine	phosphorylated	tyrosine	NN	B-NP	B-proteinphosphorylated	LAT	phosphorylated	JJ	I-NP	I-proteinLAT	which	LAT	NN	I-NP	I-proteinwhich	contains	which	WDT	B-NP	Ocontains	binding	contain	VBZ	B-VP	Obinding	sites	bind	VBG	B-NP	B-DNAsites	for	site	NNS	I-NP	I-DNAfor	the	for	IN	B-PP	Othe	Gads	the	DT	B-NP	OGads	SH2	Gad	NNS	I-NP	B-proteinSH2	domain	SH2	NN	I-NP	I-proteindomain	.	domain	NN	I-NP	I-protein.	Gads	.	.	O	OGads	is	Gad	NNS	B-NP	B-proteinis	distinguished	be	VBZ	B-VP	Odistinguished	from	distinguish	VBN	I-VP	Ofrom	Grb2	from	IN	B-PP	OGrb2	and	Grb2	NN	B-NP	B-proteinand	the	and	CC	O	Othe	closely	the	DT	B-NP	Oclosely	related	closely	RB	I-NP	Orelated	Grap	related	JJ	I-NP	OGrap	protein	Grap	NN	I-NP	B-proteinprotein	by	protein	NN	I-NP	I-proteinby	the	by	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	a	of	IN	B-PP	Oa	120	a	DT	B-NP	O120	amino	120	CD	I-NP	B-DNAamino	acid	amino	NN	I-NP	I-DNAacid	unique	acid	NN	I-NP	I-DNAunique	region	unique	JJ	I-NP	I-DNAregion	between	region	NN	I-NP	I-DNAbetween	the	between	IN	B-PP	Othe	SH2	the	DT	B-NP	OSH2	domain	SH2	NN	I-NP	B-proteindomain	and	domain	NN	I-NP	I-proteinand	the	and	CC	O	Othe	carboxy	the	DT	B-NP	Ocarboxy	terminal	carboxy	NN	I-NP	B-proteinterminal	SH3	terminal	JJ	I-NP	I-proteinSH3	domain	SH3	NN	I-NP	I-proteindomain	.	domain	NN	I-NP	I-protein.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	demonstrate	we	PRP	B-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	unique	the	DT	B-NP	Ounique	region	unique	JJ	I-NP	Oregion	of	region	NN	I-NP	Oof	Gads	of	IN	B-PP	OGads	contains	Gad	NNS	B-NP	B-proteincontains	a	contain	VBZ	B-VP	Oa	capase	a	DT	B-NP	Ocapase	cleavage	capase	NN	I-NP	B-DNAcleavage	site	cleavage	NN	I-NP	I-DNAsite	.	site	NN	I-NP	I-DNA.	Induction	.	.	O	OInduction	of	Induction	NN	B-NP	Oof	apoptosis	of	IN	B-PP	Oapoptosis	in	apoptosis	NN	B-NP	Oin	lymphocytes	in	IN	B-PP	Olymphocytes	results	lymphocyte	NNS	B-NP	B-cell_typeresults	in	result	VBZ	B-VP	Oin	detectable	in	IN	B-PP	Odetectable	Gads	detectable	JJ	B-NP	OGads	cleavage	Gad	NNS	I-NP	Ocleavage	by	cleavage	NN	I-NP	Oby	60	by	IN	B-PP	O60	min	60	CD	B-NP	Omin	.	min	NN	I-NP	O.	Gads	.	.	O	OGads	cleavage	Gad	NNS	B-NP	Ocleavage	is	cleavage	NN	I-NP	Ois	blocked	be	VBZ	B-VP	Oblocked	in	block	VBN	I-VP	Oin	vivo	in	FW	B-ADVP	Ovivo	by	vivo	FW	I-ADVP	Oby	treating	by	IN	B-PP	Otreating	cells	treat	VBG	B-VP	Ocells	with	cell	NNS	B-NP	Owith	a	with	IN	B-PP	Oa	caspase	a	DT	B-NP	Ocaspase	3	caspase	NN	I-NP	B-protein3	inhibitor	3	CD	I-NP	I-proteininhibitor	.	inhibitor	NN	I-NP	I-protein.	A	.	.	O	OA	putative	A	DT	B-NP	Oputative	caspase	putative	JJ	I-NP	B-DNAcaspase	3	caspase	NN	I-NP	I-DNA3	cleavage	3	CD	I-NP	I-DNAcleavage	site	cleavage	NN	I-NP	I-DNAsite	was	site	NN	I-NP	I-DNAwas	identified	be	VBD	B-VP	Oidentified	within	identify	VBN	I-VP	Owithin	the	within	IN	B-PP	Othe	unique	the	DT	B-NP	Ounique	region	unique	JJ	I-NP	Oregion	and	region	NN	I-NP	Oand	mutation	and	CC	I-NP	Omutation	of	mutation	NN	I-NP	Oof	this	of	IN	B-PP	Othis	site	this	DT	B-NP	Osite	prevented	site	NN	I-NP	Oprevented	Gads	prevent	VBD	B-VP	OGads	cleavage	Gad	NNS	B-NP	Ocleavage	in	cleavage	NN	I-NP	Oin	vitro	in	FW	B-ADVP	Ovitro	","	vitro	FW	I-ADVP	O","	and	","	","	O	Oand	in	and	CC	O	Oin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	The	.	.	O	OThe	Gads	The	DT	B-NP	OGads	cleavage	Gads	NNP	I-NP	B-proteincleavage	products	cleavage	NN	I-NP	I-proteinproducts	retained	product	NNS	I-NP	I-proteinretained	the	retain	VBD	B-VP	Othe	predicted	the	DT	B-NP	Opredicted	binding	predict	VBN	I-NP	Obinding	specificity	binding	NN	I-NP	Ospecificity	for	specificity	NN	I-NP	Ofor	SLP-76	for	IN	B-PP	OSLP-76	and	SLP-76	NN	B-NP	B-proteinand	LAT	and	CC	I-NP	OLAT	.	LAT	NN	I-NP	B-protein.	Expression	.	.	O	OExpression	of	Expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	Gads	the	DT	B-NP	OGads	cleavage	Gads	NNP	I-NP	B-proteincleavage	products	cleavage	NN	I-NP	I-proteinproducts	in	product	NNS	I-NP	I-proteinin	Jurkat	in	IN	B-PP	OJurkat	T	Jurkat	NN	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	inhibited	cell	NNS	I-NP	I-cell_lineinhibited	NFAT	inhibit	VBD	B-VP	ONFAT	activation	NFAT	NN	B-NP	B-proteinactivation	following	activation	NN	I-NP	Ofollowing	TCR	follow	VBG	B-PP	OTCR	cross	TCR	NN	B-NP	B-proteincross	linking	cross	NN	I-NP	Olinking	.	linking	NN	I-NP	O.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	indicate	finding	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	cleavage	that	IN	B-SBAR	Ocleavage	of	cleavage	NN	B-NP	Oof	Gads	of	IN	B-PP	OGads	in	Gad	NNPS	B-NP	B-proteinin	vivo	in	FW	B-ADVP	Ovivo	could	vivo	FW	I-ADVP	Ocould	function	could	MD	B-VP	Ofunction	to	function	VB	I-VP	Oto	alter	to	TO	I-VP	Oalter	signalling	alter	VB	I-VP	Osignalling	downstream	signalling	NN	B-NP	Odownstream	of	downstream	RB	B-ADVP	Oof	the	of	IN	B-PP	Othe	T	the	DT	B-NP	OT	cell	T	NN	I-NP	B-proteincell	receptor	cell	NN	I-NP	I-proteinreceptor	by	receptor	NN	I-NP	I-proteinby	disrupting	by	IN	B-PP	Odisrupting	cross	disrupt	VBG	B-VP	Ocross	talk	cross	JJ	B-NP	Otalk	between	talk	NN	I-NP	Obetween	SLP-76	between	IN	B-PP	OSLP-76	and	SLP-76	NN	B-NP	B-proteinand	LAT	and	CC	I-NP	OLAT	.	LAT	NN	I-NP	B-protein.	Targeting	.	.	O	OTargeting	of	Targeting	NN	B-NP	Oof	p300	of	IN	B-PP	Op300	to	p300	NN	B-NP	B-proteinto	the	to	TO	B-PP	Othe	interleukin-2	the	DT	B-NP	Ointerleukin-2	promoter	interleukin-2	NN	I-NP	B-DNApromoter	via	promoter	NN	I-NP	I-DNAvia	CREB-Rel	via	IN	B-PP	OCREB-Rel	cross-talk	CREB-Rel	NN	B-NP	B-proteincross-talk	during	cross-talk	NN	I-NP	I-proteinduring	mitogen	during	IN	B-PP	I-proteinmitogen	and	mitogen	NN	B-NP	I-proteinand	oncogenic	and	CC	O	Ooncogenic	molecular	oncogenic	JJ	B-NP	Omolecular	signaling	molecular	JJ	I-NP	Osignaling	in	signaling	NN	I-NP	Oin	activated	in	IN	B-PP	Oactivated	T-cells	activate	VBN	B-NP	B-cell_typeT-cells	.	T-cell	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	report	this	DT	B-NP	Oreport	","	report	NN	I-NP	O","	we	","	","	O	Owe	explore	we	PRP	B-NP	Oexplore	the	explore	VBP	B-VP	Othe	mechanisms	the	DT	B-NP	Omechanisms	of	mechanism	NNS	I-NP	Oof	targeting	of	IN	B-PP	Otargeting	of	targeting	NN	B-NP	Oof	p300	of	IN	B-PP	Op300	to	p300	NN	B-NP	B-proteinto	the	to	TO	B-PP	Othe	interleukin-2	the	DT	B-NP	Ointerleukin-2	(	interleukin-2	NN	I-NP	B-DNA(	IL-2	(	(	O	I-DNAIL-2	)	IL-2	NN	B-NP	I-DNA)	promoter	)	)	O	I-DNApromoter	in	promoter	NN	B-NP	I-DNAin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	mitogenic	to	TO	B-PP	Omitogenic	and	mitogenic	JJ	B-NP	Oand	oncogenic	and	CC	I-NP	Ooncogenic	molecular	oncogenic	JJ	I-NP	Omolecular	signals	molecular	JJ	I-NP	Osignals	.	signal	NNS	I-NP	O.	Recruitment	.	.	O	ORecruitment	of	Recruitment	NN	B-NP	Oof	p300	of	IN	B-PP	Op300	by	p300	NN	B-NP	B-proteinby	cAMP-responsive	by	IN	B-PP	OcAMP-responsive	element-binding	cAMP-responsive	JJ	B-NP	B-proteinelement-binding	protein-Rel	element-binding	JJ	I-NP	I-proteinprotein-Rel	cross-talk	protein-Rel	NN	I-NP	I-proteincross-talk	at	cross-talk	NN	I-NP	I-proteinat	the	at	IN	B-PP	Othe	composite	the	DT	B-NP	Ocomposite	CD28	composite	JJ	I-NP	B-DNACD28	response	CD28	NN	I-NP	I-DNAresponse	element	response	NN	I-NP	I-DNAelement	(	element	NN	I-NP	I-DNA(	CD28RE	(	(	O	OCD28RE	)	CD28RE	NN	B-NP	B-DNA)	-	)	)	O	O-	TRE	-	HYPH	B-NP	OTRE	element	TRE	NN	I-NP	B-DNAelement	of	element	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	is	promoter	NN	I-NP	I-DNAis	essential	be	VBZ	B-VP	Oessential	for	essential	JJ	B-ADJP	Ofor	promoter	for	IN	B-PP	Opromoter	inducibility	promoter	NN	B-NP	Oinducibility	during	inducibility	NN	I-NP	Oduring	T-cell	during	IN	B-PP	OT-cell	activation	T-cell	NN	B-NP	Oactivation	","	activation	NN	I-NP	O","	and	","	","	O	Oand	CD28RE-TRE	and	CC	O	OCD28RE-TRE	is	CD28RE-TRE	NN	B-NP	B-DNAis	the	be	VBZ	B-VP	Othe	exclusive	the	DT	B-NP	Oexclusive	target	exclusive	JJ	I-NP	Otarget	of	target	NN	I-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	T-cell	human	JJ	I-NP	B-proteinT-cell	lymphotropic	T-cell	NN	I-NP	I-proteinlymphotropic	virus	lymphotropic	JJ	I-NP	I-proteinvirus	type	virus	NN	I-NP	I-proteintype	I	type	NN	I-NP	I-proteinI	oncoprotein	I	CD	I-NP	I-proteinoncoprotein	Tax	oncoprotein	NN	I-NP	I-proteinTax	.	Tax	NN	I-NP	B-protein.	The	.	.	O	OThe	intrinsic	The	DT	B-NP	Ointrinsic	histone	intrinsic	JJ	I-NP	Ohistone	acetyltransferase	histone	NN	I-NP	B-proteinacetyltransferase	activity	acetyltransferase	NN	I-NP	I-proteinactivity	of	activity	NN	I-NP	Oof	p300	of	IN	B-PP	Op300	is	p300	NN	B-NP	B-proteinis	dispensable	be	VBZ	B-VP	Odispensable	for	dispensable	JJ	B-ADJP	Ofor	activation	for	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	","	promoter	NN	I-NP	I-DNA","	and	","	","	O	Oand	the	and	CC	O	Othe	N-terminal	the	DT	B-NP	ON-terminal	743	N-terminal	JJ	I-NP	B-protein743	residues	743	CD	I-NP	I-proteinresidues	contain	residue	NNS	I-NP	I-proteincontain	the	contain	VBP	B-VP	Othe	minimal	the	DT	B-NP	Ominimal	structural	minimal	JJ	I-NP	Ostructural	requirements	structural	JJ	I-NP	Orequirements	for	requirement	NNS	I-NP	Ofor	synergistic	for	IN	B-PP	Osynergistic	transactivation	synergistic	JJ	B-NP	Otransactivation	of	transactivation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	CD28RE-TRE	the	DT	B-NP	OCD28RE-TRE	","	CD28RE-TRE	NN	I-NP	B-DNA","	the	","	","	O	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	","	promoter	NN	I-NP	I-DNA","	and	","	","	O	Oand	endogenous	and	CC	O	Oendogenous	IL-2	endogenous	JJ	B-NP	OIL-2	gene	IL-2	NN	I-NP	Ogene	expression	gene	NN	I-NP	Oexpression	.	expression	NN	I-NP	O.	Mutational	.	.	O	OMutational	analysis	Mutational	JJ	B-NP	Oanalysis	of	analysis	NN	I-NP	Oof	p300	of	IN	B-PP	Op300	reveals	p300	NN	B-NP	B-proteinreveals	differential	reveal	VBZ	B-VP	Odifferential	structural	differential	JJ	B-NP	Ostructural	requirements	structural	JJ	I-NP	Orequirements	for	requirement	NNS	I-NP	Ofor	the	for	IN	B-PP	Othe	N-terminal	the	DT	B-NP	ON-terminal	p300	N-terminal	JJ	I-NP	B-proteinp300	module	p300	NN	I-NP	I-proteinmodule	by	module	NN	I-NP	I-proteinby	individual	by	IN	B-PP	Oindividual	cis-elements	individual	JJ	B-NP	Ocis-elements	within	cis-element	NNS	I-NP	B-DNAwithin	the	within	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	provide	finding	NNS	I-NP	Oprovide	evidence	provide	VBP	B-VP	Oevidence	that	evidence	NN	B-NP	Othat	p300	that	IN	B-SBAR	Op300	assembles	p300	NN	B-NP	B-proteinassembles	at	assemble	NNS	I-NP	Oat	the	at	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	to	promoter	NN	I-NP	I-DNAto	form	to	TO	B-VP	Oform	an	form	VB	I-VP	Oan	enhanceosome-like	an	DT	B-NP	Oenhanceosome-like	signal	enhanceosome-like	JJ	I-NP	Osignal	transduction	signal	NN	I-NP	Otransduction	target	transduction	NN	I-NP	Otarget	that	target	NN	I-NP	Othat	is	that	WDT	B-NP	Ois	centrally	be	VBZ	B-VP	Ocentrally	integrated	centrally	RB	I-VP	Ointegrated	at	integrate	VBN	I-VP	Oat	the	at	IN	B-PP	Othe	CD28RE-TRE	the	DT	B-NP	OCD28RE-TRE	element	CD28RE-TRE	NN	I-NP	B-DNAelement	of	element	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	through	promoter	NN	I-NP	I-DNAthrough	specific	through	IN	B-PP	Ospecific	protein	specific	JJ	B-NP	Oprotein	module-targeted	protein	NN	I-NP	Omodule-targeted	associations	module-targeted	JJ	I-NP	Oassociations	in	association	NNS	I-NP	Oin	activated	in	IN	B-PP	Oactivated	T-cells	activate	VBN	B-NP	B-cell_typeT-cells	.	T-cell	NNS	I-NP	I-cell_type.	Regulation	.	.	O	ORegulation	of	Regulation	NN	B-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	production	cytokine	NN	B-NP	B-proteinproduction	in	production	NN	I-NP	Oin	T-cell	in	IN	B-PP	OT-cell	responses	T-cell	NN	B-NP	Oresponses	to	response	NNS	I-NP	Oto	inhalant	to	TO	B-VP	Oinhalant	allergen	inhalant	VB	I-VP	Oallergen	:	allergen	NN	B-NP	O:	GATA-3	:	:	O	OGATA-3	expression	GATA-3	NN	B-NP	B-proteinexpression	distinguishes	expression	NN	I-NP	Odistinguishes	between	distinguish	VBZ	B-VP	Obetween	Th1-	between	IN	B-PP	OTh1-	and	Th1-	NN	B-NP	Oand	Th2-polarized	and	CC	O	OTh2-polarized	immunity	Th2-polarized	JJ	B-NP	Oimmunity	.	immunity	NN	I-NP	O.	BACKGROUND	.	.	O	OBACKGROUND	:	BACKGROUND	NN	B-NP	O:	The	:	:	O	OThe	precise	The	DT	B-NP	Oprecise	nature	precise	JJ	I-NP	Onature	of	nature	NN	I-NP	Oof	allergen-specific	of	IN	B-PP	Oallergen-specific	cytokine	allergen-specific	JJ	B-NP	B-proteincytokine	responses	cytokine	NN	I-NP	I-proteinresponses	in	response	NNS	I-NP	Oin	atopics	in	IN	B-PP	Oatopics	versus	atopic	NNS	B-NP	Oversus	non-atopics	versus	IN	B-PP	Onon-atopics	","	non-atopic	NNS	B-NP	O","	in	","	","	O	Oin	particular	in	IN	B-PP	Oparticular	the	particular	JJ	B-ADJP	Othe	'Th1	the	DT	B-NP	O'Th1	polarity	'Th1	NN	I-NP	Opolarity	'	polarity	NN	I-NP	O'	of	'	''	O	Oof	responses	of	IN	B-PP	Oresponses	in	response	NNS	B-NP	Oin	non-atopics	in	IN	B-PP	Onon-atopics	","	non-atopic	NNS	B-NP	O","	remains	","	","	O	Oremains	controversial	remain	VBZ	B-VP	Ocontroversial	.	controversial	JJ	B-ADJP	O.	This	.	.	O	OThis	is	This	DT	B-NP	Ois	due	be	VBZ	B-VP	Odue	in	due	JJ	B-ADJP	Oin	part	in	IN	B-PP	Opart	to	part	NN	B-NP	Oto	the	to	TO	B-PP	Othe	relative	the	DT	B-NP	Orelative	insensitivity	relative	JJ	I-NP	Oinsensitivity	of	insensitivity	NN	I-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	detection	cytokine	NN	B-NP	B-proteindetection	systems	detection	NN	I-NP	Osystems	","	system	NNS	I-NP	O","	and	","	","	O	Oand	associated	and	CC	O	Oassociated	variations	associate	VBN	B-VP	Ovariations	in	variation	NNS	B-NP	Oin	kinetics	in	IN	B-PP	Okinetics	of	kinetic	NNS	B-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	production	cytokine	NN	B-NP	B-proteinproduction	and	production	NN	I-NP	Oand	catabolism	and	CC	I-NP	Ocatabolism	in	catabolism	NN	I-NP	Oin	in	in	IN	B-PP	Oin	vitro	in	FW	B-NP	Ovitro	culture	vitro	FW	I-NP	Oculture	systems	culture	NN	I-NP	Osystems	.	system	NNS	I-NP	O.	As	.	.	O	OAs	an	As	IN	B-PP	Oan	alternative	an	DT	B-NP	Oalternative	to	alternative	NN	I-NP	Oto	cytokine	to	TO	B-PP	Ocytokine	measurement	cytokine	NN	B-NP	B-proteinmeasurement	","	measurement	NN	I-NP	O","	this	","	","	O	Othis	study	this	DT	B-NP	Ostudy	focuses	study	NN	I-NP	Ofocuses	on	focus	VBZ	B-VP	Oon	expression	on	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	GATA-3	factor	NN	I-NP	I-proteinGATA-3	for	GATA-3	NN	I-NP	B-proteinfor	analysis	for	IN	B-PP	Oanalysis	of	analysis	NN	B-NP	Oof	allergen-specific	of	IN	B-PP	Oallergen-specific	Th	allergen-specific	JJ	B-NP	OTh	cell	Th	NN	I-NP	Ocell	responses	cell	NN	I-NP	Oresponses	.	response	NNS	I-NP	O.	METHODS	.	.	O	OMETHODS	:	METHODS	NNS	B-NP	O:	Cord	:	:	O	OCord	blood	Cord	NN	B-NP	B-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	Th1-	be	VBD	B-VP	OTh1-	or	Th1-	NN	B-NP	Oor	Th2-polarized	or	CC	O	OTh2-polarized	by	Th2-polarize	VBN	B-VP	Oby	culture	by	IN	B-PP	Oculture	in	culture	NN	B-NP	Oin	IL-12-	in	IN	B-PP	OIL-12-	or	IL-12-	NN	B-NP	B-proteinor	IL-4-employing	or	CC	O	OIL-4-employing	established	IL-4-employing	JJ	B-NP	Oestablished	methods	established	JJ	I-NP	Omethods	;	method	NNS	I-NP	O;	PBMC	;	:	O	OPBMC	from	PBMC	NN	B-NP	B-cell_typefrom	house	from	IN	B-PP	Ohouse	dust	house	NN	B-NP	Odust	mite	dust	NN	I-NP	Omite	(	mite	NN	I-NP	O(	HDM	(	(	O	OHDM	)	HDM	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	atopics	#NAME?	JJ	B-NP	Oatopics	and	atopic	NNS	I-NP	Oand	controls	and	CC	I-NP	Ocontrols	were	control	NNS	I-NP	Owere	stimulated	be	VBD	B-VP	Ostimulated	overnight	stimulate	VBN	I-VP	Oovernight	with	overnight	RB	B-ADVP	Owith	HDM	with	IN	B-PP	OHDM	;	HDM	NN	B-NP	B-protein;	cytokine	;	:	O	Ocytokine	production	cytokine	NN	B-NP	B-proteinproduction	was	production	NN	I-NP	Owas	measured	be	VBD	B-VP	Omeasured	by	measure	VBN	I-VP	Oby	ELISA	by	IN	B-PP	OELISA	and	ELISA	NN	B-NP	Oand	GATA-3	and	CC	I-NP	OGATA-3	mRNA	GATA-3	NN	I-NP	B-RNAmRNA	expression	mRNA	NN	I-NP	I-RNAexpression	by	expression	NN	I-NP	Oby	PCR	by	IN	B-PP	OPCR	.	PCR	NN	B-NP	O.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	Cytokine	:	:	O	OCytokine	#NAME?	Cytokine	NN	B-NP	B-protein#NAME?	Th2	#NAME?	JJ	I-NP	OTh2	polarization	Th2	NN	I-NP	Opolarization	of	polarization	NN	I-NP	Oof	naive	of	IN	B-PP	Onaive	T	naive	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	is	cell	NNS	I-NP	I-cell_typeis	associated	be	VBZ	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	marked	with	IN	B-PP	Omarked	upregulation	marked	JJ	B-NP	Oupregulation	of	upregulation	NN	I-NP	Oof	GATA-3	of	IN	B-PP	OGATA-3	expression	GATA-3	NN	B-NP	B-proteinexpression	","	expression	NN	I-NP	O","	whereas	","	","	O	Owhereas	a	whereas	IN	O	Oa	reciprocal	a	DT	B-NP	Oreciprocal	expression	reciprocal	JJ	I-NP	Oexpression	pattern	expression	NN	I-NP	Opattern	accompanies	pattern	NN	I-NP	Oaccompanies	differentiation	accompany	VBZ	B-VP	Odifferentiation	towards	differentiation	NN	B-NP	Otowards	the	towards	IN	B-PP	Othe	Th1	the	DT	B-NP	OTh1	cytokine	Th1	NN	I-NP	B-proteincytokine	phenotype	cytokine	NN	I-NP	I-proteinphenotype	.	phenotype	NN	I-NP	O.	In	.	.	O	OIn	T	In	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	HDM	from	IN	B-PP	OHDM	skin	HDM	NN	B-NP	Oskin	prick	skin	NN	I-NP	Oprick	test-positive	prick	NN	I-NP	Otest-positive	(	test-positive	JJ	B-ADJP	O(	HDM-SPT+/HDM-IgE+	(	(	O	OHDM-SPT+/HDM-IgE+	)	HDM-SPT+/HDM-IgE+	JJ	B-ADJP	O)	volunteers	)	)	O	Ovolunteers	","	volunteer	NNS	B-NP	O","	overnight	","	","	O	Oovernight	stimulation	overnight	JJ	B-NP	Ostimulation	results	stimulation	NN	I-NP	Oresults	in	result	VBZ	B-VP	Oin	marked	in	IN	B-PP	Omarked	upregulation	marked	JJ	B-NP	Oupregulation	of	upregulation	NN	I-NP	Oof	GATA-3	of	IN	B-PP	OGATA-3	expression	GATA-3	NN	B-NP	B-proteinexpression	","	expression	NN	I-NP	O","	compared	","	","	O	Ocompared	to	compare	VBN	B-PP	Oto	an	to	TO	B-PP	Oan	equally	an	DT	B-NP	Oequally	marked	equally	RB	I-NP	Omarked	downregulation	marked	JJ	I-NP	Odownregulation	of	downregulation	NN	I-NP	Oof	expression	of	IN	B-PP	Oexpression	in	expression	NN	B-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	SPT-/IgE-	from	IN	B-PP	OSPT-/IgE-	subjects	SPT-/IgE-	JJ	B-NP	Osubjects	.	subject	NNS	I-NP	O.	In	.	.	O	OIn	subjects	In	IN	B-PP	Osubjects	who	subject	NNS	B-NP	Owho	are	who	WP	B-NP	Oare	HDM-SPT+	be	VBP	B-VP	OHDM-SPT+	but	HDM-SPT+	JJ	B-ADJP	Obut	IgE-	but	CC	I-ADJP	OIgE-	","	IgE-	JJ	I-ADJP	B-protein","	GATA-3	","	","	O	OGATA-3	expression	GATA-3	NN	B-NP	B-proteinexpression	levels	expression	NN	I-NP	Olevels	remained	level	NNS	I-NP	Oremained	relatively	remain	VBD	B-VP	Orelatively	stable	relatively	RB	B-ADJP	Ostable	during	stable	JJ	I-ADJP	Oduring	culture	during	IN	B-PP	Oculture	with	culture	NN	B-NP	Owith	HDM	with	IN	B-PP	OHDM	.	HDM	NN	B-NP	B-protein.	CONCLUSIONS	.	.	O	OCONCLUSIONS	:	CONCLUSIONS	NNS	B-NP	O:	Upregulation	:	:	O	OUpregulation	of	Upregulation	NN	B-NP	Oof	GATA-3	of	IN	B-PP	OGATA-3	expression	GATA-3	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	PBMC	in	IN	B-PP	OPBMC	is	PBMC	NN	B-NP	B-cell_typeis	a	be	VBZ	B-VP	Oa	hallmark	a	DT	B-NP	Ohallmark	of	hallmark	NN	I-NP	Oof	the	of	IN	B-PP	Othe	early	the	DT	B-NP	Oearly	phase	early	JJ	I-NP	Ophase	of	phase	NN	I-NP	Oof	Th2	of	IN	B-PP	OTh2	recall	Th2	NN	B-NP	Orecall	responses	recall	NN	I-NP	Oresponses	to	response	NNS	I-NP	Oto	specific	to	TO	B-PP	Ospecific	allergen	specific	JJ	B-NP	Oallergen	in	allergen	NN	I-NP	Oin	atopics	in	IN	B-PP	Oatopics	.	atopic	NNS	B-NP	O.	The	.	.	O	OThe	reciprocal	The	DT	B-NP	Oreciprocal	expression	reciprocal	JJ	I-NP	Oexpression	pattern	expression	NN	I-NP	Opattern	observed	pattern	NN	I-NP	Oobserved	in	observe	VBN	B-VP	Oin	HDM-specific	in	IN	B-PP	OHDM-specific	recall	HDM-specific	JJ	B-NP	Orecall	responses	recall	NN	I-NP	Oresponses	of	response	NNS	I-NP	Oof	non-atopics	of	IN	B-PP	Onon-atopics	provides	non-atopic	NNS	B-NP	Oprovides	independent	provide	VBZ	B-VP	Oindependent	confirmation	independent	JJ	B-NP	Oconfirmation	of	confirmation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	underlying	of	IN	B-PP	Ounderlying	Th1-like	underlie	VBG	B-VP	OTh1-like	immunity	Th1-like	JJ	B-NP	Oimmunity	in	immunity	NN	I-NP	Oin	these	in	IN	B-PP	Othese	subjects	these	DT	B-NP	Osubjects	.	subject	NNS	I-NP	O.	The	.	.	O	OThe	parallel	The	DT	B-NP	Oparallel	findings	parallel	JJ	I-NP	Ofindings	in	finding	NNS	I-NP	Oin	neonatal	in	IN	B-PP	Oneonatal	T	neonatal	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	suggest	cell	NNS	I-NP	I-cell_typesuggest	that	suggest	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	same	the	DT	B-NP	Osame	approach	same	JJ	I-NP	Oapproach	may	approach	NN	I-NP	Omay	be	may	MD	B-VP	Obe	utilized	be	VB	I-VP	Outilized	for	utilize	VBN	I-VP	Ofor	monitoring	for	IN	B-PP	Omonitoring	the	monitor	VBG	B-VP	Othe	progress	the	DT	B-NP	Oprogress	of	progress	NN	I-NP	Oof	allergen-specific	of	IN	B-PP	Oallergen-specific	Th1/Th2	allergen-specific	JJ	B-NP	OTh1/Th2	memory	Th1/Th2	NN	I-NP	Omemory	development	memory	NN	I-NP	Odevelopment	during	development	NN	I-NP	Oduring	early	during	IN	B-PP	Oearly	childhood	early	JJ	B-NP	Ochildhood	","	childhood	NN	I-NP	O","	and	","	","	O	Oand	hence	and	CC	O	Ohence	in	hence	RB	B-ADVP	Oin	assessment	in	IN	B-PP	Oassessment	of	assessment	NN	B-NP	Oof	risk	of	IN	B-PP	Orisk	for	risk	NN	B-NP	Ofor	future	for	IN	B-PP	Ofuture	allergic	future	JJ	B-NP	Oallergic	disease	allergic	JJ	I-NP	Odisease	.	disease	NN	I-NP	O.	Copyright	.	.	O	OCopyright	2001	Copyright	NN	B-NP	O2001	S.	2001	CD	I-NP	OS.	Karger	S.	NNP	I-NP	OKarger	AG	Karger	NNP	I-NP	OAG	","	AG	NNP	I-NP	O","	Basel	","	","	O	OBasel	The	Basel	NNP	B-NP	OThe	heat	The	DT	B-NP	Oheat	shock	heat	NN	I-NP	Oshock	response	shock	NN	I-NP	Oresponse	reduces	response	NN	I-NP	Oreduces	myelin	reduce	VBZ	B-VP	Omyelin	oligodendrocyte	myelin	NN	B-NP	B-proteinoligodendrocyte	glycoprotein	oligodendrocyte	NN	I-NP	I-proteinglycoprotein	#NAME?	glycoprotein	NN	I-NP	I-protein#NAME?	experimental	#NAME?	JJ	I-NP	Oexperimental	autoimmune	experimental	JJ	I-NP	Oautoimmune	encephalomyelitis	autoimmune	JJ	I-NP	Oencephalomyelitis	in	encephalomyelitis	NN	I-NP	Oin	mice	in	IN	B-PP	Omice	.	mouse	NNS	B-NP	O.	The	.	.	O	OThe	stress	The	DT	B-NP	Ostress	response	stress	NN	I-NP	Oresponse	(	response	NN	I-NP	O(	SR	(	(	O	OSR	)	SR	NN	B-NP	B-protein)	can	)	)	O	Ocan	block	can	MD	B-VP	Oblock	inflammatory	block	VB	I-VP	Oinflammatory	gene	inflammatory	JJ	B-NP	Ogene	expression	gene	NN	I-NP	Oexpression	by	expression	NN	I-NP	Oby	preventing	by	IN	B-PP	Opreventing	activation	prevent	VBG	B-VP	Oactivation	of	activation	NN	B-NP	Oof	transcription	of	IN	B-PP	Otranscription	factor	transcription	NN	B-NP	B-proteinfactor	nuclear	factor	NN	I-NP	I-proteinnuclear	factor-kappa	nuclear	JJ	I-NP	B-proteinfactor-kappa	B	factor-kappa	NN	I-NP	I-proteinB	(	B	NN	I-NP	I-protein(	NF-kappaB	(	(	O	ONF-kappaB	)	NF-kappaB	NN	B-NP	B-protein)	.	)	)	O	O.	As	.	.	O	OAs	inflammatory	As	IN	B-SBAR	Oinflammatory	gene	inflammatory	JJ	B-NP	Ogene	expression	gene	NN	I-NP	Oexpression	contributes	expression	NN	I-NP	Ocontributes	to	contribute	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	pathogenesis	the	DT	B-NP	Opathogenesis	of	pathogenesis	NN	I-NP	Oof	demyelinating	of	IN	B-PP	Odemyelinating	diseases	demyelinate	VBG	B-VP	Odiseases	","	disease	NNS	B-NP	O","	we	","	","	O	Owe	tested	we	PRP	B-NP	Otested	the	test	VBD	B-VP	Othe	effects	the	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	SR	the	DT	B-NP	OSR	on	SR	NN	I-NP	B-proteinon	the	on	IN	B-PP	Othe	progression	the	DT	B-NP	Oprogression	of	progression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	demyelinating	the	DT	B-NP	Odemyelinating	disease	demyelinate	VBG	I-NP	Odisease	experimental	disease	NN	I-NP	Oexperimental	autoimmune	experimental	JJ	I-NP	Oautoimmune	encephalomyelitis	autoimmune	JJ	I-NP	Oencephalomyelitis	(	encephalomyelitis	NN	I-NP	O(	EAE	(	(	O	OEAE	)	EAE	NN	B-NP	B-protein)	.	)	)	O	O.	EAE	.	.	O	OEAE	was	EAE	NN	B-NP	B-proteinwas	actively	be	VBD	B-VP	Oactively	induced	actively	RB	I-VP	Oinduced	in	induce	VBN	I-VP	Oin	C57BL/6	in	IN	B-PP	OC57BL/6	mice	C57BL/6	NN	B-NP	Omice	using	mouse	NNS	I-NP	Ousing	an	use	VBG	B-VP	Oan	encephalitogenic	an	DT	B-NP	Oencephalitogenic	myelin	encephalitogenic	JJ	I-NP	Omyelin	oligodendrocyte	myelin	NN	I-NP	Ooligodendrocyte	glycoprotein	oligodendrocyte	NN	I-NP	Oglycoprotein	(	glycoprotein	NN	I-NP	O(	MOG	(	(	O	OMOG	(	MOG	NN	B-NP	O(	35-55	(	(	O	O35-55	)	35-55	CD	B-NP	O)	)	)	)	O	O)	peptide	)	)	O	Opeptide	.	peptide	NN	B-NP	O.	Whole	.	.	O	OWhole	body	Whole	JJ	B-NP	Obody	hyperthermia	body	NN	I-NP	Ohyperthermia	was	hyperthermia	NN	I-NP	Owas	used	be	VBD	B-VP	Oused	to	use	VBN	I-VP	Oto	induce	to	TO	B-VP	Oinduce	a	induce	VB	I-VP	Oa	heat	a	DT	B-NP	Oheat	shock	heat	NN	I-NP	Oshock	response	shock	NN	I-NP	Oresponse	(	response	NN	I-NP	O(	HSR	(	(	O	OHSR	)	HSR	NN	B-NP	B-protein)	in	)	)	O	Oin	immunized	in	IN	B-PP	Oimmunized	mice	immunize	VBN	B-NP	Omice	2	mouse	NNS	I-NP	O2	days	2	CD	B-NP	Odays	after	day	NNS	I-NP	Oafter	the	after	IN	B-PP	Othe	booster	the	DT	B-NP	Obooster	MOG	booster	NN	I-NP	OMOG	(	MOG	NN	I-NP	O(	35-55	(	(	O	O35-55	)	35-55	CD	B-NP	O)	peptide	)	)	O	Opeptide	injection	peptide	NN	B-NP	Oinjection	.	injection	NN	I-NP	O.	The	.	.	O	OThe	HSR	The	DT	B-NP	OHSR	reduced	HSR	NN	I-NP	B-proteinreduced	the	reduce	VBD	B-VP	Othe	incidence	the	DT	B-NP	Oincidence	of	incidence	NN	I-NP	Oof	EAE	of	IN	B-PP	OEAE	by	EAE	NN	B-NP	B-proteinby	70	by	IN	B-PP	O70	%	70	CD	B-NP	O%	","	%	NN	I-NP	O","	delayed	","	","	O	Odelayed	disease	delay	VBD	B-VP	Odisease	onset	disease	NN	B-NP	Oonset	by	onset	NN	I-NP	Oby	6	by	IN	B-PP	O6	days	6	CD	B-NP	Odays	","	day	NNS	I-NP	O","	and	","	","	O	Oand	attenuated	and	CC	O	Oattenuated	disease	attenuate	VBD	B-VP	Odisease	severity	disease	NN	B-NP	Oseverity	.	severity	NN	I-NP	O.	The	.	.	O	OThe	HSR	The	DT	B-NP	OHSR	attenuated	HSR	NN	I-NP	B-proteinattenuated	leukocyte	attenuate	VBD	B-VP	Oleukocyte	infiltration	leukocyte	NN	B-NP	Oinfiltration	into	infiltration	NN	I-NP	Ointo	CNS	into	IN	B-PP	OCNS	assessed	CNS	NN	B-NP	B-proteinassessed	by	assess	VBN	B-VP	Oby	quantitation	by	IN	B-PP	Oquantitation	of	quantitation	NN	B-NP	Oof	perivascular	of	IN	B-PP	Operivascular	infiltrates	perivascular	JJ	B-NP	B-cell_typeinfiltrates	","	infiltrate	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	by	and	CC	O	Oby	reduced	by	IN	B-PP	Oreduced	staining	reduce	VBN	B-NP	Ostaining	for	staining	NN	I-NP	Ofor	CD4	for	IN	B-PP	OCD4	and	CD4	NN	B-NP	B-proteinand	CD25	and	CC	I-NP	OCD25	immunopositive	CD25	NN	I-NP	B-proteinimmunopositive	T-cells	immunopositive	JJ	I-NP	OT-cells	.	T-cell	NNS	I-NP	O.	T-cell	.	.	O	OT-cell	activation	T-cell	NN	B-NP	Oactivation	","	activation	NN	I-NP	O","	assessed	","	","	O	Oassessed	by	assess	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	production	the	DT	B-NP	Oproduction	of	production	NN	I-NP	Oof	interferon	of	IN	B-PP	Ointerferon	gamma	interferon	NN	B-NP	B-proteingamma	(	gamma	NN	I-NP	I-protein(	IFNgamma	(	(	O	OIFNgamma	)	IFNgamma	NN	B-NP	B-protein)	in	)	)	O	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	I-PP	Oto	MOG	to	TO	I-PP	OMOG	(	MOG	NN	B-NP	O(	35-55	(	(	O	O35-55	)	35-55	CD	B-NP	O)	","	)	)	O	O","	was	","	","	O	Owas	also	be	VBD	B-VP	Oalso	decreased	also	RB	I-VP	Odecreased	by	decrease	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	HSR	the	DT	B-NP	OHSR	.	HSR	NN	I-NP	B-protein.	The	.	.	O	OThe	HSR	The	DT	B-NP	OHSR	reduced	HSR	NN	I-NP	B-DNAreduced	inflammatory	reduce	VBD	B-VP	I-DNAinflammatory	gene	inflammatory	JJ	B-NP	I-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	in	expression	NN	I-NP	Oin	the	in	IN	B-PP	Othe	brain	the	DT	B-NP	Obrain	that	brain	NN	I-NP	Othat	normally	that	WDT	B-NP	Onormally	occurs	normally	RB	B-ADVP	Ooccurs	during	occur	VBZ	B-VP	Oduring	EAE	during	IN	B-PP	OEAE	","	EAE	NN	B-NP	B-protein","	including	","	","	O	Oincluding	the	include	VBG	B-PP	Othe	early	the	DT	B-NP	Oearly	increase	early	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	RANTES	in	IN	B-PP	ORANTES	(	RANTES	NN	B-NP	B-protein(	regulated	(	(	O	Oregulated	on	regulate	VBN	B-VP	Oon	activation	on	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	normal	of	IN	B-PP	Onormal	T-cell	normal	JJ	B-NP	OT-cell	expressed	T-cell	NN	I-NP	Oexpressed	and	express	VBN	B-VP	Oand	secreted	and	CC	I-VP	Osecreted	)	secrete	VBN	I-VP	O)	expression	)	)	O	Oexpression	","	expression	NN	B-NP	O","	and	","	","	O	Oand	the	and	CC	O	Othe	later	the	DT	B-NP	Olater	expression	later	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	inducible	the	DT	B-NP	Oinducible	form	inducible	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	nitric	of	IN	B-PP	Onitric	oxide	nitric	JJ	B-NP	B-proteinoxide	synthase	oxide	NN	I-NP	I-proteinsynthase	.	synthase	NN	I-NP	I-protein.	The	.	.	O	OThe	early	The	DT	B-NP	Oearly	activation	early	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	factor	transcription	NN	B-NP	B-proteinfactor	NF-kappaB	factor	NN	I-NP	I-proteinNF-kappaB	was	NF-kappaB	NN	I-NP	B-proteinwas	also	be	VBD	B-VP	Oalso	blocked	also	RB	I-VP	Oblocked	by	block	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	HSR	the	DT	B-NP	OHSR	.	HSR	NN	I-NP	B-protein.	The	.	.	O	OThe	finding	The	DT	B-NP	Ofinding	that	finding	NN	I-NP	Othat	the	that	IN	B-SBAR	Othe	SR	the	DT	B-NP	OSR	reduces	SR	NN	I-NP	B-proteinreduces	inflammation	reduce	VBZ	B-VP	Oinflammation	in	inflammation	NN	B-NP	Oin	the	in	IN	B-PP	Othe	brain	the	DT	B-NP	Obrain	and	brain	NN	I-NP	Oand	the	and	CC	O	Othe	clinical	the	DT	B-NP	Oclinical	severity	clinical	JJ	I-NP	Oseverity	of	severity	NN	I-NP	Oof	EAE	of	IN	B-PP	OEAE	opens	EAE	NN	B-NP	B-proteinopens	a	open	VBZ	B-VP	Oa	novel	a	DT	B-NP	Onovel	therapeutic	novel	JJ	I-NP	Otherapeutic	approach	therapeutic	JJ	I-NP	Oapproach	for	approach	NN	I-NP	Ofor	prevention	for	IN	B-PP	Oprevention	of	prevention	NN	B-NP	Oof	autoimmune	of	IN	B-PP	Oautoimmune	diseases	autoimmune	JJ	B-NP	Odiseases	.	disease	NNS	I-NP	O.	In	.	.	O	OIn	vivo	In	FW	B-NP	Ovivo	detection	vivo	FW	I-NP	Odetection	of	detection	NN	I-NP	Oof	intracellular	of	IN	B-PP	Ointracellular	signaling	intracellular	JJ	B-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	in	pathway	NNS	I-NP	Oin	developing	in	IN	B-PP	Odeveloping	thymocytes	develop	VBG	B-NP	B-cell_typethymocytes	.	thymocyte	NNS	I-NP	I-cell_type.	Information	.	.	O	OInformation	regarding	Information	NN	B-NP	Oregarding	the	regard	VBG	B-VP	Othe	intracellular	the	DT	B-NP	Ointracellular	signaling	intracellular	JJ	I-NP	Osignaling	processes	signaling	NN	I-NP	Oprocesses	that	process	NNS	I-NP	Othat	occur	that	WDT	B-NP	Ooccur	during	occur	VBP	B-VP	Oduring	the	during	IN	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	T	of	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	has	cell	NNS	I-NP	I-cell_typehas	largely	have	VBZ	B-VP	Olargely	been	largely	RB	I-VP	Obeen	obtained	be	VBN	I-VP	Oobtained	with	obtain	VBN	I-VP	Owith	the	with	IN	B-PP	Othe	use	the	DT	B-NP	Ouse	of	use	NN	I-NP	Oof	transgenic	of	IN	B-PP	Otransgenic	mouse	transgenic	JJ	B-NP	Omouse	models	mouse	NN	I-NP	Omodels	","	model	NNS	I-NP	O","	which	","	","	O	Owhich	although	which	WDT	B-NP	Oalthough	providing	although	IN	B-SBAR	Oproviding	invaluable	provide	VBG	B-VP	Oinvaluable	information	invaluable	JJ	B-NP	Oinformation	are	information	NN	I-NP	Oare	time	be	VBP	B-VP	Otime	consuming	time	NN	B-NP	Oconsuming	and	consuming	JJ	B-ADJP	Oand	costly	and	CC	I-ADJP	Ocostly	.	costly	JJ	I-ADJP	O.	To	.	.	O	OTo	this	To	TO	B-PP	Othis	end	this	DT	B-NP	Oend	","	end	NN	I-NP	O","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	developed	have	VBP	B-VP	Odeveloped	a	develop	VBN	I-VP	Oa	novel	a	DT	B-NP	Onovel	system	novel	JJ	I-NP	Osystem	that	system	NN	I-NP	Othat	facilitates	that	WDT	B-NP	Ofacilitates	the	facilitate	VBZ	B-VP	Othe	in	the	DT	B-NP	Oin	vivo	in	FW	I-NP	Ovivo	analysis	vivo	FW	I-NP	Oanalysis	of	analysis	NN	I-NP	Oof	signal	of	IN	B-PP	Osignal	transduction	signal	NN	B-NP	Otransduction	pathways	transduction	NN	I-NP	Opathways	during	pathway	NNS	I-NP	Oduring	T-lymphocyte	during	IN	B-PP	OT-lymphocyte	development	T-lymphocyte	NN	B-NP	Odevelopment	.	development	NN	I-NP	O.	This	.	.	O	OThis	approach	This	DT	B-NP	Oapproach	uses	approach	NN	I-NP	Ouses	reporter-plasmids	use	VBZ	B-VP	Oreporter-plasmids	for	reporter-plasmid	NNS	B-NP	B-DNAfor	the	for	IN	B-PP	Othe	detection	the	DT	B-NP	Odetection	of	detection	NN	I-NP	Oof	intracellular	of	IN	B-PP	Ointracellular	signals	intracellular	JJ	B-NP	Osignals	mediated	signal	NNS	I-NP	Omediated	by	mediate	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	mitogen-activated	the	DT	B-NP	Omitogen-activated	protein	mitogen-activated	JJ	I-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	or	kinase	NN	I-NP	I-proteinor	cyclic	or	CC	O	Ocyclic	AMP-dependent	cyclic	JJ	B-NP	B-proteinAMP-dependent	protein	AMP-dependent	JJ	I-NP	I-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	.	kinase	NN	I-NP	I-protein.	Reporter-plasmids	.	.	O	OReporter-plasmids	are	Reporter-plasmid	NNS	B-NP	B-DNAare	transfected	be	VBP	B-VP	Otransfected	into	transfecte	VBN	I-VP	Ointo	thymocytes	into	IN	B-PP	Othymocytes	in	thymocyte	NNS	B-NP	B-cell_typein	fetal	in	IN	B-PP	Ofetal	thymic	fetal	JJ	B-NP	B-cell_linethymic	organ	thymic	JJ	I-NP	I-cell_lineorgan	culture	organ	NN	I-NP	I-cell_lineculture	by	culture	NN	I-NP	I-cell_lineby	accelerated	by	IN	B-PP	Oaccelerated	DNA/particle	accelerate	VBN	B-NP	ODNA/particle	bombardment	DNA/particle	NN	I-NP	Obombardment	(	bombardment	NN	I-NP	O(	gene	(	(	O	Ogene	gun	gene	NN	B-NP	Ogun	)	gun	NN	I-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	the	and	CC	O	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	a	of	IN	B-PP	Oa	signaling	a	DT	B-NP	Osignaling	pathway	signaling	NN	I-NP	Opathway	is	pathway	NN	I-NP	Ois	determined	be	VBZ	B-VP	Odetermined	in	determine	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	form	the	DT	B-NP	Oform	of	form	NN	I-NP	Oof	a	of	IN	B-PP	Oa	standard	a	DT	B-NP	Ostandard	luciferase	standard	JJ	I-NP	Oluciferase	assay	luciferase	NN	I-NP	B-proteinassay	.	assay	NN	I-NP	O.	Importantly	.	.	O	OImportantly	","	Importantly	RB	B-ADVP	O","	this	","	","	O	Othis	powerful	this	DT	B-NP	Opowerful	technique	powerful	JJ	I-NP	Otechnique	preserves	technique	NN	I-NP	Opreserves	the	preserve	VBZ	B-VP	Othe	structural	the	DT	B-NP	Ostructural	integrity	structural	JJ	I-NP	Ointegrity	of	integrity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	thymus	the	DT	B-NP	Othymus	","	thymus	NN	I-NP	O","	and	","	","	O	Oand	will	and	CC	O	Owill	provide	will	MD	B-VP	Oprovide	an	provide	VB	I-VP	Oan	invaluable	an	DT	B-NP	Oinvaluable	tool	invaluable	JJ	I-NP	Otool	to	tool	NN	I-NP	Oto	study	to	TO	B-VP	Ostudy	how	study	VB	I-VP	Ohow	thymocytes	how	WRB	B-ADVP	Othymocytes	respond	thymocyte	NNS	B-NP	B-cell_typerespond	to	respond	VBP	B-VP	Oto	normal	to	TO	B-PP	Onormal	environmental	normal	JJ	B-NP	Oenvironmental	stimuli	environmental	JJ	I-NP	Ostimuli	encountered	stimulus	NNS	I-NP	Oencountered	during	encounter	VBN	B-VP	Oduring	differentiation	during	IN	B-PP	Odifferentiation	within	differentiation	NN	B-NP	Owithin	the	within	IN	B-PP	Othe	thymic	the	DT	B-NP	Othymic	milieu	thymic	JJ	I-NP	Omilieu	.	milieu	NN	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	this	","	","	O	Othis	method	this	DT	B-NP	Omethod	allows	method	NN	I-NP	Oallows	for	allow	VBZ	B-VP	Ofor	the	for	IN	B-PP	Othe	monitoring	the	DT	B-NP	Omonitoring	of	monitoring	NN	I-NP	Oof	signals	of	IN	B-PP	Osignals	that	signal	NNS	B-NP	Othat	occur	that	WDT	B-NP	Ooccur	in	occur	VBP	B-VP	Oin	a	in	IN	B-PP	Oa	biological	a	DT	B-NP	Obiological	time	biological	JJ	I-NP	Otime	frame	time	NN	I-NP	Oframe	","	frame	NN	I-NP	O","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	during	as	IN	I-PP	Oduring	differentiation	during	IN	B-PP	Odifferentiation	","	differentiation	NN	B-NP	O","	and	","	","	O	Oand	within	and	CC	O	Owithin	the	within	IN	B-PP	Othe	natural	the	DT	B-NP	Onatural	environment	natural	JJ	I-NP	Oenvironment	of	environment	NN	I-NP	Oof	differentiating	of	IN	B-PP	Odifferentiating	cells	differentiate	VBG	B-VP	B-cell_typecells	.	cell	NNS	B-NP	I-cell_type.	Core-binding	.	.	O	OCore-binding	factor	Core-binding	JJ	B-NP	B-proteinfactor	beta	factor	NN	I-NP	I-proteinbeta	(	beta	NN	I-NP	I-protein(	CBFbeta	(	(	O	OCBFbeta	)	CBFbeta	NN	B-NP	B-protein)	","	)	)	O	O","	but	","	","	O	Obut	not	but	CC	O	Onot	CBFbeta-smooth	not	RB	O	OCBFbeta-smooth	muscle	CBFbeta-smooth	JJ	B-NP	B-proteinmuscle	myosin	muscle	NN	I-NP	I-proteinmyosin	heavy	myosin	NN	I-NP	I-proteinheavy	chain	heavy	JJ	I-NP	I-proteinchain	","	chain	NN	I-NP	I-protein","	rescues	","	","	O	Orescues	definitive	rescue	VBZ	B-VP	Odefinitive	hematopoiesis	definitive	JJ	B-NP	Ohematopoiesis	in	hematopoiesis	NN	I-NP	Oin	CBFbeta	in	IN	B-PP	OCBFbeta	#NAME?	CBFbeta	NN	B-NP	B-cell_line#NAME?	embryonic	#NAME?	JJ	I-NP	I-cell_lineembryonic	stem	embryonic	JJ	I-NP	I-cell_linestem	cells	stem	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Core-binding	.	.	O	OCore-binding	factor	Core-binding	JJ	B-NP	B-proteinfactor	beta	factor	NN	I-NP	I-proteinbeta	(	beta	NN	I-NP	I-protein(	CBFbeta	(	(	O	OCBFbeta	)	CBFbeta	NN	B-NP	B-protein)	is	)	)	O	Ois	the	be	VBZ	B-VP	Othe	non-DNA-binding	the	DT	B-NP	Onon-DNA-binding	subunit	non-DNA-binding	JJ	I-NP	B-proteinsubunit	of	subunit	NN	I-NP	I-proteinof	the	of	IN	B-PP	Othe	heterodimeric	the	DT	B-NP	Oheterodimeric	CBFs	heterodimeric	JJ	I-NP	B-proteinCBFs	.	CBF	NNS	I-NP	I-protein.	Genes	.	.	O	OGenes	encoding	Gene	NNS	B-NP	Oencoding	CBFbeta	encode	VBG	B-VP	OCBFbeta	(	CBFbeta	NN	B-NP	B-protein(	CBFB	(	(	O	OCBFB	)	CBFB	NN	B-NP	B-protein)	","	)	)	O	O","	and	","	","	O	Oand	one	and	CC	O	Oone	of	one	CD	B-NP	Oof	the	of	IN	B-PP	Othe	DNA-binding	the	DT	B-NP	ODNA-binding	CBFalpha	DNA-binding	JJ	I-NP	B-proteinCBFalpha	subunits	CBFalpha	NN	I-NP	I-proteinsubunits	","	subunit	NNS	I-NP	I-protein","	Runx1	","	","	O	ORunx1	(	Runx1	NN	B-NP	B-protein(	also	(	(	O	Oalso	known	also	RB	B-VP	Oknown	as	know	VBN	I-VP	Oas	CBFalpha2	as	IN	B-PP	OCBFalpha2	","	CBFalpha2	NN	B-NP	B-protein","	AML1	","	","	O	OAML1	","	AML1	NN	B-NP	B-protein","	and	","	","	O	Oand	PEBP2alphaB	and	CC	O	OPEBP2alphaB	)	PEBP2alphaB	NN	B-NP	B-protein)	","	)	)	O	O","	are	","	","	O	Oare	required	be	VBP	B-VP	Orequired	for	require	VBN	I-VP	Ofor	normal	for	IN	B-PP	Onormal	hematopoiesis	normal	JJ	B-NP	Ohematopoiesis	and	hematopoiesis	NN	I-NP	Oand	are	and	CC	O	Oare	also	be	VBP	B-VP	Oalso	frequent	also	RB	B-ADVP	Ofrequent	targets	frequent	JJ	B-NP	Otargets	of	target	NNS	I-NP	Oof	chromosomal	of	IN	B-PP	Ochromosomal	translocations	chromosomal	JJ	B-NP	Otranslocations	in	translocation	NNS	I-NP	Oin	acute	in	IN	B-PP	Oacute	leukemias	acute	JJ	B-NP	Oleukemias	in	leukemia	NNS	I-NP	Oin	humans	in	IN	B-PP	Ohumans	.	human	NNS	B-NP	O.	Homozygous	.	.	O	OHomozygous	disruption	Homozygous	JJ	B-NP	Odisruption	of	disruption	NN	I-NP	Oof	either	of	IN	B-PP	Oeither	the	either	CC	O	Othe	Runx1	the	DT	B-NP	ORunx1	or	Runx1	NN	I-NP	B-proteinor	Cbfb	or	CC	I-NP	OCbfb	gene	Cbfb	NN	I-NP	B-DNAgene	in	gene	NN	I-NP	I-DNAin	mice	in	IN	B-PP	Omice	results	mouse	NNS	B-NP	Oresults	in	result	VBZ	B-VP	Oin	embryonic	in	IN	B-PP	Oembryonic	lethality	embryonic	JJ	B-NP	Olethality	at	lethality	NN	I-NP	Oat	midgestation	at	IN	B-PP	Omidgestation	due	midgestation	NN	B-NP	Odue	to	due	JJ	B-ADJP	Oto	hemorrhaging	to	TO	B-PP	Ohemorrhaging	in	hemorrhaging	NN	B-NP	Oin	the	in	IN	B-PP	Othe	central	the	DT	B-NP	Ocentral	nervous	central	JJ	I-NP	Onervous	system	nervous	JJ	I-NP	Osystem	","	system	NN	I-NP	O","	and	","	","	O	Oand	severely	and	CC	O	Oseverely	impairs	severely	RB	B-VP	Oimpairs	fetal	impair	VBZ	I-VP	Ofetal	liver	fetal	JJ	B-NP	Oliver	hematopoiesis	liver	NN	I-NP	Ohematopoiesis	.	hematopoiesis	NN	I-NP	O.	Results	.	.	O	OResults	of	Result	NNS	B-NP	Oof	this	of	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	show	study	NN	I-NP	Oshow	that	show	VBP	B-VP	Othat	Cbfb-deficient	that	IN	B-SBAR	OCbfb-deficient	mouse	Cbfb-deficient	JJ	B-NP	B-cell_typemouse	embryonic	mouse	NN	I-NP	I-cell_typeembryonic	stem	embryonic	JJ	I-NP	I-cell_typestem	(	stem	NN	I-NP	I-cell_type(	ES	(	(	O	I-cell_typeES	)	ES	NN	B-NP	I-cell_type)	cells	)	)	O	I-cell_typecells	can	cell	NNS	B-NP	I-cell_typecan	differentiate	can	MD	B-VP	Odifferentiate	into	differentiate	VB	I-VP	Ointo	primitive	into	IN	B-PP	Oprimitive	erythroid	primitive	JJ	B-NP	B-cell_lineerythroid	colonies	erythroid	JJ	I-NP	I-cell_linecolonies	in	colony	NNS	I-NP	I-cell_linein	vitro	in	FW	B-ADVP	Ovitro	","	vitro	FW	I-ADVP	O","	but	","	","	O	Obut	are	but	CC	O	Oare	impaired	be	VBP	B-VP	Oimpaired	in	impair	VBN	I-VP	Oin	their	in	IN	B-PP	Otheir	ability	their	PRP$	B-NP	Oability	to	ability	NN	I-NP	Oto	produce	to	TO	B-VP	Oproduce	definitive	produce	VB	I-VP	Odefinitive	erythroid	definitive	JJ	B-NP	Oerythroid	and	erythroid	JJ	I-NP	Oand	myeloid	and	CC	I-NP	Omyeloid	colonies	myeloid	JJ	I-NP	B-cell_linecolonies	","	colony	NNS	I-NP	I-cell_line","	mimicking	","	","	O	Omimicking	the	mimic	VBG	B-VP	Othe	in	the	DT	B-NP	Oin	vivo	in	FW	I-NP	Ovivo	defect	vivo	FW	I-NP	Odefect	.	defect	NN	I-NP	O.	Definitive	.	.	O	ODefinitive	hematopoiesis	Definitive	JJ	B-NP	Ohematopoiesis	is	hematopoiesis	NN	I-NP	Ois	restored	be	VBZ	B-VP	Orestored	by	restore	VBN	I-VP	Oby	ectopic	by	IN	B-PP	Oectopic	expression	ectopic	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	full-length	of	IN	B-PP	Ofull-length	Cbfb	full-length	JJ	B-NP	B-DNACbfb	transgenes	Cbfb	NN	I-NP	I-DNAtransgenes	","	transgene	NNS	I-NP	I-DNA","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	by	as	IN	I-CONJP	Oby	a	by	IN	B-PP	Oa	transgene	a	DT	B-NP	Otransgene	encoding	transgene	NN	I-NP	B-DNAencoding	only	encode	VBG	B-VP	Oonly	the	only	RB	B-NP	Othe	heterodimerization	the	DT	I-NP	Oheterodimerization	domain	heterodimerization	NN	I-NP	B-proteindomain	of	domain	NN	I-NP	I-proteinof	CBFbeta	of	IN	B-PP	OCBFbeta	.	CBFbeta	NN	B-NP	B-protein.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	the	","	","	O	Othe	CBFbeta	the	DT	B-NP	OCBFbeta	-	CBFbeta	NN	I-NP	B-protein-	smooth	-	HYPH	B-NP	I-proteinsmooth	muscle	smooth	JJ	I-NP	I-proteinmuscle	myosin	muscle	NN	I-NP	I-proteinmyosin	heavy	myosin	NN	I-NP	I-proteinheavy	chain	heavy	JJ	I-NP	I-proteinchain	(	chain	NN	I-NP	I-protein(	SMMHC	(	(	O	I-proteinSMMHC	)	SMMHC	NN	B-NP	I-protein)	fusion	)	)	O	I-proteinfusion	protein	fusion	NN	B-NP	I-proteinprotein	generated	protein	NN	I-NP	I-proteingenerated	by	generate	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	inv	the	DT	B-NP	Oinv	(	inv	NN	I-NP	O(	16	(	(	O	O16	)	16	CD	B-NP	O)	associated	)	)	O	Oassociated	with	associate	VBN	B-VP	Owith	acute	with	IN	B-PP	Oacute	myeloid	acute	JJ	B-NP	Omyeloid	leukemias	myeloid	JJ	I-NP	Oleukemias	(	leukemia	NNS	I-NP	O(	M4Eo	(	(	O	OM4Eo	)	M4Eo	NN	B-NP	O)	can	)	)	O	Ocan	not	can	MD	B-VP	Onot	rescue	not	RB	I-VP	Orescue	definitive	rescue	VB	I-VP	Odefinitive	hematopoiesis	definitive	JJ	B-NP	Ohematopoiesis	by	hematopoiesis	NN	I-NP	Oby	Cbfb-deficient	by	IN	B-PP	OCbfb-deficient	ES	Cbfb-deficient	JJ	B-NP	B-cell_typeES	cells	ES	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Sequences	.	.	O	OSequences	responsible	Sequence	NNS	B-NP	Oresponsible	for	responsible	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	inability	the	DT	B-NP	Oinability	of	inability	NN	I-NP	Oof	CBFbeta	of	IN	B-PP	OCBFbeta	#NAME?	CBFbeta	NN	B-NP	B-protein#NAME?	to	#NAME?	NN	I-NP	Oto	rescue	to	TO	B-VP	Orescue	definitive	rescue	VB	I-VP	Odefinitive	hematopoiesis	definitive	JJ	B-NP	Ohematopoiesis	reside	hematopoiesis	NN	I-NP	Oreside	in	reside	NN	I-NP	Oin	the	in	IN	B-PP	Othe	SMMHC	the	DT	B-NP	OSMMHC	portion	SMMHC	NN	I-NP	B-proteinportion	of	portion	NN	I-NP	Oof	the	of	IN	B-PP	Othe	fusion	the	DT	B-NP	Ofusion	protein	fusion	NN	I-NP	B-proteinprotein	.	protein	NN	I-NP	I-protein.	Results	.	.	O	OResults	also	Result	NNS	B-NP	Oalso	show	also	RB	B-ADVP	Oshow	that	show	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	CBFbeta-SMMHC	the	DT	B-NP	OCBFbeta-SMMHC	fusion	CBFbeta-SMMHC	NN	I-NP	B-proteinfusion	protein	fusion	NN	I-NP	I-proteinprotein	transdominantly	protein	NN	I-NP	I-proteintransdominantly	inhibits	transdominantly	RB	B-ADVP	Oinhibits	definitive	inhibit	VBZ	B-VP	Odefinitive	hematopoiesis	definitive	JJ	B-NP	Ohematopoiesis	","	hematopoiesis	NN	I-NP	O","	but	","	","	O	Obut	not	but	CC	O	Onot	to	not	RB	O	Oto	the	to	TO	B-PP	Othe	same	the	DT	B-NP	Osame	extent	same	JJ	I-NP	Oextent	as	extent	NN	I-NP	Oas	homozygous	as	IN	B-PP	Ohomozygous	loss	homozygous	JJ	B-NP	Oloss	of	loss	NN	I-NP	Oof	Runx1	of	IN	B-PP	ORunx1	or	Runx1	NN	B-NP	B-proteinor	Cbfb	or	CC	I-NP	OCbfb	.	Cbfb	NN	I-NP	B-protein.	CBFbeta-SMMHC	.	.	O	OCBFbeta-SMMHC	preferentially	CBFbeta-SMMHC	NN	B-NP	B-proteinpreferentially	inhibits	preferentially	RB	B-ADVP	Oinhibits	the	inhibit	VBZ	B-VP	Othe	differentiation	the	DT	B-NP	Odifferentiation	of	differentiation	NN	I-NP	Oof	myeloid	of	IN	B-PP	Omyeloid	lineage	myeloid	JJ	B-NP	B-cell_typelineage	cells	lineage	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	while	","	","	O	Owhile	increasing	while	IN	B-SBAR	Oincreasing	the	increase	VBG	B-VP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	blastlike	of	IN	B-PP	Oblastlike	cells	blastlike	JJ	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	culture	in	IN	B-PP	Oculture	.	culture	NN	B-NP	O.	The	.	.	O	OThe	latency	The	DT	B-NP	Olatency	pattern	latency	NN	I-NP	Opattern	of	pattern	NN	I-NP	Oof	Epstein-Barr	of	IN	B-PP	OEpstein-Barr	virus	Epstein-Barr	JJ	B-NP	Ovirus	infection	virus	NN	I-NP	Oinfection	and	infection	NN	I-NP	Oand	viral	and	CC	O	Oviral	IL-10	viral	JJ	B-NP	OIL-10	expression	IL-10	NN	I-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	cutaneous	in	IN	B-PP	Ocutaneous	natural	cutaneous	JJ	B-NP	B-cell_typenatural	killer/T-cell	natural	JJ	I-NP	I-cell_typekiller/T-cell	lymphomas	killer/T-cell	NN	I-NP	I-cell_typelymphomas	.	lymphoma	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	nasal	The	DT	B-NP	Onasal	type	nasal	JJ	I-NP	Otype	","	type	NN	I-NP	O","	extranodal	","	","	O	Oextranodal	natural	extranodal	JJ	B-NP	Onatural	killer	natural	JJ	I-NP	Okiller	or	killer	NN	I-NP	Oor	T	or	CC	O	OT	(	T	NN	B-NP	O(	NK/T	(	(	O	ONK/T	)	NK/T	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	lymphoma	#NAME?	JJ	B-NP	Olymphoma	is	lymphoma	NN	I-NP	Ois	usually	be	VBZ	B-VP	Ousually	associated	usually	RB	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	latent	with	IN	B-PP	Olatent	Epstein-Barr	latent	JJ	O	OEpstein-Barr	virus	Epstein-Barr	JJ	B-NP	Ovirus	(	virus	NN	I-NP	O(	EBV	(	(	O	OEBV	)	EBV	NN	B-NP	O)	infection	)	)	O	Oinfection	.	infection	NN	B-NP	O.	In	.	.	O	OIn	order	In	IN	B-SBAR	Oorder	to	order	NN	O	Oto	elucidate	to	TO	B-VP	Oelucidate	the	elucidate	VB	I-VP	Othe	EBV	the	DT	B-NP	OEBV	gene	EBV	NN	I-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	patterns	expression	NN	I-NP	Opatterns	in	pattern	NNS	I-NP	Oin	vivo	in	FW	B-ADVP	Ovivo	","	vivo	FW	I-ADVP	O","	we	","	","	O	Owe	examined	we	PRP	B-NP	Oexamined	eight	examine	VBD	B-VP	Oeight	patients	eight	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	cutaneous	with	IN	B-PP	Ocutaneous	EBV-related	cutaneous	JJ	B-NP	OEBV-related	NK/T-cell	EBV-related	JJ	I-NP	ONK/T-cell	lymphomas	NK/T-cell	NN	I-NP	Olymphomas	","	lymphoma	NNS	I-NP	O","	including	","	","	O	Oincluding	six	include	VBG	B-PP	Osix	patients	six	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	a	with	IN	B-PP	Oa	NK-cell	a	DT	B-NP	ONK-cell	phenotype	NK-cell	NN	I-NP	Ophenotype	and	phenotype	NN	I-NP	Oand	two	and	CC	O	Otwo	patients	two	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	a	with	IN	B-PP	Oa	T-cell	a	DT	B-NP	OT-cell	phenotype	T-cell	NN	I-NP	Ophenotype	.	phenotype	NN	I-NP	O.	The	.	.	O	OThe	implication	The	DT	B-NP	Oimplication	of	implication	NN	I-NP	Oof	EBV	of	IN	B-PP	OEBV	in	EBV	NN	B-NP	Oin	the	in	IN	B-PP	Othe	skin	the	DT	B-NP	Oskin	lesions	skin	NN	I-NP	Olesions	was	lesion	NNS	I-NP	Owas	determined	be	VBD	B-VP	Odetermined	by	determine	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	EBV-DNA	of	IN	B-PP	OEBV-DNA	","	EBV-DNA	NN	B-NP	B-DNA","	EBV-encoded	","	","	O	OEBV-encoded	nuclear	EBV-encoded	JJ	B-NP	B-RNAnuclear	RNA	nuclear	JJ	I-NP	I-RNARNA	(	RNA	NN	I-NP	I-RNA(	EBER	(	(	O	OEBER	)	EBER	NN	B-NP	B-protein)	and	)	)	O	Oand	a	and	CC	O	Oa	clonality	a	DT	B-NP	Oclonality	of	clonality	NN	I-NP	Oof	EBV-DNA	of	IN	B-PP	OEBV-DNA	fragments	EBV-DNA	NN	B-NP	B-DNAfragments	containing	fragment	NNS	I-NP	I-DNAcontaining	the	contain	VBG	B-VP	Othe	terminal	the	DT	B-NP	Oterminal	repeats	terminal	JJ	I-NP	B-DNArepeats	.	repeat	NNS	I-NP	I-DNA.	Transcripts	.	.	O	OTranscripts	of	Transcript	NNS	B-NP	Oof	EBV-encoded	of	IN	B-PP	OEBV-encoded	genes	EBV-encoded	JJ	B-NP	B-DNAgenes	were	gene	NNS	I-NP	I-DNAwere	screened	be	VBD	B-VP	Oscreened	by	screen	VBN	I-VP	Oby	reverse	by	IN	B-PP	Oreverse	transcription-	reverse	JJ	B-NP	Otranscription-	polymerase	transcription-	NN	I-NP	Opolymerase	chain	polymerase	NN	I-NP	Ochain	reaction	chain	NN	I-NP	Oreaction	(	reaction	NN	I-NP	O(	RT-PCR	(	(	O	ORT-PCR	)	RT-PCR	NN	B-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	confirmed	and	CC	O	Oconfirmed	by	confirm	VBN	B-VP	Oby	Southern	by	IN	B-PP	OSouthern	blot	Southern	JJ	B-NP	Oblot	hybridization	blot	NN	I-NP	Ohybridization	.	hybridization	NN	I-NP	O.	The	.	.	O	OThe	expression	The	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	EBV-related	of	IN	B-PP	OEBV-related	antigens	EBV-related	JJ	B-NP	B-proteinantigens	was	antigen	NNS	I-NP	I-proteinwas	examined	be	VBD	B-VP	Oexamined	by	examine	VBN	I-VP	Oby	immunostaining	by	IN	B-PP	Oimmunostaining	using	immunostaining	NN	B-NP	Ousing	paraffin-embedded	use	VBG	B-VP	Oparaffin-embedded	tissue	paraffin-embedded	JJ	B-NP	Otissue	sections	tissue	NN	I-NP	Osections	and	section	NNS	I-NP	Oand	cell	and	CC	O	Ocell	pellets	cell	NN	B-NP	Opellets	of	pellet	NNS	I-NP	Oof	EBV-positive	of	IN	B-PP	OEBV-positive	cell	EBV-positive	JJ	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	.	line	NNS	I-NP	I-cell_line.	Our	.	.	O	OOur	study	Our	PRP$	B-NP	Ostudy	demonstrated	study	NN	I-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	all	that	IN	B-SBAR	Oall	samples	all	DT	B-NP	Osamples	from	sample	NNS	I-NP	Ofrom	the	from	IN	B-PP	Othe	patients	the	DT	B-NP	Opatients	contained	patient	NNS	I-NP	Ocontained	EBV	contain	VBD	B-VP	OEBV	nuclear	EBV	NN	B-NP	B-RNAnuclear	antigen	nuclear	JJ	I-NP	I-RNAantigen	(	antigen	NN	I-NP	I-RNA(	EBNA	(	(	O	I-RNAEBNA	)	EBNA	NN	B-NP	I-RNA)	-1	)	)	O	I-RNA-1	mRNA	-1	CD	B-NP	I-RNAmRNA	which	mRNA	NN	I-NP	I-RNAwhich	was	which	WDT	B-NP	Owas	transcribed	be	VBD	B-VP	Otranscribed	using	transcribe	VBN	I-VP	Ousing	the	use	VBG	I-VP	Othe	Q	the	DT	B-NP	OQ	promoter	Q	NN	I-NP	B-DNApromoter	","	promoter	NN	I-NP	I-DNA","	whereas	","	","	O	Owhereas	both	whereas	IN	O	Oboth	the	both	CC	O	Othe	Q	the	DT	B-NP	OQ	promoter	Q	NN	I-NP	B-DNApromoter	and	promoter	NN	I-NP	I-DNAand	another	and	CC	O	Oanother	upstream	another	DT	B-NP	Oupstream	promoter	upstream	JJ	I-NP	B-DNApromoter	(	promoter	NN	I-NP	I-DNA(	Cp/Wp	(	(	O	OCp/Wp	)	Cp/Wp	NN	B-NP	O)	were	)	)	O	Owere	used	be	VBD	B-VP	Oused	in	use	VBN	I-VP	Oin	EBV-positive	in	IN	B-PP	OEBV-positive	cell	EBV-positive	JJ	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	","	line	NNS	I-NP	I-cell_line","	B95.8	","	","	O	OB95.8	","	B95.8	NN	B-NP	B-cell_line","	Raji	","	","	O	ORaji	and	Raji	NN	B-NP	B-cell_lineand	Jiyoye	and	CC	I-NP	OJiyoye	.	Jiyoye	NN	I-NP	O.	Latent	.	.	O	OLatent	membrane	Latent	JJ	B-NP	B-proteinmembrane	protein-1	membrane	NN	I-NP	I-proteinprotein-1	(	protein-1	NN	I-NP	I-protein(	LMP-1	(	(	O	OLMP-1	)	LMP-1	NN	B-NP	B-protein)	mRNA	)	)	O	OmRNA	was	mRNA	NN	B-NP	Owas	detected	be	VBD	B-VP	Odetected	in	detect	VBN	I-VP	Oin	seven	in	IN	B-PP	Oseven	of	seven	CD	B-NP	Oof	eight	of	IN	B-PP	Oeight	patients	eight	CD	B-NP	Opatients	and	patient	NNS	I-NP	Oand	all	and	CC	O	Oall	cell	all	DT	B-NP	Ocell	lines	cell	NN	I-NP	B-cell_linelines	","	line	NNS	I-NP	I-cell_line","	whereas	","	","	O	Owhereas	EBNA-2	whereas	IN	O	OEBNA-2	transcripts	EBNA-2	NN	B-NP	B-RNAtranscripts	were	transcript	NNS	I-NP	I-RNAwere	found	be	VBD	B-VP	Ofound	only	find	VBN	I-VP	Oonly	in	only	RB	B-PP	Oin	the	in	IN	I-PP	Othe	cell	the	DT	B-NP	Ocell	lines	cell	NN	I-NP	B-cell_linelines	.	line	NNS	I-NP	I-cell_line.	Immunostaining	.	.	O	OImmunostaining	showed	Immunostaining	NN	B-NP	Oshowed	no	show	VBD	B-VP	Ono	LMP-1	no	DT	B-NP	OLMP-1	","	LMP-1	NN	I-NP	B-protein","	EBNA-2	","	","	O	OEBNA-2	or	EBNA-2	NN	B-NP	B-proteinor	ZEBRA	or	CC	O	OZEBRA	antigens	ZEBRA	NN	B-NP	B-proteinantigens	in	antigen	NNS	I-NP	I-proteinin	the	in	IN	B-PP	Othe	paraffin-embedded	the	DT	B-NP	Oparaffin-embedded	tissue	paraffin-embedded	JJ	I-NP	Otissue	sections	tissue	NN	I-NP	Osections	","	section	NNS	I-NP	O","	although	","	","	O	Oalthough	they	although	IN	B-SBAR	Othey	were	they	PRP	B-NP	Owere	positive	be	VBD	B-VP	Opositive	in	positive	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	line	cell	NN	I-NP	Oline	cells	line	NN	I-NP	Ocells	.	cell	NNS	I-NP	O.	Latent	.	.	O	OLatent	BHRF1	Latent	JJ	B-NP	B-RNABHRF1	transcripts	BHRF1	NN	I-NP	I-RNAtranscripts	encoding	transcript	NNS	I-NP	I-RNAencoding	bcl-2	encode	VBG	B-VP	Obcl-2	homologue	bcl-2	NN	B-NP	B-RNAhomologue	and	homologue	NN	I-NP	I-RNAand	BCRF1	and	CC	O	I-RNABCRF1	transcripts	BCRF1	NN	B-NP	I-RNAtranscripts	encoding	transcript	NNS	I-NP	I-RNAencoding	viral	encode	VBG	B-VP	Oviral	interleukin	viral	JJ	B-NP	B-proteininterleukin	(	interleukin	NN	I-NP	I-protein(	vIL	(	(	O	I-proteinvIL	)	vIL	NN	B-NP	I-protein)	-10	)	)	O	I-protein-10	were	-10	CD	B-NP	I-proteinwere	detected	be	VBD	B-VP	Odetected	in	detect	VBN	I-VP	Oin	one	in	IN	B-PP	Oone	and	one	CD	B-NP	Oand	two	and	CC	I-NP	Otwo	of	two	CD	I-NP	Oof	eight	of	IN	B-PP	Oeight	patients	eight	CD	B-NP	Opatients	","	patient	NNS	I-NP	O","	respectively	","	","	O	Orespectively	.	respectively	RB	B-ADVP	O.	A	.	.	O	OA	patient	A	DT	B-NP	Opatient	with	patient	NN	I-NP	Owith	NK-cell	with	IN	B-PP	ONK-cell	lymphoma	NK-cell	NN	B-NP	Olymphoma	expressing	lymphoma	NN	I-NP	Oexpressing	both	express	VBG	B-VP	Oboth	transcripts	both	DT	B-NP	Otranscripts	died	transcript	NNS	I-NP	Odied	of	die	VBD	B-VP	Oof	rapid	of	IN	B-PP	Orapid	progression	rapid	JJ	B-NP	Oprogression	of	progression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	illness	the	DT	B-NP	Oillness	.	illness	NN	I-NP	O.	Our	.	.	O	OOur	results	Our	PRP$	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	restricted	the	DT	B-NP	Orestricted	expression	restricted	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	latency-associated	the	DT	B-NP	Olatency-associated	EBV	latency-associated	JJ	I-NP	OEBV	genes	EBV	NN	I-NP	B-DNAgenes	and	gene	NNS	I-NP	I-DNAand	the	and	CC	O	Othe	production	the	DT	B-NP	Oproduction	of	production	NN	I-NP	Oof	vIL-10	of	IN	B-PP	OvIL-10	and	vIL-10	NN	B-NP	B-proteinand	bcl-2	and	CC	I-NP	Obcl-2	homologue	bcl-2	NN	I-NP	B-proteinhomologue	may	homologue	NN	I-NP	I-proteinmay	favour	may	MD	B-VP	Ofavour	tumour	favour	VB	I-VP	Otumour	growth	tumour	NN	B-NP	Ogrowth	","	growth	NN	I-NP	O","	evading	","	","	O	Oevading	the	evade	VBG	B-VP	Othe	host	the	DT	B-NP	Ohost	immune	host	NN	I-NP	Oimmune	surveillance	immune	JJ	I-NP	Osurveillance	.	surveillance	NN	I-NP	O.	Copyright	.	.	O	OCopyright	2001	Copyright	NN	B-NP	O2001	Cancer	2001	CD	I-NP	OCancer	Research	Cancer	NNP	I-NP	OResearch	Campaign	Research	NNP	I-NP	OCampaign	.	Campaign	NNP	I-NP	O.	Oxidized	.	.	O	OOxidized	alkyl	Oxidize	VBN	B-NP	Oalkyl	phospholipids	alkyl	NN	I-NP	Ophospholipids	are	phospholipid	NNS	I-NP	Oare	specific	be	VBP	B-VP	Ospecific	","	specific	JJ	B-NP	O","	high	","	","	I-NP	Ohigh	affinity	high	JJ	I-NP	B-proteinaffinity	peroxisome	affinity	NN	I-NP	I-proteinperoxisome	proliferator-activated	peroxisome	NN	I-NP	I-proteinproliferator-activated	receptor	proliferator-activated	JJ	I-NP	I-proteinreceptor	gamma	receptor	NN	I-NP	I-proteingamma	ligands	gamma	NN	I-NP	I-proteinligands	and	ligand	NNS	I-NP	I-proteinand	agonists	and	CC	I-NP	Oagonists	.	agonist	NNS	I-NP	O.	Synthetic	.	.	O	OSynthetic	high	Synthetic	JJ	B-NP	B-proteinhigh	affinity	high	JJ	I-NP	I-proteinaffinity	peroxisome	affinity	NN	I-NP	I-proteinperoxisome	proliferator-activated	peroxisome	NN	I-NP	I-proteinproliferator-activated	receptor	proliferator-activated	JJ	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	PPAR	(	(	O	OPPAR	)	PPAR	NN	B-NP	B-protein)	agonists	)	)	O	Oagonists	are	agonist	NNS	B-NP	Oare	known	be	VBP	B-VP	Oknown	","	know	VBN	I-VP	O","	but	","	","	O	Obut	biologic	but	CC	O	Obiologic	ligands	biologic	JJ	B-NP	Oligands	are	ligand	NNS	I-NP	Oare	of	be	VBP	B-VP	Oof	low	of	IN	B-PP	Olow	affinity	low	JJ	B-NP	Oaffinity	.	affinity	NN	I-NP	O.	Oxidized	.	.	O	OOxidized	low	Oxidize	VBN	B-NP	Olow	density	low	JJ	I-NP	Odensity	lipoprotein	density	NN	I-NP	Olipoprotein	(	lipoprotein	NN	I-NP	O(	oxLDL	(	(	O	OoxLDL	)	oxLDL	NN	B-NP	B-protein)	is	)	)	O	Ois	inflammatory	be	VBZ	B-VP	Oinflammatory	and	inflammatory	JJ	B-ADJP	Oand	signals	and	CC	O	Osignals	through	signal	NNS	B-NP	Othrough	PPARs	through	IN	B-PP	OPPARs	.	PPAR	NNS	B-NP	B-protein.	We	.	.	O	OWe	showed	We	PRP	B-NP	Oshowed	","	show	VBD	B-VP	O","	by	","	","	O	Oby	phospholipase	by	IN	B-PP	Ophospholipase	A	phospholipase	NN	B-NP	B-proteinA	(	A	NN	I-NP	I-protein(	1	(	(	O	O1	)	1	CD	B-NP	O)	digestion	)	)	O	Odigestion	","	digestion	NN	B-NP	O","	that	","	","	O	Othat	PPARgamma	that	IN	B-SBAR	OPPARgamma	agonists	PPARgamma	NN	B-NP	B-proteinagonists	in	agonist	NNS	I-NP	Oin	oxLDL	in	IN	B-PP	OoxLDL	arise	oxLDL	NN	B-NP	B-proteinarise	from	arise	VBP	B-VP	Ofrom	the	from	IN	B-PP	Othe	small	the	DT	B-NP	Osmall	pool	small	JJ	I-NP	Opool	of	pool	NN	I-NP	Oof	alkyl	of	IN	B-PP	Oalkyl	phosphatidylcholines	alkyl	NN	B-NP	Ophosphatidylcholines	in	phosphatidylcholine	NNS	I-NP	Oin	LDL	in	IN	B-PP	OLDL	.	LDL	NN	B-NP	B-protein.	We	.	.	O	OWe	identified	We	PRP	B-NP	Oidentified	an	identify	VBD	B-VP	Oan	abundant	an	DT	B-NP	Oabundant	oxidatively	abundant	JJ	I-NP	Ooxidatively	fragmented	oxidatively	RB	I-NP	Ofragmented	alkyl	fragmented	JJ	I-NP	Oalkyl	phospholipid	alkyl	NN	I-NP	Ophospholipid	in	phospholipid	NN	I-NP	Oin	oxLDL	in	IN	B-PP	OoxLDL	","	oxLDL	NN	B-NP	B-protein","	hexadecyl	","	","	O	Ohexadecyl	azelaoyl	hexadecyl	NN	B-NP	Oazelaoyl	phosphatidylcholine	azelaoyl	NN	I-NP	Ophosphatidylcholine	(	phosphatidylcholine	NN	I-NP	O(	azPC	(	(	O	OazPC	)	azPC	NN	B-NP	O)	","	)	)	O	O","	as	","	","	O	Oas	a	as	IN	B-PP	Oa	high	a	DT	B-NP	Ohigh	affinity	high	JJ	I-NP	Oaffinity	ligand	affinity	NN	I-NP	Oligand	and	ligand	NN	I-NP	Oand	agonist	and	CC	I-NP	Oagonist	for	agonist	NN	I-NP	Ofor	PPARgamma	for	IN	B-PP	OPPARgamma	.	PPARgamma	NN	B-NP	B-protein.	[	.	.	O	O[	(	[	(	O	O(	3	(	(	O	O3	)	3	CD	O	O)	H	)	)	O	OH	]	H	NN	B-NP	O]	azPC	]	)	O	OazPC	bound	azPC	NN	B-NP	Obound	recombinant	bind	VBD	B-VP	Orecombinant	PPARgamma	recombinant	JJ	B-NP	B-proteinPPARgamma	with	PPARgamma	NN	I-NP	I-proteinwith	an	with	IN	B-PP	Oan	affinity	an	DT	B-NP	Oaffinity	(	affinity	NN	I-NP	O(	K	(	(	O	OK	(	K	NN	B-NP	O(	d	(	(	O	Od	)	d	NN	B-NP	O)	(	)	)	O	O(	(	(	(	O	O(	app	(	(	O	Oapp	)	app	NN	B-NP	O)	)	)	)	O	O)	approximately	)	)	O	Oapproximately	40	approximately	RB	B-NP	O40	nm	40	CD	I-NP	Onm	)	nm	NN	I-NP	O)	that	)	)	O	Othat	was	that	WDT	B-NP	Owas	equivalent	be	VBD	B-VP	Oequivalent	to	equivalent	JJ	B-ADJP	Oto	rosiglitazone	to	TO	B-PP	Orosiglitazone	(	rosiglitazone	NN	B-NP	O(	BRL49653	(	(	O	OBRL49653	)	BRL49653	NN	B-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	competition	and	CC	O	Ocompetition	with	competition	NN	B-NP	Owith	rosiglitazone	with	IN	B-PP	Orosiglitazone	showed	rosiglitazone	NN	B-NP	Oshowed	that	show	VBD	B-VP	Othat	binding	that	IN	B-SBAR	Obinding	occurred	binding	NN	B-NP	Ooccurred	in	occur	VBD	B-VP	Oin	the	in	IN	B-PP	Othe	ligand-binding	the	DT	B-NP	Oligand-binding	pocket	ligand-binding	JJ	I-NP	Opocket	.	pocket	NN	I-NP	O.	azPC	.	.	O	OazPC	induced	azPC	NN	B-NP	Oinduced	PPRE	induce	VBD	B-VP	OPPRE	reporter	PPRE	NN	B-NP	B-DNAreporter	gene	reporter	NN	I-NP	I-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	","	expression	NN	I-NP	O","	as	","	","	O	Oas	did	as	IN	B-SBAR	Odid	rosiglitazone	do	VBD	O	Orosiglitazone	","	rosiglitazone	NN	B-NP	O","	with	","	","	O	Owith	a	with	IN	B-PP	Oa	half-maximal	a	DT	B-NP	Ohalf-maximal	effect	half-maximal	JJ	I-NP	Oeffect	at	effect	NN	I-NP	Oat	100	at	IN	B-PP	O100	nm	100	CD	B-NP	Onm	.	nm	NN	I-NP	O.	Overexpression	.	.	O	OOverexpression	of	Overexpression	NN	B-NP	Oof	PPARalpha	of	IN	B-PP	OPPARalpha	or	PPARalpha	NN	B-NP	B-proteinor	PPARgamma	or	CC	I-NP	OPPARgamma	revealed	PPARgamma	NN	I-NP	B-proteinrevealed	that	reveal	VBD	B-VP	Othat	azPC	that	IN	B-SBAR	OazPC	was	azPC	NN	B-NP	Owas	a	be	VBD	B-VP	Oa	specific	a	DT	B-NP	Ospecific	PPARgamma	specific	JJ	I-NP	OPPARgamma	agonist	PPARgamma	NN	I-NP	B-proteinagonist	.	agonist	NN	I-NP	O.	The	.	.	O	OThe	scavenger	The	DT	B-NP	Oscavenger	receptor	scavenger	NN	I-NP	B-proteinreceptor	CD36	receptor	NN	I-NP	I-proteinCD36	is	CD36	NN	I-NP	B-proteinis	encoded	be	VBZ	B-VP	Oencoded	by	encode	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	PPRE-responsive	a	DT	B-NP	OPPRE-responsive	gene	PPRE-responsive	JJ	I-NP	B-DNAgene	","	gene	NN	I-NP	I-DNA","	and	","	","	O	Oand	azPC	and	CC	O	OazPC	enhanced	azPC	NN	B-NP	Oenhanced	expression	enhance	VBD	B-VP	Oexpression	of	expression	NN	B-NP	Oof	CD36	of	IN	B-PP	OCD36	in	CD36	NN	B-NP	B-proteinin	primary	in	IN	B-PP	Oprimary	human	primary	JJ	B-NP	B-cell_typehuman	monocytes	human	JJ	I-NP	I-cell_typemonocytes	.	monocyte	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	found	We	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	anti-CD36	that	IN	B-SBAR	Oanti-CD36	inhibited	anti-CD36	NN	B-NP	B-proteininhibited	azPC	inhibit	VBD	B-VP	OazPC	uptake	azPC	NN	B-NP	Ouptake	","	uptake	NN	I-NP	O","	and	","	","	O	Oand	it	and	CC	O	Oit	inhibited	it	PRP	B-NP	Oinhibited	PPRE	inhibit	VBD	B-VP	OPPRE	reporter	PPRE	NN	B-NP	Oreporter	induction	reporter	NN	I-NP	Oinduction	.	induction	NN	I-NP	O.	Results	.	.	O	OResults	with	Result	NNS	B-NP	Owith	a	with	IN	B-PP	Oa	small	a	DT	B-NP	Osmall	molecule	small	JJ	I-NP	Omolecule	phospholipid	molecule	NN	I-NP	Ophospholipid	flippase	phospholipid	NN	I-NP	Oflippase	mimetic	flippase	NN	I-NP	Omimetic	suggest	mimetic	NN	I-NP	Osuggest	azPC	suggest	VBP	B-VP	OazPC	acts	azPC	NN	B-NP	Oacts	intracellularly	act	VBZ	B-VP	Ointracellularly	and	intracellularly	RB	B-ADVP	Oand	that	and	CC	O	Othat	cellular	that	IN	B-SBAR	Ocellular	azPC	cellular	JJ	B-NP	OazPC	accumulation	azPC	NN	I-NP	Oaccumulation	was	accumulation	NN	I-NP	Owas	efficient	be	VBD	B-VP	Oefficient	.	efficient	JJ	B-ADJP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	certain	","	","	O	Ocertain	alkyl	certain	JJ	B-NP	Oalkyl	phospholipid	alkyl	NN	I-NP	Ophospholipid	oxidation	phospholipid	NN	I-NP	Ooxidation	products	oxidation	NN	I-NP	Oproducts	in	product	NNS	I-NP	Oin	oxLDL	in	IN	B-PP	OoxLDL	are	oxLDL	NN	B-NP	B-proteinare	specific	be	VBP	B-VP	Ospecific	","	specific	JJ	B-NP	O","	high	","	","	I-NP	Ohigh	affinity	high	JJ	I-NP	Oaffinity	extracellular	affinity	NN	I-NP	Oextracellular	ligands	extracellular	JJ	I-NP	Oligands	and	ligand	NNS	I-NP	Oand	agonists	and	CC	I-NP	Oagonists	for	agonist	NNS	I-NP	Ofor	PPARgamma	for	IN	B-PP	OPPARgamma	that	PPARgamma	NN	B-NP	B-proteinthat	induce	that	WDT	B-NP	Oinduce	PPAR-responsive	induce	VBP	B-VP	OPPAR-responsive	genes	PPAR-responsive	JJ	B-NP	B-DNAgenes	Regulation	gene	NNS	I-NP	I-DNARegulation	of	Regulation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	MAT2B	human	JJ	I-NP	B-DNAMAT2B	gene	MAT2B	NN	I-NP	I-DNAgene	encoding	gene	NN	I-NP	I-DNAencoding	the	encode	VBG	B-VP	Othe	regulatory	the	DT	B-NP	Oregulatory	beta	regulatory	JJ	I-NP	B-proteinbeta	subunit	beta	NN	I-NP	I-proteinsubunit	of	subunit	NN	I-NP	I-proteinof	methionine	of	IN	B-PP	Omethionine	adenosyltransferase	methionine	NN	B-NP	B-proteinadenosyltransferase	","	adenosyltransferase	NN	I-NP	I-protein","	MAT	","	","	O	OMAT	II	MAT	NN	B-NP	B-proteinII	.	II	CD	I-NP	I-protein.	Methionine	.	.	O	OMethionine	adenosyltransferase	Methionine	NN	B-NP	B-proteinadenosyltransferase	(	adenosyltransferase	NN	I-NP	I-protein(	MAT	(	(	O	OMAT	)	MAT	NN	B-NP	O)	catalyzes	)	)	O	Ocatalyzes	the	catalyze	VBZ	B-VP	Othe	biosynthesis	the	DT	B-NP	Obiosynthesis	of	biosynthesis	NN	I-NP	Oof	S-adenosylmethionine	of	IN	B-PP	OS-adenosylmethionine	(	S-adenosylmethionine	NN	B-NP	O(	AdoMet	(	(	O	OAdoMet	)	AdoMet	NN	B-NP	O)	","	)	)	O	O","	a	","	","	O	Oa	key	a	DT	B-NP	Okey	molecule	key	JJ	I-NP	Omolecule	in	molecule	NN	I-NP	Oin	transmethylation	in	IN	B-PP	Otransmethylation	reactions	transmethylation	NN	B-NP	Oreactions	and	reaction	NNS	I-NP	Oand	polyamine	and	CC	O	Opolyamine	biosynthesis	polyamine	NN	B-NP	Obiosynthesis	.	biosynthesis	NN	I-NP	O.	The	.	.	O	OThe	MAT	The	DT	B-NP	OMAT	II	MAT	NN	I-NP	B-proteinII	isozyme	II	CD	I-NP	I-proteinisozyme	consists	isozyme	NN	I-NP	I-proteinconsists	of	consist	VBZ	B-VP	Oof	a	of	IN	B-PP	Oa	catalytic	a	DT	B-NP	Ocatalytic	alpha2	catalytic	JJ	I-NP	B-proteinalpha2	and	alpha2	NN	I-NP	I-proteinand	a	and	CC	O	Oa	regulatory	a	DT	B-NP	Oregulatory	beta	regulatory	JJ	I-NP	B-proteinbeta	subunit	beta	NN	I-NP	I-proteinsubunit	.	subunit	NN	I-NP	I-protein.	Down-regulation	.	.	O	ODown-regulation	of	Down-regulation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	MAT	the	DT	B-NP	OMAT	II	MAT	NN	I-NP	B-proteinII	beta	II	CD	I-NP	I-proteinbeta	subunit	beta	SYM	I-NP	I-proteinsubunit	expression	subunit	NN	I-NP	I-proteinexpression	causes	expression	NN	I-NP	Ocauses	a	cause	VBZ	B-VP	Oa	6-10-fold	a	DT	B-NP	O6-10-fold	increase	6-10-fold	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	intracellular	in	IN	B-PP	Ointracellular	AdoMet	intracellular	JJ	B-NP	OAdoMet	levels	AdoMet	NN	I-NP	Olevels	.	level	NNS	I-NP	O.	To	.	.	O	OTo	understand	To	TO	B-VP	Ounderstand	the	understand	VB	I-VP	Othe	mechanism	the	DT	B-NP	Omechanism	by	mechanism	NN	I-NP	Oby	which	by	IN	B-PP	Owhich	the	which	WDT	B-NP	Othe	beta	the	DT	B-NP	Obeta	subunit	beta	NN	I-NP	B-proteinsubunit	expression	subunit	NN	I-NP	I-proteinexpression	is	expression	NN	I-NP	Ois	regulated	be	VBZ	B-VP	Oregulated	","	regulate	VBN	I-VP	O","	we	","	","	O	Owe	cloned	we	PRP	B-NP	Ocloned	the	clone	VBD	B-VP	Othe	MAT2B	the	DT	B-NP	OMAT2B	gene	MAT2B	NN	I-NP	B-DNAgene	","	gene	NN	I-NP	I-DNA","	determined	","	","	O	Odetermined	its	determine	VBD	B-VP	Oits	organization	its	PRP$	B-NP	Oorganization	","	organization	NN	I-NP	O","	characterized	","	","	O	Ocharacterized	its	characterize	VBD	B-VP	Oits	5'-flanking	its	PRP$	B-NP	O5'-flanking	sequences	5'-flanking	JJ	I-NP	B-DNAsequences	","	sequence	NNS	I-NP	I-DNA","	and	","	","	O	Oand	elucidated	and	CC	O	Oelucidated	the	elucidate	VBD	B-VP	Othe	in	the	DT	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	and	vitro	FW	I-NP	Oand	in	and	CC	O	Oin	vivo	in	FW	B-NP	Ovivo	regulation	vivo	FW	I-NP	Oregulation	of	regulation	NN	I-NP	Oof	its	of	IN	B-PP	Oits	promoter	its	PRP$	B-NP	Opromoter	.	promoter	NN	I-NP	B-DNA.	Transcription	.	.	O	OTranscription	of	Transcription	NN	B-NP	Oof	the	of	IN	B-PP	Othe	MAT2B	the	DT	B-NP	OMAT2B	gene	MAT2B	NN	I-NP	B-DNAgene	initiates	gene	NN	I-NP	I-DNAinitiates	at	initiate	VBZ	B-VP	Oat	position	at	IN	B-PP	Oposition	-203	position	NN	B-NP	B-DNA-203	relative	-203	CD	I-NP	I-DNArelative	to	relative	JJ	B-ADVP	Oto	the	to	TO	B-PP	Othe	translation	the	DT	B-NP	Otranslation	start	translation	NN	I-NP	B-DNAstart	site	start	NN	I-NP	I-DNAsite	.	site	NN	I-NP	I-DNA.	Promoter	.	.	O	OPromoter	deletion	Promoter	NN	B-NP	Odeletion	analysis	deletion	NN	I-NP	Oanalysis	defined	analysis	NN	I-NP	Odefined	a	define	VBD	B-VP	Oa	minimal	a	DT	B-NP	Ominimal	promoter	minimal	JJ	I-NP	B-DNApromoter	between	promoter	NN	I-NP	I-DNAbetween	positions	between	IN	B-PP	Opositions	52	position	NNS	B-NP	O52	and	52	CD	B-NP	Oand	93	and	CC	I-NP	O93	base	93	CD	I-NP	Obase	pairs	base	NN	I-NP	Opairs	","	pair	NNS	I-NP	O","	a	","	","	O	Oa	GC-rich	a	DT	B-NP	OGC-rich	region	GC-rich	JJ	I-NP	B-proteinregion	.	region	NN	I-NP	I-protein.	Inclusion	.	.	O	OInclusion	of	Inclusion	NN	B-NP	Oof	the	of	IN	B-PP	Othe	sequences	the	DT	B-NP	Osequences	between	sequence	NNS	I-NP	Obetween	-4	between	IN	B-PP	O-4	and	-4	CD	B-NP	Oand	52	and	CC	I-NP	O52	enhanced	52	CD	I-NP	Oenhanced	promoter	enhance	VBD	B-VP	Opromoter	activity	promoter	NN	B-NP	Oactivity	;	activity	NN	I-NP	O;	this	;	:	O	Othis	was	this	DT	B-NP	Owas	primarily	be	VBD	B-VP	Oprimarily	because	primarily	RB	B-ADVP	Obecause	of	because	IN	B-PP	Oof	an	of	IN	I-PP	Oan	Sp1	an	DT	B-NP	OSp1	recognition	Sp1	NN	I-NP	B-DNArecognition	site	recognition	NN	I-NP	I-DNAsite	at	site	NN	I-NP	I-DNAat	0.6	at	IN	B-PP	O0.6	.	0.6	CD	B-NP	O.	The	.	.	O	OThe	inclusion	The	DT	B-NP	Oinclusion	of	inclusion	NN	I-NP	Oof	sequences	of	IN	B-PP	Osequences	up	sequence	NNS	B-NP	Oup	to	up	RB	B-PP	Oto	position	to	TO	B-PP	Oposition	-115	position	NN	B-NP	O-115	provided	-115	CD	I-NP	Oprovided	full	provide	VBD	B-VP	Ofull	activity	full	JJ	B-NP	Oactivity	;	activity	NN	I-NP	O;	this	;	:	O	Othis	was	this	DT	B-NP	Owas	attributed	be	VBD	B-VP	Oattributed	to	attribute	VBN	I-VP	Oto	a	to	TO	B-PP	Oa	TATA	a	DT	B-NP	OTATA	at	TATA	NN	I-NP	B-DNAat	-32	at	IN	B-PP	O-32	.	-32	CD	B-NP	O.	The	.	.	O	OThe	Sp1	The	DT	B-NP	OSp1	site	Sp1	NN	I-NP	B-DNAsite	at	site	NN	I-NP	I-DNAat	position	at	IN	B-PP	Oposition	9	position	NN	B-NP	B-DNA9	was	9	CD	I-NP	I-DNAwas	key	be	VBD	B-VP	Okey	for	key	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	formation	the	DT	B-NP	Oformation	of	formation	NN	I-NP	Oof	protein.DNA	of	IN	B-PP	Oprotein.DNA	complexes	protein.DNA	NN	B-NP	B-proteincomplexes	.	complex	NNS	I-NP	I-protein.	Mutation	.	.	O	OMutation	of	Mutation	NN	B-NP	Oof	both	of	IN	B-PP	Oboth	the	both	CC	O	Othe	Sp1	the	DT	B-NP	OSp1	site	Sp1	NN	I-NP	B-DNAsite	at	site	NN	I-NP	I-DNAat	9	at	IN	B-PP	O9	and	9	CD	B-NP	Oand	the	and	CC	O	Othe	TATA	the	DT	B-NP	OTATA	at	TATA	NN	I-NP	B-DNAat	-32	at	IN	B-PP	O-32	reduced	-32	CD	B-NP	B-DNAreduced	promoter	reduce	VBD	B-VP	I-DNApromoter	activity	promoter	NN	B-NP	I-DNAactivity	to	activity	NN	I-NP	Oto	its	to	TO	B-PP	Oits	minimal	its	PRP$	B-NP	Ominimal	level	minimal	JJ	I-NP	Olevel	.	level	NN	I-NP	O.	Supershift	.	.	O	OSupershift	assays	Supershift	NN	B-NP	Oassays	showed	assay	NNS	I-NP	Oshowed	no	show	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	the	of	IN	B-PP	Othe	anti-Sp1	the	DT	B-NP	Oanti-Sp1	antibody	anti-Sp1	JJ	I-NP	B-proteinantibody	on	antibody	NN	I-NP	I-proteinon	complex	on	IN	B-PP	Ocomplex	formation	complex	NN	B-NP	Oformation	","	formation	NN	I-NP	O","	whereas	","	","	O	Owhereas	the	whereas	IN	O	Othe	anti-Sp3	the	DT	B-NP	Oanti-Sp3	antibody	anti-Sp3	JJ	I-NP	B-proteinantibody	had	antibody	NN	I-NP	I-proteinhad	a	have	VBD	B-VP	Oa	strong	a	DT	B-NP	Ostrong	effect	strong	JJ	I-NP	Oeffect	on	effect	NN	I-NP	Oon	protein.DNA	on	IN	B-PP	Oprotein.DNA	complex	protein.DNA	NN	B-NP	Ocomplex	formation	complex	NN	I-NP	Oformation	","	formation	NN	I-NP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	Sp3	that	IN	B-SBAR	OSp3	is	Sp3	NN	B-NP	B-proteinis	one	be	VBZ	B-VP	Oone	of	one	CD	B-NP	Oof	the	of	IN	B-PP	Othe	main	the	DT	B-NP	Omain	factors	main	JJ	I-NP	B-proteinfactors	binding	factor	NNS	I-NP	I-proteinbinding	to	bind	VBG	B-VP	Oto	this	to	TO	B-PP	Othis	Sp1	this	DT	B-NP	OSp1	site	Sp1	NN	I-NP	B-DNAsite	.	site	NN	I-NP	I-DNA.	Chromatin	.	.	O	OChromatin	immunoprecipitation	Chromatin	NN	B-NP	B-DNAimmunoprecipitation	assays	immunoprecipitation	NN	I-NP	Oassays	supported	assay	NNS	I-NP	Osupported	the	support	VBD	B-VP	Othe	involvement	the	DT	B-NP	Oinvolvement	of	involvement	NN	I-NP	Oof	both	of	IN	B-PP	Oboth	Sp1	both	CC	O	OSp1	and	Sp1	NN	B-NP	B-proteinand	Sp3	and	CC	O	OSp3	in	Sp3	NN	B-NP	B-proteinin	complexes	in	IN	B-PP	Ocomplexes	formed	complex	NNS	B-NP	Oformed	on	form	VBN	B-VP	Oon	the	on	IN	B-PP	Othe	MAT2B	the	DT	B-NP	OMAT2B	promoter	MAT2B	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	The	.	.	O	OThe	data	The	DT	B-NP	Odata	show	datum	NNS	I-NP	Oshow	that	show	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	5'-untranslated	the	DT	B-NP	O5'-untranslated	sequences	5'-untranslated	JJ	I-NP	B-DNAsequences	play	sequence	NNS	I-NP	I-DNAplay	an	play	VBP	B-VP	Oan	important	an	DT	B-NP	Oimportant	role	important	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	regulating	in	IN	B-PP	Oregulating	the	regulate	VBG	B-VP	Othe	MAT2B	the	DT	B-NP	OMAT2B	gene	MAT2B	NN	I-NP	B-DNAgene	and	gene	NN	I-NP	I-DNAand	identifies	and	CC	O	Oidentifies	the	identify	VBZ	B-VP	Othe	Sp1	the	DT	B-NP	OSp1	site	Sp1	NN	I-NP	B-DNAsite	at	site	NN	I-NP	I-DNAat	9	at	IN	B-PP	O9	as	9	CD	B-NP	Oas	a	as	IN	B-PP	Oa	potential	a	DT	B-NP	Opotential	target	potential	JJ	I-NP	Otarget	for	target	NN	I-NP	Ofor	modulating	for	IN	B-PP	Omodulating	MAT2B	modulate	VBG	B-VP	OMAT2B	expression	MAT2B	NN	B-NP	B-proteinexpression	","	expression	NN	I-NP	O","	a	","	","	O	Oa	process	a	DT	B-NP	Oprocess	that	process	NN	I-NP	Othat	can	that	WDT	B-NP	Ocan	have	can	MD	B-VP	Ohave	a	have	VB	I-VP	Oa	major	a	DT	B-NP	Omajor	effect	major	JJ	I-NP	Oeffect	on	effect	NN	I-NP	Oon	intracellular	on	IN	B-PP	Ointracellular	AdoMet	intracellular	JJ	B-NP	OAdoMet	levels	AdoMet	NN	I-NP	Olevels	.	level	NNS	I-NP	O.	Molecular	.	.	O	OMolecular	pathogenesis	Molecular	JJ	B-NP	Opathogenesis	of	pathogenesis	NN	I-NP	Oof	influenza	of	IN	B-PP	Oinfluenza	A	influenza	NN	B-NP	OA	virus	A	NN	I-NP	Ovirus	infection	virus	NN	I-NP	Oinfection	and	infection	NN	I-NP	Oand	virus-induced	and	CC	O	Ovirus-induced	regulation	virus-induced	JJ	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	gene	cytokine	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	.	expression	NN	I-NP	O.	Despite	.	.	O	ODespite	vaccines	Despite	IN	B-PP	Ovaccines	and	vaccine	NNS	B-NP	Oand	antiviral	and	CC	O	Oantiviral	substances	antiviral	JJ	B-NP	Osubstances	influenza	substance	NNS	I-NP	Oinfluenza	still	influenza	NN	I-NP	Ostill	causes	still	RB	B-ADVP	Ocauses	significant	cause	VBZ	B-VP	Osignificant	morbidity	significant	JJ	B-NP	Omorbidity	and	morbidity	NN	I-NP	Oand	mortality	and	CC	I-NP	Omortality	world	mortality	NN	I-NP	Oworld	wide	world	NN	I-NP	Owide	.	wide	RB	B-ADVP	O.	Better	.	.	O	OBetter	understanding	Good	JJR	B-NP	Ounderstanding	of	understanding	NN	I-NP	Oof	the	of	IN	B-PP	Othe	molecular	the	DT	B-NP	Omolecular	mechanisms	molecular	JJ	I-NP	Omechanisms	of	mechanism	NNS	I-NP	Oof	influenza	of	IN	B-PP	Oinfluenza	virus	influenza	NN	B-NP	Ovirus	replication	virus	NN	I-NP	Oreplication	","	replication	NN	I-NP	O","	pathogenesis	","	","	O	Opathogenesis	and	pathogenesis	NN	B-NP	Oand	host	and	CC	O	Ohost	immune	host	NN	B-NP	Oimmune	responses	immune	JJ	I-NP	Oresponses	is	response	NNS	I-NP	Ois	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	more	of	IN	B-PP	Omore	efficient	more	JJR	B-NP	Oefficient	means	efficient	JJ	I-NP	Omeans	of	mean	NNS	I-NP	Oof	prevention	of	IN	B-PP	Oprevention	and	prevention	NN	B-NP	Oand	treatment	and	CC	I-NP	Otreatment	of	treatment	NN	I-NP	Oof	influenza	of	IN	B-PP	Oinfluenza	.	influenza	NN	B-NP	O.	Influenza	.	.	O	OInfluenza	A	Influenza	NN	B-NP	OA	virus	A	NN	I-NP	Ovirus	","	virus	NN	I-NP	O","	which	","	","	O	Owhich	replicates	which	WDT	B-NP	Oreplicates	in	replicate	VBZ	B-VP	Oin	epithelial	in	IN	B-PP	Oepithelial	cells	epithelial	JJ	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	leukocytes	and	CC	O	Oleukocytes	","	leukocyte	NNS	B-NP	B-cell_type","	regulates	","	","	O	Oregulates	host	regulate	VBZ	B-VP	Ohost	cell	host	NN	B-NP	Ocell	transcriptional	cell	NN	I-NP	Otranscriptional	and	transcriptional	JJ	I-NP	Oand	translational	and	CC	I-NP	Otranslational	systems	translational	JJ	I-NP	Osystems	and	system	NNS	I-NP	Oand	activates	and	CC	O	Oactivates	","	activate	VBZ	B-VP	O","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	downregulates	as	IN	I-CONJP	Odownregulates	apoptotic	downregulate	VBZ	B-VP	Oapoptotic	pathways	apoptotic	JJ	B-NP	Opathways	.	pathway	NNS	I-NP	O.	Influenza	.	.	O	OInfluenza	A	Influenza	NN	B-NP	OA	virus	A	NN	I-NP	Ovirus	infection	virus	NN	I-NP	Oinfection	results	infection	NN	I-NP	Oresults	in	result	VBZ	B-VP	Oin	the	in	IN	B-PP	Othe	production	the	DT	B-NP	Oproduction	of	production	NN	I-NP	Oof	chemotactic	of	IN	B-PP	Ochemotactic	(	chemotactic	JJ	B-NP	O(	RANTES	(	(	O	ORANTES	","	RANTES	NN	B-NP	B-protein","	MIP-1	","	","	O	OMIP-1	alpha	MIP-1	NN	B-NP	B-proteinalpha	","	alpha	NN	I-NP	I-protein","	MCP-1	","	","	O	OMCP-1	","	MCP-1	NN	B-NP	B-protein","	MCP-3	","	","	O	OMCP-3	","	MCP-3	NN	B-NP	B-protein","	and	","	","	O	Oand	IP-10	and	CC	O	OIP-10	)	IP-10	NN	B-NP	B-protein)	","	)	)	O	O","	pro-inflammatory	","	","	O	Opro-inflammatory	(	pro-inflammatory	JJ	B-ADJP	O(	IL-1	(	(	O	OIL-1	beta	IL-1	NN	B-NP	B-proteinbeta	","	beta	NN	I-NP	I-protein","	IL-6	","	","	O	OIL-6	","	IL-6	NN	B-NP	B-protein","	IL-18	","	","	O	OIL-18	","	IL-18	NN	B-NP	B-protein","	and	","	","	O	Oand	TNF-alpha	and	CC	O	OTNF-alpha	)	TNF-alpha	NN	B-NP	B-protein)	","	)	)	O	O","	and	","	","	O	Oand	antiviral	and	CC	O	Oantiviral	(	antiviral	JJ	B-ADJP	B-protein(	IFN-alpha/beta	(	(	O	I-proteinIFN-alpha/beta	)	IFN-alpha/beta	NN	B-NP	I-protein)	cytokines	)	)	O	I-proteincytokines	.	cytokine	NNS	B-NP	I-protein.	Cytokine	.	.	O	OCytokine	gene	Cytokine	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	is	expression	NN	I-NP	Ois	associated	be	VBZ	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	the	with	IN	B-PP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	","	B	NN	I-NP	I-protein","	AP-1	","	","	O	OAP-1	","	AP-1	NN	B-NP	B-protein","	STAT	","	","	O	OSTAT	and	STAT	NN	B-NP	B-proteinand	IRF	and	CC	O	OIRF	signal	IRF	NN	B-NP	B-proteinsignal	transducing	signal	NN	I-NP	I-proteintransducing	molecules	transducing	NN	I-NP	I-proteinmolecules	in	molecule	NNS	I-NP	I-proteinin	influenza	in	IN	B-PP	Oinfluenza	A	influenza	NN	B-NP	B-cell_typeA	virus-infected	A	NN	I-NP	I-cell_typevirus-infected	cells	virus-infected	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	of	addition	NN	B-NP	Oof	upregulating	of	IN	B-PP	Oupregulating	cytokine	upregulate	VBG	B-VP	Ocytokine	gene	cytokine	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	","	expression	NN	I-NP	O","	influenza	","	","	O	Oinfluenza	A	influenza	NN	B-NP	OA	virus	A	NN	I-NP	Ovirus	infection	virus	NN	I-NP	Oinfection	activates	infection	NN	I-NP	Oactivates	caspase-1	activate	VBZ	B-VP	Ocaspase-1	enzyme	caspase-1	NN	B-NP	B-proteinenzyme	","	enzyme	NN	I-NP	I-protein","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	involved	be	VBZ	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	proteolytic	the	DT	B-NP	Oproteolytic	processing	proteolytic	JJ	I-NP	Oprocessing	of	processing	NN	I-NP	Oof	proIL-1	of	IN	B-PP	OproIL-1	beta	proIL-1	NN	B-NP	B-proteinbeta	and	beta	NN	I-NP	I-proteinand	proIL-18	and	CC	I-NP	OproIL-18	into	proIL-18	NN	I-NP	B-proteininto	their	into	IN	B-PP	Otheir	biologically	their	PRP$	B-NP	Obiologically	active	biologically	RB	I-NP	Oactive	forms	active	JJ	I-NP	Oforms	.	form	NNS	I-NP	O.	Influenza	.	.	O	OInfluenza	A	Influenza	NN	B-NP	OA	virus-induced	A	DT	B-NP	Ovirus-induced	IFN-alpha/beta	virus-induced	JJ	I-NP	OIFN-alpha/beta	is	IFN-alpha/beta	NN	I-NP	B-proteinis	essential	be	VBZ	B-VP	Oessential	in	essential	JJ	B-ADJP	Oin	host	in	IN	B-PP	Ohost	's	host	NN	B-NP	O's	antiviral	's	POS	B-NP	Oantiviral	defence	antiviral	JJ	I-NP	Odefence	by	defence	NN	I-NP	Oby	activating	by	IN	B-PP	Oactivating	the	activate	VBG	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	antiviral	of	IN	B-PP	Oantiviral	Mx	antiviral	JJ	B-NP	B-proteinMx	","	Mx	NN	I-NP	I-protein","	PKR	","	","	O	OPKR	and	PKR	NN	B-NP	B-proteinand	oligoadenylate	and	CC	O	Ooligoadenylate	synthetase	oligoadenylate	NN	B-NP	Osynthetase	genes	synthetase	NN	I-NP	Ogenes	.	gene	NNS	I-NP	O.	IFN-alpha/beta	.	.	O	OIFN-alpha/beta	also	IFN-alpha/beta	NN	B-NP	B-proteinalso	prolongs	also	RB	B-ADVP	Oprolongs	T	prolong	VBZ	B-VP	OT	cell	T	NN	B-NP	Ocell	survival	cell	NN	I-NP	Osurvival	","	survival	NN	I-NP	O","	upregulates	","	","	O	Oupregulates	IL-12	upregulate	VBZ	B-VP	OIL-12	and	IL-12	NN	B-NP	B-proteinand	IL-18	and	CC	I-NP	OIL-18	receptor	IL-18	NN	I-NP	B-proteinreceptor	gene	receptor	NN	I-NP	Ogene	expression	gene	NN	I-NP	Oexpression	and	expression	NN	I-NP	Oand	together	and	CC	O	Otogether	with	together	RB	B-ADVP	Owith	IL-18	with	IN	B-PP	OIL-18	stimulates	IL-18	NN	B-NP	B-proteinstimulates	NK	stimulate	VBZ	B-VP	ONK	and	NK	NN	B-NP	Oand	T	and	CC	I-NP	OT	cell	T	NN	I-NP	Ocell	IFN-gamma	cell	NN	I-NP	OIFN-gamma	production	IFN-gamma	NN	I-NP	B-proteinproduction	and	production	NN	I-NP	Oand	the	and	CC	O	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	Th1-type	of	IN	B-PP	OTh1-type	immune	Th1-type	JJ	B-NP	Oimmune	response	immune	JJ	I-NP	Oresponse	.	response	NN	I-NP	O.	Comparison	.	.	O	OComparison	of	Comparison	NN	B-NP	Oof	hprt	of	IN	B-PP	Ohprt	and	hprt	NN	B-NP	Oand	lacI	and	CC	I-NP	OlacI	mutant	lacI	NN	I-NP	Omutant	frequency	mutant	JJ	I-NP	Ofrequency	with	frequency	NN	I-NP	Owith	DNA	with	IN	B-PP	ODNA	adduct	DNA	NN	B-NP	Oadduct	formation	adduct	NN	I-NP	Oformation	in	formation	NN	I-NP	Oin	N-hydroxy-2-acetylaminofluorene-treated	in	IN	B-PP	ON-hydroxy-2-acetylaminofluorene-treated	Big	N-hydroxy-2-acetylaminofluorene-treated	JJ	B-NP	OBig	Blue	Big	JJ	I-NP	OBlue	rats	Blue	NN	I-NP	Orats	.	rat	NNS	I-NP	O.	N-Hydroxy-2-acetylaminofluorene	.	.	O	ON-Hydroxy-2-acetylaminofluorene	(	N-Hydroxy-2-acetylaminofluorene	NN	B-NP	O(	N-OH-AAF	(	(	O	ON-OH-AAF	)	N-OH-AAF	NN	B-NP	B-protein)	is	)	)	O	Ois	the	be	VBZ	B-VP	Othe	proximate	the	DT	B-NP	Oproximate	carcinogenic	proximate	JJ	I-NP	Ocarcinogenic	metabolite	carcinogenic	JJ	I-NP	Ometabolite	of	metabolite	NN	I-NP	Oof	the	of	IN	B-PP	Othe	powerful	the	DT	B-NP	Opowerful	rat	powerful	JJ	I-NP	Orat	liver	rat	NN	I-NP	Oliver	carcinogen	liver	NN	I-NP	Ocarcinogen	2-acetylaminofluorene	carcinogen	NN	I-NP	O2-acetylaminofluorene	.	2-acetylaminofluorene	NN	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	transgenic	","	","	O	Otransgenic	Big	transgenic	JJ	B-NP	OBig	Blue	Big	JJ	I-NP	OBlue	(	Blue	NN	I-NP	O(	R	(	(	O	OR	)	R	NN	B-NP	O)	rats	)	)	O	Orats	were	rat	NNS	B-NP	Owere	used	be	VBD	B-VP	Oused	to	use	VBN	I-VP	Oto	examine	to	TO	B-VP	Oexamine	the	examine	VB	I-VP	Othe	relationship	the	DT	B-NP	Orelationship	between	relationship	NN	I-NP	Obetween	in	between	IN	B-PP	Oin	vivo	in	FW	B-NP	Ovivo	mutagenicity	vivo	FW	I-NP	Omutagenicity	and	mutagenicity	NN	I-NP	Oand	DNA	and	CC	I-NP	ODNA	adduct	DNA	NN	I-NP	Oadduct	formation	adduct	NN	I-NP	Oformation	by	formation	NN	I-NP	Oby	N-OH-AAF	by	IN	B-PP	ON-OH-AAF	in	N-OH-AAF	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	target	the	DT	B-NP	Otarget	liver	target	NN	I-NP	Oliver	compared	liver	NN	I-NP	Ocompared	with	compare	VBN	B-VP	Owith	that	with	IN	B-PP	Othat	in	that	DT	B-NP	Oin	nontarget	in	IN	B-PP	Onontarget	tissues	nontarget	JJ	B-NP	Otissues	.	tissue	NNS	I-NP	O.	Male	.	.	O	OMale	rats	Male	JJ	B-NP	Orats	were	rat	NNS	I-NP	Owere	given	be	VBD	B-VP	Ogiven	one	give	VBN	I-VP	Oone	","	one	CD	B-NP	O","	two	","	","	I-NP	Otwo	","	two	CD	I-NP	O","	or	","	","	O	Oor	four	or	CC	O	Ofour	doses	four	CD	B-NP	Odoses	of	dose	NNS	I-NP	Oof	25	of	IN	B-PP	O25	mg	25	CD	B-NP	Omg	N-OH-AAF/kg	mg	NN	I-NP	ON-OH-AAF/kg	body	N-OH-AAF/kg	NN	I-NP	Obody	weight	body	NN	I-NP	Oweight	by	weight	NN	I-NP	Oby	i.p.	by	IN	B-PP	Oi.p.	injection	i.p.	JJ	B-NP	Oinjection	at	injection	NN	I-NP	Oat	4-day	at	IN	B-PP	O4-day	intervals	4-day	JJ	B-NP	Ointervals	","	interval	NNS	I-NP	O","	and	","	","	O	Oand	groups	and	CC	O	Ogroups	of	group	NNS	B-NP	Oof	treated	of	IN	B-PP	Otreated	and	treat	VBN	B-NP	Oand	control	and	CC	I-NP	Ocontrol	rats	control	NN	I-NP	Orats	were	rat	NNS	I-NP	Owere	euthanized	be	VBD	B-VP	Oeuthanized	up	euthanize	VBN	I-VP	Oup	to	up	RB	B-NP	Oto	10	to	TO	I-NP	O10	weeks	10	CD	I-NP	Oweeks	after	week	NNS	I-NP	Oafter	beginning	after	IN	B-PP	Obeginning	the	begin	VBG	B-VP	Othe	dosing	the	DT	B-NP	Odosing	.	dosing	NN	I-NP	O.	Mutant	.	.	O	OMutant	frequencies	Mutant	JJ	B-NP	Ofrequencies	were	frequency	NNS	I-NP	Owere	measured	be	VBD	B-VP	Omeasured	in	measure	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	spleen	the	DT	B-NP	Ospleen	lymphocyte	spleen	NN	I-NP	B-DNAlymphocyte	hprt	lymphocyte	NN	I-NP	I-DNAhprt	gene	hprt	NN	I-NP	I-DNAgene	","	gene	NN	I-NP	I-DNA","	and	","	","	O	Oand	lacI	and	CC	O	OlacI	mutant	lacI	NN	B-NP	Omutant	frequencies	mutant	JJ	I-NP	Ofrequencies	were	frequency	NNS	I-NP	Owere	determined	be	VBD	B-VP	Odetermined	in	determine	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	liver	the	DT	B-NP	Oliver	and	liver	NN	I-NP	Oand	spleen	and	CC	I-NP	Ospleen	lymphocytes	spleen	NN	I-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	At	.	.	O	OAt	6	At	IN	B-PP	O6	weeks	6	CD	B-NP	Oweeks	after	week	NNS	I-NP	Oafter	beginning	after	IN	B-PP	Obeginning	the	begin	VBG	B-VP	Othe	dosing	the	DT	B-NP	Odosing	","	dosing	NN	I-NP	O","	the	","	","	O	Othe	hprt	the	DT	B-NP	Ohprt	mutant	hprt	NN	I-NP	Omutant	frequency	mutant	JJ	I-NP	Ofrequency	in	frequency	NN	I-NP	Oin	spleen	in	IN	B-PP	Ospleen	lymphocytes	spleen	NN	B-NP	B-cell_typelymphocytes	from	lymphocyte	NNS	I-NP	I-cell_typefrom	the	from	IN	B-PP	Othe	four-dose	the	DT	B-NP	Ofour-dose	group	four-dose	JJ	I-NP	Ogroup	was	group	NN	I-NP	Owas	16.5	be	VBD	B-VP	O16.5	x	16.5	CD	B-NP	Ox	10	x	SYM	O	O10	(	10	CD	B-NP	O(	-6	(	(	O	O-6	)	-6	CD	B-NP	O)	compared	)	)	O	Ocompared	with	compare	VBN	B-PP	Owith	3.2	with	IN	B-PP	O3.2	x	3.2	CD	B-NP	Ox	10	x	SYM	I-NP	O10	(	10	CD	I-NP	O(	-6	(	(	O	O-6	)	-6	CD	B-NP	O)	in	)	)	O	Oin	control	in	IN	B-PP	Ocontrol	animals	control	NN	B-NP	Oanimals	.	animal	NNS	I-NP	O.	Also	.	.	O	OAlso	at	Also	RB	B-ADVP	Oat	6	at	IN	B-PP	O6	weeks	6	CD	B-NP	Oweeks	","	week	NNS	I-NP	O","	rats	","	","	O	Orats	given	rat	NNS	B-NP	Ogiven	one	give	VBN	B-PP	Oone	","	one	CD	B-NP	O","	two	","	","	I-NP	Otwo	","	two	CD	I-NP	O","	or	","	","	O	Oor	four	or	CC	O	Ofour	doses	four	CD	B-NP	Odoses	of	dose	NNS	I-NP	Oof	N-OH-AAF	of	IN	B-PP	ON-OH-AAF	had	N-OH-AAF	NN	B-NP	Ohad	lacI	have	VBD	B-VP	OlacI	mutant	lacI	NN	B-NP	Omutant	frequencies	mutant	JJ	I-NP	Ofrequencies	in	frequency	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	liver	the	DT	B-NP	Oliver	of	liver	NN	I-NP	Oof	97.6	of	IN	B-PP	O97.6	","	97.6	CD	B-NP	O","	155.6	","	","	I-NP	O155.6	","	155.6	CD	I-NP	O","	and	","	","	O	Oand	406.8	and	CC	O	O406.8	x	406.8	CD	B-NP	Ox	10	x	CC	I-NP	O10	(	10	CD	I-NP	O(	-6	(	(	O	O-6	)	-6	CD	B-NP	O)	","	)	)	O	O","	respectively	","	","	O	Orespectively	","	respectively	RB	B-ADVP	O","	compared	","	","	O	Ocompared	with	compare	VBN	B-PP	Owith	a	with	IN	B-PP	Oa	control	a	DT	B-NP	Ocontrol	frequency	control	NN	I-NP	Ofrequency	of	frequency	NN	I-NP	Oof	25.7	of	IN	B-PP	O25.7	x	25.7	CD	B-NP	Ox	10	x	SYM	I-NP	O10	(	10	CD	I-NP	O(	-6	(	(	O	O-6	)	-6	CD	B-NP	O)	;	)	)	O	O;	rats	;	:	O	Orats	given	rat	NNS	B-NP	Ogiven	four	give	VBN	B-VP	Ofour	doses	four	CD	B-NP	Odoses	had	dose	NNS	I-NP	Ohad	lacI	have	VBD	B-VP	OlacI	mutant	lacI	NN	B-NP	Omutant	frequencies	mutant	JJ	I-NP	Ofrequencies	in	frequency	NNS	I-NP	Oin	spleen	in	IN	B-PP	Ospleen	lymphocytes	spleen	NN	B-NP	B-cell_typelymphocytes	of	lymphocyte	NNS	I-NP	I-cell_typeof	55.8	of	IN	B-PP	O55.8	x	55.8	CD	B-NP	Ox	10	x	SYM	I-NP	O10	(	10	CD	I-NP	O(	-6	(	(	O	O-6	)	-6	CD	B-NP	O)	compared	)	)	O	Ocompared	with	compare	VBN	B-PP	Owith	a	with	IN	B-PP	Oa	control	a	DT	B-NP	Ocontrol	frequency	control	NN	I-NP	Ofrequency	of	frequency	NN	I-NP	Oof	20.4	of	IN	B-PP	O20.4	x	20.4	CD	B-NP	Ox	10	x	SYM	I-NP	O10	(	10	CD	I-NP	O(	-6	(	(	O	O-6	)	-6	CD	B-NP	O)	.	)	)	O	O.	Additional	.	.	O	OAdditional	rats	Additional	JJ	B-NP	Orats	were	rat	NNS	I-NP	Owere	evaluated	be	VBD	B-VP	Oevaluated	for	evaluate	VBN	I-VP	Ofor	DNA	for	IN	B-PP	ODNA	adduct	DNA	NN	B-NP	Oadduct	formation	adduct	NN	I-NP	Oformation	in	formation	NN	I-NP	Oin	the	in	IN	B-PP	Othe	liver	the	DT	B-NP	Oliver	","	liver	NN	I-NP	O","	spleen	","	","	O	Ospleen	lymphocytes	spleen	NN	B-NP	B-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	bone	and	CC	O	Obone	marrow	bone	NN	B-NP	Omarrow	by	marrow	NN	I-NP	Oby	(	by	IN	B-PP	O(	32	(	(	O	O32	)	32	CD	B-NP	O)	P-postlabeling	)	)	O	OP-postlabeling	.	P-postlabeling	NN	B-NP	O.	Adduct	.	.	O	OAdduct	analysis	Adduct	NN	B-NP	Oanalysis	was	analysis	NN	I-NP	Owas	conducted	be	VBD	B-VP	Oconducted	1	conduct	VBN	I-VP	O1	day	1	CD	B-NP	Oday	after	day	NN	I-NP	Oafter	one	after	IN	B-PP	Oone	","	one	CD	B-NP	O","	two	","	","	I-NP	Otwo	","	two	CD	I-NP	O","	and	","	","	O	Oand	four	and	CC	O	Ofour	treatments	four	CD	B-NP	Otreatments	with	treatment	NNS	I-NP	Owith	N-OH-AAF	with	IN	B-PP	ON-OH-AAF	","	N-OH-AAF	NN	B-NP	O","	5	","	","	O	O5	days	5	CD	B-NP	Odays	after	day	NNS	I-NP	Oafter	one	after	IN	B-PP	Oone	treatment	one	CD	B-NP	Otreatment	","	treatment	NN	I-NP	O","	and	","	","	O	Oand	9	and	CC	O	O9	days	9	CD	B-NP	Odays	after	day	NNS	I-NP	Oafter	two	after	IN	B-PP	Otwo	treatments	two	CD	B-NP	Otreatments	.	treatment	NNS	I-NP	O.	N-	.	.	O	ON-	(	N-	NN	B-NP	O(	Deoxyguanosin-8-yl	(	(	O	ODeoxyguanosin-8-yl	)	Deoxyguanosin-8-yl	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	was	#NAME?	NN	B-NP	Owas	the	be	VBD	B-VP	Othe	major	the	DT	B-NP	Omajor	DNA	major	JJ	I-NP	ODNA	adduct	DNA	NN	I-NP	Oadduct	identified	adduct	NN	I-NP	Oidentified	in	identify	VBN	B-VP	Oin	all	in	IN	B-PP	Oall	the	all	PDT	B-NP	Othe	tissues	the	DT	I-NP	Otissues	examined	tissue	NNS	I-NP	Oexamined	.	examine	VBN	B-VP	O.	Adduct	.	.	O	OAdduct	concentrations	Adduct	NN	B-NP	Oconcentrations	increased	concentration	NNS	I-NP	Oincreased	with	increase	VBD	B-VP	Owith	total	with	IN	B-PP	Ototal	dose	total	JJ	B-NP	Odose	to	dose	NN	I-NP	Oto	maximum	to	TO	B-PP	Omaximum	values	maximum	JJ	B-NP	Ovalues	in	value	NNS	I-NP	Oin	samples	in	IN	B-PP	Osamples	taken	sample	NNS	B-NP	Otaken	1	take	VBN	B-VP	O1	day	1	CD	B-NP	Oday	after	day	NN	I-NP	Oafter	two	after	IN	B-PP	Otwo	doses	two	CD	B-NP	Odoses	","	dose	NNS	I-NP	O","	and	","	","	O	Oand	remained	and	CC	O	Oremained	essentially	remain	VBD	B-VP	Oessentially	the	essentially	RB	B-NP	Othe	same	the	DT	I-NP	Osame	after	same	JJ	I-NP	Oafter	four	after	IN	B-PP	Ofour	doses	four	CD	B-NP	Odoses	.	dose	NNS	I-NP	O.	In	.	.	O	OIn	samples	In	IN	B-PP	Osamples	taken	sample	NNS	B-NP	Otaken	after	take	VBN	B-VP	Oafter	four	after	IN	B-PP	Ofour	doses	four	CD	B-NP	Odoses	","	dose	NNS	I-NP	O","	adduct	","	","	O	Oadduct	levels	adduct	NN	B-NP	Olevels	were	level	NNS	I-NP	Owere	103	be	VBD	B-VP	O103	","	103	CD	B-NP	O","	28	","	","	I-NP	O28	","	28	CD	I-NP	O","	and	","	","	O	Oand	7	and	CC	O	O7	fmol/microg	7	CD	B-NP	Ofmol/microg	of	fmol/microg	NN	I-NP	Oof	DNA	of	IN	B-PP	ODNA	in	DNA	NN	B-NP	Oin	liver	in	IN	B-PP	Oliver	","	liver	NN	B-NP	O","	spleen	","	","	O	Ospleen	lymphocytes	spleen	NN	B-NP	B-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	bone	and	CC	O	Obone	marrow	bone	NN	B-NP	Omarrow	","	marrow	NN	I-NP	O","	respectively	","	","	O	Orespectively	.	respectively	RB	B-ADVP	O.	The	.	.	O	OThe	results	The	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	extent	the	DT	B-NP	Oextent	of	extent	NN	I-NP	Oof	both	of	IN	B-PP	Oboth	DNA	both	CC	O	ODNA	adduct	DNA	NN	B-NP	Oadduct	formation	adduct	NN	I-NP	Oformation	and	formation	NN	I-NP	Oand	mutant	and	CC	O	Omutant	induction	mutant	JJ	B-NP	Oinduction	correlates	induction	NN	I-NP	Ocorrelates	with	correlate	VBZ	B-VP	Owith	the	with	IN	B-PP	Othe	organ	the	DT	B-NP	Oorgan	specificity	organ	NN	I-NP	Ospecificity	for	specificity	NN	I-NP	Ofor	N-OH-AAF	for	IN	B-PP	ON-OH-AAF	carcinogenesis	N-OH-AAF	NN	B-NP	Ocarcinogenesis	in	carcinogenesis	NN	I-NP	Oin	the	in	IN	B-PP	Othe	rat	the	DT	B-NP	Orat	.	rat	NN	I-NP	O.	Environ.	.	.	O	OEnviron.	Mol.	Environ.	NNP	B-NP	OMol.	Mutagen.	Mol.	NNP	I-NP	OMutagen.	37	Mutagen.	NNP	I-NP	O37	:	37	CD	I-NP	O:	195-202	:	:	O	O195-202	","	195-202	CD	B-NP	O","	2001	","	","	I-NP	O2001	.	2001	CD	I-NP	O.	Published	.	.	O	OPublished	2001	Published	NNP	B-NP	O2001	Wiley-Liss	2001	CD	I-NP	OWiley-Liss	","	Wiley-Liss	NNP	I-NP	O","	Inc	","	","	O	OInc	.	Inc	NNP	B-NP	O.	Expression	.	.	O	OExpression	of	Expression	NN	B-NP	Oof	Mad1	of	IN	B-PP	OMad1	in	Mad1	NN	B-NP	B-proteinin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	leads	cell	NNS	I-NP	I-cell_typeleads	to	lead	VBZ	B-VP	Oto	reduced	to	TO	B-PP	Oreduced	thymic	reduce	VBN	B-NP	Othymic	cellularity	thymic	JJ	I-NP	Ocellularity	and	cellularity	NN	I-NP	Oand	impaired	and	CC	O	Oimpaired	mitogen-induced	impaired	JJ	B-NP	Omitogen-induced	proliferation	mitogen-induced	JJ	I-NP	Oproliferation	.	proliferation	NN	I-NP	O.	To	.	.	O	OTo	investigate	To	TO	B-VP	Oinvestigate	Mad1	investigate	VB	I-VP	OMad1	function	Mad1	NN	B-NP	B-proteinfunction	in	function	NN	I-NP	Oin	vivo	in	FW	B-ADVP	Ovivo	","	vivo	FW	I-ADVP	O","	transgenic	","	","	O	Otransgenic	mice	transgenic	JJ	B-NP	Omice	were	mouse	NNS	I-NP	Owere	generated	be	VBD	B-VP	Ogenerated	that	generate	VBN	I-VP	Othat	express	that	WDT	B-NP	Oexpress	a	express	VBP	B-VP	Oa	Mad1	a	DT	B-NP	OMad1	transgene	Mad1	NN	I-NP	B-DNAtransgene	in	transgene	NN	I-NP	I-DNAin	T	in	IN	B-PP	OT	lineage	T	NN	B-NP	B-cell_typelineage	cells	lineage	NN	I-NP	I-cell_typecells	under	cell	NNS	I-NP	I-cell_typeunder	the	under	IN	B-PP	Othe	control	the	DT	B-NP	Ocontrol	of	control	NN	I-NP	Oof	the	of	IN	B-PP	Othe	proximal	the	DT	B-NP	Oproximal	lck	proximal	JJ	I-NP	B-DNAlck	promoter	lck	NN	I-NP	I-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Thymus	.	.	O	OThymus	size	Thymus	NN	B-NP	Osize	in	size	NN	I-NP	Oin	lck-Mad1	in	IN	B-PP	Olck-Mad1	transgenic	lck-Mad1	NN	B-NP	Otransgenic	mice	transgenic	JJ	I-NP	Omice	is	mouse	NNS	I-NP	Ois	drastically	be	VBZ	B-VP	Odrastically	reduced	drastically	RB	I-VP	Oreduced	although	reduce	VBN	I-VP	Oalthough	representation	although	IN	B-SBAR	Orepresentation	of	representation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	various	the	DT	B-NP	Ovarious	thymocyte	various	JJ	I-NP	Othymocyte	sub	thymocyte	NN	I-NP	B-cell_typesub	populations	sub	NN	I-NP	I-cell_typepopulations	appears	population	NNS	I-NP	I-cell_typeappears	normal	appear	VBZ	B-VP	Onormal	.	normal	JJ	B-ADJP	O.	To	.	.	O	OTo	investigate	To	TO	B-VP	Oinvestigate	more	investigate	VB	I-VP	Omore	closely	more	RBR	B-ADVP	Oclosely	any	closely	RB	I-ADVP	Oany	effects	any	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	Mad1	of	IN	B-PP	OMad1	expression	Mad1	NN	B-NP	B-proteinexpression	on	expression	NN	I-NP	Oon	thymocytes	on	IN	B-PP	Othymocytes	","	thymocyte	NNS	B-NP	B-cell_type","	we	","	","	O	Owe	examined	we	PRP	B-NP	Oexamined	thymic	examine	VBD	B-VP	Othymic	selection	thymic	JJ	B-NP	Oselection	using	selection	NN	I-NP	Ousing	MHC	use	VBG	B-VP	OMHC	class	MHC	NN	B-NP	Oclass	I-restricted	class	NN	I-NP	OI-restricted	H-Y-TCR	I-restricted	JJ	I-NP	OH-Y-TCR	transgenic	H-Y-TCR	NN	I-NP	Otransgenic	mice	transgenic	JJ	I-NP	Omice	.	mouse	NNS	I-NP	O.	Mad1	.	.	O	OMad1	expression	Mad1	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	vivo	in	FW	B-ADVP	Ovivo	reduces	vivo	FW	I-ADVP	Oreduces	the	reduce	VBZ	B-VP	Othe	efficiency	the	DT	B-NP	Oefficiency	of	efficiency	NN	I-NP	Oof	positive	of	IN	B-PP	Opositive	selection	positive	JJ	B-NP	Oselection	.	selection	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	thymocytes	","	","	O	Othymocytes	and	thymocyte	NNS	B-NP	B-cell_typeand	splenic	and	CC	O	Osplenic	T	splenic	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	lck-Mad1	from	IN	B-PP	Olck-Mad1	transgenic	lck-Mad1	NN	B-NP	Otransgenic	mice	transgenic	JJ	I-NP	Omice	display	mouse	NNS	I-NP	Odisplay	a	display	VBP	B-VP	Oa	profound	a	DT	B-NP	Oprofound	proliferative	profound	JJ	I-NP	Oproliferative	defect	proliferative	JJ	I-NP	Odefect	in	defect	NN	I-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	I-PP	Oto	activation	to	TO	I-PP	Oactivation	with	activation	NN	B-NP	Owith	either	with	IN	B-PP	Oeither	PMA/Ionomycin	either	CC	O	OPMA/Ionomycin	or	PMA/Ionomycin	NN	B-NP	Oor	immobilized	or	CC	O	Oimmobilized	anti-CD3/CD28	immobilize	VBN	B-NP	Oanti-CD3/CD28	antibody	anti-CD3/CD28	JJ	I-NP	B-proteinantibody	.	antibody	NN	I-NP	I-protein.	This	.	.	O	OThis	proliferative	This	DT	B-NP	Oproliferative	defect	proliferative	JJ	I-NP	Odefect	is	defect	NN	I-NP	Ois	not	be	VBZ	B-VP	Onot	reversed	not	RB	I-VP	Oreversed	by	reverse	VBN	I-VP	Oby	addition	by	IN	B-PP	Oaddition	of	addition	NN	B-NP	Oof	exogenous	of	IN	B-PP	Oexogenous	IL-2	exogenous	JJ	B-NP	OIL-2	and	IL-2	NN	I-NP	B-proteinand	is	and	CC	O	Ois	p53-independent	be	VBZ	B-VP	Op53-independent	.	p53-independent	JJ	B-ADJP	O.	The	.	.	O	OThe	growth	The	DT	B-NP	Ogrowth	inhibition	growth	NN	I-NP	Oinhibition	caused	inhibition	NN	I-NP	Ocaused	by	cause	VBN	B-VP	Oby	Mad1	by	IN	B-PP	OMad1	is	Mad1	NN	B-NP	B-proteinis	overcome	be	VBZ	B-VP	Oovercome	by	overcome	VBN	I-VP	Oby	expression	by	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	active	of	IN	B-PP	Oactive	c-Myc	active	JJ	B-NP	Oc-Myc	.	c-Myc	NN	I-NP	B-protein.	Differential	.	.	O	ODifferential	requirement	Differential	JJ	B-NP	Orequirement	for	requirement	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	PU.1	factor	NN	I-NP	I-proteinPU.1	in	PU.1	NN	I-NP	B-proteinin	the	in	IN	B-PP	Othe	generation	the	DT	B-NP	Ogeneration	of	generation	NN	I-NP	Oof	natural	of	IN	B-PP	Onatural	killer	natural	JJ	B-NP	B-cell_typekiller	cells	killer	NN	I-NP	I-cell_typecells	versus	cell	NNS	I-NP	I-cell_typeversus	B	versus	CC	O	OB	and	B	NN	B-NP	Oand	T	and	CC	O	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	B-NP	I-cell_type.	PU.1	.	.	O	OPU.1	is	PU.1	NN	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	member	a	DT	B-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	Ets	the	DT	B-NP	OEts	family	Ets	NN	I-NP	B-proteinfamily	of	family	NN	I-NP	I-proteinof	transcription	of	IN	B-PP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	required	factor	NNS	I-NP	I-proteinrequired	for	require	VBN	B-VP	Ofor	the	for	IN	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	various	of	IN	B-PP	Ovarious	lymphoid	various	JJ	B-NP	Olymphoid	and	lymphoid	JJ	I-NP	Oand	myeloid	and	CC	I-NP	Omyeloid	cell	myeloid	JJ	I-NP	B-cell_typecell	lineages	cell	NN	I-NP	I-cell_typelineages	","	lineage	NNS	I-NP	I-cell_type","	but	","	","	O	Obut	its	but	CC	O	Oits	role	its	PRP$	B-NP	Orole	in	role	NN	I-NP	Oin	natural	in	IN	B-PP	Onatural	killer	natural	JJ	B-NP	Okiller	(	killer	NN	I-NP	O(	NK	(	(	O	ONK	)	NK	NN	B-NP	O)	cell	)	)	O	Ocell	development	cell	NN	B-NP	Odevelopment	is	development	NN	I-NP	Ois	not	be	VBZ	B-VP	Onot	known	not	RB	I-VP	Oknown	.	know	VBN	I-VP	O.	The	.	.	O	OThe	study	The	DT	B-NP	Ostudy	shows	study	NN	I-NP	Oshows	that	show	VBZ	B-VP	Othat	PU.1	that	IN	B-SBAR	OPU.1	is	PU.1	NN	B-NP	B-proteinis	expressed	be	VBZ	B-VP	Oexpressed	in	express	VBN	I-VP	Oin	NK	in	IN	B-PP	ONK	cells	NK	NN	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	that	and	CC	O	Othat	","	that	IN	B-SBAR	O","	on	","	","	O	Oon	cell	on	IN	B-PP	Ocell	transfer	cell	NN	B-NP	Otransfer	into	transfer	NN	I-NP	Ointo	alymphoid	into	IN	B-PP	Oalymphoid	Rag2/gammac	alymphoid	JJ	B-NP	B-proteinRag2/gammac	(	Rag2/gammac	NN	I-NP	I-protein(	-/-	(	(	O	O-/-	)	-/-	JJ	O	O)	mice	)	)	O	Omice	","	mouse	NNS	B-NP	O","	hematopoietic	","	","	O	Ohematopoietic	progenitors	hematopoietic	JJ	B-NP	B-cell_typeprogenitors	of	progenitor	NNS	I-NP	I-cell_typeof	PU.1	of	IN	B-PP	OPU.1	(	PU.1	NN	B-NP	B-protein(	-/-	(	(	O	O-/-	)	-/-	JJ	B-ADJP	O)	fetal	)	)	O	Ofetal	liver	fetal	JJ	B-NP	Oliver	cells	liver	NN	I-NP	Ocells	could	cell	NNS	I-NP	Ocould	generate	could	MD	B-VP	Ogenerate	functional	generate	VB	I-VP	Ofunctional	NK	functional	JJ	B-NP	ONK	cells	NK	NN	I-NP	B-cell_typecells	but	cell	NNS	I-NP	I-cell_typebut	not	but	CC	B-NP	Onot	B	not	RB	I-NP	OB	or	B	NN	B-NP	Oor	T	or	CC	O	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Nevertheless	.	.	O	ONevertheless	","	Nevertheless	RB	B-ADVP	O","	the	","	","	O	Othe	numbers	the	DT	B-NP	Onumbers	of	number	NNS	I-NP	Oof	bone	of	IN	B-PP	Obone	marrow	bone	NN	B-NP	B-cell_typemarrow	NK	marrow	NN	I-NP	I-cell_typeNK	cell	NK	NN	I-NP	I-cell_typecell	precursors	cell	NN	I-NP	I-cell_typeprecursors	and	precursor	NNS	I-NP	I-cell_typeand	splenic	and	CC	O	Osplenic	mature	splenic	JJ	B-NP	B-cell_typemature	NK	mature	JJ	I-NP	I-cell_typeNK	cells	NK	NN	I-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	reduced	be	VBD	B-VP	Oreduced	compared	reduce	VBN	I-VP	Ocompared	to	compare	VBN	B-PP	Oto	controls	to	TO	B-PP	Ocontrols	.	control	NNS	B-NP	O.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	PU.1	","	","	O	OPU.1	(	PU.1	NN	B-NP	B-protein(	-/-	(	(	O	O-/-	)	-/-	JJ	O	O)	NK	)	)	O	ONK	cells	NK	NN	B-NP	B-cell_typecells	displayed	cell	NNS	I-NP	I-cell_typedisplayed	reduced	display	VBD	B-VP	Oreduced	expression	reduce	VBN	I-VP	Oexpression	of	expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	receptors	the	DT	B-NP	Oreceptors	for	receptor	NNS	I-NP	Ofor	stem	for	IN	B-PP	Ostem	cell	stem	NN	B-NP	B-proteincell	factor	cell	NN	I-NP	I-proteinfactor	and	factor	NN	I-NP	I-proteinand	interleukin	and	CC	O	Ointerleukin	(	interleukin	NN	B-NP	B-protein(	IL	(	(	O	I-proteinIL	)	IL	NN	B-NP	I-protein)	-7	)	)	O	I-protein-7	","	-7	CD	B-NP	I-protein","	suggesting	","	","	O	Osuggesting	a	suggest	VBG	B-VP	Oa	nonredundant	a	DT	B-NP	Ononredundant	role	nonredundant	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	PU.1	for	IN	B-PP	OPU.1	in	PU.1	NN	B-NP	B-proteinin	regulating	in	IN	B-PP	Oregulating	the	regulate	VBG	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	these	of	IN	B-PP	Othese	cytokine	these	DT	B-NP	Ocytokine	receptor	cytokine	NN	I-NP	B-DNAreceptor	genes	receptor	NN	I-NP	I-DNAgenes	during	gene	NNS	I-NP	I-DNAduring	NK	during	IN	B-PP	ONK	cell	NK	NN	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	.	development	NN	I-NP	O.	PU.1	.	.	O	OPU.1	(	PU.1	NN	B-NP	B-protein(	-/-	(	(	O	O-/-	)	-/-	JJ	O	O)	NK	)	)	O	ONK	cells	NK	NN	B-NP	B-cell_typecells	also	cell	NNS	I-NP	I-cell_typealso	showed	also	RB	B-ADVP	Oshowed	defective	show	VBD	B-VP	Odefective	expression	defective	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	inhibitory	of	IN	B-PP	Oinhibitory	and	inhibitory	JJ	O	Oand	activating	and	CC	O	Oactivating	members	activate	VBG	B-VP	Omembers	of	member	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	Ly49	the	DT	B-NP	OLy49	family	Ly49	NN	I-NP	B-proteinfamily	and	family	NN	I-NP	I-proteinand	failed	and	CC	O	Ofailed	to	fail	VBD	B-VP	Oto	proliferate	to	TO	I-VP	Oproliferate	in	proliferate	VB	I-VP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	IL-2	to	TO	B-PP	OIL-2	and	IL-2	NN	B-NP	B-proteinand	IL-12	and	CC	I-NP	OIL-12	.	IL-12	NN	I-NP	B-protein.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	despite	","	","	O	Odespite	the	despite	IN	B-PP	Othe	less	the	DT	B-NP	Oless	stringent	less	RBR	I-NP	Ostringent	requirement	stringent	JJ	I-NP	Orequirement	for	requirement	NN	I-NP	Ofor	PU.1	for	IN	B-PP	OPU.1	in	PU.1	NN	B-NP	B-proteinin	NK	in	IN	B-PP	ONK	cell	NK	NN	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	compared	development	NN	I-NP	Ocompared	to	compare	VBN	B-VP	Oto	B	to	TO	B-PP	OB	and	B	NN	B-NP	B-cell_typeand	T	and	CC	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	","	cell	NNS	B-NP	I-cell_type","	PU.1	","	","	O	OPU.1	regulates	PU.1	NN	B-NP	B-proteinregulates	NK	regulate	VBZ	B-VP	ONK	cell	NK	NN	B-NP	B-cell_typecell	differentiation	cell	NN	I-NP	I-cell_typedifferentiation	and	differentiation	NN	I-NP	Oand	homeostasis	and	CC	O	Ohomeostasis	.	homeostasis	NN	B-NP	O.	Benzene-extracted	.	.	O	OBenzene-extracted	components	Benzene-extracted	JJ	B-NP	Ocomponents	are	component	NNS	I-NP	Oare	important	be	VBP	B-VP	Oimportant	for	important	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	major	the	DT	B-NP	Omajor	activity	major	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	diesel	of	IN	B-PP	Odiesel	exhaust	diesel	NN	B-NP	Oexhaust	particles	exhaust	NN	I-NP	Oparticles	:	particle	NNS	I-NP	O:	effect	:	:	O	Oeffect	on	effect	NN	B-NP	Oon	interleukin-8	on	IN	B-PP	Ointerleukin-8	gene	interleukin-8	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	in	expression	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	bronchial	human	JJ	B-NP	B-cell_typebronchial	epithelial	bronchial	JJ	I-NP	I-cell_typeepithelial	cells	epithelial	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Epidemiologic	.	.	O	OEpidemiologic	and	Epidemiologic	JJ	B-NP	Oand	experimental	and	CC	I-NP	Oexperimental	studies	experimental	JJ	I-NP	Ostudies	suggest	study	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	diesel	that	IN	B-SBAR	Odiesel	exhaust	diesel	NN	B-NP	Oexhaust	particles	exhaust	NN	I-NP	Oparticles	(	particle	NNS	I-NP	O(	DEPs	(	(	O	ODEPs	)	DEP	NNS	B-NP	O)	may	)	)	O	Omay	be	may	MD	B-VP	Obe	related	be	VB	I-VP	Orelated	to	relate	VBN	I-VP	Oto	increasing	to	TO	B-PP	Oincreasing	respiratory	increase	VBG	B-VP	Orespiratory	mortality	respiratory	JJ	B-NP	Omortality	and	mortality	NN	I-NP	Oand	morbidity	and	CC	I-NP	Omorbidity	.	morbidity	NN	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	shown	have	VBP	B-VP	Oshown	that	show	VBN	I-VP	Othat	DEPs	that	IN	B-SBAR	ODEPs	augmented	DEP	NNS	B-NP	Oaugmented	the	augment	VBD	B-VP	Othe	production	the	DT	B-NP	Oproduction	of	production	NN	I-NP	Oof	inflammatory	of	IN	B-PP	Oinflammatory	cytokines	inflammatory	JJ	B-NP	B-proteincytokines	by	cytokine	NNS	I-NP	I-proteinby	human	by	IN	B-PP	Ohuman	airway	human	JJ	B-NP	B-cell_typeairway	epithelial	airway	NN	I-NP	I-cell_typeepithelial	cells	epithelial	JJ	I-NP	I-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	To	.	.	O	OTo	better	To	TO	B-VP	Obetter	understand	well	RBR	I-VP	Ounderstand	the	understand	VB	I-VP	Othe	mechanisms	the	DT	B-NP	Omechanisms	of	mechanism	NNS	I-NP	Oof	their	of	IN	B-PP	Otheir	proinflammatory	their	PRP$	B-NP	Oproinflammatory	activities	proinflammatory	JJ	I-NP	Oactivities	","	activity	NNS	I-NP	O","	we	","	","	O	Owe	studied	we	PRP	B-NP	Ostudied	the	study	VBD	B-VP	Othe	effects	the	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	several	of	IN	B-PP	Oseveral	components	several	JJ	B-NP	Ocomponents	extracted	component	NNS	I-NP	Oextracted	from	extract	VBN	B-VP	Ofrom	DEPs	from	IN	B-PP	ODEPs	on	DEP	NNS	B-NP	Oon	interleukin	on	IN	B-PP	Ointerleukin	(	interleukin	NN	B-NP	B-protein(	IL	(	(	O	I-proteinIL	)	IL	NN	B-NP	I-protein)	-8	)	)	O	I-protein-8	expression	-8	CD	B-NP	I-proteinexpression	in	expression	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	bronchial	human	JJ	B-NP	B-cell_linebronchial	epithelial	bronchial	JJ	I-NP	I-cell_lineepithelial	cell	epithelial	JJ	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	BEAS-2B	line	NN	I-NP	I-cell_lineBEAS-2B	and	BEAS-2B	NN	I-NP	Oand	normal	and	CC	O	Onormal	human	normal	JJ	B-NP	B-cell_typehuman	airway	human	JJ	I-NP	I-cell_typeairway	epithelial	airway	NN	I-NP	I-cell_typeepithelial	cells	epithelial	JJ	I-NP	I-cell_typecells	obtained	cell	NNS	I-NP	I-cell_typeobtained	from	obtain	VBN	B-VP	Ofrom	very	from	IN	B-PP	Overy	peripheral	very	RB	B-NP	Operipheral	airways	peripheral	JJ	I-NP	Oairways	by	airway	NNS	I-NP	Oby	an	by	IN	B-PP	Oan	ultrathin	an	DT	B-NP	Oultrathin	bronchoscope	ultrathin	JJ	I-NP	Obronchoscope	.	bronchoscope	NN	I-NP	O.	We	.	.	O	OWe	used	We	PRP	B-NP	Oused	several	use	VBD	B-VP	Oseveral	agents	several	JJ	B-NP	Oagents	active	agent	NNS	I-NP	Oactive	on	active	JJ	B-ADJP	Oon	signal	on	IN	B-PP	Osignal	transduction	signal	NN	B-NP	Otransduction	pathways	transduction	NN	I-NP	Opathways	in	pathway	NNS	I-NP	Oin	cytokine	in	IN	B-PP	Ocytokine	expression	cytokine	NN	B-NP	B-proteinexpression	","	expression	NN	I-NP	O","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	the	as	IN	I-PP	Othe	protein	the	DT	B-NP	Oprotein	kinase	protein	NN	I-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	inhibitor	C	NN	I-NP	I-proteininhibitor	staurosporin	inhibitor	NN	I-NP	Ostaurosporin	","	staurosporin	NN	I-NP	O","	antioxidant	","	","	O	Oantioxidant	agents	antioxidant	JJ	B-NP	Oagents	including	agent	NNS	I-NP	Oincluding	N-acetyl	include	VBG	B-PP	ON-acetyl	cysteine	N-acetyl	NN	B-NP	Ocysteine	(	cysteine	NN	I-NP	O(	NAC	(	(	O	ONAC	)	NAC	NN	B-NP	O)	and	)	)	O	Oand	pyrrolidine	and	CC	O	Opyrrolidine	dithiocarbamate	pyrrolidine	NN	B-NP	Odithiocarbamate	(	dithiocarbamate	NN	I-NP	O(	PDTC	(	(	O	OPDTC	)	PDTC	NN	B-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	p38	and	CC	O	Op38	mitogen-activated	p38	NN	B-NP	B-proteinmitogen-activated	protein	mitogen-activated	JJ	I-NP	I-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	MAPK	(	(	O	OMAPK	)	MAPK	NN	B-NP	B-protein)	inhibitor	)	)	O	Oinhibitor	SB203580	inhibitor	NN	B-NP	OSB203580	.	SB203580	NN	I-NP	O.	Benzene-extracted	.	.	O	OBenzene-extracted	components	Benzene-extracted	JJ	B-NP	Ocomponents	showed	component	NNS	I-NP	Oshowed	effects	show	VBD	B-VP	Oeffects	mimicking	effect	NNS	B-NP	Omimicking	DEPs	mimic	VBG	B-VP	ODEPs	on	DEP	NNS	B-NP	Oon	IL-8	on	IN	B-PP	OIL-8	gene	IL-8	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	","	expression	NN	I-NP	O","	release	","	","	O	Orelease	of	release	NN	B-NP	Oof	several	of	IN	B-PP	Oseveral	cytokines	several	JJ	B-NP	Ocytokines	(	cytokine	NNS	I-NP	B-protein(	IL-8	(	(	O	OIL-8	;	IL-8	NN	B-NP	B-protein;	granulocyte	;	:	O	Ogranulocyte	macrophage	granulocyte	NN	B-NP	B-proteinmacrophage	colony-stimulating	macrophage	NN	B-NP	I-proteincolony-stimulating	factor	colony-stimulating	JJ	I-NP	I-proteinfactor	;	factor	NN	I-NP	I-protein;	and	;	:	O	Oand	regulated	and	CC	O	Oregulated	on	regulate	VBN	B-VP	Oon	activation	on	IN	B-PP	Oactivation	","	activation	NN	B-NP	O","	normal	","	","	O	Onormal	T	normal	JJ	B-NP	OT	cells	T	NN	I-NP	B-cell_typecells	expressed	cell	NNS	I-NP	I-cell_typeexpressed	and	express	VBN	B-VP	Oand	secreted	and	CC	I-VP	Osecreted	)	secrete	VBN	I-VP	O)	and	)	)	O	Oand	nuclear	and	CC	O	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	NF	(	(	O	I-proteinNF	)	NF	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	B	#NAME?	NN	B-NP	I-proteinB	activation	B	NN	I-NP	I-proteinactivation	.	activation	NN	I-NP	O.	We	.	.	O	OWe	also	We	PRP	B-NP	Oalso	found	also	RB	B-ADVP	Ofound	that	find	VBD	B-VP	Othat	NAC	that	IN	B-SBAR	ONAC	","	NAC	NN	B-NP	O","	PDTC	","	","	O	OPDTC	","	PDTC	NN	B-NP	O","	and	","	","	O	Oand	SB203580	and	CC	O	OSB203580	suppressed	SB203580	NN	B-NP	Osuppressed	the	suppress	VBD	B-VP	Othe	activities	the	DT	B-NP	Oactivities	of	activity	NNS	I-NP	Oof	DEPs	of	IN	B-PP	ODEPs	and	DEP	NNS	B-NP	B-proteinand	their	and	CC	O	Otheir	benzene	their	PRP$	B-NP	Obenzene	extracts	benzene	NN	I-NP	Oextracts	","	extract	NNS	I-NP	O","	suggesting	","	","	O	Osuggesting	the	suggest	VBG	B-VP	Othe	roles	the	DT	B-NP	Oroles	of	role	NNS	I-NP	Oof	oxidants-mediated	of	IN	B-PP	Ooxidants-mediated	NF-kappa	oxidants-mediated	JJ	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	and	activation	NN	I-NP	Oand	p38MAPK	and	CC	O	Op38MAPK	pathways	p38MAPK	NN	B-NP	B-proteinpathways	.	pathway	NNS	I-NP	O.	Finally	.	.	O	OFinally	","	Finally	RB	B-ADVP	O","	benzo	","	","	O	Obenzo	[	benzo	NN	B-NP	O[	a	[	(	O	Oa	]	a	DT	O	O]	pyrene	]	)	O	Opyrene	","	pyrene	NN	B-NP	O","	one	","	","	O	Oone	of	one	CD	B-NP	Oof	the	of	IN	B-PP	Othe	important	the	DT	B-NP	Oimportant	compounds	important	JJ	I-NP	Ocompounds	included	compound	NNS	I-NP	Oincluded	in	include	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	benzene	the	DT	B-NP	Obenzene	component	benzene	NN	I-NP	Ocomponent	","	component	NN	I-NP	O","	replicated	","	","	O	Oreplicated	the	replicate	VBD	B-VP	Othe	activities	the	DT	B-NP	Oactivities	shown	activity	NNS	I-NP	Oshown	by	show	VBN	B-VP	Oby	DEPs	by	IN	B-PP	ODEPs	.	DEP	NNS	B-NP	B-protein.	The	.	.	O	OThe	nuclear	The	DT	B-NP	Onuclear	receptor	nuclear	JJ	I-NP	B-proteinreceptor	PPAR	receptor	NN	I-NP	I-proteinPPAR	gamma	PPAR	NN	I-NP	I-proteingamma	is	gamma	NN	I-NP	I-proteinis	expressed	be	VBZ	B-VP	Oexpressed	by	express	VBN	I-VP	Oby	mouse	by	IN	B-PP	Omouse	T	mouse	NN	B-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	PPAR	and	CC	O	OPPAR	gamma	PPAR	NN	B-NP	B-proteingamma	agonists	gamma	NN	I-NP	I-proteinagonists	induce	agonist	NNS	I-NP	Oinduce	apoptosis	induce	VBP	B-VP	Oapoptosis	.	apoptosis	NN	B-NP	O.	Peroxisome	.	.	O	OPeroxisome	proliferator-activated	Peroxisome	NN	B-NP	B-proteinproliferator-activated	receptor	proliferator-activated	JJ	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	PPAR	(	(	O	OPPAR	)	PPAR	NN	B-NP	B-protein)	#NAME?	)	)	O	O#NAME?	is	#NAME?	NN	B-NP	Ois	a	be	VBZ	B-VP	Oa	nuclear	a	DT	B-NP	Onuclear	hormone	nuclear	JJ	I-NP	B-proteinhormone	receptor	hormone	NN	I-NP	I-proteinreceptor	that	receptor	NN	I-NP	I-proteinthat	serves	that	WDT	B-NP	Oserves	as	serve	VBZ	B-VP	Oas	a	as	IN	B-PP	Oa	trans	a	DT	B-NP	Otrans	factor	trans	JJ	I-NP	B-proteinfactor	to	factor	NN	I-NP	I-proteinto	regulate	to	TO	B-VP	Oregulate	lipid	regulate	VB	I-VP	Olipid	metabolism	lipid	NN	B-NP	Ometabolism	.	metabolism	NN	I-NP	O.	Intense	.	.	O	OIntense	interest	Intense	JJ	B-NP	Ointerest	is	interest	NN	I-NP	Ois	focused	be	VBZ	B-VP	Ofocused	on	focus	VBN	I-VP	Oon	PPAR-gamma	on	IN	B-PP	OPPAR-gamma	and	PPAR-gamma	NN	B-NP	B-proteinand	its	and	CC	O	Oits	ligands	its	PRP$	B-NP	Oligands	owing	ligand	NNS	I-NP	Oowing	to	owe	VBG	B-VP	Oto	its	to	TO	B-PP	Oits	putative	its	PRP$	B-NP	Oputative	role	putative	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	adipocyte	in	IN	B-PP	Oadipocyte	differentiation	adipocyte	NN	B-NP	B-cell_typedifferentiation	.	differentiation	NN	I-NP	O.	Little	.	.	O	OLittle	is	Little	JJ	B-NP	Ois	known	be	VBZ	B-VP	Oknown	","	know	VBN	I-VP	O","	however	","	","	O	Ohowever	","	however	RB	B-ADVP	O","	about	","	","	O	Oabout	the	about	IN	B-PP	Othe	functions	the	DT	B-NP	Ofunctions	of	function	NNS	I-NP	Oof	PPAR-gamma	of	IN	B-PP	OPPAR-gamma	in	PPAR-gamma	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	immune	the	DT	B-NP	Oimmune	system	immune	JJ	I-NP	Osystem	","	system	NN	I-NP	O","	especially	","	","	O	Oespecially	in	especially	RB	B-ADVP	Oin	T	in	IN	B-PP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	demonstrate	We	PRP	B-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	both	that	IN	B-SBAR	Oboth	naive	both	CC	O	Onaive	and	naive	JJ	B-ADJP	Oand	activated	and	CC	O	Oactivated	ovalbumin-specific	activate	VBN	B-VP	B-cell_typeovalbumin-specific	T	ovalbumin-specific	JJ	B-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	DO11.10-transgenic	from	IN	B-PP	ODO11.10-transgenic	mice	DO11.10-transgenic	JJ	B-NP	Omice	express	mouse	NNS	I-NP	Oexpress	PPAR-gamma	express	VBP	B-VP	OPPAR-gamma	mRNA	PPAR-gamma	NN	B-NP	B-RNAmRNA	and	mRNA	NN	I-NP	I-RNAand	protein	and	CC	I-NP	Oprotein	.	protein	NN	I-NP	O.	In	.	.	O	OIn	order	In	IN	B-SBAR	Oorder	to	order	NN	O	Oto	determine	to	TO	B-VP	Odetermine	the	determine	VB	I-VP	Othe	function	the	DT	B-NP	Ofunction	of	function	NN	I-NP	Oof	PPAR-gamma	of	IN	B-PP	OPPAR-gamma	","	PPAR-gamma	NN	B-NP	B-protein","	T	","	","	O	OT	cells	T	NN	B-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	stimulated	be	VBD	B-VP	Ostimulated	with	stimulate	VBN	I-VP	Owith	phorbol	with	IN	B-PP	Ophorbol	12-myristate	phorbol	NN	B-NP	O12-myristate	13-acetate	12-myristate	NN	I-NP	O13-acetate	and	13-acetate	NN	I-NP	Oand	ionomycin	and	CC	O	Oionomycin	or	ionomycin	NN	B-NP	Oor	antigen	or	CC	O	Oantigen	and	antigen	NN	B-NP	Oand	antigen-presenting	and	CC	O	Oantigen-presenting	cells	antigen-presenting	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Simultaneous	.	.	O	OSimultaneous	exposure	Simultaneous	JJ	B-NP	Oexposure	to	exposure	NN	I-NP	Oto	PPAR-gamma	to	TO	B-PP	OPPAR-gamma	ligands	PPAR-gamma	NN	B-NP	B-proteinligands	(	ligand	NNS	I-NP	I-protein(	e.g.	(	(	O	Oe.g.	15-deoxy-Delta	e.g.	FW	B-NP	O15-deoxy-Delta	(	15-deoxy-Delta	FW	I-NP	O(	12	(	(	O	O12	","	12	CD	B-NP	O","	14	","	","	O	O14	)	14	CD	B-NP	O)	#NAME?	)	)	O	O#NAME?	J	#NAME?	NN	B-NP	OJ	(	J	NN	I-NP	O(	2	(	(	O	O2	)	2	CD	B-NP	O)	","	)	)	O	O","	troglitazone	","	","	O	Otroglitazone	)	troglitazone	NN	B-NP	O)	showed	)	)	O	Oshowed	drastic	show	VBD	B-VP	Odrastic	inhibition	drastic	JJ	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	proliferation	of	IN	B-PP	Oproliferation	and	proliferation	NN	B-NP	Oand	significant	and	CC	O	Osignificant	decreases	significant	JJ	B-NP	Odecreases	in	decrease	NNS	I-NP	Oin	cell	in	IN	B-PP	Ocell	viability	cell	NN	B-NP	Oviability	.	viability	NN	I-NP	O.	The	.	.	O	OThe	decrease	The	DT	B-NP	Odecrease	in	decrease	NN	I-NP	Oin	cell	in	IN	B-PP	Ocell	viability	cell	NN	B-NP	Oviability	was	viability	NN	I-NP	Owas	due	be	VBD	B-VP	Odue	to	due	IN	B-PP	Oto	apoptosis	to	TO	B-PP	Oapoptosis	of	apoptosis	NN	B-NP	Oof	the	of	IN	B-PP	Othe	T	the	DT	B-NP	OT	lymphocytes	T	NN	I-NP	B-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	occurred	and	CC	O	Ooccurred	only	occur	VBD	B-VP	Oonly	when	only	RB	B-ADVP	Owhen	cells	when	WRB	I-ADVP	Ocells	were	cell	NNS	B-NP	Owere	treated	be	VBD	B-VP	Otreated	with	treat	VBN	I-VP	Owith	PPAR-gamma	with	IN	B-PP	OPPAR-gamma	","	PPAR-gamma	NN	B-NP	B-protein","	and	","	","	B-NP	Oand	not	and	CC	I-NP	Onot	PPAR-alpha	not	RB	I-NP	OPPAR-alpha	agonists	PPAR-alpha	NN	B-NP	B-proteinagonists	","	agonist	NNS	I-NP	O","	revealing	","	","	O	Orevealing	specificity	reveal	VBG	B-VP	Ospecificity	of	specificity	NN	B-NP	Oof	this	of	IN	B-PP	Othis	response	this	DT	B-NP	Oresponse	for	response	NN	I-NP	Ofor	PPAR-gamma	for	IN	B-PP	OPPAR-gamma	.	PPAR-gamma	NN	B-NP	B-protein.	These	.	.	O	OThese	observations	These	DT	B-NP	Oobservations	suggest	observation	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	PPAR-gamma	that	IN	B-SBAR	OPPAR-gamma	agonists	PPAR-gamma	NN	B-NP	B-proteinagonists	play	agonist	NNS	I-NP	Oplay	an	play	VBP	B-VP	Oan	important	an	DT	B-NP	Oimportant	role	important	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	regulating	in	IN	B-PP	Oregulating	T	regulate	VBG	B-VP	OT	cell-mediated	T	NN	B-NP	Ocell-mediated	immune	cell-mediated	JJ	I-NP	Oimmune	responses	immune	JJ	I-NP	Oresponses	by	response	NNS	I-NP	Oby	inducing	by	IN	B-PP	Oinducing	apoptosis	induce	VBG	B-VP	Oapoptosis	.	apoptosis	NN	B-NP	O.	T	.	.	O	OT	cell	T	NN	B-NP	Ocell	death	cell	NN	I-NP	Odeath	via	death	NN	I-NP	Ovia	PPAR-gamma	via	IN	B-PP	OPPAR-gamma	ligation	PPAR-gamma	NN	B-NP	B-proteinligation	may	ligation	NN	I-NP	Omay	act	may	MD	B-VP	Oact	as	act	VB	I-VP	Oas	a	as	IN	B-PP	Oa	potent	a	DT	B-NP	Opotent	anti-inflammatory	potent	JJ	I-NP	Oanti-inflammatory	signal	anti-inflammatory	JJ	I-NP	Osignal	in	signal	NN	I-NP	Oin	the	in	IN	B-PP	Othe	immune	the	DT	B-NP	Oimmune	system	immune	JJ	I-NP	Osystem	","	system	NN	I-NP	O","	and	","	","	O	Oand	ligands	and	CC	O	Oligands	could	ligand	NNS	B-NP	Ocould	possibly	could	MD	B-VP	Opossibly	be	possibly	RB	I-VP	Obe	used	be	VB	I-VP	Oused	to	use	VBN	I-VP	Oto	control	to	TO	B-VP	Ocontrol	disorders	control	VB	I-VP	Odisorders	in	disorder	NNS	B-NP	Oin	which	in	IN	B-PP	Owhich	excessive	which	WDT	B-NP	Oexcessive	inflammation	excessive	JJ	B-NP	Oinflammation	occurs	inflammation	NN	I-NP	Ooccurs	.	occur	VBZ	B-VP	O.	Suppression	.	.	O	OSuppression	of	Suppression	NN	B-NP	Oof	lung	of	IN	B-PP	Olung	inflammation	lung	NN	B-NP	Oinflammation	in	inflammation	NN	I-NP	Oin	rats	in	IN	B-PP	Orats	by	rat	NNS	B-NP	Oby	prevention	by	IN	B-PP	Oprevention	of	prevention	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	activation	NF-kappaB	NN	B-NP	B-proteinactivation	in	activation	NN	I-NP	Oin	the	in	IN	B-PP	Othe	liver	the	DT	B-NP	Oliver	.	liver	NN	I-NP	O.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	and	NF-kappaB	NN	B-NP	B-proteinand	production	and	CC	I-NP	Oproduction	of	production	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	#NAME?	NF-kappaB	NN	B-NP	B-protein#NAME?	chemokines	#NAME?	JJ	I-NP	Ochemokines	are	chemokine	NNS	I-NP	B-proteinare	thought	be	VBP	B-VP	Othought	to	think	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	involved	be	VB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	pathogenesis	the	DT	B-NP	Opathogenesis	of	pathogenesis	NN	I-NP	Oof	neutrophilic	of	IN	B-PP	Oneutrophilic	lung	neutrophilic	JJ	B-NP	Olung	inflammation	lung	NN	I-NP	Oinflammation	.	inflammation	NN	I-NP	O.	Calpain-1	.	.	O	OCalpain-1	inhibitor	Calpain-1	NN	B-NP	B-proteininhibitor	(	inhibitor	NN	I-NP	O(	CI-1	(	(	O	OCI-1	)	CI-1	NN	B-NP	B-protein)	blocks	)	)	O	Oblocks	activation	block	VBZ	B-VP	Oactivation	of	activation	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	by	NF-kappaB	NN	B-NP	B-proteinby	preventing	by	IN	B-PP	Opreventing	proteolysis	prevent	VBG	B-VP	Oproteolysis	of	proteolysis	NN	B-NP	Oof	the	of	IN	B-PP	Othe	inhibitory	the	DT	B-NP	Oinhibitory	protein	inhibitory	JJ	I-NP	B-proteinprotein	IkappaB-alpha	protein	NN	I-NP	I-proteinIkappaB-alpha	by	IkappaB-alpha	NN	I-NP	B-proteinby	the	by	IN	B-PP	Othe	ubiquitin/proteasome	the	DT	B-NP	Oubiquitin/proteasome	pathway	ubiquitin/proteasome	JJ	I-NP	Opathway	.	pathway	NN	I-NP	O.	We	.	.	O	OWe	hypothesized	We	PRP	B-NP	Ohypothesized	that	hypothesize	VBD	B-VP	Othat	inhibition	that	IN	B-SBAR	Oinhibition	of	inhibition	NN	B-NP	Oof	proteasome	of	IN	B-PP	Oproteasome	function	proteasome	NN	B-NP	B-proteinfunction	with	function	NN	I-NP	Owith	CI-1	with	IN	B-PP	OCI-1	would	CI-1	NN	B-NP	B-proteinwould	block	would	MD	B-VP	Oblock	NF-kappaB	block	VB	I-VP	ONF-kappaB	activation	NF-kappaB	NN	B-NP	B-proteinactivation	in	activation	NN	I-NP	Oin	vivo	in	FW	B-ADVP	Ovivo	after	vivo	FW	I-ADVP	Oafter	intraperitoneal	after	IN	B-PP	Ointraperitoneal	(	intraperitoneal	JJ	O	O(	i.p.	(	(	O	Oi.p.	)	i.p.	JJ	B-ADJP	O)	treatment	)	)	O	Otreatment	with	treatment	NN	B-NP	Owith	bacterial	with	IN	B-PP	Obacterial	lipopolysaccharide	bacterial	JJ	B-NP	Olipopolysaccharide	(	lipopolysaccharide	NN	I-NP	O(	LPS	(	(	O	OLPS	)	LPS	NN	B-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	that	and	CC	O	Othat	NF-kappaB	that	IN	B-SBAR	ONF-kappaB	inhibition	NF-kappaB	NN	B-NP	B-proteininhibition	would	inhibition	NN	I-NP	Owould	be	would	MD	B-VP	Obe	associated	be	VB	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	suppression	with	IN	B-PP	Osuppression	of	suppression	NN	B-NP	Oof	chemokine	of	IN	B-PP	Ochemokine	gene	chemokine	NN	B-NP	B-proteingene	expression	gene	NN	I-NP	Oexpression	and	expression	NN	I-NP	Oand	attenuation	and	CC	O	Oattenuation	of	attenuation	NN	B-NP	Oof	neutrophilic	of	IN	B-PP	Oneutrophilic	alveolitis	neutrophilic	JJ	B-NP	Oalveolitis	.	alveolitis	NN	I-NP	O.	We	.	.	O	OWe	treated	We	PRP	B-NP	Otreated	rats	treat	VBD	B-VP	Orats	with	rat	NNS	B-NP	Owith	a	with	IN	B-PP	Oa	single	a	DT	B-NP	Osingle	i.p.	single	JJ	I-NP	Oi.p.	injection	i.p.	JJ	I-NP	Oinjection	of	injection	NN	I-NP	Oof	CI-1	of	IN	B-PP	OCI-1	(	CI-1	NN	B-NP	B-protein(	10	(	(	O	O10	mg/kg	10	CD	B-NP	Omg/kg	)	mg/kg	NN	I-NP	O)	two	)	)	O	Otwo	hours	two	CD	B-NP	Ohours	prior	hour	NNS	I-NP	Oprior	to	prior	RB	B-ADVP	Oto	i.p.	to	TO	B-PP	Oi.p.	LPS	i.p.	JJ	B-NP	OLPS	(	LPS	NN	I-NP	O(	7	(	(	O	O7	mg/kg	7	CD	B-NP	Omg/kg	)	mg/kg	NN	I-NP	O)	.	)	)	O	O.	Treatment	.	.	O	OTreatment	with	Treatment	NN	B-NP	Owith	Cl-1	with	IN	B-PP	OCl-1	prevented	Cl-1	NN	B-NP	B-proteinprevented	degradation	prevent	VBD	B-VP	Odegradation	of	degradation	NN	B-NP	Oof	IkappaB-alpha	of	IN	B-PP	OIkappaB-alpha	and	IkappaB-alpha	NN	B-NP	B-proteinand	activation	and	CC	I-NP	Oactivation	of	activation	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	in	NF-kappaB	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	liver	the	DT	B-NP	Oliver	in	liver	NN	I-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	LPS	to	TO	B-PP	OLPS	;	LPS	NN	B-NP	O;	however	;	:	O	Ohowever	","	however	RB	B-ADVP	O","	Cl-1	","	","	O	OCl-1	treatment	Cl-1	NN	B-NP	B-proteintreatment	had	treatment	NN	I-NP	Ohad	no	have	VBD	B-VP	Ono	detected	no	DT	B-NP	Odetected	effect	detect	VBN	I-NP	Oeffect	on	effect	NN	I-NP	Oon	NF-kappaB	on	IN	B-PP	ONF-kappaB	activation	NF-kappaB	NN	B-NP	B-proteinactivation	in	activation	NN	I-NP	Oin	lung	in	IN	B-PP	Olung	tissue	lung	NN	B-NP	Otissue	.	tissue	NN	I-NP	O.	CI-1	.	.	O	OCI-1	treatment	CI-1	NN	B-NP	B-proteintreatment	prior	treatment	NN	I-NP	Oprior	to	prior	JJ	B-ADJP	Oto	LPS	to	TO	B-PP	OLPS	resulted	LPS	NN	B-NP	Oresulted	in	result	VBD	B-VP	Oin	40	in	IN	B-PP	O40	%	40	CD	B-NP	O%	lower	%	NN	I-NP	Olower	MIP-2	low	JJR	B-NP	OMIP-2	concentration	MIP-2	NN	I-NP	B-proteinconcentration	in	concentration	NN	I-NP	Oin	lung	in	IN	B-PP	Olung	lavage	lung	NN	B-NP	Olavage	fluid	lavage	NN	I-NP	Ofluid	compared	fluid	NN	I-NP	Ocompared	to	compare	VBN	B-VP	Oto	rats	to	TO	B-PP	Orats	treated	rat	NNS	B-NP	Otreated	with	treat	VBN	B-VP	Owith	vehicle	with	IN	B-PP	Ovehicle	prior	vehicle	NN	B-NP	Oprior	to	prior	JJ	B-ADJP	Oto	LPS	to	TO	B-PP	OLPS	(	LPS	NN	B-NP	O(	502	(	(	O	O502	+/-	502	CD	B-NP	O+/-	112	+/-	SYM	I-NP	O112	pg/ml	112	CD	I-NP	Opg/ml	vs.	pg/ml	NN	I-NP	Ovs.	859	vs.	IN	B-PP	O859	+/-144	859	CD	B-NP	O+/-144	pg/ml	+/-144	CD	I-NP	Opg/ml	","	pg/ml	NN	I-NP	O","	P	","	","	O	OP	<	P	NN	B-NP	O<	0.05	<	SYM	B-NP	O0.05	)	0.05	CD	I-NP	O)	.	)	)	O	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	CI-1	","	","	O	OCI-1	treatment	CI-1	NN	B-NP	B-proteintreatment	substantially	treatment	NN	I-NP	Osubstantially	inhibited	substantially	RB	B-VP	Oinhibited	LPS-induced	inhibit	VBD	I-VP	OLPS-induced	neutrophilic	LPS-induced	JJ	B-NP	Oneutrophilic	alveolitis	neutrophilic	JJ	I-NP	Oalveolitis	(	alveolitis	NN	I-NP	O(	2.7+	(	(	O	O2.7+	/-	2.7+	CD	B-NP	O/-	1.2	/-	SYM	O	O1.2	x	1.2	CD	B-NP	Ox	10	x	SYM	I-NP	O10	(	10	CD	I-NP	O(	5	(	(	O	O5	)	5	CD	B-NP	O)	vs.	)	)	O	Ovs.	43.7	vs.	IN	B-PP	O43.7	+/-	43.7	CD	B-NP	O+/-	12.2	+/-	SYM	I-NP	O12.2	x	12.2	CD	I-NP	Ox	10	x	SYM	I-NP	O10	(	10	CD	I-NP	O(	5	(	(	O	O5	)	5	CD	B-NP	O)	lung	)	)	O	Olung	lavage	lung	NN	B-NP	B-cell_typelavage	neutrophils	lavage	NN	I-NP	I-cell_typeneutrophils	","	neutrophil	NNS	I-NP	I-cell_type","	P	","	","	O	OP	<	P	NN	B-NP	O<	0.01	<	SYM	B-NP	O0.01	)	0.01	CD	I-NP	O)	.	)	)	O	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	indicate	datum	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	NF-kappaB	that	IN	B-SBAR	ONF-kappaB	inhibition	NF-kappaB	NN	B-NP	B-proteininhibition	in	inhibition	NN	I-NP	Oin	the	in	IN	B-PP	Othe	liver	the	DT	B-NP	Oliver	can	liver	NN	I-NP	Ocan	alter	can	MD	B-VP	Oalter	lung	alter	VB	I-VP	Olung	inflammation	lung	NN	B-NP	Oinflammation	induced	inflammation	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	systemic	by	IN	B-PP	Osystemic	LPS	systemic	JJ	B-NP	OLPS	treatment	LPS	NN	I-NP	Otreatment	and	treatment	NN	I-NP	Oand	suggest	and	CC	O	Osuggest	that	suggest	VBP	B-VP	Othat	a	that	IN	B-SBAR	Oa	liver-lung	a	DT	B-NP	Oliver-lung	interaction	liver-lung	JJ	I-NP	Ointeraction	contributes	interaction	NN	I-NP	Ocontributes	to	contribute	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	inflammatory	the	DT	B-NP	Oinflammatory	response	inflammatory	JJ	I-NP	Oresponse	of	response	NN	I-NP	Oof	the	of	IN	B-PP	Othe	lung	the	DT	B-NP	Olung	.	lung	NN	I-NP	O.	Notch1	.	.	O	ONotch1	regulates	Notch1	NN	B-NP	B-proteinregulates	maturation	regulate	VBZ	B-VP	Omaturation	of	maturation	NN	B-NP	Oof	CD4+	of	IN	B-PP	OCD4+	and	CD4+	JJ	B-NP	B-cell_typeand	CD8+	and	CC	I-NP	I-cell_typeCD8+	thymocytes	CD8+	JJ	I-NP	I-cell_typethymocytes	by	thymocyte	NNS	I-NP	I-cell_typeby	modulating	by	IN	B-PP	Omodulating	TCR	modulate	VBG	B-VP	OTCR	signal	TCR	NN	B-NP	B-proteinsignal	strength	signal	NN	I-NP	Ostrength	.	strength	NN	I-NP	O.	Notch	.	.	O	ONotch	signaling	Notch	NN	B-NP	Osignaling	regulates	signaling	NN	I-NP	Oregulates	cell	regulate	VBZ	B-VP	Ocell	fate	cell	NN	B-NP	Ofate	decisions	fate	NN	I-NP	Odecisions	in	decision	NNS	I-NP	Oin	multiple	in	IN	B-PP	Omultiple	lineages	multiple	JJ	B-NP	B-cell_typelineages	.	lineage	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	demonstrate	We	PRP	B-NP	Odemonstrate	in	demonstrate	VBP	B-VP	Oin	this	in	IN	B-PP	Othis	report	this	DT	B-NP	Oreport	that	report	NN	I-NP	Othat	retroviral	that	IN	B-SBAR	Oretroviral	expression	retroviral	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	activated	of	IN	B-PP	Oactivated	Notch1	activate	VBN	B-NP	ONotch1	in	Notch1	NN	I-NP	B-proteinin	mouse	in	IN	B-PP	Omouse	thymocytes	mouse	NN	B-NP	B-cell_typethymocytes	abrogates	thymocyte	NNS	I-NP	I-cell_typeabrogates	differentiation	abrogate	VBZ	B-VP	Odifferentiation	of	differentiation	NN	B-NP	Oof	immature	of	IN	B-PP	Oimmature	CD4+CD8+	immature	JJ	B-NP	B-cell_typeCD4+CD8+	thymocytes	CD4+CD8+	JJ	I-NP	I-cell_typethymocytes	into	thymocyte	NNS	I-NP	I-cell_typeinto	both	into	IN	B-PP	Oboth	CD4	both	CC	O	OCD4	and	CD4	NN	B-NP	B-proteinand	CD8	and	CC	O	OCD8	mature	CD8	NN	B-NP	B-cell_typemature	single-positive	mature	JJ	I-NP	I-cell_typesingle-positive	T	single-positive	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	ability	The	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	Notch1	of	IN	B-PP	ONotch1	to	Notch1	NN	B-NP	B-proteinto	inhibit	to	TO	B-VP	Oinhibit	T	inhibit	VB	I-VP	OT	cell	T	NN	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	was	development	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	vitro	in	FW	B-ADVP	Ovitro	and	vitro	FW	I-ADVP	Oand	in	and	CC	O	Oin	vivo	in	FW	B-ADVP	Ovivo	with	vivo	FW	I-ADVP	Owith	both	with	IN	B-PP	Oboth	normal	both	CC	B-NP	Onormal	and	normal	JJ	I-NP	Oand	TCR	and	CC	O	OTCR	transgenic	TCR	NN	B-NP	B-proteintransgenic	thymocytes	transgenic	JJ	I-NP	Othymocytes	.	thymocyte	NNS	I-NP	O.	Notch1	.	.	O	ONotch1	#NAME?	Notch1	NN	B-NP	B-protein#NAME?	developmental	#NAME?	JJ	I-NP	Odevelopmental	arrest	developmental	JJ	I-NP	Oarrest	was	arrest	NN	I-NP	Owas	dose	be	VBD	B-VP	Odose	dependent	dose	NN	B-NP	Odependent	and	dependent	JJ	B-ADJP	Oand	was	and	CC	O	Owas	associated	be	VBD	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	impaired	with	IN	B-PP	Oimpaired	thymocyte	impair	VBN	B-NP	Othymocyte	responses	thymocyte	NN	I-NP	Oresponses	to	response	NNS	I-NP	Oto	TCR	to	TO	B-PP	OTCR	stimulation	TCR	NN	B-NP	B-proteinstimulation	.	stimulation	NN	I-NP	O.	Notch1	.	.	O	ONotch1	also	Notch1	NN	B-NP	B-proteinalso	inhibited	also	RB	B-ADVP	Oinhibited	TCR-mediated	inhibit	VBD	B-VP	OTCR-mediated	signaling	TCR-mediated	JJ	B-NP	Osignaling	in	signaling	NN	I-NP	Oin	Jurkat	in	IN	B-PP	OJurkat	T	Jurkat	NN	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	indicate	datum	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	constitutively	that	IN	B-SBAR	Oconstitutively	active	constitutively	RB	B-NP	Oactive	Notch1	active	JJ	I-NP	ONotch1	abrogates	Notch1	NN	I-NP	B-proteinabrogates	CD4+	abrogate	VBZ	B-VP	OCD4+	and	CD4+	JJ	B-NP	Oand	CD8+	and	CC	I-NP	OCD8+	maturation	CD8+	JJ	I-NP	Omaturation	by	maturation	NN	I-NP	Oby	interfering	by	IN	B-PP	Ointerfering	with	interfere	VBG	B-VP	Owith	TCR	with	IN	B-PP	OTCR	signal	TCR	NN	B-NP	B-proteinsignal	strength	signal	NN	I-NP	Ostrength	and	strength	NN	I-NP	Oand	provide	and	CC	O	Oprovide	an	provide	VBP	B-VP	Oan	explanation	an	DT	B-NP	Oexplanation	for	explanation	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	physiological	the	DT	B-NP	Ophysiological	regulation	physiological	JJ	I-NP	Oregulation	of	regulation	NN	I-NP	Oof	Notch	of	IN	B-PP	ONotch	expression	Notch	NN	B-NP	Oexpression	during	expression	NN	I-NP	Oduring	thymocyte	during	IN	B-PP	Othymocyte	development	thymocyte	NN	B-NP	B-cell_typedevelopment	.	development	NN	I-NP	O.	Expression	.	.	O	OExpression	of	Expression	NN	B-NP	Oof	SART3	of	IN	B-PP	OSART3	antigen	SART3	NN	B-NP	B-proteinantigen	and	antigen	NN	I-NP	I-proteinand	induction	and	CC	O	Oinduction	of	induction	NN	B-NP	Oof	CTLs	of	IN	B-PP	OCTLs	by	CTL	NNS	B-NP	B-cell_typeby	SART3-derived	by	IN	B-PP	OSART3-derived	peptides	SART3-derived	JJ	B-NP	Opeptides	in	peptide	NNS	I-NP	Oin	breast	in	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	patients	cancer	NN	I-NP	Opatients	.	patient	NNS	I-NP	O.	We	.	.	O	OWe	recently	We	PRP	B-NP	Orecently	reported	recently	RB	B-ADVP	Oreported	the	report	VBD	B-VP	Othe	SART3	the	DT	B-NP	OSART3	tumour-rejection	SART3	NN	I-NP	B-proteintumour-rejection	antigen	tumour-rejection	NN	I-NP	I-proteinantigen	as	antigen	NN	I-NP	I-proteinas	possessing	as	IN	B-PP	Opossessing	tumour	possess	VBG	B-VP	Otumour	epitopes	tumour	NN	B-NP	B-proteinepitopes	capable	epitope	NNS	I-NP	I-proteincapable	of	capable	JJ	B-ADJP	Oof	inducing	of	IN	B-PP	Oinducing	HLA-class	induce	VBG	B-VP	OHLA-class	I-restricted	HLA-class	JJ	B-NP	B-cell_typeI-restricted	cytotoxic	I-restricted	JJ	I-NP	I-cell_typecytotoxic	T	cytotoxic	JJ	I-NP	I-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	(	lymphocyte	NNS	I-NP	I-cell_type(	CTLs	(	(	O	OCTLs	)	CTL	NNS	B-NP	B-cell_type)	.	)	)	O	O.	This	.	.	O	OThis	study	This	DT	B-NP	Ostudy	investigated	study	NN	I-NP	Oinvestigated	expression	investigate	VBD	B-VP	Oexpression	of	expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	SART3	the	DT	B-NP	OSART3	antigen	SART3	NN	I-NP	B-proteinantigen	in	antigen	NN	I-NP	I-proteinin	breast	in	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	to	cancer	NN	I-NP	Oto	explore	to	TO	B-VP	Oexplore	an	explore	VB	I-VP	Oan	appropriate	an	DT	B-NP	Oappropriate	molecule	appropriate	JJ	I-NP	Omolecule	for	molecule	NN	I-NP	Ofor	use	for	IN	B-PP	Ouse	in	use	NN	B-NP	Oin	specific	in	IN	B-PP	Ospecific	immunotherapy	specific	JJ	B-NP	Oimmunotherapy	of	immunotherapy	NN	I-NP	Oof	breast	of	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	patients	cancer	NN	I-NP	Opatients	.	patient	NNS	I-NP	O.	The	.	.	O	OThe	SART3	The	DT	B-NP	OSART3	antigen	SART3	NN	I-NP	B-proteinantigen	was	antigen	NN	I-NP	I-proteinwas	detected	be	VBD	B-VP	Odetected	in	detect	VBN	I-VP	Oin	all	in	IN	B-PP	Oall	of	all	DT	B-NP	Oof	the	of	IN	B-PP	Othe	breast	the	DT	B-NP	Obreast	cancer	breast	NN	I-NP	B-cell_linecancer	cell	cancer	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	tested	line	NNS	I-NP	I-cell_linetested	","	test	VBN	B-VP	O","	30	","	","	O	O30	of	30	CD	B-NP	Oof	40	of	IN	B-PP	O40	(	40	CD	B-NP	O(	75	(	(	O	O75	%	75	CD	B-NP	O%	)	%	NN	I-NP	O)	breast	)	)	O	Obreast	cancer	breast	NN	B-NP	Ocancer	tissue	cancer	NN	I-NP	Otissue	samples	tissue	NN	I-NP	Osamples	","	sample	NNS	I-NP	O","	and	","	","	O	Oand	0	and	CC	O	O0	of	0	CD	B-NP	Oof	3	of	IN	B-PP	O3	non-tumourous	3	CD	B-NP	Onon-tumourous	breast	non-tumourous	JJ	I-NP	Obreast	tissue	breast	NN	I-NP	Otissue	samples	tissue	NN	I-NP	Osamples	.	sample	NNS	I-NP	O.	SART3	.	.	O	OSART3	derived	SART3	NN	B-NP	B-proteinderived	peptides	derive	VBN	I-NP	Opeptides	at	peptide	NNS	I-NP	Oat	positions	at	IN	B-PP	Opositions	109-118	position	NNS	B-NP	O109-118	and	109-118	CD	B-NP	Oand	315-323	and	CC	I-NP	O315-323	induced	315-323	CD	I-NP	Oinduced	HLA-A24	induce	VBD	B-VP	OHLA-A24	restricted	HLA-A24	NN	B-NP	B-proteinrestricted	CTLs	restricted	JJ	I-NP	OCTLs	that	CTL	NNS	I-NP	Othat	reacted	that	WDT	B-NP	Oreacted	to	react	VBD	B-VP	Oto	breast	to	TO	B-PP	Obreast	cancer	breast	NN	B-NP	B-cell_typecancer	cells	cancer	NN	I-NP	I-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	the	from	IN	B-PP	Othe	peripheral	the	DT	B-NP	Operipheral	blood	peripheral	JJ	I-NP	B-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	PBMCs	(	(	O	OPBMCs	)	PBMC	NNS	B-NP	B-cell_type)	of	)	)	O	Oof	breast	of	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	patients	cancer	NN	I-NP	Opatients	.	patient	NNS	I-NP	O.	Therefore	.	.	O	OTherefore	","	Therefore	RB	B-ADVP	O","	the	","	","	O	Othe	SART3	the	DT	B-NP	OSART3	antigen	SART3	NN	I-NP	B-proteinantigen	and	antigen	NN	I-NP	I-proteinand	its	and	CC	O	Oits	peptides	its	PRP$	B-NP	Opeptides	could	peptide	NNS	I-NP	Ocould	be	could	MD	B-VP	Obe	an	be	VB	I-VP	Oan	appropriate	an	DT	B-NP	Oappropriate	molecule	appropriate	JJ	I-NP	Omolecule	for	molecule	NN	I-NP	Ofor	use	for	IN	B-PP	Ouse	in	use	NN	B-NP	Oin	specific	in	IN	B-PP	Ospecific	immunotherapy	specific	JJ	B-NP	Oimmunotherapy	of	immunotherapy	NN	I-NP	Oof	the	of	IN	B-PP	Othe	majority	the	DT	B-NP	Omajority	of	majority	NN	I-NP	Oof	HLA-A24-positive	of	IN	B-PP	OHLA-A24-positive	breast	HLA-A24-positive	JJ	B-NP	Obreast	cancer	breast	NN	I-NP	Ocancer	patients	cancer	NN	I-NP	Opatients	Autostimulation	patient	NNS	I-NP	OAutostimulation	of	Autostimulation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	Epstein-Barr	the	DT	B-NP	OEpstein-Barr	virus	Epstein-Barr	JJ	I-NP	B-DNAvirus	BRLF1	virus	NN	I-NP	I-DNABRLF1	promoter	BRLF1	NN	I-NP	I-DNApromoter	is	promoter	NN	I-NP	I-DNAis	mediated	be	VBZ	B-VP	Omediated	through	mediate	VBN	I-VP	Othrough	consensus	through	IN	B-PP	Oconsensus	Sp1	consensus	NN	B-NP	B-DNASp1	and	Sp1	NN	I-NP	I-DNAand	Sp3	and	CC	O	I-DNASp3	binding	Sp3	NN	B-NP	I-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	.	site	NNS	I-NP	I-DNA.	As	.	.	O	OAs	an	As	IN	B-PP	Oan	essential	an	DT	B-NP	Oessential	step	essential	JJ	I-NP	Ostep	in	step	NN	I-NP	Oin	the	in	IN	B-PP	Othe	lytic	the	DT	B-NP	Olytic	cascade	lytic	JJ	I-NP	Ocascade	","	cascade	NN	I-NP	O","	the	","	","	O	Othe	Rta	the	DT	B-NP	ORta	homologues	Rta	NN	I-NP	B-proteinhomologues	of	homologue	NNS	I-NP	I-proteinof	gammaherpesviruses	of	IN	B-PP	Ogammaherpesviruses	all	gammaherpesvirus	NNS	B-NP	Oall	activate	all	DT	B-ADVP	Oactivate	their	activate	VBP	B-VP	Otheir	own	their	PRP$	B-NP	Oown	expression	own	JJ	I-NP	Oexpression	.	expression	NN	I-NP	O.	Consistent	.	.	O	OConsistent	with	Consistent	JJ	B-ADJP	Owith	this	with	IN	B-PP	Othis	biologic	this	DT	B-NP	Obiologic	function	biologic	JJ	I-NP	Ofunction	","	function	NN	I-NP	O","	the	","	","	O	Othe	Epstein-Barr	the	DT	B-NP	OEpstein-Barr	virus	Epstein-Barr	JJ	I-NP	B-proteinvirus	(	virus	NN	I-NP	I-protein(	EBV	(	(	O	I-proteinEBV	)	EBV	NN	B-NP	I-protein)	Rta	)	)	O	I-proteinRta	protein	Rta	NN	B-NP	I-proteinprotein	powerfully	protein	NN	I-NP	I-proteinpowerfully	stimulates	powerfully	RB	B-ADVP	Ostimulates	the	stimulate	VBZ	B-VP	Othe	promoter	the	DT	B-NP	Opromoter	of	promoter	NN	I-NP	B-DNAof	its	of	IN	B-PP	Oits	own	its	PRP$	B-NP	Oown	gene	own	JJ	I-NP	Ogene	","	gene	NN	I-NP	O","	Rp	","	","	O	ORp	","	Rp	NN	B-NP	B-DNA","	in	","	","	O	Oin	EBV-positive	in	IN	B-PP	OEBV-positive	B	EBV-positive	JJ	B-NP	B-cell_lineB	cells	B	NN	I-NP	I-cell_linecells	in	cell	NNS	I-NP	I-cell_linein	transient-transfection	in	IN	B-PP	Otransient-transfection	reporter-based	transient-transfection	JJ	B-NP	Oreporter-based	assays	reporter-based	JJ	I-NP	Oassays	.	assay	NNS	I-NP	O.	We	.	.	O	OWe	analyzed	We	PRP	B-NP	Oanalyzed	the	analyze	VBD	B-VP	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	RpCAT	of	IN	B-PP	ORpCAT	in	RpCAT	NN	B-NP	B-proteinin	response	in	IN	B-PP	Oresponse	to	response	NN	I-PP	Oto	Rta	to	TO	I-PP	ORta	by	Rta	NN	B-NP	B-proteinby	deletional	by	IN	B-PP	Odeletional	and	deletional	JJ	B-NP	Oand	site-directed	and	CC	I-NP	Osite-directed	mutagenesis	site-directed	JJ	I-NP	Omutagenesis	.	mutagenesis	NN	I-NP	O.	Two	.	.	O	OTwo	cognate	Two	CD	B-NP	Ocognate	Sp1	cognate	JJ	I-NP	B-DNASp1	binding	Sp1	NN	I-NP	I-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	located	site	NNS	I-NP	I-DNAlocated	at	located	JJ	B-ADJP	Oat	-279	at	IN	B-PP	O-279	and	-279	CD	B-NP	B-DNAand	-45	and	CC	I-NP	I-DNA-45	relative	-45	CD	I-NP	I-DNArelative	to	relative	JJ	B-ADVP	Oto	the	to	TO	B-PP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	start	transcriptional	JJ	I-NP	B-DNAstart	site	start	NN	I-NP	I-DNAsite	proved	site	NN	I-NP	I-DNAproved	crucial	prove	VBD	B-VP	Ocrucial	for	crucial	JJ	B-ADJP	Ofor	Rta-mediated	for	IN	B-PP	ORta-mediated	activation	Rta-mediated	JJ	B-NP	Oactivation	.	activation	NN	I-NP	O.	Previously	.	.	O	OPreviously	described	Previously	RB	B-ADVP	Odescribed	binding	describe	VBN	B-VP	Obinding	sites	bind	VBG	B-NP	B-DNAsites	for	site	NNS	I-NP	I-DNAfor	the	for	IN	B-PP	Othe	cellular	the	DT	B-NP	Ocellular	transcription	cellular	JJ	I-NP	Otranscription	factor	transcription	NN	I-NP	Ofactor	Zif268	factor	NN	I-NP	OZif268	and	Zif268	NN	I-NP	B-proteinand	the	and	CC	O	Othe	viral	the	DT	B-NP	Oviral	transactivator	viral	JJ	I-NP	B-proteintransactivator	ZEBRA	transactivator	NN	I-NP	I-proteinZEBRA	were	ZEBRA	NN	I-NP	B-proteinwere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	dispensable	be	VB	I-VP	Odispensable	for	dispensable	JJ	B-ADJP	Ofor	activation	for	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	RpCAT	of	IN	B-PP	ORpCAT	by	RpCAT	NN	B-NP	B-proteinby	Rta	by	IN	B-PP	ORta	.	Rta	NN	B-NP	B-protein.	Gel	.	.	O	OGel	shift	Gel	NN	B-NP	Oshift	analysis	shift	NN	I-NP	Oanalysis	","	analysis	NN	I-NP	O","	using	","	","	O	Ousing	extracts	use	VBG	B-VP	Oextracts	of	extract	NNS	B-NP	Oof	B	of	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	latency	in	IN	B-PP	Olatency	or	latency	NN	B-NP	Oor	induced	or	CC	O	Oinduced	into	induce	VBN	B-VP	Ointo	the	into	IN	B-PP	Othe	lytic	the	DT	B-NP	Olytic	cycle	lytic	JJ	I-NP	Ocycle	","	cycle	NN	I-NP	O","	identified	","	","	O	Oidentified	Sp1	identify	VBD	B-VP	OSp1	and	Sp1	NN	B-NP	B-proteinand	Sp3	and	CC	I-NP	OSp3	as	Sp3	NN	I-NP	B-proteinas	the	as	IN	B-PP	Othe	predominant	the	DT	B-NP	Opredominant	cellular	predominant	JJ	I-NP	Ocellular	proteins	cellular	JJ	I-NP	B-proteinproteins	bound	protein	NNS	I-NP	I-proteinbound	to	bind	VBN	B-VP	Oto	Rp	to	TO	B-PP	ORp	near	Rp	NN	B-NP	B-proteinnear	-45	near	IN	B-PP	O-45	.	-45	CD	B-NP	O.	During	.	.	O	ODuring	the	During	IN	B-PP	Othe	lytic	the	DT	B-NP	Olytic	cycle	lytic	JJ	I-NP	Ocycle	","	cycle	NN	I-NP	O","	ZEBRA	","	","	O	OZEBRA	bound	ZEBRA	NN	B-NP	B-proteinbound	Rp	bind	VBD	B-VP	ORp	near	Rp	NN	B-NP	B-proteinnear	the	near	IN	B-PP	Othe	Sp1/Sp3	the	DT	B-NP	OSp1/Sp3	site	Sp1/Sp3	NN	I-NP	B-DNAsite	.	site	NN	I-NP	I-DNA.	The	.	.	O	OThe	binding	The	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	Sp1	of	IN	B-PP	OSp1	and	Sp1	NN	B-NP	B-proteinand	Sp3	and	CC	O	OSp3	to	Sp3	NN	B-NP	B-proteinto	Rp	to	TO	B-PP	ORp	correlated	Rp	NN	B-NP	B-proteincorrelated	with	correlate	VBD	B-VP	Owith	the	with	IN	B-PP	Othe	reporter	the	DT	B-NP	Oreporter	activities	reporter	NN	I-NP	Oactivities	in	activity	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	mutagenesis	the	DT	B-NP	Omutagenesis	study	mutagenesis	NN	I-NP	Ostudy	","	study	NN	I-NP	O","	establishing	","	","	O	Oestablishing	a	establish	VBG	B-VP	Oa	direct	a	DT	B-NP	Odirect	link	direct	JJ	I-NP	Olink	between	link	NN	I-NP	Obetween	transcriptional	between	IN	B-PP	Otranscriptional	activation	transcriptional	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	Rp	of	IN	B-PP	ORp	by	Rp	NN	B-NP	B-proteinby	Rta	by	IN	B-PP	ORta	and	Rta	NN	B-NP	B-proteinand	DNA	and	CC	I-NP	ODNA	binding	DNA	NN	I-NP	Obinding	by	binding	NN	I-NP	Oby	Sp1	by	IN	B-PP	OSp1	and/or	Sp1	NN	B-NP	B-proteinand/or	Sp3	and/or	CC	O	OSp3	.	Sp3	NN	B-NP	B-protein.	The	.	.	O	OThe	relative	The	DT	B-NP	Orelative	abundance	relative	JJ	I-NP	Oabundance	or	abundance	NN	I-NP	Oor	functional	or	CC	O	Ofunctional	state	functional	JJ	B-NP	Ostate	of	state	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cellular	the	DT	B-NP	Ocellular	Sp1	cellular	JJ	I-NP	OSp1	and	Sp1	NN	I-NP	B-proteinand	Sp3	and	CC	O	OSp3	transcription	Sp3	NN	B-NP	B-proteintranscription	factors	transcription	NN	I-NP	B-proteinfactors	may	factor	NNS	I-NP	I-proteinmay	be	may	MD	B-VP	Obe	altered	be	VB	I-VP	Oaltered	in	alter	VBN	I-VP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	stimuli	to	TO	B-PP	Ostimuli	that	stimulus	NNS	B-NP	Othat	induce	that	WDT	B-NP	Oinduce	the	induce	VBP	B-VP	Othe	BRLF1	the	DT	B-NP	OBRLF1	promoter	BRLF1	NN	I-NP	B-DNApromoter	and	promoter	NN	I-NP	I-DNAand	thereby	and	CC	O	Othereby	contribute	thereby	RB	B-VP	Ocontribute	to	contribute	VBP	I-VP	Oto	the	to	TO	B-PP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	viral	the	DT	B-NP	Oviral	lytic	viral	JJ	I-NP	Olytic	cycle	lytic	JJ	I-NP	Ocycle	.	cycle	NN	I-NP	O.	Gene	.	.	O	OGene	transfer	Gene	NN	B-NP	Otransfer	of	transfer	NN	I-NP	Oof	antisense	of	IN	B-PP	Oantisense	hypoxia	antisense	JJ	B-NP	B-proteinhypoxia	inducible	hypoxia	NN	I-NP	I-proteininducible	factor-1	inducible	JJ	I-NP	I-proteinfactor-1	alpha	factor-1	NN	I-NP	I-proteinalpha	enhances	alpha	NN	I-NP	I-proteinenhances	the	enhance	VBZ	B-VP	Othe	therapeutic	the	DT	B-NP	Otherapeutic	efficacy	therapeutic	JJ	I-NP	Oefficacy	of	efficacy	NN	I-NP	Oof	cancer	of	IN	B-PP	Ocancer	immunotherapy	cancer	NN	B-NP	Oimmunotherapy	.	immunotherapy	NN	I-NP	O.	Solid	.	.	O	OSolid	tumors	Solid	JJ	B-NP	Otumors	meet	tumor	NNS	I-NP	Omeet	their	meet	VBP	B-VP	Otheir	demands	their	PRP$	B-NP	Odemands	for	demand	NNS	I-NP	Ofor	nascent	for	IN	B-PP	Onascent	blood	nascent	JJ	B-NP	Oblood	vessels	blood	NN	I-NP	Ovessels	and	vessel	NNS	I-NP	Oand	increased	and	CC	O	Oincreased	glycolysis	increase	VBN	B-NP	Oglycolysis	","	glycolysis	NN	I-NP	O","	to	","	","	O	Oto	combat	to	TO	B-VP	Ocombat	hypoxia	combat	VB	I-VP	Ohypoxia	","	hypoxia	NN	B-NP	O","	by	","	","	O	Oby	activating	by	IN	B-PP	Oactivating	multiple	activate	VBG	B-VP	Omultiple	genes	multiple	JJ	B-NP	Ogenes	involved	gene	NNS	I-NP	Oinvolved	in	involve	VBN	B-VP	Oin	angiogenesis	in	IN	B-PP	Oangiogenesis	and	angiogenesis	NN	B-NP	Oand	glucose	and	CC	I-NP	Oglucose	metabolism	glucose	NN	I-NP	Ometabolism	.	metabolism	NN	I-NP	O.	Hypoxia	.	.	O	OHypoxia	inducible	Hypoxia	NN	B-NP	B-proteininducible	factor-1	inducible	JJ	I-NP	I-proteinfactor-1	(	factor-1	NN	I-NP	I-protein(	HIF-1	(	(	O	OHIF-1	)	HIF-1	NN	B-NP	B-protein)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	constitutively	a	DT	B-NP	Oconstitutively	expressed	constitutively	RB	I-NP	Oexpressed	basic	express	VBN	I-NP	Obasic	helix-loop-helix	basic	JJ	I-NP	B-proteinhelix-loop-helix	transcription	helix-loop-helix	JJ	I-NP	I-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	","	factor	NN	I-NP	I-protein","	formed	","	","	O	Oformed	by	form	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	assembly	the	DT	B-NP	Oassembly	of	assembly	NN	I-NP	Oof	HIF-1alpha	of	IN	B-PP	OHIF-1alpha	and	HIF-1alpha	NN	B-NP	B-proteinand	HIF-1beta	and	CC	O	OHIF-1beta	(	HIF-1beta	NN	B-NP	B-protein(	Arnt	(	(	O	OArnt	)	Arnt	NN	B-NP	B-protein)	","	)	)	O	O","	that	","	","	O	Othat	is	that	WDT	B-NP	Ois	stablized	be	VBZ	B-VP	Ostablized	in	stablize	VBN	I-VP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	hypoxia	to	TO	B-PP	Ohypoxia	","	hypoxia	NN	B-NP	O","	and	","	","	O	Oand	rapidly	and	CC	O	Orapidly	degraded	rapidly	RB	B-VP	Odegraded	under	degrade	VBN	I-VP	Ounder	normoxic	under	IN	B-PP	Onormoxic	conditions	normoxic	JJ	B-NP	Oconditions	.	condition	NNS	I-NP	O.	It	.	.	O	OIt	activates	It	PRP	B-NP	Oactivates	the	activate	VBZ	B-VP	Othe	transcription	the	DT	B-NP	Otranscription	of	transcription	NN	I-NP	Oof	genes	of	IN	B-PP	Ogenes	important	gene	NNS	B-NP	B-DNAimportant	for	important	JJ	B-ADJP	Ofor	maintaining	for	IN	B-PP	Omaintaining	oxygen	maintain	VBG	B-VP	Ooxygen	homeostasis	oxygen	NN	B-NP	Ohomeostasis	.	homeostasis	NN	I-NP	O.	Here	.	.	O	OHere	","	Here	RB	B-ADVP	O","	we	","	","	O	Owe	demonstrate	we	PRP	B-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	engineered	that	IN	B-SBAR	Oengineered	down-regulation	engineer	VBN	B-NP	Odown-regulation	of	down-regulation	NN	I-NP	Oof	HIF-1alpha	of	IN	B-PP	OHIF-1alpha	by	HIF-1alpha	NN	B-NP	B-proteinby	intratumoral	by	IN	B-PP	Ointratumoral	gene	intratumoral	JJ	B-NP	Ogene	transfer	gene	NN	I-NP	Otransfer	of	transfer	NN	I-NP	Oof	an	of	IN	B-PP	Oan	antisense	an	DT	B-NP	Oantisense	HIF-1alpha	antisense	JJ	I-NP	B-DNAHIF-1alpha	plasmid	HIF-1alpha	NN	I-NP	I-DNAplasmid	leads	plasmid	NN	I-NP	I-DNAleads	to	lead	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	down-regulation	the	DT	B-NP	Odown-regulation	of	down-regulation	NN	I-NP	Oof	VEGF	of	IN	B-PP	OVEGF	","	VEGF	NN	B-NP	B-protein","	and	","	","	O	Oand	decreased	and	CC	O	Odecreased	tumor	decrease	VBD	B-VP	Otumor	microvessel	tumor	NN	B-NP	Omicrovessel	density	microvessel	NN	I-NP	Odensity	.	density	NN	I-NP	O.	Antisense	.	.	O	OAntisense	HIF-1alpha	Antisense	JJ	B-NP	OHIF-1alpha	monotherapy	HIF-1alpha	NN	I-NP	Omonotherapy	resulted	monotherapy	NN	I-NP	Oresulted	in	result	VBD	B-VP	Oin	the	in	IN	B-PP	Othe	complete	the	DT	B-NP	Ocomplete	and	complete	JJ	I-NP	Oand	permanent	and	CC	I-NP	Opermanent	rejection	permanent	JJ	I-NP	Orejection	of	rejection	NN	I-NP	Oof	small	of	IN	B-PP	Osmall	(	small	JJ	B-NP	O(	0.1	(	(	O	O0.1	cm	0.1	CD	B-NP	Ocm	in	cm	NN	I-NP	Oin	diameter	in	IN	B-PP	Odiameter	)	diameter	NN	B-NP	O)	EL-4	)	)	O	OEL-4	tumors	EL-4	NN	B-NP	Otumors	","	tumor	NNS	I-NP	O","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	unusual	be	VBZ	B-VP	Ounusual	for	unusual	JJ	B-ADJP	Ofor	an	for	IN	B-PP	Oan	anti-angiogenic	an	DT	B-NP	Oanti-angiogenic	agent	anti-angiogenic	JJ	I-NP	Oagent	where	agent	NN	I-NP	Owhere	transient	where	WRB	B-ADVP	Otransient	suppression	transient	JJ	B-NP	Osuppression	of	suppression	NN	I-NP	Oof	tumor	of	IN	B-PP	Otumor	growth	tumor	NN	B-NP	Ogrowth	is	growth	NN	I-NP	Ois	the	be	VBZ	B-VP	Othe	norm	the	DT	B-NP	Onorm	.	norm	NN	I-NP	O.	It	.	.	O	OIt	induced	It	PRP	B-NP	Oinduced	NK	induce	VBD	B-VP	ONK	cell	NK	NN	B-NP	B-cell_typecell	#NAME?	cell	NN	I-NP	I-cell_type#NAME?	rejection	#NAME?	JJ	I-NP	Orejection	of	rejection	NN	I-NP	Oof	tumors	of	IN	B-PP	Otumors	","	tumor	NNS	B-NP	O","	but	","	","	O	Obut	failed	but	CC	O	Ofailed	to	fail	VBD	B-VP	Oto	stimulate	to	TO	I-VP	Ostimulate	systemic	stimulate	VB	I-VP	Osystemic	T	systemic	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	#NAME?	cell	NN	I-NP	O#NAME?	anti-tumor	#NAME?	JJ	I-NP	Oanti-tumor	immunity	anti-tumor	JJ	I-NP	Oimmunity	","	immunity	NN	I-NP	O","	and	","	","	O	Oand	synergized	and	CC	O	Osynergized	with	synergize	VBD	B-VP	Owith	B7-1-mediated	with	IN	B-PP	OB7-1-mediated	immunotherapy	B7-1-mediated	JJ	B-NP	Oimmunotherapy	to	immunotherapy	NN	I-NP	Oto	cause	to	TO	B-VP	Ocause	the	cause	VB	I-VP	Othe	NK	the	DT	B-NP	ONK	cell	NK	NN	I-NP	B-cell_typecell	and	cell	NN	I-NP	I-cell_typeand	CD8	and	CC	I-NP	OCD8	T	CD8	NN	I-NP	B-cell_typeT	cell	T	NN	I-NP	I-cell_typecell	#NAME?	cell	NN	I-NP	I-cell_type#NAME?	rejection	#NAME?	JJ	I-NP	Orejection	of	rejection	NN	I-NP	Oof	larger	of	IN	B-PP	Olarger	EL-4	large	JJR	B-NP	OEL-4	tumors	EL-4	NN	I-NP	Otumors	(	tumor	NNS	I-NP	O(	0.4	(	(	O	O0.4	cm	0.4	CD	B-NP	Ocm	in	cm	NN	I-NP	Oin	diameter	in	IN	B-PP	Odiameter	)	diameter	NN	B-NP	O)	that	)	)	O	Othat	were	that	WDT	B-NP	Owere	refractory	be	VBD	B-VP	Orefractory	to	refractory	JJ	B-ADJP	Oto	monotherapies	to	TO	B-PP	Omonotherapies	.	monotherapy	NNS	B-NP	O.	Mice	.	.	O	OMice	cured	Mouse	NNS	B-NP	Ocured	of	cure	VBN	B-VP	Oof	their	of	IN	B-PP	Otheir	tumors	their	PRP$	B-NP	Otumors	by	tumor	NNS	I-NP	Oby	combination	by	IN	B-PP	Ocombination	therapy	combination	NN	B-NP	Otherapy	resisted	therapy	NN	I-NP	Oresisted	a	resist	VBD	B-VP	Oa	rechallenge	a	DT	B-NP	Orechallenge	with	rechallenge	NN	I-NP	Owith	parental	with	IN	B-PP	Oparental	tumor	parental	JJ	B-NP	B-cell_typetumor	cells	tumor	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	indicating	","	","	O	Oindicating	systemic	indicate	VBG	B-VP	Osystemic	antitumor	systemic	JJ	B-NP	Oantitumor	immunity	antitumor	NN	I-NP	Oimmunity	had	immunity	NN	I-NP	Ohad	been	have	VBD	B-VP	Obeen	achieved	be	VBN	I-VP	Oachieved	.	achieve	VBN	I-VP	O.	In	.	.	O	OIn	summary	In	IN	B-PP	Osummary	","	summary	NN	B-NP	O","	whilst	","	","	O	Owhilst	intensive	whilst	IN	B-PP	Ointensive	investigations	intensive	JJ	B-NP	Oinvestigations	are	investigation	NNS	I-NP	Oare	in	be	VBP	B-VP	Oin	progress	in	IN	B-PP	Oprogress	to	progress	NN	B-NP	Oto	target	to	TO	B-VP	Otarget	the	target	VB	I-VP	Othe	many	the	DT	B-NP	Omany	HIF-1	many	JJ	I-NP	OHIF-1	effectors	HIF-1	NN	I-NP	B-proteineffectors	","	effector	NNS	I-NP	I-protein","	the	","	","	O	Othe	results	the	DT	B-NP	Oresults	herein	result	NNS	I-NP	Oherein	indicate	herein	RB	B-VP	Oindicate	that	indicate	VBP	I-VP	Othat	blocking	that	IN	B-SBAR	Oblocking	hypoxia-inducible	block	VBG	B-VP	Ohypoxia-inducible	pathways	hypoxia-inducible	JJ	B-NP	Opathways	and	pathway	NNS	I-NP	Oand	enhancing	and	CC	O	Oenhancing	NK-mediated	enhance	VBG	B-VP	ONK-mediated	antitumor	NK-mediated	JJ	B-NP	Oantitumor	immunity	antitumor	NN	I-NP	Oimmunity	by	immunity	NN	I-NP	Oby	targeting	by	IN	B-PP	Otargeting	HIF-1	target	VBG	B-VP	OHIF-1	itself	HIF-1	NN	B-NP	B-proteinitself	may	itself	PRP	B-NP	Omay	be	may	MD	B-VP	Obe	advantageous	be	VB	I-VP	Oadvantageous	","	advantageous	JJ	B-ADJP	O","	especially	","	","	O	Oespecially	when	especially	RB	B-ADVP	Owhen	combined	when	WRB	B-ADVP	Ocombined	with	combine	VBN	B-VP	Owith	cancer	with	IN	B-PP	Ocancer	immunotherapy	cancer	NN	B-NP	Oimmunotherapy	.	immunotherapy	NN	I-NP	O.	Runx2	.	.	O	ORunx2	:	Runx2	NN	B-NP	B-protein:	a	:	:	O	Oa	novel	a	DT	B-NP	Onovel	oncogenic	novel	JJ	I-NP	Ooncogenic	effector	oncogenic	JJ	I-NP	Oeffector	revealed	effector	NN	I-NP	Orevealed	by	reveal	VBN	B-VP	Oby	in	by	IN	B-PP	Oin	vivo	in	FW	B-NP	Ovivo	complementation	vivo	FW	I-NP	Ocomplementation	and	complementation	NN	I-NP	Oand	retroviral	and	CC	O	Oretroviral	tagging	retroviral	JJ	B-NP	Otagging	.	tagging	NN	I-NP	O.	The	.	.	O	OThe	Runx2	The	DT	B-NP	ORunx2	(	Runx2	NN	I-NP	B-protein(	Cbfa1	(	(	O	OCbfa1	","	Cbfa1	NN	B-NP	B-protein","	Pebp2alphaA	","	","	O	OPebp2alphaA	","	Pebp2alphaA	NN	B-NP	B-protein","	Aml3	","	","	O	OAml3	)	Aml3	NN	B-NP	O)	gene	)	)	O	Ogene	was	gene	NN	B-NP	Owas	previously	be	VBD	B-VP	Opreviously	identified	previously	RB	I-VP	Oidentified	as	identify	VBN	I-VP	Oas	a	as	IN	B-PP	Oa	frequent	a	DT	B-NP	Ofrequent	target	frequent	JJ	I-NP	Otarget	for	target	NN	I-NP	Ofor	transcriptional	for	IN	B-PP	Otranscriptional	activation	transcriptional	JJ	B-NP	Oactivation	by	activation	NN	I-NP	Oby	proviral	by	IN	B-PP	Oproviral	insertion	proviral	JJ	B-NP	Oinsertion	in	insertion	NN	I-NP	Oin	T-cell	in	IN	B-PP	OT-cell	lymphomas	T-cell	NN	B-NP	B-cell_typelymphomas	of	lymphoma	NNS	I-NP	I-cell_typeof	CD2-MYC	of	IN	B-PP	OCD2-MYC	transgenic	CD2-MYC	NN	B-NP	Otransgenic	mice	transgenic	JJ	I-NP	Omice	.	mouse	NNS	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	recently	have	VBP	B-VP	Orecently	shown	recently	RB	I-VP	Oshown	that	show	VBN	I-VP	Othat	over-expression	that	IN	B-SBAR	Oover-expression	of	over-expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	full-length	the	DT	B-NP	Ofull-length	","	full-length	NN	I-NP	B-DNA","	most	","	","	O	Omost	highly	most	RBS	B-NP	Ohighly	expressed	highly	RB	I-NP	Oexpressed	Runx2	express	VBN	I-NP	ORunx2	isoform	Runx2	NN	I-NP	B-proteinisoform	in	isoform	NN	I-NP	I-proteinin	the	in	IN	B-PP	Othe	thymus	the	DT	B-NP	Othymus	perturbs	thymus	NN	I-NP	Operturbs	T-cell	perturb	VBZ	B-VP	OT-cell	development	T-cell	NN	B-NP	Odevelopment	","	development	NN	I-NP	O","	leads	","	","	O	Oleads	to	lead	VBZ	B-VP	Oto	development	to	TO	B-PP	Odevelopment	of	development	NN	B-NP	Oof	spontaneous	of	IN	B-PP	Ospontaneous	lymphomas	spontaneous	JJ	B-NP	Olymphomas	at	lymphoma	NNS	I-NP	Oat	low	at	IN	B-PP	Olow	frequency	low	JJ	B-NP	Ofrequency	and	frequency	NN	I-NP	Oand	is	and	CC	O	Ois	strongly	be	VBZ	B-VP	Ostrongly	synergistic	strongly	RB	B-ADJP	Osynergistic	with	synergistic	JJ	I-ADJP	Owith	Myc	with	IN	B-PP	OMyc	.	Myc	NN	B-NP	B-protein.	To	.	.	O	OTo	gain	To	TO	B-VP	Ogain	further	gain	VB	I-VP	Ofurther	insight	further	JJ	B-NP	Oinsight	into	insight	NN	I-NP	Ointo	the	into	IN	B-PP	Othe	relationship	the	DT	B-NP	Orelationship	of	relationship	NN	I-NP	Oof	Runx2	of	IN	B-PP	ORunx2	to	Runx2	NN	B-NP	B-proteinto	other	to	TO	B-PP	Oother	lymphomagenic	other	JJ	B-NP	Olymphomagenic	pathways	lymphomagenic	JJ	I-NP	Opathways	","	pathway	NNS	I-NP	O","	we	","	","	O	Owe	tested	we	PRP	B-NP	Otested	the	test	VBD	B-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	combining	of	IN	B-PP	Ocombining	the	combine	VBG	B-VP	Othe	CD2-Runx2	the	DT	B-NP	OCD2-Runx2	transgene	CD2-Runx2	NN	I-NP	B-DNAtransgene	either	transgene	NN	I-NP	I-DNAeither	with	either	CC	B-PP	Owith	a	with	IN	I-PP	Oa	Pim1	a	DT	B-NP	OPim1	transgene	Pim1	NN	I-NP	B-DNAtransgene	(	transgene	NN	I-NP	I-DNA(	E	(	(	O	OE	(	E	NN	B-NP	O(	mu	(	(	O	Omu	)	mu	NN	B-NP	O)	#REF!	)	)	O	O0	)	0	NN	B-NP	O)	or	)	)	O	Oor	with	or	CC	O	Owith	the	with	IN	B-PP	Othe	p53	the	DT	B-NP	Op53	null	p53	NN	I-NP	B-proteinnull	genotype	null	JJ	I-NP	Ogenotype	","	genotype	NN	I-NP	O","	as	","	","	O	Oas	each	as	IN	B-SBAR	Oeach	of	each	DT	B-NP	Oof	these	of	IN	B-PP	Othese	displays	these	DT	B-NP	Odisplays	independent	display	NNS	I-NP	Oindependent	synergy	independent	JJ	B-NP	Osynergy	with	synergy	NN	I-NP	Owith	Myc	with	IN	B-PP	OMyc	.	Myc	NN	B-NP	B-protein.	In	.	.	O	OIn	both	In	IN	B-PP	Oboth	cases	both	DT	B-NP	Ocases	we	case	NNS	I-NP	Owe	observed	we	PRP	B-NP	Oobserved	synergistic	observe	VBD	B-VP	Osynergistic	tumour	synergistic	JJ	B-NP	Otumour	development	tumour	NN	I-NP	Odevelopment	.	development	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	Runx2	","	","	O	ORunx2	appeared	Runx2	NN	B-NP	B-proteinappeared	to	appear	VBD	B-VP	Oto	have	to	TO	I-VP	Ohave	a	have	VB	I-VP	Oa	dominant	a	DT	B-NP	Odominant	effect	dominant	JJ	I-NP	Oeffect	on	effect	NN	I-NP	Oon	the	on	IN	B-PP	Othe	tumour	the	DT	B-NP	Otumour	phenotype	tumour	NN	I-NP	Ophenotype	in	phenotype	NN	I-NP	Oin	each	in	IN	B-PP	Oeach	case	each	DT	B-NP	Ocase	","	case	NN	I-NP	O","	with	","	","	O	Owith	most	with	IN	B-PP	Omost	tumours	most	JJS	B-NP	Otumours	conforming	tumour	NNS	I-NP	Oconforming	to	conform	VBG	B-VP	Oto	the	to	TO	B-PP	Othe	CD3	the	DT	B-NP	OCD3	(	CD3	NN	I-NP	O(	+	(	(	O	O+	)	+	SYM	B-NP	O)	","	)	)	O	O","	CD8	","	","	O	OCD8	(	CD8	NN	B-NP	B-protein(	+	(	(	O	O+	)	+	SYM	B-NP	O)	","	)	)	O	O","	CD4	","	","	O	OCD4	(	CD4	NN	B-NP	B-protein(	+/-	(	(	O	O+/-	)	+/-	CC	O	O)	phenotype	)	)	O	Ophenotype	seen	phenotype	NN	B-NP	Oseen	in	see	VBN	B-VP	Oin	CD2-Runx2	in	IN	B-PP	OCD2-Runx2	mice	CD2-Runx2	NN	B-NP	Omice	.	mouse	NNS	I-NP	O.	Neonatal	.	.	O	ONeonatal	infection	Neonatal	JJ	B-NP	Oinfection	of	infection	NN	I-NP	Oof	CD2-Runx2	of	IN	B-PP	OCD2-Runx2	mice	CD2-Runx2	NN	B-NP	Omice	with	mouse	NNS	I-NP	Owith	Moloney	with	IN	B-PP	OMoloney	murine	Moloney	NN	B-NP	Omurine	leukaemia	murine	JJ	I-NP	Oleukaemia	virus	leukaemia	NN	I-NP	Ovirus	(	virus	NN	I-NP	O(	Moloney	(	(	O	OMoloney	MLV	Moloney	NN	B-NP	OMLV	)	MLV	NN	I-NP	O)	also	)	)	O	Oalso	led	also	RB	B-ADVP	Oled	to	lead	VBD	B-VP	Oto	a	to	TO	B-PP	Oa	dramatic	a	DT	B-NP	Odramatic	acceleration	dramatic	JJ	I-NP	Oacceleration	of	acceleration	NN	I-NP	Oof	tumour	of	IN	B-PP	Otumour	onset	tumour	NN	B-NP	Oonset	.	onset	NN	I-NP	O.	Analysis	.	.	O	OAnalysis	of	Analysis	NN	B-NP	Oof	known	of	IN	B-PP	Oknown	Moloney	known	JJ	B-NP	OMoloney	MLV	Moloney	NNP	I-NP	OMLV	target	MLV	NNP	I-NP	Otarget	genes	target	NN	I-NP	B-DNAgenes	in	gene	NNS	I-NP	I-DNAin	these	in	IN	B-PP	Othese	lymphomas	these	DT	B-NP	Olymphomas	showed	lymphoma	NNS	I-NP	Oshowed	a	show	VBD	B-VP	Oa	high	a	DT	B-NP	Ohigh	frequency	high	JJ	I-NP	Ofrequency	of	frequency	NN	I-NP	Oof	rearrangement	of	IN	B-PP	Orearrangement	at	rearrangement	NN	B-NP	Oat	c-Myc	at	IN	B-PP	Oc-Myc	or	c-Myc	NN	B-NP	B-proteinor	N-Myc	or	CC	O	ON-Myc	(	N-Myc	NN	B-NP	B-protein(	82	(	(	O	O82	%	82	CD	B-NP	O%	)	%	NN	I-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	a	and	CC	O	Oa	significant	a	DT	B-NP	Osignificant	number	significant	JJ	I-NP	Onumber	at	number	NN	I-NP	Oat	Pim1	at	IN	B-PP	OPim1	or	Pim1	NN	B-NP	B-proteinor	Pim2	or	CC	I-NP	OPim2	(	Pim2	NN	I-NP	B-protein(	23	(	(	O	O23	%	23	CD	B-NP	O%	)	%	NN	I-NP	O)	","	)	)	O	O","	and	","	","	B-PP	Oand	at	and	CC	I-PP	Oat	Pal1/Gfi1	at	IN	B-PP	OPal1/Gfi1	(	Pal1/Gfi1	NN	B-NP	O(	18	(	(	O	O18	%	18	CD	B-NP	O%	)	%	NN	I-NP	O)	.	)	)	O	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	Runx2	that	IN	B-SBAR	ORunx2	makes	Runx2	NN	B-NP	B-proteinmakes	a	make	VBZ	B-VP	Oa	distinct	a	DT	B-NP	Odistinct	contribution	distinct	JJ	I-NP	Ocontribution	to	contribution	NN	I-NP	Oto	T-cell	to	TO	B-PP	OT-cell	lymphoma	T-cell	NN	B-NP	Olymphoma	development	lymphoma	NN	I-NP	Odevelopment	which	development	NN	I-NP	Owhich	does	which	WDT	B-NP	Odoes	not	do	VBZ	B-VP	Onot	coincide	not	RB	I-VP	Ocoincide	with	coincide	VB	I-VP	Owith	any	with	IN	B-PP	Oany	of	any	DT	B-NP	Oof	the	of	IN	B-PP	Othe	oncogene	the	DT	B-NP	Ooncogene	complementation	oncogene	NN	I-NP	Ocomplementation	groups	complementation	NN	I-NP	Ogroups	previously	group	NNS	I-NP	Opreviously	identified	previously	RB	B-VP	Oidentified	by	identify	VBN	I-VP	Oby	retroviral	by	IN	B-PP	Oretroviral	tagging	retroviral	JJ	B-NP	Otagging	.	tagging	NN	I-NP	O.	The	.	.	O	OThe	involvement	The	DT	B-NP	Oinvolvement	of	involvement	NN	I-NP	Oof	TNF-alpha	of	IN	B-PP	OTNF-alpha	#NAME?	TNF-alpha	NN	B-NP	B-protein#NAME?	apoptosis-inducing	#NAME?	JJ	I-NP	Oapoptosis-inducing	ligand	apoptosis-inducing	JJ	I-NP	B-proteinligand	in	ligand	NN	I-NP	I-proteinin	the	in	IN	B-PP	Othe	enhanced	the	DT	B-NP	Oenhanced	cytotoxicity	enhance	VBN	I-NP	Ocytotoxicity	of	cytotoxicity	NN	I-NP	Oof	IFN-beta	of	IN	B-PP	OIFN-beta	#NAME?	IFN-beta	NN	B-NP	B-protein#NAME?	human	#NAME?	JJ	I-NP	Ohuman	dendritic	human	JJ	I-NP	Odendritic	cells	dendritic	JJ	I-NP	Ocells	to	cell	NNS	I-NP	Oto	tumor	to	TO	B-PP	Otumor	cells	tumor	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	TNF-alpha	.	.	O	OTNF-alpha	#NAME?	TNF-alpha	NN	B-NP	B-protein#NAME?	apoptosis-inducing	#NAME?	JJ	I-NP	Oapoptosis-inducing	ligand	apoptosis-inducing	JJ	I-NP	B-proteinligand	(	ligand	NN	I-NP	I-protein(	TRAIL	(	(	O	OTRAIL	)	TRAIL	NN	B-NP	B-protein)	is	)	)	O	Ois	characterized	be	VBZ	B-VP	Ocharacterized	by	characterize	VBN	I-VP	Oby	its	by	IN	B-PP	Oits	preferential	its	PRP$	B-NP	Opreferential	induction	preferential	JJ	I-NP	Oinduction	of	induction	NN	I-NP	Oof	apoptosis	of	IN	B-PP	Oapoptosis	of	apoptosis	NN	B-NP	Oof	tumor	of	IN	B-PP	Otumor	cells	tumor	NN	B-NP	B-cell_typecells	but	cell	NNS	I-NP	I-cell_typebut	not	but	CC	O	Onot	normal	not	RB	O	Onormal	cells	normal	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Dendritic	.	.	O	ODendritic	cells	Dendritic	JJ	B-NP	B-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	DCs	(	(	O	ODCs	)	DC	NNS	B-NP	B-cell_type)	","	)	)	O	O","	besides	","	","	O	Obesides	their	besides	IN	B-PP	Otheir	role	their	PRP$	B-NP	Orole	as	role	NN	I-NP	Oas	APCs	as	IN	B-PP	OAPCs	","	APC	NNS	B-NP	B-cell_type","	now	","	","	O	Onow	have	now	RB	B-ADVP	Ohave	been	have	VBP	B-VP	Obeen	demonstrated	be	VBN	I-VP	Odemonstrated	to	demonstrate	VBN	I-VP	Oto	exert	to	TO	I-VP	Oexert	cytotoxicity	exert	VB	I-VP	Ocytotoxicity	or	cytotoxicity	NN	B-NP	Oor	cytostasis	or	CC	I-NP	Ocytostasis	on	cytostasis	NN	I-NP	Oon	some	on	IN	B-PP	Osome	tumor	some	DT	B-NP	Otumor	cells	tumor	NN	I-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Here	.	.	O	OHere	","	Here	RB	B-ADVP	O","	we	","	","	O	Owe	report	we	PRP	B-NP	Oreport	that	report	VBP	B-VP	Othat	both	that	IN	B-SBAR	Oboth	human	both	CC	O	Ohuman	CD34	human	JJ	B-NP	B-cell_lineCD34	(	CD34	NN	I-NP	I-cell_line(	+	(	(	O	I-cell_line+	)	+	SYM	O	I-cell_line)	stem	)	)	O	I-cell_linestem	cell	stem	NN	B-NP	I-cell_linecell	#NAME?	cell	NN	I-NP	I-cell_line#NAME?	DCs	#NAME?	JJ	I-NP	I-cell_lineDCs	(	DC	NNS	I-NP	I-cell_line(	CD34DCs	(	(	O	OCD34DCs	)	CD34DC	NNS	B-NP	B-cell_type)	and	)	)	O	Oand	human	and	CC	O	Ohuman	CD14	human	JJ	B-NP	OCD14	(	CD14	NN	I-NP	O(	+	(	(	O	O+	)	+	SYM	O	O)	monocyte	)	)	O	Omonocyte	#NAME?	monocyte	NN	B-NP	O#NAME?	DCs	#NAME?	JJ	I-NP	ODCs	(	DC	NNS	I-NP	B-cell_type(	MoDCs	(	(	O	OMoDCs	)	MoDC	NNS	B-NP	O)	express	)	)	O	Oexpress	TRAIL	express	VBP	B-VP	OTRAIL	and	TRAIL	NN	B-NP	B-proteinand	exhibit	and	CC	O	Oexhibit	cytotoxicity	exhibit	VBP	B-VP	Ocytotoxicity	to	cytotoxicity	NN	B-NP	Oto	some	to	TO	B-PP	Osome	types	some	DT	B-NP	Otypes	of	type	NNS	I-NP	Oof	tumor	of	IN	B-PP	Otumor	cells	tumor	NN	B-NP	B-cell_typecells	partially	cell	NNS	I-NP	I-cell_typepartially	through	partially	RB	B-ADVP	Othrough	TRAIL	through	IN	B-PP	OTRAIL	.	TRAIL	NN	B-NP	B-protein.	Moderate	.	.	O	OModerate	expression	Moderate	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	TRAIL	of	IN	B-PP	OTRAIL	appeared	TRAIL	NN	B-NP	B-proteinappeared	on	appear	VBD	B-VP	Oon	CD34DCs	on	IN	B-PP	OCD34DCs	from	CD34DC	NNS	B-NP	B-cell_typefrom	the	from	IN	B-PP	Othe	8th	the	DT	B-NP	O8th	day	8th	JJ	I-NP	Oday	of	day	NN	I-NP	Oof	culture	of	IN	B-PP	Oculture	and	culture	NN	B-NP	Oand	was	and	CC	O	Owas	also	be	VBD	B-VP	Oalso	seen	also	RB	I-VP	Oseen	on	see	VBN	I-VP	Oon	freshly	on	IN	B-PP	Ofreshly	isolated	freshly	RB	B-NP	B-cell_typeisolated	monocytes	isolate	VBN	I-NP	I-cell_typemonocytes	.	monocyte	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	level	The	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	TRAIL	of	IN	B-PP	OTRAIL	expression	TRAIL	NN	B-NP	B-proteinexpression	remained	expression	NN	I-NP	Oremained	constant	remain	VBD	B-VP	Oconstant	until	constant	JJ	B-ADJP	Ountil	DC	until	IN	B-SBAR	ODC	maturation	DC	NN	B-NP	B-cell_typematuration	.	maturation	NN	I-NP	O.	TRAIL	.	.	O	OTRAIL	expression	TRAIL	NN	B-NP	B-proteinexpression	on	expression	NN	I-NP	Oon	immature	on	IN	B-PP	Oimmature	CD34DCs	immature	JJ	B-NP	B-cell_typeCD34DCs	or	CD34DC	NNS	I-NP	I-cell_typeor	MoDCs	or	CC	I-NP	OMoDCs	was	MoDC	NNS	I-NP	Owas	greatly	be	VBD	B-VP	Ogreatly	up-regulated	greatly	RB	I-VP	Oup-regulated	after	up-regulate	VBN	I-VP	Oafter	IFN-beta	after	IN	B-PP	OIFN-beta	stimulation	IFN-beta	NN	B-NP	B-proteinstimulation	.	stimulation	NN	I-NP	O.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	IFN-beta	","	","	O	OIFN-beta	could	IFN-beta	NN	B-NP	B-proteincould	strikingly	could	MD	B-VP	Ostrikingly	enhance	strikingly	RB	I-VP	Oenhance	the	enhance	VB	I-VP	Othe	ability	the	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	CD34DCs	of	IN	B-PP	OCD34DCs	or	CD34DC	NNS	B-NP	B-cell_typeor	MoDCs	or	CC	I-NP	OMoDCs	to	MoDC	NNS	I-NP	Oto	kill	to	TO	B-VP	Okill	TRAIL-sensitive	kill	VB	I-VP	OTRAIL-sensitive	tumor	TRAIL-sensitive	JJ	B-NP	B-cell_typetumor	cells	tumor	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	but	","	","	O	Obut	LPS	but	CC	O	OLPS	did	LPS	NN	B-NP	Odid	not	do	VBD	B-VP	Onot	have	not	RB	I-VP	Ohave	such	have	VB	I-VP	Osuch	an	such	JJ	B-NP	Oan	effect	an	DT	I-NP	Oeffect	.	effect	NN	I-NP	O.	The	.	.	O	OThe	up-regulation	The	DT	B-NP	Oup-regulation	of	up-regulation	NN	I-NP	Oof	TRAIL	of	IN	B-PP	OTRAIL	on	TRAIL	NN	B-NP	B-proteinon	IFN-beta	on	IN	B-PP	OIFN-beta	#NAME?	IFN-beta	NN	B-NP	B-protein#NAME?	DCs	#NAME?	JJ	I-NP	ODCs	partially	DC	NNS	I-NP	B-cell_typepartially	contributed	partially	RB	B-ADVP	Ocontributed	to	contribute	VBD	B-VP	Oto	the	to	TO	B-PP	Othe	increased	the	DT	B-NP	Oincreased	cytotoxicity	increase	VBN	I-NP	Ocytotoxicity	of	cytotoxicity	NN	I-NP	Oof	DCS	of	IN	B-PP	ODCS	:	DCS	NN	B-NP	B-cell_type:	Pretreatment	:	:	O	OPretreatment	of	Pretreatment	NN	B-NP	Oof	TRAIL-sensitive	of	IN	B-PP	OTRAIL-sensitive	tumor	TRAIL-sensitive	JJ	B-NP	B-cell_typetumor	cells	tumor	NN	I-NP	I-cell_typecells	with	cell	NNS	I-NP	I-cell_typewith	caspase-3	with	IN	B-PP	Ocaspase-3	inhibitor	caspase-3	NN	B-NP	Oinhibitor	could	inhibitor	NN	I-NP	Ocould	significantly	could	MD	B-VP	Osignificantly	increase	significantly	RB	I-VP	Oincrease	their	increase	VB	I-VP	Otheir	resistance	their	PRP$	B-NP	Oresistance	to	resistance	NN	I-NP	Oto	the	to	TO	B-PP	Othe	cytotoxicity	the	DT	B-NP	Ocytotoxicity	of	cytotoxicity	NN	I-NP	Oof	IFN-beta	of	IN	B-PP	OIFN-beta	#NAME?	IFN-beta	NN	B-NP	B-protein#NAME?	DCS	#NAME?	JJ	I-NP	ODCS	:	DCS	NN	I-NP	B-cell_type:	In	:	:	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	NF-kappaB	","	","	O	ONF-kappaB	inhibitor	NF-kappaB	NN	B-NP	B-proteininhibitor	could	inhibitor	NN	I-NP	Ocould	significantly	could	MD	B-VP	Osignificantly	increase	significantly	RB	I-VP	Oincrease	the	increase	VB	I-VP	Othe	sensitivity	the	DT	B-NP	Osensitivity	of	sensitivity	NN	I-NP	Oof	tumor	of	IN	B-PP	Otumor	cells	tumor	NN	B-NP	B-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	the	to	TO	B-PP	Othe	killing	the	DT	B-NP	Okilling	by	killing	NN	I-NP	Oby	nonstimulated	by	IN	B-PP	Ononstimulated	or	nonstimulated	JJ	B-NP	Oor	LPS-stimulated	or	CC	I-NP	OLPS-stimulated	DCS	LPS-stimulated	JJ	I-NP	ODCS	:	DCS	NN	I-NP	B-cell_type:	Our	:	:	O	OOur	studies	Our	PRP$	B-NP	Ostudies	demonstrate	study	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	IFN-beta	that	IN	B-SBAR	OIFN-beta	#NAME?	IFN-beta	NN	B-NP	B-protein#NAME?	DCs	#NAME?	JJ	I-NP	ODCs	are	DC	NNS	I-NP	B-cell_typeare	functionally	be	VBP	B-VP	Ofunctionally	cytotoxic	functionally	RB	B-ADJP	Ocytotoxic	.	cytotoxic	JJ	I-ADJP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	an	","	","	O	Oan	innate	an	DT	B-NP	Oinnate	mechanism	innate	JJ	I-NP	Omechanism	of	mechanism	NN	I-NP	Oof	DC-mediated	of	IN	B-PP	ODC-mediated	antitumor	DC-mediated	JJ	B-NP	Oantitumor	immunity	antitumor	NN	I-NP	Oimmunity	might	immunity	NN	I-NP	Omight	exist	might	MD	B-VP	Oexist	in	exist	VB	I-VP	Oin	vivo	in	FW	B-ADVP	Ovivo	in	vivo	FW	I-ADVP	Oin	which	in	IN	B-PP	Owhich	DCs	which	WDT	B-NP	ODCs	act	DC	NNS	B-NP	B-cell_typeact	as	act	VBP	B-VP	Oas	effectors	as	IN	B-SBAR	Oeffectors	to	effector	NNS	B-NP	Oto	directly	to	TO	B-VP	Odirectly	kill	directly	RB	I-VP	Okill	tumor	kill	VB	I-VP	Otumor	cells	tumor	NN	B-NP	B-cell_typecells	partially	cell	NNS	I-NP	I-cell_typepartially	via	partially	RB	B-ADVP	Ovia	TRAIL	via	IN	B-PP	OTRAIL	.	TRAIL	NN	B-NP	B-protein.	Subsequently	.	.	O	OSubsequently	","	Subsequently	RB	B-ADVP	O","	DCs	","	","	O	ODCs	act	DC	NNS	B-NP	B-cell_typeact	as	act	VBP	B-VP	Oas	APCs	as	IN	B-SBAR	OAPCs	involved	APC	NNS	B-NP	B-cell_typeinvolved	in	involve	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	uptake	the	DT	B-NP	Ouptake	","	uptake	NN	I-NP	O","	processing	","	","	O	Oprocessing	","	processing	NN	B-NP	O","	and	","	","	O	Oand	presentation	and	CC	O	Opresentation	of	presentation	NN	B-NP	Oof	apoptotic	of	IN	B-PP	Oapoptotic	tumor	apoptotic	JJ	B-NP	B-proteintumor	Ags	tumor	NN	I-NP	I-proteinAgs	to	Ag	NNS	I-NP	I-proteinto	cross-prime	to	TO	B-PP	Ocross-prime	CD8	cross-prime	JJ	B-NP	B-cell_typeCD8	(	CD8	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	CTL	)	)	O	I-cell_typeCTL	cells	CTL	NN	B-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Tumor	.	.	O	OTumor	cells	Tumor	NN	B-NP	B-cell_typecells	regulate	cell	NNS	I-NP	I-cell_typeregulate	the	regulate	VBP	B-VP	Othe	lytic	the	DT	B-NP	Olytic	activity	lytic	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	tumor-specific	of	IN	B-PP	Otumor-specific	cytotoxic	tumor-specific	JJ	B-NP	B-cell_typecytotoxic	t	cytotoxic	JJ	I-NP	I-cell_typet	lymphocytes	t	NN	I-NP	I-cell_typelymphocytes	by	lymphocyte	NNS	I-NP	I-cell_typeby	modulating	by	IN	B-PP	Omodulating	the	modulate	VBG	B-VP	Othe	inhibitory	the	DT	B-NP	Oinhibitory	natural	inhibitory	JJ	I-NP	B-proteinnatural	killer	natural	JJ	I-NP	I-proteinkiller	receptor	killer	NN	I-NP	I-proteinreceptor	function	receptor	NN	I-NP	I-proteinfunction	.	function	NN	I-NP	O.	Tumor-infiltrating	.	.	O	OTumor-infiltrating	p58+	Tumor-infiltrating	JJ	B-NP	B-cell_typep58+	T	p58+	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	a	from	IN	B-PP	Oa	renal	a	DT	B-NP	Orenal	tumor	renal	JJ	I-NP	Otumor	were	tumor	NN	I-NP	Owere	specifically	be	VBD	B-VP	Ospecifically	expanded	specifically	RB	I-VP	Oexpanded	in	expand	VBN	I-VP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	tumor	to	TO	B-PP	Otumor	cell	tumor	NN	B-NP	Ocell	stimulation	cell	NN	I-NP	Ostimulation	and	stimulation	NN	I-NP	Oand	cloned	and	CC	O	Ocloned	.	clone	VBN	B-VP	O.	These	.	.	O	OThese	p58+	These	DT	B-NP	Op58+	T	p58+	JJ	I-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	express	to	TO	I-VP	Oexpress	a	express	VB	I-VP	Oa	memory	a	DT	B-NP	Omemory	phenotype	memory	NN	I-NP	Ophenotype	and	phenotype	NN	I-NP	Oand	corresponded	and	CC	O	Ocorresponded	to	correspond	VBD	B-VP	Oto	clonal	to	TO	B-PP	Oclonal	TCRBV3	clonal	JJ	B-NP	OTCRBV3	T-cell	TCRBV3	NN	I-NP	OT-cell	expansion	T-cell	NN	I-NP	Oexpansion	.	expansion	NN	I-NP	O.	Functionally	.	.	O	OFunctionally	","	Functionally	RB	B-ADVP	O","	p58	","	","	O	Op58	(	p58	NN	B-NP	B-protein(	+	(	(	O	I-protein+	)	+	SYM	O	I-protein)	CTLs	)	)	O	I-proteinCTLs	displayed	CTL	NNS	B-NP	I-proteindisplayed	a	display	VBD	B-VP	Oa	low	a	DT	B-NP	Olow	lytic	low	JJ	I-NP	Olytic	activity	lytic	JJ	I-NP	Oactivity	for	activity	NN	I-NP	Ofor	HLA-A2	for	IN	B-PP	OHLA-A2	tumor	HLA-A2	NN	B-NP	B-proteintumor	and	tumor	NN	I-NP	Oand	normal	and	CC	O	Onormal	cells	normal	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	this	","	","	O	Othis	lytic	this	DT	B-NP	Olytic	activity	lytic	JJ	I-NP	Oactivity	was	activity	NN	I-NP	Owas	significantly	be	VBD	B-VP	Osignificantly	increased	significantly	RB	I-VP	Oincreased	after	increase	VBN	I-VP	Oafter	blockade	after	IN	B-PP	Oblockade	of	blockade	NN	B-NP	Oof	p58	of	IN	B-PP	Op58	with	p58	NN	B-NP	B-proteinwith	specific	with	IN	B-PP	Ospecific	monoclonal	specific	JJ	B-NP	Omonoclonal	antibodies	monoclonal	JJ	I-NP	B-proteinantibodies	.	antibody	NNS	I-NP	I-protein.	Interestingly	.	.	O	OInterestingly	","	Interestingly	RB	B-ADVP	O","	we	","	","	O	Owe	demonstrated	we	PRP	B-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	stimulation	that	IN	B-SBAR	Ostimulation	by	stimulation	NN	B-NP	Oby	tumor	by	IN	B-PP	Otumor	cells	tumor	NN	B-NP	B-cell_typecells	was	cell	NNS	I-NP	I-cell_typewas	required	be	VBD	B-VP	Orequired	to	require	VBN	I-VP	Oto	trigger	to	TO	I-VP	Otrigger	the	trigger	VB	I-VP	Othe	inhibitory	the	DT	B-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	p58	of	IN	B-PP	Op58	on	p58	NN	B-NP	B-proteinon	the	on	IN	B-PP	Othe	lytic	the	DT	B-NP	Olytic	activity	lytic	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	antigen-specific	of	IN	B-PP	Oantigen-specific	CTLs	antigen-specific	JJ	B-NP	B-cell_typeCTLs	and	CTL	NNS	I-NP	I-cell_typeand	that	and	CC	O	Othat	stimulation	that	IN	B-SBAR	Ostimulation	of	stimulation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	inhibitory	the	DT	B-NP	Oinhibitory	function	inhibitory	JJ	I-NP	Ofunction	of	function	NN	I-NP	Oof	p58	of	IN	B-PP	Op58	by	p58	NN	B-NP	B-proteinby	tumor	by	IN	B-PP	Otumor	cells	tumor	NN	B-NP	B-cell_typecells	correlated	cell	NNS	I-NP	I-cell_typecorrelated	with	correlate	VBD	B-VP	Owith	an	with	IN	B-PP	Oan	inhibition	an	DT	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor-kappaB	nuclear	JJ	B-NP	B-proteinfactor-kappaB	activation	factor-kappaB	NN	I-NP	I-proteinactivation	in	activation	NN	I-NP	Oin	p58+	in	IN	B-PP	Op58+	tumor-specific	p58+	JJ	B-NP	B-cell_typetumor-specific	CTLS	tumor-specific	JJ	I-NP	I-cell_typeCTLS	.	CTLS	NN	I-NP	I-cell_type.	T-cell	.	.	O	OT-cell	factor-1	T-cell	NN	B-NP	B-proteinfactor-1	expression	factor-1	NN	I-NP	I-proteinexpression	during	expression	NN	I-NP	Oduring	human	during	IN	B-PP	Ohuman	natural	human	JJ	B-NP	Onatural	killer	natural	JJ	I-NP	Okiller	cell	killer	NN	I-NP	Ocell	development	cell	NN	I-NP	Odevelopment	and	development	NN	I-NP	Oand	in	and	CC	B-PP	Oin	circulating	in	IN	B-PP	Ocirculating	CD56	circulate	VBG	B-VP	B-cell_typeCD56	(	CD56	NN	B-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	bright	)	)	O	I-cell_typebright	natural	bright	JJ	B-NP	I-cell_typenatural	killer	natural	JJ	I-NP	I-cell_typekiller	cells	killer	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Transcription	.	.	O	OTranscription	factors	Transcription	NN	B-NP	B-proteinfactors	are	factor	NNS	I-NP	I-proteinare	essential	be	VBP	B-VP	Oessential	to	essential	JJ	B-ADJP	Oto	govern	to	TO	B-VP	Ogovern	differentiation	govern	VB	I-VP	Odifferentiation	along	differentiation	NN	B-NP	Oalong	the	along	IN	B-PP	Othe	lymphoid	the	DT	B-NP	Olymphoid	lineage	lymphoid	JJ	I-NP	B-cell_typelineage	from	lineage	NN	I-NP	I-cell_typefrom	uncommitted	from	IN	B-PP	Ouncommitted	hematopoietic	uncommitted	JJ	B-NP	B-cell_typehematopoietic	stem	hematopoietic	JJ	I-NP	I-cell_typestem	cells	stem	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Although	.	.	O	OAlthough	many	Although	IN	B-SBAR	Omany	of	many	JJ	B-NP	Oof	these	of	IN	B-PP	Othese	transcription	these	DT	B-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	have	factor	NNS	I-NP	I-proteinhave	putative	have	VBP	B-VP	Oputative	roles	putative	JJ	B-NP	Oroles	based	role	NNS	I-NP	Obased	on	base	VBN	B-PP	Oon	murine	on	IN	B-PP	Omurine	knockout	murine	JJ	B-NP	Oknockout	experiments	knockout	NN	I-NP	Oexperiments	","	experiment	NNS	I-NP	O","	their	","	","	O	Otheir	function	their	PRP$	B-NP	Ofunction	in	function	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	lymphoid	human	JJ	B-NP	Olymphoid	development	lymphoid	JJ	I-NP	Odevelopment	is	development	NN	I-NP	Ois	less	be	VBZ	B-VP	Oless	known	less	RBR	B-ADJP	Oknown	and	known	JJ	I-ADJP	Oand	was	and	CC	O	Owas	studied	be	VBD	B-VP	Ostudied	further	study	VBN	I-VP	Ofurther	.	further	RB	B-ADVP	O.	Transcription	.	.	O	OTranscription	factor	Transcription	NN	B-NP	B-proteinfactor	expression	factor	NN	I-NP	I-proteinexpression	in	expression	NN	I-NP	Oin	fresh	in	IN	B-PP	Ofresh	and	fresh	JJ	B-ADJP	Oand	cultured	and	CC	O	Ocultured	adult	culture	VBN	B-VP	Oadult	human	adult	JJ	B-NP	Ohuman	bone	human	JJ	I-NP	Obone	marrow	bone	NN	I-NP	Omarrow	and	marrow	NN	I-NP	Oand	umbilical	and	CC	O	Oumbilical	cord	umbilical	JJ	B-NP	B-cell_typecord	blood	cord	NN	I-NP	I-cell_typeblood	progenitors	blood	NN	I-NP	I-cell_typeprogenitors	was	progenitor	NNS	I-NP	I-cell_typewas	evaluated	be	VBD	B-VP	Oevaluated	.	evaluate	VBN	I-VP	O.	We	.	.	O	OWe	found	We	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	fresh	that	IN	B-SBAR	Ofresh	CD34	fresh	JJ	B-NP	OCD34	(	CD34	NN	I-NP	O(	+	(	(	O	O+	)	+	SYM	O	O)	Lin	)	)	O	OLin	(	Lin	NN	B-NP	O(	-	(	(	O	O-	)	-	SYM	O	O)	cells	)	)	O	Ocells	that	cell	NNS	B-NP	Othat	are	that	WDT	B-NP	Oare	human	be	VBP	B-VP	Ohuman	leukocyte	human	JJ	B-NP	B-proteinleukocyte	antigen	leukocyte	NN	I-NP	I-proteinantigen	(	antigen	NN	I-NP	I-protein(	HLA	(	(	O	OHLA	)	HLA	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	(	#NAME?	NN	B-NP	O(	-	(	(	O	O-	)	-	SYM	B-NP	O)	or	)	)	O	Oor	CD38	or	CC	O	OCD38	(	CD38	NN	B-NP	B-protein(	-	(	(	O	O-	)	-	SYM	B-NP	O)	constitutively	)	)	O	Oconstitutively	express	constitutively	RB	B-ADVP	Oexpress	GATA-3	express	VBP	B-VP	OGATA-3	but	GATA-3	NN	B-NP	B-proteinbut	not	but	CC	B-NP	Onot	T-cell	not	RB	I-NP	OT-cell	factor-1	T-cell	NN	B-NP	B-proteinfactor-1	(	factor-1	NN	I-NP	I-protein(	TCF-1	(	(	O	OTCF-1	)	TCF-1	NN	B-NP	B-protein)	or	)	)	O	Oor	Id-3	or	CC	O	OId-3	.	Id-3	NN	B-NP	B-protein.	Culture	.	.	O	OCulture	with	Culture	NN	B-NP	Owith	the	with	IN	B-PP	Othe	murine	the	DT	B-NP	Omurine	fetal	murine	JJ	I-NP	Ofetal	liver	fetal	JJ	I-NP	Oliver	cell	liver	NN	I-NP	Ocell	line	cell	NN	I-NP	Oline	AFT024	line	NN	I-NP	OAFT024	and	AFT024	NN	I-NP	Oand	defined	and	CC	O	Odefined	cytokines	define	VBN	B-NP	Ocytokines	was	cytokine	NNS	I-NP	B-proteinwas	capable	be	VBD	B-VP	Ocapable	of	capable	JJ	B-ADJP	Oof	inducing	of	IN	B-PP	Oinducing	TCF-1	induce	VBG	B-VP	OTCF-1	mRNA	TCF-1	NN	B-NP	B-RNAmRNA	.	mRNA	NN	I-NP	I-RNA.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	no	","	","	O	Ono	T-cell	no	DT	B-NP	OT-cell	receptor	T-cell	NN	I-NP	B-DNAreceptor	gene	receptor	NN	I-NP	I-DNAgene	rearrangement	gene	NN	I-NP	I-DNArearrangement	was	rearrangement	NN	I-NP	Owas	identified	be	VBD	B-VP	Oidentified	in	identify	VBN	I-VP	Oin	cultured	in	IN	B-PP	Ocultured	progeny	culture	VBN	B-NP	B-cell_lineprogeny	.	progeny	NN	I-NP	I-cell_line.	Id-3	.	.	O	OId-3	","	Id-3	NN	B-NP	B-protein","	a	","	","	O	Oa	basic	a	DT	B-NP	Obasic	helix	basic	JJ	I-NP	B-proteinhelix	loop	helix	NN	I-NP	I-proteinloop	helix	loop	NN	I-NP	I-proteinhelix	factor	helix	NN	I-NP	I-proteinfactor	with	factor	NN	I-NP	I-proteinwith	dominant	with	IN	B-PP	Odominant	negative	dominant	JJ	B-NP	Onegative	function	negative	JJ	I-NP	Ofunction	for	function	NN	I-NP	Ofor	T-cell	for	IN	B-PP	OT-cell	differentiation	T-cell	NN	B-NP	B-proteindifferentiation	transcription	differentiation	NN	I-NP	I-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	","	factor	NNS	I-NP	I-protein","	also	","	","	O	Oalso	was	also	RB	B-ADVP	Owas	upregulated	be	VBD	B-VP	Oupregulated	and	upregulate	VBN	I-VP	Oand	may	and	CC	O	Omay	explain	may	MD	B-VP	Oexplain	unsuccessful	explain	VB	I-VP	Ounsuccessful	T-cell	unsuccessful	JJ	B-NP	OT-cell	maturation	T-cell	NN	I-NP	Omaturation	.	maturation	NN	I-NP	O.	To	.	.	O	OTo	better	To	TO	B-VP	Obetter	understand	well	RBR	I-VP	Ounderstand	the	understand	VB	I-VP	Othe	developmental	the	DT	B-NP	Odevelopmental	link	developmental	JJ	I-NP	Olink	between	link	NN	I-NP	Obetween	natural	between	IN	B-PP	Onatural	killer	natural	JJ	B-NP	B-cell_typekiller	(	killer	NN	I-NP	I-cell_type(	NK	(	(	O	I-cell_typeNK	)	NK	NN	B-NP	I-cell_type)	cells	)	)	O	I-cell_typecells	derived	cell	NNS	B-NP	I-cell_typederived	from	derive	VBN	B-VP	Ofrom	progenitors	from	IN	B-PP	Oprogenitors	","	progenitor	NNS	B-NP	B-cell_type","	we	","	","	O	Owe	studied	we	PRP	B-NP	Ostudied	NK	study	VBD	B-VP	ONK	cell	NK	NN	B-NP	B-cell_typecell	subsets	cell	NN	I-NP	I-cell_typesubsets	circulating	subset	NNS	I-NP	I-cell_typecirculating	in	circulate	VBG	B-VP	Oin	blood	in	IN	B-PP	Oblood	.	blood	NN	B-NP	O.	CD56	.	.	O	OCD56	(	CD56	NN	B-NP	B-protein(	#NAME?	(	(	O	O#NAME?	)	#NAME?	NN	B-NP	O)	","	)	)	O	O","	but	","	","	O	Obut	not	but	CC	O	Onot	CD56	not	RB	O	OCD56	(	CD56	NN	B-NP	B-protein(	#NAME?	(	(	O	O#NAME?	)	#NAME?	NN	B-NP	O)	","	)	)	O	O","	NK	","	","	O	ONK	cells	NK	NN	B-NP	B-cell_typecells	constitutively	cell	NNS	I-NP	I-cell_typeconstitutively	express	constitutively	RB	B-ADVP	Oexpress	TCF-1	express	VBP	B-VP	OTCF-1	by	TCF-1	NN	B-NP	B-proteinby	reverse	by	IN	B-PP	Oreverse	transcriptase	reverse	JJ	B-NP	B-proteintranscriptase	polymerase	transcriptase	NN	I-NP	I-proteinpolymerase	chain	polymerase	NN	I-NP	Ochain	reaction	chain	NN	I-NP	Oreaction	and	reaction	NN	I-NP	Oand	Western	and	CC	O	OWestern	blot	Western	NN	B-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	.	analysis	NN	I-NP	O.	The	.	.	O	OThe	TCF-1	The	DT	B-NP	OTCF-1	isoform	TCF-1	NN	I-NP	B-proteinisoform	found	isoform	NN	I-NP	I-proteinfound	in	find	VBN	B-VP	Oin	CD56	in	IN	B-PP	OCD56	(	CD56	NN	B-NP	B-protein(	#NAME?	(	(	O	O#NAME?	)	#NAME?	NN	B-NP	O)	cells	)	)	I-NP	Ocells	","	cell	NNS	I-NP	O","	which	","	","	O	Owhich	express	which	WDT	B-NP	Oexpress	lectin	express	VBP	B-VP	Olectin	but	lectin	NN	B-NP	B-proteinbut	not	but	CC	B-NP	Onot	immunoglobulin	not	RB	I-NP	Oimmunoglobulin	class	immunoglobulin	NN	B-NP	B-proteinclass	I	class	NN	I-NP	I-proteinI	recognizing	I	CD	I-NP	I-proteinrecognizing	inhibitory	recognize	VBG	B-VP	I-proteininhibitory	receptors	inhibitory	JJ	B-NP	I-proteinreceptors	","	receptor	NNS	I-NP	I-protein","	was	","	","	O	Owas	identical	be	VBD	B-VP	Oidentical	to	identical	JJ	B-ADJP	Oto	that	to	TO	B-PP	Othat	induced	that	DT	B-NP	Oinduced	in	induce	VBN	B-VP	Oin	NK	in	IN	B-PP	ONK	cell	NK	NN	B-NP	B-cell_typecell	differentiation	cell	NN	I-NP	I-cell_typedifferentiation	culture	differentiation	NN	I-NP	Oculture	and	culture	NN	I-NP	Oand	was	and	CC	O	Owas	distinctly	be	VBD	B-VP	Odistinctly	different	distinctly	RB	B-ADJP	Odifferent	from	different	JJ	I-ADJP	Ofrom	isoforms	from	IN	B-PP	Oisoforms	in	isoform	NNS	B-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	TCF-1	that	IN	B-SBAR	OTCF-1	does	TCF-1	NN	B-NP	B-proteindoes	not	do	VBZ	B-VP	Onot	target	not	RB	I-VP	Otarget	human	target	VB	I-VP	Ohuman	killer	human	JJ	B-NP	B-DNAkiller	immunoglobulin	killer	NN	I-NP	I-DNAimmunoglobulin	receptor	immunoglobulin	NN	I-NP	I-DNAreceptor	genes	receptor	NN	I-NP	I-DNAgenes	","	gene	NNS	I-NP	I-DNA","	TCF-1	","	","	O	OTCF-1	is	TCF-1	NN	B-NP	B-proteinis	uniquely	be	VBZ	B-VP	Ouniquely	expressed	uniquely	RB	I-VP	Oexpressed	in	express	VBN	I-VP	Oin	circulating	in	IN	B-PP	Ocirculating	CD56	circulate	VBG	B-VP	B-cell_typeCD56	(	CD56	NN	B-NP	I-cell_type(	#NAME?	(	(	O	I-cell_type#NAME?	)	#NAME?	NN	B-NP	I-cell_type)	NK	)	)	O	I-cell_typeNK	cells	NK	NN	B-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	specific	and	CC	O	Ospecific	TCF-1	specific	JJ	B-NP	OTCF-1	isoforms	TCF-1	NN	I-NP	B-proteinisoforms	may	isoform	NNS	I-NP	I-proteinmay	play	may	MD	B-VP	Oplay	an	play	VB	I-VP	Oan	important	an	DT	B-NP	Oimportant	role	important	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	regulating	in	IN	B-PP	Oregulating	NK	regulate	VBG	B-VP	ONK	differentiation	NK	NN	B-NP	Odifferentiation	from	differentiation	NN	I-NP	Ofrom	a	from	IN	B-PP	Oa	common	a	DT	B-NP	Ocommon	NK/T-cell	common	JJ	I-NP	ONK/T-cell	progenitor	NK/T-cell	NN	I-NP	Oprogenitor	.	progenitor	NN	I-NP	O.	Transcriptional	.	.	O	OTranscriptional	activation	Transcriptional	JJ	B-NP	Oactivation	by	activation	NN	I-NP	Oby	a	by	IN	B-PP	Oa	matrix	a	DT	B-NP	Omatrix	associating	matrix	NN	I-NP	B-proteinassociating	region-binding	associate	VBG	B-VP	I-proteinregion-binding	protein	region-binding	JJ	B-NP	I-proteinprotein	.	protein	NN	I-NP	I-protein.	contextual	.	.	O	Ocontextual	requirements	contextual	JJ	B-NP	Orequirements	for	requirement	NNS	I-NP	Ofor	the	for	IN	B-PP	Othe	function	the	DT	B-NP	Ofunction	of	function	NN	I-NP	Oof	bright	of	IN	B-PP	Obright	.	bright	NN	B-NP	O.	Bright	.	.	O	OBright	(	Bright	JJ	B-NP	O(	B	(	(	O	OB	cell	B	NN	B-NP	Ocell	regulator	cell	NN	I-NP	Oregulator	of	regulator	NN	I-NP	Oof	IgH	of	IN	B-PP	OIgH	transcription	IgH	NN	B-NP	Otranscription	)	transcription	NN	I-NP	O)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	B	a	DT	B-NP	OB	cell	B	NN	I-NP	Ocell	#NAME?	cell	NN	I-NP	O#NAME?	","	#NAME?	JJ	B-ADJP	O","	matrix	","	","	O	Omatrix	associating	matrix	NN	B-NP	B-proteinassociating	region-binding	associate	VBG	B-VP	I-proteinregion-binding	protein	region-binding	JJ	B-NP	I-proteinprotein	that	protein	NN	I-NP	I-proteinthat	transactivates	that	WDT	B-NP	Otransactivates	gene	transactivate	VBZ	B-VP	Ogene	expression	gene	NN	B-NP	Oexpression	from	expression	NN	I-NP	Ofrom	the	from	IN	B-PP	Othe	IgH	the	DT	B-NP	OIgH	intronic	IgH	NN	I-NP	B-DNAintronic	enhancer	intronic	JJ	I-NP	I-DNAenhancer	(	enhancer	NN	I-NP	I-DNA(	E	(	(	O	OE	mu	E	NN	B-NP	B-proteinmu	)	mu	NN	I-NP	I-protein)	.	)	)	O	O.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	here	show	VBP	B-VP	Ohere	that	here	RB	B-ADVP	Othat	Bright	that	IN	B-SBAR	OBright	has	Bright	NNP	B-NP	Ohas	multiple	have	VBZ	B-VP	Omultiple	contextual	multiple	JJ	B-NP	Ocontextual	requirements	contextual	JJ	I-NP	Orequirements	to	requirement	NNS	I-NP	Oto	function	to	TO	B-VP	Ofunction	as	function	VB	I-VP	Oas	a	as	IN	B-PP	Oa	transcriptional	a	DT	B-NP	Otranscriptional	activator	transcriptional	JJ	I-NP	B-proteinactivator	.	activator	NN	I-NP	I-protein.	Bright	.	.	O	OBright	can	Bright	NNP	B-NP	Ocan	not	can	MD	B-VP	Onot	transactivate	not	RB	I-VP	Otransactivate	via	transactivate	VB	I-VP	Ovia	out	via	IN	B-PP	Oout	of	out	IN	B-PP	Oof	context	of	IN	B-PP	Ocontext	","	context	NN	B-NP	O","	concatenated	","	","	O	Oconcatenated	binding	concatenate	VBN	B-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	.	site	NNS	I-NP	I-DNA.	Transactivation	.	.	O	OTransactivation	is	Transactivation	NN	B-NP	Ois	maximal	be	VBZ	B-VP	Omaximal	on	maximal	JJ	B-ADJP	Oon	integrated	on	IN	B-PP	Ointegrated	substrates	integrate	VBN	B-NP	Osubstrates	.	substrate	NNS	I-NP	O.	Two	.	.	O	OTwo	of	Two	CD	B-NP	Oof	the	of	IN	B-PP	Othe	three	the	DT	B-NP	Othree	previously	three	CD	I-NP	Opreviously	identified	previously	RB	I-NP	Oidentified	binding	identify	VBN	I-NP	Obinding	sites	bind	VBG	I-NP	B-DNAsites	in	site	NNS	I-NP	I-DNAin	E	in	IN	B-PP	OE	mu	E	NN	B-NP	B-proteinmu	are	mu	NN	I-NP	I-proteinare	required	be	VBP	B-VP	Orequired	for	require	VBN	I-VP	Ofor	full	for	IN	B-PP	Ofull	Bright	full	JJ	B-NP	OBright	transactivation	Bright	JJ	I-NP	Otransactivation	.	transactivation	NN	I-NP	O.	The	.	.	O	OThe	Bright	The	DT	B-NP	OBright	DNA	Bright	NNP	I-NP	ODNA	binding	DNA	NN	I-NP	B-proteinbinding	domain	binding	NN	I-NP	I-proteindomain	defined	domain	NN	I-NP	I-proteindefined	a	define	VBD	B-VP	Oa	new	a	DT	B-NP	Onew	family	new	JJ	I-NP	Ofamily	","	family	NN	I-NP	O","	which	","	","	O	Owhich	includes	which	WDT	B-NP	Oincludes	SWI1	include	VBZ	B-VP	OSWI1	","	SWI1	NN	B-NP	B-protein","	a	","	","	O	Oa	component	a	DT	B-NP	Ocomponent	of	component	NN	I-NP	Oof	the	of	IN	B-PP	Othe	SWI.SNF	the	DT	B-NP	OSWI.SNF	complex	SWI.SNF	NN	I-NP	B-proteincomplex	shown	complex	NN	I-NP	I-proteinshown	to	show	VBN	B-VP	Oto	have	to	TO	I-VP	Ohave	high	have	VB	I-VP	Ohigh	mobility	high	JJ	B-NP	Omobility	group-like	mobility	NN	I-NP	Ogroup-like	DNA	group-like	JJ	I-NP	ODNA	binding	DNA	NN	I-NP	Obinding	characteristics	binding	NN	I-NP	Ocharacteristics	.	characteristic	NNS	I-NP	O.	Similar	.	.	O	OSimilar	to	Similar	JJ	B-ADJP	Oto	one	to	TO	B-PP	Oone	group	one	CD	B-NP	Ogroup	of	group	NN	I-NP	Oof	high	of	IN	B-PP	Ohigh	mobility	high	JJ	B-NP	B-proteinmobility	group	mobility	NN	I-NP	I-proteingroup	box	group	NN	I-NP	I-proteinbox	proteins	box	NN	I-NP	I-proteinproteins	","	protein	NNS	I-NP	I-protein","	Bright	","	","	O	OBright	distorts	Bright	NNP	B-NP	Odistorts	E	distort	VBZ	B-VP	OE	mu	E	NNP	B-NP	Omu	binding	mu	NN	I-NP	Obinding	site	binding	NN	I-NP	Osite	#NAME?	site	NN	I-NP	O#NAME?	DNA	#NAME?	JJ	I-NP	ODNA	on	DNA	NN	I-NP	Oon	binding	on	IN	B-PP	Obinding	","	binding	NN	B-NP	O","	supporting	","	","	O	Osupporting	the	support	VBG	B-VP	Othe	concept	the	DT	B-NP	Oconcept	that	concept	NN	I-NP	Othat	it	that	IN	B-SBAR	Oit	mediates	it	PRP	B-NP	Omediates	E	mediate	VBZ	B-VP	OE	mu	E	NN	B-NP	Omu	remodeling	mu	NN	I-NP	Oremodeling	.	remodeling	NN	I-NP	O.	Transfection	.	.	O	OTransfection	studies	Transfection	NN	B-NP	Ostudies	further	study	NNS	I-NP	Ofurther	implicate	further	RB	B-ADVP	Oimplicate	Bright	implicate	VBP	B-VP	OBright	in	Bright	NNP	B-NP	Oin	facilitating	in	IN	B-PP	Ofacilitating	spatially	facilitate	VBG	B-VP	Ospatially	separated	spatially	RB	B-NP	Oseparated	promoter-enhancer	separate	VBN	I-NP	Opromoter-enhancer	interactions	promoter-enhancer	JJ	I-NP	Ointeractions	in	interaction	NNS	I-NP	Oin	both	in	IN	B-PP	Oboth	transient	both	CC	B-NP	Otransient	and	transient	JJ	I-NP	Oand	stable	and	CC	I-NP	Ostable	assays	stable	JJ	I-NP	Oassays	.	assay	NNS	I-NP	O.	Finally	.	.	O	OFinally	","	Finally	RB	B-ADVP	O","	we	","	","	O	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	overexpression	that	IN	B-SBAR	Ooverexpression	of	overexpression	NN	B-NP	Oof	Bright	of	IN	B-PP	OBright	leads	Bright	NNP	B-NP	Oleads	to	lead	VBZ	B-VP	Oto	enhanced	to	TO	B-PP	Oenhanced	DNase	enhance	VBN	B-NP	ODNase	I	DNase	NN	I-NP	B-proteinI	sensitivity	I	CD	I-NP	I-proteinsensitivity	of	sensitivity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	endogenous	the	DT	B-NP	Oendogenous	E	endogenous	JJ	I-NP	B-DNAE	mu	E	NN	I-NP	I-DNAmu	matrix	mu	NN	I-NP	I-DNAmatrix	associating	matrix	NN	I-NP	I-DNAassociating	regions	associate	VBG	B-VP	I-DNAregions	.	region	NNS	B-NP	I-DNA.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	further	datum	NNS	I-NP	Ofurther	suggest	further	RB	B-VP	Osuggest	that	suggest	VBP	I-VP	Othat	Bright	that	IN	B-SBAR	OBright	may	Bright	NNP	B-NP	Omay	contribute	may	MD	B-VP	Ocontribute	to	contribute	VB	I-VP	Oto	increased	to	TO	B-PP	Oincreased	gene	increase	VBN	B-NP	Ogene	expression	gene	NN	I-NP	Oexpression	by	expression	NN	I-NP	Oby	remodeling	by	IN	B-PP	Oremodeling	the	remodel	VBG	B-VP	Othe	immunoglobulin	the	DT	B-NP	Oimmunoglobulin	locus	immunoglobulin	NN	I-NP	B-DNAlocus	during	locus	NN	I-NP	I-DNAduring	B	during	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	.	development	NN	I-NP	O.	Analysis	.	.	O	OAnalysis	of	Analysis	NN	B-NP	Oof	BCL-6	of	IN	B-PP	OBCL-6	mutations	BCL-6	NN	B-NP	B-proteinmutations	in	mutation	NNS	I-NP	Oin	classic	in	IN	B-PP	Oclassic	Hodgkin	classic	JJ	B-NP	OHodgkin	disease	Hodgkin	NN	I-NP	Odisease	of	disease	NN	I-NP	Oof	the	of	IN	B-PP	Othe	B-	the	DT	B-NP	OB-	and	B-	NN	I-NP	B-cell_typeand	T-cell	and	CC	I-NP	I-cell_typeT-cell	type	T-cell	NN	I-NP	I-cell_typetype	.	type	NN	I-NP	I-cell_type.	BCL-6	.	.	O	OBCL-6	is	BCL-6	NN	B-NP	B-proteinis	essential	be	VBZ	B-VP	Oessential	for	essential	JJ	B-ADJP	Ofor	germinal	for	IN	B-PP	Ogerminal	center	germinal	JJ	B-NP	Ocenter	formation	center	NN	I-NP	Oformation	and	formation	NN	I-NP	Oand	thus	and	CC	O	Othus	for	thus	RB	B-ADVP	Ofor	affinity	for	IN	B-PP	Oaffinity	maturation	affinity	NN	B-NP	Omaturation	of	maturation	NN	I-NP	Oof	immunoglobulin	of	IN	B-PP	Oimmunoglobulin	(	immunoglobulin	NN	B-NP	B-DNA(	Ig	(	(	O	I-DNAIg	)	Ig	NN	B-NP	I-DNA)	genes	)	)	O	I-DNAgenes	by	gene	NNS	B-NP	I-DNAby	somatic	by	IN	B-PP	Osomatic	mutations	somatic	JJ	B-NP	Omutations	.	mutation	NNS	I-NP	O.	The	.	.	O	OThe	5'-noncoding	The	DT	B-NP	O5'-noncoding	region	5'-noncoding	JJ	I-NP	B-DNAregion	of	region	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	BCL-6	the	DT	B-NP	OBCL-6	gene	BCL-6	NN	I-NP	B-DNAgene	is	gene	NN	I-NP	I-DNAis	even	be	VBZ	B-VP	Oeven	a	even	RB	B-NP	Oa	target	a	DT	I-NP	Otarget	for	target	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	mutation	the	DT	B-NP	Omutation	machinery	mutation	NN	I-NP	Omachinery	.	machinery	NN	I-NP	O.	Translocations	.	.	O	OTranslocations	of	Translocation	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	BCL-6	the	DT	B-NP	OBCL-6	gene	BCL-6	NN	I-NP	B-DNAgene	to	gene	NN	I-NP	I-DNAto	heterologous	to	TO	B-PP	Oheterologous	promoters	heterologous	JJ	B-NP	B-DNApromoters	and	promoter	NNS	I-NP	I-DNAand	mutations	and	CC	I-NP	Omutations	of	mutation	NNS	I-NP	Oof	its	of	IN	B-PP	Oits	5'-noncoding	its	PRP$	B-NP	O5'-noncoding	regulatory	5'-noncoding	JJ	I-NP	B-DNAregulatory	region	regulatory	JJ	I-NP	I-DNAregion	were	region	NN	I-NP	I-DNAwere	reported	be	VBD	B-VP	Oreported	to	report	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	potential	be	VB	I-VP	Opotential	mechanisms	potential	JJ	B-NP	Omechanisms	for	mechanism	NNS	I-NP	Ofor	deregulating	for	IN	B-PP	Oderegulating	BCL-6	deregulate	VBG	B-VP	OBCL-6	expression	BCL-6	NN	B-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	for	and	CC	B-PP	Ofor	playing	for	IN	B-PP	Oplaying	a	play	VBG	B-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	genesis	the	DT	B-NP	Ogenesis	of	genesis	NN	I-NP	Oof	non-Hodgkin	of	IN	B-PP	Onon-Hodgkin	lymphoma	non-Hodgkin	JJ	B-NP	Olymphoma	.	lymphoma	NN	I-NP	O.	In	.	.	O	OIn	line	In	IN	B-PP	Oline	with	line	NN	B-NP	Owith	this	with	IN	B-PP	Othis	hypothesis	this	DT	B-NP	Ohypothesis	is	hypothesis	NN	I-NP	Ois	the	be	VBZ	B-VP	Othe	observation	the	DT	B-NP	Oobservation	that	observation	NN	I-NP	Othat	B-cell	that	IN	B-SBAR	OB-cell	lymphoma	B-cell	NN	B-NP	B-cell_typelymphoma	with	lymphoma	NN	I-NP	I-cell_typewith	somatic	with	IN	B-PP	Osomatic	mutations	somatic	JJ	B-NP	Omutations	","	mutation	NNS	I-NP	O","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	diffuse	as	IN	I-PP	Odiffuse	large	diffuse	JJ	B-NP	Olarge	B-cell	large	JJ	I-NP	OB-cell	lymphoma	B-cell	NN	I-NP	Olymphoma	and	lymphoma	NN	I-NP	Oand	follicular	and	CC	O	Ofollicular	lymphoma	follicular	JJ	B-NP	Olymphoma	","	lymphoma	NN	I-NP	O","	also	","	","	O	Oalso	carry	also	RB	B-ADVP	Ocarry	BCL-6	carry	VBP	B-VP	OBCL-6	mutations	BCL-6	NN	B-NP	B-proteinmutations	","	mutation	NNS	I-NP	O","	some	","	","	O	Osome	of	some	DT	B-NP	Oof	which	of	IN	B-PP	Owhich	are	which	WDT	B-NP	Oare	recurrently	be	VBP	B-VP	Orecurrently	detectable	recurrently	RB	B-ADJP	Odetectable	.	detectable	JJ	I-ADJP	O.	Classic	.	.	O	OClassic	Hodgkin	Classic	JJ	B-NP	OHodgkin	disease	Hodgkin	NN	I-NP	Odisease	(	disease	NN	I-NP	O(	cHD	(	(	O	OcHD	)	cHD	NN	B-NP	O)	is	)	)	O	Ois	also	be	VBZ	B-VP	Oalso	derived	also	RB	I-VP	Oderived	from	derive	VBN	I-VP	Ofrom	B	from	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	with	cell	NNS	I-NP	I-cell_typewith	high	with	IN	B-PP	Ohigh	loads	high	JJ	B-NP	Oloads	of	load	NNS	I-NP	Oof	somatic	of	IN	B-PP	Osomatic	mutations	somatic	JJ	B-NP	Omutations	and	mutation	NNS	I-NP	Oand	thus	and	CC	O	Othus	a	thus	RB	O	Oa	further	a	DT	B-NP	Ofurther	candidate	further	JJ	I-NP	Ocandidate	for	candidate	NN	I-NP	Ofor	BCL-6	for	IN	B-PP	OBCL-6	mutations	BCL-6	NN	B-NP	B-proteinmutations	.	mutation	NNS	I-NP	O.	To	.	.	O	OTo	determine	To	TO	B-VP	Odetermine	the	determine	VB	I-VP	Othe	presence	the	DT	B-NP	Opresence	and	presence	NN	I-NP	Oand	potential	and	CC	I-NP	Opotential	role	potential	JJ	I-NP	Orole	of	role	NN	I-NP	Oof	BCL-6	of	IN	B-PP	OBCL-6	mutations	BCL-6	NN	B-NP	B-proteinmutations	in	mutation	NNS	I-NP	Oin	cHD	in	IN	B-PP	OcHD	","	cHD	NN	B-NP	O","	the	","	","	O	Othe	5'-noncoding	the	DT	B-NP	O5'-noncoding	BCL-6	5'-noncoding	JJ	I-NP	OBCL-6	proportion	BCL-6	NN	I-NP	B-proteinproportion	of	proportion	NN	I-NP	Oof	single	of	IN	B-PP	Osingle	Hodgkin	single	JJ	B-NP	OHodgkin	and	Hodgkin	NN	I-NP	Oand	Reed-Sternberg	and	CC	I-NP	OReed-Sternberg	(	Reed-Sternberg	NN	I-NP	B-cell_line(	HRS	(	(	I-NP	I-cell_lineHRS	)	HRS	NN	I-NP	I-cell_line)	cells	)	)	I-NP	I-cell_linecells	from	cell	NNS	I-NP	I-cell_linefrom	6	from	IN	B-PP	O6	cases	6	CD	B-NP	Ocases	of	case	NNS	I-NP	Oof	cHD	of	IN	B-PP	OcHD	and	cHD	NN	B-NP	Oand	6	and	CC	O	O6	cases	6	CD	B-NP	Ocases	of	case	NNS	I-NP	Oof	HD-derived	of	IN	B-PP	OHD-derived	cell	HD-derived	JJ	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	was	line	NNS	I-NP	I-cell_linewas	analyzed	be	VBD	B-VP	Oanalyzed	.	analyze	VBN	I-VP	O.	All	.	.	O	OAll	B-cell-derived	All	DT	B-NP	OB-cell-derived	HD	B-cell-derived	JJ	I-NP	B-cell_lineHD	cases	HD	NN	I-NP	I-cell_linecases	and	case	NNS	I-NP	I-cell_lineand	cell	and	CC	O	I-cell_linecell	lines	cell	NN	B-NP	I-cell_linelines	harbored	line	NNS	I-NP	I-cell_lineharbored	BCL-6	harbor	VBD	B-VP	OBCL-6	mutations	BCL-6	NN	B-NP	B-proteinmutations	.	mutation	NNS	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	both	","	","	O	Oboth	T-cell-derived	both	DT	B-NP	OT-cell-derived	HD	T-cell-derived	JJ	I-NP	B-cell_lineHD	cases	HD	NN	I-NP	I-cell_linecases	and	case	NNS	I-NP	I-cell_lineand	cell	and	CC	O	I-cell_linecell	lines	cell	NN	B-NP	I-cell_linelines	were	line	NNS	I-NP	I-cell_linewere	devoid	be	VBD	B-VP	Odevoid	of	devoid	JJ	B-ADJP	Oof	BCL-6	of	IN	B-PP	OBCL-6	mutations	BCL-6	NN	B-NP	B-proteinmutations	.	mutation	NNS	I-NP	O.	With	.	.	O	OWith	only	With	IN	B-PP	Oonly	one	only	RB	B-NP	Oone	exception	one	CD	I-NP	Oexception	","	exception	NN	I-NP	O","	there	","	","	O	Othere	were	there	EX	B-NP	Owere	no	be	VBD	B-VP	Ono	lymphoma-specific	no	DT	B-NP	Olymphoma-specific	recurrent	lymphoma-specific	JJ	I-NP	Orecurrent	BCL-6	recurrent	JJ	I-NP	OBCL-6	mutations	BCL-6	NN	I-NP	B-proteinmutations	detected	mutation	NNS	I-NP	Odetected	","	detect	VBN	B-VP	O","	and	","	","	O	Oand	BCL-6	and	CC	O	OBCL-6	protein	BCL-6	NN	B-NP	B-proteinprotein	was	protein	NN	I-NP	I-proteinwas	absent	be	VBD	B-VP	Oabsent	from	absent	JJ	B-ADJP	Ofrom	the	from	IN	B-PP	Othe	HRS	the	DT	B-NP	OHRS	cells	HRS	NN	I-NP	B-cell_linecells	of	cell	NNS	I-NP	I-cell_lineof	most	of	IN	B-PP	Omost	cases	most	JJS	B-NP	Ocases	.	case	NNS	I-NP	O.	In	.	.	O	OIn	conclusion	In	IN	B-PP	Oconclusion	","	conclusion	NN	B-NP	O","	(	","	","	O	O(	1	(	(	B-LST	O1	)	1	LS	I-LST	O)	somatic	)	)	O	Osomatic	BCL-6	somatic	JJ	B-NP	OBCL-6	mutations	BCL-6	NN	I-NP	B-proteinmutations	are	mutation	NNS	I-NP	Oare	restricted	be	VBP	B-VP	Orestricted	to	restricted	JJ	B-ADJP	Oto	cHD	to	TO	B-PP	OcHD	cases	cHD	NN	B-NP	Ocases	of	case	NNS	I-NP	Oof	B-cell	of	IN	B-PP	OB-cell	origin	B-cell	NN	B-NP	B-cell_typeorigin	","	origin	NN	I-NP	I-cell_type","	and	","	","	O	Oand	(	and	CC	O	O(	2	(	(	B-LST	O2	)	2	LS	I-LST	O)	the	)	)	O	Othe	BCL-6	the	DT	B-NP	OBCL-6	mutations	BCL-6	NN	I-NP	B-proteinmutations	represent	mutation	NNS	I-NP	Orepresent	mostly	represent	VBP	B-VP	Omostly	irrelevant	mostly	RB	B-NP	Oirrelevant	somatic	irrelevant	JJ	I-NP	Osomatic	base	somatic	JJ	I-NP	Obase	substitutions	base	NN	I-NP	Osubstitutions	without	substitution	NNS	I-NP	Owithout	consequences	without	IN	B-PP	Oconsequences	for	consequence	NNS	B-NP	Ofor	BCL-6	for	IN	B-PP	OBCL-6	protein	BCL-6	NN	B-NP	B-proteinprotein	expression	protein	NN	I-NP	I-proteinexpression	and	expression	NN	I-NP	Oand	the	and	CC	O	Othe	pathogenesis	the	DT	B-NP	Opathogenesis	of	pathogenesis	NN	I-NP	Oof	cHD	of	IN	B-PP	OcHD	.	cHD	NN	B-NP	O.	Gadd45gamma	.	.	O	OGadd45gamma	is	Gadd45gamma	NN	B-NP	B-proteinis	dispensable	be	VBZ	B-VP	Odispensable	for	dispensable	JJ	B-ADJP	Ofor	normal	for	IN	B-PP	Onormal	mouse	normal	JJ	B-NP	Omouse	development	mouse	NN	I-NP	Odevelopment	and	development	NN	I-NP	Oand	T-cell	and	CC	O	OT-cell	proliferation	T-cell	NN	B-NP	Oproliferation	.	proliferation	NN	I-NP	O.	Gadd45gamma	.	.	O	OGadd45gamma	","	Gadd45gamma	NN	B-NP	B-protein","	a	","	","	O	Oa	family	a	DT	B-NP	Ofamily	member	family	NN	I-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	growth	the	DT	B-NP	Ogrowth	arrest	growth	NN	I-NP	Oarrest	and	arrest	NN	I-NP	Oand	DNA	and	CC	O	ODNA	damage-inducible	DNA	NN	B-NP	Odamage-inducible	gene	damage-inducible	JJ	I-NP	Ogene	family	gene	NN	I-NP	Ofamily	45	family	NN	I-NP	O45	(	45	CD	I-NP	O(	Gadd45	(	(	O	OGadd45	)	Gadd45	NN	B-NP	B-protein)	","	)	)	O	O","	is	","	","	O	Ois	strongly	be	VBZ	B-VP	Ostrongly	induced	strongly	RB	I-VP	Oinduced	by	induce	VBN	I-VP	Oby	interleukin-2	by	IN	B-PP	Ointerleukin-2	(	interleukin-2	NN	B-NP	B-protein(	IL-2	(	(	O	OIL-2	)	IL-2	NN	B-NP	B-protein)	in	)	)	O	Oin	peripheral	in	IN	B-PP	Operipheral	T	peripheral	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	While	.	.	O	OWhile	in	While	IN	B-SBAR	Oin	most	in	IN	B-PP	Omost	tissues	most	JJS	B-NP	Otissues	all	tissue	NNS	I-NP	Oall	Gadd45	all	DT	B-NP	OGadd45	family	Gadd45	NN	I-NP	B-proteinfamily	members	family	NN	I-NP	I-proteinmembers	are	member	NNS	I-NP	I-proteinare	expressed	be	VBP	B-VP	Oexpressed	","	express	VBN	I-VP	O","	Gadd45gamma	","	","	O	OGadd45gamma	is	Gadd45gamma	NN	B-NP	B-proteinis	the	be	VBZ	B-VP	Othe	only	the	DT	B-NP	Oonly	member	only	JJ	I-NP	Omember	that	member	NN	I-NP	Othat	is	that	WDT	B-NP	Ois	induced	be	VBZ	B-VP	Oinduced	by	induce	VBN	I-VP	Oby	IL-2	by	IN	B-PP	OIL-2	.	IL-2	NN	B-NP	B-protein.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	IL-2	the	DT	B-NP	OIL-2	#NAME?	IL-2	NN	I-NP	B-protein#NAME?	expression	#NAME?	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	Gadd45gamma	of	IN	B-PP	OGadd45gamma	is	Gadd45gamma	NN	B-NP	B-proteinis	dependent	be	VBZ	B-VP	Odependent	on	dependent	JJ	B-ADJP	Oon	a	on	IN	B-PP	Oa	signaling	a	DT	B-NP	Osignaling	pathway	signaling	NN	I-NP	Opathway	mediated	pathway	NN	I-NP	Omediated	by	mediate	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	tyrosine	the	DT	B-NP	Otyrosine	kinase	tyrosine	NN	I-NP	B-proteinkinase	Jak3	kinase	NN	I-NP	I-proteinJak3	and	Jak3	NN	I-NP	B-proteinand	the	and	CC	O	Othe	transcription	the	DT	B-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	Stat5a	factor	NNS	I-NP	I-proteinStat5a	and	Stat5a	NN	B-NP	B-proteinand	Stat5b	and	CC	O	OStat5b	(	Stat5b	NN	B-NP	B-protein(	signal	(	(	O	Osignal	transducer	signal	NN	B-NP	B-proteintransducer	and	transducer	NN	I-NP	I-proteinand	activator	and	CC	O	I-proteinactivator	of	activator	NN	B-NP	I-proteinof	transcription	of	IN	B-PP	I-proteintranscription	)	transcription	NN	B-NP	I-protein)	.	)	)	O	O.	Previous	.	.	O	OPrevious	studies	Previous	JJ	B-NP	Ostudies	with	study	NNS	I-NP	Owith	ectopically	with	IN	B-PP	Oectopically	overexpressed	ectopically	RB	B-NP	Ooverexpressed	Gadd45gamma	overexpresse	VBN	I-NP	OGadd45gamma	in	Gadd45gamma	NN	I-NP	B-proteinin	various	in	IN	B-PP	Ovarious	cell	various	JJ	B-NP	Ocell	lines	cell	NN	I-NP	B-cell_linelines	implicated	line	NNS	I-NP	I-cell_lineimplicated	its	implicate	VBD	B-VP	Oits	function	its	PRP$	B-NP	Ofunction	in	function	NN	I-NP	Oin	negative	in	IN	B-PP	Onegative	growth	negative	JJ	B-NP	Ogrowth	control	growth	NN	I-NP	Ocontrol	.	control	NN	I-NP	O.	To	.	.	O	OTo	analyze	To	TO	B-VP	Oanalyze	the	analyze	VB	I-VP	Othe	physiological	the	DT	B-NP	Ophysiological	role	physiological	JJ	I-NP	Orole	of	role	NN	I-NP	Oof	Gadd45gamma	of	IN	B-PP	OGadd45gamma	we	Gadd45gamma	NN	B-NP	B-proteinwe	used	we	PRP	B-NP	Oused	homologous	use	VBD	B-VP	Ohomologous	recombination	homologous	JJ	B-NP	Orecombination	to	recombination	NN	I-NP	Oto	generate	to	TO	B-VP	Ogenerate	mice	generate	VB	I-VP	Omice	lacking	mouse	NNS	B-NP	Olacking	Gadd45gamma	lack	VBG	B-VP	OGadd45gamma	.	Gadd45gamma	NN	B-NP	B-protein.	Gadd45gamma	.	.	O	OGadd45gamma	#NAME?	Gadd45gamma	NN	B-NP	B-protein#NAME?	mice	#NAME?	JJ	I-NP	Omice	develop	mouse	NNS	I-NP	Odevelop	normally	develop	VBP	B-VP	Onormally	","	normally	RB	B-ADVP	O","	are	","	","	O	Oare	indistinguishable	be	VBP	B-VP	Oindistinguishable	from	indistinguishable	JJ	B-ADJP	Ofrom	their	from	IN	B-PP	Otheir	littermates	their	PRP$	B-NP	Olittermates	","	littermate	NNS	I-NP	O","	and	","	","	O	Oand	are	and	CC	O	Oare	fertile	be	VBP	B-VP	Ofertile	.	fertile	JJ	B-ADJP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	hematopoiesis	","	","	O	Ohematopoiesis	in	hematopoiesis	NN	B-NP	Oin	mice	in	IN	B-PP	Omice	lacking	mouse	NNS	B-NP	Olacking	Gadd45gamma	lack	VBG	B-VP	OGadd45gamma	is	Gadd45gamma	NN	B-NP	B-proteinis	not	be	VBZ	B-VP	Onot	impaired	not	RB	O	Oimpaired	and	impaired	JJ	B-ADJP	Oand	Gadd45gamma	and	CC	O	OGadd45gamma	#NAME?	Gadd45gamma	NN	B-NP	O#NAME?	T	#NAME?	JJ	I-NP	OT	lymphocytes	T	NN	I-NP	B-cell_typelymphocytes	show	lymphocyte	NNS	I-NP	I-cell_typeshow	normal	show	VBP	B-VP	Onormal	responses	normal	JJ	B-NP	Oresponses	to	response	NNS	I-NP	Oto	IL-2	to	TO	B-PP	OIL-2	.	IL-2	NN	B-NP	B-protein.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	demonstrate	datum	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	Gadd45gamma	that	IN	B-SBAR	OGadd45gamma	is	Gadd45gamma	NN	B-NP	B-proteinis	not	be	VBZ	B-VP	Onot	essential	not	RB	O	Oessential	for	essential	JJ	B-ADJP	Ofor	normal	for	IN	B-PP	Onormal	mouse	normal	JJ	B-NP	Omouse	development	mouse	NN	I-NP	Odevelopment	and	development	NN	I-NP	Oand	hematopoiesis	and	CC	I-NP	Ohematopoiesis	","	hematopoiesis	NN	I-NP	O","	possibly	","	","	O	Opossibly	due	possibly	RB	B-ADVP	Odue	to	due	JJ	B-PP	Oto	functional	to	TO	B-PP	Ofunctional	redundancy	functional	JJ	B-NP	Oredundancy	among	redundancy	NN	I-NP	Oamong	the	among	IN	B-PP	Othe	Gadd45	the	DT	B-NP	OGadd45	family	Gadd45	NN	I-NP	B-proteinfamily	members	family	NN	I-NP	I-proteinmembers	.	member	NNS	I-NP	I-protein.	Gadd45gamma	.	.	O	OGadd45gamma	is	Gadd45gamma	NN	B-NP	B-proteinis	also	be	VBZ	B-VP	Oalso	dispensable	also	RB	B-ADVP	Odispensable	for	dispensable	JJ	B-ADJP	Ofor	IL-2	for	IN	B-PP	OIL-2	#NAME?	IL-2	NN	B-NP	B-protein#NAME?	T-cell	#NAME?	JJ	I-NP	OT-cell	proliferation	T-cell	NN	I-NP	Oproliferation	.	proliferation	NN	I-NP	O.	Decreased	.	.	O	ODecreased	expression	Decrease	VBN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	c-myc	of	IN	B-PP	Oc-myc	family	c-myc	NN	B-NP	B-DNAfamily	genes	family	NN	I-NP	I-DNAgenes	in	gene	NNS	I-NP	I-DNAin	thymuses	in	IN	B-PP	Othymuses	from	thymus	NNS	B-NP	Ofrom	myasthenia	from	IN	B-PP	Omyasthenia	gravis	myasthenia	NN	B-NP	Ogravis	patients	gravis	NN	I-NP	Opatients	.	patient	NNS	I-NP	O.	The	.	.	O	OThe	thymus	The	DT	B-NP	Othymus	is	thymus	NN	I-NP	Ois	a	be	VBZ	B-VP	Oa	critical	a	DT	B-NP	Ocritical	organ	critical	JJ	I-NP	Oorgan	for	organ	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	elimination	the	DT	B-NP	Oelimination	of	elimination	NN	I-NP	Oof	autoreactive	of	IN	B-PP	Oautoreactive	T	autoreactive	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	apoptosis	by	IN	B-PP	Oapoptosis	.	apoptosis	NN	B-NP	O.	We	.	.	O	OWe	studied	We	PRP	B-NP	Ostudied	the	study	VBD	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	apoptosis-associated	of	IN	B-PP	Oapoptosis-associated	genes	apoptosis-associated	JJ	B-NP	B-DNAgenes	","	gene	NNS	I-NP	I-DNA","	bcl-xL	","	","	O	Obcl-xL	","	bcl-xL	NN	B-NP	B-protein","	bad	","	","	O	Obad	","	bad	NN	B-NP	B-protein","	caspase-3	","	","	O	Ocaspase-3	","	caspase-3	NN	B-NP	B-protein","	and	","	","	O	Oand	c-myc	and	CC	O	Oc-myc	family	c-myc	NN	B-NP	B-DNAfamily	genes	family	NN	I-NP	I-DNAgenes	in	gene	NNS	I-NP	I-DNAin	myasthenia	in	IN	B-PP	Omyasthenia	gravis	myasthenia	NN	B-NP	Ogravis	(	gravis	NN	I-NP	O(	MG	(	(	O	OMG	)	MG	NN	B-NP	O)	thymuses	)	)	O	Othymuses	.	thymus	NNS	B-NP	O.	We	.	.	O	OWe	observed	We	PRP	B-NP	Oobserved	that	observe	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	mRNA	the	DT	B-NP	OmRNA	levels	mRNA	NN	I-NP	B-RNAlevels	of	level	NNS	I-NP	Oof	myc	of	IN	B-PP	Omyc	family	myc	NN	B-NP	B-DNAfamily	genes	family	NN	I-NP	I-DNAgenes	","	gene	NNS	I-NP	I-DNA","	c-myc	","	","	O	Oc-myc	and	c-myc	NN	B-NP	B-DNAand	max	and	CC	O	Omax	","	max	NN	B-NP	B-protein","	were	","	","	O	Owere	markedly	be	VBD	B-VP	Omarkedly	reduced	markedly	RB	I-VP	Oreduced	in	reduce	VBN	I-VP	Oin	MG	in	IN	B-PP	OMG	thymuses	MG	NN	B-NP	Othymuses	.	thymus	NNS	I-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	c-myc	that	IN	B-SBAR	Oc-myc	#NAME?	c-myc	NN	B-NP	B-DNA#NAME?	signaling	#NAME?	JJ	I-NP	Osignaling	is	signaling	NN	I-NP	Ois	abnormal	be	VBZ	B-VP	Oabnormal	in	abnormal	JJ	B-ADJP	Oin	MG	in	IN	B-PP	OMG	thymuses	MG	NN	B-NP	Othymuses	.	thymus	NNS	I-NP	O.	The	.	.	O	OThe	levels	The	DT	B-NP	Olevels	of	level	NNS	I-NP	Oof	molecules	of	IN	B-PP	Omolecules	whose	molecule	NNS	B-NP	Owhose	expressions	whose	WP$	B-NP	Oexpressions	are	expression	NNS	I-NP	Oare	associated	be	VBP	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	myc	with	IN	B-PP	Omyc	","	myc	NN	B-NP	B-protein","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	STAM	as	IN	I-PP	OSTAM	","	STAM	NN	B-NP	B-protein","	prothymosin-alpha	","	","	O	Oprothymosin-alpha	","	prothymosin-alpha	NN	B-NP	B-protein","	and	","	","	O	Oand	NFkappaB	and	CC	O	ONFkappaB	Immunohistochemical	NFkappaB	NN	B-NP	B-proteinImmunohistochemical	detection	Immunohistochemical	JJ	B-NP	Odetection	of	detection	NN	I-NP	Oof	interferon-gamma-producing	of	IN	B-PP	Ointerferon-gamma-producing	cells	interferon-gamma-producing	JJ	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	dermatophytosis	in	IN	B-PP	Odermatophytosis	.	dermatophytosis	NN	B-NP	O.	Skin	.	.	O	OSkin	lesions	Skin	NN	B-NP	Olesions	of	lesion	NNS	I-NP	Oof	dermatophytosis	of	IN	B-PP	Odermatophytosis	are	dermatophytosis	NN	B-NP	Oare	thought	be	VBP	B-VP	Othought	to	think	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	a	be	VB	I-VP	Oa	result	a	DT	B-NP	Oresult	of	result	NN	I-NP	Oof	a	of	IN	B-PP	Oa	T	a	DT	B-NP	OT	cell	T	NN	I-NP	Ocell	#NAME?	cell	NN	I-NP	O#NAME?	inflammatory	#NAME?	JJ	I-NP	Oinflammatory	response	inflammatory	JJ	I-NP	Oresponse	that	response	NN	I-NP	Othat	is	that	WDT	B-NP	Ois	mediated	be	VBZ	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	various	by	IN	B-PP	Ovarious	cytokines	various	JJ	B-NP	Ocytokines	.	cytokine	NNS	I-NP	B-protein.	We	.	.	O	OWe	examined	We	PRP	B-NP	Oexamined	whether	examine	VBD	B-VP	Owhether	IFN-gamma-positive	whether	IN	B-SBAR	OIFN-gamma-positive	cells	IFN-gamma-positive	JJ	B-NP	B-cell_linecells	(	cell	NNS	I-NP	I-cell_line(	as	(	(	O	Oas	expression	as	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	Th1	of	IN	B-PP	OTh1	response	Th1	NN	B-NP	Oresponse	)	response	NN	I-NP	O)	were	)	)	O	Owere	present	be	VBD	B-VP	Opresent	in	present	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	skin	the	DT	B-NP	Oskin	lesions	skin	NN	I-NP	Olesions	of	lesion	NNS	I-NP	Oof	dermatophytosis	of	IN	B-PP	Odermatophytosis	in	dermatophytosis	NN	B-NP	Oin	situ	in	FW	B-ADVP	Ositu	by	situ	FW	I-ADVP	Oby	immunohistochemical	by	IN	B-PP	Oimmunohistochemical	techniques	immunohistochemical	JJ	B-NP	Otechniques	.	technique	NNS	I-NP	O.	Mixtures	.	.	O	OMixtures	of	Mixture	NNS	B-NP	Oof	CD4-positive	of	IN	B-PP	OCD4-positive	T	CD4-positive	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	CD8-positive	and	CC	O	OCD8-positive	T	CD8-positive	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	present	be	VB	I-VP	Opresent	in	present	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	dermal	the	DT	B-NP	Odermal	infiltrates	dermal	JJ	I-NP	Oinfiltrates	of	infiltrate	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	lesions	the	DT	B-NP	Olesions	.	lesion	NNS	I-NP	O.	Considerable	.	.	O	OConsiderable	numbers	Considerable	JJ	B-NP	Onumbers	of	number	NNS	I-NP	Oof	CD1a-positive	of	IN	B-PP	OCD1a-positive	cells	CD1a-positive	JJ	B-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	detected	be	VBD	B-VP	Odetected	in	detect	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	upper	the	DT	B-NP	Oupper	dermis	upper	JJ	I-NP	Odermis	and	dermis	NN	I-NP	Oand	epidermis	and	CC	I-NP	Oepidermis	.	epidermis	NN	I-NP	O.	A	.	.	O	OA	marked	A	DT	B-NP	Omarked	accumulation	marked	JJ	I-NP	Oaccumulation	of	accumulation	NN	I-NP	Oof	CD68-positive	of	IN	B-PP	OCD68-positive	cells	CD68-positive	JJ	B-NP	B-cell_linecells	was	cell	NNS	I-NP	I-cell_linewas	found	be	VBD	B-VP	Ofound	in	find	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	upper	the	DT	B-NP	Oupper	dermis	upper	JJ	I-NP	Odermis	.	dermis	NN	I-NP	O.	IFN-gamma-positive	.	.	O	OIFN-gamma-positive	cells	IFN-gamma-positive	JJ	B-NP	B-cell_linecells	were	cell	NNS	I-NP	I-cell_linewere	present	be	VBD	B-VP	Opresent	in	present	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	upper	the	DT	B-NP	Oupper	dermis	upper	JJ	I-NP	Odermis	of	dermis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	lesions	the	DT	B-NP	Olesions	.	lesion	NNS	I-NP	O.	The	.	.	O	OThe	pattern	The	DT	B-NP	Opattern	of	pattern	NN	I-NP	Oof	IFN-gamma	of	IN	B-PP	OIFN-gamma	staining	IFN-gamma	NN	B-NP	B-proteinstaining	appeared	staining	NN	I-NP	Oappeared	to	appear	VBD	B-VP	Oto	be	to	TO	I-VP	Obe	intracellular	be	VB	I-VP	Ointracellular	in	intracellular	JJ	B-ADJP	Oin	mononuclear	in	IN	B-PP	Omononuclear	lymphoid	mononuclear	JJ	B-NP	B-cell_typelymphoid	cells	lymphoid	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	staining	The	DT	B-NP	Ostaining	was	staining	NN	I-NP	Owas	considered	be	VBD	B-VP	Oconsidered	to	consider	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	highly	be	VB	I-VP	Ohighly	specific	highly	RB	B-ADJP	Ospecific	because	specific	JJ	I-ADJP	Obecause	it	because	IN	B-SBAR	Oit	could	it	PRP	B-NP	Ocould	be	could	MD	B-VP	Obe	completely	be	VB	I-VP	Ocompletely	blocked	completely	RB	I-VP	Oblocked	by	block	VBN	I-VP	Oby	preabsorption	by	IN	B-PP	Opreabsorption	with	preabsorption	NN	B-NP	Owith	recombinant	with	IN	B-PP	Orecombinant	IFN-gamma	recombinant	JJ	B-NP	OIFN-gamma	.	IFN-gamma	NN	I-NP	B-protein.	Our	.	.	O	OOur	data	Our	PRP$	B-NP	Odata	support	datum	NNS	I-NP	Osupport	the	support	VBP	B-VP	Othe	hypothesis	the	DT	B-NP	Ohypothesis	that	hypothesis	NN	I-NP	Othat	the	that	IN	B-SBAR	Othe	skin	the	DT	B-NP	Oskin	lesions	skin	NN	I-NP	Olesions	of	lesion	NNS	I-NP	Oof	dermatophytosis	of	IN	B-PP	Odermatophytosis	may	dermatophytosis	NN	B-NP	Omay	be	may	MD	B-VP	Obe	associated	be	VB	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	a	with	IN	B-PP	Oa	Th1	a	DT	B-NP	OTh1	response	Th1	NN	I-NP	Oresponse	.	response	NN	I-NP	O.	Th1	.	.	O	OTh1	response	Th1	NN	B-NP	Oresponse	","	response	NN	I-NP	O","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	characterized	be	VBZ	B-VP	Ocharacterized	by	characterize	VBN	I-VP	Oby	IFN-gamma	by	IN	B-PP	OIFN-gamma	release	IFN-gamma	NN	B-NP	B-proteinrelease	","	release	NN	I-NP	O","	is	","	","	O	Ois	thought	be	VBZ	B-VP	Othought	to	think	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	involved	be	VB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	host	the	DT	B-NP	Ohost	defense	host	NN	I-NP	Odefense	against	defense	NN	I-NP	Oagainst	dermatophytes	against	IN	B-PP	Odermatophytes	and	dermatophyte	NNS	B-NP	Oand	to	and	CC	O	Oto	reflect	to	TO	B-VP	Oreflect	cutaneous	reflect	VB	I-VP	Ocutaneous	reaction	cutaneous	JJ	B-NP	Oreaction	in	reaction	NN	I-NP	Oin	dermatophytosis	in	IN	B-PP	Odermatophytosis	.	dermatophytosis	NN	B-NP	O.	Regulation	.	.	O	ORegulation	of	Regulation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	helix-loop-helix	the	DT	B-NP	Ohelix-loop-helix	proteins	helix-loop-helix	JJ	I-NP	B-proteinproteins	","	protein	NNS	I-NP	I-protein","	E2A	","	","	O	OE2A	and	E2A	NN	B-NP	B-proteinand	Id3	and	CC	I-NP	OId3	","	Id3	NN	I-NP	B-protein","	by	","	","	O	Oby	the	by	IN	B-PP	Othe	Ras	the	DT	B-NP	ORas	-	Ras	NN	I-NP	B-protein-	ERK	-	HYPH	B-NP	OERK	MAPK	ERK	NN	I-NP	B-proteinMAPK	cascade	MAPK	NN	I-NP	I-proteincascade	.	cascade	NN	I-NP	O.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	mitogen-activated	of	IN	B-PP	Omitogen-activated	protein	mitogen-activated	JJ	B-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	MAPK	(	(	O	OMAPK	)	MAPK	NN	B-NP	B-protein)	pathways	)	)	O	Opathways	leads	pathway	NNS	B-NP	Oleads	to	lead	VBZ	B-VP	Oto	cellular	to	TO	B-PP	Ocellular	differentiation	cellular	JJ	B-NP	Odifferentiation	and/or	differentiation	NN	I-NP	Oand/or	proliferation	and/or	CC	O	Oproliferation	in	proliferation	NN	B-NP	Oin	a	in	IN	B-PP	Oa	wide	a	DT	B-NP	Owide	variety	wide	JJ	I-NP	Ovariety	of	variety	NN	I-NP	Oof	cell	of	IN	B-PP	Ocell	types	cell	NN	B-NP	Otypes	","	type	NNS	I-NP	O","	including	","	","	O	Oincluding	developing	include	VBG	B-PP	Odeveloping	thymocytes	develop	VBG	B-NP	Othymocytes	.	thymocyte	NNS	I-NP	B-cell_type.	The	.	.	O	OThe	basic	The	DT	B-NP	Obasic	helix-loop-helix	basic	JJ	I-NP	B-proteinhelix-loop-helix	(	helix-loop-helix	JJ	I-NP	I-protein(	bHLH	(	(	O	I-proteinbHLH	)	bHLH	JJ	B-ADJP	I-protein)	proteins	)	)	O	I-proteinproteins	E12	protein	NNS	B-NP	I-proteinE12	and	E12	NN	I-NP	B-proteinand	E47	and	CC	I-NP	OE47	and	E47	NN	I-NP	B-proteinand	an	and	CC	O	Oan	inhibitor	an	DT	B-NP	Oinhibitor	HLH	inhibitor	NN	I-NP	B-proteinHLH	protein	HLH	NN	I-NP	I-proteinprotein	","	protein	NN	I-NP	I-protein","	Id3	","	","	O	OId3	","	Id3	NN	B-NP	B-protein","	play	","	","	O	Oplay	key	play	VBP	B-VP	Okey	roles	key	JJ	B-NP	Oroles	in	role	NNS	I-NP	Oin	thymocyte	in	IN	B-PP	Othymocyte	differentiation	thymocyte	NN	B-NP	B-cell_typedifferentiation	.	differentiation	NN	I-NP	O.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	here	show	VBP	B-VP	Ohere	that	here	RB	B-ADVP	Othat	E2A	that	IN	B-SBAR	OE2A	DNA	E2A	NN	B-NP	B-proteinDNA	binding	DNA	NN	I-NP	Obinding	is	binding	NN	I-NP	Ois	lowered	be	VBZ	B-VP	Olowered	in	lower	VBN	I-VP	Oin	primary	in	IN	B-PP	Oprimary	immature	primary	JJ	B-NP	B-cell_typeimmature	thymocytes	immature	JJ	I-NP	I-cell_typethymocytes	consequent	thymocyte	NNS	I-NP	I-cell_typeconsequent	to	consequent	JJ	B-ADJP	Oto	T	to	TO	B-PP	OT	cell	T	NN	B-NP	B-proteincell	receptor	cell	NN	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	TCR	(	(	I-NP	OTCR	)	TCR	NN	I-NP	B-protein)	#NAME?	)	)	I-NP	O#NAME?	ligation	#NAME?	JJ	I-NP	Oligation	.	ligation	NN	I-NP	O.	Whereas	.	.	O	OWhereas	expression	Whereas	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	E2A	of	IN	B-PP	OE2A	mRNA	E2A	NN	B-NP	B-RNAmRNA	and	mRNA	NN	I-NP	I-RNAand	protein	and	CC	I-NP	Oprotein	are	protein	NN	I-NP	Oare	unaltered	be	VBP	B-VP	Ounaltered	","	unaltered	JJ	B-ADJP	O","	Id3	","	","	O	OId3	transcripts	Id3	NN	B-NP	B-RNAtranscripts	are	transcript	NNS	I-NP	I-RNAare	rapidly	be	VBP	B-VP	Orapidly	induced	rapidly	RB	I-VP	Oinduced	upon	induce	VBN	I-VP	Oupon	signaling	upon	IN	B-PP	Osignaling	from	signaling	NN	B-NP	Ofrom	the	from	IN	B-PP	Othe	TCR	the	DT	B-NP	OTCR	.	TCR	NN	I-NP	B-protein.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	Id3	of	IN	B-PP	OId3	transcription	Id3	NN	B-NP	B-proteintranscription	is	transcription	NN	I-NP	Ois	regulated	be	VBZ	B-VP	Oregulated	in	regulate	VBN	I-VP	Oin	a	in	IN	B-PP	Oa	dose-dependent	a	DT	B-NP	Odose-dependent	manner	dose-dependent	JJ	I-NP	Omanner	by	manner	NN	I-NP	Oby	the	by	IN	B-PP	Othe	extracellular	the	DT	B-NP	Oextracellular	signal-regulated	extracellular	JJ	I-NP	B-proteinsignal-regulated	kinase	signal-regulated	JJ	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	ERK	(	(	O	OERK	)	ERK	NN	B-NP	B-protein)	MAPK	)	)	O	OMAPK	module	MAPK	NN	B-NP	Omodule	.	module	NN	I-NP	O.	These	.	.	O	OThese	observations	These	DT	B-NP	Oobservations	directly	observation	NNS	I-NP	Odirectly	connect	directly	RB	B-VP	Oconnect	the	connect	VBP	I-VP	Othe	ERK	the	DT	B-NP	OERK	MAPK	ERK	NN	I-NP	B-proteinMAPK	cascade	MAPK	NN	I-NP	I-proteincascade	and	cascade	NN	I-NP	I-proteinand	HLH	and	CC	I-NP	I-proteinHLH	proteins	HLH	NN	I-NP	I-proteinproteins	in	protein	NNS	I-NP	I-proteinin	a	in	IN	B-PP	Oa	linear	a	DT	B-NP	Olinear	pathway	linear	JJ	I-NP	Opathway	.	pathway	NN	I-NP	O.	Retinoic	.	.	O	ORetinoic	acid	Retinoic	JJ	B-NP	Oacid	up-regulates	acid	NN	I-NP	Oup-regulates	myeloid	up-regulate	VBZ	B-VP	Omyeloid	ICAM-3	myeloid	JJ	B-NP	OICAM-3	expression	ICAM-3	NN	I-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	function	and	CC	O	Ofunction	in	function	NN	B-NP	Oin	a	in	IN	B-PP	Oa	cell-specific	a	DT	B-NP	Ocell-specific	fashion	cell-specific	JJ	I-NP	Ofashion	--	fashion	NN	I-NP	O--	evidence	--	:	O	Oevidence	for	evidence	NN	B-NP	Ofor	retinoid	for	IN	B-PP	Oretinoid	signaling	retinoid	NN	B-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	in	pathway	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	mast	the	DT	B-NP	Omast	cell	mast	NN	I-NP	B-cell_typecell	lineage	cell	NN	I-NP	I-cell_typelineage	.	lineage	NN	I-NP	I-cell_type.	Investigation	.	.	O	OInvestigation	of	Investigation	NN	B-NP	Oof	mast	of	IN	B-PP	Omast	cell	mast	NN	B-NP	Ocell	responsiveness	cell	NN	I-NP	Oresponsiveness	toward	responsiveness	NN	I-NP	Otoward	retinoic	toward	IN	B-PP	Oretinoic	acid	retinoic	JJ	B-NP	Oacid	(	acid	NN	I-NP	O(	RA	(	(	O	ORA	)	RA	NN	B-NP	O)	revealed	)	)	O	Orevealed	selective	reveal	VBD	B-VP	Oselective	promotion	selective	JJ	B-NP	Opromotion	of	promotion	NN	I-NP	Oof	ICAM-3	of	IN	B-PP	OICAM-3	expression	ICAM-3	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	the	in	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	mast	human	JJ	I-NP	B-cell_linemast	cell	mast	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	HMC-1	line	NN	I-NP	I-cell_lineHMC-1	.	HMC-1	NN	I-NP	I-cell_line.	This	.	.	O	OThis	process	This	DT	B-NP	Oprocess	was	process	NN	I-NP	Owas	dose-	be	VBD	B-VP	Odose-	and	dose-	NN	B-NP	Oand	time-dependent	and	CC	O	Otime-dependent	and	time-dependent	JJ	B-NP	Oand	detectable	and	CC	I-NP	Odetectable	by	detectable	JJ	I-NP	Oby	flow	by	IN	B-PP	Oflow	cytometry	flow	NN	B-NP	Ocytometry	","	cytometry	NN	I-NP	O","	Western	","	","	O	OWestern	blot	Western	NN	B-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	","	analysis	NN	I-NP	O","	ELISA	","	","	O	OELISA	","	ELISA	NN	B-NP	O","	and	","	","	O	Oand	Northern	and	CC	O	ONorthern	blot	Northern	NN	B-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	.	analysis	NN	I-NP	O.	ICAM-3	.	.	O	OICAM-3	modulation	ICAM-3	NN	B-NP	B-proteinmodulation	was	modulation	NN	I-NP	Owas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	cell-type	be	VB	I-VP	Ocell-type	dependent	cell-type	JJ	B-NP	Odependent	","	dependent	JJ	I-NP	O","	detectable	","	","	I-NP	Odetectable	also	detectable	JJ	I-NP	Oalso	for	also	RB	B-ADVP	Ofor	HL-60	for	IN	B-PP	OHL-60	cells	HL-60	NN	B-NP	B-cell_linecells	and	cell	NNS	I-NP	I-cell_lineand	monocytes	and	CC	O	Omonocytes	but	monocyte	NNS	B-NP	B-cell_typebut	not	but	CC	B-NP	Onot	U-937	not	RB	I-NP	OU-937	and	U-937	NN	B-NP	B-cell_lineand	only	and	CC	O	Oonly	weakly	only	RB	B-ADVP	Oweakly	for	weakly	RB	I-ADVP	Ofor	KU812	for	IN	B-PP	OKU812	cells	KU812	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Terminally	.	.	O	OTerminally	differentiated	Terminally	RB	B-NP	B-cell_typedifferentiated	skin	differentiate	VBN	I-NP	I-cell_typeskin	mast	skin	NN	I-NP	I-cell_typemast	cells	mast	NN	I-NP	I-cell_typecells	also	cell	NNS	I-NP	I-cell_typealso	failed	also	RB	B-ADVP	Ofailed	to	fail	VBD	B-VP	Oto	up-modulate	to	TO	I-VP	Oup-modulate	their	up-modulate	VB	I-VP	Otheir	ICAM-3	their	PRP$	B-NP	OICAM-3	","	ICAM-3	NN	I-NP	B-protein","	suggesting	","	","	O	Osuggesting	the	suggest	VBG	B-VP	Othe	requirement	the	DT	B-NP	Orequirement	for	requirement	NN	I-NP	Ofor	some	for	IN	B-PP	Osome	degree	some	DT	B-NP	Odegree	of	degree	NN	I-NP	Oof	immaturity	of	IN	B-PP	Oimmaturity	for	immaturity	NN	B-NP	Ofor	the	for	IN	B-PP	Othe	process	the	DT	B-NP	Oprocess	.	process	NN	I-NP	O.	RA-mediated	.	.	O	ORA-mediated	effects	RA-mediated	JJ	B-NP	Oeffects	on	effect	NNS	I-NP	Oon	ICAM-1	on	IN	B-PP	OICAM-1	expression	ICAM-1	NN	B-NP	B-proteinexpression	","	expression	NN	I-NP	O","	studied	","	","	O	Ostudied	in	study	VBN	B-VP	Oin	parallel	in	IN	B-PP	Oparallel	","	parallel	NN	B-NP	O","	were	","	","	O	Owere	clearly	be	VBD	B-VP	Oclearly	distinct	clearly	RB	B-ADJP	Odistinct	from	distinct	JJ	I-ADJP	Ofrom	those	from	IN	B-PP	Othose	on	those	DT	B-NP	Oon	ICAM-3	on	IN	B-PP	OICAM-3	.	ICAM-3	NN	B-NP	B-protein.	Investigation	.	.	O	OInvestigation	of	Investigation	NN	B-NP	Oof	retinoid	of	IN	B-PP	Oretinoid	receptor	retinoid	NN	B-NP	B-proteinreceptor	expression	receptor	NN	I-NP	I-proteinexpression	","	expression	NN	I-NP	O","	known	","	","	O	Oknown	to	know	VBN	B-VP	Oto	mediate	to	TO	I-VP	Omediate	intracellular	mediate	VB	I-VP	Ointracellular	RA	intracellular	JJ	B-NP	ORA	signaling	RA	NN	I-NP	Osignaling	","	signaling	NN	I-NP	O","	revealed	","	","	O	Orevealed	presence	reveal	VBD	B-VP	Opresence	of	presence	NN	B-NP	Oof	RAR	of	IN	B-PP	ORAR	alpha	RAR	NN	B-NP	B-proteinalpha	","	alpha	NN	I-NP	I-protein","	RAR	","	","	O	ORAR	gamma	RAR	NN	B-NP	B-proteingamma	","	gamma	NN	I-NP	I-protein","	RXR	","	","	O	ORXR	beta	RXR	NN	B-NP	B-proteinbeta	","	beta	NN	I-NP	I-protein","	and	","	","	O	Oand	RXR	and	CC	O	ORXR	gamma	RXR	NN	B-NP	B-proteingamma	transcripts	gamma	NN	I-NP	Otranscripts	in	transcript	NNS	I-NP	Oin	all	in	IN	B-PP	Oall	cell	all	DT	B-NP	Ocell	lines	cell	NN	I-NP	B-cell_linelines	studied	line	NNS	I-NP	I-cell_linestudied	","	study	VBN	B-VP	O","	and	","	","	O	Oand	HMC-1	and	CC	O	OHMC-1	cells	HMC-1	NN	B-NP	B-cell_linecells	were	cell	NNS	I-NP	I-cell_linewere	the	be	VBD	B-VP	Othe	only	the	DT	B-NP	Oonly	line	only	JJ	I-NP	Oline	lacking	line	NN	I-NP	Olacking	RXR	lack	VBG	B-VP	ORXR	alpha	RXR	NN	B-NP	B-proteinalpha	.	alpha	NN	I-NP	I-protein.	RAR	.	.	O	ORAR	beta	RAR	NN	B-NP	B-proteinbeta	","	beta	SYM	B-NP	I-protein","	not	","	","	O	Onot	expressed	not	RB	B-VP	Oexpressed	at	express	VBN	I-VP	Oat	baseline	at	IN	B-PP	Obaseline	","	baseline	NN	B-NP	O","	was	","	","	O	Owas	induced	be	VBD	B-VP	Oinduced	by	induce	VBN	I-VP	Oby	RA	by	IN	B-PP	ORA	in	RA	NN	B-NP	Oin	a	in	IN	B-PP	Oa	fashion	a	DT	B-NP	Ofashion	obviously	fashion	NN	I-NP	Oobviously	correlating	obviously	RB	B-VP	Ocorrelating	with	correlate	VBG	I-VP	Owith	ICAM-3	with	IN	B-PP	OICAM-3	up-regulation	ICAM-3	NN	B-NP	B-proteinup-regulation	.	up-regulation	NN	I-NP	O.	Increased	.	.	O	OIncreased	ICAM-3	Increase	VBN	B-NP	OICAM-3	expression	ICAM-3	NN	I-NP	B-proteinexpression	was	expression	NN	I-NP	Owas	of	be	VBD	B-VP	Oof	functional	of	IN	B-PP	Ofunctional	significance	functional	JJ	B-NP	Osignificance	","	significance	NN	I-NP	O","	such	","	","	O	Osuch	that	such	JJ	B-ADJP	Othat	processes	that	IN	B-SBAR	Oprocesses	stimulated	process	NNS	B-NP	Ostimulated	or	stimulate	VBN	B-VP	Oor	co-stimulated	or	CC	I-VP	Oco-stimulated	via	co-stimulate	VBN	I-VP	Ovia	ICAM-3	via	IN	B-PP	OICAM-3	(	ICAM-3	NN	B-NP	B-protein(	homotypic	(	(	O	Ohomotypic	aggregation	homotypic	JJ	B-NP	Oaggregation	","	aggregation	NN	I-NP	O","	IL-8	","	","	O	OIL-8	secretion	IL-8	NN	B-NP	B-proteinsecretion	)	secretion	NN	I-NP	O)	were	)	)	O	Owere	clearly	be	VBD	B-VP	Oclearly	enhanced	clearly	RB	I-VP	Oenhanced	upon	enhance	VBN	I-VP	Oupon	RA	upon	IN	B-PP	ORA	pretreatment	RA	NN	B-NP	Opretreatment	","	pretreatment	NN	I-NP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	RA	that	IN	B-SBAR	ORA	may	RA	NN	B-NP	B-proteinmay	contribute	may	MD	B-VP	Ocontribute	via	contribute	VB	I-VP	Ovia	hitherto	via	IN	B-PP	Ohitherto	unrecognized	hitherto	RB	B-NP	Ounrecognized	pathways	unrecognized	JJ	I-NP	Opathways	to	pathway	NNS	I-NP	Oto	immune	to	TO	B-PP	Oimmune	function	immune	JJ	B-NP	Ofunction	and	function	NN	I-NP	Oand	host	and	CC	I-NP	Ohost	defense	host	NN	I-NP	Odefense	.	defense	NN	I-NP	O.	CD28	.	.	O	OCD28	and	CD28	NN	B-NP	B-proteinand	T	and	CC	I-NP	OT	cell	T	NN	I-NP	Ocell	co-stimulation	cell	NN	I-NP	Oco-stimulation	.	co-stimulation	NN	I-NP	O.	Over	.	.	O	OOver	the	Over	IN	B-PP	Othe	last	the	DT	B-NP	Olast	decade	last	JJ	I-NP	Odecade	the	decade	NN	I-NP	Othe	concept	the	DT	B-NP	Oconcept	of	concept	NN	I-NP	Oof	T	of	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	co-stimulation	cell	NN	I-NP	Oco-stimulation	has	co-stimulation	NN	I-NP	Ohas	emerged	have	VBZ	B-VP	Oemerged	to	emerge	VBN	I-VP	Oto	take	to	TO	I-VP	Otake	a	take	VB	I-VP	Oa	central	a	DT	B-NP	Ocentral	role	central	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	process	the	DT	B-NP	Oprocess	of	process	NN	I-NP	Oof	T	of	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	.	activation	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	the	","	","	O	Othe	exact	the	DT	B-NP	Oexact	definition	exact	JJ	I-NP	Odefinition	of	definition	NN	I-NP	Oof	co-stimulation	of	IN	B-PP	Oco-stimulation	is	co-stimulation	NN	B-NP	Ois	still	be	VBZ	B-VP	Ostill	unclear	still	RB	B-ADVP	Ounclear	.	unclear	JJ	B-ADJP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	review	this	DT	B-NP	Oreview	","	review	NN	I-NP	O","	we	","	","	O	Owe	re-examine	we	PRP	B-NP	Ore-examine	the	re-examine	VBP	B-VP	Othe	concept	the	DT	B-NP	Oconcept	of	concept	NN	I-NP	Oof	co-stimulation	of	IN	B-PP	Oco-stimulation	.	co-stimulation	NN	B-NP	O.	We	.	.	O	OWe	suggest	We	PRP	B-NP	Osuggest	that	suggest	VBP	B-VP	Othat	while	that	IN	B-SBAR	Owhile	co-stimulation	while	IN	B-SBAR	Oco-stimulation	is	co-stimulation	NN	B-NP	Ois	important	be	VBZ	B-VP	Oimportant	","	important	JJ	B-ADJP	O","	there	","	","	O	Othere	is	there	EX	B-NP	Ois	little	be	VBZ	B-VP	Olittle	evidence	little	JJ	B-NP	Oevidence	to	evidence	NN	I-NP	Oto	link	to	TO	B-VP	Olink	co-stimulation	link	VB	I-VP	Oco-stimulation	with	co-stimulation	NN	B-NP	Owith	T	with	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	anergy	cell	NN	I-NP	Oanergy	.	anergy	NN	I-NP	O.	We	.	.	O	OWe	then	We	PRP	B-NP	Othen	suggest	then	RB	B-ADVP	Osuggest	a	suggest	VBP	B-VP	Oa	framework	a	DT	B-NP	Oframework	for	framework	NN	I-NP	Ofor	studying	for	IN	B-PP	Ostudying	co-stimulation	study	VBG	B-VP	Oco-stimulation	.	co-stimulation	NN	B-NP	O.	Focusing	.	.	O	OFocusing	on	Focus	VBG	B-VP	Oon	recent	on	IN	B-PP	Orecent	advances	recent	JJ	B-NP	Oadvances	in	advance	NNS	I-NP	Oin	our	in	IN	B-PP	Oour	understanding	our	PRP$	B-NP	Ounderstanding	of	understanding	NN	I-NP	Oof	CD28	of	IN	B-PP	OCD28	","	CD28	NN	B-NP	B-protein","	we	","	","	O	Owe	discuss	we	PRP	B-NP	Odiscuss	four	discuss	VBP	B-VP	Ofour	areas	four	CD	B-NP	Oareas	of	area	NNS	I-NP	Oof	T	of	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	where	activation	NN	I-NP	Owhere	co-stimulation	where	WRB	B-ADVP	Oco-stimulation	may	co-stimulation	NN	B-NP	Omay	play	may	MD	B-VP	Oplay	a	play	VB	I-VP	Oa	role	a	DT	B-NP	Orole	.	role	NN	I-NP	O.	Regulation	.	.	O	ORegulation	of	Regulation	NN	B-NP	Oof	activator	of	IN	B-PP	Oactivator	protein-1	activator	NN	B-NP	B-proteinprotein-1	and	protein-1	NN	I-NP	I-proteinand	NF-kappa	and	CC	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	in	B	NN	I-NP	I-proteinin	CD8+	in	IN	B-PP	OCD8+	T	CD8+	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	exposed	cell	NNS	I-NP	I-cell_typeexposed	to	expose	VBN	B-VP	Oto	peripheral	to	TO	B-PP	Operipheral	self-antigens	peripheral	JJ	B-NP	B-proteinself-antigens	.	self-antigen	NNS	I-NP	I-protein.	The	.	.	O	OThe	transcriptional	The	DT	B-NP	Otranscriptional	events	transcriptional	JJ	I-NP	Oevents	that	event	NNS	I-NP	Othat	control	that	WDT	B-NP	Ocontrol	T	control	VBP	B-VP	OT	cell	T	NN	B-NP	Ocell	tolerance	cell	NN	I-NP	Otolerance	to	tolerance	NN	I-NP	Oto	peripheral	to	TO	B-PP	Operipheral	self	peripheral	JJ	B-NP	B-proteinself	Ags	self	NN	I-NP	I-proteinAgs	are	Ag	NNS	I-NP	I-proteinare	still	be	VBP	B-VP	Ostill	unknown	still	RB	B-ADVP	Ounknown	.	unknown	JJ	B-ADJP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	analyzed	we	PRP	B-NP	Oanalyzed	the	analyze	VBD	B-VP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	AP-1	of	IN	B-PP	OAP-1	-	AP-1	NN	B-NP	B-protein-	and	-	HYPH	B-NP	Oand	NF-kappa	and	CC	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	#NAME?	B	NN	I-NP	I-protein#NAME?	transcription	#NAME?	JJ	I-NP	Otranscription	during	transcription	NN	I-NP	Oduring	in	during	IN	B-PP	Oin	vivo	in	FW	B-NP	Ovivo	induction	vivo	FW	I-NP	Oinduction	of	induction	NN	I-NP	Oof	tolerance	of	IN	B-PP	Otolerance	to	tolerance	NN	B-NP	Oto	a	to	TO	B-PP	Oa	self	a	DT	B-NP	Oself	Ag	self	NN	I-NP	B-proteinAg	expressed	Ag	NN	I-NP	I-proteinexpressed	exclusively	express	VBN	B-VP	Oexclusively	on	exclusively	RB	B-ADVP	Oon	hepatocytes	on	IN	B-PP	Ohepatocytes	.	hepatocyte	NNS	B-NP	B-cell_type.	Naive	.	.	O	ONaive	CD8	Naive	JJ	B-NP	B-cell_typeCD8	(	CD8	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	Desire	)	)	O	I-cell_typeDesire	(	Desire	NN	B-NP	I-cell_type(	Des	(	(	O	I-cell_typeDes	)	De	NNS	B-NP	I-cell_type)	(	)	)	O	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	isolated	cell	NNS	I-NP	I-cell_typeisolated	from	isolate	VBN	B-VP	Ofrom	the	from	IN	B-PP	Othe	Des	the	DT	B-NP	ODes	TCR-transgenic	De	NNPS	I-NP	OTCR-transgenic	mice	TCR-transgenic	JJ	I-NP	Omice	that	mouse	NNS	I-NP	Othat	are	that	WDT	B-NP	Oare	specific	be	VBP	B-VP	Ospecific	for	specific	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	H-2K	the	DT	B-NP	OH-2K	(	H-2K	NN	I-NP	B-protein(	b	(	(	O	I-proteinb	)	b	NN	B-NP	I-protein)	class	)	)	O	I-proteinclass	I	class	NN	B-NP	I-proteinI	Ag	I	CD	I-NP	I-proteinAg	were	Ag	NN	I-NP	I-proteinwere	transferred	be	VBD	B-VP	Otransferred	into	transfer	VBN	I-VP	Ointo	Alb-K	into	IN	B-PP	OAlb-K	(	Alb-K	NN	B-NP	B-protein(	b	(	(	B-LST	Ob	)	b	LS	I-LST	O)	#NAME?	)	)	O	O#NAME?	mice	#NAME?	JJ	B-NP	Omice	that	mouse	NNS	I-NP	Othat	express	that	WDT	B-NP	Oexpress	the	express	VBP	B-VP	Othe	H-2K	the	DT	B-NP	OH-2K	(	H-2K	NN	I-NP	B-protein(	b	(	(	O	I-proteinb	)	b	NN	B-NP	I-protein)	Ag	)	)	O	I-proteinAg	on	Ag	NN	B-NP	I-proteinon	hepatocytes	on	IN	B-PP	Ohepatocytes	only	hepatocyte	NNS	B-NP	B-cell_typeonly	.	only	RB	B-ADVP	O.	Tolerance	.	.	O	OTolerance	develops	Tolerance	NNP	B-NP	Odevelops	in	develop	VBZ	B-VP	Oin	these	in	IN	B-PP	Othese	mice	these	DT	B-NP	Omice	.	mouse	NNS	I-NP	O.	We	.	.	O	OWe	found	We	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	self-reactive	the	DT	B-NP	Oself-reactive	CD8	self-reactive	JJ	I-NP	B-cell_typeCD8	(	CD8	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	Des	)	)	O	I-cell_typeDes	(	De	NNPS	B-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	transiently	be	VBD	B-VP	Otransiently	activated	transiently	RB	I-VP	Oactivated	","	activate	VBN	I-VP	O","	then	","	","	O	Othen	became	then	RB	B-ADVP	Obecame	unresponsive	become	VBD	B-VP	Ounresponsive	and	unresponsive	JJ	B-ADJP	Oand	were	and	CC	O	Owere	further	be	VBD	B-VP	Ofurther	deleted	further	RB	I-VP	Odeleted	.	delete	VBN	I-VP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	to	contrast	NN	B-NP	Oto	CD8	to	TO	B-PP	OCD8	(	CD8	NN	B-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	Des	)	)	O	I-cell_typeDes	(	De	NNPS	B-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	activated	cell	NNS	I-NP	I-cell_typeactivated	in	activate	VBN	B-VP	Oin	vivo	in	FW	B-ADVP	Ovivo	with	vivo	FW	I-ADVP	Owith	APCs	with	IN	B-PP	OAPCs	","	APC	NNS	B-NP	B-cell_type","	which	","	","	O	Owhich	express	which	WDT	B-NP	Oexpress	high	express	VBP	B-VP	Ohigh	AP-1	high	JJ	B-NP	OAP-1	and	AP-1	NN	I-NP	B-proteinand	high	and	CC	O	Ohigh	NF-kappa	high	JJ	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	transcriptional	B	NN	I-NP	I-proteintranscriptional	activity	transcriptional	JJ	I-NP	Oactivity	","	activity	NN	I-NP	O","	the	","	","	O	Othe	unresponsive	the	DT	B-NP	Ounresponsive	CD8	unresponsive	JJ	I-NP	B-cell_typeCD8	(	CD8	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	Des	)	)	O	I-cell_typeDes	(	De	NNPS	B-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	expressed	cell	NNS	I-NP	I-cell_typeexpressed	no	express	VBD	B-VP	Ono	AP-1	no	DT	B-NP	OAP-1	and	AP-1	NN	I-NP	B-proteinand	only	and	CC	O	Oonly	weak	only	RB	B-NP	Oweak	NF-kappa	weak	JJ	I-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	transcriptional	B	NN	I-NP	I-proteintranscriptional	activity	transcriptional	JJ	I-NP	Oactivity	.	activity	NN	I-NP	O.	The	.	.	O	OThe	differences	The	DT	B-NP	Odifferences	in	difference	NNS	I-NP	Oin	NF-kappa	in	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	transcriptional	B	NN	I-NP	I-proteintranscriptional	activity	transcriptional	JJ	I-NP	Oactivity	correlated	activity	NN	I-NP	Ocorrelated	with	correlate	VBD	B-VP	Owith	the	with	IN	B-PP	Othe	generation	the	DT	B-NP	Ogeneration	of	generation	NN	I-NP	Oof	distinct	of	IN	B-PP	Odistinct	NF-kappa	distinct	JJ	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	complexes	B	NN	I-NP	I-proteincomplexes	.	complex	NNS	I-NP	I-protein.	Indeed	.	.	O	OIndeed	","	Indeed	RB	B-ADVP	O","	in	","	","	O	Oin	vivo	in	FW	B-ADVP	Ovivo	primed	vivo	FW	I-ADVP	Oprimed	T	prim	VBN	B-NP	OT	cells	T	NN	I-NP	B-cell_typecells	predominantly	cell	NNS	I-NP	I-cell_typepredominantly	express	predominantly	RB	B-ADVP	Oexpress	p50/p50	express	VBP	B-VP	Op50/p50	and	p50/p50	NN	B-NP	B-proteinand	p65/p50	and	CC	I-NP	Op65/p50	dimers	p65/p50	NN	I-NP	B-proteindimers	","	dimer	NNS	I-NP	I-protein","	whereas	","	","	O	Owhereas	these	whereas	IN	O	Othese	p50-containing	these	DT	B-NP	Op50-containing	complexes	p50-containing	JJ	I-NP	B-proteincomplexes	are	complex	NNS	I-NP	I-proteinare	barely	be	VBP	B-VP	Obarely	detectable	barely	RB	B-ADJP	Odetectable	in	detectable	JJ	I-ADJP	Oin	tolerant	in	IN	B-PP	Otolerant	T	tolerant	JJ	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	that	cell	NNS	I-NP	I-cell_linethat	express	that	WDT	B-NP	Oexpress	p65-	express	VBP	B-VP	Op65-	and	p65-	NN	B-NP	B-proteinand	c-Rel-containing	and	CC	I-NP	I-proteinc-Rel-containing	complexes	c-Rel-containing	NN	I-NP	I-proteincomplexes	.	complex	NNS	I-NP	I-protein.	These	.	.	O	OThese	observations	These	DT	B-NP	Oobservations	suggest	observation	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	fine	that	IN	B-SBAR	Ofine	regulation	fine	JJ	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	complex	B	NN	I-NP	I-proteincomplex	formation	complex	NN	I-NP	I-proteinformation	may	formation	NN	I-NP	Omay	determine	may	MD	B-VP	Odetermine	T	determine	VB	I-VP	OT	cell	T	NN	B-NP	Ocell	fate	cell	NN	I-NP	Ofate	.	fate	NN	I-NP	O.	Transcriptional	.	.	O	OTranscriptional	regulation	Transcriptional	JJ	B-NP	Oregulation	in	regulation	NN	I-NP	Oin	lymphocytes	in	IN	B-PP	Olymphocytes	.	lymphocyte	NNS	B-NP	B-cell_type.	Lymphocytes	.	.	O	OLymphocytes	have	Lymphocyte	NNS	B-NP	B-cell_typehave	been	have	VBP	B-VP	Obeen	used	be	VBN	I-VP	Oused	to	use	VBN	I-VP	Oto	investigate	to	TO	B-VP	Oinvestigate	many	investigate	VB	I-VP	Omany	cellular	many	JJ	B-NP	Ocellular	processes	cellular	JJ	I-NP	Oprocesses	","	process	NNS	I-NP	O","	including	","	","	O	Oincluding	lineage	include	VBG	B-PP	Olineage	commitment	lineage	NN	B-NP	Ocommitment	","	commitment	NN	I-NP	O","	differentiation	","	","	O	Odifferentiation	","	differentiation	NN	B-NP	O","	proliferation	","	","	O	Oproliferation	and	proliferation	NN	B-NP	Oand	apoptosis	and	CC	I-NP	Oapoptosis	.	apoptosis	NN	I-NP	O.	The	.	.	O	OThe	transcription	The	DT	B-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	that	factor	NNS	I-NP	I-proteinthat	mediate	that	WDT	B-NP	Omediate	these	mediate	VBP	B-VP	Othese	processes	these	DT	B-NP	Oprocesses	are	process	NNS	I-NP	Oare	often	be	VBP	B-VP	Ooften	expressed	often	RB	I-VP	Oexpressed	broadly	express	VBN	I-VP	Obroadly	in	broadly	RB	B-ADVP	Oin	many	in	IN	B-PP	Omany	cell	many	JJ	B-NP	Ocell	types	cell	NN	I-NP	Otypes	.	type	NNS	I-NP	O.	The	.	.	O	OThe	emerging	The	DT	B-NP	Oemerging	theme	emerge	VBG	I-NP	Otheme	is	theme	NN	I-NP	Ois	one	be	VBZ	B-VP	Oone	of	one	CD	B-NP	Oof	cell-type-specific	of	IN	B-PP	Ocell-type-specific	regulation	cell-type-specific	JJ	B-NP	Oregulation	","	regulation	NN	I-NP	O","	affecting	","	","	O	Oaffecting	not	affect	VBG	B-VP	Onot	only	not	RB	B-CONJP	Oonly	the	only	RB	I-CONJP	Othe	functional	the	DT	B-NP	Ofunctional	activation	functional	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	but	factor	NNS	I-NP	I-proteinbut	also	but	CC	B-CONJP	Oalso	their	also	RB	I-CONJP	Otheir	access	their	PRP$	B-NP	Oaccess	to	access	NN	I-NP	Oto	appropriate	to	TO	B-PP	Oappropriate	regions	appropriate	JJ	B-NP	Oregions	of	region	NNS	I-NP	Oof	DNA	of	IN	B-PP	ODNA	.	DNA	NN	B-NP	O.	Existence	.	.	O	OExistence	of	Existence	NN	B-NP	Oof	retinoic	of	IN	B-PP	Oretinoic	acid-receptor	retinoic	JJ	B-NP	B-proteinacid-receptor	#NAME?	acid-receptor	NN	I-NP	I-protein#NAME?	retinoid	#NAME?	JJ	I-NP	Oretinoid	X-receptor	retinoid	NN	I-NP	B-proteinX-receptor	#NAME?	X-receptor	NN	I-NP	I-protein#NAME?	pathway	#NAME?	JJ	I-NP	Opathway	in	pathway	NN	I-NP	Oin	myeloid	in	IN	B-PP	Omyeloid	cell	myeloid	JJ	B-NP	B-cell_typecell	function	cell	NN	I-NP	I-cell_typefunction	.	function	NN	I-NP	O.	We	.	.	O	OWe	previously	We	PRP	B-NP	Opreviously	reported	previously	RB	B-ADVP	Oreported	that	report	VBD	B-VP	Othat	ER-27191	that	IN	B-SBAR	OER-27191	(	ER-27191	NN	B-NP	O(	4-	(	(	O	O4-	[	4-	CD	B-NP	O[	4	[	(	O	O4	","	4	CD	B-NP	O","	5	","	","	I-NP	O5	","	5	CD	I-NP	O","	7	","	","	I-NP	O7	","	7	CD	I-NP	O","	8	","	","	I-NP	O8	","	8	CD	I-NP	O","	9	","	","	I-NP	O9	","	9	CD	I-NP	O","	10-hexahydro-7	","	","	I-NP	O10-hexahydro-7	","	10-hexahydro-7	CD	I-NP	O","	7	","	","	I-NP	O7	","	7	CD	I-NP	O","	10	","	","	I-NP	O10	","	10	CD	I-NP	O","	10-tetramethyl-1-	","	","	I-NP	O10-tetramethyl-1-	(	10-tetramethyl-1-	CD	I-NP	O(	3-pyridylmethyl	(	(	O	O3-pyridylmethyl	)	3-pyridylmethyl	NN	B-NP	O)	anthra	)	)	O	Oanthra	[	anthra	NN	B-NP	O[	1	[	(	O	O1	","	1	CD	B-NP	O","	2-b	","	","	O	O2-b	]	2-b	JJ	B-NP	O]	pyrrol-3-yl	]	)	I-NP	Opyrrol-3-yl	]	pyrrol-3-yl	NN	I-NP	O]	benzoic	]	)	I-NP	Obenzoic	acid	benzoic	JJ	I-NP	Oacid	)	acid	NN	I-NP	O)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	potent	a	DT	B-NP	Opotent	antagonist	potent	JJ	I-NP	Oantagonist	of	antagonist	NN	I-NP	Oof	retinoic	of	IN	B-PP	Oretinoic	acid	retinoic	JJ	B-NP	B-proteinacid	receptor	acid	NN	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	RAR	(	(	O	ORAR	)	RAR	NN	B-NP	B-protein)	","	)	)	O	O","	and	","	","	O	Oand	ER-35795	and	CC	O	OER-35795	(	ER-35795	NN	B-NP	B-protein(	(	(	(	O	O(	2E	(	(	O	O2E	","	2E	NN	B-NP	O","	4E	","	","	O	O4E	","	4E	NN	B-NP	O","	6E	","	","	O	O6E	)	6E	NN	B-NP	O)	-7-	)	)	O	O-7-	[	-7-	CD	B-NP	O[	1-	[	(	O	O1-	(	1-	NN	B-NP	O(	1-methylethyl	(	(	O	O1-methylethyl	)	1-methylethyl	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	","	#NAME?	CD	B-NP	O","	2	","	","	I-NP	O2	","	2	CD	I-NP	O","	3	","	","	I-NP	O3	","	3	CD	I-NP	O","	4-tetrahydroquinolin-6-yl	","	","	I-NP	O4-tetrahydroquinolin-6-yl	]	4-tetrahydroquinolin-6-yl	NN	I-NP	O]	#NAME?	]	)	O	O#NAME?	","	#NAME?	CD	B-NP	O","	4	","	","	I-NP	O4	","	4	CD	I-NP	O","	6-nonatrienoic	","	","	O	O6-nonatrienoic	acid	6-nonatrienoic	JJ	B-NP	Oacid	)	acid	NN	I-NP	O)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	novel	a	DT	B-NP	Onovel	retinoid	novel	JJ	I-NP	Oretinoid	X	retinoid	NN	I-NP	B-proteinX	receptor	X	NN	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	RXR	(	(	I-NP	ORXR	)	RXR	NN	I-NP	B-protein)	#NAME?	)	)	I-NP	O#NAME?	agonist	#NAME?	JJ	I-NP	Oagonist	.	agonist	NN	I-NP	O.	By	.	.	O	OBy	using	By	IN	B-PP	Ousing	these	use	VBG	B-VP	Othese	compounds	these	DT	B-NP	Ocompounds	","	compound	NNS	I-NP	O","	we	","	","	O	Owe	investigated	we	PRP	B-NP	Oinvestigated	whether	investigate	VBD	B-VP	Owhether	distinct	whether	IN	B-SBAR	Odistinct	RAR	distinct	JJ	B-NP	ORAR	#NAME?	RAR	NN	I-NP	B-protein#NAME?	and	#NAME?	JJ	B-ADJP	Oand	RXR	and	CC	O	ORXR	#NAME?	RXR	NN	B-NP	B-protein#NAME?	pathways	#NAME?	JJ	I-NP	Opathways	operate	pathway	NNS	I-NP	Ooperate	to	operate	VBP	B-VP	Oto	mediate	to	TO	I-VP	Omediate	the	mediate	VB	I-VP	Othe	diverse	the	DT	B-NP	Odiverse	activities	diverse	JJ	I-NP	Oactivities	of	activity	NNS	I-NP	Oof	retinoids	of	IN	B-PP	Oretinoids	","	retinoid	NNS	B-NP	O","	particularly	","	","	O	Oparticularly	","	particularly	RB	B-ADVP	O","	the	","	","	O	Othe	effects	the	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	RXR	the	DT	B-NP	ORXR	pathway	RXR	NN	I-NP	B-proteinpathway	on	pathway	NN	I-NP	Oon	cellular	on	IN	B-PP	Ocellular	function	cellular	JJ	B-NP	Ofunction	.	function	NN	I-NP	O.	ER-27191	.	.	O	OER-27191	completely	ER-27191	NN	B-NP	Ocompletely	antagonized	completely	RB	B-ADVP	Oantagonized	HL60	antagonize	VBD	B-VP	OHL60	cell	HL60	NN	B-NP	Ocell	differentiation	cell	NN	I-NP	Odifferentiation	induced	differentiation	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	all-trans-retinoic	by	IN	B-PP	Oall-trans-retinoic	acid	all-trans-retinoic	JJ	B-NP	Oacid	(	acid	NN	I-NP	O(	atRA	(	(	O	OatRA	)	atRA	NN	B-NP	O)	.	)	)	O	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	the	","	","	O	Othe	differentiation	the	DT	B-NP	Odifferentiation	induced	differentiation	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	ER-35795	the	DT	B-NP	OER-35795	was	ER-35795	NN	I-NP	B-proteinwas	not	be	VBD	B-VP	Onot	antagonized	not	RB	I-VP	Oantagonized	at	antagonize	VBN	I-VP	Oat	all	at	IN	B-ADVP	Oall	by	all	DT	I-ADVP	Oby	the	by	IN	B-PP	Othe	RAR	the	DT	B-NP	ORAR	antagonist	RAR	NN	I-NP	B-proteinantagonist	","	antagonist	NN	I-NP	O","	but	","	","	O	Obut	was	but	CC	O	Owas	inhibited	be	VBD	B-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	an	by	IN	B-PP	Oan	RXR	an	DT	B-NP	ORXR	homodimer	RXR	NN	I-NP	B-proteinhomodimer	antagonist	homodimer	NN	I-NP	Oantagonist	(	antagonist	NN	I-NP	O(	LGD100754	(	(	O	OLGD100754	","	LGD100754	NN	B-NP	O","	(	","	","	O	O(	2E	(	(	O	O2E	","	2E	NN	B-NP	O","	4E	","	","	O	O4E	","	4E	NN	B-NP	O","	6Z	","	","	O	O6Z	)	6Z	NN	B-NP	O)	-7-	)	)	O	O-7-	(	-7-	CD	B-NP	O(	3-n-propoxy-5	(	(	O	O3-n-propoxy-5	","	3-n-propoxy-5	CD	B-NP	O","	6	","	","	I-NP	O6	","	6	CD	I-NP	O","	7	","	","	I-NP	O7	","	7	CD	I-NP	O","	8-tetrahydro-5	","	","	I-NP	O8-tetrahydro-5	","	8-tetrahydro-5	CD	I-NP	O","	5	","	","	I-NP	O5	","	5	CD	I-NP	O","	8	","	","	I-NP	O8	","	8	CD	I-NP	O","	8-tetramethylnaphthalen-2-yl	","	","	I-NP	O8-tetramethylnaphthalen-2-yl	)	8-tetramethylnaphthalen-2-yl	NN	I-NP	O)	#NAME?	)	)	O	O#NAME?	","	#NAME?	CD	B-NP	O","	4	","	","	I-NP	O4	","	4	CD	I-NP	O","	6-trienoic	","	","	O	O6-trienoic	acid	6-trienoic	JJ	B-NP	Oacid	)	acid	NN	I-NP	O)	.	)	)	O	O.	Its	.	.	O	OIts	agonistic	Its	PRP$	B-NP	Oagonistic	action	agonistic	JJ	I-NP	Oaction	on	action	NN	I-NP	Oon	RXR/RAR	on	IN	B-PP	ORXR/RAR	heterodimer	RXR/RAR	NN	B-NP	B-proteinheterodimer	","	heterodimer	NN	I-NP	I-protein","	on	","	","	O	Oon	the	on	IN	B-PP	Othe	other	the	DT	B-NP	Oother	hand	other	JJ	I-NP	Ohand	","	hand	NN	I-NP	O","	was	","	","	O	Owas	neutralized	be	VBD	B-VP	Oneutralized	by	neutralize	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	RAR	the	DT	B-NP	ORAR	antagonist	RAR	NN	I-NP	B-proteinantagonist	.	antagonist	NN	I-NP	O.	During	.	.	O	ODuring	HL60	During	IN	B-PP	OHL60	cell	HL60	NN	B-NP	B-cell_linecell	differentiation	cell	NN	I-NP	I-cell_linedifferentiation	","	differentiation	NN	I-NP	O","	atRA	","	","	O	OatRA	induced	atRA	NN	B-NP	Oinduced	RARbeta	induce	VBD	B-VP	ORARbeta	mRNA	RARbeta	NN	B-NP	B-RNAmRNA	","	mRNA	NN	I-NP	I-RNA","	while	","	","	O	Owhile	the	while	IN	B-SBAR	Othe	RXR	the	DT	B-NP	ORXR	had	RXR	NN	I-NP	B-proteinhad	no	have	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	.	effect	NN	I-NP	O.	Interestingly	.	.	O	OInterestingly	","	Interestingly	RB	B-ADVP	O","	a	","	","	O	Oa	functional	a	DT	B-NP	Ofunctional	RXR	functional	JJ	I-NP	ORXR	#NAME?	RXR	NN	I-NP	B-protein#NAME?	was	#NAME?	NN	I-NP	Owas	also	be	VBD	B-VP	Oalso	seen	also	RB	I-VP	Oseen	in	see	VBN	I-VP	Oin	lipopolysaccharide-induced	in	IN	B-PP	Olipopolysaccharide-induced	inhibition	lipopolysaccharide-induced	JJ	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	mouse	of	IN	B-PP	Omouse	splenocyte	mouse	NN	B-NP	B-cell_typesplenocyte	proliferation	splenocyte	NN	I-NP	I-cell_typeproliferation	.	proliferation	NN	I-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	strongly	result	NNS	I-NP	Ostrongly	suggest	strongly	RB	B-VP	Osuggest	the	suggest	VBP	I-VP	Othe	existence	the	DT	B-NP	Oexistence	of	existence	NN	I-NP	Oof	a	of	IN	B-PP	Oa	pharmacological	a	DT	B-NP	Opharmacological	RXR	pharmacological	JJ	I-NP	ORXR	#NAME?	RXR	NN	I-NP	B-protein#NAME?	pathway	#NAME?	JJ	I-NP	Opathway	that	pathway	NN	I-NP	Othat	is	that	WDT	B-NP	Ois	activated	be	VBZ	B-VP	Oactivated	by	activate	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	ligand	a	DT	B-NP	Oligand	that	ligand	NN	I-NP	Othat	can	that	WDT	B-NP	Ocan	bind	can	MD	B-VP	Obind	to	bind	VB	I-VP	Oto	RXR	to	TO	B-PP	ORXR	.	RXR	NN	B-NP	B-protein.	Targeting	.	.	O	OTargeting	Src	Target	VBG	B-VP	OSrc	homology	Src	NN	B-NP	B-proteinhomology	2	homology	NN	I-NP	I-protein2	domain-containing	2	CD	I-NP	I-proteindomain-containing	tyrosine	domain-containing	JJ	I-NP	I-proteintyrosine	phosphatase	tyrosine	NN	I-NP	I-proteinphosphatase	(	phosphatase	NN	I-NP	I-protein(	SHP-1	(	(	O	OSHP-1	)	SHP-1	NN	B-NP	B-protein)	into	)	)	O	Ointo	lipid	into	IN	B-PP	Olipid	rafts	lipid	NN	B-NP	Orafts	inhibits	raft	NNS	I-NP	Oinhibits	CD3	inhibit	VBZ	B-VP	OCD3	#NAME?	CD3	NN	B-NP	B-protein#NAME?	T	#NAME?	JJ	I-NP	OT	cell	T	NN	I-NP	Ocell	activation	cell	NN	I-NP	Oactivation	.	activation	NN	I-NP	O.	To	.	.	O	OTo	study	To	TO	B-VP	Ostudy	the	study	VB	I-VP	Othe	mechanism	the	DT	B-NP	Omechanism	by	mechanism	NN	I-NP	Oby	which	by	IN	B-PP	Owhich	protein	which	WDT	B-NP	Oprotein	tyrosine	protein	NN	B-NP	B-proteintyrosine	phosphatases	tyrosine	NN	I-NP	I-proteinphosphatases	(	phosphatas	NNS	I-NP	I-protein(	PTPs	(	(	O	OPTPs	)	PTP	NNS	B-NP	B-protein)	regulate	)	)	O	Oregulate	CD3	regulate	VBP	B-VP	OCD3	#NAME?	CD3	NN	B-NP	B-protein#NAME?	tyrosine	#NAME?	JJ	I-NP	Otyrosine	phosphorylation	tyrosine	NN	I-NP	Ophosphorylation	","	phosphorylation	NN	I-NP	O","	we	","	","	O	Owe	investigated	we	PRP	B-NP	Oinvestigated	the	investigate	VBD	B-VP	Othe	distribution	the	DT	B-NP	Odistribution	of	distribution	NN	I-NP	Oof	PTPs	of	IN	B-PP	OPTPs	in	PTP	NNS	B-NP	B-proteinin	subdomains	in	IN	B-PP	Osubdomains	of	subdomain	NNS	B-NP	Oof	plasma	of	IN	B-PP	Oplasma	membrane	plasma	NN	B-NP	Omembrane	.	membrane	NN	I-NP	O.	We	.	.	O	OWe	report	We	PRP	B-NP	Oreport	here	report	VBP	B-VP	Ohere	that	here	RB	B-ADVP	Othat	the	that	IN	B-SBAR	Othe	bulk	the	DT	B-NP	Obulk	PTP	bulk	NN	I-NP	OPTP	activity	PTP	NN	I-NP	Oactivity	associated	activity	NN	I-NP	Oassociated	with	associate	VBN	B-VP	Owith	T	with	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	membrane	cell	NN	I-NP	Omembrane	is	membrane	NN	I-NP	Ois	present	be	VBZ	B-VP	Opresent	outside	present	JJ	B-ADJP	Ooutside	the	outside	IN	B-PP	Othe	lipid	the	DT	B-NP	Olipid	rafts	lipid	NN	I-NP	Orafts	","	raft	NNS	I-NP	O","	as	","	","	O	Oas	determined	as	IN	B-SBAR	Odetermined	by	determine	VBN	B-VP	Oby	sucrose	by	IN	B-PP	Osucrose	density	sucrose	NN	B-NP	Odensity	gradient	density	NN	I-NP	Ogradient	sedimentation	gradient	NN	I-NP	Osedimentation	.	sedimentation	NN	I-NP	O.	In	.	.	O	OIn	Jurkat	In	IN	B-PP	OJurkat	T	Jurkat	NN	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	approximately	","	","	O	Oapproximately	5	approximately	RB	B-NP	O5	--	5	CD	I-NP	O--	10	--	HYPH	I-NP	O10	%	10	CD	I-NP	O%	of	%	NN	I-NP	Oof	Src	of	IN	B-PP	OSrc	homology	Src	NN	B-NP	B-proteinhomology	2	homology	NN	I-NP	I-protein2	domain-containing	2	CD	I-NP	I-proteindomain-containing	tyrosine	domain-containing	JJ	I-NP	I-proteintyrosine	phosphatase	tyrosine	NN	I-NP	I-proteinphosphatase	(	phosphatase	NN	I-NP	I-protein(	SHP-1	(	(	O	OSHP-1	)	SHP-1	NN	B-NP	B-protein)	is	)	)	O	Ois	constitutively	be	VBZ	B-VP	Oconstitutively	associated	constitutively	RB	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	plasma	with	IN	B-PP	Oplasma	membrane	plasma	NN	B-NP	Omembrane	","	membrane	NN	I-NP	O","	and	","	","	O	Oand	nearly	and	CC	O	Onearly	50	nearly	RB	B-NP	O50	%	50	CD	I-NP	O%	of	%	NN	I-NP	Oof	SHP-2	of	IN	B-PP	OSHP-2	is	SHP-2	NN	B-NP	B-proteinis	translocated	be	VBZ	B-VP	Otranslocated	to	translocate	VBN	I-VP	Oto	plasma	to	TO	B-PP	Oplasma	membrane	plasma	NN	B-NP	Omembrane	after	membrane	NN	I-NP	Oafter	vanadate	after	IN	B-PP	Ovanadate	treatment	vanadate	NN	B-NP	Otreatment	.	treatment	NN	I-NP	O.	Similar	.	.	O	OSimilar	to	Similar	JJ	B-ADJP	Oto	transmembrane	to	TO	B-PP	Otransmembrane	PTP	transmembrane	JJ	B-NP	B-proteinPTP	","	PTP	NN	I-NP	I-protein","	CD45	","	","	O	OCD45	","	CD45	NN	B-NP	B-protein","	the	","	","	O	Othe	membrane-associated	the	DT	B-NP	Omembrane-associated	populations	membrane-associated	JJ	I-NP	B-cell_typepopulations	of	population	NNS	I-NP	I-cell_typeof	SHP-1	of	IN	B-PP	OSHP-1	and	SHP-1	NN	B-NP	B-proteinand	SHP-2	and	CC	I-NP	OSHP-2	are	SHP-2	NN	I-NP	B-proteinare	essentially	be	VBP	B-VP	Oessentially	excluded	essentially	RB	I-VP	Oexcluded	from	exclude	VBN	I-VP	Ofrom	lipid	from	IN	B-PP	Olipid	rafts	lipid	NN	B-NP	Orafts	","	raft	NNS	I-NP	O","	where	","	","	O	Owhere	other	where	WRB	B-ADVP	Oother	signaling	other	JJ	B-NP	Osignaling	molecules	signal	VBG	I-NP	B-proteinmolecules	such	molecule	NNS	I-NP	I-proteinsuch	as	such	JJ	B-PP	Oas	Lck	as	IN	I-PP	OLck	","	Lck	NN	B-NP	B-protein","	linker	","	","	O	Olinker	for	linker	NN	B-NP	Ofor	activation	for	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	T	of	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	CD3	and	CC	O	OCD3	zeta	CD3	NN	B-NP	B-proteinzeta	are	zeta	NN	I-NP	I-proteinare	enriched	be	VBP	B-VP	Oenriched	.	enrich	VBN	I-VP	O.	We	.	.	O	OWe	further	We	PRP	B-NP	Ofurther	demonstrated	further	RB	B-ADVP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	CD3	that	IN	B-SBAR	OCD3	#NAME?	CD3	NN	B-NP	B-protein#NAME?	tyrosine	#NAME?	JJ	I-NP	Otyrosine	phosphorylation	tyrosine	NN	I-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	these	of	IN	B-PP	Othese	substrates	these	DT	B-NP	Osubstrates	is	substrate	NNS	I-NP	Ois	largely	be	VBZ	B-VP	Olargely	restricted	largely	RB	B-ADJP	Orestricted	to	restricted	JJ	I-ADJP	Oto	lipid	to	TO	B-PP	Olipid	rafts	lipid	NN	B-NP	Orafts	","	raft	NNS	I-NP	O","	unless	","	","	O	Ounless	PTPs	unless	IN	B-SBAR	OPTPs	are	PTP	NNS	B-NP	B-proteinare	inhibited	be	VBP	B-VP	Oinhibited	.	inhibit	VBN	I-VP	O.	It	.	.	O	OIt	suggests	It	PRP	B-NP	Osuggests	that	suggest	VBZ	B-VP	Othat	a	that	IN	B-SBAR	Oa	restricted	a	DT	B-NP	Orestricted	partition	restricted	JJ	I-NP	Opartition	of	partition	NN	I-NP	Oof	PTPs	of	IN	B-PP	OPTPs	among	PTP	NNS	B-NP	B-proteinamong	membrane	among	IN	B-PP	Omembrane	subdomains	membrane	NN	B-NP	B-proteinsubdomains	may	subdomain	NNS	I-NP	I-proteinmay	regulate	may	MD	B-VP	Oregulate	protein	regulate	VB	I-VP	Oprotein	tyrosine	protein	NN	B-NP	Otyrosine	phosphorylation	tyrosine	NN	I-NP	Ophosphorylation	in	phosphorylation	NN	I-NP	Oin	T	in	IN	B-PP	OT	cell	T	NN	B-NP	B-cell_typecell	membrane	cell	NN	I-NP	I-cell_typemembrane	.	membrane	NN	I-NP	O.	To	.	.	O	OTo	test	To	TO	B-VP	Otest	this	test	VB	I-VP	Othis	hypothesis	this	DT	B-NP	Ohypothesis	","	hypothesis	NN	I-NP	O","	we	","	","	O	Owe	targeted	we	PRP	B-NP	Otargeted	SHP-1	target	VBD	B-VP	OSHP-1	into	SHP-1	NN	B-NP	B-proteininto	lipid	into	IN	B-PP	Olipid	rafts	lipid	NN	B-NP	Orafts	by	raft	NNS	I-NP	Oby	using	by	IN	B-PP	Ousing	the	use	VBG	B-VP	Othe	N-terminal	the	DT	B-NP	ON-terminal	region	N-terminal	JJ	I-NP	B-proteinregion	of	region	NN	I-NP	I-proteinof	Lck	of	IN	B-PP	OLck	(	Lck	NN	B-NP	B-protein(	residues	(	(	O	Oresidues	1	residue	NNS	B-NP	O1	--	1	CD	I-NP	O--	14	--	HYPH	I-NP	O14	)	14	CD	I-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	results	The	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	Lck/SHP-1	of	IN	B-PP	OLck/SHP-1	chimera	Lck/SHP-1	NN	B-NP	B-proteinchimera	inside	chimera	NN	I-NP	I-proteininside	lipid	inside	IN	B-PP	Olipid	rafts	lipid	NN	B-NP	Orafts	profoundly	raft	NNS	I-NP	Oprofoundly	inhibits	profoundly	RB	B-ADVP	Oinhibits	CD3	inhibit	VBZ	B-VP	OCD3	#NAME?	CD3	NN	B-NP	B-protein#NAME?	tyrosine	#NAME?	JJ	I-NP	Otyrosine	phosphorylation	tyrosine	NN	I-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	CD3	of	IN	B-PP	OCD3	zeta/epsilon	CD3	NN	B-NP	B-proteinzeta/epsilon	","	zeta/epsilon	NN	I-NP	O","	IL-2	","	","	O	OIL-2	generation	IL-2	NN	B-NP	B-proteingeneration	","	generation	NN	I-NP	O","	and	","	","	O	Oand	nuclear	and	CC	O	Onuclear	mobilization	nuclear	JJ	B-NP	Omobilization	of	mobilization	NN	I-NP	Oof	NF-AT	of	IN	B-PP	ONF-AT	.	NF-AT	NN	B-NP	B-protein.	Collectively	.	.	O	OCollectively	","	Collectively	RB	B-ADVP	O","	these	","	","	O	Othese	results	these	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	exclusion	the	DT	B-NP	Oexclusion	of	exclusion	NN	I-NP	Oof	PTPs	of	IN	B-PP	OPTPs	from	PTP	NNS	B-NP	B-proteinfrom	lipid	from	IN	B-PP	Olipid	rafts	lipid	NN	B-NP	Orafts	may	raft	NNS	I-NP	Omay	be	may	MD	B-VP	Obe	a	be	VB	I-VP	Oa	mechanism	a	DT	B-NP	Omechanism	that	mechanism	NN	I-NP	Othat	potentiates	that	WDT	B-NP	Opotentiates	TCR	potentiate	VBZ	B-VP	OTCR	/	TCR	NN	B-NP	B-protein/	CD3	/	SYM	O	OCD3	activation	CD3	NN	B-NP	B-proteinactivation	An	activation	NN	I-NP	OAn	instructive	An	DT	B-NP	Oinstructive	component	instructive	JJ	I-NP	Ocomponent	in	component	NN	I-NP	Oin	T	in	IN	B-PP	OT	helper	T	NN	B-NP	Ohelper	cell	helper	NN	I-NP	Ocell	type	cell	NN	I-NP	Otype	2	type	NN	I-NP	O2	(	2	CD	I-NP	O(	Th2	(	(	O	OTh2	)	Th2	NN	B-NP	O)	development	)	)	O	Odevelopment	mediated	development	NN	B-NP	Omediated	by	mediate	VBN	B-VP	Oby	GATA-3	by	IN	B-PP	OGATA-3	.	GATA-3	NN	B-NP	B-protein.	Although	.	.	O	OAlthough	interleukin	Although	IN	B-SBAR	Ointerleukin	(	interleukin	NN	B-NP	B-protein(	IL	(	(	O	I-proteinIL	)	IL	NN	B-NP	I-protein)	-12	)	)	O	I-protein-12	and	-12	CD	B-NP	I-proteinand	IL-4	and	CC	O	OIL-4	polarize	IL-4	NN	B-NP	B-proteinpolarize	naive	polarize	VBP	B-VP	Onaive	CD4	naive	JJ	B-NP	B-cell_typeCD4	(	CD4	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	toward	cell	NNS	I-NP	I-cell_typetoward	T	toward	IN	B-PP	OT	helper	T	NN	B-NP	Ohelper	cell	helper	NN	I-NP	Ocell	type	cell	NN	I-NP	Otype	1	type	NN	I-NP	O1	(	1	CD	I-NP	O(	Th1	(	(	O	OTh1	)	Th1	NN	B-NP	O)	or	)	)	O	Oor	Th2	or	CC	O	OTh2	phenotypes	Th2	NN	B-NP	B-cell_typephenotypes	","	phenotype	NNS	I-NP	I-cell_type","	it	","	","	O	Oit	is	it	PRP	B-NP	Ois	not	be	VBZ	B-VP	Onot	known	not	RB	I-VP	Oknown	whether	know	VBN	I-VP	Owhether	cytokines	whether	IN	B-SBAR	Ocytokines	instruct	cytokine	NNS	B-NP	B-proteininstruct	the	instruct	VBP	B-VP	Othe	developmental	the	DT	B-NP	Odevelopmental	fate	developmental	JJ	I-NP	Ofate	in	fate	NN	I-NP	Oin	uncommitted	in	IN	B-PP	Ouncommitted	progenitors	uncommitted	JJ	B-NP	B-cell_typeprogenitors	or	progenitor	NNS	I-NP	I-cell_typeor	select	or	CC	O	Oselect	for	select	VB	B-VP	Ofor	outgrowth	for	IN	B-PP	Ooutgrowth	of	outgrowth	NN	B-NP	Oof	cells	of	IN	B-PP	Ocells	that	cell	NNS	B-NP	Othat	have	that	WDT	B-NP	Ohave	stochastically	have	VBP	B-VP	Ostochastically	committed	stochastically	RB	I-VP	Ocommitted	to	commit	VBN	I-VP	Oto	a	to	TO	B-PP	Oa	particular	a	DT	B-NP	Oparticular	fate	particular	JJ	I-NP	Ofate	.	fate	NN	I-NP	O.	To	.	.	O	OTo	distinguish	To	TO	B-VP	Odistinguish	these	distinguish	VB	I-VP	Othese	instructive	these	DT	B-NP	Oinstructive	and	instructive	JJ	I-NP	Oand	selective	and	CC	I-NP	Oselective	models	selective	JJ	I-NP	Omodels	","	model	NNS	I-NP	O","	we	","	","	O	Owe	used	we	PRP	B-NP	Oused	surface	use	VBD	B-VP	Osurface	affinity	surface	NN	B-NP	Oaffinity	matrix	affinity	NN	I-NP	Omatrix	technology	matrix	NN	I-NP	Otechnology	to	technology	NN	I-NP	Oto	isolate	to	TO	B-VP	Oisolate	committed	isolate	VB	I-VP	Ocommitted	progenitors	committed	JJ	B-NP	B-cell_typeprogenitors	based	progenitor	NNS	I-NP	I-cell_typebased	on	base	VBN	B-VP	Oon	cytokine	on	IN	B-PP	Ocytokine	secretion	cytokine	NN	B-NP	B-proteinsecretion	phenotype	secretion	NN	I-NP	Ophenotype	and	phenotype	NN	I-NP	Oand	developed	and	CC	O	Odeveloped	retroviral-based	develop	VBD	B-VP	Oretroviral-based	tagging	retroviral-based	JJ	B-NP	Otagging	approaches	tag	VBG	I-NP	Oapproaches	to	approach	NNS	I-NP	Oto	directly	to	TO	B-VP	Odirectly	monitor	directly	RB	I-VP	Omonitor	individual	monitor	VB	I-VP	Oindividual	progenitor	individual	JJ	B-NP	Oprogenitor	fate	progenitor	NN	I-NP	Ofate	decisions	fate	NN	I-NP	Odecisions	at	decision	NNS	I-NP	Oat	the	at	IN	B-PP	Othe	clonal	the	DT	B-NP	Oclonal	and	clonal	JJ	I-NP	Oand	population	and	CC	I-NP	Opopulation	levels	population	NN	I-NP	Olevels	.	level	NNS	I-NP	O.	We	.	.	O	OWe	observe	We	PRP	B-NP	Oobserve	IL-4	observe	VBP	B-VP	OIL-4	#NAME?	IL-4	NN	B-NP	B-protein#NAME?	redirection	#NAME?	JJ	I-NP	Oredirection	of	redirection	NN	I-NP	Oof	phenotype	of	IN	B-PP	Ophenotype	in	phenotype	NN	B-NP	Oin	cells	in	IN	B-PP	Ocells	that	cell	NNS	B-NP	Othat	have	that	WDT	B-NP	Ohave	already	have	VBP	B-VP	Oalready	committed	already	RB	I-VP	Ocommitted	to	commit	VBN	I-VP	Oto	a	to	TO	B-PP	Oa	non-IL-4-producing	a	DT	B-NP	Onon-IL-4-producing	fate	non-IL-4-producing	JJ	I-NP	Ofate	","	fate	NN	I-NP	O","	inconsistent	","	","	O	Oinconsistent	with	inconsistent	JJ	B-ADJP	Owith	predictions	with	IN	B-PP	Opredictions	of	prediction	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	selective	the	DT	B-NP	Oselective	model	selective	JJ	I-NP	Omodel	.	model	NN	I-NP	O.	Further	.	.	O	OFurther	","	Further	RB	B-ADVP	O","	retroviral	","	","	O	Oretroviral	tagging	retroviral	JJ	B-NP	Otagging	of	tagging	NN	I-NP	Oof	naive	of	IN	B-PP	Onaive	progenitors	naive	JJ	B-NP	B-cell_typeprogenitors	with	progenitor	NNS	I-NP	I-cell_typewith	the	with	IN	B-PP	Othe	Th2-specific	the	DT	B-NP	OTh2-specific	transcription	Th2-specific	JJ	I-NP	B-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	GATA-3	factor	NN	I-NP	I-proteinGATA-3	provided	GATA-3	NN	I-NP	B-proteinprovided	direct	provide	VBD	B-VP	Odirect	evidence	direct	JJ	B-NP	Oevidence	for	evidence	NN	I-NP	Ofor	instructive	for	IN	B-PP	Oinstructive	differentiation	instructive	JJ	B-NP	Odifferentiation	","	differentiation	NN	I-NP	O","	and	","	","	O	Oand	no	and	CC	O	Ono	evidence	no	DT	B-NP	Oevidence	for	evidence	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	selective	the	DT	B-NP	Oselective	outgrowth	selective	JJ	I-NP	Ooutgrowth	of	outgrowth	NN	I-NP	Oof	cells	of	IN	B-PP	Ocells	committed	cell	NNS	B-NP	Ocommitted	to	commit	VBN	B-VP	Oto	either	to	TO	B-PP	Oeither	the	either	CC	O	Othe	Th1	the	DT	B-NP	OTh1	or	Th1	NN	I-NP	B-cell_typeor	Th2	or	CC	I-NP	OTh2	fate	Th2	NN	I-NP	Ofate	.	fate	NN	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	would	datum	NNS	I-NP	Owould	seem	would	MD	B-VP	Oseem	to	seem	VB	I-VP	Oto	exclude	to	TO	I-VP	Oexclude	selection	exclude	VB	I-VP	Oselection	as	selection	NN	B-NP	Oas	an	as	IN	B-PP	Oan	exclusive	an	DT	B-NP	Oexclusive	mechanism	exclusive	JJ	I-NP	Omechanism	in	mechanism	NN	I-NP	Oin	Th1	in	IN	B-PP	OTh1	/	Th1	NN	B-NP	B-cell_type/	Th2	/	SYM	B-NP	OTh2	differentiation	Th2	NN	I-NP	Odifferentiation	","	differentiation	NN	I-NP	O","	and	","	","	O	Oand	support	and	CC	O	Osupport	an	support	VBP	B-VP	Oan	instructive	an	DT	B-NP	Oinstructive	model	instructive	JJ	I-NP	Omodel	of	model	NN	I-NP	Oof	cytokine-driven	of	IN	B-PP	Ocytokine-driven	transcriptional	cytokine-driven	JJ	B-NP	Otranscriptional	programming	transcriptional	JJ	I-NP	Oprogramming	of	programming	NN	I-NP	Oof	cell	of	IN	B-PP	Ocell	fate	cell	NN	B-NP	Ofate	decisions	fate	NN	I-NP	Odecisions	.	decision	NNS	I-NP	O.	In	.	.	O	OIn	vitro-activated	In	IN	B-PP	Ovitro-activated	human	vitro-activated	JJ	B-NP	B-cell_linehuman	lupus	human	JJ	I-NP	I-cell_linelupus	T	lupus	NN	I-NP	I-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	express	cell	NNS	I-NP	I-cell_lineexpress	normal	express	VBP	B-VP	Onormal	estrogen	normal	JJ	B-NP	Oestrogen	receptor	estrogen	NN	I-NP	B-proteinreceptor	proteins	receptor	NN	I-NP	I-proteinproteins	which	protein	NNS	I-NP	I-proteinwhich	bind	which	WDT	B-NP	Obind	to	bind	VBP	B-VP	Oto	the	to	TO	B-PP	Othe	estrogen	the	DT	B-NP	Oestrogen	response	estrogen	NN	I-NP	B-DNAresponse	element	response	NN	I-NP	I-DNAelement	.	element	NN	I-NP	I-DNA.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	shown	have	VBP	B-VP	Oshown	that	show	VBN	I-VP	Othat	estrogen	that	IN	B-SBAR	Oestrogen	receptor	estrogen	NN	B-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	ERalpha	(	(	O	OERalpha	","	ERalpha	NN	B-NP	B-protein","	ERbeta	","	","	O	OERbeta	)	ERbeta	NN	B-NP	B-protein)	transcripts	)	)	O	Otranscripts	are	transcript	NNS	B-NP	Oare	expressed	be	VBP	B-VP	Oexpressed	in	express	VBN	I-VP	Oin	SLE	in	IN	B-PP	OSLE	and	SLE	NN	B-NP	Oand	normal	and	CC	I-NP	Onormal	T	normal	JJ	I-NP	OT	cells	T	NN	I-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	T	","	","	O	OT	cell	T	NN	B-NP	Ocell	nuclear	cell	NN	I-NP	Onuclear	extracts	nuclear	JJ	I-NP	Oextracts	from	extract	NNS	I-NP	Ofrom	female	from	IN	B-PP	Ofemale	lupus	female	JJ	B-NP	Olupus	patients	lupus	NN	I-NP	Opatients	and	patient	NNS	I-NP	Oand	normal	and	CC	O	Onormal	donors	normal	JJ	B-NP	Odonors	were	donor	NNS	I-NP	Owere	tested	be	VBD	B-VP	Otested	for	test	VBN	I-VP	Ofor	biologically	for	IN	B-PP	Obiologically	active	biologically	RB	B-NP	Oactive	ER	active	JJ	I-NP	OER	proteins	ER	NN	I-NP	B-proteinproteins	capable	protein	NNS	I-NP	I-proteincapable	of	capable	JJ	B-ADJP	Oof	binding	of	IN	B-PP	Obinding	to	bind	VBG	B-VP	Oto	the	to	TO	B-PP	Othe	human	the	DT	B-NP	Ohuman	estrogen	human	JJ	I-NP	B-DNAestrogen	response	estrogen	NN	I-NP	I-DNAresponse	element	response	NN	I-NP	I-DNAelement	(	element	NN	I-NP	I-DNA(	hERE	(	(	O	OhERE	)	hERE	NN	B-NP	O)	by	)	)	O	Oby	electrophoretic	by	IN	B-PP	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assays	shift	NN	I-NP	Oassays	.	assay	NNS	I-NP	O.	When	.	.	O	OWhen	peripheral	When	WRB	B-ADVP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	T	blood	NN	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	stimulated	be	VBD	B-VP	Ostimulated	with	stimulate	VBN	I-VP	Owith	17beta-estradiol	with	IN	B-PP	O17beta-estradiol	(	17beta-estradiol	NN	B-NP	O(	E2	(	(	O	OE2	)	E2	NN	B-NP	B-protein)	","	)	)	O	O","	PMA	","	","	O	OPMA	and	PMA	NN	B-NP	Oand	ionomycin	and	CC	O	Oionomycin	","	ionomycin	NN	B-NP	O","	two	","	","	O	Otwo	major	two	CD	B-NP	Omajor	retarded	major	JJ	I-NP	Oretarded	bands	retard	VBN	I-NP	Obands	in	band	NNS	I-NP	Oin	T	in	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	nuclear	cell	NN	I-NP	Onuclear	extracts	nuclear	JJ	I-NP	Oextracts	exhibited	extract	NNS	I-NP	Oexhibited	a	exhibit	VBD	B-VP	Oa	migration	a	DT	B-NP	Omigration	pattern	migration	NN	I-NP	Opattern	similar	pattern	NN	I-NP	Osimilar	to	similar	JJ	B-ADJP	Oto	slow	to	TO	B-VP	Oslow	migrating	slow	VB	I-VP	Omigrating	protein-ERE	migrate	VBG	I-VP	Oprotein-ERE	complexes	protein-ERE	JJ	B-NP	B-proteincomplexes	in	complex	NNS	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	breast	human	JJ	B-NP	B-cell_typebreast	cancer	breast	NN	I-NP	I-cell_typecancer	cell	cancer	NN	I-NP	I-cell_typecell	extracts	cell	NN	I-NP	I-cell_typeextracts	.	extract	NNS	I-NP	O.	T	.	.	O	OT	cells	T	NN	B-NP	B-cell_typecells	cultured	cell	NNS	I-NP	I-cell_typecultured	only	culture	VBN	B-VP	Oonly	with	only	RB	B-ADVP	Owith	E2	with	IN	B-PP	OE2	did	E2	NN	B-NP	B-proteindid	not	do	VBD	B-VP	Onot	have	not	RB	I-VP	Ohave	these	have	VB	I-VP	Othese	complexes	these	DT	B-NP	Ocomplexes	.	complex	NNS	I-NP	O.	The	.	.	O	OThe	formation	The	DT	B-NP	Oformation	of	formation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	complexes	the	DT	B-NP	Ocomplexes	was	complex	NNS	I-NP	Owas	inhibited	be	VBD	B-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	competition	by	IN	B-PP	Ocompetition	with	competition	NN	B-NP	Owith	the	with	IN	B-PP	Othe	hERE	the	DT	B-NP	OhERE	cold	hERE	NN	I-NP	Ocold	oligonucleotide	cold	JJ	I-NP	Ooligonucleotide	and	oligonucleotide	NN	I-NP	Oand	partially	and	CC	O	Opartially	with	partially	RB	B-ADVP	Owith	anti-ERalpha	with	IN	B-PP	Oanti-ERalpha	antibodies	anti-ERalpha	JJ	B-NP	B-proteinantibodies	.	antibody	NNS	I-NP	I-protein.	There	.	.	O	OThere	was	There	EX	B-NP	Owas	no	be	VBD	B-VP	Ono	notable	no	DT	B-NP	Onotable	difference	notable	JJ	I-NP	Odifference	in	difference	NN	I-NP	Oin	the	in	IN	B-PP	Othe	migration	the	DT	B-NP	Omigration	pattern	migration	NN	I-NP	Opattern	of	pattern	NN	I-NP	Oof	ERE-binding	of	IN	B-PP	OERE-binding	proteins	ERE-binding	JJ	B-NP	B-proteinproteins	between	protein	NNS	I-NP	I-proteinbetween	the	between	IN	B-PP	Othe	SLE	the	DT	B-NP	OSLE	and	SLE	NN	I-NP	Oand	normal	and	CC	I-NP	Onormal	T	normal	JJ	I-NP	OT	cell	T	NN	I-NP	Ocell	extracts	cell	NN	I-NP	Oextracts	.	extract	NNS	I-NP	O.	Together	.	.	O	OTogether	","	Together	RB	B-ADVP	O","	these	","	","	O	Othese	results	these	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	activated	that	IN	B-SBAR	Oactivated	human	activate	VBN	B-NP	Ohuman	T	human	JJ	I-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	whether	","	","	O	Owhether	lupus-derived	whether	IN	B-SBAR	Olupus-derived	or	lupus-derived	JJ	B-ADJP	Oor	normal-derived	or	CC	I-ADJP	Onormal-derived	","	normal-derived	JJ	I-ADJP	O","	contain	","	","	O	Ocontain	biologically	contain	VBP	B-VP	Obiologically	active	biologically	RB	B-NP	Oactive	ERalpha	active	JJ	I-NP	OERalpha	proteins	ERalpha	NN	I-NP	B-proteinproteins	.	protein	NNS	I-NP	I-protein.	Other	.	.	O	OOther	factors	Other	JJ	B-NP	Ofactors	may	factor	NNS	I-NP	Omay	be	may	MD	B-VP	Obe	responsible	be	VB	I-VP	Oresponsible	for	responsible	JJ	B-ADJP	Ofor	differential	for	IN	B-PP	Odifferential	sensitivity	differential	JJ	B-NP	Osensitivity	of	sensitivity	NN	I-NP	Oof	lupus	of	IN	B-PP	Olupus	T	lupus	NN	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	estrogen	to	TO	B-PP	Oestrogen	.	estrogen	NN	B-NP	O.	Mechanism	.	.	O	OMechanism	of	Mechanism	NN	B-NP	Oof	the	of	IN	B-PP	Othe	inhibitory	the	DT	B-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	protease	of	IN	B-PP	Oprotease	inhibitor	protease	NN	B-NP	B-proteininhibitor	on	inhibitor	NN	I-NP	Oon	tumor	on	IN	B-PP	Otumor	necrosis	tumor	NN	B-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	alpha	factor	NN	I-NP	I-proteinalpha	production	alpha	NN	I-NP	I-proteinproduction	of	production	NN	I-NP	Oof	monocytes	of	IN	B-PP	Omonocytes	.	monocyte	NNS	B-NP	B-cell_type.	If	.	.	O	OIf	the	If	IN	B-SBAR	Othe	inflammatory	the	DT	B-NP	Oinflammatory	response	inflammatory	JJ	I-NP	Oresponse	becomes	response	NN	I-NP	Obecomes	excessive	become	VBZ	B-VP	Oexcessive	or	excessive	JJ	B-NP	Oor	uncontrolled	or	CC	I-NP	Ouncontrolled	by	uncontrolled	JJ	I-NP	Oby	some	by	IN	B-PP	Osome	stimuli	some	DT	B-NP	Ostimuli	","	stimulus	NNS	I-NP	O","	inappropriate	","	","	O	Oinappropriate	inflammatory	inappropriate	JJ	B-NP	Oinflammatory	responses	inflammatory	JJ	I-NP	Oresponses	occur	response	NNS	I-NP	Ooccur	.	occur	VBP	B-VP	O.	Monocytes	.	.	O	OMonocytes	are	Monocyte	NNS	B-NP	B-cell_typeare	extremely	be	VBP	B-VP	Oextremely	important	extremely	RB	B-NP	Oimportant	cells	important	JJ	I-NP	Ocells	for	cell	NNS	I-NP	Ofor	regulating	for	IN	B-PP	Oregulating	the	regulate	VBG	B-VP	Othe	cytokine	the	DT	B-NP	Ocytokine	network	cytokine	NN	I-NP	B-proteinnetwork	and	network	NN	I-NP	Oand	tumor	and	CC	O	Otumor	necrosis	tumor	NN	B-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	alpha	factor	NN	I-NP	I-proteinalpha	(	alpha	NN	I-NP	I-protein(	TNFalpha	(	(	O	OTNFalpha	)	TNFalpha	NN	B-NP	B-protein)	and	)	)	O	Oand	interleukin-	and	CC	O	Ointerleukin-	(	interleukin-	NN	B-NP	B-protein(	IL	(	(	O	I-proteinIL	)	IL	NN	B-NP	I-protein)	10	)	)	O	I-protein10	","	10	CD	B-NP	I-protein","	which	","	","	O	Owhich	are	which	WDT	B-NP	Oare	mainly	be	VBP	B-VP	Omainly	synthesized	mainly	RB	I-VP	Osynthesized	by	synthesize	VBN	I-VP	Oby	monocytes	by	IN	B-PP	Omonocytes	","	monocyte	NNS	B-NP	B-cell_type","	are	","	","	O	Oare	representative	be	VBP	B-VP	Orepresentative	cytokines	representative	JJ	B-NP	Ocytokines	that	cytokine	NNS	I-NP	B-proteinthat	play	that	WDT	B-NP	Oplay	a	play	VBP	B-VP	Oa	central	a	DT	B-NP	Ocentral	role	central	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	cytokine	the	DT	B-NP	Ocytokine	network	cytokine	NN	I-NP	B-proteinnetwork	.	network	NN	I-NP	I-protein.	Protease	.	.	O	OProtease	inhibitors	Protease	NN	B-NP	Oinhibitors	such	inhibitor	NNS	I-NP	Osuch	as	such	JJ	B-PP	Oas	gabexate	as	IN	I-PP	Ogabexate	mesilate	gabexate	NN	B-NP	Omesilate	(	mesilate	NN	I-NP	O(	GM	(	(	O	OGM	)	GM	NN	B-NP	O)	and	)	)	O	Oand	ulinastatin	and	CC	O	Oulinastatin	(	ulinastatin	NN	B-NP	O(	UTI	(	(	O	OUTI	)	UTI	NN	B-NP	O)	have	)	)	O	Ohave	been	have	VBP	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	have	to	TO	I-VP	Ohave	various	have	VB	I-VP	Ovarious	beneficial	various	JJ	B-NP	Obeneficial	effects	beneficial	JJ	I-NP	Oeffects	by	effect	NNS	I-NP	Oby	inhibiting	by	IN	B-PP	Oinhibiting	the	inhibit	VBG	B-VP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	leukocytes	of	IN	B-PP	Oleukocytes	","	leukocyte	NNS	B-NP	B-cell_type","	but	","	","	O	Obut	the	but	CC	O	Othe	mechanism	the	DT	B-NP	Omechanism	for	mechanism	NN	I-NP	Ofor	this	for	IN	B-PP	Othis	has	this	DT	B-NP	Ohas	yet	have	VBZ	B-VP	Oyet	to	yet	RB	I-VP	Oto	be	to	TO	I-VP	Obe	fully	be	VB	I-VP	Ofully	elucidated	fully	RB	I-VP	Oelucidated	.	elucidate	VBN	I-VP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	we	study	NN	I-NP	Owe	investigated	we	PRP	B-NP	Oinvestigated	the	investigate	VBD	B-VP	Othe	mechanism	the	DT	B-NP	Omechanism	of	mechanism	NN	I-NP	Oof	the	of	IN	B-PP	Othe	inhibitory	the	DT	B-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	protease	of	IN	B-PP	Oprotease	inhibitors	protease	NN	B-NP	Oinhibitors	on	inhibitor	NNS	I-NP	Oon	the	on	IN	B-PP	Othe	proinflammatory	the	DT	B-NP	Oproinflammatory	cytokine	proinflammatory	JJ	I-NP	B-proteincytokine	production	cytokine	NN	I-NP	I-proteinproduction	of	production	NN	I-NP	Oof	lipopolysaccharide-	of	IN	B-PP	Olipopolysaccharide-	(	lipopolysaccharide-	NN	B-NP	B-cell_line(	LPS	(	(	O	I-cell_lineLPS	)	LPS	NN	B-NP	I-cell_line)	stimulated	)	)	O	I-cell_linestimulated	monocytes	stimulate	VBN	B-NP	I-cell_linemonocytes	.	monocyte	NNS	I-NP	I-cell_line.	LPS-stimulated	.	.	O	OLPS-stimulated	monocytes	LPS-stimulated	JJ	B-NP	B-cell_linemonocytes	were	monocyte	NNS	I-NP	I-cell_linewere	treated	be	VBD	B-VP	Otreated	with	treat	VBN	I-VP	Owith	GM	with	IN	B-PP	OGM	or	GM	NNP	B-NP	Oor	UTI	or	CC	I-NP	OUTI	.	UTI	NNP	I-NP	O.	The	.	.	O	OThe	value	The	DT	B-NP	Ovalue	of	value	NN	I-NP	Oof	TNFalpha	of	IN	B-PP	OTNFalpha	and	TNFalpha	NN	B-NP	B-proteinand	IL-10	and	CC	I-NP	OIL-10	in	IL-10	NN	I-NP	B-proteinin	the	in	IN	B-PP	Othe	culture	the	DT	B-NP	Oculture	medium	culture	NN	I-NP	Omedium	of	medium	NN	I-NP	Oof	monocytes	of	IN	B-PP	Omonocytes	was	monocyte	NNS	B-NP	B-cell_typewas	measured	be	VBD	B-VP	Omeasured	and	measure	VBN	I-VP	Oand	each	and	CC	O	Oeach	mRNA	each	DT	B-NP	OmRNA	expression	mRNA	NN	I-NP	B-RNAexpression	was	expression	NN	I-NP	Owas	assayed	be	VBD	B-VP	Oassayed	.	assay	VBN	I-VP	O.	The	.	.	O	OThe	inhibitory	The	DT	B-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	protease	of	IN	B-PP	Oprotease	inhibitors	protease	NN	B-NP	Oinhibitors	on	inhibitor	NNS	I-NP	Oon	the	on	IN	B-PP	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	intracellular	of	IN	B-PP	Ointracellular	signal	intracellular	JJ	B-NP	Osignal	transduction	signal	NN	I-NP	Otransduction	pathways	transduction	NN	I-NP	Opathways	such	pathway	NNS	I-NP	Osuch	as	such	JJ	B-PP	Oas	protein	as	IN	I-PP	Oprotein	kinase	protein	NN	B-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	(	C	NN	I-NP	I-protein(	PKC	(	(	O	OPKC	)	PKC	NN	B-NP	B-protein)	and	)	)	O	Oand	nuclear	and	CC	O	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	kappa	factor	NN	I-NP	I-proteinkappa	B	kappa	NN	I-NP	I-proteinB	(	B	NN	I-NP	I-protein(	NFkappaB	(	(	O	ONFkappaB	)	NFkappaB	NN	B-NP	B-protein)	were	)	)	O	Owere	also	be	VBD	B-VP	Oalso	evaluated	also	RB	I-VP	Oevaluated	.	evaluate	VBN	I-VP	O.	GM	.	.	O	OGM	decreased	GM	NNP	B-NP	Odecreased	the	decrease	VBD	B-VP	Othe	TNFalpha	the	DT	B-NP	OTNFalpha	production	TNFalpha	NN	I-NP	B-proteinproduction	of	production	NN	I-NP	Oof	LPS-stimulated	of	IN	B-PP	OLPS-stimulated	monocytes	LPS-stimulated	JJ	B-NP	B-cell_linemonocytes	as	monocyte	NNS	I-NP	I-cell_lineas	shown	as	IN	B-SBAR	Oshown	by	show	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	inhibition	the	DT	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	mRNA	of	IN	B-PP	OmRNA	expression	mRNA	NN	B-NP	B-RNAexpression	and	expression	NN	I-NP	Oand	increased	and	CC	O	Oincreased	the	increase	VBD	B-VP	Othe	IL-10	the	DT	B-NP	OIL-10	production	IL-10	NN	I-NP	B-proteinproduction	of	production	NN	I-NP	Oof	LPS-stimulated	of	IN	B-PP	OLPS-stimulated	monocytes	LPS-stimulated	JJ	B-NP	B-cell_linemonocytes	.	monocyte	NNS	I-NP	I-cell_line.	GM	.	.	O	OGM	also	GM	NNP	B-NP	Oalso	suppressed	also	RB	B-ADVP	Osuppressed	the	suppress	VBD	B-VP	Othe	NFkappaB	the	DT	B-NP	ONFkappaB	activity	NFkappaB	NN	I-NP	B-proteinactivity	of	activity	NN	I-NP	Oof	LPS-stimulated	of	IN	B-PP	OLPS-stimulated	monocytes	LPS-stimulated	JJ	B-NP	B-cell_linemonocytes	.	monocyte	NNS	I-NP	I-cell_line.	UTI	.	.	O	OUTI	decreased	UTI	NN	B-NP	Odecreased	the	decrease	VBD	B-VP	Othe	TNFalpha	the	DT	B-NP	OTNFalpha	production	TNFalpha	NN	I-NP	B-proteinproduction	of	production	NN	I-NP	Oof	LPS-stimulated	of	IN	B-PP	OLPS-stimulated	monocytes	LPS-stimulated	JJ	B-NP	B-cell_linemonocytes	","	monocyte	NNS	I-NP	I-cell_line","	but	","	","	O	Obut	did	but	CC	O	Odid	not	do	VBD	B-VP	Onot	inhibit	not	RB	I-VP	Oinhibit	the	inhibit	VB	I-VP	Othe	TNFalpha	the	DT	B-NP	OTNFalpha	mRNA	TNFalpha	NN	I-NP	B-RNAmRNA	expression	mRNA	NN	I-NP	I-RNAexpression	.	expression	NN	I-NP	O.	The	.	.	O	OThe	present	The	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	shows	study	NN	I-NP	Oshows	that	show	VBZ	B-VP	Othat	the	that	IN	B-SBAR	Othe	inhibitory	the	DT	B-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	GM	of	IN	B-PP	OGM	on	GM	NNP	B-NP	Oon	the	on	IN	B-PP	Othe	TNFalpha	the	DT	B-NP	OTNFalpha	production	TNFalpha	NN	I-NP	B-proteinproduction	of	production	NN	I-NP	Oof	activated	of	IN	B-PP	Oactivated	human	activate	VBN	B-NP	B-cell_typehuman	monocytes	human	JJ	I-NP	I-cell_typemonocytes	is	monocyte	NNS	I-NP	I-cell_typeis	mediated	be	VBZ	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	suppression	the	DT	B-NP	Osuppression	of	suppression	NN	I-NP	Oof	NFkappaB	of	IN	B-PP	ONFkappaB	activation	NFkappaB	NN	B-NP	B-proteinactivation	","	activation	NN	I-NP	O","	while	","	","	O	Owhile	the	while	IN	B-SBAR	Othe	mechanism	the	DT	B-NP	Omechanism	of	mechanism	NN	I-NP	Oof	UTI	of	IN	B-PP	OUTI	inhibiting	UTI	NN	B-NP	B-DNAinhibiting	TNFalpha	inhibit	VBG	B-VP	OTNFalpha	production	TNFalpha	NN	B-NP	B-proteinproduction	of	production	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	monocytes	human	JJ	B-NP	B-cell_typemonocytes	may	monocyte	NNS	I-NP	I-cell_typemay	be	may	MD	B-VP	Obe	due	be	VB	I-VP	Odue	to	due	JJ	B-ADVP	Oto	the	to	TO	B-PP	Othe	inhibition	the	DT	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	either	of	IN	B-PP	Oeither	the	either	CC	O	Othe	translation	the	DT	B-NP	Otranslation	or	translation	NN	I-NP	Oor	secretion	or	CC	I-NP	Osecretion	of	secretion	NN	I-NP	Oof	TNFalpha	of	IN	B-PP	OTNFalpha	.	TNFalpha	NN	B-NP	B-protein.	Homocysteine	.	.	O	OHomocysteine	stimulates	Homocysteine	NN	B-NP	Ostimulates	the	stimulate	VBZ	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	monocyte	of	IN	B-PP	Omonocyte	chemoattractant	monocyte	NN	B-NP	B-proteinchemoattractant	protein-1	chemoattractant	NN	I-NP	I-proteinprotein-1	in	protein-1	NN	I-NP	I-proteinin	endothelial	in	IN	B-PP	Oendothelial	cells	endothelial	JJ	B-NP	B-cell_typecells	leading	cell	NNS	I-NP	I-cell_typeleading	to	lead	VBG	B-VP	Oto	enhanced	to	TO	B-PP	Oenhanced	monocyte	enhance	VBN	B-NP	Omonocyte	chemotaxis	monocyte	NN	I-NP	Ochemotaxis	.	chemotaxis	NN	I-NP	O.	Hyperhomocysteinemia	.	.	O	OHyperhomocysteinemia	has	Hyperhomocysteinemia	NN	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	identified	be	VBN	I-VP	Oidentified	as	identify	VBN	I-VP	Oas	an	as	IN	B-PP	Oan	independent	an	DT	B-NP	Oindependent	risk	independent	JJ	I-NP	Orisk	factor	risk	NN	I-NP	Ofactor	for	factor	NN	I-NP	Ofor	atherosclerosis	for	IN	B-PP	Oatherosclerosis	.	atherosclerosis	NN	B-NP	O.	The	.	.	O	OThe	infiltration	The	DT	B-NP	Oinfiltration	of	infiltration	NN	I-NP	Oof	monocytes	of	IN	B-PP	Omonocytes	into	monocyte	NNS	B-NP	B-cell_typeinto	the	into	IN	B-PP	Othe	arterial	the	DT	B-NP	Oarterial	wall	arterial	JJ	I-NP	Owall	is	wall	NN	I-NP	Ois	one	be	VBZ	B-VP	Oone	of	one	CD	B-NP	Oof	the	of	IN	B-PP	Othe	key	the	DT	B-NP	Okey	events	key	JJ	I-NP	Oevents	during	event	NNS	I-NP	Oduring	atherogenesis	during	IN	B-PP	Oatherogenesis	.	atherogenesis	NN	B-NP	O.	Monocyte	.	.	O	OMonocyte	chemoattractant	Monocyte	NN	B-NP	B-proteinchemoattractant	protein-1	chemoattractant	NN	I-NP	I-proteinprotein-1	(	protein-1	NN	I-NP	I-protein(	MCP-1	(	(	O	OMCP-1	)	MCP-1	NN	B-NP	B-protein)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	potent	a	DT	B-NP	Opotent	chemokine	potent	JJ	I-NP	Ochemokine	that	chemokine	NN	I-NP	B-proteinthat	stimulates	that	WDT	B-NP	Ostimulates	the	stimulate	VBZ	B-VP	Othe	migration	the	DT	B-NP	Omigration	of	migration	NN	I-NP	Oof	monocytes	of	IN	B-PP	Omonocytes	into	monocyte	NNS	B-NP	B-cell_typeinto	the	into	IN	B-PP	Othe	intima	the	DT	B-NP	Ointima	of	intima	NN	I-NP	Oof	the	of	IN	B-PP	Othe	arterial	the	DT	B-NP	Oarterial	wall	arterial	JJ	I-NP	Owall	.	wall	NN	I-NP	O.	The	.	.	O	OThe	mechanism	The	DT	B-NP	Omechanism	by	mechanism	NN	I-NP	Oby	which	by	IN	B-PP	Owhich	increased	which	WDT	B-NP	Oincreased	monocyte	increase	VBD	B-VP	Omonocyte	infiltration	monocyte	NN	B-NP	Oinfiltration	occurs	infiltration	NN	I-NP	Ooccurs	in	occur	VBZ	B-VP	Oin	atherosclerotic	in	IN	B-PP	Oatherosclerotic	lesions	atherosclerotic	JJ	B-NP	Olesions	in	lesion	NNS	I-NP	Oin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	hyperhomocysteinemia	with	IN	B-PP	Ohyperhomocysteinemia	has	hyperhomocysteinemia	NN	B-NP	Ohas	not	have	VBZ	B-VP	Onot	been	not	RB	I-VP	Obeen	delineated	be	VBN	I-VP	Odelineated	.	delineate	VBN	I-VP	O.	The	.	.	O	OThe	objective	The	DT	B-NP	Oobjective	of	objective	NN	I-NP	Oof	the	of	IN	B-PP	Othe	present	the	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	was	study	NN	I-NP	Owas	to	be	VBD	B-VP	Oto	investigate	to	TO	B-VP	Oinvestigate	the	investigate	VB	I-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	homocysteine	of	IN	B-PP	Ohomocysteine	on	homocysteine	NN	B-NP	Oon	MCP-1	on	IN	B-PP	OMCP-1	production	MCP-1	NN	B-NP	B-proteinproduction	in	production	NN	I-NP	Oin	endothelial	in	IN	B-PP	Oendothelial	cells	endothelial	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Cells	.	.	O	OCells	were	Cell	NNS	B-NP	Owere	incubated	be	VBD	B-VP	Oincubated	with	incubate	VBN	I-VP	Owith	homocysteine	with	IN	B-PP	Ohomocysteine	.	homocysteine	NN	B-NP	O.	The	.	.	O	OThe	secretion	The	DT	B-NP	Osecretion	of	secretion	NN	I-NP	Oof	MCP-1	of	IN	B-PP	OMCP-1	protein	MCP-1	NN	B-NP	B-proteinprotein	was	protein	NN	I-NP	I-proteinwas	significantly	be	VBD	B-VP	Osignificantly	increased	significantly	RB	I-VP	Oincreased	(	increase	VBN	I-VP	O(	195	(	(	O	O195	%	195	CD	B-NP	O%	as	%	NN	I-NP	Oas	compared	as	IN	B-SBAR	Ocompared	to	compare	VBN	B-PP	Oto	the	to	TO	B-PP	Othe	control	the	DT	B-NP	Ocontrol	)	control	NN	I-NP	O)	in	)	)	O	Oin	cells	in	IN	B-PP	Ocells	treated	cell	NNS	B-NP	Otreated	with	treat	VBN	B-VP	Owith	pathological	with	IN	B-PP	Opathological	concentrations	pathological	JJ	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	homocysteine	of	IN	B-PP	Ohomocysteine	.	homocysteine	NN	B-NP	O.	Such	.	.	O	OSuch	effect	Such	JJ	B-NP	Oeffect	was	effect	NN	I-NP	Owas	accompanied	be	VBD	B-VP	Oaccompanied	by	accompany	VBN	I-VP	Oby	an	by	IN	B-PP	Oan	increased	an	DT	B-NP	Oincreased	expression	increase	VBN	I-NP	Oexpression	of	expression	NN	I-NP	Oof	MCP-1	of	IN	B-PP	OMCP-1	mRNA	MCP-1	NN	B-NP	B-RNAmRNA	(	mRNA	NN	I-NP	I-RNA(	176	(	(	O	O176	%	176	CD	B-NP	O%	as	%	NN	I-NP	Oas	compared	as	IN	B-SBAR	Ocompared	to	compare	VBN	B-PP	Oto	the	to	TO	B-PP	Othe	control	the	DT	B-NP	Ocontrol	)	control	NN	I-NP	O)	in	)	)	O	Oin	endothelial	in	IN	B-PP	Oendothelial	cells	endothelial	JJ	B-NP	B-cell_typecells	which	cell	NNS	I-NP	I-cell_typewhich	resulted	which	WDT	B-NP	Oresulted	in	result	VBD	B-VP	Oin	enhanced	in	IN	B-PP	Oenhanced	monocyte	enhance	VBN	B-NP	Omonocyte	chemotaxis	monocyte	NN	I-NP	Ochemotaxis	.	chemotaxis	NN	I-NP	O.	The	.	.	O	OThe	p38	The	DT	B-NP	Op38	MAP	p38	NN	I-NP	B-proteinMAP	kinase	MAP	NN	I-NP	I-proteinkinase	as	kinase	NN	I-NP	I-proteinas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	other	as	IN	I-CONJP	Oother	members	other	JJ	B-NP	Omembers	of	member	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	p38	the	DT	B-NP	Op38	MAP	p38	NN	I-NP	B-proteinMAP	kinase	MAP	NN	I-NP	I-proteinkinase	pathway	kinase	NN	I-NP	I-proteinpathway	","	pathway	NN	I-NP	O","	including	","	","	O	Oincluding	MKK3	include	VBG	B-PP	OMKK3	","	MKK3	NN	B-NP	B-protein","	MKK6	","	","	I-NP	OMKK6	","	MKK6	NN	I-NP	B-protein","	ATF-2	","	","	I-NP	OATF-2	and	ATF-2	NN	I-NP	B-proteinand	Elk-1	and	CC	I-NP	OElk-1	","	Elk-1	NN	I-NP	B-protein","	were	","	","	O	Owere	activated	be	VBD	B-VP	Oactivated	in	activate	VBN	I-VP	Oin	homocysteine-treated	in	IN	B-PP	Ohomocysteine-treated	cells	homocysteine-treated	JJ	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Homocysteine-induced	.	.	O	OHomocysteine-induced	MCP-1	Homocysteine-induced	JJ	B-NP	OMCP-1	expression	MCP-1	NN	I-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	subsequent	and	CC	O	Osubsequent	monocyte	subsequent	JJ	B-NP	Omonocyte	chemotaxis	monocyte	NN	I-NP	Ochemotaxis	were	chemotaxis	NN	I-NP	Owere	blocked	be	VBD	B-VP	Oblocked	by	block	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	p38	a	DT	B-NP	Op38	MAP	p38	NN	I-NP	OMAP	kinase	MAP	NN	I-NP	Okinase	inhibitor	kinase	NN	I-NP	Oinhibitor	(	inhibitor	NN	I-NP	O(	SB203580	(	(	O	OSB203580	)	SB203580	NN	B-NP	O)	suggesting	)	)	O	Osuggesting	that	suggest	VBG	B-VP	Othat	the	that	IN	B-SBAR	Othe	p38	the	DT	B-NP	Op38	MAP	p38	NN	I-NP	B-proteinMAP	kinase	MAP	NN	I-NP	I-proteinkinase	pathway	kinase	NN	I-NP	I-proteinpathway	might	pathway	NN	I-NP	Omight	be	might	MD	B-VP	Obe	involved	be	VB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	homocysteine-induced	in	IN	B-PP	Ohomocysteine-induced	MCP-1	homocysteine-induced	JJ	B-NP	OMCP-1	expression	MCP-1	NN	I-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	endothelial	in	IN	B-PP	Oendothelial	cells	endothelial	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	staurosporine	","	","	O	Ostaurosporine	","	staurosporine	NN	B-NP	O","	a	","	","	O	Oa	protein	a	DT	B-NP	Oprotein	kinase	protein	NN	I-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	inhibitor	C	NN	I-NP	I-proteininhibitor	","	inhibitor	NN	I-NP	O","	had	","	","	O	Ohad	no	have	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	on	effect	NN	I-NP	Oon	homocysteine-induced	on	IN	B-PP	Ohomocysteine-induced	MCP-1	homocysteine-induced	JJ	B-NP	OMCP-1	expression	MCP-1	NN	I-NP	B-proteinexpression	.	expression	NN	I-NP	O.	In	.	.	O	OIn	conclusion	In	IN	B-PP	Oconclusion	","	conclusion	NN	B-NP	O","	our	","	","	O	Oour	results	our	PRP$	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	homocysteine	that	IN	B-SBAR	Ohomocysteine	stimulates	homocysteine	NN	B-NP	Ostimulates	MCP-1	stimulate	VBZ	B-VP	OMCP-1	expression	MCP-1	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	endothelial	in	IN	B-PP	Oendothelial	cells	endothelial	JJ	B-NP	B-cell_typecells	leading	cell	NNS	I-NP	I-cell_typeleading	to	lead	VBG	B-VP	Oto	enhanced	to	TO	B-PP	Oenhanced	monocyte	enhance	VBN	B-NP	Omonocyte	chemotaxis	monocyte	NN	I-NP	Ochemotaxis	.	chemotaxis	NN	I-NP	O.	Inducible	.	.	O	OInducible	resistance	Inducible	JJ	B-NP	Oresistance	to	resistance	NN	I-NP	Oto	Fas-mediated	to	TO	B-PP	OFas-mediated	apoptosis	Fas-mediated	JJ	B-NP	Oapoptosis	in	apoptosis	NN	I-NP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Apoptosis	.	.	O	OApoptosis	produced	Apoptosis	NN	B-NP	Oproduced	in	produce	VBN	B-VP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	through	cell	NNS	I-NP	I-cell_typethrough	Fas	through	IN	B-PP	OFas	(	Fas	NN	B-NP	B-protein(	APO-1	(	(	O	OAPO-1	","	APO-1	NN	B-NP	B-protein","	CD95	","	","	O	OCD95	)	CD95	NN	B-NP	B-protein)	triggering	)	)	O	Otriggering	is	triggering	NN	B-NP	Ois	regulated	be	VBZ	B-VP	Oregulated	by	regulate	VBN	I-VP	Oby	signals	by	IN	B-PP	Osignals	derived	signal	NNS	B-NP	Oderived	from	derive	VBN	B-VP	Ofrom	other	from	IN	B-PP	Oother	surface	other	JJ	B-NP	Osurface	receptors	surface	NN	I-NP	B-proteinreceptors	:	receptor	NNS	I-NP	I-protein:	CD40	:	:	O	OCD40	engagement	CD40	NN	B-NP	B-proteinengagement	produces	engagement	NN	I-NP	Oproduces	upregulation	produce	VBZ	B-VP	Oupregulation	of	upregulation	NN	B-NP	Oof	Fas	of	IN	B-PP	OFas	expression	Fas	NN	B-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	marked	and	CC	O	Omarked	susceptibility	marked	JJ	B-NP	Osusceptibility	to	susceptibility	NN	I-NP	Oto	Fas	to	TO	B-PP	OFas	#NAME?	Fas	NN	B-NP	B-protein#NAME?	cell	#NAME?	JJ	I-NP	Ocell	death	cell	NN	I-NP	Odeath	","	death	NN	I-NP	O","	whereas	","	","	O	Owhereas	antigen	whereas	IN	O	Oantigen	receptor	antigen	NN	B-NP	B-proteinreceptor	engagement	receptor	NN	I-NP	I-proteinengagement	","	engagement	NN	I-NP	O","	or	","	","	O	Oor	IL-4R	or	CC	O	OIL-4R	engagement	IL-4R	NN	B-NP	B-proteinengagement	","	engagement	NN	I-NP	O","	inhibits	","	","	O	Oinhibits	Fas	inhibit	VBZ	B-VP	OFas	killing	Fas	NN	B-NP	B-proteinkilling	and	killing	NN	I-NP	Oand	in	and	CC	B-PP	Oin	so	in	IN	B-PP	Oso	doing	so	RB	B-VP	Odoing	induces	do	VBG	I-VP	Oinduces	a	induce	VBZ	B-VP	Oa	state	a	DT	B-NP	Ostate	of	state	NN	I-NP	Oof	Fas	of	IN	B-PP	OFas	#NAME?	Fas	NN	B-NP	B-protein#NAME?	","	#NAME?	NN	I-NP	O","	even	","	","	O	Oeven	in	even	RB	B-ADVP	Oin	otherwise	in	IN	B-PP	Ootherwise	sensitive	otherwise	RB	B-NP	Osensitive	","	sensitive	JJ	I-NP	O","	CD40	","	","	I-NP	OCD40	#NAME?	CD40	NN	I-NP	B-protein#NAME?	targets	#NAME?	JJ	I-NP	Otargets	.	target	NNS	I-NP	O.	Surface	.	.	O	OSurface	immunoglobulin	Surface	NN	B-NP	B-proteinimmunoglobulin	and	immunoglobulin	NN	I-NP	I-proteinand	IL-4R	and	CC	I-NP	OIL-4R	utilize	IL-4R	NN	I-NP	B-proteinutilize	at	utilize	VBP	B-VP	Oat	least	at	IN	B-ADVP	Oleast	partially	least	JJS	I-ADVP	Opartially	distinct	partially	RB	B-NP	Odistinct	pathways	distinct	JJ	I-NP	Opathways	to	pathway	NNS	I-NP	Oto	produce	to	TO	B-VP	Oproduce	Fas	produce	VB	I-VP	OFas	#NAME?	Fas	NN	B-NP	B-protein#NAME?	that	#NAME?	NN	I-NP	Othat	differentially	that	WDT	B-NP	Odifferentially	depend	differentially	RB	B-ADVP	Odepend	on	depend	VBP	B-VP	Oon	PKC	on	IN	B-PP	OPKC	and	PKC	NN	B-NP	B-proteinand	STAT6	and	CC	I-NP	OSTAT6	","	STAT6	NN	I-NP	B-protein","	respectively	","	","	O	Orespectively	.	respectively	RB	B-ADVP	O.	Further	.	.	O	OFurther	","	Further	RB	B-ADVP	O","	surface	","	","	O	Osurface	immunoglobulin	surface	NN	B-NP	B-proteinimmunoglobulin	signaling	immunoglobulin	NN	I-NP	I-proteinsignaling	for	signaling	NN	I-NP	Ofor	inducible	for	IN	B-PP	Oinducible	Fas	inducible	JJ	B-NP	OFas	#NAME?	Fas	NN	I-NP	B-protein#NAME?	bypasses	#NAME?	NN	I-NP	Obypasses	Btk	bypass	VBZ	B-VP	OBtk	","	Btk	NN	B-NP	B-protein","	requires	","	","	O	Orequires	NF-kappaB	require	VBZ	B-VP	ONF-kappaB	","	NF-kappaB	NN	B-NP	B-protein","	and	","	","	O	Oand	entails	and	CC	O	Oentails	new	entail	VBZ	B-VP	Onew	macromolecular	new	JJ	B-NP	Omacromolecular	synthesis	macromolecular	JJ	I-NP	Osynthesis	.	synthesis	NN	I-NP	O.	Terminal	.	.	O	OTerminal	effectors	Terminal	JJ	B-NP	Oeffectors	of	effector	NNS	I-NP	Oof	B	of	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	Fas	cell	NN	I-NP	OFas	#NAME?	Fas	NN	I-NP	O#NAME?	include	#NAME?	NN	I-NP	Oinclude	the	include	VBP	B-VP	Othe	known	the	DT	B-NP	Oknown	anti-apoptotic	known	JJ	I-NP	Oanti-apoptotic	gene	anti-apoptotic	JJ	I-NP	B-proteingene	products	gene	NN	I-NP	I-proteinproducts	","	product	NNS	I-NP	I-protein","	Bcl-xL	","	","	O	OBcl-xL	and	Bcl-xL	NN	B-NP	B-proteinand	FLIP	and	CC	I-NP	OFLIP	","	FLIP	NN	I-NP	B-protein","	and	","	","	O	Oand	a	and	CC	O	Oa	novel	a	DT	B-NP	Onovel	anti-apoptotic	novel	JJ	I-NP	B-DNAanti-apoptotic	gene	anti-apoptotic	JJ	I-NP	I-DNAgene	that	gene	NN	I-NP	I-DNAthat	encodes	that	WDT	B-NP	Oencodes	FAIM	encode	VBZ	B-VP	OFAIM	(	FAIM	NN	B-NP	O(	Fas	(	(	O	OFas	Apoptosis	Fas	NN	B-NP	B-proteinApoptosis	Inhibitory	Apoptosis	NN	I-NP	I-proteinInhibitory	Molecule	Inhibitory	JJ	I-NP	I-proteinMolecule	)	Molecule	NN	I-NP	I-protein)	.	)	)	O	O.	faim	.	.	O	Ofaim	was	faim	NN	B-NP	Owas	identified	be	VBD	B-VP	Oidentified	by	identify	VBN	I-VP	Oby	differential	by	IN	B-PP	Odifferential	display	differential	JJ	B-NP	Odisplay	and	display	NN	I-NP	Oand	exists	and	CC	O	Oexists	in	exist	VBZ	B-VP	Oin	two	in	IN	B-PP	Otwo	alternatively	two	CD	B-NP	Oalternatively	spliced	alternatively	RB	I-NP	Ospliced	forms	splice	VBN	I-NP	Oforms	;	form	NNS	I-NP	O;	faim-S	;	:	O	Ofaim-S	is	faim-S	NN	B-NP	Ois	broadly	be	VBZ	B-VP	Obroadly	expressed	broadly	RB	I-VP	Oexpressed	","	express	VBN	I-VP	O","	but	","	","	O	Obut	faim-L	but	CC	O	Ofaim-L	expression	faim-L	NN	B-NP	Oexpression	is	expression	NN	I-NP	Ois	tissue-specific	be	VBZ	B-VP	Otissue-specific	.	tissue-specific	JJ	B-ADJP	O.	The	.	.	O	OThe	FAIM	The	DT	B-NP	OFAIM	sequence	FAIM	NN	I-NP	B-DNAsequence	is	sequence	NN	I-NP	I-DNAis	highly	be	VBZ	B-VP	Ohighly	evolu-	highly	RB	B-ADJP	Oevolu-	tionarily	evolu-	JJ	I-ADJP	Otionarily	conserved	tionarily	RB	B-VP	Oconserved	","	conserve	VBN	I-VP	O","	suggesting	","	","	O	Osuggesting	an	suggest	VBG	B-VP	Oan	important	an	DT	B-NP	Oimportant	role	important	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	this	for	IN	B-PP	Othis	molecule	this	DT	B-NP	Omolecule	throughout	molecule	NN	I-NP	Othroughout	phylogeny	throughout	IN	B-PP	Ophylogeny	.	phylogeny	NN	B-NP	O.	Inducible	.	.	O	OInducible	resistance	Inducible	JJ	B-NP	Oresistance	to	resistance	NN	I-NP	Oto	Fas	to	TO	B-PP	OFas	killing	Fas	NN	B-NP	B-proteinkilling	is	killing	NN	I-NP	Ois	hypothesized	be	VBZ	B-VP	Ohypothesized	to	hypothesize	VBN	I-VP	Oto	protect	to	TO	I-VP	Oprotect	foreign	protect	VB	I-VP	Oforeign	antigen-specific	foreign	JJ	B-NP	B-cell_typeantigen-specific	B	antigen-specific	JJ	I-NP	I-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	during	cell	NNS	I-NP	I-cell_typeduring	potentially	during	IN	B-PP	Opotentially	hazardous	potentially	RB	B-NP	Ohazardous	interactions	hazardous	JJ	I-NP	Ointeractions	with	interaction	NNS	I-NP	Owith	FasL-bearing	with	IN	B-PP	OFasL-bearing	T	FasL-bearing	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	whereas	","	","	O	Owhereas	autoreactive	whereas	IN	O	Oautoreactive	B	autoreactive	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	fail	cell	NNS	I-NP	I-cell_typefail	to	fail	VBP	B-VP	Oto	become	to	TO	I-VP	Obecome	Fas	become	VB	I-VP	OFas	#NAME?	Fas	NN	B-NP	B-protein#NAME?	and	#NAME?	JJ	I-NP	Oand	are	and	CC	O	Oare	deleted	be	VBP	B-VP	Odeleted	via	delete	VBN	I-VP	Ovia	Fas	via	IN	B-PP	OFas	#NAME?	Fas	NN	B-NP	B-protein#NAME?	cytotoxicity	#NAME?	JJ	I-NP	Ocytotoxicity	.	cytotoxicity	NN	I-NP	O.	Inadvertent	.	.	O	OInadvertent	or	Inadvertent	JJ	B-NP	Oor	aberrant	or	CC	I-NP	Oaberrant	acquisition	aberrant	JJ	I-NP	Oacquisition	of	acquisition	NN	I-NP	Oof	Fas	of	IN	B-PP	OFas	#NAME?	Fas	NN	B-NP	B-protein#NAME?	may	#NAME?	NN	I-NP	Omay	permit	may	MD	B-VP	Opermit	autoreactive	permit	VB	I-VP	Oautoreactive	B	autoreactive	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	escape	to	TO	B-VP	Oescape	Fas	escape	VB	I-VP	OFas	deletion	Fas	NN	B-NP	B-proteindeletion	","	deletion	NN	I-NP	O","	and	","	","	O	Oand	malignant	and	CC	O	Omalignant	lymphocytes	malignant	JJ	B-NP	B-cell_typelymphocytes	to	lymphocyte	NNS	I-NP	I-cell_typeto	impede	to	TO	B-VP	Oimpede	anti-tumor	impede	VB	I-VP	Oanti-tumor	immunity	anti-tumor	JJ	B-NP	Oimmunity	.	immunity	NN	I-NP	O.	Stromal	.	.	O	OStromal	cell-derived	Stromal	JJ	B-NP	B-proteincell-derived	factor	cell-derived	JJ	I-NP	I-proteinfactor	1	factor	NN	I-NP	I-protein1	alpha	1	CD	I-NP	I-proteinalpha	#NAME?	alpha	NN	I-NP	I-protein#NAME?	chemotaxis	#NAME?	JJ	I-NP	Ochemotaxis	in	chemotaxis	NN	I-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	is	cell	NNS	I-NP	I-cell_typeis	mediated	be	VBZ	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	nitric	by	IN	B-PP	Onitric	oxide	nitric	JJ	B-NP	Ooxide	signaling	oxide	NN	I-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	.	pathway	NNS	I-NP	O.	Stromal	.	.	O	OStromal	cell-derived	Stromal	JJ	B-NP	B-proteincell-derived	factor	cell-derived	JJ	I-NP	I-proteinfactor	1	factor	NN	I-NP	I-protein1	alpha	1	CD	I-NP	I-proteinalpha	(	alpha	NN	I-NP	I-protein(	SDF1	(	(	O	OSDF1	alpha	SDF1	NN	B-NP	B-proteinalpha	)	alpha	NN	I-NP	I-protein)	and	)	)	O	Oand	its	and	CC	O	Oits	cognate	its	PRP$	B-NP	Ocognate	chemokine	cognate	JJ	I-NP	Ochemokine	receptor	chemokine	NN	I-NP	Oreceptor	CXCR4	receptor	NN	I-NP	OCXCR4	act	CXCR4	NN	I-NP	B-proteinact	as	act	VBP	B-VP	Oas	potent	as	IN	B-PP	Opotent	chemoattractants	potent	JJ	B-NP	Ochemoattractants	and	chemoattractant	NNS	I-NP	B-proteinand	regulate	and	CC	O	Oregulate	trafficking	regulate	VB	B-VP	Otrafficking	and	trafficking	NN	B-NP	Oand	homing	and	CC	I-NP	Ohoming	of	homing	NN	I-NP	Oof	hematopoietic	of	IN	B-PP	Ohematopoietic	progenitor	hematopoietic	JJ	B-NP	B-cell_typeprogenitor	cells	progenitor	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	lymphocytes	and	CC	O	Olymphocytes	.	lymphocyte	NNS	B-NP	B-cell_type.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	the	","	","	O	Othe	molecular	the	DT	B-NP	Omolecular	mechanisms	molecular	JJ	I-NP	Omechanisms	regulating	mechanism	NNS	I-NP	Oregulating	SDF1	regulate	VBG	B-VP	OSDF1	alpha	SDF1	NN	B-NP	Oalpha	#NAME?	alpha	NN	I-NP	O#NAME?	cell	#NAME?	JJ	I-NP	Ocell	migration	cell	NN	I-NP	Omigration	are	migration	NN	I-NP	Oare	not	be	VBP	B-VP	Onot	well	not	RB	I-VP	Owell	defined	well	RB	I-VP	Odefined	.	define	VBN	I-VP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	explored	have	VBP	B-VP	Oexplored	the	explore	VBN	I-VP	Othe	roles	the	DT	B-NP	Oroles	of	role	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	second	the	DT	B-NP	Osecond	messenger	second	JJ	I-NP	Omessenger	NO	messenger	NN	I-NP	ONO	and	NO	NN	I-NP	Oand	the	and	CC	O	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	NF-kappa	factor	NN	I-NP	I-proteinNF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	in	B	NN	I-NP	I-proteinin	SDF1	in	IN	B-PP	OSDF1	alpha	SDF1	NN	B-NP	B-proteinalpha	#NAME?	alpha	NN	I-NP	I-protein#NAME?	T	#NAME?	JJ	I-NP	OT	cell	T	NN	I-NP	Ocell	migration	cell	NN	I-NP	Omigration	.	migration	NN	I-NP	O.	SDF1	.	.	O	OSDF1	alpha	SDF1	NN	B-NP	Oalpha	treatment	alpha	NN	I-NP	Otreatment	of	treatment	NN	I-NP	Oof	Jurkat	of	IN	B-PP	OJurkat	T	Jurkat	NN	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	increased	cell	NNS	I-NP	I-cell_lineincreased	the	increase	VBD	B-VP	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	NO	of	IN	B-PP	ONO	synthase	NO	NN	B-NP	B-proteinsynthase	","	synthase	NN	I-NP	I-protein","	which	","	","	O	Owhich	catalyzes	which	WDT	B-NP	Ocatalyzes	the	catalyze	VBZ	B-VP	Othe	generation	the	DT	B-NP	Ogeneration	of	generation	NN	I-NP	Oof	NO	of	IN	B-PP	ONO	.	NO	NN	B-NP	O.	We	.	.	O	OWe	observed	We	PRP	B-NP	Oobserved	that	observe	VBD	B-VP	Othat	pretreatment	that	IN	B-SBAR	Opretreatment	of	pretreatment	NN	B-NP	Oof	Jurkat	of	IN	B-PP	OJurkat	cells	Jurkat	NN	B-NP	B-cell_linecells	or	cell	NNS	I-NP	I-cell_lineor	activated	or	CC	O	Oactivated	PBLs	activate	VBN	B-VP	B-cell_typePBLs	with	PBL	NNS	B-NP	I-cell_typewith	several	with	IN	B-PP	Oseveral	NO	several	JJ	B-NP	ONO	donors	NO	NN	I-NP	Odonors	significantly	donor	NNS	I-NP	Osignificantly	enhanced	significantly	RB	B-ADVP	Oenhanced	the	enhance	VBD	B-VP	Othe	SDF1	the	DT	B-NP	OSDF1	alpha	SDF1	NN	I-NP	B-proteinalpha	#NAME?	alpha	NN	I-NP	I-protein#NAME?	migration	#NAME?	JJ	I-NP	Omigration	","	migration	NN	I-NP	O","	whereas	","	","	O	Owhereas	various	whereas	IN	O	Ovarious	inhibitors	various	JJ	B-NP	Oinhibitors	of	inhibitor	NNS	I-NP	Oof	NO	of	IN	B-PP	ONO	synthase	NO	NN	B-NP	B-proteinsynthase	markedly	synthase	NN	I-NP	I-proteinmarkedly	abrogated	markedly	RB	B-ADVP	Oabrogated	the	abrogate	VBD	B-VP	Othe	chemotactic	the	DT	B-NP	Ochemotactic	response	chemotactic	JJ	I-NP	Oresponse	in	response	NN	I-NP	Oin	a	in	IN	B-PP	Oa	concentration-dependent	a	DT	B-NP	Oconcentration-dependent	manner	concentration-dependent	JJ	I-NP	Omanner	.	manner	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	we	","	","	O	Owe	observed	we	PRP	B-NP	Oobserved	that	observe	VBD	B-VP	Othat	inhibitors	that	IN	B-SBAR	Oinhibitors	of	inhibitor	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	NF-kappa	factor	NN	I-NP	I-proteinNF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	","	B	NN	I-NP	I-protein","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	linked	be	VBZ	B-VP	Olinked	to	link	VBN	I-VP	Oto	NO	to	TO	B-PP	ONO	signaling	NO	NN	B-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	","	pathway	NNS	I-NP	O","	also	","	","	O	Oalso	significantly	also	RB	B-ADVP	Osignificantly	blocked	significantly	RB	B-VP	Oblocked	the	block	VBD	I-VP	Othe	SDF1	the	DT	B-NP	OSDF1	alpha	SDF1	NN	I-NP	B-proteinalpha	#NAME?	alpha	NN	I-NP	I-protein#NAME?	chemotactic	#NAME?	JJ	I-NP	Ochemotactic	response	chemotactic	JJ	I-NP	Oresponse	.	response	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	these	","	","	O	Othese	compounds	these	DT	B-NP	Ocompounds	did	compound	NNS	I-NP	Odid	not	do	VBD	B-VP	Onot	have	not	RB	I-VP	Ohave	a	have	VB	I-VP	Oa	significant	a	DT	B-NP	Osignificant	effect	significant	JJ	I-NP	Oeffect	on	effect	NN	I-NP	Oon	SDF1	on	IN	B-PP	OSDF1	alpha	SDF1	NN	B-NP	B-proteinalpha	#NAME?	alpha	NN	I-NP	I-protein#NAME?	mitogen-activated	#NAME?	JJ	I-NP	Omitogen-activated	protein	mitogen-activated	JJ	I-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	activity	kinase	NN	I-NP	I-proteinactivity	.	activity	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	the	","	","	O	Othe	MAP/Erk	the	DT	B-NP	OMAP/Erk	kinase	MAP/Erk	NN	I-NP	B-proteinkinase	kinase	kinase	NN	I-NP	I-proteinkinase	inhibitor	kinase	NN	I-NP	I-proteininhibitor	PD98059	inhibitor	NN	I-NP	OPD98059	did	PD98059	NN	I-NP	Odid	not	do	VBD	B-VP	Onot	abrogate	not	RB	I-VP	Oabrogate	SDF1	abrogate	VB	I-VP	OSDF1	alpha	SDF1	NN	B-NP	B-proteinalpha	#NAME?	alpha	NN	I-NP	I-protein#NAME?	chemotaxis	#NAME?	JJ	I-NP	Ochemotaxis	.	chemotaxis	NN	I-NP	O.	AKT	.	.	O	OAKT	","	AKT	NN	B-NP	B-protein","	which	","	","	O	Owhich	has	which	WDT	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	mediate	to	TO	I-VP	Omediate	NO	mediate	VB	I-VP	ONO	production	NO	NN	B-NP	Oproduction	","	production	NN	I-NP	O","	was	","	","	O	Owas	also	be	VBD	B-VP	Oalso	phosphorylated	also	RB	I-VP	Ophosphorylated	upon	phosphorylate	VBN	I-VP	Oupon	SDF1	upon	IN	B-PP	OSDF1	alpha	SDF1	NN	B-NP	B-proteinalpha	stimulation	alpha	NN	I-NP	I-proteinstimulation	.	stimulation	NN	I-NP	O.	These	.	.	O	OThese	studies	These	DT	B-NP	Ostudies	suggest	study	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	NO-related	that	IN	B-SBAR	ONO-related	signaling	NO-related	JJ	B-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	may	pathway	NNS	I-NP	Omay	mediate	may	MD	B-VP	Omediate	SDF1	mediate	VB	I-VP	OSDF1	alpha	SDF1	NN	B-NP	B-proteinalpha	#NAME?	alpha	NN	I-NP	I-protein#NAME?	chemotaxis	#NAME?	JJ	I-NP	Ochemotaxis	","	chemotaxis	NN	I-NP	O","	but	","	","	O	Obut	not	but	CC	O	Onot	mitogen-activated	not	RB	O	Omitogen-activated	protein	mitogen-activated	JJ	B-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	activation	kinase	NN	I-NP	I-proteinactivation	.	activation	NN	I-NP	O.	The	.	.	O	OThe	lack	The	DT	B-NP	Olack	of	lack	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	transactivation	B	NN	I-NP	I-proteintransactivation	and	transactivation	NN	I-NP	Oand	PKC	and	CC	O	OPKC	epsilon	PKC	NN	B-NP	B-proteinepsilon	expression	epsilon	NN	I-NP	I-proteinexpression	in	expression	NN	I-NP	Oin	CD4	in	IN	B-PP	OCD4	(	CD4	NN	B-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	CD8	)	)	O	I-cell_typeCD8	(	CD8	NN	B-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	thymocytes	)	)	O	I-cell_typethymocytes	correlates	thymocyte	NNS	B-NP	I-cell_typecorrelates	with	correlate	VBZ	B-VP	Owith	negative	with	IN	B-PP	Onegative	selection	negative	JJ	B-NP	Oselection	.	selection	NN	I-NP	O.	Deletion	.	.	O	ODeletion	of	Deletion	NN	B-NP	Oof	autoreactive	of	IN	B-PP	Oautoreactive	thymocytes	autoreactive	JJ	B-NP	B-cell_typethymocytes	at	thymocyte	NNS	I-NP	I-cell_typeat	the	at	IN	B-PP	Othe	DP	the	DT	B-NP	ODP	stage	DP	NN	I-NP	Ostage	is	stage	NN	I-NP	Ois	the	be	VBZ	B-VP	Othe	basis	the	DT	B-NP	Obasis	for	basis	NN	I-NP	Ofor	tolerance	for	IN	B-PP	Otolerance	to	tolerance	NN	B-NP	Oto	thymus-expressed	to	TO	B-PP	Othymus-expressed	self	thymus-expressed	JJ	B-NP	B-proteinself	antigens	self	NN	I-NP	I-proteinantigens	.	antigen	NNS	I-NP	I-protein.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	we	study	NN	I-NP	Owe	investigated	we	PRP	B-NP	Oinvestigated	whether	investigate	VBD	B-VP	Owhether	distinct	whether	IN	B-SBAR	Odistinct	signalling	distinct	JJ	B-NP	Osignalling	pathways	signalling	NN	I-NP	Opathways	are	pathway	NNS	I-NP	Oare	induced	be	VBP	B-VP	Oinduced	in	induce	VBN	I-VP	Oin	DP	in	IN	B-PP	ODP	thymocytes	DP	NN	B-NP	B-cell_typethymocytes	as	thymocyte	NNS	I-NP	I-cell_typeas	compared	as	IN	B-SBAR	Ocompared	to	compare	VBN	B-VP	Oto	mature	to	TO	B-PP	Omature	T	mature	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	upon	cell	NNS	I-NP	I-cell_typeupon	stimulation	upon	IN	B-PP	Ostimulation	with	stimulation	NN	B-NP	Owith	antigen	with	IN	B-PP	Oantigen	.	antigen	NN	B-NP	O.	Using	.	.	O	OUsing	triple	Use	VBG	B-VP	Otriple	transgenic	triple	JJ	B-NP	Otransgenic	mice	transgenic	JJ	I-NP	Omice	expressing	mouse	NNS	I-NP	Oexpressing	a	express	VBG	B-VP	Oa	TCR	a	DT	B-NP	OTCR	transgene	TCR	NN	I-NP	B-DNAtransgene	","	transgene	NN	I-NP	I-DNA","	dominant	","	","	O	Odominant	negative	dominant	JJ	B-NP	B-proteinnegative	ras/Mek	negative	JJ	I-NP	I-proteinras/Mek	proteins	ras/Mek	NN	I-NP	I-proteinproteins	and	protein	NNS	I-NP	I-proteinand	a	and	CC	O	Oa	reporter	a	DT	B-NP	Oreporter	gene	reporter	NN	I-NP	B-DNAgene	construct	gene	NN	I-NP	I-DNAconstruct	with	construct	NN	I-NP	I-DNAwith	AP-1	with	IN	B-PP	OAP-1	or	AP-1	NN	B-NP	B-proteinor	NF-kappa	or	CC	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-DNAB	binding	B	NN	I-NP	I-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	","	site	NNS	I-NP	I-DNA","	we	","	","	O	Owe	showed	we	PRP	B-NP	Oshowed	a	show	VBD	B-VP	Oa	complete	a	DT	B-NP	Ocomplete	lack	complete	JJ	I-NP	Olack	of	lack	NN	I-NP	Oof	transcriptional	of	IN	B-PP	Otranscriptional	activity	transcriptional	JJ	B-NP	Oactivity	of	activity	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	but	B	NN	I-NP	I-proteinbut	not	but	CC	B-NP	Onot	AP-1	not	RB	I-NP	OAP-1	in	AP-1	NN	B-NP	B-proteinin	DP	in	IN	B-PP	ODP	thymocytes	DP	NN	B-NP	B-cell_typethymocytes	","	thymocyte	NNS	I-NP	I-cell_type","	whereas	","	","	O	Owhereas	both	whereas	IN	O	Oboth	were	both	DT	B-NP	Owere	transcriptionally	be	VBD	B-VP	Otranscriptionally	active	transcriptionally	RB	B-ADJP	Oactive	in	active	JJ	I-ADJP	Oin	mature	in	IN	B-PP	Omature	T	mature	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	after	cell	NNS	I-NP	I-cell_typeafter	antigenic	after	IN	B-PP	Oantigenic	stimulation	antigenic	JJ	B-NP	Ostimulation	.	stimulation	NN	I-NP	O.	Lack	.	.	O	OLack	of	Lack	NN	B-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	induction	B	NN	I-NP	I-proteininduction	correlated	induction	NN	I-NP	Ocorrelated	with	correlate	VBD	B-VP	Owith	increased	with	IN	B-PP	Oincreased	death	increase	VBN	B-NP	Odeath	in	death	NN	I-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	I-PP	Oto	antigen	to	TO	I-PP	Oantigen	.	antigen	NN	B-NP	O.	AP-1	.	.	O	OAP-1	induction	AP-1	NN	B-NP	B-proteininduction	was	induction	NN	I-NP	Owas	dependent	be	VBD	B-VP	Odependent	on	dependent	JJ	B-ADJP	Oon	the	on	IN	B-PP	Othe	integrity	the	DT	B-NP	Ointegrity	of	integrity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	ras/Mek	the	DT	B-NP	Oras/Mek	pathway	ras/Mek	NN	I-NP	B-proteinpathway	indicating	pathway	NN	I-NP	Oindicating	that	indicate	VBG	B-VP	Othat	this	that	IN	B-SBAR	Othis	pathway	this	DT	B-NP	Opathway	was	pathway	NN	I-NP	Owas	activated	be	VBD	B-VP	Oactivated	in	activate	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	DP	the	DT	B-NP	ODP	thymocytes	DP	NN	I-NP	B-cell_typethymocytes	.	thymocyte	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	a	find	VBD	B-VP	Oa	complete	a	DT	B-NP	Ocomplete	lack	complete	JJ	I-NP	Olack	of	lack	NN	I-NP	Oof	constitutive	of	IN	B-PP	Oconstitutive	expression	constitutive	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	epsilon	the	DT	B-NP	Oepsilon	isoform	epsilon	NN	I-NP	B-proteinisoform	of	isoform	NN	I-NP	I-proteinof	Protein	of	IN	B-PP	OProtein	Kinase	Protein	NN	B-NP	B-proteinKinase	C	Kinase	NN	I-NP	I-proteinC	(	C	NN	I-NP	I-protein(	PKC	(	(	O	OPKC	)	PKC	NN	B-NP	B-protein)	in	)	)	O	Oin	DP	in	IN	B-PP	ODP	thymocytes	DP	NN	B-NP	B-cell_typethymocytes	","	thymocyte	NNS	I-NP	I-cell_type","	although	","	","	O	Oalthough	it	although	IN	B-SBAR	Oit	was	it	PRP	B-NP	Owas	present	be	VBD	B-VP	Opresent	in	present	JJ	B-ADJP	Oin	mature	in	IN	B-PP	Omature	thymocytes	mature	JJ	B-NP	B-cell_typethymocytes	and	thymocyte	NNS	I-NP	I-cell_typeand	peripheral	and	CC	O	Operipheral	T	peripheral	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Taken	.	.	O	OTaken	together	Take	VBN	B-VP	Otogether	the	together	RB	B-ADVP	Othe	results	the	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	lack	the	DT	B-NP	Olack	of	lack	NN	I-NP	Oof	PKC	of	IN	B-PP	OPKC	epsilon	PKC	NN	B-NP	B-proteinepsilon	in	epsilon	NN	I-NP	I-proteinin	DP	in	IN	B-PP	ODP	thymocytes	DP	NN	B-NP	B-cell_typethymocytes	could	thymocyte	NNS	I-NP	I-cell_typecould	lead	could	MD	B-VP	Olead	to	lead	VB	I-VP	Oto	the	to	TO	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	activity	B	NN	I-NP	I-proteinactivity	after	activity	NN	I-NP	Oafter	antigenic	after	IN	B-PP	Oantigenic	stimulation	antigenic	JJ	B-NP	Ostimulation	contributing	stimulation	NN	I-NP	Ocontributing	to	contribute	VBG	B-VP	Oto	negative	to	TO	B-PP	Onegative	selection	negative	JJ	B-NP	Oselection	.	selection	NN	I-NP	O.	Cell	.	.	O	OCell	Death	Cell	NN	B-NP	ODeath	and	Death	NN	I-NP	Oand	Differentiation	and	CC	O	ODifferentiation	(	Differentiation	NN	B-NP	B-protein(	2000	(	(	O	I-protein2000	)	2000	CD	B-NP	I-protein)	7	)	)	O	I-protein7	","	7	CD	B-NP	I-protein","	1253	","	","	O	O1253	-	1253	CD	B-NP	O-	1262	-	HYPH	I-NP	O1262	.	1262	CD	I-NP	O.	CD2	.	.	O	OCD2	stimulation	CD2	NN	B-NP	B-proteinstimulation	leads	stimulation	NN	I-NP	Oleads	to	lead	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	delayed	the	DT	B-NP	Odelayed	and	delay	VBN	I-NP	Oand	prolonged	and	CC	I-NP	Oprolonged	activation	prolong	VBN	I-NP	Oactivation	of	activation	NN	I-NP	Oof	STAT1	of	IN	B-PP	OSTAT1	in	STAT1	NN	B-NP	B-proteinin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	but	cell	NNS	I-NP	I-cell_typebut	not	but	CC	B-NP	Onot	NK	not	RB	I-NP	ONK	cells	NK	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	OBJECTIVE	.	.	O	OOBJECTIVE	:	OBJECTIVE	NN	B-NP	O:	T	:	:	O	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	can	lymphocyte	NNS	I-NP	I-cell_typecan	be	can	MD	B-VP	Obe	activated	be	VB	I-VP	Oactivated	by	activate	VBN	I-VP	Oby	soluble	by	IN	B-PP	Osoluble	factors	soluble	JJ	B-NP	B-proteinfactors	such	factor	NNS	I-NP	I-proteinsuch	as	such	JJ	B-PP	Oas	cytokines	as	IN	I-PP	Ocytokines	or	cytokine	NNS	B-NP	B-proteinor	through	or	CC	B-PP	Othrough	direct	through	IN	B-PP	Odirect	cell-cell	direct	JJ	B-NP	Ocell-cell	interactions	cell-cell	JJ	I-NP	Ointeractions	.	interaction	NNS	I-NP	O.	Although	.	.	O	OAlthough	cytokine	Although	IN	B-SBAR	Ocytokine	receptors	cytokine	NN	B-NP	B-proteinreceptors	are	receptor	NNS	I-NP	I-proteinare	known	be	VBP	B-VP	Oknown	to	know	VBN	I-VP	Oto	signal	to	TO	I-VP	Osignal	through	signal	VB	I-VP	Othrough	STAT	through	IN	B-PP	OSTAT	family	STAT	NN	B-NP	B-proteinfamily	transcription	family	NN	I-NP	I-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	","	factor	NNS	I-NP	I-protein","	the	","	","	O	Othe	mechanisms	the	DT	B-NP	Omechanisms	by	mechanism	NNS	I-NP	Oby	which	by	IN	B-PP	Owhich	other	which	WDT	B-NP	Oother	cell-surface	other	JJ	B-NP	Ocell-surface	molecules	cell-surface	JJ	I-NP	B-proteinmolecules	","	molecule	NNS	I-NP	I-protein","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	CD2	as	IN	I-PP	OCD2	","	CD2	NN	B-NP	B-protein","	transduce	","	","	O	Otransduce	signals	transduce	VB	B-VP	Osignals	is	signal	NNS	B-NP	Ois	unclear	be	VBZ	B-VP	Ounclear	.	unclear	JJ	B-ADJP	O.	The	.	.	O	OThe	goal	The	DT	B-NP	Ogoal	of	goal	NN	I-NP	Oof	this	of	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	was	study	NN	I-NP	Owas	to	be	VBD	B-VP	Oto	determine	to	TO	B-VP	Odetermine	whether	determine	VB	I-VP	Owhether	stimulation	whether	IN	B-SBAR	Ostimulation	of	stimulation	NN	B-NP	Oof	T	of	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	through	cell	NNS	I-NP	I-cell_typethrough	CD2	through	IN	B-PP	OCD2	recapitulates	CD2	NN	B-NP	B-proteinrecapitulates	aspects	recapitulate	VBZ	B-VP	Oaspects	of	aspect	NNS	B-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	#NAME?	cytokine	NN	B-NP	B-protein#NAME?	T-cell	#NAME?	JJ	I-NP	OT-cell	activation	T-cell	NN	I-NP	Oactivation	by	activation	NN	I-NP	Oby	use	by	IN	B-PP	Ouse	of	use	NN	B-NP	Oof	STAT	of	IN	B-PP	OSTAT	transcription	STAT	NN	B-NP	B-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	.	factor	NNS	I-NP	I-protein.	MATERIALS	.	.	O	OMATERIALS	AND	MATERIALS	NNS	B-NP	OAND	METHODS	AND	CC	I-NP	OMETHODS	:	METHODS	NNS	I-NP	O:	T	:	:	O	OT	cells	T	NN	B-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	treated	be	VBD	B-VP	Otreated	with	treat	VBN	I-VP	Owith	anti-CD2	with	IN	B-PP	Oanti-CD2	antibodies	anti-CD2	JJ	B-NP	B-proteinantibodies	or	antibody	NNS	I-NP	I-proteinor	cells	or	CC	I-NP	Ocells	bearing	cell	NNS	I-NP	Obearing	the	bear	VBG	B-VP	Othe	natural	the	DT	B-NP	Onatural	CD2	natural	JJ	I-NP	OCD2	ligand	CD2	NN	I-NP	Oligand	CD58	ligand	NN	I-NP	OCD58	","	CD58	NN	I-NP	B-protein","	after	","	","	O	Oafter	which	after	IN	B-PP	Owhich	signaling	which	WDT	B-NP	Osignaling	through	signaling	NN	B-NP	Othrough	STAT	through	IN	B-PP	OSTAT	transcription	STAT	NN	B-NP	B-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	was	factor	NNS	I-NP	I-proteinwas	assessed	be	VBD	B-VP	Oassessed	.	assess	VBN	I-VP	O.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	Stimulation	:	:	O	OStimulation	of	Stimulation	NN	B-NP	Oof	CD2	of	IN	B-PP	OCD2	on	CD2	NN	B-NP	B-proteinon	primary	on	IN	B-PP	Oprimary	T	primary	JJ	B-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	leads	lymphocyte	NNS	I-NP	I-cell_typeleads	to	lead	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	tyrosine	the	DT	B-NP	Otyrosine	phosphorylation	tyrosine	NN	I-NP	Ophosphorylation	","	phosphorylation	NN	I-NP	O","	nuclear	","	","	O	Onuclear	translocation	nuclear	JJ	B-NP	Otranslocation	","	translocation	NN	I-NP	O","	and	","	","	O	Oand	DNA	and	CC	O	ODNA	binding	DNA	NN	B-NP	Obinding	of	binding	NN	I-NP	Oof	STAT1	of	IN	B-PP	OSTAT1	.	STAT1	NN	B-NP	B-protein.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	to	contrast	NN	B-NP	Oto	stimulation	to	TO	B-PP	Ostimulation	by	stimulation	NN	B-NP	Oby	cytokines	by	IN	B-PP	Ocytokines	","	cytokine	NNS	B-NP	B-protein","	the	","	","	O	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	STAT1	of	IN	B-PP	OSTAT1	in	STAT1	NN	B-NP	B-proteinin	response	in	IN	B-PP	Oresponse	to	response	NN	I-PP	Oto	CD2	to	TO	I-PP	OCD2	ligation	CD2	NN	B-NP	B-proteinligation	is	ligation	NN	I-NP	Ois	delayed	be	VBZ	B-VP	Odelayed	and	delay	VBN	I-VP	Oand	does	and	CC	O	Odoes	not	do	VBZ	B-VP	Onot	involve	not	RB	I-VP	Oinvolve	Jak	involve	VB	I-VP	OJak	kinases	Jak	NN	B-NP	B-proteinkinases	.	kinase	NNS	I-NP	I-protein.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	while	","	","	O	Owhile	STAT	while	IN	B-SBAR	OSTAT	phosphorylation	STAT	NN	B-NP	B-proteinphosphorylation	induced	phosphorylation	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	cytokines	by	IN	B-PP	Ocytokines	is	cytokine	NNS	B-NP	B-proteinis	generally	be	VBZ	B-VP	Ogenerally	transient	generally	RB	B-ADJP	Otransient	","	transient	JJ	I-ADJP	O","	STAT1	","	","	O	OSTAT1	phosphorylation	STAT1	NN	B-NP	B-proteinphosphorylation	following	phosphorylation	NN	I-NP	Ofollowing	CD2	follow	VBG	B-PP	OCD2	stimulation	CD2	NN	B-NP	B-proteinstimulation	persists	stimulation	NN	I-NP	Opersists	for	persist	VBZ	B-VP	Ofor	a	for	IN	B-PP	Oa	period	a	DT	B-NP	Operiod	of	period	NN	I-NP	Oof	days	of	IN	B-PP	Odays	.	day	NNS	B-NP	O.	Transcription	.	.	O	OTranscription	of	Transcription	NN	B-NP	Oof	key	of	IN	B-PP	Okey	target	key	JJ	B-NP	B-DNAtarget	genes	target	NN	I-NP	I-DNAgenes	such	gene	NNS	I-NP	I-DNAsuch	as	such	JJ	B-PP	Oas	IRF1	as	IN	I-PP	OIRF1	and	IRF1	NN	B-NP	B-proteinand	c-fos	and	CC	I-NP	Oc-fos	proceeds	c-fos	NN	I-NP	B-DNAproceeds	with	proceed	VBZ	B-VP	Owith	delayed	with	IN	B-PP	Odelayed	kinetics	delay	VBN	B-NP	Okinetics	following	kinetic	NNS	I-NP	Ofollowing	CD2	follow	VBG	B-PP	OCD2	stimulation	CD2	NN	B-NP	B-proteinstimulation	","	stimulation	NN	I-NP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	this	that	IN	B-SBAR	Othis	unique	this	DT	B-NP	Ounique	pattern	unique	JJ	I-NP	Opattern	of	pattern	NN	I-NP	Oof	STAT	of	IN	B-PP	OSTAT	activation	STAT	NN	B-NP	B-proteinactivation	may	activation	NN	I-NP	Omay	lead	may	MD	B-VP	Olead	to	lead	VB	I-VP	Oto	a	to	TO	B-PP	Oa	distinct	a	DT	B-NP	Odistinct	cellular	distinct	JJ	I-NP	Ocellular	response	cellular	JJ	I-NP	Oresponse	following	response	NN	I-NP	Ofollowing	CD2	follow	VBG	B-PP	OCD2	ligation	CD2	NN	B-NP	B-proteinligation	.	ligation	NN	I-NP	O.	This	.	.	O	OThis	pathway	This	DT	B-NP	Opathway	appears	pathway	NN	I-NP	Oappears	to	appear	VBZ	B-VP	Oto	be	to	TO	I-VP	Obe	restricted	be	VB	I-VP	Orestricted	to	restrict	VBN	I-VP	Oto	T	to	TO	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	as	","	","	O	Oas	stimulation	as	IN	B-PP	Ostimulation	of	stimulation	NN	B-NP	Oof	CD2	of	IN	B-PP	OCD2	on	CD2	NN	B-NP	B-proteinon	NK	on	IN	B-PP	ONK	cells	NK	NN	B-NP	B-cell_typecells	does	cell	NNS	I-NP	I-cell_typedoes	not	do	VBZ	B-VP	Onot	lead	not	RB	I-VP	Olead	to	lead	VB	I-VP	Oto	STAT1	to	TO	B-PP	OSTAT1	activation	STAT1	NN	B-NP	B-proteinactivation	.	activation	NN	I-NP	O.	CONCLUSION	.	.	O	OCONCLUSION	:	CONCLUSION	NN	B-NP	O:	Stimulation	:	:	O	OStimulation	of	Stimulation	NN	B-NP	Oof	T	of	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	through	cell	NNS	I-NP	I-cell_typethrough	cell-surface	through	IN	B-PP	Ocell-surface	molecules	cell-surface	JJ	B-NP	B-proteinmolecules	such	molecule	NNS	I-NP	I-proteinsuch	as	such	JJ	B-PP	Oas	CD2	as	IN	I-PP	OCD2	involves	CD2	NN	B-NP	B-proteininvolves	activation	involve	VBZ	B-VP	Oactivation	of	activation	NN	B-NP	Oof	STAT	of	IN	B-PP	OSTAT	transcription	STAT	NN	B-NP	B-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	","	factor	NNS	I-NP	I-protein","	thus	","	","	O	Othus	recapitulating	thus	RB	B-ADVP	Orecapitulating	elements	recapitulate	VBG	B-VP	Oelements	of	element	NNS	B-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	signaling	cytokine	NN	B-NP	B-proteinsignaling	.	signaling	NN	I-NP	O.	NFATc1	.	.	O	ONFATc1	and	NFATc1	NN	B-NP	B-proteinand	NFATc2	and	CC	I-NP	ONFATc2	together	NFATc2	NN	I-NP	B-proteintogether	control	together	RB	B-ADVP	Ocontrol	both	control	VBP	B-VP	Oboth	T	both	CC	O	OT	and	T	NN	B-NP	Oand	B	and	CC	I-NP	OB	cell	B	NN	I-NP	Ocell	activation	cell	NN	I-NP	Oactivation	and	activation	NN	B-NP	Oand	differentiation	and	CC	O	Odifferentiation	.	differentiation	NN	B-NP	O.	NFAT	.	.	O	ONFAT	transcription	NFAT	NN	B-NP	B-proteintranscription	factors	transcription	NN	I-NP	B-proteinfactors	play	factor	NNS	I-NP	I-proteinplay	critical	play	VBP	B-VP	Ocritical	roles	critical	JJ	B-NP	Oroles	in	role	NNS	I-NP	Oin	gene	in	IN	B-PP	Ogene	transcription	gene	NN	B-NP	Otranscription	during	transcription	NN	I-NP	Oduring	immune	during	IN	B-PP	Oimmune	responses	immune	JJ	B-NP	Oresponses	.	response	NNS	I-NP	O.	To	.	.	O	OTo	investigate	To	TO	B-VP	Oinvestigate	further	investigate	VB	I-VP	Ofurther	the	further	RBR	B-ADVP	Othe	two	the	DT	B-NP	Otwo	most	two	CD	I-NP	Omost	prominent	most	RBS	I-NP	Oprominent	NFAT	prominent	JJ	I-NP	ONFAT	family	NFAT	NN	I-NP	B-proteinfamily	members	family	NN	I-NP	I-proteinmembers	","	member	NNS	I-NP	I-protein","	NFATc1	","	","	O	ONFATc1	and	NFATc1	NN	B-NP	B-proteinand	NFATc2	and	CC	I-NP	ONFATc2	","	NFATc2	NN	I-NP	B-protein","	we	","	","	O	Owe	generated	we	PRP	B-NP	Ogenerated	mice	generate	VBD	B-VP	Omice	bearing	mouse	NNS	B-NP	Obearing	lymphoid	bear	VBG	B-VP	Olymphoid	systems	lymphoid	JJ	B-NP	Osystems	devoid	system	NNS	I-NP	Odevoid	of	devoid	JJ	B-ADJP	Oof	both	of	IN	B-PP	Oboth	.	both	DT	B-NP	O.	Doubly	.	.	O	ODoubly	deficient	Doubly	RB	B-NP	Odeficient	T	deficient	JJ	I-NP	OT	cells	T	NN	I-NP	Ocells	displayed	cell	NNS	I-NP	Odisplayed	cell	display	VBD	B-VP	Ocell	surface	cell	NN	B-NP	B-proteinsurface	markers	surface	NN	I-NP	I-proteinmarkers	of	marker	NNS	I-NP	I-proteinof	activation	of	IN	B-PP	Oactivation	yet	activation	NN	B-NP	Oyet	were	yet	RB	B-ADVP	Owere	significantly	be	VBD	B-VP	Osignificantly	deficient	significantly	RB	B-ADJP	Odeficient	in	deficient	JJ	I-ADJP	Oin	the	in	IN	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	multiple	of	IN	B-PP	Omultiple	effector	multiple	JJ	B-NP	Oeffector	functions	effector	NN	I-NP	Ofunctions	","	function	NNS	I-NP	O","	including	","	","	O	Oincluding	Th	include	VBG	B-PP	OTh	cytokine	Th	NN	B-NP	B-proteincytokine	production	cytokine	NN	I-NP	I-proteinproduction	","	production	NN	I-NP	O","	surface	","	","	O	Osurface	effector	surface	NN	B-NP	B-proteineffector	molecule	effector	NN	I-NP	I-proteinmolecule	expression	molecule	NN	I-NP	I-proteinexpression	","	expression	NN	I-NP	O","	and	","	","	O	Oand	cytolytic	and	CC	O	Ocytolytic	activity	cytolytic	JJ	B-NP	Oactivity	.	activity	NN	I-NP	O.	Nevertheless	.	.	O	ONevertheless	","	Nevertheless	RB	B-ADVP	O","	doubly	","	","	O	Odoubly	deficient	doubly	RB	B-NP	Odeficient	B	deficient	JJ	I-NP	OB	cells	B	NN	I-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	hyperactivated	be	VBD	B-VP	Ohyperactivated	","	hyperactivate	VBN	I-VP	O","	as	","	","	O	Oas	evidenced	as	IN	B-SBAR	Oevidenced	by	evidence	VBN	B-VP	Oby	extremely	by	IN	B-PP	Oextremely	elevated	extremely	RB	B-NP	Oelevated	serum	elevated	JJ	I-NP	Oserum	IgG1	serum	NN	I-NP	OIgG1	and	IgG1	NN	I-NP	Oand	IgE	and	CC	I-NP	OIgE	","	IgE	NN	I-NP	B-protein","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	plasma	as	IN	I-CONJP	Oplasma	cell	plasma	NN	B-NP	Ocell	expansion	cell	NN	I-NP	Oexpansion	and	expansion	NN	I-NP	Oand	infiltration	and	CC	O	Oinfiltration	of	infiltration	NN	B-NP	Oof	end	of	IN	B-PP	Oend	organs	end	NN	B-NP	Oorgans	.	organ	NNS	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	in	","	","	O	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	NFATc1	","	","	O	ONFATc1	and	NFATc1	NN	B-NP	B-proteinand	NFATc2	and	CC	I-NP	ONFATc2	are	NFATc2	NN	I-NP	B-proteinare	dispensable	be	VBP	B-VP	Odispensable	for	dispensable	JJ	B-ADJP	Ofor	inflammatory	for	IN	B-PP	Oinflammatory	reactivity	inflammatory	JJ	B-NP	Oreactivity	but	reactivity	NN	I-NP	Obut	are	but	CC	O	Oare	required	be	VBP	B-VP	Orequired	for	require	VBN	I-VP	Ofor	effector	for	IN	B-PP	Oeffector	differentiation	effector	NN	B-NP	Odifferentiation	","	differentiation	NN	I-NP	O","	while	","	","	O	Owhile	in	while	IN	B-SBAR	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	NFATs	","	","	O	ONFATs	regulate	NFAT	NNS	B-NP	B-proteinregulate	both	regulate	VBP	B-VP	Oboth	normal	both	CC	O	Onormal	homeostasis	normal	JJ	B-ADJP	Ohomeostasis	and	homeostasis	NN	B-NP	Oand	differentiation	and	CC	O	Odifferentiation	.	differentiation	NN	B-NP	O.	Epstein-barr	.	.	O	OEpstein-barr	virus	Epstein-barr	JJ	B-NP	B-proteinvirus	immediate-early	virus	NN	I-NP	I-proteinimmediate-early	protein	immediate-early	JJ	I-NP	I-proteinprotein	BZLF1	protein	NN	I-NP	I-proteinBZLF1	is	BZLF1	NN	I-NP	B-proteinis	SUMO-1	be	VBZ	B-VP	OSUMO-1	modified	SUMO-1	NN	B-NP	B-proteinmodified	and	modify	VBN	B-VP	Oand	disrupts	and	CC	O	Odisrupts	promyelocytic	disrupt	VBZ	B-VP	Opromyelocytic	leukemia	promyelocytic	JJ	B-NP	B-cell_typeleukemia	bodies	leukemia	NN	I-NP	I-cell_typebodies	.	body	NNS	I-NP	I-cell_type.	Although	.	.	O	OAlthough	the	Although	IN	B-SBAR	Othe	immediate-early	the	DT	B-NP	Oimmediate-early	proteins	immediate-early	JJ	I-NP	B-proteinproteins	of	protein	NNS	I-NP	I-proteinof	both	of	IN	B-PP	Oboth	herpes	both	CC	O	Oherpes	simplex	herpes	NN	B-NP	Osimplex	virus	simplex	NN	I-NP	Ovirus	(	virus	NN	I-NP	O(	HSV	(	(	O	OHSV	)	HSV	NN	B-NP	O)	and	)	)	O	Oand	cytomegalovirus	and	CC	O	Ocytomegalovirus	(	cytomegalovirus	NN	B-NP	O(	CMV	(	(	O	OCMV	)	CMV	NN	B-NP	O)	are	)	)	O	Oare	known	be	VBP	B-VP	Oknown	to	know	VBN	I-VP	Oto	modify	to	TO	I-VP	Omodify	promyelocytic	modify	VB	I-VP	Opromyelocytic	leukemia	promyelocytic	JJ	B-NP	Oleukemia	(	leukemia	NN	I-NP	O(	PML	(	(	O	OPML	)	PML	NN	B-NP	O)	(	)	)	O	O(	ND10	(	(	O	OND10	)	ND10	NN	B-NP	B-protein)	bodies	)	)	O	Obodies	in	body	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	nucleus	the	DT	B-NP	Onucleus	of	nucleus	NN	I-NP	Oof	the	of	IN	B-PP	Othe	host	the	DT	B-NP	Ohost	cell	host	NN	I-NP	Ocell	","	cell	NN	I-NP	O","	it	","	","	O	Oit	has	it	PRP	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	unclear	be	VBN	I-VP	Ounclear	whether	unclear	JJ	B-ADJP	Owhether	lytic	whether	IN	B-SBAR	Olytic	infection	lytic	JJ	B-NP	Oinfection	with	infection	NN	I-NP	Owith	gamma	with	IN	B-PP	Ogamma	herpesviruses	gamma	NN	B-NP	Oherpesviruses	induces	herpesvirus	NNS	I-NP	Oinduces	a	induce	VBZ	B-VP	Oa	similar	a	DT	B-NP	Osimilar	effect	similar	JJ	I-NP	Oeffect	.	effect	NN	I-NP	O.	The	.	.	O	OThe	PML	The	DT	B-NP	OPML	protein	PML	NN	I-NP	B-proteinprotein	is	protein	NN	I-NP	I-proteinis	induced	be	VBZ	B-VP	Oinduced	by	induce	VBN	I-VP	Oby	interferon	by	IN	B-PP	Ointerferon	","	interferon	NN	B-NP	B-protein","	involved	","	","	O	Oinvolved	in	involve	VBN	B-VP	Oin	major	in	IN	B-PP	Omajor	histocompatibility	major	JJ	B-NP	Ohistocompatibility	complex	histocompatibility	NN	I-NP	Ocomplex	class	complex	NN	I-NP	Oclass	I	class	NN	I-NP	OI	presentation	I	CD	I-NP	Opresentation	","	presentation	NN	I-NP	O","	and	","	","	O	Oand	necessary	and	CC	O	Onecessary	for	necessary	JJ	B-ADJP	Ofor	certain	for	IN	B-PP	Ocertain	types	certain	JJ	B-NP	Otypes	of	type	NNS	I-NP	Oof	apoptosis	of	IN	B-PP	Oapoptosis	.	apoptosis	NN	B-NP	O.	Therefore	.	.	O	OTherefore	","	Therefore	RB	B-ADVP	O","	it	","	","	O	Oit	is	it	PRP	B-NP	Ois	likely	be	VBZ	B-VP	Olikely	that	likely	JJ	B-ADJP	Othat	PML	that	IN	B-SBAR	OPML	bodies	PML	NN	B-NP	B-proteinbodies	function	body	NNS	I-NP	I-proteinfunction	in	function	VBP	B-VP	Oin	an	in	IN	B-PP	Oan	antiviral	an	DT	B-NP	Oantiviral	capacity	antiviral	JJ	I-NP	Ocapacity	.	capacity	NN	I-NP	O.	SUMO-1	.	.	O	OSUMO-1	modification	SUMO-1	NN	B-NP	Omodification	of	modification	NN	I-NP	Oof	PML	of	IN	B-PP	OPML	is	PML	NN	B-NP	B-proteinis	known	be	VBZ	B-VP	Oknown	to	know	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	required	be	VB	I-VP	Orequired	for	require	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	formation	the	DT	B-NP	Oformation	of	formation	NN	I-NP	Oof	PML	of	IN	B-PP	OPML	bodies	PML	NN	B-NP	B-proteinbodies	.	body	NNS	I-NP	I-protein.	To	.	.	O	OTo	examine	To	TO	B-VP	Oexamine	whether	examine	VB	I-VP	Owhether	Epstein-Barr	whether	IN	B-SBAR	OEpstein-Barr	virus	Epstein-Barr	JJ	B-NP	Ovirus	(	virus	NN	I-NP	O(	EBV	(	(	O	OEBV	)	EBV	NN	B-NP	O)	lytic	)	)	O	Olytic	replication	lytic	JJ	B-NP	Oreplication	interferes	replication	NN	I-NP	Ointerferes	with	interfere	VBZ	B-VP	Owith	PML	with	IN	B-PP	OPML	bodies	PML	NN	B-NP	B-proteinbodies	","	body	NNS	I-NP	I-protein","	we	","	","	O	Owe	expressed	we	PRP	B-NP	Oexpressed	the	express	VBD	B-VP	Othe	EBV	the	DT	B-NP	OEBV	immediate-early	EBV	NN	I-NP	B-DNAimmediate-early	genes	immediate-early	JJ	I-NP	I-DNAgenes	BZLF1	gene	NNS	I-NP	I-DNABZLF1	(	BZLF1	NN	I-NP	B-protein(	Z	(	(	O	OZ	)	Z	NN	B-NP	B-protein)	and	)	)	O	Oand	BRLF1	and	CC	O	OBRLF1	(	BRLF1	NN	B-NP	B-protein(	R	(	(	O	OR	)	R	NN	B-NP	B-protein)	in	)	)	O	Oin	EBV-positive	in	IN	B-PP	OEBV-positive	cell	EBV-positive	JJ	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	and	line	NNS	I-NP	I-cell_lineand	examined	and	CC	O	Oexamined	PML	examine	VBN	B-NP	OPML	localization	PML	NN	I-NP	Olocalization	.	localization	NN	I-NP	O.	Both	.	.	O	OBoth	Z	Both	CC	O	OZ	and	Z	NN	B-NP	B-proteinand	R	and	CC	I-NP	OR	expression	R	NN	I-NP	Oexpression	resulted	expression	NN	I-NP	Oresulted	in	result	VBD	B-VP	Oin	PML	in	IN	B-PP	OPML	dispersion	PML	NN	B-NP	Odispersion	in	dispersion	NN	I-NP	Oin	EBV-positive	in	IN	B-PP	OEBV-positive	cells	EBV-positive	JJ	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Z	.	.	O	OZ	but	Z	NN	B-NP	B-proteinbut	not	but	CC	B-NP	Onot	R	not	RB	I-NP	OR	expression	R	NN	B-NP	B-proteinexpression	is	expression	NN	I-NP	Ois	sufficient	be	VBZ	B-VP	Osufficient	to	sufficient	JJ	B-ADJP	Oto	disrupt	to	TO	B-VP	Odisrupt	PML	disrupt	VB	I-VP	OPML	bodies	PML	NN	B-NP	B-proteinbodies	in	body	NNS	I-NP	I-proteinin	EBV-negative	in	IN	B-PP	OEBV-negative	cell	EBV-negative	JJ	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	.	line	NNS	I-NP	I-cell_line.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	dispersion	that	IN	B-SBAR	Odispersion	of	dispersion	NN	B-NP	Oof	PML	of	IN	B-PP	OPML	bodies	PML	NN	B-NP	B-proteinbodies	by	body	NNS	I-NP	I-proteinby	Z	by	IN	B-PP	OZ	requires	Z	NN	B-NP	B-proteinrequires	a	require	VBZ	B-VP	Oa	portion	a	DT	B-NP	Oportion	of	portion	NN	I-NP	Oof	the	of	IN	B-PP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	activation	transcriptional	JJ	I-NP	B-proteinactivation	domain	activation	NN	I-NP	I-proteindomain	of	domain	NN	I-NP	I-proteinof	Z	of	IN	B-PP	OZ	but	Z	NN	B-NP	B-proteinbut	not	but	CC	B-NP	Onot	the	not	RB	I-NP	Othe	DNA-binding	the	DT	B-NP	ODNA-binding	function	DNA-binding	JJ	I-NP	Ofunction	.	function	NN	I-NP	O.	As	.	.	O	OAs	was	As	IN	B-SBAR	Owas	previously	be	VBD	B-VP	Opreviously	reported	previously	RB	I-VP	Oreported	for	report	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	HSV-1	the	DT	B-NP	OHSV-1	ICP0	HSV-1	NN	I-NP	OICP0	and	ICP0	NN	I-NP	B-proteinand	CMV	and	CC	O	OCMV	IE1	CMV	NN	B-NP	B-proteinIE1	proteins	IE1	NN	I-NP	I-proteinproteins	","	protein	NNS	I-NP	I-protein","	Z	","	","	O	OZ	reduces	Z	NN	B-NP	B-proteinreduces	the	reduce	VBZ	B-VP	Othe	amount	the	DT	B-NP	Oamount	of	amount	NN	I-NP	Oof	SUMO-1-modified	of	IN	B-PP	OSUMO-1-modified	PML	SUMO-1-modified	JJ	B-NP	OPML	.	PML	NN	I-NP	O.	We	.	.	O	OWe	also	We	PRP	B-NP	Oalso	found	also	RB	B-ADVP	Ofound	that	find	VBD	B-VP	Othat	Z	that	IN	B-SBAR	OZ	itself	Z	NN	B-NP	B-proteinitself	is	itself	PRP	B-NP	Ois	SUMO-1	be	VBZ	B-VP	OSUMO-1	modified	SUMO-1	NN	B-NP	B-proteinmodified	(	modify	VBN	B-VP	O(	through	(	(	O	Othrough	amino	through	IN	B-PP	Oamino	acid	amino	NN	B-NP	B-proteinacid	12	acid	NN	I-NP	I-protein12	)	12	CD	I-NP	I-protein)	and	)	)	O	Oand	that	and	CC	O	Othat	Z	that	IN	B-SBAR	OZ	competes	Z	NN	B-NP	B-proteincompetes	with	compete	VBZ	B-VP	Owith	PML	with	IN	B-PP	OPML	for	PML	NN	B-NP	B-proteinfor	limiting	for	IN	B-PP	Olimiting	amounts	limit	VBG	B-VP	Oamounts	of	amount	NNS	B-NP	Oof	SUMO-1	of	IN	B-PP	OSUMO-1	.	SUMO-1	NN	B-NP	B-protein.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	disruption	that	IN	B-SBAR	Odisruption	of	disruption	NN	B-NP	Oof	PML	of	IN	B-PP	OPML	bodies	PML	NN	B-NP	B-proteinbodies	is	body	NNS	I-NP	I-proteinis	important	be	VBZ	B-VP	Oimportant	for	important	JJ	B-ADJP	Ofor	efficient	for	IN	B-PP	Oefficient	lytic	efficient	JJ	B-NP	Olytic	replication	lytic	JJ	I-NP	Oreplication	of	replication	NN	I-NP	Oof	EBV	of	IN	B-PP	OEBV	.	EBV	NN	B-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	Z	","	","	O	OZ	may	Z	NN	B-NP	B-proteinmay	potentially	may	MD	B-VP	Opotentially	alter	potentially	RB	I-VP	Oalter	the	alter	VB	I-VP	Othe	function	the	DT	B-NP	Ofunction	of	function	NN	I-NP	Oof	a	of	IN	B-PP	Oa	variety	a	DT	B-NP	Ovariety	of	variety	NN	I-NP	Oof	cellular	of	IN	B-PP	Ocellular	proteins	cellular	JJ	B-NP	B-proteinproteins	by	protein	NNS	I-NP	I-proteinby	inhibiting	by	IN	B-PP	Oinhibiting	SUMO-1	inhibit	VBG	B-VP	OSUMO-1	modification	SUMO-1	NN	B-NP	Omodification	Suppression	modification	NN	I-NP	OSuppression	of	Suppression	NN	B-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor-kappaB	nuclear	JJ	B-NP	B-proteinfactor-kappaB	and	factor-kappaB	NN	I-NP	I-proteinand	stimulation	and	CC	I-NP	Ostimulation	of	stimulation	NN	I-NP	Oof	inhibitor	of	IN	B-PP	Oinhibitor	kappaB	inhibitor	NN	B-NP	B-proteinkappaB	by	kappaB	NN	I-NP	I-proteinby	troglitazone	by	IN	B-PP	Otroglitazone	:	troglitazone	NN	B-NP	O:	evidence	:	:	O	Oevidence	for	evidence	NN	B-NP	Ofor	an	for	IN	B-PP	Oan	anti-inflammatory	an	DT	B-NP	Oanti-inflammatory	effect	anti-inflammatory	JJ	I-NP	Oeffect	and	effect	NN	I-NP	Oand	a	and	CC	O	Oa	potential	a	DT	B-NP	Opotential	antiatherosclerotic	potential	JJ	I-NP	Oantiatherosclerotic	effect	antiatherosclerotic	JJ	I-NP	Oeffect	in	effect	NN	I-NP	Oin	the	in	IN	B-PP	Othe	obese	the	DT	B-NP	Oobese	.	obese	NN	I-NP	O.	To	.	.	O	OTo	elucidate	To	TO	B-VP	Oelucidate	whether	elucidate	VB	I-VP	Owhether	troglitazone	whether	IN	B-SBAR	Otroglitazone	exerts	troglitazone	NN	B-NP	Oexerts	an	exert	VBZ	B-VP	Oan	antiinflammatory	an	DT	B-NP	Oantiinflammatory	effect	antiinflammatory	JJ	I-NP	Oeffect	in	effect	NN	I-NP	Oin	humans	in	IN	B-PP	Ohumans	","	human	NNS	B-NP	O","	in	","	","	O	Oin	vivo	in	FW	B-ADVP	Ovivo	","	vivo	FW	I-ADVP	O","	we	","	","	O	Owe	investigated	we	PRP	B-NP	Oinvestigated	the	investigate	VBD	B-VP	Othe	suppression	the	DT	B-NP	Osuppression	of	suppression	NN	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	kappaB	factor	NN	I-NP	I-proteinkappaB	(	kappaB	NN	I-NP	I-protein(	NFkappaB	(	(	O	ONFkappaB	)	NFkappaB	NN	B-NP	B-protein)	in	)	)	O	Oin	mononuclear	in	IN	B-PP	Omononuclear	cells	mononuclear	JJ	B-NP	B-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	MNC	(	(	O	OMNC	)	MNC	NN	B-NP	B-cell_type)	by	)	)	O	Oby	this	by	IN	B-PP	Othis	drug	this	DT	B-NP	Odrug	.	drug	NN	I-NP	O.	We	.	.	O	OWe	measured	We	PRP	B-NP	Omeasured	intranuclear	measure	VBD	B-VP	Ointranuclear	NFkappaB	intranuclear	JJ	B-NP	ONFkappaB	","	NFkappaB	NN	I-NP	B-protein","	total	","	","	O	Ototal	cellular	total	JJ	B-NP	Ocellular	NFkappaB	cellular	JJ	I-NP	ONFkappaB	","	NFkappaB	NN	I-NP	B-protein","	inhibitor	","	","	O	Oinhibitor	kappaB	inhibitor	NN	B-NP	OkappaB	(	kappaB	NN	I-NP	O(	IkappaB	(	(	O	OIkappaB	)	IkappaB	NN	B-NP	B-protein)	alpha	)	)	O	Oalpha	","	alpha	NN	B-NP	O","	reactive	","	","	O	Oreactive	oxygen	reactive	JJ	B-NP	Ooxygen	species	oxygen	NN	I-NP	Ospecies	(	specie	NNS	I-NP	O(	ROS	(	(	O	OROS	)	ROS	NN	B-NP	O)	generation	)	)	O	Ogeneration	","	generation	NN	B-NP	O","	and	","	","	O	Oand	p47	and	CC	O	Op47	(	p47	NN	B-NP	B-protein(	phox	(	(	O	I-proteinphox	)	phox	NN	B-NP	I-protein)	subunit	)	)	O	I-proteinsubunit	(	subunit	NN	B-NP	I-protein(	a	(	(	O	Oa	key	a	DT	B-NP	Okey	component	key	JJ	I-NP	B-proteincomponent	protein	component	NN	I-NP	I-proteinprotein	of	protein	NN	I-NP	I-proteinof	nicotinamide	of	IN	B-PP	Onicotinamide	adenine	nicotinamide	NN	B-NP	B-proteinadenine	dinucleotide	adenine	NN	I-NP	I-proteindinucleotide	phosphate	dinucleotide	NN	I-NP	I-proteinphosphate	oxidase	phosphate	NN	I-NP	I-proteinoxidase	)	oxidase	NN	I-NP	I-protein)	in	)	)	O	Oin	MNC	in	IN	B-PP	OMNC	.	MNC	NN	B-NP	B-cell_type.	Plasma	.	.	O	OPlasma	tumor	Plasma	NN	B-NP	B-proteintumor	necrosis	tumor	NN	I-NP	I-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	TNF	(	(	O	OTNF	)	TNF	NN	B-NP	B-protein)	#NAME?	)	)	O	O#NAME?	","	#NAME?	NN	B-NP	O","	soluble	","	","	O	Osoluble	intercellular	soluble	JJ	B-NP	Ointercellular	adhesion	intercellular	JJ	I-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	(	molecule-1	NN	I-NP	I-protein(	sICAM-1	(	(	O	OsICAM-1	)	sICAM-1	NN	B-NP	B-protein)	","	)	)	O	O","	monocyte	","	","	O	Omonocyte	chemoattractant	monocyte	NN	B-NP	B-proteinchemoattractant	protein-1	chemoattractant	NN	I-NP	I-proteinprotein-1	(	protein-1	NN	I-NP	I-protein(	MCP-1	(	(	O	OMCP-1	)	MCP-1	NN	B-NP	B-protein)	","	)	)	O	O","	plasminogen	","	","	O	Oplasminogen	activator	plasminogen	NN	B-NP	B-proteinactivator	inhibitor	activator	NN	I-NP	I-proteininhibitor	type	inhibitor	NN	I-NP	I-proteintype	1	type	NN	I-NP	I-protein1	(	1	CD	I-NP	I-protein(	PAI-1	(	(	O	OPAI-1	)	PAI-1	NN	B-NP	B-protein)	","	)	)	O	O","	C-reactive	","	","	O	OC-reactive	protein	C-reactive	JJ	B-NP	B-proteinprotein	(	protein	NN	I-NP	I-protein(	CRP	(	(	O	OCRP	)	CRP	NN	B-NP	B-protein)	","	)	)	O	O","	and	","	","	O	Oand	interleukin	and	CC	O	Ointerleukin	(	interleukin	NN	B-NP	B-protein(	IL	(	(	O	I-proteinIL	)	IL	NN	B-NP	I-protein)	-10	)	)	O	I-protein-10	(	-10	CD	B-NP	I-protein(	antiinflammatory	(	(	O	Oantiinflammatory	cytokine	antiinflammatory	JJ	O	B-proteincytokine	)	cytokine	NN	O	I-protein)	concentrations	)	)	O	Oconcentrations	were	concentration	NNS	B-NP	Owere	also	be	VBD	B-VP	Oalso	measured	also	RB	I-VP	Omeasured	as	measure	VBN	I-VP	Oas	mediators	as	IN	B-PP	Omediators	of	mediator	NNS	B-NP	Oof	inflammatory	of	IN	B-PP	Oinflammatory	activity	inflammatory	JJ	B-NP	Oactivity	that	activity	NN	I-NP	Othat	are	that	WDT	B-NP	Oare	regulated	be	VBP	B-VP	Oregulated	by	regulate	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	proinflammatory	the	DT	B-NP	Oproinflammatory	transcription	proinflammatory	JJ	I-NP	B-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	NFkappaB	factor	NN	I-NP	I-proteinNFkappaB	.	NFkappaB	NN	I-NP	B-protein.	Seven	.	.	O	OSeven	nondiabetic	Seven	CD	B-NP	Onondiabetic	obese	nondiabetic	JJ	I-NP	Oobese	patients	obese	JJ	I-NP	Opatients	were	patient	NNS	I-NP	Owere	given	be	VBD	B-VP	Ogiven	400	give	VBN	I-VP	O400	mg	400	CD	B-NP	Omg	troglitazone	mg	NN	I-NP	Otroglitazone	daily	troglitazone	NN	I-NP	Odaily	for	daily	RB	B-ADVP	Ofor	4	for	IN	B-PP	O4	weeks	4	CD	B-NP	Oweeks	.	week	NNS	I-NP	O.	Blood	.	.	O	OBlood	samples	Blood	NN	B-NP	Osamples	were	sample	NNS	I-NP	Owere	collected	be	VBD	B-VP	Ocollected	before	collect	VBN	I-VP	Obefore	and	before	IN	B-PP	Oand	at	and	CC	I-PP	Oat	weekly	at	IN	I-PP	Oweekly	intervals	weekly	JJ	B-NP	Ointervals	thereafter	interval	NNS	I-NP	Othereafter	.	thereafter	RB	B-ADVP	O.	MNC	.	.	O	OMNC	were	MNC	NN	B-NP	B-cell_typewere	separated	be	VBD	B-VP	Oseparated	;	separate	VBN	I-VP	O;	and	;	:	O	Oand	the	and	CC	O	Othe	levels	the	DT	B-NP	Olevels	of	level	NNS	I-NP	Oof	intranuclear	of	IN	B-PP	Ointranuclear	NFkappaB	intranuclear	JJ	B-NP	ONFkappaB	","	NFkappaB	NN	I-NP	B-protein","	total	","	","	O	Ototal	cellular	total	JJ	B-NP	Ocellular	NFkappaB	cellular	JJ	I-NP	ONFkappaB	","	NFkappaB	NN	I-NP	B-protein","	IkappaBalpha	","	","	O	OIkappaBalpha	","	IkappaBalpha	NN	B-NP	B-protein","	and	","	","	O	Oand	p47	and	CC	O	Op47	(	p47	NN	B-NP	B-protein(	phox	(	(	O	I-proteinphox	)	phox	NN	B-NP	I-protein)	subunit	)	)	O	I-proteinsubunit	and	subunit	NN	B-NP	I-proteinand	ROS	and	CC	I-NP	OROS	generation	ROS	NN	I-NP	Ogeneration	were	generation	NN	I-NP	Owere	determined	be	VBD	B-VP	Odetermined	.	determine	VBN	I-VP	O.	Plasma	.	.	O	OPlasma	was	Plasma	NN	B-NP	Owas	used	be	VBD	B-VP	Oused	to	use	VBN	I-VP	Oto	measure	to	TO	B-VP	Omeasure	insulin	measure	VB	I-VP	Oinsulin	glucose	insulin	NN	B-NP	Oglucose	","	glucose	NN	I-NP	O","	TNFalpha	","	","	O	OTNFalpha	","	TNFalpha	NN	B-NP	B-protein","	sICAM	","	","	O	OsICAM	","	sICAM	NN	B-NP	O","	MCP-1	","	","	O	OMCP-1	","	MCP-1	NN	B-NP	B-protein","	PAI-1	","	","	O	OPAI-1	","	PAI-1	NN	B-NP	B-protein","	CRP	","	","	O	OCRP	","	CRP	NN	B-NP	B-protein","	and	","	","	O	Oand	IL-10	and	CC	O	OIL-10	.	IL-10	NN	B-NP	B-protein.	Plasma	.	.	O	OPlasma	insulin	Plasma	NN	B-NP	Oinsulin	concentrations	insulin	NN	I-NP	Oconcentrations	fell	concentration	NNS	I-NP	Ofell	significantly	fall	VBD	B-VP	Osignificantly	at	significantly	RB	B-ADVP	Oat	week	at	IN	B-PP	Oweek	1	week	NN	B-NP	O1	","	1	CD	I-NP	O","	from	","	","	O	Ofrom	31.2	from	IN	B-PP	O31.2	+/-	31.2	CD	B-NP	O+/-	29.1	+/-	SYM	I-NP	O29.1	to	29.1	CD	I-NP	Oto	14.2	to	TO	I-NP	O14.2	+/-	14.2	CD	I-NP	O+/-	11.4	+/-	SYM	I-NP	O11.4	mU/L	11.4	CD	I-NP	OmU/L	(	mU/L	NN	I-NP	O(	P	(	(	O	OP	<	P	NN	B-NP	O<	0.01	<	SYM	O	O0.01	)	0.01	CD	B-NP	O)	and	)	)	O	Oand	remained	and	CC	O	Oremained	low	remain	VBD	B-VP	Olow	throughout	low	JJ	B-ADJP	Othroughout	4	throughout	IN	B-PP	O4	weeks	4	CD	B-NP	Oweeks	.	week	NNS	I-NP	O.	Plasma	.	.	O	OPlasma	glucose	Plasma	NN	B-NP	Oglucose	concentrations	glucose	NN	I-NP	Oconcentrations	did	concentration	NNS	I-NP	Odid	not	do	VBD	B-VP	Onot	alter	not	RB	I-VP	Oalter	significantly	alter	VB	I-VP	Osignificantly	.	significantly	RB	B-ADVP	O.	There	.	.	O	OThere	was	There	EX	B-NP	Owas	a	be	VBD	B-VP	Oa	fall	a	DT	B-NP	Ofall	in	fall	NN	I-NP	Oin	intranuclear	in	IN	B-PP	Ointranuclear	NFkappaB	intranuclear	JJ	B-NP	ONFkappaB	","	NFkappaB	NN	I-NP	B-protein","	total	","	","	O	Ototal	cellular	total	JJ	B-NP	Ocellular	NFkappaB	cellular	JJ	I-NP	ONFkappaB	","	NFkappaB	NN	I-NP	B-protein","	and	","	","	O	Oand	p47	and	CC	O	Op47	(	p47	NN	B-NP	B-protein(	phox	(	(	O	I-proteinphox	)	phox	NN	B-NP	I-protein)	subunit	)	)	O	I-proteinsubunit	","	subunit	NN	B-NP	I-protein","	with	","	","	O	Owith	an	with	IN	B-PP	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	cellular	in	IN	B-PP	Ocellular	IkappaBalpha	cellular	JJ	B-NP	OIkappaBalpha	at	IkappaBalpha	NN	I-NP	B-proteinat	week	at	IN	B-PP	Oweek	2	week	NN	B-NP	O2	","	2	CD	I-NP	O","	which	","	","	O	Owhich	persisted	which	WDT	B-NP	Opersisted	until	persist	VBD	B-VP	Ountil	week	until	IN	B-SBAR	Oweek	4	week	NN	B-NP	O4	.	4	CD	I-NP	O.	There	.	.	O	OThere	was	There	EX	B-NP	Owas	a	be	VBD	B-VP	Oa	parallel	a	DT	B-NP	Oparallel	fall	parallel	JJ	I-NP	Ofall	in	fall	NN	I-NP	Oin	ROS	in	IN	B-PP	OROS	generation	ROS	NN	B-NP	Ogeneration	by	generation	NN	I-NP	Oby	MNC	by	IN	B-PP	OMNC	at	MNC	NN	B-NP	B-cell_typeat	week	at	IN	B-PP	Oweek	1	week	NN	B-NP	O1	;	1	CD	I-NP	O;	this	;	:	O	Othis	progressed	this	DT	B-NP	Oprogressed	and	progress	VBD	B-VP	Oand	persisted	and	CC	I-VP	Opersisted	until	persist	VBD	I-VP	Ountil	week	until	IN	B-SBAR	Oweek	4	week	NN	B-NP	O4	(	4	CD	I-NP	O(	P	(	(	O	OP	<	P	NN	B-NP	O<	0.001	<	SYM	O	O0.001	)	0.001	CD	B-NP	O)	.	)	)	O	O.	Plasma	.	.	O	OPlasma	TNF-alpha	Plasma	NN	B-NP	OTNF-alpha	","	TNF-alpha	NN	I-NP	B-protein","	sICAM-1	","	","	O	OsICAM-1	","	sICAM-1	NN	B-NP	O","	MCP-1	","	","	O	OMCP-1	","	MCP-1	NN	B-NP	B-protein","	and	","	","	O	Oand	PAI-1	and	CC	O	OPAI-1	concentrations	PAI-1	NN	B-NP	B-proteinconcentrations	fell	concentration	NNS	I-NP	Ofell	significantly	fall	VBD	B-VP	Osignificantly	at	significantly	RB	B-ADVP	Oat	week	at	IN	B-PP	Oweek	4	week	NN	B-NP	B-DNA4	.	4	CD	I-NP	I-DNA.	Plasma	.	.	O	OPlasma	IL-10	Plasma	NN	B-NP	OIL-10	concentration	IL-10	NN	I-NP	B-proteinconcentration	increased	concentration	NN	I-NP	Oincreased	significantly	increase	VBD	B-VP	Osignificantly	","	significantly	RB	B-ADVP	O","	whereas	","	","	O	Owhereas	plasma	whereas	IN	O	Oplasma	CRP	plasma	NN	B-NP	OCRP	concentrations	CRP	NN	I-NP	Oconcentrations	decreased	concentration	NNS	I-NP	Odecreased	.	decrease	VBD	B-VP	O.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	troglitazone	that	IN	B-SBAR	Otroglitazone	has	troglitazone	NN	B-NP	Ohas	an	have	VBZ	B-VP	Oan	antiinflammatory	an	DT	B-NP	Oantiinflammatory	action	antiinflammatory	JJ	I-NP	Oaction	that	action	NN	I-NP	Othat	may	that	WDT	B-NP	Omay	contribute	may	MD	B-VP	Ocontribute	to	contribute	VB	I-VP	Oto	its	to	TO	B-PP	Oits	putative	its	PRP$	B-NP	Oputative	antiatherosclerotic	putative	JJ	I-NP	Oantiatherosclerotic	effects	antiatherosclerotic	JJ	I-NP	Oeffects	.	effect	NNS	I-NP	O.	Tyrosine	.	.	O	OTyrosine	phosphorylation-dependent	Tyrosine	NN	B-NP	Ophosphorylation-dependent	activation	phosphorylation-dependent	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	.	B	NN	I-NP	I-protein.	Requirement	.	.	O	ORequirement	for	Requirement	NN	B-NP	Ofor	p56	for	IN	B-PP	Op56	LCK	p56	NN	B-NP	B-proteinLCK	and	LCK	NN	I-NP	I-proteinand	ZAP-70	and	CC	O	OZAP-70	protein	ZAP-70	NN	B-NP	B-proteinprotein	tyrosine	protein	NN	I-NP	I-proteintyrosine	kinases	tyrosine	NN	I-NP	I-proteinkinases	.	kinase	NNS	I-NP	I-protein.	Phosphorylation	.	.	O	OPhosphorylation	of	Phosphorylation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	N-terminal	the	DT	B-NP	ON-terminal	domain	N-terminal	JJ	I-NP	B-proteindomain	of	domain	NN	I-NP	I-proteinof	I	of	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	inhibitory	B	NN	I-NP	I-proteininhibitory	subunits	inhibitory	JJ	I-NP	I-proteinsubunits	induces	subunit	NNS	I-NP	I-proteininduces	activation	induce	VBZ	B-VP	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	NF-kappa	factor	NN	I-NP	I-proteinNF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	.	B	NN	I-NP	I-protein.	Although	.	.	O	OAlthough	serine	Although	IN	B-SBAR	Oserine	phosphorylation	serine	NN	B-NP	Ophosphorylation	has	phosphorylation	NN	I-NP	Ohas	been	have	VBZ	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	induce	to	TO	I-VP	Oinduce	ubiquitination	induce	VB	I-VP	Oubiquitination	and	ubiquitination	NN	B-NP	Oand	subsequent	and	CC	O	Osubsequent	proteasome-mediated	subsequent	JJ	B-NP	Oproteasome-mediated	degradation	proteasome-mediated	JJ	I-NP	Odegradation	of	degradation	NN	I-NP	Oof	I	of	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B-alpha	kappa	NN	I-NP	I-proteinB-alpha	","	B-alpha	NN	I-NP	I-protein","	little	","	","	O	Olittle	is	little	JJ	B-NP	Ois	known	be	VBZ	B-VP	Oknown	about	know	VBN	I-VP	Oabout	the	about	IN	B-PP	Othe	mechanisms	the	DT	B-NP	Omechanisms	that	mechanism	NNS	I-NP	Othat	lead	that	WDT	B-NP	Olead	to	lead	VBP	B-VP	Oto	release	to	TO	I-VP	Orelease	of	release	VB	I-VP	Oof	active	of	IN	B-PP	Oactive	NF-kappa	active	JJ	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	in	B	NN	I-NP	I-proteinin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	as	cell	NNS	I-NP	I-cell_typeas	a	as	IN	B-PP	Oa	consequence	a	DT	B-NP	Oconsequence	of	consequence	NN	I-NP	Oof	tyrosine	of	IN	B-PP	Otyrosine	phosphorylation	tyrosine	NN	B-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	I	of	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B-alpha	kappa	NN	I-NP	I-proteinB-alpha	[	B-alpha	NN	I-NP	I-protein[	Imbert	[	(	O	OImbert	","	Imbert	NNP	B-NP	O","	V.	","	","	O	OV.	","	V.	NNP	B-NP	O","	Rupec	","	","	O	ORupec	","	Rupec	NNP	B-NP	O","	R.A.	","	","	O	OR.A.	","	R.A.	NNP	B-NP	O","	Livolsi	","	","	O	OLivolsi	","	Livolsi	NNP	B-NP	O","	A.	","	","	O	OA.	","	A.	NNP	B-NP	O","	Pahl	","	","	O	OPahl	","	Pahl	NNP	B-NP	O","	H.L.	","	","	O	OH.L.	","	H.L.	NNP	B-NP	O","	Traenckner	","	","	O	OTraenckner	","	Traenckner	NNP	B-NP	O","	B.M.	","	","	O	OB.M.	","	B.M.	NNP	B-NP	O","	Mueller-Dieckmann	","	","	O	OMueller-Dieckmann	","	Mueller-Dieckmann	NNP	B-NP	O","	C.	","	","	O	OC.	","	C.	NNP	B-NP	O","	Farahifar	","	","	O	OFarahifar	","	Farahifar	NNP	B-NP	O","	D.	","	","	O	OD.	","	D.	NNP	B-NP	O","	Rossi	","	","	O	ORossi	","	Rossi	NNP	B-NP	O","	B.	","	","	O	OB.	","	B.	NNP	B-NP	O","	Auberger	","	","	O	OAuberger	","	Auberger	NNP	B-NP	O","	P.	","	","	O	OP.	","	P.	NNP	B-NP	O","	Baeuerle	","	","	O	OBaeuerle	","	Baeuerle	NNP	B-NP	O","	P.	","	","	O	OP.	&	P.	NNP	B-NP	O&	Peyron	&	CC	I-NP	OPeyron	","	Peyron	NNP	I-NP	O","	J.F.	","	","	O	OJ.F.	(	J.F.	NNP	B-NP	O(	1996	(	(	O	O1996	)	1996	CD	B-NP	O)	Cell	)	)	O	OCell	86	Cell	NNP	B-NP	O86	","	86	CD	I-NP	O","	787	","	","	I-NP	O787	--	787	CD	I-NP	O--	798	--	:	O	O798	]	798	CD	B-NP	O]	.	]	)	O	O.	The	.	.	O	OThe	involvement	The	DT	B-NP	Oinvolvement	of	involvement	NN	I-NP	Oof	the	of	IN	B-PP	Othe	tyrosine	the	DT	B-NP	Otyrosine	kinases	tyrosine	NN	I-NP	B-proteinkinases	p56	kinase	NNS	I-NP	I-proteinp56	(	p56	NN	I-NP	B-protein(	lck	(	(	O	I-proteinlck	)	lck	NN	B-NP	I-protein)	and	)	)	O	I-proteinand	ZAP-70	and	CC	O	OZAP-70	in	ZAP-70	NN	B-NP	B-proteinin	this	in	IN	B-PP	Othis	reaction	this	DT	B-NP	Oreaction	is	reaction	NN	I-NP	Ois	demonstrated	be	VBZ	B-VP	Odemonstrated	here	demonstrate	VBN	I-VP	Ohere	using	here	RB	B-ADVP	Ousing	specific	use	VBG	B-VP	Ospecific	pharmacological	specific	JJ	B-NP	Opharmacological	inhibitors	pharmacological	JJ	I-NP	Oinhibitors	and	inhibitor	NNS	I-NP	Oand	Jurkat	and	CC	O	OJurkat	mutants	Jurkat	NN	B-NP	B-cell_linemutants	unable	mutant	NNS	I-NP	I-cell_lineunable	to	unable	JJ	B-ADJP	Oto	express	to	TO	B-VP	Oexpress	these	express	VB	I-VP	Othese	kinases	these	DT	B-NP	Okinases	.	kinase	NNS	I-NP	B-protein.	Although	.	.	O	OAlthough	the	Although	IN	B-SBAR	Othe	inhibitors	the	DT	B-NP	Oinhibitors	prevented	inhibitor	NNS	I-NP	Oprevented	both	prevent	VBD	B-VP	Oboth	pervanadate-induced	both	CC	O	Opervanadate-induced	phosphorylation	pervanadate-induced	JJ	B-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	I	of	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B-alpha	kappa	NN	I-NP	I-proteinB-alpha	on	B-alpha	NN	I-NP	I-proteinon	Tyr42	on	IN	B-PP	OTyr42	and	Tyr42	NN	B-NP	B-proteinand	NF-kappa	and	CC	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	","	activation	NN	I-NP	O","	we	","	","	O	Owe	observed	we	PRP	B-NP	Oobserved	that	observe	VBD	B-VP	Othat	","	that	IN	B-SBAR	O","	in	","	","	O	Oin	p56	in	IN	B-PP	Op56	(	p56	NN	B-NP	B-protein(	lck	(	(	O	I-proteinlck	)	lck	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	Jurkat	#NAME?	JJ	B-NP	OJurkat	mutants	Jurkat	NN	I-NP	B-cell_linemutants	","	mutant	NNS	I-NP	I-cell_line","	NF-kappa	","	","	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	could	B	NN	I-NP	I-proteincould	still	could	MD	B-VP	Ostill	associate	still	RB	I-VP	Oassociate	with	associate	VB	I-VP	Owith	I	with	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B-alpha	kappa	NN	I-NP	I-proteinB-alpha	despite	B-alpha	NN	I-NP	I-proteindespite	phosphorylation	despite	IN	B-PP	Ophosphorylation	on	phosphorylation	NN	B-NP	Oon	Tyr42	on	IN	B-PP	OTyr42	.	Tyr42	NN	B-NP	B-protein.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	the	","	","	O	Othe	SH2	the	DT	B-NP	OSH2	domain	SH2	NN	I-NP	B-proteindomain	of	domain	NN	I-NP	I-proteinof	p56	of	IN	B-PP	Op56	(	p56	NN	B-NP	B-protein(	lck	(	(	O	I-proteinlck	)	lck	NN	B-NP	I-protein)	appeared	)	)	O	I-proteinappeared	to	appear	VBD	B-VP	Oto	be	to	TO	I-VP	Obe	required	be	VB	I-VP	Orequired	for	require	VBN	I-VP	Ofor	pervanadate-induced	for	IN	B-PP	Opervanadate-induced	NF-kappa	pervanadate-induced	JJ	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	but	activation	NN	I-NP	Obut	not	but	CC	B-PP	Onot	for	not	RB	B-PP	Ofor	Tyr42	for	IN	I-PP	OTyr42	phosphorylation	Tyr42	NN	B-NP	B-proteinphosphorylation	.	phosphorylation	NN	I-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	show	result	NNS	I-NP	Oshow	that	show	VBP	B-VP	Othat	p56	that	IN	B-SBAR	Op56	(	p56	NN	B-NP	B-protein(	lck	(	(	O	I-proteinlck	)	lck	NN	B-NP	I-protein)	and	)	)	O	I-proteinand	ZAP-70	and	CC	O	OZAP-70	are	ZAP-70	NN	B-NP	B-proteinare	key	be	VBP	B-VP	Okey	components	key	JJ	B-NP	Ocomponents	of	component	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	signaling	the	DT	B-NP	Osignaling	pathway	signaling	NN	I-NP	Opathway	that	pathway	NN	I-NP	Othat	leads	that	WDT	B-NP	Oleads	to	lead	VBZ	B-VP	Oto	phosphotyrosine-dependent	to	TO	B-PP	Ophosphotyrosine-dependent	NF-kappa	phosphotyrosine-dependent	JJ	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	in	activation	NN	I-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	confirm	and	CC	O	Oconfirm	that	confirm	VBP	B-VP	Othat	tyrosine	that	IN	B-SBAR	Otyrosine	kinases	tyrosine	NN	B-NP	B-proteinkinases	must	kinase	NNS	I-NP	I-proteinmust	control	must	MD	B-VP	Ocontrol	at	control	VB	I-VP	Oat	least	at	IN	B-NP	Oleast	two	least	JJS	I-NP	Otwo	different	two	CD	I-NP	Odifferent	steps	different	JJ	I-NP	Osteps	to	step	NNS	I-NP	Oto	induce	to	TO	B-VP	Oinduce	activation	induce	VB	I-VP	Oactivation	of	activation	NN	B-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	.	B	NN	I-NP	I-protein.	Finally	.	.	O	OFinally	","	Finally	RB	B-ADVP	O","	we	","	","	O	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	H	that	IN	B-SBAR	OH	(	H	NN	B-NP	B-protein(	2	(	(	O	I-protein2	)	2	CD	B-NP	I-protein)	O	)	)	O	I-proteinO	(	O	NN	B-NP	I-protein(	2	(	(	O	O2	)	2	CD	B-NP	O)	","	)	)	O	O","	which	","	","	O	Owhich	stimulates	which	WDT	B-NP	Ostimulates	p56	stimulate	VBZ	B-VP	Op56	(	p56	NN	B-NP	B-protein(	lck	(	(	O	I-proteinlck	)	lck	NN	B-NP	I-protein)	and	)	)	O	I-proteinand	ZAP-70	and	CC	O	OZAP-70	in	ZAP-70	NN	B-NP	B-proteinin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	is	","	","	O	Ois	an	be	VBZ	B-VP	Oan	activator	an	DT	B-NP	Oactivator	of	activator	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	through	B	NN	I-NP	I-proteinthrough	tyrosine	through	IN	B-PP	Otyrosine	phosphorylation	tyrosine	NN	B-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	I	of	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B-alpha	kappa	NN	I-NP	I-proteinB-alpha	.	B-alpha	NN	I-NP	I-protein.	Specific	.	.	O	OSpecific	missense	Specific	JJ	B-NP	Omissense	mutations	missense	JJ	I-NP	Omutations	in	mutation	NNS	I-NP	Oin	NEMO	in	IN	B-PP	ONEMO	result	NEMO	NN	B-NP	B-proteinresult	in	result	VBP	B-VP	Oin	hyper-IgM	in	IN	B-PP	Ohyper-IgM	syndrome	hyper-IgM	NN	B-NP	Osyndrome	with	syndrome	NN	I-NP	Owith	hypohydrotic	with	IN	B-PP	Ohypohydrotic	ectodermal	hypohydrotic	JJ	B-NP	Oectodermal	dysplasia	ectodermal	JJ	I-NP	Odysplasia	.	dysplasia	NN	I-NP	O.	The	.	.	O	OThe	gene	The	DT	B-NP	Ogene	that	gene	NN	I-NP	Othat	encodes	that	WDT	B-NP	Oencodes	nuclear	encode	VBZ	B-VP	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	kappaB	factor	NN	I-NP	I-proteinkappaB	(	kappaB	NN	I-NP	I-protein(	NF-kappaB	(	(	O	ONF-kappaB	)	NF-kappaB	NN	B-NP	B-protein)	essential	)	)	O	Oessential	modulator	essential	JJ	B-NP	Omodulator	(	modulator	NN	I-NP	O(	or	(	(	O	Oor	NEMO	or	CC	O	ONEMO	","	NEMO	NN	B-NP	B-protein","	also	","	","	O	Oalso	known	also	RB	B-VP	Oknown	as	know	VBN	I-VP	Oas	IKKgamma	as	IN	B-PP	OIKKgamma	)	IKKgamma	NN	B-NP	B-protein)	is	)	)	O	Ois	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	activation	for	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	NF-kappaB	factor	NN	I-NP	I-proteinNF-kappaB	.	NF-kappaB	NN	I-NP	B-protein.	We	.	.	O	OWe	describe	We	PRP	B-NP	Odescribe	mutations	describe	VBP	B-VP	Omutations	in	mutation	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	putative	the	DT	B-NP	Oputative	zinc-finger	putative	JJ	I-NP	B-proteinzinc-finger	domain	zinc-finger	NN	I-NP	I-proteindomain	of	domain	NN	I-NP	I-proteinof	NEMO	of	IN	B-PP	ONEMO	that	NEMO	NN	B-NP	B-proteinthat	result	that	WDT	B-NP	Oresult	in	result	VBP	B-VP	Oin	an	in	IN	B-PP	Oan	X-linked	an	DT	B-NP	OX-linked	primary	X-linked	JJ	I-NP	Oprimary	immunodeficiency	primary	JJ	I-NP	Oimmunodeficiency	characterized	immunodeficiency	NN	I-NP	Ocharacterized	by	characterize	VBN	B-VP	Oby	hyper-IgM	by	IN	B-PP	Ohyper-IgM	syndrome	hyper-IgM	NN	B-NP	Osyndrome	and	syndrome	NN	I-NP	Oand	hypohydrotic	and	CC	O	Ohypohydrotic	ectodermal	hypohydrotic	JJ	B-NP	Oectodermal	dysplasia	ectodermal	JJ	I-NP	Odysplasia	(	dysplasia	NN	I-NP	O(	XHM-ED	(	(	O	OXHM-ED	)	XHM-ED	NN	B-NP	O)	.	)	)	O	O.	These	.	.	O	OThese	mutations	These	DT	B-NP	Omutations	prevent	mutation	NNS	I-NP	Oprevent	CD40	prevent	VBP	B-VP	OCD40	ligand	CD40	NN	B-NP	B-proteinligand	(	ligand	NN	I-NP	I-protein(	CD40L	(	(	O	OCD40L	)	CD40L	NN	B-NP	B-protein)	#NAME?	)	)	O	O#NAME?	degradation	#NAME?	JJ	B-NP	Odegradation	of	degradation	NN	I-NP	Oof	inhibitor	of	IN	B-PP	Oinhibitor	of	inhibitor	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	alpha	NF-kappaB	NN	B-NP	B-proteinalpha	(	alpha	NN	I-NP	I-protein(	IkappaB-alpha	(	(	O	OIkappaB-alpha	)	IkappaB-alpha	NN	B-NP	B-protein)	and	)	)	O	Oand	account	and	CC	O	Oaccount	for	account	VBP	B-VP	Ofor	the	for	IN	B-PP	Othe	following	the	DT	B-NP	Ofollowing	observations	follow	VBG	I-NP	Oobservations	:	observation	NNS	I-NP	O:	B	:	:	O	OB	cells	B	NN	B-NP	B-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	XHM-ED	from	IN	B-PP	OXHM-ED	patients	XHM-ED	JJ	B-NP	Opatients	are	patient	NNS	I-NP	Oare	unable	be	VBP	B-VP	Ounable	to	unable	JJ	B-ADJP	Oto	undergo	to	TO	B-VP	Oundergo	immunoglobulin	undergo	VB	I-VP	Oimmunoglobulin	class-switch	immunoglobulin	NN	B-NP	B-proteinclass-switch	recombination	class-switch	JJ	I-NP	Orecombination	and	recombination	NN	I-NP	Oand	antigen-presenting	and	CC	O	Oantigen-presenting	cells	antigen-presenting	JJ	B-NP	B-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	APCs	(	(	O	OAPCs	)	APC	NNS	B-NP	B-cell_type)	are	)	)	O	Oare	unable	be	VBP	B-VP	Ounable	to	unable	JJ	B-ADJP	Oto	synthesize	to	TO	B-VP	Osynthesize	the	synthesize	VB	I-VP	Othe	NF-kappaB-regulated	the	DT	B-NP	ONF-kappaB-regulated	cytokines	NF-kappaB-regulated	JJ	I-NP	B-proteincytokines	interleukin	cytokine	NNS	I-NP	I-proteininterleukin	12	interleukin	NN	I-NP	B-protein12	(	12	CD	I-NP	I-protein(	IL-12	(	(	O	OIL-12	)	IL-12	NN	B-NP	B-protein)	or	)	)	O	Oor	tumor	or	CC	O	Otumor	necrosis	tumor	NN	B-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	alpha	factor	NN	I-NP	I-proteinalpha	(	alpha	NN	I-NP	I-protein(	TNF-alpha	(	(	O	OTNF-alpha	)	TNF-alpha	NN	B-NP	B-protein)	when	)	)	O	Owhen	stimulated	when	WRB	B-ADVP	Ostimulated	with	stimulate	VBN	B-VP	Owith	CD40L	with	IN	B-PP	OCD40L	.	CD40L	NN	B-NP	B-protein.	Nevertheless	.	.	O	ONevertheless	","	Nevertheless	RB	B-ADVP	O","	innate	","	","	O	Oinnate	immunity	innate	JJ	B-NP	Oimmunity	is	immunity	NN	I-NP	Ois	preserved	be	VBZ	B-VP	Opreserved	in	preserve	VBN	I-VP	Oin	XHM-ED	in	IN	B-PP	OXHM-ED	patients	XHM-ED	JJ	B-NP	Opatients	because	patient	NNS	I-NP	Obecause	APCs	because	IN	B-SBAR	OAPCs	retain	APC	NNS	B-NP	B-cell_typeretain	the	retain	VBP	B-VP	Othe	capacity	the	DT	B-NP	Ocapacity	to	capacity	NN	I-NP	Oto	respond	to	TO	B-VP	Orespond	to	respond	VB	I-VP	Oto	stimulation	to	TO	B-PP	Ostimulation	by	stimulation	NN	B-NP	Oby	lipopolysaccharide	by	IN	B-PP	Olipopolysaccharide	or	lipopolysaccharide	NN	B-NP	Oor	Staphylococcus	or	CC	O	OStaphylococcus	aureus	Staphylococcus	NNP	B-NP	B-proteinaureus	Cowan	aureus	NNP	I-NP	I-proteinCowan	's	Cowan	NNP	I-NP	I-protein's	antigen	's	POS	B-NP	I-proteinantigen	(	antigen	NN	I-NP	I-protein(	SAC	(	(	O	OSAC	)	SAC	NN	B-NP	O)	.	)	)	O	O.	Overall	.	.	O	OOverall	","	Overall	RB	B-ADVP	O","	the	","	","	O	Othe	phenotype	the	DT	B-NP	Ophenotype	observed	phenotype	NN	I-NP	Oobserved	in	observe	VBN	B-VP	Oin	XHM-ED	in	IN	B-PP	OXHM-ED	patients	XHM-ED	JJ	B-NP	Opatients	shows	patient	NNS	I-NP	Oshows	that	show	VBZ	B-VP	Othat	the	that	IN	B-SBAR	Othe	putative	the	DT	B-NP	Oputative	zinc-finger	putative	JJ	I-NP	B-proteinzinc-finger	domain	zinc-finger	NN	I-NP	I-proteindomain	of	domain	NN	I-NP	I-proteinof	NEMO	of	IN	B-PP	ONEMO	has	NEMO	NN	B-NP	B-proteinhas	a	have	VBZ	B-VP	Oa	regulatory	a	DT	B-NP	Oregulatory	function	regulatory	JJ	I-NP	Ofunction	and	function	NN	I-NP	Oand	demonstrates	and	CC	O	Odemonstrates	the	demonstrate	VBZ	B-VP	Othe	definite	the	DT	B-NP	Odefinite	requirement	definite	JJ	I-NP	Orequirement	of	requirement	NN	I-NP	Oof	CD40	of	IN	B-PP	OCD40	#NAME?	CD40	NN	B-NP	B-protein#NAME?	NF-kappaB	#NAME?	JJ	I-NP	ONF-kappaB	activation	NF-kappaB	NN	I-NP	B-proteinactivation	for	activation	NN	I-NP	Ofor	B	for	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	immunoglobulin	cell	NN	I-NP	Oimmunoglobulin	class-switching	immunoglobulin	NN	I-NP	Oclass-switching	.	class-switching	NN	I-NP	O.	Granulocytic	.	.	O	OGranulocytic	differentiation	Granulocytic	JJ	B-NP	Odifferentiation	of	differentiation	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	NB4	human	JJ	B-NP	B-cell_lineNB4	promyelocytic	NB4	NN	I-NP	I-cell_linepromyelocytic	leukemia	promyelocytic	JJ	I-NP	I-cell_lineleukemia	cells	leukemia	NN	I-NP	I-cell_linecells	induced	cell	NNS	I-NP	I-cell_lineinduced	by	induce	VBN	B-VP	Oby	all-trans	by	IN	B-PP	Oall-trans	retinoic	all-trans	JJ	B-NP	Oretinoic	acid	retinoic	JJ	I-NP	Oacid	metabolites	acid	NN	I-NP	Ometabolites	.	metabolite	NNS	I-NP	O.	The	.	.	O	OThe	metabolism	The	DT	B-NP	Ometabolism	of	metabolism	NN	I-NP	Oof	all-trans	of	IN	B-PP	Oall-trans	retinoic	all-trans	JJ	B-NP	Oretinoic	acid	retinoic	JJ	I-NP	Oacid	(	acid	NN	I-NP	O(	ATRA	(	(	O	OATRA	)	ATRA	NN	B-NP	O)	has	)	)	O	Ohas	been	have	VBZ	B-VP	Obeen	reported	be	VBN	I-VP	Oreported	to	report	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	partly	be	VB	I-VP	Opartly	responsible	partly	RB	B-ADJP	Oresponsible	for	responsible	JJ	I-ADJP	Ofor	the	for	IN	B-PP	Othe	in	the	DT	B-NP	Oin	vivo	in	FW	I-NP	Ovivo	resistance	vivo	FW	I-NP	Oresistance	to	resistance	NN	I-NP	Oto	ATRA	to	TO	B-PP	OATRA	seen	ATRA	NN	B-NP	Oseen	in	see	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	of	treatment	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	acute	human	JJ	B-NP	Oacute	promyelocytic	acute	JJ	I-NP	Opromyelocytic	leukemia	promyelocytic	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	APL	(	(	O	OAPL	)	APL	NN	B-NP	O)	.	)	)	O	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	ATRA	","	","	O	OATRA	metabolism	ATRA	NN	B-NP	Ometabolism	appears	metabolism	NN	I-NP	Oappears	to	appear	VBZ	B-VP	Oto	be	to	TO	I-VP	Obe	involved	be	VB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	growth	the	DT	B-NP	Ogrowth	inhibition	growth	NN	I-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	several	of	IN	B-PP	Oseveral	cancer	several	JJ	B-NP	Ocancer	cell	cancer	NN	I-NP	Ocell	lines	cell	NN	I-NP	Olines	in	line	NNS	I-NP	Oin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	The	.	.	O	OThe	purpose	The	DT	B-NP	Opurpose	of	purpose	NN	I-NP	Oof	this	of	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	was	study	NN	I-NP	Owas	to	be	VBD	B-VP	Oto	evaluate	to	TO	B-VP	Oevaluate	the	evaluate	VB	I-VP	Othe	in	the	DT	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	activity	vitro	FW	I-NP	Oactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	principal	the	DT	B-NP	Oprincipal	metabolites	principal	JJ	I-NP	Ometabolites	of	metabolite	NNS	I-NP	Oof	ATRA	of	IN	B-PP	OATRA	[	ATRA	NN	B-NP	O[	4-hydroxy-retinoic	[	(	O	O4-hydroxy-retinoic	acid	4-hydroxy-retinoic	JJ	B-NP	Oacid	(	acid	NN	I-NP	O(	4-OH-RA	(	(	O	O4-OH-RA	)	4-OH-RA	NN	B-NP	O)	","	)	)	O	O","	18-hydroxy-retinoic	","	","	O	O18-hydroxy-retinoic	acid	18-hydroxy-retinoic	JJ	B-NP	Oacid	(	acid	NN	I-NP	O(	18-OH-RA	(	(	O	O18-OH-RA	)	18-OH-RA	NN	B-NP	O)	","	)	)	O	O","	4-oxo-retinoic	","	","	O	O4-oxo-retinoic	acid	4-oxo-retinoic	JJ	B-NP	Oacid	(	acid	NN	I-NP	O(	4-oxo-RA	(	(	O	O4-oxo-RA	)	4-oxo-RA	NN	B-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	5	and	CC	O	O5	","	5	CD	B-NP	O","	6-epoxy-retinoic	","	","	O	O6-epoxy-retinoic	acid	6-epoxy-retinoic	JJ	B-NP	Oacid	(	acid	NN	I-NP	O(	5	(	(	O	O5	","	5	CD	B-NP	O","	6-epoxy-RA	","	","	O	O6-epoxy-RA	)	6-epoxy-RA	NN	B-NP	O)	]	)	)	O	O]	in	]	)	O	Oin	NB4	in	IN	B-PP	ONB4	","	NB4	NN	B-NP	B-cell_line","	a	","	","	O	Oa	human	a	DT	B-NP	Ohuman	promyelocytic	human	JJ	I-NP	B-cell_linepromyelocytic	leukemia	promyelocytic	JJ	I-NP	I-cell_lineleukemia	cell	leukemia	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	that	line	NN	I-NP	I-cell_linethat	exhibits	that	WDT	B-NP	Oexhibits	the	exhibit	VBZ	B-VP	Othe	APL	the	DT	B-NP	OAPL	diagnostic	APL	NN	I-NP	Odiagnostic	t	diagnostic	JJ	I-NP	Ot	(	t	NN	I-NP	O(	15	(	(	O	O15	;	15	CD	B-NP	O;	17	;	:	O	O17	)	17	CD	B-NP	O)	chromosomal	)	)	I-NP	Ochromosomal	translocation	chromosomal	JJ	I-NP	Otranslocation	and	translocation	NN	I-NP	Oand	expresses	and	CC	O	Oexpresses	the	express	VBZ	B-VP	Othe	PML-RAR	the	DT	B-NP	OPML-RAR	alpha	PML-RAR	NN	I-NP	B-proteinalpha	fusion	alpha	NN	I-NP	I-proteinfusion	protein	fusion	NN	I-NP	I-proteinprotein	.	protein	NN	I-NP	I-protein.	We	.	.	O	OWe	established	We	PRP	B-NP	Oestablished	that	establish	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	four	the	DT	B-NP	Ofour	ATRA	four	CD	I-NP	OATRA	metabolites	ATRA	NN	I-NP	Ometabolites	were	metabolite	NNS	I-NP	Owere	indeed	be	VBD	B-VP	Oindeed	formed	indeed	RB	I-VP	Oformed	by	form	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	NB4	the	DT	B-NP	ONB4	cells	NB4	NN	I-NP	B-cell_linecells	in	cell	NNS	I-NP	I-cell_linein	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	NB4	.	.	O	ONB4	cell	NB4	NN	B-NP	Ocell	growth	cell	NN	I-NP	Ogrowth	was	growth	NN	I-NP	Owas	inhibited	be	VBD	B-VP	Oinhibited	(	inhibit	VBN	I-VP	O(	69-78	(	(	O	O69-78	%	69-78	CD	B-NP	O%	at	%	NN	I-NP	Oat	120	at	IN	B-PP	O120	h	120	CD	B-NP	Oh	)	h	NN	I-NP	O)	and	)	)	O	Oand	cell	and	CC	O	Ocell	cycle	cell	NN	B-NP	Ocycle	progression	cycle	NN	I-NP	Oprogression	in	progression	NN	I-NP	Oin	the	in	IN	B-PP	Othe	G1	the	DT	B-NP	OG1	phase	G1	NN	I-NP	Ophase	(	phase	NN	I-NP	O(	82-85	(	(	O	O82-85	%	82-85	CD	B-NP	O%	at	%	NN	I-NP	Oat	120	at	IN	B-PP	O120	h	120	CD	B-NP	Oh	)	h	NN	I-NP	O)	was	)	)	O	Owas	blocked	be	VBD	B-VP	Oblocked	by	block	VBN	I-VP	Oby	ATRA	by	IN	B-PP	OATRA	and	ATRA	NN	B-NP	Oand	all	and	CC	O	Oall	of	all	DT	B-NP	Oof	the	of	IN	B-PP	Othe	metabolites	the	DT	B-NP	Ometabolites	at	metabolite	NNS	I-NP	Oat	1	at	IN	B-PP	O1	microM	1	CD	B-NP	OmicroM	concentration	microM	NN	I-NP	Oconcentration	.	concentration	NN	I-NP	O.	ATRA	.	.	O	OATRA	and	ATRA	NN	B-NP	Oand	its	and	CC	O	Oits	metabolites	its	PRP$	B-NP	Ometabolites	could	metabolite	NNS	I-NP	Ocould	induce	could	MD	B-VP	Oinduce	NB4	induce	VB	I-VP	ONB4	cells	NB4	NN	B-NP	B-cell_linecells	differentiation	cell	NNS	I-NP	I-cell_linedifferentiation	with	differentiation	NN	B-VP	Owith	similar	with	IN	B-PP	Osimilar	activity	similar	JJ	B-NP	Oactivity	","	activity	NN	I-NP	O","	as	","	","	O	Oas	evaluated	as	IN	B-SBAR	Oevaluated	by	evaluate	VBN	B-VP	Oby	cell	by	IN	B-PP	Ocell	morphology	cell	NN	B-NP	Omorphology	","	morphology	NN	I-NP	O","	by	","	","	O	Oby	the	by	IN	B-PP	Othe	nitroblue	the	DT	B-NP	Onitroblue	tetrazolium	nitroblue	JJ	I-NP	Otetrazolium	reduction	tetrazolium	NN	I-NP	Oreduction	test	reduction	NN	I-NP	Otest	(	test	NN	I-NP	O(	82-88	(	(	O	O82-88	%	82-88	CD	B-NP	O%	at	%	NN	I-NP	Oat	120	at	IN	B-PP	O120	h	120	CD	B-NP	Oh	)	h	NN	I-NP	O)	or	)	)	O	Oor	by	or	CC	O	Oby	the	by	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	maturation	the	DT	B-NP	Omaturation	specific	maturation	NN	I-NP	Ospecific	cell	specific	JJ	I-NP	Ocell	surface	cell	NN	I-NP	Osurface	marker	surface	NN	I-NP	Omarker	CD11c	marker	NN	I-NP	OCD11c	.	CD11c	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	nuclear	","	","	O	Onuclear	body	nuclear	JJ	B-NP	Obody	reorganization	body	NN	I-NP	Oreorganization	to	reorganization	NN	I-NP	Oto	macropunctated	to	TO	B-PP	Omacropunctated	structures	macropunctate	VBN	B-NP	Ostructures	","	structure	NNS	I-NP	O","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	the	as	IN	I-CONJP	Othe	degradation	the	DT	B-NP	Odegradation	of	degradation	NN	I-NP	Oof	PML-RAR	of	IN	B-PP	OPML-RAR	alpha	PML-RAR	NN	B-NP	B-proteinalpha	","	alpha	NN	I-NP	I-protein","	was	","	","	O	Owas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	similar	be	VB	I-VP	Osimilar	for	similar	JJ	B-ADJP	Ofor	ATRA	for	IN	B-PP	OATRA	and	ATRA	NN	B-NP	Oand	all	and	CC	O	Oall	of	all	DT	B-NP	Oof	its	of	IN	B-PP	Oits	metabolites	its	PRP$	B-NP	Ometabolites	.	metabolite	NNS	I-NP	O.	Comparison	.	.	O	OComparison	of	Comparison	NN	B-NP	Oof	the	of	IN	B-PP	Othe	relative	the	DT	B-NP	Orelative	potency	relative	JJ	I-NP	Opotency	of	potency	NN	I-NP	Oof	the	of	IN	B-PP	Othe	retinoids	the	DT	B-NP	Oretinoids	using	retinoid	NNS	I-NP	Ousing	the	use	VBG	B-VP	Othe	nitroblue	the	DT	B-NP	Onitroblue	tetrazolium	nitroblue	JJ	I-NP	Otetrazolium	reduction	tetrazolium	NN	I-NP	Oreduction	test	reduction	NN	I-NP	Otest	showed	test	NN	I-NP	Oshowed	effective	show	VBD	B-VP	Oeffective	concentrations	effective	JJ	B-NP	Oconcentrations	required	concentration	NNS	I-NP	Orequired	to	require	VBN	B-VP	Oto	differentiate	to	TO	I-VP	Odifferentiate	50	differentiate	VB	I-VP	O50	%	50	CD	B-NP	O%	of	%	NN	I-NP	Oof	cells	of	IN	B-PP	Ocells	in	cell	NNS	B-NP	Oin	72	in	IN	B-PP	O72	h	72	CD	B-NP	Oh	as	h	NN	I-NP	Oas	follows	as	IN	B-SBAR	Ofollows	:	follow	VBZ	B-VP	O:	ATRA	:	:	O	OATRA	","	ATRA	NN	B-NP	O","	15.8	","	","	O	O15.8	+/-	15.8	CD	B-NP	O+/-	1.7	+/-	SYM	I-NP	O1.7	nM	1.7	CD	I-NP	OnM	;	nM	NN	I-NP	O;	4-oxo-RA	;	:	O	O4-oxo-RA	","	4-oxo-RA	NN	B-NP	O","	38.3	","	","	O	O38.3	+/-	38.3	CD	B-NP	O+/-	1.3	+/-	SYM	I-NP	O1.3	nM	1.3	CD	I-NP	OnM	;	nM	NN	I-NP	O;	18-OH-RA	;	:	O	O18-OH-RA	","	18-OH-RA	NN	B-NP	O","	55.5	","	","	O	O55.5	+/-	55.5	CD	B-NP	O+/-	1.8	+/-	SYM	I-NP	O1.8	nM	1.8	CD	I-NP	OnM	;	nM	NN	I-NP	O;	4-OH-RA	;	:	O	O4-OH-RA	","	4-OH-RA	NN	B-NP	O","	79.8	","	","	O	O79.8	+/-	79.8	CD	B-NP	O+/-	1.8	+/-	SYM	I-NP	O1.8	nM	1.8	CD	I-NP	OnM	;	nM	NN	I-NP	O;	and	;	:	O	Oand	5	and	CC	O	O5	","	5	CD	B-NP	O","	6-epoxy-RA	","	","	O	O6-epoxy-RA	","	6-epoxy-RA	NN	B-NP	O","	99.5	","	","	O	O99.5	+/-	99.5	CD	B-NP	O+/-	1.5	+/-	SYM	I-NP	O1.5	nM	1.5	CD	I-NP	OnM	.	nM	NN	I-NP	O.	The	.	.	O	OThe	ATRA	The	DT	B-NP	OATRA	metabolites	ATRA	NN	I-NP	Ometabolites	were	metabolite	NNS	I-NP	Owere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	exert	to	TO	I-VP	Oexert	their	exert	VB	I-VP	Otheir	differentiation	their	PRP$	B-NP	Odifferentiation	effects	differentiation	NN	I-NP	Oeffects	via	effect	NNS	I-NP	Ovia	the	via	IN	B-PP	Othe	RAR	the	DT	B-NP	ORAR	alpha	RAR	NN	I-NP	B-proteinalpha	nuclear	alpha	NN	I-NP	I-proteinnuclear	receptors	nuclear	JJ	I-NP	I-proteinreceptors	","	receptor	NNS	I-NP	I-protein","	because	","	","	O	Obecause	the	because	IN	B-SBAR	Othe	RAR	the	DT	B-NP	ORAR	alpha-specific	RAR	NN	I-NP	B-proteinalpha-specific	antagonist	alpha-specific	JJ	I-NP	Oantagonist	BMS614	antagonist	NN	I-NP	OBMS614	blocked	BMS614	NN	I-NP	Oblocked	metabolite-induced	block	VBD	B-VP	Ometabolite-induced	CD11c	metabolite-induced	JJ	B-NP	OCD11c	expression	CD11c	NN	I-NP	Oexpression	in	expression	NN	I-NP	Oin	NB4	in	IN	B-PP	ONB4	cells	NB4	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	demonstrate	datum	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	principal	the	DT	B-NP	Oprincipal	ATRA	principal	JJ	I-NP	OATRA	Phase	ATRA	NN	I-NP	OPhase	1	Phase	NN	I-NP	O1	metabolites	1	CD	B-NP	Ometabolites	can	metabolite	NNS	I-NP	Ocan	elicit	can	MD	B-VP	Oelicit	leukemia	elicit	VB	I-VP	Oleukemia	cell	leukemia	NN	B-NP	Ocell	growth	cell	NN	I-NP	Ogrowth	inhibition	growth	NN	I-NP	Oinhibition	and	inhibition	NN	I-NP	Oand	differentiation	and	CC	O	Odifferentiation	in	differentiation	NN	B-NP	Oin	vitro	in	FW	B-ADVP	Ovitro	through	vitro	FW	I-ADVP	Othrough	the	through	IN	B-PP	Othe	RAR	the	DT	B-NP	ORAR	alpha	RAR	NN	I-NP	B-proteinalpha	signaling	alpha	NN	I-NP	I-proteinsignaling	pathway	signaling	NN	I-NP	Opathway	","	pathway	NN	I-NP	O","	and	","	","	O	Oand	they	and	CC	O	Othey	suggest	they	PRP	B-NP	Osuggest	that	suggest	VBP	B-VP	Othat	these	that	IN	B-SBAR	Othese	metabolites	these	DT	B-NP	Ometabolites	may	metabolite	NNS	I-NP	Omay	play	may	MD	B-VP	Oplay	a	play	VB	I-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	ATRA	in	IN	B-PP	OATRA	antileukemic	ATRA	NN	B-NP	Oantileukemic	activity	antileukemic	JJ	I-NP	Oactivity	in	activity	NN	I-NP	Oin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	Expression	.	.	O	OExpression	of	Expression	NN	B-NP	Oof	oestrogen	of	IN	B-PP	Ooestrogen	and	oestrogen	NN	B-NP	Oand	progesterone	and	CC	O	Oprogesterone	receptors	progesterone	NN	B-NP	B-proteinreceptors	by	receptor	NNS	B-NP	I-proteinby	mast	by	IN	B-PP	Omast	cells	mast	NN	B-NP	B-cell_typecells	alone	cell	NNS	I-NP	I-cell_typealone	","	alone	RB	B-ADVP	O","	but	","	","	O	Obut	not	but	CC	B-NP	Onot	lymphocytes	not	RB	I-NP	Olymphocytes	","	lymphocyte	NNS	B-NP	B-cell_type","	macrophages	","	","	O	Omacrophages	or	macrophage	NNS	B-NP	B-cell_typeor	other	or	CC	O	Oother	immune	other	JJ	B-NP	Oimmune	cells	immune	JJ	I-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	human	in	IN	B-PP	Ohuman	upper	human	JJ	B-NP	Oupper	airways	upper	JJ	I-NP	Oairways	.	airway	NNS	I-NP	O.	BACKGROUND	.	.	O	OBACKGROUND	:	BACKGROUND	NN	B-NP	O:	Nasal	:	:	O	ONasal	polyposis	Nasal	JJ	B-NP	Opolyposis	often	polyposis	NN	I-NP	Ooften	coexists	often	RB	B-ADVP	Ocoexists	with	coexist	VBZ	B-VP	Owith	asthma	with	IN	B-PP	Oasthma	in	asthma	NN	B-NP	Oin	airway	in	IN	B-PP	Oairway	inflammatory	airway	NN	B-NP	Oinflammatory	conditions	inflammatory	JJ	I-NP	Oconditions	characterised	condition	NNS	I-NP	Ocharacterised	by	characterise	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	infiltration	the	DT	B-NP	Oinfiltration	of	infiltration	NN	I-NP	Oof	a	of	IN	B-PP	Oa	range	a	DT	B-NP	Orange	of	range	NN	I-NP	Oof	immune	of	IN	B-PP	Oimmune	cells	immune	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	A	.	.	O	OA	potentially	A	DT	B-NP	Opotentially	important	potentially	RB	I-NP	Oimportant	role	important	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	ovarian	for	IN	B-PP	Oovarian	hormones	ovarian	JJ	B-NP	Ohormones	has	hormone	NNS	I-NP	Ohas	been	have	VBZ	B-VP	Obeen	implicated	be	VBN	I-VP	Oimplicated	in	implicate	VBN	I-VP	Oin	airway	in	IN	B-PP	Oairway	inflammation	airway	NN	B-NP	Oinflammation	but	inflammation	NN	I-NP	Obut	the	but	CC	O	Othe	cellular	the	DT	B-NP	Ocellular	target	cellular	JJ	I-NP	Otarget	for	target	NN	I-NP	Ofor	such	for	IN	B-PP	Osuch	action	such	JJ	B-NP	Oaction	is	action	NN	I-NP	Ois	not	be	VBZ	B-VP	Onot	known	not	RB	O	Oknown	.	know	VBN	B-ADJP	O.	METHODS	.	.	O	OMETHODS	:	METHODS	NNS	B-NP	O:	Expression	:	:	O	OExpression	of	Expression	NN	B-NP	Oof	oestrogen	of	IN	B-PP	Ooestrogen	receptors	oestrogen	NN	B-NP	B-proteinreceptors	(	receptor	NNS	I-NP	I-protein(	ER	(	(	O	OER	)	ER	NN	B-NP	B-protein)	and	)	)	O	Oand	progesterone	and	CC	O	Oprogesterone	receptors	progesterone	NN	B-NP	B-proteinreceptors	(	receptor	NNS	B-NP	I-protein(	PR	(	(	O	OPR	)	PR	NN	B-NP	B-protein)	was	)	)	O	Owas	examined	be	VBD	B-VP	Oexamined	using	examine	VBN	I-VP	Ousing	immunohistochemistry	use	VBG	B-VP	Oimmunohistochemistry	in	immunohistochemistry	NN	B-NP	Oin	formalin	in	IN	B-PP	Oformalin	fixed	formalin	NN	B-NP	Ofixed	nasal	fixed	JJ	I-NP	Onasal	polyp	nasal	JJ	I-NP	Opolyp	tissues	polyp	NN	I-NP	Otissues	from	tissue	NNS	I-NP	Ofrom	47	from	IN	B-PP	O47	subjects	47	CD	B-NP	Osubjects	.	subject	NNS	I-NP	O.	The	.	.	O	OThe	cells	The	DT	B-NP	Ocells	positive	cell	NNS	I-NP	Opositive	for	positive	JJ	B-ADJP	Ofor	ER	for	IN	B-PP	OER	or	ER	NN	B-NP	B-proteinor	PR	or	CC	I-NP	OPR	were	PR	NN	I-NP	B-proteinwere	confirmed	be	VBD	B-VP	Oconfirmed	by	confirm	VBN	I-VP	Oby	spatial	by	IN	B-PP	Ospatial	location	spatial	JJ	B-NP	Olocation	","	location	NN	I-NP	O","	dual	","	","	O	Odual	immunolabelling	dual	JJ	B-NP	Oimmunolabelling	","	immunolabelling	NN	I-NP	O","	and	","	","	O	Oand	histochemical	and	CC	O	Ohistochemical	staining	histochemical	JJ	B-NP	Ostaining	.	staining	NN	I-NP	O.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	Consistent	:	:	O	OConsistent	with	Consistent	JJ	B-ADJP	Owith	the	with	IN	B-PP	Othe	known	the	DT	B-NP	Oknown	features	known	JJ	I-NP	Ofeatures	of	feature	NNS	I-NP	Oof	nasal	of	IN	B-PP	Onasal	polyps	nasal	JJ	B-NP	Opolyps	","	polyp	NNS	I-NP	O","	CD4+	","	","	O	OCD4+	(	CD4+	JJ	B-NP	O(	T	(	(	I-NP	OT	helper/inducer	T	NN	I-NP	Ohelper/inducer	)	helper/inducer	NN	I-NP	O)	","	)	)	O	O","	CD8+	","	","	O	OCD8+	(	CD8+	JJ	B-ADJP	B-protein(	cytotoxic/suppressor	(	(	O	Ocytotoxic/suppressor	)	cytotoxic/suppressor	NN	B-NP	B-protein)	","	)	)	O	O","	CD68+	","	","	O	OCD68+	(	CD68+	JJ	B-ADJP	O(	macrophages	(	(	O	Omacrophages	)	macrophage	NNS	B-NP	B-cell_type)	","	)	)	O	O","	mast	","	","	O	Omast	cells	mast	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	eosinophils	","	","	O	Oeosinophils	and	eosinophil	NNS	B-NP	B-cell_typeand	neutrophils	and	CC	I-NP	Oneutrophils	were	neutrophil	NNS	I-NP	B-cell_typewere	all	be	VBD	B-VP	Oall	clearly	all	DT	O	Oclearly	detected	clearly	RB	B-VP	Odetected	by	detect	VBN	I-VP	Oby	their	by	IN	B-PP	Otheir	relevant	their	PRP$	B-NP	Orelevant	monoclonal	relevant	JJ	I-NP	B-proteinmonoclonal	antibodies	monoclonal	JJ	I-NP	I-proteinantibodies	or	antibody	NNS	I-NP	I-proteinor	appropriate	or	CC	O	Oappropriate	histochemical	appropriate	JJ	B-NP	Ohistochemical	staining	histochemical	JJ	I-NP	Ostaining	","	staining	NN	I-NP	O","	but	","	","	O	Obut	only	but	CC	O	Oonly	mast	only	RB	B-NP	Omast	cells	mast	NN	I-NP	B-cell_typecells	tested	cell	NNS	I-NP	I-cell_typetested	positive	test	VBD	B-VP	Opositive	for	positive	JJ	B-ADJP	Ofor	ER	for	IN	B-PP	OER	/PR	ER	NN	B-NP	B-protein/PR	labelling	/PR	NN	I-NP	I-proteinlabelling	with	label	VBG	B-VP	Owith	their	with	IN	B-PP	Otheir	polyclonal	their	PRP$	B-NP	Opolyclonal	and	polyclonal	JJ	I-NP	Oand	monoclonal	and	CC	I-NP	Omonoclonal	antibodies	monoclonal	JJ	I-NP	B-proteinantibodies	.	antibody	NNS	I-NP	I-protein.	The	.	.	O	OThe	frequencies	The	DT	B-NP	Ofrequencies	for	frequency	NNS	I-NP	Ofor	expression	for	IN	B-PP	Oexpression	were	expression	NN	B-NP	Owere	61.7	be	VBD	B-VP	O61.7	%	61.7	CD	B-NP	O%	for	%	NN	I-NP	Ofor	ER	for	IN	B-PP	OER	positive	ER	NN	B-NP	B-proteinpositive	and	positive	JJ	I-NP	Oand	59.6	and	CC	O	O59.6	%	59.6	CD	B-NP	O%	for	%	NN	I-NP	Ofor	PR	for	IN	B-PP	OPR	positive	PR	NN	B-NP	B-proteinpositive	cells	positive	JJ	I-NP	Ocells	.	cell	NNS	I-NP	O.	The	.	.	O	OThe	expression	The	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	ER	of	IN	B-PP	OER	/	ER	NN	B-NP	B-protein/	PR	/	SYM	B-NP	OPR	was	PR	NN	I-NP	B-proteinwas	independent	be	VBD	B-VP	Oindependent	of	independent	JJ	B-ADJP	Oof	patient	of	IN	B-PP	Opatient	sex	patient	NN	B-NP	Osex	and	sex	NN	I-NP	Oand	age	and	CC	I-NP	Oage	but	age	NN	I-NP	Obut	was	but	CC	O	Owas	highly	be	VBD	B-VP	Ohighly	correlated	highly	RB	I-VP	Ocorrelated	with	correlate	VBN	I-VP	Owith	the	with	IN	B-PP	Othe	numbers	the	DT	B-NP	Onumbers	of	number	NNS	I-NP	Oof	mast	of	IN	B-PP	Omast	cells	mast	NN	B-NP	B-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	r	(	(	O	Or	=	r	NN	B-NP	O=	0.973	=	SYM	B-VP	O0.973	","	0.973	CD	B-NP	O","	p	","	","	O	Op	<	p	NN	B-NP	O<	0.001	<	SYM	B-VP	O0.001	for	0.001	CD	B-NP	Ofor	ER	for	IN	B-PP	OER	;	ER	NN	B-NP	B-protein;	r	;	:	O	Or	=	r	NN	B-NP	O=	0.955	=	SYM	B-VP	O0.955	","	0.955	CD	B-NP	O","	p	","	","	O	Op	<	p	NN	B-NP	O<	0.001	<	SYM	B-VP	O0.001	for	0.001	CD	B-NP	Ofor	PR	for	IN	B-PP	OPR	)	PR	NN	B-NP	B-protein)	.	)	)	O	O.	Fewer	.	.	O	OFewer	than	Few	JJR	B-NP	Othan	5	than	IN	I-NP	O5	%	5	CD	I-NP	O%	of	%	NN	I-NP	Oof	mast	of	IN	B-PP	Omast	cells	mast	NN	B-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	negative	be	VB	I-VP	Onegative	for	negative	JJ	B-ADJP	Ofor	ER	for	IN	B-PP	OER	/	ER	NN	B-NP	B-protein/	PR	/	SYM	O	OPR	expression	PR	NN	B-NP	B-proteinexpression	.	expression	NN	I-NP	O.	CONCLUSIONS	.	.	O	OCONCLUSIONS	:	CONCLUSIONS	NNS	B-NP	O:	Mast	:	:	O	OMast	cells	Mast	JJ	B-NP	B-cell_typecells	alone	cell	NNS	I-NP	I-cell_typealone	","	alone	RB	B-ADVP	O","	but	","	","	O	Obut	not	but	CC	B-NP	Onot	lymphocytes	not	RB	I-NP	Olymphocytes	","	lymphocyte	NNS	B-NP	B-cell_type","	macrophages	","	","	O	Omacrophages	","	macrophage	NNS	B-NP	B-cell_type","	or	","	","	O	Oor	other	or	CC	O	Oother	immune	other	JJ	B-NP	Oimmune	cells	immune	JJ	I-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	express	","	","	O	Oexpress	ER	express	VBP	B-VP	OER	/	ER	NN	B-NP	B-protein/	PR	/	SYM	B-NP	OPR	in	PR	NN	I-NP	B-proteinin	human	in	IN	B-PP	Ohuman	upper	human	JJ	B-NP	Oupper	airways	upper	JJ	I-NP	Oairways	.	airway	NNS	I-NP	O.	Numerous	.	.	O	ONumerous	ER/PR	Numerous	JJ	B-NP	OER/PR	positive	ER/PR	NN	I-NP	Opositive	mast	positive	JJ	I-NP	Omast	cells	mast	NN	I-NP	Ocells	exist	cell	NNS	I-NP	Oexist	in	exist	VBP	B-VP	Oin	nasal	in	IN	B-PP	Onasal	polyps	nasal	JJ	B-NP	Opolyps	","	polyp	NNS	I-NP	O","	indicating	","	","	O	Oindicating	that	indicate	VBG	B-VP	Othat	this	that	IN	B-SBAR	Othis	may	this	DT	B-NP	Omay	be	may	MD	B-VP	Obe	a	be	VB	I-VP	Oa	major	a	DT	B-NP	Omajor	route	major	JJ	I-NP	Oroute	for	route	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	involvement	the	DT	B-NP	Oinvolvement	of	involvement	NN	I-NP	Oof	sex	of	IN	B-PP	Osex	hormones	sex	NN	B-NP	Ohormones	in	hormone	NNS	I-NP	Oin	airway	in	IN	B-PP	Oairway	inflammation	airway	NN	B-NP	Oinflammation	when	inflammation	NN	I-NP	Owhen	exposed	when	WRB	B-ADVP	Oexposed	to	expose	VBN	B-VP	Oto	the	to	TO	B-PP	Othe	higher	the	DT	B-NP	Ohigher	and	high	JJR	I-NP	Oand	varying	and	CC	I-NP	Ovarying	concentration	vary	VBG	I-NP	Oconcentration	of	concentration	NN	I-NP	Oof	oestrogen	of	IN	B-PP	Ooestrogen	and	oestrogen	NN	B-NP	Oand	progesterone	and	CC	O	Oprogesterone	characteristic	progesterone	NN	B-NP	Ocharacteristic	of	characteristic	JJ	B-ADJP	Oof	females	of	IN	B-PP	Ofemales	.	female	NNS	B-NP	O.	NF	.	.	O	ONF	kappa	NF	NN	B-NP	B-proteinkappa	b	kappa	NN	I-NP	I-proteinb	signaling	b	NN	I-NP	I-proteinsignaling	in	signaling	NN	I-NP	Oin	posthypoxic	in	IN	B-PP	Oposthypoxic	endothelial	posthypoxic	JJ	B-NP	B-cell_typeendothelial	cells	endothelial	JJ	I-NP	I-cell_typecells	:	cell	NNS	I-NP	I-cell_type:	relevance	:	:	O	Orelevance	to	relevance	NN	B-NP	Oto	E-selectin	to	TO	B-PP	OE-selectin	expression	E-selectin	NN	B-NP	B-proteinexpression	and	expression	NN	B-NP	Oand	neutrophil	and	CC	O	Oneutrophil	adhesion	neutrophil	NN	B-NP	B-cell_typeadhesion	.	adhesion	NN	I-NP	O.	Our	.	.	O	OOur	previous	Our	PRP$	B-NP	Oprevious	studies	previous	JJ	I-NP	Ostudies	have	study	NNS	I-NP	Ohave	implicated	have	VBP	B-VP	Oimplicated	the	implicate	VBN	I-VP	Othe	nuclear	the	DT	B-NP	Onuclear	transcription	nuclear	JJ	I-NP	Otranscription	factor	transcription	NN	I-NP	Ofactor	kappa	factor	NN	I-NP	Okappa	B	kappa	NN	I-NP	OB	(	B	NN	I-NP	O(	NF	(	(	O	ONF	kappa	NF	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	)	B	NN	I-NP	I-protein)	in	)	)	O	Oin	the	in	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	adhesion	of	IN	B-PP	Oadhesion	molecule	adhesion	NN	B-NP	B-proteinmolecule	expression	molecule	NN	I-NP	I-proteinexpression	in	expression	NN	I-NP	Oin	endothelial	in	IN	B-PP	Oendothelial	cells	endothelial	JJ	B-NP	B-cell_typecells	exposed	cell	NNS	I-NP	I-cell_typeexposed	to	expose	VBN	B-VP	Oto	anoxia-reoxygenation	to	TO	B-PP	Oanoxia-reoxygenation	(	anoxia-reoxygenation	NN	B-NP	O(	A/R	(	(	O	OA/R	)	A/R	NN	B-NP	O)	or	)	)	O	Oor	a	or	CC	O	Oa	redox	a	DT	B-NP	Oredox	imbalance	redox	NN	I-NP	Oimbalance	.	imbalance	NN	I-NP	O.	The	.	.	O	OThe	objectives	The	DT	B-NP	Oobjectives	of	objective	NNS	I-NP	Oof	this	of	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	were	study	NN	I-NP	Owere	(	be	VBD	B-VP	O(	1	(	(	B-LST	O1	)	1	LS	I-LST	O)	to	)	)	O	Oto	define	to	TO	B-VP	Odefine	the	define	VB	I-VP	Othe	kinetics	the	DT	B-NP	Okinetics	of	kinetic	NNS	I-NP	Oof	NF	of	IN	B-PP	ONF	kappa	NF	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	activation	B	NN	I-NP	I-proteinactivation	by	activation	NN	I-NP	Oby	examining	by	IN	B-PP	Oexamining	I	examine	VBG	B-VP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	degradation	alpha	NN	I-NP	I-proteindegradation	and	degradation	NN	I-NP	Oand	the	and	CC	O	Othe	nuclear	the	DT	B-NP	Onuclear	translocation	nuclear	JJ	I-NP	Otranslocation	of	translocation	NN	I-NP	Oof	p65	of	IN	B-PP	Op65	in	p65	NN	B-NP	B-proteinin	response	in	IN	B-PP	Oresponse	to	response	NN	I-PP	Oto	A/R	to	TO	I-PP	OA/R	or	A/R	NN	B-NP	Oor	redox	or	CC	I-NP	Oredox	imbalance	redox	NN	I-NP	Oimbalance	(	imbalance	NN	I-NP	O(	induced	(	(	O	Oinduced	by	induce	VBN	B-VP	Oby	treatment	by	IN	B-PP	Otreatment	of	treatment	NN	B-NP	Oof	cells	of	IN	B-PP	Ocells	with	cell	NNS	B-NP	Owith	diamide	with	IN	B-PP	Odiamide	and	diamide	NN	B-NP	Oand	buthionine	and	CC	I-NP	Obuthionine	sulfoximine	buthionine	NN	I-NP	Osulfoximine	)	sulfoximine	NN	I-NP	O)	and	)	)	O	Oand	(	and	CC	O	O(	2	(	(	B-LST	O2	)	2	LS	I-LST	O)	to	)	)	O	Oto	determine	to	TO	B-VP	Odetermine	whether	determine	VB	I-VP	Owhether	the	whether	IN	B-SBAR	Othe	signal	the	DT	B-NP	Osignal	for	signal	NN	I-NP	Ofor	I	for	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	degradation	alpha	NN	I-NP	I-proteindegradation	","	degradation	NN	I-NP	O","	nuclear	","	","	O	Onuclear	translocation	nuclear	JJ	B-NP	Otranslocation	of	translocation	NN	I-NP	Oof	p65	of	IN	B-PP	Op65	","	p65	NN	B-NP	B-protein","	and	","	","	O	Oand	E-selectin	and	CC	O	OE-selectin	#NAME?	E-selectin	NN	B-NP	B-protein#NAME?	neutrophil	#NAME?	JJ	I-NP	Oneutrophil	adhesion	neutrophil	NN	I-NP	Oadhesion	is	adhesion	NN	I-NP	Ois	related	be	VBZ	B-VP	Orelated	to	related	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	protein	of	IN	B-PP	Oprotein	tyrosine	protein	NN	B-NP	B-proteintyrosine	kinase	tyrosine	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	PTK	(	(	O	OPTK	)	PTK	NN	B-NP	B-protein)	","	)	)	O	O","	protein	","	","	O	Oprotein	tyrosine	protein	NN	B-NP	B-proteintyrosine	phosphatase	tyrosine	NN	I-NP	I-proteinphosphatase	(	phosphatase	NN	I-NP	I-protein(	PTPase	(	(	O	OPTPase	)	PTPase	NN	B-NP	B-protein)	and/or	)	)	O	Oand/or	protein	and/or	CC	O	Oprotein	kinase	protein	NN	B-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	(	C	NN	I-NP	I-protein(	PKC	(	(	O	OPKC	)	PKC	NN	B-NP	B-protein)	.	)	)	O	O.	The	.	.	O	OThe	results	The	DT	B-NP	Oresults	demonstrate	result	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	both	that	IN	B-SBAR	Oboth	A/R	both	CC	O	OA/R	and	A/R	NN	B-NP	Oand	redox	and	CC	O	Oredox	imbalance	redox	NN	B-NP	Oimbalance	led	imbalance	NN	I-NP	Oled	to	lead	VBD	B-VP	Oto	I	to	TO	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	degradation	alpha	NN	I-NP	I-proteindegradation	within	degradation	NN	I-NP	Owithin	30	within	IN	B-PP	O30	min	30	CD	B-NP	Omin	and	min	NN	I-NP	Oand	the	and	CC	O	Othe	concomitant	the	DT	B-NP	Oconcomitant	appearance	concomitant	JJ	I-NP	Oappearance	of	appearance	NN	I-NP	Oof	p65	of	IN	B-PP	Op65	in	p65	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	nucleus	the	DT	B-NP	Onucleus	","	nucleus	NN	I-NP	O","	consistent	","	","	O	Oconsistent	with	consistent	JJ	B-ADJP	Owith	rapid	with	IN	B-PP	Orapid	cytosolic	rapid	JJ	B-NP	Ocytosolic	activation	cytosolic	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	NF	of	IN	B-PP	ONF	kappa	NF	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	and	B	NN	I-NP	I-proteinand	subsequent	and	CC	O	Osubsequent	nuclear	subsequent	JJ	B-NP	Onuclear	translocation	nuclear	JJ	I-NP	Otranslocation	of	translocation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	activated	the	DT	B-NP	Oactivated	p65	activate	VBN	I-NP	Op65	subunit	p65	NN	I-NP	B-proteinsubunit	.	subunit	NN	I-NP	I-protein.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	PKC	of	IN	B-PP	OPKC	blocked	PKC	NN	B-NP	B-proteinblocked	I	block	VBD	B-VP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	degradation	alpha	NN	I-NP	I-proteindegradation	and	degradation	NN	I-NP	Oand	p65	and	CC	O	Op65	translocation	p65	NN	B-NP	B-proteintranslocation	in	translocation	NN	I-NP	Oin	A/R-challenged	in	IN	B-PP	OA/R-challenged	","	A/R-challenged	JJ	B-NP	O","	but	","	","	I-NP	Obut	not	but	CC	I-NP	Onot	redox-altered	not	RB	I-NP	Oredox-altered	","	redox-altered	JJ	I-NP	O","	endothelial	","	","	I-NP	Oendothelial	cells	endothelial	JJ	I-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	both	","	","	O	Oboth	A/R-	both	CC	O	OA/R-	and	A/R-	NN	B-NP	Oand	redox-induced	and	CC	O	Oredox-induced	NF	redox-induced	JJ	B-NP	ONF	kappa	NF	NN	I-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	activation	B	NN	I-NP	I-proteinactivation	was	activation	NN	I-NP	Owas	blocked	be	VBD	B-VP	Oblocked	by	block	VBN	I-VP	Oby	inhibition	by	IN	B-PP	Oinhibition	of	inhibition	NN	B-NP	Oof	PTK	of	IN	B-PP	OPTK	.	PTK	NN	B-NP	B-protein.	Similarly	.	.	O	OSimilarly	","	Similarly	RB	B-ADVP	O","	A/R-induced	","	","	O	OA/R-induced	E-selectin	A/R-induced	JJ	B-NP	OE-selectin	expression	E-selectin	NN	I-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	neutrophil-endothelial	and	CC	O	Oneutrophil-endothelial	cell	neutrophil-endothelial	JJ	B-NP	Ocell	adhesion	cell	NN	I-NP	Oadhesion	were	adhesion	NN	I-NP	Owere	blocked	be	VBD	B-VP	Oblocked	by	block	VBN	I-VP	Oby	inhibition	by	IN	B-PP	Oinhibition	of	inhibition	NN	B-NP	Oof	PKC	of	IN	B-PP	OPKC	or	PKC	NN	B-NP	B-proteinor	PTK	or	CC	I-NP	OPTK	","	PTK	NN	I-NP	B-protein","	while	","	","	O	Owhile	only	while	IN	B-SBAR	Oonly	PTK	only	RB	B-NP	OPTK	inhibited	PTK	NN	I-NP	B-proteininhibited	the	inhibit	VBD	B-VP	Othe	redox-induced	the	DT	B-NP	Oredox-induced	adhesion	redox-induced	JJ	I-NP	Oadhesion	response	adhesion	NN	I-NP	Oresponse	.	response	NN	I-NP	O.	Pretreatment	.	.	O	OPretreatment	of	Pretreatment	NN	B-NP	Oof	cells	of	IN	B-PP	Ocells	with	cell	NNS	B-NP	Owith	N-acetyl	with	IN	B-PP	ON-acetyl	cysteine	N-acetyl	NN	B-NP	Ocysteine	effectively	cysteine	NN	I-NP	Oeffectively	blocked	effectively	RB	B-ADVP	Oblocked	A/R-	block	VBD	B-VP	OA/R-	or	A/R-	NN	B-NP	Oor	redox-induced	or	CC	O	Oredox-induced	I	redox-induced	JJ	B-NP	OI	kappa	I	NN	I-NP	Okappa	B	kappa	NN	I-NP	OB	degradation	B	NN	I-NP	Odegradation	and	degradation	NN	I-NP	Oand	significantly	and	CC	O	Osignificantly	attenuated	significantly	RB	B-VP	Oattenuated	the	attenuate	VBD	I-VP	Othe	respective	the	DT	B-NP	Orespective	neutrophil	respective	JJ	I-NP	Oneutrophil	adhesion	neutrophil	NN	I-NP	Oadhesion	responses	adhesion	NN	I-NP	Oresponses	.	response	NNS	I-NP	O.	Collectively	.	.	O	OCollectively	","	Collectively	RB	B-ADVP	O","	these	","	","	O	Othese	findings	these	DT	B-NP	Ofindings	indicate	finding	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	A/R-induced	that	IN	B-SBAR	OA/R-induced	E-selectin	A/R-induced	JJ	B-NP	OE-selectin	expression	E-selectin	NN	I-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	neutrophil-endothelial	and	CC	O	Oneutrophil-endothelial	cell	neutrophil-endothelial	JJ	B-NP	Ocell	adhesion	cell	NN	I-NP	Oadhesion	are	adhesion	NN	I-NP	Oare	mediated	be	VBP	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	both	by	IN	B-PP	Oboth	PKC	both	CC	O	OPKC	and	PKC	NN	B-NP	B-proteinand	PTK	and	CC	I-NP	OPTK	","	PTK	NN	I-NP	B-protein","	which	","	","	O	Owhich	signal	which	WDT	B-NP	Osignal	rapid	signal	VBP	B-VP	Orapid	activation	rapid	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	NF	of	IN	B-PP	ONF	kappa	NF	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	.	B	NN	I-NP	I-protein.	This	.	.	O	OThis	A/R-induced	This	DT	B-NP	OA/R-induced	NF	A/R-induced	JJ	I-NP	ONF	kappa	NF	NN	I-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	signaling	B	NN	I-NP	I-proteinsignaling	response	signaling	NN	I-NP	Oresponse	appears	response	NN	I-NP	Oappears	to	appear	VBZ	B-VP	Oto	be	to	TO	I-VP	Obe	mediated	be	VB	I-VP	Omediated	","	mediate	VBN	I-VP	O","	at	","	","	O	Oat	least	at	IN	B-ADVP	Oleast	in	least	JJS	I-ADVP	Oin	part	in	IN	B-PP	Opart	","	part	NN	B-NP	O","	by	","	","	O	Oby	intracellular	by	IN	B-PP	Ointracellular	redox	intracellular	JJ	B-NP	Oredox	imbalance	redox	NN	I-NP	Oimbalance	.	imbalance	NN	I-NP	O.	Copyright	.	.	O	OCopyright	2001	Copyright	NN	B-NP	O2001	S.	2001	CD	I-NP	OS.	Karger	S.	NNP	I-NP	OKarger	AG	Karger	NNP	I-NP	OAG	","	AG	NNP	I-NP	O","	Basel	","	","	O	OBasel	Induction	Basel	NNP	B-NP	OInduction	of	Induction	NN	B-NP	Oof	apoptosis	of	IN	B-PP	Oapoptosis	in	apoptosis	NN	B-NP	Oin	human	in	IN	B-PP	Ohuman	lymphocytes	human	JJ	B-NP	B-cell_typelymphocytes	by	lymphocyte	NNS	I-NP	I-cell_typeby	the	by	IN	B-PP	Othe	herbicide	the	DT	B-NP	Oherbicide	2	herbicide	NN	I-NP	O2	","	2	CD	I-NP	O","	4-dichlorophenoxyacetic	","	","	O	O4-dichlorophenoxyacetic	acid	4-dichlorophenoxyacetic	JJ	B-NP	Oacid	.	acid	NN	I-NP	O.	Dimethylammonium	.	.	O	ODimethylammonium	salt	Dimethylammonium	NN	B-NP	Osalt	of	salt	NN	I-NP	Oof	2	of	IN	B-PP	O2	","	2	CD	B-NP	O","	4-dichlorophenoxyacetic	","	","	O	O4-dichlorophenoxyacetic	acid	4-dichlorophenoxyacetic	JJ	B-NP	Oacid	(	acid	NN	I-NP	O(	DMA-2	(	(	O	ODMA-2	","	DMA-2	NN	B-NP	B-protein","	4-D	","	","	O	O4-D	)	4-D	NN	B-NP	O)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	widely	a	DT	B-NP	Owidely	used	widely	RB	I-NP	Oused	herbicide	use	VBN	I-NP	Oherbicide	that	herbicide	NN	I-NP	Othat	is	that	WDT	B-NP	Ois	considered	be	VBZ	B-VP	Oconsidered	moderately	consider	VBN	I-VP	Omoderately	toxic	moderately	RB	B-ADJP	Otoxic	.	toxic	JJ	I-ADJP	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	present	the	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	we	study	NN	I-NP	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	DMA-2	that	IN	B-SBAR	ODMA-2	","	DMA-2	NN	B-NP	B-protein","	4-D	","	","	O	O4-D	is	4-D	NN	B-NP	Ois	able	be	VBZ	B-VP	Oable	to	able	JJ	B-ADJP	Oto	cause	to	TO	B-VP	Ocause	apoptosis	cause	VB	I-VP	Oapoptosis	in	apoptosis	NN	B-NP	Oin	peripheral	in	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	lymphocytes	blood	NN	I-NP	I-cell_typelymphocytes	of	lymphocyte	NNS	I-NP	I-cell_typeof	healthy	of	IN	B-PP	Ohealthy	individuals	healthy	JJ	B-NP	Oindividuals	and	individual	NNS	I-NP	Oand	Jurkat	and	CC	O	OJurkat	T	Jurkat	NN	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Apoptosis	.	.	O	OApoptosis	induced	Apoptosis	NN	B-NP	Oinduced	by	induce	VBN	B-VP	Oby	DMA-2	by	IN	B-PP	ODMA-2	","	DMA-2	NN	B-NP	B-protein","	4-D	","	","	O	O4-D	was	4-D	NN	B-NP	Owas	dose	be	VBD	B-VP	Odose	and	dose	NN	B-NP	Oand	time	and	CC	I-NP	Otime	dependent	time	NN	I-NP	Odependent	","	dependent	JJ	B-ADJP	O","	independent	","	","	O	Oindependent	of	independent	JJ	B-ADJP	Oof	Fas	of	IN	B-PP	OFas	","	Fas	NN	B-NP	B-protein","	TNF	","	","	O	OTNF	receptor	TNF	NN	B-NP	B-proteinreceptor	1	receptor	NN	I-NP	I-protein1	or	1	CD	I-NP	I-proteinor	the	or	CC	O	Othe	aromatic	the	DT	B-NP	Oaromatic	hydrocarbon	aromatic	JJ	I-NP	B-proteinhydrocarbon	receptor	hydrocarbon	NN	I-NP	I-proteinreceptor	","	receptor	NN	I-NP	I-protein","	and	","	","	O	Oand	involved	and	CC	O	Oinvolved	disruption	involve	VBN	B-VP	Odisruption	of	disruption	NN	B-NP	Oof	the	of	IN	B-PP	Othe	mitochondrial	the	DT	B-NP	Omitochondrial	transmembrane	mitochondrial	JJ	I-NP	Otransmembrane	potential	transmembrane	JJ	I-NP	Opotential	and	potential	NN	I-NP	Oand	activation	and	CC	I-NP	Oactivation	of	activation	NN	I-NP	Oof	caspase-9	of	IN	B-PP	Ocaspase-9	.	caspase-9	NN	B-NP	B-protein.	ZVAD-FMK	.	.	O	OZVAD-FMK	","	ZVAD-FMK	NN	B-NP	B-protein","	a	","	","	O	Oa	broad-spectrum	a	DT	B-NP	Obroad-spectrum	inhibitor	broad-spectrum	JJ	I-NP	Oinhibitor	of	inhibitor	NN	I-NP	Oof	caspases	of	IN	B-PP	Ocaspases	","	caspas	NNS	B-NP	B-protein","	blocked	","	","	O	Oblocked	DMA-2	block	VBD	B-VP	ODMA-2	","	DMA-2	NN	B-NP	B-protein","	4-D-induced	","	","	O	O4-D-induced	apoptosis	4-D-induced	JJ	B-NP	Oapoptosis	completely	apoptosis	NN	I-NP	Ocompletely	.	completely	RB	B-ADVP	O.	While	.	.	O	OWhile	an	While	IN	B-SBAR	Oan	inhibitor	an	DT	B-NP	Oinhibitor	of	inhibitor	NN	I-NP	Oof	caspase-9	of	IN	B-PP	Ocaspase-9	","	caspase-9	NN	B-NP	B-protein","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	caspase-9	as	IN	I-CONJP	Ocaspase-9	and	caspase-9	NN	B-NP	B-proteinand	caspase-3	and	CC	I-NP	Ocaspase-3	inhibitors	caspase-3	NN	I-NP	Oinhibitors	in	inhibitor	NNS	I-NP	Oin	combination	in	IN	B-PP	Ocombination	","	combination	NN	B-NP	O","	strongly	","	","	O	Ostrongly	blocked	strongly	RB	B-VP	Oblocked	DMA-2	block	VBD	I-VP	ODMA-2	","	DMA-2	NN	B-NP	B-protein","	4-D-induced	","	","	O	O4-D-induced	apoptosis	4-D-induced	JJ	B-NP	Oapoptosis	","	apoptosis	NN	I-NP	O","	an	","	","	O	Oan	inhibitor	an	DT	B-NP	Oinhibitor	of	inhibitor	NN	I-NP	Oof	caspase-3	of	IN	B-PP	Ocaspase-3	had	caspase-3	NN	B-NP	B-proteinhad	a	have	VBD	B-VP	Oa	moderate	a	DT	B-NP	Omoderate	inhibitory	moderate	JJ	I-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	.	effect	NN	I-NP	O.	Unlike	.	.	O	OUnlike	Fas	Unlike	IN	B-PP	OFas	#NAME?	Fas	NN	B-NP	B-protein#NAME?	apoptosis	#NAME?	JJ	I-NP	Oapoptosis	","	apoptosis	NN	I-NP	O","	the	","	","	O	Othe	initiator	the	DT	B-NP	Oinitiator	caspase	initiator	NN	I-NP	Ocaspase	","	caspase	NN	I-NP	O","	caspase-8	","	","	O	Ocaspase-8	","	caspase-8	NN	B-NP	B-protein","	was	","	","	O	Owas	not	be	VBD	B-VP	Onot	involved	not	RB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	DMA-2	in	IN	B-PP	ODMA-2	","	DMA-2	NN	B-NP	B-protein","	4-D-induced	","	","	O	O4-D-induced	apoptosis	4-D-induced	JJ	B-NP	Oapoptosis	.	apoptosis	NN	I-NP	O.	Transfection	.	.	O	OTransfection	of	Transfection	NN	B-NP	Oof	Jurkat	of	IN	B-PP	OJurkat	cells	Jurkat	NN	B-NP	B-cell_linecells	with	cell	NNS	I-NP	I-cell_linewith	Bcl-2	with	IN	B-PP	OBcl-2	prevented	Bcl-2	NN	B-NP	B-proteinprevented	DMA-2	prevent	VBD	B-VP	ODMA-2	","	DMA-2	NN	B-NP	B-protein","	4-D-induced	","	","	O	O4-D-induced	disruption	4-D-induced	JJ	B-NP	Odisruption	of	disruption	NN	I-NP	Oof	the	of	IN	B-PP	Othe	mitochondrial	the	DT	B-NP	Omitochondrial	transmembrane	mitochondrial	JJ	I-NP	Otransmembrane	potential	transmembrane	JJ	I-NP	Opotential	and	potential	NN	I-NP	Oand	led	and	CC	O	Oled	to	lead	VBD	B-VP	Oto	a	to	TO	B-PP	Oa	complete	a	DT	B-NP	Ocomplete	blockage	complete	JJ	I-NP	Oblockage	of	blockage	NN	I-NP	Oof	apoptosis	of	IN	B-PP	Oapoptosis	.	apoptosis	NN	B-NP	O.	Our	.	.	O	OOur	data	Our	PRP$	B-NP	Odata	indicate	datum	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	DMA-2	that	IN	B-SBAR	ODMA-2	","	DMA-2	NN	B-NP	B-protein","	4-D	","	","	O	O4-D	kills	4-D	NN	B-NP	Okills	human	kill	VBZ	B-VP	Ohuman	lymphocytes	human	JJ	B-NP	B-cell_typelymphocytes	by	lymphocyte	NNS	I-NP	I-cell_typeby	initiating	by	IN	B-PP	Oinitiating	apoptosis	initiate	VBG	B-VP	Oapoptosis	via	apoptosis	NN	B-NP	Ovia	a	via	IN	B-PP	Oa	direct	a	DT	B-NP	Odirect	effect	direct	JJ	I-NP	Oeffect	on	effect	NN	I-NP	Oon	mitochondria	on	IN	B-PP	Omitochondria	.	mitochondrion	NNS	B-NP	O.	The	.	.	O	OThe	activation	The	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	caspases	of	IN	B-PP	Ocaspases	occurs	caspas	NNS	B-NP	B-proteinoccurs	downstream	occur	VBZ	B-VP	Odownstream	of	downstream	RB	B-ADVP	Oof	mitochondrial	of	IN	B-PP	Omitochondrial	damage	mitochondrial	JJ	B-NP	Odamage	","	damage	NN	I-NP	O","	and	","	","	O	Oand	the	and	CC	O	Othe	dysfunction	the	DT	B-NP	Odysfunction	of	dysfunction	NN	I-NP	Oof	mitochondria	of	IN	B-PP	Omitochondria	appears	mitochondrion	NNS	B-NP	Oappears	to	appear	VBZ	B-VP	Oto	be	to	TO	I-VP	Obe	sufficient	be	VB	I-VP	Osufficient	for	sufficient	JJ	B-ADJP	Ofor	triggering	for	IN	B-PP	Otriggering	all	trigger	VBG	B-VP	Oall	downstream	all	DT	B-NP	Odownstream	events	downstream	JJ	I-NP	Oevents	leading	event	NNS	I-NP	Oleading	to	lead	VBG	B-VP	Oto	apoptosis	to	TO	B-PP	Oapoptosis	.	apoptosis	NN	B-NP	O.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	Th1	of	IN	B-PP	OTh1	differentiation	Th1	NN	B-NP	Odifferentiation	by	differentiation	NN	I-NP	Oby	IL-6	by	IN	B-PP	OIL-6	is	IL-6	NN	B-NP	B-proteinis	mediated	be	VBZ	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	SOCS1	by	IN	B-PP	OSOCS1	.	SOCS1	NN	B-NP	B-protein.	Interleukin	.	.	O	OInterleukin	6	Interleukin	NN	B-NP	B-protein6	(	6	CD	I-NP	I-protein(	IL-6	(	(	O	OIL-6	)	IL-6	NN	B-NP	B-protein)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	cytokine	a	DT	B-NP	Ocytokine	produced	cytokine	NN	I-NP	B-proteinproduced	by	produce	VBN	B-VP	Oby	immune	by	IN	B-PP	Oimmune	and	immune	JJ	B-NP	Oand	nonimmune	and	CC	I-NP	Ononimmune	cells	nonimmune	JJ	I-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	exhibits	and	CC	O	Oexhibits	functional	exhibit	VBZ	B-VP	Ofunctional	pleiotropy	functional	JJ	B-NP	Opleiotropy	and	pleiotropy	NN	I-NP	Oand	redundancy	and	CC	I-NP	Oredundancy	.	redundancy	NN	I-NP	O.	IL-6	.	.	O	OIL-6	plays	IL-6	NN	B-NP	B-proteinplays	an	play	VBZ	B-VP	Oan	important	an	DT	B-NP	Oimportant	role	important	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	differentiation	the	DT	B-NP	Odifferentiation	of	differentiation	NN	I-NP	Oof	several	of	IN	B-PP	Oseveral	cell	several	JJ	B-NP	Ocell	types	cell	NN	I-NP	Otypes	.	type	NNS	I-NP	O.	Here	.	.	O	OHere	","	Here	RB	B-ADVP	O","	we	","	","	O	Owe	describe	we	PRP	B-NP	Odescribe	a	describe	VBP	B-VP	Oa	novel	a	DT	B-NP	Onovel	function	novel	JJ	I-NP	Ofunction	of	function	NN	I-NP	Oof	IL-6	of	IN	B-PP	OIL-6	:	IL-6	NN	B-NP	B-protein:	the	:	:	O	Othe	negative	the	DT	B-NP	Onegative	regulation	negative	JJ	I-NP	Oregulation	of	regulation	NN	I-NP	Oof	CD4	of	IN	B-PP	OCD4	+	CD4	NN	B-NP	B-protein+	Th1	+	SYM	B-NP	OTh1	cell	Th1	NN	I-NP	Ocell	differentiation	cell	NN	I-NP	Odifferentiation	.	differentiation	NN	I-NP	O.	While	.	.	O	OWhile	IL-6	While	IN	B-SBAR	OIL-6	#NAME?	IL-6	NN	B-NP	B-protein#NAME?	CD4	#NAME?	JJ	I-NP	OCD4	+	CD4	NN	I-NP	B-protein+	Th2	+	SYM	B-NP	OTh2	differentiation	Th2	NN	I-NP	Odifferentiation	is	differentiation	NN	I-NP	Ois	mediated	be	VBZ	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	IL-4	by	IN	B-PP	OIL-4	","	IL-4	NN	B-NP	B-protein","	inhibition	","	","	O	Oinhibition	of	inhibition	NN	B-NP	Oof	Th1	of	IN	B-PP	OTh1	differentiation	Th1	NN	B-NP	Odifferentiation	by	differentiation	NN	I-NP	Oby	IL-6	by	IN	B-PP	OIL-6	is	IL-6	NN	B-NP	B-proteinis	independent	be	VBZ	B-VP	Oindependent	of	independent	JJ	B-ADJP	Oof	IL-4	of	IN	B-PP	OIL-4	.	IL-4	NN	B-NP	B-protein.	IL-6	.	.	O	OIL-6	upregulates	IL-6	NN	B-NP	B-proteinupregulates	suppressor	upregulate	VBZ	B-VP	Osuppressor	of	suppressor	NN	B-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	signaling	cytokine	NN	B-NP	B-proteinsignaling	1	signaling	NN	I-NP	O1	(	1	CD	I-NP	O(	SOCS1	(	(	O	OSOCS1	)	SOCS1	NN	B-NP	B-protein)	expression	)	)	O	Oexpression	in	expression	NN	B-NP	Oin	activated	in	IN	B-PP	Oactivated	CD4+	activate	VBN	B-NP	B-cell_typeCD4+	T	CD4+	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	thereby	","	","	O	Othereby	interfering	thereby	RB	B-VP	Ointerfering	with	interfere	VBG	I-VP	Owith	signal	with	IN	B-PP	Osignal	transducer	signal	NN	B-NP	B-proteintransducer	and	transducer	NN	I-NP	I-proteinand	activator	and	CC	I-NP	I-proteinactivator	of	activator	NN	I-NP	I-proteinof	transcription	of	IN	B-PP	I-proteintranscription	1	transcription	NN	B-NP	I-protein1	(	1	CD	I-NP	I-protein(	STAT1	(	(	O	OSTAT1	)	STAT1	NN	B-NP	B-protein)	phosphorylation	)	)	O	Ophosphorylation	induced	phosphorylation	NN	B-NP	Oinduced	by	induce	VBN	B-VP	Oby	interferon	by	IN	B-PP	Ointerferon	gamma	interferon	NN	B-NP	B-proteingamma	(	gamma	NN	I-NP	I-protein(	IFNgamma	(	(	O	OIFNgamma	)	IFNgamma	NN	B-NP	B-protein)	.	)	)	O	O.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	IFNgamma	of	IN	B-PP	OIFNgamma	receptor-mediated	IFNgamma	NN	B-NP	B-proteinreceptor-mediated	signals	receptor-mediated	JJ	I-NP	Osignals	by	signal	NNS	I-NP	Oby	IL-6	by	IN	B-PP	OIL-6	prevents	IL-6	NN	B-NP	B-proteinprevents	autoregulation	prevent	VBZ	B-VP	Oautoregulation	of	autoregulation	NN	B-NP	Oof	IFNgamma	of	IN	B-PP	OIFNgamma	gene	IFNgamma	NN	B-NP	B-proteingene	expression	gene	NN	I-NP	Oexpression	by	expression	NN	I-NP	Oby	IFNgamma	by	IN	B-PP	OIFNgamma	during	IFNgamma	NN	B-NP	B-proteinduring	CD4+	during	IN	B-PP	OCD4+	T	CD4+	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	activation	cell	NN	I-NP	Oactivation	","	activation	NN	I-NP	O","	thereby	","	","	O	Othereby	preventing	thereby	RB	B-VP	Opreventing	Th1	prevent	VBG	I-VP	OTh1	differentiation	Th1	NN	B-NP	Odifferentiation	.	differentiation	NN	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	IL-6	","	","	O	OIL-6	promotes	IL-6	NN	B-NP	B-proteinpromotes	CD4	promote	VBZ	B-VP	OCD4	+	CD4	NN	B-NP	B-protein+	Th2	+	SYM	I-NP	OTh2	differentiation	Th2	NN	I-NP	Odifferentiation	and	differentiation	NN	I-NP	Oand	inhibits	and	CC	O	Oinhibits	Th1	inhibit	VBZ	B-VP	OTh1	differentiation	Th1	NN	B-NP	Odifferentiation	by	differentiation	NN	I-NP	Oby	two	by	IN	B-PP	Otwo	independent	two	CD	B-NP	Oindependent	molecular	independent	JJ	I-NP	Omolecular	mechanisms	molecular	JJ	I-NP	Omechanisms	.	mechanism	NNS	I-NP	O.	Interaction	.	.	O	OInteraction	between	Interaction	NN	B-NP	Obetween	CCAAT/enhancer	between	IN	B-PP	OCCAAT/enhancer	binding	CCAAT/enhancer	NN	B-NP	B-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	and	protein	NN	I-NP	I-proteinand	cyclic	and	CC	O	Ocyclic	AMP	cyclic	JJ	B-NP	B-proteinAMP	response	AMP	NN	I-NP	I-proteinresponse	element	response	NN	I-NP	I-proteinelement	binding	element	NN	I-NP	I-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	1	protein	NN	I-NP	I-protein1	regulates	1	CD	I-NP	I-proteinregulates	human	regulate	VBZ	B-VP	Ohuman	immunodeficiency	human	JJ	B-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	transcription	1	CD	I-NP	Otranscription	in	transcription	NN	I-NP	Oin	cells	in	IN	B-PP	Ocells	of	cell	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	monocyte/macrophage	the	DT	B-NP	Omonocyte/macrophage	lineage	monocyte/macrophage	NN	I-NP	B-cell_typelineage	.	lineage	NN	I-NP	I-cell_type.	Recent	.	.	O	ORecent	observations	Recent	JJ	B-NP	Oobservations	have	observation	NNS	I-NP	Ohave	shown	have	VBP	B-VP	Oshown	two	show	VBN	I-VP	Otwo	CCAAT/enhancer	two	CD	B-NP	OCCAAT/enhancer	binding	CCAAT/enhancer	NN	I-NP	B-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	C/EBP	(	(	O	OC/EBP	)	C/EBP	NN	B-NP	O)	binding	)	)	O	Obinding	sites	bind	VBG	B-NP	Osites	to	site	NNS	I-NP	Oto	be	to	TO	B-VP	Obe	critically	be	VB	I-VP	Ocritically	important	critically	RB	B-ADJP	Oimportant	for	important	JJ	I-ADJP	Ofor	efficient	for	IN	B-PP	Oefficient	human	efficient	JJ	B-NP	Ohuman	immunodeficiency	human	JJ	I-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	(	1	CD	I-NP	O(	HIV-1	(	(	O	OHIV-1	)	HIV-1	NN	B-NP	O)	replication	)	)	O	Oreplication	within	replication	NN	B-NP	Owithin	cells	within	IN	B-PP	Ocells	of	cell	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	monocyte/macrophage	the	DT	B-NP	Omonocyte/macrophage	lineage	monocyte/macrophage	NN	I-NP	B-cell_typelineage	","	lineage	NN	I-NP	I-cell_type","	a	","	","	O	Oa	cell	a	DT	B-NP	Ocell	type	cell	NN	I-NP	Otype	likely	type	NN	I-NP	Olikely	involved	likely	RB	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	transport	in	IN	B-PP	Otransport	of	transport	NN	B-NP	Oof	the	of	IN	B-PP	Othe	virus	the	DT	B-NP	Ovirus	to	virus	NN	I-NP	Oto	the	to	TO	B-PP	Othe	brain	the	DT	B-NP	Obrain	.	brain	NN	I-NP	O.	Additionally	.	.	O	OAdditionally	","	Additionally	RB	B-ADVP	O","	sequence	","	","	O	Osequence	variation	sequence	NN	B-NP	Ovariation	at	variation	NN	I-NP	Oat	C/EBP	at	IN	B-PP	OC/EBP	site	C/EBP	NN	B-NP	B-DNAsite	I	site	NN	I-NP	I-DNAI	","	I	CD	I-NP	O","	which	","	","	O	Owhich	lies	which	WDT	B-NP	Olies	immediately	lie	VBZ	B-VP	Oimmediately	upstream	immediately	RB	B-ADVP	Oupstream	of	upstream	JJ	B-NP	Oof	the	of	IN	B-PP	Othe	distal	the	DT	B-NP	Odistal	nuclear	distal	JJ	I-NP	B-DNAnuclear	factor	nuclear	JJ	I-NP	I-DNAfactor	kappa	factor	NN	I-NP	I-DNAkappa	B	kappa	NN	I-NP	I-DNAB	site	B	NN	I-NP	I-DNAsite	and	site	NN	I-NP	I-DNAand	immediately	and	CC	O	Oimmediately	downstream	immediately	RB	B-ADJP	Odownstream	of	downstream	JJ	I-ADJP	Oof	a	of	IN	B-PP	Oa	binding	a	DT	B-NP	Obinding	site	bind	VBG	I-NP	B-DNAsite	for	site	NN	I-NP	I-DNAfor	activating	for	IN	B-PP	Oactivating	transcription	activate	VBG	B-VP	Otranscription	factor	transcription	NN	B-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	ATF	(	(	O	OATF	)	ATF	NN	B-NP	B-protein)	/	)	)	O	O/	cyclic	/	SYM	B-NP	Ocyclic	AMP	cyclic	JJ	I-NP	B-proteinAMP	response	AMP	NN	I-NP	I-proteinresponse	element	response	NN	I-NP	I-proteinelement	binding	element	NN	I-NP	I-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	CREB	(	(	O	OCREB	)	CREB	NN	B-NP	B-protein)	","	)	)	O	O","	has	","	","	O	Ohas	been	have	VBZ	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	affect	to	TO	I-VP	Oaffect	HIV-1	affect	VB	I-VP	OHIV-1	long	HIV-1	NN	B-NP	B-DNAlong	terminal	long	JJ	I-NP	I-DNAterminal	repeat	terminal	JJ	I-NP	I-DNArepeat	(	repeat	NN	I-NP	I-DNA(	LTR	(	(	O	OLTR	)	LTR	NN	B-NP	B-DNA)	activity	)	)	O	Oactivity	.	activity	NN	B-NP	O.	Given	.	.	O	OGiven	that	Give	VBN	B-VP	Othat	C/EBP	that	IN	B-SBAR	OC/EBP	proteins	C/EBP	NN	B-NP	B-proteinproteins	have	protein	NNS	I-NP	I-proteinhave	been	have	VBP	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	interact	to	TO	I-VP	Ointeract	with	interact	VB	I-VP	Owith	many	with	IN	B-PP	Omany	other	many	JJ	B-NP	Oother	transcription	other	JJ	I-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	including	factor	NNS	I-NP	I-proteinincluding	members	include	VBG	B-PP	Omembers	of	member	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	ATF/CREB	the	DT	B-NP	OATF/CREB	family	ATF/CREB	NN	I-NP	B-proteinfamily	","	family	NN	I-NP	I-protein","	we	","	","	O	Owe	proceeded	we	PRP	B-NP	Oproceeded	to	proceed	VBD	B-VP	Oto	determine	to	TO	I-VP	Odetermine	whether	determine	VB	I-VP	Owhether	an	whether	IN	B-SBAR	Oan	adjacent	an	DT	B-NP	Oadjacent	ATF/CREB	adjacent	JJ	I-NP	B-DNAATF/CREB	binding	ATF/CREB	NN	I-NP	I-DNAbinding	site	binding	NN	I-NP	I-DNAsite	could	site	NN	I-NP	I-DNAcould	affect	could	MD	B-VP	Oaffect	C/EBP	affect	VB	I-VP	OC/EBP	protein	C/EBP	NN	B-NP	B-proteinprotein	binding	protein	NN	I-NP	I-proteinbinding	to	bind	VBG	B-VP	Oto	C/EBP	to	TO	B-PP	OC/EBP	site	C/EBP	NN	B-NP	B-DNAsite	I	site	NN	I-NP	I-DNAI	.	I	CD	I-NP	O.	Electrophoretic	.	.	O	OElectrophoretic	mobility	Electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	analyses	shift	NN	I-NP	Oanalyses	indicated	analysis	NNS	I-NP	Oindicated	that	indicate	VBD	B-VP	Othat	selected	that	IN	B-SBAR	Oselected	ATF/CREB	select	VBN	B-NP	OATF/CREB	site	ATF/CREB	NN	I-NP	Osite	variants	site	NN	I-NP	Ovariants	assisted	variant	NNS	I-NP	Oassisted	in	assist	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	recruitment	the	DT	B-NP	Orecruitment	of	recruitment	NN	I-NP	Oof	C/EBP	of	IN	B-PP	OC/EBP	proteins	C/EBP	NN	B-NP	B-proteinproteins	to	protein	NNS	I-NP	I-proteinto	an	to	TO	B-PP	Oan	adjacent	an	DT	B-NP	Oadjacent	","	adjacent	JJ	I-NP	O","	naturally	","	","	O	Onaturally	occurring	naturally	RB	B-VP	Ooccurring	","	occur	VBG	I-VP	O","	low-affinity	","	","	O	Olow-affinity	C/EBP	low-affinity	JJ	B-NP	OC/EBP	site	C/EBP	NN	I-NP	B-DNAsite	.	site	NN	I-NP	I-DNA.	This	.	.	O	OThis	biophysical	This	DT	B-NP	Obiophysical	interaction	biophysical	JJ	I-NP	Ointeraction	appears	interaction	NN	I-NP	Oappears	to	appear	VBZ	B-VP	Oto	occur	to	TO	I-VP	Ooccur	via	occur	VB	I-VP	Ovia	at	via	IN	B-PP	Oat	least	at	IN	B-NP	Oleast	two	least	JJS	I-NP	Otwo	mechanisms	two	CD	I-NP	Omechanisms	.	mechanism	NNS	I-NP	O.	First	.	.	O	OFirst	","	First	RB	B-ADVP	O","	low	","	","	O	Olow	amounts	low	JJ	B-NP	Oamounts	of	amount	NNS	I-NP	Oof	CREB-1	of	IN	B-PP	OCREB-1	and	CREB-1	NN	B-NP	B-proteinand	C/EBP	and	CC	I-NP	OC/EBP	appear	C/EBP	NN	I-NP	B-proteinappear	to	appear	VBP	B-VP	Oto	heterodimerize	to	TO	I-VP	Oheterodimerize	and	heterodimerize	VB	I-VP	Oand	bind	and	CC	O	Obind	to	bind	VB	B-VP	Oto	a	to	TO	B-PP	Oa	site	a	DT	B-NP	Osite	consisting	site	NN	I-NP	Oconsisting	of	consist	VBG	B-VP	Oof	a	of	IN	B-PP	Oa	half	a	DT	B-NP	Ohalf	site	half	JJ	I-NP	B-DNAsite	from	site	NN	I-NP	I-DNAfrom	both	from	IN	B-PP	Oboth	the	both	CC	O	Othe	ATF/CREB	the	DT	B-NP	OATF/CREB	and	ATF/CREB	NN	I-NP	B-DNAand	C/EBP	and	CC	I-NP	I-DNAC/EBP	binding	C/EBP	NN	I-NP	I-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	.	site	NNS	I-NP	I-DNA.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	CREB-1	","	","	O	OCREB-1	homodimers	CREB-1	NN	B-NP	B-proteinhomodimers	bind	homodimer	NNS	I-NP	I-proteinbind	to	bind	VBP	B-VP	Oto	the	to	TO	B-PP	Othe	ATF/CREB	the	DT	B-NP	OATF/CREB	site	ATF/CREB	NN	I-NP	B-DNAsite	and	site	NN	I-NP	I-DNAand	recruit	and	CC	O	Orecruit	C/EBP	recruit	NN	B-NP	B-proteinC/EBP	dimers	C/EBP	NN	I-NP	I-proteindimers	to	dimer	NNS	I-NP	I-proteinto	their	to	TO	B-PP	Otheir	cognate	their	PRP$	B-NP	Ocognate	weak	cognate	JJ	I-NP	B-DNAweak	binding	weak	JJ	I-NP	I-DNAbinding	sites	bind	VBG	I-NP	I-DNAsites	.	site	NNS	I-NP	I-DNA.	This	.	.	O	OThis	interaction	This	DT	B-NP	Ointeraction	is	interaction	NN	I-NP	Ois	reciprocal	be	VBZ	B-VP	Oreciprocal	","	reciprocal	JJ	B-ADJP	O","	since	","	","	O	Osince	C/EBP	since	IN	B-SBAR	OC/EBP	dimer	C/EBP	NN	B-NP	B-proteindimer	binding	dimer	NN	I-NP	I-proteinbinding	to	bind	VBG	B-VP	Oto	a	to	TO	B-PP	Oa	strong	a	DT	B-NP	Ostrong	C/EBP	strong	JJ	I-NP	OC/EBP	site	C/EBP	NN	I-NP	B-DNAsite	leads	site	NN	I-NP	I-DNAleads	to	lead	VBZ	B-VP	Oto	enhanced	to	TO	B-PP	Oenhanced	CREB-1	enhance	VBN	B-NP	OCREB-1	recruitment	CREB-1	NN	I-NP	B-proteinrecruitment	to	recruitment	NN	I-NP	Oto	ATF/CREB	to	TO	B-PP	OATF/CREB	sites	ATF/CREB	NN	B-NP	B-DNAsites	that	site	NNS	I-NP	I-DNAthat	are	that	WDT	B-NP	Oare	weakly	be	VBP	B-VP	Oweakly	bound	weakly	RB	I-VP	Obound	by	bind	VBN	I-VP	Oby	CREB	by	IN	B-PP	OCREB	.	CREB	NN	B-NP	B-protein.	Sequence	.	.	O	OSequence	variation	Sequence	NN	B-NP	Ovariation	at	variation	NN	I-NP	Oat	both	at	IN	B-PP	Oboth	C/EBP	both	CC	O	OC/EBP	and	C/EBP	NN	B-NP	B-proteinand	ATF/CREB	and	CC	I-NP	OATF/CREB	sites	ATF/CREB	NN	I-NP	B-DNAsites	affects	site	NNS	I-NP	I-DNAaffects	the	affect	VBZ	B-VP	Othe	molecular	the	DT	B-NP	Omolecular	interactions	molecular	JJ	I-NP	Ointeractions	involved	interaction	NNS	I-NP	Oinvolved	in	involve	VBN	B-VP	Oin	mediating	in	IN	B-PP	Omediating	both	mediate	VBG	B-VP	Oboth	of	both	DT	B-NP	Oof	these	of	IN	B-PP	Othese	mechanisms	these	DT	B-NP	Omechanisms	.	mechanism	NNS	I-NP	O.	Most	.	.	O	OMost	importantly	Most	RBS	B-ADVP	Oimportantly	","	importantly	RB	I-ADVP	O","	sequence	","	","	O	Osequence	variation	sequence	NN	B-NP	Ovariation	at	variation	NN	I-NP	Oat	the	at	IN	B-PP	Othe	ATF/CREB	the	DT	B-NP	OATF/CREB	binding	ATF/CREB	NN	I-NP	B-DNAbinding	site	binding	NN	I-NP	I-DNAsite	affected	site	NN	I-NP	I-DNAaffected	basal	affect	VBD	B-VP	Obasal	LTR	basal	JJ	B-NP	OLTR	activity	LTR	NN	I-NP	B-DNAactivity	as	activity	NN	I-NP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	LTR	as	IN	I-CONJP	OLTR	function	LTR	NN	B-NP	B-DNAfunction	following	function	NN	I-NP	Ofollowing	interleukin-6	follow	VBG	B-PP	Ointerleukin-6	stimulation	interleukin-6	NN	B-NP	B-proteinstimulation	","	stimulation	NN	I-NP	O","	a	","	","	O	Oa	treatment	a	DT	B-NP	Otreatment	that	treatment	NN	I-NP	Othat	leads	that	WDT	B-NP	Oleads	to	lead	VBZ	B-VP	Oto	increases	to	TO	B-PP	Oincreases	in	increase	NNS	B-NP	Oin	C/EBP	in	IN	B-PP	OC/EBP	activation	C/EBP	NN	B-NP	B-proteinactivation	.	activation	NN	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	HIV-1	","	","	O	OHIV-1	LTR	HIV-1	NN	B-NP	B-DNALTR	ATF/CREB	LTR	NN	I-NP	I-DNAATF/CREB	binding	ATF/CREB	NN	I-NP	Obinding	site	binding	NN	I-NP	Osite	sequence	site	NN	I-NP	Osequence	variation	sequence	NN	I-NP	Ovariation	may	variation	NN	I-NP	Omay	modulate	may	MD	B-VP	Omodulate	cellular	modulate	VB	I-VP	Ocellular	signaling	cellular	JJ	B-NP	Osignaling	at	signaling	NN	I-NP	Oat	the	at	IN	B-PP	Othe	viral	the	DT	B-NP	Oviral	promoter	viral	JJ	I-NP	B-DNApromoter	through	promoter	NN	I-NP	I-DNAthrough	the	through	IN	B-PP	Othe	C/EBP	the	DT	B-NP	OC/EBP	pathway	C/EBP	NN	I-NP	B-proteinpathway	Selective	pathway	NN	I-NP	OSelective	inhibition	Selective	JJ	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	interleukin-4	of	IN	B-PP	Ointerleukin-4	gene	interleukin-4	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	in	expression	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	T	human	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	aspirin	by	IN	B-PP	Oaspirin	.	aspirin	NN	B-NP	O.	Previous	.	.	O	OPrevious	studies	Previous	JJ	B-NP	Ostudies	indicated	study	NNS	I-NP	Oindicated	that	indicate	VBD	B-VP	Othat	aspirin	that	IN	B-SBAR	Oaspirin	(	aspirin	NN	B-NP	O(	acetylsalicylic	(	(	O	Oacetylsalicylic	acid	acetylsalicylic	JJ	B-NP	Oacid	[	acid	NN	I-NP	O[	ASA	[	(	O	OASA	]	ASA	NN	B-NP	O]	)	]	)	O	O)	can	)	)	O	Ocan	have	can	MD	B-VP	Ohave	profound	have	VB	I-VP	Oprofound	immunomodulatory	profound	JJ	B-NP	Oimmunomodulatory	effects	immunomodulatory	JJ	I-NP	Oeffects	by	effect	NNS	I-NP	Oby	regulating	by	IN	B-PP	Oregulating	cytokine	regulate	VBG	B-VP	Ocytokine	gene	cytokine	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	in	expression	NN	I-NP	Oin	several	in	IN	B-PP	Oseveral	types	several	JJ	B-NP	Otypes	of	type	NNS	I-NP	Oof	cells	of	IN	B-PP	Ocells	.	cell	NNS	B-NP	O.	This	.	.	O	OThis	study	This	DT	B-NP	Ostudy	is	study	NN	I-NP	Ois	the	be	VBZ	B-VP	Othe	first	the	DT	B-NP	Ofirst	in	first	JJ	I-NP	Oin	which	in	IN	B-PP	Owhich	concentrations	which	WDT	B-NP	Oconcentrations	of	concentration	NNS	B-NP	Oof	ASA	of	IN	B-PP	OASA	in	ASA	NN	B-NP	Oin	the	in	IN	B-PP	Othe	therapeutic	the	DT	B-NP	Otherapeutic	range	therapeutic	JJ	I-NP	Orange	were	range	NN	I-NP	Owere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	significantly	to	TO	I-VP	Osignificantly	reduce	significantly	RB	I-VP	Oreduce	interleukin	reduce	VB	I-VP	Ointerleukin	(	interleukin	NN	B-NP	B-protein(	IL	(	(	O	I-proteinIL	)	IL	NN	B-NP	I-protein)	-4	)	)	O	I-protein-4	secretion	-4	CD	B-NP	I-proteinsecretion	and	secretion	NN	I-NP	Oand	RNA	and	CC	O	ORNA	expression	RNA	NN	B-NP	Oexpression	in	expression	NN	I-NP	Oin	freshly	in	IN	B-PP	Ofreshly	isolated	freshly	RB	B-NP	Oisolated	and	isolate	VBN	I-NP	Oand	mitogen-primed	and	CC	I-NP	Omitogen-primed	human	mitogen-primed	JJ	I-NP	B-cell_linehuman	CD4+	human	JJ	I-NP	I-cell_lineCD4+	T	CD4+	JJ	I-NP	I-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	ASA	","	","	O	OASA	did	ASA	NN	B-NP	Odid	not	do	VBD	B-VP	Onot	affect	not	RB	I-VP	Oaffect	IL-13	affect	VB	I-VP	OIL-13	","	IL-13	NN	B-NP	B-protein","	interferon-gamma	","	","	O	Ointerferon-gamma	","	interferon-gamma	NN	B-NP	B-protein","	and	","	","	O	Oand	IL-2	and	CC	O	OIL-2	expression	IL-2	NN	B-NP	B-proteinexpression	.	expression	NN	I-NP	O.	ASA	.	.	O	OASA	inhibited	ASA	NN	B-NP	Oinhibited	IL-4	inhibit	VBD	B-VP	OIL-4	","	IL-4	NN	B-NP	B-protein","	but	","	","	O	Obut	not	but	CC	O	Onot	IL-2	not	RB	O	OIL-2	","	IL-2	NN	B-NP	B-protein","	promoter-driven	","	","	O	Opromoter-driven	chloramphenicol	promoter-driven	JJ	B-NP	Ochloramphenicol	acetyltransferase	chloramphenicol	NN	I-NP	B-proteinacetyltransferase	expression	acetyltransferase	NN	I-NP	I-proteinexpression	in	expression	NN	I-NP	Oin	transiently	in	IN	B-PP	Otransiently	transfected	transiently	RB	B-NP	B-cell_linetransfected	Jurkat	transfecte	VBN	I-NP	I-cell_lineJurkat	T	Jurkat	NN	I-NP	I-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	The	.	.	O	OThe	structurally	The	DT	B-NP	Ostructurally	unrelated	structurally	RB	I-NP	Ounrelated	nonsteroidal	unrelated	JJ	I-NP	Ononsteroidal	anti-inflammatory	nonsteroidal	JJ	I-NP	Oanti-inflammatory	drugs	anti-inflammatory	JJ	I-NP	Odrugs	indomethacin	drug	NNS	I-NP	Oindomethacin	and	indomethacin	NN	I-NP	Oand	flurbiprofen	and	CC	I-NP	Oflurbiprofen	did	flurbiprofen	NN	I-NP	Odid	not	do	VBD	B-VP	Onot	affect	not	RB	I-VP	Oaffect	cytokine	affect	VB	I-VP	Ocytokine	gene	cytokine	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	in	expression	NN	I-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	whereas	","	","	O	Owhereas	the	whereas	IN	O	Othe	weak	the	DT	B-NP	Oweak	cyclo-oxygenase	weak	JJ	I-NP	Ocyclo-oxygenase	inhibitor	cyclo-oxygenase	NN	I-NP	Oinhibitor	salicylic	inhibitor	NN	I-NP	Osalicylic	acid	salicylic	JJ	I-NP	Oacid	was	acid	NN	I-NP	Owas	at	be	VBD	B-VP	Oat	least	at	IN	B-ADVP	Oleast	as	least	JJS	I-ADVP	Oas	effective	as	RB	B-ADJP	Oeffective	as	effective	JJ	I-ADJP	Oas	ASA	as	IN	B-PP	OASA	in	ASA	NN	B-NP	Oin	inhibiting	in	IN	B-PP	Oinhibiting	IL-4	inhibit	VBG	B-VP	OIL-4	expression	IL-4	NN	B-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	promoter	and	CC	O	Opromoter	activity	promoter	NN	B-NP	Oactivity	.	activity	NN	I-NP	O.	The	.	.	O	OThe	inhibitory	The	DT	B-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	ASA	of	IN	B-PP	OASA	on	ASA	NN	B-NP	Oon	IL-4	on	IN	B-PP	OIL-4	transcription	IL-4	NN	B-NP	B-proteintranscription	was	transcription	NN	I-NP	Owas	not	be	VBD	B-VP	Onot	mediated	not	RB	I-VP	Omediated	by	mediate	VBN	I-VP	Oby	decreased	by	IN	B-PP	Odecreased	nuclear	decrease	VBN	B-NP	Onuclear	expression	nuclear	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	known	the	DT	B-NP	Oknown	salicylate	know	VBN	I-NP	Osalicylate	target	salicylate	NN	I-NP	B-proteintarget	nuclear	target	NN	I-NP	I-proteinnuclear	factor	nuclear	JJ	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	NF	(	(	O	I-proteinNF	)	NF	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	and	#NAME?	NN	B-NP	I-proteinand	was	and	CC	O	Owas	accompanied	be	VBD	B-VP	Oaccompanied	by	accompany	VBN	I-VP	Oby	reduced	by	IN	B-PP	Oreduced	binding	reduce	VBN	B-NP	Obinding	of	binding	NN	I-NP	Oof	an	of	IN	B-PP	Oan	inducible	an	DT	B-NP	Oinducible	factor	inducible	JJ	I-NP	B-proteinfactor	to	factor	NN	I-NP	I-proteinto	an	to	TO	B-PP	Oan	IL-4	an	DT	B-NP	OIL-4	promoter	IL-4	NN	I-NP	B-DNApromoter	region	promoter	NN	I-NP	I-DNAregion	upstream	region	NN	I-NP	I-DNAupstream	of	upstream	RB	B-ADVP	Oof	","	of	IN	B-PP	O","	but	","	","	O	Obut	not	but	CC	O	Onot	overlapping	not	RB	O	Ooverlapping	","	overlap	VBG	B-VP	O","	the	","	","	O	Othe	NF	the	DT	B-NP	ONF	of	NF	NN	I-NP	B-proteinof	activated	of	IN	B-PP	I-proteinactivated	T	activate	VBN	B-NP	I-proteinT	cells-	T	NN	I-NP	I-proteincells-	and	cells-	NNS	I-NP	I-proteinand	NF-kappaB-binding	and	CC	O	ONF-kappaB-binding	P1	NF-kappaB-binding	JJ	B-NP	B-DNAP1	element	P1	NN	I-NP	I-DNAelement	.	element	NN	I-NP	I-DNA.	It	.	.	O	OIt	is	It	PRP	B-NP	Ois	concluded	be	VBZ	B-VP	Oconcluded	that	conclude	VBN	I-VP	Othat	anti-inflammatory	that	IN	B-SBAR	Oanti-inflammatory	salicylates	anti-inflammatory	JJ	B-NP	Osalicylates	","	salicylate	NNS	I-NP	O","	by	","	","	O	Oby	means	by	IN	B-PP	Omeans	of	mean	NNS	B-NP	Oof	a	of	IN	B-PP	Oa	previously	a	DT	B-NP	Opreviously	unrecognized	previously	RB	I-NP	Ounrecognized	mechanism	unrecognized	JJ	I-NP	Omechanism	of	mechanism	NN	I-NP	Oof	action	of	IN	B-PP	Oaction	","	action	NN	B-NP	O","	can	","	","	O	Ocan	influence	can	MD	B-VP	Oinfluence	the	influence	VB	I-VP	Othe	nature	the	DT	B-NP	Onature	of	nature	NN	I-NP	Oof	adaptive	of	IN	B-PP	Oadaptive	immune	adaptive	JJ	B-NP	Oimmune	responses	immune	JJ	I-NP	Oresponses	by	response	NNS	I-NP	Oby	selectively	by	IN	B-PP	Oselectively	inhibiting	selectively	RB	B-VP	Oinhibiting	the	inhibit	VBG	I-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	IL-4	of	IN	B-PP	OIL-4	","	IL-4	NN	B-NP	B-protein","	a	","	","	O	Oa	critical	a	DT	B-NP	Ocritical	effector	critical	JJ	I-NP	Oeffector	of	effector	NN	I-NP	Oof	these	of	IN	B-PP	Othese	responses	these	DT	B-NP	Oresponses	","	response	NNS	I-NP	O","	in	","	","	O	Oin	CD4+	in	IN	B-PP	OCD4+	T	CD4+	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Molecular	.	.	O	OMolecular	and	Molecular	JJ	B-NP	Oand	cellular	and	CC	I-NP	Ocellular	mediators	cellular	JJ	I-NP	Omediators	of	mediator	NNS	I-NP	Oof	interleukin-1	of	IN	B-PP	Ointerleukin-1	#NAME?	interleukin-1	NN	B-NP	B-protein#NAME?	acute	#NAME?	JJ	I-NP	Oacute	inflammatory	acute	JJ	I-NP	Oinflammatory	arthritis	inflammatory	JJ	I-NP	Oarthritis	.	arthritis	NN	I-NP	O.	OBJECTIVE	.	.	O	OOBJECTIVE	:	OBJECTIVE	NN	B-NP	O:	To	:	:	O	OTo	examine	To	TO	B-VP	Oexamine	the	examine	VB	I-VP	Othe	molecular	the	DT	B-NP	Omolecular	and	molecular	JJ	I-NP	Oand	cellular	and	CC	I-NP	Ocellular	mechanisms	cellular	JJ	I-NP	Omechanisms	in	mechanism	NNS	I-NP	Oin	a	in	IN	B-PP	Oa	model	a	DT	B-NP	Omodel	of	model	NN	I-NP	Oof	acute	of	IN	B-PP	Oacute	inflammatory	acute	JJ	B-NP	Oinflammatory	monarticular	inflammatory	JJ	I-NP	Omonarticular	arthritis	monarticular	JJ	I-NP	Oarthritis	induced	arthritis	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	methylated	by	IN	B-PP	Omethylated	bovine	methylate	VBN	B-NP	Obovine	serum	bovine	JJ	I-NP	B-proteinserum	albumin	serum	NN	I-NP	I-proteinalbumin	(	albumin	NN	I-NP	I-protein(	mBSA	(	(	O	OmBSA	)	mBSA	NN	B-NP	O)	and	)	)	O	Oand	interleukin-1	and	CC	O	Ointerleukin-1	(	interleukin-1	NN	B-NP	B-protein(	IL-1	(	(	O	OIL-1	)	IL-1	NN	B-NP	B-protein)	.	)	)	O	O.	METHODS	.	.	O	OMETHODS	:	METHODS	NNS	B-NP	O:	Mice	:	:	O	OMice	were	Mouse	NNS	B-NP	Owere	injected	be	VBD	B-VP	Oinjected	intraarticularly	inject	VBN	I-VP	Ointraarticularly	with	intraarticularly	RB	B-ADVP	Owith	mBSA	with	IN	B-PP	OmBSA	on	mBSA	NN	B-NP	Oon	day	on	IN	B-PP	Oday	0	day	NN	B-NP	O0	and	0	CD	I-NP	Oand	subcutaneously	and	CC	O	Osubcutaneously	with	subcutaneously	RB	B-ADVP	Owith	recombinant	with	IN	B-PP	Orecombinant	human	recombinant	JJ	B-NP	B-proteinhuman	IL-1beta	human	JJ	I-NP	I-proteinIL-1beta	on	IL-1beta	NN	I-NP	I-proteinon	days	on	IN	B-PP	Odays	0-2	day	NNS	B-NP	O0-2	.	0-2	CD	B-NP	O.	At	.	.	O	OAt	day	At	IN	B-PP	Oday	7	day	NN	B-NP	O7	","	7	CD	I-NP	O","	knee	","	","	O	Oknee	joints	knee	NN	B-NP	Ojoints	were	joint	NNS	I-NP	Owere	removed	be	VBD	B-VP	Oremoved	and	remove	VBN	I-VP	Oand	assessed	and	CC	O	Oassessed	histologically	assess	VBN	B-VP	Ohistologically	.	histologically	RB	B-ADVP	O.	Flow	.	.	O	OFlow	cytometry	Flow	NN	B-NP	Ocytometry	and	cytometry	NN	I-NP	Oand	RNase	and	CC	O	ORNase	protection	RNase	NN	B-NP	B-proteinprotection	were	protection	NN	I-NP	Owere	used	be	VBD	B-VP	Oused	to	use	VBN	I-VP	Oto	analyze	to	TO	B-VP	Oanalyze	IL-1	analyze	VB	I-VP	OIL-1	#NAME?	IL-1	NN	B-NP	B-protein#NAME?	events	#NAME?	JJ	I-NP	Oevents	.	event	NNS	I-NP	O.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	C57BL/6	:	:	O	OC57BL/6	(	C57BL/6	NN	B-NP	O(	B6	(	(	O	OB6	)	B6	NN	B-NP	B-protein)	","	)	)	O	O","	129/Sv	","	","	O	O129/Sv	","	129/Sv	NN	B-NP	O","	and	","	","	O	Oand	(	and	CC	O	O(	B6	(	(	O	OB6	x	B6	NN	B-NP	Ox	129/	x	SYM	O	O129/	Sv	129/	CD	B-NP	OSv	)	Sv	NN	I-NP	O)	F1	)	)	O	OF1	hybrid	F1	NN	B-NP	Ohybrid	mice	hybrid	NN	I-NP	Omice	","	mouse	NNS	I-NP	O","	all	","	","	O	Oall	H-2b	all	DT	B-NP	OH-2b	strains	H-2b	NN	I-NP	Ostrains	","	strain	NNS	I-NP	O","	were	","	","	O	Owere	susceptible	be	VBD	B-VP	Osusceptible	to	susceptible	JJ	B-ADJP	Oto	mBSA	to	TO	B-PP	OmBSA	/IL-1-induced	mBSA	NN	B-NP	O/IL-1-induced	arthritis	/IL-1-induced	JJ	I-NP	Oarthritis	","	arthritis	NN	I-NP	O","	whereas	","	","	O	Owhereas	C3H/HeJ	whereas	IN	O	OC3H/HeJ	(	C3H/HeJ	NN	B-NP	B-protein(	H-2k	(	(	O	OH-2k	)	H-2k	NN	B-NP	O)	mice	)	)	O	Omice	were	mouse	NNS	B-NP	Owere	not	be	VBD	B-VP	Onot	.	not	RB	O	O.	B6	.	.	O	OB6	mice	B6	NN	B-NP	Omice	lacking	mouse	NNS	I-NP	Olacking	T	lack	VBG	B-VP	OT	and	T	NN	B-NP	B-cell_typeand	B	and	CC	I-NP	I-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	RAG1-/-	(	(	O	ORAG1-/-	)	RAG1-/-	JJ	B-ADJP	O)	or	)	)	O	Oor	major	or	CC	O	Omajor	histocompatibility	major	JJ	B-NP	B-proteinhistocompatibility	complex	histocompatibility	NN	I-NP	I-proteincomplex	(	complex	NN	I-NP	I-protein(	MHC	(	(	O	I-proteinMHC	)	MHC	NN	B-NP	I-protein)	class	)	)	O	I-proteinclass	II	class	NN	B-NP	I-proteinII	antigens	II	CD	B-NP	I-proteinantigens	(	antigen	NNS	I-NP	I-protein(	MHCII-/-	(	(	O	OMHCII-/-	)	MHCII-/-	JJ	B-ADVP	O)	","	)	)	O	O","	and	","	","	O	Oand	B6	and	CC	O	OB6	mice	B6	NN	B-NP	Omice	treated	mouse	NNS	I-NP	Otreated	with	treat	VBN	B-VP	Owith	a	with	IN	B-PP	Oa	CD4+	a	DT	B-NP	OCD4+	T	CD4+	JJ	I-NP	B-proteinT	cell-depleting	T	NN	I-NP	I-proteincell-depleting	monoclonal	cell-depleting	JJ	I-NP	I-proteinmonoclonal	antibody	monoclonal	JJ	I-NP	I-proteinantibody	","	antibody	NN	I-NP	I-protein","	were	","	","	O	Owere	resistant	be	VBD	B-VP	Oresistant	to	resistant	JJ	B-ADJP	Oto	disease	to	TO	B-PP	Odisease	.	disease	NN	B-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	B	","	","	O	OB	cell-deficient	B	NN	B-NP	Ocell-deficient	(	cell-deficient	JJ	B-ADJP	O(	muMT/	(	(	O	OmuMT/	muMT	muMT/	NN	B-NP	OmuMT	)	muMT	NN	I-NP	O)	mice	)	)	O	Omice	developed	mouse	NNS	B-NP	Odeveloped	arthritis	develop	VBD	B-VP	Oarthritis	at	arthritis	NN	B-NP	Oat	an	at	IN	B-PP	Oan	incidence	an	DT	B-NP	Oincidence	and	incidence	NN	I-NP	Oand	severity	and	CC	I-NP	Oseverity	similar	severity	NN	I-NP	Osimilar	to	similar	JJ	B-ADJP	Oto	that	to	TO	B-PP	Othat	of	that	DT	B-NP	Oof	controls	of	IN	B-PP	Ocontrols	.	control	NNS	B-NP	O.	RelB-deficient	.	.	O	ORelB-deficient	(	RelB-deficient	JJ	O	O(	RelB-/-	(	(	O	ORelB-/-	)	RelB-/-	JJ	B-ADJP	O)	bone	)	)	O	Obone	marrow	bone	NN	B-NP	Omarrow	chimeric	marrow	NN	I-NP	Ochimeric	mice	chimeric	JJ	I-NP	Omice	had	mouse	NNS	I-NP	Ohad	arthritis	have	VBD	B-VP	Oarthritis	that	arthritis	NN	B-NP	Othat	was	that	WDT	B-NP	Owas	significantly	be	VBD	B-VP	Osignificantly	reduced	significantly	RB	I-VP	Oreduced	in	reduce	VBN	I-VP	Oin	incidence	in	IN	B-PP	Oincidence	and	incidence	NN	B-NP	Oand	severity	and	CC	I-NP	Oseverity	.	severity	NN	I-NP	O.	In	.	.	O	OIn	B6	In	IN	B-PP	OB6	mice	B6	NN	B-NP	Omice	","	mouse	NNS	I-NP	O","	flow	","	","	O	Oflow	cytometry	flow	NN	B-NP	Ocytometry	demonstrated	cytometry	NN	I-NP	Odemonstrated	an	demonstrate	VBD	B-VP	Oan	IL-1-dependent	an	DT	B-NP	OIL-1-dependent	leukocyte	IL-1-dependent	JJ	I-NP	Oleukocyte	infiltration	leukocyte	NN	I-NP	Oinfiltration	into	infiltration	NN	I-NP	Ointo	the	into	IN	B-PP	Othe	synovial	the	DT	B-NP	Osynovial	compartment	synovial	JJ	I-NP	Ocompartment	and	compartment	NN	I-NP	Oand	RNase	and	CC	I-NP	ORNase	protection	RNase	NN	I-NP	B-proteinprotection	assays	protection	NN	I-NP	Oassays	revealed	assay	NNS	I-NP	Orevealed	induction	reveal	VBD	B-VP	Oinduction	of	induction	NN	B-NP	Oof	messenger	of	IN	B-PP	Omessenger	RNA	messenger	NN	B-NP	B-RNARNA	(	RNA	NN	I-NP	I-RNA(	mRNA	(	(	O	OmRNA	)	mRNA	NN	B-NP	B-RNA)	for	)	)	O	Ofor	the	for	IN	B-PP	Othe	chemokines	the	DT	B-NP	Ochemokines	monocyte	chemokine	NNS	I-NP	B-proteinmonocyte	chemoattractant	monocyte	NN	I-NP	B-proteinchemoattractant	protein	chemoattractant	NN	I-NP	I-proteinprotein	1	protein	NN	I-NP	I-protein1	","	1	CD	I-NP	I-protein","	macrophage	","	","	O	Omacrophage	inhibitory	macrophage	NN	B-NP	B-proteininhibitory	protein	inhibitory	JJ	I-NP	I-proteinprotein	2	protein	NN	I-NP	I-protein2	(	2	CD	I-NP	I-protein(	MIP-2	(	(	O	OMIP-2	)	MIP-2	NN	B-NP	B-protein)	","	)	)	O	O","	RANTES	","	","	O	ORANTES	","	RANTES	NN	B-NP	B-protein","	MIP-1alpha	","	","	O	OMIP-1alpha	","	MIP-1alpha	NN	B-NP	B-protein","	and	","	","	O	Oand	MIP-1beta	and	CC	O	OMIP-1beta	","	MIP-1beta	NN	B-NP	B-protein","	in	","	","	O	Oin	vivo	in	FW	B-ADVP	Ovivo	and	vivo	FW	I-ADVP	Oand	in	and	CC	O	Oin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	CONCLUSION	.	.	O	OCONCLUSION	:	CONCLUSION	NN	B-NP	O:	Arthritis	:	:	O	OArthritis	induced	Arthritis	NN	B-NP	Oinduced	by	induce	VBN	B-VP	Oby	mBSA	by	IN	B-PP	OmBSA	/	mBSA	NN	B-NP	B-protein/	IL-1	/	SYM	B-NP	OIL-1	is	IL-1	NN	I-NP	B-proteinis	strain	be	VBZ	B-VP	Ostrain	specific	strain	NN	B-NP	Ospecific	and	specific	JJ	I-NP	Oand	dependent	and	CC	I-NP	Odependent	on	dependent	JJ	I-NP	Oon	CD4+	on	IN	B-PP	OCD4+	T	CD4+	JJ	B-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	at	and	CC	O	Oat	least	at	IN	B-ADVP	Oleast	partially	least	JJS	I-ADVP	Opartially	on	partially	RB	B-ADVP	Oon	RelB	on	IN	B-PP	ORelB	","	RelB	NN	B-NP	B-protein","	but	","	","	B-PP	Obut	not	but	CC	I-PP	Onot	on	not	RB	B-PP	Oon	B	on	IN	I-PP	OB	lymphocytes	B	NN	B-NP	B-cell_typelymphocytes	or	lymphocyte	NNS	I-NP	I-cell_typeor	antibody	or	CC	O	Oantibody	.	antibody	NN	B-NP	O.	IL-1	.	.	O	OIL-1	contributes	IL-1	NN	B-NP	B-proteincontributes	to	contribute	VBZ	B-VP	Oto	leukocyte	to	TO	I-VP	Oleukocyte	recruitment	leukocyte	VB	I-VP	Orecruitment	to	recruitment	NN	B-NP	Oto	the	to	TO	B-PP	Othe	synovium	the	DT	B-NP	Osynovium	and	synovium	NN	I-NP	Oand	directly	and	CC	O	Odirectly	induces	directly	RB	B-VP	Oinduces	chemokine	induce	VBZ	I-VP	Ochemokine	mRNA	chemokine	NN	B-NP	B-RNAmRNA	production	mRNA	NN	I-NP	I-RNAproduction	by	production	NN	I-NP	Oby	synovial	by	IN	B-PP	Osynovial	cells	synovial	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	This	.	.	O	OThis	model	This	DT	B-NP	Omodel	of	model	NN	I-NP	Oof	acute	of	IN	B-PP	Oacute	monarticular	acute	JJ	B-NP	Omonarticular	arthritis	monarticular	JJ	I-NP	Oarthritis	is	arthritis	NN	I-NP	Ois	particularly	be	VBZ	B-VP	Oparticularly	suitable	particularly	RB	B-ADJP	Osuitable	for	suitable	JJ	I-ADJP	Ofor	further	for	IN	B-PP	Ofurther	investigations	further	JJ	B-NP	Oinvestigations	into	investigation	NNS	I-NP	Ointo	cell-mediated	into	IN	B-PP	Ocell-mediated	immunity	cell-mediated	JJ	B-NP	Oimmunity	in	immunity	NN	I-NP	Oin	arthritis	in	IN	B-PP	Oarthritis	and	arthritis	NN	B-NP	Oand	the	and	CC	O	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	IL-1	of	IN	B-PP	OIL-1	.	IL-1	NN	B-NP	B-protein.	Positive	.	.	O	OPositive	and	Positive	JJ	B-NP	Oand	negative	and	CC	I-NP	Onegative	regulation	negative	JJ	I-NP	Oregulation	of	regulation	NN	I-NP	Oof	granulopoiesis	of	IN	B-PP	Ogranulopoiesis	by	granulopoiesis	NN	B-NP	Oby	endogenous	by	IN	B-PP	Oendogenous	RARalpha	endogenous	JJ	B-NP	ORARalpha	.	RARalpha	NN	I-NP	B-protein.	Acute	.	.	O	OAcute	promyelocytic	Acute	JJ	B-NP	Opromyelocytic	leukemia	promyelocytic	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	APL	(	(	O	OAPL	)	APL	NN	B-NP	O)	is	)	)	O	Ois	always	be	VBZ	B-VP	Oalways	associated	always	RB	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	chromosomal	with	IN	B-PP	Ochromosomal	translocations	chromosomal	JJ	B-NP	Otranslocations	that	translocation	NNS	I-NP	Othat	disrupt	that	WDT	B-NP	Odisrupt	the	disrupt	VBP	B-VP	Othe	retinoic	the	DT	B-NP	Oretinoic	acid	retinoic	JJ	I-NP	B-DNAacid	receptor	acid	NN	I-NP	I-DNAreceptor	alpha	receptor	NN	I-NP	I-DNAalpha	(	alpha	NN	I-NP	I-DNA(	RARalpha	(	(	O	I-DNARARalpha	)	RARalpha	NN	B-NP	I-DNA)	gene	)	)	O	I-DNAgene	.	gene	NN	B-NP	I-DNA.	Whether	.	.	O	OWhether	these	Whether	IN	B-SBAR	Othese	translocations	these	DT	B-NP	Otranslocations	relate	translocation	NNS	I-NP	Orelate	to	relate	VBP	B-VP	Oto	a	to	TO	B-PP	Oa	role	a	DT	B-NP	Orole	for	role	NN	I-NP	Ofor	endogenous	for	IN	B-PP	Oendogenous	RARalpha	endogenous	JJ	B-NP	B-proteinRARalpha	in	RARalpha	NN	I-NP	I-proteinin	normal	in	IN	B-PP	Onormal	granulopoiesis	normal	JJ	B-NP	Ogranulopoiesis	remains	granulopoiesis	NN	I-NP	Oremains	uncertain	remain	VBZ	B-VP	Ouncertain	because	uncertain	JJ	B-ADJP	Obecause	most	because	IN	B-SBAR	Omost	studies	most	JJS	B-NP	Ostudies	addressing	study	NNS	I-NP	Oaddressing	this	address	VBG	B-VP	Othis	question	this	DT	B-NP	Oquestion	have	question	NN	I-NP	Ohave	used	have	VBP	B-VP	Oused	non-physiological	use	VBN	I-VP	Onon-physiological	overexpression	non-physiological	JJ	B-NP	Ooverexpression	systems	overexpression	NN	I-NP	Osystems	.	system	NNS	I-NP	O.	Granulocyte	.	.	O	OGranulocyte	differentiation	Granulocyte	NN	B-NP	Odifferentiation	in	differentiation	NN	I-NP	Oin	cells	in	IN	B-PP	Ocells	derived	cell	NNS	B-NP	Oderived	from	derive	VBN	B-VP	Ofrom	RARalpha-deficient	from	IN	B-PP	ORARalpha-deficient	(	RARalpha-deficient	JJ	B-NP	O(	RARalpha	(	(	O	ORARalpha	(	RARalpha	NN	B-NP	B-protein(	-/-	(	(	O	O-/-	)	-/-	JJ	B-ADJP	O)	)	)	)	O	O)	mice	)	)	O	Omice	was	mouse	NNS	B-NP	Owas	studied	be	VBD	B-VP	Ostudied	and	study	VBN	I-VP	Oand	evaluated	and	CC	O	Oevaluated	in	evaluate	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	context	the	DT	B-NP	Ocontext	of	context	NN	I-NP	Oof	agonist-bound	of	IN	B-PP	Oagonist-bound	and	agonist-bound	JJ	B-NP	Oand	ligand-free	and	CC	I-NP	Oligand-free	RARalpha	ligand-free	JJ	I-NP	ORARalpha	.	RARalpha	NN	I-NP	B-protein.	Our	.	.	O	OOur	results	Our	PRP$	B-NP	Oresults	demonstrate	result	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	RARalpha	that	IN	B-SBAR	ORARalpha	is	RARalpha	NN	B-NP	B-proteinis	dispensable	be	VBZ	B-VP	Odispensable	for	dispensable	JJ	B-ADJP	Ofor	granulopoiesis	for	IN	B-PP	Ogranulopoiesis	","	granulopoiesis	NN	B-NP	O","	as	","	","	O	Oas	RARalpha	as	IN	B-SBAR	ORARalpha	(	RARalpha	NN	B-NP	B-protein(	-/-	(	(	O	O-/-	)	-/-	JJ	O	O)	mice	)	)	O	Omice	have	mouse	NNS	B-NP	Ohave	a	have	VBP	B-VP	Oa	normal	a	DT	B-NP	Onormal	granulocyte	normal	JJ	I-NP	B-cell_typegranulocyte	population	granulocyte	NN	I-NP	I-cell_typepopulation	despite	population	NN	I-NP	I-cell_typedespite	an	despite	IN	B-PP	Oan	impaired	an	DT	B-NP	Oimpaired	ability	impaired	JJ	I-NP	Oability	to	ability	NN	I-NP	Oto	respond	to	TO	B-VP	Orespond	to	respond	VB	I-VP	Oto	retinoids	to	TO	B-PP	Oretinoids	.	retinoid	NNS	B-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	although	","	","	O	Oalthough	it	although	IN	B-SBAR	Oit	is	it	PRP	B-NP	Ois	not	be	VBZ	B-VP	Onot	absolutely	not	RB	O	Oabsolutely	required	absolutely	RB	B-VP	Orequired	","	require	VBN	I-VP	O","	RARalpha	","	","	O	ORARalpha	can	RARalpha	NN	B-NP	B-proteincan	bidirectionally	can	MD	B-VP	Obidirectionally	modulate	bidirectionally	RB	I-VP	Omodulate	granulopoiesis	modulate	VB	I-VP	Ogranulopoiesis	.	granulopoiesis	NN	B-NP	O.	RARalpha	.	.	O	ORARalpha	stimulates	RARalpha	NN	B-NP	B-proteinstimulates	differentiation	stimulate	VBZ	B-VP	Odifferentiation	in	differentiation	NN	B-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	exogenous	to	TO	B-PP	Oexogenous	retinoic	exogenous	JJ	B-NP	Oretinoic	acid	retinoic	JJ	I-NP	Oacid	.	acid	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	endogenous	","	","	O	Oendogenous	retinoids	endogenous	JJ	B-NP	Oretinoids	control	retinoid	NNS	I-NP	Ocontrol	granulopoiesis	control	VBP	B-VP	Ogranulopoiesis	in	granulopoiesis	NN	B-NP	Oin	vivo	in	FW	B-ADVP	Ovivo	","	vivo	FW	I-ADVP	O","	as	","	","	O	Oas	either	as	IN	B-SBAR	Oeither	vitamin	either	DT	B-NP	Ovitamin	A-deficient	vitamin	NN	I-NP	OA-deficient	mice	A-deficient	JJ	I-NP	Omice	or	mouse	NNS	I-NP	Oor	animals	or	CC	I-NP	Oanimals	treated	animal	NNS	I-NP	Otreated	with	treat	VBN	B-VP	Owith	an	with	IN	B-PP	Oan	RAR	an	DT	B-NP	ORAR	antagonist	RAR	NN	I-NP	B-proteinantagonist	accumulate	antagonist	NN	I-NP	Oaccumulate	more	accumulate	VBP	B-VP	Omore	immature	more	RBR	B-NP	Oimmature	granulocytes	immature	JJ	I-NP	B-cell_typegranulocytes	in	granulocyte	NNS	I-NP	I-cell_typein	their	in	IN	B-PP	Otheir	bone	their	PRP$	B-NP	Obone	marrow	bone	NN	I-NP	Omarrow	.	marrow	NN	I-NP	O.	Conversely	.	.	O	OConversely	","	Conversely	RB	B-ADVP	O","	RARalpha	","	","	O	ORARalpha	acts	RARalpha	NN	B-NP	B-proteinacts	to	act	VBZ	B-VP	Oto	limit	to	TO	I-VP	Olimit	differentiation	limit	VB	I-VP	Odifferentiation	in	differentiation	NN	B-NP	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	ligand	of	IN	B-PP	Oligand	because	ligand	NN	B-NP	Obecause	granulocyte	because	IN	B-SBAR	Ogranulocyte	precursors	granulocyte	NN	B-NP	B-cell_typeprecursors	from	precursor	NNS	I-NP	I-cell_typefrom	RARalpha	from	IN	B-PP	ORARalpha	(	RARalpha	NN	B-NP	B-protein(	-/-	(	(	O	O-/-	)	-/-	JJ	O	O)	mice	)	)	O	Omice	differentiate	mouse	NNS	B-NP	Odifferentiate	earlier	differentiate	VBP	B-VP	Oearlier	in	earlier	RBR	B-ADVP	Oin	culture	in	IN	B-PP	Oculture	.	culture	NN	B-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	the	","	","	O	Othe	block	the	DT	B-NP	Oblock	in	block	NN	I-NP	Oin	granulopoiesis	in	IN	B-PP	Ogranulopoiesis	exerted	granulopoiesis	NN	B-NP	Oexerted	by	exert	VBN	B-VP	Oby	RARalpha	by	IN	B-PP	ORARalpha	fusion	RARalpha	NN	B-NP	B-proteinfusion	proteins	fusion	NN	I-NP	I-proteinproteins	expressed	protein	NNS	I-NP	I-proteinexpressed	in	express	VBN	B-VP	Oin	APL	in	IN	B-PP	OAPL	cells	APL	NN	B-NP	B-cell_typecells	may	cell	NNS	I-NP	I-cell_typemay	correspond	may	MD	B-VP	Ocorrespond	to	correspond	VB	I-VP	Oto	an	to	TO	B-PP	Oan	amplification	an	DT	B-NP	Oamplification	of	amplification	NN	I-NP	Oof	a	of	IN	B-PP	Oa	normal	a	DT	B-NP	Onormal	function	normal	JJ	I-NP	Ofunction	of	function	NN	I-NP	Oof	unliganded	of	IN	B-PP	Ounliganded	RARalpha	unliganded	JJ	B-NP	B-proteinRARalpha	.	RARalpha	NN	I-NP	I-protein.	Expression	.	.	O	OExpression	and	Expression	NN	B-NP	Oand	function	and	CC	I-NP	Ofunction	of	function	NN	I-NP	Oof	a	of	IN	B-PP	Oa	stem	a	DT	B-NP	Ostem	cell	stem	NN	I-NP	Ocell	promoter	cell	NN	I-NP	Opromoter	for	promoter	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	murine	the	DT	B-NP	Omurine	CBFalpha2	murine	JJ	I-NP	B-DNACBFalpha2	gene	CBFalpha2	NN	I-NP	I-DNAgene	:	gene	NN	I-NP	I-DNA:	distinct	:	:	O	Odistinct	roles	distinct	JJ	B-NP	Oroles	and	role	NNS	I-NP	Oand	regulation	and	CC	O	Oregulation	in	regulation	NN	B-NP	Oin	natural	in	IN	B-PP	Onatural	killer	natural	JJ	B-NP	Okiller	and	killer	NN	I-NP	Oand	T	and	CC	O	OT	cell	T	NN	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	.	development	NN	I-NP	O.	The	.	.	O	OThe	Runt	The	DT	B-NP	ORunt	family	Runt	NN	I-NP	B-proteinfamily	transcription	family	NN	I-NP	I-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	CBFalpha2	factor	NN	I-NP	I-proteinCBFalpha2	(	CBFalpha2	NN	I-NP	B-protein(	AML1	(	(	O	OAML1	","	AML1	NN	B-NP	B-protein","	PEBP2alphaB	","	","	O	OPEBP2alphaB	","	PEBP2alphaB	NN	B-NP	B-protein","	or	","	","	O	Oor	Runx1	or	CC	O	ORunx1	)	Runx1	NN	B-NP	B-protein)	is	)	)	O	Ois	required	be	VBZ	B-VP	Orequired	by	require	VBN	I-VP	Oby	hematopoietic	by	IN	B-PP	Ohematopoietic	stem	hematopoietic	JJ	B-NP	B-cell_typestem	cells	stem	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	expressed	and	CC	O	Oexpressed	at	express	VBN	B-VP	Oat	high	at	IN	B-PP	Ohigh	levels	high	JJ	B-NP	Olevels	in	level	NNS	I-NP	Oin	T-lineage	in	IN	B-PP	OT-lineage	cells	T-lineage	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	human	In	IN	B-PP	Ohuman	T	human	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	CBFalpha2	cell	NNS	I-NP	I-cell_typeCBFalpha2	is	CBFalpha2	NN	I-NP	B-proteinis	usually	be	VBZ	B-VP	Ousually	transcribed	usually	RB	I-VP	Otranscribed	from	transcribe	VBN	I-VP	Ofrom	a	from	IN	B-PP	Oa	different	a	DT	B-NP	Odifferent	promoter	different	JJ	I-NP	Opromoter	(	promoter	NN	I-NP	O(	distal	(	(	O	Odistal	promoter	distal	JJ	B-NP	B-DNApromoter	)	promoter	NN	I-NP	I-DNA)	than	)	)	O	Othan	in	than	IN	B-PP	Oin	myeloid	in	IN	B-PP	Omyeloid	cells	myeloid	JJ	B-NP	B-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	proximal	(	(	O	Oproximal	promoter	proximal	JJ	B-NP	B-DNApromoter	)	promoter	NN	I-NP	I-DNA)	","	)	)	O	O","	but	","	","	O	Obut	the	but	CC	O	Othe	developmental	the	DT	B-NP	Odevelopmental	and	developmental	JJ	I-NP	Oand	functional	and	CC	I-NP	Ofunctional	significance	functional	JJ	I-NP	Osignificance	of	significance	NN	I-NP	Oof	this	of	IN	B-PP	Othis	promoter	this	DT	B-NP	Opromoter	switch	promoter	NN	I-NP	Oswitch	has	switch	NN	I-NP	Ohas	not	have	VBZ	B-VP	Onot	been	not	RB	I-VP	Obeen	known	be	VBN	I-VP	Oknown	.	know	VBN	I-VP	O.	Here	.	.	O	OHere	","	Here	RB	B-ADVP	O","	we	","	","	O	Owe	report	we	PRP	B-NP	Oreport	that	report	VBP	B-VP	Othat	both	that	IN	B-SBAR	Oboth	coding	both	CC	O	Ocoding	and	cod	VBG	B-VP	Oand	noncoding	and	CC	O	Ononcoding	sequences	noncoding	JJ	B-NP	Osequences	of	sequence	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	distal	the	DT	B-NP	Odistal	5	distal	JJ	I-NP	B-DNA5	'	5	CD	I-NP	I-DNA'	end	'	SYM	I-NP	I-DNAend	are	end	NN	I-NP	I-DNAare	highly	be	VBP	B-VP	Ohighly	conserved	highly	RB	I-VP	Oconserved	between	conserve	VBN	I-VP	Obetween	the	between	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	and	human	JJ	I-NP	Oand	the	and	CC	O	Othe	murine	the	DT	B-NP	Omurine	genes	murine	JJ	I-NP	B-DNAgenes	","	gene	NNS	I-NP	I-DNA","	and	","	","	O	Oand	the	and	CC	O	Othe	distal	the	DT	B-NP	Odistal	promoter	distal	JJ	I-NP	B-DNApromoter	is	promoter	NN	I-NP	I-DNAis	responsible	be	VBZ	B-VP	Oresponsible	for	responsible	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	overwhelming	the	DT	B-NP	Ooverwhelming	majority	overwhelming	JJ	I-NP	Omajority	of	majority	NN	I-NP	Oof	CBFalpha2	of	IN	B-PP	OCBFalpha2	expression	CBFalpha2	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	murine	in	IN	B-PP	Omurine	hematopoietic	murine	JJ	B-NP	B-cell_linehematopoietic	stem	hematopoietic	JJ	I-NP	I-cell_linestem	cells	stem	NN	I-NP	I-cell_linecells	as	cell	NNS	I-NP	I-cell_lineas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	in	as	IN	I-CONJP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Distal	.	.	O	ODistal	promoter	Distal	JJ	B-NP	B-DNApromoter	activity	promoter	NN	I-NP	I-DNAactivity	is	activity	NN	I-NP	Ois	maintained	be	VBZ	B-VP	Omaintained	throughout	maintain	VBN	I-VP	Othroughout	T	throughout	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	and	development	NN	I-NP	Oand	at	and	CC	B-PP	Oat	lower	at	IN	B-PP	Olower	levels	low	JJR	B-NP	Olevels	in	level	NNS	I-NP	Oin	B	in	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	","	development	NN	I-NP	O","	but	","	","	O	Obut	downregulated	but	CC	O	Odownregulated	in	downregulate	VBD	B-VP	Oin	natural	in	IN	B-PP	Onatural	killer	natural	JJ	B-NP	Okiller	cell	killer	NN	I-NP	Ocell	development	cell	NN	I-NP	Odevelopment	.	development	NN	I-NP	O.	The	.	.	O	OThe	distal	The	DT	B-NP	Odistal	N-terminal	distal	JJ	I-NP	B-proteinN-terminal	isoform	N-terminal	JJ	I-NP	I-proteinisoform	binds	isoform	NN	I-NP	I-proteinbinds	to	bind	VBZ	B-VP	Oto	functionally	to	TO	B-PP	Ofunctionally	important	functionally	RB	B-NP	Oimportant	regulatory	important	JJ	I-NP	Oregulatory	sites	regulatory	JJ	I-NP	Osites	from	site	NNS	I-NP	Ofrom	known	from	IN	B-PP	Oknown	target	know	VBN	B-NP	Otarget	genes	target	NN	I-NP	B-DNAgenes	with	gene	NNS	I-NP	I-DNAwith	two-	with	IN	B-PP	Otwo-	to	two-	CD	B-NP	Oto	threefold	to	TO	B-PP	Othreefold	higher	threefold	RB	B-NP	Ohigher	affinity	high	JJR	I-NP	Oaffinity	than	affinity	NN	I-NP	Othan	the	than	IN	B-PP	Othe	proximal	the	DT	B-NP	Oproximal	N-terminal	proximal	JJ	I-NP	B-proteinN-terminal	isoform	N-terminal	JJ	I-NP	I-proteinisoform	.	isoform	NN	I-NP	I-protein.	Neither	.	.	O	ONeither	full-length	Neither	CC	O	Ofull-length	isoform	full-length	JJ	B-NP	B-proteinisoform	alters	isoform	NN	I-NP	I-proteinalters	growth	alter	VBZ	B-VP	Ogrowth	of	growth	NN	B-NP	Oof	a	of	IN	B-PP	Oa	myeloid	a	DT	B-NP	Omyeloid	cell	myeloid	JJ	I-NP	B-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	under	line	NN	I-NP	I-cell_lineunder	nondifferentiating	under	IN	B-PP	Onondifferentiating	conditions	nondifferentiating	JJ	B-NP	Oconditions	","	condition	NNS	I-NP	O","	but	","	","	O	Obut	the	but	CC	O	Othe	proximal	the	DT	B-NP	Oproximal	isoform	proximal	JJ	I-NP	B-proteinisoform	selectively	isoform	NN	I-NP	I-proteinselectively	delays	selectively	RB	B-ADVP	Odelays	mitotic	delay	VBZ	B-VP	Omitotic	arrest	mitotic	JJ	B-NP	Oarrest	of	arrest	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	line	cell	NN	I-NP	B-cell_lineline	under	line	NN	I-NP	I-cell_lineunder	differentiating	under	IN	B-PP	Odifferentiating	conditions	differentiate	VBG	B-VP	Oconditions	","	condition	NNS	B-NP	O","	resulting	","	","	O	Oresulting	in	result	VBG	B-VP	Oin	the	in	IN	B-PP	Othe	generation	the	DT	B-NP	Ogeneration	of	generation	NN	I-NP	Oof	greater	of	IN	B-PP	Ogreater	numbers	great	JJR	B-NP	Onumbers	of	number	NNS	I-NP	Oof	neutrophils	of	IN	B-PP	Oneutrophils	.	neutrophil	NNS	B-NP	B-cell_type.	Constitutive	.	.	O	OConstitutive	PI3-K	Constitutive	JJ	B-NP	OPI3-K	activity	PI3-K	NN	I-NP	B-proteinactivity	is	activity	NN	I-NP	Ois	essential	be	VBZ	B-VP	Oessential	for	essential	JJ	B-ADJP	Ofor	proliferation	for	IN	B-PP	Oproliferation	","	proliferation	NN	B-NP	O","	but	","	","	B-NP	Obut	not	but	CC	I-NP	Onot	survival	not	RB	I-NP	Osurvival	","	survival	NN	B-NP	O","	of	","	","	O	Oof	Theileria	of	IN	B-PP	OTheileria	parva-transformed	Theileria	NNP	B-NP	B-cell_typeparva-transformed	B	parva-transformed	JJ	I-NP	I-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Theileria	.	.	O	OTheileria	is	Theileria	NNP	B-NP	Ois	an	be	VBZ	B-VP	Oan	intracellular	an	DT	B-NP	Ointracellular	parasite	intracellular	JJ	I-NP	Oparasite	that	parasite	NN	I-NP	Othat	causes	that	WDT	B-NP	Ocauses	lymphoproliferative	cause	VBZ	B-VP	Olymphoproliferative	disorders	lymphoproliferative	JJ	B-NP	Odisorders	in	disorder	NNS	I-NP	Oin	cattle	in	IN	B-PP	Ocattle	","	cattle	NNS	B-NP	O","	and	","	","	O	Oand	infection	and	CC	O	Oinfection	of	infection	NN	B-NP	Oof	leucocytes	of	IN	B-PP	Oleucocytes	induces	leucocyte	NNS	B-NP	B-cell_typeinduces	a	induce	VBZ	B-VP	Oa	transformed	a	DT	B-NP	Otransformed	phenotype	transform	VBN	I-NP	Ophenotype	similar	phenotype	NN	I-NP	Osimilar	to	similar	JJ	B-ADJP	Oto	tumour	to	TO	B-PP	Otumour	cells	tumour	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	but	","	","	O	Obut	the	but	CC	O	Othe	mechanisms	the	DT	B-NP	Omechanisms	by	mechanism	NNS	I-NP	Oby	which	by	IN	B-PP	Owhich	the	which	WDT	B-NP	Othe	parasite	the	DT	B-NP	Oparasite	induces	parasite	NN	I-NP	Oinduces	this	induce	VBZ	B-VP	Othis	phenotype	this	DT	B-NP	Ophenotype	are	phenotype	NN	I-NP	Oare	not	be	VBP	B-VP	Onot	understood	not	RB	I-VP	Ounderstood	.	understand	VBN	I-VP	O.	Here	.	.	O	OHere	","	Here	RB	B-ADVP	O","	we	","	","	O	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	infected	that	IN	B-SBAR	Oinfected	B	infected	JJ	B-NP	OB	lymphocytes	B	NN	I-NP	B-cell_typelymphocytes	display	lymphocyte	NNS	I-NP	I-cell_typedisplay	constitutive	display	VBP	B-VP	Oconstitutive	phosphoinositide	constitutive	JJ	B-NP	B-proteinphosphoinositide	3-kinase	phosphoinositide	NN	I-NP	I-protein3-kinase	(	3-kinase	NN	I-NP	I-protein(	PI3-K	(	(	O	OPI3-K	)	PI3-K	NN	B-NP	B-protein)	activity	)	)	O	Oactivity	","	activity	NN	B-NP	O","	which	","	","	O	Owhich	appears	which	WDT	B-NP	Oappears	to	appear	VBZ	B-VP	Oto	be	to	TO	I-VP	Obe	necessary	be	VB	I-VP	Onecessary	for	necessary	JJ	B-ADJP	Ofor	proliferation	for	IN	B-PP	Oproliferation	","	proliferation	NN	B-NP	O","	but	","	","	B-NP	Obut	not	but	CC	I-NP	Onot	survival	not	RB	I-NP	Osurvival	.	survival	NN	B-NP	O.	Importantly	.	.	O	OImportantly	","	Importantly	RB	B-ADVP	O","	we	","	","	O	Owe	demonstrate	we	PRP	B-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	one	that	IN	B-SBAR	Oone	mechanism	one	CD	B-NP	Omechanism	by	mechanism	NN	I-NP	Oby	which	by	IN	B-PP	Owhich	PI3-K	which	WDT	B-NP	OPI3-K	mediates	PI3-K	NN	B-NP	B-proteinmediates	the	mediate	VBZ	B-VP	Othe	proliferation	the	DT	B-NP	Oproliferation	of	proliferation	NN	I-NP	Oof	infected	of	IN	B-PP	Oinfected	B	infected	JJ	B-NP	B-cell_typeB	lymphocytes	B	NN	I-NP	I-cell_typelymphocytes	is	lymphocyte	NNS	I-NP	I-cell_typeis	through	be	VBZ	B-VP	Othrough	the	through	IN	B-PP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	a	of	IN	B-PP	Oa	granulocyte-monocyte	a	DT	B-NP	Ogranulocyte-monocyte	colony-stimulating	granulocyte-monocyte	JJ	I-NP	B-proteincolony-stimulating	factor	colony-stimulating	JJ	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	GM-CSF	(	(	O	OGM-CSF	)	GM-CSF	NN	B-NP	B-protein)	#NAME?	)	)	O	O#NAME?	autocrine	#NAME?	JJ	B-NP	Oautocrine	loop	autocrine	JJ	I-NP	Oloop	.	loop	NN	I-NP	O.	PI3-K	.	.	O	OPI3-K	induction	PI3-K	NN	B-NP	B-proteininduction	of	induction	NN	I-NP	Oof	GM-CSF	of	IN	B-PP	OGM-CSF	appears	GM-CSF	NN	B-NP	B-proteinappears	to	appear	VBZ	B-VP	Oto	be	to	TO	I-VP	Obe	at	be	VB	I-VP	Oat	the	at	IN	B-PP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	level	transcriptional	JJ	I-NP	Olevel	and	level	NN	I-NP	Oand	","	and	CC	O	O","	consistently	","	","	O	Oconsistently	","	consistently	RB	B-ADVP	O","	we	","	","	O	Owe	demonstrate	we	PRP	B-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	PI3-K	that	IN	B-SBAR	OPI3-K	is	PI3-K	NN	B-NP	B-proteinis	also	be	VBZ	B-VP	Oalso	involved	also	RB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	constitutive	the	DT	B-NP	Oconstitutive	induction	constitutive	JJ	I-NP	Oinduction	of	induction	NN	I-NP	Oof	AP-1	of	IN	B-PP	OAP-1	and	AP-1	NN	B-NP	B-proteinand	NF-kappaB	and	CC	I-NP	ONF-kappaB	","	NF-kappaB	NN	I-NP	B-protein","	which	","	","	O	Owhich	characterizes	which	WDT	B-NP	Ocharacterizes	Theileria-infected	characterize	VBZ	B-VP	OTheileria-infected	leucocytes	Theileria-infected	JJ	B-NP	B-cell_typeleucocytes	.	leucocyte	NNS	I-NP	I-cell_type.	Taken	.	.	O	OTaken	together	Take	VBN	B-VP	Otogether	","	together	RB	B-ADVP	O","	our	","	","	O	Oour	results	our	PRP$	B-NP	Oresults	highlight	result	NNS	I-NP	Ohighlight	a	highlight	VBP	B-VP	Oa	novel	a	DT	B-NP	Onovel	strategy	novel	JJ	I-NP	Ostrategy	exploited	strategy	NN	I-NP	Oexploited	by	exploit	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	intracellular	the	DT	B-NP	Ointracellular	parasite	intracellular	JJ	I-NP	Oparasite	Theileria	parasite	NN	I-NP	OTheileria	to	Theileria	NN	I-NP	Oto	induce	to	TO	B-VP	Oinduce	continued	induce	VB	I-VP	Ocontinued	proliferation	continued	JJ	B-NP	Oproliferation	of	proliferation	NN	I-NP	Oof	its	of	IN	B-PP	Oits	host	its	PRP$	B-NP	Ohost	leucocyte	host	NN	I-NP	Oleucocyte	.	leucocyte	NN	I-NP	O.	Lymphokine	.	.	O	OLymphokine	dependence	Lymphokine	NN	B-NP	B-proteindependence	of	dependence	NN	I-NP	Oof	STAT3	of	IN	B-PP	OSTAT3	activation	STAT3	NN	B-NP	B-proteinactivation	produced	activation	NN	I-NP	Oproduced	by	produce	VBN	B-VP	Oby	surface	by	IN	B-PP	Osurface	immunoglobulin	surface	NN	B-NP	B-proteinimmunoglobulin	cross-linking	immunoglobulin	NN	I-NP	I-proteincross-linking	and	cross-linking	NN	I-NP	Oand	by	and	CC	B-PP	Oby	phorbol	by	IN	B-PP	Ophorbol	ester	phorbol	NN	B-NP	Oester	plus	ester	NN	I-NP	Oplus	calcium	plus	CC	O	Ocalcium	ionophore	calcium	NN	B-NP	Oionophore	treatment	ionophore	NN	I-NP	Otreatment	in	treatment	NN	I-NP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Stimulation	.	.	O	OStimulation	of	Stimulation	NN	B-NP	Oof	B	of	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	surface	by	IN	B-PP	Osurface	immunoglobulin	surface	NN	B-NP	B-proteinimmunoglobulin	(	immunoglobulin	NN	I-NP	I-protein(	sIg	(	(	O	OsIg	)	sIg	NN	B-NP	O)	triggering	)	)	O	Otriggering	","	triggering	NN	B-NP	O","	or	","	","	O	Oor	through	or	CC	O	Othrough	the	through	IN	B-PP	Othe	mitogenic	the	DT	B-NP	Omitogenic	combination	mitogenic	JJ	I-NP	Ocombination	of	combination	NN	I-NP	Oof	phorbol	of	IN	B-PP	Ophorbol	ester	phorbol	NN	B-NP	Oester	and	ester	NN	I-NP	Oand	calcium	and	CC	O	Ocalcium	ionophore	calcium	NN	B-NP	Oionophore	","	ionophore	NN	I-NP	O","	is	","	","	O	Ois	accompanied	be	VBZ	B-VP	Oaccompanied	by	accompany	VBN	I-VP	Oby	activation	by	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	STAT	of	IN	B-PP	OSTAT	transcription	STAT	NN	B-NP	B-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	.	factor	NNS	I-NP	I-protein.	The	.	.	O	OThe	mechanism	The	DT	B-NP	Omechanism	responsible	mechanism	NN	I-NP	Oresponsible	for	responsible	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	delayed	the	DT	B-NP	Odelayed	nuclear	delay	VBN	I-NP	Onuclear	accumulation	nuclear	JJ	I-NP	Oaccumulation	of	accumulation	NN	I-NP	Oof	phosphorylated	of	IN	B-PP	Ophosphorylated	STAT3	phosphorylate	VBN	B-NP	OSTAT3	was	STAT3	NN	I-NP	B-proteinwas	examined	be	VBD	B-VP	Oexamined	in	examine	VBN	I-VP	Oin	detail	in	IN	B-PP	Odetail	","	detail	NN	B-NP	O","	focusing	","	","	O	Ofocusing	on	focus	VBG	B-VP	Oon	the	on	IN	B-PP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	B	of	IN	B-PP	OB	cell-derived	B	NN	B-NP	B-proteincell-derived	lymphokines	cell-derived	JJ	I-NP	I-proteinlymphokines	.	lymphokine	NNS	I-NP	I-protein.	sIg	.	.	O	OsIg	#NAME?	sIg	NN	B-NP	B-protein#NAME?	activation	#NAME?	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	STAT3	of	IN	B-PP	OSTAT3	was	STAT3	NN	B-NP	B-proteinwas	partially	be	VBD	B-VP	Opartially	inhibited	partially	RB	I-VP	Oinhibited	in	inhibit	VBN	I-VP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	obtained	cell	NNS	I-NP	I-cell_typeobtained	from	obtain	VBN	B-VP	Ofrom	IL-6-	from	IN	B-PP	OIL-6-	or	IL-6-	NN	B-NP	Oor	IL-10-deficient	or	CC	O	OIL-10-deficient	mice	IL-10-deficient	JJ	B-NP	Omice	","	mouse	NNS	I-NP	O","	and	","	","	O	Oand	was	and	CC	O	Owas	partially	be	VBD	B-VP	Opartially	blocked	partially	RB	I-VP	Oblocked	by	block	VBN	I-VP	Oby	neutralizing	by	IN	B-PP	Oneutralizing	antibodies	neutralize	VBG	B-VP	B-proteinantibodies	directed	antibody	NNS	B-NP	I-proteindirected	against	direct	VBN	B-VP	Oagainst	either	against	IN	B-PP	Oeither	of	either	DT	B-NP	Oof	these	of	IN	B-PP	Othese	lymphokines	these	DT	B-NP	Olymphokines	.	lymphokine	NNS	I-NP	B-protein.	sIg	.	.	O	OsIg	#NAME?	sIg	NN	B-NP	B-protein#NAME?	STAT3	#NAME?	JJ	I-NP	OSTAT3	activation	STAT3	NN	I-NP	B-proteinactivation	was	activation	NN	I-NP	Owas	completely	be	VBD	B-VP	Ocompletely	inhibited	completely	RB	I-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	combining	by	IN	B-PP	Ocombining	IL-6-	combine	VBG	B-VP	OIL-6-	and	IL-6-	NN	B-NP	B-proteinand	IL-10-specific	and	CC	O	OIL-10-specific	neutralizing	IL-10-specific	JJ	B-NP	B-proteinneutralizing	antibodies	neutralize	VBG	I-NP	I-proteinantibodies	","	antibody	NNS	I-NP	I-protein","	or	","	","	O	Oor	by	or	CC	O	Oby	adding	by	IN	B-PP	Oadding	individual	add	VBG	B-VP	Oindividual	neutralizing	individual	JJ	B-NP	Oneutralizing	antibodies	neutralize	VBG	I-NP	Oantibodies	to	antibody	NNS	I-NP	B-proteinto	B	to	TO	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	obtained	cell	NNS	I-NP	I-cell_typeobtained	from	obtain	VBN	B-VP	Ofrom	lymphokine-deficient	from	IN	B-PP	Olymphokine-deficient	animals	lymphokine-deficient	JJ	B-NP	Oanimals	.	animal	NNS	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	IL-10	","	","	O	OIL-10	alone	IL-10	NN	B-NP	B-proteinalone	appeared	alone	RB	B-ADVP	Oappeared	to	appear	VBD	B-VP	Oto	account	to	TO	I-VP	Oaccount	for	account	VB	I-VP	Ofor	STAT3	for	IN	B-PP	OSTAT3	activation	STAT3	NN	B-NP	B-proteinactivation	resulting	activation	NN	I-NP	Oresulting	from	result	VBG	B-VP	Ofrom	B	from	IN	B-PP	OB	cell	B	NN	B-NP	B-cell_typecell	stimulation	cell	NN	I-NP	I-cell_typestimulation	with	stimulation	NN	I-NP	Owith	phorbol	with	IN	B-PP	Ophorbol	ester	phorbol	NN	B-NP	Oester	and	ester	NN	I-NP	Oand	calcium	and	CC	O	Ocalcium	ionophore	calcium	NN	B-NP	Oionophore	.	ionophore	NN	I-NP	O.	In	.	.	O	OIn	keeping	In	IN	B-PP	Okeeping	with	keep	VBG	B-NP	Owith	these	with	IN	B-PP	Othese	results	these	DT	B-NP	Oresults	","	result	NNS	I-NP	O","	soluble	","	","	O	Osoluble	IL-6	soluble	JJ	B-NP	OIL-6	and	IL-6	NN	I-NP	B-proteinand	IL-10	and	CC	I-NP	OIL-10	were	IL-10	NN	I-NP	B-proteinwere	found	be	VBD	B-VP	Ofound	in	find	VBN	I-VP	Oin	supernatant	in	IN	B-PP	Osupernatant	fluid	supernatant	JJ	B-NP	Ofluid	obtained	fluid	NN	I-NP	Oobtained	from	obtain	VBN	B-VP	Ofrom	stimulated	from	IN	B-PP	Ostimulated	B	stimulate	VBN	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	This	.	.	O	OThis	work	This	DT	B-NP	Owork	indicates	work	NN	I-NP	Oindicates	that	indicate	VBZ	B-VP	Othat	a	that	IN	B-SBAR	Oa	lymphokine	a	DT	B-NP	Olymphokine	pathway	lymphokine	NN	I-NP	B-proteinpathway	is	pathway	NN	I-NP	Ois	responsible	be	VBZ	B-VP	Oresponsible	for	responsible	JJ	B-ADJP	Ofor	STAT3	for	IN	B-PP	OSTAT3	activation	STAT3	NN	B-NP	B-proteinactivation	that	activation	NN	I-NP	Othat	occurs	that	WDT	B-NP	Ooccurs	late	occur	VBZ	B-VP	Olate	after	late	RB	B-ADVP	Oafter	B	after	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	stimulation	cell	NN	I-NP	Ostimulation	","	stimulation	NN	I-NP	O","	and	","	","	O	Oand	points	and	CC	O	Opoints	out	point	VBZ	B-VP	Oout	differences	out	RP	B-PRT	Odifferences	in	difference	NNS	B-NP	Oin	B	in	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	that	activation	NN	I-NP	Othat	result	that	WDT	B-NP	Oresult	from	result	VBP	B-VP	Ofrom	stimulation	from	IN	B-PP	Ostimulation	through	stimulation	NN	B-NP	Othrough	the	through	IN	B-PP	Othe	antigen	the	DT	B-NP	Oantigen	receptor	antigen	NN	I-NP	B-proteinreceptor	and	receptor	NN	I-NP	I-proteinand	through	and	CC	B-PP	Othrough	pharmacological	through	IN	B-PP	Opharmacological	mimicry	pharmacological	JJ	B-NP	Omimicry	of	mimicry	NN	I-NP	Oof	signaling	of	IN	B-PP	Osignaling	mediators	signaling	NN	B-NP	B-proteinmediators	.	mediator	NNS	I-NP	I-protein.	Transcription	.	.	O	OTranscription	factor	Transcription	NN	B-NP	B-proteinfactor	AP-4	factor	NN	I-NP	I-proteinAP-4	is	AP-4	NN	I-NP	B-proteinis	a	be	VBZ	B-VP	Oa	ligand	a	DT	B-NP	Oligand	for	ligand	NN	I-NP	Ofor	immunoglobulin-kappa	for	IN	B-PP	Oimmunoglobulin-kappa	promoter	immunoglobulin-kappa	NN	B-NP	B-DNApromoter	E-box	promoter	NN	I-NP	I-DNAE-box	elements	E-box	NN	I-NP	I-DNAelements	.	element	NNS	I-NP	I-DNA.	Immunoglobulin	.	.	O	OImmunoglobulin	(	Immunoglobulin	NN	B-NP	B-DNA(	Ig	(	(	O	I-DNAIg	)	Ig	NN	B-NP	I-DNA)	#NAME?	)	)	O	I-DNA#NAME?	promoters	#NAME?	NN	B-NP	I-DNApromoters	from	promoter	NNS	I-NP	I-DNAfrom	humans	from	IN	B-PP	Ohumans	and	human	NNS	B-NP	Oand	mice	and	CC	I-NP	Omice	share	mouse	NNS	I-NP	Oshare	conserved	share	VBP	B-VP	Oconserved	sequences	conserve	VBN	B-NP	Osequences	.	sequence	NNS	I-NP	O.	The	.	.	O	OThe	octamer	The	DT	B-NP	Ooctamer	element	octamer	NN	I-NP	B-DNAelement	is	element	NN	I-NP	I-DNAis	common	be	VBZ	B-VP	Ocommon	to	common	JJ	B-ADJP	Oto	all	to	TO	B-PP	Oall	Ig	all	DT	B-NP	OIg	promoters	Ig	NN	I-NP	B-DNApromoters	and	promoter	NNS	I-NP	I-DNAand	pivotal	and	CC	O	Opivotal	for	pivotal	JJ	B-ADJP	Ofor	their	for	IN	B-PP	Otheir	function	their	PRP$	B-NP	Ofunction	.	function	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	other	","	","	O	Oother	conserved	other	JJ	B-NP	Oconserved	sequence	conserve	VBN	I-NP	B-DNAsequence	motifs	sequence	NN	I-NP	I-DNAmotifs	","	motif	NNS	I-NP	I-DNA","	that	","	","	O	Othat	differ	that	WDT	B-NP	Odiffer	between	differ	VBP	B-VP	Obetween	Ig	between	IN	B-PP	OIg	variable	Ig	NN	B-NP	B-proteinvariable	gene	variable	JJ	I-NP	Ogene	families	gene	NN	I-NP	Ofamilies	","	family	NNS	I-NP	O","	are	","	","	O	Oare	required	be	VBP	B-VP	Orequired	for	require	VBN	I-VP	Ofor	normal	for	IN	B-PP	Onormal	promoter	normal	JJ	B-NP	Opromoter	function	promoter	NN	I-NP	Ofunction	.	function	NN	I-NP	O.	These	.	.	O	OThese	conserved	These	DT	B-NP	Oconserved	motifs	conserve	VBN	I-NP	B-DNAmotifs	do	motif	NNS	I-NP	I-DNAdo	not	do	VBP	B-VP	Onot	stimulate	not	RB	I-VP	Ostimulate	transcription	stimulate	VB	I-VP	Otranscription	in	transcription	NN	B-NP	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	an	of	IN	B-PP	Oan	octamer	an	DT	B-NP	Ooctamer	.	octamer	NN	I-NP	B-DNA.	One	.	.	O	OOne	example	One	CD	B-NP	Oexample	is	example	NN	I-NP	Ois	an	be	VBZ	B-VP	Oan	E-box	an	DT	B-NP	OE-box	of	E-box	NN	I-NP	B-DNAof	the	of	IN	B-PP	Othe	E47/E12	the	DT	B-NP	OE47/E12	type	E47/E12	NN	I-NP	Otype	(	type	NN	I-NP	O(	5'-CAGCTG-3	(	(	O	O5'-CAGCTG-3	'	5'-CAGCTG-3	NN	B-NP	B-DNA'	)	'	''	O	I-DNA)	","	)	)	O	O","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	found	be	VBZ	B-VP	Ofound	in	find	VBN	I-VP	Oin	all	in	IN	B-PP	Oall	promoters	all	DT	B-NP	Opromoters	of	promoter	NNS	I-NP	B-DNAof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	and	human	JJ	I-NP	B-DNAand	murine	and	CC	I-NP	I-DNAmurine	Ig-kappa	murine	JJ	I-NP	I-DNAIg-kappa	gene	Ig-kappa	NN	I-NP	I-DNAgene	subgroups/families	gene	NN	I-NP	I-DNAsubgroups/families	","	subgroups/family	NNS	I-NP	O","	with	","	","	O	Owith	the	with	IN	B-PP	Othe	exception	the	DT	B-NP	Oexception	of	exception	NN	I-NP	Oof	subgroups	of	IN	B-PP	Osubgroups	II	subgroup	NNS	B-NP	OII	and	II	CD	B-NP	Oand	VI	and	CC	I-NP	OVI	and	VI	CD	I-NP	Oand	their	and	CC	O	Otheir	related	their	PRP$	B-NP	Orelated	murine	relate	VBN	I-NP	Omurine	families	murine	JJ	I-NP	B-proteinfamilies	.	family	NNS	I-NP	I-protein.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	present	the	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	we	study	NN	I-NP	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	ubiquitously	the	DT	B-NP	Oubiquitously	expressed	ubiquitously	RB	I-NP	Oexpressed	transcription	express	VBN	I-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	AP-4	factor	NN	I-NP	I-proteinAP-4	","	AP-4	NN	I-NP	B-protein","	and	","	","	B-NP	Oand	not	and	CC	I-NP	Onot	E47	not	RB	I-NP	OE47	","	E47	NN	B-NP	B-protein","	interacts	","	","	O	Ointeracts	specifically	interact	VBZ	B-VP	Ospecifically	with	specifically	RB	B-ADVP	Owith	the	with	IN	B-PP	Othe	kappa	the	DT	B-NP	Okappa	promoter	kappa	NN	I-NP	B-DNApromoter	E-boxes	promoter	NN	I-NP	I-DNAE-boxes	when	E-box	NNS	I-NP	I-DNAwhen	tested	when	WRB	B-ADVP	Otested	in	test	VBN	B-VP	Oin	electrophoretic	in	IN	B-PP	Oelectrophoretic	mobility-shift	electrophoretic	JJ	B-NP	Omobility-shift	assays	mobility-shift	JJ	I-NP	Oassays	using	assay	NNS	I-NP	Ousing	nuclear	use	VBG	B-VP	Onuclear	extracts	nuclear	JJ	B-NP	Oextracts	derived	extract	NNS	I-NP	Oderived	from	derive	VBN	B-VP	Ofrom	human	from	IN	B-PP	Ohuman	and	human	JJ	B-NP	B-cell_lineand	murine	and	CC	I-NP	I-cell_linemurine	B-cell	murine	JJ	I-NP	I-cell_lineB-cell	lines	B-cell	NN	I-NP	I-cell_linelines	.	line	NNS	I-NP	I-cell_line.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	AP-4	","	","	O	OAP-4	","	AP-4	NN	B-NP	B-protein","	unlike	","	","	O	Ounlike	E47	unlike	IN	B-PP	OE47	","	E47	NN	B-NP	B-protein","	did	","	","	O	Odid	not	do	VBD	B-VP	Onot	act	not	RB	I-VP	Oact	as	act	VB	I-VP	Oas	a	as	IN	B-PP	Oa	transactivator	a	DT	B-NP	Otransactivator	","	transactivator	NN	I-NP	B-protein","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	in	be	VBZ	B-VP	Oin	agreement	in	IN	B-PP	Oagreement	with	agreement	NN	B-NP	Owith	previous	with	IN	B-PP	Oprevious	studies	previous	JJ	B-NP	Ostudies	on	study	NNS	I-NP	Oon	intact	on	IN	B-PP	Ointact	kappa	intact	JJ	B-NP	Okappa	promoters	kappa	NN	I-NP	B-DNApromoters	","	promoter	NNS	I-NP	I-DNA","	showing	","	","	O	Oshowing	that	show	VBG	B-VP	Othat	transcription	that	IN	B-SBAR	Otranscription	is	transcription	NN	B-NP	Ois	absent	be	VBZ	B-VP	Oabsent	when	absent	JJ	B-ADJP	Owhen	the	when	WRB	B-ADVP	Othe	octamer	the	DT	B-NP	Ooctamer	element	octamer	NN	I-NP	B-DNAelement	has	element	NN	I-NP	I-DNAhas	been	have	VBZ	B-VP	Obeen	mutated	be	VBN	I-VP	Omutated	.	mutate	VBN	I-VP	O.	Based	.	.	O	OBased	on	Base	VBN	B-PP	Oon	these	on	IN	B-PP	Othese	data	these	DT	B-NP	Odata	","	datum	NNS	I-NP	O","	and	","	","	O	Oand	the	and	CC	O	Othe	conservation	the	DT	B-NP	Oconservation	of	conservation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	5'-CAGCTG-3	the	DT	B-NP	O5'-CAGCTG-3	'	5'-CAGCTG-3	NN	I-NP	B-DNA'	motif	'	POS	B-NP	I-DNAmotif	among	motif	NN	I-NP	I-DNAamong	human	among	IN	B-PP	Ohuman	and	human	JJ	B-NP	B-DNAand	murine	and	CC	I-NP	I-DNAmurine	kappa	murine	JJ	I-NP	I-DNAkappa	promoters	kappa	NN	I-NP	I-DNApromoters	","	promoter	NNS	I-NP	I-DNA","	we	","	","	O	Owe	propose	we	PRP	B-NP	Opropose	that	propose	VBP	B-VP	Othat	AP-4	that	IN	B-SBAR	OAP-4	is	AP-4	NN	B-NP	B-proteinis	the	be	VBZ	B-VP	Othe	major	the	DT	B-NP	Omajor	ligand	major	JJ	I-NP	Oligand	for	ligand	NN	I-NP	Ofor	Ig-kappa	for	IN	B-PP	OIg-kappa	promoter	Ig-kappa	NN	B-NP	B-proteinpromoter	E-boxes	promoter	NN	I-NP	I-proteinE-boxes	.	E-box	NNS	I-NP	I-protein.	A	.	.	O	OA	16-mer	A	DT	B-NP	O16-mer	peptide	16-mer	NN	I-NP	Opeptide	(	peptide	NN	I-NP	O(	RQIKIWFQNRRMKWKK	(	(	O	ORQIKIWFQNRRMKWKK	)	RQIKIWFQNRRMKWKK	NN	B-NP	B-protein)	from	)	)	O	Ofrom	antennapedia	from	IN	B-PP	Oantennapedia	preferentially	antennapedia	NNS	B-NP	Opreferentially	targets	preferentially	RB	B-ADVP	Otargets	the	target	VBZ	B-VP	Othe	Class	the	DT	B-NP	OClass	I	Class	NN	I-NP	OI	pathway	I	CD	I-NP	Opathway	.	pathway	NN	I-NP	O.	Translocation	.	.	O	OTranslocation	of	Translocation	NN	B-NP	Oof	antigenic	of	IN	B-PP	Oantigenic	peptides	antigenic	JJ	B-NP	Opeptides	into	peptide	NNS	I-NP	Ointo	the	into	IN	B-PP	Othe	cytosol	the	DT	B-NP	Ocytosol	of	cytosol	NN	I-NP	Oof	antigen	of	IN	B-PP	Oantigen	presenting	antigen	NN	B-NP	B-cell_typepresenting	cells	presenting	NN	I-NP	I-cell_typecells	facilitates	cell	NNS	I-NP	I-cell_typefacilitates	proteosomal	facilitate	VBZ	B-VP	Oproteosomal	processing	proteosomal	JJ	B-NP	Oprocessing	and	processing	NN	I-NP	Oand	loading	and	CC	I-NP	Oloading	into	loading	NN	I-NP	Ointo	Class	into	IN	B-PP	OClass	I	Class	NN	B-NP	B-proteinI	molecules	I	CD	B-NP	I-proteinmolecules	for	molecule	NNS	I-NP	I-proteinfor	MHC	for	IN	B-PP	OMHC	presentation	MHC	NN	B-NP	B-proteinpresentation	on	presentation	NN	I-NP	Oon	the	on	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	surface	cell	NN	I-NP	Osurface	.	surface	NN	I-NP	O.	The	.	.	O	OThe	DNA	The	DT	B-NP	ODNA	binding	DNA	NN	I-NP	B-proteinbinding	domain	binding	NN	I-NP	I-proteindomain	of	domain	NN	I-NP	I-proteinof	the	of	IN	B-PP	Othe	Drosophila	the	DT	B-NP	ODrosophila	transcription	Drosophila	FW	I-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	Antennapedia	(	(	O	OAntennapedia	)	Antennapedia	NN	B-NP	O)	","	)	)	O	O","	a	","	","	O	Oa	60	a	DT	B-NP	O60	amino	60	CD	I-NP	B-proteinamino	acid	amino	NN	I-NP	I-proteinacid	protein	acid	NN	I-NP	I-proteinprotein	","	protein	NN	I-NP	I-protein","	is	","	","	O	Ois	rapidly	be	VBZ	B-VP	Orapidly	taken	rapidly	RB	I-VP	Otaken	up	take	VBN	I-VP	Oup	by	up	RP	B-PRT	Oby	cells	by	IN	B-PP	Ocells	and	cell	NNS	B-NP	Oand	has	and	CC	O	Ohas	been	have	VBZ	B-VP	Obeen	fused	be	VBN	I-VP	Ofused	to	fuse	VBN	I-VP	Oto	selected	to	TO	B-PP	Oselected	antigens	select	VBN	B-NP	Oantigens	to	antigen	NNS	I-NP	Oto	enhance	to	TO	B-VP	Oenhance	their	enhance	VB	I-VP	Otheir	immunogenicity	their	PRP$	B-NP	Oimmunogenicity	.	immunogenicity	NN	I-NP	O.	We	.	.	O	OWe	now	We	PRP	B-NP	Onow	demonstrate	now	RB	B-ADVP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	a	that	IN	B-SBAR	Oa	16	a	DT	B-NP	O16	amino	16	CD	I-NP	Oamino	acid	amino	NN	I-NP	Oacid	peptide	acid	NN	I-NP	Opeptide	from	peptide	NN	I-NP	Ofrom	antennapedia	from	IN	B-PP	Oantennapedia	can	antennapedia	NNS	B-NP	Ocan	facilitate	can	MD	B-VP	Ofacilitate	the	facilitate	VB	I-VP	Othe	cytoplasmic	the	DT	B-NP	Ocytoplasmic	uptake	cytoplasmic	JJ	I-NP	Ouptake	of	uptake	NN	I-NP	Oof	CTL	of	IN	B-PP	OCTL	epitope	CTL	NN	B-NP	Oepitope	9-mer	epitope	NN	I-NP	O9-mer	peptides	9-mer	NN	I-NP	Opeptides	.	peptide	NNS	I-NP	O.	Synthetic	.	.	O	OSynthetic	peptides	Synthetic	JJ	B-NP	Opeptides	were	peptide	NNS	I-NP	Owere	made	be	VBD	B-VP	Omade	containing	make	VBN	I-VP	Ocontaining	the	contain	VBG	B-VP	Othe	16-mer	the	DT	B-NP	O16-mer	antennapedia	16-mer	NN	I-NP	Oantennapedia	peptide	antennapedia	NN	I-NP	Opeptide	linked	peptide	NN	I-NP	Olinked	in	link	VBN	B-VP	Oin	tandem	in	IN	B-PP	Otandem	to	tandem	NN	B-NP	Oto	the	to	TO	B-PP	Othe	ovalbumin	the	DT	B-NP	Oovalbumin	SIINFEKL	ovalbumin	NN	I-NP	OSIINFEKL	CTL	SIINFEKL	NN	I-NP	OCTL	peptide	CTL	NN	I-NP	Opeptide	.	peptide	NN	I-NP	O.	The	.	.	O	OThe	peptide	The	DT	B-NP	Opeptide	complex	peptide	NN	I-NP	B-proteincomplex	was	complex	NN	I-NP	I-proteinwas	shown	be	VBD	B-VP	Oshown	to	show	VBN	I-VP	Oto	rapidly	to	TO	I-VP	Orapidly	internalise	rapidly	RB	I-VP	Ointernalise	into	internalise	VB	I-VP	Ointo	APCs	into	IN	B-PP	OAPCs	by	APC	NNS	B-NP	B-cell_typeby	confocal	by	IN	B-PP	Oconfocal	microscopy	confocal	JJ	B-NP	Omicroscopy	.	microscopy	NN	I-NP	O.	This	.	.	O	OThis	peptide	This	DT	B-NP	Opeptide	induced	peptide	NN	I-NP	Oinduced	CTL	induce	VBD	B-VP	OCTL	in	CTL	NN	B-NP	B-cell_typein	C57BL/6	in	IN	B-PP	OC57BL/6	mice	C57BL/6	NN	B-NP	Omice	and	mouse	NNS	I-NP	Oand	protected	and	CC	O	Oprotected	them	protect	VBD	B-VP	Othem	against	them	PRP	B-NP	Oagainst	growth	against	IN	B-PP	Ogrowth	of	growth	NN	B-NP	Oof	an	of	IN	B-PP	Oan	ovalbumin	an	DT	B-NP	Oovalbumin	expressing	ovalbumin	NN	I-NP	B-cell_lineexpressing	tumour	express	VBG	B-VP	I-cell_linetumour	cell	tumour	NN	B-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	(	line	NN	I-NP	I-cell_line(	E.G7-OVA	(	(	O	OE.G7-OVA	)	E.G7-OVA	NN	B-NP	B-protein)	.	)	)	O	O.	The	.	.	O	OThe	ability	The	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	the	of	IN	B-PP	Othe	hybrid	the	DT	B-NP	Ohybrid	peptide	hybrid	NN	I-NP	Opeptide	to	peptide	NN	I-NP	Oto	be	to	TO	B-VP	Obe	processed	be	VB	I-VP	Oprocessed	and	process	VBN	I-VP	Oand	presented	and	CC	I-VP	Opresented	by	present	VBN	I-VP	Oby	APCs	by	IN	B-PP	OAPCs	was	APC	NNS	B-NP	B-cell_typewas	similar	be	VBD	B-VP	Osimilar	","	similar	JJ	B-ADJP	O","	whether	","	","	O	Owhether	the	whether	IN	B-SBAR	Othe	SIINFEKL	the	DT	B-NP	OSIINFEKL	sequence	SIINFEKL	NN	I-NP	B-DNAsequence	was	sequence	NN	I-NP	I-DNAwas	appended	be	VBD	B-VP	Oappended	at	append	VBN	I-VP	Oat	the	at	IN	B-PP	Othe	C-terminus	the	DT	B-NP	OC-terminus	or	C-terminus	NN	I-NP	B-proteinor	N-terminus	or	CC	I-NP	ON-terminus	of	N-terminus	NN	I-NP	B-proteinof	the	of	IN	B-PP	Othe	Antennapedia	the	DT	B-NP	OAntennapedia	peptide	Antennapedia	NNP	I-NP	Opeptide	.	peptide	NN	I-NP	O.	The	.	.	O	OThe	production	The	DT	B-NP	Oproduction	of	production	NN	I-NP	Oof	synthetic	of	IN	B-PP	Osynthetic	peptides	synthetic	JJ	B-NP	Opeptides	containing	peptide	NNS	I-NP	Ocontaining	other	contain	VBG	B-VP	Oother	CTL	other	JJ	B-NP	OCTL	peptide	CTL	NN	I-NP	B-proteinpeptide	epitopes	peptide	NN	I-NP	I-proteinepitopes	may	epitope	NNS	I-NP	I-proteinmay	be	may	MD	B-VP	Obe	useful	be	VB	I-VP	Ouseful	for	useful	JJ	B-ADJP	Ofor	priming	for	IN	B-PP	Opriming	CTLs	prim	VBG	B-VP	OCTLs	in	CTL	NNS	B-NP	B-cell_typein	vitro	in	FW	B-ADVP	Ovitro	and	vitro	FW	I-ADVP	Oand	in	and	CC	O	Oin	vivo	in	FW	B-ADVP	Ovivo	Bone	vivo	FW	I-ADVP	OBone	marrow	Bone	NN	B-NP	B-cell_typemarrow	cells	marrow	NN	I-NP	I-cell_typecells	promote	cell	NNS	I-NP	I-cell_typepromote	TH2	promote	VBP	B-VP	OTH2	polarization	TH2	NN	B-NP	Opolarization	and	polarization	NN	I-NP	Oand	inhibit	and	CC	O	Oinhibit	virus-specific	inhibit	VBP	B-VP	Ovirus-specific	CTL	virus-specific	JJ	B-NP	OCTL	generation	CTL	NN	I-NP	Ogeneration	.	generation	NN	I-NP	O.	This	.	.	O	OThis	laboratory	This	DT	B-NP	Olaboratory	recently	laboratory	NN	I-NP	Orecently	reported	recently	RB	B-ADVP	Oreported	that	report	VBD	B-VP	Othat	human	that	IN	B-SBAR	Ohuman	bone	human	JJ	B-NP	B-cell_typebone	marrow	bone	NN	I-NP	I-cell_typemarrow	cells	marrow	NN	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	BMC	(	(	O	OBMC	)	BMC	NN	B-NP	B-cell_type)	inhibit	)	)	O	Oinhibit	the	inhibit	VBP	B-VP	Othe	generation	the	DT	B-NP	Ogeneration	of	generation	NN	I-NP	Oof	virus-specific	of	IN	B-PP	Ovirus-specific	CTL	virus-specific	JJ	B-NP	B-cell_typeCTL	in	CTL	NN	I-NP	I-cell_typein	culture	in	IN	B-PP	Oculture	.	culture	NN	B-NP	O.	The	.	.	O	OThe	culture	The	DT	B-NP	Oculture	supernatants	culture	NN	I-NP	Osupernatants	contained	supernatant	NNS	I-NP	Ocontained	increased	contain	VBD	B-VP	Oincreased	levels	increase	VBN	B-NP	Olevels	of	level	NNS	I-NP	Oof	prostaglandin	of	IN	B-PP	Oprostaglandin	E	prostaglandin	NN	B-NP	OE	(	E	NN	I-NP	O(	2	(	(	O	O2	)	2	CD	B-NP	O)	(	)	)	O	O(	PGE	(	(	O	OPGE	(	PGE	NN	B-NP	O(	2	(	(	O	O2	)	2	CD	B-NP	O)	)	)	)	O	O)	(	)	)	O	O(	shown	(	(	O	Oshown	to	show	VBN	B-VP	Oto	favor	to	TO	I-VP	Ofavor	TH2	favor	VB	I-VP	OTH2	cell	TH2	NN	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	)	development	NN	I-NP	O)	and	)	)	O	Oand	also	and	CC	O	Oalso	inhibited	also	RB	B-ADVP	Oinhibited	EBV-CTL	inhibit	VBD	B-VP	OEBV-CTL	effector	EBV-CTL	NN	B-NP	Oeffector	cell	effector	NN	I-NP	Ocell	development	cell	NN	I-NP	Odevelopment	.	development	NN	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	obtained	we	PRP	B-NP	Oobtained	PBL	obtain	VBD	B-VP	OPBL	from	PBL	NN	B-NP	B-cell_typefrom	Epstein-Barr	from	IN	B-PP	OEpstein-Barr	virus	Epstein-Barr	JJ	B-NP	Ovirus	(	virus	NN	I-NP	O(	EBV	(	(	O	OEBV	)	EBV	NN	B-NP	O)	IgG	)	)	O	OIgG	antibody	IgG	NN	B-NP	Oantibody	positive	antibody	NN	I-NP	Opositive	kidney	positive	JJ	I-NP	Okidney	transplant	kidney	NN	I-NP	Otransplant	recipients	transplant	NN	I-NP	Orecipients	(	recipient	NNS	I-NP	O(	R	(	(	O	OR	)	R	NN	B-NP	B-protein)	and	)	)	O	Oand	their	and	CC	O	Otheir	living-related	their	PRP$	B-NP	Oliving-related	donors	living-related	JJ	I-NP	Odonors	(	donor	NNS	I-NP	O(	LRD	(	(	O	OLRD	)	LRD	NN	B-NP	O)	one	)	)	O	Oone	year	one	CD	B-NP	Oyear	after	year	NN	I-NP	Oafter	renal	after	IN	B-PP	Orenal	transplantation	renal	JJ	B-NP	Otransplantation	.	transplantation	NN	I-NP	O.	EBV-specific	.	.	O	OEBV-specific	CTL	EBV-specific	JJ	B-NP	B-cell_typeCTL	were	CTL	NN	I-NP	I-cell_typewere	then	be	VBD	B-VP	Othen	generated	then	RB	I-VP	Ogenerated	in	generate	VBN	I-VP	Oin	vitro	in	FW	B-ADVP	Ovitro	by	vitro	FW	I-ADVP	Oby	stimulating	by	IN	B-PP	Ostimulating	PBL	stimulate	VBG	B-VP	OPBL	with	PBL	NN	B-NP	B-cell_typewith	autologous	with	IN	B-PP	Oautologous	EBV-transformed	autologous	JJ	B-NP	B-cell_lineEBV-transformed	B	EBV-transformed	JJ	I-NP	I-cell_lineB	cells	B	NN	I-NP	I-cell_linecells	(	cell	NNS	I-NP	I-cell_line(	EBV-B	(	(	O	OEBV-B	)	EBV-B	NN	B-NP	B-protein)	in	)	)	O	Oin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	or	presence	NN	I-NP	Oor	absence	or	CC	I-NP	Oabsence	of	absence	NN	I-NP	Oof	autologous	of	IN	B-PP	Oautologous	BMC	autologous	JJ	B-NP	B-cell_typeBMC	.	BMC	NN	I-NP	I-cell_type.	The	.	.	O	OThe	addition	The	DT	B-NP	Oaddition	of	addition	NN	I-NP	Oof	BMC	of	IN	B-PP	OBMC	to	BMC	NN	B-NP	B-cell_typeto	the	to	TO	B-PP	Othe	EBV-CTL	the	DT	B-NP	OEBV-CTL	generation	EBV-CTL	NN	I-NP	B-cell_linegeneration	cultures	generation	NN	I-NP	I-cell_linecultures	increased	culture	NNS	I-NP	I-cell_lineincreased	the	increase	VBD	B-VP	Othe	intracellular	the	DT	B-NP	Ointracellular	expression	intracellular	JJ	I-NP	Oexpression	in	expression	NN	I-NP	Oin	CD3+	in	IN	B-PP	OCD3+	cells	CD3+	JJ	B-NP	B-cell_typecells	of	cell	NNS	I-NP	I-cell_typeof	IL-4	of	IN	B-PP	OIL-4	","	IL-4	NN	B-NP	B-protein","	-5	","	","	O	O-5	","	-5	CD	B-NP	O","	-6	","	","	I-NP	O-6	","	-6	CD	I-NP	O","	-10	","	","	I-NP	O-10	","	-10	CD	I-NP	O","	and	","	","	O	Oand	-13	and	CC	O	O-13	.	-13	CD	B-NP	O.	These	.	.	O	OThese	CD3+	These	DT	B-NP	OCD3+	cells	CD3+	JJ	I-NP	B-cell_typecells	also	cell	NNS	I-NP	I-cell_typealso	expressed	also	RB	B-ADVP	Oexpressed	increased	express	VBD	B-VP	Oincreased	levels	increase	VBN	B-NP	Olevels	of	level	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	TH2	the	DT	B-NP	OTH2	associated	TH2	NN	I-NP	B-proteinassociated	receptor	associated	JJ	I-NP	I-proteinreceptor	CCR3	receptor	NN	I-NP	I-proteinCCR3	.	CCR3	NN	I-NP	B-protein.	Inhibition	.	.	O	OInhibition	was	Inhibition	NN	B-NP	Owas	even	be	VBD	B-VP	Oeven	observed	even	RB	I-VP	Oobserved	by	observe	VBN	I-VP	Oby	preparing	by	IN	B-PP	Opreparing	EBV-CTL	prepare	VBG	B-VP	OEBV-CTL	generating	EBV-CTL	NN	B-NP	B-cell_linegenerating	cultures	generate	VBG	B-VP	I-cell_linecultures	in	culture	NNS	B-NP	I-cell_linein	trans-wells	in	IN	B-PP	Otrans-wells	that	trans-well	NNS	B-NP	Othat	separated	that	WDT	B-NP	Oseparated	the	separate	VBD	B-VP	Othe	autologous	the	DT	B-NP	Oautologous	BMC	autologous	JJ	I-NP	OBMC	from	BMC	NN	I-NP	Ofrom	the	from	IN	B-PP	Othe	PBL	the	DT	B-NP	OPBL	+	PBL	NN	I-NP	B-cell_type+	EBV-B	+	SYM	B-NP	OEBV-B	.	EBV-B	NN	I-NP	B-protein.	It	.	.	O	OIt	was	It	PRP	B-NP	Owas	then	be	VBD	B-VP	Othen	observed	then	RB	I-VP	Oobserved	that	observe	VBN	I-VP	Othat	CD3+	that	IN	B-SBAR	OCD3+	cells	CD3+	JJ	B-NP	B-cell_typecells	obtained	cell	NNS	I-NP	I-cell_typeobtained	after	obtain	VBN	B-VP	Oafter	7	after	IN	B-PP	O7	days	7	CD	B-NP	Odays	of	day	NNS	I-NP	Oof	culture	of	IN	B-PP	Oculture	in	culture	NN	B-NP	Oin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	autologous	of	IN	B-PP	Oautologous	BMC	autologous	JJ	B-NP	OBMC	could	BMC	NN	I-NP	Ocould	be	could	MD	B-VP	Obe	used	be	VB	I-VP	Oused	as	use	VBN	I-VP	Oas	inhibitors	as	IN	B-PP	Oinhibitors	of	inhibitor	NNS	B-NP	Oof	EBV-CTL	of	IN	B-PP	OEBV-CTL	generation	EBV-CTL	NN	B-NP	Ogeneration	.	generation	NN	I-NP	O.	Protein	.	.	O	OProtein	Kinase	Protein	NN	B-NP	B-proteinKinase	A	Kinase	NN	I-NP	I-proteinA	(	A	NN	I-NP	I-protein(	PKA	(	(	O	OPKA	)	PKA	NN	B-NP	B-protein)	","	)	)	O	O","	a	","	","	O	Oa	cAMP	a	DT	B-NP	OcAMP	kinase	cAMP	NN	I-NP	B-proteinkinase	that	kinase	NN	I-NP	I-proteinthat	is	that	WDT	B-NP	Ois	involved	be	VBZ	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	upregulation	the	DT	B-NP	Oupregulation	of	upregulation	NN	I-NP	Oof	TH2	of	IN	B-PP	OTH2	cytokine	TH2	NN	B-NP	B-proteincytokine	activity	cytokine	NN	I-NP	I-proteinactivity	","	activity	NN	I-NP	O","	was	","	","	O	Owas	increased	be	VBD	B-VP	Oincreased	in	increase	VBN	I-VP	Oin	EBV-CTL	in	IN	B-PP	OEBV-CTL	cultures	EBV-CTL	NN	B-NP	B-cell_linecultures	by	culture	NNS	I-NP	I-cell_lineby	the	by	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	BMC	of	IN	B-PP	OBMC	.	BMC	NN	B-NP	B-cell_type.	Additionally	.	.	O	OAdditionally	","	Additionally	RB	B-ADVP	O","	IL-4-mediated	","	","	O	OIL-4-mediated	signal	IL-4-mediated	JJ	B-NP	Osignal	transduction	signal	NN	I-NP	Otransduction	and	transduction	NN	I-NP	Oand	activation	and	CC	O	Oactivation	of	activation	NN	B-NP	Oof	transcription	of	IN	B-PP	Otranscription	(	transcription	NN	B-NP	O(	STAT-6	(	(	O	OSTAT-6	)	STAT-6	NN	B-NP	B-protein)	phosphorylation	)	)	O	Ophosphorylation	was	phosphorylation	NN	B-NP	Owas	slightly	be	VBD	B-VP	Oslightly	increased	slightly	RB	I-VP	Oincreased	.	increase	VBN	I-VP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	show	result	NNS	I-NP	Oshow	that	show	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	BMC	the	DT	B-NP	OBMC	inhibition	BMC	NN	I-NP	Oinhibition	is	inhibition	NN	I-NP	Ois	mediated	be	VBZ	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	soluble	by	IN	B-PP	Osoluble	factors	soluble	JJ	B-NP	B-proteinfactors	(	factor	NNS	I-NP	I-protein(	cytokines	(	(	O	Ocytokines	)	cytokine	NNS	B-NP	B-protein)	and	)	)	O	Oand	that	and	CC	O	Othat	cell-cell	that	IN	B-SBAR	Ocell-cell	contact	cell-cell	JJ	B-NP	Ocontact	in	contact	NN	I-NP	Oin	this	in	IN	B-PP	Othis	autologous	this	DT	B-NP	Oautologous	system	autologous	JJ	I-NP	Osystem	is	system	NN	I-NP	Ois	not	be	VBZ	B-VP	Onot	required	not	RB	I-VP	Orequired	","	require	VBN	I-VP	O","	so	","	","	O	Oso	that	so	IN	B-SBAR	Othat	BMC	that	IN	I-SBAR	OBMC	(	BMC	NN	B-NP	B-cell_type(	at	(	(	O	Oat	least	at	IN	B-ADVP	Oleast	partially	least	JJS	I-ADVP	Opartially	","	partially	RB	B-ADVP	O","	via	","	","	O	Ovia	cytokine	via	IN	B-PP	Ocytokine	production	cytokine	NN	B-NP	B-proteinproduction	)	production	NN	I-NP	O)	promote	)	)	O	Opromote	TH2	promote	VBP	B-VP	OTH2	polarization	TH2	NN	B-NP	Opolarization	in	polarization	NN	I-NP	Oin	culture	in	IN	B-PP	Oculture	.	culture	NN	B-NP	O.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	TH2	","	","	O	OTH2	cells	TH2	NN	B-NP	B-cell_linecells	induced	cell	NNS	I-NP	I-cell_lineinduced	by	induce	VBN	B-VP	Oby	culturing	by	IN	B-PP	Oculturing	with	culture	VBG	B-VP	Owith	autologous	with	IN	B-PP	Oautologous	BMC	autologous	JJ	B-NP	OBMC	directly	BMC	NN	I-NP	Odirectly	inhibit	directly	RB	B-VP	Oinhibit	EBV-CTL	inhibit	VBP	I-VP	OEBV-CTL	generation	EBV-CTL	NN	B-NP	Ogeneration	","	generation	NN	I-NP	O","	and	","	","	O	Oand	TH2	and	CC	O	OTH2	associated	TH2	NN	B-NP	B-cell_lineassociated	PKA	associate	VBN	B-VP	OPKA	","	PKA	NN	B-NP	B-protein","	CCR3	","	","	O	OCCR3	","	CCR3	NN	B-NP	B-protein","	and	","	","	O	Oand	STAT-6	and	CC	O	OSTAT-6	phosphorylation	STAT-6	NN	B-NP	B-proteinphosphorylation	are	phosphorylation	NN	I-NP	Oare	enhanced	be	VBP	B-VP	Oenhanced	by	enhance	VBN	I-VP	Oby	BMC	by	IN	B-PP	OBMC	.	BMC	NN	B-NP	B-cell_type.	Reduction	.	.	O	OReduction	in	Reduction	NN	B-NP	Oin	DNA	in	IN	B-PP	ODNA	binding	DNA	NN	B-NP	Obinding	activity	binding	NN	I-NP	Oactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	Pax-5a	factor	NN	I-NP	I-proteinPax-5a	in	Pax-5a	NN	I-NP	B-proteinin	B	in	IN	B-PP	OB	lymphocytes	B	NN	B-NP	B-cell_typelymphocytes	of	lymphocyte	NNS	I-NP	I-cell_typeof	aged	of	IN	B-PP	Oaged	mice	aged	JJ	B-NP	Omice	.	mouse	NNS	I-NP	O.	Aging	.	.	O	OAging	has	Aging	NN	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	associated	be	VBN	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	intrinsic	with	IN	B-PP	Ointrinsic	changes	intrinsic	JJ	B-NP	Ochanges	of	change	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	humoral	the	DT	B-NP	Ohumoral	immune	humoral	JJ	I-NP	Oimmune	response	immune	JJ	I-NP	Oresponse	","	response	NN	I-NP	O","	which	","	","	O	Owhich	may	which	WDT	B-NP	Omay	lead	may	MD	B-VP	Olead	to	lead	VB	I-VP	Oto	an	to	TO	B-PP	Oan	increased	an	DT	B-NP	Oincreased	occurrence	increase	VBN	I-NP	Ooccurrence	of	occurrence	NN	I-NP	Oof	autoimmune	of	IN	B-PP	Oautoimmune	disorders	autoimmune	JJ	B-NP	Odisorders	and	disorder	NNS	I-NP	Oand	pathogenic	and	CC	O	Opathogenic	susceptibility	pathogenic	JJ	B-NP	Osusceptibility	.	susceptibility	NN	I-NP	O.	The	.	.	O	OThe	transcription	The	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	Pax-5	factor	NN	I-NP	I-proteinPax-5	is	Pax-5	NN	I-NP	B-proteinis	a	be	VBZ	B-VP	Oa	key	a	DT	B-NP	Okey	regulator	key	JJ	I-NP	Oregulator	of	regulator	NN	I-NP	Oof	B	of	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	.	development	NN	I-NP	O.	Pax-5a/B	.	.	O	OPax-5a/B	cell-specific	Pax-5a/B	NN	B-NP	B-proteincell-specific	activator	cell-specific	JJ	I-NP	I-proteinactivator	protein	activator	NN	I-NP	I-proteinprotein	and	protein	NN	I-NP	I-proteinand	an	and	CC	O	Oan	alternatively	an	DT	B-NP	Oalternatively	spliced	alternatively	RB	I-NP	Ospliced	isoform	splice	VBN	I-NP	Oisoform	","	isoform	NN	I-NP	O","	Pax-5d	","	","	O	OPax-5d	","	Pax-5d	NN	B-NP	B-protein","	may	","	","	O	Omay	have	may	MD	B-VP	Ohave	opposing	have	VB	I-VP	Oopposing	functions	oppose	VBG	I-VP	Ofunctions	in	function	NNS	B-NP	Oin	transcriptional	in	IN	B-PP	Otranscriptional	regulation	transcriptional	JJ	B-NP	Oregulation	due	regulation	NN	I-NP	Odue	to	due	JJ	B-PP	Oto	the	to	TO	B-PP	Othe	lack	the	DT	B-NP	Olack	of	lack	NN	I-NP	Oof	a	of	IN	B-PP	Oa	transactivation	a	DT	B-NP	Otransactivation	domain	transactivation	NN	I-NP	B-proteindomain	in	domain	NN	I-NP	I-proteinin	Pax-5d	in	IN	B-PP	OPax-5d	.	Pax-5d	NN	B-NP	B-protein.	To	.	.	O	OTo	study	To	TO	B-VP	Ostudy	B	study	VB	I-VP	OB	cell	B	NN	B-NP	Ocell	#NAME?	cell	NN	I-NP	O#NAME?	changes	#NAME?	JJ	I-NP	Ochanges	that	change	NNS	I-NP	Othat	occur	that	WDT	B-NP	Ooccur	during	occur	VBP	B-VP	Oduring	the	during	IN	B-PP	Othe	aging	the	DT	B-NP	Oaging	process	aging	NN	I-NP	Oprocess	","	process	NN	I-NP	O","	we	","	","	O	Owe	investigated	we	PRP	B-NP	Oinvestigated	expression	investigate	VBD	B-VP	Oexpression	patterns	expression	NN	B-NP	Opatterns	of	pattern	NNS	I-NP	Oof	Pax-5a	of	IN	B-PP	OPax-5a	and	Pax-5a	NN	B-NP	B-proteinand	5d	and	CC	I-NP	O5d	in	5d	NN	I-NP	Oin	mature	in	IN	B-PP	Omature	B	mature	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	of	cell	NNS	I-NP	I-cell_typeof	young	of	IN	B-PP	Oyoung	and	young	JJ	B-NP	Oand	aged	and	CC	I-NP	Oaged	mice	aged	JJ	I-NP	Omice	.	mouse	NNS	I-NP	O.	RNase	.	.	O	ORNase	protection	RNase	NN	B-NP	B-proteinprotection	assays	protection	NN	I-NP	Oassays	showed	assay	NNS	I-NP	Oshowed	a	show	VBD	B-VP	Oa	similar	a	DT	B-NP	Osimilar	transcriptional	similar	JJ	I-NP	Otranscriptional	pattern	transcriptional	JJ	I-NP	Opattern	for	pattern	NN	I-NP	Ofor	both	for	IN	B-PP	Oboth	age	both	DT	B-NP	Oage	groups	age	NN	I-NP	Ogroups	that	group	NNS	I-NP	Othat	indicates	that	WDT	B-NP	Oindicates	that	indicate	VBZ	B-VP	Othat	aging	that	IN	B-SBAR	Oaging	has	aging	NN	B-NP	Ohas	no	have	VBZ	B-VP	Ono	affect	no	DT	B-NP	Oaffect	on	affect	NN	I-NP	Oon	transcription	on	IN	B-PP	Otranscription	initiation	transcription	NN	B-NP	Oinitiation	or	initiation	NN	I-NP	Oor	alternative	or	CC	O	Oalternative	splicing	alternative	JJ	B-NP	Osplicing	for	splicing	NN	I-NP	Ofor	either	for	IN	B-PP	Oeither	isoform	either	DT	B-NP	Oisoform	.	isoform	NN	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	a	","	","	O	Oa	significant	a	DT	B-NP	Osignificant	reduction	significant	JJ	I-NP	Oreduction	in	reduction	NN	I-NP	Oin	the	in	IN	B-PP	Othe	DNA	the	DT	B-NP	ODNA	binding	DNA	NN	I-NP	Obinding	activity	binding	NN	I-NP	Oactivity	of	activity	NN	I-NP	Oof	Pax-5a	of	IN	B-PP	OPax-5a	but	Pax-5a	NN	B-NP	B-proteinbut	not	but	CC	B-NP	Onot	Pax-5d	not	RB	I-NP	OPax-5d	protein	Pax-5d	NN	B-NP	B-proteinprotein	was	protein	NN	I-NP	I-proteinwas	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	aged	in	IN	B-PP	Oaged	B	aged	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	vitro	in	FW	B-ADVP	Ovitro	","	vitro	FW	I-ADVP	O","	while	","	","	O	Owhile	Western	while	IN	B-SBAR	OWestern	blot	Western	JJ	B-NP	Oblot	analyses	blot	NN	I-NP	Oanalyses	showed	analysis	NNS	I-NP	Oshowed	that	show	VBD	B-VP	Othat	similar	that	IN	B-SBAR	Osimilar	levels	similar	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	Pax-5a	of	IN	B-PP	OPax-5a	and	Pax-5a	NN	B-NP	B-proteinand	5d	and	CC	I-NP	O5d	proteins	5d	NN	I-NP	B-proteinproteins	were	protein	NNS	I-NP	I-proteinwere	present	be	VBD	B-VP	Opresent	in	present	JJ	B-ADJP	Oin	both	in	IN	B-PP	Oboth	age	both	CC	O	Oage	groups	age	NN	B-NP	Ogroups	.	group	NNS	I-NP	O.	The	.	.	O	OThe	observed	The	DT	B-NP	Oobserved	decrease	observe	VBN	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	Pax-5a	in	IN	B-PP	OPax-5a	binding	Pax-5a	NN	B-NP	B-proteinbinding	activity	binding	NN	I-NP	Oactivity	correlated	activity	NN	I-NP	Ocorrelated	with	correlate	VBD	B-VP	Owith	changes	with	IN	B-PP	Ochanges	in	change	NNS	B-NP	Oin	expression	in	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	two	of	IN	B-PP	Otwo	Pax-5	two	CD	B-NP	OPax-5	target	Pax-5	NN	I-NP	B-DNAtarget	genes	target	NN	I-NP	I-DNAgenes	in	gene	NNS	I-NP	I-DNAin	aged	in	IN	B-PP	Oaged	B	aged	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Expression	.	.	O	OExpression	of	Expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	Ig	the	DT	B-NP	OIg	J	Ig	NN	I-NP	B-proteinJ	chain	J	NN	I-NP	I-proteinchain	and	chain	NN	I-NP	I-proteinand	the	and	CC	O	Othe	secreted	the	DT	B-NP	Osecreted	form	secrete	VBN	I-NP	B-RNAform	of	form	NN	I-NP	I-RNAof	Ig	of	IN	B-PP	OIg	mu	Ig	NN	B-NP	B-proteinmu	","	mu	NN	I-NP	I-protein","	which	","	","	O	Owhich	are	which	WDT	B-NP	Oare	both	be	VBP	B-VP	Oboth	known	both	DT	O	Oknown	to	know	VBN	B-VP	Oto	be	to	TO	I-VP	Obe	suppressed	be	VB	I-VP	Osuppressed	by	suppress	VBN	I-VP	Oby	Pax-5a	by	IN	B-PP	OPax-5a	in	Pax-5a	NN	B-NP	B-proteinin	mature	in	IN	B-PP	Omature	B	mature	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	were	","	","	O	Owere	increased	be	VBD	B-VP	Oincreased	in	increase	VBN	I-VP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	of	cell	NNS	I-NP	I-cell_typeof	aged	of	IN	B-PP	Oaged	mice	aged	JJ	B-NP	Omice	.	mouse	NNS	I-NP	O.	Together	.	.	O	OTogether	","	Together	RB	B-ADVP	O","	our	","	","	O	Oour	studies	our	PRP$	B-NP	Ostudies	suggest	study	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	changes	that	IN	B-SBAR	Ochanges	associated	change	NNS	B-NP	Oassociated	with	associate	VBN	B-VP	Owith	the	with	IN	B-PP	Othe	aging	the	DT	B-NP	Oaging	phenotype	aging	NN	I-NP	Ophenotype	cause	phenotype	NN	I-NP	Ocause	posttranslational	cause	VBP	B-VP	Oposttranslational	modification	posttranslational	JJ	B-NP	Omodification	(	modification	NN	I-NP	O(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	of	)	)	O	Oof	Pax-5a	of	IN	B-PP	OPax-5a	but	Pax-5a	NN	B-NP	B-proteinbut	not	but	CC	B-NP	Onot	Pax-5d	not	RB	I-NP	OPax-5d	","	Pax-5d	NN	B-NP	B-protein","	which	","	","	O	Owhich	may	which	WDT	B-NP	Omay	lead	may	MD	B-VP	Olead	to	lead	VB	I-VP	Oto	an	to	TO	B-PP	Oan	abnormal	an	DT	B-NP	Oabnormal	B	abnormal	JJ	I-NP	OB	cell	B	NN	I-NP	Ocell	phenotype	cell	NN	I-NP	Ophenotype	in	phenotype	NN	I-NP	Oin	aged	in	IN	B-PP	Oaged	mice	aged	JJ	B-NP	Omice	","	mouse	NNS	I-NP	O","	associated	","	","	O	Oassociated	with	associate	VBN	B-VP	Owith	elevated	with	IN	B-PP	Oelevated	levels	elevate	VBN	B-NP	Olevels	of	level	NNS	I-NP	Oof	J	of	IN	B-PP	OJ	chain	J	NN	B-NP	B-proteinchain	","	chain	NN	I-NP	I-protein","	and	","	","	O	Oand	secretion	and	CC	O	Osecretion	of	secretion	NN	B-NP	Oof	IgM	of	IN	B-PP	OIgM	NF-kappa	IgM	NN	B-NP	B-proteinNF-kappa	B/Rel	NF-kappa	NN	B-NP	B-proteinB/Rel	participation	B/Rel	NN	I-NP	I-proteinparticipation	in	participation	NN	I-NP	Oin	the	in	IN	B-PP	Othe	lymphokine-dependent	the	DT	B-NP	Olymphokine-dependent	proliferation	lymphokine-dependent	JJ	I-NP	Oproliferation	of	proliferation	NN	I-NP	Oof	T	of	IN	B-PP	OT	lymphoid	T	NN	B-NP	B-cell_typelymphoid	cells	lymphoid	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Proliferative	.	.	O	OProliferative	responses	Proliferative	JJ	B-NP	Oresponses	of	response	NNS	I-NP	Oof	lymphoid	of	IN	B-PP	Olymphoid	cells	lymphoid	JJ	B-NP	B-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	IL-2	to	TO	B-PP	OIL-2	and	IL-2	NN	B-NP	B-proteinand	IL-4	and	CC	I-NP	OIL-4	depend	IL-4	NN	I-NP	B-proteindepend	on	depend	VBP	B-VP	Oon	activation	on	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	cells	the	DT	B-NP	Ocells	","	cell	NNS	I-NP	O","	but	","	","	O	Obut	the	but	CC	O	Othe	mechanism	the	DT	B-NP	Omechanism	(	mechanism	NN	I-NP	O(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	by	)	)	O	Oby	which	by	IN	B-PP	Owhich	activation	which	WDT	B-NP	Oactivation	enhances	activation	NN	B-NP	Oenhances	cellular	enhance	VBZ	B-VP	Ocellular	competence	cellular	JJ	B-NP	Ocompetence	to	competence	NN	I-NP	Oto	respond	to	TO	B-VP	Orespond	to	respond	VB	I-VP	Oto	cytokines	to	TO	B-PP	Ocytokines	is	cytokine	NNS	B-NP	B-proteinis	not	be	VBZ	B-VP	Onot	fully	not	RB	I-VP	Ofully	understood	fully	RB	I-VP	Ounderstood	.	understand	VBN	I-VP	O.	The	.	.	O	OThe	NF-kappaB/Rel	The	DT	B-NP	ONF-kappaB/Rel	family	NF-kappaB/Rel	NN	I-NP	B-proteinfamily	represents	family	NN	I-NP	I-proteinrepresents	one	represent	VBZ	B-VP	Oone	signal	one	CD	B-NP	Osignal	transduction	signal	NN	I-NP	Otransduction	pathway	transduction	NN	I-NP	Opathway	induced	pathway	NN	I-NP	Oinduced	during	induce	VBN	B-VP	Oduring	such	during	IN	B-PP	Osuch	activation	such	JJ	B-NP	Oactivation	.	activation	NN	I-NP	O.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	in	show	VBP	B-VP	Oin	this	in	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	that	study	NN	I-NP	Othat	inhibition	that	IN	B-SBAR	Oinhibition	of	inhibition	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	through	NF-kappaB	NN	B-NP	B-proteinthrough	the	through	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	an	of	IN	B-PP	Oan	IkappaBalpha	an	DT	B-NP	OIkappaBalpha	(	IkappaBalpha	NN	I-NP	B-protein(	inhibitory	(	(	O	Oinhibitory	protein	inhibitory	JJ	B-NP	B-proteinprotein	that	protein	NN	I-NP	I-proteinthat	dissociates	that	WDT	B-NP	Odissociates	from	dissociate	VBZ	B-VP	Ofrom	NF-kappaB	from	IN	B-PP	ONF-kappaB	)	NF-kappaB	NN	B-NP	B-protein)	mutant	)	)	O	Omutant	refractory	mutant	NN	B-NP	Orefractory	to	refractory	JJ	B-ADJP	Oto	signal-induced	to	TO	B-PP	Osignal-induced	degradation	signal-induced	JJ	B-NP	Odegradation	(	degradation	NN	I-NP	O(	IkappaBalpha	(	(	O	OIkappaBalpha	(	IkappaBalpha	NN	B-NP	B-protein(	DeltaN	(	(	O	ODeltaN	)	DeltaN	NN	B-NP	O)	)	)	)	O	O)	interfered	)	)	O	Ointerfered	with	interfere	VBD	B-VP	Owith	the	with	IN	B-PP	Othe	acquisition	the	DT	B-NP	Oacquisition	of	acquisition	NN	I-NP	Oof	competence	of	IN	B-PP	Ocompetence	to	competence	NN	B-NP	Oto	proliferate	to	TO	B-VP	Oproliferate	in	proliferate	VB	I-VP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	IL-4	to	TO	B-PP	OIL-4	as	IL-4	NN	B-NP	B-proteinas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	IL-2	as	IN	I-CONJP	OIL-2	.	IL-2	NN	B-NP	B-protein.	Thymocytes	.	.	O	OThymocytes	and	Thymocyte	NNS	B-NP	B-cell_typeand	T	and	CC	O	OT	cells	T	NN	B-NP	B-cell_typecells	from	cell	NNS	B-NP	I-cell_typefrom	IkappaBalpha	from	IN	B-PP	OIkappaBalpha	(	IkappaBalpha	NN	B-NP	B-protein(	DeltaN	(	(	O	ODeltaN	)	DeltaN	NN	B-NP	O)	transgenic	)	)	O	Otransgenic	mice	transgenic	JJ	B-NP	Omice	expressed	mouse	NNS	I-NP	Oexpressed	normal	express	VBD	B-VP	Onormal	levels	normal	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	IL-2R	of	IN	B-PP	OIL-2R	subunits	IL-2R	NN	B-NP	B-proteinsubunits	.	subunit	NNS	I-NP	I-protein.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	transgenic	","	","	O	Otransgenic	cells	transgenic	JJ	B-NP	B-cell_typecells	exhibited	cell	NNS	I-NP	I-cell_typeexhibited	a	exhibit	VBD	B-VP	Oa	dramatic	a	DT	B-NP	Odramatic	defect	dramatic	JJ	I-NP	Odefect	in	defect	NN	I-NP	Oin	Stat5A	in	IN	B-PP	OStat5A	activation	Stat5A	NN	B-NP	B-proteinactivation	treatment	activation	NN	I-NP	Otreatment	with	treatment	NN	I-NP	Owith	IL-2	with	IN	B-PP	OIL-2	","	IL-2	NN	B-NP	B-protein","	and	","	","	O	Oand	a	and	CC	O	Oa	similar	a	DT	B-NP	Osimilar	defect	similar	JJ	I-NP	Odefect	was	defect	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	for	observe	VBN	I-VP	Ofor	IL-4	for	IN	B-PP	OIL-4	#NAME?	IL-4	NN	B-NP	B-protein#NAME?	Stat5	#NAME?	JJ	I-NP	OStat5	.	Stat5	NN	I-NP	B-protein.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	T	","	","	O	OT	lymphoid	T	NN	B-NP	B-cell_typelymphoid	cells	lymphoid	JJ	I-NP	I-cell_typecells	with	cell	NNS	I-NP	I-cell_typewith	inhibition	with	IN	B-PP	Oinhibition	of	inhibition	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	showed	NF-kappaB	NN	B-NP	B-proteinshowed	normal	show	VBD	B-VP	Onormal	insulin	normal	JJ	B-NP	Oinsulin	receptor	insulin	NN	I-NP	Oreceptor	substrate-2	receptor	NN	I-NP	Osubstrate-2	phosphorylation	substrate-2	NN	I-NP	Ophosphorylation	and	phosphorylation	NN	I-NP	Oand	only	and	CC	O	Oonly	a	only	RB	B-NP	Oa	modest	a	DT	I-NP	Omodest	decrease	modest	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	Stat6	in	IN	B-PP	OStat6	activation	Stat6	NN	B-NP	B-proteinactivation	and	activation	NN	I-NP	Oand	insulin	and	CC	O	Oinsulin	receptor	insulin	NN	B-NP	B-proteinreceptor	substrate-1	receptor	NN	I-NP	I-proteinsubstrate-1	phosphorylation	substrate-1	NN	I-NP	I-proteinphosphorylation	after	phosphorylation	NN	I-NP	Oafter	IL-4	after	IN	B-PP	OIL-4	stimulation	IL-4	NN	B-NP	B-proteinstimulation	.	stimulation	NN	I-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	NF-kappaB/Rel/IkappaBalpha	the	DT	B-NP	ONF-kappaB/Rel/IkappaBalpha	system	NF-kappaB/Rel/IkappaBalpha	NN	I-NP	B-proteinsystem	can	system	NN	I-NP	Ocan	regulate	can	MD	B-VP	Oregulate	cytokine	regulate	VB	I-VP	Ocytokine	receptor	cytokine	NN	B-NP	B-proteinreceptor	capacitation	receptor	NN	I-NP	I-proteincapacitation	through	capacitation	NN	I-NP	Othrough	effects	through	IN	B-PP	Oeffects	on	effect	NNS	B-NP	Oon	the	on	IN	B-PP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	downstream	of	IN	B-PP	Odownstream	signaling	downstream	JJ	B-NP	Osignaling	by	signaling	NN	I-NP	Oby	the	by	IN	B-PP	Othe	Stat	the	DT	B-NP	OStat	transcription	Stat	NN	I-NP	B-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	family	factor	NN	I-NP	I-proteinfamily	.	family	NN	I-NP	I-protein.	BMS-189453	.	.	O	OBMS-189453	","	BMS-189453	NN	B-NP	O","	a	","	","	O	Oa	novel	a	DT	B-NP	Onovel	retinoid	novel	JJ	I-NP	Oretinoid	receptor	retinoid	NN	I-NP	B-proteinreceptor	antagonist	receptor	NN	I-NP	I-proteinantagonist	","	antagonist	NN	I-NP	O","	is	","	","	O	Ois	a	be	VBZ	B-VP	Oa	potent	a	DT	B-NP	Opotent	testicular	potent	JJ	I-NP	Otesticular	toxin	testicular	JJ	I-NP	Otoxin	.	toxin	NN	I-NP	O.	BMS-189453	.	.	O	OBMS-189453	is	BMS-189453	NN	B-NP	Ois	a	be	VBZ	B-VP	Oa	synthetic	a	DT	B-NP	Osynthetic	retinoid	synthetic	JJ	I-NP	Oretinoid	that	retinoid	NN	I-NP	Othat	acts	that	WDT	B-NP	Oacts	as	act	VBZ	B-VP	Oas	an	as	IN	B-PP	Oan	antagonist	an	DT	B-NP	Oantagonist	at	antagonist	NN	I-NP	Oat	retinoic	at	IN	B-PP	Oretinoic	acid	retinoic	JJ	B-NP	B-proteinacid	receptors	acid	NN	I-NP	I-proteinreceptors	alpha	receptor	NNS	I-NP	I-proteinalpha	","	alpha	NN	I-NP	I-protein","	beta	","	","	O	Obeta	","	beta	NN	B-NP	O","	and	","	","	O	Oand	gamma	and	CC	O	Ogamma	.	gamma	NN	B-NP	O.	In	.	.	O	OIn	Sprague	In	IN	B-PP	OSprague	Dawley	Sprague	NNP	B-NP	ODawley	rats	Dawley	NNP	I-NP	Orats	at	rat	NNS	I-NP	Oat	daily	at	IN	B-PP	Odaily	oral	daily	JJ	B-NP	Ooral	doses	oral	JJ	I-NP	Odoses	of	dose	NNS	I-NP	Oof	15	of	IN	B-PP	O15	","	15	CD	B-NP	O","	60	","	","	I-NP	O60	","	60	CD	I-NP	O","	or	","	","	O	Oor	240	or	CC	O	O240	mg/kg	240	CD	B-NP	Omg/kg	for	mg/kg	NN	I-NP	Ofor	1	for	IN	B-PP	O1	month	1	CD	B-NP	Omonth	","	month	NN	I-NP	O","	BMS-189453	","	","	O	OBMS-189453	produced	BMS-189453	NN	B-NP	Oproduced	increases	produce	VBD	B-VP	Oincreases	in	increase	NNS	B-NP	Oin	leukocyte	in	IN	B-PP	Oleukocyte	counts	leukocyte	NN	B-NP	Ocounts	","	count	NNS	I-NP	O","	alkaline	","	","	O	Oalkaline	phosphatase	alkaline	NN	B-NP	B-proteinphosphatase	and	phosphatase	NN	I-NP	I-proteinand	alanine	and	CC	I-NP	Oalanine	aminotransferase	alanine	NN	I-NP	Oaminotransferase	levels	aminotransferase	NN	I-NP	Olevels	","	level	NNS	I-NP	O","	and	","	","	O	Oand	marked	and	CC	O	Omarked	testicular	mark	VBD	B-VP	Otesticular	degeneration	testicular	JJ	B-NP	Odegeneration	and	degeneration	NN	I-NP	Oand	atrophy	and	CC	I-NP	Oatrophy	at	atrophy	NN	I-NP	Oat	all	at	IN	B-PP	Oall	doses	all	DT	B-NP	Odoses	.	dose	NNS	I-NP	O.	Significant	.	.	O	OSignificant	overt	Significant	JJ	B-NP	Oovert	signs	overt	JJ	I-NP	Osigns	of	sign	NNS	I-NP	Oof	toxicity	of	IN	B-PP	Otoxicity	and	toxicity	NN	B-NP	Oand	deaths	and	CC	I-NP	Odeaths	occurred	death	NNS	I-NP	Ooccurred	at	occur	VBD	B-VP	Oat	240	at	IN	B-PP	O240	mg/kg	240	CD	B-NP	Omg/kg	","	mg/kg	NN	I-NP	O","	whereas	","	","	O	Owhereas	body-weight	whereas	IN	O	Obody-weight	and	body-weight	NN	B-NP	Oand	food-consumption	and	CC	I-NP	Ofood-consumption	decreases	food-consumption	NN	I-NP	Odecreases	occurred	decrease	NNS	I-NP	Ooccurred	at	occur	VBD	B-VP	Oat	60	at	IN	B-PP	O60	and	60	CD	B-NP	Oand	240	and	CC	I-NP	O240	mg/kg	240	CD	I-NP	Omg/kg	.	mg/kg	NN	I-NP	O.	When	.	.	O	OWhen	BMS-189453	When	WRB	B-ADVP	OBMS-189453	was	BMS-189453	NN	B-NP	Owas	administered	be	VBD	B-VP	Oadministered	to	administer	VBN	I-VP	Oto	male	to	TO	B-PP	Omale	rats	male	JJ	B-NP	Orats	at	rat	NNS	I-NP	Oat	daily	at	IN	B-PP	Odaily	doses	daily	JJ	B-NP	Odoses	ranging	dose	NNS	I-NP	Oranging	from	range	VBG	B-VP	Ofrom	12.5	from	IN	B-PP	O12.5	to	12.5	CD	B-NP	Oto	100	to	TO	I-NP	O100	mg/kg	100	CD	I-NP	Omg/kg	for	mg/kg	NN	I-NP	Ofor	1	for	IN	B-PP	O1	week	1	CD	B-NP	Oweek	","	week	NN	I-NP	O","	only	","	","	O	Oonly	minimal	only	RB	B-NP	Ominimal	testicular	minimal	JJ	I-NP	Otesticular	changes	testicular	JJ	I-NP	Ochanges	occurred	change	NNS	I-NP	Ooccurred	at	occur	VBD	B-VP	Oat	all	at	IN	B-PP	Oall	doses	all	DT	B-NP	Odoses	","	dose	NNS	I-NP	O","	shortly	","	","	O	Oshortly	after	shortly	RB	B-ADVP	Oafter	the	after	IN	B-PP	Othe	dosing	the	DT	B-NP	Odosing	period	dosing	NN	I-NP	Operiod	.	period	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	after	","	","	O	Oafter	a	after	IN	B-PP	Oa	1-month	a	DT	B-NP	O1-month	drug-free	1-month	JJ	I-NP	Odrug-free	observation	drug-free	JJ	I-NP	Oobservation	period	observation	NN	I-NP	Operiod	","	period	NN	I-NP	O","	marked	","	","	O	Omarked	testicular	marked	JJ	B-NP	Otesticular	atrophy	testicular	JJ	I-NP	Oatrophy	was	atrophy	NN	I-NP	Owas	evident	be	VBD	B-VP	Oevident	at	evident	JJ	B-ADJP	Oat	all	at	IN	B-PP	Oall	doses	all	DT	B-NP	Odoses	.	dose	NNS	I-NP	O.	BMS-189453	.	.	O	OBMS-189453	was	BMS-189453	NN	B-NP	Owas	then	be	VBD	B-VP	Othen	administered	then	RB	I-VP	Oadministered	at	administer	VBN	I-VP	Oat	doses	at	IN	B-PP	Odoses	of	dose	NNS	B-NP	Oof	2	of	IN	B-PP	O2	","	2	CD	B-NP	O","	10	","	","	I-NP	O10	","	10	CD	I-NP	O","	or	","	","	O	Oor	50	or	CC	O	O50	mg/kg	50	CD	B-NP	Omg/kg	to	mg/kg	NN	I-NP	Oto	male	to	TO	B-PP	Omale	rats	male	JJ	B-NP	Orats	for	rat	NNS	I-NP	Ofor	1	for	IN	B-PP	O1	","	1	CD	B-NP	O","	3	","	","	I-NP	O3	","	3	CD	I-NP	O","	or	","	","	O	Oor	7	or	CC	O	O7	consecutive	7	CD	B-NP	Oconsecutive	days	consecutive	JJ	I-NP	Odays	.	day	NNS	I-NP	O.	Dose-	.	.	O	ODose-	and	Dose-	JJ	B-NP	Oand	duration-dependent	and	CC	I-NP	Oduration-dependent	testicular	duration-dependent	JJ	I-NP	Otesticular	toxicity	testicular	JJ	I-NP	Otoxicity	that	toxicity	NN	I-NP	Othat	occurred	that	WDT	B-NP	Ooccurred	after	occur	VBD	B-VP	Oafter	a	after	IN	B-PP	Oa	1-month	a	DT	B-NP	O1-month	observation	1-month	JJ	I-NP	Oobservation	period	observation	NN	I-NP	Operiod	did	period	NN	I-NP	Odid	not	do	VBD	B-VP	Onot	recover	not	RB	I-VP	Orecover	","	recover	VB	I-VP	O","	and	","	","	O	Oand	","	and	CC	O	O","	in	","	","	O	Oin	some	in	IN	B-PP	Osome	cases	some	DT	B-NP	Ocases	","	case	NNS	I-NP	O","	was	","	","	O	Owas	more	be	VBD	B-VP	Omore	severe	more	RBR	B-ADJP	Osevere	4	severe	JJ	I-ADJP	O4	months	4	CD	B-NP	Omonths	after	month	NNS	I-NP	Oafter	the	after	IN	B-PP	Othe	last	the	DT	B-NP	Olast	dose	last	JJ	I-NP	Odose	.	dose	NN	I-NP	O.	In	.	.	O	OIn	rabbits	In	IN	B-PP	Orabbits	administered	rabbit	NNS	B-NP	Oadministered	BMS-189453	administer	VBN	B-VP	OBMS-189453	at	BMS-189453	NN	B-NP	Oat	oral	at	IN	B-PP	Ooral	doses	oral	JJ	B-NP	Odoses	of	dose	NNS	I-NP	Oof	2	of	IN	B-PP	O2	","	2	CD	B-NP	O","	10	","	","	I-NP	O10	","	10	CD	I-NP	O","	or	","	","	O	Oor	50	or	CC	O	O50	mg/kg	50	CD	B-NP	Omg/kg	for	mg/kg	NN	I-NP	Ofor	1	for	IN	B-PP	O1	week	1	CD	B-NP	Oweek	","	week	NN	I-NP	O","	testicular	","	","	O	Otesticular	degeneration	testicular	JJ	B-NP	Odegeneration	and	degeneration	NN	I-NP	Oand	atrophy	and	CC	I-NP	Oatrophy	were	atrophy	NN	I-NP	Owere	evident	be	VBD	B-VP	Oevident	in	evident	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	high-dose	the	DT	B-NP	Ohigh-dose	group	high-dose	JJ	I-NP	Ogroup	at	group	NN	I-NP	Oat	1	at	IN	B-PP	O1	month	1	CD	B-NP	Omonth	following	month	NN	I-NP	Ofollowing	treatment	follow	VBG	B-PP	Otreatment	.	treatment	NN	B-NP	O.	These	.	.	O	OThese	studies	These	DT	B-NP	Ostudies	indicate	study	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	retinoid	that	IN	B-SBAR	Oretinoid	antagonists	retinoid	JJ	B-NP	Oantagonists	can	antagonist	NNS	I-NP	Ocan	selectively	can	MD	B-VP	Oselectively	produce	selectively	RB	I-VP	Oproduce	progressive	produce	VB	I-VP	Oprogressive	and	progressive	JJ	B-NP	Oand	prolonged	and	CC	I-NP	Oprolonged	testicular	prolonged	JJ	I-NP	Otesticular	toxicity	testicular	JJ	I-NP	Otoxicity	after	toxicity	NN	I-NP	Oafter	single	after	IN	B-PP	Osingle	or	single	JJ	B-NP	Oor	repeated	or	CC	I-NP	Orepeated	oral	repeat	VBN	I-NP	Ooral	doses	oral	JJ	I-NP	Odoses	that	dose	NNS	I-NP	Othat	are	that	WDT	B-NP	Oare	otherwise	be	VBP	B-VP	Ootherwise	well	otherwise	RB	I-VP	Owell	tolerated	well	RB	I-VP	Otolerated	.	tolerate	VBN	I-VP	O.	Sequential	.	.	O	OSequential	involvement	Sequential	JJ	B-NP	Oinvolvement	of	involvement	NN	I-NP	Oof	NFAT	of	IN	B-PP	ONFAT	and	NFAT	NN	B-NP	B-proteinand	Egr	and	CC	I-NP	OEgr	transcription	Egr	NN	I-NP	B-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	in	factor	NNS	I-NP	I-proteinin	FasL	in	IN	B-PP	OFasL	regulation	FasL	NN	B-NP	B-proteinregulation	.	regulation	NN	I-NP	O.	The	.	.	O	OThe	critical	The	DT	B-NP	Ocritical	function	critical	JJ	I-NP	Ofunction	of	function	NN	I-NP	Oof	NFAT	of	IN	B-PP	ONFAT	proteins	NFAT	NN	B-NP	B-proteinproteins	in	protein	NNS	I-NP	I-proteinin	maintaining	in	IN	B-PP	Omaintaining	lymphoid	maintain	VBG	B-VP	Olymphoid	homeostasis	lymphoid	JJ	B-NP	Ohomeostasis	was	homeostasis	NN	I-NP	Owas	revealed	be	VBD	B-VP	Orevealed	in	reveal	VBN	I-VP	Oin	mice	in	IN	B-PP	Omice	lacking	mouse	NNS	B-NP	Olacking	both	lack	VBG	B-VP	Oboth	NFATp	both	CC	O	ONFATp	and	NFATp	NN	B-NP	B-proteinand	NFAT4	and	CC	O	ONFAT4	(	NFAT4	NN	B-NP	B-protein(	DKO	(	(	O	ODKO	)	DKO	NN	B-NP	B-protein)	.	)	)	O	O.	DKO	.	.	O	ODKO	mice	DKO	NN	B-NP	Omice	exhibit	mouse	NNS	I-NP	Oexhibit	increased	exhibit	VBP	B-VP	Oincreased	lymphoproliferation	increase	VBN	B-NP	Olymphoproliferation	","	lymphoproliferation	NN	I-NP	O","	decreased	","	","	O	Odecreased	activation-induced	decrease	VBD	B-VP	Oactivation-induced	cell	activation-induced	JJ	B-NP	Ocell	death	cell	NN	I-NP	Odeath	","	death	NN	I-NP	O","	and	","	","	O	Oand	impaired	and	CC	O	Oimpaired	induction	impaired	JJ	B-NP	Oinduction	of	induction	NN	I-NP	Oof	FasL	of	IN	B-PP	OFasL	.	FasL	NN	B-NP	B-protein.	The	.	.	O	OThe	transcription	The	DT	B-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	Egr2	factor	NNS	I-NP	I-proteinEgr2	and	Egr2	NN	B-NP	B-proteinand	Egr3	and	CC	I-NP	OEgr3	are	Egr3	NN	I-NP	B-proteinare	potent	be	VBP	B-VP	Opotent	activators	potent	JJ	B-NP	Oactivators	of	activator	NNS	I-NP	Oof	FasL	of	IN	B-PP	OFasL	expression	FasL	NN	B-NP	B-proteinexpression	.	expression	NN	I-NP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	find	we	PRP	B-NP	Ofind	that	find	VBP	B-VP	Othat	Egr2	that	IN	B-SBAR	OEgr2	and	Egr2	NN	B-NP	B-proteinand	Egr3	and	CC	I-NP	OEgr3	are	Egr3	NN	I-NP	B-proteinare	NFAT	be	VBP	B-VP	ONFAT	target	NFAT	NN	B-NP	B-DNAtarget	genes	target	NN	I-NP	I-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	FasL	of	IN	B-PP	OFasL	occurs	FasL	NN	B-NP	B-proteinoccurs	via	occur	VBZ	B-VP	Ovia	the	via	IN	B-PP	Othe	NFAT	the	DT	B-NP	ONFAT	#NAME?	NFAT	NN	I-NP	B-protein#NAME?	induction	#NAME?	JJ	I-NP	Oinduction	of	induction	NN	I-NP	Oof	Egr3	of	IN	B-PP	OEgr3	","	Egr3	NN	B-NP	B-protein","	as	","	","	O	Oas	demonstrated	as	IN	B-SBAR	Odemonstrated	by	demonstrate	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	ability	the	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	exogenously	of	IN	B-PP	Oexogenously	provided	exogenously	RB	B-NP	Oprovided	NFATp	provide	VBN	I-NP	ONFATp	to	NFATp	NN	I-NP	B-proteinto	restore	to	TO	B-VP	Orestore	Egr	restore	VB	I-VP	OEgr	#NAME?	Egr	NN	B-NP	B-protein#NAME?	FasL	#NAME?	JJ	I-NP	OFasL	promoter	FasL	NN	I-NP	B-DNApromoter	activity	promoter	NN	I-NP	I-DNAactivity	in	activity	NN	I-NP	Oin	DKO	in	IN	B-PP	ODKO	lymph	DKO	NN	B-NP	B-cell_typelymph	node	lymph	NN	I-NP	I-cell_typenode	cells	node	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Further	.	.	O	OFurther	","	Further	RB	B-ADVP	O","	Egr3	","	","	O	OEgr3	expression	Egr3	NN	B-NP	B-proteinexpression	is	expression	NN	I-NP	Ois	enriched	be	VBZ	B-VP	Oenriched	in	enrich	VBN	I-VP	Oin	Th1	in	IN	B-PP	OTh1	cells	Th1	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	suggesting	","	","	O	Osuggesting	a	suggest	VBG	B-VP	Oa	molecular	a	DT	B-NP	Omolecular	basis	molecular	JJ	I-NP	Obasis	for	basis	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	known	the	DT	B-NP	Oknown	preferential	known	JJ	I-NP	Opreferential	expression	preferential	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	FasL	of	IN	B-PP	OFasL	in	FasL	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	Th1	the	DT	B-NP	OTh1	versus	Th1	NN	I-NP	B-cell_typeversus	Th2	versus	IN	B-PP	I-cell_typeTh2	subset	Th2	NN	B-NP	I-cell_typesubset	.	subset	NN	I-NP	I-cell_type.	Mechanisms	.	.	O	OMechanisms	and	Mechanism	NNS	B-NP	Oand	clinical	and	CC	O	Oclinical	relevance	clinical	JJ	B-NP	Orelevance	of	relevance	NN	I-NP	Oof	nongenomic	of	IN	B-PP	Onongenomic	glucocorticoid	nongenomic	JJ	B-NP	Oglucocorticoid	actions	glucocorticoid	NN	I-NP	Oactions	.	action	NNS	I-NP	O.	Glucocorticoids	.	.	O	OGlucocorticoids	have	Glucocorticoid	NNS	B-NP	Ohave	profound	have	VBP	B-VP	Oprofound	anti-inflammatory	profound	JJ	B-NP	Oanti-inflammatory	and	anti-inflammatory	JJ	I-NP	Oand	immunosuppressive	and	CC	I-NP	Oimmunosuppressive	actions	immunosuppressive	JJ	I-NP	Oactions	when	action	NNS	I-NP	Owhen	used	when	WRB	B-ADVP	Oused	therapeutically	use	VBN	B-VP	Otherapeutically	.	therapeutically	RB	B-ADVP	O.	The	.	.	O	OThe	therapeutic	The	DT	B-NP	Otherapeutic	dose	therapeutic	JJ	I-NP	Odose	is	dose	NN	I-NP	Ois	quite	be	VBZ	B-VP	Oquite	variable	quite	RB	B-ADJP	Ovariable	and	variable	JJ	I-ADJP	Oand	depends	and	CC	O	Odepends	on	depend	VBZ	B-VP	Oon	the	on	IN	B-PP	Othe	disease	the	DT	B-NP	Odisease	","	disease	NN	I-NP	O","	but	","	","	O	Obut	ranges	but	CC	O	Oranges	from	range	VBZ	B-VP	Ofrom	very	from	IN	B-PP	Overy	low	very	RB	B-NP	Olow	to	low	JJ	I-NP	Oto	extremely	to	TO	B-PP	Oextremely	high	extremely	RB	B-ADJP	Ohigh	.	high	JJ	I-ADJP	O.	The	.	.	O	OThe	rationale	The	DT	B-NP	Orationale	for	rationale	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	use	the	DT	B-NP	Ouse	of	use	NN	I-NP	Oof	various	of	IN	B-PP	Ovarious	dosage	various	JJ	B-NP	Odosage	regimens	dosage	NN	I-NP	Oregimens	for	regimen	NNS	I-NP	Ofor	specific	for	IN	B-PP	Ospecific	clinical	specific	JJ	B-NP	Oclinical	indications	clinical	JJ	I-NP	Oindications	is	indication	NNS	I-NP	Ois	the	be	VBZ	B-VP	Othe	existence	the	DT	B-NP	Oexistence	of	existence	NN	I-NP	Oof	three	of	IN	B-PP	Othree	distinct	three	CD	B-NP	Odistinct	","	distinct	JJ	I-NP	O","	therapeutically	","	","	I-NP	Otherapeutically	relevant	therapeutically	RB	I-NP	Orelevant	effects	relevant	JJ	I-NP	Oeffects	:	effect	NNS	I-NP	O:	genomic	:	:	O	Ogenomic	","	genomic	JJ	B-NP	O","	specific	","	","	I-NP	Ospecific	nongenomic	specific	JJ	I-NP	Onongenomic	and	nongenomic	JJ	I-NP	Oand	unspecific	and	CC	I-NP	Ounspecific	nongenomic	unspecific	JJ	I-NP	Onongenomic	.	nongenomic	JJ	I-NP	O.	Genomic	.	.	O	OGenomic	effects	Genomic	JJ	B-NP	Oeffects	are	effect	NNS	I-NP	Oare	mediated	be	VBP	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	cytosolic	by	IN	B-PP	Ocytosolic	receptors	cytosolic	JJ	B-NP	B-proteinreceptors	that	receptor	NNS	I-NP	I-proteinthat	alter	that	WDT	B-NP	Oalter	expression	alter	VBP	B-VP	Oexpression	of	expression	NN	B-NP	Oof	specific	of	IN	B-PP	Ospecific	genes	specific	JJ	B-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Specific	.	.	O	OSpecific	nongenomic	Specific	JJ	B-NP	Onongenomic	effects	nongenomic	JJ	I-NP	Oeffects	occur	effect	NNS	I-NP	Ooccur	within	occur	VBP	B-VP	Owithin	a	within	IN	B-PP	Oa	few	a	DT	B-NP	Ofew	minutes	few	JJ	I-NP	Ominutes	and	minute	NNS	I-NP	Oand	are	and	CC	O	Oare	mediated	be	VBP	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	steroid-selective	by	IN	B-PP	Osteroid-selective	membrane	steroid-selective	JJ	B-NP	B-proteinmembrane	receptors	membrane	NN	I-NP	I-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	Unspecific	.	.	O	OUnspecific	nongenomic	Unspecific	JJ	B-NP	Onongenomic	effects	nongenomic	JJ	I-NP	Oeffects	occur	effect	NNS	I-NP	Ooccur	within	occur	VBP	B-VP	Owithin	seconds	within	IN	B-PP	Oseconds	","	second	NNS	B-NP	O","	but	","	","	O	Obut	only	but	CC	O	Oonly	at	only	RB	B-ADVP	Oat	high	at	IN	B-PP	Ohigh	glucocorticoid	high	JJ	B-NP	Oglucocorticoid	dosages	glucocorticoid	NN	I-NP	Odosages	","	dosage	NNS	I-NP	O","	and	","	","	O	Oand	seem	and	CC	O	Oseem	to	seem	VBP	B-VP	Oto	result	to	TO	I-VP	Oresult	from	result	VB	I-VP	Ofrom	direct	from	IN	B-PP	Odirect	interactions	direct	JJ	B-NP	Ointeractions	with	interaction	NNS	I-NP	Owith	biological	with	IN	B-PP	Obiological	membranes	biological	JJ	B-NP	Omembranes	.	membrane	NNS	I-NP	O.	For	.	.	O	OFor	unspecific	For	IN	B-PP	Ounspecific	nongenomic	unspecific	JJ	B-NP	Onongenomic	effects	nongenomic	JJ	I-NP	Oeffects	","	effect	NNS	I-NP	O","	methylprednisolone	","	","	O	Omethylprednisolone	and	methylprednisolone	NN	B-NP	Oand	other	and	CC	O	Oother	glucocorticoids	other	JJ	B-NP	Oglucocorticoids	have	glucocorticoid	NNS	I-NP	Ohave	been	have	VBP	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	inhibit	to	TO	I-VP	Oinhibit	cation	inhibit	VB	I-VP	Ocation	cycling	cation	NN	B-NP	Ocycling	across	cycling	NN	I-NP	Oacross	the	across	IN	B-PP	Othe	plasma	the	DT	B-NP	Oplasma	membrane	plasma	NN	I-NP	Omembrane	","	membrane	NN	I-NP	O","	but	","	","	O	Obut	to	but	CC	O	Oto	have	to	TO	B-VP	Ohave	little	have	VB	I-VP	Olittle	effect	little	JJ	B-NP	Oeffect	on	effect	NN	I-NP	Oon	protein	on	IN	B-PP	Oprotein	synthesis	protein	NN	B-NP	Osynthesis	.	synthesis	NN	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	glucocorticoids	","	","	O	Oglucocorticoids	could	glucocorticoid	NNS	B-NP	Ocould	diminish	could	MD	B-VP	Odiminish	or	diminish	VB	I-VP	Oor	prevent	or	CC	I-VP	Oprevent	the	prevent	VB	I-VP	Othe	acute	the	DT	B-NP	Oacute	immune	acute	JJ	I-NP	Oimmune	response	immune	JJ	I-NP	Oresponse	by	response	NN	I-NP	Oby	interfering	by	IN	B-PP	Ointerfering	with	interfere	VBG	B-VP	Owith	processes	with	IN	B-PP	Oprocesses	such	process	NNS	B-NP	Osuch	as	such	JJ	B-PP	Oas	the	as	IN	I-PP	Othe	rise	the	DT	B-NP	Orise	in	rise	NN	I-NP	Oin	intracellular	in	IN	B-PP	Ointracellular	Ca2+	intracellular	JJ	B-NP	OCa2+	concentration	Ca2+	NN	I-NP	Oconcentration	.	concentration	NN	I-NP	O.	It	.	.	O	OIt	is	It	PRP	B-NP	Ois	proposed	be	VBZ	B-VP	Oproposed	that	propose	VBN	I-VP	Othat	the	that	IN	B-SBAR	Othe	additional	the	DT	B-NP	Oadditional	therapeutic	additional	JJ	I-NP	Otherapeutic	benefit	therapeutic	JJ	I-NP	Obenefit	of	benefit	NN	I-NP	Oof	higher	of	IN	B-PP	Ohigher	doses	high	JJR	B-NP	Odoses	is	dose	NNS	I-NP	Ois	obtained	be	VBZ	B-VP	Oobtained	via	obtain	VBN	I-VP	Ovia	these	via	IN	B-PP	Othese	nongenomic	these	DT	B-NP	Onongenomic	effects	nongenomic	JJ	I-NP	Oeffects	.	effect	NNS	I-NP	O.	High	.	.	O	OHigh	glucose-induced	High	JJ	B-NP	Oglucose-induced	intercellular	glucose-induced	JJ	I-NP	Ointercellular	adhesion	intercellular	JJ	I-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	(	molecule-1	NN	I-NP	I-protein(	ICAM-1	(	(	O	OICAM-1	)	ICAM-1	NN	B-NP	B-protein)	expression	)	)	O	Oexpression	through	expression	NN	B-NP	Othrough	an	through	IN	B-PP	Oan	osmotic	an	DT	B-NP	Oosmotic	effect	osmotic	JJ	I-NP	Oeffect	in	effect	NN	I-NP	Oin	rat	in	IN	B-PP	Orat	mesangial	rat	NN	B-NP	B-cell_typemesangial	cells	mesangial	JJ	I-NP	I-cell_typecells	is	cell	NNS	I-NP	I-cell_typeis	PKC-NF-kappa	be	VBZ	B-VP	OPKC-NF-kappa	B-dependent	PKC-NF-kappa	NN	B-NP	OB-dependent	.	B-dependent	JJ	B-ADJP	O.	AIMS/HYPOTHESIS	.	.	O	OAIMS/HYPOTHESIS	:	AIMS/HYPOTHESIS	NNS	B-NP	O:	Infiltration	:	:	O	OInfiltration	of	Infiltration	NN	B-NP	Oof	mononuclear	of	IN	B-PP	Omononuclear	cells	mononuclear	JJ	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	glomerular	and	CC	O	Oglomerular	enlargement	glomerular	JJ	B-NP	Oenlargement	accompanied	enlargement	NN	I-NP	Oaccompanied	by	accompany	VBN	B-VP	Oby	glomerular	by	IN	B-PP	Oglomerular	cell	glomerular	JJ	B-NP	Ocell	proliferation	cell	NN	I-NP	Oproliferation	are	proliferation	NN	I-NP	Oare	very	be	VBP	B-VP	Overy	early	very	RB	B-NP	Oearly	characteristics	early	JJ	I-NP	Ocharacteristics	of	characteristic	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	pathophysiology	the	DT	B-NP	Opathophysiology	of	pathophysiology	NN	I-NP	Oof	diabetes	of	IN	B-PP	Odiabetes	.	diabete	NNS	B-NP	O.	To	.	.	O	OTo	clarify	To	TO	B-VP	Oclarify	the	clarify	VB	I-VP	Othe	mechanism	the	DT	B-NP	Omechanism	of	mechanism	NN	I-NP	Oof	early	of	IN	B-PP	Oearly	diabetic	early	JJ	B-NP	Odiabetic	nephropathy	diabetic	JJ	I-NP	Onephropathy	","	nephropathy	NN	I-NP	O","	we	","	","	O	Owe	measured	we	PRP	B-NP	Omeasured	[	measure	VBD	B-VP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	#NAME?	]	)	I-NP	O#NAME?	incorporation	#NAME?	JJ	I-NP	Oincorporation	and	incorporation	NN	I-NP	Oand	cell	and	CC	I-NP	Ocell	numbers	cell	NN	I-NP	Onumbers	to	number	NNS	I-NP	Oto	show	to	TO	B-VP	Oshow	the	show	VB	I-VP	Othe	influence	the	DT	B-NP	Oinfluence	of	influence	NN	I-NP	Oof	a	of	IN	B-PP	Oa	high	a	DT	B-NP	Ohigh	ambient	high	JJ	I-NP	Oambient	glucose	ambient	JJ	I-NP	Oglucose	concentration	glucose	NN	I-NP	Oconcentration	and	concentration	NN	I-NP	Oand	the	and	CC	O	Othe	osmotic	the	DT	B-NP	Oosmotic	effect	osmotic	JJ	I-NP	Oeffect	on	effect	NN	I-NP	Oon	rat	on	IN	B-PP	Orat	mesangial	rat	NN	B-NP	B-cell_typemesangial	cell	mesangial	JJ	I-NP	I-cell_typecell	proliferation	cell	NN	I-NP	I-cell_typeproliferation	.	proliferation	NN	I-NP	O.	We	.	.	O	OWe	also	We	PRP	B-NP	Oalso	measured	also	RB	B-ADVP	Omeasured	the	measure	VBD	B-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	high	of	IN	B-PP	Ohigh	glucose	high	JJ	B-NP	Oglucose	on	glucose	NN	I-NP	Oon	the	on	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	intercellular	of	IN	B-PP	Ointercellular	adhesion	intercellular	JJ	B-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	and	molecule-1	NN	I-NP	I-proteinand	vascular	and	CC	O	Ovascular	adhesion	vascular	JJ	B-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	by	molecule-1	NN	I-NP	I-proteinby	flow	by	IN	B-PP	Oflow	cytometry	flow	NN	B-NP	Ocytometry	and	cytometry	NN	I-NP	Oand	semiquantitative	and	CC	O	Osemiquantitative	RT-PCR	semiquantitative	JJ	B-NP	ORT-PCR	in	RT-PCR	NN	I-NP	Oin	mesangial	in	IN	B-PP	Omesangial	cells	mesangial	JJ	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	the	and	CC	O	Othe	adhesion	the	DT	B-NP	Oadhesion	of	adhesion	NN	I-NP	Oof	leukocytes	of	IN	B-PP	Oleukocytes	to	leukocyte	NNS	B-NP	B-cell_typeto	mesangial	to	TO	B-PP	Omesangial	cells	mesangial	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	METHODS/RESULTS	.	.	O	OMETHODS/RESULTS	:	METHODS/RESULTS	NNS	B-NP	O:	Cells	:	:	O	OCells	exposed	Cell	NNS	B-NP	Oexposed	to	expose	VBN	B-VP	Oto	high	to	TO	B-PP	Ohigh	D-glucose	high	JJ	B-NP	OD-glucose	(	D-glucose	NN	I-NP	O(	30	(	(	O	O30	mmol/l	30	CD	B-NP	Ommol/l	)	mmol/l	NN	I-NP	O)	caused	)	)	O	Ocaused	an	cause	VBD	B-VP	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	[	in	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	#NAME?	]	)	I-NP	O#NAME?	incorporation	#NAME?	JJ	I-NP	Oincorporation	and	incorporation	NN	I-NP	Oand	cell	and	CC	I-NP	Ocell	numbers	cell	NN	I-NP	Onumbers	at	number	NNS	I-NP	Oat	24	at	IN	B-PP	O24	and	24	CD	B-NP	Oand	48	and	CC	I-NP	O48	h	48	CD	I-NP	Oh	and	h	NN	I-NP	Oand	normalized	and	CC	O	Onormalized	at	normalize	VBD	B-VP	Oat	72	at	IN	B-PP	O72	h	72	CD	B-NP	Oh	(	h	NN	I-NP	O(	p	(	(	O	Op	<	p	NN	B-NP	O<	0.05	<	SYM	O	O0.05	)	0.05	CD	B-NP	O)	","	)	)	O	O","	whereas	","	","	O	Owhereas	these	whereas	IN	O	Othese	changes	these	DT	B-NP	Ochanges	were	change	NNS	I-NP	Owere	not	be	VBD	B-VP	Onot	found	not	RB	I-VP	Ofound	in	find	VBN	I-VP	Oin	high	in	IN	B-PP	Ohigh	mannitol	high	JJ	B-NP	Omannitol	(	mannitol	NN	I-NP	O(	30	(	(	O	O30	mmol/l	30	CD	B-NP	Ommol/l	)	mmol/l	NN	I-NP	O)	","	)	)	O	O","	IL-1	","	","	O	OIL-1	beta	IL-1	NN	B-NP	B-proteinbeta	","	beta	NN	I-NP	I-protein","	or	","	","	O	Oor	TNF	or	CC	O	OTNF	alpha	TNF	NN	B-NP	B-proteinalpha	#NAME?	alpha	NN	I-NP	I-protein#NAME?	mesangial	#NAME?	JJ	I-NP	Omesangial	cells	mesangial	JJ	I-NP	Ocells	.	cell	NNS	I-NP	O.	Cells	.	.	O	OCells	exposed	Cell	NNS	B-NP	Oexposed	to	expose	VBN	B-VP	Oto	high-glucose	to	TO	B-PP	Ohigh-glucose	(	high-glucose	JJ	B-NP	O(	15	(	(	O	O15	","	15	CD	B-NP	O","	30	","	","	I-NP	O30	","	30	CD	I-NP	O","	or	","	","	O	Oor	60	or	CC	O	O60	mmol/l	60	CD	B-NP	Ommol/l	)	mmol/l	NN	I-NP	O)	or	)	)	O	Oor	osmotic	or	CC	O	Oosmotic	agents	osmotic	JJ	B-NP	Oagents	(	agent	NNS	I-NP	O(	L-glucose	(	(	O	OL-glucose	","	L-glucose	NN	B-NP	O","	raffinose	","	","	O	Oraffinose	and	raffinose	NN	B-NP	Oand	mannitol	and	CC	O	Omannitol	)	mannitol	NN	B-NP	O)	showed	)	)	O	Oshowed	that	show	VBD	B-VP	Othat	intercellular	that	IN	B-SBAR	Ointercellular	adhesion	intercellular	JJ	B-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	expression	molecule-1	NN	I-NP	I-proteinexpression	began	expression	NN	I-NP	Obegan	to	begin	VBD	B-VP	Oto	increase	to	TO	I-VP	Oincrease	after	increase	VB	I-VP	Oafter	24	after	IN	B-PP	O24	h	24	CD	B-NP	Oh	","	h	NN	I-NP	O","	reached	","	","	O	Oreached	its	reach	VBD	B-VP	Oits	maximum	its	PRP$	B-NP	Omaximum	at	maximum	NN	I-NP	Oat	24	at	IN	B-PP	O24	and	24	CD	B-NP	Oand	48	and	CC	I-NP	O48	h	48	CD	I-NP	Oh	and	h	NN	I-NP	Oand	gradually	and	CC	O	Ogradually	decreased	gradually	RB	B-VP	Odecreased	afterwards	decrease	VBD	I-VP	Oafterwards	.	afterwards	RB	B-ADVP	O.	The	.	.	O	OThe	stimulatory	The	DT	B-NP	Ostimulatory	effects	stimulatory	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	high	of	IN	B-PP	Ohigh	glucose	high	JJ	B-NP	Oglucose	and	glucose	NN	I-NP	Oand	high	and	CC	O	Ohigh	mannitol	high	JJ	B-NP	Omannitol	on	mannitol	NN	I-NP	Oon	mRNA	on	IN	B-PP	OmRNA	expression	mRNA	NN	B-NP	B-RNAexpression	were	expression	NN	I-NP	Owere	observed	be	VBD	B-VP	Oobserved	as	observe	VBN	I-VP	Oas	early	as	RB	B-ADVP	Oearly	as	early	RB	I-ADVP	Oas	6	as	IN	B-PP	O6	h	6	CD	B-NP	Oh	and	h	NN	I-NP	Oand	reached	and	CC	O	Oreached	its	reach	VBD	B-VP	Oits	maximum	its	PRP$	B-NP	Omaximum	at	maximum	NN	I-NP	Oat	12	at	IN	B-PP	O12	h	12	CD	B-NP	Oh	.	h	NN	I-NP	O.	Up-regulation	.	.	O	OUp-regulation	of	Up-regulation	NN	B-NP	Oof	ICAM-1	of	IN	B-PP	OICAM-1	protein	ICAM-1	NN	B-NP	B-proteinprotein	and	protein	NN	I-NP	I-proteinand	mRNA	and	CC	O	OmRNA	was	mRNA	NN	B-NP	B-RNAwas	also	be	VBD	B-VP	Oalso	found	also	RB	I-VP	Ofound	in	find	VBN	I-VP	Oin	IL-1-beta	in	IN	B-PP	OIL-1-beta	and	IL-1-beta	NN	B-NP	B-proteinand	TNF-alpha	and	CC	O	OTNF-alpha	#NAME?	TNF-alpha	NN	B-NP	B-protein#NAME?	mesangial	#NAME?	JJ	I-NP	Omesangial	cells	mesangial	JJ	I-NP	Ocells	.	cell	NNS	I-NP	O.	Neither	.	.	O	ONeither	vascular	Neither	CC	O	Ovascular	adhesion	vascular	JJ	B-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	protein	molecule-1	NN	I-NP	I-proteinprotein	nor	protein	NN	I-NP	I-proteinnor	mRNA	nor	CC	O	OmRNA	expression	mRNA	NN	B-NP	Oexpression	was	expression	NN	I-NP	Owas	","	be	VBD	B-VP	O","	however	","	","	O	Ohowever	","	however	RB	B-ADVP	O","	affected	","	","	O	Oaffected	by	affect	VBN	B-VP	Oby	high	by	IN	B-PP	Ohigh	glucose	high	JJ	B-NP	Oglucose	and	glucose	NN	I-NP	Oand	high	and	CC	O	Ohigh	mannitol	high	JJ	B-NP	Omannitol	.	mannitol	NN	I-NP	O.	Notably	.	.	O	ONotably	","	Notably	RB	B-ADVP	O","	the	","	","	O	Othe	protein	the	DT	B-NP	Oprotein	kinase	protein	NN	I-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	inhibitors	C	NN	I-NP	I-proteininhibitors	calphostin	inhibitor	NNS	I-NP	Ocalphostin	C	calphostin	NN	I-NP	OC	and	C	NN	I-NP	Oand	staurosporine	and	CC	O	Ostaurosporine	reduced	staurosporine	NN	B-NP	Oreduced	high	reduce	VBD	B-VP	Ohigh	glucose-	high	JJ	B-NP	Oglucose-	or	glucose-	NN	I-NP	Oor	high	or	CC	O	Ohigh	mannitol-induced	high	JJ	B-NP	Omannitol-induced	intercellular	mannitol-induced	JJ	I-NP	Ointercellular	adhesion	intercellular	JJ	I-NP	Oadhesion	molecule-1	adhesion	NN	I-NP	Omolecule-1	mRNA	molecule-1	NN	I-NP	OmRNA	expression	mRNA	NN	I-NP	Oexpression	and	expression	NN	I-NP	Oand	high	and	CC	O	Ohigh	glucose-induced	high	JJ	B-NP	Oglucose-induced	proliferation	glucose-induced	JJ	I-NP	Oproliferation	.	proliferation	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	the	","	","	O	Othe	NF-kappa	the	DT	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	inhibitor	B	NN	I-NP	I-proteininhibitor	N-tosyl-L-phenylalanine	inhibitor	NN	I-NP	ON-tosyl-L-phenylalanine	chloromethyl	N-tosyl-L-phenylalanine	NN	I-NP	Ochloromethyl	ketone	chloromethyl	NN	I-NP	Oketone	reduced	ketone	NN	I-NP	Oreduced	high	reduce	VBD	B-VP	Ohigh	glucose-	high	JJ	B-NP	Oglucose-	or	glucose-	NN	I-NP	Oor	high	or	CC	O	Ohigh	mannitol-induced	high	JJ	B-NP	Omannitol-induced	intercellular	mannitol-induced	JJ	I-NP	Ointercellular	adhesion	intercellular	JJ	I-NP	Oadhesion	molecule-1	adhesion	NN	I-NP	Omolecule-1	mRNA	molecule-1	NN	I-NP	OmRNA	expression	mRNA	NN	I-NP	Oexpression	and	expression	NN	I-NP	Oand	high	and	CC	O	Ohigh	glucose-induced	high	JJ	B-NP	Oglucose-induced	proliferation	glucose-induced	JJ	I-NP	Oproliferation	.	proliferation	NN	I-NP	O.	Results	.	.	O	OResults	showed	Result	NNS	B-NP	Oshowed	that	show	VBD	B-VP	Othat	high	that	IN	B-SBAR	Ohigh	glucose	high	JJ	B-NP	Oglucose	(	glucose	NN	I-NP	O(	15	(	(	O	O15	","	15	CD	B-NP	O","	30	","	","	O	O30	mmol/l	30	CD	B-NP	Ommol/l	)	mmol/l	NN	I-NP	O)	or	)	)	O	Oor	high	or	CC	O	Ohigh	concentrations	high	JJ	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	osmotic	of	IN	B-PP	Oosmotic	agents	osmotic	JJ	B-NP	Oagents	remarkably	agent	NNS	I-NP	Oremarkably	increased	remarkably	RB	B-ADVP	Oincreased	the	increase	VBD	B-VP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	adherent	of	IN	B-PP	Oadherent	leukocytes	adherent	JJ	B-NP	B-cell_typeleukocytes	to	leukocyte	NNS	I-NP	I-cell_typeto	mesangial	to	TO	B-PP	Omesangial	cells	mesangial	JJ	B-NP	B-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	p	(	(	O	Op	<	p	NN	B-NP	O<	0.01	<	SYM	O	O0.01	)	0.01	CD	B-NP	O)	compared	)	)	O	Ocompared	with	compare	VBN	B-PP	Owith	control	with	IN	B-PP	Ocontrol	cells	control	JJ	B-NP	B-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	5	(	(	O	O5	mmol/l	5	CD	B-NP	Ommol/l	D-glucose	mmol/l	NN	I-NP	OD-glucose	)	D-glucose	NN	I-NP	O)	.	)	)	O	O.	Functional	.	.	O	OFunctional	blocking	Functional	JJ	B-NP	Oblocking	of	blocking	NN	I-NP	Oof	intercellular	of	IN	B-PP	Ointercellular	adhesion	intercellular	JJ	B-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	on	molecule-1	NN	I-NP	I-proteinon	mesangial	on	IN	B-PP	Omesangial	cells	mesangial	JJ	B-NP	B-cell_typecells	with	cell	NNS	I-NP	I-cell_typewith	rat	with	IN	B-PP	Orat	intercellular	rat	NN	B-NP	B-proteinintercellular	adhesion	intercellular	JJ	I-NP	I-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	monoclonal	molecule-1	NN	I-NP	I-proteinmonoclonal	antibody	monoclonal	JJ	I-NP	I-proteinantibody	","	antibody	NN	I-NP	I-protein","	calphostin	","	","	O	Ocalphostin	C	calphostin	NN	B-NP	OC	","	C	NN	I-NP	O","	staurosporine	","	","	O	Ostaurosporine	","	staurosporine	NN	B-NP	O","	or	","	","	O	Oor	N-tosyl-L-phenylalanine	or	CC	O	ON-tosyl-L-phenylalanine	chloromethyl	N-tosyl-L-phenylalanine	NN	B-NP	Ochloromethyl	ketone	chloromethyl	NN	I-NP	Oketone	significantly	ketone	NN	I-NP	Osignificantly	inhibited	significantly	RB	B-ADVP	Oinhibited	high	inhibit	VBD	B-VP	Ohigh	glucose-	high	JJ	B-NP	Oglucose-	or	glucose-	NN	I-NP	Oor	high	or	CC	O	Ohigh	mannitol-induced	high	JJ	B-NP	Omannitol-induced	increase	mannitol-induced	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	leukocyte	in	IN	B-PP	Oleukocyte	adhesion	leukocyte	NN	B-NP	Oadhesion	(	adhesion	NN	I-NP	O(	p	(	(	O	Op	<	p	NN	B-NP	O<	<	<	SYM	O	O<	0.05	<	SYM	O	O0.05	)	0.05	CD	B-NP	O)	.	)	)	O	O.	CONCLUSION/INTERPRETATION	.	.	O	OCONCLUSION/INTERPRETATION	:	CONCLUSION/INTERPRETATION	NN	B-NP	O:	These	:	:	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	high	that	IN	B-SBAR	Ohigh	glucose	high	JJ	B-NP	Oglucose	can	glucose	NN	I-NP	Ocan	upregulate	can	MD	B-VP	Oupregulate	intercellular	upregulate	VB	I-VP	Ointercellular	adhesion	intercellular	JJ	B-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	protein	molecule-1	NN	I-NP	I-proteinprotein	and	protein	NN	I-NP	I-proteinand	mRNA	and	CC	O	OmRNA	expression	mRNA	NN	B-NP	B-RNAexpression	but	expression	NN	I-NP	Obut	not	but	CC	B-PP	Onot	vascular	not	RB	B-NP	Ovascular	adhesion	vascular	JJ	I-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	expression	molecule-1	NN	I-NP	I-proteinexpression	in	expression	NN	I-NP	Oin	mesangial	in	IN	B-PP	Omesangial	cells	mesangial	JJ	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	promote	and	CC	O	Opromote	leukocyte	promote	VB	B-VP	Oleukocyte	adhesion	leukocyte	NN	B-NP	Oadhesion	through	adhesion	NN	I-NP	Othrough	up-regulation	through	IN	B-PP	Oup-regulation	of	up-regulation	NN	B-NP	Oof	intercellular	of	IN	B-PP	Ointercellular	adhesion	intercellular	JJ	B-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	through	molecule-1	NN	I-NP	I-proteinthrough	osmotic	through	IN	B-PP	Oosmotic	effect	osmotic	JJ	B-NP	Oeffect	","	effect	NN	I-NP	O","	possibly	","	","	O	Opossibly	depending	possibly	RB	B-ADVP	Odepending	on	depend	VBG	B-PP	Oon	the	on	IN	B-PP	Othe	protein	the	DT	B-NP	Oprotein	kinase	protein	NN	I-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	nuclear	C	NN	I-NP	I-proteinnuclear	factor-kappa	nuclear	JJ	I-NP	Ofactor-kappa	B	factor-kappa	NN	I-NP	OB	(	B	NN	I-NP	O(	PKC	(	(	O	OPKC	-	PKC	NN	B-NP	B-protein-	NF-kappa	-	HYPH	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	)	B	NN	I-NP	I-protein)	pathway	)	)	O	Opathway	.	pathway	NN	B-NP	O.	High	.	.	O	OHigh	glucose	High	JJ	B-NP	Oglucose	itself	glucose	NN	I-NP	Oitself	can	itself	PRP	B-NP	Ocan	also	can	MD	B-VP	Oalso	promote	also	RB	I-VP	Opromote	mesangial	promote	VB	I-VP	Omesangial	cell	mesangial	JJ	B-NP	Ocell	proliferation	cell	NN	I-NP	Oproliferation	through	proliferation	NN	I-NP	Othrough	the	through	IN	B-PP	Othe	PKC-NF-kappa	the	DT	B-NP	OPKC-NF-kappa	B	PKC-NF-kappa	NN	I-NP	OB	pathways	B	NN	I-NP	Opathways	.	pathway	NNS	I-NP	O.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	hyperglycaemia	that	IN	B-SBAR	Ohyperglycaemia	in	hyperglycaemia	NN	B-NP	Oin	itself	in	IN	B-PP	Oitself	seems	itself	PRP	B-NP	Oseems	to	seem	VBZ	B-VP	Oto	be	to	TO	I-VP	Obe	an	be	VB	I-VP	Oan	important	an	DT	B-NP	Oimportant	factor	important	JJ	I-NP	Ofactor	in	factor	NN	I-NP	Oin	the	in	IN	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	early	of	IN	B-PP	Oearly	diabetic	early	JJ	B-NP	Odiabetic	nephropathy	diabetic	JJ	I-NP	Onephropathy	.	nephropathy	NN	I-NP	O.	Combined	.	.	O	OCombined	corticosteroid/	Combine	VBN	B-NP	Ocorticosteroid/	granulocyte	corticosteroid/	NN	I-NP	Ogranulocyte	colony-stimulating	granulocyte	NN	I-NP	Ocolony-stimulating	factor	colony-stimulating	JJ	I-NP	Ofactor	(	factor	NN	I-NP	O(	G-CSF	(	(	O	OG-CSF	)	G-CSF	NN	B-NP	B-protein)	therapy	)	)	O	Otherapy	in	therapy	NN	B-NP	Oin	the	in	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	of	treatment	NN	I-NP	Oof	severe	of	IN	B-PP	Osevere	congenital	severe	JJ	B-NP	Ocongenital	neutropenia	congenital	JJ	I-NP	Oneutropenia	unresponsive	neutropenia	NN	I-NP	Ounresponsive	to	unresponsive	JJ	B-ADJP	Oto	G-CSF	to	TO	B-PP	OG-CSF	:	G-CSF	NN	B-NP	B-protein:	Activated	:	:	O	OActivated	glucocorticoid	Activate	VBN	B-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	synergize	receptor	NNS	I-NP	I-proteinsynergize	with	synergize	VBP	B-VP	Owith	G-CSF	with	IN	B-PP	OG-CSF	signals	G-CSF	NN	B-NP	B-proteinsignals	.	signal	NNS	I-NP	O.	More	.	.	O	OMore	than	More	JJR	B-NP	Othan	90	than	IN	I-NP	O90	%	90	CD	I-NP	O%	of	%	NN	I-NP	Oof	patients	of	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	severe	with	IN	B-PP	Osevere	congenital	severe	JJ	B-NP	Ocongenital	neutropenia	congenital	JJ	I-NP	Oneutropenia	(	neutropenia	NN	I-NP	O(	SCN	(	(	O	OSCN	)	SCN	NN	B-NP	B-protein)	respond	)	)	O	Orespond	to	respond	VBP	B-VP	Oto	granulocyte	to	TO	I-VP	Ogranulocyte	colony-stimulating	granulocyte	VB	I-VP	Ocolony-stimulating	factor	colony-stimulating	JJ	B-NP	Ofactor	(	factor	NN	I-NP	O(	G-CSF	(	(	O	OG-CSF	)	G-CSF	NN	B-NP	B-protein)	therapy	)	)	O	Otherapy	.	therapy	NN	B-NP	O.	The	.	.	O	OThe	basis	The	DT	B-NP	Obasis	for	basis	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	refractory	the	DT	B-NP	Orefractory	state	refractory	JJ	I-NP	Ostate	in	state	NN	I-NP	Oin	the	in	IN	B-PP	Othe	remaining	the	DT	B-NP	Oremaining	patients	remain	VBG	I-NP	Opatients	is	patient	NNS	I-NP	Ois	unknown	be	VBZ	B-VP	Ounknown	.	unknown	JJ	B-ADJP	O.	To	.	.	O	OTo	address	To	TO	B-VP	Oaddress	this	address	VB	I-VP	Othis	issue	this	DT	B-NP	Oissue	","	issue	NN	I-NP	O","	we	","	","	O	Owe	studied	we	PRP	B-NP	Ostudied	a	study	VBD	B-VP	Oa	child	a	DT	B-NP	Ochild	with	child	NN	I-NP	Owith	SCN	with	IN	B-PP	OSCN	who	SCN	NN	B-NP	B-proteinwho	was	who	WP	B-NP	Owas	totally	be	VBD	B-VP	Ototally	unresponsive	totally	RB	B-ADJP	Ounresponsive	to	unresponsive	JJ	I-ADJP	Oto	G-CSF	to	TO	B-PP	OG-CSF	and	G-CSF	NN	B-NP	B-proteinand	had	and	CC	O	Ohad	a	have	VBD	B-VP	Oa	novel	a	DT	B-NP	Onovel	point	novel	JJ	I-NP	Opoint	mutation	point	NN	I-NP	Omutation	in	mutation	NN	I-NP	Oin	the	in	IN	B-PP	Othe	extracellular	the	DT	B-NP	Oextracellular	domain	extracellular	JJ	I-NP	B-proteindomain	of	domain	NN	I-NP	I-proteinof	the	of	IN	B-PP	Othe	G-CSF	the	DT	B-NP	OG-CSF	receptor	G-CSF	NN	I-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	GCSF-R	(	(	O	OGCSF-R	)	GCSF-R	NN	B-NP	B-protein)	.	)	)	O	O.	Marrow	.	.	O	OMarrow	stromal	Marrow	JJ	B-NP	Ostromal	support	stromal	JJ	I-NP	Osupport	of	support	NN	I-NP	Oof	granulopoiesis	of	IN	B-PP	Ogranulopoiesis	was	granulopoiesis	NN	B-NP	Owas	evaluated	be	VBD	B-VP	Oevaluated	by	evaluate	VBN	I-VP	Oby	plating	by	IN	B-PP	Oplating	CD34	plat	VBG	B-VP	OCD34	(	CD34	NN	B-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	cells	)	)	O	I-cell_typecells	on	cell	NNS	B-NP	I-cell_typeon	preformed	on	IN	B-PP	Opreformed	stromal	preformed	JJ	B-NP	Ostromal	layers	stromal	JJ	I-NP	Olayers	.	layer	NNS	I-NP	O.	Nonadherent	.	.	O	ONonadherent	cells	Nonadherent	JJ	B-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	harvested	be	VBD	B-VP	Oharvested	and	harvest	VBN	I-VP	Oand	assayed	and	CC	O	Oassayed	in	assay	VBN	B-VP	Oin	clonogenic	in	IN	B-PP	Oclonogenic	assays	clonogenic	JJ	B-NP	Oassays	for	assay	NNS	I-NP	Ofor	granulocytic	for	IN	B-PP	Ogranulocytic	colony	granulocytic	JJ	B-NP	Ocolony	production	colony	NN	I-NP	Oproduction	.	production	NN	I-NP	O.	The	.	.	O	OThe	in	The	DT	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	effect	vitro	FW	I-NP	Oeffect	of	effect	NN	I-NP	Oof	G-CSF	of	IN	B-PP	OG-CSF	and	G-CSF	NN	B-NP	B-proteinand	corticosteroids	and	CC	I-NP	Ocorticosteroids	on	corticosteroid	NNS	I-NP	Oon	granulopoiesis	on	IN	B-PP	Ogranulopoiesis	was	granulopoiesis	NN	B-NP	Owas	evaluated	be	VBD	B-VP	Oevaluated	in	evaluate	VBN	I-VP	Oin	clonogenic	in	IN	B-PP	Oclonogenic	assays	clonogenic	JJ	B-NP	Oassays	of	assay	NNS	I-NP	Oof	marrow	of	IN	B-PP	Omarrow	mononuclear	marrow	NN	B-NP	B-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	by	","	","	O	Oby	proliferation	by	IN	B-PP	Oproliferation	studies	proliferation	NN	B-NP	Ostudies	of	study	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	murine	the	DT	B-NP	Omurine	myeloid	murine	JJ	I-NP	B-cell_linemyeloid	cell	myeloid	JJ	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	32D	line	NN	I-NP	I-cell_line32D	expressing	32D	NN	I-NP	Oexpressing	the	express	VBG	B-VP	Othe	patient	the	DT	B-NP	Opatient	's	patient	NN	I-NP	O's	mutated	's	POS	B-NP	Omutated	G-CSFR	mutate	VBN	I-NP	OG-CSFR	","	G-CSFR	NN	I-NP	B-protein","	and	","	","	B-PP	Oand	by	and	CC	I-PP	Oby	measuring	by	IN	B-PP	Omeasuring	STAT5	measure	VBG	B-VP	OSTAT5	activation	STAT5	NN	B-NP	B-proteinactivation	in	activation	NN	I-NP	Oin	nuclear	in	IN	B-PP	Onuclear	extracts	nuclear	JJ	B-NP	Oextracts	from	extract	NNS	I-NP	Ofrom	stimulated	from	IN	B-PP	Ostimulated	cells	stimulate	VBN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Patient	.	.	O	OPatient	's	Patient	NN	B-NP	O's	stroma	's	POS	B-NP	Ostroma	supported	stroma	NN	I-NP	Osupported	granulopoiesis	support	VBD	B-VP	Ogranulopoiesis	derived	granulopoiesis	NN	B-NP	Oderived	from	derive	VBN	B-VP	Ofrom	control	from	IN	B-PP	Ocontrol	marrow	control	NN	B-NP	B-cell_linemarrow	CD34	marrow	NN	I-NP	I-cell_lineCD34	(	CD34	NN	I-NP	I-cell_line(	+	(	(	O	I-cell_line+	)	+	SYM	O	I-cell_line)	cells	)	)	O	I-cell_linecells	in	cell	NNS	B-NP	I-cell_linein	a	in	IN	B-PP	Oa	normal	a	DT	B-NP	Onormal	manner	normal	JJ	I-NP	Omanner	.	manner	NN	I-NP	O.	Normal	.	.	O	ONormal	stroma	Normal	JJ	B-NP	Ostroma	","	stroma	NN	I-NP	O","	however	","	","	O	Ohowever	","	however	RB	B-ADVP	O","	failed	","	","	O	Ofailed	to	fail	VBD	B-VP	Oto	induce	to	TO	I-VP	Oinduce	granulopoiesis	induce	VB	I-VP	Ogranulopoiesis	from	granulopoiesis	NN	B-NP	Ofrom	patient	from	IN	B-PP	Opatient	's	patient	NN	B-NP	O's	CD34	's	POS	B-NP	OCD34	(	CD34	NN	I-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	cells	)	)	O	I-cell_typecells	.	cell	NNS	B-NP	I-cell_type.	Clonogenic	.	.	O	OClonogenic	assays	Clonogenic	JJ	B-NP	Oassays	of	assay	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	patient	the	DT	B-NP	Opatient	's	patient	NN	I-NP	O's	marrow	's	POS	B-NP	Omarrow	mononuclear	marrow	NN	I-NP	B-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	incorporating	cell	NNS	I-NP	I-cell_typeincorporating	either	incorporate	VBG	B-VP	Oeither	G-CSF	either	CC	O	OG-CSF	or	G-CSF	NN	B-NP	B-proteinor	hydrocortisone	or	CC	I-NP	Ohydrocortisone	produced	hydrocortisone	NN	I-NP	Oproduced	little	produce	VBD	B-VP	Olittle	neutrophil	little	JJ	B-NP	Oneutrophil	growth	neutrophil	NN	I-NP	Ogrowth	.	growth	NN	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	inclusion	","	","	O	Oinclusion	of	inclusion	NN	B-NP	Oof	both	of	IN	B-PP	Oboth	G-CSF	both	CC	O	OG-CSF	and	G-CSF	NN	B-NP	B-proteinand	hydrocortisone	and	CC	I-NP	Ohydrocortisone	in	hydrocortisone	NN	I-NP	Oin	the	in	IN	B-PP	Othe	cytokine	the	DT	B-NP	Ocytokine	``	cytokine	NN	I-NP	B-protein``	cocktail	``	``	I-NP	Ococktail	''	cocktail	NN	I-NP	O''	markedly	''	''	O	Omarkedly	increased	markedly	RB	B-ADVP	Oincreased	the	increase	VBD	B-VP	Othe	neutrophil	the	DT	B-NP	Oneutrophil	numbers	neutrophil	NN	I-NP	B-cell_typenumbers	.	number	NNS	I-NP	O.	Proliferation	.	.	O	OProliferation	of	Proliferation	NN	B-NP	Oof	32D	of	IN	B-PP	O32D	cells	32D	NN	B-NP	B-cell_linecells	expressing	cell	NNS	I-NP	I-cell_lineexpressing	the	express	VBG	B-VP	Othe	mutated	the	DT	B-NP	Omutated	receptor	mutate	VBN	I-NP	Oreceptor	and	receptor	NN	I-NP	Oand	STAT5	and	CC	I-NP	OSTAT5	activation	STAT5	NN	I-NP	B-proteinactivation	were	activation	NN	I-NP	Owere	improved	be	VBD	B-VP	Oimproved	by	improve	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	combination	a	DT	B-NP	Ocombination	of	combination	NN	I-NP	Oof	G-CSF	of	IN	B-PP	OG-CSF	and	G-CSF	NN	B-NP	B-proteinand	dexamethasone	and	CC	I-NP	Odexamethasone	.	dexamethasone	NN	I-NP	O.	When	.	.	O	OWhen	small	When	WRB	B-ADVP	Osmall	daily	small	JJ	B-NP	Odaily	doses	daily	JJ	I-NP	Odoses	of	dose	NNS	I-NP	Oof	oral	of	IN	B-PP	Ooral	prednisone	oral	JJ	B-NP	Oprednisone	were	prednisone	NN	I-NP	Owere	then	be	VBD	B-VP	Othen	administered	then	RB	I-VP	Oadministered	to	administer	VBN	I-VP	Oto	the	to	TO	B-PP	Othe	patient	the	DT	B-NP	Opatient	with	patient	NN	I-NP	Owith	conventional	with	IN	B-PP	Oconventional	doses	conventional	JJ	B-NP	Odoses	of	dose	NNS	I-NP	Oof	subcutaneous	of	IN	B-PP	Osubcutaneous	G-CSF	subcutaneous	JJ	B-NP	OG-CSF	","	G-CSF	NN	I-NP	B-protein","	the	","	","	O	Othe	patient	the	DT	B-NP	Opatient	responded	patient	NN	I-NP	Oresponded	with	respond	VBD	B-VP	Owith	increased	with	IN	B-PP	Oincreased	neutrophil	increase	VBN	B-NP	Oneutrophil	numbers	neutrophil	NN	I-NP	Onumbers	and	number	NNS	I-NP	Oand	with	and	CC	B-PP	Owith	a	with	IN	B-PP	Oa	complete	a	DT	B-NP	Ocomplete	reversal	complete	JJ	I-NP	Oreversal	of	reversal	NN	I-NP	Oof	the	of	IN	B-PP	Othe	infectious	the	DT	B-NP	Oinfectious	problems	infectious	JJ	I-NP	Oproblems	.	problem	NNS	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	provide	datum	NNS	I-NP	Oprovide	insight	provide	VBP	B-VP	Oinsight	into	insight	NN	B-NP	Ointo	SCN	into	IN	B-PP	OSCN	unresponsive	SCN	NN	B-NP	Ounresponsive	to	unresponsive	JJ	B-ADJP	Oto	standard	to	TO	B-PP	Ostandard	G-CSF	standard	JJ	B-NP	OG-CSF	treatment	G-CSF	NN	I-NP	B-proteintreatment	and	treatment	NN	I-NP	Oand	to	and	CC	B-PP	Oto	the	to	TO	B-PP	Othe	potential	the	DT	B-NP	Opotential	corrective	potential	JJ	I-NP	Ocorrective	action	corrective	JJ	I-NP	Oaction	of	action	NN	I-NP	Oof	combined	of	IN	B-PP	Ocombined	treatment	combined	JJ	B-NP	Otreatment	with	treatment	NN	I-NP	Owith	G-CSF	with	IN	B-PP	OG-CSF	and	G-CSF	NN	B-NP	B-proteinand	corticosteroids	and	CC	I-NP	Ocorticosteroids	through	corticosteroid	NNS	I-NP	Othrough	synergistic	through	IN	B-PP	Osynergistic	activation	synergistic	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	STAT5	of	IN	B-PP	OSTAT5	.	STAT5	NN	B-NP	B-protein.	Human	.	.	O	OHuman	renal	Human	JJ	B-NP	B-cell_typerenal	mesangial	renal	JJ	I-NP	I-cell_typemesangial	cells	mesangial	JJ	I-NP	I-cell_typecells	are	cell	NNS	I-NP	I-cell_typeare	a	be	VBP	B-VP	Oa	target	a	DT	B-NP	Otarget	for	target	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	anti-inflammatory	the	DT	B-NP	Oanti-inflammatory	action	anti-inflammatory	JJ	I-NP	Oaction	of	action	NN	I-NP	Oof	9-cis	of	IN	B-PP	O9-cis	retinoic	9-cis	JJ	B-NP	Oretinoic	acid	retinoic	JJ	I-NP	Oacid	.	acid	NN	I-NP	O.	Mesangial	.	.	O	OMesangial	cells	Mesangial	JJ	B-NP	B-cell_typecells	play	cell	NNS	I-NP	I-cell_typeplay	an	play	VBP	B-VP	Oan	active	an	DT	B-NP	Oactive	role	active	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	inflammatory	the	DT	B-NP	Oinflammatory	response	inflammatory	JJ	I-NP	Oresponse	to	response	NN	I-NP	Oto	glomerular	to	TO	B-PP	Oglomerular	injury	glomerular	JJ	B-NP	Oinjury	.	injury	NN	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	studied	have	VBP	B-VP	Ostudied	in	study	VBN	I-VP	Oin	cultured	in	IN	B-PP	Ocultured	human	culture	VBN	B-NP	B-cell_linehuman	mesangial	human	JJ	I-NP	I-cell_linemesangial	cells	mesangial	JJ	I-NP	I-cell_linecells	(	cell	NNS	I-NP	I-cell_line(	CHMC	(	(	O	OCHMC	)	CHMC	NN	B-NP	B-cell_type)	several	)	)	O	Oseveral	effects	several	JJ	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	9-cis	of	IN	B-PP	O9-cis	retinoic	9-cis	JJ	B-NP	Oretinoic	acid	retinoic	JJ	I-NP	Oacid	(	acid	NN	I-NP	O(	9-cRA	(	(	O	O9-cRA	)	9-cRA	NN	B-NP	O)	","	)	)	O	O","	an	","	","	O	Oan	activator	an	DT	B-NP	Oactivator	of	activator	NN	I-NP	Oof	both	of	IN	B-PP	Oboth	retinoic	both	CC	O	Oretinoic	acid	retinoic	JJ	B-NP	B-proteinacid	receptors	acid	NN	I-NP	I-proteinreceptors	(	receptor	NNS	I-NP	I-protein(	RARs	(	(	O	ORARs	)	RAR	NNS	B-NP	B-protein)	and	)	)	O	Oand	retinoid	and	CC	O	Oretinoid	X	retinoid	NN	B-NP	B-proteinX	receptors	X	NN	I-NP	I-proteinreceptors	(	receptor	NNS	I-NP	I-protein(	RXRs	(	(	O	ORXRs	)	RXR	NNS	B-NP	B-protein)	.	)	)	O	O.	9-cRA	.	.	O	O9-cRA	inhibited	9-cRA	NN	B-NP	Oinhibited	foetal	inhibit	VBD	B-VP	Ofoetal	calf	foetal	JJ	B-NP	Ocalf	serum-induced	calf	NN	I-NP	Oserum-induced	CHMC	serum-induced	JJ	I-NP	OCHMC	proliferation	CHMC	NN	I-NP	Oproliferation	.	proliferation	NN	I-NP	O.	It	.	.	O	OIt	also	It	PRP	B-NP	Oalso	prevented	also	RB	B-ADVP	Oprevented	CHMC	prevent	VBD	B-VP	OCHMC	death	CHMC	NN	B-NP	Odeath	induced	death	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	inflammatory	the	DT	B-NP	Oinflammatory	mediator	inflammatory	JJ	I-NP	Omediator	H	mediator	NN	I-NP	OH	(	H	NN	I-NP	O(	2	(	(	O	O2	)	2	CD	B-NP	O)	O	)	)	O	OO	(	O	NN	B-NP	O(	2	(	(	O	O2	)	2	CD	B-NP	O)	.	)	)	O	O.	This	.	.	O	OThis	preventive	This	DT	B-NP	Opreventive	effect	preventive	JJ	I-NP	Oeffect	was	effect	NN	I-NP	Owas	not	be	VBD	B-VP	Onot	due	not	RB	O	Odue	to	due	JJ	B-ADJP	Oto	any	to	TO	B-PP	Oany	increase	any	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	H	in	IN	B-PP	OH	(	H	NN	B-NP	B-protein(	2	(	(	O	I-protein2	)	2	CD	B-NP	I-protein)	O	)	)	O	I-proteinO	(	O	NN	B-NP	I-protein(	2	(	(	O	O2	)	2	CD	B-NP	O)	catabolism	)	)	O	Ocatabolism	and	catabolism	NN	B-NP	Oand	it	and	CC	O	Oit	persisted	it	PRP	B-NP	Opersisted	even	persist	VBD	B-VP	Oeven	when	even	RB	B-ADVP	Owhen	both	when	WRB	I-ADVP	Oboth	catalase	both	CC	O	Ocatalase	and	catalase	NN	B-NP	B-proteinand	glutathione	and	CC	O	Oglutathione	synthesis	glutathione	NN	B-NP	Osynthesis	were	synthesis	NN	I-NP	Owere	inhibited	be	VBD	B-VP	Oinhibited	.	inhibit	VBN	I-VP	O.	Finally	.	.	O	OFinally	","	Finally	RB	B-ADVP	O","	9-cRA	","	","	O	O9-cRA	diminished	9-cRA	NN	B-NP	Odiminished	monocyte	diminish	VBD	B-VP	Omonocyte	adhesion	monocyte	NN	B-NP	Oadhesion	to	adhesion	NN	I-NP	Oto	FCS-stimulated	to	TO	B-PP	OFCS-stimulated	CHMC	FCS-stimulated	JJ	B-NP	B-cell_typeCHMC	.	CHMC	NN	I-NP	I-cell_type.	Interestingly	.	.	O	OInterestingly	","	Interestingly	RB	B-ADVP	O","	the	","	","	O	Othe	retinoid	the	DT	B-NP	Oretinoid	also	retinoid	NN	I-NP	Oalso	inhibited	also	RB	B-ADVP	Oinhibited	in	inhibit	VBD	B-VP	Oin	FCS-stimulated	in	IN	B-PP	OFCS-stimulated	cells	FCS-stimulated	JJ	B-NP	B-cell_linecells	the	cell	NNS	I-NP	I-cell_linethe	protein	the	DT	B-NP	Oprotein	expression	protein	NN	I-NP	Oexpression	of	expression	NN	I-NP	Oof	two	of	IN	B-PP	Otwo	mesangial	two	CD	B-NP	Omesangial	adhesion	mesangial	JJ	I-NP	B-proteinadhesion	molecules	adhesion	NN	I-NP	I-proteinmolecules	","	molecule	NNS	I-NP	I-protein","	fibronectin	","	","	O	Ofibronectin	and	fibronectin	NN	B-NP	B-proteinand	osteopontin	and	CC	I-NP	Oosteopontin	","	osteopontin	NN	I-NP	B-protein","	but	","	","	O	Obut	it	but	CC	O	Oit	did	it	PRP	B-NP	Odid	not	do	VBD	B-VP	Onot	modify	not	RB	I-VP	Omodify	the	modify	VB	I-VP	Othe	protein	the	DT	B-NP	Oprotein	expression	protein	NN	I-NP	Oexpression	of	expression	NN	I-NP	Oof	intercellular	of	IN	B-PP	Ointercellular	adhesion	intercellular	JJ	B-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	and	molecule-1	NN	I-NP	I-proteinand	vascular	and	CC	O	Ovascular	adhesion	vascular	JJ	B-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	.	molecule-1	NN	I-NP	I-protein.	All	.	.	O	OAll	major	All	DT	B-NP	Omajor	RARs	major	JJ	I-NP	ORARs	and	RAR	NNS	I-NP	B-proteinand	RXRs	and	CC	I-NP	ORXRs	isotypes	RXR	NNS	I-NP	B-proteinisotypes	were	isotype	NNS	I-NP	I-proteinwere	expressed	be	VBD	B-VP	Oexpressed	in	express	VBN	I-VP	Oin	CHMC	in	IN	B-PP	OCHMC	regardless	CHMC	NN	B-NP	B-cell_typeregardless	of	regardless	RB	B-ADVP	Oof	the	of	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	or	presence	NN	I-NP	Oor	absence	or	CC	I-NP	Oabsence	of	absence	NN	I-NP	Oof	9-cRA	of	IN	B-PP	O9-cRA	.	9-cRA	NN	B-NP	O.	Transcripts	.	.	O	OTranscripts	to	Transcript	NNS	B-NP	Oto	RAR-alpha	to	TO	B-PP	ORAR-alpha	","	RAR-alpha	NN	B-NP	B-protein","	RAR-beta	","	","	I-NP	ORAR-beta	and	RAR-beta	NN	I-NP	B-proteinand	RXR-alpha	and	CC	I-NP	ORXR-alpha	increased	RXR-alpha	NN	I-NP	B-proteinincreased	after	increase	VBD	B-VP	Oafter	incubation	after	IN	B-PP	Oincubation	with	incubation	NN	B-NP	Owith	9-cRA	with	IN	B-PP	O9-cRA	whereas	9-cRA	NN	B-NP	Owhereas	RXR-gamma	whereas	IN	B-PP	ORXR-gamma	was	RXR-gamma	NN	B-NP	B-proteinwas	inhibited	be	VBD	B-VP	Oinhibited	","	inhibit	VBN	I-VP	O","	suggesting	","	","	O	Osuggesting	a	suggest	VBG	B-VP	Oa	major	a	DT	B-NP	Omajor	role	major	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	RARs	for	IN	B-PP	ORARs	and	RAR	NNS	B-NP	B-proteinand	RXRs	and	CC	I-NP	ORXRs	in	RXR	NNS	I-NP	B-proteinin	9-cRA-anti-inflammatory	in	IN	B-PP	O9-cRA-anti-inflammatory	effects	9-cRA-anti-inflammatory	JJ	B-NP	Oeffects	.	effect	NNS	I-NP	O.	9-cRA	.	.	O	O9-cRA	was	9-cRA	NN	B-NP	Owas	toxic	be	VBD	B-VP	Otoxic	only	toxic	JJ	B-ADJP	Oonly	at	only	RB	B-ADVP	Oat	50	at	IN	B-PP	O50	microM	50	CD	B-NP	OmicroM	(	microM	NN	I-NP	O(	a	(	(	O	Oa	concentration	a	DT	B-NP	Oconcentration	50	concentration	NN	I-NP	O50	-	50	CD	I-NP	O-	5000	-	HYPH	I-NP	O5000	times	5000	CD	I-NP	Otimes	higher	time	NNS	I-ADJP	Ohigher	than	high	JJR	I-ADJP	Othan	required	than	IN	B-PP	Orequired	for	require	VBN	B-VP	Ofor	the	for	IN	B-PP	Othe	effects	the	DT	B-NP	Oeffects	above	effect	NNS	I-NP	Oabove	)	above	IN	B-PP	O)	.	)	)	O	O.	Cell	.	.	O	OCell	death	Cell	NN	B-NP	Odeath	occurred	death	NN	I-NP	Ooccurred	by	occur	VBD	B-VP	Oby	apoptosis	by	IN	B-PP	Oapoptosis	","	apoptosis	NN	B-NP	O","	whose	","	","	O	Owhose	onset	whose	WP$	B-NP	Oonset	was	onset	NN	I-NP	Owas	associated	be	VBD	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	a	with	IN	B-PP	Oa	pronounced	a	DT	B-NP	Opronounced	increase	pronounced	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	catalase	in	IN	B-PP	Ocatalase	activity	catalase	NN	B-NP	B-proteinactivity	and	activity	NN	I-NP	Oand	reduced	and	CC	O	Oreduced	glutathione	reduce	VBN	B-NP	Oglutathione	content	glutathione	NN	I-NP	Ocontent	","	content	NN	I-NP	O","	being	","	","	O	Obeing	more	be	VBG	B-VP	Omore	effectively	more	RBR	I-VP	Oeffectively	induced	effectively	RB	I-VP	Oinduced	by	induce	VBN	I-VP	Oby	all-trans	by	IN	B-PP	Oall-trans	retinoic	all-trans	JJ	B-NP	Oretinoic	acid	retinoic	JJ	I-NP	Oacid	.	acid	NN	I-NP	O.	Modulation	.	.	O	OModulation	of	Modulation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	oxidant/antioxidant	the	DT	B-NP	Ooxidant/antioxidant	balance	oxidant/antioxidant	JJ	I-NP	Obalance	failed	balance	NN	I-NP	Ofailed	to	fail	VBD	B-VP	Oto	inhibit	to	TO	I-VP	Oinhibit	apoptosis	inhibit	VB	I-VP	Oapoptosis	.	apoptosis	NN	B-NP	O.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	mesangial	that	IN	B-SBAR	Omesangial	cells	mesangial	JJ	B-NP	B-cell_typecells	might	cell	NNS	I-NP	I-cell_typemight	be	might	MD	B-VP	Obe	a	be	VB	I-VP	Oa	target	a	DT	B-NP	Otarget	for	target	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	of	treatment	NN	I-NP	Oof	inflammatory	of	IN	B-PP	Oinflammatory	glomerulopathies	inflammatory	JJ	B-NP	Oglomerulopathies	with	glomerulopathy	NNS	I-NP	Owith	9-cRA	with	IN	B-PP	O9-cRA	.	9-cRA	NN	B-NP	O.	Expression	.	.	O	OExpression	of	Expression	NN	B-NP	Oof	mammalian	of	IN	B-PP	Omammalian	defensin	mammalian	JJ	B-NP	B-DNAdefensin	genes	defensin	NN	I-NP	I-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Antimicrobial	.	.	O	OAntimicrobial	peptides	Antimicrobial	JJ	B-NP	Opeptides	are	peptide	NNS	I-NP	Oare	a	be	VBP	B-VP	Oa	prevalent	a	DT	B-NP	Oprevalent	mechanism	prevalent	JJ	I-NP	Omechanism	of	mechanism	NN	I-NP	Oof	host	of	IN	B-PP	Ohost	defense	host	NN	B-NP	Odefense	found	defense	NN	I-NP	Ofound	throughout	find	VBN	B-VP	Othroughout	nature	throughout	IN	B-PP	Onature	.	nature	NN	B-NP	O.	In	.	.	O	OIn	mammals	In	IN	B-PP	Omammals	","	mammal	NNS	B-NP	O","	defensins	","	","	O	Odefensins	are	defensin	NNS	B-NP	B-proteinare	among	be	VBP	B-VP	Oamong	the	among	IN	B-PP	Othe	most	the	DT	B-NP	Omost	abundant	most	RBS	I-NP	Oabundant	of	abundant	JJ	I-NP	Oof	these	of	IN	B-PP	Othese	broad-spectrum	these	DT	B-NP	Obroad-spectrum	antibiotics	broad-spectrum	JJ	I-NP	Oantibiotics	","	antibiotic	NNS	I-NP	O","	and	","	","	O	Oand	are	and	CC	O	Oare	expressed	be	VBP	B-VP	Oexpressed	in	express	VBN	I-VP	Oin	epithelial	in	IN	B-PP	Oepithelial	and	epithelial	JJ	B-NP	B-cell_typeand	hematopoietic	and	CC	I-NP	I-cell_typehematopoietic	cells	hematopoietic	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	defensin	The	DT	B-NP	Odefensin	peptides	defensin	NN	I-NP	Opeptides	are	peptide	NNS	I-NP	Oare	especially	be	VBP	B-VP	Oespecially	abundant	especially	RB	B-ADJP	Oabundant	in	abundant	JJ	I-ADJP	Oin	neutrophils	in	IN	B-PP	Oneutrophils	;	neutrophil	NNS	B-NP	B-cell_type;	however	;	:	O	Ohowever	","	however	RB	B-ADVP	O","	gene	","	","	O	Ogene	expression	gene	NN	B-NP	Oexpression	is	expression	NN	I-NP	Ois	limited	be	VBZ	B-VP	Olimited	to	limit	VBN	I-VP	Oto	the	to	TO	B-PP	Othe	promyelocyte	the	DT	B-NP	Opromyelocyte	stage	promyelocyte	JJ	I-NP	B-cell_typestage	.	stage	NN	I-NP	I-cell_type.	In	.	.	O	OIn	epithelial	In	IN	B-PP	Oepithelial	cells	epithelial	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	defensin	","	","	O	Odefensin	genes	defensin	NN	B-NP	B-DNAgenes	are	gene	NNS	I-NP	I-DNAare	found	be	VBP	B-VP	Ofound	as	find	VBN	I-VP	Oas	both	as	IN	B-PP	Oboth	constitutively	both	DT	B-NP	Oconstitutively	expressed	constitutively	RB	I-NP	Oexpressed	and	express	VBN	I-NP	Oand	inducible	and	CC	I-NP	Oinducible	.	inducible	JJ	I-NP	O.	Induction	.	.	O	OInduction	has	Induction	NN	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	observed	be	VBN	I-VP	Oobserved	in	observe	VBN	I-VP	Oin	vitro	in	FW	B-ADVP	Ovitro	by	vitro	FW	I-ADVP	Oby	stimulation	by	IN	B-PP	Ostimulation	with	stimulation	NN	B-NP	Owith	bacterial	with	IN	B-PP	Obacterial	lipopolysaccharide	bacterial	JJ	B-NP	Olipopolysaccharide	as	lipopolysaccharide	NN	I-NP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	inflammatory	as	IN	I-CONJP	Oinflammatory	mediators	inflammatory	JJ	B-NP	B-proteinmediators	.	mediator	NNS	I-NP	I-protein.	In	.	.	O	OIn	vivo	In	FW	B-ADVP	Ovivo	","	vivo	FW	I-ADVP	O","	up-regulation	","	","	O	Oup-regulation	of	up-regulation	NN	B-NP	Oof	several	of	IN	B-PP	Oseveral	defensin	several	JJ	B-NP	Odefensin	genes	defensin	NN	I-NP	B-DNAgenes	occurs	gene	NNS	I-NP	I-DNAoccurs	in	occur	VBZ	B-VP	Oin	both	in	IN	B-PP	Oboth	infectious	both	CC	B-NP	Oinfectious	and	infectious	JJ	I-NP	Oand	inflammatory	and	CC	I-NP	Oinflammatory	states	inflammatory	JJ	I-NP	Ostates	.	state	NNS	I-NP	O.	Gene	.	.	O	OGene	regulation	Gene	NN	B-NP	Oregulation	occurs	regulation	NN	I-NP	Ooccurs	via	occur	VBZ	B-VP	Ovia	signal	via	IN	B-PP	Osignal	transduction	signal	NN	B-NP	Otransduction	pathways	transduction	NN	I-NP	Opathways	common	pathway	NNS	I-NP	Ocommon	to	common	JJ	B-ADJP	Oto	other	to	TO	B-PP	Oother	innate	other	JJ	B-NP	Oinnate	immune	innate	JJ	I-NP	Oimmune	responses	immune	JJ	I-NP	Oresponses	","	response	NNS	I-NP	O","	utilizing	","	","	O	Outilizing	transcription	utilize	VBG	B-VP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	such	factor	NNS	I-NP	I-proteinsuch	as	such	JJ	B-PP	Oas	nuclear	as	IN	I-PP	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	NF	(	(	O	I-proteinNF	)	NF	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	and	#NAME?	NN	B-NP	I-proteinand	NF	and	CC	O	ONF	interleukin-6	NF	NN	B-NP	B-proteininterleukin-6	.	interleukin-6	NN	I-NP	I-protein.	Together	.	.	O	OTogether	","	Together	RB	B-ADVP	O","	the	","	","	O	Othe	data	the	DT	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	a	suggest	VBP	B-VP	Oa	broad-based	a	DT	B-NP	Obroad-based	innate	broad-based	JJ	I-NP	Oinnate	host	innate	JJ	I-NP	Ohost	defense	host	NN	I-NP	Odefense	whereby	defense	NN	I-NP	Owhereby	potent	whereby	WRB	B-ADVP	Opotent	antimicrobial	potent	JJ	B-NP	Oantimicrobial	peptides	antimicrobial	JJ	I-NP	Opeptides	are	peptide	NNS	I-NP	Oare	present	be	VBP	B-VP	Opresent	to	present	JJ	B-ADJP	Oto	prevent	to	TO	B-VP	Oprevent	initial	prevent	VB	I-VP	Oinitial	colonization	initial	JJ	B-NP	Ocolonization	by	colonization	NN	I-NP	Oby	pathogenic	by	IN	B-PP	Opathogenic	microorganisms	pathogenic	JJ	B-NP	Omicroorganisms	.	microorganism	NNS	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	the	","	","	O	Othe	recognition	the	DT	B-NP	Orecognition	of	recognition	NN	I-NP	Oof	bacteria	of	IN	B-PP	Obacteria	coupled	bacteria	NNS	B-NP	Ocoupled	with	couple	VBN	B-VP	Owith	a	with	IN	B-PP	Oa	nascent	a	DT	B-NP	Onascent	inflammatory	nascent	JJ	I-NP	Oinflammatory	response	inflammatory	JJ	I-NP	Oresponse	can	response	NN	I-NP	Ocan	bolster	can	MD	B-VP	Obolster	this	bolster	VB	I-VP	Othis	defense	this	DT	B-NP	Odefense	by	defense	NN	I-NP	Oby	a	by	IN	B-PP	Oa	coordinated	a	DT	B-NP	Ocoordinated	up-regulation	coordinate	VBN	I-NP	Oup-regulation	of	up-regulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	peptides	the	DT	B-NP	Opeptides	.	peptide	NNS	I-NP	O.	Multiple	.	.	O	OMultiple	signals	Multiple	JJ	B-NP	Osignals	required	signal	NNS	I-NP	Orequired	for	require	VBN	B-VP	Ofor	cyclic	for	IN	B-PP	Ocyclic	AMP-responsive	cyclic	JJ	B-NP	B-proteinAMP-responsive	element	AMP-responsive	JJ	I-NP	I-proteinelement	binding	element	NN	I-NP	I-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	CREB	(	(	O	OCREB	)	CREB	NN	B-NP	B-protein)	binding	)	)	O	Obinding	protein	binding	NN	B-NP	Oprotein	interaction	protein	NN	I-NP	Ointeraction	induced	interaction	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	CD3/CD28	by	IN	B-PP	OCD3/CD28	costimulation	CD3/CD28	NN	B-NP	B-proteincostimulation	.	costimulation	NN	I-NP	O.	The	.	.	O	OThe	optimal	The	DT	B-NP	Ooptimal	activation	optimal	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	cAMP-responsive	of	IN	B-PP	OcAMP-responsive	element	cAMP-responsive	JJ	B-NP	B-proteinelement	binding	element	NN	I-NP	I-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	CREB	(	(	O	OCREB	)	CREB	NN	B-NP	B-protein)	","	)	)	O	O","	similar	","	","	O	Osimilar	to	similar	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	full	the	DT	B-NP	Ofull	activation	full	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	T	of	IN	B-PP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	requires	","	","	O	Orequires	the	require	VBZ	B-VP	Othe	stimulation	the	DT	B-NP	Ostimulation	of	stimulation	NN	I-NP	Oof	both	of	IN	B-PP	Oboth	CD3	both	CC	O	OCD3	and	CD3	NN	B-NP	B-proteinand	CD28	and	CC	I-NP	OCD28	.	CD28	NN	I-NP	B-protein.	Using	.	.	O	OUsing	a	Use	VBG	B-VP	Oa	reporter	a	DT	B-NP	Oreporter	system	reporter	NN	I-NP	Osystem	to	system	NN	I-NP	Oto	detect	to	TO	B-VP	Odetect	interaction	detect	VB	I-VP	Ointeraction	of	interaction	NN	B-NP	Oof	CREB	of	IN	B-PP	OCREB	and	CREB	NN	B-NP	B-proteinand	CREB-binding	and	CC	O	OCREB-binding	protein	CREB-binding	JJ	B-NP	B-proteinprotein	(	protein	NN	I-NP	I-protein(	CBP	(	(	O	OCBP	)	CBP	NN	B-NP	B-protein)	","	)	)	O	O","	in	","	","	O	Oin	this	in	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	we	study	NN	I-NP	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	CREB	that	IN	B-SBAR	OCREB	binds	CREB	NN	B-NP	B-proteinbinds	to	bind	VBZ	B-VP	Oto	CBP	to	TO	B-PP	OCBP	only	CBP	NN	B-NP	B-proteinonly	by	only	RB	B-ADVP	Oby	engagement	by	IN	B-PP	Oengagement	of	engagement	NN	B-NP	Oof	both	of	IN	B-PP	Oboth	CD3	both	CC	O	OCD3	and	CD3	NN	B-NP	B-proteinand	CD28	and	CC	I-NP	OCD28	.	CD28	NN	I-NP	B-protein.	CD3/CD28	.	.	O	OCD3/CD28	#NAME?	CD3/CD28	NN	B-NP	B-protein#NAME?	CREB	#NAME?	VBD	B-VP	OCREB	-	CREB	NN	B-NP	B-protein-	CBP	-	HYPH	B-NP	OCBP	interaction	CBP	NN	I-NP	B-proteininteraction	was	interaction	NN	I-NP	Owas	dependent	be	VBD	B-VP	Odependent	on	dependent	JJ	B-ADJP	Oon	p38	on	IN	B-PP	Op38	mitogen-activated	p38	NN	B-NP	B-proteinmitogen-activated	protein	mitogen-activated	JJ	I-NP	I-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	MAPK	(	(	O	OMAPK	)	MAPK	NN	B-NP	B-protein)	and	)	)	O	Oand	calcium/calmodulin-dependent	and	CC	O	Ocalcium/calmodulin-dependent	protein	calcium/calmodulin-dependent	JJ	B-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	CaMK	(	(	O	OCaMK	)	CaMK	NN	B-NP	B-protein)	IV	)	)	O	OIV	in	IV	CD	B-NP	Oin	addition	in	IN	B-PP	Oaddition	to	addition	NN	B-NP	Oto	the	to	TO	B-PP	Othe	previously	the	DT	B-NP	Opreviously	identified	previously	RB	I-NP	Oidentified	extracellular	identify	VBN	I-NP	Oextracellular	signal-regulated	extracellular	JJ	I-NP	B-proteinsignal-regulated	kinase	signal-regulated	JJ	I-NP	I-proteinkinase	pathway	kinase	NN	I-NP	I-proteinpathway	.	pathway	NN	I-NP	O.	Extracellular	.	.	O	OExtracellular	signal-regulated	Extracellular	JJ	B-NP	B-proteinsignal-regulated	kinase	signal-regulated	JJ	I-NP	I-proteinkinase	","	kinase	NN	I-NP	I-protein","	CaMKIV	","	","	O	OCaMKIV	","	CaMKIV	NN	B-NP	B-protein","	and	","	","	O	Oand	p38	and	CC	O	Op38	MAPK	p38	NN	B-NP	B-proteinMAPK	were	MAPK	NN	I-NP	I-proteinwere	also	be	VBD	B-VP	Oalso	the	also	RB	B-ADVP	Othe	kinases	the	DT	B-NP	Okinases	involved	kinase	NNS	I-NP	B-proteininvolved	in	involve	VBN	B-VP	Oin	CREB	in	IN	B-PP	OCREB	Ser	CREB	NN	B-NP	B-proteinSer	(	Ser	NN	I-NP	O(	133	(	(	O	O133	)	133	CD	B-NP	O)	phosphorylation	)	)	O	Ophosphorylation	induced	phosphorylation	NN	B-NP	Oinduced	by	induce	VBN	B-VP	Oby	CD3/CD28	by	IN	B-PP	OCD3/CD28	.	CD3/CD28	NN	B-NP	B-protein.	A	.	.	O	OA	reconstitution	A	DT	B-NP	Oreconstitution	experiment	reconstitution	NN	I-NP	Oexperiment	illustrated	experiment	NN	I-NP	Oillustrated	that	illustrate	VBD	B-VP	Othat	optimum	that	IN	B-SBAR	Ooptimum	CREB	optimum	JJ	B-NP	OCREB	-	CREB	NN	I-NP	B-protein-	CBP	-	HYPH	B-NP	OCBP	interaction	CBP	NN	I-NP	B-proteininteraction	and	interaction	NN	I-NP	Oand	CREB	and	CC	I-NP	OCREB	trans-activation	CREB	NN	I-NP	B-proteintrans-activation	were	trans-activation	NN	I-NP	Owere	attained	be	VBD	B-VP	Oattained	when	attain	VBN	I-VP	Owhen	these	when	WRB	B-ADVP	Othese	three	these	DT	B-NP	Othree	kinase	three	CD	I-NP	Okinase	pathways	kinase	NN	I-NP	Opathways	were	pathway	NNS	I-NP	Owere	simultaneously	be	VBD	B-VP	Osimultaneously	activated	simultaneously	RB	I-VP	Oactivated	in	activate	VBN	I-VP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Our	.	.	O	OOur	results	Our	PRP$	B-NP	Oresults	demonstrate	result	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	coordinated	that	IN	B-SBAR	Ocoordinated	activation	coordinate	VBN	B-NP	Oactivation	of	activation	NN	I-NP	Oof	different	of	IN	B-PP	Odifferent	kinases	different	JJ	B-NP	Okinases	leads	kinase	NNS	I-NP	B-proteinleads	to	lead	VBZ	B-VP	Oto	full	to	TO	B-PP	Ofull	activation	full	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	CREB	of	IN	B-PP	OCREB	.	CREB	NN	B-NP	B-protein.	Notably	.	.	O	ONotably	","	Notably	RB	B-ADVP	O","	CD28	","	","	O	OCD28	ligation	CD28	NN	B-NP	B-proteinligation	activated	ligation	NN	I-NP	Oactivated	p38	activate	VBD	B-VP	Op38	MAPK	p38	NN	B-NP	B-proteinMAPK	and	MAPK	NN	I-NP	I-proteinand	CaMKIV	and	CC	I-NP	OCaMKIV	","	CaMKIV	NN	I-NP	B-protein","	the	","	","	O	Othe	kinases	the	DT	B-NP	Okinases	stimulated	kinase	NNS	I-NP	B-proteinstimulated	by	stimulate	VBN	B-VP	Oby	CD3	by	IN	B-PP	OCD3	engagement	CD3	NN	B-NP	B-proteinengagement	","	engagement	NN	I-NP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	CD28	that	IN	B-SBAR	OCD28	acts	CD28	NN	B-NP	B-proteinacts	by	act	VBZ	B-VP	Oby	increasing	by	IN	B-PP	Oincreasing	the	increase	VBG	B-VP	Othe	activation	the	DT	B-NP	Oactivation	extent	activation	NN	I-NP	Oextent	of	extent	NN	I-NP	Oof	p38	of	IN	B-PP	Op38	MAPK	p38	NN	B-NP	B-proteinMAPK	and	MAPK	NN	I-NP	I-proteinand	CaMKIV	and	CC	I-NP	OCaMKIV	.	CaMKIV	NN	I-NP	B-protein.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	support	result	NNS	I-NP	Osupport	the	support	VBP	B-VP	Othe	model	the	DT	B-NP	Omodel	of	model	NN	I-NP	Oof	a	of	IN	B-PP	Oa	minimum	a	DT	B-NP	Ominimum	activation	minimum	JJ	I-NP	Oactivation	threshold	activation	NN	I-NP	Othreshold	for	threshold	NN	I-NP	Ofor	CREB	for	IN	B-PP	OCREB	-	CREB	NN	B-NP	B-protein-	CBP	-	HYPH	I-NP	OCBP	interaction	CBP	NN	I-NP	B-proteininteraction	that	interaction	NN	I-NP	Othat	can	that	WDT	B-NP	Ocan	be	can	MD	B-VP	Obe	reached	be	VB	I-VP	Oreached	only	reach	VBN	I-VP	Oonly	when	only	RB	B-ADVP	Owhen	both	when	WRB	I-ADVP	Oboth	CD3	both	CC	O	OCD3	and	CD3	NN	B-NP	B-proteinand	CD28	and	CC	I-NP	OCD28	are	CD28	NN	I-NP	B-proteinare	stimulated	be	VBP	B-VP	Ostimulated	.	stimulate	VBN	I-VP	O.	The	.	.	O	OThe	murine	The	DT	B-NP	Omurine	IL-2	murine	JJ	I-NP	B-DNAIL-2	promoter	IL-2	NN	I-NP	I-DNApromoter	contains	promoter	NN	I-NP	I-DNAcontains	distal	contain	VBZ	B-VP	Odistal	regulatory	distal	JJ	B-NP	B-DNAregulatory	elements	regulatory	JJ	I-NP	I-DNAelements	responsive	element	NNS	I-NP	I-DNAresponsive	to	responsive	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	Ah	the	DT	B-NP	OAh	receptor	Ah	NN	I-NP	B-proteinreceptor	","	receptor	NN	I-NP	I-protein","	a	","	","	O	Oa	member	a	DT	B-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	evolutionarily	the	DT	B-NP	Oevolutionarily	conserved	evolutionarily	RB	I-NP	B-proteinconserved	bHLH-PAS	conserve	VBN	I-NP	I-proteinbHLH-PAS	transcription	bHLH-PAS	JJ	I-NP	I-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	family	factor	NN	I-NP	I-proteinfamily	.	family	NN	I-NP	I-protein.	Signaling	.	.	O	OSignaling	through	Signal	VBG	B-VP	Othrough	the	through	IN	B-PP	Othe	TCR	the	DT	B-NP	OTCR	and	TCR	NN	I-NP	B-proteinand	costimulatory	and	CC	O	Ocostimulatory	signals	costimulatory	JJ	B-NP	Osignals	primarily	signal	NNS	I-NP	Oprimarily	control	primarily	RB	B-ADVP	Ocontrol	transcription	control	VBP	B-VP	Otranscription	of	transcription	NN	B-NP	Oof	the	of	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	gene	IL-2	NN	I-NP	B-DNAgene	in	gene	NN	I-NP	I-DNAin	naive	in	IN	B-PP	Onaive	T	naive	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	minimal	The	DT	B-NP	Ominimal	promoter	minimal	JJ	I-NP	B-DNApromoter	necessary	promoter	NN	I-NP	I-DNAnecessary	for	necessary	JJ	B-ADJP	Ofor	this	for	IN	B-PP	Othis	expression	this	DT	B-NP	Oexpression	lies	expression	NN	I-NP	Olies	proximal	lie	VBZ	B-VP	Oproximal	","	proximal	JJ	B-ADJP	O","	between	","	","	O	Obetween	-300	between	IN	B-PP	O-300	and	-300	CD	B-NP	Oand	the	and	CC	O	Othe	transcription	the	DT	B-NP	Otranscription	start	transcription	NN	I-NP	B-DNAstart	site	start	NN	I-NP	I-DNAsite	.	site	NN	I-NP	I-DNA.	We	.	.	O	OWe	had	We	PRP	B-NP	Ohad	previously	have	VBD	B-VP	Opreviously	shown	previously	RB	I-VP	Oshown	that	show	VBN	I-VP	Othat	activation	that	IN	B-SBAR	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	arylhydrocarbon	the	DT	B-NP	Oarylhydrocarbon	receptor	arylhydrocarbon	NN	I-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	AHR	(	(	O	OAHR	)	AHR	NN	B-NP	B-protein)	","	)	)	O	O","	a	","	","	O	Oa	member	a	DT	B-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	bHLH-PAS	the	DT	B-NP	ObHLH-PAS	family	bHLH-PAS	JJ	I-NP	B-proteinfamily	of	family	NN	I-NP	I-proteinof	transcription	of	IN	B-PP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	","	factor	NNS	I-NP	I-protein","	leads	","	","	O	Oleads	to	lead	VBZ	B-VP	Oto	increased	to	TO	B-PP	Oincreased	mRNA	increase	VBN	B-NP	OmRNA	expression	mRNA	NN	I-NP	B-RNAexpression	of	expression	NN	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	in	IL-2	NN	B-NP	B-proteinin	murine	in	IN	B-PP	Omurine	fetal	murine	JJ	B-NP	B-cell_typefetal	thymocytes	fetal	JJ	I-NP	I-cell_typethymocytes	.	thymocyte	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	AHR	The	DT	B-NP	OAHR	is	AHR	NN	I-NP	B-proteinis	abundant	be	VBZ	B-VP	Oabundant	in	abundant	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	thymus	the	DT	B-NP	Othymus	and	thymus	NN	I-NP	Oand	may	and	CC	O	Omay	play	may	MD	B-VP	Oplay	a	play	VB	I-VP	Oa	role	a	DT	B-NP	Orole	for	role	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	the	of	IN	B-PP	Othe	immune	the	DT	B-NP	Oimmune	system	immune	JJ	I-NP	Osystem	.	system	NN	I-NP	O.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	its	","	","	O	Oits	overactivation	its	PRP$	B-NP	Ooveractivation	by	overactivation	NN	I-NP	Oby	chemicals	by	IN	B-PP	Ochemicals	such	chemical	NNS	B-NP	Osuch	as	such	JJ	B-PP	Oas	dioxins	as	IN	I-PP	Odioxins	leads	dioxin	NNS	B-NP	Oleads	to	lead	VBZ	B-VP	Oto	immunosuppression	to	TO	B-PP	Oimmunosuppression	and	immunosuppression	NN	B-NP	Oand	thymic	and	CC	O	Othymic	involution	thymic	JJ	B-NP	Oinvolution	.	involution	NN	I-NP	O.	Binding	.	.	O	OBinding	motifs	Binding	NN	B-NP	B-DNAmotifs	for	motif	NNS	I-NP	I-DNAfor	the	for	IN	B-PP	Othe	liganded	the	DT	B-NP	Oliganded	AHR	liganded	JJ	I-NP	OAHR	can	AHR	NN	I-NP	B-proteincan	be	can	MD	B-VP	Obe	identified	be	VB	I-VP	Oidentified	in	identify	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	distal	the	DT	B-NP	Odistal	region	distal	JJ	I-NP	Oregion	-1300	region	NN	I-NP	O-1300	to	-1300	CD	I-NP	Oto	-800	to	TO	B-PP	O-800	of	-800	CD	B-NP	Oof	the	of	IN	B-PP	Othe	mouse	the	DT	B-NP	Omouse	IL-2	mouse	NN	I-NP	B-DNAIL-2	promoter	IL-2	NN	I-NP	I-DNApromoter	.	promoter	NN	I-NP	I-DNA.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	here	show	VBP	B-VP	Ohere	that	here	RB	B-ADVP	Othat	these	that	IN	B-SBAR	Othese	DNA	these	DT	B-NP	ODNA	motifs	DNA	NN	I-NP	B-DNAmotifs	","	motif	NNS	I-NP	I-DNA","	the	","	","	O	Othe	so-called	the	DT	B-NP	Oso-called	dioxin	so-called	JJ	I-NP	Odioxin	response	dioxin	NN	I-NP	B-DNAresponse	elements	response	NN	I-NP	I-DNAelements	","	element	NNS	I-NP	I-DNA","	after	","	","	O	Oafter	binding	after	IN	B-PP	Obinding	to	bind	VBG	B-VP	Oto	the	to	TO	B-PP	Othe	liganded	the	DT	B-NP	Oliganded	AHR	liganded	JJ	I-NP	OAHR	are	AHR	NN	I-NP	B-proteinare	sufficient	be	VBP	B-VP	Osufficient	to	sufficient	JJ	B-ADJP	Oto	transactivate	to	TO	B-VP	Otransactivate	luciferase	transactivate	VB	I-VP	Oluciferase	expression	luciferase	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	a	in	IN	B-PP	Oa	reporter	a	DT	B-NP	Oreporter	gene	reporter	NN	I-NP	B-DNAgene	system	gene	NN	I-NP	I-DNAsystem	.	system	NN	I-NP	O.	The	.	.	O	OThe	IL-2	The	DT	B-NP	OIL-2	gene	IL-2	NN	I-NP	B-DNAgene	can	gene	NN	I-NP	I-DNAcan	be	can	MD	B-VP	Obe	induced	be	VB	I-VP	Oinduced	by	induce	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	AHR	the	DT	B-NP	OAHR	also	AHR	NN	I-NP	B-proteinalso	in	also	RB	B-ADVP	Oin	thymocytes	in	IN	B-PP	Othymocytes	in	thymocyte	NNS	B-NP	B-cell_typein	vivo	in	FW	B-ADVP	Ovivo	after	vivo	FW	I-ADVP	Oafter	injection	after	IN	B-PP	Oinjection	of	injection	NN	B-NP	Oof	2	of	IN	B-PP	O2	","	2	CD	B-NP	O","	3	","	","	I-NP	O3	","	3	CD	I-NP	O","	7	","	","	I-NP	O7	","	7	CD	I-NP	O","	8-tetrachlorodibenzo-p-dioxin	","	","	O	O8-tetrachlorodibenzo-p-dioxin	","	8-tetrachlorodibenzo-p-dioxin	NN	B-NP	O","	a	","	","	O	Oa	potent	a	DT	B-NP	Opotent	ligand	potent	JJ	I-NP	Oligand	of	ligand	NN	I-NP	Oof	the	of	IN	B-PP	Othe	AHR	the	DT	B-NP	OAHR	.	AHR	NN	I-NP	B-protein.	The	.	.	O	OThe	AHR	The	DT	B-NP	OAHR	mediates	AHR	NN	I-NP	B-proteinmediates	the	mediate	VBZ	B-VP	Othe	IL-2	the	DT	B-NP	OIL-2	induction	IL-2	NN	I-NP	B-proteininduction	as	induction	NN	I-NP	Oas	shown	as	IN	B-SBAR	Oshown	with	show	VBN	B-VP	Owith	AHR	with	IN	B-PP	OAHR	#NAME?	AHR	NN	B-NP	B-protein#NAME?	mice	#NAME?	JJ	I-NP	Omice	.	mouse	NNS	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	in	","	","	O	Oin	spleen	in	IN	B-PP	Ospleen	cells	spleen	NN	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	vitro	in	FW	B-NP	Ovitro	costimulation	vitro	FW	I-NP	Ocostimulation	via	costimulation	NN	I-NP	Ovia	the	via	IN	B-PP	Othe	TCR	the	DT	B-NP	OTCR	is	TCR	NN	I-NP	B-proteinis	necessary	be	VBZ	B-VP	Onecessary	for	necessary	JJ	B-ADJP	Ofor	optimal	for	IN	B-PP	Ooptimal	IL-2	optimal	JJ	B-NP	OIL-2	gene	IL-2	NN	I-NP	B-DNAgene	induction	gene	NN	I-NP	I-DNAinduction	.	induction	NN	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	the	","	","	O	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	region	promoter	NN	I-NP	I-DNAregion	contains	region	NN	I-NP	I-DNAcontains	novel	contain	VBZ	B-VP	Onovel	distal	novel	JJ	B-NP	Odistal	regulatory	distal	JJ	I-NP	B-DNAregulatory	elements	regulatory	JJ	I-NP	I-DNAelements	that	element	NNS	I-NP	I-DNAthat	can	that	WDT	B-NP	Ocan	be	can	MD	B-VP	Obe	addressed	be	VB	I-VP	Oaddressed	by	address	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	AHR	the	DT	B-NP	OAHR	to	AHR	NN	I-NP	B-proteinto	induce	to	TO	B-VP	Oinduce	IL-2	induce	VB	I-VP	OIL-2	and	IL-2	NN	B-NP	B-proteinand	can	and	CC	O	Ocan	cooperate	can	MD	B-VP	Ocooperate	with	cooperate	VB	I-VP	Owith	the	with	IN	B-PP	Othe	proximal	the	DT	B-NP	Oproximal	promoter	proximal	JJ	I-NP	B-DNApromoter	Visualization	promoter	NN	I-NP	I-DNAVisualization	of	Visualization	NN	B-NP	Oof	Syk-antigen	of	IN	B-PP	OSyk-antigen	receptor	Syk-antigen	NN	B-NP	B-proteinreceptor	interactions	receptor	NN	I-NP	I-proteininteractions	using	interaction	NNS	I-NP	Ousing	green	use	VBG	B-VP	Ogreen	fluorescent	green	JJ	B-NP	B-proteinfluorescent	protein	fluorescent	JJ	I-NP	I-proteinprotein	:	protein	NN	I-NP	I-protein:	differential	:	:	O	Odifferential	roles	differential	JJ	B-NP	Oroles	for	role	NNS	I-NP	Ofor	Syk	for	IN	B-PP	OSyk	and	Syk	NN	B-NP	B-proteinand	Lyn	and	CC	I-NP	OLyn	in	Lyn	NN	I-NP	B-proteinin	the	in	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	receptor	of	IN	B-PP	Oreceptor	capping	receptor	NN	B-NP	Ocapping	and	capping	NN	I-NP	Oand	internalization	and	CC	I-NP	Ointernalization	.	internalization	NN	I-NP	O.	The	.	.	O	OThe	cross-linking	The	DT	B-NP	Ocross-linking	of	cross-linking	NN	I-NP	Oof	the	of	IN	B-PP	Othe	B	the	DT	B-NP	OB	cell	B	NN	I-NP	B-proteincell	Ag	cell	NN	I-NP	I-proteinAg	receptor	Ag	NN	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	BCR	(	(	O	OBCR	)	BCR	NN	B-NP	B-protein)	is	)	)	O	Ois	coupled	be	VBZ	B-VP	Ocoupled	to	couple	VBN	I-VP	Oto	the	to	TO	B-PP	Othe	stimulation	the	DT	B-NP	Ostimulation	of	stimulation	NN	I-NP	Oof	multiple	of	IN	B-PP	Omultiple	intracellular	multiple	JJ	B-NP	Ointracellular	signal	intracellular	JJ	I-NP	Osignal	transduction	signal	NN	I-NP	Otransduction	cascades	transduction	NN	I-NP	Ocascades	via	cascade	NNS	I-NP	Ovia	receptor-associated	via	IN	B-PP	Oreceptor-associated	","	receptor-associated	JJ	B-NP	O","	protein	","	","	I-NP	Oprotein	tyrosine	protein	NN	I-NP	B-proteintyrosine	kinases	tyrosine	NN	I-NP	I-proteinkinases	of	kinase	NNS	I-NP	I-proteinof	both	of	IN	B-PP	Oboth	the	both	CC	O	Othe	Src	the	DT	B-NP	OSrc	and	Src	NN	I-NP	B-proteinand	Syk	and	CC	I-NP	OSyk	families	Syk	NN	I-NP	B-proteinfamilies	.	family	NNS	I-NP	O.	To	.	.	O	OTo	monitor	To	TO	B-VP	Omonitor	changes	monitor	VB	I-VP	Ochanges	in	change	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	subcellular	the	DT	B-NP	Osubcellular	distribution	subcellular	JJ	I-NP	Odistribution	of	distribution	NN	I-NP	Oof	Syk	of	IN	B-PP	OSyk	in	Syk	NN	B-NP	B-proteinin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	responding	cell	NNS	I-NP	I-cell_typeresponding	to	respond	VBG	B-VP	Oto	BCR	to	TO	B-PP	OBCR	cross-linking	BCR	NN	B-NP	B-proteincross-linking	","	cross-linking	NN	I-NP	O","	we	","	","	O	Owe	expressed	we	PRP	B-NP	Oexpressed	in	express	VBD	B-VP	Oin	Syk	in	IN	B-PP	OSyk	#NAME?	Syk	NN	B-NP	B-cell_line#NAME?	DT40	#NAME?	JJ	I-NP	I-cell_lineDT40	B	DT40	NN	I-NP	I-cell_lineB	cells	B	NN	I-NP	I-cell_linecells	a	cell	NNS	I-NP	I-cell_linea	fusion	a	DT	B-NP	Ofusion	protein	fusion	NN	I-NP	B-proteinprotein	consisting	protein	NN	I-NP	I-proteinconsisting	of	consist	VBG	B-VP	Oof	Syk	of	IN	B-PP	OSyk	coupled	Syk	NN	B-NP	B-proteincoupled	to	couple	VBN	B-VP	Oto	green	to	TO	B-PP	Ogreen	fluorescent	green	JJ	B-NP	B-proteinfluorescent	protein	fluorescent	JJ	I-NP	I-proteinprotein	.	protein	NN	I-NP	I-protein.	Treatment	.	.	O	OTreatment	of	Treatment	NN	B-NP	Oof	these	of	IN	B-PP	Othese	cells	these	DT	B-NP	Ocells	with	cell	NNS	I-NP	Owith	anti-IgM	with	IN	B-PP	Oanti-IgM	Abs	anti-IgM	JJ	B-NP	B-proteinAbs	leads	Ab	NNS	I-NP	I-proteinleads	to	lead	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	recruitment	the	DT	B-NP	Orecruitment	of	recruitment	NN	I-NP	Oof	the	of	IN	B-PP	Othe	kinase	the	DT	B-NP	Okinase	from	kinase	NN	I-NP	B-proteinfrom	cytoplasmic	from	IN	B-PP	Ocytoplasmic	and	cytoplasmic	JJ	B-NP	Oand	nuclear	and	CC	I-NP	Onuclear	compartments	nuclear	JJ	I-NP	Ocompartments	to	compartment	NNS	I-NP	Oto	the	to	TO	B-PP	Othe	site	the	DT	B-NP	Osite	of	site	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cross-linked	the	DT	B-NP	Ocross-linked	receptor	cross-linked	JJ	I-NP	B-proteinreceptor	at	receptor	NN	I-NP	I-proteinat	the	at	IN	B-PP	Othe	plasma	the	DT	B-NP	Oplasma	membrane	plasma	NN	I-NP	Omembrane	.	membrane	NN	I-NP	O.	The	.	.	O	OThe	Syk-receptor	The	DT	B-NP	OSyk-receptor	complexes	Syk-receptor	NN	I-NP	B-proteincomplexes	aggregate	complex	NNS	I-NP	I-proteinaggregate	into	aggregate	VBP	B-VP	Ointo	membrane	into	IN	B-PP	Omembrane	patches	membrane	NN	B-NP	Opatches	that	patch	NNS	I-NP	Othat	redistribute	that	WDT	B-NP	Oredistribute	to	redistribute	VBP	B-VP	Oto	form	to	TO	I-VP	Oform	a	form	VB	I-VP	Oa	cap	a	DT	B-NP	Ocap	at	cap	NN	I-NP	B-proteinat	one	at	IN	B-PP	Oone	pole	one	CD	B-NP	Opole	of	pole	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	.	cell	NN	I-NP	O.	Syk	.	.	O	OSyk	is	Syk	NN	B-NP	B-proteinis	not	be	VBZ	B-VP	Onot	demonstrably	not	RB	I-VP	Odemonstrably	associated	demonstrably	RB	I-VP	Oassociated	with	associate	VBN	I-VP	Owith	the	with	IN	B-PP	Othe	internalized	the	DT	B-NP	Ointernalized	receptor	internalize	VBN	I-NP	B-proteinreceptor	.	receptor	NN	I-NP	I-protein.	Catalytically	.	.	O	OCatalytically	active	Catalytically	RB	B-NP	Oactive	Syk	active	JJ	I-NP	OSyk	promotes	Syk	NN	I-NP	B-proteinpromotes	and	promote	VBZ	B-VP	Oand	stabilizes	and	CC	I-VP	Ostabilizes	the	stabilize	VBZ	I-VP	Othe	formation	the	DT	B-NP	Oformation	of	formation	NN	I-NP	Oof	tightly	of	IN	B-PP	Otightly	capped	tightly	RB	B-NP	Ocapped	BCR	cap	VBN	I-NP	OBCR	complexes	BCR	NN	I-NP	B-proteincomplexes	at	complex	NNS	I-NP	I-proteinat	the	at	IN	B-PP	Othe	plasma	the	DT	B-NP	Oplasma	membrane	plasma	NN	I-NP	Omembrane	.	membrane	NN	I-NP	O.	Lyn	.	.	O	OLyn	is	Lyn	NN	B-NP	B-proteinis	not	be	VBZ	B-VP	Onot	required	not	RB	I-VP	Orequired	for	require	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	recruitment	the	DT	B-NP	Orecruitment	of	recruitment	NN	I-NP	Oof	Syk	of	IN	B-PP	OSyk	to	Syk	NN	B-NP	B-proteinto	the	to	TO	B-PP	Othe	cross-linked	the	DT	B-NP	Ocross-linked	receptor	cross-linked	JJ	I-NP	B-proteinreceptor	","	receptor	NN	I-NP	I-protein","	but	","	","	O	Obut	is	but	CC	O	Ois	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	internalization	the	DT	B-NP	Ointernalization	of	internalization	NN	I-NP	Oof	the	of	IN	B-PP	Othe	clustered	the	DT	B-NP	Oclustered	BCR	cluster	VBN	I-NP	OBCR	complexes	BCR	NN	I-NP	B-proteincomplexes	.	complex	NNS	I-NP	I-protein.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	Lyn	of	IN	B-PP	OLyn	","	Lyn	NN	B-NP	B-protein","	receptor-Syk	","	","	O	Oreceptor-Syk	complexes	receptor-Syk	NN	B-NP	B-proteincomplexes	at	complex	NNS	I-NP	I-proteinat	the	at	IN	B-PP	Othe	plasma	the	DT	B-NP	Oplasma	membrane	plasma	NN	I-NP	Omembrane	are	membrane	NN	I-NP	Oare	long	be	VBP	B-VP	Olong	lived	long	JJ	B-ADJP	Olived	","	live	VBN	B-VP	O","	and	","	","	O	Oand	the	and	CC	O	Othe	receptor-mediated	the	DT	B-NP	Oreceptor-mediated	activation	receptor-mediated	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	NF-AT	the	DT	B-NP	ONF-AT	transcription	NF-AT	NN	I-NP	B-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	is	factor	NN	I-NP	I-proteinis	enhanced	be	VBZ	B-VP	Oenhanced	.	enhance	VBN	I-VP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	Lyn	","	","	O	OLyn	appears	Lyn	NN	B-NP	B-proteinappears	to	appear	VBZ	B-VP	Oto	function	to	TO	I-VP	Ofunction	to	function	VB	I-VP	Oto	negatively	to	TO	B-VP	Onegatively	regulate	negatively	RB	I-VP	Oregulate	aspects	regulate	VB	I-VP	Oaspects	of	aspect	NNS	B-NP	Oof	BCR	of	IN	B-PP	OBCR	#NAME?	BCR	NN	B-NP	B-protein#NAME?	signaling	#NAME?	JJ	I-NP	Osignaling	by	signaling	NN	I-NP	Oby	stimulating	by	IN	B-PP	Ostimulating	receptor	stimulate	VBG	B-VP	Oreceptor	internalization	receptor	NN	B-NP	Ointernalization	and	internalization	NN	I-NP	Oand	down-regulation	and	CC	I-NP	Odown-regulation	.	down-regulation	NN	I-NP	O.	Renal	.	.	O	ORenal	interstitial	Renal	JJ	B-NP	Ointerstitial	fibrosis	interstitial	JJ	I-NP	Ofibrosis	is	fibrosis	NN	I-NP	Ois	reduced	be	VBZ	B-VP	Oreduced	in	reduce	VBN	I-VP	Oin	angiotensin	in	IN	B-PP	Oangiotensin	II	angiotensin	NN	B-NP	B-proteinII	type	II	CD	I-NP	I-proteintype	1a	type	NN	I-NP	I-protein1a	receptor	1a	NN	I-NP	I-proteinreceptor	#NAME?	receptor	NN	I-NP	I-protein#NAME?	mice	#NAME?	JJ	I-NP	Omice	.	mouse	NNS	I-NP	O.	Unilateral	.	.	O	OUnilateral	ureteral	Unilateral	JJ	B-NP	Oureteral	obstruction	ureteral	JJ	I-NP	Oobstruction	(	obstruction	NN	I-NP	O(	UUO	(	(	O	OUUO	)	UUO	NN	B-NP	O)	results	)	)	O	Oresults	in	result	VBZ	B-VP	Oin	tubulointerstitial	in	IN	B-PP	Otubulointerstitial	fibrosis	tubulointerstitial	JJ	B-NP	Ofibrosis	of	fibrosis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	affected	the	DT	B-NP	Oaffected	kidney	affect	VBN	I-NP	Okidney	by	kidney	NN	I-NP	Oby	stimulating	by	IN	B-PP	Ostimulating	the	stimulate	VBG	B-VP	Othe	renin-angiotensin	the	DT	B-NP	Orenin-angiotensin	system	renin-angiotensin	NN	I-NP	Osystem	.	system	NN	I-NP	O.	This	.	.	O	OThis	study	This	DT	B-NP	Ostudy	established	study	NN	I-NP	Oestablished	a	establish	VBD	B-VP	Oa	UUO	a	DT	B-NP	OUUO	model	UUO	NNP	I-NP	Omodel	in	model	NN	I-NP	Oin	angiotensin	in	IN	B-PP	Oangiotensin	type	angiotensin	NN	B-NP	B-proteintype	1a	type	NN	I-NP	I-protein1a	receptor	1a	NN	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	AT1a	(	(	O	OAT1a	)	AT1a	NN	B-NP	O)	deficient	)	)	O	Odeficient	(	deficient	JJ	O	O(	mutant	(	(	O	Omutant	)	mutant	JJ	B-ADJP	O)	mice	)	)	O	Omice	to	mouse	NNS	B-NP	Oto	elucidate	to	TO	B-VP	Oelucidate	the	elucidate	VB	I-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	angiotensin	of	IN	B-PP	Oangiotensin	II	angiotensin	NN	B-NP	B-proteinII	through	II	CD	I-NP	I-proteinthrough	AT1a	through	IN	B-PP	OAT1a	on	AT1a	NN	B-NP	B-proteinon	the	on	IN	B-PP	Othe	fibrosis	the	DT	B-NP	Ofibrosis	of	fibrosis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	obstructed	the	DT	B-NP	Oobstructed	kidney	obstruct	VBN	I-NP	Okidney	(	kidney	NN	I-NP	O(	OBK	(	(	O	OOBK	)	OBK	NN	B-NP	B-protein)	.	)	)	O	O.	The	.	.	O	OThe	relative	The	DT	B-NP	Orelative	volume	relative	JJ	I-NP	Ovolume	of	volume	NN	I-NP	Oof	the	of	IN	B-PP	Othe	tubulointerstitium	the	DT	B-NP	Otubulointerstitium	was	tubulointerstitium	NN	I-NP	Owas	measured	be	VBD	B-VP	Omeasured	by	measure	VBN	I-VP	Oby	an	by	IN	B-PP	Oan	image	an	DT	B-NP	Oimage	analyzer	image	NN	I-NP	Oanalyzer	;	analyzer	NN	I-NP	O;	deposition	;	:	O	Odeposition	of	deposition	NN	B-NP	Oof	collagen	of	IN	B-PP	Ocollagen	types	collagen	NN	B-NP	B-proteintypes	III	type	NNS	I-NP	I-proteinIII	and	III	CD	B-NP	I-proteinand	IV	and	CC	I-NP	OIV	and	IV	CD	I-NP	Oand	monocyte	and	CC	O	Omonocyte	/	monocyte	NN	B-NP	B-cell_type/	macrophage	/	SYM	O	Omacrophage	infiltration	macrophage	NN	B-NP	Oinfiltration	were	infiltration	NN	I-NP	Owere	histologically	be	VBD	B-VP	Ohistologically	examined	histologically	RB	I-VP	Oexamined	using	examine	VBN	I-VP	Ousing	specific	use	VBG	B-VP	Ospecific	antibodies	specific	JJ	B-NP	B-proteinantibodies	.	antibody	NNS	I-NP	I-protein.	Also	.	.	O	OAlso	determined	Also	RB	B-VP	Odetermined	were	determine	VBN	I-VP	Owere	the	be	VBD	B-VP	Othe	mRNA	the	DT	B-NP	OmRNA	levels	mRNA	NN	I-NP	B-RNAlevels	of	level	NNS	I-NP	Oof	transforming	of	IN	B-PP	Otransforming	growth	transform	VBG	B-NP	B-proteingrowth	factor-beta	growth	NN	I-NP	I-proteinfactor-beta	by	factor-beta	NN	I-NP	I-proteinby	Northern	by	IN	B-PP	ONorthern	blot	Northern	NN	B-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	.	analysis	NN	I-NP	O.	Nuclear	.	.	O	ONuclear	factor-kappaB	Nuclear	JJ	B-NP	B-proteinfactor-kappaB	activity	factor-kappaB	NN	I-NP	I-proteinactivity	was	activity	NN	I-NP	Owas	assessed	be	VBD	B-VP	Oassessed	by	assess	VBN	I-VP	Oby	gel	by	IN	B-PP	Ogel	shift	gel	NN	B-NP	Oshift	assay	shift	NN	I-NP	Oassay	.	assay	NN	I-NP	O.	UUO	.	.	O	OUUO	in	UUO	NN	B-NP	Oin	wild	in	IN	B-PP	Owild	mice	wild	JJ	B-NP	Omice	resulted	mouse	NNS	I-NP	Oresulted	in	result	VBD	B-VP	Oin	a	in	IN	B-PP	Oa	marked	a	DT	B-NP	Omarked	expansion	marked	JJ	I-NP	Oexpansion	of	expansion	NN	I-NP	Oof	relative	of	IN	B-PP	Orelative	volume	relative	JJ	B-NP	Ovolume	of	volume	NN	I-NP	Oof	the	of	IN	B-PP	Othe	tubulointerstitium	the	DT	B-NP	Otubulointerstitium	","	tubulointerstitium	NN	I-NP	O","	together	","	","	O	Otogether	with	together	RB	B-ADVP	Owith	increased	with	IN	B-PP	Oincreased	deposition	increase	VBN	B-NP	Odeposition	of	deposition	NN	I-NP	Oof	collagen	of	IN	B-PP	Ocollagen	types	collagen	NN	B-NP	B-proteintypes	III	type	NNS	I-NP	I-proteinIII	and	III	CD	B-NP	I-proteinand	IV	and	CC	I-NP	OIV	and	IV	CD	I-NP	Oand	number	and	CC	I-NP	Onumber	of	number	NN	I-NP	Oof	infiltrated	of	IN	B-PP	Oinfiltrated	monocytes	infiltrate	VBN	B-NP	Omonocytes	/	monocyte	NNS	I-NP	B-cell_type/	macrophages	/	SYM	B-VP	B-cell_typemacrophages	in	macrophage	NNS	B-NP	I-cell_typein	the	in	IN	B-PP	Othe	interstitium	the	DT	B-NP	Ointerstitium	","	interstitium	NN	I-NP	O","	relative	","	","	O	Orelative	to	relative	JJ	B-ADVP	Oto	sham-operated	to	TO	B-PP	Osham-operated	mice	sham-operated	JJ	B-NP	Omice	.	mouse	NNS	I-NP	O.	In	.	.	O	OIn	comparison	In	IN	B-PP	Ocomparison	","	comparison	NN	B-NP	O","	these	","	","	O	Othese	changes	these	DT	B-NP	Ochanges	were	change	NNS	I-NP	Owere	significantly	be	VBD	B-VP	Osignificantly	lower	significantly	RB	B-ADJP	Olower	in	low	JJR	I-ADJP	Oin	mutant	in	IN	B-PP	Omutant	mice	mutant	JJ	B-NP	Omice	with	mouse	NNS	I-NP	Owith	UUO	with	IN	B-PP	OUUO	.	UUO	NN	B-NP	B-protein.	The	.	.	O	OThe	mRNA	The	DT	B-NP	OmRNA	level	mRNA	NN	I-NP	B-RNAlevel	of	level	NN	I-NP	Oof	transforming	of	IN	B-PP	Otransforming	growth	transform	VBG	B-NP	B-proteingrowth	factor-beta	growth	NN	I-NP	I-proteinfactor-beta	was	factor-beta	NN	I-NP	I-proteinwas	significantly	be	VBD	B-VP	Osignificantly	higher	significantly	RB	B-ADJP	Ohigher	in	high	JJR	I-ADJP	Oin	the	in	IN	B-PP	Othe	OBK	the	DT	B-NP	OOBK	of	OBK	NN	I-NP	B-proteinof	wild	of	IN	B-PP	Owild	mice	wild	JJ	B-NP	Omice	with	mouse	NNS	I-NP	Owith	UUO	with	IN	B-PP	OUUO	compared	UUO	NN	B-NP	B-proteincompared	with	compare	VBN	B-PP	Owith	sham-operated	with	IN	B-PP	Osham-operated	mice	sham-operated	JJ	B-NP	Omice	.	mouse	NNS	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	the	","	","	O	Othe	increase	the	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	mRNA	in	IN	B-PP	OmRNA	level	mRNA	NN	B-NP	B-RNAlevel	in	level	NN	I-NP	Oin	the	in	IN	B-PP	Othe	OBK	the	DT	B-NP	OOBK	of	OBK	NN	I-NP	B-proteinof	mutant	of	IN	B-PP	Omutant	mice	mutant	JJ	B-NP	Omice	was	mouse	NNS	I-NP	Owas	significantly	be	VBD	B-VP	Osignificantly	less	significantly	RB	B-ADJP	Oless	than	less	JJR	I-ADJP	Othan	in	than	IN	B-PP	Oin	wild	in	IN	B-PP	Owild	mice	wild	JJ	B-NP	Omice	.	mouse	NNS	I-NP	O.	Finally	.	.	O	OFinally	","	Finally	RB	B-ADVP	O","	UUO	","	","	O	OUUO	resulted	UUO	NN	B-NP	B-proteinresulted	in	result	VBD	B-VP	Oin	activation	in	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor-kappaB	nuclear	JJ	B-NP	B-proteinfactor-kappaB	in	factor-kappaB	NN	I-NP	I-proteinin	wild	in	IN	B-PP	Owild	mice	wild	JJ	B-NP	Omice	but	mouse	NNS	I-NP	Obut	was	but	CC	O	Owas	inhibited	be	VBD	B-VP	Oinhibited	in	inhibit	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	OBK	the	DT	B-NP	OOBK	of	OBK	NN	I-NP	B-proteinof	mutant	of	IN	B-PP	Omutant	mice	mutant	JJ	B-NP	Omice	.	mouse	NNS	I-NP	O.	The	.	.	O	OThe	results	The	DT	B-NP	Oresults	provide	result	NNS	I-NP	Oprovide	direct	provide	VBP	B-VP	Odirect	evidence	direct	JJ	B-NP	Oevidence	that	evidence	NN	I-NP	Othat	angiotensin	that	IN	B-SBAR	Oangiotensin	II	angiotensin	NN	B-NP	B-proteinII	acting	II	CD	I-NP	I-proteinacting	via	act	VBG	B-VP	Ovia	the	via	IN	B-PP	Othe	AT1a	the	DT	B-NP	OAT1a	plays	AT1a	NN	I-NP	Oplays	a	play	VBZ	B-VP	Oa	pivotal	a	DT	B-NP	Opivotal	role	pivotal	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	tubulointerstitial	of	IN	B-PP	Otubulointerstitial	fibrosis	tubulointerstitial	JJ	B-NP	Ofibrosis	in	fibrosis	NN	I-NP	Oin	UUO	in	IN	B-PP	OUUO	.	UUO	NN	B-NP	B-protein.	HLA-DQ	.	.	O	OHLA-DQ	tetramers	HLA-DQ	NN	B-NP	B-proteintetramers	identify	tetramer	NNS	I-NP	I-proteinidentify	epitope-specific	identify	VBP	B-VP	Oepitope-specific	T	epitope-specific	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	peripheral	in	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	Oblood	of	blood	NN	I-NP	Oof	herpes	of	IN	B-PP	Oherpes	simplex	herpes	NN	B-NP	Osimplex	virus	simplex	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	2-infected	type	NN	I-NP	O2-infected	individuals	2-infected	JJ	I-NP	Oindividuals	:	individual	NNS	I-NP	O:	direct	:	:	O	Odirect	detection	direct	JJ	B-NP	Odetection	of	detection	NN	I-NP	Oof	immunodominant	of	IN	B-PP	Oimmunodominant	antigen-responsive	immunodominant	JJ	B-NP	B-cell_typeantigen-responsive	cells	antigen-responsive	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Ag-specific	.	.	O	OAg-specific	CD4+	Ag-specific	JJ	B-NP	B-cell_typeCD4+	T	CD4+	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	are	cell	NNS	I-NP	I-cell_typeare	present	be	VBP	B-VP	Opresent	in	present	JJ	B-ADJP	Oin	peripheral	in	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	Oblood	in	blood	NN	I-NP	Oin	low	in	IN	B-PP	Olow	frequency	low	JJ	B-NP	Ofrequency	","	frequency	NN	I-NP	O","	where	","	","	O	Owhere	they	where	WRB	B-ADVP	Othey	undergo	they	PRP	B-NP	Oundergo	recruitment	undergo	VBP	B-VP	Orecruitment	and	recruitment	NN	B-NP	Oand	expansion	and	CC	I-NP	Oexpansion	during	expansion	NN	I-NP	Oduring	immune	during	IN	B-PP	Oimmune	responses	immune	JJ	B-NP	Oresponses	and	response	NNS	I-NP	Oand	in	and	CC	B-PP	Oin	the	in	IN	B-PP	Othe	pathogenesis	the	DT	B-NP	Opathogenesis	of	pathogenesis	NN	I-NP	Oof	numerous	of	IN	B-PP	Onumerous	autoimmune	numerous	JJ	B-NP	Oautoimmune	diseases	autoimmune	JJ	I-NP	Odiseases	.	disease	NNS	I-NP	O.	MHC	.	.	O	OMHC	tetramers	MHC	NN	B-NP	B-proteintetramers	","	tetramer	NNS	I-NP	I-protein","	which	","	","	O	Owhich	constitute	which	WDT	B-NP	Oconstitute	a	constitute	VBP	B-VP	Oa	labeled	a	DT	B-NP	Olabeled	MHC-peptide	label	VBN	I-NP	OMHC-peptide	ligand	MHC-peptide	NN	I-NP	Oligand	suitable	ligand	NN	I-NP	Osuitable	for	suitable	JJ	B-ADJP	Ofor	binding	for	IN	B-PP	Obinding	to	bind	VBG	B-VP	Oto	the	to	TO	B-PP	Othe	Ag-specific	the	DT	B-NP	OAg-specific	receptor	Ag-specific	JJ	I-NP	B-proteinreceptor	on	receptor	NN	I-NP	I-proteinon	T	on	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	provide	","	","	O	Oprovide	a	provide	VBP	B-VP	Oa	novel	a	DT	B-NP	Onovel	approach	novel	JJ	I-NP	Oapproach	for	approach	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	detection	the	DT	B-NP	Odetection	and	detection	NN	I-NP	Oand	characterization	and	CC	I-NP	Ocharacterization	of	characterization	NN	I-NP	Oof	such	of	IN	B-PP	Osuch	rare	such	JJ	B-NP	Orare	cells	rare	JJ	I-NP	Ocells	.	cell	NNS	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	utilized	we	PRP	B-NP	Outilized	this	utilize	VBD	B-VP	Othis	technology	this	DT	B-NP	Otechnology	to	technology	NN	I-NP	Oto	identify	to	TO	B-VP	Oidentify	HLA	identify	VB	I-VP	OHLA	DQ	HLA	NN	B-NP	B-proteinDQ	#NAME?	DQ	NN	I-NP	I-protein#NAME?	Ag-specific	#NAME?	JJ	I-NP	OAg-specific	T	Ag-specific	JJ	I-NP	OT	cells	T	NN	I-NP	Ocells	in	cell	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	peripheral	the	DT	B-NP	Operipheral	blood	peripheral	JJ	I-NP	Oblood	of	blood	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	subjects	human	JJ	B-NP	Osubjects	and	subject	NNS	I-NP	Oand	to	and	CC	O	Oto	identify	to	TO	B-VP	Oidentify	immunodominant	identify	VB	I-VP	Oimmunodominant	epitopes	immunodominant	JJ	B-NP	B-proteinepitopes	associated	epitope	NNS	I-NP	I-proteinassociated	with	associate	VBN	B-VP	Owith	viral	with	IN	B-PP	Oviral	infection	viral	JJ	B-NP	Oinfection	.	infection	NN	I-NP	O.	Peptides	.	.	O	OPeptides	representing	Peptide	NNS	B-NP	Orepresenting	potential	represent	VBG	B-VP	Opotential	epitope	potential	JJ	B-NP	Oepitope	regions	epitope	NN	I-NP	Oregions	of	region	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	VP16	the	DT	B-NP	OVP16	protein	VP16	NN	I-NP	B-proteinprotein	from	protein	NN	I-NP	I-proteinfrom	HSV-2	from	IN	B-PP	OHSV-2	were	HSV-2	NN	B-NP	Owere	loaded	be	VBD	B-VP	Oloaded	onto	load	VBN	I-VP	Oonto	recombinant	onto	IN	B-PP	Orecombinant	DQ0602	recombinant	JJ	B-NP	B-proteinDQ0602	molecules	DQ0602	NN	I-NP	I-proteinmolecules	to	molecule	NNS	I-NP	I-proteinto	generate	to	TO	B-VP	Ogenerate	a	generate	VB	I-VP	Oa	panel	a	DT	B-NP	Opanel	of	panel	NN	I-NP	Oof	Ag-specific	of	IN	B-PP	OAg-specific	DQ0602	Ag-specific	JJ	B-NP	ODQ0602	tetramers	DQ0602	NN	I-NP	Otetramers	.	tetramer	NNS	I-NP	O.	VP16	.	.	O	OVP16	Ag	VP16	NN	B-NP	B-proteinAg	#NAME?	Ag	NN	I-NP	I-protein#NAME?	DQ-restricted	#NAME?	JJ	I-NP	ODQ-restricted	T	DQ-restricted	JJ	I-NP	OT	cells	T	NN	I-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	identified	be	VBD	B-VP	Oidentified	and	identify	VBN	I-VP	Oand	expanded	and	CC	O	Oexpanded	from	expand	VBN	B-VP	Ofrom	the	from	IN	B-PP	Othe	peripheral	the	DT	B-NP	Operipheral	blood	peripheral	JJ	I-NP	Oblood	of	blood	NN	I-NP	Oof	HSV-2-infected	of	IN	B-PP	OHSV-2-infected	individuals	HSV-2-infected	JJ	B-NP	Oindividuals	","	individual	NNS	I-NP	O","	representing	","	","	O	Orepresenting	two	represent	VBG	B-VP	Otwo	predominant	two	CD	B-NP	Opredominant	epitope	predominant	JJ	I-NP	Oepitope	specificities	epitope	NN	I-NP	Ospecificities	.	specificity	NNS	I-NP	O.	Although	.	.	O	OAlthough	the	Although	IN	B-SBAR	Othe	VP16	the	DT	B-NP	OVP16	369-380	VP16	NN	I-NP	O369-380	peptide	369-380	CD	I-NP	Opeptide	has	peptide	NN	I-NP	Ohas	a	have	VBZ	B-VP	Oa	lower	a	DT	B-NP	Olower	binding	low	JJR	I-NP	Obinding	affinity	binding	NN	I-NP	Oaffinity	for	affinity	NN	I-NP	Ofor	DQ0602	for	IN	B-PP	ODQ0602	molecules	DQ0602	NN	B-NP	B-proteinmolecules	than	molecule	NNS	I-NP	I-proteinthan	the	than	IN	B-PP	Othe	VP16	the	DT	B-NP	OVP16	33-52	VP16	NN	I-NP	O33-52	peptide	33-52	CD	I-NP	Opeptide	","	peptide	NN	I-NP	O","	T	","	","	O	OT	cells	T	NN	B-NP	B-cell_typecells	that	cell	NNS	I-NP	I-cell_typethat	recognized	that	WDT	B-NP	Orecognized	the	recognize	VBD	B-VP	Othe	VP16	the	DT	B-NP	OVP16	369-380	VP16	NN	I-NP	O369-380	peptide	369-380	CD	I-NP	Opeptide	occurred	peptide	NN	I-NP	Ooccurred	at	occur	VBD	B-VP	Oat	a	at	IN	B-PP	Oa	much	a	DT	B-NP	Omuch	higher	much	RB	I-NP	Ohigher	frequency	high	JJR	I-NP	Ofrequency	than	frequency	NN	I-NP	Othan	those	than	IN	B-PP	Othose	that	those	DT	B-NP	Othat	were	that	WDT	B-NP	Owere	specific	be	VBD	B-VP	Ospecific	for	specific	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	VP16	the	DT	B-NP	OVP16	33-52	VP16	NN	I-NP	O33-52	peptide	33-52	CD	I-NP	Opeptide	.	peptide	NN	I-NP	O.	Down-regulation	.	.	O	ODown-regulation	of	Down-regulation	NN	B-NP	Oof	BOB.1/OBF.1	of	IN	B-PP	OBOB.1/OBF.1	and	BOB.1/OBF.1	NN	B-NP	B-proteinand	2-Oct	and	CC	I-NP	O2-Oct	in	2-Oct	NN	I-NP	B-proteinin	classical	in	IN	B-PP	Oclassical	Hodgkin	classical	JJ	B-NP	OHodgkin	disease	Hodgkin	NN	I-NP	Odisease	but	disease	NN	I-NP	Obut	not	but	CC	B-PP	Onot	in	not	RB	B-PP	Oin	lymphocyte	in	IN	I-PP	Olymphocyte	predominant	lymphocyte	NN	B-NP	B-cell_typepredominant	Hodgkin	predominant	JJ	I-NP	OHodgkin	disease	Hodgkin	NN	I-NP	Odisease	correlates	disease	NN	I-NP	Ocorrelates	with	correlate	VBZ	B-VP	Owith	immunoglobulin	with	IN	B-PP	Oimmunoglobulin	transcription	immunoglobulin	NN	B-NP	B-proteintranscription	.	transcription	NN	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	to	contrast	NN	B-NP	Oto	the	to	TO	B-PP	Othe	tumor	the	DT	B-NP	Otumor	cells	tumor	NN	I-NP	B-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	L	(	(	O	OL	&	L	NN	B-NP	B-cell_type&	H	&	CC	I-NP	I-cell_typeH	cells	H	NN	I-NP	I-cell_typecells	)	cell	NNS	I-NP	I-cell_type)	of	)	)	O	Oof	lymphocyte	of	IN	B-PP	Olymphocyte	predominant	lymphocyte	NN	B-NP	Opredominant	Hodgkin	predominant	JJ	I-NP	OHodgkin	disease	Hodgkin	NN	I-NP	Odisease	(	disease	NN	I-NP	O(	LPHD	(	(	O	OLPHD	)	LPHD	NN	B-NP	O)	","	)	)	O	O","	Hodgkin	","	","	O	OHodgkin	and	Hodgkin	NN	B-NP	B-cell_lineand	Reed-Sternberg	and	CC	O	I-cell_lineReed-Sternberg	(	Reed-Sternberg	NN	B-NP	I-cell_line(	HRS	(	(	O	I-cell_lineHRS	)	HRS	NN	B-NP	I-cell_line)	cells	)	)	O	I-cell_linecells	of	cell	NNS	B-NP	I-cell_lineof	classical	of	IN	B-PP	Oclassical	Hodgkin	classical	JJ	B-NP	OHodgkin	disease	Hodgkin	NN	I-NP	Odisease	(	disease	NN	I-NP	O(	cHD	(	(	O	OcHD	)	cHD	NN	B-NP	O)	are	)	)	O	Oare	unable	be	VBP	B-VP	Ounable	to	unable	JJ	B-ADJP	Oto	transcribe	to	TO	B-VP	Otranscribe	immunoglobulin	transcribe	VB	I-VP	Oimmunoglobulin	","	immunoglobulin	NN	B-NP	B-protein","	despite	","	","	O	Odespite	the	despite	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	rearranged	of	IN	B-PP	Orearranged	immunoglobulin	rearrange	VBN	B-NP	Oimmunoglobulin	genes	immunoglobulin	NN	I-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Although	.	.	O	OAlthough	initial	Although	IN	B-SBAR	Oinitial	studies	initial	JJ	B-NP	Ostudies	have	study	NNS	I-NP	Ohave	suggested	have	VBP	B-VP	Osuggested	crippling	suggest	VBN	I-VP	Ocrippling	immunoglobulin	cripple	VBG	I-VP	Oimmunoglobulin	gene	immunoglobulin	NN	B-NP	B-DNAgene	mutations	gene	NN	I-NP	I-DNAmutations	to	mutation	NNS	I-NP	Oto	be	to	TO	B-VP	Obe	the	be	VB	I-VP	Othe	cause	the	DT	B-NP	Ocause	of	cause	NN	I-NP	Oof	absent	of	IN	B-PP	Oabsent	immunoglobulin	absent	JJ	B-NP	Oimmunoglobulin	expression	immunoglobulin	NN	I-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	cHD	in	IN	B-PP	OcHD	","	cHD	NN	B-NP	O","	recent	","	","	O	Orecent	work	recent	JJ	B-NP	Owork	of	work	NN	I-NP	Oof	our	of	IN	B-PP	Oour	group	our	PRP$	B-NP	Ogroup	has	group	NN	I-NP	Ohas	demonstrated	have	VBZ	B-VP	Odemonstrated	an	demonstrate	VBN	I-VP	Oan	impaired	an	DT	B-NP	Oimpaired	activation	impaired	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	immunoglobulin	the	DT	B-NP	Oimmunoglobulin	promoter	immunoglobulin	NN	I-NP	B-DNApromoter	as	promoter	NN	I-NP	I-DNAas	a	as	IN	B-PP	Oa	superior	a	DT	B-NP	Osuperior	mechanism	superior	JJ	I-NP	Omechanism	.	mechanism	NN	I-NP	O.	As	.	.	O	OAs	immunoglobulin	As	IN	B-SBAR	Oimmunoglobulin	transcription	immunoglobulin	NN	B-NP	B-proteintranscription	is	transcription	NN	I-NP	Ois	mainly	be	VBZ	B-VP	Omainly	regulated	mainly	RB	I-VP	Oregulated	by	regulate	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	B-cell	the	DT	B-NP	OB-cell	transcription	B-cell	NN	I-NP	B-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	2-Oct	factor	NNS	I-NP	I-protein2-Oct	and	2-Oct	NN	B-NP	B-proteinand	BOB.1/OBF.1	and	CC	I-NP	OBOB.1/OBF.1	","	BOB.1/OBF.1	NN	I-NP	B-protein","	we	","	","	O	Owe	analyzed	we	PRP	B-NP	Oanalyzed	35	analyze	VBD	B-VP	O35	cases	35	CD	B-NP	Ocases	of	case	NNS	I-NP	Oof	LPHD	of	IN	B-PP	OLPHD	","	LPHD	NN	B-NP	O","	32	","	","	O	O32	cases	32	CD	B-NP	Ocases	of	case	NNS	I-NP	Oof	cHD	of	IN	B-PP	OcHD	","	cHD	NN	B-NP	O","	and	","	","	O	Oand	2	and	CC	O	O2	Hodgkin	2	CD	B-NP	OHodgkin	disease	Hodgkin	NN	I-NP	B-cell_linedisease	cell	disease	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	for	line	NNS	I-NP	I-cell_linefor	the	for	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	these	of	IN	B-PP	Othese	transcription	these	DT	B-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	and	factor	NNS	I-NP	I-proteinand	also	and	CC	O	Oalso	in	also	RB	B-ADVP	Oin	parallel	in	IN	B-PP	Oparallel	for	parallel	NN	B-NP	Ofor	immunoglobulin	for	IN	B-PP	Oimmunoglobulin	expression	immunoglobulin	NN	B-NP	B-proteinexpression	.	expression	NN	I-NP	O.	Our	.	.	O	OOur	results	Our	PRP$	B-NP	Oresults	demonstrate	result	NNS	I-NP	Odemonstrate	an	demonstrate	VBP	B-VP	Oan	absence	an	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	2-Oct	of	IN	B-PP	O2-Oct	and/or	2-Oct	NN	B-NP	B-proteinand/or	BOB.1/OBF.1	and/or	CC	I-NP	OBOB.1/OBF.1	in	BOB.1/OBF.1	NN	I-NP	B-proteinin	cHD	in	IN	B-PP	OcHD	and	cHD	NN	B-NP	Oand	a	and	CC	O	Oa	striking	a	DT	B-NP	Ostriking	overexpression	striking	JJ	I-NP	Ooverexpression	of	overexpression	NN	I-NP	Oof	2-Oct	of	IN	B-PP	O2-Oct	in	2-Oct	NN	B-NP	B-proteinin	LPHD	in	IN	B-PP	OLPHD	.	LPHD	NN	B-NP	O.	Immunoglobulin	.	.	O	OImmunoglobulin	expression	Immunoglobulin	NN	B-NP	B-proteinexpression	was	expression	NN	I-NP	Owas	lacking	be	VBD	B-VP	Olacking	in	lack	VBG	I-VP	Oin	cHD	in	IN	B-PP	OcHD	but	cHD	NN	B-NP	Obut	present	but	CC	O	Opresent	in	present	JJ	B-ADJP	Oin	LPHD	in	IN	B-PP	OLPHD	.	LPHD	NN	B-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	the	","	","	O	Othe	reintroduction	the	DT	B-NP	Oreintroduction	of	reintroduction	NN	I-NP	Oof	BOB.1/OBF.1	of	IN	B-PP	OBOB.1/OBF.1	and	BOB.1/OBF.1	NN	B-NP	B-proteinand	2-Oct	and	CC	I-NP	O2-Oct	into	2-Oct	NN	I-NP	B-proteininto	cultured	into	IN	B-PP	Ocultured	HRS	culture	VBN	B-NP	B-cell_lineHRS	cells	HRS	NN	I-NP	I-cell_linecells	restored	cell	NNS	I-NP	I-cell_linerestored	the	restore	VBD	B-VP	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	cotransduced	of	IN	B-PP	Ocotransduced	immunoglobulin	cotransduce	VBN	B-NP	Oimmunoglobulin	promoter	immunoglobulin	NN	I-NP	B-DNApromoter	constructs	promoter	NN	I-NP	I-DNAconstructs	.	construct	NNS	I-NP	I-DNA.	Our	.	.	O	OOur	findings	Our	PRP$	B-NP	Ofindings	dismiss	finding	NNS	I-NP	Odismiss	the	dismiss	VBP	B-VP	Othe	concept	the	DT	B-NP	Oconcept	that	concept	NN	I-NP	Othat	the	that	IN	B-SBAR	Othe	different	the	DT	B-NP	Odifferent	immunoglobulin	different	JJ	I-NP	Oimmunoglobulin	expression	immunoglobulin	NN	I-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	cHD	in	IN	B-PP	OcHD	and	cHD	NN	B-NP	Oand	LPHD	and	CC	I-NP	OLPHD	is	LPHD	NN	I-NP	Ois	due	be	VBZ	B-VP	Odue	to	due	JJ	B-ADJP	Oto	disrupting	to	TO	B-PP	Odisrupting	mutations	disrupt	VBG	B-VP	Omutations	of	mutation	NNS	B-NP	Oof	immunoglobulin	of	IN	B-PP	Oimmunoglobulin	V	immunoglobulin	NN	B-NP	B-DNAV	genes	V	NN	I-NP	I-DNAgenes	in	gene	NNS	I-NP	I-DNAin	cHD	in	IN	B-PP	OcHD	but	cHD	NN	B-NP	Obut	is	but	CC	O	Ois	most	be	VBZ	B-VP	Omost	likely	most	RBS	B-ADVP	Olikely	due	likely	RB	I-ADVP	Odue	to	due	IN	B-PP	Oto	a	to	TO	B-PP	Oa	down-regulation	a	DT	B-NP	Odown-regulation	of	down-regulation	NN	I-NP	Oof	2-Oct	of	IN	B-PP	O2-Oct	and/or	2-Oct	NN	B-NP	B-proteinand/or	BOB.1/OBF.1	and/or	CC	I-NP	OBOB.1/OBF.1	.	BOB.1/OBF.1	NN	I-NP	B-protein.	This	.	.	O	OThis	study	This	DT	B-NP	Ostudy	further	study	NN	I-NP	Ofurther	revealed	further	RBR	B-ADVP	Orevealed	2-Oct	reveal	VBD	B-VP	O2-Oct	as	2-Oct	NN	B-NP	B-proteinas	a	as	IN	B-PP	Oa	new	a	DT	B-NP	Onew	and	new	JJ	I-NP	Oand	valuable	and	CC	I-NP	Ovaluable	marker	valuable	JJ	I-NP	Omarker	for	marker	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	identification	the	DT	B-NP	Oidentification	of	identification	NN	I-NP	Oof	L	of	IN	B-PP	OL	&	L	NN	B-NP	B-cell_type&	H	&	CC	I-NP	I-cell_typeH	cells	H	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	their	and	CC	O	Otheir	distinction	their	PRP$	B-NP	Odistinction	from	distinction	NN	I-NP	Ofrom	HRS	from	IN	B-PP	OHRS	cells	HRS	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	The	.	.	O	OThe	impairment	The	DT	B-NP	Oimpairment	of	impairment	NN	I-NP	Oof	immunoglobulin	of	IN	B-PP	Oimmunoglobulin	transcription	immunoglobulin	NN	B-NP	Otranscription	with	transcription	NN	I-NP	Owith	a	with	IN	B-PP	Oa	down-regulated	a	DT	B-NP	Odown-regulated	synthesis	down-regulated	JJ	I-NP	Osynthesis	of	synthesis	NN	I-NP	Oof	2-Oct	of	IN	B-PP	O2-Oct	and	2-Oct	NN	B-NP	B-proteinand	BOB.1/OBF.1	and	CC	I-NP	OBOB.1/OBF.1	is	BOB.1/OBF.1	NN	I-NP	B-proteinis	the	be	VBZ	B-VP	Othe	first	the	DT	B-NP	Ofirst	established	first	JJ	I-NP	Oestablished	general	establish	VBN	I-NP	Ogeneral	recurrent	general	JJ	I-NP	Orecurrent	defect	recurrent	JJ	I-NP	Odefect	found	defect	NN	I-NP	Ofound	in	find	VBN	B-VP	Oin	HRS	in	IN	B-PP	OHRS	cells	HRS	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Constitutive	.	.	O	OConstitutive	expression	Constitutive	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	is	B	NN	I-NP	I-proteinis	a	be	VBZ	B-VP	Oa	characteristic	a	DT	B-NP	Ocharacteristic	feature	characteristic	JJ	I-NP	Ofeature	of	feature	NN	I-NP	Oof	mycosis	of	IN	B-PP	Omycosis	fungoides	mycosis	NN	B-NP	Ofungoides	:	fungoide	NNS	I-NP	O:	implications	:	:	O	Oimplications	for	implication	NNS	B-NP	Ofor	apoptosis	for	IN	B-PP	Oapoptosis	resistance	apoptosis	NN	B-NP	Oresistance	and	resistance	NN	I-NP	Oand	pathogenesis	and	CC	I-NP	Opathogenesis	.	pathogenesis	NN	I-NP	O.	The	.	.	O	OThe	NF-kappa	The	DT	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	family	B	NN	I-NP	I-proteinfamily	of	family	NN	I-NP	I-proteinof	transcription	of	IN	B-PP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	is	factor	NNS	I-NP	I-proteinis	an	be	VBZ	B-VP	Oan	important	an	DT	B-NP	Oimportant	regulator	important	JJ	I-NP	Oregulator	of	regulator	NN	I-NP	Oof	genes	of	IN	B-PP	Ogenes	expressed	gene	NNS	B-NP	B-DNAexpressed	during	express	VBN	B-VP	Oduring	inflammatory	during	IN	B-PP	Oinflammatory	responses	inflammatory	JJ	B-NP	Oresponses	","	response	NNS	I-NP	O","	immunoglobulin	","	","	O	Oimmunoglobulin	(	immunoglobulin	NN	B-NP	B-protein(	Ig	(	(	O	OIg	)	Ig	NN	B-NP	O)	class	)	)	O	Oclass	switching	class	NN	B-NP	Oswitching	","	switching	NN	I-NP	O","	cellular	","	","	O	Ocellular	differentiation	cellular	JJ	B-NP	Odifferentiation	","	differentiation	NN	I-NP	O","	and	","	","	O	Oand	apoptosis	and	CC	O	Oapoptosis	.	apoptosis	NN	B-NP	O.	Recently	.	.	O	ORecently	","	Recently	RB	B-ADVP	O","	members	","	","	O	Omembers	of	member	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	NF-kappaB	the	DT	B-NP	ONF-kappaB	family	NF-kappaB	NN	I-NP	B-proteinfamily	","	family	NN	I-NP	I-protein","	including	","	","	O	Oincluding	p65	include	VBG	B-PP	Op65	(	p65	NN	B-NP	B-protein(	Rel	(	(	O	ORel	A	Rel	NN	B-NP	B-proteinA	)	A	NN	I-NP	I-protein)	","	)	)	O	O","	have	","	","	O	Ohave	been	have	VBP	B-VP	Obeen	implicated	be	VBN	I-VP	Oimplicated	in	implicate	VBN	I-VP	Oin	promoting	in	IN	B-PP	Opromoting	survival	promote	VBG	B-VP	Osurvival	of	survival	NN	B-NP	Oof	various	of	IN	B-PP	Ovarious	hematopoeitic	various	JJ	B-NP	Ohematopoeitic	neoplasms	hematopoeitic	JJ	I-NP	B-cell_typeneoplasms	","	neoplasm	NNS	I-NP	I-cell_type","	including	","	","	O	Oincluding	T	include	VBG	B-PP	OT	cell	T	NN	B-NP	Ocell	malignancies	cell	NN	I-NP	Omalignancies	such	malignancy	NNS	I-NP	Osuch	as	such	JJ	B-PP	Oas	adult	as	IN	I-PP	Oadult	T	adult	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	leukemia-lymphoma	cell	NN	I-NP	Oleukemia-lymphoma	.	leukemia-lymphoma	NN	I-NP	O.	We	.	.	O	OWe	investigated	We	PRP	B-NP	Oinvestigated	the	investigate	VBD	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	active	of	IN	B-PP	Oactive	NF-kappa	active	JJ	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	p65	B	NN	I-NP	I-proteinp65	(	p65	NN	I-NP	O(	Rel	(	(	O	ORel	A	Rel	NN	B-NP	B-proteinA	)	A	NN	I-NP	I-protein)	in	)	)	O	Oin	cases	in	IN	B-PP	Ocases	of	case	NNS	B-NP	Oof	mycosis	of	IN	B-PP	Omycosis	fungoides	mycosis	NN	B-NP	Ofungoides	(	fungoide	NNS	I-NP	O(	MF	(	(	O	OMF	)	MF	NNS	B-NP	B-protein)	and	)	)	O	Oand	the	and	CC	O	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	chemical	of	IN	B-PP	Ochemical	inhibitors	chemical	JJ	B-NP	Oinhibitors	of	inhibitor	NNS	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	on	B	NN	I-NP	I-proteinon	apoptosis	on	IN	B-PP	Oapoptosis	in	apoptosis	NN	B-NP	Oin	cutaneous	in	IN	B-PP	Ocutaneous	T	cutaneous	JJ	B-NP	B-cell_lineT	cell	T	NN	I-NP	I-cell_linecell	lymphoma	cell	NN	I-NP	I-cell_linelymphoma	(	lymphoma	NN	I-NP	I-cell_line(	CTCL	(	(	O	I-cell_lineCTCL	)	CTCL	NN	B-NP	I-cell_line)	cell	)	)	O	I-cell_linecell	lines	cell	NN	B-NP	I-cell_linelines	.	line	NNS	I-NP	I-cell_line.	Paraffin-embedded	.	.	O	OParaffin-embedded	tissues	Paraffin-embedded	JJ	B-NP	Otissues	from	tissue	NNS	I-NP	Ofrom	23	from	IN	B-PP	O23	cutaneous	23	CD	B-NP	Ocutaneous	lesions	cutaneous	JJ	I-NP	Olesions	and	lesion	NNS	I-NP	Oand	a	and	CC	O	Oa	single	a	DT	B-NP	Osingle	lymph	single	JJ	I-NP	Olymph	node	lymph	NN	I-NP	Onode	biopsy	node	NN	I-NP	Obiopsy	from	biopsy	NN	I-NP	Ofrom	patients	from	IN	B-PP	Opatients	diagnosed	patient	NNS	B-NP	Odiagnosed	with	diagnose	VBN	B-VP	Owith	MF	with	IN	B-PP	OMF	were	MF	NN	B-NP	Owere	evaluated	be	VBD	B-VP	Oevaluated	for	evaluate	VBN	I-VP	Ofor	p65	for	IN	B-PP	Op65	(	p65	NN	B-NP	B-protein(	Rel	(	(	O	ORel	A	Rel	NN	B-NP	B-proteinA	)	A	NN	I-NP	I-protein)	expression	)	)	O	Oexpression	by	expression	NN	B-NP	Oby	using	by	IN	B-PP	Ousing	a	use	VBG	B-VP	Oa	monoclonal	a	DT	B-NP	Omonoclonal	mouse	monoclonal	JJ	I-NP	B-proteinmouse	antibody	mouse	NN	I-NP	I-proteinantibody	that	antibody	NN	I-NP	I-proteinthat	detects	that	WDT	B-NP	Odetects	the	detect	VBZ	B-VP	Othe	activated	the	DT	B-NP	Oactivated	form	activated	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	p65	of	IN	B-PP	Op65	(	p65	NN	B-NP	B-protein(	Rel	(	(	O	ORel	A	Rel	NN	B-NP	B-proteinA	)	A	NN	I-NP	I-protein)	.	)	)	O	O.	Apoptosis	.	.	O	OApoptosis	after	Apoptosis	NN	B-NP	Oafter	treatment	after	IN	B-PP	Otreatment	with	treatment	NN	B-NP	Owith	the	with	IN	B-PP	Othe	NF-kappa	the	DT	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	inhibitors	B	NN	I-NP	I-proteininhibitors	gliotoxin	inhibitor	NNS	I-NP	Ogliotoxin	","	gliotoxin	NN	I-NP	O","	MG132	","	","	O	OMG132	","	MG132	NN	B-NP	O","	BAY	","	","	O	OBAY	Nov-82	BAY	NN	B-NP	ONov-82	","	Nov-82	CD	I-NP	O","	and	","	","	O	Oand	BAY	and	CC	O	OBAY	Nov-85	BAY	NN	B-NP	ONov-85	was	Nov-85	CD	I-NP	Owas	quantitatively	be	VBD	B-VP	Oquantitatively	measured	quantitatively	RB	I-VP	Omeasured	in	measure	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	CTCL	the	DT	B-NP	OCTCL	cell	CTCL	NN	I-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	HuT-78	line	NNS	I-NP	I-cell_lineHuT-78	and	HuT-78	NN	B-NP	B-cell_lineand	HH	and	CC	O	OHH	by	HH	NN	B-NP	Oby	propidium	by	IN	B-PP	Opropidium	iodide	propidium	NN	B-NP	Oiodide	(	iodide	NN	I-NP	O(	PI	(	(	O	OPI	)	PI	NN	B-NP	O)	/cell	)	)	O	O/cell	cycle	/cell	VBP	B-VP	Ocycle	analysis	cycle	NN	B-NP	Oanalysis	for	analysis	NN	I-NP	Ofor	detection	for	IN	B-PP	Odetection	of	detection	NN	B-NP	Oof	a	of	IN	B-PP	Oa	hypodiploid	a	DT	B-NP	Ohypodiploid	(	hypodiploid	JJ	I-NP	O(	sub-G	(	(	O	Osub-G	(	sub-G	NN	B-NP	O(	0	(	(	O	O0	)	0	CD	B-NP	O)	)	)	)	O	O)	population	)	)	O	Opopulation	and	population	NN	B-NP	Oand	by	and	CC	B-PP	Oby	determination	by	IN	B-PP	Odetermination	of	determination	NN	B-NP	Oof	increased	of	IN	B-PP	Oincreased	Annexin	increase	VBN	B-NP	OAnnexin	V/7-amino-actinomycin	Annexin	NN	I-NP	OV/7-amino-actinomycin	D	V/7-amino-actinomycin	NN	I-NP	OD	(	D	NN	I-NP	O(	7-AAD	(	(	O	O7-AAD	)	7-AAD	NN	B-NP	O)	expression	)	)	O	Oexpression	.	expression	NN	B-NP	O.	Nuclear	.	.	O	ONuclear	extracts	Nuclear	JJ	B-NP	Oextracts	from	extract	NNS	I-NP	Ofrom	CTCL	from	IN	B-PP	OCTCL	cells	CTCL	NN	B-NP	B-cell_linecells	before	cell	NNS	I-NP	I-cell_linebefore	and	before	IN	B-PP	Oand	after	and	CC	I-PP	Oafter	chemical	after	IN	I-PP	Ochemical	inhibition	chemical	JJ	B-NP	Oinhibition	were	inhibition	NN	I-NP	Owere	analyzed	be	VBD	B-VP	Oanalyzed	for	analyze	VBN	I-VP	Ofor	NF-kappa	for	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	nuclear	B	NN	I-NP	I-proteinnuclear	DNA-binding	nuclear	JJ	I-NP	ODNA-binding	activity	DNA-binding	JJ	I-NP	Oactivity	by	activity	NN	I-NP	Oby	electrophoretic	by	IN	B-PP	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assay	shift	NN	I-NP	Oassay	(	assay	NN	I-NP	O(	EMSA	(	(	O	OEMSA	)	EMSA	NN	B-NP	O)	with	)	)	O	Owith	quantitative	with	IN	B-PP	Oquantitative	densitometry	quantitative	JJ	B-NP	Odensitometry	.	densitometry	NN	I-NP	O.	Nuclear	.	.	O	ONuclear	expression	Nuclear	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	p65	of	IN	B-PP	Op65	(	p65	NN	B-NP	O(	Rel	(	(	O	ORel	A	Rel	NN	B-NP	B-proteinA	)	A	NN	I-NP	I-protein)	before	)	)	O	Obefore	and	before	IN	B-PP	Oand	after	and	CC	I-PP	Oafter	treatment	after	IN	I-PP	Otreatment	with	treatment	NN	B-NP	Owith	the	with	IN	B-PP	Othe	various	the	DT	B-NP	Ovarious	inhibitory	various	JJ	I-NP	Oinhibitory	compounds	inhibitory	JJ	I-NP	Ocompounds	was	compound	NNS	I-NP	Owas	measured	be	VBD	B-VP	Omeasured	by	measure	VBN	I-VP	Oby	immunofluorescence	by	IN	B-PP	Oimmunofluorescence	staining	immunofluorescence	NN	B-NP	Ostaining	in	staining	NN	I-NP	Oin	each	in	IN	B-PP	Oeach	CTCL	each	DT	B-NP	OCTCL	cell	CTCL	NN	I-NP	B-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	.	line	NN	I-NP	I-cell_line.	Neoplastic	.	.	O	ONeoplastic	T	Neoplastic	JJ	B-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	from	lymphocyte	NNS	I-NP	I-cell_typefrom	22	from	IN	B-PP	O22	of	22	CD	B-NP	Oof	24	of	IN	B-PP	O24	cases	24	CD	B-NP	Ocases	of	case	NNS	I-NP	Oof	MF	of	IN	B-PP	OMF	showed	MF	NN	B-NP	Oshowed	strong	show	VBD	B-VP	Ostrong	nuclear	strong	JJ	B-NP	Onuclear	and	nuclear	JJ	I-NP	Oand	cytoplasmic	and	CC	I-NP	Ocytoplasmic	expression	cytoplasmic	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	active	of	IN	B-PP	Oactive	p65	active	JJ	B-NP	Op65	(	p65	NN	I-NP	O(	Rel	(	(	O	ORel	A	Rel	NN	B-NP	B-proteinA	)	A	NN	I-NP	I-protein)	.	)	)	O	O.	Compared	.	.	O	OCompared	with	Compare	VBN	B-PP	Owith	untreated	with	IN	B-PP	Ountreated	control	untreated	JJ	B-NP	B-cell_typecontrol	cells	control	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	a	","	","	O	Oa	marked	a	DT	B-NP	Omarked	increase	marked	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	apoptosis	in	IN	B-PP	Oapoptosis	","	apoptosis	NN	B-NP	O","	a	","	","	O	Oa	significant	a	DT	B-NP	Osignificant	decrease	significant	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	NF-kappa	in	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	DNA-binding	B	NN	I-NP	I-proteinDNA-binding	activity	DNA-binding	JJ	I-NP	Oactivity	","	activity	NN	I-NP	O","	and	","	","	O	Oand	a	and	CC	O	Oa	marked	a	DT	B-NP	Omarked	decrease	marked	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	nuclear	in	IN	B-PP	Onuclear	p65	nuclear	JJ	B-NP	Op65	(	p65	NN	I-NP	O(	Rel	(	(	O	ORel	A	Rel	NN	B-NP	B-proteinA	)	A	NN	I-NP	I-protein)	expression	)	)	O	Oexpression	were	expression	NN	B-NP	Owere	seen	be	VBD	B-VP	Oseen	in	see	VBN	I-VP	Oin	cells	in	IN	B-PP	Ocells	from	cell	NNS	B-NP	Ofrom	both	from	IN	B-PP	Oboth	CTCL	both	CC	O	OCTCL	cell	CTCL	NN	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	after	line	NNS	I-NP	I-cell_lineafter	chemical	after	IN	B-PP	Ochemical	NF-kappa	chemical	JJ	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	inhibition	B	NN	I-NP	I-proteininhibition	.	inhibition	NN	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	show	datum	NNS	I-NP	Oshow	that	show	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	active	the	DT	B-NP	Oactive	form	active	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	p65	B	NN	I-NP	I-proteinp65	(	p65	NN	I-NP	I-protein(	Rel	(	(	O	ORel	A	Rel	NN	B-NP	B-proteinA	)	A	NN	I-NP	I-protein)	is	)	)	O	Ois	commonly	be	VBZ	B-VP	Ocommonly	expressed	commonly	RB	I-VP	Oexpressed	in	express	VBN	I-VP	Oin	neoplastic	in	IN	B-PP	Oneoplastic	T	neoplastic	JJ	B-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	in	lymphocyte	NNS	I-NP	I-cell_typein	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	MF	with	IN	B-PP	OMF	.	MF	NN	B-NP	O.	In	.	.	O	OIn	CTCL	In	IN	B-PP	OCTCL	cell	CTCL	NN	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	","	line	NNS	I-NP	I-cell_line","	the	","	","	O	Othe	significant	the	DT	B-NP	Osignificant	decrease	significant	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	nuclear	in	IN	B-PP	Onuclear	NF-kappa	nuclear	JJ	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	expression	B	NN	I-NP	I-proteinexpression	and	expression	NN	I-NP	Oand	the	and	CC	O	Othe	marked	the	DT	B-NP	Omarked	increase	marked	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	spontaneous	in	IN	B-PP	Ospontaneous	apoptosis	spontaneous	JJ	B-NP	Oapoptosis	caused	apoptosis	NN	I-NP	Ocaused	by	cause	VBN	B-VP	Oby	chemical	by	IN	B-PP	Ochemical	NF-kappa	chemical	JJ	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	inhibition	B	NN	I-NP	I-proteininhibition	suggest	inhibition	NN	I-NP	Osuggest	a	suggest	VBP	B-VP	Oa	critical	a	DT	B-NP	Ocritical	role	critical	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	NF-kappa	for	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	in	B	NN	I-NP	I-proteinin	the	in	IN	B-PP	Othe	pathogenesis	the	DT	B-NP	Opathogenesis	and	pathogenesis	NN	I-NP	Oand	tumor	and	CC	I-NP	Otumor	cell	tumor	NN	I-NP	Ocell	maintenance	cell	NN	I-NP	Omaintenance	of	maintenance	NN	I-NP	Oof	CTCLs	of	IN	B-PP	OCTCLs	.	CTCLs	NN	B-NP	B-protein.	HUM	.	.	O	OHUM	PATHOL	HUM	NN	B-NP	OPATHOL	31	PATHOL	NN	I-NP	O31	:	31	CD	I-NP	O:	1482-1490	:	:	O	O1482-1490	.	1482-1490	CD	B-NP	O.	Human	.	.	O	OHuman	T-cell	Human	JJ	B-NP	B-proteinT-cell	leukemia	T-cell	NN	I-NP	I-proteinleukemia	virus	leukemia	NN	I-NP	I-proteinvirus	type	virus	NN	I-NP	I-proteintype	1	type	NN	I-NP	I-protein1	tax	1	CD	I-NP	I-proteintax	protein	tax	NN	I-NP	I-proteinprotein	activates	protein	NN	I-NP	I-proteinactivates	transcription	activate	VBZ	B-VP	Otranscription	through	transcription	NN	B-NP	Othrough	AP-1	through	IN	B-PP	OAP-1	site	AP-1	NN	B-NP	B-DNAsite	by	site	NN	I-NP	I-DNAby	inducing	by	IN	B-PP	Oinducing	DNA	induce	VBG	B-VP	ODNA	binding	DNA	NN	B-NP	Obinding	activity	binding	NN	I-NP	Oactivity	in	activity	NN	I-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Human	.	.	O	OHuman	T-cell	Human	JJ	B-NP	B-proteinT-cell	leukemia	T-cell	NN	I-NP	I-proteinleukemia	virus	leukemia	NN	I-NP	I-proteinvirus	type	virus	NN	I-NP	I-proteintype	1	type	NN	I-NP	I-protein1	(	1	CD	I-NP	I-protein(	HTLV-1	(	(	O	I-proteinHTLV-1	)	HTLV-1	NN	B-NP	I-protein)	Tax	)	)	O	I-proteinTax	protein	Tax	NN	B-NP	I-proteinprotein	induces	protein	NN	I-NP	I-proteininduces	the	induce	VBZ	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	various	of	IN	B-PP	Ovarious	family	various	JJ	B-NP	Ofamily	members	family	NN	I-NP	Omembers	of	member	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	AP-1	factor	NN	I-NP	I-proteinAP-1	","	AP-1	NN	I-NP	B-protein","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	c-Jun	as	IN	I-PP	Oc-Jun	","	c-Jun	NN	B-NP	B-protein","	JunD	","	","	O	OJunD	","	JunD	NN	B-NP	B-protein","	c-Fos	","	","	O	Oc-Fos	","	c-Fos	NN	B-NP	B-protein","	and	","	","	O	Oand	Fra-1	and	CC	O	OFra-1	","	Fra-1	NN	B-NP	B-protein","	at	","	","	O	Oat	the	at	IN	B-PP	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	RNA	of	IN	B-PP	ORNA	expression	RNA	NN	B-NP	Oexpression	in	expression	NN	I-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	examined	We	PRP	B-NP	Oexamined	the	examine	VBD	B-VP	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	Tax	of	IN	B-PP	OTax	in	Tax	NN	B-NP	B-proteinin	transcription	in	IN	B-PP	Otranscription	through	transcription	NN	B-NP	Othrough	AP-1-binding	through	IN	B-PP	OAP-1-binding	sites	AP-1-binding	JJ	B-NP	B-DNAsites	(	site	NNS	I-NP	I-DNA(	AP-1	(	(	O	OAP-1	site	AP-1	NN	B-NP	B-DNAsite	)	site	NN	I-NP	I-DNA)	in	)	)	O	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Transient	.	.	O	OTransient	transfection	Transient	JJ	B-NP	Otransfection	studies	transfection	NN	I-NP	Ostudies	showed	study	NNS	I-NP	Oshowed	that	show	VBD	B-VP	Othat	Tax	that	IN	B-SBAR	OTax	activated	Tax	NN	B-NP	B-proteinactivated	the	activate	VBD	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	a	of	IN	B-PP	Oa	luciferase	a	DT	B-NP	Oluciferase	gene	luciferase	NN	I-NP	B-DNAgene	regulated	gene	NN	I-NP	I-DNAregulated	by	regulate	VBN	B-VP	Oby	two	by	IN	B-PP	Otwo	copies	two	CD	B-NP	Ocopies	of	copy	NNS	I-NP	Oof	an	of	IN	B-PP	Oan	AP-1	an	DT	B-NP	OAP-1	site	AP-1	NN	I-NP	B-DNAsite	in	site	NN	I-NP	I-DNAin	the	in	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	Jurkat	human	JJ	I-NP	B-cell_lineJurkat	T-cell	Jurkat	NN	I-NP	I-cell_lineT-cell	line	T-cell	NN	I-NP	I-cell_lineline	.	line	NN	I-NP	I-cell_line.	Tax	.	.	O	OTax	activates	Tax	NN	B-NP	B-proteinactivates	the	activate	VBZ	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	viral	of	IN	B-PP	Oviral	and	viral	JJ	B-NP	B-DNAand	cellular	and	CC	I-NP	I-DNAcellular	genes	cellular	JJ	I-NP	I-DNAgenes	through	gene	NNS	I-NP	I-DNAthrough	two	through	IN	B-PP	Otwo	different	two	CD	B-NP	Odifferent	enhancers	different	JJ	I-NP	Oenhancers	:	enhancer	NNS	I-NP	B-DNA:	a	:	:	O	Oa	cAMP-responsive	a	DT	O	OcAMP-responsive	(	cAMP-responsive	JJ	O	B-DNA(	CRE	(	(	O	I-DNACRE	)	CRE	NN	B-NP	I-DNA)	#NAME?	)	)	O	I-DNA#NAME?	element	#NAME?	JJ	B-NP	I-DNAelement	and	element	NN	I-NP	I-DNAand	a	and	CC	O	Oa	kappaB	a	DT	B-NP	OkappaB	element	kappaB	NN	I-NP	B-DNAelement	.	element	NN	I-NP	I-DNA.	Two	.	.	O	OTwo	Tax	Two	CD	B-NP	OTax	mutants	Tax	NN	I-NP	B-proteinmutants	differentially	mutant	NNS	I-NP	I-proteindifferentially	activated	differentially	RB	B-ADVP	Oactivated	expression	activate	VBD	B-VP	Oexpression	of	expression	NN	B-NP	Oof	these	of	IN	B-PP	Othese	two	these	DT	B-NP	Otwo	elements	two	CD	I-NP	Oelements	.	element	NNS	I-NP	O.	Tax703	.	.	O	OTax703	preferentially	Tax703	NN	B-NP	B-proteinpreferentially	activated	preferentially	RB	B-ADVP	Oactivated	the	activate	VBD	B-VP	Othe	kappaB	the	DT	B-NP	OkappaB	element	kappaB	NN	I-NP	B-DNAelement	but	element	NN	I-NP	I-DNAbut	not	but	CC	B-NP	Onot	the	not	RB	I-NP	Othe	CRE-like	the	DT	B-NP	OCRE-like	one	CRE-like	JJ	I-NP	Oone	","	one	NN	I-NP	O","	whereas	","	","	O	Owhereas	TaxM22	whereas	IN	O	OTaxM22	showed	TaxM22	NN	B-NP	B-proteinshowed	the	show	VBD	B-VP	Othe	reverse	the	DT	B-NP	Oreverse	.	reverse	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	Tax703	","	","	O	OTax703	and	Tax703	NN	B-NP	B-proteinand	Tax	and	CC	I-NP	OTax	","	Tax	NN	I-NP	B-protein","	but	","	","	B-NP	Obut	not	but	CC	I-NP	Onot	TaxM22	not	RB	I-NP	OTaxM22	","	TaxM22	NN	B-NP	B-protein","	converted	","	","	O	Oconverted	cell	convert	VBD	B-VP	Ocell	growth	cell	NN	B-NP	Ogrowth	of	growth	NN	I-NP	Oof	a	of	IN	B-PP	Oa	mouse	a	DT	B-NP	Omouse	T-cell	mouse	NN	I-NP	B-cell_lineT-cell	line	T-cell	NN	I-NP	I-cell_lineline	from	line	NN	I-NP	I-cell_linefrom	being	from	IN	B-PP	Obeing	interleukin	be	VBG	B-VP	Ointerleukin	(	interleukin	NN	B-NP	O(	IL	(	(	O	OIL	)	IL	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	to	#NAME?	JJ	B-ADJP	Oto	being	to	TO	B-PP	Obeing	IL-2-independent	be	VBG	B-VP	OIL-2-independent	.	IL-2-independent	JJ	B-ADJP	O.	Unlike	.	.	O	OUnlike	the	Unlike	IN	B-PP	Othe	wild-type	the	DT	B-NP	Owild-type	Tax	wild-type	JJ	I-NP	B-proteinTax	","	Tax	NN	I-NP	I-protein","	Tax703	","	","	I-NP	OTax703	and	Tax703	NN	I-NP	B-proteinand	TaxM22	and	CC	I-NP	OTaxM22	only	TaxM22	NN	I-NP	B-proteinonly	weakly	only	RB	B-ADVP	Oweakly	activated	weakly	RB	I-ADVP	Oactivated	the	activate	VBD	B-VP	Othe	AP-1	the	DT	B-NP	OAP-1	site	AP-1	NN	I-NP	B-DNAsite	in	site	NN	I-NP	I-DNAin	the	in	IN	B-PP	Othe	T-cell	the	DT	B-NP	OT-cell	line	T-cell	NN	I-NP	B-cell_lineline	.	line	NN	I-NP	I-cell_line.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	Tax	","	","	O	OTax	seems	Tax	NN	B-NP	B-proteinseems	to	seem	VBZ	B-VP	Oto	activate	to	TO	I-VP	Oactivate	the	activate	VB	I-VP	Othe	AP-1	the	DT	B-NP	OAP-1	site	AP-1	NN	I-NP	B-DNAsite	via	site	NN	I-NP	I-DNAvia	mechanisms	via	IN	B-PP	Omechanisms	distinct	mechanism	NNS	B-NP	Odistinct	from	distinct	JJ	B-ADJP	Ofrom	those	from	IN	B-PP	Othose	of	those	DT	B-NP	Oof	kappaB	of	IN	B-PP	OkappaB	or	kappaB	NN	B-NP	B-proteinor	CRE-like	or	CC	O	OCRE-like	elements	CRE-like	JJ	B-NP	B-DNAelements	","	element	NNS	I-NP	I-DNA","	and	","	","	O	Oand	the	and	CC	O	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	AP-1	the	DT	B-NP	OAP-1	site	AP-1	NN	I-NP	B-DNAsite	is	site	NN	I-NP	I-DNAis	dispensable	be	VBZ	B-VP	Odispensable	for	dispensable	JJ	B-ADJP	Ofor	IL-2-independent	for	IN	B-PP	OIL-2-independent	growth	IL-2-independent	JJ	B-NP	Ogrowth	of	growth	NN	I-NP	Oof	CTLL-2	of	IN	B-PP	OCTLL-2	.	CTLL-2	NN	B-NP	B-protein.	Electrophoretic	.	.	O	OElectrophoretic	mobility	Electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assays	shift	NN	I-NP	Oassays	showed	assay	NNS	I-NP	Oshowed	that	show	VBD	B-VP	Othat	Tax	that	IN	B-SBAR	OTax	induced	Tax	NN	B-NP	B-proteininduced	strong	induce	VBD	B-VP	Ostrong	binding	strong	JJ	B-NP	Obinding	activity	binding	NN	I-NP	Oactivity	to	activity	NN	I-NP	Oto	an	to	TO	B-PP	Oan	AP-1	an	DT	B-NP	OAP-1	site	AP-1	NN	I-NP	B-DNAsite	in	site	NN	I-NP	I-DNAin	CTLL-2	in	IN	B-PP	OCTLL-2	","	CTLL-2	NN	B-NP	B-cell_line","	whereas	","	","	O	Owhereas	Tax703	whereas	IN	O	OTax703	did	Tax703	NN	B-NP	B-proteindid	not	do	VBD	B-VP	Onot	","	not	RB	O	O","	indicating	","	","	O	Oindicating	that	indicate	VBG	B-VP	Othat	the	that	IN	B-SBAR	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	binding	of	IN	B-PP	Obinding	activity	binding	NN	B-NP	Oactivity	to	activity	NN	I-NP	Oto	the	to	TO	B-PP	Othe	AP-1	the	DT	B-NP	OAP-1	site	AP-1	NN	I-NP	B-DNAsite	is	site	NN	I-NP	I-DNAis	essential	be	VBZ	B-VP	Oessential	for	essential	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	activation	transcriptional	JJ	I-NP	Oactivation	by	activation	NN	I-NP	Oby	Tax	by	IN	B-PP	OTax	.	Tax	NN	B-NP	B-protein.	The	.	.	O	OThe	binding	The	DT	B-NP	Obinding	complex	binding	NN	I-NP	B-proteincomplex	induced	complex	NN	I-NP	I-proteininduced	by	induce	VBN	B-VP	Oby	Tax	by	IN	B-PP	OTax	in	Tax	NN	B-NP	B-proteinin	CTLL-2	in	IN	B-PP	OCTLL-2	contained	CTLL-2	NN	B-NP	B-cell_linecontained	JunD	contain	VBD	B-VP	OJunD	and	JunD	NN	B-NP	B-proteinand	Fra-2	and	CC	I-NP	OFra-2	.	Fra-2	NN	I-NP	B-protein.	Other	.	.	O	OOther	AP-1	Other	JJ	B-NP	OAP-1	proteins	AP-1	NN	I-NP	B-proteinproteins	were	protein	NNS	I-NP	I-proteinwere	undetectable	be	VBD	B-VP	Oundetectable	.	undetectable	JJ	B-ADJP	O.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	transcription	of	IN	B-PP	Otranscription	through	transcription	NN	B-NP	Othrough	the	through	IN	B-PP	Othe	AP-1	the	DT	B-NP	OAP-1	site	AP-1	NN	I-NP	B-DNAsite	in	site	NN	I-NP	I-DNAin	Jurkat	in	IN	B-PP	OJurkat	cells	Jurkat	NN	B-NP	B-cell_linecells	by	cell	NNS	I-NP	I-cell_lineby	JunD	by	IN	B-PP	OJunD	and/or	JunD	NN	B-NP	B-proteinand/or	Fra-2	and/or	CC	O	OFra-2	was	Fra-2	NN	B-NP	B-proteinwas	weak	be	VBD	B-VP	Oweak	.	weak	JJ	B-ADJP	O.	c-Jun	.	.	O	Oc-Jun	","	c-Jun	NN	B-NP	B-protein","	JunB	","	","	O	OJunB	","	JunB	NN	B-NP	B-protein","	and	","	","	O	Oand	c-Fos	and	CC	O	Oc-Fos	activation	c-Fos	NN	B-NP	B-proteinactivation	was	activation	NN	I-NP	Owas	greater	be	VBD	B-VP	Ogreater	","	great	JJR	B-ADJP	O","	although	","	","	O	Oalthough	the	although	IN	B-SBAR	Othe	level	the	DT	B-NP	Olevel	was	level	NN	I-NP	Owas	still	be	VBD	B-VP	Ostill	less	still	RB	B-ADJP	Oless	than	less	JJR	I-ADJP	Othan	that	than	IN	B-PP	Othat	with	that	DT	B-NP	Owith	Tax	with	IN	B-PP	OTax	.	Tax	NN	B-NP	B-protein.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	the	","	","	O	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	AP-1	of	IN	B-PP	OAP-1	mRNA	AP-1	NN	B-NP	B-RNAmRNA	by	mRNA	NN	I-NP	I-RNAby	Tax	by	IN	B-PP	OTax	may	Tax	NN	B-NP	B-proteinmay	not	may	MD	B-VP	Onot	be	not	RB	I-VP	Obe	sufficient	be	VB	I-VP	Osufficient	for	sufficient	JJ	B-ADJP	Ofor	a	for	IN	B-PP	Oa	complete	a	DT	B-NP	Ocomplete	activation	complete	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	AP-1	of	IN	B-PP	OAP-1	site	AP-1	NN	B-NP	B-DNAsite	by	site	NN	I-NP	I-DNAby	Tax	by	IN	B-PP	OTax	.	Tax	NN	B-NP	B-protein.	Our	.	.	O	OOur	results	Our	PRP$	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	Tax	that	IN	B-SBAR	OTax	activates	Tax	NN	B-NP	B-proteinactivates	the	activate	VBZ	B-VP	Othe	transcription	the	DT	B-NP	Otranscription	of	transcription	NN	I-NP	Oof	cellular	of	IN	B-PP	Ocellular	genes	cellular	JJ	B-NP	B-DNAgenes	with	gene	NNS	I-NP	I-DNAwith	AP-1	with	IN	B-PP	OAP-1	sites	AP-1	NN	B-NP	B-DNAsites	by	site	NNS	I-NP	I-DNAby	inducing	by	IN	B-PP	Oinducing	the	induce	VBG	B-VP	Othe	DNA-binding	the	DT	B-NP	ODNA-binding	activity	DNA-binding	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	AP-1	of	IN	B-PP	OAP-1	proteins	AP-1	NN	B-NP	B-proteinproteins	in	protein	NNS	I-NP	I-proteinin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	a	","	","	O	Oa	mechanism	a	DT	B-NP	Omechanism	distinct	mechanism	NN	I-NP	Odistinct	from	distinct	JJ	B-ADJP	Ofrom	those	from	IN	B-PP	Othose	of	those	DT	B-NP	Oof	CRE-like	of	IN	B-PP	OCRE-like	and	CRE-like	JJ	B-NP	Oand	kappaB	and	CC	I-NP	OkappaB	elements	kappaB	NN	I-NP	B-DNAelements	.	element	NNS	I-NP	I-DNA.	Copyright	.	.	O	OCopyright	2001	Copyright	NN	B-NP	O2001	Academic	2001	CD	I-NP	OAcademic	Press	Academic	NNP	I-NP	OPress	.	Press	NNP	I-NP	O.	Strict	.	.	O	OStrict	control	Strict	JJ	B-NP	Ocontrol	of	control	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	immunodeficiency	human	JJ	B-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	replication	1	CD	I-NP	Oreplication	by	replication	NN	I-NP	Oby	a	by	IN	B-PP	Oa	genetic	a	DT	B-NP	Ogenetic	switch	genetic	JJ	I-NP	Oswitch	:	switch	NN	I-NP	O:	Tet	:	:	O	OTet	for	Tet	NN	B-NP	Ofor	Tat	for	IN	B-PP	OTat	.	Tat	NN	B-NP	B-protein.	Live-attenuated	.	.	O	OLive-attenuated	human	Live-attenuated	JJ	B-NP	Ohuman	immunodeficiency	human	JJ	I-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	(	1	CD	I-NP	O(	HIV-1	(	(	O	OHIV-1	)	HIV-1	NN	B-NP	O)	variants	)	)	O	Ovariants	have	variant	NNS	B-NP	Ohave	shown	have	VBP	B-VP	Oshown	great	show	VBN	I-VP	Ogreat	promise	great	JJ	B-NP	Opromise	as	promise	NN	I-NP	Oas	AIDS	as	IN	B-PP	OAIDS	vaccines	AIDS	NN	B-NP	Ovaccines	","	vaccine	NNS	I-NP	O","	but	","	","	O	Obut	continued	but	CC	O	Ocontinued	replication	continue	VBD	B-VP	Oreplication	can	replication	NN	B-NP	Ocan	lead	can	MD	B-VP	Olead	to	lead	VB	I-VP	Oto	the	to	TO	B-PP	Othe	selection	the	DT	B-NP	Oselection	of	selection	NN	I-NP	Oof	faster-replicating	of	IN	B-PP	Ofaster-replicating	variants	faster-replicating	JJ	B-NP	B-proteinvariants	that	variant	NNS	I-NP	I-proteinthat	are	that	WDT	B-NP	Oare	pathogenic	be	VBP	B-VP	Opathogenic	.	pathogenic	JJ	B-ADJP	O.	We	.	.	O	OWe	therefore	We	PRP	B-NP	Otherefore	designed	therefore	RB	B-ADVP	Odesigned	HIV-1	design	VBD	B-VP	OHIV-1	genomes	HIV-1	NN	B-NP	B-DNAgenomes	that	genome	NNS	I-NP	I-DNAthat	replicate	that	WDT	B-NP	Oreplicate	exclusively	replicate	VBP	B-VP	Oexclusively	upon	exclusively	RB	B-ADVP	Oupon	addition	upon	IN	B-PP	Oaddition	of	addition	NN	B-NP	Oof	the	of	IN	B-PP	Othe	nontoxic	the	DT	B-NP	Onontoxic	effector	nontoxic	JJ	I-NP	Oeffector	doxycycline	effector	NN	I-NP	Odoxycycline	(	doxycycline	NN	I-NP	O(	dox	(	(	O	Odox	)	dox	NN	B-NP	O)	.	)	)	O	O.	This	.	.	O	OThis	was	This	DT	B-NP	Owas	achieved	be	VBD	B-VP	Oachieved	by	achieve	VBN	I-VP	Oby	replacement	by	IN	B-PP	Oreplacement	of	replacement	NN	B-NP	Oof	the	of	IN	B-PP	Othe	viral	the	DT	B-NP	Oviral	TAR-Tat	viral	JJ	I-NP	OTAR-Tat	system	TAR-Tat	NN	I-NP	Osystem	for	system	NN	I-NP	Ofor	transcriptional	for	IN	B-PP	Otranscriptional	activation	transcriptional	JJ	B-NP	Oactivation	by	activation	NN	I-NP	Oby	the	by	IN	B-PP	Othe	Escherichia	the	DT	B-NP	OEscherichia	coli-derived	Escherichia	NNP	I-NP	Ocoli-derived	Tet	coli-derived	JJ	I-NP	OTet	system	Tet	NN	I-NP	Osystem	for	system	NN	I-NP	Ofor	inducible	for	IN	B-PP	Oinducible	gene	inducible	JJ	B-NP	Ogene	expression	gene	NN	I-NP	Oexpression	.	expression	NN	I-NP	O.	These	.	.	O	OThese	designer	These	DT	B-NP	Odesigner	``	designer	NN	I-NP	O``	HIV-rtTA	``	``	I-NP	OHIV-rtTA	''	HIV-rtTA	NN	I-NP	O''	viruses	''	''	I-NP	Oviruses	replicate	virus	NNS	I-NP	Oreplicate	in	replicate	VBP	B-VP	Oin	a	in	IN	B-PP	Oa	strictly	a	DT	B-NP	Ostrictly	dox-dependent	strictly	RB	I-NP	Odox-dependent	manner	dox-dependent	JJ	I-NP	Omanner	both	manner	NN	I-NP	Oboth	in	both	CC	B-PP	Oin	a	in	IN	B-PP	Oa	T-cell	a	DT	B-NP	OT-cell	line	T-cell	NN	I-NP	B-cell_lineline	and	line	NN	I-NP	I-cell_lineand	in	and	CC	B-PP	Oin	primary	in	IN	B-PP	Oprimary	blood	primary	JJ	B-NP	B-cell_typeblood	cells	blood	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	the	and	CC	O	Othe	rate	the	DT	B-NP	Orate	of	rate	NN	I-NP	Oof	replication	of	IN	B-PP	Oreplication	can	replication	NN	B-NP	Ocan	be	can	MD	B-VP	Obe	fine-tuned	be	VB	I-VP	Ofine-tuned	by	fine-tune	VBN	I-VP	Oby	simple	by	IN	B-PP	Osimple	variation	simple	JJ	B-NP	Ovariation	of	variation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	dox	the	DT	B-NP	Odox	concentration	dox	NN	I-NP	Oconcentration	.	concentration	NN	I-NP	O.	These	.	.	O	OThese	HIV-rtTA	These	DT	B-NP	OHIV-rtTA	viruses	HIV-rtTA	NN	I-NP	Oviruses	provide	virus	NNS	I-NP	Oprovide	a	provide	VBP	B-VP	Oa	tool	a	DT	B-NP	Otool	to	tool	NN	I-NP	Oto	perform	to	TO	B-VP	Operform	genetics	perform	VB	I-VP	Ogenetics	","	genetic	NNS	B-NP	O","	e.g.	","	","	O	Oe.g.	","	e.g.	FW	B-NP	O","	selection	","	","	I-NP	Oselection	and	selection	NN	I-NP	Oand	optimization	and	CC	I-NP	Ooptimization	experiments	optimization	NN	I-NP	Oexperiments	","	experiment	NNS	I-NP	O","	with	","	","	O	Owith	the	with	IN	B-PP	Othe	E.	the	DT	B-NP	OE.	coli-derived	E.	NNP	I-NP	Ocoli-derived	Tet	coli-derived	JJ	I-NP	OTet	reagents	Tet	NN	I-NP	Oreagents	in	reagent	NNS	I-NP	Oin	a	in	IN	B-PP	Oa	eukaryotic	a	DT	B-NP	Oeukaryotic	background	eukaryotic	JJ	I-NP	Obackground	.	background	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	such	","	","	O	Osuch	viruses	such	JJ	B-NP	Oviruses	may	virus	NNS	I-NP	Omay	represent	may	MD	B-VP	Orepresent	improved	represent	VB	I-VP	Oimproved	vaccine	improved	JJ	B-NP	Ovaccine	candidates	vaccine	NN	I-NP	Ocandidates	because	candidate	NNS	I-NP	Obecause	their	because	IN	B-SBAR	Otheir	replication	their	PRP$	B-NP	Oreplication	can	replication	NN	I-NP	Ocan	be	can	MD	B-VP	Obe	turned	be	VB	I-VP	Oturned	on	turn	VBN	I-VP	Oon	and	on	RP	B-PRT	Oand	off	and	CC	O	Ooff	at	off	RP	B-PRT	Oat	will	at	IN	B-PP	Owill	.	will	NN	B-NP	O.	Synovial	.	.	O	OSynovial	fluid	Synovial	JJ	B-NP	Ofluid	induced	fluid	NN	I-NP	Oinduced	nuclear	induce	VBD	B-VP	Onuclear	factor-kappaB	nuclear	JJ	B-NP	B-proteinfactor-kappaB	DNA	factor-kappaB	NN	I-NP	I-proteinDNA	binding	DNA	NN	I-NP	Obinding	in	binding	NN	I-NP	Oin	a	in	IN	B-PP	Oa	monocytic	a	DT	B-NP	Omonocytic	cell	monocytic	JJ	I-NP	B-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	.	line	NN	I-NP	I-cell_line.	OBJECTIVE	.	.	O	OOBJECTIVE	:	OBJECTIVE	NN	B-NP	O:	To	:	:	O	OTo	determine	To	TO	B-VP	Odetermine	the	determine	VB	I-VP	Othe	effects	the	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	synovial	of	IN	B-PP	Osynovial	fluids	synovial	JJ	B-NP	Ofluids	(	fluid	NNS	I-NP	O(	SF	(	(	O	OSF	)	SF	NN	B-NP	B-protein)	on	)	)	O	Oon	DNA	on	IN	B-PP	ODNA	binding	DNA	NN	B-NP	Obinding	activity	binding	NN	I-NP	Oactivity	of	activity	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	factor	transcription	NN	B-NP	B-proteinfactor	nuclear	factor	NN	I-NP	I-proteinnuclear	factor-kappaB	nuclear	JJ	I-NP	B-proteinfactor-kappaB	(	factor-kappaB	NN	I-NP	I-protein(	NF-kappaB	(	(	O	ONF-kappaB	)	NF-kappaB	NN	B-NP	B-protein)	in	)	)	O	Oin	the	in	IN	B-PP	Othe	Mono	the	DT	B-NP	OMono	Mac	Mono	NN	I-NP	B-cell_lineMac	6	Mac	NN	I-NP	I-cell_line6	monocytic/macrophage	6	CD	I-NP	I-cell_linemonocytic/macrophage	cell	monocytic/macrophage	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	as	line	NN	I-NP	I-cell_lineas	a	as	IN	B-PP	Oa	model	a	DT	B-NP	Omodel	for	model	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	interaction	the	DT	B-NP	Ointeraction	between	interaction	NN	I-NP	Obetween	SF	between	IN	B-PP	OSF	and	SF	NN	B-NP	B-proteinand	synovial	and	CC	O	Osynovial	tissue	synovial	JJ	B-NP	B-cell_typetissue	macrophages	tissue	NN	I-NP	I-cell_typemacrophages	in	macrophage	NNS	I-NP	I-cell_typein	arthritis	in	IN	B-PP	Oarthritis	.	arthritis	NN	B-NP	O.	METHODS	.	.	O	OMETHODS	:	METHODS	NNS	B-NP	O:	Mono	:	:	O	OMono	Mac	Mono	NN	B-NP	B-cell_lineMac	6	Mac	NN	I-NP	I-cell_line6	cells	6	CD	B-NP	I-cell_linecells	were	cell	NNS	I-NP	I-cell_linewere	incubated	be	VBD	B-VP	Oincubated	with	incubate	VBN	I-VP	Owith	SF	with	IN	B-PP	OSF	from	SF	NN	B-NP	B-proteinfrom	the	from	IN	B-PP	Othe	knee	the	DT	B-NP	Oknee	joints	knee	NN	I-NP	Ojoints	of	joint	NNS	I-NP	Oof	human	of	IN	B-PP	Ohuman	subjects	human	JJ	B-NP	Osubjects	with	subject	NNS	I-NP	Owith	rheumatoid	with	IN	B-PP	Orheumatoid	arthritis	rheumatoid	JJ	B-NP	Oarthritis	(	arthritis	NN	I-NP	O(	RA	(	(	O	ORA	)	RA	NN	B-NP	O)	","	)	)	O	O","	undifferentiated	","	","	O	Oundifferentiated	seronegative	undifferentiated	JJ	B-NP	Oseronegative	oligoarthritis	seronegative	JJ	I-NP	Ooligoarthritis	","	oligoarthritis	NN	I-NP	O","	and	","	","	O	Oand	osteoarthritis	and	CC	O	Oosteoarthritis	(	osteoarthritis	NN	B-NP	O(	OA	(	(	O	OOA	)	OA	NN	B-NP	O)	.	)	)	O	O.	Nuclear	.	.	O	ONuclear	extracts	Nuclear	JJ	B-NP	Oextracts	prepared	extract	NNS	I-NP	Oprepared	from	prepare	VBN	B-VP	Ofrom	the	from	IN	B-PP	Othe	Mono	the	DT	B-NP	OMono	Mac	Mono	NN	I-NP	B-cell_lineMac	6	Mac	NN	I-NP	I-cell_line6	cells	6	CD	B-NP	I-cell_linecells	and	cell	NNS	I-NP	I-cell_lineand	RA	and	CC	O	ORA	synovial	RA	NN	B-NP	Osynovial	tissue	synovial	JJ	I-NP	Otissue	were	tissue	NN	I-NP	Owere	analyzed	be	VBD	B-VP	Oanalyzed	by	analyze	VBN	I-VP	Oby	electrophoretic	by	IN	B-PP	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	analysis	shift	NN	I-NP	Oanalysis	(	analysis	NN	I-NP	O(	EMSA	(	(	O	OEMSA	)	EMSA	NN	B-NP	O)	for	)	)	O	Ofor	NF-kappaB	for	IN	B-PP	ONF-kappaB	DNA	NF-kappaB	NN	B-NP	B-proteinDNA	binding	DNA	NN	I-NP	B-proteinbinding	proteins	binding	NN	I-NP	I-proteinproteins	.	protein	NNS	I-NP	I-protein.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	Induction	:	:	O	OInduction	of	Induction	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	DNA	NF-kappaB	NN	B-NP	B-proteinDNA	binding	DNA	NN	I-NP	Obinding	by	binding	NN	I-NP	Oby	the	by	IN	B-PP	Othe	p65	the	DT	B-NP	Op65	(	p65	NN	I-NP	B-protein(	RelA	(	(	O	I-proteinRelA	)	RelA	NN	B-NP	I-protein)	/p50	)	)	O	I-protein/p50	heterodimer	/p50	CD	B-NP	I-proteinheterodimer	was	heterodimer	NN	I-NP	I-proteinwas	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	incubation	to	TO	B-PP	Oincubation	of	incubation	NN	B-NP	Oof	Mono	of	IN	B-PP	OMono	Mac	Mono	NN	B-NP	B-cell_lineMac	6	Mac	NN	I-NP	I-cell_line6	cells	6	CD	B-NP	I-cell_linecells	with	cell	NNS	I-NP	I-cell_linewith	SF	with	IN	B-PP	OSF	(	SF	NN	B-NP	B-protein(	20	(	(	O	O20	%	20	CD	B-NP	O%	in	%	NN	I-NP	Oin	culture	in	IN	B-PP	Oculture	medium	culture	NN	B-NP	Omedium	)	medium	NN	I-NP	O)	from	)	)	O	Ofrom	5	from	IN	B-PP	O5	of	5	CD	B-NP	Oof	8	of	IN	B-PP	O8	subjects	8	CD	B-NP	Osubjects	with	subject	NNS	I-NP	Owith	RA	with	IN	B-PP	ORA	","	RA	NN	B-NP	O","	4	","	","	O	O4	of	4	CD	B-NP	Oof	5	of	IN	B-PP	O5	with	5	CD	B-NP	Owith	OA	with	IN	B-PP	OOA	","	OA	NN	B-NP	O","	and	","	","	O	Oand	none	and	CC	O	Onone	of	none	NN	B-NP	Oof	3	of	IN	B-PP	O3	with	3	CD	B-NP	Owith	undifferentiated	with	IN	B-PP	Oundifferentiated	seronegative	undifferentiated	JJ	B-NP	Oseronegative	oligoarthritis	seronegative	JJ	I-NP	Ooligoarthritis	.	oligoarthritis	NN	I-NP	O.	Incubation	.	.	O	OIncubation	of	Incubation	NN	B-NP	Oof	SF	of	IN	B-PP	OSF	with	SF	NN	B-NP	B-proteinwith	neutralizing	with	IN	B-PP	Oneutralizing	antibodies	neutralize	VBG	B-VP	B-proteinantibodies	against	antibody	NNS	B-NP	I-proteinagainst	tumor	against	IN	B-PP	Otumor	necrosis	tumor	NN	B-NP	B-proteinnecrosis	factor-alpha	necrosis	NN	I-NP	I-proteinfactor-alpha	(	factor-alpha	NN	I-NP	I-protein(	TNF-alpha	(	(	O	OTNF-alpha	)	TNF-alpha	NN	B-NP	B-protein)	","	)	)	O	O","	but	","	","	O	Obut	not	but	CC	B-NP	Onot	antibodies	not	RB	I-NP	Oantibodies	against	antibody	NNS	B-NP	B-proteinagainst	interleukin	against	IN	B-PP	Ointerleukin	6	interleukin	NN	B-NP	B-protein6	(	6	CD	I-NP	I-protein(	IL-6	(	(	O	OIL-6	)	IL-6	NN	B-NP	B-protein)	","	)	)	O	O","	significantly	","	","	O	Osignificantly	reduced	significantly	RB	B-VP	Oreduced	the	reduce	VBD	I-VP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	p65/p50	of	IN	B-PP	Op65/p50	binding	p65/p50	NN	B-NP	B-proteinbinding	activity	binding	NN	I-NP	Oactivity	in	activity	NN	I-NP	Oin	SF	in	IN	B-PP	OSF	from	SF	NN	B-NP	B-proteinfrom	subjects	from	IN	B-PP	Osubjects	with	subject	NNS	B-NP	Owith	RA	with	IN	B-PP	ORA	and	RA	NN	B-NP	B-proteinand	OA	and	CC	I-NP	OOA	.	OA	NN	I-NP	O.	Unexpectedly	.	.	O	OUnexpectedly	","	Unexpectedly	RB	B-ADVP	O","	a	","	","	O	Oa	slowly	a	DT	B-NP	Oslowly	migrating	slowly	RB	I-NP	Omigrating	SF	migrate	VBG	I-NP	OSF	inducible	SF	NN	I-NP	B-proteininducible	NF-kappaB	inducible	JJ	I-NP	ONF-kappaB	#NAME?	NF-kappaB	NN	I-NP	B-protein#NAME?	complex	#NAME?	JJ	I-NP	Ocomplex	was	complex	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	EMSA	in	IN	B-PP	OEMSA	of	EMSA	NN	B-NP	Oof	Mono	of	IN	B-PP	OMono	Mac	Mono	NN	B-NP	B-cell_lineMac	6	Mac	NN	I-NP	I-cell_line6	cells	6	CD	B-NP	I-cell_linecells	after	cell	NNS	I-NP	I-cell_lineafter	incubation	after	IN	B-PP	Oincubation	with	incubation	NN	B-NP	Owith	SF	with	IN	B-PP	OSF	from	SF	NN	B-NP	B-proteinfrom	5	from	IN	B-PP	O5	of	5	CD	B-NP	Oof	8	of	IN	B-PP	O8	RA	8	CD	B-NP	ORA	and	RA	NN	I-NP	Oand	2	and	CC	O	O2	of	2	CD	B-NP	Oof	5	of	IN	B-PP	O5	OA	5	CD	B-NP	OOA	subjects	OA	NN	I-NP	Osubjects	.	subject	NNS	I-NP	O.	The	.	.	O	OThe	induction	The	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	this	of	IN	B-PP	Othis	complex	this	DT	B-NP	Ocomplex	by	complex	NN	I-NP	Oby	SF	by	IN	B-PP	OSF	was	SF	NN	B-NP	B-proteinwas	not	be	VBD	B-VP	Onot	affected	not	RB	I-VP	Oaffected	by	affect	VBN	I-VP	Oby	neutralization	by	IN	B-PP	Oneutralization	of	neutralization	NN	B-NP	Oof	TNF-alpha	of	IN	B-PP	OTNF-alpha	or	TNF-alpha	NN	B-NP	B-proteinor	IL-6	or	CC	I-NP	OIL-6	in	IL-6	NN	I-NP	B-proteinin	SF	in	IN	B-PP	OSF	","	SF	NN	B-NP	O","	and	","	","	O	Oand	the	and	CC	O	Othe	complex	the	DT	B-NP	Ocomplex	was	complex	NN	I-NP	Owas	not	be	VBD	B-VP	Onot	inducible	not	RB	O	Oinducible	by	inducible	JJ	B-ADJP	Oby	TNF-alpha	by	IN	B-PP	OTNF-alpha	","	TNF-alpha	NN	B-NP	B-protein","	IL-1beta	","	","	O	OIL-1beta	","	IL-1beta	NN	B-NP	B-protein","	TNF-alpha	","	","	O	OTNF-alpha	/	TNF-alpha	NN	B-NP	B-protein/	IL-1beta	/	SYM	I-NP	OIL-1beta	","	IL-1beta	NN	I-NP	B-protein","	IL-6	","	","	O	OIL-6	","	IL-6	NN	B-NP	B-protein","	platelet	","	","	O	Oplatelet	derived	platelet	NN	B-NP	B-proteinderived	growth	derive	VBN	I-NP	I-proteingrowth	factor	growth	NN	I-NP	I-proteinfactor	","	factor	NN	I-NP	I-protein","	lipopolysaccharide	","	","	O	Olipopolysaccharide	","	lipopolysaccharide	NN	B-NP	O","	or	","	","	O	Oor	tetradecanoyl	or	CC	O	Otetradecanoyl	phorbol	tetradecanoyl	NN	B-NP	Ophorbol	acetate	phorbol	NN	I-NP	Oacetate	.	acetate	NN	I-NP	O.	The	.	.	O	OThe	slowly	The	DT	B-NP	Oslowly	migrating	slowly	RB	I-NP	B-proteinmigrating	complex	migrating	JJ	I-NP	I-proteincomplex	could	complex	NN	I-NP	I-proteincould	not	could	MD	B-VP	Onot	be	not	RB	I-VP	Obe	supershifted	be	VB	I-VP	Osupershifted	with	supershifte	VBN	I-VP	Owith	antibodies	with	IN	B-PP	Oantibodies	against	antibody	NNS	B-NP	B-proteinagainst	NF-kappaB	against	IN	B-PP	ONF-kappaB	","	NF-kappaB	NN	B-NP	B-protein","	Jun	","	","	O	OJun	","	Jun	NN	B-NP	B-protein","	or	","	","	O	Oor	the	or	CC	O	Othe	transcriptional	the	DT	B-NP	Otranscriptional	coactivators	transcriptional	JJ	I-NP	B-proteincoactivators	p300	coactivator	NNS	I-NP	I-proteinp300	or	p300	NN	I-NP	B-proteinor	CBP	or	CC	I-NP	OCBP	.	CBP	NN	I-NP	B-protein.	A	.	.	O	OA	NF-kappaB-binding	A	DT	B-NP	ONF-kappaB-binding	complex	NF-kappaB-binding	JJ	I-NP	B-proteincomplex	with	complex	NN	I-NP	I-proteinwith	similar	with	IN	B-PP	Osimilar	slow	similar	JJ	B-NP	Oslow	mobility	slow	JJ	I-NP	Omobility	was	mobility	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	nuclear	in	IN	B-PP	Onuclear	extracts	nuclear	JJ	B-NP	Oextracts	prepared	extract	NNS	I-NP	Oprepared	from	prepare	VBN	B-VP	Ofrom	fresh	from	IN	B-PP	Ofresh	human	fresh	JJ	B-NP	Ohuman	RA	human	JJ	I-NP	ORA	synovial	RA	NN	I-NP	Osynovial	tissue	synovial	JJ	I-NP	Otissue	.	tissue	NN	I-NP	O.	CONCLUSION	.	.	O	OCONCLUSION	:	CONCLUSION	NN	B-NP	O:	Biological	:	:	O	OBiological	activity	Biological	JJ	B-NP	Oactivity	of	activity	NN	I-NP	Oof	TNF-alpha	of	IN	B-PP	OTNF-alpha	in	TNF-alpha	NN	B-NP	B-proteinin	SF	in	IN	B-PP	OSF	from	SF	NN	B-NP	B-proteinfrom	RA	from	IN	B-PP	ORA	and	RA	NN	B-NP	Oand	OA	and	CC	I-NP	OOA	subjects	OA	NN	I-NP	Osubjects	is	subject	NNS	I-NP	Ois	capable	be	VBZ	B-VP	Ocapable	of	capable	JJ	B-ADJP	Oof	inducing	of	IN	B-PP	Oinducing	p65/p50	induce	VBG	B-VP	Op65/p50	NF-kappaB	p65/p50	NN	B-NP	B-proteinNF-kappaB	DNA	NF-kappaB	NN	I-NP	B-proteinDNA	binding	DNA	NN	I-NP	Obinding	activity	binding	NN	I-NP	Oactivity	in	activity	NN	I-NP	Oin	macrophages	in	IN	B-PP	Omacrophages	.	macrophage	NNS	B-NP	B-cell_type.	A	.	.	O	OA	property	A	DT	B-NP	Oproperty	of	property	NN	I-NP	Oof	SF	of	IN	B-PP	OSF	that	SF	NN	B-NP	B-proteinthat	is	that	WDT	B-NP	Ois	independent	be	VBZ	B-VP	Oindependent	of	independent	JJ	B-ADJP	Oof	TNF-alpha	of	IN	B-PP	OTNF-alpha	and	TNF-alpha	NN	B-NP	B-proteinand	other	and	CC	O	Oother	cytokines	other	JJ	B-NP	Ocytokines	is	cytokine	NNS	I-NP	B-proteinis	responsible	be	VBZ	B-VP	Oresponsible	for	responsible	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	a	of	IN	B-PP	Oa	novel	a	DT	B-NP	Onovel	slowly	novel	JJ	I-NP	Oslowly	migrating	slowly	RB	B-VP	Omigrating	NF-kappaB-binding	migrate	VBG	I-VP	ONF-kappaB-binding	complex	NF-kappaB-binding	JJ	B-NP	B-proteincomplex	.	complex	NN	I-NP	I-protein.	Soluble	.	.	O	OSoluble	mediators	Soluble	JJ	B-NP	Omediators	in	mediator	NNS	I-NP	Oin	SF	in	IN	B-PP	OSF	of	SF	NN	B-NP	Oof	subjects	of	IN	B-PP	Osubjects	with	subject	NNS	B-NP	Owith	RA	with	IN	B-PP	ORA	and	RA	NN	B-NP	B-proteinand	OA	and	CC	I-NP	OOA	can	OA	NN	I-NP	B-proteincan	therefore	can	MD	B-VP	Otherefore	modulate	therefore	RB	I-VP	Omodulate	binding	modulate	VB	I-VP	Obinding	of	binding	NN	B-NP	Oof	nuclear	of	IN	B-PP	Onuclear	proteins	nuclear	JJ	B-NP	B-proteinproteins	to	protein	NNS	I-NP	I-proteinto	the	to	TO	B-PP	Othe	NF-kappaB	the	DT	B-NP	ONF-kappaB	binding	NF-kappaB	NN	I-NP	B-DNAbinding	site	binding	NN	I-NP	I-DNAsite	in	site	NN	I-NP	I-DNAin	macrophages	in	IN	B-PP	Omacrophages	and	macrophage	NNS	B-NP	B-cell_typeand	may	and	CC	O	Omay	play	may	MD	B-VP	Oplay	a	play	VB	I-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	inflammatory	in	IN	B-PP	Oinflammatory	gene	inflammatory	JJ	B-NP	Ogene	expression	gene	NN	I-NP	Oexpression	in	expression	NN	I-NP	Oin	arthritis	in	IN	B-PP	Oarthritis	.	arthritis	NN	B-NP	O.	Peroxisome	.	.	O	OPeroxisome	proliferator	Peroxisome	NN	B-NP	B-proteinproliferator	activator	proliferator	NN	I-NP	I-proteinactivator	receptor-gamma	activator	NN	I-NP	I-proteinreceptor-gamma	agonists	receptor-gamma	NN	I-NP	I-proteinagonists	and	agonist	NNS	I-NP	Oand	15-deoxy-Delta	and	CC	O	O15-deoxy-Delta	(	15-deoxy-Delta	NN	B-NP	O(	12	(	(	O	O12	","	12	CD	B-NP	O","	14	","	","	I-NP	O14	)	14	CD	I-NP	O)	(	)	)	O	O(	12	(	(	O	O12	","	12	CD	B-NP	O","	14	","	","	O	O14	)	14	CD	B-NP	O)	#NAME?	)	)	O	O#NAME?	(	#NAME?	NN	B-NP	O(	2	(	(	O	O2	)	2	CD	B-NP	O)	induce	)	)	O	Oinduce	apoptosis	induce	VBP	B-VP	Oapoptosis	in	apoptosis	NN	B-NP	Oin	normal	in	IN	B-PP	Onormal	and	normal	JJ	B-NP	B-cell_typeand	malignant	and	CC	I-NP	I-cell_typemalignant	B-lineage	malignant	JJ	I-NP	I-cell_typeB-lineage	cells	B-lineage	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	research	The	DT	B-NP	Oresearch	described	research	NN	I-NP	Odescribed	herein	describe	VBN	B-VP	Oherein	evaluates	herein	RB	B-ADVP	Oevaluates	the	evaluate	VBZ	B-VP	Othe	expression	the	DT	B-NP	Oexpression	and	expression	NN	I-NP	Oand	functional	and	CC	O	Ofunctional	significance	functional	JJ	B-NP	Osignificance	of	significance	NN	I-NP	Oof	peroxisome	of	IN	B-PP	Operoxisome	proliferator	peroxisome	NN	B-NP	B-proteinproliferator	activator	proliferator	NN	I-NP	I-proteinactivator	receptor-gamma	activator	NN	I-NP	I-proteinreceptor-gamma	(	receptor-gamma	NN	I-NP	I-protein(	PPAR-gamma	(	(	O	OPPAR-gamma	)	PPAR-gamma	NN	B-NP	B-protein)	on	)	)	O	Oon	B-lineage	on	IN	B-PP	OB-lineage	cells	B-lineage	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Normal	.	.	O	ONormal	mouse	Normal	JJ	B-NP	Omouse	B	mouse	NN	I-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	a	and	CC	O	Oa	variety	a	DT	B-NP	Ovariety	of	variety	NN	I-NP	Oof	B	of	IN	B-PP	OB	lymphoma	B	NN	B-NP	Olymphoma	cells	lymphoma	NN	I-NP	Ocells	reflective	cell	NNS	I-NP	Oreflective	of	reflective	JJ	B-ADJP	Oof	stages	of	IN	B-PP	Ostages	of	stage	NNS	B-NP	Oof	B	of	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	differentiation	cell	NN	I-NP	Odifferentiation	(	differentiation	NN	I-NP	O(	e.g.	(	(	O	Oe.g.	","	e.g.	FW	B-NP	O","	70Z/3	","	","	O	O70Z/3	","	70Z/3	NN	B-NP	B-protein","	CH31	","	","	O	OCH31	","	CH31	NN	B-NP	B-protein","	WEHI-231	","	","	O	OWEHI-231	","	WEHI-231	NN	B-NP	B-cell_line","	CH12	","	","	O	OCH12	","	CH12	NN	B-NP	B-protein","	and	","	","	O	Oand	J558	and	CC	O	OJ558	)	J558	NN	B-NP	B-protein)	express	)	)	O	Oexpress	PPAR-gamma	express	VBP	B-VP	OPPAR-gamma	mRNA	PPAR-gamma	NN	B-NP	B-RNAmRNA	and	mRNA	NN	I-NP	I-RNAand	","	and	CC	O	O","	by	","	","	O	Oby	Western	by	IN	B-PP	OWestern	blot	Western	JJ	B-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	","	analysis	NN	I-NP	O","	the	","	","	O	Othe	67-kDa	the	DT	B-NP	O67-kDa	PPAR-gamma	67-kDa	JJ	I-NP	B-proteinPPAR-gamma	protein	PPAR-gamma	NN	I-NP	I-proteinprotein	.	protein	NN	I-NP	I-protein.	15-Deoxy-Delta	.	.	O	O15-Deoxy-Delta	(	15-Deoxy-Delta	NN	B-NP	O(	12	(	(	O	O12	","	12	CD	B-NP	O","	14	","	","	O	O14	)	14	CD	B-NP	O)	#NAME?	)	)	O	O#NAME?	(	#NAME?	NN	B-NP	O(	2	(	(	O	O2	)	2	CD	B-NP	O)	(	)	)	O	O(	15d-PGJ	(	(	O	O15d-PGJ	(	15d-PGJ	NN	B-NP	O(	2	(	(	O	O2	)	2	CD	B-NP	O)	)	)	)	O	O)	","	)	)	O	O","	a	","	","	O	Oa	PPAR-gamma	a	DT	B-NP	OPPAR-gamma	agonist	PPAR-gamma	NN	I-NP	B-proteinagonist	","	agonist	NN	I-NP	O","	has	","	","	O	Ohas	a	have	VBZ	B-VP	Oa	dose-dependent	a	DT	B-NP	Odose-dependent	antiproliferative	dose-dependent	JJ	I-NP	Oantiproliferative	and	antiproliferative	JJ	I-NP	Oand	cytotoxic	and	CC	I-NP	Ocytotoxic	effect	cytotoxic	JJ	I-NP	Oeffect	on	effect	NN	I-NP	Oon	normal	on	IN	B-PP	Onormal	and	normal	JJ	B-NP	Oand	malignant	and	CC	I-NP	Omalignant	B	malignant	JJ	I-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	as	cell	NNS	I-NP	I-cell_typeas	shown	as	IN	B-SBAR	Oshown	by	show	VBN	B-VP	Oby	[	by	IN	B-PP	O[	(	[	(	O	O(	3	(	(	O	O3	)	3	CD	O	O)	H	)	)	O	OH	]	H	NN	B-NP	O]	thymidine	]	)	O	Othymidine	and	thymidine	NN	B-NP	Oand	3-	and	CC	O	O3-	[	3-	CD	B-NP	O[	4	[	(	O	O4	","	4	CD	B-NP	O","	5-dimethylthiazol-2-yl	","	","	O	O5-dimethylthiazol-2-yl	]	5-dimethylthiazol-2-yl	NN	B-NP	O]	-2	]	)	O	O-2	","	-2	CD	B-NP	O","	5-diphenyltetrazolium	","	","	O	O5-diphenyltetrazolium	bromide	5-diphenyltetrazolium	NN	B-NP	Obromide	assays	bromide	NN	I-NP	Oassays	.	assay	NNS	I-NP	O.	Only	.	.	O	OOnly	PPAR-gamma	Only	RB	B-NP	OPPAR-gamma	agonists	PPAR-gamma	NN	I-NP	B-proteinagonists	(	agonist	NNS	I-NP	O(	thiazolidinediones	(	(	O	Othiazolidinediones	)	thiazolidinedione	NNS	B-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	not	and	CC	O	Onot	PPAR-alpha	not	RB	O	OPPAR-alpha	agonists	PPAR-alpha	NN	B-NP	B-proteinagonists	","	agonist	NNS	I-NP	O","	mimicked	","	","	O	Omimicked	the	mimic	VBD	B-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	15d-PGJ	of	IN	B-PP	O15d-PGJ	(	15d-PGJ	NN	B-NP	O(	2	(	(	O	O2	)	2	CD	B-NP	O)	on	)	)	O	Oon	B-lineage	on	IN	B-PP	OB-lineage	cells	B-lineage	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	indicating	","	","	O	Oindicating	that	indicate	VBG	B-VP	Othat	the	that	IN	B-SBAR	Othe	mechanism	the	DT	B-NP	Omechanism	by	mechanism	NN	I-NP	Oby	which	by	IN	B-PP	Owhich	15d-PGJ	which	WDT	B-NP	O15d-PGJ	(	15d-PGJ	NN	B-NP	O(	2	(	(	O	O2	)	2	CD	B-NP	O)	negatively	)	)	O	Onegatively	affects	negatively	RB	B-ADVP	Oaffects	B-lineage	affect	VBZ	B-VP	OB-lineage	cells	B-lineage	NN	B-NP	B-cell_typecells	involves	cell	NNS	I-NP	I-cell_typeinvolves	in	involve	VBZ	B-VP	Oin	part	in	IN	B-PP	Opart	PPAR-gamma	part	NN	B-NP	OPPAR-gamma	.	PPAR-gamma	NN	I-NP	O.	The	.	.	O	OThe	mechanism	The	DT	B-NP	Omechanism	by	mechanism	NN	I-NP	Oby	which	by	IN	B-PP	Owhich	PPAR-gamma	which	WDT	B-NP	OPPAR-gamma	agonists	PPAR-gamma	NN	B-NP	B-proteinagonists	induce	agonist	NNS	I-NP	Oinduce	cytotoxicity	induce	VBP	B-VP	Ocytotoxicity	is	cytotoxicity	NN	B-NP	Ois	via	be	VBZ	B-VP	Ovia	apoptosis	via	IN	B-PP	Oapoptosis	","	apoptosis	NN	B-NP	O","	as	","	","	O	Oas	shown	as	IN	B-SBAR	Oshown	by	show	VBN	B-VP	Oby	annexin	by	IN	B-PP	Oannexin	V	annexin	NN	B-NP	OV	staining	V	NN	I-NP	Ostaining	and	staining	NN	I-NP	Oand	as	and	CC	O	Oas	confirmed	as	IN	B-SBAR	Oconfirmed	by	confirm	VBN	B-VP	Oby	DNA	by	IN	B-PP	ODNA	fragmentation	DNA	NN	B-NP	Ofragmentation	detected	fragmentation	NN	I-NP	Odetected	using	detect	VBN	B-VP	Ousing	the	use	VBG	B-VP	Othe	TUNEL	the	DT	B-NP	OTUNEL	assay	TUNEL	NN	I-NP	Oassay	.	assay	NN	I-NP	O.	Interestingly	.	.	O	OInterestingly	","	Interestingly	RB	B-ADVP	O","	addition	","	","	O	Oaddition	of	addition	NN	B-NP	Oof	PGF	of	IN	B-PP	OPGF	(	PGF	NN	B-NP	B-protein(	2alpha	(	(	O	O2alpha	)	2alpha	NN	B-NP	O)	","	)	)	O	O","	which	","	","	O	Owhich	was	which	WDT	B-NP	Owas	not	be	VBD	B-VP	Onot	known	not	RB	I-VP	Oknown	to	know	VBN	I-VP	Oto	affect	to	TO	I-VP	Oaffect	lymphocytes	affect	VB	I-VP	Olymphocytes	","	lymphocyte	NNS	B-NP	B-cell_type","	dramatically	","	","	O	Odramatically	attenuated	dramatically	RB	B-VP	Oattenuated	the	attenuate	VBD	I-VP	Othe	deleterious	the	DT	B-NP	Odeleterious	effects	deleterious	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	PPAR-gamma	of	IN	B-PP	OPPAR-gamma	agonists	PPAR-gamma	NN	B-NP	B-proteinagonists	on	agonist	NNS	I-NP	Oon	B	on	IN	B-PP	OB	lymphomas	B	NN	B-NP	Olymphomas	.	lymphoma	NNS	I-NP	O.	Surprisingly	.	.	O	OSurprisingly	","	Surprisingly	RB	B-ADVP	O","	15d-PGJ	","	","	O	O15d-PGJ	(	15d-PGJ	NN	B-NP	O(	2	(	(	O	O2	)	2	CD	B-NP	O)	induced	)	)	O	Oinduced	a	induce	VBD	B-VP	Oa	massive	a	DT	B-NP	Omassive	increase	massive	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	nuclear	in	IN	B-PP	Onuclear	mitogen-activated	nuclear	JJ	B-NP	B-proteinmitogen-activated	protein	mitogen-activated	JJ	I-NP	I-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	activation	kinase	NN	I-NP	I-proteinactivation	","	activation	NN	I-NP	O","	and	","	","	O	Oand	pretreatment	and	CC	O	Opretreatment	with	pretreatment	NN	B-NP	Owith	PGF	with	IN	B-PP	OPGF	(	PGF	NN	B-NP	B-protein(	2alpha	(	(	O	O2alpha	)	2alpha	NN	B-NP	O)	blunted	)	)	O	Oblunted	the	blunt	VBD	B-VP	Othe	mitogen-activated	the	DT	B-NP	Omitogen-activated	protein	mitogen-activated	JJ	I-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	activation	kinase	NN	I-NP	I-proteinactivation	.	activation	NN	I-NP	O.	This	.	.	O	OThis	is	This	DT	B-NP	Ois	the	be	VBZ	B-VP	Othe	first	the	DT	B-NP	Ofirst	study	first	JJ	I-NP	Ostudy	evaluating	study	NN	I-NP	Oevaluating	PPAR-gamma	evaluate	VBG	B-VP	OPPAR-gamma	expression	PPAR-gamma	NN	B-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	its	and	CC	O	Oits	significance	its	PRP$	B-NP	Osignificance	on	significance	NN	I-NP	Oon	B	on	IN	B-PP	OB	lymphocytes	B	NN	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	PPAR-gamma	.	.	O	OPPAR-gamma	agonists	PPAR-gamma	NN	B-NP	B-proteinagonists	may	agonist	NNS	I-NP	Omay	serve	may	MD	B-VP	Oserve	as	serve	VB	I-VP	Oas	a	as	IN	B-PP	Oa	counterbalance	a	DT	B-NP	Ocounterbalance	to	counterbalance	NN	I-NP	Oto	the	to	TO	B-PP	Othe	stimulating	the	DT	B-NP	Ostimulating	effects	stimulate	VBG	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	other	of	IN	B-PP	Oother	PGs	other	JJ	B-NP	OPGs	","	PG	NNS	I-NP	B-protein","	namely	","	","	O	Onamely	PGE	namely	RB	B-NP	OPGE	(	PGE	NN	I-NP	O(	2	(	(	O	O2	)	2	CD	B-NP	O)	","	)	)	O	O","	which	","	","	O	Owhich	promotes	which	WDT	B-NP	Opromotes	B	promote	VBZ	B-VP	OB	cell	B	NN	B-NP	Ocell	differentiation	cell	NN	I-NP	Odifferentiation	.	differentiation	NN	I-NP	O.	Finally	.	.	O	OFinally	","	Finally	RB	B-ADVP	O","	the	","	","	O	Othe	use	the	DT	B-NP	Ouse	of	use	NN	I-NP	Oof	PGs	of	IN	B-PP	OPGs	","	PG	NNS	B-NP	O","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	15d-PGJ	as	IN	I-PP	O15d-PGJ	(	15d-PGJ	NN	B-NP	O(	2	(	(	O	O2	)	2	CD	B-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	synthetic	and	CC	O	Osynthetic	PPAR-gamma	synthetic	JJ	B-NP	OPPAR-gamma	agonists	PPAR-gamma	NN	I-NP	Oagonists	to	agonist	NNS	I-NP	Oto	induce	to	TO	B-VP	Oinduce	apoptosis	induce	VB	I-VP	Oapoptosis	in	apoptosis	NN	B-NP	Oin	B-lineage	in	IN	B-PP	OB-lineage	cells	B-lineage	NN	B-NP	B-cell_typecells	may	cell	NNS	I-NP	I-cell_typemay	lead	may	MD	B-VP	Olead	to	lead	VB	I-VP	Oto	the	to	TO	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	novel	of	IN	B-PP	Onovel	therapies	novel	JJ	B-NP	Otherapies	for	therapy	NNS	I-NP	Ofor	fatal	for	IN	B-PP	Ofatal	B	fatal	JJ	B-NP	OB	lymphomas	B	NN	I-NP	Olymphomas	Inhibition	lymphoma	NNS	I-NP	OInhibition	of	Inhibition	NN	B-NP	Oof	STAT3	of	IN	B-PP	OSTAT3	signaling	STAT3	NN	B-NP	B-proteinsignaling	leads	signaling	NN	I-NP	Oleads	to	lead	VBZ	B-VP	Oto	apoptosis	to	TO	B-PP	Oapoptosis	of	apoptosis	NN	B-NP	Oof	leukemic	of	IN	B-PP	Oleukemic	large	leukemic	JJ	B-NP	B-cell_typelarge	granular	large	JJ	I-NP	I-cell_typegranular	lymphocytes	granular	JJ	I-NP	I-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	decreased	and	CC	O	Odecreased	Mcl-1	decrease	VBN	B-NP	OMcl-1	expression	Mcl-1	NN	I-NP	B-proteinexpression	.	expression	NN	I-NP	O.	Large	.	.	O	OLarge	granular	Large	JJ	B-NP	B-cell_typegranular	lymphocyte	granular	JJ	I-NP	I-cell_typelymphocyte	(	lymphocyte	NN	I-NP	I-cell_type(	LGL	(	(	O	OLGL	)	LGL	NN	B-NP	B-cell_type)	leukemia	)	)	O	Oleukemia	is	leukemia	NN	B-NP	Ois	characterized	be	VBZ	B-VP	Ocharacterized	by	characterize	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	expansion	the	DT	B-NP	Oexpansion	of	expansion	NN	I-NP	Oof	antigen-activated	of	IN	B-PP	Oantigen-activated	cytotoxic	antigen-activated	JJ	B-NP	B-cell_typecytotoxic	T	cytotoxic	JJ	I-NP	I-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	These	.	.	O	OThese	leukemic	These	DT	B-NP	Oleukemic	cells	leukemic	JJ	I-NP	B-cell_typecells	are	cell	NNS	I-NP	I-cell_typeare	resistant	be	VBP	B-VP	Oresistant	to	resistant	JJ	B-ADJP	Oto	Fas-mediated	to	TO	B-PP	OFas-mediated	apoptosis	Fas-mediated	JJ	B-NP	Oapoptosis	despite	apoptosis	NN	I-NP	Odespite	expressing	despite	IN	B-PP	Oexpressing	high	express	VBG	B-VP	Ohigh	levels	high	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	Fas	of	IN	B-PP	OFas	.	Fas	NN	B-NP	B-protein.	We	.	.	O	OWe	found	We	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	leukemic	that	IN	B-SBAR	Oleukemic	LGL	leukemic	JJ	B-NP	OLGL	from	LGL	NN	I-NP	Ofrom	19	from	IN	B-PP	O19	patients	19	CD	B-NP	Opatients	displayed	patient	NNS	I-NP	Odisplayed	high	display	VBD	B-VP	Ohigh	levels	high	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	activated	of	IN	B-PP	Oactivated	STAT3	activate	VBN	B-NP	OSTAT3	.	STAT3	NN	I-NP	B-protein.	Treatment	.	.	O	OTreatment	of	Treatment	NN	B-NP	Oof	leukemic	of	IN	B-PP	Oleukemic	LGL	leukemic	JJ	B-NP	OLGL	with	LGL	NN	I-NP	Owith	the	with	IN	B-PP	Othe	JAK-selective	the	DT	B-NP	OJAK-selective	tyrosine	JAK-selective	JJ	I-NP	B-proteintyrosine	kinase	tyrosine	NN	I-NP	I-proteinkinase	inhibitor	kinase	NN	I-NP	I-proteininhibitor	AG-490	inhibitor	NN	I-NP	OAG-490	induced	AG-490	NN	I-NP	Oinduced	apoptosis	induce	VBD	B-VP	Oapoptosis	with	apoptosis	NN	B-NP	Owith	a	with	IN	B-PP	Oa	corresponding	a	DT	B-NP	Ocorresponding	decrease	corresponding	JJ	I-NP	Odecrease	in	decrease	NN	I-NP	Oin	STAT	in	IN	B-PP	OSTAT	#NAME?	STAT	NN	B-NP	B-protein#NAME?	binding	#NAME?	NN	I-NP	Obinding	activity	binding	NN	I-NP	Oactivity	.	activity	NN	I-NP	O.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	using	","	","	O	Ousing	an	use	VBG	B-VP	Oan	antisense	an	DT	B-NP	Oantisense	oligonucleotide	antisense	JJ	I-NP	Ooligonucleotide	approach	oligonucleotide	NN	I-NP	Oapproach	to	approach	NN	I-NP	Oto	diminish	to	TO	B-VP	Odiminish	STAT3	diminish	VB	I-VP	OSTAT3	expression	STAT3	NN	B-NP	B-proteinexpression	","	expression	NN	I-NP	O","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	Fas	that	IN	B-SBAR	OFas	sensitivity	Fas	NN	B-NP	B-proteinsensitivity	was	sensitivity	NN	I-NP	Owas	restored	be	VBD	B-VP	Orestored	in	restore	VBN	I-VP	Oin	leukemic	in	IN	B-PP	Oleukemic	LGL	leukemic	JJ	B-NP	B-cell_typeLGL	.	LGL	NN	I-NP	I-cell_type.	AG-490-induced	.	.	O	OAG-490-induced	apoptosis	AG-490-induced	JJ	B-NP	Oapoptosis	in	apoptosis	NN	I-NP	Oin	leukemic	in	IN	B-PP	Oleukemic	LGL	leukemic	JJ	B-NP	B-cell_typeLGL	was	LGL	NN	I-NP	I-cell_typewas	independent	be	VBD	B-VP	Oindependent	of	independent	JJ	B-ADJP	Oof	Bcl-xL	of	IN	B-PP	OBcl-xL	or	Bcl-xL	NN	B-NP	B-proteinor	Bcl-2	or	CC	I-NP	OBcl-2	expression	Bcl-2	NN	I-NP	B-proteinexpression	.	expression	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	Bcl-2-family	the	DT	B-NP	OBcl-2-family	protein	Bcl-2-family	NN	I-NP	B-proteinprotein	Mcl-1	protein	NN	I-NP	I-proteinMcl-1	was	Mcl-1	NN	I-NP	B-proteinwas	significantly	be	VBD	B-VP	Osignificantly	reduced	significantly	RB	I-VP	Oreduced	by	reduce	VBN	I-VP	Oby	AG-490	by	IN	B-PP	OAG-490	treatment	AG-490	NN	B-NP	Otreatment	.	treatment	NN	I-NP	O.	Activated	.	.	O	OActivated	STAT3	Activate	VBN	B-NP	OSTAT3	was	STAT3	NN	I-NP	B-proteinwas	shown	be	VBD	B-VP	Oshown	to	show	VBN	I-VP	Oto	bind	to	TO	I-VP	Obind	an	bind	VB	I-VP	Oan	SIE-related	an	DT	B-NP	OSIE-related	element	SIE-related	JJ	I-NP	B-DNAelement	in	element	NN	I-NP	I-DNAin	the	in	IN	B-PP	Othe	murine	the	DT	B-NP	Omurine	mcl-1	murine	JJ	I-NP	B-DNAmcl-1	promoter	mcl-1	NN	I-NP	I-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Using	.	.	O	OUsing	a	Use	VBG	B-VP	Oa	luciferase	a	DT	B-NP	Oluciferase	reporter	luciferase	NN	I-NP	Oreporter	assay	reporter	NN	I-NP	Oassay	","	assay	NN	I-NP	O","	we	","	","	O	Owe	demonstrated	we	PRP	B-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	v-src	that	IN	B-SBAR	Ov-src	overexpression	v-src	JJ	B-NP	Ooverexpression	in	overexpression	NN	I-NP	Oin	NIH3T3	in	IN	B-PP	ONIH3T3	induced	NIH3T3	NN	B-NP	B-proteininduced	STAT3	induce	VBD	B-VP	OSTAT3	#NAME?	STAT3	NN	B-NP	B-protein#NAME?	transcriptional	#NAME?	JJ	I-NP	Otranscriptional	activity	transcriptional	JJ	I-NP	Oactivity	from	activity	NN	I-NP	Ofrom	the	from	IN	B-PP	Othe	mcl-1	the	DT	B-NP	Omcl-1	promoter	mcl-1	NN	I-NP	B-DNApromoter	and	promoter	NN	I-NP	I-DNAand	increased	and	CC	O	Oincreased	endogenous	increase	VBD	B-VP	Oendogenous	Mcl-1	endogenous	JJ	B-NP	OMcl-1	protein	Mcl-1	NN	I-NP	Oprotein	levels	protein	NN	I-NP	Olevels	.	level	NNS	I-NP	O.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	STAT3	that	IN	B-SBAR	OSTAT3	activation	STAT3	NN	B-NP	B-proteinactivation	contributed	activation	NN	I-NP	Ocontributed	to	contribute	VBD	B-VP	Oto	accumulation	to	TO	B-PP	Oaccumulation	of	accumulation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	leukemic	the	DT	B-NP	Oleukemic	LGL	leukemic	JJ	I-NP	B-cell_lineLGL	clones	LGL	NN	I-NP	I-cell_lineclones	.	clone	NNS	I-NP	I-cell_line.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	suggest	finding	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	investigation	that	IN	B-SBAR	Oinvestigation	should	investigation	NN	B-NP	Oshould	focus	should	MD	B-VP	Ofocus	on	focus	VB	I-VP	Oon	novel	on	IN	B-PP	Onovel	strategies	novel	JJ	B-NP	Ostrategies	targeting	strategy	NNS	I-NP	Otargeting	STAT3	target	VBG	B-VP	OSTAT3	in	STAT3	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	of	treatment	NN	I-NP	Oof	LGL	of	IN	B-PP	OLGL	leukemia	LGL	NN	B-NP	Oleukemia	.	leukemia	NN	I-NP	O.	Decreased	.	.	O	ODecreased	immediate	Decrease	VBN	B-NP	Oimmediate	inflammatory	immediate	JJ	I-NP	B-DNAinflammatory	gene	inflammatory	JJ	I-NP	I-DNAgene	induction	gene	NN	I-NP	I-DNAinduction	in	induction	NN	I-NP	Oin	activating	in	IN	B-PP	Oactivating	transcription	activate	VBG	B-VP	Otranscription	factor-2	transcription	NN	B-NP	Ofactor-2	mutant	factor-2	NN	I-NP	Omutant	mice	mutant	JJ	I-NP	Omice	.	mouse	NNS	I-NP	O.	Transcription	.	.	O	OTranscription	factor	Transcription	NN	B-NP	B-proteinfactor	activating	factor	NN	I-NP	I-proteinactivating	transcription	activate	VBG	B-VP	Otranscription	factor	transcription	NN	B-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	ATF	(	(	O	OATF	)	ATF	NN	B-NP	O)	-2	)	)	O	O-2	is	-2	CD	B-NP	Ois	activated	be	VBZ	B-VP	Oactivated	by	activate	VBN	I-VP	Oby	inflammatory	by	IN	B-PP	Oinflammatory	signals	inflammatory	JJ	B-NP	Osignals	transduced	signal	NNS	I-NP	Otransduced	by	transduce	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	JNK	the	DT	B-NP	OJNK	and	JNK	NN	I-NP	B-proteinand	p38	and	CC	I-NP	Op38	MAP	p38	NN	I-NP	B-proteinMAP	kinase	MAP	NN	I-NP	Okinase	pathways	kinase	NN	I-NP	Opathways	.	pathway	NNS	I-NP	O.	To	.	.	O	OTo	better	To	TO	B-VP	Obetter	define	well	RBR	I-VP	Odefine	the	define	VB	I-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	ATF-2	of	IN	B-PP	OATF-2	in	ATF-2	NN	B-NP	B-proteinin	inflammation	in	IN	B-PP	Oinflammation	","	inflammation	NN	B-NP	O","	adult	","	","	O	Oadult	mice	adult	JJ	B-NP	Omice	expressing	mouse	NNS	I-NP	Oexpressing	small	express	VBG	B-VP	Osmall	amounts	small	JJ	B-NP	Oamounts	of	amount	NNS	I-NP	Oof	a	of	IN	B-PP	Oa	mutant	a	DT	B-NP	Omutant	ATF-2	mutant	JJ	I-NP	B-proteinATF-2	protein	ATF-2	NN	I-NP	I-proteinprotein	were	protein	NN	I-NP	I-proteinwere	challenged	be	VBD	B-VP	Ochallenged	with	challenge	VBN	I-VP	Owith	lipopolysaccharide	with	IN	B-PP	Olipopolysaccharide	(	lipopolysaccharide	NN	B-NP	O(	LPS	(	(	O	OLPS	)	LPS	NN	B-NP	O)	","	)	)	O	O","	anti-CD3	","	","	O	Oanti-CD3	antibody	anti-CD3	JJ	B-NP	B-proteinantibody	or	antibody	NN	I-NP	I-proteinor	virus	or	CC	I-NP	Ovirus	.	virus	NN	I-NP	O.	Within	.	.	O	OWithin	3	Within	IN	B-PP	O3	h	3	CD	B-NP	Oh	of	h	NN	I-NP	Oof	challenge	of	IN	B-PP	Ochallenge	by	challenge	NN	B-NP	Oby	LPS	by	IN	B-PP	OLPS	","	LPS	NN	B-NP	O","	ATF-2	","	","	O	OATF-2	mutant	ATF-2	NN	B-NP	B-proteinmutant	mice	mutant	JJ	I-NP	Omice	had	mouse	NNS	I-NP	Ohad	decreased	have	VBD	B-VP	Odecreased	induction	decrease	VBN	I-VP	Oinduction	of	induction	NN	B-NP	Oof	the	of	IN	B-PP	Othe	adhesion	the	DT	B-NP	Oadhesion	molecules	adhesion	NN	I-NP	B-proteinmolecules	E-selectin	molecule	NNS	I-NP	I-proteinE-selectin	","	E-selectin	NN	I-NP	B-protein","	P-selectin	","	","	I-NP	OP-selectin	and	P-selectin	NN	I-NP	B-proteinand	VCAM-1	and	CC	I-NP	OVCAM-1	as	VCAM-1	NN	I-NP	B-proteinas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	the	as	IN	I-CONJP	Othe	cytokines	the	DT	B-NP	Ocytokines	tumor	cytokine	NNS	I-NP	B-proteintumor	necrosis	tumor	NN	I-NP	B-proteinnecrosis	factor-alpha	necrosis	NN	I-NP	I-proteinfactor-alpha	","	factor-alpha	NN	I-NP	I-protein","	IL-1beta	","	","	O	OIL-1beta	and	IL-1beta	NN	B-NP	B-proteinand	IL-6	and	CC	I-NP	OIL-6	compared	IL-6	NN	I-NP	B-proteincompared	with	compare	VBN	B-PP	Owith	control	with	IN	B-PP	Ocontrol	mice	control	NN	B-NP	Omice	.	mouse	NNS	I-NP	O.	Stimulation	.	.	O	OStimulation	of	Stimulation	NN	B-NP	Oof	T	of	IN	B-PP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	by	lymphocyte	NNS	I-NP	I-cell_typeby	anti-CD3	by	IN	B-PP	Oanti-CD3	antibody	anti-CD3	JJ	B-NP	B-proteinantibody	also	antibody	NN	I-NP	I-proteinalso	showed	also	RB	B-ADVP	Oshowed	less	show	VBD	B-VP	Oless	induction	less	JJR	B-NP	Oinduction	of	induction	NN	I-NP	Oof	IL-1	of	IN	B-PP	OIL-1	and	IL-1	NN	B-NP	B-proteinand	IL-6	and	CC	I-NP	OIL-6	in	IL-6	NN	I-NP	B-proteinin	ATF-2	in	IN	B-PP	OATF-2	mutant	ATF-2	NN	B-NP	B-proteinmutant	tissues	mutant	JJ	I-NP	Otissues	.	tissue	NNS	I-NP	O.	ATF-2	.	.	O	OATF-2	mutant	ATF-2	NN	B-NP	B-proteinmutant	thymocytes	mutant	JJ	I-NP	Othymocytes	treated	thymocyte	NNS	I-NP	Otreated	with	treat	VBN	B-VP	Owith	anti-CD3	with	IN	B-PP	Oanti-CD3	antibody	anti-CD3	JJ	B-NP	B-proteinantibody	in	antibody	NN	I-NP	I-proteinin	vitro	in	FW	B-ADVP	Ovitro	demonstrated	vitro	FW	I-ADVP	Odemonstrated	reduced	demonstrate	VBD	B-VP	Oreduced	induction	reduce	VBN	B-NP	Oinduction	of	induction	NN	I-NP	Oof	c-Jun	of	IN	B-PP	Oc-Jun	","	c-Jun	NN	B-NP	B-protein","	JunB	","	","	O	OJunB	","	JunB	NN	B-NP	B-protein","	JunD	","	","	O	OJunD	and	JunD	NN	B-NP	B-proteinand	Fra-2	and	CC	I-NP	OFra-2	.	Fra-2	NN	I-NP	B-protein.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	similar	","	","	O	Osimilar	to	similar	JJ	B-ADJP	Oto	what	to	TO	B-PP	Owhat	was	what	WP	B-NP	Owas	observed	be	VBD	B-VP	Oobserved	after	observe	VBN	I-VP	Oafter	p38	after	IN	B-PP	Op38	kinase	p38	NN	B-NP	B-proteinkinase	inhibition	kinase	NN	I-NP	I-proteininhibition	in	inhibition	NN	I-NP	Oin	normal	in	IN	B-PP	Onormal	mice	normal	JJ	B-NP	Omice	","	mouse	NNS	I-NP	O","	relative	","	","	O	Orelative	ATF-2	relative	JJ	B-NP	OATF-2	deficiency	ATF-2	NN	I-NP	B-proteindeficiency	did	deficiency	NN	I-NP	Odid	not	do	VBD	B-VP	Onot	prevent	not	RB	I-VP	Oprevent	the	prevent	VB	I-VP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	a	of	IN	B-PP	Oa	mononuclear	a	DT	B-NP	Omononuclear	cell	mononuclear	JJ	I-NP	Ocell	infiltrate	cell	NN	I-NP	Oinfiltrate	in	infiltrate	NN	I-NP	Oin	the	in	IN	B-PP	Othe	week	the	DT	B-NP	Oweek	following	week	NN	I-NP	Ofollowing	an	follow	VBG	B-PP	Oan	inflammatory	an	DT	B-NP	Oinflammatory	stimulus	inflammatory	JJ	I-NP	Ostimulus	.	stimulus	NN	I-NP	O.	ATF-2	.	.	O	OATF-2	mutant	ATF-2	NN	B-NP	B-proteinmutant	mice	mutant	JJ	I-NP	Omice	proved	mouse	NNS	I-NP	Oproved	more	prove	VBD	B-VP	Omore	susceptible	more	RBR	B-ADJP	Osusceptible	to	susceptible	JJ	I-ADJP	Oto	death	to	TO	B-PP	Odeath	than	death	NN	B-NP	Othan	control	than	IN	B-PP	Ocontrol	mice	control	NN	B-NP	Omice	from	mouse	NNS	I-NP	Ofrom	LPS	from	IN	B-PP	OLPS	plus	LPS	NN	B-NP	Oplus	D-galactosamine	plus	CC	I-NP	OD-galactosamine	injection	D-galactosamine	NN	B-NP	Oinjection	or	injection	NN	I-NP	Oor	Coxsackievirus	or	CC	O	OCoxsackievirus	B3	Coxsackievirus	NN	B-NP	OB3	infection	B3	NN	I-NP	Oinfection	and	infection	NN	I-NP	Oand	had	and	CC	O	Ohad	a	have	VBD	B-VP	Oa	higher	a	DT	B-NP	Ohigher	incidence	high	JJR	I-NP	Oincidence	of	incidence	NN	I-NP	Oof	mononuclear	of	IN	B-PP	Omononuclear	pulmonary	mononuclear	JJ	B-NP	B-cell_typepulmonary	infiltrates	pulmonary	JJ	I-NP	I-cell_typeinfiltrates	after	infiltrate	NNS	I-NP	I-cell_typeafter	exposure	after	IN	B-PP	Oexposure	to	exposure	NN	B-NP	Oto	Herpes	to	TO	B-PP	OHerpes	simplex	Herpes	NNP	B-NP	Osimplex	virus-1	simplex	NN	I-NP	Ovirus-1	.	virus-1	NN	I-NP	O.	ATF-2	.	.	O	OATF-2	is	ATF-2	NN	B-NP	B-proteinis	essential	be	VBZ	B-VP	Oessential	for	essential	JJ	B-ADJP	Ofor	maximal	for	IN	B-PP	Omaximal	immediate	maximal	JJ	B-NP	Oimmediate	induction	immediate	JJ	I-NP	Oinduction	of	induction	NN	I-NP	Oof	adhesion	of	IN	B-PP	Oadhesion	molecules	adhesion	NN	B-NP	B-proteinmolecules	and	molecule	NNS	I-NP	I-proteinand	cytokine	and	CC	O	Ocytokine	genes	cytokine	NN	B-NP	B-DNAgenes	","	gene	NNS	I-NP	I-DNA","	but	","	","	O	Obut	at	but	CC	O	Oat	later	at	IN	B-PP	Olater	time	late	JJR	B-NP	Otime	points	time	NN	I-NP	Opoints	may	point	NNS	I-NP	Omay	even	may	MD	B-VP	Oeven	protect	even	RB	I-VP	Oprotect	against	protect	VB	I-VP	Oagainst	overactive	against	IN	B-PP	Ooveractive	immune	overactive	JJ	B-NP	Oimmune	responses	immune	JJ	I-NP	Oresponses	.	response	NNS	I-NP	O.	LIGHT	.	.	O	OLIGHT	","	LIGHT	NN	B-NP	O","	a	","	","	O	Oa	TNF-like	a	DT	B-NP	OTNF-like	molecule	TNF-like	JJ	I-NP	B-proteinmolecule	","	molecule	NN	I-NP	I-protein","	costimulates	","	","	O	Ocostimulates	T	costimulate	VBZ	B-VP	OT	cell	T	NN	B-NP	Ocell	proliferation	cell	NN	I-NP	Oproliferation	and	proliferation	NN	I-NP	Oand	is	and	CC	O	Ois	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	dendritic	for	IN	B-PP	Odendritic	cell	dendritic	JJ	B-NP	B-cell_typecell	#NAME?	cell	NN	I-NP	I-cell_type#NAME?	allogeneic	#NAME?	JJ	I-NP	Oallogeneic	T	allogeneic	JJ	I-NP	OT	cell	T	NN	I-NP	Ocell	response	cell	NN	I-NP	Oresponse	.	response	NN	I-NP	O.	LIGHT	.	.	O	OLIGHT	is	LIGHT	NN	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	recently	a	DT	B-NP	Orecently	identified	recently	RB	I-NP	Oidentified	member	identify	VBN	I-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	TNF	the	DT	B-NP	OTNF	superfamily	TNF	NN	I-NP	B-proteinsuperfamily	and	superfamily	NN	I-NP	I-proteinand	its	and	CC	O	Oits	receptors	its	PRP$	B-NP	Oreceptors	","	receptor	NNS	I-NP	O","	herpesvirus	","	","	O	Oherpesvirus	entry	herpesvirus	NN	B-NP	B-proteinentry	mediator	entry	NN	I-NP	I-proteinmediator	and	mediator	NN	I-NP	I-proteinand	lymphotoxin	and	CC	O	Olymphotoxin	beta	lymphotoxin	NN	B-NP	B-proteinbeta	receptor	beta	NN	I-NP	I-proteinreceptor	","	receptor	NN	I-NP	I-protein","	are	","	","	O	Oare	found	be	VBP	B-VP	Ofound	in	find	VBN	I-VP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	stromal	and	CC	O	Ostromal	cells	stromal	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	demonstrate	we	PRP	B-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	LIGHT	that	IN	B-SBAR	OLIGHT	is	LIGHT	NN	B-NP	B-proteinis	selectively	be	VBZ	B-VP	Oselectively	expressed	selectively	RB	I-VP	Oexpressed	on	express	VBN	I-VP	Oon	immature	on	IN	B-PP	Oimmature	dendritic	immature	JJ	B-NP	B-cell_typedendritic	cells	dendritic	JJ	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	DCs	(	(	O	ODCs	)	DC	NNS	B-NP	B-cell_type)	generated	)	)	O	Ogenerated	from	generate	VBN	B-VP	Ofrom	human	from	IN	B-PP	Ohuman	PBMCs	human	JJ	B-NP	B-cell_typePBMCs	.	PBMC	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	LIGHT	","	","	O	OLIGHT	is	LIGHT	NN	B-NP	B-proteinis	not	be	VBZ	B-VP	Onot	detectable	not	RB	O	Odetectable	in	detectable	JJ	B-ADJP	Oin	DCs	in	IN	B-PP	ODCs	either	DC	NNS	B-NP	B-cell_typeeither	freshly	either	CC	O	Ofreshly	isolated	freshly	RB	B-VP	Oisolated	from	isolate	VBN	I-VP	Ofrom	PBMCs	from	IN	B-PP	OPBMCs	or	PBMC	NNS	B-NP	B-cell_typeor	rendered	or	CC	O	Orendered	mature	render	VBN	B-VP	Omature	in	mature	JJ	B-ADJP	Oin	vitro	in	FW	B-ADVP	Ovitro	by	vitro	FW	I-ADVP	Oby	LPS	by	IN	B-PP	OLPS	treatment	LPS	NN	B-NP	Otreatment	.	treatment	NN	I-NP	O.	Blockade	.	.	O	OBlockade	of	Blockade	NN	B-NP	Oof	LIGHT	of	IN	B-PP	OLIGHT	by	LIGHT	NN	B-NP	B-proteinby	its	by	IN	B-PP	Oits	soluble	its	PRP$	B-NP	Osoluble	receptors	soluble	JJ	I-NP	B-proteinreceptors	","	receptor	NNS	I-NP	I-protein","	lymphotoxin	","	","	O	Olymphotoxin	beta	lymphotoxin	NN	B-NP	B-proteinbeta	receptor-Ig	beta	NN	I-NP	I-proteinreceptor-Ig	or	receptor-Ig	NN	I-NP	I-proteinor	HVEM-Ig	or	CC	I-NP	OHVEM-Ig	","	HVEM-Ig	NN	I-NP	B-protein","	inhibits	","	","	O	Oinhibits	the	inhibit	VBZ	B-VP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	DC	of	IN	B-PP	ODC	#NAME?	DC	NN	B-NP	B-cell_type#NAME?	primary	#NAME?	JJ	I-NP	Oprimary	allogeneic	primary	JJ	I-NP	Oallogeneic	T	allogeneic	JJ	I-NP	OT	cell	T	NN	I-NP	Ocell	response	cell	NN	I-NP	Oresponse	.	response	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	engagement	","	","	O	Oengagement	of	engagement	NN	B-NP	Oof	LIGHT	of	IN	B-PP	OLIGHT	costimulates	LIGHT	NN	B-NP	Ocostimulates	human	costimulate	VBZ	B-VP	Ohuman	T	human	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	proliferation	cell	NN	I-NP	Oproliferation	","	proliferation	NN	I-NP	O","	amplifies	","	","	O	Oamplifies	the	amplify	VBZ	B-VP	Othe	NF-kappaB	the	DT	B-NP	ONF-kappaB	signaling	NF-kappaB	NN	I-NP	B-proteinsignaling	pathway	signaling	NN	I-NP	Opathway	","	pathway	NN	I-NP	O","	and	","	","	O	Oand	preferentially	and	CC	O	Opreferentially	induces	preferentially	RB	B-VP	Oinduces	the	induce	VBZ	I-VP	Othe	production	the	DT	B-NP	Oproduction	of	production	NN	I-NP	Oof	IFN-gamma	of	IN	B-PP	OIFN-gamma	","	IFN-gamma	NN	B-NP	B-protein","	but	","	","	B-NP	Obut	not	but	CC	I-NP	Onot	IL-4	not	RB	I-NP	OIL-4	","	IL-4	NN	B-NP	B-protein","	in	","	","	O	Oin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	an	of	IN	B-PP	Oan	antigenic	an	DT	B-NP	Oantigenic	signal	antigenic	JJ	I-NP	Osignal	.	signal	NN	I-NP	O.	Our	.	.	O	OOur	results	Our	PRP$	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	LIGHT	that	IN	B-SBAR	OLIGHT	is	LIGHT	NN	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	costimulatory	a	DT	B-NP	Ocostimulatory	molecule	costimulatory	JJ	I-NP	B-proteinmolecule	involved	molecule	NN	I-NP	I-proteininvolved	in	involve	VBN	B-VP	Oin	DC	in	IN	B-PP	ODC	#NAME?	DC	NN	B-NP	B-cell_type#NAME?	cellular	#NAME?	JJ	I-NP	Ocellular	immune	cellular	JJ	I-NP	Oimmune	responses	immune	JJ	I-NP	Oresponses	.	response	NNS	I-NP	O.	Suppression	.	.	O	OSuppression	of	Suppression	NN	B-NP	Oof	HIV	of	IN	B-PP	OHIV	type	HIV	NN	B-NP	Otype	1	type	NN	I-NP	O1	replication	1	CD	I-NP	Oreplication	by	replication	NN	I-NP	Oby	a	by	IN	B-PP	Oa	dominant-negative	a	DT	B-NP	Odominant-negative	Ets-1	dominant-negative	JJ	I-NP	B-proteinEts-1	mutant	Ets-1	NN	I-NP	I-proteinmutant	.	mutant	NN	I-NP	I-protein.	Activity	.	.	O	OActivity	of	Activity	NN	B-NP	Oof	the	of	IN	B-PP	Othe	distal	the	DT	B-NP	Odistal	region	distal	JJ	I-NP	B-DNAregion	of	region	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	immunodeficiency	human	JJ	I-NP	B-DNAimmunodeficiency	virus	immunodeficiency	NN	I-NP	I-DNAvirus	(	virus	NN	I-NP	I-DNA(	HIV-1	(	(	O	I-DNAHIV-1	)	HIV-1	NN	B-NP	I-DNA)	long	)	)	O	I-DNAlong	terminal	long	JJ	B-NP	I-DNAterminal	repeat	terminal	JJ	I-NP	I-DNArepeat	(	repeat	NN	I-NP	I-DNA(	LTR	(	(	O	OLTR	)	LTR	NN	B-NP	B-DNA)	","	)	)	O	O","	which	","	","	O	Owhich	contains	which	WDT	B-NP	Ocontains	binding	contain	VBZ	B-VP	Obinding	sites	bind	VBG	B-NP	B-DNAsites	for	site	NNS	I-NP	I-DNAfor	the	for	IN	B-PP	Othe	Ets-1	the	DT	B-NP	OEts-1	and	Ets-1	NN	I-NP	B-proteinand	USF-1	and	CC	I-NP	OUSF-1	proteins	USF-1	NN	I-NP	B-proteinproteins	","	protein	NNS	I-NP	I-protein","	is	","	","	O	Ois	integral	be	VBZ	B-VP	Ointegral	for	integral	JJ	B-ADJP	Ofor	HIV-1	for	IN	B-PP	OHIV-1	replication	HIV-1	NN	B-NP	Oreplication	.	replication	NN	I-NP	O.	The	.	.	O	OThe	Ets-1	The	DT	B-NP	OEts-1	and	Ets-1	NN	I-NP	B-proteinand	USF-1	and	CC	I-NP	OUSF-1	proteins	USF-1	NN	I-NP	B-proteinproteins	play	protein	NNS	I-NP	I-proteinplay	a	play	VBP	B-VP	Oa	critical	a	DT	B-NP	Ocritical	role	critical	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	HIV-1	the	DT	B-NP	OHIV-1	LTR	HIV-1	NN	I-NP	B-DNALTR	distal	LTR	NN	I-NP	I-DNAdistal	enhancer	distal	JJ	I-NP	Oenhancer	region	enhancer	NN	I-NP	Oregion	","	region	NN	I-NP	O","	as	","	","	O	Oas	indicated	as	IN	B-SBAR	Oindicated	by	indicate	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	potent	the	DT	B-NP	Opotent	dominant	potent	JJ	I-NP	Odominant	negative	dominant	JJ	I-NP	Onegative	effect	negative	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	a	of	IN	B-PP	Oa	mutant	a	DT	B-NP	Omutant	Ets-1	mutant	JJ	I-NP	OEts-1	lacking	Ets-1	NN	I-NP	B-proteinlacking	trans-activation	lack	VBG	B-VP	Otrans-activation	domains	trans-activation	NN	B-NP	B-proteindomains	on	domain	NNS	I-NP	I-proteinon	the	on	IN	B-PP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	activity	transcriptional	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	LTR	the	DT	B-NP	OLTR	.	LTR	NN	I-NP	B-DNA.	To	.	.	O	OTo	determine	To	TO	B-VP	Odetermine	the	determine	VB	I-VP	Othe	biological	the	DT	B-NP	Obiological	relevance	biological	JJ	I-NP	Orelevance	of	relevance	NN	I-NP	Oof	the	of	IN	B-PP	Othe	Ets-1	the	DT	B-NP	OEts-1	and	Ets-1	NN	I-NP	B-proteinand	USF-1	and	CC	I-NP	OUSF-1	proteins	USF-1	NN	I-NP	B-proteinproteins	in	protein	NNS	I-NP	I-proteinin	HIV-1	in	IN	B-PP	OHIV-1	replication	HIV-1	NN	B-NP	Oreplication	","	replication	NN	I-NP	O","	we	","	","	O	Owe	examined	we	PRP	B-NP	Oexamined	the	examine	VBD	B-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	expression	of	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	dominant-negative	the	DT	B-NP	Odominant-negative	mutant	dominant-negative	JJ	I-NP	B-proteinmutant	of	mutant	NN	I-NP	I-proteinof	Ets-1	of	IN	B-PP	OEts-1	(	Ets-1	NN	B-NP	B-protein(	dnEts-1	(	(	O	OdnEts-1	)	dnEts-1	NN	B-NP	O)	on	)	)	O	Oon	HIV-1	on	IN	B-PP	OHIV-1	infection	HIV-1	NN	B-NP	Oinfection	of	infection	NN	I-NP	Oof	T	of	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	demonstrated	We	PRP	B-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	expression	that	IN	B-SBAR	Oexpression	of	expression	NN	B-NP	Oof	dnEts	of	IN	B-PP	OdnEts	markedly	dnEt	NNS	B-NP	Omarkedly	suppressed	markedly	RB	B-ADVP	Osuppressed	HIV-1	suppress	VBD	B-VP	OHIV-1	infection	HIV-1	NN	B-NP	Oinfection	of	infection	NN	I-NP	Oof	a	of	IN	B-PP	Oa	T	a	DT	B-NP	OT	cell	T	NN	I-NP	B-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	.	line	NN	I-NP	I-cell_line.	This	.	.	O	OThis	finding	This	DT	B-NP	Ofinding	indicates	finding	NN	I-NP	Oindicates	that	indicate	VBZ	B-VP	Othat	formation	that	IN	B-SBAR	Oformation	of	formation	NN	B-NP	Oof	a	of	IN	B-PP	Oa	transcriptionaly	a	DT	B-NP	Otranscriptionaly	active	transcriptionaly	RB	I-NP	Oactive	USF-1/Ets-1	active	JJ	I-NP	OUSF-1/Ets-1	complex	USF-1/Ets-1	NN	I-NP	B-proteincomplex	is	complex	NN	I-NP	I-proteinis	important	be	VBZ	B-VP	Oimportant	in	important	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	productive	the	DT	B-NP	Oproductive	infection	productive	JJ	I-NP	Oinfection	of	infection	NN	I-NP	Oof	cells	of	IN	B-PP	Ocells	by	cell	NNS	B-NP	Oby	HIV-1	by	IN	B-PP	OHIV-1	","	HIV-1	NN	B-NP	O","	and	","	","	O	Oand	suggests	and	CC	O	Osuggests	that	suggest	VBZ	B-VP	Othat	inhibition	that	IN	B-SBAR	Oinhibition	of	inhibition	NN	B-NP	Oof	the	of	IN	B-PP	Othe	interaction	the	DT	B-NP	Ointeraction	between	interaction	NN	I-NP	Obetween	USF-1	between	IN	B-PP	OUSF-1	and	USF-1	NN	B-NP	B-proteinand	Ets-1	and	CC	I-NP	OEts-1	with	Ets-1	NN	I-NP	B-proteinwith	the	with	IN	B-PP	Othe	HIV-1	the	DT	B-NP	OHIV-1	LTR	HIV-1	NN	I-NP	B-DNALTR	may	LTR	NN	I-NP	I-DNAmay	provide	may	MD	B-VP	Oprovide	a	provide	VB	I-VP	Oa	new	a	DT	B-NP	Onew	target	new	JJ	I-NP	Otarget	for	target	NN	I-NP	Ofor	anti-HIV-1	for	IN	B-PP	Oanti-HIV-1	gene	anti-HIV-1	NN	B-NP	Ogene	therapy	gene	NN	I-NP	Otherapy	.	therapy	NN	I-NP	O.	Human	.	.	O	OHuman	eosinophils	Human	JJ	B-NP	B-cell_typeeosinophils	constitutively	eosinophil	NNS	I-NP	I-cell_typeconstitutively	express	constitutively	RB	B-ADVP	Oexpress	nuclear	express	VBP	B-VP	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	of	factor	NN	I-NP	I-proteinof	activated	of	IN	B-PP	I-proteinactivated	T	activate	VBN	B-NP	I-proteinT	cells	T	NN	I-NP	I-proteincells	p	cell	NNS	I-NP	I-proteinp	and	p	NN	I-NP	Oand	c	and	CC	I-NP	Oc	.	c	NN	I-NP	O.	BACKGROUND	.	.	O	OBACKGROUND	:	BACKGROUND	NN	B-NP	O:	Eosinophils	:	:	O	OEosinophils	are	Eosinophil	NNS	B-NP	B-cell_typeare	now	be	VBP	B-VP	Onow	known	now	RB	I-VP	Oknown	to	know	VBN	I-VP	Oto	produce	to	TO	B-VP	Oproduce	a	produce	VB	I-VP	Oa	variety	a	DT	B-NP	Ovariety	of	variety	NN	I-NP	Oof	proinflammatory	of	IN	B-PP	Oproinflammatory	cytokines	proinflammatory	JJ	B-NP	B-proteincytokines	","	cytokine	NNS	I-NP	I-protein","	although	","	","	O	Oalthough	the	although	IN	B-SBAR	Othe	molecular	the	DT	B-NP	Omolecular	factors	molecular	JJ	I-NP	B-proteinfactors	that	factor	NNS	I-NP	I-proteinthat	regulate	that	WDT	B-NP	Oregulate	their	regulate	VBP	B-VP	Otheir	production	their	PRP$	B-NP	Oproduction	are	production	NN	I-NP	Oare	poorly	be	VBP	B-VP	Opoorly	understood	poorly	RB	I-VP	Ounderstood	.	understand	VBN	I-VP	O.	The	.	.	O	OThe	expression	The	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	almost	of	IN	B-PP	Oalmost	all	almost	RB	B-NP	Oall	of	all	DT	I-NP	Oof	the	of	IN	B-PP	Othe	cytokines	the	DT	B-NP	Ocytokines	produced	cytokine	NNS	I-NP	B-proteinproduced	by	produce	VBN	B-VP	Oby	eosinophils	by	IN	B-PP	Oeosinophils	","	eosinophil	NNS	B-NP	B-cell_type","	including	","	","	O	Oincluding	the	include	VBG	B-PP	Othe	proallergic	the	DT	B-NP	Oproallergic	cytokine	proallergic	JJ	I-NP	Ocytokine	IL-4	cytokine	NN	I-NP	B-proteinIL-4	","	IL-4	NN	I-NP	B-protein","	is	","	","	O	Ois	now	be	VBZ	B-VP	Onow	known	now	RB	I-VP	Oknown	to	know	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	regulated	be	VB	I-VP	Oregulated	at	regulate	VBN	I-VP	Oat	the	at	IN	B-PP	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	by	transcription	NN	B-NP	Oby	members	by	IN	B-PP	Omembers	of	member	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	factor	nuclear	JJ	I-NP	B-proteinfactor	of	factor	NN	I-NP	I-proteinof	activated	of	IN	B-PP	I-proteinactivated	T	activate	VBN	B-NP	I-proteinT	cells	T	NN	I-NP	I-proteincells	(	cell	NNS	I-NP	I-protein(	NFAT	(	(	O	ONFAT	)	NFAT	NN	B-NP	B-protein)	family	)	)	O	Ofamily	of	family	NN	B-NP	Oof	transcription	of	IN	B-PP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	.	factor	NNS	I-NP	I-protein.	OBJECTIVE	.	.	O	OOBJECTIVE	:	OBJECTIVE	NN	B-NP	O:	We	:	:	O	OWe	sought	We	PRP	B-NP	Osought	to	seek	VBD	B-VP	Oto	characterize	to	TO	I-VP	Ocharacterize	the	characterize	VB	I-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	different	of	IN	B-PP	Odifferent	NFAT	different	JJ	B-NP	ONFAT	proteins	NFAT	NN	I-NP	B-proteinproteins	in	protein	NNS	I-NP	I-proteinin	resting	in	IN	B-PP	Oresting	and	rest	VBG	B-NP	Oand	activated	and	CC	I-NP	Oactivated	eosinophils	activate	VBN	I-NP	B-cell_typeeosinophils	.	eosinophil	NNS	I-NP	I-cell_type.	METHODS	.	.	O	OMETHODS	:	METHODS	NNS	B-NP	O:	Nuclear	:	:	O	ONuclear	and	Nuclear	JJ	B-NP	Oand	whole	and	CC	I-NP	Owhole	cell	whole	JJ	I-NP	Ocell	extracts	cell	NN	I-NP	Oextracts	were	extract	NNS	I-NP	Owere	obtained	be	VBD	B-VP	Oobtained	from	obtain	VBN	I-VP	Ofrom	both	from	IN	B-PP	Oboth	peripheral	both	CC	B-NP	Operipheral	blood	peripheral	JJ	I-NP	B-cell_typeblood	eosinophils	blood	NN	I-NP	I-cell_typeeosinophils	and	eosinophil	NNS	I-NP	I-cell_typeand	those	and	CC	O	Othose	obtained	those	DT	B-NP	Oobtained	from	obtain	VBN	B-VP	Ofrom	bronchoalveolar	from	IN	B-PP	Obronchoalveolar	lavage	bronchoalveolar	JJ	B-NP	Olavage	fluid	lavage	NN	I-NP	Ofluid	of	fluid	NN	I-NP	Oof	asthmatic	of	IN	B-PP	Oasthmatic	subjects	asthmatic	JJ	B-NP	Osubjects	after	subject	NNS	I-NP	Oafter	endobronchial	after	IN	B-PP	Oendobronchial	allergen	endobronchial	JJ	B-NP	Oallergen	challenge	allergen	NN	I-NP	Ochallenge	.	challenge	NN	I-NP	O.	NFAT	.	.	O	ONFAT	expression	NFAT	NN	B-NP	B-proteinexpression	was	expression	NN	I-NP	Owas	determined	be	VBD	B-VP	Odetermined	by	determine	VBN	I-VP	Oby	using	by	IN	B-PP	Ousing	immunoprecipitation	use	VBG	B-VP	Oimmunoprecipitation	and	immunoprecipitation	NN	B-NP	Oand	Western	and	CC	I-NP	OWestern	blot	Western	NN	I-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	","	analysis	NN	I-NP	O","	DNA-binding	","	","	O	ODNA-binding	assays	DNA-binding	JJ	B-NP	Oassays	","	assay	NNS	I-NP	O","	and	","	","	O	Oand	RT-PCR	and	CC	O	ORT-PCR	analysis	RT-PCR	NN	B-NP	Oanalysis	of	analysis	NN	I-NP	Oof	eosinophil	of	IN	B-PP	Oeosinophil	mRNA	eosinophil	NN	B-NP	B-RNAmRNA	.	mRNA	NN	I-NP	I-RNA.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	Both	:	:	O	OBoth	peripheral	Both	CC	O	Operipheral	blood	peripheral	JJ	B-NP	Oblood	and	blood	NN	I-NP	Oand	bronchoalveolar	and	CC	O	Obronchoalveolar	lavage	bronchoalveolar	JJ	B-NP	B-cell_typelavage	fluid	lavage	NN	I-NP	I-cell_typefluid	eosinophils	fluid	NN	I-NP	I-cell_typeeosinophils	expressed	eosinophil	NNS	I-NP	I-cell_typeexpressed	NFATp	express	VBD	B-VP	ONFATp	and	NFATp	NN	B-NP	B-proteinand	NFATc	and	CC	I-NP	ONFATc	protein	NFATc	NN	I-NP	B-proteinprotein	.	protein	NN	I-NP	I-protein.	Unlike	.	.	O	OUnlike	activated	Unlike	IN	B-PP	Oactivated	T	activate	VBN	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	which	","	","	O	Owhich	express	which	WDT	B-NP	Oexpress	multiple	express	VBP	B-VP	Omultiple	NFATc	multiple	JJ	B-NP	ONFATc	isoforms	NFATc	NN	I-NP	B-proteinisoforms	","	isoform	NNS	I-NP	I-protein","	eosinophils	","	","	O	Oeosinophils	preferentially	eosinophil	NNS	B-NP	B-cell_typepreferentially	express	preferentially	RB	B-ADVP	Oexpress	the	express	VBP	B-VP	Othe	approximately	the	DT	B-NP	Oapproximately	85-kd	approximately	RB	I-NP	O85-kd	isoform	85-kd	JJ	I-NP	B-proteinisoform	.	isoform	NN	I-NP	I-protein.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	eosinophils	","	","	O	Oeosinophils	were	eosinophil	NNS	B-NP	B-cell_typewere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	constitutively	to	TO	I-VP	Oconstitutively	express	constitutively	RB	I-VP	Oexpress	NFATc	express	VB	I-VP	ONFATc	mRNA	NFATc	NN	B-NP	B-RNAmRNA	.	mRNA	NN	I-NP	I-RNA.	A	.	.	O	OA	brief	A	DT	B-NP	Obrief	incubation	brief	JJ	I-NP	Oincubation	with	incubation	NN	I-NP	Owith	the	with	IN	B-PP	Othe	T	the	DT	B-NP	OT	(	T	NN	I-NP	B-protein(	H	(	(	O	I-proteinH	)	H	NN	B-NP	I-protein)	2	)	)	O	I-protein2	cytokines	2	CD	B-NP	I-proteincytokines	IL-4	cytokine	NNS	I-NP	I-proteinIL-4	and	IL-4	NN	I-NP	B-proteinand	IL-5	and	CC	I-NP	OIL-5	was	IL-5	NN	I-NP	B-proteinwas	sufficient	be	VBD	B-VP	Osufficient	to	sufficient	JJ	B-ADJP	Oto	induce	to	TO	B-VP	Oinduce	the	induce	VB	I-VP	Othe	nuclear	the	DT	B-NP	Onuclear	translocation	nuclear	JJ	I-NP	Otranslocation	of	translocation	NN	I-NP	Oof	NFATc	of	IN	B-PP	ONFATc	.	NFATc	NN	B-NP	B-protein.	Eosinophil	.	.	O	OEosinophil	nuclear	Eosinophil	NN	B-NP	Onuclear	extracts	nuclear	JJ	I-NP	Oextracts	contain	extract	NNS	I-NP	Ocontain	multiple	contain	VBP	B-VP	Omultiple	factors	multiple	JJ	B-NP	Ofactors	that	factor	NNS	I-NP	Othat	can	that	WDT	B-NP	Ocan	specifically	can	MD	B-VP	Ospecifically	recognize	specifically	RB	I-VP	Orecognize	the	recognize	VB	I-VP	Othe	IL-4	the	DT	B-NP	OIL-4	promoter	IL-4	NN	I-NP	B-DNApromoter	P1	promoter	NN	I-NP	I-DNAP1	NFAT	P1	NN	I-NP	I-DNANFAT	site	NFAT	NN	I-NP	I-DNAsite	in	site	NN	I-NP	I-DNAin	DNA-binding	in	IN	B-PP	ODNA-binding	assays	DNA-binding	JJ	B-NP	Oassays	","	assay	NNS	I-NP	O","	including	","	","	O	Oincluding	NFATp	include	VBG	B-PP	ONFATp	.	NFATp	NN	B-NP	B-protein.	CONCLUSION	.	.	O	OCONCLUSION	:	CONCLUSION	NN	B-NP	O:	NFATp	:	:	O	ONFATp	and	NFATp	NN	B-NP	B-proteinand	NFATc	and	CC	I-NP	ONFATc	can	NFATc	NN	I-NP	B-proteincan	regulate	can	MD	B-VP	Oregulate	the	regulate	VB	I-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	cytokines	of	IN	B-PP	Ocytokines	and	cytokine	NNS	B-NP	B-proteinand	other	and	CC	O	Oother	genes	other	JJ	B-NP	Ogenes	in	gene	NNS	I-NP	Oin	eosinophils	in	IN	B-PP	Oeosinophils	but	eosinophil	NNS	B-NP	B-cell_typebut	appear	but	CC	O	Oappear	to	appear	VBP	B-VP	Oto	be	to	TO	I-VP	Obe	regulated	be	VB	I-VP	Oregulated	by	regulate	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	novel	a	DT	B-NP	Onovel	signal	novel	JJ	I-NP	Osignal	transduction	signal	NN	I-NP	Otransduction	mechanism	transduction	NN	I-NP	Omechanism	in	mechanism	NN	I-NP	Oin	these	in	IN	B-PP	Othese	cells	these	DT	B-NP	Ocells	.	cell	NNS	I-NP	O.	BLyS	.	.	O	OBLyS	BINDS	BLyS	NN	B-NP	OBINDS	TO	BINDS	NNS	I-NP	OTO	B	TO	TO	B-PP	OB	CELLS	B	NN	B-NP	OCELLS	WITH	CELLS	NN	I-NP	OWITH	HIGH	WITH	NN	I-NP	OHIGH	AFFINITY	HIGH	NN	I-NP	OAFFINITY	AND	AFFINITY	NN	I-NP	OAND	INDUCES	AND	CC	O	OINDUCES	ACTIVATION	INDUCES	VBZ	B-VP	OACTIVATION	OF	ACTIVATION	NN	B-NP	OOF	THE	OF	IN	B-PP	OTHE	TRANSCRIPTION	THE	DT	B-NP	OTRANSCRIPTION	FACTORS	TRANSCRIPTION	NN	I-NP	B-proteinFACTORS	NF-kappaB	FACTORS	NN	I-NP	I-proteinNF-kappaB	AND	NF-kappaB	NN	I-NP	B-proteinAND	ELF-1	AND	NN	I-NP	OELF-1	.	ELF-1	NN	I-NP	B-protein.	B	.	.	O	OB	lymphocyte	B	NN	B-NP	B-cell_typelymphocyte	stimulator	lymphocyte	NN	I-NP	I-cell_typestimulator	(	stimulator	NN	I-NP	O(	BLyS	(	(	O	OBLyS	)	BLyS	NN	B-NP	O)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	novel	a	DT	B-NP	Onovel	member	novel	JJ	I-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	TNF	the	DT	B-NP	OTNF	family	TNF	NN	I-NP	B-proteinfamily	of	family	NN	I-NP	I-proteinof	proteins	of	IN	B-PP	Oproteins	expressed	protein	NNS	B-NP	Oexpressed	by	express	VBN	B-VP	Oby	myeloid	by	IN	B-PP	Omyeloid	cells	myeloid	JJ	B-NP	B-cell_typecells	as	cell	NNS	I-NP	I-cell_typeas	membrane-bound	as	IN	B-PP	Omembrane-bound	and	membrane-bound	JJ	B-NP	B-proteinand	soluble	and	CC	I-NP	I-proteinsoluble	forms	soluble	JJ	I-NP	I-proteinforms	.	form	NNS	I-NP	I-protein.	BLyS	.	.	O	OBLyS	was	BLyS	NN	B-NP	Owas	shown	be	VBD	B-VP	Oshown	to	show	VBN	I-VP	Oto	act	to	TO	I-VP	Oact	specifically	act	VB	I-VP	Ospecifically	on	specifically	RB	B-ADVP	Oon	B	on	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	inducing	","	","	O	Oinducing	proliferation	induce	VBG	B-VP	Oproliferation	and	proliferation	NN	B-NP	Oand	immunoglobulin	and	CC	O	Oimmunoglobulin	production	immunoglobulin	NN	B-NP	B-proteinproduction	both	production	NN	I-NP	Oboth	in	both	CC	O	Oin	vitro	in	FW	B-ADVP	Ovitro	and	vitro	FW	I-ADVP	Oand	in	and	CC	O	Oin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	The	.	.	O	OThe	present	The	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	was	study	NN	I-NP	Owas	undertaken	be	VBD	B-VP	Oundertaken	to	undertake	VBN	I-VP	Oto	characterize	to	TO	I-VP	Ocharacterize	binding	characterize	VB	I-VP	Obinding	of	binding	NN	B-NP	Oof	radiolabeled	of	IN	B-PP	Oradiolabeled	BLyS	radiolabele	VBN	B-NP	OBLyS	to	BLyS	NN	I-NP	Oto	its	to	TO	B-PP	Oits	cognate	its	PRP$	B-NP	Ocognate	receptor	cognate	JJ	I-NP	B-proteinreceptor	on	receptor	NN	I-NP	I-proteinon	human	on	IN	B-PP	Ohuman	B	human	JJ	B-NP	B-cell_typeB	lymphocytes	B	NN	I-NP	I-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	examine	and	CC	O	Oexamine	intracellular	examine	VB	B-VP	Ointracellular	events	intracellular	JJ	B-NP	Oevents	initiated	event	NNS	I-NP	Oinitiated	by	initiate	VBN	B-VP	Oby	BLyS	by	IN	B-PP	OBLyS	binding	BLyS	NN	B-NP	Obinding	.	binding	NN	I-NP	O.	Similar	.	.	O	OSimilar	to	Similar	JJ	B-ADJP	Oto	other	to	TO	B-PP	Oother	TNF	other	JJ	B-NP	OTNF	family	TNF	NN	I-NP	B-proteinfamily	members	family	NN	I-NP	I-proteinmembers	","	member	NNS	I-NP	I-protein","	BLyS	","	","	O	OBLyS	is	BLyS	NN	B-NP	Ois	present	be	VBZ	B-VP	Opresent	in	present	JJ	B-ADJP	Oin	solution	in	IN	B-PP	Osolution	as	solution	NN	B-NP	Oas	a	as	IN	B-PP	Oa	homotrimer	a	DT	B-NP	Ohomotrimer	as	homotrimer	NN	I-NP	Oas	determined	as	IN	B-SBAR	Odetermined	by	determine	VBN	B-VP	Oby	gel	by	IN	B-PP	Ogel	filtration	gel	NN	B-NP	Ofiltration	chromatography	filtration	NN	I-NP	Ochromatography	and	chromatography	NN	I-NP	Oand	light	and	CC	O	Olight	scattering	light	NN	B-NP	Oscattering	analysis	scattering	NN	I-NP	Oanalysis	.	analysis	NN	I-NP	O.	BLyS	.	.	O	OBLyS	binding	BLyS	NN	B-NP	Obinding	to	binding	NN	I-NP	Oto	B	to	TO	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	is	cell	NNS	I-NP	I-cell_typeis	specific	be	VBZ	B-VP	Ospecific	as	specific	JJ	B-ADJP	Oas	other	as	IN	B-SBAR	Oother	TNF	other	JJ	B-NP	OTNF	family	TNF	NN	I-NP	B-proteinfamily	members	family	NN	I-NP	I-proteinmembers	tested	member	NNS	I-NP	I-proteintested	did	test	VBN	B-VP	Odid	not	do	VBD	B-VP	Onot	compete	not	RB	I-VP	Ocompete	for	compete	VB	I-VP	Ofor	(	for	IN	B-PP	O(	125	(	(	O	O125	)	125	CD	B-NP	O)	I-	)	)	O	OI-	BLyS	I-	NN	B-NP	OBLyS	binding	BLyS	NN	I-NP	Obinding	.	binding	NN	I-NP	O.	Analysis	.	.	O	OAnalysis	of	Analysis	NN	B-NP	Oof	equilibrium	of	IN	B-PP	Oequilibrium	binding	equilibrium	NN	B-NP	Obinding	of	binding	NN	I-NP	Oof	(	of	IN	B-PP	O(	125	(	(	O	O125	)	125	CD	B-NP	O)	I-labeled	)	)	O	OI-labeled	BLyS	I-labeled	JJ	B-NP	OBLyS	to	BLyS	NN	I-NP	Oto	purified	to	TO	B-PP	Opurified	human	purify	VBN	B-NP	Ohuman	tonsillar	human	JJ	I-NP	B-cell_typetonsillar	B	tonsillar	JJ	I-NP	I-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	demonstrated	cell	NNS	I-NP	I-cell_typedemonstrated	saturable	demonstrate	VBD	B-VP	Osaturable	binding	saturable	JJ	B-NP	Obinding	.	binding	NN	I-NP	O.	Scatchard	.	.	O	OScatchard	analysis	Scatchard	NN	B-NP	Oanalysis	of	analysis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	binding	the	DT	B-NP	Obinding	data	bind	VBG	I-NP	Odata	revealed	datum	NNS	I-NP	Orevealed	a	reveal	VBD	B-VP	Oa	single	a	DT	B-NP	Osingle	class	single	JJ	I-NP	Oclass	of	class	NN	I-NP	Oof	high-affinity	of	IN	B-PP	Ohigh-affinity	binding	high-affinity	JJ	B-NP	Obinding	on	binding	NN	I-NP	Oon	human	on	IN	B-PP	Ohuman	B	human	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	with	cell	NNS	I-NP	I-cell_typewith	approximately	with	IN	B-PP	Oapproximately	2600	approximately	RB	B-NP	O2600	binding	2600	CD	I-NP	B-DNAbinding	sites	bind	VBG	I-NP	I-DNAsites	per	site	NNS	I-NP	I-DNAper	cell	per	IN	B-PP	Ocell	and	cell	NN	B-NP	Oand	an	and	CC	O	Oan	apparent	an	DT	B-NP	Oapparent	dissociation	apparent	JJ	I-NP	Odissociation	constant	dissociation	NN	I-NP	Oconstant	(	constant	NN	I-NP	O(	K	(	(	O	OK	(	K	NN	B-NP	O(	D	(	(	O	OD	)	D	NN	B-NP	O)	)	)	)	O	O)	of	)	)	O	Oof	about	of	IN	B-PP	Oabout	0.1	about	RB	B-NP	O0.1	nM	0.1	CD	I-NP	OnM	.	nM	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	we	addition	NN	B-NP	Owe	report	we	PRP	B-NP	Oreport	that	report	VBP	B-VP	Othat	BLyS	that	IN	B-SBAR	OBLyS	binding	BLyS	NN	B-NP	Obinding	to	binding	NN	I-NP	Oto	B	to	TO	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	results	cell	NNS	I-NP	I-cell_typeresults	in	result	VBZ	B-VP	Oin	the	in	IN	B-PP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	and	NF-kappaB	NN	B-NP	B-proteinand	the	and	CC	O	Othe	Ets	the	DT	B-NP	OEts	family	Ets	NN	I-NP	B-proteinfamily	transcription	family	NN	I-NP	I-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	","	factor	NN	I-NP	I-protein","	ELF-1	","	","	O	OELF-1	","	ELF-1	NN	B-NP	B-protein","	and	","	","	O	Oand	in	and	CC	O	Oin	the	in	IN	B-PP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	mRNA	of	IN	B-PP	OmRNA	for	mRNA	NN	B-NP	B-RNAfor	Polo-like	for	IN	B-PP	OPolo-like	kinase	Polo-like	JJ	B-NP	B-proteinkinase	(	kinase	NN	I-NP	I-protein(	PLK	(	(	O	OPLK	)	PLK	NN	B-NP	B-protein)	.	)	)	O	O.	Copyright	.	.	O	OCopyright	2001	Copyright	NN	B-NP	O2001	Academic	2001	CD	I-NP	OAcademic	Press	Academic	NNP	I-NP	OPress	.	Press	NNP	I-NP	O.	Design	.	.	O	ODesign	and	Design	NN	B-NP	Oand	use	and	CC	I-NP	Ouse	of	use	NN	I-NP	Oof	an	of	IN	B-PP	Oan	inducibly	an	DT	B-NP	Oinducibly	activated	inducibly	RB	I-NP	Oactivated	human	activate	VBN	I-NP	Ohuman	immunodeficiency	human	JJ	I-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	Nef	1	CD	I-NP	ONef	to	Nef	NN	I-NP	B-proteinto	study	to	TO	B-VP	Ostudy	immune	study	VB	I-VP	Oimmune	modulation	immune	JJ	B-NP	Omodulation	.	modulation	NN	I-NP	O.	The	.	.	O	OThe	Nef	The	DT	B-NP	ONef	protein	Nef	NN	I-NP	B-proteinprotein	of	protein	NN	I-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	immunodeficiency	human	JJ	I-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	(	1	CD	I-NP	O(	HIV-1	(	(	O	OHIV-1	)	HIV-1	NN	B-NP	O)	has	)	)	O	Ohas	been	have	VBZ	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	to	show	VBN	I-VP	Oto	enhance	to	TO	I-VP	Oenhance	the	enhance	VB	I-VP	Othe	infectivity	the	DT	B-NP	Oinfectivity	of	infectivity	NN	I-NP	Oof	virus	of	IN	B-PP	Ovirus	particles	virus	NN	B-NP	Oparticles	","	particle	NNS	I-NP	O","	downmodulate	","	","	O	Odownmodulate	cell	downmodulate	VBP	B-VP	Ocell	surface	cell	NN	B-NP	B-proteinsurface	proteins	surface	NN	I-NP	I-proteinproteins	","	protein	NNS	I-NP	I-protein","	and	","	","	O	Oand	associate	and	CC	O	Oassociate	with	associate	VBP	B-VP	Owith	many	with	IN	B-PP	Omany	intracellular	many	JJ	B-NP	B-proteinintracellular	proteins	intracellular	JJ	I-NP	I-proteinproteins	that	protein	NNS	I-NP	I-proteinthat	are	that	WDT	B-NP	Oare	thought	be	VBP	B-VP	Othought	to	think	VBN	I-VP	Oto	facilitate	to	TO	I-VP	Ofacilitate	HIV	facilitate	VB	I-VP	OHIV	infection	HIV	NN	B-NP	Oinfection	.	infection	NN	I-NP	O.	One	.	.	O	OOne	of	One	CD	B-NP	Oof	the	of	IN	B-PP	Othe	challenges	the	DT	B-NP	Ochallenges	in	challenge	NNS	I-NP	Oin	defining	in	IN	B-PP	Odefining	the	define	VBG	B-VP	Othe	molecular	the	DT	B-NP	Omolecular	events	molecular	JJ	I-NP	Oevents	regulated	event	NNS	I-NP	Oregulated	by	regulate	VBN	B-VP	Oby	Nef	by	IN	B-PP	ONef	has	Nef	NN	B-NP	B-proteinhas	been	have	VBZ	B-VP	Obeen	obtaining	be	VBN	I-VP	Oobtaining	good	obtain	VBG	I-VP	Ogood	expression	good	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	Nef	of	IN	B-PP	ONef	protein	Nef	NN	B-NP	B-proteinprotein	in	protein	NN	I-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	This	.	.	O	OThis	has	This	DT	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	attributed	be	VBN	I-VP	Oattributed	to	attribute	VBN	I-VP	Oto	effects	to	TO	B-PP	Oeffects	of	effect	NNS	B-NP	Oof	Nef	of	IN	B-PP	ONef	on	Nef	NN	B-NP	B-proteinon	cell	on	IN	B-PP	Ocell	proliferation	cell	NN	B-NP	Oproliferation	and	proliferation	NN	I-NP	Oand	apoptosis	and	CC	I-NP	Oapoptosis	.	apoptosis	NN	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	designed	have	VBP	B-VP	Odesigned	a	design	VBN	I-VP	Oa	Nef	a	DT	B-NP	ONef	protein	Nef	NN	I-NP	B-proteinprotein	that	protein	NN	I-NP	Othat	is	that	WDT	B-NP	Ois	readily	be	VBZ	B-VP	Oreadily	expressed	readily	RB	I-VP	Oexpressed	in	express	VBN	I-VP	Oin	T-cell	in	IN	B-PP	OT-cell	lines	T-cell	NN	B-NP	B-cell_linelines	and	line	NNS	I-NP	I-cell_lineand	whose	and	CC	O	Owhose	function	whose	WP$	B-NP	Ofunction	is	function	NN	I-NP	Ois	inducibly	be	VBZ	B-VP	Oinducibly	activated	inducibly	RB	I-VP	Oactivated	.	activate	VBN	I-VP	O.	It	.	.	O	OIt	is	It	PRP	B-NP	Ois	composed	be	VBZ	B-VP	Ocomposed	of	compose	VBN	I-VP	Oof	a	of	IN	B-PP	Oa	fusion	a	DT	B-NP	Ofusion	between	fusion	NN	I-NP	Obetween	full-length	between	IN	B-PP	Ofull-length	Nef	full-length	JJ	B-NP	ONef	and	Nef	NN	I-NP	B-proteinand	the	and	CC	O	Othe	estrogen	the	DT	B-NP	Oestrogen	receptor	estrogen	NN	I-NP	B-proteinreceptor	hormone-binding	receptor	NN	I-NP	I-proteinhormone-binding	domain	hormone-binding	JJ	I-NP	I-proteindomain	(	domain	NN	I-NP	I-protein(	Nef-ER	(	(	O	ONef-ER	)	Nef-ER	NN	B-NP	B-protein)	.	)	)	O	O.	The	.	.	O	OThe	Nef-ER	The	DT	B-NP	ONef-ER	is	Nef-ER	NN	I-NP	Ois	kept	be	VBZ	B-VP	Okept	in	keep	VBN	I-VP	Oin	an	in	IN	B-PP	Oan	inactive	an	DT	B-NP	Oinactive	state	inactive	JJ	I-NP	Ostate	due	state	NN	I-NP	Odue	to	due	JJ	B-PP	Oto	steric	to	TO	B-PP	Osteric	hindrance	steric	JJ	B-NP	Ohindrance	","	hindrance	NN	I-NP	O","	and	","	","	O	Oand	addition	and	CC	O	Oaddition	of	addition	NN	B-NP	Oof	the	of	IN	B-PP	Othe	membrane-permeable	the	DT	B-NP	Omembrane-permeable	drug	membrane-permeable	JJ	I-NP	Odrug	4-hydroxytamoxifen	drug	NN	I-NP	O4-hydroxytamoxifen	(	4-hydroxytamoxifen	NN	I-NP	O(	4-HT	(	(	O	O4-HT	)	4-HT	NN	B-NP	O)	","	)	)	O	O","	which	","	","	O	Owhich	binds	which	WDT	B-NP	Obinds	to	bind	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	ER	the	DT	B-NP	OER	domain	ER	NN	I-NP	B-proteindomain	","	domain	NN	I-NP	I-protein","	leads	","	","	O	Oleads	to	lead	VBZ	B-VP	Oto	inducible	to	TO	B-PP	Oinducible	activation	inducible	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	Nef-ER	of	IN	B-PP	ONef-ER	within	Nef-ER	NN	B-NP	B-cell_linewithin	cells	within	IN	B-PP	I-cell_linecells	.	cell	NNS	B-NP	I-cell_line.	We	.	.	O	OWe	demonstrate	We	PRP	B-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	Nef-ER	that	IN	B-SBAR	ONef-ER	inducibly	Nef-ER	NN	B-NP	B-proteininducibly	associates	inducibly	RB	B-ADVP	Oassociates	with	associate	VBZ	B-VP	Owith	the	with	IN	B-PP	Othe	62-kDa	the	DT	B-NP	O62-kDa	Ser/Thr	62-kDa	JJ	I-NP	B-proteinSer/Thr	kinase	Ser/Thr	NN	I-NP	I-proteinkinase	and	kinase	NN	I-NP	I-proteinand	is	and	CC	O	Ois	localized	be	VBZ	B-VP	Olocalized	to	localized	JJ	B-ADJP	Oto	specific	to	TO	B-PP	Ospecific	membrane	specific	JJ	B-NP	Omembrane	microdomains	membrane	NN	I-NP	B-proteinmicrodomains	(	microdomain	NNS	I-NP	I-protein(	lipid	(	(	O	Olipid	rafts	lipid	NN	B-NP	Orafts	)	raft	NNS	I-NP	O)	only	)	)	O	Oonly	after	only	RB	B-PP	Oafter	activation	after	IN	I-PP	Oactivation	.	activation	NN	B-NP	O.	Using	.	.	O	OUsing	this	Use	VBG	B-VP	Othis	inducible	this	DT	B-NP	Oinducible	Nef	inducible	JJ	I-NP	ONef	","	Nef	NN	I-NP	B-protein","	we	","	","	O	Owe	also	we	PRP	B-NP	Oalso	compared	also	RB	B-ADVP	Ocompared	the	compare	VBD	B-VP	Othe	specific	the	DT	B-NP	Ospecific	requirements	specific	JJ	I-NP	Orequirements	for	requirement	NNS	I-NP	Ofor	CD4	for	IN	B-PP	OCD4	and	CD4	NN	B-NP	B-proteinand	HLA-A2	and	CC	I-NP	OHLA-A2	downmodulation	HLA-A2	NN	I-NP	B-proteindownmodulation	in	downmodulation	NN	I-NP	Oin	a	in	IN	B-PP	Oa	SupT1	a	DT	B-NP	OSupT1	T-cell	SupT1	NN	I-NP	B-cell_lineT-cell	line	T-cell	NN	I-NP	I-cell_lineline	.	line	NN	I-NP	I-cell_line.	Half-maximal	.	.	O	OHalf-maximal	downmodulation	Half-maximal	JJ	B-NP	Odownmodulation	of	downmodulation	NN	I-NP	Oof	cell	of	IN	B-PP	Ocell	surface	cell	NN	B-NP	B-proteinsurface	CD4	surface	NN	I-NP	I-proteinCD4	required	CD4	NN	I-NP	I-proteinrequired	very	require	VBD	B-VP	Overy	little	very	RB	B-NP	Olittle	active	little	JJ	I-NP	Oactive	Nef-ER	active	JJ	I-NP	ONef-ER	and	Nef-ER	NN	I-NP	Oand	occurred	and	CC	O	Ooccurred	as	occur	VBD	B-VP	Oas	early	as	RB	B-ADVP	Oearly	as	early	RB	I-ADVP	Oas	4	as	IN	B-PP	O4	h	4	CD	B-NP	Oh	after	h	NN	I-NP	Oafter	addition	after	IN	B-PP	Oaddition	of	addition	NN	B-NP	Oof	4-HT	of	IN	B-PP	O4-HT	.	4-HT	NN	B-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	50	","	","	O	O50	%	50	CD	B-NP	O%	downmodulation	%	NN	I-NP	Odownmodulation	of	downmodulation	NN	I-NP	Oof	HLA-A2	of	IN	B-PP	OHLA-A2	by	HLA-A2	NN	B-NP	B-proteinby	Nef	by	IN	B-PP	ONef	required	Nef	NN	B-NP	B-proteinrequired	16	require	VBD	B-VP	O16	to	16	CD	B-NP	Oto	24	to	TO	B-PP	O24	h	24	CD	B-NP	Oh	and	h	NN	I-NP	Oand	about	and	CC	O	Oabout	50-	about	RB	B-NP	O50-	to	50-	CD	I-NP	Oto	100-fold-greater	to	TO	B-PP	O100-fold-greater	concentrations	100-fold-greater	JJ	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	4-HT	of	IN	B-PP	O4-HT	.	4-HT	NN	B-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	HLA-A2	that	IN	B-SBAR	OHLA-A2	downmodulation	HLA-A2	NN	B-NP	B-proteindownmodulation	may	downmodulation	NN	I-NP	Omay	require	may	MD	B-VP	Orequire	certain	require	VB	I-VP	Ocertain	threshold	certain	JJ	B-NP	Othreshold	levels	threshold	NN	I-NP	Olevels	of	level	NNS	I-NP	Oof	active	of	IN	B-PP	Oactive	Nef	active	JJ	B-NP	ONef	.	Nef	NN	I-NP	B-protein.	The	.	.	O	OThe	differential	The	DT	B-NP	Odifferential	timing	differential	JJ	I-NP	Otiming	of	timing	NN	I-NP	Oof	CD4	of	IN	B-PP	OCD4	and	CD4	NN	B-NP	B-proteinand	HLA-A2	and	CC	I-NP	OHLA-A2	downmodulation	HLA-A2	NN	I-NP	B-proteindownmodulation	may	downmodulation	NN	I-NP	Omay	have	may	MD	B-VP	Ohave	implications	have	VB	I-VP	Oimplications	for	implication	NNS	B-NP	Ofor	HIV	for	IN	B-PP	OHIV	pathogenesis	HIV	NN	B-NP	Opathogenesis	and	pathogenesis	NN	I-NP	Oand	immune	and	CC	O	Oimmune	evasion	immune	JJ	B-NP	Oevasion	.	evasion	NN	I-NP	O.	Regulation	.	.	O	ORegulation	of	Regulation	NN	B-NP	Oof	chemokine	of	IN	B-PP	Ochemokine	mRNA	chemokine	NN	B-NP	B-RNAmRNA	expression	mRNA	NN	I-NP	I-RNAexpression	in	expression	NN	I-NP	Oin	a	in	IN	B-PP	Oa	rat	a	DT	B-NP	Orat	model	rat	NN	I-NP	Omodel	of	model	NN	I-NP	Oof	vanadium-induced	of	IN	B-PP	Ovanadium-induced	pulmonary	vanadium-induced	JJ	B-NP	Opulmonary	inflammation	pulmonary	JJ	I-NP	Oinflammation	.	inflammation	NN	I-NP	O.	Environmental	.	.	O	OEnvironmental	and	Environmental	JJ	B-NP	Oand	occupational	and	CC	I-NP	Ooccupational	exposure	occupational	JJ	I-NP	Oexposure	to	exposure	NN	I-NP	Oto	vanadium	to	TO	B-PP	Ovanadium	dusts	vanadium	NN	B-NP	Odusts	results	dust	NNS	I-NP	Oresults	in	result	VBZ	B-VP	Oin	toxic	in	IN	B-PP	Otoxic	effects	toxic	JJ	B-NP	Oeffects	mainly	effect	NNS	I-NP	Omainly	confined	mainly	RB	B-ADVP	Oconfined	to	confine	VBD	B-VP	Oto	the	to	TO	B-PP	Othe	respiratory	the	DT	B-NP	Orespiratory	system	respiratory	JJ	I-NP	Osystem	.	system	NN	I-NP	O.	Using	.	.	O	OUsing	a	Use	VBG	B-VP	Oa	rat	a	DT	B-NP	Orat	model	rat	NN	I-NP	Omodel	of	model	NN	I-NP	Oof	acute	of	IN	B-PP	Oacute	lung	acute	JJ	B-NP	Olung	inflammation	lung	NN	I-NP	Oinflammation	induced	inflammation	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	intratracheal	by	IN	B-PP	Ointratracheal	instillation	intratracheal	JJ	B-NP	Oinstillation	of	instillation	NN	I-NP	Oof	sodium	of	IN	B-PP	Osodium	metavanadate	sodium	NN	B-NP	Ometavanadate	(	metavanadate	NN	I-NP	O(	NaVO3	(	(	O	ONaVO3	)	NaVO3	NN	B-NP	O)	at	)	)	O	Oat	the	at	IN	B-PP	Othe	dose	the	DT	B-NP	Odose	of	dose	NN	I-NP	Oof	200	of	IN	B-PP	O200	microg	200	CD	B-NP	Omicrog	V/kg	microg	NN	I-NP	OV/kg	","	V/kg	NN	I-NP	O","	we	","	","	O	Owe	investigated	we	PRP	B-NP	Oinvestigated	the	investigate	VBD	B-VP	Othe	relationship	the	DT	B-NP	Orelationship	between	relationship	NN	I-NP	Obetween	the	between	IN	B-PP	Othe	cytologic	the	DT	B-NP	Ocytologic	characterization	cytologic	JJ	I-NP	Ocharacterization	of	characterization	NN	I-NP	Oof	pulmonary	of	IN	B-PP	Opulmonary	inflammation	pulmonary	JJ	B-NP	Oinflammation	and	inflammation	NN	I-NP	Oand	the	and	CC	O	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	chemokine	of	IN	B-PP	Ochemokine	mRNA	chemokine	NN	B-NP	B-RNAmRNA	.	mRNA	NN	I-NP	I-RNA.	Significant	.	.	O	OSignificant	polymorphonuclear	Significant	JJ	B-NP	Opolymorphonuclear	leukocyte	polymorphonuclear	JJ	I-NP	Oleukocyte	(	leukocyte	NN	I-NP	O(	PMN	(	(	O	OPMN	)	PMN	NN	B-NP	B-cell_type)	influx	)	)	O	Oinflux	(	influx	NN	B-NP	O(	P	(	(	O	OP	<	P	NN	B-NP	O<	0.01	<	SYM	B-NP	O0.01	)	0.01	CD	I-NP	O)	into	)	)	O	Ointo	the	into	IN	B-PP	Othe	lung	the	DT	B-NP	Olung	was	lung	NN	I-NP	Owas	noted	be	VBD	B-VP	Onoted	4	note	VBN	I-VP	O4	h	4	CD	B-NP	Oh	after	h	NN	I-NP	Oafter	NaVO3	after	IN	B-PP	ONaVO3	instillation	NaVO3	NN	B-NP	Oinstillation	","	instillation	NN	I-NP	O","	whereas	","	","	O	Owhereas	alveolar	whereas	IN	O	Oalveolar	macrophages	alveolar	JJ	B-NP	B-cell_typemacrophages	(	macrophage	NNS	I-NP	I-cell_type(	AMs	(	(	O	OAMs	)	AM	NNS	B-NP	B-cell_type)	in	)	)	O	Oin	bronchoalveolar	in	IN	B-PP	Obronchoalveolar	lavage	bronchoalveolar	JJ	B-NP	B-cell_typelavage	(	lavage	NN	I-NP	I-cell_type(	BAL	(	(	O	I-cell_typeBAL	)	BAL	NN	B-NP	I-cell_type)	cells	)	)	I-NP	I-cell_typecells	appeared	cell	NNS	I-NP	I-cell_typeappeared	to	appear	VBD	B-VP	Oto	decrease	to	TO	I-VP	Odecrease	significantly	decrease	VB	I-VP	Osignificantly	.	significantly	RB	B-ADVP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	neither	","	","	O	Oneither	PMNs	neither	CC	O	OPMNs	nor	PMN	NNS	B-NP	B-cell_typenor	AMs	nor	CC	I-NP	OAMs	changed	AM	NNS	I-NP	B-cell_typechanged	substantially	change	VBD	B-VP	Osubstantially	1	substantially	RB	B-NP	O1	h	1	CD	I-NP	Oh	after	h	NN	I-NP	Oafter	NaVO3	after	IN	B-PP	ONaVO3	instillation	NaVO3	NN	B-NP	Oinstillation	.	instillation	NN	I-NP	O.	By	.	.	O	OBy	Northern	By	IN	B-PP	ONorthern	analysis	Northern	NN	B-NP	Oanalysis	","	analysis	NN	I-NP	O","	macrophage	","	","	O	Omacrophage	inflammatory	macrophage	NN	B-NP	B-proteininflammatory	protein	inflammatory	JJ	I-NP	I-proteinprotein	(	protein	NN	I-NP	I-protein(	MIP	(	(	O	OMIP	)	MIP	NN	B-NP	O)	-2	)	)	O	O-2	mRNA	-2	CD	B-NP	OmRNA	in	mRNA	NN	I-NP	Oin	BAL	in	IN	B-PP	OBAL	cells	BAL	NN	B-NP	B-cell_linecells	increased	cell	NNS	I-NP	I-cell_lineincreased	markedly	increase	VBD	B-VP	Omarkedly	1	markedly	RB	B-NP	O1	h	1	CD	I-NP	Oh	after	h	NN	I-NP	Oafter	NaVO3	after	IN	B-PP	ONaVO3	instillation	NaVO3	NN	B-NP	Oinstillation	and	instillation	NN	I-NP	Oand	reduced	and	CC	O	Oreduced	a	reduce	VBD	B-VP	Oa	little	a	DT	B-NP	Olittle	bit	little	JJ	I-NP	Obit	at	bit	NN	I-NP	Oat	4	at	IN	B-PP	O4	h	4	CD	B-NP	Oh	","	h	NN	I-NP	O","	whereas	","	","	O	Owhereas	MIP-1alpha	whereas	IN	O	OMIP-1alpha	mRNA	MIP-1alpha	NN	B-NP	B-RNAmRNA	in	mRNA	NN	I-NP	I-RNAin	BAL	in	IN	B-PP	OBAL	cells	BAL	NN	B-NP	B-cell_linecells	was	cell	NNS	I-NP	I-cell_linewas	expressed	be	VBD	B-VP	Oexpressed	relatively	express	VBN	I-VP	Orelatively	high	relatively	RB	B-NP	Ohigh	1	high	JJ	I-NP	O1	h	1	CD	I-NP	Oh	after	h	NN	I-NP	Oafter	NaVO3	after	IN	B-PP	ONaVO3	instillation	NaVO3	NN	B-NP	Oinstillation	","	instillation	NN	I-NP	O","	although	","	","	O	Oalthough	a	although	IN	B-SBAR	Oa	basal	a	DT	B-NP	Obasal	expression	basal	JJ	I-NP	Oexpression	was	expression	NN	I-NP	Owas	detected	be	VBD	B-VP	Odetected	in	detect	VBN	I-VP	Oin	control	in	IN	B-PP	Ocontrol	group	control	NN	B-NP	Ogroup	","	group	NN	I-NP	O","	and	","	","	O	Oand	returned	and	CC	O	Oreturned	rapidly	return	VBD	B-VP	Orapidly	nearly	rapidly	RB	B-ADVP	Onearly	to	nearly	RB	B-ADVP	Oto	control	to	TO	B-VP	Ocontrol	level	control	VB	I-VP	Olevel	at	level	NN	B-NP	Oat	4	at	IN	B-PP	O4	h	4	CD	B-NP	Oh	.	h	NN	I-NP	O.	Since	.	.	O	OSince	MIP-2	Since	IN	B-SBAR	OMIP-2	is	MIP-2	NN	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	potent	a	DT	B-NP	Opotent	PMN	potent	JJ	I-NP	OPMN	chemoattractant	PMN	NN	I-NP	B-proteinchemoattractant	and	chemoattractant	NN	I-NP	I-proteinand	MIP-1alpha	and	CC	I-NP	OMIP-1alpha	is	MIP-1alpha	NN	I-NP	B-proteinis	a	be	VBZ	B-VP	Oa	potent	a	DT	B-NP	Opotent	macrophage/monocyte	potent	JJ	I-NP	Omacrophage/monocyte	chemoattractant	macrophage/monocyte	NN	I-NP	B-proteinchemoattractant	has	chemoattractant	NN	I-NP	I-proteinhas	been	have	VBZ	B-VP	Obeen	well	be	VBN	I-VP	Owell	known	well	RB	I-VP	Oknown	.	know	VBN	I-VP	O.	The	.	.	O	OThe	facts	The	DT	B-NP	Ofacts	that	fact	NNS	I-NP	Othat	PMN	that	IN	B-SBAR	OPMN	influx	PMN	NN	B-NP	B-cell_typeinflux	was	influx	NN	I-NP	Owas	preceded	be	VBD	B-VP	Opreceded	by	precede	VBN	I-VP	Oby	increased	by	IN	B-PP	Oincreased	MIP-2	increase	VBN	B-NP	OMIP-2	mRNA	MIP-2	NN	I-NP	B-RNAmRNA	expression	mRNA	NN	I-NP	I-RNAexpression	","	expression	NN	I-NP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	MIP-2	that	IN	B-SBAR	OMIP-2	is	MIP-2	NN	B-NP	B-proteinis	involved	be	VBZ	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	NaVO3-induced	of	IN	B-PP	ONaVO3-induced	pulmonary	NaVO3-induced	JJ	B-NP	Opulmonary	inflammation	pulmonary	JJ	I-NP	Oinflammation	","	inflammation	NN	I-NP	O","	whereas	","	","	O	Owhereas	increased	whereas	IN	O	Oincreased	MIP-1alpha	increase	VBN	B-NP	OMIP-1alpha	mRNA	MIP-1alpha	NN	I-NP	B-RNAmRNA	expression	mRNA	NN	I-NP	I-RNAexpression	was	expression	NN	I-NP	Owas	followed	be	VBD	B-VP	Ofollowed	by	follow	VBN	I-VP	Oby	decreased	by	IN	B-PP	Odecreased	AMs	decrease	VBN	B-NP	OAMs	in	AM	NNS	I-NP	B-proteinin	BAL	in	IN	B-PP	OBAL	cells	BAL	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	suggesting	","	","	O	Osuggesting	AMs	suggest	VBG	B-VP	OAMs	might	AM	NNS	B-NP	B-proteinmight	be	might	MD	B-VP	Obe	activated	be	VB	I-VP	Oactivated	by	activate	VBN	I-VP	Oby	MIP-1alpha	by	IN	B-PP	OMIP-1alpha	","	MIP-1alpha	NN	B-NP	B-protein","	adherent	","	","	O	Oadherent	to	adherent	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	lining	the	DT	B-NP	Olining	surface	lining	JJ	I-NP	Osurface	of	surface	NN	I-NP	Oof	the	of	IN	B-PP	Othe	airways	the	DT	B-NP	Oairways	and	airway	NNS	I-NP	Oand	then	and	CC	O	Othen	resistant	then	RB	B-ADJP	Oresistant	to	resistant	JJ	I-ADJP	Oto	be	to	TO	B-VP	Obe	washed	be	VB	I-VP	Owashed	out	wash	VBN	I-VP	Oout	.	out	RP	B-PRT	O.	To	.	.	O	OTo	delineate	To	TO	B-VP	Odelineate	the	delineate	VB	I-VP	Othe	mechanisms	the	DT	B-NP	Omechanisms	of	mechanism	NNS	I-NP	Oof	transcriptional	of	IN	B-PP	Otranscriptional	activation	transcriptional	JJ	B-NP	Oactivation	","	activation	NN	I-NP	O","	we	","	","	O	Owe	recently	we	PRP	B-NP	Orecently	cloned	recently	RB	B-ADVP	Ocloned	the	clone	VBD	B-VP	Othe	5'-flanking	the	DT	B-NP	O5'-flanking	region	5'-flanking	JJ	I-NP	B-DNAregion	of	region	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	MIP-2	the	DT	B-NP	OMIP-2	gene	MIP-2	NN	I-NP	B-DNAgene	.	gene	NN	I-NP	I-DNA.	The	.	.	O	OThe	promotor	The	DT	B-NP	Opromotor	region	promotor	NN	I-NP	B-DNAregion	contains	region	NN	I-NP	I-DNAcontains	consensus	contain	VBZ	B-VP	Oconsensus	binding	consensus	NN	B-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	for	site	NNS	I-NP	I-DNAfor	transcription	for	IN	B-PP	Otranscription	factor	transcription	NN	B-NP	B-proteinfactor	nuclear	factor	NN	I-NP	I-proteinnuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	kappaB	factor	NN	I-NP	I-proteinkappaB	(	kappaB	NN	I-NP	I-protein(	NF-kappaB	(	(	O	ONF-kappaB	)	NF-kappaB	NN	B-NP	B-protein)	and	)	)	O	Oand	activator	and	CC	O	Oactivator	protein-1	activator	NN	B-NP	B-proteinprotein-1	(	protein-1	NN	I-NP	I-protein(	AP-1	(	(	O	OAP-1	)	AP-1	NN	B-NP	B-protein)	.	)	)	O	O.	Using	.	.	O	OUsing	electrophoretic	Use	VBG	B-VP	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assay	shift	NN	I-NP	Oassay	","	assay	NN	I-NP	O","	increased	","	","	O	Oincreased	nuclear	increase	VBN	B-NP	Onuclear	NF-kappaB	nuclear	JJ	I-NP	ONF-kappaB	","	NF-kappaB	NN	I-NP	B-protein","	not	","	","	B-NP	Onot	AP-1	not	RB	I-NP	OAP-1	","	AP-1	NN	B-NP	B-protein","	binding	","	","	O	Obinding	activity	binding	NN	B-NP	Oactivity	was	activity	NN	I-NP	Owas	detected	be	VBD	B-VP	Odetected	1	detect	VBN	I-VP	O1	h	1	CD	B-NP	Oh	after	h	NN	I-NP	Oafter	NaVO3	after	IN	B-PP	ONaVO3	instillation	NaVO3	NN	B-NP	Oinstillation	","	instillation	NN	I-NP	O","	which	","	","	O	Owhich	correlated	which	WDT	B-NP	Ocorrelated	with	correlate	VBD	B-VP	Owith	the	with	IN	B-PP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	MIP-2	of	IN	B-PP	OMIP-2	mRNA	MIP-2	NN	B-NP	B-RNAmRNA	.	mRNA	NN	I-NP	I-RNA.	p65	.	.	O	Op65	(	p65	NN	B-NP	O(	Rel	(	(	O	ORel	A	Rel	NN	B-NP	B-proteinA	)	A	NN	I-NP	I-protein)	and	)	)	O	Oand	p50	and	CC	O	Op50	protein	p50	NN	B-NP	B-proteinprotein	appears	protein	NN	I-NP	I-proteinappears	to	appear	VBZ	B-VP	Oto	be	to	TO	I-VP	Obe	involved	be	VB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	MIP-2	in	IN	B-PP	OMIP-2	NF-kappaB	MIP-2	NN	B-NP	B-proteinNF-kappaB	binding	NF-kappaB	NN	I-NP	B-proteinbinding	.	binding	NN	I-NP	O.	Taken	.	.	O	OTaken	together	Take	VBN	B-VP	Otogether	","	together	RB	B-ADVP	O","	our	","	","	O	Oour	studies	our	PRP$	B-NP	Ostudies	suggest	study	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	MIP-2	that	IN	B-SBAR	OMIP-2	is	MIP-2	NN	B-NP	B-proteinis	an	be	VBZ	B-VP	Oan	important	an	DT	B-NP	Oimportant	mediator	important	JJ	I-NP	Omediator	of	mediator	NN	I-NP	Oof	NaVO3-induced	of	IN	B-PP	ONaVO3-induced	pulmonary	NaVO3-induced	JJ	B-NP	Opulmonary	inflammation	pulmonary	JJ	I-NP	Oinflammation	in	inflammation	NN	I-NP	Oin	the	in	IN	B-PP	Othe	rat	the	DT	B-NP	Orat	model	rat	NN	I-NP	Omodel	.	model	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	elevated	","	","	O	Oelevated	MIP-2	elevated	JJ	B-NP	OMIP-2	mRNA	MIP-2	NN	I-NP	B-RNAmRNA	levels	mRNA	NN	I-NP	I-RNAlevels	are	level	NNS	I-NP	Oare	accompanied	be	VBP	B-VP	Oaccompanied	by	accompany	VBN	I-VP	Oby	increased	by	IN	B-PP	Oincreased	NF-kappaB	increase	VBN	B-NP	ONF-kappaB	binding	NF-kappaB	NN	I-NP	B-proteinbinding	activity	binding	NN	I-NP	Oactivity	in	activity	NN	I-NP	Oin	BAL	in	IN	B-PP	OBAL	cells	BAL	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	suggesting	","	","	O	Osuggesting	possible	suggest	VBG	B-VP	Opossible	MIP-2	possible	JJ	B-NP	OMIP-2	transcriptional	MIP-2	NN	I-NP	Otranscriptional	regulation	transcriptional	JJ	I-NP	Oregulation	through	regulation	NN	I-NP	Othrough	NF-kappaB	through	IN	B-PP	ONF-kappaB	.	NF-kappaB	NN	B-NP	B-protein.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	signal	of	IN	B-PP	Osignal	transduction	signal	NN	B-NP	Otransduction	and	transduction	NN	I-NP	Oand	apoptosis	and	CC	I-NP	Oapoptosis	in	apoptosis	NN	I-NP	Oin	healthy	in	IN	B-PP	Ohealthy	lymphomonocytes	healthy	JJ	B-NP	B-cell_typelymphomonocytes	exposed	lymphomonocyte	NNS	I-NP	I-cell_typeexposed	to	expose	VBN	B-VP	Oto	bystander	to	TO	B-VP	Obystander	HIV-1-infected	bystander	VB	I-VP	OHIV-1-infected	cells	HIV-1-infected	JJ	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Persistent	.	.	O	OPersistent	activation	Persistent	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	immune	the	DT	B-NP	Oimmune	system	immune	JJ	I-NP	Osystem	is	system	NN	I-NP	Ois	one	be	VBZ	B-VP	Oone	of	one	CD	B-NP	Oof	the	of	IN	B-PP	Othe	hallmarks	the	DT	B-NP	Ohallmarks	of	hallmark	NNS	I-NP	Oof	HIV-1	of	IN	B-PP	OHIV-1	infection	HIV-1	NN	B-NP	Oinfection	.	infection	NN	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	we	study	NN	I-NP	Owe	analysed	we	PRP	B-NP	Oanalysed	the	analyse	VBD	B-VP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	factors	of	IN	B-PP	Ofactors	involved	factor	NNS	B-NP	Oinvolved	in	involve	VBN	B-VP	Oin	cytokine	in	IN	B-PP	Ocytokine	signal	cytokine	NN	B-NP	B-proteinsignal	transduction	signal	NN	I-NP	Otransduction	","	transduction	NN	I-NP	O","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	STAT	as	IN	I-PP	OSTAT	1	STAT	NN	B-NP	B-protein1	proteins	1	CD	I-NP	I-proteinproteins	and	protein	NNS	I-NP	I-proteinand	IRF-1	and	CC	O	OIRF-1	mRNA	IRF-1	NN	B-NP	B-RNAmRNA	","	mRNA	NN	I-NP	I-RNA","	in	","	","	O	Oin	normal	in	IN	B-PP	Onormal	peripheral	normal	JJ	B-NP	B-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	PBMC	(	(	O	OPBMC	)	PBMC	NN	B-NP	B-cell_type)	exposed	)	)	O	Oexposed	to	expose	VBN	B-VP	Oto	HIV-infected	to	TO	B-PP	OHIV-infected	cells	HIV-infected	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	the	and	CC	O	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	apoptosis	of	IN	B-PP	Oapoptosis	.	apoptosis	NN	B-NP	O.	Western	.	.	O	OWestern	blot	Western	JJ	B-NP	Oblot	analyses	blot	NN	I-NP	Oanalyses	and	analysis	NNS	I-NP	Oand	reverse	and	CC	O	Oreverse	transcriptase-polymerase	reverse	JJ	B-NP	Otranscriptase-polymerase	chain	transcriptase-polymerase	NN	I-NP	Ochain	reaction	chain	NN	I-NP	Oreaction	results	reaction	NN	I-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	both	that	IN	B-SBAR	Oboth	cells	both	DT	B-NP	Ocells	infected	cell	NNS	I-NP	Oinfected	with	infect	VBN	B-VP	Owith	a	with	IN	B-PP	Oa	X4	a	DT	B-NP	OX4	strain	X4	NN	I-NP	Ostrain	and	strain	NN	I-NP	Oand	cells	and	CC	O	Ocells	infected	cell	NNS	B-NP	Oinfected	with	infect	VBN	B-VP	Owith	a	with	IN	B-PP	Oa	R5	a	DT	B-NP	OR5	strain	R5	NN	I-NP	Ostrain	are	strain	NN	I-NP	Oare	able	be	VBP	B-VP	Oable	to	able	JJ	B-ADJP	Oto	increase	to	TO	B-VP	Oincrease	intracellular	increase	VB	I-VP	Ointracellular	levels	intracellular	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	STAT	of	IN	B-PP	OSTAT	1alpha	STAT	NN	B-NP	B-protein1alpha	and	1alpha	NN	I-NP	I-proteinand	beta	and	CC	O	Obeta	proteins	beta	NN	B-NP	Oproteins	as	protein	NNS	I-NP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	IRF-1	as	IN	I-CONJP	OIRF-1	mRNA	IRF-1	NN	B-NP	B-RNAmRNA	.	mRNA	NN	I-NP	I-RNA.	This	.	.	O	OThis	effect	This	DT	B-NP	Oeffect	was	effect	NN	I-NP	Owas	prevented	be	VBD	B-VP	Oprevented	by	prevent	VBN	I-VP	Oby	neutralizing	by	IN	B-PP	Oneutralizing	antibodies	neutralize	VBG	B-VP	B-proteinantibodies	against	antibody	NNS	B-NP	I-proteinagainst	interferon-alpha	against	IN	B-PP	Ointerferon-alpha	(	interferon-alpha	NN	B-NP	B-protein(	IFN-alpha	(	(	O	OIFN-alpha	)	IFN-alpha	NN	B-NP	B-protein)	.	)	)	O	O.	HIV-1-infected	.	.	O	OHIV-1-infected	cells	HIV-1-infected	JJ	B-NP	B-cell_linecells	dose-dependently	cell	NNS	I-NP	I-cell_linedose-dependently	induced	dose-dependently	RB	B-ADVP	Oinduced	apoptotic	induce	VBD	B-VP	Oapoptotic	commitment	apoptotic	JJ	B-NP	Ocommitment	in	commitment	NN	I-NP	Oin	normal	in	IN	B-PP	Onormal	PBMC	normal	JJ	B-NP	OPBMC	","	PBMC	NN	I-NP	B-cell_type","	as	","	","	O	Oas	revealed	as	IN	B-SBAR	Orevealed	by	reveal	VBN	B-VP	Oby	DNA	by	IN	B-PP	ODNA	fragmentation	DNA	NN	B-NP	Ofragmentation	analysis	fragmentation	NN	I-NP	Oanalysis	","	analysis	NN	I-NP	O","	but	","	","	O	Obut	this	but	CC	O	Othis	was	this	DT	B-NP	Owas	not	be	VBD	B-VP	Onot	accompanied	not	RB	I-VP	Oaccompanied	by	accompany	VBN	I-VP	Oby	an	by	IN	B-PP	Oan	increase	an	DT	B-NP	Oincrease	of	increase	NN	I-NP	Oof	caspase-3	of	IN	B-PP	Ocaspase-3	activity	caspase-3	NN	B-NP	B-proteinactivity	","	activity	NN	I-NP	O","	even	","	","	O	Oeven	if	even	RB	B-SBAR	Oif	a	if	IN	I-SBAR	Oa	slight	a	DT	B-NP	Oslight	up-regulation	slight	JJ	I-NP	Oup-regulation	of	up-regulation	NN	I-NP	Oof	IL-1beta-converting	of	IN	B-PP	OIL-1beta-converting	enzyme	IL-1beta-converting	JJ	B-NP	B-RNAenzyme	mRNA	enzyme	NN	I-NP	I-RNAmRNA	was	mRNA	NN	I-NP	I-RNAwas	detected	be	VBD	B-VP	Odetected	.	detect	VBN	I-VP	O.	Apoptosis	.	.	O	OApoptosis	induction	Apoptosis	NN	B-NP	Oinduction	could	induction	NN	I-NP	Ocould	be	could	MD	B-VP	Obe	abrogated	be	VB	I-VP	Oabrogated	mainly	abrogate	VBN	I-VP	Omainly	by	mainly	RB	B-ADVP	Oby	antibodies	by	IN	B-PP	Oantibodies	against	antibody	NNS	B-NP	B-proteinagainst	tumour	against	IN	B-PP	Otumour	necrosis	tumour	NN	B-NP	B-proteinnecrosis	factor-alpha	necrosis	NN	I-NP	I-proteinfactor-alpha	(	factor-alpha	NN	I-NP	I-protein(	TNF-alpha	(	(	O	OTNF-alpha	)	TNF-alpha	NN	B-NP	B-protein)	and	)	)	O	Oand	","	and	CC	O	O","	to	","	","	O	Oto	a	to	TO	B-PP	Oa	lesser	a	DT	B-NP	Olesser	extent	less	JJR	I-NP	Oextent	","	extent	NN	I-NP	O","	by	","	","	O	Oby	antibodies	by	IN	B-PP	Oantibodies	against	antibody	NNS	B-NP	B-proteinagainst	IFN-gamma	against	IN	B-PP	OIFN-gamma	.	IFN-gamma	NN	B-NP	B-protein.	All	.	.	O	OAll	these	All	PDT	B-NP	Othese	findings	these	DT	I-NP	Ofindings	suggest	finding	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	uninfected	that	IN	B-SBAR	Ouninfected	PBMC	uninfected	JJ	B-NP	OPBMC	can	PBMC	NN	I-NP	B-cell_typecan	undergo	can	MD	B-VP	Oundergo	activation	undergo	VB	I-VP	Oactivation	of	activation	NN	B-NP	Oof	signal	of	IN	B-PP	Osignal	transduction	signal	NN	B-NP	Otransduction	and	transduction	NN	I-NP	Oand	apoptosis	and	CC	I-NP	Oapoptosis	after	apoptosis	NN	I-NP	Oafter	exposure	after	IN	B-PP	Oexposure	to	exposure	NN	B-NP	Oto	bystander	to	TO	B-VP	Obystander	HIV-infected	bystander	VB	I-VP	OHIV-infected	cells	HIV-infected	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	subsequent	","	","	O	Osubsequent	to	subsequent	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	cytokines	of	IN	B-PP	Ocytokines	such	cytokine	NNS	B-NP	B-proteinsuch	as	such	JJ	B-PP	Oas	IFNs	as	IN	I-PP	OIFNs	and	IFN	NNS	B-NP	B-proteinand	TNF-alpha	and	CC	O	OTNF-alpha	.	TNF-alpha	NN	B-NP	B-protein.	The	.	.	O	OThe	physical	The	DT	B-NP	Ophysical	association	physical	JJ	I-NP	Oassociation	of	association	NN	I-NP	Oof	protein	of	IN	B-PP	Oprotein	kinase	protein	NN	B-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	theta	C	NN	I-NP	I-proteintheta	with	theta	NN	I-NP	Owith	a	with	IN	B-PP	Oa	lipid	a	DT	B-NP	Olipid	raft-associated	lipid	NN	I-NP	Oraft-associated	inhibitor	raft-associated	JJ	I-NP	Oinhibitor	of	inhibitor	NN	I-NP	Oof	kappa	of	IN	B-PP	Okappa	B	kappa	NN	B-NP	B-proteinB	factor	B	NN	I-NP	I-proteinfactor	kinase	factor	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	IKK	(	(	O	OIKK	)	IKK	NN	B-NP	B-protein)	complex	)	)	O	Ocomplex	plays	complex	NN	B-NP	Oplays	a	play	VBZ	B-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	NF-kappa	the	DT	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	cascade	B	NN	I-NP	I-proteincascade	by	cascade	NN	I-NP	Oby	TCR	by	IN	B-PP	OTCR	and	TCR	NN	B-NP	B-proteinand	CD28	and	CC	I-NP	OCD28	.	CD28	NN	I-NP	B-protein.	We	.	.	O	OWe	investigated	We	PRP	B-NP	Oinvestigated	the	investigate	VBD	B-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	protein	of	IN	B-PP	Oprotein	kinase	protein	NN	B-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	theta	C	NN	I-NP	I-proteintheta	(	theta	NN	I-NP	O(	PKCtheta	(	(	O	OPKCtheta	)	PKCtheta	NN	B-NP	B-protein)	in	)	)	O	Oin	the	in	IN	B-PP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	NF-kappaB	the	DT	B-NP	ONF-kappaB	cascade	NF-kappaB	NN	I-NP	B-proteincascade	in	cascade	NN	I-NP	Oin	primary	in	IN	B-PP	Oprimary	human	primary	JJ	B-NP	B-cell_typehuman	CD4	human	JJ	I-NP	I-cell_typeCD4	(	CD4	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	lymphocytes	)	)	O	I-cell_typelymphocytes	.	lymphocyte	NNS	B-NP	I-cell_type.	Among	.	.	O	OAmong	six	Among	IN	B-PP	Osix	or	six	CD	B-NP	Oor	so	or	CC	I-NP	Oso	PKC	so	RB	I-NP	OPKC	isoforms	PKC	NN	I-NP	B-proteinisoforms	expressed	isoform	NNS	I-NP	I-proteinexpressed	in	express	VBN	B-VP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	only	","	","	O	Oonly	PKCtheta	only	RB	B-NP	OPKCtheta	participates	PKCtheta	NN	I-NP	B-proteinparticipates	in	participate	VBZ	B-VP	Oin	the	in	IN	B-PP	Othe	assembly	the	DT	B-NP	Oassembly	of	assembly	NN	I-NP	Oof	the	of	IN	B-PP	Othe	supramolecular	the	DT	B-NP	Osupramolecular	activation	supramolecular	JJ	I-NP	Oactivation	clusters	activation	NN	I-NP	Oclusters	at	cluster	NNS	I-NP	Oat	the	at	IN	B-PP	Othe	contact	the	DT	B-NP	Ocontact	site	contact	NN	I-NP	Osite	of	site	NN	I-NP	Oof	the	of	IN	B-PP	Othe	TCR	the	DT	B-NP	OTCR	with	TCR	NN	I-NP	B-proteinwith	Ag	with	IN	B-PP	OAg	.	Ag	NN	B-NP	B-protein.	Signaling	.	.	O	OSignaling	via	Signal	VBG	B-VP	Ovia	both	via	IN	B-PP	Oboth	the	both	CC	O	Othe	TCR	the	DT	B-NP	OTCR	and	TCR	NN	I-NP	B-proteinand	CD28	and	CC	I-NP	OCD28	is	CD28	NN	I-NP	B-proteinis	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	optimal	for	IN	B-PP	Ooptimal	activation	optimal	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	multisubunit	the	DT	B-NP	Omultisubunit	IkappaB	multisubunit	JJ	I-NP	B-proteinIkappaB	kinase	IkappaB	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	IKK	(	(	O	I-proteinIKK	)	IKK	NN	B-NP	I-protein)	complex	)	)	O	I-proteincomplex	in	complex	NN	B-NP	I-proteinin	primary	in	IN	B-PP	Oprimary	human	primary	JJ	B-NP	B-cell_typehuman	T	human	JJ	I-NP	I-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	;	lymphocyte	NNS	I-NP	I-cell_type;	this	;	:	O	Othis	activation	this	DT	B-NP	Oactivation	could	activation	NN	I-NP	Ocould	be	could	MD	B-VP	Obe	inhibited	be	VB	I-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	Ca	a	DT	B-NP	OCa	(	Ca	NN	I-NP	O(	2+	(	(	O	O2+	)	2+	JJ	B-ADJP	O)	#NAME?	)	)	O	O#NAME?	PKC	#NAME?	JJ	B-NP	OPKC	isoform	PKC	NN	I-NP	B-proteinisoform	inhibitor	isoform	NN	I-NP	I-proteininhibitor	","	inhibitor	NN	I-NP	O","	rottlerin	","	","	O	Orottlerin	.	rottlerin	NN	B-NP	O.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	endogenous	","	","	O	Oendogenous	PKCtheta	endogenous	JJ	B-NP	OPKCtheta	physically	PKCtheta	NN	I-NP	B-proteinphysically	associates	physically	RB	B-ADVP	Oassociates	with	associate	VBZ	B-VP	Owith	activated	with	IN	B-PP	Oactivated	IKK	activate	VBN	B-NP	OIKK	complexes	IKK	NN	I-NP	B-proteincomplexes	in	complex	NNS	I-NP	I-proteinin	CD3/CD28-costimulated	in	IN	B-PP	OCD3/CD28-costimulated	primary	CD3/CD28-costimulated	JJ	B-NP	B-cell_typeprimary	CD4	primary	JJ	I-NP	I-cell_typeCD4	(	CD4	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	same	The	DT	B-NP	Osame	set	same	JJ	I-NP	Oset	of	set	NN	I-NP	Oof	stimuli	of	IN	B-PP	Ostimuli	also	stimulus	NNS	B-NP	Oalso	induced	also	RB	B-ADVP	Oinduced	relocation	induce	VBD	B-VP	Orelocation	of	relocation	NN	B-NP	Oof	endogenous	of	IN	B-PP	Oendogenous	PKCtheta	endogenous	JJ	B-NP	OPKCtheta	and	PKCtheta	NN	I-NP	B-proteinand	IKKs	and	CC	I-NP	OIKKs	to	IKK	NNS	I-NP	B-proteinto	a	to	TO	B-PP	Oa	GM1	a	DT	B-NP	OGM1	ganglioside-enriched	GM1	NN	I-NP	B-DNAganglioside-enriched	","	ganglioside-enriched	JJ	I-NP	O","	detergent-insoluble	","	","	I-NP	Odetergent-insoluble	membrane	detergent-insoluble	JJ	I-NP	Omembrane	compartment	membrane	NN	I-NP	Ocompartment	in	compartment	NN	I-NP	Oin	primary	in	IN	B-PP	Oprimary	T	primary	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	IKKs	.	.	O	OIKKs	recruited	IKK	NNS	B-NP	B-proteinrecruited	to	recruit	VBN	B-VP	Oto	these	to	TO	B-PP	Othese	lipid	these	DT	B-NP	Olipid	rafts	lipid	NN	I-NP	Orafts	were	raft	NNS	I-NP	Owere	capable	be	VBD	B-VP	Ocapable	of	capable	JJ	B-ADJP	Oof	phosphorylating	of	IN	B-PP	Ophosphorylating	a	phosphorylate	VBG	B-VP	Oa	recombinant	a	DT	B-NP	Orecombinant	IkappaBalpha	recombinant	JJ	I-NP	OIkappaBalpha	sustrate	IkappaBalpha	NN	I-NP	B-proteinsustrate	.	sustrate	NN	I-NP	O.	Confocal	.	.	O	OConfocal	microscopy	Confocal	JJ	B-NP	Omicroscopy	further	microscopy	NN	I-NP	Ofurther	demonstrated	further	RBR	B-ADVP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	exogenously	that	IN	B-SBAR	Oexogenously	expressed	exogenously	RB	B-NP	Oexpressed	PKCtheta	express	VBN	I-NP	OPKCtheta	and	PKCtheta	NN	I-NP	B-proteinand	IKKss	and	CC	I-NP	OIKKss	colocalize	IKKss	NN	I-NP	Ocolocalize	in	colocalize	VBP	B-VP	Oin	the	in	IN	B-PP	Othe	membrane	the	DT	B-NP	Omembrane	of	membrane	NN	I-NP	Oof	CD3/CD28-costimulated	of	IN	B-PP	OCD3/CD28-costimulated	Jurkat	CD3/CD28-costimulated	JJ	B-NP	B-cell_lineJurkat	T	Jurkat	NN	I-NP	I-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Constitutively	.	.	O	OConstitutively	active	Constitutively	RB	B-ADJP	Oactive	but	active	JJ	I-ADJP	Obut	not	but	CC	B-CONJP	Onot	kinase-inactive	not	RB	I-CONJP	Okinase-inactive	PKCtheta	kinase-inactive	JJ	B-NP	OPKCtheta	activated	PKCtheta	NN	I-NP	B-proteinactivated	IKKbeta	activate	VBD	B-VP	OIKKbeta	in	IKKbeta	NN	B-NP	B-proteinin	Jurkat	in	IN	B-PP	OJurkat	T	Jurkat	NN	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Expression	.	.	O	OExpression	of	Expression	NN	B-NP	Oof	dominant-active	of	IN	B-PP	Odominant-active	PKCtheta	dominant-active	JJ	B-NP	OPKCtheta	also	PKCtheta	NN	I-NP	B-proteinalso	had	also	RB	B-ADVP	Ohad	stimulatory	have	VBD	B-VP	Ostimulatory	effects	stimulatory	JJ	B-NP	Oeffects	on	effect	NNS	I-NP	Oon	the	on	IN	B-PP	Othe	CD28	the	DT	B-NP	OCD28	response	CD28	NN	I-NP	B-DNAresponse	element	response	NN	I-NP	I-DNAelement	of	element	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Taken	.	.	O	OTaken	together	Take	VBN	B-VP	Otogether	","	together	RB	B-ADVP	O","	these	","	","	O	Othese	data	these	DT	B-NP	Odata	show	datum	NNS	I-NP	Oshow	that	show	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	PKCtheta	of	IN	B-PP	OPKCtheta	by	PKCtheta	NN	B-NP	B-proteinby	the	by	IN	B-PP	Othe	TCR	the	DT	B-NP	OTCR	and	TCR	NN	I-NP	B-proteinand	CD28	and	CC	I-NP	OCD28	plays	CD28	NN	I-NP	B-proteinplays	an	play	VBZ	B-VP	Oan	important	an	DT	B-NP	Oimportant	role	important	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	assembly	the	DT	B-NP	Oassembly	and	assembly	NN	I-NP	Oand	activation	and	CC	I-NP	Oactivation	of	activation	NN	I-NP	Oof	IKK	of	IN	B-PP	OIKK	complexes	IKK	NN	B-NP	B-proteincomplexes	in	complex	NNS	I-NP	I-proteinin	the	in	IN	B-PP	Othe	T	the	DT	B-NP	OT	cell	T	NN	I-NP	Ocell	membrane	cell	NN	I-NP	Omembrane	T-cell	membrane	NN	I-NP	OT-cell	#NAME?	T-cell	NN	B-NP	O#NAME?	regulation	#NAME?	JJ	I-NP	Oregulation	of	regulation	NN	I-NP	Oof	osteoclastogenesis	of	IN	B-PP	Oosteoclastogenesis	by	osteoclastogenesis	NN	B-NP	Oby	signalling	by	IN	B-PP	Osignalling	cross-talk	signalling	NN	B-NP	Ocross-talk	between	cross-talk	NN	I-NP	Obetween	RANKL	between	IN	B-PP	ORANKL	and	RANKL	NN	B-NP	B-proteinand	IFN-gamma	and	CC	I-NP	OIFN-gamma	.	IFN-gamma	NN	I-NP	B-protein.	Bone	.	.	O	OBone	resorption	Bone	NN	B-NP	Oresorption	is	resorption	NN	I-NP	Ois	regulated	be	VBZ	B-VP	Oregulated	by	regulate	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	immune	the	DT	B-NP	Oimmune	system	immune	JJ	I-NP	Osystem	","	system	NN	I-NP	O","	where	","	","	O	Owhere	T-cell	where	WRB	B-ADVP	OT-cell	expression	T-cell	NN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	RANKL	of	IN	B-PP	ORANKL	(	RANKL	NN	B-NP	B-protein(	receptor	(	(	O	Oreceptor	activator	receptor	NN	B-NP	Oactivator	of	activator	NN	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	(	factor	NN	I-NP	I-protein(	NF	(	(	O	I-proteinNF	)	NF	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	ligand	#NAME?	NN	B-NP	I-proteinligand	)	ligand	NN	I-NP	O)	","	)	)	O	O","	a	","	","	O	Oa	member	a	DT	B-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	tumour-necrosis	the	DT	B-NP	Otumour-necrosis	factor	tumour-necrosis	NN	I-NP	B-proteinfactor	family	factor	NN	I-NP	I-proteinfamily	that	family	NN	I-NP	I-proteinthat	is	that	WDT	B-NP	Ois	essential	be	VBZ	B-VP	Oessential	for	essential	JJ	B-ADJP	Ofor	osteoclastogenesis	for	IN	B-PP	Oosteoclastogenesis	","	osteoclastogenesis	NN	B-NP	O","	may	","	","	O	Omay	contribute	may	MD	B-VP	Ocontribute	to	contribute	VB	I-VP	Oto	pathological	to	TO	B-PP	Opathological	conditions	pathological	JJ	B-NP	Oconditions	","	condition	NNS	I-NP	O","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	autoimmune	as	IN	I-PP	Oautoimmune	arthritis	autoimmune	JJ	B-NP	Oarthritis	.	arthritis	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	whether	","	","	O	Owhether	activated	whether	IN	B-SBAR	Oactivated	T	activate	VBN	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	maintain	cell	NNS	I-NP	I-cell_typemaintain	bone	maintain	VBP	B-VP	Obone	homeostasis	bone	NN	B-NP	Ohomeostasis	by	homeostasis	NN	I-NP	Oby	counterbalancing	by	IN	B-PP	Ocounterbalancing	the	counterbalance	VBG	B-VP	Othe	action	the	DT	B-NP	Oaction	of	action	NN	I-NP	Oof	RANKL	of	IN	B-PP	ORANKL	remains	RANKL	NN	B-NP	B-proteinremains	unknown	remain	VBZ	B-VP	Ounknown	.	unknown	JJ	B-ADJP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	T-cell	that	IN	B-SBAR	OT-cell	production	T-cell	NN	B-NP	Oproduction	of	production	NN	I-NP	Oof	interferon	of	IN	B-PP	Ointerferon	(	interferon	NN	B-NP	B-protein(	IFN	(	(	O	I-proteinIFN	)	IFN	NN	B-NP	I-protein)	#NAME?	)	)	O	I-protein#NAME?	strongly	#NAME?	NN	B-NP	I-proteinstrongly	suppresses	strongly	RB	B-ADVP	Osuppresses	osteoclastogenesis	suppress	VBZ	B-VP	Oosteoclastogenesis	by	osteoclastogenesis	NN	B-NP	Oby	interfering	by	IN	B-PP	Ointerfering	with	interfere	VBG	B-VP	Owith	the	with	IN	B-PP	Othe	RANKL	the	DT	B-NP	ORANKL	#NAME?	RANKL	NN	I-NP	B-protein#NAME?	signalling	#NAME?	NN	I-NP	I-proteinsignalling	pathway	signalling	NN	I-NP	Opathway	.	pathway	NN	I-NP	O.	IFN-gamma	.	.	O	OIFN-gamma	induces	IFN-gamma	NN	B-NP	B-proteininduces	rapid	induce	VBZ	B-VP	Orapid	degradation	rapid	JJ	B-NP	Odegradation	of	degradation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	RANK	the	DT	B-NP	ORANK	adapter	RANK	NN	I-NP	B-proteinadapter	protein	adapter	NN	I-NP	I-proteinprotein	","	protein	NN	I-NP	I-protein","	TRAF6	","	","	O	OTRAF6	(	TRAF6	NN	B-NP	B-protein(	tumour	(	(	O	Otumour	necrosis	tumour	NN	B-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	receptor-associated	factor	NN	I-NP	I-proteinreceptor-associated	factor	receptor-associated	JJ	I-NP	I-proteinfactor	6	factor	NN	I-NP	I-protein6	)	6	CD	I-NP	I-protein)	","	)	)	O	O","	which	","	","	O	Owhich	results	which	WDT	B-NP	Oresults	in	result	VBZ	B-VP	Oin	strong	in	IN	B-PP	Ostrong	inhibition	strong	JJ	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	the	of	IN	B-PP	Othe	RANKL	the	DT	B-NP	ORANKL	#NAME?	RANKL	NN	I-NP	B-protein#NAME?	activation	#NAME?	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	NF-kappaB	factor	NN	I-NP	I-proteinNF-kappaB	and	NF-kappaB	NN	I-NP	B-proteinand	JNK	and	CC	I-NP	OJNK	.	JNK	NN	I-NP	B-protein.	This	.	.	O	OThis	inhibition	This	DT	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	osteoclastogenesis	of	IN	B-PP	Oosteoclastogenesis	is	osteoclastogenesis	NN	B-NP	Ois	rescued	be	VBZ	B-VP	Orescued	by	rescue	VBN	I-VP	Oby	overexpressing	by	IN	B-PP	Ooverexpressing	TRAF6	overexpresse	VBG	B-VP	OTRAF6	in	TRAF6	NN	B-NP	B-proteinin	precursor	in	IN	B-PP	Oprecursor	cells	precursor	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	which	","	","	O	Owhich	indicates	which	WDT	B-NP	Oindicates	that	indicate	VBZ	B-VP	Othat	TRAF6	that	IN	B-SBAR	OTRAF6	is	TRAF6	NN	B-NP	B-proteinis	the	be	VBZ	B-VP	Othe	target	the	DT	B-NP	Otarget	critical	target	NN	I-NP	Ocritical	for	critical	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	IFN-gamma	the	DT	B-NP	OIFN-gamma	action	IFN-gamma	NN	I-NP	B-proteinaction	.	action	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	we	","	","	O	Owe	provide	we	PRP	B-NP	Oprovide	evidence	provide	VBP	B-VP	Oevidence	that	evidence	NN	B-NP	Othat	the	that	IN	B-SBAR	Othe	accelerated	the	DT	B-NP	Oaccelerated	degradation	accelerate	VBN	I-NP	Odegradation	of	degradation	NN	I-NP	Oof	TRAF6	of	IN	B-PP	OTRAF6	requires	TRAF6	NN	B-NP	B-proteinrequires	both	require	VBZ	B-VP	Oboth	its	both	CC	O	Oits	ubiquitination	its	PRP$	B-NP	Oubiquitination	","	ubiquitination	NN	I-NP	O","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	initiated	be	VBZ	B-VP	Oinitiated	by	initiate	VBN	I-VP	Oby	RANKL	by	IN	B-PP	ORANKL	","	RANKL	NN	B-NP	B-protein","	and	","	","	O	Oand	IFN-gamma	and	CC	O	OIFN-gamma	#NAME?	IFN-gamma	NN	B-NP	B-protein#NAME?	activation	#NAME?	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	ubiquitin-proteasome	the	DT	B-NP	Oubiquitin-proteasome	system	ubiquitin-proteasome	JJ	I-NP	Osystem	.	system	NN	I-NP	O.	Our	.	.	O	OOur	study	Our	PRP$	B-NP	Ostudy	shows	study	NN	I-NP	Oshows	that	show	VBZ	B-VP	Othat	there	that	IN	B-SBAR	Othere	is	there	EX	B-NP	Ois	cross-talk	be	VBZ	B-VP	Ocross-talk	between	cross-talk	NN	B-NP	Obetween	the	between	IN	B-PP	Othe	tumour	the	DT	B-NP	Otumour	necrosis	tumour	NN	I-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	and	factor	NN	I-NP	I-proteinand	IFN	and	CC	I-NP	OIFN	families	IFN	NN	I-NP	B-proteinfamilies	of	family	NNS	I-NP	I-proteinof	cytokines	of	IN	B-PP	Ocytokines	","	cytokine	NNS	B-NP	B-protein","	through	","	","	O	Othrough	which	through	IN	B-PP	Owhich	IFN-gamma	which	WDT	B-NP	OIFN-gamma	provides	IFN-gamma	NN	B-NP	B-proteinprovides	a	provide	VBZ	B-VP	Oa	negative	a	DT	B-NP	Onegative	link	negative	JJ	I-NP	Olink	between	link	NN	I-NP	Obetween	T-cell	between	IN	B-PP	OT-cell	activation	T-cell	NN	B-NP	Oactivation	and	activation	NN	I-NP	Oand	bone	and	CC	O	Obone	resorption	bone	NN	B-NP	Oresorption	.	resorption	NN	I-NP	O.	Our	.	.	O	OOur	results	Our	PRP$	B-NP	Oresults	may	result	NNS	I-NP	Omay	offer	may	MD	B-VP	Ooffer	a	offer	VB	I-VP	Oa	therapeutic	a	DT	B-NP	Otherapeutic	approach	therapeutic	JJ	I-NP	Oapproach	to	approach	NN	I-NP	Oto	treat	to	TO	B-VP	Otreat	the	treat	VB	I-VP	Othe	inflammation-induced	the	DT	B-NP	Oinflammation-induced	tissue	inflammation-induced	JJ	I-NP	Otissue	breakdown	tissue	NN	I-NP	Obreakdown	.	breakdown	NN	I-NP	O.	Stromal-derived	.	.	O	OStromal-derived	factor	Stromal-derived	JJ	B-NP	B-proteinfactor	1	factor	NN	I-NP	I-protein1	and	1	CD	I-NP	I-proteinand	thrombopoietin	and	CC	O	Othrombopoietin	regulate	thrombopoietin	NN	B-NP	B-proteinregulate	distinct	regulate	VBP	B-VP	Odistinct	aspects	distinct	JJ	B-NP	Oaspects	of	aspect	NNS	I-NP	Oof	human	of	IN	B-PP	Ohuman	megakaryopoiesis	human	JJ	B-NP	Omegakaryopoiesis	.	megakaryopoiesis	NN	I-NP	O.	The	.	.	O	OThe	role	The	DT	B-NP	Orole	of	role	NN	I-NP	Oof	the	of	IN	B-PP	Othe	chemokine	the	DT	B-NP	Ochemokine	binding	chemokine	NN	I-NP	B-proteinbinding	stromal-derived	binding	NN	I-NP	I-proteinstromal-derived	factor	stromal-derived	JJ	I-NP	I-proteinfactor	1	factor	NN	I-NP	I-protein1	(	1	CD	I-NP	I-protein(	SDF-1	(	(	O	OSDF-1	)	SDF-1	NN	B-NP	B-protein)	in	)	)	O	Oin	normal	in	IN	B-PP	Onormal	human	normal	JJ	B-NP	Ohuman	megakaryopoiesis	human	JJ	I-NP	Omegakaryopoiesis	at	megakaryopoiesis	NN	I-NP	Oat	the	at	IN	B-PP	Othe	cellular	the	DT	B-NP	Ocellular	and	cellular	JJ	I-NP	Oand	molecular	and	CC	I-NP	Omolecular	levels	molecular	JJ	I-NP	Olevels	and	level	NNS	I-NP	Oand	its	and	CC	O	Oits	comparison	its	PRP$	B-NP	Ocomparison	with	comparison	NN	I-NP	Owith	that	with	IN	B-PP	Othat	of	that	DT	B-NP	Oof	thrombopoietin	of	IN	B-PP	Othrombopoietin	(	thrombopoietin	NN	B-NP	B-protein(	TPO	(	(	O	OTPO	)	TPO	NN	B-NP	B-protein)	have	)	)	O	Ohave	not	have	VBP	B-VP	Onot	been	not	RB	I-VP	Obeen	determined	be	VBN	I-VP	Odetermined	.	determine	VBN	I-VP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	it	study	NN	I-NP	Oit	was	it	PRP	B-NP	Owas	found	be	VBD	B-VP	Ofound	that	find	VBN	I-VP	Othat	SDF-1	that	IN	B-SBAR	OSDF-1	","	SDF-1	NN	B-NP	B-protein","	unlike	","	","	O	Ounlike	TPO	unlike	IN	B-PP	OTPO	","	TPO	NN	B-NP	B-protein","	does	","	","	O	Odoes	not	do	VBZ	B-VP	Onot	stimulate	not	RB	I-VP	Ostimulate	alpha	stimulate	VB	I-VP	Oalpha	(	alpha	NN	B-NP	O(	IIb	(	(	O	OIIb	)	IIb	NN	B-NP	O)	beta	)	)	O	Obeta	(	beta	NN	B-NP	O(	3	(	(	O	O3	)	3	CD	B-NP	O)	(	)	)	O	O(	+	(	(	O	O+	)	+	SYM	O	O)	cell	)	)	O	Ocell	proliferation	cell	NN	B-NP	Oproliferation	or	proliferation	NN	I-NP	Oor	differentiation	or	CC	O	Odifferentiation	or	differentiation	NN	B-NP	Oor	have	or	CC	O	Ohave	an	have	VB	B-VP	Oan	antiapoptotic	an	DT	B-NP	Oantiapoptotic	effect	antiapoptotic	JJ	I-NP	Oeffect	.	effect	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	it	","	","	O	Oit	does	it	PRP	B-NP	Odoes	induce	do	VBZ	B-VP	Oinduce	chemotaxis	induce	VB	I-VP	Ochemotaxis	","	chemotaxis	NN	B-NP	O","	trans-Matrigel	","	","	O	Otrans-Matrigel	migration	trans-Matrigel	NN	B-NP	Omigration	","	migration	NN	I-NP	O","	and	","	","	O	Oand	secretion	and	CC	O	Osecretion	of	secretion	NN	B-NP	Oof	matrix	of	IN	B-PP	Omatrix	metalloproteinase	matrix	NN	B-NP	B-proteinmetalloproteinase	9	metalloproteinase	NN	I-NP	I-protein9	(	9	CD	I-NP	I-protein(	MMP-9	(	(	O	OMMP-9	)	MMP-9	NN	B-NP	B-protein)	and	)	)	O	Oand	vascular	and	CC	O	Ovascular	endothelial	vascular	JJ	B-NP	B-proteinendothelial	growth	endothelial	JJ	I-NP	I-proteingrowth	factor	growth	NN	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	VEGF	(	(	O	OVEGF	)	VEGF	NN	B-NP	B-protein)	by	)	)	O	Oby	these	by	IN	B-PP	Othese	cells	these	DT	B-NP	Ocells	","	cell	NNS	I-NP	O","	and	","	","	O	Oand	both	and	CC	O	Oboth	SDF-1	both	CC	O	OSDF-1	and	SDF-1	NN	B-NP	B-proteinand	TPO	and	CC	I-NP	OTPO	increase	TPO	NN	I-NP	B-proteinincrease	the	increase	VBP	B-VP	Othe	adhesion	the	DT	B-NP	Oadhesion	of	adhesion	NN	I-NP	Oof	alpha	of	IN	B-PP	Oalpha	(	alpha	NN	B-NP	B-cell_type(	IIb	(	(	O	I-cell_typeIIb	)	IIb	NN	B-NP	I-cell_type)	beta	)	)	O	I-cell_typebeta	(	beta	NN	B-NP	I-cell_type(	3	(	(	O	I-cell_type3	)	3	CD	B-NP	I-cell_type)	(	)	)	O	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	cells	)	)	O	I-cell_typecells	to	cell	NNS	B-NP	I-cell_typeto	fibrinogen	to	TO	B-PP	Ofibrinogen	and	fibrinogen	NN	B-NP	B-proteinand	vitronectin	and	CC	I-NP	Ovitronectin	.	vitronectin	NN	I-NP	B-protein.	Investigating	.	.	O	OInvestigating	the	Investigate	VBG	B-VP	Othe	intracellular	the	DT	B-NP	Ointracellular	signaling	intracellular	JJ	I-NP	Osignaling	pathways	signaling	NN	I-NP	Opathways	induced	pathway	NNS	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	SDF-1	by	IN	B-PP	OSDF-1	and	SDF-1	NN	B-NP	B-proteinand	TPO	and	CC	I-NP	OTPO	revealed	TPO	NN	I-NP	B-proteinrevealed	some	reveal	VBD	B-VP	Osome	overlapping	some	DT	B-NP	Ooverlapping	patterns	overlap	VBG	I-NP	Opatterns	of	pattern	NNS	I-NP	Oof	protein	of	IN	B-PP	Oprotein	phosphorylation/activation	protein	NN	B-NP	Ophosphorylation/activation	(	phosphorylation/activation	NN	I-NP	O(	mitogen-activated	(	(	O	Omitogen-activated	protein	mitogen-activated	JJ	B-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	[	kinase	NN	I-NP	I-protein[	MAPK	[	(	O	OMAPK	]	MAPK	NN	B-NP	B-protein]	p42/44	]	)	O	Op42/44	","	p42/44	NN	B-NP	B-protein","	MAPK	","	","	O	OMAPK	p38	MAPK	NN	B-NP	B-proteinp38	","	p38	NN	I-NP	I-protein","	and	","	","	O	Oand	AKT	and	CC	O	OAKT	[	AKT	NN	B-NP	B-protein[	protein	[	(	I-NP	Oprotein	kinase	protein	NN	I-NP	B-proteinkinase	B	kinase	NN	I-NP	I-proteinB	]	B	NN	I-NP	I-protein]	)	]	)	O	O)	and	)	)	O	Oand	some	and	CC	O	Osome	that	some	DT	B-NP	Othat	were	that	WDT	B-NP	Owere	distinct	be	VBD	B-VP	Odistinct	for	distinct	JJ	B-ADJP	Ofor	TPO	for	IN	B-PP	OTPO	(	TPO	NN	B-NP	B-protein(	eg	(	(	O	Oeg	","	eg	FW	B-NP	O","	JAK-STAT	","	","	I-NP	OJAK-STAT	)	JAK-STAT	NN	I-NP	B-protein)	and	)	)	O	Oand	for	and	CC	O	Ofor	SDF-1	for	IN	B-PP	OSDF-1	(	SDF-1	NN	B-NP	B-protein(	eg	(	(	O	Oeg	","	eg	FW	B-NP	O","	NF-kappa	","	","	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	)	B	NN	I-NP	I-protein)	.	)	)	O	O.	It	.	.	O	OIt	was	It	PRP	B-NP	Owas	also	be	VBD	B-VP	Oalso	found	also	RB	I-VP	Ofound	that	find	VBN	I-VP	Othat	though	that	IN	B-SBAR	Othough	inhibition	though	IN	B-SBAR	Oinhibition	of	inhibition	NN	B-NP	Oof	phosphatidyl-inositol	of	IN	B-PP	Ophosphatidyl-inositol	3-kinase	phosphatidyl-inositol	NN	B-NP	B-protein3-kinase	(	3-kinase	NN	I-NP	I-protein(	PI-3K	(	(	O	OPI-3K	)	PI-3K	NN	B-NP	B-protein)	by	)	)	O	Oby	LY294002	by	IN	B-PP	OLY294002	in	LY294002	NN	B-NP	Oin	alpha	in	IN	B-PP	Oalpha	(	alpha	NN	B-NP	B-cell_line(	IIb	(	(	O	I-cell_lineIIb	)	IIb	NN	B-NP	I-cell_line)	beta	)	)	O	I-cell_linebeta	(	beta	NN	B-NP	I-cell_line(	3	(	(	O	I-cell_line3	)	3	CD	B-NP	I-cell_line)	(	)	)	O	I-cell_line(	+	(	(	O	I-cell_line+	)	+	SYM	O	I-cell_line)	cells	)	)	O	I-cell_linecells	induced	cell	NNS	B-NP	I-cell_lineinduced	apoptosis	induce	VBD	B-VP	Oapoptosis	and	apoptosis	NN	B-NP	Oand	inhibited	and	CC	O	Oinhibited	chemotaxis	inhibit	VBD	B-VP	Ochemotaxis	adhesion	chemotaxis	NN	B-NP	Oadhesion	and	adhesion	NN	I-NP	Oand	the	and	CC	O	Othe	secretion	the	DT	B-NP	Osecretion	of	secretion	NN	I-NP	Oof	MMP-9	of	IN	B-PP	OMMP-9	and	MMP-9	NN	B-NP	B-proteinand	VEGF	and	CC	I-NP	OVEGF	","	VEGF	NN	I-NP	B-protein","	the	","	","	O	Othe	inhibition	the	DT	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	MAPK	of	IN	B-PP	OMAPK	p42/44	MAPK	NN	B-NP	B-proteinp42/44	(	p42/44	NN	I-NP	O(	by	(	(	O	Oby	the	by	IN	B-PP	Othe	MEK	the	DT	B-NP	OMEK	inhibitor	MEK	NN	I-NP	B-proteininhibitor	U0126	inhibitor	NN	I-NP	OU0126	)	U0126	NN	I-NP	O)	had	)	)	O	Ohad	no	have	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	on	effect	NN	I-NP	Oon	the	on	IN	B-PP	Othe	survival	the	DT	B-NP	Osurvival	","	survival	NN	I-NP	O","	proliferation	","	","	O	Oproliferation	","	proliferation	NN	B-NP	O","	and	","	","	O	Oand	migration	and	CC	O	Omigration	of	migration	NN	B-NP	Oof	these	of	IN	B-PP	Othese	cells	these	DT	B-NP	Ocells	.	cell	NNS	I-NP	O.	Hence	.	.	O	OHence	","	Hence	RB	B-ADVP	O","	it	","	","	O	Oit	is	it	PRP	B-NP	Ois	suggested	be	VBZ	B-VP	Osuggested	that	suggest	VBN	I-VP	Othat	the	that	IN	B-SBAR	Othe	proliferative	the	DT	B-NP	Oproliferative	effect	proliferative	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	TPO	of	IN	B-PP	OTPO	is	TPO	NN	B-NP	B-proteinis	more	be	VBZ	B-VP	Omore	related	more	RBR	B-ADJP	Orelated	to	related	JJ	I-ADJP	Oto	activation	to	TO	B-PP	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	JAK-STAT	the	DT	B-NP	OJAK-STAT	pathway	JAK-STAT	NN	I-NP	Opathway	(	pathway	NN	I-NP	O(	unique	(	(	O	Ounique	to	unique	JJ	B-ADJP	Oto	TPO	to	TO	B-PP	OTPO	)	TPO	NN	B-NP	B-protein)	","	)	)	O	O","	and	","	","	O	Oand	the	and	CC	O	Othe	PI-3K-AKT	the	DT	B-NP	OPI-3K-AKT	axis	PI-3K-AKT	NN	I-NP	Oaxis	is	axis	NN	I-NP	Ois	differentially	be	VBZ	B-VP	Odifferentially	involved	differentially	RB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	TPO-	in	IN	B-PP	OTPO-	and	TPO-	NN	B-NP	B-proteinand	SDF-1-dependent	and	CC	O	OSDF-1-dependent	signaling	SDF-1-dependent	JJ	B-NP	Osignaling	.	signaling	NN	I-NP	O.	Accordingly	.	.	O	OAccordingly	","	Accordingly	RB	B-ADVP	O","	PI-3K	","	","	O	OPI-3K	is	PI-3K	NN	B-NP	B-proteinis	involved	be	VBZ	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	TPO	in	IN	B-PP	OTPO	#NAME?	TPO	NN	B-NP	B-protein#NAME?	inhibition	#NAME?	JJ	I-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	apoptosis	of	IN	B-PP	Oapoptosis	","	apoptosis	NN	B-NP	O","	TPO-	","	","	O	OTPO-	and	TPO-	NN	B-NP	B-proteinand	SDF-1-regulated	and	CC	O	OSDF-1-regulated	adhesion	SDF-1-regulated	JJ	B-NP	Oadhesion	to	adhesion	NN	I-NP	Oto	fibrinogen	to	TO	B-PP	Ofibrinogen	and	fibrinogen	NN	B-NP	B-proteinand	vitronectin	and	CC	I-NP	Ovitronectin	","	vitronectin	NN	I-NP	B-protein","	and	","	","	O	Oand	SDF-1	and	CC	O	OSDF-1	#NAME?	SDF-1	NN	B-NP	B-protein#NAME?	migration	#NAME?	JJ	I-NP	Omigration	.	migration	NN	I-NP	O.	This	.	.	O	OThis	study	This	DT	B-NP	Ostudy	expands	study	NN	I-NP	Oexpands	the	expand	VBZ	B-VP	Othe	understanding	the	DT	B-NP	Ounderstanding	of	understanding	NN	I-NP	Oof	the	of	IN	B-PP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	SDF-1	of	IN	B-PP	OSDF-1	and	SDF-1	NN	B-NP	B-proteinand	TPO	and	CC	I-NP	OTPO	in	TPO	NN	I-NP	B-proteinin	normal	in	IN	B-PP	Onormal	human	normal	JJ	B-NP	Ohuman	megakaryopoiesis	human	JJ	I-NP	Omegakaryopoiesis	and	megakaryopoiesis	NN	I-NP	Oand	indicates	and	CC	O	Oindicates	the	indicate	VBZ	B-VP	Othe	molecular	the	DT	B-NP	Omolecular	basis	molecular	JJ	I-NP	Obasis	of	basis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	observed	the	DT	B-NP	Oobserved	differences	observe	VBN	I-NP	Odifferences	in	difference	NNS	I-NP	Oin	cellular	in	IN	B-PP	Ocellular	responses	cellular	JJ	B-NP	Oresponses	.	response	NNS	I-NP	O.	(	.	.	O	O(	Blood.	(	(	O	OBlood.	2000	Blood.	NNP	B-NP	O2000	;	2000	CD	I-NP	O;	96	;	:	O	O96	:	96	CD	B-NP	O:	4142-4151	:	:	O	O4142-4151	)	4142-4151	CD	B-NP	O)	Adhesion	)	)	O	OAdhesion	of	Adhesion	NN	B-NP	Oof	immature	of	IN	B-PP	Oimmature	and	immature	JJ	B-NP	B-cell_typeand	mature	and	CC	I-NP	I-cell_typemature	T	mature	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	induces	cell	NNS	I-NP	I-cell_typeinduces	in	induce	VBZ	B-VP	Oin	human	in	IN	B-PP	Ohuman	thymic	human	JJ	B-NP	B-cell_typethymic	epithelial	thymic	JJ	I-NP	I-cell_typeepithelial	cells	epithelial	JJ	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	TEC	(	(	O	OTEC	)	TEC	NNS	B-NP	B-cell_type)	activation	)	)	O	Oactivation	of	activation	NN	B-NP	Oof	IL-6	of	IN	B-PP	OIL-6	gene	IL-6	NN	B-NP	B-DNAgene	trascription	gene	NN	I-NP	I-DNAtrascription	factors	trascription	NN	I-NP	Ofactors	(	factor	NNS	I-NP	O(	NF-kappaB	(	(	O	ONF-kappaB	and	NF-kappaB	NN	B-NP	B-proteinand	NF-IL6	and	CC	O	ONF-IL6	)	NF-IL6	NN	B-NP	B-protein)	and	)	)	O	Oand	IL-6	and	CC	O	OIL-6	gene	IL-6	NN	B-NP	B-proteingene	expression	gene	NN	I-NP	Oexpression	:	expression	NN	I-NP	O:	role	:	:	O	Orole	of	role	NN	B-NP	Oof	alpha3beta1	of	IN	B-PP	Oalpha3beta1	and	alpha3beta1	NN	B-NP	B-proteinand	alpha6beta4	and	CC	I-NP	Oalpha6beta4	integrins	alpha6beta4	NN	I-NP	B-proteinintegrins	.	integrin	NNS	I-NP	I-protein.	T	.	.	O	OT	cell	T	NN	B-NP	B-cell_typecell	precursors	cell	NN	I-NP	I-cell_typeprecursors	homed	precursor	NNS	I-NP	I-cell_typehomed	to	home	VBN	B-VP	Oto	thymus	to	TO	B-PP	Othymus	develop	thymus	NN	B-NP	Odevelop	in	develop	NN	I-NP	Oin	close	in	IN	B-PP	Oclose	contact	close	JJ	B-NP	Ocontact	with	contact	NN	I-NP	Owith	stromal	with	IN	B-PP	Ostromal	cells	stromal	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Among	.	.	O	OAmong	them	Among	IN	B-PP	Othem	","	them	PRP	B-NP	O","	thymic	","	","	O	Othymic	epithelial	thymic	JJ	B-NP	B-cell_typeepithelial	cells	epithelial	JJ	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	TEC	(	(	O	OTEC	)	TEC	NNS	B-NP	B-cell_type)	are	)	)	O	Oare	known	be	VBP	B-VP	Oknown	to	know	VBN	I-VP	Oto	exert	to	TO	I-VP	Oexert	dominant	exert	VB	I-VP	Odominant	roles	dominant	JJ	B-NP	Oroles	in	role	NNS	I-NP	Oin	their	in	IN	B-PP	Otheir	survival	their	PRP$	B-NP	Osurvival	and	survival	NN	I-NP	Oand	functional	and	CC	I-NP	Ofunctional	shaping	functional	JJ	I-NP	Oshaping	.	shaping	NN	I-NP	O.	Key	.	.	O	OKey	molecules	Key	NN	B-NP	Omolecules	mediating	molecule	NNS	I-NP	Omediating	TEC	mediate	VBG	B-VP	OTEC	/	TEC	NN	B-NP	B-cell_type/	thymocytes	/	SYM	I-NP	Othymocytes	interactions	thymocyte	NNS	I-NP	B-cell_typeinteractions	include	interaction	NNS	I-NP	Oinclude	cytokines	include	VBP	B-VP	Ocytokines	and	cytokine	NNS	B-NP	B-proteinand	growth	and	CC	O	Ogrowth	factors	growth	NN	B-NP	B-proteinfactors	secreted	factor	NNS	I-NP	I-proteinsecreted	by	secrete	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	two	the	DT	B-NP	Otwo	cell	two	CD	I-NP	Ocell	types	cell	NN	I-NP	Otypes	and	type	NNS	I-NP	Oand	adhesion	and	CC	O	Oadhesion	receptors	adhesion	NN	B-NP	B-proteinreceptors	mediating	receptor	NNS	I-NP	I-proteinmediating	cell	mediate	VBG	B-VP	Ocell	contact	cell	NN	B-NP	Ocontact	.	contact	NN	I-NP	O.	Signaling	.	.	O	OSignaling	events	Signaling	NN	B-NP	Oevents	triggered	event	NNS	I-NP	Otriggered	in	trigger	VBN	B-VP	Oin	thymocytes	in	IN	B-PP	Othymocytes	by	thymocyte	NNS	B-NP	B-cell_typeby	adhesion	by	IN	B-PP	Oadhesion	to	adhesion	NN	B-NP	Oto	epithelial	to	TO	B-PP	Oepithelial	cells	epithelial	JJ	B-NP	B-cell_typecells	have	cell	NNS	I-NP	I-cell_typehave	been	have	VBP	B-VP	Obeen	extensively	be	VBN	I-VP	Oextensively	investigated	extensively	RB	I-VP	Oinvestigated	","	investigate	VBN	I-VP	O","	whereas	","	","	O	Owhereas	little	whereas	IN	O	Olittle	is	little	JJ	B-NP	Ois	known	be	VBZ	B-VP	Oknown	on	know	VBN	I-VP	Oon	the	on	IN	B-PP	Othe	opposite	the	DT	B-NP	Oopposite	phenomenon	opposite	JJ	I-NP	Ophenomenon	.	phenomenon	NN	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	previously	have	VBP	B-VP	Opreviously	investigated	previously	RB	I-VP	Oinvestigated	this	investigate	VBN	I-VP	Othis	issue	this	DT	B-NP	Oissue	in	issue	NN	I-NP	Oin	a	in	IN	B-PP	Oa	co-culture	a	DT	B-NP	Oco-culture	system	co-culture	NN	I-NP	Osystem	composed	system	NN	I-NP	Ocomposed	of	compose	VBN	B-VP	Oof	TEC	of	IN	B-PP	OTEC	cultures	TEC	NN	B-NP	B-cell_linecultures	derived	culture	NNS	I-NP	I-cell_linederived	from	derive	VBN	B-VP	Ofrom	human	from	IN	B-PP	Ohuman	normal	human	JJ	B-NP	Onormal	thymus	normal	JJ	I-NP	Othymus	and	thymus	NN	I-NP	Oand	heterologous	and	CC	O	Oheterologous	thymocytes	heterologous	JJ	B-NP	B-cell_typethymocytes	.	thymocyte	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	demonstrated	We	PRP	B-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	thymocytes	that	IN	B-SBAR	Othymocytes	adhere	thymocyte	NNS	B-NP	B-cell_typeadhere	to	adhere	VBP	B-VP	Oto	TEC	to	TO	B-PP	OTEC	involving	TEC	NN	B-NP	B-cell_typeinvolving	beta1	involve	VBG	B-VP	Obeta1	and	beta1	NN	B-NP	B-proteinand	beta4	and	CC	I-NP	I-proteinbeta4	integrins	beta4	NN	I-NP	I-proteinintegrins	and	integrin	NNS	I-NP	I-proteinand	induce	and	CC	O	Oinduce	the	induce	VB	B-VP	Othe	clustering	the	DT	B-NP	Oclustering	of	clustering	NN	I-NP	Oof	alpha3beta1	of	IN	B-PP	Oalpha3beta1	and	alpha3beta1	NN	B-NP	B-proteinand	alpha6beta4	and	CC	I-NP	Oalpha6beta4	heterodimers	alpha6beta4	NN	I-NP	B-proteinheterodimers	at	heterodimer	NNS	I-NP	I-proteinat	the	at	IN	B-PP	Othe	TEC	the	DT	B-NP	OTEC	surface	TEC	NN	I-NP	B-cell_typesurface	.	surface	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	thymocyte	addition	NN	B-NP	Othymocyte	adhesion	thymocyte	NN	I-NP	Oadhesion	was	adhesion	NN	I-NP	Owas	followed	be	VBD	B-VP	Ofollowed	by	follow	VBN	I-VP	Oby	activation	by	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	and	NF-kappaB	NN	B-NP	B-proteinand	NF-IL6	and	CC	I-NP	ONF-IL6	gene	NF-IL6	NN	I-NP	B-proteingene	transcription	gene	NN	I-NP	I-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	and	factor	NNS	I-NP	I-proteinand	enhanced	and	CC	O	Oenhanced	IL-6	enhance	VBN	B-VP	OIL-6	production	IL-6	NN	B-NP	B-proteinproduction	.	production	NN	I-NP	O.	The	.	.	O	OThe	two	The	DT	B-NP	Otwo	latter	two	CD	I-NP	Olatter	phenomena	latter	JJ	I-NP	Ophenomena	were	phenomenon	NNS	I-NP	Owere	reproduced	be	VBD	B-VP	Oreproduced	by	reproduce	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	cross-linking	the	DT	B-NP	Ocross-linking	of	cross-linking	NN	I-NP	Oof	the	of	IN	B-PP	Othe	alpha3	the	DT	B-NP	Oalpha3	","	alpha3	NN	I-NP	B-protein","	alpha6	","	","	I-NP	Oalpha6	","	alpha6	NN	I-NP	B-protein","	beta1	","	","	I-NP	Obeta1	and	beta1	NN	I-NP	B-proteinand	beta4	and	CC	I-NP	Obeta4	integrins	beta4	NN	I-NP	B-proteinintegrins	","	integrin	NNS	I-NP	I-protein","	thus	","	","	O	Othus	implying	thus	RB	B-ADVP	Oimplying	that	imply	VBG	B-VP	Othat	the	that	IN	B-SBAR	Othe	alpha3beta1	the	DT	B-NP	Oalpha3beta1	and	alpha3beta1	NN	I-NP	B-proteinand	alpha6beta4	and	CC	I-NP	Oalpha6beta4	heterodimers	alpha6beta4	NN	I-NP	B-proteinheterodimers	can	heterodimer	NNS	I-NP	I-proteincan	signal	can	MD	B-VP	Osignal	during	signal	VB	I-VP	Oduring	thymocyte	during	IN	B-PP	Othymocyte	adhesion	thymocyte	NN	B-NP	Oadhesion	.	adhesion	NN	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	extended	have	VBP	B-VP	Oextended	our	extend	VBN	I-VP	Oour	previous	our	PRP$	B-NP	Oprevious	work	previous	JJ	I-NP	Owork	investigating	work	NN	I-NP	Oinvestigating	in	investigate	VBG	B-VP	Oin	the	in	IN	B-PP	Othe	same	the	DT	B-NP	Osame	experimental	same	JJ	I-NP	Oexperimental	setting	experimental	JJ	I-NP	Osetting	the	set	VBG	B-VP	Othe	inducing	the	DT	B-NP	Oinducing	activity	induce	VBG	I-NP	Oactivity	of	activity	NN	I-NP	Oof	non	of	IN	B-PP	Onon	stimulated	non	NN	B-NP	Ostimulated	or	stimulate	VBN	B-VP	Oor	activated	or	CC	I-VP	Oactivated	policlonal	activate	VBN	I-VP	Opoliclonal	or	policlonal	JJ	B-NP	Oor	clonal	or	CC	I-NP	Oclonal	mature	clonal	JJ	I-NP	Omature	T	mature	JJ	I-NP	OT	cells	T	NN	I-NP	Ocells	as	cell	NNS	I-NP	Oas	representative	as	IN	B-PP	Orepresentative	of	representative	NN	B-NP	Oof	the	of	IN	B-PP	Othe	more	the	DT	B-NP	Omore	mature	more	RBR	I-NP	Omature	thymocyte	mature	JJ	I-NP	B-cell_typethymocyte	subset	thymocyte	NN	I-NP	I-cell_typesubset	.	subset	NN	I-NP	I-cell_type.	We	.	.	O	OWe	found	We	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	adhesion	that	IN	B-SBAR	Oadhesion	of	adhesion	NN	B-NP	Oof	unstimulated	of	IN	B-PP	Ounstimulated	T	unstimulated	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	i	cell	NN	I-NP	Oi	)	i	NN	I-NP	O)	involved	)	)	O	Oinvolved	beta1	involve	VBD	B-VP	Obeta1	","	beta1	NN	B-NP	O","	but	","	","	O	Obut	not	but	CC	O	Onot	beta4	not	RB	O	Obeta4	integrin	beta4	NN	B-NP	B-proteinintegrin	functions	integrin	NN	I-NP	I-proteinfunctions	at	function	VBZ	B-VP	Oat	the	at	IN	B-PP	Othe	surface	the	DT	B-NP	Osurface	ii	surface	NN	I-NP	Oii	)	ii	NN	I-NP	O)	induced	)	)	O	Oinduced	the	induce	VBD	B-VP	Othe	clustering	the	DT	B-NP	Oclustering	of	clustering	NN	I-NP	Oof	alpha3beta1	of	IN	B-PP	Oalpha3beta1	","	alpha3beta1	NN	B-NP	B-protein","	but	","	","	B-NP	Obut	not	but	CC	I-NP	Onot	alpha2beta1	not	RB	I-NP	Oalpha2beta1	heterodimers	alpha2beta1	NN	B-NP	B-proteinheterodimers	at	heterodimer	NNS	I-NP	I-proteinat	the	at	IN	B-PP	Othe	TEC	the	DT	B-NP	OTEC	surface	TEC	NN	I-NP	B-cell_typesurface	and	surface	NN	I-NP	Oand	iii	and	CC	O	Oiii	)	iii	NN	B-NP	O)	up-regulated	)	)	O	Oup-regulated	the	up-regulate	VBD	B-VP	Othe	nuclear	the	DT	B-NP	Onuclear	binding	nuclear	JJ	I-NP	Obinding	activity	binding	NN	I-NP	Oactivity	of	activity	NN	I-NP	Oof	NF-kappaB	of	IN	B-PP	ONF-kappaB	transcription	NF-kappaB	NN	B-NP	B-proteintranscription	factor	transcription	NN	I-NP	B-proteinfactor	and	factor	NN	I-NP	I-proteinand	the	and	CC	O	Othe	IL-6	the	DT	B-NP	OIL-6	secretion	IL-6	NN	I-NP	B-proteinsecretion	.	secretion	NN	I-NP	O.	We	.	.	O	OWe	propose	We	PRP	B-NP	Opropose	that	propose	VBP	B-VP	Othat	alpha3beta1	that	IN	B-SBAR	Oalpha3beta1	and	alpha3beta1	NN	B-NP	B-proteinand	alpha6beta4	and	CC	I-NP	Oalpha6beta4	heterodimers	alpha6beta4	NN	I-NP	B-proteinheterodimers	are	heterodimer	NNS	I-NP	I-proteinare	induced	be	VBP	B-VP	Oinduced	to	induce	VBN	I-VP	Oto	cluster	to	TO	I-VP	Ocluster	at	cluster	VB	I-VP	Oat	the	at	IN	B-PP	Othe	TEC	the	DT	B-NP	OTEC	surface	TEC	NN	I-NP	B-proteinsurface	recognizing	surface	NN	I-NP	I-proteinrecognizing	yet	recognize	VBG	B-VP	I-proteinyet	unknown	yet	RB	B-NP	I-proteinunknown	cellular	unknown	JJ	I-NP	I-proteincellular	ligands	cellular	JJ	I-NP	I-proteinligands	differentially	ligand	NNS	I-NP	I-proteindifferentially	expressed	differentially	RB	B-VP	Oexpressed	during	express	VBN	I-VP	Oduring	T	during	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	development	cell	NN	I-NP	Odevelopment	.	development	NN	I-NP	O.	Identification	.	.	O	OIdentification	and	Identification	NN	B-NP	Oand	characterization	and	CC	I-NP	Ocharacterization	of	characterization	NN	I-NP	Oof	SKAT-2	of	IN	B-PP	OSKAT-2	","	SKAT-2	NN	B-NP	B-protein","	a	","	","	O	Oa	novel	a	DT	B-NP	Onovel	Th2-specific	novel	JJ	I-NP	B-DNATh2-specific	zinc	Th2-specific	JJ	I-NP	I-DNAzinc	finger	zinc	NN	I-NP	I-DNAfinger	gene	finger	NN	I-NP	I-DNAgene	.	gene	NN	I-NP	I-DNA.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	identified	have	VBP	B-VP	Oidentified	a	identify	VBN	I-VP	Oa	novel	a	DT	B-NP	Onovel	Kruppel-type	novel	JJ	I-NP	B-DNAKruppel-type	zinc	Kruppel-type	JJ	I-NP	I-DNAzinc	finger	zinc	NN	I-NP	I-DNAfinger	(	finger	NN	I-NP	I-DNA(	ZF	(	(	O	I-DNAZF	)	ZF	NN	B-NP	I-DNA)	gene	)	)	O	I-DNAgene	","	gene	NN	B-NP	I-DNA","	SKAT-2	","	","	O	OSKAT-2	","	SKAT-2	NN	B-NP	B-protein","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	selectively	be	VBZ	B-VP	Oselectively	expressed	selectively	RB	I-VP	Oexpressed	by	express	VBN	I-VP	Oby	murine	by	IN	B-PP	Omurine	Th2	murine	JJ	B-NP	B-cell_lineTh2	cells	Th2	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	The	.	.	O	OThe	protein	The	DT	B-NP	Oprotein	encoded	protein	NN	I-NP	Oencoded	by	encode	VBN	B-VP	Oby	this	by	IN	B-PP	Othis	gene	this	DT	B-NP	Ogene	has	gene	NN	I-NP	Ohas	14	have	VBZ	B-VP	O14	C2H2-type	14	CD	B-NP	OC2H2-type	ZF	C2H2-type	JJ	I-NP	OZF	tandemly	ZF	NN	I-NP	Otandemly	arrayed	tandemly	RB	B-ADVP	Oarrayed	at	array	VBD	B-VP	Oat	its	at	IN	B-PP	Oits	C	its	PRP$	B-NP	OC	terminus	C	NN	I-NP	B-proteinterminus	and	terminus	NN	I-NP	I-proteinand	N-terminal	and	CC	O	ON-terminal	SCAN	N-terminal	JJ	B-NP	B-proteinSCAN	box	SCAN	NN	I-NP	I-proteinbox	and	box	NN	I-NP	I-proteinand	KRAB	and	CC	O	OKRAB	domains	KRAB	NN	B-NP	B-proteindomains	.	domain	NNS	I-NP	I-protein.	SKAT-2	.	.	O	OSKAT-2	is	SKAT-2	NN	B-NP	B-proteinis	tissue	be	VBZ	B-VP	Otissue	restricted	tissue	NN	B-NP	Orestricted	in	restrict	VBN	B-VP	Oin	expression	in	IN	B-PP	Oexpression	at	expression	NN	B-NP	Oat	the	at	IN	B-PP	Othe	RNA	the	DT	B-NP	ORNA	level	RNA	NN	I-NP	Olevel	","	level	NN	I-NP	O","	detectable	","	","	O	Odetectable	only	detectable	JJ	B-ADJP	Oonly	in	only	RB	B-PP	Oin	brain	in	IN	I-PP	Obrain	and	brain	NN	B-NP	Oand	at	and	CC	B-PP	Oat	low	at	IN	B-PP	Olow	levels	low	JJ	B-NP	Olevels	in	level	NNS	I-NP	Oin	kidney	in	IN	B-PP	Okidney	and	kidney	NN	B-NP	Oand	spleen	and	CC	O	Ospleen	and	spleen	NN	B-NP	Oand	few	and	CC	O	Ofew	hematopoietic	few	JJ	B-NP	Ohematopoietic	cell	hematopoietic	JJ	I-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	.	line	NNS	I-NP	I-cell_line.	By	.	.	O	OBy	in	By	IN	B-PP	Oin	situ	in	FW	B-NP	Ositu	hybridization	situ	FW	I-NP	Ohybridization	","	hybridization	NN	I-NP	O","	SKAT-2	","	","	O	OSKAT-2	expression	SKAT-2	NN	B-NP	B-proteinexpression	was	expression	NN	I-NP	Owas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	peak	to	TO	I-VP	Opeak	in	peak	VB	I-VP	Oin	antigen-stimulated	in	IN	B-PP	Oantigen-stimulated	CD4	antigen-stimulated	JJ	B-NP	B-cell_typeCD4	(	CD4	NN	I-NP	I-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	after	cell	NNS	I-NP	I-cell_typeafter	3-Feb	after	IN	B-PP	O3-Feb	days	3-Feb	CD	B-NP	Odays	of	day	NNS	I-NP	Oof	culture	of	IN	B-PP	Oculture	under	culture	NN	B-NP	Ounder	Th2	under	IN	B-PP	OTh2	but	Th2	NN	B-NP	B-cell_typebut	not	but	CC	B-NP	Onot	Th1	not	RB	I-NP	OTh1	biasing	Th1	NN	B-NP	Obiasing	conditions	biasing	NN	I-NP	Oconditions	.	condition	NNS	I-NP	O.	This	.	.	O	OThis	pattern	This	DT	B-NP	Opattern	of	pattern	NN	I-NP	Oof	expression	of	IN	B-PP	Oexpression	closely	expression	NN	B-NP	Oclosely	mirrored	closely	RB	B-ADVP	Omirrored	that	mirror	VBD	B-VP	Othat	of	that	IN	B-SBAR	Oof	GATA-3	of	IN	B-PP	OGATA-3	in	GATA-3	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	same	the	DT	B-NP	Osame	cells	same	JJ	I-NP	Ocells	.	cell	NNS	I-NP	O.	In	.	.	O	OIn	transient	In	IN	B-PP	Otransient	transfection	transient	JJ	B-NP	Otransfection	experiments	transfection	NN	I-NP	Oexperiments	in	experiment	NNS	I-NP	Oin	phorbol	in	IN	B-PP	Ophorbol	12-myristate	phorbol	NN	B-NP	B-cell_line12-myristate	13-acetate/ionomycin-stimulated	12-myristate	NN	I-NP	I-cell_line13-acetate/ionomycin-stimulated	EL4	13-acetate/ionomycin-stimulated	JJ	I-NP	I-cell_lineEL4	cells	EL4	NN	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	SKAT-2	","	","	O	OSKAT-2	was	SKAT-2	NN	B-NP	B-proteinwas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	up-regulate	to	TO	I-VP	Oup-regulate	the	up-regulate	VB	I-VP	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	IL-4	the	DT	B-NP	OIL-4	but	IL-4	NN	I-NP	B-proteinbut	not	but	CC	B-NP	Onot	the	not	RB	I-NP	Othe	IL-5	the	DT	B-NP	OIL-5	promoter	IL-5	NN	I-NP	B-DNApromoter	","	promoter	NN	I-NP	I-DNA","	contrasting	","	","	O	Ocontrasting	with	contrast	VBG	B-VP	Owith	the	with	IN	B-PP	Othe	ability	the	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	GATA-3	of	IN	B-PP	OGATA-3	to	GATA-3	NN	B-NP	B-proteinto	activate	to	TO	B-VP	Oactivate	both	activate	VB	I-VP	Oboth	promoters	both	DT	B-NP	Opromoters	.	promoter	NNS	I-NP	B-DNA.	This	.	.	O	OThis	result	This	DT	B-NP	Oresult	was	result	NN	I-NP	Owas	confirmed	be	VBD	B-VP	Oconfirmed	using	confirm	VBN	I-VP	Ousing	clones	use	VBG	B-VP	Oclones	of	clone	NNS	B-NP	Oof	EL4	of	IN	B-PP	OEL4	cells	EL4	NN	B-NP	B-cell_linecells	stably	cell	NNS	I-NP	I-cell_linestably	expressing	stably	RB	B-VP	Oexpressing	an	express	VBG	I-VP	Oan	inducible	an	DT	B-NP	Oinducible	form	inducible	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	SKAT-2	of	IN	B-PP	OSKAT-2	","	SKAT-2	NN	B-NP	B-protein","	thus	","	","	O	Othus	SKAT-2	thus	RB	B-ADVP	OSKAT-2	is	SKAT-2	NN	B-NP	B-proteinis	a	be	VBZ	B-VP	Oa	novel	a	DT	B-NP	Onovel	Th2-specific	novel	JJ	I-NP	B-DNATh2-specific	gene	Th2-specific	JJ	I-NP	I-DNAgene	that	gene	NN	I-NP	I-DNAthat	may	that	WDT	B-NP	Omay	play	may	MD	B-VP	Oplay	a	play	VB	I-VP	Oa	role	a	DT	B-NP	Orole	in	role	NN	I-NP	Oin	selective	in	IN	B-PP	Oselective	regulation	selective	JJ	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	genes	cytokine	NN	B-NP	B-DNAgenes	in	gene	NNS	I-NP	I-DNAin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	hsp70	.	.	O	Ohsp70	interacting	hsp70	NN	B-NP	B-proteininteracting	protein	interact	VBG	B-VP	Oprotein	Hip	protein	NN	B-NP	OHip	does	Hip	NN	I-NP	B-proteindoes	not	do	VBZ	B-VP	Onot	affect	not	RB	I-VP	Oaffect	glucocorticoid	affect	VB	I-VP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	folding	receptor	NN	I-NP	I-proteinfolding	by	folding	NN	I-NP	Oby	the	by	IN	B-PP	Othe	hsp90-based	the	DT	B-NP	Ohsp90-based	chaperone	hsp90-based	JJ	I-NP	Ochaperone	machinery	chaperone	NN	I-NP	Omachinery	except	machinery	NN	I-NP	Oexcept	to	except	IN	B-SBAR	Oto	oppose	to	TO	B-VP	Ooppose	the	oppose	VB	I-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	BAG-1	of	IN	B-PP	OBAG-1	.	BAG-1	NN	B-NP	B-protein.	Reticulocyte	.	.	O	OReticulocyte	lysate	Reticulocyte	NN	B-NP	Olysate	contains	lysate	NN	I-NP	Ocontains	a	contain	VBZ	B-VP	Oa	chaperone	a	DT	B-NP	Ochaperone	system	chaperone	NN	I-NP	Osystem	that	system	NN	I-NP	Othat	assembles	that	WDT	B-NP	Oassembles	glucocorticoid	assemble	VBZ	B-VP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	GR	(	(	O	OGR	)	GR	NN	B-NP	B-protein)	.hsp90	)	)	O	O.hsp90	heterocomplexes	.hsp90	CD	B-NP	Oheterocomplexes	.	heterocomplex	NNS	I-NP	O.	Using	.	.	O	OUsing	purified	Use	VBG	B-VP	Opurified	proteins	purify	VBN	B-NP	B-proteinproteins	","	protein	NNS	I-NP	I-protein","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	prepared	have	VBP	B-VP	Oprepared	a	prepare	VBN	I-VP	Oa	five-protein	a	DT	B-NP	Ofive-protein	heterocomplex	five-protein	JJ	I-NP	Oheterocomplex	assembly	heterocomplex	NN	I-NP	Oassembly	system	assembly	NN	I-NP	Osystem	consisting	system	NN	I-NP	Oconsisting	of	consist	VBG	B-VP	Oof	two	of	IN	B-PP	Otwo	proteins	two	CD	B-NP	Oproteins	essential	protein	NNS	I-NP	Oessential	for	essential	JJ	B-ADJP	Ofor	heterocomplex	for	IN	B-PP	Oheterocomplex	assembly-	heterocomplex	JJ	B-NP	B-proteinassembly-	hsp90	assembly-	NN	I-NP	I-proteinhsp90	and	hsp90	NN	I-NP	I-proteinand	hsp70	and	CC	I-NP	Ohsp70	#NAME?	hsp70	NN	I-NP	B-protein#NAME?	three	#NAME?	SYM	B-NP	Othree	proteins	three	CD	B-NP	Oproteins	that	protein	NNS	I-NP	Othat	act	that	WDT	B-NP	Oact	as	act	VBP	B-VP	Oas	co-chaperones	as	IN	B-SBAR	Oco-chaperones	to	co-chaperone	NNS	B-NP	Oto	enhance	to	TO	B-VP	Oenhance	assembly-	enhance	VB	I-VP	Oassembly-	Hop	assembly-	RP	B-PRT	OHop	","	Hop	NNP	B-NP	O","	hsp40	","	","	O	Ohsp40	","	hsp40	NN	B-NP	B-protein","	p23	","	","	O	Op23	[	p23	NN	B-NP	B-protein[	Morishima	[	(	O	OMorishima	","	Morishima	NNP	B-NP	O","	Y.	","	","	O	OY.	","	Y.	NNP	B-NP	O","	Kanelakis	","	","	O	OKanelakis	","	Kanelakis	NNP	B-NP	O","	K.	","	","	O	OK.	C.	K.	NNP	B-NP	OC.	","	C.	NNP	I-NP	O","	Silverstein	","	","	O	OSilverstein	","	Silverstein	NNP	B-NP	O","	A.	","	","	O	OA.	M.	A.	NNP	B-NP	OM.	","	M.	NNP	I-NP	O","	Dittmar	","	","	O	ODittmar	","	Dittmar	NNP	B-NP	O","	K.	","	","	O	OK.	D.	K.	NNP	B-NP	OD.	","	D.	NNP	I-NP	O","	Estrada	","	","	O	OEstrada	","	Estrada	NNP	B-NP	O","	L.	","	","	O	OL.	","	L.	NNP	B-NP	O","	and	","	","	O	Oand	Pratt	and	CC	O	OPratt	","	Pratt	NNP	B-NP	O","	W.	","	","	O	OW.	B.	W.	NNP	B-NP	OB.	(	B.	NNP	I-NP	O(	2000	(	(	O	O2000	)	2000	CD	B-NP	O)	J.	)	)	O	OJ.	Biol.	J.	NNP	B-NP	OBiol.	Chem.	Biol.	NNP	I-NP	OChem.	275	Chem.	NNP	I-NP	O275	","	275	CD	I-NP	O","	6894-6900	","	","	I-NP	O6894-6900	]	6894-6900	CD	I-NP	O]	.	]	)	O	O.	The	.	.	O	OThe	hsp70	The	DT	B-NP	Ohsp70	co-chaperone	hsp70	NN	I-NP	B-proteinco-chaperone	Hip	co-chaperone	NN	I-NP	OHip	has	Hip	NN	I-NP	Ohas	been	have	VBZ	B-VP	Obeen	recovered	be	VBN	I-VP	Orecovered	in	recover	VBN	I-VP	Oin	receptor.hsp90	in	IN	B-PP	Oreceptor.hsp90	heterocomplexes	receptor.hsp90	NN	B-NP	Oheterocomplexes	at	heterocomplex	NNS	I-NP	Oat	an	at	IN	B-PP	Oan	intermediate	an	DT	B-NP	Ointermediate	stage	intermediate	JJ	I-NP	Ostage	of	stage	NN	I-NP	Oof	assembly	of	IN	B-PP	Oassembly	in	assembly	NN	B-NP	Oin	reticulocyte	in	IN	B-PP	Oreticulocyte	lysate	reticulocyte	NN	B-NP	Olysate	","	lysate	NN	I-NP	O","	and	","	","	O	Oand	Hip	and	CC	O	OHip	is	Hip	NNP	B-NP	B-proteinis	also	be	VBZ	B-VP	Oalso	thought	also	RB	I-VP	Othought	to	think	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	an	be	VB	I-VP	Oan	intrinsic	an	DT	B-NP	Ointrinsic	component	intrinsic	JJ	I-NP	Ocomponent	of	component	NN	I-NP	Oof	the	of	IN	B-PP	Othe	assembly	the	DT	B-NP	Oassembly	machinery	assembly	NN	I-NP	Omachinery	.	machinery	NN	I-NP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	immunodepletion	that	IN	B-SBAR	Oimmunodepletion	of	immunodepletion	NN	B-NP	Oof	Hip	of	IN	B-PP	OHip	from	Hip	NN	B-NP	B-proteinfrom	reticulocyte	from	IN	B-PP	Oreticulocyte	lysate	reticulocyte	NN	B-NP	Olysate	or	lysate	NN	I-NP	Oor	addition	or	CC	I-NP	Oaddition	of	addition	NN	I-NP	Oof	high	of	IN	B-PP	Ohigh	levels	high	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	Hip	of	IN	B-PP	OHip	to	Hip	NNP	B-NP	B-proteinto	the	to	TO	B-PP	Othe	purified	the	DT	B-NP	Opurified	five-protein	purify	VBN	I-NP	Ofive-protein	system	five-protein	JJ	I-NP	Osystem	does	system	NN	I-NP	Odoes	not	do	VBZ	B-VP	Onot	affect	not	RB	I-VP	Oaffect	GR.hsp90	affect	VB	I-VP	OGR.hsp90	heterocomplex	GR.hsp90	NN	B-NP	B-proteinheterocomplex	assembly	heterocomplex	NN	I-NP	Oassembly	or	assembly	NN	I-NP	Oor	the	or	CC	O	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	steroid	of	IN	B-PP	Osteroid	binding	steroid	NN	B-NP	Obinding	activity	binding	NN	I-NP	Oactivity	that	activity	NN	I-NP	Othat	occurs	that	WDT	B-NP	Ooccurs	with	occur	VBZ	B-VP	Owith	assembly	with	IN	B-PP	Oassembly	.	assembly	NN	B-NP	O.	Despite	.	.	O	ODespite	the	Despite	IN	B-PP	Othe	fact	the	DT	B-NP	Ofact	that	fact	NN	I-NP	Othat	Hip	that	IN	B-SBAR	OHip	does	Hip	NN	B-NP	B-proteindoes	not	do	VBZ	B-VP	Onot	affect	not	RB	I-VP	Oaffect	assembly	affect	VB	I-VP	Oassembly	","	assembly	RB	B-ADVP	O","	it	","	","	O	Oit	is	it	PRP	B-NP	Ois	recovered	be	VBZ	B-VP	Orecovered	in	recover	VBN	I-VP	Oin	GR.hsp90	in	IN	B-PP	OGR.hsp90	heterocomplexes	GR.hsp90	NN	B-NP	B-proteinheterocomplexes	assembled	heterocomplex	NNS	I-NP	I-proteinassembled	by	assemble	VBN	B-VP	Oby	both	by	IN	B-PP	Oboth	systems	both	DT	B-NP	Osystems	.	system	NNS	I-NP	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	five-protein	the	DT	B-NP	Ofive-protein	system	five-protein	JJ	I-NP	Osystem	","	system	NN	I-NP	O","	Hip	","	","	O	OHip	prevents	Hip	NN	B-NP	B-proteinprevents	inhibition	prevent	VBZ	B-VP	Oinhibition	of	inhibition	NN	B-NP	Oof	assembly	of	IN	B-PP	Oassembly	by	assembly	NN	B-NP	Oby	the	by	IN	B-PP	Othe	hsp70	the	DT	B-NP	Ohsp70	co-chaperone	hsp70	NN	I-NP	B-proteinco-chaperone	BAG-1	co-chaperone	NN	I-NP	OBAG-1	","	BAG-1	NN	I-NP	O","	and	","	","	O	Oand	cotransfection	and	CC	O	Ocotransfection	of	cotransfection	NN	B-NP	Oof	Hip	of	IN	B-PP	OHip	with	Hip	NN	B-NP	B-proteinwith	BAG-1	with	IN	B-PP	OBAG-1	opposes	BAG-1	NN	B-NP	B-proteinopposes	BAG-1	oppose	VBZ	B-VP	OBAG-1	reduction	BAG-1	NN	B-NP	B-proteinreduction	of	reduction	NN	I-NP	Oof	steroid	of	IN	B-PP	Osteroid	binding	steroid	NN	B-NP	Obinding	activity	binding	NN	I-NP	Oactivity	in	activity	NN	I-NP	Oin	COS	in	IN	B-PP	OCOS	cells	COS	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	Hip	that	IN	B-SBAR	OHip	is	Hip	NN	B-NP	B-proteinis	not	be	VBZ	B-VP	Onot	a	not	RB	O	Oa	component	a	DT	B-NP	Ocomponent	of	component	NN	I-NP	Oof	the	of	IN	B-PP	Othe	assembly	the	DT	B-NP	Oassembly	machinery	assembly	NN	I-NP	Omachinery	but	machinery	NN	I-NP	Obut	that	but	CC	O	Othat	it	that	IN	B-SBAR	Oit	could	it	PRP	B-NP	Ocould	play	could	MD	B-VP	Oplay	a	play	VB	I-VP	Oa	regulatory	a	DT	B-NP	Oregulatory	role	regulatory	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	opposition	in	IN	B-PP	Oopposition	to	opposition	NN	B-NP	Oto	BAG-1	to	TO	B-PP	OBAG-1	.	BAG-1	NN	B-NP	B-protein.	Cutting	.	.	O	OCutting	edge	Cutting	JJ	B-NP	Oedge	:	edge	NN	I-NP	O:	STAT6-deficient	:	:	O	OSTAT6-deficient	mice	STAT6-deficient	JJ	B-NP	Omice	have	mouse	NNS	I-NP	Ohave	enhanced	have	VBP	B-VP	Oenhanced	tumor	enhance	VBN	I-VP	Otumor	immunity	tumor	NN	B-NP	Oimmunity	to	immunity	NN	I-NP	Oto	primary	to	TO	B-PP	Oprimary	and	primary	JJ	B-NP	Oand	metastatic	and	CC	I-NP	Ometastatic	mammary	metastatic	JJ	I-NP	Omammary	carcinoma	mammary	JJ	I-NP	Ocarcinoma	.	carcinoma	NN	I-NP	O.	STAT4	.	.	O	OSTAT4	and	STAT4	NN	B-NP	B-proteinand	STAT6	and	CC	I-NP	OSTAT6	are	STAT6	NN	I-NP	B-proteinare	essential	be	VBP	B-VP	Oessential	for	essential	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	CD4	of	IN	B-PP	OCD4	(	CD4	NN	B-NP	O(	+	(	(	O	O+	)	+	SYM	O	O)	Th1	)	)	O	OTh1	and	Th1	NN	B-NP	Oand	Th2	and	CC	I-NP	OTh2	development	Th2	NN	I-NP	Odevelopment	","	development	NN	I-NP	O","	respectively	","	","	O	Orespectively	.	respectively	RB	B-ADVP	O.	Tumor	.	.	O	OTumor	immunologists	Tumor	NN	B-NP	Oimmunologists	have	immunologist	NNS	I-NP	Ohave	hypothesized	have	VBP	B-VP	Ohypothesized	that	hypothesize	VBN	I-VP	Othat	Th1	that	IN	B-SBAR	OTh1	cells	Th1	NN	B-NP	B-cell_typecells	are	cell	NNS	I-NP	I-cell_typeare	critical	be	VBP	B-VP	Ocritical	in	critical	JJ	B-ADJP	Oin	tumor	in	IN	B-PP	Otumor	immunity	tumor	NN	B-NP	Oimmunity	because	immunity	NN	I-NP	Obecause	they	because	IN	B-SBAR	Othey	facilitate	they	PRP	B-NP	Ofacilitate	differentiation	facilitate	VBP	B-VP	Odifferentiation	of	differentiation	NN	B-NP	Oof	CD8	of	IN	B-PP	OCD8	(	CD8	NN	B-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	which	","	","	O	Owhich	are	which	WDT	B-NP	Oare	potent	be	VBP	B-VP	Opotent	anti-tumor	potent	JJ	B-NP	Oanti-tumor	effectors	anti-tumor	JJ	I-NP	Oeffectors	.	effector	NNS	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	used	have	VBP	B-VP	Oused	STAT4	use	VBN	I-VP	OSTAT4	(	STAT4	NN	B-NP	B-protein(	-/-	(	(	O	O-/-	)	-/-	JJ	B-ADJP	O)	and	)	)	O	Oand	STAT6	and	CC	O	OSTAT6	(	STAT6	NN	B-NP	B-protein(	-/-	(	(	O	O-/-	)	-/-	JJ	O	O)	mice	)	)	O	Omice	to	mouse	NNS	B-NP	Oto	test	to	TO	B-VP	Otest	this	test	VB	I-VP	Othis	hypothesis	this	DT	B-NP	Ohypothesis	.	hypothesis	NN	I-NP	O.	BALB/c	.	.	O	OBALB/c	and	BALB/c	NN	B-NP	Oand	knockout	and	CC	I-NP	Oknockout	mice	knockout	NN	I-NP	Omice	were	mouse	NNS	I-NP	Owere	challenged	be	VBD	B-VP	Ochallenged	in	challenge	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	mammary	the	DT	B-NP	Omammary	gland	mammary	JJ	I-NP	Ogland	with	gland	NN	I-NP	Owith	the	with	IN	B-PP	Othe	highly	the	DT	B-NP	Ohighly	malignant	highly	RB	I-NP	Omalignant	and	malignant	JJ	I-NP	Oand	spontaneously	and	CC	I-NP	Ospontaneously	metastatic	spontaneously	RB	I-NP	Ometastatic	BALB/c-derived	metastatic	JJ	I-NP	OBALB/c-derived	4T1	BALB/c-derived	JJ	I-NP	O4T1	mammary	4T1	NN	I-NP	Omammary	carcinoma	mammary	JJ	I-NP	Ocarcinoma	.	carcinoma	NN	I-NP	O.	Primary	.	.	O	OPrimary	tumor	Primary	JJ	B-NP	Otumor	growth	tumor	NN	I-NP	Ogrowth	and	growth	NN	I-NP	Oand	metastatic	and	CC	O	Ometastatic	disease	metastatic	JJ	B-NP	Odisease	are	disease	NN	I-NP	Oare	reduced	be	VBP	B-VP	Oreduced	in	reduce	VBN	I-VP	Oin	STAT6	in	IN	B-PP	OSTAT6	(	STAT6	NN	B-NP	B-protein(	-/-	(	(	O	O-/-	)	-/-	JJ	O	O)	mice	)	)	O	Omice	relative	mouse	NNS	B-NP	Orelative	to	relative	JJ	B-ADJP	Oto	BALB/c	to	TO	B-PP	OBALB/c	and	BALB/c	NN	B-NP	B-cell_typeand	STAT4	and	CC	I-NP	OSTAT4	(	STAT4	NN	I-NP	B-protein(	-/-	(	(	O	O-/-	)	-/-	JJ	O	O)	mice	)	)	O	Omice	.	mouse	NNS	B-NP	O.	Ab	.	.	O	OAb	depletions	Ab	NN	B-NP	Odepletions	demonstrate	depletion	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	effect	the	DT	B-NP	Oeffect	is	effect	NN	I-NP	Ois	mediated	be	VBZ	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	CD8	by	IN	B-PP	OCD8	(	CD8	NN	B-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	T	)	)	O	I-cell_typeT	cells	T	NN	B-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	immunized	and	CC	O	Oimmunized	STAT6	immunize	VBN	B-NP	OSTAT6	(	STAT6	NN	I-NP	B-protein(	-/-	(	(	O	O-/-	)	-/-	JJ	O	O)	mice	)	)	O	Omice	have	mouse	NNS	B-NP	Ohave	higher	have	VBP	B-VP	Ohigher	levels	high	JJR	B-NP	Olevels	of	level	NNS	I-NP	Oof	4T1-specific	of	IN	B-PP	O4T1-specific	CTL	4T1-specific	JJ	B-NP	B-cell_typeCTL	than	CTL	NN	I-NP	I-cell_typethan	BALB/c	than	IN	B-PP	OBALB/c	or	BALB/c	NN	B-NP	B-proteinor	STAT4	or	CC	I-NP	OSTAT4	(	STAT4	NN	I-NP	B-protein(	-/-	(	(	O	O-/-	)	-/-	JJ	O	O)	mice	)	)	O	Omice	.	mouse	NNS	B-NP	O.	Surprisingly	.	.	O	OSurprisingly	","	Surprisingly	RB	B-ADVP	O","	Th1	","	","	O	OTh1	or	Th1	NN	B-NP	B-cell_lineor	Th2	or	CC	I-NP	OTh2	cells	Th2	NN	I-NP	B-cell_typecells	are	cell	NNS	I-NP	I-cell_typeare	not	be	VBP	B-VP	Onot	involved	not	RB	I-VP	Oinvolved	","	involve	VBN	I-VP	O","	because	","	","	O	Obecause	CD4	because	IN	B-SBAR	OCD4	depletion	CD4	NN	B-NP	B-proteindepletion	does	depletion	NN	I-NP	Odoes	not	do	VBZ	B-VP	Onot	diminish	not	RB	I-VP	Odiminish	the	diminish	VB	I-VP	Othe	anti-tumor	the	DT	B-NP	Oanti-tumor	effect	anti-tumor	JJ	I-NP	Oeffect	.	effect	NN	I-NP	O.	Therefore	.	.	O	OTherefore	","	Therefore	RB	B-ADVP	O","	deletion	","	","	O	Odeletion	of	deletion	NN	B-NP	Oof	the	of	IN	B-PP	Othe	STAT6	the	DT	B-NP	OSTAT6	gene	STAT6	NN	I-NP	B-DNAgene	facilitates	gene	NN	I-NP	I-DNAfacilitates	development	facilitate	VBZ	B-VP	Odevelopment	of	development	NN	B-NP	Oof	potent	of	IN	B-PP	Opotent	anti-tumor	potent	JJ	B-NP	Oanti-tumor	immunity	anti-tumor	JJ	I-NP	Oimmunity	via	immunity	NN	I-NP	Ovia	a	via	IN	B-PP	Oa	CD4	a	DT	B-NP	OCD4	(	CD4	NN	I-NP	O(	+	(	(	O	O+	)	+	SYM	O	O)	#NAME?	)	)	O	O#NAME?	pathway	#NAME?	JJ	B-NP	Opathway	.	pathway	NN	I-NP	O.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	oncogenic	of	IN	B-PP	Ooncogenic	transcription	oncogenic	JJ	B-NP	B-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	AP-1	factor	NN	I-NP	I-proteinAP-1	in	AP-1	NN	I-NP	B-proteinin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	infected	cell	NNS	I-NP	I-cell_typeinfected	with	infect	VBN	B-VP	Owith	human	with	IN	B-PP	Ohuman	T	human	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	leukemia	cell	NN	I-NP	Oleukemia	virus	leukemia	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	.	1	CD	I-NP	O.	Human	.	.	O	OHuman	T	Human	JJ	B-NP	B-proteinT	cell	T	NN	I-NP	I-proteincell	leukemia	cell	NN	I-NP	I-proteinleukemia	virus	leukemia	NN	I-NP	I-proteinvirus	type	virus	NN	I-NP	I-proteintype	1	type	NN	I-NP	I-protein1	(	1	CD	I-NP	I-protein(	HTLV-1	(	(	O	I-proteinHTLV-1	)	HTLV-1	NN	B-NP	I-protein)	Tax	)	)	O	I-proteinTax	protein	Tax	NN	B-NP	I-proteinprotein	transforms	protein	NN	I-NP	I-proteintransforms	primary	transform	VBZ	B-VP	Oprimary	human	primary	JJ	B-NP	B-cell_typehuman	T	human	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	We	.	.	O	OWe	previously	We	PRP	B-NP	Opreviously	showed	previously	RB	B-ADVP	Oshowed	that	show	VBD	B-VP	Othat	Tax	that	IN	B-SBAR	OTax	induces	Tax	NN	B-NP	B-proteininduces	the	induce	VBZ	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	various	of	IN	B-PP	Ovarious	family	various	JJ	B-NP	Ofamily	members	family	NN	I-NP	Omembers	of	member	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	AP-1	factor	NN	I-NP	I-proteinAP-1	such	AP-1	NN	I-NP	B-proteinsuch	as	such	JJ	B-PP	Oas	c-Jun	as	IN	I-PP	Oc-Jun	","	c-Jun	NN	B-NP	B-protein","	JunD	","	","	O	OJunD	","	JunD	NN	B-NP	B-protein","	c-Fos	","	","	O	Oc-Fos	","	c-Fos	NN	B-NP	B-protein","	and	","	","	O	Oand	Fra-1	and	CC	O	OFra-1	at	Fra-1	NN	B-NP	B-proteinat	the	at	IN	B-PP	Othe	mRNA	the	DT	B-NP	OmRNA	level	mRNA	NN	I-NP	B-RNAlevel	in	level	NN	I-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	examined	have	VBP	B-VP	Oexamined	the	examine	VBN	I-VP	Othe	ability	the	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	Tax	of	IN	B-PP	OTax	to	Tax	NN	B-NP	B-proteinto	activate	to	TO	B-VP	Oactivate	transcription	activate	VB	I-VP	Otranscription	through	transcription	NN	B-NP	Othrough	the	through	IN	B-PP	Othe	AP-1-binding	the	DT	B-NP	OAP-1-binding	site	AP-1-binding	JJ	I-NP	B-DNAsite	(	site	NN	I-NP	I-DNA(	AP-1	(	(	O	OAP-1	site	AP-1	NN	B-NP	B-DNAsite	)	site	NN	I-NP	I-DNA)	.	)	)	O	O.	A	.	.	O	OA	transient	A	DT	B-NP	Otransient	transfection	transient	JJ	I-NP	Otransfection	study	transfection	NN	I-NP	Ostudy	showed	study	NN	I-NP	Oshowed	that	show	VBD	B-VP	Othat	Tax	that	IN	B-SBAR	OTax	can	Tax	NN	B-NP	B-proteincan	activate	can	MD	B-VP	Oactivate	transcription	activate	VB	I-VP	Otranscription	through	transcription	NN	B-NP	Othrough	the	through	IN	B-PP	Othe	AP-1-binding	the	DT	B-NP	OAP-1-binding	site	AP-1-binding	JJ	I-NP	B-DNAsite	in	site	NN	I-NP	I-DNAin	a	in	IN	B-PP	Oa	human	a	DT	B-NP	Ohuman	T	human	JJ	I-NP	B-cell_lineT	cell	T	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	","	line	NN	I-NP	I-cell_line","	whereas	","	","	O	Owhereas	any	whereas	IN	O	Oany	combination	any	DT	B-NP	Ocombination	of	combination	NN	I-NP	Oof	AP-1	of	IN	B-PP	OAP-1	proteins	AP-1	NN	B-NP	B-proteinproteins	did	protein	NNS	I-NP	I-proteindid	so	do	VBD	B-VP	Oso	much	so	RB	B-ADJP	Omuch	less	much	RB	I-ADJP	Oless	than	less	JJR	I-ADJP	Othan	Tax	than	IN	B-PP	OTax	","	Tax	NN	B-NP	B-protein","	indicating	","	","	O	Oindicating	that	indicate	VBG	B-VP	Othat	the	that	IN	B-SBAR	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	AP-1	the	DT	B-NP	OAP-1	site	AP-1	NN	I-NP	B-DNAsite	by	site	NN	I-NP	I-DNAby	Tax	by	IN	B-PP	OTax	may	Tax	NN	B-NP	B-proteinmay	require	may	MD	B-VP	Orequire	a	require	VB	I-VP	Oa	mechanism	a	DT	B-NP	Omechanism	other	mechanism	NN	I-NP	Oother	than	other	JJ	B-ADJP	Othan	the	than	IN	B-PP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	AP-1	of	IN	B-PP	OAP-1	mRNA	AP-1	NN	B-NP	B-RNAmRNA	.	mRNA	NN	I-NP	I-RNA.	Fresh	.	.	O	OFresh	peripheral	Fresh	JJ	B-NP	Operipheral	blood	peripheral	JJ	I-NP	Oblood	leukemia	blood	NN	I-NP	Oleukemia	cells	leukemia	NN	I-NP	Ocells	of	cell	NNS	I-NP	Oof	all	of	IN	B-PP	Oall	surveyed	all	DT	B-NP	Osurveyed	ATL	survey	VBN	I-NP	OATL	patients	ATL	NN	I-NP	Opatients	displayed	patient	NNS	I-NP	Odisplayed	constitutive	display	VBD	B-VP	Oconstitutive	AP-1	constitutive	JJ	B-NP	OAP-1	DNA-binding	AP-1	NN	I-NP	B-proteinDNA-binding	activity	DNA-binding	JJ	I-NP	Oactivity	","	activity	NN	I-NP	O","	whereas	","	","	O	Owhereas	no	whereas	IN	O	Ono	normal	no	DT	B-NP	Onormal	individuals	normal	JJ	I-NP	Oindividuals	did	individual	NNS	I-NP	Odid	.	do	VBD	B-VP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	the	","	","	O	Othe	HTLV-1	the	DT	B-NP	OHTLV-1	genes	HTLV-1	NN	I-NP	B-DNAgenes	","	gene	NNS	I-NP	I-DNA","	including	","	","	O	Oincluding	tax	include	VBG	B-PP	Otax	","	tax	NN	B-NP	B-protein","	are	","	","	O	Oare	not	be	VBP	B-VP	Onot	significantly	not	RB	I-VP	Osignificantly	expressed	significantly	RB	I-VP	Oexpressed	in	express	VBN	I-VP	Oin	fresh	in	IN	B-PP	Ofresh	leukemia	fresh	JJ	B-NP	Oleukemia	cells	leukemia	NN	I-NP	Ocells	from	cell	NNS	I-NP	Ofrom	ATL	from	IN	B-PP	OATL	patients	ATL	NN	B-NP	Opatients	.	patient	NNS	I-NP	O.	Our	.	.	O	OOur	present	Our	PRP$	B-NP	Opresent	results	present	JJ	I-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	activation	that	IN	B-SBAR	Oactivation	of	activation	NN	B-NP	Oof	AP-1	of	IN	B-PP	OAP-1	occurs	AP-1	NN	B-NP	B-proteinoccurs	through	occur	VBZ	B-VP	Othrough	Tax-dependent	through	IN	B-PP	OTax-dependent	and	Tax-dependent	JJ	B-NP	Oand	#NAME?	and	CC	I-NP	O#NAME?	mechanisms	#NAME?	JJ	I-NP	Omechanisms	in	mechanism	NNS	I-NP	Oin	HTLV-1-infected	in	IN	B-PP	OHTLV-1-infected	T	HTLV-1-infected	JJ	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	which	","	","	O	Owhich	may	which	WDT	B-NP	Omay	play	may	MD	B-VP	Oplay	some	play	VB	I-VP	Osome	roles	some	DT	B-NP	Oroles	in	role	NNS	I-NP	Oin	dysregulated	in	IN	B-PP	Odysregulated	phenotypes	dysregulate	VBN	B-NP	Ophenotypes	of	phenotype	NNS	I-NP	Oof	HTLV-1-infected	of	IN	B-PP	OHTLV-1-infected	cells	HTLV-1-infected	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	2	.	.	O	O2	","	2	CD	B-NP	O","	2	","	","	I-NP	O2	'	2	CD	I-NP	O'	","	'	SYM	I-NP	O","	4	","	","	O	O4	","	4	CD	B-NP	O","	6	","	","	I-NP	O6	","	6	CD	I-NP	O","	6'-pentachlorobiphenyl	","	","	O	O6'-pentachlorobiphenyl	induces	6'-pentachlorobiphenyl	NN	B-NP	Oinduces	apoptosis	induce	VBZ	B-VP	Oapoptosis	in	apoptosis	NN	B-NP	Oin	human	in	IN	B-PP	Ohuman	monocytic	human	JJ	B-NP	B-cell_typemonocytic	cells	monocytic	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Polychlorinatedbiphenyls	.	.	O	OPolychlorinatedbiphenyls	(	Polychlorinatedbiphenyl	NNS	B-NP	O(	PCBs	(	(	O	OPCBs	)	PCB	NNS	B-NP	B-protein)	are	)	)	O	Oare	a	be	VBP	B-VP	Oa	group	a	DT	B-NP	Ogroup	of	group	NN	I-NP	Oof	persistent	of	IN	B-PP	Opersistent	and	persistent	JJ	O	Oand	widely	and	CC	O	Owidely	dispersed	widely	RB	B-VP	Odispersed	environmental	disperse	VBD	I-VP	Oenvironmental	pollutants	environmental	JJ	B-NP	Opollutants	","	pollutant	NNS	I-NP	O","	some	","	","	O	Osome	of	some	DT	B-NP	Oof	which	of	IN	B-PP	Owhich	may	which	WDT	B-NP	Omay	be	may	MD	B-VP	Obe	immunotoxic	be	VB	I-VP	Oimmunotoxic	.	immunotoxic	JJ	B-ADJP	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	present	the	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	investigated	we	PRP	B-NP	Oinvestigated	the	investigate	VBD	B-VP	Othe	effect	the	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	PCBs	of	IN	B-PP	OPCBs	on	PCB	NNS	B-NP	B-proteinon	immune	on	IN	B-PP	Oimmune	system	immune	JJ	B-NP	Osystem	by	system	NN	I-NP	Oby	assessing	by	IN	B-PP	Oassessing	apoptotic	assess	VBG	B-VP	Oapoptotic	cell	apoptotic	JJ	B-NP	Ocell	death	cell	NN	I-NP	Odeath	in	death	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	monocytic	human	JJ	B-NP	B-cell_linemonocytic	U937	monocytic	JJ	I-NP	I-cell_lineU937	cells	U937	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Among	.	.	O	OAmong	the	Among	IN	B-PP	Othe	various	the	DT	B-NP	Ovarious	congeners	various	JJ	I-NP	Ocongeners	tested	congener	NNS	I-NP	Otested	","	test	VBN	B-VP	O","	2	","	","	O	O2	","	2	CD	B-NP	O","	2	","	","	I-NP	O2	'	2	CD	I-NP	O'	","	'	SYM	I-NP	O","	4	","	","	O	O4	","	4	CD	B-NP	O","	6	","	","	I-NP	O6	","	6	CD	I-NP	O","	6'-pentachlorobiphenyl	","	","	O	O6'-pentachlorobiphenyl	(	6'-pentachlorobiphenyl	NN	B-NP	O(	PeCB	(	(	O	OPeCB	)	PeCB	NN	B-NP	B-protein)	","	)	)	O	O","	a	","	","	O	Oa	highly	a	DT	B-NP	Ohighly	ortho-substituted	highly	RB	I-NP	Oortho-substituted	congener	ortho-substituted	JJ	I-NP	Ocongener	","	congener	NN	I-NP	O","	specifically	","	","	O	Ospecifically	induced	specifically	RB	B-ADVP	Oinduced	DNA	induce	VBD	B-VP	ODNA	fragmentation	DNA	NN	B-NP	Ofragmentation	","	fragmentation	NN	I-NP	O","	a	","	","	O	Oa	hallmark	a	DT	B-NP	Ohallmark	of	hallmark	NN	I-NP	Oof	apoptosis	of	IN	B-PP	Oapoptosis	","	apoptosis	NN	B-NP	O","	while	","	","	O	Owhile	the	while	IN	B-SBAR	Othe	other	the	DT	B-NP	Oother	examined	other	JJ	I-NP	Oexamined	di-	examine	VBN	I-NP	Odi-	","	di-	NN	I-NP	O","	tri-	","	","	O	Otri-	","	tri-	NN	B-NP	O","	tetra-	","	","	O	Otetra-	","	tetra-	NN	B-NP	O","	and	","	","	O	Oand	pentachlorobiphenyls	and	CC	O	Opentachlorobiphenyls	did	pentachlorobiphenyl	NNS	B-NP	Odid	not	do	VBD	B-VP	Onot	.	not	RB	O	O.	To	.	.	O	OTo	further	To	TO	B-VP	Ofurther	study	further	RB	I-VP	Ostudy	the	study	VB	I-VP	Othe	2	the	DT	B-NP	O2	","	2	CD	I-NP	O","	2	","	","	I-NP	O2	'	2	CD	I-NP	O'	","	'	SYM	I-NP	O","	4	","	","	O	O4	","	4	CD	B-NP	O","	6	","	","	I-NP	O6	","	6	CD	I-NP	O","	6'-PeCB-induced	","	","	I-NP	O6'-PeCB-induced	cell	6'-PeCB-induced	JJ	I-NP	Ocell	death	cell	NN	I-NP	Odeath	","	death	NN	I-NP	O","	various	","	","	O	Ovarious	features	various	JJ	B-NP	Ofeatures	of	feature	NNS	I-NP	Oof	apoptosis	of	IN	B-PP	Oapoptosis	were	apoptosis	NN	B-NP	Owere	examined	be	VBD	B-VP	Oexamined	.	examine	VBN	I-VP	O.	2	.	.	O	O2	","	2	CD	B-NP	O","	2	","	","	I-NP	O2	'	2	CD	I-NP	O'	","	'	SYM	I-NP	O","	4	","	","	O	O4	","	4	CD	B-NP	O","	6	","	","	I-NP	O6	","	6	CD	I-NP	O","	6'-PeCB	","	","	I-NP	O6'-PeCB	caused	6'-PeCB	NN	I-NP	Ocaused	a	cause	VBD	B-VP	Oa	decrease	a	DT	B-NP	Odecrease	in	decrease	NN	I-NP	Oin	cell	in	IN	B-PP	Ocell	viability	cell	NN	B-NP	Oviability	and	viability	NN	I-NP	Oand	induced	and	CC	O	Oinduced	cellular	induce	VBD	B-VP	Ocellular	morphologic	cellular	JJ	B-NP	Omorphologic	features	morphologic	JJ	I-NP	Ofeatures	characteristic	feature	NNS	I-NP	Ocharacteristic	of	characteristic	JJ	B-ADJP	Oof	apoptosis	of	IN	B-PP	Oapoptosis	such	apoptosis	NN	B-NP	Osuch	as	such	JJ	B-PP	Oas	chromatin	as	IN	I-PP	Ochromatin	aggregation	chromatin	NN	B-NP	B-DNAaggregation	and	aggregation	NN	I-NP	Oand	apoptotic	and	CC	O	Oapoptotic	bodies	apoptotic	JJ	B-NP	Obodies	.	body	NNS	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	caspase-3	","	","	O	Ocaspase-3	","	caspase-3	NN	B-NP	B-protein","	an	","	","	O	Oan	executioner	an	DT	B-NP	Oexecutioner	of	executioner	NN	I-NP	Oof	apoptosis	of	IN	B-PP	Oapoptosis	","	apoptosis	NN	B-NP	O","	was	","	","	O	Owas	activated	be	VBD	B-VP	Oactivated	and	activate	VBN	I-VP	Oand	its	and	CC	O	Oits	substrate	its	PRP$	B-NP	Osubstrate	","	substrate	NN	I-NP	O","	poly	","	","	O	Opoly	(	poly	NN	B-NP	B-protein(	ADP-ribose	(	(	O	I-proteinADP-ribose	)	ADP-ribose	NN	B-NP	I-protein)	polymerase	)	)	O	I-proteinpolymerase	(	polymerase	NN	B-NP	I-protein(	PARP	(	(	O	OPARP	)	PARP	NN	B-NP	B-protein)	","	)	)	O	O","	was	","	","	O	Owas	cleaved	be	VBD	B-VP	Ocleaved	during	cleave	VBN	I-VP	Oduring	2	during	IN	B-PP	O2	","	2	CD	B-NP	O","	2	","	","	I-NP	O2	'	2	CD	I-NP	O'	","	'	SYM	I-NP	O","	4	","	","	O	O4	","	4	CD	B-NP	O","	6	","	","	I-NP	O6	","	6	CD	I-NP	O","	6'-PeCB-induced	","	","	I-NP	O6'-PeCB-induced	apoptosis	6'-PeCB-induced	JJ	I-NP	Oapoptosis	.	apoptosis	NN	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	3	","	","	O	O3	","	3	CD	B-NP	O","	3	","	","	I-NP	O3	'	3	CD	I-NP	O'	","	'	SYM	I-NP	O","	4	","	","	O	O4	","	4	CD	B-NP	O","	4	","	","	I-NP	O4	'	4	CD	I-NP	O'	","	'	SYM	I-NP	O","	5-PeCB	","	","	O	O5-PeCB	","	5-PeCB	NN	B-NP	B-protein","	a	","	","	O	Oa	congener	a	DT	B-NP	Ocongener	of	congener	NN	I-NP	Oof	coplanar	of	IN	B-PP	Ocoplanar	structure	coplanar	JJ	B-NP	Ostructure	","	structure	NN	I-NP	O","	as	","	","	O	Oas	well	as	RB	B-NP	Owell	as	well	RB	I-NP	Oas	2	as	IN	I-NP	O2	","	2	CD	I-NP	O","	3	","	","	I-NP	O3	","	3	CD	I-NP	O","	7	","	","	I-NP	O7	","	7	CD	I-NP	O","	8-TCDD	","	","	O	O8-TCDD	did	8-TCDD	NN	B-NP	Odid	not	do	VBD	B-VP	Onot	induce	not	RB	I-VP	Oinduce	apoptosis	induce	VB	I-VP	Oapoptosis	in	apoptosis	NN	B-NP	Oin	these	in	IN	B-PP	Othese	human	these	DT	B-NP	Ohuman	monocytic	human	JJ	I-NP	B-cell_typemonocytic	cells	monocytic	JJ	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	although	","	","	O	Oalthough	they	although	IN	B-SBAR	Othey	potently	they	PRP	B-NP	Opotently	induced	potently	RB	B-ADVP	Oinduced	CYP	induce	VBD	B-VP	OCYP	1A1	CYP	NN	B-NP	B-protein1A1	in	1A1	NN	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	hepatoma	human	JJ	B-NP	B-cell_linehepatoma	Hep	hepatoma	NN	I-NP	I-cell_lineHep	G2	Hep	NN	I-NP	I-cell_lineG2	cells	G2	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Taken	.	.	O	OTaken	together	Take	VBN	B-VP	Otogether	","	together	RB	B-ADVP	O","	the	","	","	O	Othe	data	the	DT	B-NP	Odata	indicate	datum	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	2	that	IN	B-SBAR	O2	","	2	CD	B-NP	O","	2	","	","	I-NP	O2	'	2	CD	I-NP	O'	","	'	SYM	B-NP	O","	4	","	","	O	O4	","	4	CD	B-NP	O","	6	","	","	I-NP	O6	","	6	CD	I-NP	O","	6'-PeCB	","	","	O	O6'-PeCB	induces	6'-PeCB	NN	B-NP	B-proteininduces	apoptosis	induce	VBZ	B-VP	Oapoptosis	in	apoptosis	NN	B-NP	Oin	human	in	IN	B-PP	Ohuman	monocytic	human	JJ	B-NP	B-cell_typemonocytic	cells	monocytic	JJ	I-NP	I-cell_typecells	through	cell	NNS	I-NP	I-cell_typethrough	a	through	IN	B-PP	Oa	mechanism	a	DT	B-NP	Omechanism	that	mechanism	NN	I-NP	Othat	is	that	WDT	B-NP	Ois	independent	be	VBZ	B-VP	Oindependent	of	independent	JJ	B-ADJP	Oof	the	of	IN	B-PP	Othe	arylhydrocarbon	the	DT	B-NP	Oarylhydrocarbon	receptor	arylhydrocarbon	NN	I-NP	B-proteinreceptor	.	receptor	NN	I-NP	I-protein.	This	.	.	O	OThis	suggests	This	DT	B-NP	Osuggests	a	suggest	VBZ	B-VP	Oa	possibly	a	DT	B-NP	Opossibly	separate	possibly	RB	I-NP	Oseparate	mechanism	separate	JJ	I-NP	Omechanism	by	mechanism	NN	I-NP	Oby	which	by	IN	B-PP	Owhich	PCBs	which	WDT	B-NP	OPCBs	cause	PCB	NNS	B-NP	B-proteincause	immunosuppression	cause	VBP	B-VP	Oimmunosuppression	.	immunosuppression	NN	B-NP	O.	Effects	.	.	O	OEffects	of	Effect	NNS	B-NP	Oof	deregulated	of	IN	B-PP	Oderegulated	Raf	deregulate	VBN	B-NP	ORaf	activation	Raf	NN	I-NP	B-proteinactivation	on	activation	NN	I-NP	Oon	integrin	on	IN	B-PP	Ointegrin	","	integrin	NN	B-NP	B-protein","	cytokine-receptor	","	","	O	Ocytokine-receptor	expression	cytokine-receptor	NN	B-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	the	and	CC	O	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	apoptosis	of	IN	B-PP	Oapoptosis	in	apoptosis	NN	B-NP	Oin	hematopoietic	in	IN	B-PP	Ohematopoietic	cells	hematopoietic	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	effects	The	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	deregulated	of	IN	B-PP	Oderegulated	Raf	deregulate	VBN	B-NP	ORaf	activation	Raf	NN	I-NP	B-proteinactivation	on	activation	NN	I-NP	Oon	the	on	IN	B-PP	Othe	growth	the	DT	B-NP	Ogrowth	and	growth	NN	I-NP	Oand	differentiation	and	CC	I-NP	Odifferentiation	of	differentiation	NN	I-NP	Oof	hematopoietic	of	IN	B-PP	Ohematopoietic	cells	hematopoietic	JJ	B-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	investigated	be	VBD	B-VP	Oinvestigated	.	investigate	VBN	I-VP	O.	The	.	.	O	OThe	cytokine-dependent	The	DT	B-NP	Ocytokine-dependent	murine	cytokine-dependent	JJ	I-NP	B-cell_linemurine	myeloid	murine	JJ	I-NP	I-cell_linemyeloid	FDC-P1	myeloid	JJ	I-NP	I-cell_lineFDC-P1	and	FDC-P1	NN	I-NP	I-cell_lineand	human	and	CC	O	I-cell_linehuman	erythroleukemic	human	JJ	B-NP	I-cell_lineerythroleukemic	TF-1	erythroleukemic	JJ	I-NP	I-cell_lineTF-1	cell	TF-1	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	were	line	NNS	I-NP	I-cell_linewere	transformed	be	VBD	B-VP	Otransformed	to	transform	VBN	I-VP	Oto	grow	to	TO	I-VP	Ogrow	in	grow	VB	I-VP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	deregulated	to	TO	B-PP	Oderegulated	Raf	deregulate	VBN	B-NP	ORaf	expression	Raf	NN	I-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	exogenous	of	IN	B-PP	Oexogenous	cytokines	exogenous	JJ	B-NP	B-proteincytokines	.	cytokine	NNS	I-NP	I-protein.	The	.	.	O	OThe	conditionally	The	DT	B-NP	Oconditionally	active	conditionally	RB	I-NP	Oactive	Raf	active	JJ	I-NP	ORaf	proteins	Raf	NN	I-NP	B-proteinproteins	were	protein	NNS	I-NP	I-proteinwere	regulated	be	VBD	B-VP	Oregulated	by	regulate	VBN	I-VP	Oby	beta-estradiol	by	IN	B-PP	Obeta-estradiol	as	beta-estradiol	NN	B-NP	Oas	cDNAs	as	IN	B-PP	OcDNAs	containing	cDNA	NNS	B-NP	B-DNAcontaining	the	contain	VBG	B-VP	Othe	Raf	the	DT	B-NP	ORaf	catalytic	Raf	NN	I-NP	B-proteincatalytic	","	catalytic	JJ	B-ADJP	O","	but	","	","	O	Obut	lacking	but	CC	O	Olacking	negative-regulatory	lack	VBG	B-VP	Onegative-regulatory	domains	negative-regulatory	JJ	B-NP	B-DNAdomains	","	domain	NNS	I-NP	I-DNA","	were	","	","	O	Owere	ligated	be	VBD	B-VP	Oligated	to	ligate	VBN	I-VP	Oto	the	to	TO	B-PP	Othe	hormone	the	DT	B-NP	Ohormone	binding	hormone	NN	I-NP	B-proteinbinding	domain	binding	NN	I-NP	I-proteindomain	of	domain	NN	I-NP	I-proteinof	the	of	IN	B-PP	Othe	estrogen	the	DT	B-NP	Oestrogen	receptor	estrogen	NN	I-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	deltaRaf	(	(	O	OdeltaRaf	:	deltaRaf	NN	B-NP	O:	ER	:	:	O	OER	)	ER	NN	B-NP	B-protein)	.	)	)	O	O.	Continuous	.	.	O	OContinuous	deltaRaf	Continuous	JJ	B-NP	OdeltaRaf	expression	deltaRaf	NN	I-NP	Oexpression	prevented	expression	NN	I-NP	Oprevented	apoptosis	prevent	VBD	B-VP	Oapoptosis	in	apoptosis	NN	B-NP	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	exogenous	of	IN	B-PP	Oexogenous	cytokines	exogenous	JJ	B-NP	B-proteincytokines	and	cytokine	NNS	I-NP	I-proteinand	altered	and	CC	O	Oaltered	the	alter	VBD	B-VP	Othe	morphology	the	DT	B-NP	Omorphology	of	morphology	NN	I-NP	Oof	the	of	IN	B-PP	Othe	FD/deltaRaf	the	DT	B-NP	OFD/deltaRaf	:	FD/deltaRaf	NNP	I-NP	O:	ER	:	:	O	OER	cells	ER	NN	B-NP	B-cell_typecells	as	cell	NNS	I-NP	I-cell_typeas	they	as	IN	B-SBAR	Othey	grew	they	PRP	B-NP	Ogrew	in	grow	VBD	B-VP	Oin	large	in	IN	B-PP	Olarge	aggregated	large	JJ	B-NP	Oaggregated	masses	aggregated	JJ	I-NP	Omasses	(	mass	NNS	I-NP	O(	>	(	(	O	O>	100	>	SYM	B-NP	B-cell_line100	cells	100	CD	I-NP	I-cell_linecells	)	cell	NNS	I-NP	I-cell_line)	whereas	)	)	O	Owhereas	the	whereas	IN	B-PP	Othe	parental	the	DT	B-NP	Oparental	cytokine-dependent	parental	JJ	I-NP	B-cell_linecytokine-dependent	FDC-P1	cytokine-dependent	JJ	I-NP	I-cell_lineFDC-P1	cells	FDC-P1	NN	I-NP	I-cell_linecells	grew	cell	NNS	I-NP	I-cell_linegrew	in	grow	VBD	B-VP	Oin	smaller	in	IN	B-PP	Osmaller	grape-like	small	JJR	B-NP	Ogrape-like	clusters	grape-like	JJ	I-NP	Oclusters	(	cluster	NNS	I-NP	O(	<	(	(	O	O<	10	<	SYM	B-NP	O10	cells	10	CD	I-NP	Ocells	)	cell	NNS	I-NP	O)	.	)	)	O	O.	FD/deltaRaf-1	.	.	O	OFD/deltaRaf-1	:	FD/deltaRaf-1	NN	B-NP	O:	ER	:	:	O	OER	cells	ER	NN	B-NP	B-cell_typecells	growing	cell	NNS	I-NP	I-cell_typegrowing	in	grow	VBG	B-VP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-PP	Oto	Raf	to	TO	I-PP	ORaf	activation	Raf	NN	B-NP	B-proteinactivation	displayed	activation	NN	I-NP	Odisplayed	decreased	display	VBD	B-VP	Odecreased	levels	decrease	VBN	B-NP	Olevels	of	level	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	Mac-2	the	DT	B-NP	OMac-2	and	Mac-2	NN	I-NP	B-proteinand	Mac-3	and	CC	I-NP	OMac-3	molecules	Mac-3	NN	I-NP	B-proteinmolecules	on	molecule	NNS	I-NP	I-proteinon	their	on	IN	B-PP	Otheir	cell	their	PRP$	B-NP	Ocell	surface	cell	NN	I-NP	Osurface	.	surface	NN	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	when	","	","	O	Owhen	these	when	WRB	B-ADVP	Othese	cells	these	DT	B-NP	Ocells	were	cell	NNS	I-NP	Owere	cultured	be	VBD	B-VP	Ocultured	in	culture	VBN	I-VP	Oin	IL-3	in	IN	B-PP	OIL-3	","	IL-3	NN	B-NP	B-protein","	higher	","	","	O	Ohigher	levels	high	JJR	B-NP	Olevels	of	level	NNS	I-NP	Oof	these	of	IN	B-PP	Othese	adhesion	these	DT	B-NP	Oadhesion	molecules	adhesion	NN	I-NP	B-proteinmolecules	were	molecule	NNS	I-NP	I-proteinwere	detected	be	VBD	B-VP	Odetected	.	detect	VBN	I-VP	O.	Expression	.	.	O	OExpression	of	Expression	NN	B-NP	Oof	activated	of	IN	B-PP	Oactivated	Raf	activate	VBN	B-NP	ORaf	oncoproteins	Raf	NN	I-NP	B-proteinoncoproteins	also	oncoprotein	NNS	I-NP	I-proteinalso	abrogated	also	RB	B-ADVP	Oabrogated	cytokine	abrogate	VBD	B-VP	Ocytokine	dependency	cytokine	NN	B-NP	B-proteindependency	and	dependency	NN	I-NP	Oand	prevented	and	CC	O	Oprevented	apoptosis	prevent	VBD	B-VP	Oapoptosis	of	apoptosis	NN	B-NP	Oof	TF-1	of	IN	B-PP	OTF-1	cells	TF-1	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	the	","	","	O	Othe	differentiation	the	DT	B-NP	Odifferentiation	status	differentiation	NN	I-NP	Ostatus	of	status	NN	I-NP	Oof	these	of	IN	B-PP	Othese	Raf-responsive	these	DT	B-NP	ORaf-responsive	cells	Raf-responsive	JJ	I-NP	B-cell_linecells	was	cell	NNS	I-NP	I-cell_linewas	more	be	VBD	B-VP	Omore	immature	more	RBR	B-ADJP	Oimmature	upon	immature	JJ	I-ADJP	Oupon	Raf	upon	IN	B-PP	ORaf	activation	Raf	NN	B-NP	B-proteinactivation	as	activation	NN	I-NP	Oas	culture	as	IN	B-PP	Oculture	with	culture	NN	B-NP	Owith	the	with	IN	B-PP	Othe	differentiation-inducing	the	DT	B-NP	Odifferentiation-inducing	agent	differentiation-inducing	JJ	I-NP	Oagent	phorbol	agent	NN	I-NP	Ophorbol	12	phorbol	NN	I-NP	O12	myristate	12	CD	I-NP	Omyristate	13-acetate	myristate	NN	I-NP	O13-acetate	(	13-acetate	NN	I-NP	O(	PMA	(	(	O	OPMA	)	PMA	NN	B-NP	O)	and	)	)	O	Oand	beta-estradiol	and	CC	O	Obeta-estradiol	resulted	beta-estradiol	NN	B-NP	Oresulted	in	result	VBD	B-VP	Oin	decreased	in	IN	B-PP	Odecreased	levels	decrease	VBN	B-NP	Olevels	of	level	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	CD11b	the	DT	B-NP	OCD11b	and	CD11b	NN	I-NP	B-proteinand	CD18	and	CC	I-NP	OCD18	integrin	CD18	NN	I-NP	B-proteinintegrin	molecules	integrin	NN	I-NP	I-proteinmolecules	on	molecule	NNS	I-NP	I-proteinon	the	on	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	surface	cell	NN	I-NP	Osurface	.	surface	NN	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	when	contrast	NN	B-NP	Owhen	the	when	WRB	B-ADVP	Othe	Raf-responsive	the	DT	B-NP	ORaf-responsive	cells	Raf-responsive	JJ	I-NP	B-cell_linecells	were	cell	NNS	I-NP	I-cell_linewere	induced	be	VBD	B-VP	Oinduced	to	induce	VBN	I-VP	Oto	differentiate	to	TO	B-VP	Odifferentiate	with	differentiate	VB	I-VP	Owith	PMA	with	IN	B-PP	OPMA	and	PMA	NN	B-NP	Oand	GM-CSF	and	CC	I-NP	OGM-CSF	","	GM-CSF	NN	I-NP	B-protein","	in	","	","	O	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	deltaRaf	of	IN	B-PP	OdeltaRaf	:	deltaRaf	NN	B-NP	B-protein:	ER	:	:	O	OER	activation	ER	NN	B-NP	B-proteinactivation	","	activation	NN	I-NP	O","	increased	","	","	O	Oincreased	levels	increase	VBN	B-NP	Olevels	of	level	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	CD11b	the	DT	B-NP	OCD11b	and	CD11b	NN	I-NP	B-proteinand	CD18	and	CC	I-NP	OCD18	molecules	CD18	NN	I-NP	B-proteinmolecules	were	molecule	NNS	I-NP	Owere	detected	be	VBD	B-VP	Odetected	.	detect	VBN	I-VP	O.	Retinoic	.	.	O	ORetinoic	acid	Retinoic	JJ	B-NP	Oacid	(	acid	NN	I-NP	O(	RA	(	(	O	ORA	)	RA	NN	B-NP	O)	inhibited	)	)	O	Oinhibited	3H-thymidine	inhibit	VBD	B-VP	O3H-thymidine	incorporation	3H-thymidine	NN	B-NP	Oincorporation	in	incorporation	NN	I-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	I-PP	Oto	GM-CSF	to	TO	I-PP	OGM-CSF	.	GM-CSF	NN	B-NP	B-protein.	Interestingly	.	.	O	OInterestingly	","	Interestingly	RB	B-ADVP	O","	Raf	","	","	O	ORaf	activation	Raf	NN	B-NP	B-proteinactivation	counterbalanced	activation	NN	I-NP	Ocounterbalanced	the	counterbalance	VBD	B-VP	Othe	inhibition	the	DT	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	DNA	of	IN	B-PP	ODNA	synthesis	DNA	NN	B-NP	Osynthesis	caused	synthesis	NN	I-NP	Ocaused	by	cause	VBN	B-VP	Oby	RA	by	IN	B-PP	ORA	but	RA	NN	B-NP	Obut	not	but	CC	B-NP	Onot	PMA	not	RB	I-NP	OPMA	.	PMA	NN	B-NP	O.	Thus	.	.	O	OThus	deregulated	Thus	RB	B-NP	Oderegulated	Raf	deregulate	VBN	I-NP	ORaf	expression	Raf	NN	I-NP	B-proteinexpression	can	expression	NN	I-NP	Ocan	alter	can	MD	B-VP	Oalter	cytokine	alter	VB	I-VP	Ocytokine	dependency	cytokine	NN	B-NP	B-proteindependency	","	dependency	NN	I-NP	O","	integrin	","	","	O	Ointegrin	expression	integrin	NN	B-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	the	and	CC	O	Othe	stage	the	DT	B-NP	Ostage	of	stage	NN	I-NP	Oof	differentiation	of	IN	B-PP	Odifferentiation	.	differentiation	NN	B-NP	O.	These	.	.	O	OThese	Raf-responsive	These	DT	B-NP	ORaf-responsive	cell	Raf-responsive	JJ	I-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	will	line	NNS	I-NP	I-cell_linewill	be	will	MD	B-VP	Obe	useful	be	VB	I-VP	Ouseful	in	useful	JJ	B-ADJP	Oin	elucidating	in	IN	B-PP	Oelucidating	the	elucidate	VBG	B-VP	Othe	roles	the	DT	B-NP	Oroles	of	role	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	MAP	the	DT	B-NP	OMAP	kinase	MAP	NN	I-NP	B-proteinkinase	cascade	kinase	NN	I-NP	I-proteincascade	on	cascade	NN	I-NP	Oon	hematopoietic	on	IN	B-PP	Ohematopoietic	cell	hematopoietic	JJ	B-NP	B-cell_typecell	differentiation	cell	NN	I-NP	I-cell_typedifferentiation	and	differentiation	NN	I-NP	Oand	malignant	and	CC	O	Omalignant	transformation	malignant	JJ	B-NP	Otransformation	Cyclic	transformation	NN	I-NP	OCyclic	AMP	Cyclic	JJ	B-NP	OAMP	activates	AMP	NN	I-NP	Oactivates	p38	activate	VBZ	B-VP	Op38	mitogen-activated	p38	NN	B-NP	B-proteinmitogen-activated	protein	mitogen-activated	JJ	I-NP	I-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	in	kinase	NN	I-NP	I-proteinin	Th2	in	IN	B-PP	OTh2	cells	Th2	NN	B-NP	B-cell_typecells	:	cell	NNS	I-NP	I-cell_type:	phosphorylation	:	:	O	Ophosphorylation	of	phosphorylation	NN	B-NP	Oof	GATA-3	of	IN	B-PP	OGATA-3	and	GATA-3	NN	B-NP	B-proteinand	stimulation	and	CC	I-NP	Ostimulation	of	stimulation	NN	I-NP	Oof	Th2	of	IN	B-PP	OTh2	cytokine	Th2	NN	B-NP	B-DNAcytokine	gene	cytokine	NN	I-NP	I-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	.	expression	NN	I-NP	O.	cAMP	.	.	O	OcAMP	is	cAMP	NN	B-NP	Ois	an	be	VBZ	B-VP	Oan	important	an	DT	B-NP	Oimportant	second	important	JJ	I-NP	Osecond	messenger	second	JJ	I-NP	Omessenger	with	messenger	NN	I-NP	Owith	immunomodulatory	with	IN	B-PP	Oimmunomodulatory	properties	immunomodulatory	JJ	B-NP	Oproperties	.	property	NNS	I-NP	O.	Elevation	.	.	O	OElevation	of	Elevation	NN	B-NP	Oof	intracellular	of	IN	B-PP	Ointracellular	cAMP	intracellular	JJ	B-NP	OcAMP	in	cAMP	NN	I-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	induced	","	","	O	Oinduced	by	induce	VBN	B-VP	Oby	agents	by	IN	B-PP	Oagents	such	agent	NNS	B-NP	Osuch	as	such	JJ	B-PP	Oas	IL-1alpha	as	IN	I-PP	OIL-1alpha	or	IL-1alpha	NN	B-NP	B-proteinor	PGs	or	CC	I-NP	OPGs	","	PG	NNS	I-NP	B-protein","	inhibits	","	","	O	Oinhibits	T	inhibit	VBZ	B-VP	OT	cell	T	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	.	activation	NN	I-NP	O.	In	.	.	O	OIn	effector	In	IN	B-PP	Oeffector	T	effector	NN	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	an	","	","	O	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	the	in	IN	B-PP	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	intracellular	of	IN	B-PP	Ointracellular	cAMP	intracellular	JJ	B-NP	OcAMP	inhibits	cAMP	NN	I-NP	Oinhibits	cytokine	inhibit	VBZ	B-VP	Ocytokine	production	cytokine	NN	B-NP	B-proteinproduction	in	production	NN	I-NP	Oin	Th1	in	IN	B-PP	OTh1	cells	Th1	NN	B-NP	B-cell_typecells	but	cell	NNS	I-NP	I-cell_typebut	stimulates	but	CC	O	Ostimulates	cytokine	stimulate	VBZ	B-VP	Ocytokine	production	cytokine	NN	B-NP	B-proteinproduction	in	production	NN	I-NP	Oin	Th2	in	IN	B-PP	OTh2	cells	Th2	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	report	we	PRP	B-NP	Oreport	that	report	VBP	B-VP	Othat	cAMP-induced	that	IN	B-SBAR	OcAMP-induced	effects	cAMP-induced	JJ	B-NP	Oeffects	in	effect	NNS	I-NP	Oin	Th2	in	IN	B-PP	OTh2	cells	Th2	NN	B-NP	B-cell_typecells	occur	cell	NNS	I-NP	I-cell_typeoccur	independently	occur	VBP	B-VP	Oindependently	of	independently	RB	B-ADVP	Oof	the	of	IN	B-PP	Othe	protein	the	DT	B-NP	Oprotein	kinase	protein	NN	I-NP	B-proteinkinase	A	kinase	NN	I-NP	I-proteinA	pathway	A	NN	I-NP	I-proteinpathway	","	pathway	NN	I-NP	O","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	the	be	VBZ	B-VP	Othe	major	the	DT	B-NP	Omajor	mediator	major	JJ	I-NP	Omediator	of	mediator	NN	I-NP	Oof	cAMP-induced	of	IN	B-PP	OcAMP-induced	signaling	cAMP-induced	JJ	B-NP	Osignaling	events	signaling	NN	I-NP	Oevents	in	event	NNS	I-NP	Oin	most	in	IN	B-PP	Omost	cell	most	JJS	B-NP	Ocell	types	cell	NN	I-NP	Otypes	.	type	NNS	I-NP	O.	Instead	.	.	O	OInstead	","	Instead	RB	B-ADVP	O","	cAMP	","	","	O	OcAMP	stimulates	cAMP	NN	B-NP	Ostimulates	activation	stimulate	VBZ	B-VP	Oactivation	of	activation	NN	B-NP	Oof	p38	of	IN	B-PP	Op38	mitogen-activated	p38	NN	B-NP	B-proteinmitogen-activated	protein	mitogen-activated	JJ	I-NP	I-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	in	kinase	NN	I-NP	I-proteinin	Th2	in	IN	B-PP	OTh2	cells	Th2	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	This	.	.	O	OThis	appears	This	DT	B-NP	Oappears	to	appear	VBZ	B-VP	Oto	be	to	TO	I-VP	Obe	a	be	VB	I-VP	Oa	Th2	a	DT	B-NP	OTh2	#NAME?	Th2	NN	I-NP	O#NAME?	event	#NAME?	JJ	I-NP	Oevent	because	event	NN	I-NP	Obecause	cAMP	because	IN	B-SBAR	OcAMP	barely	cAMP	NN	B-NP	Obarely	increased	barely	RB	B-ADVP	Oincreased	p38	increase	VBD	B-VP	Op38	phosphorylation	p38	NN	B-NP	B-proteinphosphorylation	in	phosphorylation	NN	I-NP	Oin	Th1	in	IN	B-PP	OTh1	cells	Th1	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	in	that	IN	B-SBAR	Oin	Th2	in	IN	B-PP	OTh2	cells	Th2	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	cAMP	","	","	O	OcAMP	promotes	cAMP	NN	B-NP	Opromotes	the	promote	VBZ	B-VP	Othe	production	the	DT	B-NP	Oproduction	of	production	NN	I-NP	Oof	both	of	IN	B-PP	Oboth	IL-5	both	CC	O	OIL-5	and	IL-5	NN	B-NP	B-proteinand	IL-13	and	CC	I-NP	OIL-13	","	IL-13	NN	I-NP	B-protein","	which	","	","	O	Owhich	play	which	WDT	B-NP	Oplay	distinct	play	VBP	B-VP	Odistinct	but	distinct	JJ	B-NP	Obut	critical	but	CC	I-NP	Ocritical	roles	critical	JJ	I-NP	Oroles	in	role	NNS	I-NP	Oin	asthma	in	IN	B-PP	Oasthma	pathogenesis	asthma	NN	B-NP	Opathogenesis	.	pathogenesis	NN	I-NP	O.	Our	.	.	O	OOur	data	Our	PRP$	B-NP	Odata	also	datum	NNS	I-NP	Oalso	show	also	RB	B-ADVP	Oshow	that	show	VBP	B-VP	Othat	cAMP	that	IN	B-SBAR	OcAMP	causes	cAMP	NN	B-NP	Ocauses	increased	cause	VBZ	B-VP	Oincreased	phosphorylation	increase	VBN	B-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	GATA-3	factor	NN	I-NP	I-proteinGATA-3	","	GATA-3	NN	I-NP	B-protein","	which	","	","	O	Owhich	we	which	WDT	B-NP	Owe	have	we	PRP	B-NP	Ohave	shown	have	VBP	B-VP	Oshown	is	show	VBN	I-VP	Ois	a	be	VBZ	B-VP	Oa	critical	a	DT	B-NP	Ocritical	regulator	critical	JJ	I-NP	Oregulator	of	regulator	NN	I-NP	Oof	Th2	of	IN	B-PP	OTh2	cytokine	Th2	NN	B-NP	B-DNAcytokine	gene	cytokine	NN	I-NP	I-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	and	expression	NN	I-NP	Oand	","	and	CC	O	O","	in	","	","	O	Oin	turn	in	IN	B-PP	Oturn	","	turn	NN	B-NP	O","	of	","	","	O	Oof	airway	of	IN	B-PP	Oairway	inflammation	airway	NN	B-NP	Oinflammation	in	inflammation	NN	I-NP	Oin	mice	in	IN	B-PP	Omice	.	mouse	NNS	B-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	Th2	","	","	O	OTh2	#NAME?	Th2	NN	B-NP	O#NAME?	GATA-3	#NAME?	JJ	I-NP	OGATA-3	expression	GATA-3	NN	I-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	p38	and	CC	O	Op38	mitogen-activated	p38	NN	B-NP	B-proteinmitogen-activated	protein	mitogen-activated	JJ	I-NP	I-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	activation	kinase	NN	I-NP	I-proteinactivation	together	activation	NN	I-NP	Otogether	provide	together	RB	B-ADVP	Oprovide	a	provide	VBP	B-VP	Oa	molecular	a	DT	B-NP	Omolecular	basis	molecular	JJ	I-NP	Obasis	for	basis	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	differential	the	DT	B-NP	Odifferential	effects	differential	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	cAMP	of	IN	B-PP	OcAMP	in	cAMP	NN	B-NP	Oin	the	in	IN	B-PP	Othe	two	the	DT	B-NP	Otwo	T	two	CD	I-NP	OT	helper	T	NN	I-NP	B-cell_typehelper	cell	helper	NN	I-NP	I-cell_typecell	subsets	cell	NN	I-NP	I-cell_typesubsets	.	subset	NNS	I-NP	I-cell_type.	Characterization	.	.	O	OCharacterization	of	Characterization	NN	B-NP	Oof	IL-4	of	IN	B-PP	OIL-4	and	IL-4	NN	B-NP	B-proteinand	IL-13	and	CC	I-NP	OIL-13	signals	IL-13	NN	I-NP	B-proteinsignals	dependent	signal	NNS	I-NP	Odependent	on	dependent	JJ	B-ADJP	Oon	the	on	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	IL-13	human	JJ	I-NP	OIL-13	receptor	IL-13	NN	I-NP	Oreceptor	alpha	receptor	NN	I-NP	Oalpha	chain	alpha	NN	I-NP	Ochain	1	chain	NN	I-NP	O1	:	1	CD	I-NP	O:	redundancy	:	:	O	Oredundancy	of	redundancy	NN	B-NP	Oof	requirement	of	IN	B-PP	Orequirement	of	requirement	NN	B-NP	Oof	tyrosine	of	IN	B-PP	Otyrosine	residue	tyrosine	NN	B-NP	Oresidue	for	residue	NN	I-NP	Ofor	STAT3	for	IN	B-PP	OSTAT3	activation	STAT3	NN	B-NP	B-proteinactivation	.	activation	NN	I-NP	O.	IL-4	.	.	O	OIL-4	and	IL-4	NN	B-NP	B-proteinand	IL-13	and	CC	I-NP	OIL-13	are	IL-13	NN	I-NP	B-proteinare	pleiotropic	be	VBP	B-VP	Opleiotropic	cytokines	pleiotropic	JJ	B-NP	B-proteincytokines	whose	cytokine	NNS	I-NP	I-proteinwhose	biological	whose	WP$	B-NP	Obiological	activities	biological	JJ	I-NP	Oactivities	overlap	activity	NNS	I-NP	Ooverlap	with	overlap	VBP	B-VP	Owith	each	with	IN	B-PP	Oeach	other	each	DT	B-NP	Oother	.	other	JJ	I-NP	O.	IL-13	.	.	O	OIL-13	receptor	IL-13	NN	B-NP	B-proteinreceptor	alpha	receptor	NN	I-NP	I-proteinalpha	chain	alpha	NN	I-NP	I-proteinchain	1	chain	NN	I-NP	I-protein1	(	1	CD	I-NP	I-protein(	IL-13R	(	(	O	OIL-13R	alpha	IL-13R	NN	B-NP	B-proteinalpha	1	alpha	SYM	B-NP	I-protein1	)	1	CD	I-NP	I-protein)	is	)	)	O	Ois	necessary	be	VBZ	B-VP	Onecessary	for	necessary	JJ	B-ADJP	Ofor	binding	for	IN	B-PP	Obinding	to	bind	VBG	B-VP	Oto	IL-13	to	TO	B-PP	OIL-13	","	IL-13	NN	B-NP	B-protein","	and	","	","	O	Oand	the	and	CC	O	Othe	heterodimer	the	DT	B-NP	Oheterodimer	composed	heterodimer	NN	I-NP	B-proteincomposed	of	compose	VBN	B-VP	Oof	IL-13R	of	IN	B-PP	OIL-13R	alpha	IL-13R	NN	B-NP	B-proteinalpha	1	alpha	NN	I-NP	I-protein1	and	1	CD	I-NP	I-proteinand	IL-4R	and	CC	I-NP	OIL-4R	alpha	IL-4R	NN	I-NP	B-proteinalpha	chain	alpha	NN	I-NP	I-proteinchain	transduces	chain	NN	I-NP	I-proteintransduces	IL-13	transduce	VBZ	B-VP	OIL-13	and	IL-13	NN	B-NP	B-proteinand	IL-4	and	CC	I-NP	OIL-4	signals	IL-4	NN	I-NP	B-proteinsignals	;	signal	NNS	I-NP	O;	however	;	:	O	Ohowever	","	however	RB	B-ADVP	O","	the	","	","	O	Othe	functional	the	DT	B-NP	Ofunctional	mapping	functional	JJ	I-NP	Omapping	of	mapping	NN	I-NP	Oof	the	of	IN	B-PP	Othe	intracellular	the	DT	B-NP	Ointracellular	domain	intracellular	JJ	I-NP	B-proteindomain	of	domain	NN	I-NP	I-proteinof	IL-13R	of	IN	B-PP	OIL-13R	alpha	IL-13R	NN	B-NP	B-proteinalpha	1	alpha	NN	I-NP	I-protein1	is	1	CD	I-NP	I-proteinis	not	be	VBZ	B-VP	Onot	fully	not	RB	O	Ofully	understood	fully	RB	B-ADJP	Ounderstood	.	understand	VBN	I-ADJP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	constructed	we	PRP	B-NP	Oconstructed	wild	construct	VBD	B-VP	Owild	and	wild	JJ	B-NP	Oand	mutated	and	CC	I-NP	Omutated	types	mutate	VBN	I-NP	Otypes	of	type	NNS	I-NP	Oof	human	of	IN	B-PP	Ohuman	IL-13R	human	JJ	B-NP	B-proteinIL-13R	alpha	IL-13R	NN	I-NP	I-proteinalpha	1	alpha	NN	I-NP	I-protein1	","	1	CD	I-NP	I-protein","	and	","	","	O	Oand	analyzed	and	CC	O	Oanalyzed	IL-4	analyze	VBD	B-VP	OIL-4	and	IL-4	NN	B-NP	B-proteinand	IL-13	and	CC	I-NP	OIL-13	signals	IL-13	NN	I-NP	B-proteinsignals	using	signal	NNS	I-NP	Ousing	an	use	VBG	B-VP	Oan	IL-13R	an	DT	B-NP	OIL-13R	alpha	IL-13R	NN	I-NP	B-cell_linealpha	1	alpha	NN	I-NP	I-cell_line1	#NAME?	1	CD	I-NP	I-cell_line#NAME?	human	#NAME?	JJ	I-NP	I-cell_linehuman	B	human	JJ	I-NP	I-cell_lineB	cell	B	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	.	line	NN	I-NP	I-cell_line.	Expression	.	.	O	OExpression	of	Expression	NN	B-NP	Oof	IL-13R	of	IN	B-PP	OIL-13R	alpha	IL-13R	NN	B-NP	B-proteinalpha	1	alpha	NN	I-NP	I-protein1	evoked	1	CD	I-NP	I-proteinevoked	STAT3	evoke	VBD	B-VP	OSTAT3	activation	STAT3	NN	B-NP	B-proteinactivation	by	activation	NN	I-NP	Oby	IL-4	by	IN	B-PP	OIL-4	and	IL-4	NN	B-NP	B-proteinand	IL-13	and	CC	I-NP	OIL-13	","	IL-13	NN	I-NP	B-protein","	and	","	","	O	Oand	in	and	CC	O	Oin	stimulated	in	IN	B-PP	Ostimulated	human	stimulate	VBN	B-NP	B-cell_linehuman	B	human	JJ	I-NP	I-cell_lineB	cells	B	NN	I-NP	I-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	on	","	","	O	Oon	which	on	IN	B-PP	Owhich	IL-13R	which	WDT	B-NP	OIL-13R	alpha	IL-13R	NN	B-NP	B-proteinalpha	1	alpha	NN	I-NP	I-protein1	was	1	CD	I-NP	I-proteinwas	highly	be	VBD	B-VP	Ohighly	expressed	highly	RB	I-VP	Oexpressed	","	express	VBN	I-VP	O","	IL-4	","	","	O	OIL-4	and	IL-4	NN	B-NP	B-proteinand	IL-13	and	CC	I-NP	OIL-13	induced	IL-13	NN	I-NP	B-proteininduced	STAT3	induce	VBD	B-VP	OSTAT3	activation	STAT3	NN	B-NP	B-proteinactivation	.	activation	NN	I-NP	O.	Replacement	.	.	O	OReplacement	of	Replacement	NN	B-NP	Oof	the	of	IN	B-PP	Othe	two	the	DT	B-NP	Otwo	tyrosine	two	CD	I-NP	Otyrosine	residues	tyrosine	NN	I-NP	Oresidues	completely	residue	NNS	I-NP	Ocompletely	abolished	completely	RB	B-ADVP	Oabolished	STAT3	abolish	VBD	B-VP	OSTAT3	activation	STAT3	NN	B-NP	B-proteinactivation	","	activation	NN	I-NP	O","	although	","	","	O	Oalthough	replacing	although	IN	B-SBAR	Oreplacing	either	replace	VBG	B-VP	Oeither	tyrosine	either	CC	B-NP	Otyrosine	residue	tyrosine	NN	I-NP	Oresidue	alone	residue	NN	I-NP	Oalone	retained	alone	RB	B-ADVP	Oretained	it	retain	VBD	B-VP	Oit	.	it	PRP	B-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	Box1	the	DT	B-NP	OBox1	region	Box1	NN	I-NP	B-DNAregion	and	region	NN	I-NP	I-DNAand	the	and	CC	O	Othe	C-terminal	the	DT	B-NP	OC-terminal	tail	C-terminal	JJ	I-NP	B-proteintail	of	tail	NN	I-NP	I-proteinof	IL-13R	of	IN	B-PP	OIL-13R	alpha	IL-13R	NN	B-NP	B-proteinalpha	1	alpha	NN	I-NP	I-protein1	were	1	CD	I-NP	I-proteinwere	critical	be	VBD	B-VP	Ocritical	for	critical	JJ	B-ADJP	Ofor	binding	for	IN	B-PP	Obinding	to	bind	VBG	B-VP	Oto	Tyk2	to	TO	B-PP	OTyk2	","	Tyk2	NN	B-NP	B-protein","	and	","	","	O	Oand	activation	and	CC	O	Oactivation	of	activation	NN	B-NP	Oof	Jak1	of	IN	B-PP	OJak1	","	Jak1	NN	B-NP	B-protein","	Tyk2	","	","	O	OTyk2	","	Tyk2	NN	B-NP	B-protein","	the	","	","	O	Othe	insulin	the	DT	B-NP	Oinsulin	receptor	insulin	NN	I-NP	B-proteinreceptor	substrate-1	receptor	NN	I-NP	I-proteinsubstrate-1	and	substrate-1	NN	I-NP	I-proteinand	STAT6	and	CC	I-NP	OSTAT6	respectively	STAT6	NN	I-NP	B-proteinrespectively	.	respectively	RB	B-ADVP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	STAT3	that	IN	B-SBAR	OSTAT3	activation	STAT3	NN	B-NP	B-proteinactivation	is	activation	NN	I-NP	Ois	involved	be	VBZ	B-VP	Oinvolved	with	involve	VBN	I-VP	Owith	IL-4	with	IN	B-PP	OIL-4	and	IL-4	NN	B-NP	B-proteinand	IL-13	and	CC	I-NP	OIL-13	signals	IL-13	NN	I-NP	B-proteinsignals	in	signal	NNS	I-NP	Oin	human	in	IN	B-PP	Ohuman	B	human	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	along	cell	NNS	I-NP	I-cell_typealong	with	along	IN	B-PP	Owith	the	with	IN	I-PP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	STAT6	of	IN	B-PP	OSTAT6	","	STAT6	NN	B-NP	B-protein","	and	","	","	O	Oand	that	and	CC	O	Othat	there	that	IN	B-SBAR	Othere	is	there	EX	B-NP	Ois	a	be	VBZ	B-VP	Oa	unique	a	DT	B-NP	Ounique	sequence	unique	JJ	I-NP	B-DNAsequence	in	sequence	NN	I-NP	I-DNAin	IL-13R	in	IN	B-PP	OIL-13R	alpha	IL-13R	NN	B-NP	B-proteinalpha	1	alpha	SYM	B-NP	I-protein1	to	1	CD	I-NP	I-proteinto	activate	to	TO	B-VP	Oactivate	STAT3	activate	VB	I-VP	OSTAT3	.	STAT3	NN	B-NP	B-protein.	Functional	.	.	O	OFunctional	uncoupling	Functional	JJ	B-NP	Ouncoupling	of	uncoupling	NN	I-NP	Oof	the	of	IN	B-PP	Othe	Janus	the	DT	B-NP	OJanus	kinase	Janus	NN	I-NP	B-proteinkinase	3-Stat5	kinase	NN	I-NP	I-protein3-Stat5	pathway	3-Stat5	NN	I-NP	Opathway	in	pathway	NN	I-NP	Oin	malignant	in	IN	B-PP	Omalignant	growth	malignant	JJ	B-NP	Ogrowth	of	growth	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	T	human	JJ	B-NP	B-cell_typeT	cell	T	NN	I-NP	I-cell_typecell	leukemia	cell	NN	I-NP	I-cell_typeleukemia	virus	leukemia	NN	I-NP	I-cell_typevirus	type	virus	NN	I-NP	I-cell_typetype	1-transformed	type	NN	I-NP	I-cell_type1-transformed	human	1-transformed	JJ	I-NP	I-cell_typehuman	T	human	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Human	.	.	O	OHuman	T	Human	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	leukemia	cell	NN	I-NP	Oleukemia	virus	leukemia	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	(	1	CD	I-NP	O(	HTLV-1	(	(	O	OHTLV-1	)	HTLV-1	NN	B-NP	O)	transforms	)	)	O	Otransforms	cytokine	transform	VBZ	B-VP	Ocytokine	#NAME?	cytokine	NN	B-NP	B-protein#NAME?	T	#NAME?	JJ	I-NP	OT	lymphocytes	T	NN	I-NP	Olymphocytes	and	lymphocyte	NNS	I-NP	Oand	causes	and	CC	O	Ocauses	adult	cause	VBZ	B-VP	Oadult	T	adult	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	leukemia	cell	NN	I-NP	Oleukemia	.	leukemia	NN	I-NP	O.	Janus	.	.	O	OJanus	tyrosine	Janus	NN	B-NP	B-proteintyrosine	kinase	tyrosine	NN	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	Jak	(	(	O	OJak	)	Jak	NN	B-NP	B-protein)	3	)	)	O	O3	and	3	CD	B-NP	Oand	transcription	and	CC	O	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	Stat5a	factor	NNS	I-NP	I-proteinStat5a	and	Stat5a	NN	B-NP	B-proteinand	Stat5b	and	CC	I-NP	OStat5b	are	Stat5b	NN	I-NP	B-proteinare	essential	be	VBP	B-VP	Oessential	for	essential	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	proliferation	the	DT	B-NP	Oproliferation	of	proliferation	NN	I-NP	Oof	normal	of	IN	B-PP	Onormal	T	normal	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	are	and	CC	O	Oare	constitutively	be	VBP	B-VP	Oconstitutively	hyperactivated	constitutively	RB	I-VP	Ohyperactivated	in	hyperactivate	VBN	I-VP	Oin	both	in	IN	B-PP	Oboth	HTLV-1-transformed	both	CC	B-NP	OHTLV-1-transformed	human	HTLV-1-transformed	JJ	I-NP	B-cell_linehuman	T	human	JJ	I-NP	I-cell_lineT	cell	T	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	and	line	NNS	I-NP	I-cell_lineand	lymphocytes	and	CC	O	Olymphocytes	isolated	lymphocyte	NNS	B-NP	B-cell_typeisolated	from	isolate	VBN	B-VP	Ofrom	HTLV-1-infected	from	IN	B-PP	OHTLV-1-infected	patients	HTLV-1-infected	JJ	B-NP	Opatients	;	patient	NNS	I-NP	O;	therefore	;	:	O	Otherefore	","	therefore	RB	B-ADVP	O","	a	","	","	O	Oa	critical	a	DT	B-NP	Ocritical	role	critical	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	Jak3-Stat5	the	DT	B-NP	OJak3-Stat5	pathway	Jak3-Stat5	NN	I-NP	B-proteinpathway	in	pathway	NN	I-NP	Oin	the	in	IN	B-PP	Othe	progression	the	DT	B-NP	Oprogression	of	progression	NN	I-NP	Oof	this	of	IN	B-PP	Othis	disease	this	DT	B-NP	Odisease	has	disease	NN	I-NP	Ohas	been	have	VBZ	B-VP	Obeen	postulated	be	VBN	I-VP	Opostulated	.	postulate	VBN	I-VP	O.	We	.	.	O	OWe	recently	We	PRP	B-NP	Orecently	reported	recently	RB	B-ADVP	Oreported	that	report	VBD	B-VP	Othat	tyrphostin	that	IN	B-SBAR	Otyrphostin	AG-490	tyrphostin	NN	B-NP	OAG-490	selectively	AG-490	NN	I-NP	Oselectively	blocked	selectively	RB	B-ADVP	Oblocked	IL-2	block	VBD	B-VP	OIL-2	activation	IL-2	NN	B-NP	B-proteinactivation	of	activation	NN	I-NP	Oof	Jak3/Stat5	of	IN	B-PP	OJak3/Stat5	and	Jak3/Stat5	NN	B-NP	Oand	growth	and	CC	I-NP	Ogrowth	of	growth	NN	I-NP	Oof	murine	of	IN	B-PP	Omurine	T	murine	JJ	B-NP	B-cell_lineT	cell	T	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	.	line	NNS	I-NP	I-cell_line.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	demonstrate	we	PRP	B-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	disruption	that	IN	B-SBAR	Odisruption	of	disruption	NN	B-NP	Oof	Jak3/Stat5a/b	of	IN	B-PP	OJak3/Stat5a/b	signaling	Jak3/Stat5a/b	NN	B-NP	Osignaling	with	signaling	NN	I-NP	Owith	AG-490	with	IN	B-PP	OAG-490	(	AG-490	NN	B-NP	O(	50	(	(	O	O50	&	50	CD	B-NP	O&	mgr	&	CC	I-NP	Omgr	;	mgr	NN	I-NP	O;	M	;	:	O	OM	)	M	NN	B-NP	O)	blocked	)	)	O	Oblocked	the	block	VBD	B-VP	Othe	proliferation	the	DT	B-NP	Oproliferation	of	proliferation	NN	I-NP	Oof	primary	of	IN	B-PP	Oprimary	human	primary	JJ	B-NP	B-cell_typehuman	T	human	JJ	I-NP	I-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	but	","	","	O	Obut	paradoxically	but	CC	O	Oparadoxically	failed	paradoxically	RB	B-VP	Ofailed	to	fail	VBD	I-VP	Oto	inhibit	to	TO	I-VP	Oinhibit	the	inhibit	VB	I-VP	Othe	proliferation	the	DT	B-NP	Oproliferation	of	proliferation	NN	I-NP	Oof	HTLV-1-transformed	of	IN	B-PP	OHTLV-1-transformed	human	HTLV-1-transformed	JJ	B-NP	B-cell_linehuman	T	human	JJ	I-NP	I-cell_lineT	cell	T	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	","	line	NNS	I-NP	I-cell_line","	HuT-102	","	","	O	OHuT-102	and	HuT-102	NN	B-NP	B-cell_lineand	MT-2	and	CC	I-NP	OMT-2	.	MT-2	NN	I-NP	B-cell_line.	Structural	.	.	O	OStructural	homologues	Structural	JJ	B-NP	Ohomologues	of	homologue	NNS	I-NP	Oof	AG-490	of	IN	B-PP	OAG-490	also	AG-490	NN	B-NP	Oalso	inhibited	also	RB	B-ADVP	Oinhibited	the	inhibit	VBD	B-VP	Othe	proliferation	the	DT	B-NP	Oproliferation	of	proliferation	NN	I-NP	Oof	primary	of	IN	B-PP	Oprimary	human	primary	JJ	B-NP	B-cell_typehuman	T	human	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	but	","	","	O	Obut	not	but	CC	O	Onot	HTLV-1-infected	not	RB	O	OHTLV-1-infected	cells	HTLV-1-infected	JJ	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Disruption	.	.	O	ODisruption	of	Disruption	NN	B-NP	Oof	constitutive	of	IN	B-PP	Oconstitutive	Jak3/Stat5	constitutive	JJ	B-NP	OJak3/Stat5	activation	Jak3/Stat5	NN	I-NP	Oactivation	by	activation	NN	I-NP	Oby	AG-490	by	IN	B-PP	OAG-490	was	AG-490	NN	B-NP	Owas	demonstrated	be	VBD	B-VP	Odemonstrated	by	demonstrate	VBN	I-VP	Oby	inhibition	by	IN	B-PP	Oinhibition	of	inhibition	NN	B-NP	Oof	1	of	IN	B-PP	O1	)	1	CD	B-NP	O)	tyrosine	)	)	O	Otyrosine	phosphorylation	tyrosine	NN	B-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	Jak3	of	IN	B-PP	OJak3	","	Jak3	NN	B-NP	B-protein","	Stat5a	","	","	O	OStat5a	(	Stat5a	NN	B-NP	B-protein(	Tyr	(	(	O	OTyr	(	Tyr	NN	B-NP	B-protein(	694	(	(	O	O694	)	694	CD	B-NP	O)	)	)	)	O	O)	","	)	)	O	O","	and	","	","	O	Oand	Stat5b	and	CC	O	OStat5b	(	Stat5b	NN	B-NP	B-protein(	Tyr	(	(	O	OTyr	(	Tyr	NN	B-NP	B-protein(	699	(	(	O	O699	)	699	CD	B-NP	O)	)	)	)	O	O)	;	)	)	O	O;	2	;	:	O	O2	)	2	LS	B-LST	O)	serine	)	)	O	Oserine	phosphorylation	serine	NN	B-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	Stat5a	of	IN	B-PP	OStat5a	(	Stat5a	NN	B-NP	B-protein(	Ser	(	(	O	OSer	(	Ser	NN	B-NP	O(	726	(	(	O	O726	)	726	CD	B-NP	O)	)	)	)	O	O)	as	)	)	O	Oas	determined	as	IN	B-SBAR	Odetermined	by	determine	VBN	B-VP	Oby	a	by	IN	B-PP	Oa	novel	a	DT	B-NP	Onovel	phosphospecific	novel	JJ	I-NP	Ophosphospecific	Ab	phosphospecific	JJ	I-NP	B-proteinAb	;	Ab	NN	I-NP	I-protein;	and	;	:	O	Oand	3	and	CC	O	O3	)	3	LS	B-LST	O)	Stat5a/b	)	)	O	OStat5a/b	DNA	Stat5a/b	NN	B-NP	ODNA	binding	DNA	NN	I-NP	Obinding	to	bind	VBG	B-VP	Oto	the	to	TO	B-PP	Othe	Stat5-responsive	the	DT	B-NP	OStat5-responsive	beta-casein	Stat5-responsive	JJ	I-NP	B-DNAbeta-casein	promoter	beta-casein	NN	I-NP	I-DNApromoter	.	promoter	NN	I-NP	I-DNA.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	AG-490	","	","	O	OAG-490	had	AG-490	NN	B-NP	Ohad	no	have	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	on	effect	NN	I-NP	Oon	DNA	on	IN	B-PP	ODNA	binding	DNA	NN	B-NP	Obinding	by	binding	NN	I-NP	Oby	p50/p65	by	IN	B-PP	Op50/p65	components	p50/p65	NN	B-NP	B-proteincomponents	of	component	NNS	I-NP	I-proteinof	NF-kappaB	of	IN	B-PP	ONF-kappaB	","	NF-kappaB	NN	B-NP	B-protein","	a	","	","	O	Oa	transcription	a	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	activated	factor	NN	I-NP	I-proteinactivated	by	activate	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	HTLV-1-encoded	the	DT	B-NP	OHTLV-1-encoded	phosphoprotein	HTLV-1-encoded	JJ	I-NP	B-proteinphosphoprotein	","	phosphoprotein	NN	I-NP	I-protein","	Tax	","	","	O	OTax	.	Tax	NN	B-NP	B-protein.	Collectively	.	.	O	OCollectively	","	Collectively	RB	B-ADVP	O","	these	","	","	O	Othese	data	these	DT	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	Jak3-Stat5	the	DT	B-NP	OJak3-Stat5	pathway	Jak3-Stat5	NN	I-NP	B-proteinpathway	in	pathway	NN	I-NP	Oin	HTLV-1-transformed	in	IN	B-PP	OHTLV-1-transformed	T	HTLV-1-transformed	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	has	cell	NNS	I-NP	I-cell_typehas	become	have	VBZ	B-VP	Obecome	functionally	become	VBN	I-VP	Ofunctionally	redundant	functionally	RB	B-ADJP	Oredundant	for	redundant	JJ	I-ADJP	Ofor	proliferation	for	IN	B-PP	Oproliferation	.	proliferation	NN	B-NP	O.	Reversal	.	.	O	OReversal	of	Reversal	NN	B-NP	Oof	this	of	IN	B-PP	Othis	functional	this	DT	B-NP	Ofunctional	uncoupling	functional	JJ	I-NP	Ouncoupling	may	uncoupling	NN	I-NP	Omay	be	may	MD	B-VP	Obe	required	be	VB	I-VP	Orequired	before	require	VBN	I-VP	Obefore	Jak3/Stat5	before	IN	B-PP	OJak3/Stat5	inhibitors	Jak3/Stat5	NN	B-NP	B-proteininhibitors	will	inhibitor	NNS	I-NP	I-proteinwill	be	will	MD	B-VP	Obe	useful	be	VB	I-VP	Ouseful	in	useful	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	treatment	the	DT	B-NP	Otreatment	of	treatment	NN	I-NP	Oof	this	of	IN	B-PP	Othis	malignancy	this	DT	B-NP	Omalignancy	.	malignancy	NN	I-NP	O.	The	.	.	O	OThe	Epstein-Barr	The	DT	B-NP	OEpstein-Barr	virus	Epstein-Barr	JJ	I-NP	B-DNAvirus	promoter	virus	NN	I-NP	I-DNApromoter	initiating	promoter	NN	I-NP	I-DNAinitiating	B-cell	initiate	VBG	B-VP	OB-cell	transformation	B-cell	NN	B-NP	Otransformation	is	transformation	NN	I-NP	Ois	activated	be	VBZ	B-VP	Oactivated	by	activate	VBN	I-VP	Oby	RFX	by	IN	B-PP	ORFX	proteins	RFX	NN	B-NP	B-proteinproteins	and	protein	NNS	I-NP	I-proteinand	the	and	CC	O	Othe	B-cell-specific	the	DT	B-NP	OB-cell-specific	activator	B-cell-specific	JJ	I-NP	B-proteinactivator	protein	activator	NN	I-NP	I-proteinprotein	BSAP/Pax5	protein	NN	I-NP	I-proteinBSAP/Pax5	.	BSAP/Pax5	NN	I-NP	O.	Epstein-Barr	.	.	O	OEpstein-Barr	virus	Epstein-Barr	JJ	B-NP	Ovirus	(	virus	NN	I-NP	O(	EBV	(	(	O	OEBV	)	EBV	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	B-cell	#NAME?	JJ	B-NP	OB-cell	growth	B-cell	NN	I-NP	Ogrowth	transformation	growth	NN	I-NP	Otransformation	","	transformation	NN	I-NP	O","	a	","	","	O	Oa	central	a	DT	B-NP	Ocentral	feature	central	JJ	I-NP	Ofeature	of	feature	NN	I-NP	Oof	the	of	IN	B-PP	Othe	virus	the	DT	B-NP	Ovirus	'	virus	NN	I-NP	O'	strategy	'	POS	B-NP	Ostrategy	for	strategy	NN	I-NP	Ofor	colonizing	for	IN	B-PP	Ocolonizing	the	colonize	VBG	B-VP	Othe	human	the	DT	B-NP	Ohuman	B-cell	human	JJ	I-NP	OB-cell	system	B-cell	NN	I-NP	Osystem	","	system	NN	I-NP	O","	requires	","	","	O	Orequires	full	require	VBZ	B-VP	Ofull	virus	full	JJ	B-NP	Ovirus	latent	virus	NN	I-NP	Olatent	gene	latent	JJ	I-NP	Ogene	expression	gene	NN	I-NP	Oexpression	and	expression	NN	I-NP	Oand	is	and	CC	O	Ois	initiated	be	VBZ	B-VP	Oinitiated	by	initiate	VBN	I-VP	Oby	transcription	by	IN	B-PP	Otranscription	from	transcription	NN	B-NP	Ofrom	the	from	IN	B-PP	Othe	viral	the	DT	B-NP	Oviral	promoter	viral	JJ	I-NP	B-DNApromoter	Wp	promoter	NN	I-NP	I-DNAWp	.	Wp	NN	I-NP	O.	Interestingly	.	.	O	OInterestingly	","	Interestingly	RB	B-ADVP	O","	when	","	","	O	Owhen	EBV	when	WRB	B-ADVP	OEBV	accesses	EBV	NN	B-NP	Oaccesses	other	access	VBZ	B-VP	Oother	cell	other	JJ	B-NP	Ocell	types	cell	NN	I-NP	Otypes	","	type	NNS	I-NP	O","	this	","	","	O	Othis	growth-transforming	this	DT	B-NP	Ogrowth-transforming	program	growth-transforming	JJ	I-NP	Oprogram	is	program	NN	I-NP	Ois	not	be	VBZ	B-VP	Onot	activated	not	RB	I-VP	Oactivated	.	activate	VBN	I-VP	O.	The	.	.	O	OThe	present	The	DT	B-NP	Opresent	work	present	JJ	I-NP	Owork	focuses	work	NN	I-NP	Ofocuses	on	focus	VBZ	B-VP	Oon	a	on	IN	B-PP	Oa	region	a	DT	B-NP	Oregion	of	region	NN	I-NP	Oof	Wp	of	IN	B-PP	OWp	which	Wp	NN	B-NP	B-DNAwhich	in	which	WDT	B-NP	Oin	reporter	in	IN	B-PP	Oreporter	assays	reporter	NN	B-NP	Oassays	confers	assay	NNS	I-NP	Oconfers	B-cell	confer	VBZ	B-VP	OB-cell	#NAME?	B-cell	NN	B-NP	B-cell_type#NAME?	activity	#NAME?	JJ	I-NP	Oactivity	.	activity	NN	I-NP	O.	Bandshift	.	.	O	OBandshift	studies	Bandshift	NN	B-NP	Ostudies	indicate	study	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	this	that	IN	B-SBAR	Othis	region	this	DT	B-NP	Oregion	contains	region	NN	I-NP	Ocontains	three	contain	VBZ	B-VP	Othree	factor	three	CD	B-NP	Ofactor	binding	factor	NN	I-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	","	site	NNS	I-NP	I-DNA","	termed	","	","	O	Otermed	sites	term	VBN	B-NP	Osites	B	site	NNS	I-NP	B-DNAB	","	B	NN	I-NP	I-DNA","	C	","	","	O	OC	","	C	NN	B-NP	B-protein","	and	","	","	O	Oand	D	and	CC	O	OD	","	D	NNP	B-NP	O","	in	","	","	O	Oin	addition	in	IN	B-PP	Oaddition	to	addition	NN	B-NP	Oto	a	to	TO	B-PP	Oa	previously	a	DT	B-NP	Opreviously	characterized	previously	RB	I-NP	Ocharacterized	CREB	characterize	VBN	I-NP	OCREB	site	CREB	NN	I-NP	B-DNAsite	.	site	NN	I-NP	I-DNA.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	site	that	IN	B-SBAR	Osite	C	site	NN	B-NP	B-DNAC	binds	C	NN	I-NP	I-DNAbinds	members	bind	VBZ	B-VP	Omembers	of	member	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	ubiquitously	the	DT	B-NP	Oubiquitously	expressed	ubiquitously	RB	I-NP	B-proteinexpressed	RFX	express	VBN	I-NP	I-proteinRFX	family	RFX	NN	I-NP	I-proteinfamily	of	family	NN	I-NP	I-proteinof	proteins	of	IN	B-PP	Oproteins	","	protein	NNS	B-NP	O","	notably	","	","	O	Onotably	RFX1	notably	RB	B-ADVP	ORFX1	","	RFX1	NN	B-NP	B-protein","	RFX3	","	","	O	ORFX3	","	RFX3	NN	B-NP	B-protein","	and	","	","	O	Oand	the	and	CC	O	Othe	associated	the	DT	B-NP	Oassociated	factor	associate	VBN	I-NP	Ofactor	MIBP1	factor	NN	I-NP	OMIBP1	","	MIBP1	NN	I-NP	B-protein","	whereas	","	","	O	Owhereas	sites	whereas	IN	O	Osites	B	site	NNS	B-NP	B-DNAB	and	B	NN	B-NP	I-DNAand	D	and	CC	O	OD	both	D	NN	B-NP	Oboth	bind	both	DT	B-NP	Obind	the	bind	VBP	B-VP	Othe	B-cell-specific	the	DT	B-NP	OB-cell-specific	activator	B-cell-specific	JJ	I-NP	B-proteinactivator	protein	activator	NN	I-NP	I-proteinprotein	BSAP/Pax5	protein	NN	I-NP	I-proteinBSAP/Pax5	.	BSAP/Pax5	NN	I-NP	O.	In	.	.	O	OIn	reporter	In	IN	B-PP	Oreporter	assays	reporter	NN	B-NP	Oassays	with	assay	NNS	I-NP	Owith	mutant	with	IN	B-PP	Omutant	Wp	mutant	JJ	B-NP	B-DNAWp	constructs	Wp	NN	I-NP	I-DNAconstructs	","	construct	NNS	I-NP	I-DNA","	the	","	","	O	Othe	loss	the	DT	B-NP	Oloss	of	loss	NN	I-NP	Oof	factor	of	IN	B-PP	Ofactor	binding	factor	NN	B-NP	Obinding	to	bind	VBG	B-VP	Oto	any	to	TO	B-PP	Oany	one	any	DT	B-NP	Oone	of	one	CD	I-NP	Oof	these	of	IN	B-PP	Othese	sites	these	DT	B-NP	Osites	severely	site	NNS	I-NP	Oseverely	impaired	severely	RB	B-ADVP	Oimpaired	promoter	impair	VBD	B-VP	Opromoter	activity	promoter	NN	B-NP	Oactivity	in	activity	NN	I-NP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	while	","	","	O	Owhile	the	while	IN	B-SBAR	Othe	wild-type	the	DT	B-NP	Owild-type	promoter	wild-type	JJ	I-NP	B-DNApromoter	could	promoter	NN	I-NP	I-DNAcould	be	could	MD	B-VP	Obe	activated	be	VB	I-VP	Oactivated	in	activate	VBN	I-VP	Oin	non-B	in	IN	B-PP	Onon-B	cells	non-B	JJ	B-NP	B-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	ectopic	by	IN	B-PP	Oectopic	BSAP	ectopic	JJ	B-NP	OBSAP	expression	BSAP	NN	I-NP	B-proteinexpression	.	expression	NN	I-NP	O.	We	.	.	O	OWe	suggest	We	PRP	B-NP	Osuggest	that	suggest	VBP	B-VP	Othat	Wp	that	IN	B-SBAR	OWp	regulation	Wp	NN	B-NP	Oregulation	by	regulation	NN	I-NP	Oby	BSAP	by	IN	B-PP	OBSAP	helps	BSAP	NN	B-NP	B-proteinhelps	to	help	VBZ	B-VP	Oto	ensure	to	TO	I-VP	Oensure	the	ensure	VB	I-VP	Othe	B-cell	the	DT	B-NP	OB-cell	specificity	B-cell	NN	I-NP	Ospecificity	of	specificity	NN	I-NP	Oof	EBV	of	IN	B-PP	OEBV	's	EBV	NN	B-NP	O's	growth-transforming	's	POS	B-NP	Ogrowth-transforming	function	growth-transforming	JJ	I-NP	Ofunction	.	function	NN	I-NP	O.	Activation	.	.	O	OActivation	of	Activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	Lck	the	DT	B-NP	OLck	tyrosine	Lck	NN	I-NP	B-proteintyrosine	protein	tyrosine	NN	I-NP	I-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	by	kinase	NN	I-NP	I-proteinby	the	by	IN	B-PP	Othe	Herpesvirus	the	DT	B-NP	OHerpesvirus	saimiri	Herpesvirus	NN	I-NP	B-proteinsaimiri	tip	saimiri	NN	I-NP	I-proteintip	protein	tip	NN	I-NP	I-proteinprotein	involves	protein	NN	I-NP	I-proteininvolves	two	involve	VBZ	B-VP	Otwo	binding	two	CD	B-NP	Obinding	interactions	bind	VBG	I-NP	Ointeractions	.	interaction	NNS	I-NP	O.	The	.	.	O	OThe	Tip	The	DT	B-NP	OTip	protein	Tip	NN	I-NP	B-proteinprotein	of	protein	NN	I-NP	I-proteinof	Herpesvirus	of	IN	B-PP	OHerpesvirus	saimiri	Herpesvirus	NN	B-NP	B-proteinsaimiri	strain	saimiri	NN	I-NP	I-proteinstrain	484C	strain	NN	I-NP	I-protein484C	binds	484C	NN	I-NP	I-proteinbinds	to	bind	VBZ	B-VP	Oto	and	to	TO	B-PP	Oand	activates	and	CC	O	Oactivates	the	activate	VBZ	B-VP	Othe	Lck	the	DT	B-NP	OLck	tyrosine	Lck	NN	I-NP	B-proteintyrosine	protein	tyrosine	NN	I-NP	I-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	.	kinase	NN	I-NP	I-protein.	Two	.	.	O	OTwo	sequences	Two	CD	B-NP	Osequences	in	sequence	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	Tip	the	DT	B-NP	OTip	protein	Tip	NN	I-NP	B-proteinprotein	were	protein	NN	I-NP	I-proteinwere	previously	be	VBD	B-VP	Opreviously	shown	previously	RB	I-VP	Oshown	to	show	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	involved	be	VB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	binding	in	IN	B-PP	Obinding	to	binding	NN	B-NP	Oto	Lck	to	TO	B-PP	OLck	.	Lck	NN	B-NP	B-protein.	A	.	.	O	OA	proline-rich	A	DT	B-NP	Oproline-rich	region	proline-rich	JJ	I-NP	B-proteinregion	","	region	NN	I-NP	I-protein","	residues	","	","	O	Oresidues	132-141	residue	NNS	B-NP	O132-141	","	132-141	CD	B-NP	O","	binds	","	","	O	Obinds	to	bind	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	SH3	the	DT	B-NP	OSH3	domain	SH3	NN	I-NP	B-proteindomain	of	domain	NN	I-NP	I-proteinof	the	of	IN	B-PP	Othe	Lck	the	DT	B-NP	OLck	protein	Lck	NN	I-NP	B-proteinprotein	.	protein	NN	I-NP	I-protein.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	here	show	VBP	B-VP	Ohere	that	here	RB	B-ADVP	Othat	the	that	IN	B-SBAR	Othe	other	the	DT	B-NP	Oother	Lck-binding	other	JJ	I-NP	OLck-binding	domain	Lck-binding	JJ	I-NP	B-proteindomain	","	domain	NN	I-NP	I-protein","	residues	","	","	O	Oresidues	104-113	residue	NNS	B-NP	O104-113	","	104-113	CD	B-NP	O","	binds	","	","	O	Obinds	to	bind	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	carboxyl-terminal	the	DT	B-NP	Ocarboxyl-terminal	half	carboxyl-terminal	JJ	I-NP	B-proteinhalf	of	half	NN	I-NP	I-proteinof	Lck	of	IN	B-PP	OLck	and	Lck	NN	B-NP	B-proteinand	that	and	CC	O	Othat	this	that	IN	B-SBAR	Othis	binding	this	DT	B-NP	Obinding	does	binding	NN	I-NP	Odoes	not	do	VBZ	B-VP	Onot	require	not	RB	I-VP	Orequire	the	require	VB	I-VP	Othe	Lck	the	DT	B-NP	OLck	SH3	Lck	NN	I-NP	B-proteinSH3	domain	SH3	NN	I-NP	I-proteindomain	.	domain	NN	I-NP	I-protein.	Mutated	.	.	O	OMutated	Tip	Mutate	VBN	B-NP	OTip	containing	Tip	NN	I-NP	B-proteincontaining	only	contain	VBG	B-VP	Oonly	one	only	RB	B-NP	Oone	functional	one	CD	I-NP	Ofunctional	Lck-binding	functional	JJ	I-NP	OLck-binding	domain	Lck-binding	JJ	I-NP	B-proteindomain	can	domain	NN	I-NP	I-proteincan	bind	can	MD	B-VP	Obind	stably	bind	VB	I-VP	Ostably	to	stably	RB	B-ADVP	Oto	Lck	to	TO	B-PP	OLck	","	Lck	NN	B-NP	B-protein","	although	","	","	O	Oalthough	not	although	IN	B-SBAR	Onot	as	not	RB	O	Oas	strongly	as	RB	B-ADVP	Ostrongly	as	strongly	RB	I-ADVP	Oas	wild-type	as	IN	B-PP	Owild-type	Tip	wild-type	JJ	B-NP	B-proteinTip	.	Tip	NN	I-NP	I-protein.	Interaction	.	.	O	OInteraction	of	Interaction	NN	B-NP	Oof	Tip	of	IN	B-PP	OTip	with	Tip	NN	B-NP	B-proteinwith	Lck	with	IN	B-PP	OLck	through	Lck	NN	B-NP	B-proteinthrough	either	through	IN	B-PP	Oeither	Lck-binding	either	CC	B-NP	OLck-binding	domain	Lck-binding	JJ	I-NP	B-proteindomain	increases	domain	NN	I-NP	I-proteinincreases	the	increase	VBZ	B-VP	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	Lck	of	IN	B-PP	OLck	in	Lck	NN	B-NP	B-proteinin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	Simultaneous	.	.	O	OSimultaneous	binding	Simultaneous	JJ	B-NP	Obinding	of	binding	NN	I-NP	Oof	both	of	IN	B-PP	Oboth	domains	both	DT	B-NP	Odomains	is	domain	NNS	I-NP	Ois	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	maximal	for	IN	B-PP	Omaximal	activation	maximal	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	Lck	of	IN	B-PP	OLck	.	Lck	NN	B-NP	B-protein.	The	.	.	O	OThe	transient	The	DT	B-NP	Otransient	expression	transient	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	Tip	of	IN	B-PP	OTip	in	Tip	NN	B-NP	B-proteinin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	was	cell	NNS	I-NP	I-cell_typewas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	stimulate	to	TO	I-VP	Ostimulate	both	stimulate	VB	I-VP	Oboth	Stat3	both	CC	O	OStat3	#NAME?	Stat3	NN	B-ADJP	B-protein#NAME?	and	#NAME?	JJ	I-ADJP	Oand	NF-AT	and	CC	O	ONF-AT	#NAME?	NF-AT	NN	B-NP	B-protein#NAME?	transcription	#NAME?	JJ	I-NP	Otranscription	.	transcription	NN	I-NP	O.	Mutant	.	.	O	OMutant	forms	Mutant	JJ	B-NP	Oforms	of	form	NNS	I-NP	Oof	Tip	of	IN	B-PP	OTip	lacking	Tip	NN	B-NP	B-proteinlacking	one	lack	VBG	B-VP	Oone	or	one	CD	B-NP	Oor	the	or	CC	O	Othe	other	the	DT	B-NP	Oother	of	other	JJ	I-NP	Oof	the	of	IN	B-PP	Othe	two	the	DT	B-NP	Otwo	Lck-binding	two	CD	I-NP	OLck-binding	domains	Lck-binding	JJ	I-NP	B-proteindomains	retained	domain	NNS	I-NP	I-proteinretained	the	retain	VBD	B-VP	Othe	ability	the	DT	B-NP	Oability	to	ability	NN	I-NP	Oto	stimulate	to	TO	B-VP	Ostimulate	Stat3	stimulate	VB	I-VP	OStat3	#NAME?	Stat3	NN	B-NP	B-protein#NAME?	transcription	#NAME?	JJ	I-NP	Otranscription	.	transcription	NN	I-NP	O.	Tip	.	.	O	OTip	lacking	Tip	NN	B-NP	B-proteinlacking	the	lack	VBG	B-VP	Othe	proline-rich	the	DT	B-NP	Oproline-rich	Lck-binding	proline-rich	JJ	I-NP	B-proteinLck-binding	domain	Lck-binding	JJ	I-NP	I-proteindomain	exhibited	domain	NN	I-NP	I-proteinexhibited	almost	exhibit	VBD	B-VP	Oalmost	wild-type	almost	RB	B-NP	Owild-type	activity	wild-type	JJ	I-NP	Oactivity	in	activity	NN	I-NP	Oin	this	in	IN	B-PP	Othis	assay	this	DT	B-NP	Oassay	.	assay	NN	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	ablation	","	","	O	Oablation	of	ablation	NN	B-NP	Oof	either	of	IN	B-PP	Oeither	Lck-binding	either	CC	B-NP	OLck-binding	domain	Lck-binding	JJ	I-NP	B-proteindomain	abolished	domain	NN	I-NP	I-proteinabolished	the	abolish	VBD	B-VP	Othe	ability	the	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	Tip	of	IN	B-PP	OTip	to	Tip	NN	B-NP	B-proteinto	stimulate	to	TO	B-VP	Ostimulate	NF-AT	stimulate	VB	I-VP	ONF-AT	#NAME?	NF-AT	NN	B-NP	B-protein#NAME?	transcription	#NAME?	JJ	I-NP	Otranscription	.	transcription	NN	I-NP	O.	Full	.	.	O	OFull	biological	Full	JJ	B-NP	Obiological	activity	biological	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	Tip	of	IN	B-PP	OTip	","	Tip	NN	B-NP	B-protein","	therefore	","	","	O	Otherefore	","	therefore	RB	B-ADVP	O","	appears	","	","	O	Oappears	to	appear	VBZ	B-VP	Oto	require	to	TO	I-VP	Orequire	both	require	VB	I-VP	Oboth	Lck-binding	both	DT	B-NP	OLck-binding	domains	Lck-binding	JJ	I-NP	B-proteindomains	.	domain	NNS	I-NP	I-protein.	Accumulation	.	.	O	OAccumulation	of	Accumulation	NN	B-NP	Oof	RXR	of	IN	B-PP	ORXR	alpha	RXR	NN	B-NP	B-proteinalpha	during	alpha	SYM	B-NP	I-proteinduring	activation	during	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	cycling	of	IN	B-PP	Ocycling	human	cycle	VBG	B-VP	Ohuman	T	human	JJ	B-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	:	lymphocyte	NNS	I-NP	I-cell_type:	modulation	:	:	O	Omodulation	of	modulation	NN	B-NP	Oof	RXRE	of	IN	B-PP	ORXRE	transactivation	RXRE	NN	B-NP	Otransactivation	function	transactivation	NN	I-NP	Ofunction	by	function	NN	I-NP	Oby	mitogen-activated	by	IN	B-PP	Omitogen-activated	protein	mitogen-activated	JJ	B-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	pathways	kinase	NN	I-NP	I-proteinpathways	.	pathway	NNS	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	previously	have	VBP	B-VP	Opreviously	reported	previously	RB	I-VP	Oreported	that	report	VBN	I-VP	Othat	the	that	IN	B-SBAR	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	resting	of	IN	B-PP	Oresting	human	rest	VBG	B-NP	B-cell_typehuman	immature	human	JJ	I-NP	I-cell_typeimmature	peripheral	immature	JJ	I-NP	I-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	T	blood	NN	I-NP	I-cell_typeT	(	T	NN	I-NP	I-cell_type(	PBT	(	(	O	I-cell_typePBT	)	PBT	NN	B-NP	I-cell_type)	lymphocytes	)	)	O	I-cell_typelymphocytes	is	lymphocyte	NNS	B-NP	I-cell_typeis	associated	be	VBZ	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	the	with	IN	B-PP	Othe	loss	the	DT	B-NP	Oloss	of	loss	NN	I-NP	Oof	retinoid	of	IN	B-PP	Oretinoid	X	retinoid	NN	B-NP	B-proteinX	receptor	X	NN	I-NP	I-proteinreceptor	alpha	receptor	NN	I-NP	I-proteinalpha	(	alpha	NN	I-NP	I-protein(	RXRalpha	(	(	O	ORXRalpha	)	RXRalpha	NN	B-NP	B-protein)	expression	)	)	O	Oexpression	.	expression	NN	B-NP	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	present	the	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	demonstrated	have	VBP	B-VP	Odemonstrated	that	demonstrate	VBN	I-VP	Othat	","	that	IN	B-SBAR	O","	unlike	","	","	O	Ounlike	resting	unlike	IN	B-PP	Oresting	cells	rest	VBG	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	activation	","	","	O	Oactivation	of	activation	NN	B-NP	Oof	cycling	of	IN	B-PP	Ocycling	human	cycle	VBG	B-VP	B-cell_typehuman	mature	human	JJ	B-NP	I-cell_typemature	PBT	mature	JJ	I-NP	I-cell_typePBT	lymphocytes	PBT	NN	I-NP	I-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	T	and	CC	O	OT	lymphocyte	T	NN	B-NP	B-cell_linelymphocyte	leukemia	lymphocyte	NN	I-NP	I-cell_lineleukemia	cell	leukemia	NN	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	is	line	NNS	I-NP	I-cell_lineis	accompanied	be	VBZ	B-VP	Oaccompanied	by	accompany	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	accumulation	the	DT	B-NP	Oaccumulation	of	accumulation	NN	I-NP	Oof	RXRalpha	of	IN	B-PP	ORXRalpha	mRNA	RXRalpha	NN	B-NP	B-RNAmRNA	and	mRNA	NN	I-NP	I-RNAand	protein	and	CC	I-NP	Oprotein	.	protein	NN	I-NP	O.	Interestingly	.	.	O	OInterestingly	","	Interestingly	RB	B-ADVP	O","	cyclosporin	","	","	O	Ocyclosporin	A	cyclosporin	NN	B-NP	OA	further	A	NN	I-NP	Ofurther	augmented	further	RBR	B-ADVP	Oaugmented	RXRalpha	augment	VBD	B-VP	ORXRalpha	expression	RXRalpha	NN	B-NP	B-proteinexpression	","	expression	NN	I-NP	O","	indicating	","	","	O	Oindicating	the	indicate	VBG	B-VP	Othe	involvement	the	DT	B-NP	Oinvolvement	of	involvement	NN	I-NP	Oof	calcineurin	of	IN	B-PP	Ocalcineurin	pathways	calcineurin	NN	B-NP	B-proteinpathways	in	pathway	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	process	the	DT	B-NP	Oprocess	.	process	NN	I-NP	O.	9-cis	.	.	O	O9-cis	retinoic	9-cis	JJ	B-NP	Oretinoic	acid	retinoic	JJ	I-NP	Oacid	inhibited	acid	NN	I-NP	Oinhibited	the	inhibit	VBD	B-VP	Othe	accumulation	the	DT	B-NP	Oaccumulation	","	accumulation	NN	I-NP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	retinoids	that	IN	B-SBAR	Oretinoids	can	retinoid	NNS	B-NP	Ocan	regulate	can	MD	B-VP	Oregulate	the	regulate	VB	I-VP	Othe	synthesis	the	DT	B-NP	Osynthesis	of	synthesis	NN	I-NP	Oof	their	of	IN	B-PP	Otheir	own	their	PRP$	B-NP	Oown	receptors	own	JJ	I-NP	B-proteinreceptors	during	receptor	NNS	I-NP	I-proteinduring	T	during	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	.	activation	NN	I-NP	O.	Transfection	.	.	O	OTransfection	analysis	Transfection	NN	B-NP	Oanalysis	in	analysis	NN	I-NP	Oin	Jurkat	in	IN	B-PP	OJurkat	cells	Jurkat	NN	B-NP	B-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	using	","	","	O	Ousing	RXRE-dependent	use	VBG	B-VP	ORXRE-dependent	reporter	RXRE-dependent	JJ	B-NP	Oreporter	assays	reporter	NN	I-NP	Oassays	","	assay	NNS	I-NP	O","	showed	","	","	O	Oshowed	that	show	VBD	B-VP	Othat	RXRalpha	that	IN	B-SBAR	ORXRalpha	accumulated	RXRalpha	NN	B-NP	B-proteinaccumulated	during	accumulate	VBN	B-VP	Oduring	T	during	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	was	activation	NN	I-NP	Owas	transcriptionally	be	VBD	B-VP	Otranscriptionally	inactive	transcriptionally	RB	B-ADJP	Oinactive	.	inactive	JJ	I-ADJP	O.	To	.	.	O	OTo	investigate	To	TO	B-VP	Oinvestigate	the	investigate	VB	I-VP	Othe	mechanism	the	DT	B-NP	Omechanism	of	mechanism	NN	I-NP	Oof	such	of	IN	B-PP	Osuch	inhibition	such	JJ	B-NP	Oinhibition	","	inhibition	NN	I-NP	O","	the	","	","	O	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	two	of	IN	B-PP	Otwo	mitogen-activated	two	CD	B-NP	Omitogen-activated	protein	mitogen-activated	JJ	I-NP	B-proteinprotein	kinase	protein	NN	I-NP	I-proteinkinase	pathways	kinase	NN	I-NP	I-proteinpathways	","	pathway	NNS	I-NP	O","	c-Jun	","	","	O	Oc-Jun	N-terminal	c-Jun	NN	B-NP	B-proteinN-terminal	kinase	N-terminal	JJ	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	JNK	(	(	O	OJNK	)	JNK	NN	B-NP	B-protein)	and	)	)	O	Oand	extracellular	and	CC	O	Oextracellular	signal-regulated	extracellular	JJ	B-NP	B-proteinsignal-regulated	kinase	signal-regulated	JJ	I-NP	I-proteinkinase	(	kinase	NN	I-NP	I-protein(	ERK	(	(	O	OERK	)	ERK	NN	B-NP	B-protein)	","	)	)	O	O","	in	","	","	O	Oin	modulating	in	IN	B-PP	Omodulating	RXRE-dependent	modulate	VBG	B-VP	ORXRE-dependent	transcription	RXRE-dependent	JJ	B-NP	Otranscription	","	transcription	NN	I-NP	O","	was	","	","	O	Owas	explored	be	VBD	B-VP	Oexplored	.	explore	VBN	I-VP	O.	The	.	.	O	OThe	expression	The	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	constitutively	of	IN	B-PP	Oconstitutively	active	constitutively	RB	B-NP	B-proteinactive	MAP/ERK	active	JJ	I-NP	I-proteinMAP/ERK	kinase	MAP/ERK	NN	I-NP	I-proteinkinase	kinase	kinase	NN	I-NP	I-proteinkinase	1	kinase	NN	I-NP	I-protein1	(	1	CD	I-NP	I-protein(	MEKK1	(	(	O	OMEKK1	)	MEKK1	NN	B-NP	B-protein)	inhibited	)	)	O	Oinhibited	RXRE-dependent	inhibit	VBD	B-VP	ORXRE-dependent	transcription	RXRE-dependent	JJ	B-NP	Otranscription	","	transcription	NN	I-NP	O","	whereas	","	","	O	Owhereas	dominant	whereas	IN	O	Odominant	negative	dominant	JJ	B-NP	B-proteinnegative	MEKK1	negative	JJ	I-NP	I-proteinMEKK1	increased	MEKK1	NN	I-NP	I-proteinincreased	the	increase	VBD	B-VP	Othe	transcription	the	DT	B-NP	Otranscription	","	transcription	NN	I-NP	O","	indicating	","	","	O	Oindicating	the	indicate	VBG	B-VP	Othe	involvement	the	DT	B-NP	Oinvolvement	of	involvement	NN	I-NP	Oof	JNK	of	IN	B-PP	OJNK	signaling	JNK	NN	B-NP	B-proteinsignaling	pathways	signaling	NN	I-NP	Opathways	in	pathway	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	process	the	DT	B-NP	Oprocess	.	process	NN	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	expression	","	","	O	Oexpression	of	expression	NN	B-NP	Oof	constitutively	of	IN	B-PP	Oconstitutively	active	constitutively	RB	B-NP	Oactive	MEK1	active	JJ	I-NP	OMEK1	","	MEK1	NN	I-NP	B-protein","	which	","	","	O	Owhich	activates	which	WDT	B-NP	Oactivates	ERK	activate	VBZ	B-VP	OERK	pathway	ERK	NN	B-NP	B-proteinpathway	","	pathway	NN	I-NP	O","	enhanced	","	","	O	Oenhanced	RXRE-dependent	enhance	VBD	B-VP	ORXRE-dependent	activation	RXRE-dependent	JJ	B-NP	Oactivation	.	activation	NN	I-NP	O.	When	.	.	O	OWhen	both	When	WRB	B-ADVP	Oboth	were	both	DT	B-NP	Owere	activated	be	VBD	B-VP	Oactivated	simultaneously	activate	VBN	I-VP	Osimultaneously	","	simultaneously	RB	B-ADVP	O","	JNK	","	","	O	OJNK	pathway	JNK	NN	B-NP	B-proteinpathway	was	pathway	NN	I-NP	Owas	dominant	be	VBD	B-VP	Odominant	over	dominant	JJ	B-ADJP	Oover	ERK	over	IN	B-PP	OERK	pathway	ERK	NN	B-NP	B-proteinpathway	and	pathway	NN	I-NP	Oand	resulted	and	CC	O	Oresulted	in	result	VBD	B-VP	Oin	inhibition	in	IN	B-PP	Oinhibition	of	inhibition	NN	B-NP	Oof	RXRE-mediated	of	IN	B-PP	ORXRE-mediated	transcription	RXRE-mediated	JJ	B-NP	Otranscription	.	transcription	NN	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	demonstrate	datum	NNS	I-NP	Odemonstrate	a	demonstrate	VBP	B-VP	Oa	dual	a	DT	B-NP	Odual	regulatory	dual	JJ	I-NP	Oregulatory	control	regulatory	JJ	I-NP	Ocontrol	of	control	NN	I-NP	Oof	RXRalpha	of	IN	B-PP	ORXRalpha	expression	RXRalpha	NN	B-NP	B-proteinexpression	during	expression	NN	I-NP	Oduring	the	during	IN	B-PP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	resting	of	IN	B-PP	Oresting	and	rest	VBG	B-VP	Oand	cycling	and	CC	I-VP	Ocycling	T	cycle	VBG	I-VP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	indicate	and	CC	O	Oindicate	a	indicate	VBP	B-VP	Oa	dynamic	a	DT	B-NP	Odynamic	balance	dynamic	JJ	I-NP	Obalance	between	balance	NN	I-NP	Obetween	JNK	between	IN	B-PP	OJNK	and	JNK	NN	B-NP	B-proteinand	ERK	and	CC	I-NP	OERK	pathways	ERK	NN	I-NP	B-proteinpathways	in	pathway	NNS	I-NP	Oin	modulating	in	IN	B-PP	Omodulating	RXRE-mediated	modulate	VBG	B-VP	ORXRE-mediated	transactivation	RXRE-mediated	JJ	B-NP	Otransactivation	.	transactivation	NN	I-NP	O.	The	.	.	O	OThe	proteasome	The	DT	B-NP	Oproteasome	regulates	proteasome	NN	I-NP	B-proteinregulates	receptor-mediated	regulate	VBZ	B-VP	Oreceptor-mediated	endocytosis	receptor-mediated	JJ	B-NP	Oendocytosis	of	endocytosis	NN	I-NP	Oof	interleukin-2	of	IN	B-PP	Ointerleukin-2	.	interleukin-2	NN	B-NP	B-protein.	Recent	.	.	O	ORecent	studies	Recent	JJ	B-NP	Ostudies	have	study	NNS	I-NP	Ohave	increasingly	have	VBP	B-VP	Oincreasingly	implicated	increasingly	RB	I-VP	Oimplicated	the	implicate	VBN	I-VP	Othe	proteasome	the	DT	B-NP	Oproteasome	in	proteasome	NN	I-NP	B-proteinin	the	in	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	cell	of	IN	B-PP	Ocell	surface	cell	NN	B-NP	B-proteinsurface	receptors	surface	NN	I-NP	I-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	present	the	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	","	study	NN	I-NP	O","	we	","	","	O	Owe	investigated	we	PRP	B-NP	Oinvestigated	the	investigate	VBD	B-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	the	of	IN	B-PP	Othe	proteasome	the	DT	B-NP	Oproteasome	for	proteasome	NN	I-NP	B-proteinfor	ligand-dependent	for	IN	B-PP	Oligand-dependent	endocytosis	ligand-dependent	JJ	B-NP	Oendocytosis	and	endocytosis	NN	I-NP	Oand	degradation	and	CC	I-NP	Odegradation	of	degradation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	interleukin-2	the	DT	B-NP	Ointerleukin-2	(	interleukin-2	NN	I-NP	B-protein(	IL-2	(	(	O	OIL-2	)	IL-2	NN	B-NP	B-protein)	#NAME?	)	)	O	O#NAME?	receptor	#NAME?	CD	B-NP	Oreceptor	(	receptor	NN	I-NP	O(	IL-2R	(	(	O	OIL-2R	)	IL-2R	NN	B-NP	B-protein)	complex	)	)	O	Ocomplex	.	complex	NN	B-NP	O.	Proteasome	.	.	O	OProteasome	inhibitors	Proteasome	NN	B-NP	B-proteininhibitors	impaired	inhibitor	NNS	I-NP	Oimpaired	internalization	impair	VBD	B-VP	Ointernalization	of	internalization	NN	B-NP	Oof	IL-2.IL-2R	of	IN	B-PP	OIL-2.IL-2R	and	IL-2.IL-2R	NN	B-NP	B-proteinand	prevented	and	CC	O	Oprevented	the	prevent	VBD	B-VP	Othe	lysosomal	the	DT	B-NP	Olysosomal	degradation	lysosomal	JJ	I-NP	Odegradation	of	degradation	NN	I-NP	Oof	this	of	IN	B-PP	Othis	cytokine	this	DT	B-NP	Ocytokine	.	cytokine	NN	I-NP	B-protein.	Based	.	.	O	OBased	on	Base	VBN	B-PP	Oon	time-course	on	IN	B-PP	Otime-course	studies	time-course	JJ	B-NP	Ostudies	","	study	NNS	I-NP	O","	proteasome	","	","	O	Oproteasome	activity	proteasome	NN	B-NP	B-proteinactivity	is	activity	NN	I-NP	Ois	primarily	be	VBZ	B-VP	Oprimarily	required	primarily	RB	I-VP	Orequired	after	require	VBN	I-VP	Oafter	initial	after	IN	B-PP	Oinitial	endocytosis	initial	JJ	B-NP	Oendocytosis	of	endocytosis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	IL-2.IL-2R	the	DT	B-NP	OIL-2.IL-2R	.	IL-2.IL-2R	NN	I-NP	B-protein.	Proteasome	.	.	O	OProteasome	function	Proteasome	NN	B-NP	B-proteinfunction	was	function	NN	I-NP	Owas	also	be	VBD	B-VP	Oalso	necessary	also	RB	B-ADVP	Onecessary	for	necessary	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	lysosomal	the	DT	B-NP	Olysosomal	degradation	lysosomal	JJ	I-NP	Odegradation	of	degradation	NN	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	internalized	IL-2	NN	B-NP	B-proteininternalized	by	internalize	VBN	B-VP	Oby	IL-2R	by	IN	B-PP	OIL-2R	that	IL-2R	NN	B-NP	B-proteinthat	were	that	WDT	B-NP	Owere	comprised	be	VBD	B-VP	Ocomprised	of	comprise	VBN	I-VP	Oof	cytoplasmic	of	IN	B-PP	Ocytoplasmic	tailless	cytoplasmic	JJ	B-NP	B-proteintailless	beta-	tailless	JJ	I-NP	I-proteinbeta-	or	beta-	NN	I-NP	I-proteinor	gamma	or	CC	I-NP	Ogamma	c-subunits	gamma	NN	I-NP	B-proteinc-subunits	","	c-subunit	NNS	I-NP	I-protein","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	the	that	IN	B-SBAR	Othe	target	the	DT	B-NP	Otarget	protein	target	NN	I-NP	Oprotein	for	protein	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	proteasome	the	DT	B-NP	Oproteasome	is	proteasome	NN	I-NP	B-proteinis	independent	be	VBZ	B-VP	Oindependent	of	independent	JJ	B-ADJP	Oof	either	of	IN	B-PP	Oeither	the	either	CC	O	Othe	cytoplasmic	the	DT	B-NP	Ocytoplasmic	tail	cytoplasmic	JJ	I-NP	B-proteintail	of	tail	NN	I-NP	I-proteinof	the	of	IN	B-PP	Othe	IL-2R	the	DT	B-NP	OIL-2R	beta-	IL-2R	NN	I-NP	B-proteinbeta-	or	beta-	NN	I-NP	I-proteinor	gamma	or	CC	I-NP	Ogamma	c-subunits	gamma	NN	I-NP	B-proteinc-subunits	and	c-subunit	NNS	I-NP	I-proteinand	their	and	CC	O	Otheir	associated	their	PRP$	B-NP	Oassociated	signaling	associate	VBN	I-NP	Osignaling	components	signaling	NN	I-NP	Ocomponents	.	component	NNS	I-NP	O.	Therefore	.	.	O	OTherefore	","	Therefore	RB	B-ADVP	O","	a	","	","	O	Oa	functional	a	DT	B-NP	Ofunctional	proteasome	functional	JJ	I-NP	Oproteasome	is	proteasome	NN	I-NP	B-proteinis	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	optimal	for	IN	B-PP	Ooptimal	endocytosis	optimal	JJ	B-NP	Oendocytosis	of	endocytosis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	IL-2R/ligand	the	DT	B-NP	OIL-2R/ligand	complex	IL-2R/ligand	NN	I-NP	B-proteincomplex	and	complex	NN	I-NP	I-proteinand	is	and	CC	O	Ois	essential	be	VBZ	B-VP	Oessential	for	essential	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	subsequent	the	DT	B-NP	Osubsequent	lysosomal	subsequent	JJ	I-NP	Olysosomal	degradation	lysosomal	JJ	I-NP	Odegradation	of	degradation	NN	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	","	IL-2	NN	B-NP	B-protein","	possibly	","	","	O	Opossibly	by	possibly	RB	B-ADVP	Oby	regulating	by	IN	B-PP	Oregulating	trafficking	regulate	VBG	B-VP	Otrafficking	to	trafficking	NN	B-NP	Oto	the	to	TO	B-PP	Othe	lysosome	the	DT	B-NP	Olysosome	.	lysosome	NN	I-NP	O.	Functional	.	.	O	OFunctional	characterization	Functional	JJ	B-NP	Ocharacterization	of	characterization	NN	I-NP	Oof	the	of	IN	B-PP	Othe	two	the	DT	B-NP	Otwo	alternative	two	CD	I-NP	Oalternative	promoters	alternative	JJ	I-NP	B-DNApromoters	of	promoter	NNS	I-NP	I-DNAof	human	of	IN	B-PP	Ohuman	p45	human	JJ	B-NP	B-DNAp45	NF-E2	p45	NN	I-NP	I-DNANF-E2	gene	NF-E2	NN	I-NP	I-DNAgene	.	gene	NN	I-NP	I-DNA.	OBJECTIVE	.	.	O	OOBJECTIVE	:	OBJECTIVE	NN	B-NP	O:	The	:	:	O	OThe	transcription	The	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	NF-E2	factor	NN	I-NP	I-proteinNF-E2	","	NF-E2	NN	I-NP	B-protein","	a	","	","	O	Oa	heterodimeric	a	DT	B-NP	Oheterodimeric	protein	heterodimeric	JJ	I-NP	B-proteinprotein	complex	protein	NN	I-NP	I-proteincomplex	composed	complex	NN	I-NP	I-proteincomposed	of	compose	VBN	B-VP	Oof	p45	of	IN	B-PP	Op45	and	p45	NN	B-NP	B-proteinand	small	and	CC	O	Osmall	Maf	small	JJ	B-NP	B-proteinMaf	family	Maf	NN	I-NP	I-proteinfamily	proteins	family	NN	I-NP	I-proteinproteins	","	protein	NNS	I-NP	I-protein","	is	","	","	O	Ois	considered	be	VBZ	B-VP	Oconsidered	crucial	consider	VBN	I-VP	Ocrucial	for	crucial	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	proper	the	DT	B-NP	Oproper	differentiation	proper	JJ	I-NP	Odifferentiation	of	differentiation	NN	I-NP	Oof	erythrocytes	of	IN	B-PP	Oerythrocytes	and	erythrocyte	NNS	B-NP	B-cell_typeand	megakaryocytes	and	CC	I-NP	Omegakaryocytes	in	megakaryocyte	NNS	I-NP	B-cell_typein	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	We	.	.	O	OWe	report	We	PRP	B-NP	Oreport	the	report	VBP	B-VP	Othe	results	the	DT	B-NP	Oresults	of	result	NNS	I-NP	Oof	studies	of	IN	B-PP	Ostudies	aimed	study	NNS	B-NP	Oaimed	at	aim	VBN	B-VP	Oat	understanding	at	IN	B-PP	Ounderstanding	the	understand	VBG	B-VP	Othe	regulatory	the	DT	B-NP	Oregulatory	mechanisms	regulatory	JJ	I-NP	Omechanisms	controlling	mechanism	NNS	I-NP	Ocontrolling	p45	control	VBG	B-VP	Op45	gene	p45	NN	B-NP	B-proteingene	expression	gene	NN	I-NP	Oexpression	in	expression	NN	I-NP	Oin	erythroid	in	IN	B-PP	Oerythroid	cells	erythroid	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	MATERIALS	.	.	O	OMATERIALS	AND	MATERIALS	NNS	B-NP	OAND	METHODS	AND	CC	I-NP	OMETHODS	:	METHODS	NNS	I-NP	O:	Human	:	:	O	OHuman	p45	Human	JJ	B-NP	B-RNAp45	mRNAs	p45	NN	I-NP	I-RNAmRNAs	have	mRNA	NNS	I-NP	I-RNAhave	two	have	VBP	B-VP	Otwo	alternative	two	CD	B-NP	Oalternative	isoforms	alternative	JJ	I-NP	Oisoforms	","	isoform	NNS	I-NP	O","	aNF-E2	","	","	O	OaNF-E2	and	aNF-E2	NN	B-NP	Oand	fNF-E2	and	CC	I-NP	OfNF-E2	","	fNF-E2	NN	I-NP	B-protein","	and	","	","	O	Oand	these	and	CC	O	Othese	isoforms	these	DT	B-NP	Oisoforms	are	isoform	NNS	I-NP	B-proteinare	transcribed	be	VBP	B-VP	Otranscribed	from	transcribe	VBN	I-VP	Ofrom	the	from	IN	B-PP	Othe	alternative	the	DT	B-NP	Oalternative	promoters	alternative	JJ	I-NP	B-DNApromoters	.	promoter	NNS	I-NP	I-DNA.	We	.	.	O	OWe	investigated	We	PRP	B-NP	Oinvestigated	lineage-specific	investigate	VBD	B-VP	Olineage-specific	expression	lineage-specific	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	both	of	IN	B-PP	Oboth	isomers	both	DT	B-NP	Oisomers	in	isomer	NNS	I-NP	Oin	human	in	IN	B-PP	Ohuman	erythroid	human	JJ	B-NP	B-cell_typeerythroid	and	erythroid	JJ	I-NP	I-cell_typeand	megakaryocytic	and	CC	I-NP	I-cell_typemegakaryocytic	cells	megakaryocytic	JJ	I-NP	I-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	reverse	by	IN	B-PP	Oreverse	transcriptase	reverse	JJ	B-NP	B-proteintranscriptase	polymerase	transcriptase	NN	I-NP	I-proteinpolymerase	chain	polymerase	NN	I-NP	Ochain	reaction	chain	NN	I-NP	Oreaction	or	reaction	NN	I-NP	Oor	Northern	or	CC	O	ONorthern	blot	Northern	JJ	B-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	.	analysis	NN	I-NP	O.	For	.	.	O	OFor	functional	For	IN	B-PP	Ofunctional	characterization	functional	JJ	B-NP	Ocharacterization	of	characterization	NN	I-NP	Oof	both	of	IN	B-PP	Oboth	promoters	both	DT	B-NP	Opromoters	","	promoter	NNS	I-NP	B-DNA","	plasmids	","	","	O	Oplasmids	in	plasmid	NNS	B-NP	B-DNAin	which	in	IN	B-PP	Owhich	reporter	which	WDT	B-NP	Oreporter	genes	reporter	NN	B-NP	B-DNAgenes	were	gene	NNS	I-NP	I-DNAwere	placed	be	VBD	B-VP	Oplaced	under	place	VBN	I-VP	Ounder	the	under	IN	B-PP	Othe	control	the	DT	B-NP	Ocontrol	of	control	NN	I-NP	Oof	a	of	IN	B-PP	Oa	series	a	DT	B-NP	Oseries	of	series	NN	I-NP	Oof	truncated	of	IN	B-PP	Otruncated	or	truncate	VBN	B-NP	Oor	mutated	or	CC	I-NP	Omutated	promoter	mutate	VBN	I-NP	B-DNApromoter	fragments	promoter	NN	I-NP	I-DNAfragments	were	fragment	NNS	I-NP	I-DNAwere	transfected	be	VBD	B-VP	Otransfected	to	transfecte	VBN	I-VP	Oto	human	to	TO	B-PP	Ohuman	hematopoietic	human	JJ	B-NP	B-cell_linehematopoietic	cell	hematopoietic	JJ	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	.	line	NNS	I-NP	I-cell_line.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	When	:	:	O	OWhen	CD34	When	WRB	B-ADVP	OCD34	(	CD34	NN	B-NP	B-cell_type(	+	(	(	O	I-cell_type+	)	+	SYM	O	I-cell_type)	cells	)	)	O	I-cell_typecells	isolated	cell	NNS	B-NP	I-cell_typeisolated	from	isolate	VBN	B-VP	Ofrom	human	from	IN	B-PP	Ohuman	cord	human	JJ	B-NP	Ocord	blood	cord	NN	I-NP	Oblood	were	blood	NN	I-NP	Owere	induced	be	VBD	B-VP	Oinduced	to	induce	VBN	I-VP	Oto	unilineage	to	TO	B-PP	Ounilineage	erythroid	unilineage	JJ	B-NP	Oerythroid	or	erythroid	JJ	I-NP	Oor	megakaryocytic	or	CC	I-NP	Omegakaryocytic	differentiation	megakaryocytic	JJ	I-NP	Odifferentiation	in	differentiation	NN	I-NP	Oin	liquid	in	IN	B-PP	Oliquid	suspension	liquid	JJ	B-NP	B-cell_linesuspension	culture	suspension	NN	I-NP	I-cell_lineculture	","	culture	NN	I-NP	I-cell_line","	both	","	","	O	Oboth	transcripts	both	DT	B-NP	Otranscripts	","	transcript	NNS	I-NP	O","	although	","	","	O	Oalthough	barely	although	IN	B-SBAR	Obarely	detected	barely	RB	B-VP	Odetected	at	detect	VBN	I-VP	Oat	day	at	IN	B-PP	Oday	0	day	NN	B-NP	O0	","	0	CD	I-NP	O","	were	","	","	O	Owere	induced	be	VBD	B-VP	Oinduced	in	induce	VBN	I-VP	Oin	both	in	IN	B-PP	Oboth	erythroid	both	CC	B-NP	Oerythroid	and	erythroid	JJ	I-NP	Oand	megakaryocytic	and	CC	I-NP	Omegakaryocytic	cultures	megakaryocytic	JJ	I-NP	B-cell_linecultures	.	culture	NNS	I-NP	I-cell_line.	fNF-E2	.	.	O	OfNF-E2	mRNA	fNF-E2	NN	B-NP	B-RNAmRNA	was	mRNA	NN	I-NP	I-RNAwas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	more	be	VB	I-VP	Omore	abundant	more	RBR	B-ADJP	Oabundant	in	abundant	JJ	I-ADJP	Oin	erythroid	in	IN	B-PP	Oerythroid	cells	erythroid	JJ	B-NP	B-cell_typecells	than	cell	NNS	I-NP	I-cell_typethan	megakaryocytic	than	IN	B-PP	Omegakaryocytic	cells	megakaryocytic	JJ	B-NP	B-cell_typecells	at	cell	NNS	I-NP	I-cell_typeat	day	at	IN	B-PP	Oday	7	day	NN	B-NP	O7	of	7	CD	I-NP	Oof	culture	of	IN	B-PP	Oculture	.	culture	NN	B-NP	O.	Although	.	.	O	OAlthough	both	Although	IN	B-SBAR	Oboth	isomers	both	DT	B-NP	Oisomers	were	isomer	NNS	I-NP	Owere	expressed	be	VBD	B-VP	Oexpressed	in	express	VBN	I-VP	Oin	human	in	IN	B-PP	Ohuman	erythroid-megakaryocytic	human	JJ	B-NP	B-cell_lineerythroid-megakaryocytic	cell	erythroid-megakaryocytic	JJ	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	","	line	NNS	I-NP	I-cell_line","	megakaryocytic	","	","	O	Omegakaryocytic	maturation	megakaryocytic	JJ	B-NP	Omaturation	with	maturation	NN	I-NP	Owith	loss	with	IN	B-PP	Oloss	of	loss	NN	B-NP	Oof	erythroid	of	IN	B-PP	Oerythroid	phenotype	erythroid	JJ	B-NP	B-cell_typephenotype	induced	phenotype	NN	I-NP	I-cell_typeinduced	by	induce	VBN	B-VP	Oby	phorbol	by	IN	B-PP	Ophorbol	12-myristate	phorbol	NN	B-NP	O12-myristate	13-acetate	12-myristate	NN	I-NP	O13-acetate	(	13-acetate	NN	I-NP	O(	PMA	(	(	O	OPMA	)	PMA	NN	B-NP	O)	resulted	)	)	O	Oresulted	in	result	VBD	B-VP	Oin	exclusive	in	IN	B-PP	Oexclusive	downregulation	exclusive	JJ	B-NP	Odownregulation	of	downregulation	NN	I-NP	Oof	fNF-E2	of	IN	B-PP	OfNF-E2	","	fNF-E2	NN	B-NP	B-protein","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	fNF-E2	that	IN	B-SBAR	OfNF-E2	promoter	fNF-E2	NN	B-NP	B-DNApromoter	is	promoter	NN	I-NP	I-DNAis	more	be	VBZ	B-VP	Omore	erythroid	more	RBR	B-ADJP	Oerythroid	specific	erythroid	JJ	I-ADJP	Ospecific	.	specific	JJ	B-ADJP	O.	Functional	.	.	O	OFunctional	analysis	Functional	JJ	B-NP	Oanalysis	of	analysis	NN	I-NP	Oof	fNF-E2	of	IN	B-PP	OfNF-E2	promoter	fNF-E2	NN	B-NP	B-DNApromoter	showed	promoter	NN	I-NP	I-DNAshowed	that	show	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	promoter	the	DT	B-NP	Opromoter	is	promoter	NN	I-NP	B-DNAis	active	be	VBZ	B-VP	Oactive	only	active	JJ	B-ADJP	Oonly	in	only	RB	B-PP	Oin	erythroid-megakaryocytic	in	IN	I-PP	Oerythroid-megakaryocytic	cells	erythroid-megakaryocytic	JJ	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	that	and	CC	O	Othat	the	that	IN	B-SBAR	Othe	double	the	DT	B-NP	Odouble	GATA	double	JJ	I-NP	OGATA	sit	GATA	NN	I-NP	B-DNAsit	e	sit	NN	I-NP	I-DNAe	in	e	NN	I-NP	I-DNAin	the	in	IN	B-PP	Othe	proximal	the	DT	B-NP	Oproximal	region	proximal	JJ	I-NP	B-DNAregion	is	region	NN	I-NP	I-DNAis	necessary	be	VBZ	B-VP	Onecessary	for	necessary	JJ	B-ADJP	Ofor	its	for	IN	B-PP	Oits	efficient	its	PRP$	B-NP	Oefficient	activity	efficient	JJ	I-NP	Oactivity	.	activity	NN	I-NP	O.	CONCLUSION	.	.	O	OCONCLUSION	:	CONCLUSION	NN	B-NP	O:	These	:	:	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	GATA	that	IN	B-SBAR	OGATA	proteins	GATA	NN	B-NP	B-proteinproteins	","	protein	NNS	I-NP	I-protein","	which	","	","	O	Owhich	govern	which	WDT	B-NP	Ogovern	the	govern	VBP	B-VP	Othe	differentiation	the	DT	B-NP	Odifferentiation	of	differentiation	NN	I-NP	Oof	erythroid	of	IN	B-PP	Oerythroid	lineage	erythroid	JJ	B-NP	B-cell_typelineage	cells	lineage	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	are	","	","	O	Oare	required	be	VBP	B-VP	Orequired	for	require	VBN	I-VP	Ofor	full	for	IN	B-PP	Ofull	promoter	full	JJ	B-NP	Opromoter	activity	promoter	NN	I-NP	Oactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	p45	the	DT	B-NP	Op45	gene	p45	NN	I-NP	B-DNAgene	.	gene	NN	I-NP	I-DNA.	Transcriptional	.	.	O	OTranscriptional	activation	Transcriptional	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	heme	of	IN	B-PP	Oheme	oxygenase-1	heme	NN	B-NP	B-proteinoxygenase-1	and	oxygenase-1	NN	I-NP	I-proteinand	its	and	CC	O	Oits	functional	its	PRP$	B-NP	Ofunctional	significance	functional	JJ	I-NP	Osignificance	in	significance	NN	I-NP	Oin	acetaminophen-induced	in	IN	B-PP	Oacetaminophen-induced	hepatitis	acetaminophen-induced	JJ	B-NP	Ohepatitis	and	hepatitis	NN	I-NP	Oand	hepatocellular	and	CC	O	Ohepatocellular	injury	hepatocellular	JJ	B-NP	Oinjury	in	injury	NN	I-NP	Oin	the	in	IN	B-PP	Othe	rat	the	DT	B-NP	Orat	.	rat	NN	I-NP	O.	BACKGROUND/AIM	.	.	O	OBACKGROUND/AIM	:	BACKGROUND/AIM	NN	B-NP	O:	Glutathione	:	:	O	OGlutathione	depletion	Glutathione	NN	B-NP	Odepletion	contributes	depletion	NN	I-NP	Ocontributes	to	contribute	VBZ	B-VP	Oto	acetaminophen	to	TO	I-VP	Oacetaminophen	hepatotoxicity	acetaminophen	VB	I-VP	Ohepatotoxicity	and	hepatotoxicity	NN	B-NP	Oand	is	and	CC	O	Ois	known	be	VBZ	B-VP	Oknown	to	know	VBN	I-VP	Oto	induce	to	TO	I-VP	Oinduce	the	induce	VB	I-VP	Othe	oxidative	the	DT	B-NP	Ooxidative	stress	oxidative	JJ	I-NP	B-proteinstress	reactant	stress	NN	I-NP	I-proteinreactant	heme	reactant	NN	I-NP	I-proteinheme	oxygenase-1	heme	NN	I-NP	I-proteinoxygenase-1	.	oxygenase-1	NN	I-NP	I-protein.	The	.	.	O	OThe	metabolites	The	DT	B-NP	Ometabolites	of	metabolite	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	heme	the	DT	B-NP	Oheme	oxygenase	heme	NN	I-NP	B-proteinoxygenase	pathway	oxygenase	NN	I-NP	I-proteinpathway	","	pathway	NN	I-NP	O","	biliverdin	","	","	O	Obiliverdin	","	biliverdin	NN	B-NP	O","	carbon	","	","	O	Ocarbon	monoxide	carbon	NN	B-NP	Omonoxide	","	monoxide	NN	I-NP	O","	and	","	","	O	Oand	iron	and	CC	O	Oiron	may	iron	NN	B-NP	Omay	modulate	may	MD	B-VP	Omodulate	acetaminophen	modulate	VB	I-VP	Oacetaminophen	toxicity	acetaminophen	NN	B-NP	Otoxicity	.	toxicity	NN	I-NP	O.	The	.	.	O	OThe	aim	The	DT	B-NP	Oaim	of	aim	NN	I-NP	Oof	this	of	IN	B-PP	Othis	study	this	DT	B-NP	Ostudy	was	study	NN	I-NP	Owas	to	be	VBD	B-VP	Oto	assess	to	TO	B-VP	Oassess	cell-type	assess	VB	I-VP	Ocell-type	specific	cell-type	JJ	B-NP	Ospecific	expression	specific	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	heme	of	IN	B-PP	Oheme	oxygenase-1	heme	NN	B-NP	B-proteinoxygenase-1	and	oxygenase-1	NN	I-NP	I-proteinand	its	and	CC	O	Oits	impact	its	PRP$	B-NP	Oimpact	on	impact	NN	I-NP	Oon	liver	on	IN	B-PP	Oliver	injury	liver	NN	B-NP	Oinjury	and	injury	NN	I-NP	Oand	microcirculatory	and	CC	O	Omicrocirculatory	disturbances	microcirculatory	JJ	B-NP	Odisturbances	in	disturbance	NNS	I-NP	Oin	a	in	IN	B-PP	Oa	model	a	DT	B-NP	Omodel	of	model	NN	I-NP	Oof	acetaminophen-induced	of	IN	B-PP	Oacetaminophen-induced	hepatitis	acetaminophen-induced	JJ	B-NP	Ohepatitis	.	hepatitis	NN	I-NP	O.	METHODS	.	.	O	OMETHODS	:	METHODS	NNS	B-NP	O:	Gene	:	:	O	OGene	expression	Gene	NN	B-NP	Oexpression	of	expression	NN	I-NP	Oof	heme	of	IN	B-PP	Oheme	oxygenase-1	heme	NN	B-NP	B-proteinoxygenase-1	was	oxygenase-1	NN	I-NP	I-proteinwas	studied	be	VBD	B-VP	Ostudied	by	study	VBN	I-VP	Oby	Northern-	by	IN	B-PP	ONorthern-	and	Northern-	NN	B-NP	Oand	Western	and	CC	O	OWestern	analysis	Western	JJ	B-NP	Oanalysis	as	analysis	NN	I-NP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	immunohistochemistry	as	IN	I-CONJP	Oimmunohistochemistry	.	immunohistochemistry	NN	B-NP	O.	The	.	.	O	OThe	time	The	DT	B-NP	Otime	course	time	NN	I-NP	Ocourse	of	course	NN	I-NP	Oof	heme	of	IN	B-PP	Oheme	oxygenase-1	heme	NN	B-NP	B-proteinoxygenase-1	and	oxygenase-1	NN	I-NP	I-proteinand	-2	and	CC	O	I-protein-2	","	-2	CD	B-NP	I-protein","	cytokine-induced	","	","	O	Ocytokine-induced	neutrophil	cytokine-induced	JJ	B-NP	Oneutrophil	chemoattractant-1	neutrophil	NN	I-NP	Ochemoattractant-1	","	chemoattractant-1	NN	I-NP	O","	and	","	","	O	Oand	intercellular	and	CC	O	Ointercellular	adhesion	intercellular	JJ	B-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	was	molecule-1	NN	I-NP	I-proteinwas	studied	be	VBD	B-VP	Ostudied	by	study	VBN	I-VP	Oby	Northern	by	IN	B-PP	ONorthern	analysis	Northern	JJ	B-NP	Oanalysis	.	analysis	NN	I-NP	O.	DNA-binding	.	.	O	ODNA-binding	activity	DNA-binding	JJ	B-NP	Oactivity	of	activity	NN	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor-kappaB	nuclear	JJ	B-NP	B-proteinfactor-kappaB	was	factor-kappaB	NN	I-NP	I-proteinwas	determined	be	VBD	B-VP	Odetermined	by	determine	VBN	I-VP	Oby	electrophoretic	by	IN	B-PP	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assay	shift	NN	I-NP	Oassay	.	assay	NN	I-NP	O.	Sinusoidal	.	.	O	OSinusoidal	perfusion	Sinusoidal	JJ	B-NP	Operfusion	and	perfusion	NN	I-NP	Oand	leukocyte-endothelial	and	CC	O	Oleukocyte-endothelial	interactions	leukocyte-endothelial	JJ	B-NP	Ointeractions	were	interaction	NNS	I-NP	Owere	assessed	be	VBD	B-VP	Oassessed	by	assess	VBN	I-VP	Oby	intravital	by	IN	B-PP	Ointravital	microscopy	intravital	JJ	B-NP	Omicroscopy	.	microscopy	NN	I-NP	O.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	Acetaminophen	:	:	O	OAcetaminophen	caused	Acetaminophen	NN	B-NP	Ocaused	a	cause	VBD	B-VP	Oa	moderate	a	DT	B-NP	Omoderate	sinusoidal	moderate	JJ	I-NP	Osinusoidal	perfusion	sinusoidal	JJ	I-NP	Operfusion	failure	perfusion	NN	I-NP	Ofailure	(	failure	NN	I-NP	O(	-15	(	(	O	O-15	%	-15	CD	B-NP	O%	)	%	NN	I-NP	O)	and	)	)	O	Oand	infiltration	and	CC	O	Oinfiltration	of	infiltration	NN	B-NP	Oof	neutrophils	of	IN	B-PP	Oneutrophils	along	neutrophil	NNS	B-NP	B-cell_typealong	with	along	IN	B-PP	Owith	activation	with	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor-kappaB	nuclear	JJ	B-NP	B-proteinfactor-kappaB	and	factor-kappaB	NN	I-NP	I-proteinand	intercellular	and	CC	O	Ointercellular	adhesion	intercellular	JJ	B-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	and	molecule-1	NN	I-NP	I-proteinand	cytokine-induced	and	CC	O	Ocytokine-induced	neutrophil	cytokine-induced	JJ	B-NP	B-RNAneutrophil	chemoattractant-1	neutrophil	NN	I-NP	I-RNAchemoattractant-1	mRNAs	chemoattractant-1	NN	I-NP	I-RNAmRNAs	.	mRNA	NNS	I-NP	I-RNA.	Induction	.	.	O	OInduction	of	Induction	NN	B-NP	Oof	heme	of	IN	B-PP	Oheme	oxygenase-1	heme	NN	B-NP	B-RNAoxygenase-1	mRNA	oxygenase-1	NN	I-NP	I-RNAmRNA	and	mRNA	NN	I-NP	I-RNAand	protein	and	CC	O	Oprotein	(	protein	NN	B-NP	O(	approximately	(	(	O	Oapproximately	30-fold	approximately	RB	B-ADVP	O30-fold	)	30-fold	RB	I-ADVP	O)	in	)	)	O	Oin	hepatocytes	in	IN	B-PP	Ohepatocytes	and	hepatocyte	NNS	B-NP	B-cell_typeand	non-parenchymal	and	CC	O	Onon-parenchymal	cells	non-parenchymal	JJ	B-NP	B-cell_typecells	paralleled	cell	NNS	I-NP	I-cell_typeparalleled	the	parallel	VBD	B-VP	Othe	inflammatory	the	DT	B-NP	Oinflammatory	response	inflammatory	JJ	I-NP	Oresponse	.	response	NN	I-NP	O.	Blockade	.	.	O	OBlockade	of	Blockade	NN	B-NP	Oof	heme	of	IN	B-PP	Oheme	oxygenase	heme	NN	B-NP	B-proteinoxygenase	activity	oxygenase	NN	I-NP	I-proteinactivity	with	activity	NN	I-NP	Owith	tin-protoporphyrin-IX	with	IN	B-PP	Otin-protoporphyrin-IX	abrogated	tin-protoporphyrin-IX	NN	B-NP	Oabrogated	acetaminophen-induced	abrogate	VBD	B-VP	Oacetaminophen-induced	hepatic	acetaminophen-induced	JJ	B-NP	Ohepatic	neutrophil	hepatic	JJ	I-NP	Oneutrophil	accumulation	neutrophil	NN	I-NP	Oaccumulation	and	accumulation	NN	I-NP	Oand	nuclear	and	CC	O	Onuclear	factor-kappaB	nuclear	JJ	B-NP	B-proteinfactor-kappaB	activation	factor-kappaB	NN	I-NP	I-proteinactivation	","	activation	NN	I-NP	O","	but	","	","	O	Obut	failed	but	CC	O	Ofailed	to	fail	VBD	B-VP	Oto	affect	to	TO	I-VP	Oaffect	sinusoidal	affect	VB	I-VP	Osinusoidal	perfusion	sinusoidal	JJ	B-NP	Operfusion	and	perfusion	NN	I-NP	Oand	liver	and	CC	I-NP	Oliver	injury	liver	NN	I-NP	Oinjury	.	injury	NN	I-NP	O.	CONCLUSIONS	.	.	O	OCONCLUSIONS	:	CONCLUSIONS	NNS	B-NP	O:	The	:	:	O	OThe	inflammatory	The	DT	B-NP	Oinflammatory	response	inflammatory	JJ	I-NP	Oresponse	associated	response	NN	I-NP	Oassociated	with	associate	VBN	B-VP	Owith	acetaminophen	with	IN	B-PP	Oacetaminophen	hepatotoxicity	acetaminophen	NN	B-NP	Ohepatotoxicity	is	hepatotoxicity	NN	I-NP	Ois	modulated	be	VBZ	B-VP	Omodulated	by	modulate	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	parallel	the	DT	B-NP	Oparallel	induction	parallel	JJ	I-NP	Oinduction	of	induction	NN	I-NP	Oof	the	of	IN	B-PP	Othe	heme	the	DT	B-NP	Oheme	oxygenase-1	heme	NN	I-NP	B-DNAoxygenase-1	gene	oxygenase-1	NN	I-NP	I-DNAgene	.	gene	NN	I-NP	I-DNA.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	heme	","	","	O	Oheme	oxygenase-1	heme	NN	B-NP	B-proteinoxygenase-1	has	oxygenase-1	NN	I-NP	I-proteinhas	no	have	VBZ	B-VP	Ono	permissive	no	DT	B-NP	Opermissive	effect	permissive	JJ	I-NP	Oeffect	on	effect	NN	I-NP	Oon	sinusoidal	on	IN	B-PP	Osinusoidal	perfusion	sinusoidal	JJ	B-NP	Operfusion	and	perfusion	NN	I-NP	Oand	does	and	CC	O	Odoes	not	do	VBZ	B-VP	Onot	affect	not	RB	I-VP	Oaffect	liver	affect	VB	I-VP	Oliver	injury	liver	NN	B-NP	Oinjury	in	injury	NN	I-NP	Oin	this	in	IN	B-PP	Othis	model	this	DT	B-NP	Omodel	.	model	NN	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	argue	datum	NNS	I-NP	Oargue	against	argue	VBP	B-VP	Oagainst	a	against	IN	B-PP	Oa	central	a	DT	B-NP	Ocentral	role	central	JJ	I-NP	Orole	of	role	NN	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor-kappaB	nuclear	JJ	B-NP	B-proteinfactor-kappaB	activation	factor-kappaB	NN	I-NP	I-proteinactivation	and	activation	NN	I-NP	Oand	neutrophil	and	CC	O	Oneutrophil	infiltration	neutrophil	NN	B-NP	Oinfiltration	as	infiltration	NN	I-NP	Oas	perpetuating	as	IN	B-PP	Operpetuating	factors	perpetuate	VBG	B-VP	B-proteinfactors	of	factor	NNS	B-NP	I-proteinof	liver	of	IN	B-PP	Oliver	injury	liver	NN	B-NP	Oinjury	in	injury	NN	I-NP	Oin	acetaminophen	in	IN	B-PP	Oacetaminophen	toxicity	acetaminophen	NN	B-NP	Otoxicity	.	toxicity	NN	I-NP	O.	Tumor	.	.	O	OTumor	necrosis	Tumor	NN	B-NP	B-proteinnecrosis	factor-alpha	necrosis	NN	I-NP	I-proteinfactor-alpha	#NAME?	factor-alpha	NN	I-NP	I-protein#NAME?	proliferation	#NAME?	JJ	I-NP	Oproliferation	requires	proliferation	NN	I-NP	Orequires	synthesis	require	VBZ	B-VP	Osynthesis	of	synthesis	NN	B-NP	Oof	granulocyte-macrophage	of	IN	B-PP	Ogranulocyte-macrophage	colony-stimulating	granulocyte-macrophage	JJ	B-NP	B-proteincolony-stimulating	factor	colony-stimulating	JJ	I-NP	I-proteinfactor	.	factor	NN	I-NP	I-protein.	OBJECTIVE	.	.	O	OOBJECTIVE	:	OBJECTIVE	NN	B-NP	O:	Tumor	:	:	O	OTumor	necrosis	Tumor	NN	B-NP	B-proteinnecrosis	factor-	necrosis	NN	I-NP	I-proteinfactor-	alpha	factor-	NN	I-NP	I-proteinalpha	(	alpha	NN	I-NP	I-protein(	TNF-alpha	(	(	O	OTNF-alpha	)	TNF-alpha	NN	B-NP	B-protein)	induces	)	)	O	Oinduces	a	induce	VBZ	B-VP	Oa	variety	a	DT	B-NP	Ovariety	of	variety	NN	I-NP	Oof	cellular	of	IN	B-PP	Ocellular	responses	cellular	JJ	B-NP	Oresponses	","	response	NNS	I-NP	O","	some	","	","	O	Osome	of	some	DT	B-NP	Oof	them	of	IN	B-PP	Othem	being	them	PRP	B-NP	Obeing	at	be	VBG	B-VP	Oat	least	at	IN	B-ADVP	Oleast	seemingly	least	JJS	I-ADVP	Oseemingly	contradictory	seemingly	RB	B-ADJP	Ocontradictory	.	contradictory	JJ	I-ADJP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	we	","	","	O	Owe	set	we	PRP	B-NP	Oset	out	set	VBD	B-VP	Oout	to	out	RP	B-PRT	Oto	find	to	TO	B-VP	Ofind	differences	find	VB	I-VP	Odifferences	in	difference	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	modes	the	DT	B-NP	Omodes	of	mode	NNS	I-NP	Oof	proliferative	of	IN	B-PP	Oproliferative	and	proliferative	JJ	B-NP	Oand	apoptotic	and	CC	I-NP	Oapoptotic	responses	apoptotic	JJ	I-NP	Oresponses	to	response	NNS	I-NP	Oto	TNF-	to	TO	B-PP	OTNF-	alpha	TNF-	NN	B-NP	B-proteinalpha	.	alpha	NN	I-NP	I-protein.	MATERIALS	.	.	O	OMATERIALS	AND	MATERIALS	NNS	B-NP	OAND	METHODS	AND	CC	I-NP	OMETHODS	:	METHODS	NNS	I-NP	O:	We	:	:	O	OWe	screened	We	PRP	B-NP	Oscreened	a	screen	VBD	B-VP	Oa	panel	a	DT	B-NP	Opanel	of	panel	NN	I-NP	Oof	acute	of	IN	B-PP	Oacute	myeloid	acute	JJ	B-NP	B-cell_linemyeloid	leukemia-derived	myeloid	JJ	I-NP	I-cell_lineleukemia-derived	cell	leukemia-derived	JJ	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	for	line	NNS	I-NP	I-cell_linefor	TNF-	for	IN	B-PP	OTNF-	alpha	TNF-	NN	B-NP	B-proteinalpha	#NAME?	alpha	NN	I-NP	I-protein#NAME?	.	#NAME?	NN	I-NP	O.	In	.	.	O	OIn	two	In	IN	B-PP	Otwo	lines	two	CD	B-NP	Olines	(	line	NNS	I-NP	O(	OCI-AML-1	(	(	O	OOCI-AML-1	","	OCI-AML-1	NN	B-NP	B-protein","	OCI-AML-11	","	","	I-NP	OOCI-AML-11	)	OCI-AML-11	NN	I-NP	B-protein)	","	)	)	O	O","	TNF-	","	","	O	OTNF-	alpha	TNF-	NN	B-NP	B-proteinalpha	acted	alpha	NN	I-NP	I-proteinacted	as	act	VBD	B-VP	Oas	an	as	IN	B-PP	Oan	apoptotic	an	DT	B-NP	Oapoptotic	agent	apoptotic	JJ	I-NP	Oagent	;	agent	NN	I-NP	O;	in	;	:	O	Oin	others	in	IN	B-PP	Oothers	(	other	NNS	B-NP	O(	HU-3	(	(	O	OHU-3	","	HU-3	NN	B-NP	B-protein","	M-07e	","	","	O	OM-07e	","	M-07e	NN	B-NP	O","	TF-1	","	","	O	OTF-1	)	TF-1	NN	B-NP	B-protein)	","	)	)	O	O","	it	","	","	O	Oit	had	it	PRP	B-NP	Ohad	the	have	VBD	B-VP	Othe	opposite	the	DT	B-NP	Oopposite	effect	opposite	JJ	I-NP	Oeffect	","	effect	NN	I-NP	O","	preventing	","	","	O	Opreventing	apoptosis	prevent	VBG	B-VP	Oapoptosis	and	apoptosis	NN	B-NP	Oand	inducing	and	CC	O	Oinducing	proliferation	induce	VBG	B-VP	Oproliferation	.	proliferation	NN	B-NP	O.	Direct	.	.	O	ODirect	and	Direct	JJ	B-NP	Oand	indirect	and	CC	I-NP	Oindirect	signaling	indirect	JJ	I-NP	Osignaling	mechanisms	signaling	NN	I-NP	Omechanisms	","	mechanism	NNS	I-NP	O","	including	","	","	O	Oincluding	NF-kappaB	include	VBG	B-PP	ONF-kappaB	activation	NF-kappaB	NN	B-NP	B-proteinactivation	and	activation	NN	I-NP	Oand	cytokine	and	CC	O	Ocytokine	synthesis	cytokine	NN	B-NP	B-proteinsynthesis	","	synthesis	NN	I-NP	O","	were	","	","	O	Owere	analyzed	be	VBD	B-VP	Oanalyzed	.	analyze	VBN	I-VP	O.	RESULTS	.	.	O	ORESULTS	:	RESULTS	NNS	B-NP	O:	All	:	:	O	OAll	cell	All	DT	B-NP	Ocell	lines	cell	NN	I-NP	B-cell_linelines	tested	line	NNS	I-NP	I-cell_linetested	expressed	test	VBN	B-VP	Oexpressed	TNF-	express	VBD	B-VP	OTNF-	alpha	TNF-	NN	B-NP	Oalpha	receptors	alpha	SYM	B-NP	Oreceptors	I	receptor	NNS	I-NP	OI	and	I	CD	B-NP	Oand	II	and	CC	I-NP	OII	and	II	CD	I-NP	Oand	responded	and	CC	O	Oresponded	to	respond	VBD	B-VP	Oto	TNF-	to	TO	B-PP	OTNF-	alpha	TNF-	NN	B-NP	B-proteinalpha	by	alpha	NN	I-NP	I-proteinby	upregulation	by	IN	B-PP	Oupregulation	of	upregulation	NN	B-NP	Oof	intercellular	of	IN	B-PP	Ointercellular	adhesion	intercellular	JJ	B-NP	B-proteinadhesion	molecule-1	adhesion	NN	I-NP	I-proteinmolecule-1	.	molecule-1	NN	I-NP	I-protein.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	to	contrast	NN	B-NP	Oto	granulocyte-macrophage	to	TO	B-PP	Ogranulocyte-macrophage	colony-stimulating	granulocyte-macrophage	JJ	B-NP	B-proteincolony-stimulating	factor	colony-stimulating	JJ	I-NP	I-proteinfactor	(	factor	NN	I-NP	I-protein(	GM-CSF	(	(	O	OGM-CSF	)	GM-CSF	NN	B-NP	B-protein)	","	)	)	O	O","	TNF-	","	","	O	OTNF-	alpha	TNF-	NN	B-NP	B-proteinalpha	did	alpha	NN	I-NP	I-proteindid	not	do	VBD	B-VP	Onot	activate	not	RB	I-VP	Oactivate	the	activate	VB	I-VP	Othe	MAP	the	DT	B-NP	OMAP	kinase	MAP	NN	I-NP	B-proteinkinase	and	kinase	NN	I-NP	I-proteinand	p70S6	and	CC	O	Op70S6	kinase	p70S6	NN	B-NP	B-proteinkinase	pathways	kinase	NN	I-NP	I-proteinpathways	.	pathway	NNS	I-NP	O.	Nevertheless	.	.	O	ONevertheless	","	Nevertheless	RB	B-ADVP	O","	inhibitors	","	","	O	Oinhibitors	of	inhibitor	NNS	B-NP	Oof	these	of	IN	B-PP	Othese	pathways	these	DT	B-NP	Opathways	clearly	pathway	NNS	I-NP	Oclearly	reduced	clearly	RB	B-ADVP	Oreduced	the	reduce	VBD	B-VP	Othe	TNF-alpha	the	DT	B-NP	OTNF-alpha	#NAME?	TNF-alpha	NN	I-NP	B-protein#NAME?	cell	#NAME?	JJ	I-NP	Ocell	growth	cell	NN	I-NP	Ogrowth	","	growth	NN	I-NP	O","	indicating	","	","	O	Oindicating	that	indicate	VBG	B-VP	Othat	TNF-	that	IN	B-SBAR	OTNF-	alpha-proliferative	TNF-	NN	B-NP	B-cell_linealpha-proliferative	cells	alpha-proliferative	JJ	I-NP	I-cell_linecells	produced	cell	NNS	I-NP	I-cell_lineproduced	a	produce	VBD	B-VP	Oa	growth	a	DT	B-NP	Ogrowth	factor	growth	NN	I-NP	B-proteinfactor	that	factor	NN	I-NP	I-proteinthat	induced	that	WDT	B-NP	Oinduced	proliferation	induce	VBD	B-VP	Oproliferation	upon	proliferation	NN	B-NP	Oupon	stimulation	upon	IN	B-PP	Ostimulation	of	stimulation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	above	the	DT	B-NP	Oabove	pathways	above	JJ	I-NP	Opathways	.	pathway	NNS	I-NP	O.	Anti-GM-CSF	.	.	O	OAnti-GM-CSF	antibodies	Anti-GM-CSF	JJ	B-NP	B-proteinantibodies	inhibited	antibody	NNS	I-NP	I-proteininhibited	the	inhibit	VBD	B-VP	Othe	TNF-alpha	the	DT	B-NP	OTNF-alpha	#NAME?	TNF-alpha	NN	I-NP	B-protein#NAME?	growth	#NAME?	JJ	I-NP	Ogrowth	","	growth	NN	I-NP	O","	suggesting	","	","	O	Osuggesting	the	suggest	VBG	B-VP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	an	of	IN	B-PP	Oan	autocrine	an	DT	B-NP	Oautocrine	loop	autocrine	JJ	I-NP	Oloop	for	loop	NN	I-NP	Ofor	cell	for	IN	B-PP	Ocell	proliferation	cell	NN	B-NP	Oproliferation	mediated	proliferation	NN	I-NP	Omediated	by	mediate	VBN	B-VP	Oby	GM-CSF	by	IN	B-PP	OGM-CSF	.	GM-CSF	NN	B-NP	B-protein.	Supporting	.	.	O	OSupporting	this	Support	VBG	B-VP	Othis	notion	this	DT	B-NP	Onotion	","	notion	NN	I-NP	O","	TNF-alpha	","	","	O	OTNF-alpha	#NAME?	TNF-alpha	NN	B-NP	B-protein#NAME?	upregulation	#NAME?	JJ	I-NP	Oupregulation	of	upregulation	NN	I-NP	Oof	GM-CSF	of	IN	B-PP	OGM-CSF	mRNA	GM-CSF	NN	B-NP	B-RNAmRNA	levels	mRNA	NN	I-NP	I-RNAlevels	and	level	NNS	I-NP	Oand	protein	and	CC	O	Oprotein	secretion	protein	NN	B-NP	Osecretion	in	secretion	NN	I-NP	Oin	the	in	IN	B-PP	Othe	TNF-alpha	the	DT	B-NP	OTNF-alpha	#NAME?	TNF-alpha	NN	I-NP	B-protein#NAME?	","	#NAME?	JJ	B-ADJP	O","	but	","	","	O	Obut	not	but	CC	B-PP	Onot	in	not	RB	B-PP	Oin	the	in	IN	I-PP	Othe	TNF-alpha-apoptotic	the	DT	B-NP	OTNF-alpha-apoptotic	cell	TNF-alpha-apoptotic	JJ	I-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	.	line	NNS	I-NP	I-cell_line.	CONCLUSION	.	.	O	OCONCLUSION	:	CONCLUSION	NN	B-NP	O:	These	:	:	O	OThese	data	These	DT	B-NP	Odata	identify	datum	NNS	I-NP	Oidentify	GM-CSF	identify	VBP	B-VP	OGM-CSF	synthesis	GM-CSF	NN	B-NP	B-proteinsynthesis	as	synthesis	NN	I-NP	Oas	an	as	IN	B-PP	Oan	early	an	DT	B-NP	Oearly	and	early	JJ	I-NP	Oand	essential	and	CC	I-NP	Oessential	step	essential	JJ	I-NP	Ostep	in	step	NN	I-NP	Oin	TNF-	in	IN	B-PP	OTNF-	alpha-induced	TNF-	NN	B-NP	Oalpha-induced	proliferation	alpha-induced	JJ	I-NP	Oproliferation	.	proliferation	NN	I-NP	O.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	for	show	VBP	B-VP	Ofor	the	for	IN	B-PP	Othe	first	the	DT	B-NP	Ofirst	time	first	JJ	I-NP	Otime	that	time	NN	I-NP	Othat	TNF-alpha-treated	that	IN	B-ADVP	OTNF-alpha-treated	cell	TNF-alpha-treated	JJ	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	producing	line	NNS	I-NP	I-cell_lineproducing	no	produce	VBG	B-VP	Ono	or	no	RB	B-ADVP	Oor	only	or	CC	I-ADVP	Oonly	minimal	only	RB	B-NP	Ominimal	amounts	minimal	JJ	I-NP	Oamounts	of	amount	NNS	I-NP	Oof	GM-CSF	of	IN	B-PP	OGM-CSF	demonstrate	GM-CSF	NN	B-NP	B-proteindemonstrate	an	demonstrate	VBP	B-VP	Oan	apoptotic	an	DT	B-NP	Oapoptotic	phenotype	apoptotic	JJ	I-NP	B-cell_linephenotype	","	phenotype	NN	I-NP	I-cell_line","	while	","	","	O	I-cell_linewhile	cell	while	IN	B-SBAR	I-cell_linecell	lines	cell	NN	B-NP	I-cell_linelines	with	line	NNS	I-NP	I-cell_linewith	high	with	IN	B-PP	Ohigh	GM-CSF	high	JJ	B-NP	OGM-CSF	expression	GM-CSF	NN	I-NP	B-proteinexpression	rates	expression	NN	I-NP	Orates	can	rate	NNS	I-NP	Ocan	escape	can	MD	B-VP	Oescape	from	escape	VB	I-VP	Ofrom	growth	from	IN	B-PP	Ogrowth	arrest	growth	NN	B-NP	Oarrest	or	arrest	NN	I-NP	Oor	even	or	CC	B-NP	Oeven	apoptosis	even	RB	I-NP	Oapoptosis	.	apoptosis	NN	B-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	context	this	DT	B-NP	Ocontext	","	context	NN	I-NP	O","	we	","	","	O	Owe	discuss	we	PRP	B-NP	Odiscuss	arguments	discuss	VBP	B-VP	Oarguments	pointing	argument	NNS	B-NP	Opointing	at	point	VBG	B-VP	Oat	NF-kappaB	at	IN	B-PP	ONF-kappaB	as	NF-kappaB	NN	B-NP	B-proteinas	regulator	as	IN	B-PP	Oregulator	of	regulator	NN	B-NP	Oof	GM-CSF	of	IN	B-PP	OGM-CSF	synthesis	GM-CSF	NN	B-NP	B-proteinsynthesis	and	synthesis	NN	I-NP	Oand	thus	and	CC	O	Othus	indirectly	thus	RB	B-ADVP	Oindirectly	as	indirectly	RB	B-ADVP	Oas	regulator	as	IN	B-PP	Oregulator	for	regulator	NN	B-NP	Ofor	the	for	IN	B-PP	Othe	escape	the	DT	B-NP	Oescape	of	escape	NN	I-NP	Oof	TNF-alpha	of	IN	B-PP	OTNF-alpha	#NAME?	TNF-alpha	NN	B-NP	B-protein#NAME?	apoptosis	#NAME?	JJ	I-NP	Oapoptosis	Glucocorticoid	apoptosis	NN	I-NP	OGlucocorticoid	receptor	Glucocorticoid	NN	B-NP	B-proteinreceptor	content	receptor	NN	I-NP	I-proteincontent	of	content	NN	I-NP	Oof	T	of	IN	B-PP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	:	lymphocyte	NNS	I-NP	I-cell_type:	evidence	:	:	O	Oevidence	for	evidence	NN	B-NP	Ofor	heterogeneity	for	IN	B-PP	Oheterogeneity	.	heterogeneity	NN	B-NP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	receptors	Glucocorticoid	NN	B-NP	B-proteinreceptors	were	receptor	NNS	I-NP	I-proteinwere	measured	be	VBD	B-VP	Omeasured	in	measure	VBN	I-VP	Oin	T	in	IN	B-PP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	that	lymphocyte	NNS	I-NP	I-cell_typethat	were	that	WDT	B-NP	Owere	isolated	be	VBD	B-VP	Oisolated	from	isolate	VBN	I-VP	Ofrom	peripheral	from	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	Oblood	by	blood	NN	I-NP	Oby	either	by	IN	B-PP	Oeither	nylon	either	CC	O	Onylon	wool	nylon	NN	B-NP	Owool	filtration	wool	NN	I-NP	Ofiltration	or	filtration	NN	I-NP	Oor	E-rosette	or	CC	O	OE-rosette	sedimentation	E-rosette	NN	B-NP	Osedimentation	.	sedimentation	NN	I-NP	O.	T	.	.	O	OT	cells	T	NN	B-NP	B-cell_typecells	isolated	cell	NNS	I-NP	I-cell_typeisolated	by	isolate	VBN	B-VP	Oby	nylon	by	IN	B-PP	Onylon	wool	nylon	NN	B-NP	Owool	filtration	wool	NN	I-NP	Ofiltration	specifically	filtration	NN	I-NP	Ospecifically	bind	specifically	RB	B-ADVP	Obind	6.7	bind	VBP	B-VP	O6.7	+/-	6.7	CD	B-NP	O+/-	0.2	+/-	SYM	I-NP	O0.2	fmol	0.2	CD	I-NP	Ofmol	of	fmol	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	per	dexamethasone	NN	B-NP	B-cell_lineper	million	per	IN	B-PP	I-cell_linemillion	cells	million	CD	B-NP	I-cell_linecells	(	cell	NNS	B-NP	I-cell_line(	equivalent	(	(	O	Oequivalent	to	equivalent	JJ	B-ADJP	Oto	4000	to	TO	B-PP	O4000	+/-	4000	CD	B-NP	O+/-	200	+/-	CC	I-NP	O200	receptors	200	CD	I-NP	Oreceptors	per	receptor	NNS	I-NP	Oper	cell	per	IN	B-PP	Ocell	)	cell	NN	B-NP	O)	","	)	)	O	O","	whereas	","	","	O	Owhereas	T	whereas	IN	O	OT	cells	T	NN	B-NP	B-cell_typecells	isolated	cell	NNS	I-NP	I-cell_typeisolated	by	isolate	VBN	B-VP	Oby	E-rosette	by	IN	B-PP	OE-rosette	sedimentation	E-rosette	NN	B-NP	Osedimentation	bind	sedimentation	NN	I-NP	Obind	12	bind	VBP	B-VP	O12	+/-	12	CD	B-NP	O+/-	0.7	+/-	SYM	I-NP	O0.7	fmol	0.7	CD	I-NP	Ofmol	of	fmol	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	per	dexamethasone	NN	B-NP	B-cell_lineper	million	per	IN	B-PP	I-cell_linemillion	cells	million	CD	B-NP	I-cell_linecells	(	cell	NNS	B-NP	I-cell_line(	equivalent	(	(	O	Oequivalent	to	equivalent	JJ	B-ADJP	Oto	7200	to	TO	B-PP	O7200	+/-	7200	CD	B-NP	O+/-	400	+/-	CC	I-NP	O400	receptors	400	CD	I-NP	Oreceptors	per	receptor	NNS	I-NP	Oper	cell	per	IN	B-PP	Ocell	)	cell	NN	B-NP	O)	.	)	)	O	O.	This	.	.	O	OThis	difference	This	DT	B-NP	Odifference	in	difference	NN	I-NP	Oin	the	in	IN	B-PP	Othe	amount	the	DT	B-NP	Oamount	of	amount	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	bound	dexamethasone	NN	B-NP	Obound	by	bind	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	two	the	DT	B-NP	Otwo	T	two	CD	I-NP	OT	cell	T	NN	I-NP	Ocell	preparations	cell	NN	I-NP	Opreparations	was	preparation	NNS	I-NP	Owas	significant	be	VBD	B-VP	Osignificant	(	significant	JJ	B-ADJP	O(	p	(	(	O	Op	less	p	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.001	than	IN	B-PP	O0.001	)	0.001	CD	B-NP	O)	and	)	)	O	Oand	was	and	CC	O	Owas	present	be	VBD	B-VP	Opresent	immediately	present	JJ	B-ADJP	Oimmediately	after	immediately	RB	B-ADVP	Oafter	cell	after	IN	B-PP	Ocell	isolation	cell	NN	B-NP	Oisolation	.	isolation	NN	I-NP	O.	The	.	.	O	OThe	binding	The	DT	B-NP	Obinding	affinities	binding	NN	I-NP	Oaffinities	of	affinity	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	different	the	DT	B-NP	Odifferent	T	different	JJ	I-NP	OT	cell	T	NN	I-NP	Ocell	preparations	cell	NN	I-NP	Opreparations	for	preparation	NNS	I-NP	Ofor	dexamethasone	for	IN	B-PP	Odexamethasone	were	dexamethasone	NN	B-NP	Owere	similar	be	VBD	B-VP	Osimilar	.	similar	JJ	B-ADJP	O.	T	.	.	O	OT	cells	T	NN	B-NP	B-cell_typecells	that	cell	NNS	I-NP	I-cell_typethat	are	that	WDT	B-NP	Oare	isolated	be	VBP	B-VP	Oisolated	by	isolate	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	combination	a	DT	B-NP	Ocombination	of	combination	NN	I-NP	Oof	nylon	of	IN	B-PP	Onylon	wool	nylon	NN	B-NP	Owool	filtration	wool	NN	I-NP	Ofiltration	followed	filtration	NN	I-NP	Ofollowed	by	follow	VBN	B-VP	Oby	E-rosette	by	IN	B-PP	OE-rosette	sedimentation	E-rosette	NN	B-NP	Osedimentation	bind	sedimentation	NN	I-NP	Obind	the	bind	VBP	B-VP	Othe	same	the	DT	B-NP	Osame	amount	same	JJ	I-NP	Oamount	of	amount	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	as	dexamethasone	NN	B-NP	Oas	T	as	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	isolated	cell	NNS	I-NP	I-cell_typeisolated	by	isolate	VBN	B-VP	Oby	nylon	by	IN	B-PP	Onylon	wool	nylon	NN	B-NP	Owool	filtration	wool	NN	I-NP	Ofiltration	alone	filtration	NN	I-NP	Oalone	.	alone	RB	B-ADVP	O.	T	.	.	O	OT	cells	T	NN	B-NP	B-cell_typecells	isolated	cell	NNS	I-NP	I-cell_typeisolated	by	isolate	VBN	B-VP	Oby	a	by	IN	B-PP	Oa	combination	a	DT	B-NP	Ocombination	of	combination	NN	I-NP	Oof	E-rosette	of	IN	B-PP	OE-rosette	sedimentation	E-rosette	NN	B-NP	Osedimentation	following	sedimentation	NN	I-NP	Ofollowing	by	follow	VBG	B-PP	Oby	nylon	by	IN	B-PP	Onylon	wool	nylon	NN	B-NP	Owool	filtration	wool	NN	I-NP	Ofiltration	bind	filtration	NN	I-NP	Obind	less	bind	VBP	B-VP	Oless	dexamethasone	less	JJR	B-NP	Odexamethasone	than	dexamethasone	NN	I-NP	Othan	do	than	IN	B-SBAR	Odo	T	do	VBP	O	OT	cells	T	NN	B-NP	B-cell_typecells	isolated	cell	NNS	I-NP	I-cell_typeisolated	by	isolate	VBN	B-VP	Oby	E-rosette	by	IN	B-PP	OE-rosette	sedimentation	E-rosette	NN	B-NP	Osedimentation	alone	sedimentation	NN	I-NP	Oalone	.	alone	RB	B-ADVP	O.	These	.	.	O	OThese	findings	These	DT	B-NP	Ofindings	suggest	finding	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	T	that	IN	B-SBAR	OT	cells	T	NN	B-NP	B-cell_typecells	are	cell	NNS	I-NP	I-cell_typeare	heterogeneous	be	VBP	B-VP	Oheterogeneous	with	heterogeneous	JJ	B-ADJP	Owith	respect	with	IN	B-PP	Orespect	to	respect	NN	B-NP	Oto	their	to	TO	B-PP	Otheir	quantity	their	PRP$	B-NP	Oquantity	of	quantity	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	Isolation	.	.	O	OIsolation	of	Isolation	NN	B-NP	Oof	T	of	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	E-rosette	by	IN	B-PP	OE-rosette	sedimentation	E-rosette	NN	B-NP	Osedimentation	enriches	sedimentation	NN	I-NP	Oenriches	for	enrich	VBZ	B-VP	Ofor	T	for	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	that	cell	NNS	I-NP	I-cell_typethat	have	that	WDT	B-NP	Ohave	a	have	VBP	B-VP	Oa	greater	a	DT	B-NP	Ogreater	number	great	JJR	I-NP	Onumber	of	number	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	","	receptor	NNS	I-NP	I-protein","	and	","	","	O	Oand	isolation	and	CC	O	Oisolation	of	isolation	NN	B-NP	Oof	T	of	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	nylon	by	IN	B-PP	Onylon	wool	nylon	NN	B-NP	Owool	filtration	wool	NN	I-NP	Ofiltration	enriches	filtration	NN	I-NP	Oenriches	for	enrich	VBZ	B-VP	Ofor	T	for	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	that	cell	NNS	I-NP	I-cell_typethat	have	that	WDT	B-NP	Ohave	a	have	VBP	B-VP	Oa	lesser	a	DT	B-NP	Olesser	number	less	JJR	I-NP	Onumber	of	number	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	Glucocorticoid	.	.	O	OGlucocorticoid	receptors	Glucocorticoid	NN	B-NP	B-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	glucocorticoid	and	CC	O	Oglucocorticoid	sensitivity	glucocorticoid	NN	B-NP	Osensitivity	of	sensitivity	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	leukemic	human	JJ	B-NP	B-cell_typeleukemic	cells	leukemic	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	established	have	VBP	B-VP	Oestablished	optimal	establish	VBN	I-VP	Ooptimal	conditions	optimal	JJ	B-NP	Oconditions	for	condition	NNS	I-NP	Ofor	the	for	IN	B-PP	Othe	measurement	the	DT	B-NP	Omeasurement	of	measurement	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	(	receptor	NNS	I-NP	I-protein(	GR	(	(	O	OGR	)	GR	NN	B-NP	B-protein)	in	)	)	O	Oin	human	in	IN	B-PP	Ohuman	white	human	JJ	B-NP	B-cell_typewhite	cells	white	JJ	I-NP	I-cell_typecells	using	cell	NNS	I-NP	I-cell_typeusing	a	use	VBG	B-VP	Oa	whole-cell	a	DT	B-NP	Owhole-cell	binding	whole-cell	JJ	I-NP	Obinding	assay	binding	NN	I-NP	Oassay	with	assay	NN	I-NP	Owith	[	with	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	dexamethasone	]	)	I-NP	Odexamethasone	as	dexamethasone	NN	I-NP	Oas	the	as	IN	B-PP	Othe	ligand	the	DT	B-NP	Oligand	","	ligand	NN	I-NP	O","	and	","	","	O	Oand	the	and	CC	O	Othe	subsequent	the	DT	B-NP	Osubsequent	determination	subsequent	JJ	I-NP	Odetermination	of	determination	NN	I-NP	Oof	the	of	IN	B-PP	Othe	GR	the	DT	B-NP	OGR	content	GR	NN	I-NP	B-proteincontent	in	content	NN	I-NP	Oin	normal	in	IN	B-PP	Onormal	human	normal	JJ	B-NP	B-cell_typehuman	lymphocytes	human	JJ	I-NP	I-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	in	and	CC	B-PP	Oin	leukemic	in	IN	B-PP	Oleukemic	cells	leukemic	JJ	B-NP	B-cell_typecells	of	cell	NNS	I-NP	I-cell_typeof	patients	of	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	various	with	IN	B-PP	Ovarious	forms	various	JJ	B-NP	Oforms	of	form	NNS	I-NP	Oof	acute	of	IN	B-PP	Oacute	and	acute	JJ	B-NP	Oand	chronic	and	CC	I-NP	Ochronic	leukemia	chronic	JJ	I-NP	Oleukemia	.	leukemia	NN	I-NP	O.	A	.	.	O	OA	number	A	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	leukemia	of	IN	B-PP	Oleukemia	cell	leukemia	NN	B-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	in	line	NNS	I-NP	I-cell_linein	continuous	in	IN	B-PP	Ocontinuous	culture	continuous	JJ	B-NP	B-cell_lineculture	were	culture	NN	I-NP	I-cell_linewere	also	be	VBD	B-VP	Oalso	subjected	also	RB	I-VP	Osubjected	to	subject	VBN	I-VP	Oto	the	to	TO	B-PP	Othe	GR	the	DT	B-NP	OGR	assay	GR	NN	I-NP	B-proteinassay	","	assay	NN	I-NP	O","	and	","	","	O	Oand	the	and	CC	O	Othe	results	the	DT	B-NP	Oresults	were	result	NNS	I-NP	Owere	correlated	be	VBD	B-VP	Ocorrelated	with	correlate	VBN	I-VP	Owith	the	with	IN	B-PP	Othe	sensitivity	the	DT	B-NP	Osensitivity	of	sensitivity	NN	I-NP	Oof	these	of	IN	B-PP	Othese	cell	these	DT	B-NP	Ocell	lines	cell	NN	I-NP	B-cell_linelines	to	line	NNS	I-NP	I-cell_lineto	glucocorticoid	to	TO	B-PP	Oglucocorticoid	steroids	glucocorticoid	NN	B-NP	Osteroids	in	steroid	NNS	I-NP	Oin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	The	.	.	O	OThe	GR	The	DT	B-NP	OGR	content	GR	NN	I-NP	B-proteincontent	of	content	NN	I-NP	Oof	normal	of	IN	B-PP	Onormal	human	normal	JJ	B-NP	B-cell_typehuman	lymphocytes	human	JJ	I-NP	I-cell_typelymphocytes	amounted	lymphocyte	NNS	I-NP	I-cell_typeamounted	to	amounte	VBD	B-VP	Oto	4	to	TO	B-PP	O4	","	4	CD	B-NP	O","	850	","	","	I-NP	O850	+/-	850	CD	I-NP	O+/-	1	+/-	SYM	I-NP	O1	","	1	CD	I-NP	O","	340	","	","	I-NP	O340	(	340	CD	I-NP	O(	mean	(	(	O	Omean	+/-	mean	NN	B-NP	O+/-	SD	+/-	SYM	O	OSD	)	SD	NN	B-NP	O)	receptors/cell	)	)	O	Oreceptors/cell	.	receptors/cell	NN	B-NP	O.	The	.	.	O	OThe	mean	The	DT	B-NP	Omean	equilibrium	mean	JJ	I-NP	Oequilibrium	dissociation	equilibrium	NN	I-NP	Odissociation	constant	dissociation	NN	I-NP	Oconstant	(	constant	NN	I-NP	O(	KD	(	(	O	OKD	)	KD	NN	B-NP	O)	of	)	)	O	Oof	the	of	IN	B-PP	Othe	interaction	the	DT	B-NP	Ointeraction	of	interaction	NN	I-NP	Oof	[	of	IN	B-PP	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	dexamethasone	]	)	O	Odexamethasone	with	dexamethasone	NN	B-NP	Owith	the	with	IN	B-PP	Othe	GR	the	DT	B-NP	OGR	was	GR	NN	I-NP	B-proteinwas	1.2	be	VBD	B-VP	O1.2	x	1.2	CD	B-NP	Ox	10	x	SYM	O	O10	(	10	CD	B-NP	O(	-8	(	(	O	O-8	)	-8	CD	B-NP	O)	M	)	)	O	OM	.	M	NN	B-NP	O.	Steroidal	.	.	O	OSteroidal	compounds	Steroidal	JJ	B-NP	Ocompounds	with	compound	NNS	I-NP	Owith	a	with	IN	B-PP	Oa	known	a	DT	B-NP	Oknown	glucocorticoid	know	VBN	I-NP	Oglucocorticoid	potency	glucocorticoid	NN	I-NP	Opotency	effectively	potency	NN	I-NP	Oeffectively	competed	effectively	RB	B-ADVP	Ocompeted	for	compete	VBD	B-VP	Ofor	the	for	IN	B-PP	Othe	binding	the	DT	B-NP	Obinding	","	binding	NN	I-NP	O","	whereas	","	","	O	Owhereas	steroids	whereas	IN	O	Osteroids	devoid	steroid	NNS	B-NP	Odevoid	of	devoid	JJ	B-ADJP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	activity	glucocorticoid	NN	B-NP	Oactivity	(	activity	NN	I-NP	O(	e.g.	(	(	O	Oe.g.	estradiol-17	e.g.	FW	B-PP	Oestradiol-17	beta	estradiol-17	NN	B-NP	Obeta	and	beta	NN	I-NP	Oand	testosterone	and	CC	O	Otestosterone	)	testosterone	NN	B-NP	O)	were	)	)	O	Owere	ineffective	be	VBD	B-VP	Oineffective	.	ineffective	JJ	B-ADJP	O.	The	.	.	O	OThe	GR	The	DT	B-NP	OGR	content	GR	NN	I-NP	B-proteincontent	of	content	NN	I-NP	Oof	the	of	IN	B-PP	Othe	blast	the	DT	B-NP	Oblast	cells	blast	NN	I-NP	B-cell_typecells	obtained	cell	NNS	I-NP	I-cell_typeobtained	from	obtain	VBN	B-VP	Ofrom	eight	from	IN	B-PP	Oeight	patients	eight	CD	B-NP	Opatients	suffering	patient	NNS	I-NP	Osuffering	from	suffer	VBG	B-VP	Ofrom	acute	from	IN	B-PP	Oacute	leukemia	acute	JJ	B-NP	Oleukemia	and	leukemia	NN	I-NP	Oand	four	and	CC	O	Ofour	patients	four	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	a	with	IN	B-PP	Oa	blast	a	DT	B-NP	Oblast	crisis	blast	NN	I-NP	Ocrisis	of	crisis	NN	I-NP	Oof	chronic	of	IN	B-PP	Ochronic	myelocytic	chronic	JJ	B-NP	Omyelocytic	leukemia	myelocytic	JJ	I-NP	Oleukemia	was	leukemia	NN	I-NP	Owas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	highly	be	VB	I-VP	Ohighly	variable	highly	RB	B-ADJP	Ovariable	(	variable	JJ	I-ADJP	O(	3	(	(	O	O3	","	3	CD	B-NP	O","	230-29	","	","	I-NP	O230-29	","	230-29	CD	I-NP	O","	900	","	","	I-NP	O900	receptors/cell	900	CD	I-NP	Oreceptors/cell	)	receptors/cell	NNS	I-NP	O)	","	)	)	O	O","	while	","	","	O	Owhile	the	while	IN	B-SBAR	Othe	lymphocytes	the	DT	B-NP	Olymphocytes	of	lymphocyte	NNS	I-NP	B-cell_typeof	six	of	IN	B-PP	Osix	patients	six	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	chronic	with	IN	B-PP	Ochronic	lymphatic	chronic	JJ	B-NP	Olymphatic	leukemia	lymphatic	JJ	I-NP	Oleukemia	contained	leukemia	NN	I-NP	Ocontained	a	contain	VBD	B-VP	Oa	rather	a	DT	B-NP	Orather	stable	rather	RB	I-NP	Ostable	GR	stable	JJ	I-NP	OGR	content	GR	NN	I-NP	B-proteincontent	(	content	NN	I-NP	O(	2	(	(	O	O2	","	2	CD	B-NP	O","	930-5	","	","	I-NP	O930-5	","	930-5	CD	I-NP	O","	120	","	","	I-NP	O120	receptors/cell	120	CD	I-NP	Oreceptors/cell	)	receptors/cell	NNS	I-NP	O)	","	)	)	O	O","	which	","	","	O	Owhich	was	which	WDT	B-NP	Owas	comparable	be	VBD	B-VP	Ocomparable	with	comparable	JJ	B-ADJP	Owith	that	with	IN	B-PP	Othat	of	that	DT	B-NP	Oof	normal	of	IN	B-PP	Onormal	lymphocytes	normal	JJ	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	GR	.	.	O	OGR	was	GR	NN	B-NP	B-proteinwas	identified	be	VBD	B-VP	Oidentified	in	identify	VBN	I-VP	Oin	all	in	IN	B-PP	Oall	the	all	PDT	B-NP	Othe	12	the	DT	I-NP	O12	malignant	12	CD	I-NP	B-cell_linemalignant	continuous	malignant	JJ	I-NP	I-cell_linecontinuous	white	continuous	JJ	I-NP	I-cell_linewhite	cell	white	JJ	I-NP	I-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	studied	line	NNS	I-NP	I-cell_linestudied	.	study	VBN	B-VP	O.	Large	.	.	O	OLarge	cells	Large	JJ	B-NP	B-cell_typecells	contained	cell	NNS	I-NP	I-cell_typecontained	more	contain	VBD	B-VP	Omore	GR	more	JJR	B-NP	OGR	than	GR	NN	I-NP	B-proteinthan	the	than	IN	B-PP	Othe	smaller	the	DT	B-NP	Osmaller	ones	small	JJR	I-NP	Oones	.	one	NNS	I-NP	O.	There	.	.	O	OThere	was	There	EX	B-NP	Owas	no	be	VBD	B-VP	Ono	apparent	no	DT	B-NP	Oapparent	correlation	apparent	JJ	I-NP	Ocorrelation	between	correlation	NN	I-NP	Obetween	the	between	IN	B-PP	Othe	GR	the	DT	B-NP	OGR	concentration	GR	NN	I-NP	B-proteinconcentration	and	concentration	NN	I-NP	Oand	the	and	CC	O	Othe	sensitivity	the	DT	B-NP	Osensitivity	of	sensitivity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cells	the	DT	B-NP	Ocells	in	cell	NNS	I-NP	Oin	vitro	in	FW	B-PP	Ovitro	to	vitro	FW	B-NP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	as	glucocorticoid	NNS	B-NP	Oas	judged	as	IN	B-SBAR	Ojudged	by	judge	VBN	B-VP	Oby	[	by	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	thymidine	]	)	I-NP	Othymidine	incorporation	thymidine	NN	I-NP	Oincorporation	studies	incorporation	NN	I-NP	Ostudies	.	study	NNS	I-NP	O.	Distribution	.	.	O	ODistribution	of	Distribution	NN	B-NP	Oof	the	of	IN	B-PP	Othe	surface	the	DT	B-NP	Osurface	markers	surface	NN	I-NP	B-proteinmarkers	in	marker	NNS	I-NP	I-proteinin	the	in	IN	B-PP	Othe	leukemic	the	DT	B-NP	Oleukemic	cell	leukemic	JJ	I-NP	B-cell_linecell	lines	cell	NN	I-NP	I-cell_linelines	did	line	NNS	I-NP	I-cell_linedid	not	do	VBD	B-VP	Onot	relate	not	RB	I-VP	Orelate	to	relate	VB	I-VP	Oto	the	to	TO	B-PP	Othe	GR	the	DT	B-NP	OGR	concentration	GR	NN	I-NP	B-proteinconcentration	.	concentration	NN	I-NP	O.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	GR	of	IN	B-PP	OGR	is	GR	NN	B-NP	B-proteinis	probably	be	VBZ	B-VP	Oprobably	a	probably	RB	B-ADVP	Oa	universal	a	DT	B-NP	Ouniversal	feature	universal	JJ	I-NP	Ofeature	of	feature	NN	I-NP	Oof	the	of	IN	B-PP	Othe	leukemic	the	DT	B-NP	Oleukemic	cells	leukemic	JJ	I-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	","	and	CC	O	O","	from	","	","	O	Ofrom	a	from	IN	B-PP	Oa	clinical	a	DT	B-NP	Oclinical	standpoint	clinical	JJ	I-NP	Ostandpoint	","	standpoint	NN	I-NP	O","	probably	","	","	O	Oprobably	does	probably	RB	B-ADVP	Odoes	not	do	VBZ	B-VP	Onot	alone	not	RB	I-VP	Oalone	imply	alone	RB	I-VP	Oimply	steroid	imply	VB	I-VP	Osteroid	responsiveness	steroid	NN	B-NP	Oresponsiveness	.	responsiveness	NN	I-NP	O.	Evidence	.	.	O	OEvidence	for	Evidence	NN	B-NP	Ofor	a	for	IN	B-PP	Oa	steroid	a	DT	B-NP	Osteroid	receptor	steroid	NN	I-NP	B-proteinreceptor	in	receptor	NN	I-NP	I-proteinin	rheumatoid	in	IN	B-PP	Orheumatoid	synovial	rheumatoid	JJ	B-NP	B-cell_typesynovial	tissue	synovial	JJ	I-NP	I-cell_typetissue	cells	tissue	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	One	.	.	O	OOne	mechanism	One	CD	B-NP	Omechanism	by	mechanism	NN	I-NP	Oby	which	by	IN	B-PP	Owhich	glucocorticoids	which	WDT	B-NP	Oglucocorticoids	could	glucocorticoid	NNS	B-NP	Ocould	exert	could	MD	B-VP	Oexert	their	exert	VB	I-VP	Otheir	anti-inflammatory	their	PRP$	B-NP	Oanti-inflammatory	action	anti-inflammatory	JJ	I-NP	Oaction	is	action	NN	I-NP	Ois	via	be	VBZ	B-VP	Ovia	rapidly	via	IN	B-PP	Orapidly	saturable	rapidly	RB	B-NP	Osaturable	","	saturable	JJ	I-NP	O","	stereo-specific	","	","	I-NP	Ostereo-specific	cytoplasmic	stereo-specific	JJ	I-NP	B-proteincytoplasmic	protein	cytoplasmic	JJ	I-NP	I-proteinprotein	receptors	protein	NN	I-NP	I-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	This	.	.	O	OThis	report	This	DT	B-NP	Oreport	is	report	NN	I-NP	Ois	of	be	VBZ	B-VP	Oof	an	of	IN	B-PP	Oan	investigation	an	DT	B-NP	Oinvestigation	into	investigation	NN	I-NP	Ointo	such	into	IN	B-PP	Osuch	a	such	JJ	B-NP	Oa	possibility	a	DT	I-NP	Opossibility	in	possibility	NN	I-NP	Oin	synovial	in	IN	B-PP	Osynovial	cells	synovial	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Synovium	.	.	O	OSynovium	","	Synovium	NN	B-NP	O","	obtained	","	","	O	Oobtained	from	obtain	VBN	B-VP	Ofrom	knee	from	IN	B-PP	Oknee	joints	knee	NN	B-NP	Ojoints	of	joint	NNS	I-NP	Oof	rheumatoid	of	IN	B-PP	Orheumatoid	patients	rheumatoid	JJ	B-NP	Opatients	undergoing	patient	NNS	I-NP	Oundergoing	surgery	undergo	VBG	B-VP	Osurgery	","	surgery	NN	B-NP	O","	was	","	","	O	Owas	incubated	be	VBD	B-VP	Oincubated	with	incubate	VBN	I-VP	Owith	clostridiopeptidase	with	IN	B-PP	Oclostridiopeptidase	A	clostridiopeptidase	NN	B-NP	OA	and	A	NN	I-NP	Oand	trypsin-EDTA	and	CC	O	Otrypsin-EDTA	to	trypsin-EDTA	NN	B-NP	B-proteinto	obtain	to	TO	B-VP	Oobtain	cell	obtain	VB	I-VP	Ocell	suspensions	cell	NN	B-NP	Osuspensions	.	suspension	NNS	I-NP	O.	These	.	.	O	OThese	","	These	DT	B-NP	O","	together	","	","	O	Otogether	with	together	RB	B-ADVP	Owith	cells	with	IN	B-PP	Ocells	obtained	cell	NNS	B-NP	Oobtained	from	obtain	VBN	B-VP	Ofrom	synovial	from	IN	B-PP	Osynovial	fluid	synovial	JJ	B-NP	Ofluid	aspirated	fluid	NN	I-NP	Oaspirated	from	aspirate	VBN	B-VP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	rheumatoid	with	IN	B-PP	Orheumatoid	arthritis	rheumatoid	JJ	B-NP	Oarthritis	","	arthritis	NN	I-NP	O","	were	","	","	O	Owere	identified	be	VBD	B-VP	Oidentified	by	identify	VBN	I-VP	Oby	electron	by	IN	B-PP	Oelectron	microscopy	electron	NN	B-NP	Omicroscopy	.	microscopy	NN	I-NP	O.	Duplicate	.	.	O	ODuplicate	samples	Duplicate	JJ	B-NP	Osamples	of	sample	NNS	I-NP	Oof	these	of	IN	B-PP	Othese	cell	these	DT	B-NP	Ocell	suspensions	cell	NN	I-NP	Osuspensions	were	suspension	NNS	I-NP	Owere	incubated	be	VBD	B-VP	Oincubated	with	incubate	VBN	I-VP	Owith	increasing	with	IN	B-PP	Oincreasing	concentrations	increase	VBG	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	H3Dexamethasone	of	IN	B-PP	OH3Dexamethasone	(	H3Dexamethasone	NN	B-NP	O(	1	(	(	O	O1	x	1	CD	B-NP	Ox	10	x	NN	I-NP	O10	(	10	CD	I-NP	O(	-10	(	(	O	O-10	)	-10	CD	B-NP	O)	M-1	)	)	O	OM-1	x	M-1	NN	B-NP	Ox	10	x	SYM	O	O10	(	10	CD	B-NP	O(	-9	(	(	O	O-9	)	-9	CD	B-NP	O)	M	)	)	O	OM	)	M	NN	B-NP	O)	for	)	)	O	Ofor	30	for	IN	B-PP	O30	minutes	30	CD	B-NP	Ominutes	at	minute	NNS	I-NP	Oat	37	at	IN	B-PP	O37	degrees	37	CD	B-NP	Odegrees	C	degree	NNS	I-NP	OC	.	C	JJ	B-ADJP	O.	Analysis	.	.	O	OAnalysis	of	Analysis	NN	B-NP	Oof	the	of	IN	B-PP	Othe	proportion	the	DT	B-NP	Oproportion	of	proportion	NN	I-NP	Oof	steroid	of	IN	B-PP	Osteroid	bound	steroid	NN	B-NP	Obound	to	bind	VBD	B-VP	Oto	whole	to	TO	B-PP	Owhole	cells	whole	JJ	B-NP	B-cell_typecells	showed	cell	NNS	I-NP	I-cell_typeshowed	evidence	show	VBD	B-VP	Oevidence	for	evidence	NN	B-NP	Ofor	specific	for	IN	B-PP	Ospecific	","	specific	JJ	B-NP	O","	rapidly	","	","	O	Orapidly	saturable	rapidly	RB	B-ADJP	Osaturable	","	saturable	JJ	I-ADJP	O","	receptors	","	","	O	Oreceptors	in	receptor	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	cells	the	DT	B-NP	Ocells	obtained	cell	NNS	I-NP	Oobtained	from	obtain	VBN	B-VP	Ofrom	synovial	from	IN	B-PP	Osynovial	tissue	synovial	JJ	B-NP	Otissue	","	tissue	NN	I-NP	O","	but	","	","	O	Obut	this	but	CC	O	Othis	was	this	DT	B-NP	Owas	not	be	VBD	B-VP	Onot	found	not	RB	I-VP	Ofound	in	find	VBN	I-VP	Oin	synovial	in	IN	B-PP	Osynovial	fluid	synovial	JJ	B-NP	B-cell_typefluid	cells	fluid	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Electron	.	.	O	OElectron	micrographs	Electron	NN	B-NP	Omicrographs	showed	micrograph	NNS	I-NP	Oshowed	that	show	VBD	B-VP	Othat	cells	that	IN	B-SBAR	Ocells	obtained	cell	NNS	B-NP	Oobtained	from	obtain	VBN	B-VP	Ofrom	synovial	from	IN	B-PP	Osynovial	tissue	synovial	JJ	B-NP	Otissue	consisted	tissue	NN	I-NP	Oconsisted	of	consist	VBD	B-VP	Oof	synovial	of	IN	B-PP	Osynovial	fibroblast	synovial	JJ	B-NP	B-cell_typefibroblast	-	fibroblast	NN	I-NP	I-cell_type-	and	-	HYPH	B-ADJP	Oand	macrophage-types	and	CC	O	Omacrophage-types	","	macrophage-type	NNS	B-NP	O","	lymphocytes	","	","	O	Olymphocytes	","	lymphocyte	NNS	B-NP	B-cell_type","	monocytes	","	","	O	Omonocytes	and	monocyte	NNS	B-NP	B-cell_typeand	macrophages	and	CC	O	Omacrophages	.	macrophage	NNS	B-NP	B-cell_type.	Polymorphonuclear	.	.	O	OPolymorphonuclear	leucocytes	Polymorphonuclear	JJ	B-NP	B-cell_typeleucocytes	appeared	leucocyte	NNS	I-NP	I-cell_typeappeared	to	appear	VBD	B-VP	Oto	be	to	TO	I-VP	Obe	absent	be	VB	I-VP	Oabsent	.	absent	JJ	B-ADJP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	in	","	","	O	Oin	synovial	in	IN	B-PP	Osynovial	fluid	synovial	JJ	B-NP	B-cell_typefluid	cell	fluid	NN	I-NP	I-cell_typecell	type	cell	NN	I-NP	I-cell_typetype	polymorphonuclear	type	NN	I-NP	I-cell_typepolymorphonuclear	leucocytes	polymorphonuclear	JJ	I-NP	I-cell_typeleucocytes	were	leucocyte	NNS	I-NP	I-cell_typewere	the	be	VBD	B-VP	Othe	predominant	the	DT	B-NP	Opredominant	cell	predominant	JJ	I-NP	Ocell	type	cell	NN	I-NP	Otype	.	type	NN	I-NP	O.	We	.	.	O	OWe	concluded	We	PRP	B-NP	Oconcluded	from	conclude	VBD	B-VP	Ofrom	this	from	IN	B-PP	Othis	","	this	DT	B-NP	O","	that	","	","	O	Othat	one	that	IN	B-SBAR	Oone	or	one	CD	B-NP	Oor	more	or	CC	I-NP	Omore	of	more	JJR	I-NP	Oof	the	of	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	types	cell	NN	I-NP	Otypes	present	type	NNS	I-NP	Opresent	in	present	JJ	B-ADJP	Oin	synovial	in	IN	B-PP	Osynovial	tissue	synovial	JJ	B-NP	Otissue	contain	tissue	NN	I-NP	Ocontain	a	contain	VBP	B-VP	Oa	specific	a	DT	B-NP	Ospecific	steroid	specific	JJ	I-NP	Osteroid	receptor	steroid	NN	I-NP	B-proteinreceptor	","	receptor	NN	I-NP	I-protein","	but	","	","	O	Obut	that	but	CC	O	Othat	this	that	IN	B-SBAR	Othis	is	this	DT	B-NP	Ois	lacking	be	VBZ	B-VP	Olacking	in	lack	VBG	I-VP	Oin	synovial	in	IN	B-PP	Osynovial	fluid	synovial	JJ	B-NP	B-cell_typefluid	polymorphonuclear	fluid	NN	I-NP	I-cell_typepolymorphonuclear	leucocytes	polymorphonuclear	JJ	I-NP	I-cell_typeleucocytes	.	leucocyte	NNS	I-NP	I-cell_type.	Clinical	.	.	O	OClinical	implications	Clinical	JJ	B-NP	Oimplications	of	implication	NNS	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	leukemia	human	JJ	B-NP	Oleukemia	.	leukemia	NN	I-NP	O.	Glucorticoid	.	.	O	OGlucorticoid	receptors	Glucorticoid	NN	B-NP	B-proteinreceptors	were	receptor	NNS	I-NP	I-proteinwere	studied	be	VBD	B-VP	Ostudied	in	study	VBN	I-VP	Oin	various	in	IN	B-PP	Ovarious	populations	various	JJ	B-NP	Opopulations	of	population	NNS	I-NP	Oof	normal	of	IN	B-PP	Onormal	human	normal	JJ	B-NP	B-cell_typehuman	peripheral	human	JJ	I-NP	I-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	lymphocytes	blood	NN	I-NP	I-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	leukemic	and	CC	O	Oleukemic	lymphoblasts	leukemic	JJ	B-NP	B-cell_typelymphoblasts	.	lymphoblast	NNS	I-NP	I-cell_type.	Normal	.	.	O	ONormal	lymphocytes	Normal	JJ	B-NP	B-cell_typelymphocytes	contain	lymphocyte	NNS	I-NP	I-cell_typecontain	low	contain	VBP	B-VP	Olow	levels	low	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	approximately	(	(	O	Oapproximately	2	approximately	RB	B-NP	O2	","	2	CD	I-NP	O","	500	","	","	I-NP	O500	sites/cell	500	CD	I-NP	Osites/cell	)	sites/cell	NNS	I-NP	O)	which	)	)	O	Owhich	are	which	WDT	B-NP	Oare	identical	be	VBP	B-VP	Oidentical	in	identical	JJ	B-ADJP	Oin	T-	in	IN	B-PP	OT-	and	T-	NN	B-NP	Oand	non-T-fractions	and	CC	I-NP	Onon-T-fractions	.	non-T-fraction	NNS	I-NP	O.	Phytohemagglutinin	.	.	O	OPhytohemagglutinin	treatment	Phytohemagglutinin	NN	B-NP	B-proteintreatment	increases	treatment	NN	I-NP	Oincreases	levels	increase	VBZ	B-VP	Olevels	about	level	NNS	B-NP	Oabout	3-fold	about	IN	B-PP	O3-fold	.	3-fold	RB	B-NP	O.	Leukemic	.	.	O	OLeukemic	lymphoblasts	Leukemic	JJ	B-NP	B-cell_typelymphoblasts	contain	lymphoblast	NNS	I-NP	I-cell_typecontain	larger	contain	VBP	B-VP	Olarger	numbers	large	JJR	B-NP	Onumbers	of	number	NNS	I-NP	Oof	receptor	of	IN	B-PP	Oreceptor	sites	receptor	NN	B-NP	Osites	.	site	NNS	I-NP	O.	Presence	.	.	O	OPresence	of	Presence	NN	B-NP	Oof	receptor	of	IN	B-PP	Oreceptor	is	receptor	NN	B-NP	Ois	correlated	be	VBZ	B-VP	Ocorrelated	with	correlate	VBN	I-VP	Owith	in	with	IN	B-PP	Oin	vitro	in	FW	B-NP	Ovitro	sensitivitiy	vitro	FW	I-NP	Osensitivitiy	to	sensitivitiy	NN	I-NP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	and	glucocorticoid	NNS	B-NP	Oand	in	and	CC	O	Oin	vivo	in	FW	B-NP	Ovivo	response	vivo	FW	I-NP	Oresponse	to	response	NN	I-NP	Oto	therapy	to	TO	B-PP	Otherapy	.	therapy	NN	B-NP	O.	Quantity	.	.	O	OQuantity	of	Quantity	NN	B-NP	Oof	receptor	of	IN	B-PP	Oreceptor	is	receptor	NN	B-NP	Ois	also	be	VBZ	B-VP	Oalso	correlated	also	RB	I-VP	Ocorrelated	with	correlate	VBN	I-VP	Owith	complete	with	IN	B-PP	Ocomplete	remission	complete	JJ	B-NP	Oremission	duration	remission	NN	I-NP	Oduration	independently	duration	NN	I-NP	Oindependently	of	independently	RB	B-ADVP	Oof	leukemic	of	IN	B-PP	Oleukemic	cell	leukemic	JJ	B-NP	B-cell_typecell	type	cell	NN	I-NP	I-cell_typetype	(	type	NN	I-NP	I-cell_type(	T	(	(	O	OT	or	T	NN	B-NP	Oor	null	or	CC	O	Onull	)	null	NN	B-NP	O)	","	)	)	O	O","	initial	","	","	O	Oinitial	WBC	initial	JJ	B-NP	OWBC	","	WBC	NNP	I-NP	O","	or	","	","	O	Oor	age	or	CC	O	Oage	of	age	NN	B-NP	Oof	patient	of	IN	B-PP	Opatient	.	patient	NN	B-NP	O.	Quantitative	.	.	O	OQuantitative	determination	Quantitative	JJ	B-NP	Odetermination	of	determination	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	levels	receptor	NN	I-NP	I-proteinlevels	in	level	NNS	I-NP	Oin	acute	in	IN	B-PP	Oacute	lymphoblastic	acute	JJ	B-NP	Olymphoblastic	leukemia	lymphoblastic	JJ	I-NP	Oleukemia	may	leukemia	NN	I-NP	Omay	be	may	MD	B-VP	Obe	of	be	VB	I-VP	Oof	value	of	IN	B-PP	Ovalue	both	value	NN	B-NP	Oboth	as	both	CC	B-PP	Oas	an	as	IN	B-PP	Oan	independent	an	DT	B-NP	Oindependent	prognostic	independent	JJ	I-NP	Oprognostic	variable	prognostic	JJ	I-NP	Ovariable	and	variable	NN	I-NP	Oand	in	and	CC	B-PP	Oin	suggesting	in	IN	B-PP	Osuggesting	which	suggest	VBG	B-VP	Owhich	patients	which	WDT	B-NP	Opatients	should	patient	NNS	B-NP	Oshould	receive	should	MD	B-VP	Oreceive	glucocorticoid	receive	VB	I-VP	Oglucocorticoid	therapy	glucocorticoid	NN	B-NP	Otherapy	.	therapy	NN	I-NP	O.	Functional	.	.	O	OFunctional	and	Functional	JJ	B-NP	Oand	physical	and	CC	I-NP	Ophysical	interaction	physical	JJ	I-NP	Ointeraction	of	interaction	NN	I-NP	Oof	protein-tyrosine	of	IN	B-PP	Oprotein-tyrosine	kinases	protein-tyrosine	JJ	B-NP	B-proteinkinases	Fyn	kinase	NNS	I-NP	I-proteinFyn	and	Fyn	NN	I-NP	B-proteinand	Csk	and	CC	I-NP	OCsk	in	Csk	NN	I-NP	B-proteinin	the	in	IN	B-PP	Othe	T-cell	the	DT	B-NP	OT-cell	signaling	T-cell	NN	I-NP	Osignaling	system	signaling	NN	I-NP	Osystem	.	system	NN	I-NP	O.	The	.	.	O	OThe	Src-like	The	DT	B-NP	OSrc-like	protein-tyrosine	Src-like	JJ	I-NP	B-proteinprotein-tyrosine	kinase	protein-tyrosine	NN	I-NP	I-proteinkinase	Fyn	kinase	NN	I-NP	I-proteinFyn	is	Fyn	NN	I-NP	B-proteinis	associated	be	VBZ	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	T-cell	with	IN	B-PP	OT-cell	antigen	T-cell	NN	B-NP	B-proteinantigen	receptor	antigen	NN	I-NP	I-proteinreceptor	.	receptor	NN	I-NP	I-protein.	Transient	.	.	O	OTransient	expression	Transient	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	actively	of	IN	B-PP	Oactively	mutated	actively	RB	B-NP	Omutated	Fyn	mutate	VBN	I-NP	OFyn	","	Fyn	NN	I-NP	B-protein","	having	","	","	O	Ohaving	Phe-528	have	VBG	B-VP	OPhe-528	instead	Phe-528	NN	B-NP	Oinstead	of	instead	RB	B-CONJP	Oof	Tyr-528	of	IN	I-CONJP	OTyr-528	or	Tyr-528	NN	B-NP	Oor	Thr-338	or	CC	I-NP	OThr-338	instead	Thr-338	NN	I-NP	B-proteininstead	of	instead	RB	B-PP	Oof	Ile-338	of	IN	I-PP	OIle-338	","	Ile-338	NN	B-NP	B-protein","	in	","	","	O	Oin	Jurkat	in	IN	B-PP	OJurkat	T-cells	Jurkat	NN	B-NP	B-cell_lineT-cells	stimulated	T-cell	NNS	I-NP	I-cell_linestimulated	the	stimulate	VBD	B-VP	Othe	serum	the	DT	B-NP	Oserum	response	serum	NN	I-NP	B-DNAresponse	element	response	NN	I-NP	I-DNAelement	(	element	NN	I-NP	I-DNA(	SRE	(	(	O	OSRE	)	SRE	NN	B-NP	B-DNA)	","	)	)	O	O","	12-O-tetradecanoyl-phorbol-13-acetate	","	","	O	O12-O-tetradecanoyl-phorbol-13-acetate	response	12-O-tetradecanoyl-phorbol-13-acetate	NN	B-NP	B-DNAresponse	element	response	NN	I-NP	I-DNAelement	","	element	NN	I-NP	I-DNA","	cyclic	","	","	O	Ocyclic	AMP	cyclic	JJ	B-NP	B-DNAAMP	response	AMP	NN	I-NP	I-DNAresponse	element	response	NN	I-NP	I-DNAelement	","	element	NN	I-NP	I-DNA","	and	","	","	O	Oand	c-fos	and	CC	O	Oc-fos	promoter	c-fos	NN	B-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	The	.	.	O	OThe	stimulation	The	DT	B-NP	Ostimulation	of	stimulation	NN	I-NP	Oof	SRE	of	IN	B-PP	OSRE	was	SRE	NN	B-NP	B-DNAwas	particularly	be	VBD	B-VP	Oparticularly	prominent	particularly	RB	B-ADJP	Oprominent	not	prominent	JJ	I-ADJP	Onot	only	not	RB	B-CONJP	Oonly	with	only	RB	I-CONJP	Owith	active	with	IN	B-PP	Oactive	Fyn	active	JJ	B-NP	OFyn	but	Fyn	NN	I-NP	B-proteinbut	also	but	CC	B-CONJP	Oalso	with	also	RB	I-CONJP	Owith	normal	with	IN	B-PP	Onormal	(	normal	JJ	B-ADJP	O(	wild-type	(	(	O	Owild-type	)	wild-type	JJ	O	O)	Fyn	)	)	O	OFyn	.	Fyn	NN	B-NP	B-protein.	SRE	.	.	O	OSRE	was	SRE	NN	B-NP	B-DNAwas	also	be	VBD	B-VP	Oalso	stimulated	also	RB	I-VP	Ostimulated	by	stimulate	VBN	I-VP	Oby	both	by	IN	B-PP	Oboth	normal	both	CC	B-NP	Onormal	and	normal	JJ	I-NP	Oand	active	and	CC	I-NP	Oactive	Lck	active	JJ	I-NP	OLck	.	Lck	NN	I-NP	B-protein.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	normal	","	","	O	Onormal	and	normal	JJ	B-NP	Oand	active	and	CC	I-NP	Oactive	Fyn	active	JJ	I-NP	OFyn	stimulated	Fyn	NN	I-NP	B-proteinstimulated	transcription	stimulate	VBD	B-VP	Otranscription	from	transcription	NN	B-NP	Ofrom	the	from	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	gene	IL-2	NN	I-NP	B-DNAgene	promoter	gene	NN	I-NP	I-DNApromoter	when	promoter	NN	I-NP	I-DNAwhen	transfected	when	WRB	B-ADVP	Otransfected	cells	transfecte	VBN	B-NP	B-cell_linecells	were	cell	NNS	I-NP	I-cell_linewere	stimulated	be	VBD	B-VP	Ostimulated	by	stimulate	VBN	I-VP	Oby	concanavalin	by	IN	B-PP	Oconcanavalin	A	concanavalin	NN	B-NP	OA	plus	A	NN	I-NP	Oplus	12-O-tetradecanoylphorbol-13-acetate	plus	CC	O	O12-O-tetradecanoylphorbol-13-acetate	.	12-O-tetradecanoylphorbol-13-acetate	NN	B-NP	O.	Under	.	.	O	OUnder	the	Under	IN	B-PP	Othe	same	the	DT	B-NP	Osame	conditions	same	JJ	I-NP	Oconditions	","	condition	NNS	I-NP	O","	Lck	","	","	O	OLck	did	Lck	NN	B-NP	B-proteindid	not	do	VBD	B-VP	Onot	stimulate	not	RB	I-VP	Ostimulate	IL-2	stimulate	VB	I-VP	OIL-2	promoter	IL-2	NN	B-NP	B-DNApromoter	unless	promoter	NN	I-NP	I-DNAunless	it	unless	IN	B-SBAR	Oit	was	it	PRP	B-NP	Owas	activated	be	VBD	B-VP	Oactivated	by	activate	VBN	I-VP	Oby	mutation	by	IN	B-PP	Omutation	.	mutation	NN	B-NP	O.	Interestingly	.	.	O	OInterestingly	","	Interestingly	RB	B-ADVP	O","	a	","	","	O	Oa	mutant	a	DT	B-NP	Omutant	Fyn	mutant	JJ	I-NP	OFyn	","	Fyn	NN	I-NP	B-protein","	which	","	","	O	Owhich	has	which	WDT	B-NP	Ohas	deletions	have	VBZ	B-VP	Odeletions	within	deletion	NNS	B-NP	Owithin	the	within	IN	B-PP	Othe	SH2	the	DT	B-NP	OSH2	region	SH2	NN	I-NP	B-DNAregion	and	region	NN	I-NP	I-DNAand	so	and	CC	O	Oso	is	so	RB	B-ADVP	Ois	able	be	VBZ	B-VP	Oable	to	able	JJ	B-ADJP	Oto	transform	to	TO	B-VP	Otransform	chicken	transform	VB	I-VP	Ochicken	embryo	chicken	NN	B-NP	B-cell_typeembryo	fibroblasts	embryo	NN	I-NP	I-cell_typefibroblasts	","	fibroblast	NNS	I-NP	I-cell_type","	did	","	","	O	Odid	not	do	VBD	B-VP	Onot	stimulate	not	RB	I-VP	Ostimulate	either	stimulate	VB	I-VP	Oeither	the	either	CC	O	Othe	c-fos	the	DT	B-NP	Oc-fos	or	c-fos	NN	I-NP	B-DNAor	IL-2	or	CC	I-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	","	promoter	NN	I-NP	I-DNA","	suggesting	","	","	O	Osuggesting	the	suggest	VBG	B-VP	Othe	importance	the	DT	B-NP	Oimportance	of	importance	NN	I-NP	Oof	this	of	IN	B-PP	Othis	region	this	DT	B-NP	Oregion	in	region	NN	I-NP	Oin	T-cell	in	IN	B-PP	OT-cell	signaling	T-cell	NN	B-NP	Osignaling	.	signaling	NN	I-NP	O.	Csk	.	.	O	OCsk	","	Csk	NN	B-NP	B-protein","	which	","	","	O	Owhich	phosphorylates	which	WDT	B-NP	Ophosphorylates	tyrosine	phosphorylate	VBZ	B-VP	Otyrosine	residues	tyrosine	NN	B-NP	Oresidues	in	residue	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	negative	the	DT	B-NP	Onegative	regulatory	negative	JJ	I-NP	B-DNAregulatory	sites	regulatory	JJ	I-NP	I-DNAsites	of	site	NNS	I-NP	I-DNAof	Src	of	IN	B-PP	OSrc	family	Src	NN	B-NP	B-proteinfamily	kinases	family	NN	I-NP	I-proteinkinases	","	kinase	NNS	I-NP	I-protein","	down-regulated	","	","	O	Odown-regulated	Fyn-	down-regulate	VBN	B-NP	OFyn-	and	Fyn-	NN	I-NP	Oand	Lck-mediated	and	CC	O	OLck-mediated	stimulation	Lck-mediated	JJ	B-NP	Ostimulation	of	stimulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	serum	the	DT	B-NP	Oserum	response	serum	NN	I-NP	B-DNAresponse	element	response	NN	I-NP	I-DNAelement	and	element	NN	I-NP	I-DNAand	Fyn-mediated	and	CC	O	OFyn-mediated	enhancement	Fyn-mediated	JJ	B-NP	Oenhancement	of	enhancement	NN	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	promoter	IL-2	NN	B-NP	B-DNApromoter	activity	promoter	NN	I-NP	I-DNAactivity	.	activity	NN	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	suggest	datum	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	Fyn	that	IN	B-SBAR	OFyn	and	Fyn	NN	B-NP	B-proteinand	Lck	and	CC	I-NP	OLck	","	Lck	NN	I-NP	B-protein","	whose	","	","	O	Owhose	activities	whose	WP$	B-NP	Oactivities	are	activity	NNS	I-NP	Oare	regulated	be	VBP	B-VP	Oregulated	by	regulate	VBN	I-VP	Oby	Csk	by	IN	B-PP	OCsk	","	Csk	NN	B-NP	B-protein","	are	","	","	O	Oare	involved	be	VBP	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	different	in	IN	B-PP	Odifferent	phases	different	JJ	B-NP	Ophases	of	phase	NNS	I-NP	Oof	T-cell	of	IN	B-PP	OT-cell	activation	T-cell	NN	B-NP	Oactivation	.	activation	NN	I-NP	O.	A	.	.	O	OA	novel	A	DT	B-NP	Onovel	NF-kappa	novel	JJ	I-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	complex	B	NN	I-NP	I-proteincomplex	containing	complex	NN	I-NP	I-proteincontaining	p65	contain	VBG	B-VP	Op65	homodimers	p65	NN	B-NP	B-proteinhomodimers	:	homodimer	NNS	I-NP	I-protein:	implications	:	:	O	Oimplications	for	implication	NNS	B-NP	Ofor	transcriptional	for	IN	B-PP	Otranscriptional	control	transcriptional	JJ	B-NP	Ocontrol	at	control	NN	I-NP	Oat	the	at	IN	B-PP	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	subunit	of	IN	B-PP	Osubunit	dimerization	subunit	NN	B-NP	Odimerization	.	dimerization	NN	I-NP	O.	The	.	.	O	OThe	predominant	The	DT	B-NP	Opredominant	inducible	predominant	JJ	I-NP	Oinducible	form	inducible	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	the	of	IN	B-PP	Othe	NF-kappa	the	DT	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	transcription	B	NN	I-NP	I-proteintranscription	factor	transcription	NN	I-NP	I-proteinfactor	is	factor	NN	I-NP	I-proteinis	a	be	VBZ	B-VP	Oa	heteromeric	a	DT	B-NP	Oheteromeric	complex	heteromeric	JJ	I-NP	B-proteincomplex	containing	complex	NN	I-NP	I-proteincontaining	two	contain	VBG	B-VP	Otwo	Rel-related	two	CD	B-NP	ORel-related	DNA-binding	Rel-related	JJ	I-NP	B-proteinDNA-binding	subunits	DNA-binding	JJ	I-NP	I-proteinsubunits	","	subunit	NNS	I-NP	I-protein","	termed	","	","	O	Otermed	p65	term	VBN	B-NP	Op65	and	p65	NN	I-NP	B-proteinand	p50	and	CC	I-NP	Op50	.	p50	NN	I-NP	B-protein.	Prior	.	.	O	OPrior	transfection	Prior	JJ	B-NP	Otransfection	studies	transfection	NN	I-NP	Ostudies	have	study	NNS	I-NP	Ohave	shown	have	VBP	B-VP	Oshown	that	show	VBN	I-VP	Othat	when	that	IN	B-SBAR	Owhen	these	when	WRB	B-ADVP	Othese	p65	these	DT	B-NP	Op65	and	p65	NN	I-NP	B-proteinand	p50	and	CC	I-NP	Op50	subunits	p50	NN	I-NP	B-proteinsubunits	are	subunit	NNS	I-NP	I-proteinare	expressed	be	VBP	B-VP	Oexpressed	independently	express	VBN	I-VP	Oindependently	as	independently	RB	B-ADVP	Oas	stable	as	IN	B-PP	Ostable	homodimers	stable	JJ	B-NP	Ohomodimers	","	homodimer	NNS	I-NP	B-protein","	p65	","	","	O	Op65	stimulates	p65	NN	B-NP	B-proteinstimulates	kappa	stimulate	VBZ	B-VP	Okappa	B-directed	kappa	NN	B-NP	OB-directed	transcription	B-directed	JJ	I-NP	Otranscription	","	transcription	NN	I-NP	O","	whereas	","	","	O	Owhereas	p50	whereas	IN	O	Op50	functions	p50	NN	B-NP	B-proteinfunctions	as	function	VBZ	B-VP	Oas	a	as	IN	B-PP	Oa	kappa	a	DT	B-NP	Okappa	B-specific	kappa	NN	I-NP	B-proteinB-specific	repressor	B-specific	JJ	I-NP	I-proteinrepressor	.	repressor	NN	I-NP	I-protein.	While	.	.	O	OWhile	authentic	While	IN	B-SBAR	Oauthentic	p50	authentic	JJ	B-NP	B-proteinp50	homodimers	p50	NN	I-NP	I-proteinhomodimers	(	homodimer	NNS	I-NP	I-protein(	previously	(	(	O	Opreviously	termed	previously	RB	B-NP	Otermed	KBF1	term	VBN	I-NP	OKBF1	)	KBF1	NN	I-NP	B-protein)	have	)	)	O	Ohave	been	have	VBP	B-VP	Obeen	detected	be	VBN	I-VP	Odetected	in	detect	VBN	I-VP	Oin	nuclear	in	IN	B-PP	Onuclear	extracts	nuclear	JJ	B-NP	Oextracts	from	extract	NNS	I-NP	Ofrom	nontransfected	from	IN	B-PP	Onontransfected	cells	nontransfected	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	experimental	","	","	O	Oexperimental	evidence	experimental	JJ	B-NP	Oevidence	supporting	evidence	NN	I-NP	Osupporting	the	support	VBG	B-VP	Othe	existence	the	DT	B-NP	Oexistence	of	existence	NN	I-NP	Oof	p65	of	IN	B-PP	Op65	homodimers	p65	NN	B-NP	B-proteinhomodimers	in	homodimer	NNS	I-NP	I-proteinin	vivo	in	FW	B-ADVP	Ovivo	was	vivo	FW	I-ADVP	Owas	lacking	be	VBD	B-VP	Olacking	.	lack	VBG	I-VP	O.	We	.	.	O	OWe	now	We	PRP	B-NP	Onow	provide	now	RB	B-ADVP	Oprovide	direct	provide	VBP	B-VP	Odirect	biochemical	direct	JJ	B-NP	Obiochemical	evidence	biochemical	JJ	I-NP	Oevidence	for	evidence	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	an	of	IN	B-PP	Oan	endogenous	an	DT	B-NP	Oendogenous	pool	endogenous	JJ	I-NP	Opool	of	pool	NN	I-NP	Oof	inducible	of	IN	B-PP	Oinducible	p65	inducible	JJ	B-NP	Op65	homodimers	p65	NN	I-NP	B-proteinhomodimers	in	homodimer	NNS	I-NP	I-proteinin	intact	in	IN	B-PP	Ointact	human	intact	JJ	B-NP	B-cell_typehuman	T	human	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	As	.	.	O	OAs	with	As	IN	B-PP	Owith	the	with	IN	B-PP	Othe	prototypical	the	DT	B-NP	Oprototypical	NF-kappa	prototypical	JJ	I-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	p50-p65	B	NN	I-NP	I-proteinp50-p65	heterodimer	p50-p65	NN	I-NP	B-proteinheterodimer	","	heterodimer	NN	I-NP	I-protein","	this	","	","	O	Othis	novel	this	DT	B-NP	Onovel	p65	novel	JJ	I-NP	Op65	homodimeric	p65	NN	I-NP	B-proteinhomodimeric	form	homodimeric	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	is	B	NN	I-NP	I-proteinis	functionally	be	VBZ	B-VP	Ofunctionally	sequestered	functionally	RB	I-VP	Osequestered	in	sequester	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	cytoplasm	the	DT	B-NP	Ocytoplasm	but	cytoplasm	NN	I-NP	Obut	rapidly	but	CC	O	Orapidly	appears	rapidly	RB	B-VP	Oappears	in	appear	VBZ	I-VP	Oin	the	in	IN	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	compartment	nuclear	JJ	I-NP	Ocompartment	following	compartment	NN	I-NP	Ofollowing	cellular	follow	VBG	B-PP	Ocellular	stimulation	cellular	JJ	B-NP	Ostimulation	.	stimulation	NN	I-NP	O.	Site-directed	.	.	O	OSite-directed	mutagenesis	Site-directed	JJ	B-NP	Omutagenesis	studies	mutagenesis	NN	I-NP	Ostudies	indicate	study	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	homodimerization	the	DT	B-NP	Ohomodimerization	function	homodimerization	NN	I-NP	Ofunction	of	function	NN	I-NP	Oof	p65	of	IN	B-PP	Op65	is	p65	NN	B-NP	B-proteinis	dependent	be	VBZ	B-VP	Odependent	upon	dependent	JJ	B-ADJP	Oupon	the	upon	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	cysteine	of	IN	B-PP	Ocysteine	216	cysteine	NN	B-NP	O216	and	216	CD	I-NP	Oand	a	and	CC	O	Oa	conserved	a	DT	B-NP	Oconserved	recognition	conserve	VBN	I-NP	B-DNArecognition	motif	recognition	NN	I-NP	I-DNAmotif	for	motif	NN	I-NP	I-DNAfor	protein	for	IN	B-PP	Oprotein	kinase	protein	NN	B-NP	B-proteinkinase	A	kinase	NN	I-NP	I-proteinA	(	A	NN	I-NP	I-protein(	RRPS	(	(	O	ORRPS	;	RRPS	NN	B-NP	B-protein;	amino	;	:	O	Oamino	acids	amino	NN	B-NP	B-proteinacids	273	acid	NNS	I-NP	I-protein273	to	273	CD	B-NP	I-proteinto	276	to	TO	B-PP	I-protein276	)	276	CD	B-NP	I-protein)	","	)	)	O	O","	both	","	","	O	Oboth	of	both	DT	B-NP	Oof	which	of	IN	B-PP	Owhich	reside	which	WDT	B-NP	Oreside	within	reside	VBP	B-VP	Owithin	a	within	IN	B-PP	Oa	91-amino-acid	a	DT	B-NP	O91-amino-acid	segment	91-amino-acid	JJ	I-NP	B-proteinsegment	of	segment	NN	I-NP	I-proteinof	the	of	IN	B-PP	Othe	Rel	the	DT	B-NP	ORel	homology	Rel	NN	I-NP	B-proteinhomology	domain	homology	NN	I-NP	I-proteindomain	that	domain	NN	I-NP	I-proteinthat	mediates	that	WDT	B-NP	Omediates	self-association	mediate	VBZ	B-VP	Oself-association	.	self-association	NN	B-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	mutations	","	","	O	Omutations	at	mutation	NNS	B-NP	Oat	these	at	IN	B-PP	Othese	two	these	DT	B-NP	Otwo	sites	two	CD	I-NP	Osites	do	site	NNS	I-NP	Odo	not	do	VBP	B-VP	Onot	affect	not	RB	I-VP	Oaffect	heterodimerization	affect	VB	I-VP	Oheterodimerization	of	heterodimerization	NN	B-NP	Oof	p65	of	IN	B-PP	Op65	with	p65	NN	B-NP	B-proteinwith	p50	with	IN	B-PP	Op50	or	p50	NN	B-NP	B-proteinor	its	or	CC	O	Oits	functional	its	PRP$	B-NP	Ofunctional	interaction	functional	JJ	I-NP	Ointeraction	with	interaction	NN	I-NP	Owith	I	with	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	.	alpha	NN	I-NP	I-protein.	These	.	.	O	OThese	later	These	DT	B-NP	Olater	findings	later	JJ	I-NP	Ofindings	indicate	finding	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	neither	that	IN	B-SBAR	Oneither	homo-	neither	CC	B-NP	Ohomo-	nor	homo-	JJ	I-NP	Onor	heterodimer	nor	CC	I-NP	Oheterodimer	formation	heterodimer	NN	I-NP	Oformation	is	formation	NN	I-NP	Ois	an	be	VBZ	B-VP	Oan	absolute	an	DT	B-NP	Oabsolute	prerequisite	absolute	JJ	I-NP	Oprerequisite	for	prerequisite	NN	I-NP	Ofor	I	for	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	recognition	alpha	NN	I-NP	I-proteinrecognition	of	recognition	NN	I-NP	Oof	p65	of	IN	B-PP	Op65	.	p65	NN	B-NP	B-protein.	Taken	.	.	O	OTaken	together	Take	VBN	B-VP	Otogether	with	together	RB	B-ADVP	Owith	prior	with	IN	B-PP	Oprior	in	prior	JJ	B-NP	Oin	vivo	in	FW	I-NP	Ovivo	transcription	vivo	FW	I-NP	Otranscription	studies	transcription	NN	I-NP	Ostudies	","	study	NNS	I-NP	O","	these	","	","	O	Othese	results	these	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	biological	the	DT	B-NP	Obiological	activities	biological	JJ	I-NP	Oactivities	of	activity	NNS	I-NP	Oof	p65	of	IN	B-PP	Op65	and	p65	NN	B-NP	B-proteinand	p50	and	CC	I-NP	Op50	homodimers	p50	NN	I-NP	B-proteinhomodimers	are	homodimer	NNS	I-NP	I-proteinare	independently	be	VBP	B-VP	Oindependently	regulated	independently	RB	I-VP	Oregulated	","	regulate	VBN	I-VP	O","	thereby	","	","	O	Othereby	providing	thereby	RB	B-VP	Oproviding	an	provide	VBG	I-VP	Oan	integrated	an	DT	B-NP	Ointegrated	and	integrated	JJ	I-NP	Oand	flexible	and	CC	I-NP	Oflexible	control	flexible	JJ	I-NP	Ocontrol	mechanism	control	NN	I-NP	Omechanism	for	mechanism	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	rapid	the	DT	B-NP	Orapid	activation	rapid	JJ	I-NP	Oactivation	and	activation	NN	I-NP	Oand	repression	and	CC	O	Orepression	of	repression	NN	B-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	/	B	NN	I-NP	I-protein/	Rel	/	SYM	B-NP	ORel	#NAME?	Rel	NN	I-NP	B-protein#NAME?	gene	#NAME?	JJ	I-NP	Ogene	expression	gene	NN	I-NP	Oexpression	.	expression	NN	I-NP	O.	Carrier	.	.	O	OCarrier	determination	Carri	JJR	B-NP	Odetermination	for	determination	NN	I-NP	Ofor	X-linked	for	IN	B-PP	OX-linked	agammaglobulinemia	X-linked	JJ	B-NP	Oagammaglobulinemia	using	agammaglobulinemia	NN	I-NP	Ousing	X	use	VBG	B-VP	OX	inactivation	X	NN	B-NP	Oinactivation	analysis	inactivation	NN	I-NP	Oanalysis	of	analysis	NN	I-NP	Oof	purified	of	IN	B-PP	Opurified	B	purify	VBN	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	report	We	PRP	B-NP	Oreport	the	report	VBP	B-VP	Othe	development	the	DT	B-NP	Odevelopment	of	development	NN	I-NP	Oof	a	of	IN	B-PP	Oa	relatively	a	DT	B-NP	Orelatively	quick	relatively	RB	I-NP	Oquick	and	quick	JJ	I-NP	Oand	simple	and	CC	I-NP	Osimple	method	simple	JJ	I-NP	Omethod	for	method	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	assessment	the	DT	B-NP	Oassessment	of	assessment	NN	I-NP	Oof	X	of	IN	B-PP	OX	inactivation	X	NN	B-NP	Oinactivation	status	inactivation	NN	I-NP	Ostatus	for	status	NN	I-NP	Ofor	carrier	for	IN	B-PP	Ocarrier	determination	carrier	NN	B-NP	Odetermination	in	determination	NN	I-NP	Oin	families	in	IN	B-PP	Ofamilies	affected	family	NNS	B-NP	Oaffected	by	affect	VBN	B-VP	Oby	X-linked	by	IN	B-PP	OX-linked	agammaglobulinemia	X-linked	JJ	B-NP	Oagammaglobulinemia	(	agammaglobulinemia	NN	I-NP	O(	XLA	(	(	O	OXLA	)	XLA	NN	B-NP	O)	.	)	)	O	O.	This	.	.	O	OThis	method	This	DT	B-NP	Omethod	utilises	method	NN	I-NP	Outilises	an	utilise	VBZ	B-VP	Oan	immunomagnetic	an	DT	B-NP	Oimmunomagnetic	separation	immunomagnetic	JJ	I-NP	Oseparation	technique	separation	NN	I-NP	Otechnique	for	technique	NN	I-NP	Ofor	B	for	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	purification	cell	NN	I-NP	Opurification	and	purification	NN	I-NP	Oand	a	and	CC	O	Oa	polymerase	a	DT	B-NP	Opolymerase	chain	polymerase	NN	I-NP	Ochain	reaction	chain	NN	I-NP	Oreaction	(	reaction	NN	I-NP	O(	PCR	(	(	O	OPCR	)	PCR	NN	B-NP	O)	based	)	)	O	Obased	assay	based	JJ	B-NP	Oassay	for	assay	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	determination	the	DT	B-NP	Odetermination	of	determination	NN	I-NP	Oof	methylation	of	IN	B-PP	Omethylation	status	methylation	NN	B-NP	Ostatus	at	status	NN	I-NP	Oat	the	at	IN	B-PP	Othe	androgen	the	DT	B-NP	Oandrogen	receptor	androgen	NN	I-NP	B-proteinreceptor	(	receptor	NN	I-NP	I-protein(	AR	(	(	O	OAR	)	AR	NN	B-NP	O)	gene	)	)	O	Ogene	locus	gene	NN	B-NP	Olocus	to	locus	NN	I-NP	Oto	assess	to	TO	B-VP	Oassess	whether	assess	VB	I-VP	Owhether	X	whether	IN	B-SBAR	OX	inactivation	X	NN	B-NP	Oinactivation	is	inactivation	NN	I-NP	Ois	random	be	VBZ	B-VP	Orandom	or	random	JJ	B-ADJP	Oor	non-random	or	CC	I-ADJP	Onon-random	at	non-random	JJ	I-ADJP	Oat	this	at	IN	B-PP	Othis	locus	this	DT	B-NP	Olocus	.	locus	NN	I-NP	O.	We	.	.	O	OWe	report	We	PRP	B-NP	Oreport	the	report	VBP	B-VP	Othe	results	the	DT	B-NP	Oresults	we	result	NNS	I-NP	Owe	have	we	PRP	B-NP	Ohave	obtained	have	VBP	B-VP	Oobtained	using	obtain	VBN	I-VP	Ousing	this	use	VBG	I-VP	Othis	assay	this	DT	B-NP	Oassay	to	assay	NN	I-NP	Oto	investigate	to	TO	B-VP	Oinvestigate	females	investigate	VB	I-VP	Ofemales	known	female	NNS	B-NP	Oknown	to	know	VBN	B-VP	Oto	be	to	TO	I-VP	Obe	carriers	be	VB	I-VP	Ocarriers	of	carrier	NNS	B-NP	Oof	various	of	IN	B-PP	Ovarious	X-linked	various	JJ	B-NP	OX-linked	immunodeficiency	X-linked	JJ	I-NP	Oimmunodeficiency	disorders	immunodeficiency	NN	I-NP	Odisorders	.	disorder	NNS	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	we	","	","	O	Owe	investigated	we	PRP	B-NP	Oinvestigated	four	investigate	VBD	B-VP	Ofour	females	four	CD	B-NP	Ofemales	from	female	NNS	I-NP	Ofrom	different	from	IN	B-PP	Odifferent	families	different	JJ	B-NP	Ofamilies	affected	family	NNS	I-NP	Oaffected	by	affect	VBN	B-VP	Oby	XLA	by	IN	B-PP	OXLA	","	XLA	NN	B-NP	O","	two	","	","	O	Otwo	of	two	CD	B-NP	Oof	whom	of	IN	B-PP	Owhom	were	whom	WP	B-NP	Owere	of	be	VBD	B-VP	Oof	unknown	of	IN	B-PP	Ounknown	carrier	unknown	JJ	B-NP	Ocarrier	status	carrier	NN	I-NP	Ostatus	","	status	NN	I-NP	O","	and	","	","	O	Oand	we	and	CC	O	Owe	discuss	we	PRP	B-NP	Odiscuss	the	discuss	VBP	B-VP	Othe	results	the	DT	B-NP	Oresults	obtained	result	NNS	I-NP	Oobtained	with	obtain	VBN	B-VP	Owith	this	with	IN	B-PP	Othis	and	this	DT	B-NP	Oand	other	and	CC	O	Oother	X-inactivation	other	JJ	B-NP	OX-inactivation	assays	X-inactivation	NN	I-NP	Oassays	.	assay	NNS	I-NP	O.	A	.	.	O	OA	similar	A	DT	B-NP	Osimilar	assay	similar	JJ	I-NP	Oassay	has	assay	NN	I-NP	Ohas	recently	have	VBZ	B-VP	Orecently	been	recently	RB	I-VP	Obeen	described	be	VBN	I-VP	Odescribed	by	describe	VBN	I-VP	Oby	Allen	by	IN	B-PP	OAllen	et	Allen	NNP	B-NP	Oet	al.	et	FW	I-NP	Oal.	(	al.	FW	I-NP	O(	1992	(	(	O	O1992	)	1992	CD	B-NP	O)	and	)	)	O	Oand	applied	and	CC	O	Oapplied	to	apply	VBN	B-VP	Oto	members	to	TO	B-PP	Omembers	of	member	NNS	B-NP	Oof	one	of	IN	B-PP	Oone	family	one	CD	B-NP	Ofamily	affected	family	NN	I-NP	Oaffected	by	affect	VBN	B-VP	Oby	XLA	by	IN	B-PP	OXLA	.	XLA	NN	B-NP	B-protein.	Effects	.	.	O	OEffects	of	Effect	NNS	B-NP	Oof	IL-4	of	IN	B-PP	OIL-4	and	IL-4	NN	B-NP	B-proteinand	Fc	and	CC	I-NP	OFc	gamma	Fc	NN	I-NP	B-proteingamma	receptor	gamma	NN	I-NP	I-proteinreceptor	II	receptor	NN	I-NP	I-proteinII	engagement	II	CD	I-NP	I-proteinengagement	on	engagement	NN	I-NP	Oon	Egr-1	on	IN	B-PP	OEgr-1	expression	Egr-1	NN	B-NP	B-proteinexpression	during	expression	NN	I-NP	Oduring	stimulation	during	IN	B-PP	Ostimulation	of	stimulation	NN	B-NP	Oof	B	of	IN	B-PP	OB	lymphocytes	B	NN	B-NP	B-cell_typelymphocytes	by	lymphocyte	NNS	I-NP	I-cell_typeby	membrane	by	IN	B-PP	Omembrane	immunoglobulin	membrane	NN	B-NP	B-proteinimmunoglobulin	crosslinking	immunoglobulin	NN	I-NP	I-proteincrosslinking	.	crosslinking	NN	I-NP	O.	Egr-1	.	.	O	OEgr-1	is	Egr-1	NN	B-NP	B-proteinis	an	be	VBZ	B-VP	Oan	immediate	an	DT	B-NP	Oimmediate	early	immediate	JJ	I-NP	B-DNAearly	gene	early	JJ	I-NP	I-DNAgene	that	gene	NN	I-NP	I-DNAthat	is	that	WDT	B-NP	Ois	rapidly	be	VBZ	B-VP	Orapidly	upregulated	rapidly	RB	I-VP	Oupregulated	in	upregulate	VBN	I-VP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	mitogenic	to	TO	B-PP	Omitogenic	signals	mitogenic	JJ	B-NP	Osignals	induced	signal	NNS	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	antigen	by	IN	B-PP	Oantigen	receptor	antigen	NN	B-NP	B-proteinreceptor	crosslinking	receptor	NN	I-NP	I-proteincrosslinking	on	crosslinking	NN	I-NP	Oon	murine	on	IN	B-PP	Omurine	B	murine	JJ	B-NP	B-cell_typeB	lymphocytes	B	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	It	.	.	O	OIt	has	It	PRP	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	that	show	VBN	I-VP	Othat	levels	that	IN	B-SBAR	Olevels	of	level	NNS	B-NP	Oof	Egr-1	of	IN	B-PP	OEgr-1	expression	Egr-1	NN	B-NP	B-proteinexpression	are	expression	NN	I-NP	Oare	closely	be	VBP	B-VP	Oclosely	correlated	closely	RB	I-VP	Ocorrelated	with	correlate	VBN	I-VP	Owith	B	with	IN	B-PP	OB	cell	B	NN	B-NP	B-cell_typecell	proliferation	cell	NN	I-NP	I-cell_typeproliferation	in	proliferation	NN	I-NP	Oin	several	in	IN	B-PP	Oseveral	models	several	JJ	B-NP	Omodels	of	model	NNS	I-NP	Oof	B	of	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	and	activation	NN	I-NP	Oand	tolerance	and	CC	O	Otolerance	.	tolerance	NN	B-NP	O.	We	.	.	O	OWe	compared	We	PRP	B-NP	Ocompared	the	compare	VBD	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	Egr-1	of	IN	B-PP	OEgr-1	during	Egr-1	NN	B-NP	B-proteinduring	B	during	IN	B-PP	OB	cell	B	NN	B-NP	Ocell	stimulation	cell	NN	I-NP	Ostimulation	with	stimulation	NN	I-NP	Owith	Fab'2	with	IN	B-PP	OFab'2	and	Fab'2	NN	B-NP	B-proteinand	IgG	and	CC	I-NP	OIgG	anti-immunoglobulin	IgG	NN	I-NP	B-proteinanti-immunoglobulin	(	anti-immunoglobulin	JJ	B-ADJP	O(	anti-Ig	(	(	O	Oanti-Ig	)	anti-Ig	JJ	B-ADJP	B-protein)	","	)	)	O	O","	since	","	","	O	Osince	it	since	IN	B-SBAR	Oit	is	it	PRP	B-NP	Ois	known	be	VBZ	B-VP	Oknown	that	know	VBN	I-VP	Othat	Fab'2	that	IN	B-SBAR	OFab'2	anti-Ig	Fab'2	NN	B-NP	B-proteinanti-Ig	is	anti-Ig	NN	I-NP	B-proteinis	mitogenic	be	VBZ	B-VP	Omitogenic	while	mitogenic	JJ	B-ADJP	Owhile	IgG	while	IN	B-SBAR	OIgG	anti-Ig	IgG	NN	B-NP	B-proteinanti-Ig	is	anti-Ig	NN	I-NP	I-proteinis	not	be	VBZ	B-VP	Onot	","	not	RB	O	O","	owing	","	","	O	Oowing	to	owe	VBG	B-VP	Oto	a	to	TO	B-PP	Oa	dominant	a	DT	B-NP	Odominant	inhibitory	dominant	JJ	I-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	crosslinking	of	IN	B-PP	Ocrosslinking	the	crosslinke	VBG	B-VP	Othe	B	the	DT	B-NP	OB	cell	B	NN	I-NP	Ocell	Fc	cell	NN	I-NP	OFc	gamma	Fc	NN	I-NP	B-proteingamma	RII	gamma	NN	I-NP	I-proteinRII	to	RII	NN	I-NP	I-proteinto	membrane	to	TO	B-PP	Omembrane	Ig	membrane	NN	B-NP	OIg	.	Ig	NN	I-NP	O.	While	.	.	O	OWhile	mitogenic	While	IN	B-SBAR	Omitogenic	doses	mitogenic	JJ	B-NP	Odoses	of	dose	NNS	I-NP	Oof	Fab'2	of	IN	B-PP	OFab'2	anti-Ig	Fab'2	NN	B-NP	Oanti-Ig	induce	anti-Ig	NN	I-NP	B-proteininduce	large	induce	VBP	B-VP	Olarge	and	large	JJ	B-NP	Oand	rapid	and	CC	I-NP	Orapid	increases	rapid	JJ	I-NP	Oincreases	in	increase	NNS	I-NP	Oin	Egr-1	in	IN	B-PP	OEgr-1	expression	Egr-1	NN	B-NP	B-proteinexpression	","	expression	NN	I-NP	O","	IgG	","	","	O	OIgG	anti-Ig	IgG	NN	B-NP	B-proteinanti-Ig	results	anti-Ig	NN	I-NP	I-proteinresults	in	result	VBZ	B-VP	Oin	smaller	in	IN	B-PP	Osmaller	increases	small	JJR	B-NP	Oincreases	in	increase	NNS	I-NP	Oin	Egr-1	in	IN	B-PP	OEgr-1	mRNA	Egr-1	NN	B-NP	B-RNAmRNA	","	mRNA	NN	I-NP	I-RNA","	comparable	","	","	O	Ocomparable	to	comparable	JJ	B-ADJP	Oto	that	to	TO	B-PP	Othat	seen	that	DT	B-NP	Oseen	with	see	VBN	B-VP	Owith	submitogenic	with	IN	B-PP	Osubmitogenic	concentrations	submitogenic	JJ	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	Fab'2	of	IN	B-PP	OFab'2	anti-Ig	Fab'2	NN	B-NP	Oanti-Ig	.	anti-Ig	NN	I-NP	B-protein.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	the	","	","	O	Othe	correlation	the	DT	B-NP	Ocorrelation	between	correlation	NN	I-NP	Obetween	Egr-1	between	IN	B-PP	OEgr-1	expression	Egr-1	NN	B-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	B	and	CC	O	OB	cell	B	NN	B-NP	Ocell	proliferation	cell	NN	I-NP	Oproliferation	breaks	proliferation	NN	I-NP	Obreaks	down	break	NNS	I-NP	Odown	when	down	RB	B-ADVP	Owhen	IL-4	when	WRB	B-ADVP	OIL-4	is	IL-4	NN	B-NP	B-proteinis	added	be	VBZ	B-VP	Oadded	as	add	VBN	I-VP	Oas	a	as	IN	B-PP	Oa	co-mitogen	a	DT	B-NP	Oco-mitogen	to	co-mitogen	NN	I-NP	Oto	induce	to	TO	B-VP	Oinduce	B	induce	VB	I-VP	OB	cell	B	NN	B-NP	Ocell	proliferation	cell	NN	I-NP	Oproliferation	with	proliferation	NN	I-NP	Owith	IgG	with	IN	B-PP	OIgG	anti-Ig	IgG	NN	B-NP	B-proteinanti-Ig	or	anti-Ig	JJ	I-NP	Oor	submitogenic	or	CC	I-NP	Osubmitogenic	concentrations	submitogenic	JJ	I-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	Fab'2	of	IN	B-PP	OFab'2	anti-Ig	Fab'2	NN	B-NP	Oanti-Ig	.	anti-Ig	NN	I-NP	B-protein.	No	.	.	O	ONo	corresponding	No	DT	B-NP	Ocorresponding	increases	correspond	VBG	I-NP	Oincreases	in	increase	NNS	I-NP	Oin	Egr-1	in	IN	B-PP	OEgr-1	mRNA	Egr-1	NN	B-NP	B-RNAmRNA	levels	mRNA	NN	I-NP	I-RNAlevels	are	level	NNS	I-NP	Oare	observed	be	VBP	B-VP	Oobserved	when	observe	VBN	I-VP	Owhen	IL-4	when	WRB	B-ADVP	OIL-4	is	IL-4	NN	B-NP	B-proteinis	added	be	VBZ	B-VP	Oadded	.	add	VBN	I-VP	O.	Therefore	.	.	O	OTherefore	","	Therefore	RB	B-ADVP	O","	IL-4	","	","	O	OIL-4	overcomes	IL-4	NN	B-NP	B-proteinovercomes	Fc	overcome	VBZ	B-VP	OFc	receptor-mediated	Fc	NN	B-NP	Oreceptor-mediated	inhibition	receptor-mediated	JJ	I-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	B	of	IN	B-PP	OB	cell	B	NN	B-NP	B-cell_typecell	proliferation	cell	NN	I-NP	I-cell_typeproliferation	without	proliferation	NN	I-NP	Owithout	affecting	without	IN	B-PP	Oaffecting	inhibition	affect	VBG	B-VP	Oinhibition	of	inhibition	NN	B-NP	Oof	Egr-1	of	IN	B-PP	OEgr-1	mRNA	Egr-1	NN	B-NP	B-RNAmRNA	induction	mRNA	NN	I-NP	I-RNAinduction	","	induction	NN	I-NP	O","	as	","	","	O	Oas	demonstrated	as	IN	B-SBAR	Odemonstrated	earlier	demonstrate	VBN	B-VP	Oearlier	for	earlier	RBR	B-ADVP	Ofor	c-myc	for	IN	B-PP	Oc-myc	mRNA	c-myc	NN	B-NP	B-RNAmRNA	in	mRNA	NN	I-NP	I-RNAin	this	in	IN	B-PP	Othis	system	this	DT	B-NP	Osystem	.	system	NN	I-NP	O.	Identification	.	.	O	OIdentification	of	Identification	NN	B-NP	Oof	a	of	IN	B-PP	Oa	novel	a	DT	B-NP	Onovel	cyclosporin-sensitive	novel	JJ	I-NP	Ocyclosporin-sensitive	element	cyclosporin-sensitive	JJ	I-NP	B-DNAelement	in	element	NN	I-NP	I-DNAin	the	in	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	tumor	human	JJ	I-NP	B-DNAtumor	necrosis	tumor	NN	I-NP	I-DNAnecrosis	factor	necrosis	NN	I-NP	I-DNAfactor	alpha	factor	NN	I-NP	I-DNAalpha	gene	alpha	NN	I-NP	I-DNAgene	promoter	gene	NN	I-NP	I-DNApromoter	.	promoter	NN	I-NP	I-DNA.	Tumor	.	.	O	OTumor	necrosis	Tumor	NN	B-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	alpha	factor	NN	I-NP	I-proteinalpha	(	alpha	NN	I-NP	I-protein(	TNF-alpha	(	(	O	OTNF-alpha	)	TNF-alpha	NN	B-NP	B-protein)	","	)	)	O	O","	a	","	","	O	Oa	cytokine	a	DT	B-NP	Ocytokine	with	cytokine	NN	I-NP	B-proteinwith	pleiotropic	with	IN	B-PP	Opleiotropic	biological	pleiotropic	JJ	B-NP	Obiological	effects	biological	JJ	I-NP	Oeffects	","	effect	NNS	I-NP	O","	is	","	","	O	Ois	produced	be	VBZ	B-VP	Oproduced	by	produce	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	variety	a	DT	B-NP	Ovariety	of	variety	NN	I-NP	Oof	cell	of	IN	B-PP	Ocell	types	cell	NN	B-NP	Otypes	in	type	NNS	I-NP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	induction	to	TO	B-PP	Oinduction	by	induction	NN	B-NP	Oby	diverse	by	IN	B-PP	Odiverse	stimuli	diverse	JJ	B-NP	Ostimuli	.	stimulus	NNS	I-NP	O.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	paper	this	DT	B-NP	Opaper	","	paper	NN	I-NP	O","	TNF-alpha	","	","	O	OTNF-alpha	mRNA	TNF-alpha	NN	B-NP	B-RNAmRNA	is	mRNA	NN	I-NP	I-RNAis	shown	be	VBZ	B-VP	Oshown	to	show	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	highly	be	VB	I-VP	Ohighly	induced	highly	RB	I-VP	Oinduced	in	induce	VBN	I-VP	Oin	a	in	IN	B-PP	Oa	murine	a	DT	B-NP	Omurine	T	murine	JJ	I-NP	B-cell_lineT	cell	T	NN	I-NP	I-cell_linecell	clone	cell	NN	I-NP	I-cell_lineclone	by	clone	NN	I-NP	I-cell_lineby	stimulation	by	IN	B-PP	Ostimulation	with	stimulation	NN	B-NP	Owith	T	with	IN	B-PP	OT	cell	T	NN	B-NP	B-proteincell	receptor	cell	NN	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	TCR	(	(	O	OTCR	)	TCR	NN	B-NP	B-protein)	ligands	)	)	O	Oligands	or	ligand	NNS	B-NP	Oor	by	or	CC	B-PP	Oby	calcium	by	IN	B-PP	Ocalcium	ionophores	calcium	NN	B-NP	Oionophores	alone	ionophore	VBZ	B-VP	Oalone	.	alone	RB	B-ADVP	O.	Induction	.	.	O	OInduction	is	Induction	NN	B-NP	Ois	rapid	be	VBZ	B-VP	Orapid	","	rapid	JJ	B-ADJP	O","	does	","	","	O	Odoes	not	do	VBZ	B-VP	Onot	require	not	RB	I-VP	Orequire	de	require	VB	I-VP	Ode	novo	de	FW	B-NP	Onovo	protein	novo	FW	I-NP	Oprotein	synthesis	protein	NN	I-NP	Osynthesis	","	synthesis	NN	I-NP	O","	and	","	","	O	Oand	is	and	CC	O	Ois	completely	be	VBZ	B-VP	Ocompletely	blocked	completely	RB	I-VP	Oblocked	by	block	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	immunosuppressant	the	DT	B-NP	Oimmunosuppressant	cyclosporin	immunosuppressant	JJ	I-NP	Ocyclosporin	A	cyclosporin	NN	I-NP	OA	(	A	NN	I-NP	O(	CsA	(	(	O	OCsA	)	CsA	NN	B-NP	O)	.	)	)	O	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	identified	have	VBP	B-VP	Oidentified	a	identify	VBN	I-VP	Oa	human	a	DT	B-NP	Ohuman	TNF-alpha	human	JJ	I-NP	B-DNATNF-alpha	promoter	TNF-alpha	NN	I-NP	I-DNApromoter	element	promoter	NN	I-NP	I-DNAelement	","	element	NN	I-NP	I-DNA","	kappa	","	","	O	Okappa	3	kappa	NN	B-NP	B-DNA3	","	3	CD	I-NP	I-DNA","	which	","	","	O	Owhich	plays	which	WDT	B-NP	Oplays	a	play	VBZ	B-VP	Oa	key	a	DT	B-NP	Okey	role	key	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	the	in	IN	B-PP	Othe	calcium-mediated	the	DT	B-NP	Ocalcium-mediated	inducibility	calcium-mediated	JJ	I-NP	Oinducibility	and	inducibility	NN	I-NP	Oand	CsA	and	CC	I-NP	OCsA	sensitivity	CsA	NN	I-NP	Osensitivity	of	sensitivity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	gene	the	DT	B-NP	Ogene	.	gene	NN	I-NP	O.	In	.	.	O	OIn	electrophoretic	In	IN	B-PP	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assays	shift	NN	I-NP	Oassays	","	assay	NNS	I-NP	O","	an	","	","	O	Oan	oligonucleotide	an	DT	B-NP	Ooligonucleotide	containing	oligonucleotide	NN	I-NP	Ocontaining	kappa	contain	VBG	B-VP	Okappa	3	kappa	NN	B-NP	B-DNA3	forms	3	CD	I-NP	I-DNAforms	two	form	VBZ	B-VP	Otwo	DNA	two	CD	B-NP	ODNA	protein	DNA	NN	I-NP	B-proteinprotein	complexes	protein	NN	I-NP	I-proteincomplexes	with	complex	NNS	I-NP	I-proteinwith	proteins	with	IN	B-PP	Oproteins	that	protein	NNS	B-NP	Othat	are	that	WDT	B-NP	Oare	present	be	VBP	B-VP	Opresent	in	present	JJ	B-ADJP	Oin	extracts	in	IN	B-PP	Oextracts	from	extract	NNS	B-NP	Ofrom	unstimulated	from	IN	B-PP	Ounstimulated	T	unstimulated	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	These	.	.	O	OThese	complexes	These	DT	B-NP	Ocomplexes	appear	complex	NNS	I-NP	Oappear	in	appear	VBP	B-VP	Oin	nuclear	in	IN	B-PP	Onuclear	extracts	nuclear	JJ	B-NP	Oextracts	only	extract	NNS	I-NP	Oonly	after	only	RB	B-ADVP	Oafter	T	after	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	stimulation	cell	NN	I-NP	Ostimulation	.	stimulation	NN	I-NP	O.	Induction	.	.	O	OInduction	of	Induction	NN	B-NP	Oof	the	of	IN	B-PP	Othe	inducible	the	DT	B-NP	Oinducible	nuclear	inducible	JJ	I-NP	B-proteinnuclear	complexes	nuclear	JJ	I-NP	I-proteincomplexes	is	complex	NNS	I-NP	I-proteinis	rapid	be	VBZ	B-VP	Orapid	","	rapid	JJ	B-ADJP	O","	independent	","	","	O	Oindependent	of	independent	JJ	B-ADJP	Oof	protein	of	IN	B-PP	Oprotein	synthesis	protein	NN	B-NP	Osynthesis	","	synthesis	NN	I-NP	O","	and	","	","	O	Oand	blocked	and	CC	O	Oblocked	by	block	VBN	B-VP	Oby	CsA	by	IN	B-PP	OCsA	","	CsA	NN	B-NP	O","	and	","	","	O	Oand	thus	and	CC	O	Othus	","	thus	RB	O	O","	exactly	","	","	O	Oexactly	parallels	exactly	RB	B-ADVP	Oparallels	the	parallel	VBZ	B-VP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	TNF-alpha	of	IN	B-PP	OTNF-alpha	mRNA	TNF-alpha	NN	B-NP	B-RNAmRNA	by	mRNA	NN	I-NP	I-RNAby	TCR	by	IN	B-PP	OTCR	ligands	TCR	NN	B-NP	B-proteinligands	or	ligand	NNS	I-NP	Oor	by	or	CC	B-PP	Oby	calcium	by	IN	B-PP	Ocalcium	ionophore	calcium	NN	B-NP	Oionophore	.	ionophore	NN	I-NP	O.	Our	.	.	O	OOur	studies	Our	PRP$	B-NP	Ostudies	indicate	study	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	kappa	the	DT	B-NP	Okappa	3	kappa	NN	I-NP	B-protein3	binding	3	CD	I-NP	I-proteinbinding	factor	binding	NN	I-NP	I-proteinfactor	resembles	factor	NN	I-NP	I-proteinresembles	the	resemble	VBZ	B-VP	Othe	preexisting	the	DT	B-NP	Opreexisting	component	preexist	VBG	I-NP	Ocomponent	of	component	NN	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor	nuclear	JJ	B-NP	B-proteinfactor	of	factor	NN	I-NP	I-proteinof	activated	of	IN	B-PP	I-proteinactivated	T	activate	VBN	B-NP	I-proteinT	cells	T	NN	I-NP	I-proteincells	.	cell	NNS	I-NP	I-protein.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	the	","	","	O	Othe	TNF-alpha	the	DT	B-NP	OTNF-alpha	gene	TNF-alpha	NN	I-NP	B-DNAgene	is	gene	NN	I-NP	I-DNAis	an	be	VBZ	B-VP	Oan	immediate	an	DT	B-NP	Oimmediate	early	immediate	JJ	I-NP	B-DNAearly	gene	early	JJ	I-NP	I-DNAgene	in	gene	NN	I-NP	I-DNAin	activated	in	IN	B-PP	Oactivated	T	activate	VBN	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	provides	and	CC	O	Oprovides	a	provide	VBZ	B-VP	Oa	new	a	DT	B-NP	Onew	model	new	JJ	I-NP	Omodel	system	model	NN	I-NP	Osystem	in	system	NN	I-NP	Oin	which	in	IN	B-PP	Owhich	to	which	WDT	B-NP	Oto	study	to	TO	B-VP	Ostudy	CsA-sensitive	study	VB	I-VP	OCsA-sensitive	gene	CsA-sensitive	JJ	B-NP	B-DNAgene	induction	gene	NN	I-NP	I-DNAinduction	in	induction	NN	I-NP	Oin	activated	in	IN	B-PP	Oactivated	T	activate	VBN	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Differences	.	.	O	ODifferences	in	Difference	NNS	B-NP	Oin	expression	in	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	transcription	of	IN	B-PP	Otranscription	factor	transcription	NN	B-NP	B-proteinfactor	AP-1	factor	NN	I-NP	I-proteinAP-1	in	AP-1	NN	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	promyelocytic	human	JJ	B-NP	B-cell_linepromyelocytic	HL-60	promyelocytic	JJ	I-NP	I-cell_lineHL-60	cells	HL-60	NN	I-NP	I-cell_linecells	during	cell	NNS	I-NP	I-cell_lineduring	differentiation	during	IN	B-PP	Odifferentiation	towards	differentiation	NN	B-NP	Otowards	macrophages	towards	IN	B-PP	Omacrophages	versus	macrophage	NNS	B-NP	B-cell_typeversus	granulocytes	versus	IN	B-PP	Ogranulocytes	.	granulocyte	NNS	B-NP	B-cell_type.	Commitment	.	.	O	OCommitment	of	Commitment	NN	B-NP	Oof	HL-60	of	IN	B-PP	OHL-60	cells	HL-60	NN	B-NP	B-cell_linecells	to	cell	NNS	I-NP	I-cell_lineto	macrophage	to	TO	B-PP	Omacrophage	or	macrophage	NN	B-NP	B-cell_typeor	granulocytic	or	CC	O	Ogranulocytic	differentiation	granulocytic	JJ	B-NP	Odifferentiation	was	differentiation	NN	I-NP	Owas	achieved	be	VBD	B-VP	Oachieved	by	achieve	VBN	I-VP	Oby	incubation	by	IN	B-PP	Oincubation	with	incubation	NN	B-NP	Owith	4	with	IN	B-PP	O4	beta-phorbol	4	CD	B-NP	Obeta-phorbol	12-myristate	beta-phorbol	NN	I-NP	O12-myristate	13-acetate	12-myristate	NN	I-NP	O13-acetate	(	13-acetate	NN	I-NP	O(	PMA	(	(	O	OPMA	)	PMA	NN	B-NP	O)	for	)	)	O	Ofor	30-60	for	IN	B-PP	O30-60	min	30-60	CD	B-NP	Omin	or	min	NN	I-NP	Oor	with	or	CC	B-PP	Owith	dimethyl	with	IN	B-PP	Odimethyl	sulphoxide	dimethyl	NN	B-NP	Osulphoxide	(	sulphoxide	NN	I-NP	O(	DMSO	(	(	O	ODMSO	)	DMSO	NN	B-NP	O)	for	)	)	O	Ofor	24	for	IN	B-PP	O24	h	24	CD	B-NP	Oh	respectively	h	NN	I-NP	Orespectively	.	respectively	RB	B-ADVP	O.	The	.	.	O	OThe	commitment	The	DT	B-NP	Ocommitment	stage	commitment	NN	I-NP	Ostage	towards	stage	NN	I-NP	Otowards	PMA-induced	towards	IN	B-PP	OPMA-induced	macrophage	PMA-induced	JJ	B-NP	Omacrophage	differentiation	macrophage	NN	I-NP	Odifferentiation	was	differentiation	NN	I-NP	Owas	associated	be	VBD	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	increases	with	IN	B-PP	Oincreases	in	increase	NNS	B-NP	Oin	jun	in	IN	B-PP	Ojun	B	jun	NN	B-NP	B-DNAB	and	B	NN	I-NP	I-DNAand	c-fos	and	CC	O	Oc-fos	mRNA	c-fos	NN	B-NP	B-RNAmRNA	levels	mRNA	NN	B-NP	I-RNAlevels	","	level	NNS	I-NP	O","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	with	as	IN	I-CONJP	Owith	an	with	IN	B-PP	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	the	in	IN	B-PP	Othe	binding	the	DT	B-NP	Obinding	activity	binding	NN	I-NP	Oactivity	of	activity	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	factor	transcription	NN	B-NP	B-proteinfactor	AP-1	factor	NN	I-NP	I-proteinAP-1	.	AP-1	NN	I-NP	I-protein.	Nevertheless	.	.	O	ONevertheless	","	Nevertheless	RB	B-ADVP	O","	gel	","	","	O	Ogel	retardation	gel	NN	B-NP	Oretardation	analysis	retardation	NN	I-NP	Oanalysis	indicated	analysis	NN	I-NP	Oindicated	that	indicate	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	AP-1	the	DT	B-NP	OAP-1	activity	AP-1	NN	I-NP	B-proteinactivity	detected	activity	NN	I-NP	Odetected	in	detect	VBN	B-VP	Oin	untreated	in	IN	B-PP	Ountreated	cells	untreated	JJ	B-NP	B-cell_typecells	was	cell	NNS	I-NP	I-cell_typewas	drastically	be	VBD	B-VP	Odrastically	reduced	drastically	RB	I-VP	Oreduced	during	reduce	VBN	I-VP	Oduring	the	during	IN	B-PP	Othe	commitment	the	DT	B-NP	Ocommitment	stage	commitment	NN	I-NP	Ostage	of	stage	NN	I-NP	Oof	DMSO-induced	of	IN	B-PP	ODMSO-induced	HL-60	DMSO-induced	JJ	B-NP	OHL-60	differentiation	HL-60	NN	I-NP	Odifferentiation	towards	differentiation	NN	I-NP	Otowards	granulocytes	towards	IN	B-PP	Ogranulocytes	.	granulocyte	NNS	B-NP	B-cell_type.	When	.	.	O	OWhen	HL-60	When	WRB	B-ADVP	OHL-60	cells	HL-60	NN	B-NP	B-cell_linecells	were	cell	NNS	I-NP	I-cell_linewere	treated	be	VBD	B-VP	Otreated	with	treat	VBN	I-VP	Owith	sodium	with	IN	B-PP	Osodium	butyrate	sodium	NN	B-NP	Obutyrate	","	butyrate	NN	I-NP	O","	which	","	","	O	Owhich	induced	which	WDT	B-NP	Oinduced	monocytic	induce	VBD	B-VP	Omonocytic	differentiation	monocytic	JJ	B-NP	Odifferentiation	","	differentiation	NN	I-NP	O","	a	","	","	O	Oa	remarkable	a	DT	B-NP	Oremarkable	increase	remarkable	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	AP-1	in	IN	B-PP	OAP-1	binding	AP-1	NN	B-NP	B-proteinbinding	activity	binding	NN	I-NP	Oactivity	was	activity	NN	I-NP	Owas	detected	be	VBD	B-VP	Odetected	.	detect	VBN	I-VP	O.	Treatment	.	.	O	OTreatment	of	Treatment	NN	B-NP	Oof	HL-60	of	IN	B-PP	OHL-60	cells	HL-60	NN	B-NP	B-cell_linecells	with	cell	NNS	I-NP	I-cell_linewith	1	with	IN	B-PP	O1	alpha	1	CD	B-NP	Oalpha	","	alpha	SYM	B-ADJP	O","	25-dihydroxyvitamin	","	","	O	O25-dihydroxyvitamin	D3	25-dihydroxyvitamin	NN	B-NP	OD3	","	D3	NN	I-NP	O","	another	","	","	O	Oanother	monocytic	another	DT	B-NP	Omonocytic	differentiation	monocytic	JJ	I-NP	Odifferentiation	agent	differentiation	NN	I-NP	Oagent	","	agent	NN	I-NP	O","	induced	","	","	O	Oinduced	a	induce	VBD	B-VP	Oa	weak	a	DT	B-NP	Oweak	","	weak	JJ	I-NP	O","	but	","	","	O	Obut	appreciable	but	CC	O	Oappreciable	","	appreciable	JJ	B-ADJP	O","	increase	","	","	O	Oincrease	in	increase	NN	B-NP	Oin	AP-1	in	IN	B-PP	OAP-1	activity	AP-1	NN	B-NP	B-proteinactivity	.	activity	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	addition	","	","	O	Oaddition	of	addition	NN	B-NP	Oof	sodium	of	IN	B-PP	Osodium	butyrate	sodium	NN	B-NP	Obutyrate	or	butyrate	NN	I-NP	Oor	1	or	CC	O	O1	alpha	1	CD	B-NP	Oalpha	","	alpha	NN	I-NP	O","	25-dihydroxyvitamin	","	","	O	O25-dihydroxyvitamin	D3	25-dihydroxyvitamin	NN	B-NP	OD3	to	D3	NN	I-NP	Oto	HL-60	to	TO	B-PP	OHL-60	cells	HL-60	NN	B-NP	B-cell_linecells	induced	cell	NNS	I-NP	I-cell_lineinduced	the	induce	VBD	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	c-fos	of	IN	B-PP	Oc-fos	","	c-fos	NN	B-NP	B-DNA","	c-jun	","	","	O	Oc-jun	","	c-jun	NN	B-NP	B-DNA","	jun	","	","	O	Ojun	B	jun	NN	B-NP	B-DNAB	and	B	NN	I-NP	I-DNAand	jun	and	CC	O	Ojun	D	jun	NN	B-NP	B-DNAD	proto-oncogenes	D	NN	I-NP	I-DNAproto-oncogenes	.	proto-oncogene	NNS	B-NP	I-DNA.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	when	","	","	O	Owhen	HL-60	when	WRB	B-ADVP	OHL-60	cells	HL-60	NN	B-NP	B-cell_linecells	were	cell	NNS	I-NP	I-cell_linewere	treated	be	VBD	B-VP	Otreated	with	treat	VBN	I-VP	Owith	retinoic	with	IN	B-PP	Oretinoic	acid	retinoic	JJ	B-NP	Oacid	","	acid	NN	I-NP	O","	a	","	","	O	Oa	granulocytic	a	DT	B-NP	Ogranulocytic	differentiation	granulocytic	JJ	I-NP	Odifferentiation	inducer	differentiation	NN	I-NP	Oinducer	","	inducer	NN	I-NP	O","	no	","	","	O	Ono	enhanced	no	DT	B-NP	Oenhanced	AP-1	enhance	VBN	I-NP	OAP-1	binding	AP-1	NN	I-NP	B-proteinbinding	activity	binding	NN	I-NP	Oactivity	was	activity	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	","	observe	VBN	I-VP	O","	and	","	","	O	Oand	only	and	CC	O	Oonly	a	only	RB	B-NP	Oa	weak	a	DT	I-NP	Oweak	increase	weak	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	jun	in	IN	B-PP	Ojun	D	jun	NN	B-NP	B-RNAD	mRNA	D	NN	I-NP	I-RNAmRNA	level	mRNA	NN	I-NP	I-RNAlevel	was	level	NN	I-NP	Owas	detected	be	VBD	B-VP	Odetected	.	detect	VBN	I-VP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	indicate	datum	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	formation	that	IN	B-SBAR	Oformation	of	formation	NN	B-NP	Oof	AP-1	of	IN	B-PP	OAP-1	is	AP-1	NN	B-NP	B-proteinis	not	be	VBZ	B-VP	Onot	required	not	RB	I-VP	Orequired	for	require	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	HL-60	of	IN	B-PP	OHL-60	differentiation	HL-60	NN	B-NP	Odifferentiation	towards	differentiation	NN	I-NP	Otowards	granulocytes	towards	IN	B-PP	Ogranulocytes	","	granulocyte	NNS	B-NP	B-cell_type","	whereas	","	","	O	Owhereas	induction	whereas	IN	O	Oinduction	of	induction	NN	B-NP	Oof	monocytic	of	IN	B-PP	Omonocytic	differentiation	monocytic	JJ	B-NP	Odifferentiation	is	differentiation	NN	I-NP	Ois	correlated	be	VBZ	B-VP	Ocorrelated	with	correlate	VBN	I-VP	Owith	an	with	IN	B-PP	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	AP-1	in	IN	B-PP	OAP-1	activity	AP-1	NN	B-NP	B-proteinactivity	.	activity	NN	I-NP	O.	The	.	.	O	OThe	differential	The	DT	B-NP	Odifferential	expression	differential	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	AP-1	of	IN	B-PP	OAP-1	activity	AP-1	NN	B-NP	B-proteinactivity	may	activity	NN	I-NP	Omay	be	may	MD	B-VP	Obe	critical	be	VB	I-VP	Ocritical	in	critical	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	differentiation	the	DT	B-NP	Odifferentiation	of	differentiation	NN	I-NP	Oof	HL-60	of	IN	B-PP	OHL-60	cells	HL-60	NN	B-NP	B-cell_linecells	towards	cell	NNS	I-NP	I-cell_linetowards	monocytic	towards	IN	B-PP	Omonocytic	or	monocytic	JJ	B-NP	Oor	granulocytic	or	CC	I-NP	Ogranulocytic	lineages	granulocytic	JJ	I-NP	B-cell_typelineages	Glucocorticoid	lineage	NNS	I-NP	I-cell_typeGlucocorticoid	receptors	Glucocorticoid	NN	B-NP	B-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	sensitivity	and	CC	O	Osensitivity	in	sensitivity	NN	B-NP	Oin	leukemias	in	IN	B-PP	Oleukemias	.	leukemia	NNS	B-NP	O.	In	.	.	O	OIn	an	In	IN	B-PP	Oan	attempt	an	DT	B-NP	Oattempt	to	attempt	NN	I-NP	Oto	investigate	to	TO	B-VP	Oinvestigate	the	investigate	VB	I-VP	Othe	utility	the	DT	B-NP	Outility	of	utility	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	determination	receptor	NN	I-NP	I-proteindetermination	to	determination	NN	I-NP	Oto	predict	to	TO	B-VP	Opredict	clinical	predict	VB	I-VP	Oclinical	responsiveness	clinical	JJ	B-NP	Oresponsiveness	in	responsiveness	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	leukemias	human	JJ	B-NP	Oleukemias	we	leukemia	NNS	I-NP	Owe	have	we	PRP	B-NP	Ohave	studied	have	VBP	B-VP	Ostudied	glucocorticoid	study	VBN	I-VP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	the	in	IN	B-PP	Othe	leukemic	the	DT	B-NP	Oleukemic	cells	leukemic	JJ	I-NP	B-cell_typecells	from	cell	NNS	I-NP	I-cell_typefrom	46	from	IN	B-PP	O46	patients	46	CD	B-NP	Opatients	and	patient	NNS	I-NP	Oand	in	and	CC	B-PP	Oin	the	in	IN	B-PP	Othe	lymphocytes	the	DT	B-NP	Olymphocytes	from	lymphocyte	NNS	I-NP	B-cell_typefrom	18	from	IN	B-PP	O18	normal	18	CD	B-NP	Onormal	donors	normal	JJ	I-NP	Odonors	.	donor	NNS	I-NP	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	normal	the	DT	B-NP	Onormal	lymphocytes	normal	JJ	I-NP	B-cell_typelymphocytes	there	lymphocyte	NNS	I-NP	I-cell_typethere	were	there	EX	B-NP	Owere	3	be	VBD	B-VP	O3	","	3	CD	B-NP	O","	875	","	","	I-NP	O875	(	875	CD	I-NP	O(	Median	(	(	O	OMedian	)	Median	NN	B-NP	O)	specific	)	)	O	Ospecific	binding	specific	JJ	B-NP	Obinding	sites	bind	VBG	I-NP	Osites	per	site	NNS	I-NP	Oper	cell	per	IN	B-PP	Ocell	.	cell	NN	B-NP	O.	The	.	.	O	OThe	blasts	The	DT	B-NP	Oblasts	from	blast	NNS	I-NP	B-cell_typefrom	17	from	IN	B-PP	O17	patients	17	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	ANLL	with	IN	B-PP	OANLL	had	ANLL	NN	B-NP	Ohad	on	have	VBD	B-VP	Oon	average	on	IN	B-PP	Oaverage	higher	average	JJ	B-NP	Ohigher	levels	high	JJR	I-NP	Olevels	of	level	NNS	I-NP	Oof	binding	of	IN	B-PP	Obinding	sites	bind	VBG	B-NP	Osites	per	site	NNS	I-NP	Oper	cell	per	IN	B-PP	Ocell	(	cell	NN	B-NP	O(	Median	(	(	O	OMedian	=	Median	NN	B-NP	O=	7	=	SYM	B-VP	O7	","	7	CD	B-NP	O","	250	","	","	O	O250	","	250	CD	B-NP	O","	range	","	","	O	Orange	:	range	NN	B-NP	O:	0	:	:	O	O0	to	0	CD	B-NP	Oto	15	to	TO	I-NP	O15	","	15	CD	I-NP	O","	295	","	","	I-NP	O295	)	295	CD	I-NP	O)	than	)	)	O	Othan	the	than	IN	B-PP	Othe	other	the	DT	B-NP	Oother	leukemias	other	JJ	I-NP	Oleukemias	.	leukemia	NNS	I-NP	O.	Of	.	.	O	OOf	the	Of	IN	B-PP	Othe	15	the	DT	B-NP	O15	patients	15	CD	I-NP	Opatients	with	patient	NNS	I-NP	Owith	CLL	with	IN	B-PP	OCLL	","	CLL	NN	B-NP	O","	six	","	","	O	Osix	had	six	CD	B-NP	Ohad	received	have	VBD	B-VP	Oreceived	glucocorticoid	receive	VBN	I-VP	Oglucocorticoid	treatment	glucocorticoid	NN	B-NP	Otreatment	for	treatment	NN	I-NP	Ofor	3	for	IN	B-PP	O3	to	3	CD	B-NP	Oto	5	to	TO	I-NP	O5	years	5	CD	I-NP	Oyears	.	year	NNS	I-NP	O.	Their	.	.	O	OTheir	lymphocytes	Their	PRP$	B-NP	Olymphocytes	had	lymphocyte	NNS	I-NP	B-cell_typehad	lower	have	VBD	B-VP	Olower	number	low	JJR	B-NP	Onumber	of	number	NN	I-NP	Oof	receptors	of	IN	B-PP	Oreceptors	(	receptor	NNS	B-NP	B-protein(	Median	(	(	O	OMedian	=	Median	NN	B-NP	O=	2	=	SYM	B-VP	O2	","	2	CD	B-NP	O","	0	","	","	O	O0	)	0	CD	B-NP	O)	than	)	)	O	Othan	the	than	IN	B-PP	Othe	other	the	DT	B-NP	Oother	cases	other	JJ	I-NP	Ocases	which	case	NNS	I-NP	Owhich	were	which	WDT	B-NP	Owere	newly	be	VBD	B-VP	Onewly	diagnosed	newly	RB	I-VP	Odiagnosed	(	diagnose	VBN	I-VP	O(	Median	(	(	O	OMedian	=	Median	NN	B-NP	O=	4	=	SYM	B-VP	O4	","	4	CD	B-NP	O","	500	","	","	O	O500	)	500	CD	B-NP	O)	.	)	)	O	O.	Four	.	.	O	OFour	patients	Four	CD	B-NP	Opatients	had	patient	NNS	I-NP	Ohad	ALL/AUL	have	VBD	B-VP	OALL/AUL	","	ALL/AUL	NN	B-NP	O","	three	","	","	O	Othree	patients	three	CD	B-NP	Opatients	had	patient	NNS	I-NP	Ohad	blast	have	VBD	B-VP	Oblast	crisis	blast	NN	B-NP	Ocrisis	as	crisis	NN	I-NP	Oas	terminal	as	IN	B-PP	Oterminal	phase	terminal	JJ	B-NP	Ophase	of	phase	NN	I-NP	Oof	CML	of	IN	B-PP	OCML	","	CML	NN	B-NP	O","	and	","	","	O	Oand	seven	and	CC	O	Oseven	had	seven	CD	B-NP	Ohad	leukemic	have	VBD	B-VP	Oleukemic	Non-Hodgkin	leukemic	JJ	B-NP	ONon-Hodgkin	lymphomas	Non-Hodgkin	JJ	I-NP	Olymphomas	(	lymphoma	NNS	I-NP	O(	Median	(	(	O	OMedian	=	Median	NN	B-NP	O=	3	=	SYM	B-VP	O3	","	3	CD	B-NP	O","	500	","	","	O	O500	sites/cell	500	CD	B-NP	Osites/cell	)	sites/cell	NNS	I-NP	O)	.	)	)	O	O.	In	.	.	O	OIn	24	In	IN	B-PP	O24	patients	24	CD	B-NP	Opatients	we	patient	NNS	I-NP	Owe	have	we	PRP	B-NP	Ohave	also	have	VBP	B-VP	Oalso	studied	also	RB	I-VP	Ostudied	the	study	VBN	I-VP	Othe	in	the	DT	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	sensitivity	vitro	FW	I-NP	Osensitivity	of	sensitivity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	leukemic	the	DT	B-NP	Oleukemic	cells	leukemic	JJ	I-NP	B-cell_typecells	to	cell	NNS	I-NP	I-cell_typeto	dexamethasone	to	TO	B-PP	Odexamethasone	.	dexamethasone	NN	B-NP	O.	There	.	.	O	OThere	was	There	EX	B-NP	Owas	no	be	VBD	B-VP	Ono	marked	no	DT	B-NP	Omarked	correlation	marked	JJ	I-NP	Ocorrelation	between	correlation	NN	I-NP	Obetween	glucocorticoid	between	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	levels	receptor	NN	I-NP	I-proteinlevels	and	level	NNS	I-NP	Oand	in	and	CC	O	Oin	vitro	in	FW	B-NP	Ovitro	sensitivity	vitro	FW	I-NP	Osensitivity	.	sensitivity	NN	I-NP	O.	An	.	.	O	OAn	attempt	An	DT	B-NP	Oattempt	to	attempt	NN	I-NP	Oto	correlate	to	TO	B-VP	Ocorrelate	receptor	correlate	VB	I-VP	Oreceptor	levels	receptor	NN	B-NP	Olevels	with	level	NNS	I-NP	Owith	clinical	with	IN	B-PP	Oclinical	responsiveness	clinical	JJ	B-NP	Oresponsiveness	demonstrated	responsiveness	NN	I-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	glucocorticoid	that	IN	B-SBAR	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	determination	receptor	NN	I-NP	I-proteindetermination	might	determination	NN	I-NP	Omight	be	might	MD	B-VP	Obe	of	be	VB	I-VP	Oof	value	of	IN	B-PP	Ovalue	in	value	NN	B-NP	Oin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	lymphoid	with	IN	B-PP	Olymphoid	malignancies	lymphoid	JJ	B-NP	Omalignancies	but	malignancy	NNS	I-NP	Obut	probably	but	CC	O	Oprobably	not	probably	RB	B-ADVP	Onot	in	not	RB	O	Oin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	other	with	IN	B-PP	Oother	leukemias	other	JJ	B-NP	Oleukemias	.	leukemia	NNS	I-NP	O.	'Activation-labile	.	.	O	O'Activation-labile	'	'Activation-labile	JJ	B-NP	O'	glucocorticoid-receptor	'	''	I-NP	Oglucocorticoid-receptor	complexes	glucocorticoid-receptor	NN	I-NP	B-proteincomplexes	of	complex	NNS	I-NP	I-proteinof	a	of	IN	B-PP	Oa	steroid-resistant	a	DT	B-NP	Osteroid-resistant	variant	steroid-resistant	JJ	I-NP	Ovariant	of	variant	NN	I-NP	Oof	CEM-C7	of	IN	B-PP	OCEM-C7	human	CEM-C7	NN	B-NP	B-cell_linehuman	lymphoid	human	JJ	I-NP	I-cell_linelymphoid	cells	lymphoid	JJ	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	For	.	.	O	OFor	cytoplasmic	For	IN	B-PP	Ocytoplasmic	glucocorticoid-receptor	cytoplasmic	JJ	B-NP	B-proteinglucocorticoid-receptor	complexes	glucocorticoid-receptor	NN	I-NP	I-proteincomplexes	to	complex	NNS	I-NP	I-proteinto	enter	to	TO	B-VP	Oenter	and	enter	VB	I-VP	Oand	accumulate	and	CC	I-VP	Oaccumulate	in	accumulate	VB	I-VP	Oin	the	in	IN	B-PP	Othe	nucleus	the	DT	B-NP	Onucleus	a	nucleus	NN	I-NP	Oa	temperature-dependent	a	DT	B-NP	Otemperature-dependent	event	temperature-dependent	JJ	I-NP	Oevent	","	event	NN	I-NP	O","	'activation	","	","	O	O'activation	'	'activation	NN	B-NP	O'	is	'	''	O	Ois	required	be	VBZ	B-VP	Orequired	.	require	VBN	I-VP	O.	Activation	.	.	O	OActivation	can	Activation	NN	B-NP	Ocan	be	can	MD	B-VP	Obe	achieved	be	VB	I-VP	Oachieved	in	achieve	VBN	I-VP	Oin	vitro	in	FW	B-ADVP	Ovitro	by	vitro	FW	I-ADVP	Oby	increased	by	IN	B-PP	Oincreased	ionic	increase	VBN	B-NP	Oionic	strength	ionic	JJ	I-NP	Ostrength	","	strength	NN	I-NP	O","	dilution	","	","	O	Odilution	or	dilution	NN	B-NP	Oor	gel	or	CC	O	Ogel	filtration	gel	NN	B-NP	Ofiltration	and	filtration	NN	I-NP	Oand	is	and	CC	O	Ois	manifested	be	VBZ	B-VP	Omanifested	by	manifest	VBN	I-VP	Oby	an	by	IN	B-PP	Oan	increased	an	DT	B-NP	Oincreased	affinity	increase	VBN	I-NP	Oaffinity	of	affinity	NN	I-NP	Oof	steroid-receptor	of	IN	B-PP	Osteroid-receptor	complex	steroid-receptor	JJ	B-NP	B-proteincomplex	for	complex	NN	I-NP	I-proteinfor	DNA	for	IN	B-PP	ODNA	and	DNA	NN	B-NP	Oand	an	and	CC	O	Oan	altered	an	DT	B-NP	Oaltered	elution	altered	JJ	I-NP	Oelution	profile	elution	NN	I-NP	Oprofile	from	profile	NN	I-NP	Ofrom	ion-exchange	from	IN	B-PP	Oion-exchange	resins	ion-exchange	NN	B-NP	B-proteinresins	.	resin	NNS	I-NP	I-protein.	Munck	.	.	O	OMunck	and	Munck	NNP	B-NP	Oand	Foley	and	CC	I-NP	OFoley	have	Foley	NNP	I-NP	Ohave	shown	have	VBP	B-VP	Oshown	that	show	VBN	I-VP	Othat	activated	that	IN	B-SBAR	Oactivated	complexes	activate	VBN	B-NP	Ocomplexes	isolated	complex	NNS	I-NP	Oisolated	from	isolate	VBN	B-VP	Ofrom	thymocytes	from	IN	B-PP	Othymocytes	elute	thymocyte	NNS	B-NP	B-cell_typeelute	from	elute	VBP	B-VP	Ofrom	DEAE-cellulose	from	IN	B-PP	ODEAE-cellulose	in	DEAE-cellulose	NN	B-NP	Oin	a	in	IN	B-PP	Oa	manner	a	DT	B-NP	Omanner	identical	manner	NN	I-NP	Oidentical	to	identical	JJ	B-ADJP	Oto	complexes	to	TO	B-PP	Ocomplexes	activated	complex	NNS	B-NP	Oactivated	in	activate	VBN	B-VP	Oin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	We	.	.	O	OWe	report	We	PRP	B-NP	Oreport	here	report	VBP	B-VP	Ohere	that	here	RB	B-ADVP	Othat	DEAE-cellulose	that	IN	B-SBAR	ODEAE-cellulose	chromatography	DEAE-cellulose	NN	B-NP	Ochromatography	of	chromatography	NN	I-NP	Oof	steroid-receptor	of	IN	B-PP	Osteroid-receptor	complexes	steroid-receptor	JJ	B-NP	B-proteincomplexes	from	complex	NNS	I-NP	I-proteinfrom	CEM-C7	from	IN	B-PP	OCEM-C7	","	CEM-C7	NN	B-NP	B-cell_line","	a	","	","	O	Oa	cloned	a	DT	B-NP	Ocloned	human	clone	VBN	I-NP	B-cell_linehuman	leukaemic	human	JJ	I-NP	I-cell_lineleukaemic	T-cell	leukaemic	JJ	I-NP	I-cell_lineT-cell	line	T-cell	NN	I-NP	I-cell_lineline	sensitive	line	NN	I-NP	I-cell_linesensitive	to	sensitive	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	cytolytic	the	DT	B-NP	Ocytolytic	action	cytolytic	JJ	I-NP	Oaction	of	action	NN	I-NP	Oof	glucocorticoids	of	IN	B-PP	Oglucocorticoids	","	glucocorticoid	NNS	B-NP	O","	and	","	","	O	Oand	its	and	CC	O	Oits	steroid-resistant	its	PRP$	B-NP	Osteroid-resistant	subclone	steroid-resistant	JJ	I-NP	B-proteinsubclone	4R4	subclone	NN	I-NP	I-protein4R4	demonstrated	4R4	NN	I-NP	I-proteindemonstrated	that	demonstrate	VBD	B-VP	Othat	steroid	that	IN	B-SBAR	Osteroid	receptors	steroid	NN	B-NP	B-proteinreceptors	of	receptor	NNS	I-NP	I-proteinof	clone	of	IN	B-PP	Oclone	4R4	clone	NN	B-NP	B-protein4R4	can	4R4	NN	I-NP	I-proteincan	not	can	MD	B-VP	Onot	form	not	RB	I-VP	Oform	stable	form	VB	I-VP	Ostable	activated	stable	JJ	B-NP	B-proteinactivated	complexes	activate	VBN	I-NP	I-proteincomplexes	.	complex	NNS	I-NP	I-protein.	This	.	.	O	OThis	defines	This	DT	B-NP	Odefines	a	define	VBZ	B-VP	Oa	new	a	DT	B-NP	Onew	defect	new	JJ	I-NP	Odefect	in	defect	NN	I-NP	Oin	receptor	in	IN	B-PP	Oreceptor	action	receptor	NN	B-NP	Oaction	","	action	NN	I-NP	O","	activation	","	","	O	Oactivation	lability	activation	NN	B-NP	Olability	(	lability	NN	I-NP	O(	r+act1	(	(	O	Or+act1	)	r+act1	NN	B-NP	B-protein)	","	)	)	O	O","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	unlike	be	VBZ	B-VP	Ounlike	either	unlike	IN	B-PP	Oeither	the	either	CC	O	Othe	r-	the	DT	B-NP	Or-	","	r-	NN	I-NP	O","	r+nt-	","	","	O	Or+nt-	","	r+nt-	NN	B-NP	O","	or	","	","	O	Oor	r+nti	or	CC	O	Or+nti	phenotypes	r+nti	AFX	B-NP	Ophenotypes	previously	phenotype	NNS	I-NP	Opreviously	described	previously	RB	B-VP	Odescribed	for	describe	VBN	I-VP	Ofor	mouse	for	IN	B-PP	Omouse	lymphoid	mouse	NN	B-NP	B-cell_linelymphoid	variants	lymphoid	JJ	I-NP	I-cell_linevariants	.	variant	NNS	I-NP	I-cell_line.	Granulocytes	.	.	O	OGranulocytes	in	Granulocyte	NNS	B-NP	B-cell_typein	the	in	IN	B-PP	Othe	endometrium	the	DT	B-NP	Oendometrium	of	endometrium	NN	I-NP	Oof	post-partum	of	IN	B-PP	Opost-partum	women	post-partum	JJ	B-NP	Owomen	.	woman	NNS	I-NP	O.	Endometrial	.	.	O	OEndometrial	samples	Endometrial	JJ	B-NP	Osamples	of	sample	NNS	I-NP	Oof	women	of	IN	B-PP	Owomen	at	woman	NNS	B-NP	Oat	various	at	IN	B-PP	Ovarious	stages	various	JJ	B-NP	Ostages	of	stage	NNS	I-NP	Oof	gonadal	of	IN	B-PP	Ogonadal	activity	gonadal	JJ	B-NP	Oactivity	after	activity	NN	I-NP	Oafter	parturition	after	IN	B-PP	Oparturition	were	parturition	NN	B-NP	Owere	examined	be	VBD	B-VP	Oexamined	for	examine	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	and	presence	NN	I-NP	Oand	numbers	and	CC	I-NP	Onumbers	of	number	NNS	I-NP	Oof	endometrial	of	IN	B-PP	Oendometrial	granulocytes	endometrial	JJ	B-NP	B-cell_typegranulocytes	.	granulocyte	NNS	I-NP	I-cell_type.	Although	.	.	O	OAlthough	samples	Although	IN	B-SBAR	Osamples	at	sample	NNS	B-NP	Oat	all	at	IN	B-PP	Oall	the	all	PDT	B-NP	Othe	stages	the	DT	I-NP	Ostages	contained	stage	NNS	I-NP	Ocontained	significant	contain	VBD	B-VP	Osignificant	numbers	significant	JJ	B-NP	Onumbers	of	number	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	granulocytes	the	DT	B-NP	Ogranulocytes	(	granulocyte	NNS	I-NP	B-cell_type(	i.e.	(	(	O	Oi.e.	greater	i.e.	FW	B-NP	Ogreater	than	great	JJR	B-ADJP	Othan	7/high-power	than	IN	B-PP	O7/high-power	field	7/high-pow	JJR	B-NP	Ofield	)	field	NN	I-NP	O)	","	)	)	O	O","	the	","	","	O	Othe	100	the	DT	B-NP	O100	%	100	CD	I-NP	O%	values	%	NN	I-NP	Ovalues	for	value	NNS	I-NP	Ofor	late-proliferative	for	IN	B-PP	Olate-proliferative	and	late-proliferative	JJ	B-NP	Oand	adaptation	and	CC	I-NP	Oadaptation	hyperplasia	adaptation	NN	I-NP	Ohyperplasia	were	hyperplasia	NN	I-NP	Owere	significantly	be	VBD	B-VP	Osignificantly	higher	significantly	RB	B-ADJP	Ohigher	than	high	JJR	I-ADJP	Othan	the	than	IN	B-PP	Othe	values	the	DT	B-NP	Ovalues	for	value	NNS	I-NP	Ofor	the	for	IN	B-PP	Othe	resting	the	DT	B-NP	Oresting	(	resting	NN	I-NP	O(	81.8	(	(	O	O81.8	%	81.8	CD	B-NP	O%	)	%	NN	I-NP	O)	","	)	)	O	O","	early	","	","	O	Oearly	(	early	JJ	B-ADVP	O(	82.4	(	(	O	O82.4	%	82.4	CD	B-NP	O%	)	%	NN	I-NP	O)	and	)	)	O	Oand	mid-	and	CC	O	Omid-	(	mid-	NN	B-NP	O(	87.9	(	(	O	O87.9	%	87.9	CD	B-NP	O%	)	%	NN	I-NP	O)	proliferative	)	)	O	Oproliferative	and	proliferative	JJ	B-ADJP	Oand	secretory	and	CC	I-ADJP	Osecretory	(	secretory	JJ	I-ADJP	O(	83.3	(	(	O	O83.3	%	83.3	CD	B-NP	O%	)	%	NN	I-NP	O)	phases	)	)	O	Ophases	.	phase	NNS	B-NP	O.	We	.	.	O	OWe	suggest	We	PRP	B-NP	Osuggest	that	suggest	VBP	B-VP	Othat	this	that	IN	B-SBAR	Othis	correlates	this	DT	B-NP	Ocorrelates	with	correlate	VBZ	B-VP	Owith	the	with	IN	B-PP	Othe	suggestion	the	DT	B-NP	Osuggestion	that	suggestion	NN	I-NP	Othat	the	that	IN	B-SBAR	Othe	granulocytes	the	DT	B-NP	Ogranulocytes	constitute	granulocyte	NNS	I-NP	B-cell_typeconstitute	a	constitute	VBP	B-VP	Oa	receptor	a	DT	B-NP	Oreceptor	system	receptor	NN	I-NP	Osystem	for	system	NN	I-NP	Ofor	oestrogens	for	IN	B-PP	Ooestrogens	.	oestrogen	NNS	B-NP	O.	Interaction	.	.	O	OInteraction	of	Interaction	NN	B-NP	Oof	glucocorticoids	of	IN	B-PP	Oglucocorticoids	with	glucocorticoid	NNS	B-NP	Owith	macrophages	with	IN	B-PP	Omacrophages	.	macrophage	NNS	B-NP	B-cell_type.	Identification	.	.	O	OIdentification	of	Identification	NN	B-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	monocytes	in	IN	B-PP	Omonocytes	and	monocyte	NNS	B-NP	B-cell_typeand	macrophages	and	CC	O	Omacrophages	.	macrophage	NNS	B-NP	B-cell_type.	Glucocorticoid	.	.	O	OGlucocorticoid	binding	Glucocorticoid	NN	B-NP	Obinding	was	binding	NN	I-NP	Owas	measured	be	VBD	B-VP	Omeasured	in	measure	VBN	I-VP	Oin	resident	in	IN	B-PP	Oresident	and	resident	JJ	B-NP	Oand	thioglycollate-elicited	and	CC	I-NP	Othioglycollate-elicited	mouse	thioglycollate-elicited	JJ	I-NP	B-cell_typemouse	peritoneal	mouse	NN	I-NP	I-cell_typeperitoneal	macrophages	peritoneal	JJ	I-NP	I-cell_typemacrophages	","	macrophage	NNS	I-NP	I-cell_type","	rabbit	","	","	O	Orabbit	alveolar	rabbit	NN	B-NP	B-cell_typealveolar	macrophages	alveolar	JJ	I-NP	I-cell_typemacrophages	","	macrophage	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	human	and	CC	O	Ohuman	monocytes	human	JJ	B-NP	B-cell_typemonocytes	.	monocyte	NNS	I-NP	I-cell_type.	Two	.	.	O	OTwo	assays	Two	CD	B-NP	Oassays	of	assay	NNS	I-NP	Oof	binding	of	IN	B-PP	Obinding	were	binding	NN	B-NP	Owere	used	be	VBD	B-VP	Oused	--	use	VBN	I-VP	O--	an	--	:	O	Oan	assay	an	DT	B-NP	Oassay	with	assay	NN	I-NP	Owith	intact	with	IN	B-PP	Ointact	cells	intact	JJ	B-NP	B-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	suspension	in	IN	B-PP	Osuspension	or	suspension	NN	B-NP	Oor	monolayers	or	CC	I-NP	Omonolayers	","	monolayer	NNS	I-NP	O","	and	","	","	O	Oand	an	and	CC	O	Oan	assay	an	DT	B-NP	Oassay	of	assay	NN	I-NP	Oof	cytosol	of	IN	B-PP	Ocytosol	and	cytosol	NN	B-NP	Oand	nuclear	and	CC	O	Onuclear	forms	nuclear	JJ	B-NP	Oforms	of	form	NNS	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	.	receptor	NNS	I-NP	I-protein.	The	.	.	O	OThe	mononuclear	The	DT	B-NP	Omononuclear	phagocytes	mononuclear	JJ	I-NP	B-cell_typephagocytes	contained	phagocyte	NNS	I-NP	I-cell_typecontained	approximately	contain	VBD	B-VP	Oapproximately	equal	approximately	RB	B-ADJP	Oequal	to	equal	JJ	I-ADJP	Oto	4	to	TO	B-PP	O4	--	4	CD	B-NP	O--	10	--	SYM	B-NP	O10	X	10	CD	I-NP	OX	10	X	SYM	I-NP	O10	(	10	CD	I-NP	O(	3	(	(	O	O3	)	3	CD	B-NP	O)	high	)	)	O	Ohigh	affinity	high	JJ	B-NP	Oaffinity	receptor	affinity	NN	I-NP	Oreceptor	sites	receptor	NN	I-NP	Osites	per	site	NNS	I-NP	Oper	cell	per	IN	B-PP	Ocell	","	cell	NN	B-NP	O","	with	","	","	O	Owith	dissociation	with	IN	B-PP	Odissociation	constants	dissociation	NN	B-NP	Oconstants	of	constant	NNS	I-NP	Oof	approximately	of	IN	B-PP	Oapproximately	equal	approximately	RB	B-NP	Oequal	to	equal	JJ	I-NP	Oto	2	to	TO	B-PP	O2	--	2	CD	B-NP	O--	8	--	:	O	O8	nM	8	CD	B-NP	OnM	dexamethasone	nM	NN	I-NP	Odexamethasone	.	dexamethasone	NN	I-NP	O.	The	.	.	O	OThe	binding	The	DT	B-NP	Obinding	to	binding	NN	I-NP	Oto	the	to	TO	B-PP	Othe	saturable	the	DT	B-NP	Osaturable	sites	saturable	JJ	I-NP	B-DNAsites	was	site	NNS	I-NP	I-DNAwas	specific	be	VBD	B-VP	Ospecific	for	specific	JJ	B-ADJP	Ofor	steroids	for	IN	B-PP	Osteroids	with	steroid	NNS	B-NP	Owith	glucocorticoid	with	IN	B-PP	Oglucocorticoid	or	glucocorticoid	NN	B-NP	Oor	antiglucocorticoid	or	CC	I-NP	Oantiglucocorticoid	activity	antiglucocorticoid	NN	I-NP	Oactivity	.	activity	NN	I-NP	O.	Cortisol	.	.	O	OCortisol	","	Cortisol	NN	B-NP	O","	corticosterone	","	","	O	Ocorticosterone	","	corticosterone	NN	B-NP	O","	and	","	","	O	Oand	progesterone	and	CC	O	Oprogesterone	competed	progesterone	NN	B-NP	Ocompeted	with	compete	VBD	B-VP	Owith	dexamethasone	with	IN	B-PP	Odexamethasone	for	dexamethasone	NN	B-NP	Ofor	binding	for	IN	B-PP	Obinding	","	binding	NN	B-NP	O","	whereas	","	","	O	Owhereas	estradiol	whereas	IN	B-PP	Oestradiol	","	estradiol	NN	B-NP	O","	dihydrotestosterone	","	","	O	Odihydrotestosterone	","	dihydrotestosterone	NN	B-NP	O","	and	","	","	O	Oand	11-epicortisol	and	CC	O	O11-epicortisol	competed	11-epicortisol	NN	B-NP	Ocompeted	very	compete	VBD	B-VP	Overy	little	very	RB	B-ADJP	Olittle	.	little	JJ	I-ADJP	O.	Binding	.	.	O	OBinding	of	Binding	NN	B-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	to	dexamethasone	NN	B-NP	Oto	cytosol	to	TO	B-PP	Ocytosol	and	cytosol	NN	B-NP	Oand	nuclear	and	CC	O	Onuclear	forms	nuclear	JJ	B-NP	Oforms	of	form	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	receptor	the	DT	B-NP	Oreceptor	complex	receptor	NN	I-NP	B-proteincomplex	and	complex	NN	I-NP	I-proteinand	temperature-sensitive	and	CC	O	Otemperature-sensitive	translocation	temperature-sensitive	JJ	B-NP	Otranslocation	of	translocation	NN	I-NP	Oof	cytosol	of	IN	B-PP	Ocytosol	forms	cytosol	NN	B-NP	B-proteinforms	to	form	NNS	I-NP	I-proteinto	nuclear	to	TO	B-PP	Onuclear	forms	nuclear	JJ	B-NP	Oforms	were	form	NNS	I-NP	Owere	shown	be	VBD	B-VP	Oshown	.	show	VBN	I-VP	O.	At	.	.	O	OAt	37	At	IN	B-PP	O37	degrees	37	CD	B-NP	Odegrees	C	degree	NNS	I-NP	OC	the	C	JJ	B-ADJP	Othe	predominant	the	DT	B-NP	Opredominant	form	predominant	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	the	of	IN	B-PP	Othe	hormone-receptor	the	DT	B-NP	Ohormone-receptor	complex	hormone-receptor	NN	I-NP	B-proteincomplex	was	complex	NN	I-NP	I-proteinwas	nuclear	be	VBD	B-VP	Onuclear	.	nuclear	JJ	B-ADJP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	demonstrate	result	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	corticosteroids	that	IN	B-SBAR	Ocorticosteroids	interact	corticosteroid	NNS	B-NP	Ointeract	with	interact	VBP	B-VP	Owith	macrophages	with	IN	B-PP	Omacrophages	at	macrophage	NNS	B-NP	B-cell_typeat	physiological	at	IN	B-PP	Ophysiological	concentrations	physiological	JJ	B-NP	Oconcentrations	.	concentration	NNS	I-NP	O.	Nitric	.	.	O	ONitric	oxide	Nitric	JJ	B-NP	Ooxide	signaling	oxide	NN	I-NP	Osignaling	:	signaling	NN	I-NP	O:	a	:	:	O	Oa	possible	a	DT	B-NP	Opossible	role	possible	JJ	I-NP	Orole	for	role	NN	I-NP	Ofor	G	for	IN	B-PP	OG	proteins	G	NN	B-NP	B-proteinproteins	.	protein	NNS	I-NP	I-protein.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	previously	have	VBP	B-VP	Opreviously	reported	previously	RB	I-VP	Oreported	various	report	VBN	I-VP	Ovarious	inductive	various	JJ	B-NP	Oinductive	effects	inductive	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	nitric	of	IN	B-PP	Onitric	oxide	nitric	JJ	B-NP	Ooxide	on	oxide	NN	I-NP	Oon	human	on	IN	B-PP	Ohuman	PBMC	human	JJ	B-NP	B-cell_typePBMC	.	PBMC	NN	I-NP	I-cell_type.	We	.	.	O	OWe	describe	We	PRP	B-NP	Odescribe	a	describe	VBP	B-VP	Oa	novel	a	DT	B-NP	Onovel	and	novel	JJ	I-NP	Oand	potentially	and	CC	I-NP	Opotentially	important	potentially	RB	I-NP	Oimportant	mechanism	important	JJ	I-NP	Omechanism	of	mechanism	NN	I-NP	Oof	nitric	of	IN	B-PP	Onitric	oxide	nitric	JJ	B-NP	Ooxide	signaling-through	oxide	NN	I-NP	Osignaling-through	direct	signaling-through	JJ	I-NP	Odirect	activation	direct	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	guanine	of	IN	B-PP	Oguanine	nucleotide-binding	guanine	NN	B-NP	B-proteinnucleotide-binding	proteins	nucleotide-binding	JJ	I-NP	I-proteinproteins	(	protein	NNS	I-NP	I-protein(	G	(	(	O	OG	proteins	G	NN	B-NP	B-proteinproteins	)	protein	NNS	I-NP	I-protein)	.	)	)	O	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	found	have	VBP	B-VP	Ofound	that	find	VBN	I-VP	Othat	nitric	that	IN	B-SBAR	Onitric	oxide	nitric	JJ	B-NP	Ooxide	treatment	oxide	NN	I-NP	Otreatment	of	treatment	NN	I-NP	Oof	membranes	of	IN	B-PP	Omembranes	isolated	membrane	NNS	B-NP	Oisolated	from	isolate	VBN	B-VP	Ofrom	fresh	from	IN	B-PP	Ofresh	human	fresh	JJ	B-NP	Ohuman	PBMC	human	JJ	I-NP	OPBMC	enhances	PBMC	NN	I-NP	B-cell_typeenhances	the	enhance	VBZ	B-VP	Othe	ability	the	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	these	of	IN	B-PP	Othese	membranes	these	DT	B-NP	Omembranes	to	membrane	NNS	I-NP	Oto	hydrolyze	to	TO	B-VP	Ohydrolyze	[	hydrolyze	VB	I-VP	O[	gamma-32P	[	(	O	Ogamma-32P	]	gamma-32P	NN	B-NP	O]	GTP	]	)	O	OGTP	and	GTP	NN	B-NP	Oand	bind	and	CC	I-NP	Obind	[	bind	NN	I-NP	O[	gamma-35S	[	(	I-NP	Ogamma-35S	]	gamma-35S	NN	I-NP	O]	GTP	]	)	I-NP	OGTP	.	GTP	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	treatment	","	","	O	Otreatment	of	treatment	NN	B-NP	Oof	whole	of	IN	B-PP	Owhole	cells	whole	JJ	B-NP	B-cell_typecells	with	cell	NNS	I-NP	I-cell_typewith	nitric	with	IN	B-PP	Onitric	oxide	nitric	JJ	B-NP	Ooxide	yielded	oxide	NN	I-NP	Oyielded	membranes	yield	VBD	B-VP	Omembranes	with	membrane	NNS	B-NP	Owith	enhanced	with	IN	B-PP	Oenhanced	GTPase	enhance	VBN	B-NP	OGTPase	activity	GTPase	NN	I-NP	B-proteinactivity	.	activity	NN	I-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	the	","	","	O	Othe	GTPase	the	DT	B-NP	OGTPase	activity	GTPase	NN	I-NP	B-proteinactivity	of	activity	NN	I-NP	Oof	pure	of	IN	B-PP	Opure	","	pure	JJ	B-NP	O","	recombinant	","	","	I-NP	Orecombinant	Gs	recombinant	JJ	I-NP	B-proteinGs	alpha	Gs	NN	I-NP	I-proteinalpha	","	alpha	SYM	B-NP	I-protein","	Gi	","	","	O	OGi	alpha	Gi	NN	B-NP	B-proteinalpha	1	alpha	NN	I-NP	I-protein1	","	1	CD	I-NP	I-protein","	and	","	","	O	Oand	p21ras	and	CC	O	Op21ras	was	p21ras	NN	B-NP	B-proteinwas	greatly	be	VBD	B-VP	Ogreatly	enhanced	greatly	RB	I-VP	Oenhanced	by	enhance	VBN	I-VP	Oby	nitric	by	IN	B-PP	Onitric	oxide	nitric	JJ	B-NP	Ooxide	.	oxide	NN	I-NP	O.	In	.	.	O	OIn	support	In	IN	B-PP	Osupport	of	support	NN	B-NP	Oof	the	of	IN	B-PP	Othe	existence	the	DT	B-NP	Oexistence	of	existence	NN	I-NP	Oof	this	of	IN	B-PP	Othis	pathway	this	DT	B-NP	Opathway	in	pathway	NN	I-NP	Oin	whole	in	IN	B-PP	Owhole	cells	whole	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	we	","	","	O	Owe	found	we	PRP	B-NP	Ofound	that	find	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	G	the	DT	B-NP	OG	protein	G	NN	I-NP	B-proteinprotein	inhibitor	protein	NN	I-NP	I-proteininhibitor	","	inhibitor	NN	I-NP	O","	GDP-beta-S	","	","	O	OGDP-beta-S	","	GDP-beta-S	NN	B-NP	B-protein","	blocked	","	","	O	Oblocked	NF-kappa	block	VBD	B-VP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	translocation	B	NN	I-NP	I-proteintranslocation	induced	translocation	NN	I-NP	Oinduced	by	induce	VBN	B-VP	Oby	nitric	by	IN	B-PP	Onitric	oxide	nitric	JJ	B-NP	Ooxide	or	oxide	NN	I-NP	Oor	LPS	or	CC	I-NP	OLPS	in	LPS	NN	I-NP	Oin	permeabilized	in	IN	B-PP	Opermeabilized	cells	permeabilized	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	nitric	","	","	O	Onitric	oxide	nitric	JJ	B-NP	Ooxide	greatly	oxide	NN	I-NP	Ogreatly	reduced	greatly	RB	B-VP	Oreduced	the	reduce	VBD	I-VP	Othe	pertussis	the	DT	B-NP	Opertussis	toxin-mediated	pertussis	NN	I-NP	Otoxin-mediated	ADP-ribosylation	toxin-mediated	JJ	I-NP	OADP-ribosylation	of	ADP-ribosylation	NN	I-NP	Oof	45-	of	IN	B-PP	O45-	and	45-	CD	B-NP	B-proteinand	41-kDa	and	CC	O	I-protein41-kDa	proteins	41-kDa	JJ	B-NP	I-proteinproteins	in	protein	NNS	I-NP	I-proteinin	membranes	in	IN	B-PP	Omembranes	of	membrane	NNS	B-NP	Oof	these	of	IN	B-PP	Othese	cells	these	DT	B-NP	Ocells	.	cell	NNS	I-NP	O.	Because	.	.	O	OBecause	G	Because	IN	B-SBAR	OG	proteins	G	NN	B-NP	B-proteinproteins	play	protein	NNS	I-NP	I-proteinplay	a	play	VBP	B-VP	Oa	central	a	DT	B-NP	Ocentral	role	central	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	many	in	IN	B-PP	Omany	diverse	many	JJ	B-NP	Odiverse	signaling	diverse	JJ	I-NP	Osignaling	systems	signaling	NN	I-NP	Osystems	","	system	NNS	I-NP	O","	activation	","	","	O	Oactivation	by	activation	NN	B-NP	Oby	an	by	IN	B-PP	Oan	endogenous	an	DT	B-NP	Oendogenous	and	endogenous	JJ	I-NP	Oand	inducible	and	CC	I-NP	Oinducible	oxidant	inducible	JJ	I-NP	Ooxidant	may	oxidant	NN	I-NP	Omay	represent	may	MD	B-VP	Orepresent	a	represent	VB	I-VP	Oa	novel	a	DT	B-NP	Onovel	signaling	novel	JJ	I-NP	Osignaling	pathway	signaling	NN	I-NP	Opathway	.	pathway	NN	I-NP	O.	The	.	.	O	OThe	granulocyte-macrophage	The	DT	B-NP	Ogranulocyte-macrophage	colony-stimulating	granulocyte-macrophage	JJ	I-NP	B-DNAcolony-stimulating	factor	colony-stimulating	JJ	I-NP	I-DNAfactor	promoter	factor	NN	I-NP	I-DNApromoter	cis-acting	promoter	NN	I-NP	I-DNAcis-acting	element	cis-acting	JJ	I-NP	Oelement	CLE0	element	NN	I-NP	OCLE0	mediates	CLE0	NN	I-NP	B-DNAmediates	induction	mediate	VBZ	B-VP	Oinduction	signals	induction	NN	B-NP	Osignals	in	signal	NNS	I-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	is	and	CC	O	Ois	recognized	be	VBZ	B-VP	Orecognized	by	recognize	VBN	I-VP	Oby	factors	by	IN	B-PP	Ofactors	related	factor	NNS	B-NP	Orelated	to	related	JJ	B-ADJP	Oto	AP1	to	TO	B-PP	OAP1	and	AP1	NN	B-NP	B-proteinand	NFAT	and	CC	I-NP	ONFAT	.	NFAT	NN	I-NP	B-protein.	Expression	.	.	O	OExpression	of	Expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	granulocyte-macrophage	the	DT	B-NP	Ogranulocyte-macrophage	colony-stimulating	granulocyte-macrophage	JJ	I-NP	B-DNAcolony-stimulating	factor	colony-stimulating	JJ	I-NP	I-DNAfactor	(	factor	NN	I-NP	I-DNA(	GM-CSF	(	(	O	I-DNAGM-CSF	)	GM-CSF	NN	B-NP	I-DNA)	gene	)	)	O	I-DNAgene	in	gene	NN	B-NP	I-DNAin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	is	cell	NNS	I-NP	I-cell_typeis	activated	be	VBZ	B-VP	Oactivated	by	activate	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	combination	the	DT	B-NP	Ocombination	of	combination	NN	I-NP	Oof	phorbol	of	IN	B-PP	Ophorbol	ester	phorbol	NN	B-NP	Oester	(	ester	NN	I-NP	O(	phorbol	(	(	O	Ophorbol	myristate	phorbol	NN	B-NP	Omyristate	acetate	myristate	NN	I-NP	Oacetate	)	acetate	NN	I-NP	O)	and	)	)	O	Oand	calcium	and	CC	O	Ocalcium	ionophore	calcium	NN	B-NP	Oionophore	(	ionophore	NN	I-NP	O(	A23187	(	(	O	OA23187	)	A23187	NN	B-NP	O)	","	)	)	O	O","	which	","	","	O	Owhich	mimic	which	WDT	B-NP	Omimic	antigen	mimic	VBP	B-VP	Oantigen	stimulation	antigen	NN	B-NP	Ostimulation	through	stimulation	NN	I-NP	Othrough	the	through	IN	B-PP	Othe	T-cell	the	DT	B-NP	OT-cell	receptor	T-cell	NN	I-NP	B-proteinreceptor	.	receptor	NN	I-NP	I-protein.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	previously	have	VBP	B-VP	Opreviously	shown	previously	RB	I-VP	Oshown	that	show	VBN	I-VP	Othat	a	that	IN	B-SBAR	Oa	fragment	a	DT	B-NP	Ofragment	containing	fragment	NN	I-NP	Ocontaining	bp	contain	VBG	B-VP	Obp	-95	bp	NN	B-NP	O-95	to	-95	CD	I-NP	Oto	27	to	TO	B-PP	O27	of	27	CD	B-NP	Oof	the	of	IN	B-PP	Othe	mouse	the	DT	B-NP	Omouse	GM-CSF	mouse	NN	I-NP	B-DNAGM-CSF	promoter	GM-CSF	NN	I-NP	I-DNApromoter	can	promoter	NN	I-NP	I-DNAcan	confer	can	MD	B-VP	Oconfer	inducibility	confer	VB	I-VP	Oinducibility	to	inducibility	NN	B-NP	Oto	reporter	to	TO	B-PP	Oreporter	genes	reporter	NN	B-NP	B-DNAgenes	in	gene	NNS	I-NP	I-DNAin	the	in	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	Jurkat	human	JJ	I-NP	B-cell_lineJurkat	T-cell	Jurkat	NN	I-NP	I-cell_lineT-cell	line	T-cell	NN	I-NP	I-cell_lineline	.	line	NN	I-NP	I-cell_line.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	use	we	PRP	B-NP	Ouse	an	use	VBP	B-VP	Oan	in	an	DT	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	transcription	vitro	FW	I-NP	Otranscription	system	transcription	NN	I-NP	Osystem	to	system	NN	I-NP	Oto	demonstrate	to	TO	B-VP	Odemonstrate	that	demonstrate	VB	I-VP	Othat	a	that	IN	B-SBAR	Oa	cis-acting	a	DT	B-NP	Ocis-acting	element	cis-acting	JJ	I-NP	B-DNAelement	(	element	NN	I-NP	I-DNA(	positions	(	(	O	Opositions	-54	position	NNS	B-NP	B-DNA-54	to	-54	CD	B-NP	I-DNAto	-40	to	TO	B-PP	I-DNA-40	)	-40	CD	B-NP	I-DNA)	","	)	)	O	O","	referred	","	","	O	Oreferred	to	refer	VBN	B-VP	Oto	as	to	TO	B-PP	Oas	CLE0	as	IN	B-PP	OCLE0	","	CLE0	NN	B-NP	B-DNA","	is	","	","	O	Ois	a	be	VBZ	B-VP	Oa	target	a	DT	B-NP	Otarget	for	target	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	induction	the	DT	B-NP	Oinduction	signals	induction	NN	I-NP	Osignals	.	signal	NNS	I-NP	O.	We	.	.	O	OWe	observed	We	PRP	B-NP	Oobserved	induction	observe	VBD	B-VP	Oinduction	with	induction	NN	B-NP	Owith	templates	with	IN	B-PP	Otemplates	containing	template	NNS	B-NP	Ocontaining	intact	contain	VBG	B-VP	Ointact	CLE0	intact	JJ	B-NP	OCLE0	but	CLE0	NN	I-NP	B-DNAbut	not	but	CC	B-PP	Onot	with	not	RB	B-PP	Owith	templates	with	IN	I-PP	Otemplates	with	template	NNS	B-NP	Owith	deleted	with	IN	B-PP	Odeleted	or	delete	VBN	B-NP	Oor	mutated	or	CC	I-NP	Omutated	CLE0	mutate	VBN	I-NP	OCLE0	.	CLE0	NN	I-NP	B-DNA.	We	.	.	O	OWe	also	We	PRP	B-NP	Oalso	observed	also	RB	B-ADVP	Oobserved	that	observe	VBD	B-VP	Othat	two	that	IN	B-SBAR	Otwo	distinct	two	CD	B-NP	Odistinct	signals	distinct	JJ	I-NP	Osignals	were	signal	NNS	I-NP	Owere	required	be	VBD	B-VP	Orequired	for	require	VBN	I-VP	Ofor	the	for	IN	B-PP	Othe	stimulation	the	DT	B-NP	Ostimulation	through	stimulation	NN	I-NP	Othrough	CLE0	through	IN	B-PP	OCLE0	","	CLE0	NN	B-NP	B-DNA","	since	","	","	O	Osince	only	since	IN	B-SBAR	Oonly	extracts	only	JJ	B-NP	Oextracts	from	extract	NNS	I-NP	Ofrom	cells	from	IN	B-PP	Ocells	treated	cell	NNS	B-NP	Otreated	with	treat	VBN	B-VP	Owith	both	with	IN	B-PP	Oboth	phorbol	both	CC	O	Ophorbol	myristate	phorbol	NN	B-NP	Omyristate	acetate	myristate	NN	I-NP	Oacetate	and	acetate	NN	I-NP	Oand	A23187	and	CC	I-NP	OA23187	supported	A23187	NN	I-NP	Osupported	optimal	support	VBD	B-VP	Ooptimal	induction	optimal	JJ	B-NP	Oinduction	.	induction	NN	I-NP	O.	Stimulation	.	.	O	OStimulation	probably	Stimulation	NN	B-NP	Oprobably	was	probably	RB	B-ADVP	Owas	mediated	be	VBD	B-VP	Omediated	by	mediate	VBN	I-VP	Oby	CLE0-binding	by	IN	B-PP	OCLE0-binding	proteins	CLE0-binding	JJ	B-NP	B-proteinproteins	because	protein	NNS	I-NP	I-proteinbecause	depletion	because	IN	B-SBAR	Odepletion	of	depletion	NN	B-NP	Oof	these	of	IN	B-PP	Othese	proteins	these	DT	B-NP	Oproteins	specifically	protein	NNS	I-NP	Ospecifically	reduced	specifically	RB	B-ADVP	Oreduced	GM-CSF	reduce	VBD	B-VP	OGM-CSF	transcription	GM-CSF	NN	B-NP	B-proteintranscription	.	transcription	NN	I-NP	O.	One	.	.	O	OOne	of	One	CD	B-NP	Oof	the	of	IN	B-PP	Othe	binding	the	DT	B-NP	Obinding	factors	bind	VBG	I-NP	B-proteinfactors	possessed	factor	NNS	I-NP	I-proteinpossessed	biochemical	possess	VBD	B-VP	Obiochemical	and	biochemical	JJ	B-NP	Oand	immunological	and	CC	I-NP	Oimmunological	features	immunological	JJ	I-NP	Ofeatures	identical	feature	NNS	I-NP	Oidentical	to	identical	JJ	B-ADJP	Oto	those	to	TO	B-PP	Othose	of	those	DT	B-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	AP1	factor	NN	I-NP	I-proteinAP1	.	AP1	NN	I-NP	B-protein.	Another	.	.	O	OAnother	factor	Another	DT	B-NP	Ofactor	resembled	factor	NN	I-NP	Oresembled	the	resemble	VBD	B-VP	Othe	T-cell-specific	the	DT	B-NP	OT-cell-specific	factor	T-cell-specific	JJ	I-NP	B-proteinfactor	NFAT	factor	NN	I-NP	I-proteinNFAT	.	NFAT	NN	I-NP	B-protein.	The	.	.	O	OThe	characteristics	The	DT	B-NP	Ocharacteristics	of	characteristic	NNS	I-NP	Oof	these	of	IN	B-PP	Othese	two	these	DT	B-NP	Otwo	factors	two	CD	I-NP	Ofactors	are	factor	NNS	I-NP	Oare	consistent	be	VBP	B-VP	Oconsistent	with	consistent	JJ	B-ADJP	Owith	their	with	IN	B-PP	Otheir	involvement	their	PRP$	B-NP	Oinvolvement	in	involvement	NN	I-NP	Oin	GM-CSF	in	IN	B-PP	OGM-CSF	induction	GM-CSF	NN	B-NP	B-proteininduction	.	induction	NN	I-NP	O.	The	.	.	O	OThe	presence	The	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	CLE0-like	of	IN	B-PP	OCLE0-like	elements	CLE0-like	JJ	B-NP	B-DNAelements	in	element	NNS	I-NP	I-DNAin	the	in	IN	B-PP	Othe	promoters	the	DT	B-NP	Opromoters	of	promoter	NNS	I-NP	B-DNAof	interleukin-3	of	IN	B-PP	Ointerleukin-3	(	interleukin-3	NN	B-NP	B-protein(	IL-3	(	(	O	OIL-3	)	IL-3	NN	B-NP	B-protein)	","	)	)	O	O","	IL-4	","	","	O	OIL-4	","	IL-4	NN	B-NP	B-protein","	IL-5	","	","	O	OIL-5	","	IL-5	NN	B-NP	B-protein","	GM-CSF	","	","	O	OGM-CSF	","	GM-CSF	NN	B-NP	B-protein","	and	","	","	O	Oand	NFAT	and	CC	O	ONFAT	sites	NFAT	NN	B-NP	B-DNAsites	in	site	NNS	I-NP	I-DNAin	the	in	IN	B-PP	Othe	IL-2	the	DT	B-NP	OIL-2	promoter	IL-2	NN	I-NP	B-DNApromoter	suggests	promoter	NN	I-NP	I-DNAsuggests	that	suggest	VBZ	B-VP	Othat	the	that	IN	B-SBAR	Othe	factors	the	DT	B-NP	Ofactors	we	factor	NNS	I-NP	Owe	detected	we	PRP	B-NP	Odetected	","	detect	VBD	B-VP	O","	or	","	","	O	Oor	related	or	CC	O	Orelated	factors	relate	VBN	B-NP	Ofactors	that	factor	NNS	I-NP	Othat	recognize	that	WDT	B-NP	Orecognize	these	recognize	VBP	B-VP	Othese	sites	these	DT	B-NP	Osites	","	site	NNS	I-NP	O","	may	","	","	O	Omay	account	may	MD	B-VP	Oaccount	for	account	VB	I-VP	Ofor	the	for	IN	B-PP	Othe	coordinate	the	DT	B-NP	Ocoordinate	induction	coordinate	JJ	I-NP	Oinduction	of	induction	NN	I-NP	Oof	these	of	IN	B-PP	Othese	genes	these	DT	B-NP	Ogenes	during	gene	NNS	I-NP	Oduring	T-cell	during	IN	B-PP	OT-cell	activation	T-cell	NN	B-NP	Oactivation	.	activation	NN	I-NP	O.	Identification	.	.	O	OIdentification	and	Identification	NN	B-NP	Oand	characterization	and	CC	I-NP	Ocharacterization	of	characterization	NN	I-NP	Oof	an	of	IN	B-PP	Oan	Alu-containing	an	DT	B-NP	OAlu-containing	","	Alu-containing	JJ	I-NP	O","	T-cell-specific	","	","	I-NP	OT-cell-specific	enhancer	T-cell-specific	JJ	I-NP	B-DNAenhancer	located	enhancer	NN	I-NP	I-DNAlocated	in	located	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	last	the	DT	B-NP	Olast	intron	last	JJ	I-NP	B-DNAintron	of	intron	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	CD8	human	JJ	I-NP	B-DNACD8	alpha	CD8	NN	I-NP	I-DNAalpha	gene	alpha	NN	I-NP	I-DNAgene	.	gene	NN	I-NP	I-DNA.	Expression	.	.	O	OExpression	of	Expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	CD8	human	JJ	I-NP	B-DNACD8	alpha	CD8	NN	I-NP	I-DNAalpha	gene	alpha	NN	I-NP	I-DNAgene	is	gene	NN	I-NP	I-DNAis	restricted	be	VBZ	B-VP	Orestricted	to	restrict	VBN	I-VP	Oto	cells	to	TO	B-PP	Ocells	of	cell	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	lymphoid	the	DT	B-NP	Olymphoid	lineage	lymphoid	JJ	I-NP	B-cell_typelineage	and	lineage	NN	I-NP	I-cell_typeand	developmentally	and	CC	O	Odevelopmentally	regulated	developmentally	RB	B-VP	Oregulated	during	regulate	VBN	I-VP	Oduring	thymopoiesis	during	IN	B-PP	Othymopoiesis	.	thymopoiesis	NN	B-NP	O.	As	.	.	O	OAs	an	As	IN	B-PP	Oan	initial	an	DT	B-NP	Oinitial	step	initial	JJ	I-NP	Ostep	towards	step	NN	I-NP	Otowards	understanding	towards	IN	B-PP	Ounderstanding	the	understand	VBG	B-VP	Othe	molecular	the	DT	B-NP	Omolecular	basis	molecular	JJ	I-NP	Obasis	for	basis	NN	I-NP	Ofor	tissue-specific	for	IN	B-PP	Otissue-specific	expression	tissue-specific	JJ	B-NP	Oexpression	of	expression	NN	I-NP	Oof	this	of	IN	B-PP	Othis	gene	this	DT	B-NP	Ogene	","	gene	NN	I-NP	O","	we	","	","	O	Owe	surveyed	we	PRP	B-NP	Osurveyed	the	survey	VBD	B-VP	Othe	surrounding	the	DT	B-NP	Osurrounding	chromatin	surround	VBG	I-NP	Ochromatin	structure	chromatin	NN	I-NP	B-DNAstructure	for	structure	NN	I-NP	Ofor	potential	for	IN	B-PP	Opotential	cis-acting	potential	JJ	B-NP	Ocis-acting	regulatory	cis-acting	JJ	I-NP	B-DNAregulatory	regions	regulatory	JJ	I-NP	I-DNAregions	by	region	NNS	I-NP	I-DNAby	DNase	by	IN	B-PP	ODNase	I	DNase	NN	B-NP	B-proteinI	hypersensitivity	I	CD	I-NP	I-proteinhypersensitivity	mapping	hypersensitivity	NN	I-NP	Omapping	and	mapping	NN	I-NP	Oand	found	and	CC	O	Ofound	four	find	VBD	B-VP	Ofour	hypersensitive	four	CD	B-NP	Ohypersensitive	sites	hypersensitive	JJ	I-NP	B-DNAsites	","	site	NNS	I-NP	I-DNA","	three	","	","	O	Othree	of	three	CD	B-NP	Oof	which	of	IN	B-PP	Owhich	were	which	WDT	B-NP	Owere	T	be	VBD	B-VP	OT	cell	T	NN	B-NP	Ocell	restricted	cell	NN	I-NP	Orestricted	.	restrict	VBN	B-VP	O.	By	.	.	O	OBy	using	By	IN	B-PP	Ousing	a	use	VBG	B-VP	Oa	reporter-based	a	DT	B-NP	Oreporter-based	expression	reporter-based	JJ	I-NP	Oexpression	approach	expression	NN	I-NP	Oapproach	","	approach	NN	I-NP	O","	a	","	","	O	Oa	T-cell-specific	a	DT	B-NP	OT-cell-specific	enhancer	T-cell-specific	JJ	I-NP	B-DNAenhancer	was	enhancer	NN	I-NP	I-DNAwas	identified	be	VBD	B-VP	Oidentified	by	identify	VBN	I-VP	Oby	its	by	IN	B-PP	Oits	close	its	PRP$	B-NP	Oclose	association	close	JJ	I-NP	Oassociation	with	association	NN	I-NP	Owith	a	with	IN	B-PP	Oa	prominent	a	DT	B-NP	Oprominent	T-cell-restricted	prominent	JJ	I-NP	B-DNAT-cell-restricted	hypersensitive	T-cell-restricted	JJ	I-NP	I-DNAhypersensitive	sites	hypersensitive	JJ	I-NP	I-DNAsites	in	site	NNS	I-NP	I-DNAin	the	in	IN	B-PP	Othe	last	the	DT	B-NP	Olast	intron	last	JJ	I-NP	B-DNAintron	of	intron	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	CD8	the	DT	B-NP	OCD8	alpha	CD8	NN	I-NP	B-DNAalpha	gene	alpha	NN	I-NP	I-DNAgene	.	gene	NN	I-NP	I-DNA.	Deletion	.	.	O	ODeletion	studies	Deletion	NN	B-NP	Ostudies	demonstrated	study	NNS	I-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	minimal	the	DT	B-NP	Ominimal	enhancer	minimal	JJ	I-NP	B-DNAenhancer	is	enhancer	NN	I-NP	I-DNAis	adjacent	be	VBZ	B-VP	Oadjacent	to	adjacent	JJ	B-ADJP	Oto	a	to	TO	B-PP	Oa	negative	a	DT	B-NP	Onegative	regulatory	negative	JJ	I-NP	B-DNAregulatory	element	regulatory	JJ	I-NP	I-DNAelement	.	element	NN	I-NP	I-DNA.	DNA	.	.	O	ODNA	sequence	DNA	NN	B-NP	Osequence	analysis	sequence	NN	I-NP	Oanalysis	of	analysis	NN	I-NP	Oof	the	of	IN	B-PP	Othe	minimal	the	DT	B-NP	Ominimal	enhancer	minimal	JJ	I-NP	B-DNAenhancer	revealed	enhancer	NN	I-NP	I-DNArevealed	a	reveal	VBD	B-VP	Oa	striking	a	DT	B-NP	Ostriking	cluster	striking	JJ	I-NP	Ocluster	of	cluster	NN	I-NP	Oof	consensus	of	IN	B-PP	Oconsensus	binding	consensus	NN	B-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	for	site	NNS	I-NP	I-DNAfor	Ets-1	for	IN	B-PP	OEts-1	","	Ets-1	NN	B-NP	B-protein","	TCF-1	","	","	O	OTCF-1	","	TCF-1	NN	B-NP	B-protein","	CRE	","	","	O	OCRE	","	CRE	NN	B-NP	B-DNA","	GATA-3	","	","	O	OGATA-3	","	GATA-3	NN	B-NP	B-protein","	LyF-1	","	","	O	OLyF-1	","	LyF-1	NN	B-NP	B-protein","	and	","	","	O	Oand	bHLH	and	CC	O	ObHLH	proteins	bHLH	JJ	B-NP	B-proteinproteins	which	protein	NNS	I-NP	I-proteinwhich	were	which	WDT	B-NP	Owere	verified	be	VBD	B-VP	Overified	by	verify	VBN	I-VP	Oby	electrophoretic	by	IN	B-PP	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assays	shift	NN	I-NP	Oassays	.	assay	NNS	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	the	","	","	O	Othe	5	the	DT	B-NP	O5	'	5	CD	I-NP	B-DNA'	end	'	SYM	I-NP	I-DNAend	of	end	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	enhancer	the	DT	B-NP	Oenhancer	was	enhancer	NN	I-NP	B-DNAwas	composed	be	VBD	B-VP	Ocomposed	of	compose	VBN	I-VP	Oof	an	of	IN	B-PP	Oan	Alu	an	DT	B-NP	OAlu	repeat	Alu	NN	I-NP	B-DNArepeat	which	repeat	NN	I-NP	I-DNAwhich	contained	which	WDT	B-NP	Ocontained	the	contain	VBD	B-VP	Othe	GATA-3	the	DT	B-NP	OGATA-3	","	GATA-3	NN	I-NP	B-protein","	bHLH	","	","	O	ObHLH	","	bHLH	NN	B-NP	B-protein","	and	","	","	O	Oand	LyF-1	and	CC	O	OLyF-1	binding	LyF-1	NN	B-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	.	site	NNS	I-NP	I-DNA.	Site-directed	.	.	O	OSite-directed	mutation	Site-directed	JJ	B-NP	Omutation	of	mutation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	Ets-1	the	DT	B-NP	OEts-1	and	Ets-1	NN	I-NP	B-proteinand	GATA-3	and	CC	I-NP	OGATA-3	sites	GATA-3	NN	I-NP	Osites	dramatically	site	NNS	I-NP	Odramatically	reduced	dramatically	RB	B-ADVP	Oreduced	enhancer	reduce	VBD	B-VP	Oenhancer	activity	enhancer	NN	B-NP	Oactivity	.	activity	NN	I-NP	O.	The	.	.	O	OThe	functional	The	DT	B-NP	Ofunctional	importance	functional	JJ	I-NP	Oimportance	of	importance	NN	I-NP	Oof	the	of	IN	B-PP	Othe	other	the	DT	B-NP	Oother	binding	other	JJ	I-NP	Obinding	sites	bind	VBG	I-NP	B-DNAsites	only	site	NNS	I-NP	I-DNAonly	became	only	RB	B-ADVP	Obecame	apparent	become	VBD	B-VP	Oapparent	when	apparent	JJ	B-ADJP	Owhen	combinations	when	WRB	B-ADVP	Ocombinations	of	combination	NNS	B-NP	Oof	mutations	of	IN	B-PP	Omutations	were	mutation	NNS	B-NP	Owere	analyzed	be	VBD	B-VP	Oanalyzed	.	analyze	VBN	I-VP	O.	Taken	.	.	O	OTaken	together	Take	VBN	B-VP	Otogether	","	together	RB	B-ADVP	O","	these	","	","	O	Othese	results	these	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	the	that	IN	B-SBAR	Othe	human	the	DT	B-NP	Ohuman	CD8	human	JJ	I-NP	B-DNACD8	alpha	CD8	NN	I-NP	I-DNAalpha	gene	alpha	NN	I-NP	I-DNAgene	is	gene	NN	I-NP	I-DNAis	regulated	be	VBZ	B-VP	Oregulated	by	regulate	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	interaction	the	DT	B-NP	Ointeraction	of	interaction	NN	I-NP	Oof	multiple	of	IN	B-PP	Omultiple	T-cell	multiple	JJ	B-NP	OT-cell	nuclear	T-cell	NN	I-NP	B-proteinnuclear	proteins	nuclear	JJ	I-NP	I-proteinproteins	with	protein	NNS	I-NP	I-proteinwith	a	with	IN	B-PP	Oa	transcriptional	a	DT	B-NP	Otranscriptional	enhancer	transcriptional	JJ	I-NP	B-DNAenhancer	located	enhancer	NN	I-NP	I-DNAlocated	in	located	JJ	B-ADJP	Oin	the	in	IN	B-PP	Othe	last	the	DT	B-NP	Olast	intron	last	JJ	I-NP	B-DNAintron	of	intron	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	gene	the	DT	B-NP	Ogene	.	gene	NN	I-NP	O.	Comparison	.	.	O	OComparison	of	Comparison	NN	B-NP	Oof	the	of	IN	B-PP	Othe	CD8	the	DT	B-NP	OCD8	alpha	CD8	NN	I-NP	B-DNAalpha	enhancer	alpha	NN	I-NP	I-DNAenhancer	with	enhancer	NN	I-NP	I-DNAwith	other	with	IN	B-PP	Oother	recently	other	JJ	B-NP	Orecently	identified	recently	RB	I-NP	Oidentified	T-cell-specific	identify	VBN	I-NP	OT-cell-specific	regulatory	T-cell-specific	JJ	I-NP	B-DNAregulatory	elements	regulatory	JJ	I-NP	I-DNAelements	suggests	element	NNS	I-NP	I-DNAsuggests	that	suggest	VBZ	B-VP	Othat	a	that	IN	B-SBAR	Oa	common	a	DT	B-NP	Ocommon	set	common	JJ	I-NP	Oset	of	set	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	regulates	factor	NNS	I-NP	I-proteinregulates	several	regulate	VBZ	B-VP	Oseveral	T-cell	several	JJ	B-NP	OT-cell	genes	T-cell	NN	I-NP	B-DNAgenes	.	gene	NNS	I-NP	I-DNA.	Molecular	.	.	O	OMolecular	regulation	Molecular	JJ	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	IL-3	human	JJ	I-NP	B-DNAIL-3	gene	IL-3	NN	I-NP	I-DNAgene	:	gene	NN	I-NP	I-DNA:	inducible	:	:	O	Oinducible	T	inducible	JJ	B-NP	OT	cell-restricted	T	NN	I-NP	Ocell-restricted	expression	cell-restricted	JJ	I-NP	Oexpression	requires	expression	NN	I-NP	Orequires	intact	require	VBZ	B-VP	Ointact	AP-1	intact	JJ	B-NP	OAP-1	and	AP-1	NN	I-NP	B-proteinand	Elf-1	and	CC	I-NP	OElf-1	nuclear	Elf-1	NN	I-NP	B-proteinnuclear	protein	nuclear	JJ	I-NP	Oprotein	binding	protein	NN	I-NP	Obinding	sites	binding	NN	I-NP	Osites	.	site	NNS	I-NP	O.	Interleukin	.	.	O	OInterleukin	3	Interleukin	NN	B-NP	B-protein3	(	3	CD	I-NP	I-protein(	IL-3	(	(	O	OIL-3	)	IL-3	NN	B-NP	B-protein)	is	)	)	O	Ois	a	be	VBZ	B-VP	Oa	hematopoietic	a	DT	B-NP	Ohematopoietic	stem-cell	hematopoietic	JJ	I-NP	B-proteinstem-cell	growth	stem-cell	NN	I-NP	I-proteingrowth	and	growth	NN	I-NP	I-proteinand	differentiation	and	CC	O	I-proteindifferentiation	factor	differentiation	NN	B-NP	I-proteinfactor	that	factor	NN	I-NP	I-proteinthat	is	that	WDT	B-NP	Ois	expressed	be	VBZ	B-VP	Oexpressed	solely	express	VBN	I-VP	Osolely	in	solely	RB	B-ADVP	Oin	activated	in	IN	B-PP	Oactivated	T	activate	VBN	B-NP	OT	and	T	NN	I-NP	Oand	NK	and	CC	I-NP	ONK	cells	NK	NN	I-NP	Ocells	.	cell	NNS	I-NP	O.	Studies	.	.	O	OStudies	to	Study	NNS	B-NP	Oto	date	to	TO	B-PP	Odate	have	date	NN	B-NP	Ohave	identified	have	VBP	B-VP	Oidentified	elements	identify	VBN	I-VP	Oelements	5	element	NNS	B-NP	O5	'	5	CD	B-NP	O'	to	'	SYM	B-NP	Oto	the	to	TO	B-PP	Othe	IL-3	the	DT	B-NP	OIL-3	coding	IL-3	NN	I-NP	B-DNAcoding	sequences	coding	NN	I-NP	I-DNAsequences	that	sequence	NNS	I-NP	I-DNAthat	regulate	that	WDT	B-NP	Oregulate	its	regulate	VBP	B-VP	Oits	transcription	its	PRP$	B-NP	Otranscription	","	transcription	NN	I-NP	O","	but	","	","	O	Obut	the	but	CC	O	Othe	sequences	the	DT	B-NP	Osequences	that	sequence	NNS	I-NP	Othat	confer	that	WDT	B-NP	Oconfer	T	confer	VBP	B-VP	OT	cell-specific	T	NN	B-NP	Ocell-specific	expression	cell-specific	JJ	I-NP	Oexpression	remain	expression	NN	I-NP	Oremain	to	remain	VBP	B-VP	Oto	be	to	TO	I-VP	Obe	clearly	be	VB	I-VP	Oclearly	defined	clearly	RB	I-VP	Odefined	.	define	VBN	I-VP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	now	have	VBP	B-VP	Onow	identified	now	RB	I-VP	Oidentified	DNA	identify	VBN	I-VP	ODNA	sequences	DNA	NN	B-NP	B-DNAsequences	that	sequence	NNS	I-NP	I-DNAthat	are	that	WDT	B-NP	Oare	required	be	VBP	B-VP	Orequired	for	require	VBN	I-VP	Ofor	T	for	IN	B-PP	OT	cell-restricted	T	NN	B-NP	B-DNAcell-restricted	IL-3	cell-restricted	JJ	I-NP	I-DNAIL-3	gene	IL-3	NN	I-NP	I-DNAgene	transcription	gene	NN	I-NP	I-DNAtranscription	.	transcription	NN	I-NP	O.	A	.	.	O	OA	series	A	DT	B-NP	Oseries	of	series	NN	I-NP	Oof	transient	of	IN	B-PP	Otransient	transfections	transient	JJ	B-NP	Otransfections	performed	transfection	NNS	I-NP	Operformed	with	perform	VBN	B-VP	Owith	human	with	IN	B-PP	Ohuman	IL-3-chloramphenicol	human	JJ	B-NP	B-DNAIL-3-chloramphenicol	acetyltransferase	IL-3-chloramphenicol	NN	I-NP	I-DNAacetyltransferase	(	acetyltransferase	NN	I-NP	I-DNA(	CAT	(	(	O	I-DNACAT	)	CAT	NN	B-NP	I-DNA)	reporter	)	)	O	I-DNAreporter	plasmids	reporter	NN	B-NP	I-DNAplasmids	in	plasmid	NNS	I-NP	I-DNAin	T	in	IN	B-PP	OT	and	T	NN	B-NP	B-cell_typeand	non-T	and	CC	I-NP	I-cell_typenon-T	cells	non-T	JJ	I-NP	I-cell_typecells	revealed	cell	NNS	I-NP	I-cell_typerevealed	that	reveal	VBD	B-VP	Othat	a	that	IN	B-SBAR	Oa	plasmid	a	DT	B-NP	Oplasmid	containing	plasmid	NN	I-NP	B-DNAcontaining	319	contain	VBG	B-VP	O319	bp	319	CD	B-NP	Obp	of	bp	NN	I-NP	Oof	5	of	IN	B-PP	O5	'	5	CD	B-NP	B-DNA'	flanking	'	SYM	I-NP	I-DNAflanking	sequences	flanking	NN	I-NP	I-DNAsequences	was	sequence	NNS	I-NP	I-DNAwas	active	be	VBD	B-VP	Oactive	exclusively	active	JJ	B-ADJP	Oexclusively	in	exclusively	RB	B-ADVP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Deletion	.	.	O	ODeletion	analysis	Deletion	NN	B-NP	Oanalysis	revealed	analysis	NN	I-NP	Orevealed	that	reveal	VBD	B-VP	Othat	T	that	IN	B-SBAR	OT	cell	T	NN	B-NP	Ocell	specificity	cell	NN	I-NP	Ospecificity	was	specificity	NN	I-NP	Owas	conferred	be	VBD	B-VP	Oconferred	by	confer	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	49-bp	a	DT	B-NP	O49-bp	fragment	49-bp	JJ	I-NP	B-DNAfragment	(	fragment	NN	I-NP	I-DNA(	bp	(	(	O	Obp	-319	bp	NN	B-NP	O-319	to	-319	CD	I-NP	Oto	-270	to	TO	I-NP	O-270	)	-270	CD	I-NP	O)	that	)	)	O	Othat	included	that	WDT	B-NP	Oincluded	a	include	VBD	B-VP	Oa	potential	a	DT	B-NP	Opotential	binding	potential	JJ	I-NP	Obinding	site	bind	VBG	I-NP	Osite	for	site	NN	I-NP	Ofor	AP-1	for	IN	B-PP	OAP-1	transcription	AP-1	NN	B-NP	B-proteintranscription	factors	transcription	NN	I-NP	Ofactors	6	factor	NNS	I-NP	O6	bp	6	CD	B-NP	Obp	upstream	bp	NN	I-NP	Oupstream	of	upstream	RB	B-ADVP	Oof	a	of	IN	B-PP	Oa	binding	a	DT	B-NP	Obinding	site	bind	VBG	I-NP	B-DNAsite	for	site	NN	I-NP	I-DNAfor	Elf-1	for	IN	B-PP	OElf-1	","	Elf-1	NN	B-NP	B-protein","	a	","	","	O	Oa	member	a	DT	B-NP	Omember	of	member	NN	I-NP	Oof	the	of	IN	B-PP	Othe	Ets	the	DT	B-NP	OEts	family	Ets	NN	I-NP	B-proteinfamily	of	family	NN	I-NP	I-proteinof	transcription	of	IN	B-PP	Otranscription	factors	transcription	NN	B-NP	B-proteinfactors	.	factor	NNS	I-NP	I-protein.	DNaseI	.	.	O	ODNaseI	footprint	DNaseI	NN	B-NP	B-proteinfootprint	and	footprint	NN	I-NP	Oand	electrophoretic	and	CC	O	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assay	shift	NN	I-NP	Oassay	analyses	assay	NN	I-NP	Oanalyses	performed	analysis	NNS	I-NP	Operformed	with	perform	VBN	B-VP	Owith	MLA-144	with	IN	B-PP	OMLA-144	T	MLA-144	NN	B-NP	OT	cell	T	NN	I-NP	Ocell	nuclear	cell	NN	I-NP	Onuclear	extracts	nuclear	JJ	I-NP	Oextracts	demonstrated	extract	NNS	I-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	this	that	IN	B-SBAR	Othis	49-bp	this	DT	B-NP	O49-bp	region	49-bp	JJ	I-NP	B-DNAregion	contains	region	NN	I-NP	I-DNAcontains	a	contain	VBZ	B-VP	Oa	nuclear	a	DT	B-NP	Onuclear	protein	nuclear	JJ	I-NP	B-proteinprotein	binding	protein	NN	I-NP	I-proteinbinding	region	binding	NN	I-NP	I-proteinregion	that	region	NN	I-NP	I-proteinthat	includes	that	WDT	B-NP	Oincludes	consensus	include	VBZ	B-VP	Oconsensus	AP-1	consensus	NN	B-NP	B-DNAAP-1	and	AP-1	NN	I-NP	I-DNAand	Elf-1	and	CC	O	I-DNAElf-1	binding	Elf-1	NN	B-NP	I-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	.	site	NNS	I-NP	I-DNA.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	extracts	","	","	O	Oextracts	prepared	extract	NNS	B-NP	Oprepared	from	prepare	VBN	B-VP	Ofrom	purified	from	IN	B-PP	Opurified	human	purify	VBN	B-NP	B-cell_typehuman	T	human	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	contained	cell	NNS	I-NP	I-cell_typecontained	proteins	contain	VBD	B-VP	Oproteins	that	protein	NNS	B-NP	Othat	bound	that	WDT	B-NP	Obound	to	bind	VBD	B-VP	Oto	synthetic	to	TO	B-PP	Osynthetic	oligonucleotides	synthetic	JJ	B-NP	Ooligonucleotides	corresponding	oligonucleotide	NNS	I-NP	Ocorresponding	to	correspond	VBG	B-VP	Oto	the	to	TO	B-PP	Othe	AP-1	the	DT	B-NP	OAP-1	and	AP-1	NN	I-NP	B-DNAand	Elf-1	and	CC	I-NP	I-DNAElf-1	binding	Elf-1	NN	I-NP	I-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	.	site	NNS	I-NP	I-DNA.	In	.	.	O	OIn	vitro-transcribed	In	IN	B-PP	Ovitro-transcribed	and	vitro-transcribed	JJ	B-NP	Oand	#NAME?	and	CC	I-NP	O#NAME?	Elf-1	#NAME?	JJ	I-NP	OElf-1	protein	Elf-1	NN	I-NP	B-proteinprotein	bound	protein	NN	I-NP	I-proteinbound	specifically	bind	VBD	B-VP	Ospecifically	to	specifically	RB	B-ADVP	Oto	the	to	TO	B-PP	Othe	Elf-1	the	DT	B-NP	OElf-1	site	Elf-1	NN	I-NP	B-DNAsite	","	site	NN	I-NP	I-DNA","	and	","	","	O	Oand	Elf-1	and	CC	O	OElf-1	antisera	Elf-1	NN	B-NP	B-proteinantisera	competed	antiserum	NNS	I-NP	Ocompeted	and	compete	VBD	B-VP	Oand	super	and	CC	O	Osuper	shifted	super	JJ	B-NP	Oshifted	nuclear	shift	VBN	I-NP	Onuclear	protein	nuclear	JJ	I-NP	B-proteinprotein	complexes	protein	NN	I-NP	I-proteincomplexes	present	complex	NNS	I-NP	I-proteinpresent	in	present	JJ	B-ADJP	Oin	MLA-144	in	IN	B-PP	OMLA-144	nuclear	MLA-144	NN	B-NP	Onuclear	extracts	nuclear	JJ	I-NP	Oextracts	.	extract	NNS	I-NP	O.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	addition	","	","	O	Oaddition	of	addition	NN	B-NP	Oof	anti-Jun	of	IN	B-PP	Oanti-Jun	family	anti-Jun	JJ	B-NP	B-proteinfamily	antiserum	family	NN	I-NP	I-proteinantiserum	in	antiserum	NN	I-NP	Oin	electrophoretic	in	IN	B-PP	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assay	shift	NN	I-NP	Oassay	reactions	assay	NN	I-NP	Oreactions	completely	reaction	NNS	I-NP	Ocompletely	blocked	completely	RB	B-ADVP	Oblocked	formation	block	VBD	B-VP	Oformation	of	formation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	AP-1-related	the	DT	B-NP	OAP-1-related	complexes	AP-1-related	JJ	I-NP	B-proteincomplexes	.	complex	NNS	I-NP	I-protein.	Transient	.	.	O	OTransient	transfection	Transient	JJ	B-NP	Otransfection	studies	transfection	NN	I-NP	Ostudies	in	study	NNS	I-NP	Oin	MLA-144	in	IN	B-PP	OMLA-144	T	MLA-144	NN	B-NP	B-cell_lineT	cells	T	NN	I-NP	I-cell_linecells	revealed	cell	NNS	I-NP	I-cell_linerevealed	that	reveal	VBD	B-VP	Othat	constructs	that	IN	B-SBAR	Oconstructs	containing	construct	NNS	B-NP	Ocontaining	mutations	contain	VBG	B-VP	Omutations	in	mutation	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	AP-1	the	DT	B-NP	OAP-1	site	AP-1	NN	I-NP	B-DNAsite	almost	site	NN	I-NP	I-DNAalmost	completely	almost	RB	B-ADVP	Ocompletely	abolished	completely	RB	I-ADVP	Oabolished	CAT	abolish	VBD	B-VP	OCAT	activity	CAT	NN	B-NP	B-proteinactivity	while	activity	NN	I-NP	Owhile	mutation	while	IN	B-SBAR	Omutation	of	mutation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	Elf-1	the	DT	B-NP	OElf-1	site	Elf-1	NN	I-NP	B-DNAsite	or	site	NN	I-NP	I-DNAor	the	or	CC	O	Othe	NF-IL-3	the	DT	B-NP	ONF-IL-3	site	NF-IL-3	NN	I-NP	B-DNAsite	","	site	NN	I-NP	I-DNA","	a	","	","	O	Oa	previously	a	DT	B-NP	Opreviously	described	previously	RB	I-NP	Odescribed	nuclear	describe	VBN	I-NP	Onuclear	protein	nuclear	JJ	I-NP	B-DNAprotein	binding	protein	NN	I-NP	I-DNAbinding	site	binding	NN	I-NP	I-DNAsite	(	site	NN	I-NP	I-DNA(	bp.	(	(	O	Obp.	-155	bp.	NN	B-NP	B-DNA-155	to	-155	CD	I-NP	I-DNAto	-148	to	TO	I-NP	I-DNA-148	)	-148	CD	I-NP	I-DNA)	in	)	)	O	Oin	the	in	IN	B-PP	Othe	IL-3	the	DT	B-NP	OIL-3	promoter	IL-3	NN	I-NP	B-DNApromoter	","	promoter	NN	I-NP	I-DNA","	reduced	","	","	O	Oreduced	CAT	reduce	VBD	B-VP	OCAT	activity	CAT	NN	B-NP	B-proteinactivity	to	activity	NN	I-NP	Oto	<	to	TO	B-PP	O<	25	<	SYM	B-NP	O25	%	25	CD	B-NP	O%	of	%	NN	I-NP	Oof	the	of	IN	B-PP	Othe	activity	the	DT	B-NP	Oactivity	given	activity	NN	I-NP	Ogiven	by	give	VBN	B-VP	Oby	wild-type	by	IN	B-PP	Owild-type	constructs	wild-type	JJ	B-NP	B-DNAconstructs	.	construct	NNS	I-NP	I-DNA.	We	.	.	O	OWe	conclude	We	PRP	B-NP	Oconclude	that	conclude	VBP	B-VP	Othat	expression	that	IN	B-SBAR	Oexpression	of	expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	IL-3	human	JJ	I-NP	B-DNAIL-3	gene	IL-3	NN	I-NP	I-DNAgene	requires	gene	NN	I-NP	I-DNArequires	the	require	VBZ	B-VP	Othe	AP-1	the	DT	B-NP	OAP-1	and	AP-1	NN	I-NP	B-DNAand	Elf-1	and	CC	I-NP	I-DNAElf-1	binding	Elf-1	NN	I-NP	I-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	;	site	NNS	I-NP	I-DNA;	however	;	:	O	Ohowever	","	however	RB	B-ADVP	O","	unlike	","	","	O	Ounlike	other	unlike	IN	B-PP	Oother	previously	other	JJ	B-NP	Opreviously	characterized	previously	RB	I-NP	Ocharacterized	cytokine	characterize	VBN	I-NP	Ocytokine	genes	cytokine	NN	I-NP	B-DNAgenes	such	gene	NNS	I-NP	I-DNAsuch	as	such	JJ	B-PP	Oas	IL-2	as	IN	I-PP	OIL-2	","	IL-2	NN	B-NP	B-protein","	the	","	","	O	Othe	AP-1	the	DT	B-NP	OAP-1	and	AP-1	NN	I-NP	B-proteinand	Elf-1	and	CC	I-NP	OElf-1	factors	Elf-1	NN	I-NP	B-proteinfactors	can	factor	NNS	I-NP	I-proteincan	bind	can	MD	B-VP	Obind	independently	bind	VB	I-VP	Oindependently	in	independently	RB	B-ADVP	Oin	the	in	IN	B-PP	Othe	IL-3	the	DT	B-NP	OIL-3	gene	IL-3	NN	I-NP	B-DNAgene	.	gene	NN	I-NP	I-DNA.	(	.	.	O	O(	ABSTRACT	(	(	O	OABSTRACT	TRUNCATED	ABSTRACT	NN	B-NP	OTRUNCATED	AT	TRUNCATED	VBN	B-VP	OAT	400	AT	IN	B-PP	O400	WORDS	400	CD	B-NP	OWORDS	)	WORDS	NNS	I-NP	O)	Combination	)	)	O	OCombination	IL-2	Combination	NN	B-NP	OIL-2	and	IL-2	NN	I-NP	B-proteinand	IL-4	and	CC	I-NP	OIL-4	reduces	IL-4	NN	I-NP	B-proteinreduces	glucocorticoid	reduce	VBZ	B-VP	Oglucocorticoid	receptor-binding	glucocorticoid	NN	B-NP	Oreceptor-binding	affinity	receptor-binding	JJ	I-NP	Oaffinity	and	affinity	NN	I-NP	Oand	T	and	CC	I-NP	OT	cell	T	NN	I-NP	Ocell	response	cell	NN	I-NP	Oresponse	to	response	NN	I-NP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	.	glucocorticoid	NNS	B-NP	O.	The	.	.	O	OThe	mechanisms	The	DT	B-NP	Omechanisms	contributing	mechanism	NNS	I-NP	Ocontributing	to	contribute	VBG	B-VP	Oto	persistent	to	TO	B-PP	Opersistent	T	persistent	JJ	B-NP	OT	cell	T	NN	I-NP	Ocell	activation	cell	NN	I-NP	Oactivation	and	activation	NN	I-NP	Oand	poor	and	CC	O	Opoor	response	poor	JJ	B-NP	Oresponse	to	response	NN	I-NP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	in	glucocorticoid	NNS	B-NP	Oin	chronic	in	IN	B-PP	Ochronic	inflammatory	chronic	JJ	B-NP	Oinflammatory	illnesses	inflammatory	JJ	I-NP	Oillnesses	such	illness	NNS	I-NP	Osuch	as	such	JJ	B-PP	Oas	steroid	as	IN	I-PP	Osteroid	resistant	steroid	NN	B-NP	Oresistant	(	resistant	JJ	B-ADJP	O(	SR	(	(	O	OSR	)	SR	NN	B-NP	O)	asthma	)	)	I-NP	Oasthma	are	asthma	NN	I-NP	Oare	poorly	be	VBP	B-VP	Opoorly	defined	poorly	RB	I-VP	Odefined	.	define	VBN	I-VP	O.	We	.	.	O	OWe	examined	We	PRP	B-NP	Oexamined	the	examine	VBD	B-VP	Othe	possibility	the	DT	B-NP	Opossibility	that	possibility	NN	I-NP	Othat	certain	that	IN	B-SBAR	Ocertain	cytokines	certain	JJ	B-NP	Ocytokines	","	cytokine	NNS	I-NP	B-protein","	specifically	","	","	O	Ospecifically	IL-2	specifically	RB	B-NP	OIL-2	and	IL-2	NN	I-NP	B-proteinand	IL-4	and	CC	I-NP	OIL-4	","	IL-4	NN	I-NP	B-protein","	could	","	","	O	Ocould	affect	could	MD	B-VP	Oaffect	T	affect	VB	I-VP	OT	cell	T	NN	B-NP	Ocell	response	cell	NN	I-NP	Oresponse	to	response	NN	I-NP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	.	glucocorticoid	NNS	B-NP	O.	A	.	.	O	OA	[	A	DT	B-NP	O[	3H	[	(	I-NP	O3H	]	3H	NN	I-NP	O]	dexamethasone	]	)	I-NP	Odexamethasone	radioligand-binding	dexamethasone	NN	I-NP	Oradioligand-binding	assay	radioligand-binding	JJ	I-NP	Oassay	was	assay	NN	I-NP	Owas	used	be	VBD	B-VP	Oused	to	use	VBN	I-VP	Oto	measure	to	TO	B-VP	Omeasure	the	measure	VB	I-VP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	(	receptor	NNS	I-NP	I-protein(	GR	(	(	O	OGR	)	GR	NN	B-NP	B-protein)	and	)	)	O	Oand	dissociation	and	CC	O	Odissociation	constant	dissociation	NN	B-NP	Oconstant	(	constant	NN	I-NP	O(	Kd	(	(	O	OKd	)	Kd	NN	B-NP	O)	in	)	)	O	Oin	PBMC	in	IN	B-PP	OPBMC	from	PBMC	NN	B-NP	B-cell_typefrom	normal	from	IN	B-PP	Onormal	donors	normal	JJ	B-NP	Odonors	and	donor	NNS	I-NP	Oand	patients	and	CC	O	Opatients	with	patient	NNS	B-NP	Owith	SR	with	IN	B-PP	OSR	asthma	SR	NN	B-NP	Oasthma	","	asthma	NN	I-NP	O","	cultured	","	","	O	Ocultured	in	culture	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	absence	the	DT	B-NP	Oabsence	and	absence	NN	I-NP	Oand	presence	and	CC	I-NP	Opresence	of	presence	NN	I-NP	Oof	these	of	IN	B-PP	Othese	cytokines	these	DT	B-NP	Ocytokines	.	cytokine	NNS	I-NP	B-protein.	PBMC	.	.	O	OPBMC	from	PBMC	NN	B-NP	B-cell_typefrom	normal	from	IN	B-PP	Onormal	donors	normal	JJ	B-NP	Odonors	incubated	donor	NNS	I-NP	Oincubated	for	incubate	VBN	B-VP	Ofor	48	for	IN	B-PP	O48	h	48	CD	B-NP	Oh	in	h	NN	I-NP	Oin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	combination	of	IN	B-PP	Ocombination	IL-2	combination	NN	B-NP	OIL-2	+	IL-2	NN	I-NP	B-protein+	IL-4	+	SYM	O	OIL-4	had	IL-4	NN	B-NP	B-proteinhad	nuclear	have	VBD	B-VP	Onuclear	GR	nuclear	JJ	B-NP	OGR	with	GR	NN	I-NP	B-proteinwith	significantly	with	IN	B-PP	Osignificantly	reduced	significantly	RB	B-NP	Oreduced	binding	reduce	VBN	I-NP	Obinding	affinity	binding	NN	I-NP	Oaffinity	(	affinity	NN	I-NP	O(	GR	(	(	O	OGR	Kd	GR	NN	B-NP	B-proteinKd	=	Kd	NN	I-NP	O=	36.1	=	SYM	B-VP	O36.1	+/-	36.1	CD	B-NP	O+/-	1.63	+/-	SYM	I-NP	O1.63	nM	1.63	CD	I-NP	OnM	","	nM	NN	I-NP	O","	mean	","	","	O	Omean	+/-	mean	NN	B-NP	O+/-	SEM	+/-	CC	I-NP	OSEM	;	SEM	NN	I-NP	O;	p	;	:	O	Op	=	p	NN	B-NP	O=	0.0001	=	SYM	B-VP	O0.0001	)	0.0001	CD	B-NP	O)	as	)	)	O	Oas	compared	as	IN	B-PP	Ocompared	with	compare	VBN	B-PP	Owith	PBMC	with	IN	B-PP	OPBMC	incubated	PBMC	NN	B-NP	B-cell_typeincubated	with	incubate	VBN	B-VP	Owith	medium	with	IN	B-PP	Omedium	alone	medium	NN	B-NP	Oalone	(	alone	RB	B-ADVP	O(	GR	(	(	O	OGR	Kd	GR	NN	B-NP	B-proteinKd	=	Kd	NN	I-NP	O=	6.74	=	SYM	B-VP	O6.74	+/-	6.74	CD	B-NP	O+/-	0.46	+/-	SYM	I-NP	O0.46	nM	0.46	CD	I-NP	OnM	)	nM	NN	I-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	cytosolic	The	DT	B-NP	Ocytosolic	GR	cytosolic	JJ	I-NP	OGR	Kd	GR	NN	I-NP	OKd	remained	Kd	NN	I-NP	Oremained	unchanged	remain	VBD	B-VP	Ounchanged	.	unchanged	JJ	B-ADJP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	when	","	","	O	Owhen	PBMC	when	WRB	B-ADVP	OPBMC	were	PBMC	NN	B-NP	B-cell_typewere	incubated	be	VBD	B-VP	Oincubated	with	incubate	VBN	I-VP	Owith	IL-2	with	IN	B-PP	OIL-2	alone	IL-2	NN	B-NP	B-proteinalone	or	alone	RB	B-ADVP	Oor	IL-4	or	CC	O	OIL-4	alone	IL-4	NN	B-NP	B-proteinalone	","	alone	RB	B-ADVP	O","	no	","	","	O	Ono	change	no	DT	B-NP	Ochange	in	change	NN	I-NP	Oin	GR-binding	in	IN	B-PP	OGR-binding	affinity	GR-binding	JJ	B-NP	Oaffinity	was	affinity	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	.	observe	VBN	I-VP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	when	","	","	O	Owhen	T	when	WRB	B-ADVP	OT	cells	T	NN	B-NP	B-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	non-T	and	CC	O	Onon-T	cells	non-T	JJ	B-NP	B-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	individually	be	VBD	B-VP	Oindividually	stimulated	individually	RB	I-VP	Ostimulated	with	stimulate	VBN	I-VP	Owith	combination	with	IN	B-PP	Ocombination	IL-2	combination	NN	B-NP	OIL-2	+	IL-2	NN	I-NP	B-protein+	IL-4	+	CC	I-NP	OIL-4	","	IL-4	NN	I-NP	B-protein","	a	","	","	O	Oa	significant	a	DT	B-NP	Osignificant	reduction	significant	JJ	I-NP	Oreduction	in	reduction	NN	I-NP	Oin	GR-binding	in	IN	B-PP	OGR-binding	affinity	GR-binding	JJ	B-NP	Oaffinity	was	affinity	NN	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	only	observe	VBN	I-VP	Oonly	in	only	RB	B-ADVP	Oin	the	in	IN	B-PP	Othe	T	the	DT	B-NP	OT	cell	T	NN	I-NP	Ocell	population	cell	NN	I-NP	Opopulation	(	population	NN	I-NP	O(	p	(	(	O	Op	=	p	NN	B-NP	O=	0.0001	=	SYM	B-VP	O0.0001	)	0.0001	CD	B-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	IL-2	The	DT	B-NP	OIL-2	+	IL-2	NN	I-NP	B-protein+	IL-4-induced	+	SYM	B-VP	OIL-4-induced	alteration	IL-4-induced	JJ	B-NP	Oalteration	in	alteration	NN	I-NP	Oin	PBMC	in	IN	B-PP	OPBMC	GR	PBMC	NN	B-NP	B-cell_typeGR	Kd	GR	NN	I-NP	OKd	was	Kd	NN	I-NP	Owas	associated	be	VBD	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	an	with	IN	B-PP	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	GR	in	IN	B-PP	OGR	number	GR	NN	B-NP	B-proteinnumber	(	number	NN	I-NP	O(	8348	(	(	O	O8348	+/-	8348	CD	B-NP	O+/-	964	+/-	CC	I-NP	O964	vs	964	CD	I-NP	Ovs	1710	vs	CC	I-NP	O1710	+/-	1710	CD	I-NP	O+/-	228	+/-	CC	I-NP	O228	sites/cell	228	CD	I-NP	Osites/cell	;	sites/cell	NNS	I-NP	O;	p	;	:	O	Op	=	p	NN	B-NP	O=	0.0003	=	SYM	B-VP	O0.0003	)	0.0003	CD	B-NP	O)	.	)	)	O	O.	More	.	.	O	OMore	importantly	More	RBR	B-ADVP	Oimportantly	","	importantly	RB	I-ADVP	O","	the	","	","	O	Othe	alteration	the	DT	B-NP	Oalteration	in	alteration	NN	I-NP	Oin	PBMC	in	IN	B-PP	OPBMC	GR-binding	PBMC	NN	B-NP	B-cell_typeGR-binding	affinity	GR-binding	JJ	I-NP	Oaffinity	with	affinity	NN	I-NP	Owith	IL-2	with	IN	B-PP	OIL-2	+	IL-2	NN	B-NP	B-protein+	IL-4	+	CC	I-NP	OIL-4	was	IL-4	NN	I-NP	B-proteinwas	associated	be	VBD	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	a	with	IN	B-PP	Oa	functional	a	DT	B-NP	Ofunctional	change	functional	JJ	I-NP	Ochange	in	change	NN	I-NP	Oin	T	in	IN	B-PP	OT	cell	T	NN	B-NP	B-cell_typecell	response	cell	NN	I-NP	I-cell_typeresponse	to	response	NN	I-NP	Oto	methylprednisolone	to	TO	B-PP	Omethylprednisolone	MPN	methylprednisolone	NN	B-NP	OMPN	","	MPN	NN	I-NP	O","	i.e.	","	","	O	Oi.e.	","	i.e.	FW	B-NP	O","	a	","	","	O	Oa	reduced	a	DT	B-NP	Oreduced	inhibitory	reduce	VBN	I-NP	Oinhibitory	effect	inhibitory	JJ	I-NP	Oeffect	of	effect	NN	I-NP	Oof	MPN	of	IN	B-PP	OMPN	on	MPN	NN	B-NP	B-proteinon	PMA/ionomycin-induced	on	IN	B-PP	OPMA/ionomycin-induced	T	PMA/ionomycin-induced	JJ	B-NP	B-cell_typeT	cell	T	NN	I-NP	I-cell_typecell	proliferation	cell	NN	I-NP	I-cell_typeproliferation	.	proliferation	NN	I-NP	O.	These	.	.	O	OThese	effects	These	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	+	IL-2	NN	B-NP	B-protein+	IL-4	+	CC	I-NP	OIL-4	on	IL-4	NN	I-NP	B-proteinon	PBMC	on	IN	B-PP	OPBMC	GR	PBMC	NN	B-NP	B-cell_typeGR	affinity	GR	NN	I-NP	Oaffinity	and	affinity	NN	I-NP	Oand	response	and	CC	O	Oresponse	to	response	NN	B-NP	Oto	MPN	to	TO	B-PP	OMPN	were	MPN	NN	B-NP	B-proteinwere	blocked	be	VBD	B-VP	Oblocked	by	block	VBN	I-VP	Oby	co-incubation	by	IN	B-PP	Oco-incubation	with	co-incubation	NN	B-NP	Owith	IFN-gamma	with	IN	B-PP	OIFN-gamma	.	IFN-gamma	NN	B-NP	B-protein.	Freshly	.	.	O	OFreshly	isolated	Freshly	RB	B-NP	Oisolated	PBMC	isolate	VBN	I-NP	OPBMC	from	PBMC	NN	I-NP	B-cell_typefrom	four	from	IN	B-PP	Ofour	patients	four	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	SR	with	IN	B-PP	OSR	asthma	SR	NN	B-NP	Oasthma	had	asthma	NN	I-NP	Ohad	a	have	VBD	B-VP	Oa	significantly	a	DT	B-NP	Osignificantly	reduced	significantly	RB	I-NP	Oreduced	GR-binding	reduce	VBN	I-NP	OGR-binding	affinity	GR-binding	JJ	I-NP	Oaffinity	(	affinity	NN	I-NP	O(	Kd	(	(	O	OKd	=	Kd	NN	B-NP	O=	40	=	SYM	B-VP	O40	+/-	40	CD	B-NP	O+/-	2.68	+/-	SYM	I-NP	O2.68	nM	2.68	CD	I-NP	OnM	;	nM	NN	I-NP	O;	p	;	:	O	Op	=	p	NN	B-NP	O=	0.0001	=	SYM	B-VP	O0.0001	)	0.0001	CD	B-NP	O)	when	)	)	O	Owhen	compared	when	WRB	B-ADVP	Ocompared	with	compare	VBN	B-PP	Owith	seven	with	IN	B-PP	Oseven	normal	seven	CD	B-NP	Onormal	subjects	normal	JJ	I-NP	Osubjects	(	subject	NNS	I-NP	O(	7.15	(	(	O	O7.15	+/-	7.15	CD	B-NP	O+/-	0.41	+/-	SYM	I-NP	O0.41	nM	0.41	CD	I-NP	OnM	)	nM	NN	I-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	altered	The	DT	B-NP	Oaltered	PBMC	altered	JJ	I-NP	OPBMC	GR	PBMC	NN	I-NP	B-cell_typeGR	binding	GR	NN	I-NP	Obinding	from	binding	NN	I-NP	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	SR	with	IN	B-PP	OSR	asthma	SR	NN	B-NP	Oasthma	reversed	asthma	NN	I-NP	Oreversed	to	reverse	VBD	B-VP	Oto	normal	to	TO	B-PP	Onormal	when	normal	JJ	B-ADJP	Owhen	incubated	when	WRB	B-ADVP	Oincubated	with	incubate	VBN	B-VP	Owith	medium	with	IN	B-PP	Omedium	alone	medium	NN	B-NP	Oalone	","	alone	RB	B-ADVP	O","	but	","	","	O	Obut	was	but	CC	O	Owas	sustained	be	VBD	B-VP	Osustained	with	sustain	VBN	I-VP	Owith	IL-2	with	IN	B-PP	OIL-2	+	IL-2	NN	B-NP	B-protein+	IL-4	+	SYM	B-NP	OIL-4	.	IL-4	NN	I-NP	B-protein.	These	.	.	O	OThese	observations	These	DT	B-NP	Oobservations	suggest	observation	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	with	that	IN	B-SBAR	Owith	persistent	with	IN	B-PP	Opersistent	inflammation	persistent	JJ	B-NP	Oinflammation	certain	inflammation	NN	I-NP	Ocertain	cytokines	certain	JJ	I-NP	Ocytokines	may	cytokine	NNS	I-NP	B-proteinmay	contribute	may	MD	B-VP	Ocontribute	to	contribute	VB	I-VP	Oto	an	to	TO	B-PP	Oan	impaired	an	DT	B-NP	Oimpaired	response	impaired	JJ	I-NP	Oresponse	to	response	NN	I-NP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	.	glucocorticoid	NNS	B-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	the	","	","	O	Othe	effects	the	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	and	IL-2	NN	B-NP	B-proteinand	IL-4	and	CC	I-NP	OIL-4	were	IL-4	NN	I-NP	B-proteinwere	blocked	be	VBD	B-VP	Oblocked	by	block	VBN	I-VP	Oby	IFN-gamma	by	IN	B-PP	OIFN-gamma	.	IFN-gamma	NN	B-NP	B-protein.	Characterization	.	.	O	OCharacterization	of	Characterization	NN	B-NP	Oof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	CD4	human	JJ	I-NP	B-DNACD4	gene	CD4	NN	I-NP	I-DNAgene	promoter	gene	NN	I-NP	I-DNApromoter	:	promoter	NN	I-NP	I-DNA:	transcription	:	:	O	Otranscription	from	transcription	NN	B-NP	Ofrom	the	from	IN	B-PP	Othe	CD4	the	DT	B-NP	OCD4	gene	CD4	NN	I-NP	B-DNAgene	core	gene	NN	I-NP	I-DNAcore	promoter	core	NN	I-NP	I-DNApromoter	is	promoter	NN	I-NP	I-DNAis	tissue-specific	be	VBZ	B-VP	Otissue-specific	and	tissue-specific	JJ	B-ADJP	Oand	is	and	CC	O	Ois	activated	be	VBZ	B-VP	Oactivated	by	activate	VBN	I-VP	Oby	Ets	by	IN	B-PP	OEts	proteins	Ets	NN	B-NP	B-proteinproteins	.	protein	NNS	I-NP	I-protein.	We	.	.	O	OWe	analyzed	We	PRP	B-NP	Oanalyzed	the	analyze	VBD	B-VP	Othe	5	the	DT	B-NP	O5	'	5	CD	I-NP	B-DNA'	transcription	'	SYM	I-NP	I-DNAtranscription	control	transcription	NN	I-NP	I-DNAcontrol	sequences	control	NN	I-NP	I-DNAsequences	of	sequence	NNS	I-NP	I-DNAof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	CD4	human	JJ	I-NP	B-DNACD4	gene	CD4	NN	I-NP	I-DNAgene	.	gene	NN	I-NP	I-DNA.	We	.	.	O	OWe	located	We	PRP	B-NP	Olocated	the	locate	VBD	B-VP	Othe	transcription	the	DT	B-NP	Otranscription	initiation	transcription	NN	I-NP	B-DNAinitiation	site	initiation	NN	I-NP	I-DNAsite	and	site	NN	I-NP	I-DNAand	showed	and	CC	O	Oshowed	that	show	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	CD4	the	DT	B-NP	OCD4	core	CD4	NN	I-NP	B-DNAcore	promoter	core	NN	I-NP	I-DNApromoter	(	promoter	NN	I-NP	I-DNA(	positions	(	(	O	Opositions	-40	position	NNS	B-NP	O-40	to	-40	CD	B-NP	Oto	16	to	TO	B-PP	O16	)	16	CD	B-NP	O)	lacks	)	)	O	Olacks	a	lack	VBZ	B-VP	Oa	classical	a	DT	B-NP	Oclassical	``	classical	JJ	I-NP	O``	TATA	``	``	I-NP	OTATA	''	TATA	NN	I-NP	B-DNA''	or	''	''	O	I-DNAor	initiator	or	CC	O	Oinitiator	positioning	initiator	NN	B-NP	Opositioning	consensus	position	VBG	B-VP	Oconsensus	sequence	consensus	NN	B-NP	B-DNAsequence	but	sequence	NN	I-NP	I-DNAbut	directs	but	CC	O	Odirects	precise	direct	VBZ	B-VP	Oprecise	and	precise	JJ	B-NP	Oand	efficient	and	CC	I-NP	Oefficient	transcription	efficient	JJ	I-NP	Otranscription	when	transcription	NN	I-NP	Owhen	coupled	when	WRB	B-ADVP	Ocoupled	to	couple	VBN	B-VP	Oto	the	to	TO	B-PP	Othe	ubiquitously	the	DT	B-NP	Oubiquitously	active	ubiquitously	RB	I-NP	B-DNAactive	simian	active	JJ	I-NP	I-DNAsimian	virus	simian	JJ	I-NP	I-DNAvirus	40	virus	NN	I-NP	I-DNA40	enhancer	40	CD	I-NP	I-DNAenhancer	.	enhancer	NN	I-NP	I-DNA.	The	.	.	O	OThe	transcriptional	The	DT	B-NP	Otranscriptional	activity	transcriptional	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	CD4	the	DT	B-NP	OCD4	gene	CD4	NN	I-NP	B-DNAgene	promoter	gene	NN	I-NP	I-DNApromoter	correlated	promoter	NN	I-NP	I-DNAcorrelated	with	correlate	VBD	B-VP	Owith	CD4	with	IN	B-PP	OCD4	expression	CD4	NN	B-NP	B-proteinexpression	in	expression	NN	I-NP	Oin	various	in	IN	B-PP	Ovarious	cell	various	JJ	B-NP	Ocell	types	cell	NN	I-NP	Otypes	.	type	NNS	I-NP	O.	Interestingly	.	.	O	OInterestingly	","	Interestingly	RB	B-ADVP	O","	the	","	","	O	Othe	CD4	the	DT	B-NP	OCD4	core	CD4	NN	I-NP	B-DNAcore	promoter	core	NN	I-NP	I-DNApromoter	also	promoter	NN	I-NP	I-DNAalso	displayed	also	RB	B-ADVP	Odisplayed	a	display	VBD	B-VP	Oa	tissue-specific	a	DT	B-NP	Otissue-specific	transcriptional	tissue-specific	JJ	I-NP	Otranscriptional	activity	transcriptional	JJ	I-NP	Oactivity	.	activity	NN	I-NP	O.	Within	.	.	O	OWithin	this	Within	IN	B-PP	Othis	fragment	this	DT	B-NP	Ofragment	","	fragment	NN	I-NP	O","	three	","	","	O	Othree	nucleic	three	CD	B-NP	Onucleic	acid	nucleic	JJ	I-NP	Oacid	sequences	acid	NN	I-NP	Osequences	are	sequence	NNS	I-NP	Oare	completely	be	VBP	B-VP	Ocompletely	conserved	completely	RB	I-VP	Oconserved	in	conserve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	murine	the	DT	B-NP	Omurine	CD4	murine	JJ	I-NP	B-DNACD4	gene	CD4	NN	I-NP	I-DNAgene	.	gene	NN	I-NP	I-DNA.	One	.	.	O	OOne	of	One	CD	B-NP	Oof	these	of	IN	B-PP	Othese	sequences	these	DT	B-NP	Osequences	contains	sequence	NNS	I-NP	Ocontains	a	contain	VBZ	B-VP	Oa	perfect	a	DT	B-NP	Operfect	ETS	perfect	JJ	I-NP	B-DNAETS	consensus	ETS	NN	I-NP	I-DNAconsensus	sequence	consensus	NN	I-NP	I-DNAsequence	.	sequence	NN	I-NP	I-DNA.	Another	.	.	O	OAnother	ETS	Another	DT	B-NP	OETS	consensus	ETS	NN	I-NP	B-DNAconsensus	sequence	consensus	NN	I-NP	I-DNAsequence	is	sequence	NN	I-NP	I-DNAis	located	be	VBZ	B-VP	Olocated	1060	located	JJ	B-NP	O1060	nt	1060	CD	I-NP	Ont	upstream	nt	NN	I-NP	Oupstream	.	upstream	RB	B-ADVP	O.	Electrophoretic-mobility-shift	.	.	O	OElectrophoretic-mobility-shift	assays	Electrophoretic-mobility-shift	JJ	B-NP	Oassays	showed	assay	NNS	I-NP	Oshowed	that	show	VBD	B-VP	Othat	the	that	IN	B-SBAR	Othe	core	the	DT	B-NP	Ocore	promoter	core	NN	I-NP	B-DNApromoter	ETS	promoter	NN	I-NP	I-DNAETS	motif	ETS	NN	I-NP	I-DNAmotif	binds	motif	NN	I-NP	I-DNAbinds	an	bind	VBZ	B-VP	Oan	Ets-related	an	DT	B-NP	OEts-related	protein	Ets-related	JJ	I-NP	B-proteinprotein	specifically	protein	NN	I-NP	I-proteinspecifically	expressed	specifically	RB	B-VP	Oexpressed	at	express	VBN	I-VP	Oat	high	at	IN	B-PP	Ohigh	levels	high	JJ	B-NP	Olevels	in	level	NNS	I-NP	Oin	CD4+	in	IN	B-PP	OCD4+	cells	CD4+	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Moreover	.	.	O	OMoreover	","	Moreover	RB	B-ADVP	O","	in	","	","	O	Oin	CD4-	in	IN	B-PP	OCD4-	cells	CD4-	NN	B-NP	B-cell_linecells	","	cell	NNS	I-NP	I-cell_line","	overexpression	","	","	O	Ooverexpression	of	overexpression	NN	B-NP	Oof	Ets-1	of	IN	B-PP	OEts-1	or	Ets-1	NN	B-NP	B-proteinor	Ets-2	or	CC	I-NP	OEts-2	efficiently	Ets-2	NN	I-NP	B-proteinefficiently	and	efficiently	RB	B-ADVP	Oand	specifically	and	CC	I-ADVP	Ospecifically	activated	specifically	RB	I-ADVP	Oactivated	transcription	activate	VBN	B-NP	Otranscription	from	transcription	NN	I-NP	Ofrom	the	from	IN	B-PP	Othe	CD4	the	DT	B-NP	OCD4	promoter	CD4	NN	I-NP	B-DNApromoter	and	promoter	NN	I-NP	I-DNAand	core	and	CC	I-NP	Ocore	promoter	core	NN	I-NP	Opromoter	.	promoter	NN	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	indicate	datum	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	Ets	that	IN	B-SBAR	OEts	transcription	Ets	NN	B-NP	B-proteintranscription	factors	transcription	NN	I-NP	I-proteinfactors	play	factor	NNS	I-NP	I-proteinplay	a	play	VBP	B-VP	Oa	central	a	DT	B-NP	Ocentral	role	central	JJ	I-NP	Orole	in	role	NN	I-NP	Oin	controlling	in	IN	B-PP	Ocontrolling	CD4	control	VBG	B-VP	OCD4	gene	CD4	NN	B-NP	B-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	","	expression	NN	I-NP	O","	by	","	","	O	Oby	binding	by	IN	B-PP	Obinding	to	bind	VBG	B-VP	Oto	both	to	TO	B-PP	Oboth	a	both	CC	O	Oa	classical	a	DT	B-NP	Oclassical	remote	classical	JJ	I-NP	B-DNAremote	site	remote	JJ	I-NP	I-DNAsite	and	site	NN	I-NP	I-DNAand	an	and	CC	O	Oan	unusual	an	DT	B-NP	Ounusual	proximal	unusual	JJ	I-NP	B-DNAproximal	activator	proximal	JJ	I-NP	I-DNAactivator	sequence	activator	NN	I-NP	I-DNAsequence	Glucocorticoid	sequence	NN	I-NP	I-DNAGlucocorticoid	receptor	Glucocorticoid	NN	B-NP	B-proteinreceptor	activation	receptor	NN	I-NP	I-proteinactivation	and	activation	NN	I-NP	Oand	inactivation	and	CC	O	Oinactivation	in	inactivation	NN	B-NP	Oin	c	in	IN	B-PP	Oc	ultured	c	NN	B-NP	Oultured	human	ulture	VBN	B-VP	Ohuman	lymphocytes	human	JJ	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Although	.	.	O	OAlthough	glucocorticoids	Although	IN	B-SBAR	Oglucocorticoids	are	glucocorticoid	NNS	B-NP	Oare	not	be	VBP	B-VP	Onot	cytolytic	not	RB	O	Ocytolytic	for	cytolytic	JJ	B-ADJP	Ofor	and	for	IN	B-PP	Oand	do	and	CC	O	Odo	not	do	VBP	B-VP	Onot	inhibit	not	RB	I-VP	Oinhibit	the	inhibit	VB	I-VP	Othe	growth	the	DT	B-NP	Ogrowth	of	growth	NN	I-NP	Oof	the	of	IN	B-PP	Othe	IM-9	the	DT	B-NP	OIM-9	line	IM-9	NN	I-NP	B-cell_lineline	of	line	NN	I-NP	I-cell_lineof	cultured	of	IN	B-PP	Ocultured	human	culture	VBN	B-NP	B-cell_linehuman	lymphoblasts	human	JJ	I-NP	I-cell_linelymphoblasts	","	lymphoblast	NNS	I-NP	I-cell_line","	these	","	","	O	Othese	cells	these	DT	B-NP	Ocells	have	cell	NNS	I-NP	Ohave	a	have	VBP	B-VP	Oa	high	a	DT	B-NP	Ohigh	steroid-binding	high	JJ	I-NP	Osteroid-binding	capacity	steroid-binding	JJ	I-NP	Ocapacity	.	capacity	NN	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	used	have	VBP	B-VP	Oused	IM-9	use	VBN	I-VP	OIM-9	cells	IM-9	NN	B-NP	B-cell_linecells	in	cell	NNS	I-NP	I-cell_linein	order	in	IN	B-SBAR	Oorder	to	order	NN	O	Oto	examine	to	TO	B-VP	Oexamine	whether	examine	VB	I-VP	Owhether	unoccupied	whether	IN	B-SBAR	Ounoccupied	glucocorticoid	unoccupied	JJ	B-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	are	receptor	NNS	I-NP	I-proteinare	inactivated	be	VBP	B-VP	Oinactivated	and	inactivate	VBN	I-VP	Oand	activated	and	CC	I-VP	Oactivated	in	activate	VBN	I-VP	Oin	intact	in	IN	B-PP	Ointact	cells	intact	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	when	.	.	O	Owhen	IM-9	when	WRB	B-ADVP	OIM-9	cells	IM-9	NN	B-NP	B-cell_linecells	are	cell	NNS	I-NP	I-cell_lineare	incubated	be	VBP	B-VP	Oincubated	in	incubate	VBN	I-VP	Oin	glucose-free	in	IN	B-PP	Oglucose-free	medium	glucose-free	JJ	B-NP	Omedium	in	medium	NN	I-NP	Oin	a	in	IN	B-PP	Oa	nitrogen	a	DT	B-NP	Onitrogen	atmosphere	nitrogen	NN	I-NP	Oatmosphere	","	atmosphere	NN	I-NP	O","	both	","	","	O	Oboth	their	both	DT	O	Otheir	ability	their	PRP$	B-NP	Oability	to	ability	NN	I-NP	Oto	bind	to	TO	B-VP	Obind	triamcinolone	bind	VB	I-VP	Otriamcinolone	acetonide	triamcinolone	NN	B-NP	Oacetonide	and	acetonide	NN	I-NP	Oand	their	and	CC	O	Otheir	ATP	their	PRP$	B-NP	OATP	levels	ATP	NN	I-NP	Olevels	decline	level	NNS	I-NP	Odecline	and	decline	VBP	B-VP	Oand	","	and	CC	O	O","	when	","	","	O	Owhen	glucose	when	WRB	B-ADVP	Oglucose	and	glucose	NN	B-NP	Oand	oxygen	and	CC	I-NP	Ooxygen	are	oxygen	NN	I-NP	Oare	reintroduced	be	VBP	B-VP	Oreintroduced	","	reintroduce	VBN	I-VP	O","	ATP	","	","	O	OATP	levels	ATP	NN	B-NP	Olevels	and	level	NNS	I-NP	Oand	receptor	and	CC	O	Oreceptor	activity	receptor	NN	B-NP	Oactivity	return	activity	NN	I-NP	Oreturn	.	return	NN	I-NP	O.	The	.	.	O	OThe	specific	The	DT	B-NP	Ospecific	glucocorticoid-binding	specific	JJ	I-NP	Oglucocorticoid-binding	activity	glucocorticoid-binding	JJ	I-NP	Oactivity	of	activity	NN	I-NP	Oof	cytosol	of	IN	B-PP	Ocytosol	prepared	cytosol	NN	B-NP	Oprepared	from	prepare	VBN	B-VP	Ofrom	cells	from	IN	B-PP	Ocells	exposed	cell	NNS	B-NP	Oexposed	to	expose	VBN	B-VP	Oto	various	to	TO	B-PP	Ovarious	degrees	various	JJ	B-NP	Odegrees	of	degree	NNS	I-NP	Oof	energy	of	IN	B-PP	Oenergy	limitation	energy	NN	B-NP	Olimitation	is	limitation	NN	I-NP	Ois	directly	be	VBZ	B-VP	Odirectly	correlated	directly	RB	I-VP	Ocorrelated	with	correlate	VBN	I-VP	Owith	the	with	IN	B-PP	Othe	ATP	the	DT	B-NP	OATP	content	ATP	NN	I-NP	Ocontent	.	content	NN	I-NP	O.	Receptor	.	.	O	OReceptor	activation	Receptor	NN	B-NP	Oactivation	in	activation	NN	I-NP	Oin	intact	in	IN	B-PP	Ointact	cells	intact	JJ	B-NP	B-cell_typecells	is	cell	NNS	I-NP	I-cell_typeis	rapid	be	VBZ	B-VP	Orapid	and	rapid	JJ	B-ADJP	Oand	independent	and	CC	I-ADJP	Oindependent	of	independent	JJ	I-ADJP	Oof	protein	of	IN	B-PP	Oprotein	synthesis	protein	NN	B-NP	Osynthesis	.	synthesis	NN	I-NP	O.	Cytosol	.	.	O	OCytosol	prepared	Cytosol	NN	B-NP	Oprepared	from	prepare	VBN	B-VP	Ofrom	inactivated	from	IN	B-PP	Oinactivated	cells	inactivate	VBN	B-NP	B-cell_typecells	can	cell	NNS	I-NP	I-cell_typecan	not	can	MD	B-VP	Onot	be	not	RB	I-VP	Obe	activated	be	VB	I-VP	Oactivated	by	activate	VBN	I-VP	Oby	addition	by	IN	B-PP	Oaddition	of	addition	NN	B-NP	Oof	ATP	of	IN	B-PP	OATP	.	ATP	NN	B-NP	O.	The	.	.	O	OThe	inactivation	The	DT	B-NP	Oinactivation	of	inactivation	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	that	receptor	NNS	I-NP	I-proteinthat	occurs	that	WDT	B-NP	Ooccurs	when	occur	VBZ	B-VP	Owhen	cytosol	when	WRB	B-ADVP	Ocytosol	from	cytosol	NN	B-NP	Ofrom	normal	from	IN	B-PP	Onormal	IM-9	normal	JJ	B-NP	B-cell_lineIM-9	cells	IM-9	NN	I-NP	I-cell_linecells	is	cell	NNS	I-NP	I-cell_lineis	incubated	be	VBZ	B-VP	Oincubated	at	incubate	VBN	I-VP	Oat	25	at	IN	B-PP	O25	degrees	25	CD	B-NP	Odegrees	C	degree	NNS	I-NP	OC	is	C	NN	I-NP	Ois	inhibited	be	VBZ	B-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	molybdate	by	IN	B-PP	Omolybdate	","	molybdate	NN	B-NP	O","	vanadate	","	","	O	Ovanadate	","	vanadate	NN	B-NP	O","	fluoride	","	","	O	Ofluoride	","	fluoride	NN	B-NP	O","	ATP	","	","	O	OATP	","	ATP	NN	B-NP	O","	and	","	","	O	Oand	several	and	CC	O	Oseveral	other	several	JJ	B-NP	Oother	nucleotides	other	JJ	I-NP	Onucleotides	.	nucleotide	NNS	I-NP	O.	The	.	.	O	OThe	experiments	The	DT	B-NP	Oexperiments	with	experiment	NNS	I-NP	Owith	intact	with	IN	B-PP	Ointact	human	intact	JJ	B-NP	B-cell_typehuman	lymphoblasts	human	JJ	I-NP	I-cell_typelymphoblasts	suggest	lymphoblast	NNS	I-NP	I-cell_typesuggest	that	suggest	VBP	B-VP	Othat	assays	that	IN	B-SBAR	Oassays	of	assay	NNS	B-NP	Oof	specific	of	IN	B-PP	Ospecific	glucocorticoid-binding	specific	JJ	B-NP	Oglucocorticoid-binding	capacity	glucocorticoid-binding	JJ	I-NP	Ocapacity	do	capacity	NN	I-NP	Odo	not	do	VBP	B-VP	Onot	necessarily	not	RB	I-VP	Onecessarily	reflect	necessarily	RB	I-VP	Oreflect	the	reflect	VB	I-VP	Othe	cellular	the	DT	B-NP	Ocellular	content	cellular	JJ	I-NP	Ocontent	of	content	NN	I-NP	Oof	receptor	of	IN	B-PP	Oreceptor	protein	receptor	NN	B-NP	B-proteinprotein	.	protein	NN	I-NP	I-protein.	Glucocorticoids	.	.	O	OGlucocorticoids	and	Glucocorticoid	NNS	B-NP	Oand	lymphocytes	and	CC	I-NP	Olymphocytes	.	lymphocyte	NNS	I-NP	B-cell_type.	II	.	.	O	OII	.	II	CD	B-NP	O.	Cell	.	.	O	OCell	cycle-dependent	Cell	NN	B-NP	Ocycle-dependent	changes	cycle-dependent	JJ	I-NP	Ochanges	in	change	NNS	I-NP	Oin	glucocorticoid	in	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	content	receptor	NN	I-NP	I-proteincontent	.	content	NN	I-NP	O.	To	.	.	O	OTo	study	To	TO	B-VP	Ostudy	variations	study	VB	I-VP	Ovariations	in	variation	NNS	B-NP	Oin	glucocorticoid	in	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	levels	receptor	NN	I-NP	I-proteinlevels	during	level	NNS	I-NP	Oduring	the	during	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	cycle	cell	NN	I-NP	Ocycle	","	cycle	NN	I-NP	O","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	separated	have	VBP	B-VP	Oseparated	mitogen-stimulated	separate	VBN	I-VP	Omitogen-stimulated	human	mitogen-stimulated	JJ	B-NP	Ohuman	peripheral	human	JJ	I-NP	B-cell_typeperipheral	lymphocytes	peripheral	JJ	I-NP	I-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	rat	and	CC	O	Orat	lymph	rat	NN	B-NP	B-cell_typelymph	node	lymph	NN	I-NP	I-cell_typenode	cells	node	NN	I-NP	I-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	unit	by	IN	B-PP	Ounit	gravity	unit	NN	B-NP	Ogravity	sedimentation	gravity	NN	I-NP	Osedimentation	and	sedimentation	NN	I-NP	Oand	measured	and	CC	O	Omeasured	glucocorticoid	measure	VBN	B-NP	Oglucocorticoid	binding	glucocorticoid	NN	I-NP	Obinding	in	binding	NN	I-NP	Oin	the	in	IN	B-PP	Othe	resultant	the	DT	B-NP	Oresultant	fractions	resultant	JJ	I-NP	Ofractions	.	fraction	NNS	I-NP	O.	By	.	.	O	OBy	morphologic	By	IN	B-PP	Omorphologic	criteria	morphologic	JJ	B-NP	Ocriteria	and	criterion	NNS	I-NP	Oand	thymidine	and	CC	O	Othymidine	incorporation	thymidine	NN	B-NP	Oincorporation	","	incorporation	NN	I-NP	O","	the	","	","	O	Othe	fractions	the	DT	B-NP	Ofractions	were	fraction	NNS	I-NP	Owere	separated	be	VBD	B-VP	Oseparated	into	separate	VBN	I-VP	Ointo	populations	into	IN	B-PP	Opopulations	of	population	NNS	B-NP	Oof	G0	of	IN	B-PP	OG0	and	G0	NN	B-NP	Oand	G1	and	CC	I-NP	OG1	phase	G1	NN	I-NP	Ophase	and	phase	NN	I-NP	Oand	S	and	CC	O	OS	and	S	NN	B-NP	Oand	post-S	and	CC	O	Opost-S	phase	post-S	JJ	B-NP	Ophase	cells	phase	NN	I-NP	Ocells	.	cell	NNS	I-NP	O.	A	.	.	O	OA	2-	A	DT	B-NP	O2-	to	2-	CD	I-NP	Oto	3-fold	to	TO	B-PP	O3-fold	increase	3-fold	JJ	B-NP	Oincrease	in	increase	NN	I-NP	Oin	glucocorticoid	in	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	sites	receptor	NN	I-NP	I-proteinsites	per	site	NNS	I-NP	Oper	cell	per	IN	B-PP	Ocell	","	cell	NN	B-NP	O","	for	","	","	O	Ofor	cells	for	IN	B-PP	Ocells	in	cell	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	S	the	DT	B-NP	OS	and	S	NN	I-NP	Oand	post-S	and	CC	I-NP	Opost-S	phase	post-S	JJ	I-NP	Ophase	over	phase	NN	I-NP	Oover	those	over	IN	B-PP	Othose	in	those	DT	B-NP	Oin	G0	in	IN	B-PP	OG0	and	G0	NN	B-NP	Oand	G1	and	CC	I-NP	OG1	","	G1	NN	I-NP	O","	was	","	","	O	Owas	observed	be	VBD	B-VP	Oobserved	with	observe	VBN	I-VP	Owith	both	with	IN	B-PP	Oboth	nonstimulated	both	CC	B-NP	Ononstimulated	rat	nonstimulated	JJ	I-NP	Orat	lymph	rat	NN	I-NP	Olymph	node	lymph	NN	I-NP	Onode	cell	node	NN	I-NP	Ocell	suspensions	cell	NN	I-NP	Osuspensions	and	suspension	NNS	I-NP	Oand	concanavalin	and	CC	O	Oconcanavalin	A-stimulated	concanavalin	NN	B-NP	OA-stimulated	human	A-stimulated	JJ	I-NP	Ohuman	peripheral	human	JJ	I-NP	Operipheral	lymphocytes	peripheral	JJ	I-NP	Olymphocytes	.	lymphocyte	NNS	I-NP	O.	These	.	.	O	OThese	observations	These	DT	B-NP	Oobservations	together	observation	NNS	I-NP	Otogether	with	together	RB	B-ADVP	Owith	those	with	IN	B-PP	Othose	from	those	DT	B-NP	Ofrom	other	from	IN	B-PP	Oother	studies	other	JJ	B-NP	Ostudies	indicate	study	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	formation	that	IN	B-SBAR	Oformation	of	formation	NN	B-NP	Oof	new	of	IN	B-PP	Onew	glucocorticoid	new	JJ	B-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	near	receptor	NNS	I-NP	I-proteinnear	the	near	IN	B-PP	Othe	S	the	DT	B-NP	OS	phase	S	NN	I-NP	Ophase	may	phase	NN	I-NP	Omay	be	may	MD	B-VP	Obe	a	be	VB	I-VP	Oa	general	a	DT	B-NP	Ogeneral	phenomenon	general	JJ	I-NP	Ophenomenon	in	phenomenon	NN	I-NP	Oin	proliferating	in	IN	B-PP	Oproliferating	cells	proliferate	VBG	B-VP	B-cell_typecells	.	cell	NNS	B-NP	I-cell_type.	We	.	.	O	OWe	propose	We	PRP	B-NP	Opropose	that	propose	VBP	B-VP	Othat	this	that	IN	B-SBAR	Othis	increase	this	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	glucocorticoid	in	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	during	receptor	NNS	I-NP	I-proteinduring	the	during	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	cycle	cell	NN	I-NP	Ocycle	may	cycle	NN	I-NP	Omay	explain	may	MD	B-VP	Oexplain	the	explain	VB	I-VP	Othe	increase	the	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	glucocorticoid	in	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	mitogen-stimulated	in	IN	B-PP	Omitogen-stimulated	lymphocytes	mitogen-stimulated	JJ	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	leukocyte	The	DT	B-NP	Oleukocyte	migration	leukocyte	NN	I-NP	Omigration	inhibition	migration	NN	I-NP	Oinhibition	response	inhibition	NN	I-NP	Oresponse	to	response	NN	I-NP	Oto	certain	to	TO	B-PP	Ocertain	breast	certain	JJ	B-NP	Obreast	cancer-related	breast	NN	I-NP	Ocancer-related	antigens	cancer-related	JJ	I-NP	Oantigens	(	antigen	NNS	I-NP	O(	MCF-7	(	(	O	OMCF-7	and	MCF-7	NN	B-NP	B-proteinand	MuMTV	and	CC	O	OMuMTV	)	MuMTV	NN	B-NP	O)	:	)	)	O	O:	their	:	:	O	Otheir	potential	their	PRP$	B-NP	Opotential	as	potential	NN	I-NP	Oas	discriminants	as	IN	B-PP	Odiscriminants	.	discriminant	NNS	B-NP	O.	Certain	.	.	O	OCertain	oncogenic	Certain	JJ	B-NP	Ooncogenic	viruses	oncogenic	JJ	I-NP	Oviruses	have	virus	NNS	I-NP	Ohave	been	have	VBP	B-VP	Obeen	implicated	be	VBN	I-VP	Oimplicated	in	implicate	VBN	I-VP	Oin	human	in	IN	B-PP	Ohuman	breast	human	JJ	B-NP	Obreast	cancer	breast	NN	I-NP	Ocancer	","	cancer	NN	I-NP	O","	including	","	","	O	Oincluding	the	include	VBG	B-PP	Othe	murine	the	DT	B-NP	Omurine	mammary	murine	JJ	I-NP	Omammary	tumor	mammary	JJ	I-NP	Otumor	virus	tumor	NN	I-NP	Ovirus	(	virus	NN	I-NP	O(	MuMTV	(	(	O	OMuMTV	)	MuMTV	NN	B-NP	O)	and	)	)	O	Oand	the	and	CC	O	Othe	Mason-Pfizer	the	DT	B-NP	OMason-Pfizer	monkey	Mason-Pfizer	NNP	I-NP	Omonkey	virus	monkey	NN	I-NP	Ovirus	(	virus	NN	I-NP	O(	MPMV	(	(	O	OMPMV	)	MPMV	NN	B-NP	O)	.	)	)	O	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	used	have	VBP	B-VP	Oused	the	use	VBN	I-VP	Othe	leukocyte	the	DT	B-NP	Oleukocyte	migration	leukocyte	NN	I-NP	Omigration	inhibition	migration	NN	I-NP	Oinhibition	(	inhibition	NN	I-NP	O(	LMI	(	(	O	OLMI	)	LMI	NN	B-NP	O)	response	)	)	O	Oresponse	to	response	NN	B-NP	Oto	assay	to	TO	B-VP	Oassay	the	assay	VB	I-VP	Othe	response	the	DT	B-NP	Oresponse	to	response	NN	I-NP	Oto	several	to	TO	B-PP	Oseveral	potential	several	JJ	B-NP	Opotential	breast	potential	JJ	I-NP	Obreast	cancer-related	breast	NN	I-NP	Ocancer-related	antigens	cancer-related	JJ	I-NP	Oantigens	","	antigen	NNS	I-NP	O","	including	","	","	O	Oincluding	MuMTV	include	VBG	B-PP	OMuMTV	","	MuMTV	NN	B-NP	B-protein","	MPMV	","	","	O	OMPMV	","	MPMV	NN	B-NP	O","	and	","	","	O	Oand	a	and	CC	O	Oa	breast	a	DT	B-NP	Obreast	cancer	breast	NN	I-NP	B-cell_linecancer	cultured	cancer	NN	I-NP	I-cell_linecultured	cell	culture	VBN	B-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	","	line	NN	I-NP	I-cell_line","	MCF-7	","	","	O	OMCF-7	","	MCF-7	NN	B-NP	B-protein","	in	","	","	O	Oin	96	in	IN	B-PP	O96	breast	96	CD	B-NP	Obreast	cancer	breast	NN	I-NP	Ocancer	patients	cancer	NN	I-NP	Opatients	","	patient	NNS	I-NP	O","	in	","	","	O	Oin	32	in	IN	B-PP	O32	women	32	CD	B-NP	Owomen	with	woman	NNS	I-NP	Owith	benign	with	IN	B-PP	Obenign	breast	benign	JJ	B-NP	Obreast	disease	breast	NN	I-NP	Odisease	","	disease	NN	I-NP	O","	and	","	","	O	Oand	in	and	CC	O	Oin	67	in	IN	B-PP	O67	normal	67	CD	B-NP	Onormal	women	normal	JJ	I-NP	Owomen	.	woman	NNS	I-NP	O.	The	.	.	O	OThe	lowest	The	DT	B-NP	Olowest	tenth	low	JJS	I-NP	Otenth	percentile	tenth	NN	I-NP	Opercentile	of	percentile	NN	I-NP	Oof	control	of	IN	B-PP	Ocontrol	(	control	NN	B-NP	O(	LMI	(	(	O	OLMI	)	LMI	NN	B-NP	O)	responses	)	)	O	Oresponses	was	response	NNS	B-NP	Owas	used	be	VBD	B-VP	Oused	as	use	VBN	I-VP	Oas	the	as	IN	B-PP	Othe	cutoff	the	DT	B-NP	Ocutoff	point	cutoff	NN	I-NP	Opoint	to	point	NN	I-NP	Oto	designate	to	TO	B-VP	Odesignate	responders	designate	VB	I-VP	Oresponders	.	responder	NNS	B-NP	O.	Breast	.	.	O	OBreast	cancer	Breast	NN	B-NP	Ocancer	patients	cancer	NN	I-NP	Opatients	showed	patient	NNS	I-NP	Oshowed	significant	show	VBD	B-VP	Osignificant	responses	significant	JJ	B-NP	Oresponses	to	response	NNS	I-NP	Oto	MuMTV	to	TO	B-PP	OMuMTV	(	MuMTV	NN	B-NP	B-protein(	49	(	(	O	O49	%	49	CD	B-NP	O%	and	%	NN	I-NP	Oand	to	and	CC	B-PP	Oto	MCF-7	to	TO	B-PP	OMCF-7	(	MCF-7	NN	B-NP	B-protein(	50	(	(	O	O50	%	50	CD	B-NP	O%	)	%	NN	I-NP	O)	","	)	)	O	O","	but	","	","	O	Obut	not	but	CC	O	Onot	to	not	RB	O	Oto	MPMV	to	TO	B-PP	OMPMV	(	MPMV	NN	B-NP	O(	29	(	(	O	O29	%	29	CD	B-NP	O%	)	%	NN	I-NP	O)	.	)	)	O	O.	In	.	.	O	OIn	a	In	IN	B-PP	Oa	paired-antigen	a	DT	B-NP	Opaired-antigen	study	paired-antigen	NN	I-NP	Ostudy	using	study	NN	I-NP	Ousing	MuMTV	use	VBG	B-VP	OMuMTV	and	MuMTV	NN	B-NP	B-proteinand	MCF-7	and	CC	I-NP	OMCF-7	","	MCF-7	NN	I-NP	B-protein","	75	","	","	O	O75	%	75	CD	B-NP	O%	of	%	NN	I-NP	Oof	the	of	IN	B-PP	Othe	breast	the	DT	B-NP	Obreast	cancer	breast	NN	I-NP	Ocancer	patients	cancer	NN	I-NP	Opatients	responded	patient	NNS	I-NP	Oresponded	","	respond	VBD	B-VP	O","	versus	","	","	O	Oversus	18	versus	IN	B-ADVP	O18	%	18	CD	B-NP	O%	of	%	NN	I-NP	Oof	the	of	IN	B-PP	Othe	normal	the	DT	B-NP	Onormal	women	normal	JJ	I-NP	Owomen	(	woman	NNS	I-NP	O(	P	(	(	O	OP	less	P	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.005	than	IN	B-PP	O0.005	)	0.005	CD	B-NP	O)	.	)	)	O	O.	The	.	.	O	OThe	potential	The	DT	B-NP	Opotential	for	potential	NN	I-NP	Ofor	this	for	IN	B-PP	Othis	assay	this	DT	B-NP	Oassay	to	assay	NN	I-NP	Oto	distinguish	to	TO	B-VP	Odistinguish	``	distinguish	VB	I-VP	O``	normal	``	``	O	Onormal	''	normal	JJ	B-ADJP	O''	from	''	''	O	Ofrom	``	from	IN	B-PP	O``	breast	``	``	O	Obreast	cancer	breast	NN	B-NP	Ocancer	''	cancer	NN	I-NP	O''	was	''	''	O	Owas	analyzed	be	VBD	B-VP	Oanalyzed	using	analyze	VBN	I-VP	Ousing	a	use	VBG	I-VP	Oa	migration	a	DT	B-NP	Omigration	index	migration	NN	I-NP	Oindex	derived	index	NN	I-NP	Oderived	from	derive	VBN	B-VP	Ofrom	discriminant	from	IN	B-PP	Odiscriminant	analysis	discriminant	JJ	B-NP	Oanalysis	.	analysis	NN	I-NP	O.	The	.	.	O	OThe	ability	The	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	the	of	IN	B-PP	Othe	assay	the	DT	B-NP	Oassay	to	assay	NN	I-NP	Oto	discriminate	to	TO	B-VP	Odiscriminate	``	discriminate	VB	I-VP	O``	normal	``	``	O	Onormal	''	normal	JJ	B-ADJP	O''	from	''	''	O	Ofrom	``	from	IN	B-PP	O``	cancer	``	``	O	Ocancer	''	cancer	NN	B-NP	O''	was	''	''	O	Owas	significant	be	VBD	B-VP	Osignificant	(	significant	JJ	B-ADJP	O(	P	(	(	O	OP	less	P	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.001	than	IN	B-PP	O0.001	)	0.001	CD	B-NP	O)	and	)	)	O	Oand	showed	and	CC	O	Oshowed	a	show	VBD	B-VP	Oa	sensitivity	a	DT	B-NP	Osensitivity	of	sensitivity	NN	I-NP	Oof	detecting	of	IN	B-PP	Odetecting	``	detect	VBG	B-VP	O``	cancer	``	``	B-NP	Ocancer	''	cancer	NN	I-NP	O''	of	''	''	O	Oof	75	of	IN	B-PP	O75	%	75	CD	B-NP	O%	.	%	NN	I-NP	O.	The	.	.	O	OThe	overall	The	DT	B-NP	Ooverall	responses	overall	JJ	I-NP	Oresponses	to	response	NNS	I-NP	Oto	MuMTV	to	TO	B-PP	OMuMTV	and	MuMTV	NN	B-NP	B-proteinand	MCF-7	and	CC	I-NP	OMCF-7	were	MCF-7	NN	I-NP	B-proteinwere	analyzed	be	VBD	B-VP	Oanalyzed	with	analyze	VBN	I-VP	Owith	reference	with	IN	B-PP	Oreference	to	reference	NN	B-NP	Oto	certain	to	TO	B-PP	Ocertain	prognostic	certain	JJ	B-NP	Oprognostic	factors	prognostic	JJ	I-NP	Ofactors	","	factor	NNS	I-NP	O","	but	","	","	O	Obut	showed	but	CC	O	Oshowed	no	show	VBD	B-VP	Ono	relation	no	DT	B-NP	Orelation	to	relation	NN	I-NP	Oto	age	to	TO	B-PP	Oage	","	age	NN	B-NP	O","	menstrual	","	","	O	Omenstrual	status	menstrual	JJ	B-NP	Ostatus	","	status	NN	I-NP	O","	estrogen	","	","	O	Oestrogen	receptor	estrogen	NN	B-NP	B-proteinreceptor	status	receptor	NN	I-NP	I-proteinstatus	","	status	NN	I-NP	O","	or	","	","	O	Oor	stage	or	CC	O	Ostage	of	stage	NN	B-NP	Oof	disease	of	IN	B-PP	Odisease	.	disease	NN	B-NP	O.	The	.	.	O	OThe	above	The	DT	B-NP	Oabove	reactions	above	JJ	I-NP	Oreactions	suggest	reaction	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	a	that	IN	B-SBAR	Oa	large	a	DT	B-NP	Olarge	proportion	large	JJ	I-NP	Oproportion	of	proportion	NN	I-NP	Oof	breast	of	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	patients	cancer	NN	I-NP	Opatients	exhibit	patient	NNS	I-NP	Oexhibit	presensitization	exhibit	VBP	B-VP	Opresensitization	to	presensitization	NN	B-NP	Oto	antigenfs	to	TO	B-PP	Oantigenfs	found	antigenf	NNS	B-NP	Ofound	in	find	VBN	B-VP	Oin	MuMTV	in	IN	B-PP	OMuMTV	and	MuMTV	NN	B-NP	Oand	MCF-7	and	CC	I-NP	OMCF-7	","	MCF-7	NN	I-NP	B-protein","	which	","	","	O	Owhich	may	which	WDT	B-NP	Omay	be	may	MD	B-VP	Obe	cross-reactive	be	VB	I-VP	Ocross-reactive	with	cross-reactive	JJ	B-ADJP	Owith	antigens	with	IN	B-PP	Oantigens	in	antigen	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	primary	the	DT	B-NP	Oprimary	cancer	primary	JJ	I-NP	Ocancer	.	cancer	NN	I-NP	O.	These	.	.	O	OThese	responses	These	DT	B-NP	Oresponses	appear	response	NNS	I-NP	Oappear	to	appear	VBP	B-VP	Oto	be	to	TO	I-VP	Obe	independent	be	VB	I-VP	Oindependent	of	independent	JJ	B-ADJP	Oof	major	of	IN	B-PP	Omajor	prognostic	major	JJ	B-NP	Oprognostic	variables	prognostic	JJ	I-NP	Ovariables	.	variable	NNS	I-NP	O.	Further	.	.	O	OFurther	refinement	Further	JJ	B-NP	Orefinement	of	refinement	NN	I-NP	Oof	this	of	IN	B-PP	Othis	assay	this	DT	B-NP	Oassay	may	assay	NN	I-NP	Omay	yield	may	MD	B-VP	Oyield	one	yield	VB	I-VP	Oone	which	one	CD	B-NP	Owhich	is	which	WDT	B-NP	Ois	more	be	VBZ	B-VP	Omore	highly	more	RBR	B-ADVP	Ohighly	discriminating	highly	RB	I-ADVP	Odiscriminating	for	discriminate	VBG	B-VP	Ofor	breast	for	IN	B-PP	Obreast	cancer	breast	NN	B-NP	Ocancer	.	cancer	NN	I-NP	O.	Chronic	.	.	O	OChronic	lymphatic	Chronic	JJ	B-NP	Olymphatic	leukaemia	lymphatic	JJ	I-NP	Oleukaemia	:	leukaemia	NN	I-NP	O:	cellular	:	:	O	Ocellular	effects	cellular	JJ	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	glucocorticoids	of	IN	B-PP	Oglucocorticoids	in	glucocorticoid	NNS	B-NP	Oin	vitro	in	FW	B-ADJP	Ovitro	.	vitro	FW	I-ADJP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	receptor	Glucocorticoid	NN	B-NP	B-proteinreceptor	levels	receptor	NN	I-NP	I-proteinlevels	and	level	NNS	I-NP	Oand	steroid	and	CC	O	Osteroid	induced	steroid	NN	B-NP	Oinduced	inhibition	induce	VBD	B-VP	Oinhibition	of	inhibition	NN	B-NP	Oof	nucleic	of	IN	B-PP	Onucleic	acid	nucleic	JJ	B-NP	B-proteinacid	precursors	acid	NN	I-NP	I-proteinprecursors	have	precursor	NNS	I-NP	I-proteinhave	been	have	VBP	B-VP	Obeen	examined	be	VBN	I-VP	Oexamined	in	examine	VBN	I-VP	Oin	lymphocytes	in	IN	B-PP	Olymphocytes	from	lymphocyte	NNS	B-NP	B-cell_typefrom	27	from	IN	B-PP	O27	patients	27	CD	B-NP	Opatients	at	patient	NNS	I-NP	Oat	different	at	IN	B-PP	Odifferent	stages	different	JJ	B-NP	Ostages	of	stage	NNS	I-NP	Oof	chronic	of	IN	B-PP	Ochronic	lymphatic	chronic	JJ	B-NP	Olymphatic	leukaemia	lymphatic	JJ	I-NP	Oleukaemia	.	leukaemia	NN	I-NP	O.	No	.	.	O	ONo	correlation	No	DT	B-NP	Ocorrelation	can	correlation	NN	I-NP	Ocan	be	can	MD	B-VP	Obe	found	be	VB	I-VP	Ofound	between	find	VBN	I-VP	Obetween	the	between	IN	B-PP	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	the	and	CC	O	Othe	stage	the	DT	B-NP	Ostage	of	stage	NN	I-NP	Oof	the	of	IN	B-PP	Othe	disease	the	DT	B-NP	Odisease	.	disease	NN	I-NP	O.	On	.	.	O	OOn	the	On	IN	B-PP	Othe	other	the	DT	B-NP	Oother	hand	other	JJ	I-NP	Ohand	","	hand	NN	I-NP	O","	a	","	","	O	Oa	significant	a	DT	B-NP	Osignificant	difference	significant	JJ	I-NP	Odifference	(	difference	NN	I-NP	O(	P	(	(	O	OP	less	P	NN	B-NP	Oless	than	less	JJR	B-ADJP	Othan	0.02	than	IN	B-PP	O0.02	)	0.02	CD	B-NP	O)	was	)	)	O	Owas	found	be	VBD	B-VP	Ofound	between	find	VBN	I-VP	Obetween	stage	between	IN	B-PP	Ostage	O	stage	NN	B-NP	OO	and	O	NN	I-NP	Oand	stage	and	CC	O	Ostage	III/IV	stage	NN	B-NP	OIII/IV	patients	III/IV	CD	B-NP	Opatients	","	patient	NNS	I-NP	O","	in	","	","	O	Oin	terms	in	IN	B-PP	Oterms	of	term	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	in	the	DT	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	effect	vitro	FW	I-NP	Oeffect	of	effect	NN	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	on	dexamethasone	NN	B-NP	Oon	[	on	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	uridine	]	)	I-NP	Ouridine	incorporation	uridine	NN	I-NP	Oincorporation	.	incorporation	NN	I-NP	O.	Pyrrolidine	.	.	O	OPyrrolidine	dithiocarbamate	Pyrrolidine	NN	B-NP	Odithiocarbamate	inhibits	dithiocarbamate	NN	I-NP	Oinhibits	NF-kappa	inhibit	VBZ	B-VP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	mobilization	B	NN	I-NP	I-proteinmobilization	and	mobilization	NN	I-NP	Oand	TNF	and	CC	O	OTNF	production	TNF	NN	B-NP	B-proteinproduction	in	production	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	monocytes	human	JJ	B-NP	B-cell_typemonocytes	.	monocyte	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	human	The	DT	B-NP	Ohuman	TNF	human	JJ	I-NP	B-DNATNF	promoter	TNF	NN	I-NP	I-DNApromoter	contains	promoter	NN	I-NP	I-DNAcontains	four	contain	VBZ	B-VP	Ofour	potential	four	CD	B-NP	Opotential	nuclear	potential	JJ	I-NP	Onuclear	factor-kappa	nuclear	JJ	I-NP	B-proteinfactor-kappa	B	factor-kappa	NN	I-NP	I-proteinB	(	B	NN	I-NP	I-protein(	NF-kappa	(	(	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	)	B	NN	I-NP	I-protein)	#NAME?	)	)	O	O#NAME?	sites	#NAME?	JJ	B-NP	Osites	","	site	NNS	I-NP	O","	with	","	","	O	Owith	the	with	IN	B-PP	Othe	strongest	the	DT	B-NP	Ostrongest	binding	strong	JJS	I-NP	Obinding	seen	binding	NN	I-NP	Oseen	for	see	VBN	B-VP	Ofor	the	for	IN	B-PP	Othe	-605	the	DT	B-NP	O-605	motif	-605	CD	I-NP	B-DNAmotif	.	motif	NN	I-NP	I-DNA.	Nuclear	.	.	O	ONuclear	extracts	Nuclear	JJ	B-NP	Oextracts	from	extract	NNS	I-NP	Ofrom	unstimulated	from	IN	B-PP	Ounstimulated	cells	unstimulated	JJ	B-NP	B-cell_typecells	of	cell	NNS	I-NP	I-cell_typeof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	monocytic	human	JJ	I-NP	B-cell_linemonocytic	cell	monocytic	JJ	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	","	line	NN	I-NP	I-cell_line","	Mono	","	","	O	OMono	Mac	Mono	NN	B-NP	B-cell_lineMac	6	Mac	NN	I-NP	I-cell_line6	","	6	CD	I-NP	I-cell_line","	contain	","	","	O	Ocontain	one	contain	VBP	B-VP	Oone	specific	one	CD	B-NP	Ospecific	binding	specific	JJ	I-NP	Obinding	protein	bind	VBG	I-NP	Oprotein	(	protein	NN	I-NP	O(	complex	(	(	O	Ocomplex	II	complex	NN	B-NP	B-proteinII	)	II	CD	I-NP	I-protein)	","	)	)	O	O","	consistent	","	","	O	Oconsistent	with	consistent	JJ	B-ADJP	Owith	a	with	IN	B-PP	Oa	constitutive	a	DT	B-NP	Oconstitutive	p50	constitutive	JJ	I-NP	B-proteinp50	homodimer	p50	NN	I-NP	I-proteinhomodimer	.	homodimer	NN	I-NP	I-protein.	Stimulation	.	.	O	OStimulation	of	Stimulation	NN	B-NP	Oof	Mono	of	IN	B-PP	OMono	Mac	Mono	NN	B-NP	B-cell_lineMac	6	Mac	NN	I-NP	I-cell_line6	cells	6	CD	B-NP	I-cell_linecells	with	cell	NNS	I-NP	I-cell_linewith	LPS	with	IN	B-PP	OLPS	will	LPS	NN	B-NP	Owill	increase	will	MD	B-VP	Oincrease	complex	increase	VB	I-VP	Ocomplex	II	complex	NN	B-NP	B-proteinII	and	II	CD	I-NP	I-proteinand	will	and	CC	O	Owill	strongly	will	MD	B-VP	Ostrongly	induce	strongly	RB	I-VP	Oinduce	a	induce	VB	I-VP	Oa	second	a	DT	B-NP	Osecond	specific	second	JJ	I-NP	Ospecific	complex	specific	JJ	I-NP	Ocomplex	(	complex	NN	I-NP	O(	complex	(	(	O	Ocomplex	I	complex	NN	B-NP	B-proteinI	)	I	CD	I-NP	I-protein)	","	)	)	O	O","	which	","	","	O	Owhich	represents	which	WDT	B-NP	Orepresents	the	represent	VBZ	B-VP	Othe	p50/65	the	DT	B-NP	Op50/65	heterodimer	p50/65	NN	I-NP	B-proteinheterodimer	.	heterodimer	NN	I-NP	I-protein.	Treatment	.	.	O	OTreatment	of	Treatment	NN	B-NP	Oof	Mono	of	IN	B-PP	OMono	Mac	Mono	NN	B-NP	B-cell_lineMac	6	Mac	NN	I-NP	I-cell_line6	cells	6	CD	B-NP	I-cell_linecells	with	cell	NNS	I-NP	I-cell_linewith	pyrrolidine-dithiocarbamate	with	IN	B-PP	Opyrrolidine-dithiocarbamate	(	pyrrolidine-dithiocarbamate	NN	B-NP	O(	PDTC	(	(	O	OPDTC	)	PDTC	NN	B-NP	O)	at	)	)	O	Oat	300	at	IN	B-PP	O300	microM	300	CD	B-NP	OmicroM	will	microM	NN	I-NP	Owill	block	will	MD	B-VP	Oblock	the	block	VB	I-VP	Othe	LPS-induced	the	DT	B-NP	OLPS-induced	complex	LPS-induced	JJ	I-NP	B-proteincomplex	I	complex	NN	I-NP	I-proteinI	almost	I	PRP	B-NP	Oalmost	completely	almost	RB	B-ADVP	Ocompletely	and	completely	RB	I-ADVP	Oand	will	and	CC	O	Owill	reduce	will	MD	B-VP	Oreduce	complex	reduce	VB	I-VP	Ocomplex	II	complex	NN	B-NP	B-proteinII	to	II	CD	I-NP	I-proteinto	the	to	TO	B-PP	Othe	constitutive	the	DT	B-NP	Oconstitutive	level	constitutive	JJ	I-NP	Olevel	.	level	NN	I-NP	O.	Binding	.	.	O	OBinding	activity	Binding	NN	B-NP	Oactivity	of	activity	NN	I-NP	Oof	other	of	IN	B-PP	Oother	nuclear	other	JJ	B-NP	Onuclear	factors	nuclear	JJ	I-NP	B-proteinfactors	that	factor	NNS	I-NP	I-proteinthat	recognize	that	WDT	B-NP	Orecognize	the	recognize	VBP	B-VP	Othe	SP-1	the	DT	B-NP	OSP-1	and	SP-1	NN	I-NP	B-proteinand	c/EBP	and	CC	I-NP	Oc/EBP	motifs	c/EBP	NN	I-NP	B-proteinmotifs	of	motif	NNS	I-NP	I-proteinof	the	of	IN	B-PP	Othe	human	the	DT	B-NP	Ohuman	TNF	human	JJ	I-NP	B-DNATNF	promoter	TNF	NN	I-NP	I-DNApromoter	is	promoter	NN	I-NP	I-DNAis	not	be	VBZ	B-VP	Onot	affected	not	RB	I-VP	Oaffected	by	affect	VBN	I-VP	Oby	such	by	IN	B-PP	Osuch	treatment	such	JJ	B-NP	Otreatment	.	treatment	NN	I-NP	O.	Northern	.	.	O	ONorthern	blot	Northern	NN	B-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	demonstrates	analysis	NN	I-NP	Odemonstrates	that	demonstrate	VBZ	B-VP	Othat	PDTC	that	IN	B-SBAR	OPDTC	treatment	PDTC	NN	B-NP	Otreatment	will	treatment	NN	I-NP	Owill	strongly	will	MD	B-VP	Ostrongly	reduce	strongly	RB	I-VP	Oreduce	LPS-induced	reduce	VB	I-VP	OLPS-induced	TNF	LPS-induced	JJ	B-NP	B-RNATNF	transcripts	TNF	NN	I-NP	I-RNAtranscripts	.	transcript	NNS	I-NP	I-RNA.	Secreted	.	.	O	OSecreted	TNF	Secrete	VBN	B-NP	OTNF	protein	TNF	NN	I-NP	B-proteinprotein	as	protein	NN	I-NP	I-proteinas	detected	as	IN	B-SBAR	Odetected	in	detect	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	Wehi	the	DT	B-NP	OWehi	164S/ActD	Wehi	NNP	I-NP	O164S/ActD	bioassay	164S/ActD	NN	I-NP	Obioassay	and	bioassay	NN	I-NP	Oand	in	and	CC	B-PP	Oin	a	in	IN	B-PP	Oa	sandwich	a	DT	B-NP	Osandwich	immunoassay	sandwich	JJ	I-NP	Oimmunoassay	was	immunoassay	NN	I-NP	Owas	similarly	be	VBD	B-VP	Osimilarly	reduced	similarly	RB	I-VP	Oreduced	by	reduce	VBN	I-VP	Oby	PDTC	by	IN	B-PP	OPDTC	.	PDTC	NN	B-NP	O.	Kinetic	.	.	O	OKinetic	analyses	Kinetic	JJ	B-NP	Oanalyses	show	analysis	NNS	I-NP	Oshow	that	show	VBP	B-VP	Othat	after	that	IN	B-SBAR	Oafter	LPS	after	IN	B-SBAR	OLPS	stimulation	LPS	NN	B-NP	Ostimulation	","	stimulation	NN	I-NP	O","	NF-kappa	","	","	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	will	B	NN	I-NP	I-proteinwill	peak	will	MD	B-VP	Opeak	at	peak	VB	I-VP	Oat	1	at	IN	B-PP	O1	h	1	CD	B-NP	Oh	","	h	NN	I-NP	O","	TNF	","	","	O	OTNF	transcript	TNF	NN	B-NP	B-proteintranscript	prevalence	transcript	NN	I-NP	Oprevalence	at	prevalence	NN	I-NP	Oat	2	at	IN	B-PP	O2	h	2	CD	B-NP	Oh	","	h	NN	I-NP	O","	and	","	","	O	Oand	TNF	and	CC	O	OTNF	protein	TNF	NN	B-NP	B-proteinprotein	at	protein	NN	I-NP	I-proteinat	4	at	IN	B-PP	O4	h	4	CD	B-NP	Oh	.	h	NN	I-NP	O.	PDTC	.	.	O	OPDTC	did	PDTC	NN	B-NP	Odid	not	do	VBD	B-VP	Onot	shift	not	RB	I-VP	Oshift	this	shift	VB	I-VP	Othis	response	this	DT	B-NP	Oresponse	to	response	NN	I-NP	Oto	LPS	to	TO	B-PP	OLPS	to	LPS	NN	B-NP	Oto	a	to	TO	B-PP	Oa	later	a	DT	B-NP	Olater	time	later	JJ	I-NP	Otime	","	time	NN	I-NP	O","	but	","	","	O	Obut	suppressed	but	CC	O	Osuppressed	NF-kappa	suppress	VBD	B-VP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	mobilization	B	NN	I-NP	I-proteinmobilization	","	mobilization	NN	I-NP	O","	TNF	","	","	O	OTNF	transcripts	TNF	NN	B-NP	B-RNAtranscripts	","	transcript	NNS	I-NP	I-RNA","	and	","	","	O	Oand	TNF	and	CC	O	OTNF	protein	TNF	NN	B-NP	B-proteinprotein	over	protein	NN	I-NP	I-proteinover	the	over	IN	B-PP	Othe	entire	the	DT	B-NP	Oentire	8-h	entire	JJ	I-NP	O8-h	observation	8-h	JJ	I-NP	Oobservation	period	observation	NN	I-NP	Operiod	.	period	NN	I-NP	O.	Analysis	.	.	O	OAnalysis	of	Analysis	NN	B-NP	Oof	freshly	of	IN	B-PP	Ofreshly	isolated	freshly	RB	B-NP	Oisolated	","	isolate	VBN	I-NP	O","	LPS-stimulated	","	","	I-NP	OLPS-stimulated	blood	LPS-stimulated	JJ	I-NP	B-cell_typeblood	monocytes	blood	NN	I-NP	I-cell_typemonocytes	showed	monocyte	NNS	I-NP	I-cell_typeshowed	a	show	VBD	B-VP	Oa	similar	a	DT	B-NP	Osimilar	blockade	similar	JJ	I-NP	Oblockade	of	blockade	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	.	B	NN	I-NP	I-protein.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	in	","	","	O	Oin	these	in	IN	B-PP	Othese	primary	these	DT	B-NP	Oprimary	cells	primary	JJ	I-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	induction	","	","	O	Oinduction	of	induction	NN	B-NP	Oof	TNF	of	IN	B-PP	OTNF	transcripts	TNF	NN	B-NP	B-RNAtranscripts	","	transcript	NNS	I-NP	I-RNA","	as	","	","	O	Oas	determined	as	IN	B-SBAR	Odetermined	by	determine	VBN	B-VP	Oby	Northern	by	IN	B-PP	ONorthern	blot	Northern	NN	B-NP	Oblot	analysis	blot	NN	I-NP	Oanalysis	and	analysis	NN	I-NP	Oand	by	and	CC	B-PP	Oby	quantitative	by	IN	B-PP	Oquantitative	polymerase	quantitative	JJ	B-NP	Opolymerase	chain	polymerase	NN	I-NP	Ochain	reaction	chain	NN	I-NP	Oreaction	","	reaction	NN	I-NP	O","	was	","	","	O	Owas	prevented	be	VBD	B-VP	Oprevented	by	prevent	VBN	I-VP	Oby	PDTC	by	IN	B-PP	OPDTC	as	PDTC	NN	B-NP	Oas	was	as	IN	B-SBAR	Owas	TNF	be	VBD	B-VP	OTNF	protein	TNF	NN	B-NP	B-proteinprotein	production	protein	NN	I-NP	I-proteinproduction	.	production	NN	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	show	datum	NNS	I-NP	Oshow	that	show	VBP	B-VP	Othat	dithiocarbamates	that	IN	B-SBAR	Odithiocarbamates	can	dithiocarbamate	NNS	B-NP	Ocan	profoundly	can	MD	B-VP	Oprofoundly	affect	profoundly	RB	I-VP	Oaffect	cytokine	affect	VB	I-VP	Ocytokine	expression	cytokine	NN	B-NP	B-proteinexpression	and	expression	NN	I-NP	Oand	suggest	and	CC	O	Osuggest	that	suggest	VBP	B-VP	Othat	NF-kappa	that	IN	B-SBAR	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	is	B	NN	I-NP	I-proteinis	involved	be	VBZ	B-VP	Oinvolved	in	involve	VBN	I-VP	Oin	LPS-induced	in	IN	B-PP	OLPS-induced	TNF	LPS-induced	JJ	B-NP	OTNF	gene	TNF	NN	I-NP	B-proteingene	expression	gene	NN	I-NP	Oexpression	in	expression	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	monocytes	human	JJ	B-NP	B-cell_typemonocytes	.	monocyte	NNS	I-NP	I-cell_type.	Comparing	.	.	O	OComparing	regions	Compare	VBG	B-VP	Oregions	of	region	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	Epstein-Barr	the	DT	B-NP	OEpstein-Barr	virus	Epstein-Barr	JJ	I-NP	B-proteinvirus	ZEBRA	virus	NN	I-NP	I-proteinZEBRA	protein	ZEBRA	NN	I-NP	I-proteinprotein	which	protein	NN	I-NP	I-proteinwhich	function	which	WDT	B-NP	Ofunction	as	function	VBP	B-VP	Oas	transcriptional	as	IN	B-PP	Otranscriptional	activating	transcriptional	JJ	B-NP	B-DNAactivating	sequences	activate	VBG	I-NP	I-DNAsequences	in	sequence	NNS	I-NP	I-DNAin	Saccharomyces	in	IN	B-PP	OSaccharomyces	cerevisiae	Saccharomyces	NNP	B-NP	Ocerevisiae	and	cerevisiae	NNP	I-NP	Oand	in	and	CC	B-PP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	ZEBRA	The	DT	B-NP	OZEBRA	protein	ZEBRA	NN	I-NP	B-proteinprotein	activates	protein	NN	I-NP	I-proteinactivates	expression	activate	VBZ	B-VP	Oexpression	of	expression	NN	B-NP	Oof	Epstein-Barr	of	IN	B-PP	OEpstein-Barr	virus	Epstein-Barr	JJ	B-NP	B-DNAvirus	early-lytic-cycle	virus	NN	I-NP	I-DNAearly-lytic-cycle	genes	early-lytic-cycle	JJ	I-NP	I-DNAgenes	in	gene	NNS	I-NP	I-DNAin	human	in	IN	B-PP	Ohuman	B	human	JJ	B-NP	B-cell_typeB	lymphocytes	B	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Here	.	.	O	OHere	it	Here	RB	B-ADVP	Oit	is	it	PRP	B-NP	Ois	shown	be	VBZ	B-VP	Oshown	that	show	VBN	I-VP	Othat	ZEBRA	that	IN	B-SBAR	OZEBRA	also	ZEBRA	NN	B-NP	B-proteinalso	behaves	also	RB	B-ADVP	Obehaves	as	behave	VBZ	B-VP	Oas	a	as	IN	B-PP	Oa	sequence-specific	a	DT	B-NP	Osequence-specific	transcriptional	sequence-specific	JJ	I-NP	B-proteintranscriptional	activator	transcriptional	JJ	I-NP	I-proteinactivator	in	activator	NN	I-NP	I-proteinin	Saccharomyces	in	IN	B-PP	OSaccharomyces	cerevisiae	Saccharomyces	NNP	B-NP	Ocerevisiae	.	cerevisiae	NNP	I-NP	O.	Deletional	.	.	O	ODeletional	mutagenesis	Deletional	JJ	B-NP	Omutagenesis	defined	mutagenesis	NN	I-NP	Odefined	three	define	VBD	B-VP	Othree	regions	three	CD	B-NP	Oregions	of	region	NNS	I-NP	Oof	ZEBRA	of	IN	B-PP	OZEBRA	that	ZEBRA	NN	B-NP	B-proteinthat	participate	that	WDT	B-NP	Oparticipate	in	participate	VBP	B-VP	Oin	activation	in	IN	B-PP	Oactivation	in	activation	NN	B-NP	Oin	S.	in	IN	B-PP	OS.	cerevisiae	S.	FW	B-NP	Ocerevisiae	.	cerevisiae	FW	I-NP	O.	These	.	.	O	OThese	regions	These	DT	B-NP	Oregions	are	region	NNS	I-NP	Oare	designated	be	VBP	B-VP	Odesignated	YI	designate	VBN	I-VP	OYI	(	YI	NN	B-NP	O(	amino	(	(	O	Oamino	acids	amino	JJ	B-NP	Oacids	[	acid	NNS	I-NP	O[	aa	[	(	O	Oaa	]	aa	NNS	B-NP	O]	1	]	)	O	O1	to	1	CD	B-NP	Oto	25	to	TO	B-PP	O25	)	25	CD	B-NP	O)	","	)	)	O	O","	YII	","	","	O	OYII	(	YII	NN	B-NP	B-protein(	aa	(	(	O	Oaa	51	aa	NNS	B-NP	O51	to	51	CD	B-NP	Oto	102	to	TO	B-PP	O102	)	102	CD	B-NP	O)	","	)	)	O	O","	and	","	","	O	Oand	YIII	and	CC	O	OYIII	(	YIII	NN	B-NP	B-protein(	aa	(	(	O	Oaa	228	aa	NNS	B-NP	O228	to	228	CD	B-NP	Oto	245	to	TO	B-PP	O245	)	245	CD	B-NP	O)	.	)	)	O	O.	Two	.	.	O	OTwo	of	Two	CD	B-NP	Oof	the	of	IN	B-PP	Othe	three	the	DT	B-NP	Othree	regions	three	CD	I-NP	Oregions	of	region	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	native	the	DT	B-NP	Onative	ZEBRA	native	JJ	I-NP	B-proteinZEBRA	protein	ZEBRA	NN	I-NP	I-proteinprotein	act	protein	NN	I-NP	I-proteinact	together	act	VBP	B-VP	Otogether	to	together	RB	B-ADVP	Oto	mediate	to	TO	B-VP	Omediate	activation	mediate	VB	I-VP	Oactivation	when	activation	NN	B-NP	Owhen	assayed	when	WRB	B-ADVP	Oassayed	on	assay	VBN	B-VP	Oon	ZEBRA	on	IN	B-PP	OZEBRA	binding	ZEBRA	NN	B-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	.	site	NNS	I-NP	I-DNA.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	when	","	","	O	Owhen	fused	when	WRB	B-ADVP	Ofused	to	fuse	VBN	B-VP	Oto	the	to	TO	B-PP	Othe	DNA	the	DT	B-NP	ODNA	binding	DNA	NN	I-NP	B-proteinbinding	domain	binding	NN	I-NP	I-proteindomain	of	domain	NN	I-NP	I-proteinof	GAL	of	IN	B-PP	OGAL	4	GAL	NN	B-NP	B-protein4	and	4	CD	I-NP	I-proteinand	assayed	and	CC	O	Oassayed	on	assay	VBN	B-VP	Oon	GAL4	on	IN	B-PP	OGAL4	binding	GAL4	NN	B-NP	B-DNAbinding	sites	binding	NN	I-NP	I-DNAsites	","	site	NNS	I-NP	I-DNA","	regions	","	","	O	Oregions	YII	region	NNS	B-NP	OYII	and	YII	NN	I-NP	B-proteinand	YIII	and	CC	I-NP	OYIII	were	YIII	NN	I-NP	B-proteinwere	each	be	VBD	B-VP	Oeach	sufficient	each	DT	O	Osufficient	to	sufficient	JJ	B-ADJP	Oto	confer	to	TO	B-VP	Oconfer	activation	confer	VB	I-VP	Oactivation	in	activation	NN	B-NP	Oin	S.	in	IN	B-PP	OS.	cerevisiae	S.	FW	B-NP	Ocerevisiae	.	cerevisiae	FW	I-NP	O.	Regions	.	.	O	ORegions	of	Region	NNS	B-NP	Oof	ZEBRA	of	IN	B-PP	OZEBRA	which	ZEBRA	NN	B-NP	B-proteinwhich	affected	which	WDT	B-NP	Oaffected	activation	affect	VBD	B-VP	Oactivation	in	activation	NN	B-NP	Oin	S.	in	IN	B-PP	OS.	cerevisiae	S.	FW	B-NP	Ocerevisiae	were	cerevisiae	FW	I-NP	Owere	also	be	VBD	B-VP	Oalso	required	also	RB	I-VP	Orequired	in	require	VBN	I-VP	Oin	human	in	IN	B-PP	Ohuman	B	human	JJ	B-NP	B-cell_typeB	lymphocytes	B	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	amino-terminal	The	DT	B-NP	Oamino-terminal	region	amino-terminal	JJ	I-NP	B-proteinregion	of	region	NN	I-NP	I-proteinof	ZEBRA	of	IN	B-PP	OZEBRA	(	ZEBRA	NN	B-NP	B-protein(	aa	(	(	O	Oaa	1	aa	NNS	B-NP	O1	to	1	CD	B-NP	Oto	98	to	TO	B-PP	O98	)	98	CD	B-NP	O)	was	)	)	O	Owas	required	be	VBD	B-VP	Orequired	for	require	VBN	I-VP	Ofor	activation	for	IN	B-PP	Oactivation	both	activation	NN	B-NP	Oboth	in	both	CC	B-PP	Oin	S.	in	IN	B-PP	OS.	cerevisiae	S.	FW	B-NP	Ocerevisiae	and	cerevisiae	FW	I-NP	Oand	in	and	CC	O	Oin	human	in	IN	B-PP	Ohuman	B	human	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	;	cell	NNS	I-NP	I-cell_type;	deletion	;	:	O	Odeletion	of	deletion	NN	B-NP	Oof	the	of	IN	B-PP	Othe	carboxy-terminal	the	DT	B-NP	Ocarboxy-terminal	18	carboxy-terminal	JJ	I-NP	B-protein18	aa	18	CD	I-NP	I-proteinaa	also	aa	NN	I-NP	I-proteinalso	significantly	also	RB	B-ADVP	Osignificantly	reduced	significantly	RB	B-VP	Oreduced	activation	reduce	VBD	I-VP	Oactivation	in	activation	NN	B-NP	Oin	both	in	IN	B-PP	Oboth	cell	both	DT	B-NP	Ocell	types	cell	NN	I-NP	Otypes	.	type	NNS	I-NP	O.	Thus	.	.	O	OThus	","	Thus	RB	B-ADVP	O","	the	","	","	O	Othe	behavior	the	DT	B-NP	Obehavior	of	behavior	NN	I-NP	Oof	ZEBRA	of	IN	B-PP	OZEBRA	in	ZEBRA	NN	B-NP	B-proteinin	human	in	IN	B-PP	Ohuman	B	human	JJ	B-NP	B-cell_typeB	cells	B	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	S.	and	CC	O	OS.	cerevisiae	S.	FW	B-NP	Ocerevisiae	suggests	cerevisiae	FW	I-NP	Osuggests	that	suggest	VBZ	B-VP	Othat	the	that	IN	B-SBAR	Othe	protein	the	DT	B-NP	Oprotein	contains	protein	NN	I-NP	Ocontains	universal	contain	VBZ	B-VP	Ouniversal	activation	universal	JJ	B-NP	B-DNAactivation	motifs	activation	NN	I-NP	I-DNAmotifs	that	motif	NNS	I-NP	I-DNAthat	interact	that	WDT	B-NP	Ointeract	with	interact	VBP	B-VP	Owith	conserved	with	IN	B-PP	Oconserved	components	conserve	VBN	B-NP	Ocomponents	of	component	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	transcription	the	DT	B-NP	Otranscription	machinery	transcription	NN	I-NP	Omachinery	.	machinery	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	certain	","	","	O	Ocertain	deletion	certain	JJ	B-NP	Odeletion	mutants	deletion	NN	I-NP	Omutants	of	mutant	NNS	I-NP	Oof	ZEBRA	of	IN	B-PP	OZEBRA	containing	ZEBRA	NN	B-NP	B-proteincontaining	mutations	contain	VBG	B-VP	Omutations	in	mutation	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	N-terminal	the	DT	B-NP	ON-terminal	region	N-terminal	JJ	I-NP	B-proteinregion	exhibited	region	NN	I-NP	I-proteinexhibited	discordant	exhibit	VBD	B-VP	Odiscordant	behaviors	discordant	JJ	B-NP	Obehaviors	in	behavior	NNS	I-NP	Oin	S.	in	IN	B-PP	OS.	cerevisiae	S.	FW	B-NP	Ocerevisiae	and	cerevisiae	FW	I-NP	Oand	in	and	CC	B-PP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	For	.	.	O	OFor	example	For	IN	B-PP	Oexample	","	example	NN	B-NP	O","	deletion	","	","	O	Odeletion	of	deletion	NN	B-NP	Oof	ZEBRA	of	IN	B-PP	OZEBRA	aa	ZEBRA	NN	B-NP	B-proteinaa	26	aa	NNS	I-NP	I-protein26	to	26	CD	B-NP	I-proteinto	51	to	TO	B-PP	O51	impaired	51	CD	B-NP	Oimpaired	activation	impaired	JJ	I-NP	Oactivation	to	activation	NN	I-NP	Oto	a	to	TO	B-PP	Oa	great	a	DT	B-NP	Ogreat	extent	great	JJ	I-NP	Oextent	in	extent	NN	I-NP	Oin	B	in	IN	B-PP	OB	cells	B	NN	B-NP	B-cell_typecells	but	cell	NNS	I-NP	I-cell_typebut	had	but	CC	O	Ohad	little	have	VBD	B-VP	Olittle	or	little	JJ	B-NP	Oor	no	or	CC	I-NP	Ono	effect	no	DT	I-NP	Oeffect	in	effect	NN	I-NP	Oin	S.	in	IN	B-PP	OS.	cerevisiae	S.	FW	B-NP	Ocerevisiae	.	cerevisiae	FW	I-NP	O.	The	.	.	O	OThe	discordant	The	DT	B-NP	Odiscordant	mutants	discordant	JJ	I-NP	Omutants	may	mutant	NNS	I-NP	Omay	reflect	may	MD	B-VP	Oreflect	interactions	reflect	VB	I-VP	Ointeractions	with	interaction	NNS	B-NP	Owith	a	with	IN	B-PP	Oa	variable	a	DT	B-NP	Ovariable	domain	variable	JJ	I-NP	B-proteindomain	of	domain	NN	I-NP	I-proteinof	a	of	IN	B-PP	Oa	conserved	a	DT	B-NP	Oconserved	component	conserve	VBN	I-NP	Ocomponent	or	component	NN	I-NP	Oor	unique	or	CC	O	Ounique	interactions	unique	JJ	B-NP	Ointeractions	with	interaction	NNS	I-NP	Owith	specialized	with	IN	B-PP	Ospecialized	components	specialize	VBN	B-NP	Ocomponents	of	component	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	basal	the	DT	B-NP	Obasal	transcription	basal	JJ	I-NP	Otranscription	apparatus	transcription	NN	I-NP	Oapparatus	in	apparatus	NN	I-NP	Oin	different	in	IN	B-PP	Odifferent	cells	different	JJ	B-NP	Ocells	.	cell	NNS	I-NP	O.	Functional	.	.	O	OFunctional	interaction	Functional	JJ	B-NP	Ointeraction	of	interaction	NN	I-NP	Oof	the	of	IN	B-PP	Othe	v-Rel	the	DT	B-NP	Ov-Rel	and	v-Rel	NN	I-NP	B-proteinand	c-Rel	and	CC	I-NP	Oc-Rel	oncoproteins	c-Rel	NN	I-NP	B-proteinoncoproteins	with	oncoprotein	NNS	I-NP	I-proteinwith	the	with	IN	B-PP	Othe	TATA-binding	the	DT	B-NP	OTATA-binding	protein	TATA-binding	JJ	I-NP	B-proteinprotein	and	protein	NN	I-NP	I-proteinand	association	and	CC	I-NP	Oassociation	with	association	NN	I-NP	Owith	transcription	with	IN	B-PP	Otranscription	factor	transcription	NN	B-NP	B-proteinfactor	IIB	factor	NN	I-NP	I-proteinIIB	.	IIB	NN	I-NP	O.	Rel	.	.	O	ORel	family	Rel	NN	B-NP	B-proteinfamily	proteins	family	NN	I-NP	I-proteinproteins	regulate	protein	NNS	I-NP	I-proteinregulate	the	regulate	VBP	B-VP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	genes	of	IN	B-PP	Ogenes	linked	gene	NNS	B-NP	Olinked	to	link	VBN	B-VP	Oto	kappa	to	TO	B-PP	Okappa	B-binding	kappa	NN	B-NP	B-DNAB-binding	motifs	B-binding	JJ	I-NP	I-DNAmotifs	.	motif	NNS	I-NP	I-DNA.	Little	.	.	O	OLittle	is	Little	JJ	B-NP	Ois	known	be	VBZ	B-VP	Oknown	","	know	VBN	I-VP	O","	however	","	","	O	Ohowever	","	however	RB	B-ADVP	O","	of	","	","	O	Oof	the	of	IN	B-PP	Othe	mechanism	the	DT	B-NP	Omechanism	by	mechanism	NN	I-NP	Oby	which	by	IN	B-PP	Owhich	they	which	WDT	B-NP	Othey	enhance	they	PRP	B-NP	Oenhance	transcription	enhance	VBP	B-VP	Otranscription	.	transcription	NN	B-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	investigated	have	VBP	B-VP	Oinvestigated	the	investigate	VBN	I-VP	Othe	ability	the	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	the	of	IN	B-PP	Othe	v-Rel	the	DT	B-NP	Ov-Rel	and	v-Rel	NN	I-NP	B-proteinand	c-Rel	and	CC	I-NP	Oc-Rel	oncoproteins	c-Rel	NN	I-NP	B-proteinoncoproteins	to	oncoprotein	NNS	I-NP	I-proteinto	interact	to	TO	B-VP	Ointeract	with	interact	VB	I-VP	Owith	components	with	IN	B-PP	Ocomponents	of	component	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	basal	the	DT	B-NP	Obasal	transcription	basal	JJ	I-NP	Otranscription	machinery	transcription	NN	I-NP	Omachinery	.	machinery	NN	I-NP	O.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	report	we	PRP	B-NP	Oreport	that	report	VBP	B-VP	Othat	both	that	IN	B-SBAR	Oboth	the	both	CC	O	Othe	acidic	the	DT	B-NP	Oacidic	transcription	acidic	JJ	I-NP	B-proteintranscription	activation	transcription	NN	I-NP	I-proteinactivation	domain	activation	NN	I-NP	I-proteindomain	mapping	domain	NN	I-NP	I-proteinmapping	to	map	VBG	B-VP	Oto	the	to	TO	B-PP	Othe	unique	the	DT	B-NP	Ounique	C	unique	JJ	I-NP	OC	terminus	C	NN	I-NP	B-proteinterminus	of	terminus	NN	I-NP	I-proteinof	chicken	of	IN	B-PP	Ochicken	c-Rel	chicken	NN	B-NP	B-proteinc-Rel	and	c-Rel	NN	I-NP	I-proteinand	the	and	CC	O	Othe	F9	the	DT	B-NP	OF9	cell-specific	F9	NN	I-NP	Ocell-specific	activation	cell-specific	JJ	I-NP	Oactivation	region	activation	NN	I-NP	Oregion	common	region	NN	I-NP	Ocommon	to	common	JJ	B-ADJP	Oto	both	to	TO	B-PP	Oboth	v-Rel	both	CC	O	Ov-Rel	and	v-Rel	NN	B-NP	B-proteinand	c-Rel	and	CC	I-NP	Oc-Rel	interact	c-Rel	NN	I-NP	B-proteininteract	with	interact	VBP	B-VP	Owith	the	with	IN	B-PP	Othe	TATA-binding	the	DT	B-NP	OTATA-binding	protein	TATA-binding	JJ	I-NP	B-proteinprotein	(	protein	NN	I-NP	I-protein(	TBP	(	(	O	OTBP	)	TBP	NN	B-NP	B-protein)	and	)	)	O	Oand	transcription	and	CC	O	Otranscription	factor	transcription	NN	B-NP	B-proteinfactor	IIB	factor	NN	I-NP	I-proteinIIB	(	IIB	NN	I-NP	O(	TFIIB	(	(	O	OTFIIB	)	TFIIB	NN	B-NP	B-protein)	in	)	)	O	Oin	vitro	in	FW	B-ADVP	Ovitro	and	vitro	FW	I-ADVP	Oand	in	and	CC	O	Oin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	We	.	.	O	OWe	also	We	PRP	B-NP	Oalso	demonstrate	also	RB	B-ADVP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	TPB	that	IN	B-SBAR	OTPB	interaction	TPB	NN	B-NP	B-proteininteraction	with	interaction	NN	I-NP	Owith	Rel	with	IN	B-PP	ORel	activation	Rel	NN	B-NP	B-proteinactivation	regions	activation	NN	I-NP	I-proteinregions	leads	region	NNS	I-NP	I-proteinleads	to	lead	VBZ	B-VP	Oto	synergistic	to	TO	B-PP	Osynergistic	activation	synergistic	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	transcription	of	IN	B-PP	Otranscription	of	transcription	NN	B-NP	Oof	a	of	IN	B-PP	Oa	kappa	a	DT	B-NP	Okappa	B-linked	kappa	NN	I-NP	B-DNAB-linked	reporter	B-linked	JJ	I-NP	I-DNAreporter	gene	reporter	NN	I-NP	I-DNAgene	.	gene	NN	I-NP	I-DNA.	Combined	.	.	O	OCombined	with	Combine	VBN	B-VP	Owith	the	with	IN	B-PP	Othe	observation	the	DT	B-NP	Oobservation	that	observation	NN	I-NP	Othat	the	that	IN	B-SBAR	Othe	mouse	the	DT	B-NP	Omouse	c-Rel	mouse	NN	I-NP	Oc-Rel	and	c-Rel	NN	I-NP	B-proteinand	human	and	CC	O	Ohuman	RelA	human	JJ	B-NP	B-proteinRelA	proteins	RelA	NN	I-NP	I-proteinproteins	also	protein	NNS	I-NP	I-proteinalso	interact	also	RB	B-ADVP	Ointeract	with	interact	VBP	B-VP	Owith	TBP	with	IN	B-PP	OTBP	and	TBP	NN	B-NP	B-proteinand	TFIIB	and	CC	I-NP	OTFIIB	in	TFIIB	NN	I-NP	B-proteinin	vitro	in	FW	B-ADVP	Ovitro	","	vitro	FW	I-ADVP	O","	these	","	","	O	Othese	results	these	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	association	that	IN	B-SBAR	Oassociation	with	association	NN	B-NP	Owith	basal	with	IN	B-PP	Obasal	transcription	basal	JJ	B-NP	Otranscription	factors	transcription	NN	I-NP	B-proteinfactors	is	factor	NNS	I-NP	I-proteinis	important	be	VBZ	B-VP	Oimportant	for	important	JJ	B-ADJP	Ofor	the	for	IN	B-PP	Othe	transcriptional	the	DT	B-NP	Otranscriptional	activities	transcriptional	JJ	I-NP	Oactivities	of	activity	NNS	I-NP	Oof	Rel	of	IN	B-PP	ORel	family	Rel	NN	B-NP	B-proteinfamily	proteins	family	NN	I-NP	I-proteinproteins	.	protein	NNS	I-NP	I-protein.	p21ras	.	.	O	Op21ras	and	p21ras	NN	B-NP	B-proteinand	calcineurin	and	CC	I-NP	Ocalcineurin	synergize	calcineurin	NN	I-NP	B-proteinsynergize	to	synergize	VBP	B-VP	Oto	regulate	to	TO	I-VP	Oregulate	the	regulate	VB	I-VP	Othe	nuclear	the	DT	B-NP	Onuclear	factor	nuclear	JJ	I-NP	B-proteinfactor	of	factor	NN	I-NP	I-proteinof	activated	of	IN	B-PP	I-proteinactivated	T	activate	VBN	B-NP	I-proteinT	cells	T	NN	I-NP	I-proteincells	.	cell	NNS	I-NP	I-protein.	In	.	.	O	OIn	T	In	IN	B-PP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	triggering	","	","	O	Otriggering	of	trigger	VBG	B-VP	Oof	the	of	IN	B-PP	Othe	T	the	DT	B-NP	OT	cell	T	NN	I-NP	B-proteincell	receptor	cell	NN	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	TCR	(	(	O	OTCR	)	TCR	NN	B-NP	B-protein)	induces	)	)	O	Oinduces	several	induce	VBZ	B-VP	Oseveral	signaling	several	JJ	B-NP	Osignaling	cascades	signal	VBG	I-NP	Ocascades	which	cascade	NNS	I-NP	Owhich	ultimately	which	WDT	B-NP	Oultimately	synergize	ultimately	RB	B-ADVP	Osynergize	to	synergize	VBP	B-VP	Oto	induce	to	TO	I-VP	Oinduce	the	induce	VB	I-VP	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	factor	nuclear	JJ	I-NP	B-proteinfactor	of	factor	NN	I-NP	I-proteinof	activated	of	IN	B-PP	I-proteinactivated	T	activate	VBN	B-NP	I-proteinT	cells	T	NN	I-NP	I-proteincells	(	cell	NNS	I-NP	I-protein(	NFAT	(	(	O	ONFAT	)	NFAT	NN	B-NP	B-protein)	","	)	)	O	O","	a	","	","	O	Oa	DNA	a	DT	B-NP	ODNA	binding	DNA	NN	I-NP	B-proteinbinding	complex	binding	NN	I-NP	I-proteincomplex	critical	complex	NN	I-NP	I-proteincritical	to	critical	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	inducibility	the	DT	B-NP	Oinducibility	and	inducibility	NN	I-NP	Oand	T	and	CC	I-NP	OT	cell	T	NN	I-NP	Ocell	specificity	cell	NN	I-NP	Ospecificity	of	specificity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	T	the	DT	B-NP	OT	cell	T	NN	I-NP	B-proteincell	growth	cell	NN	I-NP	I-proteingrowth	factor	growth	NN	I-NP	I-proteinfactor	interleukin	factor	NN	I-NP	I-proteininterleukin	2	interleukin	NN	I-NP	I-protein2	.	2	CD	I-NP	I-protein.	One	.	.	O	OOne	immediate	One	CD	B-NP	Oimmediate	consequence	immediate	JJ	I-NP	Oconsequence	of	consequence	NN	I-NP	Oof	T	of	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	via	activation	NN	I-NP	Ovia	the	via	IN	B-PP	Othe	TCR	the	DT	B-NP	OTCR	is	TCR	NN	I-NP	B-proteinis	an	be	VBZ	B-VP	Oan	increase	an	DT	B-NP	Oincrease	in	increase	NN	I-NP	Oin	cytosolic	in	IN	B-PP	Ocytosolic	calcium	cytosolic	JJ	B-NP	Ocalcium	.	calcium	NN	I-NP	O.	Calcium	.	.	O	OCalcium	signals	Calcium	NN	B-NP	Osignals	are	signal	NNS	I-NP	Oare	important	be	VBP	B-VP	Oimportant	for	important	JJ	B-ADJP	Ofor	NFAT	for	IN	B-PP	ONFAT	induction	NFAT	NN	B-NP	B-proteininduction	","	induction	NN	I-NP	O","	and	","	","	O	Oand	recent	and	CC	O	Orecent	studies	recent	JJ	B-NP	Ostudies	have	study	NNS	I-NP	Ohave	identified	have	VBP	B-VP	Oidentified	calcineurin	identify	VBN	I-VP	Ocalcineurin	","	calcineurin	NN	B-NP	B-protein","	a	","	","	O	Oa	calcium-calmodulin	a	DT	B-NP	Ocalcium-calmodulin	dependent	calcium-calmodulin	NN	I-NP	B-proteindependent	serine-threonine	dependent	JJ	I-NP	Oserine-threonine	phosphatase	serine-threonine	NN	I-NP	B-proteinphosphatase	","	phosphatase	NN	I-NP	I-protein","	as	","	","	O	Oas	a	as	IN	B-PP	Oa	prominent	a	DT	B-NP	Oprominent	component	prominent	JJ	I-NP	Ocomponent	of	component	NN	I-NP	Oof	the	of	IN	B-PP	Othe	calcium	the	DT	B-NP	Ocalcium	signaling	calcium	NN	I-NP	Osignaling	pathway	signaling	NN	I-NP	Opathway	in	pathway	NN	I-NP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	A	.	.	O	OA	second	A	DT	B-NP	Osecond	important	second	JJ	I-NP	Oimportant	molecule	important	JJ	I-NP	Omolecule	in	molecule	NN	I-NP	Oin	TCR	in	IN	B-PP	OTCR	signal	TCR	NN	B-NP	B-proteinsignal	transduction	signal	NN	I-NP	Otransduction	is	transduction	NN	I-NP	Ois	the	be	VBZ	B-VP	Othe	guanine	the	DT	B-NP	Oguanine	nucleotide	guanine	NN	I-NP	B-proteinnucleotide	binding	nucleotide	NN	I-NP	I-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	","	protein	NN	I-NP	I-protein","	p21ras	","	","	O	Op21ras	","	p21ras	NN	B-NP	B-protein","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	coupled	be	VBZ	B-VP	Ocoupled	to	couple	VBN	I-VP	Oto	the	to	TO	B-PP	Othe	TCR	the	DT	B-NP	OTCR	by	TCR	NN	I-NP	B-proteinby	a	by	IN	B-PP	Oa	protein	a	DT	B-NP	Oprotein	tyrosine	protein	NN	I-NP	B-proteintyrosine	kinase	tyrosine	NN	I-NP	I-proteinkinase	dependent	kinase	NN	I-NP	I-proteindependent	mechanism	dependent	JJ	I-NP	Omechanism	.	mechanism	NN	I-NP	O.	The	.	.	O	OThe	experiments	The	DT	B-NP	Oexperiments	presented	experiment	NNS	I-NP	Opresented	here	present	VBN	B-VP	Ohere	show	here	RB	B-ADVP	Oshow	that	show	VBP	B-VP	Othat	expression	that	IN	B-SBAR	Oexpression	by	expression	NN	B-NP	Oby	transfection	by	IN	B-PP	Otransfection	of	transfection	NN	B-NP	Oof	mutationally	of	IN	B-PP	Omutationally	activated	mutationally	RB	B-NP	Oactivated	calcineurin	activate	VBN	I-NP	Ocalcineurin	or	calcineurin	NN	I-NP	B-proteinor	activated	or	CC	O	Oactivated	p21ras	activate	VBN	B-NP	Op21ras	alone	p21ras	NN	I-NP	B-proteinalone	is	alone	RB	B-ADVP	Ois	insufficient	be	VBZ	B-VP	Oinsufficient	for	insufficient	JJ	B-ADJP	Ofor	NFAT	for	IN	B-PP	ONFAT	transactivation	NFAT	NN	B-NP	B-proteintransactivation	.	transactivation	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	coexpression	","	","	O	Ocoexpression	of	coexpression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	activated	the	DT	B-NP	Oactivated	calcineurin	activate	VBN	I-NP	Ocalcineurin	with	calcineurin	NN	I-NP	B-proteinwith	activated	with	IN	B-PP	Oactivated	p21ras	activate	VBN	B-NP	Op21ras	could	p21ras	NN	I-NP	B-proteincould	mimic	could	MD	B-VP	Omimic	TCR	mimic	VB	I-VP	OTCR	signals	TCR	NN	B-NP	B-proteinsignals	in	signal	NNS	I-NP	Oin	NFAT	in	IN	B-PP	ONFAT	induction	NFAT	NN	B-NP	B-proteininduction	.	induction	NN	I-NP	O.	These	.	.	O	OThese	data	These	DT	B-NP	Odata	identify	datum	NNS	I-NP	Oidentify	calcineurin	identify	VBP	B-VP	Ocalcineurin	and	calcineurin	NN	B-NP	B-proteinand	p21ras	and	CC	I-NP	Op21ras	as	p21ras	NN	I-NP	B-proteinas	cooperative	as	IN	B-PP	Ocooperative	partners	cooperative	JJ	B-NP	Opartners	in	partner	NNS	I-NP	Oin	T	in	IN	B-PP	OT	cell	T	NN	B-NP	Ocell	activation	cell	NN	I-NP	Oactivation	.	activation	NN	I-NP	O.	Expression	.	.	O	OExpression	of	Expression	NN	B-NP	Oof	the	of	IN	B-PP	Othe	chicken	the	DT	B-NP	Ochicken	GATA	chicken	NN	I-NP	B-proteinGATA	factor	GATA	NN	I-NP	I-proteinfactor	family	factor	NN	I-NP	I-proteinfamily	during	family	NN	I-NP	I-proteinduring	early	during	IN	B-PP	Oearly	erythroid	early	JJ	B-NP	Oerythroid	development	erythroid	JJ	I-NP	Odevelopment	and	development	NN	I-NP	Oand	differentiation	and	CC	O	Odifferentiation	.	differentiation	NN	B-NP	O.	The	.	.	O	OThe	DNA	The	DT	B-NP	ODNA	motif	DNA	NN	I-NP	Omotif	WGATAR	motif	NN	I-NP	OWGATAR	has	WGATAR	NN	I-NP	Ohas	been	have	VBZ	B-VP	Obeen	identified	be	VBN	I-VP	Oidentified	within	identify	VBN	I-VP	Owithin	transcriptional	within	IN	B-PP	Otranscriptional	regulatory	transcriptional	JJ	B-NP	B-proteinregulatory	domains	regulatory	JJ	I-NP	I-proteindomains	of	domain	NNS	I-NP	I-proteinof	globin	of	IN	B-PP	Oglobin	and	globin	NN	B-NP	B-proteinand	other	and	CC	O	Oother	erythroid-specific	other	JJ	B-NP	Oerythroid-specific	genes	erythroid-specific	JJ	I-NP	B-DNAgenes	and	gene	NNS	I-NP	I-DNAand	the	and	CC	O	Othe	activator	the	DT	B-NP	Oactivator	proteins	activator	NN	I-NP	B-proteinproteins	that	protein	NNS	I-NP	I-proteinthat	bind	that	WDT	B-NP	Obind	to	bind	VBP	B-VP	Oto	this	to	TO	B-PP	Othis	regulatory	this	DT	B-NP	Oregulatory	element	regulatory	JJ	I-NP	B-DNAelement	","	element	NN	I-NP	I-DNA","	the	","	","	O	Othe	GATA	the	DT	B-NP	OGATA	factors	GATA	NN	I-NP	B-proteinfactors	","	factor	NNS	I-NP	I-protein","	belong	","	","	O	Obelong	to	belong	VBP	B-VP	Oto	a	to	TO	B-PP	Oa	multi-gene	a	DT	B-NP	Omulti-gene	family	multi-gene	JJ	I-NP	B-proteinfamily	that	family	NN	I-NP	I-proteinthat	is	that	WDT	B-NP	Ois	expressed	be	VBZ	B-VP	Oexpressed	in	express	VBN	I-VP	Oin	chicken	in	IN	B-PP	Ochicken	erythroid	chicken	NN	B-NP	B-cell_typeerythroid	cells	erythroid	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Here	.	.	O	OHere	we	Here	RB	B-ADVP	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	","	that	IN	B-SBAR	O","	as	","	","	O	Oas	in	as	IN	B-PP	Oin	chickens	in	IN	B-PP	Ochickens	","	chicken	NNS	B-NP	O","	multiple	","	","	O	Omultiple	members	multiple	JJ	B-NP	Omembers	of	member	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	GATA	the	DT	B-NP	OGATA	factor	GATA	NN	I-NP	B-proteinfactor	family	factor	NN	I-NP	I-proteinfamily	are	family	NN	I-NP	I-proteinare	expressed	be	VBP	B-VP	Oexpressed	in	express	VBN	I-VP	Oin	human	in	IN	B-PP	Ohuman	and	human	JJ	B-NP	B-cell_typeand	murine	and	CC	I-NP	I-cell_typemurine	erythroid	murine	JJ	I-NP	I-cell_typeerythroid	cells	erythroid	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	During	.	.	O	ODuring	the	During	IN	B-PP	Othe	early	the	DT	B-NP	Oearly	stages	early	JJ	I-NP	Ostages	of	stage	NNS	I-NP	Oof	chicken	of	IN	B-PP	Ochicken	embryogenesis	chicken	NN	B-NP	Oembryogenesis	(	embryogenesis	NN	I-NP	O(	well	(	(	O	Owell	before	well	RB	B-ADVP	Obefore	blood	before	IN	B-PP	Oblood	island	blood	NN	B-NP	Oisland	formation	island	NN	I-NP	Oformation	)	formation	NN	I-NP	O)	","	)	)	O	O","	each	","	","	O	Oeach	of	each	DT	B-NP	Oof	the	of	IN	B-PP	Othe	GATA	the	DT	B-NP	OGATA	family	GATA	NN	I-NP	B-proteinfamily	members	family	NN	I-NP	I-proteinmembers	is	member	NNS	I-NP	I-proteinis	transcribed	be	VBZ	B-VP	Otranscribed	with	transcribe	VBN	I-VP	Owith	a	with	IN	B-PP	Oa	unique	a	DT	B-NP	Ounique	temporal	unique	JJ	I-NP	Otemporal	and	temporal	JJ	I-NP	Oand	spatial	and	CC	I-NP	Ospatial	pattern	spatial	JJ	I-NP	Opattern	.	pattern	NN	I-NP	O.	In	.	.	O	OIn	the	In	IN	B-PP	Othe	primitive	the	DT	B-NP	Oprimitive	erythroid	primitive	JJ	I-NP	B-cell_typeerythroid	lineage	erythroid	JJ	I-NP	I-cell_typelineage	","	lineage	NN	I-NP	I-cell_type","	transcription	","	","	O	Otranscription	of	transcription	NN	B-NP	Oof	the	of	IN	B-PP	Othe	embryonic	the	DT	B-NP	Oembryonic	epsilon-globin	embryonic	JJ	I-NP	B-DNAepsilon-globin	gene	epsilon-globin	NN	I-NP	I-DNAgene	parallels	gene	NN	I-NP	I-DNAparallels	GATA-1	parallel	VBZ	B-VP	OGATA-1	expression	GATA-1	NN	B-NP	B-proteinexpression	while	expression	NN	I-NP	Owhile	the	while	IN	B-SBAR	Othe	switch	the	DT	B-NP	Oswitch	to	switch	NN	I-NP	Oto	beta-globin	to	TO	B-PP	Obeta-globin	transcription	beta-globin	NN	B-NP	B-proteintranscription	in	transcription	NN	I-NP	Oin	definitive	in	IN	B-PP	Odefinitive	erythroid	definitive	JJ	B-NP	Oerythroid	cells	erythroid	JJ	I-NP	B-cell_typecells	is	cell	NNS	I-NP	I-cell_typeis	directly	be	VBZ	B-VP	Odirectly	preceded	directly	RB	I-VP	Opreceded	by	precede	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	pronounced	a	DT	B-NP	Opronounced	increase	pronounced	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	GATA-3	in	IN	B-PP	OGATA-3	accumulation	GATA-3	NN	B-NP	B-proteinaccumulation	.	accumulation	NN	I-NP	O.	The	.	.	O	OThe	timing	The	DT	B-NP	Otiming	and	timing	NN	I-NP	Oand	pattern	and	CC	I-NP	Opattern	of	pattern	NN	I-NP	Oof	expression	of	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	these	of	IN	B-PP	Othese	different	these	DT	B-NP	Odifferent	mRNAs	different	JJ	I-NP	OmRNAs	during	mRNA	NNS	I-NP	B-RNAduring	avian	during	IN	B-PP	Oavian	erythroid	avian	JJ	B-NP	Oerythroid	development	erythroid	JJ	I-NP	Odevelopment	and	development	NN	I-NP	Oand	differentiation	and	CC	O	Odifferentiation	suggests	differentiation	NN	B-NP	Osuggests	that	suggest	VBZ	B-VP	Othat	temporally	that	IN	B-SBAR	Otemporally	regulated	temporally	RB	B-NP	Oregulated	changes	regulate	VBN	I-NP	Ochanges	in	change	NNS	I-NP	Oin	GATA	in	IN	B-PP	OGATA	factor	GATA	NN	B-NP	B-proteinfactor	expression	factor	NN	I-NP	I-proteinexpression	are	expression	NN	I-NP	Oare	required	be	VBP	B-VP	Orequired	for	require	VBN	I-VP	Ofor	vertebrate	for	IN	B-PP	Overtebrate	hematopoiesis	vertebrate	NN	B-NP	Ohematopoiesis	.	hematopoiesis	NN	I-NP	O.	Molecular	.	.	O	OMolecular	regulation	Molecular	JJ	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	interleukin	human	JJ	B-NP	Ointerleukin	2	interleukin	NN	I-NP	O2	and	2	CD	I-NP	Oand	T-cell	and	CC	I-NP	OT-cell	function	T-cell	NN	I-NP	Ofunction	by	function	NN	I-NP	Oby	interleukin	by	IN	B-PP	Ointerleukin	4	interleukin	NN	B-NP	B-protein4	.	4	CD	I-NP	I-protein.	Distinct	.	.	O	ODistinct	functional	Distinct	JJ	B-NP	B-cell_typefunctional	T-cell	functional	JJ	I-NP	I-cell_typeT-cell	subsets	T-cell	NN	I-NP	I-cell_typesubsets	","	subset	NNS	I-NP	I-cell_type","	differing	","	","	O	Odiffering	in	differ	VBG	B-VP	Oin	the	in	IN	B-PP	Othe	patterns	the	DT	B-NP	Opatterns	of	pattern	NNS	I-NP	Oof	lymphokines	of	IN	B-PP	Olymphokines	produced	lymphokine	NNS	B-NP	B-proteinproduced	","	produce	VBN	B-VP	O","	regulate	","	","	O	Oregulate	cell-mediated	regulate	VBP	B-VP	Ocell-mediated	and	cell-mediated	JJ	B-NP	Oand	humoral	and	CC	I-NP	Ohumoral	immune	humoral	JJ	I-NP	Oimmune	responses	immune	JJ	I-NP	Oresponses	.	response	NNS	I-NP	O.	The	.	.	O	OThe	two	The	DT	B-NP	Otwo	major	two	CD	I-NP	Omajor	types	major	JJ	I-NP	Otypes	and	type	NNS	I-NP	Oand	their	and	CC	O	Otheir	principal	their	PRP$	B-NP	Oprincipal	products	principal	JJ	I-NP	Oproducts	","	product	NNS	I-NP	O","	interleukin	","	","	O	Ointerleukin	4	interleukin	NN	B-NP	B-protein4	and	4	CD	I-NP	I-proteinand	interferon	and	CC	O	Ointerferon	gamma	interferon	NN	B-NP	B-proteingamma	(	gamma	NN	I-NP	I-protein(	IL-4	(	(	O	OIL-4	and	IL-4	NN	B-NP	B-proteinand	IFN-gamma	and	CC	O	OIFN-gamma	)	IFN-gamma	NN	B-NP	B-protein)	","	)	)	O	O","	are	","	","	O	Oare	reciprocally	be	VBP	B-VP	Oreciprocally	negatively	reciprocally	RB	B-ADVP	Onegatively	interactive	negatively	RB	B-ADJP	Ointeractive	.	interactive	JJ	I-ADJP	O.	To	.	.	O	OTo	analyze	To	TO	B-VP	Oanalyze	the	analyze	VB	I-VP	Othe	molecular	the	DT	B-NP	Omolecular	mechanism	molecular	JJ	I-NP	Omechanism	of	mechanism	NN	I-NP	Oof	IL-4-mediated	of	IN	B-PP	OIL-4-mediated	suppression	IL-4-mediated	JJ	B-NP	Osuppression	of	suppression	NN	I-NP	Oof	cell-mediated	of	IN	B-PP	Ocell-mediated	immunity	cell-mediated	JJ	B-NP	Oimmunity	we	immunity	NN	I-NP	Owe	studied	we	PRP	B-NP	Ostudied	its	study	VBD	B-VP	Oits	effects	its	PRP$	B-NP	Oeffects	on	effect	NNS	I-NP	Oon	expression	on	IN	B-PP	Oexpression	of	expression	NN	B-NP	Oof	interleukin	of	IN	B-PP	Ointerleukin	2	interleukin	NN	B-NP	B-protein2	(	2	CD	I-NP	I-protein(	IL-2	(	(	O	OIL-2	)	IL-2	NN	B-NP	B-protein)	and	)	)	O	Oand	IFN-gamma	and	CC	O	OIFN-gamma	.	IFN-gamma	NN	B-NP	B-protein.	IL-4	.	.	O	OIL-4	pretreatment	IL-4	NN	B-NP	B-proteinpretreatment	of	pretreatment	NN	I-NP	Oof	Jurkat	of	IN	B-PP	OJurkat	cells	Jurkat	NN	B-NP	B-cell_linecells	prior	cell	NNS	I-NP	I-cell_lineprior	to	prior	RB	B-ADVP	Oto	stimulation	to	TO	B-PP	Ostimulation	resulted	stimulation	NN	B-NP	Oresulted	in	result	VBD	B-VP	Oin	a	in	IN	B-PP	Oa	decrease	a	DT	B-NP	Odecrease	in	decrease	NN	I-NP	Oin	transcription	in	IN	B-PP	Otranscription	of	transcription	NN	B-NP	Oof	the	of	IN	B-PP	Othe	IL2	the	DT	B-NP	OIL2	gene	IL2	NN	I-NP	B-DNAgene	.	gene	NN	I-NP	I-DNA.	IL-4	.	.	O	OIL-4	suppressed	IL-4	NN	B-NP	B-proteinsuppressed	IL-2	suppress	VBD	B-VP	OIL-2	and	IL-2	NN	B-NP	B-proteinand	IFN-gamma	and	CC	O	OIFN-gamma	mRNA	IFN-gamma	NN	B-NP	B-RNAmRNA	levels	mRNA	NN	I-NP	I-RNAlevels	in	level	NNS	I-NP	Oin	primary	in	IN	B-PP	Oprimary	human	primary	JJ	B-NP	B-cell_typehuman	T	human	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	addition	and	CC	O	Oaddition	of	addition	NN	B-NP	Oof	anti-CD28	of	IN	B-PP	Oanti-CD28	antibodies	anti-CD28	JJ	B-NP	B-proteinantibodies	relieved	antibody	NNS	I-NP	I-proteinrelieved	this	relieve	VBD	B-VP	Othis	suppression	this	DT	B-NP	Osuppression	.	suppression	NN	I-NP	O.	Using	.	.	O	OUsing	enhancer-reporter	Use	VBG	B-VP	Oenhancer-reporter	constructs	enhancer-reporter	JJ	B-NP	B-DNAconstructs	","	construct	NNS	I-NP	I-DNA","	IL-4	","	","	O	OIL-4	specifically	IL-4	NN	B-NP	B-proteinspecifically	down-regulated	specifically	RB	B-ADVP	Odown-regulated	the	down-regulate	VBD	B-VP	Othe	NFIL-2B	the	DT	B-NP	ONFIL-2B	element	NFIL-2B	NN	I-NP	B-DNAelement	.	element	NN	I-NP	I-DNA.	Electrophoretic	.	.	O	OElectrophoretic	mobility	Electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assays	shift	NN	I-NP	Oassays	using	assay	NNS	I-NP	Ousing	a	use	VBG	B-VP	Oa	DNA	a	DT	B-NP	ODNA	oligomer	DNA	NN	I-NP	Ooligomer	containing	oligomer	NN	I-NP	Ocontaining	the	contain	VBG	B-VP	Othe	NFIL-2B	the	DT	B-NP	ONFIL-2B	binding	NFIL-2B	NN	I-NP	B-DNAbinding	site	binding	NN	I-NP	I-DNAsite	indicated	site	NN	I-NP	I-DNAindicated	that	indicate	VBD	B-VP	Othat	IL-4	that	IN	B-SBAR	OIL-4	inhibited	IL-4	NN	B-NP	B-proteininhibited	the	inhibit	VBD	B-VP	Othe	NFIL-2B	the	DT	B-NP	ONFIL-2B	complex	NFIL-2B	NN	I-NP	B-proteincomplex	and	complex	NN	I-NP	I-proteinand	that	and	CC	O	Othat	the	that	IN	B-SBAR	Othe	NFIL-2B	the	DT	B-NP	ONFIL-2B	DNA	NFIL-2B	NN	I-NP	B-proteinDNA	binding	DNA	NN	I-NP	I-proteinbinding	factor	binding	NN	I-NP	I-proteinfactor	is	factor	NN	I-NP	I-proteinis	distinct	be	VBZ	B-VP	Odistinct	from	distinct	JJ	B-ADJP	Ofrom	AP-	from	IN	B-PP	OAP-	1	AP-	NN	B-NP	B-protein1	.	1	CD	I-NP	I-protein.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	IL-4	that	IN	B-SBAR	OIL-4	may	IL-4	NN	B-NP	B-proteinmay	regulate	may	MD	B-VP	Oregulate	development	regulate	VB	I-VP	Odevelopment	and	development	NN	B-NP	Oand	function	and	CC	I-NP	Ofunction	of	function	NN	I-NP	Oof	T-cell	of	IN	B-PP	OT-cell	subsets	T-cell	NN	B-NP	B-cell_typesubsets	involved	subset	NNS	I-NP	I-cell_typeinvolved	in	involve	VBN	B-VP	Oin	cell-mediated	in	IN	B-PP	Ocell-mediated	immunity	cell-mediated	JJ	B-NP	Oimmunity	in	immunity	NN	I-NP	Oin	part	in	IN	B-PP	Opart	by	part	NN	B-NP	Oby	inhibiting	by	IN	B-PP	Oinhibiting	factors	inhibit	VBG	B-VP	B-proteinfactors	required	factor	NNS	B-NP	I-proteinrequired	for	require	VBN	B-VP	Ofor	transcription	for	IN	B-PP	Otranscription	of	transcription	NN	B-NP	Oof	the	of	IN	B-PP	Othe	IL2	the	DT	B-NP	OIL2	gene	IL2	NN	I-NP	B-DNAgene	Immunochemical	gene	NN	I-NP	I-DNAImmunochemical	differences	Immunochemical	JJ	B-NP	Odifferences	between	difference	NNS	I-NP	Obetween	glucocorticoid	between	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	from	receptor	NNS	I-NP	I-proteinfrom	corticoid-sensitive	from	IN	B-PP	Ocorticoid-sensitive	and	corticoid-sensitive	JJ	B-NP	Oand	#NAME?	and	CC	I-NP	O#NAME?	malignant	#NAME?	JJ	I-NP	B-cell_linemalignant	lymphocytes	malignant	JJ	I-NP	I-cell_linelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_line.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	explored	have	VBP	B-VP	Oexplored	the	explore	VBN	I-VP	Othe	possibility	the	DT	B-NP	Opossibility	of	possibility	NN	I-NP	Oof	using	of	IN	B-PP	Ousing	antibodies	use	VBG	B-VP	Oantibodies	against	antibody	NNS	B-NP	B-proteinagainst	purified	against	IN	B-PP	Opurified	rat	purify	VBN	B-NP	Orat	liver	rat	NN	I-NP	Oliver	glucocorticoid	liver	NN	I-NP	Oglucocorticoid	receptors	glucocorticoid	NN	I-NP	B-proteinreceptors	to	receptor	NNS	I-NP	I-proteinto	study	to	TO	B-VP	Ostudy	the	study	VB	I-VP	Othe	immunochemical	the	DT	B-NP	Oimmunochemical	properties	immunochemical	JJ	I-NP	Oproperties	of	property	NNS	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	from	receptor	NNS	I-NP	I-proteinfrom	murine	from	IN	B-PP	Omurine	and	murine	JJ	B-NP	B-cell_typeand	human	and	CC	I-NP	I-cell_typehuman	malignant	human	JJ	I-NP	I-cell_typemalignant	lymphocytes	malignant	JJ	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	For	.	.	O	OFor	this	For	IN	B-PP	Othis	purpose	this	DT	B-NP	Opurpose	","	purpose	NN	I-NP	O","	purified	","	","	O	Opurified	immune	purify	VBN	B-VP	Oimmune	immunoglobulin	immune	JJ	B-NP	Oimmunoglobulin	G	immunoglobulin	NN	I-NP	OG	was	G	NN	I-NP	Owas	covalently	be	VBD	B-VP	Ocovalently	linked	covalently	RB	I-VP	Olinked	to	link	VBN	I-VP	Oto	Sepharose	to	TO	B-PP	OSepharose	CL-4B	Sepharose	NN	B-NP	B-proteinCL-4B	.	CL-4B	NN	I-NP	I-protein.	We	.	.	O	OWe	then	We	PRP	B-NP	Othen	examined	then	RB	B-ADVP	Oexamined	the	examine	VBD	B-VP	Othe	ability	the	DT	B-NP	Oability	of	ability	NN	I-NP	Oof	the	of	IN	B-PP	Othe	affinity	the	DT	B-NP	Oaffinity	gel	affinity	NN	I-NP	Ogel	to	gel	NN	I-NP	Oto	recognize	to	TO	B-VP	Orecognize	cytosolic	recognize	VB	I-VP	Ocytosolic	[	cytosolic	JJ	B-NP	B-protein[	3H	[	(	I-NP	I-protein3H	]	3H	NN	I-NP	I-protein]	triamcinolone	]	)	I-NP	I-proteintriamcinolone	acetonide-receptor	triamcinolone	NN	I-NP	I-proteinacetonide-receptor	complexes	acetonide-receptor	NN	I-NP	I-proteincomplexes	from	complex	NNS	I-NP	I-proteinfrom	the	from	IN	B-PP	Othe	corticoid-sensitive	the	DT	B-NP	Ocorticoid-sensitive	(	corticoid-sensitive	JJ	I-NP	O(	CS	(	(	O	OCS	)	CS	JJ	B-ADJP	O)	and	)	)	O	Oand	#NAME?	and	CC	O	O#NAME?	strains	#NAME?	JJ	B-NP	Ostrains	of	strain	NNS	I-NP	Oof	mouse	of	IN	B-PP	Omouse	lymphoma	mouse	NN	B-NP	Olymphoma	P1798	lymphoma	NN	I-NP	OP1798	","	P1798	NN	I-NP	O","	from	","	","	O	Ofrom	CS	from	IN	B-PP	OCS	lymphocytes	CS	JJ	B-NP	B-cell_typelymphocytes	of	lymphocyte	NNS	I-NP	I-cell_typeof	patients	of	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	chronic	with	IN	B-PP	Ochronic	lymphatic	chronic	JJ	B-NP	Olymphatic	leukemia	lymphatic	JJ	I-NP	Oleukemia	","	leukemia	NN	I-NP	O","	and	","	","	B-PP	Oand	from	and	CC	I-PP	Ofrom	a	from	IN	B-PP	Oa	CS	a	DT	B-NP	OCS	clone	CS	JJ	I-NP	B-cell_lineclone	of	clone	NN	I-NP	I-cell_lineof	human	of	IN	B-PP	Ohuman	leukemic	human	JJ	B-NP	B-cell_typeleukemic	lymphoblasts	leukemic	JJ	I-NP	I-cell_typelymphoblasts	in	lymphoblast	NNS	I-NP	I-cell_typein	tissue	in	IN	B-PP	Otissue	culture	tissue	NN	B-NP	Oculture	(	culture	NN	I-NP	O(	CH6	(	(	O	OCH6	)	CH6	NN	B-NP	B-protein)	.	)	)	O	O.	Mouse	.	.	O	OMouse	thymus	Mouse	NN	B-NP	Othymus	was	thymus	NN	I-NP	Owas	used	be	VBD	B-VP	Oused	as	use	VBN	I-VP	Oas	a	as	IN	B-PP	Oa	source	a	DT	B-NP	Osource	of	source	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	from	receptor	NN	I-NP	I-proteinfrom	normal	from	IN	B-PP	Onormal	CS	normal	JJ	B-NP	B-cell_typeCS	lymphocytes	CS	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Whereas	.	.	O	OWhereas	the	Whereas	IN	B-SBAR	Othe	immunoaffinity	the	DT	B-NP	Oimmunoaffinity	column	immunoaffinity	NN	I-NP	Ocolumn	retained	column	NN	I-NP	Oretained	70	retain	VBD	B-VP	O70	to	70	CD	B-NP	Oto	84	to	TO	B-PP	O84	%	84	CD	B-NP	O%	of	%	NN	I-NP	Oof	the	of	IN	B-PP	Othe	58-	the	DT	B-NP	O58-	to	58-	CD	I-NP	Oto	62-A	to	TO	B-PP	O62-A	(	62-A	NN	B-NP	O(	Stokes	(	(	O	OStokes	radius	Stokes	NNP	B-NP	Oradius	)	radius	NN	I-NP	O)	[	)	)	O	O[	3H	[	(	O	O3H	]	3H	NN	B-NP	O]	triamcinolone	]	)	I-NP	Otriamcinolone	acetonide-receptor	triamcinolone	NN	I-NP	B-proteinacetonide-receptor	complexes	acetonide-receptor	NN	I-NP	I-proteincomplexes	characteristic	complex	NNS	I-NP	I-proteincharacteristic	of	characteristic	JJ	B-ADJP	Oof	the	of	IN	B-PP	Othe	CS	the	DT	B-NP	OCS	mouse	CS	JJ	I-NP	Omouse	and	mouse	NN	I-NP	Oand	human	and	CC	O	Ohuman	lymphocytes	human	JJ	B-NP	B-cell_typelymphocytes	","	lymphocyte	NNS	I-NP	I-cell_type","	it	","	","	O	Oit	failed	it	PRP	B-NP	Ofailed	to	fail	VBD	B-VP	Oto	recognize	to	TO	I-VP	Orecognize	the	recognize	VB	I-VP	Othe	27-	the	DT	B-NP	O27-	to	27-	CD	I-NP	Oto	28-A	to	TO	B-PP	O28-A	(	28-A	NN	B-NP	O(	Stokes	(	(	O	OStokes	radius	Stokes	NNP	B-NP	Oradius	)	radius	NN	I-NP	O)	glucocorticoid	)	)	O	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	present	receptor	NN	I-NP	I-proteinpresent	in	present	JJ	B-ADJP	Oin	corticoid-resistant	in	IN	B-PP	Ocorticoid-resistant	mouse	corticoid-resistant	JJ	B-NP	B-cell_linemouse	lymphoma	mouse	NN	I-NP	I-cell_linelymphoma	P1798	lymphoma	NN	I-NP	I-cell_lineP1798	cells	P1798	NN	I-NP	I-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Therefore	.	.	O	OTherefore	","	Therefore	RB	B-ADVP	O","	under	","	","	O	Ounder	appropriate	under	IN	B-PP	Oappropriate	experimental	appropriate	JJ	B-NP	Oexperimental	conditions	experimental	JJ	I-NP	Oconditions	","	condition	NNS	I-NP	O","	it	","	","	O	Oit	was	it	PRP	B-NP	Owas	possible	be	VBD	B-VP	Opossible	to	possible	JJ	B-ADJP	Oto	demonstrate	to	TO	B-VP	Odemonstrate	cross-reactivity	demonstrate	VB	I-VP	Ocross-reactivity	between	cross-reactivity	NN	B-NP	Obetween	the	between	IN	B-PP	Othe	antiserum	the	DT	B-NP	Oantiserum	against	antiserum	NN	I-NP	Oagainst	rat	against	IN	B-PP	Orat	liver	rat	NN	B-NP	B-proteinliver	glucocorticoid	liver	NN	I-NP	I-proteinglucocorticoid	receptor	glucocorticoid	NN	I-NP	I-proteinreceptor	and	receptor	NN	I-NP	I-proteinand	the	and	CC	O	Othe	58-	the	DT	B-NP	O58-	to	58-	CD	I-NP	Oto	62-A	to	TO	B-PP	O62-A	(	62-A	NN	B-NP	O(	Stokes	(	(	O	OStokes	radius	Stokes	NNP	B-NP	Oradius	)	radius	NN	I-NP	O)	glucocorticoid	)	)	O	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	from	receptor	NN	I-NP	I-proteinfrom	species	from	IN	B-PP	Ospecies	as	specie	NNS	B-NP	Oas	diverse	as	RB	B-ADJP	Odiverse	as	diverse	JJ	I-ADJP	Oas	mouse	as	IN	B-PP	Omouse	and	mouse	NN	B-NP	Oand	humans	and	CC	O	Ohumans	.	human	NNS	B-NP	O.	Heterogeneity	.	.	O	OHeterogeneity	of	Heterogeneity	NN	B-NP	Oof	the	of	IN	B-PP	Othe	in	the	DT	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	responses	vitro	FW	I-NP	Oresponses	to	response	NNS	I-NP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	in	glucocorticoid	NNS	B-NP	Oin	acute	in	IN	B-PP	Oacute	leukemia	acute	JJ	B-NP	Oleukemia	.	leukemia	NN	I-NP	O.	In	.	.	O	OIn	leukocyte	In	IN	B-PP	Oleukocyte	population	leukocyte	NN	B-NP	B-cell_typepopulation	freshly	population	NN	I-NP	I-cell_typefreshly	isolated	freshly	RB	B-VP	Oisolated	from	isolate	VBN	I-VP	Ofrom	the	from	IN	B-PP	Othe	blood	the	DT	B-NP	Oblood	of	blood	NN	I-NP	Oof	26	of	IN	B-PP	O26	patients	26	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	acute	with	IN	B-PP	Oacute	leukemia	acute	JJ	B-NP	Oleukemia	","	leukemia	NN	I-NP	O","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	measured	have	VBP	B-VP	Omeasured	several	measure	VBN	I-VP	Oseveral	parameters	several	JJ	B-NP	Oparameters	including	parameter	NNS	I-NP	Oincluding	glucocorticoid	include	VBG	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	","	receptor	NNS	I-NP	I-protein","	nucleoside	","	","	O	Onucleoside	incorporation	nucleoside	NN	B-NP	Oincorporation	","	incorporation	NN	I-NP	O","	percentage	","	","	O	Opercentage	of	percentage	NN	B-NP	Oof	cells	of	IN	B-PP	Ocells	in	cell	NNS	B-NP	Oin	S	in	IN	B-PP	OS	phase	S	NN	B-NP	Ophase	","	phase	NN	I-NP	O","	and	","	","	O	Oand	steroid-induced	and	CC	O	Osteroid-induced	cell	steroid-induced	JJ	B-NP	Ocell	lysis	cell	NN	I-NP	Olysis	.	lysis	NN	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	in	","	","	O	Oin	some	in	IN	B-PP	Osome	cases	some	DT	B-NP	Ocases	","	case	NNS	I-NP	O","	the	","	","	O	Othe	short-term	the	DT	B-NP	Oshort-term	response	short-term	JJ	I-NP	Oresponse	to	response	NN	I-NP	Oto	steroid	to	TO	B-PP	Osteroid	therapy	steroid	NN	B-NP	Otherapy	was	therapy	NN	I-NP	Owas	determined	be	VBD	B-VP	Odetermined	.	determine	VBN	I-VP	O.	Although	.	.	O	OAlthough	","	Although	IN	B-SBAR	O","	in	","	","	O	Oin	all	in	IN	B-PP	Oall	the	all	PDT	B-NP	Othe	patients	the	DT	I-NP	Opatients	studied	patient	NNS	I-NP	Ostudied	","	study	VBN	B-VP	O","	leukocytes	","	","	O	Oleukocytes	were	leukocyte	NNS	B-NP	B-cell_typewere	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	contain	to	TO	I-VP	Ocontain	glucocorticoid	contain	VB	I-VP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	","	receptor	NNS	I-NP	I-protein","	we	","	","	O	Owe	failed	we	PRP	B-NP	Ofailed	to	fail	VBD	B-VP	Oto	demonstrate	to	TO	I-VP	Odemonstrate	any	demonstrate	VB	I-VP	Oany	correlation	any	DT	B-NP	Ocorrelation	between	correlation	NN	I-NP	Obetween	the	between	IN	B-PP	Othe	level	the	DT	B-NP	Olevel	of	level	NN	I-NP	Oof	binding	of	IN	B-PP	Obinding	sites	bind	VBG	B-NP	B-proteinsites	and	site	NNS	I-NP	I-proteinand	the	and	CC	O	Othe	in	the	DT	B-NP	Oin	vitro	in	FW	I-NP	Ovitro	or	vitro	FW	I-NP	Oor	in	or	CC	O	Oin	vivo	in	FW	B-NP	Ovivo	response	vivo	FW	I-NP	Oresponse	to	response	NN	I-NP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	.	glucocorticoid	NNS	B-NP	O.	This	.	.	O	OThis	absence	This	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	correlation	of	IN	B-PP	Ocorrelation	could	correlation	NN	B-NP	Ocould	be	could	MD	B-VP	Obe	in	be	VB	I-VP	Oin	part	in	IN	B-PP	Opart	explained	part	NN	B-NP	Oexplained	by	explain	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	marked	the	DT	B-NP	Omarked	heterogeneity	marked	JJ	I-NP	Oheterogeneity	of	heterogeneity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	steroid	the	DT	B-NP	Osteroid	response	steroid	NN	I-NP	Oresponse	demonstrated	response	NN	I-NP	Odemonstrated	in	demonstrate	VBD	B-VP	Oin	leukocyte	in	IN	B-PP	Oleukocyte	subpopulations	leukocyte	NN	B-NP	B-cell_typesubpopulations	.	subpopulation	NNS	I-NP	I-cell_type.	It	.	.	O	OIt	appears	It	PRP	B-NP	Oappears	","	appear	VBZ	B-VP	O","	however	","	","	O	Ohowever	","	however	RB	B-ADVP	O","	that	","	","	O	Othat	the	that	IN	B-SBAR	Othe	degree	the	DT	B-NP	Odegree	of	degree	NN	I-NP	Oof	steroid	of	IN	B-PP	Osteroid	action	steroid	NN	B-NP	Oaction	in	action	NN	I-NP	Oin	vitro	in	FW	B-ADVP	Ovitro	as	vitro	FW	I-ADVP	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	the	as	IN	I-CONJP	Othe	extent	the	DT	B-NP	Oextent	of	extent	NN	I-NP	Oof	spontaneous	of	IN	B-PP	Ospontaneous	and	spontaneous	JJ	B-NP	Oand	dexamethasone-induced	and	CC	I-NP	Odexamethasone-induced	cell	dexamethasone-induced	JJ	I-NP	Ocell	death	cell	NN	I-NP	Odeath	may	death	NN	I-NP	Omay	be	may	MD	B-VP	Obe	related	be	VB	I-VP	Orelated	to	related	JJ	B-ADJP	Oto	the	to	TO	B-PP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	cells	of	IN	B-PP	Ocells	in	cell	NNS	B-NP	Oin	the	in	IN	B-PP	Othe	S	the	DT	B-NP	OS	phase	S	NN	I-NP	Ophase	of	phase	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	cycle	cell	NN	I-NP	Ocycle	.	cycle	NN	I-NP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	receptors	Glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	cytosol	in	IN	B-PP	Ocytosol	and	cytosol	NN	B-NP	Oand	nuclear	and	CC	O	Onuclear	extract	nuclear	JJ	B-NP	Oextract	of	extract	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	leukocytes	human	JJ	B-NP	B-cell_typeleukocytes	.	leukocyte	NNS	I-NP	I-cell_type.	Cortisol	.	.	O	OCortisol	binding	Cortisol	NN	B-NP	Obinding	by	binding	NN	I-NP	Oby	cytosol	by	IN	B-PP	Ocytosol	and	cytosol	NN	B-NP	Oand	0.4	and	CC	O	O0.4	M	0.4	CD	B-NP	OM	KCl	M	NN	I-NP	OKCl	extract	KCl	NN	I-NP	Oextract	of	extract	NN	I-NP	Oof	the	of	IN	B-PP	Othe	nuclear	the	DT	B-NP	Onuclear	fraction	nuclear	JJ	I-NP	Ofraction	of	fraction	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	leukocytes	human	JJ	B-NP	B-cell_typeleukocytes	were	leukocyte	NNS	I-NP	I-cell_typewere	studied	be	VBD	B-VP	Ostudied	by	study	VBN	I-VP	Oby	gel	by	IN	B-PP	Ogel	chromatography	gel	NN	B-NP	Ochromatography	and	chromatography	NN	I-NP	Oand	ion	and	CC	O	Oion	exchange	ion	NN	B-NP	Oexchange	filtration	exchange	NN	I-NP	Ofiltration	on	filtration	NN	I-NP	Oon	DEAE	on	IN	B-PP	ODEAE	cellulose	DEAE	NN	B-NP	Ocellulose	.	cellulose	NN	I-NP	O.	The	.	.	O	OThe	cytoplasmic	The	DT	B-NP	Ocytoplasmic	cortisol	cytoplasmic	JJ	I-NP	B-proteincortisol	binding	cortisol	NN	I-NP	I-proteinbinding	protein	binding	NN	I-NP	I-proteinprotein	has	protein	NN	I-NP	I-proteinhas	a	have	VBZ	B-VP	Oa	molecular	a	DT	B-NP	Omolecular	weight	molecular	JJ	I-NP	Oweight	95	weight	NN	I-NP	O95	0	95	CD	I-NP	O0	and	0	CD	I-NP	Oand	the	and	CC	O	Othe	soluble	the	DT	B-NP	Osoluble	nuclear	soluble	JJ	I-NP	Onuclear	binding	nuclear	JJ	I-NP	Obinding	protein	bind	VBG	I-NP	Oprotein	50	protein	NN	I-NP	O50	0	50	CD	I-NP	O0	.	0	CD	I-NP	O.	The	.	.	O	OThe	absence	The	DT	B-NP	Oabsence	of	absence	NN	I-NP	Oof	the	of	IN	B-PP	Othe	uptake	the	DT	B-NP	Ouptake	of	uptake	NN	I-NP	Oof	radioactive	of	IN	B-PP	Oradioactive	cortisol	radioactive	JJ	B-NP	Ocortisol	by	cortisol	NN	I-NP	Oby	isolated	by	IN	B-PP	Oisolated	nuclei	isolate	VBN	B-NP	Onuclei	and	nucleus	NNS	I-NP	Oand	the	and	CC	O	Othe	apparent	the	DT	B-NP	Oapparent	requirement	apparent	JJ	I-NP	Orequirement	of	requirement	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cytosol	the	DT	B-NP	Ocytosol	for	cytosol	NN	I-NP	Ofor	glucocorticoid	for	IN	B-PP	Oglucocorticoid	specific	glucocorticoid	NN	B-NP	Ospecific	binding	specific	JJ	I-NP	Obinding	in	binding	NN	I-NP	Oin	nuclear	in	IN	B-PP	Onuclear	receptor	nuclear	JJ	B-NP	Oreceptor	sites	receptor	NN	I-NP	Osites	was	site	NNS	I-NP	Owas	observed	be	VBD	B-VP	Oobserved	.	observe	VBN	I-VP	O.	The	.	.	O	OThe	association	The	DT	B-NP	Oassociation	constant	association	NN	I-NP	Oconstant	characterising	constant	NN	I-NP	Ocharacterising	the	characterise	VBG	B-VP	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	cortisol	of	IN	B-PP	Ocortisol	to	cortisol	NN	B-NP	Oto	cytosol	to	TO	B-PP	Ocytosol	was	cytosol	NN	B-NP	Owas	KA	be	VBD	B-VP	OKA	=	KA	NN	B-NP	O=	3.5	=	SYM	B-VP	O3.5	.	3.5	CD	B-NP	O.	10	.	SYM	I-NP	O10	(	10	CD	I-NP	O(	9	(	(	O	O9	)	9	CD	B-NP	O)	l/mol	)	)	O	Ol/mol	.	l/mol	NN	B-NP	O.	Corticosteroid-induced	.	.	O	OCorticosteroid-induced	lymphopenia	Corticosteroid-induced	JJ	B-NP	Olymphopenia	","	lymphopenia	NN	I-NP	O","	immunosuppression	","	","	O	Oimmunosuppression	","	immunosuppression	NN	B-NP	O","	and	","	","	O	Oand	body	and	CC	O	Obody	defense	body	NN	B-NP	Odefense	.	defense	NN	I-NP	O.	The	.	.	O	OThe	apparent	The	DT	B-NP	Oapparent	paradox	apparent	JJ	I-NP	Oparadox	of	paradox	NN	I-NP	Oof	heightened	of	IN	B-PP	Oheightened	adrenal	heighten	VBN	B-NP	Oadrenal	corticosteroid	adrenal	JJ	I-NP	Ocorticosteroid	levels	corticosteroid	NN	I-NP	Olevels	associated	level	NNS	I-NP	Oassociated	with	associate	VBN	B-VP	Owith	reduction	with	IN	B-PP	Oreduction	in	reduction	NN	B-NP	Oin	the	in	IN	B-PP	Othe	competence	the	DT	B-NP	Ocompetence	of	competence	NN	I-NP	Oof	the	of	IN	B-PP	Othe	body	the	DT	B-NP	Obody	's	body	NN	I-NP	O's	defensive	's	POS	B-NP	Odefensive	apparatus	defensive	JJ	I-NP	Oapparatus	to	apparatus	NN	I-NP	Oto	cope	to	TO	B-VP	Ocope	with	cope	VB	I-VP	Owith	exposure	with	IN	B-PP	Oexposure	to	exposure	NN	B-NP	Oto	new	to	TO	B-PP	Onew	microbial	new	JJ	B-NP	Omicrobial	antigens	microbial	JJ	I-NP	B-proteinantigens	is	antigen	NNS	I-NP	I-proteinis	considered	be	VBZ	B-VP	Oconsidered	.	consider	VBN	I-VP	O.	The	.	.	O	OThe	question	The	DT	B-NP	Oquestion	is	question	NN	I-NP	Ois	asked	be	VBZ	B-VP	Oasked	how	ask	VBN	I-VP	Ohow	this	how	WRB	B-ADVP	Othis	lowered	this	DT	B-NP	Olowered	defensive	lower	VBN	I-NP	Odefensive	capability	defensive	JJ	I-NP	Ocapability	","	capability	NN	I-NP	O","	which	","	","	O	Owhich	occurs	which	WDT	B-NP	Ooccurs	in	occur	VBZ	B-VP	Oin	the	in	IN	B-PP	Othe	face	the	DT	B-NP	Oface	of	face	NN	I-NP	Oof	a	of	IN	B-PP	Oa	threat	a	DT	B-NP	Othreat	to	threat	NN	I-NP	Oto	body	to	TO	B-PP	Obody	integrity	body	NN	B-NP	Ointegrity	","	integrity	NN	I-NP	O","	is	","	","	O	Ois	consistent	be	VBZ	B-VP	Oconsistent	with	consistent	JJ	B-ADJP	Owith	Cannon	with	IN	B-PP	OCannon	's	Cannon	NNP	B-NP	O's	principals	's	POS	B-NP	Oprincipals	of	principal	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	``	the	DT	B-NP	O``	wisdom	``	``	I-NP	Owisdom	of	wisdom	NN	I-NP	Oof	the	of	IN	B-PP	Othe	body.	the	DT	B-NP	Obody.	''	body.	NN	I-NP	O''	The	''	''	O	OThe	suggestion	The	DT	B-NP	Osuggestion	is	suggestion	NN	I-NP	Ois	offered	be	VBZ	B-VP	Ooffered	that	offer	VBN	I-VP	Othat	the	that	IN	B-SBAR	Othe	immunologic	the	DT	B-NP	Oimmunologic	response	immunologic	JJ	I-NP	Oresponse	to	response	NN	I-NP	Oto	self-antigens	to	TO	B-PP	Oself-antigens	exposed	self-antigen	NNS	B-NP	B-proteinexposed	by	expose	VBN	B-VP	Oby	disease	by	IN	B-PP	Odisease	or	disease	NN	B-NP	Oor	trauma	or	CC	I-NP	Otrauma	may	trauma	NN	I-NP	Omay	be	may	MD	B-VP	Obe	suppressed	be	VB	I-VP	Osuppressed	by	suppress	VBN	I-VP	Oby	corticosteroid	by	IN	B-PP	Ocorticosteroid	to	corticosteroid	NN	B-NP	Oto	offset	to	TO	B-VP	Ooffset	the	offset	VB	I-VP	Othe	likelihood	the	DT	B-NP	Olikelihood	of	likelihood	NN	I-NP	Oof	autoimmune	of	IN	B-PP	Oautoimmune	attack	autoimmune	JJ	B-NP	Oattack	.	attack	NN	I-NP	O.	Protein	.	.	O	OProtein	tyrosine	Protein	NN	B-NP	B-proteintyrosine	kinase	tyrosine	NN	I-NP	I-proteinkinase	activation	kinase	NN	I-NP	I-proteinactivation	is	activation	NN	I-NP	Ois	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	lipopolysaccharide	for	IN	B-PP	Olipopolysaccharide	induction	lipopolysaccharide	NN	B-NP	Oinduction	of	induction	NN	I-NP	Oof	cytokines	of	IN	B-PP	Ocytokines	in	cytokine	NNS	B-NP	B-proteinin	human	in	IN	B-PP	Ohuman	blood	human	JJ	B-NP	B-cell_typeblood	monocytes	blood	NN	I-NP	I-cell_typemonocytes	.	monocyte	NNS	I-NP	I-cell_type.	Bacterial	.	.	O	OBacterial	LPS	Bacterial	JJ	B-NP	OLPS	induce	LPS	NN	I-NP	Oinduce	production	induce	VBP	B-VP	Oproduction	of	production	NN	B-NP	Oof	cytokines	of	IN	B-PP	Ocytokines	such	cytokine	NNS	B-NP	B-proteinsuch	as	such	JJ	B-PP	Oas	IL-1	as	IN	I-PP	OIL-1	","	IL-1	NN	B-NP	B-protein","	IL-6	","	","	O	OIL-6	","	IL-6	NN	B-NP	B-protein","	and	","	","	O	Oand	TNF	and	CC	O	OTNF	in	TNF	NN	B-NP	B-proteinin	mononuclear	in	IN	B-PP	Omononuclear	phagocytes	mononuclear	JJ	B-NP	B-cell_typephagocytes	","	phagocyte	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	this	and	CC	O	Othis	represents	this	DT	B-NP	Orepresents	a	represent	VBZ	B-VP	Oa	central	a	DT	B-NP	Ocentral	component	central	JJ	I-NP	Ocomponent	in	component	NN	I-NP	Oin	the	in	IN	B-PP	Othe	pathogenesis	the	DT	B-NP	Opathogenesis	of	pathogenesis	NN	I-NP	Oof	septic	of	IN	B-PP	Oseptic	shock	septic	JJ	B-NP	Oshock	syndrome	shock	NN	I-NP	Osyndrome	.	syndrome	NN	I-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	the	","	","	O	Othe	mechanisms	the	DT	B-NP	Omechanisms	by	mechanism	NNS	I-NP	Oby	which	by	IN	B-PP	Owhich	LPS	which	WDT	B-NP	OLPS	activates	LPS	NN	B-NP	Oactivates	these	activate	VBZ	B-VP	Othese	cells	these	DT	B-NP	Ocells	to	cell	NNS	I-NP	Oto	express	to	TO	B-VP	Oexpress	cytokines	express	VB	I-VP	Ocytokines	are	cytokine	NNS	B-NP	B-proteinare	not	be	VBP	B-VP	Onot	completely	not	RB	I-VP	Ocompletely	characterized	completely	RB	I-VP	Ocharacterized	.	characterize	VBN	I-VP	O.	The	.	.	O	OThe	present	The	DT	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	addressed	study	NN	I-NP	Oaddressed	the	address	VBD	B-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	different	of	IN	B-PP	Odifferent	protein	different	JJ	B-NP	Oprotein	kinases	protein	NN	I-NP	B-proteinkinases	in	kinase	NNS	I-NP	I-proteinin	the	in	IN	B-PP	Othe	LPS	the	DT	B-NP	OLPS	induction	LPS	NN	I-NP	Oinduction	of	induction	NN	I-NP	Oof	cytokines	of	IN	B-PP	Ocytokines	.	cytokine	NNS	B-NP	B-protein.	It	.	.	O	OIt	is	It	PRP	B-NP	Ois	shown	be	VBZ	B-VP	Oshown	that	show	VBN	I-VP	Othat	LPS	that	IN	B-SBAR	OLPS	induced	LPS	NN	B-NP	Oinduced	a	induce	VBD	B-VP	Oa	12-	a	DT	B-NP	O12-	to	12-	CD	I-NP	Oto	16-fold	to	TO	B-PP	O16-fold	increase	16-fold	JJ	B-NP	Oincrease	in	increase	NN	I-NP	Oin	IL-1	in	IN	B-PP	OIL-1	beta	IL-1	NN	B-NP	B-proteinbeta	","	beta	NN	I-NP	I-protein","	IL-6	","	","	O	OIL-6	","	IL-6	NN	B-NP	B-protein","	and	","	","	O	Oand	TNF-alpha	and	CC	O	OTNF-alpha	mRNA	TNF-alpha	NN	B-NP	B-RNAmRNA	levels	mRNA	NN	I-NP	I-RNAlevels	","	level	NNS	I-NP	O","	and	","	","	O	Oand	this	and	CC	O	Othis	was	this	DT	B-NP	Owas	completely	be	VBD	B-VP	Ocompletely	or	completely	RB	B-ADVP	Oor	more	or	CC	O	Omore	than	more	JJR	B-NP	Othan	80	than	IN	I-NP	O80	%	80	CD	I-NP	O%	blocked	%	NN	I-NP	Oblocked	by	block	VBN	B-VP	Oby	the	by	IN	B-PP	Othe	protein	the	DT	B-NP	Oprotein	tyrosine	protein	NN	I-NP	B-proteintyrosine	kinase	tyrosine	NN	I-NP	I-proteinkinase	specific	kinase	NN	I-NP	I-proteinspecific	inhibitors	specific	JJ	I-NP	Oinhibitors	herbimycin	inhibitor	NNS	I-NP	Oherbimycin	A	herbimycin	NN	I-NP	OA	and	A	NN	I-NP	Oand	genistein	and	CC	O	Ogenistein	at	genistein	NN	B-NP	Oat	the	at	IN	B-PP	Othe	concentrations	the	DT	B-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	1.7	of	IN	B-PP	O1.7	and	1.7	CD	B-NP	Oand	37	and	CC	I-NP	O37	microM	37	CD	I-NP	OmicroM	","	microM	NN	I-NP	O","	respectively	","	","	O	Orespectively	.	respectively	RB	B-ADVP	O.	Protein	.	.	O	OProtein	kinase	Protein	NN	B-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	inhibition	C	NN	I-NP	I-proteininhibition	by	inhibition	NN	I-NP	Oby	staurosporine	by	IN	B-PP	Ostaurosporine	reduced	staurosporine	NN	B-NP	Oreduced	LPS	reduce	VBD	B-VP	OLPS	induction	LPS	NN	B-NP	Oinduction	of	induction	NN	I-NP	Oof	TNF-alpha	of	IN	B-PP	OTNF-alpha	","	TNF-alpha	NN	B-NP	B-protein","	whereas	","	","	O	Owhereas	it	whereas	IN	O	Oit	had	it	PRP	B-NP	Ohad	no	have	VBD	B-VP	Ono	effects	no	DT	B-NP	Oeffects	on	effect	NNS	I-NP	Oon	IL-6	on	IN	B-PP	OIL-6	and	IL-6	NN	B-NP	B-proteinand	IL-1	and	CC	O	OIL-1	beta	IL-1	NN	B-NP	B-proteinbeta	.	beta	NN	I-NP	I-protein.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	protein	of	IN	B-PP	Oprotein	kinase	protein	NN	B-NP	B-proteinkinase	A	kinase	NN	I-NP	I-proteinA	by	A	NN	I-NP	I-proteinby	H89	by	IN	B-PP	OH89	reduced	H89	NN	B-NP	B-proteinreduced	IL-6	reduce	VBD	B-VP	OIL-6	mRNA	IL-6	NN	B-NP	B-RNAmRNA	levels	mRNA	NN	I-NP	I-RNAlevels	but	level	NNS	I-NP	Obut	did	but	CC	O	Odid	not	do	VBD	B-VP	Onot	detectably	not	RB	I-VP	Odetectably	change	detectably	RB	I-VP	Ochange	IL-1	change	VB	I-VP	OIL-1	beta	IL-1	NN	B-NP	B-proteinbeta	or	beta	NN	I-NP	I-proteinor	TNF-alpha	or	CC	O	OTNF-alpha	mRNA	TNF-alpha	NN	B-NP	B-RNAmRNA	levels	mRNA	NN	I-NP	I-RNAlevels	.	level	NNS	I-NP	O.	In	.	.	O	OIn	contrast	In	IN	B-PP	Ocontrast	","	contrast	NN	B-NP	O","	LPS	","	","	O	OLPS	did	LPS	NN	B-NP	Odid	not	do	VBD	B-VP	Onot	increase	not	RB	I-VP	Oincrease	leukemia	increase	VB	I-VP	Oleukemia	inhibitory	leukemia	NN	B-NP	B-RNAinhibitory	factor	inhibitory	JJ	I-NP	I-RNAfactor	mRNA	factor	NN	I-NP	I-RNAmRNA	","	mRNA	NN	I-NP	I-RNA","	which	","	","	O	Owhich	was	which	WDT	B-NP	Owas	constitutively	be	VBD	B-VP	Oconstitutively	expressed	constitutively	RB	I-VP	Oexpressed	and	express	VBN	I-VP	Oand	not	and	CC	O	Onot	significantly	not	RB	B-VP	Osignificantly	reduced	significantly	RB	I-VP	Oreduced	by	reduce	VBN	I-VP	Oby	these	by	IN	B-PP	Othese	inhibitors	these	DT	B-NP	Oinhibitors	.	inhibitor	NNS	I-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	to	addition	NN	B-NP	Oto	cytokine	to	TO	B-PP	Ocytokine	mRNA	cytokine	NN	B-NP	B-RNAmRNA	levels	mRNA	NN	I-NP	I-RNAlevels	","	level	NNS	I-NP	O","	LPS-induced	","	","	O	OLPS-induced	IL-6	LPS-induced	JJ	B-NP	OIL-6	protein	IL-6	NN	I-NP	B-proteinprotein	synthesis	protein	NN	I-NP	I-proteinsynthesis	and	synthesis	NN	I-NP	Oand	IL-6	and	CC	O	OIL-6	bioactivity	IL-6	NN	B-NP	B-proteinbioactivity	were	bioactivity	NN	I-NP	Owere	also	be	VBD	B-VP	Oalso	reduced	also	RB	I-VP	Oreduced	to	reduce	VBN	I-VP	Oto	baseline	to	TO	B-PP	Obaseline	levels	baseline	NN	B-NP	Olevels	by	level	NNS	I-NP	Oby	the	by	IN	B-PP	Othe	PTK	the	DT	B-NP	OPTK	inhibitors	PTK	NN	I-NP	B-proteininhibitors	herbimycin	inhibitor	NNS	I-NP	Oherbimycin	A	herbimycin	NN	I-NP	OA	and	A	NN	I-NP	Oand	genistein	and	CC	I-NP	Ogenistein	.	genistein	NN	I-NP	O.	Both	.	.	O	OBoth	PTK	Both	DT	B-NP	OPTK	inhibitors	PTK	NN	I-NP	B-proteininhibitors	also	inhibitor	NNS	I-NP	Oalso	reduced	also	RB	B-ADVP	Oreduced	the	reduce	VBD	B-VP	Othe	LPS	the	DT	B-NP	OLPS	activation	LPS	NN	I-NP	Oactivation	of	activation	NN	I-NP	Oof	nuclear	of	IN	B-PP	Onuclear	factor-kappa	nuclear	JJ	B-NP	B-proteinfactor-kappa	B	factor-kappa	NN	I-NP	I-proteinB	(	B	NN	I-NP	I-protein(	NF-kappa	(	(	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	)	B	NN	I-NP	I-protein)	","	)	)	O	O","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	a	be	VBZ	B-VP	Oa	transcription	a	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	involved	factor	NN	I-NP	I-proteininvolved	in	involve	VBN	B-VP	Oin	the	in	IN	B-PP	Othe	expression	the	DT	B-NP	Oexpression	of	expression	NN	I-NP	Oof	cytokine	of	IN	B-PP	Ocytokine	genes	cytokine	NN	B-NP	B-DNAgenes	such	gene	NNS	I-NP	I-DNAsuch	as	such	JJ	B-PP	Oas	IL-6	as	IN	I-PP	OIL-6	and	IL-6	NN	B-NP	B-proteinand	TNF-alpha	and	CC	I-NP	OTNF-alpha	.	TNF-alpha	NN	I-NP	B-protein.	The	.	.	O	OThe	activation	The	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	was	B	NN	I-NP	I-proteinwas	also	be	VBD	B-VP	Oalso	reduced	also	RB	I-VP	Oreduced	by	reduce	VBN	I-VP	Oby	H89	by	IN	B-PP	OH89	","	H89	NN	B-NP	B-protein","	whereas	","	","	O	Owhereas	staurosporine	whereas	IN	O	Ostaurosporine	had	staurosporine	NN	B-NP	Ohad	no	have	VBD	B-VP	Ono	effect	no	DT	B-NP	Oeffect	on	effect	NN	I-NP	Oon	this	on	IN	B-PP	Othis	response	this	DT	B-NP	Oresponse	.	response	NN	I-NP	O.	In	.	.	O	OIn	summary	In	IN	B-PP	Osummary	","	summary	NN	B-NP	O","	these	","	","	O	Othese	findings	these	DT	B-NP	Ofindings	suggest	finding	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	protein	that	IN	B-SBAR	Oprotein	kinase	protein	NN	B-NP	B-proteinkinase	C	kinase	NN	I-NP	I-proteinC	and	C	NN	I-NP	I-proteinand	protein	and	CC	O	Oprotein	kinase	protein	NN	B-NP	B-proteinkinase	A	kinase	NN	I-NP	I-proteinA	appear	A	NN	I-NP	I-proteinappear	to	appear	VBP	B-VP	Oto	have	to	TO	I-VP	Ohave	selective	have	VB	I-VP	Oselective	effects	selective	JJ	B-NP	Oeffects	in	effect	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	LPS	the	DT	B-NP	OLPS	induction	LPS	NN	I-NP	Oinduction	of	induction	NN	I-NP	Oof	cytokines	of	IN	B-PP	Ocytokines	","	cytokine	NNS	B-NP	B-protein","	whereas	","	","	O	Owhereas	PTK	whereas	IN	O	OPTK	is	PTK	NN	B-NP	B-proteinis	required	be	VBZ	B-VP	Orequired	for	require	VBN	I-VP	Ofor	LPS	for	IN	B-PP	OLPS	induction	LPS	NN	B-NP	Oinduction	of	induction	NN	I-NP	Oof	a	of	IN	B-PP	Oa	broad	a	DT	B-NP	Obroad	spectrum	broad	JJ	I-NP	Ospectrum	of	spectrum	NN	I-NP	Oof	cytokines	of	IN	B-PP	Ocytokines	and	cytokine	NNS	B-NP	B-proteinand	NF-kappa	and	CC	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	in	activation	NN	I-NP	Oin	monocytes	in	IN	B-PP	Omonocytes	.	monocyte	NNS	B-NP	B-cell_type.	In	.	.	O	OIn	vivo	In	FW	B-NP	Ovivo	control	vivo	FW	I-NP	Ocontrol	of	control	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	by	activation	NN	I-NP	Oby	I	by	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	.	alpha	NN	I-NP	I-protein.	The	.	.	O	OThe	transcription	The	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	NF-kappa	factor	NN	I-NP	I-proteinNF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	is	B	NN	I-NP	I-proteinis	stored	be	VBZ	B-VP	Ostored	in	store	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	cytoplasm	the	DT	B-NP	Ocytoplasm	in	cytoplasm	NN	I-NP	Oin	complexes	in	IN	B-PP	Ocomplexes	with	complex	NNS	B-NP	Owith	the	with	IN	B-PP	Othe	inhibitor	the	DT	B-NP	Oinhibitor	protein	inhibitor	NN	I-NP	Oprotein	I	protein	NN	I-NP	OI	kappa	I	NN	I-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	.	alpha	NN	I-NP	I-protein.	It	.	.	O	OIt	has	It	PRP	B-NP	Ohas	been	have	VBZ	B-VP	Obeen	shown	be	VBN	I-VP	Oshown	in	show	VBN	I-VP	Oin	vitro	in	FW	B-ADVP	Ovitro	that	vitro	FW	I-ADVP	Othat	dissociation	that	IN	B-SBAR	Odissociation	of	dissociation	NN	B-NP	Oof	I	of	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	from	alpha	NN	I-NP	I-proteinfrom	these	from	IN	B-PP	Othese	complexes	these	DT	B-NP	Ocomplexes	results	complex	NNS	I-NP	Oresults	in	result	VBZ	B-VP	Oin	active	in	IN	B-PP	Oactive	NF-kappa	active	JJ	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	.	B	NN	I-NP	I-protein.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	report	this	DT	B-NP	Oreport	we	report	NN	I-NP	Owe	show	we	PRP	B-NP	Oshow	that	show	VBP	B-VP	Othat	lipopolysaccharide	that	IN	B-SBAR	Olipopolysaccharide	(	lipopolysaccharide	NN	B-NP	O(	LPS	(	(	O	OLPS	)	LPS	NN	B-NP	O)	#NAME?	)	)	O	O#NAME?	activation	#NAME?	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	B	of	IN	B-PP	OB	or	B	NN	B-NP	Oor	pre-B	or	CC	O	Opre-B	cells	pre-B	JJ	B-NP	B-cell_typecells	results	cell	NNS	I-NP	I-cell_typeresults	in	result	VBZ	B-VP	Oin	loss	in	IN	B-PP	Oloss	of	loss	NN	B-NP	Oof	I	of	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	from	alpha	NN	I-NP	I-proteinfrom	NF-kappa	from	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	complexes	B	NN	I-NP	I-proteincomplexes	in	complex	NNS	I-NP	I-proteinin	vivo	in	FW	B-ADVP	Ovivo	.	vivo	FW	I-ADVP	O.	Many	.	.	O	OMany	liberated	Many	JJ	B-NP	Oliberated	NF-kappa	liberate	VBN	I-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	dimers	B	NN	I-NP	I-proteindimers	reached	dimer	NNS	I-NP	I-proteinreached	the	reach	VBD	B-VP	Othe	nucleus	the	DT	B-NP	Onucleus	","	nucleus	NN	I-NP	O","	where	","	","	O	Owhere	increased	where	WRB	B-ADVP	Oincreased	c-rel	increase	VBN	B-NP	Oc-rel	","	c-rel	NN	I-NP	B-protein","	p65	","	","	O	Op65	and	p65	NN	B-NP	B-proteinand	p50	and	CC	O	Op50	were	p50	NN	B-NP	B-proteinwere	detected	be	VBD	B-VP	Odetected	by	detect	VBN	I-VP	Oby	immunoblotting	by	IN	B-PP	Oimmunoblotting	and	immunoblotting	NN	B-NP	Oand	by	and	CC	B-PP	Oby	DNA	by	IN	B-PP	ODNA	binding	DNA	NN	B-NP	Obinding	assays	binding	NN	I-NP	Oassays	.	assay	NNS	I-NP	O.	Some	.	.	O	OSome	liberated	Some	DT	B-NP	Oliberated	dimers	liberate	VBN	I-NP	Odimers	were	dimer	NNS	I-NP	Owere	retained	be	VBD	B-VP	Oretained	in	retain	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	cytoplasm	the	DT	B-NP	Ocytoplasm	","	cytoplasm	NN	I-NP	O","	however	","	","	O	Ohowever	","	however	RB	B-ADVP	O","	through	","	","	O	Othrough	binding	through	IN	B-PP	Obinding	to	bind	VBG	B-VP	Oto	newly	to	TO	B-PP	Onewly	synthesized	newly	RB	B-NP	Osynthesized	I	synthesize	VBN	I-NP	OI	kappa	I	NN	I-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	","	alpha	NN	I-NP	I-protein","	a	","	","	O	Oa	finding	a	DT	B-NP	Ofinding	which	finding	NN	I-NP	Owhich	strongly	which	WDT	B-NP	Ostrongly	suggests	strongly	RB	B-VP	Osuggests	(	suggest	VBZ	I-VP	O(	i	(	(	O	Oi	)	i	NN	B-NP	O)	that	)	)	O	Othat	the	that	IN	B-SBAR	Othe	LPS-induced	the	DT	B-NP	OLPS-induced	signal	LPS-induced	JJ	I-NP	Osignal	causes	signal	NN	I-NP	Ocauses	dissociation	cause	VBZ	B-VP	Odissociation	of	dissociation	NN	B-NP	Oof	complexes	of	IN	B-PP	Ocomplexes	rather	complex	NNS	B-NP	Orather	than	rather	RB	B-PP	Othan	preventing	than	IN	I-PP	Opreventing	their	prevent	VBG	B-VP	Otheir	association	their	PRP$	B-NP	Oassociation	and	association	NN	I-NP	Oand	(	and	CC	O	O(	ii	(	(	B-LST	Oii	)	ii	LS	I-LST	O)	that	)	)	O	Othat	dissociation	that	IN	B-SBAR	Odissociation	results	dissociation	NN	B-NP	Oresults	from	result	VBZ	B-VP	Ofrom	modification	from	IN	B-PP	Omodification	of	modification	NN	B-NP	Oof	I	of	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	and	alpha	NN	I-NP	I-proteinand	not	and	CC	B-PP	Onot	of	not	RB	B-PP	Oof	c-rel	of	IN	I-PP	Oc-rel	or	c-rel	NN	B-NP	B-proteinor	p65	or	CC	I-NP	Op65	.	p65	NN	I-NP	B-protein.	No	.	.	O	ONo	effect	No	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	LPS	of	IN	B-PP	OLPS	treatment	LPS	NN	B-NP	Otreatment	was	treatment	NN	I-NP	Owas	detected	be	VBD	B-VP	Odetected	on	detect	VBN	I-VP	Oon	p105	on	IN	B-PP	Op105	or	p105	NN	B-NP	B-proteinor	p100	or	CC	I-NP	Op100	","	p100	NN	I-NP	B-protein","	which	","	","	O	Owhich	also	which	WDT	B-NP	Oalso	retain	also	RB	B-ADVP	Oretain	rel	retain	VBP	B-VP	Orel	family	rel	NN	B-NP	B-proteinfamily	members	family	NN	I-NP	I-proteinmembers	in	member	NNS	I-NP	I-proteinin	the	in	IN	B-PP	Othe	cytoplasm	the	DT	B-NP	Ocytoplasm	.	cytoplasm	NN	I-NP	O.	Quite	.	.	O	OQuite	unexpectedly	Quite	RB	B-ADVP	Ounexpectedly	","	unexpectedly	RB	I-ADVP	O","	we	","	","	O	Owe	also	we	PRP	B-NP	Oalso	found	also	RB	B-ADVP	Ofound	that	find	VBD	B-VP	Othat	in	that	IN	B-SBAR	Oin	unstimulated	in	IN	B-PP	Ounstimulated	cells	unstimulated	JJ	B-NP	B-cell_typecells	there	cell	NNS	I-NP	I-cell_typethere	is	there	EX	B-NP	Ois	a	be	VBZ	B-VP	Oa	constant	a	DT	B-NP	Oconstant	ongoing	constant	JJ	I-NP	Oongoing	process	ongoing	JJ	I-NP	Oprocess	of	process	NN	I-NP	Oof	degradation	of	IN	B-PP	Odegradation	and	degradation	NN	B-NP	Oand	replacement	and	CC	I-NP	Oreplacement	of	replacement	NN	I-NP	Oof	complexed	of	IN	B-PP	Ocomplexed	I	complexe	VBN	B-NP	OI	kappa	I	NN	I-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	.	alpha	NN	I-NP	I-protein.	We	.	.	O	OWe	propose	We	PRP	B-NP	Opropose	that	propose	VBP	B-VP	Othat	this	that	IN	B-SBAR	Othis	turnover	this	DT	B-NP	Oturnover	results	turnover	NN	I-NP	Oresults	in	result	VBZ	B-VP	Oin	the	in	IN	B-PP	Othe	low	the	DT	B-NP	Olow	level	low	JJ	I-NP	Olevel	of	level	NN	I-NP	Oof	active	of	IN	B-PP	Oactive	NF-kappa	active	JJ	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	presumably	B	NN	I-NP	I-proteinpresumably	necessary	presumably	RB	B-ADJP	Onecessary	even	necessary	JJ	I-ADJP	Oeven	in	even	RB	B-ADVP	Oin	the	in	IN	B-PP	Othe	unstimulated	the	DT	B-NP	Ounstimulated	cell	unstimulated	JJ	I-NP	B-cell_typecell	","	cell	NN	I-NP	I-cell_type","	and	","	","	O	Oand	that	and	CC	O	Othat	the	that	IN	B-SBAR	Othe	high	the	DT	B-NP	Ohigh	rate	high	JJ	I-NP	Orate	of	rate	NN	I-NP	Oof	synthesis	of	IN	B-PP	Osynthesis	of	synthesis	NN	B-NP	Oof	I	of	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	provides	alpha	NN	I-NP	I-proteinprovides	the	provide	VBZ	B-VP	Othe	ability	the	DT	B-NP	Oability	to	ability	NN	I-NP	Oto	turn	to	TO	B-VP	Oturn	off	turn	VB	I-VP	Ooff	NF-kappa	off	RP	B-PRT	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	activity	B	NN	I-NP	I-proteinactivity	rapidly	activity	NN	I-NP	Orapidly	as	rapidly	RB	B-ADVP	Oas	soon	as	RB	B-ADVP	Osoon	as	soon	RB	I-ADVP	Oas	the	as	IN	B-SBAR	Othe	activating	the	DT	B-NP	Oactivating	signal	activate	VBG	I-NP	Osignal	ceases	signal	NN	I-NP	B-proteinceases	.	cease	NNS	I-NP	I-protein.	Identification	.	.	O	OIdentification	of	Identification	NN	B-NP	Oof	a	of	IN	B-PP	Oa	killer	a	DT	B-NP	Okiller	cell-specific	killer	NN	I-NP	B-DNAcell-specific	regulatory	cell-specific	JJ	I-NP	I-DNAregulatory	element	regulatory	JJ	I-NP	I-DNAelement	of	element	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	mouse	the	DT	B-NP	Omouse	perforin	mouse	NN	I-NP	B-DNAperforin	gene	perforin	NN	I-NP	I-DNAgene	:	gene	NN	I-NP	I-DNA:	an	:	:	O	Oan	Ets-binding	an	DT	B-NP	OEts-binding	site-homologous	Ets-binding	JJ	I-NP	B-DNAsite-homologous	motif	site-homologous	JJ	I-NP	I-DNAmotif	that	motif	NN	I-NP	I-DNAthat	interacts	that	WDT	B-NP	Ointeracts	with	interact	VBZ	B-VP	Owith	Ets-related	with	IN	B-PP	OEts-related	proteins	Ets-related	JJ	B-NP	B-proteinproteins	.	protein	NNS	I-NP	I-protein.	The	.	.	O	OThe	gene	The	DT	B-NP	Ogene	encoding	gene	NN	I-NP	Oencoding	the	encode	VBG	B-VP	Othe	cytolytic	the	DT	B-NP	Ocytolytic	protein	cytolytic	JJ	I-NP	B-proteinprotein	perforin	protein	NN	I-NP	I-proteinperforin	is	perforin	NN	I-NP	Ois	selectively	be	VBZ	B-VP	Oselectively	expressed	selectively	RB	I-VP	Oexpressed	by	express	VBN	I-VP	Oby	activated	by	IN	B-PP	Oactivated	killer	activate	VBN	B-NP	B-cell_typekiller	lymphocytes	killer	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	To	.	.	O	OTo	understand	To	TO	B-VP	Ounderstand	the	understand	VB	I-VP	Othe	mechanisms	the	DT	B-NP	Omechanisms	underlying	mechanism	NNS	I-NP	Ounderlying	the	underlie	VBG	B-VP	Othe	cell-type-specific	the	DT	B-NP	Ocell-type-specific	expression	cell-type-specific	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	this	of	IN	B-PP	Othis	gene	this	DT	B-NP	Ogene	","	gene	NN	I-NP	O","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	characterized	have	VBP	B-VP	Ocharacterized	the	characterize	VBN	I-VP	Othe	regulatory	the	DT	B-NP	Oregulatory	functions	regulatory	JJ	I-NP	Ofunctions	and	function	NNS	I-NP	Oand	the	and	CC	O	Othe	DNA-protein	the	DT	B-NP	ODNA-protein	interactions	DNA-protein	JJ	I-NP	Ointeractions	of	interaction	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	5'-flanking	the	DT	B-NP	O5'-flanking	region	5'-flanking	JJ	I-NP	B-DNAregion	of	region	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	mouse	the	DT	B-NP	Omouse	perforin	mouse	NN	I-NP	B-DNAperforin	gene	perforin	NN	I-NP	I-DNAgene	(	gene	NN	I-NP	I-DNA(	Pfp	(	(	O	OPfp	)	Pfp	NN	B-NP	B-protein)	.	)	)	O	O.	A	.	.	O	OA	region	A	DT	B-NP	Oregion	extending	region	NN	I-NP	Oextending	from	extend	VBG	B-VP	Ofrom	residues	from	IN	B-PP	Oresidues	62	residue	NNS	B-NP	O62	through	62	CD	B-NP	Othrough	-141	through	IN	B-PP	O-141	","	-141	CD	B-NP	O","	which	","	","	O	Owhich	possesses	which	WDT	B-NP	Opossesses	the	possess	VBZ	B-VP	Othe	essential	the	DT	B-NP	Oessential	promoter	essential	JJ	I-NP	Opromoter	activity	promoter	NN	I-NP	Oactivity	","	activity	NN	I-NP	O","	and	","	","	O	Oand	regions	and	CC	O	Oregions	further	region	NNS	B-NP	Ofurther	upstream	further	RBR	B-ADVP	Oupstream	","	upstream	RB	I-ADVP	O","	which	","	","	O	Owhich	are	which	WDT	B-NP	Oare	able	be	VBP	B-VP	Oable	to	able	JJ	B-ADJP	Oto	either	to	TO	B-PP	Oeither	enhance	either	CC	O	Oenhance	or	enhance	VBP	B-VP	Oor	suppress	or	CC	I-VP	Osuppress	gene	suppress	VBP	I-VP	Ogene	expression	gene	NN	B-NP	Oexpression	","	expression	NN	I-NP	O","	were	","	","	O	Owere	identified	be	VBD	B-VP	Oidentified	.	identify	VBN	I-VP	O.	The	.	.	O	OThe	region	The	DT	B-NP	Oregion	between	region	NN	I-NP	Obetween	residues	between	IN	B-PP	Oresidues	-411	residue	NNS	B-NP	O-411	and	-411	CD	B-NP	Oand	-566	and	CC	I-NP	O-566	was	-566	CD	I-NP	Owas	chosen	be	VBD	B-VP	Ochosen	for	choose	VBN	I-VP	Ofor	further	for	IN	B-PP	Ofurther	characterization	further	JJ	B-NP	Ocharacterization	","	characterization	NN	I-NP	O","	since	","	","	O	Osince	it	since	IN	B-SBAR	Oit	contains	it	PRP	B-NP	Ocontains	an	contain	VBZ	B-VP	Oan	enhancer-like	an	DT	B-NP	Oenhancer-like	activity	enhancer-like	JJ	I-NP	Oactivity	.	activity	NN	I-NP	O.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	identified	have	VBP	B-VP	Oidentified	a	identify	VBN	I-VP	Oa	32-mer	a	DT	B-NP	O32-mer	sequence	32-mer	NN	I-NP	B-DNAsequence	(	sequence	NN	I-NP	I-DNA(	residues	(	(	O	Oresidues	-491	residue	NNS	B-NP	O-491	to	-491	CD	B-NP	Oto	-522	to	TO	B-PP	O-522	)	-522	CD	B-NP	O)	which	)	)	O	Owhich	appeared	which	WDT	B-NP	Oappeared	to	appear	VBD	B-VP	Oto	be	to	TO	I-VP	Obe	capable	be	VB	I-VP	Ocapable	of	capable	JJ	B-ADJP	Oof	enhancing	of	IN	B-PP	Oenhancing	gene	enhance	VBG	B-VP	Ogene	expression	gene	NN	B-NP	Oexpression	in	expression	NN	I-NP	Oin	a	in	IN	B-PP	Oa	killer	a	DT	B-NP	Okiller	cell-specific	killer	NN	I-NP	Ocell-specific	manner	cell-specific	JJ	I-NP	Omanner	.	manner	NN	I-NP	O.	Within	.	.	O	OWithin	this	Within	IN	B-PP	Othis	segment	this	DT	B-NP	Osegment	","	segment	NN	I-NP	O","	a	","	","	O	Oa	9-mer	a	DT	B-NP	O9-mer	motif	9-mer	NN	I-NP	B-DNAmotif	(	motif	NN	I-NP	I-DNA(	5'-ACAGGAAGT-3	(	(	O	O5'-ACAGGAAGT-3	'	5'-ACAGGAAGT-3	NN	B-NP	B-DNA'	","	'	''	O	I-DNA","	residues	","	","	O	Oresidues	-505	residue	NNS	B-NP	O-505	to	-505	CD	B-NP	Oto	-497	to	TO	B-PP	O-497	;	-497	CD	B-NP	O;	designated	;	:	O	Odesignated	NF-P	designate	VBN	B-NP	ONF-P	motif	NF-P	NN	I-NP	B-proteinmotif	)	motif	NN	I-NP	I-protein)	","	)	)	O	O","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	highly	be	VBZ	B-VP	Ohighly	homologous	highly	RB	B-ADJP	Ohomologous	to	homologous	JJ	I-ADJP	Oto	the	to	TO	B-PP	Othe	Ets	the	DT	B-NP	OEts	proto-oncoprotein-binding	Ets	NN	I-NP	B-DNAproto-oncoprotein-binding	site	proto-oncoprotein-binding	JJ	I-NP	I-DNAsite	","	site	NN	I-NP	I-DNA","	was	","	","	O	Owas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	interact	to	TO	I-VP	Ointeract	with	interact	VB	I-VP	Owith	two	with	IN	B-PP	Otwo	proteins	two	CD	B-NP	Oproteins	","	protein	NNS	I-NP	O","	NF-P1	","	","	O	ONF-P1	and	NF-P1	NN	B-NP	B-proteinand	NF-P2	and	CC	I-NP	ONF-P2	.	NF-P2	NN	I-NP	B-protein.	NF-P2	.	.	O	ONF-P2	appears	NF-P2	NN	B-NP	B-proteinappears	to	appear	VBZ	B-VP	Oto	be	to	TO	I-VP	Obe	induced	be	VB	I-VP	Oinduced	by	induce	VBN	I-VP	Oby	reagents	by	IN	B-PP	Oreagents	known	reagent	NNS	B-NP	Oknown	to	know	VBN	B-VP	Oto	up-regulate	to	TO	B-VP	Oup-regulate	the	up-regulate	VB	I-VP	Othe	perforin	the	DT	B-NP	Operforin	message	perforin	NN	I-NP	Omessage	level	message	NN	I-NP	Olevel	and	level	NN	I-NP	Oand	is	and	CC	O	Ois	present	be	VBZ	B-VP	Opresent	exclusively	present	JJ	B-ADJP	Oexclusively	in	exclusively	RB	B-ADVP	Oin	killer	in	IN	B-PP	Okiller	cells	killer	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Electrophoretic	.	.	O	OElectrophoretic	mobility	Electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assay	shift	NN	I-NP	Oassay	and	assay	NN	I-NP	Oand	UV	and	CC	O	OUV	cross-linking	UV	NN	B-NP	Ocross-linking	experiments	cross-linking	NN	I-NP	Oexperiments	revealed	experiment	NNS	I-NP	Orevealed	that	reveal	VBD	B-VP	Othat	NF-P1	that	IN	B-SBAR	ONF-P1	and	NF-P1	NN	B-NP	B-proteinand	NF-P2	and	CC	I-NP	ONF-P2	may	NF-P2	NN	I-NP	B-proteinmay	possess	may	MD	B-VP	Opossess	common	possess	VB	I-VP	Ocommon	DNA-binding	common	JJ	B-NP	ODNA-binding	subunits	DNA-binding	JJ	I-NP	B-proteinsubunits	.	subunit	NNS	I-NP	I-protein.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	the	","	","	O	Othe	larger	the	DT	B-NP	Olarger	native	large	JJR	I-NP	Onative	molecular	native	JJ	I-NP	Omolecular	mass	molecular	JJ	I-NP	Omass	of	mass	NN	I-NP	Oof	NF-P1	of	IN	B-PP	ONF-P1	suggests	NF-P1	NN	B-NP	B-proteinsuggests	that	suggest	VBZ	B-VP	Othat	NF-P1	that	IN	B-SBAR	ONF-P1	contains	NF-P1	NN	B-NP	B-proteincontains	an	contain	VBZ	B-VP	Oan	additional	an	DT	B-NP	Oadditional	non-DNA-binding	additional	JJ	I-NP	Onon-DNA-binding	subunit	non-DNA-binding	JJ	I-NP	B-proteinsubunit	(	subunit	NN	I-NP	I-protein(	s	(	(	I-NP	Os	)	s	NNS	I-NP	O)	.	)	)	O	O.	In	.	.	O	OIn	view	In	IN	B-PP	Oview	of	view	NN	B-NP	Oof	the	of	IN	B-PP	Othe	homology	the	DT	B-NP	Ohomology	between	homology	NN	I-NP	Obetween	the	between	IN	B-PP	Othe	NF-P	the	DT	B-NP	ONF-P	motif	NF-P	NN	I-NP	B-proteinmotif	and	motif	NN	I-NP	I-proteinand	other	and	CC	O	Oother	Ets	other	JJ	B-NP	OEts	proto-oncoprotein-binding	Ets	NN	I-NP	B-DNAproto-oncoprotein-binding	sites	proto-oncoprotein-binding	JJ	I-NP	I-DNAsites	","	site	NNS	I-NP	I-DNA","	it	","	","	O	Oit	is	it	PRP	B-NP	Ois	postulated	be	VBZ	B-VP	Opostulated	that	postulate	VBN	I-VP	Othat	NF-P1	that	IN	B-SBAR	ONF-P1	and	NF-P1	NN	B-NP	B-proteinand	NF-P2	and	CC	I-NP	ONF-P2	belong	NF-P2	NN	I-NP	B-proteinbelong	to	belong	VBP	B-VP	Oto	the	to	TO	B-PP	Othe	Ets	the	DT	B-NP	OEts	protein	Ets	NN	I-NP	B-proteinprotein	family	protein	NN	I-NP	I-proteinfamily	.	family	NN	I-NP	I-protein.	Results	.	.	O	OResults	obtained	Result	NNS	B-NP	Oobtained	from	obtain	VBN	B-VP	Ofrom	the	from	IN	B-PP	Othe	binding	the	DT	B-NP	Obinding	competition	bind	VBG	I-NP	Ocompetition	assay	competition	NN	I-NP	Oassay	","	assay	NN	I-NP	O","	nevertheless	","	","	O	Onevertheless	","	nevertheless	RB	B-ADVP	O","	suggest	","	","	O	Osuggest	that	suggest	VBP	B-VP	Othat	NF-P1	that	IN	B-SBAR	ONF-P1	and	NF-P1	NN	B-NP	B-proteinand	NF-P2	and	CC	I-NP	ONF-P2	are	NF-P2	NN	I-NP	B-proteinare	related	be	VBP	B-VP	Orelated	to	related	JJ	B-ADJP	Oto	but	to	TO	B-PP	Obut	distinct	but	CC	O	Odistinct	from	distinct	JJ	B-ADJP	Ofrom	Ets	from	IN	B-PP	OEts	proteins	Ets	NN	B-NP	B-proteinproteins	","	protein	NNS	I-NP	I-protein","	e.g.	","	","	O	Oe.g.	","	e.g.	FW	B-NP	O","	Ets-1	","	","	O	OEts-1	","	Ets-1	NN	B-NP	B-protein","	Ets-2	","	","	O	OEts-2	","	Ets-2	NN	B-NP	B-protein","	and	","	","	O	Oand	NF-AT/Elf-1	and	CC	O	ONF-AT/Elf-1	","	NF-AT/Elf-1	NN	B-NP	B-protein","	known	","	","	O	Oknown	to	know	VBN	B-VP	Oto	be	to	TO	I-VP	Obe	expressed	be	VB	I-VP	Oexpressed	in	express	VBN	I-VP	Oin	T	in	IN	B-PP	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	role	The	DT	B-NP	Orole	of	role	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B1	NF-kappa	NN	B-NP	B-proteinB1	(	B1	NN	I-NP	I-protein(	p50/p105	(	(	O	Op50/p105	)	p50/p105	NN	B-NP	O)	gene	)	)	O	Ogene	expression	gene	NN	B-NP	Oexpression	in	expression	NN	I-NP	Oin	activation	in	IN	B-PP	Oactivation	of	activation	NN	B-NP	Oof	human	of	IN	B-PP	Ohuman	blood	human	JJ	B-NP	B-cell_typeblood	T-lymphocytes	blood	NN	I-NP	I-cell_typeT-lymphocytes	via	T-lymphocyte	NNS	I-NP	I-cell_typevia	CD2	via	IN	B-PP	OCD2	and	CD2	NN	B-NP	B-proteinand	CD28	and	CC	I-NP	OCD28	adhesion	CD28	NN	I-NP	B-proteinadhesion	molecules	adhesion	NN	I-NP	B-proteinmolecules	.	molecule	NNS	I-NP	I-protein.	Stimulation	.	.	O	OStimulation	of	Stimulation	NN	B-NP	Oof	primary	of	IN	B-PP	Oprimary	human	primary	JJ	B-NP	B-cell_typehuman	T-lymphocytes	human	JJ	I-NP	I-cell_typeT-lymphocytes	via	T-lymphocyte	NNS	I-NP	I-cell_typevia	CD2	via	IN	B-PP	OCD2	and	CD2	NN	B-NP	B-proteinand	CD28	and	CC	I-NP	OCD28	adhesion	CD28	NN	I-NP	B-proteinadhesion	molecules	adhesion	NN	I-NP	B-proteinmolecules	induces	molecule	NNS	I-NP	I-proteininduces	a	induce	VBZ	B-VP	Oa	long-lasting	a	DT	B-NP	Olong-lasting	proliferation	long-lasting	JJ	I-NP	Oproliferation	(	proliferation	NN	I-NP	O(	>	(	(	O	O>	3	>	SYM	B-NP	O3	weeks	3	CD	B-NP	Oweeks	)	week	NNS	I-NP	O)	.	)	)	O	O.	This	.	.	O	OThis	potent	This	DT	B-NP	Opotent	activation	potent	JJ	I-NP	Oactivation	does	activation	NN	I-NP	Odoes	not	do	VBZ	B-VP	Onot	require	not	RB	I-VP	Orequire	accessory	require	VB	I-VP	Oaccessory	cells	accessory	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	such	","	","	O	Osuch	as	such	JJ	B-PP	Oas	monocytes	as	IN	I-PP	Omonocytes	","	monocyte	NNS	B-NP	B-cell_type","	but	","	","	O	Obut	depends	but	CC	O	Odepends	on	depend	VBZ	B-VP	Oon	persistent	on	IN	B-PP	Opersistent	interleukin	persistent	JJ	B-NP	Ointerleukin	2	interleukin	NN	I-NP	O2	(	2	CD	I-NP	O(	IL-2	(	(	O	OIL-2	)	IL-2	NN	B-NP	B-protein)	secretion	)	)	O	Osecretion	and	secretion	NN	B-NP	Oand	receptivity	and	CC	I-NP	Oreceptivity	","	receptivity	NN	I-NP	O","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	associated	be	VBZ	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	high	with	IN	B-PP	Ohigh	and	high	JJ	B-NP	Oand	prolonged	and	CC	I-NP	Oprolonged	expression	prolonged	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	the	of	IN	B-PP	Othe	inducible	the	DT	B-NP	Oinducible	CD25/IL-2	inducible	JJ	I-NP	B-DNACD25/IL-2	receptor	CD25/IL-2	NN	I-NP	I-DNAreceptor	alpha	receptor	NN	I-NP	I-DNAalpha	(	alpha	NN	I-NP	I-DNA(	IL-2R	(	(	O	I-DNAIL-2R	alpha	IL-2R	NN	B-NP	I-DNAalpha	)	alpha	NN	I-NP	I-DNA)	chain	)	)	O	I-DNAchain	gene	chain	NN	B-NP	I-DNAgene	.	gene	NN	I-NP	I-DNA.	The	.	.	O	OThe	transcription	The	DT	B-NP	Otranscription	factor	transcription	NN	I-NP	B-proteinfactor	NF-kappa	factor	NN	I-NP	I-proteinNF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	participates	B	NN	I-NP	I-proteinparticipates	in	participate	VBZ	B-VP	Oin	the	in	IN	B-PP	Othe	regulation	the	DT	B-NP	Oregulation	of	regulation	NN	I-NP	Oof	both	of	IN	B-PP	Oboth	IL-2	both	CC	O	OIL-2	and	IL-2	NN	B-NP	B-proteinand	IL-2R	and	CC	O	OIL-2R	alpha	IL-2R	NN	B-NP	B-DNAalpha	genes	alpha	NN	I-NP	I-DNAgenes	","	gene	NNS	I-NP	I-DNA","	as	","	","	O	Oas	well	as	RB	B-CONJP	Owell	as	well	RB	I-CONJP	Oas	multiple	as	IN	I-CONJP	Omultiple	cellular	multiple	JJ	B-NP	Ocellular	genes	cellular	JJ	I-NP	B-DNAgenes	involved	gene	NNS	I-NP	I-DNAinvolved	in	involve	VBN	B-VP	Oin	T-cell	in	IN	B-PP	OT-cell	proliferation	T-cell	NN	B-NP	Oproliferation	.	proliferation	NN	I-NP	O.	To	.	.	O	OTo	evaluate	To	TO	B-VP	Oevaluate	the	evaluate	VB	I-VP	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	in	B	NN	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	peripheral	human	JJ	B-NP	B-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	T-lymphocytes	blood	NN	I-NP	I-cell_typeT-lymphocytes	","	T-lymphocyte	NNS	I-NP	I-cell_type","	we	","	","	O	Owe	previously	we	PRP	B-NP	Opreviously	analyzed	previously	RB	B-ADVP	Oanalyzed	the	analyze	VBD	B-VP	Othe	activation	the	DT	B-NP	Oactivation	of	activation	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B-related	NF-kappa	NN	B-NP	B-proteinB-related	complexes	B-related	JJ	I-NP	I-proteincomplexes	in	complex	NNS	I-NP	I-proteinin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	CD2+CD28	to	TO	B-PP	OCD2+CD28	costimulation	CD2+CD28	NN	B-NP	B-proteincostimulation	.	costimulation	NN	I-NP	O.	We	.	.	O	OWe	demonstrated	We	PRP	B-NP	Odemonstrated	a	demonstrate	VBD	B-VP	Oa	long-term	a	DT	B-NP	Olong-term	induction	long-term	JJ	I-NP	Oinduction	of	induction	NN	I-NP	Oof	p50/p65	of	IN	B-PP	Op50/p65	heterodimer	p50/p65	NN	B-NP	B-proteinheterodimer	","	heterodimer	NN	I-NP	I-protein","	a	","	","	O	Oa	putative	a	DT	B-NP	Oputative	p65/c-Rel	putative	JJ	I-NP	Op65/c-Rel	heterodimer	p65/c-Rel	NN	I-NP	B-proteinheterodimer	","	heterodimer	NN	I-NP	I-protein","	and	","	","	O	Oand	a	and	CC	O	Oa	constitutive	a	DT	B-NP	Oconstitutive	nuclear	constitutive	JJ	I-NP	Onuclear	expression	nuclear	JJ	I-NP	Oexpression	of	expression	NN	I-NP	Oof	KBF1/p50	of	IN	B-PP	OKBF1/p50	homodimers	KBF1/p50	NN	B-NP	B-proteinhomodimers	.	homodimer	NNS	I-NP	I-protein.	As	.	.	O	OAs	the	As	IN	B-SBAR	Othe	role	the	DT	B-NP	Orole	of	role	NN	I-NP	Oof	p50	of	IN	B-PP	Op50	remains	p50	NN	B-NP	B-proteinremains	unclear	remain	VBZ	B-VP	Ounclear	","	unclear	JJ	B-ADJP	O","	we	","	","	O	Owe	focused	we	PRP	B-NP	Ofocused	our	focus	VBD	B-VP	Oour	present	our	PRP$	B-NP	Opresent	study	present	JJ	I-NP	Ostudy	on	study	NN	I-NP	Oon	NF-kappa	on	IN	B-PP	ONF-kappa	B1	NF-kappa	NN	B-NP	B-DNAB1	(	B1	NN	I-NP	I-DNA(	p50/p105	(	(	O	I-DNAp50/p105	)	p50/p105	NN	B-NP	I-DNA)	gene	)	)	O	I-DNAgene	regulation	gene	NN	B-NP	I-DNAregulation	.	regulation	NN	I-NP	O.	Using	.	.	O	OUsing	electrophoretic	Use	VBG	B-VP	Oelectrophoretic	mobility	electrophoretic	JJ	B-NP	Omobility	shift	mobility	NN	I-NP	Oshift	assays	shift	NN	I-NP	Oassays	and	assay	NNS	I-NP	Oand	Western	and	CC	O	OWestern	and	Western	JJ	B-NP	Oand	Northern	and	CC	I-NP	ONorthern	blot	Northern	JJ	I-NP	Oblot	analyses	blot	NN	I-NP	Oanalyses	","	analysis	NNS	I-NP	O","	we	","	","	O	Owe	studied	we	PRP	B-NP	Ostudied	NF-kappa	study	VBD	B-VP	ONF-kappa	B1	NF-kappa	NN	B-NP	B-proteinB1	gene	B1	NN	I-NP	I-proteingene	expression	gene	NN	I-NP	Oexpression	during	expression	NN	I-NP	Oduring	T-cell	during	IN	B-PP	OT-cell	stimulation	T-cell	NN	B-NP	Ostimulation	via	stimulation	NN	I-NP	Ovia	CD2+CD28	via	IN	B-PP	OCD2+CD28	.	CD2+CD28	NN	B-NP	B-protein.	We	.	.	O	OWe	observed	We	PRP	B-NP	Oobserved	a	observe	VBD	B-VP	Oa	transient	a	DT	B-NP	Otransient	4-	transient	JJ	I-NP	O4-	to	4-	NN	I-NP	Oto	5-fold	to	TO	B-PP	O5-fold	increase	5-fold	JJ	B-NP	Oincrease	of	increase	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B1	NF-kappa	NN	B-NP	B-proteinB1	gene	B1	NN	I-NP	I-proteingene	expression	gene	NN	I-NP	Oexpression	at	expression	NN	I-NP	Oat	both	at	IN	B-PP	Oboth	the	both	CC	O	Othe	mRNA	the	DT	B-NP	OmRNA	and	mRNA	NN	I-NP	B-RNAand	protein	and	CC	I-NP	Oprotein	levels	protein	NN	I-NP	Olevels	","	level	NNS	I-NP	O","	lasting	","	","	O	Olasting	for	last	VBG	B-VP	Ofor	at	for	IN	B-PP	Oat	least	at	IN	B-NP	Oleast	24	least	JJS	I-NP	O24	h	24	CD	I-NP	Oh	.	h	NN	I-NP	O.	p50	.	.	O	Op50	DNA-binding	p50	NN	B-NP	B-proteinDNA-binding	activity	DNA-binding	JJ	I-NP	Oactivity	apparently	activity	NN	I-NP	Oapparently	stays	apparently	RB	B-ADVP	Ostays	highly	stay	VBZ	B-VP	Ohighly	controlled	highly	RB	I-VP	Ocontrolled	when	control	VBN	I-VP	Owhen	p105	when	WRB	B-ADVP	Op105	expression	p105	NN	B-NP	B-proteinexpression	is	expression	NN	I-NP	Ois	enhanced	be	VBZ	B-VP	Oenhanced	by	enhance	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	physiological	a	DT	B-NP	Ophysiological	stimulus	physiological	JJ	I-NP	Ostimulus	of	stimulus	NN	I-NP	Oof	peripheral	of	IN	B-PP	Operipheral	blood	peripheral	JJ	B-NP	B-cell_typeblood	T-cells	blood	NN	I-NP	I-cell_typeT-cells	.	T-cell	NNS	I-NP	I-cell_type.	Partial	.	.	O	OPartial	inhibition	Partial	JJ	B-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	p50	of	IN	B-PP	Op50	and	p50	NN	B-NP	B-proteinand	p105	and	CC	O	Op105	expression	p105	NN	B-NP	B-proteinexpression	by	expression	NN	I-NP	Oby	NF-kappa	by	IN	B-PP	ONF-kappa	B1	NF-kappa	NN	B-NP	B-proteinB1	antisense	B1	NN	I-NP	I-proteinantisense	oligonucleotides	antisense	JJ	I-NP	Ooligonucleotides	significantly	oligonucleotide	NNS	I-NP	Osignificantly	reduced	significantly	RB	B-ADVP	Oreduced	T-cell	reduce	VBD	B-VP	OT-cell	proliferation	T-cell	NN	B-NP	Oproliferation	and	proliferation	NN	I-NP	Oand	CD25/IL-2R	and	CC	O	OCD25/IL-2R	alpha	CD25/IL-2R	NN	B-NP	Oalpha	cell	alpha	NN	I-NP	Ocell	surface	cell	NN	I-NP	Osurface	expression	surface	NN	I-NP	Oexpression	.	expression	NN	I-NP	O.	(	.	.	O	O(	ABSTRACT	(	(	O	OABSTRACT	TRUNCATED	ABSTRACT	NN	B-NP	OTRUNCATED	AT	TRUNCATED	VBN	B-VP	OAT	250	AT	IN	B-PP	O250	WORDS	250	CD	B-NP	OWORDS	)	WORDS	NNS	I-NP	O)	Vitamin	)	)	O	OVitamin	D	Vitamin	NN	B-NP	B-proteinD	receptor	D	NN	I-NP	I-proteinreceptor	quantitation	receptor	NN	I-NP	I-proteinquantitation	in	quantitation	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	blood	human	JJ	B-NP	B-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	in	cell	NNS	I-NP	I-cell_typein	health	in	IN	B-PP	Ohealth	and	health	NN	B-NP	Oand	disease	and	CC	I-NP	Odisease	.	disease	NN	I-NP	O.	Vitamin	.	.	O	OVitamin	D	Vitamin	NN	B-NP	B-proteinD	receptor	D	NN	I-NP	I-proteinreceptor	(	receptor	NN	I-NP	I-protein(	VDR	(	(	O	OVDR	)	VDR	NN	B-NP	B-protein)	concentration	)	)	O	Oconcentration	was	concentration	NN	B-NP	Owas	quantitated	be	VBD	B-VP	Oquantitated	in	quantitate	VBN	I-VP	Oin	human	in	IN	B-PP	Ohuman	peripheral	human	JJ	B-NP	B-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	mononuclear	blood	NN	I-NP	I-cell_typemononuclear	cells	mononuclear	JJ	I-NP	I-cell_typecells	(	cell	NNS	I-NP	I-cell_type(	PBMC	(	(	O	OPBMC	)	PBMC	NN	B-NP	B-cell_type)	from	)	)	O	Ofrom	patients	from	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	absorptive	with	IN	B-PP	Oabsorptive	hypercalciuria	absorptive	JJ	B-NP	Ohypercalciuria	(	hypercalciuria	NN	I-NP	O(	AH	(	(	O	OAH	)	AH	NN	B-NP	O)	and	)	)	O	Oand	patients	and	CC	O	Opatients	with	patient	NNS	B-NP	Owith	high	with	IN	B-PP	Ohigh	1	high	JJ	B-NP	O1	","	1	CD	I-NP	O","	25	","	","	I-NP	O25	(	25	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	due	2D3	NN	B-NP	Odue	to	due	JJ	B-ADJP	Oto	acquired	to	TO	B-PP	Oacquired	or	acquire	VBN	B-NP	Oor	transient	or	CC	I-NP	Otransient	disease	transient	JJ	I-NP	Odisease	states	disease	NN	I-NP	Ostates	and	state	NNS	I-NP	Oand	the	and	CC	O	Othe	results	the	DT	B-NP	Oresults	compared	result	NNS	I-NP	Ocompared	to	compare	VBN	B-VP	Oto	those	to	TO	B-PP	Othose	in	those	DT	B-NP	Oin	normal	in	IN	B-PP	Onormal	subjects	normal	JJ	B-NP	Osubjects	.	subject	NNS	I-NP	O.	VDR	.	.	O	OVDR	concentration	VDR	NN	B-NP	B-proteinconcentration	in	concentration	NN	I-NP	Oin	resting	in	IN	B-PP	Oresting	cells	rest	VBG	B-NP	B-cell_typecells	was	cell	NNS	I-NP	I-cell_typewas	not	be	VBD	B-VP	Onot	different	not	RB	O	Odifferent	between	different	JJ	B-ADJP	Obetween	the	between	IN	B-PP	Othe	three	the	DT	B-NP	Othree	groups	three	CD	I-NP	Ogroups	and	group	NNS	I-NP	Oand	represented	and	CC	O	Orepresented	constitutive	represent	VBN	B-NP	Oconstitutive	receptor	constitutive	JJ	I-NP	Oreceptor	expression	receptor	NN	I-NP	Oexpression	of	expression	NN	I-NP	Oof	monocytes	of	IN	B-PP	Omonocytes	.	monocyte	NNS	B-NP	B-cell_type.	Following	.	.	O	OFollowing	activation	Follow	VBG	B-PP	Oactivation	with	activation	NN	B-NP	Owith	phytohemagglutinin	with	IN	B-PP	Ophytohemagglutinin	","	phytohemagglutinin	NN	B-NP	B-protein","	patients	","	","	O	Opatients	with	patient	NNS	B-NP	Owith	hypercalcitriolemia	with	IN	B-PP	Ohypercalcitriolemia	demonstrated	hypercalcitriolemia	NN	B-NP	Odemonstrated	significantly	demonstrate	VBD	B-VP	Osignificantly	greater	significantly	RB	B-NP	Ogreater	VDR	great	JJR	I-NP	OVDR	concentrations	VDR	NN	I-NP	B-proteinconcentrations	.	concentration	NNS	I-NP	O.	Patients	.	.	O	OPatients	with	Patient	NNS	B-NP	Owith	AH	with	IN	B-PP	OAH	demonstrated	AH	NN	B-NP	Odemonstrated	a	demonstrate	VBD	B-VP	Oa	normal	a	DT	B-NP	Onormal	value	normal	JJ	I-NP	Ovalue	for	value	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	group	the	DT	B-NP	Ogroup	","	group	NN	I-NP	O","	but	","	","	O	Obut	6	but	CC	O	O6	patients	6	CD	B-NP	Opatients	had	patient	NNS	I-NP	Ohad	significantly	have	VBD	B-VP	Osignificantly	greater	significantly	RB	B-NP	Ogreater	concentrations	great	JJR	I-NP	Oconcentrations	of	concentration	NNS	I-NP	Oof	VDR	of	IN	B-PP	OVDR	despite	VDR	NN	B-NP	B-proteindespite	normal	despite	IN	B-PP	Onormal	plasma	normal	JJ	B-NP	Oplasma	1	plasma	NN	I-NP	O1	","	1	CD	I-NP	O","	25	","	","	I-NP	O25	(	25	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	in	2D3	NN	B-NP	Oin	four	in	IN	B-PP	Ofour	of	four	CD	B-NP	Oof	the	of	IN	B-PP	Othe	patients	the	DT	B-NP	Opatients	.	patient	NNS	I-NP	O.	Proliferation	.	.	O	OProliferation	","	Proliferation	NN	B-NP	O","	as	","	","	O	Oas	assessed	as	IN	B-SBAR	Oassessed	from	assess	VBN	B-VP	Ofrom	[	from	IN	B-PP	O[	3H	[	(	B-NP	O3H	]	3H	NN	I-NP	O]	thymidine	]	)	I-NP	Othymidine	incorporation	thymidine	NN	I-NP	Oincorporation	was	incorporation	NN	I-NP	Owas	inversely	be	VBD	B-VP	Oinversely	correlated	inversely	RB	I-VP	Ocorrelated	with	correlate	VBN	I-VP	Owith	serum	with	IN	B-PP	Oserum	1	serum	NN	B-NP	O1	","	1	CD	I-NP	O","	25	","	","	I-NP	O25	(	25	CD	I-NP	O(	OH	(	(	O	OOH	)	OH	NN	B-NP	O)	2D3	)	)	O	O2D3	and	2D3	NN	B-NP	Oand	was	and	CC	O	Owas	significant	be	VBD	B-VP	Osignificant	(	significant	JJ	B-ADJP	O(	R	(	(	O	OR	=	R	NN	B-NP	O=	-0.299	=	SYM	B-VP	O-0.299	","	-0.299	CD	B-NP	O","	p	","	","	O	Op	=	p	NN	B-NP	O=	0.048	=	SYM	B-VP	O0.048	)	0.048	CD	B-NP	O)	.	)	)	O	O.	Taken	.	.	O	OTaken	together	Take	VBN	B-VP	Otogether	","	together	RB	B-ADVP	O","	the	","	","	O	Othe	results	the	DT	B-NP	Oresults	suggest	result	NNS	I-NP	Osuggest	that	suggest	VBP	B-VP	Othat	PBMC	that	IN	B-SBAR	OPBMC	provide	PBMC	NN	B-NP	B-cell_typeprovide	a	provide	VBP	B-VP	Oa	useful	a	DT	B-NP	Ouseful	system	useful	JJ	I-NP	Osystem	for	system	NN	I-NP	Ofor	studying	for	IN	B-PP	Ostudying	VDR	study	VBG	B-VP	OVDR	status	VDR	NN	B-NP	B-proteinstatus	in	status	NN	I-NP	Oin	transient	in	IN	B-PP	Otransient	or	transient	JJ	B-NP	Oor	acquired	or	CC	I-NP	Oacquired	states	acquire	VBN	I-NP	Ostates	of	state	NNS	I-NP	Oof	hypercalcitriolemia	of	IN	B-PP	Ohypercalcitriolemia	.	hypercalcitriolemia	NN	B-NP	O.	Furthermore	.	.	O	OFurthermore	","	Furthermore	RB	B-ADVP	O","	the	","	","	O	Othe	studies	the	DT	B-NP	Ostudies	in	study	NNS	I-NP	Oin	patients	in	IN	B-PP	Opatients	with	patient	NNS	B-NP	Owith	absorptive	with	IN	B-PP	Oabsorptive	hypercalciuria	absorptive	JJ	B-NP	Ohypercalciuria	disclosed	hypercalciuria	NN	I-NP	Odisclosed	it	disclose	VBD	B-VP	Oit	to	it	PRP	B-NP	Oto	be	to	TO	B-VP	Obe	a	be	VB	I-VP	Oa	heterogeneous	a	DT	B-NP	Oheterogeneous	disorder	heterogeneous	JJ	I-NP	Odisorder	","	disorder	NN	I-NP	O","	characterized	","	","	O	Ocharacterized	by	characterize	VBN	B-VP	Oby	both	by	IN	B-PP	Oboth	vitamin	both	CC	O	Ovitamin	D-dependent	vitamin	NN	B-NP	OD-dependent	and	D-dependent	JJ	I-NP	Oand	D-independent	and	CC	I-NP	OD-independent	forms	D-independent	JJ	I-NP	Oforms	of	form	NNS	I-NP	Oof	receptor	of	IN	B-PP	Oreceptor	up-regulation	receptor	NN	B-NP	Oup-regulation	.	up-regulation	NN	I-NP	O.	Reactive	.	.	O	OReactive	oxygen	Reactive	JJ	B-NP	Ooxygen	intermediates	oxygen	NN	I-NP	Ointermediates	activate	intermediate	NNS	I-NP	Oactivate	NF-kappa	activate	VBP	B-VP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	in	B	NN	I-NP	I-proteinin	a	in	IN	B-PP	Oa	tyrosine	a	DT	B-NP	Otyrosine	kinase-dependent	tyrosine	NN	I-NP	Okinase-dependent	mechanism	kinase-dependent	JJ	I-NP	Omechanism	and	mechanism	NN	I-NP	Oand	in	and	CC	B-PP	Oin	combination	in	IN	B-PP	Ocombination	with	combination	NN	B-NP	Owith	vanadate	with	IN	B-PP	Ovanadate	activate	vanadate	NN	B-NP	Oactivate	the	activate	VBP	B-VP	Othe	p56lck	the	DT	B-NP	Op56lck	and	p56lck	NN	I-NP	B-proteinand	p59fyn	and	CC	I-NP	Op59fyn	tyrosine	p59fyn	NN	I-NP	B-proteintyrosine	kinases	tyrosine	NN	I-NP	I-proteinkinases	in	kinase	NNS	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	lymphocytes	human	JJ	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	previously	have	VBP	B-VP	Opreviously	observed	previously	RB	I-VP	Oobserved	that	observe	VBN	I-VP	Othat	ionizing	that	IN	B-SBAR	Oionizing	radiation	ionize	VBG	B-VP	Oradiation	induces	radiation	NN	B-NP	Oinduces	tyrosine	induce	VBZ	B-VP	Otyrosine	phosphorylation	tyrosine	NN	B-NP	Ophosphorylation	in	phosphorylation	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	B-lymphocyte	human	JJ	B-NP	B-cell_typeB-lymphocyte	precursors	B-lymphocyte	NN	I-NP	I-cell_typeprecursors	by	precursor	NNS	I-NP	I-cell_typeby	stimulation	by	IN	B-PP	Ostimulation	of	stimulation	NN	B-NP	Oof	unidentified	of	IN	B-PP	Ounidentified	tyrosine	unidentified	JJ	B-NP	B-proteintyrosine	kinases	tyrosine	NN	I-NP	I-proteinkinases	and	kinase	NNS	I-NP	I-proteinand	this	and	CC	O	Othis	phosphorylation	this	DT	B-NP	Ophosphorylation	is	phosphorylation	NN	I-NP	Ois	substantially	be	VBZ	B-VP	Osubstantially	augmented	substantially	RB	I-VP	Oaugmented	by	augment	VBN	I-VP	Oby	vanadate	by	IN	B-PP	Ovanadate	.	vanadate	NN	B-NP	O.	Ionizing	.	.	O	OIonizing	radiation	Ionize	VBG	B-VP	Oradiation	generates	radiation	NN	B-NP	Ogenerates	reactive	generate	VBZ	B-VP	Oreactive	oxygen	reactive	JJ	B-NP	Ooxygen	intermediates	oxygen	NN	I-NP	Ointermediates	(	intermediate	NNS	I-NP	O(	ROI	(	(	O	OROI	)	ROI	NN	B-NP	O)	.	)	)	O	O.	Because	.	.	O	OBecause	H2O2	Because	IN	B-SBAR	OH2O2	is	H2O2	NN	B-NP	Ois	a	be	VBZ	B-VP	Oa	potent	a	DT	B-NP	Opotent	ROI	potent	JJ	I-NP	OROI	generator	ROI	NN	I-NP	Ogenerator	that	generator	NN	I-NP	Othat	readily	that	WDT	B-NP	Oreadily	crosses	readily	RB	B-ADVP	Ocrosses	the	cross	VBZ	B-VP	Othe	plasma	the	DT	B-NP	Oplasma	membrane	plasma	NN	I-NP	Omembrane	","	membrane	NN	I-NP	O","	we	","	","	O	Owe	used	we	PRP	B-NP	Oused	H2O2	use	VBD	B-VP	OH2O2	to	H2O2	NN	B-NP	Oto	examine	to	TO	B-VP	Oexamine	the	examine	VB	I-VP	Othe	effects	the	DT	B-NP	Oeffects	of	effect	NNS	I-NP	Oof	ROI	of	IN	B-PP	OROI	on	ROI	NN	B-NP	Oon	signal	on	IN	B-PP	Osignal	transduction	signal	NN	B-NP	Otransduction	.	transduction	NN	I-NP	O.	We	.	.	O	OWe	now	We	PRP	B-NP	Onow	provide	now	RB	B-ADVP	Oprovide	evidence	provide	VBP	B-VP	Oevidence	that	evidence	NN	B-NP	Othat	the	that	IN	B-SBAR	Othe	tyrosine	the	DT	B-NP	Otyrosine	kinase	tyrosine	NN	I-NP	B-proteinkinase	inhibitor	kinase	NN	I-NP	I-proteininhibitor	herbimycin	inhibitor	NN	I-NP	Oherbimycin	A	herbimycin	NN	I-NP	OA	and	A	NN	I-NP	Oand	the	and	CC	O	Othe	free	the	DT	B-NP	Ofree	radical	free	JJ	I-NP	Oradical	scavenger	radical	NN	I-NP	Oscavenger	N-acetyl-cysteine	scavenger	NN	I-NP	ON-acetyl-cysteine	inhibit	N-acetyl-cysteine	NN	I-NP	Oinhibit	both	inhibit	VBP	B-VP	Oboth	radiation-induced	both	CC	O	Oradiation-induced	and	radiation-induced	JJ	B-NP	Oand	H2O2-induced	and	CC	I-NP	OH2O2-induced	activation	H2O2-induced	JJ	I-NP	Oactivation	of	activation	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	","	B	NN	I-NP	I-protein","	indicating	","	","	O	Oindicating	that	indicate	VBG	B-VP	Othat	activation	that	IN	B-SBAR	Oactivation	triggered	activation	NN	B-NP	Otriggered	by	trigger	VBN	B-VP	Oby	ROI	by	IN	B-PP	OROI	is	ROI	NN	B-NP	Ois	dependent	be	VBZ	B-VP	Odependent	on	dependent	JJ	B-ADJP	Oon	tyrosine	on	IN	B-PP	Otyrosine	kinase	tyrosine	NN	B-NP	B-proteinkinase	activity	kinase	NN	I-NP	I-proteinactivity	.	activity	NN	I-NP	O.	H2O2	.	.	O	OH2O2	was	H2O2	NN	B-NP	Owas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	stimulate	to	TO	I-VP	Ostimulate	Ins-1	stimulate	VB	I-VP	OIns-1	","	Ins-1	NN	B-NP	B-protein","	4	","	","	O	O4	","	4	CD	B-NP	O","	5-P3	","	","	O	O5-P3	production	5-P3	NN	B-NP	Oproduction	in	production	NN	I-NP	Oin	a	in	IN	B-PP	Oa	tyrosine	a	DT	B-NP	Otyrosine	kinase-dependent	tyrosine	NN	I-NP	Okinase-dependent	manner	kinase-dependent	JJ	I-NP	Omanner	and	manner	NN	I-NP	Oand	to	and	CC	O	Oto	induce	to	TO	B-VP	Oinduce	calcium	induce	VB	I-VP	Ocalcium	signals	calcium	NN	B-NP	Osignals	that	signal	NNS	I-NP	Othat	were	that	WDT	B-NP	Owere	greatly	be	VBD	B-VP	Ogreatly	augmented	greatly	RB	I-VP	Oaugmented	by	augment	VBN	I-VP	Oby	vanadate	by	IN	B-PP	Ovanadate	.	vanadate	NN	B-NP	O.	The	.	.	O	OThe	synergistic	The	DT	B-NP	Osynergistic	induction	synergistic	JJ	I-NP	Oinduction	of	induction	NN	I-NP	Oof	tyrosine	of	IN	B-PP	Otyrosine	phosphorylation	tyrosine	NN	B-NP	Ophosphorylation	by	phosphorylation	NN	I-NP	Oby	H2O2	by	IN	B-PP	OH2O2	plus	H2O2	NN	B-NP	Oplus	vanadate	plus	CC	I-NP	Ovanadate	included	vanadate	NN	I-NP	B-proteinincluded	physiologically	include	VBD	B-VP	I-proteinphysiologically	relevant	physiologically	RB	B-NP	I-proteinrelevant	proteins	relevant	JJ	I-NP	I-proteinproteins	such	protein	NNS	I-NP	I-proteinsuch	as	such	JJ	B-PP	Oas	PLC	as	IN	I-PP	OPLC	gamma	PLC	NN	B-NP	B-proteingamma	1	gamma	NN	I-NP	I-protein1	.	1	CD	I-NP	I-protein.	Although	.	.	O	OAlthough	treatment	Although	IN	B-SBAR	Otreatment	of	treatment	NN	B-NP	Oof	cells	of	IN	B-PP	Ocells	with	cell	NNS	B-NP	Owith	H2O2	with	IN	B-PP	OH2O2	alone	H2O2	NN	B-NP	Oalone	did	alone	RB	B-ADVP	Odid	not	do	VBD	B-VP	Onot	affect	not	RB	I-VP	Oaffect	the	affect	VB	I-VP	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	src	of	IN	B-PP	Osrc	family	src	NN	B-NP	B-proteinfamily	kinases	family	NN	I-NP	I-proteinkinases	","	kinase	NNS	I-NP	I-protein","	treatment	","	","	O	Otreatment	with	treatment	NN	B-NP	Owith	H2O2	with	IN	B-PP	OH2O2	plus	H2O2	NN	B-NP	Oplus	vanadate	plus	CC	I-NP	Ovanadate	led	vanadate	NN	I-NP	Oled	to	lead	VBD	B-VP	Oto	activation	to	TO	B-PP	Oactivation	of	activation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	p56lck	the	DT	B-NP	Op56lck	and	p56lck	NN	I-NP	B-proteinand	p59fyn	and	CC	I-NP	Op59fyn	tyrosine	p59fyn	NN	I-NP	B-proteintyrosine	kinases	tyrosine	NN	I-NP	I-proteinkinases	.	kinase	NNS	I-NP	I-protein.	The	.	.	O	OThe	combined	The	DT	B-NP	Ocombined	inhibition	combined	JJ	I-NP	Oinhibition	of	inhibition	NN	I-NP	Oof	phosphatases	of	IN	B-PP	Ophosphatases	and	phosphatas	NNS	B-NP	B-proteinand	activation	and	CC	O	Oactivation	of	activation	NN	B-NP	Oof	kinases	of	IN	B-PP	Okinases	provides	kinase	NNS	B-NP	B-proteinprovides	a	provide	VBZ	B-VP	Oa	potent	a	DT	B-NP	Opotent	mechanism	potent	JJ	I-NP	Omechanism	for	mechanism	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	synergistic	the	DT	B-NP	Osynergistic	effects	synergistic	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	H2O2	of	IN	B-PP	OH2O2	plus	H2O2	NN	B-NP	Oplus	vanadate	plus	CC	I-NP	Ovanadate	.	vanadate	NN	I-NP	O.	Induction	.	.	O	OInduction	of	Induction	NN	B-NP	Oof	tyrosine	of	IN	B-PP	Otyrosine	phosphorylation	tyrosine	NN	B-NP	Ophosphorylation	by	phosphorylation	NN	I-NP	Oby	ROI	by	IN	B-PP	OROI	may	ROI	NN	B-NP	Omay	thus	may	MD	B-VP	Othus	lead	thus	RB	I-VP	Olead	to	lead	VB	I-VP	Oto	many	to	TO	B-PP	Omany	of	many	JJ	B-NP	Oof	the	of	IN	B-PP	Othe	pleiotropic	the	DT	B-NP	Opleiotropic	effects	pleiotropic	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	ROI	of	IN	B-PP	OROI	in	ROI	NN	B-NP	Oin	lymphoid	in	IN	B-PP	Olymphoid	cells	lymphoid	JJ	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	including	","	","	O	Oincluding	downstream	include	VBG	B-PP	Odownstream	activation	downstream	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	PLC	of	IN	B-PP	OPLC	gamma	PLC	NN	B-NP	B-proteingamma	1	gamma	NN	I-NP	I-protein1	and	1	CD	I-NP	I-proteinand	NF-kappa	and	CC	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	Influence	B	NN	I-NP	I-proteinInfluence	of	Influence	NN	B-NP	Oof	sex	of	IN	B-PP	Osex	hormone	sex	NN	B-NP	B-proteinhormone	binding	hormone	NN	I-NP	I-proteinbinding	globulin	binding	NN	I-NP	I-proteinglobulin	and	globulin	NN	I-NP	I-proteinand	serum	and	CC	I-NP	Oserum	albumin	serum	NN	I-NP	B-proteinalbumin	on	albumin	NN	I-NP	I-proteinon	the	on	IN	B-PP	Othe	conversion	the	DT	B-NP	Oconversion	of	conversion	NN	I-NP	Oof	androstenedione	of	IN	B-PP	Oandrostenedione	to	androstenedione	NN	B-NP	Oto	testosterone	to	TO	B-PP	Otestosterone	by	testosterone	NN	B-NP	Oby	human	by	IN	B-PP	Ohuman	erythrocytes	human	JJ	B-NP	B-cell_typeerythrocytes	.	erythrocyte	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	influence	The	DT	B-NP	Oinfluence	of	influence	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	serum	human	JJ	B-NP	B-proteinserum	albumin	serum	NN	I-NP	I-proteinalbumin	and	albumin	NN	I-NP	I-proteinand	sex	and	CC	O	Osex	hormone	sex	NN	B-NP	B-proteinhormone	binding	hormone	NN	I-NP	I-proteinbinding	globulin	binding	NN	I-NP	I-proteinglobulin	(	globulin	NN	I-NP	I-protein(	SHBG	(	(	O	OSHBG	)	SHBG	NN	B-NP	B-protein)	on	)	)	O	Oon	the	on	IN	B-PP	Othe	enzymic	the	DT	B-NP	Oenzymic	conversion	enzymic	JJ	I-NP	Oconversion	of	conversion	NN	I-NP	Oof	androstenedione	of	IN	B-PP	Oandrostenedione	to	androstenedione	NN	B-NP	Oto	testosterone	to	TO	B-PP	Otestosterone	in	testosterone	NN	B-NP	Oin	human	in	IN	B-PP	Ohuman	erythrocytes	human	JJ	B-NP	B-cell_typeerythrocytes	was	erythrocyte	NNS	I-NP	I-cell_typewas	investigated	be	VBD	B-VP	Oinvestigated	in	investigate	VBN	I-VP	Oin	vitro	in	FW	B-ADVP	Ovitro	.	vitro	FW	I-ADVP	O.	Total	.	.	O	OTotal	plasma	Total	JJ	B-NP	Oplasma	and	plasma	NN	I-NP	Oand	albumin	and	CC	I-NP	Oalbumin	delayed	albumin	NN	I-NP	Odelayed	the	delay	VBD	B-VP	Othe	conversion	the	DT	B-NP	Oconversion	rate	conversion	NN	I-NP	Orate	of	rate	NN	I-NP	Oof	androstenedione	of	IN	B-PP	Oandrostenedione	","	androstenedione	NN	B-NP	O","	while	","	","	O	Owhile	SHBG	while	IN	B-SBAR	OSHBG	increased	SHBG	NN	B-NP	B-proteinincreased	it	increase	VBD	B-VP	Oit	markedly	it	PRP	B-NP	Omarkedly	.	markedly	RB	B-ADVP	O.	The	.	.	O	OThe	effect	The	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	SHBG	of	IN	B-PP	OSHBG	was	SHBG	NN	B-NP	B-proteinwas	largely	be	VBD	B-VP	Olargely	abolished	largely	RB	I-VP	Oabolished	by	abolish	VBN	I-VP	Oby	heating	by	IN	B-PP	Oheating	to	heat	VBG	B-VP	Oto	60	to	TO	B-PP	O60	degrees	60	CD	B-NP	Odegrees	C	degree	NNS	I-NP	OC	for	C	JJ	B-ADJP	Ofor	1	for	IN	B-PP	O1	h	1	CD	B-NP	Oh	and	h	NN	I-NP	Oand	by	and	CC	B-PP	Oby	saturating	by	IN	B-PP	Osaturating	its	saturate	VBG	B-VP	Oits	binding	its	PRP$	B-NP	Obinding	sites	bind	VBG	I-NP	Osites	by	site	NNS	I-NP	Oby	DHT	by	IN	B-PP	ODHT	.	DHT	NN	B-NP	O.	The	.	.	O	OThe	effect	The	DT	B-NP	Oeffect	of	effect	NN	I-NP	Oof	both	of	IN	B-PP	Oboth	proteins	both	DT	B-NP	Oproteins	was	protein	NNS	I-NP	Owas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	related	be	VB	I-VP	Orelated	to	relate	VBN	I-VP	Oto	their	to	TO	B-PP	Otheir	concentration	their	PRP$	B-NP	Oconcentration	.	concentration	NN	I-NP	O.	It	.	.	O	OIt	appears	It	PRP	B-NP	Oappears	that	appear	VBZ	B-VP	Othat	the	that	IN	B-SBAR	Othe	binding	the	DT	B-NP	Obinding	sites	bind	VBG	I-NP	B-DNAsites	of	site	NNS	I-NP	I-DNAof	albumin	of	IN	B-PP	Oalbumin	provide	albumin	NN	B-NP	B-proteinprovide	a	provide	VBP	B-VP	Oa	mechanism	a	DT	B-NP	Omechanism	for	mechanism	NN	I-NP	Ofor	retarding	for	IN	B-PP	Oretarding	androstenedione	retard	VBG	B-VP	Oandrostenedione	uptake	androstenedione	NN	B-NP	Ouptake	by	uptake	NN	I-NP	Oby	the	by	IN	B-PP	Othe	erythrocytes	the	DT	B-NP	Oerythrocytes	and	erythrocyte	NNS	I-NP	B-cell_typeand	that	and	CC	O	Othat	the	that	IN	B-SBAR	Othe	high	the	DT	B-NP	Ohigh	binding	high	JJ	I-NP	Obinding	affinity	binding	NN	I-NP	Oaffinity	of	affinity	NN	I-NP	Oof	SHBG	of	IN	B-PP	OSHBG	for	SHBG	NN	B-NP	B-proteinfor	testosterone	for	IN	B-PP	Otestosterone	facilitates	testosterone	NN	B-NP	Ofacilitates	the	facilitate	VBZ	B-VP	Othe	diffusion	the	DT	B-NP	Odiffusion	of	diffusion	NN	I-NP	Oof	this	of	IN	B-PP	Othis	steroid	this	DT	B-NP	Osteroid	out	steroid	NN	I-NP	Oout	of	out	IN	B-PP	Oof	the	of	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	and	cell	NN	I-NP	Oand	thus	and	CC	O	Othus	","	thus	RB	O	O","	displaces	","	","	O	Odisplaces	the	displace	VBZ	B-VP	Othe	chemical	the	DT	B-NP	Ochemical	equilibrium	chemical	JJ	I-NP	Oequilibrium	within	equilibrium	NN	I-NP	Owithin	the	within	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	.	cell	NN	I-NP	O.	Glucocorticoids	.	.	O	OGlucocorticoids	and	Glucocorticoid	NNS	B-NP	Oand	lymphocytes	and	CC	I-NP	Olymphocytes	.	lymphocyte	NNS	I-NP	B-cell_type.	I	.	.	O	OI	.	I	PRP	B-NP	O.	Increased	.	.	O	OIncreased	glucocorticoid	Increase	VBN	B-NP	Oglucocorticoid	receptor	glucocorticoid	NN	I-NP	B-proteinreceptor	levels	receptor	NN	I-NP	I-proteinlevels	in	level	NNS	I-NP	Oin	antigen-stimulated	in	IN	B-PP	Oantigen-stimulated	lymphocytes	antigen-stimulated	JJ	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Recently	.	.	O	ORecently	a	Recently	RB	B-ADVP	Oa	2-	a	DT	B-NP	O2-	to	2-	CD	I-NP	Oto	3-fold	to	TO	B-PP	O3-fold	increase	3-fold	JJ	B-NP	Oincrease	in	increase	NN	I-NP	Oin	the	in	IN	B-PP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	human	in	IN	B-PP	Ohuman	peripheral	human	JJ	B-NP	B-cell_typeperipheral	lymphocytes	peripheral	JJ	I-NP	I-cell_typelymphocytes	has	lymphocyte	NNS	I-NP	I-cell_typehas	been	have	VBZ	B-VP	Obeen	noted	be	VBN	I-VP	Onoted	after	note	VBN	I-VP	Oafter	in	after	IN	B-PP	Oin	vitro	in	FW	B-NP	Ovitro	mitogen	vitro	FW	I-NP	Omitogen	stimulation	mitogen	NN	I-NP	Ostimulation	.	stimulation	NN	I-NP	O.	Here	.	.	O	OHere	","	Here	RB	B-ADVP	O","	we	","	","	O	Owe	extend	we	PRP	B-NP	Oextend	these	extend	VBP	B-VP	Othese	observations	these	DT	B-NP	Oobservations	to	observation	NNS	I-NP	Oto	in	to	TO	B-PP	Oin	vivo	in	FW	B-NP	Ovivo	immunization	vivo	FW	I-NP	Oimmunization	.	immunization	NN	I-NP	O.	After	.	.	O	OAfter	unilateral	After	IN	B-PP	Ounilateral	immunization	unilateral	JJ	B-NP	Oimmunization	of	immunization	NN	I-NP	Oof	adrenalectomized	of	IN	B-PP	Oadrenalectomized	male	adrenalectomize	VBN	B-NP	Omale	rats	male	JJ	I-NP	Orats	","	rat	NNS	I-NP	O","	a	","	","	O	Oa	50	a	DT	B-NP	O50	%	50	CD	I-NP	O%	increase	%	NN	I-NP	Oincrease	in	increase	NN	I-NP	Oin	glucocorticoid	in	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	sites	receptor	NN	I-NP	I-proteinsites	per	site	NNS	I-NP	Oper	cell	per	IN	B-PP	Ocell	","	cell	NN	B-NP	O","	determined	","	","	O	Odetermined	by	determine	VBN	B-VP	Oby	binding	by	IN	B-PP	Obinding	of	binding	NN	B-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	","	dexamethasone	NN	B-NP	O","	was	","	","	O	Owas	observed	be	VBD	B-VP	Oobserved	in	observe	VBN	I-VP	Oin	cell	in	IN	B-PP	Ocell	suspensions	cell	NN	B-NP	Osuspensions	of	suspension	NNS	I-NP	Oof	homolateral	of	IN	B-PP	Ohomolateral	lymph	homolateral	JJ	B-NP	Olymph	nodes	lymph	NN	I-NP	Onodes	over	node	NNS	I-NP	Oover	those	over	IN	B-PP	Othose	from	those	DT	B-NP	Ofrom	the	from	IN	B-PP	Othe	contralateral	the	DT	B-NP	Ocontralateral	nonimmunized	contralateral	JJ	I-NP	Ononimmunized	side	nonimmunized	JJ	I-NP	Oside	of	side	NN	I-NP	Oof	the	of	IN	B-PP	Othe	same	the	DT	B-NP	Osame	animal	same	JJ	I-NP	Oanimal	.	animal	NN	I-NP	O.	The	.	.	O	OThe	association	The	DT	B-NP	Oassociation	constant	association	NN	I-NP	Oconstant	for	constant	NN	I-NP	Ofor	dexamethasone	for	IN	B-PP	Odexamethasone	was	dexamethasone	NN	B-NP	Owas	similar	be	VBD	B-VP	Osimilar	in	similar	JJ	B-ADJP	Oin	both	in	IN	B-PP	Oboth	groups	both	DT	B-NP	Ogroups	","	group	NNS	I-NP	O","	as	","	","	O	Oas	was	as	IN	B-SBAR	Owas	the	be	VBD	B-VP	Othe	stereospecificity	the	DT	B-NP	Ostereospecificity	for	stereospecificity	NN	I-NP	Ofor	various	for	IN	B-PP	Ovarious	steroids	various	JJ	B-NP	Osteroids	","	steroid	NNS	I-NP	O","	the	","	","	O	Othe	time	the	DT	B-NP	Otime	course	time	NN	I-NP	Ocourse	of	course	NN	I-NP	Oof	cytoplasmic	of	IN	B-PP	Ocytoplasmic	and	cytoplasmic	JJ	B-NP	Oand	nuclear	and	CC	I-NP	Onuclear	association	nuclear	JJ	I-NP	Oassociation	","	association	NN	I-NP	O","	and	","	","	O	Oand	cytoplasmic-to-nuclear	and	CC	O	Ocytoplasmic-to-nuclear	translocation	cytoplasmic-to-nuclear	JJ	B-NP	Otranslocation	.	translocation	NN	I-NP	O.	Despite	.	.	O	ODespite	a	Despite	IN	B-PP	Oa	50	a	DT	B-NP	O50	%	50	CD	I-NP	O%	increase	%	NN	I-NP	Oincrease	in	increase	NN	I-NP	Oin	the	in	IN	B-PP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	sites	receptor	NN	I-NP	I-proteinsites	per	site	NNS	I-NP	Oper	cell	per	IN	B-PP	Ocell	","	cell	NN	B-NP	O","	the	","	","	O	Othe	cells	the	DT	B-NP	Ocells	from	cell	NNS	I-NP	Ofrom	the	from	IN	B-PP	Othe	homolateral	the	DT	B-NP	Ohomolateral	and	homolateral	JJ	I-NP	Oand	controlateral	and	CC	I-NP	Ocontrolateral	lymph	controlateral	JJ	I-NP	Olymph	nodes	lymph	NN	I-NP	Onodes	were	node	NNS	I-NP	Owere	equally	be	VBD	B-VP	Oequally	sensitive	equally	RB	B-ADJP	Osensitive	to	sensitive	JJ	I-ADJP	Oto	the	to	TO	B-PP	Othe	inhibitory	the	DT	B-NP	Oinhibitory	effects	inhibitory	JJ	I-NP	Oeffects	of	effect	NNS	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	","	dexamethasone	NN	B-NP	O","	as	","	","	O	Oas	determined	as	IN	B-SBAR	Odetermined	by	determine	VBN	B-VP	Oby	measurements	by	IN	B-PP	Omeasurements	of	measurement	NNS	B-NP	Oof	the	of	IN	B-PP	Othe	incorporation	the	DT	B-NP	Oincorporation	of	incorporation	NN	I-NP	Oof	radiolabeled	of	IN	B-PP	Oradiolabeled	precursors	radiolabele	VBN	B-NP	Oprecursors	of	precursor	NNS	I-NP	Oof	protein	of	IN	B-PP	Oprotein	","	protein	NN	B-NP	O","	RNA	","	","	O	ORNA	","	RNA	NN	B-NP	O","	and	","	","	O	Oand	DNA	and	CC	O	ODNA	","	DNA	NN	B-NP	O","	or	","	","	O	Oor	measurements	or	CC	O	Omeasurements	of	measurement	NNS	B-NP	Oof	in	of	IN	B-PP	Oin	vitro	in	FW	B-NP	Ovitro	cell	vitro	FW	I-NP	Ocell	survival	cell	NN	I-NP	Osurvival	.	survival	NN	I-NP	O.	Glucocorticoid	.	.	O	OGlucocorticoid	receptors	Glucocorticoid	NN	B-NP	B-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	actions	and	CC	I-NP	Oactions	in	action	NNS	I-NP	Oin	rat	in	IN	B-PP	Orat	thymocytes	rat	NN	B-NP	B-cell_typethymocytes	and	thymocyte	NNS	I-NP	I-cell_typeand	immunologically	and	CC	O	Oimmunologically	stimulated	immunologically	RB	B-NP	Ostimulated	human	stimulate	VBN	I-NP	Ohuman	peripheral	human	JJ	I-NP	B-cell_typeperipheral	lymphocytes	peripheral	JJ	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	After	.	.	O	OAfter	reviewing	After	IN	B-PP	Oreviewing	briefly	review	VBG	B-VP	Obriefly	our	briefly	RB	B-ADVP	Oour	earlier	our	PRP$	B-NP	Oearlier	studies	early	JJR	I-NP	Ostudies	on	study	NNS	I-NP	Oon	glucocorticoid	on	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	mechanisms	and	CC	I-NP	Omechanisms	in	mechanism	NNS	I-NP	Oin	thymus	in	IN	B-PP	Othymus	cells	thymus	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	we	","	","	O	Owe	have	we	PRP	B-NP	Ohave	outlined	have	VBP	B-VP	Ooutlined	results	outline	VBN	I-VP	Oresults	from	result	NNS	B-NP	Ofrom	the	from	IN	B-PP	Othe	following	the	DT	B-NP	Ofollowing	two	follow	VBG	I-NP	Otwo	areas	two	CD	I-NP	Oareas	of	area	NNS	I-NP	Oof	current	of	IN	B-PP	Ocurrent	interest	current	JJ	B-NP	Ointerest	in	interest	NN	I-NP	Oin	our	in	IN	B-PP	Oour	laboratories	our	PRP$	B-NP	Olaboratories	:	laboratory	NNS	I-NP	O:	the	:	:	O	Othe	``	the	DT	B-NP	O``	life-cycle	``	``	I-NP	Olife-cycle	''	life-cycle	NN	I-NP	O''	of	''	''	O	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	complexes	and	CC	I-NP	Ocomplexes	in	complex	NNS	I-NP	Oin	thymus	in	IN	B-PP	Othymus	cells	thymus	NN	B-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	and	","	","	O	Oand	the	and	CC	O	Othe	levels	the	DT	B-NP	Olevels	of	level	NNS	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	and	receptor	NNS	I-NP	I-proteinand	sensitivity	and	CC	O	Osensitivity	in	sensitivity	NN	B-NP	Oin	immunologically	in	IN	B-PP	Oimmunologically	stimulated	immunologically	RB	B-NP	B-cell_typestimulated	human	stimulate	VBN	I-NP	I-cell_typehuman	peripheral	human	JJ	I-NP	I-cell_typeperipheral	lymphocytes	peripheral	JJ	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Several	.	.	O	OSeveral	of	Several	JJ	B-NP	Oof	our	of	IN	B-PP	Oour	results	our	PRP$	B-NP	Oresults	on	result	NNS	I-NP	Oon	energetics	on	IN	B-PP	Oenergetics	and	energetic	NNS	B-NP	Oand	kinetics	and	CC	I-NP	Okinetics	of	kinetic	NNS	I-NP	Oof	hormone	of	IN	B-PP	Ohormone	binding	hormone	NN	B-NP	Obinding	to	binding	NN	I-NP	Oto	glucocorticoid	to	TO	B-PP	Oglucocorticoid	receptors	glucocorticoid	NN	B-NP	B-proteinreceptors	in	receptor	NNS	I-NP	I-proteinin	rat	in	IN	B-PP	Orat	thymus	rat	NN	B-NP	B-cell_typethymus	cells	thymus	NN	I-NP	I-cell_typecells	seem	cell	NNS	I-NP	I-cell_typeseem	to	seem	VBP	B-VP	Oto	require	to	TO	I-VP	Orequire	extension	require	VB	I-VP	Oextension	of	extension	NN	B-NP	Oof	the	of	IN	B-PP	Othe	simplest	the	DT	B-NP	Osimplest	model	simple	JJS	I-NP	Omodel	of	model	NN	I-NP	Oof	hormone-receptor	of	IN	B-PP	Ohormone-receptor	transformations	hormone-receptor	NN	B-NP	Otransformations	in	transformation	NNS	I-NP	Oin	intact	in	IN	B-PP	Ointact	cells	intact	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	ATP-depletion	.	.	O	OATP-depletion	experiments	ATP-depletion	NN	B-NP	Oexperiments	suggest	experiment	NNS	I-NP	Osuggest	the	suggest	VBP	B-VP	Othe	existence	the	DT	B-NP	Oexistence	of	existence	NN	I-NP	Oof	a	of	IN	B-PP	Oa	nonbinding	a	DT	B-NP	Ononbinding	form	nonbinding	JJ	I-NP	Oform	of	form	NN	I-NP	Oof	the	of	IN	B-PP	Othe	receptor	the	DT	B-NP	Oreceptor	;	receptor	NN	I-NP	O;	``	;	:	O	O``	chase	``	``	B-VP	Ochase	''	chase	VB	I-VP	O''	experiments	''	''	O	Oexperiments	suggest	experiment	NNS	B-NP	Osuggest	reaction	suggest	VBP	B-VP	Oreaction	of	reaction	NN	B-NP	Oof	hormone	of	IN	B-PP	Ohormone	directly	hormone	NN	B-NP	Odirectly	with	directly	RB	B-ADVP	Owith	nuclear-bound	with	IN	B-PP	Onuclear-bound	receptor	nuclear-bound	JJ	B-NP	B-proteinreceptor	;	receptor	NN	I-NP	I-protein;	experiments	;	:	O	Oexperiments	on	experiment	NNS	B-NP	Oon	depletion	on	IN	B-PP	Odepletion	and	depletion	NN	B-NP	Oand	replenishment	and	CC	I-NP	Oreplenishment	of	replenishment	NN	I-NP	Oof	cytoplasmic	of	IN	B-PP	Ocytoplasmic	receptor	cytoplasmic	JJ	B-NP	B-proteinreceptor	using	receptor	NN	I-NP	I-proteinusing	cortisol	use	VBG	B-VP	Ocortisol	and	cortisol	NN	B-NP	Oand	dexamethasone	and	CC	I-NP	Odexamethasone	suggest	dexamethasone	NN	I-NP	Osuggest	the	suggest	VBP	B-VP	Othe	existence	the	DT	B-NP	Oexistence	of	existence	NN	I-NP	Oof	at	of	IN	B-PP	Oat	least	at	IN	B-NP	Oleast	two	least	JJS	I-NP	Otwo	subpopulations	two	CD	I-NP	Osubpopulations	of	subpopulation	NNS	I-NP	Oof	nuclear-bound	of	IN	B-PP	Onuclear-bound	hormone-receptor	nuclear-bound	JJ	B-NP	B-proteinhormone-receptor	complex	hormone-receptor	NN	I-NP	I-proteincomplex	.	complex	NN	I-NP	I-protein.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	found	have	VBP	B-VP	Ofound	that	find	VBN	I-VP	Othat	mitogen	that	IN	B-SBAR	Omitogen	or	mitogen	NN	B-NP	Oor	immunologic	or	CC	O	Oimmunologic	stimulation	immunologic	JJ	B-NP	Ostimulation	of	stimulation	NN	I-NP	Oof	human	of	IN	B-PP	Ohuman	peripheral	human	JJ	B-NP	B-cell_typeperipheral	lymphocytes	peripheral	JJ	I-NP	I-cell_typelymphocytes	in	lymphocyte	NNS	I-NP	I-cell_typein	culture	in	IN	B-PP	Oculture	leads	culture	NN	B-NP	Oleads	within	lead	VBZ	B-VP	Owithin	24	within	IN	B-PP	O24	h	24	CD	B-NP	Oh	or	h	NN	I-NP	Oor	so	or	CC	I-NP	Oso	to	so	RB	I-NP	Oto	a	to	TO	B-PP	Oa	striking	a	DT	B-NP	Ostriking	increase	striking	JJ	I-NP	Oincrease	in	increase	NN	I-NP	Oin	the	in	IN	B-PP	Othe	number	the	DT	B-NP	Onumber	of	number	NN	I-NP	Oof	glucocorticoid	of	IN	B-PP	Oglucocorticoid	receptor	glucocorticoid	NN	B-NP	B-proteinreceptor	sites	receptor	NN	I-NP	I-proteinsites	per	site	NNS	I-NP	Oper	cell	per	IN	B-PP	Ocell	.	cell	NN	B-NP	O.	We	.	.	O	OWe	believe	We	PRP	B-NP	Obelieve	this	believe	VBP	B-VP	Othis	increase	this	DT	B-NP	Oincrease	may	increase	NN	I-NP	Omay	be	may	MD	B-VP	Obe	due	be	VB	I-VP	Odue	to	due	JJ	B-ADVP	Oto	partial	to	TO	B-PP	Opartial	synchronization	partial	JJ	B-NP	Osynchronization	of	synchronization	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	population	cell	NN	I-NP	Opopulation	in	population	NN	I-NP	Oin	a	in	IN	B-PP	Oa	phase	a	DT	B-NP	Ophase	of	phase	NN	I-NP	Oof	the	of	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	cycle	cell	NN	I-NP	Ocycle	in	cycle	NN	I-NP	Oin	which	in	IN	B-PP	Owhich	receptor	which	WDT	B-NP	Oreceptor	content	receptor	NN	B-NP	Ocontent	is	content	NN	I-NP	Ois	high	be	VBZ	B-VP	Ohigh	.	high	JJ	B-ADJP	O.	Contrary	.	.	O	OContrary	to	Contrary	JJ	B-ADVP	Oto	the	to	TO	B-PP	Othe	widely	the	DT	B-NP	Owidely	held	widely	RB	I-NP	Oheld	view	held	JJ	I-NP	Oview	that	view	NN	I-NP	Othat	mitogen-stimulated	that	IN	B-SBAR	Omitogen-stimulated	cells	mitogen-stimulated	JJ	B-NP	B-cell_linecells	become	cell	NNS	I-NP	I-cell_linebecome	insensitive	become	VBP	B-VP	Oinsensitive	to	insensitive	JJ	B-ADJP	Oto	glucocorticoids	to	TO	B-PP	Oglucocorticoids	","	glucocorticoid	NNS	B-NP	O","	our	","	","	O	Oour	experiments	our	PRP$	B-NP	Oexperiments	show	experiment	NNS	I-NP	Oshow	that	show	VBP	B-VP	Othat	with	that	IN	B-SBAR	Owith	respect	with	IN	B-PP	Orespect	to	respect	NN	B-NP	Oto	inhibition	to	TO	B-PP	Oinhibition	of	inhibition	NN	B-NP	Oof	thymidine	of	IN	B-PP	Othymidine	and	thymidine	NN	B-NP	Oand	uridine	and	CC	I-NP	Ouridine	incorporation	uridine	NN	I-NP	Oincorporation	and	incorporation	NN	I-NP	Oand	glucose	and	CC	O	Oglucose	uptake	glucose	NN	B-NP	Ouptake	","	uptake	NN	I-NP	O","	the	","	","	O	Othe	cells	the	DT	B-NP	Ocells	are	cell	NNS	I-NP	Oare	highly	be	VBP	B-VP	Ohighly	sensitive	highly	RB	B-ADJP	Osensitive	to	sensitive	JJ	I-ADJP	Oto	dexamethasone	to	TO	B-PP	Odexamethasone	at	dexamethasone	NN	B-NP	Oat	24	at	IN	B-PP	O24	","	24	CD	B-NP	O","	48	","	","	I-NP	O48	","	48	CD	I-NP	O","	and	","	","	O	Oand	72	and	CC	O	O72	h	72	CD	B-NP	Oh	after	h	NN	I-NP	Oafter	stimulation	after	IN	B-PP	Ostimulation	with	stimulation	NN	B-NP	Owith	concanavalin	with	IN	B-PP	Oconcanavalin	A	concanavalin	NN	B-NP	OA	.	A	NN	I-NP	O.	Nuclear	.	.	O	ONuclear	glucocorticoid	Nuclear	JJ	B-NP	Oglucocorticoid	binding	glucocorticoid	NN	I-NP	Obinding	in	binding	NN	I-NP	Oin	chronic	in	IN	B-PP	Ochronic	lymphatic	chronic	JJ	B-NP	B-cell_typelymphatic	leukemia	lymphatic	JJ	I-NP	I-cell_typeleukemia	lymphocytes	leukemia	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	A	.	.	O	OA	reliable	A	DT	B-NP	Oreliable	procedure	reliable	JJ	I-NP	Oprocedure	is	procedure	NN	I-NP	Ois	described	be	VBZ	B-VP	Odescribed	for	describe	VBN	I-VP	Ofor	isolating	for	IN	B-PP	Oisolating	3H-triamcinolone	isolate	VBG	B-VP	O3H-triamcinolone	acetonide	3H-triamcinolone	JJ	B-NP	B-proteinacetonide	(	acetonide	NN	I-NP	I-protein(	3H-TA	(	(	O	I-protein3H-TA	)	3H-TA	NN	B-NP	I-protein)	receptor	)	)	O	I-proteinreceptor	complexes	receptor	NN	B-NP	I-proteincomplexes	from	complex	NNS	I-NP	I-proteinfrom	purified	from	IN	B-PP	Opurified	chronic	purify	VBN	B-NP	Ochronic	lymphatic	chronic	JJ	I-NP	Olymphatic	leukemia	lymphatic	JJ	I-NP	Oleukemia	(	leukemia	NN	I-NP	O(	CLL	(	(	O	OCLL	)	CLL	NN	B-NP	O)	lymphocyte	)	)	O	Olymphocyte	nuclei	lymphocyte	NN	B-NP	Onuclei	","	nucleus	NNS	I-NP	O","	based	","	","	O	Obased	on	base	VBN	B-PP	Oon	the	on	IN	B-PP	Othe	use	the	DT	B-NP	Ouse	of	use	NN	I-NP	Oof	carbobenzoxy-L-phenylalanine	of	IN	B-PP	Ocarbobenzoxy-L-phenylalanine	(	carbobenzoxy-L-phenylalanine	NN	B-NP	O(	CBZ-L-phe	(	(	O	OCBZ-L-phe	)	CBZ-L-phe	NN	B-NP	O)	to	)	)	O	Oto	prevent	to	TO	B-VP	Oprevent	breakdown	prevent	VB	I-VP	Obreakdown	of	breakdown	NN	B-NP	Oof	hormone-receptor	of	IN	B-PP	Ohormone-receptor	complexes	hormone-receptor	NN	B-NP	B-proteincomplexes	during	complex	NNS	I-NP	I-proteinduring	extraction	during	IN	B-PP	Oextraction	of	extraction	NN	B-NP	Oof	nuclei	of	IN	B-PP	Onuclei	with	nucleus	NNS	B-NP	Owith	0.6M	with	IN	B-PP	O0.6M	KCl	0.6M	NN	B-NP	OKCl	.	KCl	NN	I-NP	O.	Using	.	.	O	OUsing	this	Use	VBG	B-VP	Othis	method	this	DT	B-NP	Omethod	","	method	NN	I-NP	O","	specific	","	","	O	Ospecific	nuclear	specific	JJ	B-NP	Onuclear	glucocorticoid	nuclear	JJ	I-NP	Oglucocorticoid	binding	glucocorticoid	NN	I-NP	Obinding	was	binding	NN	I-NP	Owas	demonstrated	be	VBD	B-VP	Odemonstrated	in	demonstrate	VBN	I-VP	Oin	14/14	in	IN	B-PP	O14/14	patients	14/14	CD	B-NP	Opatients	with	patient	NNS	I-NP	Owith	untreated	with	IN	B-PP	Ountreated	CLL	untreated	JJ	B-NP	OCLL	.	CLL	NN	I-NP	O.	No	.	.	O	ONo	correlation	No	DT	B-NP	Ocorrelation	was	correlation	NN	I-NP	Owas	found	be	VBD	B-VP	Ofound	between	find	VBN	I-VP	Obetween	levels	between	IN	B-PP	Olevels	of	level	NNS	B-NP	Oof	nuclear-associated	of	IN	B-PP	Onuclear-associated	3H-TA	nuclear-associated	JJ	B-NP	B-protein3H-TA	and	3H-TA	NN	I-NP	I-proteinand	peripheral	and	CC	I-NP	Operipheral	white	peripheral	JJ	I-NP	Owhite	blood	white	JJ	I-NP	Oblood	cell	blood	NN	I-NP	Ocell	count	cell	NN	I-NP	Ocount	or	count	NN	I-NP	Oor	rosetting	or	CC	O	Orosetting	ability	rosette	VBG	B-VP	Oability	of	ability	NN	B-NP	Oof	circulating	of	IN	B-PP	Ocirculating	lymphocytes	circulate	VBG	B-VP	B-cell_typelymphocytes	.	lymphocyte	NNS	B-NP	I-cell_type.	Multiple	.	.	O	OMultiple	closely-linked	Multiple	JJ	B-NP	Oclosely-linked	NFAT/octamer	closely-linked	JJ	I-NP	ONFAT/octamer	and	NFAT/octamer	NN	I-NP	Oand	HMG	and	CC	O	OHMG	I	HMG	NN	B-NP	B-proteinI	(	I	CD	I-NP	I-protein(	Y	(	(	O	OY	)	Y	NN	B-NP	O)	binding	)	)	O	Obinding	sites	binding	NN	B-NP	Osites	are	site	NNS	I-NP	Oare	part	be	VBP	B-VP	Opart	of	part	NN	B-NP	Oof	the	of	IN	B-PP	Othe	interleukin-4	the	DT	B-NP	Ointerleukin-4	promoter	interleukin-4	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	We	.	.	O	OWe	show	We	PRP	B-NP	Oshow	here	show	VBP	B-VP	Ohere	that	here	RB	B-ADVP	Othat	the	that	IN	B-SBAR	Othe	immediate	the	DT	B-NP	Oimmediate	upstream	immediate	JJ	I-NP	B-DNAupstream	region	upstream	JJ	I-NP	I-DNAregion	(	region	NN	I-NP	I-DNA(	from	(	(	O	Ofrom	position	from	IN	B-PP	Oposition	-12	position	NN	B-NP	B-DNA-12	to	-12	CD	I-NP	I-DNAto	-270	to	TO	B-PP	I-DNA-270	)	-270	CD	B-NP	I-DNA)	of	)	)	O	Oof	the	of	IN	B-PP	Othe	murine	the	DT	B-NP	Omurine	interleukin	murine	JJ	I-NP	B-DNAinterleukin	4	interleukin	NN	I-NP	I-DNA4	(	4	CD	I-NP	I-DNA(	Il-4	(	(	O	I-DNAIl-4	)	Il-4	NN	B-NP	I-DNA)	gene	)	)	O	I-DNAgene	harbors	gene	NN	B-NP	I-DNAharbors	a	harbor	VBZ	B-VP	Oa	strong	a	DT	B-NP	Ostrong	cell-type	strong	JJ	I-NP	Ocell-type	specific	cell-type	NN	I-NP	Ospecific	transcriptional	specific	JJ	I-NP	Otranscriptional	enhancer	transcriptional	JJ	I-NP	B-DNAenhancer	.	enhancer	NN	I-NP	I-DNA.	In	.	.	O	OIn	T	In	IN	B-PP	OT	lymphoma	T	NN	B-NP	B-cell_typelymphoma	cells	lymphoma	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	the	","	","	O	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	Il-4	the	DT	B-NP	OIl-4	promoter/enhancer	Il-4	NN	I-NP	B-DNApromoter/enhancer	is	promoter/enhancer	NN	I-NP	I-DNAis	stimulated	be	VBZ	B-VP	Ostimulated	by	stimulate	VBN	I-VP	Oby	phorbol	by	IN	B-PP	Ophorbol	esters	phorbol	NN	B-NP	Oesters	","	ester	NNS	I-NP	O","	Ca++	","	","	O	OCa++	ionophores	Ca++	JJ	B-NP	Oionophores	and	ionophore	NNS	I-NP	Oand	agonists	and	CC	O	Oagonists	of	agonist	NNS	B-NP	Oof	protein	of	IN	B-PP	Oprotein	kinase	protein	NN	B-NP	B-proteinkinase	A	kinase	NN	I-NP	I-proteinA	and	A	NN	I-NP	I-proteinand	inhibited	and	CC	O	Oinhibited	by	inhibit	VBN	B-VP	Oby	low	by	IN	B-PP	Olow	doses	low	JJ	B-NP	Odoses	of	dose	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	immunosuppressant	the	DT	B-NP	Oimmunosuppressant	cyclosporin	immunosuppressant	JJ	I-NP	Ocyclosporin	A	cyclosporin	NN	I-NP	OA	.	A	NN	I-NP	O.	The	.	.	O	OThe	Il-4	The	DT	B-NP	OIl-4	promoter/enhancer	Il-4	NN	I-NP	B-DNApromoter/enhancer	is	promoter/enhancer	NN	I-NP	I-DNAis	transcriptionally	be	VBZ	B-VP	Otranscriptionally	inactive	transcriptionally	RB	B-ADJP	Oinactive	in	inactive	JJ	I-ADJP	Oin	B	in	IN	B-PP	OB	lymphoma	B	NN	B-NP	B-cell_typelymphoma	cells	lymphoma	NN	I-NP	I-cell_typecells	and	cell	NNS	I-NP	I-cell_typeand	HeLa	and	CC	O	OHeLa	cells	HeLa	NN	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	DNase	.	.	O	ODNase	I	DNase	NN	B-NP	B-proteinI	footprint	I	CD	I-NP	I-proteinfootprint	protection	footprint	NN	I-NP	Oprotection	experiments	protection	NN	I-NP	Oexperiments	revealed	experiment	NNS	I-NP	Orevealed	six	reveal	VBD	B-VP	Osix	sites	six	CD	B-NP	Osites	of	site	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	Il-4	the	DT	B-NP	OIl-4	promoter/enhancer	Il-4	NN	I-NP	B-DNApromoter/enhancer	to	promoter/enhancer	NN	I-NP	I-DNAto	be	to	TO	B-VP	Obe	bound	be	VB	I-VP	Obound	by	bind	VBN	I-VP	Oby	nuclear	by	IN	B-PP	Onuclear	proteins	nuclear	JJ	B-NP	B-proteinproteins	from	protein	NNS	I-NP	I-proteinfrom	lymphoid	from	IN	B-PP	Olymphoid	and	lymphoid	JJ	B-NP	B-cell_typeand	myeloid	and	CC	I-NP	I-cell_typemyeloid	cells	myeloid	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Among	.	.	O	OAmong	them	Among	IN	B-PP	Othem	are	them	PRP	B-NP	Oare	four	be	VBP	B-VP	Ofour	purine	four	CD	B-NP	Opurine	boxes	purine	JJ	I-NP	B-DNAboxes	which	box	NNS	I-NP	I-DNAwhich	have	which	WDT	B-NP	Ohave	been	have	VBP	B-VP	Obeen	described	be	VBN	I-VP	Odescribed	to	describe	VBN	I-VP	Oto	be	to	TO	I-VP	Obe	important	be	VB	I-VP	Oimportant	sequence	important	JJ	B-NP	Osequence	motifs	sequence	NN	I-NP	Omotifs	of	motif	NNS	I-NP	Oof	the	of	IN	B-PP	Othe	Il-2	the	DT	B-NP	OIl-2	promoter	Il-2	NN	I-NP	B-DNApromoter	.	promoter	NN	I-NP	I-DNA.	They	.	.	O	OThey	contain	They	PRP	B-NP	Ocontain	the	contain	VBP	B-VP	Othe	motif	the	DT	B-NP	Omotif	GGAAA	motif	NN	I-NP	OGGAAA	and	GGAAA	NN	I-NP	Oand	are	and	CC	O	Oare	recognized	be	VBP	B-VP	Orecognized	by	recognize	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	inducible	the	DT	B-NP	Oinducible	and	inducible	JJ	I-NP	Oand	cyclosporin	and	CC	I-NP	Ocyclosporin	A-sensitive	cyclosporin	NN	I-NP	OA-sensitive	transcription	A-sensitive	JJ	I-NP	Otranscription	factor	transcription	NN	I-NP	Ofactor	NFAT-1	factor	NN	I-NP	ONFAT-1	.	NFAT-1	NN	I-NP	B-protein.	Three	.	.	O	OThree	of	Three	CD	B-NP	Oof	the	of	IN	B-PP	Othe	Il-4	the	DT	B-NP	OIl-4	NFAT-1	Il-4	NN	I-NP	B-DNANFAT-1	sites	NFAT-1	NN	I-NP	I-DNAsites	are	site	NNS	I-NP	I-DNAare	closely	be	VBP	B-VP	Oclosely	linked	closely	RB	I-VP	Olinked	to	link	VBN	I-VP	Oto	weak	to	TO	B-PP	Oweak	binding	weak	JJ	B-NP	Obinding	sites	bind	VBG	I-NP	Osites	of	site	NNS	I-NP	Oof	Octamer	of	IN	B-PP	OOctamer	factors	Octamer	NN	B-NP	B-proteinfactors	.	factor	NNS	I-NP	I-protein.	Several	.	.	O	OSeveral	purine	Several	JJ	B-NP	Opurine	boxes	purine	NN	I-NP	B-DNAboxes	and	box	NNS	I-NP	I-DNAand	an	and	CC	O	Oan	AT-rich	an	DT	B-NP	OAT-rich	protein-binding	AT-rich	JJ	I-NP	B-DNAprotein-binding	site	protein-binding	JJ	I-NP	I-DNAsite	of	site	NN	I-NP	I-DNAof	the	of	IN	B-PP	Othe	Il-4	the	DT	B-NP	OIl-4	promoter	Il-4	NN	I-NP	B-DNApromoter	are	promoter	NN	I-NP	I-DNAare	also	be	VBP	B-VP	Oalso	recognized	also	RB	I-VP	Orecognized	by	recognize	VBN	I-VP	Oby	the	by	IN	B-PP	Othe	high	the	DT	B-NP	Ohigh	mobility	high	JJ	I-NP	B-proteinmobility	group	mobility	NN	I-NP	I-proteingroup	protein	group	NN	I-NP	I-proteinprotein	HMG	protein	NN	I-NP	I-proteinHMG	I	HMG	NN	I-NP	B-proteinI	(	I	CD	I-NP	I-protein(	Y	(	(	O	I-proteinY	)	Y	NN	B-NP	I-protein)	.	)	)	O	I-protein.	Whereas	.	.	O	OWhereas	the	Whereas	IN	B-SBAR	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	NFAT-1	of	IN	B-PP	ONFAT-1	and	NFAT-1	NN	B-NP	B-proteinand	Octamer	and	CC	I-NP	OOctamer	factors	Octamer	NN	I-NP	B-proteinfactors	enhance	factor	NNS	I-NP	I-proteinenhance	the	enhance	VBP	B-VP	Othe	activity	the	DT	B-NP	Oactivity	of	activity	NN	I-NP	Oof	the	of	IN	B-PP	Othe	Il-4	the	DT	B-NP	OIl-4	promoter	Il-4	NN	I-NP	B-DNApromoter	","	promoter	NN	I-NP	I-DNA","	the	","	","	O	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	HMG	of	IN	B-PP	OHMG	I	HMG	NN	B-NP	B-proteinI	(	I	CD	I-NP	I-protein(	Y	(	(	O	I-proteinY	)	Y	NN	B-NP	I-protein)	suppresses	)	)	O	I-proteinsuppresses	its	suppress	VBZ	B-VP	Oits	activity	its	PRP$	B-NP	Oactivity	and	activity	NN	I-NP	Oand	","	and	CC	O	O","	therefore	","	","	O	Otherefore	","	therefore	RB	B-ADVP	O","	appears	","	","	O	Oappears	to	appear	VBZ	B-VP	Oto	be	to	TO	I-VP	Obe	involved	be	VB	I-VP	Oinvolved	in	involve	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	suppression	the	DT	B-NP	Osuppression	of	suppression	NN	I-NP	Oof	Il-4	of	IN	B-PP	OIl-4	transcription	Il-4	NN	B-NP	B-proteintranscription	in	transcription	NN	I-NP	Oin	resting	in	IN	B-PP	Oresting	T	rest	VBG	B-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	.	lymphocyte	NNS	I-NP	I-cell_type.	Reversibility	.	.	O	OReversibility	of	Reversibility	NN	B-NP	Oof	the	of	IN	B-PP	Othe	differentiated	the	DT	B-NP	Odifferentiated	state	differentiate	VBN	I-NP	Ostate	in	state	NN	I-NP	Oin	somatic	in	IN	B-PP	Osomatic	cells	somatic	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Analysis	.	.	O	OAnalysis	of	Analysis	NN	B-NP	Oof	de	of	IN	B-PP	Ode	novo	de	FW	B-NP	Onovo	gene	novo	FW	I-NP	Ogene	activation	gene	NN	I-NP	Oactivation	in	activation	NN	I-NP	Oin	multinucleated	in	IN	B-PP	Omultinucleated	heterokaryons	multinucleated	JJ	B-NP	B-cell_lineheterokaryons	has	heterokaryon	NNS	I-NP	I-cell_linehas	shown	have	VBZ	B-VP	Oshown	that	show	VBN	I-VP	Othat	the	that	IN	B-SBAR	Othe	differentiated	the	DT	B-NP	Odifferentiated	state	differentiate	VBN	I-NP	Ostate	","	state	NN	I-NP	O","	although	","	","	O	Oalthough	stable	although	IN	B-SBAR	Ostable	","	stable	JJ	B-ADJP	O","	is	","	","	O	Ois	not	be	VBZ	B-VP	Onot	irreversible	not	RB	O	Oirreversible	","	irreversible	JJ	B-ADJP	O","	and	","	","	O	Oand	can	and	CC	O	Ocan	be	can	MD	B-VP	Obe	reprogrammed	be	VB	I-VP	Oreprogrammed	in	reprogramme	VBN	I-VP	Oin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	appropriate	of	IN	B-PP	Oappropriate	combinations	appropriate	JJ	B-NP	Ocombinations	of	combination	NNS	I-NP	Oof	trans-acting	of	IN	B-PP	Otrans-acting	regulatory	trans-acting	JJ	B-NP	B-proteinregulatory	molecules	regulatory	JJ	I-NP	I-proteinmolecules	.	molecule	NNS	I-NP	I-protein.	These	.	.	O	OThese	properties	These	DT	B-NP	Oproperties	have	property	NNS	I-NP	Ohave	been	have	VBP	B-VP	Obeen	exploited	be	VBN	I-VP	Oexploited	to	exploit	VBN	I-VP	Oto	design	to	TO	I-VP	Odesign	strategies	design	VB	I-VP	Ostrategies	for	strategy	NNS	B-NP	Ofor	identifying	for	IN	B-PP	Oidentifying	novel	identify	VBG	B-VP	Onovel	regulators	novel	JJ	B-NP	Oregulators	of	regulator	NNS	I-NP	Oof	cellular	of	IN	B-PP	Ocellular	differentiation	cellular	JJ	B-NP	Odifferentiation	.	differentiation	NN	I-NP	O.	Phosphatidylcholine	.	.	O	OPhosphatidylcholine	hydrolysis	Phosphatidylcholine	NN	B-NP	Ohydrolysis	activates	hydrolysis	NN	I-NP	Oactivates	NF-kappa	activate	VBZ	B-VP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	and	B	NN	I-NP	I-proteinand	increases	and	CC	O	Oincreases	human	increase	VBZ	B-VP	Ohuman	immunodeficiency	human	JJ	B-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	replication	virus	NN	I-NP	Oreplication	in	replication	NN	I-NP	Oin	human	in	IN	B-PP	Ohuman	monocytes	human	JJ	B-NP	B-cell_typemonocytes	and	monocyte	NNS	B-NP	I-cell_typeand	T	and	CC	O	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	B-NP	I-cell_type.	We	.	.	O	OWe	have	We	PRP	B-NP	Ohave	tested	have	VBP	B-VP	Otested	whether	test	VBN	I-VP	Owhether	breakdown	whether	IN	B-SBAR	Obreakdown	of	breakdown	NN	B-NP	Oof	phosphatidylcholine	of	IN	B-PP	Ophosphatidylcholine	(	phosphatidylcholine	NN	B-NP	O(	PC	(	(	O	OPC	)	PC	NN	B-NP	O)	initiated	)	)	O	Oinitiated	by	initiate	VBN	B-VP	Oby	exogenous	by	IN	B-PP	Oexogenous	addition	exogenous	JJ	B-NP	Oaddition	of	addition	NN	I-NP	Oof	a	of	IN	B-PP	Oa	PC-specific	a	DT	B-NP	OPC-specific	phospholipase	PC-specific	JJ	I-NP	B-cell_linephospholipase	C	phospholipase	NN	I-NP	I-cell_lineC	(	C	NN	I-NP	I-cell_line(	PC-PLC	(	(	O	OPC-PLC	)	PC-PLC	NN	B-NP	O)	from	)	)	O	Ofrom	Bacillus	from	IN	B-PP	OBacillus	cereus	Bacillus	NN	B-NP	Ocereus	or	cereus	NN	I-NP	Oor	by	or	CC	B-PP	Oby	endogenous	by	IN	B-PP	Oendogenous	overexpression	endogenous	JJ	B-NP	Ooverexpression	of	overexpression	NN	I-NP	Oof	PC-PLC	of	IN	B-PP	OPC-PLC	induces	PC-PLC	NN	B-NP	B-proteininduces	functional	induce	VBZ	B-VP	Ofunctional	activation	functional	JJ	B-NP	Oactivation	of	activation	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	and	B	NN	I-NP	I-proteinand	increases	and	CC	O	Oincreases	human	increase	VBZ	B-VP	Ohuman	immunodeficiency	human	JJ	B-NP	B-DNAimmunodeficiency	virus	immunodeficiency	NN	I-NP	I-DNAvirus	(	virus	NN	I-NP	I-DNA(	HIV	(	(	O	I-DNAHIV	)	HIV	NN	B-NP	I-DNA)	enhancer	)	)	O	I-DNAenhancer	activity	enhancer	NN	B-NP	I-DNAactivity	.	activity	NN	I-NP	O.	PC-PLC-activated	.	.	O	OPC-PLC-activated	hydrolysis	PC-PLC-activated	JJ	B-NP	Ohydrolysis	of	hydrolysis	NN	I-NP	Oof	PC	of	IN	B-PP	OPC	was	PC	NN	B-NP	B-cell_typewas	found	be	VBD	B-VP	Ofound	to	find	VBN	I-VP	Oto	induce	to	TO	I-VP	Oinduce	bona	induce	VB	I-VP	Obona	fide	bona	NN	B-NP	Ofide	p50/p65	fide	NN	I-NP	Op50/p65	NF-kappa	p50/p65	NN	I-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	binding	B	NN	I-NP	I-proteinbinding	activity	binding	NN	I-NP	Oactivity	in	activity	NN	I-NP	Oin	three	in	IN	B-PP	Othree	different	three	CD	B-NP	Odifferent	cell	different	JJ	I-NP	Ocell	lines	cell	NN	I-NP	B-cell_linelines	of	line	NNS	I-NP	I-cell_lineof	human	of	IN	B-PP	Ohuman	or	human	JJ	B-NP	Oor	murine	or	CC	I-NP	Omurine	origin	murine	JJ	I-NP	Oorigin	.	origin	NN	I-NP	O.	No	.	.	O	ONo	significant	No	DT	B-NP	Osignificant	changes	significant	JJ	I-NP	Ochanges	in	change	NNS	I-NP	Oin	the	in	IN	B-PP	Othe	turnover	the	DT	B-NP	Oturnover	of	turnover	NN	I-NP	Oof	other	of	IN	B-PP	Oother	cellular	other	JJ	B-NP	Ocellular	phospholipids	cellular	JJ	I-NP	Ophospholipids	were	phospholipid	NNS	I-NP	Owere	detected	be	VBD	B-VP	Odetected	in	detect	VBN	I-VP	Oin	PC-PLC-treated	in	IN	B-PP	OPC-PLC-treated	cells	PC-PLC-treated	JJ	B-NP	B-cell_linecells	.	cell	NNS	I-NP	I-cell_line.	Induction	.	.	O	OInduction	of	Induction	NN	B-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	by	B	NN	I-NP	I-proteinby	PC-PLC	by	IN	B-PP	OPC-PLC	did	PC-PLC	NN	B-NP	B-proteindid	not	do	VBD	B-VP	Onot	depend	not	RB	I-VP	Odepend	on	depend	VB	I-VP	Oon	de	on	IN	B-PP	Ode	novo	de	FW	B-NP	Onovo	synthesis	novo	FW	I-NP	Osynthesis	of	synthesis	NN	I-NP	Oof	proteins	of	IN	B-PP	Oproteins	or	protein	NNS	B-NP	Oor	autocrine	or	CC	O	Oautocrine	secretion	autocrine	JJ	B-NP	Osecretion	of	secretion	NN	I-NP	Oof	either	of	IN	B-PP	Oeither	tumor	either	CC	O	Otumor	necrosis	tumor	NN	B-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	or	factor	NN	I-NP	I-proteinor	interleukin	or	CC	O	Ointerleukin	1	interleukin	NN	B-NP	B-protein1	.	1	CD	I-NP	I-protein.	In	.	.	O	OIn	human	In	IN	B-PP	Ohuman	monocytic	human	JJ	B-NP	Omonocytic	and	monocytic	JJ	I-NP	Oand	lymphoblastoid	and	CC	I-NP	Olymphoblastoid	T-cell	lymphoblastoid	JJ	I-NP	B-cell_lineT-cell	lines	T-cell	NN	I-NP	I-cell_linelines	","	line	NNS	I-NP	I-cell_line","	induction	","	","	O	Oinduction	of	induction	NN	B-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	by	B	NN	I-NP	I-proteinby	PC-PLC	by	IN	B-PP	OPC-PLC	resulted	PC-PLC	NN	B-NP	B-proteinresulted	in	result	VBD	B-VP	Oin	clear	in	IN	B-PP	Oclear	induction	clear	JJ	B-NP	Oinduction	of	induction	NN	I-NP	Oof	luciferase	of	IN	B-PP	Oluciferase	expression	luciferase	NN	B-NP	B-DNAexpression	vectors	expression	NN	I-NP	I-DNAvectors	placed	vector	NNS	I-NP	I-DNAplaced	under	place	VBN	B-VP	Ounder	the	under	IN	B-PP	Othe	control	the	DT	B-NP	Ocontrol	of	control	NN	I-NP	Oof	synthetic	of	IN	B-PP	Osynthetic	kappa	synthetic	JJ	B-NP	B-DNAkappa	B	kappa	NN	I-NP	I-DNAB	enhancers	B	NN	I-NP	I-DNAenhancers	or	enhancer	NNS	I-NP	I-DNAor	wild	or	CC	O	Owild	type	wild	JJ	B-NP	Otype	","	type	NN	I-NP	O","	but	","	","	O	Obut	not	but	CC	O	Onot	kappa	not	RB	O	Okappa	B-mutated	kappa	NN	B-NP	OB-mutated	","	B-mutated	JJ	B-ADJP	O","	HIV	","	","	O	OHIV	long	HIV	NN	B-NP	B-DNAlong	terminal	long	JJ	I-NP	I-DNAterminal	repeat	terminal	JJ	I-NP	I-DNArepeat	constructs	repeat	NN	I-NP	I-DNAconstructs	.	construct	NNS	I-NP	I-DNA.	HIV	.	.	O	OHIV	replication	HIV	NN	B-NP	Oreplication	was	replication	NN	I-NP	Owas	increased	be	VBD	B-VP	Oincreased	by	increase	VBN	I-VP	Oby	PC-PLC	by	IN	B-PP	OPC-PLC	in	PC-PLC	NN	B-NP	B-proteinin	chronically	in	IN	B-PP	Ochronically	infected	chronically	RB	B-NP	Oinfected	monocytes	infected	JJ	I-NP	Omonocytes	and	monocyte	NNS	I-NP	B-cell_typeand	T	and	CC	O	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	.	lymphocyte	NNS	B-NP	I-cell_type.	NF-kappa	.	.	O	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	promoted	activation	NN	I-NP	Opromoted	by	promote	VBN	B-VP	Oby	addition	by	IN	B-PP	Oaddition	of	addition	NN	B-NP	Oof	exogenous	of	IN	B-PP	Oexogenous	PC-PLC	exogenous	JJ	B-NP	OPC-PLC	correlated	PC-PLC	NN	I-NP	Ocorrelated	with	correlate	VBD	B-VP	Owith	an	with	IN	B-PP	Oan	intense	an	DT	B-NP	Ointense	production	intense	JJ	I-NP	Oproduction	of	production	NN	I-NP	Oof	diacylglycerol	of	IN	B-PP	Odiacylglycerol	.	diacylglycerol	NN	B-NP	O.	However	.	.	O	OHowever	","	However	RB	B-ADVP	O","	addition	","	","	O	Oaddition	of	addition	NN	B-NP	Oof	a	of	IN	B-PP	Oa	phosphatidylinositol-specific	a	DT	B-NP	Ophosphatidylinositol-specific	PLC	phosphatidylinositol-specific	JJ	I-NP	OPLC	from	PLC	NN	I-NP	Ofrom	B.cereus	from	IN	B-PP	OB.cereus	also	B.cereus	NNP	B-NP	Oalso	induced	also	RB	B-ADVP	Oinduced	diacylglycerol	induce	VBD	B-VP	Odiacylglycerol	but	diacylglycerol	NN	B-NP	Obut	did	but	CC	O	Odid	not	do	VBD	B-VP	Onot	activate	not	RB	I-VP	Oactivate	kappa	activate	VB	I-VP	Okappa	B	kappa	NN	B-NP	OB	enhancer-directed	B	NN	I-NP	Oenhancer-directed	vectors	enhancer-directed	JJ	I-NP	Ovectors	.	vector	NNS	I-NP	O.	PC-PLC-induced	.	.	O	OPC-PLC-induced	NF-kappa	PC-PLC-induced	JJ	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	activation	B	NN	I-NP	I-proteinactivation	could	activation	NN	I-NP	Ocould	not	could	MD	B-VP	Onot	be	not	RB	I-VP	Obe	blocked	be	VB	I-VP	Oblocked	by	block	VBN	I-VP	Oby	a	by	IN	B-PP	Oa	specific	a	DT	B-NP	Ospecific	inhibitor	specific	JJ	I-NP	Oinhibitor	of	inhibitor	NN	I-NP	Oof	phorbol	of	IN	B-PP	Ophorbol	ester-inducible	phorbol	NN	B-NP	B-proteinester-inducible	protein	ester-inducible	JJ	I-NP	I-proteinprotein	kinases	protein	NN	I-NP	I-proteinkinases	C	kinase	NNS	I-NP	I-proteinC	.	C	NN	I-NP	I-protein.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	indicate	result	NNS	I-NP	Oindicate	that	indicate	VBP	B-VP	Othat	a	that	IN	B-SBAR	Oa	cellular	a	DT	B-NP	Ocellular	transduction	cellular	JJ	I-NP	Otransduction	pathway	transduction	NN	I-NP	Opathway	","	pathway	NN	I-NP	O","	dependent	","	","	O	Odependent	on	dependent	JJ	B-ADJP	Oon	specific	on	IN	B-PP	Ospecific	PC	specific	JJ	B-NP	OPC	breakdown	PC	NN	I-NP	Obreakdown	","	breakdown	NN	I-NP	O","	is	","	","	O	Ois	functional	be	VBZ	B-VP	Ofunctional	in	functional	JJ	B-ADJP	Oin	T	in	IN	B-PP	OT	lymphocytes	T	NN	B-NP	B-cell_typelymphocytes	and	lymphocyte	NNS	I-NP	I-cell_typeand	monocytes	and	CC	O	Omonocytes	and	monocyte	NNS	B-NP	B-cell_typeand	may	and	CC	O	Omay	be	may	MD	B-VP	Obe	used	be	VB	I-VP	Oused	by	use	VBN	I-VP	Oby	various	by	IN	B-PP	Ovarious	transmembrane	various	JJ	B-NP	Otransmembrane	receptors	transmembrane	NN	I-NP	B-proteinreceptors	to	receptor	NNS	I-NP	I-proteinto	activate	to	TO	B-VP	Oactivate	HIV	activate	VB	I-VP	OHIV	transcription	HIV	NN	B-NP	Otranscription	through	transcription	NN	I-NP	Othrough	NF-kappa	through	IN	B-PP	ONF-kappa	B-dependent	NF-kappa	NN	B-NP	OB-dependent	induction	B-dependent	JJ	I-NP	Oinduction	of	induction	NN	I-NP	Oof	the	of	IN	B-PP	Othe	HIV	the	DT	B-NP	OHIV	enhancer	HIV	NN	I-NP	B-DNAenhancer	.	enhancer	NN	I-NP	I-DNA.	Novel	.	.	O	ONovel	mechanism	Novel	JJ	B-NP	Omechanism	for	mechanism	NN	I-NP	Ofor	inhibition	for	IN	B-PP	Oinhibition	of	inhibition	NN	B-NP	Oof	human	of	IN	B-PP	Ohuman	T	human	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	glucocorticoids	by	IN	B-PP	Oglucocorticoids	.	glucocorticoid	NNS	B-NP	O.	Glucocorticoids	.	.	O	OGlucocorticoids	inhibit	Glucocorticoid	NNS	B-NP	Oinhibit	signal	inhibit	VBP	B-VP	Osignal	transduction	signal	NN	B-NP	Otransduction	through	transduction	NN	I-NP	Othrough	IL-2	through	IN	B-PP	OIL-2	receptor	IL-2	NN	B-NP	B-proteinreceptor	.	receptor	NN	I-NP	I-protein.	Interaction	.	.	O	OInteraction	of	Interaction	NN	B-NP	Oof	IL-2	of	IN	B-PP	OIL-2	with	IL-2	NN	B-NP	B-proteinwith	its	with	IN	B-PP	Oits	high	its	PRP$	B-NP	Ohigh	affinity	high	JJ	I-NP	B-proteinaffinity	membrane	affinity	NN	I-NP	I-proteinmembrane	receptor	membrane	NN	I-NP	I-proteinreceptor	complex	receptor	NN	I-NP	I-proteincomplex	(	complex	NN	I-NP	I-protein(	IL-2R	(	(	O	OIL-2R	)	IL-2R	NN	B-NP	B-protein)	present	)	)	O	Opresent	on	present	JJ	B-ADJP	Oon	activated	on	IN	B-PP	Oactivated	T	activate	VBN	B-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	induces	lymphocyte	NNS	I-NP	I-cell_typeinduces	cell	induce	VBZ	B-VP	Ocell	proliferation	cell	NN	B-NP	Oproliferation	and	proliferation	NN	I-NP	Oand	mediates	and	CC	O	Omediates	effector	mediate	VBZ	B-VP	Oeffector	functions	effector	NN	B-NP	Ofunctions	.	function	NNS	I-NP	O.	Glucocorticoids	.	.	O	OGlucocorticoids	inhibit	Glucocorticoid	NNS	B-NP	Oinhibit	IL-2	inhibit	VBP	B-VP	OIL-2	production	IL-2	NN	B-NP	B-proteinproduction	by	production	NN	I-NP	Oby	inhibiting	by	IN	B-PP	Oinhibiting	TCR-mediated	inhibit	VBG	B-VP	OTCR-mediated	signal	TCR-mediated	JJ	B-NP	Osignal	transduction	signal	NN	I-NP	Otransduction	.	transduction	NN	I-NP	O.	We	.	.	O	OWe	asked	We	PRP	B-NP	Oasked	whether	ask	VBD	B-VP	Owhether	they	whether	IN	B-SBAR	Othey	also	they	PRP	B-NP	Oalso	inhibit	also	RB	B-ADVP	Oinhibit	the	inhibit	VBP	B-VP	Othe	action	the	DT	B-NP	Oaction	of	action	NN	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	by	IL-2	NN	B-NP	B-proteinby	inhibiting	by	IN	B-PP	Oinhibiting	signal	inhibit	VBG	B-VP	Osignal	transduction	signal	NN	B-NP	Otransduction	through	transduction	NN	I-NP	Othrough	IL-2R	through	IN	B-PP	OIL-2R	.	IL-2R	NN	B-NP	B-protein.	Human	.	.	O	OHuman	peripheral	Human	JJ	B-NP	B-cell_typeperipheral	blood	peripheral	JJ	I-NP	I-cell_typeblood	T	blood	NN	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	stimulated	","	","	O	Ostimulated	with	stimulate	VBN	B-VP	Owith	PMA	with	IN	B-PP	OPMA	for	PMA	NN	B-NP	Ofor	48	for	IN	B-PP	O48	h	48	CD	B-NP	Oh	(	h	NN	I-NP	O(	PMA	(	(	O	OPMA	blasts	PMA	NN	B-NP	B-cell_typeblasts	)	blast	NNS	I-NP	I-cell_type)	","	)	)	O	O","	were	","	","	O	Owere	incubated	be	VBD	B-VP	Oincubated	with	incubate	VBN	I-VP	Owith	IL-2	with	IN	B-PP	OIL-2	in	IL-2	NN	B-NP	B-proteinin	the	in	IN	B-PP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	incremental	of	IN	B-PP	Oincremental	dosages	incremental	JJ	B-NP	Odosages	of	dosage	NNS	I-NP	Oof	dexamethasone	of	IN	B-PP	Odexamethasone	(	dexamethasone	NN	B-NP	O(	Dex	(	(	O	ODex	;	Dex	NN	B-NP	O;	10	;	:	O	O10	(	10	CD	B-NP	O(	-5	(	(	O	O-5	)	-5	CD	B-NP	O)	-10	)	)	O	O-10	(	-10	CD	B-NP	O(	-9	(	(	O	O-9	)	-9	CD	B-NP	O)	M	)	)	O	OM	)	M	NN	B-NP	O)	.	)	)	O	O.	Dex	.	.	O	ODex	inhibited	Dex	NN	B-NP	Oinhibited	the	inhibit	VBD	B-VP	Othe	IL-2-dependent	the	DT	B-NP	OIL-2-dependent	proliferation	IL-2-dependent	JJ	I-NP	Oproliferation	of	proliferation	NN	I-NP	Oof	PMA	of	IN	B-PP	OPMA	blasts	PMA	NN	B-NP	B-cell_typeblasts	in	blast	NNS	I-NP	I-cell_typein	a	in	IN	B-PP	Oa	dose-dependent	a	DT	B-NP	Odose-dependent	fashion	dose-dependent	JJ	I-NP	Ofashion	(	fashion	NN	I-NP	O(	IC50	(	(	O	OIC50	","	IC50	NN	B-NP	O","	5	","	","	O	O5	x	5	CD	B-NP	Ox	10	x	NN	I-NP	O10	(	10	CD	I-NP	O(	-8	(	(	O	O-8	)	-8	CD	B-NP	O)	M	)	)	O	OM	)	M	NN	B-NP	O)	.	)	)	O	O.	Cell	.	.	O	OCell	surface	Cell	NN	B-NP	Osurface	expression	surface	NN	I-NP	Oexpression	of	expression	NN	I-NP	Oof	IL-2R	of	IN	B-PP	OIL-2R	alpha-	IL-2R	NN	B-NP	B-proteinalpha-	and	alpha-	NN	I-NP	I-proteinand	beta-chains	and	CC	O	Obeta-chains	as	beta-chain	NNS	B-NP	B-proteinas	determined	as	IN	B-SBAR	Odetermined	by	determine	VBN	B-VP	Oby	immunofluorescence	by	IN	B-PP	Oimmunofluorescence	analysis	immunofluorescence	NN	B-NP	Oanalysis	was	analysis	NN	I-NP	Owas	not	be	VBD	B-VP	Onot	affected	not	RB	I-VP	Oaffected	by	affect	VBN	I-VP	Oby	Dex	by	IN	B-PP	ODex	.	Dex	NN	B-NP	O.	In	.	.	O	OIn	addition	In	IN	B-PP	Oaddition	","	addition	NN	B-NP	O","	Scatchard	","	","	O	OScatchard	plot	Scatchard	NN	B-NP	Oplot	analysis	plot	NN	I-NP	Oanalysis	of	analysis	NN	I-NP	Oof	125I-labeled	of	IN	B-PP	O125I-labeled	IL-2	125I-labeled	JJ	B-NP	OIL-2	showed	IL-2	NN	I-NP	B-proteinshowed	that	show	VBD	B-VP	Othat	Dex	that	IN	B-SBAR	ODex	did	Dex	NN	B-NP	Odid	not	do	VBD	B-VP	Onot	affect	not	RB	I-VP	Oaffect	the	affect	VB	I-VP	Othe	binding	the	DT	B-NP	Obinding	of	binding	NN	I-NP	Oof	IL-2	of	IN	B-PP	OIL-2	","	IL-2	NN	B-NP	B-protein","	thus	","	","	O	Othus	suggesting	thus	RB	B-ADVP	Osuggesting	that	suggest	VBG	B-VP	Othat	inhibition	that	IN	B-SBAR	Oinhibition	is	inhibition	NN	B-NP	Ois	due	be	VBZ	B-VP	Odue	to	due	IN	B-PP	Oto	a	to	TO	B-PP	Oa	postreceptor	a	DT	B-NP	Opostreceptor	effect	postreceptor	NN	I-NP	Oeffect	.	effect	NN	I-NP	O.	Inhibition	.	.	O	OInhibition	of	Inhibition	NN	B-NP	Oof	T	of	IN	B-PP	OT	cell	T	NN	B-NP	B-cell_typecell	proliferation	cell	NN	I-NP	I-cell_typeproliferation	by	proliferation	NN	I-NP	Oby	Dex	by	IN	B-PP	ODex	was	Dex	NN	B-NP	Owas	associated	be	VBD	B-VP	Oassociated	with	associate	VBN	I-VP	Owith	decreased	with	IN	B-PP	Odecreased	IL-2-dependent	decrease	VBN	B-NP	OIL-2-dependent	tyrosine	IL-2-dependent	JJ	I-NP	Otyrosine	phosphorylation	tyrosine	NN	I-NP	Ophosphorylation	of	phosphorylation	NN	I-NP	Oof	several	of	IN	B-PP	Oseveral	intracellular	several	JJ	B-NP	Ointracellular	proteins	intracellular	JJ	I-NP	B-proteinproteins	and	protein	NNS	I-NP	I-proteinand	decreased	and	CC	O	Odecreased	phosphorylation	decrease	VBD	B-VP	Ophosphorylation	of	phosphorylation	NN	B-NP	Oof	the	of	IN	B-PP	Othe	retinoblastoma	the	DT	B-NP	Oretinoblastoma	gene	retinoblastoma	NN	I-NP	B-proteingene	product	gene	NN	I-NP	I-proteinproduct	Rb	product	NN	I-NP	I-proteinRb	","	Rb	NN	I-NP	B-protein","	a	","	","	O	Oa	protein	a	DT	B-NP	Oprotein	essential	protein	NN	I-NP	Oessential	for	essential	JJ	B-ADJP	Ofor	controlling	for	IN	B-PP	Ocontrolling	the	control	VBG	B-VP	Othe	progression	the	DT	B-NP	Oprogression	of	progression	NN	I-NP	Oof	cells	of	IN	B-PP	Ocells	through	cell	NNS	B-NP	Othrough	the	through	IN	B-PP	Othe	cell	the	DT	B-NP	Ocell	cycle	cell	NN	I-NP	Ocycle	.	cycle	NN	I-NP	O.	IL-2-dependent	.	.	O	OIL-2-dependent	IL-2R	IL-2-dependent	JJ	B-NP	OIL-2R	alpha	IL-2R	NN	I-NP	B-proteinalpha	expression	alpha	NN	I-NP	I-proteinexpression	in	expression	NN	I-NP	Oin	PMA	in	IN	B-PP	OPMA	blasts	PMA	NN	B-NP	B-cell_typeblasts	and	blast	NNS	I-NP	I-cell_typeand	NF-kB	and	CC	O	ONF-kB	induction	NF-kB	NN	B-NP	B-proteininduction	in	induction	NN	I-NP	Oin	resting	in	IN	B-PP	Oresting	human	rest	VBG	B-NP	B-cell_typehuman	T	human	JJ	I-NP	I-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	were	cell	NNS	I-NP	I-cell_typewere	also	be	VBD	B-VP	Oalso	inhibited	also	RB	I-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	Dex	by	IN	B-PP	ODex	.	Dex	NN	B-NP	O.	These	.	.	O	OThese	results	These	DT	B-NP	Oresults	demonstrate	result	NNS	I-NP	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	glucocorticoids	that	IN	B-SBAR	Oglucocorticoids	inhibit	glucocorticoid	NNS	B-NP	Oinhibit	preactivated	inhibit	VBP	B-VP	Opreactivated	T	preactivated	JJ	B-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	by	cell	NNS	I-NP	I-cell_typeby	down-regulating	by	IN	B-PP	Odown-regulating	signal	down-regulate	VBG	B-VP	Osignal	transduction	signal	NN	B-NP	Otransduction	through	transduction	NN	I-NP	Othrough	IL-2R	through	IN	B-PP	OIL-2R	.	IL-2R	NN	B-NP	B-protein.	Chronic	.	.	O	OChronic	human	Chronic	JJ	B-NP	Ohuman	immunodeficiency	human	JJ	I-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	infection	1	CD	I-NP	Oinfection	stimulates	infection	NN	I-NP	Ostimulates	distinct	stimulate	VBZ	B-VP	Odistinct	NF-kappa	distinct	JJ	B-NP	ONF-kappa	B/rel	NF-kappa	NN	I-NP	B-proteinB/rel	DNA	B/rel	NN	I-NP	I-proteinDNA	binding	DNA	NN	I-NP	Obinding	activities	binding	NN	I-NP	Oactivities	in	activity	NNS	I-NP	Oin	myelomonoblastic	in	IN	B-PP	Omyelomonoblastic	cells	myelomonoblastic	JJ	B-NP	B-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	The	.	.	O	OThe	relationship	The	DT	B-NP	Orelationship	between	relationship	NN	I-NP	Obetween	human	between	IN	B-PP	Ohuman	immunodeficiency	human	JJ	B-NP	Oimmunodeficiency	virus	immunodeficiency	NN	I-NP	Ovirus	type	virus	NN	I-NP	Otype	1	type	NN	I-NP	O1	(	1	CD	I-NP	O(	HIV-1	(	(	O	OHIV-1	)	HIV-1	NN	B-NP	O)	infection	)	)	O	Oinfection	and	infection	NN	B-NP	Oand	the	and	CC	O	Othe	induction	the	DT	B-NP	Oinduction	of	induction	NN	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	binding	B	NN	I-NP	I-proteinbinding	activity	binding	NN	I-NP	Oactivity	was	activity	NN	I-NP	Owas	examined	be	VBD	B-VP	Oexamined	in	examine	VBN	I-VP	Oin	a	in	IN	B-PP	Oa	myeloid	a	DT	B-NP	Omyeloid	cell	myeloid	JJ	I-NP	Ocell	model	cell	NN	I-NP	Omodel	of	model	NN	I-NP	Oof	HIV-1	of	IN	B-PP	OHIV-1	infection	HIV-1	NN	B-NP	Oinfection	derived	infection	NN	I-NP	Oderived	from	derive	VBN	B-VP	Ofrom	the	from	IN	B-PP	Othe	PLB-985	the	DT	B-NP	OPLB-985	cell	PLB-985	NN	I-NP	B-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	.	line	NN	I-NP	I-cell_line.	Chronic	.	.	O	OChronic	infection	Chronic	JJ	B-NP	Oinfection	of	infection	NN	I-NP	Oof	PLB-985	of	IN	B-PP	OPLB-985	cells	PLB-985	NN	B-NP	B-cell_linecells	led	cell	NNS	I-NP	I-cell_lineled	to	lead	VBD	B-VP	Oto	increased	to	TO	B-PP	Oincreased	monocyte-specific	increase	VBN	B-NP	Omonocyte-specific	surface	monocyte-specific	JJ	I-NP	B-proteinsurface	marker	surface	NN	I-NP	I-proteinmarker	expression	marker	NN	I-NP	I-proteinexpression	","	expression	NN	I-NP	O","	increased	","	","	O	Oincreased	c-fms	increase	VBD	B-VP	Oc-fms	gene	c-fms	NN	B-NP	B-DNAgene	transcription	gene	NN	I-NP	I-DNAtranscription	","	transcription	NN	I-NP	O","	and	","	","	O	Oand	morphological	and	CC	O	Omorphological	alterations	morphological	JJ	B-NP	Oalterations	consistent	alteration	NNS	I-NP	Oconsistent	with	consistent	JJ	B-ADJP	Owith	differentiation	with	IN	B-PP	Odifferentiation	along	differentiation	NN	B-NP	Oalong	the	along	IN	B-PP	Othe	monocytic	the	DT	B-NP	Omonocytic	pathway	monocytic	JJ	I-NP	Opathway	.	pathway	NN	I-NP	O.	PLB-IIIB	.	.	O	OPLB-IIIB	cells	PLB-IIIB	NN	B-NP	B-cell_linecells	displayed	cell	NNS	I-NP	I-cell_linedisplayed	a	display	VBD	B-VP	Oa	constitutive	a	DT	B-NP	Oconstitutive	NF-kappa	constitutive	JJ	I-NP	ONF-kappa	B-like	NF-kappa	NN	I-NP	OB-like	binding	B-like	JJ	I-NP	Obinding	activity	binding	NN	I-NP	Oactivity	that	activity	NN	I-NP	Othat	was	that	WDT	B-NP	Owas	distinct	be	VBD	B-VP	Odistinct	from	distinct	JJ	B-ADJP	Ofrom	that	from	IN	B-PP	Othat	induced	that	DT	B-NP	Oinduced	by	induce	VBN	B-VP	Oby	tumor	by	IN	B-PP	Otumor	necrosis	tumor	NN	B-NP	B-proteinnecrosis	factor	necrosis	NN	I-NP	I-proteinfactor	alpha	factor	NN	I-NP	I-proteinalpha	or	alpha	NN	I-NP	I-proteinor	phorbol	or	CC	O	Ophorbol	12-myristate	phorbol	NN	B-NP	O12-myristate	13-acetate	12-myristate	NN	I-NP	O13-acetate	treatment	13-acetate	NN	I-NP	Otreatment	of	treatment	NN	I-NP	Oof	the	of	IN	B-PP	Othe	parental	the	DT	B-NP	Oparental	PLB-985	parental	JJ	I-NP	B-cell_linePLB-985	cell	PLB-985	NN	I-NP	I-cell_linecell	line	cell	NN	I-NP	I-cell_lineline	.	line	NN	I-NP	I-cell_line.	This	.	.	O	OThis	unique	This	DT	B-NP	Ounique	DNA	unique	JJ	I-NP	ODNA	binding	DNA	NN	I-NP	Obinding	activity	binding	NN	I-NP	Oactivity	consisted	activity	NN	I-NP	Oconsisted	of	consist	VBD	B-VP	Oof	proteins	of	IN	B-PP	Oproteins	of	protein	NNS	B-NP	Oof	70	of	IN	B-PP	O70	","	70	CD	B-NP	O","	90	","	","	I-NP	O90	","	90	CD	I-NP	O","	and	","	","	O	Oand	100	and	CC	O	O100	kDa	100	CD	B-NP	B-proteinkDa	with	kDa	NN	I-NP	I-proteinwith	a	with	IN	B-PP	Oa	high	a	DT	B-NP	Ohigh	degree	high	JJ	I-NP	Odegree	of	degree	NN	I-NP	Oof	binding	of	IN	B-PP	Obinding	specificity	binding	NN	B-NP	Ospecificity	for	specificity	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	NF-kappa	the	DT	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-DNAB	site	B	NN	I-NP	I-DNAsite	within	site	NN	I-NP	I-DNAwithin	the	within	IN	B-PP	Othe	PRDII	the	DT	B-NP	OPRDII	domain	PRDII	NN	I-NP	B-DNAdomain	of	domain	NN	I-NP	I-DNAof	beta	of	IN	B-PP	Obeta	interferon	beta	SYM	B-NP	B-proteininterferon	.	interferon	NN	I-NP	I-protein.	In	.	.	O	OIn	this	In	IN	B-PP	Othis	report	this	DT	B-NP	Oreport	","	report	NN	I-NP	O","	we	","	","	O	Owe	characterize	we	PRP	B-NP	Ocharacterize	the	characterize	VBP	B-VP	Othe	nature	the	DT	B-NP	Onature	of	nature	NN	I-NP	Oof	these	of	IN	B-PP	Othese	proteins	these	DT	B-NP	Oproteins	and	protein	NNS	I-NP	Oand	demonstrate	and	CC	O	Odemonstrate	that	demonstrate	VBP	B-VP	Othat	binding	that	IN	B-SBAR	Obinding	of	binding	NN	B-NP	Oof	these	of	IN	B-PP	Othese	proteins	these	DT	B-NP	Oproteins	is	protein	NNS	I-NP	Ois	also	be	VBZ	B-VP	Oalso	induced	also	RB	I-VP	Oinduced	following	induce	VBN	I-VP	Ofollowing	Sendai	follow	VBG	B-PP	OSendai	paramyxovirus	Sendai	NNP	B-NP	Oparamyxovirus	infection	paramyxovirus	NN	I-NP	Oinfection	.	infection	NN	I-NP	O.	The	.	.	O	OThe	70-kDa	The	DT	B-NP	O70-kDa	protein	70-kDa	JJ	I-NP	B-proteinprotein	corresponds	protein	NN	I-NP	I-proteincorresponds	to	correspond	VBZ	B-VP	Oto	the	to	TO	B-PP	Othe	NF-kappa	the	DT	B-NP	ONF-kappa	B	NF-kappa	NN	I-NP	B-proteinB	RelA	B	NN	I-NP	I-proteinRelA	(	RelA	NN	I-NP	I-protein(	p65	(	(	O	I-proteinp65	)	p65	NN	B-NP	I-protein)	subunit	)	)	O	I-proteinsubunit	","	subunit	NN	B-NP	I-protein","	which	","	","	O	Owhich	is	which	WDT	B-NP	Ois	activated	be	VBZ	B-VP	Oactivated	in	activate	VBN	I-VP	Oin	response	in	IN	B-PP	Oresponse	to	response	NN	B-NP	Oto	an	to	TO	B-PP	Oan	acute	an	DT	B-NP	Oacute	paramyxovirus	acute	JJ	I-NP	Oparamyxovirus	infection	paramyxovirus	NN	I-NP	Oinfection	or	infection	NN	I-NP	Oor	a	or	CC	O	Oa	chronic	a	DT	B-NP	Ochronic	HIV-1	chronic	JJ	I-NP	OHIV-1	infection	HIV-1	NN	I-NP	Oinfection	.	infection	NN	I-NP	O.	Virus	.	.	O	OVirus	infection	Virus	NN	B-NP	Oinfection	does	infection	NN	I-NP	Odoes	not	do	VBZ	B-VP	Onot	appear	not	RB	I-VP	Oappear	to	appear	VB	I-VP	Oto	alter	to	TO	I-VP	Oalter	the	alter	VB	I-VP	Othe	amount	the	DT	B-NP	Oamount	of	amount	NN	I-NP	Oof	RelA	of	IN	B-PP	ORelA	(	RelA	NN	B-NP	B-protein(	p65	(	(	O	Op65	)	p65	NN	B-NP	B-protein)	or	)	)	O	Oor	NFKB1	or	CC	O	ONFKB1	(	NFKB1	NN	B-NP	B-protein(	p50	(	(	O	Op50	)	p50	NN	B-NP	B-protein)	but	)	)	O	Obut	rather	but	CC	O	Orather	affects	rather	RB	B-VP	Oaffects	the	affect	VBZ	I-VP	Othe	capacity	the	DT	B-NP	Ocapacity	of	capacity	NN	I-NP	Oof	I	of	IN	B-PP	OI	kappa	I	NN	B-NP	B-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha	B	NN	I-NP	I-proteinalpha	to	alpha	NN	I-NP	I-proteinto	sequester	to	TO	B-VP	Osequester	RelA	sequester	VB	I-VP	ORelA	(	RelA	NN	B-NP	B-protein(	p65	(	(	O	Op65	)	p65	NN	B-NP	B-protein)	","	)	)	O	O","	therefore	","	","	O	Otherefore	leading	therefore	RB	B-ADVP	Oleading	to	lead	VBG	B-VP	Oto	constitutive	to	TO	B-PP	Oconstitutive	levels	constitutive	JJ	B-NP	Olevels	of	level	NNS	I-NP	Oof	RelA	of	IN	B-PP	ORelA	DNA	RelA	NN	B-NP	B-proteinDNA	binding	DNA	NN	I-NP	Obinding	activity	binding	NN	I-NP	Oactivity	and	activity	NN	I-NP	Oand	to	and	CC	B-PP	Oto	increased	to	TO	B-PP	Oincreased	levels	increase	VBN	B-NP	Olevels	of	level	NNS	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B-dependent	NF-kappa	NN	B-NP	B-DNAB-dependent	gene	B-dependent	JJ	I-NP	I-DNAgene	activity	gene	NN	I-NP	I-DNAactivity	.	activity	NN	I-NP	O.	The	.	.	O	OThe	virally	The	DT	B-NP	Ovirally	induced	virally	RB	I-NP	Oinduced	90-	induce	VBN	I-NP	O90-	to	90-	CD	I-NP	Oto	100-kDa	to	TO	B-PP	O100-kDa	proteins	100-kDa	JJ	B-NP	B-proteinproteins	have	protein	NNS	I-NP	I-proteinhave	a	have	VBP	B-VP	Oa	distinct	a	DT	B-NP	Odistinct	binding	distinct	JJ	I-NP	Obinding	specificity	binding	NN	I-NP	Ospecificity	for	specificity	NN	I-NP	Ofor	the	for	IN	B-PP	Othe	PRDII	the	DT	B-NP	OPRDII	domain	PRDII	NN	I-NP	B-DNAdomain	and	domain	NN	I-NP	I-DNAand	an	and	CC	O	Oan	AT-rich	an	DT	B-NP	OAT-rich	sequence	AT-rich	JJ	I-NP	B-DNAsequence	but	sequence	NN	I-NP	I-DNAbut	do	but	CC	O	Odo	not	do	VBP	B-VP	Onot	cross-react	not	RB	I-VP	Ocross-react	with	cross-react	VB	I-VP	Owith	NF-kappa	with	IN	B-PP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	subunit-specific	B	NN	I-NP	I-proteinsubunit-specific	antisera	subunit-specific	JJ	I-NP	Oantisera	directed	antiserum	NNS	I-NP	Odirected	against	direct	VBN	B-VP	Oagainst	NFKB1	against	IN	B-PP	ONFKB1	(	NFKB1	NN	B-NP	B-protein(	p105	(	(	O	Op105	or	p105	NN	B-NP	B-proteinor	p50	or	CC	O	Op50	)	p50	NN	B-NP	B-protein)	","	)	)	O	O","	NFKB2	","	","	O	ONFKB2	(	NFKB2	NN	B-NP	B-protein(	p100	(	(	O	Op100	or	p100	NN	B-NP	B-proteinor	p52	or	CC	O	Op52	)	p52	NN	B-NP	B-protein)	","	)	)	O	O","	RelA	","	","	O	ORelA	(	RelA	NN	B-NP	B-protein(	p65	(	(	O	Op65	)	p65	NN	B-NP	B-protein)	","	)	)	O	O","	or	","	","	O	Oor	c-rel	or	CC	O	Oc-rel	.	c-rel	NN	B-NP	B-protein.	DNA	.	.	O	ODNA	binding	DNA	NN	B-NP	Obinding	of	binding	NN	I-NP	Oof	the	of	IN	B-PP	Othe	90-	the	DT	B-NP	O90-	to	90-	CD	I-NP	Oto	100-kDa	to	TO	B-PP	O100-kDa	proteins	100-kDa	JJ	B-NP	B-proteinproteins	was	protein	NNS	I-NP	I-proteinwas	not	be	VBD	B-VP	Onot	inhibited	not	RB	I-VP	Oinhibited	by	inhibit	VBN	I-VP	Oby	recombinant	by	IN	B-PP	Orecombinant	I	recombinant	JJ	B-NP	B-proteinI	kappa	I	NN	I-NP	I-proteinkappa	B	kappa	NN	I-NP	I-proteinB	alpha/MAD-3	B	NN	I-NP	I-proteinalpha/MAD-3	and	alpha/MAD-3	NN	I-NP	I-proteinand	was	and	CC	O	Owas	resistant	be	VBD	B-VP	Oresistant	to	resistant	JJ	B-ADJP	Oto	tryptic	to	TO	B-PP	Otryptic	digestion	tryptic	JJ	B-NP	Odigestion	","	digestion	NN	I-NP	O","	suggesting	","	","	O	Osuggesting	that	suggest	VBG	B-VP	Othat	these	that	IN	B-SBAR	Othese	proteins	these	DT	B-NP	Oproteins	may	protein	NNS	I-NP	Omay	not	may	MD	B-VP	Onot	be	not	RB	I-VP	Obe	NF-kappa	be	VB	I-VP	ONF-kappa	B	NF-kappa	NN	B-NP	B-proteinB	related	B	NN	I-NP	I-proteinrelated	.	relate	VBN	B-VP	O.	Transient	.	.	O	OTransient	cotransfection	Transient	JJ	B-NP	Ocotransfection	experiments	cotransfection	NN	I-NP	Oexperiments	demonstrated	experiment	NNS	I-NP	Odemonstrated	that	demonstrate	VBD	B-VP	Othat	RelA	that	IN	B-SBAR	ORelA	and	RelA	NN	B-NP	B-proteinand	NFKB1	and	CC	I-NP	ONFKB1	expression	NFKB1	NN	I-NP	B-proteinexpression	maximally	expression	NN	I-NP	Omaximally	stimulated	maximally	RB	B-ADVP	Ostimulated	HIV-1	stimulate	VBD	B-VP	OHIV-1	LTR-	HIV-1	NN	B-NP	B-DNALTR-	and	LTR-	NN	I-NP	I-DNAand	NF-kappa	and	CC	O	ONF-kappa	B-dependent	NF-kappa	NN	B-NP	OB-dependent	reporter	B-dependent	JJ	I-NP	Oreporter	genes	reporter	NN	I-NP	B-DNAgenes	;	gene	NNS	I-NP	I-DNA;	differences	;	:	O	Odifferences	in	difference	NNS	B-NP	Oin	NF-kappa	in	IN	B-PP	ONF-kappa	B-like	NF-kappa	NN	B-NP	OB-like	binding	B-like	JJ	I-NP	Obinding	activity	binding	NN	I-NP	Oactivity	were	activity	NN	I-NP	Owere	also	be	VBD	B-VP	Oalso	reflected	also	RB	I-VP	Oreflected	in	reflect	VBN	I-VP	Oin	higher	in	IN	B-PP	Ohigher	constitutive	high	JJR	B-NP	Oconstitutive	levels	constitutive	JJ	I-NP	Olevels	of	level	NNS	I-NP	Oof	NF-kappa	of	IN	B-PP	ONF-kappa	B-regulated	NF-kappa	NN	B-NP	B-DNAB-regulated	gene	B-regulated	JJ	I-NP	I-DNAgene	expression	gene	NN	I-NP	I-DNAexpression	in	expression	NN	I-NP	Oin	HIV-1-infected	in	IN	B-PP	OHIV-1-infected	myeloid	HIV-1-infected	JJ	B-NP	B-cell_typemyeloid	cells	myeloid	JJ	I-NP	I-cell_typecells	.	cell	NNS	I-NP	I-cell_type.	Presence	.	.	O	OPresence	of	Presence	NN	B-NP	Oof	estrogen-binding	of	IN	B-PP	Oestrogen-binding	sites	estrogen-binding	JJ	B-NP	B-DNAsites	on	site	NNS	I-NP	I-DNAon	macrophage-like	on	IN	B-PP	Omacrophage-like	synoviocytes	macrophage-like	JJ	B-NP	B-cell_typesynoviocytes	and	synoviocyte	NNS	I-NP	I-cell_typeand	CD8+	and	CC	O	OCD8+	","	CD8+	JJ	B-NP	O","	CD29+	","	","	I-NP	OCD29+	","	CD29+	JJ	I-NP	O","	CD45RO+	","	","	I-NP	OCD45RO+	T	CD45RO+	JJ	I-NP	B-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	in	lymphocyte	NNS	I-NP	I-cell_typein	normal	in	IN	B-PP	Onormal	and	normal	JJ	B-NP	Oand	rheumatoid	and	CC	I-NP	Orheumatoid	synovium	rheumatoid	JJ	I-NP	Osynovium	.	synovium	NN	I-NP	O.	OBJECTIVE	.	.	O	OOBJECTIVE	.	OBJECTIVE	NN	B-NP	O.	To	.	.	O	OTo	study	To	TO	B-VP	Ostudy	the	study	VB	I-VP	Othe	presence	the	DT	B-NP	Opresence	of	presence	NN	I-NP	Oof	estrogen-binding	of	IN	B-PP	Oestrogen-binding	sites	estrogen-binding	JJ	B-NP	B-DNAsites	(	site	NNS	I-NP	I-DNA(	EBS	(	(	O	OEBS	)	EBS	NN	B-NP	B-DNA)	in	)	)	O	Oin	the	in	IN	B-PP	Othe	synovial	the	DT	B-NP	Osynovial	tissues	synovial	JJ	I-NP	Otissues	of	tissue	NNS	I-NP	Oof	male	of	IN	B-PP	Omale	and	male	JJ	B-NP	Oand	female	and	CC	I-NP	Ofemale	patients	female	JJ	I-NP	Opatients	with	patient	NNS	I-NP	Owith	rheumatoid	with	IN	B-PP	Orheumatoid	arthritis	rheumatoid	JJ	B-NP	Oarthritis	(	arthritis	NN	I-NP	O(	RA	(	(	O	ORA	)	RA	NN	B-NP	O)	and	)	)	O	Oand	in	and	CC	O	Oin	age-	in	IN	B-PP	Oage-	and	age-	NN	B-NP	Oand	sex-matched	and	CC	O	Osex-matched	healthy	sex-matched	JJ	B-NP	Ohealthy	controls	healthy	JJ	I-NP	Ocontrols	.	control	NNS	I-NP	O.	METHODS	.	.	O	OMETHODS	.	METHODS	NNS	B-NP	O.	Both	.	.	O	OBoth	type	Both	CC	O	Otype	1	type	NN	B-NP	O1	(	1	CD	I-NP	O(	high	(	(	O	Ohigh	affinity	high	JJ	B-NP	Oaffinity	","	affinity	NN	I-NP	O","	low	","	","	O	Olow	binding	low	JJ	B-NP	Obinding	capacity	binding	NN	I-NP	Ocapacity	)	capacity	NN	I-NP	O)	and	)	)	O	Oand	type	and	CC	O	Otype	2	type	NN	B-NP	O2	(	2	CD	I-NP	O(	reduced	(	(	O	Oreduced	affinity	reduce	VBN	B-VP	Oaffinity	","	affinity	NN	B-NP	O","	higher	","	","	O	Ohigher	binding	high	JJR	B-NP	Obinding	capacity	binding	NN	I-NP	Ocapacity	)	capacity	NN	I-NP	O)	EBS	)	)	O	OEBS	were	EBS	NN	B-NP	Owere	investigated	be	VBD	B-VP	Oinvestigated	in	investigate	VBN	I-VP	Oin	both	in	IN	B-PP	Oboth	soluble	both	CC	B-NP	Osoluble	and	soluble	JJ	I-NP	Oand	nuclear	and	CC	I-NP	Onuclear	fractions	nuclear	JJ	I-NP	Ofractions	of	fraction	NNS	I-NP	Oof	homogenized	of	IN	B-PP	Ohomogenized	synovial	homogenize	VBN	B-NP	Osynovial	tissue	synovial	JJ	I-NP	Otissue	samples	tissue	NN	I-NP	Osamples	by	sample	NNS	I-NP	Oby	a	by	IN	B-PP	Oa	dextran-coated	a	DT	B-NP	Odextran-coated	charcoal	dextran-coated	JJ	I-NP	Ocharcoal	method	charcoal	NN	I-NP	Omethod	.	method	NN	I-NP	O.	To	.	.	O	OTo	determine	To	TO	B-VP	Odetermine	what	determine	VB	I-VP	Owhat	type	what	WP	B-NP	Otype	of	type	NN	I-NP	Oof	synovial	of	IN	B-PP	Osynovial	cell	synovial	JJ	B-NP	B-cell_typecell	was	cell	NN	I-NP	I-cell_typewas	positive	be	VBD	B-VP	Opositive	for	positive	JJ	B-ADJP	Ofor	EBS	for	IN	B-PP	OEBS	","	EBS	NN	B-NP	B-protein","	cryosections	","	","	O	Ocryosections	of	cryosection	NNS	B-NP	Oof	synovial	of	IN	B-PP	Osynovial	tissues	synovial	JJ	B-NP	Otissues	were	tissue	NNS	I-NP	Owere	immunostained	be	VBD	B-VP	Oimmunostained	with	immunostaine	VBN	I-VP	Owith	a	with	IN	B-PP	Oa	specific	a	DT	B-NP	Ospecific	monoclonal	specific	JJ	I-NP	Omonoclonal	anti-estrogen	monoclonal	JJ	I-NP	B-proteinanti-estrogen	receptor	anti-estrogen	JJ	I-NP	I-proteinreceptor	antibody	receptor	NN	I-NP	I-proteinantibody	(	antibody	NN	I-NP	I-protein(	anti-ER	(	(	O	Oanti-ER	MAb	anti-ER	JJ	B-NP	B-proteinMAb	)	MAb	NN	I-NP	I-protein)	using	)	)	O	Ousing	both	use	VBG	B-VP	Oboth	immunofluorescence	both	CC	O	Oimmunofluorescence	and	immunofluorescence	NN	B-NP	Oand	immunoperoxidase	and	CC	I-NP	Oimmunoperoxidase	techniques	immunoperoxidase	NN	I-NP	Otechniques	.	technique	NNS	I-NP	O.	Double	.	.	O	ODouble	immunostaining	Double	JJ	B-NP	Oimmunostaining	with	immunostaining	NN	I-NP	Owith	the	with	IN	B-PP	Othe	anti-ER	the	DT	B-NP	Oanti-ER	MAb	anti-ER	JJ	I-NP	B-proteinMAb	and	MAb	NN	I-NP	I-proteinand	with	and	CC	B-PP	Owith	specific	with	IN	B-PP	Ospecific	MAb	specific	JJ	B-NP	OMAb	to	MAb	NN	I-NP	B-proteinto	detect	to	TO	B-VP	Odetect	different	detect	VB	I-VP	Odifferent	macrophage	different	JJ	B-NP	Omacrophage	antigens	macrophage	NN	I-NP	B-proteinantigens	(	antigen	NNS	I-NP	I-protein(	Ber-MAC3	(	(	O	OBer-MAC3	","	Ber-MAC3	NN	B-NP	O","	MAC387	","	","	O	OMAC387	","	MAC387	NN	B-NP	B-protein","	CD68	","	","	O	OCD68	)	CD68	NN	B-NP	B-protein)	and	)	)	O	Oand	CD8+	and	CC	O	OCD8+	T	CD8+	JJ	B-NP	B-cell_typeT	cell	T	NN	I-NP	I-cell_typecell	subsets	cell	NN	I-NP	I-cell_typesubsets	(	subset	NNS	I-NP	I-cell_type(	CD29+	(	(	O	OCD29+	","	CD29+	NN	B-NP	O","	CD45RO+	","	","	I-NP	OCD45RO+	and	CD45RO+	NN	I-NP	Oand	CD29-	and	CC	I-NP	OCD29-	","	CD29-	NN	I-NP	B-protein","	CD45RO-	","	","	O	OCD45RO-	)	CD45RO-	NN	B-NP	B-protein)	was	)	)	O	Owas	performed	be	VBD	B-VP	Operformed	.	perform	VBN	I-VP	O.	RESULTS	.	.	O	ORESULTS	.	RESULTS	NNS	B-NP	O.	Higher	.	.	O	OHigher	affinity	High	JJR	B-NP	Oaffinity	EBS	affinity	NN	I-NP	OEBS	were	EBS	NN	I-NP	Owere	found	be	VBD	B-VP	Ofound	mostly	find	VBN	I-VP	Omostly	in	mostly	RB	B-ADVP	Oin	nuclear	in	IN	B-PP	Onuclear	cell	nuclear	JJ	B-NP	Ocell	fractions	cell	NN	I-NP	Ofractions	of	fraction	NNS	I-NP	Oof	either	of	IN	B-PP	Oeither	RA	either	CC	O	ORA	or	RA	NN	B-NP	B-proteinor	control	or	CC	O	Ocontrol	synovial	control	NN	B-NP	Osynovial	tissues	synovial	JJ	I-NP	Otissues	(	tissue	NNS	I-NP	O(	28	(	(	O	O28	of	28	CD	B-NP	Oof	the	of	IN	B-PP	Othe	33	the	DT	B-NP	O33	)	33	CD	I-NP	O)	.	)	)	O	O.	These	.	.	O	OThese	EBS	These	DT	B-NP	OEBS	were	EBS	NNP	I-NP	B-DNAwere	present	be	VBD	B-VP	Opresent	to	present	JJ	B-ADJP	Oto	a	to	TO	B-PP	Oa	lesser	a	DT	B-NP	Olesser	extent	less	JJR	I-NP	Oextent	in	extent	NN	I-NP	Oin	soluble	in	IN	B-PP	Osoluble	cell	soluble	JJ	B-NP	Ocell	fractions	cell	NN	I-NP	Ofractions	(	fraction	NNS	I-NP	O(	11	(	(	O	O11	of	11	CD	B-NP	Oof	the	of	IN	B-PP	Othe	33	the	DT	B-NP	O33	)	33	CD	I-NP	O)	.	)	)	O	O.	Immunostaining	.	.	O	OImmunostaining	showed	Immunostaining	NN	B-NP	Oshowed	the	show	VBD	B-VP	Othe	estrogen	the	DT	B-NP	Oestrogen	receptor-positive	estrogen	NN	I-NP	B-cell_linereceptor-positive	cells	receptor-positive	JJ	I-NP	I-cell_linecells	to	cell	NNS	I-NP	I-cell_lineto	be	to	TO	B-VP	Obe	the	be	VB	I-VP	Othe	macrophage-like	the	DT	B-NP	Omacrophage-like	synoviocytes	macrophage-like	JJ	I-NP	B-cell_typesynoviocytes	and	synoviocyte	NNS	I-NP	I-cell_typeand	the	and	CC	O	Othe	CD8+	the	DT	B-NP	OCD8+	","	CD8+	JJ	I-NP	O","	CD29+	","	","	I-NP	OCD29+	T	CD29+	JJ	I-NP	B-cell_typeT	cells	T	NN	I-NP	I-cell_typecells	both	cell	NNS	I-NP	I-cell_typeboth	in	both	CC	B-PP	Oin	RA	in	IN	B-PP	ORA	and	RA	NN	B-NP	Oand	in	and	CC	B-PP	Oin	control	in	IN	B-PP	Ocontrol	synovial	control	NN	B-NP	Osynovial	tissues	synovial	JJ	I-NP	Otissues	.	tissue	NNS	I-NP	O.	Higher	.	.	O	OHigher	nuclear	High	JJR	B-NP	Onuclear	content	nuclear	JJ	I-NP	Ocontent	of	content	NN	I-NP	Oof	EBS	of	IN	B-PP	OEBS	was	EBS	NN	B-NP	B-proteinwas	consistent	be	VBD	B-VP	Oconsistent	with	consistent	JJ	B-ADJP	Owith	more	with	IN	B-PP	Omore	intense	more	RBR	B-NP	Ointense	nuclear	intense	JJ	I-NP	Onuclear	staining	nuclear	JJ	I-NP	Ostaining	of	staining	NN	I-NP	Oof	synoviocytes	of	IN	B-PP	Osynoviocytes	and	synoviocyte	NNS	B-NP	B-cell_typeand	T	and	CC	O	OT	cells	T	NN	B-NP	B-cell_typecells	.	cell	NNS	B-NP	I-cell_type.	CONCLUSION	.	.	O	OCONCLUSION	.	CONCLUSION	NN	B-NP	O.	It	.	.	O	OIt	is	It	PRP	B-NP	Ois	conceivable	be	VBZ	B-VP	Oconceivable	that	conceivable	JJ	B-ADJP	Othat	the	that	IN	B-SBAR	Othe	immunomodulatory	the	DT	B-NP	Oimmunomodulatory	activity	immunomodulatory	JJ	I-NP	Oactivity	exerted	activity	NN	I-NP	Oexerted	by	exert	VBN	B-VP	Oby	estrogens	by	IN	B-PP	Oestrogens	is	estrogen	NNS	B-NP	Ois	at	be	VBZ	B-VP	Oat	least	at	IN	B-ADVP	Oleast	partly	least	JJS	I-ADVP	Opartly	mediated	partly	RB	B-VP	Omediated	through	mediate	VBN	I-VP	Othrough	their	through	IN	B-PP	Otheir	interaction	their	PRP$	B-NP	Ointeraction	with	interaction	NN	I-NP	Owith	EBS	with	IN	B-PP	OEBS	that	EBS	NN	B-NP	B-proteinthat	are	that	WDT	B-NP	Oare	present	be	VBP	B-VP	Opresent	on	present	JJ	B-ADJP	Oon	macrophage-like	on	IN	B-PP	Omacrophage-like	synoviocytes	macrophage-like	JJ	B-NP	B-cell_typesynoviocytes	","	synoviocyte	NNS	I-NP	I-cell_type","	functioning	","	","	O	Ofunctioning	as	function	VBG	B-VP	Oas	antigen-processing	as	IN	B-PP	Oantigen-processing	and	antigen-processing	JJ	B-NP	Oand	antigen-presenting	and	CC	I-NP	Oantigen-presenting	cells	antigen-presenting	JJ	I-NP	B-cell_typecells	","	cell	NNS	I-NP	I-cell_type","	and	","	","	B-PP	Oand	on	and	CC	I-PP	Oon	antigen-experienced	on	IN	B-PP	Oantigen-experienced	(	antigen-experienced	JJ	B-NP	B-cell_type(	memory	(	(	I-NP	I-cell_typememory	)	memory	NN	I-NP	I-cell_type)	CD8+	)	)	I-NP	I-cell_typeCD8+	T	CD8+	JJ	I-NP	I-cell_typeT	lymphocytes	T	NN	I-NP	I-cell_typelymphocytes	(	lymphocyte	NNS	I-NP	I-cell_type(	CD29+	(	(	O	OCD29+	","	CD29+	JJ	B-ADJP	O","	CD45RO+	","	","	O	OCD45RO+		CD45RO+	JJ	B-ADJP	O